id|nct_id|organization|name|phone|email|extension
20566984|NCT03062488|Nemours Children's Healthcare System|Carlos A. Archilla, MD|4076507646|carlos.archilla@nemours.org|
20566985|NCT00108355|VA-CT Healthcare System|Guadalupe Garcia-Tsao|203-932-5711|guadalupe.garcia-tsao@yale.edu|2210
20536596|NCT03744910|CSL Behring|Study Director|16108784000|clinicaltrials@cslbehring.com|
20536597|NCT01461499|Shiga University of Medical Science|Steering Committee: Takashi Uzu|81-77-548-2222|takuzu@belle.shiga-med.ac.jp|
20536598|NCT01747343|University of Kansas|Brian D. Greer, Ph.D.|386-852-7171|brian.greer@unmc.edu|
20536599|NCT00336284|Biotronik, Inc.|Justin Michalski, M.S. / Clinical Studies Engineer|503-675-2155|justin.michalski@biotronik.com|
20536600|NCT03308968|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20536601|NCT01432145|University of Oxford Clinical Trials & Research Governance|Ms Heather House|01865 572245|heather.house@admin.ox.ac.uk|
20536602|NCT00473889|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20536603|NCT04729972|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20551799|NCT01698463|University of Waterloo|Dr. Lora Giangregorio|(519) 888-4567|lmgiangr@uwaterloo.ca|36357
20551800|NCT02356783|Hospital for Special Surgery|Robert Griffin, MD, PhD|212-774-2944|griffinr@hss.edu|
20551801|NCT05123222|Center for Immunization Research|Anna Durbin|667-306-9772|adurbin1@jhu.edu|
20551802|NCT02608268|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20551803|NCT01925404|RAND|Deborah Cohen|310 3930411|dcohen@rand.org|
20551804|NCT02994732|Biomed Valley Discoveries|Associate Director of Translational Sciences|636-887-6429|Dknoerzer@biomed-valley.com|
20551805|NCT00706979|Medical University of South Carolina'|Matthew J. Carpenter|843-792-3974|carpente@musc.edu|
20551806|NCT01701115|HSS|Dr. Daniel Maalouf|(212) 606-1000|MaaloufD@HSS.EDU|
20551807|NCT01266460|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20551808|NCT00151320|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
20551809|NCT00909779|Sunovion|Respiratory Medical Director|1-866-503-6351||
20551810|NCT00629499|Sarah Cannon Research Institute|Director, Breast Cancer Research|615-329-7274|asksarah@scresearch.net|
20551811|NCT02738333|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20551812|NCT05413369|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20551813|NCT02809677|UT Southwestern Medical Center|Dr. E. Sherwood Brown|24-645-6950|sherwood.brown@utsouthwestern.edu|
20551814|NCT03165110|Ascensia Diabetes|Jane Wallace|(574) 850-1467|jane.wallace@ascensia.com|
20551815|NCT01335230|University of Cincinnati, Associate Prof., PI.|Mohamed Tarek M. shata|(513) 558-6110|mohamed.shata@uc.edu|
20551816|NCT01679002|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20551817|NCT03971188|Washington University in St. Louis|Dr. Charles Goldfarb|(314) 362-3768|goldfarbc@wustl.edu|
20551818|NCT05172544|Najít Technologies, Inc.|Dr. Ian Amanna|9717273569|iamanna@najittech.com|
20551819|NCT00612924|Terumo|Amanda Isula, Clinical Research Coordinator|800-262-3304|amanda.isula@terumomedical.com|5549
20551820|NCT00730912|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20566986|NCT01364597|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20566987|NCT03493282|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
20566988|NCT02038049|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20566989|NCT00667017|University of Texas Southwestern Medical Center|Larry Andeson, MD|214-648-7097||
20566990|NCT01823224|Womack Army Medical Center|Anthony R Plunkett, MD|910-907-6000|anthonyrplunkett@gmail.com|
20566991|NCT00587171|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H.|813-975-8690|pedig@jaeb.org|
20566992|NCT01303796|Cyclacel Ltd|Mark H. Kirschbaum MD|+1 908 517 7330|mkirschbaum@cyclacel.com|
20566993|NCT02148705|MediWound|Keren David Zarbiv|972-77-9714103|kerend@mediwound.com|
20566994|NCT02094534|Orange County Research Center|Joel M. Neutel, M.D., Study Director|714-550-9990|jmneutel@aol.com|
20536604|NCT01208324|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
20536605|NCT02978157|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20536606|NCT00694577|Massachusetts General Hospital|Alphonse Taghian|6177261160|ataghian@mgh.harvard.edu|
20536607|NCT00654836|Loyola University|Shelly S. Lo, M.D.|708-327-3154|shlo@lumc.edu|
20536608|NCT00700622|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20536609|NCT00383331|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20536610|NCT02253433|Environmental Health, Baylor College of Medicine|Dr. Winifred J. Hamilton|713-798-1052|hamilton@bcm.edu|
20536611|NCT01756573|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
20536612|NCT00807586|Minneapolis Heart Institute Foundation|Dr. Daniel Melby|612-863-3900|daniel.melby@allina.com|
20536613|NCT02229825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20536614|NCT00372619|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|ResultsReportingCoordinator@childrensoncologygroup.org|
20536615|NCT00066222|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20536616|NCT00405392|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536617|NCT02136004|Weill Cornell Medical College|S. Chiu Wong, MD|212-746-4644|scwong@med.cornell.edu|
20536618|NCT02689206|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20551821|NCT01335581|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20551822|NCT04311424|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20566995|NCT01737021|Imperial College London|Professor Elena Garralda|+44 (0)20 3312 6085|e.garralda@imperial.ac.uk|
20551823|NCT04351087|The Ohio State University|Dr. Michael Baria|614-293-8196|michael.baria@osumc.edu|
20566996|NCT01673594|Massachusetts General Hospital|Research Regulatory Coordinator|617-726-4651|apulli@mgh.harvard.edu|
20566997|NCT01711294|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
20566998|NCT02605174|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20536619|NCT02998671|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20536620|NCT04560686|UT MD Anderson Cancer Center|Dr. Tina Cascone,MD- Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 792-6363|tcascone@mdanderson.org|
20536621|NCT00595881|Children's Hospital of Pittsburgh|Jennifer Marin|412-692-7692|jennifer.marin@chp.edu|
20536622|NCT02131311|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
20536623|NCT01479764|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20536624|NCT02473471|Jordanian University of science and Technology|Dr.Amal Alkebsi|00966552358684|amalkibsi@gmail.com,aalkebsi13@den.just.edu.jo|
20536625|NCT03082677|Memorial Sloan Kettering Cancer Center|Dr. Doris Ponce, MD|646-608-3739|ponced@mskcc.org|
20536626|NCT00191945|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20536627|NCT02846792|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
20551824|NCT05517382|Yale University|Claudia-Santi Fernandes|203-785-2885|Claudiasanti.fernandes@yale.edu|
20551825|NCT02155647|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20551826|NCT00967993|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-379|medicalinfo@keryx.com|
20551827|NCT04418999|Illinois College of Optometry|Jennifer Harthan|3129497249|JHarthan@ico.edu|
20551828|NCT03525210|KU Leuven / UZ Leuven|Head of Leuven University Vaccinology Center|+32 16 321 078|luvac@kuleuven.be|
20551829|NCT01374087|Ipsen|Medical Director|use email|clinical.trials@ipsen.com|
20551830|NCT02461225|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
20551831|NCT00271947|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
20551832|NCT01786954|Duke Eye Center|Dr Paul Hahn|919-684-5631|paul.s.hahn@duke.edu|
20551833|NCT01522365|Dentsply Sirona Implants|Director Center of Clinical Research, AnnaKarin Lundgren|+46 (0)31 376 30 00|clinicalresearchmolndal@dentsplysirona.com|
20551834|NCT00651755|University of Texas MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||xzhou@mdanderson.org|
20551835|NCT04170348|CUIMC|Dr. Margaret T. Lee, Professor of Pediatric|212-305-6290|ml653@cumc.columbia.edu|
20551836|NCT01120756|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@va.gov|
20551837|NCT04026048|Memorial University of Newfoundland|Dr. Sheila Garland|(709) 864-4897|sheila.garland@mun.ca|
20551838|NCT00506155|University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
20551839|NCT01467947|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
20551840|NCT03616899|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results011@kalarx.com|
20551841|NCT02517996|Johns Hopkins University School of Medicine|Dr. Tola Fashokun|410-464-6641|bunmi_omo@hotmail.com|
20551842|NCT05104567|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20551843|NCT01464346|Medtronic Diabetes Clinical Research|Pamela Haworth||pamela.c.haworth@medtronic.com|
20551844|NCT02295995|Durham VA HCS|Dr. Katherine S. Hall|919-286-0411|katherine.hall@duke.edu|6734
20566999|NCT04250636|The Rockefeller University|Marina Caskey|2123277396|mcaskey@rockefeller.edu|
20567000|NCT01779050|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu|
20551845|NCT02124863|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@telenet.be|
20551846|NCT02005250|Odense Universitetshospital, afd.M|Prof. Steen Bonnema|+4527339180|steen.bonnema@rsyd.dk|
20551847|NCT04007094|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
20551848|NCT02653560|UT Southwestern Medical Center|Dr Wanpen Vongpatanasin|2146489078|wanpen.vongpatanasin@utsouthwestern.edu|
20551849|NCT03628703|Cincinnati Children's Hospital Medical Center|Steve W. Wu, M.D.|513-636-4222|steve.wu@cchmc.org|
20551850|NCT04350788|UNC-CH School of Nursing|Biostatistician|919-966-7181|peiran@live.unc.edu|
20551851|NCT01581307|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sarah Hoffe|813-745-4380|sarah.hoffe@moffitt.org|
20551852|NCT04994444|Brown University|Dr. Patricia Cioe|4018636638|patricia_cioe@brown.edu|
20551853|NCT02117999|Studio Italiano di Oftalmologia|Marco Lombardo|+39 331 34 38 300|mlombardo@visioeng.it|
20551854|NCT00378209|Dana-Farber Cancer Institute|Dr. Paul Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
20551855|NCT01894581|University of Colorado Denver|Dr. Alex Polotsky|303-724-2001|alex.polotsky@ucdenver.edu|
20551856|NCT03939897|Washington University in St. Louis School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
20551857|NCT03482791|Washington University School of Medicine|Gregory Vlacich, M.D., Ph.D.|314-362-8610|gvlacich@wustl.edu|
20551858|NCT01918761|Cecog|MD Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
20551859|NCT01816893|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
20551860|NCT01239368|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
20551861|NCT04709575|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20567001|NCT01353274|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20506239|NCT01096446|OSF Saint Francis Medical Center|Dr. Kamlesh Macwan|309-624-0611|kamlesh.s.macwan@osfhealthcare.org|
20536628|NCT02063984|Geisel School of Medicine at Dartmouth Center for Technology and Behavioral Health|Alan J. Budney, Ph.D|603-646-7088|alan.budney@dartmouth.edu|
20536629|NCT04175340|Bausch + Lomb Incorporated|Senior Manager, Clinical Trials|(585) 623-9588|Margaret.Swartzenberg@bausch.com|
20551862|NCT02145039|University of Minnesota Cancer Center|Dr. Claudio Brunstein|612-625-8942|bruns072@umn.edu|
20536630|NCT01958580|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio - Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
20536631|NCT02901249|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|51999185180|afbslima@gmail.com.br|
20536632|NCT01169701|Novartis Pharmaceuticals|Study Director|862-778-8300||
20551863|NCT03181399|Weill Cornell Medicine|Dr. Juan Pascual|(212) 746-3278|jup9003@med.cornell.edu|
20567002|NCT03648541|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20567003|NCT03068312|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
20567004|NCT00273052|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567005|NCT05005351|Swing Therapeutics, Inc.|Clinical Project Manager|1 (415) 662-0415|research@swingtherapeutics.com|
20567006|NCT01852045|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20567007|NCT02827201|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20521410|NCT03190330|Johnson & Johnson Private Limited|Sr. Medical Advisor|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20567008|NCT02736188|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20567009|NCT02630186|Clovis Oncology, Inc.|Elizabeth Bradley|1-415-409-5495|ebradley@clovisoncology.com|
20567010|NCT00439218|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
20567011|NCT03176407|Ovesco Endoscopy AG|Prof. Dr. T. Gottwald|0049707196528||160
20567012|NCT01482325|GE Healthcare|Global Research Manager|414 721 2423|Jeffrey.Conner@ge.com|
20567013|NCT01428583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567014|NCT01817491|Cleveland Clinic|Michael Macknin, MD|216 444-5512|macknim@ccf.org|
20567015|NCT00768755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567016|NCT00670488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567017|NCT02708498|Department of Health Sciences, Lund University|Professor Gerd Ahlström|+46702747767|gerd.ahlstrom@med.lu.se|
20567018|NCT01890954|University of Virginia|Daniel Chernavvsky|434-243-1395|drc2v@virginia.edu|
20567019|NCT03052517|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20567020|NCT00546156|Dana-Farber Cancer Institute|Dr Ian Krop|617-632-2335|ian.krop@dfci.harvard.edu|
20567021|NCT04263714|McMaster University|Dr. Stuart Phillips|9055259140|phillis@mcmaster.ca|24465
20567022|NCT05260437|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20567023|NCT00787176|Northwerstern University|Paloma Toledo|312-472-3585|p-toledo@northwestern.edu|
20567024|NCT05794191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567025|NCT02486939|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
20567026|NCT01485887|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567027|NCT04278755|University of North Carolina at Chapel Hill|Jessica Baker, PhD|984-974-3929|jhbaker@med.unc.edu|
20567028|NCT02108171|Guangzhou First People's Hospital, Affiliated Hospital of Guangzhou Medical College|Dr. Xiangcai Ruan|+8620-81048306|xc_ruan@hotmail.com|
20567029|NCT03418545|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20567030|NCT04864834|Sandoz|Clinical Disclosure Representative|+49 8024 / 908 0|sandoz.disclosure@sandoz.com|
20567031|NCT01676298|Spartan Bioscience Inc.|Dr. Chris Harder|613-228-7756|chris.harder@spartanbio.com|778
20567032|NCT01972776|Novartis|Study Director|862-778-8300||
20521411|NCT02081209|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20567033|NCT01607320|Greenville Health System|Bruce Lessey|864-455-1600|blessey@ghs.org|
20567034|NCT03784898|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20567035|NCT02356198|Mayo Clinic|Dr. Dorin T. Colibaseanu, MD|904-953-2596|colibaseanu.dorin@mayo.edu|
20506240|NCT01760993|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20506241|NCT04710862|Syracuse University|Dr. Soren Lowell|315-443-9615|slowell@syr.edu|
20536633|NCT02619591|UMASS Memorial Department of Emergency Medicine|Executive Vice Chairman|508-421-1400|Romolo.Gaspari@umassmemorial.org|
20536634|NCT02455336|James J. Peters VA Medical Center|Michael F. La Fountaine, EdD, ATC, FACSM|718-584-9000|michael.lafountaine@va.gov|3121
20536635|NCT00391430|NYU Langone|Marylene Cloitre|2122632471|marylene.cloitre@nyulangone.org|
20536636|NCT01574287|Emory University|Schuster, David|404-712-4859|dschust@emory.edu|
20536637|NCT00429182|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
20536638|NCT03497039|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20536639|NCT02781571|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20536640|NCT00861692|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20536641|NCT02122666|Washington University School of Medicine|Samantha Adamson, MD, PhD|314-362-3500|sadamson@wustl.edu|
20506242|NCT01520324|Cosmo Pharmaceuticals NV|Dr. Richard Jones|+353 18170370|RJones@cosmopharma.com|
20536642|NCT04201639|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20536643|NCT02712996|Vanderbilt University Medical Center|Michael Tramontana,PhD|615-327-7144|michael.tramontana@vumc.org|
20521412|NCT02370329|Mayo Clinic Arizona|Jeanne M. Palmer, MD|480/342-8000|palmer.jeanne@mayo.edu|
20567036|NCT03162614|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
20506243|NCT01328249|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
20506244|NCT00748553|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
20536644|NCT03693144|University of Michigan|Dr. Susan Woolford|734 615-8214|swoolfor@med.umich.edu|
20567037|NCT04638816|QMedAB|Clinical Project Manager|(817) 961-500|aestheticclinicaltrials@galderma.com|
20567038|NCT02251652|Icahn School of Medicine at Mount Sinai|Dr. Gary Goldenberg|212-241-9728|garygoldenbergmd@gmail.com|
20521413|NCT04616430|Atossagenetics|Dr. Steven Quay|206.419.4873|steven.quay@atossainc.com|
20521414|NCT02022748|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
20551864|NCT01536379|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551865|NCT02410382|University of Arizona|Dr. Sun K. Yi|(520) 694-7236|sunkyi@email.arizona.edu|
20567039|NCT00087022|Heidelberg Pharma AG (previously Wilex AG)|Head of R&D||info@hdpharma.com|
20567040|NCT01957163|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567041|NCT02422524|Duke University|Julius Wilder, MD, PhD|919-668-3063|julius.wilder@duke.edu|
20567042|NCT05200416|Coloplast A/S|Senior Clinical Strategy Project Manager|+4549111341|dkteaa@coloplast.com|
20567043|NCT04224272|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20567044|NCT02609048|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20567045|NCT04069247|Chinese University of Hong Kong|Dr. Yun Kwok Wing|+852 39197593|ykwing@cuhk.edu.hk|
20567046|NCT00604890|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
20567047|NCT02969356|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20567048|NCT02678455|University of Vermont|Beth Kirkpatrick MD|802-656-5822|beth.kirkpatrick@med.uvm.edu|
20567049|NCT03508700|Tonix Pharmaceuticals|Gregory Sullivan|(862) 904-0355|greg.sullivan@tonixpharma.com|
20567050|NCT04924608|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20567051|NCT04992273|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20567052|NCT03774849|Candela|Dr. Konika Patel Schallen|5083580357|cie.studyinfo@candelamedical.com|
20567053|NCT01380145|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20567054|NCT02698475|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20567055|NCT02771366|University of Florida|Adam Woods, Ph.D.|352-294-5842|ajwoods@phhp.ufl.edu|
20567056|NCT01363128|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD/ Professor|7137924764|ejabbour@mdanderson.org|
20567057|NCT02660086|Massachusetts General Hospital|Dr. Anne Thorndike, Prinicipal Investigator|6177244608|athorndike@mgh.harvard.edu|
20567058|NCT01653509|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506245|NCT00948818|Forest Research Institute|Paul F.C. Eng Ph.D Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
20567059|NCT00785798|Yale University School of Medicine|Francine Foss, MD||Francine.Foss@yale.edu|
20567060|NCT01214200|Temple University School of Medicine|Mark Weir, MBChB|215-707-5864|mark.weir@tuhs.temple.edu|
20567061|NCT00326196|Roudebush VAMC|Masoor Kamalesh, MD|317-988-2401|masoor.kamalesh@va.gov|
20567062|NCT03928743|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20567063|NCT02117310|The Ohio State University|Dr. Daniel Prevedello, Associate Professor|(614) 685-1965|daniel.prevedello@osumc.edu|
20567064|NCT00022672|Hoffman-LaRoche|Medical Communications|800-821-8590||
20567065|NCT00403494|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
20567066|NCT05005247|MinervaX|CMO|004553883002|LIO@minervax.com|
20567067|NCT01271244|VA NEBRASKA WESTERN IOWA VA HEALTHCARE|SRIRAM RAMASWAMY MD|4029954712|SRIRAM.RAMASWAMY@VA.GOV|
20567068|NCT04658784|Ascension Saint Thomas Medical Group|Dr. Amanda Merriman|615-397-6919|amanda.yacko@gmail.com|
20567069|NCT02958553|Ottobock Healthcare|Russ Lundstrom|512-806-2606|russ.lundstrom@ottobock.com|
20567070|NCT01083706|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
20567071|NCT01738698|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20567072|NCT02125292|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20567073|NCT01951703|Clinical Compliance Manager|Jurandir Araujo|904 443-1379|jaraujo7@jnj.com|
20567074|NCT01487954|Case Comprehensive Cancer Center AND Summa Health System|Dr. Charles A. Kunos, MD, PhD|(330) 375-3557|kunosc@summahealth.org|
20567075|NCT00240994|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20567076|NCT05124210|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20567077|NCT04220983|Weill Cornell Medicine|Sharanya Chandrasekhar|646-962-3110|shc2043@med.cornell.edu|
20506246|NCT00745368|University of Rochester|Robert DiCenzo|518 694 7228|rob.dicenzo@acphs.edu|
20506247|NCT02364947|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
20506248|NCT00423085|Novartis Pharmaceuticals|Study Director|862-778-8300||
20506249|NCT02405429|University of Iowa|Edward F. Bell, MD|319-356-4006|edward-bell@uiowa.edu|
20567078|NCT02124044|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
20506250|NCT00441441|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506251|NCT01725152|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
20506252|NCT00849121|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-265-8131|dm3@medicine.wisc.edu|
20506253|NCT02808312|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20506254|NCT01826422|IMSS|Dr. Maricela Rodriguez-Cruz|5256276900|maricela.rodriguez.cruz@gmail.com|. 22483
20506255|NCT05151471|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|908-607-1980|information@mt-pharma-us.com|
20506256|NCT04263142|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20506257|NCT03010423|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20551866|NCT02064907|Takeda Study Registration Call Center|Takeda|+1-877-825-3327|medicalinformation@tpna.com|
20567079|NCT03142932|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|(443) 287-2969|jgolub@jhmi.edu|
20551867|NCT00265473|Schulze Diabetes Institute, University of Minnesota|Melena D. Bellin, MD|612-625-4686|bell0130@umn.edu|
20536645|NCT01451749|Dongzhimen Hospital,Beijing University of Chinese Medicine|Dr.Jinzhou Tian|86-10-84013380|jztian@hotmail.com|
20551868|NCT06063603|Mayo Clinic|Andrea L. Cheville, MD|507-284-2511|cheville.andrea@mayo.edu|
20506258|NCT02236546|Vanderbilt-Ingram Cancer Center|Dr. Tom Yankeelov||thomas.yankeelov@utexas.edu|
20506259|NCT00312884|Imperial College london|Professor Cowie|0207 349 7716|m.cowie@imperial.ac.uk|
20506260|NCT00115349|UCL Cancer Institute|John Porter, MD, Principal Investigator|+011 (44) 207 679 6224|j.porter@ucl.ac.uk|
20506261|NCT04402008|Assertio Holdings|Howard Franklin, MD|224 419 7106|Hfranklin@assertiotx.com|
20506262|NCT05132569|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20506263|NCT03656926|Zambon S.p.A.|Enrica Bucchioni, M.D., PhD, Global Clinical Development Head|+39 02 665241|clinicaltrials@zambongroup.com|
20536646|NCT02227810|Chang Gung memorial hospital|Dr Huang Chung-Chi|88632118800|yhchen@mail.cgu.edu.tw|5233
20536647|NCT00972517|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506264|NCT00069095|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20506265|NCT02869854|RegionSkane|Mr Peter Nymberg|0705759810|peter.nymberg@med.lu.se|
20506266|NCT05610176|BIOTRONIK SE & Co. KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20506267|NCT03249792|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506268|NCT00216099|Hoosier Cancer Research Network|Jeff Smith|317-921-2050|jsmith@hoosiercancer.org|
20506269|NCT02902172|St. Louis University|Dr. Jennifer Goldkamp|3149772200|jen.goldkamp@health.slu.edu|
20506270|NCT01434472|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
20506271|NCT00138034|Radboud University Medical Center Nijmegen|Professor Doctor F.W.A. Verheugt|+31(0)24-3614533|f.verheugt@cardio.umcn.nl|
20506272|NCT00532948|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20506273|NCT01773135|Ain Shams University Maternity Hospital|Mohamed Saied Eldein El-Safty, Lecturer of Obstetrics and Gynecology Faculty of Medicine - Ain Shams|01003922211|dr.mai_elshahm@yahoo.com|002
20506274|NCT02702193|University of Miami|Victoria Mitrani|305 284-9139|vmitrani@miami.edu|
20506275|NCT04272216|Clinical Project Manager|Paige Gowen|908-208-3749|paige.gowen@terumomedical.com|
20506276|NCT01201798|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20506277|NCT05174039|Theranexus|Chief Medical Officer|0688941976|marie.sebille@theranexus.com|+33
20506278|NCT01734512|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD|(415) 502-7301|sabine.mueller@ucsf.edu|
20567080|NCT02128269|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
20567081|NCT00878189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567082|NCT00638456|Univeristy of California, San Diego|Dr. Ranjan Dohil|(858) 966-4003|rdohil@ucsd.edu|
20567083|NCT02007070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567084|NCT01640288|Duke University School of Medicine, Department of Radiology|H. Cecil Charles, Ph.D.|919-684-7921|cecil.charles@duke.edu|
20567085|NCT02234141|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20506279|NCT05692154|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20567086|NCT00895245|University of Washington|Dr. Keith Eaton|206-288-2048|kdeaton@uw.edu|
20506280|NCT02154750|UC San Diego Health|Gregory Feld, MD|(858) 246-2972|gfeld@health.ucsd.edu|
20567087|NCT02095678|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Vikas Gulani|+1 216-844-3312|Vikas.Gulani@UHhospitals.org|
20536648|NCT02311881|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536649|NCT04068948|University of Washington|Travis Nelson|206-543-0980|tmnelson@uw.edu|
20536650|NCT04704713|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
20551869|NCT04439253|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20506281|NCT01912729|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
20506282|NCT00904826|Mayo Clinic|Dr. Sean J. Pittock|507-284-4741|pittock.sean@mayo.edu|
20506283|NCT01429987|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
20506284|NCT03860311|UAB|Dr. Stephen Ruffenach|5202707665|stephenruffenach@gmail.com|
20551870|NCT03971695|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20521415|NCT00633243|Yale University|R. Douglas Bruce|(203) 737-6133|robert.bruce@yale.edu|
20521416|NCT02700386|University of Colorado, Denver|Christine Fisher, MD, MPH|720-848-0154|christine.fisher@cuanschutz.edu|
20567088|NCT00681109|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|(617) 573-4331|Reza_Dana@meei.harvard.edu|
20567089|NCT02706483|Bausch Health|Matt Markovich|908-541-1341|Matthew.Markovich@bauschhealth.com|
20567090|NCT04660799|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20567091|NCT02144597|Imperial College London|Prof Gary Frost|07872850308|g.frost@imperial.ac.uk|
20567092|NCT01228734|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20567093|NCT03672032|University of Iowa Hospitals and Clinics|Dr. Henning Gerke|319-384-6582|henning-gerke@uiowa.edu|
20567094|NCT00462072|University of Rochester|Rick Barrett|585-275-1647|rick_barrett@urmc.rochester.edu|
20536651|NCT03063606|Yale University|Dr. Carlos Grilo|203-785-7210|carlos.grilo@yale.edu|
20567095|NCT00407888|Medical Oncology University of Washington|Hannah Linden MD FACP|206-288-6989|hmlinden@uw.edu|
20536652|NCT01433042|Given Imaging Ltd.|Director of Clinical affairs|+972-4-9097774|Hila.Debby@givenimaging.com|
20567096|NCT00659373|IBCSG|Rudolph Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
20567097|NCT03042767|Emory University|Dr. Miriam Vos|404-727-5383|mvos@emory.edu|
20567098|NCT01934452|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567099|NCT02382640|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20567100|NCT01543204|Amgen Inc.|Study Director|866-572-6436||
20567101|NCT01220999|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20567102|NCT00603018|UCSD|Walter Kaye, MD/Director, Eating Disorders Program Professor, UCSD Department of Psychiatry|858- 534-8019|wkaye@ucsd.edu|
20567103|NCT01560429|Queen's University|Dr. Vidur Shyam|(613) 548-7827|shyamv@kgh.kari.net|
20567104|NCT02449902|TherapeuticsMD|Shelli Graham, PhD|561-961-1900|Shelli.Graham@TherapeuticsMD.com|
20567105|NCT01365546|Octapharma|Director of Clinical Operations|4152609577|sylvia.werner@octapharma.com|
20567106|NCT03326856|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
20567107|NCT02037568|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9277|biel@ucdenver.edu|
20567108|NCT00721734|Amgen, Inc.|Study Director|866-572-6436||
20567109|NCT05353296|Columbia University|Carmela Alcantara, PhD|212-851-2187|ca2543@cumc.columbia.edu|
20567110|NCT01074242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567111|NCT04889989|Ethicon, Inc.|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
20506285|NCT04285346|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20506286|NCT02432287|Albert Einstein College of Medicine|Erika Brutsaert|7188397961|erika.brutsaert@einstein.yu.edu|
20506287|NCT01975272|Maastricht University Medical Centre|Prof. dr. Roy Kruitwagen|0031-3874764|r.kruitwagen@mumc.nl|
20506288|NCT02915367|Massachusetts General Hospital|Jessica Haberer|617-643-9195|jhaberer@partners.org|
20506289|NCT00722553|Allos Therapeutics, Inc.|Medical Monitor|303-426-6262|gweems@allos.com|
20521417|NCT00379340|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20506290|NCT03259334|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20536653|NCT00848237|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
20536654|NCT02195700|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20506291|NCT00436215|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
20506292|NCT00309777|Kowa Research Europe, Ltd.|Neil Hounslow|01189229004|nhounslow@kowa.co.uk|
20506293|NCT00683475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20506294|NCT05138783|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20506295|NCT02429258|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|sergey.zhuplatov@astrazeneca.com|
20506296|NCT00554463|NRG Onocology|Wendy Seiferheld||wseiferheld@nrgonology.org|
20506297|NCT03364335|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
20506298|NCT03987919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20506299|NCT01247220|Retina Associates of Florida|Ivan J. Suner, MD|813-875-6373|ivansuner@gmail.com|
20506300|NCT03813719|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
20506301|NCT02330549|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20506302|NCT01156597|University of Miami Miller School of Medicine|Armando J. Mendez, Ph.D.|305-243-5342|a.mendez@miami.edu|
20506303|NCT02536170|Emory University|Claudia Morris|404-727-5500|claudia.r.morris@emory.edu|
20506304|NCT00853489|Saint Louis University|Dr. Lisa Kaye Cannada|3145778850|LCannada@slu.edu|7
20506305|NCT05525975|University of Iowa Health Care|Brendan Patterson|319 678-8451|brendan-patterson@uiowa.edu|
20506306|NCT02326467|Boston Children's Hospital|Celeste Chandonnet|781-216-0050|celeste.chandonnet@childrens.harvard.edu|
20506307|NCT04253834|Emory University|Dr. Jeffrey Miller|404-252-6104|jeffrey.miller@emory.edu|
20506308|NCT01392989|Stanford University|Everett Meyer, Assistant Professor of Medicine (Blood and Marrow Transplantation)|650) 725-5816|evmeyer@stanford.edu|
20506309|NCT01251276|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506310|NCT02658994|Human Development Research Foundation|Siham Sikander|+923330590373|sihamsikander@gmail.com|
20506311|NCT01051986|Seoul National University Hospital|Ki-Bong Kim|+82-2-2072-3482|kimkb@snu.ac.kr|
20506312|NCT00262080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20521418|NCT06378749|Pro-Change Behavior Systems, Inc.|Kerry E. Evers|4013602985|kevers@prochange.com|
20536655|NCT01963767|University of South Florida|Dr. Brent Small|813-974-9746|bsmall@usf.edu|
20536656|NCT02521974|FIDEC Corporationa|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
20521419|NCT04347122|KUMC|Kyle Sweeney, MD|913886100|ksweeney2@kumc.edu|
20521420|NCT05538065|Brigham and Women's Hospital|Niteesh Choudhry|617-278-0930|nkchoudhry@bwh.harvard.edu|
20521421|NCT04994483|Cassava Sciences, Inc.|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
20521422|NCT00112866|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
20521423|NCT01539135|Tulane University Hospital and Clinics|Dr. Sabrina Bent|5049887137|sabrina.bent@hcahealthcare.com|
20536657|NCT02949024|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20536658|NCT01082081|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551871|NCT04447417|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20506313|NCT02728258|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|gedeonl@nrgoncology.org|
20536659|NCT00670930|Novartis Pharmaceuticals|Study Director|862-778-8300||
20567112|NCT04278833|Stanford University|Clinical Research Coordinator|(650) 723-0003|jessn16@stanford.edu|
20506314|NCT03007485|Northwell Health|Dr. Negin Hajizadeh|516-600-1401|Nhajizadeh@northwell.edu|
20536660|NCT01042158|Johns Hopkins University|Paul Hassoun, MD|410-614-5158|phassoun@jhmi.edu|
20567113|NCT04186247|Amsterdam University Medical Center|Johan Van Limbergen, MD, PhD|+31-20 566 9111|j.e.vanlimbergen@amsterdamumc.nl|
20506315|NCT01848054|PRA International|Lynn R. Webster, MD|801-892-5140|LRWebsterMD@gmail.com|
20506316|NCT03580382|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
20506317|NCT02420223|Medical College of Wisconsin|Dr. Jennifer Knight|866-680-0505|jknight@mcw.edu|
20506318|NCT01361009|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20506319|NCT04549597|Ardelyx|David Rosenbaum|6175134929|drosenbaum@ardelyx.com|
20506320|NCT04009096|University of Oxford|Dr. Angela Minassian|01865611425|angela.minassian@ndm.ox.ac.uk|
20536661|NCT00921115|University of Kansas Cancer Center|Qamar Khan, MD|(913) 588-6029|QKHAN@kumc.edu|
20536662|NCT01575808|Toyko Jikei University Hospital|Dr. Takao Ohki|81-090-2478-8304|takohki@msn.com|
20551872|NCT01002755|The University of Texas M D Anderson Cancer Center|Ferrajoli,Alessandra M.D.|713-792-2063|aferrajo@mdanderson.org|
20506321|NCT01351077|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
20506322|NCT00520676|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20506323|NCT03568539|Innovent Biologics (Suzhou) Co., Ltd.|YiBo|+8613382419112|jessica.yi@innoventbio.com|
20506324|NCT03484923|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20506325|NCT03439748|UCLA|Dr. Michelle G. Craske|(310) 825-8403|mcraske@mednet.ucla.edu|
20506326|NCT03696758|UT Southwestern, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
20506327|NCT03298412|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20521424|NCT04228783|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521425|NCT00735306|Duke University|Dr. Brian Czito|919-668-7336|brian.czito@duke.edu|
20521426|NCT03002571|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20521427|NCT03151811|Oncopeptides AB|Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
20506328|NCT00803010|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-4673|Joseph.Pidala@moffitt.org|2556
20506329|NCT02780765|Tata Memorial Hospital, Mumbai|Dr Vijaya Patil|+91-2224177000|vijayappatil@yahoo.com|7048
20506330|NCT01028651|United Therapeutics Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
20506331|NCT01533935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20506332|NCT05631548|The University of Texas Health Science Center at Houston|Heather Webber, PhD|713-486-2723|Heather.E.Webber@uth.tmc.edu|
20506333|NCT02935634|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20506334|NCT04075266|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20506335|NCT01554956|Kedrion SpA|Clinical Trial Manager|+39 05831969231|a.lotti@kedrion.com|
20506336|NCT00913978|Northwestern University|Meltem Yilmaz, MD|312-695-0061|m-yilmaz@northwestern.edu|
20506337|NCT00210158|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20506338|NCT04716933|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20506339|NCT01327651|Fred Hutchinson Cancer Research Center|Maoji Li (Statistical Research Associate)|2066676035|mli2@fredhutch.org|
20506340|NCT03484533|Makerere University Infectious Diseases Institute|Andrew Mujugira|206 520 3800|mujugira@uw.edu|
20506341|NCT01842308|Mayo Clinic|Suzanne R. Hayman, M.D|(855) 776-0015|hayman.suzanne@mayo.edu|
20506342|NCT00370695|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20506343|NCT02913222|Washington University School of Medicine|Marcie Harris-Hayes, PT, DPT, MSCI, Professor, Physical Therapy and Orthopaedic Surgery|314-286-1435|harrisma@wustl.edu|
20506344|NCT00809458|UNM Cancer Center|Richard Lauer, MD|505-925-0390|rlauer@salud.unm.edu|
20506345|NCT01507584|ucsdmed|Eunice Williams-Steppe|8588221133|emwilliamssteppe@ucsd.edu|
20506346|NCT03521687|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
20506347|NCT02458690|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, PhD., Principal Investigator|317-274-6761|jstew@iupui.edu|
20506348|NCT01040208|Sprout Pharmaceuticals|Krista Barbour|9198820850|kbarbour@sproutpharma.com|
20506349|NCT03609359|National Cancer Center Hospital East|Dr.Kohei Shitara|(+81)-4-7133-1111|LenvaPembro_core@east.ncc.go.jp|91520
20506350|NCT01716468|VA Pittsburgh Healthcare System|Jocelyn Tan, MD|412-360-6178|Jocelyn.Tan@va.gov|
20506351|NCT00610935|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20506352|NCT00740779|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
20506353|NCT03220048|hVIVO|Tim Sharpington|02071480862|t.sharpington@hvivo.com|
20506354|NCT02399813|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
20521428|NCT00054665|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
20506355|NCT03345836|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20506356|NCT01167595|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
20506357|NCT01915849|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20506358|NCT00619684|Fred Hutchinson Cancer Research Ctr|Dr. William Bensinger|2066674730|wbensing@fredhutch.org|
20506359|NCT03403504|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
20506360|NCT02761993|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
20506361|NCT01842620|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506362|NCT00488033|Intermountain Heart Institute|J.Brent Muhlestein|8015074702|jbrent.muhlestein@imail.org|
20506363|NCT01515306|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20506364|NCT04973228|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20521429|NCT01085734|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
20506365|NCT03566108|University of Alabama at Birmingham|Dr. Maria Geisinger, PI, Professor, Director of Advanced Education in Periodontology|205-934-4984|miagdds@uab.edu|
20506366|NCT05299983|UC San Diego|Andrea LaCroix|(858) 822-0627|alacroix@ucsd.edu|
20506367|NCT02614287|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20506368|NCT02891798|VA Pittsburgh Health System, and University of Pittsburgh|Brian A. Williams, MD, MBA|412-360-1602|brian.williams6@va.gov|
20506369|NCT02294318|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
20506370|NCT01694420|Duke University Medical Center|Mehri McKeller, MD|919-668-0242|kara.mcgee@duke.edu|
20506371|NCT03725202|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20506372|NCT00495495|Indiana University School of Dentistry|Domenick T. Zero, DDS MS Principal Investigator|317-274-8822|dzero@iupui.edu|
20506373|NCT02702518|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
20506374|NCT03331666|Columbia University Irving Medical Center|Dr. Nan Wang|212-342-1761|nw30@cumc.columbia.edu|
20506375|NCT00434512|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506376|NCT01575197|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
20506377|NCT03303092|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20506378|NCT00050986|University of Texas, M. D. Anderson Cancer Center|W.K. Yung,MD/Clinical Professor, Neuro-Oncology|(713) 794-1285|wyung@mdanderson.org|
20506379|NCT03222076|MD Anderson Cancer Center|Dr. Ahmed Kaseb|(713) 792-2828|akaseb@mdanderson.org|
20506380|NCT00833248|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20506381|NCT01030458|University of Leuven|Prof. Dr. Jan A Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
20506382|NCT00208494|DePuy Orthopaedics, Inc.|Jennifer Hoag, MS, Project Leader, Clinical Research|574-372-7399|JHoag2@its.jnj.com|
20506383|NCT00411788|Yale University|Abu-Khalaf, Maysa|(203) 785-4095|maysa.abu-khalaf@yale.edu|
20536663|NCT02025634|AdventHealth|Brad Homan|407-303-4270|Brad.Homan.MD@AdventHealth.com|
20536664|NCT01527045|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fredhutch.org|
20506384|NCT02874404|University of Nebraska Medical Center|Dr. Matthew Lunning, DO, Associate Professor|402-559-7164|mlunning@unmc.edu|
20506385|NCT00995345|ActivX Biosciences|Dr. Diane Plotkin, Sr. Director Clinical Development|858-558-5558|dianep@activx.com|
20506386|NCT05122650|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20506387|NCT04026412|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20536665|NCT03280303|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506388|NCT00830037|Indiana University School of Medicine & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
20506389|NCT00660504|Cancer Hospital of Chinese Academy of Medical Sciences|Dr.Sunyan|86-10-87788519|suny@csco.org.cn|
20506390|NCT02439281|U Pittsbutgh, UPMC Children's Hospital|Mihaela Visoiu|4126925260|visoium@upmc.edu|
20506391|NCT03392753|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
20506392|NCT03280550|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20506393|NCT03115801|Weill Cornell Medicine|Sharanya Chandrasekhar|6469623110|shc2043@med.cornell.edu|
20506394|NCT02188121|McLean Hospital|Dr. Dost Ongur|617 855 3922|dongur@partners.org|
20506395|NCT00222729|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
20506396|NCT02775864|Columbia University|Dr. Scott Stroup|646-774-8435|Scott.Stroup@nyspi.columbia.edu|
20506397|NCT02028338|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
20506398|NCT02094586|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
20506399|NCT00256867|GlaxoSmithKline|GSK Response Center|866-435-7343||
20521430|NCT02651259|Family Health International (FHI 360|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20521431|NCT00123474|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20521432|NCT00616629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20521433|NCT01963143|Bio Products Laboratory|Head of Medical Information|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
20521434|NCT00742924|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20521435|NCT00660400|H. Lee Moffitt Cancer Center and Research Institute|Teresa Field, M.D., Ph.D.|813-745-7202|teresa.field@moffitt.org|
20521436|NCT03149445|Saniona A/S|Janus Schreiber Larsen|+457070 5225|janus.larsen@saniona.com|
20521437|NCT05594264|University of Delaware|Dr. Yendelela Cuffee|(302) 831-1302|ylcuffee@udel.edu|
20521438|NCT02699060|IMSechenovMMA|MD, PhD Ivashkin Vladimir Trofimovich|+79252667987|motility_2013@mail.ru|
20521439|NCT01045135|Akershus University Hospital|Dr.Jette Stær-Jensen, Dr. Franziska Siafarikas|+47-6796000|jett@ahus.no|
20521440|NCT04916444|University of Florida Norman Fixel Institute for Neurological Diseases|Dr. Jun Yu|352-294-5400|jun.yu@neurology.ufl.edu|
20521441|NCT04005352|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20521442|NCT06017479|Department of Urology, Faculty of Medicine University of Indonesia - Cipto Mangunkusumo General Hospital|Prof. dr. Harrina Erlianti Rahardjo, Sp.U(K), PhD|+62 816-825-226|harrinaerlianti@gmail.com|
20551873|NCT00702403|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
20521443|NCT05005312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521444|NCT01283035|DFCI|Joyce Liu, MD, MPH|617-632-5269|joyce_liu@dfci.harvard.edu|
20521445|NCT02421224|University of California, San Francisco|Dr. Justin S. White|415-476-8045|justin.white@ucsf.edu|
20521446|NCT02695537|University of Alabama at Birmingham|Dr. Martina Bebin, MD|205-934-3866|ebebin@uab.edu|
20521447|NCT02792699|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20506400|NCT01442129|Mount Sinai|Deborah D. Ascheim, MD, Associate Professor, Clinical Director of Research, InCHOIR|212-659-9567|deborah.ascheim@mountsinai.org|
20506401|NCT00041717|Acorda Therapeutics, Inc.|Andrew Blight, Ph.D. Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
20506402|NCT00527111|US Oncology Network, McKesson Specialty Health|Dr. David McCollum|214-370-1080|david.mccollum@usoncology.com|
20506403|NCT02993224|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20506404|NCT01930799|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20506405|NCT02916498|Boston Scientific|Director, Clinical Sciences and Scientific Communication|855-213-9890|BSNClinicalTrials@bsci.com|
20506406|NCT00875017|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20506407|NCT02689219|IndianaU|Dr. Nabil Adra|(317) 944-5349|nadra@iu.edu|
20521448|NCT04420273|Northwestern University Feinberg School of Medicine|Dr. June Robinson|3129433703|june-robinson@northwestern.edu|
20521449|NCT03870477|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574-371-9784|ryan.boylan@zimmerbiomet.com|
20521450|NCT02849938|Billings Clinic|Patricia M Notario, MD|406-238-2143|pnotario@billingsclinic.org|
20521451|NCT02256436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521452|NCT02174432|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
20521453|NCT02970318|Astrazeneca Clinical Trial|Study Director|1-888-292-9613|information.center@astrazeneca.com|
20521454|NCT01222286|Innate Pharma|Dr Renaud Buffet|33 4 30 30 30 32|renaud.buffet@innate-pharma.fr|
20521455|NCT02500641|A. Menarini Industrie Farmaceutiche Riunite SrL|Post-Registration Clinical Trial Responsible|+39 055 5680459|pfabrizzi@menarini.it|
20521456|NCT03233230|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20521457|NCT00475150|University of Wisconsin Comprehensive Cancer Center|Mark B. Juckett, MD||mbj@medicine.wisc.edu|
20521458|NCT01584843|GlaxoSmithKline|GSK Response Center|866-435-7343||
20521459|NCT04126213|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20521460|NCT00392236|Feinstein Institute for Medical Research|Delbert Robinson, M.D.|718 470-8195|drobinso@nshs.edu|
20521461|NCT02196701|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20521462|NCT03275064|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20521463|NCT02829294|Eosera Inc|Joseph Griffin PhD|8447327929|info@eosera.com|
20521464|NCT00620555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536666|NCT00948857|Center for Human Reproduction|Dr. Norbert Gleicher|212-994-4400|ngleicher@thechr.com|
20536667|NCT03430843|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20521465|NCT03796039|University of New Brunswick|Dr. Danielle Bouchard|(506) 443-3908|dboucha1@unb.ca|
20521466|NCT01140503|Stanford University Department of Dermatology|David Fiorentino|650-721-7160|fiorentino@stanford.edu|
20521467|NCT00750308|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
20521468|NCT00513682|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20536668|NCT03452033|D. Western Therapeutics Institute|Shigenobu Nakazora|+81-52-218-8785|shinakazora@dwti.co.jp|
20521469|NCT04156620|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20521470|NCT02450526|Ipsen|Medical Director||clinical.trials@ipsen.com|
20521471|NCT01672970|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20521472|NCT04568031|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20521473|NCT04874636|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20521474|NCT01770392|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20521475|NCT00228423|University Of Ottawa Heart Institute|Dr. Marc Ruel||mruel@ottawaheart.ca|
20521476|NCT03401450|NYU Langone|Dr. Prianka Desai|212-263-5072|prianka.desai@nyulangone.org|
20521477|NCT02642536|VA|Dr. Gina Evans|713-440-4459|gina.evans@va.gov|
20521478|NCT00030992|National Cancer Institute, National Institutes of Health|Tito Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
20521479|NCT01233921|Fred Hutchinson Cancer Research Cetner|Dr. Paul J. Martin|206-667-4798|pmartin@fhcrc.org|
20521480|NCT03258853|Massachusetts General Hospital|Dr. Melissa Putman|617-726-1847|msputman@mgh.harvard.edu|
20521481|NCT03567382|University of North Carolina at Chapel Hill|Peyton Thompson, MD, MSCR|919-445-0854|peyton_thompson@med.unc.edu|
20521482|NCT00786994|Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Tübingen, Germany|Dr Annette Pflugfelder||annette.pflugfelder@med.uni-tuebingen.de|
20521483|NCT02011386|Rigshospitalet, Denmark|Professor Mikkel Østergaard, MD, PhD, DMSc|+45 38633014|mo@dadlnet.dk|
20521484|NCT04555720|Duke University Medical Center|Kyle Mitchell, MD|919-668-2879|kyle.mitchell@duke.edu|
20521485|NCT03753763|Zambon S.p.A.|Director of Clinical Trial - Charlotte Keywood, MD|+39 02 665241|charlotte.keywood@zambongroup.com|
20521486|NCT00719849|Fred Hutchinson Cancer Research Center|Dr. Colleen Delaney|2066671385|cdelaney@fredhutch.org|
20521487|NCT06219278|Candela|Katherine Coleman|508-358-7400|katherinec@candelamedical.com|28533
20521488|NCT02201290|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20521489|NCT03907462|University of California, San Diego|Dr. Job Godino|6195152344|jobg@fhcsd.org|2344
20521490|NCT03589768|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-5328|kneuzil@medicine.umaryland.edu|
20521491|NCT04663295|Medtronic MiniMed|Senior Statistician|+18185764034|dz.dai@medtronic.com|
20521492|NCT00554190|Carbylan BioSurgery Inc.|Marcee Maroney, VP Clinical Affairs|650 855 6774|mmaroney@carbylan.com|
20521493|NCT02087995|Dexcom, Inc|Andrew Balo/ EVP|8582000203|abalo@dexcom.com|
20536669|NCT05360966|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
20506408|NCT03342469|American University|Dr. Kathleen Holton|(202) 885-3797|holton@american.edu|
20536670|NCT04439539|Janssen Research & Development, LLC|Senior Director Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20506409|NCT01477892|Seoul National University Hospital|Pf. Han-suk Kim|+82-2-2072-0647|kimhans@snu.ac.kr|
20506410|NCT01452126|UNM Department of Anesthesiology|Dr Tim Petersen|5052722610|timpetersen@salud.unm.edu|505
20506411|NCT01921257|Circassia Ltd|VP Clinical Operations|+44 1864 405560||
20506412|NCT01081223|TVAX Biomedical, Inc.|Gary Wood PhD|913-961-1327|gwood@tvaxbiomedical.com|
20506413|NCT00363805|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
20506414|NCT05515601|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20506415|NCT01689207|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
20521494|NCT01502410|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20536671|NCT01477710|University of Cincinnati|Richard Branson|513-558-6785|bransonrd@uc.edu|
20536672|NCT05258890|Brigham and Women's Hospital|Amar Dhand, MD, PhD|617-732-7432|adhand@bwh.harvard.edu|
20536673|NCT02351063|Alere, Inc.|William Arnold, PhD|8588053177|william.arnold@alere.com|
20536674|NCT03372434|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|EThoma39@its.jnj.com|
20536675|NCT05516797|HealthPartners Institute|Holly Willis|952-993-3219|holly.willis@parknicollet.com|
20536676|NCT05959447|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20536677|NCT01282242|Massachusetts General Hospital|Lee H. Schwamm, MD|617-724-1597|lschwamm@mgh.harvard.edu|
20536678|NCT00500357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20536679|NCT02263326|Northwestern University|Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
20536680|NCT01893411|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20536681|NCT00566982|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20536682|NCT00161616|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20536683|NCT00854724|BPRL, McLean Hospital|David M. Penetar|617-855-2913|dpenetar@mclean.harvard.edu|
20536684|NCT00879034|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
20536685|NCT00933608|NYU School of Medicine|Lidia Glodzik|212.263.5698|Lidia.Glodzik@nyumc.org|
20536686|NCT02159898|Merit Medical, Inc|Casey Holland|7816817983|casey.holland@merit.com|
20536687|NCT01498744|Ann and Robert H. Lurie Children's Hospital of Chicago|Katherine A Barsness|3122274210|kbarsness@luriechildrens.org|
20536688|NCT01861704|InSound Medical, Newark, California|Tanya Arbogast, Study Principal Investigator|510-792-4000|Srikant.Mantha@phonak.com|
20536689|NCT03654040|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20536690|NCT01475643|Valeant Pharmaceuticals NA|Denise Raimondo|9089721885|denise.raimondo@valeant.com|
20536691|NCT02008942|PLx Pharma|Ronald Zimmerman, President & CEO|713-842-1249|ron.zimmerman@plxpharma.com|205
20536692|NCT03415581|New York State Psychiatric Institute|Jermaine Jones PhD|6467746113|jermaine.jones@nyspi.columbia.edu|
20536693|NCT04918381|Pulse Biosciences, Inc.|William Knape / VP, Clinical, Regulatory and Quality Affairs|919-757-2033|bknape@pulsebiosciences.com|
20551874|NCT01341600|University of Maryland School of Medicine|Richard Horenstein M.D., Associate Professor of Medicine|410-706-0154|rhorenst@medicine.umaryland.edu|
20551875|NCT00858442|coaniquem|M Beatriz Quezada.MD|56-2-28734077|investigacion@coaniquem.cl|
20551876|NCT01280552|ImmunoCellular Therapeutics Ltd.|Anthony Gringeri, Ph.D. Senior Vice President Strategic Resources|818 264 2300|anthony.gringeri@imuc.com|
20551877|NCT02155738|University of Pittsburgh|Halina Zyczynski|412-641-1440|hzyczynski@mail.magee.edu|
20551878|NCT02016625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551879|NCT03303404|University of Texas at Austin|Brandon Fico|512-471-8594|bfico@utexas.edu|
20551880|NCT02953990|Virginia Commonwealth University School of Nursing|Patricia Kinser, PI|804-828-0724|kinserpa@vcu.edu|
20521495|NCT05958888|University of North Carolina at Chapel Hill|Marissa Hall, PhD|(919) 445-1310|mghall@unc.edu|
20521496|NCT00699283|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20521497|NCT00805675|Novartis Pharmaceuticals|Study Director|862-778-8300||
20521498|NCT02771795|Samsung Bioepis Co., Ltd.|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20521499|NCT03929757|Janssen Vaccines & Prevention B.V.|Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521500|NCT00114166|NRG Oncology, Statistics and Data Management Center - Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
20521501|NCT01154816|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20521502|NCT04715932|Montreal Heart Institute|Dr Jocelyn Dupuis (Principal Investigator)|514 376-3330|jocelyn.dupuis@icm-mhi.org|3477
20521503|NCT02393248|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20521504|NCT03560986|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
20521505|NCT02603393|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20521506|NCT01868893|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20521507|NCT01857271|Albert Einstein Cancer Center|Dr. Haiying Cheng|718-405-8404|hcheng@montefiore.org|
20521508|NCT01783548|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20521509|NCT03825341|St. Jude Children's Research Hospital|Jeremie Estepp, MD|(901) 595-5703|jeremie.estepp@stjude.org|
20506416|NCT01912768|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20521510|NCT00110136|Wake Forest CCOP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20536694|NCT01309997|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
20536695|NCT00282087|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
20536696|NCT03226249|Northwestern University, Feinberg School of Medicine|Jane N. Winter, M.D.|(312) 695-4538|j-winter@northwestern.edu|
20536697|NCT01532921|Medtronic, Bakken Research Center Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen|+3143356 6566|ber.kleijnen@medtronic.com|
20536698|NCT01260688|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
20536699|NCT02579421|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
20536700|NCT02767869|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
20536701|NCT04301934|Mayo Clinic|Johnny Yi, M.D.|480-342-0612|Yi.Johnny@mayo.edu|
20551881|NCT00380978|Department of Anesthesiology; Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
20536702|NCT03125031|Masimo|Tala Harake||studies@masimo.com|
20551882|NCT00824044|Massachusetts General Hospital|Dr. Amy Farabaugh|617-726-1629|afarabaugh@partners.org|
20536703|NCT03660865|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
20536704|NCT05141708|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536705|NCT01703091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20536706|NCT02550288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20536707|NCT02888691|Steno Diabetes Center Copenhagen|Dr Signe Schmidt|+4551174785|signe.schmidt@regionh.dk|
20536708|NCT05420961|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20551883|NCT02189473|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
20536709|NCT00803361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20551884|NCT04608500|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20551885|NCT01881230|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20536710|NCT04660552|JelikaLite Corp|Katya Sverdlov, Chief Executive Officer|9175668151|katya@jelikalite.com|
20536711|NCT00470262|Denver VA Medical Center|Dr. Neda Rasouli|303-399-8020|neda.rasouli@ucdenver.edu|4314
20506417|NCT00088634|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20536712|NCT04855240|Acadia Pharmaceuticals Inc.|Study Director|844-422-2342|medicalinformation@acadia-pharm.com|
20506418|NCT02426658|Wake Forest University Health Sciences|Study Nurse|336-716-2121|saverill@wakehealth.edu|
20506419|NCT00524316|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20506420|NCT01199263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|linda.gedeon@roswellpark.org|
20506421|NCT00634244|ECOG Statistical Office|Study Statistician|617-632-3012||
20506422|NCT02467387|CardioCell, LLC|Sergey Sikora, President and CEO|760-315-0861|SSIKORA@STEMCARDIOCELL.COM|
20506423|NCT02330627|University of California, San Diego|Dr. Charles Taylor|8585349446|c1taylor@ucsd.edu|
20506424|NCT03453151|Duke University|Marat Fudim|(919) 681-5816|marat.fudim@duke.edu|
20506425|NCT02227329|Mayo Clinic|Dr. Ryan Hurt|507-284-4461|Hurt.Ryan@mayo.edu|
20521511|NCT00459121|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|313-576-8753|sgadgeel@med.umich.edu|
20521512|NCT04540406|Notitia Biotechnologies|Clinical Research Associate|732-230-3175|ciarra.williams@notitiabio.com|
20521513|NCT03875859|Stanford University|Kavita Yang Sarin|650-804-2899|ksarin@stanford.edu|
20521514|NCT04053465|University at Buffalo|Dr. Riana Pryor|7168295456|rpryor@buffalo.edu|
20521515|NCT02885181|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20521516|NCT03317834|Smith+Nephew, Inc.|Helena Kyriakou|+1 8186995700|Helena.Kyriakou@smith-nephew.com|
20521517|NCT00996775|Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System|Michael A. Cucciare, Ph.D.|501-257-1068|michael.cucciare@va.gov|
20521518|NCT01517373|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536713|NCT02812238|NHLBI|Dr. Michael N. Sack|301-402-9259|sackm@nih.gov|
20536714|NCT03902392|University of Bari|Thea TM Magrone, BD|+39 080 5478584|thea.magrone@uniba.it|
20536715|NCT03799952|University of New Brunswick|Dr. Danielle Bouchard|1 (506) 443-3908|danielle.bouchard@unb.ca|
20536716|NCT03248167|NYU Langone Health|Charles Marmar, MD|646-754-4855|Charles.marmar@nyumc.org|
20536717|NCT01107392|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20536718|NCT00851552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20536719|NCT00177294|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
20536720|NCT01536561|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551886|NCT00112502|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Chair Ad Interim, Neuro-Oncology|713-745-3072|jdegroot@mdanderson.org|
20521519|NCT04015908|University of Utah|Dr. Jeffrey D. Swenson|801-581-6393|jeff.swenson@hsc.utah.edu|
20521520|NCT03490344|Memorial Sloan Kettering Cancer Center|Dr. Sham Mailankody, MBBS|646-608-3712|mailanks@mskcc.org|
20521521|NCT04154631|Department of Psychology, University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
20521522|NCT01441947|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-643-5415|sisakoff@partners.org|
20521523|NCT03384654|Janssen-Cilag International NV|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521524|NCT02927366|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20536721|NCT01030952|Novartis Pharmaceuticals|Study Director|+1-800-244-7668||
20536722|NCT02467192|Hopitaux Universitaires de Geneve|Dr Jerome Stirnemann|+41223729101|jerome.stirnemann@hcuge.ch|
20506426|NCT02592629|Penn State Hershey Medical Center|Robert Gallo, M.D.|7175310003|rgallo@pennstatehershey.psu.edu|289222
20536723|NCT00958347|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
20536724|NCT01603043|Alcon Research, Ltd.|Yamini Patel, PhD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20536725|NCT02591472|University of Florida|MaryBeth Horodyski, EdD|352-273-7074|horodmb@ortho.ufl.edu|
20536726|NCT05111002|University of Washington|Lisa E Manhart|206-744-3646|lmanhart@uw.edu|
20536727|NCT00809926|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536728|NCT02530476|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/Associate Professor|713-794-4392|NDaver@mdanderson.org|
20536729|NCT02870985|Fuwai Hospital|Prof. Yuejin Yang|008613701151408|yangyjfw@126.com|
20536730|NCT00343564|Cytokinetics,Inc.|Project Manager|650-624-2918||
20536731|NCT03913013|UCLA Semel Institute for Neuroscience and Behavior|David J. Miklowitz, Ph.D., Principal Investigator|(310) 267-2659|dmiklowitz@mednet.ucla.edu|
20521525|NCT00724048|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20536732|NCT04776720|University of California, San Francisco|Alison Huang, MD, MAS, MPhil|415-353-7900|alison.huang@ucsf.edu|
20551887|NCT00834210|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20551888|NCT00914810|Minneapolis VA Health Care System|Ken Kunisaki, M.D.|612-467-4400|kunis001@umn.edu|
20551889|NCT02747420|NYU Langone Health|Dr. Benjamin Brucker|+1 646 825 6300|Benjamin.Brucker@nyulangone.org|
20521526|NCT00587990|EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@emmes.com|221
20521527|NCT00206323|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
20521528|NCT03334617|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20521529|NCT03657342|Zambon SpA|Enrica Bucchioni, MD, PhD, Global Clinical Development Senior Director|+3902665241|clinicaltrials@zambongroup.com|
20521530|NCT00827632|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
20551890|NCT05129488|Bausch & Lomb|Study Director|15853386399|robert.steffen@bausch.com|
20551891|NCT00706641|Hoosier Cancer Research Network, Inc.|Noah Hahn, MD|317-921-2050|jsmith@hoosiercancer.org|
20551892|NCT03684512|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
20551893|NCT04782856|Uconn Health|Francesco S. Celi, MD, MHSc.|860-679-2715|celi@uchs.edu|
20551894|NCT00798369|Novartis Pharmaceuticals|Study Director|862-778-8300||
20551895|NCT03492099|Johns Hopkins University School of Medicine|Dr. Sophie Lanzkron|4105028642|slanzkr@jhmi.edu|
20521531|NCT04314414|Boston Medical Center|Sabrina A Assoumou, MD MPH|(617) 414-5282|sabrina.assoumou@bmc.org|
20551896|NCT03739112|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
20551897|NCT00588822|Mayo Clinic|Dr. Benn E. Smith|480-301-6711|bsmith@mayo.edu|
20536733|NCT03321071|University of South Carolina|R. Glenn Weaver|803-777-5606|weaverrg@email.edu|
20536734|NCT00790582|Forbes Norris MDA/ALS Center|Giovanna Kushner|415-600-3983|kushneg@cpmcri.org|
20536735|NCT00803595|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20536736|NCT02953561|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Associate Professor|713-794-4392|ndaver@mdanderson.org|
20536737|NCT01027650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20536738|NCT03159468|Arizona State University|Kelly Cue Davis|602-496-3217|Kelly.Cue.Davis@asu.edu|
20536739|NCT00912782|Emory University|Monnie Wasse MD/MPH / Associate Professor of Medicine|404-727-1598|hwasse@emory.edu|
20536740|NCT02712983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20551898|NCT01948739|Rice University|Marcia K. O'Malley, PhD|(713) 348-3545|omalley@rice.edu|
20551899|NCT01810666|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20551900|NCT02436759|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|9088091423|mvelasco@osmotica.com|
20551901|NCT02584504|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20551902|NCT03839511|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
20536741|NCT05396014|UNC Chapel Hill|Matthew Mauck, MD, PhD|(919) 966-5136|Matt_Mauck@med.unc.edu|
20536742|NCT01675297|Hanlim Pharma|Clinical Trial Unit|82-2-3489-6297|yrsong@hanlim.com|
20551903|NCT01290666|University of California, Irvine|Michael J Stamos, MD|888-532-4123||
20551904|NCT00775931|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
20551905|NCT01652664|Alcon Research, Ltd.|Subha Venkataraman, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20551906|NCT00297037|University of Utah|Dr. Christopher Hull|801-581-6465|christopher.hull@hsc.utah.edu|
20551907|NCT00581776|University of Wisconsin- Madison|Brad S Kahl|608-263-1836|bsk@medicine.wisc.edu|
20551908|NCT01628601|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20551909|NCT01199744|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551910|NCT02876900|Noven Pharmaceuticals|George Harb, MD, MPH - Executive Director, Clinical Development|1-551-233-2656|gharb@noven.com|
20551911|NCT00117559|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4797|amy.silberbogen@va.gov|
20551912|NCT00099437|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20521532|NCT03734666|Moffitt Cancer Center|Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
20536743|NCT00501592|Intercept Pharmaceuticals, Inc.|Cathi Sciacca, Sr. Director, Clinical Operations|858-652-6800|csciacca@interceptpharma.com|
20536744|NCT02789345|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20536745|NCT03379259|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536746|NCT02836717|Department of Surgery, Cantonal Hospital St. Gallen|Dr Lukas Marti|+41 71 494 11 11|lukas.marti@kssg.ch|
20536747|NCT03462641|University of Michigan|Stiven Roytman|734 998-8400|stivenr@med.umich.edu|
20536748|NCT01804049|VAORD - Portland VA Health Care System|Dr Robert Klein|503-220-8268|kleinro@ohsu.edu|57496
20536749|NCT03938103|University of North Carolina at Chapel Hill|Derek Hales, PhD|919-966-6089|derekh@email.unc.edu|
20506427|NCT01204658|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506428|NCT04594239|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20506429|NCT04237207|Advanced Bionics, LLC|Ankur Kaushal, VP of Global Regulatory Affairs|661 362 1400|clinicalresearch@advancedbionics.com|
20506430|NCT02678780|Kapadi|Start Up Unit|+34961452190|maria.rocasalbas@kapadi.com|
20506431|NCT02100748|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20506432|NCT03047993|The University of Texas MD Anderson Cancer Center|Courtney DiNardo/Professor|713-794-1141|cdinardo@mdanderson.org|
20506433|NCT00091390|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20506434|NCT03492463|Duke University|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu|
20506435|NCT00406640|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20506436|NCT04748783|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD, MS|919-537-3424|ljacox@live.unc.edu|
20506437|NCT01686503|Eastern Virginia Medical School|Dr. Stephanie Troy|757-446-8999|troysb@evms.edu|
20506438|NCT05345691|Biocon Biologics Limited|Sarika S Deodhar|0802808|Sarika.Deodhar@biocon.com|5301
20506439|NCT03050359|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20506440|NCT02020031|Mayo Clinic|Dr. Mark J. Spanghel|480-301-5685|Spangehl.Mark@mayo.edu|
20506441|NCT01136668|Hospital for Sick Children|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
20506442|NCT05209932|Family Transitions - PTW, LLC|Michele M Porter, PhD - Co-PI/Partner|4802037550|m.marie.porter@gmail.com|
20506443|NCT01592409|Centre for Addiction and Mental Health|Dr. Robert Mann, Senior Scientist|416-535-8501|robert.mann@camh.ca|34496
20506444|NCT01728584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506445|NCT03207022|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
20521533|NCT00511095|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
20536750|NCT00436046|Baylor College of Medicine|Robert Couch, MD|713-798-4474|rcouch@bcm.tmc.edu|
20521534|NCT01943110|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
20536751|NCT00392834|University of Arkansas for Medical Sciences|Jeannette Lee, Ph.D.|501-526-6712|jylee@uams.edu|
20521535|NCT01910389|New England Research Institutes|Brian Harty|617-972-3224|bhartY@neriscience.com|
20521536|NCT01898650|Washington University School of Medicine|Gary Skolnick|13144544005|gskolnic@wustl.edu|
20551913|NCT02410954|University of California, San Francisco|Andrew Krystal, MD|(415) 476-7702|andrew.krystal@ucsf.edu|
20536752|NCT02201329|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20536753|NCT01262638|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20521537|NCT00753220|Prostate Institute of America|Dr. Duke K. Bahn|888-234-0004|DKBahn@CMHhospital.org|
20521538|NCT05896202|University of Miami|Marlon L. Wong|3052842670|mwong2@miami.edu|
20521539|NCT03923530|NF South Ga VAMC|Dr. Anthony Bavry|352-548-4726|anthony.bavry@va.gov|
20536754|NCT01122446|LundU|Helena Elding Larsson, PI|+4640337676|helena.elding_larsson@med.lu.se|
20536755|NCT01369199|University of Pittsburgh|Dr. Steven Belle|412-624-5419|belle@edc.pitt.edu|
20536756|NCT01071252|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536757|NCT01066104|MGH|Dr. Ellen Dutta|6177248256|edutta@mgh.harvard.edu|
20536758|NCT03087604|Wake Forest University Health Sciences|Dr. Sean Dobson|3367168834|sdobson@wakehealth.edu|
20536759|NCT00244725|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536760|NCT04004221|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536761|NCT02122146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536762|NCT01970241|HCMC|Lisa Fish MD|612-873-2705|lisa.fish@hcmed.org|
20536763|NCT03472495|Virginia Commonwealth University|Tammy Nguyen, PharmD|8046630969|Tammy.Nguyen@vcuhealth.org|
20536764|NCT02110485|Nationwide Children's Hospital|Beth Fischer|614-355-0338|beth.fischer@nationwidechildrens.org|
20536765|NCT00992056|University of Miami|Richard A Preston MD MSPH MBA|305 243 5930|rpreston@med.miami.edu|
20536766|NCT00295334|Ben-Gurion University of the Negev|Iris Shai|+972086477443|irish@bgu.ac.il|
20536767|NCT01001767|University Hospitals Case Medical Center|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
20551914|NCT00006101|University of California, Irvine|Dr. Thomas Ahlering|(714) 456-6068|tahlerin@uci.edu|
20536768|NCT02584452|Vanderbilt University Medical Center|Christopher Sobey, MD|615-322-4311|christopher.m.sobey@vumc.org|
20536769|NCT02038946|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20551915|NCT01748643|Ziekenhuis Oost-Limburg|Dr. Pascal Vanelderen|+3289325298|pascal.vanelderen@gmail.com|
20521540|NCT00407758|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
20521541|NCT04154150|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
20536770|NCT00652314|Vascular Solutions, Inc.|Lisa Gallatin, RAC|763-656-4399|lgallatin@vasc.com|
20536771|NCT01558596|Minneapolis VA Medical Center|Santiago Garcia, MD|6124673670|santiago.garcia@va.gov|
20536772|NCT02548910|Ottawa Hospital Research Institute|Dr. Guillaume Martel|6137378899|gumartel@toh.ca|71053
20521542|NCT03347006|Queen Mary University of London|Professor Jesmond Dalli|+442078828263|j.dalli@qmul.ac.uk|
20521543|NCT04669691|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20536773|NCT01916824|Emory University|Boadie Dunlop, MD|404-727-8969|bdunlop@emory.edu|
20521544|NCT02722148|University of North Carolina at Chapel Hill|Dr. Evan S. Dellon|(919) 966-2513|evan_dellon@med.unc.edu|
20521545|NCT05161806|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20536774|NCT00626886|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20521546|NCT00855803|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|robert.timmerman@utsouthwestern.edu|
20536775|NCT02057640|Cleveland Clinic Taussig Cancer Center|Jason Valent, MD|216-445-7238|valentj3@ccf.org|
20551916|NCT00454987|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551917|NCT02205333|MedImmune, LLC|Victoria Chiou|301-398-4330|chiouv@MedImmune.com|
20551918|NCT02447133|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
20551919|NCT01176266|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
20551920|NCT01172184|Kaohsiung veterans general hospital|Dr. Shih-Hung Hsiao|886-7-3422121|irb@vghks.gov.tw|1518
20551921|NCT01675128|National Cancer Institute|Dr.Tim Greten|301-451-4723|gretentf@mail.nih.gov|
20551922|NCT03011307|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|eisenach@wakehealth.edu|
20551923|NCT03526458|University of Wisconsin, School of Medicine and Public Health, Department of Urology|Shuang Li|6082638336|lis@urology.wisc.edu|
20551924|NCT01782664|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551925|NCT02404285|Next Science|Matt Myntti PHD, President|9046474161|mmyntti@nextscience.org|
20551926|NCT00698581|UCB|UCB Cares|+1 877 822 9493||
20551927|NCT03760146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551928|NCT01082965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551929|NCT03642717|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551930|NCT02587065|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20551931|NCT03022292|Stein Eye Institute of UCLA|Dr. David Sarraf|310-825-7836|DSarraf@ucla.edu|
20521547|NCT00809159|Novartis|Study Director|862-778-8300||
20551932|NCT02642432|AbbVie|Global Medical Services|800-633-9110||
20551933|NCT03999892|Johns Hopkins|Gail Daumit|410 614 6460|gduamit@jhmi.edu|
20551934|NCT01848756|Esanex Inc|Eric Orlemans, Chief Scientific Officer|919-338-2019|eorlemans@esanexpharma.com|
20551935|NCT03245008|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20506446|NCT02336594|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
20551936|NCT02075658|UCI Health Department of Urology|Clinical Research Coordinator|714-456-8176|yoonrh@uci.edu|
20551937|NCT01286012|Rockwell Medical|Raymond Pratt, MD CMO|248 960 9009|rd@rockwellmed.com|
20551938|NCT00827983|IBSA Institut biochimique|Clinical trial manager|+41583601000|barbara.cometti@ibsa.ch|
20551939|NCT04056195|Oscotec Inc.|Sungsil Lee/Team Leader of Clinical Development|+82316287624|sslee@oscotec.com|
20551940|NCT02406651|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
20551941|NCT00718328|Johns Hopkins University SOM (former employer during the study)|Neeraj Naval|9042026290|neerajnaval@gmail.com|
20506447|NCT00471536|Karmanos Cancer Institute at Wayne State University|Ulka Vaishampayan, M.D.||vaishamu@karmanos.org|
20551942|NCT01876485|Department of Veterans Affairs|Dr. LeChauncy Woodard|(713) 440-4441|woodard.lechauncy@va.gov|
20551943|NCT00663052|Wyeth, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551944|NCT05734443|Virginia Tech|Michael Madigan|5402313543|mlm@vt.edu|
20551945|NCT01602380|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20551946|NCT00496756|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
20551947|NCT01230931|The University of Texas Health Science Center at Houston|Catherine G. Ambrose, PhD||Catherine.G.Ambrose@uth.tmc.edu|
20551948|NCT06145542|Zhejiang University|Dr. Xiao Tan|18651218270|xiao.tan@zju.edu.cn|
20506448|NCT02651194|AbbVie|Global Medical Services|800-633-9110||
20506449|NCT02403830|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
20551949|NCT01254227|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20551950|NCT00887354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20551951|NCT01466348|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551952|NCT01291056|University of Utah Department of Obstetrics & Gynecology|Dr. Jessica Pittman|801-339-4103|jessica.pittman@hsc.utah.edu|
20506450|NCT01980706|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
20521548|NCT02103270|The Sean N. Parker Center for Allergy Research at Stanford|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|9544465645|andresap@stanford.edu|
20521549|NCT01576874|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20521550|NCT04430855|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20551953|NCT00192504|MedImmune, LLC|Genevieve A. Losonsky, MD/VP Clinical Development|301-398-0000|losonskyG@medimmune.com|
20536776|NCT00771927|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20536777|NCT03835481|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551954|NCT03989440|ReNetX Bio, Inc.|George D. Maynard, Ph.D., Study Director|2032088925|info@renetx.com|
20551955|NCT02974296|Columbia University|DR. Marta Moreno-Ortega|9142187311|mm4355@cumc.columbia.edu|
20536778|NCT03020004|Ascletis Pharmaceuticals Co., Ltd|Clinical Trial Disclosures|+86057185389732|yicheng.zhao@ascletis.com|
20536779|NCT01267864|Albert Einstein College of Medicine, Montefiore Medical Center|Benjamin Friedman, MD|718-920-6626|befriedm@montefiore.org|
20536780|NCT00581399|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
20536781|NCT01270880|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath, M.D.|313-576-8715|heathe@karmanos.org|
20551956|NCT01955161|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20506451|NCT02546674|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20506452|NCT03248947|Duke University|Dr. Li-Tzy Wu|919-889-9369|litzy.wu@duke.edu|
20536782|NCT01356498|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
20551957|NCT02784821|University of Florida|Dr. Josef Neu|352-733-0111|neuj@peds.ufl.edu|
20551958|NCT02794103|Université de Montréal|Dr. Sylvie Le May, Professor & Researcher|514 345-4931|sylvie.lemay@umontreal.ca|4938
20521551|NCT00186043|Bipolar and Depression Research Program, Stanford University, School of Medicine, VA Palo Alto Health Care System|Trisha Suppes MD, PhD|6504962567|tsuppes@stanford.edu|
20521552|NCT01362127|Karolinska Institutet|Fredrik Klevebro|+46858580000|fredrik.klevebro@ki.se|11111
20521553|NCT04188301|Washington University in St. Louis|Dr. Gary Weil|3144547787|gary.j.weil@wustl.edu|
20521554|NCT01666197|Novartis Consumer Health SA|Clinical Project Leader|41223635293||
20521555|NCT01709838|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20521556|NCT00620659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521557|NCT01193127|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
20521558|NCT00578669|UT Austin School of Nursing|Dr. Richard A. Brown|512-471-8584|brown2@utmail.utexas.edu|
20521559|NCT03564444|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
20521560|NCT03246646|CMC VA Medical Center|Steven L. Sayers|(215) 823-5196|steven.sayers@va.gov|
20521561|NCT02569112|Venus Concept Ltd.|Dr. Yoni Iger|8889070115|yoni@venusconcept.com|
20521562|NCT02352779|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH. Assistant Professor|585-275-7827|Luke_Peppone@urmc.rochester.edu|
20521563|NCT00529282|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clincal Team Lead|908 927-3785||
20521564|NCT00968799|Cantonal Hospital St.Gallen|Sascha Müller, MD|+41 71 494 1317|ulrich.beutner@kssg.ch|
20521565|NCT01540773|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
20521566|NCT01104779|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
20521567|NCT03867097|CiVi Biopharma, Inc.|Chief Executive Officer|301-968-2390|sj@civibio.com|
20521568|NCT01372774|Mayo Clinic|Paul D. Brown, M.D.|(713) 563-2415|brown.paul@mayo.edu|
20521569|NCT00389831|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20521570|NCT01398943|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
20521571|NCT01580813|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20521572|NCT04639713|Novoxel Ltd|Ifat Klein|972-52-6009860|ifat@novoxel.com|
20521573|NCT02903030|Nisonger Center|Dr. L. Eugene Arnold, MD, MED. Professor Emeritus College of Medicine|614-685-6701|l.arnold@osumc.edu|
20536783|NCT01221753|Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA02215|Robert Haddad, MD|617-632-3090|robert_haddad@dfci.harvard.edu|
20536784|NCT04552288|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2342|markovaa@mskcc.org|
20536785|NCT04532294|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536786|NCT03089047|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
20536787|NCT03599518|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20551959|NCT03928847|University of California at San Francisco|Harold A. Chapman, M.D.|415-514-1210|hal.chapman@ucsf.edu|
20551960|NCT04475588|Biocon Biologics India Limited|Dr. Subramanian Loganathan|0802808|subramanian.l101@biocon.com|5466
20551961|NCT01327300|University of Florida|Dr. Baharak Moshiree|(352)273-8393|bmoshiree@med.miami.edu|
20536788|NCT02008149|Department of Veterans Affairs|Dr. Gary S. Beaupre|(650) 493-5000|Gary.Beaupre@va.gov|64272
20551962|NCT03020823|Syncore|Dr. Lin|0227603688|JWLin@syncorebio.com|
20521574|NCT04345601|Baylor College of Medicine|Dr. Laquisa Hill|713-441-1450|LaQuisa.Hill@bcm.edu|
20551963|NCT02082210|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20551964|NCT04762680|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20551965|NCT03340337|Universidad Maimónides - Universidad Nacional Arturo Jauretche - Instituto Universitario de Ciencias de la Salud Fundación H.A. Barceló|Oscar Ronzio|+54-11-4905-1140|ronzio.oscar@maimonides.edu|
20551966|NCT01268111|Mayo Clinic|A J Vinaya Simha|5072664321|simha.aj@mayo.edu|
20551967|NCT03493828|New York Methodist Hospital|Dr Joel Yarmush|(718) 780-3279|joelyarmush@gmail.com|
20551968|NCT04307446|Tufts University|Nancy Baker|617 627 5562|nancy.baker@tufts.edu|
20551969|NCT02094716|Mylan Pharmaceuticals Pvt Ltd|Clinical Sciences Program Lead||prasannac.ganapathi@mylan.in|
20551970|NCT01727141|Novartis Pharmaceuticals|Study Director|862-778-8300||
20551971|NCT03538158|Weill Cornell Medicine|Chelsie Burchett|212-746-1417|cob2014@med.cornell.edu|
20551972|NCT03425331|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|(617) 632-3468|mark_awad@dfci.harvard.edu|
20551973|NCT01232920|Proctor Foundation, University of California San Francisco|Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
20551974|NCT01413360|Seoul National University Hospital|Jung-Hwan Yoon|+82-2-2072-2228|yoonjh@snu.ac.kr|
20551975|NCT02246673|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
20551976|NCT02418468|Novartis Pharmaceuticals|Study Director|862-778-8300||
20551977|NCT02914769|UFRN|Draulio Barros de Araujo|+5584991225987|draulio@neuro.ufrn.br|
20521575|NCT03610516|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20521576|NCT03700385|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|kschneider@farapulse.com|
20521577|NCT01811316|Sunstar Americas, Inc.|Akane Takemura|+1-847-794-4276|akane.takemura@us.sunstar.com|
20551978|NCT04356963|University of Maryland School of Medicine|Dr. Nicholas Morris|410-328-4515|nicholas.morris@som.umaryland.edu|
20551979|NCT02285907|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
20551980|NCT00791518|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551981|NCT02488681|Medtronic|Micra CA Study Manager|800-328-2518|rs.micracontinuedaccess@medtronic.com|
20551982|NCT02658136|Rigshospitalet|Dr Kiran Mirza|004535451442|KMIR0003@regionh.dk|
20521578|NCT00658515|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20551983|NCT00720057|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20551984|NCT04949165|University of Minnesota|Protocol Manager for BLIS|(612)590-2697|telke001@umn.edu|
20536789|NCT00375505|Novartis|Study Director|862-778-8300||
20521579|NCT01555671|Prof.Dr.Cemil Tascioglu City Hospital|Orhan SAHIN|+90 532 240 00 12|drorhansahin@gmail.com|
20551985|NCT04969224|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20521580|NCT02684630|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
20551986|NCT01498952|MedImmune LLC|Mohammed Dar|+301-398-0000|information.center@astrazeneca.com|
20551987|NCT02726074|Eisai Inc.|Eisai Korea Inc. Medical department|+82-2-3451-5539|h3-park@eisaikorea.com|
20551988|NCT00579826|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
20521581|NCT03047629|Enterin|Dr. Richard Larson, Chief Medical Officer|5054692670|l.larson@enterininc.com|
20521582|NCT04590040|UT Health San Antonio|Bennett Amaechi BDS, MD, PhD|210 567 3185|amaechi@uthscsa.edu|
20551989|NCT02009046|PHI|Norman A. Constantine, Ph.D.|925-284-8118|nconstantine@berkeley.edu|
20551990|NCT01170091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551991|NCT03194321|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
20551992|NCT00643682|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|6176386563|brian.jacobson@bmc.org|
20551993|NCT02084147|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
20551994|NCT03755414|Washington University School of Medicine|Dr. Ramzi Abboud|314-454-8304|rabboud@wustl.edu|
20551995|NCT04595513|Cincinnati Children's Hospital Medical Center|Darcy A. Krueger, MD., PhD|513-636-4222|krueger_darcy@cchmc.org|
20551996|NCT01395329|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
20551997|NCT02865915|Millendo Therapeutics US, Inc.|Director of Clinical Operations|734-845-9000|millendo@millendo.com|
20551998|NCT06002958|University of North Carolina at Chapel Hill|Kelsey Ludwig, PhD|(919) 962-1401|kelsey_ludwig@med.unc.edu|
20551999|NCT05497284|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20552000|NCT05760300|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20552001|NCT00877058|Göteborg University|Professor Synneve Dahlin-Ivanoff (Research leader)|+46317865733|synneve.dahlin-ivanoff@gu.se|
20552002|NCT03878446|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20552003|NCT01722240|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Paresh Dandona|7169574325|pdandona@kaleidahealth.org|
20552004|NCT03615105|Memorial Sloan Kettering Cancer Center|Dr. Brian Shaffer, MD|646-608-3737|shaffeb1@mskcc.org|
20552005|NCT05041322|Spaulding Hospital Cambridge|Jason Hamner|6177585501|jhamner@mgb.org|
20552006|NCT03313804|University of Kentucky|Dr. John Villano|8593234405|jlvillano@uky.edu|
20552007|NCT01502423|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20552008|NCT00567892|Washington University|Dr. Jay F. Piccirillo|314.362.8641|piccirilloj@ent.wustl.edu|
20552009|NCT04814433|NYU Langone Health|Thomas Calahan|929-455-5826|Thomas.Calahan@nyulangone.org|
20552010|NCT02556333|National Institutes of Health, National Institute of Allergy and Infectious Diseases|Alice Pau, Pharm.D., Staff Scientist (Clinical)|301-451-3740|apau@niaid.nih.gov|
20552011|NCT02967692|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
20552012|NCT00066066|The Forsyth Institute|Ricardo P Teles, DDS, DMSc|617 892-8556|rteles@forsyth.org|
20552013|NCT01063764|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20552014|NCT00697515|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20552015|NCT03054857|King Chulalongkorn Memorial Hospital|Dr.Yada Thongsuk|+66817738629|thongsuk.y@hotmail.com|
20552016|NCT01319812|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
20552017|NCT02759120|Weill Cornell Medicine|Elizabeth Peters|646-962-2742|elp2018@med.cornell.edu|
20552018|NCT01633892|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
20552019|NCT03240679|Mayo Clinic|Dr. Kenneth K. Wang|507-284-2691|wang.kenneth@mayo.edu|
20552020|NCT02255981|Escuela Neijing|Researcher|5744211000|lhgut2001@gmail.com|
20552021|NCT00912990|Rady Children's Hospital San Diego|Dr. Sandeep Khanna|858-966-5863||
20552022|NCT02631954|INHA UNIVERSITY HOSPITAL|Sang-Heon Cho, Ph.D.|82-32-890-1122|shcho123@inha.ac.kr|
20552023|NCT00470574|Memorial Sloan Kettering Cancer Center|Teresa Gilewski, MD|(212) 639-2000|gilewskt@mskcc.org|
20552024|NCT01229423|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20552025|NCT01454570|James J Peters VA Medical Center|Dr. Ann Spungen - PI|718-584-9000|ann.spungen@va.gov|5420
20552026|NCT00949325|Johns Hopkins University|David M. Loeb, M.D., Ph.D.|410-502-7247|loebda@jhmi.edu|
20552027|NCT05533632|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20552028|NCT02701647|The Hong Kong Polytechnic University|Chloe Chung|2766|chloe.lh.chung@connect.polyu.hk|7092
20552029|NCT03054870|Cyclomedica Australia Pty Ltd|James McBrayer|+61 2 9541 0411|clinicaltrials@cyclomedica.com|
20521583|NCT01531439|Children's Mercy Hospital|Dr Ben Pieters|816-234-3464|bjpieters@cmh.edu|
20521584|NCT00000378|New York State Psychiatric Institute|Steven Roose MD|646-774-8661|spr2@columbia.edu|
20521585|NCT02813265|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results006@kalarx.com|
20521586|NCT01284361|Hollister Incorporated|Malford Cullum PhD/Sr Clin Res Scientist|847-918-3975|malford.cullum@hollister.com|
20521587|NCT02026687|Dept of anaesthesia, Linköping University Hospital, Sweden|Dr Lena Nilsson|0046101030000|lena.nilsson@regionostergotland.se|
20552030|NCT01096810|Mount Sinai|Dr. Sundar Jagannath|2122417873|sundar.jagannath@mountsinai.org|
20552031|NCT00304356|VA Houston|Daniel Musher|713-794-7386|daniel.musher@va.gov|
20552032|NCT01807897|VA Boston Healthcare System|Dr. Daniel Gottlieb|857-203-6175|daniel.gottlieb@va.gov|
20521588|NCT02198183|Hospital for Special Surgery, Anesthesiology|Dr Jacques Yadeau|2126061036|Yadeauj@hss.edu|
20552033|NCT04120974|Becton, Dickinson and Company|Sandra van Guldener, Director OUS Clinical Affairs|+31646900840|sandra.vanguldener@bd.com|
20552034|NCT02951338|University Health Network|Avril Mansfield|416-597-3422|avril.mansfield@uhn.ca|7831
20552035|NCT00973479|Centocor, Inc.|Director Clinical Research|1-800-457-6399||
20552036|NCT05075850|Monteris Medical|Christa Seligman|(952) 463-7747|cseligman@monteris.com|
20552037|NCT04256785|Universidad de Granada|Dr. Elena Pita Calandre|+34 958246291|epita@ugr.es|
20552038|NCT01154218|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552039|NCT01265849|CEL-SCI Corporation|John Cipriano, Senior VP Regulatory Affairs, Eyal Talor Chief Scientific Officer|(205) 586-6947|jcipriano@cel-sci.com|
20552040|NCT00362115|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20506453|NCT04490265|US Department of Veterans Affairs|Lisa McAndrew|862-400-3317|lisa.mcandrew@va.gov|
20506454|NCT01864018|Mayo Clinic|Shaji Kumar|507-284-2511|Kumar.Shaji@mayo.edu|
20506455|NCT02509598|Cardinal Health 414, LLC|Director, Regulatory & Medical Affairs|6147570226|npsmedicalaffairs@cardinalhealth.com|
20506456|NCT01750398|SKCCC at Johns Hopkins|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
20506457|NCT04056455|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20506458|NCT02512068|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20552041|NCT00271609|National Cancer Institute, National Institutes of Health|Teri Kreisl, M.D.|301-402-3423|kreislt@mail.nih.gov|
20552042|NCT02188589|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20552043|NCT01547000|University of South Florida|Tanya K. Murphy, MD, MS|813-974-2201|tmurphy@health.usf.edu|
20552044|NCT03341533|Mayo Clinic|Dr. Tatnai Burnett|507-538-5783|burnett.tatnai@mayo.edu|
20552045|NCT02153112|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20552046|NCT03168308|University of Texas Southwestern|Tiffany Moon, MD|4694195790|Tiffany.Moon@UTSouthwestern.edu|
20552047|NCT04039412|Zagazig University-Faculty of Human Medicine|Dr. Ayman Fathy Elsayed|+201125020593|aymanf28@yahoo.com|
20552048|NCT00003641|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20552049|NCT00944450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567114|NCT04493424|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567115|NCT00949117|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Coordinator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
20567116|NCT03769090|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
20567117|NCT03964974|University of Michigan|Mark Ilgen|734-845-3646|marki@med.umich.edu|
20567118|NCT02014402|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
20567119|NCT00279409|USSF|Laurence Greenhill||larrylgreenhill@gmail.com|
20567120|NCT02542202|UChicago|Rohan Katipally|773-702-0137|Rohan.Katipally@bsd.uchicago.edu|
20567121|NCT02713594|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
20567122|NCT00670449|Novartis Pharmaceuticals|Study Director|862 778-8300||
20567123|NCT00413283|Amgen Inc.|Study Director|866-572-6436||
20567124|NCT02068157|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20567125|NCT02002689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20506459|NCT04365985|William Beaumont Hospitals|Matthew Sims, MD|248 551-0027|matthew.sims@beaumont.org|
20506460|NCT04891770|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20506461|NCT01401010|Michigan State University|Gary E Stein|517-353-5126|Gary.Stein@hc.msu.edu|
20506462|NCT01952834|Medical College of Wisconsin|Dr. Michael Widlansky|414-955-6755|mwidlans@mcw.edu|
20506463|NCT02110121|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20506464|NCT04360187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506465|NCT04058054|KeraNetics, Inc.|Chris Holder, PhD|336-413-3393|cholder@keranetics.com|
20506466|NCT02203838|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20506467|NCT05091060|Erchonia Corporation|Travis Sammons|3214731251|tsammons@erchonia.com|
20567126|NCT00671853|University Hospitals Cleveland Medical Center|Dr. Kemp Gao|216-844-2865|keming.gao@UHhopsitals.org|
20567127|NCT01450007|Mayo Clinic|Dr. David M. Rosenfeld|480-301-7586|Rosenfeld.David@mayo.edu|
20567128|NCT02224755|Abbott|Joyce Chuang/Principal scientist|925-353-5817|joyce.chuang@abbott.com|
20506468|NCT01798706|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20506469|NCT00496873|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
20506470|NCT05896761|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20506471|NCT01318083|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20506472|NCT04747808|MediPrint Ophthalmics, Inc.|Chief Operating Officer|(858) 522-0815|clinical@mediprintlens.com|
20506473|NCT00843310|NYU Cancer Institute|Hearn J. Cho, MD|212-263-9274|hearn.jay.cho@med.nyu.edu|
20506474|NCT03552549|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506475|NCT01257217|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20506476|NCT02739594|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20506477|NCT01231633|Long Island Vitreoretinal Consultants|Vincent A. Deramo, MD|5164660390|vaderamo@gmail.com|222
20506478|NCT00668434|Kaiser Permanente, Northern California|Dr. Andrew Avins|510-891-3557|andy.l.avins@kp.org|
20506479|NCT01270581|Mount Sinai School of Medicine|Dr. Andrea Weintraub|212-241-6186|andrea.weintraub@mssm.edu|
20521589|NCT01957397|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
20521590|NCT00540293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20521591|NCT03537599|The Ohio State University Comprehensive Cancer Center|Dr. Sumithira Vasu|614-293-9869|Sumithira.Vasu@osumc.edu|
20521592|NCT01823497|Medical College of Wisconsin|Keri R. Hainsworth|414-266-6306|khainswo@mcw.edu|
20521593|NCT00325195|Savient Pharmaceuticals, Inc.|Medical Director|732-418-9300||
20552050|NCT03019939|The University of Texas MD Anderson Cancer Center|Prithviraj Bose MD/Associate Porfessor|713-792-7747|PBose@mdanderson.org|
20552051|NCT02154581|UT Health San Antonio|Research Compliance Coordinator-Senior|210-567-8554|NijlandK@uthscsa.edu|
20521594|NCT00806286|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20521595|NCT02958982|Rhizen Pharmaceuticals S.A.|Dr. Prajak Barde|+41 32 580 0113|pjb@rhizen.com|
20521596|NCT01749995|General Hospital Groeninge, Kortrijk, Belgium|Dr. Philip Debruyne|+32 056 63 39 00|philip.debruyne@azgroeninge.be|
20521597|NCT00977379|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20521598|NCT00699374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521599|NCT02067468|Universidad de Antioquia|Dr Gloria I Sanchez|+57 (4) 219 6062|sanchezg@une.net.co|
20552052|NCT00878709|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20521600|NCT02174419|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
20521601|NCT00593736|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20521602|NCT01853930|Jesse Brown VA Medical Center|Dr. Janet P. Szlyk, PhD|312-997-3644|janet.szlyk@va.gov|
20552053|NCT02225743|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsosh@musc.edu|
20521603|NCT04283500|NYU Langone Health|Ryan McCormack|2122632862|Ryan.McCormack@nyulangone.org|
20552054|NCT01347541|University of Washington School of Medicine|Dr, Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
20552055|NCT03886220|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20521604|NCT03599271|Intersect ENT|Andrew Campbell PhD, MPH Clinical Affairs Director|6506412100|acampbell@intersectent.com|
20521605|NCT01043653|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
20521606|NCT02006693|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20521607|NCT03682224|Southern Illinois University School of Medicine|Sowmy Thuppal, Research Assistant Professor|217-545-2320|sthuppal83@siumed.edu|
20521608|NCT01119508|UT MD Anderson Cancer Center|Dr. Sapna P. Patel, Assistant Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20521609|NCT00265395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20552056|NCT02591147|University of Iowa College of Dentistry|Dr. Justine Kolker|(319) 335-7583|justine-kolker@uiowa.edu|
20552057|NCT00768300|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20552058|NCT02664909|UConn Health|Vincent Williams, M.D.|(860) 679-8384|vwilliams@uchc.edu|
20552059|NCT02068222|AbbVie|Global Medical Information|800-633-9110||
20552060|NCT03082599|Carolina Eyecare Physicians, LLC|Dr. Helga P Sandoval, Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
20552061|NCT03706794|Albert Einstein College of Medicine|Dr. Elizabeth Seng|646-592-4368|Elizabeth.Seng@einsteinmed.edu|
20552062|NCT00281684|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552063|NCT03098173|Tokyo University|Dr. Ryota Niikura|+81-3-3815-5411|niikura-dky@umin.ac.jp|
20552064|NCT01559012|Città della Salute e della Scienza Ospedale Sant'Anna. Servizio di Medicina Interna|Dr. Aldo Maina M.D. Obstetric Medicine|0039011313|amaina@cittadellasalute.to.it|5735
20552065|NCT00946712|SWOG Statistics & Data Management Center|Lung Committee Statistican|2066675712|jmiao@fredhutch.org|
20552066|NCT00853723|UPittsburgh|Mara J Horwitz|4126922848|horwitz@pitt.edu|
20521610|NCT01955837|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
20521611|NCT02563106|Synthetic Biologics|Michael Kaleko, MD|(240) 238-3862|mkaleko@syntheticbiologics.com|
20521612|NCT04729309|Hoffmann - LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20521613|NCT01212588|IndianaU|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
20521614|NCT01136967|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20521615|NCT05084716|RAND|Laura Bogart|3103930411|lbogart@rand.org|
20521616|NCT01716715|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
20521617|NCT01234922|Wake Forest Baptist Health|William J. Petty, MD|336-716-3313|wpetty@wakehealth.edu|
20521618|NCT01081834|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20521619|NCT01161407|Purdue University|Kathleen M. Hill Gallant|765-494-0101|hillgallant@purdue.edu|
20521620|NCT01777620|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20552067|NCT00445965|Memorial Sloan Kettering Cancer Center|Dr. Kim Kramer MD|212-639-6410|kramerk@MSKCC.ORG|
20552068|NCT02447081|Abbott|Ryan Gage, Senior Scientist|651 756 3334|Ryan.Gage@abbott.com|
20552069|NCT01787175|University of Utah Health Care System|Dr. Jonathan Nebeker|801-582-1565|Jonathan.Nebeker@hsc.utah.edu|2458
20552070|NCT05778786|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
20552071|NCT03188094|NYU Langone Health|Jennifer Zanowiak|212 263 0485|Jennifer.Zanowiak@nyulangone.org|
20552072|NCT04690751|SK Life Science, Inc.|Executive Director and Head, Clinical Pharmacology|862-271-2645|vvashi@sklsi.com|
20521621|NCT02701270|Danisco Sweeteners Oy|Kirsti Tiihonen|+358 10 431 050|kirsti.tiihonen@dupont.com|
20552073|NCT01331148|Carolinas Healthcare System|Ifeyinwa Osunkwo, MD, MPH, Principal Investigator|980 442 5001|ify.osunkwo@carolinashealthcare.org|
20521622|NCT02955758|Stanford University|Dr. Joel W. Neal|(650) 498-6000|jwneal@stanford.edu|
20552074|NCT01545817|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20521623|NCT05502081|Mansoura University Hospital|Dr. Ahmed Hosny|+2001554658010|ahmedony26@gmail.com|+200115584
20521624|NCT00462124|BioProtect|Galit Itzhaki|+972-9-7731929|galit@bioprotect.co.il|
20552075|NCT00476021|University of Pittsburgh|Principal Investigator|412-641-5496|chenba@upmc.edu|
20552076|NCT03752307|University of New Mexico|Corey Ford, M.D., Ph.D.|505-925-4124|cford@salud.unm.edu|
20552077|NCT03181828|Children's National|Dr. Nicholas Ah Mew|2025452513|nahmew@childrensnational.org|
20552078|NCT05477875|University of Florida Oaks Eye Center|Yujia Zhou|3522652020|yzhou1996@ufl.edu|
20552079|NCT05447156|Masonic Cancer Center|Dana Mowls Carroll, Ph.D., M.P.H.|612-624-4511|dcarroll@umn.edu|
20552080|NCT01012622|Janssen Korea MAF, Korea|Clinical Research Associate|82-2-2094-4837||
20552081|NCT02515942|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
20552082|NCT03257631|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20552083|NCT05005390|The University of Texas Health Science Center at Houston|Travis Markham, MD|713-500-6200|Travis.H.Markham@uth.tmc.edu|
20521625|NCT01090752|University Hospital Geneva and Lausanne, Switzerland|Zanchi Anne, MD|0041213140775|azanchidel@hotmail.com|
20521626|NCT01756079|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552084|NCT02603432|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552085|NCT00666757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20552086|NCT02529137|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
20521627|NCT03597529|Director, Child and Adolescent Headache Program, UCSF Benioff Children's Hospitals|Dr. Amy A. Gelfand|415-502-1914|Amy.Gelfand@ucsf.edu|
20552087|NCT02130063|Pharmacosmos|Chief Medical Officer|+45 5948 5959|llt@pharmacosmos.com|
20552088|NCT01723163|Durham Veterans Affairs Medical Center|Dr. Patrick Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
20552089|NCT02510794|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20552090|NCT01649375|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20552091|NCT04855643|The University of Texas Health Science Center at Houston|Antonio L. Teixeira, MD, PhD, MSc|713-486-2555|Antonio.L.Teixeira@uth.tmc.edu|
20552092|NCT00613028|Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|919-668-1409|reard003@mc.duke.edu|
20521628|NCT03769714|Maimonides Medical Center|Pedram Bral, MD|7182836000|pbral@maimonidesmed.org|
20552093|NCT01686841|Zeltiq Aesthetics|Lori Brandt, Director Clinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
20552094|NCT02066467|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
20552095|NCT05853250|Cleveland Clinic|Nancy M. Albert, PhD, Associate Chief Nursing Officer|216-444-7028|albertn@ccf.org|47028
20552096|NCT04461015|Mayo Clinic|Adrian Vella|507-255-6515|vella.adrian@mayo.edu|
20552097|NCT02063854|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20521629|NCT03464630|Georgia State University|Dr. Kathleen Baggett|404-413-1571|kbaggett@gsu.edu|
20521630|NCT04524364|Biosense Webster, Inc.|Associate Director - Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521631|NCT00670202|Brigham and Women's Hospital|Anju Nohria|617-525-7052|anohria@partners.org|617
20521632|NCT01316315|N30 Pharmaceuticals Inc.|Janice M. Troha|720-945-7714|janice.troha@n30pharma.com|
20552098|NCT00405587|Plexxikon Inc.|Dr. Henry Hsu|510-647-4000|hhsu@plexxikon.com|
20552099|NCT00390325|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|Manisha.Shah@osumc.edu|
20521633|NCT00998309|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521634|NCT03769207|Stanford University|Marco Perez, Associate Professor of Medicine|(650) 723-9363|mvperez@stanford.edu|
20521635|NCT00735397|Eisai Inc.|Eisai Call Center|888-422-4743||
20552100|NCT02829463|Third Xiangya Hospital of Central South University|Dr. Jinshen He|8613517470997|jinshen.he@hotmail.com|
20521636|NCT00380744|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20521637|NCT02865460|Miami VA Healthcare System|Nancy Klimas, MD|305-575-7000|nancy.klimas@va.gov|1-4800
20521638|NCT00555152|University of Texas (UT) MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention||CR_Study_Registration@mdanderson.org|
20521639|NCT00901576|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20521640|NCT02922738|University of Vermont|Marianne Burke|802-236-0075|marianne.burke@uvm.edu|
20521641|NCT00171951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20552101|NCT02419742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20552102|NCT00507442|Millennium Pharmaceuticals, Inc|Dixie-Lee Esseltine, MD|(617) 679-7000||
20552103|NCT04236804|University of Pittsburgh|Brian O'Connell|3023997506|oconnellb2@upmc.edu|
20552104|NCT04335279|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
20552105|NCT01046682|UHospitalsCleveland|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
20552106|NCT02808130|Ondokuz Mayıs University Dentalfaculty Periodontology Dep.|Assoc Prof Muge Lutfioglu|+905063073738|mugelutfioglu@hotmail.com|
20552107|NCT06002347|Boise State University|Dr. Aida Midgett|2084261219|aidamidgett@boisestate.edu|
20552108|NCT02864251|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20552109|NCT03506373|Mayo Clinic Jacksonville|Asher Chanan-Khan, MD|904-953-2708|chanan-khan.asher@mayo.edu|
20552110|NCT00885755|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20521642|NCT06077149|University of Rochester|Ann Falsey, MD|585-922-4339|Ann_Falsey@URMC.Rochester.edu|
20552111|NCT04196140|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20552112|NCT00107198|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20552113|NCT01820416|Dept. of Communication Sciences & Disorders, University of Iowa|Shawn S Goodman|319-335-8700|shawn-goodman@uiowa.edu|
20552114|NCT00755131|University of Naples Federico II|Prof. Carlo Vigorito, Director Cardiac Rehabilitation Unit, Federico II University|+39081746|vigorito@unina.it|2639
20552115|NCT03340025|University of Alabama at Birmingham|Benjamin Greene, MD|205-801-7855|bjgreene@uabmc.edu|
20506480|NCT04286412|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552116|NCT00322842|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
20552117|NCT00832585|Rush University Medical Center - Department of Dermatology|Dr. Michael D. Tharp|312-563-4001|derm@rush.edu|
20552118|NCT00735878|Dartmouth-Hitchcock Medical Center (DHMC)|Konstantin H. Dragnev, MD|(603) 650-6344|konstantin.h.dragnev@hitchcock.org|
20552119|NCT04404855|UT Health San Antonio|Michael Liss, MD|210-567-5676|liss@uthscsa.edu|
20552120|NCT04665050|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552121|NCT00302458|Massachusetts General Hospital|Dr. Thomas Spencer|617-726-1731|spencer@helix.mgh.harvard.edu|
20552122|NCT02867709|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20552123|NCT01001442|Biotest AG|Iris Bobenhausen|+49 6103 801|iris.bobenhausen@biotest.com|4832
20552124|NCT01400516|Brigham and Women's Hospital|Daniel H Solomon, MD, MPH||dsolomon@partners.org|
20552125|NCT02946047|Mayo Clinic|Dr. Nathan Cummins|507-284-3747|Cummins.Nathan@mayo.edu|
20552126|NCT01344161|Tehran University of Medical Sciences|Dr.Farzad Shidfar|09123082922|f-shidfar@tums.ac.ir|
20552127|NCT04364620|Alethia Biotherapeutics ULC|Dr. Julie Laurin, Vice-President, Drug Development|514-581-8125|julie.laurin@alethiabio.com|
20506481|NCT00952289|Incyte Corporation|Study Director|855 463-3463||
20506482|NCT01515176|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
20506483|NCT02932475|University of North Carolina at Chapel Hill|Kim Boggess, MD|919-966-1601|kboggess@med.unc.edu|
20506484|NCT00777491|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
20506485|NCT00364845|Amgen Inc.|Study Director|866-572-6436||
20506486|NCT01423617|Analyze & Realize|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
20506487|NCT03255291|Washington University School of Medicine|Erika Waters, MPH, Ph.D.|314-286-2757|waterse@wustl.edu|
20506488|NCT02963714|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
20506489|NCT04019093|University of Florida|Jeff Boissoneault, PhD|352-273-6147|jboissoneault@phhp.ufl.edu|
20506490|NCT04369430|Alkahest, Inc.|Clinical Development|(650) 801-0474|trials@alkahest.com|
20506491|NCT00444626|Genzyme|Genzyme Medical Information (MedInfo)||medinfo@genzyme.com|
20506492|NCT00008138|SWOG Statistical Center|GYN Committee Statistician|206-667-4623||
20506493|NCT00142519|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl, MD|646-888-2681|moryln@mskcc.org|
20506494|NCT04574297|Changhai Hospital|Dr. Zhuan Liao|86-21-31161004|liaozhuan@smmu.edu.cn|
20506495|NCT05818527|Cairo university|mohamed atfy abdelmotaleb ( PhD student )|01222798922|atfy2002@yahoo.com|
20506496|NCT01687413|Washington University School of Medicine|Jason Rich, M.D.|314-747-3742|richj@wustl.edu|
20506497|NCT00306917|DePuy Orthopaedics, Inc|Barry Sisson|574-372-7156|BSisson@its.jnj.com|
20506498|NCT03229759|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
20506499|NCT00500045|Palo Alto Medical Foundation|Renee Kaneshiro|650-853-4744|kaneshr@pamf.org|
20506500|NCT02669862|Aclaris Therapeutics, Inc.|Judy Schnyder, Senior Director of Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
20506501|NCT00734344|University of Alabama at Bimingham|Principal Investigator|996-2371|heaths@uab.edu|
20506502|NCT00762372|Baxter Healthcare|Baxter Clinical Trial Disclosures Call Center|(224)948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20506503|NCT02670915|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20506504|NCT00818207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506505|NCT02616185|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506506|NCT01346371|Minnesota Eye Consultants, P.A.|Ahmad Fahmy, OD|612-813-3665|amfahmy@mneye.com|
20506507|NCT03309787|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
20506508|NCT01670656|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506509|NCT00074724|MedStar Health Research Institute|Scientific Center Administrator|301-560-7300|Research@medstar.net|
20506510|NCT02622724|Faron Pharmaceuticals|Chief Medical Officer|+3584005529411|medical@faron.com|
20506511|NCT00111475|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20506512|NCT01062568|UCSD|Dr. R. Jeffery Chang|858-534-8930|rjchang@ucsd.edu|
20506513|NCT01170117|Columbia Center for Eating Disorders|Dr. Evelyn Attia|646-774-8085|ea12@cumc.columbia.edu|
20506514|NCT01026389|Guerbet|Post M. A. Clinical Unit Manager|+33 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
20506515|NCT01995136|Alcon Japan, Ltd.|Senior Manager, Phase IV|1-888-451-3937|alcon.medinfo@alcon.com|
20506516|NCT03544268|University of North Carolina at Chapel Hill|Director, Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20506517|NCT02543398|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
20506518|NCT02417870|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
20506519|NCT01830543|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20506520|NCT03496467|Mati Therapeutics|Deepank Utkhede|6046379717|dutkhede@matitherapeutics.com|
20506521|NCT01151046|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20506522|NCT02695524|University of São Paulo|Anamaria Siriani de Oliveira|+551633154415|siriani@fmrp.usp.br|
20506523|NCT00127530|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|914-347-4300|ablight@acorda.com|102
20506524|NCT01206478|University of Kansas Medical Center|Ann M Davis, PI|913-588-6300|adavis6@kumc.edu|
20567129|NCT02822599|Nicklaus Children's Hospital|Jenny Esteves|786-624-2854|jenny.esteves@nicklaushealth.org|
20521643|NCT02238795|Jena University Hospital, Center for Clinical Studies|Prof. Dr. Frank M. Brunkhorst|+49 3641 939|frank.brunkhorst@med.uni-jena.de|6687
20567130|NCT00703092|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
20521644|NCT02143973|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
20521645|NCT02800213|San Antonio Uniformed Services Health Education Consortium|Dr. Michael D. April|2109160808|Michael.D.April@post.harvard.edu|210
20521646|NCT04159935|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20521647|NCT01341782|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20521648|NCT02036775|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20521649|NCT02472223|Washington University School of Medicine|Mae Gordon|3143623716|gordon.mae@wustl.edu|
20521650|NCT01676415|NORTHWESTERN UNIVERSITY|BRUCE TAN|3126958182|CPRICE2@NM.ORG|
20521651|NCT03541980|Newark Beth Israel Medical Center|Dr Cena Tejani|973 926 7337|ctejani5@gmail.com|
20521652|NCT02329847|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521653|NCT01222390|Northwestern University|John Y.S. Kim, MD|312-695-0208|jokim@nmh.org|
20521654|NCT01822275|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
20521655|NCT05034276|University of Utah|Eric Garland|801-581-3826|eric.garland@socwk.utah.edu|
20521656|NCT00911807|EBEWE Pharma|Dr. Philipp Novak|01143-7665-8123|philipp.novak@ebewe.com|733
20521657|NCT03918109|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
20521658|NCT00871741|GlaxoSmithKline|GSK Response Center|866-435-7343||
20521659|NCT05323123|Columbia University|Corina Lelutiu-Weinberger, PhD|(212) 342-1502|cl4265@cumc.columbia.edu|
20521660|NCT05529472|Abbott Vascular|Ikuko Kishimoto, Principal Clinical Scientist|651.756.4878|ikuko.kishimoto@abbott.com|
20521661|NCT03510598|Zeltiq Aesthetics|Lori Brandt, Director Clinical Trial Management|925 621-7460|lori.brandt@abbvie.com|
20521662|NCT04036799|Hospital for Sick Children|Seema Mital, Staff Cardiologist|416-813-7418|seema.mital@sickkids.ca|
20521663|NCT04240392|Yale School of Medicine|Ariadna Forray, MD|203-785-2618|ariadna.forray@yale.edu|
20521664|NCT00191113|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20521665|NCT04086407|Sleep Systems|Director of Operations|978-835-7036|e.lyons@sleepsystems-llc.com|
20521666|NCT04241315|On Target Laboratories, Inc.|Tommy Lee|214-289-6422|tlee@ontargetlabs.com|
20521667|NCT03047330|Brigham and Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
20521668|NCT00631657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521669|NCT03035929|Vanderbilt University Medical Center|Grace Henderson, Study Coordinator|615-936-5356|grace.henderson@vumc.org|
20521670|NCT03796598|Richmond VA Medical center|Jasmohan Bajaj|8046755802|jasmohan.bajaj@va.gov|
20521671|NCT05773794|North Carolina A&T State University|Dr. Shengmin Sang|7042505710|ssang@ncat.edu|
20521672|NCT00661895|Creighton Cardiac Center|Tammy Burns, PharmD, Research Manager|402-280-4292|TammyBurns@creighton.edu|
20521673|NCT03376061|Population Health Research Institute|Research assistant|19055212100|Austin.Browne@phri.ca|40582
20521674|NCT01806571|Mayo Clinic|Aref Al-Kali, M.D.|(507) 538-0591|alkali.aref@mayo.edu|
20552128|NCT00156533|University of Rochester|Wilfred Pigeon|585 275-3374|wilfred_pigeon@urmc.rochester.edu|
20552129|NCT01541969|University of Nottingham|Professor Deborah Hall, Professor of Hearing Sciences|+44 (0) 115 823 2600|deborah.hall@nottingham.ac.uk|
20552130|NCT01365507|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20552131|NCT01263301|Mennonite Christian Hospital|Ling-Chih Wu MD|88638241234|lingchihwu@yahoo.com|1810
20552132|NCT03265249|Duke University|Alisha Mavis, M.D.|919-684-5068|alisha.mavis@duke.edu|
20552133|NCT01614990|Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System|Jose Garcia, MD, PhD|(206) 764-2984|jg77@uw.edu|
20552134|NCT05630274|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20552135|NCT02255500|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20552136|NCT00525174|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
20552137|NCT04254978|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552138|NCT03244865|UF Health Department of Anesthesiology|Dr. Tammy Euliano|352-514-7460|teuliano@anest.ufl.edu|
20567131|NCT01480258|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552139|NCT00277212|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20552140|NCT00902564|H. Lundbeck A/S|Study Director|Email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
20567132|NCT01482091|Albert Einstein College of Medicine/Children's Hospital at Montefiore|Dr. Daniel Fein|718-920-5312|dfein@montefiore.org|
20506525|NCT02935699|TerSera Therapeutics|Medical Affairs|844-334-4035|tersera@medinfodept.com|
20506526|NCT03913221|University of North Carolina at Chapel Hill|Wesley Jackson, MD, MPH|984-215-3449|wesley.jackson@unc.edu|
20506527|NCT00798655|University of Pittsburgh|Robert Ferris, MD|412-647-4654|ferrrl@UPMC.EDU|
20506528|NCT03446651|Yale School of Medicine|Jeffrey Testani, MD, MTR|(203) 785-7191|jeffrey.testani@yale.edu|
20506529|NCT00343291|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20506530|NCT05250830|The Ohio State University|Kara Rood|440-321-0264|Kara.Rood@osumc.edu|
20506531|NCT00960934|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20506532|NCT02343276|Instituto de Cardiologia de Santa Catarina|Roberto Léo da Silva|55 48 32719077|robertoleo@hotmail.com|
20521675|NCT04247100|Virginia Commonwealth University|Gisela Chelimsky, MD|804-628-4859|gisela.chelimsky@vcuhealth.org|
20536543|NCT03037476|University of Washington|Jason Kilmer, Ph.D.|206-685-4512|jkilmer@uw.edu|
20521676|NCT05083585|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20552141|NCT06076694|Clinical Study Center of the First Hospital of Jilin University|TenNor|0512-86861979|info@tennorx.com|
20552142|NCT03336216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20521677|NCT03469336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521678|NCT01090921|BVARI|Nikhil C. Munshi, M.D.|857-203-6172|nikhil_munshi@dfci.harvard.edu|
20521679|NCT00686075|MedImmune, LLC.|Filip Dubovsky, Vice President, Clinical Development|301-398-0000|dubovskyf@medimmune.com|
20521680|NCT02740699|National Heart, Lung, and Blood Institute at the National Institutes of Health|Dr. Marcus Chen|301.496.0077|chenmy@nhlbi.nih.gov|
20521681|NCT01108406|Sonitus Medical, Inc.|Lily Woodby, AuD|8668162076|lily@sonitusmedical.com|
20521682|NCT02585934|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
20521683|NCT04713553|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20521684|NCT03544424|University of Manchester|Dr Joanne Taylor|0161 306 6000|joanne.taylor-2@manchester.ac.uk|
20521685|NCT01359969|Pharming Technologies BV|Anurag Relan, MD, VP Clinical Research & Medical Affairs|+31 715247400|a.relan@pharming.com|
20521686|NCT01996449|UT Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|Wanpen.Vongpatanasin@UTSouthwestern.edu|
20521687|NCT02338193|Woman's Hospital|Dr Karen Elkind-Hirsch, Director of Research|225 231-5278|karen.elkind-hirsch@womans.org|
20521688|NCT02240030|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
20521689|NCT04689867|University of Michigan|Lindsay Bornheimer|(734) 615-2915|bornheim@umich.edu|
20521690|NCT01735955|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20521691|NCT01740726|Emory University School of Medicine|Research Coordinator|404-727-4799|sean.carey@emory.edu|
20521692|NCT00952211|UCSD|Dr. Joel Dimsdale||jdimsdale@ucsd.edu|
20521693|NCT01025453|Memorial Sloan Kettering Cancer Center|Dr. Eric Sherman, MD|646-888-4234|shermane@mskcc.org|
20521694|NCT00936897|Amgen Inc.|Study Director|866-572-6436||
20521695|NCT00417170|Novartis Pharmaceuticals|Study Director|862-778-8300||
20521696|NCT04058067|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20521697|NCT00927394|Novartis Pharmaceuticals|Study Directors|862-778-8300||
20521698|NCT01221363|Research Centre for Prevention and Health|Mette Aadahl|+45 38663359|mette.aadahl@regionh.dk|
20521699|NCT04628793|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521700|NCT02315430|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
20521701|NCT00176423|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
20521702|NCT01329549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20521703|NCT04623086|University of Washington|Arthi Thirumalai|206-221-0521|arthidoc@uw.edu|
20521704|NCT01755767|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20521705|NCT00191165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20521706|NCT00715624|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20521707|NCT03200912|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8259|USMedInfo@tevapharm.com|
20521708|NCT03007238|City of Hope Medical Center|Dr. Amandeep Salhotra|626-359-8111|asalhotra@coh.org|
20521709|NCT03196635|GE Healthcare|Sara Lam|262-548-2369|sara.j.lam@ge.com|
20521710|NCT00735618|UT MD Anderson Cancer Center|Ying Guo, MD, MS/Associate Professor||jaallo@mdanderson.org|
20521711|NCT01273896|Memorial Sloan Kettering Cancer Center|Modi, Shanu/Medicine (Assistant Attending)|+1646-888-4564|modis@mskcc.org|
20521712|NCT00229723|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20521713|NCT02309138|University of Pittsburgh|Director of Center for Research on Health Care Data Center|412-692-2023|dcenter@pitt.edu|
20521714|NCT03369197|The Johns Hopkins University|Dr. Laeben Lester|410-955-7519|llester4@jhmi.edu|
20521715|NCT02677714|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20521716|NCT01045174|University Hospitals Cleveland Medical Center|Dr. Jerri Rose|216-844-7147|jerri.rose@uhhospitals.org|
20521717|NCT01997229|Alexion Pharmaceuticals, Inc.|Jing-Jing Wang, MD|+1 (475) 230-2596|JingJing.Wang@alexion.com|
20521718|NCT00477295|Eisai Call Center|Eisai Inc.|888-422-4743||
20521719|NCT03039179|Istituto Ortopedico Rizzoli|Head of the Research Nursing Unit|0516366694|cristiana.forni@ior.it|0039
20521720|NCT03276780|University of Alabama at Birmingham, Department of Psychiatry and Behavioral Neurobiology|Dr. Karen Cropsey|205-975-4204|kcropsey@uabmc.edu|
20536790|NCT01625416|University of Washington|Dr. Douglas Zatzick|2067446701|dzatzick@uw.edu|
20536791|NCT02561481|Univ of Massachusetts Medical School|Andrew Zimmerman, MD|4109350488|andrew.zimmerman@umassmemorial.org|
20536792|NCT00005947|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
20536793|NCT02146131|Medical University of South Carolina|Kate Taylor|843-792-2297|Talykat@musc.edu|
20536794|NCT02567799|Humanetics Corporation|Michael D. Kaytor|952-400-0406|mkaytor@humaneticscorp.com|
20536795|NCT03335150|VASDHS|Dr. Dawn Schiehser|858-552-8585|Dawn.Schiehser@va.gov|2664
20536796|NCT02991898|Masonic Cancer Center, University of Minnesota|Claudio Brunstein|612-625-3918|bruns072@umn.edu|
20536797|NCT02218697|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536798|NCT03148379|Medacta USA|Rena Mandino, Director of Clinical Research|352-359-3581|rmandino@medacta.us.com|
20536799|NCT04380753|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20536800|NCT05356910|University of California, San Diego|Heather Pines|619-594-2481|hpines@health.ucsd.edu|
20536801|NCT03306433|University of Colorado, SoDM|Clifton Carey|3037241046|clifton.carey@cuanschutz.edu|
20536802|NCT00819156|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20521721|NCT02304458|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20521722|NCT01425723|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
20521723|NCT00390221|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20521724|NCT02351544|The Ohio State University|Dr. Jeffrey Janis|(614) 293-8566|jeffrey.janis@osumc.edu|
20521725|NCT02175576|Zimmer Biomet|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
20521726|NCT03365011|Washington University School of Medicine in St. Louis|Jay F. Piccirillo, MD, FACS|(314) 362-8641|piccirij@wustl.edu|
20521727|NCT03582826|MEBO Research|Maria De la Torre, Executive Director|786 228-6880|maria.delatorre@meboresearch.org|
20521728|NCT00319982|Brigham and Women's Hospital|Carolyn Ho, MD|617-732-5685|cho@partners.org|
20521729|NCT00761865|University of Rochester|Benedict DiGiovanni|5852731611|benedict_digiovanni@urmc.rochester.edu|
20521730|NCT00758680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521731|NCT01246063|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@wustl.edu|
20521732|NCT00810576|UT MD Anderson Cancer Center|Barbara Pro, MD|713-792-2933||
20521733|NCT01565850|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20521734|NCT05065567|SpectrumLakeland|Research Specialist|(240)389-7340|rachelle.pichot@corewellhealth.org|
20521735|NCT03665441|Erytech Pharma Inc|Anu Gupta, Senior Study Team Lead|7327424937|anu.gupta@erytech.com|
20521736|NCT00362466|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20521737|NCT00663026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521738|NCT02487303|Medical University of South Carolina|Sylvia Wilson|8437921414|wilsosh@musc.edu|
20521739|NCT03964649|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521740|NCT03783039|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
20521741|NCT00918138|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20521742|NCT03972163|UMass Chan Medical School|Dr. Jennifer Tjia, Principal Investigator|774-455-3538|jennifer.tjia@umassmed.edu|
20521743|NCT00837473|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20521744|NCT03400943|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20521745|NCT00537303|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20521746|NCT03839823|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20521747|NCT03327792|Yale University|Dr. Suchitra Krishnan-Sarin|203-974-7595|suchitra.krishnan-sarin@yale.edu|
20521748|NCT03490760|Miami Cancer Institute at Baptist Health, Inc.|Michael Chuong, M.D.|(786) 596-2000|michaelchu@baptisthealth.net|
20521749|NCT03511326|Galderma R&D SNC|CTA Coordinator|+33 0493 95 70 85|cta.coordinator@galderma.com|
20521750|NCT01305044|Huntsman Cancer Institute|Anita Kinney, PhD, RN|801-585-1151|anita.kinney@hci.utah.edu|
20521751|NCT04314648|RAND|Dr. Allison Ober|3103930411|ober@rand.org|6639
20521752|NCT01392625|ISCI / University of Miami Miller School of Medicine|Joshua M. Hare, MD|305-243-5579|JHare@med.miami.edu|
20521753|NCT00849186|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20521754|NCT00492024|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20521755|NCT03303196|Children's Hospital of Philadelphia|Lauren Mitteer|267-426-9915|MitteerL@email.chop.edu|
20521756|NCT03416829|Massachusetts General Hospital|Jarrad H Van Stan|617-643-8410|jvanstan@mghihp.edu|
20521757|NCT02351271|Ziemer Ophthalmic Systems AG|Sarah Moyle|970 308 9199|sarah.moyle@ziemergroup.com|
20521758|NCT02201212|Dana Farber Cancer Institute|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
20521759|NCT00867503|University Of Arizona|Dr. Setsuko K Chambers|520/626-0950|schambers@azcc.arizona.edu|
20521760|NCT02704403|GENFIT|Carol Addy, MD MMSc|+01 6179536469|clinicaltrial@genfit.com|
20521761|NCT01839318|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20521762|NCT02287818|TWi Biotechnology Inc.|JingYi Lee|886-2-26571788|jingyi.lee@twibiotech.com|201
20521763|NCT01844856|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
20521764|NCT01001988|Sanofi Pasteur|Medical Director|800-633-1610|RegistryContactUS@sanofi.com|
20521765|NCT03340207|VA Western NY Healthcare System|Dr. Nader D. Nader|716-862-8707|nnader@buffalo.edu|
20521766|NCT00613886|University of California, Irvine|Chris Nishi Clinical Trials Coordinator|949-824-3238|cnishi@uci.edu|
20521767|NCT03421730|Vectura Limited|Gary Burgess, MD|+44 (0)1249 667700|clinical.enquiries@vectura.com|
20521768|NCT02901548|Moffitt Cancer Center|Jingsong Zhang, MD, PhD|813-745-6926|Jingsong.Zhang@moffitt.org|
20521769|NCT01006018|Emory University|Mary Rhee, M.D.|404-778-1666|mrhee@emory.edu|
20521770|NCT01497808|University of Pennsylvania|Dr. Amit Maity|(215) 615-6767|maity@uphs.upenn.edu|
20521771|NCT01338870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521772|NCT02467478|GW MFA|Sabyasachi Sen|3014616676|ssen1@gwu.edu|
20521773|NCT01955083|Chang Gung Memorial Hospital|Dr. Hsueh-Yu Li|886-3-3281200|hyli38@adm.cgmh.org.tw|3967
20521774|NCT00258128|Joslin Diabetes Center|Allison B. Goldfine, MD|617-309-2400|allison.goldfine@joslin.harvard.edu|
20521775|NCT02763826|Medical University or SC|Scott Hutchison, Manager of COBRE Research Operations|843-792-2712|hutchis@musc.edu|
20521776|NCT01559389|Loyola University Medical Center|Elizabeth Mueller, MD|708-216-2180|emuelle@lumc.edu|
20521777|NCT02871492|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
20521778|NCT04546724|Valn|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
20521779|NCT03583086|Vanderbilt-Ingram Cancer Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
20521780|NCT04113785|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
20536803|NCT00703846|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552143|NCT00843713|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|Priscilla.Hsue@ucsf.edu|
20552144|NCT02666183|Case Western Reserve University|Sara L. Douglas, PhD, RN, Professor FPB School of Nursing|216-368-0702|sld4@case.edu|
20552145|NCT05954052|University of Chicago|Karam Radwan, MD|7738346686|radwan@uchicago.edu|
20552146|NCT01957462|Coloplast|Daniel Carter|+45 49222523|dkdac@coloplast.com|
20552147|NCT01856790|Yale University School of Medicine|Dr. Jennifer Sherr|203-785-5831|jennifer.sherr@yale.edu|
20552148|NCT01124604|Neuroscience Department, Clinical Science Department, R&D in Janssen Japan Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
20521781|NCT00435812|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
20552149|NCT04939727|HealthPartners Institute|Dr. Rebecca Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
20521782|NCT00396812|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20521783|NCT01881984|University of Pittsburgh|Dr. Gerard Vockley|412-692-7746|gerard.vockley@chp.edu|
20521784|NCT03201445|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20521785|NCT01228019|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521786|NCT02914210|Duke Clinical Research Institute|Janet Bettger, ScD|919-613-0379|janet.bettger@duke.edu|
20521787|NCT01346293|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20521788|NCT02687217|Lady Hardinge Medical College and associated Hospitals|Dr. Swati Sattavan|9891777424|swatisattavan@gmail.com|91
20521789|NCT01844505|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20521790|NCT02730351|GlaxoSmithKline|GSK Response Center|866-435-7343|sarah.l.west@gsk.com|
20521791|NCT00128830|Tibotec Pharmaceuticals|Trial Physician|+32-14-607-767||
20521792|NCT00311402|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20521793|NCT00838435|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
20521794|NCT02640053|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
20521795|NCT01135186|Stanford University|Dr. Linda Anh B. Nguyen|650-736-5555|nguyenlb@stanford.edu|
20521796|NCT01268501|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
20521797|NCT04058249|Stanford University|Protocol Director|650-800-6920|brainstimulationstudy@stanford.edu|
20521798|NCT04181723|Acadia Pharmaceuticals Inc.|Study Director|844-422-2342|medicalinformation@acadia-pharm.com|
20521799|NCT02754856|University of Texas M D Anderson Cancer Center|Dr. Michael Overman|(713) 792-2828|moverman@mdanderson.org|
20521800|NCT04874155|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
20521801|NCT03735316|Mayo Clinic|James A. Nelson, M.B.B.S.|480-342-1800|Nelson.James1@mayo.edu|
20521802|NCT00530218|City of Hope National Medical Center|Ricardo Spielberger, MD|626-359-8111|RSpielberger@coh.org|65298
20521803|NCT00678886|GlaxoSmithKline|GSK Response Center|866-435-7343||
20521804|NCT03477903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20521805|NCT01147107|University of Hawaii at Manoa John A Burns School of Medicine|Dr. Cecilia Shikuma|8086921328|shikuma@hawaii.edu|
20521806|NCT01413516|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu|
20521807|NCT03480386|Mayo Clinic|Roberto P. Benzo, MD|507-284-0561|Benzo.Roberto@mayo.edu|
20521808|NCT00574912|University of Maryland, Baltimore|Dr. Stephen N. Davis|4103282488|sdavis@medicine.umaryland.edu|
20521809|NCT01282723|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
20521810|NCT04180163|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20521811|NCT04730349|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20521812|NCT02629354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20521813|NCT03155945|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20521814|NCT02013674|ISCI / University of Miami Miller School of Medicine|Marietsy pujol / Senior Regulatory Specialist|305-243-7273|mpujol@med.miami.edu|
20521815|NCT03558061|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20521816|NCT03483363|The University of Texas Health Science Center at Houston|Nagi Demian, MDDS|(713) 500-5082|Nagi.Demian@uth.tmc.edu|
20521817|NCT03433755|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20521818|NCT03936101|Columbia University|Jessica L Giordano, CGC|516-521-5604|jlg2197@cumc.columbia.edu|
20521819|NCT06913153|Tianjin Medical University|Zhenqiang Song, M.S., Associate Professor and Master's Supervisor|8622-18602276218|Zsong@tmu.edu.cn|
20521820|NCT02155543|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20521821|NCT05307510|The University of Toledo|Laura Schmelzer|419-530-5068|laura.schmelzer@utoledo.edu|
20521822|NCT04003896|Penn State Health|Dr. Nelson Yee|7175310003|nyee@pennstatehealth.psu.edu|280677
20521823|NCT01682863|Novartis Pharmaceuticals|Study Director|862-778-8300||
20521824|NCT02315196|Cancer Institute of New Jersey|Deborah L Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu|
20521825|NCT01635218|Hospital Juárez de México|Dr. Emma del Carmen Macías-Cortés|+52 55 5747 7605|ecmc2008@hotmail.es|
20521826|NCT04576923|Indiana University|Samer Gawrieh, MD|317-278-9326|sgawrieh@iu.edu|
20521827|NCT01475097|GE Healthcare|Debra Mansfield|609-514-6329|dabra.mansfield@ge.com|
20521828|NCT01635283|Jonsson Comprehensieve Cancer Center|Dr. Robert Prins|310-825-7647|rprins@mednet.ucla.edu|
20521829|NCT04516759|St George Street Capital|Mike Johnson, Managing Director|+447768335460|mike@sgscapital.org|
20521830|NCT01994291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521831|NCT01775189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521832|NCT00856375|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
20521833|NCT02227446|METRC|Susan Collins|4105028966|scolli21@jhu.edu|
20521834|NCT02121392|University of Chicago Medical Center|Dr. Hue Luu|773-702-6937|hluu@bsd.uchicago.edu|
20521835|NCT01352416|William Beaumont Hospital|Ilana Kutinsky, DO|248-267-5050|ikutinsky@beaumont.edu|
20521836|NCT03904264|Department of Veterans Affairs|Tara Zaugg, AuD / CRH REC Consultant, VISN 20 and REC ICC Clinical Lead, VISN 20|208-422-1000|tara.zaugg@va.gov|
20521837|NCT00819637|Henry Ford Health System, Detroit, Michigan|Richard M Nowak MD|313 881 0023|rnowak1@hfhs.staff|
20521838|NCT01054404|Northwestern University|Dr. John F. Bebawy, Assistant Professor of Anesthesiology & Neurological Surgery|312-695-0061|j-bebawy@northwestern.edu|
20521839|NCT02876757|ICES Western|Blayne Welk|5196466000|blayne.welk@sjhc.london.on.ca|
20521840|NCT00118534|VA Puget Sound (Seattle)|Dr. Miles McFall|(206) 764-2177|Miles.McFall@va.gov|
20521841|NCT00961402|University of Minnesota|Beth Lewis|612-625-0756|blewis@umn.edu|
20521842|NCT03016975|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20552150|NCT03102918|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
20521843|NCT01661062|University of Michigan Comprehensive Cancer Center|Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
20552151|NCT01344447|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20552152|NCT01660711|NorthShore University/University of Chicago|Dr Robert Marsh|847-5702112|rmarsh@northshore.org|
20552153|NCT03460587|UCLA|Steven C. Cramer, MD|424-522-7273|sccramer@mednet.ucla.edu|
20552154|NCT00952341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552155|NCT00456521|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|Medinfo@Orexigen.com|
20552156|NCT01316276|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
20552157|NCT01442363|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
20567133|NCT04347941|National University of Ireland, Galway|Dr Bairbre McNicholas|+35391893063|bmcnicholas@nuigalway.ie|
20552158|NCT00076011|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567134|NCT03131713|Tufts Medical Center|Bichchau Nguyen, Principal Investigato|617-636-1286|bnguyen2@tuftsmedicalcenter.org|
20521844|NCT00873457|Duke University Medical Center|Daphne Friedman, MD|919-684-9220|daphne.friedman@dm.duke.edu|
20552159|NCT04302389|University of Connecticut|Dr. Sherry Pagoto|860-486-8979|sherry.pagoto@uconn.edu|
20521845|NCT00276861|Dept. of Oncology Johns Hopkins Singapore Intl Medical Center|Gilberto Lopes MD|656-880-2240|glopes@imc.jhmi.edu|
20521846|NCT02348723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20521847|NCT01798316|Northwell|Director of Clinical Research, Department of Anesthesiology|718-470-7630|odowling@northwell.edu|
20521848|NCT02910063|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20521849|NCT03496610|Duke University|Hector F. Martinez-Wilson, MD, PhD|919-681-6437|hector.martinez-wilson@duke.edu|
20521850|NCT04435184|Johns Hopkins University - Baltimore, MD|Dr. Charles Lowenstein|4105020391|clowens1@jhmi.edu|
20521851|NCT04693416|University of Tennessee Health Science Center|Karen Derefinko, PhD|901-448-2526|kderefin@uthsc.edu|
20521852|NCT03750292|University of Rochester|Daniel Croft|(585) 275-4861|daniel_croft@urmc.rochester.edu|
20521853|NCT00474266|GlaxoSmithKline|GSK Response Center|866-435-7343||
20521854|NCT00048737|UT MD Anderson Cancer Center|Issa Khouri, MD / Professor||rvalverde@mdanderson.org|
20521855|NCT02774642|San Diego VA Healthcare System|Dr. Peter Colvonen|858-552-8585|peter.colvonen@va.gov|2468
20521856|NCT01404832|Dallas VAMC|Stuart Spechler|214-374-7799|sjspechler@aol.com|
20521857|NCT01695863|Aurora Gastroenterology, West Allis WI|Maqsood Khan MD FACG|414-328-8750|mkhangi@yahoo.com|
20521858|NCT05330468|Abbott|Director, Clinical Programs Structural Interventions & Cardiac Surgery|(651)-202-8362|ryan.palmer@abbott.com|
20521859|NCT00369317|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
20521860|NCT02365558|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20521861|NCT00589329|MetroHealth Medical CEnter|Larraine Presley|216-778-8927|lpresley@metrohealth.org|
20521862|NCT00420459|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
20521863|NCT01687244|FKD Therapies Oy|David Sawutz, PhD|416-607-9515|david.sawutz@fkdtherapies.com|
20521864|NCT01330420|Massachusetts General Hospital|Kathleen Miller, RN|781-485-6176|kmiller16@partners.org|
20521865|NCT02819050|Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center|Virender Rehan|3102221965|vrehan@labiomed.org|
20521866|NCT02373189|Rush University Medical Center|John Burns|13129420379|john_burns@rush.edu|
20521867|NCT03095638|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20521868|NCT06281171|dfusion Inc.|Lane Edwards, MPH, Project Director|8314402192|Lane.edwards@dfusioninc.com|
20521869|NCT01158573|University of Michigan|Michael Coffey M.D.|734-936-6267|coffeym@umich.edu|
20521870|NCT00073021|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20521871|NCT01458106|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
20521872|NCT03835221|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20521873|NCT03375294|Palo Alto Veterans Affairs|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
20521874|NCT00861198|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
20521875|NCT02288182|gwd consult · contract research|Dr. Manfred Klasser|+49 (6108) 8256520|manfred.klasser@gwd-consult.de|
20521876|NCT00612430|Duke University Medical Center|David Reardon, MD|919-668-2329|David_Reardon@DFCI.harvard.edu|
20521877|NCT01088802|Johns Hopkins Medicine|Harry Quon, MD|410-502-3877|hquon2@jhmi.edu|
20521878|NCT02823652|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20521879|NCT04619992|Hollister Incorporated|Director of Global Clinical Affairs|+1 224-206-2857|sara.wegener@hollister.com|
20567135|NCT02764970|Medical University of Graz|Assoc. Prof. Dr. Dirk von Lewinski|31638580684|dirk.von-lewinski@medunigraz.at|316
20521880|NCT01197755|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20521881|NCT04428333|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20552160|NCT05469100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20567136|NCT06631313|Becton, Dickinson and Company|Director of Clinical Affairs|551-225-1164|kirsten.hammitt@bd.com|
20552161|NCT03056755|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20567137|NCT02362789|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20552162|NCT05230082|HealthPartners Institute Neuroscience Research Center|Amanda Herrmann, PhD|651-495-6363|Amanda.A.Herrmann@HealthPartners.com|
20552163|NCT00464568|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552164|NCT02004028|Verastem Oncology|Clinical Trials|+1-781-292-4204|clinicaltrials@verastem.com|
20567138|NCT02684136|HenryFordHS|Timothy Roehrs PhD Study Investigator|313-916-5177|troehrs1@hfhs.org|
20552165|NCT03406858|Wayne State University/Karmanos Cancer Institute|Dr. Abhinav Deol|313-576-8093|deola@karmanos.org|
20552166|NCT06027866|Queen's University Belfast/Western Health & Social Care Trust|Carla McClintock|07706482050|cmcclintock02@qub.ac.uk|
20552167|NCT00930579|Columbia University|Dawn Hershman, MD|212-305-1945|dlh23@cumc.columbia.edu|
20521882|NCT00499174|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
20552168|NCT04434131|University of New Mexico Health Sciences Center|Dr. Michelle Harkins|5052724751|mharkins@salud.unm.edu|
20552169|NCT02672423|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20552170|NCT05071183|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20552171|NCT02046148|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552172|NCT02492269|Nationwide Children's Hosp.|Dr. Aymen Naguib|614-722-4200|Aymen.Naguib@nationwidechildrens.org|
20552173|NCT02420691|UT MD Anderson Cancer Center|Arvind Dasari,MBBS|713-792-2828|adasari@mdanderson.org|
20552174|NCT03002012|University of Minnesota|David Boulware|612-624-1966|boulw001@umn.edu|
20552175|NCT02120950|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20552176|NCT01852812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552177|NCT00177970|UPittsburgh|Dr. George Arnold|4126212334|arnoldgl@upmc.edu|
20552178|NCT01752855|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20552179|NCT02625090|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20552180|NCT03168464|Weill Cornell Medicine|Sharanya Chandrasekhar|646-962-3110|shc2043@med.cornell.edu|
20521883|NCT02269163|Prometic Biotherapeutics Inc|Director, External Biologics|438-802-3497|clinical@prometic.com|
20521884|NCT00804713|USUHS|James Mancuso|301-295-3734|james.mancuso@usuhs.edu|
20552181|NCT04649164|Rush University Medical Center|Dr. Jori Fleisher|3125632900|jori_fleisher@rush.edu|
20521885|NCT01214915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20552182|NCT02250443|Novartis Pharmaceutical|Study Director|862-778-8300||
20552183|NCT01549964|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20521886|NCT01208220|LSUShreveport|Dr. Stanley McCallon|318-813-2996|smccal@lsushc.edu|
20521887|NCT02351960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20521888|NCT03866902|University of Miami|Hudson Santos|3052845812|hsantos@miami.edu|
20521889|NCT00469911|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-0183|groplerr@mir.wustl.edu|
20521890|NCT03613727|Virginia Commonwealth University|BMT- CIT Team|804-628-6430|masseybmt@vcu.edu|
20521891|NCT00638027|University of Rochester|Cynthia Irish, RN, MSCN|585-275-6120|cindy_irish@urmc.rochester.edu|
20521892|NCT02377427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20521893|NCT01143766|Indiana University|Gregory A. Cote|317-944-2740|gcote@iupui.edu|
20521894|NCT01328379|Acorda Therapeutics|Vice President - Clinical Development & Medical Affairs|(914) 347- 4300|hhenney@acorda.com|5138
20552184|NCT01835743|Coughlin Foot and Ankle Clinic|Michael Coughlin, MD|208-367-3330|thefootmd@gmail.com|
20552185|NCT00751348|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552186|NCT02735551|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20552187|NCT00620828|Duke UMC|Michael Bolognesi, MD|919-668-4732|bolog002@mc.duke.edu|2
20521895|NCT02886624|Hôpital Saint Antoine|Prof. Karine Lacombe|+33 1 49 28 24 38|karine.lacombe2@aphp.fr|
20521896|NCT00998868|Seoul National University Hospital|Tai Ryoon Han, MD, PhD./Professor|+82-2-2072-3218|tairyoon@snu.ac.kr|
20521897|NCT03151408|Helsinn Healthcare SA|Francesco Scarci|+41 (0)91 985 1946|francesco.scarci@helsinn.com|
20521898|NCT02784444|Cirius Therapeutics Inc.|Jules Lee|8583336274|jlee@ciriustx.com|514
20552188|NCT02918851|Stony Brook Medicine|Dr. Elliott Bennett-Guerrero|6314442979|elliott.bennett-guerrero@stonybrookmedicine.edu|
20552189|NCT03965962|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20552190|NCT00741039|Memorial Sloan Kettering Cancer Center|Dr. Susan Seo|212-639-3151|seos@mskcc.org|
20552191|NCT01712854|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20552192|NCT01340144|Colorado Joint Replacement|Raymond Kim, MD|720-524-1367|raymondkim@ccentura.org|
20552193|NCT01466387|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20552194|NCT01319877|Hoffmann-La Roche|Medical Communications|800-821-8590||
20552195|NCT01724060|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20521899|NCT03262038|University of Michigan|Elizabeth Putnam|734-763-2435|eread@umich.edu|
20521900|NCT04933968|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
20552196|NCT02677987|Northwestern University Feinberg School of Medicine|Lisa M. Wu, Ph.D.|(312) 503-7722|lisa.wu1@northwestern.edu|
20552197|NCT03200899|The University of Texas at Austin|Dr. Alexa Stuifbergen|+1 (512) 471-4100|astuifbergen@mail.utexas.edu|
20521901|NCT01724489|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@mgh.harvard.edu|
20552198|NCT00302133|University of Miami Miller School of Medicine|Ihsan Salloum, MD, MPH|305 243-7931|isalloum@med.miami.edu|
20552199|NCT00549562|Indiana University School of Medicine|David D. Dunn MD|317-944-8164|ddunn@iupui.edu|
20552200|NCT04439318|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20552201|NCT02485912|University of Oxford|Adrian V Hill, DPhil FRCP||vaccinetrials@ndm.ox.ac.uk|
20552202|NCT00947297|Hyperion Therapeutics|Craig James|650-745 7840|craig.james@hyperiontx.com|
20552203|NCT00699972|Eisai Call Center|Eisai Inc.|888-422-4743||
20552204|NCT02059928|Health Partners|Dr. Ralph J Frascone|6512545304|ralph.j.frascone@healthpartners.com|
20552205|NCT00571259|Satellite Healthcare, Inc.|Veronica Legg, MS: Director of Research Business|360-607-6892|leggv@satellitehealth.com|
20552206|NCT02310919|UCSF Center for Reproductive Health|Dr. Yanett Anaya, Assistant Professor|832-654-8361|Yanett.anaya2@ucsf.edu|
20552207|NCT00922766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567139|NCT00407485|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20552208|NCT02622828|University of Manitoba|Dr. Jacquie Ripat|204-789-3303|jacquie.ripat@umanitoba.ca|
20567140|NCT03861234|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567141|NCT00621842|Case Western Reserve University|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
20552209|NCT01231581|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567142|NCT00432445|University of Texas (UT) MD Anderson Cancer Center|Dan Gombos, MD/Professor, Ophthalmology|713-792-6920|CR_Study_Registration@mdanderson.org|
20552210|NCT03616912|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20567143|NCT00526994|CDC|Joanne Klevens|770-488-1386|dzk8@cdc.gov|
20567144|NCT03026166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20552211|NCT01921829|University of Pittsburgh|Dr. Kelly Liang|507-269-7812|liangk@upmc.edu|
20552212|NCT04091646|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20552213|NCT01762943|University of North Carolina at Chapel Hill|Dr. Crystal Schiller|9199664810|crystal_schiller@med.unc.edu|
20552214|NCT00539838|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20552215|NCT02681549|Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center|Harriet Kluger, MD|(203) 200-6622|harriet.kluger@yale.edu|
20552216|NCT01660893|University of Maryland|Dr. Sharon M. Gordon|410-706-1656|sgordon@dental.umaryland.edu|
20552217|NCT02658890|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20552218|NCT02474199|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20521902|NCT05119348|Desmond Tutu Health Foundation|Dr. Philip Smith|+27216501895|Philip.Smith@hiv-research.org.za|
20521903|NCT01664130|Case Comprehensive Cancer Center|Kevin Stephans MD|216-445-8285|stephak@ccf.org|
20521904|NCT01473524|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20521905|NCT02045147|University of Nebraska Medical Center|Lani Zimmerman|402-472-3847|lzimmerm@unmc.edu|
20521906|NCT04839692|Massachusetts General Hospital|Dr. Dieter Manstein|617-726-4893|dmanstein@mgh.harvard.edu|
20521907|NCT03146962|Weill Cornell Medicine|Dr. Manish Shah, Sponsor-Investigator|646-962-6200|mas9313@med.cornell.edu|
20552219|NCT03090100|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521908|NCT02383810|Helsinn Healthcare SA|Director of Clinical Division|+41 91 9852121|info@helsinn.com|
20521909|NCT02105558|The University of Texas Health Science Center at Houston|Madhumani Rupasinghe, MD|(713) 500-6200|Madhumani.Rupasinghe@uth.tmc.edu|
20521910|NCT03247816|Shield TX (UK) Limited|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
20521911|NCT02861014|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20521912|NCT01837524|Kaiser Center for Clinical and Outcomes Research|Kristina Lewis|404-364-7150|khlewis@wakehealth.edu|
20521913|NCT00926783|Biosense Webster EMEA|Ellen Harris, Sr. Clinical Research Associate, Clinical Operations|(800) 729-9010|eharris@its.jnj.com|
20521914|NCT00696787|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20521915|NCT02278055|Memorial Sloan Kettering Cancer Center|Dr. Michael Morris, MD|646-422-4469|morrism@MSKCC.ORG|
20521916|NCT04040192|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521917|NCT00469144|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
20521918|NCT00717041|University of Rochester|Manish N. Shah, MD MPH|585-275-1198|manish.shah@rochester.edu|
20521919|NCT01292226|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20521920|NCT04106661|Husson University|William Lindblad, Director of Research and Scholarship|20-7992-1958|lindbladw@husson.edu|
20521921|NCT00233402|Photocure|Yngvil Kloster Thomas|+1 2167732505|ykt@photocure.no|
20521922|NCT03503864|Sun Yat-sen Memorial Hospital|Dr Yang Li|02081332045|drliyang@126.com|
20521923|NCT00426361|GlaxoSmithKline|GSK Response Center|866-435-7343||
20521924|NCT02828241|Dr. Reddy's Laboratories|Katherine D'Angelo|609-282-1400|kdangelo@drreddys.com|
20521925|NCT02151877|Advocate Health Care|Chawki Elzein, MD, FACS|7086843029|chawki.elzein@advocatehealth.com|
20521926|NCT02012348|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(585)-657-8390|dermstudies@ucsd.edu|
20521927|NCT04572893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20521928|NCT05038800|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20521929|NCT00121134|DFCI|Dr Harold J. Burstein|617-632-3800|hal_burstein@dfci.harvard.edu|
20521930|NCT04080544|The University of Texas at Dallas|Dr. Joseph Hennessee|408-813-4488|joseph.hennessee@utdallas.edu|
20521931|NCT04967508|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20521932|NCT03316378|University of Iowa, Department of Physical Therapy & Rehabilitation Science|Ruth Chimenti, Assistant Professor|319-335-9791|ruth-chimenti@uiowa.edu|
20521933|NCT03050060|University of Washington|Dr. Ramesh Rengan, Department Chair|206-598-4100|rengan@uw.edu|
20521934|NCT00510289|Duke University Medical Center|David Rizzieri, MD|919-668-1014|David.Rizzieri@duke.edu|
20521935|NCT01436799|Gachon University Gil Medical Center|Dr.HJ Kwak|82-32-460-3400|hyun615@gilhospital.com|
20521936|NCT04853992|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20521937|NCT01094886|Janssen Scientific Affairs, LLC|VP Medical Affairs, Internal Medicine|1 908 218-7250||
20521938|NCT02519738|University of Michigan|Ron Hirschl|734 764-6482|rhirschl@med.umich.edu|
20521939|NCT02062294|Hoffmann-LaRoche|Clinical Operations Department|800-821-8590|switzerland.clinical-research@roche.com|
20521940|NCT00371397|Ohio State University Institute for Behavioral Medicine Research|Janice Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
20521941|NCT01284621|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20521942|NCT02392351|Boston Scientific|Clinical Trial Manager|970-294-4082|nicole.kilburn@bsci.com|
20521943|NCT02342639|University of Kansas Medical Center|Dr. Jason Stubbs|9135886074|jstubbs@kumc.edu|
20521944|NCT02293863|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20521945|NCT00704847|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+45 22901317|bjr@nordicbioscience.com|
20521946|NCT00416884|Center for Hematologic Malignancies|Center for Hematologic Malignancies|503-494-1551||
20521947|NCT03982199|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521948|NCT03395405|Northwestern University Feinberg School of Medicine|Michael G Ison|3126954186|mgison@northwestern.edu|
20521949|NCT05424679|Johns Hopkins Center for Indigenous Health|Dr. Emily Haroz|(410) 449-0051|eharoz1@jhu.edu|
20521950|NCT00450801|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
20521951|NCT05048329|NorthShore university HealthSystem|Nirav S Shah|847-570-3542|nshah@northshore.org|
20521952|NCT00324649|Gilead Sciences|Pedro Ferrer|+34 91 771 2478|pedro.ferrer@gilead.com|
20521953|NCT04684238|Sedana Medical AB|Ida Sverud|+46 8 124 052 00|medinfo@sedanamedical.com|
20521954|NCT01396512|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20521955|NCT02152605|GlaxoSmithKline|GSK Response Center|866-435-7343||
20521956|NCT00470392|Louis Stokes VA Medical Center and University Hospitals Case Medical Center|Kevin D. Cooper MD|216 844 3111|kevin.cooper@uhhospitals.org|
20521957|NCT02657928|Mayo Clinic|Gerardo Colon-Otero, MD|904/953-2000|gcolonotero@mayo.edu|
20521958|NCT01564537|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20521959|NCT05776862|University of Miami|Mark Nash, PhD|305-243-3628|mnash@med.miami.edu|
20521960|NCT02448706|Northwestern University|Pamela Souza|8474912433|p-souza@northwestern.edu|
20521961|NCT01199471|Abbott|Global Medical Services|800-633-9110||
20521962|NCT02065700|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20521963|NCT04732624|University of Washington/Nepal cleft and burn center|Dr. Raslina Shrestha|+977 9849978888|raslinas@uw.edu|
20521964|NCT03634475|Panoptes Pharma|Study Director|+43 664 851 5865|ssperl@kiorapharma.com|
20521965|NCT00554606|Novartis|Study Director|+41613241111|Novartis.email@novartis.com|
20521966|NCT03323437|Weill Cornell Medicine|Dr. Dikoma C. Shungu|212-746-2481|dcs7001@med.cornell.edu|
20521967|NCT00843479|Laboratory of Investigation on Metabolism and Diabetes - LIMED / State University of Campinas - Brazil|Dr. Bruno Geloneze|+55 19 35218589|bgeloneze@terra.com.br|
20521968|NCT01235195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521969|NCT01171118|University of Rochester|Dr. Suzanne Karan|585-275-5161|suzanne_karan@urmc.rochester.edu|
20521970|NCT01544179|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|haiyi.jiang@astrazeneca.com|
20521971|NCT01386983|GlaxoSmithKline|GSK Response Center|866-435-7343||
20521972|NCT00049530|ECOG Statistical Office|Study Statistician|617-632-3012||
20521973|NCT00282919|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521974|NCT04505956|Vanderbilt University Medical Center - Department of Urology|Nicole Miller, M.D.|(615) 322-3807|nicole.miller@vumc.org|
20521975|NCT01917214|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521976|NCT01439009|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
20521977|NCT03257865|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20521978|NCT03857750|Rigshospitalet|Dr. Matias Vested|+4524464955|matiasvested@gmail.com|
20521979|NCT01504958|Beth Israel Deaconess Medical Center|Alvaro Pascual-Leone, M.D., Ph.D.|617-667-0203|apleone@bidmc.harvard.edu|
20521980|NCT00127218|The Johns Hopkins Hospital, Department of Medicine, Division of Cardiology|Dr. Joao AC Lima|410-614-1284|jlima@jhmi.edu|
20521981|NCT01934335|Holden Comprehensive Cancer Center|Ronald Weigel, MD, PhD|319-353-7474|ronald-weigel@uiowa.edu|
20521982|NCT05384171|VA Boston Healthcare system|Dr. Dawne Vogt|857-364-5976|dawne.vogt@va.gov|
20521983|NCT01421511|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
20521984|NCT01111825|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20521985|NCT01377987|Brigham and Women's Hospital|Dr. Scott Sands|617 278 0911|sasands@bwh.harvard.edu|
20552220|NCT05394025|Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System|Project Manager|503-220-8262|Holly.McCready2@va.gov|51856
20552221|NCT02752191|UCLA|J. Paul Finn|(310) 825-5344|ohrpp@research.ucla.edu|
20521986|NCT02137486|cardiovascular section|taipei city hospital Ren-Ai branch|0088627093600|chenyuehchung.tw@yahoo.com.tw|3741
20521987|NCT03150407|J3 Bioscience, Inc|R. Tyler McCabe, Ph.D.|801-550-9956|tmccabe@j3bio.com|
20521988|NCT04893018|Cancer Immunotherapy Trials Network|Clinical Trial Manager|206-667-2541|citn.core.reg@hvtn.org|
20552222|NCT04765358|Jaeb Center for Health Research|Robin Gal|813-975-8690|rgal@jaeb.org|
20521989|NCT00195338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521990|NCT00811928|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20552223|NCT02731729|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
20521991|NCT00599053|University of Alabama at Birmingham|Dr. David Randolph|205-934-4680|drandolph@peds.uab.edu|
20521992|NCT06154200|SCCO at MBKU|Dr. Jerry Paugh, Professor Emeritus|7144497487|jpaugh@ketchum.edu|
20521993|NCT00423319|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20521994|NCT02639052|Lewis Katz School of Medicine at Temple University|Susan G. Fisher, M.S., Ph.D., Associate Dean and Director, Temple Clinical Research Institute|215-707-3577|susan.fisher@tuhs.temple.edu|
20521995|NCT03065218|MedStar Health Research Institute|Dr. Douglas Van Nostrand|202-877-0300|douglasvannostrand@gmail.com|
20521996|NCT02087189|BIOTRONIK SE & Co. KG|Mathias Freudigmann, Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|1248
20521997|NCT01671332|University of Wisconsin|Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
20521998|NCT00635232|Ligand Pharmaceuticals|Director of Project Management|858-550-7892|hzientek@ligand.com|
20521999|NCT05278650|Duke University|Eleanor McConnell, Ph.D.|919-684-9229|eleanor.mcconnell@duke.edu|
20522000|NCT02533375|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20552224|NCT00159588|St. Olavs Hospital|Professor Knut Hagen|+47 95401579|knut.hagen@stolav.no|
20552225|NCT04322396|Gentofte Hospital|Prof. Jens-Ulrik Stæhr Jensen, MD PHD|+4538673057|jens.ulrik.jensen@regionh.dk|
20552226|NCT03446040|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20567145|NCT05270460|Processa Pharmaceuticals Inc.|Dr. Sian Bigora|410-693-6844|sbigora@processapharmaceuticals.com|
20567146|NCT00380250|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20567147|NCT00783952|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-314-2222|rkacmarek@partners.org|
20567148|NCT02170532|Duke University Medical Center|Neil MacIntyre, MD|(919) 681-2720|macin001@mc.duke.edu|
20567149|NCT02833948|The Heart Center - Rigshospitalet, Copenhagen, Denmark|Ole De Backer, MD, PhD|+45-35457086|ole.debacker@gmail.com|
20522001|NCT00673387|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20567150|NCT02397707|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20567151|NCT03897699|University of Minnesota|Dr. Kathryn Cullen|612-273-9732|rega0026@umn.edu|
20567152|NCT00680771|University of rochester|Wilfred Pigeon|(585) 275-3374|Wilfred_pigeon@urmc.rochester.edu|
20567153|NCT02691702|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567154|NCT05613088|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20567155|NCT05169684|Bristol Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20522002|NCT00960115|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20522003|NCT00418821|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20522004|NCT03040323|Indiana University Department of Radiology|Jordan Swensson ,MD|317-944-1831|jswensso@iupui.edu|
20522005|NCT02092467|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522006|NCT03014180|Microport CRM|Director of Scientific Communication|0677164209|anne.rousseauplasse@crm.microport.com|
20522007|NCT02099682|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20522008|NCT02802631|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
20522009|NCT02212379|Inserm, Sorbonne Universite, IPLESP|Dr Lambert Assoumou|0142164280|lambert.assoumou@iplesp.upmc.fr|
20522010|NCT00704730|Exelixis, Inc|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20522011|NCT04308226|Division of General Internal Medicine, Massachusetts General Hospital|Travis Baggett, MD, MPH|617-643-9314|tbaggett@mgh.harvard.edu|
20522012|NCT00213135|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20522013|NCT01908907|Sanford Health|Lora Black, Senior Director of Clinical Research|605-328-1368|lora.black@sanfordhealth.org|
20522014|NCT00660907|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20522015|NCT04975191|Rutgers University|Dr. Danielle Dick|732-235-5607|Danielle.M.Dick@rutgers.edu|
20522016|NCT05264129|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20522017|NCT00761657|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
20522018|NCT04648696|Wake Forest University Health Sciences|John Williamson, PhD|336.713.3431|johnwill@wakehealth.edu|
20522019|NCT03593538|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
20522020|NCT00618332|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
20522021|NCT00359801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20522022|NCT01027195|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
20522023|NCT00826007|William Beaumont Hospital|Tamra Dukatz, CRNA, MSN|2489924741|tdukatz@beaumont.edu|
20522024|NCT02929056|Prisma Health|Dr. Thomas Oliver|864-454-8272|Tom.Oliver@prismahealth.org|
20522025|NCT02420912|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD/Associate Professor|713-745-6080|njain@mdanderson.org|
20522026|NCT02245412|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20522027|NCT01056289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522028|NCT01917916|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552227|NCT00605475|Novartis Pharmaceuticals|Study Director|862 778 8300||
20522029|NCT01650584|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20522030|NCT00402116|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20522031|NCT00270855|Penn State Hershey Medical Center|Dr. David Gater|7175314263|dgater@hmc.psu.edu|
20522032|NCT01794455|Vanderbilt University|Dr. Warren Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
20522033|NCT02711878|Emory university|Dr. Eun Ok IM|404-712-9805|eun.ok.im@emory.edu|
20522034|NCT02618759|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20567156|NCT01668719|SWOG Statistics and Data Management Center|Myeloma Committee Statistician|2066674623|rachaels@crab.org|
20522035|NCT01988129|Brigham and Women's Hospital|Steven W. Lockley PhD|16177324977|slockley@hms.harvard.edu|
20522036|NCT02500043|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20522037|NCT01371747|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20522038|NCT02094417|Kyowa Kirin Korea Co. Ltd.,|Clinical Development Team, Clinical Development Department|82221912918|kyungmo.lee.m6@kyowakirin.com|
20567157|NCT03539055|Vanderbilt Cardiovascular Research Enterprise|Terry Weyand, MS., CCRP|6153229349|terry.l.weyand@vumc.org|
20567158|NCT03796767|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20567159|NCT04603586|Changhai Hospital|Xiaofei Zhu|86-021-31162222|zhuxiaofei_zxf@163.com|
20567160|NCT04939233|Departments of Mechanical Engineering and Electrical and Computer Engineering, Virginia Tech|Dr. Pinhas Ben-Tzvi|NA|bentzvi@vt.edu|
20567161|NCT02506283|University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr. Erich Hohenauer|+41813000175|erich.hohenauer@supsi.ch|
20567162|NCT01638000|Astellas Pharma Europe Ltd|Medical Director||Astellas.resultsdisclosure@astellas.com|
20567163|NCT05484661|UT Health San Antonio|Monica Serra|210-949-9759|serram@Uthscsa.edu|
20567164|NCT00875706|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
20567165|NCT03652610|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20567166|NCT03775213|Duke University|Dr. Marc D. Ryser|(919) 684 8294|marc.ryser@duke.edu|
20567167|NCT00786188|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
20567168|NCT00326183|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20567169|NCT01990794|Cardno|Dr. David Galbraith|415-618-3211|david.galbraith@cardno.com|
20567170|NCT01742832|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
20522039|NCT03022084|VA RR&D National Center for Rehabilitative Auditory Research|Dr. James Henry|503-220-8262|James.Henry@va.gov|
20536804|NCT04601532|University of Pittsburgh|Eleanor Shirley, MA CCRC|412-383-7712|shirleye@upmc.edu|
20552228|NCT02596854|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
20552229|NCT01797328|UHLinkopeing|Fredrik H Nystrom|+46101037749|fredrik.h.nystrom@liu.se|
20552230|NCT04773158|Indiana University School of Medicine, Pediatrics|William E Bennett, MD|317-944-3774|webjr@iu.edu|
20552231|NCT03897179|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20552232|NCT00704535|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20552233|NCT01480076|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20552234|NCT02503332|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20552235|NCT04053101|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
20552236|NCT04415281|University of Florida|Eric Weber|3522737802|ebweber@ufl.edu|
20552237|NCT05694546|University of Maryland Baltimore|Cassidy Claassen|316-727-6185|cclaassen@ihv.umaryland.edu|
20552238|NCT02424383|Becton Dickinson|Sharon Christensen|612-757-0750|Sharon.Christensen@bd.com|
20552239|NCT03559179|HealthPartners Institute|Dr. Rebecca C Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
20552240|NCT00325754|Harbo-UCLA Research and Education Institute|Richard Casaburi|310-22-8249|casaburi@ucla.edu|
20552241|NCT01334723|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552242|NCT03836963|Edward Hines Jr. VA Hospital|Sandra Kletzel|708-202-5735|sandra.kletzel@va.gov|
20552243|NCT02916563|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|3037246713|satish.garg@ucdenver.edu|
20552244|NCT02149173|University of Washington|Hannah M Linden|206-606-2053|hmlinden@uw.edu|
20552245|NCT01969812|Atrium Health|Bradley Hurst, M.D.|704-355-3153|brad.hurst@atriumhealth.org|
20552246|NCT04916795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552247|NCT02290821|Novartis Consumer Health|Clinical Research Director Pain, CH Clinical Research & Development Lead|+41225672574||
20552248|NCT02438722|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
20552249|NCT02449174|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
20552250|NCT02653456|Ra Medical Systems, Inc.|Vice President of Regulatory Affairs and Quality Assurance|877-635-1800|vchester@ramed.com|207
20552251|NCT01520363|Hugo W. Moser Research Institute at Kennedy Krieger , Inc.|Dr. Sakkubai Naidu|443 923 2778|naidu@kennedykrieger.org|
20552252|NCT00178841|Vanderbilt University Dermatology|John Zic, MD|615-322-6485|john.zic@vanderbilt.edu|
20552253|NCT04191382|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20552254|NCT05237206|Alloplex Biotherapeutics|Dr. Sharron Gargosky, Chief Development Offier|+1 503-915-1400|sgargosky@alloplexbio.com|
20552255|NCT03038815|Institute for Biomechanics ETH Zürich|Silvio Lorenzetti|078 608 14 84|sl@ethz.ch|
20552256|NCT01476696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20552257|NCT05365750|Kaiser Permanente Colorado|Ingrid A Binswanger, MD, MPH|720-416-7104|ingrid.a.binswanger@kp.org|
20552258|NCT04962009|Mati Therapeutics Inc.|Deepank Utkhede|778-991-3301|dutkhede@matitherapeutics.com|
20552259|NCT00768144|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
20567171|NCT03787628|UCLA David Geffen School of Medicine|Dr. Edythe London|3106142150|elondon@mednet.ucla.edu|
20567172|NCT00570505|Apollo Endosurgery|Laura Eaton|949-468-9301|laura.eaton@apolloendo.com|
20567173|NCT03016871|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
20567174|NCT02485925|Biosense Webster, Inc.|Kendra McInnis|949-450-7783|kmcinnis@its.jnj.com|
20567175|NCT06922643|Nanogen Biopharmaceutical JSC|Dr. Thuy Phuong Nguyen|+84 903 754 559|phuongthuy@nanogenpharma.com|
20567176|NCT06943638|"General Oncology Hospital of Kifissia Agioi Anargyroi"|Christine Mavrogiannopoulou, Physiotherapist and Study coordinator|+30 6941464095|x.mavrogiannopoulou@gmail.com|
20567177|NCT05992350|Children's Mercy Research Institute|Priscilla Connell|8166014543|Endocrine-RisingT1deAlliance@cmh.edu|
20567178|NCT01668355|VA|Alexander Young|310-794-7219|alexander.young@va.gov|
20567179|NCT02786966|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
20567180|NCT03627299|Johns Hopkins University|Christine Durand, MD|410-955-5684|ChristineDurand@jhmi.edu|
20567181|NCT01190124|Hospital de Santa Maria - Centro Hospitalar Lisboa Norte|Doroana, Maria Manuela, M.D.|351 217938043|manuela.doroana@hsm.min-saude.pt|
20567182|NCT00070707|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20567183|NCT03690219|Rehabilitation Research Laboratory, University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr Ron Clijsen|0041 81 300 01 78|ron.clijsen@supsi.ch|
20567184|NCT01523392|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
20567185|NCT04809623|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20567186|NCT02354417|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
20567187|NCT01928732|Palo Alto CSPCC|Lisa Zehm|(650) 493-5000|Lisa.Zehm@va.gov|28805
20567188|NCT01185340|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20567189|NCT01719172|Covidien|Julie Totten|781-839-1729|Julie.Totten@Covidien.com|
20552260|NCT01150123|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20552261|NCT05821842|Sound Health Systems, Inc.|Paramesh Gopi|313-509-8237|pgopi@soundhealth.life|
20552262|NCT02530450|UT Health Science Center in San Antonio|Dr. Maria Rayas, Assistant Professor in Pediatric Endocrinology and Diabetes|210-567-5283|rayas@uthscsa.edu|
20552263|NCT01057017|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
20552264|NCT02347189|Medtronic|Megan Mueller, Clinical Research Manager|612-916-4771|megan.d.mueller@medtronic.com|
20552265|NCT00091273|University of Virginia|Craig L. Slingluff, MD|434-924-1730|cls8h@virginia.edu|
20552266|NCT00673179|UT MD Anderson Cancer Center|Peter M. Anderson, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
20552267|NCT03745092|Xuanwu Hospital, Capital Medical University|Pro. Ran Meng|+86-10-83199280|ranmeng2011@pku.org.cn|
20552268|NCT01531387|St. Jude Children's Research Hospital|James M. Boyett, PhD|901-595-4986|james.boyett@stjude.org|
20552269|NCT04248933|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
20552270|NCT00578942|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20552271|NCT02753699|Debiopharm International, S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20552272|NCT01412866|DArtmouth-Hitchcock|Mary F. Brunette|603-27105747|mary.f.brunette@dartmouth.edu|
20552273|NCT00128921|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
20552274|NCT00323115|Dartmouth-Hitchcock Medical Center|Dr. Camilo Fadul|603-653-6312|camilo.e.fadul@hitchcock.org|
20552275|NCT03509675|University of Washington|Stuart Taylor|206-221-3772|stuartt@uw.edu|
20552276|NCT03898349|VA|Vera Yakovchenko|7816873374|vera.yakovchenko@va.gov|
20552277|NCT04296006|University of Kentucky|Joshua Lile, Ph.D.|859-323-6034|jalile2@uky.edu|
20552278|NCT03314584|VAORD|Dr. Albert Leung|858-552-8585|ayleung@health.ucsd.edu|3331
20552279|NCT06134817|NYU Langone Health|Bedros Taslakian, MD|332-237-9866|Bedros.Taslakian@nyulangone.org|
20552280|NCT04345614|CalciMedica, Inc.|Sudarshan Hebbar, MD|8168387105|sudarshan@calcimedica.com|
20552281|NCT04133168|Boston Scientific|Stephanie Roelke, Clinical Trial Manager|651-582-4000|Stephanie.Roelke@bsci.com|
20552282|NCT02855437|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
20552283|NCT03970590|VA Bedford Healthcare System Center for Health Organization and Implementation Research|Sarah Cutrona, MD|781-687-2861|sarah.cutrona@va.gov|
20552284|NCT04343521|Emory University|Gonzalo Vazquez-Prokopec, PhD|404-727-4217|gmvazqu@emory.edu|
20552285|NCT02532647|PAION UK Ltd|Trial Information||reg_paion@paion.com|
20552286|NCT02939560|Medical University of South Carolina|McLeod F. Gwynette, MD|843-792-9162|gwynette@musc.edu|
20552287|NCT00634088|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20552288|NCT00499096|Department of Veterans Affairs|Dr. Amy M. Kilbourne, PhD, MPH|734-845-3502|Amy.Kilbourne@va.gov|
20552289|NCT01110421|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
20552290|NCT02439320|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20552291|NCT03343483|University of Rochester Medical Center|Dr. Kim Van Orden (PI)|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
20552292|NCT01272830|Clinic Orthopaedic Center|Thomas Bear, MD|330-375-3906|kovacikm@summahealth.org|
20552293|NCT01251380|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20552294|NCT00600756|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
20552295|NCT04503564|Capillary BioMedical, Inc.|Director of Clinical Affairs|949-317-1711|alayne.lehman@capillarybio.com|
20552296|NCT03261947|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20552297|NCT03969992|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
20552298|NCT02063737|Carolinas HealthCare System|Dr. Daniel Patterson|704-446-0433|Daniel.Patterson@carolinas.org|
20567190|NCT01148017|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20567191|NCT01848483|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
20567192|NCT05062161|Columbia University Medical Center|Marwah Abdalla|212 342 1275|ma2947@cumc.columbia.edu|
20567193|NCT01093690|Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University|Suthinee Ithimakin, MD|6624197000|aesi105@yahoo.co.th|4489
20567194|NCT00246129|imperial College Kidney & Transplant Centre|Dr Adam McLean|+44 (0) 208 383 5164|adam.mclean@imperial.nhs.uk|356164
20567195|NCT03740737|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20567196|NCT03469258|Beth Israel Deaconess Medical Center|A. James Moser, MD|(617) 632-1032|ajmoser@bidmc.harvard.edu|
20567197|NCT02005172|University at Buffalo|Deepika Narasimha||deepikan@buffalo.edu|
20567198|NCT02236611|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567199|NCT03041090|Saint Louis University|Medhat Osman, MD, PhD - Professor of Radiology, Director of Nuclear Medicine and PET/CT|314-577-8047|medhat.osman@health.slu.edu|
20567200|NCT03403036|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
20567201|NCT02701296|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Sanjay Sinha, MD||sanjaysinha@comcast.net|
20567202|NCT01682928|Mednax|Ana Braescu|480-969-5999|ana_braescu@mednax.com|
20567203|NCT01409837|University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu|Dr. Anthony Mbah, Principal investigator|2348051519065|cmd_unth@yahoo.com|
20567204|NCT01335061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567205|NCT03851094|ResMed|Clinical Research Team|800-424-0737|clinicaltrials@resmed.com.au|
20567206|NCT00484198|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20567207|NCT03302091|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567208|NCT01536704|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567209|NCT03490032|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20567210|NCT00308308|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20567211|NCT02392507|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20567212|NCT02551224|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20567213|NCT01802333|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|206-667-4623|amoseley@fredhutch.org|
20567214|NCT01759459|Allina Health|David Gurda|612-863-6566|david.gurda@allina.com|
20567215|NCT01299285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20567216|NCT01021748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567217|NCT01829711|MedImmune, LLC|Priti Patel|+1-650-264-9079|information.center@astrazeneca.com|
20567218|NCT03259568|Dept of Neurology, Duke University School of Medicine|Simon W Davis|9195991927|simon.davis@duke.edu|
20567219|NCT04248868|Eminence Clinical Research, Inc.|Christopher A. Schultz|9715067552|cschultz@ecr-inc.com|
20567220|NCT03128099|Vanderbilt University|Dr. Sohee Park, Project Director|6153223435|sohee.park@vanderbilt.edu|
20567221|NCT00089791|Amgen Inc.|Study Director|866-572-6436||
20567222|NCT02941692|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
20567223|NCT02527694|Seoul National University Hospital|So Yeon Kong|82220724412|soyeon.kong@gmail.com|
20567224|NCT02070276|Hôpitaux Universitaires de Genève|Dr. med. Samuele Ceruti|0765661181|samuele.ceruti@me.com|
20567225|NCT05074433|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20567226|NCT04397263|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20567227|NCT01989689|Emory University|Arshed Ali Quyyumi MD/FACC|404-727-3655|aquyyum@emory.edu|
20567228|NCT02066636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20567229|NCT04806100|The University of Iowa|Jason M Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
20567230|NCT00391170|National Heart Lung and Blood Institute|Clara, Joseph|+1 301 402 2399|joseph.clara@nih.gov|
20567231|NCT02494336|Johns Hopkins All Children's Hospital|Nicole Chandler, MD|7277674170|nicole.chandler@jhmi.edu|
20567232|NCT01989793|Johns Hopkins University|Dr. Jeremy D. Walston, M.D. , Raymond and Anna Lublin Professor of Geriatric Medicine|410-550-1003|jwalston@jhmi.edu|
20567233|NCT02696200|Cincinnati Childrens Hospital|Kim Foss|513-636-5971|kim.foss@cchmc.org|
20567234|NCT03567616|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20567235|NCT00849485|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-3848-5525|clinicaltrialqueries@tevausa.com|
20567236|NCT01235936|Akebia Therapeutics, Inc|Akebia Therapeutics, Inc|617-844-6128|trials@akebia.com|
20567237|NCT00556478|Plethora Solutions|Chief Scientific Officer|+44 (0) 20 3077 5400|mail@plethorasolutions.co.uk|
20567238|NCT00705159|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20567239|NCT03205488|Northwestern University|Dr. Tanya Simuni|312-503-2970|Tatyana.Simuni@nm.org|
20567240|NCT00824408|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567241|NCT02110381|University of Michigan|Dr. Elizabeth Jackson|734-998-7411|lisjacks@med.umich.edu|
20567242|NCT04821271|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
20567243|NCT02521493|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20522040|NCT01701011|UMCU|Henrietta Ockhuijsen 1,*, Agnes van den Hoogen, Marinus Eijkemans , Nick Macklon, Jacky Boivin|+31307553628|h.d.l.ockhuysen@umcutrecht.nl|
20567244|NCT01218594|Sun Yat-Sen University Cancer Center|Ming Chen|86-20-87343640|chenming@sysucc.org.cn|
20567245|NCT01450397|Hospital for Special Surgery|Scott W. Wolfe|212-606-1529|WolfeS@hss.edu|
20567246|NCT03530631|University of Alabama, Birmingham|Karen Cropsey|(205) 975-7809|kcropsey@uabmc.edu|
20567247|NCT00286325|Duke University Medical Center|Dr. Russell P Hall|919-684-3110|hall0009@mc.duke.edu|
20567248|NCT07016568|LLC UkrMedGroup|Yevheniia Poliakova|+380502818399|jenyapolyakova@gmail.com|
20567249|NCT03905642|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
20567250|NCT02159989|MD Anderson Cancer Center|Aung Naing|713-563-3885|anaing@mdanderson.org|
20567251|NCT05338476|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20567252|NCT06716632|Gulab Devi Hospital, Lahore|Dr. Zain Himayoun|03043862033|Zain.1080@gmail.com|
20567253|NCT04937504|Boston Medical Center, Psychiatry Department|Sarah Valentine, PhD|(617) 414-1989|sarah.valentine@bmc.org|
20567254|NCT01212822|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
20567255|NCT01128959|Lundbeck LCC|Lundbeck LLC|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
20506533|NCT00980785|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-256-1901|cmc@medicine.wisc.edu|11691
20567256|NCT01332266|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20567257|NCT01947491|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
20567258|NCT00724009|The University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
20567259|NCT03236779|Head of iPhysio Research Group. Editor-in-Chief Journal of Invasive Techniques in Physical Therapy|Dr. Pablo Herrero Gallego. PT, PhD.|(+34) 646168248|pherrero@usj.es|
20506534|NCT04281030|NYU Langone Health|Mia Minen|9294555130|Mia.Minen@nyulangone.org|
20506535|NCT01395368|Washington University in St. Louis|Dr. Jay F. Piccirillo, Professor|314 362-8641|piccirilloj@ent.wustl.edu|
20567260|NCT03070548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
20567261|NCT01260883|Seattle Children's Hospital|Anne Lynn MD|206 987-2518|anne.lynn@seattlechildrens.org|
20567262|NCT02935673|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20567263|NCT01836523|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20506536|NCT03474406|Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University.|Asist. Prof. Suratsawadee Wangnamthip|6624197842|suratsawadee.wan@mahidol.ac.th|
20506537|NCT00922194|Sircar Diabetes Clinic|Dr. Amulya R Sircar|+ 91 (522) 2324747|arsircar@yahoo.com|
20506538|NCT04131517|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20506539|NCT00288860|Nationa Center for PTSD Dissemination & Training Division|Craig S. Rosen|650-493-5000|craig.rosen@va.gov|22812
20567264|NCT03775915|University of Oxford|Dr Melanie Fleming, Research Associate|+441865611461|melanie.fleming@ndcn.ox.ac.uk|
20506540|NCT05142332|University of California San Francsico|Robert Rodriguez|(628) 206-5875|Robert.Rodriguez@ucsf.edu|
20567265|NCT00624377|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567266|NCT03054506|Massachusetts General Hospital|Dr. Kyle Staller|617-726-3080|kstaller@mgh.harvard.edu|
20506541|NCT00390416|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
20567267|NCT00148122|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
20506542|NCT01219959|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20506543|NCT01842841|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20506544|NCT01409031|University of Colorado, Denver|John Kinsella, MD|303-724-2853|John.Kinsella@ucdenver.edu|
20567268|NCT00274287|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
20567269|NCT04492475|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20506545|NCT02345252|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20506546|NCT01504854|Alzheimer's Disease Cooperative Study|Michael Rafii, MD, PhD|858-846-1300|mrafii@ucsd.edu|
20506547|NCT01094730|Johnson & Johnson Vision Care|John R. Buch, O.D., M.S., F.A.A.O., Principal Research Optometrist|1-904-443-1707|jbuch@its.jnj.com|
20567270|NCT03150758|Cleveland Clinic|Dr. Eric Klein|1-800-223-2273|CancerCenterResearch@ccf.org|
20506548|NCT02232087|Quotient Clinical Ltd|Pui Leung|44(0)115 974 9000|Pui Leung <Pui.Leung@quotientclinical.com>|
20506549|NCT01958125|electroCore Inc.|Director Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20567271|NCT02359916|Rush University Medical Center|Brad Appelhans, PhD (PI)|312-942-3477|brad_appelhans@rush.edu|
20567272|NCT03200574|Corcym S.r.l.|Elisa Cerutti|+393459182413|elisa.cerutti@corcym.com|
20506550|NCT04096326|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
20567273|NCT02233998|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20567274|NCT03035942|Pontificia Catholic University of Sao Paulo|Dr. Eduardo Toshiyuki Moro|+5515997728015|edumoro85@gmail.com|
20506551|NCT04804033|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567275|NCT01989104|Pennington Biomedical Research Center|Dr. William Johnson|225-763-2932|William.Johnson@pbrc.edu|
20506552|NCT01879176|Medical University of Vienna|Dr. Martin H. Bernardi|004314040041090|martin.bernardi@meduniwien.ac.at|
20506553|NCT03929588|EyeQue|VP Science and Technology|5104558168|noam.sapiens@eyeque.com|
20567276|NCT02074384|Park Nicollet Institute|Dr. Deborah Mullen|952-993-2070|deborah.mullen@parknicollet.com|
20506554|NCT02335216|St. Jude Medical|Roni Diaz|+19723098601|rdiaz@sjm.com|
20567277|NCT05163353|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20567278|NCT02790281|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20567279|NCT06086028|Tulane University|Leia Y. Saltzman Associate Professor|504-247-1452|lsaltzman@tulane.edu|
20567280|NCT00718120|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567281|NCT03292692|University of Miami|Dr. Brian Doss|305-284-1101|bdoss@miami.edu|
20567282|NCT05640167|University of Rhode Island|Dr Christine Clarkin, Principal Investigator|4018742998|chrisclarkin@uri.edu|
20506555|NCT01672996|GE Healthcare|Rubin Sheng, MD|609-514-6899|Rubin.Sheng@ge.com|
20506556|NCT03591146|Taiwan Liposome Company|Cynthia Lin|+886 2 2655 7377|cynthia_lin@tlcbio.com|
20506557|NCT04737031|University of Pennsylvania|Robert Schnoll, PhD|215.746.7143|schnoll@pennmedicine.upenn.edu|
20506558|NCT02435277|NuSirt Biopharma|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
20506559|NCT01067508|UCLA Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
20506560|NCT00962039|The Ohio State University|John V. Campo|614-581-5984|john.campo@hsc.wvu.edu|
20506561|NCT00462020|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
20506562|NCT00958308|Bio-K+ International. Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
20506563|NCT01468909|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
20506564|NCT02635737|UHSM|Mr James Harvey|01612914436|james.harvey@uhsm.nhs.uk|
20506565|NCT01552928|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20506566|NCT01511419|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20506567|NCT00937768|Mayo Clinic|Dr. R. Jeffrey Karnes|507 284-4430|Karnes.R@mayo.edu|
20506568|NCT03302793|UTHealth|Dr. Sheng Li|713-797-7125|Sheng.Li@uth.tmc.edu|
20506569|NCT04357379|Medical University of South Carolina|Dr. Tracy Smith|8437925164|smithtra@musc.edu|
20506570|NCT06704178|Citruslabs|Patrick Renner|+1 805-876-4484|hello@citruslabs.com|
20567283|NCT04083781|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20506571|NCT00992446|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20506572|NCT00755846|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20506573|NCT04047121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506574|NCT00810459|Philips|Jeff Jasko|412-542-3651|Jeff.Jasko@philips.com|
20506575|NCT02604810|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20506576|NCT03754933|GeoVax, Inc.|Kelly T. McKee, Jr., MD, MPH|(678) 384-7220|kmckee@geovax.com|
20506577|NCT02922634|BWH|Dr. Gregory Crosby|617-732-7330|gcrosby@bwh.harvard.edu|
20506578|NCT02723604|Barbara Ann Karmanos Cancer Institute|Dr. Harold Kim|313-576-9543|kimh@karmanos.org|
20506579|NCT00311181|St Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
20506580|NCT03534063|University of Florida|Dr. Larisa Cavallari|(352) 273-8245|LCavallari@cop.ufl.edu|
20506581|NCT00078559|University of Wisconsin - Department of Medicine, Madison, Wisconsin|Arjang Djamali, MD, MS, FASN|608-262-7330|axd@medicine.wisc.edu|
20506582|NCT01313520|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20506583|NCT00506948|University of Texas (UT) MD Anderson Cancer Center|Amin Alousi, MD /Professor, Stem Cell Transplantation|713-745-8613|aalousi@mdanderson.org|
20506584|NCT02395653|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
20506585|NCT01194804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
20506586|NCT02494778|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
20506587|NCT01303380|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20506588|NCT03621943|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
20506589|NCT02174861|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20506590|NCT01215734|Vanderbilt University|Natasha Halasa, Associate Professor of Pediatrics|615-322-3346|natasha.halasa@vanderbilt.edu|
20567284|NCT03803475|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
20567285|NCT01880736|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20567286|NCT01706666|Mayo Clinic Cancer Center|Craig B Reeder, MD|4803018335|Reeder.Craig@mayo.edu|
20567287|NCT02203032|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20567288|NCT01640340|Ohio State University Medical Center|Rachel Layman, MD|614-293-0066|Rachel.Layman@osumc.edu|
20567289|NCT02241785|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20567290|NCT04748341|Lahore school of nursing, University of lahore, Pakistan|Ms. Mishal Liaqat (Principal Investigator)|+923441481666|mishee861@gmail.com|
20567291|NCT01213940|University of South Alabama, Department of Surgery|William O. Richards, MD|251-471-7993|brichards@health.southalabama.edu|
20567292|NCT02106325|New York University School of Medicine|Stephen Ross, MD/ Principal Investigator|212 562 4097|Stephen.Ross@nyumc.org|
20567293|NCT00452114|University of Massachusetts Medical School|Stephen Krinzman, Principal Investigator|508-856-1975|stephen.krinzman@umassmed.edu|
20567294|NCT02656199|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
20567295|NCT04197713|University of M D Anderson Cancer Center|Dr. Timothy Yap|713) 563-1784|tyap@mdanderson.org|
20567296|NCT02334215|Friends Research Institute|Robert P. Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
20567297|NCT05615363|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20567298|NCT01836445|Northwestern University|Dr. Brian Mustanski|312-503-5421|brian@northwestern.edu|
20567299|NCT04602728|Emory University|Soumitri Sil, PhD|404-727-2712|soumitri.sil@emory.edu|
20567300|NCT03365622|University of Rochester Medical Center|Joseph Dooley, MD|5852752141|joseph_dooley@urmc.rochester.edu|
20567301|NCT05376449|HealthPartners Institute Neuroscience Research Center|Amanda Herrmann, PhD|651-495-6363|Amanda.A.Herrmann@HealthPartners.com|
20567302|NCT06164743|VivaVisionBio|Dr. Joanne Li|(86) 021-58598290|joanne.li@vivavisionbio.com|
20567303|NCT00210236|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Palissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20567304|NCT05289037|The Hope Clinic of Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20567305|NCT02831049|National Institute on Drug Abuse (NIDA)|Dr David Epstein|1-667-312-5092|david.epstein@nih.gov|
20567306|NCT05995977|Karaman Provincial Health Directorate|Handan Altunkan|05367443152|handanaltunkan@gmail.com|
20567307|NCT04181788|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567308|NCT04025125|Duke University|Gerald Bloomfield|919-668-8702|gerald.bloomfield@duke.edu|
20567309|NCT04535414|National Cancer Institute|Dr. Andrew Blakely|240-760-7647|andrew.blakely@nih.gov|
20567310|NCT03662659|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20567311|NCT04852978|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|18447346643|clinicaltrials@regeneron.com|
20567312|NCT02421679|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|862-904-0355|greg.sullivan@tonixpharma.com|
20567313|NCT01458015|Universitätsklinikum Schleswig-Holstein, Campus Kiel; Sektion neurologische Schmerzforschung und -therapie|Prof. Ralf Baron|+4943123911|r.baron@neurologie.uni-kiel.de|
20567314|NCT01276509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20567315|NCT01534052|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|800-888-7704 Ext:5473|astellas.resultsdisclosure@astellas.com|
20567316|NCT06149416|Stryker Sustainability Solutions|Senior Principal Regulatory Affairs|5602-410-0204|moira.barton@stryker.com|
20567317|NCT04173000|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20567318|NCT02470312|Abbott|Kristin Ruffner, Clinical Program Director|+1 651 756 6717|Kristin.Ruffner@abbott.com|
20567319|NCT00535626|Stryker Orthopedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
20567320|NCT02830893|University of California Irvine|Dr. Steven Cramer|(949) 824-8423|SCCramer@mednet.ucla.edu|
20567321|NCT01277302|Genentech, Inc.|Medical Communications|800 821-8590||
20567322|NCT01386632|Sanford Clinical Research|Dr. Steven Powell|605-328-8000|patientquestionsSHDCA@sanfordhealth.org|
20567323|NCT02710669|Vanderbilt University Medical Center|Benjamin Shoemaker, MD|615-322-2318|moore.b.shoemaker@vumc.org|
20567324|NCT03332589|Spirita Oncology, LLC|Chief Development Officer|+1 (713) 898-8965|linda.paradiso@spiritaoncology.com|
20567325|NCT04633200|Environment and Health Group|Patricia Flynn Weitzman|617-455-5976|pat.weitzman@gmail.com|
20567326|NCT02507297|University of Michigan|Leslie Swanson|734-764-2242|lmswan@umich.edu|
20567327|NCT02489799|The Johns Hopkins University School of Medicine|Rebecca Aslakson, M.D., Ph.D.|410-955-9082|raslaks1@jhmi.edu|
20567328|NCT05139615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567329|NCT03462966|Cedars-Sinai medical center|Mohamad Rashid|310-423-0617|mohamad.rashid@cshs.org|
20567330|NCT04669366|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567331|NCT01808534|IndianaU|Dr. Lawrence H. Einhorn|(317)274-3515|leinhorn@iu.edu|
20567332|NCT01377844|Theracos Sub, LLC|Albert Collinson, Ph.D.|(508) 688-4221|acollinson@theracos.com|
20567333|NCT02092285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567334|NCT00087516|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20567335|NCT00278395|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
20567336|NCT02494076|University Colorado School of Medicine, Chidren's Hospital Colorado|Nidhya Navanandan, MD|847-636-0817|nidhya.navanandan@childrenscolorado.org|
20567337|NCT00770874|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
20567338|NCT02202317|University of Miami Miller School of Medicine|Dr Jason Salsamendi|305-585-7500|jsalsamendi@miami.edu|
20567339|NCT02338999|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Kaplan, Mariana|+1 301 496 0517|mariana.kaplan@nih.gov|
20567340|NCT04053699|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
20567341|NCT00569166|Mayo Clinic|Dr. Amit Sood|507-538-7623|sood.amit@mayo.edu|8-7623
20567342|NCT02746107|Carol Davila University of Medicine and Pharmacy Bucharest|Professor Cristian Baicus|+40788302355|cbaicus@gmail.com|
20567343|NCT01853384|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20567344|NCT02067663|Stanford University School of Medicine|Lisa Goldthwaite|541-515-1825|lgoldthw@stanford.edu|
20567345|NCT00704340|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
20567346|NCT00486954|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567347|NCT00403845|Novartis Pharmaceuticals|Study Director|862 778-8300||
20567348|NCT03316170|University of Kentucky|Dr. Jessica Burris|+1 859-257-9612|jessica.burris@uky.edu|
20567349|NCT02169414|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20567350|NCT00578344|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
20567351|NCT00321971|Duquesne University School of Nursing|Linda Garand PhD|412-396-6543|garandl@duq.edu|
20567352|NCT03374254|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20567353|NCT02309515|Mayo Clinic|Tait D. Shanafelt, MD|507.284.2511|shanafelt.tait@mayo.edu|
20567354|NCT02605876|University of North Carolina at Chapel Hill|Troy Blackburn|9198432021|troyb@email.unc.edu|
20567355|NCT00239642|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|601-650-4200|mfalone@luitpold.com|
20567356|NCT04070105|University of Michigan|Dr. Deanna Gates|7346472698|gatesd@umich.edu|
20567357|NCT04026256|Massachusetts General Hospital|Benjamin Leder|617-724-2039|bzleder@mgh.harvard.edu|
20567358|NCT02395692|ABTC|Sr. Research Program Manager|410-955-8837|ABTC@jhmi.edu|
20567359|NCT00854594|Louis Stokes VA Medical Center|Jeneen Shell-Boyd|(216) 791-2300|Jeneen.shell-boyd@va.gov|5831
20567360|NCT00749944|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567361|NCT02547974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20567362|NCT01513902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567363|NCT00923078|VA Connecticut Healthcare System|Dr Jason K. Johannesen|2039325711|jason.johannesen@va.gov|2224
20567364|NCT01102426|Pharma Mar, S.A.|Pharma Mar, S.A.|0034918466000|clinicaltrials@pharmamar.com|
20567365|NCT01393964|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20522041|NCT02932306|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
20522042|NCT04176406|Duke University|Dr. Lawrence G. Appelbaum|919-613-7664|greg@duke.edu|
20522043|NCT03559400|University of California, San Francisco|David Shearer, MD, MPH, Associate Professor|628-206-8812|david.shearer@ucsf.edu|
20522044|NCT00509366|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
20522045|NCT02119819|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20522046|NCT04497948|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20522047|NCT04074616|The University of Texas Health Science Center at Houston|Argyrios Stampas, MD|713-797-5938|argyrios.stampas@uth.tmc.edu|
20522048|NCT01739699|Northshore University Healthsystem, Evanston Hospital|Dr. Steven Greenberg|8475702760|sbgreenb@gmail.com|
20522049|NCT04482387|Cambridge University Hospitals NHS Foundation Trust|Stephen Kelleher|01223217418|research@addenbrookes.nhs.uk|
20522050|NCT00314951|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522051|NCT01504997|Shizuoka Cancer Center|Doctor Masanori Tokunaga|81-55098908777|m.tokunaga@scchr.jp|
20522052|NCT01651793|University of Georgia|Dr. Patrick J. O'Connor|706-542-4382|poconnor@uga.edu|
20522053|NCT02015065|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
20522054|NCT03280381|PATH|Dr. Patricia S. Coffey|206-302-4704|pcoffey@path.org|
20522055|NCT04581330|UT Southwestern Medical Center|Dr. Heather Goff|2146484229|heather.goff@utsouthwestern.edu|
20522056|NCT00468650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20522057|NCT02655666|Medtronic Minimed|Willam Lv|86-21-20325454|william.lv@medtronic.com|
20522058|NCT00478426|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2082|amit.oza@uhn.ca|
20522059|NCT03203564|Isofol Medical AB|Chief Medical Officer|+46 (0)707646500|karin.ganlov@isofolmedical.com|
20522060|NCT00789737|Daiichi Sankyo Pharma Development|Director Metabolic Clinical Development|732-590-5000||
20522061|NCT01189487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522062|NCT04630158|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20567366|NCT02988713|Boston Scientific|Director, Clinical Sciences and Scientific Communication|855-213-9890|BSNClinicalTrials@bsci.com|
20567367|NCT04679675|Kaiser Permanente Washington Health Research Institute|Dr. Beverly Green|206-220-2997|bev.b.green@kp.org|
20567368|NCT00529204|University of California Davis Medical Center|Christopher L. Bowlus, MD|916-734-8986|chris.bowlus@ucdmc.ucdavis.edu|
20506591|NCT00315705|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
20567369|NCT03265132|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
20567370|NCT01702259|Surgeon's Inc.|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
20522063|NCT05162014|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567371|NCT03909100|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20567372|NCT03241810|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
20567373|NCT01263496|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20506592|NCT01716533|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506593|NCT01393171|Kaiser Permanente|Dr John Nguyen|562-657-2642|john.n.nguyen@kp.org|
20506594|NCT02295735|Charité Universitätsmedizin Berlin, Department of Dermatology and Allergy|PD Dr. Jan Kottner|+4930450518218|jan.kottner@charite.de|
20506595|NCT00849251|University of Washington|Dr. Pamela Becker|206-616-1589|pbecker@uw.edu|
20506596|NCT00165841|Eisai Medical Research Inc.|Yufang Lu, Study Director|201-403-2500||
20506597|NCT00789958|SWOG|SWOG Statistician|206-667-4408||
20506598|NCT00296725|New York State Psychiatric Institute|Jonathan W. Stewart, M.D., Principle Investigator|646-774-8070|jws6@cumc.columbia.edu|
20506599|NCT00487084|Northwestern University|Cynthia A. Wong,M.D.|630-472-3555|c-wong2@northwestern.edu|
20506600|NCT00254293|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20506601|NCT04863417|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506602|NCT02059213|University of Michigan Rogel Cancer Center|Phillip Palmbos, M.D., Ph.D.|734-936-3591|ppalmbos@umich.edu|
20506603|NCT05439460|Stanford University|Chandra Ramamoorthy, MD|(650) 723-5728|chandrar@stanford.edu|
20506604|NCT03712345|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
20506605|NCT01819311|Florida International University|Jeremy W. Pettit (PI)|305-348-1671|jpettit@fiu.edu|
20506606|NCT00884052|University od California San Diego|Sponsor and Principal Investigator|8588226700|rhaas@ucsd.edu|
20506607|NCT00839423|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20506608|NCT01071096|Clinvest|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
20506609|NCT02585999|Boston Medical Center|Dr. Antonella Lavelanet|6174143745|Katharine.White@bmc.org|
20506610|NCT01332019|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20506611|NCT01369849|Mayo Clinic|Wei Ding, MBBS, PhD||ding.wei@mayo.edu|
20506612|NCT00871377|UCLA School of Medicine|Christopher M. DeGiorgio, MD|310-206-3753|cmd@mednet.ucla.edu|
20506613|NCT00330863|Medical College of Georgia, Georgia Regents University|Peter F. Buckley, MD|706-721-2231|pbuckley@gru.edu|
20506614|NCT00401622|LifeScan Scotland|Mike Grady|(44) 01463 721889|mgrady@its.jnj.com|
20506615|NCT02179515|National Cancer Institute|Dr. James Gulley|301-480-8870|James_Gulley@nih.gov|
20506616|NCT02116660|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506617|NCT01718509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20506618|NCT02561299|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clintrials_csi@csi360.com|
20506619|NCT05906732|Thryv Therapeutics Inc.|VP Clinical Research|514-973-0915|admin@thryvtrx.com|
20506620|NCT02052778|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
20506621|NCT04168593|USaoPauloGH|Andre Wan Wen Tsai|5511981456449|tsai.andre@gmail.com|
20522064|NCT03136965|University of Wisconsin School of Medicine and Public Health|Kenneth Lee, MD, MBA|(608) 263-9387|klee2@uwhealth.org|
20506622|NCT04183179|Michigan State University College of Nursing|Jiying Ling|5173538591|lingjiyi@msu.edu|
20506623|NCT02864940|Rush University Medical Center|Michael Chen, MD|312-563-2817|Michael_Chen@rush.edu|
20506624|NCT02175771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20506625|NCT03558555|Icahn School of Medicine at Mount Sinai|Dr. Alopi Patel|(212) 523-6357|Alopi.patel@mountsinai.org|
20506626|NCT00004418|Kennedy Krieger Institute|Gerald Raymond|443-923-2750|raymond@kennedykrieger.org|
20522065|NCT00390559|Virginia Commonwealth University|Thomas Eissenberg|804.827.4617|teissenb@vcu.edu|
20522066|NCT00575887|Marmara University|Ufuk Abacioglu|902123853100|ufuk@abacioglu.com|
20506627|NCT04124536|University of North Carolina at Chapel Hill|Benjamin Chi, MD, MSc|919-445-4174|bchi@med.unc.edu|
20522067|NCT01210612|University of Toledo Health Science Campus|Phillip Gribble|(419) 530-2691|pgribbl@UTNet.UToledo.Edu|
20506628|NCT03741725|University of North Carolina, Project-China|Dr. Weiming Tang|+86-15920567132|weiming_tang@med.unc.edu|
20506629|NCT01106625|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
20522068|NCT02290223|Kaiser NCAL Division of Research|Monique Does, Project Manager|510-891-3612|monique.does@kp.org|
20522069|NCT05293639|Johnson & Johnson MedTech|Reecha Sharma|949.789.3919|rshar120@its.jnj.com|
20506630|NCT02496585|Memorial Sloan Kettering Cancer Center|Dr. Zachary Moore, MD, PhD|929-687-0151|moorez@mskcc.org|
20522070|NCT02143648|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
20522071|NCT01943994|Sheppard Pratt|Dr. Matthew W. Johnson|443 862 0461|mjohnson3@sheppardpratt.org|
20522072|NCT00813800|Mayo Clinic|Mark Frye, MD|507-255-9391|mfrye@mayo.edu|
20522073|NCT01860677|McLean Imaging Center, McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
20522074|NCT03322930|Retina Foundation of the Southwest|Dr. David Birch|214-363-3911|dbirch@retinafoundation.org|105
20522075|NCT00642278|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20506631|NCT01100307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522076|NCT00090363|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20506632|NCT00997321|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
20506633|NCT00590018|Baylor College of Medicine|Dr. Heather Dickerson|832-826-5637|had@bcm.edu|
20506634|NCT01276457|Novartis Pharmaceuticals|Study director|862 778-8300||
20506635|NCT02065869|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384 1100|clinicaltrials@bellicum.com|
20506636|NCT03827473|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
20506637|NCT03705962|University of Virginia|Eric McVey|434.243.5382|edm9u@hscmail.mcc.virginia.edu|
20506638|NCT00303108|New York Oncology Hematology, Albany Medical Center|Dr. Rufus Collea|518-262-6696|rufus.collea@usoncology.com|
20506639|NCT04158908|Weill Cornell Medicine|Sophia Kakarala|(646) 962-5650|sok4004@med.cornell.edu|
20506640|NCT00894413|Johns Hopkins University School of Medicine|Zubair Khan, MD|410-955-3157|zkhan@jhmi.edu|
20506641|NCT03855137|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20506642|NCT03054077|Virginia Commonwealth University|Debra Shockey|804-828-3744|dpshockey@vcu.edu|
20506643|NCT02427477|Johnson & Johnson Vision Care Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-443-3500|JBUCH@its.jnj.com|1707
20506644|NCT00471445|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20506645|NCT02065622|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20506646|NCT01249872|University Hospital Of Patras, Greece|Dr Anastasia Zotou|0026130603341|anzotou@hotmail.com|
20506647|NCT00488618|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
20506648|NCT00659724|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20506649|NCT02389712|Mayo Clinic|Mark A. Frye, M.D.|507-255-7164|MFrye@mayo.edu|
20506650|NCT00786032|Hines Coordinating Center|Project Manager|708-202-5785|tamara.paine@va.gov|
20506651|NCT02625324|Medtronic|Rianna Rapson - Clinical Study Manager|763-526.2170|rianna.k.rapson@medtronic.com|
20506652|NCT00304265|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20506653|NCT00967226|Childrens Research Institute|Nancy M. Bauman MD, Principle Investigator|2024764270|nbauman@cnmc.org|
20506654|NCT02320695|Johnson & Johnson Consumer and Personal Products Worldwide|Christopher Nunez, PhD|973-385-7984|cnunez1@its.jnj.com|
20506655|NCT01648452|National Eye Institute|Paul A Sieving, MD, PhD|301-496-2234|ps261o@nih.gov|
20506656|NCT00797797|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
20506657|NCT01000727|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506658|NCT03137121|Univ Alabama Birmingham|Rudolph M Navari|574-261-8385|rmnavari@gmail.com|
20506659|NCT03196193|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
20506660|NCT02207478|Shanghai Chest hospital|Dr. Jiayuan Sun|+86 18017321598|jysun1976@163.com|
20506661|NCT01290445|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506662|NCT02709083|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
20506663|NCT02568345|Central Hospital, Irmandade da Santa Casa de Misericórdia (ISCM)|Mauro Prado da Silva|+55 11 2176 7000|comissaocientifica@fcmsantacasasp.edu.br|
20506664|NCT01697267|Cambridge University Hospitals NHS Foundation Trust|Prof David Jayne|01223 748062|dj106@cam.ac.uk|
20522077|NCT03713619|Novarts Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20506665|NCT02006667|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20506666|NCT01626352|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
20506667|NCT02152670|Yale University|Gustavo Angarita, MD, Assistant Professor of Clinical Psychiatry|(203) 974-7536|gustavo.angarita@yale.edu|
20506668|NCT02681055|MediciNova, Inc.|Director, Research and Development|8583444535|makhay@medicinova.com|
20506669|NCT00310388|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20522078|NCT01758588|Weill Cornell Medicine|Assistant Director of Leukemia and BMT Clinical Trials|646-962-9305|ell2028@med.cornell.edu|
20506670|NCT05161351|Imperial College London Faculty of Medicine|Agnese Zicari,Quality Assurance Facilitator|+44(0)2075946615|a.zicari08@imperial.ac.uk|
20506671|NCT00782418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506672|NCT00882999|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20506673|NCT02082145|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20506674|NCT01757405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20506675|NCT01434641|St. Luke's-Roosevelt Hospital|E. Gordon DePuey, M.D.|212-523-3400|edepuey@chpnet.org|
20506676|NCT00082758|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20506677|NCT00238303|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|galanis.evanthia@mayo.edu|
20506678|NCT01833741|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20506679|NCT00937560|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20506680|NCT00848549|Eisai Call Center|Eisai Inc.|888-422-4743||
20522079|NCT02552212|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20522080|NCT00118131|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20506681|NCT00941889|Washington University|Steven Hunt, MD|314-454-7177|hunts@wudosis.wustl.edu|
20506682|NCT01248130|Massachusetts General Hospital|Gagan Joshi, MD|617-726-4651|lkfeinberg@mgh.harvard.edu|
20506683|NCT00305643|UT MD Anderson Cancer Center|Scott Kopetz, MD, PHD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20506684|NCT01994226|Keele University|Sponsor|01782|research.governance@keele.ac.uk|734882
20522081|NCT02067273|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
20506685|NCT02190747|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20506686|NCT04322994|Stanford University|Dr Thomas Caruso, MD, PhD|6507235728|tjcaruso@stanford.edu|
20506687|NCT02488551|Central Arkansas Veterans Health Care System|Michael Cucciare|501-526-8179|michael.cucciare@va.gov|
20506688|NCT03664193|Weill Cornell Medicine|Josephine Kang|212-746-3607|jok9106@med.cornell.edu|
20506689|NCT01157416|Tulane University School of Medicine|Dr. Michael Scheeringa|5046692322|mscheer@tulane.edu|
20522082|NCT02906566|Stanford University|Dr. Anne L. Chang|650-721-7195|alschang@stanford.edu|
20506690|NCT02239770|Penn State College of Medicine|Dr. Patricia Sue Grigson|717-531-5772|psg6@psu.edu|
20506691|NCT04507867|Universidad Anáhuac México Norte|Dr. Fernando Leal Martínez|+52 5521094339|ferman5@hotmail.com|
20506692|NCT01515995|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|mohamed.badawy@utsouthwestern.edu|
20506693|NCT01860534|University of Texas medical Branch, Galveston|Dr. Cara Geary|409-772-2815|cageary@utmb.edu|
20506694|NCT01188564|Pharming Technologies|Anurag Relan, Vice President Clinical Research and Medical Affairs||a.relan@pharming.com|
20506695|NCT04171037|The University of Texas MD Anderson Cancer Center|Gang Zheng, MD|(713) 563-2731|gzheng@mdanderson.org|
20506696|NCT01934894|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
20506697|NCT02520518|COLORADO STATE UNIVERSITY|Manager of Research Operations|970-491-2242|Laurie.Biela@colostate.edu|
20506698|NCT00301028|UT MD Anderson Cancer Center|Merrill S. Kies, MD / Professor||CR_Study_Registration@mdanderson.org|
20506699|NCT03364673|Dana-Farber Cancer Institute|Alexi Wright, MD, MPH|617-632-2334|alexi_wright@dfci.harvard.edu|
20506700|NCT02208024|University of Cincinnati Cancer Center|Jordan Kharofa, Associate Professor, Department of Radiation Oncology|(513)-584-4073|kharofjr@ucmail.uc.edu|
20506701|NCT00779324|Indiana University School of Medicine|Flora Hammond, MD|3173292106|flora.hammond@rhin.com|
20506702|NCT02207556|Medical College of Wisconsin|Dr. Anita D'Souza|414-805-0637|dsouza@mcw.edu|
20506703|NCT00194025|Case Western Reserve University and Unversity Hospitals Case Medical Center|Martha Sajatovic MD|216-844-2808|martha.sajatovic@uhhospitals.org|
20506704|NCT04732819|Hebrew SeniorLife|Sarah Berry, MD|617-971-5355|sarahberry@hsl.harvard.edu|
20506705|NCT00511342|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20506706|NCT02432040|University of the Philippines - Philippine General Hospital Section of Dermatology|Dr. Sharlene Chua|2418118|sharlene_chua@yahoo.com|
20506707|NCT01153763|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506708|NCT04544709|University of Utah Orthopaedics Center|Heather Littell, Regulatory Coordinator|801-587-5432|u6041929@utah.edu|
20506709|NCT03238235|Italfarmaco SpA|Maurizio Caserini, MD|+ 39 02 64431|m.caserini@italfarmacogroup.com|
20506710|NCT04436822|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
20506711|NCT04715230|InterveXion Therapeutics|Chief Operating Officer|5015542377|misty.stevens@intervexion.com|
20506712|NCT00654511|Children's National Medical Center|Julia Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
20506713|NCT05366413|Dana-Farber Cancer Institute|Andrea Enzinger, MD|617-582-7335|andrea_enzinger@dfci.harvard.edu|
20506714|NCT02457182|University of New Mexico|Gregg Kanter, MD|818-599-3456|greggkanter@gmail.com|
20506715|NCT01009983|Wake Forest University Health Sciences|Dr. Susan Melin|336-716-2839|smelin@wakehealth.edu|
20506716|NCT04410198|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-097Study@fibrogen.com|
20506717|NCT00748085|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
20506718|NCT02943265|University of Kansas Medical Center|Simon Lee|(913) 588-2689|slee21@kumc.edu|
20522083|NCT04400682|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
20506719|NCT02338492|IlluminOss Medical Inc.|Gene DiPoto|401-714-0008|gdipoto@illuminoss.com|202
20506720|NCT00756886|Surgery - Cardiovascular/Thoracic|Ayesha S. Bryant, MD|(205) 996-7561|abryant@uab.edu|
20506721|NCT00274768|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-6192|awolff@jhmi.edu|
20506722|NCT00120289|Axio Research, LLC|Ruth McBride|206-577-0212|ruthm@axioresearch.com|
20506723|NCT01590394|Mayo Clinic|Christopher J. Gostout|507-284-7647|gostout.christopher@mayo.edu|
20522084|NCT02105974|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506724|NCT04348656|McMaster University/Hamilton Health Sciences|Dr Donald Arnold|905 525 9140|arnold@mcmaster.ca|28603
20506725|NCT04087343|The University of Texas Health Science Center at Houston|Jessica Lee, MD, MS, Assistant Professor|713-500-5457|Jessica.Lee@uth.tmc.edu|
20506726|NCT01911845|AbbVie|Global Medical Information|800-633-9110||
20506727|NCT00501046|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20522085|NCT00477633|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20506728|NCT01576016|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
20506729|NCT00689819|Wayne State University|Phillip Levy, MD|3139938558|plevy@med.wayne.edu|
20506730|NCT00543569|Astellas Pharma Global Development, Inc. (APGD)|Global Head Global Medical Sciences--Transplant and Immunology/Inflammation||Astellas.resultsdisclosure@astellas.com|
20506731|NCT00862849|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
20506732|NCT02918409|National Jewish Health|Dr. Milene Saavedra|303-270-2333|saavedram@njhealth.org|
20506733|NCT00677690|Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
20522086|NCT02968849|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20506734|NCT00803543|University of Alabama at Birmingham|Nicholas Van Wagoner|205-934-2840|nvw@uab.edu|
20506735|NCT00555048|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
20506736|NCT00503880|University of Nebraska Medical Center|Lori Maness-Harris, MD|402-559-3848|lmaness@unmc.edu|
20506737|NCT03198754|Icahn School of Medicine at Mount Sinai|Heiðdís B. Valdimarsdottir|(212) 659-5678|heiddis.valdimarsdottir@mssm.edu|
20506738|NCT00668200|Novartis Pharmaceuticals|Study Director|8627788300||
20522087|NCT00815360|Retina Associates of Florida, P.A.|Dr. Ivan J. Suner|813-875-6373|ivansuner@gmail.com|
20522088|NCT03722589|Centers for Disease Control and Prevention|Fatimah Dawood, Medical Officer|404-639-0431|hgj0@cdc.gov|
20506739|NCT03615469|Indiana University|Dr. Christine Haedtke|317-274-5358|chaedtke@iu.edu|
20506740|NCT00837512|Emory University School of Medicine|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
20506741|NCT01474746|University of California, Davis, MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
20506742|NCT00853333|University of Alabama at Birmigham|Michael Froelich|(205)975-0145|froelich@uab.edu|
20506743|NCT00039195|Memorial Slaon Kettering|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
20506744|NCT01606761|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20506745|NCT05086289|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20506746|NCT03150108|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20506747|NCT00515008|tufts medical center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
20506748|NCT03135028|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20506749|NCT01814800|ADMA Biologics|Jimmy Mond, M.D., Ph.D|201-478-5552|jmond@admabio.com|
20506750|NCT02402218|Johns Hopkins School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
20506751|NCT03807739|Genentech, Inc|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20506752|NCT02371759|University of Belgrade, Faculty of Dental Medicine|DDS PhD Professor Dragica Stojic, DDS PhD Professor Bozidar Brkovic, DDS PhD Marija Milic|+ 381 11 2685 280|brkovic73@yahoo.com|244
20506753|NCT02322320|The Emmes Company|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20506754|NCT00430625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20506755|NCT03375112|Henry Ford Health System|Dr. Michael Charters|1-800-436-7936|mcharte1@hfhs.org|
20506756|NCT02774226|Augusta University|Dr. Ryan Harris|706-721-5483|ryharris@augusta.edu|
20506757|NCT03599141|Indiana University|Heather K. Hardin|317.274.5966|hhardin@iu.edu|
20506758|NCT03136185|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506759|NCT00125658|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|carolynn.patten@va.gov|4160
20506760|NCT02876055|Mayo Clinic|Dr. Jason K. Panchamia|507-284-9698|panchamia.jason@mayo.edu|
20506761|NCT03744780|McGill University|Mallory Frayn, PhD(c)|N/A|mallory.frayn@mail.mcgill.ca|
20506762|NCT05118386|Gates Medical Research Institute|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20506763|NCT00086957|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
20506764|NCT00369668|University of Florida, Motor Behavior Laboratory|James Cauraugh, Ph.D., PI|352-294-1623|jcaura@hhp.ufl.edu|
20506765|NCT00321100|Fox Chase Cancer Center|Dr. Steven Cohen|215-214-1676|steven.cohen@fccc.edu|
20506766|NCT03201198|University of Michigan School of Nursing|Dr. Janet Larson|7346470126|janetlar@med.umich.edu|
20506767|NCT00218036|The University of Texas Health Science Center at Houston|Joy M Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
20506768|NCT03126539|Johns Hopkins University|Dr. Anna Chien|410-502-7546|CTReP@jhmi.edu|
20506769|NCT03645408|Boston Medical Center/Boston University School of Medicine|Dr. Eric Devine|617-414-1990|eric.devine@bmc.org|
20506770|NCT03213626|IndianaU|Dr. Patrick Loehrer|(317) 278-7418|ploehrer@iu.edu|
20506771|NCT02596711|UT MD Anderson Cancer Center|Dr. Marcel A. de Dios / Health Disparities Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20506772|NCT01005732|University of Washington|Loren Engrav|206-744-3209|engrav@u.washington.edu|
20506773|NCT04030104|Seno Medical Instruments, Inc.|Vice President of Clinical Operations|210-615-6501|sschaeffer@senomedical.com|
20506774|NCT00632463|ADMA Biologics|Chief Medical Officer|201-478-5552|agrossman@admabio.com|
20506775|NCT02366663|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
20506776|NCT01767194|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20522089|NCT01200069|Rutgers/New Jersey Medical School|Vasanti Tilak, MD|974 972-5254|tilakva@njms.rutgers.edu|
20506777|NCT02112994|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20506778|NCT02223455|CADRE - Iowa City VAHCS|Heather Reisinger|319-338-0581|heather.reisinger@va.gov|7715
20506779|NCT01683071|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20506780|NCT04211155|University of Minnesota|Bonny Donzella|6126244351|donzella@umn.edu|
20506781|NCT00352755|Washington University School of Medicine|Dr. James Fleshman|314-747-4610|James.Fleshman@BSWHealth.org|
20506782|NCT02397694|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20522090|NCT03408639|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|Anjidani.N@orchidpharmed.com|
20522091|NCT04998851|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20506783|NCT01116687|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
20506784|NCT00424528|Sepracor Inc|Respiratory Medical Affairs Director|866-503-6351||
20506785|NCT02115113|Novartis Pharmaceuticals|Study Director|862-778-8300||
20506786|NCT02278640|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20506787|NCT00789191|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20506788|NCT02168933|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465||
20506789|NCT03497429|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20506790|NCT03736629|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20506791|NCT00280150|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20506792|NCT02939937|assistant|dr.alireza gholizade|989112550646|a.gholizade13@yahoo.com|
20506793|NCT00568958|Yale University School of Medicine|Dr. Stephanie S. O'Malley|203-974-7590|stephanie.omalley@yale.edu|
20506794|NCT02607254|Johns Hopkins University|Dr. Mohammad Khoshnoodi|410-955-5406|mkhoshn1@jhmi.edu|
20506795|NCT03583372|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20506796|NCT02796391|Moffitt Cancer Center|Dr. Vani Simmons|813-745-4816|Vani.Simmons@moffitt.org|
20506797|NCT00377611|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506798|NCT04831515|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
20506799|NCT03623334|UT Southwestern Medical Center|Sarah Hardee|214-648-1836|sarah.hardee@utsouthwestern.edu|
20506800|NCT05254613|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20506801|NCT03377244|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
20506802|NCT00174785|sanofi-aventis|International Clinical Development (ICD), Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
20506803|NCT02387372|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506804|NCT01902953|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
20506805|NCT04866303|University of Washington|Clinical Trial Manager|2066169195|cgregor2@uw.edu|
20522092|NCT00070499|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
20506806|NCT00436566|Mayo Clinic|Dr. Edith A. Perez|507-266-0800|perez.edith@mayo.edu|
20506807|NCT01954251|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506808|NCT02581111|Washington University in St. Louis School of Medicine|Dr. Rajat Dhar|3143622999|dharr@neuro.wustl.edu|
20506809|NCT02504268|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20506810|NCT03025217|Massachusetts General Hospital|Dr. Michelle Dossett|617-643-6034|mdossett@mgh.harvard.edu|
20506811|NCT04019275|University of Pittsburgh|Elizabeth Skidmore|412-383-6620|skidmore@pitt.edu|
20506812|NCT00617409|H. Lee Moffitt Cancer Center and Research Institute|Dr. Scott Antonia|813-745-3883|scott.antonia@moffitt.org|
20522093|NCT00805467|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20506813|NCT02344407|Division of Biostatistics, University of Minnesota|Greg Grandits|612-626-9033|grand001@umn.edu|
20506814|NCT01362686|Regenstrief Insitute|Dr. Noll Campbell|317-274-9051|cambenl@regenstrief.org|
20506815|NCT01496430|Takeda|Medical Director; Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20506816|NCT02108951|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20506817|NCT01580592|Charité - University of Berlin; Dpt. of Dermatology and Allergy|Professor Dr. Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
20506818|NCT00421343|Hebrew SeiorLife|Sarah Berry|617-971-5355|sarahberry@hrca.harvard.edu|
20522094|NCT03785600|VA Portland Health Care System|Jonathan Elliott|503-220-8262|jonathan.elliott@va.gov|53874
20506819|NCT01962714|VA Puget Sound Health Care System|David Kearney, MD|206-277-1445|david.kearney@va.gov|
20506820|NCT01151579|Genesys Regional Medical Center|Dr. Fahim Khorfan|810-606-7722|kbarber@genesys.org|
20506821|NCT00608530|VA San Diego Healthcare System|Joseph H. Atkinson MD, Principal Investigator|858 642 3775|joseph.atkinson@va.gov|
20522095|NCT02185690|Princess Margaret Cancer Centre, University Health Network|Dr. Natasha Leighl, Sponsor-Investigator, Division of Medical Oncology|416-946-4645|natasha.leighl@uhn.ca|
20506822|NCT00077610|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20522096|NCT00478244|Masonic Cancer Center, University of Minnesota|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
20522097|NCT00459043|DFCI|Robert Haddad|6176326725|robert_haddad@dfci.harvard.edu|
20522098|NCT01392963|Seton Family of Hospitals|Katherine Sebastian|512-324-9999|krsebastian@seton.org|89612
20522099|NCT01689779|Massachusetts General Hospital|Sadeq A. Quraishi, MD|617-726-3030|squraishi@mgh.harvard.edu|
20522100|NCT02928055|MetroHealth Medical Center|Richard Wilson, MD|216-778-4414|rwilson@metrohealth.org|
20522101|NCT02856555|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20522102|NCT00580788|University of Pittsburgh|Mara J Horwitz, MD|4126922848|horwitz@pitt.edu|
20522103|NCT00411411|Gentofte University Hospital|Dr. Kasper Aaboe|+4522170200|kasper@dadlnet.dk|
20522104|NCT03301649|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20522105|NCT01403051|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20522106|NCT00674739|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
20522107|NCT00573378|University of Michigan Rogel Cancer Center|Dale L. Bixby, MD|734-936-4991|dbixby@med.umich.edu|
20522108|NCT00887289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522109|NCT00591773|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20522110|NCT02135614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20522111|NCT03134248|CooperVision|Jose A.Vega OD MSc., FAAO|9256213761|javega@coopervision.com|
20522112|NCT02679235|University of Sherbrooke|Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20522113|NCT00923273|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
20522114|NCT00605540|HC/FMB-Unesp|Renata Ferrari|55 14 38116213|renataferrarifisio@gmail.com|
20522115|NCT01327508|Smith & Nephew, Inc.|Cathy Newbill|800-821-5700|cathy.newbill@smith-nephew.com|
20522116|NCT01438996|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
20522117|NCT01433549|Alcon Research, Ltd.|R. Alan Landers, O.D., M.S., F.A.A.O.|1-888-451-3937|alcon.medinfo@alcon.com|
20522118|NCT01631071|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20522119|NCT02246114|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
20522120|NCT02740114|UT MD Anderson Cancer Center|Pedro Ramirez, MD /Professor, Gyn Onc & Reproductive Med|713-745-5498|peramire@mdanderson.org|
20552299|NCT00439556|UT MD Anderson Cancer Center|Dr. Khouri,Issa,M.D. / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
20552300|NCT01642238|Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon|(212) 241-8484|Juan.Badimon@mssm.edu|
20552301|NCT01324388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20552302|NCT01405963|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20552303|NCT01498640|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20552304|NCT01737047|Imperial College London|Alan Winston|02033121603|a.winston@imperial.ac.uk|1603
20522121|NCT01551030|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@MSKCC.ORG|
20522122|NCT01957761|Ann & Robert H. Lurie Children's Hospital of Chicago|Larry Kociolek, MD, MSCI|312-227-4080|lkociolek@luriechildrens.org|
20552305|NCT00129129|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522123|NCT02656069|Xeris Pharamaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
20552306|NCT00922883|NHLBI|Cynthia E Dunbar|301-496-5093|dunbarc@nhlbi.nih.gov|
20522124|NCT01696058|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552307|NCT02140567|Imperial College Healthcare NHS Trust in London, United Kingdom|Dr. Phang Boon Lim|+44|p.b.lim@imperial.ac.uk|(0)20 3313
20552308|NCT01209442|University of Colorado|Douglas Ney, M.D.|303-724-2184|Douglas.Ney@ucdenver.edu|
20552309|NCT02802592|Johns Hopkins University School of Medicine|Dr. Kenneth Horvath|301-896-3100||
20552310|NCT02882854|Vanderbilt University Medical Center|Stephen Harvey, MD|(615) 936-3198|stephen.harvey@vumc.org|
20552311|NCT00788892|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|215-832-3750||
20552312|NCT01358357|Sunovion Pharmaceuticlas Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20552313|NCT01826487|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20552314|NCT02590939|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
20552315|NCT00368654|Kaiser Permanente (Current), UC Davis (Previous)|Chai Sue Lee||lam.nguyen@ucdmc.ucdavis.edu|
20552316|NCT00731770|Penn State University|Erin Banta|717-531-6525|ebanta@hmc.psu.edu|1
20552317|NCT02171260|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20552318|NCT00323492|Gilead Sciences|Camille Aubron-Olivier|+33(0)1 42 737130|camille.aubron-olivier@gilead.com|
20552319|NCT02486042|UC San Diego Health|Sarah Lazar, clinical research manager|(858) 249-1711|slazar@health.ucsd.edu|
20552320|NCT00566150|Yale University|Dr. Zubin Bhagwagar|203-974-7560|zubin.bhagwagar@yale.edu|
20552321|NCT03320564|Wake Forest Baptist Health|Katie Holbrook Bingman|336-713-7765|krholbro@wakehealth.edu|
20552322|NCT00352846|The University of Texas (UT) MD Anderson Cancer Center|Fredrick Hagemeister, MD/Professor||psanjorjo@mdanderson.org|
20522125|NCT03781037|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
20522126|NCT02186834|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
20552323|NCT01527682|ASST Spedali Civili di Brescia|Prof. Luciano Quaranta|+39 030 3995|luciano.quaranta@unibs.it|847
20552324|NCT03979638|Bellus Health Inc|Senior Director Clinical Development|833-703-0708|lharvey@bellushealth.com|
20552325|NCT02586896|NYU School of Medicine|Michael Bogenschutz|646-501-4026|michael.bogenschutz@nyulangone.org|
20552326|NCT00600938|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20552327|NCT04220411|Arjil Pharmaceuticals LLC.|YEH B, WU|+886-3-573-3608|ybw333@arjilbio.com|
20552328|NCT02680639|Philips|Senior Clinical Development Scientist|(724) 733-5835|chuck.cain@philips.com|
20552329|NCT04646499|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
20552330|NCT04837131|Mayo Clinic|Michael Pham, M.D.|480-301-8318|Pham.Michael@mayo.edu|
20552331|NCT02496533|Midwestern Regional Medical Center, Inc.|Jessica Kapustin, RN-C||Jessica.Kapustin@CTCA-Hope.com|
20552332|NCT00983281|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
20552333|NCT02327429|University of Alberta|Catherine Chan|780-492-9939|cbchan@ualberta.ca|
20552334|NCT03256552|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20552335|NCT03722017|Tennessee Valley Healthcare System Nashville Campus|Amanda Mixon, MD MSPH MS|(615) 936-3710|amanda.mixon@va.gov|
20552336|NCT02268409|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552337|NCT05083442|Mayo Clinic Rochester|Dr. Ivana Croghan|507 284-2511|gimresearchstudies@mayo.edu|
20552338|NCT03878316|National Institute on Alcohol Abuse and Alcoholism|Dr. Daniel Falk|301-443-0788|falkde@mail.nih.gov|
20552339|NCT01554891|Geisel School of Medicine at Dartmouth|Laura A. Flashman, Ph.D.|6036505824|flashman@dartmouth.edu|
20552340|NCT03961100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20522127|NCT00749892|UT MD Anderson Cancer Center|Dr. Arlene O. Siefker-Radtke,Professor, Genitourinary Medical Oncology|(713) 792-2830|asiefker@mdanderson.org|
20522128|NCT04581369|Indiana University|Eric Orman|317-278-1630|esorman@iu.edu|
20552341|NCT04865354|Alcon Research, LLC|Sr. Project Lead, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20552342|NCT03873987|Melinta Therapeutics, Inc.|Vice President Clinical Operations|9086171319|kfusaro@melinta.com|
20522129|NCT00780910|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20522130|NCT01053000|Roger H. Stewart MD PA|Barry Galitzer MD|954-491-0510|barry@galitzer.com|
20522131|NCT00089024|University of Nebraska Medical Center|Jean L Grem|402-552-3233|jgrem@unmc.edu|
20552343|NCT01465022|University of New Mexico|Eve Espey MD, MPH, Principal Investigator|505 272 6372|eespey@salud.unm.edu|
20522132|NCT00106964|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20522133|NCT04746794|University of Washington|Faith Beers|206-543-1733|fabeers@uw.edu|
20522134|NCT03207243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20552344|NCT00004888|Eastern Cooperative Oncology Group Statistical Office|Study Statistician|617-632-3012||
20552345|NCT00136084|St. Jude Children's Research Hospital|Jeffrey Rubnitz, M.D|1-866-278-5833|info@stjude.org|
20552346|NCT02579265|Fresenius Kabi Deutschland GmbH|Dr. Jean-Marc Lohse, Director Clinical Operations PN NAM & ELAMA|+49 6172 686|Jean-Marc.Lohse@fresenius-kabi.com|4911
20552347|NCT02174848|Chiesi Canada Corp.|Fernando Tricta, MD|416--558-6342|f.tricta@chiesi.com|
20552348|NCT01074164|Northwestern University Department of Dermatology|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
20552349|NCT02229318|The Children's Hospital of Philadelphia|Dr Christina Bergqvist, M.D., Study Principal Investigator|+1 215 590 1719|Bergqvist@Email.CHoP.Edu|
20552350|NCT02520011|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|+1-210-414-7702|Susan.smith@sdponcology.com|
20552351|NCT00644969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552352|NCT05620576|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20552353|NCT03239470|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
20552354|NCT03483935|University of Dundee|Prof Charlotte Proby|+44 1382 383289|c.proby@dundee.ac.uk|
20552355|NCT04061694|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
20552356|NCT01742338|Rutgers Robert Wood Johnson Medical School|Dr. Jeffrey L. Carson|732-235-7122|jeffrey.carson@rutgers.edu|
20552357|NCT03249779|Mayo Clinic|Melissa C. Lipford, M.D.|507-255-9230|Lipford.Melissa@mayo.edu|
20552358|NCT02826681|American Regent, Inc.|Mark Falone|631.772.3544|mfalone@americanregent.com|244
20552359|NCT01794806|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
20552360|NCT01052207|CHOA/Emory|Dr. Kiran Hebbar|404-785-6135|khebbar@emory.edu|
20552361|NCT03167879|RAND Corporation|Dr. Glenn Wagner|310-393-0411|gwagner@rand.org|7698
20552362|NCT02245841|Cleveland Clinic|Anthony Fernandez, MD, PhD|216-445-8776|fernana6@ccf.org|
20552363|NCT01505608|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
20552364|NCT01488097|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|475-230-2596|clinicaltrials@alexion.com|
20552365|NCT01577758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20552366|NCT01293240|Alcon Research|Peter Bergenske|1-800-241-7629||
20552367|NCT03394768|Changi General Hospital|Serene Yeow, Senior Executive, Clinical Trials and Research Unit|+6581258267|serene_yeow@cgh.com.sg|+656426781
20552368|NCT03342742|"University of Colorado Denver | Anschutz"|Kristen Nowak|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20552369|NCT04383210|Elevation Oncology|Medical Information|+1-716-371-1125|medinfo@elevationoncology.com|
20552370|NCT03095456|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20552371|NCT02404350|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
20552372|NCT05389657|University of California, San Francisco|Erin Accurso|415-476-5139|erin.accurso@ucsf.edu|
20552373|NCT03089606|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS ACRP-CP, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
20552374|NCT00335972|Cleveland Clinic|Rafi Avitsian, M.D|(216)-444-9735|avitsir@ccf.org|
20552375|NCT04017936|Virginia Commonwealth University|Dr. Jordana Kron, MD|804-828-7565|jordana.kron@vcuhealth.org|
20552376|NCT00369512|University of Alabama at Birmingham|Eben Rosenthal, MD Department of Surgery Department|(205) 934-9714|erosenthal@uabmc.edu|
20567374|NCT00046475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20567375|NCT05011292|Emory University|Dr. Jean Welsh|404-375-1165|jwelsh1@emory.edu|
20567376|NCT00266656|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20567377|NCT03242863|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
20567378|NCT05940688|University of Alabama at Birmingham|Dr. Rachel Sinkey|(205) 934-5612|rsinkey@uabmc.edu|
20552377|NCT00867451|Cincinnati Children's Hospital Medical Center|Richard Gilman, Ph.D.|513-636-8172|richard.gilman@cchmc.org|
20552378|NCT02039674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552379|NCT01408030|Cure HHT|James R. Gossage, MD, Medical Director of Cure HHT|706-721-6789|jgossage@augusta.edu|
20552380|NCT00108160|VA Ann Arbor Healthcare System|Suzanne F. Bradley, M.D.|734-845-5820|sbradley@umich.edu|55826
20552381|NCT05045144|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20552382|NCT02081079|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20552383|NCT01035944|HemCon Medical Technolgoies|Dr. Jody Oyama|503.245.0459|jody.oyama@hemcon.com|
20552384|NCT02535845|The University of Chicago|Dr. Jasmin Tiro|773-834-4384|jtiro@bsd.uchicago.edu|
20552385|NCT00788827|Imperial College London|Professor Charles Pusey|+44 3313 2308|c.pusey@imperial.ac.uk|
20552386|NCT01218555|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
20552387|NCT02742987|Campus Bio-Medico University|Dr. Fabio Mangiacapra|003906225411612|f.mangiacapra@unicampus.it|
20552388|NCT01308450|BioBDx|Calvin R. Sumner, MD, CMO, Sr. VP for Clinical Development|978-431-5103|calvin_sumner@biobdx.com|
20552389|NCT00699556|Yale University|Sherry McKee|(203) 737-3529|sherry.mckee@yale.edu|
20552390|NCT01457885|University of Michigan Comprehensive Cancer Center|Dr. John Magenau, M.D.|734-936-8785|johnmage@umich.edu|
20552391|NCT04668950|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
20552392|NCT04993287|NorthShore University HealthSystem|Dr. Nirav Shah|847-657-5959|nshah2@northshore.org|
20552393|NCT01342510|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
20552394|NCT04365556|Cincinnati Children's Hospital Medical Center|Rachelle Ramsey|513-803-0415|rachelle.ramsey@cchmc.org|
20552395|NCT05756790|University of California San Francisco|Dr. Amy Conroy|303-522-9439|amy.conroy@ucsf.edu|
20552396|NCT00483223|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-726-4920|SISAKOFF@mgh.harvard.edu|
20552397|NCT00322335|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552398|NCT00502697|Vanderbilt University|Melanie Lutenbacher, PhD, MSN, FAAN|615-343-3314|melanie.lutenbacher@vanderbilt.edu|
20552399|NCT00864474|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552400|NCT00610532|The Ohio State University|Dr. Jim McAuley|614-292-9713|mcauley.5@osu.edu|
20552401|NCT04076644|University of Missouri|Matt Schmidt|573-882-5688|schmidtmw@health.missouri.edu|
20552402|NCT00589108|Mayo Clinic|Dr. Robert T. Trousdale|507-284-3663|trousdale.robert@mayo.edu|
20552403|NCT01713868|Boston University|Michael Corwin, MD||mjcorwin@bu.edu|
20552404|NCT02376946|TuftsU|Dr. Archana Viswanath|617-636-3578|Archana.Viswanath@tufts.edu|
20552405|NCT00489853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20552406|NCT02449239|Sesen Bio, Inc.|Dr. Rachelle Dillon|204-296-6579|rachelle.dillon@sesenbio.com|
20567379|NCT04369664|NYU Langone Health|Jeffrey Berger, MD|212-263-4004|jeffrey.berger@nyulangone.org|
20567380|NCT04995601|Recovery Force Health, University of Massachusetts Amherst|Jeff Schwegman (PI), Dr. Karen Giuliano (PI, clinical trial subaward)|317-605-4696; 224-725-0270|kschwegman@recoveryforceusa.com; kkgiuliano@umass.edu|
20567381|NCT01567852|University of NewMexico|Dr. Tony Yen|505-272-2610|tyen@salud.unm.edu|
20567382|NCT00215943|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
20567383|NCT00443820|Novartis Pharmaceuticals|Study Director|862-778-8300||
20567384|NCT04205669|CERMEL|Julian Matthewman|00241 07-98-91-91|julianmatthewman@gmail.com|
20567385|NCT02132520|University of Minnesota|Bin He|612-626-1115|binhe@umn.edu|
20567386|NCT01686152|Teva Pharmaceuticals USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
20567387|NCT00929526|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567388|NCT00996164|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20567389|NCT04803734|Intech Biopharm Ltd.|Sabina Chien|+886-2-7721-8877|sabina.i198@intechbiopharm.com|631
20567390|NCT00667953|Penn|Tara C Mitchell|215-662-4000|Tara.Mitchell@pennmedicine.upenn.edu|
20567391|NCT02143713|AbbVie|Global Medical Services|800-633-9110||
20567392|NCT04264156|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|2154889300|psimmons@windtreetx.com|
20567393|NCT01768572|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20567394|NCT02245620|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20567395|NCT01999335|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20567396|NCT04766996|Emory University|Kelly Wiltse Nicely, MD|404-727-6946|kelly.wiltse.nicely@emory.edu|
20567397|NCT00080119|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20567398|NCT01322386|Stanford University|Kenneth L Cox, MD / Principal Investigator|650-723-5070|KCox@stanfordchildrens.org|
20552407|NCT01023581|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20552408|NCT03856437|University of Maryland, College Park|Xiaoli Nan|301-405-0640|nan@umd.edu|
20567399|NCT00949234|UCLA CARE Center|Dr. Raphael Landovitz|310-557-1891|rlandovitz@mednet.ucla.edu|
20567400|NCT00508183|Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|74700
20567401|NCT03785756|Reckitt Benckiser (Health) Limited|Clinical Project Manager|+44 1482 326151|clinicaldatacontroller@reckitt.com|
20567402|NCT05228834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567403|NCT00871494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567404|NCT02637999|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
20567405|NCT00889863|Novartis Pharmaceuticals|Study Director|862-778-8300||
20567406|NCT00564447|Inspire Pharmaceuticals, Inc.|Director of Clinical Research|010-941-9777|kkuhn@inspirepharm.com|
20567407|NCT04410445|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20567408|NCT01320683|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
20567409|NCT02291861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20567410|NCT04332991|Mass General Hopsital (PETAL Network Coordinating Center)|B.Taylor Thompson, MD|617-726-8854|TTHOMPSON1@mgh.harvard.edu|
20567411|NCT03879538|Cleveland Clinic|Alparslan Turan|2162172312|turana@ccf.org|
20567412|NCT03082313|University of Southern California|Beth Smith|13234424072|beth.smith@usc.edu|
20567413|NCT02336958|Helios Kliniken Schwerin|Dr. med. Ronald Seidel|0049 (0)385 5204251|ronald.seidel@helios-kliniken.de|
20567414|NCT03547154|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567415|NCT02404441|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20567416|NCT01918033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567417|NCT01338506|Medical University of South Carolina|Dr. Sudie Back|843-792-9383|backs@musc.edu|
20567418|NCT02802111|Children's Hospital Los Angeles|Dr. Patrick Ross|323-361-7864|pross@chla.usc.edu|
20567419|NCT02424968|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
20567420|NCT05012462|Zynex Monitoring Solutions|ZMS Clinical|800-495-6670|clinical@zynexmonitoring.com|
20567421|NCT00088166|Celtic Pharma Development Services America Inc|Patrick O'Connor, MD, Managing Director Clinical Development|212-616-4050|patrick.oconnor@dev.celticpharma.com|
20567422|NCT02671266|Massachusetts General Hospital/Harvard Medical School|Dr. Angela Fang|617-643-7717|afang@mgh.harvard.edu|
20567423|NCT04884191|CTI BioPharma, Inc.|John Volpone SVP, Strategic Operations|+1 (206) 272-4652|jvolpone@ctibiopharma.com|
20567424|NCT02065609|Washington University School of Medicine in St. Louis|Dr. Farrokh Dehdashti|314-362-1474|dehdashtif@wustl.edu|
20567425|NCT00666705|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20567426|NCT01976507|Vanderbilt University Medical Center|Christopher Ellis||christopher.ellis@Vanderbilt.Edu|
20567427|NCT01762982|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567428|NCT01794299|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
20567429|NCT00022490|OHSU Knight Cancer Institute|Dr. Brian Druker|(503) 494 5596|drukerb@ohsu.edu|
20567430|NCT01029704|Theracos, Inc.|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20567431|NCT03845517|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567432|NCT03006393|Emory University|Dr. Michael Treadway|(404) 727-3166|mtreadway@emory.edu|
20567433|NCT01109979|Brigham and Women's Hospital|Ellen Seely, MD|617-732-5012|eseely@partners.org|
20567434|NCT03500406|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
20567435|NCT00807599|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun, MD|212-639-3228|hassounh@mskcc.org|
20567436|NCT02161458|University of Pennsylvania|Yvette Sheline, Principal Investigator|215-746-2637|cndslab@pennmedicine.upenn.edu|
20567437|NCT03136861|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20567438|NCT03390166|Mahidol|Punnee Pitisuttithum|6626435599|punnee.pit@mahidol.ac.th|
20567439|NCT00186446|Stanford University|aimee-noelle swanson|650-736-4559|aimnoe@stanford.edu|
20567440|NCT01262456|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20567441|NCT03938272|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
20567442|NCT02538094|Johns Hopkins University SOM|Dr. Tracy Vannorsdall|4105023701|TVannor1@jhmi.edu|
20567443|NCT00695188|Department of Clinical Pharmacology, Medical University of Vienna|Eva-Luise Hobl|+43 1 40400 2981|eva-luise.hobl@meduniwien.ac.at|
20567444|NCT01860079|AcibademU|Prof.Dr.Şevket Görgülü|+902623174444|sevket5@yahoo.com|4123
20567445|NCT01323790|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
20567446|NCT02915783|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20567447|NCT02950961|VA Greater Los Angeles Healthcare System, West Los Angeles, CA|Alison B Hamilton, PhD MPH|(310) 478-3711|alison.hamilton@va.gov|44157
20567448|NCT00703391|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20567449|NCT02114515|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|partner@uic.edu|
20567450|NCT00667732|Oregon Health and Science University|Dr. Matthew Riddle|503-494-0557|riddlem@ohsu.edu|
20567451|NCT02725372|Bellerophon Therapeutics Inc|Bobae Kim|(917) 675-2254|bobae.kim@bellerophon.com|
20567452|NCT00747149|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20567453|NCT01513447|Northwestern University Feinberg School of Medicine|Cynthia A. Wong, M.D.|312-472-3585|c-wong2@northwestern.edu|
20567454|NCT02534129|ProTechSure Scientific Inc.|L. Michael Glode, MD|303-526-9031|mike.glode@ucdenver.edu|
20567455|NCT03840200|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20567456|NCT05522777|Yakult U.S.A. Inc|Hideyuki Shibata|714-434-6500|hideyuki.shibata@yakultusa.com|
20567457|NCT05489770|EKHUFT|Dr Jane Povey- Research Facilitator|01227766877|jane.povey2@nhs.net|
20567458|NCT05487300|University of Utah|Dr. Guillaume Lamotte|801-585-7575|guillaume.lamotte@hsc.utah.edu|
20506823|NCT01204255|Virginia Commonwealth University|Thomas J. Smith, MD|804-828-9723|tsmith5@mcvh-vcu.edu|
20567459|NCT03141177|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20567460|NCT05006703|University Hospital Southampton|Professor Graham Roberts|02381 204335|g.c.roberts@soton.ac.uk|
20522135|NCT03196219|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
20552409|NCT01176292|Anderson Orthopaedic Research Institute|Dr. William Hamilton|703-619-4411|research@aori.org|
20567461|NCT03854734|Penn State College of Medicine|Dr. Jennifer Kraschnewski, Professor of Medicine and Public Health Sciences|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
20567462|NCT02196259|University of Michigan|Dr. Scott Peltier|734-647-8077|spelt@umich.edu|
20567463|NCT04909593|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20567464|NCT01018992|Emory University|Dr. Boadie Dunlop|404-727-8474|bdunlop@emory.edu|
20567465|NCT01825785|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20567466|NCT04721600|Inmode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
20567467|NCT01205126|Janssen Research & Development, LLC|Director, Established Products|+1 609 730 3387;||
20567468|NCT00805792|Mayo Clinic|James F. Meschia, MD|904-953-2903|meschia.james@mayo.edu|
20567469|NCT01773707|Yale University|Dr. Kevan Herold|203-785-6507|Kevan.Herold@Yale.edu|
20522136|NCT01422187|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
20522137|NCT00168818|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522138|NCT01056315|Grünenthal|Study Director|+49 (0)-241-569-3223|clinical-trials@grunenthal.com|
20522139|NCT00603837|University of Oklahoma Health Sciences Center|Doug Dannaway, MD|405-271-5215|douglas-dannaway@ouhsc.edu|42048
20522140|NCT04611529|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20522141|NCT04867174|University of Southern California|Professor Mireille Jacobson|(213) 740-5156|mireillj@usc.edu|
20522142|NCT00451048|Princess Margaret Hospital|Dr. Karen Yee|416-946-4495|karen.yee2@uhn.on.ca|
20522143|NCT02794597|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
20522144|NCT02538965|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosur|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20552410|NCT01933048|Uniformed Services University of the Health Sciences|Eugene V. Millar, PhD|301-816-8451|emillar@idcrp.org|
20552411|NCT02780804|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20552412|NCT02476968|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20552413|NCT01859507|Cairo University. Department of Obstetrics and Gynecology|Abdelmaguid Ramzy|+201008606060|amramzy@gmail.com|
20552414|NCT04476030|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20552415|NCT02404311|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20552416|NCT02155335|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552417|NCT01536496|Denver Health Medical Center|Ernest E. Moore|303.602.1817|Ernest.Moore@dhha.org|
20552418|NCT02256891|Health Partners|Michael Walsh|(952) 831-8742|michael.walsh@tria.com|
20552419|NCT04171414|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
20552420|NCT02586493|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552421|NCT01378221|Heart and Diabetes Center North Rhine-Westphalia, Germany|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
20552422|NCT04896658|University of Maryland, Baltimore|Ashraf Badros, MD|410-328-1230|abadros@umm.edu|
20552423|NCT00076687|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20552424|NCT04493060|Mayo Clinic|Dr. Robert R McWilliams|507-284-2511|mcwilliams.robert@mayo.edu|
20552425|NCT01589445|Ministry of Science and Technology, Government of the People's Republic of Bangladesh|Dr. Masuma Parvin|88 01819141258|acmasuma@gmail.com|
20552426|NCT01990495|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
20567470|NCT04471805|University of Iowa, Department of Health and Human Physiology|Thorsten Rudroff, PhD|(319)467-0363|thorsten-rudroff@uiowa.edu|
20552427|NCT03412084|University of Wisconsin - Madison|Dr. Kelli F Koltyn|608-263-6746|kelli.koltyn@wisc.edu|
20552428|NCT01420289|Calvary Hospital|Oscar M. Alvarez PhD, Director Center for Curative and Palliative Wound Care|718-518-2577|oalvarez@calvaryhospital.org|
20552429|NCT01928862|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20552430|NCT00703885|UCSD|Murray B. Stein MD, MPH|858-534-6451|mstein@ucsd.edu|
20552431|NCT01478321|Northwestern University|Karan Dixit, MD|312-695-1301|karan.dixit@northwestern.edu|
20552432|NCT01100242|University of New Mexico|Richard Lauer, MD|5052725837|rlauer@salud.unm.edu|
20552433|NCT00181207|Johns Hopkins University|Gregory Diette|410-955-3497|gdiette@jhmi.edu|
20552434|NCT00314574|Hoffman-LaRoche|Medical Communications|800-821-8590||
20552435|NCT02418195|University of Alabama at Birmingham|Samantha White/ Clinical Trials Manager|12059349189|swwhite@uabmc.edu|
20552436|NCT02053753|Amgen Inc.|Study Director|866-572-6436||
20552437|NCT01565330|Avid Radiopharmaceuticals|Chief Medical Officer|215-290-0700|clinicaloperations@avidrp.com|
20552438|NCT02972632|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20552439|NCT03999411|University of Miami|Dr. Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
20552440|NCT00337103|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20552441|NCT02016482|AbbVie|Global Medical Services|800-633-9110||
20552442|NCT01289847|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
20552443|NCT03441633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552444|NCT05876273|Center for Diabetes Technology, University of Virginia School of Medicine|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu|
20552445|NCT03552575|University of Glasgow|Professor John McMurray|0141 330 2627|john.mcmurray@glasgow.ac.uk|
20567471|NCT01393600|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20567472|NCT01072149|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567473|NCT02784834|UC San Diego|Dr. Michael Choi|(858) 534-1765|mychoi@ucsd.edu|
20567474|NCT03800563|Alma Lasers|Dr Meital Grafi-Cohen|+972-523708780|meital.grafi@almalasers.co.il|
20567475|NCT00950235|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD Principle Investigator|503 335 6751|victor.j.stevens@kpchr.org|
20567476|NCT01163214|Mayo Clinic|Mark J. Spangehl, M.D.|480-342-2377|spangehl.mark@mayo.edu|
20567477|NCT01090739|University of Michigan, Professor of Obstetrics and Gynecology|Dee Fenner, MD, Study Coordinating Investigator|734-647-5866|deef@med.umich.edu|
20567478|NCT00988429|Bial - portela & Cª, S.A.|Head of Clinical Research|+351 22 986 6100|clinical.trials@bial.com|
20567479|NCT00441168|Jan-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492|rangermu@its.jnj.com|
20567480|NCT02964234|University of Illinois at Chicago|Dr. Yamile Molina|312-355-2679|ymolin2@uic.edu|
20567481|NCT00825318|St. Luke's-Roosevelt Hospital Center|James Jones, MD|2125233530|JaJones@chpnet.org|
20567482|NCT01799993|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20567483|NCT04405180|University of Pittsburgh|Dr. Daniel Forman|412-864-2507|formand@pitt.edu|
20567484|NCT02580799|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20567485|NCT00201825|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-6529|Tanios.Saab@osumc.edu|
20567486|NCT05919732|Nemours|Dr. Gohalem Felema|904-416-5430|gohalem.felema@nemours.org|
20567487|NCT03125148|Medical College of Wisconsin|Kulwinder Dua, MD|4149556896|kdua@mcw.edu|
20567488|NCT01735214|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20567489|NCT01328756|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20567490|NCT00257309|Centro Nacional de Investigaciones Cardiovasculares|Héctor Bueno|(+34) 914 531 200|hbueno@cnic.es|4110
20567491|NCT03692871|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567492|NCT00257894|Veterans Affairs Medical Center (VAMC), Providence|Damaris J. Rohsenow, Ph.D.|401-863-6648|damaris.rohsenow@va.gov|
20567493|NCT02852824|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567494|NCT01316913|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567495|NCT04867382|HealthPartners Institute|Stephanie Hooker, PhD, MPH, MS, Principal Investigator|(952) 967-5056|Stephanie.A.HookerShowalter@HealthPartners.com|
20567496|NCT02102724|Rush University College of Nursing|Barbara Swanson|3129428977|BARBARA_A_SWANSON@RUSH.EDU|
20567497|NCT05445557|Raziel Therapeutics|Racheli Gueta, Director of Clinical Trials|97289124670|racheli@raziel-therapy.com|
20567498|NCT02008916|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20567499|NCT04063124|UT Health San Antonio|Mitzi Gonzales, PhD|210-450-9047|Gonzalesm20@uthscsa.edu|
20567500|NCT01971255|National Institute of Allergy and Infectious Diseases|Matthew James Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
20567501|NCT01915914|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567502|NCT00145145|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20567503|NCT00428714|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20567504|NCT02432274|Eisai Ltd.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20567505|NCT00309751|Kowa Research Institute Inc|Bill Arana|919 433 1600|barana@kowaus.com|
20567506|NCT01736475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20567507|NCT00513071|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20567508|NCT01479010|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
20567509|NCT03565640|Atrium Wake Forest Baptist Health|Sachin Vyas|7865564412|svyas@wakehealth.edu|
20567510|NCT00264576|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20567511|NCT02659059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20567512|NCT00092456|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567513|NCT04783389|Connect Biopharma|Dr. Malinda Longphre, PhD, Head of Clinical Operations|+1 510 520 3361|mlongphre@connectpharm.com|
20567514|NCT01241448|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20567515|NCT01304940|VA ORD|Suzanne Pineles|857-364-5906|suzanne.pineles@va.gov|
20567516|NCT02065895|Boston Children's Hospital|Garry M. Steil, PhD|617-355-7504|garry.steil@childrens.harvard.edu|
20567517|NCT03137784|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20567518|NCT04311983|Washington University School of Medicine|Matthew Kreuter, Ph.D.|314-935-3701|mkreuter@wustl.edu|
20567519|NCT03331978|RAND Corporation|Laura Bogart|3103930411|lbogart@rand.org|7281
20567520|NCT00630409|University of Pittsburgh|Leonard Appleman, MD, PhD|412-648-6538|applemanlj@upmc.edu|
20567521|NCT02165202|PATH|Heather Kelly|650-392-2510|hkelly@path.org|
20567522|NCT01689740|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20567523|NCT01420328|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Husam Ghanim|7169574325|ghanim@buffalo.edu|
20567524|NCT01975701|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novatis.com|
20567525|NCT01655498|Pelvalon|Director of Clinical|650-276-0130||
20567526|NCT02753075|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567527|NCT01062165|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
20567528|NCT04361617|Wake Forest University Health Sciences|Lindsay Reynolds, PhD|336.713.1134|lireynol@wakehealth.edu|
20567529|NCT02005484|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20567530|NCT00687297|PrECOG|Study Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
20567531|NCT04534738|University of Maryland Baltimore|Amber Kleckner, PhD|410-706-5961|amber.kleckner@umaryland.edu|
20567532|NCT03695185|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20567533|NCT01670877|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
20567534|NCT02525744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20567535|NCT02069379|University of Michigan|Alison Berent-Spillson|(734) 936-4400|berent@umich.edu|
20567536|NCT02206607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567537|NCT03398798|University of North Carolina at Chapel Hill|Christian Piers, DDS, MS, MFA|(828) 433-1242|christian.piers@gmail.com|
20567538|NCT04183491|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
20567539|NCT04604652|HighTide Therapeutics|VP Clinical Operations|760-809-3523|cbennett@hightidetx.com|
20567540|NCT00337610|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20567541|NCT01888484|Clinical Research Management Group|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
20567542|NCT01326455|UAlberta|Jennifer Fech||jennifer.fech@albertahealthservices.ca|
20567543|NCT01441596|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567544|NCT03055988|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567545|NCT01528605|Peking University|Xiaoming Lin|010-82805336|linbjmu@bjmu.edu.cn|
20567546|NCT01681511|ICET, Inc.|Dr. Shantha Sarangapani|781-769-6064|Shantha@icetinc.com|
20567547|NCT01156675|Globus Medical|Director, Clinical Affairs|610-930-1800|jmyer@globusmedical.com|1669
20567548|NCT02151994|BIAL-Portela & Ca, S.A.,|Head of Clinical Research|(+351)-22-9866100|clinical.trials@bial.com|
20567549|NCT02613403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522145|NCT02960490|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
20567550|NCT02807857|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20567551|NCT00800176|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20567552|NCT00779194|STATE UNIVERSITY OF NEW YORK|Andras Perl|3154644194|perla@upstate.edu|
20567553|NCT02326220|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20567554|NCT02699099|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20567555|NCT01094106|Kuopio University Hospital|Matti Reinikainen|+358447176681|matti.reinikainen@kuh.fi|
20567556|NCT01240590|National Cancer Institute|Dr. James Gulley|301-480-7164|gulleyj@mail.nih.gov|
20567557|NCT02659540|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20567558|NCT00824850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567559|NCT02739100|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
20567560|NCT01075152|University of Minnesota|Dr. David R Boulware|6126249996|coat.trial@gmail.com|
20567561|NCT04820491|Virginia Commonwealth University|Jordan Tozer|804-828-5250|jordan.tozer@vcuhealth.org|
20567562|NCT01840722|University of Kentucky|Michele Staton, Associate Professor|859-257-2483|mstaton@uky.edu|
20567563|NCT02144285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20567564|NCT01529632|Novartis Pharmaceuticals|Study Director|862-778-8300||
20522146|NCT00627861|The Rogosin Institute|Warren Bobb, N.P.|212-746-9114|wab9006@nyp.org|
20522147|NCT03344861|on behalf of Concordia Laboratories Inc.|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
20522148|NCT04642365|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20522149|NCT02728843|Chiesi Canada Corp.|Caroline Fradette, PhD|1-800-854-3534|c.fradette@chiesi.com|7014
20522150|NCT02478320|M D Anderson Cancer Center|Dr. David Hong|(713) 563-5844|dshong@mdanderson.org|
20522151|NCT01595386|University of Alabama at Birmingham, Pediatric Cardiac Critical Care|Jeffrey Alten, M.D., Director of Clinical and Translational Research Department|205-975-3123|jalten@peds.uab.edu|
20522152|NCT02952898|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
20522153|NCT00399880|Vanderbilt University Medical Center|Kathryn Goggins, Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
20522154|NCT04844762|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20522155|NCT04051619|Brown University|Carolina Haass-Koffler, PharmD, PhD (PI)|4155191385|carolina_haass-koffler@brown.edu|
20522156|NCT02899195|PrECOG|Dr. Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
20522157|NCT03758716|Oneness Biotech Co., Ltd.|NienYi Chen PhD|+886 2 2655 8687|nienyichen@onenessbio.com.tw|613
20522158|NCT03156504|Mayo Clinic|Dr. Jennifer Vande Voort|507-255-6782|VandeVoort.Jennifer@mayo.edu|
20522159|NCT04778904|Barinthus Biotherapeutics|Chief Medical Officer|+44 (0) 1865 818 808|clinicaltrials@barinthusbio.com|
20522160|NCT03452137|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20522161|NCT04138043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20522162|NCT03772717|Emory University|Sumit Verma, MD|404-785-9893|sumit.verma@emory.edu|
20522163|NCT02856802|Upsher-Smith Laboratories, LLC|Clinical Operations|(763) 315-2000|uslinfo@upsher-smith.com|
20522164|NCT00587860|Mayo Clinic|Yuri A. Saito Loftus, M.D., M.P.H.|507-284-5010|saito.yuri@mayo.edu|
20522165|NCT01659125|Institute of Living|Gretchen J. Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
20522166|NCT00261443|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20522167|NCT02755649|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20522168|NCT01286753|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20522169|NCT02089659|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522170|NCT02126826|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567565|NCT02759575|University of Cincinnati|Vinita Takiar, MD, PhD, Associate Professor|(513)584-8956|Vinita.Takiar@UCHealth.com|
20567566|NCT05184062|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20567567|NCT01818063|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edith Mitchell|215-955-8874|edith.mitchell@jefferson.edu|
20567568|NCT04445337|University of Nebraska Medical Center|Michael Lankhorst|402-559-4081|michael.lankhorst@unmc.edu|
20567569|NCT03659136|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20567570|NCT03786471|University of California Los Angeles|Jenny Summapund|3233660667|jsummapund@mednet.ucla.edu|
20567571|NCT03346200|KARMA project, Karolinska Institute|PI Professor MD Per Hall|+46 8 524 85000|Per.hall@ki.se|
20567572|NCT02556606|Michael E. DeBakey VA Medical Center|Marijn Lijffijt, PhD|3618274395|marijn.lijffijt@bcm.edu|
20567573|NCT04351243|Kinevant Sciences, Inc. on behalf of Kinevant Sciences GmbH|Simon Lowry, MD, Chief Medical Officer|(646) 495-5368|simon.lowry@roivant.com|
20567574|NCT04328467|University of Minnesota|Radha Rajasingham, MD|612-626-8171|radha@umn.edu|
20567575|NCT00990184|SIBCR|Steven E. Kahn|206-277-5515|skahn@u.washington.edu|
20567576|NCT03835416|Durham VA Medical Center|Dr. Connie Bales, Assoc. Director, GRECC|919-286-0411|connie.bales@va.gov|6780
20567577|NCT01301183|Massachusetts General Hospital|Madhu Misra|6177265790|mmisra@mgh.harvard.edu|
20567578|NCT02152384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20567579|NCT00823966|Pfizer, Inc.|Pfizer ClinicalTraials.gov Call Center|1-800-718-1021|ClinicalTraials.govCallCenter@pfizer.com|
20567580|NCT00603798|Graceway Pharmaceuticals|Sharon F Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
20567581|NCT04540952|Atrium Health|Dr. Paul Marshburn|704-619-2537|Paul.Marshburn@atriumhealth.org|
20567582|NCT01215253|University of Rochester|Wojciech Zareba|585-275-5391|wojciech.zareba@heart.rochester.edu|
20567583|NCT02067000|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|7044
20567584|NCT00825734|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20567585|NCT02137785|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
20567586|NCT02584257|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
20567587|NCT00417885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567588|NCT02309892|Helix BioPharma Corp.|Brenda Lee, Director, Clinical Operations|416 642 1807|blee@helixbiopharma.com|
20567589|NCT01672242|University of Maryland School of Medicine|Carl Shanholtz, MD|410.328.8141|cshanhol@som.umaryland.edu|
20567590|NCT03146845|Smith & Nephew, Inc.|Judith Horner|+44 1482 673251|judith.horner@smith-nephew.com|
20567591|NCT05376397|Rutgers School of Public Health|Dr. Devin English, Prinicipal Investigator|19739727212|devin.english@rutgers.edu|
20567592|NCT02721147|Fox Chase Cancer Center|Dr. Jennifer Reese, Assistant Professor|215-214-3223|Jennifer.Reese@fccc.edu|
20567593|NCT03403153|Department of Veterans Affairs|Dr, Suzannah Creech Ph.D|254-297-3025|suzannah.creech@va.gov|
20567594|NCT01722097|Herlev Hospital, University of Copenhagen, Department of Anaesthesiology|Dr. Matias Vested Madsen|+45 38683868|matias.vested.madsen@regionh.dk|
20567595|NCT00711022|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
20567596|NCT01535261|Novartis|Study Director|862-778-8300||
20567597|NCT01137682|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20567598|NCT01912599|University of North Carolina|Jean-Claude Mwanza, MD, MPH, PhD|919-843-4917|jean-claude_mwanza@med.unc.edu|
20567599|NCT00722865|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
20567600|NCT02791308|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
20567601|NCT00042939|ECOG Statistical Office|Study Statistician|617-632-3012||
20567602|NCT03349476|Icahn School of Medicine at Mount Sinai|Stephanie Harcum|(212) 824-8927|stephanie.harcum@mountsinai.org|
20567603|NCT04417907|Stanford University|Kimford Meador|650-721-5552|kmeador@stanford.edu|
20567604|NCT00674765|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
20567605|NCT00472082|Emory University|Kenneth A. Newell, MD, PhD|404-727-2489|kanewel@emory.edu|
20567606|NCT00248794|VA Connecticut Healthcare System|Gary Bryson|860-594-6348|gary.bryson@va.gov|
20567607|NCT03449979|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
20567608|NCT03195127|University of Maryland, Baltimore|Avelino C. Verceles, M.D., M.S.|4103288141|avercele@medicine.umaryland.edu|
20567609|NCT04617847|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
20567610|NCT01762345|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
20567611|NCT00700999|Jesse Brown VA Medical Center|Dr. K Luan Phan|312-569-7161|Kinh.Phan@va.gov|
20567612|NCT02379078|St. Michael's Hospital (Unity Health Toronto)|Dr. Catherine Yu|(416) 360-4000|catherine.yu@unityhealth.to|
20567613|NCT00244751|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567614|NCT00761267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567615|NCT04144088|Chung Shan Medical University Hospital|Dr. Cheng Chung Wei|+886-4-24739595|wei3228@gmail.com|34718
20567616|NCT01777932|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20567617|NCT02466958|UCLA|Helen Lavretsky, MD|310-794-4619|HLavretsky@mednet.ucla.edu|
20567618|NCT03936699|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513.236.6799|samlung@elira.com|
20567619|NCT00068107|Baylor Research Institute|Dr. Raphael Schiffmann|214-820-4533|raphael.schiffmann@baylorhealth.edu|
20567620|NCT03288506|Queen's University Belfast|Dr Paul Best|0289097|p.best@qub.ac.uk|3256
20567621|NCT00090519|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
20567622|NCT00116649|Graceway Pharmaceuticals LLC|Sharon Levy, MD VP Product Development|267-948-0500|sharon.levy@gracewaypharma.com|
20567623|NCT02161146|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20567624|NCT00845520|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
20567625|NCT01782209|University of Alabama at Birmingham|Richard J. Whitley, MD|205.638.2530|rwhitley@peds.uab.edu|
20567626|NCT01079949|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20567627|NCT00452452|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20567628|NCT02713217|Central Arkansas Veterans Healthcare System|Richard R. Owen, MD|5012574802|richard.owen2@va.gov|
20567629|NCT04620733|CymaBay Therapeutics, Inc.|CymaBay Study Director|1-510-293-8800|medinfo@cymabay.com|
20567630|NCT02221934|Neuros Medical, Inc.|Nick Hargus, PhD. Vice President of Clinical and Medical Affairs|440-951-2565|nhargus@neurosmedical.com|
20567631|NCT01921166|AtriumHealth|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|brad.hurst@atriumhealth.org|
20567632|NCT00230009|Wayne State University|Steven J. Ondersma, ,PI|313-577-6680|s.ondersma@wayne.edu|
20567633|NCT04555694|Cleveland Eye Clinic|Dr. Thomas Chester, OD|440-526-1974|tchester@midwestvision.com|
20567634|NCT00451906|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20567635|NCT01250717|BIDMC|Glenn Bubley MD, Director of GU ONC|617-735-2062|gbubley@bidmc.harvard.edu|
20567636|NCT01578278|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20567637|NCT02121808|Laval University|Jean S. Bussières|418 656-8711|jbuss@criucpq.ulaval.ca|
20567638|NCT02164578|Medical Clinic III, Universitätsklinikum Carl Gustav Carus, Dresden, Germany|Dr. Frank Pistrosch|0049 351 458|frank.pistrosch@uniklinikum-dresden.de|5955
20567639|NCT00112827|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20567640|NCT03924193|Yale University School of Medicine|Dr. Valentina Ivezaj|2037857807|valentina.ivezaj@yale.edu|
20567641|NCT01562275|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20567642|NCT01863368|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20567643|NCT00647699|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
20567644|NCT04371471|NumaHealth international|Dr. Kamyar Hedayat|+33660404192|khedayat@numahealth.com|
20567645|NCT00515112|The University of Chicago|Dr. Walter Stadler|773-702-4400|wstadler@medicine.bsd.uchicago.edu|
20567646|NCT01366976|Vanderbilt University School of Medicine|Mias Pretorius|16153220758|mias.pretorius@vanderbilt.edu|
20567647|NCT03029585|US Biotest, Inc.|Gere S. diZerega, MD, Responsible Medical Officer|1-805-595-1300|gere.dizerega@usbiotest.com|
20567648|NCT00307489|Gilead Sciences, Inc.|Stephen J. Rossi, PharmD|650-522-4212|stephen.rossi@gilead.com|
20567649|NCT04425252|Clear Creek Bio, Inc.|Vice President Clinical Operations|(617) 765-2252|clinical@clearcreekbio.com|
20567650|NCT01458288|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
20567651|NCT00304278|Southern Illinois University|Dr. Krishna Rao|217-545-7969|krao@siumed.edu|
20567652|NCT04025762|University of Cambridge|Dr Charlotte Boughton|+441223769066|cb2000@medschl.cam.ac.uk|
20567653|NCT00759798|The University of Texas MD Anderson Cancer Center|William Wierda MD/Professor|713-745-0428|wwierda@mdanderson.org|
20567654|NCT03340961|Dr. Reddy's Lab, INC|Dr. Srinivas Sidgiddi, Senior Director|908-458-5362|Srinivassidgiddi@drreddys.com|
20567655|NCT01286311|Northwestern University|Stephen D. Persell, MD MPH|312-503-6464|spersell@nmff.org|
20567656|NCT03034863|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
20567657|NCT01381549|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567658|NCT02981953|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20567659|NCT02958826|University of Missouri|Dr. Hope Gole|573-882-8030|golehk@health.missouri.edu|
20567660|NCT02446015|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
20567661|NCT00759681|Greenville Memorial Hospital|David Cull, MD|864-455-9825||
20567662|NCT00473512|Janssen R & D|Senior Director, Clinical Research|(310) 943-8040||2917
20567663|NCT02662023|University of California, San Diego|Brian M. Ilfeld, MD, MS||bilfeld@ucsd.edu|
20506824|NCT00790738|The Zucker Hillside Hospital|Raphael J. Braga, MD|718-4708060|rbraga@nshs.edu|
20567664|NCT01828476|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu|
20506825|NCT00305253|University of California San Francisco (UCSF)|Suellen Miller|415 597 9394|smiller@globalhealth.ucsf.edu , suellenmiller@gmail.com|
20506826|NCT01357915|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506827|NCT01098461|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506828|NCT02841787|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
20506829|NCT03633227|Intercept Pharmaceuticals, Inc.|Medical Information|+1 844-782-4278|medinfo@interceptpharma.com|
20506830|NCT03491553|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20506831|NCT00400829|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20506832|NCT04836455|University of North Carolina at Chapel Hill|Dr. Seth M. Noar|9192607269|noar@unc.edu|
20552446|NCT03583996|HepQuant LLC|Elyse Handley|3037480524|elyse.handley@hepquant.com|
20552447|NCT02151448|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
20552448|NCT04227236|dFusion, Inc.|Regina Firpo-Triplett|831-222-5094|regina.firpo@dfusioninc.com|
20552449|NCT00651573|Cleveland Clinic Foundation|Daniel Sessler, MD|216-4444900|ds@or.org|
20552450|NCT01278485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552451|NCT05265260|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20552452|NCT01774786|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20552453|NCT02268812|Eisai Europe Ltd.|Eisai Medical Services|+44 (0)20 8600 1400||
20567665|NCT00267956|Centocor Research & Development, Inc|Senior Director Clinical Research|1-800-457-6399||
20522171|NCT03092219|Teoxane SA|Clinical Project Manager|+41(0) 22 344 96 36|m.chenet@teoxane.com|
20552454|NCT02385084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20506833|NCT01766336|Transition Therapeutics Ireland Limited|Aleksandar Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
20506834|NCT03976531|Institut Bergonié|Pr S Mathoulin-Pélissier|33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20506835|NCT02605447|Boston Scientific Corp.|Peter Maurer, Director Clinical Trials|+1 (508) 683|Peter.Maurer@bsci.com|6678
20506836|NCT01479374|Alcon Research, Ltd.|Abhijit Narvekar, MS, MBBS|1-888-451-3937|alcon.medinfo@alcon.com|
20506837|NCT01062074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506838|NCT02045212|Regenera Pharma Ltd|Dr Konstantin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
20506839|NCT00145249|University of Alabama at Birmingham|Peter G. Pappas, MD|205-934-9951|pappas@uab.edu|
20506840|NCT00540969|Mayo Clinic|Matthew Callstrom, M.D., Ph.D.|5072664532|callstrom.matthew@mayo.edu|
20506841|NCT01975935|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
20506842|NCT00243230|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506843|NCT02742077|Corindus, Inc.|Clinical Research Manager|(757) 910-4818|tina.ridgeway@corindus.com|
20506844|NCT03992768|Hamamatsu Photonics, K.K.|MCG Manager|+81-53-435-1560|fujisaka@sys.hpk.co.jp|
20506845|NCT00586924|MedImmune, LLC|Nai Shun Yao, MD|1-301-398-5936|information.center@astrazenea.com|
20506846|NCT03185455|UPenn|Dr. Adi Hirshberg|917-553-9643|adi.hirshberg@uphs.upenn.edu|
20506847|NCT00626912|Centre de Recherches du Centre Hospitalier de l'Université de Montréal|Ruby Klink, coordinator|(514) 890 8000|ruby.klink@crchum.qc.ca|25245
20506848|NCT03483506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20506849|NCT04570657|AstraZeneca AB|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20506850|NCT02998554|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20506851|NCT02349789|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
20506852|NCT03522350|Weill Cornell Medical College|Nikica Zaninovic, PhD|212-746-5790|nizanin@med.cornell.edu|
20506853|NCT02860845|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
20506854|NCT00836277|University of Pittsburgh Cancer Institute|Weijing Sun, MD|412-864-7764|sunw@upmc.edu|
20506855|NCT03209440|University of Florida|Dr. Diana Wilkie|352-273-6401|diwilkie@ufl.edu|
20506856|NCT00509496|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20506857|NCT01709136|Children's Hospital of Pittsburgh|Dr. Rakesh Sindhi, MD|412-692-6110|rakesh.sindhi@chp.edu|
20506858|NCT00831441|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20506859|NCT05674344|Masimo Corporation|Chelsea Frank|(949) 297-7000|clinicalresearchdept@masimo.com|
20567666|NCT01263223|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20567667|NCT02246647|Mayo Clinic|Madhusudan Grover, MBBS|507-253-5384|Grover.Madhusudan@mayo.edu|
20567668|NCT02416973|Regenesis Biomedical Inc.|Heather Vander Ploeg|602-428-7041|Heather.VanderPloeg@regenesisbio.com|
20567669|NCT04387773|Oregon Health & Science University|Dr. Amie Hiller|503-494-7772|peterami@ohsu.edu|
20567670|NCT01113541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567671|NCT02132676|VA Ann Arbor Healthcare System Center for Clinical Management & Research|Dr. Michele Heisler|734-845-3502|mheisler@umich.edu|
20567672|NCT01584648|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20567673|NCT02450747|Johnson & Johnson Vision Care Inc.|Tom Karkkainen O.D., M.S., F.A.A.O- Sr. Research Principal Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
20567674|NCT03029156|Tufts Medical Center|Nicholas S. Hill|617-636-0688|nhill@tuftsmedicalcenter.org|
20567675|NCT04812977|Hayatabad Medical Complex, Peshawar|Yousaf Jamal Mahsood|091921714047|yousaf82@hotmail.com|
20567676|NCT02009332|Aadi Bioscience|Berta Grigorian|818-416-8378|bgrigorian@aadibio.com|
20567677|NCT03798756|Keele University|Mrs Sarah Lawton|01782 734887|s.a.lawton@keele.ac.uk|
20567678|NCT01757288|UT Southwestern Medical Center|Dr. Yuanyuan Zhang|214-648-6764|Yuanyuan.Zhang@UTSouthwestern.edu|
20567679|NCT02825550|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|3624/5603
20567680|NCT03386344|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20567681|NCT00795639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567682|NCT04421456|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20567683|NCT01419184|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
20567684|NCT01414192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567685|NCT03989232|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20567686|NCT04658888|Penn State Health Milton S Hershey Medical Center|Dr. Christina Scartozzi|484-650-0885|Cscartozzi@pennstatehealth.psu.edu|
20567687|NCT03400579|University of North Carolina at Chapel Hill|Mehul Patel, PhD|919-843-7307|mehul_patel@med.unc.edu|
20567688|NCT02644122|University of California, San Diego|Ezra Cohen, MD|(858)822-5800|ecohen@ucsd.edu|
20567689|NCT01604122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506860|NCT00111917|National Jewish Health|Lisa Maier, MD|303-398-1983|maierl@njhealth.org|
20506861|NCT01640925|Houston Methodist Hospital|Dr. Joshua Swan|713-441-0165|jtswan@houstonmethodist.org|
20506862|NCT02156492|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20506863|NCT02363270|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
20506864|NCT02311309|CHU de Caen|Dr Jean-Luc Hanouz|2 31 06 47 36|hanouz-jl@chu-caen.fr|33
20506865|NCT01319110|Beth Israel Deaconess Medical Center|Dr. Michael Cocchi||mcocchi@bidmc.harvard.edu|
20506866|NCT03837353|NYU Langone Health|David Wise, MD, PhD|(212) 731-5405|David.Wise@nyulangone.org|
20506867|NCT00442013|Johns Hopkins University|Janet Holbrook|443-287-3170|ala-acrc@jhsph.edu|
20506868|NCT03508661|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
20506869|NCT00485589|F. Hoffmann-La Roche AG|Medical Communications|41 616878333|global.trial_information@roche.com|
20506870|NCT01944969|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
20506871|NCT03072719|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506872|NCT01236742|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766 6100|pauline.cho@polyu.edu.hk|
20506873|NCT03421964|Virginia Commonwealth University|Nancy Hsu, PsyD, PI|804-327-1166|nancy.hsu@vcuhealth.org|
20506874|NCT02938585|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20506875|NCT03709810|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20506876|NCT02665364|Neovacs|Head of Regulatory Affairs|+33153109300|info@neovacs.com|
20506877|NCT03888391|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
20506878|NCT00502320|Lehigh Valley Hospital|Edward R. Norris, MD|610-402-5766|Edward.Norris@lvh.com|
20506879|NCT03654755|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
20506880|NCT02835677|VA Medical Center|Dr. Linda Nichols, Co-Director Caregiver Center|901 523-8990|linda.nichols@va.gov|5082
20506881|NCT00781599|University of Kansas Medical Center|Dr. Nikki Nollen|(913) 588-3784|NNOLLEN@kumc.edu|
20506882|NCT01202721|Population Health Research Institute|Dr. Tara McCready, Program Director||tara.mccready@phri.ca|
20506883|NCT02740504|ResMed|Paul Phillips|+447789633508|paul.phillips@resmed.com|
20506884|NCT00974051|UColorado|Dr. H Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
20506885|NCT01088438|University of Illinois at Chicago|Dr. Alan Schwartz|312-996-2070|alansz@uic.edu|
20506886|NCT01199055|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20506887|NCT00718666|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506888|NCT00932152|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
20506889|NCT02196038|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
20506890|NCT00360243|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20506891|NCT02528097|NYU Langone Medical Center|The Office of Clinical Trials|646.754.7431|clinicaltrials@nyumc.org|
20506892|NCT02569411|St. Michael's Hospital|Dr. Areti Angeliki Veroniki|416-360-4000|averonik@cc.uoi.gr|
20506893|NCT03471767|Duke University|James Davis, MD|919-668-5055|james.m.davis@duke.edu|
20506894|NCT00678587|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506895|NCT03806179|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
20506896|NCT00116857|Washington University School of Medicine|Robert M. Carney, Ph.D.|314-286-1313|carneyr@bmc.wustl.edu|
20506897|NCT01952730|Massachusetts General Hospital|Cristina R. Ferrone, MD|617-643-6189|CFERRONE@PARTNERS.ORG|
20506898|NCT02076321|University of Missouri, Department of Orthopaedics|Dr. Daniel Hoernschemeyer|(573)882-1351|hoernschemeyerd@health.missouri.edu|
20506899|NCT02991937|NYU Langone Health|Jason Fisher, MD|212-263-7391|Jason.Fisher@nyulangone.org|
20506900|NCT01785810|Abramson Cancer Center|Michael Gardo|215-615-2232|michael.gardo@uphs.upenn.edu|
20506901|NCT01514188|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20506902|NCT02662985|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20506903|NCT01019486|University of Colorado, Denver|Robert A. Quaife M.D.|720-848-6562|robert.quaife@ucdenver.edu|
20506904|NCT01277341|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20506905|NCT03134313|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20506906|NCT05373706|University of Washington|Dr. Anne Fairlie|(206) 221-5896|afairlie@uw.edu|
20506907|NCT03442829|Bournemouth University|Prof. Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
20506908|NCT01486784|Abramson Cancer Center at the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
20506909|NCT02724774|University of Washington|Carol Rhodes, Director of Sponsored Programs|206 543-2139|carhodes@uw.edu|
20506910|NCT03029650|University of Iowa|Nicole Brogden|319-335-8752|nicole-brogden@uiowa.edu|
20506911|NCT02237157|RenovoRx|Charles Li|(650) 284-4433|charles@renovorx.com|
20506912|NCT03628508|The Hong Kong Polytechnic University|Dr Amy Fu|8522766 6726|amy.fu@polyu.edu.hk|
20506913|NCT01996748|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
20506914|NCT03011840|Tata Memorial Hospital, Mumbai|Dr. Sumitra Bakshi|+912224177058|sumitrabakshi@yahoo.com|
20506915|NCT03738566|Mayo Clinic|Dr. Jeffrey A. Alexander|507-538-0474|Alexander.Jeffrey14@mayo.edu|
20506916|NCT03448718|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20506917|NCT04539249|Federal Medical Centre, Yenagoa|Dr. Olakunle I. Makinde|08032136315|olakunleife@gmail.com|
20506918|NCT00516269|UT MD Anderson Cancer Center|Carmen Escalante, MD / Professor||RABaker@mdanderson.org|
20506919|NCT00926796|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
20552455|NCT02268786|Illumina|Tasha Kalista|858-202-4500|tkalista@illumina.com|
20552456|NCT00363779|National Cancer Institute (NCI), National Institutes of Health (NIH)|Thomas Waldmann, M.D.|301-496-6653|Thomas_Waldmann@nih.gov|
20552457|NCT01062555|University of Minenesota|Arthur Matas|612-625-5151|matas001@umn.edu|
20552458|NCT02968979|CHUGAI PHARMA FRANCE|Dr Luz BOBADILLA, Medical Affairs Director|+33 1 56 37 05 28|bobadilla@chugai-pharm.fr|
20552459|NCT00729183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552460|NCT01359254|The University of Chicago Medicine|Andrew Artz, MD, MS|(773) 834-8980|aartz@medicine.bsd.uchicago.edu|
20552461|NCT01124643|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20506920|NCT01628016|Hunan Normal University|Dr. Wenhui Yang|+86 731 8873076|yangwh110@163.com|
20506921|NCT01341652|University of Wisconsin Carbone Cancer Center|Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
20506922|NCT02410707|Einstein Healthcare Network|Joseph Herres, DO, Director of Research|215-456-6666|herresjo@einstein.edu|
20506923|NCT01079962|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20506924|NCT01072539|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506925|NCT01331239|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20506926|NCT02010216|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20506927|NCT00946530|Stanford University|Jerome A. Yesavage, MD|650-493-5000|yesavage@stanford.edu|x64330
20506928|NCT01008995|Janssen R&D US|Director, Clinical Research|1 215-793-7646||
20506929|NCT03689504|Wuqu' Kawoq|Peter Rohloff, Chief Medical Officer|011-502-4958-1253|peter@wuqukawoq.org|
20506930|NCT00115804|University of Cincinnati|Dr. Lesley Arnold|513-475-8110|lesley.arnold@uc.edu|
20506931|NCT00621855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20506932|NCT03675737|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20506933|NCT00605722|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20506934|NCT02560493|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632869|amanda.staiano@pbrc.edu|
20506935|NCT00356863|The Gertner Institute for Epidemiology and Health Service Research|Rachel S Dankner, MD, MPH|972-3-5305390|RachelD@gertner.health.gov.il|
20506936|NCT03303040|University of Florida|Dr. Barbara K. Smith|352-294-5315|bksmith@ufl.edu|
20506937|NCT02871401|Vanderbilt University Medical Center|Jonathan Kropski MD|615-322-3412|jon.kropski@vumc.org|
20506938|NCT02581865|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20506939|NCT01993615|Madigan Army Medical Center|Daniel Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
20506940|NCT02621619|Albany Medical Center|Dr. Andrew Chang|518-262-0042|changa1@amc.edu|
20506941|NCT01354353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20506942|NCT00131677|Centers for Disease Control and Prevention (CDC)|Taraz Samandari|404-639-1676|tts0@cdc.gov|
20506943|NCT02924688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20506944|NCT02574858|University of Michigan|Dr. D. Kim Turgeon|734-764-6860|kturgeon@med.umich.edu|
20506945|NCT00882102|The University of Texas MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor|713-563-1586|eharriso@mdanderson.org|
20506946|NCT00868959|Sunovion|Medical Director, CNS|1-866-503-6351||
20506947|NCT02600325|Erasmus MC|Dr. B. J. A. Rijnders|0|b.rijnders@erasmusmc.nl|
20506948|NCT01104584|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20506949|NCT02370498|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506950|NCT04017442|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|daniel.katz@mountsinai.org|
20506951|NCT01453569|Shanghai Greenvalley Pharmaceutical Co., Ltd.|Dr. Xianliang Xin|86 21-50504988|xinxianliang@hotmail.com|1370
20506952|NCT02586233|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20506953|NCT03225716|DFCI|Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
20506954|NCT00848250|Vanderbilt University Medical Center|Mias Pretorius|615-8757402|mias.pretorius@vanderbilt.edu|
20506955|NCT01122030|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20506956|NCT01205451|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506957|NCT02373241|University of Alabama at Birmingham|Jeffrey Lebensbugrer|2056389285|jlebensburger@uabmc.edu|
20506958|NCT03575884|Seattle Children's Research Institute|Jason Mendoza, MD, MPH|206.884.1261|Jay.Mendoza@seattlechildrens.org|
20506959|NCT01850745|Liver Section. Hospital del Mar|Professor Ricard Sola|0034932483200|35783@parcdesalutmar.cat|
20506960|NCT03075176|University of Utah John A. Moran Eye Center|Mark Mifflin, MD|801-213-4152|Mark.Mifflin@hsc.utah.edu|
20506961|NCT02106455|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20506962|NCT00213980|University of Wisconsin Carbone Cancer Center|Dr. Daniel Mulkerin|608-265-8090|dm2@medicine.wisc.edu|
20522172|NCT03278626|NYU Langone Health - Perlmutter Cancer Center|Jennifer Wu, MD|212-263-3809|Jennifer.Wu@nyulangone.org|
20506963|NCT03607838|Seikagaku Corporation|General Manager, Clinical Development Department|(81)3-5220-8593|reply@seikagaku.co.jp|
20506964|NCT02411201|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
20506965|NCT01260467|University of Rochester Medical Center|Jennifer Serventi Research Associate|585-276-3971|jennifer_serventi@urmc.rochester.edu|
20506966|NCT00798694|Wills Eye Hospital|Principal Investigator|215-928-3197|ljaykatz@gmail.com|
20506967|NCT05117229|Mayo Clinic|Rafael J. Sierra, M.D.|507-284-2226|Sierra.Rafael@mayo.edu|
20506968|NCT01774344|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20522173|NCT03333941|AVITA Medical|VP Clinical Research|661-367-9710|clinicaltrial@avitamedical.com|
20506969|NCT03546413|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20522174|NCT04971187|M D Anderson Cancer Center|Dr. Xiuning Le|(713) 792-6980|xle1@mdanderson.org|
20522175|NCT00547586|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20506970|NCT03364608|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
20506971|NCT02173392|Valeant Pharmaceuticals|Director of Clinical Trials|908|lindsey.mathew@valeant.com|
20552462|NCT02028988|Dana-Farber Cancer Institute|Glenn Bubley MD|617-735-2062|gbubley@bidmc.harvard.edu|
20552463|NCT02803307|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|carlb@tlcbio.com|
20552464|NCT02678676|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20552465|NCT02181556|FFCD|Mrs Karine Le Malicot, Head of biostatistics|+33 3 80 39.34.79|karine.le-malicot@u-bourgogne.fr|
20522176|NCT01368653|Rutgers, The State University of New Jersey|Danielle E. McCarthy, Ph.D.|608-265-5949|demccarthy@wisc.edu|
20506972|NCT00838006|Central Arkansas Veterans Healthcare System|Jeff Pyne, MD|501-257-1083|jeffrey.pyne@va.gov|
20506973|NCT02124707|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20506974|NCT01363713|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20506975|NCT00913133|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
20506976|NCT02932332|UT MD Anderson Cancer Center|David Hui, MD, Associate Professor/Palliative Care Med|713-792-6258|dhui@mdanderson.org|
20506977|NCT01875367|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20506978|NCT01419665|Hexal AG / Novartis Pharmaceuticals|Study Director|+41613241111|novartis.email@novartis.com|
20506979|NCT03977727|Texas Diabetes & Endocrinology|Thomas Blevins, MD|512-334-3505|blevins@texasdiabetes.com|1
20522177|NCT01207583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506980|NCT03731364|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
20506981|NCT02953782|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20506982|NCT00665288|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
20506983|NCT01934192|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522178|NCT05177718|Vumc|Natalizumab and chronic Blood Brain Barrier Breakdown|6159360060|francesca.r.bagnato@VUMC.ORG|
20522179|NCT02549027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522180|NCT02242045|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20522181|NCT03578549|Univeristy of Michigan|Dr. Darya Dabiri|4198821017|daryad@umich.edu|
20522182|NCT04414345|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
20522183|NCT00875797|UMCLjubljana|Lidija Kompan, principal Investigator|0038651301781|lidija.kompan@gmail.com|
20522184|NCT02156167|Cochlear|Christiane D'hondt, Clinical Research Specialist|+32 15 76 55 14|cdhondt@cochlear.com|
20522185|NCT00741286|Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine|Sang Won Han|82-2-950-8864|swhan@paik.ac.kr|
20522186|NCT03138590|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
20522187|NCT00425373|Novartis Pharmaceuticals|Study Director|862 778-8300||
20522188|NCT00242684|Central Arkansas Veterans Healthcare System|Melinda Bopp, Project Coordinator|501-257-2045|melinda.bopp@va.gov|
20522189|NCT01590797|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20522190|NCT01900561|Department of Veterans Affairs|Dr. Sarah Hawley|734-936-8816|sarahawl@umich.edu|
20522191|NCT00242632|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
20522192|NCT01708967|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
20522193|NCT01085357|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20522194|NCT03100123|Ottawa Hospital Research Institute|Dr. Leslie Skeith|403-944-5246|laskeith@ucalgary.ca|
20522195|NCT04520009|Dartmouth Geisel School of Medicine|Tor D. Tosteson, ScD|603 646-5724|tor.d.tosteson@dartmouth.edu|
20522196|NCT02910011|University of Florida|Dr. Anna DeBenedetto|352 594 1500|adebenedetto@dermatology.ufl.edu|
20522197|NCT00920790|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
20522198|NCT02460679|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20522199|NCT04411914|Temple University|Mary Morrison, MD, MS|215=707=4037|mary.morrison@temple.edu|
20522200|NCT00706485|Massachusetts General Hospital|Thomas F. DeLaney, M.D.|617-726-6876|tdelaney@mgh.harvard.edu|
20552466|NCT00997503|Boston Scientific Corporation|Peter Maurer, Director of Clinical Trials|1-508-683-6678|Peter.Maurer@bsci.com|
20522201|NCT02895100|Protagonist Therapeutics, Inc|Director Clinical Development|(+1) 888-899-1543|ptgxclintrials@ptgx-inc.com|
20522202|NCT01120704|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
20522203|NCT00339144|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20522204|NCT00345943|New York State Psychiatric Institute|Dr. Rachel Marsh|6467745774|rachel.marsh@nyspi.columbia.edu|
20522205|NCT00895414|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
20522206|NCT00912925|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
20522207|NCT02181790|Icahn School of Medicine at Mount Sinai|Dr Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
20522208|NCT03661697|University of Miami|Lisa D Grunebaum MD|3052433223|lgrunebaum@med.miami.edu|
20522209|NCT02752087|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20522210|NCT02458287|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20522211|NCT00843635|University of Miami|Donald T. Weed MD FACS|305-243-9095|dweed@miami.edu|
20522212|NCT02785952|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20522213|NCT01144715|Kinetic Muscles|James Koeneman, PhD|602-677-5256|jimkoeneman509@gmail.com|
20522214|NCT03553576|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20522215|NCT03565679|Medline Industries, Inc|Kara Cassady|847-643-3809|kcassady@medline.com|
20522216|NCT03020589|University of North Carolina at Chapel Hill|Robert Dupuis, PharmD|919-966-6194|re_dupuis@unc.edu|
20522217|NCT00401986|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|(412) 716-0717|grubbm@bsci.com|
20522218|NCT00351533|University of Vermont|Renee Stapleton, MD PhD|802-656-7975|renee.stapleton@uvm.edu|
20552467|NCT00380393|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552468|NCT03865329|Mayo Clinic|Dr. Roberto Benzo|(507) 284-0561|Benzo.Roberto@mayo.edu|
20522219|NCT03185013|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20522220|NCT02575976|Federal University of Minas Gerais|Professor Raquel Britto|+55 31 99970-4527|r3britto@gmail.com|
20522221|NCT00197496|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
20522222|NCT01881113|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20522223|NCT00857584|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20522224|NCT01102374|University of Colorado School of Medicine|Adit Ginde, MD, MPH, Professor of Emergency Medicine|720-848-6777|adit.ginde@ucdenver.edu|
20522225|NCT01432379|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20522226|NCT01175031|Shanghai Jiao Tong University School of Medicine|Quing Yun Li, MD, PhD|86-21-64314162|liqingyun68@hotmail.com|
20522227|NCT00658021|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20522228|NCT01806506|Department of General, Transplant and Liver Surgery, Medical University of Warsaw|Piotr Kalinowski|0048 22 599 2546|kalip@o2.pl|
20522229|NCT02091466|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Dr. Ricardo Caio Gracco De Bernardis|55-11-21767280|rcaiog@yahoo.com.br|
20522230|NCT02542605|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20522231|NCT04324073|Hopital Hotel-Dieu (AP-HP)|Dr Raphael Porcher|+33(0)1.42.34.89.87|raphael.porcher@aphp.fr|
20522232|NCT03383523|Drugs for Neglected Diseases Initiative|Jean Yves Gillon|+41229069232|jygillon@dndi.org|
20522233|NCT01784055|NeoChord, Inc.|Lori E Adels, PhD|1-952-698-7804|ladels@neochord.com|
20522234|NCT01924754|University of California, San Francisco|Dr. Joel Palefsky, MD|(415) 476-8885|Joel.Palefsy@ucsf.edu|
20522235|NCT03132155|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20522236|NCT04320823|Haemonetics Corporation|Jan Hartmann, MD, Vice President of Medical Affairs and Clinical Development|(781) 348 7396|Jan.Hartmann@haemonetics.com|
20522237|NCT03120325|Stanford University|Linda Nguyen|650-736-0431|nguyenlb@stanford.edu|
20522238|NCT02925403|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|vaccinetrials@ndm.ox.ac.uk|
20522239|NCT05289869|The Ohio State University|Heather Frey, MD, MSCI|614-688-6798|Heather.Frey@osumc.edu|
20522240|NCT01613768|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
20522241|NCT05013008|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20522242|NCT01443728|Columbia University|Gary Brittenham, MD|212-305-7005|gmb31@cumc.columbia.edu|
20522243|NCT00264550|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
20522244|NCT00129389|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20522245|NCT00866879|Northwestern University|Lorenzo Gallon, MD|3126954457|l-gallon@northwestern.edu|
20522246|NCT02691143|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|240-766-0300|jslaski@ssrehab.com|838
20522247|NCT01831258|SleepMed of South Carolina|Dr Richard Bogan|8777537633|rbogan@sleepmedinc.com|
20522248|NCT02597127|The Medicine's Company|Global Health Science Center|1-888-997-6326|Medical.Information@themedco.com|
20522249|NCT02564887|University of Pittsburgh|Christine Harrison, Clinical Research Coordinator|412-647-9665|harrisonta@upmc.edu|
20552469|NCT00526058|B. Braun Medical Inc.|Kevin Minnich, Manager Clinical Affairs/Safety Officer|610-596-2358|kevin.minnich@bbraun.com|
20552470|NCT01746784|N30 Pharmaceuticals|Dr. Steven Shoemaker|720-945-7700|steven.shoemaker@n30pharma.com|
20552471|NCT04920123|University of Massachusetts Amherst|Juhyeon Lee|413-404-4732|juhyeonlee@cs.umass.edu|
20552472|NCT03893799|Renibus Therapeutics|Donald J Keyser, Chief Operating Officer|18178756991|jkeyser@renibus.com|
20552473|NCT00218296|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
20552474|NCT02623803|Mayo Clinic|Dr. Elird Bojaxhi|904-956-3327|bojaxhi.elrid@mayo.edu|
20552475|NCT04693585|University of California San Francisco|Nadia Diamond-Smith|415-353-4545|nadia.diamond-smith@ucsf.edu|
20552476|NCT03221595|Denver Health Medical Center|Research Coordinator|303-602-6213|Kiara.Leasia@dhha.org|
20552477|NCT02212587|Hospital of Sick Children|Dr. Valerie Waters|416-813-1500|valerie.waters@sickkids.ca|
20552478|NCT00134381|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
20552479|NCT00278954|Bio Products Laboratory|Margaret Stratford Bobbitt|+44 20 8258 2288|Margaret.Stratford-Bobbitt@bpl.co.uk|
20552480|NCT04452331|University of Illinois Chicago|Dr. Alan Schwartz|3129962070|alansz@uic.edu|
20552481|NCT00826800|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
20552482|NCT03760796|Johns Hopkins University School of Medicine|Dr. Seth Martin|(610) 331 - 3842|smart100@jhmi.edu|
20552483|NCT02836600|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20552484|NCT02211131|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20552485|NCT05664490|University of California, San Francisco|Dr. Jennifer Velloza|9173923561|Jennifer.Velloza@ucsf.edu|
20552486|NCT05442554|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20552487|NCT02269280|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Mnaero|713-745-3428|ggarciam@mdanderson.org|
20552488|NCT03869450|Q-Med AB|Clinical Project Manager|+4618 474 9000|reception.seupp@galderma.com|
20552489|NCT00449956|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20552490|NCT02882321|The University of Texas MD Anderson Cancer Center|Marina Konopleva MD./Professor|713-794-1628|mkonople@mdanderson.org|
20552491|NCT01446965|University of California, San Francisco|Jeffrey Olgin, MD|415-476-1000|jeffrey.olgin@ucsf.edu|
20552492|NCT04064294|Portland VA Health Care System|Dr. Kathryn Chung|(503) 721 -1091|Kathryn.Chung@va.gov|
20552493|NCT01451775|boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552494|NCT02457403|The Ohio State University|A James Hanje|614 293 6255|james.hanje@osumc.edu|
20552495|NCT03818516|Emory University|David R. Goldsmith, MD|404-727-3735|drgolds@emory.edu|
20522250|NCT01199016|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522251|NCT02318303|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20522252|NCT00561418|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|craig.hofmeister@osumc.edu|
20522253|NCT02667067|NuVasive, Inc.|Nicole Czaplewski|308-660-2021|nczaplewski@nuvasive.com|
20522254|NCT02842073|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
20522255|NCT00385008|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522256|NCT01333397|Ipsen|Medical Director|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20522257|NCT04082338|Center for Asian Health, Lewis Katz School of Medicine, Temple University|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
20522258|NCT05320887|Wake Forest School of Medicine|Darcy Lockhart, Project Manager I|3367166182|alaverdi@wakehealth.edu|
20522259|NCT02279108|CHU Saint-Etienne|Pr Céline CHAULEUR|04 77 82 86 11|celine.chauleur@chu-st-etienne.fr|+33
20522260|NCT03907657|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|9199620000|melahat.garipagaoglu@gmail.com|
20522261|NCT02010645|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
20522262|NCT01994850|University of Pennsylvania Abramson Cancer Center|Jakub Svoboda, MD|855-216-0098|PennCancerTrials@emergingmed.com|
20522263|NCT05084924|University of North Carolina at Chapel Hill|Justin Riddle, PhD|850-644-9869|justin_riddle@med.unc.edu|
20522264|NCT03774407|Texas Tech|Dr Mirla Avila|8322448072|mirla.avila@ttuhsc.edu|
20522265|NCT00182325|Department of Family Medicine, McMaster University|Dr. Heather Waters|(905) 575-6782|watersh@mcmaster.ca|
20522266|NCT01992185|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
20522267|NCT03225001|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
20522268|NCT01420965|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
20522269|NCT03485365|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20522270|NCT00205803|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522271|NCT01024686|U.S. Military Malaria Vaccine Program (USMMVP)|Dr. Michele Spring|301-319-9307||
20522272|NCT01104792|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com,|
20522273|NCT03255655|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
20522274|NCT02056392|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
20522275|NCT00555360|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
20522276|NCT00373698|VA Medical Center, White River Junction, VT|Dr. Paula Schnurr and Dr. Mathew Friedman|802-296-5132|Paula.Schnurr@va.gov; Matthew.Friedman@va.gov|
20522277|NCT01119794|Brown University Oncology Research Group (BrUOG)|Eric Winer, MD|4018633000|kayla_rosati@brown.edu|
20522278|NCT03862755|Shanghai Pulmonary Hospital|Dr. Lei Shen|86-21-65115006|sh_leisen@126.com|2054
20522279|NCT05819203|Pharmndev Experts|Dr Bernard Gout|+41798659000|bgout@pharmndev.ch|
20522280|NCT02297698|LumaBridge|Dr. George Peoples|210 557 4291|gpeoples@lumabridge.com|
20522281|NCT04784533|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20522282|NCT00963560|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
20522283|NCT01462773|The Ohio State University Comprehensive Cancer Center|William Carson|614-293-6306|william.carson@osumc.edu|
20522284|NCT04123561|Taiwan Liposome Company|Dr. Tien-Tzu Tai|+886 2 2655 7377|tttai@tlcbio.com|801
20522285|NCT02454127|Tufts Medical Center|Michael Dansinger, MD|617-636-5000|mdansinger@tuftsmedicalcenter.org|
20522286|NCT02203331|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20522287|NCT02777073|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
20522288|NCT03844386|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-843-2726|cynthia_gay@med.unc.edu|
20522289|NCT01191827|Denver VA Medical Center|Research Biologist|303-724-6232|jason.tregellas@va.gov|
20522290|NCT02682927|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20522291|NCT01178528|IRCCS San Raffaele|G Rosano|0652252309|giuseppe.rosano@sanraffaele.it|
20522292|NCT03462459|University of Wisconsin-Madison|Nasia Safdar, Professor|608-265-1545|ns2@medicine.wisc.edu|
20522293|NCT03739645|Johns Hopkins University|Fred Lenz|443.287.1609|flenz1@jhmi.edu|
20522294|NCT02551666|Virginia Tech|Professor Michael L. Madigan, PhD|540-231-3543|mlm@vt.edu|
20522295|NCT01177059|Janssen-Cilag Pty Ltd, Australia|Executive Director Medical & Scientific|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20522296|NCT05833139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522297|NCT03128060|University of Southern California|Susan Enguidanos|(213) 740-9822|enguidan@usc.edu|
20522298|NCT00369486|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Adam R. Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
20522299|NCT04981717|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20522300|NCT00974922|UCHC|Dr. William White|860-679-2104|wwhite@uchc.edu|
20522301|NCT00287586|Brigham and Women's Hospital|Shalendar Bhasin, MD||Sbhasin@partners.org|
20522302|NCT03831711|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
20522303|NCT02640482|AbbVie|Global Medical Services|800-633-9110||
20522304|NCT00517881|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20522305|NCT00113763|Amgen Inc.|Study Director|866-572-6436||
20522306|NCT03743415|University of Arizona College of Nursing|Terry Badger, PhD|520-626-6058|tbadger@arizona.edu|
20522307|NCT02968602|Maryland Psychiatric Research Center|Heidi J Wehring|410-402-6854|hwehring@som.umaryland.edu|
20522308|NCT00094861|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
20522309|NCT02540850|BioChain (Beijing) Science and Technology, Inc.|Dr. Lele Song|86-10-63401580|songlele@biochainbj.com|
20522310|NCT03112642|RutgersSUNJ|William R Grubb MD|7327426528|wrgrubb@aol.com|
20522311|NCT02462291|University of Verona|Massimo Venturelli - PI|+39 02503 14648|massimo.venturelli@univr.it|
20567690|NCT03031782|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20522312|NCT00576316|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20522313|NCT02814890|Huashan Hospital, Fudan University, Shanghai|Dr. Jun Zhang|0086-021-52887694|snapzhang@aliyun.com|
20522314|NCT02794246|Univ. of Pennsylvania|Emerging Med|855-216-0098|penncancertrials@emergingmed.com|
20522315|NCT04141930|University of Washington|Research Coordinator|2066165859|jheimo@uw.edu|
20567691|NCT01930188|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20522316|NCT00253448|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Research Investigator|937-395-8646|douglas.einstein@khnetwork.org|
20567692|NCT03576118|Ajou University Hospital|Dr. Jong Yeop Kim|+82312195574|kjyeop@ajou.ac.kr|
20567693|NCT02170207|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20522317|NCT01342757|Emory University School of Medicine|Jeffrey J. Olson, MD|404-778-3091|jolson@emory.edu|
20522318|NCT02052011|Yale School of Medicine|Dr. Basmah Safdar|2037853453|basmah.safdar@yale.edu|
20567694|NCT03122860|Biosplice Therapeutics, Inc.|Christopher Swearingen, PhD, VP of Biometrics|858.926.2952|chris.swearingen@biosplice.com|
20522319|NCT00000620|Wake Forest School of Medicine|Tim Craven / Senior Biostatistician|336-716-6109|tcraven@wakehealth.edu|
20522320|NCT03551821|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
20522321|NCT01851330|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20522322|NCT02648932|University of Chicago|Hongtao Liu|773-834-0589|hliu2@medicine.bsd.uchicago.edu|
20522323|NCT02368314|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20567695|NCT01138657|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20522324|NCT01266031|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
20522325|NCT01753557|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20522326|NCT03106987|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
20522327|NCT01307111|University of New Mexico|Eve Espey, MD, MPH, Principle Investigator|505-272-6372|eespey@salud.unm.edu|
20567696|NCT00869609|University of Pittsburgh|Trevor J Orchard|412-383-1032|tjo@pitt.edu|
20522328|NCT03336528|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
20567697|NCT00346398|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20567698|NCT03979040|VA Finger Lakes Health Care System|Dr. Nik Allan - Study Statistician|(850) 274-0567|Nicholas.Allan@osumc.edu|
20522329|NCT00682357|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
20567699|NCT04012970|Edinburgh Napier Univerisity|Rebecca Hamilton, PhD student|0131 455|rebeccaisabel.hamilton@napier.ac.uk|2350
20567700|NCT02773732|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20567701|NCT02978183|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
20567702|NCT01894503|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
20567703|NCT02203513|National Cancer Institute|Dr. Jung-min Lee|240-760-6128|leej6@mail.nih.gov|
20567704|NCT03347396|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20567705|NCT04182217|Université d'État d'Haïti|Axler JEAN PAUL, Author|+50943776900|jeanpaulaxler@hotmail.com|
20567706|NCT01974102|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
20567707|NCT02579915|McLean Hospital|Courtney Beard|16178553557|CBEARD@MCLEAN.HARVARD.EDU|
20567708|NCT02067819|Weill Cornell Medicine|Shannon Bennett, PhD|646-962-2820|smb9017@med.cornell.edu|
20567709|NCT00805441|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20567710|NCT02935894|USDA, ARS Western Human Nutrition Research Center|Dr. John W. Newman|530-752-1009|john.newman@ars.usda.gov|
20567711|NCT02033174|IiSGM|Dr Alvarez-Sala|+34 915868287|luisantonio.alvarezsala@salud.madrid.org|
20567712|NCT04914897|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20567713|NCT03020914|Hospital for Special Surgery|Marla Sharp, MPH, MA|646-797-8419|sharpm@hss.edu|
20567714|NCT03976102|Dr. Reddy's Laboratories Ltd.|Head - Clinical Development|91-40-4464-4000|RI-01-006@drreddys.com|
20567715|NCT02834624|University of Missouri-Columbia|Dr. Naomi Lauriello|573-882-2272|lauriellon@health.missouri.edu|
20567716|NCT05066230|Kodiak Sciences Inc|Chief Medical Officer|1 (650) 281-0850|ClinOps@kodiak.com|
20567717|NCT03072238|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20567718|NCT01448447|Mercy|Dr. Robert Frazier|314-251-6844|Robert.Frazier@mercy.net|
20567719|NCT01053897|Garnet BioTherapeutics, Inc.|Gerri Henwood, CEO|484-395-2440|ghenwood@garnetbio.com|
20567720|NCT02889900|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazenca.com|
20522330|NCT00569855|University of Arkansas, Arkansas Children's Hospital, Dept. of Pediatrics|Research Program Manager, Cardiovascular Surgery, Dept. of Pediatrics|501-364-1100|althagekarena@uams.edu|5859
20522331|NCT03300843|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|steven-rosenberg@nih.gov|
20522332|NCT01256944|Taipei Medical University - WanFang Hospital|Dr. Ming-I Hsu|886-2-2930-7930|hsumigni@yahoo.com.tw|2508
20522333|NCT00005957|Juravinski Cancer Centre at Hamilton Health Sciences|Dr. Timothy J. Whelan|1(905) 387-9495|twhelan@HHSC.CA|
20522334|NCT02047734|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20567721|NCT01690000|Aarhus University|Anne Kristine Amstrup|4578467681|anne_kristine_am@hotmail.com|
20567722|NCT04785794|FluGen|Pamuk Bilsel, CSO|608-442-6562|pbilsel@flugen.com|
20567723|NCT00813709|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20567724|NCT03840993|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|Please email|information@mt-pharma-us.com|
20567725|NCT01587703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20567726|NCT04751929|Dana-Farber Cancer Institute|Atish Choudhury, MD PhD|6176326328|atish_choudhury@dfci.harvard.edu|
20567727|NCT01123356|Medical University of South Carolina|Clinical Trials Network Manager|843-792-1753|adraleta@musc.edu|
20567728|NCT03015961|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20567729|NCT00376259|Novartis Pharmaceuticals|Study Director|862-778-8300||
20567730|NCT03734588|Spark Therapeutics|Tiffany Chang, MD, MAS Clinical Development Lead, Hematology|Please Email|Tiffany.chang@sparktx.com|
20567731|NCT00930644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20567732|NCT01877720|Seoul National University College of Medicine|Dr. Han-Suk Kim|82-2-2072-1696|kimhans@snu.ac.kr|
20567733|NCT02962609|Istanbul University|Duygu Gözen (Associate Professor)|+902124400000|dgozen@istanbul.edu.tr|27082
20567734|NCT01129011|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
20567735|NCT01012999|University of Utah|Robert Stephen, MD|801-587-7653|rlstephen@comcast.net|
20567736|NCT01369147|Emory University|Thomas Ziegler, MD|404-727-7351|tzieg01@emory.edu|
20567737|NCT01567150|Hollister Incorporated|Director, Global Clinical Affairs|8479183996|ginger.salvadalena@hollister.com|
20567738|NCT01494467|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
20567739|NCT03711279|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Project manager|+86-18036618962|qianna.zhan@hengrui.com|
20567740|NCT02410278|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20567741|NCT00185692|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
20567742|NCT04184271|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
20567743|NCT01516710|Oslo University Hospital|Dr. Aasmund A. Fretland|004723070100|aafret@ous-hf.no|
20567744|NCT01280721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
20567745|NCT01180400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20567746|NCT05188248|NYU Langone|Matthew Lustberg|929-455-5090|matthew.lustberg@nyulangone.org|
20567747|NCT01182285|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
20522335|NCT02441660|UT Health San Antonio|Michelle Trbovich|210-617-5300|TrbovichM@uthscsa.edu|18192
20522336|NCT00582010|University of Alabama at Birmingham|Rakesh Patel|205-934-3411|rakeshp@uab.edu|
20522337|NCT00958893|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20522338|NCT01890434|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20522339|NCT03898908|Grupo Español Multidisciplinar en Melanoma (GEM)|GEM Technical Secretary|0034934344412|secretaria@groupgem.es|
20522340|NCT01267994|North Shore-LIJ Health System|Andrea Vambutas, MD, FACS|718-470-7748|vambutas@nshs.edu|
20522341|NCT02950818|University of Michigan School of Public Health|Cathleen Connell|734-647-3189|cathleen@umich.edu|
20522342|NCT05199090|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20522343|NCT04868968|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|novartis.email@novartis.com|
20522344|NCT03276078|AstraZeneca PLC|Dr Sami Daoud|1-877-240-9479|Information.centre@astrazeneca.com|
20522345|NCT02552732|Fisher and Paykel Healthcare|Dr Stanislav Tatkov|09 5740100|stanislav.tatkov@fphcare.co.nz|
20522346|NCT03332979|Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London|Dr Kirsten Moore|020 7679 9488|kirsten.moore@ucl.ac.uk|
20522347|NCT00763061|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20522348|NCT05147324|University of North Carolina at Chapel Hill|Angelica Cristello Sarteau|919-445-1191|angcri@live.unc.edu|
20522349|NCT01275430|Bard Access Systems, Inc.|Sharon Molotsky|856-266-1327|sharon.molotsky@crbard.com|
20522350|NCT04988087|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20522351|NCT02613182|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
20522352|NCT02714426|University of Florida|Michael Marsiske, Ph.D.|352.273.5097|marsiske@phhp.ufl.edu|
20522353|NCT01727726|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
20522354|NCT00025259|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20522355|NCT00863772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522356|NCT00086281|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650-496-3777||
20522357|NCT03456453|University of Kentucky|Michele Staton|859-312-8245|mstaton@uky.edu|
20522358|NCT00896480|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522359|NCT02803229|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@cumc.columbia.edu|
20522360|NCT02071849|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
20522361|NCT00103610|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
20522362|NCT02494180|Kwong Wah Hospital|Dr SF Lai|85223322311|lsf087@ha.org.hk|
20522363|NCT00088621|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20522364|NCT01680497|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20522365|NCT00725205|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20522366|NCT02260570|Department of Veterans Affairs|Andrew Kayser, MD PhD|925-372-2000|Andrew.Kayser@va.gov|
20522367|NCT03996447|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20567748|NCT03209492|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20567749|NCT01525875|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
20522368|NCT05849454|Center for Behavioral Cardiovascular Health|Nadia Liyanage-Don|917-280-3776|nal2151@cumc.columbia.edu|
20522369|NCT02896712|The University of Texas Health Science Center at Houston|Joy Schmitz, PhD|713-486-2867|joy.m.schmitz@uth.tmc.edu|
20522370|NCT01810302|University of Florida|Dr. Spiros Blackburn|(352) 273-9000|spiros.blackburn@neurosurgery.ufl.edu|
20522371|NCT03888066|Vifor Pharma, Inc.|DIAMOND Clinical Study Team|+41 588 518 000|Diamond_Information@viforpharma.com|
20522372|NCT02207634|Amgen Inc.|Study Director|866-572-6436||
20522373|NCT02077140|Medtronic Spine and Biologics|Clinical Affairs|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20522374|NCT02129608|Mayo Clinic|Ivana Croghan|507-266-1944|domcro@mayo.edu|
20522375|NCT00451204|University of California Los Angeles|Dr. Rhonda Voskuhl|310-206-4636|rvoskuhl@mednet.ucla.edu|
20522376|NCT03760185|Denver Health and Hospital Authority|Dr Cristos Ifantides|303-436-4949|Cristos.Ifantides@dhha.org|
20522377|NCT02473523|St. Jude Children's Research Hospital|Kirsten Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
20522378|NCT02495259|Emory University|Dr. Igor Zhukov|404-268-1404|izhukov@live.com|
20522379|NCT00976911|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20522380|NCT01191944|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522381|NCT05204082|Mayo Clinic|Michael E. Nemergut, M.D., Ph.D.|507-255-7976|Nemergut.Michael@mayo.edu|
20522382|NCT02954991|Mirati Therapeutics|Clinical Operations Director|858-381-5289|LatvenL@Mirati.com|
20522383|NCT02552303|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
20522384|NCT01830790|Duke University|Sharon Fekrat: Associate Professor of Ophthalmology|(919) 681-0341|Sharon.Fekrat@dm.duke.edu|
20522385|NCT04602546|Medtronic|Keith Holloman|6126707136|keith.holloman@medtronic.com|
20522386|NCT02114385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522387|NCT04204057|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
20522388|NCT03545893|University of Pennsylvania|Arden McAllister, Research Program Manager|215-662-3532|arden.mcallister@pennmedicine.upenn.edu|
20522389|NCT01609023|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20522390|NCT01174043|IndianaU|Dr. Hamid Sayar|(317)278-6871|ssayar@iu.edu|
20522391|NCT03904108|Stony Brook University|Dr. Roger Keresztes|631-638-1000|roger.keresztes@stonybrookmedicine.edu|
20522392|NCT02646761|University of Pittsburgh|Dr. James J. Irrgang|(412) 383-9865|jirrgang@pitt.edu|
20522393|NCT04172597|Assertio Holdings|Howard Franklin, MD|224 419 7106|Hfranklin@assertiotx.com|
20522394|NCT04797221|Veterans Health Administration|Joseph Simonetti|7207236491|joseph.simonetti@va.gov|
20522395|NCT02029196|Fontem Ventures|Dr Ana Cravo|+441173322528|AnaMaria.Cravo@fontemventures.com|
20522396|NCT01853332|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
20522397|NCT00486031|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
20522398|NCT03495921|Gradalis, Inc.|Clinical and Regulatory Operations|(214) 442-8100|info@gradalisinc.com|
20522399|NCT02289456|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20522400|NCT02681510|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
20522401|NCT00900822|Institut Straumann AG|Clinial Trial Manager|+41 61 965 11 11|info@straumann.com|
20522402|NCT01721317|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522403|NCT01072617|BIDMC|Alvaro Pascual-Leone|617-667-0203|apleone@bidmc.harvard.edu|
20522404|NCT03168334|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
20522405|NCT03366207|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
20522406|NCT02130622|Dartmouth-Hitchcock|Gastroenterology Research Team Lead|603-653-9033|Jessica.I.Chevalier@hitchcock.org|
20522407|NCT02806024|University of Washington|Mallory Kremer|206.616.5258|mkremer@uw.edu|
20522408|NCT02892149|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
20522409|NCT01098474|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522410|NCT00711880|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20522411|NCT04841577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20522412|NCT03617783|Maryland Psychiatric Research Center|Dr. Robert Buchanan|410-402-7876|rwbuchanan@som.umaryland.edu|
20522413|NCT02054338|Institut de Recherche Pierre Fabre|Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
20522414|NCT00652340|Tragara Pharmaceuticals|Tracy Parrott|858-350-6919|tparrott@tragarapharma.com|
20552496|NCT04372602|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8491|jdipersi@wustl.edu|
20552497|NCT01085097|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20552498|NCT03615807|Balgrist University Hospital|Professor Ilker UCKAY|+41 44 386 37 05|ilker.uckay@balgrist.ch|
20552499|NCT00176592|Rutgers New Jersey Medical School|Stuart Cook, MD|973-972-2550|cooksd@njms.rutgers.edu|
20552500|NCT03742141|Icahn School of Medicine at Mount Sinai|Dr. David Steinmetz|646-831-5950|dsteinmetz0@gmail.com|
20552501|NCT03023085|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20552502|NCT00850395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552503|NCT06049043|KDHRC|Andrew Simkus, Research Analyst|7046073567|asimkus@kdhrc.com|
20552504|NCT02180412|University of Texas Medical Branch, Galveston|Dr. Karl Anderson, MD|409-772-9092|kanderso@utmb.edu|
20552505|NCT01113632|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20552506|NCT01354496|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20552507|NCT03774433|Dartmouth College|Dr. Lisa Marsch|603-646-7092|Lisa.A.Marsch@dartmouth.edu|
20552508|NCT01708174|Novartis Pharmaceuticals|Study Director|862-778-8300||
20567750|NCT03481725|University of California San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|m1medeiros@health.ucsd.edu|
20567751|NCT01125436|Case Western Reserve University|Research Compliance Officer|216-368-0134|kav6@case.edu|
20567752|NCT01694199|Regenesis Biomedical, Inc.|Dr. Rick Isenberg|877-970-4970|isenberg@regenesisbio.com|
20567753|NCT01894620|University of Manitoba|Dr Zahra Moussavi|204 474-7023|Zahra.Moussavi@umanitoba.ca|
20567754|NCT02877680|Baylor College of Medicine|Marisa Hilliard, Associate Professor of Pediatrics|832-824-7209|marisa.hilliard@bcm.edu|
20567755|NCT01133678|University of Chicago|Everett Vokes, MD|(773) 702-6227|evokes@medicine.bsd.uchicago.edu|
20567756|NCT03424187|Imperial College London|Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
20567757|NCT00879710|Medical College of Wisconsin|Srividya Kidambi, MD, MS|414-955-4843|skidambi@mcw.edu|
20567758|NCT01864200|BTG|Shirley Steiner, Director of Clinical Operations|610 943 3631|shirley.steiner@btgplc.com|
20567759|NCT00424476|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522415|NCT03682107|Cincinnati Children's Hospital|Dr. Grant Paulsen|513-636-4578|Grant.Paulsen@cchmc.org|
20567760|NCT02514824|Dana-Farber Cancer Institute|Robert Haddad, MD|617.632.3090|Robert_Haddad@dfci.harvard.edu|
20522416|NCT00879411|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522417|NCT03837743|DURECT Corporation|Executive Director of Regulatory Affairs|408-777-1829|jill.burns@durect.com|
20567761|NCT00529529|Novartis Pharmaceuticals|Study Director|862 778-8300||
20567762|NCT02607956|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20522418|NCT02257385|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522419|NCT01316302|The Medical Research Network, LLC|Michael R. Liebowitz, M.D.|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
20522420|NCT03489109|Clinical Center|Hadigan, Colleen|+1 301 594 5754|hadiganc@nih.gov|
20522421|NCT01547130|Wyckoff Heights Medical Center|Dr Vijaypal Arya|718-326-0400|varyamd@yahoo.com|
20522422|NCT03968978|AstraZeneca|Global Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
20522423|NCT01178216|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|3102488186|noriko.ammerman@cshs.org|
20522424|NCT03287843|Ege University Hospital|Erhan Akgun,MD, Proffessor|+902323905050|z.erhan.akgun@ege.edu.tr|
20522425|NCT03149757|University of Minnesota|Keith Horvath|619-594-3346|khorvath@sdsu.edu|
20522426|NCT00908310|GE Healthcare|Debra Mansfield|609-514-6329|debra.mansfield@ge.com|
20567763|NCT01916109|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
20522427|NCT01004003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522428|NCT00563576|Columiba University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
20567764|NCT02354144|Division of Cancer Epidemiology, Department of Oncology, McGill University|Dr. Eduardo Franco|514-398-6032|eduardo.franco@mcgill.ca|
20522429|NCT00315731|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522430|NCT03597464|Aurinia Pharmaceuticals|Clinical Trials Information|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20522431|NCT04328961|University of Washington|Ruanne Barnabas|206 520 3800|rbarnaba@uw.edu|
20522432|NCT01621477|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
20522433|NCT01243775|Chonnam National University Hwasun Hospital|Dr. Young-Chul Kim|82-61-379-7614|kyc0923@jnu.ac.kr|
20522434|NCT03834142|University of Pittsburgh|Amy Monroe|412-623-6382|monroeal@upmc.edu|
20522435|NCT01753297|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
20522436|NCT00230178|Sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
20522437|NCT01275729|University of Chicago|Dr. Jay L Koyner|773-702-4842|jkoyner@uchicago.edu|
20522438|NCT02252406|University of Florida, Jacksonville|Gladys Velarde, MD|904-244-2060|gladys.velarde@jax.ufl.edu|
20522439|NCT02533180|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20522440|NCT00447876|Ipsen|Medical Director||clinical.trials@ipsen.com|
20522441|NCT03751007|Precigen Actobio T1D, LLC|Sven Blomme|+3292771177|sblomme@actobio.com|
20522442|NCT03717012|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522443|NCT00789035|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522444|NCT01520870|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
20522445|NCT02463357|University of Colorado Denver|Robert Roach||clinicalresearchsupportcenter@ucdenver.edu|
20522446|NCT03509857|Montefiore MC|Dr. Aravind Pothula|9178015577|apothula@montefiore.org|
20522447|NCT01371539|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
20522448|NCT01399658|Dana-Farber Cancer Institute|Martin King, MD|617-732-4332|Martin_King@dfci.harvard.edu|
20522449|NCT02620579|University of Florida|Dr. Samuel S. Wu|3522945910|samwu@biostat.ufl.edu|
20522450|NCT01277159|HSS|Dr. Yadeau|212.606.1206|YadeauJ@hss.edu|
20522451|NCT00796107|Hoffmann-La Roche, Ltd.|Study Director|888-662-6728 (U.S.)|global-roche-genentech-trials@gene.com|
20522452|NCT01778634|University of Maryland|Rose Marie Viscardi, M.D.|410-706-1913|rviscard@som.umaryland.edu|
20522453|NCT00378573|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
20522454|NCT00687830|Cleveland Clinic Florida|Dr. Shibu Varughese and Dr. Anand Kumar|305-310-1238|akuma003@fiu.edu|
20522455|NCT00626808|MedImmune, LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
20522456|NCT03066258|Regenxbio Inc.|Sherri Van Everen, PharmD/ Vice President of Clinical Development|240.552.8181|svaneveren@regenxbio.com|
20567765|NCT00103857|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20522457|NCT02165735|University of Rochester|Dr. Kevin Fiscella, PI|5853244563|kevin_fiscella@urmc.rochester.edu|
20522458|NCT02784795|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20536805|NCT02566785|University of Nebraska Medical Center College of Nursing|Dr. Rita McGuire|402-472-4712|rita.mcguire@unmc.edu|
20522459|NCT00626561|University of Texas MD Anderson Cancer Center|Michael M. Frumovitz, MD / Professor, Gynecologic Oncology|713-792-9599|CR_Study_Registration@mdanderson.org|
20522460|NCT00595309|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
20522461|NCT00101283|ECOG Statistical Office|Study Statistician|617-632-3012||
20522462|NCT02797171|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20522463|NCT03993379|CytomX Therapeutics|Lawrence Lu|(650) 515-3185|clinicaltrials@cytomx.com|
20522464|NCT01654315|The Ohio State University|Dr. Stephen Page|614-292-5490|STEPHEN.PAGE@OSUMC.EDU|614
20522465|NCT03094637|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero MD/Professor|713-745-3428|ggarciam@mdanderson.org|
20522466|NCT00704132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20522467|NCT00442962|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20522468|NCT03348163|The University of Texas Health Science Center at Houston|Jordan Elizabeth Lake, MD, Associate Professor|(713) 500-6759|Jordan.E.Lake@uth.tmc.edu|
20522469|NCT02756208|Institute of Human Virology|Dr. Mohammad Sajadi|410-7061779|msajadi@ihv.umaryland.edu|
20522470|NCT02585778|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20522471|NCT00356525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20522472|NCT02281422|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20522473|NCT00214383|University of Wisconsin - Madison|Alice Pulvermacher|(608) 262-8448|alice.pulvermacher@chess.wisc.edu|
20522474|NCT01044264|Perrigo Company|Manager|718-960-0119|jonathan.schwartz@perrigo.com|
20522475|NCT04052334|Moffitt Cancer Center|John E. Mullinax, MD, FACS|813-745-4673|John.Mullinax@moffitt.org|
20522476|NCT05831774|Houston Methodist Hospital|Haley Goble|713-441-3930|hmgoble@houstonmethodist.org|
20522477|NCT01898221|Houston Methodist Hospital, Dept of Cardiology|Miguel Valderrabano, MD|713 441 5231|MValderrabano@houstonmethodist.org|
20522478|NCT00252239|University of Virginia Health System|Dr. E. Clarke Haley, Jr.|434-924-8041|ech@virginia.edu|
20522479|NCT04791514|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
20522480|NCT02288156|UZ Leuven|Prof. Dr. Hellings|016336340|nkogh@uzleuven.be|
20522481|NCT00767624|STANFORD UNIVERSITY|Rachel Manber, PhD|6504981266|rmanber@stanford.edu|
20522482|NCT02686138|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20522483|NCT01685840|Duke University Health System|G. Michael Felker, M.D.|919-668-8919|michael.felker@duke.edu|
20522484|NCT00710866|British Columbia Centre for Disease Control|Danuta M Skowronski, MD|604-660-6067|danuta.skowronski@bccdc.ca|
20522485|NCT03423186|Swedish Orphan Biovitrum AB|Anders Bröijersén, Medical Director|+46 8 697 20 00|anders.broijersen@sobi.com|
20522486|NCT00337181|Thai Ministry of Public Health|Supachai Rerks-Ngarm|6629659571|supachai@health.moph.go.th|
20522487|NCT00534404|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
20522488|NCT04252092|Eksen Sağlık ve Rehabilitasyon|PT,Cansu Hayıroğlu|+905378405948|cansu5309@gmail.com|
20522489|NCT02996487|Beaumont Hospitals|Maureen Cooney|248 551-0099|maureen.cooney@corewellhealth.org|
20522490|NCT02027428|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20522491|NCT01128543|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522492|NCT02676765|Virginia Commonwealth University|Dr. Brant Ward|804-828-1941|brant.ward@vcuhealth.org|
20522493|NCT03340974|Galera Therapeutics|Judy Schnyder, Sr. Vice President Clinical Operations and Data Management|484-870-9625|jschnyder@galeratx.com|
20522494|NCT02374346|Attikon Hospital|P. Matsota|00302105831000|matsota@yahoo.gr|
20522495|NCT02391987|Mayo Clinic|Charles J. Bruce|904-953-7227|bruce.charles@mayo.edu|
20522496|NCT03097991|University of South Florida|Dr. James McHale|7278734848|jmchale@usf.edu|
20522497|NCT00246324|LSU Health Sciences Center in Shreveport Department of Neurology|Alireza Minagar, MD|318-813-1481|aminag@lsuhsc.edu|
20522498|NCT00299130|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20522499|NCT01462812|OptiNose|Sr. Director of Clinical Development|(267) 364-3620|jennifer.carothers@optinose.com|
20522500|NCT01374269|Grupo Rehabilitacion en Salud|Dr. Fabio Salinas Duran|5742196475|fabios@une.net.co|
20522501|NCT02125721|NYU Langone Health|David Goldfarb|212 263 0744|David.Goldfarb@nyulangone.org|
20522502|NCT01613313|GerutZ|Dr. Zachary E.Gerut|516 295-2100|Drgerut@drgerut.com|
20522503|NCT03316547|Washington University|Roberta Pineda|314-286-1304|bobbi.pineda@chan.usc.edu|
20522504|NCT00996892|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20522505|NCT01653912|Novartis Pharma AG|Study Director|+41 613241111||
20522506|NCT00708227|Nemours Children's Specialty Care|Kathryn Blake|9046973806|kathryn.blake@nemours.org|
20522507|NCT04007991|Emalex Biosciences, Inc.|Clinical contact|7150562|dkim@emalexbiosciences.com|1847
20522508|NCT01987479|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20522509|NCT00278889|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20522510|NCT03654599|Arizona State University|Dr. Sunny Kim|602-496-6789|Sunny.Kim@asu.edu|
20522511|NCT05314816|Medical College of Wisconsin|Dr. Kelly Graff|414-266-4123|kegraff@mcw.edu|
20522512|NCT04042376|Janssen Research & Development, LLC|Executive Medical Director Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20522513|NCT02638090|Moffitt Cancer Center|Dr. Jhanelle E. Gray|813-745-7282|Jhanelle.Gray@Moffitt.org|
20522514|NCT04582149|Emory University|Ofer Sadan, MD, PhD|470-480-6956|ofer.sadan@emory.edu|
20522515|NCT02017015|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20567766|NCT03032965|University of Michigan|Hamid Ghanbari|734-963-7141|ghhamid@med.umich.edu|
20522516|NCT03102606|BeyondSpring Pharmaceuticals|Ramon Mohanlal|6468491102|rmohanlal@beyondspringpharma.com|
20522517|NCT00836407|The Sidney Kimmel Comprehensive Cancer Center at Johns|Dr. Dung Le||dle@jhmi.edu|
20522518|NCT01762800|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522519|NCT02847260|United Therapeutics Corporation|Leigh Peterson, Director, Product Development, Product Development & Global Clinical Operations|919-425-8165|lpeterson@unither.com|
20522520|NCT03104400|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20522521|NCT02906358|The University of Texas Health Science Center at San Antonio|Barbara J Turner|210-562-5551|turner@uthscsa.edu|
20522522|NCT02699684|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20522523|NCT01549405|Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital|Dr Derya Özkan|00903125962553|derya_z@yahoo.com|
20522524|NCT00492778|NRG Oncology|Linda Gedeon for Danielle Enserro, PhD.|7168451169|gedeonl@nrgoncology.org|
20522525|NCT00841828|Department of Medical Oncology, Hospital Universitario Virgen de la Victoria|Dr. Emilio Alba||emilioalbac@gmail.com|
20522526|NCT00362336|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20522527|NCT04414618|RedHill Biopharma Ltd.|Vered Katz Ben-Yair|+13474144462|vered@redhillbio.com|
20522528|NCT00658879|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522529|NCT02640690|Atlanta VA Health Care System|Dr. Ursula Kelly|4047272715|ukelly@emory.edu|
20522530|NCT01118975|University of Maryland|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
20522531|NCT01645787|Columbia University|Claudia A. Chiriboga, MD, MPH|(212) 305-8549|cac3@columbia.edu|
20522532|NCT04902014|Colorado State University|Dr. Kayla Nuss|9705814824|kayla.nuss@colostate.edu|
20522533|NCT01783912|Center for Tobacco Research and Intervention|Bruce Christiansen|608-262-4087|bc1@ctri.wisc.edu|
20522534|NCT01545518|Emory University|Dr. Charles M. Epstein|404-778-3633|cepstei@emory.edu|
20522535|NCT04315506|Duke University|Devon Noonan|919-684-3786|devon.noonan@duke.edu|
20522536|NCT02661217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20522537|NCT00377832|Weill Cornell Medical College|Daniel W. Skupski, MD|718-670-1495|dwskupsk@med.cornell.edu|
20522538|NCT02032680|VA, University of Pittsburgh|Dr. Armando Rotondi|412-360-2494|ArmandoRotondi1@gmail.com|
20522539|NCT03086486|TB Alliance|Morounfolu Olugbosi|1 212 227 7540|morounfolu.olugbosi@tballiance.org|
20522540|NCT00719615|University of Nebraska Medical Center|Whitney S Goldner, MD|402-559-6205|wgoldner@unmc.edu|
20522541|NCT04238650|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
20522542|NCT03633825|Harvard University|Principal Investigator|617-496-4484|jaroszewski@fas.harvard.edu|
20522543|NCT05246670|Geisinger Medical Center|Mellar P. Davis, MD, FCCP, FAAHPM|570-271-7383|mdavis2@geisinger.edu|
20522544|NCT02614924|UHCW NHS Trust|Dr Ratidzo Danha|02476 964000|Ratidzo.Danha@uhcw.nhs.uk|25871
20522545|NCT04152291|Wihuri Research Institute|Professor Katariina Öörni|+358 40 7023711|kati.oorni@wri.fi|
20522546|NCT03597295|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
20522547|NCT05124691|Instituto de Salud Global de Barcelona - ISGLOBAL|Jose Muñoz|+34608774071|jose.munoz@isglobal.org|
20522548|NCT05211726|University of Delaware|Christopher Martens|302-831-7270|cmartens@udel.edu|
20522549|NCT03509467|Moffitt Cancer Center|Peter Kanetsky, PhD, MPH|813-745-3988|Peter.Kanetsky@moffitt.org|
20522550|NCT00428116|University of Washington|Grace John-Stewart|206 543 4278|gjohn@uw.edu|
20522551|NCT01038297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522552|NCT01141205|Statens Serum Institut|Dr Anders Fomsgaard|+45-32683460|afo@ssi.dk|
20522553|NCT03985852|University of Utah|Dr. Kimberly Kaphingst|801-213-5724|kim.kaphingst@hci.utah.edu|
20522554|NCT01822366|University of Washington|Dr. Shannon Dorsey|(206) 543-4527|dorsey2@uw.edu|
20522555|NCT00384930|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20522556|NCT03431493|Johns Hopkins University|Ann Parker, MD, PhD|443-287-2616|aparke36@jhu.edu|
20522557|NCT01449370|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20522558|NCT01357148|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522559|NCT02495623|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
20522560|NCT01307748|Oregon Health & Science University|Irina Chamine|503.577.6211|fonareva@ohsu.edu|
20522561|NCT03473015|Oxford Heart Centre, Oxford University Hospitals, Oxford, United Kingdom|Professor Adrian Banning|1865 228934|adrian.banning@ouh.nhs.uk|+44
20522562|NCT01252277|University of Kansas Medical Center|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
20522563|NCT04487067|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20522564|NCT02881840|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
20522565|NCT01098487|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522566|NCT00345631|Cordis Corporation, a Johnson&Johnson company|Hans-Peter Stoll, M.D.|908-541-4770|hpstoll@its.jnj.com|
20522567|NCT00517556|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
20522568|NCT01885195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522569|NCT03390426|Duke University Medical Center|William Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
20522570|NCT02593682|University of California, San Francisco|Dr. Andrew Goddard|(317) 274-3960|agoddard@fresno.ucsf.edu|
20522571|NCT02906241|Wayne State University/Karmanos Cancer Institute|Susan Eggly, PhD|313-576-8260|egglys@karmanos.org|
20522572|NCT00259272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20522573|NCT03301623|Cedars-Sinai Medical Center|Brennan Spiegel|310-423-6467|brennan.spiegel@cshs.org|
20522574|NCT02516553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522575|NCT01203020|WV Cancer Institute|Abraham Kanate|3049065228|tlr0011@hsc.wvu.edu|
20522576|NCT04614246|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20522577|NCT02521376|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20522578|NCT00676780|LSUShreveport|Dr. Jerry W. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
20522579|NCT00340678|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Dr. Robert Nelson|(602) 200-5205|rnelson@phx.niddk.nih.gov|
20522580|NCT03532373|Stanford University|Robin Kamal|650-721-7629|rnkamal@stanford.edu|
20522581|NCT02759692|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO|904 443-1290|BPALL@its.jnj.com|
20522582|NCT03245827|Saint Louis University|Sandeep Dhindsa|716-977-4911|sandeep.dhindsa@health.slu.edu|
20522583|NCT00553735|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@MEEI.Harvard.edu|
20522584|NCT01954745|Massachusetts General Hospital Cancer Center|Dr. Lipika Goyal|617-724-4000|Lgoyal@partners.org|
20522585|NCT03764618|Rigel Pharmaceuticals, Inc.|Executive Director, Global Clinical Operations|(650) 624-1100|clinicaltrials@rigel.com|
20522586|NCT05292183|Dartmouth-Hitchcock Medical Center|Dr. Krzysztof Bujarski|603 650 5104|krzysztof.a.bujarski@hitchcock.org|
20522587|NCT05573763|Fisher & Paykel Healthcare Ltd|Kelly Tay|+64 9-282-9734|kelly.tay@fphcare.co.nz|5634
20522588|NCT03975491|Pennington Biomedical Research Center|Dr. Justin Brown|2257632715|Justin.Brown@pbrc.edu|
20522589|NCT03922529|University of Pittsburgh|Daniel Forman, MD|412-360-2411|formand@pitt.edu|
20522590|NCT01277601|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20522591|NCT04034927|NRG Oncology|Christopher Purdy on behalf of Danielle Enserro, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20522592|NCT02291510|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
20522593|NCT00459355|Bedford VA Medical Center|Dr. Kathy Horvath|781-687-2006|Kathy.Horvath@va.gov|
20522594|NCT00478062|Johns Hopkins Sidney Kimmel Cancer Center|Yvette Kasamon|4109135018|ykasamon@jhmi.edu|
20522595|NCT01173120|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20522596|NCT03870880|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
20522597|NCT00180661|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20522598|NCT01383707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20522599|NCT02923232|Pacific University|Dr. Shun-nan Yang|5033522852|shunnan.yang@pacificu.edu|
20522600|NCT01977417|University of Iowa|Gary Pierce, PhD|319-335-9487|gary-pierce@uiowa.edu|
20567767|NCT03541369|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20567768|NCT02707952|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20522601|NCT02013817|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20522602|NCT01145508|ECOG Statistical Office|Study Statistician|617-632-3012||
20567769|NCT00696241|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20567770|NCT02279732|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20567771|NCT01790659|Instituto Conmemorativo Gorgas de Estudios de la Salud|Nestor Sosa, MD, FACP|507-527-4950|drnsosa@gmail.com|
20567772|NCT03072862|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20567773|NCT02513667|UT Southwestern Medical Center|Dr. Sawsan Rashdan|214-648-4180|Sawsan.Rashdan@UTSouthwestern.edu|
20567774|NCT01297595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567775|NCT01047709|University of Michigan|Devin Brown, MD|7349369075|devinb@umich.edu|
20567776|NCT01331408|Galderma Uppsala|Head of Medical Affairs|+46 (0)18 474 9000|receptionen.SEUPP@galderma.com|
20567777|NCT01673256|St. Jude Medical Inc.|Kyle Brunner|651.756.3482|kbrunner02@sjm.com|
20567778|NCT01670526|Hines CSPCC|Tom Sindowski|708-202-5858|tom.sindowski@va.gov|
20567779|NCT00392197|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20567780|NCT01970527|University of Washington Medical Center|Dr. Ramesh Rengan|206-598-4100|rengan@uw.edu|
20567781|NCT03060525|University of Rochester|Dr. Steven Barnett|585-273-2548|steven_barnett@urmc.rochester.edu|
20567782|NCT02147093|Johnson & Johnson Vision Care INC.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
20567783|NCT02302157|Lineage|Avi Ben Shabat, MD|+972-509105205|avi@cellcure.co.il|
20567784|NCT04000399|University of Pittsburgh|Stephanie D. Stepp, PhD|4127155447|steppsd@upmc.edu|
20567785|NCT04343716|University of Alabama at Birmingham|Dr. Robert Sorge|2059348563|rsorge@uab.edu|
20567786|NCT01437540|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20567787|NCT00506025|University of California Irvine Medical Center|Deborah A. Wing, MD|714-456-5967|dwing@uci.edu|
20567788|NCT01574105|Saskatoon Health Region|Mark Rosin|306-655-2128|mark.rosin@sasktoonhealthregion.ca|
20567789|NCT00608959|Cadence Pharmaceuticals, Inc|Catherine J Hardalo, MD Vice President, Anti-Infectives Clinical Development|858 4361439|chardalo@cadencepharm.com|
20567790|NCT01416285|Chang Gung Memorial Hospital|CHAO-HUNG WANG, MD|+886-2-24313131|bearty54@gmail.com|2923
20567791|NCT01005602|University of Illinois at Chicago|Dr. Robert J. DiDomenico|(312) 413-4654|rdidom1@uic.edu|
20567792|NCT01248715|University Louisville|Dr. Paula Peyrani|502-852-3905|paula.peyrani@louisville.edu|
20567793|NCT02416102|University of Miami|Matthias Salathe, MD|913-588-6000|msalathe@kumc.edu|
20567794|NCT01919489|Emory University|Dr. Francisco Pasquel|404-778-1695|fpasque@emory.edu|
20567795|NCT03761849|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20567796|NCT01131325|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20567797|NCT03884478|Loyola Marymount University|Dr. Sarah C. Boyle, Senior Research Scientist|3105686681|sarah.boyle@lmu.edu|
20522603|NCT05992623|Inova Schar Heart and Vascular|Brett D. Atwater MD|9192390127|brett.atwater@inova.org|
20522604|NCT03624920|Theranexus|Chief Medical Officer|+33680026779|werner.rein@theranexus.fr|
20522605|NCT01125371|Johns Hopkins University|Dr. Geetanjali Chander|443-287-2030|gchande1@jhmi.edu|
20567798|NCT01807234|Johns Hopkins University School of Medicine|Dr. B. Lee Peterlin|410-550-9550|hnitchi1@jhmi.edu|
20567799|NCT01540474|Walter Reed Institute of Research|Jason W. Bennett|3013199477|jason.w.bennett.mil@mail.mil|
20567800|NCT00857311|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20522606|NCT02111603|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20567801|NCT00828139|SWOG Statistical Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org|
20522607|NCT01582152|The University of Texas (UT) MD Anderson Cancer Center|Dr. Alfred Yung, Clinical Professor, Neuro-Oncology|713-792-7734|wyung@mdanderson.org|
20567802|NCT01714947|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20522608|NCT03055624|UCSD|Andrew Picel MD|619-543-3436|apicel@stanford.edu|
20522609|NCT01434810|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
20522610|NCT04036838|ARJ Medical, Inc.|President|813-855-1557|info@gulfcoastscientific.com|
20522611|NCT00979199|CNR Institute of Clinical Physiology, Pisa, Italy and Fondazione Toscana G. Monasterio, Pisa, Italy|Dr. Danilo Neglia|+390503152019|dneglia@ifc.cnr.it|2019
20522612|NCT05676814|Wake Forest University Health Sciences|Scott Coleman, DO|336-716-2712|srcolema@wakehealth.edu|
20522613|NCT02437903|Baumann Cosmetic and Research Institute|Leslie Baumann, MD|(305) 531-5788|studies@derm.net|
20522614|NCT02652611|U Maryland|Haley Demyanovich|4107063935|hdemyanovich@som.umaryland.edu|
20522615|NCT02237092|Tver Regional Perinatal Center|Dr. Alexandr Ronenson|011-7-4822-776213|ronensonam@gmail.com|
20522616|NCT03577301|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
20522617|NCT02229474|Northumbria Healthcare NHS Foundation Trust|Professor Richard Walker|+441912932709|richard.walker@nhct.nhs.uk|
20522618|NCT01608061|Functional Neuromodulation|Todd Langevin|7636071214|todd@fxneuromod.com|
20522619|NCT00799825|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522620|NCT00794339|ACR|Donna Hartfeil|215-717-2765|dhartfeil@acr.org|
20522621|NCT01611857|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
20522622|NCT01109147|Hopital Sainte Marguerite - APHM - Service du Pr. Azorin|Dr. Eric Fakra||eric.fakra@ap-hm.fr|
20522623|NCT02439970|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20522624|NCT02934191|Children's Hospital of Philadelphia|Dr. John Germiller|215-590-3440|germiller@email.chop.edu|
20522625|NCT02952586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522626|NCT01931878|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
20522627|NCT02559180|Cleveland Clinic Foundation|Rishi P Singh|772-223-5945|singhr@ccf.org|13014
20522628|NCT02075515|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522629|NCT01297985|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
20522630|NCT00741338|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20522631|NCT03593395|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20522632|NCT03713632|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20522633|NCT01524978|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20522634|NCT02995408|Massachusetts General Hospital|Karen Kuhlthau, PhD Researcher|6177242842|kkuhlthau@partners.org|
20522635|NCT05560386|Icahn School of Medicine at Mount Sinai|Nita Vangeepuram|917-478-2106|nita.vangeepuram@mssm.edu|
20522636|NCT04237272|Medical University of South Carolina|Dr. Tracy Smith|843 792 5164|smithtra@musc.edu|
20522637|NCT00295061|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20522638|NCT01598194|UT MD Anderson Cancer Center|Weston,Brian,MD / Gastroenterology Hepatology & Nutrition|713-792-7734|BWESTON@MDANDERSON.ORG|
20522639|NCT01372748|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
20522640|NCT00134901|New York State Psychiatric Institute|Dr Adam Bisaga|(646) 774-6155|bisagaa@nyspi.columbia.edu|
20522641|NCT00606632|Heidelberg Pharma AG (former Wilex AG)|Head of R&D||info@hdpharma.com|
20522642|NCT03908437|University of Pennsylvania, Dpt of Psychiatry, Perelman School of Medicine|Dr. David Metzger, Research Professor, Director of HIV Prevention Research Unit|215-746-7355|dsm@pennmedicine.upenn.edu|
20522643|NCT00396565|Janssen Pharmaceutical K.K.|Director of Clinical R&D Dept. 3|81-3-4411-5652||10118
20522644|NCT03516513|University of Washington|Michael Pullmann|6158304563|pullmann@uw.edu|
20522645|NCT01589497|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20522646|NCT01325181|Seoul National University Hospital|Jang Won Heo|82220720836|hjw68@snu.ac.kr|
20522647|NCT03052127|Aura Biosciences|Uma Chandrasekaran, Director, Clinical Development Scientist|706-294-3454|UChandrasekaran@aurabiosciences.com|
20522648|NCT03694327|MyDigitalStudy|Alankar Gupta, VP, Medical Affairs & Clinical Development|862-485-9279|agupta@clicktherapeutics.com|
20522649|NCT03131544|Prostate Laser Center, PLLC|Dr. Ara Karamanian, Medical Director of the Prostate Program|(713) 904-4014|drkaramanian@halodx.com|
20522650|NCT00754546|Dartmouth-Hitchcock Medical Center|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
20522651|NCT01862484|The University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-0136|pliszka@uthscsa.edu|
20522652|NCT00721227|Ethicon Endo Surgery, Inc.|Amy Mahanes, Senior Clinical Research Associate|513-337-8366|amahanes@its.jnj.com|
20522653|NCT04021238|UNC Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20522654|NCT05026177|Cassava Sciences, Inc.|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
20522655|NCT04514679|Dartmouth Geisel School of Medicine|Tor D. Tosteson, ScD|603 646-5274|tor.d.tosteson@dartmouth.edu|
20522656|NCT03956355|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20522657|NCT03355469|Rutgers University|Dr. Steven Malin|848-932-705|steven.malin@rutgers.edu|
20522658|NCT02731638|University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|+1 415 502 2666|jennifer.rose-nussbaumer@ucsf.edu|
20522659|NCT04158245|Tulane University|Brian Lewis|504-988-6300|blewis@tulane.edu|
20522660|NCT02454608|Massachusetts Eye and Ear Infirmary|Benjamin Bleier|(617) 573-6966|Benjamin_Bleier@MEEI.HARVARD.EDU|
20522661|NCT05612685|UCLA|Kristen Choi, Associate Professor|3107947493|krchoi@ucla.edu|
20522662|NCT01887171|Republican scientific and practical center for organ and tissue transplantation|Aliaksej Shcherba|+375293330689|aleina@tut.by|
20522663|NCT03659929|Azurity Pharmaceuticals, Inc.|Vice President of Clinical Development|1-800-461-7449|david.sequeira@azurity.com|
20522664|NCT04856930|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20552509|NCT01894152|Abbott Vascular|Roy Leong|+65 (6277) 3202|roy.leong@abbott.com|
20522665|NCT00916643|B. Braun Medical, Inc.|Kevin Minnich|610 596 2358|kevin.minnich@bbraun.com|
20552510|NCT02741700|VA ORD: Birmingham VA Medical Center|Dr. Jasvinder Singh|205-934-3235|jasvinder.md@gmail.com|
20552511|NCT00923559|Dept of Women's and Children's Health, Karolinska Institutet|Björn Salomonsson|+46851777206|bjorn.salomonsson@ki.se|
20522666|NCT01433055|Maryland Psychiatric Research Center|Deanna L. Kelly, Pharm.D., BCPP|410-402-6861|dkelly@mprc.umaryland.edu|
20522667|NCT04721808|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522668|NCT01728844|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
20522669|NCT00678210|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522670|NCT04825912|Duke University|Katherine Ramos, Ph.D.|919-416-3434|Katherine.Ramos@duke.edu|
20522671|NCT01808547|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
20522672|NCT01009814|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20522673|NCT00618371|University of Pittsburgh|Deborah McMahon|412-383-1675|mcmahond@pitt.edu|
20522674|NCT03965689|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20552512|NCT04544293|Savara Inc.|Raymond D Pratt, MD FACP|512 614 1848|ray.pratt@savarapharma.com|
20552513|NCT04903249|Dartmouth-Hitchcock Medical Center|Courtney J. Stevens, PhD, Principal Investigator|603-650-9643|courtney.j.stevens@dartmouth.edu|
20552514|NCT03556579|Johnson & Johnson Vision Care Inc.|John Buch, O.D. F.A.A.O - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
20552515|NCT02965703|Northwestern University|Dr. Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
20552516|NCT01144442|Masonic Cancer Center|Peter Argenta, MD|612-626-3111|argenta@umn.edu|
20552517|NCT01951157|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
20552518|NCT00744627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20552519|NCT03560531|Zeno Alpha Inc.|Head of Regulatory Affairs|(858) 263-4333|RegLeads@zentalis.com|
20552520|NCT01471379|UNC Chapel Hill|Dr. Spencer Dorn Associate Professor|919-966-0141|sdorn@med.unc.edu|
20552521|NCT01200797|Vanderbilt-Ingram Cancer Center|Marta A. Crispens, M.D.|615-322-8072|marta.crispens@Vanderbilt.Edu|
20552522|NCT03745144|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
20552523|NCT03608774|University of Washington|Julia C. Dombrowski, MD, MPH|206-744-5640|jdombrow@uw.edu|
20552524|NCT00642668|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20552525|NCT01586819|Loyola University Chicago|Rebecca Tung, M.D.|708-216-8000|rtung@lumc.edu|
20552526|NCT00589316|Fred Hutchinson Cancer Center|Johnnie Orozco, MD, PhD|(206) 667-4102|jorozco@fredhutch.org|
20552527|NCT01883427|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
20552528|NCT01324349|Covidien|Vice President, Medical Affairs|203-500-4256|amy.pollack@covidien.com|
20552529|NCT00748215|University of Texas (UT) MD Anderson Cancer Center|Bryan Kee, MD/Assistant Professor, GI Medical Oncology|713-792-2828|bkkee@mdanderson.org|
20566908|NCT00485693|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20522675|NCT02090725|Dartmouth-Hitchcock|Jeffrey A. Cohen, MD|603-650-4211|jeffrey.a.cohen@hitchcock.org|
20522676|NCT01214655|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20522677|NCT04933383|Aquilon Pharmaceuticals SA|Clinical Operations|003242292800|clinops@aquilonpharma.com|
20522678|NCT02037425|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cay, M.D.|417-883-7889|rcady@banyangroupinc.com|
20522679|NCT05256134|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20522680|NCT04974749|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20522681|NCT01121562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522682|NCT00919126|University Hospital Schleswig-Holstein|Prof. Dr. Med Berthold BEIN|+49(0)431-5973 739|bein@anasthesie.uni-kiel.de|
20522683|NCT00637494|Corcept Therapeutics|Thaddeus S. Block, MD|(650) 688-8816|tblock@corcept.com|
20522684|NCT02540083|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
20522685|NCT01439581|Henry Ford Health System|Robert Behrendt|313-874-9537|Rbehren9@hfhs.org|
20566909|NCT02309294|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20566910|NCT01227421|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
20566911|NCT01827839|GlaxoSmithKline|GSK Response Center|866-435-7343||
20566912|NCT01695291|New York State Psychiatric Institute|Kelsey Hill, Research Coordinator|646-774-5793|Kelsey.Hill@nyspi.columbia.edu|
20566913|NCT00614614|GlaxoSmithKline|GSK Response Center|866-435-7343||
20566914|NCT05426109|Virginia Tech|Dr. Larson-Meyer|540-231-1025|enette@vt.edu|
20566915|NCT05212285|Huadong hospital,Shanghai ,China|Dr.Yinggang Zhu,Dr Ting Zhao|1374321007|robinzyg-zhu@vip.sina.com;vivianzaza@163.com|+86
20566916|NCT02222493|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566917|NCT03132298|Stony Brook University|Jessica Schleider|631-632-4131|jessica.schleider@stonybrook.edu|
20566918|NCT01000805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20566919|NCT02542943|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522686|NCT02301390|Icahn School of Medicine at Mount Sinai|Betsy Ellsworth, Research Program Director|212-824-8902|betsy.ellsworth@mountsinai.org|
20522687|NCT00185588|Stanford University|George Albert Fisher, Associate Professor of Medicine, Stanford University|650-725-9057|georgeaf@stanford.edu|
20522688|NCT02604407|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20522689|NCT00398866|Hospital for Special Surgery|Dr. Lisa Mandl|2127742754|MandlL@hss.edu|
20522690|NCT02268877|Denver Health and Hospital Authority|Dr. John Kendall|(303)602-5187|John.Kendall@dhha.org|
20567803|NCT04271254|University of North Carolina Lineberger Comprehensive Cancer Center|David Lalush|9195137671|dlalush@email.unc.edu|
20522691|NCT02481869|University of Missouri|Dr. James Cook|5738827615|cookjl@health.missouri.edu|
20522692|NCT02779166|Northwestern Univeristy Department of Orthopaedic Surgery|Dr. Michael Terry|312-926-4444||
20522693|NCT05445492|Analog Devices, Inc.|Emily Wycallis|9784351644|emily.wycallis@analog.com|
20552530|NCT00851799|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20552531|NCT01449526|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
20567804|NCT02068352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20552532|NCT01538862|Vanderbilt University|Haydar Frangoul, MD, MS|615-342-7339|Haydar.Frangoul@hcahealthcare.com|
20552533|NCT00244712|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552534|NCT04476537|Columbia University|Gulam Manji, MD|212-342-5162|gam2140@cumc.columbia.edu|
20552535|NCT02283814|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20552536|NCT01398566|The Ohio State University|Lise Worthen-Chaudhari|614-304-1421|liseworthen@gmail.com|
20552537|NCT00427635|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20552538|NCT00838201|Amgen Inc.|Study Director|866-572-6436||
20552539|NCT02558790|Massachusetts General Hospital|Craig Surman, MD|617-726-8422|csurman@partners.org|
20567805|NCT02740517|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
20567806|NCT03745651|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20567807|NCT04175834|Providence Health & Services|Chiayi Chen, Director of WC/PBSI Clinical Research Program|503-216-1012|Chiayi.Chen@providence.org|
20567808|NCT01322347|Rockwell Medical|Senior Director, Clinical Research & Development|248-960-9009|rd@rockwellmed.com|
20567809|NCT04883541|Üsküdar Üniversitesi|Assistant Professor Tuğba YILMAZ ESENCAN|+905057084946|tugba.yilmazesencan@uskudar.edu.tr|
20567810|NCT02823574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.gov|
20567811|NCT00590759|W. L. Gore and Associates, Inc.|Robert Makowsky|6232345784|rmakowsk@wlgore.com|
20567812|NCT01580306|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552540|NCT04066426|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
20552541|NCT02984384|University of Maryland School of Medicine|Robert O'Toole|410-328-6280|rotoole@som.umaryland.edu|
20552542|NCT01117727|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
20552543|NCT02711800|Duke University|Nancy Zucker|9196680075|zucke001@mc.duke.edu|
20552544|NCT02098161|The University of Texas MD Anderson Cancer Center|Naveen Pemmaraju MD/ Associate Professor|713-792-4956|NPemmaraju@mdanderson.org|
20552545|NCT01295515|National Cancer Institute|Dr. Frank Maldarelli|301- 846-5611|frank_maldarelli@nih.gov|
20552546|NCT04938232|Dana-Farber Cancer Institute|Reid Merryman|6176326844|reid_merryman@dfci.harvard.edu|
20552547|NCT03754959|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552548|NCT02023151|Johns Hopkins University|Sarbjit Saini|4105502191|ssaini@jhmi.edu|
20552549|NCT03450707|BIDMC|Dr. Michael Donnino|6177542882|mdonnino@bidmc.harvard.edu|
20552550|NCT00004412|Boston University School of Medicine|Douglas V. Faller, Ph.D., M.D., Susan P. Perrine, M.D.|(617) 638-5639|sperrine@bu.edu|
20552551|NCT00481195|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
20552552|NCT02932904|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20552553|NCT00006478|University of Nebraska Medical Center Division of Oncology/Hematology|Bryan Ludwig, Regulatory Coordinator|402-559-8071|bmludwig@unmc.edu|
20552554|NCT04534764|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
20552555|NCT03161483|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20552556|NCT04128683|University of California San Diego|Dr. Guido Frank|858-246-2053|gfrank@health.ucsd.edu|
20552557|NCT03007394|National Institute on Drug Abuse|David McCann, Ph.D.|301-827-5934|dmccann@nida.nih.gov|
20552558|NCT02901951|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
20552559|NCT00537446|Columbia University Irving Medical Center|Robert Basner, MD||rcb42@cumc.columbia.edu|
20552560|NCT00805766|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20552561|NCT01841151|KIND, KBH, Karolinska Institutet|Prof. Sven Bölte|0046703170105|sven.bolte@ki.se|
20552562|NCT00228917|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552563|NCT00409617|Abbott|Global Medical Services|800-633-9110||
20552564|NCT00914862|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20552565|NCT00591942|University of Iowa|Dr. Clark Stanford|319-335-7381|Clark-Stanford@uiowa.edu|
20552566|NCT00149747|Stanford Prevention Research Center|Abby C. King|6507252826|king@stanford.edu|
20552567|NCT04649775|Duke University|Loretta Que, M.D.|919-681-8551|loretta.que@duke.edu|
20552568|NCT00694369|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20552569|NCT02871739|Massachusetts General Hospital Health Decision Sciences Center|Karen Sepucha|617-724-3350|ksepucha@partners.org|
20522694|NCT00191191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20552570|NCT00594464|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20552571|NCT00706836|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
20552572|NCT02907359|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20552573|NCT03131440|Northwestern University|Siobhan Phillips|312-503-4235|smphillips@northwestern.edu|
20552574|NCT00746941|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20552575|NCT01805024|Santhera Pharmaceuticals|Roxana Drake|+41 61 906 89 29|roxana.drake@santhera.com|
20552576|NCT02508571|Department of Pediatrics, Seoul National University College of Medicine|Dr. Ee-Kyung Kim|82-2-2072-3628|kimek@snu.ac.kr|
20552577|NCT04654117|Department of Psychology, Michigan State University|Dr. Brooke Ingersoll, Professor|517-432-8412|ingers19@msu.edu|
20552578|NCT01524692|University of Virginia|Dr. Patrick Dillon|4349821495|pmd5b@virginia.edu|
20552579|NCT03190889|The Ohio State University Wexner Medical Center|Nathaniel A. Bates|614-293-9013|nathaniel.bates@osumc.edu|
20552580|NCT01709695|Icahn School of Medicine at Mount Sinai|Department of Psychiatry|212-241-6623||
20552581|NCT04007523|Michigan Medicine|Dr. Phillip Vlisides|734-936-4280|pvliside@med.umich.edu|
20552582|NCT01821534|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20552583|NCT02323854|Medtronic|Dr. Jaime Kean|303-882-6759|Jaime.m.Kean@medtronic.com|
20552584|NCT02818777|University of Colorado|Dr. Maureen Anne Leehey|303-724-2194|maureen.leehey@ucdenver.edu|
20552585|NCT01418937|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552586|NCT04059146|University of Iowa|Dr. Ruth Chimenti|319-335-9802|ruth-chimenti@uiowa.edu|
20552587|NCT01623596|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
20552588|NCT00747435|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
20552589|NCT02531321|University of Southern California|Dr. Nicole Bender|3234093416|nicole.bender@med.usc.edu|
20552590|NCT01976442|University of Rochester Medical Center|Neil Blumberg MD|(585) 275-3189|neil_blumberg@urmc.rochester.edu|
20552591|NCT01951339|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
20552592|NCT02204748|The University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
20552593|NCT03007758|Prisma Health|Abby Birrell, Study Coordinator|8645222117|abby.birrell@prismahealth.org|
20552594|NCT00082433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20552595|NCT01796197|Dana-Farber Cancer Institute|Beth Overmoyer, MD, FACP|617.632.3800|beth_overmoyer@dfci.harvard.edu|
20552596|NCT01519882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20552597|NCT02818218|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
20552598|NCT02280941|University of Ottawa Heart Institute|Dr. Terrence Ruddy|6136967000|truddy@ottawaheart.ca|7267
20552599|NCT04328207|University of Alabama at Birmingham|Cynthia Owsley|2053258635|cynthiaowsley@uabmc.edu|
20552600|NCT03026257|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Clin Dev Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20567813|NCT02542696|Sumitomo Pharma America, Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20552601|NCT04380857|Cleveland Eye Clinic|Kathleen Jee, MD|440-526-1974|kjee@midwestvision.com|
20552602|NCT01364090|Viral Hepatits Clinical Research Program - The Kirby Institute - UNSW Sydney|Dr. Jason Grebely|+61 2938 50957|Jgrebely@kirby.unsw.edu.au|
20552603|NCT02042924|Masonic Cancer Center, University of Minnesota|Dr. Susanta Hui|626-218-0556|shui@coh.org|
20552604|NCT04033003|University of Michigan, School of Nursing|Jody R. Lori PhD, Associate Dean for Global Affairs, Director, PAHO/WHO Collaborating Center|734-763-0097|jrlori@med.umich.edu|
20552605|NCT02487394|UTMB|William Calhoun, M.D.|409-772-1176|wjcalhou@utmb.edu|
20552606|NCT01018420|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20552607|NCT00265616|CHUV Lausanne|Dr Andrea O. Rossetti|+41 21 314 1190|andrea.rosseti@chuv.ch|
20552608|NCT01828034|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
20552609|NCT01988571|Wake Forest NCI Community Oncology Research Program Research Base|Lead Biostatistician|336-716-0891|NCORP@wakehealth.edu|
20552610|NCT02719158|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20552611|NCT03137693|Moffitt Cancer Center|Michael Montejo, MD|813-745-8424|Michael.Montejo@moffitt.org|
20552612|NCT03144180|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|9152155103|christina.bracamontes@ttuhsc.edu|
20552613|NCT01142310|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
20552614|NCT03387813|Abbott|Fei San Lee, PhD, Sr Clinical Research Scientist|925-694-2109|feisan.lee@abbott.com|
20552615|NCT01052545|Michael E. DeBakey VA Medical Center|Barbara Trautner, MD, PhD|713-440-4438|barbar.trautner@va.gov|
20552616|NCT03792672|Takeda|Medical Director|1-877-825-3327|medicalinformation@tpna.com|
20552617|NCT00453999|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
20552618|NCT00802412|VA San Diego|Neal Doran, PhD|8585528585|neal.doran@va.gov|2421
20552619|NCT00112242|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof Olivier Michielin|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
20552620|NCT02767427|Columbia University|Dr. Kiehyun Daniel Riew, Professor of Orthopedic Surgery|212-932-4410|kr2637@cumc.columbia.edu|
20552621|NCT04238728|University of Rochester Medical Center|Julie Ryan, MD|585-276-3862|Julie_Ryan@URMC.Rochester.edu|
20552622|NCT04630093|University of Florida|Dr. Julio Duarte|352-273-8132|juliod@cop.ufl.edu|
20522695|NCT03474874|NeXtGen Biologics Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
20552623|NCT01073865|AstraZeneca|Global Clinical Lead|+44 1509 645895|clinicaltrialtransparency@astrazeneca.com|
20552624|NCT00743652|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552625|NCT04590547|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
20552626|NCT04120610|Medtronic|Janki Shah|732-266-2503|janki.shah@medtronic.com|
20552627|NCT03373383|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20552628|NCT02159521|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
20552629|NCT00907374|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
20552630|NCT00544076|City of Hope|Laura Crocitto, M.D.|626-218-3708|lcrocitto@coh.org|
20552631|NCT03892460|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
20552632|NCT02136576|Tufts University School of Dental Medicine|Dr. Britta Magnuson|617-636-3878|britta.magnuson@tufts.edu|
20552633|NCT02197806|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20552634|NCT03352323|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20552635|NCT00537381|Janssen Research & Development, L.L.C.|Senior Director|908-927-2116||
20552636|NCT00680901|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20552637|NCT05544786|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552638|NCT00500292|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20552639|NCT03065244|Dept. of Pediatrics UCSD School of Medicine|Dr. Jane Burns|858-246-0155|jcburns@health.ucsd.edu|
20552640|NCT03717480|Dana-Farber Cancer Institute|Dr. Vincent Ho|617-632-6256|vincent_ho@dfci.harvard.edu|
20552641|NCT00075582|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20552642|NCT01625455|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
20552643|NCT04809220|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20552644|NCT05218018|University of Washington|Angela Hanson|206-897-5393|hansonaj@uw.edu|
20552645|NCT03035955|WakeForest|Director of Clinical Trials|336-716-3775||
20552646|NCT02120794|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
20552647|NCT00827255|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20552648|NCT01048723|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Zager, M.D.|813-745-1085|jonathan.zager@moffitt.org|
20552649|NCT00994240|University of Wisconsin-Madison|Clinical Research Administrator|608-287-2640|dbock@dermatology.wisc.edu|
20552650|NCT04258605|Zimmer Biomet|Carina Hafner|+41797073093|carina.hafner@zimmerbiomet.com|
20552651|NCT04681482|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552652|NCT00896337|Boston Scientific|Angela Schutt|763-494-2166|schutta@bsci.com|
20552653|NCT01177540|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20552654|NCT00265512|VA Center for Innovation to Implementation|Todd Wagner|6504935000|todd.wagner@va.gov|22048
20552655|NCT04222712|Tarsier Pharma|COO|+972508371319|zohar@tarsierpharma.com|
20552656|NCT04448210|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
20552657|NCT00868712|Walter Reed Army Medical Center, Cardiology Service|Todd C. Villines, MD|301-295-7839|todd.villines@us.army.mil|
20552658|NCT04662801|Yale School of Medicine|Dr Valentina Ivezaj, Assistant Professor of Psychiatry|+1 (203) 785-7807|valentina.ivezaj@yale.edu|
20552659|NCT00828191|IBSA Institut Biochimique SA|IBSA U.S. Agent|805 376 00 78|cejtwsxx@verizon.net|
20552660|NCT04697693|New York State Psychiatric Institute|Dr. Bret Rutherford|646-774-8660|bret.rutherford@nyspi.columbia.edu|
20552661|NCT02910167|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552662|NCT00656630|The Scripps Research Institute|Barbara J. Mason, Ph.D.-Principal Investigator|858784-7328|mason@scripps.edu|
20552663|NCT04052542|University of Pittsburgh School of Medicine|Timothy D Girard, MD, MSCI|(412) 383-0582|timothy.girard@pitt.edu|
20552664|NCT01667978|Montefiore|Jessica Atrio|718 405 82 60|jatrio@montefiore.org|
20552665|NCT00856908|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20552666|NCT01063595|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
20552667|NCT06021951|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20552668|NCT01070316|Cincinnati Children's Hospital Medical Center|Elizabeth Hoskins|(513) 803-7263|elizabeth.hoskins@cchmc.org|
20552669|NCT02013167|Amgen Inc.|Study Director|866-572-6436||
20552670|NCT02138461|MDbackline, LLC|John A. Hovanesian, MD|949 951 9248|jhovanesian@mdbackline.com|
20552671|NCT00026793|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
20552672|NCT04151290|Cognoa|Senior Director Clinical Research|4082076659|minda.seal@cognoa.com|
20552673|NCT01633320|Edouard Herriot hôspital Anaesthesia and intensive care|Dr Emmanuel Boselli|+334711689|emmanuel.boselli@chu-lyon.fr|
20552674|NCT04097821|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20552675|NCT02776917|University of California, San Diego|Barbara Parker, MD|(858) 657-6100|baparker@health.ucsd.edu|
20552676|NCT00574405|Arkansas Children's Hospital Research Institute|Kathryn Thrailkill, MD|501-364-1430|thrailkillkathrynm@uams.edu|
20552677|NCT04320940|Hikma Pharmaceuticals|Amy Schutte|440-201-5010|aschutte@Hikma.com|
20552678|NCT01088646|Givenimaging|Hilla Debby/Director of clinical affairs|97249097774|hila.debby@givenimaging.com|7774
20552679|NCT01572038|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20552680|NCT02431754|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20552681|NCT02281851|University of Birmingham|Mathew Soden|07800549318|matthewsoden33@gmail.com|
20552682|NCT00394212|Davol Inc., Subsidiary of C.R. Bard|Dawn Heimer, Clinical Research|401-825-8681|Dawn.Heimer@crbard.com|
20522696|NCT04289363|NYU Langone Health|Ryan McCormack|2122632862|Ryan.McCormack@nyulangone.org|
20552683|NCT00588445|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
20552684|NCT03240133|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20552685|NCT00554671|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100|wen-chih.wu@va.gov|6237
20552686|NCT00116831|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552687|NCT04904185|National Center for Cancer Immune Therapy (CCIT-DK)|MD, PhD Tine Juul Monberg|38682983|tine.monberg@regionh.dk|
20552688|NCT02945410|Technical University of Munich|Dr. Karsten Koehler|+49 89 289 24488|karsten.koehler@tum.de|
20552689|NCT02061969|Emory University|Saumeth Cardona MD|404-616-4827|scardon@emory.edu|
20552690|NCT00110812|University of Minnesota|Deborah Wentworth|612-726-9005|wentw001@umn.edu|
20552691|NCT03567850|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kristopher.Attwood@roswellpark.org|
20552692|NCT04200248|Ribomic, Inc.|Dr. Yoshikazu Nakamura|81-3-3440-3303|yoshi@ribomic.com|
20552693|NCT01454726|Xuan Wu Hospital of Capital Medical University|Dr. Jianping JIA|0086-10-83198899|jiajp@vip.sina.com|8650
20552694|NCT02919670|DFCI|Kelly Masone|6176324167|kmasone@partners.org|
20552695|NCT02227485|Shiraz University of Medical Sciences|Dr. Mahsa Rostami-Chijan|+989111960300|mahsa_59_2007@yahoo.com|
20552696|NCT02118428|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832|ray.goodrich@terumobct.com|
20552697|NCT01714310|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
20552698|NCT01641367|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20552699|NCT00826267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552700|NCT02146482|Stanford University|Grant Ognibene|9518343465|grantog@stanford.edu|
20552701|NCT01675882|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
20552702|NCT00735371|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20552703|NCT01604343|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20552704|NCT00850200|University of Florida Proton Therapy Institute|Bradford Hoppe, MD, MPH|904-588-1800|bhoppe@floridaproton.org|
20552705|NCT00097721|Eisai Inc|Eisai Call Center|888-422-4743||
20552706|NCT02963493|Oncopeptides|Global Clinical Project Lead|866-596-6626|info@oncopeptides.com|
20552707|NCT03663283|Mayo Clinic|Steven J. Hattrup, M.D.|480-301-8519|hattrup.steven@mayo.edu|
20552708|NCT02667483|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20552709|NCT02346136|MGH Biostatistics|Eric Macklin, PhD|617-724-9828|emacklin@mgh.harvard.edu|
20552710|NCT02308735|University of Oklahoma Health Sciences Center|Douglas Dannaway|405-271-5215|douglas-dannaway@ouhsc.edu|42048
20552711|NCT03608488|SultanAbdulhamid|Tugba OZsoy-Unubol|+905074583382|tugbaozsoyy@gmail.com|
20552712|NCT02127632|DorkuzEU|Anaesthesiology and Reanimation|90.505.525.29.01|ozbilginsule@gmail.com|
20552713|NCT01632202|Weill Cornell Medicine|Sr. Research Compliance Specialist|646-962-4065|lao2003@med.cornell.edu|
20552714|NCT00983216|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20552715|NCT01971853|"University of Colorado Denver | Anschutz"|Director, Clinical Research Administration||clinicalresearchsupportcenter@ucdenver.edu|
20552716|NCT01417481|Instituto Nacional de Enfermedades Respiratorias|Dr. Mario H. Vargas|(+55)54871771|mhvargasb@yahoo.com.mx|
20552717|NCT04964453|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552718|NCT00829296|University of Chicago|Dr. George Bakris|773-702-7936|gbakris@medicine.bsd.uchicago.edu|
20552719|NCT01907828|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
20552720|NCT01193907|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
20552721|NCT04960228|Lady Davis Institute for Medical Research|Ben Haward, Research Assistant|514-340-8222|ben.haward@ladydavis.ca|23978
20552722|NCT03029624|Valencia Technologies|Stacy Chambliss, Chief of Clinical Trials|661-775-1414|schambliss@valenciatechnologies.com|1002
20552723|NCT01364428|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20552724|NCT01987427|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20552725|NCT02547129|Mayo Clinic|Dr. Michael J. Taunton|507-284-7692|Taunton.Michael@mayo.edu|
20552726|NCT03925324|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
20552727|NCT03799484|The University of Texas Health Science Center at Houston|Karina Richani-Reverol, MD|(713) 559-5200|Karina.RichaniReverol@uth.tmc.edu|
20552728|NCT00794196|Parc Sanitari Sant Joan de Déu|Dr. Antoni Serrano Blanco|+34936406350|aserrano@pssjd.org|12215
20552729|NCT04414553|University of Colorado|Lisa Ross DeCamp|3037246499|lisa.decamp@cuanschutz.edu|
20552730|NCT00259090|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20552731|NCT02129803|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
20552732|NCT02689258|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
20552733|NCT03317431|Department of Anesthesia,Xinhua hospital affiliated to Shanghai Jiaotong University School of Medicine|Dr.Lai Jiang|021-25078999|jianglaimz@sina.com|
20552734|NCT04753164|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+18566613721|idorsiaclinicaltrials@idorsia.com|
20552735|NCT02508636|University of California, San Francisco|Dr. Hao Nguyen|(415) 514-5541|Hao.Nguyen@ucsf.edu|
20552736|NCT01465464|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
20552737|NCT03458130|Eidos Therapeutics|Mark McGovern, Vice President of Clinical Operations|415-887-1471|medinfo@eidostx.com|
20552738|NCT03395314|Yale School of Medicine|Sarah Fineberg, MD, PhD|(203) 974-7265|sarah.fineberg@yale.edu|
20552739|NCT00785486|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
20522697|NCT03277066|Noven Pharmaceuticals, Inc.|Gunnar Klauss, MD|1-551-233-2656|gklauss@noven.com|
20522698|NCT03790657|Malcom Randall VA Medical Center|David Clark|3523761611|david.clark1@va.gov|105244
20522699|NCT03126435|SynCore Biotechnology Co., Ltd.|Albert Lin, Ph.D./Special Assistant to GM|+886-2-2760-3688|JWLin@syncorebio.com|2308
20552740|NCT00775437|AbbVie|Global Medical Information|800-633-9110||
20552741|NCT04371380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20552742|NCT01132495|St. Jude Medical|Sr. Director, Global Clinical Affairs|651-756-5586|jmifek@sjm.com|
20552743|NCT02276612|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230|GileadClinicalTrials@gilead.com|
20552744|NCT02214277|Claret Medical|Director of Clinical Research|707-528-9300|info@claretmedical.com|
20552745|NCT01077804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20552746|NCT02620046|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20552747|NCT04866771|University Of Illinois At Chicago|PRS Training Lead|(312) 996-4995|awards@uic.edu|
20552748|NCT00403273|minneapolis VAMC|jasvinder singh|205-504-9559||
20552749|NCT04041869|University of Iowa|Lucas Carr|319-353-5432|lucas-carr@uiowa.edu|
20552750|NCT01336738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552751|NCT01083433|Rainbow Babies and Children's Hospital|Sarah A. MacLeish, DO|216-844-3661|sarah.macleish2@uhhospitals.org|
20552752|NCT02383667|The University of Toledo|Saima Karim, DO|419-383-3697|Saima.Karim@utoledo.edu|
20552753|NCT03003520|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20552754|NCT01332149|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552755|NCT04982029|Brigham and Women's Hospital|Dr. Joji Suzuki|617-455-7981|jsuzuki2@bwh.harvard.edu|
20552756|NCT03264404|Columbia University|Ruth White, MD, PhD|212-342-5162|raw2168@cumc.columbia.edu|
20552757|NCT04615949|CardiolRx|Andrea B. Parker, MSc. PhD, Senior Director Clinical Operations|+1 289 9100862|andrea.parker@cardiolRx.com|
20552758|NCT03036566|University of Michigan|Dennis J. Fasbinder, DDS|7346474450|djfas@umich.edu|
20552759|NCT05458856|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20552760|NCT01852292|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20552761|NCT01195467|St Stephen's AIDS Trust|Dr Mark Nelson|02033|mark.nelson@chelwest.nhs.uk|155610
20552762|NCT02388737|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20552763|NCT01888497|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552764|NCT04152447|Massachusetts General Hospital|Dr. Marilyn Heng|617-643-0149|mheng@mgh.harvard.edu|
20552765|NCT04013191|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
20552766|NCT03662100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20552767|NCT02159547|Akdeniz University|Cenker EKEN|00905321593948|cenkereken@akdeniz.edu.tr|
20552768|NCT03711162|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20552769|NCT03034954|University of Michigan|Dr. Annalise Rahman-Filipiak|734-763-9259|rahmanam@med.umich.edu|
20552770|NCT02340299|Charité - Universitätsmedizin Berlin|PD Dr. Christoph Czernik, principal investigator|+49 30 450|christoph.czernik@charite.de|566122
20552771|NCT02904057|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20552772|NCT01275066|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|(800) 983-4587|medinfo@bmrn.com|
20552773|NCT01344369|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20552774|NCT01886833|CIDRZ|Dr. Roma Chilengi|+2609173724935|Roma.Chilengi@cidrz.org|
20552775|NCT01661712|2Guy's and St Thomas' NHS Foundation Trust, Lane Fox Respiratory Unit/Sleep Disorders Centre, London, UK|Dr Joerg Steier|020 7188 3430|joerg.steier@gstt.nhs.uk|
20552776|NCT02342704|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20552777|NCT00614913|Radiation Medicine - Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@dominion.llumc.edu|
20552778|NCT02462967|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
20552779|NCT02871375|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20552780|NCT03592121|Applied Biology, Inc.|Dr. Andy Goren|(949) 387-4526|andyg@appliedbiology.com|
20552781|NCT00579111|Baylor|Rammurti Kamble, MD|713-394-6252|rtkamble@tmhs.org|
20552782|NCT04327999|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20522700|NCT03971474|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20522701|NCT01375946|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
20522702|NCT02370238|Dompé Farmaceutici SpA|Dr Pier Adelchi Ruffini, MD|+39 02 583831|info@dompe.it|
20522703|NCT01807065|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20522704|NCT01153425|University of Pennsylvania, Perelman School of Medicine|Felix W. Wehrli, Ph.D.|215-662-7951|wehrli@mail.med.upenn.edu|
20522705|NCT01482312|Alcon Research|Director of Alcon Clinical|1-800-241-7629||
20522706|NCT01699815|Duke University School of Nursing|Virginia C. Muckler|919-684-9307|chris.muckler@duke.edu|
20522707|NCT01295320|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522708|NCT04759768|Opiant Pharmaceuticals|Clinical Director|18043791090|PatientSafetyNA@Indivior.com|
20522709|NCT00537511|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20522710|NCT03010683|2nd Cardiology Department, National and Kapodistrian University of Athens, Attikon Hospital|Dr Ignatios Ikonomidis|+30 6944805732|ignoik@gmail.com|
20522711|NCT04324021|Swedish Orphan Biovitrum|Henrick Andersson, Director of Statistical Science|+46760011816|henrik.andersson@sobi.com|
20522712|NCT02006732|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522713|NCT02211417|Dignity Sciences Ltd|Study Director|+353 1 2933590|dsbiopharma.regulatory@dsbiopharma.com|
20522714|NCT01198132|Merck KGaA|Title: Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20552783|NCT00422032|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026|eharriso@mdanderson.org|
20552784|NCT02872116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20552785|NCT00980395|University of Arizona|Amy Selegue, NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
20567814|NCT03693989|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20567815|NCT01190436|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20567816|NCT02077374|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20567817|NCT00446095|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20522715|NCT01277211|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20567818|NCT03400748|Spiration, Inc.|Lauri DeVore|425-636-5464|lauri.devore@olympus.com|
20567819|NCT01469585|University of Hawaii|Investigator|808-203-6500|blissk@hawaii.edu|
20552786|NCT00594061|University of Iowa|Bruce Gantz|319-353-8776|bruce-gantz@uiowa.edu|
20552787|NCT02319031|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20552788|NCT03917420|UNC Chapel Hill|Amanda Poliseno|919-962-5344|amanda_poliseno@unc.edu|
20552789|NCT02319005|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20552790|NCT02356692|CooperVision|Donald Siegel, OD|602 485 3414|dsiegel@coopervision.com|
20552791|NCT03712410|University of Pennsylvania|George Demiris|2158988559|gdemiris@upenn.edu|
20552792|NCT00696137|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
20552793|NCT01015586|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
20552794|NCT00314236|Piramal Healthcare (Canada) Limited|Alberto Restrepo, MD, Director of Medical and Clinical Affairs|450-686-2437|alberto.restrepo@piramal.com|315
20552795|NCT01183975|Ethicon, Inc.|Birgit Temiz|+49 (0) 40 5297 3144|btemiz@its.jnj.com|
20552796|NCT03316885|Alcon Research, LLC|Director, Clinical Projects - CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20552797|NCT01102413|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
20552798|NCT04180020|Yale School of Medicine|Sandra Springer, MD|877-554-3578|sandra.springer@yale.edu|
20552799|NCT00262509|Atlanta VA Rehabilitation R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
20567820|NCT00886834|University of Utah, Department of Obstetrics and Gynecology|Dr. David Turok|801-581-7647|david.turok@hsc.utah.edu|
20552800|NCT01425879|The Ohio State University|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
20566920|NCT05986617|University of Iowa|Victoria Tappa|3193846136|victoria-tappa@uiowa.edu|
20566921|NCT05432986|Rhaeos, Inc.|Anna Somera|855-814-3569|info@rhaeos.com|
20566922|NCT02556918|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
20566923|NCT00768716|Washington State University|Dr Michael H. Court|5093350817|michael.court@wsu.edu|
20566924|NCT06134089|University of Utah|Andy King|801-646-4274|andy.king@utah.edu|
20566925|NCT05643885|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566926|NCT04511702|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20566927|NCT05349721|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20566928|NCT06006455|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
20566929|NCT02271906|UT MD Anderson Cancer Center|George Simon, MD|713-792-7734|GSimon@mdanderson.org|
20566930|NCT03377049|UW School of Medicine and Public Health|Azam Ahmed, MD, FAANS, FACS|608-263-0485|azam.ahmed@neurosurgery.wisc.edu|
20566931|NCT00985088|GlaxoSmithKline|GSK Response Center|866-435-7343||
20566932|NCT01550952|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
20566933|NCT01970878|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20566934|NCT06571695|Loyola University Medical Center|Dr. Dane H. Salazar|773-562-0456|dsalazar@lumc.edu|
20566935|NCT00597376|Rush University Medical Center|Raj C. Shah, MD|312-563-2902|Raj_C_Shah@rush.edu|
20566936|NCT02634307|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20566937|NCT03926026|Nicox Ophthalmics, inc.|Doug Hubatsch|832-360-3022|hubatsch@nicox.com|
20566938|NCT01467934|Columbia University|Melissa Stockwell|212-342-5732|mss2112@columbia.edu|
20566939|NCT01532648|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20566940|NCT02824198|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
20566941|NCT03883828|Montefiore Medical Center|Dr. Beth McLellan|718.862.8840|bmclella@montefiore.org|
20566942|NCT00568087|Minneapolis VA Health Care System|Gihyun Yoon, MD|612-467-3996|Gihyun.Yoon@va.gov|
20566943|NCT01005615|Kennedy Krieger institute|Cristina Sadowsky|443-923-9232|sadowsky@kennedykrieger.org|
20566944|NCT03510195|Universiti Putra Malaysia|Dr. Aneesa Abdul Rashid|03-86092956|aneesa@upm.edu.my|
20566945|NCT03737110|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
20566946|NCT02575365|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20566947|NCT01019135|University Health Network & York University|Dr. Sherry L Grace|416.736.2100|sgrace@yorku.ca|22364
20566948|NCT05197452|Research Manager|Dr. Yolanda Cartwright|224-420-0323|yolanda_cartwright@rush.edu|
20566949|NCT04885998|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20566950|NCT01858688|Brigham and Women's Hospital/Dana-Farber Cancer Institute|Neil Martin, MD|(617) 632-3000|NEMARTIN@PARTNERS.ORG|
20566951|NCT00195819|Abbott|Global Medical Services|800-633-9110||
20566952|NCT01124045|Alcon Research, Ltd.|Pam Kaur, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20566953|NCT00884806|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20566954|NCT03298087|West LA VAMC|Nathanael Kane|3104783711|nathanael.kane@va.gov|46735
20566955|NCT01530334|SPARC CONSULTING SRL|Claudio Iannacone|+39 0243119667|info@sparcconsulting.com|
20566956|NCT01303510|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20552801|NCT01640366|Smith & Nephew Inc|Rachael Winter, Director of Clinical Operations|+44 1482 673475|rachael.winter@smith-nephew.com|
20552802|NCT02739269|The University of Hong Kong|Dr. Raymond Li|+852 22554517|raymondli@hku.hk|
20552803|NCT02244580|Biontech Diagnostics GmbH|Dr. Michael Oed|+49 6131/ 6358030|michael.oed@theracode.de|
20552804|NCT01519453|Johns Hopkins School of Medicine|Dr. Michelle Eakin|410-550-0487|meakin1@jhmi.edu|
20552805|NCT00405548|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
20552806|NCT01228747|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20552807|NCT02036502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552808|NCT04652479|Stanford University|Marilyn Tan, MD, FACE|(650) 721-1300|mjtan@stanford.edu|
20552809|NCT00811577|Capstone Therapeutics Corp.|Denise Lamon|602-286-5206|dlamon@capstonethx.com|
20552810|NCT04251221|Yale University|Dr. Ansel Hillmer|203-737-6400|ansel.hillmer@yale.edu|
20567821|NCT00657709|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20567822|NCT02574286|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20552811|NCT02357940|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
20552812|NCT02442778|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20552813|NCT02482025|VA Greater Los Angeles Healthcare System|Steven R. Simon, MD|310.268.3132|steven.simon2@va.gov|
20552814|NCT02641379|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20552815|NCT01165138|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552816|NCT04964128|Medtronic|Roseline Re|+33684520425|roseline.re@medtronic.com|
20552817|NCT01148511|Novartis Pharmaceuticals|Study Director|862 778-8300||
20552818|NCT00446147|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20552819|NCT01644175|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
20552820|NCT01025427|University of California, San Francisco|Hiroyu Hatano|415-476-4082|hhatano@php.ucsf.edu|122
20552821|NCT01017237|University of North Carolina School of Dentistry|Jay Anderson, DDS, MD|919-966-1126|janderson@aims.unc.edu|
20552822|NCT00543764|BIDMC|Bernard Lee|617-632-7835|blee3@bidmc.harvard.edu|
20552823|NCT05300295|University of Minnesota|Lindsey Weiler, PhD|612-301-9345|lmweiler@umn.edu|
20552824|NCT00842348|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20552825|NCT03200925|Kettering Health Network|Catherine Caponero, DO|937-723-4124|catherine.caponero@ketteringhealth.org|
20552826|NCT01113879|The Ohio State University|Stacy Harnish|614-688-1471|harnish.18@osu.edu|
20552827|NCT00358527|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20552828|NCT00749463|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20552829|NCT01381861|TRACON Pharmaceuticals|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
20552830|NCT02809430|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
20552831|NCT00913744|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16 751 310|Petra.kozma@thrombogenics.com|
20552832|NCT01127503|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
20552833|NCT00254995|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
20552834|NCT00302003|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20552835|NCT01218516|Morphotek (subsidiary of Eisai)|Morphotek (subsidiary of Eisai)|1-888-422-4743|esi_medinfo@eisai.com|
20552836|NCT01539226|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
20552837|NCT01632891|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20552838|NCT00935428|OHSU|Dr. John Mayberry|503-494-5300|mayberrj@ohsu.edu|
20552839|NCT04070833|Brigham and Women's Hospital|Pamela M. Rist|617-278-0835|prist@bwh.harvard.edu|
20552840|NCT02378844|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
20552841|NCT03341052|Mayo Clinic|Andres Acosta|15072666931|acosta.andres@mayo.edu|
20552842|NCT01010282|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20552843|NCT00782210|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552844|NCT03405142|Stanford Medicine at Stanford University|Roan Courtney Raymundo|650-721-4071|rcraymun@stanford.edu|
20552845|NCT00820612|University of Michigan|B. Joseph Elmunzer, MD.|735 615 6652|badihe@umich.edu|
20552846|NCT00436748|Amgen Inc.|Study Director|866-572-6436||
20552847|NCT01610791|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20552848|NCT04883632|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
20552849|NCT01105247|Pharmacyclics|Danelle James|855-427-8846|medinfo@pcyc.com|
20552850|NCT00651482|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
20552851|NCT01978314|University of Alabama, Birmingham|Dana Victor Rizk, M.D.||drizk@uab.edu|
20552852|NCT02121483|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552853|NCT02086110|University of California, Davis Health System|Dr. Kathleen Angkustsiri|916-703-0278|kangkustsiri@ucdavis.edu|
20552854|NCT01869192|University of Colorado|Anthony Elias, MD|17208480347|anthony.elias@ucdenver.edu|
20522716|NCT02252354|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20552855|NCT01203072|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
20552856|NCT00577512|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
20567823|NCT03875729|Sanofi|Clinical and Translational Medicine Lead|1-703-344-2992|laura.knecht@sanofi.com|
20552857|NCT02272413|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552858|NCT01067768|Hospital Pablo Tobón Uribe|Dr. María Victoria Restrepo|57-4-4459315|mrestrepo@hptu.org.co|
20552859|NCT02126969|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
20552860|NCT02153944|National Institute of Mental Health (NIMH)|Dr Maryland Pao|301-435-5770|paom@mail.nih.gov|
20552861|NCT05583903|Department of Surgery, Houston Methodist Hospital|Dr. Hina Faisal|713-714-4973|hfaisal@houstonmethodist.org|
20552862|NCT01533246|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
20552863|NCT02286193|Group Health Research Institute|Clarissa Hsu, PhD|206-287-4276|hsu.c@ghc.org|
20552864|NCT00354172|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
20552865|NCT00423891|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20552866|NCT01734551|University of Kentucky|Dr. Henrietta S. Bada, Professor and Vice Chair, Academic Affairs|859-323-1019|hbada2@uky.edu|
20552867|NCT06431061|CooperVision Inc.|Jose A Vega, OD,MSc,PhD|925-621-3761|JVega2@coopervision.com|
20552868|NCT04225923|Nobelpharma Co. Ltd.|Research & Development Divion|81-3-6670-3800|watanabe.tatsuya@nobelpharma.co.jp|
20552869|NCT00855309|Comprehensive Cancer Center of Wake Forest University|LeAnne Kenndy, PharmD|336-713-3416|lakenned@wakehealth.edu|
20552870|NCT01585766|MedImmune|Armando Flor, MD, Director, Clinical Development|301-398-1955|information.center@astrazeneca.com|
20552871|NCT04116710|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|barana@nighthawkbio.com|203
20552872|NCT04296396|George Washington University Biostatistics Center|MFMU Principal Investigator|301-881-9260|mfmudatasets@bsc.gwu.edu|
20552873|NCT01256593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552874|NCT00582933|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
20552875|NCT01371656|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20552876|NCT01874262|AstraZeneca|Susanna Jerström|+46 8 553 260 00||
20552877|NCT03621878|imam abdulrahman bin faisal university|Mohammed Alghamdi|+966556852888|mohdg.ios@gmail.com|
20552878|NCT04334460|Blade Therapeutics|SVP, Global Regulatory Affairs, Quality, and Safety|(650) 278 4291|dmody@blademed.com|
20552879|NCT01820754|Duke University Medical Center|Neal Ready, MD|919 681-6932|neal.ready@duke.edu|
20552880|NCT01845792|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
20552881|NCT01566448|West Virginia University Hospitals|Aaron Cumpston|304-598-4000|cumpstona@wvumedicine.org|73350
20552882|NCT02376166|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|(212) 659-5599|matthew.galsky@mssm.edu|
20552883|NCT02045511|Johns Hopkins University School of Medicine Dept. Otolaryngology-HNS|Carrie Nieman|3025368362|cnieman1@jhmi.edu|
20552884|NCT00847288|Medtronic Cardiac Rhythm Disease Management|OptiVol Care Pathway Clinical Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
20552885|NCT01068509|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
20552886|NCT01429272|Laureate Institute for Brain Research|Jonathan Savitz; Principal Investigator|918 502 5104|jsavitz@laureateinstitute.org|
20552887|NCT03483675|FHCRC|Kate Chilson|206-667-6069|kchilson@fredhutch.org|
20552888|NCT00181961|Massachusetts General Hospital|Dr. Christina Dording|6177249457|cdording@mgh.harvard.edu|
20552889|NCT00799578|Columbia University|Dr. Joel Lavine|212 304 5533|jl3553@columbia.edu|
20552890|NCT01162382|Washington University School of Medicine|Kathy Pierce|314-362-5626|jenkerson_m@wustl.edu|
20552891|NCT01886807|UTSouthwestern Medical Center|Dr. Jeffrey Steiner, PI|214-456-0606|jeffrey.steiner@utsouthwestern.edu|
20552892|NCT01965288|CooperVision|Jose A. Vega Sr. Mgr. Global Medical Scientific Affairs|(925) 621-3761|jvega2@coopervision.com|
20552893|NCT01712256|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
20552894|NCT00962104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20552895|NCT04944901|Scioto Biosciences|Phoevos Hughes, VP Clinical Operations|866-672-4686|phoevos@sciotobiosciences.com|700
20552896|NCT05516082|CooperVision, Inc.|José A. Vega OD, MSc, FAAO|19256213761|javega@coopervision.com|
20552897|NCT02603835|TherOx, Inc.|Jeffrey L. Creech, Ph.D.|(949) 225-6587|jcreech@therox.com|
20552898|NCT03913091|NYU Langone Health|Uchenna O. Umeh, MD|(212) 598-6085|Uchenna.Umeh@nyulangone.org|
20552899|NCT01726738|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20552900|NCT02196324|Menlo Therapeutics Inc. (formerly Tigercat Pharma, Inc.)|Iain Stuart, PhD.|1- 800-775-7936|Iain.Stuart@foamix.com|
20552901|NCT04243538|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
20552902|NCT00655564|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
20552903|NCT04536727|University of Illinois at Chicago|Dr. David Marquez|(312) 996-1209|marquezd@uic.edu|
20552904|NCT00344773|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20552905|NCT04859868|Mayo Clinic|Gaurav N. Pradhan, Ph.D.|480-301-5351|Pradhan.Gaurav@mayo.edu|
20552906|NCT00500370|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20552907|NCT05627518|Cinclus Pharma AB|Kristofer Katkits Nilsson, Global Trial Manager|+46 7064955|kristofer.katkits@cincluspharma.com|
20552908|NCT02917031|AstraZeneca R&D|AstraZeneca R&D|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20552909|NCT01581593|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
20552910|NCT01558700|Northwestern University|Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
20552911|NCT03369717|Montefiore Medical Center|Nadeem Akbar MD|7189204646|nakbar@montefiore.org|
20552912|NCT05308901|Providence Portland Medical Center|Dr. Matthew Taylor|503-215-1979|canrsrchstudies@providence.org|
20567824|NCT02764320|Mayo Clinic|Dr. Todd J. Schwedt|480-301-9443|Schwedt.Todd@mayo.edu|
20567825|NCT05303324|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20567826|NCT00753896|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20567827|NCT01280656|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20567828|NCT04085614|Philips Medical Systems Nederland B.V.|Peter Eshuis|+31628739280|peter.g.eshuis@philips.com|
20567829|NCT00952523|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
20567830|NCT05265247|HALEON|Haleon Response Center|+4407880182593|ww.clinical-trial-register@haleon.com|
20567831|NCT01029925|University of California Los Angeles Jonsson Comprehensive Cancer Center|Edward Garon, MD|310 586 2098|egaron@mednet.ucla.edu|
20567832|NCT02399449|University of Maryland Baltimore|James Polli|410-465-3466|jpolli@rx.umaryland.edu|
20567833|NCT02516202|Fred Hutchinson Cancer Research Center|Dr. Katherine A. Guthrie|2066675595|kguthrie@fredhutch.org|
20567834|NCT02841449|University of Bath|Dr Harriet Carroll|+447706548573|hac38@bath.ac.uk|
20567835|NCT02159352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20567836|NCT01020435|Palmer College of Chiropractic|Christine M Goertz, DC, PhD (Study Principal Investigator)|563-884-5150|christine.goertz@palmer.edu|
20567837|NCT03065400|Icahn School of Medicine at Mount Sinai|Mikaela Dougherty|212-241-8839|Mikaela.dougherty@mssm.edu|
20567838|NCT04749797|University of Pennsylvania|Timothy Lucas|(215) 662-3487|Timothy.Lucas@pennmedicine.upenn.edu|
20567839|NCT00632736|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567840|NCT00871715|University of Southern California|Carolee Winstein, Principal Investigator|3234422903|winstein@usc.edu|
20567841|NCT02189759|University of Alabama at Birmingham|Manimaran Ramani|2054731425|mramani@peds.uab.edu|
20567842|NCT01147471|Virginia Commonwealth University|Ajai K Malhotra, MD|804-827-2409|akmalhot@mcvh-vcu.edu|
20567843|NCT03020498|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20522717|NCT02064985|Pharmaceutical Product Development, LLC.|Rong Fu|86-021-80135112|rong.fu@ppdi.com|
20522718|NCT02520297|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20522719|NCT01326923|LSU Health Shreveport|J.K. Miller|318 8131406|jmil12@lsuhsc.edu|
20522720|NCT01130597|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20522721|NCT03371459|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
20522722|NCT03071276|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
20522723|NCT01290302|Luitpold Pharmaceutical, Inc|Marsha Simon|631-772-3507|msimon@lpicrd.com|61807
20522724|NCT01496976|Moffitt Cancer Center|Celeste M. Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
20522725|NCT05938621|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
20522726|NCT03598790|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20522727|NCT04140032|UCLA Fielding School of Public Health|Dr. Burt Cowgill|310-794-3569|bcowgill@ucla.edu|
20522728|NCT03686488|Moffitt Cancer Center|Dae Won Kim, MD|813-745-1277|daewon.kim@moffitt.org|
20522729|NCT01059786|National Cancer Institute|Dr. Robert J. Kreitman|301-480-6187|kreitmar@mail.nih.gov|
20522730|NCT04205812|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20522731|NCT04559347|The Guthrie Clinic|Poovendran Saththasivam MD|5708874882|Poovendran.Saththasivam@guthrie.org|
20567844|NCT03890484|University of Washington|Dr. Jessica Canning|206.221.4430|jrcannin@uw.edu|
20567845|NCT00518206|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20522732|NCT00371033|University of Pennsylvania|J. Richard Landis, PhD|215-573-4922|hultman@upenn.edu|
20522733|NCT02905240|Zimmer Biomet|Jennifer Woodell-May, Research Associate Director|5742651885|jennifer.woodell-may@zimmerbiomet.com|
20522734|NCT05789576|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20522735|NCT03367572|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
20522736|NCT05929651|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
20552913|NCT04625803|The First Affiliated Hospital, Zhejiang University School of Medicine|Weijia Fang|+86 87235147|weijiafang@zju.edu.cn|
20552914|NCT05087875|University of Kentucky|Carolyn Lauckner|8595623335|carolyn.lauckner@uky.edu|
20552915|NCT01914666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20552916|NCT02586012|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
20552917|NCT03252522|Oregon Health & Science University|Jeanette Johnstone, PhD|5034943700|jojeanet@ohsu.edu|
20552918|NCT03018392|Bone and Joint Clinic of Baton Rouge|Research Projects Director|2254218207|aobrien@bjcbr.com|
20552919|NCT03299842|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20552920|NCT00071812|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552921|NCT01816139|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20552922|NCT03661814|Icahn School of Medicine at Mount Sinai|Dr. Joel Bauer|914-715-4242|jjb.msh@gmail.com|
20552923|NCT01940120|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-430-1329|chithra.sangli@av.abbott.com|
20552924|NCT03277846|University of Pennsylvania|Michael Perlis|215-746-3577|mperlis@upenn.edu|
20552925|NCT02554656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552926|NCT03240575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20552927|NCT02488785|Joslin Diabetes Center|Sylvia Rosas|6173092486|sylvia.rosas@joslin.harvard.edu|
20552928|NCT05543928|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20552929|NCT02400723|VA Palo Alto Health Care System|Christine Gould, PhD|650-493-5000|Christine.gould@va.gov|68899
20552930|NCT03568942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20552931|NCT02433834|Pearl Therapeutics, Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
20567846|NCT01294644|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20552932|NCT00283439|Amgen Inc.|Study Director|866-572-6436||
20552933|NCT02638298|Medical University of South Carolina|Dr. Leddy|843-876-1119|leddyl@musc.edu|
20567847|NCT02188459|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@pennmedicine.upenn.edu|
20567848|NCT02612285|Esanex Inc|Eric Orlemans PhD||eorlemans@esanexpharma.com|
20567849|NCT02548585|MedImmune, LLC|Philip Ambery|+44 (0) 1223 895997|information.center@astrazeneca.com|
20567850|NCT02399111|Northwell Health System|Dr. Kambhampaty Krishnasastry|516-233-3643|kkrishna@northwell.edu|
20567851|NCT00853957|Novartis Pharmaceuticals|Study Director|862-778-8300||
20567852|NCT02942771|University of Kentucky|Dr. Linda Van Eldik|(859) 257-5566|linda.vaneldik@uky.edu|
20567853|NCT01186809|Asst Papa Giovanni XXIII|Prof Alessandro Rambaldi|+390352673681|arambaldi@asst-pg23.it|
20567854|NCT04895085|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
20567855|NCT01303744|Cerespir|Richard Margolin|(646) 202-2562|rmargolin@cerespir.com|
20567856|NCT04919499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567857|NCT01605435|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
20567858|NCT00711555|University of Illinois|Sandra Cuellar|312-996-6985|scuell1@uic.edu|
20567859|NCT01298219|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20567860|NCT03624023|Transwell Biotech Co., Ltd.|Dr. Bin-Ru She|+886-3-5670399|binru.she@tw-bio.com|207
20567861|NCT02400749|Innovaderm Research Inc.|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
20567862|NCT00507429|OXiGENE, Inc.|Peter Langecker, MD, PhD|650 635 7008|plangecker@oxigene.com|
20567863|NCT01732419|Maxima Medical Center|Dr. J. Kraal|+31612520944|j.kraal@mmc.nl|
20567864|NCT01074099|Harvest Technologies|Director of Clinical Operations|508-732-7530|CLI2011communication@harvesttech.com|
20567865|NCT03557307|AstraZeneca|Maria Jison, MD Global Clinical Head, FASENRA, Late-stage R&I|+13013980340|Maria.Jison@astrazeneca.com|
20567866|NCT02755948|Imperial College London|Professor Christopher Chiu|(0)20 8383 2301|c.chiu@imperial.ac.uk|
20567867|NCT03456856|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20567868|NCT00113529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20567869|NCT00648895|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
20567870|NCT02955225|Rush University Medical Center|Dr. Markus Wimmer, Director Motion Analysis Laboratory|(312) 942 2789|markus_a_wimmer@rush.edu|
20567871|NCT01077284|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20567872|NCT00096278|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
20567873|NCT04626128|Clearside Biomedical, Inc.|Susan Coultas, PhD|678.270.3639|susan.coultas@clearsidebio.com|
20567874|NCT00841321|Portland VA Medical Center Multiple Sclerosis Center of Excellence|Dennis Bourdette, MD|503-220-8262|dennis.bourdette@va.gov|54594
20567875|NCT02137603|All Children's Hospital Johns Hopkins Medicine|Dr. Nicole Chandler|727-767-4170|Nicole.Chandler@jhmi.edu|
20567876|NCT02632747|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567877|NCT00379210|University of Pennsylvania|Amishi Jha|215-898-8011|apjha@psych.upenn.edu|
20567878|NCT03444155|Otto Loewi Research Center, Chair of Physiological Medicine, Medical University of Graz, Austria|Dr. Willibald Wonisch|00436505299540|willibald.wonisch@medunigraz.at|
20567879|NCT02991118|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20567880|NCT02627794|Cedars-Sinai Medical Center|Dr. Martin L. Hopp|310-657-7704|marty@towerent.com|
20567881|NCT01214109|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567882|NCT01000649|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20567883|NCT03132571|Yale School of Medicine, Department of Psychiatry|Dr. Cenk Tek|(203) 974-7500|cenk.tek@yale.edu|
20567884|NCT01856569|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567885|NCT01287832|St. John Hospital and Medical Center|Leonard Johnson MD|3133438823|leonard.johnson@stjohn.org|
20567886|NCT01794689|Johns Hopkins University|Dr. Michael T. Smith, PhD|410-550-7000|msmith62@jhmi.edu|
20567887|NCT00537914|Sandoz|Clinical Disclosure Representative|+4980249080|sandoz.disclosure@sandoz.com|
20567888|NCT02312258|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20567889|NCT01697956|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20567890|NCT01964547|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20567891|NCT01115309|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20567892|NCT05700851|University of Nottingham|Prof. Maarten Taal|01332224618|m.taal@nottingham.ac.uk|
20567893|NCT03246724|Boston Medical Center|Marissa Fiorello, Clinical Research Manager|617-414-8848|Marissa.Fiorello@bmc.org|
20552934|NCT05358821|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
20552935|NCT00645333|University of Michigan|Anne F. Schott, MD|1-800-865-1125|canceranswerline@umich.edu|
20552936|NCT00048542|Abbott|Global Medical Services|800-633-9110||
20552937|NCT05847153|Massachusetts General Hospital|Dr. Christine Ritchie|4156721780|csritchie@mgh.harvard.edu|
20552938|NCT02704364|NGM Biopharmaceuticals, Inc|Clinical Trial Information and Disclosure|650-243-5555|ngm282@ngmbio.com|
20552939|NCT04609020|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
20552940|NCT04627064|Dana-Farber Cancer Institute|Toni Choueiri, M.D|617-6325456|toni_choueiri@dfci.harvard.edu|
20552941|NCT02107599|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20552942|NCT00779103|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
20552943|NCT04098458|Medical University of South Carolina|Evan M. Graboyes, MD, MPH (principal investigator)|843-792-0719|graboyes@musc.edu|
20552944|NCT00006489|University of Pennsylvania|Dr. Edna Foa|215-746-3327|foa@mail.med.upenn.edu|
20567894|NCT02978716|G1 Therapeutics, Inc|Clinical Trial Info|+1 9192139835|clinicalinfo@g1therapeutics.com|
20567895|NCT00589628|Duke Health Systems|Dr. C. Egla Rabinovich|919-668-0238|egla.rabinovich@duke.edu|
20567896|NCT01862159|Region Örebro län, Sweden AND Örebro University, Sweden|Dr Erik Stenberg|+46196021000|erik.stenberg@regionorebrolan.se|
20567897|NCT01138969|KaohsiungVGH|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
20567898|NCT00689351|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
20567899|NCT01766206|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
20567900|NCT01662505|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567901|NCT04588207|University of Pittsburgh School of Medicine|Dr. Helbert Rondon Berrios, Professor of Medicine|4126473120|rondonberriosh@upmc.edu|
20567902|NCT01661972|Duke University Medical Center|John Strickler, M.D.|919-668-1861|john.strickler@duke.edu|
20567903|NCT01229176|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
20567904|NCT03075878|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20567905|NCT04348357|Texas Tech University Health and Science Center El Paso|Dr Steven Radtke|2177254940|dr.radtke@gmail.com|
20567906|NCT00623714|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20567907|NCT00882050|University of Pennsylvania|Kim Lacy, RN BSN|215-893-7234|kim.lacy@uphs.upenn.edu|
20567908|NCT01986348|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20567909|NCT01695044|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
20567910|NCT02158806|University of Auckland|Professor Andrew Jull|+64 9 923 4259|a.jull@auckland.ac.nz|
20567911|NCT01898299|New York State Psychiatric Institute|Joshua Kantrowitz|6467746738|jk3380@cumc.columbia.edu|
20567912|NCT02340806|Northwestern University|Elizabeth Lange, MD|312-472-3585|elizabeth.lange@northwestern.edu|
20567913|NCT02591056|Regulatory Insight, Inc.|Elvira Cawthon, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20567914|NCT01159600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20567915|NCT00760877|Novartis|Study Director|862-778-8300||
20567916|NCT02024477|The George Washington University|Dr Saby Sen|202-994-8560|ssen1@gwu.edu|
20567917|NCT00090064|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20567918|NCT04820023|Bridge Biotherapeutics, Inc.|Clinical Trial Lead|+82-31-8092-3280|Clinicaltrials.gov_inquiries@bridgebiorx.com|
20567919|NCT02240810|Boston Scientific|Director, Clinical Trials|508-683-6678|peter.maurer@bsci.com|
20567920|NCT01945593|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20567921|NCT00228813|Emory University|Kuang-Yueh Chiang, MD|404-785-0858|kchian2@emory.edu|
20567922|NCT04714359|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20567923|NCT01279447|Northwestern|Lawrence Hsu, MD|312 9262000|larryphsu@gmail.com|
20567924|NCT02213094|UNC at Chapel Hill|Kim Boggess MD Principal Investigator|919-966-1601|kboggess@med.unc.edu|
20567925|NCT01074229|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
20567926|NCT02163499|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20567927|NCT01922102|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20567928|NCT00365599|H. Lee Moffitt Cancer Center and Research Institute|Susan Minton, D.O.|813-745-3806|susan.minton@moffitt.org|
20567929|NCT04343989|NYU Langone Health|Bonnie Lonze, MD, PhD|212-263-3865|bonnie.lonze@nyulangone.org|
20567930|NCT06182631|SUNY Buffalo|Jill Fenenll|716-323-0220|jillfenn@buffalo.edu|
20567931|NCT01345253|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20567932|NCT04077437|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20567933|NCT00476151|EpiCept Corporation|Chief Medical Officer|914-606-3500|deverton@epicept.com|
20567934|NCT00447499|Ipsen|Bert Bakker, MD, PhD.|+1 650 238 1669|bert.bakker@ipsen.com|
20567935|NCT01286870|Mentor Worldwide, LLC|Laura Vellucci|(805) 879-6000|lvelucci@its.jnj.com|
20567936|NCT05087849|UCSF|Ayan Kusari|4153537800|ayan.kusari@ucsf.edu|
20567937|NCT01767376|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567938|NCT00946088|Stanford University School of Medicine|Deirdre Lyell, MD|(650) 384-5107|deirdre.lyell@stanford.edu|
20567939|NCT04239911|Weill Cornell Medicine|Dr. Madeline Sterling|646-962-5029|mrs9012@med.cornell.edu|
20567940|NCT03823794|Guy's & St Thomas' NHS Foundation Trust|Carsten Flohr|020 7188 8884|carsten.flohr@kcl.ac.uk|
20567941|NCT01052272|University of Alabama at Birmingham|Louis . J. Dell'Italia, M.D|205-934-3969|Dell'Italia@PHYSIOLOGY.UAB.EDU|
20567942|NCT00237718|Vanderbilt University|T. Alp Ikizler, MD||alp.ikizler@vanderbilt.edu|
20567943|NCT04908488|Alcon Research, LLC|Sr. Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20567944|NCT01107912|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20567945|NCT02432183|KU Leuven|Dominique MA Bullens|3216341338|dominique.bullens@kuleuven.be|
20567946|NCT01124916|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
20567947|NCT00887471|SUNY Downsate Medical Center|Nira A Goldstein, MD|718-270-1638|ngoldstein@downstate.edu|
20567948|NCT05756647|Washington University, Department of Otolaryngology - Head and Neck Surgery|Jay F. Piccirillo, MD|314-362-8641|piccirj@wustl.edu|
20567949|NCT00595959|Spectranetics Inc|Thomas M. Rasmussen V.P. Clinical Affairs|719-447-2471|thomas.rasmussen@spnc.com|
20567950|NCT01958346|Teamhealth Anesthesia|Devanand Mangar MD|813-844-4434|devanandmangar@teamhealth.com|
20567951|NCT02562521|Yale University School of Medicine|Dr. Krysten Bold|2039747603|krysten.bold@yale.edu|
20567952|NCT00963924|Nathan Klein Institute for Psychiatric Research|Dr. Donald C Goff|646-754-4843|donald.goff@nyumc.org|
20567953|NCT03014726|Urotronic, Inc.|Ian Schorn, Vice President of Clinical Affairs|320.282.6312|schorni@urotronic.com|
20567954|NCT02428595|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
20522737|NCT06831760|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
20522738|NCT00733005|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20522739|NCT01769456|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20552945|NCT00578175|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552946|NCT01232296|Novartis Pharmaceuticals|Study Director|862-778-8300||
20552947|NCT02108821|Children's Mercy Hospital, Kansas City|Alka Goyal MD|816-302-3069|agoyal4@stanford.edu|
20552948|NCT01461096|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20552949|NCT04889625|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-904-254-0152|TKarkkai@its.jnj.com|
20552950|NCT05052190|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20552951|NCT00699010|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
20552952|NCT00404352|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20552953|NCT01479621|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
20552954|NCT04370691|Abbott|Vinuta Rau|+ 1 408-834-0621|vinuta.rau@abbott.com|
20552955|NCT04152226|Dermbiont, Inc|Emma Taylor, MD (Chief Medical Officer)|510-607-8155|emma@dermbiont.com|
20552956|NCT01094548|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20552957|NCT01112293|AbramsonCC|James Robinson|215-662-8758|jamesrobinson2@pennmedicine.upenn.edu|
20552958|NCT01271868|Aptevo Therapeutics|Dr. David Schaaf|206-859-6655|schaafd@apvo.com|
20552959|NCT00606892|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20552960|NCT00966238|VaxInnate|Dr. David N. Taylor|609-860-2260|david.taylor@vaxinnate.com|
20552961|NCT00358462|University of Washington|Lisa E. Manhart, PhD - PI|206-744-3646|lmanhart@uw.edu|
20552962|NCT00738972|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552963|NCT03554291|University of Washington|Peter Leary|206-685-2484|learyp@uw.edu|
20552964|NCT02074995|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20552965|NCT00056563|Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D, Study Investigator|(708) 202-2414|Frances.Weaver@va.gov|
20552966|NCT00329407|Boston University|Ofra sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
20552967|NCT00978068|University of California, San Francisco|Tamara Clark|415-206-8790|tamara.clark@ucsf.edu|
20552968|NCT01751386|National Institute on Alcohol Abuse and Alcoholism|Lorenzo Leggio|+1 301 435 9398|lorenzo.leggio@mail.nih.gov|
20552969|NCT01398956|UCB Cares|UCB (Study Director)|+1887822||9493
20552970|NCT00451035|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20552971|NCT03274986|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20552972|NCT03323658|UT MD Anderson Cancer Center|Priya Thomas,MD-Associate Professor, Clinical Cancer Prevention|(713) 745-1075|psthomas@mdanderson.org|
20552973|NCT00615056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20552974|NCT03639766|University of Central Florida|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
20552975|NCT01380184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20552976|NCT03350503|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20552977|NCT04010266|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
20552978|NCT02679911|Galderma|Farzaneh SIDOU Clinical Project Manager|0493957051|farzaneh.sidou@galderma.com|33
20552979|NCT02131402|Optics Department, University of Valencia 46100 Valencia, Spain|Dr. Robert Montés-Mico O.D., MPhil, PhD|34-9635-44764|robert.montes@uv.es|
20552980|NCT00249470|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20552981|NCT02766244|Texas Tech University Health Sciences Center|Dr. Sharmila Dissanaike|8067435609|sharmila.dissanaike@ttuhsc.edu|
20552982|NCT04804813|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20552983|NCT00560950|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20552984|NCT05535777|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20552985|NCT02970968|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20552986|NCT02565381|Massachusetts General Hospital|Travis P. Baggett, MD, MPH (Principal Investigator)|617-643-9314|tbaggett@mgh.harvard.edu|
20552987|NCT01904604|DAIT/NIAID|Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20552988|NCT01945489|Allergan, Inc|Vice President Medical Affairs|1-877-277-8566|IR-CTRegistration@allergan.com|
20552989|NCT04147442|Bernafon AG|Dr Barbara Simon|+41 31 998 1515|bsim@bernafon.com|1684
20552990|NCT02674412|Cleveland Clinic|Scott Gabbard, MD|216 444-6523|gabbars@ccf.org|
20552991|NCT04144166|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
20552992|NCT00697346|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20552993|NCT03643562|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
20552994|NCT04145895|Beaumont Hospitals|Diane Studzinski|2485512570|diane.studzinski@corewellhealth.org|
20552995|NCT01236755|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766-6100|pauline.cho@polyu.edu.hk|
20522740|NCT01068548|VANTHCS|Eric Mortensen, MD|214-857-1588|ericm.mortensen@va.gov|
20522741|NCT02185339|Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital|Dr. Sanghyun Hong|82-2-2258-2236|shhong7272@gmail.com|
20522742|NCT01602068|Eyegate Pharmaceuticals, Inc.|Lisa Brandano|781-398-3806|lbrandano@eyegatepharma.com|
20522743|NCT02465398|Zimmer Biomet|Elliott Goff|+41 79 222 23 08|elliott.goff@zimmerbiomet.com|
20522744|NCT00599248|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
20567955|NCT04765046|Medtronic|Ami Stuart|8017934800|ami.stuart@medtronic.com|
20567956|NCT02959866|St. Michael's Hospital|Anne Rucchetto, Research Coordinator|416-864-6060|rucchettoa@smh.ca|76155
20567957|NCT03150589|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20567958|NCT03529942|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
20567959|NCT02314000|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
20567960|NCT00999336|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20567961|NCT00476957|Medtronic Bakken Research Center|Dr. Frank van Leeuwen, Director Clinical Research Coronary and Renal Denervation|+31 43 3566622|frank.van.leeuwen@medtronic.com|
20567962|NCT00409747|NIH/NIMH/PDN Branch|Dr. Susan Swedo|301-496-5323|swedos@mail.nih.gov|
20567963|NCT00636168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20567964|NCT02951702|St. Luke's Hospital|Ryan Medas, Pharm.D.|314-205-6053|ryan.medas@stlukes-stl.com|
20567965|NCT01852175|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
20567966|NCT01141075|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20567967|NCT02006641|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20567968|NCT02132195|Emory University|Dr. Greenbaum|404-712-6374|LGREEN6@emory.edu|
20567969|NCT03015220|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20567970|NCT00912964|Astellas Pharma Global Development, Europe|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
20567971|NCT04447287|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20567972|NCT00613405|Medical University of South Carolina|Aimee McRae-Clark, PharmD|843-792-5126|mcraeal@musc.edu|
20567973|NCT00655824|GlaxoSmithKline|GSK Response Center|866-435-7343||
20552996|NCT01481116|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20552997|NCT00805935|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20552998|NCT01489969|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
20552999|NCT02547662|Mayo Clinic|Shaji Kumar MD|507 284 2511|Kumar.Shaji@mayo.edu|
20553000|NCT02223767|Universitätsklinikum Würzburg|Prof. Dr. M Herrmann|093120176650|Herrmann_m@ukw.de|
20553001|NCT01200875|Stanford University|Jason Dragoo, Associate Professor|(650) 721-3430|jdragoo@stanford.edu|
20553002|NCT00333229|Novartis Pharmaceuticals|Study Director|862-778-8300||
20553003|NCT03237234|Shepherd Center|Dr. Edelle C. Field-Fote|404-603-4274|edee.field-fote@shepherd.org|
20553004|NCT04118010|Emory University|Dr. Vin Tangpricha|404-727-7254|vtangpr@emory.edu|
20553005|NCT02111252|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
20553006|NCT00430092|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325|jbrace@siriontherapeutics.com|343
20553007|NCT01166594|Sunnybrook Health Sciences Centre|Dr Catherine Birt|416 480-5882|catherine.birt@sunnybrook.ca|
20553008|NCT02299050|University of Texas Health San Antonio|Mariam Alatrach|210-358-7220|alatrach@uthscsa.edu|
20553009|NCT02822508|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20553010|NCT00654381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20553011|NCT03100825|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20553012|NCT00542750|Medical University of South Carolina|Kevin M. Gray, M.D.|8437920135|graykm@musc.edu|
20553013|NCT00994448|UCLA|Keith Heinzerling MD|310-794-0619|KHeinzerling@mednet.ucla.edu|
20553014|NCT02981381|VA Providence|Noah S. Philip MD|401-273-7100|noah.philip@va.gov|12369
20553015|NCT04164901|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
20553016|NCT00235872|Abbott|Global Medical Services|800-633-9110||
20553017|NCT02852265|University of California, Davis|Dr. Melissa Chen|916-734-6670|mejchen@ucdavis.edu|
20553018|NCT02432716|HealthPartners Neuroscience Research|Clinical Trial Manager|651-495-6363|maria.x.pyle@healthpartners.com|
20553019|NCT01800916|Coloplast A/S|Marian Sinvani|+45 49112356|dkmards@coloplast.com|
20553020|NCT00534235|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
20553021|NCT00151814|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20553022|NCT00937547|Instituto de Oncología Dr. Luis Razetti, Caracas Venezuela|Dr. Jorge Sánchez-Lander Corresponding Author|582129870165|animamotrix@live.com|
20553023|NCT01234467|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20553024|NCT00559962|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867||
20553025|NCT00792610|National Taiwan University Hospital|Jan, Chyi-Feng|886-2-23562147|jcf036@ntu.edu.tw|
20553026|NCT03047135|Johns Hopkins University|Catherine Handy Marshall, MD|410-955-0231|chm@jhmi.edu|
20553027|NCT02927457|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20553028|NCT03778931|Stemline Therapeutics, Inc.|Carlos A. Garay, MD, Senior Vice President, Clinical Development & Medical Affairs - Solid Tumors|+1-877-332-7967|clinicaltrials@menarinistemline.com|
20553029|NCT00915798|UC Irvine|Dr. Jean Gehricke|949-267-0404|jgehrick@uci.edu|
20567974|NCT00960206|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
20553030|NCT02130765|Abbott|Senior Clinical Research Scientist|6517562885|amber.miller@abbott.com|
20553031|NCT01764607|University of Florida|Priya K Gopalan|352-273-8699|gopalpk@ufl.edu|
20553032|NCT00167934|Washington University School of Medicine|Michael Yingling|573-579-1412|yinglingm@wustl.edu|
20553033|NCT04514991|University of Pennsylvania- Endodontic Department|Dr. Bekir Karabucak|2158984927|bekirk@upenn.edu|
20553034|NCT01537783|Brigham and Women's Hospital|Scott Weiner, MD, MPH|617-732-5640|sweiner@bwh.harvard.edu|
20553035|NCT03216850|University Hospital Hradec Kralove|Dr. David Astapenko|+420495833218|astapenko.d@seznam.cz|
20553036|NCT01116232|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|404-778-5984|zalkadh@emory.edu|
20553037|NCT00603746|GlaxoSmithKline|GSK Response Center|866-435-7343||
20553038|NCT05233566|Washington University School of Medicine|Dr. Bradley Fritz|3142733453|bafritz@wustl.edu|
20553039|NCT03664752|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20567975|NCT00507767|MD Anderson Cancer Center|Dr. Vassiliki Papadimitrakopoulou, Professor|713-792-6363|vpapadim@mdanderson.org|
20553040|NCT01524627|UPenn|Teresa R. Franklin, Ph.D.|215-746-1883|teresafr@mail.med.upenn.edu|
20553041|NCT00969553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20553042|NCT02469116|Washington University School of Medicine|David G. Mutch, M.D.|314-362-3181|mutchd@wustl.edu|
20553043|NCT01251588|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
20553044|NCT04248816|University of Pennsylvania|Dr. Shivan Mehta|215-898-6027|shivan.mehta@pennmedicine.upenn.edu|
20553045|NCT02357147|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20553046|NCT04399928|Smith & Nephew|Fleur Derdeyn, Clinical Study Manager|+32497602032|fleur.derdeyn@smith-nephew.com|
20553047|NCT05965349|University of Washington|Dr. Linda Ko|2066854978|lindako@uw.edu|
20553048|NCT03962543|SpringWorks Therapeutics, Inc.|Head of Clinical Operations|8772794870|clinical@springworkstx.com|
20553049|NCT05168475|Cambridge University Hospitals NHS Foundation Trust|Professor David Jayne|01223 336816|dj106@cam.ac.uk|
20553050|NCT01589822|Ethicon|Director of Clinical Development|1 908 218-2492|JBatill2@its.jnj.com|
20553051|NCT04482179|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
20553052|NCT01302964|Massachusetts General Hospital|Christopher J. McDougle, MD|781-860-1783|cmcdougle@mgh.harvard.edu|
20553053|NCT04718870|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20553054|NCT04127786|Sanofi Pasteur|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
20553055|NCT05124665|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
20553056|NCT03569371|Incyte Corporation|Incyte Corporation Call Center, Study Director|1-855-463-3463|medinfo@incyte.com|
20553057|NCT02347527|University of Colorado School of Medicine|Dr. Kristina Legget|3037245809|kristina.legget@cuanschutz.edu|
20553058|NCT00596011|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
20553059|NCT00934544|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20553060|NCT02643251|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
20553061|NCT02129075|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
20553062|NCT00348556|Mayo Clinic|Dr. Horng Chen|507-284-8846|chen.horng@mayo.edu|
20553063|NCT00240071|University of Alabama at Birmingham|Carla I Falkson|205-975-2691|cfalkson@uab.edu|
20553064|NCT01466270|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
20553065|NCT01944059|University Cincinnati Physicians Company|Vincent Martin, MD|513-558-7581|vincent.martin@uc.edu|
20553066|NCT02821962|University of Ottawa Heart Institute|Dr. Robert Reid|613-696-7393|breid@ottawaheart.ca|
20553067|NCT01818804|Aalborg University hospital|Salome Kristensen, MD. PhD|+45 97664015|sakr@rn.dk|
20553068|NCT02224872|Johns Hopkins University|Amy DeZern|4105027208|Adezern1@jhmi.edu|
20553069|NCT04206293|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20553070|NCT01400841|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
20553071|NCT01631474|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20553072|NCT01467076|Wayne State University|Beena Sood, M.D.|313-745-5638|bsood@med.wayne.edu|
20553073|NCT01691027|Kansas City VA Medical center|Health Scientist|816-861-4700|George.Timberlake@va.gov|52755
20553074|NCT05040152|The Ohio State University Comprehensive Cancer Center|Xiaochen Zhang|614-293-9600|xiaochen.zhang@osumc.edu|
20553075|NCT01188577|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
20553076|NCT06138756|Theranica|Dr Dagan Harris|+972-73-3703649|daganh@theranica.com|
20553077|NCT04476017|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20553078|NCT02075840|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20553079|NCT04063761|Attune Medical|Clinical Research Coordinator|888.534.4873|info@attune-medical.com|
20553080|NCT03795610|University of California, San Diego|Dr. Assuntina Sacco|(858) 822-6100|agsacco@health.ucsd.edu|
20553081|NCT02775344|Queen Mary Hospital|Dr Manwa Lui|22554647|ellenlui@hku.hk|
20553082|NCT04664998|University of Washington|Dr. Renee Heffron|2065203817|rheffron@uw.edu|
20553083|NCT03909165|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553084|NCT00414661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553085|NCT00654069|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
20553086|NCT00748956|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-659-9145|adriana.feder@mssm.edu|
20553087|NCT02561130|McMaster University|Natalia McInnes|905-521-2100|natalia.mcinnes@mcmaster.ca|
20553088|NCT00717769|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20553089|NCT01076504|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20567976|NCT01502813|University of Utah, Diagnostic Neuroimaging Lab|Deborah Yurgelun-Todd, Ph.D.|801-587-1538|Deborah.Yurgelun-Todd@hsc.utah.edu|
20553090|NCT02321462|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
20553091|NCT04425746|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
20553092|NCT01183169|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20567977|NCT00725959|Colorado School of Public Health|Dr. Sheana Bull|303-724-1238||
20567978|NCT02470806|Smith & Nephew, Inc.|Natasha Schappell, CCRP|817-302-3949|natasha.schappell@smith-nephew.com|
20567979|NCT03032198|Seno Medical, Inc.|Shaan Schaeffer|6106983259|sschaeffer@senomedical.com|
20567980|NCT00866619|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567981|NCT02934932|Duke University|Dr. Steven Szabo|919-681-8742|steven.szabo@duke.edu|
20567982|NCT02892019|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20567983|NCT01313663|GlaxoSmithKline|GSK Response Center|866-435-7343||
20567984|NCT02367794|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20567985|NCT02383043|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
20567986|NCT00946998|University of Texas Southwestern Medical Center|Susan Hedayati, MD, Professor of Medicine|214-645-6106|susan.hedayati@utsouthwestern.edu|
20567987|NCT01857362|Swedish Orphan Biovitrum|Dr Erik Brouwer, Medical Director|+4686972000|erik.brouwer@sobi.com|
20567988|NCT03833934|Addario Lung Cancer Medical Institute (ALCMI)|Ericka Izzo, Clinical Project Manager|941-713-1225|eizzo@alcmi.org|
20567989|NCT03239899|National Institutes of Health|Avindra Nath, MD|301-496-1561|avindra.nath@nih.gov|
20567990|NCT01020487|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20567991|NCT02802176|University of California, San Francisco|Marcelle Cedars, MD, Director, Division of Reproductive Endocrinology|(415) 353-7475|Marcelle.Cedars@ucsf.edu|
20567992|NCT01330953|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20567993|NCT00674609|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20567994|NCT01272388|Washington University School of Medicine|Brian R. Lindman, MD|314-747-3617|brlindman@wustl.edu|
20567995|NCT00234832|Abbott|Global Medical Services|800-633-9110||
20567996|NCT00538629|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20567997|NCT01107717|University of Texas Health Science Center at San Antonio|Muhammad Abdul-Ghani, MD|210-557-1157|abdulghani@uthscsa.edu|
20567998|NCT02301299|Northwestern University|Erin Wymore|3125033243|erin.wymore@northwestern.edu|
20567999|NCT03512041|Washington University School of Medicine|Catherine E Lang|314-286-1945|langc@wustl.edu|
20568000|NCT00555620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568001|NCT05203822|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20568002|NCT05361304|Johnson & Johnson Vision Care, Inc. (JJVC)|John R. Buch, OD, MS, FAAO|800-843-2020|jbuch@its.jnj.com|
20568003|NCT03320941|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20568004|NCT03360071|John Hopkins University School of Medicine|Jody Tversky, MD|410-550-2300|hoddin1@jhmi.edu|
20568005|NCT03490942|Xeris Pharmaceuticals|B J. Witkin|919-412-6483|bwitkin@xerispharma.com|
20568006|NCT01193283|NIH NHLBI|Dr. Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
20568007|NCT01383616|Hospital for Special Surgery|Brian Rebolledo, MD|212-606-1172|rebolledob@hss.edu|
20568008|NCT00896389|University of Maryland, Baltimore|Dr. Yen Pei Christy Chang|410-706-6737|cchang@som.umaryland.edu|
20568009|NCT03184519|IVIValencia|LAURA CARACENA (STUDY COORDINATOR)|034 963050900|laura.caracena@ivirma.com|
20568010|NCT01183013|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568011|NCT02043652|CDC|Alexande Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
20568012|NCT00584909|UAB|J. MIchael Straughn, MD|205-934-4986|Michael.Straughn@ccc.uab.edu|
20568013|NCT03262389|Mayo Clinic|Michael C. Roarke, M.D.|480-342-0988|Roarke.Michael@mayo.edu|
20568014|NCT02074709|University of Texas Southwestern Medical Center|Irina Gasanova|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
20568015|NCT02865083|Saint Louis University|Jennifer Goldkamp, MD|314-977-2574|jgolka2@slu.edu|
20568016|NCT02105688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568017|NCT01358175|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20568018|NCT00329771|Doylestown Hospital, Pennsylvania|Abraham A. Ashkenazi, M.D./Principal Investigator|215-625-2894|aashkenzai2001@yahoo.com|
20568019|NCT02469155|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20568020|NCT00901459|Duke Center for Nicotine and Smoking Cessation Research|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@mc.duke.edu|
20568021|NCT01597856|VA Connecticut/ Yale University|Christina Lazar|203-932-5711|Christina.Lazar@Yale.edu|4833
20568022|NCT00963105|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20568023|NCT01405508|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20568024|NCT02291549|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
20568025|NCT01180959|UT MD Anderson Cancer Center|Dr. Ahmed Kaseb, MD- Professor, GI Medical Oncology|(713) 792-2828|akaseb@mdanderson.org|
20568026|NCT00663819|CMU College of Medicine|Dr. Anthony Senagore|989-790-1001|anthony.senagore@cmich.edu|
20568027|NCT02138838|Amgen Inc.|Study Director|866-572-6436||
20568028|NCT00860457|Lombardi Comprehensive Cancer Center, Georgetown University Hospital|Dr. Bruce D. Cheson|202-444-7932|bdc4@georgetown.edu|
20568029|NCT02010684|University of California Los Angeles|Dr. Jeanne Miranda|310-794-3710|mirandaj@ucla.edu|
20568030|NCT04520321|Trefoil Therapeutics.com|Thomas M Tremblay, RN, BSN|4153053491|ttremblay@trefoiltherapeutics.com|
20568031|NCT01517282|MorphoSys|Roman Korolkiewicz|+49 89 89927 208|roman.korolkiewicz@morphosys.com|
20568032|NCT01884571|Emory University|Jonathan Glass, MD|404-727-3507|jglas03@emory.edu|
20568033|NCT01175980|Barbara Ann Karmanos Cancer Institute|Dr. Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
20568034|NCT03444298|University of North Carolina at Chapel Hill|Carole Robinette|919-966-5638|carole_robinette@med.unc.edu|
20568035|NCT01045057|Atos Medical AB|Director of Clinical Affairs|+1 352 870 0872|Corina.van.As@atosmedical.com|
20553093|NCT01514396|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
20553094|NCT00692770|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20553095|NCT04327986|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|udo.rudloff@nih.gov|
20553096|NCT02769702|Washington University School of Medicine|Richard Brasington MD|314-454-7255|rbrasing@wustl.edu|
20553097|NCT00834912|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20553098|NCT03044197|UTexasGalveston|Lori Simon|409-772-1978|lasimon@utmb.edu|
20553099|NCT04492891|Baylor College of Medicine|Michelle Almarez: Clinical Research Manager|713-798-3680|malmarez@bcm.edu|
20553100|NCT03829046|Icahn School of Medicine at Mount Sinai|Dr. Qinzhong Chen|212-659-8864|qinzhong.chen@mssm.edu|
20553101|NCT00262067|Genentech, Inc.|Medical Communications|800 821-8590||
20553102|NCT00816101|Sheftel Associates Dermatology, LLC|Scott Sheftel, MD|520-293-5757|ssheftel@sheftelderm.com|7106
20553103|NCT01399593|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
20553104|NCT02849548|Howard University|Ihori Kobayashi|202-865-7185|ihori.kobayashi@gmail.com|
20553105|NCT00714259|UAB|William Vaughan, MD|20-934-0066|liwilliams@uabmc.edu|
20553106|NCT00638885|Atlanta VAMC|J Douglas Bremner MD|404-712-9569|jdbremn@emory.edu|
20553107|NCT01140477|Bausch & Lomb, a division of Valeant Corporation|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
20553108|NCT01076985|Abbott|Global Medical Services|800-633-9110||
20553109|NCT03641378|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@mgb.org|
20553110|NCT01433107|Novartis|Clinical Project leader|+41223633111||
20553111|NCT01982253|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@takeda.com|
20553112|NCT03848845|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20553113|NCT02789176|University of Michigan|Stephanie Rau|734-232-8474|shatchew@med.umich.edu|
20553114|NCT05194020|Midwest Evaluation and Research|Dr. Matthew Shepherd|833-643-9377|matt.shepherd@midwestevaluation.com|
20553115|NCT00192075|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20553116|NCT00779675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553117|NCT01569529|University of Illinois at Chicago, Institute for Health Research and Policy|Dr. Robin Mermelstein|312 996-1469|robinm@uic.edu|
20553118|NCT02633956|Intercept Pharmaceuticals, Inc|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20553119|NCT03863210|University of Split School of Medicine|Dr. Slavica Jurić Petričević||slavica.juric01@gmail.com|
20553120|NCT05028374|Karmanos Cancer Institute|Dr. Jeffery Zonder|313-576-8732|zonderj@karmanos.org|
20553121|NCT03427658|Bournemouth University|Dr Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
20553122|NCT01956110|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20553123|NCT01857258|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
20553124|NCT01163604|jinling hospital|xinfeng Liu|025-84801861|xfliu2@vip.163.com|
20553125|NCT00742313|Duke University Medical Center|Terry Ainsworth, Director, Clinical Research Operations, Education & Training|919-681-7084|terry.ainsworth@duke.edu|
20553126|NCT03097653|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Paola Mosconi and Dr. Anna Roberto|+390239014503|donnainformata-mammografia@marionegri.it; paola.mosconi@marionegri.it|
20553127|NCT03325166|Oregon Health and Science University|Gerda Teglassy, MD|503-494-4526|tothg@ohsu.edu|
20553128|NCT00910715|UMC Ljubljana, Department of Infectious Diseases|Dr.Dasa Stupica|+386 1 522 2110|cerar.dasa@gmail.com|
20553129|NCT00706966|University of California San Francisco|Mack Roach, MD|415-353-9855|tdiep@radonc.ucsf.edu|
20553130|NCT03354429|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20553131|NCT00386256|VA Greater Los Angeles Healthcare System|Nancy Harada, PhD|310-268-3632|Nancy.Harada@va.gov|
20553132|NCT05923229|Washington University School of Medicine|Kerri Rawson|314-273-1053|rawson@wustl.edu|
20553133|NCT05288556|Cleveland Clinic|Eric Yudelevich Blumrosen, MD|216 445-6914|YUDELEE@ccf.org|56914
20553134|NCT02465528|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20553135|NCT01241903|University of Kentucky|Dr. Susan S. Smyth|(859) 323-2274|ssmyt2@uky.edu|
20553136|NCT03752619|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3623|rwilson@metrohealth.org|
20553137|NCT03907683|The Pennsylvania State University|Dr David E Conroy|814-863-3451|conroy@psu.edu|
20553138|NCT03400332|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20553139|NCT02027844|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Deagu, Repulic of Korea|Sun Mee Jung, M.D.|+82-53-620-3368|applejsm@gmail.com|
20553140|NCT00378014|Novartis Pharmaceuticals|Study Director|862-778-8300||
20553141|NCT01054703|Acclarent|Laura England, Manager-Clinical Research|650-687-4466|lenglan1@its.jnj.com|
20553142|NCT02662387|Loma Linda University Children's Hospital|Dr. Janeth Ejike|9095584000|jejike@llu.edu|44250
20553143|NCT03013543|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20553144|NCT00323414|Cleveland Clinic Foundation|Srinivasan Dasarathy MD|216-444-2766|dasaras@ccf.org|
20553145|NCT04087122|Valley Health|Rebekah Smith, RN, BSN|540-536-5547|rsmith3@valleyhealthlink.com|
20553146|NCT02552316|University of Pennsylvania|Junko Takeshita|215-349-5551|Junko.Takeshita@pennmedicine.upenn.edu|
20553147|NCT02659020|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20553148|NCT04382911|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20553149|NCT04521166|Northwestern University|Varsha Rallapalli|847-467-0897|varsha8904@gmail.com|
20553150|NCT02614547|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20553151|NCT00577083|Indiana University|Douglas K Rex, MD|317-948-8741|drex@iu.edu|
20553152|NCT01120210|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Translational Medicine|858.320.3408|wradzisz@its.jnj.com|
20568036|NCT01199302|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20568037|NCT04433091|Vanderbilt University Medical Center|M.Benjamin Shoemaker,MD MSCI|615-322-2318|moore.b.shoemaker@vumc.org|
20568038|NCT01730118|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20568039|NCT05379400|NYU Langone Health|Sharine Wittkopp|646-501-7733|Sharine.Wittkopp@nyulangone.org|
20568040|NCT02680314|Montefiore Medical Center|Peter Bernstein, MD|718-904-2767|pbernste@montefiore.org|
20568041|NCT02101554|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568042|NCT04049578|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20568043|NCT03409276|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20568044|NCT03605745|Boston Scientific|Kaitlyn Rainbow, Clinical Research Associate|952-930-6627|kat.rainbow@bsci.com|
20522745|NCT05244122|BrighamHospital|Jeremy Wolfe, Principle Investigator|617-851-1166|jwolfe@bwh.harvard.edu|
20568045|NCT04454125|University of Pittsburgh|Dr. Franziska Rosser|412-692-8429|franziska.rosser2@chp.edu|
20568046|NCT04694300|University of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD. Professor of Oral Surgery and Pharmacology|215-898-9686|evhersh@upenn.edu|
20568047|NCT01074437|Seattle childrens research institute|Jonathan Perkins, Prinicipal Investigator|206-987-1927|jonathan.perkins@seattlechildrens.org|
20568048|NCT03345407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20568049|NCT00547456|North Shore LIJ Health System|Rubin Cohen, MD|516-465-5400|rocohen@nshs.edu|
20568050|NCT02256553|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568051|NCT02092909|Idera Pharmaceuticals|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20568052|NCT03436797|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20568053|NCT04739306|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4190|keumyoung.ahn@celltrion.com|
20568054|NCT03651271|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
20568055|NCT00821093|Novartis Pharmaceuticals|Study Director|862 778-8300||
20568056|NCT02010021|Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
20568057|NCT00834483|Rush University Medical Center|Dr. Brett R. Levine|312-432-2466|brettlevine@gmail.com|
20568058|NCT05104242|University Hospitals of Derby & Burton NHS Foundation Trust, Royal Derby Hospital|Catherine Johnson|01332 789354|catherine.johnson16@nhs.net|
20568059|NCT01508117|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
20568060|NCT04930263|National Yang Ming Chiao Tung University|Mrs Cheng-Chen Chou|28267176|chou8278@gmail.com|
20568061|NCT02812706|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20568062|NCT02465632|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20568063|NCT04791917|University of Florida Department of Clinical and Health Psychology|Jeff Boissoneault, PhD|352-273-6200|jboissoneault@phhp.ufl.edu|
20568064|NCT00910871|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
20568065|NCT01989156|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20568066|NCT00850993|Mallinckrodt Pharmaceuticals|Medical Information Call Center|1-800-844-2830|clinicaltrials@mnk.com|5
20568067|NCT03839355|Mayo Clinic|Dr. Malini Madhavan|507-255-4152|Madhavan.Malini@mayo.edu|
20568068|NCT00349713|University of Bamako|Mahamadou A. Thera, MD, MPH, Professor|223-20-22-81-09|mthera@icermaili.org|
20568069|NCT05866887|Dana-Farber Cancer Institute|Maimouna Oumar|617-632-3000|maimouna_sy@dfci.harvard.edu|
20568070|NCT03816202|Integra LifeSciences|Andrew Tummon, Director, Global Clinical Trials|609-936-5490|andrew.tummon@integralife.com|
20568071|NCT04501614|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20568072|NCT02555397|Henry Ford Health System|Shyam Nyati|734-272-1751|snyati1@hfhs.org|
20568073|NCT04529941|Cedars-Sinai Medical Center|Dr. Peng-Sheng Chen|310-967-2707|Peng-Sheng.Chen@cshs.org|
20568074|NCT01240785|Department of Obstetrics and Gynecology, Turku University Central Hospital|Dr Kristiina Tertti|+358 2 3130000|kristiina.tertti@tyks.fi|
20568075|NCT00237809|Yale University|Dr. Deepak Cyril D'Souza|203-932-5711|deepak.dsouza@yale.edu|2594
20568076|NCT00872339|New England Research Institutes|Felicia Trachtenberg|6179723120|ftrachtenberg@neriscience.com|
20568077|NCT01107795|University of Alabama at Birmingham|Dr. Kirk Withrow|(205) 801-7874|kwithrow@uabmc.edu|
20568078|NCT02417376|GCD Indore|Dr Divya Singh Hada|+918720898289|dr_dshada@yahoo.com|
20568079|NCT01468597|Medical University of Graz|Elisabeth Mahla, MD|0043 316 385 13027|elisabeth.mahla@medunigraz.at|
20568080|NCT00091572|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20568081|NCT00267774|Stanford University|William F. Fearon, MD|650 725-2621|wfearon@stanford.edu|
20568082|NCT01078402|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20522746|NCT01216735|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
20522747|NCT01692626|West Virginia University|Mohammed Almubarak, MD, Assistant Professor|304-293-4229|malmubarak@hsc.wvu.edu|
20522748|NCT00855894|Genentech, Inc.|Medical Communications|800 821-8590||
20553153|NCT06219915|University of Michigan|Principle Investigator|734-998-8400|pchatkae@umich.edu|
20553154|NCT06105528|ProMIS Neurosciences, Inc.|Wendy Luca|617-250-0365|promisclinical@promisneurosciences.com|
20553155|NCT01077960|EMD Serono|EMD Serono Medical Information|1-888-ASK-SERO (275-7376)||
20553156|NCT05619692|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
20553157|NCT01246791|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
20553158|NCT04049760|Amicus Therapeutics, Inc.|Patient Advocacy|001 609-662-2000|clinicaltrials@amicusrx.com|
20553159|NCT02457598|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20568083|NCT03677986|Johns Hopkins University School of Medicine|Kenneth Silverman, Professor|4105502694|ksilverm@jhmi.edu|
20568084|NCT02332889|University of Louisville|Nancy Alsip|5028522905|nancy.alsip@louisville.edu|502
20568085|NCT01892007|NIHR Nottingham Biomedical Research Centre, University of Nottingham|Dr Helen Henshaw|+44 (0)115 8232606|helen.henshaw@nottingham.ac.uk|
20568086|NCT01634165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568087|NCT00635609|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20568088|NCT04097535|Imperial College London|Professor Eric Aboagye|02083833759|eric.aboagye@imperial.ac.uk|
20568089|NCT03016091|Davidoff Cancer Center at Rabin Medical Center|Shlomit Yust-Katz MD|92739378002|shlomit2@clalit.org.il|
20568090|NCT04520256|The Miriam Hospital|Dr. J. Graham Thomas|(401) 793-8154|jthomas4@brownhealth.org|
20568091|NCT05480410|Fundación Universitaria María Cano|Physiotherapy professor|+573206728934|catalinaloperamuneton@fumc.edu.co|
20568092|NCT05356130|Kaiser Permanente Center for Health Research|Greg Clarke, PhD|503-335-2400|greg.clarke@kpchr.org|
20568093|NCT04851587|University of Florida|Emily Bartley|352-273-8934|EBartley@dental.ufl.edu|
20568094|NCT02109172|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20568095|NCT02232009|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
20568096|NCT02169089|University Hospitals Cleveland Medical Center|Dr. Sanjay Rajagopalan|216-844-5191|Sanjay.Rajagopalan@uhhospitals.org|
20568097|NCT01309802|Southern Illinois University School of Medicine|Research Administrator|217-545-2531|surgeryresearch@siumed.edu|
20568098|NCT01816165|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicaresearchsupportcenter@ucdenver.edu|
20568099|NCT03960437|Columbia University|Thomas L.Nickolas, MD, MS|212-305-9847|tln2001@cumc.columbia.edu|
20568100|NCT03614923|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
20568101|NCT00113334|University of Texas (UT) MD Anderson Cancer Center|Edward Kim, MD, BS / Assistant Professor|713-792-6363|CR_Study_Registration@mdanderson.org|
20568102|NCT01882088|Federal research Center of Nutrition and Biotechnology|Dr Sergey Morozov, Senior Reseracher, Dpt Gastroenterology and Hepatology|+74996131091|morosoffsv@mail.ru|
20568103|NCT00125619|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|patten@phhp.ufl.edu|4160
20568104|NCT00830284|Boston Children's Hospital|John Kheir|6179194712|john.kheir@childrens.harvard.edu|
20568105|NCT01493947|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
20568106|NCT01189370|University of Kansas Cancer Center|Dr. Peter Van Velduizen|913-945-5059|SWILLIAM@kumc.edu|
20568107|NCT00065611|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
20568108|NCT01951105|Northwestern University|Apkar Vania Apkarian|312-503-0404|a-apkarian@northwestern.edu|
20568109|NCT04175392|Beaumont Hospitals|Kirsten Gage, CRM|947-521-8519|kirsten.gage@beaumont.org|
20568110|NCT02727998|Yale School of Medicine|Dr. Ilan Harpaz-Rotem|(203) 937-4760|ilan.harpaz-rotem@yale.edu|
20568111|NCT05072795|Medical University of South Carolina|Dr. Andreana Benitez|843-876-8479|benitez@musc.edu|
20568112|NCT00138645|Pennington Biomedical Research Center|Corby K. Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
20568113|NCT01601821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568114|NCT00212888|OHRI|Dr. Jonathan B Angel|613-737-8442|JANGEL@toh.ca|
20568115|NCT01901302|Cubist Pharamceuticals|Vice President Clinical Research|1.781.860.8660||
20568116|NCT00422162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568117|NCT05274906|Fred Hutchinson Cancer Center|Marian L. Neuhouser, Principal Investigator|206-667-4797|mneuhous@fredhutch.org|
20568118|NCT04463004|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-628-1215|antonio.abbate@vcuhealth.org|
20568119|NCT01532830|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
20568120|NCT01005914|Oregon Health & Science University|Dr. Brandon Hayes-Lattin|503-494-1551|hayeslat@ohsu.edu|
20568121|NCT01613599|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20568122|NCT00321555|National Cancer Institute|Dr. Robert Kreitman|301-648-7375|robert_kreitman@nih.gov|
20568123|NCT02066389|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20568124|NCT01755598|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20568125|NCT04016415|Milton S. Hershey Medical Center, Penn State Hershey College of Medicine|Dr. Nazia T Raja-Khan, M.D., M.S., Associate Prof, Dept of Medicine, Div. of Endocrin & Diabetes|717-531-8395|nrajakhan@pennstatehealth.psu.edu|
20568126|NCT00828178|Johns Hopkins University School of Medicine|Dr. Michelle Petri|410-955-9114|mpetri@jhmi.edu|
20568127|NCT02429115|Penn State College of Medicine - Penn State Health|Nasrollah Ghahramani|7175318156|nghahramani@pennstatehealth.psu.edu|
20568128|NCT02260154|Abbott|Tatiana V. Vladimirova MD, PhD|+7 495-258-4280|tatiana.vladimirova@abbott.com|
20568129|NCT02684435|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20568130|NCT02561195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568131|NCT01664806|University of Colorado School of Medicine|Dr. Thomas Robinson|303-724-2728|thomas.robinson@Ucdenver.edu|
20568132|NCT03905512|Selecta Biosciences, Inc.|Study Director|617-923-1400|ptraber@selectabio.com|
20568133|NCT03293238|Andrews Research & Education Foundation|Dr. Joshua Hackel|850-916-8796|jghackelmd@yahoo.com|
20568134|NCT04990388|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20568135|NCT03547167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568136|NCT00070317|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
20568137|NCT00736502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568138|NCT00645411|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20568139|NCT03560206|University of Kentucky|Misook Chung, PhD|(859) 323-8024|misook.chung@uky.edu|
20568140|NCT03100370|Rice University|Marcia O'Malley, PhD|713-348-3545|omalleym@rice.edu|
20568141|NCT05062343|Brigham and Women's Hospital|Sarah Little|6174557372|selittle@bwh.harvard.edu|
20568142|NCT01307800|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568143|NCT02674399|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
20568144|NCT02255474|The Ohio State University|Dr. Jeffrey Walline|614-247-6840|walline.1@osu.edu|
20522749|NCT03395288|Washington University|Jerry Lowder, MD|314-362-0063|lowderj@wustl.edu|
20522750|NCT01983566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568145|NCT02394912|Volcano|VP Clinical Trials|858-720-8731|jonathan.batiller@philips.com|
20568146|NCT01127737|Northwestern University|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
20568147|NCT00780741|Jaeb Center for Health Research|Ray Kraker, Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20568148|NCT00442507|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5740|dmorgens@dom.wustl.edu|
20568149|NCT01084772|Smith & Nephew, Inc.|Stuart Pratt|+1 (901) 497-0365|stuart.pratt@smith-nephew.com|
20568150|NCT01867307|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568151|NCT00835328|The Children's Hospital of Philadelphia|Diva D. Deleon, MD,MSCE|215-590-3420|deleon@email.chop.edu|
20568152|NCT01082159|Vertos Medical|VP Clinical Research|949-349-0008|cmyers@vertosmed.com|216
20568153|NCT02736175|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
20568154|NCT02009865|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
20568155|NCT03070301|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes, MD|646-888-4185|reidyd@mskcc.org|
20568156|NCT03154827|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
20568157|NCT00489489|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
20568158|NCT04206397|UC San Diego|Dr. Laura Case|858-246-4968|lcase@health.ucsd.edu|
20568159|NCT03978130|NYU Langone Health|John Dodson, MD|6465012714|john.dodson@nyulangone.org|
20568160|NCT03523897|Virtua Health|Dr. Jeremy Reid|8008967326|jreid@reconstructiveortho.com|
20568161|NCT02880293|Memorial Sloan Kettering Cancer Center|Dr. Brian Shaffer, MD|646-608-3737|shaffeb1@mskcc.org|
20568162|NCT04198428|HealthPartners Institute|Dr. Rebecca Rossom, Co-Principal Investigator|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
20522751|NCT02753920|Northwell Health|Marjorie Pilkinton|5166225114|mlpilk@gmail.com|
20568163|NCT04396860|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20568164|NCT03473665|Columbia University|Runsheng Wang|212-305-4308|rw2646@cumc.columbia.edu|
20568165|NCT00668746|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
20568166|NCT04179799|University of Florida|Emily Fox|352-273-6500|ejfox@phhp.ufl.edu|
20568167|NCT03696342|Medical Affairs Operations Chief|Dr. Alejandra Sanchez-Rios|33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
20568168|NCT02409732|Dartmouth-Hitchcock Medical Center|Dr. Michael Shane Chapman Section Chief of Dermatology|603-650-3106|Michael.Shane.Chapman@hitchcock.org|
20568169|NCT00553800|Hossein.Borghaei@fccc.edu|Hossein Borghaei|215-214-4297|Hossein.Borghaei@fccc.edu|
20568170|NCT01838499|AstraZeneca|Humphrey Gardner MD FCAP|+1 781 839 4523|Humphrey.Gardner@astrazeneca.com|
20568171|NCT01797705|DeVilbiss Healthcare|Jim Froehlich|814-443-7692|Jim.Froehlich@devilbisshc.com|
20568172|NCT01838447|Children's Hospital of Eastern Ontario|Katie O'Hearn, PICU Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
20568173|NCT01585597|Emory University|Christopher Horn|404 387 7320|cmhorn@emory.edu|
20568174|NCT00168805|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568175|NCT01114217|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20568176|NCT06247488|Azurity Pharmaceuticals, Inc.|Vice President of Clinical Development|(913) 389-7961|david.sequeira@azurity.com|
20568177|NCT00561678|Icahn School of Medicine at Mount Sinai|Dr. Stacie Deiner|212-241-7749|stacie.deiner@mountsinai.org|
20568178|NCT01103141|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
20568179|NCT00427297|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
20568180|NCT02741297|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
20568181|NCT00848198|TearLab, Inc.|Michael Berg, VP of Regulatory|858-795-6887|mberg@TearLab.com|
20568182|NCT02062827|The University of Alabama at Birmingham|James Markert, MD|(205) 934-7171|jmarkert@uabmc.edu|
20568183|NCT03708744|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
20568184|NCT02604199|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20568185|NCT03075449|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568186|NCT02342275|Sichuan University|Yi jJi|+86 02885423453|jijiyuanyuan@163.com|
20568187|NCT02100189|OHSU|John Hunter, MD|503-494-4937|hunterj@ohsu.edu|
20568188|NCT01357564|Center of Innovation on Disability and Rehabilitation Research, Department of Veterans Affairs; St. Catherine University, Department of Occupational Therapy|Dr. Paul Arthur|3176881499|pbarthur824@stkate.edu|
20568189|NCT04362176|Vanderbilt University Medical Center|Todd Rice, M.D., MSc|615-343-8010|vcc@vumc.org|
20568190|NCT01842360|Inmunotek S.L|Miguel Casanovas|34691490175|mcasanovas@inmunotek.com|
20568191|NCT05740371|Mitsubishi Tanabe Pharma GmbH|Clinical Trials, Information Desk|Please email|regulatory@mt-pharma-eu.com|
20568192|NCT02051972|Abbott Medical|Nicole Harbert|1-972-526-4841|nicole.harbert@abbott.com|
20568193|NCT03800602|Emory University|Olumide B. Gbolahan MBBS, MSc|404-778-0032|ogbolah@emory.edu|
20522752|NCT00181714|Massachusetts General Hospital|Paul Hammerness, MD|617-503-1063|phammerness@partners.org|
20568194|NCT00617708|SWOG|Study Statistician|206-667-4623||
20522753|NCT03437031|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
20568195|NCT02991456|Duke University|James Herndon II, Ph.D.|919-668-8145|james.herndon@duke.edu|
20568196|NCT01699178|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
20522754|NCT02794870|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20568197|NCT04407442|University of California, San Francisco|Dr. Alfred Chung|(415) 353-2421|Alfred.Chung@ucsf.edu|
20568198|NCT02907489|Cairo university|Mohamed Omaia Ahmed|00201224474609|mohamed.omaia@dentistry.cu.edu.eg|
20568199|NCT00762853|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
20568200|NCT01885559|Mayo Clinic|Dr. Vicente Torres||torres.vicente@mayo.edu|
20568201|NCT02502019|Biom'Up|Dr. William Spotnitz, Chief Medical Officer|352-514-5009|wspotnitz@gmail.com|
20568202|NCT03987074|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20568203|NCT00508144|The University of Texas (UT) MD Anderson Cancer Center|Ralph Zinner, MD/Thoracic & Head and Neck Medicine|713-792-7734|CR_Study_Registration@mdanderson.org|
20568204|NCT00525915|University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
20568205|NCT00424502|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20568206|NCT02135445|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20522755|NCT06376682|quantum surgical|MESSNER Laetitia, Chief Clinical officer|+33 (0) 4 48 19 40 50|clinical.department@quantumsurgical.com|
20568207|NCT03820024|UNC Lineberger|Leslie Clark|919-966-5996|leslie_Clark@med.unc.edu|
20568208|NCT03556891|Valencia Technologies|Jackie Dister|7604294787|jdister@valenciatechnologies.com|
20568209|NCT02004132|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568210|NCT00729053|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20568211|NCT00282828|Rush University Medical Center|Mark Pollack, M.D.|312-942-5372|mark_pollack@rush.edu|
20568212|NCT06091982|National Cardivascular Center Harapan Kita|Prieta Adriane MD|+62 21 5684093|prietaadriane@gmail.com|7406
20568213|NCT05349123|Mayo Clinic|Roberto P Benzo|507-284-0561|benzo.roberto@mayo.edu|
20568214|NCT00612716|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
20568215|NCT02136797|Memorial Sloan Kettering Cancer Center|Dr. Kevin Curran, MD|212-639-5836|currank@mskcc.org|
20568216|NCT04523571|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20568217|NCT03782545|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20568218|NCT02123797|Baptist Cancer Center|Dr. Raymond Osarogiagbon|901-752-6131|Raymond.Osarogiagbon@bmg.md|
20568219|NCT05030467|Brigham and Women's Hospial|Niteesh Choudhry|617-278-0930|nkchoudhry@bwh.harvard.edu|
20568220|NCT05878990|Hackensack Meridian Health|Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN|2018803443|lisa.carterbawa@hmh-cdi.org|
20568221|NCT01933776|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20568222|NCT02011568|University of Ottawa Heart Institute|Dr Michel Le May|613-696-7000|mlemay@ottawaheart.ca|14646
20568223|NCT03344458|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ads@ascendispharma.com|
20568224|NCT00396409|Novartis Pharmaceuticals|Study Director|862-778-8300||
20568225|NCT00331799|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
20522756|NCT01625988|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568226|NCT02889809|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20568227|NCT04203199|Wake Forest University Health Sciences|Colleen Hanlon, PhD|844-386-7001|DeepTMS@brainsway.com|
20568228|NCT00113880|MedImmune, LLC|Chris Ambrose, MD, Sr Director, Medical Affairs|301-398-0000|ambrosec@medimmune.com|
20568229|NCT02630147|University of Sherbrooke Hospital Research Center, QC, Canada|Dr Jean-Paul Praud|819-346-1110|jean-paul.praud@usherbrooke.ca|14851
20568230|NCT01634620|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
20568231|NCT01537900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568232|NCT03314233|Childrens Hospital of Philadelphia|Dr. Elizabeth Foglia|215-590-1653|foglia@email.chop.edu|
20568233|NCT02030847|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
20568234|NCT02186587|University of Missouri - Department of Orthopaedic Surgery|Sonny B. Bal, MD, PI|573-882-6762|BalB@health.missouri.edu|
20568235|NCT03785210|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|gretentf@mail.nih.gov|
20568236|NCT00460434|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20568237|NCT00641797|Lehigh Valley Health Network|Regina Sacco, DPT, BA, BHSC|610-969-0300|Regina_R.Sacco@lvhn.org|
20568238|NCT00510783|Emory|Brittney Copeland|404-616-0301|bcopel3@emory.edu|
20568239|NCT00316121|Advanced Technologies and Regenerative Medicine, LLC|Manny Lazaro, Director, Clinical Affairs|508-828-2741|mlazaro@its.jnj.com|
20568240|NCT01318356|Radboud university medical center|S.P. Keijmel, MD PhD|0031243611111|stephan.keijmel@radboudumc.nl|
20568241|NCT01979211|University of Cincinnati Cancer Center|Vinita Takiar, Associate Professor, MD|513-584-4775|vinita.takiar@uc.edu|
20568242|NCT01648491|Beaumont Hospital - Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.org|
20568243|NCT00460577|Novartis Pharmaceuticals|Study Director|862-778-8300||
20568244|NCT04374435|University of California, Irvine|Anand Ganesan, MD, Professor|949-824-0606|aganesan@uci.edu|
20568245|NCT02632045|Columbia University|Melissa Accordino, MD|212-342-5162|mkg2134@cumc.columbia.edu|
20568246|NCT05878522|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568247|NCT04551053|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20568248|NCT02971683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20568249|NCT04206501|University of Rochester Medical Center|Spencer Z. Rosero, M.D.|5852752756|spencer_rosero@urmc.rochester.edu|
20568250|NCT02091102|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20568251|NCT01158716|Cardiovasular RS|Theodoros Zografos|+306956161001|theodoroszografos@gmail.com|
20568252|NCT03503188|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568253|NCT02993926|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20568254|NCT05777772|University of Washington|Dr. Elizabeth Phelan|(206) 520-5000|phelane@uw.edu|
20568255|NCT04604899|jCyte, Inc.|Chief Strategy Officer|9492430687|media@jcyte.com|
20568256|NCT00732498|University of Arizona|NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
20568257|NCT03000829|Intermountain Health|Dr. Ithan Peltan|801-507-6556|ithan.peltan@imail.org|
20568258|NCT03394508|Karolinska Institutet|Jon Konradsen|+46704242058|jon.konradsen@ki.se|
20568259|NCT00267865|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|yarchoar@nih.gov|
20568260|NCT03458416|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
20568261|NCT00083122|Mayo Clinic Cancer Center|Keith C. Bible, M.D, Ph.D.||Bible.Keith@mayo.edu|
20568262|NCT04295499|Unicon Optical Co., Ltd.|Dr. Jimmy Chou|+88635775586|ra@uniconvision.com.tw|1307
20568263|NCT03122548|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
20568264|NCT00308113|University of Pittsburgh|Dr. Paula R. Clemens|412-648-9762|pclemens@pitt.edu|
20568265|NCT02819141|Mayo Clinic|Dr. Linda L. Chlan, Professor of Nursing|507-255-7859|chlan.linda@mayo.edu|
20568266|NCT05492786|Geisinger health|Gail Rosenbaum|570-243-1199|grosenbaum@geisinger.edu|
20568267|NCT01613807|Sansum Diabetes Research Institute|Dr. Kristin Castorino|8056827640|kcastorino@sansum.org|256
20568268|NCT00676195|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
20568269|NCT01184859|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20568270|NCT00961298|Allegheny General Hospital|Alicia Kaplan MD|412-330-4069|akaplan@wpahs.org|
20568271|NCT02388932|Cleveland Clinic, Case Comprehensive Cancer Center|Shlomo Koyfman, MD|216-444-7552|koyfmas@ccf.org|
20568272|NCT04588246|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20568273|NCT05927753|Bruno Vision|Richard E Lippman|301-580-3931|richard.lippman@gmail.com|
20568274|NCT02132598|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
20568275|NCT00627523|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568276|NCT00406276|Emory University|Dr.Suresh Ramalingam, MD|404-778-5378|ssramal@emory.edu|
20568277|NCT01038128|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
20568278|NCT00984334|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
20568279|NCT01136733|Eisai Medical Inc.|Eisai Medical Services|1-888-422-4743||
20568280|NCT01745380|University of Pennsylvania School of Dental Medicine|Elliott V. Hersh, Principal Investigator|215-898-9686|evhersh@pobox.upenn.edu|
20568281|NCT02186015|Loyola University Chicago|Patricia Sheean|708-216-0344|psheean1@luc.edu|
20568282|NCT02368691|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
20568283|NCT03863184|Weill Cornell Medicine|Jia Ruan, MD, PhD|646-962-2064|jruan@med.cornell.edu|
20568284|NCT02069366|Wayne State University|Dr. Christine Rabinak|(313) 577-9875|rabinak@wayne.edu|
20568285|NCT01533181|H. Lee Moffitt Cancer Center and Research Institute|Dr. Alberto Chiappori|813-745-2158|alberto.chiappori@moffitt.org|
20568286|NCT01837719|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20568287|NCT01703988|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20568288|NCT04468633|Duke University|Andrew Gross, MD|919-684-8656|andrew.gross@duke.edu|
20568289|NCT02722278|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
20568290|NCT01403805|Department of Dentistry, Yubari Kibounomori, Japan|Dr. Masahiro Hatta|+81-123-52-4339|masahiro.hatta@hotmail.co.jp|
20568291|NCT00815347|University of Connecticut Health Center|MArk Metersky, MD|860-679-3582|metersky@nso.uchc.edu|
20568292|NCT00724750|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
20568293|NCT02213458|University of California, San Francisco|Dr. Katherine Possin|(415) 476-1889|katherine.possin@ucsf.edu|
20568294|NCT04043806|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20568295|NCT01622088|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
20568296|NCT05607147|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|7328247241|subramga@sdm.rutgers.edu|
20568297|NCT02499497|Brigham and Women's hospital|Dr. Shalender Bhasin, Principal Investigator|617 525 9150|sbhasin@bwh.harvard.edu|
20568298|NCT01721109|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
20568299|NCT03045302|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
20568300|NCT00134056|University of Southern California Norris Comprehensive Cancer Center|Dr. David I Quinn|3238653956|diquinn@med.usc.edu|
20568301|NCT03166215|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20568302|NCT02035345|Massachusetts General Hospital|Dr. Aleena Banerji|6177263850|abanerji@mgh.harvard.edu|
20568303|NCT00742560|AbbVie|Global Medical Services|800-633-9110||
20568304|NCT02438410|Mayo Clinic|Dr. Darrell Pardi|(507) 538-1827|pardi.darrell@mayo.edu|
20568305|NCT04985604|Day One Biopharmaceuticals, Inc.|Study Director|1-650-484-0899|clinicaltrials@dayonebio.com|
20568306|NCT04598776|CeraRoot CLINIC|Dr. Josep Oliva-Ochoa. Director of Clinical Trials|+34 935950247|josep.oliva@cerarootclinic.com|
20568307|NCT00348283|Abbott|Medical Information Specialist|800-633-9110||
20568308|NCT04453709|University of Massachusetts Amherst|Kalpana Poudel-Tandukar, Associate Professor|413-545-5095|kalpana@umass.edu|
20568309|NCT02282761|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20568310|NCT00515281|University of Chicago|Michael D. Schreiber, MD|773-702-6205|mschreiber@bsd.uchicago.edu|
20568311|NCT00658632|Eisai Inc.|Eisai Medical Services|888-422-4743||
20568312|NCT03590847|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
20568313|NCT06312566|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20568314|NCT03747575|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20568315|NCT02423447|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
20568316|NCT03010878|Colorado State University|Dr. Arlene Schmid|9704917562|arlene.schmid@colostate.edu|
20568317|NCT05615870|University of Arkansas for Medical Sciences|Jing Jin|501-214-2236|JJin@UAMS.edu|
20568318|NCT02130401|Scion NeuroStim|Dr. Robert Black|(919) 260-5528|bacllc@earthlink.net|
20568319|NCT03163472|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
20568320|NCT00927849|Mansoura university hospital|ayman elnakeeb|0020106752021|elnakeebayman@yahoo.com|
20568321|NCT01549951|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
20568322|NCT03266419|Asan Medical Center|Dr. Byung-Moon Choi|82-2-3010-1704|byungmoonchoi7@gmail.com|
20568323|NCT00738400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20568324|NCT01542502|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@vcu.edu|
20568325|NCT00990314|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
20568326|NCT01760876|Queen Mary Hospital,University of Hong kong|Prof. Stephen Wai-luen LEE|(852) 22555409 or 28181314|prof.stephenlee@gmail.com ; kongsl@hku.hk|
20568327|NCT02168855|University of Arkansas|Dr. Brian Primack|479-575-3208|bprimack@uark.edu|
20522757|NCT00616421|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
20568328|NCT03584282|University of Washington|Dr. Joanne Stekler, Primary Investigator|(206) 744-8312|jstekler@uw.edu|
20568329|NCT00604461|H. Lee Moffitt Cancer Center and Research Institute|Tawee Tanvetyanon, M.D.|813-745-3050|tawee.tanvetyanon@moffitt.org|
20568330|NCT03689452|Icahn School of Medicine at Mount Sinai|Dr. Danielle P. Dubin|212-731-3311|DPDubin121@gmail.com|
20568331|NCT02676778|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
20568332|NCT04992494|NYU Langone Health|Amanda Shallcross|646-501-3426|Amanda.Shallcross@nyulangone.org|
20568333|NCT01430299|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
20568334|NCT06466655|University of Delaware|Jody Greaney, PhD|3028312193|jgreaney@udel.edu|
20568335|NCT03686176|Johns Hopkins University|Therese Canares|4109964711|tcanare1@jhmi.edu|
20568336|NCT00515879|Boston University|Dr. Stefan G. Hofmann, Ph.D., Professor of Psychology|617 353 9233|shofmann@bu.edu|
20568337|NCT01154699|University of California San Diego|Robert L. Owens|8586575258|rowens@ucsd.edu|
20568338|NCT01612221|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
20568339|NCT04413149|Peking Union Medical College Hospital|Dr. Shi Juhong|+86-13701178492|Shijh@pumch.cn|
20568340|NCT01044901|The University of Chicago|Dr. Amit Patel, MD|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
20568341|NCT02878590|InnoMed Healthscience|Javier Collazo|9547739656|jcollazo@innomedhs.com|
20568342|NCT02661490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20568343|NCT03322514|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
20568344|NCT00814632|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
20568345|NCT02514577|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
20568346|NCT00409006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568347|NCT01742949|Hopital Bichat-Claude Bernard|Dr Marie-Pia D'Ortho|+33140258080|marie-pia.dortho@bch.aphp.fr|
20568348|NCT03050372|Medical University of South Carolina|Thomas W. Uhde, M.D.|843-792-0028|uhde@musc.edu|
20568349|NCT01093976|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
20568350|NCT00376935|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20568351|NCT03602053|PATH|Dr Niraj Rathi, MD; Senior Medical Officer|+91 11 4064 0000|nrathi@path.org|
20568352|NCT01234675|Cleveland Sleep Research Center|Mansoor Ahmed, MD|4402438044|sleepresearchcenter@yahoo.com|
20568353|NCT05065918|The University of Arkansas for Medical Sciences|Jocelyn Anderson|501-686-7712|andersonjocelyn@uams.edu|
20568354|NCT03149887|UPittsburgh|Dr. Steven L. Orebaugh|412-877-5832|orebaughsl@anes.upmc.edu|
20568355|NCT01107353|Roxane Laboratories, Inc.|Anton (Tony) Amann, PhD., Executive Director, DRAMA|614-272-4785|tony.amann@boehringer-ingelheim.com|
20568356|NCT02660034|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20568357|NCT02333071|AMAG Pharmaceuticals|Medical Information|1-877-411-2510|amag@druginfo.com|
20568358|NCT02995733|Brigham and Women's Hospital|Dr. Elliot Israel|617-732-8110|eisrael@bwh.harvard.edu|
20568359|NCT02795819|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|877-462-7739|AskMassey@vcu.edu|
20568360|NCT02720198|Duke University Medical Center|Dr. Narei Hong|984-215-8493|narei.hong@duke.edu|
20568361|NCT04879823|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|4126926874|shafferad@upmc.edu|
20522758|NCT01495702|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20568362|NCT03897075|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
20568363|NCT01498445|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
20568364|NCT02465866|Charleston Laboratories, Inc|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
20568365|NCT02023099|AbbVie|Global Medical Services|800-633-9110||
20568366|NCT00203502|University of Arkansas for Medical Sciences|Dr. Issam Makhoul|5016868274|MakhoulIssam@uams.edu|
20568367|NCT02592434|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568368|NCT01469819|Texas Tech University Health Sciences Center El Paso|Dr. Irene Sarosiek|(915)215-5254|irene.sarosiek@ttuhsc.edu|
20568369|NCT03082196|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-251-6831|drmilgrom@silverarrest.com|
20568370|NCT01695993|University of Rochester Medical Center|Joseph A. Roscoe, PhD Associate Research Professor|585 275-9962|joseph_roscoe@urmc.rochester.edu|
20568371|NCT00147745|Daiichi Sankyo, Inc|John Raia, Senior Director, Professional Affairs|(973) 944-2683|jraia@dsi.com|
20568372|NCT03912298|University of Pennsylvania|Peggy Compton|2158986679|pcompton@nursing.upenn.edu|
20568373|NCT00385697|Provention Bio, Inc|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
20568374|NCT02305797|Cardinal Health Regulatory Sciences|Director of Regulatory Affairs and Product Development|913.451.3955|david.rhein@cardinalhealth.com|
20568375|NCT01368874|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20568376|NCT02732899|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
20568377|NCT02790788|National and Kapodistrian University of Athens|Associate Professor in Intensive Care Medicine|00302132043307|sdmentzelopoulos@yahoo.com|
20568378|NCT01648699|Janssen Philippines|Medical Affairs Manager|+632-8248935||
20568379|NCT01536795|Institut Pasteur, Tunisia|Afif Ben Salah, MD|011-216-71-792-429|afif.bensalah@pateur.rns.tn|
20568380|NCT02267746|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
20568381|NCT01812837|UC Davis|Dr. Raja Sivamani|9167035145|rksivamani@ucdavis.edu|
20568382|NCT03720717|University of Alabama at Birmingham|Timothy J Ness MD PhD, Professor Emeritus|2059079743|tness@uabmc.edu|
20568383|NCT05008224|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20568384|NCT05234632|Smith & Nephew, Inc.|Dr Rochelle O'Hara|+44 1923 477218|Rochelle.OHara@smith-nephew.com|
20568385|NCT05263492|Virginia Commonwealth University Massey Cancer Center|Massey IIT Research Operations|804-628-6430|masseyepd@vcu.edu|
20568386|NCT03680092|University of California, San Diego|Dr. Dimitrios Tzachanis|(858) 822-6600|dtzachanis@health.ucsd.edu|
20568387|NCT03345420|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov/CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
20568388|NCT05216835|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20568389|NCT05179603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20568390|NCT03861078|Virginia Commonwealth University|Alison Breland|804 628 2300|abbrelan@vcu.edu|
20568391|NCT01075815|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20568392|NCT00596960|VAMC|Eric Dieperink, MD|612-467-3964|eric.dieperink@va.gov|
20568393|NCT02058992|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20568394|NCT01292005|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-2175|vege.santhi@mayo.edu|
20568395|NCT02924051|University of Kentucky|Dr. Frances Hardin-Fanning|(859) 257-4866|fdbowe2@uky.edu|
20568396|NCT01229527|Department of Anesthesia and Intensive Care|Dr. Massimo Agostoni|+39.02.2643.2656|agostoni.massimo@hsr.it|
20568397|NCT02916745|on behalf of Concordia Laboratories Inc./Advanz Pharma|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
20568398|NCT00914732|Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|sharon.frey@health.slu.edu|
20568399|NCT03005106|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
20568400|NCT01855399|VA HSRD: CCMR Ann Arbor and University of Michigan Medical School|Dr. Michele Heisler|(734) 845-3614|mheisler@umich.edu|
20568401|NCT00321672|NeurogesX|Trudy Vanhove, VP Clinical Development|650-393-7444|tvanhove@neurogesx.com|
20568402|NCT00512902|University of California at Los Angeles|Dr. Daniel Furst, Carl M Pearson Professor of Rheumatology|310-794-9504|defurst@mednet.ucla.edu|
20568403|NCT03019289|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
20568404|NCT00936065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568405|NCT04313985|Stanford University|Geoffrey Gurtner|(520) 626-2222|gurtner@surgery.arizona.edu|
20568406|NCT01052714|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
20568407|NCT02704156|Changhai Hospital affiliated to Naval Medical University|Huojun Zhang|86-021-31162207|chyyzhj@163.com|
20568408|NCT01288729|Stanford Childrens Health|Bruce Buckingham|650725-6549|buckingham@stanford.edu|
20568409|NCT03214198|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20568410|NCT03282071|The University of Hong Kong|Dr. Yuying Sun|(852)39179144|gyysun@hku.hk|
20568411|NCT04448561|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20568412|NCT01178281|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20568413|NCT01232569|Hoffmann-La Roche|Medical Communications|800 821-8590||
20568414|NCT02956122|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20568415|NCT02652390|Hässleholm Hospital, Hässleholm, Sweden|Dr. Isam Atroshi|+46443091260|Isam.Atroshi@skane.se|
20568416|NCT00392704|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20568417|NCT05335005|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568418|NCT01862614|The Ohio State University College of Dentistry|Dr. John Nusstein, Professor|614-292-3596|nusstein.1@osu.edu|
20568419|NCT04441996|Emory University|Cheryl Maier MD, PhD|404-712-2795|cheryl.maier@emory.edu|
20568420|NCT00678899|Cochlear Americas|Ginger Grant/Clinical Project Manager|410-375-0883|ggrant@cochlear.com|
20568421|NCT01769352|Johns Hopkins University School of Medicine|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
20568422|NCT05129592|Johns Hopkins Bloomberg School of Public Health|Caitlin Weiger|3017128357|cweiger2@jhmi.edu|
20568423|NCT04203225|Harbor-UCLA Medical Center|Kelly D. Young, MD|424-306-5431|kyoung3@dhs.lacounty.gov|
20506984|NCT01737840|Akdeniz University|Cenker Eken|00905321593948|cenkereken@akdeniz.edu.tr|
20506985|NCT02118610|Maryland Psychiatric Research Center|Ann Kearns, MS|4104066854|akearns@som.umaryland.edu|
20506986|NCT03105700|Dartmouth Hitchcock Medical Center|Krzysztof Bujarski, MD|6036505000|krzysztof.a.bujarski@hitchcock.org|
20506987|NCT02768194|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506988|NCT00242385|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20506989|NCT03089216|Federal University of Goias|Dr. Terezinha de Jesus Esteves Barata|+55 62 3209-6325|terezinhabarata@yahoo.com.br|
20506990|NCT03095521|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
20506991|NCT01536119|University of Toronto|Jennifer Abbass Dick||jennifer.abbass@mail.utoronto.ca|
20506992|NCT03521193|Centro Cardiologico Monzino, IRCCS|Clinical Trials' Office Chief|+390258002|alessandra.terragni@ccfm.it|675
20506993|NCT01810042|Pusan National University Hospital|Ji Eun Lee|+82-51-240-7957|jlee@pusan.ac.kr|
20506994|NCT01208038|Chelsea and Westminster NHS Trust|Dr Kate Maclaran|020 3315 3000|kate.maclaran@nhs.net|
20506995|NCT01454401|Reapplix Blokken 45 3460 Birkerød Denmark|MD, PhD Senior Consultant Magnus Löndahl||magnus.londahl@med.lu.se|
20506996|NCT04614545|The Cleveland Clinic Foundation|Dr. Marcio Griebeler|216.444.6568|jenkink@ccf.org|
20522759|NCT01427608|Weill Cornell Medicine|Dr. George S. Alexopoulos|(914) 997-5767|gsalexop@med.cornell.edu|
20522760|NCT02422797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20553160|NCT03837899|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20553161|NCT00974571|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568424|NCT03672188|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20568425|NCT03997409|Vanderbilt University Medical Center|Dr. Sara Duffus|+1 (615)322-7427|sara.duffus@vumc.org|
20568426|NCT01753323|Novartis Pharmaceuticals|Study Director|862-778-8300||
20568427|NCT02115542|Moffitt Cancer Center|Richard Kim, MD|813-745-1432|Richard.Kim@moffitt.org|
20568428|NCT01870999|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800-562-3974||
20568429|NCT01636258|The Cleveland Clinic|Adam M. Bernstein MD|216-448-8538|bernsta2@ccf.org|
20568430|NCT03416335|Sumitomo Pharma America|Reyna Bishop|617-674-6800|reyna.bishop@us.sumitomo-pharma.com|
20568431|NCT00116584|ULouisville|Dr. In Kim|502-629-7212|in.kim@louisville.edu|
20568432|NCT03034772|Wills Eye Physicians, Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
20568433|NCT03327051|Stanford University|Aida Habtezion|650-736-5555|aidah@stanford.edu|
20568434|NCT02798861|University of Pittsburgh|Andres Duarte-Rojo|412-647-7922|duarterojoa@pitt.edu|
20568435|NCT01843920|Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
20568436|NCT04117711|Applied Therapeutics, Inc|Riccardo Perfetti, MD|2122209226|rperfetti@appliedtherapeutics.com|
20568437|NCT04057937|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20568438|NCT02029521|Intermountain Healthcare|Clark Bishop|385 224 7343|clark.bishop@imail.org|
20568439|NCT01072396|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568440|NCT00472199|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568441|NCT01540071|Io Therapeutics, Inc.|Martin E. Sanders, M.D.|(650) 219-5973|msanders@io-therapeutics.com|
20568442|NCT02446912|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20568443|NCT01268488|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|914-333-6280|carmine.greene@ascensia.com|
20568444|NCT00828542|Sao Paulo University|Dr. Milena Bastos Brito|551636022814|milenabastos@usp.br|
20568445|NCT01106586|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20568446|NCT01757171|Weill Cornell Medical College|Navjot Kaur, GI Program Manager|646-962-9350|nak2028@med.cornell.edu|
20568447|NCT00103116|UKentucky|Edward Hirschowitz|8596081981|eahirs2@uky.edu|
20568448|NCT00105521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20568449|NCT00094497|University Hospital of Wuerzburg, Germany|Martin Fassnacht|+49-931-201-39021|fassnacht_m@ukw.de|
20568450|NCT00442559|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568451|NCT03906240|VISN 17 Center of Excellence for Research on Returning War Veterans|Dr. Adam McGuire|254-297-5173|adam.mcguire@va.gov|
20568452|NCT02713698|Centro Hospitalar do Porto|Ana Maria Araujo|22 2077549|amfariaaraujo@gmail.com|1280
20568453|NCT03287947|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
20568454|NCT02815709|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20568455|NCT03317288|UT Southwestern Medical Center|Dr. Yi-Ting Tzen|2146481786|Yi-Ting.Tzen@UTSouthwestern.edu|
20553162|NCT01589302|The Ohio State University Comprehensive Cancer Center|Kami Maddocks, MD|614-293-3507|Kami.Maddocks@osumc.edu|
20553163|NCT02703636|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20553164|NCT00868621|Cleveland Clinic Florida|Gamal M. Ghoniem, MD, FACS|954-659-5188|ghonieg@ccf.org|
20553165|NCT02016963|Human Genome Sciences Inc.|GSK Response Center|866-435-7343||
20553166|NCT00384813|Emory University School of Medicine|Marianne Celano, PhD, ABPP|404-778-1536|mcelano@emory.edu|
20568456|NCT01132378|Heekin Institute for Orthopaedic Research|R. David Heekin MD, FACS|904-634-0640|drheekin@heekinortho.com|
20568457|NCT00538616|Duke University|Dr. Carmelo Graffagnino|919/681-3751|Carmelo.Graffagnino@duke.edu|
20568458|NCT01591655|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20568459|NCT02032420|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu|
20568460|NCT01426217|Dartmouth-Hitchcock Medical Center|Randy Loftus, MD|(603) 650-6177|Randy.W.Loftus@hitchcock.org|
20568461|NCT03023878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20506997|NCT04552535|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20506998|NCT00430521|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20506999|NCT05108805|Vanderbilt University Medical Center|Dr. Olalekan Oluwole|(615) 936-8422|olalekan.oluwole@vumc.org|
20507000|NCT02198651|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20507001|NCT00369746|New York State Psychiatric Institute|Patrick J. McGrath, M.D.|646-774-8076|mcgrath@nyspi.columbia.edu|
20507002|NCT00961662|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
20507003|NCT01042613|St. Jude Children's Research Hospital|Luis Trujillo Huaccho, MD|1-866-278-5833|info@stjude.org|
20507004|NCT00333619|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|cathy.alessi@va.gov|
20507005|NCT03379506|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507006|NCT03006471|INSITITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20507007|NCT05283863|Case Western Reserve University|Jennifer Sweet, MD|216-844-3192|Jennifer.Sweet@UHhospitals.org|
20507008|NCT01120379|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
20507009|NCT03162055|AstraZeneca|Vice President, Inhalation and Oral Respiratory|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20507010|NCT04031404|University of North Carolina at Chapel Hill|Rachel B. Force, PhD|9199669929|rachel_force@med.unc.edu|
20507011|NCT03235817|Anesthesiology|T. Wesley Templeton, MD|336-716-4498|ttemplet@wakehealth.edu|
20507012|NCT02282982|AbbVie|Global Medical Services|800-633-9110||
20507013|NCT00734734|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
20507014|NCT01295580|Bioventus, LLC|Director, Regulatory and Clinical Affairs|1-800-396-4325||
20507015|NCT04032171|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20507016|NCT01742078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20522761|NCT04071405|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522762|NCT05044195|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20522763|NCT02292940|Northern California Kaiser Permanente, Division of Research|Mary Reed, DrPH|510-891-3808|Mary.E.Reed@kp.org|
20522764|NCT03450473|Washington University School of Medicine in St. Louis|Dr. Grant Bochicchio|314-362-9347|gbochicchio@wustl.edu|
20522765|NCT01937871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20522766|NCT03154125|FHI 360|Vera Halpern, M.D., Director of Clinical Development|+1 (919) 321-3331|VHalpern@fhi360.org|3117
20522767|NCT00810511|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20522768|NCT00462904|University of Texas Southwestern Medical Center|Joseph Minei|214-648-3917|joseph.minei@utsouthwestern.edu|
20522769|NCT02652949|Medtronic|Rianna Rapson - Clinical Study Manager|763-526-2170|rianna.k.rapson@medtronic.com|
20522770|NCT00699816|Seoul National University College of Medicine|Jung-Hwan Yoon, MD, PhD|+82-2-2072-2228|yoonjh@snu.ac.kr|
20522771|NCT01569295|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|ClinicalTrialDisclosures@gilead.com|
20522772|NCT00717288|The Ohio State University|Kathleen Dungan, MD|614-292-3800|kathleen.dungan@osumc.edu|
20522773|NCT01973595|University of Florida|Dr. Bobbi Langkamp- Henken|352-392-1991|henken@ufl.edu|205
20522774|NCT02508935|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20522775|NCT02125877|Novartis|Study Director|862-778-8300||
20522776|NCT06101264|University of Connecticut School of Medicine|Prabhath Mannam|8607092371|pmannam@uchc.edu|
20522777|NCT01406444|Massachusetts General Hospital|Dr. Karen Klahr Miller|6177263870|kkmiller@mgh.harvard.org|
20522778|NCT00794508|University of California Los Angeles|Dr. Donald B. Kohn|310-794-1964|dkohn1@mednet.ucla.edu|
20522779|NCT03138655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20522780|NCT02800642|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20522781|NCT04868500|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20522782|NCT02859142|University of Chicago|Andrea King, Ph.D.|7737026181|aking@yoda.bsd.uchicago.edu|
20522783|NCT03290079|Moffitt Cancer Center|Jonathan Strosberg, MD|813-745-5553|jonathan.strosberg@moffitt.org|
20522784|NCT04642404|University of Texas Health Science Center at San Antonio|Vanessa Chrepa, DDS|210-459-3601|vanessa.chrepa@rutgers.edu|
20522785|NCT01941498|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20522786|NCT00706589|Kiho Moon|Medical Director|+82-2-3287-9009|khmoon@otsuka.co.kr|
20522787|NCT01669603|University of Virginia|Ronald Turner||rbt2n@virginia.edu|
20522788|NCT05299528|Vanderbilt University Medical Center|Daniel Larach, MD|(615) 322-6033|daniel.larach@vumc.org|
20522789|NCT04877457|Yale University|Erin Longbrake, MD|203-287-6100|erin.longbrake@yale.edu|
20522790|NCT01755091|University of Illinois at Chicago|David W. Carley, PhD|312-996-3827|dwcarley@uic.edu|
20522791|NCT00490841|Abbott Vascular|Ellen Travis|408-845-1512|Ellen.Travis@av.abbott.com|
20522792|NCT03452943|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20522793|NCT02185053|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20522794|NCT00307437|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215 793-7612||
20522795|NCT03006302|SKCCC Johns Hopkins Medical Institution|Dung Le, MD|443-287-0002|Dle@jhmi.edu|
20522796|NCT00338728|UT MD Anderson Cancer Center|Dr. Arun,Banu,M.D. / Breast Medical Oncology|713-792-2817|barun@mdanderson.org|
20522797|NCT03859765|Duke University|Sarah A Kelleher, PhD|919-416-3405|sarah.kelleher@duke.edu|
20522798|NCT02374138|Children's Research Institute|Stephen Teach, MD, MPH|202 476 5134|steach@childrensnational.org|
20522799|NCT00525798|Nordic Bioscience|Dr. Bente Juul Riis|+45 22901317|bjr@nordicbioscience.com|
20522800|NCT02933255|National Cancer Institute|Dr. James L. Gulley|301-480-716|gulleyj@mail.nih.gov|
20522801|NCT04380961|Janssen Research & Development, LLC|Director 1 Study Responsible Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20522802|NCT04803305|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522803|NCT03207867|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20522804|NCT03816878|Johns Hopkins University Center for Immunization Research|Kawsar Talaat|410-336-9164|ktalaat1@jhu.edu|
20522805|NCT05626231|Boston College School of Social Work|Dr. Maggi Price, PI|541-556-5016|priceml@bc.edu|
20522806|NCT05064384|Boston Scientific|Karen Noblett, MD, Chief Medical Officer|559-250-8082|karen.noblett@bsci.com|
20522807|NCT03765788|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20522808|NCT03203850|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20522809|NCT02717455|St. Jude Children's Research Hospital|Dr. Arzu Onar-Thomas|901-595-5499|arzu.onar@stjude.org|
20522810|NCT00486525|Ohio State University Comprehensive Cancer Center|Janice Kiecolt-Glaser, Principal Investigator|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
20522811|NCT00615199|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522812|NCT02653625|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20522813|NCT03860974|University of California, San Diego|Brian Ilfeld|8582493660|bilfeld@health.ucsd.edu|
20522814|NCT00064987|Massachusetts General Hospital|Dr. William Crowley|617-724-2470|wcrowley@partners.org|
20553167|NCT01554618|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20553168|NCT00477672|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
20522815|NCT02969382|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|CLINICALTRIALDISCLOSURE@SUNOVION.COM|
20522816|NCT00221338|University of California San Francisco|Clinical Research Coordinator|4154769489|Christopher.Tang2@ucsf.edu|
20522817|NCT04152863|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522818|NCT01644617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522819|NCT02276807|VA Center for Integrated Healthcare|Dr. Jennifer Funderburk|315-425-4400|Jennifer.Funderburk@va.gov|54703
20522820|NCT00504751|Weill Cornell Medicine|Richard Furman, MD|646.962.2064|amr2017@med.cornell.edu|
20522821|NCT01085760|Mayo Clinic|Dr. Jayant A. Talwalkar|507-538--4877|talwalkar.jayant@mayo.edu|
20522822|NCT04080739|University of Alabama at Birmingham|Dr. Anthony Morlandt|205-996-2799|morlandt@uab.edu|
20522823|NCT00799058|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
20522824|NCT03417778|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20522825|NCT02088697|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20522826|NCT03408171|Geisinger Medical Center|David L. Diehl, MD|570-214-2411|dldiehl@geisinger.edu|
20522827|NCT00247676|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20522828|NCT01012336|Samsung Medical Center|Pf Duk-Soo Bae|82-2-3410-3519|huna0@naver.com|
20568462|NCT00288353|Northwestern University|Dr. Herbert Meltzer|(312) 503-0309|h-meltzer@northwestern.edu|
20568463|NCT04799587|Northwestern University|Paul Fitzgerald, RN, BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
20568464|NCT00728884|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20568465|NCT02849509|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568466|NCT03867396|University of Colorado Anschutz SOM|Dr. Melinda Anderson|303-724-9316|melinda.anderson@cuanschutz.edu|
20568467|NCT02374476|Icahn School of Medicine at Mount Sinai|Dr. Srinivas R Dukkipati|(212) 241-7114|srinivas.dukkipati@mountsinai.org|
20568468|NCT05431543|LENZ Therapeutics, Inc.|Marc Odrich, MD|(646) 249-2800|marc@lenz-tx.com|
20568469|NCT02389894|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
20568470|NCT02228889|The Ohio State University Wexner Medical Center|Dr. Jeffrey Janis|(614) 297-2913|jeffrey.janis@osumc.edu|
20568471|NCT04617574|Holyoke Medical Center Weight Management Program|Bariatric Clinical Administrator|(413) 535 - 4759|davidson_elana@holyokehealth.com|
20568472|NCT03138499|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20568473|NCT01334606|BD Medical - Diabetes Care|Laurence J. Hirsch. Medical Director|201-847-6513|laurence_hirsch@bd.com|
20568474|NCT02312245|Mayo Clinic|S. John Weroha, M.D., Ph.D.|(507) 284-2511|weroha.saravut@mayo.edu|
20568475|NCT00448344|VA Connecticut|Dr. Lori Bastian|860-667-6853|lori.bastian@va.gov|
20568476|NCT00410150|Cincinnati Children's Hospital Medical Center|Dr. Derek Wheeler|513-636-4239|derek.wheeler@cchmc.org|
20568477|NCT02680145|Mayo Clinic|Dr. John A. Occhino|(507) 538-5883|Occhino.John@mayo.edu|
20568478|NCT01123200|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
20568479|NCT02070640|The Ohio State University Wexner Medical Center|Associate Professor|614-293-3230|raaja.narula@osumc.edu|
20568480|NCT04044352|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-4946|kneuzil@som.umaryland.edu|
20568481|NCT02176356|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20568482|NCT00515697|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568483|NCT03087851|Dep. of Endocrinology and Internal Medicine, Aarhus University Hospital|MD Anne Sophie Sølling|78 45 54 75|annesoel@rm.dk|
20568484|NCT00644332|Gilead Sciences|Emmanuelle Bellemin, Senior Manager, Regulatory Affairs||emmanuelle.bellemin@gilead.com|
20568485|NCT03694210|Interscope, Inc.|Alexis James Global Director of Clinical Affairs|508-847-9478|alexis.james@interscopemed.com|
20568486|NCT01502787|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
20568487|NCT00443755|Mayo Clinic|K. Sreekumaran Nair, MD, Ph.D.|507-255-3605|nair@mayo.edu|
20568488|NCT02775214|Riley Hospital for Children at Indiana University Health|Dr Nicole Horn|3179449981|nhorn@iuhealth.org|
20568489|NCT01896921|University of Maryland|Gregg Brogden|4107061660|gbrogden@ihv.umaryland.edu|
20568490|NCT02706834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20568491|NCT04385849|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20568492|NCT00355784|University of Michigan, Ann Arbor, Michigan|Jeffrey F. Horowitz|734-647-1076|jeffhoro@umich.edu|
20568493|NCT02543294|UT MD Anderson Cancer Center|Dr. Anecita P. Fadol,PHD/Associate Professor, Department of Nursing|713-792-8397|afadol@mdanderson.org|
20507017|NCT01094717|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465|Kristina.Duffin@hsc.utah.edu|
20507018|NCT00576251|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20507019|NCT01940510|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20507020|NCT03247413|Johns Hopkins University School of Medicine|Akhil Chhatre|443-997-5476|achhatr1@jh.edu|
20507021|NCT00642746|OHSU Knight Cancer Institute|Charles Lopez, MD|503-494-8534|lopezc@ohsu.edu|
20507022|NCT00424294|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507023|NCT01811355|Mayo Clinic, Jacksonville|Dr. Bjorn Oskarsson|9049536896|oskarsson.bjorn@mayo.edu|
20507024|NCT03337152|PATH|Gonzalo Domingo|206-285-3500|gdomingo@path.org|
20507025|NCT00976950|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507026|NCT00757484|University of Rochester Medical Center|Dr. Erin Duecy|585-275-4004|erin_duecy@urmc.rochester.edu|
20507027|NCT04124042|Xalud Therapeutics, Inc.|Director of Medical Inquiries|212-301-6673|medical.information@xaludthera.com|
20553169|NCT03078946|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
20553170|NCT02722928|The Ohio State University Wexner Medical Center|Juan Fiorda-Diaz Postdoctoral Researcher|6142933559|juan.fiorda@osumc.edu|
20522829|NCT04342819|The University of the West Indies|Naveen Seecheran, Senior Lecturer|18687537686|Naveen.Seecheran@sta.uwi.edu|
20522830|NCT00911300|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522831|NCT02455518|Albany Medical College|Dr. Andrew Chang|2125555555|achang3@yahoo.com|
20522832|NCT03901092|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20522833|NCT04151667|Moffitt Cancer Center|Dr. Rachid Baz|813-745-3163|Rachid.Baz@moffitt.org|
20522834|NCT04759703|Massachusetts General Hospital|John W. Winkelman, MD, PhD|6176436026|JWWINKELMAN@MGH.HARVARD.EDU|
20522835|NCT03307226|Washington University in St. Louis|Dr. Fred Ssewamala|3149358521|fms1@wustl.edu|
20522836|NCT01199146|University of California, San Francisco|Charles Ryan, MD|415-353-9279|charles.ryan@ucsf.edu|
20522837|NCT01107197|"Department of Clinical Nutrition and Dietetics, Azienda Ospedaliera Maggiore della Carità"|Dr. Federico D'Andrea|+39 0321.373.3275|dietologia@maggioreosp.novara.it|
20522838|NCT04697069|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20522839|NCT05180227|James J Peters VA Medical Center|Dr. Jill Maria Wecht|(718) 584-9000|JM.Wecht@va.gov|3122
20522840|NCT02779855|Moffitt Cancer Center|Hatem Soliman, MD|813-745-4985|hatem.soliman@moffitt.org|
20522841|NCT01301729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20522842|NCT05794503|UT Southwestern Medical Center|Tiffany Moon, MD|(214) 648-6400|tiffany.moon@utsouthwestern.edu|
20522843|NCT00509795|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
20522844|NCT04842292|University of Kentucky|Brittany Bissell|8593239308|bdbi223@uky.edu|
20522845|NCT00143247|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20522846|NCT02766283|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
20522847|NCT00805961|Sarah Cannon Research Institute|John D. Hainsworth, MD.|877-691-7274|ASKSARAH@scresearch.net|
20522848|NCT06360081|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522849|NCT02447744|MGH|Dr. Sara Lazar|617-724-7108|slazar@mgh.harvard.edu|
20522850|NCT00912912|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD/Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
20522851|NCT00306995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20522852|NCT05422625|William Beaumont University Hospital|Jennifer Giordano RN BSN/ Clinical Research Manager|248-551-3517|Jennifer.Giordano@corewellhealth.org|
20522853|NCT03514966|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
20522854|NCT02287922|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
20522855|NCT00668317|Hull and East Yorkshire Hospitals Trust|Clinical trials Manager|01482 624067|c.e.wright@hull.ac.uk|
20522856|NCT02664181|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nathan Pennell|1-866-223-8100|TaussigResearch@ccf.org|
20522857|NCT03345771|NYU Langone Health|Ran Schwarzkopf MD MSc|(646)-501-7300|ran.schwarzkopf@nyulangone.org|
20522858|NCT01565356|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20522859|NCT03668808|Sansum Diabetes Research Institute|Wendy C Bevier|8056827638|wbevier@sansum.org|207
20522860|NCT02839772|University of Hull|Jill Brooks. PhD student,|01491 839044|jb284@btinternet.com|
20522861|NCT01526655|Department of Obstetrics and Gynaecology, and Department of Clinical and Experimental Medicine, Linköpings universitet (LIU), Sweden|Professor Dr. Preben Kjölhede|+4638231188|preben.kjolhede@liu.se|
20522862|NCT00280735|UNC Lineberger Comprehensive Cancer|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20522863|NCT04753216|Northwestern University Feinberg School of Medicine|Daniela Matei, MD|312-472-4684|daniela.matei@northwestern.edu|
20522864|NCT02142608|Bracco Diagnostics Inc.|Maria Luigia Storto, MD, Executive Director X-Ray and Ultrasound|609-514-2262|marialuigia.storto@diag.bracco.com|
20522865|NCT02001987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20522866|NCT01965860|Ghent University|Prof. Dr. Isabelle Van Herzeele|93325108|isabelle.vanherzeele@ugent.be|+32
20522867|NCT01895777|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|8002430127|clintriage.rdg@boehringer-ingelheim.com|
20522868|NCT00955929|Memorial Sloan Kettering Cancer Center|John Mulhall, MD|646-888-6024|mulhalj1@mskcc.org|
20522869|NCT02064296|University of Michigan|Richard Harris|734-998-6996|reharris@med.umich.edu|
20522870|NCT01894087|University of Michigan|Amy Bohnert|734-845-3638|amybohne@med.umich.edu|
20522871|NCT02526667|Evic Romania|Dr. Olsavszky|40 21 335 70 90|research@evic.ro|
20522872|NCT03606343|Cincinnati Children's Hospital Medical Center|Leanne Tamm, Principal Investigator|513-803-3176|leanne.tamm@cchmc.org|
20522873|NCT00972374|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20522874|NCT04149821|Weill Cornell Medicine|Dr. John Allan, Associate Professor of Medicine|2127463481|joa9069@med.cornell.edu|
20522875|NCT02481206|Zoll|Director of Clinical Affairs|724-968-3333|mosz@zoll.com|
20522876|NCT02288325|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20522877|NCT02411916|Queens Hospital Center|Dr. Aleksandr Fuks|718 883-4035|fuksal@nychhc.org|
20522878|NCT03607487|Incyte Corporation|Incyte Corporation Call Center|1-855-463-3463|medinfo@incyte.com|
20522879|NCT01884337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20522880|NCT03203681|University of Miami|Dr. Ranjith Ramasamy|3052433670|ramasamy@miami.edu|
20522881|NCT04223752|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20553171|NCT04011410|University of Kentucky College of Medicine|Patrick Hensley|859-562-3223|patrick.hensley@uky.edu|
20553172|NCT02275481|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20568494|NCT00907517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568495|NCT00730925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568496|NCT02137239|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20568497|NCT01994538|Minneapolis VA Health Care System|Dimitri Drekonja, MD, MS|612 467 4183|dimitri.drekonja@va.gov|
20568498|NCT00428441|University of Insubria|Dr. Walter Ageno|+39 0332 278831|agewal@yahoo.com|
20568499|NCT02475733|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568500|NCT05216952|University of North Carolina at Chapel Hill|Jill Hagey, MD, MPH|919-966-5280|jmhagey1@ad.unc.edu|
20568501|NCT04864236|UCLA Anesthesiology|John Shin MD, Associate Clinical Professor|310-267-6629|JShin@mednet.ucla.edu|
20568502|NCT02131155|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568503|NCT02744898|NYU Langone Health|Franco Muggia, MD|212 263 2172|Franco.Muggia@nyulangone.org|
20568504|NCT01014013|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20568505|NCT03508830|University of California, San Francisco|Dr. Greg J. Haro|415-353-7502|greg.haro@ucsf.edu|
20568506|NCT02391714|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|skaur@salud.unm.edu|
20568507|NCT01446042|Trimel Pharmaceuticals Corp.|Natalia Tkachenko, MD Director Clinical Affairs|9054641755|ntkachenko@trimelpharmaceuticals.com|
20568508|NCT00720629|H. Lee Moffitt Cancer Center and Research Institute|Lia Perez, M.D.|813-745-7202|lia.perez@moffitt.org|
20568509|NCT04908800|Kyorin Pharmaceutical Co.,Ltd|Yoji Mimaki|+81-3-3525-4788|ml-kyorin_clinicaltrials.gov@mb.kyorin-pharm.co.jp|
20568510|NCT03751280|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20568511|NCT00296504|ViiV Healthcare|GSK Response Center|866-435-7343||
20568512|NCT01323309|Memorial Sloan Kettering Cancer Center|Dr. William Breitbart, MD|646-888-0020|breitbaw@MSKCC.ORG|
20568513|NCT03594266|BiotronikUS|Crystal Miller|503-475-4984|crystal.miller@biotronik.com|
20568514|NCT00166361|Mayo Clinic|Dr. Lance A. Mynderse|507-284-1250|mynderse.lance@mayo.edu|
20568515|NCT01047306|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20568516|NCT01878253|Zimmer Biomet Inc|Clinical Operation Director|574-371-9823|Bill.Bourdeau@zimmerbiomet.com|
20568517|NCT03647709|St Elizabeth Medical Center|Dr Andrew Wickline|315-735-4496|awickline23@gmail.com|
20568518|NCT00472056|UT MD Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor||mvpacheco@mdanderson.org|
20568519|NCT01818245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568520|NCT00449033|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20568521|NCT04393779|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
20568522|NCT05045638|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20568523|NCT03802513|VA RR&D National Center for Rehabilitative Auditory Research|Principal Investigator|503-220-8262|sarah.theodoroff@va.gov|
20568524|NCT00274846|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
20568525|NCT01109602|Colorado State University, Department of Occupational Therapy|Arlene Schmid, PhD, OTR|970-491-7562|arlene.schmid@colostate.edu|
20568526|NCT01190228|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20568527|NCT03869541|Imperial College London|Huw Woodbridge|+44 (0)20 7594 3192|h.woodbridge@imperial.ac.uk|
20568528|NCT01395914|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
20568529|NCT05287178|University of Oregon|Yoel Everett|541-346-7054|yeverett@uoregon.edu|
20568530|NCT01920178|Cambridge Health Alliance|Paul M. Heffernan, D.P.M.|617-665-2556|pheffernan@challiance.org|
20568531|NCT03613363|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
20568532|NCT03941769|The University of Texas MD Anderson Cancer Center|Gheath Al-Atrash, M.D. / Stem Cell Transplantation|713-792-7734|galatras@mdanderson.org|
20568533|NCT00763919|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
20568534|NCT00939211|AstraZeneca|Gerard Lynch|+441509645895|clinicaltrialtransparency@astrazeneca.com|
20568535|NCT00145496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20568536|NCT05957198|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568537|NCT01429285|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
20568538|NCT02168153|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|Long_C@palmer.edu|
20568539|NCT02577315|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568540|NCT03247985|Mayo Clinic|Dr. David R. Farley|507-284-7565|farley.david@mayo.edu|
20568541|NCT01754389|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
20568542|NCT05022472|UCSD|Dr. Britt Skaathun|619-543-5011|bskaathun@health.ucsd.edu|
20568543|NCT01819233|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Nicole Simone|215-955-6702|nicole.simone@jefferson.edu|
20568544|NCT05579769|St. Jude Children's Research Hospital|Dr. Ashok Srinivasan|8662785833|referralinfo@stjude.org|
20568545|NCT00710814|Columbia University|Judith Korner, M.D., PhD|2123053725|jk181@cumc.columbia.edu|
20568546|NCT00705614|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522882|NCT03071406|Moffitt Cancer Center|Sungjune Kim, MD, PhD|813-745-1898|sungjune.kim@moffitt.org|
20522883|NCT03617458|Vanderbilt University Medical Center|Research Programs Manager|615-322-4703|ph_research@vumc.org|
20522884|NCT01350583|H. Lee Moffitt Cancer Center and Research Institute|Robert J. Gillies, Ph.D. - Principal Investigator|813-745-8355|robert.gillies@moffitt.org|
20568547|NCT00925288|Johns Hopkins University|Dr. Brandon Brown|949-266-4401|bbrown@jhsph.edu|
20507028|NCT04895605|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
20507029|NCT02493426|University of Minnesota|Suma Jacob, MD, PhD|612-624-0018|sjacob@umn.edu|
20522885|NCT04186845|Blue Earth Diagnostics|Head of R&D|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
20568548|NCT00088452|Cincinnati Children's Hospital Medical Center|Tracy Glauser, MD|513-636-8854|tracy.glauser@cchmc.org|
20568549|NCT02629419|Matinas BioPharma|Theresa Matkovits, PhD|862-812-1436|tmatkovits@matinasbiopharma.com|
20568550|NCT02081196|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20568551|NCT02055053|Lahey Clinic|dmitry nepomnayshy MD|781 744 8576|dmitry.nepomnayshy@lahey.org|
20568552|NCT02515656|Laboratoire Innotech International|Director of Medical Affairs|+33 (0)1 46 15 29 00||
20568553|NCT00434577|GlaxoSmithKline|GSK Response Center|866-435-7343||
20568554|NCT00097708|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650 - 496 - 3777||
20568555|NCT01100268|Columbia University Department of Psychiatry|Dr. Carolyn Rodriguez|(646) 774-8061|cr2163@columbia.edu|
20568556|NCT01921114|AngioDynamics|Alicia Conway|774-249-8707|aconway@angiodynamics.com|
20568557|NCT01904019|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
20568558|NCT00635570|Department of Obstetrics and Gynecology, The University of Chicago|Melissa Gilliam|773-834-0840|mgilliam@babies.bsd.uchicago.edu|
20568559|NCT01101464|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20568560|NCT01064882|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20568561|NCT01537120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568562|NCT00383630|Columbia University|Yoshifumi Naka, MD, PhD|(212) 305-0828|yn33@columbia.edu|
20568563|NCT00332488|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20507030|NCT01069523|University of Texas Health Science Center at San Antonio|Steven R.Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
20568564|NCT04816708|Duke University|Christopher E. Cox, MD|919-681-7232|christopher.cox@duke.edu|
20568565|NCT00197119|GlaxoSmithKline|GSK Response Center|866-435-7343||
20568566|NCT04483791|EVP, Clinical Research|Candace Elek, M.S.|408-913-5468|celek@elixirmedical.com|
20568567|NCT01654445|University of Calgary, Department of Clinical Neurosciences|Shelagh B Coutts and Michael D Hill|4039448065|michael.hill@ucalgary.ca|
20568568|NCT03451292|Instituto Grifols, S.A.|Mireia Torres|+34 93 5710500|approach_preciosa@grifols.com|
20568569|NCT01375777|Amgen Inc.|Study Director|866-572-6436||
20568570|NCT04362111|University of Alabama at Birmingham|Walter Winn Chatham MD|205-612-7402|wchatham@uabmc.edu|
20568571|NCT01887418|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-329-3020|jjaffe@antarespharma.com|324
20568572|NCT03132753|Chestnut Health's Lighthouse Institute; Chicago, Illinois|Dennis Watson|224-534-0114|dpwatson@chestnut.org|
20568573|NCT02097056|Eisai Korea Inc.|Youngji Pyo|+82-2-3451-5533|y-pyo@eisaikorea.com|
20568574|NCT02724423|Neurelis, Inc.|Sunita Misra, M.D. Medical Director|(832) 257-1975|smisra@neurelis.com|
20568575|NCT00157209|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20568576|NCT02162771|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
20568577|NCT01348763|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
20568578|NCT00685659|University of Pennsylvania|James R. McKay, Ph.D.|215-746-7704|jimrache@mail.med.upenn.edu|
20568579|NCT01078571|Abbott|Global Medical Services|1-800-633-9110||
20568580|NCT04422210|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20568581|NCT00581009|University of California Irvine|Dr. Joseph Wu|7142252212|jcwu@uci.edu|
20568582|NCT00739024|Swedish Headache Center|Pat Barrodale, RN|206-215-3502|pat.barrodale@swedish.org|
20568583|NCT02332824|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20568584|NCT00498797|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20568585|NCT02784535|Vanderbilt University Medical center|Dr Cyndya Shibao|615-322-2318|cyndya.shibao@vumc.org|
20568586|NCT02214017|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
20568587|NCT03953079|Graybug Vision|Executive Director, Biostatistics|650-459-4235|pdinh@graybug.vision|
20568588|NCT00991185|duke|brian smith|919668951|brian.smith@duke.edu|
20568589|NCT04743999|Henry Ford Health System|Marissa Gilbert|313-556-8422|mgilber6@hfhs.org|
20568590|NCT01721759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20568591|NCT01195584|General Hospital Amstetten|Wolfgang Senker, MD|+43 7472 6040|wolfgang.senker@aon.at|6611
20568592|NCT00924833|Istituto Auxologico Italiano|Gianfranco Parati, Professor|+3961911|gianfranco.parati@unimib.it|2949
20568593|NCT00417989|Medtronic|Scott Lee, M.D.|8185764204|scott.w.lee@medtronic.com|
20568594|NCT01636778|GlaxoSmithKline|GSK Response Center|866-435-7343||
20568595|NCT01245699|Maricopa Integrated Health System|Bentley J Bobrow, MD|602-364-0580|bentley.bobrow@azdhs.gov|
20568596|NCT01846988|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani, Assistant Professor|(513) 736-1814|Neepa.Gurbani@cchmc.org|
20568597|NCT00990821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568598|NCT03530345|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
20568599|NCT04150250|PATH|Gwen Ambler|206-285-3500|gambler@path.org|
20568600|NCT01436045|HealthPartners Institute for Education and Research|Michael H Rosenbloom, MD|6512547900|michael.h.rosenbloom@healthpartners.com|
20568601|NCT01945086|Janssen Research & Development, LLC.|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20568602|NCT04853394|University of Illinois Chicago|Mary E. Mackesy-Amiti|312-355-4892|mmamiti@uic.edu|
20568603|NCT00318591|Coloplast|Anna Karina Busch, Intl. Senior Scientific Manager|+45 49112350|dkakb@coloplast.com|
20568604|NCT01184755|Rutgers - Robert Wood Johnson Medical School|Lynn Clemow, PhD|732-235-6972|lynn.clemow@rutgers.edu|
20568605|NCT00748098|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20568606|NCT04212299|University of Illinois Chicago|Andrew Sawers|312-996-1427|asawers@uic.edu|
20522886|NCT05061420|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20522887|NCT01814553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522888|NCT04138823|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20522889|NCT04036110|University of North Carolina at Chapel Hill|Jia-Rong Wu, PhD, RN|859-323-4712|jiarong.wu2@uky.edu|
20522890|NCT02466685|Northwestern University|Mahdi Arshadi|3123839950|mahdi.arshadi@northwestern.edu|
20522891|NCT00796757|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20522892|NCT02593110|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
20522893|NCT03548337|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522894|NCT01061476|Johns Hopkins University|Dr. Susheel Patil|410-550-0574|spatil@jhmi.edu|
20522895|NCT01546454|University of Arizona|Dr. Randy Bogan|520-621-1487|boganr@email.arizona.edu|
20522896|NCT01911273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522897|NCT01906515|Cairo University School Of Medicine|Dr Wael N Awada|00201006481958|waoool@hotmail.com|
20553173|NCT01215227|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553174|NCT00256698|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20553175|NCT02777125|University of Tennessee Health Sciences College of Medicine/Le Bonheur Children's Hospital|Mark Snider DO, Principal Investigator|9012875986|marksnider02@hotmail.com|
20553176|NCT00653224|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20553177|NCT02267629|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor, Director of Rodriguez Translational Therapeutics Lab|650-723-6158|cr2163@stanford.edu|
20553178|NCT02365636|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20553179|NCT00355238|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20553180|NCT01633944|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20553181|NCT01436279|Boston Medical Center|Olivera Vragovic|617 414 7304|Olivera.Vragovic@bmc.org|
20553182|NCT02096458|Takeda Development Center Americas, Inc.|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
20553183|NCT00463060|Good Samaritan Hospital Medical Center|Dr. Johnny Kao|(631) 376-4444|johhny.kao@chsli.org|
20553184|NCT00701129|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20553185|NCT02884089|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20553186|NCT02624284|University of Pennsylvania|Mary Falcone, Ph.D.|215-746-3782|mfalc@pennmedicine.upenn.edu|
20553187|NCT03064126|Boston Scientific|Cynthia Peterson|763-955-8233|Cynthia.Peterson@bsci.com|
20553188|NCT04508725|Stanford University|Dr. Alice Fan|(650) 498-6000|afan@stanford.edu|
20553189|NCT02650986|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
20553190|NCT03817320|TACL|TACL|3233615429|TACL@chla.usc.edu|
20553191|NCT06034496|Center for Applied Brain and Cognitive Sciences|Research Assistant Professor|617-627-1059|kana.okano@tufts.edu|
20553192|NCT02018458|Baylor Scott and White Health|Dr. Joyce O'Shaughnessy|214-818-8472|joyce.oshaughnessy@usoncology.com|
20553193|NCT02845752|The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Dr. Harry Rossiter|3102228200|hrossiter@lundquist.org|
20553194|NCT01428193|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
20553195|NCT03762083|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
20553196|NCT00548860|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
20553197|NCT00727714|Telemark Hospital|Dr. Anne Kristin M. Fell, MD, PhD|+4735003106|annfel@sthf.no|
20553198|NCT01265446|Novartis Consumer Health, Nyon, Switzerland|Clinical Project Leader|+41223633279|Rowland.Furcha@novartis.com|
20553199|NCT00325234|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20553200|NCT02402452|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20553201|NCT05179421|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
20553202|NCT03746522|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20553203|NCT01639040|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20553204|NCT04135703|The Oho State University|Natasha Slesnick|6142478469|slesnick.5@osu.edu|
20553205|NCT05422053|Tandem Diabetes Care|Supervisor, Clinical Operations|(858) 366-6900|clinicalaffairs@tandemdiabetes.com|
20553206|NCT00486265|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20553207|NCT01452412|Albert Einstein College of Medicine|Michal Melamed, MD|718-430-2496|michal.melamed@einstein.yu.edu|
20553208|NCT05132127|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20553209|NCT05320029|Fengh Medical Co., Ltd.|Jiao Liu|13815132106|jiao.liu@fulbrightmed.com|
20553210|NCT01403974|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20553211|NCT04697628|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553212|NCT00393939|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553213|NCT02385799|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
20553214|NCT03995953|Implenomics|Sujha Subramanian|(302) 200 8310|sujha.subramanian@implenomics.com|
20568607|NCT03537014|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20568608|NCT02442622|NYU Langone Health|Steve Vanlew, PhD|646-501-7707|Steve.Vanlew@nyulangone.org|
20568609|NCT03868735|Rush University|Dr. J. Brady Scott|3129426389|jonathan_b_scott@rush.edu|
20568610|NCT01557699|SERUM INSTITUTE OF INDIA LIMITED|Dr Prasad Kulkarni|+912026602384|drpsk@seruminstitute.com|
20568611|NCT01002547|Malcom Randall VA Medical Center|Dr. Kenneth Cusi|352-273-8662|Kenneth.Cusi@va.gov; Kenneth.Cusi@medicine.ufl.edu|
20568612|NCT03273283|Hospital Clínic de Barcelona|Pol Bruguera Soler|628162567|pbruguer@clinic.cat|
20568613|NCT02552810|University of Valencia|Dr. Luigi Canullo|+39 347 6201976|luigicanullo@yahoo.com|
20568614|NCT00958711|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20568615|NCT03722485|3M|Sher-ree Beekman|262-409-5112|sbeekman@mmm.com|
20568616|NCT02151643|Shield Therapeutics|Mark Sampson|+44 (0) 207 186 8500|msampson@shieldtx.com|
20568617|NCT00197106|GlaxoSmithKline|GSK Response Center|866-435-7343||
20568618|NCT01503515|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20568619|NCT04050722|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20568620|NCT01350102|Penn State Milton S. Hershey Medical Center|Nell Blake, DPM|(717) 531-5638|nblake@pennstatehealth.psu.edu|
20568621|NCT01828593|Entera Health|Senior Director, Clinical Research|515-963-7565|audrey.shaw@enterahealth.com|
20568622|NCT00377312|University of Pittsburgh|Mara J Horwitz|412-692-2848|horwitz@pitt.edu|
20568623|NCT00762723|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
20568624|NCT01572493|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
20568625|NCT00609245|Vanderbilt University Medical Center|Bassel Abou-Khalil, MD|615-936-0060|bassel.abou-khalil@vanderbilt.edu|
20568626|NCT01090076|Changi General Hospital|Mr Alvin Wong|68504627|alvin_wong@cgh.com.sg|
20568627|NCT00926952|Innovaderm Research Inc.|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
20568628|NCT00694564|UC San Diego|Dr. Jeannie Huang|858-576-1700|jshuang@ucsd.edu|7322
20568629|NCT02402465|University of Chicago|Fuad Baroody, MD|773-702-4790|fbaroody@surgery.bsd.uchicago.edu|
20568630|NCT01284634|GW Research Ltd|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20568631|NCT02236598|Duke University Health System|Ranee Chatterjee Montgomery, M.D.||ranee.chatterjee@duke.edu|
20568632|NCT01484314|Brigham and Womens Hospital/ Dana Farber Cancer Institute|Dr. Nancy Berliner|617-732-5840|nberliner@parnes.org|
20568633|NCT03643705|University of Washington|Dr. Chris Longenecker|2066161159|ctlongen@uw.edu|
20568634|NCT00605384|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20568635|NCT01654289|University of Wisconsin|Bruce Barrett MD PhD|608-263-2220|bruce.barrett@fammed.wisc.edu|
20568636|NCT01732627|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20568637|NCT02103816|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20568638|NCT04736602|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
20568639|NCT01379521|Novartis Pharmaceuticals|Study Director|862-778-8300||
20568640|NCT00938041|GlaxoSmithKline|GSK Response Center|866-435-7343||
20568641|NCT02504502|Geisinger Health System|Alanna Kulchak Rahm, PhD|570-214-5093|akrahm@geisinger.edu|
20568642|NCT03042559|Loma Linda University|Dr. Everett Lohman III|9095584632|elohman@llu.edu|83171
20568643|NCT01509040|University of Washington Harborview Center for Pre Hospital Emergency Care|Dr. Graham Nichol|206-521-1728|nichol@uw.edu|
20568644|NCT02389725|Mayo Clinic|Dr. Tobias Kummer|507-255-4399|kummer.tobias@mayo.edu|
20568645|NCT01485991|Janssen IDV - Janssen Dx|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
20568646|NCT02538471|Weill Cornell Medicine|Dr. Silvia Formenti|212-746-3608|formenti@med.cornell.edu|
20568647|NCT01475370|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20568648|NCT00475735|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568649|NCT00084747|UCLA|Dr. Gary Schiller|310-206-5755|gschiller@mednet.ucla.edu|
20568650|NCT03410953|UICEC, Complejo Asistencial Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL), Plataforma SCReN, Salamanca, Spain|Ricardo López-Pérez, PhD. Study Coordinator and Manager of Clinical Trial|923 291100|ricardo.lopez@scren.es|55779
20568651|NCT00125853|Imperial College London|Professor Neil Poulter|+44 2075943445|n.poulter@imperial.ac.uk|
20568652|NCT01093183|University of Nebraska Medical Center|James Schwarz, MD|402-559-5166|jkschwarz@unmc.edu|
20568653|NCT05319756|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
20568654|NCT02522299|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20568655|NCT03152409|Brigham and Women's Hospital|Dr. Jessica Harder|6177326753|jaharder@bwh.harvard.edu|
20568656|NCT03575572|University of Utah|Stephanie Goldstein|801 587-7572|stephanie.goldstein@hsc.utah.edu|
20568657|NCT04474691|New York University|Tara McAllister|212-992-9445|tkm214@nyu.edu|
20568658|NCT00310050|Wake Forest University Health Sciences|Dr. William Blackstock|3367136501|ablackst@wakehealth.edu|
20568659|NCT01257698|Mid Atlantic Retina|Jason Hsu MD|215-928-3092|jhsu@midatlanticretina.com|
20568660|NCT02488070|Stanford University|Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
20568661|NCT00050167|UT MD Anderson Cancer Center|Aman Buzdar, M.D./Professor||agmadrig@mail.mdanderson.org|
20522898|NCT00447993|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20522899|NCT02350816|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20522900|NCT01070953|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522901|NCT02503787|Medtronic Implantable Therapies|Helen Berrier|1-800-633-8766|medtronicneurotrials@medtronic.com|
20522902|NCT04700137|St. Luke's Health System|Dr. Anna K. Radin|208/381-8460|radina@slhs.org|
20522903|NCT04787627|Össur Iceland ehf.|Laurine Roussillon|+354 822 1812|lroussillon@ossur.com|
20522904|NCT00548093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522905|NCT02924727|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20522906|NCT02716727|University of North Carolina at Chapel Hill|Sumitha Ahmed, DDS|919-537-3946|sumitha_ahmed@unc.edu|
20522907|NCT01411527|Rigshospitalet|Anders Juul|+45 3545 5085|Anders.Juul@regionh.dk|
20522908|NCT01464931|Amgen Inc.|Study Director|866-572-6436||
20522909|NCT02936180|McGill University|Ines Colmegna, MD|514-934-1934|ines.colmegna@mcgill.ca|35639
20522910|NCT01982812|University of Rochester|Gretchen L. Birbeck|585-273-4265|gretchen_birbeck@urmc.rochester.edu|
20522911|NCT03648853|UCalifornia San Francisco|Pekka Talke|415 306 3602|pekka.talke@ucsf.edu|
20522912|NCT00174954|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20522913|NCT00839254|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522914|NCT00207883|Children's Healthcare of Atlanta / Emory University|Jana Stockwell, MD|404-785-1600|jana.stockwell@choa.org|
20522915|NCT04597632|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20522916|NCT00201409|University of Michigan|Dr. Robert Hyzy|7349365201|rhyzy@umich.edu|
20522917|NCT02430038|Imperial College|Professor Christoph Lees|02083831000|christoph.lees@nhs.net|
20522918|NCT00993421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20522919|NCT00352417|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
20522920|NCT03130777|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
20522921|NCT02586688|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
20522922|NCT02498613|Yale School of Medicine|Joseph Kim, MD|(203) 200-4822|joseph.w.kim@yale.edu|
20522923|NCT04761926|Oticon Medical|Nicole Amichetti, PhD|6093660424|nitc@oticonmedical.com|
20522924|NCT05109611|SaNOtize R&D Corp|Chief Science Officer|778-899-0607|chris@sanotize.com|
20553215|NCT02388997|University of Virginia|Peter W. Heymann|434-982-3654|pwh5a@virginia.edu|
20522925|NCT03631199|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20553216|NCT00006184|National Cancer Institute, National Institutes of Health|Dr, Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
20522926|NCT00573261|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|weijiang@duke.edu|
20553217|NCT04688164|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
20553218|NCT00087633|Hoffmann-La Roche|Medical Communications|800-821-8590||
20553219|NCT04707534|University of Oklahoma Health Sciences Center|Manager of Clinical Trials|405-271-6173|Dianne-Belshe@ouhsc.edu|
20553220|NCT01110915|Medtronic, Inc|Advisa MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
20553221|NCT03985813|University of Pittsburgh|Oliver Lindhiem|4122465909|lindhiemoj@upmc.edu|
20553222|NCT00627679|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|(650) 386-3100|dkellerman@mappharma.com|
20553223|NCT00409292|Dana-Farber Cancer Institute|Brian Wolpin, MD|617-632-3000|brian_wolpin@dfci.harvard.edu|
20553224|NCT02350309|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20553225|NCT01205165|GlaxoSmithKline|GSK Response Center|866-435-7343||
20553226|NCT03023488|Marmara University, School of Medicine, Department of Urology|Dr. Tarik Emre Sener|+905337620712|dr.emresener@gmail.com|
20553227|NCT01838642|National Cancer Institute|Dr. James Gulley|301-496-4916|gulleyj@mail.nih.gov|
20553228|NCT01495585|National Insitute of DIabetes and Digestive and Kidney Diseases|Dr. Theo Heller|301-402-7147|hellert@mail.nih.gov|
20553229|NCT01557400|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20553230|NCT04155008|Montefiore Medical Center|Dr. Justin Tang|718-920-4094|jtang@montefiore.org|
20553231|NCT01393405|University of North Carolina, Chapel Hill, NC|Dr. Hans Herfarth|9199666806|hherf@med.unc.edu|
20553232|NCT00739752|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
20553233|NCT02281552|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553234|NCT01434290|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20553235|NCT01224639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20553236|NCT04365699|NYU Langone Health|Stuart Katz, MD|212-263-3946|Stuart.Katz@nyulangone.org|
20553237|NCT03761732|University of Washington|Lori Zoellner|206 685 3617|ContactUWCATS@uw.edu|
20553238|NCT03925727|Mimetogen Pharmaceuticals|VP Clinical Development|514 924 7484|karen.meerovitch@mimetogen.com|
20553239|NCT02581384|Dana-Farber Cancer Institute|Karen Marcus MD|16177328783|karen_marcus@dfci.harvard.edu|
20568662|NCT03418701|University of Florida|Dr. Lori Bilello, Project Manager|904-244-9202|Lori.bilello@jax.ufl.edu|
20568663|NCT04372186|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genetech@druginfo.com|
20568664|NCT00577096|University of Arkansas for Medical Sciences|Elizabeth Ann Coleman|501-661-7902|colemanelizabetha@uams.edu|
20568665|NCT00832650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568666|NCT03219216|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20568667|NCT03305458|Medical University of South Carolina|Dr. Tatiana Davidson|8437921866|davidst@musc.edu|
20568668|NCT01370564|Medtronic|Todd Fonseca, VP Clinical|763-526-8151|todd.fonseca@medtronic.com|
20568669|NCT00440037|Kyowa Kirin Co., Ltd.|Research & Development Planning Department , Research & Development Division||clinical.info.jp@kyowakirin.com|
20568670|NCT03562117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20568671|NCT03928821|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20568672|NCT02684942|Chulabhorn hospital|Saengrawee Thanthong|+662-576-6021|saengrawee81@gmail.com|
20568673|NCT03740919|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20568674|NCT04964297|Weill Cornell Medical Center|Dr. Mehraneh Jafari|+1 646 962 2270|mdj9003@med.cornell.edu|
20568675|NCT00985621|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568676|NCT01911819|Loma Linda University|Prof. Joseph Kan|(909) 558-4980|jkan@llu.edu|
20568677|NCT01732406|Massachusetts General Hospital|Dr. Karen Miller|617-726-3870|kkmiller@partners.org|
20568678|NCT04394624|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20568679|NCT00603278|GlaxoSmithKline|GSK Response Center|866-435-7343||
20568680|NCT02418819|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568681|NCT02406859|James J. Peters VAMC|Dr. Mark Korsten|718-741-4675|mark.korsten@va.gov|6753
20568682|NCT04374253|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20568683|NCT01391234|University of Virginia Department of Radiation Oncology|Dr. Paul Read|(434) 924-5191|PWR3U@hscmail.mcc.virginia.edu|
20568684|NCT00651937|The University of Texas (UT) MD Anderson Cancer Center|Dr. Richard E Champlin,MD/Chair, Stem Cell Transplantation|713- 203-8632|rchampli@mdanderson.org|
20568685|NCT02924350|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20568686|NCT04357964|Vanderbilt University Medical Center|Alp Ikizler, Catherine McLaughlin Hakim Chair in Vascular Biology, Professor of Medicine|(615) 343-7592|alp.ikizler@vumc.org|
20568687|NCT00733226|Kecioren Education and Training Hospital|Cem Hasan RAZİ|090 312 3659000|cemrazi2@gmail.com|1139
20568688|NCT02561078|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20568689|NCT00043186|Amgen Inc.|Study Director|866-572-6436||
20568690|NCT01189617|Johnson & Johsnon Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|9285-277-0715|jhauze@its.jnj.com|
20568691|NCT02640807|Revimmune|Dr Michel Morre, DVM, Chief Scientific Officer|+33(0)603357060|m.morre@revimmune.com|
20568692|NCT00726388|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568693|NCT01530477|GE Healthcare|Yi Xia|1 (608) 221-1551|Yi.Xia@ge.com|500-3045
20568694|NCT00382408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
20568695|NCT01145417|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568696|NCT02794441|Children's Hospital of Eastern Ontario Research Institute|Dr. Roger Zemek|6137377600|rzemek@cheo.on.ca|3931
20507031|NCT00473837|Medical Research Council Unit, The Gambia|Mrs Vivat Thomas-Njie|+220-4495442/6|vthomas@mrc.gm|2204
20553240|NCT00624806|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
20553241|NCT01574352|USouthernDenmark|professor Lars Bo Andersen|+45 60114380|lars.bo.andersen@hvl.no|
20553242|NCT06425458|Unity Health Toronto|Dr. Naomi Thulien|(416) 864-6060|naomi.thulien@unityhealth.to|77476
20553243|NCT05711927|Columbia University Irving Medical Center|Toni Iurcotta, MD|646-532-8196|ti2241@cumc.columbia.edu|
20553244|NCT03945981|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20553245|NCT03750903|Department of Veterans Affairs|Dr. Joe Nocera, PI|404 321 6111|joe.nocera2@va.gov|121662
20553246|NCT00705107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20553247|NCT04477304|University of Southern California|Jason Doctor|(213) 821-8142|jdoctor@usc.edu|
20553248|NCT05677425|Haukeland University Hospital|Øyvind Ulvik|+47 97 50 00|doc.ulvik@online.no|
20553249|NCT04036500|Medical College of Wisconsin|Jenna Sarvaideo, DO|414-955-7069|jsarvaideo@mcw.edu|7069
20553250|NCT01101841|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
20553251|NCT02381392|Harbor-UCLA Medical Center|Kelly D. Young, MD|310-222-3506|kyoung@emedharbor.edu|
20553252|NCT03756558|Terumo Medical Corporation|Director of Clinical Operations|9085146154|charis.sugden@terumomedical.com|
20553253|NCT02453113|UC Irvine|Kristen Kelly|949 824 5515|kmkelly@uci.edu|
20553254|NCT02896400|Yale School of Medicine|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
20553255|NCT02984020|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553256|NCT01700179|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20553257|NCT01896895|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20553258|NCT04015219|BioTissue|Medical Affairs|8882968858|medicalaffairs@biotissue.com|
20553259|NCT00646204|Baylor College of Medicine/Houston Methodist|William G. Ondo, MD|713-363-8930|wondo@houstonmethodist.org|
20553260|NCT02582840|AstraZeneca K.K.|Yu Shimizuishi|81 6 7711 4669|Yu.Shimizuishi@astrazeneca.com|
20553261|NCT00773175|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
20553262|NCT05723770|Bausch & Lomb|Megan Cavet|5852849474|Megan.Cavet@bausch.com|
20553263|NCT00640510|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20553264|NCT01440322|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
20553265|NCT01454934|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20553266|NCT04587934|Sharp Healthcare|Dr. Anup Katheria|858-939-4170|Anup.Katheria@sharp.com|
20553267|NCT03913078|Milton S. Hershey Medical Center|Christopher Sciamanna, MD, MPH|717-531-4417|csciamanna@pennstatehealth.psu.edu|
20553268|NCT02412631|Mayo Clinic|Dr. Ryan Hurt|(507) 284-2511|gimresearchstudies@mayo.edu|
20568697|NCT00084409|University of Colorado Denver|Robert Keith, M.D.|303-399-8020|robert.keith@ucdenver.edu|3182
20568698|NCT01116440|Mereo BioPharma Group Plc.|William Moore|+44333023300|WM@mereobiopharma.com|
20568699|NCT01103271|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-0838|mfava@partners.org|
20568700|NCT01763346|University or Southern California|Dr. Thomas Buchanan|3234794319|buchanan@usc.edu|
20568701|NCT00411463|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
20568702|NCT00253019|Emory University|Carrie Cwiak, MD, MPH|404-778-1696|ccwiak@emory.edu|
20568703|NCT02143310|FontemVentures|Tanvir Walele|01779337589|tanvir.walele@fontemventures.com|
20568704|NCT05012397|Rain Oncology|Clinical Research|7082323791|clinicalresearch@rainoncology.com|
20568705|NCT03334747|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20568706|NCT01955720|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568707|NCT03303521|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20568708|NCT00191984|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568709|NCT04086576|University of Pennsylvania|Jessie Hemmons|215-746-8255|jhemmons@pennmedicine.upenn.edu|
20568710|NCT00005908|National Cancer Institute, National Institutes of Health|JoAnne Zujewski, M.D.|301-435-9207|zujewskij@mail.nih.gov|
20553269|NCT00770120|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
20553270|NCT02619409|Medical University of South Carolina|Dr. Eric Bolin|8437922322|bolin@musc.edu|
20507032|NCT01025817|Novartis|Study Director|+1 (862) 778-8300||
20507033|NCT01016691|Vistakon|Brian Schwam MD|1-904-443-1482|bschwam@its.jnj.com|
20507034|NCT04533815|University of Alabama|Dr. Lynn Snow|205-201-0312|LSNOW@ua.edu|
20507035|NCT02130258|Massachusetts General Hospital|Dr. Yi Zhang|617-724-6102|yzhang20@partners.org|
20507036|NCT00488592|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
20507037|NCT00441103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20507038|NCT02951988|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20507039|NCT05836818|University of California San Francisco|Robert Rodriguez|925-457-2145|robert.rodriguez@ucsf.edu|
20507040|NCT00807846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507041|NCT01081873|Abbott|Global Medical Services|800-633-9110||
20507042|NCT01165021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20507043|NCT02491073|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351||
20507044|NCT01655823|Wex Pharmaceuticals|Mehran Kavoosi|6046767900|mehrank@wexpharma.com|
20553271|NCT02995915|Duke University Medical Center|Angela Kirby, MS|(919) 824-7729|angela.kirby@duke.edu|
20553272|NCT01782313|Northwestern University|Mark Agulnik, MD|312 695 6182|magulnik@nm.org|
20553273|NCT00958776|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
20553274|NCT00480636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553275|NCT02583256|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20553276|NCT04027218|University|Ms. Leticia Carmen Simón López|+34 680721340|leticia.simon25@gmail.com|
20553277|NCT02506816|Medica Scientia Innovation Research (MedSIR)|Director of Operations|0034 932 214 135|alicia.garcia@medsir.org|
20568711|NCT00578929|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20568712|NCT01855997|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20568713|NCT01536535|Connecticut Childrens|Dr. Jeffrey Hyams|8605459532|jhyams@connecticutchildrens.org|
20507045|NCT02683525|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
20507046|NCT01627067|UT MD Anderson Cancer Center|Dr. Vicente Valero, MD/ Professor, Breast Medical Oncology|713- 563-0751|vvalero@mdanderson.org|
20507047|NCT01700517|Madre Teresa´s Hospital|Dr Lucio Honorio de Carvalho Júnior|+55 31 33398000|luciohcj@gmail.com|
20507048|NCT03352414|University of California, San Diego|Raymond Diep, Clinical Research Coordinator|(858) 822-5352|rhdiep@health.ucsd.edu|
20507049|NCT04593940|Washington University in St. Louis|William G. Powderly MD|314-454-8276|wpowderly@wustl.edu|
20553278|NCT02177266|Mayo Clinic|Dr. Jae K. Oh|507-284-6055|oh.jae@mayo.edu|
20568714|NCT03866434|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20568715|NCT00404547|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20568716|NCT00679549|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
20568717|NCT01136798|The University of Chicago|Eve Van Cauter, PhD|773-834-4001|evcauter@bsd.uchicago.edu|
20568718|NCT01614899|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20568719|NCT02350127|San Francisco VA|Dr. Deborah Barnes, PI|415-221-4810|deborah.barnes4@va.gov|24221
20568720|NCT03048058|Wake Forest University Health Sciences|Irma M. RIchardson, MHA;|336-716-2903|irichard@wakehealth.edu|
20568721|NCT02038803|Rush University Medical Center|Dr. Robert Balk|3129426744|Robert_Balk@rush.edu|
20568722|NCT04754594|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20507050|NCT04167306|Addiction BIology Unit - Clinical Trials, Inst Neuroecience and Physiology, Gotheburg University/ Dep of Addictions and Dependency, Sahlgrenska University Hostpital|Andrea de Bejczy|+46313424724|andrea.debejczy@neuro.gu.se|
20553279|NCT02744846|Harvard Pilgrim Health Care Institute|Dr. Jason Block|6178674841|jblock1@partners.org|
20568723|NCT01247922|Astellas Pharma Global Development, Inc.|Sr. Medical Director||Astellas.resultsdisclosure@astellas.com|
20568724|NCT02588027|University of California, San Francisco|Dr. Jennifer Tangtiphaiboontana|5622095440|Jennifer.Tangtiphaiboontana@ucsf.edu|
20568725|NCT04736472|University of Pennsylvania|Sony Tuteja, PI|215-573-7834|Sony.Tuteja@PennMedicine.upenn.edu|
20568726|NCT02116582|Astellas Pharma Europe B.V.|Executive Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
20568727|NCT01876823|Columbia Psychiatry|Dr. Gregory Pelton, MD|(646) 774-8669|ghp4@columbia.edu|
20568728|NCT02256488|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20568729|NCT00975130|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20568730|NCT02268526|Novartis Pharmaceuticals|Study Director|8627788300||
20568731|NCT01261793|Care|UCB|+1844599|UCBCares@ucb.com|2273
20568732|NCT02814279|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
20568733|NCT01207453|Brigham and Women's Hospital|Yvonne C Lee, MD, MMSc|617-732-8736|ylee9@partners.org|
20568734|NCT00676663|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|+1-858-888-3798|kmadigan@syndax.com|
20568735|NCT01114334|Denver Health and University of Colorado Denver|Dr. Robert D. Keeley|303-602-8270|robert.keeley@dhha.org|
20568736|NCT00998517|Washington University in St. Louis|Indi Trehan|5039284634|itrehan@wustl.edu|
20568737|NCT04623996|Sumitomo Pharma Oncology|Tegan Nguyen|617-674-8745|tegan.nguyen@oncology.sumitomo-pharma.com|
20568738|NCT01399905|Oregon Health and Science University|John G. Nutt, MD|503-494-9054|nuttj@ohsu.edu|
20568739|NCT00672100|William Beaumont Hospital|Craig T. Hartrick, MD|248-964-3440|chartrick@beaumont.edu|
20568740|NCT00513292|University of Texas MD Anderson Cancer Center, Houston, TX, USA|Aman U. Buzdar, MD|713-792-2817|abuzdar@mdanderson.org|
20568741|NCT02135419|University of California, San Francisco|Dr. Joel Palefsky|(415) 476-1574|joel.palefsky@ucsf.edu|
20568742|NCT01524887|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20568743|NCT04890158|Montefiore Medical Center|Dr. Alecia Thompson-Branch|718-904-4105|alethomp@montefiore.org|
20568744|NCT00383500|Stanford University|Stanley G. Rockson|650-725-7571|rockson@stanford.edu|
20568745|NCT02648282|Sidney Kimmel Cancer Center at Johns Hopkins|Lei Zheng MD, PhD|410-502-6241|lzheng6@jhmi.edu|
20568746|NCT03051984|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
20568747|NCT01816685|Duke University|Andrew Krystal|(919) 668-1212|andrew.krystal@dm.duke.edu|
20568748|NCT02720185|University of Wisconsin Carbone Cancer Center|Kari Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
20568749|NCT00381888|Masonic Cancer Center, University of Minnesota|Levi S. Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
20568750|NCT01410084|Wake Forest School of Medicine|Dr. Denise Houston|336-713-8558|dhouston@wakehealth.edu|
20568751|NCT01997437|Kuban State Medical University|Dr. Paolo Macchiarini|+7(928)-268-80-00|pmacchiarini@ksma.ru|
20568752|NCT04397614|University of Oklahoma Health Sciences Center|Krista Kezbers|405-271-8001|krista-kezbers@ouhsc.edu|45042
20568753|NCT02507687|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20568754|NCT02137499|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20568755|NCT00848393|Nationwide Children's Hospital|Aymen Naguib, MD|6147220596|Aymen.Naguib@nationwidechildrens.org|
20568756|NCT00575367|Inspire Pharmaceuticals, Inc.|Karen Kuhn/ Director|919 941-9777|kkuhn@inspirepharm.com|
20568757|NCT00598871|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
20568758|NCT02288364|Duke University Medical Center|Jay A. Baker, MD|919-684-7645|jay.baker@duke.edu|
20568759|NCT00443898|Novartis Pharmaceuticals|Study Director|862-778-8300||
20568760|NCT00755716|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
20553280|NCT03019627|Dompé|Valeria Motta, PhD|02583831|info@dompe.it|
20553281|NCT03364049|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
20553282|NCT00546715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20553283|NCT00418691|UT MD Anderson Cancer Center|Jeffrey Wefel, PHD/ Associate Professor, Neuropsychology|713-563-0514|jwefel@mdanderson.org|
20553284|NCT01369875|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20553285|NCT01802775|Daiichi Sankyo Development Inc.|Clinical Trial Information|+44 1753482800|info@dsd-eu.com|
20553286|NCT01340976|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20553287|NCT02953821|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20553288|NCT02103478|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20553289|NCT00723606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553290|NCT01096784|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20553291|NCT03761628|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
20553292|NCT00116558|University of Kentucky|Edward J. Kasarskis, M.D., Ph.D.|859-218-5061|ejkas@uky.edu|
20553293|NCT00357370|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20553294|NCT03491150|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20553295|NCT01143090|Sunovion Pharmaceuticals Inc|Medical Director, CNS|1-866-503-6351||
20553296|NCT00117143|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20553297|NCT01103934|University of Chicago|Robert M Naclerio, MD|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
20553298|NCT02315768|UCSD|Dr. Thomas Kipps|858-534-5400|tkipps@ucsd.edu|
20553299|NCT02644967|Idera Pharmaceuticals, Inc|Head of Clinical Operations|484-348-1605|lcolfer@iderapharma.com|
20553300|NCT02287896|LFB Biotechnologies|Clinical trial Information desk|33169825656|supportqcm@lfb.fr|
20522927|NCT03573830|BC Children's Hospital Research Institute|Dr. Mariana Brussoni|(604) 875-3712|mbrussoni@bcchr.ubc.ca|
20522928|NCT00233948|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
20522929|NCT03284723|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522930|NCT00764881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20522931|NCT01250210|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
20522932|NCT01567462|Emory University|Dr. Kenneth Ogan|404-778-3038|kogan@emory.edu|
20522933|NCT05021900|Rhizen Pharmaceuticals AG|Dr. Prajak Barde|+919820503970|pjb@rhizen.com|
20522934|NCT00886015|JohnHopkins U|Sheila West|410-955-2606|shwest@jhmi.edu|
20522935|NCT03182933|University of Wisconsin|Laura Zitur - research program manager|6082638118|lzitur@wisc.edu|
20522936|NCT00196326|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
20522937|NCT01473407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522938|NCT05223920|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
20522939|NCT00369941|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522940|NCT01027702|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
20522941|NCT00403585|GlaxoSmithKline|GSK Response Center|866-435-7343||
20522942|NCT02964312|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20522943|NCT04019626|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
20522944|NCT03001453|American Hip Institute|Dr. Benjamin Domb|630-455-7130|drdomb@americanhipinstitute.org|
20522945|NCT02862730|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
20522946|NCT03685344|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|
20522947|NCT02969421|Duke University Medical Center|Tashima Lambert, MD|484-201-9332|dr.tlambert@gmail.com|
20522948|NCT02121652|University at Buffalo School of Nursing|Suzanne S. Dickerson|716-829-3254|sdickers@buffalo.edu|
20522949|NCT01103492|University Hospitals Case Medical Center|Jeffrey Marks, MD|216-983-4930|Jeffrey.Marks@uhhospitals.org|
20522950|NCT00261950|Amgen Inc.|Study Director|866-572-6436||
20522951|NCT01023035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20522952|NCT02819284|Kala Pharmaceuticals, Inc.|VP Clinical Development|(781) 996-5252|Results007@kalarx.com|
20522953|NCT05584189|MP Biomedicals|Dana Hummel|8008540530|Dana.Hummel@mpbio.com|7019
20522954|NCT00445432|Abbott|Global Medical Services|800-633-9110||
20522955|NCT02789137|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20522956|NCT01090414|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20522957|NCT03594071|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
20522958|NCT05219448|University of Washington|Dr. Donald L. Chi|206-616-4332|dchi@uw.edu|
20522959|NCT03022370|SAMRC|Dr Andrew Gibbs|+27(0)312034899|andrew.gibbs@mrc.ac.za|
20522960|NCT00560391|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20522961|NCT04020887|Washington University School of Medicine|Thaddeus Budelier|314-273-8646|thaddeus.budelier@wustl.edu|
20522962|NCT03852537|Mayo Clinic|Hemang Yadav, MBBS, MS|507-266-3958|Yadav.Hemang@mayo.edu|
20522963|NCT02040077|Johns Hopkins University School of Medicine|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
20522964|NCT02683421|Navidea Biopharmaceuticals|Bonnie C. Abbruzzese, MS, RD|614-822-2327|babbruzzese@navidea.com|
20522965|NCT05534061|University of Oregon|Anne Marie Mauricio, PhD|602-920-7459|amariem@uoregon.edu|
20522966|NCT01412086|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20522967|NCT01027598|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20522968|NCT04347993|Hackensack Meridian Health|Joshua Zenreich|5519965900|joshua.zenreich@hmhn.org|
20522969|NCT02829918|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@Moffitt.org|
20522970|NCT01253902|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20522971|NCT04460560|University of Pennsylvania|K. Rajender Reddy, MD|215-662-4311|ReddyR@pennmedicine.upenn.edu|
20522972|NCT02359994|Artivion|Priya Patel|678-290-4358|priya.patel@artivion.com|
20522973|NCT01823835|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20522974|NCT03017612|Ms.|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
20522975|NCT01320150|Rush University Medical Center|Dr. Robert McCarthy|(312) 563-0448|Robert_J_McCarthy@rush.edu|
20522976|NCT04895982|BioNTech clinical trials patient information|BioNTech SE|+49 6131 90840|patients@biontech.de|
20553301|NCT01494610|GlaxoSmithKline|GSK Response Center|866-435-7343||
20553302|NCT00547703|Cleveland Clinic Florida|Fernando Castro|954-659-5646|castrof@ccf.org|
20553303|NCT02161718|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
20553304|NCT03463889|University of California, San Francisco|Dr. Robert Flavell, MD PhD|877-827-3222|Robert.Flavell@ucsf.edu|
20553305|NCT02151526|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
20553306|NCT00283933|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20553307|NCT02948842|University of South Florida|Lucas Wiegand, MD|813-844-5972|lwiegand@usf.edu|
20553308|NCT04865432|Boston University Chobanian & Avedisian School of Medicine|Michael F. Holick PhD, MD|617-358-6139|mfholick@bu.edu|
20522977|NCT00919854|Janssen R&D US|Senior Director R&D|1 609 730-7548||
20522978|NCT00789997|The Ottawa Hospital Research Institute|Dr Shawn Aaron||saaron@ohri.ca|
20522979|NCT00985491|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3261|pkeating@gidynamics.com|
20522980|NCT02213289|University of Chicago|Daniel Catenacci, MD|2-1000|dcatenac@bsd.uchicago.edu|
20522981|NCT01893346|AstraZeneca Pharmaceuticals|Paul Newell, MBBS MRCP MFPM|+44 1625 515727|paul.newell@astrazeneca.com|
20507051|NCT02357849|Northwell Health|Dr. Christoph Correll|718-470|ccorrell@northwell.edu|7000
20507052|NCT00403559|Dermatology Specialists, PSC|Joseph F. Fowler, Jr., M.D.|502-583-7546|fowlerjoe@msn.com|184
20507053|NCT03637699|Brigham and Women's Hospital|Bonnie Glanz, PhD|617-525-6574|bglanz@bwh.harvard.edu|
20507054|NCT04105244|Frances Payne Bolton School of Nursing, Case Western Reserve University|Valerie Boebel Toly, PhD, RN, CPNP-PC, FAAN|216-534-5844|vab@case.edu|
20507055|NCT04387136|University of Minnesota|Aaron Berg|612-625-7675|bergx831@umn.edu|
20507056|NCT02278289|Department of Physical Medicine and Rehabilitation, Taipei Tzuchi Hospital, Buddhist Tzuchi Medical Foundation, New Taipei City, Taiwan, ROC|Dr. Yi-Shiung Horng|+886-2-66289779|d97841001@ntu.edu.tw|64515
20507057|NCT01029886|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20507058|NCT03294681|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
20507059|NCT00417976|The Ohio State University|Tanios Bekaii-Saab|614-293-9863|Tanios.saab@osumc.edu|
20507060|NCT02720016|VHASDC|Dr. Leslie A. Morland|858-552-4324|Leslie.Morland@va.gov|
20507061|NCT03615911|University Medical Center Hamburg-Eppendorf|Prof. Marylyn M. Addo|+49 40 7410|m.addo@uke.de|51102
20507062|NCT01968954|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507063|NCT05319080|New York State Psychiatric Institute|Michael Avissar|(646) 774-5431|MichaelAvissarMDPhD@gmail.com|
20507064|NCT00751114|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
20507065|NCT02358369|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20507066|NCT05027516|Institute of Tropical Medicine Antwerp|Dr. Chris Kenyon|+32(0)32470786|ckenyon@itg.be|
20507067|NCT00448916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507068|NCT03655717|Massachusetts General Hospital|Dr. Jodi Gilman|617-643-7293|jgilman1@mgh.harvard.edu|
20507069|NCT00592553|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20507070|NCT05092971|National Institute of Mental Health (NIMH)|Dr. Maryland Pao|301-435-5770|paom@mail.nih.gov|
20507071|NCT01328158|AbbVie (prior sponsor, Abbott)|AbbVie Japan PMOS Desk|+81-3-4577-1125|abvj-pmos@abbvie.com|
20507072|NCT01968187|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
20507073|NCT01877382|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
20507074|NCT05149040|Helse Bergen|Dr. G.L. Schwarz|0047-55976850|gabriele.leonie.schwarz@helse-bergen.no|
20507075|NCT01594294|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
20507076|NCT01274338|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20507077|NCT01927744|M.D. Anderson Cancer Center|Xiuning Le, MD|713-792-6363|xle1@mdanderson.org|
20507078|NCT03906227|University of North Carolina at Chapel Hill|Anne Froment|919-445-2622|anne_froment@med.unc.edu|
20507079|NCT03342937|Duke University|Dr. Hope Uronis|919-668-1861|hope.uronis@duke.edu|
20507080|NCT00369967|VCUHS|Nicole Karjane|804-828-8614|nkarjane@mcvh-vcu.edu|
20522982|NCT02687529|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
20507081|NCT03713957|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20507082|NCT01617655|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
20507083|NCT05340322|Duke University|Nimmi Ramanujam, PhD|9196605307|nimmi@duke.edu|
20507084|NCT00418964|The Chinese University of Hong Kong|Pauline Lui|852 2632 3072|pauline@ort.cuhk.edu.hk|
20507085|NCT02351258|Johns Hopkins University|Dr. Aaron Milstone|443-287-8932|amilsto1@jhmi.edu|
20507086|NCT00423735|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20507087|NCT01089582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507088|NCT02394808|Johnson & Johnson Vision Care Inc.|Tawnya Wilson O.D. SR. MANAGER GLOBAL CLINICAL SALES EDU|443-1834|TWilson@ITS.JNJ.com|
20507089|NCT00209170|University of Miami School of Medicine|Dominique Musselman, MD|404-723-8361|dmusselman@med.miami.edu|
20507090|NCT02130427|University of Pennsylvania|Dr. Wei Zou|800-789-7366|Wei.Zou@pennmedicine.upenn.edu|
20507091|NCT00258427|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
20507092|NCT02108600|University of California, San Francisco|Sindhu Chandran|4153538374|sindhu.chandran@ucsf.edu|
20568761|NCT03681353|Duke University Medical Center|Angela Kirby, MS|919-286-0411|angela.kirby@duke.edu|175526
20568762|NCT00520403|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20568763|NCT01797562|Allerderm(dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|
20568764|NCT03930238|University of Iowa|Jacob Simmering|319-384-1107|jacob-simmering@uiowa.edu|
20568765|NCT00917462|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, MD, PhD|646-888-4183|ilsond@mskcc.org|
20568766|NCT03939793|Penn Center for Community Health Workers|Director of Evaluation|267-624-5465|molly.knowles@pennmedicine.upenn.edu|
20568767|NCT00702338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568768|NCT03341312|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20568769|NCT01812707|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
20568770|NCT01631825|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20568771|NCT01514630|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
20568772|NCT01443546|Weill Cornell Medical College|Ina Cholst, MD|646-962-3025|icholst@med.cornell.edu|
20568773|NCT03229356|Johns Hopkins University|Geetanjali Chander|443-287-2030|gchande1@jhmi.edu|
20507093|NCT00992784|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507094|NCT01124448|Complutense University Madrid|Dr. Juan M Rodríguez|34 91 3943837|jmrodrig@vet.ucm.es|
20507095|NCT01029002|Albert Einstein College of Medicine|Dr. Michal Melamed|718-430-2304|michal.melamed@einsteinmed.edu|
20507096|NCT00711269|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20507097|NCT02632110|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
20507098|NCT04146467|Apyx Medical|Kari Larson, MBA, Sr. Director, Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
20507099|NCT01189435|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
20507100|NCT00547378|Pelvic Health & Gastric Therapies|Shenita Bolstrom|763-526-8254|shenita.bolstrom@medtronic.com|
20507101|NCT01449682|Retina Macula Institute|Ron P. Gallemore, M.D., Ph. D.|310) 944-9393|rongallemoremd@gmail.com|
20507102|NCT04863014|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20507103|NCT04633473|Oregon Research Behavioral Intervention Strategies|Jessie Marquez|541-484-2123|jessie.marquez@influentsin.com|
20507104|NCT00426517|National Institute of Allergy and Infectious Diseases|Kang, Elizabeth|+1 301 402 7567|ekang@niaid.nih.gov|
20507105|NCT01982773|National Center for Telehealth and Technology|Nigel E. Bush, PhD|253-968-4153|nigel.e.bush.civ@mail.mil|
20507106|NCT01022567|Turku University Hospital|Paulina Salminen|+358 2 313 0542|paulina.salminen@tyks.fi|
20507107|NCT01003080|Montefiore Medical Center|Dr. Sun Jin Kim|718-920-2060|sukim@montefiore.org|
20507108|NCT01778127|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
20507109|NCT01348425|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
20507110|NCT01317667|US Army Medical Research Institute of Infectious Diseases (USAMRIID)|Denise P Clizbe, RN, CCRC|301.619.6869|denise.p.clizbe.civ@mail.mil|
20507111|NCT02049749|Children's Hospital of Philadelphia|Dr. Joanne Wood, PI|267-426-3107|woodjo@email.chop.edu|
20507112|NCT01032993|BIDMC|Catherine Buettner, MD MPH, Assistant Professor of Medicine|617-754-9600|cbuettne@bidmc.harvard.edu|
20522983|NCT00224289|Principal Investigator|Bruce Shields, MD|203-785-6288|bruce.shields@yale.edu|
20522984|NCT04386616|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20522985|NCT01377012|Novartis|Study Director|862-778-8300||
20522986|NCT01319500|Center for Epidemiology and Health Research Berlin|Dr Juergen Dinger|+49 (0)30 945 10145|dinger@zeg-berlin.de|
20522987|NCT03048552|Columbia University/New York State Psychiatric Institute|Dr. Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
20522988|NCT02448368|Ardea Biosciences, Inc.|Jesse Hall, MD|(858) 652-6672|JHall@ardeabio.com|
20522989|NCT01958073|Kaiser Permanente San Diego|Dr. Kimberly Ferrante|6199801439|klf0409@gmail.com|
20522990|NCT01734161|Weill Cornell Medicine|Klaus Kjaer, MD|(212) 746-2953|klk9001@med.cornell.edu|
20507113|NCT04511026|Stanford University|Amer Karam, MD|650-498-6004|amkaram@stanford.edu|
20507114|NCT04191577|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
20507115|NCT02365584|Ipsen SpA|Medical Director|see email|clinical.trials@ipsen.com|
20522991|NCT03086551|University of Waterloo, Waterloo, Ontario, Canada|Sean K Meehan, PhD|5198884567|skmeehan@uwaterloo.ca|39278
20507116|NCT01185249|Central DuPage Hospital|Dr. Alice Siehoff, Nurse Scientist|1-630-858-0260|asiehoffrn@msn.com|
20522992|NCT05410964|Enspectra Health|President|650 480-6022|clinical@enspectrahealth.com|
20507117|NCT01973452|Memorial Sloan Kettering Cancer Center|Dr. Alessia Pedoto, MD|212-639-6840|pedotoa@mskcc.org|
20507118|NCT02193815|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507119|NCT04363437|Maimonides Medical Center|Dr. Felix Yang|7182836000|fyang@maimonidesmed.org|
20507120|NCT00406783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20522993|NCT01579747|Univeristy of New Mexico|Nicholas Lam|505 272 2610|nlam@salud.unm.edu|
20507121|NCT05294211|Marani Health, Inc.|Vice President, Clinical Affairs|612-718-9699|mindy@maranihealth.com|
20507122|NCT00064350|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20507123|NCT03600714|NIDDK|Dr. Christopher Koh|301-443-9402|kohchris@mail.nih.gov|
20507124|NCT04597619|Maine Medical Center|David Sobel, MD|207-773-1728|david.sobel@mainehealth.org|
20507125|NCT01935336|U of Colorado, Division of Medical Oncology. Anschutz Medical Campus|Dr. Ross Camidge|7208480300|ross.camidge@cuanschutz.edu|
20507126|NCT03707158|Boston University|Donna Pincus|(617) 353-9610|dpincus@bu.edu|
20507127|NCT01743963|Eastern Colorado Health Care System, VA|Liron Caplan, Primary Investigator|7208575103|liron.caplan@ucdenver.edu|
20507128|NCT04092816|University of North Carolina at Chapel Hill|Zev Nakamura, MD|984-974-3829|zev_nakamura@med.unc.edu|
20507129|NCT01747811|University of Arizona|William Killgore|520-621-0605|killgore@psychiatry.arizona.edu|
20507130|NCT03073213|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20507131|NCT03057951|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507132|NCT02064205|TNO|W.J. Pasman, PhD|+31888665129|wilrike.pasman@tno.nl|
20507133|NCT02700919|Mereo BioPharma Group|Ian Hodgson, Head of Clinical Operations|+44 3330237300|enquiries@mereobiopharma.com|
20507134|NCT02680587|Johns Hopkins University|Dr. Phuoc T. Tran|4106143880|ptran12@jhmi.edu|
20507135|NCT01010854|University of California, San Francisco|Pamela Munster, MD|877-827-3222|clinicaltrials@ucsf.edu|
20507136|NCT01194869|Emory University|Elisavet Paplomata, MD|404-778-1900|elisavet.paplomata@emory.edu|
20507137|NCT01708941|ECOG-ACRIN Statistical Office|Study Statistician|(617) 632-3012|eatrials@jimmy.harvard.edu|
20507138|NCT02226146|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20507139|NCT05464836|MD Anderson Cancer Center|Miriam Garcia, DO|(713) 745-4312|mbgarcia@mdanderson.org|
20507140|NCT01522976|SWOG Statistical Center|Leukemia Committee Statistician|206-667-6597|amoseley@fredhutch.org|
20507141|NCT02883049|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20507142|NCT00229203|PharmaMar USA Inc|Claudia Silvia Corrado M.D.|1 212 201 6770|cscorrado@pharmamar.com|
20507143|NCT03457103|NYU Langone|Dr. Anna Norweg|646-501-7777|AnnaMaria.Norweg@nyulangone.org|
20507144|NCT03004469|Polichem S.A.|Francesco Scarci|+41 091 9864 005|francesco.scarci@almirall.com|
20507145|NCT01163253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507146|NCT02492997|Venus Concept Ltd.|Dr. Yoni Iger|888-907-0115|yoni@venusconcpet.com|
20507147|NCT01397552|Upstate Medical University|William Lavelle|315-464-4472|lavellew@upstate.edu|
20507148|NCT00439673|GIMEMA|Alfonso Piciocchi|+39 06.70390521|a.piciocchi@gimema.it|
20507149|NCT00654784|Santhera|Thomas Meier|+4161 906 8964|thomas.meier@santhera.com|
20507150|NCT01722487|Pharmacyclics LLC|Dr. Lori Styles, Medical Monitor|+1 (408) 215-3770|lstyles@pcyc.com|
20507151|NCT00579501|PharmaMar SA, Av de los Reyes 1 Mine Industrial Estate, 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
20507152|NCT00190983|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20507153|NCT02287402|Japan Development Center, Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited|Hitoshi Onouchi|+81-6-6204-5116|hitoshi.onouchi@takeda.com|
20507154|NCT04069156|Abbott|Nourdine Chakouri, PhD|(925) 989-5982|nourdine.chakouri@abbott.com|
20507155|NCT04247815|Aclaris Therapeutics, Inc.|Ajay Aggarwal|484-540-6296|Clintrials@aclaristx.com|
20507156|NCT03822871|Cancer Targeted Technology|Dr. Beatrice Langton-Webster, CEO|(206) 617-0699|bealw@cancertargetedtechnology.com|
20507157|NCT00089479|Hoffman-LaRoche|Medical Communications|800-821-8590||
20507158|NCT03943953|Oxford University Hospitals NHS Foundation Trust|Dr Matthew Hotton|01865 234714|matthew.hotton@ouh.nhs.uk|
20507159|NCT01102218|Fresenius Medical Care North America|Christina Kahn, Senior Manager of Clinical Trials|615-345-5542|christina.meng@fmc-na.com|
20507160|NCT00289185|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507161|NCT00986310|University of California, Davis|Lisa Bateman, MD, FRCPC||lb2863@cumc.columbia.edu|
20507162|NCT01021852|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507163|NCT02408796|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20507164|NCT00441558|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20507165|NCT04799405|Hebrew SeniorLife|Dr. Pascual-Leone|6179715372|apleone@hsl.harvard.edu|
20507166|NCT00603980|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20522994|NCT00727597|Georegtown University|Dr. Princy Kumar|2024440086|kumarp@georgetown.edu|
20522995|NCT02215967|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
20522996|NCT03514017|Moffitt Cancer Center|Julio Chavez, MD, MS|813-745-4294|julio.c.chavez@moffitt.org|
20522997|NCT03023176|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
20522998|NCT05680740|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20522999|NCT05221320|Biomed Valley Discoveries|Deborah Knoerzer, Director Translational Sciences|6368876429|dknoerzer@biomed-valley.com|
20507167|NCT00906074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507168|NCT02618928|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20507169|NCT01096849|Achaogen, Inc.|Clinical Trials Posting Group||clinical-trials@achaogen.com|
20507170|NCT04460690|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
20507171|NCT02856269|University Hospitals Cleveland Medical Center|Dr. Grace McComsey|216-8442739|Grace.McComsey@UHhospitals.org|
20507172|NCT00127062|Imperial College London|Professor Fan Chung|+44 (0)20 7594 7954|f.chung@imperial.ac.uk|
20507173|NCT01269372|Givenimaging|Hilla Debby/ Director of Clinical Affairs|97299077740|hila.debby@medtronic.com|77740
20507174|NCT03927508|Clinical Reserach Specialist|Pamela Dicamillo|719-400-7463|pdicamillo@ecr-inc.com|
20507175|NCT01253421|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
20507176|NCT00264849|Novartis Pharmaceuticals|Study Director|862-778-8300||
20507177|NCT00099359|Westat|Margaret Camarca, Project Director|301-517-4128|margaretcamarca@westat.com|
20507178|NCT02104804|AstraZeneca|Eva Johnsson, MD, PhD, Global Clinical Lead||Eva.Johnsson@astrazeneca.com|
20507179|NCT04501679|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20507180|NCT04846348|Mayo Clinic|Dr. Joseph Butterfield|507-284-3783|butterfield.joseph@mayo.edu|
20507181|NCT02121756|University of Pittsburgh Department of Medicine|Sharon Riddler, MD|412-383-1675|riddler@pitt.edu|
20507182|NCT00838916|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507183|NCT01927419|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20507184|NCT03488251|Molecular Templates, Inc.|Study Director|512 930-0304|trials@mtem.com|
20507185|NCT03019744|Fondazione Don Carlo Gnocchi|Dr Maurizio Ferrarin|+390240308305|mferrarin@dongnocchi.it|
20507186|NCT00115765|Amgen Inc.|Study Director|866-572-6436||
20507187|NCT00995670|Zablocki VA Medical Center|Thomas J. Ebert, MD, PhD|414-384-2000|thomas.ebert@va.gov|42429
20507188|NCT00675103|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
20507189|NCT01568424|St. Jude Medical|Poornima Sood|+1.781.852.8334|psood@sjm.com|
20507190|NCT02006264|Albert Einstein College of Medicine|Marla Keller, MD, Principal Investigator|718-430-3240|marla.keller@einstein.yu.edu|
20507191|NCT01244191|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20507192|NCT01752842|Washington University School of Medicine|Jean E. Schaffer, MD|314-362-8717|jschaff@wustl.edu|
20507193|NCT05584202|ModernaTX, Inc.|Moderna WeCare Team|866-663-3762|WeCareClinicalTrials@modernatx.com|
20507194|NCT02773238|University of Washington|Dr. Jing Zeng|206-598-4110|jzeng13@uw.edu|
20507195|NCT03260205|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20507196|NCT04095286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20507197|NCT00479557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507198|NCT02509494|Janssen Vaccines & Prevention B.V.|Senior Director Clinical Franchise Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20507199|NCT01511107|Children's Hospital of Pittsburgh of UPMC|Dr. Alejandro Hoberman|412-692-5249|hobermana@upmc.edu|
20507200|NCT04752189|Wayne State University|Dr. Andria Eisman, Principal Investigator|313-649-7477|aeisman@wayne.edu|
20507201|NCT00975195|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507202|NCT03052842|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
20507203|NCT05084053|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20507204|NCT02180724|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20523000|NCT06473519|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
20523001|NCT03184571|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
20523002|NCT02514447|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20523003|NCT05351164|University of Michigan|Elif Oral|734-615-7271|eliforal@med.umich.edu|
20523004|NCT06419907|University of Liverpool|Gemma Lewis|01744 646668|gemma.lewis@liverpool.ac.uk|
20523005|NCT05849259|Massachusetts General Hospital|Dr. Christine S Ritchie|415-672-1780|csritchie@mgh.harvard.edu|
20523006|NCT04856917|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20553309|NCT01256710|Abbott Medical Devices, Structure Heart Valves|Yunlong (Phil) Zhang, MD, MS, Clinical Consultant|669-203-9308|phil.yl.zhang@abbott.com|
20507205|NCT05195359|Resmed Germany Inc|Susanne Fischer / Sr. Manager Clinical Research|+491707854257|susanne.fischer@resmed.de|
20507206|NCT00847938|Clinique Jules Verne|Dr Florent CAPRON|0251171775|florent.capron@mla.fr|33
20507207|NCT01146951|Eisai Call Center|Eisai Inc.|888-422-4743||
20523007|NCT03560037|University of California Davis|Christopher L. Bowlus, MD|916-734-8851|clbowlus@health.ucdavis.edu|
20523008|NCT03620708|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
20523009|NCT05168202|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20523010|NCT04483583|University of Florida|Dominick J Angiolillo|904-244-2636|dominick.angiolillo@jax.ufl.edu|
20523011|NCT04011722|Abbott|Nels Engblom|3198533946|nels.engblom1@abbott.com|
20523012|NCT06389396|Coloplast A/S|Julie Schnipper, Medical Writer|004549111257|dkjuls@coloplast.com|
20523013|NCT01013077|Southern California College of Optometry|William Ridder|714-449-7494|wridder@scco.edu|
20523014|NCT06195930|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20523015|NCT03999996|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20523016|NCT03690388|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20523017|NCT02487966|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
20523018|NCT00266630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20523019|NCT03525886|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20523020|NCT05377749|University of North Carolina Lineberger Comprehensive Cancer Center|Zev Nakamura, MD|(984) 974-3829|zev_nakamura@med.unc.edu|
20523021|NCT04909853|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523022|NCT03397589|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
20523023|NCT00077207|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
20523024|NCT06184399|Swiss Tropical and Public Health Institute|Prof Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
20523025|NCT01474200|Baxter Healthcare Corporation|Drew Jones, MD, Senior Medical Director|224-270-2659|drew_jones@baxter.com|
20523026|NCT03071692|Kowa Research Institute, Inc.|Director, Clinical Operations|1 (919) 433-1600|CTGResults@KowaUS.com|
20523027|NCT01720225|The University of Texas MD Anderson Cancer Center|Elias Joseph MD./Professor|713-792-4764|ejabbour@mdanderson.org|
20523028|NCT02738138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20523029|NCT05387889|State University of New York at Buffalo School of Nursing|Dr. Tania Von Visger|7168292201|Taniavon@buffalo.edu|
20523030|NCT04362670|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
20523031|NCT03044028|Cleveland Clinic|Carlos Higuera|954-659-5430|higuerc@ccf.org|
20523032|NCT03571828|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20523033|NCT00666328|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
20523034|NCT02441686|Dana-Farber Cancer Institute|Emily Benjamin|6176324167|emily_benjamin@dfci.harvard.edu|
20523035|NCT03762239|Barcelona Institute for Global Health (ISGlobal)|Dr. Xavier Basagaña|(+34) 93 214 7306|xavier.basagana@isglobal.org|
20523036|NCT04471428|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20523037|NCT03151304|Helsinn Healthcare|Francesco Scarci, Clinical Operations Manager|+41 (0)91 985 2121|francesco.scarci@helsinn.com|
20523038|NCT00548470|Nathan Kline Institute for psychaitric Research|Robert C Smith MD|845-398-6531|rsmith@nki.rfmh.org|
20523039|NCT01137071|Recepta Biopharma|Director of Clinical Trials|55 11 3709-2140|recepta@receptabio.com.br|
20523040|NCT02565511|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20523041|NCT04807400|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20523042|NCT03656744|HighTide Therapeutics|Chief Medical Officer|314-791-0593|adibisceglie@hightidetx.com|
20523043|NCT01255137|National Cancer Institute, National Institutes of Health|Dr. Tito Fojo|301-496-2631|FojoT@mail.nih.gov|
20523044|NCT01696760|The Ohio State University Comprehensive Cancer Center|Joel Mayerson, MD|614-293-4420|joel.mayerson@osumc.edu|
20523045|NCT01332292|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523046|NCT03295630|Hull University Teaching Hospitals NHS Trust|Dr. Jayne Anderson|01482 875875|jayne.anderson@hey.nhs.uk|5099
20523047|NCT00098774|University of California, San Francisco|James Rubenstein, MD, PhD||jamesr@medicine.ucsf.edu|
20523048|NCT03910673|Duke Vaccine and Trials Unit|Emmanuel Walter, MD, MPH|919-620-5346|chip.walter@duke.edu|
20523049|NCT00464438|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20523050|NCT03020537|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20523051|NCT00489827|Dept Cardiothoracic Surgery, Linköping University Hospital, SE58185 Linköping, Sweden|Rolf Svedjeholm|+46101034825|rolf.svedjeholm@regionostergotland.se|
20523052|NCT02296931|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
20523053|NCT01590277|VA Connecticut Healthcare System|Deepak Cyril D'Souza, MD|203-932-5711|deepak.dsouza@va.gov|2594
20523054|NCT02159079|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
20523055|NCT01632280|Beth Israel Deaconess Medical Center|Dr. Miguel Alonso-Alonso|617-667-0240|malonso@bidmc.harvard.edu|
20523056|NCT03736031|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|915-215-5103|elp-obgynresearch@ttuhsc.edu|
20523057|NCT05022212|University of California, San Francisco|Dr Anke Hemmerling, Co-Investigator|4154765878|anke.hemmerling@ucsf.edu|
20523058|NCT00451178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20523059|NCT02729909|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20523060|NCT01260701|SWOG Statistical Center|Study Statistician|206-667-4623||
20523061|NCT00289120|Emory University|Kenneth Ogan|404-778-4898|kogan@emory.edu|
20523062|NCT03300817|Mayo Clinic|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
20523063|NCT01581437|Virginia CU|Kenneth Ellenbogen|804-828-7565|kellenbogen@mcvh-vcu.edu|
20523064|NCT03729596|MacroGenics, Inc.|Stephen L. Eck, MD|301-251-5172|info@macrogenics.com|
20523065|NCT01499095|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20523066|NCT02400996|Sir Ganga Ram Hospital, New Delhi, India|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
20523067|NCT02548156|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523068|NCT03052751|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20523069|NCT00743717|Los Alamitos Orthopaedic Group|Dr. Perry Secor|805-384-2748|vsarin@kinamed.com|
20523070|NCT00444587|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20523071|NCT00582660|University of Alabama at Birmingham|Martin J. Heslin M.D.|205-975-0450|marty.heslin@ccc.uab.edu|
20523072|NCT02229461|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20523073|NCT01221207|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20523074|NCT00661193|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
20523075|NCT01811472|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20523076|NCT03288714|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
20523077|NCT03280264|Kyowa Kirin Co., Ltd.|Research & Development Planning Department, Research & Development Division|+81-3-5205-7200|clinical.info.jp@kyowakirin.com|
20553310|NCT04352140|Mayo Clinic|J. Ross Renew, M.D.|904-956-3325|Renew.J@mayo.edu|
20553311|NCT02681302|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20553312|NCT01736696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523078|NCT02574832|Northwerstern University|Paloma Toledo, M.D.|312-472-3585|p-toledo@northwestern.edu|
20523079|NCT05273411|University of British Columbia|Jonathan Little, PhD|2508079876|jonathan.little@ubc.ca|
20523080|NCT00524420|University of Washington|David H. Avery, MD, Professor|206-744-4527|averydh@u.washington.edu|
20523081|NCT00577863|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20523082|NCT00897910|Barbara Ann Karmanos Cancer Institute|Zaid S. Al-Kadhimi, M.D.|313-576-8022|alkadhiz@karmanos.org|
20523083|NCT03127514|Amylyx Pharmaceuticals|Amylyx Pharmaceuticals, Head of Clinical R&D|(617) 682-0917|medinfo@amylyx.com|
20523084|NCT00295893|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20523085|NCT02543944|University of Arkansas for Medical Sciences|Dr. Alison H. Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
20523086|NCT00629018|UMC Ljubljana|Prof. Dr. Bojan Vrtovec|+3861 522 2844|bvrtovec@stanford.edu|
20523087|NCT02665221|MS Comprehensive Care Center NYU Langone Health|Shannon Haas|646 501 7504|Shannon.Haas@nyumc.org|
20523088|NCT03639779|University of Central Florida College of Medicine|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
20523089|NCT00645970|James A. Haley Veterans' Hospital|Kristin Phillips|813-972-2000|kristin.phillips3@va.gov|6721
20523090|NCT02413229|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20523091|NCT02932462|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20523092|NCT01995513|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523093|NCT01232452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20523094|NCT01037452|Novartis|Head New Therapeutic Opportunities|973-503-8000||
20523095|NCT01750190|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|060study@fibrogen.com|
20523096|NCT04584684|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD, MS|847-702-0988|ljacox@live.unc.edu|
20523097|NCT02009722|Mayo Clinic|Dr. Hans Sviggum|507-581-6083|sviggum.hans@mayo.edu|
20523098|NCT02955212|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20523099|NCT02319317|University of Pennsylvania|Catherine McDonald. PhD, RN|2157468355|mcdonalc@nursing.upenn.edu|
20523100|NCT00371436|VA RR&D, NCRAR|James A. Henry, Ph.D.|5032208262|james.henry@va.gov|57466
20523101|NCT02454933|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20523102|NCT01311687|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599||
20523103|NCT02071225|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20523104|NCT01342081|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20523105|NCT01973439|MRC Clinical Trials Unit at UCL|Trial manager|02076704825|silvia.forcat@ucl.ac.uk|
20523106|NCT05027308|Takeda|Study Director|1-877-825-3327|TrialDisclosures@takeda.com|
20523107|NCT01275846|Detroit Medical Center, Detroit, MI|Ileana L. Piña, MD, MPH, FAHA, FACC|216-225-7385|ilppina@aol.com|
20523108|NCT00918866|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
20523109|NCT02232984|Boston Scientific|Eszter Pais|6515825307|eszter.pais@bsci.com|
20523110|NCT01472692|UCSD|Department of Medicine|(858) 552-8585||
20523111|NCT00769379|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20523112|NCT03934541|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20523113|NCT02673775|Rutgers, the State University of New Jersey|Andrew Gow, PhD|848-445-4612|gow@pharmacy.rutgers.edu|
20523114|NCT00535405|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20523115|NCT03519087|The Ohio State University|Dr. Stephanie Di Stasi|614-685-9779|stephanie.distasi@osumc.edu|
20523116|NCT03076775|University of North Carolina at Chapel Hill|Ashley Battarbee, MD, MSCR|205-975-2361|anbattarbee@uabmc.edu|
20523117|NCT00104572|NIA|Josephine M. Egan,MD, clinical director NIA|410-558-8414|eganj@grc.nia.nih.gov|
20523118|NCT02290405|National Jewish Health|Bryan Simmons|303-398-1850|SimmonsB@NJHealth.org|
20523119|NCT02016183|Takeda|Medical Director|1-877-825-3327|trialdisclosures@takeda.com|
20553313|NCT00838565|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523120|NCT03142191|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20507208|NCT01586026|Bard Access Systems, Inc.|Christopher DiMatteo|801-522-5000|chris.dimatteo@crbard.com|
20507209|NCT02690207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20507210|NCT01353144|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20507211|NCT03224585|VCU Health|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
20523121|NCT03168022|Tonix Pharmaceuticals|Gregory Sullivan, MD||greg.sullivan@tonixpharma.com|
20507212|NCT01175213|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20507213|NCT01921634|The Pennsylvania State University, Hershey Medical Center|Andrea Benton, MD|717-531-5394|abenton@pennstatehealth.psu.edu|
20507214|NCT05136170|Dompé farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20507215|NCT03624478|Mayo Clinic|Dr. Carlos Vargas|480-342-1267|Vargas.Carlos@mayo.edu|
20507216|NCT03263117|The University of Texas Health Science Center at Houston|Peng Roc Chen, MD|713-486-8016|peng.r.chen@uth.tmc.edu|
20507217|NCT02275767|Univ of Texas Health Sci Ctr San Antonjio, Dept of Periodontics|Brian L. Mealey DDS, MS|210-567-3567|mealey@uthscsa.edu|
20507218|NCT00571688|University of Alabama at Birmingham|Tracy Manley|205-975-3442|tlmanley@uabmc.edu|
20507219|NCT01048853|The University of Texas MD Anderson Cancer Center|Kathleen Schmeler, MD|(713) 854-9150|kschmele@mdanderson.org|
20507220|NCT04999969|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20507221|NCT03739853|University of Oxford, NDORMS|Laura Coates|+441865737838|laura.coates@ndorms.ox.ac.uk|
20507222|NCT04026178|Chiesi|Metreleptin Clinical Program Lead|+3905212791|clinicaltrials_info@chiesi.com|
20507223|NCT02500602|Medical University of South Carolina|Sudie Back|843-792-9383|backs@musc.edu|
20507224|NCT03934710|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20507225|NCT04735393|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20507226|NCT01621672|University of Arkansas for Medical Sciences|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
20507227|NCT03150095|Mayo Clinic|Dr. Cassie Kennedy|507-266-3958|kennedy.cassie@mayo.edu|
20507228|NCT01735617|Diurnal Ltd.|CEO|+44 (0) 871 716 8848|info@diurnal.co.uk|
20507229|NCT04570332|Highlight Therapeutics Ltd.|M. Quintero, CEO|+34686219355|mquintero@highlighttherapeutics.com|
20507230|NCT02769351|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49617260893488|jennifer.braun@fmc-ag.com|
20507231|NCT03224104|UniversitaetsSpital Zurich - Neurology Clinic|Dr Emilie Le Rhun|+41 762847518|emilie.lerhun@usz.ch|
20507232|NCT05025787|MGH|Allison Campbell|617-595-8372|acampbell17@mgh.harvard.edu|
20507233|NCT05600309|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20507234|NCT06087328|Medical University of South Carolina|Amanda M. Palmer, PhD|843-792-1413|palmeram@musc.edu|
20507235|NCT05822830|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20507236|NCT05127044|University of Arkansas for Medical Sciences|Rebecca P Sartini, DNP|5015261580|rpsartini@uams.edu|
20507237|NCT03368664|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20507238|NCT05612581|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20507239|NCT03589326|Director|Medical|+1-877-825-3327|trialdisclosures@takeda.com|
20507240|NCT05441592|University of Michigan|Edwin Wilkins|734-936-6680|ewilkins@med.umich.edu|
20523122|NCT00825786|University of North Carolina, Department of Anesthesiology, University of North Carolina|Priya Kumar, MD|(919) 966-5136|pkumar@aims.unc.edu,|
20523123|NCT02171195|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
20553314|NCT00458484|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Mitchell Machtay MD|216-844-2530|mitchell.machtay@uhhospitals.org|
20523124|NCT03091179|Stanford University|Vladimir Nekhendzy|650-498-4055|nek@stanford.edu|
20553315|NCT03571516|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20523125|NCT00770328|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
20523126|NCT01130493|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|(908) 307-2234|Kaihong.Jiang@amneal.com|
20523127|NCT03730207|Medtronic|Jane Zhang|86+18612318110|jane.zhang7@medtronic.com|
20523128|NCT02263963|Spectrum Health|Dr. Nezar Jrebi|507-271-8284|jrebi.nezar@hotmail.com|
20523129|NCT00879086|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
20523130|NCT02969044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
20523131|NCT04728802|Applied Biology, Inc.|Dr. John McCoy|+1 (949)387-4526|johnm@appliedbiology.com|
20523132|NCT04650204|Mayo Clinic|William Tatum, D.O.|507 284-2511|Tatum.William@mayo.edu|
20523133|NCT01330303|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523134|NCT03714919|Nationwide Children's Hospital|Arlyne Thung, MD|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
20523135|NCT02517463|The University of Hong Kong|Dr. Raymond Li|+852 22553914|raymondli@hku.hk|
20523136|NCT03180645|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20553316|NCT01455012|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20553317|NCT02940327|University of Leicester|Clinical Trials Co-ordinator|0116 250 2427|ha200@le.ac.uk|
20553318|NCT02253810|Hospital for Special Surgery|Dr. Ernest Sink|2126061279|Sinke@hss.edu|
20553319|NCT01467999|NYSPI|daniel brooks|6467746171|daniel.brooks@nyspi.columbia.edu|
20553320|NCT00291668|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20553321|NCT00704028|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20553322|NCT00313612|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
20553323|NCT04656132|NYU Rory Meyers College of Nursing|Margaret M. McCarthy, PhD, RN, FNP-BC|212-992-5796|mmm529@nyu.edu|
20553324|NCT01153581|Yale School of Medicine|Nina Stachenfeld|203-562-9901|nina.stachenfeld@yale.edu|219
20523137|NCT04208750|Indiana University|Dr. Dawn Meyer|812-855-0559|meyerd@indiana.edu|
20523138|NCT04977479|National Institute of Allergy and Infectious Diseases|Pamela Frischmeyer-Guerrerio|301-402-9782|pamela.guerrerio@nih.gov|
20523139|NCT02201277|University of California, San Francisco, Interventional Radiology|Maureen Kohi, MD|(415) 353-1300|maureen.kohi@ucsf.edu|
20523140|NCT00940316|Northwestern University|Dr. Al Benson|(312) 695-0184|albenson@nm.org|
20523141|NCT02324582|Southern Illinois University School of Medicine|Dr. Krishna Rao|217-545-7969|krao@siumed.edu|
20523142|NCT04309617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553325|NCT00245765|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20553326|NCT04976530|CytoSorbents Corp|Weihong Fan|732-329-8885|wfan@cytosorbents.com|
20553327|NCT02283788|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
20553328|NCT03366077|BioGaia AB|Jenny Palming Clinical research Director|+46 738299900|jp@biogaia.se|
20553329|NCT00634647|National Cancer Institute, National Institutes of Health|Dr. William Dahut|301-435-8183|dahutw@mail.nih.gov|
20553330|NCT00667342|St. Jude Children's Research Hospital|Michael Bishop, MD|866-278-5833|referralinfo@stjude.org|
20553331|NCT01207778|University of Utah|Dr. Robin Ohls|505-400-7644|robin.ohls@hsc.utah.edu|
20553332|NCT01433263|Novartis Pharmaceuticals|Study Director|862-778-8300||
20553333|NCT04016324|Medtronic|Rianna Rapson (Prin. Clinical Research Specialist)|763-526-2170|rianna.k.rapson@medtronic.com|
20553334|NCT04709237|Coopervision|Paul Chamberlain|925-251-6682|PChamberlain@coopervision.com|
20553335|NCT04048460|University of South Florida Department of Communication Sciences & Disorders|Michelle Arnold, AuD, PhD, CCC-A Assistant Professor|(813) 974-1262|mlarnold@usf.edu|
20553336|NCT00503841|Barbara Ann Karmanos Cancer Institute|Dr. Elaina Gartner|313-576-8724|egartner@seagen.com|
20553337|NCT03285373|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20553338|NCT01359592|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
20553339|NCT02881996|Children's Mercy Hospital|Shawn St. Peter|816-234-3000|sspeter@cmh.edu|3575
20553340|NCT00326612|DIvision of Pediatric Emergency Medicine|Maija Holsti, MD, MPH|801-587-7450|maija.holsti@hsc.utah.edu|
20553341|NCT00419562|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
20553342|NCT01276314|Chang Gung Memorial Hospital, Linko|Drug Hypersensitivity Clinical and Research Center, Laboratory of Dr. Wen-Hung Chung,|886-3-328-1200|kiruamairo@gmail.com|8494
20553343|NCT00933491|University of Michigan|Tae-Ju Oh|734-647-3320|taejuoh@umich.edu|
20553344|NCT02530294|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
20553345|NCT01236196|San Francisco VA Medical Center|Dr. Timothy Carmody|415-221-4810|Timothy.Carmody@va.gov|6344
20553346|NCT01067352|Merck Serono S.p.A., Italy, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
20553347|NCT02566759|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20523143|NCT00129545|Boston Scientific|Watchman Trial Manager|1-800-227-3422||
20523144|NCT03112473|Department of Rehabilitation Science, The Hong Kong Polytechnic University|Prof. Shamay Ng|27664889|shamay.ng@polyu.edu.hk|
20523145|NCT01776632|San Diego State University|Elva Arredondo|(619) 594-3481|earredon@sdsu.edu|
20553348|NCT00976898|Massachusetts General Hospital|Theodore Sunki Hong, MD|617-724-1159|tshong1@mgh.harvard.edu|
20553349|NCT05107128|Sage Therapeutics|Amy Bullock, PhD|617-949-5151|amy.bullock@sagerx.com|
20523146|NCT02286843|Memorial Sloan Kettering Cancer Center|Dr. Gary Ulaner, MD, PhD|212-639-7373|carrasj1@mskcc.org|
20523147|NCT02536846|McLean Hospital|Dr. Dost Öngür|617-855-3922|dongur@partners.org|
20523148|NCT03164616|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20523149|NCT04388553|Tuen Mun Hospital|Anyon Chan|24680000|Ca663@ha.org.hk|+852
20523150|NCT02123446|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568774|NCT05372913|Woebot Health|Dr. Athena Robinson|(415) 209-5642|athena@woebothealth.com|
20568775|NCT03193216|Medical University of South Carolina|Dr. Puja Elias, Associate Professor, PI for study|8438764269|eliasps@musc.edu|
20568776|NCT03275402|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
20568777|NCT01514864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20568778|NCT05135156|University of Washington|Dr. Kathleen J. Ramos|2065430393|ramoskj@uw.edu|
20568779|NCT02986659|Atrium Health Wake Forest Baptist|Jingzhong Ding, PhD|336-713-8601|jding@wakehealth.edu|
20568780|NCT00647998|Hospital of the University of Pennsylvania|Steven Messe, MD|2156623363|messe@mail.med.upenn.edu|
20568781|NCT01956071|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
20568782|NCT01259440|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
20568783|NCT02254681|Allina Health|Srinevas K. Reddy|612-863-8716|laura.rockwell@allina.com|
20568784|NCT02469077|Vanderbilt University Medical Center|Stephen Bruehl, Ph.D.|615-936-1821|stephen.bruehl@vumc.org|
20568785|NCT01059526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20568786|NCT01732588|MMV|Dr Fiona Macintyre|+41 22 799 4060|macintyref@mmv.org|4078
20568787|NCT02005029|Virginia Commonwealth University|Dr. Leslie Cloud|804-662-5304|leslie.cloud@vcuhealth.org|
20568788|NCT01370018|Institute for Human Genetics and Biochemistry|Cynthia L. Bristow, MS, PhD|6314446238|cynthia.bristow@alpha1biologics.com|
20568789|NCT03690921|M D Anderson Cancer Center|Dr. Emma Holliday|713-563-2340|EBHolliday@mdanderson.org|
20568790|NCT02406495|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20568791|NCT01525641|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568792|NCT03772041|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20568793|NCT02204319|ProHealth Care|Linda LaBorde PT|262-928-5139|linda.laborde@phci.org|
20568794|NCT00383747|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
20568795|NCT03544229|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20507241|NCT01371981|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20507242|NCT01586156|Cleveland Clinic|Dr. Serpil Erzurum|216-445-6624|erzurus@ccf.org|
20507243|NCT00414960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20507244|NCT01525927|North Shore LIJ Cancer Institute|Jeffrey Revello Sr. Administrative Manager|516 734 7629|jrevello@nshs.edu|
20523151|NCT04604795|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20553350|NCT01740596|CHF Solutions|Audrey Singh|9523454217|audrey.singh@chf-solutions.com|
20568796|NCT04748445|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568797|NCT03840278|Massachusetts General Hospital Diabetes Research Center|Courtney A Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
20568798|NCT03805698|Cedars-Sinai Medical Center|David Kulber, MD, PI|3104235900|david.kulber@cshs.org|
20568799|NCT04405089|Minneapolis VA Medical Center|Dr. Shalamar Sibley, MD, MPH|612-467-1727|Shalamar.Sibley@va.gov|
20568800|NCT00139659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20568801|NCT02943109|Ohio State University College of Medicine|Prof. Ann Scheck McAlearney|614-293-8973|Ann.McAlearney@osumc.edu|
20568802|NCT01209936|University of Southern California|Dr. David Erceg|(323) 442-2900|erceg@usc.edu|
20568803|NCT02382913|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20568804|NCT00024102|University of North Carolina|Hyman Muss, MD||hyman.muss@gmail.com|
20568805|NCT03356145|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20568806|NCT00702234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568807|NCT00905255|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20536806|NCT01597908|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20553351|NCT05459129|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20553352|NCT04304001|Florida A&M University|Dr. Tanise Jackson, Director of Animal Welfare Research Integrity|850-599-3214|tanise.jackson@famu.edu|
20553353|NCT03307759|Peter MacCallum Cancer Centre|Clinical Research Development and Operations|+61 3 8559 5000|crdo@petermac.org|
20553354|NCT04649151|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20553355|NCT02975934|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
20553356|NCT02102256|University of Southern California|Dr. Laurie Eisenberg|213-764-2826|laurie.eisenberg@med.usc.edu|
20553357|NCT03362502|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553358|NCT03032796|University of California San Francisco|"Joaquin A. Anguera, Associate Professor, Neuroscape | UCSF"|415-502-7322|joaquin.anguera@ucsf.edu|
20553359|NCT05429203|Stanford University|Subhas Banerjee, MD|(650) 736-5555|subhas.banerjee@stanford.edu|
20553360|NCT00433654|Medtronic, Inc|EnRhythm MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
20553361|NCT02509065|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
20553362|NCT03523117|American Regent, Inc.|Mark A. Falone, MD|631.772.3544|mfalone@americanregent.com|
20553363|NCT03909009|Izmir Katip Çelebi University, Faculty of Medicine|Doç.Dr. Ayhan AŞKIN|00902322444444|ayhanaskin@hotmail.com|1529
20523152|NCT00611624|Yale Comprehensive Cancer Center|Kira F. Pavlik, CCRP Clinical Research Coordinator Therapeutic Radiology|(203) 737-2587|kira.pavlik@yale.edu|
20523153|NCT02864355|The Medical University of South Carolina|George Guldan, MD|843-876-5744|guldan@musc.edu|
20523154|NCT00719186|Yale University|Heping Zhang|203-785-5185|rmn-dcc@panlists.yale.edu|
20523155|NCT04768686|Hanmi Pharm. Co., Ltd.|Young Su (Bobby) Noh|82-2-410-9277|63forever@hanmi.co.kr|
20523156|NCT04502212|GE Research|Diane Minas|(518)698-3959|minas@ge.com|
20523157|NCT03022916|UAB|Director of Clinical Trials, UAB Dermatology|2055029960|Lmroop@uabmc.edu|
20523158|NCT02096744|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20523159|NCT04912232|Dartmouth Health|Norman A. Paradis|(603) 650-7254|Norman.A.Paradis@hitchcock.org|
20523160|NCT02445963|Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC)|Christopher Duplessis, MD|301-319-9047|Christopher.a.duplessis.mil@mail.mil|
20523161|NCT00125515|New York Psychiatric Institute|Dr Adam Bisaga|212-543-6542|bisagaa@nyspi.columbia.edu|
20523162|NCT01957176|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20523163|NCT01182376|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
20523164|NCT00625872|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523165|NCT01512160|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523166|NCT02972892|GE Healthcare|Research Program Integrator|262-290-6037|meghan.terry@ge.com|
20523167|NCT02905032|Mayo Clinci|Peter A. Noseworthy, M.D.|507-255-2446|Noseworthy.Peter@mayo.edu|
20523168|NCT00739063|UT MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD, MS / Associate Professor||CR_Study_Registration@mdanderson.org|
20523169|NCT02730663|Taewoong Medical Co., Ltd.|JiYoung Ahn/Assistant manager|+82-70-4649-1624|sarahahn@stent.net|628
20523170|NCT00866359|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20523171|NCT01625091|Unversity of Florida|Dr. Robert Cook|352-273-5869|cookrl@ufl.edu|
20523172|NCT02163057|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20523173|NCT02254265|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
20523174|NCT00768248|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
20523175|NCT03126448|Indiana University Health|Dr. Roman Natoli|713-516-8973|rnatoli@IUHealth.org|
20523176|NCT01547390|University of South Florida|Dr. Anthony Odibo|813-259-0828|aodibo@health.usf.edu|
20553364|NCT03277261|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20553365|NCT00499603|The University of Texas MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20523177|NCT04182334|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
20553366|NCT03323099|University of California San Francisco|Dr. Greg Marcus|4154763393|greg.marcus@ucsf.edu|
20553367|NCT05220397|Mayo Clinic|Mark Stegall, M.D.|507-266-2812|stegall.mark@mayo.edu|
20523178|NCT01959295|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20523179|NCT02698033|Massachusetts General Hospital|Wayne Shreffler|6177266147|wshreffler@mgh.harvard.edu|
20523180|NCT04917861|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20523181|NCT01004744|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
20523182|NCT01128179|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20523183|NCT01682811|Medical College of Wisconsin|Harry T. Whelan MD, Bleser Professor of Neurology|414-266-7544|hwhelan@mcw.edu|
20523184|NCT02694328|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20523185|NCT00134004|Johns Hopkins University|Dr. Ephraim Fuchs|410-419-6479|fuchsep@jhmi.edu|
20523186|NCT07112885|Istanbul University, Department of Orthopedics and Traumatology|Mehmet Yağız Yenigün, MD (Principal Investigator)|+905544383142|mehmet.yenigun@istanbul.edu.tr|
20523187|NCT00720382|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
20523188|NCT05192889|St. Jude Children's Research Hospital|Seth Karol, MD|(901) 595-1716|seth.karol@stjude.org|
20523189|NCT04536376|Mayo Clinic|Dr. Ivana T. Croghan|507-284-2511|GIMRESEARCHSTUDIES@MAYO.EDU|
20523190|NCT03325101|Mayo Clinic|Matthew Block, MD, PhD|507-266-7446|Block.Matthew@mayo.edu|
20523191|NCT00265759|Baylor College of Medicine|Matthew J. Ellis, MB, BChir, BSc., PhD, FRCP|713 798-1999|Matthew.Ellis@bcm.edu|
20523192|NCT03713593|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20523193|NCT05061134|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20523194|NCT00001521|Clinical Center|Merke, Deborah|+1 301 496 0718|dmerke@nih.gov|
20523195|NCT03176134|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20523196|NCT03915652|Brigham and Women's Hospital|Dr. Candace Feldman|6175251035|cfeldman@bwh.harvard.edu|
20523197|NCT05736861|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20523198|NCT03410056|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20523199|NCT00879255|Department of Veterans Affairs|Leslie A. Morland, Clinical Psychologist|(619) 497-8406|leslie.morland@va.gov|
20523200|NCT05239611|University of Kansas Medical Center|Joel Mermis|913-588-6045|jmermis@kumc.edu|
20523201|NCT00443729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20523202|NCT03242408|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
20523203|NCT02099786|VA RR&D National Center for Rehabilitative Auditory Research|Dr. Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
20523204|NCT03718832|MIT Sloan School of Management|Joseph doyle|6174523761|jjdoyle@mit.edu|
20523205|NCT01996241|London School of Hygiene and Tropical Medicine|Dr Tara Beattie|0044 (0)2079272613|tara.beattie@lshtm.ac.uk|
20523206|NCT04182490|Lumen Bioscience, Inc.|Senior Medical Director|206-899-1904|trials@lumen.bio|
20523207|NCT04882241|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicalTrialsDisclosure@msd.com|
20523208|NCT00074308|Abramson Cancer Center of the University of Pennsylvania|Jane Daly|215-662-2812|jane@mail.med.upenn.edu|
20523209|NCT01648530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20523210|NCT02091856|West University of Timisoara|Dr. Bogdan Tudor Tulbure|+040745753061|btulbure@gmail.com|
20523211|NCT05262387|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20523212|NCT00758524|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20553368|NCT02043015|Emory University|Patrick S Sullivan PhD/DVM|404-727-2038|pssulli@emory.edu|
20553369|NCT01990677|Wills Eye|Mitchell Fineman,MD|215-928-3092|research@midatlanticretina.com|
20553370|NCT02471521|Seoul National University Hospital|Jin-Tae Kim|82-2-2072-3661|jintae73@gmail.com|
20523213|NCT04176250|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20523214|NCT01339403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523215|NCT04090125|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
20523216|NCT00354913|Duke University Medical Center|Dr. Annick Desjardins|919-681-1691|annick.desjardins@dm.duke.edu|
20523217|NCT04747470|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20523218|NCT03440840|Nova Southeastern University|Raymond L Ownby, MD, PhD|954-262-1481|ro71@nova.edu|
20523219|NCT04720053|Mayo Clinic|Dr. Sanjeev Nanda|507-284-9919|GIMRESEARCHSTUDIES@Mayo.edu|
20523220|NCT01960257|University of California, San Diego|Dr. Sara H. Browne|619 543 8080|shbrowne@health.ucsd.edu|
20523221|NCT01942993|Icahn School of Medicine at Mount Sinai|Dr. Philip A Friedlander|212-824-8584|philip.friedlander@mssm.edu|
20523222|NCT02143128|Dept of Anaesthesia and Intensive Care, Akershus University Hospital, Norway|Dr Vladimir Kuklin|98838024|vkuklin@me.com|0047
20523223|NCT01350271|University of Kelaniya|Dr Balachandran Kumarendran|0094112961140|drbkumaran@gmail.com|
20523224|NCT02906670|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
20523225|NCT01349192|University of North Carolina, Chapel Hill|Marianne S. Muhlebach, PI|(1) 919 966 1055|Marianne_Muhlebach@med.unc.edu|
20523226|NCT03749330|Children's Hospital of Philadelphia|Jennifer Walter, MD, PhD, MS Associate Professor of Pediatrics|215-590-1000|walterj1@chop.edu|
20523227|NCT02144714|Samsung Bioepis|Samsung Bioepis|+82 31 8061 4534|sbregistry@samsung.com|
20523228|NCT02038010|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
20523229|NCT03908125|Senseonics, Inc.|Sr. Director of Clinical Operations|301-407-2946|Kathleen.Davis@senseonics.com|
20523230|NCT02262325|The Ohio State University Comprehensive Cancer Center|Dr. Eric Miller|614-293-8595|eric.miller@osumc.edu|
20523231|NCT02815995|The University of Texas MD Anderson Cancer Center|Dr. Neeta Somaiah|(713) 792-3626|nsomaiah@mdanderson.org|
20523232|NCT01071915|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20523233|NCT01125189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20523234|NCT00114140|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20523235|NCT00110396|Merck Serono SA|Bettina Stubinski/Medical Responsible|+41224143396||
20523236|NCT00387335|University of Chicago|Ezra Cohen|773-702-4137|ecohen@medicine.bsd.uchicago.edu|
20523237|NCT02414958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20523238|NCT00815880|CHF Solutions, Inc.|Audrey Singh|952-345-4217|audrey.singh@chf-solutions.com|
20523239|NCT00245466|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20523240|NCT03885661|University of Pennsylvania|John Millar, PhD|215-898-0638|jsmillar@pennmedicine.upenn.edu|
20523241|NCT05064397|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
20523242|NCT02607046|Department of Veterans Affairs|Dr. Steven Prior|410-605-7000|steven.prior@va.gov|54129
20523243|NCT04408729|Massachusetts General Hospital|Jessica Haberer, MD, MS|617-724-0351|jhaberer@mgb.org|
20523244|NCT00344448|National Institute of Dental and Craniofacial Research|Gabor G Illei, Md, principal Investigator|301 496-4072|illeig@mail.nih.gov|
20523245|NCT03164538|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
20523246|NCT04194645|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20523247|NCT03104855|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
20523248|NCT01924559|Lehigh Valley Hospital|Marna Rayl Greenberg, DO, MPH|484-884-7514|Marna.Greenberg@lvh.com|
20523249|NCT00996489|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20523250|NCT06372210|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20523251|NCT02463773|University of Minnesota|Roy Cho, MD|612-626-2637|choxx548@umn.edu|
20523252|NCT00523939|Duke University Medical Center|Dr. David Rizzieri|919-668-1040|rizzi003@mc.duke.edu|
20523253|NCT03541317|University of Michigan|Amy M Kilbourne|734-845-3452|amykilbo@umich.edu|
20523254|NCT00111241|Monash University|Prof Susan Davis|+61399030827|susan.davis@monash.edu|
20523255|NCT05934396|University of North Carolina at Chapel Hill|Marisa Marraccini, PhD|919-843-5099|mmarracc@unc.edu|
20523256|NCT02216097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523257|NCT01449812|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523258|NCT03449446|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20523259|NCT03785327|The University of Texas at Dallas|Dr. Noah Sasson|972-883-2541|nsasson@utdallas.edu|
20523260|NCT02108912|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
20523261|NCT04359797|Vanderbilt University Medical Center|Dr. Edward T. Qian|615-322-2386|edward.t.qian@vumc.org|
20523262|NCT03220854|Virginia Commonwealth University Massey Cancer Center|Alfredo I Urdaneta|(804) 828-0450|MasseyRadOnc@vcu.edu|
20523263|NCT05101343|Winthrop University|Compliance Coordinator|8033232460|smithmr@winthrop.edu|
20523264|NCT04779879|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20523265|NCT06075277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20523266|NCT02603146|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20553371|NCT05124873|Liberating Technologies, Inc.|Brianna Rozell|774-233-0876|brianna.rozell@liberatingtech.com|
20523267|NCT05355532|Privolzhsky Research Medical University|Ilya Pochinka, MD|+79030561932|pochinka4@yandex.ru|
20523268|NCT03122730|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
20523269|NCT01368497|University of Pittsburgh|Dr. Steven Belle|412-624-3758|belle@edc.pitt.edu|
20523270|NCT01130532|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20523271|NCT02762929|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
20523272|NCT01383720|Boston Scientific Corporation|Director of Clinical Trials, Valves|408-370-1550||
20523273|NCT02656303|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20523274|NCT02871011|SaNOtize Research & Development Corp.|Dr Chris Miller|778-899-0607|chris@sanotize.com|
20523275|NCT03041311|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20553372|NCT00207142|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
20553373|NCT04958109|Massachusetts General Hospital|Margaret Lippincott|6177268434|mlippincott@mgh.harvard.edu|
20568808|NCT03479502|Vanderbilt_University MC|Rosemary Sanders, Research Coordinator|16155930171|Rosemary.a.sanders@vumc.org|
20568809|NCT01332318|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20568810|NCT02040532|MGH Center for Women's Mental Health|Dr. Lee Cohen|617-724-0816|lcohen2@partners.org|
20568811|NCT04382053|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@novartis.com|
20568812|NCT00714688|Janssen-Cilag Germany|EMEA Medical Affairs Director|+49 2137 955258||
20568813|NCT01786551|Brigham and Women's Hospital|Gail K Adler|617-732-5661|gadler@partners.org|
20523276|NCT01842438|Australian Catholic University|Prof Liz Forbat, PI|+61 475978476|elizabeth.forbat@acu.edu.au|
20523277|NCT01622257|Assistant professor of Obstetrics & Gynecology, Ain-shams faculty of medicine|Dr. Moustafa Ibrahim|00201001955996|mi_monem@yahoo.com|
20523278|NCT00782626|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
20523279|NCT04054765|play4REAL XR Lab at the Yale School of Medicine|Dr. Kimberly Hieftje|2037872402|kimberly.hieftje@yale.edu|
20523280|NCT01198769|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523281|NCT01783990|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
20523282|NCT01038336|VA RR&D National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Gabrielle Saunders Ph.D.|503-220-2862|gabrielle.saunders@va.gov|56210
20523283|NCT02366689|Farid Ayad|Dr. Farid Ayad|416-473-1189|ayad.farid@gmail.com|
20523284|NCT01290068|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20523285|NCT01907490|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20523286|NCT04544241|Charles R. Drew University of Medicine & Science|Sharon Cobb|323-568-3329|sharoncobb1@cdrewu.edu|
20523287|NCT04515147|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
20523288|NCT03503669|University of California, Los Angeles|Helen Lavretsky, MD|(310) 794-4619|HLavretsky@mednet.ucla.edu|
20523289|NCT04793711|Primus Pharmaceuticals, Inc.|Clinical Project Manager|4802506689|msanstead@primusrx.com|
20523290|NCT01295112|The Emmes Corporation|Traci Clemons|1-301-251-1161|tclemons@emmes.com|10212
20523291|NCT01068262|Merck Sharp and Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20523292|NCT00853099|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20523293|NCT01231646|North Shore-LIJ Health System|Connie Lau, MS, CCRC|516-325-7022|clau@nshs.edu|
20523294|NCT00128401|National Institute of Mental Health|Cameron, Jennifer Ann|+1 301 402 9356|cameronj@mail.nih.gov|
20523295|NCT00934024|MUSC|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
20523296|NCT02719184|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20523297|NCT00200902|Laboratory of Brain, Behavior, and Pharmacology at the University of California Los Angeles|Andrew Leuchter, MD|310-825-0207|jpv@brain.ucla.edu|
20523298|NCT03105518|Brigham and Women's Hospital/Harvard Medical School|Lawrence Tsen, MD|617.732.8216|ltsen@bwh.harvard.edu|
20523299|NCT00470535|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20523300|NCT04108299|NYU Langone Health|Lu Hu|646-501-3438|lu.hu@nyulangone.org|
20523301|NCT04123405|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20523302|NCT05024747|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20523303|NCT01927575|Fujifilm Medical Systems, U.S.A., Inc.|Robert Uzenoff|(203) 602-3664|ruzenoff@fujifilm.com|
20523304|NCT00662649|Novartis Pharmaceuticals|Study Director|862 778-8300||
20523305|NCT01026194|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20523306|NCT01113723|Department of Anesthesiology, Cedars-Sinai Medical Center|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
20523307|NCT04428034|UT Health San Antonio|Kylie Meyer, PhD|210-450-5386|meyerk1@uthscsa.edu|
20523308|NCT00245518|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20523309|NCT02556801|HAL Allergy|Andrey Larionov, MD, Head of Clinical Development|+31881959189|alarionov@hal-allergy.com|
20523310|NCT05274178|Phonak Audiology Research Center|Principle Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
20523311|NCT02515331|Novartis Pharmaceuticals|Study Director|862-778-8300|novartisemail@novartis.com|
20523312|NCT00124748|Novartis Pharmaceuticals|Study Director|862-778-8300||
20523313|NCT00322712|University of New Mexico|Dr. Fa Chyi Lee|505-925-0405|flee@salud.unm.edu|
20523314|NCT00567008|UPenn|Jennifer Plebani|2152223200|jplebani@mail.med.upenn.edu|152
20523315|NCT01769248|Northwestern University|Srinadh Komanduri|312-695-0484|koman1973@gmail.com|
20568814|NCT00170950|Novartis Pharmaceuticals|Study Director|862 778-8300||
20523316|NCT03983980|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20553374|NCT02346240|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20553375|NCT02942017|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
20568815|NCT01808144|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
20523317|NCT01431079|University of Cincinnati|Dr. Manoj Sharma, PI|513-556-3878|manoj.sharma@uc.edu|
20523318|NCT01202175|Univeristy of California, San Diego|Joachim H. Ix, MD, MAS|858-552-7528|joeix@ucsd.edu|
20523319|NCT04805515|Rutgers Center for Tobacco Studies|Andrea Villanti|732 235 9585|andrea.villanti@rutgers.edu|
20523320|NCT01783886|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20523321|NCT01640249|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20523322|NCT02273388|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20523323|NCT01855828|Yale University|Lajos Pusztai, MD, DPhil|203-737-6858|lajos.pusztai@yale.edu|
20523324|NCT04239027|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20523325|NCT01184079|University of Pittsburgh Department of Family Medicine|Chyongchiou Jeng Lin, PhD|412/383-2360|cjlin@pitt.edu|
20523326|NCT03172494|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20523327|NCT04233073|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
20523328|NCT00143390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523329|NCT03417687|Polarean|Laura Sutton|919-206-7900|lsutton@polarean.com|121
20523330|NCT02764151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523331|NCT01450683|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
20523332|NCT00681031|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20523333|NCT02614274|University of Missouri|James L. Cook, Director of Research|573-884-4689|cookjl@health.missouri.edu|
20523334|NCT05329259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523335|NCT02487225|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-7474|Vege.Santhi@mayo.edu|
20523336|NCT01523002|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|
20523337|NCT01256502|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20523338|NCT02084160|Exalenz|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|
20523339|NCT00773474|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20523340|NCT00852202|Allergan Sales LLC|Therapeutic Area Head,|877-277-8566|IR-CTRegistration@allergan.com|
20523341|NCT02854527|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20523342|NCT04927845|Strive Weekly Inc|Dr. Leslie Rith-Najarian, Principal Investigator|3108002143|leslie@striveweekly.com|
20523343|NCT01191450|Eurofarma Laboratórios S.A|Eurofarma Laboratórios S.A|50 11 5090-8415|fernanda.martinez@eurofarma.com.br|
20523344|NCT05954988|Rein Therapeutics, Inc.|Shawna Evans|1 (737) 802-1989|info@reintx.com|
20523345|NCT06146361|The University of Texas Health Science Center at Houston|Maria E. Fernandez-Esquer, PhD|713-500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
20523346|NCT04952922|The Royal Marsden NHS Foundation Trust|Dr Grainne Brady|0000000000000|grainne.brady@rmh.nhs.uk|
20523347|NCT04408183|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
20523348|NCT06082843|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20523349|NCT05473182|Grand Valley State Univeristy College of Health Professions|Dr. Lisa K. Kenyon|616-331-5653|kenyonli@gvsu.edu|
20523350|NCT06227052|Queen's Medical Center|Catherine Rault|808-686-4690|crault@hawaii.edu|
20523351|NCT02848001|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20523352|NCT04358081|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20523353|NCT01582490|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
20523354|NCT03411031|Moffitt Cancer Center|Dr. Melissa Alsina|813-745-7202|Melissa.Alsina@moffitt.org|
20523355|NCT03283566|Cleveland Clinic Foundation, Department of Endocroine and Metabolism|EMI Research Director|216 445-3757|jenkink@ccf.org|
20523356|NCT02760004|UMass Chan Medical School / UMass Memorial Health|Nancy Byatt, Tenured Professor of Psychiatry, ObGyn, and Population & Quantitative Health Sciences|508.856.5812|Nancy.Byatt@umassmemorial.org|
20523357|NCT00545714|Hoffmann-La Roche|Medical Communications|800--821--8590|global-roche-genentech-trials@gene.com|
20523358|NCT02045446|University of Texas Southwestern Medical Center|Dr. Puneeth Iyengar|214/645-7603|puneeth.iyengar@utsouthwestern.edu|
20523359|NCT03889886|SilkTech Biopharmaceuticals|Brian Lawrence|6172720691|brianlawrence@silk-tech.com|
20523360|NCT00276484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20523361|NCT01121250|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
20523362|NCT03901313|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20523363|NCT02790437|Hansa Biopharma AB|Elisabeth Sonesson, Director Clinical Operations|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
20523364|NCT02423200|EIP Pharma|John Alam|617-945-0794|jalam@eippharma.com|
20523365|NCT04688671|Eliem Therapeutics|Clinical Operations|+1-888-506-2573|studyinfo@eliemtx.com|
20523366|NCT01626690|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
20523367|NCT01525329|Cleveland Clinic|Dr. Edward Maytin|216-445-6676|maytine@ccf.org|
20523368|NCT00780338|RAND|Matthew Chinman|412 683-2300|chinman@rand.org|4287
20523369|NCT02023983|Municipal Hospital Ostrava|dr. Kamil Novobílský|+420 59 619 2660|k.novobilsky@mnof.cz|
20523370|NCT02105467|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20523371|NCT01690117|University of Leipzig, Medical Faculty, Clinic and Policlinic for Psychiatry and Psychotherapy|Prof. Dr. Hermann-Josef Gertz|0049 (0)341 97 24420|Hermann-Josef.Gertz@medizin.uni-leipzig.de|
20553376|NCT03417141|Mayo Clinic|Jason C. Sluzevich, M.D.|904-953-6192|Sluzevich.Jason@mayo.edu|
20523372|NCT02676882|Massachusetts General Hospital Center for Women's Mental Health|Dr. Marlene Freeman|617-643-6403|mfreeman@partners.org|
20568816|NCT01123642|VISN 17 Center of Excellence for Research on Returning War Veterans|Sandra B. Morissette, Ph.D.|254-297-5170|sandra.morissette@va.gov|
20568817|NCT02548754|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|4052714742|stavros-stavrakis@ouhsc.edu|
20568818|NCT03098797|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20568819|NCT00509821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568820|NCT03443063|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20568821|NCT00552513|Population Health Research Institute|TIMACS Project Office|19055244322|timacs@phri.ca|
20568822|NCT01589523|Cincinnati Children's Hospital Medical Center|Ken Setchell, PhD|5136364548|kenneth.setchell@cchmc.org|
20568823|NCT00961896|Novartis|Study Director|862-778-8300||
20568824|NCT00506922|UT MD Anderson Cancer Center|Marcos de Lima, MD / Professor|713-745-3219|bmcmullin@mdanderson.org|
20523373|NCT00397462|Binghamton University, SUNY|Professor Kenneth McLeod|(607)777-5779|kmcleod@binghamton.edu|
20523374|NCT01288807|UCSD|Tobias Moeller-Bertram (PI)|7603211315|moellerbertram@yahoo.com|
20523375|NCT00958828|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20523376|NCT01518322|Aerocrine, Inc.|Nancy Herje|919-449-8873|Nancy.Herje@aerocrine.com|
20523377|NCT01269918|Cleveland Clinic|Daniel Sessler, MD|216-445-6500|sesslerd@ccf.org|
20523378|NCT00218387|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
20523379|NCT00811733|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523380|NCT02500589|Durahm VA Health Care System|Jennifer Gierisch|919-286-0411|jennifer.gierisch@va.gov; j.gierisch@duke.edu|176936
20523381|NCT00856193|Novartis Pharmaceuticals|Study Director|862-778-8300||
20523382|NCT02777372|The Johns Hopkins University School of Medicine|Liisa Hantsoo, Ph.D.|410-502-2334|LHantso1@jh.edu|
20523383|NCT04542057|Verona Pharma plc|Chief Medical Officer|See email|info@veronapharma.com|
20523384|NCT03897634|Northwestern University|Kendra Marks|847-467-0897|kendra.marks@northwestern.edu|
20523385|NCT03404674|PATH|Rahsan Erdem|202-540-4546|rerdem@path.org|
20523386|NCT01903798|SCIRE|Executive Director, Southern California Institute for Research and Education|562-826-8000|Sabry.Eassa@va.gov|5747
20523387|NCT03624192|AVITA Medical|VP, Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
20523388|NCT04660331|Fred Hutchinson Cancer Center|Dr. Parth Shah|2066676120|pshah@fredhutch.org|
20523389|NCT02765256|University of Pennsylvania|Lindsey Albenberg, DO|267-426-0139|albenbergl@email.chop.edu|
20523390|NCT01487525|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
20523391|NCT01870778|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20523392|NCT00065156|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20523393|NCT01215136|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
20523394|NCT02308124|SNUH|Jung-Ick Byun|+8224406254|mr830611@gmail.com|
20523395|NCT00708110|ViiV Healthcare|GSK Response Center|866-435-7343||
20523396|NCT01994785|Cleveland Clinic|John Vargo|216 445-5012|vargoj@ccf.org|
20523397|NCT02577991|Northwestern University Department of Orthopaedic Surgery|Surabhi Bhatt|312-472-6024|surabhi.bhatt@nm.org|
20523398|NCT00115076|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
20523399|NCT02421055|Imperial College London|Dr Nicholas Penney|020 7589 5111|n.penney@imperial.ac.uk|
20523400|NCT01329900|UT MD Anderson Cancer Center|Issa F Khouri, M.D. / Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
20523401|NCT01866098|Connecticut Mental Health Center|Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7500|cenk.tek@yale.edu|
20523402|NCT03649347|Stress, Trauma, and Anxiety Research Clinic (STARC) at Wayne State University|Kathleen Gorski, Research Coordinator|313-577-9202|kathleen.gorski2@med.wayne.edu|
20523403|NCT05275920|NYU Langone Health|Amrita Mukhopadhyay, MD|212-263-7751|amrita.mukhopadhyay@nyulangone.org|
20523404|NCT03629080|Hookipa Biotech GmbH|Hookipa Front Desk|+43 1 890 63 60 0|office@hookipapharma.com|
20523405|NCT00489255|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20523406|NCT03691727|University of Iowa|David Hasan|319-384-8669|david-hasan@uiowa.edu|
20523407|NCT01982955|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20523408|NCT05287230|University of South Carolina|Dr. Monique Brown|8037775057|brownm68@mailbox.sc.edu|
20523409|NCT03493685|Travere Therapeutics, Inc|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
20523410|NCT04452669|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
20523411|NCT06418529|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523412|NCT05126693|KU Leuven|Prof. dr. Kaat Desloovere|+32 486 40 13 73|kaat.desloovere@kuleuven.be|
20523413|NCT05525520|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20568825|NCT00792259|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
20568826|NCT00371462|Edward Hines Jr., VA Hospital|Associate Chief of Staff for Research|708-202-5689|eileen.collins@va.gov|
20568827|NCT03721978|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20568828|NCT05244226|Duke University|Lisa Einhorn, MD|919-681-4877|lisa.einhorn@duke.edu|
20523414|NCT05878093|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20523415|NCT02721732|The University of Texas MD Anderson Cancer Center|Dr. Aung Naing|(713) 563-3885|anaing@mdanderson.org|
20523416|NCT04479852|Sirtsei Pharmaceuticals|Greg Rigdon, PhD|+1 919-949-6862|grigdon@arrivobio.com|
20523417|NCT04589247|Johns Hopkins University|Ranh Voong, MD|4105506597|kvoong1@jhmi.edu|
20523418|NCT04100018|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20523419|NCT06379048|Çam and Sakura City Hospital|Dr. Emre Kar|+90 (0212) 909 60 00|emre.kar@sbu.edu.tr|11250
20523420|NCT00118157|Barbara Ann Karmanos Cancer Institute|Sayeh Lavasani, M.D.|(313) 576-8751|lavasans@karmanos.org|
20523421|NCT00696423|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523422|NCT03989102|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
20523423|NCT00818766|Brigham & Women's Hospital|David Oxman, MD|215-503-1198|doxman2001@yahoo.com|
20523424|NCT00970593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523425|NCT01561716|University of Rochester|Dr. Isabel D Fernandez|585-275-9554|Diana_Fernandez@URMC.Rochester.edu|
20568829|NCT00555997|Massachusetts General Hospital|Dr. George Papakostas|617-726-6697|gpapakostas@partners.org|
20523426|NCT01608100|Abbott Diagnostics Division|Karla Grasso, Clinical Research Manager|1 224-667-5602|karla.grasso@abbott.com|
20568830|NCT02675998|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20568831|NCT00275301|University of Minnesota|S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
20523427|NCT03805386|Mayo Clinic Arizona|Principal Investigator, Dr Johnny Yi|14803420612|yi.johnny@mayo.edu|
20523428|NCT04937881|UCLA|Dvora Joseph Davey|3107011526|dvoradavey@ucla.edu|
20523429|NCT04055740|University of Chicago|Dr. Andrew Beaser|(888) 824-0200|abeaser@bsd.uchicago.edu|
20523430|NCT01277783|Medtronic Bakken Research Center B.V.|Mireille van Ginneken, Principal Clinical Research Specialist|+31433566801|mireille.vanginneken@medronic.com|
20523431|NCT00942357|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD. and Helen Huang, MS.|716-845-1169|lgedeon@gogstats.org|
20523432|NCT01321879|UT MD Anderson Cancer Center|Dr. Issam I. Raad/ Chair, Infectious Diseases|713- 792-7943|iraad@mdanderson.org|
20523433|NCT00793871|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523434|NCT05767905|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523435|NCT03125798|Wielkoposkie Centrum Pulmonologii i Torakochirurgii|Dr Piotr Gabryel|+48616654249|piotrgabryel@gmail.com|
20523436|NCT02635984|AU Medical Center / University of Georgia College of Pharmacy|Dr. Amber Clemmons, Clinical Pharmacist - BMT/Hematology & Clinical Associate Professor|706-721-6493|aclemmons@augusta.edu|
20523437|NCT00307086|H. Lee Moffitt Cancer Center|Mellisa Alsina, MD|813-745-6886|Melissa.Alsina@moffitt.org|
20523438|NCT00100828|SKCCC at Johns Hopkins|Arlene Forastiere|410-955-9818|af@jhmi.edu|
20523439|NCT01176513|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
20523440|NCT04583735|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
20523441|NCT01125917|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20523442|NCT01197911|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20523443|NCT00858494|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
20523444|NCT03282916|Columbia University Irving Medical Center|Dr. Davangere P Devanand|646-774-8658|dpd3@cumc.columbia.edu|
20523445|NCT03354598|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
20523446|NCT00786409|University of Chicago|Linda Wagner-Weinter, MD|773-702-2245|lww@uchicago.edu|
20523447|NCT00610129|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy|646-888-4185|ReidyD@mskcc.org|
20523448|NCT02435524|London School of Hygiene & Tropical Medicine|Dr Veronique Filippi|+44 (0)20 7927 2874|veronique.filippi@lshtm.ac.uk|
20523449|NCT01042093|Towson Orthopaedic Associates|David F. Dalury, MD|410-337-7900|ddalury@gmail.com|1221
20523450|NCT04331808|Hopital Hotel Dieu (AP-HP)|Dr Raphael Porcher|+33 (0)1.42.34.89.87|raphael.porcher@aphp.fr|
20523451|NCT00952731|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
20523452|NCT04589663|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20523453|NCT00243412|Hoffman-LaRoche|Medical Communications|800-821-8590||
20523454|NCT00041132|SWOG Statistical Center|Study Statistician|206-667-4623||
20523455|NCT00736632|Washington University in St. Louis|Dr. Carlos Bernal-Mizrachi|314-362-0947|cbernal@wustl.edu|
20523456|NCT00995774|Washington DC Veterans Affairs Medical Center|Peter Lum, PhD|202-319-5181|lum@cua.edu|
20523457|NCT01808573|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|424-248-6500|clinicaltrials@pumabiotechnology.com|
20523458|NCT02513212|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20523459|NCT03953612|Yale School of Medicine|Verica Milivojevic, PhD|203-737-5201|verica.milivojevic@yale.edu|
20523460|NCT03485352|Federal University of Uberlandia|Mrs Cibele Crispim|55 34 3218-2084|cibelecrispim@gmail.com|
20523461|NCT02028676|Medical Research Council|Professor Ann Sarah Walker|+44 20 7670 4726|rmjlasw@ucl.ac.uk|
20523462|NCT01244503|Virginia Commonwealth University|Arun J Sanyal|804 828 6314|asanyal@mcvh-vcu.edu|
20523463|NCT00141778|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
20523464|NCT05655546|Scripps Research|Julia Moore Vogel|8587842275|immunocare@scripps.edu|
20523465|NCT04576507|New York State Psychiatric Institute|Caroline A. Arout, Ph.D.|646-774-6167|caroline.arout@nyspi.columbia.edu|
20523466|NCT04467840|RedHill Biopharma Ltd.|Gilead Raday, COO|+972-(0)3-541-3131|info@redhillbio.com|
20523467|NCT04470518|Leuven Unit Health Technology Assessment Research, KU Leuven|Tine De Burghgraeve, PhD|+3216377276|tine.deburghgraeve@kuleuven.be|
20523468|NCT02732730|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
20523469|NCT00711243|Northwestern University|Mary Mulcahy (MD)|312.695.6182|Mary.Mulcahy@nm.org|
20523470|NCT05989672|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20523471|NCT03514459|University of Washington|Dr. McKenna Eastment|5742101120|mceast@uw.edu|
20523472|NCT02892955|Abbott|Joyce Chuang|9253535817|joyce.chuang@abbott.com|
20523473|NCT01962103|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20523474|NCT01321749|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D.|8683198127|jixm70@hotmail.com , Jixm@ccmu.edu.cn|
20523475|NCT03825939|NYU Langone|Dr. Jan Koenig|516-678-2232|Jan.Koenig@nyulangone.org|
20523476|NCT04179838|Northwestern University|Thorsten Kahnt|3125032896|thorsten.kahnt@northwestern.edu|
20523477|NCT03456102|Johns Hopkins University School of Medicine|Petros C. Karakousis, MD|410-502-8233|petros@jhmi.edu|
20523478|NCT02763046|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20523479|NCT00080912|NCIC Clinical Trials Group|Dr. Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
20523480|NCT00086684|Janssen R&D US|SENIOR DIRECTOR CLINICAL LEADER|1 609 730-4529||
20523481|NCT02826486|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
20568832|NCT02097849|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20523482|NCT01067105|Sunovion|Respiratory Medical Director|1-866-503-6351||
20523483|NCT01917682|Corindus, Inc.|John Van Vleet, VP of Clinical and Regulatory Affairs|(260)615-8892|john.van_vleet@siemens-healthineers.com|
20507245|NCT05291949|Henry Ford Health|Director of Research, Department of Anesthesiology|313-771-7128|knowak2@hfhs.org|
20507246|NCT00717366|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20507247|NCT03497026|Auris Health|Scott Rehage|925 6832590|srehage@its.jnj.com|
20507248|NCT01423773|Alcon Research|Head, Clinical Trial Management|1-800-241-7629||
20568833|NCT01540162|National Medical University Odessa|Prof. Mykola L. Aryayev, MD & PhD|+380 48 740 5249|nataly_kononenko@ukr.net|
20568834|NCT01194271|The University of Texas (UT) MD Anderson Cancer Center|Padmanee Sharma, Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
20568835|NCT00349622|MGH|Merit Cudkowicz|617-724-1873|mcudkowicz@partners.org|
20568836|NCT03619889|Universidad Complutense de Madrid|Dra. Gema Serrano-Hernanz|669332986|gema.serrano.hernanz@gmail.com, gemase01@ucm.es|
20568837|NCT00508274|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20568838|NCT03296566|University of British Columbia|Dr. Marette Lee|604.875.5608|Marette.Lee@vch.ca|
20507249|NCT00434122|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20507250|NCT01842607|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507251|NCT00012012|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20507252|NCT02034474|NYSPI|Ragy Girgis,MD|6467745553|ragy.girgis@nyspi.columbia.edu|
20507253|NCT01391819|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507254|NCT01519284|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20507255|NCT02164513|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20507256|NCT00810719|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
20507257|NCT02487901|Seoul National Unversity College of Medicine|Chun Kee Chung|+82-2-2072-2357|chungc@snu.ac.kr|
20507258|NCT03423979|Urotronic, Inc|Sr. Clinical Project Manager|612-245-6434|jmoland@laborie.com|
20507259|NCT02598661|Geron Corp.|Study Director|650-473-7700|mds3001-info@Geron.com|
20507260|NCT03422133|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20507261|NCT03003403|Duke University|Gary G. Bennett, PhD|919-808-7821|gary.bennett@duke.edu|
20507262|NCT04857593|King's College London|Professor Carmine Pariante|020 78480807|carmine.pariante@kcl.ac.uk|
20507263|NCT05458011|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20507264|NCT05076370|Yale University, Department of Psychiatry|Joao De Aquino, M.D.|203-932-5711|joao.deaquinolima@yale.edu|12916
20507265|NCT06170866|University of Connecticut|Dr. Cristina Colon-Semenza, Assistant Professor|8604860019|cristina.colon-semenza@uconn.edu|
20507266|NCT03569449|Boston Medical Center, Boston University School of Public Health|Emily Feinberg, ScD, CPNP|617-414-1425|emfeinbe@bu.edu|
20507267|NCT04124692|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20507268|NCT02325687|Hospital for Special Surgery, Anesthesiology Department|Kethy Jules-Elysee|212-606-1206|juleselyseek@hss.edu|
20507269|NCT00205699|Florida Atlantic University|John W. Newcomer|(561) 297-0252|jnewcomer@health.fau.edu|
20507270|NCT02263014|The University of Texas (UT) MD Anderson Cancer Center|Dr. Abenaa Brewster, Professor, Clinical Cancer Prevention|713-792-7734|abrewster@mdanderson.org|
20507271|NCT05279898|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|617-278-8000|bsubrama@bidmc.harvard.edu|
20507272|NCT04393038|Abivax|Study Director|+33 1 53 83 09 63|info@abivax.com|
20507273|NCT05168813|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20507274|NCT06964165|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20507275|NCT04321252|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20507276|NCT06245044|University of Michigan|Dr. Corey Lester|734-647-8849|lesterca@umich.edu|
20507277|NCT00611897|Yale School of Medicine, Department of Psychiatry|Handan Gunduz-Bruce, MD|(203) 785-2117|handan.gunduz-bruce@yale.edu|
20507278|NCT00259740|Amgen Inc.|Study Director|866-572-6436||
20507279|NCT05848323|University of Washington|Lindsey Knowles|2067449640|lmknow@uw.edu|
20568839|NCT03065205|University of Colorado|Heather Hoch MD|720-777-4108|heather.hoch@childrenscolorado.org|
20568840|NCT00821119|Instituto Materno Infantil prof. Fernando Figueira|Jucille Meneses|55 (81) 2122-4100|jmeneses@elogica.com.br|4135
20568841|NCT01341444|Medstar Georgetown University Hospital|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
20568842|NCT05012280|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
20568843|NCT00550771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20568844|NCT01441583|Boston Scientific|Clinical Trial Manager|+18002273422|jens.goetzke@bsci.com|
20568845|NCT00839306|Eisai Inc.|Eisai Medical Services|888-422-4743||
20568846|NCT05376787|F2 Labs|Wendy Fuster|3013682586|wfuster@f2labs.com|
20568847|NCT01763645|BIOCAD|Feder Krykov|+7 (812) 380 4933|kryukov@biocad.ru|8552
20568848|NCT02396758|Boston Scientific|Nancy O'Connell|763-494-2706|nancy.oconnell@bsci.com|
20568849|NCT02176018|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
20568850|NCT00265096|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
20568851|NCT03022045|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20568852|NCT03436433|Duke Neurosugery|Claudia E. Pamanes, MPH, CCRP|9196680897|claudia.pamanes@duke.edu|
20507280|NCT01367301|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio, Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
20507281|NCT01844830|Loma Linda University|Yiming Li, DDS|909-558-4600|kkellingsworth@llu.edu|
20507282|NCT01658579|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
20507283|NCT04580394|Apnimed, Inc.|Clinical Trials|6175008880|clinicaltrials@apnimed.com|
20507284|NCT01464788|McGovern Medical School UTHealth - Houston|Dr. Andrew Barreto|713-500-7002|andrew.d.barreto@uth.tmc.edu|
20568853|NCT03568708|CIncinnati Children's Hospital Medical Center|Dr. Halley Wasserman|513-803-3815|halley.wasserman@cchmc.org|
20523484|NCT02521415|Carolinas Medical Center|Dr. Stacy Reynolds|704-355-3181|stacy.reynolds@carolinashealthcare.org|
20523485|NCT02203357|Peking University Health Science Center|Dr. Hui Zhuang|86-10-82801617|zhuangbmu@126.com|
20523486|NCT02288312|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20523487|NCT01276041|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
20523488|NCT01495000|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523489|NCT02070965|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
20523490|NCT04004481|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
20523491|NCT03347110|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20523492|NCT00116779|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20523493|NCT01004354|University of Massachusetts Medical School|Benjamin U Nwosu, MD|5083347872|benjamin.nwosu@umassmemorial.org|
20523494|NCT00707239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523495|NCT01778530|National Cancer Institute|Dr. Joohee Sul|301-402-6298|Joohee_Sul@nih.gov|
20523496|NCT01400477|University of Colorado|Dr. Robert Freedman|393 724 1000|robert.freedman@ucdenver.edu|
20523497|NCT03442751|Glaukos|Valerie Smith|9493679600|VSmith@glaukos.com|
20523498|NCT01928472|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20523499|NCT05807828|1. Academic Orthopaedic Department, Aristotle University Medical School, General Hospital Papageorgiou 2. Centre of Orthopaedic and Regenerative Medicine (CORE), Center for Interdisciplinary Research and Innovation (CIRI)-AUTh|Eustathios Kenanidis - Assistant Professor of Orthopaedic Surgery & Traumatology|6973693693|ekenanidis@auth.gr|
20523500|NCT03618017|University of Michigan Rogel Cancer Center|Lauren Wallner, Ph.D.|734-232-0788|lwallner@med.umich.edu|
20523501|NCT00890617|Barbara Ann Karmanos Cancer Institute|Dr. Frank A. Baciewicz|(313) 993-0580|FBaciewi@dmc.org; baciewic@karmanos.org|
20523502|NCT00291317|Children's Specialized Hospital|Frank Castello|732 258 7065|fcastello@childrens-specialized.org|
20523503|NCT00312338|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20523504|NCT00262028|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20523505|NCT01515423|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20523506|NCT03757819|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
20523507|NCT03490110|Veterans Affairs|Dr. Anthony Chen|925-372-2530|anthony.chen@va.gov|
20523508|NCT05824754|University of Michigan|Inbal Billie Nahum-Shani|7346609626|inbal@umich.edu|
20523509|NCT04421131|Duke University|Lavanya Vasudevan, Ph.D.|919-613-1423|lavanya.vasudevan@duke.edu|
20523510|NCT02015611|Wake Forest University School of Medicine|Dr. Denise Houston|336-713-8217|dhouston@wakehealth.edu|
20523511|NCT00613171|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20523512|NCT02501928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523513|NCT03737357|Institut Straumann|Anaïs Robert, Clinical Trial Leader|+41799258750|anais.robert@straumann.com|
20523514|NCT00951496|NRG Oncology|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
20523515|NCT02020278|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20523516|NCT00838526|Eisai Inc.|Eisai Medical Information, Eisai|+1 888 274 2378|esi_medinfo@eisai.com|
20523517|NCT01526057|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523518|NCT00571324|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
20523519|NCT01555697|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
20523520|NCT01875978|China Medical University Hospital|Dr. Dalong Chen|+886-227919696|my686chen@gmail.com|1205
20523521|NCT01169350|University of Washington|Dr. Janet F. Eary|206-598-6244|jeary@uw.edu|
20523522|NCT04429945|James A Haley Veterans Hospital|Dr. Christopher Fowler|619-647-4470|christopher.fowler3@va.gov|
20523523|NCT04201197|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20523524|NCT02553772|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
20523525|NCT05724589|Institute of Dermatology, Thailand|Dr. Supawee Phanmamuang|6623545222|dewsupawee@gmail.com|
20523526|NCT02466321|Zimmer Biomet|Elliott Goff|+41 79 222 23 08|elliott.goff@zimmerbiomet.com|
20523527|NCT00950365|Montefiore Medical Center|Roman Perez-Soler, MD|(718) 405-8505|RPEREZSO@montefiore.org|
20523528|NCT02473926|University of Colorado - Anschutz Medical Campus|Dr. Amy Huebschmann|3037242268|amy.huebschmann@cuanschutz.edu|
20523529|NCT00202930|UPMC Children's Hospital of Pittsburgh|Jean M. Tersak, M.D.|412-692-8570|jean.tersak@chp.edu|
20523530|NCT03629184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20523531|NCT01461538|Seattle Genetics, Inc.|Chief Medical Office|855-473-2436|medinfo@seagen.com|
20523532|NCT03051672|Dana-Farber Cancer Institute|Dr. Sara Tolaney|6176323800|sara_tolaney@dfci.harvard.edu|
20523533|NCT01328184|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20523534|NCT00692692|Vanderbilt University Medical Center|Jason Wendel, MD|615-936-0160|jason.wendel@vanderbilt.edu|
20523535|NCT01611779|Siesta Medical, Inc.|Michael Kolber|408-320-9424|mkolber@siestamedical.com|
20523536|NCT03475992|MVG Industries|Luc Duchesne|0033169298156|luc.duchesne@mvg-world.com|
20523537|NCT02360215|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20523538|NCT04075487|VA Maryland Health Care System, Geriatric Research, Education, and Clinical Center|Dr. Beth Hogans, M.D., Ph.D., Neurologist|410-605-7000|beth.hogans@va.gov|
20523539|NCT05411991|University Hospital Brussels - Vrije Universiteit Brussel|Prof. Dr. Frederik H. Verbrugge|024749657|frederik.verbrugge@uzbrussel.be|+32
20523540|NCT05016960|VA San Diego Healthcare System|Dr. Erin Almklov|858-552-8585|erin.almklov@va.gov|3907
20523541|NCT05579782|Medical College of Wisconsin|Tracy Wang, MD|414-955-1459|tswang@mcw.edu|
20523542|NCT02218463|University of Missouri-Kansas City School of Medicine|Dr. Tazim Dowlut-McElroy, M.D., M.S.|816-404-5150|tdowlut@cmh.edu|
20523543|NCT03700125|Barts Health NHS Trust|Dr Simon Finney|02073777000|simon.finney2@nhs.net|
20523544|NCT02059512|First Pavlov State Medical University of St. Petersburg|Vladimir V Komok, Ph.D|8-904-632-19-00|vladimir_komok@mail.ru|
20523545|NCT05201794|Janssen Research & Development, LLC|Senior Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20523546|NCT03848715|UCLA|Dr. Chloe Boyle|310 794 9383|ccboyle@mednet.ucla.edu|
20523547|NCT04653454|Mayo Clinic|Adrian Dumitrascu M.D.|904-956-0081|Dumitrascu.Adrian@mayo.edu|
20523548|NCT02439216|Astria Therapeutics, Inc|Andrew Nichols, PhD - Chief Scientific Officer|617-349-1971|anichols@astriatx.com|
20523549|NCT02094300|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|SSnyder@medinst.com|
20523550|NCT01111318|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20523551|NCT01866826|NCI|Frank Maldarelli, MD|301-846-5611|fmalli@mail.nih.gov|
20523552|NCT02493660|Stryker Company|Colleen Roden, Director, Clinical Operations|1 931 267 2041|colleen.roden@stryker.com|
20523553|NCT03073876|City University of New York - Queens College and The Graduate Center|Nancy S. Foldi, PhD; Professor|718.997.3253|nfoldi@qc.cuny.edu|
20523554|NCT01050530|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20523555|NCT04505969|Barau Dikko Teaching Hospital, Kaduna State University|Study Principal investigator|+2348066664042|abubakarabdulkareem8@gmail.com|
20523556|NCT00725491|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20523557|NCT01094704|UNC-Chapel Hill|Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
20523558|NCT02321111|University of Texas Health San Antonio|Laurie Che Kelly|210-617-5300|che@uthscsa.edu|14731
20523559|NCT02687451|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
20523560|NCT03472014|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20523561|NCT03104192|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
20523562|NCT03652051|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
20523563|NCT01936844|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
20523564|NCT02394600|Kingston General Hospital|Dr. Anne Ellis|613-548-2336|ellisa@kgh.kari.net|
20523565|NCT02569801|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20523566|NCT00428246|Indiana University|Rajiv Agarwal|317-988-2241|ragarwal@iupui.edu|
20523567|NCT02200055|General Surgery, Naval Medical Center Porstmouth|Dr. Christopher Oxner|757-953-2495|christopher.r.oxner.mil@mail.mil|
20523568|NCT00776035|Washington University School of Medicine|Linda R. Peterson, MD, Professor of Medicine and Radiology|314-362-4577|lpeterso@wustl.edu|
20523569|NCT00656656|University of Lübeck|Prof. Dr. Detlef Zillikens|+49-451-500-41500|detlef.zillikens@uksh.de|
20523570|NCT00981812|University of Cincinnati Medical Center|Mary Mahoney, MD|513-584-4396|mary.mahoney@uchealth.com|
20523571|NCT04442464|Mayo Clinic|Cherie B. Nau, O.D.|507-284-4152|Nau.Cherie@mayo.edu|
20523572|NCT01308424|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
20523573|NCT00948155|University of Pennsylvania|Andrew A. Strasser, Ph.D., Associate Professor|215 746 5788|strasse3@mail.med.upenn.edu|
20523574|NCT05966506|The University of Texas Health Science Center at Houston|Nitha Mathew Joseph, PhD, RN, CNE, CGNC|713-500-2165|Nitha.Mathew@uth.tmc.edu|
20523575|NCT01015534|Instituto Nacional de Cancerologia de Mexico|Carlos Gamboa Vignolle/ Radiation Oncologist|0155556280400|cswgamboa@yahoo.com|441
20523576|NCT04870710|BIDMC|Dr. Paulo Lizano|617-754-1227|plizano@bidmc.harvard.edu|
20523577|NCT04338022|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20523578|NCT02189837|Amgen Inc.|Study Director|866-572-6436||
20523579|NCT02198963|Mercury Street Medical|Dr. John Pullman|(406) 723-1375|john.pullman@mecurystmed.com|
20523580|NCT01876446|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20523581|NCT00619060|University of Arizona|Steve Stratton,PhD Chairman of Scientific Review Comittee|(520) 626-9295|SStratton@uacc.arizona.edu|
20523582|NCT00822692|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
20523583|NCT03420521|Johns Hopkins University|Dr. Christine Hann|410-502-0678|chann1@jh.edu|
20523584|NCT03098082|Indiana University School of Medicine|Jeffrey J. Easler, MD|3179440980|jjeasler@iu.edu|
20523585|NCT04277962|University of Texas Medical Branch Galveston|Dr. Antonio Saad Director of Clinical Research Division|409-772-0982|afsaad@utmb.edu|
20523586|NCT00683657|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20523587|NCT03423940|Rutgers, The State University of New Jersey|Brian D. Greer, Ph.D., BCBA-D|848-800-8505|brian.greer@rutgers.edu|
20523588|NCT03200717|Novartis Pharmaceuticals|Study director|+1 862-778-8300|novartis.email@novartis.com|
20523589|NCT02085447|University Hospitals Cleveland Medical Center|Dr. Martha Sajatovic|2168442808|martha.sajatovic@uhhospitals.org|
20523590|NCT03552380|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20523591|NCT03447743|University of Kentucky|Dr. Michele Staton|859-312-8245|mstaton@uky.edu|
20523592|NCT02046603|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20523593|NCT02461160|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20536807|NCT00837161|Philips Healthcare|Sarah Baxter|425-487-7665|sarah.baxter@philips.com|
20536808|NCT02931838|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20536809|NCT00104728|H. Lee Moffitt Cancer Center and Research Institute|Dr. Eric Haura|813-745-6826|eric.haura@moffitt.org|
20536810|NCT02709577|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
20536811|NCT01059864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523594|NCT01112059|UAB|Amit Gaggar, MD|934-5400|agaggar@uab.edu|
20536812|NCT00451958|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20553377|NCT03900299|Alexandria university|DR. mostafa elsayed|560566541|m_elsayed2009@yahoo.com|+966
20553378|NCT03465878|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20553379|NCT04019041|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20553380|NCT02540954|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20553381|NCT01393743|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20553382|NCT00213148|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20553383|NCT01831232|Fred Hutchinson Cancer Research Ctr|Dr, Mazyar Shadman|206-667-5467|mshadman@fredhutch.org|
20553384|NCT01723228|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20553385|NCT01806896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553386|NCT02434770|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20553387|NCT03080961|CLJI WORLDWIDE|Ty Cross, President & CEO|305-397-8880|tycross@cljiworldwide.com|
20553388|NCT00660348|Sidney Kimmel Comprehensive Cancer Center|Michael Erdek, MD|410-502-7388|merdek1@jhmi.edu|
20553389|NCT01617603|Medical School, Michael White Diabetes Centre, 220-236, Anlaby Road,|Prof. Stephen Atkin, Principal Investigator|+44(0)1482 675312|Stephen.Atkin@hyms.ac.uk|
20553390|NCT04174313|Hospital El Cruce|Nestor Pistillo|054 1142109000|npistillo@yahoo.com.ar|5636
20553391|NCT01282424|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20553392|NCT02741115|Mezzion Pharmaceuticals, Inc|Director of Clinical Trials|5734342579|kelly.williams@mezzion.com|
20553393|NCT04602624|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20553394|NCT02782949|Mayo Clinic|Dr Paul J. Limburg|507-284-2511|limburg.paul@mayo.edu|
20553395|NCT03316872|Princess Margaret Cancer Centre|Dr. Jennifer J Knox|+1-416-946-2399|jennifer.knox@uhn.ca|
20553396|NCT01966926|University of Minnesota|Dr. Jennifer Linde|612-624-0065|linde074@umn.edu|
20553397|NCT03548584|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20553398|NCT00533949|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20553399|NCT00727194|Alexion Pharmaceuticals|Alexion Pharmaceuticals|855-752-2356|clinicaltrials@alexion.com|
20553400|NCT04269161|University of Missouri|Roger Fales|5738841564|falesr@missouri.edu|
20553401|NCT01677195|University of Texas Health Science Center at San Antonio / University of California, Davis* current|Dr. Bradley H. Pollock, PI|(530) 752-7250|pbollock@ucdavis.edu|
20553402|NCT04368429|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20553403|NCT03940508|New York University|Dr. Michael A. Lindsey|212-998-5959|michael.lindsey@nyu.edu|
20553404|NCT03633396|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20553405|NCT01012817|Mayo Clinic|Andrea Wahner Hendrickson MD|507-293-0553|WahnerHendrickson.Andrea@mayo.edu|
20553406|NCT02143414|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
20553407|NCT01532362|Jonsson Comprehensive Cancer Center: University of California at Los Angeles|Dr. Jay Moon Lee|(310) 794-7333|jaymoonlee@mednet.ucla.edu|
20553408|NCT00110266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20553409|NCT04031885|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20553410|NCT00293384|Barbara Ann Karmanos Cancer Institute|Muneer Abidi, M.D.|(313) 576-8713|abidim@karmanos.org|
20553411|NCT02610192|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
20553412|NCT01344057|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20553413|NCT00145509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20553414|NCT00749775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553415|NCT05044234|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20553416|NCT03912233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20553417|NCT00326911|ImClone LLC|Chief Medical Officer||ClinicalTrials@ImClone.com|
20553418|NCT01948375|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@aliyun.com.cn|
20553419|NCT03004534|Translational Research In Oncology (TRIO)|Director, Project Management|33 158 10 09 09|030@trioncology.org|
20553420|NCT01023659|Centre for Addiction and Mental Heatlh|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|74946
20553421|NCT01288534|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-9630|sprattda@med.umich.edu|
20553422|NCT04537806|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20553423|NCT01873989|Yale University|Dr. Declan Barry|203-285-2708|declan.barry@yale.edu|
20553424|NCT00494494|University of North Carolina at Chapel Hill|Kennth L. Cohen, MD|919 843-0292|klc@med.unc.edu|
20553425|NCT03219333|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20553426|NCT01126541|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20507285|NCT00564954|Novartis Pharmaceuticals|Study Director|862-778-8300||
20507286|NCT04397718|Department of Veterans Affairs GLA|Dr. Matthew Rettig|310-478-3711|matthew.rettig@va.gov|44761
20507287|NCT05388656|University of North Carolina at Chapel Hill|Elizabeth Andersen, PhD|(970) 420-4944|elizabeth_andersen@med.unc.edu|
20507288|NCT03201965|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20523595|NCT03672227|REGENTS OF THE UNIVERSITY OF MICHIGAN|Dr. Katherine Bauer|(734)763-2546|kwbauer@umich.edu|
20523596|NCT03567980|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
20523597|NCT02575833|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20507289|NCT00156910|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20523598|NCT04599075|University of Massachusetts Chan School of Medicine|Dr. Gianna Wilkie|7743642523|Gianna.Wilkie@umassmemorial.org|
20523599|NCT02633787|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20523600|NCT01742897|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
20523601|NCT03793608|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20523602|NCT00967330|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20507290|NCT01153893|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507291|NCT00118482|University of Calgary|Dr. Robert S. Sheldon|403-2208191|sheldon@ucalgary.ca|
20507292|NCT00125190|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20507293|NCT02128763|University of Pennsylvania|Maureen G. Maguire, PhD|215-615-1501|maguirem@pennmedicine.upenn.edu|
20507294|NCT03259490|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507295|NCT00622544|University of MN|Clifford E. Kashtan|646 692 9309|cassi044@umn.edu|
20507296|NCT00255086|VA Palo Alto Health Care System|Wes Ashford, PhD, MD|650-493-5000|wes.ashford@va.gov|
20507297|NCT01963208|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20507298|NCT00379197|University of Minnesota, Dept. Medicine|Dr. Douglas Yee, MD|612-273-5700|yeexx006@umn.edu|
20507299|NCT02159469|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
20507300|NCT03629041|Innoture Ltd|Jemma Burridge, Clinical Project Manager|+44 (0)7799 902476|jburridge@innoture.co|
20507301|NCT01262755|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
20507302|NCT04427917|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507303|NCT05301322|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507304|NCT04971785|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20507305|NCT00808249|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20507306|NCT03829332|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20507307|NCT05371912|Christiana Care|Mitra Assadi, MD|3026233017|mitra.assadi@christianacare.org|
20523603|NCT02698163|UCLA School of Dentistry|Dr. Eric Sung|(310) 206-6407|esung@dentistry.ucla.edu|
20523604|NCT01133067|Dept. of Radiation Oncology, Tata Memorial Hospital|Dr. J.P. Agarwal|+91 22 24177000|agarwaljp@tmc.gov.in|7164
20523605|NCT00610428|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20523606|NCT00752128|Medtronic Bakken Research Center B.V.|Marianne Wanten|+3143356|marianne.wanten@medtronic.com|6815
20523607|NCT04135937|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
20523608|NCT02548143|LFB USA|Kerry Biron, Director US Clinical Operations|508.370.5166|kerry.biron@lfb-usa.com|
20523609|NCT04871776|Brigham and Women's Hospital|Nancy Haff, MD, MPH|857-307-3826|nhaff@partners.org|
20523610|NCT00619723|Psychoneuroendocrine Research Group|Dr. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
20523611|NCT00725283|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523612|NCT00711087|Baylor College of Medicine|Christopher P. Smith, MD, MBA, MSS|713-798-7498|cps@bcm.edu|
20523613|NCT01958437|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|7347639259|bhampste@med.umich.edu|
20523614|NCT02603887|UT MD Anderson Cancer Center|Dr. Elisabet Manasanch/ Assistant Professor, Lymphoma-Myeloma|713-745-8092|eemanasanch@mdanderson.org|
20523615|NCT04620746|Johns Hopkins University School of Medicine|Jonathan Zenilman|410-550-9080|jzenilm1@jh.edu|
20523616|NCT03473925|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20523617|NCT03411863|James J. Peters VAMC|Dr. Noam Y. Harel|718-584-9000|noam.harel@va.gov|1742
20523618|NCT04584502|Geisel School of Medicine|Sarah Lord, Ph.D.|6036467089|sarah.e.lord@dartmouth.edu|
20523619|NCT03535740|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20523620|NCT04481035|Cincinnati Children's Hospital Medical Center|Donald L. Gilbert MD|513-636-4222|donald.gilbert@cchmc.org|
20523621|NCT05198518|Icahn School of Medicine at Mount Sinai|Alfred Marc C Iloreta Jr, MD|(212) 241-9410|alfred-marc.iloreta@mountsinai.org|
20523622|NCT00501995|Johns Hopkins University|Gwen Leatherman,R.N.,M.S.|410-550-8582|gleathe@jhmi.edu|
20523623|NCT02396511|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
20523624|NCT01651078|Monteris Medical|Nissa Mollema (Clinical Operations Manager)|763-253-4710|nmollema@monteris.com|
20523625|NCT01841593|SSAT Research, Chelsea & Westminster Hospital|Dr. Marta Boffito|+442033155601|marta.boffito@chelwest.nhs.uk|
20523626|NCT03135015|Housey Healthcare ULC|Project Manager|2486637000|info@housey.com|
20523627|NCT01223378|Bausch & Lomb|H DeCory, PhD|585-338-8161|heleen.decory@bausch.com|
20523628|NCT00124917|National Cancer Institute|Dr. Deborah Citrin|301-496-5457|Debra_Citrin@nih.gov|
20523629|NCT03518008|Alcon Research|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20523630|NCT03164551|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20523631|NCT04941131|King Abdulaziz University|Dr Zuhair Natto|9666943899|znatto@kau.edu.sa|
20523632|NCT03123068|Stanford University|Professor of Anesthesia|650-723-6412|ang@stanford.edu|
20523633|NCT04782076|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20523634|NCT00462917|Brigham and Women's Hospital and Harvard Medical School|Robert C. Green, MD, MPH|617-264-5838|rcgreen@genetics.med.harvard.edu|
20523635|NCT07034820|Nimsai Academia|Cem Atabiner, Principal Investigator|05324593292|cem.atabiner@kecioutdoor.com.tr|
20523636|NCT00729937|Olive View-UCLA Medical Center|David A. Talan, MD|818-364-3107|dtalan@ucla.edu|
20523637|NCT04851873|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20523638|NCT00281957|SWOG Statistical Office|SWOG melanoma statistician|206-667-4408||
20523639|NCT03787134|University of Wisconsin - Madison|Brad Postle, PhD|608-262-4330|postle@wisc.edu|
20523640|NCT03281876|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20523641|NCT02208089|Moorfields Eye Hospital NHS Foundation Trust|Mr Bruce Allan|02075662320|bruce.allan@ucl.ac.uk|
20523642|NCT02443740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523643|NCT00456300|Montefiore Medical College|Rubina Heptulla|832824000|rubhep@gmail.com|
20523644|NCT02452476|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+39 0521 2791|clinicaltrials_info@chiesi.com|
20523645|NCT02757326|Duke University Medical Center, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy|Yubin Kang, M.D., Principal Investigator|(919) 668-2331|yubin.kang@duke.edu|
20523646|NCT03008174|Johns Hopkins University|Vinciya Pandian|4436553482|vpandia1@jhu.edu|
20523647|NCT01074944|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20523648|NCT00194779|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20523649|NCT02348112|Coloplast Corp.|Liz Driessen|1-800-258-3476|usedri@coloplast.com|
20523650|NCT02103855|Indiana University|Jeanne Chen|317-944-3570|jchen@iuhealth.org|
20523651|NCT03560128|Indiana University|Study Coordinator|317-948-0724|rlahr@iu.edu|
20523652|NCT03714828|University of Arizona Cancer Center|Clara Curiel-Lewandrowski, MD|(520) 626-5351|ccuriel@arizona.edu|
20523653|NCT01998841|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20523654|NCT00972595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20523655|NCT01263938|University of Pennsylvania School of Medicine|Dr. Ronald Collman|215-898-0193|collmanr@pennmedicine.upenn.edu|
20523656|NCT04211831|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20523657|NCT01243957|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20523658|NCT02771977|Yale University|F. Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
20523659|NCT05373108|University of California, Los Angeles|Rushi V. Parikh, MD|(310) 825-9011|RParikh@mednet.ucla.edu|
20523660|NCT00349973|University of Maryland, Baltimore|Dr. Elliot Hong, Prinicipal Investigator|410-402-6828|ehong@som.umaryland.edu|
20523661|NCT05493501|EQRx International|EQRx Clinical Trials|(650) 779-2300|clinicalstudies@eqrx.com|
20523662|NCT05620082|University of Southampton|Dr Samantha J Meredith|0238120|s.j.meredith@soton.ac.uk|4656
20523663|NCT04004403|University of Illinois Chicago|Krista Varady|3129967897|varady@uic.edu|
20523664|NCT00625820|University of Michigan|Rajiv Saran, MD|734-763-6611|rsaran@umich.edu|
20523665|NCT04665765|City of Hope Medical Center|Dr. Alex Herrera , MD|6263598111|aherrera@coh.org|
20523666|NCT00070564|SWOG Statistical Center|Breast Committee Statistician|206-667-4623|jmiao@fredhutch.org|
20523667|NCT04796961|Johns Hopkins University School of Medicine|Gail Daumit MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20523668|NCT01168232|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20523669|NCT03018288|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
20523670|NCT03593473|University of North Carollina at Chapel Hill|Alison Stuebe, MD, MSc|919-966-1601|astuebe@med.unc.edu|
20523671|NCT06700512|WSAUDAS|Dr. Veronika Littmann|+4991313080|Veronika.littmann@wsa.com|
20523672|NCT01490086|Reviva Pharmaceuticals, Inc.|Marc Cantillon, M.D|408-960-2209|mcantillon@revivapharma.com|
20523673|NCT06497699|Ocumension Therapeutics (Shanghai) Co., Ltd|Director of Clinical Trials|2289 3653|clinicalop@ocumension.com|3653
20523674|NCT04510090|Escient Pharmaceuticals|Kristin Taylor, Sr VP, Head of Clinical Development|(858) 617-8220|clinicaltrials@escientpharma.com|
20523675|NCT05825404|Penn State University|Ying-Ling Jao|8148655634|yuj15@psu.edu|
20523676|NCT01127256|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
20523677|NCT01749826|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
20523678|NCT01922037|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20523679|NCT00679211|Genentech, Inc.|Medical Communications|800-821-8590||
20523680|NCT00931528|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
20523681|NCT01730053|Regeneron Pharmaceuticals|Clinical Trial Management||clinicaltrials@regeneron.com|
20523682|NCT01470248|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
20523683|NCT05085834|University Hospitals Cleveland Medical Center|Grace McComsey|216-368-3731|Grace.McComsey@uhhospitals.org|
20553427|NCT04033159|Dynacure|Dynacure|+33 3 74 95 20 50|info@dynacure.com|
20523684|NCT01741311|University of Connecticut|Michael Copenhaver|8602083632|michael.copenhaver@uconn.edu|
20523685|NCT05842967|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20523686|NCT04673149|GeneOne Life Science|Chief Medical Officer|6106576351|dkane@genels.us|
20523687|NCT01410097|Wake Forest University|Stephen B. Kritchevsky, PhD|336-713-8548|skritche@wakehealth.edu|
20523688|NCT03657797|Nicox Ophthalmics Inc.|Doug Hubatsch / Chief Scientific Officer|832-360-3022|hubatsch@nicox.com|
20523689|NCT03103087|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
20553428|NCT02377089|UCLA Semel Insititute|Andrew F. Leuchter|310-825-0207|afl@ucla.edu|
20553429|NCT01857063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568854|NCT01126879|Northwestern University|William Catalona, MD|312-695-1301|WCatalona@nm.org|
20523690|NCT00413699|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523691|NCT01051310|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
20523692|NCT02115269|Abbott|Jean-Pascal Berrou, Global Medical Director CNS/Pain|+41614870457|jean-pascal.berrou@abbott.com|
20523693|NCT03511105|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20523694|NCT02810457|Centus Biotherapeutics Limited|Clinical Trial Information|+353 1 609 7100|Clinical-Trial@centusbio.com|
20523695|NCT01402570|University of Michigan|Claire Z. Kalpakjian|734-763-0153|clairez@umich.edu|
20523696|NCT04074941|Marcus Institute, Hebrew SeniorLife|Shivani Sahni, PhD|6179715382|shivanisahni@hsl.harvard.edu|
20523697|NCT03642262|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20523698|NCT01557504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20523699|NCT01365819|UCLA, Dept of Family Medicine|Dr. Steve Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|
20523700|NCT02750618|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20523701|NCT03077737|Northwestern University|Dr. Brian Hitsman, PhD|312-503-2074|b-hitsman@northwestern.edu|
20523702|NCT02572570|University of North Carolina at Chapel Hill|Ricardo Walter, DDS, MS|9195373596|walterr@unc.edu|
20523703|NCT02019472|Janssen-Cilag International N.V.|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20536813|NCT02175277|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20553430|NCT00531843|UCSF/SF General Hospital|M. Margaret Knudson, MD|415.205.4623|pknudson@sfghsurg.ucsf.edu|
20553431|NCT00715793|University of Pittsburgh|Hussein Tawbi, MD, PhD|713-792-6111|HTawbi@mdanderson.org|
20553432|NCT00058825|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
20553433|NCT04115358|Marmara University|Prof. Dr. Ali Mentes|+90 2164140545|alimentes@gmail.com|
20553434|NCT04399161|JSS Dental College & Hospital, JSS Academy of Higher Education & Research|Dr. Krupa NC|8105064056|kripa_555@yahoo.com|+91
20553435|NCT02800148|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
20553436|NCT04552587|Medical University of South Carolina|Katherine R. Sterba, PhD, MPH|843- 876-2419|sterba@musc.edu|
20553437|NCT01822132|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
20553438|NCT04847674|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20553439|NCT03400033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20553440|NCT05409235|Chief Development Officer|D. Scott Edwards, Ph.D.|(339) 234-1333|sedwards@ocuterratx.com|
20553441|NCT01524770|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20553442|NCT01431703|Shanghai Jiaotong university|Dr Ge zhi zheng|86021-34506250|shenyufeng303@gmail.com|
20553443|NCT00689481|GlaxoSmithKline|GSK Response Center|866-435-7343||
20553444|NCT00528528|Janssen Research & Development, LLC Titusville, NJ|Clinical Leader|609-730-3174||
20553445|NCT03508219|European Cardiovascular Research Institute (ECRI-10)|Ernest Spitzer, MD|0031102062828|e.spitzer@ecri-trials.com|
20553446|NCT04466891|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20553447|NCT00445328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20553448|NCT00316199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20553449|NCT02285504|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20553450|NCT01168024|Osprey Medical|VP Of Clinial Affairs|952-955-8230|mshepard@ospreymed.com|
20553451|NCT04074317|Xeris Pharmaceuticals Inc.|Dawn Harper, VP Clinical Devlopment|(215) 704-7290|dharper@xerispharma.com|
20553452|NCT03091192|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20553453|NCT06023394|Children's Mercy Kansas City|Dr. Emily Weisberg, pediatric anesthesiologist|9136605813|eweisberg@cmh.edu|
20553454|NCT05226104|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20553455|NCT01516268|Tehran University of Medical Sciences|Dr. Laleh Eslamian|0098218490|leslamian@tums.ac.ir|2415
20553456|NCT01595516|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
20553457|NCT02096835|Huashan Hospital Fudan University Shanghai, China|Dr.Xiaoyu Yang|086-021-52889999|yangxiaoyu@huashan.org.cn|7693
20553458|NCT01706952|McGill University Health Centre|Marc A. Tewfik|+15147976673|marc.tewfik@mcgill.ca|
20553459|NCT00023673|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
20553460|NCT02472756|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20553461|NCT02307552|UC Irvine|Thomas Ahlering, MD|714 456-6068|tahlerin@uci.edu|
20553462|NCT00978731|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20553463|NCT00218062|The University of Texas Health Science Center at Houston|Dr Joy M. Schmitz|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
20553464|NCT03107988|New Approaches to Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
20553465|NCT02871128|Chung Shan Medical University|Dr. You-Cheng Shen|+886-4-24730022|youcheng@csmu.edu.tw|12107
20553466|NCT03854916|Klein Buendel, Inc.|Dr. David Buller|3035654321|dbuller@kleinbuendel.com|
20568855|NCT00666835|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
20568856|NCT03861429|University of Utah|Dr. Gail Towsley|801-585-9085|gail.towsley@nurs.utah.edu|
20568857|NCT00511147|Grifols Therapeutics Inc|Henry Li, PhD|1 + 919 316 6042|henry.li@grifols.com|
20568858|NCT00899379|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568859|NCT00809783|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553467|NCT00548808|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20553468|NCT04300296|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20553469|NCT01962558|MicroTransponder|VP Clinical Affairs|512-371-4160|studies@microtransponder.com|
20553470|NCT00279708|The National Institutes of Health/ The National Heart, Lung, and Blood Institute|Joseph Fontana, MD|301-451-7740|fontanaj@nhlbi.nih.gov|
20553471|NCT02896127|Novartis PharmaAG|Study Lead|+41613241111|novartis.email@novartis.com|
20523704|NCT00513695|Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium|Jennifer Specht, MD|(206) 288-6889|jspecht@uw.edu|
20523705|NCT02157935|AstraZeneca|Tor Skärby||tor.skarby@astrazeneca.com|
20553472|NCT02940691|Kirby Institute|Professor Jason Grebely|+61 2 9385 0957|jgrebely@kirby.unsw.edu.au|
20553473|NCT00622427|University of Alabama at Birmingham|Rachel Fargason|205-934-5151|mfargason@uab.edu|
20553474|NCT02477020|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20523706|NCT01417156|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20523707|NCT04144413|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20553475|NCT00519649|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523708|NCT01103180|University of Chicago|Dr. Emil Coccaro|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
20523709|NCT01760304|Brigham and Women's Hospital|Dr. Miguel Divo|8573070311|mdivo@bwh.harvard.edu|
20523710|NCT04552795|UT Health San Antonio|Bess Frost, PhD|210-562-5037|bfrost@uthscsa.edu|
20523711|NCT00742209|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20523712|NCT01332487|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523713|NCT02440464|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20523714|NCT01999920|NYSPI|Franklin Schneier, MD|6464774-8041|fschneier@nyspi.columbia.edu|
20523715|NCT02058069|MAKO Surgical Corp.|Michael Conditt|7132408675|michael.conditt@stryker.com|
20523716|NCT02222922|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523717|NCT01299103|Chicago Center for Facial Plastic Surgery|Dr. Steven Dayan|(312) 335-2070|sdayan@drdayan.com|
20523718|NCT03290378|Avenue Therapeutics|VP of Clinical Operations and Program Management|781-652-4514|mryan@avenuetx.com|
20523719|NCT02002221|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20523720|NCT00882518|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20523721|NCT03238651|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20523722|NCT03743051|Helsinn Healthcare SA|Florin Muraru|+41 91985 21 21|florin.muraru@helsinn.com|
20523723|NCT01422200|Cincinnati Children's Hospital Medical Center|Dr. Brenda Wong|5136364222|brenda.wong@cchmc.org|
20523724|NCT00840749|Accuray Inc|study admin|4087164608|ccheung@accuray.com|
20523725|NCT01656460|Brown University Oncology Research Group (BrUOG)|Thomas DiPetrillo, MD|4018633000|kayla_rosati@brown.edu|
20523726|NCT01113892|Getinge Group|Elizabeth Bulger|603 880 1433|Elizabeth.Bulger@getinge.com|5368
20523727|NCT04886596|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20523728|NCT02766335|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20523729|NCT03645863|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
20523730|NCT02756611|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20523731|NCT00476190|Dana Farber Cancer Institute|Dr. Dan DeAngelo|6175828410|Daniel_Deangelo@dfci.harvard.edu|
20523732|NCT02860546|Taiho Oncology, Inc.|Taiho|844-878-2446|medicalinformation@taihooncology.com|
20523733|NCT00978874|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
20523734|NCT02586155|Resverlogix Corp.|Sr. Director of Clinical Operations|403.254.9252|clinicaltrials@resverlogix.com|
20523735|NCT02072980|Alcon Research, Ltd.|Cecile Maissa, Global Brand Medical Affairs Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20523736|NCT02139137|SDSU/UCSD Joint Doctoral Program in Clinical Psychology|Jessica Bomyea|8585528585|jbomyea@ucsd.edu|3720
20523737|NCT03367819|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20523738|NCT00550459|Otsuka Pharmaceutical Development & Commercialization, Inc.|Frank Czerwiec, MD, PhD; Sr. Director, Global Clinical Development|(240) 683-3523|frank.czerwiec@otsuka.com|
20523739|NCT02404805|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Dr. Jennifer Kiser|(303) 724-6131|jennifer.kiser@ucdenver.edu|
20523740|NCT00572936|University of Nebraska Medical Center|Carol Toris, PhD|402-559-1852|ctoris@unmc.edu|
20523741|NCT03070236|Dana-Farber Cancer Institute (DFCI)|Ann H. Partridge, MD, MPH|617-632-3800|Ann_Partridge@dfci.harvard.edu|
20523742|NCT01173523|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468||
20523743|NCT01634048|Imperial College|Professor Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
20523744|NCT02806908|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20523745|NCT02302833|The University of Texas MD Anderson Cancer Center|Dr. Camilo Jimenez|(713) 792-2841|cjimenez@mdanderson.org|
20523746|NCT04429503|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20523747|NCT05516108|University of Pittsburgh|Emily K Lindsay, PhD|412-601-0585|emily.lindsay@pitt.edu|
20523748|NCT02717507|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20523749|NCT05017246|Washington University School of Medicine|Dr. Premal H Thaker|314-747-3604|thakerp@wustl.edu|
20523750|NCT00709995|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20523751|NCT01662778|Imperial College London|Dr Omar Usmani||o.usmani@imperial.ac.uk|
20523752|NCT02562066|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
20523753|NCT02003209|NSABP Foundation|Judy Langer, Director of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20523754|NCT00638508|Maimonides Medical Center|Kalpana Tyagaraj, M.D.|718-283-9162|Kalpana_tyagaraj@msn.com|
20523755|NCT00485264|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20523756|NCT03500198|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
20523757|NCT01514461|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20536814|NCT00064259|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-405-8404|jsparano@montefiore.org|
20536815|NCT01321216|American University of Beirut|Dr Ghassan Dbaibo|961-1-350000|gdbaibo@aub.edu.lb|4819
20536816|NCT03608371|Neumora Therapeutics|Study Contact|8577600900|clinicaltrials@neumoratx.com|
20536817|NCT03062280|Diurnal Limited|Clinical Trials Information|+44 (0) 292 068 2069|info@diurnal.co.uk|
20536818|NCT00516893|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
20536819|NCT01519791|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20536820|NCT03487588|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
20536821|NCT04551963|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536822|NCT00375427|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536823|NCT03850093|faculty of medicine- Zagazig university|assistant professor Abeer M. Elnakera|00201005720754|nakera35@hotmail.com|
20536824|NCT01204905|University of Maryland, Baltimore, IHV|Gregory Brogden|410-706-1660|gbrogden@ihv.umaryland.edu|
20536825|NCT01312805|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
20536826|NCT00588237|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner|646-888-4219|konnerj@mskcc.org|
20536827|NCT03588806|University of Pittsburgh|Dr. Ajay D. Wasan|4126658030|wasanad@upmc.edu|
20536828|NCT03985943|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20536829|NCT01265563|VA- STVHCS|Dr. Shweta Bansal|2105674700|bansals3@uthscsa.edu|
20536830|NCT02029755|Taipei medical university hospital|Dr. Hsiao-Chien Tsai|+886-2-27372181|hctsai.anes@gmail.com|8310
20536831|NCT04904744|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20536832|NCT00716482|SuperSonic Imagine|Research Coordinator|+33 442 99 24 24|sharon.bruce@supersonicimagine.fr|
20536833|NCT03248531|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20536834|NCT04908865|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20536835|NCT01858545|Integra LifeSciences|Manager, Clinical Research|443-766-3869|allison.matthews@integralife.com|
20536836|NCT04075513|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20536837|NCT01524224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20536838|NCT05398159|InMode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
20536839|NCT00456625|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536840|NCT03517371|Center for Neurorehabilitation, College of Health & Rehabilitation, Sargent College, Boston University|Terry Ellis|617-353-2724|tellis@bu.edu|
20536841|NCT05411822|Icahn School of Medicine at Mount Sinai|Mariana Figueiro, PhD|(518) 366-9306|Mariana.Figueiro@mountsinai.org|
20536842|NCT05312697|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20536843|NCT04283656|Thomas Jefferson University|Dr. Walter K. Kraft|(215) 955-9077|Walter.Kraft@jefferson.edu|
20536844|NCT04445519|Nicox Ophthalmics, Inc.|Doug Hubatsch/Chief Scientific Officer|984-710-5354|hubatsch@nicox.com|
20536845|NCT02318368|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|(857) 400-0101|Clinical@aveooncology.com|
20536846|NCT01901614|Oregon Health & Science University|David Huang, MD, PhD|503-494-3000|huangd@ohsu.edu|
20536847|NCT03629223|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20536848|NCT02674464|Johns Hopkins University School of Medicine|Dr. Lisa Cooper, Principal Investigator|4106143659|lisa.cooper@jhmi.edu|
20536849|NCT00783835|Janssen-Cilag Farmaceutica Ltda|Medical Manager|+55 11 30302738||
20536850|NCT01555073|Northwestern University, Feinberg School of Medicine|Antoun Nader, MD|312-695-3045|a-nader2@northwestern.edu|
20536851|NCT03578926|CooperVision Inc.|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20536852|NCT01116466|Otto Bock Healthcare Products GmbH|Medical Affairs Manager|004315233786733|Milana.Mileusnic@ottobock.com|
20536853|NCT00976716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536854|NCT04222699|VA Maryland Healthcare System|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
20536855|NCT01145001|Yale University|Dana Cavallo, Assistant Professor|2039747607|dana.cavallo@yale.edu|
20536856|NCT01271907|National Cancer Institute, National Institutes of Health|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
20536857|NCT00617058|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
20536858|NCT01576939|Stanford University|Quynh Le|650-725-0203|qle@stanford.edu|
20536859|NCT01814046|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
20536860|NCT00564902|James A. Lovell Federal Health Care Center|Dr. Stuart P. Richer|224-610-5440|Stuart.Richer1@va.gov|
20536861|NCT02723916|The Ohio State University, College of Nursing|Dr. Susie Breitenstein|6146884614|breitenstein.5@osu.edu|
20536862|NCT03583359|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
20536863|NCT00508105|Ottawa Hospital Research Institute|Peter Lapner|613-737-8899|plapner@toh.ca|74700
20568860|NCT00126555|University of Texas MD Anderson Cancer Center|Randal S. Weber, MD / Head & Neck Surgery|7137927734|rsweber@mdanderson.org|
20536864|NCT01831466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536865|NCT02798315|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20536866|NCT02299141|Washington University School of Medicine|Ramaswamy Govindan|314-362-5654|rgovindan@wustl.edu|
20536867|NCT01667250|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20536868|NCT00434993|Acute Respiratory Distress Syndrome (ARDS) Network|David Schoenfeld, ARDSNet CCC PI|617-726-6111|dschoenfeld@partners.org|
20536869|NCT00778167|University of Colorado Denver|Dr. David R. Camidge|720-848-0449|ross.camidge@ucdenver.edu|
20536870|NCT03292640|Dr. Reddy's Laboratoris, Inc|Srinivas Sidgiddi, Senior Director, Clinical Development|9084585362|srinivassidgiddi@drreddys.com|
20568861|NCT00529555|Sunstar Americas, Inc|Marie Wilson, Clinical Program Manager|773-481-3327|marie.wilson@us.sunstar.com|
20507308|NCT01646398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568862|NCT02133066|Children's Hospital of Philadelphia|Aaron Chen|2674260383|chena2@email.chop.edu|
20507309|NCT00571519|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20507310|NCT03292952|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
20507311|NCT04656418|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20507312|NCT02475850|Yale University|Erich Greene PhD|203-737-3636|erich.greene@yale.edu|
20507313|NCT01746940|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
20568863|NCT01797822|Baylor College of Medicine|Stephen Pflugfelder|713-798-6100|stevenp@bcm.edu|
20568864|NCT01780545|Hoosier Cancer Research Network|Clinical Data Manager|3176345842|hcrndm@hoosiercancer.org|41
20568865|NCT02253147|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
20568866|NCT02223871|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure desk||clinical-trials-disclosure@idorsia.com|
20568867|NCT01939405|MGH|Dr. Nicolas Oreskovic|6177260593|noreskovic@mgh.harvard.edu|
20568868|NCT00396097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568869|NCT02973477|University of Michigan|Lynn Ang|734-232-8058|angly@med.umich.edu|
20568870|NCT03461211|Horizon Pharma USA, Inc.|Roxann Becco|866-479-6742|clinicaltrials@horizontherapeutics.com|
20568871|NCT03807700|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20568872|NCT03209050|mmc medical international services|Clinical Research Organization and Trial Manager|9492805700|laura22@mmc-medical.com|
20568873|NCT00858507|Providence VA Medical Center|Thomas O'Toole, MD|4012737100|thomas.otoole@va.gov|
20568874|NCT03187353|Perlman School of Medicine, University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
20507314|NCT03297216|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joan_price@med.unc.edu|
20507315|NCT00781963|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|Cathy.Alessi@va.gov|
20507316|NCT03434418|Duke University|Thomas Stinchcombe, MD|919-681-9509|thomas.stinchcombe@duke.edu|
20507317|NCT00696436|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20507318|NCT04241146|Children's Hospital of Nevada at UMC|Prashant Jha|702-383-2420|prashant.jha@umcsn.com|
20507319|NCT01517412|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20507320|NCT03353753|Deciphera Pharmaceuticals, LLC|INVICTUS Clinical Team|7812096400|clinicaltrials@deciphera.com|
20507321|NCT00218426|University of Pennsylvania|Dr. George E Woody|215-746-7702|woodg@pennmedicine.upenn.edu|
20507322|NCT01830816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20507323|NCT02716194|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20507324|NCT01753830|Q-Med AB|Clinical Project Manager|+46 18 4749000|reception.seupp@galderma.com|
20507325|NCT03027388|National Cancer Institute|Dr. Eric Burton|240-760-6436|eric.burton@nih.gov|
20507326|NCT03746808|University of North Texas Health Sciece Center|Scott Walters|817-735-2365|scott.walters@unthsc.edu|
20507327|NCT00671723|University of Oklahoma Health Sciences Center|Dr. Houssein Youness|405-271-6173|houssein-youness@ouhsc.edu|
20507328|NCT01754922|VA NJ Health Care System|Dr. Michael Falvo|973-676-1000|Michael.Falvo@va.gov|2423
20507329|NCT01207388|Amgen Inc.|Study Director|866-572-6436||
20507330|NCT01885078|Eli Lilly & Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20507331|NCT02093234|GW Medical Faculty Associates|Richard Katz, MD|202-741-2323|RKatz@mfa.gwu.edu|
20507332|NCT01895452|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
20568875|NCT03327571|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20568876|NCT02359552|Cleveland Clinic Lou Ruvo Center for Brain Health|Dr. Aaron Ritter|702-483-6049|rittera@ccf.org|
20568877|NCT01747629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20568878|NCT02502487|West China Hospital, Department of Anesthesiology|Dr. Guizhi Du, Associate professor|+86 18980602213|du_guizhi@yahoo.com|
20568879|NCT05021757|Shockwave Medical|Randee Randoll|408.577.7856|rrandoll@shockwavemedical.com|
20568880|NCT03799289|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
20568881|NCT04281875|Vanderbilt University Medical Center|Dr. Carmen C Solorzano|615-343-2735|carmen.solorzano@vumc.org|
20568882|NCT02033499|University of North Carolina at Chapel Hill|Dr. Katrina Donahue|919-966-5090|Katrina_Donahue@med.unc.edu|
20568883|NCT04593641|Celltrion Inc.|JiWoong Lim|82-32-850-5806|jiwoong.lim@celltrion.com|
20568884|NCT03427177|Fox Chase Cancer Center|Dr. Linda Fleisher|215-214-3757|Linda.Fleisher@fccc.edu|
20568885|NCT00794573|Jewish General Hospital / McGill University|Mark Eisenberg, MD MPH|5143408222|mark.eisenberg@ladydavis.ca|
20568886|NCT00500539|Novartis Pharmaceuticals|Study Director|862-778-8300||
20568887|NCT03993054|University of Miami|Sara St. George|305-243-0726|s.stgeorge@med.miami.edu|
20568888|NCT04387201|The University of Texas Health Science Center at Houston|Absalon D Gutierrez, MD|713-500-6641|absalon.d.gutierrez@uth.tmc.edu|
20568889|NCT04320602|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20568890|NCT00497198|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20568891|NCT01750086|Massachusetts General Hospital|Dr. Joy Tsai|617-726-6723|jntsai@mgh.harvard.edu|
20568892|NCT01983462|University of Iowa|Gary Pierce, PhD|3193359487|gary-pierce@uiowa.edu|
20568893|NCT02229396|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20507333|NCT00980343|Adult Brain Tumor Consortium (ABTC)|Charles J Nock, MD|410-955-8837|jfisher@jhmi.edu|
20507334|NCT00765128|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
20507335|NCT03060083|University of Vermont|Elias M Klemperer|8026561641|elias.klemperer@med.uvm.edu|
20507336|NCT00284739|Kaiser Permanente|Hyo-Chun Yoon, MD,PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
20536871|NCT01925040|Kulzer GmbH|Global Scientific Affairs Management|+4915116891006|andrea.leyer@kulzer-dental.com|
20536872|NCT02384044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20553476|NCT01465802|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553477|NCT03852316|University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
20553478|NCT03592641|Duke University Medical Center|John Strickler, MD|919-668-1861|john.strickler@duke.edu|
20553479|NCT01470469|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20553480|NCT02942979|VA Bedford Medical Center|David Smelson|781-687-2845|david.smelson@va.gov|
20553481|NCT02504372|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553482|NCT03912753|Columbia University|Corina Lelutiu-Weinberger, PhD|212-342-1502|cl4265@cumc.columbia.edu|
20553483|NCT01502644|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
20553484|NCT01409291|Creighton University|Kathleen Packard, PharmD, MS, BCPS (AQ Cardiology)|402-481-3915|kathleenpackard@creighton.edu|
20553485|NCT02052739|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20553486|NCT01526889|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|Novartis.email@novartis.com|
20553487|NCT01573624|GlaxoSmithKline|GSK Response Center|866-435-7343||
20553488|NCT05059600|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20553489|NCT06259331|Supernus|Charlene A. Tucker|(301) 838-2500|ctucker@supernus.com|
20553490|NCT02445027|Massachusetts General Hospital|Anna Gao RN.|617-643-6092|tearneylabtrials@partners.org|
20568894|NCT02679079|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20553491|NCT02519712|Memorial Sloan Kettering Cancer Center|Brian Shaffer, MD|212-639-2212|shaffeb1@mskcc.org|
20553492|NCT00613509|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20553493|NCT06017089|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|marc.breton@virginia.edu|
20553494|NCT01188603|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
20553495|NCT00677807|Novartis Pharmaceuticals|Study Director|862-778-8300||
20553496|NCT01686646|GlaxoSmithKline|GSK Response Center|866-435-7343||
20553497|NCT00314366|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
20553498|NCT00749931|Dune Medical Devices|Clinical Research Manager|+97246178000|shiri@dunemedical.com|
20553499|NCT01458327|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
20553500|NCT03993938|Henry Ford Health System|Trevor Szymanski MD|(313) 622-4168|tszyman1@hfhs.org|
20553501|NCT02167256|Yale University|Stephen Strittmatter|2037854878|stephen.strittmatter@yale.edu|
20553502|NCT02469610|CarmelMC|Dr LEVY FABER Dan|97248250289|DANLf@clalit.org.il|
20553503|NCT04590495|West Virginia University|Toni Marie Rudisill, MS, PhD|304-293-0687|trudisill@hsc.wvu.edu|
20553504|NCT03467425|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20553505|NCT01864291|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
20553506|NCT05093426|Closed Loop Medicine Ltd.|Nihal Noori|07443603405|nihal.noori@closedloopmedicine.com|
20536873|NCT02953093|Albert Einstein College of Medicine|Dr. Nir Barzilai|718-430-3144|nir.barzilai@einsteinmed.edu|
20536874|NCT01132651|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
20536875|NCT03054805|Chang Gung Memorial Hospital|Dr. Hsun-Chin Chao|88633281200|chaohero@yahoo.com|8969
20553507|NCT00712296|Icahn School of Medicine at Mount Sinai|Xiu-Min Li, MD|212-241-1755|Xiu-min.li@mssm.edu|
20553508|NCT01387607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568895|NCT03924947|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20536876|NCT03866538|Mayo Clinic|Joseph A. Murray, M.D.|507-284-2631|Murray.Joseph@mayo.edu|
20536877|NCT04148482|Massachusetts General Hospital|Sara Cromer|6177247303|scromer@mgh.harvard.edu|
20536878|NCT03522246|pharmaand GmbH|Medical Information Department|1-800-506-8501|medinfo@pharmaand.com|
20536879|NCT04299308|University of Kansas Medical Center|Dr. Jill Morris|9139457675|jmorris2@kumc.edu|
20536880|NCT00814580|Ortho-McNeil Janssen Scientific Affair, LLC|Senior Director of Clinical Development, Pain|(908)927-5469|GVorsang@its.jnj.com|
20536881|NCT02482428|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536882|NCT02547038|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20536883|NCT00284557|Emory University|Anne L. Dunlop, MD, MPH|404-712-8520|amlang@emory.edu|
20536884|NCT01340625|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20536885|NCT00301262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20536886|NCT01443364|UCB|UCB Clinical Trial Call Center|+1877 822||9493
20536887|NCT00623233|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20536888|NCT00559845|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20536889|NCT00459875|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
20536890|NCT01525862|Stryker ENT|Principal Clinical Research & Publications Manager|764-463-1598|ellen.omalley@stryker.com|
20536891|NCT00241176|NYU School of Medicine, NYU Child Study Center|Barbara J Coffey, M.D, M.S.|(212)263-3926|barbara.coffey@mssm.edu|
20568896|NCT03009019|BioDelivery Sciences (a subsidiary of Collegium Pharmaceutical)|Director, Scientific Communications|913-940-1789|tkunkel@collegiumpharma.com|
20536892|NCT03206970|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536893|NCT03645421|AstraZeneca|Global Clinical Lead|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
20553509|NCT02084628|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20553510|NCT00352612|Johns Hopkins University|Aaron Chen|4109556143|achen33@jhmi.edu|
20536894|NCT00924001|National Cancer Institute, National Institutes of Health|Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20536895|NCT00224120|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20536896|NCT00104416|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536897|NCT02455804|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
20536898|NCT00070109|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20536899|NCT01231334|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20536900|NCT01164891|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20536901|NCT00441142|Dana-Farber Cancer Institute|Dr. Eudocia Quant Lee|617-632-2166|eqlee@partners.org|
20536902|NCT00338286|Janssen Research and Development|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20536903|NCT04998318|Duke University Medical Center|Megan Huchko, MD, MPH|(919) 684-8111|megan.huchko@duke.edu|
20536904|NCT00022763|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20536905|NCT02141399|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20536906|NCT01345929|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
20536907|NCT00394329|Penn State College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
20536908|NCT02819297|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
20536909|NCT02858440|GlaxoSmithKline|GSK Response Center|866-435-7343|lrs54533@gsk.com|
20536910|NCT01670279|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20536911|NCT01407952|Mayo Clinic|Bernard Bendok, MD|3129269441|bendok.bernard@mayo.edu|
20536912|NCT01534351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20536913|NCT02702609|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
20536914|NCT04153981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20536915|NCT02027311|Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital|Dr. Byung Hyo Cha, Director of ETOMI-1 study|+82-64-740-8050|drhyo@hotmail.com|
20536916|NCT03928418|University of California San Francisco|Dr. Judy Hahn|415-476-5815|judy.hahn@ucsf.edu|
20536917|NCT03177512|Bridge HIV, San Francisco Department of Public Health|Albert Liu|628-217-7408|albert.liu@sfdph.org|
20536918|NCT00964002|Department of Medical Oncology, Institut bergonié|Pr Nadine Houede, oncologist||nadine.HOUEDE@chu-nimes.fr|
20536919|NCT01781806|UCLA CARE Center|Dr. Raphael J. Landovitz|(310) 825-6689|rlandovitz@mednet.ucla.edu|
20536920|NCT02771574|Stanford University School of Medicine|Cindy Lamendola|650-723-3141|clamendola@stanford.edu|
20536921|NCT02593903|Medical College of Wisconsin|Clinical Research Coordinator|414-337-3441|ebedjeti@mcw.edu|
20536922|NCT01780337|Columbia University|William Whang|212-305-8620|ww42@cumc.columbia.edu|
20536923|NCT02036580|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20536924|NCT00260832|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20536925|NCT02993822|NeRRe Therapeutics Limited|Dr. Stephen Pawsey|+44 (0)1438906960|steve.pawsey@nerretherapeutics.com|
20536926|NCT01854775|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20536927|NCT00984594|RTI Biologics|Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
20536928|NCT01659996|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20536929|NCT03206918|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536930|NCT02701764|University of Miami|Dr. Anat Galor|305-450-6050|agalor@med.miami.edu|
20536931|NCT03823287|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20536932|NCT00978419|Vanderbilt University Medical Center|Burn Unit Director|(615) 322-4590||
20568897|NCT00805285|University of Maryland, Baltimore|Raymond Cross, MD, MS|410-706-3387|rcross@medicine.umaryland.edu|
20568898|NCT05060237|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32|ameluz@biofrontera.com|66
20568899|NCT01066897|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
20568900|NCT01697592|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568901|NCT02110225|Dompé farmaceutici s.p.a.|Flavio Mantelli, MD, PhD|+39 02 583831|clinical.trials@dompe.com|
20568902|NCT00774306|Thomas Jefferson University|Dr. Scott Mintzer|215-955-1222|scott.mintzer@jefferson.edu|
20523758|NCT03499067|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20523759|NCT04650217|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|brr8@cumc.columbia.edu|
20553511|NCT00590954|Memorial Sloan Kettering Cancer Center|Thomas Kaley, MD|212-639-5122|kaleyt@mskcc.org|
20553512|NCT04413929|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20553513|NCT02742103|CSL Behring|Trial Registration Coordinator|6108784000|clinicaltrials@cslbehring.com|
20553514|NCT02533921|University of Colorado|Benzi Kluger, MD, MS, Principal Investigator|303-724-2194|Benzi.kluger@ucdenver.edu|
20553515|NCT04346615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20553516|NCT01507493|Huazhong University of Science&Technology|Xianwei Zhang|13037154560|znpain@sina.com|
20553517|NCT03853707|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20553518|NCT02349711|Food Science and Human Nutrition Department, University of Florida|Dr. Bobbi Langkamp-Henken|352-294-3721|henken@ufl.edu|
20553519|NCT01610700|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20553520|NCT02453594|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553521|NCT02097134|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20553522|NCT01845155|Deutsches Zentrum für Musiktherapieforschung (Viktor Dulger Institut) DZM e.V. - German Center for Music Therapy Research|Dr. Heike Argstatter|+49-6221-7963960|heike.argstatter@dzm-heidelberg.de|
20553523|NCT01663272|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
20553524|NCT00501540|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
20553525|NCT02331446|Federal Universisty of Pelotas|Msc. Matheus Pintanel Freitas||matheus.pintanel@hotmail.com|
20553526|NCT04879745|University of Pittsburgh Medical Center|Dr. Mehret Birru Talabi|412-383-8000|birrums@upmc.edu|
20553527|NCT00120042|The University of Western Australia|Dr Jan Dickinson|61-8-93401330|Jan.Dickinson@uwa.edu.au|
20553528|NCT00796861|Penn State Health|Dr. Leah Cream|717-531-8870|lcream@pennstatehealth.psu.edu|
20553529|NCT01860417|CITOSPIN|Dr. Javier García-Sancho,|0034 983184827|jgsancho@uva.es|
20553530|NCT00529386|Dept of Urology, Queen's University|J C Nickel|613 548 2497|jcn@queensu.ca|
20553531|NCT04532112|University of Pennsylvania|Dr. Michael Kohanski|2153495766|michael.kohanski@pennmedicine.upenn.edu|
20553532|NCT01403090|BiO2 medical|Luis Angel, MD|2102139778|langel@bio2medical.com|
20553533|NCT01049919|Zimmer Biomet|Hillary Overholser|574-373-2042|hillary.overholser@zimmerbiomet.com|
20553534|NCT02984995|Daiichi Sankyo Co., Ltd.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20553535|NCT06285981|Orthofix|Clinical Program Manager|0456719077|danielacangiano@orthofix.it|
20553536|NCT03120013|University of Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
20553537|NCT03697811|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20553538|NCT02152995|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
20553539|NCT02098109|Washington University School of Medicine|Camille Abboud, M.D.|314-454-8304|cabboud@wustl.edu|
20553540|NCT01565291|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20553541|NCT04907032|UAB|Russell Stanley|325-829-8315|russellstanley74@gmail.com|
20553542|NCT02705820|Bank Of Cyprus Oncology Centre|Dr. Harris Charalambous|+35722847300|haris.charalambous@bococ.org.cy|450
20553543|NCT02751983|Rocky Mountain Mental Illness Research, Education, and Clinical Center|Sean Barnes|720-723-6560|Sean.Barnes2@va.gov|
20553544|NCT00989833|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20553545|NCT00414388|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD (PI)|847-268-8200|shallmeyer@oncmed.net|
20553546|NCT00025883|National Institute of DIabetes and Digestive and Kidney Dseases, National Institutes of Health|Dr. Phillip Gorden|301-402-7340|phillipg@mail.nih.gov|
20568903|NCT02621047|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20568904|NCT00735462|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
20523760|NCT00595621|Texas Tech|Irene Sarosiek, MD, AGAF, FACG, CCRP|915.215.5254|Irene.sarosiek@ttuhsc.edu|
20523761|NCT00324987|SWOG Statistical Center|SWOG Statistician|206-667-4408||
20523762|NCT01302743|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|702-653-3298|jill.clark.3.ctr@us.af.mil|
20523763|NCT00897715|VA Tennessee Valley Healthcare System.|Adriana Hung|615-873-7480|adriana.hung@va.gov|
20523764|NCT01268553|Los Angeles Biomedical research INst at Harbor-UCLA|Dr. Ronald Oudiz|310-222-3560|roudiz@labiomed.org|310
20523765|NCT00513240|Baylor College of Medicine|Dr. Dean B. Andropoulos|832-826-5831|dra@bcm.edu|
20523766|NCT02714218|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20523767|NCT00860795|University of Washington|James A Taylor, MD|206-616-1206|uncjat@u.washington.edu|
20523768|NCT01930162|Novartis Pharmaceuticals|Study Director|862-778-8300||
20568905|NCT01264887|Grünenthal GmbH|Director Clinical Trials|+49 241 569|clinical-trials@grunenthal.com|3223
20568906|NCT00591409|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568907|NCT02171130|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20568908|NCT04531813|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20568909|NCT02853305|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553547|NCT00218543|COLUMBIA UNIVERSITY|Frances R Levin, MD|212-543-5896|FRL2@COLUMBIA.EDU|
20568910|NCT04772313|Horizon Therapeutics USA, Inc.|Supra Verma, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
20523769|NCT02550561|University of California, Irvine|Phuong Linh Huynh, CRC|7144566155|plhuynh@hs.uci.edu|
20523770|NCT01564693|SAPIENZA UNIVERSITY OF ROME|PROF. ALESSANDRO LAVIANO|+390649973902|alessandro.laviano@uniroma1.it|
20523771|NCT01960413|Vanderbilt University Medical Center|Michael DeBaun, MD MPH|(615) 875-3040|m.debaun@vumc.org|
20523772|NCT00791778|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20523773|NCT01285362|Columbia Universty|Dr Mercedes Martinez|212-305-3438|mm2479@cumc.columbia.edu|
20523774|NCT00931411|Innovaderm Research|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
20536933|NCT00475085|University of Rochester|Dr. Charles Heckler|585 273-1141|checkler@urmc.rochester.edu|
20523775|NCT01949662|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
20523776|NCT02291237|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20523777|NCT03207386|University of Nebraska Lincoln|Dr. Katie Edwards|6034223207|katie.edwards@unl.edu|
20507337|NCT02899377|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
20523778|NCT01478373|Novartis Pharmaceuticals|Study Director|862-778-8300||
20523779|NCT01199380|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
20507338|NCT01231607|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523780|NCT01408043|Case Comprehensive Cancer Center|Navneet Majhail|216-444-2199|majhain@ccf.org|
20523781|NCT03741400|Professor of Neurology and Neurological Sciences|Maarten G. Lansberg, MD PhD|(650) 723-4448|lansberg@stanford.edu|
20523782|NCT02552121|Genmab A/S|Genmab|7020 2728|clinicaltrials@genmab.com|+45
20523783|NCT01522456|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Associate Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
20523784|NCT04052620|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20523785|NCT01500473|Children's Hospital Los Angeles|Thomas Keens|3233612101|tkeens@chla.usc.edu|
20523786|NCT02201784|Jawaharlal Nehru Medical College, AMU, Aligarh, India|Dr. Manazir Athar|+918868056469|drmanazirathar@gmail.com|
20523787|NCT00193050|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
20523788|NCT02431364|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20523789|NCT00061932|Montefiore Medical Center|Rutvi Patel|718-379-6861|rupatel@montefiore.org|
20523790|NCT00916383|Teikoku Pharma USA, Inc.|Director of Clinical Trials|(408) 501-1821||
20523791|NCT02899962|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20523792|NCT00258960|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34 916 592 870|geicam@geicam.org|
20523793|NCT00473590|Hoffman-LaRoche|Medical Communications|800-821-8590||
20523794|NCT04778475|Medical University of South Carolina|Sinead Farrelly DPT|843-792-3069|farrelsi@musc.edu|
20523795|NCT01245283|UF&Shands Orthopaedics and Sports Medicine Institute|Kevin R. Vincent, M.D. Ph.D.|352-273-7458|vincekr@ortho.ufl.edu|
20523796|NCT02153983|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
20523797|NCT00395161|University of Utah|Jeri Burr, MS, RN-BC, CCRC|801-587-7753|jeri.burr@hsc.utah.edu|
20523798|NCT01610492|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523799|NCT00580502|NYULMC|Heekoung Youn|2122632174|younh01@nyumc.org|
20523800|NCT01757275|AstraZeneca|Huifang Chen|+86 21 60301335|ariel.chen@astrazeneca.com|
20523801|NCT03093259|Abivax|Sharon Skare|+33 (0) 1 53 83 08 41|sharon.skare@abivax.com|
20523802|NCT01821807|Adiyaman University Research Hospital, Department of Anesthesiology and Reanimation|Dr. Ruslan Abdullayev|+905063010833|ruslan_jnr@hotmail.com|
20523803|NCT04446247|Owlet Baby Care, Inc|Madison Kenley, Clinical Research Director|801-552-8383|mkenley@owletcare.com|
20523804|NCT01401452|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20523805|NCT00584454|UAMRIID Division of Medicine|LTC Robert Rivard, MD|301-619-8244|robert.g.rivard.mil@mail.mil|
20523806|NCT00254592|University of California Irvine Medical Center|Rita S. MEHTA, MD|(714) 456-5153|rsmehta@uci.edu|
20523807|NCT01459783|University of California Los Angeles|Joshua Chodosh or Barbara Vickrey|310-206-7671|jchodosh@mednet.ucla.edu|
20523808|NCT02601014|University of Minnesota Division of Hematology, Oncology and Transplantation|Emmanuel Antonarakis, MD|612-301-2180|anton401@umn.edu|
20523809|NCT02624180|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
20523810|NCT02833337|Centro de Implantologia, Cirugia Oral y Maxilofacial|Alberto Monje|+41798836264|amonjec@umich.edu|
20523811|NCT00445146|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@Gilead.com|
20523812|NCT02409927|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20523813|NCT06389487|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20523814|NCT00858273|Nemours Children's Clinic|Dominique Darmaun, MD|(904) 697 3674|ddarmaun@nemours.org|
20523815|NCT03192488|Indiana University|Robert Chapman|812-856-2452|rfchapma@indiana.edu|
20523816|NCT00867529|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
20523817|NCT02392481|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20523818|NCT00268450|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20523819|NCT03565900|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20523820|NCT01254643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20523821|NCT06160609|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20523822|NCT03359850|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20523823|NCT01280643|Fox Chase Cancer Center|Dr. Crystal Denlinger|215-214-1676|crystal.denlinger@fccc.edu|
20523824|NCT02090088|Amgen Inc.|Study Director|866-572-6436||
20523825|NCT01629511|UT MD Anderson Cancer Center|Dr. Chitra Hosing|713-792-8750|cmhosing@mdanderson.org|
20536934|NCT06899737|KDH Research & Communication|Kristen D. Holtz, PhD|4043958711|kholtz@kdhrc.com|
20523826|NCT03817125|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
20523827|NCT00942084|Duke Clinical Research Institute|P. Brian Smith, MD MPH MHS|919-668-8951|brian.smith@duke.edu|
20523828|NCT01998919|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20523829|NCT02383017|Onnit Labs|Vince Kreipke|3176954359|Vkreipke@onnit.com|
20523830|NCT01087918|UZurich|Hubertus van Hedel, PhD|+41 44 762 52 91|hubertus.vanhedel@kispi.uzh.ch|
20523831|NCT01037218|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20523832|NCT01068860|Novartis Pharmaceuticals|Dr. Tom Thuren/Global Brand Medical Director|862-778-1828|tom.thuren@novartis.com|
20523833|NCT02568072|St George's, University of London|Dr Andrew D'Silva|020 7188 7188|adsilva@nhs.net|51554
20523834|NCT00927589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20523835|NCT02695446|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
20523836|NCT02961595|University of Tampere|Hanna Viskari||hanna.viskari@uta.fi|
20523837|NCT01199939|Janssen Pharmaceuticals|SENIOR MEDICAL DIRECTOR|1 609 730-2931||
20523838|NCT04784091|Tarsus Pharmaceuticals|Mark Holdbrook, Senior Vice-President of Clinical Development|408-431-6613|mark@tarsusrx.com|
20523839|NCT03875508|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20536935|NCT01308840|University of Rochester|Aram F Hezel|585-275-5823|aram_hezel@urmc.rochester.edu|
20536936|NCT03110029|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
20536937|NCT03281629|Maryland Psychiatric Research Center, University of Maryland School of Medicine|Dr. Xiaoming Du|410 402 6036|xdu@som.umaryland.edu|
20568911|NCT01836198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20568912|NCT02754310|iLumens|Dr David Drummond|+0033144494848|david.drummond@ilumens.org|6
20523840|NCT02137252|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Fremonta Meyer, MD||flmeyer@partners.org|
20523841|NCT04460911|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523842|NCT00063934|UTMDACC|Francisco Esteva, MD, PHD / Professor|713-792-2817|Francisco.Esteva@nyumc.org|
20523843|NCT00774163|Tulane University School of Public Health and Tropical Medicine|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
20523844|NCT03957200|University of manitoba|Dr Helen Pymar|204-787-4184|hpymar@hsc.mb.ca|
20507339|NCT01583985|Minneapolis VA Health Care System|Erin Krebs, MD|612-725-2000|erin.krebs@va.gov|
20523845|NCT02285361|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20523846|NCT01283464|Johns Hopkins Dermatology|Dr. Anna L. Chien|4105027546|ctrep@jhmi.edu|
20523847|NCT03051100|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20523848|NCT01778855|UCLA|David S Liebeskind, MD|310-794-6379|dliebeskind@mednet.ucla.edu|
20523849|NCT02059135|LFB USA|Laura Massey, Sr. Clinical Project Manager|508-370-5157|laura.massey@lfb-usa.com|
20523850|NCT00489866|Durham VAMC|Christine E. Marx, MD|9192860411|marx0001@mc.duke.edu|7426
20523851|NCT05317312|Viatris|Susanne Vogt|004906172|susanne.vogt@viatris.com|88801
20523852|NCT01422213|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20523853|NCT03762265|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20523854|NCT01805089|DFCI|Dr. Wendy Chen|617-632-3800|wychen@partners.org|
20523855|NCT02857816|Medtronic Pelvic Health & Gastric Therapies|Beth Michaud / Sr. Principal Clinical Research Specialist|763.526.8102|beth.m.michaud@medtronic.com|
20523856|NCT02289729|AbbVie|Global Medical Services|800-633-9110||
20523857|NCT00470470|Memorial Sloan-Kettering Cancer Center|Dr. Richard Carvajal|646-888-4161|carvajar@mskcc.org|
20523858|NCT01149863|Emory University|Dr. Harvey|404-778-4381|rdharve@emory.edu|
20523859|NCT03326193|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20523860|NCT02845700|Florida State University|Dr. Wen Li|850-645-1409|wenli@neuro.fsu.edu|
20523861|NCT01964976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20523862|NCT01168427|Medtronic - CRDM|RIO Clinical Research Specialist.|1-800-328-2518|MedtronicCRMtrials@medtronic.com|63277
20523863|NCT00397514|University of British Columbia|Dr. Shubhayan Sanatani|6048752345|ssanatani@cw.bc.ca|7955
20523864|NCT01256879|U of Maryland|James Polli, Professor|410-706-8292|jpolli@rx.umaryland.edu|
20523865|NCT00640315|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20523866|NCT00266279|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|bcccto@louisville.edu|
20523867|NCT00725920|Federal University of Sao Paulo|Marcelo F Mello|55 11 50822860|mf-mello@uol.com.br|
20523868|NCT02623725|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
20523869|NCT03918629|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523870|NCT02456740|Amgen Inc.|Study Director|866-572-6436||
20523871|NCT01615367|Massachusetts General Hospital|Dr. Louisa Sylvia|617-643-4804|lsylvia2@partners.org|
20523872|NCT00607321|Medtronic Cardiovascular|K Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20523873|NCT01891864|Sandoz|Dr Guido Wuerth - Global Program Medical Director|+4980244762925|guido.wuerth@sandoz.com|
20523874|NCT04720105|Icahn School of Medicine at Mount Sinai|Hassan Hamade|212-844-8811|hassan.hamade@mountsinai.org|
20523875|NCT02892331|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virgina.edu|
20523876|NCT02483676|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Steven Kittner|410-706-0414|skittner@som.umaryland.edu|
20523877|NCT03717155|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20523878|NCT02286713|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20523879|NCT02654054|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20523880|NCT01333592|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
20523881|NCT02490631|Vanderbilt University Medical Center|Elizabeth Card|615-875-4611|elizabeth.b.card@vumc.org|
20523882|NCT06018129|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
20523883|NCT03832686|Stanford University|Heather Starmer, MD|650-529-5903|hstarmer@stanford.edu|
20523884|NCT03323398|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20523885|NCT02235454|Duke University|Sanjay Asrani|919-684-8656|sanjay.asrani@duke.edu|
20523886|NCT03641469|Green Sun Medical|James A. Arthur|720-202-3621|jarthur@greensunmedical.com|
20523887|NCT05479435|Istanbul Medipol University|Arzu Abalay|+905075891917|arzuabalay@hotmail.com|
20523888|NCT05081063|Loma Linda University Health|Kaushik Mukherjee|9096515948|kmukherjee@llu.edu|
20523889|NCT00955617|Guerbet|Emilie Huchet|+33 1 45 91 50 00|emilie.huchet@guerbet-group.com|7688
20523890|NCT00982657|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523891|NCT04199104|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20507340|NCT01677507|University of Michigan|Dr. Sayoko Moroi|734-763-3732|smoroi@med.umich.edu|
20523892|NCT05120193|Medtronic, Inc.|Clinical Research Specialist|800-328-2518|medtroniccrmtrials@medtronic.com|
20507341|NCT03779334|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20523893|NCT03796988|University of Miami|Hadar Lev-Tov, Assistant Professor|305-243-4472|hltevtov@med.miami.edu|
20523894|NCT04692103|UWashington|Hannah Linden, MD|206-606-2053|hmlinden@uw.edu|
20568913|NCT01061775|Children's Hospitals and Clinics of Minnesota|Dr. Jennifer Abuzzahab|651-220-6867|jennifer.abuzzahab@childrensmn.org|
20507342|NCT06533475|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20507343|NCT02170649|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
20507344|NCT02823600|University of North Carolina at Chapel Hill|Seema Garg, MD, PhD|919-966-5296|sgarg@med.unc.edu, ashton.madison@alumni.duke.edu|
20507345|NCT01309867|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
20507346|NCT00432094|Masonic Cancer Center, University of Minnesota|Dr. Najla El Jurdi|612-625-8942|neljurdi@umn.edu|
20507347|NCT01608724|Astrazeneca Investment (China) Co., Ltd.|Anya Huang, Brand Physician|+86 21 6030 2032|anya.huang@astrazeneca.com|
20507348|NCT00363246|James A. Haley Veterans' Hospital|Andrea M. Spehar, DVM, MPH, JD|813-558-3947|Andrea.Spehar@va.gov|
20507349|NCT01788306|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
20523895|NCT04563754|Baylor College of Medicine|Dr. Sharmila Anandasabapathy|713-798-8105|Sharmila.Anandasabapathy@bcm.edu|
20523896|NCT04023396|Abivax|Associate Director Clinical Operations|+33630031132|laurence.desroys@abivax.com|
20523897|NCT03150329|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
20523898|NCT04748510|Perth Hip & Knee|Dr Serene Lee, Orthopaedic Research Officer|64891720|research@hipnknee.com.au|
20523899|NCT02325973|Abbott Medical Italia|Vanoni Benedetta, Abbott Clinical Site Lead|+39340571064|benedetta.vanoni@abbott.com|
20523900|NCT02513160|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20523901|NCT01279317|Maastricht University Medical Centre|Drs. Jan-Willem van Dijk|+31(0)433881394|janwillem.vandijk@maastrichtuniversity.nl|
20523902|NCT03241862|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20523903|NCT00728260|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
20523904|NCT04796909|The Hong Kong Polytechnic University|Dr. Chi-Wen Chien, Associate Professor|+85227666703|will.chien@polyu.edu.hk|
20523905|NCT03428958|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
20523906|NCT03874117|VA Palo Alto|Tammy Sirich|6504935000|tsirich@stanford.edu|
20523907|NCT03985800|Department of Psychiatry, University of Pittsburgh|Eva Szigethy, Co-Principal Investigator, Adjunct Professor of Psychiatry, Staff Psychiatrist|412-667-0416|szigethye@upmc.edu|
20523908|NCT05012098|National Cancer Institute|Dr. Charalampos Floudas|240-858-3032|charalampos.floudas@nih.gov|
20523909|NCT05258773|Sensorion|Chief Medical Officer|+33 4 67 20 77 30|contact@sensorion-pharma.com|
20523910|NCT04815083|photonamic GmbH & Co. KG|Vice President Clinical Development & Regulatory Affairs|+49 (0)4101 78539 09|info@photonamic.de|
20523911|NCT06025721|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
20523912|NCT04514692|Stanford University|Dr. Elizabeth Kidd|(650) 723-6171|ekidd@stanford.edu|
20523913|NCT05364931|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20523914|NCT02243605|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
20523915|NCT00075816|The EMMES Corporation|Adam Mendizabal|301-251-1161|amedizabal@EMMES.com|
20523916|NCT04173507|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20523917|NCT01823328|Hennepin Healthcare|Audrey Hendrickson|612-873-9528|Audrey.Hendrickson@hcmed.org|
20523918|NCT02832687|CHRISTUS St. Vincent Regional Medical Center|Dr. Michal Gajewski, DO|(505) 913-3361|Michal.Gajewski@stvin.org|
20523919|NCT04231825|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
20523920|NCT01662635|Thoracic Oncology Unit. Instituto Nacional de Cancerología|Oscar Gerardo Arrieta-Rodríguez|+52 55 56280400|ogar@unam.mx|832
20523921|NCT03861390|University of North Carolina at Chapel Hill|Terry Noah, MD|919-966-1055|terry_noah@med.unc.edu|
20523922|NCT03588910|Montefiore Medical Center|Dr. Kari Plewniak|718-920-5157|kplewnia@montefiore.org|
20523923|NCT02547428|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20523924|NCT01892501|Institute Bergonie|Dr. Dominique Bechade, Coordinating Investigator|0556337805|d.bechade@bordeaux.unicancer.fr|
20523925|NCT06192589|U.S. Food and Drug Administration|Jeffry Florian|301-796-4847|Jeffry.Florian@fda.hhs.gov|
20523926|NCT03664232|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20523927|NCT01439802|Albert Einstein College of Medicine|Dr. Erika Levi|718-405-8260|elevi@montefiore.org|
20523928|NCT00370552|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20523929|NCT00654095|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20523930|NCT02502149|Bioverativ|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
20523931|NCT02548832|INSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA|Esperanza Martinez Abundis|3310585200|esperanzamartnezabundi@yahoo.com|34211
20523932|NCT02968576|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@ucdenver.edu|
20523933|NCT01607450|Indiana University|Kieren J Mather MD FRCPC|317-278-7826|kmather@iu.edu|
20523934|NCT03036657|Oregon Health & Science University|Alexandra Dimitrova, PI|503-494-0766|dimitroa@ohsu.edu|
20523935|NCT01062425|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20523936|NCT05263908|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523937|NCT02386319|Herlev Hospital|Dr. Anders Gram-Hanssen|004526225318|anders.gram-hanssen@regionh.dk|
20523938|NCT01651117|Corporal Michael J. Crescenz VA Medical Center|Judith A. Long, MD|215-898-4311|judith.long@va.gov|
20523939|NCT01342471|National Cancer Institute|Jeremy Steeves Ph.D.|(865)-308-3506|jeremy.steeves@nih.gov|
20523940|NCT02088177|NYSPI|Dr. Frances R. Levin||frl2@cumc.columbia.edu|
20523941|NCT01774760|Turku University Hospital, Turku, Finland|Prof. Heikki Minn|+35823130000|heikki.minn@tyks.fi|30149
20523942|NCT01641640|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20507350|NCT01822691|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
20536938|NCT00334737|University of New Mexico|Dr. Robin K Ohls|505-272-6753|rohls@salud.unm.edu|
20536939|NCT05455580|Hunter-Bellevue School of Nursing, Hunter College, The City University of New York|Tara Heagele, PhD, RN|212-396-7206|th1591@hunter.cuny.edu|
20536940|NCT03304054|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
20536941|NCT02954406|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20536942|NCT00782171|Institut Straumann AG - Clinical Research|Institut Straumann AG|+41 61 965 11 11|research@straumann.com|
20536943|NCT04309370|Indiana University|Clinical Research Manager|3178808495|iupdp@iupui.edu|
20536944|NCT01986231|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
20536945|NCT02150057|Andrews Institute for Orthopaedics & Sports Medicine|Dr. Roger Ostrander|850-916-3700|rostrander@flboneandjoint.com|3725
20536946|NCT00489424|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536947|NCT01558115|Columbia University|John P. Bilezikian, MD|212-305-6257|jpb2@cumc.columbia.edu|
20536948|NCT01436656|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536949|NCT01696994|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
20536950|NCT00335283|Vanderbilt University Medical Center|Manager, Clinical Trials|615-322-4643|tina.higginbotham@vanderbilt.edu|
20536951|NCT00880269|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536952|NCT00576628|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20536953|NCT03230890|Atrium Health Wake Forest Baptist|Charles H. Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
20536954|NCT04136548|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
20536955|NCT02516982|Imperial College London|Dr Josip Car|+44(0)2075940799|josip.car@imperial.ac.uk|
20536956|NCT02926027|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
20536957|NCT02377752|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20536958|NCT01951586|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20536959|NCT00962741|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536960|NCT02120781|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
20536961|NCT05096247|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20536962|NCT02003638|University of Pennsylvania|Dr. Emil deGoma|2156156521|emil.degoma@uphs.upenn.edu|
20536963|NCT00760435|University of California, San Diego|Dr. Adriana H. Tremoulet|858-246-0012|atremoulet@ucsd.edu|
20536964|NCT00654745|Daiichi Sankyo|James McCarthy|732-590-3430|jmccarthy@dsi.com|
20536965|NCT00748618|University of Nebraska Medical Center|Fang Yu|(402) 559-9436|fangyu@unmc.edu|
20536966|NCT00466947|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536967|NCT01995526|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20536968|NCT00924612|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
20568914|NCT00588341|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|(646) 888-4162|chapmanp@mskcc.org|
20568915|NCT02567227|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
20568916|NCT03746483|First Wave BioPharma Inc.|Chief Medical Officer|(561) 589-7020|info@firstwavebio.com|
20568917|NCT04349124|Duke University|Brenna Hughes, M.D.|919-668-0843|brenna.hughes@duke.edu|
20568918|NCT00475787|Canandaigua VA Medical Center|Paul Dougherty, DC|585-463-2673|paul.dougherty@va.gov|
20568919|NCT01954771|Beijing Anzhen Hospital|Dr.Yingsheng Zhou|0086-010-64456185|zys626@aliyun.com|
20568920|NCT00935649|PathoLase|David M Harris, PhD, Research Director|510-502-3345|bmcinc@comcast.net|
20568921|NCT02886234|The Miriam Hospital|Dr. Michael Carey|401793-8218|michael_carey@brown.edu|
20568922|NCT00957671|University of Texas Medical Branch|Randall Urban, MD|409-772-1176|rurban@utmb.edu|
20568923|NCT01026103|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
20568924|NCT03635775|University of Wisconsin Madison|Bernadette Gillick|612-625-3645|bgillick@wisc.edu|
20568925|NCT02498418|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20568926|NCT00762502|Johnson & Johnson Vision Care, Inc.|John Buch, OD|1-904-443-1707|RA-Visus-ClnclStds@its.jnj.com|
20568927|NCT05562583|Northwestern University|Judith Tedlie Moskowitz|312-503-7712|judith.moskowitz@northwestern.edu|
20568928|NCT01675050|University of Michigan|Ismaeel Hashemi, M.D. Principal Investigator|6169165566|ismaeel.hashemi@gmail.com|
20568929|NCT00264498|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20568930|NCT03794609|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568931|NCT04543942|The Ohio State University|Dr. Jessica Weafer|859-533-9878|jessica.weafer@osumc.edu|
20568932|NCT02205476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568933|NCT00179478|University of California San Diego|Revere P Kinkel MD (PI)|619-543-5295|rkinkel@ucsd.edu|
20568934|NCT00360971|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20568935|NCT00924209|National Cancer Institute, National Institutes of Health|Caryn Steakley, Deputy Clinical Director|240-858-3749|steaklec@nih.gov|
20568936|NCT02625922|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20568937|NCT02391116|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20536969|NCT03086408|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
20536970|NCT05445921|Washington University School of Medicine, Dept. of Otolaryngology - Head and Neck Surgery|Dr. Andrew Peterson, Resident Physician|314-362-5626|pandrew@wustl.edu|
20536971|NCT01977729|Yale University|Dr. Wendy Silverman|(203) 737-7053|wendy.silverman@yale.edu|
20523943|NCT01545648|University of California, San Francisco|Hope Rugo, MD|877-827-3222|cancertrials@ucsf.edu|
20523944|NCT01234350|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20523945|NCT00289848|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20523946|NCT03103438|Biocad|Nadezhda Kravtsova|+7 (812) 380 49 33|kravtsovana@biocad.ru|
20523947|NCT02792517|Amgen Inc.|Study Director|866-572-6436||
20523948|NCT01894919|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20523949|NCT01433471|NYU Langone Medical Center|Martin Wolff|(646) 329-7259|martin.wolff@nyumc.org|
20523950|NCT01823861|London School of Hygiene and Tropical Medicine|Dr. Chris Smith|07974562199|christopher.smith@lshtm.ac.uk|
20523951|NCT03711188|Immodulon Therapeutics Ltd|Clinical Trial Information Desk,|0044 0203137 6346|info@immodulon.com|
20523952|NCT04341363|Yale University|Brett King|(203) 785-7421|Brett.King@yale.edu|
20523953|NCT02570308|Immunocore, Ltd|Nicola McKelvie|484-534-5261|nicola.mckelvie@immunocore.com|
20523954|NCT02069015|Wayne State University|Julie Gleason-Comstock|313-577-6681|jgleason@med.wayne.edu|
20523955|NCT02182492|Department of ENT of Tongji Hospital Tongji Medical College Huazhong University of Science and Technology|Dr. Zheng Liu|86 027 83663807|zhengliuent@hotmail.com|
20523956|NCT03335475|Nationwide Children's Hospital|Jamie Jackson, Ph.D.|614-722-3585|jamie.jackson2@nationwidechildrens.org|
20523957|NCT02411656|The University of Texas MD Anderson Cancer Center|Bora Lim, MD|(713) 745-0689|blim@mdanderson.org|
20523958|NCT05921903|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20523959|NCT03305848|Regions Hospital|Benjamin A Willenbring, MD|651-254-3563|benjamin.a.willenbring@healthpartners.com|
20523960|NCT00789854|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20523961|NCT00923013|National Cancer Institute|Dr. Robert Kreitman|301-648-7375|kreitmar@mail.nih.gov|
20523962|NCT05365451|Washington State University|Dr. Mary Paine|509-358-7759|mary.paine@wsu.edu|
20523963|NCT03933904|Center for Cytokine Storm Treatment & Laboratory (CSTL), University of Pennsylvania|Dr. David Fajgenbaum|215-614-0935|davidfa@pennmedicine.upenn.edu|
20523964|NCT05366010|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20523965|NCT02224157|AstraZeneca AB|Stefan Ivanov|000000000|information.center@astrazeneca.com|
20523966|NCT05906628|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20523967|NCT01108718|Beth Israel Medical Center|Diana Vu|212-844-6747|dvu@bethisraelny.org|
20523968|NCT00423878|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
20523969|NCT01060072|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20523970|NCT00837148|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
20523971|NCT01416636|SciPharm SàRL|Bianca Tan||b.tan@scipharm.eu|
20523972|NCT02301169|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
20523973|NCT04075825|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20523974|NCT03220204|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
20523975|NCT02861586|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20523976|NCT04581824|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20523977|NCT03879135|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20523978|NCT05277922|Vicore Pharma AB|Cecilia Ganslandt|+46 705 797075|info@vicorepharma.com|
20523979|NCT00210210|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials' Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20523980|NCT02445248|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20523981|NCT01217112|GW Research Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223266800|rp@gwpharm.com|
20523982|NCT02596971|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20523983|NCT03190993|Pennington Biomedical Research Center|John Apolzan|225-763-2827|john.apolzan@pbrc.edu|
20523984|NCT01401361|St. Jude Medical|Nancy Ouch|+19497695041|NOuch@sjm.com|
20523985|NCT00595920|Opexa Therapeutics, Inc.|Kenny Frazier, VP of Clinical Development and Regulatory Affairs|281-775-0660|kfrazier@opexatherapeutics.com|
20523986|NCT00351468|Novartis|Study Director|862-778-8300||
20523987|NCT00611923|Weill Cornell Medical College and Yale School of Medicine|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
20523988|NCT04565145|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
20523989|NCT03096314|Massachusetts General Hospital|Nancy Ringwood, CCC Project Manager|617-724-9836|nringwood@mgh.harvard.edu|
20523990|NCT00471822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20523991|NCT03318861|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
20523992|NCT00917852|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
20523993|NCT00471081|GlaxoSmithKline|GSK Response Center|866-435-7343||
20523994|NCT05486091|Anxiety Disorders Center|Gretchen Diefenbach, Ph.D.|860-545-7396|gretchen.diefenbach@hhchealth.org|
20523995|NCT00663793|University of Washington|John K Amory, MD, MPH|206-616-1727|jamory@u.washington.edu|
20523996|NCT03428152|Derince Training and Research Hospital|Dr|+905336515650|handegrbz@gmail.com|
20523997|NCT00395629|Novartis Pharmaceuticals|Study Director|862-778-8300||
20523998|NCT01686373|University of South Carolina|Dr. Julius Fridriksson|1-803-777-5931|jfridrik@sc.edu|
20523999|NCT00754130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524000|NCT03776357|Stanford University|Derek Amanatullah, MD, PhD|650-723-2257|dfa@stanford.edu|
20524001|NCT06481709|APR Applied Pharma Research s.a.|Giorgio Reiner Chief Scientific Officer|+41.91.6957020|giorgio.reiner@apr.ch|
20524002|NCT04535141|University of North Carolina Lineberger Comprehensive Cancer Center|Jonathan Ptachcinski PharmD, BCPS, BCOP|+1 919-966-9786|Jonathan.Ptachcinski@unchealth.unc.edu|
20507351|NCT01553916|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4653|clifford.robinson@wustl.edu|
20507352|NCT00230100|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
20507353|NCT00645567|James A Haley VA, Tampa|John Lloyd|813-624-8986|john.lloyd2@va.gov|
20524003|NCT06811155|hospital universitario virgen de la victoria|eva cabrera cesar|646905201|evacabreracesar@gmail.com|
20524004|NCT01320293|University of North Carolina|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
20524005|NCT01532934|University of Rochester|Marc T. Swogger, Ph.D.|585-275-7418|marc_swogger@urmc.rochester.edu|
20524006|NCT01147068|Protein Sciences Corporation|Dr. Ruvim Izikson, M.D.|203-599-6064|rizikson@proteinsciences.com|163
20524007|NCT00793455|Northwestern University|Kenzie A. Cameron, PhD, MPH|312-503-3910|k-cameron@northwestern.edu|
20524008|NCT03181633|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20524009|NCT02641093|University of Cincinnati|Trisha Wise-Draper, MD, PhD|513 558 2826|wiseth@ucmail.uc.edu|
20524010|NCT02749617|Hematology Research Program (HRP)|Director of HRP|6048754111|alee14@bccancer.bc.ca|22958
20524011|NCT02574598|Instituto Nacional de Cancerología|Dr. Oscar Arrieta|(52) 55-5628-0400|ogar@unam.mx|71101
20524012|NCT01597778|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20524013|NCT04910100|BLP Management Group LLC|Barry Butler|813-766-9539|bbutler@blpmgmt.com|
20524014|NCT02329015|Long Island University|Marshall Hagins PhD, PT|3478048512|mhagins@liu.edu|
20524015|NCT00699998|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20524016|NCT01406574|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
20524017|NCT03093701|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
20524018|NCT03482973|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|0706
20524019|NCT00946920|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20524020|NCT04616612|Indiana University|Dr. Rebecca Bartlett Ellis|3172740047|rjbartle@iu.edu|
20524021|NCT04740918|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20524022|NCT00524940|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
20524023|NCT03759392|Cytokinetics, Inc.|Cytokinetics MD|650-624-2929|medicalaffairs@cytokinetics.com|
20524024|NCT01710787|Jean Brown Research|Adam D. Marberger, DDS|801-261-2000||
20524025|NCT04314037|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20524026|NCT01941615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
20553548|NCT02448875|Alcon Research|Senior Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20553549|NCT01282216|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
20553550|NCT02908529|Brigham and women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
20553551|NCT04099524|Stanford University|Feng Vankee Lin, PI|6082156005|vankee_lin@stanford.edu|
20553552|NCT04733157|University of Zimbabwe|Dr. Chipo Gwanzura|+263774718381|chipo.gwanzura@gmail.com|
20553553|NCT02056171|Weill Cornell Medicine|Chani Traube|212-746-3056|chr9008@med.cornell.edu|
20553554|NCT03337724|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20553555|NCT00773097|University Pittsburgh|Robert E. Schoen ME|412-648-9115|rschoen@pitt.edu|
20553556|NCT00466960|Seattle Cancer Care Alliance|Barbara Goff|206-543-3668|bgoff@u.washington.edu|
20553557|NCT04973488|"University of Medicine and Pharmacy Victor Babes Timisoara"|Dr. Novacescu Alexandru|+40745064844|novacescu_alex@yahoo.com|
20553558|NCT02219815|St. Boniface Hospital|Dr. Rakesh Arora|2042581078|rarora@sbgh.mb.ca|
20553559|NCT05114005|The Ohio State University Comprehensive Cancer Center|Dr. Lise Worthen-Chaudhari|614-293-6281|wort08@osumc.edu|
20553560|NCT03238911|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
20553561|NCT02239536|Seoul ST. Mary's hospital|Bo-In Lee|821083671055|gidoc4u@gmail.com|
20553562|NCT01038778|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
20553563|NCT05645432|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20553564|NCT03195478|Bristol-Myers Squibb|Bristol-Myers Squibb Study Directo|1-855-907-3286|Clinical.Trials@bms.com|
20553565|NCT02215070|Duke University|Anthony Sung|919-668-1000|anthony.sung@duke.edu|
20553566|NCT02449356|Xiangya Hospital|Jiali Shao|+8684327413|zwyfeng@163.com|
20553567|NCT02595567|Washington University School of Medicine|Alexander Chen, Director of Interventional Pulmonology|314-454-8764|achen@dom.wustl.edu|
20553568|NCT02492451|Zeynep Kamil Research and Teaching Hospital|Selcuk Selcuk|+905321630488|md_sel@hotmail.com|
20553569|NCT01221441|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
20553570|NCT02665481|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
20553571|NCT03285646|Regeneron Pharmaceuticals, Inc.|Study Director|844-734-6643|clinicaltrials@regeneron.com|
20568938|NCT01078376|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20568939|NCT01150500|Study Manager|Hiroko Ookubo|+81-3-6430-7017|hiroko.ookubo@medtronic.com|
20568940|NCT00741468|Repros Therapeutics Inc.|Jennifer Wike|281-719-3402|jwike@reprosrx.com|
20568941|NCT02391545|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20568942|NCT01222078|GlaxoSmithKline|GSK Response Center|866-435-7343||
20568943|NCT04089332|University of Wisconsin - Madison|Dr. William Schrage|608-262-7715|william.schrage@wisc.edu|
20568944|NCT05756348|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
20568945|NCT01363297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20568946|NCT05401149|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20568947|NCT00495612|Genentech, Inc.|Medical Communications|800 821-8590||
20568948|NCT00006099|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20568949|NCT06016127|Albany Saratoga Centers for Pain Management|Kasandra Cliff|518-371-6772|khopkins@northwayspc.com|
20568950|NCT02189122|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
20568951|NCT02656745|Click Therapeutics|Director of Scientific Affairs|646-844-2158|brian@clicktherapeutics.com|
20524027|NCT00273182|Medtronic, Inc.|InSync Registry Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
20568952|NCT03847389|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|4073231887|nini.ramirez@hillderm.com|
20568953|NCT02864147|Clinical Research Team Leader, Gynecologic Oncology, Yale Cancer Center|Alessandro Santin, MD|(203) 200-4176|alessandro.santin@yale.edu|
20568954|NCT00734851|DukeUMC|Andrew J. Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
20568955|NCT01770509|The Department of Dermatology, Sheba Medical Center|Dr. Shoshana Greenberger|972-3-5302443|shoshana.greenberger@sheba.health.gov.il|
20524028|NCT00856492|SWOG Statistical Center|Breast Committee Statistician|206-667-4623||
20524029|NCT01609790|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20524030|NCT06954493|SCYNEXIS, Inc|David Angulo, MD|(201) 884 - 5471|david.angulo@scynexis.com|
20524031|NCT04162847|Washington University in St. Louis School of Medicine|Dr. Denise Wilfley|3142862079|wilfleyd@wustl.edu|
20524032|NCT00127231|Johns Hopkins University School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
20524033|NCT02764762|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20524034|NCT01468337|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
20524035|NCT03534687|University of Michigan|Jacob Haus|734 647-2790|jmhaus@umich.edu|
20524036|NCT01836471|Novaratis Pharmaceuticals|Study Director|862-778-8300||
20524037|NCT00314340|UC Davis Medical Center|Barth Wilsey MD|916-843-7165|blwilsey@ucdavis.edu|
20553572|NCT02684591|UCSD|Rohit Loomba, MD, MHSc|858-246-2201|roloomba@ucsd.edu|
20553573|NCT00721526|NYU Grossman School of Medicine|Michael Bogenschutz|505-999-9325|Michael.Bogenschutz@nyulangone.org|
20568956|NCT01518517|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
20536972|NCT03286543|SPR Therapeutics|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
20536973|NCT05332392|Masimo|Ahmed Alghazi|949-297-7437|aalghazi@masimo.com|
20536974|NCT03636893|RUIJIN HOSPITAL|Dr BIRENDRA KUMAR SAH|0086-64370045|rjsurgeon@hotmail.com|671302
20536975|NCT00438360|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536976|NCT00758069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20536977|NCT04560816|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20536978|NCT02277691|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20536979|NCT04343534|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
20568957|NCT00981578|InSightec|Nadir Alikacem|214.360.2000|nadira@insightec.com|
20568958|NCT02865135|Dana Farber Cancer Institute (DFCI)|Kartik Sehgal, MD|617-632-3090|Kartik_Sehgal@dfci.harvard.edu|
20536980|NCT03560102|Kantonsspital Winterthur|Christoph A Binkert (Sponsor-Investigator)|+41 52 266 2602|christoph.binkert@ksw.ch|
20568959|NCT01294358|National Cancer Institute|Dr. Udo Rudloff|301-496-3098|udo_rudloff@nih.gov|
20536981|NCT01147250|Sanofi|Trail Transparency Team||Contact-US@sanofi.com|
20536982|NCT02342691|Forsyth|Hatice Hasturk|617-892-8499|hhasturk@forsyth.org|
20536983|NCT00615719|VCU|John D. Grizzard|804-828-8569|jdgrizzard@vcu.edu|
20536984|NCT01959178|Bausch Health|Study Director||robert.steffen@bausch.com|
20536985|NCT00842153|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536986|NCT03352141|Zeltiq Aesthetics|Lori Brandt, Director Cinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
20536987|NCT00586716|Loma Linda University Medical Center|Dr. Pedro Baron|909-558-6792|PBaron@llu.edu|
20536988|NCT02091362|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20536989|NCT00690430|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536990|NCT00617097|University of California, Davis|Dr. Catherine Cansino|9167346930|Catherine.Cansino@ucdmc.ucdavis.edu|
20536991|NCT02125838|DorkuzEU|Sule Ozbilgin|902324122836|ozbilginsule@gmail.com|
20536992|NCT02565147|The Medicines Company|Global Health Science Center|1.888.977.6326|medical.information@themedco.com|
20536993|NCT00787839|Atlanta VA Medical Center|Lawrence S Phillips, MD|404-728-7608|lawrence.phillips@va.gov|
20536994|NCT00286091|Amgen Inc.|Study Director|866-572-6436||
20536995|NCT01994746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20536996|NCT02936869|World Bank|Dr. Adanna Chukwuma|9173712931|adc785@mail.harvard.edu|
20536997|NCT00335738|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20536998|NCT02688270|Covis Pharma|Clinical Trial Interest|18773744177|CTInterest@covispharma.com|
20536999|NCT00745290|Pacira Pharmaceuticals Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20537000|NCT03423238|Wake Forest School of Medicine|Tina Brinkley|336-713-8534|tbrinkle@wakehealth.edu|
20537001|NCT05066750|University of Colorado Colorado Springs|Lori James|7192554172|ljames@uccs.edu|
20537002|NCT02688829|Microport Medical, Shanghai, China|Dr Zhang Haotian|8621-38954600|zhanght@microport.com|8552
20568960|NCT02963922|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20568961|NCT02150109|Ascensia Diabetes Care|Jane Wallace, Deputy Director Clinical Trials|574-257-3063|jane.wallace@ascensia.com|
20568962|NCT02181400|Sydney Eye Hospital|Maria Willilams|02 9382 7309|maria.williams@sydney.edu.au|
20568963|NCT01239056|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
20568964|NCT01180790|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20568965|NCT00655668|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20568966|NCT04763863|Coloplast AB|Catarina Sternhufvud|+46 (0)705 56 10 97|secast@coloplast.com|
20568967|NCT03840148|Venatorx Pharmaceuticals, Inc.|Paul McGovern, MD|484-329-8615|mcgovern@venatorx.com|
20568968|NCT03615404|Duke University Medical Center|Principal Investigator|919-684-0000|pedsneuronc@duke.edu|
20568969|NCT00257556|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20568970|NCT01074034|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
20568971|NCT03849300|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20568972|NCT01774929|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
20568973|NCT04839289|Sonova USCS|Lisa Standaert|331-702-0173|lisa.standaert@phonak.com|
20568974|NCT02363933|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
20568975|NCT04853238|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20568976|NCT02093897|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20568977|NCT02972242|WRNMMC Cardiology|Hampton Crimm|301-295-4500|hampton.a.crimm.mil@mail.mil|
20568978|NCT02956278|University of California San Francisco|Kathy Giacomini, PhD|415-514-4363|kathy.giacomini@ucsf.edu|
20537003|NCT00506454|Sepsicure L.L.C.|Vice President|212-606-4352|bianuale@metromediacompany.com|
20537004|NCT03800537|University of North Carolina at Chapel Hill|Desma Jones|919-843-9463|desma_jones@med.unc.edu|
20568979|NCT02329223|Novartis|Study Director|862-778-8300||
20568980|NCT02628964|NYU Langone Health|Donna Shelley, MD MPH|917-494-4210|donna.shelley@nyulangone.org|
20537005|NCT00902850|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|Robert.Steffen@bausch.com|
20537006|NCT01928290|Washington University School of Medicine|Haeseong Park, M.D.|314-747-6268|haeseongpark@wustl.edu|
20537007|NCT03745638|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20537008|NCT03098433|Virginia Commonwealth University|Francesco S. Celi, MD, MHSc.|804-828-9696|francesco.celi@vcuhealth.org|
20537009|NCT04470050|Bioxcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
20568981|NCT01157351|Janssen Research & Development|Director, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20537010|NCT01104545|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537011|NCT03640507|Beth Israel Deaconess Medical Center|Cassandra R. Duffy, MD, MPH|617-667-2636|cduffy3@bidmc.harvard.edu|
20537012|NCT02777203|The Advanced Gyn Surgery Institute|Mary Johnston|6303641112|mjohnston@drcharlesmiller.com|
20568982|NCT00684203|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20568983|NCT04140266|Hans Rosling Center for Population Health|Jen Balkus|260 616 6614|jbalkus@uw.edu|
20568984|NCT00791102|University of Chicago|Robert Naclerio, MD|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
20568985|NCT03511378|Lupin Ltd. (Lupin Research Park), Pune, India|Dr. Chirag Shah, Director|91-20-67917368|chiragshah@lupin.com|
20568986|NCT01701271|Bio Basic Europe|Prof. Fulvio Marzatico|(39) 0382 - 506390|fulviomk@unipv.it|
20568987|NCT00730847|GlaxoSmithKline|GSK Response Center|866-435-7343||
20568988|NCT00280683|UCaliforniaDavis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
20568989|NCT01243411|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20568990|NCT00082641|University of Nebraska|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
20568991|NCT03022578|UT MD Anderson Cancer Center|Dr. Barbara O'Brien, MD/Associate Professor, Neuro-Oncology|(713) 794-4380|bjobrien@mdanderson.org|
20568992|NCT04517877|Photozig, Inc.|Bruno Kajiyama|6506947496|info@photozig.com|
20568993|NCT01223963|Q-Med AB|Chief Medical Officer|+46 18 4749000|reception.seupp@galderma.com|
20568994|NCT03245762|University of Florida|Jennifer Miller, MD|352-265-7337|millejl@peds.ufl.edu|
20568995|NCT03935932|University of Pittsburgh|Tim Corcoran, Associate Professor|4126922210|corcorante@upmc.edu|
20568996|NCT02312622|Stanford University|Joel W. Neal, MD PhD, Assistant Professor of Medicine (Oncology)|(650) 498-4696|jwneal@stanford.edu|
20568997|NCT01057888|University of Rochester, Deparentment of Pediatrics|Dr. Peter Szilagyi|585 275-5798|peter_szilagyi@urmc.rochester.edu|
20568998|NCT02499835|University of Wisconsin Carbone Cancer Center|Douglas McNeel, MD|608-263-4198|dm3@medicine.wisc.edu|
20568999|NCT01751451|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher, MD|646-888-4878|scherh@MSKCC.ORG|
20569000|NCT01906658|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20569001|NCT03319719|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20569002|NCT00498433|Novartis Pharmaceuticals|Study Director|862-778-8300||
20569003|NCT00744796|University of Texas Southwestern Medical Center|Dr. Vinod Mootha|214-648-3837|peter.chen@utsouthwestern.edu|
20569004|NCT01212952|Mayo Clinic|Martha Q. Lacy, M.D.|(507) 284-8430|lacy.martha@mayo.edu|
20569005|NCT02581189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20569006|NCT02720081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569007|NCT02316847|SK Bio-pharmaceuticals Co, Ltd|MinJae Lee, Associate Manager||minj.lee@sk.com|
20569008|NCT00397020|UCSD Medical Center|Dr. David Feifel|619-543-2485|dfeifel@ucsd.edu|
20569009|NCT05110014|Wake Forest Baptist Health Sciences|Study Coordinator|336-713-3103|eswright@wakehealth.edu|
20569010|NCT03371485|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20569011|NCT01860807|UCLA|Keith Heinzerling MD|310-319-4700|kheinzerling@mednet.ucla.edu|
20569012|NCT00349388|Atlantic Health System|Dr. Joel Rosh|973-971-5676|joel.rosh@atlantichealth.org|
20569013|NCT01947153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569014|NCT02381652|Anika|Carol Pekar, VP Clinical Affairs|781.457.9218|cpekar@anikatherapeutics.com|
20569015|NCT01340300|Dana-Farber Cancer Institute|Meyerhardt, Jeffrey,M.D.,M.P.H.|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
20569016|NCT01656486|Carolinas Medical Center|David Iannitti, MD|704-446-2772|david.iannitti@carolinashealthcare.org|
20569017|NCT01961921|Alnylam Pharmaceuticals Inc|Chief Medical Officer|1-877-256-9526|Clinicaltrials@alnylam.com|
20569018|NCT03280108|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20569019|NCT01187407|Eli Lilly and Company|Chief Medical Officer|800-545-597||
20569020|NCT01820637|Boston Scientific|Lieve Cornelis, Clinical Trial Manager|+ 32 476-840-183|Lieve.Cornelis@bsci.com|
20569021|NCT00583115|Indiana University|Ronald Mark Payne MD|317-278-6329|rpayne@iu.edu|
20569022|NCT02382406|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20569023|NCT01713998|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20569024|NCT03638258|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20569025|NCT02520414|Boston Scientific|Meaghan Wilk Clinical Project Manager|5086834113|meaghan.wilk@bsci.com|
20569026|NCT00607789|Lindner Center of HOPE|Susan McElroy, MD|513-536-0718|susan.mcelroy@lindnercenter.org|
20569027|NCT01313299|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20569028|NCT02506881|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20569029|NCT01919398|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20569030|NCT03722836|ServierRussia|Medical Manager-Olga Linnik|8-495-93707-00|olga.linnik@servier.com|1316
20569031|NCT02016690|AbbVie|Global Medical Services|800-633-9110||
20524038|NCT01967862|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20524039|NCT05506046|Georgia State University|Lyudmila Popova|404-413-9338|lpopova1@gsu.edu|
20524040|NCT00191477|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20524041|NCT02479451|Mass General Hospital|Sagar Nigwekar|5857298636|sagarnigs@gmail.com|
20524042|NCT00381862|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
20524043|NCT01275365|Brigham and Women's Hospital|Shalendar Bhasin, MD|617-525-9040|Sbhasin@partners.org|
20537013|NCT03604172|University of Pennsylvania|Dr. Ariana Chao|215-746-7183|arichao@upenn.edu|
20569032|NCT02264353|University of California, San Diego|Atul Malhotra, MD|(858) 657-6159|amalhotra@ucsd.edu|
20569033|NCT04896502|Arkansas Children's Hospital|Robbie Pesek, MD|501-364-3149|rdpesek@uams.edu|
20569034|NCT04374019|University of Kentucky|Susanne Arnold MD|8592579568|smarno0@uky.edu|
20569035|NCT00884793|UCSF|Steven Yukl|415-221-4810|steven.yukl@ucsf.edu|3930
20569036|NCT00663923|Tabriz University of Medical Sciences|Mohammad R sedghipour,MD|+98 411 3306619|sedghipm@yahoo.com|
20569037|NCT02785900|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20569038|NCT04341584|Hopital Hotel-Dieu (AP-HP)|Dr Raphael Porcher|:+33 (0)1.42.34.89.87|raphael.porcher@aphp.fr|
20569039|NCT04990973|Columbia University Irving Medical Center|Dr. Marie-Pierre St-Onge|212-305-9379|ms2554@cumc.columbia.edu|
20569040|NCT01772147|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569041|NCT02025647|NCS Pearson|Dr. Paul E Williams, Sr. Research Director|952-681-4553|paul.e.williams@pearson.com|
20569042|NCT03480919|Hospital for Special Surgery|Jonathan Kirschner|6467146327|kirschnerj@hss.edu|
20569043|NCT04572997|Prof. Dr. Kristian Reich|Prof. Dr. Kristian Reich|+49 1722701941|kreich@jerucon.com|
20569044|NCT01967719|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20569045|NCT04588519|Spark Biomedical, Inc.|Navid Khodaparast, PhD|832-280-4756|navid.khodaparast@sparkbiomedical.com|
20569046|NCT03067610|University of Texas Southwestern Medical Center|Dr. David Sher|214/645-7607|david.sher@utsouthwestern.edu|
20569047|NCT01226485|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20507354|NCT00547638|Ethicon, Inc.|John Lombard, Clinical Research Manager|908 218 2877|jlombar8@its.jnj.com|
20507355|NCT00438399|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|70 51
20507356|NCT05522673|National Institute of Mental Health (NIMH)|Dr. Robert Innis|301-594-1368|robert.innis@nih.gov|
20507357|NCT00723073|Brigham and Women's Hospital|David Kubiak, Principle Investigator|617-525-8417|dwkubiak@partners.org|
20507358|NCT00349752|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
20507359|NCT00819585|Novartis Pharmaceuticals|Study Director|862-778-8300||
20507360|NCT03334396|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20507361|NCT00601796|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
20507362|NCT04914377|Novatek Pharmaceuticals|Ahmed Kaseb MD|877-662-8351|akaseb@novatekpharmaceuticals.com|
20507363|NCT03730194|University of Nebraska Medical Center|Alyson E Hanish|402-559-6731|alyson.hanish@unmc.edu|
20507364|NCT01766817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20507365|NCT02902913|University of California, Davis|Roberta R Holt|530-752-4950|rrholt@ucdavis.edu|
20507366|NCT03041909|Global Blood Therapeutics|Margaret Tonda, Sr. Director, Clinical Science|650-741-7761|mtonda@gbt.com|
20507367|NCT03011450|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20507368|NCT00383721|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20507369|NCT03814590|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20507370|NCT03519516|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20507371|NCT02300077|Department of Anesthesiology Washington University in St. Louis|Helga Komen|3148527622|komenh@anest.wustl.edu|
20507372|NCT05757427|MVG Industries SAS|Luc Duchesne|+33 (0) 6 70 33 91 20|luc.duchesne91@gmail.com|
20507373|NCT01255306|"University Hospital Sestre milosrdnice"|Mia Zoric Geber, MD|+385 1 3787 354|mia.zoric-geber@zg.t-com.hr|
20507374|NCT01179347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507375|NCT01299610|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507376|NCT02223429|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
20507377|NCT03363919|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
20524044|NCT01169064|Vanderbilt University Medical Ctr., Dept OB/GYN|Dr. Kelly Bennett; Director of Maternal Fetal Medicine|6153436275|kelly.a.bennett@vanderbilt.edu|
20524045|NCT01286467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524046|NCT01058642|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20569048|NCT00796614|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569049|NCT00740597|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
20569050|NCT00932659|Duke University|Patrick Pun, MD, MHS|919-660-6865|patrick.pun@duke.edu|
20569051|NCT00746785|The Mind Reseach Network|Kent Hutchison, Ph.D.|505-272-5028|khutchison@mrn.org|
20569052|NCT01231464|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569053|NCT03449134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569054|NCT00993798|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20569055|NCT00957996|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
20553574|NCT00348205|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20569056|NCT02983877|Case Western Reserve University|Dr. Jennifer Levin|2168445057|jennifer.levin@uhhospitals.org|
20553575|NCT02652624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20553576|NCT01434823|University of Pennsylvania|Dr. Meeta P. Kerlin|215.614.0627|meeta.prasad@uphs.upenn.edu|
20553577|NCT01299077|Eisai China Inc.|Haibo Song|0086-21-24192864|songhaibo@eisai.com.cn|
20553578|NCT01993108|University of Michigan|Chandra Sripada|734 232 0281|sripada@umich.edu|
20553579|NCT01663259|University of Michigan Rogel Cancer Center|Michelle Mierzwa|734-936-7810|mmierzwa@umich.edu|
20553580|NCT04354831|Medical College of Wisconsin|Mary Beth Graham, MD|414-955-0500|mbgraham@mcw.edu|
20524047|NCT01833481|University of Tennessee|Dr. Richard D. Komistek|8659742093|rkomiste@utk.edu|
20524048|NCT04973267|Brown University - SPH|Tyler Wray, PhD|4018636659|tyler_wray@brown.edu|
20524049|NCT03751098|Eyenovia, Inc.|VP, Development|714-269-8838|gclasby@eyenoviabio.com|
20524050|NCT01639157|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
20524051|NCT03447639|Beaumont Hospital|Director of Urology Research|248.551.0804|Deborah.Hasenau@Beaumont.org|
20524052|NCT03440229|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|james.lewis@pennmedicine.upenn.edu|
20524053|NCT02280200|University of Minnesota|Ryan Mays PhD, MPH, MS|612-625-0430|rjmays@umn.edu|
20524054|NCT02755285|Fujifilm Medical Systems USA, Inc.|Randy Vader|(360) 356-6821|randy.vader@fujifilm.com|
20524055|NCT01306305|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20524056|NCT04030299|The University of Iowa|Dr. Yu-Hsaing Wu|(319) 335-9758|yu-hsiang-wu@uiowa.edu|
20524057|NCT01451463|The Ohio State University|Sandra K Kostyk, MD, PhD|6142934969|sandra.kostyk@osumc.edu|
20524058|NCT02964247|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20524059|NCT01288079|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20524060|NCT01530464|Duke University Medical Center|Dr. Thies Schroeder|919 681 4721|thies.schroeder@duke.edu|
20524061|NCT01709500|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
20524062|NCT00226577|Karmanos Cancer Institute|Gerold Bepler, M.D., Ph.D. via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
20524063|NCT04143373|Tehran UMS|Dr. Nariman Nikparto|+989124969058|n-nikparto@razi.tums.ac.ir|
20524064|NCT02044380|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524065|NCT03888469|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20524066|NCT03539302|InCarda Therapeutics|VP Clinical Operations|510-422-5522|propst.meisa@incardatherapeutics.com|111
20524067|NCT01927120|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Betts|813-745-5410|brian.betts@moffitt.org|
20524068|NCT04507464|University of Illinois at Chicago|Dr. Ulf Bronas|3123555886|bronas@uic.edu|
20524069|NCT01853215|Vidacare Corporation|Larry J. Miller, MD|210-375-8500|larry.miller@vidacare.com|
20524070|NCT02107131|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|
20524071|NCT02696291|Emergent Product Development Gaithersburg, Inc.|Tim Babinchak, MD|(240) 631-3585|tbabinchak@ebsi.com|
20524072|NCT04707573|Akebia Therapeutics|Akebia Therapeutics|617-844-6128|trials@akebia.com|
20524073|NCT00420420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553581|NCT01018264|University of South Florida|Theresa Zesiewicz, MD, Professor of Neurology|813-974-5909|tzesiewi@health.usf.edu|
20569057|NCT00970320|Ostfold Hospital Trust|Dr Hege Hølmo Johannessen|+4799721345|hege.holmo.johannessen@so-hf.no|
20569058|NCT00381797|St. Jude Children's Research Hospital|Shengjie Wu|(901) 595-2859|shengjie.wu@stjude.org|
20569059|NCT01709123|Louisiana State University Health Science Shreveport|Sushil K. Jain, PhD|318.675.6086|sushil.jain@lsuhs.edu|
20569060|NCT01902381|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|bpowell@wakehealth.edu|
20569061|NCT02762500|Lycera Corp.|H. Jeffrey Wilkins, MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
20569062|NCT03018223|Moffitt Cancer Center|Nelli Bejanyan, MD|813-745-7208|Nellie.Bejanyan@moffitt.org|
20569063|NCT00329550|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20569064|NCT00637247|AmpliMed Corporation|Robert Dorr|520-626-7892|bdorr@azcc.arizona.edu|
20569065|NCT00488319|Johnson & Johnson Research & Development, LLC|Director Clinical Research|1-609-730-6771||
20569066|NCT01982786|Canadian cancer trials group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
20569067|NCT00111839|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
20569068|NCT01011049|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20569069|NCT00871143|Institute of Psychiatry|Dr. David Veale|0203 228 3461|david.veale@kcl.ac.uk|
20569070|NCT00352053|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20569071|NCT02435381|Baylor College of Medicine|Christopher D. Verrico Ph.D.|713-791-1414|Cverrico@bcm.edu|26020
20569072|NCT01490359|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
20569073|NCT04150341|Theravance Biopharma US, Inc|Nathan Pfeifer|001 (650) 808-3711|npfeifer@theravance.com|
20569074|NCT00833898|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9279|biel@ucdenver.edu|
20569075|NCT00387959|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
20524074|NCT02816346|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20524075|NCT02362360|Coloplast|Head of Clinical Operations|0045 49111990|dkcfv@coloplast.com|
20524076|NCT02208362|City of Hope Medical Center|Dr. Christine Brown|626-256-4673|CBrown@coh.org|83977
20553582|NCT00812929|GlaxoSmithKline|GSK Response Center|866-435-7343||
20553583|NCT04027686|UCLA Periodontics and Implant Surgery|Dr Perry Klokkevold|3108251927|pklokkevold@dentistry.ucla.edu|
20553584|NCT04589559|Columbia University Irving Medical Center|Dr. Jeffrey Birk|212-342-5503|jlb2287@cumc.columbia.edu|
20553585|NCT03217136|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553586|NCT03670810|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20553587|NCT02939404|Obesity & Diabetes Clinical Research Section, NIDDK|Douglas C. Chang, MD|602.200.5312|Douglas.Chang@nih.gov|
20553588|NCT04182100|PharmaEssentia Japan KK|Hiroaki Kawase|+81-3-6910-5103|hiroaki_kawase@pharmaessentia.com|
20553589|NCT03226652|Imperial College London|Professor M Cowie|+44 (0)207 3518856|m.cowie@imperial.ac.uk|
20553590|NCT05446909|Arizona State University|Yi-Yuan Tang|4807903577|yiyuan@asu.edu|
20553591|NCT03738826|Duke University|Kai Sun, M.D.|919-681-7417|kai.sun@duke.edu|
20553592|NCT05560932|Yale University|Amy C Justice, MD, PhD|203-932-5711|amy.justice2@va.gov|3541
20553593|NCT06640829|The University of Kansas Medical Center|Holly Hull|9135881000|hhull@kumc.edu|
20553594|NCT01350128|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20553595|NCT02915029|University of New Mexico|Dr Vallabh Shah|505-272-9615|vshah@salud.unm.edu|
20524077|NCT02290444|University at Buffalo|Curtis Wojcik, Lab Coordinator|7163230551|cmwojcik@buffalo.edu|
20524078|NCT01618344|Hunstman Cancer Institute|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu|
20524079|NCT00868530|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524080|NCT05207865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524081|NCT03296813|Duke University|Robert Mentz, MD|919-668-7121|robert.mentz@duke.edu|
20524082|NCT02546986|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20524083|NCT00739882|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
20524084|NCT04021914|Emory University|Dr. Jeffrey N. Siegelman|4042518868|jsiegelman@emory.edu|
20524085|NCT02844543|Stanford University|Dr. Jamshid Ghajar, MD, PhD|(650) 725-5562|acrevelt@stanford.edu|
20524086|NCT00955409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524087|NCT00803790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20524088|NCT04710576|Syndax Pharmaceuticals|Chief Medical Officer|781-419-1400|clinicaltrials@syndax.com|
20524089|NCT05573464|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20524090|NCT01415518|AstraZeneca|Goran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
20524091|NCT00637312|Orthofix|Ruba Sarris|214-937-2256|rubasarris@orthofix.com|
20524092|NCT03944668|HealthPartners Neuroscience Research|Amanda Herrmann, PhD|651-495-6356|amanda.a.herrmann@healthpartners.com|
20524093|NCT02068508|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20524094|NCT00813150|Jan-Cil Germany|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
20524095|NCT02024607|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
20524096|NCT05423093|Johns Hopkins University|Rheanna Platt|410-550-8753|rplatt1@jhmi.edu|
20524097|NCT03593525|The Hospital for Sick Children|Dr. Lillian Sung|416 813 5287|lillian.sung@sickkids.ca|
20524098|NCT05537233|Indiana University School of Medicine|Viral N Shah, MD|317-278-6017|shahvi@iu.edu|
20524099|NCT05338489|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20524100|NCT05857488|Massachusetts General Hospital|Guillermo Tearney, MD, PhD|617-724-2979|gtearney@mgb.org|
20524101|NCT03851406|University of North Carolina at Chapel Hill|Terry Noah, MD|919-966-1055|terry_noah@med.unc.edu|
20524102|NCT00887575|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20524103|NCT00083382|UAMS Myeloma Institute|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
20524104|NCT02739789|Stony Brook University|Dr. David Hsu, Assistant Professor of Psychiatry|(631) 638-1522|david.hsu@stonybrookmedicine.edu|
20524105|NCT03426124|Boston Scientific|Leslie Cass|206-641-4529|Leslie.Cass@bsci.com|
20524106|NCT01129440|University of California, San Francisco|Dr. Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
20524107|NCT02393950|Orion Corporation|Clinical Trials Information Desk|+358104261|clinicaltrials@orionpharma.com|
20524108|NCT04335123|Kansas University Medical Center|Dr Matthias Salathe|9135886000|msalathe@kumc.edu|
20524109|NCT00957801|University of Texas Medical Branch|Randall J Urban, Professor and Chair, Internal Medicine|409-772-1176|rurban@utmb.edu|
20524110|NCT03124368|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20524111|NCT01120808|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
20524112|NCT02626026|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20524113|NCT01592786|Forest Research Institute|Joel Trugman, MD|201-427-8000|Joel.Trugman@frx.com|8681
20524114|NCT01909934|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20524115|NCT03810092|CHD VENDEE|Romain DECOURS|02 51 44 65 72|romain.decours@ght85.fr|+33
20524116|NCT01841047|Institut Bergonié|Pr Guy KANTOR||G.Kantor@bordeaux.unicancer.fr|
20524117|NCT04578535|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20553596|NCT01859715|University of Colorado|Andrew A Monte, MD||andrew.monte@ucdenver.edu|
20524118|NCT00235755|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507378|NCT01827319|CryoLife, Inc.|Scott Capps|800-438-8285|brown.carolyn@cryolife.com|
20524119|NCT03839628|The University of Utah|Micah Drummond|801-213-2737|micah.drummond@hsc.utah.edu|
20524120|NCT04846400|University of Michigan|David A Zopf, MD|734-936-5730|davidzop@med.umich.edu|
20537014|NCT02168062|University of California, San Francisco|Li Zhang, PhD|(415) 476-5339|Li.Zhang@ucsf.edu|
20537015|NCT00182078|Massachusetts General Hospital|Dr. Frederick J. Stoddard Jr., M.D.|6173714762|fstoddard@partners.org|
20537016|NCT00395486|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20537017|NCT01076205|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20537018|NCT00602225|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
20537019|NCT03657134|NYU Langone Health|Lior Jankelson, MD, PhD|212-263-7149|Lior.Jankelson@nyulangone.org|
20537020|NCT01939977|Hospital Universitari de Bellvitge|Dr. Josep M. Cruzado|0034932607602|jmcruzado@bellvitgehospital.cat|
20537021|NCT06423456|afyonkarahisar health sciences university hospital|Dr. Betül Ahat|05467240341|drbetula@gmail.com|
20537022|NCT02097719|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20537023|NCT02091531|Memorial Sloan Kettering Cancer Center|Dr. Dana Rathkopf, MD|646-422-4379|rathkopd@mskcc.org|
20537024|NCT02597452|Penn Medicine|Dr. Ari D Brooks|215-829-8461|ari.brooks@pennmedicine.upenn.edu|
20537025|NCT01352221|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
20537026|NCT00281099|Medtronic, Inc.|MVP Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
20537027|NCT01456195|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20537028|NCT02908685|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20537029|NCT01691014|Pfizer ClinicalTrials.gov Call Center, Pfizer, Inc.|Pfizer Inc.|001 800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537030|NCT05244603|Utah State University|Dr. Sarah Yoho Leopold|6145708258|sarah.leopold@usu.edu|
20537031|NCT04523454|Imperial College London|Dr Rochan Agha-Jaffar|0203 311 3000|Rochan.Agha-Jaffar@nhs.net|21253
20537032|NCT03179982|American University|Caroline Kuo|2028853054|ckuo@american.edu|
20537033|NCT05926544|University of North Carolina at Chapel Hill|Abby Gamble, MA|828-513-0636|abigail_gamble@email.unc.edu|
20537034|NCT04683029|Janssen Pharmaceutical K.K.|Senior Director Clinical Research MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20537035|NCT02551094|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514-376-3330|jean-claude.tardif@icm-mhi.org|3612
20537036|NCT02920528|Lundquist Institute|David Tanen|310-222-3624|dtanen@emedharbor.edu|
20537037|NCT00066703|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki-Voser, PhD Head Trial Activities / Deputy Director|41 31 511 94 00|Heidi.Roschitzki@etop.ibcsg.org|
20537038|NCT01696968|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
20537039|NCT05659719|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537040|NCT01681186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20537041|NCT05160415|Edgewise Therapeutics, Inc.|Joanne Donovan MD PhD, Chief Medical Officer|720-262-7002|studies@edgewisetx.com|
20537042|NCT01375127|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537043|NCT02582814|AstraZeneca|A clinical pharmacology and long-term safety study|+819039706431|Yu.Shimizuishi@astrazeneca.com|4669
20537044|NCT01716039|Alimentiv (Formerly Robarts Clinical Trails)|Dr.Jenny Jeyarajah (Sr. Biostatistician)||jenny.jeyarajah@alimentiv.com|
20537045|NCT03530995|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
20537046|NCT01668628|The Catholic University of Korea|Dr. Hye Eun Yoon|82-32-280-5886|berrynana@catholic.ac.kr|
20537047|NCT02058511|UCSF|Matthias Behrends|415 476 3761|matthias.behrends@ucsf.edu|
20537048|NCT04308239|Virginia Tech|Michael Madigan|(540) 231-3543|mlm@vt.edu|
20537049|NCT02643615|The Ohio State University Wexner Medical Center|Dr. Sergio Bergese|6142933559|sergio.bergese@osumc.edu|
20537050|NCT00801723|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20537051|NCT04848220|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20537052|NCT03713398|University of North Carolina at Chapel Hill|Amy Wilson, PhD|919-962-3598|amyblank@email.unc.edu|
20524121|NCT05691712|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20524122|NCT05303194|The University of Texas Medical Branch|Rafael Samper-Ternent|8322057994|rasamper@utmb.edu|
20524123|NCT01210560|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20524124|NCT04837196|Astellas Pharma Inc|Clinical Transparency|08008887704|astellas.resultsdisclosure@astellas.com|
20524125|NCT01289678|Brody School of Medicine|Paul R. Walker, MD|2527441888|walkerp@ecu.edu|2527441888
20524126|NCT05271175|Cyprus rTMS|Georgios Mikellides|0035799430330|george.mikellides@gmail.com|
20524127|NCT00226499|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524128|NCT00991887|Carolinas Medical Center|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
20553597|NCT01252290|University of Kansas Medical Center|Carol J. Fabian, MD; Professor|913-588-7791|cfabian@kumc.edu|
20553598|NCT05944250|Stanford University|Dr. Yuri Ikeda|650-647-3485|yurikeda@stanford.edu|
20553599|NCT02665728|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
20553600|NCT02075437|Duke University|Dr. Nancy Zucker|919-668-0075|nancy.zucker@duke.edu|
20553601|NCT04439240|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20553602|NCT02867605|Cleveland Clinic Foundation|Dr. Carol De la Motte|216 444-5374|delamoc@ccf.org|
20553603|NCT00813124|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
20524129|NCT02387840|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Deborah Runkin Gold|1-800-641-2422|CTUReferral@UHhospitals.org|
20524130|NCT03170544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524131|NCT04564092|GE Healthcare|Yongqing Tang, MD PhD|189-1820-3986|Yongqing.Tang@ge.com|
20524132|NCT02859337|Oregon Health & Science University|Dr. A Edelman|503-418-2585|edelmana@ohsu.edu|
20524133|NCT01546025|Brown University|Suzanne Colby|4018636655|Suzanne_Colby@brown.edu|
20524134|NCT05425927|SyntheticMR|Erik Lange|+46(0)70-331 56 78|erik.lange@syntheticmr.com|
20524135|NCT02996227|Cleveland Clinic|Fabio Rodriguez|215 444-9950|rodrigf3@ccf.org|
20524136|NCT02729025|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20524137|NCT03349060|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524138|NCT00485732|GlaxoSmithKline|GSK Response Center|866-435-7343||
20553604|NCT00079274|North Central Cancer Treatment Group|Dr. Steven Alberts|507-284-8432|alberts.steven@mayo.edu|
20553605|NCT00767676|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20553606|NCT02082717|Baptist Health South Florida|Diana D'Orazio-Garcia|786-594-9737|DianaDO@baptisthealth.net|
20553607|NCT01830140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20553608|NCT00617240|The University of North Carolina at Chapel Hill|Linmarie Sikich, MD|(919) 972-7500|lsikich@med.unc.edu|
20553609|NCT01611259|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
20553610|NCT04936685|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20553611|NCT01302392|Amgen, Inc.|Study Director|866-572-6436||
20553612|NCT01702233|Biologische Heilmittel Heel|Dr Istvan Zatik|+497221501(0)|istvan.zatik@heel.com|3192
20524139|NCT05734157|Abbott|Krista Stiefel, Principal Clinical Scientist|+12246689359|krista.stiefel@abbott.com|
20553613|NCT03604692|Syndax Pharmaceuticals|Syndax Pharmaceuticals|781-419-1400|clinicaltrials@syndax.com|
20553614|NCT00637195|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507379|NCT00574119|Vanderbilt University School of Medicine|Marvin W. Kronenberg,M.D.|615 936-7437|marvin.w.kronenberg@vumc.org|
20507380|NCT02586077|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
20524140|NCT04846569|Brown University|Jennifer Pellowski|4018635453|jennifer_pellowski@brown.edu|
20507381|NCT03287245|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20524141|NCT02512302|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20524142|NCT04570670|Banner Life Sciences LLC|Thomas Lategan, PhD|3368990959|thomas.lategan@bannerls.com|
20524143|NCT02844933|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
20524144|NCT01479465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20524145|NCT04067050|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
20524146|NCT00659711|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
20524147|NCT02677753|University of Louisville|Dr. Sean Francis|5025617260|sean.francis@louisville.edu|
20524148|NCT03207776|Atrium Health|Dr. Jason Roberge|704-898-3855|Jason.Roberge@AtriumHealth.org|
20524149|NCT00460603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524150|NCT03003962|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20524151|NCT03871543|Johnson & Johnson Vision Care, Inc.|Ross Franklin|1 800-843-2020|RFRANKL1@its.jnj.com|
20524152|NCT01839708|Ohio State University|Mei-Wei Chang|(614) 292-4041|chang.1572@osu.edu|
20524153|NCT01082328|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20524154|NCT00031590|Childrens Hospital of Philadelphia|Peter Phillips|215-590-1000|phillipsp@email.chop.edu|
20524155|NCT01568892|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524156|NCT02962492|State University of NY at Buffalo|Dr. Paresh Dandona|7165351850|dandona@buffalo.edu|
20524157|NCT03328507|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
20524158|NCT05209867|University of Florida|Dr. Simone Marini|3522948951|simone.marini@ufl.edu|
20524159|NCT02755103|Medical University of South Carolina|Therese K Killeen PhD, Principal Investigator|843-792-5232|killeent@musc.edu|
20524160|NCT04177095|Massachusetts General Hospital|Hannah Gilligan, MD|617-726-2000|hgilligan@mgh.harvard.edu|
20524161|NCT00777296|Insmed Incorporated|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
20524162|NCT00658723|ETHICON, Inc.|Jonathan Batiller, Director Clinical Development|908-218-2819|JBatill2@its.jnj.com|
20524163|NCT03876743|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
20524164|NCT03889418|Ochsner Health|Principal Investigator|504-842-8256|eboni.pricehaywood@ochsner.org|
20553615|NCT05035017|CooperVision Inc.|Lee Hall BSc PhD MCOptom, FBCLA|925-251-6884|lhall@coopervision.com|
20553616|NCT00376168|Protalix Ltd.|Einat Almon|972-4-9889488|einata@protalix.com|137
20553617|NCT01020019|New York State Psychiatric Institute|Daniel Brooks|646-774-6171|brooksd@nyspi.columbia.edu|
20524165|NCT00092118|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20524166|NCT03437863|Department of Digital Health Research (previously Center for Shared Decision Making and Collaborative Care Research)|Head of Research and Development|+47 23 03 31 67|elin.borosund@rr-research.no|
20524167|NCT01139125|Georgia Regents University|Peter F. Buckley, MD|706-721-2231|PBuckley@gru.edu|
20524168|NCT00380874|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20524169|NCT03380429|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20524170|NCT02816736|Duke Clinical Research Institute|Kevin J. Anstrom, Ph.D., Director of Biostatistics|919-668-8902|kevin.anstrom@duke.edu|
20524171|NCT00218023|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
20524172|NCT01707290|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20524173|NCT01198470|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|1669
20524174|NCT02949973|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20524175|NCT01139775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20524176|NCT00586703|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20524177|NCT02774941|Children's Health - Children's Medical Center, Dallas|Clinical Research Coordinator - Respiratory Care Dept|214-456-1367|gerald.moody@childrens.com|
20524178|NCT04760626|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20524179|NCT02452944|Department of Anesthesiology, Gachon University Gil Hospital|Mi Geum Lee|82-32-460-3637|mikeum2@gilhospital.com|
20524180|NCT00806403|Sahlgren's University Hospital/S, Gothenburg|Lars Grip||lars.grip@vgregion.se|
20524181|NCT01882985|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
20524182|NCT00765102|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20524183|NCT03197389|University Hospitals Leuven|Prof. Dr. Ann Smeets|003216340903|hanne.vos@uzleuven.be|
20524184|NCT03193853|Baylor Scott and White Health|Joyce O'Shaughnessy|214-818-8472|joyce.oshaughnessy@usoncology.com|
20524185|NCT04129125|Imperative Care|Didem Aksoy, Senior Director of Clinical Affairs|650-644-8293|daksoy@imperativecare.com|
20524186|NCT02547012|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20524187|NCT01787292|Health Science Specialist|Dr. Keith McGregor|4043216111|keith.mcgregor2@va.gov|126792
20524188|NCT01827111|UT MD Anderson Cancer Center|Adi Diab, MD-Associate Professor, Melanoma Medical Oncology|(713) 745-7336|adiab@mdanderson.org|
20524189|NCT02962648|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
20524190|NCT03267212|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
20524191|NCT01560975|NYEE|Dr. Robert Ritch|+1 212 477 7540|ritchmd@earthlink.net|
20524192|NCT04132973|The University of Sheffield|Elaine Clarke|01142226533|e.n.clarke@shef.ac.uk|
20524193|NCT04383327|NYU Langone Health|Keng-Yen Huang, PhD, MPH|646-501-2879|Keng-Yen.Huang@nyulangone.org|
20524194|NCT04146012|Accidentals Inc. (Formally Artegraft Inc.)|Tony Calandra, President|973.540.1250|arc@mcguggan.com|
20536544|NCT02141633|University of Miami|Dr Adam Wanner Professor of Medicine Division of Pulmonary and Critical Care Medicine|(305) 243-3045|awanner@med.miami.edu|
20536545|NCT02403817|University of California, San Diego|Jeanne Townsend, PhD, Professor of Neurosciences|858-246-1931|jtownsend@ucsd.edu|
20536546|NCT02440204|Severance|Dr. Jae Chul Koh|82-010-8702-3931|jaykoh82@gmail.com|
20536547|NCT04908384|University of Washington|Jennifer Sonney|206-685-2161|jsonney@uw.edu|
20536548|NCT01498692|Boston Scientific|Ruth M. Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
20536549|NCT00590122|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu|
20536550|NCT00833469|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
20536551|NCT02707965|University of Maryland, School of Pharmacy|Dr. James Polli|410-706-8292|jpolli@rx.umaryland.edu|
20536552|NCT01701362|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536553|NCT00570778|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536554|NCT00249808|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20536555|NCT00711594|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20536556|NCT00443872|University of Kansas Medical Center|Dr. Kelly Lyons|9135887159|klyons@kumc.edu|
20536557|NCT01709110|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20536558|NCT01129765|Advanced Pediatrics|Mary Margaret Thorne|703-938-5555|mthorne@pop.powweb.com|
20536559|NCT03093207|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
20536560|NCT02685566|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20536561|NCT03286829|Saniona A/S|Dr.Kim Krogsgaard, MD, DMSc, CMO|+45 20 14 83 84|kim.krogsgaard@saniona.com|
20536562|NCT00485758|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20569076|NCT05109117|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20569077|NCT03972137|Rutgers, The State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
20569078|NCT03220776|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
20569079|NCT04318587|University of Pittsburgh|Naomi Ryssel|412-335-9688|agostinonr@upmc.edu|
20569080|NCT02490878|MD Anderson Cancer Center|Caroline Chung, MD|(713) 745-5422|cchung3@mdanderson.org|
20569081|NCT02959177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20569082|NCT03389451|University of Iowa Health Care|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
20536563|NCT04123093|OhioHealth|Dr. Mitch Silver|614-566-1250|mitch.silver@ohiohealth.com|
20536564|NCT00135330|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20524195|NCT01644240|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
20537053|NCT04925076|University of Minnesota|Jeff Boissoneault, PhD|612-624-7357|jboisson@umn.edu|
20537054|NCT02557100|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20537055|NCT00510718|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537056|NCT01460875|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
20537057|NCT00611442|Carl R Darnall Army Medical Center|Dr. Joel Stengel|2545531804|joel.stengel@us.army.mil|
20537058|NCT01511614|NIH/NIDA|Dr. Amy Janes|667.312.5164|amy.janes@nih.gov|
20537059|NCT05791565|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20537060|NCT00705250|Memorial Sloan Kettering Cancer Center|Craig Moskowitz, MD|(212) 639-7992|moskowic@mskcc.org|
20537061|NCT01406938|Novartis Pharmaceutical|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20537062|NCT01222091|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
20537063|NCT00316225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537064|NCT01814878|Janssen Korea/25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Director|82-2-2094-4518||
20537065|NCT02710981|OB-GYN department, Assiut University, Egypt|Essam R. Othman|+201006607801|essamrash@yahoo.com|
20537066|NCT02628405|Accru|Dr Grzegorz S. Nowakowski|507-422-6553|Nowakowski.Grzegorz@mayo.edu|
20537067|NCT03818607|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20537068|NCT02684617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537069|NCT04952597|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20537070|NCT03249909|Mölnlycke Health Care|Andrea Marie Picchietti|260 2583879|andrea.picchietti@molnlycke.com|
20537071|NCT00606034|Mountain Diabetes and Endocrine Center|Dr. Wendy Lane, Director of Clinical Research|828-258-2404|mountaindiabetes@msn.com|314
20537072|NCT02078180|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
20537073|NCT05286658|University of Wisconsin - Madison|Carrie Niziolek, PhD|(608) 262-7583|cniziolek@wisc.edu|
20537074|NCT00935493|Yale University|Christopher van Dyck|203-764-8100|christopher.vandyck@yale.edu|
20537075|NCT01355679|NMTRC at Spectrum Health|Giselle Sholler, MD|616-267-0334|giselle.sholler@helendevoschildrens.org|
20537076|NCT02676895|GlaxoSmithKline|GSK Response Center|866-435-7343|antonella.s.scire@gsk.com|
20537077|NCT01642056|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
20537078|NCT03028129|Federal University of Mato Grosso do Sul|Julio Croda|+5567981229959|julio.croda@ufms.br|
20537079|NCT00923351|National Cancer Institute, National Institutes of Health|Dr. John Glod|301-451-0391|john.glod@nih.gov|
20537080|NCT00940290|ITESM|Carlos A. Cuello-García|+52 (81)88882154|carlos.cuello@gmail.com, carlos.cuello@itesm.mx|
20537081|NCT02959853|Baylor College of Medicine|Rui Chen|812-239-1855|rui.chen2@bcm.edu|
20537082|NCT02443116|NGM Biopharmaceuticals, Inc|VP, Clinical Operations|650-243-5555|ngm282@ngmbio.com|
20537083|NCT01696981|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
20537084|NCT00295009|DePuy Synthes|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
20537085|NCT00851890|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20537086|NCT03135431|Mayo Clinic|Vanessa Torbenson, M.D.|507-266-9873|Torbenson.Vanessa@mayo.edu|
20537087|NCT01063062|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20537088|NCT02015481|Bioblast Pharma|Warren Wasiewski|717-368-0780|Warren.wasiewski@bioblastpharma.com|
20537089|NCT00943098|IBSA Institut Biochimique|Barbara Gugliotta, Clincial Research Manager|+41 58 360 10 00|barbara.gugliotta@ibsa.ch|
20537090|NCT03122145|Holy Cross Hospital|Lauren Tabor Gray|954 542 3429|lauren.tabor@holy-cross.com|
20537091|NCT00625391|Texas Tech University Health Sciences Center|Dr. Chwan-Li Shen|(806) 743-2815|Leslie.Shen@ttuhsc.edu|
20537092|NCT03108521|Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital|Dr. Xingwei Wu and Professor Enwu Long|+8615928017367|wuxw1988@126.com|
20537093|NCT05629312|UZLeuven|Prof. Maria Cadenas|+3216332017|maria.cadenas@uzleuven.be|
20537094|NCT01059357|Wake Forest University Health Sciences|Dr. Joshua Waltonen|3367169068|jwaltone@wakehealth.edu|
20537095|NCT01088295|University of California, Los Angeles|Jordan E. Lake, M.D., M.Sc.|(310)557-1891|jlake@mednet.ucla.edu|
20537096|NCT03974932|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
20524196|NCT02342678|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
20524197|NCT00350207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524198|NCT03214224|Penn State College of Medicine|Andrew Geronimo|717-531-0003|geronimo@psu.edu|282576
20524199|NCT03802825|Kaiser Permanente Center for Health Research|Dr. Stephanie L. Fitzpatrick, Senior Investigator|502-345-1476|Stephanie.L.Fitzpatrick@kpchr.org|
20524200|NCT03982511|Central Michigan University|Sarah Domoff, PhD|989-774-6461|domof1se@cmich.edu|
20524201|NCT01313897|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
20524202|NCT01837901|Okuvision GmbH|Dr. R. Schippert|+49 7121 15935|ruth.schippert@okuvision.de|50
20524203|NCT01051960|University of California, Los Angeles|Rajan Saggar, MD|(310) 794-9718|rsaggar@mednet.ucla.edu|
20524204|NCT00360282|University of Pittsburgh|Joseph M. Furman, MD, PhD|(412) 647-2115|furmanjm@upmc.edu|
20524205|NCT00661557|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537097|NCT01170273|Miami VA Medical Center|Silvina Levis MD|305-575-3388|silvina.levis-dusseau@va.gov|
20537098|NCT01673854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20537099|NCT02316353|CSL Behring|Michelle Hellstern|6102907515|michelle.hellstern@cslbehring.com|
20569083|NCT02215954|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20569084|NCT02642159|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20569085|NCT04194541|University of Miami|Hadar Lev-Tov, MD|305-243-4472|hlevtov@med.miami.edu|
20537100|NCT00375674|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1800718|ClinicalTrials.gov_Inquiries@pfizer.com|1021
20537101|NCT00258908|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20537102|NCT03224403|JNJWorldwide|Andrew Myers, MD|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
20537103|NCT00875485|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537104|NCT01271010|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20537105|NCT01631747|Northwestern University|Mary J. Kwasny|312-503-2294|m-kwasny@northwestern.edu|
20569086|NCT01287416|University of Manitoba|Shay-Lee Bolton|204-787-5082|sbolton@hsc.mb.ca|
20537106|NCT02109432|Pennington Biomedical Research Center|Corby Martin, Associate Professor|225-763-2585|corby.martin@pbrc.edu|
20569087|NCT02694198|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
20537107|NCT03372551|Coopervision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|mnguyen@coopervision.com|
20537108|NCT05897242|Fred Hutchinson Cancer Center|Jaimee Heffner, Associate Professor|2066677314|jheffner@fredhutch.org|
20569088|NCT03340766|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20569089|NCT00853021|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
20569090|NCT02269917|Janssen Research & Development|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20537109|NCT00809835|Yale University School of Medicine|Kathleen M. Carroll, Ph.D., Albert E Kent Professor of Psychiatry|203.937.3486|kathleen.carroll@yale.edu|7403
20537110|NCT03727646|University of Washington|Dr. Kevin Douglas O'Brien|2065984300|cardiac@uw.edu|
20537111|NCT05280158|University of California, Los Angeles|Yusaku Michael Shino, MD|(310) 866-6327|MShino@mednet.ucla.edu|
20537112|NCT04753658|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569091|NCT00240097|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
20569092|NCT02383927|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|KO-TIP-001@kuraoncology.com|
20537113|NCT06523010|Bitlis Eren University|Asst. Prof. Ömer Dursun|5426088687|fztomrdrsn@gmail.com|+90
20537114|NCT04812028|University of Minnesota|Gwenyth Fischer|612-625-9950|fisch662@umn.edu|
20537115|NCT05924165|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|(212) 241-1272|Mantu.Gupta@mountsinai.org|
20537116|NCT02388165|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569093|NCT00818519|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20537117|NCT01289275|UC San Diego, California Smokers' Helpline|Sharon Cummins, Ph.D.|8583001046|scummins@ucsd.edu|
20569094|NCT01393314|Case Western Reserve University|Research Compliance Officer|216-368-0134|kav6@case.edu|
20537118|NCT01576146|Amgen, Inc|Study Director|866-572-6436||
20537119|NCT01558492|Weill Cornell Medicine|Himisha Beltran, MD|646-962-2072|hip9004@med.cornell.edu|
20537120|NCT03454399|Henry Ford Hospital|Yoshihisa Morita|3059784358|YOSHIHISA.MORITA@JEFFERSON.EDU|
20537121|NCT01545934|Cal Poly|Suzanne Phelan|805-756-2087|sphelan@calpoly.edu|
20569095|NCT02335242|Stanford University|Jean Teng, MD, PhD|(650) 724-9627|jteng3@stanford.edu|
20569096|NCT03873038|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537122|NCT03654404|Dana-Farber Cancer Institute|Hermioni L. Amonoo, Director of Well-Being and Cancer Research Program|617-525-7472|Hermioni_Amonoo@dfci.harvard.edu|
20569097|NCT04222088|Research Institute for Tropical Medicine|Dr. Fe Esperanza Caridad J. Espino|63288072628|fe.espino2019@gmail.com|343
20537123|NCT01280058|The Ohio State University Comprehensive Cancer Center|Anne Noonan, MD|614-685-6912|Anne.Noonan@osumc.edu|
20537124|NCT03299881|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513-236-6799|samlung@elira.com|
20569098|NCT00595764|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu|
20537125|NCT01474772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537126|NCT03195660|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
20569099|NCT00585910|Massachusetts General Hospital|Kerry Brodziak|617-503-1043|kbrodziak@partners.org|
20569100|NCT00464737|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20537127|NCT00878254|University of Miami|Izidore Lossos MD|+1 (305) 2434785|ilossos@med.miami.edu|
20537128|NCT01132846|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
20569101|NCT02825849|UCSF|Heather Huddleston|415-353-3040|heather.huddleston@ucsf.edu|
20537129|NCT03367403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20537130|NCT00194077|Johns Hopkins University School of Medicine|Robert Findling, MD,MBA Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
20569102|NCT01544153|Truth Initiative|Amanda L. Graham, PhD|202-454-5938|agraham@truthinitiative.org|
20537131|NCT04928885|The University of Illinois at Chicago|Dr. Julie Bobitt, PhD|312.355.0247|jbobitt@uic.edu|
20537132|NCT03470194|U Mass Memorial|Dr Danielle Taylor|508-334-9840|danielle.taylor@umassmemorial.org|
20537133|NCT01822899|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537134|NCT01268046|Massachusetts General Hospital|Janet Hall, MD|617-877-1112|janet.hall@nih.gov|
20537135|NCT00759876|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20569103|NCT02127892|Children's Hospital Los Angeles|Neena Kapoor, M.D.|323-361-2546|nkapoor@chla.usc.edu|
20537136|NCT02314156|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
20569104|NCT00390806|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537137|NCT02846389|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20537138|NCT01450696|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20537139|NCT01295840|Hospital Universitario Virgen de la Victoria|Dr Javier Alzueta|+34 952 64 15 50|jalzueta@telefonica.net|
20537140|NCT02321319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20537141|NCT01334216|Indiana University School of Medicine|Stephen M. Downs, MD, MS|3172780552|stmdowns@iu.edu|317
20537142|NCT02249091|GSO mbH|Dr Anne L. Kranich|+494044195460|kranich@gsoglobal.com|
20537143|NCT05059301|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20569105|NCT01879735|Dept. of Nuclear Medicine & PET-center, Dept. of Hepatology and Gastroenterolgy. Aarhus University Hospital|Susanne Keiding M.D., Associate professor, D.Sc.|+45 7846 3031|susanne@pet.auh.dk|
20537144|NCT00853242|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20569106|NCT03169530|Beth Israel Deaconess Medical Center|Kenneth Mukamal, MD, MPH|617 754-1401|kmukamal@bidmc.harvard.edu|
20537145|NCT01380197|Morehouse School of Medicine|Iris Buchanan|404-398-9578|ibuchanan@msm.edu|
20537146|NCT05730335|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20537147|NCT03806556|University of Pittsburgh Medical Center|Meghan McCormick, MD MS|412-692-6938|meghan.mccormick3@chp.edu|
20569107|NCT01032200|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20569108|NCT00067808|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026||
20537148|NCT03915574|UAMS|Nadir Sharawi|5016866119|nelsharawi@uams.edu|
20537149|NCT05319600|University of Vermont|Amy Hughes Lansing, PhD|(802) 656-3801|amy.hughes.lansing@uvm.edu|
20537150|NCT02466425|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20569109|NCT00727259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537151|NCT05319899|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20537152|NCT03231917|White River Junction VAMC|Dr Joseph Anderson|8022959363|joseph.anderson@dartmouth.edu|
20537153|NCT03587428|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20537154|NCT05141175|Duke University|Dr. Anthony Viera|919 681 3178|anthony.viera@duke.edu|
20569110|NCT01021683|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
20537155|NCT02445014|Mass General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
20537156|NCT00787241|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
20537157|NCT01032603|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20537158|NCT01813058|Boston Children's Hospital|susan Goobie, MD, FRCPC|6173667737|susan.goobie@childrens.harvard.edu|
20537159|NCT03585764|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20537160|NCT01581021|University of Mississippi Medical Center|Dr. Lawrence Haber|601-984-6525|lhaber@umc.edu|
20569111|NCT00645099|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
20537161|NCT01849692|Alcon Research, Ltd.|Clinical Project Group Leader, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20537162|NCT01253148|H. Lee Moffitt Cancer Center and Research Institute|Sarah Hoffe, M.D.|813-745-3814|sarah.hoffe@moffitt.org|
20537163|NCT01262560|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20569112|NCT01201915|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20537164|NCT00744380|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
20537165|NCT04295759|PediatricBTC|Catherine Billups|901-595-3370|catherine.billups@stjude.org|
20537166|NCT01962428|General Hospital of Chinese People's Armed Police Forces|huiliang Liu|+8601057976707|lhl518@vip.sina.com|
20537167|NCT00465972|Duke University School of Medicine|Andrew Krystal, MD, MS, Professor of Psychiatry and Behavioral Sciences|919-681-8742|andrew.krystal@duke.edu|
20537168|NCT00349349|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569113|NCT03406507|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|1.855.752.2356|clinicaltrials@alexion.com|
20569114|NCT02319304|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
20537169|NCT02285023|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Prof. Kanokvalai Kulthanan|(662)419-4333|kanokvalai.kul@mahidol.ac.th|
20569115|NCT02316171|Viralytics|Mark Grose|+1 905 593 2891|Mark.Grose@viralytics.com|
20537170|NCT01108731|Beth_IsraelMC|Dr Benjamin Natelson|212-844-6747|bnatelson@chpnet.org|
20537171|NCT05253755|Dermbiont Inc|Joanna Jay|415.819.4816|joanna.j@dermbiont.com|
20569116|NCT01804140|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20569117|NCT01596699|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
20537172|NCT04912089|UC San Diego|Jessica Bomyea|858-822-1470|jbomyea@health.ucsd.edu|
20569118|NCT00547300|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20537173|NCT00883168|Meda Pharmaceuticals, Inc.|David Ginsberg,D.O.|732 564-2364|david.ginsberg@meda.us|
20537174|NCT01707654|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
20537175|NCT00923975|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20537176|NCT01709422|Prince of Songkhla University|Dr. Nisa Netinatsunton|6674451965|nisasan@yahoo.com|9
20537177|NCT01005316|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20537178|NCT04027803|BIOCAD|Morozova Maria|+7 (495) 992 66 28|morozovama@biocad.ru|8436
20537179|NCT01734395|Jan-Cil Korea|Clinical Research Director|82 2 2094||4518
20537180|NCT01205061|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20537181|NCT00765037|DJO Surgical|Jane M. Jacob - Manager of Clinical Affairs|512-834-6323|jane.jacob@djosurgical.com|
20537182|NCT04026009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20507382|NCT02701192|Carolinas Healthcare System|Rachel Seymour, PhD|704-355-2000|Rachel.Seymour@carolinas.org|
20507383|NCT02862548|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20507384|NCT00880763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507385|NCT02267226|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
20507386|NCT00003476|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20507387|NCT02500368|CooperVision Inc.|Sr. Manager Clinical Research|(925) 730-6754|PChamberlain@coopervision.com|
20507388|NCT03330041|University of California, Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
20507389|NCT00989612|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507390|NCT00363051|Novartis Pharmaceuticals|Novartis Study Director|(862 778-8300||
20507391|NCT02928380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20507392|NCT03050216|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612 625 3918|bruns072@umn.edu|
20507393|NCT01610076|Mayo Clinic|Kianoush Kashani; Principal Investigator|5072667093|kashani.kianoush@mayo.edu|
20524206|NCT04537078|Elshatby University Maternity Hospital|Dr. Aly Hussein|002-0119448000|emam_aly@me.com|
20524207|NCT03396653|University of Connecticut|Zeely Denmat|860-455-3842|zeely.denmat@uconn.edu|
20524208|NCT01293695|Baylor University|Dr. Gary Elkins, Director of the Mind-Body Medicine Research Laboratory|254-296-0643|gary_elkins@baylor.edu|
20524209|NCT00607620|University of Washington|Douglas Zatzick, MD|206-744-6701|dzatzick@uw.edu|206
20524210|NCT02179892|Emory University|Dr. Colette Curtis|404-778-3900|ccurti3@emory.edu|
20524211|NCT02375971|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20524212|NCT05267236|Midwest Evaluation and Research|Midwest Evaluation and Research|620-208-6143|mer@midwestevaluation.com|
20524213|NCT06180122|Imperial College Healthcare NHS Trust|Sophie Connolly|02033117322|sophie.connolly1@nhs.net|
20524214|NCT02314026|Exalenz Bioscience|Clinical trial manager|97289737513|avrahamh@exalenz.com|
20524215|NCT06684951|AlNahrain university|Omaima Ismail Khalaf|9647831475217|khokh7871@gmail.com|
20524216|NCT02723344|Eastern Colorado Health Care System, Rocky Mountain MIRECC|Dr. Lisa A Brenner|720-723-6488|lisa.brenner@va.gov|
20524217|NCT03473184|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
20524218|NCT02524847|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
20524219|NCT01326845|Novartis Pharmaceuticals|Study Director|862-778-8300||
20524220|NCT04352101|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
20524221|NCT01268527|Eisai Medical Research Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20524222|NCT02794727|Mayo Clinic|Sanjeev Nanda, MD|507-284-2511|nanda.sanjeev@mayo.edu|
20524223|NCT01008605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524224|NCT00908544|MUC Research GmbH|Dr. phil. Eva Wolf|+49 (0)89-558703-0|Eva.Wolf@MUCResearch.de|
20524225|NCT01213966|Faculty of Tropical Medicine|Professor Sasithon Pukrittayakamee|(662) 354-9400-19|yon@tropmedres.ac|1435
20524226|NCT05192239|Colorado State University|Christopher Bell, Associate Professor|(970) 491-7522|christopher.bell@colostate.edu|
20524227|NCT03223350|Henry Ford Hospital|Dr. Joseph Miller, associate research director|313-916-5419|jmiller6@hfhs.org|
20524228|NCT00740636|Memorial Sloan Kettering Cancer Center|Dr. Maria C. Pietanza|646-888-4203|PietanzM@mskcc.org|
20524229|NCT00204490|University of Texas Medical Branch Galveston|Dr. Lee Jane W. Lu|409-772-1730|llu@utmb.edu|
20524230|NCT03477006|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
20524231|NCT02174627|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20524232|NCT02245516|Kala Pharmaceuticals Inc|VP, Clinical Development||results004@kalarx.com|
20524233|NCT00682786|Washington University School of Medicine|Benjamin R. Tan, M.D.|314-362-3560|btan@dom.wustl.edu|
20524234|NCT00762710|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|Tracy.Simpson@va.gov|
20524235|NCT04762160|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20524236|NCT01370629|Correvio International|Head of Clinical Development|+41 (0) 22 907 79 70|info@correvio.com|
20524237|NCT01831635|Queen's University Belfast|Dr Lesley Anderson|02890632315|l.anderson@qub.ac.uk|
20524238|NCT01267019|VA Greater Los Angeles, VISN 22 MIRECC|Michael F. Green, PhD|(310) 268-3376|mgreen@ucla.edu|
20524239|NCT01047527|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
20524240|NCT05142722|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20524241|NCT02141438|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20524242|NCT03896503|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
20524243|NCT00437021|Saint Louis University Medical Center|Sharon E. Frey, M.D.|315-977-5500|sharon.frey@health.slu.edu|
20524244|NCT01880554|Institut Bergonie|Derek Dinart||d.dinart@bordeaux.unicancer.fr|
20524245|NCT05161481|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20524246|NCT05022667|University of Michigan Medical Center|Dr. Paul Gauger|734-936-0231|pgauger@med.umich.edu|
20524247|NCT04632927|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@Novartis.com|
20524248|NCT00838903|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524249|NCT04225715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20524250|NCT01174823|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20507394|NCT01827930|Institut Bergonié|Pr Simone Mathoulin-Pelissier|05 56 33 33 33|S.Mathoulin@bordeaux.unicancer.fr|
20524251|NCT00683618|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20524252|NCT01002989|Hypertension Center, Third University Department of Medicine, Sotiria Hospital|George S. Stergiou, MD, FRCP, Associate Professor of Medicine|+30 2107763117|gstergi@med.uoa.gr|
20569119|NCT02503982|Schneider Children's Medical Center of Israel|Dr. Liat Ashkenazi-Hoffnung|972-3-9253681|LiatA3@clalit.org.il|
20569120|NCT01502306|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
20569121|NCT01960348|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|medinfo@alnylam.com|
20569122|NCT01580995|VAORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|
20569123|NCT01821729|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
20569124|NCT02916706|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
20569125|NCT01699698|Kyushu University|Dr. Taketo Matsunaga|092-642-5444|mtaketo@surg1.med.kyushu-u.ac.jp|
20569126|NCT00719212|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+33 (1) 58 10 08 89|matthieu.rupin@trioncology.org|
20569127|NCT00837096|Acelity|VP, Global Clinical Affairs|210-255-5595|jane.hart@acelity.com|
20569128|NCT00494026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20569129|NCT02466243|Corbus Pharmaceuticals, Inc.|Head of Clinical Operations|6179630100|info@corbuspharma.com|
20524253|NCT01775813|University of Colorado School of Medicine|Dr. Megan Kelsey|720-777-0991|megan.kelsey@childrenscolorado.org|
20524254|NCT01611935|University of Pennsylvania|Dr. Carrie Sims|215-588-5154|carrie.sims@uphs.upenn.edu|
20524255|NCT05251337|Indiana University Health|Alyson Keen|3173413060|akeen2@iuhealth.org|
20524256|NCT03158038|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
20524257|NCT05177484|Royal Wolverhampton NHS Trust|Group Research Sponsorship Manager|01902|rwh-tr.sponsorshipofresearch@nhs.net|695065
20524258|NCT02549859|University of Chicago|Ms. Lani Leong, Research Coordinator|7738341688|lani@neurology.bsd.uchicago.edu|
20524259|NCT00729612|The Ohio State University|Gregory Otterson, MD|614-293-2887|Greg.Otterson@osumc.edu|
20524260|NCT02506868|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
20524261|NCT04878432|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524262|NCT03971071|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20524263|NCT03922321|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
20524264|NCT00495391|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
20524265|NCT02712320|Foresee Pharmaceuticals Co., Ltd.|Dr. John Mao|+886 2-2655-2658|john.mao@foreseepharma.com|
20524266|NCT01620138|Universidade Federal do Rio de Janeiro|Monica Gadelha|+552139382323|mgadelha@hucff.ufrj.br|
20524267|NCT00444535|Novartis Pharmaceuticals|Clinical Disclosure Office|8620778-8300||
20524268|NCT00942578|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
20524269|NCT01072773|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20524270|NCT01697748|University of South Florida|Dr Sheila Connery, Associate Professor Obstetrics and Gynecology|813-259-8542|sconnery@health.usf.edu|
20524271|NCT00553839|Stanford University|Chandra Ramamoorthy, MBBS, FRCA|650-723-5728|chandrar@stanford.edu|
20524272|NCT01704495|AstraZeneca|Medical Science Director Bengt Larsson||ClinicalTrialTransparency@astrazeneca.com|
20524273|NCT00832455|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20524274|NCT05002790|University Hospitals Coventry &Watwickshire NHS Trust|Cyprian Mendonca|02476964000|cyprian.mendonca@uhcw.nhs.uk|25874
20524275|NCT05697809|Oxular Ltd|Friedrich Asmus, MD, Chief Medical Officer|617 882 7179|friedrich.asmus@ocular-cc.com|
20524276|NCT02199964|Baylor College of Medicine|Stephen Pflugfelder, M.D.|713-798-6100|stevenp@bcm.edu|
20524277|NCT02172664|Indiana University School of Dentistry|Dr. Jeffrey Platt|3172747229|jplatt2@iu.edu|
20524278|NCT02946463|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20524279|NCT05581641|BioNTech SE|BioNTech clinical trials patient information|61319084|patients@biontech.de|+49
20524280|NCT01924689|BioMed Valley Discoveries, Inc.|Brent Kreider|816-960-4644|bkreider@biomed-valley.com|
20524281|NCT00468819|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20524282|NCT02492867|University of Michigan Rogel Cancer Center|ClinicalTrials.gov CC Admin|734-936-9499|clinicaltrialsgov_ccadmin@med.umich.edu|
20524283|NCT04306211|Indiana University|John M. DeWitt, MD|317-944-0980|jodewitt@iu.edu|
20524284|NCT03296527|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20524285|NCT01597973|University of Michigan|Jolene Daniel|732 235-7713|jd1557@rwjms.rutgers.edu|
20524286|NCT02692859|jiangsuPCDCP|Kai Chu|18915999781|chukai19812007@163.com|
20524287|NCT00122382|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
20524288|NCT01766076|Makarere University|Damalie Nakanjako|41407000|dnakanjako@gmail.com|249
20524289|NCT00359424|University of Cincinnati Academic Health Center|Joseph P. Broderick|513-558-5429|broderjp@ucmail.uc.edu|
20524290|NCT02462603|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20524291|NCT01591096|SeattleChildrens|Catherine Amlie-Lefond MD|206-987-2078|calefond@seattlechildrens.org|
20524292|NCT02817763|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
20524293|NCT00848718|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524294|NCT02389829|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
20524295|NCT00571727|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20524296|NCT03817190|DS Biopharma|Study Director|+35312933590|info@dsbiopharma.com|
20524297|NCT03576326|University of California, San Francisco|Dr. Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
20524298|NCT05086744|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20524299|NCT04170738|Icahn School of Medicine at Mount Sinai|Iliyan Ivanov|(212) 523-1924|iliyan.ivanov@mssm.edu|
20524300|NCT03055338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524301|NCT02999269|University of New Mexico|Dr. Chris Abbott, Division Chief Neuromodulaton, Department of Psychiatry|505272223|cabbott@salud.unm.edu|
20524302|NCT03100864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524303|NCT03096418|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
20524304|NCT01894841|Providence VAMC|Jennifer Primack|401 273-7100|jennifer.primack@va.gov|6295
20524305|NCT00529087|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20524306|NCT02954601|Oramed|Chief Scientific Officer|+972-2-566-0001|miriam@oramed.com|
20524307|NCT00318474|Saint Joseph's Hospital and Medical Center|Ron Hogg, M.D.|602-406-3246|ronhogg@gmail.com|
20524308|NCT01735916|Medtronic|MIRACLE EF Study Manager|(763) 514-4000|medtroniccrmtrials@medtronic.com|
20524309|NCT02004366|Emory University|Priyathama Vellanki|404-778-1665|priyathama.vellanki@emory.edu|
20524310|NCT02955355|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20524311|NCT04227197|Massachusetts General Hospital|Brian G Skotko, MD, MPP, Principal Investigator|(617) 643-3196|bskotko@mgh.harvard.edu|
20524312|NCT04547985|Weill Cornell Medicine|Dr. Holly G. Prigerson|646-962-9655|hgp2001@med.cornell.edu|
20524313|NCT01379768|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
20524314|NCT03446027|Imperial College London|Laura Burgess|0203 311 5208|l.burgess@imperial.ac.uk|
20524315|NCT01209949|Galderma Laboratories, L.P.|Norman Preston|817-961-5360|Norman.Preston@galderma.com|
20537183|NCT03748706|Cassava Sciences|Lindsay Burns, SVP of Neuroscience|512-501-2484|lburns@cassavasciences.com|
20537184|NCT01194089|Mayo Clinic|Dr. Toby N. Weingarten|507-255-1612|weingarten.toby@mayo.edu|
20537185|NCT03374683|University of British Columbia|Dr. Mariana Brussoni|604-875-3712|mbrussoni@bcchr.ubc.ca|
20537186|NCT02300558|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20537187|NCT01471028|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
20537188|NCT00695955|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20537189|NCT01059682|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20537190|NCT02957747|VISN 17 Center of Excellence for Research on Returning War Veterans|Dr. Suzannah Creech, Ph.D.|254-297-3025|Suzannah.Creech@va.gov|
20524316|NCT01067781|Valneva Austria GmbH|Head Clinical Developement|0043120620|info@valneva.com|0
20524317|NCT00708552|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524318|NCT01904526|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
20524319|NCT03334435|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20524320|NCT06188715|Swiss Tropical and Public Health Institute|Prof Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
20524321|NCT03808948|Charité - Universitätsmedizin Berlin|Prof. Dr. med. Kai Schmidt-Ott|+4930450614671|Kai.schmidt-ott@charite.de|
20524322|NCT02075203|SATVI|Dr. Mark Hatherill|+27214066145|mark.hatherill@uct.ac.za|
20524323|NCT03566199|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD.|(415) 502-7301|Sabine.Mueller@ucsf.edu|
20524324|NCT00568451|Mayo Clinic Cancer Center|Svetomir N. Markovic M.D., Ph.D.|507-284-2511|markovic.svetomir@mayo.edu|4-2511
20524325|NCT05344560|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
20524326|NCT02996968|TriHealth Inc.|Abigail Shatkin-Margolis, MD|513-463-4300|Abigail_Shatkin-margolis@trihealth.com|
20524327|NCT03922308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20537191|NCT01177553|University of South Florida|Research Coordinator|813-259-8680|obgynclinicalresearch@health.usf.edu|
20569130|NCT00875615|University of Miami Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4981|lfeun@med.miami.edu|
20569131|NCT03713073|The University of Texas Health Science Center at Houston|Chun-Teh Lee, DDS, DMSc, MS|713-486-4384|Chun-Teh.Lee@uth.tmc.edu|
20569132|NCT00405912|Mayo Clinic|Dr. Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
20569133|NCT03730662|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20569134|NCT01907113|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569135|NCT01309243|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20569136|NCT00632931|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20569137|NCT02176382|Massachusetts General Hospital|Dr. Joy Tsai|6177266723|jntsai@mgh.harvard.edu|
20524328|NCT05005507|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20524329|NCT03313180|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20524330|NCT01256450|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20537192|NCT01812213|Navidea Biopharmaceuticals|Chief Medical Officer|6149737555|mblue@navidea.com|
20537193|NCT00610857|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|4126486507|tarhiniaa@upmc.edu|
20569138|NCT01402063|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
20569139|NCT02209610|VAORD|Dr Markus Amann|801-582-1565|markus.amann@hsc.utah.edu|4358
20569140|NCT03712449|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20569141|NCT01592396|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
20569142|NCT00666198|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569143|NCT05153499|Finch Therapeutics|CEO|617-229-6499|info@finchtherapeutics.com|
20569144|NCT05786521|University of Texas Health Science Center San Antonio|TIffany M Cortes, MD|210-450-3333|cortest@uthscsa.edu|
20569145|NCT03897049|dfusion, Inc|Tamara Kuhn, Vice President & Research Scientist|831-222-5003|tamara.kuhn@dfusioninc.com|
20569146|NCT01369706|Deutsches Herzzentrum München|Prof. Dr. Christof Kolb|+49891218|kolb@dhm.mhn.de|2020
20569147|NCT03226353|CooperVision|Jose A. Vega OD MSc FAAO|(925) 621- 3761|javega@coopervision.com|
20569148|NCT03441789|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
20569149|NCT02747121|Helsetilsynet|Dr Einar Hovlid|+4721529900|eho@helsetilsynet.no|
20569150|NCT03168425|Vanderbilt University Medical Center|Sarah Osmundson, MD|+1 (615) 343-5700|sarah.osmundson@vumc.org|
20569151|NCT02166047|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20569152|NCT01960114|McNeil Consumer Healthcare|Rajesh Mishra, MD, PhD/Vice President, Medical/Clinical Affairs, Global OTC|215-273-8569 USA EST|rmishr16@its.jnj.com|
20524331|NCT03866512|University of Exeter|Dr Marlou Dirks|+44 1392 725496|m.dirks@exeter.ac.uk|
20537194|NCT04826094|Henry M Jackson Foundation for the Advancement of Military Medicine|David Fetterer, MS (Programmer Analyst)|301.500.3818|dfetterer@global-id.org|
20537195|NCT02151903|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
20537196|NCT03115827|Vanderbilt University Medical Center|Dr. Katherine McDonell|615-875-7987|katherine.mcdonell@vumc.org|
20553618|NCT05091528|Silverback Therapeutics, Inc.|Chief Scientific Officer|206-456-2900|info@silverbacktx.com|
20553619|NCT02214121|AstraZeneca|Brilinta Global Clinical Lead|+46 31 776 1000|kontakt@astrazeneca.com|
20569153|NCT01176435|University of Minnesota|C. Gail Summers, MD|612-625-6469|summe001@umn.edu|
20569154|NCT00902226|H. Lundbeck A/S|Study Director|email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
20569155|NCT00468858|GSK|Faina Rose, PhD|610-664-8986|faina.v.rose@gsk.com|
20569156|NCT00543101|Community Research Initiative of New England (CRINE)|Clavin Cohen MD|617 502 1700|ccohen@crine.org|
20537197|NCT00142168|DFCI|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
20537198|NCT06003777|Pfizer Inc.|Name or Official Title: Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537199|NCT01825512|Consorzio per Valutazioni Biologiche e Farmacologiche|Donato Bonifazi|+393936698076|ceo@cvbf.net|
20537200|NCT04181593|OmegaD LLC|Dr. Gregory Smith, MD|3023833948|SGSmith@omegad.com|
20537201|NCT01721486|Beaumont Hsopital|Kaveh Aslani, MD|248-898-1907|kaveh.aslani@beaumont.org|
20537202|NCT00582712|University of Wisconsin Carbone Cancer Center|Director of Clinical Research|608-265-0540|clinicalresearch@surgery.wisc.edu|
20569157|NCT01885936|Duke University|Dwight Koeberl, M.D., Ph.D.|919-681-9919|dwight.koeberl@duke.edu|
20569158|NCT00991029|Medical University of South Carolina|Dr. Jordan Elm|843-876-1605|elmj@musc.edu|
20569159|NCT00317603|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
20569160|NCT00523549|Novartis Pharmaceuticals|Study Director|862-778-8300||
20569161|NCT02487251|Michigan State University|Holly E. Brophy-Herb, PI|517-355-3397|hbrophy@msu.edu|
20569162|NCT00427778|Queen's University|Dr Marie-Andree Harvey|613-548-6115|harveym@queensu.ca|
20569163|NCT00439647|Novartis Pharmaceuticals|Novartis Study Director|862-778-8300||
20569164|NCT00321321|Gentofte Hospital, University of Copenhagen|Dr. Kasper Aaboe|+4539978474|Kasper@dadlnet.dk|
20569165|NCT00843115|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20569166|NCT02845375|Leiden University Medical Center|Dr Albert Dahan|+31715262301|a.dahan@lumc.nl|
20569167|NCT00225277|Takeda Global Research and Development Center Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20569168|NCT03432650|Hospital for Special Surgery, Anesthesiology|Dr. Stephen Haskins|212-606-1036|haskinss@hss.edu|
20569169|NCT01177137|Center for Clinical Trials and Evidence Synthesis, Johns Hopkins Bloomberg School of Public Health|Roberta W. Scherer, Director Data Coordinating Center|410 502 4636|rschere1@jhu.edu|
20569170|NCT04970381|Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Prof. Yan Liang|+8618801287180|fwyy2803@163.com|
20569171|NCT00677092|University of Massachusetts Medical School|Jonathan Kay, MD|508-793-6936|jonathan.kay@umassmemorial.org|
20569172|NCT01163955|Glinn and Giordano Physical Therapy|W. Brian Monroe, Doctor of Physical Therapy|661-832-9737|tandbmonroe@hotmail.com|
20569173|NCT02460562|Faculty of Dentistry, Thammasat University|Dr. Kritirat Kiatsirirote|662-9869213-5|kkritirat@yahoo.com|7150
20569174|NCT00784277|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20569175|NCT01093222|SWOG|Study Statistician|206-667-4623||
20569176|NCT02222337|Lombardi Comprehensive Cancer Center, Georgetown University|Kristi Graves, PhD|202-687-1591|Kristi.Graves@georgetown.edu|
20569177|NCT00187135|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|866-278-5833|referralinfo@stjude.org|
20569178|NCT01951261|Hospital Puerta de Hierro|Dra Patricia Mínguez Clemente|911916859|drapat3@gmail.com|
20569179|NCT01924806|Smith & Nephew|Henry Jaimes|01923-477-164|henry.jaimes@smith-nephew.com|
20569180|NCT00999141|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
20569181|NCT03690284|University of Texas Southwestern|Clinical Research Coordinator|3106127741|matthew.oh@utsouthwestern.edu|
20569182|NCT02046941|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
20569183|NCT04098497|University of Wisconsin - Madison|Amy Cochran|(608) 262-0772|cochran4@wisc.edu|
20569184|NCT03455218|Medical College of Wisconsin|Robert Niebler, MD|4142663360|rniebler@mcw.edu|
20537203|NCT00893152|VA HSR&D Center for Mental Healthcare & Outcomes Research|Ellen P. Fischer, PhD|501-257-1711|Ellen.Fischer@va.gov|
20537204|NCT04731298|Sobi|Emmanuel Monnet|+41225519156|Emmanuel.Monnet@sobi.com|
20569185|NCT00297778|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569186|NCT02996097|Johns Hopkins School of Medicine|Dr. Ginette Okoye|9142158980|ginette.okoye@howard.edu|
20569187|NCT02201771|Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr. Yunpeng Zhu|008613816819346|zypB1014@rjh.com.cn|
20569188|NCT03569475|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20569189|NCT02109107|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20569190|NCT03697083|University of Pennsylvania|Katherine K. Milkman Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
20569191|NCT01643902|Johns Hopkins University School of Medicine|Victor C. Urrutia|410-955-2228|vurruti1@jhmi.edu|
20569192|NCT03078751|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20569193|NCT01350388|University of Utah|Srinivasan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
20569194|NCT00789399|Prairie Education and Research Cooperative|Chief Operating Officer|217 492 9104|jchambers@prairieresearch.com|
20569195|NCT00580047|University of Nebraska Medical Center|Lynn Mack|402-559-6208|lmack@unmc.edu|
20569196|NCT02820298|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20569197|NCT01189136|Women & Infants Hospital of Rhode Island|Charles R. Rardin, MD|401 453-7560|crardin@wihri.org|
20569198|NCT01064856|AbbVie|Global Medical Services|800-633-9110||
20569199|NCT01894256|AstraZeneca|Dr Anitra Fielding|+44 1625 582828|anitra.fielding@astrazeneca.com|
20569200|NCT01780584|Pediatric Cardiac ICU National Cardiovascular Center Harapan Kita|Dr Eva M Marwali, Principal Investigator|+62215684085|evamarwali@yahoo.com|2807
20569201|NCT00546884|University of Minnesota|John Song MD MPH MAT|612-624-8936|songx006@umn.edu|
20569202|NCT00141271|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20569203|NCT02133131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20569204|NCT04783519|University of Washington|Mary Larimer|(206) 543-3513|larimer@uw.edu|
20569205|NCT04435522|Rhode Island Hospital|Philip Chan, M.D.|401-793-4859|philip_chan@brown.edu|
20507395|NCT01653158|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507396|NCT00421603|NYSPI|Daniel Brooks|212-740-3205|brooksd@nyspi.columbia.edu|
20507397|NCT05137730|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20507398|NCT01840228|Ohio State University|Dr. Heather Frey|614-688-6798|Heather.Frey@osumc.edu|
20507399|NCT02476357|Lausanne University Hospita! and University of Lausanne|Prof. Dr Med. Maurice MATTER|795561071|maurice.matter@chuv.ch|0041
20507400|NCT01103778|Rogosin Institute|Dr. Choli Hartono|212-746-1578|chh2001@nyp.org|
20507401|NCT05590767|Tri-Service General Hospital, National Defense Medical Center|Dr. Lu Yi-Hsiung|+886933429559|luyihsiung@gmail.com|
20507402|NCT00634114|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20507403|NCT02802878|University of Kansas Medical Center|Dr. Neil Segal|913-945-8985|segal-research@kumc.edu|
20507404|NCT01599754|SFJ Pharmaceuticals|Stewart Hallett|19252011003|stewart.hallett@sfj-pharma.com|
20507405|NCT05080179|University of Pennsylvania, Perelman School of Medicine|Dr. Erica Dixon|215-573-9987|erica.dixon@pennmedicine.upenn.edu|
20507406|NCT01577160|Janssen Research & Development|Medical Director|886 2 23762155||
20524332|NCT00323453|Santa Barbara Cottage Hospital|Laura Isaacs (Research Quality Assurance & Integrity Analyst) on behalf of Dr. Kenneth Waxman (PI)|805-324-9255|lisaacs@sbch.org|
20507407|NCT01551758|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537205|NCT03403361|Washington University School of Medicine|Dr. Clifford Robinson|314-362-8567|clifford.robinson@wustl.edu|
20553620|NCT02375672|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
20569206|NCT04130061|University of Utah|Vikas Sharma, MD|801-581-5311|vikas.sharma@hsc.utah.edu|
20569207|NCT02270463|Stemline Therapeutics, Inc.|Ira Gupta, MD, Senior Vice President, Clinical Development & Medical Affairs - Hematology|1-877-332-7967|clinicaltrials@menarinistemline.com|
20569208|NCT00092521|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569209|NCT01878383|University of Alabama at Birmingham|David Kimberlin, MD|205.638.2530|DKimberlin@peds.uab.edu|
20569210|NCT03464383|Wake Forest University School of Medicine|Heidi M. Munger Clary, MD, MPH Associate Professor of Neurology|336-716-7110|hmungerc@wakehealth.edu|
20569211|NCT00560313|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20569212|NCT03475056|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20569213|NCT02542410|BOSTON CHILDREN'S HOSPITAL|DR. AMY DIVASTA|6173556000|amy.divasta@childrens.harvard.edu|
20569214|NCT00113269|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
20569215|NCT01940523|Hospital for Special Surgery|David Mayman MD|212.774.2024|maymand@hss.edu|
20569216|NCT00451555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20569217|NCT04765553|Swedish Orphan Biovitrum AB|Veronica Asnaghi|+41 61 508 72 13|Veronica.Asnaghi@Sobi.com|
20569218|NCT03430050|MUSC|Dr. Sherman|843-792-8174|shermanb@musc.edu|
20569219|NCT00922441|Boryung Pharmaceutical|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
20569220|NCT02685007|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20569221|NCT01887990|University of Cincinnati|Cheryl McCullumsmith|513-5588022|cheryl.mccullumsmith@uc.edu|
20569222|NCT00809341|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Lode Swinnen|410-955-8603|lswinne1@jhmi.edu|
20569223|NCT00570921|University of Kentucky|Dr. Mara D. Chambers|866-340-4488|mdcham2@email.uky.edu|
20569224|NCT01372202|SKCCC|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
20569225|NCT03927222|Duke University|Mustafa Khasraw, MD|919-684-5301|mustafa.khasraw@duke.edu|
20569226|NCT00745121|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20569227|NCT03723915|Northwestern University, Feinberg School of Medicine|Devalingam Mahalingam MD, PhD Associate Professor, Division of Hematology and Oncology|312-695-6929|mahalingam@nm.org|
20569228|NCT00740870|Medtronic|Karla Mezera|612-306-4325|karla.p.mezera@medtronic.com|
20569229|NCT03041298|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
20569230|NCT00640042|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
20569231|NCT03039088|Rheumatology department, Cochin Hospital, APHP|Doctor Anna MOLTO|0158412617|anna.molto@aphp.fr|
20569232|NCT00655083|Menarini Group- Clinical Research|Angela Capriati, Clinical research Director|+ 39-055 56809990|acapriati@menarini-ricerche.it|
20569233|NCT01212484|NYU Medical Center|Horacio Kaufmann, MD; director of Dysautonomia Center|212 263 7225|horacio.kaufmann@nyumc.org|
20569234|NCT04289714|Royal Brompton Hospital|Sukeshi Makhecha|0207-3528121|s.makhecha@rbht.nhs.uk|4375
20569235|NCT03106337|Massachusetts General Hospital|Antonia Stephen, MD||ASTEPHEN@PARTNERS.ORG|
20569236|NCT06135675|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
20569237|NCT02515097|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
20569238|NCT03613454|University of Alabama at Birmingham|Dr. AJ Gunn|205-975-4850|agunn@uabmc.edu|
20569239|NCT01592383|University of Chicago|Hedy Kindler|7737020360|hkindler@medicine.bsd.uchicago.edu|
20569240|NCT04167085|David Geffen School of Medicine at UCLA|Justin P. McWilliams, MD, FSIR|(310) 267-8773|jumcwilliams@mednet.ucla.edu|
20569241|NCT03249272|Duke Cardiovascular Magnetic Resonance Center|Han Kim, MD|9196683539|han.kim@duke.edu|
20569242|NCT02273180|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20569243|NCT02154516|Smith and Nephew|Clinical Study Manager|0499905851|stephanie.rufo@smith-nephew.com|+61
20569244|NCT00966641|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
20569245|NCT03859622|Karl Landsteiner Institute of General Medicine|Dr.med.Gustav Kamenski|+4322832226|kamenski@aon.at|
20569246|NCT02965599|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20569247|NCT01431105|UC San Diego|Adriana Tremoulet|858-246-0012|atremoulet@ucsd.edu|
20537206|NCT03213938|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
20537207|NCT03641716|University of Pittsburgh|Dr. Angela Caldwell|412-383-7231|arl78@pitt.edu|
20553621|NCT00835497|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20553622|NCT00457197|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
20553623|NCT02165111|Johns Hopkins University|Dr. Ricardo J. Bello|4109557566|rbello@jhmi.edu|
20553624|NCT03921411|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20553625|NCT02114879|Washington University|Emily Lenard|314-747-5706|lenarde@wustl.edu|
20553626|NCT00330551|University of California, Los Angeles|Keith Nuechterlein, PhD|(310) 825-0036|keithn@ucla.edu|
20553627|NCT01541826|University of Wisconsin-Madison, Department of Food Science|Dr. Bradley Bolling|608-890-0212|bwbolling@wisc.edu|
20553628|NCT06561217|Emory University School of Medicine|Ravi B. Parikh, MD, MPP|(352) 422-4285|ravi.bharat.parikh@emory.edu|
20553629|NCT01365273|Monlycke Health Care|Joan Wilson, MSN, MHA, RN|706 504 8997|joan.wilson@molnlycke.com|
20553630|NCT03072134|Northwestern University|Christina Amidei, PhD|13126959124|christina.amidei@nm.org|
20553631|NCT03037528|University of Michigan|Laura Saslow|(734) 764-7836|saslowl@umich.edu|
20524333|NCT01118741|Johns Hopkins University|Michael Carducci, MD|410-614-3977|carducci@jhmi.edu|
20524334|NCT05188261|Ironwood Pharmaceuticals, Inc|Ironwood Study Chair|617-621-7722|info@ironwoodpharma.com|
20524335|NCT02721277|University of Florida|Josef Neu, MD|352-273-8985|neuj@peds.ufl.edu|
20524336|NCT02556775|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20524337|NCT01346059|Beaumont Health|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
20524338|NCT02211209|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20524339|NCT01719367|Florida Electrophysiology Associates|Matthew Kolek, MD|(561) 434-0353|info@heartrhythmexperts.com|
20524340|NCT02792062|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20524341|NCT01549587|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
20524342|NCT02025725|Evoke|Chief Medical Officer|858-345-1494|mcarlson@evokepharma.com|206
20524343|NCT01464424|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20524344|NCT00739661|Genentech, Inc|Medical Communications|800-821-8590||
20553632|NCT01833403|University of Minnesota|Lisa Chow MD|612-625-8934|chow0007@umn.edu|
20553633|NCT01106456|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
20553634|NCT02694315|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
20553635|NCT01527292|University of Louisville, James Graham Brown Cancer Center|Dr. Shiao Woo|502-561-2700|sywoo001@exchange.louisville.edu|
20553636|NCT00006916|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20553637|NCT00558103|GlaxoSmithKline|GSK Response Center|866-435-7343||
20553638|NCT02367599|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
20553639|NCT03385239|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20553640|NCT02967367|CHU Saint-pierre|Pr. Marie Bruyneel|00325354219|marie_bruyneel@stpierre-bru.be|
20553641|NCT00308711|Cytokine PharmaSciences, Inc.|Barbara L. Powers|610-687-1776|bpowers@cytokinepharmasciences.com|214
20553642|NCT01556204|Cleveland Clinic|Tommaso Falcone, M.D.|216-444-1752|falcont@ccf.org|
20553643|NCT03139916|Massachusetts General Hospital|Elizabeth R. Gerstner, MD|617-724-8770|egerstner@mgh.harvard.edu|
20553644|NCT01420081|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553645|NCT00411619|Cincinnati Children's Hospital Medical Center|Dr. David Franz|513-636-4222|david.franz@cchmc.org|
20553646|NCT02318693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553647|NCT00700011|Texas Oncology - Amarillo|Dr. Seah Lim|806-358-8654|seah.lim@usoncology.com|
20553648|NCT00678561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553649|NCT00004031|SWOG Statistics and Data Management Center|Study Statistician|2066674623||
20553650|NCT01451424|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20553651|NCT02920983|CooperVision Inc.|Jose Vega, O.D., MSc., FAAO|9256213761|jvega2@coopervision.com|
20553652|NCT02553421|ivWatch, LLC|Jason Naramore|855-485-2824|jason.naramore@ivwatch.com|7019
20553653|NCT05063734|Oxurion|Clinical Department|+32 16 75 13 10|info@oxurion.com|
20553654|NCT01105533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553655|NCT02717949|UT Southwestern Medical Center|Mamta K.Jain, MD|214-648-9914|mamta.jain@utsouthwestern.edu|
20553656|NCT02033005|Imperial College London|Dr Chris Gale|+44 (0) 2033153519|christopher.gale@imperial.ac.uk|
20553657|NCT01639001|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553658|NCT02610868|Solstice Neurosciences|Regulatory Affairs Specialist|502-815-8148|regulatoryaffairs@usworldmeds.com|
20553659|NCT00679341|Genentech, Inc.|Medical Communications|800 821-8590||
20553660|NCT02649972|Memorial Sloan Kettering Cancer Center|Dr. Eli Diamond, MD|212-610-0243|diamone1@mskcc.org|
20553661|NCT00306592|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20553662|NCT04101526|Moffitt Cancer Center|Dr. Brian Gonzalez|813-745-3219|Brian.Gonzalez@moffitt.org|
20553663|NCT00424372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553664|NCT02488629|Syncore|Dr. Lin|0227603688|JWLin@syncorebio.com|
20553665|NCT00654628|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20553666|NCT00739336|SUNY Upstate Medical University|Clinical Trials Officer|315-464-5476|Rudesj@upstate.edu|
20553667|NCT00912405|Intersect ENT|James Stambaugh|650-641-2103|jstambaugh@intersectent.com|
20553668|NCT00953329|DukeUMC|Shirley Blalock|919-668-0999|shirley.blalock@duke.edu|
20553669|NCT03058796|The MetroHealth System|Dr. Jayme Knutson|216-957-3557|jsk12@case.edu|
20553670|NCT03160703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20524345|NCT01808066|CogCubed|Chief Medical Officer|612-250-9737|monika@cogcubed.com|
20524346|NCT00745901|North America Pharmaceutical (Ortho-McNeil Janssen Scientific Affairs, LLC)|Chief Scientific Officer|1-888-526-5060||2915
20553671|NCT01358981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20553672|NCT00672438|Stanford University|Dr. Martin Angst, Professor of Anesthesia|650-498-5109|ang@stanford.edu|
20507408|NCT00101192|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
20507409|NCT03670641|University of Pittsburgh Medical Center (UPMC)|David Rometo, MD|412-586-9700|rometoda@upmc.edu|
20507410|NCT03691610|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20507411|NCT01662297|Yale University/West Haven VAMC|Dr. Albert Arias|2039325711|albert.arias@va.gov|8155
20507412|NCT00538980|Weill Cornell Medicine|Richard T. Silver, MD|646-962-2273|rtsilve@med.cornell.edu|
20507413|NCT00242580|Novartis Pharmaceuticals|Study Director|862 778-8300||
20507414|NCT01232894|Novartis|Study Director|41 61 324 1111||
20507415|NCT01981967|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20507416|NCT00753935|Vanderbilt_University MC|John A. Oates, MD|615 4343 4847|john.oates@vanderbilt.edu|
20507417|NCT03970395|Azienda Ospedaliera Città della Salute e della scienza di Torino _ Italy|Dr Claudio G Priolo|0039 3471403064|claudiog.priolo@gmail.com|
20507418|NCT00916370|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
20507419|NCT00929734|University of Oslo|Professor Torbjørn Omland|+47 40107050|torbjorn.omland@medisin.uio.no|
20507420|NCT03172520|Mayo Clinic|Eric J. Moore, M.D.|507-284-3853|Moore.Eric@mayo.edu|
20507421|NCT00121992|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20507422|NCT01318512|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20507423|NCT02756650|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20507424|NCT01948388|Arthritis & Rheumatic Disease Specialties|Joanne Sagliani|3059324162|drnbg@rheum-care.com|
20524347|NCT00758290|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20524348|NCT03591874|Ocugen|Vijay Tammara, VP, Strategic Regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
20524349|NCT01759602|Johns Hopkins University|Michael Levy, MD, PhD|443-287-4412|mlevy@jhmi.edu|
20524350|NCT02166333|Johns Hopkins University|Dr. Lawrence Appel|410-955-4156|lappel@jhmi.edu|
20524351|NCT00503698|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20524352|NCT02269098|Medstar Health Research Institute|Michelle F Magee, MD|202-877-0351|michelle.f.magee@medstar.net|
20524353|NCT03807544|Theranova|Director of Clinical Trials|14159268616|clindquist@theranova.com|
20524354|NCT03644342|Baylor College of Medicine|Michelle S. Ludwig, MD, MPH, PhD|713-566-3662|Michelle.Ludwig@bcm.edu|
20524355|NCT02716714|Korea University Ansan Hospital|Ilhwan Kim|+82314125986|kumcihk@korea.ac.kr|
20524356|NCT02045264|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20524357|NCT01769573|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
20524358|NCT05514873|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20524359|NCT01276860|Arkansas Children's Hospital|Clinical Research Coordinator|501-364-2018|boswelljl@archildrens.org|
20524360|NCT03525678|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20524361|NCT01102257|Mount Sinai School of Medicine|Dr. Penny Asbell|(212) 241-7977|penny.asbell@mssm.edu|
20524362|NCT04066244|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524363|NCT03752970|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524364|NCT03976362|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20524365|NCT04767282|Michigan State University|Amy Custack, Associate Professor|8106005656|saxeamym@msu.edu|
20524366|NCT02979587|Medtronic|Lindsey Gustafson, Clinical Study Manager|7635262782|lindsey.m.gustafson@medtronic.com|
20524367|NCT01467713|Takeda|Medical Director, Clinical Science|1-877-825-3327|trialdisclosures@takeda.com|
20524368|NCT00382200|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal, MD, PhD|646-608-3746|rampalr@mskcc.org|
20524369|NCT01120184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20524370|NCT02525783|Stryker|Matt Venegoni|612-297-0939|matthew.venegoni@stryker.com|
20524371|NCT00824772|Inje University|Kye-Min Kim, Associate Professor, Dept of Anesthesiology & Pain Medicine|82-2-950-1168|kyemin@paik.ac.kr|
20524372|NCT00536939|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20524373|NCT02235064|Cooper University Health System|Dr. Richard L Fischer|856-342-2491|fischer-richard@cooperhealth.edu|
20524374|NCT01100086|Purdue Pharma L.P.|Stephen Harris, M.D.|203-588-7592|Stephen.Harris@Pharma.com|
20524375|NCT03532425|University of Alberta|Dr. Stephen D. Shafran|780-407-6945|sshafran@ualberta.ca|
20524376|NCT02767011|Charleston Area Medical Center Research Institute|Mike Broce|304-388-9923|mike.broce@camc.org|
20507425|NCT03371160|ENvizion Medical (Nutriseal)|Clinical Director|+972-72-2288240|anath@envizionmed.com|
20507426|NCT04348591|Duke University|Dr. Andrada D. Neacsiu|919-684-6714|andrada.neacsiu@duke.edu|
20507427|NCT02038218|DEKK-TEC, Inc.|Dr. Lee Roy Morgan|504-583-6135|lrm1579@aol.com|
20507428|NCT03722784|CooperVision, Inc.|Martine Robie|9256604477|mrobie@coopervision.com|
20507429|NCT00186056|Stanford University|Brent Solvason|650-723-8331|solvason@stanford.edu|
20507430|NCT00910429|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20507431|NCT01317615|Novartis|Study Director|862-778-8300||
20507432|NCT01322646|University at Buffalo|Gregory A. Fabiano, Ph.D.|7166451130|fabiano@buffalo.edu|
20507433|NCT04465396|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20507434|NCT02648724|Symphogen AS|Medical Director|0045 45265050|info@symphogen.com|
20507435|NCT01364233|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
20507436|NCT00302718|VA HSR&D Center for Innovations in Quality, Effectiveness & Safety (IQuESt)|Dr. Laura A. Petersen|713-794-8623|Laura.Petersen@va.gov|
20524377|NCT00730483|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20524378|NCT01220466|Abbott Medical Optics|Amelia Saliba, Sr. Manager, Clinical Research|408-273-4158|amelia.saliba@amo.abbott.com|
20553673|NCT03915548|MGH Institute of Health Professions|Dr. Kathleen Lyons|617-643-5372|klyons2@mghihp.edu|
20537208|NCT02487654|Imperial College London|Professor Prapa Kanagaratnam|+44 20 3313 1000|p.kanagaratnam@imperial.ac.uk|
20537209|NCT04238481|Astellas Pharma Inc|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20507437|NCT00738374|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20537210|NCT02152371|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20553674|NCT01401530|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
20553675|NCT00678691|SUNY Upstate Medical University|Thomas Schwartz|3154643166|schwartt@upstate.edu|
20507438|NCT00632541|Hoosier Cancer Research Network|Jeff Smith|317-634-5842|jsmith@hoosiercancer.org|41
20507439|NCT02927873|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20507440|NCT01628250|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine|Dr. Bo Feng|021-64458887|fengbo2022@163.com|
20507441|NCT03833817|Fred Hutchinson Cancer Center|Megan Shen|206-667-4172|mshen2@fredhutch.org|
20507442|NCT00884221|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20507443|NCT02097485|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20507444|NCT02757092|Chang Gung Memorial Hospital|Respiratory therapist Nai-Ying Kuo|+886077317123|ellen0605@gmail.com|2648
20507445|NCT01975246|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507446|NCT00255034|Merck, Sharp & Dohme Corp.|Senior Vice Predsident, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20507447|NCT01263093|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20507448|NCT00424346|Novartis Pharmaceuticals|Study Director|862-778-8300||
20507449|NCT01109069|Pharmacyclics|James Dean|669-224-1880|jdean@pcyc.com|
20507450|NCT03947255|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20507451|NCT02499575|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|614-895-8747|hyerofac@gmail.com|
20507452|NCT01206452|University of Kansas Medical Center|Donita Atkins, RN, CCRC|(913) 588-9714|datkins2@kumc.edu|
20507453|NCT01245764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507454|NCT02667457|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20507455|NCT00603733|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20507456|NCT00680953|Daiichi Sankyo Co., Ltd.|H. Takami|+81 3 5740 3445|takami.hideo.hs@daiichisankyo.co.jp|
20507457|NCT00605696|Albert Einstein College of Medicine of Yeshiva University|Michelle Ng Gong, MD, MS|718 920 5464|mgong@montefiore.org|
20507458|NCT01842646|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
20507459|NCT01057134|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20507460|NCT05343585|Pennington Biomedical Research Center|Chloe Panizza Lozano|(225) 763-2500|cpanizza@hawaii.edu|
20507461|NCT01383109|Shin Poong Pharmaceutical Co., Ltd.|Jansik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
20507462|NCT00944216|Wright State University School of Medicine, Dept of Dermatology|Amy Chen, MD|927-224-3345|amy.chen@wright.edu|
20507463|NCT00751179|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20507464|NCT03039738|Medtronic|Anne Kinney|+1-303-876-8904|anne.r.kinney@medtronic.com|
20507465|NCT00912340|Emory University|Elisavet Paplomata, Principal Investigator|404-778-1900|elisavet.paplomata@emory.edu|
20507466|NCT00915538|Western Sky Medical Research|Lyndon Mansfield MD|915-544-2557|immunman@westernskymed.com|
20507467|NCT01253187|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20507468|NCT02527187|Inmunotek|Dr. Miguel Casanovas/ Medical Director|91 6510010|mcasanovas@inmunotek.com|
20507469|NCT05158179|University of California San Francisco|Yue Ma|415-885-7700|yue.ma@ucsf.edu|
20507470|NCT01293006|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507471|NCT01494987|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20507472|NCT04807101|Northwestern University|Greg Cohen, MD|312-695-4452|gregcohen@northwestern.edu|
20524379|NCT02992236|Nephrology University Erlangen Germany|Prof Dr Rroland Schmieder|+49 9131 8536207|roland.schmieder@uk-erlangen.de|
20524380|NCT03097341|Aronora, Inc.|Christina U. Lorentz, PhD, Senior Scientist and Project Manager|503-964-0250|christina.lorentz@aronorabio.com|
20524381|NCT05266053|Indiana University|Dr. Lisa Mims - Principal Investigator|7733074863|lamims@iupui.edu|
20524382|NCT03817853|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20524383|NCT00391768|Collaborative Antiviral Study Group|Penelope Jester|877-975-7280|PJester@peds.uab.edu|
20524384|NCT02104219|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
20524385|NCT00891020|Hoffman-LaRoche|Medical Communications|800-821-8590||
20524386|NCT00320710|Novartis|Study Director|862-778-8300||
20524387|NCT04545008|Prisma Health|Dr. Julie Martin - Director, Cancer Research|864-455-3667|julie.martin@prismahealth.org|
20524388|NCT00506415|Novartis|Study Director|862 778 8300||
20524389|NCT04578457|Sonova AG|Juliane Raether|+41 58 928 01 01|juliane.raether@sonova.com|
20524390|NCT00997373|UC Davis|Lloyd H. Smith MD, PhD|916-734-6945|lhsmith@ucdavis.edu|
20524391|NCT02841995|Sanofi ( Kadmon, a Sanofi Company )|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20524392|NCT00717912|Biofortis|Doctor|0240205799|info@mxns.com|
20524393|NCT03809663|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20524394|NCT01051596|Georgetown University|Michael Pishvaian, MD, PhD|202-444-2223|pishvaim@georgetown.edu|
20524395|NCT03376789|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
20524396|NCT01703260|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20524397|NCT05333601|Nemours Children's Health|Dr. Kimberly Canter|3026514501|kimberly.canter@nemours.org|
20524398|NCT02215369|Angiodynamics|Ariel Bloch|7742453646|abloch@angiodynamics.com|
20569248|NCT02946788|Timber Pharmaceuticals|Alan Mendelsohn, MD|12673004249|amendelsohn@timberpharma.com|
20524399|NCT02531308|Northwestern University|Dr. R Karmali|312-695-0686|reem.karmali@northwestern.edu|
20524400|NCT02275819|VA Boston Healthcare System|Dr. Jayashri Aragam|617-323-7700|Jayashri.Aragam@va.gov|
20524401|NCT00749073|Vertos Medical|VP Clinical, Regulatory, Quality|9493490008|cmyers@vertosmed.com|216
20569249|NCT02799745|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20524402|NCT03197038|University of Illinois at Chicago|Dr. Ulf Bronas|312-355-5886|bronas@uic.edu|
20524403|NCT02198664|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20569250|NCT00356993|Addictions Program|Dr. Peter Selby|416-535-8501|peter_selby@camh.net|77432
20569251|NCT00853372|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20569252|NCT02517528|AbbVie|Global Medical Services|800-633-9110||
20569253|NCT04298099|Baylor College of Medicine|Karla Wyatt-Thompson|8328245800|karla.wyatt@bcm.edu|
20569254|NCT00665132|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
20569255|NCT01093599|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
20569256|NCT01703845|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569257|NCT03756168|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20524404|NCT02632409|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20524405|NCT05600283|Mayo Clinic|Dr. Kathy MacLaughlin|507-266-4648|maclaughlin.kathy@mayo.edu|
20524406|NCT01000155|Brigham&Women's Hospital|Maureen Okam, MD, MPH|617-732-5048|mokam@partners.org|
20524407|NCT03193684|UTHSCSA|Dr. Muhammad Abdul-Ghani|210 567 6691|abdulghani@uthscsa.edu|
20524408|NCT00720213|Sleepcare Diagnostics|Shahrokh Javaheri, MD|513-459-7750|javaheri@snorenomore.com|
20524409|NCT00097448|Massachusetts Eye and Ear Infirmary|Dr. Steven Rauch|617-573-1166|steven_rauch@meei.harvard.edu|
20524410|NCT00620945|Cleveland Clinic|Muhammad A. Mumtaz, MD|216 444 9125|mumtazm@ccf.org|
20524411|NCT02092298|UT MD Anderson Cancer Center|Brian Badgwell,Professor, Surgical Oncology|713-745-3715|csentonn@mdanderson.org|
20524412|NCT00920439|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524413|NCT01420068|Noden Pharma DAC|Ciara Walsh|+ 353 1 9121573|cwalsh@nodenpharma.com|
20524414|NCT01252095|Progen Pharmaceuticals Ltd|Director of Clinical Development|+61 7 32739133||
20524415|NCT00365794|University of Southern California|Fred Sattler, MD|323-409-4635|fsattler@usc.edu|
20524416|NCT02554682|Children's Hospital of Philadelphia|Dr. Carol Ford|267-426-3938|fordc@email.chop.edu|63938
20524417|NCT00884117|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20524418|NCT02170220|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20524419|NCT01383174|University of California San Francisco|Dr. Anna Maria Napoles|415-476-6290|anapoles@ucsf.edu|
20524420|NCT00126750|VA Bedford CHOIR|Dr. Thomas Houston II|781-687-2884|thomas.houston2@va.gov|
20524421|NCT01153815|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524422|NCT01786993|St. Jude Medical|Director of Clinical Studies|972-309-8000|ccohorn@sjm.com|8087
20524423|NCT00450437|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
20524424|NCT01890122|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20524425|NCT01565889|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20524426|NCT01225250|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20524427|NCT00071110|University of Pittsburgh|Benoit H. Mulsant, MD|(416) 535-8501|benoit_mulsant@camh.net|3655
20524428|NCT03523520|University of Missouri Health Care|Dr. Kara B. Goddard|5738841605|goddardk@health.missouri.edu|
20524429|NCT03218995|Sarepta Therapeutics, Inc.|Medical Director|800-690-2003|clinicaltrials@sarepta.com|
20524430|NCT01445730|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-4717 1990|marja-riitta.taskinen@helsinki.fi|
20524431|NCT03134144|Institute of Occupational and Social Medicine and Health Services Research, University of Tübingen|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
20524432|NCT01167140|Myoscience|Francis Rogers Palmer III, MD|650-474-2600|thenry@myoscience.com|
20524433|NCT03805412|University of Washington Diabetes Institute|Dr. Nicole Ehrhardt|202-741-3422|nehrhard@uw.edu|
20524434|NCT00030901|SWOG Statistical Center|Study Statistician|206-667-4623||
20524435|NCT02576847|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20553676|NCT05773287|Duke University|Katherine Collins-Bennett, Ph.D.|919-479-2368|katherine.collins-bennett@duke.edu|
20553677|NCT01468896|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
20553678|NCT01495481|University of Pittsburgh|Dr. Gaurav Arora|412-692-6054|gaurav.arora@chp.edu|
20553679|NCT02247349|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
20553680|NCT03969212|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20553681|NCT02003625|Massachusetts General Hospital|Bimalangshu Dey, MD, PhD|617-724-1124|BDEY@mgh.harvard.edu|
20553682|NCT00075335|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
20553683|NCT00280566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20553684|NCT01147653|Duke University School of Medicine, Division of Pediatric Blood and Marrow Transplantation|Jesse Troy, PhD||cordbloodtherapyinfo@dm.duke.edu|
20553685|NCT00353366|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20569258|NCT01542398|Queen's University, Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
20569259|NCT04333732|Washington University School of Medicine in Saint Louis|Professor Michael S. Avidan|+1-(314)-273-2456|avidanm@wustl.edu|
20524436|NCT01806051|Children's Hospital Los Angeles|Linda Randolph, M.D.|323-361-2178|lrandolph@chla.usc.edu|
20537211|NCT00350870|Yale University School Of Medicine Department of Psychiatry|Dr. Kathleen M. Carroll|203-937-3486|kathleen.carroll@yale.edu|7403
20537212|NCT00349921|Wake Forest University Health Sciences|Regina Curry, RN, CCRC|(336) 716-4294|recurry@wfubmc.edu|
20537213|NCT01932372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537214|NCT05352412|Washington University School of Medicine|Dr. Michael J. Durkin, Principal Investigator|314-454-8225|mdurkin@wustl.edu|
20537215|NCT01917929|Stryker Orthopaedics|Kevin Barga, Senior Manager, Clinical Affairs|201-831-5000|kevin.barga@stryker.com|
20537216|NCT05285644|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
20537217|NCT00673231|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20537218|NCT00810771|VA Ann Arbor Healthcare System, Center for Clinical Management Research|Sarah Hawley, Ph.D.|734-936-8816|sarahawl@umich.edu|
20537219|NCT03594747|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20537220|NCT04382586|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20537221|NCT02425956|GE Healthcare|Research Manager|262-521-6819|Sandhya.Parameswaran@med.ge.com|
20537222|NCT02265536|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20537223|NCT03869385|University Hospital of Jena|Prof. Dr. Yasser Sakr|01742191538|yasser.sakr@med.uni-jena.de|0049
20537224|NCT02470585|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
20537225|NCT03028415|Ferring Pharmaceuticals|Global Clinical Compliance|-+1 833-548-1402|DK0-Disclosure@ferring.com|
20537226|NCT02907216|GlaxoSmithKline|GSK Response Center|866-435-7343|kap69137@gsk.com|
20537227|NCT05079347|Vanderbilt University Medical Center|Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
20537228|NCT02095873|University of Warwick|Paul J Thornalley|+442476968594|P.J.Thornalley@warwick.ac.uk|
20537229|NCT00792740|Italfarmaco SpA|Tiziano Oldoni, MD|+39 0264432540|t.oldoni@italfarmaco.com|
20537230|NCT03009162|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20537231|NCT00136695|Massachusetts General Hospital|Dr. Benjamin Leder|617-726-6723|bzleder@partners.org|
20537232|NCT02485639|Emory University|Rafi Ahmed, PhD|404-727-3571|rahmed@emory.edu|
20537233|NCT02016716|Amgen Inc.|Study Director|866-572-6436||
20537234|NCT00079391|NIH National Heart, Lung and Blood Institute|Minocher Battiwalla|301-402-4170|battiwalla@nhlbi.nih.gov|
20537235|NCT04818216|University of Texas Health San Antonio|Dr. Subrata Debnath, Assistant Professor|210-450-8333|nath@uthscsa.edu|
20537236|NCT04114071|University of Alabama at Birmingham|Dr. Pamela G. Bowen|12059342778|pbowen@uab.edu|
20537237|NCT03763656|Nova Laboratories Ltd|Dr Hussain Mulla, Head of Clinical Development|0116 223 0101|hussain.mulla@novalabs.co.uk|
20537238|NCT03479541|Oregon Health and Science University|Dr. Laurie King|5034182602|kingla@ohsu.edu|
20537239|NCT00107900|Daiichi Sankyo, Inc.|Victor Fernandez|732-590-5000|vfernandez@dsi.com|
20537240|NCT02374060|Johns Hopkins University|Elizabeth Sugar, PhD|(410) 614-7837|esugar2@jhu.edu|
20537241|NCT03088930|University of Colorado Cancer Center|Dr. Tejas Patil|7208489264|tajas.patil@cuanschutz.edu|
20537242|NCT03345160|Johns Hopkins School of Medicine|Dr. Robert Wood|410-919-7617|RWood@JHMI.edu|
20537243|NCT02513485|Emory University|Dr. Jennifer Felger|404-727-3987|jfelger@emory.edu|
20537244|NCT00394251|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20537245|NCT04644276|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
20537246|NCT01667224|Clinical Trial Center for Functional Food in Chonbuk National University Hospital|Dr. Soo-Wan Chae|82-63-250-2348|soowan@jbnu.ac.kr|
20537247|NCT03350035|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20537248|NCT01811485|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20537249|NCT04115748|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20537250|NCT00713349|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20537251|NCT03764631|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537252|NCT01200407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537253|NCT01505673|University of Texas Southwestern Medical Center at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20537254|NCT02974855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537255|NCT00633074|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537256|NCT02363972|Avenu Medical|Gene Reu EVP and General Manager|9492762483|greu@avenumedical.com|
20553686|NCT00259857|Medical University of South Carolina|Deborah A Bowlby, MD, Asst.Professor, Pedeiatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
20553687|NCT00670228|sanofi-aventis|Trial Transparency Team||GV-contact-us@sanofi-aventis.com|
20553688|NCT05267054|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20553689|NCT00780572|VA SLC HCS|Director HSR&D|801-582-1565|IDEAS@va.gov|
20553690|NCT01552226|St. Joseph Mercy Hospital Ann Arbor|Dr. Robert Cleary|7347128150|Robert.Cleary@trinity-health.org|
20553691|NCT00727857|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20553692|NCT00203203|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
20553693|NCT01469065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553694|NCT04542070|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20553695|NCT00858390|The University of Texas Health Science Center at Houston|G Hergenroeder, Principal Investigator|7135006130|Georgene.W.Hergenroeder@uth.tmc.edu|
20553696|NCT04646616|Drexel University School of Public Health|Dr. Mariana Lazo|2673596058|ml3629@drexel.edu|
20553697|NCT01813019|Novartis Pharmaceuticals|Study Director|862-778-8300||
20553698|NCT01696032|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20537257|NCT02752633|Landspitali - The National University Hospital of Iceland|Vidar Orn Edvardsson|+3545431000|vidare@landspitali.is|3452
20537258|NCT01843673|Virginia Commonwealth University|Joshua Evans, Ph.D.|804-628-0661|jevans2@mcvh-vcu.edu|
20537259|NCT03275246|Zimmer Biomet|Oliver Schaetti|0041588548901|oliver.schaetti@zimmerbiomet.com|
20537260|NCT02292082|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
20537261|NCT00433966|Cardiovascular Research Foundation|Ori Ben-Yehuda, MD, Executive Director, Clinical Trials Center|646-434-4123|obenyehuda@crf.org|
20537262|NCT02570152|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupport@gsk.com|
20537263|NCT01491789|Kennedy Krieger Institute|Dr. Alberrt Recio|443-923-9227|recio@kennedykrieger.org|
20537264|NCT03497975|Trevi Therapeutics, Inc.|Chief Development Officer|203-304-2499|info@trevitherapeutics.com|
20537265|NCT01296711|UCB BIOSCIENCES GmbH|Clin Trial Reg & Results Disclosure|001-844-599-2273|clinicaltrials@ucb.com|
20537266|NCT00632827|University of California, San Francisco|Lawrence Kaplan, MD|(415) 353-2661|LKaplan@ucsf.edu|
20537267|NCT01035463|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
20537268|NCT02925078|University of Michigan|Clinical Research Coordinator|7347633346|aliceou@umich.edu|
20537269|NCT02516098|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537270|NCT01092780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507473|NCT02254551|Sarah Cannon Development Innovations|Charles Davis, Sr Mgr Regulatory Strategy & Operations|615-524-4341|charles.davis2@scri-innovations.com|
20537271|NCT01257230|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537272|NCT01250184|university of Antioquia, Research Group Rehabilitation in Health|Dr. Luz Helena Lugo, Head of Research Group Rehabilitation in Health|+57 4 2196475|luzh.lugo@gmail.com|
20537273|NCT04528017|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20537274|NCT02209545|Northwestern Medicine|Dr. Magdy Milad|3126946447|mmilad@nm.org|
20537275|NCT01126268|The University of Texas Health Science Center at Houston|Dr. Adelaide A Hebert|(713) 500-8339|Adelaide.A.Hebert@uth.tmc.edu|
20537276|NCT01320553|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
20537277|NCT01988662|Novartis Pharmaceuticals|Study Director|862-778-8300||
20537278|NCT03425006|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20537279|NCT02972606|King's College London|Dr Whitney Scott|02071885421|whitney.scott@kcl.ac.uk|
20537280|NCT03831191|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20537281|NCT03070171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537282|NCT01006655|Rambam medical Center|Prof Lea Bentur|xx 972 4 854 3263|l_bentur@rambam.health.gov.il|0502062400
20537283|NCT01232504|Department of Hematology, Shanghai Jiao Tong University Affiliated First People's Hospital, China|Chun Wang||wangchun2@medmail.com.cn|
20537284|NCT00054327|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Kenneth Cooke MD|216-844-3345|kenneth.cooke@uhhospitals.org|
20537285|NCT00613327|Medical Affairs, Janssen Korea|Clinical Research Associate|+82-2-2094-4935||
20537286|NCT00344318|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537287|NCT01014936|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20537288|NCT00683930|Hoffmann-La Roche|Medical Communications|800-821-8590||
20537289|NCT01606176|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20569260|NCT01845649|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20537290|NCT01153711|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537291|NCT00361231|Massachusetts General Hospital|Dr. Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
20537292|NCT03158740|Connecting Health Innovations|Senior Scientist|8649154636|admin@chi-llc.net|
20537293|NCT01814397|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@med.umich.edu|
20537294|NCT01732510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537295|NCT00244933|Barbara Ann Karmanos Cancer Institute|Amy Weise, M.D.|313-576-8599|weisea@karmanos.org|
20537296|NCT01208961|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20537297|NCT00945529|Nemours Cardiac Center at A. I. duPont Hospital for Children|Ellen Spurrier, MD|302-651-6600|ellen.spurrier@nemours.org|
20537298|NCT02791516|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20537299|NCT02524275|University of Nebraska Medical Center|Dr. Apar Ganti|402-559-8121|aganti@unmc.edu|
20537300|NCT01439971|Catalyst Biosciences|Chief Medical Officer|1-650-266-8671|hlevy@catbio.com|
20537301|NCT02453750|SickKids|Dr Theo Moraes|416 813 2196|theo.moraes@sickkids.ca|
20537302|NCT01101958|ThoraxKlinik, University of Heidelberg|Prof. Dr. F.J.F. Herth|650-216-0176|Felix.Herth@thoraxklinik-heidelberg.de|
20537303|NCT02147197|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20537304|NCT01521871|Oslo University Hospital, Rikshospitalet|Dr. Ole Øyen|+4723070000|ooyen@ous-hf.no|
20537305|NCT02640625|Oslo University Hospital|Dr. Dag Henrik Reikvam|+4722119881|dagrei@ous-hf.no|
20537306|NCT03284333|Cutera|Margot Doucette|415-357-5518|mdoucette@cutera.com|
20537307|NCT00197145|ViiV Healthcare|GSK Response Center|866-435-7343||
20537308|NCT04500171|American Samoa Community Cancer Coalition|Va'atausili Tofaeono|648-699-0110|vtofaeono@cancercoalition.as|
20537309|NCT05422365|Biopharma Plasma LLC|Igor Rudenko, Clinical Research Physician|+380503300865|i.rudenko@biopharma.ua|
20537310|NCT03596047|Boston Medical Group|Carolina Sandoval - Director Research|+57 3133920816|csandoval@bostonmedical.com.co|
20537311|NCT00306293|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537312|NCT00185380|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20537313|NCT01842035|University of Alabama at Birmingham|Fadi Hage|2059757123|fadihage@uab.edu|
20537314|NCT02589665|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20537315|NCT01120236|Department of Medicine, Division of Oncology, University of Washington|Evan Y. Yu, MD||evenyu@u.washington.edu|
20537316|NCT00978380|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20537317|NCT02199314|Cincinnati Children's Hospital Medical Center|John J McAuliffe, MD|1513-636-4408|john.mcauliffe@cchmc.org|
20537318|NCT00176488|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20537319|NCT00327015|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20537320|NCT02650804|BPGbio Inc|Head of Clinical Operations|6175880083|clinicaltrials.connect@berghealth.com|
20537321|NCT02222909|Johns Hopkins School of Public Health|Christine Weston|443-287-8039|cweston1@jhu.edu|
20537322|NCT01981863|Stanford University Medical Center|Peter van der Starre|6507236412|pieterva@stanford.edu|
20537323|NCT02242435|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20537324|NCT02450383|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
20537325|NCT01110330|Jan-Cil Switzerland|Director Infectious Diseases|41 41 7673477||
20537326|NCT00814697|The NY Memory and Healthy Aging Services|Dr. Gayatri Devi|212-517-6881|gd@nymemory.org|
20537327|NCT00117715|Children's Mercy Hospital|J. Steven Leeder|816-234-3059|sleeder@cmh.edu|
20537328|NCT03289910|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
20537329|NCT02759107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20537330|NCT03990415|University of Missouri|Dr. Dana Duren|(573) 884-7023|durendl@health.missouri.edu|
20537331|NCT03258281|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kpbliden@gmail.com|
20537332|NCT01089413|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20537333|NCT02383420|Carestream Health, Inc.|Susan Pate, Senior Clinical Affairs Manager|585-627-6557|susan.pate@carestream.com|
20537334|NCT03811847|Massachusetts General Hospital|Steven Arnold, MD|617-643-5607|searnold@mgh.harvard.edu|
20537335|NCT02034175|Somnarus Inc|Maria Merchant|4087610884|somnarus@gmail.com|
20537336|NCT01971463|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
20537337|NCT03018418|University of Cincinnati Cancer Center|Jordan Kharofa, MD|513-584 4775|kharofjr@ucmail.uc.edu|
20537338|NCT00420004|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537339|NCT03462927|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
20537340|NCT01942668|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|smirkin@therapeuticsmd.com|1952
20537341|NCT01113008|H Virgen de la Victoria|Dr Manuel Jiménez Navarro|951 032 354|jimeneznavarro@secardiologia.es|0034
20537342|NCT03503591|Preceptis Medical|Steve Anderson, CEO|612-327-4795|steve@preceptismedical.com|
20537343|NCT00614445|Duchesnay, Inc.|Michael Gallo|450-433-7734|mgallo@duchesnay.com|
20537344|NCT02126553|The University of Texas MD Anderson Cancer Center|Tapan Kadia MD./Professor|713-563-3534|tkadia@mdanderson.org|
20537345|NCT01467037|McGill University Health Centre|Dr Caroline Quach, Pediatric Infectious Diseases Consultant & Medical Microbiologist|514-934-1934|caroline.quach@mcgill.ca|24485
20537346|NCT00158249|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
20537347|NCT01626118|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
20537348|NCT00888329|Mayo Clinic|Javier Magrina MD|480-301-8000|magrina.javier@mayo.edu|
20537349|NCT00002540|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
20537350|NCT01864148|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20537351|NCT01500252|UAlberta|Dr. Lauren Beaupre|780-407-3945|lauren.beaupre@albertahealthservices.ca|
20537352|NCT00778375|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
20537353|NCT03490292|UW Carbone Cancer Center|Nataliya Uboha, MD, PhD|(608) 265-9966|nvuboha@medicine.wisc.edu|
20537354|NCT01421303|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537355|NCT00904670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537356|NCT00435227|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20537357|NCT02120300|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20537358|NCT01901289|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
20537359|NCT00118248|Washington University School of Medicine|Jeffrey F. Moley, M.D.||moleyj@wustl.edu|
20537360|NCT00700882|ECOG-ACRIN Statistical Office|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
20537361|NCT01832493|Medtronic CRHF|Medtronic SOCR Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
20537362|NCT00869791|Impax Laboratories, Inc.|Michelle Landolfi, PhD. Sr. Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
20553699|NCT02188576|Boston Childrens Hospital|Dr. Susan Goobie, PI|6173557737|susan.goobie@childrens.harvard.edu|
20553700|NCT02203591|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
20553701|NCT05435885|Department of Rehabilitation Medicine, Pusan National University Hospital|Dr. Sanghun Kim|82-51-240-7485|kel5504@gmail.com|
20553702|NCT03306264|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20569261|NCT03991988|Emory University|Dr. Ihab Hajjar|4047121763|ihajjar@emory.edu|
20537363|NCT00290771|Novartis Pharmaceuticals|Study Director|862 778-8300||
20537364|NCT04154293|Timber Pharmaceuticals|Alan Mendelsohn, MD|2673004249|amendelsohn@timberpharma.com|
20569262|NCT00248534|North American Brain Tumor Consortium|Lauren Abrey, MD|410-955-3657|jfisher@jhmi.edu|
20569263|NCT01222533|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507474|NCT02062463|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20507475|NCT01743872|Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center|Dr. Vikram S. Kashyap|216-844-1631|vikram.kashyap@uhhospitals.org|
20507476|NCT01509872|Queen's University Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
20507477|NCT00707655|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20507478|NCT02858154|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani|513-736-1814|Neepa.Gurbani@cchmc.org|
20507479|NCT02979301|Mayo Clinic|Dr. Carrie Hruska|507-293-4719|hruska.carrie@mayo.edu|
20507480|NCT02092441|Brooke Army Medical Center|Dr. Michael D. April|210-916-6129|Michael.D.April@post.harvard.edu|
20507481|NCT00600028|Johns Hopkins University School of Medicine|Maureen R. Horton|410-955-4176|mhorton2@jhmi.edu|
20507482|NCT03172481|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
20507483|NCT00830115|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20507484|NCT01925612|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20507485|NCT01396239|Sarepta Therapeutics, Inc.|Edward M. Kaye MD, Interim CEO, SVP & Chief Medical Officer|+1-888-727-3782|clinicaltrials@sarepta.com|
20507486|NCT01107405|Bausch & Lomb Incorporated|Tuyen Ong, MD MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20507487|NCT01709786|University of Cincinnati|Betty Tsuei, MD|513-558-5661|Betty.Tsuei@uc.edu|
20507488|NCT01170702|Northwestern University Feinberg School of Medicine|Edward Yaghmour|312-695-0693|edward.yaghmour@nm.org|
20507489|NCT00085917|RCHSPB|John Tierney|301-451-5136|john.tierney@nih.gov|
20507490|NCT00947752|Teva Neuroscience, Inc.|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
20507491|NCT01360762|Institute of Tropical Medicine Antwerp|Johan Van Griensven|+32(0)32476426|jvangriensven@itg.be|
20507492|NCT03084718|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20507493|NCT02806947|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20507494|NCT00865189|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20507495|NCT02484898|Medtronic CRHF|Medtronic SEEQ Performance Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
20507496|NCT00084929|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
20507497|NCT03930641|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20507498|NCT00091026|University of Chicago|Hedy Kindler, MD|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
20507499|NCT03666858|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20507500|NCT00980980|University of California, Irvine|Dr. Susan Huang|949-824-5073|sshuang@uci.edu|
20507501|NCT02921919|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507502|NCT03550131|University of Washington|Dr. Karen Fredriksen-Goldsen|206-543-5722|fredrikk@uw.edu|
20507503|NCT00986427|Columbia University Dept of Dermatology|Julian Mackay-Wiggan, MD|212-305-6953|jc299@columbia.edu|
20507504|NCT04390568|Boehringer Ingelheimv|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507505|NCT03245723|UT Southwestern Medical Center, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
20507506|NCT00077376|ECOG Statistical Office|Study Statistician|617-632-3012||
20507507|NCT03637842|New York State Psychiatric Institute|Christina Brezing, MD|6467748181|christina.brezing@nyspi.columbia.edu|
20507508|NCT01283997|UT MD Anderson Cancer Center|Dr. Sheeba Thomas,Professor, Lymphoma-Myeloma|(713) 792-2860|sthomas@mdanderson.org|
20507509|NCT02109744|University of Rochester|Jane Liesveld|585 - 275 - 5823|Jane_Liesveld@urmc.rochester.edu|
20507510|NCT00168324|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20507511|NCT04095442|Indiana University Indianapolis|Andrew R. Coggan|3172740656|acoggan@iu.edu|
20507512|NCT01677624|Eisai Co., Ltd.|Shin Maeda|+81-3-3817-5252||
20507513|NCT01337167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507514|NCT04172701|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507515|NCT02126670|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
20507516|NCT03794752|UT Southwestern Medical Center|Peter Chen|12146283837|peter.chen@utsouthwestern.edu|
20524437|NCT02021929|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
20524438|NCT02573597|Stanford University School of Medicine|Dr. Brendan Carvalho|(650) 861-8607|bcarvalho@stanford.edu|
20524439|NCT05966584|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2380|markovaa@mskcc.org|
20524440|NCT04955691|Yale school of Medicine|Laura Nally|203-785-5831|laura.nally@yale.edu|
20524441|NCT05795153|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20524442|NCT03760744|Vanderbilt Medical Center|Dr. Manus J. Donahue|615.322.8350|mj.donahue@vumc.org|
20524443|NCT03668119|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20524444|NCT03769168|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20524445|NCT05336227|University of Alabama at Birmingham|Byron Lai|205.638.9790|blai@uabmc.edu|8-9725
20524446|NCT04050462|NYU Langone Health|Nina Beri, MD|212-731-5770|nina.beri@nyulangone.org|
20524447|NCT04042467|Vanderbilt University Medical Center|Filoteia Popescu|615-875-9083|filoteia.popescu@vumc.org|
20524448|NCT05151744|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20524449|NCT05228470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569264|NCT03418493|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20524450|NCT04053868|University of California San Francisco|Dr. Neal Benowitz|628-206-8324|neal.benowitz@ucsf.edu|
20507517|NCT01362946|Penn State Hershey Medical Center|Dr. Dan Waschbusch|7175318514|dwaschbusch@hmc.psu.edu|
20537365|NCT02661737|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
20537366|NCT03703817|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569265|NCT02028247|Baylor College of Medicine|Dr. Eric Storch|7137983579|eric.storch@bcm.edu|
20569266|NCT00526097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569267|NCT00966979|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
20569268|NCT01318317|City of Hope|Dr. Lwaliw Popplewell|626-359-8111|lpopplewell@coh.org|
20524451|NCT05731700|Abbott|Krista Stiefel, Principal Clinical Scientist|+12246689359|krista.stiefel@abbott.com|
20524452|NCT04541017|City of Hope|Paul Frankel, Ph.D.|6262185265|pfrankel@coh.org|
20524453|NCT05400655|Centers for Disease Control and Prevention|Dr. Laura Steinhardt, PhD, MPH|1 6467641472|LSteinhardt@cdc.gov|
20524454|NCT04495946|Wake Forest University School of Medicine|Marc Kowalkowski, PhD|704-355-9902|marc.kowalkowski@advocatehealth.org|
20524455|NCT01068678|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20524456|NCT02565628|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524457|NCT03058705|University of Rochester|Edward Messing, MD|585-275-0998|edward_messing@urmc.rochester.edu|
20524458|NCT03375918|UMass Chan Medical School|Jennifer Tjia|774-455-3538|jennifer.tjia@umassmed.edu|
20524459|NCT03507608|Johns Hopkins SOM, Dept of Radiation Oncology|Dana Kaplin|443-690-7007|dkaplin1@jh.edu|
20524460|NCT02088554|Medtronic|Jessica Halverson, Director of Clinical Research|(800) 633-8766|rsperigonpivotaltrial@medtronic.com|
20524461|NCT05468164|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20524462|NCT03827291|Duke University|Amanda Kumar, MD|919-681-6437|amanda.kumar@duke.edu|
20524463|NCT04795466|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20524464|NCT04652726|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524465|NCT04286269|University of Minnesota|Sonya Wang|612-301-1454|sgwang@umn.edu|
20524466|NCT04526639|University of Massachusetts Lowell|Jiabin Shen|978-934-3965|jiabin_shen@uml.edu|
20524467|NCT01135381|University of California San Francisco (UCSF); University of Alabama at Birmingham (UAB)|Dr. Christine Ritchie|415-514-0605|christine.ritchie@ucsf.edu; critchie@uab.edu|
20524468|NCT01754350|JohannWGUH|Johannes Rieger|+4969630187711|j.rieger@uni-tuebingen.de|
20524469|NCT01256164|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20524470|NCT02974686|Washington University|Dr. R. Delos Santos|314-362-8351|delossantos@wustl.edu|
20524471|NCT00866281|Novartis Pharmaceuticals|Study Director|862-778-8300||
20524472|NCT02275546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524473|NCT02918565|Stanford University|Brian Suffoletto|4129016892|suffbp@stanford.edu|
20524474|NCT02612623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524475|NCT01739231|PATH|Richard Walker|202-822-0033|rwalker@path.org|
20524476|NCT00570141|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|917-900-4000|bert.slade@healthpoint.com|
20524477|NCT01135329|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Yvette Kasamon|410-955-8839|ykasamo1@jhmi.edu|
20524478|NCT00981214|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20524479|NCT02309411|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20524480|NCT03204786|Stanford University|Antonio Hardan, MD|(650)736-1235|autismdd@stanford.edu|
20524481|NCT04268771|Dr. Reddy's Laboratories Ltd.|Head-Clinical Development|91-40-4464-4000|RI-01-007@drreddys.com|
20524482|NCT02667704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524483|NCT02883062|Washington University School of Medicine|Dr. William Gillanders|314-747-0072|gillandersw@wustl.edu|
20524484|NCT04426006|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20524485|NCT01262872|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524486|NCT01753310|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
20524487|NCT02798380|Hallux, Inc.|Thomas M Tremblay, RN BSN, Vice President of Clinical Affairs|(415) 305-3491|ttremblay@halluxinc.com|
20524488|NCT00952068|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20524489|NCT02022202|Mayo Clinic|Matthew P. Goetz MD and Judy C. Boughey MD|507-284-2511|Goetz.Matthew@mayo.edu|
20524490|NCT03957473|Penumbra, Inc.|Study Manager|+1 415-601-9561|apascua@penumbrainc.com|
20524491|NCT04390763|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20524492|NCT03831932|The Ohio State University Comprehensive Cancer Center|Dr. Dwight Owen|614-685-2039|Dwight.Owen@osumc.edu|
20524493|NCT01956773|Duke University Medical Center|Dr. Lori A. Orlando, Director Program in Precision Medicine|919-660-6606|orlan002@duke.edu|
20524494|NCT00867659|Virginia Center for Reproductive Medicine|Dr Fady Sharara|7034377722|fsharara@vcrmed.com|
20524495|NCT02040805|University of California, San Francisco|Dr. Kevin L. Delucchi|415-476-4180|kevin.delucchi@ucsf.edu|
20524496|NCT04495829|Woolfson Eye Institute|R. Doyle Stulting, MD, PhD|(770) 255-3330|dstulting@icloud.com|
20524497|NCT01845441|University Hospitals Cleveland Medical Center|Dr. Kristine Blackham|216-403-2705|kristine.blackham@gmail.com|
20524498|NCT02259010|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20524499|NCT03194542|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20524500|NCT02976129|VHsquared|Chief Medical Officer|+44 (0)1223 837650|info@vhsquared.com|
20569269|NCT00943618|UT MD Anderson Cancer Center|Paul M. Cinciripini, BS,MS,PHD/Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
20569270|NCT06142578|Kylane Laboratoires|Basste Hadjab, Sponsor|0225889611|compliance@kylane.com|
20569271|NCT03713281|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20537367|NCT01591954|Department of Biomedical Engineering, Johns Hopkins University|Jeffrey H. Siewerdsen, PhD / Professor of Biomedical Engineering|443-287-6269|jeff.siewerdsen@jhu.edu|
20537368|NCT03814382|Massachusetts General Hospital|Jessica Gerber, DAc.|617-724-1992|jgerber2@mgh.harvard.edu|
20553703|NCT00554749|Centre for Child and Adolescent Mental Health, Eastern and Southern Norway|Dr. Hanne Kristensen|+4722586000|hanne.kristensen@r-bup.no|
20553704|NCT02353247|University of Louisville|Professor Andrew Scott LaJoie, PhD, statistician on project|502-852-1879|lajoie@louisville.edu|
20553705|NCT02600637|VA Northern California|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
20553706|NCT04043312|Hospital of the University of Pennsylvania|Dr. Timothy Markman|267-593-0103|timothy.markman@uphs.upenn.edu|
20553707|NCT02702401|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553708|NCT01228968|Washington University School of Medicine|Gary Skolnick|3143625292|gskolnic@wustl.edu|
20553709|NCT00247728|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
20553710|NCT01462357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20553711|NCT04292730|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20553712|NCT02549508|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|7044
20553713|NCT01247090|Columbia University Medical Center|Anjali Ganda, MD|617-835-3789|ag355@columbia.edu|
20553714|NCT01574703|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553715|NCT00501891|The Preston Robert Tisch Brain Tumor Center at Duke|Annick Desjardins, MD|919-684-6173|annick.desjardins@duke.edu|
20553716|NCT02026115|University of Florida|Diana J. Wilkie, PhD, RN, FAAN, Professor, Prairieview Trust - Earl and Margo Powers Endowed Profess|352-273-6401|diwilkie@ufl.edu|
20553717|NCT04084769|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20553718|NCT03013491|CytomX Therapeutics, Inc.|Head of Clinical Operations|(650) 515-3185|clinicaltrials@cytomx.com|
20553719|NCT05445128|Ensoma|Ensoma head of regulatory or head of clinical research & development|6127191200|ddietz@ensoma.com|
20553720|NCT04579679|HUTCHMED International Corporation|Nick Lawn|+44 7826 422448|nickl@hutch-med.com|
20553721|NCT06893809|Başakşehir Çam and Sakura City Hospital|Dr. Emine Ozcan|05301592856|dr.emine3419@gmail.com|
20553722|NCT04953442|Baylor College of Medicine|Erica Soltero, PhD|4029100832|soltero@bcm.edu|
20553723|NCT04740034|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20553724|NCT05648565|The University of Texas Health Science Center at Houston|David Z. Allen|713-500-5427|David.Allen@uth.tmc.edu|
20553725|NCT00991302|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20553726|NCT02383758|Emory University|Dr. Nathan Call||nathan.call@choa.org|
20553727|NCT00273364|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20553728|NCT02616250|GALDERMA|Fabien AUDIBERT, Sr CPM|+33 (0) 4 9238 3034|fabien.audibert@galderma.com|
20553729|NCT04318210|Centers for Disease Control and Prevention|Dr. Allan Taylor|404-639-6120|avt0@cdc.gov|
20553730|NCT02573324|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20553731|NCT03892889|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20553732|NCT02066298|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
20553733|NCT02448303|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20553734|NCT00630877|Abbott|Medical Information Specialist|800-633-9110||
20553735|NCT02517580|Lebanese American University|Dr. Sola Aoun Bahous|+961-1-200-800|sola.bahous@lau.edu.lb|
20553736|NCT00598689|Georgia Regents University|David D. Bogorad, MD, FACS|706-721-1160|dbogorad@gru.edu|
20553737|NCT02343458|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|650-305-2600|creisner@pearltherapeutics.com|
20553738|NCT03894449|University of Veterinary & Animal Sciences, Lahore, Pakistan|Dr. Waqas Ahmed|0092-42-99211449|waqas.niaz@uvas.edu.pk|296
20553739|NCT01913041|Peking Union Medical College Hospital, Anesthesia Department|Dr. Jie Yi|+86 10 69152025|neyil@pumch.cn|
20553740|NCT01513317|Janssen Research & Development|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
20553741|NCT02873923|Institut Bergonié|Dr Carine Bellera|33 5 56 33 04 95|c.bellera@brodeaux.unicancer.fr|
20553742|NCT00182689|SWOG Statistical Center|Study Statistician|206-667-4623||
20553743|NCT02564198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20553744|NCT00659646|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20553745|NCT01640301|Fred Hutchinson Cancer Research Center|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
20553746|NCT02842060|University of Pennsylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
20553747|NCT01969838|Sierra Oncology, a GlaxoSmithKline company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20553748|NCT00408993|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20553749|NCT00298896|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
20553750|NCT02660359|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
20553751|NCT02506114|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
20553752|NCT01797536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553753|NCT02099721|Medtronic CRHF|Katy Muckala, Sr. Clinical Research Specialist|(763) 526-1767|katy.a.muckala@medtronic.com|
20553754|NCT00754247|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
20553755|NCT00844545|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
20553756|NCT02039427|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
20524501|NCT03655405|a. Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
20524502|NCT03757312|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
20524503|NCT00975611|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
20524504|NCT03123120|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524505|NCT02632175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20524506|NCT03207815|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20524507|NCT01671007|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524508|NCT03877068|Emory University|Guillermo E. Umpierrez, MD|404-778-1665|geumpie@emory.edu|
20524509|NCT00449865|University of Rochester|Karl Kieburtz, Director of CTSI|585-275-0553|Karl.kieburtz@chet.rochester.edu|
20524510|NCT00406367|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
20524511|NCT00171210|Novartis Pharmaceuticals|Study Director|862-778-8300||
20524512|NCT00253435|Chidlren's Hospital Los Angeles|Araz Marachelian, MD, NANT Medical Director|323-3691-5687|amarachelian@chla.usc.edu|
20524513|NCT03187301|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20524514|NCT01808963|UC Davis Medical Center|Dr. Neal Fleming|916-734-5394|nwfleming@ucdavis.edu|
20524515|NCT00304096|University of Virginia|Kimberly Bullock, PhD and David Brenin, MD|434-924-0180|kb9d@virginia.edu|
20524516|NCT01812109|University of Texas Southwestern Medical Center|Dr. Linda Baker|214/456-2480|Linda.baker@childrens.com|
20524517|NCT02158585|DENT Neurosciences Research Center|Dr. Jennifer Cox|716-250-7002|jcox@dentinstitute.com|
20524518|NCT01966120|Biofrontera Bioscience GmbH|Clinical Trial Department,|+49 2148763226|ameluz@biofrontera.com|
20524519|NCT00461630|Clinical Trial Service Unit, University of Oxford|Professor Jane Armitage|+44 (0)1865 743743|thrive@ctsu.ox.ac.uk|
20524520|NCT02546375|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524521|NCT01965756|Massachusetts General Hospital|Dr. Steven E. Arnold MD|617-643-5607|SEARNOLD@mgh.harvard.edu|
20524522|NCT00442897|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20524523|NCT04498182|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
20524524|NCT02182843|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
20524525|NCT05541003|Robert Wood Johnson|Dr. Keerthana Kesavarapu|6784690425|kk1132@rwjms.rutgers.edu|
20524526|NCT01788631|Dana-Farber Cancer Institute|Dr. David G. Nathan|61746322155|David_Nathan@dfci.harvard.edu|
20524527|NCT00375973|University of Cincinnati College of Medicine|Lesley M. Arnold, M.D.|513-558-7700|lesley.arnold@uc.edu|
20524528|NCT03137160|The Ohio State University- Dermatology|Dr. Benjamin Kaffenberger, MD|6143463399|Benjamin.Kaffenberger@osumc.edu|
20524529|NCT03291080|Nova Laboratories|Dr Hussain Mulla|+44 (0) 116 223 0100|hussain.mulla@novalabs.co.uk|
20524530|NCT01932060|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
20524531|NCT01339260|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
20524532|NCT02588612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20524533|NCT02348918|Allegro Ophthalmics, LLC|Director of Clinical Research|949-940-8130|info@allegroeye.com|
20524534|NCT00630825|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20524535|NCT02042014|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20524536|NCT01354652|AsanMC|Dr. Han Chu Lee|82230103915|hch@amc.seoul.kr|
20524537|NCT03123393|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20524538|NCT05245526|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
20524539|NCT00558701|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
20524540|NCT00427648|NorthShore Health|Frank F. Tu|8475702521|ftu@northshore.org|
20524541|NCT02230904|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20524542|NCT02069041|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20524543|NCT01464333|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20524544|NCT01511978|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|6099217447|kathy.ales@jacobus-pharmaceutical.com|231
20524545|NCT05047211|UTMB Galveston|Dr Antonio Saad Director of PRD|4097721795|antalar@me.com|
20524546|NCT02187198|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski, PhD|203-932-5711|elizabeth.ralevski@yale.edu|4282
20524547|NCT00561392|Novartis Pharmaceuticals|Study Director|862 778-8300||
20524548|NCT03321968|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
20524549|NCT03822468|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20524550|NCT02155283|Radiancy Ltd|Dr. Daniele Perl-Treves, Clinical Director|972-97757556|daniele@radiancy.com|
20524551|NCT00232739|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
20524552|NCT01741688|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20524553|NCT01069510|Oregon Health and Science Univ.|Dr. Craig Broberg|503-494-7400|brobergc@ohsu.edu|
20524554|NCT01514292|Dexcom, Inc|Andy Balo, SVP, Regulatory, Clinical and Biometrics|8582000200|abalo@dexcom.com|
20524555|NCT00463047|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
20524556|NCT03283787|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
20524557|NCT00426166|University of Toledo|Dr. Martin Skie|419-383-3515|martin.skie@utoledo.edu|
20524558|NCT02712554|Charleston Laboratories, Inc.|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
20524559|NCT02188147|ZOLL|Vice President Medical Affairs|412-968-3333|stevens@zoll.com|4400
20537369|NCT00656058|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
20537370|NCT02708849|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
20537371|NCT00404755|New York State Psychiatric Institute|Jonathan W. Stewart, M.D.|646-774-8000|jws6@columbia.edu|
20537372|NCT02493257|The University of Texas Health Science Center at Houston|Dr. Amber U. Luong, Associate Professor and Director of Research|(713) 500-5410|Amber.U.Luong@uth.tmc.edu|
20537373|NCT05145322|University of Minnesota School of Dentistry|Hooi Pin Chew|6126256975|chew0014@umn.edu|
20537374|NCT06359028|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20537375|NCT04700540|University of Minnesota|Dr. Jude Mikal|385-212-4185|jpmikal@umn.edu|
20537376|NCT03194568|Children's Hospital of Philadelphia|Dr. Patrick Cahill|2155901000|cahillp1@chop.edu|
20537377|NCT02952313|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20537378|NCT05818956|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20537379|NCT02628600|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
20537380|NCT00583752|University of Iowa, Holden Comprehensive Cancer Center|David Lubaroff, MD|3193561527|david-lubaroff@uiowa.edu|
20537381|NCT00830375|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
20537382|NCT01700959|St. Jude Children's Research Hospital|Tara M. Brinkman, PhD|(901) 595-5683|tara.brinkman@stjude.org|
20537383|NCT01331837|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20537384|NCT03407053|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
20537385|NCT03724981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20537386|NCT00511433|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20537387|NCT01380535|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20537388|NCT01301521|MOMH|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
20537389|NCT02791191|Eli Lilly and Company|Chief Medical Officer|800-545-5079|Clinicaltrials.gov@lilly.com|
20537390|NCT02370537|AstraZeneca AB|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
20537391|NCT04178993|University of Kentucky|Dr. Craig Rush, Ph.D.|8592575388|crush2@uky.edu|
20537392|NCT03045406|FadoiFoundation|Giorgio Vescovo|00390685355188|irenezaratti@fadoi.org|
20537393|NCT03100539|Richard L Roudebush VA Medical Center|Dr. Matthew Bair, Director of Center for Health Information and Communication|317-988-2058|Matthew.Bair@va.gov|
20537394|NCT03804021|Adverum Biotechnology, Inc.|Chief Development Officer|650-649-1413|sseyedkazemi@adverum.com|
20537395|NCT02578680|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20537396|NCT00882583|FDA|Shanthi Marur|2404026373|shanthi.marur@fda.hhs.gov|
20537397|NCT02596958|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20537398|NCT02290691|PharmaJet, Inc|Tara Miller, MS, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
20537399|NCT04324541|University of North Texas Health Science Center|Leigh Johnson, PhD|817-735-2938|Thanhtruc.Truong@unthsc.edu|
20537400|NCT05081167|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
20553757|NCT05165121|MDHearing|Dr. Sandra Porps|7346572209|slp@mdhearingaid.com|
20553758|NCT01540370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20553759|NCT01532687|OHSU Knight Cancer Institute|Dr. Christopher Ryan|503-494-9000|ryanc@ohsu.edu|
20553760|NCT00403455|Department of Veterans Affairs|Dr. Zhewu Wang|(843) 789-7949|Zhewu.Wang@va.gov|
20553761|NCT04805983|Associate Director of the Yale Alzheimer's Disease Research Unit|Adam Mecca, MD, PhD|(203) 785-4736|adam.mecca@yale.edu|
20553762|NCT00226941|Stanford Cancer Institute, Stanford University|George Albert Fisher, Jr, MD, PhD; Colleen Haas Chair, School of Medicine|650-723-2990|georgeaf@stanford.edu|
20553763|NCT01513291|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553764|NCT03732638|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20553765|NCT03728582|Johns Hopkins University|Dr. Argye Hillis|(443) 287-4610|argye@jhmi.edu|
20553766|NCT02732847|Memorial University|Reza Tabrizchi|706-864-3381|rtabrizc@mun.ca|
20553767|NCT02738775|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20553768|NCT01785524|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
20553769|NCT01060384|University of Nebraska Medical Center|Julie M. Vose|402-559-3848|jmvose@unmc.edu|
20553770|NCT01263873|University Hospitals of Cleveland|Brian Radesic|3309725175|radesic@uakron.edu|
20553771|NCT01150838|University of Virginia|George Politis MD|434-924-2283|GDP8A@hscmail.mcc.virginia.edu|
20553772|NCT02214147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20553773|NCT03204942|National Cancer Institute|Director of Ethical Committee|+201224276580|drsherryfanous@yahoo.com|
20553774|NCT02664038|VA Connecticut Healthcare System|Morris Bell, Ph.D., Senior Research Career Scientist|203-932-5711|morris.bell@va.gov|2281
20553775|NCT02100007|MEI Pharma Inc|Richard Ghalie, MD, Sr Vice President Clinical Development|858 369-7116|rghalie@meipharma.com|
20553776|NCT03758040|University of Nebraska Omaha|Nathaniel Hunt|402-554-4195|nhunt@unomaha.edu|
20553777|NCT04875520|Nationwide Children's Hospital|Jason G. Newland, MD|614-722-3416|Jason.Newland@nationwidechildrens.org|
20553778|NCT04456699|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20537401|NCT02918396|Johns Hopkins University|Dr. Tarek Zghaib|410-955-5000|tzghaib1@jhmi.edu|
20537402|NCT00583414|Massachusetts General Hospital|Matthew Eagleton, MD|617-726-8279|meagleton@mgh.harvard.edu|
20537403|NCT01018134|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
20537404|NCT00733291|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20553779|NCT04452188|The University of Michigan Health System|Dr. Nathaniel Sznycer-Taub|734-936-8993|nsznycer@umich.edu|
20537405|NCT01610557|National Eye Institute (NEI) at National Institutes of Health (NIH)|Henry E Wiley, MD, Principal Investigator|(301) 451-4260|wileyhe@mail.nih.gov|
20537406|NCT03215758|Novartis Pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
20537407|NCT01289353|NYU Langone Health - PCC CTO|Carmen Perez, MD, PhD|212-731-5003|carmen.perez@nyulangone.org|
20537408|NCT01549886|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20537409|NCT00473668|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537410|NCT02039219|Indiana University School of Medicine|Naga Chalasani, MD|(317) 278-0414|nchalasa@iu.edu|
20537411|NCT02226562|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537412|NCT04569136|National Cheng Kung University|Dr. Kuan-Yin Lin|+886-6-2353535|10802003@gs.ncku.edu.tw|6737
20537413|NCT00611468|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20537414|NCT03257202|Keck Medical Center of USC|Dr. George Hatch|323-442-5860|ghatch.md@gmail.com|
20537415|NCT01466660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537416|NCT00129701|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
20537417|NCT03576066|Assembly Biosciences|Linda Bahr, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
20537418|NCT00006164|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|James E. Everhart, MD, MPH, Project Officer|301-594-8878|EverhartJ@extra.niddk.nih.gov|
20537419|NCT02750345|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
20537420|NCT00223808|CTVHCS|Charles Burgar, MD|254/743-0085|charles.burgar1@va.gov|
20537421|NCT00365105|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20537422|NCT06004895|Aston University|Professor James S Wolffsohn|07833049245|j.s.w.wolffsohn@aston.ac.uk|
20537423|NCT00152477|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20537424|NCT00425698|Saarland University Medical Centre|Prof. Dr. Danilo Fliser|(49) 6841|indfli@uks.eu|1623526
20537425|NCT01328535|Mayo Clinic|Roxana S. Dronca, M.D.|507/284-2511|Dronca.Roxana@mayo.edu|
20537426|NCT02652208|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
20537427|NCT03655054|Valencia Technologies|Jacqueline Dister|7604294787|jdister@valenciatechnologies.com|
20537428|NCT03931382|Senior Director|John Jacob|604-875-2393|john.jacob@cw.bc.ca|
20537429|NCT00542490|University of Oklahoma|Lisa Landrum, MD|405 271-8001|lisa-landrum@ouhsc.edu|
20537430|NCT04405999|Almazov National Medical Research Centre|Evgeny Mikhaylov|+7(812)7023764|e.mikhaylov@almazovcentre.ru|
20537431|NCT03316118|Northwestern University|Paul Fitzgerald|312 695 1064|p-fitzgerald2@northwestern.edu|
20537432|NCT01106651|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise||ClinicalTrialDisclosure@its.jnj.com|
20537433|NCT02241655|Washington University|Dr. Michael Avidan, MBBCh|314-332-7265|avidanm@wustl.edu|
20537434|NCT00712725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537435|NCT04154605|Stryker|Robyn Schacherer, Manager Clinical Affairs|763-463-7054|robyn.schacherer@stryker.com|
20537436|NCT00675441|UT MD Anderson Cancer Center|Amin Alousi, MD / Assisstant Professor||CR_Study_Registration@mdanderson.org|
20537437|NCT00313144|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20537438|NCT01178944|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20537439|NCT05129449|OLYMPUS EUROPA SE & CO. KG|Dr. Peter Teichmann|+49 40 23773|peter.teichmann@olympus.com|7835
20537440|NCT01777217|Century Cancer Centers|Dr. Sanjay Mehta|713-631-8181||
20537441|NCT02901054|Washington University School of Medicine|Simon Haroutounian, PhD|3142861715|simon.haroutounian@wustl.edu|
20537442|NCT00616018|Denver Health|Jody Green|303-389-1246|jody.green@rmpdc.org|
20537443|NCT01818258|Organization: Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20537444|NCT03515551|Immunocore, Ltd|Study Director|1-844-IMMUNO-1|clinicaltrials@immunocore.com|
20537445|NCT00920387|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
20537446|NCT02835313|University of Delaware|Dr. Darcy Reisman, PT, PhD, FAPTA|302-831-0508|dreisman@udel.edu|
20537447|NCT04084366|OBI Pharma, Inc.|Dr. Wayne Saville, Chief Medical Officer|619-537-7821|waynesaville@obipharmausa.com|
20537448|NCT02241733|Edward Hines Jr., VA Hospital|Eileen Collins RN, PhD, Research Nurse Scientist|312-413-5621|ecollins@uic.edu|
20537449|NCT01866111|SK Life Science|Chief Medical Officer|201-421-3830|mkamin@sklsi.com|
20537450|NCT03802630|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20537451|NCT00157196|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20537452|NCT01252186|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20537453|NCT03236909|MED-EL Corporation|Clinical Research Manager|888-633-3524|research.us@medel.com|
20537454|NCT04420598|Medica Scientia Innovation Research (Medsir)|Alicia García Sanz PhD|611261467|contact.trials@medsir.org|+34
20537455|NCT04283994|University of Washington|Dr. Erin Kross|206-744-4649|ekross@uw.edu|
20537456|NCT04086693|Beaumont Health|Amit Bahl, MD|248-551-1792|Amit.Bahl@beaumont.edu|
20537457|NCT01159171|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20537458|NCT01892436|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|novartis.email@novartis.com|
20537459|NCT02923830|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20537460|NCT00837265|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20537461|NCT01751906|Abbott Vascular|Latania Chura / Project Manager|503.935.3002|latania.chura@abbott.com|
20537462|NCT02390414|Dana-Farber Cancer Institute|Dr. Gregory A. Abel|6176322304|gaabel@partners.org|
20537463|NCT04051710|Aurobindo Pharma|Dr. Joseph Marialouis|9196150585|jmarialouis@aurobindousa.com|4013
20507518|NCT03097614|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20507519|NCT00436982|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Eric Garling, PhD, Snr. Director Medical & Scientific Affairs Europe|+31 20 219 2660|Eric.Garling@stryker.com|
20507520|NCT00953225|Ralph H. Johnson VA Medical Center|Sebastiano Gattoni-Celli, M.D.|843-876-5103|gatttonis@musc.edu|
20507521|NCT03864536|UAB|Pariya Wheeler|2052423924|plfazeli@uab.edu|
20507522|NCT04058158|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20507523|NCT02215616|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20507524|NCT01634113|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507525|NCT01598207|Temple University|Dr. Ron Schey|215-707-9900|Ron.schey@tuhs.temple.edu|
20507526|NCT00520299|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20507527|NCT01352845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507528|NCT01956240|Methodist University of Piracicaba|Ms Dayana Patricia Rosa|+55 16 3306-6696|dad_rosa@hotmail.com|
20507529|NCT05197140|University of Arkansas for Medical Sciences|Robert Wolfe|501-526-5769|rwolfe2@uams.edu|
20507530|NCT02759562|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20507531|NCT02293993|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20507532|NCT01957709|Fred Hutchinson Cancer Research Center|Seth Pollack, MD|206-667-6629|spollack@fredhutch.org|
20507533|NCT03587584|University of Minnesota|Aaron Berg|612-625-7675|bergx831@umn.edu|
20507534|NCT00232505|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20507535|NCT01061736|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20507536|NCT00397878|University of Texas MD Anderson Cancer Center|Cathy Eng, MD / Professor|713-792-2828|ceng@mdanderson.org|
20507537|NCT01093755|Mayo Clinic|Prasad Iyer, MD|507-284-0970|Iyer.Prasad@mayo.edu|
20507538|NCT03115112|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20507539|NCT01546285|GE Healthcare|Jeffrey Conner - Global Research Manager|414.721.2423|Jeffrey.Conner@ge.com|
20507540|NCT04019795|Revian, Inc.|John Oakley|919-321-1726|joakley@knowbiollc.com|
20507541|NCT02310906|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
20507542|NCT00433446|SWOG Statistical Center|Study Statistician|206-667-4623||
20507543|NCT01188538|Galderma|Farzaneh SIDOU|00 33 4 93 95 70 51|farzaneh.sidou@galderma.com|
20507544|NCT00654953|UAMS|Alison Oliveto, Ph.D.|501-526-8441|olivetoalison@uams.edu|
20507545|NCT00664755|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20507546|NCT00098020|National Institutes of Diabetes, Digestive, and Kidney Disorders|Dr. Jeffery Kopp|301-594-3403|koppj@mail.nih.gov|
20507547|NCT00943488|Carver College of Medicine, University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
20507548|NCT03495453|NYU Langone Health|Anvar Babaev, MD, PhD|212-263-5656|Anvar.Babaev@nyulangone.org|
20507549|NCT00712933|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507550|NCT01978509|Mayo Clinic|Dr. Francisco Ramirez|(480) 301-6990|Ramirez.Francisco@mayo.edu|
20507551|NCT03641547|OCTO, University of Oxford|Dr Ruth Harman, Trial Manager|01865 617018|octo-CHARIOT@oncology.ox.ac.uk|
20507552|NCT01392053|Universidade de São Paulo|Prof Silvana Quintana|55 16 3602-2813|quintana@fmrp.usp.br|
20507553|NCT02513784|Columbia University Medical Center|Julian A Abrams, MD|2123059541|ja660@cumc.columbia.edu|
20524560|NCT02503540|Cole Eye Institute Cleveland Clinic Foundation|Dr.Justis P. Ehlers|2166360183|ehlersj@ccf.org|
20524561|NCT01662492|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20524562|NCT03175536|Harvard Medical School and Harvard Pilgrim Health Care Institute|Dr. Alison Galbraith|6178674893|alison_galbraith@harvardpilgrim.org|
20524563|NCT05286450|Sohag University|dr magdy mohamed amin|(093)- 4602963|portal@med.sohag.edu.eg|
20524564|NCT01991743|Northwestern University|Dr. Robert J McCarthy|312-695-4976|r-mccarthy@northwestern.edu|
20524565|NCT03830333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524566|NCT01129557|Columbia University Medical Center, Division of Nephrology|Andrew Bomback, MD|212-305-5020|asb68@columbia.edu|
20524567|NCT01486446|Xenon Pharmaceuticals Inc.|Dr. Y Paul Goldberg|604 484 3300|pgoldberg@xenon-pharma.com|
20524568|NCT04390113|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
20524569|NCT01611883|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524570|NCT03379727|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20524571|NCT03126968|University of Maryland|Robert M. Reed|4103288141|rreed@som.umaryland.edu|
20524572|NCT02757053|Heartland Regional Medical Center dba Mosaic Life Care|Clinical Research Development Manager|816 271 7937|Linda.Schumacher@mymlc.com|
20524573|NCT02418182|University of Alabama at Birmingham|Deidre Gunn, Assistant Professor|205-934-1030|ddowns@uabmc.edu|
20524574|NCT02747108|VA Center for Clinical Management Research|Jeffrey Kullgren, MD, MS, MPH - Principal Investigator|(734) 845-3502|jkullgre@med.umich.edu|
20524575|NCT00570687|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20524576|NCT03771898|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20524577|NCT05343000|Mayo Clinic|Roberto Benzo, M.D.|480-301-8244|benzo.roberto@mayo.edu|
20507554|NCT00065442|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
20507555|NCT01797965|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20524578|NCT03135548|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524579|NCT04623216|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
20507556|NCT00712322|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20537464|NCT00309140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537465|NCT00470093|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Carol Ann Huff|410-955-8842|huffca@jhmi.edu|
20537466|NCT00635739|Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
20537467|NCT00191724|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20537468|NCT00608023|Theratechnologies|Marilyn de Chantal, Global Senior Medical Director|1 438-315-6624|Mdechantal@theratech.com|
20537469|NCT06422364|Indiana University|Dr. Harish Rao, Assistant Professor of Clinical Pediatrics|317-948-7208|harirao@iu.edu|
20537470|NCT03713294|Mayo Clinic|Sikander Ailawadhi|904/953-6468|ailawadhi.sikander@mayo.edu|
20537471|NCT03458910|University of Southern California|Dr. Mara Mather|(213) 821-1868|mara.mather@usc.edu|
20537472|NCT04022226|The University of New Mexico|Dr. Jeremy Miller|5052724490|jermiller@salud.unm.edu|
20537473|NCT02704702|Celerion|Dr.Laura Sterling|1-402-476-2811|laura.sterling@celerion.com|
20537474|NCT00123162|MS Hershey Medical Center|Richard S Legro MD|717-531-8478|rsl1@psu.edu|
20537475|NCT04392141|Kermanshah University of Medical Sciences|Prof. Ali Mostafaie|+989188302044|amostafaie@kums.ac.ir|
20537476|NCT02357472|Ji Ai Genetics & IVF Institute|Dr.Jing Fu|86-021-63459977|fujing_givf@163.com|
20537477|NCT00832598|Memorial Sloan Kettering Cancer Center|Dr. Ronald Blasburg, MD|646-888-2211|blasberr@mskcc.org|
20537478|NCT00323960|IRCCS Istituto Giannina Gaslini|Dr. Nicolino Ruperto|+39-010-382854|nicolaruperto@gaslini.org|
20537479|NCT03768089|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20537480|NCT02135029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537481|NCT03466099|KalVista Pharmaceuticals|Director Clinical|857-999-0075|clinicalinfo@kalvista.com|
20537482|NCT01671293|Universidad del Desarrollo|J. Carola Pérez Ewert|5623279875|janetperez@udd.cl|
20537483|NCT00889603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537484|NCT03709277|Vanderbilt University Medical Center|Amanda Kibbons|615-875-4745|amanda.m.kibbons@vumc.org|
20537485|NCT03525600|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20537486|NCT02591537|Northwestern University|Dr. Robert Galiano, Associate Professor of Surgery|312.695.3908||
20537487|NCT01923363|Loma Linda University Medical Center|Dr. Steven Forland|909-558-4000|sforland@llu.edu|43980
20537488|NCT01454505|Alcon Research, Ltd.|Terri Pasquine, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20537489|NCT00005901|National Institute of Child Health and Human Development|Joan Marini|+1 301 594 3418|marinij@cc1.nichd.nih.gov|
20537490|NCT01818739|The Ohio State University Comprehensive Cancer Center|Floor Backes, MD|614-730-6968|Floor.Backes@osumc.edu|
20537491|NCT03718884|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20537492|NCT02099344|Kaiser Permanente NW|Earl Schuman, MD|503-331-6017|kathleen.ann.arnold@kpchr.org|
20537493|NCT02839720|UAB Heersink School of Medicine|Bruce R. Korf, MD, PhD|205-996-9487|bkorf@uabmc.edu|
20537494|NCT03927482|The Miriam Hospital|Beth Bock, PhD|4017938020|Beth_Bock@Brown.edu|
20537495|NCT03306979|Sunnybrook Health Sciences Centre|Dr. Krista Lanctôt, Senior Scientist|416-480-6100|krista.lanctot@sunnybrook.ca|62241
20537496|NCT05248997|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537497|NCT01453205|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
20537498|NCT05593913|Acer Medical Inc.|Regulator Manager|886-2-26960366|AcerMedicalofficial@gmail.com|
20537499|NCT02602275|Biologische Heilmittel Heel GmbH|Head of Clinical Research|+49 7221 501|info@heel.com|0
20537500|NCT01258790|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
20537501|NCT03829969|Shanghai Junshi Bioscience Co., Ltd.|Huimei Xie|86-021-50796193|huimei_xie@junshipharma.com|
20537502|NCT04113018|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20537503|NCT05005013|NYU Langone Health|Matthew Lustberg|929-455-5090|matthew.lustberg@nyulangone.org|
20537504|NCT06099223|Hartford Hospital|Aseel Walker|860-972-1778|aseel.walker@hhchealth.org|
20537505|NCT01221623|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20537506|NCT00661726|NERI|Nancy Gee, TCRN Network Manager|617-972-3295|ngee@neriscience.com|
20537507|NCT00780143|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
20553780|NCT02097992|University of Miami|Adam Wanner|(305)243-3045|awanner@med.miami.edu|
20553781|NCT02410811|Cincinnati Children's Hospital Medical Center|Dr. Charles T. Quinn|5138033086|charles.quinn@cchmc.org|
20569272|NCT05566886|Corsano Health B.V.|Clinical Research Manager|+31 61 640 7778|info@corsano.com|
20569273|NCT01990313|Stanford University|Chioma Anidi|6507236709|chioma.anidi@stanford.edu|
20569274|NCT02412111|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20569275|NCT01355978|Clinical Research Consuting|Richard J. Morishige, MS, RRT|510-606-0374|rjmorishige@gmail.com|
20569276|NCT00630552|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20569277|NCT03226106|Eastern Colorado VA Medical Center|Cory Christiansen, PT, PhD|303-724-9101|cory.christiansen@cuanschutz.edu|
20569278|NCT04349644|Vanderbilt University Medical Center|Blythe Corbett, Ph.D.|(615) 936-0280|blythe.corbett@vumc.org|
20569279|NCT01084239|Massachusetts Genderal Hospital Biostatistics Center|Pearl Zakroysky|617 724 0309|pzakroysky@partners.org|
20569280|NCT00721214|Massey Cancer Center|John M. McCarty, MD|804-828-4360|jmccarty@vcu.edu|
20569281|NCT00983905|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
20569282|NCT05006417|UW School of Medicine and Public Health|Michael Suer, MD|(608) 265-3207|suer@rehab.wisc.edu|
20569283|NCT01169636|UT MD Anderson Cancer Center|Dr. Christopher Flowers, MD/ Chair, Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
20537508|NCT02644096|University of Copenhagen|Chief researcher Britta Hørdam|+ 45 22214383|britta@hordam.dk|
20537509|NCT02461290|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20537510|NCT01457014|Sleep and Alertness Research Inc.|Sharon A. Chung|416-603-5275|sachung@uhnres.utoronto.ca|
20537511|NCT00322452|AstraZeneca|Gerard Lynch||AZTrial_results_posting@AstraZeneca.com|
20537512|NCT00526656|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Jorge Garcia, MD|216-444-7774|garciaj4@ccf.org|
20537513|NCT00790868|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
20537514|NCT02013206|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20537515|NCT01952665|CooperVision|Donald Siegel, OD Principal Investigator|(949) 597-4700|dsiegel@coopervision.com|
20537516|NCT01537081|Reckitt Benckiser LLC|Gail Solomon,MS; Director Clinical Development|973-404-2752|gail.solomon@rb.com|
20537517|NCT00678535|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
20537518|NCT01022359|Imperial College London|Neill Duncan|+44 (0 )207 594 7243|n.duncan@imperial.ac.uk|
20537519|NCT03086707|Philip Morris Products S.A.|Julia Hoeng, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
20537520|NCT00664560|POZEN Inc|Sr VP Clinical Research|919-913-1030|eorlemans@pozen.com|
20537521|NCT02379221|Travis AFB OMFS Clinic|Dr. Jason May|707-423-7085|jason.may.11@us.af.mil|
20537522|NCT02019108|University of British Columbia|Dr. Michael Hunt|604-827-4721|michael.hunt@ubc.ca|
20537523|NCT05260073|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20537524|NCT04484649|Columbia University Irving Medical Center|Samantha Garbers-Adams, PhD|212-305-0123|svg2108@cumc.columbia.edu|
20537525|NCT04924530|University of Bath|Professor Javier Gonzalez|01225 38|j.t.gonzalez@bath.ac.uk|5518
20537526|NCT03130439|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
20537527|NCT01463696|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537528|NCT04726137|Fondazione Penta ETS|Giorgia Dalla Valle|393783022748|giorgia.dallavalle@pentafoundation.org|
20537529|NCT02731820|Istituto Ortopedico Rizzoli|Director of Clinical Trials|+39 051.6366392|ctc@ior.it|
20537530|NCT04478071|The University of Texas Health Science Center at Houston|Bentley J. Bobrow, MD|713-500-7863|Bentley.J.Bobrow@uth.tmc.edu|
20537531|NCT00967694|University of Utah Department of Anesthesiology|Dr. Eric Fox|775-340-0219|ericbfox@yahoo.com|
20537532|NCT05742646|Medical University of South Carolina|Dr. Michelle Nichols|8437928515|nicholmg@musc.edu|
20537533|NCT00729677|Beth Israel Cancer Center|Victoria Rosenwald, RN MPH|212 844-8285|vrosenwa@chpnet.org|
20537534|NCT03905265|Medicines Development for Global Health Limited|Clinical Project Manager|+61 399122400|MDGH-MOX-2001@medicinesdevelopment.com|
20537535|NCT00960011|The University of Hong Kong|Dr. Joe Fan King Man|852-22553111|drfanj@gmail.com|
20537536|NCT04417218|Vanderbilt University Medical Center|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vumc.org|
20537537|NCT01074463|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20537538|NCT00758264|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537539|NCT01345513|Ontario Institute for Cancer Research|Janet E. Dancey|1-613-533-6430|janet.dancey@oicr.on.ca|
20537540|NCT02899650|University of Texas at Austin|Koichiro Hayashi|512-471-8594|k-hayashi@kokugakuin.ac.jp|
20537541|NCT02808052|Melinta Therapeutics|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
20537542|NCT03549572|Spaulding Rehabilitation Hospital|Yelena Bodien|(617) 643-3956|ybodien@mgh.harvard.edu|
20537543|NCT05623475|College of Nursing, Taipei Medical University, Taiwan|Kee-Hsin Chen, R.N., Ph.D.|+886-2-27361661|keehsin@tmu.edu.tw|3613
20537544|NCT01054560|Covidien|Director of Clinical Affairs|9498373700||
20537545|NCT00803400|Psychiatry Academic Unit at J.A.Fernandez Hospital, University of Buenos Aires Medicine School Department of Mental Health|Dr. Marcelo Rudelir|54 11 48254740|mrudelir@hotmail.com|
20537546|NCT00939029|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
20537547|NCT01535599|Alcon Research, Ltd.|Sally Scheib, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20537548|NCT03397394|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20537549|NCT00668382|UMass Medical Scool|Dr. Sheila Noone|508 856 5015|Sheil.Noone@umasmed.edu|
20537550|NCT03305419|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20537551|NCT02210689|Teva Pharmaceuticals USA. Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20537552|NCT00075946|ECOG Statistical Office|Study Statistician|617-632-3012||
20537553|NCT02231892|National Institute on Drug Abuse|Dr. Elliott Stein|443-740-2650|estein@mail.nih.gov|
20537554|NCT03832322|Evergreen General Hospital, Taiwan|Dr. Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
20537555|NCT00799227|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20537556|NCT01191736|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
20537557|NCT02186652|Duke Clinical Research Institute|Chad Livingston|919-668-1935|chad.livingston@duke.edu|
20537558|NCT01179217|Emmaus Medical, Inc|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
20537559|NCT05427539|Johnson & Johnson Vision Care, Inc. (JJVC)|Ben Straker|1-800-843-2020|bstraker@its.jnj.com|
20537560|NCT00410826|University of Washington|Renato G. Martins, MD, MPH|2062882048|rgmart@uw.edu|
20553782|NCT01193556|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20524580|NCT04998136|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20524581|NCT03521154|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20524582|NCT05386680|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524583|NCT05271370|CytoDyn|Vice President, Clinical Operations|3609808524|jmeidling@cytodyn.com|
20524584|NCT03773172|Columbia University Irving Medical Center|Henry Ginsberg, MD|212-305-9562|hng1@cumc.columbia.edu|
20524585|NCT04168112|SightMD|Dr. Alanna Nattis|631-957-2816|anattis@sightmd.com|
20524586|NCT01598064|National Cheng Kung University Hospital|Dr. Po Lin Chen|886-2353535|n939492@mail.hosp.ncku.edu.tw|4733
20524587|NCT02527746|Evivebiotech|Catrina Wang / Senior Medical Director|021-61760866|catrina.wang@evivebiotech.com|
20524588|NCT02283268|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20524589|NCT00333983|VA Maryland Health Care System, Baltimore|Dr. Susan S. Conroy|(410) 605-7000|susan.conroy@va.gov|3213
20524590|NCT04229095|The Scripps Research Institute|Dr. Barbara J. Mason, Ph.D. Professor|(858 784-7324|mason@scripps.edu|
20524591|NCT01780038|University of Nebraska Medical Center|Julia F Houfek|402-660-4046|jhoufek@unmc.edu|
20524592|NCT03270657|Duke University|Dr. Dennis Turner|919-684-7777|dennis.turner@duke.edu|
20524593|NCT00455403|Wash. Univ. School of Medicine|Janet McGill, MD|314-362-8681|jmcgill@wustl.edu|
20524594|NCT04509076|San Diego State University|D. Keith Horvath, Professor of Psychology|619-594-3346|khorvath@sdsu.edu|
20524595|NCT00459862|Mayo Clinic|Julian Molina, M.D, Ph.D.||Molina.julian@mayo.edu|
20524596|NCT02535026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20524597|NCT01343043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20524598|NCT00925704|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20524599|NCT00216125|Hoosier Cancer Research Network|Georgia Gould|3176385842|ggould@hoosiercancer.org|10
20524600|NCT05340764|Washington University School of Medicine GI Division|Dr. Chien-Huan Chen|3143623201|chen330@wustl.edu|
20524601|NCT00502242|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524602|NCT03252535|Cellavita|Cristiane Valverde Wenceslau|+55 (19) 3829.0849|cristiane.valverde@cellavitabrasil.com.br|
20524603|NCT04381728|WOMED|Pauline Chirouze|0785225561|pauline@womedtech.com|+33
20524604|NCT04548193|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-2300|Chong.Wang@roswellpark.org|
20524605|NCT01011816|formerly Spinal Restoration, Inc|Jeff Doerzbacher||jdoerzbacher@renascentmed.com|
20524606|NCT01216241|University of Rochester|Dr. Robert F. Betts|585-275-5871|robert_betts@urmc.rochester.edu|
20524607|NCT04557215|Cedars-Sinai Medical Center|Mohamad Rashid|310.423.7302|mastprogram@cshs.org|
20524608|NCT01155180|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
20524609|NCT01681212|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20524610|NCT00343044|Benaroya Research Institute at Virginia Mason|Thomas Malpass, M.D., Principal Investigator|206-223-6193|thomas.malpass@vmmc.org|
20524611|NCT01532518|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it|
20524612|NCT01575834|Amgen Inc.|Study Director|866-572-6436||
20524613|NCT00470717|UHClevelandMC|Dr. Lydia Furman|216-844-8260|Lydia.Furman@uhhospitals.org|
20524614|NCT01548040|Theragen Inc.|Richard Pearce|901 634 0544|richard.pearce@theragen.com|
20524615|NCT02282813|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
20524616|NCT01342770|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-2511|wigle.dennis@mayo.edu|
20524617|NCT02220764|Zahnärztliche Prothetik|Dr. Konstantinidis Ioannis|+49 351 458 4231|ioannis.konstantinidis@uniklinikum-dresden.de|
20524618|NCT05000164|Johnson & Johnson Vision Care (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
20524619|NCT02861807|University of New Mexico|Katie Witkiewitz|505-277-4121|katiew@unm.edu|
20524620|NCT03493854|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20524621|NCT02422446|Brigham and Women's Hospital|Dr. Luc Djousse|617-525-7591|Ldjousse@rics.bwh.harvard.edu|
20524622|NCT00410813|SWOG Statistical Center|SWOG Breast Committee Statistician|206-667-4623||
20524623|NCT00529308|Yale University|Dr. Angeli Landeros-Weisenberger||angeli.landeros-weisenberger@yale.edu|
20524624|NCT04278417|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524625|NCT06509438|EspadPharmed|Hamidreza Kafi|+989129232594|Kafi.h@orchidpharmed.com|
20524626|NCT03331796|Veterans Affairs Palo Alto Health Care System|Joy L Taylor, PhD|650-776-3385|joyt@stanford.edu|
20524627|NCT00660517|Meda Pharmaceuticals|David Ginsberg, D.O.|7325642364|david.ginsberg@meda.us|
20524628|NCT01391858|UTexas Southwestern Medical Center|Babatunde Ogunnaike|(214) 590|Babatunde.Ogunnaike@UTSouthwestern.edu|8536
20524629|NCT03146806|Emory University|Vinita Singh, MD|404-686-2410|vinita.singh@emory.edu|
20524630|NCT03337087|Accru|Dr. Tanios Bekaii-Saab|507/266-0800|Bekaii-Saab.Tanios@mayo.edu|
20524631|NCT04526288|Fred Hutchinson Cancer Center|Dr. Filippo Milano, Director of FHCC Cord Blood Transplant Program|206.667.5925|fmilano@fredhutch.org|
20524632|NCT04830969|University at Buffalo|Lu Li|7168296284|lli59@buffalo.edu|
20524633|NCT01580670|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20524634|NCT00996125|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524635|NCT02147834|North Florida South Georigai Veteran Health System|Anthony A Bavry, M.D.|352-548-6000|anthony.bavry@va.gov|104726
20524636|NCT02169271|UT MD Anderson Cancer Center|Dr. Therese Bevers / Clinical Cancer Prevention Department|713-745-8048|tbevers@mdanderson.org|
20524637|NCT04926831|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524638|NCT04025879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20524639|NCT03482635|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537561|NCT02247011|Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital,Chinese Academy of Medical Science|Dr. Weibo Xia|86-10-6915-5076|xiaweibo@medmail.com.cn|
20537562|NCT04674111|Boston Scientific Corporation|Amy Maurer, Director of Clinical Trials|800-876-9960|amy.maurer@bsci.com|
20537563|NCT00642434|University of New Mexico Health Sciences Center|Dr. Kathleen Colleran|505-272-4658|KColleran@salud.unm.edu|
20537564|NCT02609841|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20537565|NCT04470908|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20537566|NCT04621240|Center for BrainHealth at the University of Texas at Dallas|Erin Venza|972-883-3208|erin.venza@utdallas.edu|
20537567|NCT01202188|Novartis Pharmaceuticals|Study Director|862-778-8300||
20537568|NCT00772915|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20537569|NCT00487942|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
20537570|NCT00211757|Montefiore Medical Center|Dr. Eric Hollander|718-920-4287|eholland@montefiore.org|
20537571|NCT03111550|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman,OD, FAAO|+1 714-247-8628|djanaki1@its.jnj.com|
20537572|NCT04091581|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20537573|NCT03319953|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20537574|NCT02889289|Washington DC VA Medical Center|Dr. Shane Chanpimol|202-745-8000|shane.chanpimol@va.gov|55854
20537575|NCT01795495|Nationwide Children's Hospital|David Martin, MD|6147224200|David.Martin@nationwidechildrens.org|
20537576|NCT03315793|Shionogi|Shionogi Clinical Trial Administrator|+81-6-6209-7885|shionogiclinicaltrials-admin@shionogi.co.jp|
20537577|NCT04027049|Johns Hopkins University|Department of Neurology|410-955-2228|ezink1@jhmi.edu|
20537578|NCT00569309|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|Craig.Hofmeister@osumc.edu|
20537579|NCT01740089|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
20537580|NCT03703310|Sol-Gel Technologies, Ltd.|VP Clinical & Regulatory Affairs|+972-73-3729453|Ofra.Levy-Hacham@sol-gel.com|
20537581|NCT01579565|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
20537582|NCT02867813|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20537583|NCT03040011|Magee-Womens Hospital of UPMC|Dr. Lauren Giugale, PI|412-641-1498|giugalele@upmc.edu|
20537584|NCT01448824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537585|NCT01760473|New York State Psychiatric Institute|Dr. Sandra Comer|646 774-6146|sdc10@columbia.edu|
20537586|NCT01463111|Emory University|Dr. Boadie Dunlop|404-727-8969|bdunlop@emory.edu|
20537587|NCT03817463|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537588|NCT02964559|Emory University|Dr. Michael Lowe|404-778-7215|mlowe3@emory.edu|
20537589|NCT04140695|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
20537590|NCT01215643|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20537591|NCT01559259|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537592|NCT01995669|University of Texas M D Anderson Cancer Center|Dr. Loretta Nastoupil|(713) 792-2860|lnastoupil@mdanderson.org|
20537593|NCT05425732|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20537594|NCT02150551|Children's National Hospital|Catherine Bollard, MD|202-476-4776|cbollard@childrensnational.org|
20537595|NCT00218634|Mass General Hospital|Steven Safren|617 724 0817|ssafren@partners.org|
20537596|NCT00734604|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537597|NCT01461928|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20537598|NCT00731653|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
20524640|NCT04577807|Istari Oncology|Head of Operations|919-245-7662|info@istarioncology.com|
20524641|NCT02174510|Shanghai Xuhui Central Hospital, Drug Clinical Trial Institution|Prof.Hu Chaoying|13816319160|cyhu@shxh-centerlab.com|
20524642|NCT00979654|MedImmune, LLC|Jerry Green|1-888-483-7729|rtpsafety@ppdi.com|
20524643|NCT00722137|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20524644|NCT01938092|University of Missouri-Columibia, Dept. Ob/Gyn|Erma Z. Drobnis, Associate Director, Research Success Center|573-817-3124|drobnise@health.missouri.edu|
20524645|NCT01367886|Washington University School of Medicine|H. Henry Lai, MD|314-362-8295|laih@wudosis.wustl.edu|
20524646|NCT00985504|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20524647|NCT00574704|Cytos Biotechnology AG|Head of Clinical Develpment|+41 44 733 4|info@cytos.com|7 47
20524648|NCT03711786|University of North Carolina at Chapel Hill|Brian Pence, PhD|919-966-7430|bpence@unc.edu|
20524649|NCT01465412|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524650|NCT02689154|Children's Hospital of Los Angeles|Dr. Alaina Vidmar|323-361-3385|avidmar@chla.usc.edu|
20537599|NCT02526524|Elcelyx Therapeutics, Inc|Chief Scientific Officer|858-876-1814|info@elcelyx.com|
20537600|NCT03711929|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20537601|NCT00591149|University of Kansas Medical Center|Chao Huang, MD|913-588-6029|chuang2@kumc.edu|
20537602|NCT00539513|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
20537603|NCT03002818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20537604|NCT01328041|ViiV Healthcare|GSK Response Center|866-435-7343||
20537605|NCT00966849|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
20537606|NCT00711113|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
20537607|NCT02456636|University of Kansas Medical Center|Christie Befort, PhD|913 588-3338|cbefort@kumc.edu|
20537608|NCT00780481|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
20537609|NCT00100230|Retina Foundation of the Southwest|Dennis Hoffman, Ph.D., Sr. Research Scientist|214-363-3911|dhoffman@retinafoundation.org|125
20537610|NCT01606787|Memorial Sloan Kettering Cancer Center|Dr. Jonathan Coleman, MD|646-422-4432|colemanj@mskcc.org|
20537611|NCT02913430|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCR|412-647-5554|stadtermanbm@upmc.edu|
20537612|NCT05312632|Eisai Korea Inc. Medical department|Serena SoYoun Kwon|+82-10-7409-5623|s-kwon@eisaikorea.com|
20537613|NCT03015649|Envision Healthcare Scientific Intelligence, Inc.|Women's Imaging Director|9549397729|clinicaltrials@shcr.com|
20537614|NCT02200328|Cleveland Clinic Florida|Dr.Alison Schneider|9546595646|schneia2@ccf.org|
20537615|NCT00519376|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537616|NCT00484393|Fraser Health|Brandi Newby|604-585-5666|brandi.newby@fraserhealth.ca|774374
20537617|NCT01084278|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20537618|NCT01245738|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537619|NCT02688088|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20537620|NCT02642393|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-724-9611|michaels@helix.mgh.harvard.edu|
20537621|NCT00366028|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
20537622|NCT01231321|Abbott|Global Medical Services|800-633-9110||
20537623|NCT00489736|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
20537624|NCT04021524|University of Washington|Dr. Jason E. Hsu|(206) 543-3690|jehsu@uw.edu|
20537625|NCT05275010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20537626|NCT02975999|LUrie Children's Hospital|Dr. Jamie Penk, co-investigator|7735773782|jpenk@luriechildrens.org|
20537627|NCT03883165|University of Michigan Medical School|James T Eckner, MD, MS|734-647-5568|jeckner@med.umich.edu|
20537628|NCT06053541|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537629|NCT03544476|University of Washington|Sarah Iribarren|2065435211|sjiribar@uw.edu|
20537630|NCT00730041|Medtronic Xomed, Inc.|David Hodge|904-281-2774|david.l.hodge@medtronic.com|
20537631|NCT01636063|Baystate Medical Center|David R Kattan|413-794-5256|davidrkattan@gmail.com|
20537632|NCT01801436|Janssen Pharmaceutical Taiwan|Medical Affairs Director|+886-2-23762155||
20537633|NCT01294306|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20537634|NCT02447250|OHSU|Cindy McEvoy, MD|5034940223|mcevoyc@ohsu.edu|
20537635|NCT03632993|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
20537636|NCT02141867|South African Surgical Outcomes Study|Prof Bruce Biccard|+27312604328|biccardb@ukzn.ac.za|
20537637|NCT01082874|Population Health Research Institute|P.J. Devereaux, MD, PhD, FRCPC|905-527-4322|philipj@mcmaster.ca|40654
20537638|NCT03848208|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20537639|NCT05549232|Hemanext Inc.|Sr. Director, Clinical Affairs|781-301-7474|jill.bagdasarian@hemanext.com|
20537640|NCT02059499|AMC Statistical Center|Dr Himanshu Joshi, MBBS, MPH, PhD (Assistant Professor)|212-259-9635|himanshu.joshi@mountsinai.org|
20553783|NCT01924169|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
20507557|NCT02242994|Children's National|Dr. Axel Krieger|2024761284|akrieger@childrensnational.org|
20553784|NCT01482767|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20553785|NCT00556842|The Centre for Evidence-Based Orthopaedics|Paula McKay|905-521-2100|mckayp@mcmaster.ca|44131
20553786|NCT01032135|University of Pennsylvania|James McKay, PhD|215-746-7704|jimrache@mail.med.upenn.edu|
20553787|NCT01346267|Wake Forest University School of Medicine|Thomas W. McLean, MD|336-716-4085|tmclean@wfubmc.edu|
20553788|NCT01922024|Curetis USA, Inc.|Clinical Operations|800-659-1221|neil.mucci@curetis.com|
20553789|NCT02457325|University of Sao Paulo / Bauru School of Dentistry|Carlos Ferreira Santos|+551432358200|cfsantos@fob.usp.br|
20553790|NCT01541930|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
20553791|NCT01957475|Coloplast|Daniel Carter|+45 49112523|dkdac@coloplast.com|
20553792|NCT03591575|Chiesi Canada Corp.|Caroline Fradette, PhD|1-(800) 854-3534|c.fradette@chiesi.com|7014
20553793|NCT02915744|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20553794|NCT00813358|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
20553795|NCT04497987|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20553796|NCT03665038|Sage Therapeutics|Medical Monitor|(617) 299-8380|medinfo@sagerx.com|
20553797|NCT01660412|UAMS|James A Ntambi|5015265062|jantambi@uams.edu|
20553798|NCT03551210|R-Pharm|Aleksandr Chernavin, Regional Medical Director|0074959567937|chernavin@rpharm.ru|
20553799|NCT05559320|University of Connecticut Department of Kinesiology|Dr. Sudha Srinivasan|(860)-486-6192|sudha.srinivasan@uconn.edu|
20537641|NCT04210245|NGM Biopharmaceuticals|VP, Clinical Operations|(650) 243-5555|ngm282@ngmbio.com|
20569284|NCT02396953|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
20537642|NCT01802580|Wake Forest University Health Sciences|Dr. Steve Feldman, Professor of Dermatology, Public Health Scienes, and Pathology|336-716-7740|sfeldman@wakehealth.edu|
20569285|NCT02624869|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20537643|NCT03255967|NYU Langone Health|Abraham Brody|2129927341|Abraham.Brody@nyulangone.org|
20537644|NCT02664311|Beth Israel Deaconess Medical Center|Eleanor Greene|617-667-1836|ergreene@bidmc.harvard.edu|
20569286|NCT00510198|Medtronic CRDM Clinical Research and Reimbursement|Clinical Trial leader|7635262788|ming.duanmu@medtronic.com|
20537645|NCT00722722|Mayo Clinic|Mark Stegall, MD|507-266-2812|Stegall.Mark@mayo.edu|
20569287|NCT02994784|Boston Medical Center and BU School of Medicine|John M Sloan, MD|617-638-7519|mark.sloan@bmc.org|
20569288|NCT01917006|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20569289|NCT02158247|The Catholic University of Korea|Dr. Oh Saecheol|+88-42-220-9046|oscane0822@gmail.com|
20537646|NCT00778258|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20537647|NCT02406573|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20537648|NCT01098253|University of Pennsylvania, Perelman School of Medicine|Dr. Hillary R Bogner|215-746-4181|hillary.bogner@uphs.upenn.edu|
20537649|NCT02438384|Department of Emergency Medicine, UNC School of Medicine|Tim Platts-Mills, MD|559-240-6073|tim_platts-mills@med.unc.edu|
20569290|NCT01649557|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20537650|NCT02650128|Shockwave Medical, Inc.|Beaux Alexander, Vice President Clinical Affairs|510-279-4262|balexander@shockwavemedical.com|145
20537651|NCT05526781|Eye Consultants of Atlanta|Dr Joseph Christenbury|14043512220|jchristenbury@eyeconsultants.net|
20537652|NCT04085458|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20537653|NCT02743949|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20537654|NCT01921218|Emory University|Idelberto R. Badell, MD|404-712-6562|ibadell@emory.edu|
20537655|NCT03389555|Beth Israel Deaconness Medical Center Emergency Department|Michae Donnino|(617) 754-2882|mdonnino@bidmc.harvard.edu|
20537656|NCT01885208|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20537657|NCT00920218|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537658|NCT00873041|Novartis Pharmaceuticals|Study Director|862-778-8300||
20537659|NCT00313313|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20537660|NCT00201448|Virginia Commonwealth University|Stuart Adler|8048281807|sadler@vcu.edu|
20537661|NCT00368836|Carolinas Medical Center|Dr. Jeffrey Kline|704-355-3181|jkline@carolinas.org|
20537662|NCT02084706|Brigham and Women's Hospital|Dr. Philip Blazar|617-732-5384|pblazar@partners.org|
20569291|NCT02149524|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
20569292|NCT03029234|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20537663|NCT02613117|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20537664|NCT01345591|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
20537665|NCT00090142|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537666|NCT02442310|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
20537667|NCT01126437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537668|NCT01418703|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
20537669|NCT01220973|Rutgers Cancer Institute of New Jersey|Susan Goodin PharmD, FCCP, BCOP|732-235-6783|goodin@cinj.rutgers.edu|
20537670|NCT00006046|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20537671|NCT00596154|Memorial Sloan Kettering Cancer Center|Dr. Christian Grommes, MD|212-610-0344|grommesc@mskcc.org|
20537672|NCT01846663|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
20537673|NCT03691844|Amzell B.V.|Clinical Trial Manager|+41614864000|amzell-disclosure@amzell.com|
20537674|NCT00986401|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20537675|NCT01215110|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
20537676|NCT00585546|University of Michigan|Francis Pagani|734 647-2894|fpagani@med.umich.edu|
20537677|NCT02851797|Italfarmaco SpA|Dr Paolo Bettica, MD and PhD|+3902 66041503|p.bettica@italfarmacogroup.com|
20537678|NCT03077438|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20537679|NCT00813865|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
20537680|NCT02512874|Mayo Clinic|Dr. Cassie C. Kennedy|507-266-3958|kennedy.cassie@mayo.edu|
20537681|NCT03570918|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@Macrogenics.com|
20537682|NCT02970006|The Ohio State University- Neurological Institute|Vibhor Krishna, MD|6142939274|Vibhor.Krishna@osumc.edu|
20537683|NCT03888235|University of British Columbia Department of Family Practice|Dr. Helene Bertrand|7782277776|dr.hbertrand@gmail.com|
20537684|NCT00676520|Abbott Vascular|Ellen Travis|408-845-3000|Ellen.Travis@av.abbott.com|
20537685|NCT01425359|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20537686|NCT03520348|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20537687|NCT00932438|University of Louisville|Robert Martin, Md, PhD|602-629-3355|robert.martin@louisville.edu|
20537688|NCT02928029|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20569293|NCT04491006|Athira Pharma|Hans Moebius, CMO|1-866-725-0930|clinicaltrials@athira.com|
20537689|NCT01849575|Umea University, Sweden|Dr Margareta Norberg|+46907865544|margareta.norberg@umu.se|
20569294|NCT03192202|Columbia University Irving Medical Center (CUIMC)|Ahmed Sawas, MD|212-305-0591|as4386@cumc.columbia.edu|
20537690|NCT00223977|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com|
20537691|NCT01907321|University of Florida|Dr. Karen Hegland, PI|352 294-8366|kwheeler@ufl.edu|
20537692|NCT01083979|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
20537693|NCT03650803|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Holly Marshall|216-844-5330|Holly.Marshall@uhhospitals.org|
20537694|NCT02359045|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20537695|NCT03655301|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20537696|NCT01382303|Ajou University|Kwan Woo Lee|82-31-219-4526|LKW65@ajou.ac.kr|
20537697|NCT00405509|Allegheny General Hospital|Deborah Gentile, MD|412-359-6654|dgentile@wpahs.org|
20537698|NCT00835198|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20537699|NCT01639339|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20537700|NCT02649218|Novartis Pharmaceuticals|Study Lead|+1 (862) 778-8300|novartis.email@novartis.com|
20537701|NCT00367744|Case Western Reserve University|Dr. Grace McComsey|216 844 3607|mccomsey.grace@clevelandactu.org|
20569295|NCT02541942|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20569296|NCT03036150|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|Information.center@astrazeneca.com|
20569297|NCT01990664|Johnson & Johnson Vision Care, Inc.|Jurandir Araujo, Clinical Compliance Manager|9044431379|jaraujo7@its.jnj.com|
20569298|NCT01219777|The Ohio State University Comprehensive Cancer Center|Ritu Salani, MD, MBA|614-293-3873|Ritu.Salani@osumc.edu|
20569299|NCT00711997|BioCancell Ltd.|Monique Ben-Am, M.Sc.|+972-2-5486533|monique.ben-am@biocancell.com|
20569300|NCT04731675|AmMax Bio, Inc.|Dorothy Nguyen, MD|(650)285-6560|clinical@ammaxbio.com|
20569301|NCT02856490|Joylux|Colette Courtion|206.219.6444|sophia@joylux.com|
20569302|NCT01182103|Kaohsiung Chang Gung Memorial Hospital|Tiao-Lai Huang|886-7-7317123|a540520@adm.cgmh.org.tw|8753
20569303|NCT03891641|University of North Carolina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
20569304|NCT03628456|International Biophysics Corporation|VP of Engineering and Quality|512-804-0046|quality@biophysicscorp.com|
20569305|NCT04016805|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20569306|NCT02831998|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
20569307|NCT00819013|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20569308|NCT00607997|Sunesis Pharmaceuticals, Inc.|Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
20569309|NCT00839332|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20569310|NCT01376297|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
20569311|NCT02569632|Children's Hospital Oakland Research Institute (CHORI)|Dan Granoff, MD (Principal Investigator)|510-428-3000|dgranoff@chori.org|7640
20569312|NCT00549042|Covidien|Alfredo Bozzini, MD|314-654-2000|Alfredo.Bozzini@covidien.com|
20569313|NCT04414397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20569314|NCT00702273|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569315|NCT03030599|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20569316|NCT03640754|MenoGeniX|Debra Duke|303-995-7979|debra.duke@menogenix.com|
20569317|NCT01478256|George John MD|George John|5028949757|grjohn777@yahoo.com|
20569318|NCT01679613|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569319|NCT01374971|Nathan Wei, MD, PA dba Arthritis Treatment Center|Nathan Wei, MD|301-694-5800|nwei@arthritistreatmentcenter.com|
20569320|NCT00509925|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20569321|NCT00068718|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20569322|NCT00230971|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20569323|NCT00835510|Taro Pharmaceuticals|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
20569324|NCT00467298|VA Puget Sound Health Care System-Seattle|Cynthia M. Dougherty|206 764 2205|cynthia.dougherty@va.gov|
20569325|NCT01268098|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20569326|NCT01644188|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20569327|NCT01929876|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20569328|NCT01947517|Queen's University|Dr. Stephanie Baxter|613 544 3310|baxters@baxtereyemd.com|
20569329|NCT05446714|al-azhar university|dr. mohamed shendy|01223303833|Shendy_ortho@azhar.edu.eg|
20569330|NCT01522703|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
20569331|NCT04867707|University of Missouri|Dr. Luis Martinez|(573) 882-3244.|martinezlemusl@umsystem.edu|
20569332|NCT02179853|UCSD|Dr. Adriana Tremoulet|858-246-0012|atremoulet@health.ucsd.edu|
20569333|NCT04151706|Stanford University|Dr. Robert Lowsky|(650) 723-0822|rlowsky@stanford.edu|
20569334|NCT02544113|Cleveland Clinic|Dr. Bijan Eghtesad|216 444-9898|eghtesb@ccf.org|
20569335|NCT00583050|Massachusetts General Hospital|Matthew Eagleton, M. D.|617-726-8279|MEAGLETON@mgh.harvard.edu|
20569336|NCT02847637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20569337|NCT01746108|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569338|NCT01004185|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20569339|NCT03214250|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
20537702|NCT00793572|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fhcrc.org|
20537703|NCT00895752|Cincinnati Childrens Hospital|Craig Erickson MD|5136366265|craig.erickson@cchmc.org|
20569340|NCT00797511|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20569341|NCT01318538|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
20553800|NCT02851108|Heidelberg University|Prof. Dr. Olaf Müller|+49 6221 56 4904|olaf.mueller@urz.uni-heidelberg.de|
20553801|NCT00368940|Weill Cornell Medicine|Dimitris N. Kiosses, Ph.D.|914-997-4381|dkiosses@med.cornell.edu|
20553802|NCT01709318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553803|NCT03370341|The University of Texas at Dallas|Dr. Amy Pinkham|(972) 883-4462|amy.pinkham@utdallas.edu|
20553804|NCT01707004|UW Carbone Cancer Center|Aric Hall|608-262-1604|achall@medicine.wisc.edu|
20553805|NCT00646958|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
20553806|NCT03085927|Indiana University School of Nursing|Dr. Sheri Robb, MT-BC|317-274-3152|shrobb@iu.edu|
20553807|NCT00941733|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
20553808|NCT00194012|Johns Hopkins University School of Medicine|Robert Findling, MD, MBA, Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
20553809|NCT05036642|Stanford University|Allison Okamura|(650) 723-3148|aokamura@stanford.edu|
20553810|NCT01965067|Department of Anesthesiology and Pain Medicine, Hanyang University Hospital|Kyo Sang Kim, MD, PhD|+82-2-2290-8680|kimks@hanyang.ac.kr|
20553811|NCT01379963|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20553812|NCT04260191|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20553813|NCT01643473|NYU School of Medicine|Antoinette Schoenthaler|212-263-4205|antoinette.schoenthaler@nyumc.org|
20553814|NCT02284828|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20553815|NCT01519518|Liverpool Heart and Chest Hospital|Dr Rod Stables|01512281616|rod.stables@lhch.nhs.uk|1489
20553816|NCT02033889|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553817|NCT03019536|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20553818|NCT01312909|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553819|NCT03738904|Cedars-Sinai Medical Center|Dr. Karen Zaghiyan|310-289-9224|karen.zaghiyan@cshs.org|
20553820|NCT02200042|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20553821|NCT02880371|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553822|NCT03394391|Babcock University|Dr. Olumide ABIODUN|07038569725|olumiabiodun@gmail.com|7038569725
20553823|NCT04622254|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20553824|NCT01560624|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
20553825|NCT00451282|Children's Hospital of Philadelphia|Nancy Kassam-Adams|215-590-3118|nlkaphd@mail.med.upenn.edu|
20553826|NCT00098839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20553827|NCT00323739|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20553828|NCT03228680|Ferring Pharmaceuticals|Clinical Development Support|-|DK0-Disclosure@ferring.com|
20553829|NCT02167035|Cornerstone Healthcare|Michael Tepedino, MD|336-802-2255|mtepedino@wakehealth.edu|
20553830|NCT02148003|Cleveland Clinic|Nagy Mekhail, MD|216 444-9114|mekhain@ccf.org|
20553831|NCT02489981|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20553832|NCT05022810|HALEON|Marc Renard|+44 7880 182593|marc.m.renard@haleon.com|
20553833|NCT03348904|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20553834|NCT00436280|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20553835|NCT04904510|UCLA|Dr. Noah Kojima|(310) 319-4377|nkojima@ucla.edu|
20553836|NCT00087568|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20553837|NCT01034397|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20553838|NCT02002767|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20553839|NCT02476565|Vanderbilt University Medical Center|Antonio Hernandez, MD|615 322-4650|antonio.hernandez@vanderbilt.edu|
20553840|NCT00086580|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20553841|NCT03296163|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
20553842|NCT01632800|Weinberg Medical Physics LLC|Irving Weinberg MD PhD|3013467944|inweinberg@gmail.com|
20553843|NCT01000051|MD Anderson Cancer Center|Dr. Popat, Uday / Professor, Stem Cell Transplantation|713-745-3055|upopat@mdanderson.org|
20553844|NCT00673452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20553845|NCT01271543|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
20553846|NCT03495908|The University of Texas Southwestern Medical Center|Dr Pablo F Mora|469-585-0000|pf_mora@yahoo.com|
20553847|NCT03049813|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
20553848|NCT00427804|Emory University|Vin Tangpricha, M.D., Ph.D.|404-727-7254|vin.tangpricha@emory.edu|
20553849|NCT02164396|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S.- Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|190
20553850|NCT01072682|SeaStar Medical, Inc|Eric Schlorff|8444278100|eric@seastarmed.com|
20553851|NCT03025828|Icahn School of Medicine at Mount Sinai|Dr. Kirk Campbell|212-241-6271|kirk.campbell@mssm.edu|
20553852|NCT00094653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20524651|NCT00734994|Duke University, Division of Urology|Brant A. Inman, MD, MS|919 684-1322|brant.inman@duke.edu|
20524652|NCT01622673|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553853|NCT02143843|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20553854|NCT00480779|University of Pittsburgh|M. Kaye Kramer|4123831286|mkk3@pitt.edu|
20524653|NCT05009602|Imperial College London|Laura Burgess|0203 311 5208|l.burgess@imperial.ac.uk|
20553855|NCT03029689|Fundació Lluita Contra les Infeccions|Dr. Roger Paredes|(+34) 93 465 7897|rparedes@lluita.org|8209
20537704|NCT03858335|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
20537705|NCT02063867|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
20537706|NCT01335724|Novartis Consumer Health|Clinical project Leader|+41223635528||
20537707|NCT04376684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20537708|NCT01666119|BDSI|Enoch Bortey|919 582 9050|ebortey@bdsi.com|
20537709|NCT03354546|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20537710|NCT02713997|University of Minnesota|Melena Bellin|612-625-4686|bell0130@umn.edu|
20537711|NCT05487040|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537712|NCT02244840|Seoul National University Hospital|Professor|82-2-2072-2901|kjparkmd@plaza.snu.ac.kr|
20537713|NCT04570605|University of Utah School of Medicine|Glen Lau, MD|801-213-2700|Glen.Lau@hsc.utah.edu|
20537714|NCT03269968|MedStar Health Reseach Institute|Rachael Overcash|202-877-6093|rachael.overcash@medstar.net|
20537715|NCT02950155|Karolinska Institutet|Prof. Fredrik Piehl|+46 736718101|fredrik.piehl@ki.se|
20537716|NCT03569748|University of Catania|Maria Signorelli|095.378.2636/794|maria.signorelli@unict.it|
20537717|NCT02979093|University of Iowa|Lane Strathearn|3193849464|lane-strathearn@uiowa.edu|
20537718|NCT06107803|Minerva Neurosciences|Joseph Reilly|617-600-7373|JReilly@minervaneurosciences.com|
20537719|NCT05596734|BioNTech SE|BioNTech clinical trials patient information|+49 6131 90840|patients@biontech.de|
20537720|NCT01974206|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20537721|NCT00053677|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
20569342|NCT00053352|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20524654|NCT07091916|Medtronic Japan Co., Ltd.|Takuto Yamamoto|+818046716498|takuto.yamamoto@medtronic.com|
20524655|NCT04010240|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Antoine Italiano|0556333333|a.italiano@bordeaux.unicancer.fr|
20524656|NCT01682226|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker, MBBS|646-608-3756|barkerj@mskcc.org|
20524657|NCT03263936|Therapeutic Advanced in Childhood Leukemia and Lymphoma|Ellynore Florendo|323-361-3022|eflorendo@chla.usc.edu|
20524658|NCT01624740|Boston Scientific|Nitzan Mekel-Bobrov, PhD|661-949-4537|Nitzan.Mekel-Bobrov@bsci.com|
20524659|NCT05088460|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20524660|NCT06045325|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
20524661|NCT04659863|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524662|NCT03048747|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20524663|NCT00298272|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20524664|NCT00915018|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20524665|NCT00457002|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20524666|NCT00454246|Hoffman-LaRoche|Medical Communications|800-821-8590||
20524667|NCT00833105|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
20524668|NCT02898597|University of Massachusetts Boston|Dr. Sun Kim|617-287-6831|sun.kim@umb.edu|
20524669|NCT03656068|Pinnacle Clinical Research|Stephen Harrison, MD|210-982-0320|stephenharrison87@gmail.com|
20537722|NCT03989349|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20537723|NCT02488135|University of Alberta|Scott Murray|587-891-6240|sipmurray@gmail.com|
20537724|NCT02248649|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20537725|NCT02620878|Università di Padova-Italy|Dr. Daniela Bruttomesso|00390498212183|daniela.bruttomesso@unipd.it|
20537726|NCT02438683|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537727|NCT00147017|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
20537728|NCT04448392|UAB|Dr. Nicole Samies|570-271-6440|nsamies2@geisinger.edu|
20537729|NCT01585779|Medtronic Coronary and Structural Heart|Shari Benoit|(763) 514-4000|shari.g.benoit@medtronic.com|9749
20537730|NCT00082368|National Cancer Institute|Dr. Peter Choyke|301-402-8409|peter_choyke@nih.gov|
20537731|NCT03559517|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20537732|NCT01846299|Novartis|Study Director|862-778-8300||
20537733|NCT01330628|Spectranetics|Amanda Johnson, VP of Regulatory & Medical Affairs|(719) 447-2000|amanda.johnson@spnc.com|
20537734|NCT03285958|University of Michigan|Dr. Mary Janevic|734 647 3194|mjanevic@umich.edu|
20537735|NCT03116828|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20537736|NCT05243745|HALEON|Haleon Response Center|+441932 95 95 00|ww.clinical-trial-register@haleon.com|
20537737|NCT02998203|Cyprus University of Technology|Dr. Konstantinos C. Makris|00357-25-002398|konstantinos.makris@cut.ac.cy|
20537738|NCT05160168|Theseus Pharmaceuticals (a subsidiary of Concentra Biosciences)|Stew Kroll|(650) 576-9679|skroll@concentrabiosciences.com|
20537739|NCT04187144|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20537740|NCT01044745|University of Nebraska Medical Center|R. Gregory Bociek, MD|402-559-5388|rgbociek@unmc.edu|
20537741|NCT02890303|Mynosys Cellular Devices, Inc.|Daniel Marinsik|(510) 857-6296|dmarinsik@mynosys.com|
20537742|NCT04388319|Rose Research Center|Dr. Jed E. Rose|9193282345|jed.rose@roseresearchcenter.com|
20537743|NCT00789581|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
20537744|NCT03333317|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20537745|NCT03812185|Henry Ford Health System|Yoshihisa Morita|3059784358|moritayoshihisa2016@gmail.com|
20537746|NCT01591837|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20537747|NCT01681069|Analyze & Realize GmBH|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
20537748|NCT00245050|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Vivian von Gruenigen, MD|216-844-5011|vev1@case.edu|
20537749|NCT02301546|University of Utah|Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|
20537750|NCT04838054|Stony Brook University|Srinivas Rao Myneni Venkatasatya, DDS, PhD|631-632-8739|srinivas.MyneniVenkatasatya@stonybrookmedicine.edu|
20537751|NCT02130687|Yale University|Nancy J. Brown, M.D.|16153644022|nancy.j.brown@yale.edu|
20537752|NCT02449889|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20537753|NCT01973387|Janssen Research & Development, LLC|Vice President (VP)||ClinicalTrialDisclosure@its.jnj.com|
20537754|NCT01498575|The Children's Hospital of Philadelphia|Dennis Durbin, MD, MSCE|215-590-7331|DURBIND@EMAIL.CHOP.EDU|
20537755|NCT00396006|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20537756|NCT02163967|Weill Cornell Medical College|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
20537757|NCT03272828|University of Washington|Dr. Mats Kronstrom|425-877-7345|mk33@uw.edu|
20537758|NCT03176472|Regenacy Pharmaceuticals Inc.|Dr. David Michelson, CMO|2676639826|dmichelson@regenacy.com|
20537759|NCT00847665|University Hospital Virgen de las Nieves|Dr. Francisco Manzano|34958020125|fmanzano@mailpersonal.com|
20537760|NCT03582553|Pennington Biomedical Research Center|Dr. Candida Rebello|225-763-3159|Candida.Rebello@pbrc.edu|
20537761|NCT01404559|University of South Florida|William S. Quillen|8139749863|wquillen@health.usf.edu|
20537762|NCT00624585|H. Lee Moffitt Cancer Center and Research Institute|Alan F. List, Executive Vice President & President, Moffitt Medical Group|813-745-6086|alan.list@moffitt.org|
20537763|NCT04295681|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20537764|NCT04154345|University of Antwerp|Prof. Filip Struyf|32652783|filip.struyf@uantwerpen.be|0032
20569343|NCT02154477|SLU|sandeep dhindsa|314-977-4911|dhindsa@slu.edu|
20569344|NCT02741713|Wake Forest Baptist Health|Dr.Jon Wells Reynolds|336-715-9695|jreynold@wakehealth.edu|
20569345|NCT01388478|University of Kansas Medical Center|Jeffrey Burns, M.D., M.S.|913-588-0555|KUAMP@kumc.edu|
20569346|NCT04458181|University of Minnesota|Amy R. Krentzman|612-625-2312|akrentzm@umn.edu|
20569347|NCT01037413|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569348|NCT05215418|Vivus LLC|Lan Nguyen|650-934-5246|clinical@vivus.com|
20569349|NCT00619983|Wake Forest School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
20569350|NCT00931918|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20569351|NCT02975297|The University of Texas Health Science Center at Houston|Luba Yammine, PhD, APRN, FNP-C, Associate Professor|(713) 500-2005|Luba.Yammine@uth.tmc.edu|
20569352|NCT03201900|Eisai, Inc.|Inquiry Service.|none|eisai-chiken_hotline@hhc.eisai.co.jp|
20569353|NCT02971228|Zealand Pharma A/S|Kim Mark Knudsen|+45 5060 3780|KMKnudsen@zealandpharma.com|
20569354|NCT02367105|Michael E DeBakey VA Medical Center|Dennis T Villareal, MD|713-794-7156|dennis.villareal@va.gov|
20569355|NCT02560389|University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison|Josh Cisler|608-263-6100|jcisler2@wisc.edu|
20569356|NCT02716298|CooperVision|Senior Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
20569357|NCT00550446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569358|NCT03247738|University of Florida College of Medicine, Jacksonville|Dominick J. Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
20507558|NCT01887587|Medical College of Wisconsin|Ehab Atallah, MD|414-805-8900|eatallah@mcw.edu|
20524670|NCT05326529|University Hospital of Derby and Burton|Charlotte Smith|01283 593150|charlotte.smith79@nhs.net|3150
20524671|NCT00154284|Novartis Pharmaceuticals|Study Director|862-778-8300||
20524672|NCT00326716|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
20524673|NCT00684411|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617.632.6633|EDJACOBSEN@PARTNERS.ORG|
20524674|NCT05253573|University of Oklahoma Stephenson Cancer Center|Thanh Cong Bui, MD, DrPH|1-405-271-8001|thanh-c-bui@ouhsc.edu|50559
20524675|NCT01344824|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20524676|NCT03417557|CooperVision|Myhanh Nguyen, Sr. Optometrist|19257306716|MNguyen@coopervision.com|
20524677|NCT04506463|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|Clinical.Trial@sunpharma.com|5689
20524678|NCT02126579|University of Virginia|Craig Slingluff, MD; Professor, Department of Surgery; Program Director, UVA Cancer Center|4349249311|cls8h@virginia.edu|
20524679|NCT01085630|HealthPartners Cancer Care Center|Arkadiusz Z. Dudek M.D., Ph.D.|651 254-3321|Arkadiusz.Z.Dudek@HealthPartners.Com|
20524680|NCT01237041|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
20524681|NCT02366637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524682|NCT02609607|University of Pittsburgh Medical Center|Dr. David Levinthal|14123030525|levinthald@upmc.edu|
20524683|NCT01317095|Thomas Jefferson University|Hitoshi Hirose, Professor of Surgery|2159556925|Hitoshi.Hirose@jefferson.edu|
20524684|NCT03168711|Massachusetts General Hospital|Dr. Sabrina Paganoni|617-724-3914|spaganoni@mgh.harvard.edu|
20524685|NCT00651261|Dana Farber Cancer Institute|Richard Stone, MD||rstone@partners.org|
20524686|NCT01609010|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20524687|NCT01543178|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
20524688|NCT02770170|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524689|NCT03351608|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524690|NCT04029584|University of California, San Francisco|Leslie Benet, PhD|(415) 476-3853|leslie.benet@ucsf.edu|
20524691|NCT01987089|Crescenz VA Medical Center|Subhajit Chakravorty|(215)-823-5800|Subhajit.Chakravorty@va.gov|
20537765|NCT00210353|International Extranodal Lymphoma Study Group (IELSG)|Prof. Emanuele Zucca MD, Scientific and Medical Director|+41 91 811 9040|ielsg@eoc.ch|
20537766|NCT03368053|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
20537767|NCT04686084|UCLA Oral & Maxillofacial Radiology|Sanjay M Mallya|3108251689|smallya@dentistry.ucla.edu|
20537768|NCT02576041|Allergology Unit, Azienda Ospedaliero-Universitaria Policlinico di Modena|Patrizia Pepe, MD|+39. 059 4225449||
20537769|NCT02494518|Cleveland Clinic|Dr. Susan Linder|(216) 445-9815|linders@ccf.org|
20537770|NCT03172325|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|anjidani.n@orchidpharmed.com|
20537771|NCT02292758|Dana-Farber Cancer Institute|Kimmie Ng, M.D., M.P.H.|(617) 632-4150|Kimmie_Ng@dfci.harvard.edu|
20537772|NCT03639623|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
20537773|NCT01694121|Center on Gender Equity and Health at UCSD|Dr. Anita Raj|8588220229|anitaraj@ucsd.edu|
20537774|NCT00744978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537775|NCT01218958|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
20537776|NCT03773133|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
20537777|NCT00866047|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20537778|NCT00503776|Vanderbilt-Ingram Cancer Center|Barbara Murphy, MD|615-343-9444|barbara.murphy@vanderbilt.edu|
20537779|NCT00178919|Vanderbilt University|Italo Biaggioni|615-343-6499|italo.biaggioni@vanderbilt.edu|
20537780|NCT01895543|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20537781|NCT03539211|ChristianaCare|Brian Catania|302-838-4700|bcatania@christianacare.org|
20537782|NCT01024972|University of Massachusetts Medical School|Dr. Susanne Muehlschlegel|508-421-5500|susanne.muehlschlegel@umassmemorial.org|
20537783|NCT04659174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20537784|NCT04077996|Instituto Mexicano del Seguro Social|Dr. Jesus Venegas-Ramírez|3143058373|nefrojesusvr@gmail.com, jesus.venegas@imss.gob.mx|
20537785|NCT03276026|Jefferson|Dr. Adam Thaler|215-901-0749|thaler.adam@gmail.com|
20537786|NCT01534260|IndianaU|Dr. Hamid Sayar|(317) 948-7576|ssayar@iu.edu|
20537787|NCT00503581|NRG Oncology|Linda Gedeon for James Kauderer|716-845-1169|linda.gedeon@roswellpark.org|
20537788|NCT05747209|Allegheny General Hospital|Colin Champ, MD|412-734-7605|colin.champ@ahn.org|
20537789|NCT01301066|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@kowaus.com|
20537790|NCT00868140|Virginia Commonwealth University|Dr. John Nestler|(804) 828-3389|john.nestler@vcuhealth.org|
20537791|NCT04934800|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|6151-72-5200|service@emdgroup.com|+49
20537792|NCT02333396|ChildrensMemorialH|Karen Rychlik, MS|(773) 755-6310|krychlik@luriechildrens.org|
20537793|NCT05413512|Baylor University|Debroah Holland|(254) 710-1438|Deborah_L_Holland@baylor.edu|
20537794|NCT02684058|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20537795|NCT03219034|Texas A&M University College of Dentistry|Dr. Emet Schneiderman|2148288377|eschneiderman@tamu.edu|
20537796|NCT01327053|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20537797|NCT03172884|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20537798|NCT04696276|Saint Savvas Hospital of Athens|Maria Bourazani|+302106409000|mbourazani@yahoo.com|
20537799|NCT00932620|University of Ioannina|Prof Moses Elisaf|+302651007509|egepi@cc.uoi.gr|
20537800|NCT03614416|Bioserenity|Eléonore CAILLET|01 57 27 40 00.|eleonore.caillet@bioserenity.com|
20537801|NCT00230802|Brigham & Women's Hospital|Erik Alexander, MD|6177325666|ekalexander@partners.org|
20537802|NCT00983515|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
20537803|NCT01746511|University of Rochester|Carl D'Angio|585-273-4911|carol_dangio@urmc.rochester.edu|
20537804|NCT02264665|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537805|NCT01468207|AbbVie|Global Medical Information|1-800-633-9110||
20537806|NCT04385238|Harvard T.H. Chan School of Public Health|Sonia Hernandez-Diaz|6174323942|shernan@hsph.harvard.edu|
20537807|NCT01967823|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
20537808|NCT01332188|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20537809|NCT00413894|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20537810|NCT04225676|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20537811|NCT00866034|UMC Utrecht|Ouijdane Hamdine, MD|+31-88-7557524|O.Hamdine@umcutrecht.nl|
20537812|NCT01783574|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|KKMILLER@MGH.HARVARD.EDU|
20537813|NCT05289271|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537814|NCT03440723|Elm Tree Medical Inc.|CEO|2158050862|evamartin@elmtreemedical.com|
20537815|NCT03356977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537816|NCT02043197|Abbott|Tatiana V. Vladimirova|+74952584280|tatiana.vladimirova@abbott.com|
20537817|NCT03826173|Brown University School of Public Health|David M Williams|4018636248|david_m_williams@brown.edu|
20537818|NCT03552536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537819|NCT00380029|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20537820|NCT05898672|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569359|NCT00129649|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
20569360|NCT02482935|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537821|NCT04463693|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
20537822|NCT01114971|Cedars Sinai Medical Center|Proffesor Paul F. White|2147703775|paul.white@cshs.org|
20537823|NCT00515294|Boston University|Jonathan Howland, Professor|617 638 5158|jhowl@bu.edu|
20537824|NCT03119181|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
20537825|NCT02959827|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20537826|NCT01025076|Royal Alexandra Hospital/CAMIS|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
20537827|NCT03770728|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20537828|NCT02778555|Stanford University|Dr. Beth Darnall, Clinical Associate Professor, Division of Pain Medicine|(650) 721-2104|bdarnall@stanford.edu|
20537829|NCT02379988|Peace Health St. Joseph's cancer center|Victor Gonzalez|360-788-8222|vgonzalez1@peachehealth.org|
20537830|NCT00107315|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20537831|NCT00945061|University Hospitals Cleveland Medical Center , Case Comprehensive Cancer Center|Dr. Janice A. Lyons, MD|+1 216-844-2536|Janice.Lyons@uhhospitals.org|
20537832|NCT02509039|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20537833|NCT02089464|Nexstim Plc|Vice President, Medical Affairs||jarmo.laine@nexstim.com|
20537834|NCT03943550|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20537835|NCT03359785|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20537836|NCT00735826|Dartmouth-Hitchcock Medical Center|Konstnatin Dragnev, MD Professor of Medicine|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
20537837|NCT04262882|University of Texas at San Antonio|Dr. Katelyn Sileo|210-458-7900|katelyn.sileo@utsa.edu|
20537838|NCT03099174|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20537839|NCT04730635|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537840|NCT03070223|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20537841|NCT00516906|3M|J M Heilman|651-733-9897|jmheilman@mmm.com|
20537842|NCT04603495|MorphoSys AG|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
20537843|NCT02187887|RAND|Eric Pedersen|3103930411|ericp@rand.org|6078
20537844|NCT03645941|Mayo Clinic|Christi A. Patten, MD|507-266-2554|patten.Christi@mayo.edu|
20537845|NCT05470842|UNiversity of East Anglia|Dr Katharina Mattishent|01603286286|k.mattishent@uea.ac.uk|
20537846|NCT00721578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569361|NCT04952701|CooperVision|Jose Vega|9256402964|JVega2@coopervision.com|
20569362|NCT04081389|Roswell Park Comprehensive Cancer Center|Kristopher Attwood|716-845-1300|Kristopher.Attwood@roswellpark.org|
20569363|NCT04074343|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
20569364|NCT01537185|Comprehensive Clinical Development Northwest|Dr. Royce Morrison|206 285 3500|ckeech@path.org|
20569365|NCT00827775|University of Texas Southwestern Medical Center|Peter Van Buren|214-645-8293|peter.vanburen@utsouthwestern.edu|
20524692|NCT01346696|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20524693|NCT04630002|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20524694|NCT03448419|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524695|NCT03090958|UNC-Chapel Hill|Lisa Hightow Weidman, MD|919 966 2536|lisa_hightow@med.unc.edu|
20524696|NCT03020992|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20524697|NCT01006122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537847|NCT01926041|National Taiwan University Hospital & College of Medicine|Dr. Chien-Hsieh Chiang|+88623123456|jiansie@gmail.com|66699
20569366|NCT00413634|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20569367|NCT00866918|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20569368|NCT00096681|Desmond Tutu HIV Centre|Prof LG Bekker|+2721 633 6599|Linda-Gail.Bekker@hiv-research.org.za|21
20569369|NCT00527514|Daiichi Sankyo|John Raia|(973) 630-2683|jraia@dsus.com|
20569370|NCT00001941|National Cancer Institute, National Institues of Health|Thomas Waldmann, M.D.|301-496-6653|tawald@mail.nih.gov|
20569371|NCT01723514|Amgen Inc.|Study Director|866-572-6436||
20569372|NCT01547247|Digestive Diseases Center, Vítkovice Hospital, Ostrava, Czech Republic|Přemysl Falt MD|+420602689561|faltprem@centrum.cz|
20569373|NCT00802438|UW Madison|Gina Crisafi, BS|608-265-4554|gmc@medicine.wisc.edu|
20569374|NCT01281917|University of Wisconsin Carbone Cancer Center|Lymphoma Disease Oriented Team|608-265-5542|neils@wisc.edu|
20569375|NCT00096109|Barbara Ann Karmanos Cancer Institute|Elaina Gartner, M.D.|(425) 527-4398|egartner@seagen.com|
20569376|NCT04491084|Albert Einstein College of Medicine|Dr. Nitin Ohri|718-405-8550|nitin.ohri@einsteinmed.edu|
20569377|NCT02101268|Sierra Oncology, a GlaxoSmithKline company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20569378|NCT01200485|UT MD Anderson Cancer Center|Saroj Vadhan, MD/Professor, Cytokine & Supportive Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20569379|NCT06080438|University of Miami|Principal investigator|305-326-6434|wlee@med.miami.edu|
20569380|NCT01564953|Aarhus University Hospital|Dr. Sarah Hashim Ali Hussein|0045 42660308|sarsuri@hotmail.com|
20569381|NCT03589300|Zimmer Biomet|Director of Clinical Operations|800-613-6131|clinicaloperations@zimmerbiomet.com|
20569382|NCT02630706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569383|NCT01678898|Protalix Ltd|Raul Chertkoff|+972-4-9028100|raul@protalix.com|
20569384|NCT03083093|LUMC|F.A. Klok, MD PhD|003171 526 9111|f.a.klok@LUMC.nl|
20569385|NCT01123512|Benvenue Medical, Inc.|Barbara S. Lindsay, Vice President Clinical & Regulatory Affairs|408-454-9300|blindsay@benvenuemedical.com|
20569386|NCT02551692|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
20569387|NCT01227928|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569388|NCT04582864|Washington University School of Medicine|Dr. Matthew Christopher|314-273-0286|christopherm@wustl.edu|
20569389|NCT01204775|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
20569390|NCT03735147|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
20569391|NCT04380688|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20569392|NCT01879085|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MCCR, Clinical Trials Administrator|412-647-5554|stadtermanbm@upmc.edu|
20569393|NCT00951171|WIHRI|Andrew S Blazar, MD Principal Investigator|401-274-1122|ablazar@WIHRI.org|8461
20569394|NCT00919061|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa|646-888-4184|abou-alg@mskcc.org|
20569395|NCT02868788|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
20569396|NCT03579680|University of Michigan|Ted Skolarus|Ph: (734) 845-3506|tskolarus@uchicago.edu|
20569397|NCT05294328|LENZ Therapeutics, Inc.|Marc Odrich, MD|(646) 249-2800|marc@lenz-tx.com|
20569398|NCT04267393|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20524698|NCT04123496|Medical University of South Carolina|Donna Robers, MD|843-792-9343|Robertdr@musc.edu|
20524699|NCT04709562|Vapotherm Inc|Kathy Gerich|(585) 469-6753|kgerich@vtherm.com|
20524700|NCT04205643|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
20524701|NCT00488644|UT MD Anderson Cancer Center|Victor Levin, MD, BS / Professor||kuhunter@mdanderson.org|
20524702|NCT02003404|Loyola University of Chicago|Dr James Swan, MD|708-485-1271|jswan@lumc.edu|
20524703|NCT03859427|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20524704|NCT00413582|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
20524705|NCT01804946|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
20524706|NCT00669669|Fred Hutch Cancer Research Center|Hans-Peter Kiem, M.D., Ph.D.|206.667.4425|hkiem@fredhutch.org|
20524707|NCT00715273|University of Washington|Xue-Qiao Zhao|206-744-8305|xueqiao@uw.edu|
20524708|NCT01205776|Abbott Vascular|Rhonda Hensley, Clinical Project Manager|+1 828-559-0080|rhonda.hensley@abbott.com|
20524709|NCT03334344|Ceevra|Russ Yoshinaka|415-926-9434|ryoshinaka@ceevra.com|
20524710|NCT04031846|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524711|NCT02431676|Johns Hopkins University|Dr. Jessica Yeh|410-614-4316|hyeh1@jhmi.edu|
20524712|NCT03103152|Queen Mary University, London.|Professor Jack Cuzick, Director of The Wolfson Institute|+44 (0)207 882 3504|j.cuzick@qmul.ac.uk|
20524713|NCT03474965|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20569399|NCT00837590|Indiana University|Dr. Kieren Mather|317-278-2187|kmather@iupui.edu|
20569400|NCT03864341|NYU Langone Health|Kelly Doran, MD, MHS|(212) 263-5850|Kelly.doran@nyulangone.org|
20569401|NCT01066936|Smith & Nephew|Tracey Brengola|978-319-2702|tracey.brengola@smith-nephew.com|
20569402|NCT01904136|Samer Srour, MD / Stem Cellular Transplantation Department|UT MD Anderson Cancer Center|713-794-4354|ssrour@mdanderson.org|
20569403|NCT02416713|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
20569404|NCT04156399|University of Illinois Chicago|Judith Schlaeger, PhD|3124134669|jschlaeg@uic.edu|
20569405|NCT02276638|Nidek|Head, Regulatory Affairs|(800) 223-9044|support@nidek.com|
20569406|NCT02742532|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
20569407|NCT00460564|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569408|NCT00863798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569409|NCT04238520|The Ohio State University|Dr. Xi Chen, Associate Professor|614-2920474|chen.13047@osu.edu|
20569410|NCT01470599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569411|NCT00195442|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569412|NCT00624013|Charles Drew University of Medicine and Science|Diana Echeverry, MD, Principal Investigator|3235634800||
20569413|NCT02041221|SPARC|Dr Shravanti Bhowmik|+91 22 66455645||
20569414|NCT02637856|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20569415|NCT02509312|Beth Israel Deaconess Medical Center|John J. Kowalczyk, MD|617-667-3112|jkowalcz@bidmc.harvard.edu|
20569416|NCT02815735|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
20569417|NCT00702650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20569418|NCT03993457|UTexasSouthwestern|Maria Monastirsky|214-648-0174|maria.monastirsky@utsouthwestern.edu|
20569419|NCT01772823|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20569420|NCT01036165|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
20524714|NCT05096403|Swedish Orphan Biovitrum AB|Luis López Lazaro|46733319155|luis.lopezlazaro@sobi.com|
20569421|NCT03082898|Vanderbilt University|Dr. Michael Goldfarb|615 343 6924|michael.goldfarb@vanderbilt.edu|
20569422|NCT02895360|Basilea Pharmaceutica International Ltd.|Thomas Kaindl, MD, Global Medical Director, Oncology|+41615671505|Thomas.Kaindl@basilea.com|
20569423|NCT00307164|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20553856|NCT01446731|Center for Cancer ImmuneTherapy|Per Kongsted, M.D.|+45 38689255|per.kongsted@regionh.dk|
20553857|NCT00378703|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20553858|NCT02149342|Helsinki university central hospital|Md, PhD Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
20553859|NCT03181542|Penn State Hershey Medical Center|Dr Priti Dalal|717-531-6597|pdalal@pennstatehealth.psu.edu|
20553860|NCT04138615|University of Texas Southwestern Medical Center|Dr Craig Crandall|2143454623|craigcrandall@texashealth.org|
20553861|NCT01930058|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553862|NCT03012386|Vanderbilt University Medical Center|Cyndya Shibao MD|6159364584|cyndya.shibao@vumc.org|
20553863|NCT00806546|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
20553864|NCT01226719|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20553865|NCT01868633|University of Iowa|Dr. Unyime Ituk|3193562633|unyime-ituk@uiowa.edu|
20553866|NCT02353091|UCL Ear Institute|Mr Georgios Stavrinos|07856067517|georgios.stavrinos.13@ucl.ac.uk|
20569424|NCT01649297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569425|NCT01685047|St Jude Medical|Karolien Timmermans|0032 497 51 39 21|ktimmermans@sjm.com|
20569426|NCT02601105|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
20569427|NCT01732926|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20569428|NCT02262364|Zimmer Biomet|Jennifer Woodell-May, PhD||jennifer.woodell-may@zimmerbiomet.com|
20569429|NCT01049984|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20569430|NCT01271036|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|928-277-0715|jhauze@its.jnj.com|
20569431|NCT00337285|Shire Pharmaceutical Development, Inc.|Timothy Whitaker||twhitaker@shire.com|
20569432|NCT01649505|Oregon Health and Science University|Dr. Juliana Hansen|503-494-4834|hansenju@ohsu.edu|
20569433|NCT00616577|Loma Linda University|Charles Lee, MD|909-558-9408|thamilton@llu.edu|
20569434|NCT01376050|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
20569435|NCT01983553|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
20569436|NCT02832284|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412 749 1423|grubbm@bsci.com|
20569437|NCT00498615|Johns Hopkins University|Gwen Leatherman, R.N.|410-550-8582|gleathe@jhmi.edu|
20569438|NCT01321723|Unigene Laboratories, Inc.|Nozer Mehta, PhD. Chief Scientific Officer|(973) 265-1100|nmehta@unigene.com|
20569439|NCT01859611|ELECTRONIC ENGINEERING EL.EN. SPA|ALESSANDRO BIZZARRI STUDY DIRECTOR|+390558826807|A.BIZZARRI@ELEN.IT|
20569440|NCT00992719|Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Duke University School of Medicine|Geeta K. Swamy, M.D.|919-681-5220|geeta.swamy@duke.edu|
20569441|NCT01670188|Mayo Clinic|Dr. Alejandro Rabinstein|507-284-4741|Rabinstein.Alejandro@mayo.edu|
20569442|NCT02212301|Johnson & Johnson Vision Care Inc.|Tawnya Wilson OD|904-443-3500|TWilson@ITS.JNJ.com|1834
20569443|NCT01262118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569444|NCT00578318|Georgetown University Medical Center|Alfiee M. Breland-Noblem Ph.D., MHSc|2026872392|ab2892@georgetown.edu|
20569445|NCT02025985|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20569446|NCT03041701|National Cancer Institute|Dr. Christine Heske|240-760-6197|christine.heske@nih.gov|
20569447|NCT00920699|Johns Hopkins University|Christopher A. Ross M.D. Ph.D.|410-614-0011|caross@jhmi.edu|
20569448|NCT03175198|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569449|NCT02906696|The University of Texas MD Anderson Cancer Center|Philip Thompson, MD/Assistant Professor|713-792-7430|PAThompson2@mdanderson.org|
20569450|NCT05324007|University of Chicago|Dr. Hyesung Grace Hwang|(773) 834-9791|hyesung@uchicago.edu|
20569451|NCT00673127|Beth Israel Deaconess|Steven Balk|617-735-2065|sbalk@bidmc.harvard.edu|
20569452|NCT00776984|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569453|NCT00661466|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20569454|NCT01544309|Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University|Hisao Ogawa, Ph.D; Study Chair|+ 81 963735175|ogawah@kumamoto-u.ac.jp|
20569455|NCT01091519|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553867|NCT02665975|Anglia Ruskin Univeristy|Eldre Beukes|01223698847|eldre.beukes@anglia.ac.uk|2847
20553868|NCT01466192|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20553869|NCT00862784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20553870|NCT03265119|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
20553871|NCT05346406|Medical College of Wisconsin|Alina G Burek MD|414-337-7050|aburek@mcw.edu|
20553872|NCT03890367|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20553873|NCT02373124|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
20553874|NCT04524403|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
20524715|NCT03208166|Medical University of South Carolina|Marc Chimowitz, MD|843-792-3020|mchimow@musc.edu|
20524716|NCT03100903|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524717|NCT04659993|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367135440|Katie.Duckworth@advocatehealth.org|
20524718|NCT03782792|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524719|NCT01944878|Hallym University College of Medicine, Chuncheon Sacred Heart Hospital|Dr. Chang Seok Bang|+82-33-240-5000|cloudslove@naver.com|
20524720|NCT01295671|Boston Children's Hospital|Dr. David Ludwig|617-355-4878|david.ludwig@childrens.harvard.edu|
20524721|NCT01436370|Department of Internal Medicine, University of Iowa|Jack Stapleton, MD|319-356-3168|jack-stapleton@uiowa.edu|
20524722|NCT02395848|McMaster University|Christine Lee|2505191898|clee@mcmaster.ca|
20524723|NCT01754129|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20524724|NCT02276560|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20524725|NCT00616343|Loma Linda University|Dr. David Swope|909-558-4908|Thamilton@llu.edu|
20524726|NCT01033032|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20524727|NCT03691207|Ayala Pharmaceuticals|Chief Medical Officer|+1-857-444-0553|info@ayalapharma.com|
20524728|NCT01134107|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20524729|NCT00687271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524730|NCT01202578|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20524731|NCT02314260|kasr EL alini|Dr Ahmed Kamel|0201120022332|dr.ahmed.m.kamel@gmail.com|
20524732|NCT02027545|VA Ann Arbor Healthcare System|Sameer D. Saini, MD, MS|734-845-5865|sameer.saini@va.gov; sdsaini@med.umich.edu|
20524733|NCT01644292|University of Manitoba|Ed Giesbrecht|204-977-5630|Ed.Giesbrecht@med.umanitoba.ca|
20524734|NCT00695292|Sarah Cannon Research Institute|Dr. David Spigel|615-329-7274|askSARAH@scresearch.net|
20524735|NCT00693498|University of Rochester|Jill M. Cholette MD, Principle Investigator|585-275-8138|Jill_Cholette@urmc.rochester.edu|
20524736|NCT04541589|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20524737|NCT04376346|Centers for American Indian and Alaska Native Health, University of Colorado Anschutz Medical Campus|Carol Kaufman|303-880-7795|carol.kaufman@cuanschutz.edu|
20524738|NCT03581123|University of Washington|Eric Meier, Study Biostatistician|206-450-0020|emeier11@uw.edu|
20524739|NCT00162981|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20524740|NCT04195685|VA Pacific Islands Healthcare System|Dr. Judy Carlson|808-433-6677|judy.carlson@va.gov|
20524741|NCT00300235|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
20524742|NCT01323517|Memorial Sloan Kettering Cancer Center|Dr. Charlotte Ariyan, MD|212-639-6280|ariyanc@mskcc.org|
20524743|NCT02877004|Mayo Clinic|Dr. Ivana Croghan|507-266-1944|nicotineresearch@mayo.edu|
20524744|NCT01593670|Masonic Cancer Center, University of Minnesota|Dr. Erica Warlick|612-625-5467|ewarlick@umn.edu|
20524745|NCT02044302|Yale Center for Clinical Investigations|Katisha Brown CPC|(203) 737-7495|katisha.brown@yale.edu|
20524746|NCT03150719|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20524747|NCT04742400|National Institutes of Health|Daniel Reich, MD|301-496-1801|reichds@ninds.nih.gov|
20524748|NCT01051791|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20524749|NCT01691560|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524750|NCT03097757|Montefiore Medical Center|Roger Hicks|718-862-1751|roger.hicks@einsteinmed.org|
20524751|NCT00288626|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20524752|NCT01372618|NYU Langone|David Kleinberg|646 501 7504|david.kleinberg@nyumc.org|
20524753|NCT00245128|OHSU Knight Cancer Institute|Dr. Michael Mauro|503-494-1080|maurom@ohsu.edu|
20524754|NCT04610346|Jefferson Moss Rehabilitation Research Institute|Sharon Antonucci, Ph.D CCC-SLP, C-AAIS|215-663-6561|sharon.antonucci@jefferson.edu|
20524755|NCT01081769|Janssen-Cilag Germany|EMEA Medical Affairs Director Psychiatry||ClinicalTrialDisclosure@its.jnj.com|
20524756|NCT03309943|Duke University School of Medicine|Jason A. Oliver, Ph.D.|(919) 668-0093|Jason.A.Oliver@duke.edu|
20524757|NCT01483963|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20524758|NCT05028790|University of Houston|David A Berntsen, OD PhD|713-743-5836|dberntsen@uh.edu|
20524759|NCT02019264|Eisai Ltd|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20524760|NCT00628212|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20524761|NCT02914613|OcuTerra Therapeutics, Inc.|Chief Medical Officer|(617) 701-7382|info@ocuterratx.com|
20524762|NCT00546377|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens, Associate Attending|+1212-639-7053|brentjer@mskcc.org|
20524763|NCT04994691|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20524764|NCT01684423|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20524765|NCT02249728|Prana Biotechnology|Dr Dianne Angus|+61 393494906|info@pranabio.com|
20524766|NCT02744430|Baylor College of Medicine|Perla Ramirez|713-798-8514|Perla.Ramirez@bcm.edu|
20524767|NCT03850496|Imperial College London|Dr Tristan Lane, Clinical Lecturer|02033117317|tristan.lane@imperial.ac.uk|
20524768|NCT01417741|OHSU department of APOM|Dr. Christine Martin, assistant professor|503 494 7641|martich@ohsu.edu|
20524769|NCT00676364|Lehigh Valley Health Network|Jenny Boucher|610-402-8844|jenny.boucher@LVH.com|
20524770|NCT05209464|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|pbonato@mgh.harvard.edu|
20524771|NCT03821259|University of Edinburgh/NHS Tayside|Klaudia Suchorab|+44 1738 621151|klaudia.suchorab@nhs.net|
20524772|NCT00869999|Massachusetts General Hospital Cancer Center|Jeffrey Barnes, MD|617-724-4000|jabarnes@partners.org|
20524773|NCT03858998|Weill Cornell Medicine|Dr. Robert Peck|(646) 962-8140|rnp2002@med.cornell.edu|
20524774|NCT02094352|HSS|Dr. Richman|212.517.4481|RichmanD@HSS.EDU|
20524775|NCT03365635|Penn Presbyterian Medical Center|Michael R. Rudnick, MD|215-662-8738|rudnickm@uphs.upenn.edu|
20524776|NCT05343364|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
20524777|NCT01753570|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20524778|NCT01422889|Boston Scientific|Peter Maurer, MPH; Director, Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
20524779|NCT04331067|Washington University School of Medicine|Andrew Davis, M.D.|314-273-3581|aadavis@wustl.edu|
20524780|NCT02062450|TORNIER SAS|Nathalie TRETOUT|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
20524781|NCT02555228|MOHH Holdings|Dr Song Mingjun|86337635|mingjun.song0950c@gmail.com|
20524782|NCT02203721|Abbott Medical Optics|Kendra Hileman, Ph.D., Director of Clinical Research and Development|714-247-8613|kendra.hileman@abbott.com|
20524783|NCT00673439|James Graham Brown Cancer Center|Goetz H Kloecker, MD, MSPH|502/562-4358|ghkloe01@exchange.edu|
20524784|NCT00314327|NSLIJ|Delbert Robinson, M.D.|718-470-8195|Drobinson@nshs.edu|
20524785|NCT05678959|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524786|NCT04850989|National University of Singapore|Nur Hani Zainal|+65 6516 3749|hanizainal@nus.edu.sg|
20524787|NCT00617890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524788|NCT03503370|Baltimore VA Medical Center|Dr. Mary-Claire Roghmann|(410) 706-0062|Mary-Claire.Roghmann@va.gov|
20524789|NCT04545489|Durham VA Health Care System|Dr. Hayden Bosworth, PhD|919-286-0411|Hayden.Bosworth@va.gov|177101
20524790|NCT02727478|Karolinska Instituet|Dr Breiffni Leavy|+46852488814|breiffni.leavy@ki.se|
20524791|NCT02633293|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20524792|NCT01017874|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20524793|NCT02017210|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
20524794|NCT00808210|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
20524795|NCT01953302|Varazdin General Hospital|Alen Pajtak|+38542393053|alen.pajtak@obv.hr|
20524796|NCT00778817|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
20524797|NCT02356588|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20524798|NCT01418378|DePuy Synthes|Dave Whalen|574-372-7028|dwhalen@its.jnj.com|
20524799|NCT01790984|University of Surrey|Professor Bruce A.Griffin|+44 0483 689724|b.griffin@surrey.ac.uk|
20524800|NCT03892642|OU Health Stephenson Cancer Center|Associate Professor|405-271-6900|kelly-stratton@ouhsc.edu|
20524801|NCT04005404|Helios Center for Research and Innovation|Director Prof. Dr. Petra Thürmann|0049 (0)202 896-1851|petra.thuermann@helios-gesundheit.de|
20524802|NCT00558467|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524803|NCT00507455|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20524804|NCT00931255|UMaryland|Abdolreza Haririan, MD|410-328-5720|ahariria@medicine.umaryland.edu|
20524805|NCT01372995|Emory University|Jenny Han, MD|404-616-0821|jehan2@emory.edu|
20524806|NCT02344238|Medical University of South Carolina|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
20524807|NCT00746889|UCSD|Jeannie Chao|858-657-7040|j5chao@ucsd.edu|
20553875|NCT00600821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553876|NCT01607905|Karyopharm Therapeutics Inc|Jatin Shah|(617) 658-0600|jshah@karyopharm.com|
20553877|NCT02602288|Temple University|Dr. Stephen Lepore|215-204-9422|slepore@temple.edu|
20553878|NCT01310413|GlaxoSmithKline|GSK Response Center|866-435-7343||
20553879|NCT02564471|SUNY Upstate Medical University|Dr. Timothy Endy|3154647692|endyt@upstate.edu|
20553880|NCT03586869|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20553881|NCT04116229|Washington University School of Medicine|Sarah Eisenstein, Associate Professor in Psychiatry|3143627107|seisens@wustl.edu|
20553882|NCT00058240|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-3196|John.Byrd@osumc.edu|
20553883|NCT02992899|Emory University|Dr. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
20524808|NCT03038867|Weill Cornell Medical College|Research coordinator|212-746-5385|mac4015@med.cornell.edu|
20524809|NCT02414243|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
20524810|NCT01297517|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20524811|NCT01609296|Medtronic|Kristel Wittebols Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
20524812|NCT00386360|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20524813|NCT02403479|St. Joseph's Healthcare London|Dr. Leigh Sowerby|519-646-6143|leigh.sowerby@sjhc.london.on.ca|
20524814|NCT02461966|Tanta university|Sherief Abd-Elsalam|00201095159522|sherif_tropical@yahoo.com|
20524815|NCT00789373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20524816|NCT03782012|William Jewell College|Dr. Amy Elizabeth Barth|816-415-7622|bartha@william.jewell.edu|
20524817|NCT04332081|NYU Langone|David Lee|212-263-3293|David.lee@nyulanogne.org|
20524818|NCT03363776|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
20524819|NCT04157348|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20524820|NCT02527434|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20524821|NCT00568061|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20524822|NCT05027451|InterveXion Therapeutics, LLC|Chief Operating Officer|501-554-2377|misty.stevens@intervexion.com|
20524823|NCT04316104|University of Kansas Alzheimer's Disease Research Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
20524824|NCT02693002|University of Kentucky|Dr. Gretchen Wells, PI||gretchen.wells@uky.edu|
20524825|NCT02266797|NYU Langone Medical Center|Michael Gerling|(718) 630-8600|Michael.Gerling@nyumc.org|
20524826|NCT01791894|Stanford University School of Medicine, Department of Dermatology|Jean Y Tang MD PhD|650-721-7149|baileyhi@stanford.edu|
20524827|NCT02268916|VA Ann Arbor|Pearl Lee, MD|734-845-3182|Pearl.Lee2@va.gov|
20524828|NCT00594165|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20524829|NCT03546491|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20524830|NCT04495751|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|hklepin@advocatehealth.org|
20524831|NCT03289754|restor3d, Inc.|Director of Clinical Affairs|(984) 888-0593|clinicalresearch@restor3d.com|
20524832|NCT04873934|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524833|NCT00708461|University of Minnesota|Jennifer A. Linde, Ph.D.|612-624-0065|linde074@umn.edu|
20524834|NCT01934582|United Therapeutics Corp.|Global Medical Information|919-425-8350|clinicaltrials@unither.com|
20524835|NCT01786161|Massachusetts General Hospital|Hsin Lin|6177241314|hlin13@mgh.harvard.edu|
20524836|NCT00580151|University of Texas-Galveston|Walter Meyer, M.D.|409-770-6718|wmeyer@utmb.edu|
20524837|NCT03584854|University of Chicago|Dr. Naida Cole|773-702-6700|nmcole@bsd.uchicago.edu|
20524838|NCT02907177|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20524839|NCT02670525|Dana-Farber Cancer Institute|Dr. Yana Pikman|6176324754|yana_pikman@dfci.harvard.edu|
20524840|NCT01796392|Pulmonx Corporation|Narinder Shargill|650-216-0108|nshargill@pulmonx.com|
20524841|NCT02505217|University of Vermont|David J Schneider, MD|802-656-8955|david.schneider@uvm.edu|
20524842|NCT04639219|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20524843|NCT04681066|CalciMedica|Sudarshan Hebbar (Chief Medical Officer)|(816) 838-7105|sudarshan@calcimedica.com|
20524844|NCT00953654|The University of Georgia|Matthew P. Herring, PhD|706-542-4381|mph8@uga.edu|
20524845|NCT00153179|Brigham and Women's Hospital|Mark A. Creager|603-650-8283|Mark.A.Creager@hitchcock.org|
20524846|NCT03111940|Oxford Heart Centre, John Radcliffe Hospital|Prof Adrian Banning|01865 228934|Adrian.Banning@ouh.nhs.uk|
20524847|NCT02438423|Georgia Tech|Mark Prausnitz, PhD|404-894-5135|prausnitz@gatech.edu|
20524848|NCT00564850|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
20524849|NCT02640664|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20524850|NCT01205269|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20524851|NCT01408303|AstraZeneca Pharmaceuticals|Torbjörn Lundström||ClinicalTrialTransparency@astrazeneca.com|
20524852|NCT00987337|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524853|NCT02571673|Memorial Sloan Kettering Cancer Center|Dr. Talya Salz, PhD|646-227-3646|salzt@mskcc.org|
20524854|NCT02134015|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|DataSharing@dsi.com|
20524855|NCT01022307|VANCHCS|David L. Woods, Chief Clinical Neurophysiology|925-372-2571|David.Woods@va.gob|
20524856|NCT04138498|Cingulate Therapeutics|VP of Clinical Operations and Regulatory Affairs|913-942-2304|hmitzel@cingulatetherapeutics.com|
20524857|NCT05682729|University of Dayton|Mary Wagner|9372292775|mwagner8@udayton.edu|
20524858|NCT03548779|University of North Carolina at Chapel Hill|Jonathan Berg, MD, PhD|919-966-7043|jonathan_berg@med.unc.edu|
20553884|NCT01332305|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20507559|NCT00973921|Columbia University Medical Center|Giora Weisz MD|212-305 7060|gw2128@mail.cumc.columbia.edu|
20507560|NCT02754830|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20507561|NCT02670330|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
20507562|NCT04404010|Precision OS Technology|Dr. Danny P Goel|604-345-0401|danny@precisionostech.com|
20507563|NCT02120157|Johns Hopkins University|Heather Symons, MD|410-502-9961|hsymons2@jhmi.edu|
20537848|NCT04319380|London School of Hygiene and Tropical Medicine|Professor Daniel Chandramohan|+447570410351|daniel.chandramohan@lshtm.ac.uk|
20507564|NCT04368455|Cincinnati Children's Hospital Medical Center|Dr. Francis Real|5136364200|francis.real@cchmc.org|
20507565|NCT00400439|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20507566|NCT01354431|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20507567|NCT04685499|Weill Cornell Medicine|Meyer Cancer Center GI Program Manager|646-962-8189|cdo4001@med.cornell.edu|
20507568|NCT03176277|Ono Pharmaceutical Co., Ltd.|Medical Information Center|Please see email|trials.uk-eu@ono-pharma.com|
20507569|NCT00702052|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20507570|NCT03282357|Merz Pharmaceuticals GmbH.|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20507571|NCT04398199|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|mfarris@wakehealth.edu|
20507572|NCT00393913|NYU School o Medicine|Indu Ayappa, PhD|2125628437|indu.ayappa@nyumc.org|
20507573|NCT01518244|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20507574|NCT04900038|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20507575|NCT00094887|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20507576|NCT00258206|Johns Hopkins University|Dr. Carol Ann Huff|410-955-8842|chuff1@jhmi.edu|
20507577|NCT04093258|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|tkarkkai@its.jnj.com|
20507578|NCT02379390|Sanofi|Trial Transparency Team|800-633-1610|Us@sanofipasteur.com|1
20507579|NCT01559064|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
20507580|NCT01052831|University of Pennsylvania|Dr. Daniel Weintraub|12153498389|Daniel.Weintraub@uphs.upenn.edu|
20507581|NCT01608490|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|Kristi.Winterfeldt@bsci.com|
20507582|NCT04268004|Nationwide Children's Hospital|Leena Nahata|6147224502|leena.nahata@nationwidechildrens.org|
20507583|NCT01082367|Novartis|Study Director|862-778-8300||
20507584|NCT01453998|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507585|NCT02307838|Novartis Pharmaceuticals|Study Director|862-778-8300||
20507586|NCT01222572|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Raymond Mak, MD|6177328651|rmak@partners.org|
20507587|NCT02022033|Brown University Oncology Research Group|Howard Safran, MD|401-863-3000|BrUOG@BROWN.EDU|
20507588|NCT01429077|Rehabilitation Institute of Chicago|Leora R. Cherney, PhD|312-238-1117|Lcherney@ric.org|
20507589|NCT00280241|University of Pittsburgh|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
20507590|NCT01413542|Department of Medicine Vanderbilt University Medical Center|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
20507591|NCT01148563|Louisiana State Univeristy Health Care Services Division|Dr. Ron Horswell|225-763-2983|rhorsw@lsuhsc.edu|
20507592|NCT01879319|Amgen Inc.|Study Director|866-572-6436||
20507593|NCT01668030|University of Louisville School of Nursing|Dr. Carlee Lehna, Associate Professor|502-852-3913|carlee.lehna@louisville.edu|
20524859|NCT02186873|Johnson&Johnson|Senior Director Clinical Development, Immunology General||ClinicalTrialDisclosure@its.jnj.com|
20507594|NCT04724733|Washington State University College of Nursing|Julie Postma, Professor, Associate Dean for Research|509-324-7287|jpostma@wsu.edu|
20507595|NCT03067129|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20507596|NCT03372603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20537849|NCT04432064|Indiana University|Prof. Joshua Brown|812 855-9282|jwmbrown@iu.edu|
20537850|NCT02136680|University of Maryland Baltimore, School of Medicine|Dr. Carla Alexander|410-328-7129|calexand@medicine.umaryland.edu|
20537851|NCT05032690|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537852|NCT05151445|Ohio State University College of Nursing|Tara O'Brien|614-292-8045|obrien.782@osu.edu|
20537853|NCT02298179|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
20537854|NCT01352442|AcuFocus, Inc.|Eugenia Thomas, OD|949-585-9511|ethomas@acufocus.com|
20537855|NCT01311115|University of California, San Francisco|Justin White|415-476-8045|Justin.White@ucsf.edu|
20553885|NCT02074735|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
20553886|NCT03192150|Sun Pharma Global FZE|Head, Clinical development|91 2266455645|Clinical.Trials@sparcmail.com|
20507597|NCT03986190|University of Miami Miller School of Medicine|Dr. Sara St George|305-243-0726|s.stgeorge@med.miami.edu|
20507598|NCT04929613|West Virginia University|Keith Zullig, PhD|304-293-1091|kzullig@hsc.wvu.edu|
20524860|NCT03694002|SWOG Statistics and Data Management Center|Study Statistician|2066672894|mhsieh@fredhutch.org|
20524861|NCT06360588|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20524862|NCT04722315|Kennedy Krieger Institute|Dr. Jacqueline Harris|6672054295|harrisjac@kennedykrieger.org|
20524863|NCT01481766|Hospital for Sick Children, Toronto, Canada|Dr. Patricia Parkin|416-81307654|patricia.parkin@sickkids.ca|
20524864|NCT00347958|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20524865|NCT00754234|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
20524866|NCT03868930|VA Boston Healthcare System|Dr. Catherine B. Fortier|857-364-4361|Catherine.Fortier@va.gov|
20507599|NCT00289744|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524867|NCT04432831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20524868|NCT06047366|Indiana University School of Dentistry|Dr. Ken Spolnik|317-274-7280|kspolnik@iu.edu|
20524869|NCT04033237|University of Vermont|Sarah H. Heil, PhD|802-656-8712|Sarah.Heil@uvm.edu|
20524870|NCT04704050|Tulane University|Nassir Marrouche|504-988-2025|nmarrouche@tulane.edu|
20524871|NCT02151851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20524872|NCT02159053|Novartis Pharmaceuticals|Study Director|8627788300||
20524873|NCT01540487|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524874|NCT03483961|Emergent BioSolutions|Sharmila Rajendran|650-486-0244|rajendras@ebsi.com|
20524875|NCT02640950|Sheppard Pratt Health System|Director of Clinical Research|4109383125|saaronson@sheppardpratt.org|
20524876|NCT00652626|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20524877|NCT04003636|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20524878|NCT05336630|Dartmouth-Hitchcock Medical Center|Dr. Timothy B. Gardner|603-653-9033|timothy.b.gardner@hitchcock.org|
20524879|NCT01623310|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
20524880|NCT00356603|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524881|NCT01234870|Northwestern University|Dr. James Carr|(312)695-4218|jcarr@northwestern.edu|
20524882|NCT00734162|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20524883|NCT00566020|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524884|NCT01964222|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
20524885|NCT03612596|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
20524886|NCT01050582|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Clinical Leader|609-730-6581||
20524887|NCT01019694|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524888|NCT04244084|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20524889|NCT00795002|The Sidney Kimmel Comprehensive Cancer Center|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
20524890|NCT00026494|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
20524891|NCT00441129|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
20524892|NCT01455597|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20524893|NCT01737710|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20524894|NCT00656292|Mayo Clinic|Michael J. Brown, M.D.|507-284-6317|Brown.Michael3@mayo.edu|
20524895|NCT03674112|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20524896|NCT03451591|University of Edinburgh|Prof Joanna Wardlaw|0131 465 9599|joanna.wardlaw@ed.ac.uk|
20524897|NCT00214786|Baylor University Medical Center|Dr. Marlon Levy|214-820-2050|Marlon.Levy@baylorhealth.edu|
20524898|NCT00812981|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524899|NCT00999609|Spark Therapeutics|Clinical Director||clinicaltrials@sparktx.com|
20524900|NCT00694473|Massachusetts General Hospital|Steven J Russell, M.D. PhD|617-726-8722|sjrussell@mgh.harvard.edu|
20524901|NCT02818946|Duke University|Sujata Ghate, MD|919-684-2711|sujata.ghate@duke.edu|
20524902|NCT04666259|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524903|NCT04178122|VA Boston Healthcare System|Morgan Danowski|617-595-5385|morgan.danowski@va.gov|
20524904|NCT02677922|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20524905|NCT02905981|Rockwell Medical|Ray Pratt, MD|248 960-9009|rpratt@rockwellmed.com|405
20524906|NCT02105987|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524907|NCT03004638|MedImmune LLC|Richard George|+1-301-398-5681|information.center@astrazenea.com|
20524908|NCT03926117|Novo Nordisk A/S|Clinical Reporting Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20524909|NCT01699373|Changi General Hospital|Dr Lim Yean Chin|+65 68503831|yean_chin_lim@cgh.com.sg|
20524910|NCT00086138|JHU|Paul Rosenberg|410-550-9883|prosenb9@jhmi.edu|
20524911|NCT02359955|Shanghai No. 9 People's Hospital|Dr. Haixin Qian|13501961651|drqian8167@126.com|
20524912|NCT02684097|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
20524913|NCT00462709|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20524914|NCT02748356|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
20524915|NCT01732458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524916|NCT05107492|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524917|NCT05236764|Baylor College of Medicine|Dr. Erin Morales|832-826-0860|erin.moralesubico@bcm.edu|
20524918|NCT05870371|Musculoskeletal Research Laboratory (MRL) of Physiotherapy Department University of West Attica, Athens, Greece|Dr. George Georgoudis|+30-210-5387487|physiolab@uniwa.gr|
20524919|NCT01873846|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
20524920|NCT02589639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524921|NCT00347009|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524922|NCT02522884|Intact Vascular, Inc.|Joseph C. Griffin, III|4842531048|JGriffin@intactvascular.com|1043
20524923|NCT03308097|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
20524924|NCT01099618|Emory University SOM|Dawn Smiley|4047781665|dsmiley@emory.edu|
20524925|NCT03867201|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524926|NCT05763875|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20524927|NCT01262287|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
20524928|NCT00596687|Emory Univ SOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
20524929|NCT00932373|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20524930|NCT06098339|CooperVision Inc.|José A. Vega, O.D., MSc., PhD, FAAO|925-621-3761|JVega2@coopervision.com|
20524931|NCT02273063|Neuromodulation Research Clinic|Director|401-455-6200|Linda_Carpenter_MD@Brown.edu|
20524932|NCT05125848|Zynex Monitoring Solutions|ZMS Clinical|(800) 495-6670|clinical@zynexmonitoring.com|
20524933|NCT04134767|Rollins School of Public Health at Emory University|Dr. Hannah LF Cooper|404-727-0261|hcoope3@emory.edu|
20524934|NCT02058537|Temple University Hospital|Ron Schey|215-540-0120|Ron.schey@tuhs.temple.edu|
20524935|NCT02582242|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20524936|NCT00300885|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20524937|NCT00638404|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
20524938|NCT00603902|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20524939|NCT02492984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524940|NCT02101736|The University of Alabama at Birmingham|Karen Cole-Plourde, Program Director -NFCTC|(205) 514-1317|kplourde@uab.edu|
20524941|NCT02282631|Institute of Health and Society, Newcastle University|Dr Samuel Ginja|+44191208|samuel.ginja@newcastle.ac.uk|4565
20524942|NCT00459290|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
20524943|NCT02453334|American Regent, Inc|Mark A. Falone, MD MPH|631-772-3544|mfalone@americanregent.com|61844
20524944|NCT02362672|Nektar Therapeutics|Medical Affairs||StudyInquiry@nektar.com|
20524945|NCT05483686|ISA Associates, Inc.|Dr. Samantha Leaf|703-739-0880|sleaf@isagroup.com|4
20524946|NCT05780983|Wake Forest University Health Sciences|Jaime M Hughes, PhD, MPH, MSW|336-716 -0835|jane.hughes@wfusm.edu|
20524947|NCT03126630|Mayo Clinic|Dr. Aaron Mansfield|(507) 284-2511|mansfield.aaron@mayo.edu|
20524948|NCT00383760|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
20524949|NCT02829320|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20524950|NCT01954056|University of New Mexico|Dr. Kristi Watterberg|505-272-8609|KWatterberg@salud.unm.edu|
20524951|NCT03070600|University of Washington|Grace John-Stewart|206-543-4278|gjohn@uw.edu|
20537856|NCT02320812|jCyte, Inc|Terry O'Neal, Chief Operating Officer|949-243-0688|terry.oneal@jcyte.com|
20524952|NCT00105079|Hoffman-LaRoche|Medical Communications|800-821-8590||
20524953|NCT01464593|Celsion Corporation|Chief Medical Officer|609-896-9100|nborys@celsion.com|
20524954|NCT02182115|University of Minnesota|Dr. Susan Kline|612-626-3662|kline003@umn.edu|
20524955|NCT01831076|University of Colorado|Anthony Elias|720-848-0347|anthony.elias@ucdenver.edu|
20537857|NCT00845039|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537858|NCT02825420|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
20524956|NCT04747886|Cedars-Sinai Medical Center|Dr. Sarah-Jeanne Salvy|310-423-6423|sarah.salvy@cshs.org|
20537859|NCT04910074|Albert Einstein College of Medicine|Timothy P. Levine, DMD|718-918-5635|timothy.levine@nychhc.org|
20524957|NCT03777436|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20524958|NCT00685399|Novartis Pharmaceuticals|Study Director|862-778-8300||
20524959|NCT01998932|Imperial College London|Miss Sarah Onida|: +44 (0) 20 3311 7335|s.onida@imperial.ac.uk|
20537860|NCT02226198|AstraZeneca Plc|Robin Mukherjee|+46 31 776 1000|robin.mukherjee@astrazeneca.com|
20537861|NCT04545047|VA Cooperative Studies Program|Project Manager|2062774780|Sarah.Keithly@va.gov|
20524960|NCT01106911|University of Pittsburgh|Dr. Jules H. Sumkin|412-641-1976|jsumkin@upmc.edu|
20524961|NCT03728348|Exact Sciences|Alexandra Massoud, Sr. Director of Clinical Affairs|608.284.5700|clinicaltrials@exactsciences.com|
20537862|NCT03895632|Medical Physics & Clinical Engineering, Royal Liverpool Hospital|Dr. Tristan Payne|0151 7064225|tristan.payne@nhs.net|
20553887|NCT01430585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507600|NCT01256983|University Hospital Zürich|Mrs. Hanna Burkahlter|0041 76 371 12 35|hanna.burkhalter@usz.ch|
20507601|NCT00844649|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20569456|NCT00621946|The University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|Sherwood.Brown@UTSouthwestern.edu|
20507602|NCT00664209|UCaliforniaLA|Jeff Bronstein MD, PhD|310 206-9799|jbronste@mednet.ucla.edu|
20507603|NCT02767856|State University of New York College of Optometry|Dr. Jingyun Wang|212-938-5759|jwang@sunyopt.edu|
20507604|NCT00843843|Rush University Medical Center|Dr. Helen Burgess|3125634785|Helen_J_Burgess@rush.edu|
20507605|NCT00418379|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20507606|NCT01594333|Brigham & Women's Hospital|Dr. Paul Ridker and Dr. Robert Glynn|617-732-4965|pridker@bwh.harvard.edu|
20569457|NCT01196741|University of Glasgow|Prof Iain McNeish, Professor of Gynaecological Oncology|+44 (0)141 330 3968|iain.mcneish@glasgow.ac.uk|
20507607|NCT01764256|PATH|Jorge Flores|2028220033|jeflores@path.org|
20507608|NCT00304915|Central Arkansas Veterans Healthcare System|Dr. Jeff Pyne|501-257-1083|jmpyne@uams.edu|
20507609|NCT00565058|Aptose Biosciences Inc.|Peter Murray, Director Clinical Development|647-479-9812|pmurray@aptose.com|
20507610|NCT02029638|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20507611|NCT02792049|Brooke Army Medical Center|Dr. Michael D. April|(210) 916 - 0808|Michael.D.April@post.harvard.edu|
20507612|NCT00779311|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20569458|NCT05329402|Fengh Medical Co., Ltd.|Jiao Liu|13815132106|jiao.liu@fulbrightmed.com|
20507613|NCT03428997|Johnson & Johnson Consumer Inc.|Heather Smith|(908) 874-1235|HSmith21@its.jnj.com|
20524962|NCT02560922|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
20569459|NCT00276016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20524963|NCT02199795|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|
20524964|NCT02705365|Massachusetts General Hospital|Sanja Percac-Lima, MD, PhD|617-643-6980|spercaclima@partners.org|
20524965|NCT05653479|Upstream Bio|Sumathi Sivapalasingam, Vice President of Clinical Development|1 917-499-0789|sumathi.sivapalasingam@upstreambio.com|
20524966|NCT00984542|Vanderbilt-Ingram Cancer Center|Leora Horn, MD|615-936-2033|leora.horn@vanderbilt.edu|
20524967|NCT00425750|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.|615-343-4677||
20524968|NCT02064816|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20524969|NCT04468347|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20524970|NCT04339062|Dana-Farber Cancer Institute|Dr. Glenn Hanna|617-632-3090|glenn_hanna@dfci.harvard.edu|
20524971|NCT03218826|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20524972|NCT01197534|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20524973|NCT05630287|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
20524974|NCT03527589|Merit Medical|Casey Holland|6178420251|casey.holland@merit.com|
20524975|NCT04873869|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
20524976|NCT00703157|Medtronic Bakken Research Center, Coronary and Structural Heart Disease Management|Ber Kleijnen|+31 (0) 43 356 6566|ber.kleijnen@medtronic.com|
20524977|NCT01453088|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20524978|NCT02968173|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20524979|NCT04586244|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20569460|NCT02207322|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
20569461|NCT02056873|Univeristy of Florida|Dr. Michael Okun|3522945400|okun@neurology.ufl.edu|
20569462|NCT00605566|Princess Margaret Cancer Centre|Dr. Lillian Siu||lillian.siu@uhn.ca|
20569463|NCT04396847|UNC-Chapel Hill|Christian Hendershot|(919) 962-5565|christian_hendershot@med.unc.edu|
20569464|NCT01932762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569465|NCT00695136|Pediatrics & Developmental Neuroscience Branch, NIMH|Susan E. Swedo, MD|301-496-5323|swedos@mail.nih.gov|
20569466|NCT03469492|Yale School Of Medicine|Elizabeth Sanchez Rangel, MD|203-737-6067|elizabeth.sanchezrangel@yale.edu|
20569467|NCT01726049|University Hospital Groningen, NL|E.S. Hoendermis, MD, PHD|0031503616161|e.s.hoendermis@umcg.nl|
20569468|NCT01811498|Northwell Health|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu|
20569469|NCT02668198|Mayo Clinic|Dr. Michael B. Wallace|904-953-2221|wallace.michael@mayo.edu|
20569470|NCT02202109|University of Miami|Dr. Erin Kobetz|3052436185|ekobetz@med.miami.edu|
20569471|NCT04334668|Cleveland Clinic|Dr. W. H. Wilson Tang|216-444-2121|tangw@ccf.org|
20569472|NCT04831047|Bascom Palmer Eye Institute|Wendy W. Lee MD|305-243-6434|wlee@med.miami.edu|
20569473|NCT01333111|Novo Nordisk A/S|Global Clinical Regstry (GCR, 1452)||clinicaltrials@novonordisk.com|
20569474|NCT03339271|Mayo Clinic|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu|
20569475|NCT02418845|Lupin Pharmaceuticals Inc|Gregory Kaufman, MD|908.603.6062|gregorykaufman@lupin.com|
20569476|NCT01936324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20569477|NCT06178718|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
20569478|NCT00487552|MED Institute, Inc.|Scott Snyder, Ph.D., Manager, Biostatistics and Data Management, Senior Statistician|765-463-7537|ssnyder@medinst.com|
20569479|NCT03119688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20569480|NCT00320398|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569481|NCT02705625|Medivir|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
20569482|NCT00847132|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|jhuffman@partners.org|
20569483|NCT02190552|Neuravi Limited|Mairsil Claffey|0035391394123|mclaffey@neuravi.com|
20524980|NCT01334229|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
20524981|NCT03517540|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20524982|NCT00615550|Columbia Laboratories|George W Creasy MD|973-486-8797|Gcreasy@columbialabs.com|
20524983|NCT01207687|Johns Hopkins Comprehensive Neurofibromatosis Center|Dr. Jaishri Blakeley|410-614-3853|jblakel3@jhmi.edu|
20524984|NCT01801865|Cincinnati Children's Hospital Medical Center|Dr. Beth Kline-Fath|(513) 636-1856|beth.kline-fath@cchmc.org|
20524985|NCT02915705|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20524986|NCT01500382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524987|NCT01777282|GlaxoSmithKline|GSK Response Center|866-435-7343||
20524988|NCT04015518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20524989|NCT00550745|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524990|NCT00764660|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20524991|NCT03831113|University of Pittsburgh|Dr Steve Caritis|412 641 4874|scaritis@mail.magee.edu|
20524992|NCT04134429|insel Gruppe AG|Dr. med. Christa König|+41 31 632 21 11|christa.koenig@insel.ch|
20524993|NCT04392375|The Ohio State University|Kara Rood, MD|440-321-0264|Kara.Rood@osumc.edu|
20553888|NCT00482391|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
20507614|NCT03329599|Northern California Institute for Research & Education|Bruce Ovbiagele|415-750-2047|bruce.ovbiagele@va.gov|
20507615|NCT03886701|Thomas Jefferson University|Dr. Walter K. Kraft|215 955-9077|walter.kraft@jefferson.edu|
20507616|NCT01397448|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
20507617|NCT00570531|University of Michigan Comprehensive Cancer Center|Susan Urba, M.D.|734-615-4762|surba@umich.edu|
20553889|NCT01448850|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
20507618|NCT00425477|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
20507619|NCT01868776|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
20553890|NCT00779766|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507620|NCT02180217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20507621|NCT00239837|University of Oregon|Dr Leslie Leve|541-346-9528|leve@uoregon.edu|
20553891|NCT01420302|Department and Laboratory of Intensive Care Medicine KULeuven/UZLeuven|Professor Greet Van den Berghe|003216344017|greet.vandenberghe@kuleuven.be|
20507622|NCT00536978|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
20507623|NCT02055430|Cairo University|dr Mohammed Said ElSheemy|01006117755|mohammedshemy@yahoo.com|
20507624|NCT02938052|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
20507625|NCT00669916|Novartis|Study Director|862-778-8300||
20507626|NCT00622869|Novartis Pharmaceuticals|Study Director|862 778-8300||
20553892|NCT03054909|University of Minnesota, Masonic Cancer Center|Dr. Melissa Geller|+1 612-626-3111|gelle005@umn.edu|
20507627|NCT02821455|University of Edinburgh|E Alexandra Page|7938645122|s1305565@sms.ed.ac.uk|
20507628|NCT03076190|Stanford University|Dr. Beth Darnall|6507365494|bdarnall@stanford.edu|
20553893|NCT01412424|Cedars-Sinai Medical Center|Shlomo Melmed, MD|310 423-4691|melmed@csmc.edu|
20507629|NCT00870818|Provention Bio, Inc|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
20507630|NCT00772382|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20507631|NCT01709981|NYU Langone Health|Dr. Binita Shah|212-263-6631|Binita.Shah@nyulangone.org|
20507632|NCT01369212|University of Pittsburgh|Dr. Abdus Wahed|412-624-3053|wahed@pitt.edu|
20507633|NCT01582971|Michigan State University|Dr. Gwen Wyatt|517-432-5511|gwyatt@msu.edu|
20507634|NCT02007954|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20507635|NCT03784027|University of Cambridge|Prof Roman Hovorka|+44 1223 762 862|rh347@cam.ac.uk|
20507636|NCT06076148|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20507637|NCT04860752|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@Edwards.com|
20507638|NCT06025396|Tempero Bio|Director, Clinical Operations|510-250-4750|TMP-301-HNV-101@Temperobio.com|
20507639|NCT01512108|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20507640|NCT01539811|Greenville Health System|Dr. David Cull|8644548295|dcull@ghs.org|
20507641|NCT06422377|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20507642|NCT02017899|GSK Vaccines Institute for Global Health S.r.l.|Dr. Audino Podda|+39 0577 243496|audino.p.podda@gsk.com|
20507643|NCT05294341|Hershey Medical Center|Dr. Halina Yee; Primary Resident Investigator|7175313503|hyee@pennstatehealth.psu.edu|
20507644|NCT01985971|University of Pennsylvania|Lilie Lin, MD|215-662-7267|lin@xrt.upenn.edu|
20507645|NCT02843178|Stanford University|Mandy Murphy Carroll, Study Coordinator|(650) 509-0004|mandyiam@stanford.edu|
20507646|NCT00646113|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20524994|NCT02498444|Stanford University|Jeffrey Feinstein, MD|6507252297|jeff.feinstein@stanford.edu|
20524995|NCT03656692|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20524996|NCT01841762|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani / Associate Director, Clinical Operations|6508086586|scott.tsurutani@actelion.com|
20524997|NCT03981900|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20524998|NCT02669901|Univesity of New Mexico School of Medicine|Dr. Joanna Katzman, Principal Investigator|(505) 272-2321|JKatzman@salud.unm.edu|
20524999|NCT02693106|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20525000|NCT03611777|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525001|NCT00184717|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20525002|NCT01369030|Pamlab, Inc.|Lori W Barrentine, MS, PA-C, Director of Clinical Affairs|985-867-5788|lbarrentine@pamlab.com|
20525003|NCT06152224|UW School of Medicine and Public Health|Ushma Patel, MD|(608) 287-5898|upatel@uwhealth.org|
20525004|NCT04181606|The Pennsylvania State University|Dr. David Proctor|(814)863-0724|dnp3@psu.edu|
20525005|NCT06028438|Janssen Research & Development|Medical Director Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20525006|NCT05625802|University of Michigan|Christopher Fung|734-763-4091|chfung@med.umich.edu|
20525007|NCT02509507|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20525008|NCT00302848|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
20525009|NCT04090060|Medical college of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
20525010|NCT02074358|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20569484|NCT01057251|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|manfred.stapff@frx.com|8686
20569485|NCT04544865|Ethicon Endo-Surgery|SENIOR DIRECTOR OF CLINICAL AFFAIRS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20507647|NCT00591240|VA Palo Alto Health Care System|Dr. Joseph Liao|650-493-5000|joseph.liao@va.gov|65581
20507648|NCT02762799|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
20537863|NCT01440517|GE Healthcare|Arnold Jacobson, M.D.|1-609-514-6325|Arnold.Jacobson@ge.com|
20537864|NCT01288612|Mayo Clinic|Prasad G. Iyer|507-284-6469|iyer.prasad@mayo.edu|
20537865|NCT00871923|UT MD Anderson Cancer Center|James Welsh,MD- Associate Professor, Radiation Oncology Department|(713) 563-2447|jwelsh@mdanderson.org|
20537866|NCT02263911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537867|NCT01263015|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537868|NCT05599451|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Operations|+41582421111|ClinicalTrials.PMI@pmi.com|
20537869|NCT02723006|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20537870|NCT00303446|National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)|Kenneth Fischbeck, M.D.|301-435-9318|kf@ninds.nih.gov|
20537871|NCT04258995|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537872|NCT04580277|Cedars Sinai Inflammatory Bowel Disease Center|Dr. Gil Y. Melmed|310-423-4100|gil.melmed@cshs.org|
20537873|NCT00450294|Department of Anesthesia|Dr. Amit Chopra|204-880-5370|amitchopra1@live.com|
20537874|NCT03842969|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20537875|NCT01942161|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
20537876|NCT01257568|Stryker Orthopaedics|Shaherah Yancy, Director, Clinical Operations|901-650-6601|shaherah.yancy@stryker.com|
20537877|NCT02074345|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20537878|NCT03392883|Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College|Lisa A. Marsch, PhD|603-646-7092|Lisa.a.marsch@dartmouth.edu|
20537879|NCT02994953|Merck KGaA, Darmstadt, Germany|Communication Center|6151 72 5200|service@merckgroup.com|
20537880|NCT01792817|electroCore, LLC|Clinical Affairs|+1 973-355-6683|clinical@electrocorellc.com|
20537881|NCT01739933|Vanderbilt University Medical Center|Dr. Pratik Pandharipande, Vice Chair Faculty Affairs, PI|6153436268|pratik.pandharipande@vumc.org|
20537882|NCT01545232|University of Texas Health Science Center - Houston|John Holcomb, M.D.|713-500-5493|John.Holcomb@uth.tmc.edu|
20537883|NCT01846195|Zynex Monitoring Solutions|Donald Gregg|1-800-495-6670|dgregg@zynex.com|
20537884|NCT01247363|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537885|NCT00908115|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537886|NCT01728077|Cares|UCB|+1844599||2273
20537887|NCT01246479|Valneva Austria GmbH|Senior Scientist Clinical Research|+43120620|info@valneva.com|0
20537888|NCT01366612|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20537889|NCT00378599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20537890|NCT00416715|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20537891|NCT03879044|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
20537892|NCT01106859|Purdue Pharma LP|Clinical Leader|800-733-1333||
20537893|NCT03224507|University of Alabama at Birmingham|Luciano J Costa- Principal Investigator|2059349695|ljcosta@uabmc.edu|
20537894|NCT01007435|Hoffmann-La Roche|Medical Communications|800 821-8590||
20537895|NCT01032291|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20537896|NCT00347438|University of Chicago Medical Center|Dr. Funmi Olopade|773-702-1632|folopade@medicine.bsd.uchicago.edu|
20537897|NCT02545517|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20537898|NCT01529515|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20537899|NCT01706497|University Hospitals Leuven (UZ Leuven) and KU Leuven|Prof Dr Geert Meyfroidt, Associate Professor|0032 16 344021|geert.meyfroidt@uzleuven.be|
20537900|NCT03334851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537901|NCT03327220|Pacira CryoTech, Inc.|Kent Jones/ Sr. Director, Quality and Medical Affairs|510-933-1513|kent.jones@pacira.com|
20537902|NCT00523705|University of Pennsylvania|Ellen Freeman, Principal Investigator|215 662-3329|freemane@mail.med.upenn.edu|
20537903|NCT00693017|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
20537904|NCT01691885|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537905|NCT00615589|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
20537906|NCT00688324|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@som.umaryland.edu|
20537907|NCT03989427|Melaka-Manipal Medical College|Dr. Rajesh Hosadurga|+6062896662|rajesh.hosadurga@manipal.edu.my|3823
20537908|NCT01972308|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
20537909|NCT00746239|Penn State Hershey Medical Center|Ravi Singareddy|717-531-0040|rsingare@gmail.com|
20537910|NCT00642369|Guang Dong Provinical Mental Health Institute|Zhang Bin|86-20-81888553|zhang73bin@hotmail.com|
20537911|NCT01562314|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20537912|NCT01180036|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
20537913|NCT04243577|Purdue University|Georgia Malandraki|7654960206|malandraki@purdue.edu|
20537914|NCT00543803|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537915|NCT01190475|Mereo BioPharma|Jacqueline Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
20537916|NCT02330653|Boston Children's Hospital|Dr. Stacy A. Kahn|617-355-6058|stacy.kahn@childrens.harvard.edu|
20537917|NCT02256384|Cincinnati Children's Hospital Medical Center|Mario Patino|513-636-4200|mario.patino@cchmc.org|
20537918|NCT02563860|Montefiore MC|Aleksandra Djukic|7189204378|adjukic@montefiore.org|
20553894|NCT01132144|University of Sao Paulo|Dr. Wellington P Martins|55162231|wpmartins@gmail.com|
20553895|NCT01274637|Ottawa Hospital Research Institute|Dr. Marc Rodger|6137388899|mrodger@ohri.ca|
20553896|NCT02722668|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan|612-626-2961|macmi002@umn.edu|
20525011|NCT03337113|Kent State University|William Lechner|814-450-1093|wlechner@kent.edu|
20537919|NCT00666588|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20537920|NCT04043234|Infinite Biomedical Technologies, LLC|Chief Executive Officer|(443) 451-7177|rahul@i-biomed.com|
20537921|NCT03106844|Brigham and Women's Hospital|Jessica Allegretti MD MPH|617-525-7322|jallegretti@bwh.harvard.edu|
20537922|NCT03622112|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
20537923|NCT01165320|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537924|NCT01558362|University of Ottawa Heart Institute|Dr. Terrence Ruddy, Principal Investigator|613-696-7267|truddy@ottawaheart.ca|
20537925|NCT00385944|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537926|NCT01155466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537927|NCT00590824|University of Madison Carbone Cancer Center|Paul Sondel, MD, PhD|(608) 263-9069|pmsondel@humonc.wisc.edu|
20537928|NCT02075047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537929|NCT01229254|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20525012|NCT00725153|Alcon Research, Ltd.|Jessie Lemp, MS|817-615-2739|Jessie.Lemp@alconlabs.com|
20525013|NCT02176655|Clinvest/A Division of Banyan Group Inc.|Heather Manley|417-841-3664|hmanley@clinvest.com|
20525014|NCT06110494|University of Pennsylvania|Dr. Bekir Karabucak Chair of the Department of Endodontics|215-898-4927|bekirk@upenn.edu|
20525015|NCT02053766|The University of Texas Health Science Center at Houston|Maria Matuszczak|713 -500-5075|maria.matuszczak@uth.tmc.edu|
20525016|NCT00435708|Queen's University Belfast|Professor Michelle McKinley|02890978936|m.mckinley@qub.ac.uk|
20525017|NCT02464163|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20525018|NCT00775229|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
20525019|NCT02490371|QEHHongKong|Dr. Helen LUK|852-9208 5366|clkyz02@ha.org.hk|
20525020|NCT03915587|University of Colorado|Sarkis Chris Derderian|720-777-6163|sarkis.derderian@childrenscolorado.org|
20525021|NCT01718535|Mount Sinai Services Inc.|Azar Azad|416-856-8545|aazad@mtsinai.on.ca|
20525022|NCT01605552|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
20525023|NCT01163851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525024|NCT02476578|CLALIT HEALTH SERVICES|Dr. Nir Tsabar|+97246049512|NIR.TSABAR@CLALIT.ORG.IL|
20525025|NCT01073605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525026|NCT04938180|AmMax Bio., Inc.|Dorothy Nguyen, MD|(650)285-6560|clinical@ammaxbio.com|
20525027|NCT03018080|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20525028|NCT03491462|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
20525029|NCT00423332|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20525030|NCT03431831|University of Nebraska Medical Center|Trina Aguirre|308-632-0410|taguirre@unmc.edu|0412
20525031|NCT00885664|University of Cincinnati|Dr. Carl J. Fichtenbaum|513-584-6361|carl.fichtenbaum@uc.edu|
20525032|NCT02035202|UCSD|Colin Depp|858 822 4251|cdepp@ucsd.edu|
20525033|NCT00644917|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20525034|NCT00758485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20525035|NCT00921557|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20525036|NCT01566539|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
20525037|NCT03259425|Huntsman Cancer Institute|Data Manager, Research Compliance Office|8015850601|compliance@hci.utah.edu|
20525038|NCT02653144|Montefiore Medical Center|Dr. Amaresh Vydyanathan|7189204316|avydyana@montefiore.org|
20525039|NCT04724538|P. Hertsen Moscow Oncology Research Institute|Mariia Sedova, MD|+79253093463|mariya.sedova58@gmail.com|
20525040|NCT00942890|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
20525041|NCT00911612|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
20525042|NCT02097238|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20525043|NCT01282372|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20525044|NCT00648115|VA North Texas Health Care System|James LePage|210-857-0240|james.lepage@va.gov|
20525045|NCT02097745|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20537930|NCT01778049|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20537931|NCT01180894|Denver Health Hospital|Dr. Fredric Pieracci|303-436-4029|fredric.pieracci@dhha.org|
20537932|NCT04011826|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
20537933|NCT03609385|Charité-Universitätsmedizin Berlin|Dr. Christian Nolte|+4930450560676|christian.nolte@charite.de|
20537934|NCT02118766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537935|NCT01394692|Johann Wolfgang Goethe University|Dr. Christian Senft|+49 69 63015939|c.senft@med.uni-frankfurt.de|
20537936|NCT00541866|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
20537937|NCT01638013|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20537938|NCT01824823|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20553897|NCT01194297|University of Rochester|Dr. Carl D'Angio|585-275-2972|carl_dangio@urmc.rochester.edu|
20525046|NCT01435304|Maine Medical Center|Dr. Robert S Kramer|207-662-1486|Kramer@mmc.com|
20525047|NCT01959464|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
20525048|NCT03515811|Medtronic|Andrea DiScipio, Senior Clinical Research Specialist|781-491-5350|andrea.l.discipio@medtronic.com|
20525049|NCT00237458|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20525050|NCT02683928|Ichnos Sciences SA|Study Director|2013314000|clinicaltrialsdisclosuredesk@ichnossciences.com|
20525051|NCT01276756|Cairo University|Dr. Hany Shehab|00201111111071|h.shehab@drshehab.com|
20525052|NCT01014169|Boston University School of Medicine/Boston Medical Center|Dr Caroline Kistin|617-414-3642|caroline.kistin@bmc.org|
20525053|NCT05868577|Atrium Health Wake Forest Baptist|Michael Jones, DPM|704-355-2000|michael.jones4@advocatehealth.org|
20525054|NCT02630251|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
20525055|NCT03564119|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
20525056|NCT00634036|University of Pittsburgh|Dr. Fernando Holguin|412-692-2817|holguinf@upmc.edu|
20525057|NCT03896022|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
20525058|NCT04573322|Diffusion Pharmaceuticals|Chris Galloway, MD (Chief Medical Officer)|(434) 220-0718|cgalloway@diffusionpharma.com|
20525059|NCT01131455|ColumbiaOG|Vicki L Jones, Research Coordinator|573-443-2402|v.jones@columbiaorthogroup.com|4391
20525060|NCT01760655|Tevogen Bio|Dolores Grosso|848-256-5751|dolores.grosso@tevogen.com|
20525061|NCT05864612|Wake Forest University Health Sciences|Heidi Munger-Clary, MD, MPH, FACNS, FAES|336-716-7110|heidi.mungerclary@advocatehealth.org|
20525062|NCT03100968|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
20525063|NCT04738474|University of Washington|Jill Steiner|2062218240|jills8@uw.edu|
20525064|NCT04973176|University Hospitals Coventry and Warwickshire NHS Trust|Dr Cyprian Mendonnca|02476964000|cyprian.mendonca@uhcw.nhs.uk|25784
20525065|NCT03960008|Lahey Hospital & Medical Center|Julia Roache, Manger, Research Programs|7817443055|julia.roache@lahey.org|
20525066|NCT03056638|Memorial Sloan Kettering Cancer Center|Dr. Michael Zelefsky, MD|212-639-6802|zelefskm@mskcc.org|
20525067|NCT02530125|Northwestern University|Winter, Jane MD|312 695 4033|Jwinter@nm.org|
20525068|NCT00468481|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20525069|NCT03187418|Centre Hospitalier de l'Universite de Montreal (CHUM)|Dr. Michael Marchand, MD|514-890-8000|michael.marchand-gareau@umontreal.ca|
20525070|NCT01568034|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
20525071|NCT00728468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525072|NCT01637922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525073|NCT01515865|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20525074|NCT01450306|Hartford Hospital|Dr David Tolin|860-545-7685|david.tolin@hhchealth.org|
20525075|NCT04687137|Shire|Study Director|: +1 866 842 5335|ClinicalTransparency@shire.com|
20525076|NCT02510664|Baylor College of Medicine|Marisa Hilliard PhD, Principal Investigator|832-824-7209|marisa.hilliard@bcm.edu|
20525077|NCT00735969|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|High Dose Ribavirin in Combination With Peginterferon for Patients With Chronic Hepatitis C Genotype|(301) 402-5115|mg228m@nih.gov|
20525078|NCT02110758|National Committee for Quality Assurance|Sarah Hudson Scholle|202-955-1726|scholle@ncqa.org|
20525079|NCT00740792|Meda Pharmaceuticals|David Ginsberg,D.O.|7325642364|david.ginsberg@meda.us|
20525080|NCT01921322|Medtronic Diabetes|John Shin, PhD|818-576-4019|john.shin@medtronic.com|
20525081|NCT02417142|UMass Medical School|Xiaoduo Fan, MD, MPH|(508) 856 -3881|xiaoduo.fan@umassmed.edu|
20525082|NCT04632069|Medical University of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
20525083|NCT04042623|Aravive|Dr. Reshma Rangwala, Chief Medical Officer|936-355-1910|rrangwala@aravive.com|
20537939|NCT04028765|Thomas Jefferson University Health System|Dr. Whitney Bender|4342948416|whitney.bender@jefferson.edu|
20537940|NCT04857437|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537941|NCT02576535|NYU Langone Medical Center|Paul Huang|212-263-6414|Paul.Huang@nyumc.org|
20537942|NCT00504504|University of Texas (UT) MD Anderson Cancer|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
20525084|NCT02573181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569486|NCT00661544|U.T. M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD / Associate Professor|713-745-3458||
20537943|NCT04035564|"Hospital del Niño de Saltillo Dr. Federico Gomez Santos"|Carlos Sanchez|+528441757244|sanchez.carlos8516@gmail.com|
20569487|NCT00943722|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569488|NCT01848067|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jianqing Lin|(215) 955-8874|jianqing.lin@jefferson.edu|
20525085|NCT03412734|TriHealth Inc.|Catrina Crisp, MD MSc|513-463-4300|Catrina_Crisp@trihealth.com|
20569489|NCT02434523|Boston Medical Center|Dr. Jacob Pieter Noordzij|617-638-8124|Pieter.Noordzij@bmc.org|
20569490|NCT00676897|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
20569491|NCT00997932|University of North Carolina School of Medicine|Dr. G Stuart|919-962-4880|gstuart@med.unc.edu|
20569492|NCT01040403|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569493|NCT00594178|Dept of PM&R; University of Arkansas for Medical Sciences|Thomas S. Kiser|501-221-1311|kiserthomass@uams.edu|
20569494|NCT00496626|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569495|NCT01035047|Wake Forest Baptist Medical Center|Erin Harper|336-716-2059|erharper@wakehealth.edu|
20569496|NCT02840916|Kaohsiung Chang Gung Memorial Hospital|Dr. Wen-Long Hu|+886-7-731-7123|oolonghu@gmail.com|2334
20569497|NCT04191148|Medpace|Clinical Trial Manager|513-630-0130|E.Plummer@Medpace.com|
20569498|NCT01874665|Ariad Pharmaceuticals|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
20569499|NCT02647788|University of Pennsylvania|Dr. Benjamin Gray|215-294-9650|Benjamin.Gray@uphs.upenn.edu|
20569500|NCT03245619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20569501|NCT04752033|Mayo Clinic|Dr. Joseph Pleticha|5073588378|Pleticha.joseph@mayo.edu|
20569502|NCT00776659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569503|NCT00726713|Pamlab Inc.|Page Young, Clinical Project Manager|985-867-5788|pyoung@pamlab.com|
20569504|NCT01233999|Emory University|Dr. Suephy Chen|404-778-3084|schen2@emory.edu|
20569505|NCT00025506|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20569506|NCT02246218|Horizon Therapeutics, LLC|Colleen Canavan, Director|866-479-6742|clinicaltrials@horizonpharma.com|
20569507|NCT02547441|Clinical Development Dept.|Maruho Co., Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20569508|NCT01322009|University of Pittsburgh|Robert Clark|412-692-7260|clarkrs@ccm.upmc.edu|
20569509|NCT01657877|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569510|NCT01532635|Thomas Jefferson University|Neal Flomenberg, MD|215-955-8874|Neal.Flomenberg@jefferson.edu|
20569511|NCT00905034|University of Texas (UT) MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor, Leukemia|713-563-1586|CR_Study_Registration@mdanderson.org|
20569512|NCT03700372|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|cschneider@farapulse.com|
20525086|NCT00179660|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20525087|NCT03935425|Flint Rehab|Daniel Zondervan|9493137322|dzondervan@flintrehab.com|
20525088|NCT04478695|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20525089|NCT00402688|Ortho-McNeil Janssen Scientific Affairs, LLC|Therapeutic Area Lead, Anti-Infective Franchise|908-927-5220||
20525090|NCT00927862|Intermountain Healthcare|Dr. Jeffrey L. Anderson, Director of CV Research and Professor of Medicine|801-507-4704|jeffrey.anderson@imail.org|
20525091|NCT02049905|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20525092|NCT03980145|Indiana University|Peter Altenburger|3172780703|paltenbu@iu.edu|
20525093|NCT02892110|MUSC|Amanda Wagner, Program Manager|843-792-0484|wagne@musc.edu|
20525094|NCT01814696|Partners Healthcare Connected Health Innovation|Kamal Jethwani, MD, MPH|617-724-3410|kjethwani@partners.org|
20525095|NCT00713258|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
20525096|NCT01322490|Bavarian Nordic A/S|Program Lead, Clinical Operations|+ 45 3326|info@bavarian-nordic.com|8383
20525097|NCT01431716|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD, Senior Clinical Scientist|+41 61 565 5932|thomas.pfister@actelion.com|
20525098|NCT02307279|Gelesis|Harry Leider, MD, MBA|(443)934-4906|hleider@gelesis.com|
20525099|NCT04594070|University of Texas Medical Branch Galveston|Dr. Melody Safarzadeh|9082854962|mesafarz@utmb.edu|
20537944|NCT00996281|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20537945|NCT03777709|Mayo Clinic|Dr. LaPrincess Brewer|5072661376|brewer.laprincess@mayo.edu|
20525100|NCT00708214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525101|NCT02073448|Galderma K.K|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
20525102|NCT04972110|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
20525103|NCT03620643|The Royal Marsden NHS Foundation Trust|Clinical Trial Manager|02078082887|rolo.trial@rmh.nhs.uk|
20525104|NCT05310071|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20525105|NCT02418949|Shirley Ryan AbilityLab|Alexander Barry|3122381435|abarry@sralab.org|
20525106|NCT02343939|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20525107|NCT00460811|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
20525108|NCT00514215|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
20525109|NCT03480542|Hackensack Meriden Health|Cole McCoy|551-204-5529|cole.mccoy@hmhn.org|
20525110|NCT03278223|Visioncare Research Ltd.|Mr Thomas Boyes, Clinical Project Manager|+441252 718719|t.boyes@visioncare.co.uk|223
20525111|NCT02099110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525112|NCT02293512|VA Portland Healthcare System|Erin Martz, PhD|503.220.8262|erin.martz@va.gov|56006
20525113|NCT01757184|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20525114|NCT02977572|INTENSIVE CARE UNIT. HOSPITAL GENERAL UNIVERSITARI CASTELLO|Dr. Alberto Belenguer Muncharaz|0034-964-725000|belengueralberto8@gmail.com|
20525115|NCT01537042|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
20537946|NCT03505788|Ziekenhuis Oost-Limburg|Prof. dr. Wilfried Mullens|+32(0)89327140|wilfried.mullens@zol.be|
20507649|NCT03722472|Access to Advanced Health Institute (AAHI)|Christopher Fox PhD|(206) 381-0883|Christopher.Fox@aahi.org|
20507650|NCT02420795|UT MD Anderson Cancer Center|Michael Wang, MD, Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
20507651|NCT02658968|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
20507652|NCT00949910|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20507653|NCT03287869|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20507654|NCT02455388|Virginia Tech|Dr. Brenda Davy|540-231-6784|bdavy@vt.edu|
20507655|NCT04847141|Sr Manager, Clinical Research, Scientific Innovation Office (SIO)|Mireia Torres|+34 93 5710500|mireia.torres@grifols.com|
20507656|NCT00324740|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20507657|NCT00971425|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507658|NCT02528253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507659|NCT01357980|Ipsen|Medical Director Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20507660|NCT01705964|University of Louisville|Dr. Kerry Caperell|502-629-7212|k0cape01@louisville.edu|
20507661|NCT00094835|Amgen Inc.|Study Director|866-572-6436||
20507662|NCT00505752|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20507663|NCT01009918|University of South Florida|Maya Guglin, MD, PhD|813-259-0600|mguglin@health.usf.edu|
20507664|NCT03819218|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
20507665|NCT02267278|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
20507666|NCT02513771|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20507667|NCT01595438|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
20507668|NCT00550277|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
20507669|NCT00650091|Duke Clinical Research Institute|Kevin J Anstrom|919-668-8902|kevin.anstrom@duke.edu|
20507670|NCT01204697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20507671|NCT01280266|Seoul National University|Dr. Eun Bong Lee|+82 2 2072-3944|leb7616@snu.ac.kr|
20507672|NCT04295356|CELLTRION, Inc.|Sung Hyun Kim, Head of Clinical Planning Department|+82 32 850 5778|SungHyun.Kim@celltrion.com|
20507673|NCT01784588|Boston Scientific|Teresa Takle-Flach|952-930-6000|Teresa.Takle-Flach@bsci.com|
20507674|NCT02084069|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
20525116|NCT02741076|Janssen Pharmaceuticals, Inc.|John Han, Associate Director, Statistics|484-354-3547|jhan9@its.jnj.com|
20525117|NCT01329380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20525118|NCT01779440|Dartmouth-Hitchcock|Mary F. Brunette, MD|603-229-5419|Mary.F.Brunette@hitchcock.org|
20525119|NCT01115244|Vanderbilt University Medical Center|Mary Beth Cole|(615) 322-6485||
20525120|NCT00315458|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
20525121|NCT00523848|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20525122|NCT00086619|Massachusetts General Hospital|Robert Neer, MD|617-726-6723|rneer@partners.org|
20525123|NCT00489918|Zosano Pharma Inc.|Don Kellerman, VP of Clinical Development and Medical Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
20525124|NCT02748213|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20525125|NCT00913263|Dept. of Surgery, Tampere University Hospital, Tampere, Finland|Teuvo Tammela, Professor|+358-3-31164621|teuvo.tammela@uta.fi|
20525126|NCT01209520|University of Miami|Ikechukwu Akunyili MD|305-243-6626|IAkunyili@med.miami.edu|
20525127|NCT00961350|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
20525128|NCT02508077|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20525129|NCT06868654|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20525130|NCT04818034|University of California, San Francisco|Marshall Stoller|415-514-0918|victoria.hogue@ucsf.edu|
20525131|NCT04325568|New York University|Dr. Lawrence Yang|(212) 992-6334|lawrence.yang@nyu.edu|
20525132|NCT01270464|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20525133|NCT02448537|Massachusetts General Hospital|Gregory Cote, M.D., Ph.D|617-724-4000|gcote@partners.org|
20525134|NCT04725812|Cedars-Sinai Medical Center|Professor of Medicine, Cedars-Sinai Medical Center|310-423-7608|sananth.karumanchi@csmc.edu|
20507675|NCT04655703|Northwell Health System|Eugene S. Krauss|516-496-2637|ekrauss@northwell.edu|
20525135|NCT05778851|PAVmed Inc., Lucid Diagnostics Inc.|Victoria T. Lee, MD CMO, SVM Clinical Affairs|425.218.6535|VTL@PAVmed.com|
20569513|NCT00394589|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20569514|NCT03409731|Abbott medical device|Hajime Kusano|+1 408-845-1626|hajime.kusano@abbott.com|
20569515|NCT01114672|Winthrop University Hospital|Mary Schanler, Principal Investigator|5156639028|mschanler@winthrop.org|
20569516|NCT04672798|University of Pittsburgh|Dr. Stephanie Stepp|412-715-5447|steppsd@upmc.edu|
20569517|NCT01710800|Walter Reed National Military Medical Center|Dr. Fouad J. Moawad|(301) 400-1551|Fouad.Moawad@us.army.mil|
20569518|NCT02427958|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20569519|NCT00812838|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
20569520|NCT04148521|Atrium Health|Jason Roberge|7043550268|jason.roberge@atriumhealth.org|
20569521|NCT01530659|Neurotech USA, Inc.|Neurotech, Sr. Director of Clinical Operations|629-333-5804|p.davis@neurotechusa.com|
20569522|NCT00953862|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
20569523|NCT02287883|University of California, Berkeley|Patricia Ramsay, Project Drector|(510)643-8063|pramsay@berkeley.edu|
20569524|NCT00634920|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20569525|NCT03029611|UWashington (University of Washington)|Director of Clinical Operations|206-616-2305|childj@u.washington.edu|
20569526|NCT01527500|Novartis Pharmaceuticals|Study Director|862-778-8300||
20569527|NCT00372255|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569528|NCT02341599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569529|NCT01125566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569530|NCT01560585|University Hospitals Cleveland Medical Center - Cleveland, OH|Alan J Lerner,MD|1 216 464 6449|alan.lerner@uhhospitals.org|
20569531|NCT02970305|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
20569532|NCT01813305|Charsire Biotechnology Corp.|R&D associate|+886-6-702-0817|cs42@charsire.com|
20569533|NCT00988117|UCaliforniaSF|Dr. Bruce Miller|415-476-5569|bmiller@memory.ucsf.edu; kpossin@memory.ucsf.edu|
20569534|NCT04088500|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20569535|NCT00574171|UW Carbone Cancer Center|Dr. William Schelman|608-265-4347|wrs@medicine.wisc.edu|
20569536|NCT01355471|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20569537|NCT02930837|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569538|NCT02917421|Weill Medical College|Dr.Silvia Formenti|212-746-3608|shc2043@med.cornell.edu|
20569539|NCT01508832|University of California San Francisco|Ronald D Miller, MD|415 476-9034|millerr@anesthesia.ucsf.edu|
20569540|NCT02973802|Apitope International|CEO|+44(0)1291 635511|info@apitope.com|
20569541|NCT02122549|ZOLL|Vice President of Medical Affairs|412-968-3333|stevens@zoll.com|14400
20569542|NCT01850823|Teva Pharmaceuticals Inc., USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
20569543|NCT01751165|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569544|NCT00988533|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
20569545|NCT01387815|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20569546|NCT03752242|BioMimetix|Director of Clinical Operations|303-862-7268|contact@bmxpharma.com|
20569547|NCT00913523|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Senior Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20569548|NCT01202409|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-745-4317|moverman@mdanderson.org|
20569549|NCT00553605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507676|NCT00469209|University of Texas M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD/Professor, Stem Cell Transplantation|713-745-3458|mqazilba@mdanderson.org|
20569550|NCT03206476|Universidad de Guadalajara|Dra. Gabriela Macedo Ojeda|(+52) 3310585200|gabriela.macedo@cucs.udg.mx|33900
20569551|NCT05694533|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
20507677|NCT00961441|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20525136|NCT02801617|Laboratorios Sophia|Dr. Oscar Olvera|(33) 3001 4200|oscar.olvera@sophia.com.mx|1074
20525137|NCT01164579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525138|NCT02215200|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8361|cjgreen@benaroyaresearch.org|
20525139|NCT02973503|CHU Clermont-Ferrand|Armand Abergel|+33473750523|aabergel@chu-clermontferrand.fr|
20525140|NCT01620190|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
20525141|NCT02875613|UC San Diego - Moores Cancer Center|Dr. Assuntina Sacco|858-822-5210|agsacco@ucsd.edu|
20525142|NCT02347774|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20525143|NCT04306965|Tufts Medical Center|Study Coordinator|617-636-1579|courtney.donovan@tuftsmedicine.org|
20525144|NCT00820248|Canadian Cancer Trials Group|Wendy Parulekar|613-533-6430|wparulekar@ctg.queensu.ca|
20525145|NCT01562782|The Rogosin Institute|Lisa Hudgins, M.D.|646-317-0805|lih2013@nyp.org|
20525146|NCT01091662|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
20525147|NCT02308540|PATH|Dr. Steve Lamola|1-206-285-3500|slamola@path.org|
20525148|NCT04109391|Tanvex|Study Director|19494838507|jennifer.lai@tanvex.com|
20569552|NCT00292981|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
20525149|NCT02156908|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|josh.kantrowitz@nki.rfmh.org|
20553898|NCT01824303|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20525150|NCT01371110|Baylor College of Medicine (previously Icahn School of Medicine at Mount Sinai)|Wayne Goodman|713-798-4945|wayne.goodman@bcm.edu|
20569553|NCT01085812|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20569554|NCT02005393|FujiFilm Medical Systems USA|Robert Uzenoff: Executive Director of Clinical Science|(203) 602-3664|ruzenoff@fujifilm.com|
20525151|NCT00945035|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525152|NCT00835224|James J Peters VAMC|Dr. Jill M. Wecht|718 584-9000|jm.wecht@va.gov|3122
20525153|NCT02993250|Janssen Pharmaceutical K.K., Japan|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20525154|NCT00776295|H. Lee Moffitt Cancer Center|Mohamed Kharfan Dabaja, MD|961-1350000|MK143@aub.edu.lb|5350
20525155|NCT00356148|Marmara University School of Medicine|Prof. Bahadir M Gulluoglu|902164256565|bmgulluoglu@marmara.edu.tr|4012
20525156|NCT02484456|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
20525157|NCT02730403|NYU Grossman School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyulangone.org|
20525158|NCT03852264|University of Arizona|Dr. Evan MacLean|520-621-0386|evanmaclean@arizona.edu|
20525159|NCT04922255|University of Pittsburgh|Megan Bradley, MD|2487701681|megsbrad2010@gmail.com|
20525160|NCT02737930|University of Rochester|Bogachan Sahin|(585) 275-2530|bogachan_sahin@urmc.rochester.edu|
20525161|NCT03522714|Northwestern University|Peter Ullrich, Clinical Research Coordinator|3129267037|peter.ullrich@nm.org|
20525162|NCT04481789|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
20525163|NCT01413750|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20525164|NCT03124407|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
20525165|NCT03761030|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|bret.rutherford@nyspi.columbia.edu|
20525166|NCT05708976|University of California San Francisco|Ashley E. Mason, PhD|4155146820|ashley.mason@ucsf.edu|
20525167|NCT01342523|University of Wisconsin|Stevens Smith, PhD|608-262-7563|sss@ctri.wisc.edu|
20525168|NCT00556946|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
20525169|NCT02929589|MOMMC|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
20525170|NCT02755467|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20525171|NCT02091089|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20525172|NCT03187730|NYU Langone|Elizabeth Vargas|310-486-9775|elizabeth.varagas@nyulangone.org|
20525173|NCT04668248|Brigham and Women's Hospital|Julie Lauffenburger, PharmD, PhD|617-525-8865|jlauffenburger@bwh.harvard.edu|
20525174|NCT00504712|Barnsley Hospital NHS Foundation Trust|Professor TH Jones|01226 431684||
20525175|NCT01303172|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0) 20 3137 6346|info@immodulon.com|
20525176|NCT02821754|Principal Investigator|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
20525177|NCT03635515|University of Minnesota|Ronald Ordinola Zapata DDS, MS, PhD|(612) 624-9900|rordinol@umn.edu|
20525178|NCT00994461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525179|NCT00766636|University of Texas MD Anderson Cancer Center|Jason B. Fleming, MD / Surgical Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
20525180|NCT00461773|The Christ Hospital|Gina G. Chung, MD|(513) 564-7771|gina.chung@thechristhospital.com|
20525181|NCT04571645|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20525182|NCT03723850|University of Chicago|Dr. David Gallo|773-702-8829|dgallo@uchicago.edu|
20525183|NCT03147690|Boston Children's Hospital|Dr. David Mooney, MD MPH|617-355-7800|david.mooney@childrens.harvard.edu|
20525184|NCT02060838|Nationwide Children's Hospital|Aymen Naguib, MD|(614) 722-0596|Aymen.Naguib@nationwidechildrens.org|
20525185|NCT00591565|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
20525186|NCT00454363|UT MD Anderson Cancer Center|Dr. James Yao, MD/Professor, GI Medical Oncology, Study Principal Investigator|713-792-2828|jyao@mdanderson.org|
20525187|NCT02811965|Lincoln Memorial University|Jennifer Savage, DNP, APN, FNP-BC||jennifer.savage@lmunet.edu|
20525188|NCT01863667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525189|NCT01992172|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
20525190|NCT03627546|Weill Cornell Medicine|Kristen Marks|212-746-4177|markskr@med.cornell.edu|
20525191|NCT01731119|UNC-Chapel Hill|Dr. Linmarie Sikich||linmarie_sikich@med.unc.edu|
20525192|NCT01017536|Aeras|Bernard Landry|301-547-2900|blandry@aeras.org|
20525193|NCT01385137|SWOG Statistical Center|Study Statistician|206-667-4623||
20525194|NCT02837731|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20525195|NCT02965573|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20525196|NCT01294241|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
20525197|NCT01669863|Hannover Medical School|Dr Marius Hoeper|00495115323530|hoeper.marius@mh-hannover.de|
20525198|NCT02644668|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
20525199|NCT03291431|Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences|Dr. Timothy C. Durazzo/Project PI|650-493-5000|tdurazzo@stanford.edu|62982
20525200|NCT05908526|University of Maryland, Baltimore|Emerson Wickwire, PhD|410-706-4771|ewickwire@som.umaryland.edu|
20525201|NCT02835625|Cancer Registry of Norway|Prof. Solveig Hofvind|+47 22928828|solveig.hofvind@kreftregisteret.no|
20525202|NCT03850483|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525203|NCT01190410|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20525204|NCT03867409|Mayo Clinic of Jacksonville|Dr. Janice Krieger|904-953-6160|krieger.janice@mayo.edu|
20525205|NCT01108341|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20569555|NCT04582669|Montefiore Medical Center|Haley Heibel, MD|(718) 920-8352|hheibel@montefiore.org|
20525206|NCT05656534|The Ohio State University|Dr. Stephanie Gorka|614-366-1027|stephanie.gorka@osumc.edu|
20569556|NCT02090998|Rutgers/RWJMS|william grubb md|7322357827|grubbwr@rwjms.rutgers.edu|
20537947|NCT03575065|BeiGene|Study Director|+1 - 877-828-5568|clinicaltrials@beigene.com|
20569557|NCT01274559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20537948|NCT03617536|Cara Therapeutics|Director of Clinical Trials|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20569558|NCT03231969|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
20537949|NCT02323126|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20537950|NCT03333252|Weill Medical College of Cornell University|Sara J. Czaja|646-962-7141|sjc7004@med.cornell.edu|
20569559|NCT02314104|St. Barnabas Medical Center|Dr. Eric Liberman|917-696-1370|eliberma@montefiore.org|
20537951|NCT00113399|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
20537952|NCT00396136|Biotronik, Inc.|Clinical Studies|503-451-8050|katerina.demetz@biotronik.com|
20537953|NCT01779856|Medtronic, plc|RCS Sr. Director of Medical Affairs|763-505-4566|amy.denise.roettger@medtronic.com|
20537954|NCT03960580|OptiNose|John Messina, PharmD, SVP of Clinical Research & Medical Affairs|265-521-0565|john.messina@optinose.com|
20537955|NCT01528891|Children's Hospital of Pittsburgh of UPMC|Peter J. Davis, MD|4126925260|davispj@anes.upmc.edu|
20569560|NCT03503162|Motus GI|Director of Clinical Operations|954-541-8000|anniec@motusgi.com|
20537956|NCT04452435|Vicore Pharma|Carl-Johan Dalsgaard|+46 70 975 98 63|carl-johan.dalsgaard@vicorepharma.com|
20569561|NCT03416621|Duke Cancer Institute|Dr. Kathryn I Pollak|919-681-4757|kathryn.pollak@duke.edu|
20537957|NCT01437098|Medtronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
20537958|NCT00834990|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20569562|NCT00545571|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20537959|NCT01235923|University of Utah|Robin Ohls|801-581-7052|robin.ohls@hsc.utah.edu|
20537960|NCT02680041|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
20537961|NCT00521599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20537962|NCT00791479|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537963|NCT01610713|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20537964|NCT01364558|University of Minnesota|Dr. James Cloyd, Director for Center for Orphan drug research|612-624-4609|cloyd001@umn.edu|
20537965|NCT01794741|Meda Pharmaceuticals|Dr Nancy Ruiz, MD|732 564 2390|nancy.ruiz@meda.us|
20537966|NCT01774097|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|lemmoye@msn.com|
20537967|NCT00557310|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20537968|NCT00585494|University of Wisconsin Madison|Ann Marie Sheehy, M.D., M.S.|608-335-6734|asr@medicine.wisc.edu|
20537969|NCT01920568|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537970|NCT00350363|Stanford|Professor|650-723-6995|cta@stanford.edu|
20537971|NCT01703208|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20537972|NCT00252694|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
20537973|NCT03651856|Medical University of SC|Dr. Gonzalo Revuelta|843-792-7262|revuelta@musc.edu|
20537974|NCT05082428|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20537975|NCT04699032|VectivBio AG|Reda Sheik|+41615513030|clinicaltrials@vectivbio.com|
20537976|NCT01271712|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20537977|NCT00096226|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20537978|NCT04003207|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|(212) 659-9134|alexander.kolevzon@mssm.edu|
20537979|NCT00468676|Dept Psychiatry, University of Washington Medical School|Dr Wayne Katon, Professor and Vice Chair|206-543-7177|wkaton@uw.edu|
20537980|NCT04173260|University of Pennsylvania|Dr. Andres Deik|2158297049|adeik@upenn.edu|
20537981|NCT03941964|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20537982|NCT00443053|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537983|NCT01632241|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20537984|NCT05463744|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20537985|NCT03088748|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
20537986|NCT00068250|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20537987|NCT01660672|University of Rochester Medical Center|Gretchen Birbeck|585-273-4265|Gretchen_Birbeck@URMC.Rochester.edu|
20537988|NCT03955250|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|BGaudiano@Butler.org|
20537989|NCT01774253|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
20537990|NCT02240368|University of Foggia|Alberto Sciusco||alberto.sciusco@gmail.com|
20537991|NCT02793817|Kala Pharmaceuticals, Inc.|Head, Clinical Operations|781-996-5252|Results005@kalarx.com|
20537992|NCT01097642|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
20537993|NCT00871117|GlaxoSmithKline|GSK Response Center|866-435-7343||
20537994|NCT02080481|Cleveland Clinic|Aplarslan Turan, MD|216-445-9857|turana@ccf.org|
20537995|NCT00859339|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20537996|NCT00840060|Lamar University|Monica Harn|409-880-8174|monica.harn@lamar.edu|
20537997|NCT03571672|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
20537998|NCT03095027|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20569563|NCT01978236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20537999|NCT00395291|University of Virginia|W. Kline Bolton, MD|434-924-9692|wkb5s@Virginia.edu|
20538000|NCT01962987|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20538001|NCT00316693|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538002|NCT02982018|Johnson & Johnson Vision|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
20538003|NCT03638908|UTSouthwestern medical center|Kelly Chin, MD|2146456493|kelly.chin@utsouthwestern.edu|
20538004|NCT01559922|Suneva Medical, Inc.|Suneva Medical,Inc.||Acne.ScarInfo@sunevamedical.com|
20538005|NCT03245736|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
20538006|NCT01116024|Medtronic, Inc.|Ryan Palmer, Principal Clinical Research Specialist|763-514-9732|ryan.j.palmer@medtronic.com|49732
20538007|NCT00132691|Center for Presventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania|John H. Kempen, MD, PhD, MUST Trial Vice-Chairman|215-615-1500|john.kempen@uphs.upenn.edu|
20538008|NCT02251717|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20538009|NCT04098367|Alcon Research, LLC|Sr. CDMA Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20538010|NCT00445939|Abbott|Global Medical Services|800-633-9110||
20538011|NCT02154048|Duke University|Steve Melton, MD|919.668.2047|steve.melton@duke.edu|
20538012|NCT03515226|University of Washington, Department of Psychiatry & Behavioral Sciences|Dr. Patricia Arean, Director, UW ALACRITY Center|206-221-8692|parean@uw.edu|
20538013|NCT03010137|UC Davis Medical Center|Dr. Yunfeng Xue|408-603-0507|yunxue@ucdavis.edu|
20538014|NCT00322023|Nathan Kline Institute|Dr. Daniel Javitt|845-398-6534|javitt@nki.rfmh.org|
20538015|NCT01952444|Elusys Therapeutics Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
20538016|NCT01477463|Stanford University School of Medicine|Jean Y Tang MD PhD, assistant professor|650-721-7149|baileyhi@stanford.edu|
20538017|NCT00354107|Children's Oncology Group|Results Reporting Coordinator|3522730558|resultsreportingcoordinator@childrensoncologygroup.org|
20538018|NCT02002936|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
20538019|NCT00369226|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
20538020|NCT03361189|UCLA|Dr. Jeremy P. Moore|310-267-7667|RGoldstein@mednet.ucla.edu|
20538021|NCT02309645|Ethicon Inc.|Senior Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20538022|NCT04600076|University of Michigan|Katherine Jo Gold|734 998-2499|ktgold@med.umich.edu|
20538023|NCT01342965|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20538024|NCT01170598|University Health Network|Sara O'Neill|416-597-3422|o'neill.sara@torontorehab.on.ca|7860
20538025|NCT01509677|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20538026|NCT00499655|City of Hope|Karen L. Reckamp, M.D.|(626) 256-4673|kreckamp@coh.org|
20538027|NCT00607269|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D., Statistician|323-463-1601|jfletcher@friendsresearch.org|
20538028|NCT02780856|Calcivis Ltd|Director of Clinical Research|+ 44 131 658 5152|mwillins@calcivis.com|
20538029|NCT00534118|Roswell Park Cancer Institute|Theresa Hahn|716-845-2300|theresa.hahn@roswellpark.org|
20538030|NCT04270682|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20538031|NCT00589056|University of Pennsylvania|Ramesh Rengan, M.D., Ph.D.|(215) 662-2428|Rengan@xrt.upenn.edu|
20538032|NCT03894969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20538033|NCT05129072|Bausch + Lomb Incorporated|Steffen Robert, Senior Director Clinical Affairs|15853386399|robert.steffen@bauschcloud.com|
20538034|NCT02388490|Seoul National University Hospital|Tae Min Kim|82+2-2072-3559|gabriel9@snu.ac.kr|
20538035|NCT02378298|Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg|Helena Filipsson Nyström|0046-705833398|helena.filipsson@medic.gu.se|
20538036|NCT04762043|Altec, Inc.|Dr. Joshua Kline|5085458212|jkline@altecresearch.com|
20538037|NCT02308163|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
20538038|NCT05235971|University of Michigan|Lara N. Coughlin, Ph.D.|734-936-3101|laraco@med.umich.edu|
20538039|NCT03478254|Ciudad Real University Hospital. Castilla La Mancha Health Service.|Angela M. Seco Segura RN, Endocrinology and Nutrition Department.|926278000|amsese@live.com|79510
20538040|NCT00726037|Northwestern Medicine Regional Medical Group|Margret Shoup|630-352-5450|MSHOUP@lumc.edu|
20538041|NCT00118846|Director, Atherosclerosis Research Unit, University of Southern California|Howard N. Hodis, M.D.|323-442-1478|athero@usc.edu|
20538042|NCT00522418|Cyberonics, Inc|Mark Bunker, Senior Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
20538043|NCT01574157|VA Salt Lake City Healthcare System|Dr. Kalani Raphael, Principal Investigator|801-582-1565|kalani.raphael@va.gov|1794
20538044|NCT04420572|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
20538045|NCT00578877|CONRAD|Jill Schwartz, M.D.|703-276-3913|jschwartz@conrad.org|
20538046|NCT02305017|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20538047|NCT02302092|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20538048|NCT01944098|TeamHealth Anesthesia|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
20538049|NCT04669262|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20538050|NCT01357161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538051|NCT02956044|Translational Medicine Group|Program Director|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
20538052|NCT03832114|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20538053|NCT00750191|The Center for Clinical Research|Dr. Leonard Kapural|1-336-765-6181|LKapural@ccrpain.com|
20538054|NCT02910401|University of Virginia|Larry Borish, MD|4342436570|lb4@virginia.edu|
20538055|NCT01165112|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
20538056|NCT00098748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20538057|NCT00433160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20538058|NCT03802344|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
20538059|NCT01010568|Georgetown University Hospital|Bruce D. Cheson|202-444-1212|bdc4@georgetown.edu|
20538060|NCT03222973|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20538061|NCT03998670|PEDIG Coordinating Center, Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|813 975 8690|rkraker@jaeb.org|
20538062|NCT03020017|Northwestern University|Priya Kumthekar|312 908 5073|p-kumthekar@northwestern.edu|
20538063|NCT00496483|Veloxis A/S|Christina Sylvest, Sr VP, Global Clinical Development and Operations|+45 20553877|csy@veloxis.com|
20538064|NCT00428220|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538065|NCT05858450|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20538066|NCT00642174|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20538067|NCT00896363|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538068|NCT01730339|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538069|NCT01065051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20538070|NCT02068846|University of North Carolina at Chapel Hill|Jennifer Webster-Cyriaque, DDS, PhD|(919) 537-3492|jwebster@email.unc.edu|
20538071|NCT00919867|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20538072|NCT03920293|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20538073|NCT03555981|London School of Hygiene & Tropical Medicine|Dr Helen Brotherton|07481474150|helen.brotherton@lshtm.ac.uk|
20569564|NCT03367910|Washington University in St. Louis School of Medicine|Kimberly Reske, Research Coordinator|3147474041|kreske@wustl.edu|
20569565|NCT01193218|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569566|NCT00363649|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
20569567|NCT01013740|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20569568|NCT00979745|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
20569569|NCT03811834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20569570|NCT00576823|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20569571|NCT01242371|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
20569572|NCT00510146|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20569573|NCT03360110|CooperVision|Myhanh Nguyen, OD, Manager of Clinical Research|19257306716|MNguyen@coopervision.com|
20569574|NCT03188536|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20569575|NCT01930214|Cardiovascular Systems Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
20569576|NCT00025662|NHLBI|A. John Barrett|301-402-4170|barrettjj@mail.nih.gov|
20569577|NCT01748045|Tufts Medical Center|Dr. Christiane Dammann|617-636-8738|cdammann@tuftsmedicalcenter.org|
20569578|NCT02132117|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20569579|NCT04947436|University of Texas Health San Antonio|Dr. Donna Gardner|210-450-8479|dgardner62001@gmail.com|
20538074|NCT03344549|University of Colima|Ari Cisneros Hernández|3335762299|aricisneroshernandez@gmail.com|
20538075|NCT01679600|Bern University of Applied Sciences|Dr. Oliver Stoller|+41344264195|oliver.stoller@bfh.ch|
20538076|NCT00108303|VA|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
20538077|NCT01685801|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20538078|NCT03350256|Abbott|Filippo Agnesi|+19725264860|filippo.agnesi@abbott.com|
20538079|NCT00773786|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD||rzuwalla@stfranciscare.org|
20538080|NCT00543296|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
20538081|NCT03828422|University Medical Centre Ljubljana|dr. Aleš Blinc, MD, PhD|+38615227124|ales.blinc@kclj.si|
20538082|NCT00934947|UNC Department of Anesthesiology|Samuel McLean|919-966-7315|smclean@aims.unc.edu|
20538083|NCT03447314|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20538084|NCT01101971|Queen's University|Dr. Robert Reid|6135332898|reidr@queensu.ca|32898
20538085|NCT00856206|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20538086|NCT01175434|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
20538087|NCT02638207|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
20538088|NCT02868034|University of Utah|Julie Fritz|18015872237|julie.fritz@utah.edu|
20538089|NCT03022097|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20538090|NCT01451931|University of California, San Francisco|Dr. Rebecca Smith-Bindman|415-353-4946|rebecca.smith-bindman@ucsf.edu|
20538091|NCT04584346|National Institutes of Health|Dr. Debra Ehrlich|301-443-7888|debra.ehrlich@nih.gov|
20538092|NCT00358332|University of Maryland School of Medicine|Christopher V. Plowe|410-706-3082|cplowe@medicine.umaryland.edu|
20538093|NCT05479097|University of Wisconsin School of Medicine and Public Health|Dr. Sean Duffy|608-263-3111|sean.duffy@fammed.wisc.edu|
20538094|NCT01790178|Duke University|Lisa Hobson-Webb|919-668-2277|lisa.hobsonwebb@dm.duke.edu|
20538095|NCT03006458|CooperVision|Myhanh Nguyen|9257306716|MNguyen@coopervision.com|
20538096|NCT01468233|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20538097|NCT02480166|Stanford University Medical Center|Mindie H. Nguyen, MD, MAS|650-4985691|mindiehn@stanford.edu|
20538098|NCT00457821|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
20538099|NCT00842946|Department of Veterans Affairs (formerly Drexel University)|Dr. Erica England|207-239-6323|elengland02@yahoo.com|
20569580|NCT03719378|Colorado Joint Replacement|Rose Johnson, CCRP Research Lead|3032602940|roseannjohnson@centura.org|
20538100|NCT02437409|phenox GmbH|Clinical Affairs|+49 (0)234 36 919|ARTESp@phenox.info|0
20538101|NCT05131971|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20569581|NCT03352882|University of Pennsylvania|Kimberly A. Forde, MD, PhD - Principal Investigator|(215) 349-8222|kforde@pennmedicine.upenn.edu|
20569582|NCT02161185|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
20538102|NCT00445211|William Beaumont Hospital|Dr. Justin Trivax|(248)587-2300|Justin.Trivax@beaumont.edu|
20538103|NCT03549871|Sanofi ( Genzyme, a Sanofi Company )|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20538104|NCT00737568|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20538105|NCT02251561|Alcon Japan, Ltd.|Director, Clinical & Regulatory Affairs, Division of Medical Affairs||alcon.medinfo@alcon.com|
20538106|NCT01133626|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20538107|NCT00855933|The Procter & Gamble Co.|Jon Witt|513-622-2963|witt.jj.2@pg.com|
20538108|NCT00951080|KCI|VP, Global Clinical Development|12102555595|jkhart@mmm.com|
20538109|NCT01960998|Birmingham VA Medcial Center|Kathryn L. Burgio, PhD|205-999-9537|kburgio@uabmc.edu|
20538110|NCT02124018|First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens|Professor Konstantinos A. Gatzoulis|6944580369|kgatzoul@med.uoa.gr|0030
20538111|NCT00835640|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20538112|NCT01904149|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
20538113|NCT00350272|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20538114|NCT00812006|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
20538115|NCT00760461|Yale University|Anish A Sheth M.D|203-785-4576|anish.sheth@yale.edu|
20538116|NCT01044212|University of Rochester|Gunhilde Buchsbaum, Division Director Urogynecology|585-273-3233|gunhilde_buchsbaum@urmc.rochester.edu|
20538117|NCT03349645|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20538118|NCT03761394|UMass Chan Medical School|Edith Mensah Otabil|774-455-6574|edith.mensahotabil@umassmed.edu|
20538119|NCT02802241|BIDMC|Judy Nee|6176672193|jnee@bidmc.harvard.edu|
20538120|NCT01686750|Johns Hopkins University|Dr. Gregory M.Lucas|410-614-0560|glucas@jhmi.edu|
20538121|NCT02927925|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20569583|NCT03790878|Duke University|Katherine (Kibby) McMahon|917-880-1551|Kibby.McMahon@duke.edu|
20569584|NCT02864342|AstraZeneca|Medical Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20569585|NCT02573883|Medstar Health Research Institute|Dr. Cheryl Iglesia|202-877-6526|cheryl.iglesia@medstar.net|
20525207|NCT00742963|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
20525208|NCT00839800|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20525209|NCT00302328|Glostrup Hospital|Ulrik Christensen|+4538634825|bisan@regionh.dk|
20525210|NCT01288937|Columbia University|Thomas H. Brannagan, MD|(212) 305-0405|tb2325@cumc.columbia.edu|
20525211|NCT04511520|National medical research center for therapy and preventive medicine|Dr. Maria Makhinova|+79104803524|longtimeaftertomorrow@gmail.com|
20525212|NCT03421210|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
20525213|NCT00912743|Astra Zeneca LLP|Angela Sawyer, Clinical Delivery Director|+44 1625 512397|angele.sawyer@astrazeneca.com|
20525214|NCT01136356|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
20525215|NCT04112043|University of Florida|Dr. Robert Mankowski|352-294-5055|r.mankowski@ufl.edu|
20525216|NCT04157296|University of Michigan|Yanni Liu|734-936-9275|yanniliu@med.umich.edu|
20525217|NCT02237196|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20525218|NCT01750697|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20525219|NCT01057810|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20525220|NCT02088905|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
20525221|NCT00267969|Centocor Research & Development, Inc.|Dir. Clinical Research|1-800-457-6399||
20525222|NCT00862823|University of Alabama at Birmingham|Jennifer King|205-934-2696|jenking@uab.edu|
20525223|NCT00291876|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525224|NCT01309360|Helios-Kliniken Schwerin|Dr.med.Ronald Seidel|0049 (0)385 520-4251|ronald.seidel@helios-kliniken.de|
20525225|NCT00619892|UCSF Fresno|Andrew Goddard, M.D.|559-499-6580|agoddard@fresno.ucsf.edu|
20525226|NCT02901067|Denver Health Medical Center|Study Coordinator, James Chandler|303-602-3798|james.chandler@dhha.org|
20525227|NCT00288366|Northwestern University|Herbert Y Meltzer|1 312 503 0309|h-meltzer@northwestern.edu|
20525228|NCT00857896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525229|NCT02049814|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20525230|NCT05393869|The Ohio State University College of Public Health|Dr. Joanne G. Patterson|614-247-1780|patterson.1191@osu.edu|
20525231|NCT02016105|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
20525232|NCT00090493|University of Arkansas for Medical Sciences - MIRT|Frits van Rhee, MD, PhD|(501) 686-8230|vanrheefrits@uams.edu|
20525233|NCT01214083|VA Connecticut Healthcare System|Gihyun Yoon, MD|203-932-5711|gihyun.yoon@va.gov|7421
20525234|NCT01908829|Astellas Pharma Europe Ltd|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
20525235|NCT02865499|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
20525236|NCT02792192|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20525237|NCT02320058|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20525238|NCT01339923|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20525239|NCT01430403|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20525240|NCT03660189|The MetroHealth System|Dr. Chloe Castro|2167784527|ccastro@metrohealth.org|
20525241|NCT05753904|University of Missouri|Vicki Jones|573-882-7583|jonesvicki@health.missouri.edu|
20525242|NCT00183885|USC/Norris Comprehensive Cancer Center|Victoria Soto|(323) 865-0451|victoria.soto@med.usc.edu|
20569586|NCT00582114|Professor of Medicine|Dr. Rajiv Agarwal|317-988-2241|ragarwal@iu.edu|
20569587|NCT00118703|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569588|NCT00953212|Maine Medical Center|Dr. Robert Kramer|207-662-2923|KRAMER@mmc.org|
20569589|NCT00130728|Genentech, Inc.|Medical Communications Specialist|800-821-8590|genentech@druginfo.com|
20569590|NCT02301364|Memorial Sloan Kettering Cancer Center|Christian Grommes, MD|212-639-4058|grommesc@mskcc.org|
20569591|NCT01209286|Amgen Inc.|Study Director|866-572-6436||
20525243|NCT00014495|Memorial Sloan Kettering Cancer Center|Dr. Martin Tallman|212-639-3842|tallmanm@mskcc.org|
20525244|NCT00608777|DermResearch, PLLC|Leon Kircik, M.D.|502-5451-9000|wedoderm@yahoo.com|
20525245|NCT01045187|Xoft, Inc.|Kelly W Elliott RN, MS|408-419-2428|Kelliott@xoftinc.com|
20525246|NCT00396656|Novartis Pharmaceuticals|Study Director|862 778-8300||
20525247|NCT01537926|UTHealth Science Center at Houston|Dr. Ali J. Marian|713-500-2310|Ali.J.marian@uth.tmc.edu|
20525248|NCT00554515|Beth Israel Deaconess Medical Center|David F. McDermott, MD||dmcdermo@bidmc.harvard.edu|
20525249|NCT02477332|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20525250|NCT02743936|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April@post.harvard.edu|
20525251|NCT02880475|Mundipharma (China) Pharmaceutical Co. , Ltd|Junjiao Ma|01065636711|Junjiao.Ma@mundipharma.com.cn|
20525252|NCT02593097|Mayo Clinic|Amaal J. Starling, M.D.|480-301-6574|Starling.Amaal@mayo.edu|
20525253|NCT03759587|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20525254|NCT00006178|National Institutes of Health|Dr. Allan D. Kirk||allank@intra.niddk.nih.gov|
20525255|NCT00665431|Pozen|Sr VP Clinical Research|919 913 1030|eorlemans@pozen.com|
20525256|NCT01578239|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20525257|NCT01119859|Hoffmann-La Roche|Medical Communications|800 821-8590||
20525258|NCT01134939|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525259|NCT02461433|Johns Hopkins University|Mahmoud Malas|410-550-4546|bmalas1@jhmi.edu|
20525260|NCT01030289|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
20525261|NCT02703467|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20525262|NCT00757042|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20525263|NCT02934698|MUSC|Patrick Flume|843-792-3167|flumepa@musc.edu|
20525264|NCT00150488|Queen Unviersity|J. Curtis Nickel|613 548 2497|jcn@queensu.ca|
20525265|NCT00893997|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
20525266|NCT04797611|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
20525267|NCT03300505|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20525268|NCT05119595|B.Braun Aesculap|Diana Kupferschmid, Study Manager of B. Braun|0049746195|studies@aesculap.de|0
20525269|NCT03508726|University of Iowa, Holden Comprehensive Cancer Center|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
20525270|NCT01113385|Children's National|Asha Moudgil MD, Professor of Pediatrics|202-476-5058|amoudgil@childrensnational.org|
20525271|NCT01517763|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|
20525272|NCT00178685|University of Rochester|Dr. Geoffrey Williams|585-530-2050|geoffrey_williams@urmc.rochester.edu|
20525273|NCT00181285|University of Illinois at Chicago|Jerry A. Krishnan|312-413-0637|jakris@uic.edu|
20525274|NCT00887315|Department of Health Studies, University of Chicago|Dr. Sang Mee Lee|773-834-6765|slee@health.bsd.uchicago.edu|
20525275|NCT00821964|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
20525276|NCT02907918|Washington University School of Medicine|Foluso O. Ademuyiwa, M.D., MPH|314-454-8313|bisiademuyiwa@wustl.edu|
20525277|NCT03219840|The University of Texas Health Science Center at Houston|Flavia S. Lakschevitz, DDS, PhD, MSc|604-822-3863|flavia.lakschevitz@dentistry.ubc.ca|
20525278|NCT00832572|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20525279|NCT00384839|Texas Oncology, P.A|Dr. Guru Sonpavde|(281) 332-7505|Guru.Sonpavde@USOncology.com|
20525280|NCT00863343|Meso Scale Diagnostics, LLC.|Dennis Mertz, Director Regulatory and Clinical Affairs|240 631-2522|dmertz@mesoscale.com|2809
20525281|NCT00443079|UCSDMED|Dr. Heather Patton|619-543-2470|hpatton@ucsd.edu|
20525282|NCT02649439|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
20525283|NCT02714595|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20525284|NCT02257489|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525285|NCT04606394|PRISM|Gary T Ferguson, M.D.|248-514-6063|garytferguson@msn.com|
20525286|NCT01896128|Burke Rehabilitation Hospital|Pasquale Fonzetti MD|(914) 597-2502|pfonzett@burke.org|
20525287|NCT00954941|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-794-5783|eharriso@mdanderson.org|
20569592|NCT01349036|Daiichi Sankyo Inc.|Study Director|908-992-6400|CTRinfo@dsi.com|
20525288|NCT00863356|HemCon Medical Technologies|V.P., Clinical Affairs|971.223.4904|jody.oyama@hemcon.com|
20525289|NCT02023411|PGIMER|Dr Ashu Rastogi|9781001046|ashuendo@gmail.com|
20569593|NCT03796208|University of Kentucky|Kristin Ashford, PhD, Study MPI|859-257-9333|khashf0@uky.edu|
20569594|NCT05127018|Peking University School of Stomatology|Xi Gong|15201304426|gongx31480528@163.com|
20569595|NCT00519285|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20569596|NCT01020747|Massachusetts General Hospital|Monica Tettamanti|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
20569597|NCT01729923|University of Washington|Dr. Stacey Cohen, Principal Investigator|206-606-6658|shiovitz@uw.edu|
20569598|NCT04525456|NUS|Study administrator|+65 6601 7766|lsixtc@nus.edu.sg|
20569599|NCT04236245|Venclose, Inc.|Mai-Ly Wilcox|415-254-1930|mwilcox@venclose.com|
20569600|NCT00006436|National Caner Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
20507678|NCT03807245|MinervaX ApS|Dr Per Fischer|+45 20 25 20 38|pbf@minervax.com|
20507679|NCT04116073|Sidney Kimmel Comprehensive Center at Johns Hopkins|Nilo Azad|410-614-9169|nilo.azad@jhu.edu|
20525290|NCT01996254|SPR Therapeutics, Inc.|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
20525291|NCT03423173|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20525292|NCT01053663|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20525293|NCT03533114|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20525294|NCT05478135|Prova Health|Dr Jack Halligan|07742161980|jack.halligan@provahealth.com|
20525295|NCT00693238|University of Florida|Randal Henderson, MD, MBA|904-588-1800|rhenderson@floridaproton.org|
20525296|NCT02411396|Johns Hopkins University School of Medicine|Sophie Lanzkron, MD, MHS, Associate Professor of Medicine and Oncology|410-502-8642|slanzkr@jhmi.edu|
20525297|NCT01631149|Leiden University Medical center|Dr. Albert Dahan|3171 526 2301|a.dahan@lumc.nl|
20525298|NCT00436475|Tufts Medical Center|Dr. Anastassios G. Pittas|617-636-5689|apittas@tuftsmedicalcenter.org|
20525299|NCT02071706|GE Healthcare|Yvonne Celestial|+33625023857|MarieYvonne.CELESTIAL@ge.com|
20525300|NCT00179777|University of Helsinki|Professor Mikael Knip|+3582941 25222|mikael.knip@helsinki.fi|
20525301|NCT02247440|Institut de Recherche pour le Developpement|Gonzague Jourdain|+66818830065|Gonzague.Jourdain@ird.fr|
20525302|NCT00661609|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20525303|NCT00637000|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
20525304|NCT00839527|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525305|NCT01855243|Cairo University|Eman Said Sayed|01001186079|gaviota_3011@hotmail.com|002
20525306|NCT00943150|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20525307|NCT01860040|Western Regional Medical Center|Director of Clinical Research|6232073000|jessica.coats@ctca-hope.com|
20525308|NCT01931995|Massachusetts General Hospital|Dr. Mark Eldaief|6177261728|MELDAIEF@PARTNERS.ORG|
20525309|NCT04513080|Talkspace|Aarthi Padmanabhan|240-273-6191|aarthi.padmanabhan@talkspace.com|
20525310|NCT02477826|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20525311|NCT00828568|Taro Pharmaceuticals USA|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
20525312|NCT00403481|Daiichi Sankyo|John J. Raia, R.Ph, Pharm. D.|1-877-437-7763|druginfo@dsus.com|
20525313|NCT00799474|The University of North Carolina at Chapel Hill, Gillings School of Global Public Health|Dr. Noel Brewer, PhD|919-966-3282|ntb1@unc.edu|
20538122|NCT01080768|Novartis Pharmaceuticals|Study Director|862-778-8300||
20507680|NCT05814471|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20569601|NCT01071317|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
20538123|NCT00559468|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538124|NCT01939002|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20538125|NCT01527513|BIAL - Portela & Cª SA|Director R&D|+351-229866100|clinical.trials@bial.com|
20538126|NCT02794844|Nemours Children's Hospital|James P. Franciosi, MD|407-567-3832|jfrancio@nemours.org|
20538127|NCT02323204|University of Iowa/ University of Minnesota|Dr. Marizen R Ramirez|612-624-3143|mramirez@umn.edu|
20538128|NCT00101816|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20538129|NCT04508751|University of California Los Angeles|Dr. Kara Calkins|3108259330|kcalkins@mednet.ucla.edu|
20538130|NCT03023826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20538131|NCT00717522|Celgene Corporation|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20538132|NCT00072293|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
20538133|NCT02436668|Pharmacyclics, An AbbVie Company|George Cole|(408) 990-7340|gcole@pcyc.com|
20538134|NCT00167180|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-625-7409|mille011@umn.edu|
20538135|NCT04092907|Harbour Biomed|Nina Shen|18251811067|nina.shen@harbourbiomed.com|
20538136|NCT01444027|University of Washington, School of Nursing|Dr. George Demiris|206-221-3866|gdemiris@uw.edu|
20538137|NCT01485380|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|6177247200|oluwaseun.akeju@mgh.harvard.edu|
20538138|NCT03551665|Arizona State University|Daniel Peterson|602-543-9373|daniel.peterson1@asu.edu|
20538139|NCT05538312|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538140|NCT01514240|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
20538141|NCT01145352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538142|NCT04143217|Supernus Pharmaceuticals Inc.|Jonathan Rubin, MD, MBA, Senior Vice President/Chief Medical Officer|240-403-5710|jrubin@supernus.com|
20538143|NCT03824405|Botanix Pharmaceuticals|Head of Development|+1 (445) 300-3403|trials@botanixpharma.com|
20538144|NCT00496197|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538145|NCT04431713|UCL|Professor Foltynie|020 3448 8726|t.foltynie@ucl.ac.uk|
20538146|NCT01655381|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20538147|NCT00457977|University of Minnesota|Sarah Harnden|612-626-9011|sharnden@ccbr.umn.edu|
20538148|NCT00043108|Fox Chase Cancer Center|Dr. Mark Hallman|215-728-2581|Mark.Hallman@fccc.edu|
20569602|NCT02592486|Department of Pulmonary Medicine, Kameda Medical Center|Kei Nakashima, Associate Chief|81-4-7092-2211|kei.7.nakashima@gmail.com|8614
20538149|NCT03405935|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20538150|NCT04979897|Universidad del Desarrollo|Ana Castro-Avila|+56223279648|anacastro@udd.cl|
20538151|NCT04195438|University of Maryland School of Medicine|Dr. Cherif Boutros (Surgical Oncologist)|410-328-7320|cboutros@som.umaryland.edu|
20538152|NCT00868218|University of Bergen|Professor Rebecca Jane Cox|+4755974668|rebecca.cox@uib.no|
20538153|NCT00613925|Oregon health & Science University|Alison Edelman, Associate Professor|503-418-2585|edelmana@ohsu.edu|
20538154|NCT03287674|National Center for Cancer Immune Therapy, Herlev Hospital|Anders Kverneland, MD|38686467|anders.kverneland@regionh.dk|
20538155|NCT03136497|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20538156|NCT00929773|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20538157|NCT02781792|Washington University School of Medicine|Dr. Milan Chheda|314-747-2712|mchheda@wustl.edu|
20569603|NCT01283971|Hoffman-LaRoche|Medical Communications|800-821-8590||
20569604|NCT02617667|Novaliq GmbH|Dr Sonja Krösser, VP Preclinical and Clinical Development|+49 6221 50259-0||
20569605|NCT03777553|Durham Veterans Affairs Medical Center|Elizabeth Van Voorhees|919-886-5542|elizabeth.vanvoorhees@va.gov|
20569606|NCT01554371|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
20569607|NCT02598934|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20569608|NCT02811302|Medtronic - MITG, RGI|Melanie Crystal, Sr. Clinical Program Manager|720-435-5737|melanie.crystal@medtronic.com|
20569609|NCT00702520|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569610|NCT02154347|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20569611|NCT02481934|Hospital universitario 12 de octubre|Alejandra Leivas PhD|+34917792612|alejandraleial@gmail.com|4612
20538158|NCT04599959|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20538159|NCT04049266|Kodiak Sciences Inc.|Pablo Velazquez-Martin, MD|1 (650) 281-0850|ClinOps@kodiak.com|
20538160|NCT01933230|Cleveland Clinic|Dr. Jose Javier Provencio, Faculty, Neuroinflammation Research Center|216-445-242|provenj@ccf.org|
20538161|NCT03664674|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
20538162|NCT02174523|Phase I Clinical Research Unit , Shanghai Xuihui Central Hospital|Dr.Hu Chaoying|021-54036058|cyhu@shxh-centerlab.com|
20538163|NCT00794365|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538164|NCT03640052|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
20538165|NCT02637427|Rutgers, The State University of New Jersey|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@Rutgers.edu|
20538166|NCT01369680|Medical University of South Carolina|Dr. Amy-Lee Bredlau|843-792-2957|bredlau@musc.edu|62872
20538167|NCT02851407|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
20538168|NCT01713283|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20569612|NCT05041439|Massachusetts General Hospital|Dr. Julie H Levison|(617) 724-4698|jlevison@mgb.org|
20525314|NCT03139578|Johnson & Johnson Vision|Anna Sulley BSc MCOptom FAAO|+44 1344864043|asulley1@its.jnj.com|
20525315|NCT04657198|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20525316|NCT02549287|Georgia State University|Dr. Daniel Whitaker|404-413-1282|dwhitaker@gsu.edu|
20525317|NCT03793842|Michigan Medicine|Robert Hyzy, MD|734-936-5201|rhyzy@med.umich.edu|
20525318|NCT00638222|The University of Toledo, HSC|Christopher Cooper, MD|419.383.6030|christopher.cooper@utoledo.edu|
20525319|NCT00427921|Abbott Laboratories|Medical Information Specialist|Phone: (800) 633-9110||
20525320|NCT00520533|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20525321|NCT00900159|Brigham and Women's Hospital; Harvard Medical School|Dr. Orfeu M. Buxton|617-507-9177|Orfeu_Buxton@HMS.Harvard.edu|
20525322|NCT01166438|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
20525323|NCT01075256|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525324|NCT03502070|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
20525325|NCT04321356|University of Tennessee|Michael LaCour|865-974-9376|mlacour@utk.edu|
20525326|NCT02115581|Children's Medical Center|Giv Heidari-Bateni MD/MPH|3142991984|givhb@yahoo.com|
20525327|NCT01877642|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7777|ClinicalTrialsInfo@alexza.com|
20525328|NCT02434146|University of Wisconsin Carbone Cancer Center|Margo L Hoover-Regan|608-263-6200|mhooverregan@pediatrics.wisc.edu|
20525329|NCT02654977|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@umich.edu|
20525330|NCT01266291|University of Pennsylvania|John Pollard, MD|215-873-5909|john.pollard@uphs.upenn.edu|
20525331|NCT03232931|Emory University|Dr. Nathalie Maitre|404-712-8920|nathalie.linda.maitre@emory.edu|
20525332|NCT04925557|State University of New York at Buffalo|Dr. Robert Zivadinov|716-248-2140|rzivadinov@bnac.net|
20525333|NCT05488470|Division of Cardiology at the Rhode Island and Miriam Hospital, Warren Alpert School of Medicine, Brown University|Antony Chu, M.D., FACC, FAHA, FHRS, FACP, Director of Complex Ablation - Arrhythmia Services Section|401-444-8689|antony_chu@brown.edu|
20525334|NCT01941745|"Tufts Medical Center | Division of Newborn Medicine"|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
20525335|NCT00068393|ECOG Statistical Office|Study Statistician|617-632-3012||
20525336|NCT01399047|University of Rochester Medical Center|Erika Augustine, MD, MS|585-275-2808|erika_augustine@urmc.rochester.edu|
20525337|NCT00836888|Ono Pharmaceutical Co. Ltd|Ohyama Yukiya||y.ohyama@ono.co.jp|
20525338|NCT02046005|Brigham and Women's Hospital|Dr. Elizabeth Karlson|617-732-5078|ekarlson@bwh.harvard.edu|
20525339|NCT03652636|Indiana University|Jordan Swensson, MD|317-944-1837|jswensso@iu.edu|
20525340|NCT04556084|Medical College of Wisconsin|Michael Burke|4149554198|mmburke@mcw.edu|
20525341|NCT01729338|Duke University Medical Center|Gwynn Long|919-668-0838|gwynn.long@duke.edu|
20525342|NCT00251303|National Institute of Mental Health, Pediatrics and Developmental Neuroscience Branch|Dr. Susan E. Swedo|301-496-5323|swedos@mail.nih.gov|
20525343|NCT01806961|Sipirig AG|Dr. Francine Santoro|+41 62 387 87 87|francine.santoro@galderma.com|87 20
20525344|NCT04532619|University of Oregon|Camille C. Cioffi|541-525-4886|ccioffi@uoregon.edu|
20525345|NCT00679029|University of Nebraska|Elizabeth Reed|(402) 559-5388|ereed@unmc.edu|
20525346|NCT01976650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20525347|NCT02260869|Lumbrera LLC|David Cedeno|3098266974|dclumbrera@gmail.com|
20525348|NCT04019613|Mayo Clinic|Dr. Brandon M. Wiley|507-255-1051|Wiley.Brandon@mayo.edu|
20525349|NCT02986282|Warsaw Medical University|Dr Jacek Lewandowski|5992828|jlewandowski@wum.edu.pl|+48 22
20525350|NCT01283334|Emory University|Nabil F. Saba, MD|404-778-1900|nfsaba@emory.edu|
20525351|NCT03467217|Johns Hopkins Bloomberg School of Public Health|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
20525352|NCT00769067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525353|NCT05127330|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|bgaudiano@butler.org|
20525354|NCT04981470|neuroloop|Clinical Affairs|+497611543390|study@neuroloop.de|
20525355|NCT04402138|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
20525356|NCT00784238|Clinical Research Team, Medical Affairs Korea|Senior Clinical research Associate|82-2-2094-4804||
20525357|NCT04390503|Columbia University|Jessica Justman, MD|212-342-0537|jj2158@cumc.columbia.edu|
20525358|NCT03806933|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
20525359|NCT00078767|Allegheny Singer Research Institute|Judith Cohen, MD||judith.cohen@ahn.org|
20525360|NCT01068730|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20525361|NCT02919423|University of Arkansas for Medical Sciences|Merideth Addicott, Assistant Professor|501-526-8436|maddicott@uams.edu|
20525362|NCT03233529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525363|NCT03260244|Abbott|Associate Director, Clinical Research, Electrophysiology|651-756-3813|anne.sarver@abbott.com|
20525364|NCT02497040|uludag university|Dr.Banu Otlar Can|+905323827044|botlar@hotmail.com|
20525365|NCT01177293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525366|NCT03396315|Columbia University|Mariana Bucovsky|12123057225|mb3523@cumc.columbia.edu|
20525367|NCT02207803|Virginia Commonwealth University|Dr. Paul Perrin|8048273894|pperrin@vcu.edu|
20525368|NCT01828983|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
20525369|NCT00594100|W. L. Gore & Associates|Andrew Garcia|(800) 437-8181|AGarcia@WLGore.com|
20525370|NCT00956592|Oregon Health & Science University|Michael Aziz|503-494-5581|azizm@ohsu.edu|
20525371|NCT04286581|University of Minnesota|Dr. Jacob Hutchins, MD|612-624-9990|hutc0079@umn.edu|
20525372|NCT03528369|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
20525373|NCT00527644|University of Missouri Health Care|Bruce Ramshaw, M.D.|5738841925|kadysj@health.missouri.edu|
20525374|NCT04075682|University of South Carolina|Dr. James F. Thrasher|803.777.4862|thrasher@sc.edu|
20525375|NCT00744965|UT Southwestern Medical Center|Kenneth J. Leveno, MD|214-648-2316|kenneth.leveno@utsouthwestern.edu|
20525376|NCT02285166|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20525377|NCT01421225|Boston Children's Hospital|Garry Steil (Assistant Prof. of Pediatrics)|617-355-7504|garry.steil@childrens.harvard.edu|
20525378|NCT04081610|Laboratorios Sophia|Dr. Alejandra Sanchez-Rios|+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|1190
20525379|NCT01862250|University of Toronto|Estelle B. Gauda|416-813-4908|estelle.gauda@sickkids.ca|
20525380|NCT01028014|University of Alabama at Birmingham|Dr. William Jerod Greer|205-934-7874|wjgreer@uab.edu|
20525381|NCT04087720|Horizon Therapeutics USA, Inc.|Supra Verma, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
20525382|NCT01218087|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
20525383|NCT03340454|NYU Langone Health|Yi-Ling Tan|646-501-3489|yi-ling.tan@nyulangone.org|
20525384|NCT01464164|Feinstein Institutes for Medical Research|Adrianna Vlachos, MD|516-562-1506|avlachos@northwell.edu|
20525385|NCT02568189|Icahn School of Medicine at Mount Sinai|James W Tsung MD, MPH|212 241 6272|james.tsung@mountsinai.org|
20525386|NCT03000010|University of Michigan|G. Ying Li|734-936-5715|yingyuli@med.umich.edu|
20525387|NCT02347813|University of Rochester|Alice Pentland, MD|585-275-1998|alice_pentland@urmc.rochester.edu|
20525388|NCT03817229|Cincinnati Children's Hospital Medical Center|Avani Modi, Ph.D.|5136364864|avani.modi@cchmc.org|
20525389|NCT01186692|Medtronic|Susan Patterson|763.526.1544|susan.patterson@medtronic.com|
20525390|NCT03319732|RVL Pharmaceuticals, Inc.|Vice President Regulatory Affairs and Quality|908-809-1300|regulatory@rvlpharma.com|
20525391|NCT00481351|Universidade de São Paulo|Otavio Celeste Mangili, MD|+554499928818|otaviomangili@yahoo.com.br|
20525392|NCT04892706|Bausch Health Americas, Inc|Study Director|908-541-8664|alison.magnotti-nagel@bauschhealth.com|
20525393|NCT01736397|Keryx Biopharmaceuticals|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
20525394|NCT05088603|Atrium Health Wake Forest Baptist Health Department of Neurosurgery|Dr. Kyle Fargen|336-716-6702|kfargen@wakehealth.edu|
20525395|NCT02989246|Children's Hospital Los Angeles|Dr Robinder Khemani, Associate Director of Research ACCM|323-361-2376|rkhemani@chla.usc.edu|
20525396|NCT00730730|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
20525397|NCT01868438|Medicines for Malaria Venture|Stephan Duparc|+41 22 799 4070|duparcs@mmv.org|351
20525398|NCT03555565|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20525399|NCT02799667|Tufts Medical Center|Ashley T. Peterson, MD, Study Coordinator|617-636-5000|apeterson@tuftsmedicalcenter.org|2382
20525400|NCT00379080|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
20525401|NCT01222520|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525402|NCT00497289|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
20525403|NCT00955955|Massachusetts General Hospital- Depression Clinical and Research Program|Dr. George Papakostas- Director of Treatment Resistant Depression Studies|617-726-6697|gpapakostas@partners.org|
20525404|NCT03348930|University of Chicago|Dr. Jon Grant|7738341325|jgrant4@bsd.uchicago.edu|
20525405|NCT02920008|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20525406|NCT04590586|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20525407|NCT03457116|NYU Langone Health|Judy Lee, MD|(646) 501-7906|Judy.Lee@nyulangone.org|
20525408|NCT02751450|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525409|NCT01598090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20525410|NCT02587598|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
20525411|NCT04709692|University of Kentucky|R. Kiplin Guy|859-257-5290|kip.guy@uky.edu|
20525412|NCT00791661|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525413|NCT03605862|Romark Laboratories, L.C.|Jessica Fulgencio|813-282-8544|jessica.fulgencio@romark.com|
20525414|NCT00679289|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20525415|NCT00937040|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
20525416|NCT02324504|Boston Children's Hospital|Dr. Michael Agus|617 355-5849|michael.agus@childrens.harvard.edu|
20525417|NCT04002115|Penn State Health|Dr. Seema Naik|7175310003|snaik@pennstatehealth.psu.edu|289626
20525418|NCT02858583|University of Alberta|Georg Schmölzer|780-735-4647|schmolze@ualberta.ca|
20525419|NCT03170362|Department of Veteran Affairs|David Oslin|215-823-5894|dave.oslin@va.gov|
20525420|NCT01972438|National Institutes of Health|Manuel B. Datiles, III, MD, Principal Investigator, NEI|301-594-7052|DatilesM@nei.nih.gov|
20525421|NCT02171234|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
20525422|NCT01052480|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
20525423|NCT02157376|AstraZeneca|Barry Traxler||barry.traxler@astrazeneca.com|
20525424|NCT00529373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development,|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525425|NCT01094574|Stanford School of Medicine|Martin Angst, MD, Professor, Dept. of Anesthesia, Stanford SOM|650-498-5109|ang@stanford.edu|
20525426|NCT01074268|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20525427|NCT00603473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525428|NCT04200651|New York Eye Surgery Center; University of Colorado|Dr. Nicholas Tan|3476175971|tannicholas97@gmail.com|
20525429|NCT00691444|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
20525430|NCT00733421|Foot & Ankle Surgical Centre|Jan Jakobsson PI, MD, PhD, Professor|46702500960|jan.jakobsson@ki.se|
20525431|NCT02547220|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20525432|NCT04185220|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
20525433|NCT04201574|Allysta Pharmaceuticals, Inc.|Clinical Trial Admin|(510) 560-6592|clinicaltrial.admin@allysta.com|
20525434|NCT03771560|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
20525435|NCT02887183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20525436|NCT01031680|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20525437|NCT04471194|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|717-531-0003|jmoss1@pennstatehealth.psu.edu|323429
20525438|NCT01029782|Interior Health|Dawn Dalen|250-862-4449|dawn.dalen@interiorhealth.ca|
20525439|NCT03649932|University of Texas Medical Branch|Dr. Sunil Jain|4097722815|amnahqasim@gmail.com|
20525440|NCT00687544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20525441|NCT02195869|Pharmacyclics LLC, An AbbVie Company|Manuela Juretic, Associate Director, Clinical Operations|(408) 215.3628|mjuretic@pcyc.com|
20525442|NCT00789698|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
20525443|NCT00767455|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20525444|NCT01921101|University of Illinois at Chicago|Dr. Carol Braunschweig, Professor|3129962575|braunsch@uic.edu|
20525445|NCT01870973|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
20525446|NCT03456804|Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8717|heathe@karmanos.org|
20525447|NCT00389532|Sanofi pasteur Inc|Medical Director||RegistryContactUS@sanofipasteur.com|
20525448|NCT02729051|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20525449|NCT02702388|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20525450|NCT00160706|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20525451|NCT02162719|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20525452|NCT02230696|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20525453|NCT03138252|University Hospitals Cleveland Medical Center|Dr. Alison Bauer|216-844-3787|alison.bauer@uhhospitals.org|
20525454|NCT00076752|National Cancer Institute, National Institutes of Health|Dr. Steven Pavletic|301-402-4899|pavletis@mail.nih.gov|
20525455|NCT00394836|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525456|NCT00748189|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20525457|NCT02593526|UNewMexico|Mark Unruh|5052728800|MLUnruh@salud.unm.edu|
20525458|NCT00977704|Medicis R&D Clinical Research Department|Head of Clinical Trials||ClinicalTrialsQuery@Medicis.com|
20525459|NCT04696055|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20525460|NCT03969901|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20525461|NCT04411810|NYU Langone Health|David Polsky, MD, PhD|212-263-9087|David.Polsky@nyulangone.org|
20525462|NCT01920958|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20525463|NCT00610155|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525464|NCT01560234|AstraZeneca R&D|Ajay Aggarwal||ClinicalTrialTransparency@astrazeneca.com|
20525465|NCT05406479|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
20525466|NCT02028767|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525467|NCT01284348|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525468|NCT03325816|Georgetown University|Chul Kim, MD|202-444-2223|Chul.Kim@gunet.georgetown.edu|
20525469|NCT00140244|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
20525470|NCT03192306|Benu BioPharma, Inc.|Dr. Eric Morrel, VP Clinical Research|5082085634|emorrel@benubio.com|
20525471|NCT04932655|Cassava Sciences, Inc.|Nadav Friedmann, PhD, MD|512-501-2444|eschoen@cassavasciences.com|
20525472|NCT00083759|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20525473|NCT03645395|Molecular Templates, Inc.|Study Director|862-204-7184|trials@mtem.com|
20525474|NCT00892151|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20525475|NCT01089608|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
20525476|NCT00555464|Medical College of Wisconsin|Beth Drolet, MD|414-955-2817|sjoachim@mcw.edu|
20525477|NCT03575793|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20525478|NCT01250873|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20525479|NCT01940887|Ophthotech Corp.|Keith Westby|212-845-8200|Keith.Westby@ophthotech.com|
20525480|NCT03055897|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
20525481|NCT01062113|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20525482|NCT02429778|VA Palo Alto Health Care System|Christine Gould, PhD|650-493-5000|Christine.Gould@va.gov|68899
20525483|NCT03521115|PIRE|Dr. Brenda A. Miller|5105205889|BMiller@prev.org|
20525484|NCT01663285|University of Michigan Comprehensive Cancer Center|Dr. Ajjai Alva|734-647-8921|ajjai@umich.edu|
20525485|NCT02261948|Centro Cardiologoco Monzino|Piergiuseppe Agostoni|02 5800|piergiuseppe.agostoni@ccfm.it|2772
20525486|NCT02475265|Massachusetts General Hospital|Dr. Pouneh Fazeli|617-726-3870|pkfazeli@partners.org|
20538169|NCT00235391|Novartis Pharmaceuticals|Study Director|862-778-8300||
20538170|NCT04274153|Johns Hopkins SOM Department of GYN/OB|Dr. Jenell Coleman|(410)614-9178|colemanj@jhmi.edu|
20538171|NCT00580034|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20538172|NCT01182805|University of Michigan|Theodore J. Kolias, MD|(734) 615-4907|tkolias@umich.edu|
20538173|NCT00772369|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20538174|NCT03372460|Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System|Dr. Noah S Philip, MD|4012737100|noah_philip@brown.edu|16200
20538175|NCT02499900|Teva Pharmaceutical Industries Ltd.|Director, Clinical Research|+01 215-591-3000|USMedInfo@tevapharm.com|
20538176|NCT03995680|Swiss Tropical and Public Health Institute|Dr. Jennifer Keiser|+41612848218|jennifer.keiser@swisstph.ch|
20538177|NCT00916058|Weill Cornell Medical College|Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
20538178|NCT03416920|Massachusetts General Hospital|Dr. Pradeep Natarajan|617-724-3526|PNATARAJAN@PARTNERS.ORG|
20538179|NCT03385265|Nemours Children's Health|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
20538180|NCT02345772|CTCA|Jessica L. Coats, RN|6232073899|jessica.coats@ctca-hope.com|
20538181|NCT02439450|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|info@nighthawkbio.com|
20538182|NCT03403231|VA Center for Clinical Management Research|Bradley Youles, Project Manager|734-845-5055|Bradley.Youles@va.gov|
20538183|NCT01170065|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20538184|NCT02538419|Brigham and Women's Hospital|Dr. Jessie Bakker|617-732-5987|jpbakker@bwh.harvard.edu|
20538185|NCT04644796|Missouri Orthopaedic Institute|Angela Atkinson|573-884-1128|avadd9@umsystem.edu|
20538186|NCT01071200|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20538187|NCT02434354|Abramson Cancer Center|Dr. Tara Mitchell|215-662-7908|tara.mitchell@pennmedicine.upenn.edu|
20538188|NCT03730961|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20538189|NCT02071420|University of Iowa|Lucas Carr, PhD|319-353-5432|lucas-carr@uiowa.edu|
20538190|NCT01920893|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20538191|NCT01767493|Invicro|Stephanie Pizarro|203-990-1613|spizarro@invicro.com|
20538192|NCT02387801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20538193|NCT02752958|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20538194|NCT00853125|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
20538195|NCT00711490|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyelec@nei.nih.gov|
20538196|NCT01646645|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
20538197|NCT00884039|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
20538198|NCT02648022|Va San Diego Healthcare System|Dr. Samuel B. Ho|858-552-8585|Samuel.Ho2@va.gov|3280
20538199|NCT04209114|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20538200|NCT00901511|Fondazione IRCCS Policlinico San Matteo Pavia|Francesca Mariani|+39 0382 503590|fr.mariani@smatteo.pv.it|
20538201|NCT00681564|Universidad del Valle|Jorge Hernán Ramírez and Adolfo Contreras (adolfo@yahoo.com).|5723753778|jorge.h.ramirez00@gmail.com|
20538202|NCT02826421|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20538203|NCT00405964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20538204|NCT00937118|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
20538205|NCT01660737|PASCOE Pharamzeutische Präparate GmbH|Jennifer Lebert|0049+(0)641-7960-955|Jennifer.lebert@pascoe.de|
20538206|NCT02981407|Rutgers Robert Wood Johnson Medical School|Dr. Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu|
20538207|NCT01300819|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20569613|NCT02210208|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
20569614|NCT00664105|Vanderbilt-Ingram Cancer Center|Vicki Keedy, M.D.|(615) 322-4967||
20569615|NCT02185105|CooperVision, Inc|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
20569616|NCT01343251|St John Hospital and Medical Center|Dr. Robert Provenzano|313-886-8787|Rprovenzano@scsp.net|
20569617|NCT03006185|Bispebjerg Hospital|Emily Wenande|+4540505590|emilycathrinew@hotmail.com|
20569618|NCT03984513|Cincinnati Children's Hospital|Dr. Amie Duncan|513-803-2416|Amie.Duncan@cchmc.org|
20569619|NCT01468077|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20569620|NCT04843579|Weill Cornell Medicine|Multiple Myeloma Program Manager|646-962-9376|hyk4001@med.cornell.edu|
20569621|NCT03834623|Moffitt Cancer Center|Nikhil Khushalani, MD|813-745-3437|Nikhil.Khushalani@moffitt.org|
20569622|NCT00004146|Adult Brain Tumor Consortium|Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
20569623|NCT03024996|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20569624|NCT00478647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20569625|NCT00848510|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20569626|NCT04333147|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20569627|NCT04606199|University of California San Francisco|Dr. Stefanie Mayer|7345450698|Stefanie.mayer@ucsf.edu|
20569628|NCT01009762|Statens Serum Institut|Professor Anders Fomsgaard|+45-32683460|afo@ssi.dk|
20569629|NCT02363998|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
20569630|NCT00639769|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.||barbara.murphy@vanderbilt.edu|
20538208|NCT03561701|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
20538209|NCT00438854|Massachusetts General Hospital|Philip C. Amrein, M.D.|617-726-8748|pamrein@partners.org|
20569631|NCT00784147|TaiMed Biologics, Inc.|Stanley T. Lewis, Jr., MD|949-769-6543|stlewis@taimedbiologics.com|108
20569632|NCT03677245|University of Mississippi Medical Center|Dr. Meredith Flowers|662-386-5926|mmflowers@umc.edu|
20569633|NCT03596242|Wake Forest School of Medicine|Claudia L. Campos, MD|ccampos@wakehealth.edu|ccampos@wakehealth.edu|
20569634|NCT04912700|Beaumont Hospitals|Ahmit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
20569635|NCT03357471|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20569636|NCT00706914|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
20569637|NCT03294941|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
20569638|NCT01475461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569639|NCT01774019|Boston Scientific|Andrea Burbage|15086834387|Andrea.Burbage@bsci.com|
20569640|NCT00374088|University of Michigan - Pediatric Cardiology|Ranjit Aiyagari, MD|734-647-8761|ranjita@umich.edu|
20569641|NCT01167192|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu|
20569642|NCT02835092|Medifast|Linda Arterburn, VP Scientific & Clinical Affairs|443-379-5191|linda.arterburn@medifastinc.com|
20569643|NCT00713206|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20569644|NCT02561806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20569645|NCT04545476|Vanderbilt University Medical Center|Karen Arnaud|615-322-6485|karen.arnaud@vumc.org|
20569646|NCT00241969|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
20525487|NCT01913535|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@mgh.harvard.edu|
20525488|NCT03063086|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20525489|NCT01893281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20525490|NCT01316211|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
20525491|NCT05481125|Alcon Research, LLC|Director, Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20525492|NCT01769508|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20525493|NCT00910208|Albert Einstein College of Medicine|Polly Bijur, PhD|718-430-4217|polly.bijur@einstein.yu.edu|
20525494|NCT01290679|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20525495|NCT00562302|Angiotech|Thomas Doyle|352.338.0440|tdoyle@angio.com|
20525496|NCT03615144|Memorial Sloan Kettering Cancer Center|Maria Cancio, MD|212-639-7196|canciom@mskcc.org|
20525497|NCT01704651|Mayo Clinic|Dr. Jamie N. Bakkum-Gamez|507-266-8661|Bakkum.Jamie@mayo.edu|
20525498|NCT01131169|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|646-608-3731|GiraltS@mskcc.org|
20525499|NCT00634803|Yale University|Richard S. Schottenfeld, M.D.|203-974-7349|richard.schottenfeld@yale.edu|
20525500|NCT02209519|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|jschwebk@uabmc.edu|
20525501|NCT00675428|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20525502|NCT01377922|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
20525503|NCT00853645|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
20525504|NCT04615403|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
20525505|NCT02145260|Brigham and Women's Hospital|Finnian Mc Causland|6177326432|fmccausland@bwh.harvard.edu|
20525506|NCT00966992|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|pgrigsby@radonc.wustl.edu|
20525507|NCT01523782|ERYTECH Pharma|Denise Tilton, Global Head Clinical Operations & Program Management|+1 857-706-1587|dtilton@erytech.com|
20525508|NCT00596817|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20525509|NCT03063437|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|majdi@openbiome.org|
20525510|NCT04138953|Emory University|Michael Borich, DPT, PhD|404-712-0612|michael.borich@emory.edu|
20525511|NCT00602836|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
20525512|NCT03225105|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20525513|NCT03214380|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20525514|NCT03788434|Vedanta Biosciences|Jeffrey Silber|(857) 706-1427|ConsortiumIO-ctinquiries@vedantabio.com|
20525515|NCT01905553|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20525516|NCT01070095|St. Michael's Hospital|Dr. Samir Gupta|(416) 864-6060|guptas@smh.ca|2252
20525517|NCT00655707|ImperialC|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
20525518|NCT03692325|Dana-Farber Cancer Institute|Glenn Hanna, MD|617-632-3090|gjhanna@partners.org|
20525519|NCT02817516|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20525520|NCT00664859|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
20525521|NCT04481191|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525522|NCT00546117|Washington University|Judith Lieu, MD|314-454-6162|lieuj@wustl.edu|
20525523|NCT01323153|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20525524|NCT00348595|Johns Hopkins University School of Medicine|Mario Eisenberger|(410) 614-3511|eisenma@jhmi.edu|
20525525|NCT00638716|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
20525526|NCT03567005|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20525527|NCT02589626|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569647|NCT01149876|MGH|Dr. Molly Wanner|617-726-2914|harvardskinstudies@partners.org|
20569648|NCT02175745|Stanford University|Erik Mittra, MD, PhD|650-736-2859|emittra@stanford.edu|
20525528|NCT02564900|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
20525529|NCT02317276|UCSF Dermatology|Sarah Arron, MD, PhD|415-353-9684|Sarah.Arron@ucsf.edu|
20525530|NCT04292912|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20525531|NCT00280397|Eisai Co., Ltd.|Akihiko Tsuruoka|+81-3-3817-5252||5252
20569649|NCT00983892|Ann Arbor Veterans Administration|Maria J. Silveira MD MA MPH|734-763-4550|mariajs@med.umich.edu|
20538210|NCT00509093|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|+1 216-445-9354|advania@ccf.org|
20538211|NCT01103063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538212|NCT05320393|Evolus, Inc.|Rui Avelar|1-949-284-4689|rui.avelar@evolus.com|
20538213|NCT03283098|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20538214|NCT02210832|University of Vermont|Stephen T. Higgins|802-735-6267|stephen.higgins@uvm.edu|
20538215|NCT04790812|The University of Texas Health Science Center at Houston|Harry Gilbert, DDS|713-486-4315|Harry.D.Gilbert@uth.tmc.edu|
20538216|NCT00798317|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
20538217|NCT03115853|Vanderbilt University Medical Center|James Muldowney, MD|615-936-1720|james.muldowney@vanderbilt.edu|
20538218|NCT01069861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538219|NCT03093636|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|(434) 982-6484|MB6NT@uvahealth.org|
20538220|NCT00149994|Novartis Pharmaceuticals|Study Director|862-778-8300||
20538221|NCT01344538|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
20538222|NCT00297102|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20538223|NCT02324205|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
20538224|NCT03397134|Minerva Neurosciences|Senior Vice President and Head of R&D|617-600-7378|rkuchibhatla@minervaneurosciences.com|
20538225|NCT03061721|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
20538226|NCT00118352|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20538227|NCT02891681|Washington University School of Medicine|Quing Zhu, Ph.D.|314-935-7519|zhu.q@wustl.edu|
20538228|NCT01224821|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538229|NCT00683917|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20538230|NCT02725879|2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki,|Professor Assimina Galli-Tsinopoulou|+302310994802|agalli@auth.gr|
20538231|NCT03538444|Medical University of South Carolina|Gregory Sahlem MD|843-792-5716|sahlem@musc.edu|
20538232|NCT01431014|Chang Gung Memorial Hospital|Lun-Jou Lo, MD,Hye-Young Kim, MD||lunjoulo@cgmh.org.tw|
20538233|NCT01893372|The Universtiy of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
20569650|NCT00808899|St. Jude Children's Research Hospital|Wayne L. Furman|1-866-278-5833|info@stjude.org|
20569651|NCT03028012|University of Utah Physical Medicine and Rehabilitation Orthopedics|Dr. Daniel Cushman|8015852373|heidi.hansen@hsc.utah.edu|
20569652|NCT03181282|Washington University in St. Louis|Ryan Duncan|314-273-1052|duncanr@wustl.edu|
20569653|NCT02624375|University of Washington|Dr. Christine Johnston, Associate Professor|206 520 4340|cjohnsto@uw.edu|
20569654|NCT00569010|The University of MD Anderson Cancer Center|Jean-Pierre Issa, M.D./Professor|713-745-2260|eharriso@mdanderson.org|
20569655|NCT03448536|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20569656|NCT02736955|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20569657|NCT01424189|Alcon Research, Ltd.|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20569658|NCT03120949|R-Pharm|Sergey Grishin, Head of Scientific Affairs Department|0074959567937|sa.grishin@rpharm.ru|1506
20569659|NCT01705145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20569660|NCT00312845|Johnson & Johnson Pharmaceutical Research & Development|Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.||YElsaye1@ITS.JNJ.COM|
20569661|NCT01078584|Abbott|Global Medical Services|800-633-9110||
20569662|NCT01208870|SUNY Buffalo|Leonard H. Epstein, Ph.D.|716-829-3400|lhenet@buffalo.edu|
20569663|NCT01121185|MassBiologics|Director Clinical Affairs|617-474-3000|MBLclinicaldirector@umassmed.edu|
20569664|NCT01077622|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569665|NCT00424177|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569666|NCT03822377|Cardiology Clinic, Sassari University Hospital, Sassari, Italy|Prof. Guido Parodi|0039|parodiguido@gmail.com|792830626
20569667|NCT03927742|University of Minnesota|Rachel Vogel|612-624-6928|isak0023@umn.edu|
20569668|NCT01503164|Johns Hopkins University|Naresh Punjabi|410-550-6384|npunjabi@jhmi.edu|
20569669|NCT01042145|Washington University School of Medicine|Dr. Jane Garbutt|314-454-8613|jgarbutt@dom.wustl.edu|
20569670|NCT04088136|Georgia Institute of Technology|Dr. Christopher Hertzog|404-894-6774|ch18@gatech.edu|
20569671|NCT01177228|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
20569672|NCT04159805|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20569673|NCT01393613|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20569674|NCT01618227|Massachusetts General Hospital|Neal Chen|617-726-4700|nchen1@partners.org|
20569675|NCT00474383|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024.|Senior Director|310-943-8040||2917
20569676|NCT00654615|Wake Forest University Health Sciences|Zhongyu Li, MD, PhD, Professor - Department of Orthopaedic Surgery|336-716-9520|zli@wakehealth.edu|
20569677|NCT00316589|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20569678|NCT01482819|Johnson & Johnson Vision Care|Daria Wicks, Senior Clinical Research Manager|904-443-1391|RA-ClnclStds@its.jnj.com|
20569679|NCT03110692|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
20538234|NCT01779869|Washington University School of Medicine|Pamela K. Woodard, M.D.|314-362-7130|woodardp@wustl.edu|
20538235|NCT03760016|University of Cincinnati|Pierce Boyne|5135587499|Pierce.Boyne@uc.edu|
20538236|NCT04754230|Stanford University|Zara M. Patel, MD|650-723-5651|zmpatel@stanford.edu|
20538237|NCT01459653|Sandoz GmBH|Andriy Krendyukov, Global Medical Director|+49 8024 4764855|andriy.krendyukov@sandoz.com|
20538238|NCT01691105|Yale School of Medicine|Dr. Steven Bernstein|203-737-3574|steven.bernstein@yale.edu|
20538239|NCT00957944|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20538240|NCT03232645|Boston Scientific|Clinical Trial Manager|00393421994999|alberto.belligoli@bsci.com|
20538241|NCT01482169|Ochsner Clinic Foundation|Dr. Robert Bober|504-842-4135|rbober@ochsner.org|
20538242|NCT00803517|Samsung Medical Center|Jiwon Lim|82-10-9933-5596|samnyasa@naver.com|
20538243|NCT00445848|Swog Statistical Center|Lung Committee Statistican|2066674623|jmoon@fredhutch.org|
20538244|NCT00790647|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
20538245|NCT00027378|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
20538246|NCT03296137|National Center for Cancer Immune Therapy, Herlev Hospital|Anders Kverneland, MD, PhD|+4538686467|anders.kverneland@regionh.dk|
20538247|NCT00383643|Stanford University School of Medicine, Dept of Psychiatry|Dr. Jed Black|650 736 4559|jedblack@stanford.edu|
20538248|NCT01687088|Thomas Jefferson University|Michael J. Marmura, MD|215-955-2243|michael.marmura@jefferson.edu|
20538249|NCT01644695|Institute For Advanced Reconstruction|Dr. Andrew Elkwood, MD|732-741-0970|aelkwood@hotmail.com|
20538250|NCT00759356|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
20538251|NCT02585830|University of Colorado Anschutz Medical Campus|Stacey L. Simon|720-777-5681|stacey.simon@childrenscolorado.org|
20538252|NCT01657344|Lurie Children's Hospital|Elizabeth Alpern|312-227-6080|ealpern@luriechildrens.org|
20538253|NCT03054350|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
20538254|NCT03510468|Clinical Center|Dr. Joseph Kovacs|+1 301 496 9907|jkovacs@mail.nih.gov|
20538255|NCT05894538|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20538256|NCT03576755|University of California San Francisco|Principal Investigator: Dr. Monika Sarkar|415-502-2656|monika.sarkar@ucsf.edu|
20538257|NCT03444766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20538258|NCT04346108|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20538259|NCT01081301|University of Alberta|Dr. Wendy Duggleby|780-492-8660|wendy.duggleby@ualberta.ca|
20538260|NCT00724854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20538261|NCT01095653|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20538262|NCT02046226|Halyard Health, Inc.|David T Curd|470-448-5178|david.curd@hyh.com|
20538263|NCT00171925|Novartis Pharmaceuticals|Study Director|862-778-8300||
20538264|NCT03746600|University of Kentucky College of Medicine|Carolyn Lauckner, PhD|989-928-2359|carolyn.lauckner@uky.edu|
20538265|NCT00832130|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
20538266|NCT02374814|SUNY Upstate Medical University|Dr. Timothy Endy|315-464-7692|endyt@upstate.edu|
20538267|NCT02182440|AM-Pharma B.V.|JAcques Arend MD, DiMD, Chief Medical Officer|+31302598836|j.arend@am-pharma.com|
20538268|NCT03754582|Eisai Co., Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20538269|NCT01799239|Coloplast A/S|Camilla Felsvang Vibjerg, Senior Clinical manager|+45 4911 1990|dkcfv@coloplast.com|
20538270|NCT03630198|Vanderbilt Univeristy Medical center|Dr. Brian Drolet|615-322-2918|brian.c.drolet@vumc.org|
20538271|NCT01561755|Icahn School of Medicine at Mount Sinai|Dr. David Simpson|212-241-8748|david.simpson@mssm.edu|
20538272|NCT02680574|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
20538273|NCT01166958|University of Wisconsin Osteoporosis Clinical Research Program|Neil Binkley, MD|608-265-6410|uwosteoporosis@gmail.com|
20538274|NCT02403895|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
20538275|NCT01286987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538276|NCT02880514|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
20538277|NCT04151628|Shockwave Medical Inc|Randee Randoll, Director Clinical Affairs|1-408-577-7856|rrandoll@shockwavemedical.com|
20538278|NCT04899440|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
20538279|NCT02210221|UZA|Prof. Em. Dr Andrew Maas|0032 3 821 45 37|andrew.maas@uza.be|
20538280|NCT02230761|Topokine Therapeutics, Inc.|Chief Scientific Officer|617 203 2034|CSO@topokine.com|
20538281|NCT03785587|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20538282|NCT02466074|The University of Texas Health Science Center at Houston|John A. Lincoln, MD, PhD|713-500-7016|John.A.Lincoln@uth.tmc.edu|
20538283|NCT02818036|University of Pittsburgh|Dr. Tristen Inagaki|412-624-4211|inagaki@pitt.edu|
20538284|NCT03058666|Ony Biotech|James Cummings, MD|7166369096|jcummings@onybiotech.com|
20538285|NCT05434013|BU School of Public Health|Jennifer Ross, PhD|617 358 1905|jjross@bu.edu|
20538286|NCT04627675|Providence Portland Medical Center|Dr. Rom Leidner|503-215-5696|rom.leidner@providence.org|
20538287|NCT01319721|State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University|Dr. Shiyou Zhou|+86-020-87331540|zhoushiy@mail.sysu.edu.cn|
20538288|NCT00468845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538289|NCT00461305|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20538290|NCT01628614|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20538291|NCT01896271|UT Southwestern Medical Center|Dr. Raquibul Hannan|214-645-8525|Raquibul.Hannan@UTSouthwestern.edu|
20525532|NCT06175026|Stanford University|Dr. Anna H. Grummon, PhD|(650) 644-7366|agrummon@stanford.edu|
20525533|NCT04347564|Augenheilkunde Lindenthal|Daniela Claessens|017229227962|daniela.claessens@gmx.de|
20525534|NCT02225860|Tufts Medical Center|Ronald D. Perrone|6176362372|rperrone@tuftsmedicalcenter.org|
20525535|NCT05338502|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20525536|NCT02278939|University of California San Francisco, School of Nursing|Dr. Melinda Sarmiento Bender and Dr. Yoshimi Fukuoka|(415) 514-3151|melinda.bender@ucsf.edu; yoshimi.fukuoka@ucsf.edu|
20525537|NCT02669836|Washington University|David D. Limbrick MD|314-454-3212|T.Meehan@wustl.edu|
20525538|NCT02423343|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20525539|NCT01665950|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
20525540|NCT04826965|Duke University|Suhail Mithani, MD|919-681-8390|suhail.mithani@duke.edu|
20525541|NCT01127451|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20525542|NCT02111577|SOTIO a.s.|Prof. Radek Spisek, M.D., Ph.D.|+420 2241 75101|spisek@sotio.com|
20525543|NCT01014988|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525544|NCT00729157|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
20525545|NCT01683266|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
20525546|NCT00886743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525547|NCT00626821|Coloplast|Helle Aaes Senior Scientific Manager|+45 49112949|dkheaa@coloplast.com|
20525548|NCT00756236|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
20525549|NCT04903496|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525550|NCT03655470|Brown University|Anthony Spirito, PI|4014441929|anthony_spirito@brown.edu|
20525551|NCT02244463|Dana-Farber Cancer Institute|Kartik Sehgal, MD|(617) 632-3090|Kartik_Sehgal@dfci.harvard.edu|
20525552|NCT03834766|Tris Pharma, Inc.|Antonio Pardo|19175149058|apardo@trispharma.com|
20525553|NCT03702010|Hospital Universitario de Salamanca|Dr. Francisco José Sánchez Montero|923291100|fjsmontero@saludcastillayleon.es|
20538292|NCT01540409|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
20538293|NCT03966885|Columbia University|Jeremy Kane, PhD, MPH|7179914098|jk4397@cumc.columbia.edu|
20538294|NCT00549900|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538295|NCT03383757|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
20538296|NCT03187834|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
20538297|NCT02754141|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20538298|NCT01187446|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
20538299|NCT01430325|Intermountain Healthcare|Lindell K. Weaver, MD|801-408-3623|lindell.weaver@imail.org|
20538300|NCT01007123|Albireo|Dr Mats Ekelund|+46 31 741 14 80|info@albireopharma.com|
20538301|NCT00823212|Boston Scientific Corporation|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
20538302|NCT00320255|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20538303|NCT04422561|Zagazig University|Dr. Waheed Shouman|+201114812048|shouman66@gmail.com|
20538304|NCT00623545|University of Wisconsin-Madison|Dale A Schoeller|608-262-1082|dschoell@nutrisci.wisc.edu|
20538305|NCT04239222|Ottobock SE & Co. KGaA|Clinical Project Manager|+4955278483054|pawel.maciejasz@ottobock.com|
20538306|NCT04283942|Zhongshan Hospital, Fudan University|Dr. Hua Bian|+86 64041990|zhongshan_bh@126.com|
20538307|NCT05494736|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538308|NCT02685748|CPD Dr Laza Lazarevic, Belgrade, Serbia|Pavicevic Dragana|0652207970|gagapavicevic@yahoo.com|+381
20538309|NCT00328653|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
20538310|NCT00937404|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538311|NCT04854031|Boys Town National Research Hospital|Adam Bosen|531-355-5030|adam.bosen@boystown.org|
20538312|NCT01638052|Ann & Robert H. Lurie Children's Hospital of Chicago|Santhanam Suresh, MD|312-227-5147|SSuresh@luriechildrens.org|
20538313|NCT00230282|Stanford University|Steven E. Coutre, Associate Professor of Medicine|650-723-6661|coutre@stanford.edu|
20553899|NCT02606136|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-079DMDStudy@fibrogen.com|
20525554|NCT01080118|Northwestern University Feinberg School of Medicine|Dr. Gildasio DeOliveira|312-472-3573|g-jr@northwestern.edu|
20525555|NCT02196688|Hutchison Medipharma Ltd|Dr. Songhua Fan|+86 21 2067 3058|songhuaf@hmplglobal.com|5058
20525556|NCT02295020|LSUHSC-NO -Orthopaedic Department|Dr. Vinod Dasa|(504) 412-1700|vdasa@lsuhsc.edu|
20525557|NCT04791319|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20525558|NCT03628339|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20525559|NCT04431908|Yale School of Medicine|Dr. R. Peter Manes|(203) 785-5430|rpeter.manes@yale.edu|
20525560|NCT02726906|UC San Diego|Judy Pa, PhD|858-246-1333|jpa@ucsd.edu|
20525561|NCT00355147|VA Stroke QUERI Center, Roudebush VAMC|Teresa Damush, Ph.D.|317-988-4277|Teresa.Damush@va.gov|
20525562|NCT02793674|Presbyterian Hospital|Thomas Weiler, MD|505-724-7044|tweiler@gmail.com|
20525563|NCT01146379|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
20525564|NCT00765336|Medicis Global Services Corporation|Director of Clinical Trials||ClinicalTrials@Medicis.com|
20525565|NCT00153543|CDC/Arctic Investigations Program|Karen Miernyk|9077293453|kmiernyk@cdc.gov|
20525566|NCT03831360|Butler Hospital|Dr. Lisa Uebelacker|401-455-6381|LUebelacker@butler.org|
20525567|NCT03388645|National Institute of Allergy and Infectious Diseases|Lesia Dropulic|+1 301 496 7675|dropulicl@niaid.nih.gov|
20538314|NCT01752400|Massachusetts General Hospital|Alice Shaw, MD, PhD|617-724-4000|ashaw1@mgh.harvard.edu|
20538315|NCT00090233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20553900|NCT03296696|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20525568|NCT00482677|Canadian Cancer Trials Group|Keyue Ding|613-5336430|kding@ctg.queensu.ca|
20538316|NCT04863248|G1 Therapeutics, Inc|Clinical Trial Info|919-213-9835|clinicalinfo@g1therapeutics.com|
20538317|NCT02139878|University of Prince Edward Island|Kim S. Stote PhD, MPH, RD|518-587-2100|Kim.Stote@esc.edu|2873
20538318|NCT05074888|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20538319|NCT01777542|Boston Children's Hospital|Dr. Mustafa Sahin, Director of Translational Neuroscience Center|617-919-6258|ResearchTNC@childrens.harvard.edu|
20538320|NCT02270255|McGill University Health Centre|Louis-Martin boucher|5149341934|lmboucher@yahoo.com|44454
20538321|NCT04706273|W. L. Gore & Associates|Eric Novak|314-440-2110|enovak@wlgore.com|
20538322|NCT02701777|Hines VA|Reagan Morehouse|312-238-2993|rmorehouse@sralab.org|
20538323|NCT00869050|Columbia University|Dr. Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
20538324|NCT00899717|University of Santiago de Compostela|Urbano Santana Penín|0034647344093|urbano.santana@usc.es|
20507681|NCT03939637|Baylor College of Medicine/ Texas Children's Hospital|Amanda Grimes|832-822-4217|abgrimes@texaschildrens.org|
20525569|NCT00842023|Western University of Health Sciences|Dr. Sheryl L. Chow|9094695379|schow@westernu.edu|
20525570|NCT01323387|Synthes Spine|Clinical Research Associate|610-719-5942|knappk@synthes.com|
20525571|NCT00511914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20525572|NCT00697463|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
20525573|NCT03307252|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525574|NCT03482453|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20525575|NCT01554527|University of Michigan|Dr. Ronald Chervin|734-647-9064|chervin@med.umich.edu|
20525576|NCT00251238|Radboud University Nijmegen, The Netherlands|Dr. SJH Bredie, MD, PhD|0031 24 3618819|bas.bredie@radboudumc.nl|
20525577|NCT00199797|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20525578|NCT02195622|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
20525579|NCT03190668|University of Florida|Christoph Seubert, MD|352-273-8960|cseubert@anest.ufl.edu|
20525580|NCT00504725|Duke University Medical Center|Andrew Shaw MD|9192866938|andrew.shaw@duke.edu|
20525581|NCT01435018|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20525582|NCT00378508|Yale University|Kevan Herold, MD|203-785-6507|kevan.herold@yale.edu|
20525583|NCT00972816|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
20525584|NCT01770366|Baystate Medical Center|Sofija Zagarins|413-794-2876|sofija.zagarins@baystatehealth.org|
20525585|NCT00593684|Baylor Health Care System|Furgan Moin, MD|214-820-7604|Furgan.Moin@baylorhealth.edu|
20525586|NCT03625466|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20525587|NCT04082572|M.D. Anderson Cancer Center|Michael J. Overman, MD|(713) 792-2828|moverman@mdanderson.org|
20525588|NCT01058993|University of Washington|David D. Dale, MD|206-543-7215|dcdale@u.washington.edu|
20525589|NCT00809471|Vivus, Inc|Wesley W Day PhD|650-934-5200||
20525590|NCT00831311|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20525591|NCT03448575|Kaiser Permanente Washington Health Research Institute|Robert Penfold, PhD|206-316-7544|robert.b.penfold@kp.org|
20525592|NCT01665157|National Taiwan University Hospital|Han-Mo Chiu, M.D., Ph.D.||hanmochiu@ntu.edu.tw|
20525593|NCT00832871|University of New Mexico Comprehensive Cancer Center|Dr. Fa-chyi Lee|505-925-0405|FLee@salud.unm.edu|
20507682|NCT04904614|Tufts Medical Center|Dr. Jennifer Chow|617-636-5244|jennifer.chow@tuftsmedicine.org|
20507683|NCT03341923|Alcon Japan, Ltd.|Group Manager, Vision Care|+81.3.6899.5061|alcon.medinfo@alcon.com|
20507684|NCT04511819|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
20507685|NCT00082329|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
20507686|NCT00589979|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator|Use e-mail contact|clinicalsite.inquiries@endo.com|
20507687|NCT01153841|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507688|NCT02451202|Department of Anesthesiology, King Chulalongkorn Memorial Hospital|Dr. Prok Laosuwan|+66 2256 4295|plaospir@yahoo.com|
20507689|NCT03373110|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
20507690|NCT00830804|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20507691|NCT05506969|Dynavax Technologies|Ouzama Henry, MD|617-686-4796|ohenry@dynavax.com|
20507692|NCT01647464|OHSU|Jonathan Lindner|5034948750|lindnerj@ohsu.edu|
20507693|NCT05489081|Children's Hospital of Philadelphia|Dr. Gwendolyn Lawson|2674266612|lawsong@chop.edu|
20507694|NCT00510068|Novartis Pharmaceuticals|Study Director|862-778-8300||
20507695|NCT00400712|Queen's University|Brenda Brouwer|613-533-6079|brouwerb@queensu.ca|
20507696|NCT02466412|Philip Morris Products S.A.|Steffen Fredersdorf|+41 (58) 242 2182|Steffen.Fredersdorf@pmi.com|
20507697|NCT00776555|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20507698|NCT02553317|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
20507699|NCT03482141|University of California, San Francisco|Mary Norton|(415) 467 4080|mary.norton@ucsf.edu|
20507700|NCT03483116|Murdoch Children's Research Institute|Professor Julie Bines|+61 3 9345 5522|julie.bines@mcri.edu.au|
20507701|NCT01181102|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
20507702|NCT01315002|University Hospital Bonn, Department of Psychiatry and Psychotherapy|Prof. Dr. Michael Wagner|004922828716377|michael.wagner@uni-bonn.de|
20507703|NCT00769808|Bausch & Lomb Incorporated|Study Director|9083009926|susan.harris@bauschhealth.com|
20507704|NCT03438578|St Olavs Hospital|Erlend Johan Skraastad|0047 79829184|Erlend.Johan.Skraastad@stolav.no|
20507705|NCT01838590|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20507706|NCT04664855|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
20507707|NCT01529385|Center for Lower Extremity Ambulatory Research|Ryan Crews, Clinical Scientist|847-578-8437|ryan.crews@rosalindfranklin.edu|
20525594|NCT03766165|Johns Hopkins University; Indiana University|Dr. Larissa Jennings Mayo-Wilson|1-812-856-0902|ljmayowi@iu.edu|
20525595|NCT03557931|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20525596|NCT00778869|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20525597|NCT00364923|Allos Therapeutics, Inc|Michael Saunders, M.D.|303-426-6262|msaunders@allos.com|
20538325|NCT03199053|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20538326|NCT03298984|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|2104147702|Susan.smith@sdponcology.com|
20538327|NCT00970814|NIAAA|Megan Ryan - Clinical Trials Project Manager|301-443-4225|mryan1@mail.nih.gov|
20538328|NCT00585221|Huntsman Cancer Institute|Director of Clinical Trials|801-213-4241|candace.larson@hci.utah.edu|
20538329|NCT03263923|Case Western Reserve University|Dr. Carol M. Musil|216-368-2545|cmm4@case.edu|
20569680|NCT03594045|Massachusetts General Hospital|Dr. Rachel Rosovsky|617-724-4000|RPROSOVSKY@mgh.harvard.edu|
20569681|NCT01502371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569682|NCT00562484|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20569683|NCT02672514|Herzzentrum Coswig|Dr. Jessica Vogler|+491749740710|j_vo@web.de|
20538330|NCT01323270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538331|NCT05357664|DePuy Synthes|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
20538332|NCT01655043|Northwestern University|Dr. James Carr|(312)926-2270|jcarr@northwestern.edu|
20538333|NCT01924442|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-724-2798|Frederic.Grover@ucdenver.edu|
20538334|NCT01057225|Mayo Clinic|Joseph Riad Mikhael, M.D.||Mikhael.Joseph@mayo.edu|
20538335|NCT02229214|VIVUS Inc.|Craig Peterson, Sr. Director, Clinical Research|650-934-5200|ClinicalTrials@vivus.com|
20538336|NCT00246025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20538337|NCT01643850|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20538338|NCT02115750|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
20538339|NCT00931723|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20538340|NCT03305081|TulaneU|Resident of OB/GYN|858-499-2702|sjunya@tulane.edu|
20538341|NCT01571284|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20538342|NCT00075725|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20538343|NCT03352557|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20538344|NCT03242772|Duke Center for Autism and Brain Development|Dr. Geraldine Dawson, PhD, PI of Duke Autism Center of Excellence|919-668-0070|geraldine.dawson@duke.edu|
20538345|NCT04677660|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20538346|NCT02023801|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
20538347|NCT01648296|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20538348|NCT02437305|Northwestern Univeristy|Dr. Roopal Kundu|312-926-4926|rkundu@nm.org|
20538349|NCT03964246|Veterans Affairs San Diego Healthcare System|Barton W. Palmer|8582460765|bpalmer@ucsd.edu|
20538350|NCT01560637|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20538351|NCT01070693|Helsinki University Central Hospital|Dr. Georgios Pierides|+358 9 4711|georgios.pierides@hus.fi|
20538352|NCT01089023|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20538353|NCT00904618|Centre Hospitalier Universitaire de Sherbrooke|Louis-Olivier Gagnon|1-819-437-4965|louis.olivier.gagnon@gmail.com|
20538354|NCT03220581|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
20538355|NCT03410797|University of Pittsburgh|Jacqueline Gartner-Schmidt|412-232-8970|jgs@pitt.edu|
20538356|NCT01185964|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20538357|NCT03883113|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
20538358|NCT04465877|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
20538359|NCT00395135|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20538360|NCT03440918|Vanderbilt University Medical Center|Dr. Sophie Katz|615-343-6190|sophie.e.katz@vumc.org|
20538361|NCT02257177|Galecto|Professor Bertil Lindmark|+4570705210|info@galecto.com|
20538362|NCT04962230|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538363|NCT01396265|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20538364|NCT01598753|University of Washington|Dennis C. Turk, Ph.D.|(206)616-2626|turkdc@uw.edu|
20538365|NCT02275117|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20538366|NCT00386477|Indiana University School of Medicine|David M. Haas, MD, MS|317-630-7837|dahaas@iupui.edu|
20538367|NCT02014480|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538368|NCT01338610|Alcon Research, Ltd.|Christian Leisner|1-888-451-3937|alcon.medinfo@alcon.com|
20538369|NCT01865812|Intercept Pharmaceuticals, Inc.|Medical Information|+1 844-782-4278|medinfo@interceptpharma.com|
20538370|NCT02692040|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
20538371|NCT03089879|GlaxoSmithKline|GSK Response Center|866-435-7343|ass77028@gsk.com|
20538372|NCT00953680|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20538373|NCT04030247|Stanford University|Rajesh Dash, MD|650-725-7087|rdash@stanford.edu|
20538374|NCT03559699|Agios Pharmaceuticals, Inc|Medical Affairs|833-228-8474|medinfo@agios.com|
20538375|NCT01401699|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
20538376|NCT02968381|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
20538377|NCT01930890|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20538378|NCT03710876|Ferring Ventures Ltd|Lindsay Caygill Clinical Trial Manager|+44 (0) 74 213 02230|linsdsay.caygill@trizell.com|
20538379|NCT02534935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538380|NCT02209948|MFAR Clinical Research|Pau Doñate|0034934344412|investigacion@mfar.net|
20569684|NCT03325608|NYU Langone Health|Joshua Chodosh, MD, MSHS, FACP|212-263-6768|Joshua.Chodosh@nyumc.org|
20507708|NCT04009213|Advanced Medical Solutions|Tina Warburton, Senior Clinical Research Associate|07791742957|tina.warburton@admedsol.com|
20525598|NCT02449798|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0935|Gina.Gilbert@crbard.com|
20525599|NCT01721096|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20525600|NCT01985932|University of Pennsylvania|Curtiland Deville, MD|215-662-2428|deville@uphs.upenn.edu|
20525601|NCT02401048|Pharmacyclics|Emily Liu|(669) 224-1899|aliu@pcyc.com|
20525602|NCT03474731|University of Kentucky|Dr. Nancy Schoenberg|(859) 323-8175|nesch@uky.edu|
20507709|NCT00862121|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20538381|NCT02630017|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|maddicott@uams.edu|
20538382|NCT04065074|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
20538383|NCT01218100|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|Manfred.stapff@frx.com|
20538384|NCT02081638|National Institute of Allergy and Infectious Diseases|Dr. Irini Sereti|301-496-5533|isereti@niaid.nih.gov|
20538385|NCT01852825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538386|NCT02159118|The University of Texas Health Science Center|Chatchawin Assanasen, MD|210-567-7456|assanasen@uthscsa.edu|
20538387|NCT01327274|UCSF Benioff Children's Hospital|Jill Imamura-Ching, RN|415-476-3446|Jill.Imamura-Ching@ucsf.edu|
20538388|NCT02446418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20538389|NCT03114124|UF Health- Jacksonville|Andrea Goosen|904-244-5617|andrea.ggosen@jax.ufl.edu|
20538390|NCT02470754|University of California, San Francisco|Natalie Nardone, PhD|415-514-1450|natalie.nardone@ucsf.edu|
20538391|NCT03421743|Savara Inc|Paymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
20538392|NCT00435162|Novartis Pharmaceuticals|Study Director|862-778-8300||
20538393|NCT01819129|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20538394|NCT00391469|University of Washington|Francis Kim, MD Associate Professor of Medicine|206-744-8712|fkim@u.washington.edu|
20538395|NCT02825966|ZOLL|Director, Clinical Operations|4129683333|mosz@zoll.com|
20538396|NCT01863134|First Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland|Miroslaw Wilczynski|+48 32 20 24 025|miroslaw.wilczynski@cardiosurg.pl|
20538397|NCT00054691|University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD / Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
20538398|NCT02266277|University of Massachusetts Medical School|Dr. Sarah Cutrona|508-856-3086|sarah.cutrona@umassmed.edu|
20538399|NCT02836873|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20538400|NCT00694096|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
20538401|NCT03900923|NYU Langone Health|Francisco X Castellanos, MD|646-754-5194|Francisco.Castellanos@nyulangone.org|
20538402|NCT03190265|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20538403|NCT02599649|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|ggarciam@mdanderson.org|
20538404|NCT02914548|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20538405|NCT00182767|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20538406|NCT00977938|Harvard Clinical Research Institute|Priscilla Driscoll Shempp, Sr. Director Trial Design, Development and Strategy|617.307.5200|pdriscoll@hcri.harvard.edu|
20538407|NCT02540330|Atossa Therapeutics, Inc.|Heather Fraser, VP Clinical, Regulatory & CMC|206-707-3088|heather.fraser@atossainc.com|
20538408|NCT02142283|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
20538409|NCT03373890|SeattleChildrens|Kristie Bjornson, PT, PhD|206-884-2066|kristie.bjornson@seattlechildrens.org|
20538410|NCT00747344|Janssen Research & Development, LLC|Director, Clinical Research|215-793-7646||
20538411|NCT02460783|National Institute on Aging|Dimitrios Kapogiannis|+1-202-290-0433|kapogiannisd@nih.mail.gov|
20538412|NCT01484834|UNESC|Dr. Antonio Jose Grande|04834312500|grandeto@unesc.net|2571
20538413|NCT02030080|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
20538414|NCT01371643|NYU Langone Medical Center|David Kleinberg|212 263 6772|David.Kleinberg@nyumc.org|
20538415|NCT02881112|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
20538416|NCT00712530|Szent Laszlo Hospital, Budapest, Hungary|Dr. Denes Banhegyi|+3614558152|immunol@mail.datanet.hu|
20538417|NCT02214225|Seqirus|Seqirus Clinical Trial Disclosure Lead||Seqirus.ClinicalTrials@Seqirus.com|
20538418|NCT02170363|St. Jude Medical|Poornima Sood|+17818528334|PSood@sjm.com|
20538419|NCT03987932|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
20569685|NCT02188784|Duke Clinical Research Institute|Dr. Adrian Hernandez|919-668-7515|adrian.hernandez@duke.edu|
20569686|NCT02473913|University of Chicago|Stephanie Valle|773-834-3778|svalle@yoda.bsd.uchicago.edu|
20569687|NCT04013932|University of North Carolina at Chapel Hill|Joy Noel Baumgartner|919.923.8534|joy.baumgartner@unc.edu|
20569688|NCT05399082|Mayo Clinic|Ryan M. Kern, M.D.|507-266-3958|Kern.Ryan@mayo.edu|
20569689|NCT00960505|University of Illinois Chicago|Krista Varady, PhD, Associate Professor|3129967897|varady@uic.edu|
20538420|NCT01861925|Haag Streit AG|Dr. Lucio Robledo, Clinical Trials Biometry|+41 31 978 01 11|lucio.robledo@haag-streit.com|209
20538421|NCT01605227|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20538422|NCT02129478|The Hospital for Sick Children|Dr. Laura Lee Dupuis|416-813-7654|lee.dupuis@sickkids.ca|309355
20538423|NCT00624819|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538424|NCT02847858|University of California San Francisco|Dr. Kathleen Tebb|415-514-0941|Kathleen.Tebb@ucsf.edu|
20538425|NCT03468816|Åby vårdcentral, County council of Östergötland|Dr. Fredrik Iredahl|010-103 00 00|fredrik.iredahl@liu.se|
20538426|NCT02185014|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20538427|NCT03093974|Zambon S.p.A.|Michela Meroni - Clinical Trial Manager|+39 02 665241|clincaltrials@zambongroup.com|
20538428|NCT02141490|National Cancer Institute|Dr. Ismail B. Turkbey|240-760-6112|turkbeyi@nih.gov|
20538429|NCT02387164|Skåne University Hospital|Helena Elding Larsson|+4640337676|helena.larsson@med.lu.se|
20569690|NCT02250183|Allegheny Health Network-West Penn Hospital Burn Center|Ariel M. Aballay, MD|412-578-1836|Ariel.Aballay@AHN.org|
20569691|NCT03282799|University of Pittsburgh|Dr. Catherine Chappell|412-641-1403|chappelca@upmc.edu|
20569692|NCT03749616|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20525603|NCT01826513|University of Western Australia|Prof. David Hillman & Prof. Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
20525604|NCT01355575|Imperial College London|Dr Jeremy Cobbold|+44 1865228756|jeremy.cobbold@ndm.ox.ac.uk|
20525605|NCT02887248|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20525606|NCT02685358|VA Palo Alto Health Care System|Eric Kuhn, PhD|650-493-5000|eric.kuhn@va.gov|23160
20525607|NCT02438826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20525608|NCT01707108|Rambam Health Care Campus|Director of Trial|+97247772983|j_horwitz@rambam.health.gov.il|
20525609|NCT01088672|Stryker NV|Amelia Saliba, AIS Clinical Program Manager|510-413-2500|aisstudies@stryker.com|
20525610|NCT02397122|Kirikkale University|Dr. H. Gencay Keceli|+905326714377|monsieur_gencay@yahoo.com|
20525611|NCT02805179|University of Michigan|Michelle Kim, MD|734-936-4300|michekim@med.umich.edu|
20525612|NCT00478777|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20525613|NCT00305084|Clinical Operations|MolMed S.p.A.|0039 02212771|clinical.operations@molmed.com|
20525614|NCT04105218|University of Colorado Anschutz Medical Campus|Clinical Research Support Center|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20525615|NCT00926848|University of Nebraska Medical Center|Bernice Yates|402-861-1713|bcyates@unmc.edu|
20525616|NCT04678232|Case Western Reserve University|Norah Feeny, PhD|(216) 368-2695|ncf2@case.edu|
20525617|NCT00552396|Innate Pharma|Dr Renaud Buffet Senior Director, Clinical Development and Translational Research|+33430303032|renaud.buffet@innate-pharma.fr|
20525618|NCT02553499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525619|NCT01582178|Vitkovice Hospital|Premysl Falt, MD|+420595633|faltprem@centrum.cz|205
20525620|NCT01726270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525621|NCT02948751|Columbia University|Kevin Kalinsky, MD|212-305-0170|kk2693@columbia.edu|
20525622|NCT00582608|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak|212-639-7623|modaks@mskcc.org|
20525623|NCT00570063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525624|NCT02819973|Duke Clinical Research Institute|Kevin Thomas, MD|919-668-8700|kevin.thomas@duke.edu|
20525625|NCT00550043|Incyte Corporation|Study Director|1-855-463-3463||
20525626|NCT03478644|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20525627|NCT00604591|Columbia University|Edward D. Huey, MD|212-305-1134|edh2126@cumc.columbia.edu|
20525628|NCT01965366|Emory University|Dr. Barbara Rothbaum|404-712-8866|brothba@emory.edu|
20525629|NCT04152837|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
20525630|NCT00586820|Mayo Clinic|Dr. Amir Lerman|507-255-6670|lerman.amir@mayo.edu|
20525631|NCT02073929|Center of Endocrinology and Metabolism, Dept. of Internal Medicine, Herlev Gentofte Hospital, Denmark|Professor Jens Faber|+4538689016|jens.faber@regionh.dk|
20525632|NCT01483027|Boston Scientific|Chantal Laframboise|+1 613 882 0876|chantal.laframboise@bsci.com|
20525633|NCT03010800|Oklahoma University Health Science Center|Dr. Robert Hurst|405-271-3930|Robert-Hurst@ouhsc.edu|
20525634|NCT03763929|Diffusion Pharmaceuticals Inc|Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
20525635|NCT00101166|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sophie Dessureault|813-745-1965|sophie.dessureault@moffitt.org|
20525636|NCT00686829|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569693|NCT03302559|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20569694|NCT00771238|Nebraska Medical Center|Joyce Black, PhD, RN|402-559-6573|JBlack@unmc.edu|
20569695|NCT03390933|MetroHealth System|Dr. Ashwini Sehgal|216-778-8484|axs81@case.edu|
20569696|NCT03371706|University of Chicago|Dr. Emily Rogalski|855-824-7887|emily.rogalski@bsd.uchicago.edu|
20569697|NCT01999972|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569698|NCT04260464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569699|NCT00803777|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20569700|NCT03440047|Mayo Clinic|Dr. Nayantara Coelho-Prabhu|(507)284-2407|CoelhoPrabhu.Nayantara@mayo.edu|
20569701|NCT01722045|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator||clinicaltrials@regeneron.com|
20569702|NCT00612352|Yale University|Ismene Petrakis||ismene.petrakis@yale.edu|
20569703|NCT02161406|University of Michigan DCC (SABER)|Dr. Cathie Spino|734-615-5469|spino@umich.edu|
20569704|NCT00477464|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569705|NCT04067843|University Hospital Zurich|Dr. Yvonne Achermann|+41442553402|yvonne.achermann@usz.ch|
20569706|NCT04184349|The University of Texas Health Science Center at Houston|Olga Pewelek, MD|713-500-6227|Olga.I.Lyuksyutova@uth.tmc.edu|
20569707|NCT04051242|University of Pittsburgh|J. Peter Rubin, MD Principal Investigator and Endowed Chair of Plastic Surgery|412-383-8080|rubipj@UPMC.EDU|
20569708|NCT01336205|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20569709|NCT04035577|Northwestern University|Dr. Emily Lattie|3125033741|emily.lattie@northwestern.edu|
20569710|NCT00846768|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569711|NCT04358068|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20569712|NCT04353817|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20569713|NCT00948610|UCLA|Michael R. Irwin|3108258281|mirwin1@ucla.edu|
20569714|NCT00665223|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20569715|NCT00591591|ISS, Inc., Champaign Illinois|Antonios Michalos|217-359-8681|antonios.michalos@iss.com|
20538430|NCT01550341|Yale University|Dr. Frederick Altice, Principal Investigator|203-737-2883|frederick.altice@yale.edu|
20538431|NCT00033540|Southwest Oncology Group (SWOG) Statistical Center|Study Statistician|206-667-4623||
20538432|NCT01001546|Durham VA Medical Center - HSRD|Dr. Patrick S. Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
20538433|NCT01253265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20538434|NCT03271047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538435|NCT00915655|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Leader|+1 609 730-7548||
20538436|NCT00434759|Central Institute of Mental Health, Mannheim, Germany|Prof. Martin Bohus|+49 621 1703 4002|martin.bohus@zi-mannheim.de|
20538437|NCT00495521|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|609-921-7448|kathy.ales@jacobus-pharmaceutical.com|238
20538438|NCT02410824|CooperVision Inc.|Sr. Manager Clinical Research|925-730-6754|pchamberlain@coopervision.com|
20538439|NCT00392808|Centro Superior de Investigacion en Salud Publica|Javier Diez-Domingo|+34961925937|diez_jav@gva.es|
20538440|NCT02649855|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|madanr@mail.nih.gov|
20538441|NCT01038713|Dartmouth-Hitchcock Medical Center|Timothy Gardner|603-650-6472|timothy.b.gardner@hitchcock.org|
20538442|NCT03777917|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
20538443|NCT02966795|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20538444|NCT00432744|University of Florida|Dr. Peter W Stacpoole|352-273-9023|pws@ufl.edu|
20538445|NCT01416441|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20538446|NCT01243567|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20538447|NCT02653495|Rockefeller University|Dr. Ursula Andreo|212-327-7894|uandreo@gmail.com|
20538448|NCT00526110|The University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD/Professor, GI Medical Oncology|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20538449|NCT01400243|Southern Illinois University Carbondale|David G. Gilbert|618-453-3527|dgilbert@siu.edu|
20538450|NCT04895293|Midwest Eye Institute|Raj K. Maturi, M.D.|317-817-1423|maturi.md@midwesteye.com|
20538451|NCT00031460|Collaborative Antiviral Study Group|Penelope M. Jester|(205) 934-2424|pjester@peds.uab.edu|
20538452|NCT01278407|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
20538453|NCT01596335|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20538454|NCT01460719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538455|NCT01176565|University of Minnesota|Adnan I. Qureshi, MD|612-624-2431|qureshai@gmail.com|
20538456|NCT01151761|Stanford University Cancer Center|Dr. Daniel Chang|650-724-3547|dtchang@stanford.edu|
20538457|NCT03602885|DFCI|Andrea Enzinger, MD|617-582-7335|andrea_enzinger@dfci.harvard.edu|
20538458|NCT03911752|University of A Coruña|Thais Pousada García|+34 981 167 000|thais.pousada.garcia@udc.es|5870
20569716|NCT00002597|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20569717|NCT01419977|Duke University Medical Center|Nirmish Shah, MD|919-684-5350|nirmish.shah@duke.edu|
20569718|NCT00338949|UCSD/VA San Diego|Jonathan Meyer MD|8589640777|jmmeyer@ucsd.edu|
20569719|NCT02261285|Ono Pharmaceutical Co., Ltd.|Medical Information Center||clinical_trial@ono-pharma.com|
20569720|NCT01161628|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
20569721|NCT00984698|University of Arizona|Dr. Patricia Haynes, Assistant Professor|5206261855|thaynes@email.arizona.edu|
20569722|NCT01143883|University of South Florida|Jorge E. Marcet, M.D.|813-844-4545|jmateka@health.usf.edu|
20569723|NCT01263925|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20569724|NCT03029819|Georgia State University School of Public Health|Claire Spears|4044139335|cspears@gsu.edu|
20569725|NCT00806598|The University of Texas MD Anderson Cancer Center|Tapan Kadia, MD/Assistant Professor|713-563-3534|eharriso@mdanderson.org|
20569726|NCT01449747|The Catholic University of Korea|Dr. Ji Hyun Kim|82-2-961-4534|kjhyun@catholic.ac.kr|
20569727|NCT02196168|London Health Sciences centre|Dr.Eric Winquist|519-685-8500|Winquist@lhsc.on.ca|
20569728|NCT01215032|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
20569729|NCT02725008|New York Presbyterian - Brooklyn Methodist Hospital|Christopher P Kelly|718.780.5040|chk9064@nyp.org|
20569730|NCT00702546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569731|NCT01726517|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20569732|NCT00770588|AstraZeneca|Gerard Lynch|52564555|aztrial_results_posting@astrazeneca.com|86 21
20569733|NCT04688086|NIRAMAI Health Analytix Private Limited|Dr Sathiakar Collison|+919810823838|sathiakar.collison@niramai.com|
20569734|NCT05288504|Avalo Therapeutics, Inc.|Garry Neil, MD|610.254.4201|gneil@avalotx.com|
20507710|NCT05691829|NYU Langone Health|Fraustina Hsu|646-754-7124|Fraustina.Hsu@nyulangone.org|
20569735|NCT01203956|Sleep Medicine Associates of Texas|Leon Rosenthal, MD|214-750-7776|LRosenthal@sleepmed.com|
20569736|NCT00513461|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
20525637|NCT01827267|Puma Biotechnology|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20525638|NCT00869622|VA Boston Healthcare System|Antonio A. Lazzari, M.D., Ph.D|(857) 364-6381|Antonio.Lazzari@va.gov|
20525639|NCT01314872|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525640|NCT03937908|Oregon Health & Science University|Dr. Amala Soumyanath|503-494-6878|soumyana@ohsu.edu|
20525641|NCT03205761|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20525642|NCT00636194|Bausch & Lomb|Robert Steffen OD|(585) 338-6399|robert.steffen@bausch.com|
20525643|NCT03470012|cyberDERM|Danielle Fendrick|610-325-0881|dfendrick@cyberderm-inc.com|
20525644|NCT02163226|UT MD Anderson Cancer Center|Dr. Quynh-Nhu Nguyen, MD,Associate Professor, Radiation Oncology Department|(713) 563-2450|qnnguyen@mdanderson.org|
20525645|NCT01585324|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20525646|NCT00653133|I-Flow Corporation|Alan Dine Director of Clinical Research|513-253-8033|alan.dine@kcc.com|
20525647|NCT00287872|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
20525648|NCT01694069|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20525649|NCT01450826|Duke University Medical Center|Mary Lou Affronti, DNP, RN, MHSc, ANP|9196845301|mary.affronti@duke.edu|
20525650|NCT02223650|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
20525651|NCT05167370|Cincinnati Children's Hospital Medical Center|Dr. Sonata Jodele|(513) 636-5917|Sonata.Jodele@cchmc.org|
20525652|NCT01300338|Mayo Clinic|Dr. Frederick North|507-284-5164|North.Frederick@mayo.edu|
20525653|NCT00101036|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20525654|NCT02579343|Counseling and Psychological Services|Adam McCabe|239-590-7950|amccabe@fgcu.edu|
20525655|NCT02806544|Vanderbilt University|Laila Agrawal|615-322-4967|laila.saied@vanderbilt.edu|
20525656|NCT00061373|NIH/NINDS and University of Texas Southwestern, Clinical Research Institute of Austin|Steven Warach, MD, PhD; Principal Investigator|512-324-8383|swarach@seton.org|
20525657|NCT00722566|Johnson & Johnson Pharmaceutical Research & Development|Helgi Van de Velde, M.D., Ph.D.||HVDVELDE@ITS.JNJ.COM|
20525658|NCT00401544|Amgen Inc.|Study Director|866-572-6436||
20525659|NCT02780713|AstraZeneca AB|AZD9496 Global clinical leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20525660|NCT03461952|Canadian Cancer Trials Group|Janet Dancey|613-533-6430|jdancey@ctg.queensu.ca|
20525661|NCT01931475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20525662|NCT03991299|Vanderbilt University Medical Center|Dr Cyndya Shibao|6159364584|cyndya.shibao@vumc.org|
20538459|NCT02838901|Wake Forest School of Medicine|Dr. Cheryl Bushnell|336-716-4101|cbushnel@wakehealth.edu|
20538460|NCT04114604|KITE Research Institute - Toronto Rehabilitation Institute, University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
20538461|NCT02285114|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20538462|NCT03383783|Oral Health Research Institute|Domenick T Zero, DDS, MS|317-274-8822|dzero@iu.edu|
20538463|NCT01156389|Shin Poong Pharmaceutical Co., Ltd.|Jangsik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
20538464|NCT06276881|Dandelion Science|Chief Executive Officer (CEO)|628-777-3477|info@dandelion.science|
20538465|NCT02124512|University of Kentucky|Philip Kern|859-323-2232|pake222@uky.edu|
20538466|NCT00350623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538467|NCT03660228|Dana-Farber Cancer Institute|Gregory A. Abel, MD|617-632-2304|GAABEL@PARTNERS.ORG|
20538468|NCT05039671|Yale University|Dr. Elizabeth Connors|12038150685|elizabeth.connors@yale.edu|
20538469|NCT04126564|Sadhguru Center for a Conscious Planet, BIDMC|Dr. Balachundar Subramaniam|(617)632-8071|bsubrama@bidmc.harvard.edu|
20538470|NCT05740332|Medline Industries LP|Director Clinical Operations|630-418-6891|jamiller@medline.com|
20538471|NCT01035346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538472|NCT02536300|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20538473|NCT01318278|Baylor College of Medicine|Dr. Danielle R. Rios|832-826-1380|drrios@texaschildrens.org|
20538474|NCT03837665|University of Kansas Medical Center|Hinrich Staecker, MD, PhD|913-588-6701|hstaecker@kumc.edu|
20538475|NCT02233738|Ralph H. Johnson VA Medical Cneter|Dr. Elizabeth Santa Ana|843-789-7168|Elizabeth.Santaana2@va.gov|
20538476|NCT00096174|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20538477|NCT03315104|Emergent BioSolutions|Dr. Christine Hall|204-275-4200|chall@ebsi.com|4248
20538478|NCT00330928|InfraReDx, Inc|Director Clinical and Regulatory|781-221-0053|pshah@infraredx.com|
20538479|NCT01309906|Bausch Health|Study Director||robert.steffen@bausch.com|
20538480|NCT03028480|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20538481|NCT05605691|Apyx Medical|Kari Larson, Sr. Director of Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
20538482|NCT01030874|VAORD|Mark Helfand, MD|5032203406|mark.helfand@va.gov|
20538483|NCT02279719|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
20538484|NCT05257148|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
20538485|NCT03541187|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20538486|NCT02769338|Department of Veterans Affairs|Dr. Dawn M. Bravata|317-988-2676|Dawn.Bravata2@va.gov|
20538487|NCT00561002|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20538488|NCT02089113|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
20538489|NCT00294645|Medtronic CRDM|CRDM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
20538490|NCT02403635|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20538491|NCT00359944|Sunovion|Medical Director, CNS|1-866-503-6351||
20538492|NCT02509052|Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA 91010|Michael Rosenzweig, MD|626-218-2405|mrosenzweig@coh.org|
20538493|NCT00620425|Zogenix, Inc|Edward Smith III, PhD, VP Regulatory Affairs & Product Quality/Safety|510 550 8325|esmith@zogenix.com|
20538494|NCT04942665|University of Florida|Dr. Ali Zarrinpar|(352) 265-0606|ali.zarrinpar@surgery.ufl.edu|
20538495|NCT03554772|Dr Reddy's Laboratories, Inc.|Srinivas Shenoy B.|6099550249|srinivasshenoyb@drreddys.com|
20538496|NCT01690546|Duke University Medical Center|Paolo Mannelli, M.D|919-681-0613|paolo.mannelli@dm.duke.edu|
20538497|NCT02098369|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-0637|jakris@uic.edu|
20538498|NCT03362931|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20538499|NCT02061397|University of Pennsylvania|Dr. Vera Krymskaya|215-573-9861|krymskay@pennmedicine.upenn.edu|
20538500|NCT03404804|Medical College of Wisconsin|Dr. David Vyles, DO|414-266-2625|dvyles@mcw.edu|
20538501|NCT00711347|Alcon Research, Ltd.|Erin Rogut|813-426-4036|Erin.Rogut@alconlabs.com|
20538502|NCT01133405|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20538503|NCT02737553|Ege University|Ali Akdemir|+905056748904|md.aliakdemir@gmail.com|
20538504|NCT03300024|Johns Hopkins University|Thomas Reifsnyder|410-955-7518|treifsn1@jhmi.edu|
20538505|NCT04600505|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20538506|NCT01238835|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
20538507|NCT00570037|Duke University Medical Center|Emmanuel Walter MD, Principal Investigator|919-620-5374|walte002@mc.duke.edu|
20569737|NCT01329419|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569738|NCT04522778|UPMC|Ryan St. Pierre-Hetz|3154369898|stpierrehetzre@upmc.edu|
20569739|NCT02920021|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
20569740|NCT00069277|Eisai Inc|Eisai Call Center|888-422-4743||
20569741|NCT01225159|Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand|Dr.Panthila Rujirojindakul, Staff|+66 74 45 1651|rpanthi@medicine.psu.ac.th|
20569742|NCT02230306|University of Pittsburgh Cancer Institute|Melissa Burgess, MD|412-623-7277|burgessma@upmc.edu|
20538508|NCT00554619|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538509|NCT02250807|Janssen R&D BE|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
20538510|NCT00908648|Gastroenterology Unit, Valduce Hospital - Como - Italy|Dr Vittorio Terruzzi, Director of Gastroenterology Unit|+39031324009|vterruzzi@valduce.it|
20569743|NCT05400226|Vergent Bio|Maggie Neptune|+1-510-410-9124|mneptune@vergentbio.com|
20569744|NCT01145547|Legacy Health System|W. Kenneth Ward|503-413-5171|kenward503@msn.com|
20569745|NCT01770314|Inflexxion|Emil Chiauzzi|617-614-0429|echiauzzi@inflexxion.com|
20569746|NCT00361842|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20569747|NCT01220856|Dompé SpA|Luisa Daffonchio, PhD|+39 583831|daffonchio@dompe.it|
20569748|NCT03512288|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569749|NCT04206384|CAO Group|VP, Quality & Regulatory|801-256-9282|info@caogroup.com|
20569750|NCT02212197|Camurus AB|Clinical Trial Manager||info@camurus.com|
20569751|NCT03015181|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
20569752|NCT01688895|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-241-7699|hetanshi.naik@mssm.edu|
20569753|NCT01260142|Eisai Call Center|Eisai Inc.|888-422-4743||
20569754|NCT02356484|Lausanne University Hospital|Pr. Nicolas Demartines|0041213142424|demartines@chuv.ch|
20569755|NCT00618917|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
20569756|NCT00496834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569757|NCT00356759|McMaster University|Dr. Sam Schulman|19055270271|schulms@mcmaster.ca|44810
20525663|NCT04304235|The University of British Columbia|J Mark Ansermino|1 604 875 2711|anserminos@yahoo.ca|
20525664|NCT00860535|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525665|NCT04429555|Medicinova Inc|Malath Makhay|8582468680|makhay@medicinova.com|
20525666|NCT00930774|National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Dr. Gabrielle H Saunders|503-220-8262|gabrielle.saunders@va.gov|56210
20525667|NCT03200704|Novadaq Technologies ULC, now a part of Stryker|Colleen Roden, Director of Clinical Sciences and Operations|931-267-2041|colleen.roden@stryker.com|
20525668|NCT00425061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525669|NCT03436693|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20525670|NCT01680861|Miami Transplant Institute|Jeffrey Gaynor, Ph.D. biostatistician||jgaynor@med.miami.edu|
20525671|NCT00654875|Novartis Pharmaceuticals|Study Director|862-778-8300||
20525672|NCT01011465|Harvard School of Public Health|Dr. Laura Kubzansky|617-432-3589|lkubzans@hsph.harvard.edu|
20525673|NCT03921840|Johns Hopkins University|Junxin Li|4105022608|jli248@jhu.edu|
20525674|NCT02042950|UT MD Anderson Cancer Center|Dr. Hun Ju Lee/ Assistant Professor, Lymphoma/Myeloma|(713) 794-1829|hunlee@mdanderson.org|
20525675|NCT00723008|U.S. Army Institute of Surgical Research|LTC. Elizabeth Mann-Salinas, PhD, RN,CCRN,CCNS|210-916-3527|Elizabeth.Mann@us.army.mil|
20525676|NCT02935179|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
20525677|NCT00882778|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20525678|NCT02217410|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20525679|NCT00187681|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
20525680|NCT00090220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525681|NCT01471340|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569758|NCT01494298|Mercer University College of Pharmacy|Gina Ryan Clinical Professor|678.547.6222|ryan_gj@mercer.edu|
20569759|NCT03821064|Medical University of South Carolina|Evan Graboyes (PI)|843-792-0719|graboyes@musc.edu|
20569760|NCT01314014|James P. Wilmot Cancer Center, University of Rochester|Paul M. Barr, MD|585-273-3258|Paul_Barr@urmc.rochester.edu|
20569761|NCT02998918|University of South Carolina|Mark Sarzynski|8037779510|sarz@mailbox.sc.edu|
20525682|NCT03499899|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20525683|NCT04501640|Astellas Pharma China, Inc.|Clinical Trial Disclosure|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
20525684|NCT01981954|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
20525685|NCT02274870|Northwell Health|Director of Research, Anesthesiology|718-470-7630|odowling@northwell.edu|
20525686|NCT01975571|University of Iowa|Dr. Camille Dunn|3193538776|camille-dunn@uiowa.edu|
20525687|NCT00887783|Dept. Oncology, Odense University Hospital|Dr. Olfred Hansen, Professor, Ph.D.|+4524241588|olfred.hansen@rsyd.dk|
20525688|NCT00489086|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
20525689|NCT03341143|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20525690|NCT01609543|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20525691|NCT02218736|Duke Clnical Research Institute|Kathy Hijek, Associate Director of Clinical Operations|919-668-8700|kathy.hijek@duke.edu|
20525692|NCT03879525|Wake Forest School of Medicine|Heidi Munger Clary, MD, MPH|336-716-7110|hmungerc@wakehealth.edu|
20525693|NCT00565643|Lehigh Valley Health Network|Daniel Kiefer|484-664-7521|daniel_g.kiefer@lvhn.org|
20538511|NCT00907803|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
20538512|NCT04612842|Oregon Health & Science University|Dr. Hiroko Kiyoshi-Teo (Assistant Professor)|5034943858|kiyoshi@ohsu.edu|
20538513|NCT01118520|Imperial College London|Professor Neil Poulter|+44(0) 20 7594 3446|n.poulter@imperial.ac.uk|
20538514|NCT01672658|Rehabilitation Instititute of Chicago|Arun Jayaraman, PT, PhD|312-238-2091|a-jayaraman@northwestern.edu|
20538515|NCT03958656|National Cancer Institute|Dr. James N. Kochendefer|240-760-6062|kochendj@mail.nih.gov|
20538516|NCT03158012|UCSD Dermatology|Teruaki Nakatsuji|8588227814|tnakatsuji@ucsd.edu|
20538517|NCT01310179|University of Alabama at Birmingham|Eben Rosenthal, MD|205-934-9713|erosenthal@uabmc.edu|
20538518|NCT00541099|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|(313) 576-8753|sgadgeel@med.umich.edu|
20538519|NCT05291936|Johnson & Johnson Vision Care, Inc.|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
20538520|NCT01287221|Mayo Clinic|Dr. Phillip A. Low|507-284-3375|low@mayo.edu|
20538521|NCT00930969|Medtronic Cardiac Rhythm Disease Management|ST Detect Study Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
20538522|NCT00657150|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20538523|NCT02649192|St. Jude Children's Research Hospital|Nehali Patel, MD|866-278-5833|info@stjude.org|
20538524|NCT03849690|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20538525|NCT04432493|Rutgers University|Travis Baker, PhD|18622503351|travis.e.baker@rutgers.edu|
20538526|NCT01071356|Public Health Institute: Alcohol Research Group|Dr. Douglas Polcin|510-597-3440|dpolcin@arg.org|277
20538527|NCT02278614|Laboratoires Théa|Director of Medical Operations|04 73 98 50 89|J.AUGER@laboratoires-thea.fr|
20538528|NCT03762616|Exact Imaging|Dr. Brian Wodlinger|6475279032|bwodlinger@exactimaging.com|
20538529|NCT03081858|LIPAC Oncology|Karl Bean|714-900-4412|karl@lipaconcology.com|
20538530|NCT02032407|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20538531|NCT01309269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20538532|NCT03880838|Geisinger Clinic|Amir Goren|5702144395|agoren@geisinger.edu|
20538533|NCT01798641|Johns Hopkins University|Dr. Daniele Rigamonti, MD FACS|410-955-2259|hydrocephalus@jhmi.edu|
20538534|NCT05013424|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20538535|NCT04411420|Duke University|Leo Brothers|919-668-8322|joseph.l.brothers@duke.edu|
20538536|NCT05693922|University of North Carolina at Chapel Hill|Erin Bondy, PhD|919-843-7694|erin_bondy@med.unc.edu|
20538537|NCT03899064|MC2 Therapeutics|Birgitte Vestbjerg|+44 2077 2575|bve@mc2therapeutics.com|
20538538|NCT00607113|UT MD Anderson Cancer Center|Dr. James Yao|713-792-2828|mjlim@mdanderson.org|
20538539|NCT01722292|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20538540|NCT00471887|UCLA|Antoni Ribas, MD|310-206-3928|aribas@mednet.ucla.edu|
20538541|NCT05438602|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20538542|NCT02091284|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 3335-7337|emnpalacios@gmail.com|
20538543|NCT00308165|Columbia University|Jeffrey N. Bruce, MD|212-305-7346|jnb2@columbia.edu|
20538544|NCT02351349|MUHC|Sameena Iqbal|5146302225|sameena.iqbal@mcgill.ca|1841
20538545|NCT01703117|Icahn School of Medicine at Mount Sinai|Dr. Ana Pereira|212-241-6984|ana.pereira@mssm.edu|
20538546|NCT02583230|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
20538547|NCT01340937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538548|NCT00440310|Light Sciences Oncology, Inc.|Vice President of Regulatory Affairs and Clinical Operations|425-957-8986|lisak@lsoncology.com|
20538549|NCT02469415|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
20538550|NCT02119156|GlaxoSmithKline|GlaxoSmithKline|866-435-7343|GSKClinicalSupportHD@gsk.com|1
20538551|NCT04685707|University of Southern Mississippi|Dr. Nuno Oliveira|6012665804|nuno.oliveira@usm.edu|
20538552|NCT04081961|Kazakhstan Academy of Preventive Medicine|Baurzhan Zhussupov|87774822171|baurzhan.zhussupov@gmail.com|
20538553|NCT02299570|Rebiotix|Assoc. Director of Clinical Research|651-705-8778|Sarah.Mische@Ferring.com|
20538554|NCT01998893|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20538555|NCT05136898|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
20525694|NCT01254318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525695|NCT03933618|Albany Medical Center|Dr. Charles Welliver|518-262-3341|wellivr@amc.edu|
20525696|NCT01137110|Washington University|Dr Theresa Human|314-747-8799|theresa.human@bjc.org|
20525697|NCT00422695|Rutgers School of Dental Medicine|Eli Eliav|973 972 7210|eliavel@sdm.rutgers.edu|
20525698|NCT00737204|New York State Psychiatric Institute|Judith G. Rabkin, Ph.D., M.P.H.|(646) 774-8075|jgr1@columbia.edu|
20525699|NCT02394340|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
20525700|NCT02380261|Alcon, a Novartis company|Dir Clinical Operations - LACAR, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20525701|NCT04192071|University of Florida|Melissa Vilaro, Assistant Professor|352-2733525|mgraveley@ufl.edu|
20525702|NCT01732640|Johns Hopkins University|Hao Wang|410-614-3426|hwang76@jhmi.edu|
20525703|NCT04574908|Wake Forest University Health Sciences|Portable Hemodynamic Monitoring on Hosp Units|336.716.4498|akhanna@wakehealth.edu|
20538556|NCT00867087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569762|NCT00942188|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20525704|NCT03070002|Northwestern University|MASSIMO CRISTOFANILLI, MD|312-503-1114|massimo.cristofanilli@nm.org|
20538557|NCT00909545|Feinberg School of Medicine, Northwestern University|Tanya Simuni, MD|312-503-2970|TSimuni@nmff.org|
20538558|NCT05426031|University of Miami|Michael Fabbro II, DO|305-689-1106|mxf790@miami.edu|
20538559|NCT02419131|Massachusetts General Hospital, Harvard Medical School|Dr. Tim Houle|617-724-2111|thoule1@mgh.harvard.edu|
20538560|NCT03060512|AstraZeneca Pharmaceutical LP|Catherine J. Datto, MD, MS, Movantik Medical Head, USMA|+1 302 885 1180|Information.Center@astrazeneca.com|
20538561|NCT00089986|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569763|NCT02979613|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20569764|NCT00749671|Baystate|James R. Cook MD|413-794-4492|james.cook@bhs.org|
20569765|NCT01138098|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569766|NCT04944784|Cytokinetics|Cytokinetics MD|6506242929|medicalaffairs@cytokinetics.com|
20569767|NCT04510948|Department of Medicine, Yale School of Medicine|Mary Tinetti, MD|203-688-5238|MARY.TINETTI@yale.edu|
20569768|NCT03614676|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20569769|NCT02388347|MedImmune LLC|Rene van der Merwe||information.center@astrazeneca.com|
20569770|NCT00497874|Pro-Change Behavior Systems, Inc.|Deborah A. Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
20569771|NCT02080403|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
20569772|NCT01171183|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
20569773|NCT01101334|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20569774|NCT01004029|Covis Pharma|Clinical Trial Interest|1-877-374-4177|CTInterest@covispharma.com|
20569775|NCT02826798|VBI|Bebi Yassin-Rajkumar|613-749-4200|byassin-rajkumar@vbivaccines.com|151
20569776|NCT02806505|Hoffmann-La Roche|Medical Communications|800-821-8590|global.trial_information@roche.com|
20569777|NCT01181609|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20569778|NCT01339299|Fertility Clinic Regional Hospital Skive|Prof, M.D. Peter Humaidan|+45 78445760|peter.humaidan@viborg.rm.dk|
20569779|NCT00263211|Department of Medicine Div. of Oncology, Washington University School of Medicine St. Louis MO|Katherine Weilbacher, M.D,|Fax: 314-454-8973|kweiblac@dom.wustl.edu|
20569780|NCT02034162|Janssen R&D US|DIRECTOR CLINICAL LEAD||ClinicalTrialDisclosure@its.jnj.com|
20569781|NCT00760513|University Hospital Southampton|Professor CD Byrne|02381205006|c.d.byrne@soton.ac.uk|
20569782|NCT03379545|NYU Langone Health|Joseph Zuckerman, MD|212-598-6674|Joseph.Zuckerman@nyulangone.org|
20569783|NCT00384865|Penn|Steven Kawut|215-573-0258|kawut@upenn.edu|
20569784|NCT02820597|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20569785|NCT01053247|Fougera Pharmaceuticals Inc|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
20569786|NCT03458728|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
20569787|NCT01572298|UTHSCSA Periodontics|Dr. Brian Mealey|210-567-3589|mealey@uthscsa.edu|
20569788|NCT01789840|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
20569789|NCT04702893|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569790|NCT00408928|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
20569791|NCT02948569|University of Missouri|Dr. Elizabeth Parks|15738825864|parksej@missouri.edu|
20569792|NCT05145439|Vibrato Medical|Vice President of Clinical Affairs|2139215088|bisrat@vibratomedical.com|
20569793|NCT01114139|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20569794|NCT03376555|Penn State University|Professor Lacy Alexander|8148671781|lma191@psu.edu|
20569795|NCT02536742|International Breast Cancer Study Group|Head Trial Activities and Deputy Director: Dr. Heidi Roschitzki-Voser|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
20569796|NCT03954223|Children's Hospital Los Angeles|Alaina Vidmar, MD|323-361-3385|avidmar@chla.usc.edu|
20569797|NCT02431455|Lahey Hospital and Medical Center|Haddon Pantel|3013566674|Haddon.Pantel@Lahey.org|
20569798|NCT03468179|Vanderbilt University|Sean S. Davies|6153225049|sean.davies@vanderbilt.edu|
20569799|NCT00916305|London School of Hygiene & Tropical Medicine|Clare Gilbert|+44 207 958 8332|clare.gilbert@lshtm.ac.uk|
20569800|NCT00858247|Mayo Clinic|Seema Kumar, MD|507-284-3300|kumar.seema@mayo.edu|
20569801|NCT02512861|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
20569802|NCT01172639|University Hospitals Leuven|Prof. Dr. Patrick Verschueren|+32 16 34 25 41|patrick.verschueren@uzleuven.be|
20569803|NCT02447432|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569804|NCT01585298|Novartis Pharmaceuticals|Study Director|862-778-8300||
20569805|NCT00156923|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
20569806|NCT01980524|Medical University of Vienna|Dr. Peter Wolf|004314040043110|peter.wolf@meduniwien.ac.at|
20569807|NCT01880697|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20569808|NCT00874497|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20569809|NCT02591862|Akari Therapeutics plc|Chief Scientific Officer|02080040261|miles.nunn@akaritx.com|
20569810|NCT00505414|Grünenthal GmbH|Director of Clinical Trials|+49 (0)241 569 3223|Clinical-Trials@grunenthal.com|
20569811|NCT00644878|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20569812|NCT01841112|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569813|NCT00878553|Somnus Therapeutics, Inc|Dr. Christine Blumhardt, Chief Regulatory Officer|617-710-0928|cblumhardt@somnusthera.com|
20569814|NCT02143063|UConn Health|Sheila Alessi, PhD|860-679-1849|salessi@uchc.edu|
20569815|NCT03245463|Hospital for Special Surgery|Dr. James Wyss|2126061731|wyssj@hss.edu|
20569816|NCT03517111|Arizona State University|Dr. Sonia Vega-López|602-496-3350|sonia.vega.lopez@asu.edu|
20569817|NCT00912223|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20569818|NCT02719743|GlaxoSmithKline|GSK Response Center|866-435-7343|ct427449@gsk.com|
20569819|NCT01438840|Eisai Call Center|Eisai Inc.|888-422-4743||
20569820|NCT02601209|Memorial Sloan-Kettering Cancer Center|William D. Tap, MD|646-888-4156|tapw@mskcc.org|
20553901|NCT02713321|Icahn School of Medicine at Mount Sinai|Dr. Victoria Mayer|(212) 659-9194|victoria.mayer@mountsinai.org|
20507711|NCT01666145|Carolinas Healthcare System|Principal Investigator|704-446-2772|john.martinie@carolinashealthcare.org|
20507712|NCT02591238|Peking Union Medical College Hospital.|Prof. Changwei Liu. Director of vascular surgery.|+86 1069152509|aresbill@outlook.com|
20507713|NCT00640146|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20507714|NCT04055467|Johns Hopkins School of Medicine|Dr. Elise Weerts, Professor|410-550-2781|eweerts@jhmi.edu|
20507715|NCT00609804|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20507716|NCT02427750|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20507717|NCT04578015|The Ohio State University|Kartik Venkatesh, MD, PhD|614-293-2222|kartik.venkatesh@osumc.edu|
20507718|NCT00387348|Massachusetts General Hospital|William F Pirl, MD|617-724-9151|wpirl@partners.org|
20507719|NCT03628599|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20507720|NCT00278863|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20507721|NCT01624506|Ethicon|Janet DeMarchi|612-867-8727|jdemarch@its.jnj.com|
20507722|NCT01149343|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507723|NCT01016678|Premiere Research Institute|Paul Winner, DO|561-845-0500|pwinner777@aol.com|102
20507724|NCT01766219|Wake Forest University Health Sciences|Caio Max Rocha Lima|336-703-4246|crochali@wakehealth.edu|
20507725|NCT00132314|VA New England Mental Illness, Research, Education and Clinical Center|Robert Rosenheck, MD|(203) 932-5711|Robert.Rosenheck@va.gov|3723
20507726|NCT01271413|Johns Hopkins University School of Medicine|Dr. Miriam Mintzer|410 550-0529|mmintzer@jhmi.edu|
20507727|NCT01589263|Baylor College of Medicine|Christopher Smith|713-798-4001|cps@bcm.edu|
20507728|NCT03955055|UMass Chan Medical School|Anne Foley, Senior Clinical Research Coordinator|774-442-4098|anne.foley@umassmed.edu|
20507729|NCT00756093|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20507730|NCT04624672|Geisinger Medical Center|Project Manager|570-214-2245|kcunningham1@geisinger.edu|
20507731|NCT03472040|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20507732|NCT02769832|University of Iowa, Holden Comprehensive Cancer Center|Muhammad Furqan, MD|319-356-1527|muhammad-furqan@uiowa.edu|
20553902|NCT04694131|National Institutes of Health|Dr. Eric Wassermann|301-496-0151|wassermanne@nih.gov|
20553903|NCT01333488|Memorial Healthcare System|Dr Greg Zorman|954 265 1840|csareli@mhs.net|
20538562|NCT03946124|University of Pennsylvania|Dr. Lily Arya|215-662-3230|larya@pennmedicine.upenn.edu|
20538563|NCT00529126|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20525705|NCT02754427|University of British Columbia|Dr. Kristin Campbell|604-827-4704|kristin.campbell@ubc.ca|
20525706|NCT00712543|Cumberland Pharmaceuticals Inc.|Bryan Voss, Ph.D.|615-255-0068|bvoss@cumberlandpharma.com|
20525707|NCT03687684|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20525708|NCT02428309|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20525709|NCT02981082|University of Pittsburgh|Dr. Robert Lafyatis|412-648-7040|lafyatis@pitt.edu|
20525710|NCT01351480|AARDS Research, Inc.|Norman B Gaylis, MD|305-652-6676|drnbg@rheum-care.com|
20525711|NCT04250350|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20525712|NCT01106677|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
20525713|NCT03875092|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20525714|NCT04114357|Indiana University|Heba M Ismail|317-278-8326|heismail@iu.edu|
20525715|NCT03693612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20525716|NCT05318092|AngioDynamics, Inc.|Elizabeth Manning|339-237-2765|liz.manning@angiodynamics.com|
20525717|NCT04364802|University of Kentucky|Alexandra Kejner|859-323-6741|aeke234@uky.edu|
20525718|NCT01669174|Novartis Pharmaceuticals|Study Director|862-778-8300||
20525719|NCT01953601|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525720|NCT01246349|The Hospital for Sick Children|Beverly Walpole|416. 813 7654|bwalpole@uoguelph.ca|328363
20525721|NCT02991729|UNC School of Medicine Maternal Fetal Medicine|Laura Carlson, MD|8643503140|lauramosbycarlson@gmail.com|
20525722|NCT05537441|Yale University|Daniella Meeker|(213)926-2658|daniella.meeker@yale.edu|
20525723|NCT04310397|The University of Texas MD Anderson Cancer Center|Rodabe Amaria, MD|(713) 792-2921|rnamaria@mdanderson.org|
20525724|NCT05225298|Stanford University|Shuchi Anand, MD, MS|650-725-2207|sanand2@stanford.edu|
20525725|NCT00723255|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20525726|NCT00614523|Amgen Inc.|Study Director|866-572-6436||
20525727|NCT03962790|Johnson & Johnson Vision Care|Brian Pall, Director Clinical Science, Vision Care|1-800-843-2020|bpall@its.jnj.com|
20525728|NCT02877095|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-309-5544|rachel.e.olson@duke.edu|
20525729|NCT01934517|U of Montreal|Vincent Peloquin|514-343-6056|vincent-claude.peloquin@umontreal.ca|
20525730|NCT03966924|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
20525731|NCT02153671|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20525732|NCT01767506|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
20525733|NCT02796352|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|(412) 647-5554|stadtermanbm@upmc.edu|
20525734|NCT03854370|Wright State University|Dr. Geoffrey Towers|937-208-2850|geoffrey.towers@wright.edu|
20525735|NCT00452673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20525736|NCT02656290|Edwards Lifesciences, LLC|Aya Westbrook, PhD, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Aya_Westbrook@edwards.com|
20525737|NCT04638881|Stanford University School of Medicine|Dr. Richard K. Kim|3475869661|rkwkim@stanford.edu|
20525738|NCT01608087|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525739|NCT01322594|MedImmune, Limited|Ed Piper|+44 (0) 1223 471 471|pipered@medimmune.com|
20525740|NCT00908791|Norris Cotton Cancer Center|Burton Eisenberg, MD, Deputy Director, Norris Cotton Cancer Center|603-653-3613|Burton.L.Eisenberg@Dartmouth.edu|
20525741|NCT02461524|Medtronic|Kristel Wittebols Sr. Clinical Research Director|31 (0)43-3566566|kristel.wittebols@medtronic.com|
20525742|NCT00880581|Stanford University|Ronald Levy|6507256452|levy@stanford.edu|
20525743|NCT00981669|Instituto Butantan|Alexander Roberto Precioso|+5511-2627-9372|alexrp@butantan.gov.br|9372
20525744|NCT01943851|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20525745|NCT02062710|Montefiore Medcial Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
20525746|NCT00381238|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525747|NCT00843037|University Health Network|Dr. Jennifer Knox, PI|(416) 946-2000|jennifer.knox@uhn.ca|5131
20525748|NCT04984278|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20525749|NCT03535194|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20525750|NCT00382590|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-745-3428|eharriso@mdanderson.org|
20525751|NCT01289639|VA Puget Sound Health Care System|Kristina Utzschneider|206-277-3568|kutzschn@u.washington.edu|6-3568
20525752|NCT02821338|US Food and Drug Administration|Office of Generic Drugs, Center for Drug Evaluation and Research|240-402-7920|genericdrugs@fda.hhs.gov|
20525753|NCT04967885|Dartmouth College|Elizabeth Saunders|6036467006|elizabeth.c.saunders@dartmouth.edu|
20525754|NCT05835011|Taiho Oncology, Inc.|Taiho Central|844-878-2446|medicalinformation@taihooncology.com|
20525755|NCT03834974|University of Connecticut|Dr. Sherry Pagoto|860-486-8979|sherry.pagoto@uconn.edu|
20525756|NCT00941863|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20525757|NCT00823043|Vistakon|Arthur Shedden MD|904-443-1557||
20525758|NCT02655510|Mayo Clinic|Vijay Shah, M.D.|507-284-3917|Shah.Vijay@mayo.edu|
20525759|NCT01867710|Janssen Pharmaceutica N.V|Medical Affairs Director||ClinicalTrialDisclosure@its.jnj.com|
20525760|NCT00526669|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525761|NCT02828124|Bristol Myers-Squibb|Phase 1/2 Study of BMS-986183 in Subjects with Advanced Hepatocellular Carcinoma|Please email|Clinical.Trials@bms.com|
20538564|NCT02334683|Icahn School of Medicine at Mount Sinai|David Simpson, M.D.|(212) 241-8748|david.simpson@mssm.edu|
20538565|NCT00241631|Imperial College London|Ian M Adcock|+44 (0)20 7594 7840|ian.adcock@imperial.ac.uk|
20538566|NCT00145418|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
20538567|NCT01187004|UTurin|Dr Daniela Pasero|00390116335511|daniela.pasero@unito.it|
20538568|NCT00413920|Novartis Pharmaceuticals|Study Director|862-778-8300||
20538569|NCT03831880|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538570|NCT01891344|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20538571|NCT02788201|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
20538572|NCT02969590|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20538573|NCT01854632|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
20538574|NCT01414205|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20538575|NCT01457950|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538576|NCT01765426|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20538577|NCT01166373|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20569821|NCT00859976|Zimmer Biomet|Clinical Project Lead||Maggie.Shen@zimmerbiomet.com|
20569822|NCT02062645|Novartis Pharmaceuticals|Study Director|862-778-8300||
20569823|NCT00193596|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20569824|NCT00461123|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20569825|NCT02024750|University of Wisconsin School of Medicine and Public Health|Elizabeth Cox|608-263-9104|ecox@wisc.edu|
20569826|NCT00927901|Novartis Pharmaceuticals|Study Director|862 778-8300||
20569827|NCT02344173|Abbott|Principal Clinical Research Scientist|6517564067|eric.grovender@abbott.com|
20569828|NCT01612767|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
20569829|NCT01891890|Emory University|David Loring, PhD|404-778-5943|dloring@emory.edu|
20569830|NCT02383407|George Washington University|Dr. Mohamad Koubeissi|202-741-2533|mkoubeissi@mfa.gwu.edu|
20569831|NCT00746356|St. Jude Medical|Ashish Oza, Clinical Studies Director|818 362 6822|aoza@sjm.com|3648
20569832|NCT03605368|Children's Hospital of Philadelphia|Julia Parish-Morris|267-426-7540|parishmorrisj@chop.edu|
20569833|NCT02881047|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|leahyd@uphs.upenn.edu|
20569834|NCT03765164|QURE Healthcare|Director of Clinical Trials|415-321-3388|qureadmin@qurehealthcare.com|
20569835|NCT02484547|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20569836|NCT01665599|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20569837|NCT03783546|Dana-Farber Cancer Institute|Weidong Lu, MB, MPh, PhD|617-632-3322|weidong_lu@dfci.harvard.edu|
20569838|NCT05275023|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20569839|NCT02083679|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20569840|NCT01817712|VA Cooperative Studies Program|Tassos C. Kyriakides, Ph.D, Biostatistician|203-932-5711|tassos.kyriakides@va.gov|3771
20569841|NCT01831726|Novartis Pharmaceuticals|Study Director|862-778-8300||
20569842|NCT01568112|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20569843|NCT01788475|Lahey Medical Center|Christine Gould PAC, MS|9785384412|christine.gould@lahey.org|
20569844|NCT00908349|Supernus Pharmaceuticals, Inc|Janet K. Johnson, PhD|301-838-2623|jjohnson@supernus.com|
20569845|NCT01937195|Evangelical Community Hospital|Norman R. Anderson|570-222-2000|nanderson@evanhospital.com|
20569846|NCT01928693|Cornea Consultants of Nashville|Ira Shivitz MD|615-320-7200|jhatley@corneaconsultants.net|
20569847|NCT00761956|Zimmer, Inc|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
20569848|NCT02022111|Emory University|Mohammed Kumail Ali, MD|404-727-9776|mkali@emory.edu|
20569849|NCT04398368|Mayo Clinic|Stephen A. Boorjian, M.D.|507 422-5516|Boorjian.Stephen@mayo.edu|
20569850|NCT03602586|NRG Oncology|Christopher Purdy on behalf of Danielle Enserro, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20569851|NCT01479270|MetroHealth Medical Center|Robert Pollard|216-778-4444|rpollard@metrohealth.org|
20569852|NCT00030823|Memorial Sloan Kettering Cancer Center|Dr. Teresa Gilewski|646-888-4557|gilewskt@mskcc.org|
20569853|NCT04523207|Janssen Research & Development, LLC|Group Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20569854|NCT03113383|Vanderbilt University Medical Center|Thomas C Naslund, MD|5-322-2343|thomas.naslund@vumc.org|
20569855|NCT02122172|University of Chicago|Dr. Peter O'Donnell|(773) 702-7564|podonnel@bsd.uchicago.edu|
20569856|NCT03062449|Dartmouth Health|Aleksandra C. Stark|(603) 650-5104|Aleksandra.C.Stark@hitchcock.org|
20569857|NCT03765398|University of Illinois at Chicago|Tanvi Bhatt|3123554443|tbhatt6@uic.edu|
20569858|NCT01951378|Seton Family of Hospital|Director Pediatric Fellowship|512-324-9999|a.a@abc.com|
20569859|NCT03568812|Tropical and Infectious Disease Division, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Indonesia|Dr dr. Erni Juwita Nelwan, Ph.D, Sp.PD-KPTI|+62811961229|ejnelwan@yahoo.com|
20569860|NCT05252845|Mahidol-Oxford Tropical Medicine Research Unit (MORU)|Professor Lorenz von Seidlein|+66-(0)2-3549170|Lorenz@tropmedres.ac|
20569861|NCT01296763|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Thomas Brown|410-502-5328|tbrown55@jhmi.edu|
20569862|NCT03194867|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20569863|NCT00634842|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20569864|NCT00464945|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20538578|NCT01510184|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|gajanan.Bhat@sppirx.com|
20569865|NCT00543062|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20538579|NCT02498067|University of Chicago|Soo Young Lee|6513430045|sooyoungl@uchicago.edu|
20538580|NCT02310230|University of Vermont Medical Center|Alexander Friend, Clinical Research Coordinator|802-847-4259|alexander.friend@uvmhealth.org|4259
20538581|NCT03593681|Boston Scientific|Clinical Trial Project Manager|612-209-9532|blake.hedstrom@bsci.com|
20553904|NCT03235024|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20553905|NCT02357576|University of Michigan|Meghan Arnold|734-936-8978|meghanar@umich.edu|
20553906|NCT00261716|VAGLAHS at West Los Angeles|Shirley M. Glynn. Ph.D.|310-268-3939|sglynn@ucla.edu|
20553907|NCT00128180|UNewMexico|Gregory Mertz, MD|5059808601|gmertz@salud.unm.edu|
20569866|NCT03831854|Cleveland Clinic|Dr Kamal Maheshwari|216-318-7235|maheshk@ccf.org|
20569867|NCT04629443|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
20569868|NCT03463577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20569869|NCT03974100|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20569870|NCT00690378|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20569871|NCT00014222|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
20538582|NCT01229943|Dana-Farber Cancer Institute|Matthew Kulke, MD, MMSc||matthew_kulke@dfci.harvard.edu|
20538583|NCT00320749|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, M.D.|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
20538584|NCT04662073|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
20538585|NCT02961790|Mayo Clinic|Charles L. Loprinzi, M.D|507/284-4565|loprinzi.charles@mayo.edu|
20538586|NCT02594098|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
20538587|NCT02078102|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
20538588|NCT05418153|Center For Sight|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
20538589|NCT00402714|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
20538590|NCT02370641|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
20538591|NCT03398265|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
20538592|NCT03109262|Stanford University|Andrei Iagaru, PROFESSOR OF RADIOLOGY (NUCLEAR MEDICINE)|1650-725=4711|aiagaru@stanford.edu|
20538593|NCT03906656|Ottobock|Russ Lundstrom|6127182025|russ.lundstrom@ottobock.com|
20538594|NCT01036529|Boston Scientific|Valerie Lucero-Cimmarusti|661-949-4745|Valerie.Lucero-Cimmarusti@bsci.com|
20538595|NCT02342379|University of Texas Health San Antonio|Andrew Brenner, MD, PhD|210-450-5936|brennera@uthscsa.edu|
20538596|NCT00066469|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20538597|NCT00711802|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20538598|NCT01241344|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20538599|NCT02084238|Peking University People's Hospital|Dr. Jing He|86|hejing1105@126.com|1861170734
20538600|NCT02436408|University of Michigan Rogel Cancer Center|Cagri Besirli, MD, PhD|734-232-8404|cbesirli@med.umich.edu|
20538601|NCT02782325|University of North Carolina at Chapel Hill|Hans Herfarth, MD|919-966-6806|hherf@med.unc.edu|
20538602|NCT01154283|UMichigan|Kirsten Gruis|7346041172|klgruis@gmail.com|
20538603|NCT00042432|Amgen Inc.|Study Director|866-572-6436||
20538604|NCT00320372|Cyberonics, Inc|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|mark.bunker@cyberonics.com|
20538605|NCT01853072|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
20538606|NCT01800318|University of Arkansas for Medical Sciences|Richard W. Hall, professor of pediatrics, co-director of neonatal intensive care unit|501-680-7894|HallRichardw@uams.edu|
20538607|NCT03959982|University of Iowa|Dr. Spyridon Fortis|319-356-4419|spyridon-fortis@uiowa.edu|
20538608|NCT00262847|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20538609|NCT03846531|Pulse Biosciences, Inc.|William A. Knape|(510) 906-4649|bill.knape@pulsebiosciences.com|
20538610|NCT02370004|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
20538611|NCT04709484|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
20538612|NCT02231762|Ipsen|Medical Director||clinical.trials@ipsen.com|
20538613|NCT01757561|FirstSunYetSen|Juan-ying Guo|8602087755766(8273)|gjunying@aliyun.com|
20538614|NCT00989235|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20538615|NCT03249935|University of Arkansas for Medical Sciences|Jeannette Lee|501-526-6712|jylee@uams.edu|
20538616|NCT01394614|Center for Advanced Research in Sleep Medicine|Dr. Jacques Montplaisir|514-388-2693|jy.montplaisir@umontreal.ca|
20538617|NCT01669421|University of Miami|Michael Campos|305-243-3045|mcampos1@med.miami.edu|
20538618|NCT01149486|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20538619|NCT00167102|University of Minnesota|Dr. Maria Hordinsky|612-624-5721|hordi001@umn.edu|
20538620|NCT02740543|NYU Langone Health - Bellevue Hospital|Angeliki Kazeros, MD|212-263-6479|Angeliki.Kazeros@nyulangone.org|
20538621|NCT02813668|Emory University|Dr. Mary Beth Weber|404-712-1902|mbweber@emory.edu|
20538622|NCT01135914|Novartis Pharmaceuticals|Study Director|862-778-8300||
20538623|NCT01007071|Stanford University|Dr. Laurence Katznelson|650-736-9551|katznels@stanford.edu|
20538624|NCT01053013|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
20538625|NCT02042534|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
20538626|NCT00885638|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
20538627|NCT04066686|Imperial College Healthcare NHS Trust|Dr Annabelle Lee|02033121077|annabellelee@nhs.net|
20525762|NCT01590121|Imperial College London|Dr. Claire Shovlin, Principal Investigator|+44 208 383 1178|c.shovlin@imperial.ac.uk|
20525763|NCT00747474|Taiwan Liposome Company, Ltd.|Shu Chi Hsu|650-872-8816|shuchi@tlcbio.com|102
20525764|NCT02829723|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20525765|NCT03613909|Cochlear Ltd|Marian Jones, Principal Investigator|+61498008181|mjones@cochlear.com|
20525766|NCT03514485|Children's Hospital of Philadelphia|Tyra Bryant-Stephens, MD|215-590-5261|stephenst@chop.edu|
20525767|NCT02798289|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20525768|NCT03075891|Galderma|Rajeev Chavda|0033492382928|rajeev.chavda@galderma.com|
20525769|NCT02004886|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525770|NCT00638443|University of Rochester|John Markman, MD|585-340-8926|maria_frazer@urmc.rochester.edu|
20525771|NCT05229952|University of Alabama at Birmingham|Dr Sonia Fargue|2059756932|sfargue@uab.edu|
20525772|NCT00282113|University of California Davis|Mark A. Underwood MD|916-734-5061|mark.underwood@ucdmc.ucdavis.edu|
20525773|NCT02387957|Ophthotech Corp.|Denise Teuber|646-753-8461|denise.teuber@ophthotech.com|
20525774|NCT02294396|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
20525775|NCT02949843|Wake Forest Baptist Comprehensive Cancer Center|William Petty|3367163313|wpetty@wakehealth.edu|
20525776|NCT02120833|Johnson & Johnson Consumer and Personal Products Worldwide|Chirstopher Nunez, PhD/Study Director|973-385-7984 USA EST|cnunez1@its.jnj.com|
20525777|NCT04463251|R-Pharm|Sergey Grishin, Director, Dep. of Clinical Development and Medical Expertise in Autoimmune Diseases|0074959567937|sa.grishin@rpharm.ru|1506
20525778|NCT04520997|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20525779|NCT02863445|Oregon Health and Science University|Dr. Alison Edelman|503-494-3666|edelmana@ohsu.edu|
20525780|NCT03689374|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20525781|NCT05367973|Dare Bioscience, Inc.|Jessica Hatheway, VP Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
20525782|NCT03634033|Grand Valley State University|Dr. Sandra Spoelstra|616-331-5905|spoelsts@gvsu.edu|
20525783|NCT06366087|BARDA|Michael D. Schwartz, MD MPH/Division of CBRN Countermeasures|(202)-260-0849|Michael.Schwartz@hhs.gov|
20525784|NCT03717051|University of Hong Kong|Dr. Derek Cheung|39176652|derekcheung@hku.hk|
20525785|NCT01397786|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20525786|NCT04432090|AdventHealth, Orlando|Richard Pratley|407-303-2519|richard.pratley.md@adventhealth.com|
20525787|NCT00860249|Northwestern University, Department of General Internal Medicine|Kenzie A. Cameron, PhD, MPH|312-503-3910|K-Cameron@northwestern.edu|
20525788|NCT00519428|NYSPInstitute|Jonathan W. Stewart, M.D.|212-543-5745|jws6@columbia.edu|
20525789|NCT00743730|Medical College of Wisconsin|Keri R. Hainsworth, PhD, Research Director|414-266-6306|khainswo@mcw.edu|
20525790|NCT02836236|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20525791|NCT01953874|ResMed|Adam Benjafield|(858)836-6782|adam.benjafield@resmed.com|
20525792|NCT01916681|University of Pennsylvania|Dr. Lisa Levine|2156626913|lisa.levine@uphs.upenn.edu|
20525793|NCT02703272|Janssen Research & Development, LLC|Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20525794|NCT04470544|Mayo Clinic|Alan Haruo Bryce, M.D.|(480)301-8335|Bryce.Alan@mayo.edu|
20525795|NCT00384748|University of Georgia|Neale Chumbler, PhD|706-369-5975|chumbler@uga.edu|
20525796|NCT02173522|University of Miami|Shivank Bhatia|305-243-7500|sbhatia1@med.miami.edu|
20525797|NCT04720911|UMass Chan Medical School|Dr. Celine Larkin|5084211436|celine.larkin@umassmed.edu|
20525798|NCT04807205|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20525799|NCT05875025|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20525800|NCT04259424|Medical University of South Caroina|Ryan Ross|843-792-3477|rossre@musc.edu|
20525801|NCT00784303|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20525802|NCT03315286|Weill Cornell Medicine|Dr. George Varghese, Principal Investigator|646-962-3376|giv9006@med.cornell.edu|
20538628|NCT02133664|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
20538629|NCT03366103|Johns Hopkins University/SKCCC|Judy Murray|443-927-3568|jmurra33@jhmi.edu|
20507733|NCT03064568|UTHSCSA|Sally Kabro|210-567-4950|kabro@uthscsa.edu|
20538630|NCT00300482|Abbott|Medical Information Specialist|800-633-9110||
20538631|NCT01688843|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
20538632|NCT02370095|University of North Carolina at Chapel Hill|Wayne H Anderson, PhD|919-445-0351|wayne_anderson@med.unc.edu|
20538633|NCT00581828|University of Wisconsin|Dr Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
20538634|NCT01667562|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20538635|NCT02130986|University of Pittsburgh|David T Huang, MD, MPH, Associate Professor|412-647-6818|huangdt@upmc.edu|
20538636|NCT01129882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20538637|NCT02305849|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|Astellas.resultsdisclosure@astellas.com|
20538638|NCT00355342|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538639|NCT00536874|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
20538640|NCT00997425|James A. Haley VA Hospital, Tampa, FL|Dorothy H. Moore, PhD|813 558-3931|Dorothy.Moore4@va.gov|
20538641|NCT00391391|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20538642|NCT00693472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538643|NCT02575118|NORCE|Dr. Trine Lise Lundekvam Berge|+47 56 10 72 12|trbe@norceresearch.no|
20538644|NCT01256281|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|(212) 824-8056|jeffrey.glassberg@mountsinai.org|
20538645|NCT02761694|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538646|NCT02652416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20538647|NCT00787930|Duke University Medical Center|John Beyer, MD|919-668-0209|john.beyer@dm.duke.edu|
20538648|NCT02395055|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20538649|NCT02513823|Texas Woman's University|Carolyn Moore|713-794-2377|cmoore8@twu.edu|
20538650|NCT01955434|Mayo Clinic|P. Leif Bergsagel, MD|480/301-8335|Bergsagel.leif@mayo.edu|
20538651|NCT02743780|Alcon, A Novartis Division|Translational Medicine Expert II, TM-Ophthalmic|1-888-451-3937|alcon.medinfo@alcon.com|
20538652|NCT01294462|AstraZeneca|Judith Hsia||ClinicalTrialTransparency@astrazeneca.com|
20538653|NCT01357135|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538654|NCT02076399|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20538655|NCT00085254|Adult Brain Tumor Consortium (ABTC)|Louis Burt Nabors, MD|205-934-1432|bnabors@uab.edu|
20538656|NCT03503292|Mayo Clinic|Yvette N. Martin McGrew, M.D., Ph.D.|507-255-7481|martin.yvette@mayo.edu|
20538657|NCT04342689|Yale School of Medicine|Sherry Mansour, MD, MS Assistant Professor|(203) 785-4184|sherry.mansour@yale.edu|
20538658|NCT01460407|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20538659|NCT01049802|The Rehabilitation Institute of Chicago|Richard L. Harvey, MD|312-238-1000|rharvey@ric.org|
20538660|NCT00844805|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20538661|NCT04070326|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20538662|NCT01287377|UCSD|Dr. Shu-Hong Zhu|8583001056|szhu@ucsd.edu|
20538663|NCT01216943|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20538664|NCT02193087|Takeda|Medical Director Clinical Science, Study Official|+1-877-825-3327|trialdisclosures@takeda.com|
20553908|NCT02047110|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20553909|NCT00705575|Novartis Pharmaceuticals|Study Director|862 778-8300||
20538665|NCT00475865|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
20538666|NCT04316741|University of Michigan|Dr. Erin Bonar|7347647936|erinbona@med.umich.edu|
20538667|NCT02953665|Cedars-Sinai|Vicki Manoukian, Neurology Clinical Research Program Manager|310-423-5067|Vicki.Manoukian@cshs.org|
20538668|NCT02032641|Bascom Palmer Eye Institute|Dr. Sara T. Wester|3053266132|SWester2@med.miami.edu|
20538669|NCT02279498|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
20538670|NCT00737711|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20538671|NCT00624780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538672|NCT04068519|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20507734|NCT00834886|University of Bergen|Dr. Bjørn Bjorvatn|55586130|bjorn.bjorvatn@igs.uib.no|
20507735|NCT03874351|MJHS Institute for Innovation in Palliative Care, New York, NY|Helena Knotkova, PhD, PhilD|646-784-2262|HKnotkov@mjhs.org|
20507736|NCT00225147|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
20507737|NCT03024255|Botanix Pharmaceuticals|Anthony Robinson, MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20507738|NCT03532776|Dermax|Chauvel Virginie|+32 488 07 04 18|chauvelvirginie07@gmail.com|
20507739|NCT01415908|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20507740|NCT04169113|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
20507741|NCT02685995|University of Pennsylvania|Gregory Nadolski, MD|(215) 662-7892|gregory.nadolski@pennmedicine.upenn.edu|
20507742|NCT03625141|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20507743|NCT03250377|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20507744|NCT00193219|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
20507745|NCT02168803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20507746|NCT01114373|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-3425|frahbar@emory.edu|
20507747|NCT03444870|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20507748|NCT00868166|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20507749|NCT00240539|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507750|NCT02034552|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20507751|NCT00698035|University of California, San Francisco|Michelle Melisko, MD|415-353-7070|mmelisko@medicine.ucsf.edu|
20507752|NCT00074802|Temple University|Richard G. Heimberg, Ph.D.|215.204.7489|heimberg@temple.edu|
20507753|NCT03728504|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
20507754|NCT02197897|Baylor College of Medicine|Dr. Guilherme Godoy|713-798-4001|godoy@bcm.edu|
20507755|NCT02501902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507756|NCT03007719|University of California, San Francisco|Dr. Lawrence Fong|(415) 353-2051|Lawrence.Fong@ucsf.edu|
20507757|NCT01797445|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
20507758|NCT00688545|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507759|NCT04547998|AVITA|SVP Global Clinical Research|1-833-462-8482|ekirshner@avitamedical.com|
20507760|NCT01878097|University of Kentucky|Dr. Ann Coker|859-323-6758|ann.coker@uky.edu|
20507761|NCT01147406|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
20507762|NCT02892201|Yale School of Medicine|Barbara Burtness, MD|(203) 200-4622|arbara.burtness@yale.edu|
20507763|NCT03783442|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20507764|NCT00168064|Yaupon Therapeutics|H. Jeffrey Wilkins, MD|4843247935|hjwilkins@yaupontherapeutics.com|935
20507765|NCT00707343|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
20507766|NCT01309841|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
20507767|NCT01441115|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
20525803|NCT02989649|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20525804|NCT00256854|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525805|NCT02353442|São Carlos Fedetal University|Dayana Rosa|+55 16 33066695|dad_rosa@hotmail.com|
20525806|NCT03990571|The University of Texas M D Anderson Cancer Center|Dr. Renata Ferrarotto|(713) 745-6774|rferrarotto@mdanderson.org|
20525807|NCT02980341|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20525808|NCT01369108|3M Oral Care Solutions Division|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
20525809|NCT01813214|Lombardi Comprehensive Cancer Center|Dr Michael Atkins|202-687-2795|mba41@georgetown.edu|
20525810|NCT02050919|OHSU Knight Cancer Institute|Christopher Ryan, MD|503-494-8487|ryanc@ohsu.edu|
20525811|NCT04748458|IRCCS Istituto Ortopedico Rizzoli|Dr Francesco Castagnini|+390516366418|francescocastagnini@hotmail.it|
20525812|NCT02892422|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
20525813|NCT03089697|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
20525814|NCT02410798|Synapse Biomedical|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
20525815|NCT05093530|Pneumagen Ltd|CEO|+44 7748357352|douglas.thomson@pneumagen.com|
20525816|NCT00373958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20525817|NCT01777568|Cleveland Clinic|Kurz, M.D., Andrea|(216) 445-9924|KURZA@ccf.org|
20538673|NCT00969761|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507768|NCT01906866|Neurim Pharmaceuticals|Dr. Tali Nir|972-7684902|talin@neurim.com|
20507769|NCT01848899|NYU Langone Medical Center|Binita Shah|212-263-4235|binita.shah@nyumc.org|
20525818|NCT00492648|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538674|NCT00387647|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
20538675|NCT00758589|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
20538676|NCT02191605|Wayne State University, Merrill Palmer Skillman Institute|Dr. Jessica Beatty|3136642518|jbeatty@wayne.edu|
20538677|NCT05275582|VA Center for Integrated Healthcare|Dr. Julie Gass|716-834-9200|julie.gass@va.gov|25429
20538678|NCT00340379|Duke University|Frederick Cassidy|919-575-7801|cassi002@mc.duke.edu|
20538679|NCT00628589|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20538680|NCT02418312|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20538681|NCT00803413|Hospital das Clínicas - São Paulo University School of Medicine|Mario Fereira Junior|55 11 3069-7691|mariofj@uol.com.br|
20538682|NCT04524455|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20553910|NCT00354224|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20553911|NCT01959581|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu|
20553912|NCT00539526|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20553913|NCT03097068|Vitreo-Retinal Associates, P.C.|Louis C. Glazer, MD|1-616-285-1200|glazerlc@vrapc.com|
20553914|NCT02802345|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20553915|NCT00811564|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20553916|NCT02075320|UNC School of Medicine Department of Radiology|Dr. Yueh Lee|(919) 537-3730|yueh_lee@med.unc.edu|
20553917|NCT01397695|UCSD|Research Compliance and Integrity|(858) 822-4939|ctgov@ucsd.edu|
20553918|NCT03773757|Indiana University|Dr. Greg Sachs|317-278-5570|sachsg@iu.edu|
20553919|NCT00057746|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
20553920|NCT01109316|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20553921|NCT01936259|Zimmer Biomet, Inc.|Director of Clinical Operations|800-613-6131|clinicaldirector@zimmerbiomet.com|
20553922|NCT02660918|Christiana Care Health System|Dr. Matthew Hoffman Chair Department of OB/GYN|302 733 3350|mhoffman@christianacare.org|
20553923|NCT00395044|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20553924|NCT04378933|Mayo Clinic|R. Robert Auger, M.D.|507-266-1066|Auger.Raymond1@mayo.edu|
20553925|NCT03511560|Columbia University|Amanda Alonso|212-342-0261|aa2974@cumc.columbia.edu|
20553926|NCT03487913|Centessa Pharmaceuticals|Milena Kanova, MD, Vice President, Clinical Operations|+44 7780 430583|Milena.Kanova@centessa.com|
20553927|NCT02985736|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
20553928|NCT00382733|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20553929|NCT00179413|BIDMC|Dr. Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
20553930|NCT00550836|Mayo Clinic|Steven R. Alberts, M.D.||alberts.steven@mayo.edu|
20553931|NCT02144675|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
20553932|NCT03075644|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20553933|NCT00439140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20553934|NCT01458171|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20553935|NCT02270060|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
20553936|NCT00578565|Mayo Clinic|Eric. L. Matteson, M.D.|507-284-8450||
20553937|NCT01192152|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20553938|NCT03022617|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
20553939|NCT00005669|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief, Unit on Growth and Obesity|301-496-0858|yanovskj@mail.nih.gov|
20553940|NCT00854581|University of Miami|Juan Carlos Ramos MD|305-243-4909|jramos2@med.miami.edu|
20553941|NCT01339390|Clement J. Zablocki VA Medical Center|Dr. Jeff Whittle|(414) 384-2000|jeffrey.whittle@va.gov|46444
20553942|NCT02805647|Department of Pediatric Orthopedics and Traumatology Medical University of Bialystok|MichałKarpiński|692224714|gufkarp@gmail.com|+48
20553943|NCT02258152|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
20553944|NCT04011475|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20553945|NCT01621373|UZ Leuven, NICU|Liesbeth Thewissen, MD, PhD|003216343211|liesbeth.thewissen@uzleuven.be|
20553946|NCT02261818|Johns Hopkins University|Dr Jin Hui Joo|4105502282|jjoo1@jhmi.edu|410
20553947|NCT01151553|Emory University|Dr. Heather Bloom|404-321-6111|heather.bloom@emory.edu|6391
20553948|NCT03843502|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
20553949|NCT02348489|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20553950|NCT01750268|San Francisco VA Health Care System/University of California, San Francisco|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
20553951|NCT00854087|SCTI Research Foundation|Dr. Tarek Hassanein|6195220330|thassanein@livercenters.com|
20553952|NCT01777997|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20553953|NCT01694706|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20553954|NCT01923181|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20553955|NCT02944578|Emory University|Dr. Lisa Flowers|404-251-8931|flowe2@emory.edu|
20553956|NCT01878604|Central South University|Shuiping Zhao|86-731-85295806|zhaosp@medmail.com.cn|
20553957|NCT02932891|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20569872|NCT03318783|Oregon Health and Science University|Ross Martini|4013386803|martinir@ohsu.edu|
20538683|NCT02406443|Renal Physiology Laboratory|University Health Network|416-340-4800|vesta.lai@uhn.ca|8508
20538684|NCT00076336|Novartis Pharmaceuticals|Study Director|862-778-8300||
20538685|NCT04214639|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
20538686|NCT03435562|Virginia Commonwealth University|Alison Breland|804 628 2300|abbrelan@vcu.edu|
20538687|NCT01266317|University of Pittsburgh|Dr. Michael Donahoe|412-383-2049|donahoem@upmc.edu|
20538688|NCT02937766|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20538689|NCT00098722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538690|NCT01987219|NYU School of Medicine|Dr. Horacio Kaufmann|212 263 7225|horacio.kaufmann@nyumc.org|
20538691|NCT03037541|Wake Forest University Health Sciences|Joseph Jorizzo, MD|336-716-3775|jjorizzo@wakehealth.edu|
20538692|NCT01610596|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
20538693|NCT01519674|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20538694|NCT00799591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538695|NCT04599166|Penn State College of Medicine|Dr. Benjamin Levi|717-531-8778|BHLevi@psu.edu|
20538696|NCT02317809|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20538697|NCT01974752|AstraZeneca|Karin Bowen|+001 301 398 3254|karin.bowen@astrazeneca.com|
20538698|NCT02435680|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20538699|NCT02867618|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
20538700|NCT00953524|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20538701|NCT06239441|Hôpital du Sacre Coeur de Montreal|Catherine Lemiere|514 338 2492|catherine.lemiere@umontreal.ca|
20538702|NCT01975519|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
20538703|NCT03276052|AstraZeneca|Global Clinical Head|+187724094 79|information.center@astrazeneca.com|
20538704|NCT01994863|Coloplast A/S|Director Clinical Affairs||dkdac@coloplast.com|
20538705|NCT03784846|Pacific University|Michael Christopher, Ph.D.|503-352-2498|mchristopher@pacificu.edu|
20538706|NCT03597178|Johnson & Johnson|Brian Pall OD, MS, FAAO- Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
20538707|NCT01310400|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20538708|NCT01062841|University of Michigan|Lona Mody, MD, MSc|734-764-8942|lonamody@umich.edu|
20538709|NCT02046174|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
20538710|NCT01909180|GE Healthcare|RIchard Petrisko|262-548-4637|richard.petrisko@ge.com|
20538711|NCT00902018|Weill Cornell Medical College|Dr James Bussel|22-746-3474|jbussel@med.cornell.edu|
20538712|NCT00186537|Stanford University|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
20538713|NCT03180398|Henry Ford Health|Dr. Stephen Brown|3135858415|sbrown1@hfhs.org|
20538714|NCT01143051|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
20538715|NCT02337530|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
20538716|NCT03351114|Duke University|Dr. Adela R. Cardones|9196843110|adela.cardones@duke.edu|
20538717|NCT01874275|Independent Principal Investigator|Charlotte Stelly-Seitz, MD|713-523-3463|drstellyseitzmd@gmail.com|
20538718|NCT02330523|The McGuire Institute|E. Todd Scheyer DDS, MS|713-783-544|etsperio@swbell.net|
20538719|NCT02120365|Virginia Commonwealth University|Albert Arias|8046286777|albert.arias@vcuhealth.org|
20538720|NCT00343915|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538721|NCT01726673|Feinstein Institute for Medical Research at Northwell Health|Johanna Chang, Senior Research Coordinator|(516) 562-3646|jchang14@northwell.edu|
20538722|NCT02863523|East Carolina University|Dr. Doyle Cummings|252-744-2607|FLOYDS14@ecu.edu|
20538723|NCT00921310|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5737|mbaggstr@dom.wustl.edu|
20538724|NCT01719003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20538725|NCT01275092|Columbia University Medical Center, New York, NY, 10032|Giora Weisz, MD; Director of Clinical Resarch Center for Interven tional Vascular Therapy|212-305-7060|gweisz@crf.org|
20538726|NCT01344629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20538727|NCT00762996|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
20538728|NCT00837824|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
20538729|NCT00539617|University of California, San Francisco|W. Michael Korn, MD|415-502-2844|michael.korn@ucsf.edu|
20538730|NCT02312765|University of Pennsylvania|Dr Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
20538731|NCT04063787|University of Chicago|Dr. Mary Hammes|773-702-6134|mhammes@bsd.uchicago.edu|
20538732|NCT00746733|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20569873|NCT03398421|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20569874|NCT01009138|Research Institute of the Diabetes Academy Mergentheim|Dr. Bernhard Kulzer|+49 7931|kulzer@diabetes-zentrum.de|594151
20569875|NCT01690923|ResMed Ltd|Xueling Zhu, Clinical Consultant|61288842265|xueling.zhu@resmed.com.au|
20569876|NCT01426113|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20569877|NCT03579433|Alcon Research, LLC|Sr. CDMA Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20569878|NCT01494545|Alcon Research, Ltd|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20569879|NCT00468130|Rutgers University|Sherie Novotny, MD|7322354119|novotnsl@ubhc.rutgers.edu|
20569880|NCT02485899|BioMarin Pharmaceutical, Inc.|Trial Specialist|1-800-983-4587|medinfo@bmrn.com|
20569881|NCT00436956|National Cancer Institute|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
20538733|NCT01527383|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538734|NCT00849875|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538735|NCT04883528|Duke University|Stephen J. Greene, MD|919-684-3854|stephen.greene@duke.edu|
20538736|NCT01152515|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine|Dr. Shin Ok Koh|82-2-2228-2420|sokoh@yuhs.ac|
20538737|NCT03515941|Baylor College of Medicine|Eunji Jo|713-798-4923|ejo@bcm.edu|
20538738|NCT01367704|Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center|Dr. Elizabeth Miller|412-692-8504|elizabeth.miller@chp.edu|
20538739|NCT04096820|Queen's University/Kingston General Health Research Institute|Heather McFarlane, Administrative Assistant|613-549-6666|heather.mcfarlane@kingstonhsc.ca|8171
20538740|NCT02726880|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
20538741|NCT00787202|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538742|NCT01510145|Alcon Research, Ltd|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20538743|NCT01360398|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538744|NCT01453946|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
20538745|NCT00846040|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Kevin Hall, PhD|3014028248|kevinh@niddk.nih.gov|
20538746|NCT03158272|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20538747|NCT01822535|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
20538748|NCT03190694|University Medical Center Groningen|Prof.dr.H.J. Lambers-Heerspink|+31 50 361 7859|h.j.lambers.heerspink@umcg.nl|
20538749|NCT01591863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538750|NCT02558400|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
20538751|NCT02246608|Kettering Health Network|Manager, Research Operation and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
20538752|NCT00474617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538753|NCT00131456|Columbia University|Dr. Frances R. Levin|212-543-5896|frl2@columbia.edu|
20538754|NCT00434356|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20538755|NCT00240110|Univeristy of Miami|Dr. Ihsan Salloum|305-243-7931|isalloum@med.miami.edu|
20538756|NCT04699812|Apple Inc.|Clinical Health Product Clinician|866-905-5303|htclinicalquestions@apple.com|
20538757|NCT03747120|University of Texas Southwestern Medical Center|Dr. Heather McArthur, Professor IM-Hem Onc|214-645-9380|heather.mcarthur@utsouthwestern.edu|
20538758|NCT01688739|Amgen Inc.|Study Director|866-572-6436||
20538759|NCT02961946|Massachusetts General Hospital|Dr. Brian Ghoshhajra|617-726-5954|BGHOSHHAJRA@mgh.harvard.edu|
20538760|NCT01352637|Weill Cornell Medical College|Dr. JoAnn Difede|212 746 3079|jdifede@med.cornell.edu|
20538761|NCT00765882|Forest Research Institute|Paul F.C. Eng, PhD. Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
20538762|NCT01665430|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20538763|NCT00598078|Jazz Pharmaceuticals|Grace Wang, MD Director Clinical Development and Medical Monitor|650-496-3777||
20553958|NCT03511521|Northwestern University Feinberg School of Medicine|Dr. Mark Molitch, Principal Investigator|3125034130|molitch@northwestern.edu|
20553959|NCT00577122|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
20569882|NCT05674292|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|501
20553960|NCT01733368|Hospital Clinico Universitario Virgen de la Victoria|Dr. Javier Alzueta Rodríguez|951 03 20 00|jalzueta@telefonica.net|
20553961|NCT00440271|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20553962|NCT00456092|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20553963|NCT01268644|UT Southwestern Medical Center|Dr. Abhimanyu Garg|2146482895|abhimanyu.garg@utsouthwestern.edu|
20553964|NCT01416194|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20553965|NCT03358576|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
20553966|NCT01222494|Washington University|Dr. Ginger Nicol|314-362-2461|nicolg@wustl.edu|
20553967|NCT01174030|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20553968|NCT01565993|Hospital Universitario Severo Ochoa|Dra Elvira Quintanilla|34 914818000|elviramquintanilla@hotmail.com|8326
20553969|NCT04086472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20553970|NCT02252081|Nashville Campus TVHS|Dr. Adriana Hung|6153274751|adriana.hung@va.goc|6731
20553971|NCT01241734|Hackensack Meridan Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
20553972|NCT00048724|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20553973|NCT01743092|Centre for Addiction and Mental Health|Nigel Turner, Ph.D.|416-535-8501|nigel.turner@camh.ca|36063
20553974|NCT02595684|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20569883|NCT00623363|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20569884|NCT01062269|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|HBaysMD@aol.com|
20569885|NCT03004586|UT MD Anderson Cancer Center|George Eapen,MD/ Professor, Pulmonary Medicine|(713) 563-4256|geapen@mdanderson.org|
20569886|NCT01174264|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20569887|NCT00358007|Thomas Jefferson University|Pramila Rani Anne, MD|215-955-6702|Pramila.Anne@jefferson.edu|
20569888|NCT02604342|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20569889|NCT01702519|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538764|NCT01866423|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-865-0454|Victoria.Soto@med.usc.edu|
20538765|NCT01813721|Amgen Inc.|Study Director|866-572-6436||
20538766|NCT01479595|Novartis|Study Director|862-778-8300||
20538767|NCT02699450|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20538768|NCT00810901|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
20538769|NCT01009346|Johns Hopkins|Ranee Mehra, MD||rmehra1@jhmi.edu|
20538770|NCT00852527|Southern AZ VA Health Care System|Dr. Judith Babcock-Parziale, PI|520-7921450|judith.babcock@va.gov|5698
20538771|NCT00882908|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20538772|NCT03283150|University of Wisconsin-Madison|Jeremy Sullivan|6082639976|jasullivan@wisc.edu|
20538773|NCT00900146|Novartis Pharmaceuticals|Study Director|862-778-8300||
20538774|NCT00700102|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20538775|NCT01811303|RSSL|Rungano Munyuki (Clinical Project Manager)|0118 9184034||
20507770|NCT03180489|Colorado State University|Christopher Bell|9704917522|christopher.bell@colostate.edu|
20538776|NCT02525939|DalCor Pharmaceuticals|Dr. Don Black, Chief Medical Officer|‭+1 (609) 613-6637‬|dblack@dalcorpharma.com|
20538777|NCT00048815|Cedars Sinai Medical Center|Mark Hyman Rapaport, M.D.|310-423-2600|mark.rapaport@cshs.org|
20538778|NCT01028716|Fred Hutchinson Cancer Center|Rachel Salit|2066671317|rsalit@fredhutch.org|
20538779|NCT01635764|AbbVie|Global Medical Services|800-633-9110||
20538780|NCT05590000|Abbott|Devyani Nanduri, Senior Director, Clinical & Regulatory Affairs|+16698329450|devyani.nanduri@abbott.com|
20553975|NCT02370888|Univeristy of Florida Health Cancer Center|Archana Narasanna, Project Manager|(352) 273-6772|PMO@cancer.ufl.edu|
20569890|NCT03738397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20569891|NCT03536702|MS Hershey Medical Center|Monika Joshi, MD, MRCP|717-531-8678|muj14@psu.edu|
20569892|NCT01185171|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
20569893|NCT03559829|Associate Professor of Neurology and Neurological Sciences|Maarten G. Lansberg, MD PhD|(650) 723-4448|lansberg@stanford.edu|
20569894|NCT01729845|Fred Hutch Cancer Research Center|Dr. Anna Halpern|2066676233|halpern2@uw.edu|206
20569895|NCT00573651|The MetroHealth System|Nora G Singer|216-778-2138|nsinger@metrohealth.org|
20569896|NCT01837797|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20569897|NCT03797989|University of Oxford|Dr. Angela Minassian|07973684040|angela.minassian@bioch.ox.ac.uk|
20569898|NCT01664897|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD./Professor|713-794-5783|jcortes@mdanderson.org|
20569899|NCT04052997|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
20569900|NCT00953199|Penn State Hershey Medical center|Abraham Mathew MD|717 531 3834|amathew@hmc.psu.edu|
20569901|NCT04814992|University of Pennsylvania|Dr. Peggy Compton|2158988283|pcompton@nursing.upenn.edu|
20569902|NCT00557349|University of Missouri|Archana Ramaswamy, MD|573-884-4003|ramaswamya@health.missouri.edu|
20569903|NCT00097669|VITATOPS|Clinical Trial Coordinator|+61892247004|julia.o'dea@health.wa.gov.au|
20569904|NCT05250960|TriHealth|Rachel Baker|513-569-6191|Rachel_Baker2@trihealth.com|
20569905|NCT02364609|UC Davis Comprehensive Cancer Center|Leslie Garcia, Data Research Supervisor|916-734-0156|lesgarcia@ucdavis.edu|
20569906|NCT01568021|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20569907|NCT01669720|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
20569908|NCT00514813|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20569909|NCT01075100|US Oncology Research, McKesson Specialty Health|Dr. Cynthia Osborne|214-370-1057|Cynthia.Osborne@usoncology.com|
20569910|NCT00731588|University of Iowa|John A. Widness, M.D.|319-356-8102|john-widness@uiowa.edu|
20569911|NCT00143598|Centre for Clinical Epidemiology, Jewish General Hospital|Dr. Susan R Kahn|514-340-8222|susan.kahn@mcgill.ca|7587
20569912|NCT00420147|University of Delaware|Todd Royer|302-831-4351|royer@udel.edu|
20569913|NCT03900715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20569914|NCT03898700|Thomas Jefferson University|Dr. MJ Mulcahey|215-503-2888|maryjane.mulcahey@jefferson.edu|
20569915|NCT00701909|University of California, San Francisco|Dr. Kathleen Puntillo, RN, PhD|415 819 2655|kathleen.puntillo@ucsf.edu|
20569916|NCT00971997|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20569917|NCT04009629|University of Kansas Medical Center|Dr. Eric Vidoni|913-588-0555|kuamp@kumc.edu|
20569918|NCT02808975|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20569919|NCT02263040|Mount Sinai Hospital, Toronto|Dr. Allison McGeer|416-586-3118|allison.mcgeer@sinaihealthsystem.ca|
20569920|NCT00511836|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
20569921|NCT01083199|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
20569922|NCT01755546|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
20569923|NCT00891046|Novartis Pharmaceuticals|Study Director|862--778--8300||
20569924|NCT00362375|SisterLove, Inc.|Dazon Dixon-Diallo, Executive Director|404-505-7777|ddiallo@sisterlove.org|
20569925|NCT02106195|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
20569926|NCT04984239|University of Pittsburgh|William Evans|412-383-6943|will.evans@pitt.edu|
20569927|NCT02034019|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
20569928|NCT01663506|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20538781|NCT04610489|Carilion Clinic|John Epling, MD, MSEd|540-581-0123|jwepling@carilionclinic.org|
20538782|NCT02689076|James J. Peters VA Medical Center|Kimberly M. Judon|718-584-9000|Kimberly.Judon@va.gov|1174
20569929|NCT02438371|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
20525819|NCT03613649|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
20525820|NCT05831644|Vicore Pharma AB|Director Clincial Operations|+46 (0) 31 788 05 60|info@vicorepharma.com|
20525821|NCT03429244|Indianan University School of Medicine|Jennifer Lehman|3179489575|jgeck@iu.edu|
20525822|NCT00474201|National Institutes of Health|Scott Penzak|301-496-2997|sp286u@nih.gov|
20525823|NCT01500187|University of Health Science Center|Franklin Garcia-Godoy DDDS, MS PhD||fgarciagodoy@gmail.com|
20525824|NCT00750139|Merz Pharmaceuticals, LLC|Associate Medical Director- Dermatology|800-334-0514||
20525825|NCT00595517|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20525826|NCT00658775|Eisai Call Center|Eisai Inc.|888-422-4743||
20525827|NCT02521051|Massachusetts General Hospital|Justin Gainor, MD|617-724-4000|jgainor@partners.org|
20525828|NCT02784613|San Diego Sexual Medicine|Irwin Goldstein|619-265-8865|dr.irwingoldstein@gmail.com|
20525829|NCT05819086|University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention|Regulatory Manager|608-262-7568|mark.zehner@ctri.wisc.edu|
20525830|NCT02258373|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
20525831|NCT01551264|Washington University School of Medicine|Matthew Dobbs MD|561-844-5255|mdobbs@paleyinstitute.org|
20525832|NCT01435460|Bausch & Lomb, Incorporated|Tuyen Ong|(973) 360-6389|tuyen.ong@bausch.com|
20525833|NCT01706939|Icahn School of Medicine at Mount Sinai|Dr. Marshall R Posner|(212) 659-5461|marshall.posner@mssm.edu|
20525834|NCT01046903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507771|NCT02475395|Sandstone Diagnostics|Cheif Science Officer|9253157246|gsommer@sandstonedx.com|925
20507772|NCT01086150|Albany Medical College|Charles E. Argoff, MD|518 262-0034|argoffc@mail.amc.edu|
20507773|NCT02227108|MedImmune LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenea.com|
20507774|NCT02486952|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20507775|NCT00594204|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20507776|NCT00567541|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
20507777|NCT01825655|Virginia Commonwealth University|Santhosh Kumar, MD|804-628-1605|santhosh.kumar@vcuhealth.org|
20507778|NCT01890512|Guidant Europe SA/NV A Boston Scientific Company|Giovanni Raciti|+39 02 26983213|giovanni.raciti@bsci.com|
20507779|NCT01401465|Sunovion|Respiratory Medical Director|1-866-503-6351||
20507780|NCT01115738|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20507781|NCT00575094|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20569930|NCT01161446|University of Washington|Dr. David Katz|206-744-5877|dkatz7@u.washington.edu|
20569931|NCT01852032|UC Davis|John Brock Staff Research Associate|916-734-3101|jmbrock@ucdavis.edu|
20569932|NCT01010204|Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center|K.N. Roy Chengappa, Md|412-246-5006|chengappakn@upmc.edu|
20507782|NCT02721251|VA|David Thompson|602-496-0242|david.thompson4@va.gov|
20507783|NCT02921763|Mylan EPD G.K.|Takumi Kanzo|+81-3-5656-0516|takumi.kanzo@viatris.com|
20507784|NCT02659605|The University of Texas Health Science Center at Houston|Dr. Pamela D. Berens|(713) 500-6471|Pamela.D.Berens@uth.tmc.edu|
20507785|NCT01929473|IROM CS Co., Ltd.|Tsutomu Takeda|+81-92-738-0500|tsutomu-takeda@irom-cs.co.jp|
20525835|NCT01343277|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20525836|NCT01894100|University of North Carolina at Chapel Hill|Yvonne M. Golightly, PT, PhD|919-966-0566|golight@email.unc.edu|
20525837|NCT00135512|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525838|NCT01094301|SPRTherapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
20525839|NCT05476250|Masimo Coporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20525840|NCT04013672|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|David Peereboom, MD|1-866-223-8100|TaussigResearch@ccf.org|
20525841|NCT00430573|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
20525842|NCT00688662|Medical University of South Carolina|Dr Peter Cotton|8438767217|cottonp@musc.edu|
20553976|NCT04574362|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569933|NCT01513330|Coloplast A/S|Director of Clinical Trials|+45 4911 3595|dkbir@coloplast.com|
20569934|NCT01519778|Cubist Pharmaceuticals|Carisa De Anda, Phd, Vice President Clinical Research|8583522639|carisa.deanda@cubist.com|
20569935|NCT02693704|EPFL|Gilles Courtois|0041216932631|gilles.courtois@epfl.ch|
20569936|NCT01547117|Vanderbilt University Medical Center|Alfredo Gamboa, MD|6158751003|alfredo.gamboa@vumc.org|
20569937|NCT00258362|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
20569938|NCT03927690|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20569939|NCT04026399|Medical University of South Carolina|Na Jin Seo|8437920084|seon@musc.edu|
20569940|NCT03248141|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569941|NCT00675792|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20569942|NCT01844726|Northwestern University|Dr. James Reilly|312-503-4809|james.reilly@northwestern.edu|
20553977|NCT00883389|University of Maryland, School of Medicine|Dr. Jeffrey C. Fink, Associate Professor, Nephrology|410-328-5720|jfink@medicine.umaryland.edu|
20553978|NCT01600040|Massachusetts General Hospital|Andrea Russo, MD|617-726-7941|alrusso@mgh.harvard.edu|
20553979|NCT00642304|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20553980|NCT01646671|Novartis Pharmaceuticals|Study Director|+1-862-778-8300||
20553981|NCT02579616|Eisai Co.,Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
20553982|NCT02178475|Amgen Inc.|Study Director|866-572-6436||
20553983|NCT01490060|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|(713) 792-7966|CR_Study_Registration@mdanderson.org|
20553984|NCT03759223|VA Center for Integrated Healthcare|Dr. Paul King, Clinical Research Psychologist|716-862-6038|paul.king2@va.gov|
20553985|NCT05421078|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20553986|NCT02409615|Nemours/A I duPont Hospital for Children|Karen Sacks, MSN PNP|302-651-5649|ksacks@nemours.org|
20553987|NCT03698773|University of New Mexico Anesthesiology Department|Research Officer|505-272-2610|hsc-anesthesiology@salud.unm.edu|
20553988|NCT02399085|MorphoSys AG|Lisa Walz|+49 89 89927 26240|Lisa.Walz@morphosys.com|
20553989|NCT00699699|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20553990|NCT02170727|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20553991|NCT00821626|Infectious Disease Service, and Travel Clinic, University Hospital of Lausanne, Switzerland|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
20553992|NCT00414050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1 800 672 6372|ClinicalTrialsDisclosure@merck.com|
20553993|NCT00515827|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20553994|NCT03254134|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20553995|NCT02563028|Hospital for Special Surgery|Valeria Rotundo|212-774-7885|rotundov@hss.edu|
20553996|NCT01009099|Edward Hines Jr., VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
20553997|NCT01856543|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum|914-367-7273|gelblumd@mskcc.org|
20553998|NCT00075829|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20553999|NCT00799617|University of Pennsylvania, Perelman School of Medicine|Peter J. Snyder, MD|215-898-0208|pjsnyder@upenn.edu|
20554000|NCT04545515|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20554001|NCT01712984|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20554002|NCT02501096|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20554003|NCT01848990|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
20554004|NCT02553746|424 Army General Hospital|Georgios Kotsovolis|+306948182743|gskotsos@gmail.com|
20554005|NCT00512096|UT MD Anderson Cancer Center|Cherie A. Perez||caperez@mdanderson.org|
20554006|NCT02489227|Coherus BioSciences, Inc.|Barbara K. Finck, MD|650-649-3530|bfinck@coherus.com|
20554007|NCT03212963|Sun Pharma Advanced Research Company Ltd.|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
20554008|NCT01312766|IBSA Institut Biochimique SA|Dr. Barbara Cometti, Senior Clinical Research Manager, IBSA|+41 58 360 10 00|barbara.cometti@ibsa.ch|
20554009|NCT01069289|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20554010|NCT00298038|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20554011|NCT02696096|Butler Hospital|Dr. Michael Stein|401-455-6652|michael_stein@brown.edu|
20554012|NCT00827372|IndianaU|Kathy Miller, MD|317-944-0920|kathmill@iupui.edu|
20554013|NCT01010984|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
20554014|NCT02160873|Florida State University|Dr. Michael J. Ormsbee|(850) 645-5000|mormsbee@fsu.edu|
20554015|NCT02766608|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
20554016|NCT03223298|Weill Cornell Medicine|Dr. Gwendolyn S. Reeve|(212) 746-5175|gsr9001@med.cornell.edu|
20554017|NCT01265953|Oregon Health & Science University|Dr.Jackilen Shannon|503-418-9860|shannoja@ohsu.edu|
20554018|NCT01032694|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554019|NCT02866682|University of California, Los Angeles (UCLA)|Dr. Suphamai Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu|
20554020|NCT00201006|University of Florida|Michael G. Perri, PhD|352 273-6214|mperri@ufl.edu|
20554021|NCT02837744|Axio Biosolutions Pvt. Ltd.|Shailee Mehta, Clinical Research Manager|9879009940|shailee.m@axiobio.com|
20554022|NCT03151265|dorsaVi Ltd|Sangeeth Wanasinghage|+61 1800 367 728|support@dorsavi.com|
20554023|NCT00509197|Hôpital du Sacré-Coeur de Montréal|Dr Catherine Lemiere|514 338 2796|catherine.lemiere@umontreal.ca|
20569943|NCT04205955|SWOG Statistics and Data Management Center|Palliative and End of Life Care Committee Statistician|2066677685|karnold@fredhutch.org|
20569944|NCT03898960|CERENOVUS|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20569945|NCT00548847|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
20569946|NCT00236184|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
20569947|NCT01101997|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20569948|NCT00469456|Forest Research Institute, a subsidiary of Forest Laboratories Inc.|Stephen Graham, PhD|201-427-8156|stephen.graham@frx.com|
20569949|NCT01743521|Kirby Institute|A/Prof Gail Matthews|+61 (0)2 9385 0900|gmatthews@kirby.unsw.edu.au|
20569950|NCT04731142|Imperial College London|Dr Jack Halligan|+447742161980|j.halligan@imperial.ac.uk|
20554024|NCT01383681|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20554025|NCT00938431|UCB|Study Director|+1877 822 9493||
20507786|NCT01195363|UTHSCSA|Charles L Bowden, MD|210-567-5393|BowdenC@uthscsa.edu|
20507787|NCT01589510|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20525843|NCT05020665|Kronos Bio, Inc.|VP, Corporate Affairs|+16507815200|media@kronosbio.com|
20525844|NCT01868022|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20525845|NCT03297645|Virginia Commonwealth University|Robin S. Everhart, PhD|(804) 828-7249|reverhart@vcu.edu|
20569951|NCT00704171|Covidien|Jennifer L. Doyle, Global Director of Clinical Affairs|781-839-1770|jennifer.doyle@covidien.com|
20569952|NCT00078728|The Johns Hopkins University School of Medicine|Golda Ginsburg, PhD,Professor|410-955-1544|gginnsbu@jhmi.edu|
20569953|NCT00913068|Capital District Health Authority|Dr. Ricardo A. Rendon|9024736604|rrendon@dal.ca|
20569954|NCT00719043|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569955|NCT01588366|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20569956|NCT00302159|National Cancer Institute, national Institutes of Health|Kevin Camphausen, M.D.|301-496-5457|camphauk@mail.nih.gov|
20569957|NCT00813098|Lexicon Pharmaceuticals, Inc.|Clinical Project Manager|281-863-3000||
20569958|NCT04269434|Instituut van Tropische Geneeskunde Antwerpen|Dr. Chris Kenyon|+3232470786|ckenyon@itg.be|
20569959|NCT03470545|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20569960|NCT01664923|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20569961|NCT00364377|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
20569962|NCT00336817|Upittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
20569963|NCT03672175|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20569964|NCT01772563|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569965|NCT02767609|Loma Linda University medical Center|Brenda Bartnik Olson|909-558-4000|bbartnik@llu.edu|85216
20569966|NCT01086384|GlaxoSmithKline|GSK Response Center|866-435-7343||
20569967|NCT03854019|The University of Texas Health Science Center at Houston|Erin Furr Stimming, MD|713-500-7033|Erin.E.Furr@uth.tmc.edu|
20569968|NCT02586415|Stanford University/School of Medicine|Dr. Gregory Albers|650-723-4448|albers@stanford.edu|
20569969|NCT03045809|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
20569970|NCT01898442|University of Florida - Jacksonville|Dominick J. Angiolillo, MD, PhD|9042443933|dominick.angiolillo@jax.ufl.edu|
20569971|NCT00255944|University of Colorado|Dr. Sheana Bull|3037241238|sheana.bull@ucdenver.edu|303
20569972|NCT03124550|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
20569973|NCT01121913|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20569974|NCT00935259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20569975|NCT01246050|VA Medical Center Nashville|Henry Ooi|615-8736373|henry.ooi@va.gov|
20569976|NCT03856047|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20569977|NCT03410108|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20569978|NCT03990298|Hospital of the University of Pennsylvania, Dept of Otorhinolaryngology, Head & Neck Surgery|Erica Thaler, MD|215-662-4533|erica.thaler@pennmedicine.upenn.edu|
20569979|NCT00937521|Novartis Vaccines|Novartis Vaccines||RegistryContactVaccinesUS@novartis.com|
20569980|NCT02023905|University of California, San Francisco|Dr. Jennifer Clarke, MD MPH|(415) 353-2167|Jennifer.Clarke@ucsf.edu|
20569981|NCT01721746|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20569982|NCT03849768|Jiangsu Hansoh Pharmaceutical Group Co., Ltd.|Alison Li|86-21-51211850|Alison.li@hspharm.com|
20569983|NCT02447718|IWK Health Centre|Dr. Karina Top|902-470-6343|karina.top@dal.ca|
20569984|NCT00239681|AstraZeneca|Torbjorn Lundstrom||ClinicalTrialTransparency@astrazeneca.com|
20569985|NCT00934700|Imperial College London|Research Integrity Officer|+44 020 7594 1872|jrco@imperial.ac.uk|
20569986|NCT01329185|University of Minnesota|Dr. Priya Verghese, Director of Pediatric Kidney Transplantation|6126262922|pverghes@umn.edu|0
20569987|NCT02641587|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
20569988|NCT00429143|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
20569989|NCT01150045|Alliance for Clinical Trials in Oncology|Jeffrey A. Meyerhardt, MD, MPH|617-632-6855|jmeyerhardt@partners.org|
20569990|NCT03124693|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20569991|NCT01439854|University of Texas Health San Antonio|Muhammad Abdul-Ghani|210-557-1157|abdulghani@uthscsa.edu|
20507788|NCT01763866|Amgen Inc.|Study Director|866-572-6436||
20569992|NCT00328562|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-6702|Maria.Werner-Wasik@jeffersonhospital.org|
20569993|NCT00810342|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
20569994|NCT04504630|UT Southwestern Medical Center|Christian LoBue, PhD|2146484658|Christian.LoBue@utsw.edu|
20569995|NCT02367430|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
20569996|NCT00568698|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
20569997|NCT03021551|Masimo Corporation|Cristina Johnson|949-297-7000|ClinicalResearchDept@masimo.com|
20569998|NCT00412880|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20569999|NCT01288209|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
20570000|NCT02232399|University of Gothenburg|Prof. Albert Gyllencreutz Castellheim|+46708979820|albert.castellheim@gu.se|
20570001|NCT01660256|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20570002|NCT01184885|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
20570003|NCT03491215|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
20538783|NCT03236168|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
20538784|NCT02266875|OhioHealth|Dr. Kruti Patel, DO|614-857-7735|kruti.patel@ohiohealth.com|
20538785|NCT02481713|VA Connecticut Healthcare System|Joanna Fiszdon, PhD|2039325711|joanna.fiszdon@va.gov|2231
20538786|NCT01816906|Staffordshire University|Professor Nachiappan Chockalingam|+44 1782 295853|n.chockalingam@staffs.ac.uk|
20538787|NCT03412604|Massachusetts General Hospital|Emiliano Santarnecchi|617-667-0326|esantarnecchi@mgh.harvard.edu|
20538788|NCT02989844|University of Minnesota, Masonic Cancer Center|Jeffrey Miller|612-625-7409|mille011@umn.edu|
20554026|NCT02086591|University of Rochester|Carla Casulo|585-273-3258|carla_casulo@urmc.rochester.edu|
20538789|NCT01312389|University of Pennsylvania|Director of Clinical Trial Operations|215-662-3324|tracey.thomas@pennmedicine.upenn.edu|
20507789|NCT00804843|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507790|NCT03927911|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20507791|NCT04327518|Johnson & Johnson Surgical Vision|Director of Clinical Science, Ophthalmic Implants|7142478200|EThoma39@its.jnj.com|
20507792|NCT01966263|Sint Maartenskliniek Nijmegen|Dr Maaike Fenten|31243659111|m.fenten@maartenskliniek.nl|2941
20507793|NCT01297309|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20507794|NCT01804257|Zucker Hillside Hospital, Glen Oaks, NY|John M. Kane MD|(718) 470-8141|psychiatry@nshs.edu|
20507795|NCT01807091|University of Washington|Elihu Estey, MD|206-606-6744|eestey@seattlecca.org|
20507796|NCT03617913|Mayo Clinic|Parminder Singh, MD|5072555123|Singh.Parminder@mayo.edu|
20507797|NCT02016898|Duke University Health System|Michael Quist, MD|718-490-7657|michael.quist@duke.edu|
20507798|NCT01381718|Children's Hospital Boston/Harvard Medical School|Nicole J. Ullrich, MD, PhD|617-355-3193|Nicole.Ullrich@childrens.harvard.edu|
20507799|NCT00365768|Columbia University Medical Center|Julia Glade-Bender, MD|212-305-3379|jg589@cumc.columbia.edu|
20507800|NCT04015440|Walter Reed Army Institute of Research|Jeffrey M Osgood, Ph.D. Associate Director of Military Psychiatry Branch|301-319-7475|jeffrey.m.osgood.mil@mail.mil|
20507801|NCT02505542|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20507802|NCT00992186|Centocor Research & Development, Inc., PA, USA|Senior Director, Early Clinical Development Global Leader|+1-908-927-3159||
20507803|NCT00973622|University of Arkansas for Medical Sciences|Christine Sheffer, PhD|212 650 6860|csheffer@med.cuny.edu|
20507804|NCT01804036|University of Utah|Yoshio Nakamura, PhD|801-585-7690|yn5@utah.edu|
20507805|NCT00830960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20507806|NCT03074149|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507807|NCT03452891|University of Nebraska Medical Center|Amy C Killeen|402-479-6205|akilleen@unmc.edu|
20507808|NCT05053126|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
20507809|NCT00050960|Eisai Call Center|Eisai, Inc.|888-422-4743||
20507810|NCT00756496|Siemens Medical Solutions USA, Inc.|Milind Dhamankar|+1 (610) 448-6467|milind.dhamankar@siemens-healthineers.com|
20507811|NCT05127421|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20507812|NCT02235987|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
20507813|NCT00878215|Washington University School of Medicine|William C. Chapman, M.D.|314-362-7792|chapmanw@wustl.edu|
20507814|NCT01802554|University of California San Diego|Brent T Mausbach, PhD|858-822-7529|BMausbach@ucsd.edu|
20507815|NCT01632735|Azusa Pacific University|Dr. Rachel Gonzales Castaneda|6268156000|rcastaneda@apu.edu|2744
20507816|NCT00574496|Memorial Sloan Kettering Cancer Center|Dr. Miguel-Angel Perales, MD|646-608-3757|peralesm@mskcc.org|
20507817|NCT01969799|Cardeas Pharma|Bruce Montgomery, MD|2069713756|bruce.montgomery@cardeaspharma.com|
20525846|NCT02504827|University of Southern California|Paul Beringer|323-442-1402|beringer@usc.edu|
20525847|NCT03386994|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525848|NCT02842580|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20525849|NCT02965729|Pennington Biomedical Research Center|Dr. Amanda Staiano|225-763-2729|amanda.staiano@pbrc.edu|
20525850|NCT00725361|StanfordU|Lorinda Chung|650-736-0727|shauwei@stanford.edu|
20525851|NCT04740827|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20525852|NCT02147158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20507818|NCT02815293|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
20507819|NCT01056341|Pierre Fabre Dermatologie|Dr. Jean-Jacques VOISARD - General Manager -|+33 5 63 58 88 00|jean.jacques.voisard@pierre-fabre.com|
20538790|NCT00525629|Beth Israel Deaconess Medical Center|Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
20538791|NCT00283816|University of Rochester Medical Center|Kathleen M. Hoeger, MD, MPH|585-275-7891|Kathy_Hoeger@urmc.rochester.edu|
20538792|NCT01643876|Université de Montréal|Dr. Elham Emami|5143436111|elham.emami@umontreal.ca|6053
20538793|NCT02469714|Illinois Institute of Technology|Patrick Corrigan|(312)567-6751|corrigan@iit.edu|
20538794|NCT00993499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20538795|NCT01945775|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538796|NCT02876328|National Institute of Allergy and Infectious Diseases (NIAID)|John Tierney, Director of Office of the Clinical Research Policy and Regulatory Operations (OCRPRO)|301.451.5136|JTierney@niaid.nih.gov|
20538797|NCT00892606|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
20570004|NCT03539068|Department of Veterans Affairs- Office of Research and Development|Anne G. Sadler, Ph.D., R.N.|319-338-0581|anne.sadler@va.gov|7992
20570005|NCT04585737|Orlando Immunology Center|Wendy Wert, Clinical Research manager|4076473960|wwert@oicorlando.com|
20570006|NCT02720211|Axon Optics|Director of Clinical Trials|8012304851|bradley.katz@hsc.utah.edu|
20570007|NCT00541671|Christiana Care Health System|Deb Marco|302-733-4130|DMarco@christianacare.org|
20570008|NCT00551135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570009|NCT04599855|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20570010|NCT02165397|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
20570011|NCT04799418|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
20570012|NCT03297398|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20570013|NCT00424554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20570014|NCT02988349|Sichuan University|Dr. Xin Xu|86-28-85503494|xin.xu@scu.edu.cn|
20570015|NCT01379703|Abbott|Global Medical Services|1-800-633-9110||
20570016|NCT03481556|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
20570017|NCT01316887|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570018|NCT02172950|CSL Behring|Clinical Trial Disclosure Manager|use email contact|clinicaltrials@cslbehring.com|
20570019|NCT00107978|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20570020|NCT02669407|Duke University|Marat Fudim, M.D.|919-684-8111|marat.fudim@duke.edu|
20570021|NCT03634839|Yale University|Dr. Suchitra Krishnan-Sarin|(203)974-7595|suchitra.krishnan-sarin@yale.edu|
20570022|NCT00350298|MassBiologics|Director of Clinical Affairs|617-474-3000|MBLClinicalDirector@umassmed.edu|
20570023|NCT01127321|MedImmune, LLC.|David Close, Director, Clinical Development|301-398-0000|closeda@medimmune.com|
20570024|NCT01809899|Georgetown University Medical Center|Mary Ann Dutton|2026871997|mad27@georgetown.edu|
20570025|NCT00853229|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
20570026|NCT02208037|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20570027|NCT01777490|HSR&D/COIN, Durham VAHCS|Courtney Van Houtven|(919)286-6936|Courtney.VanHoutven@va.gov|
20570028|NCT04068051|Axsome Therapeutics, Inc.|Caroline Streicher, Vice President, Clinical Operations|212-332-5061|cstreicher@axsome.com|
20570029|NCT01196819|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
20570030|NCT02632812|Galeno Desenvolvimento de Pesquisas Ltda.|Gilberto De Nucci, PhD, principal investigator|55.19.32516928|denucci@gilbertodenucci.com|
20570031|NCT00832000|University of Kansas Medical Center|Richard J. Barohn, MD|913-588-6095|rbarohn@kumc.edu|
20570032|NCT02725567|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20570033|NCT02777242|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
20570034|NCT01129115|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|kuamp@kumc.edu|
20570035|NCT04626271|Healthy.io|Dr. Danielle Jeddah (Director of Clinical Development) OR Jennifer Kachel Acobas (Director of RA)|0543111050, 0528345562|danielle.jeddah@healthy.io, jennifer.acobas@healthy.io|
20570036|NCT01747837|Icahn School of Medicine at Mount Sinai|Sam Commack|212-824-8931|sam.cammack@mountsinai.org|
20570037|NCT00751634|Northwestern University|Dr. Andrew Naidech|312-503-3335|a-naidech@northwestern.edu|
20570038|NCT00817336|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|jk3380@cumc.columbia.edu|
20570039|NCT00511797|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20570040|NCT03671239|University of Pennsylvania|Jose A. Bauermeister, PhD|215-898-9993|bjose@nursing.upenn.edu|
20570041|NCT02019641|Clinical Center|Leighton Chan|+1 301 496 4733|chanle@mail.nih.gov|
20570042|NCT01017263|Duke UMC|Scott Kollins, PhD|9196810014|scott.kollins@dm.duke.edu|
20570043|NCT03121612|Arnolda Consulting|Dr Gaston Arnolda|+61 2 8068 4963|gaston.arnolda@gmail.com|
20570044|NCT02654132|Bristol Myers-Squibb|Bristol Myers-Squibb Study Director|Please email|Clinical.Trials@bms.com|
20570045|NCT03467698|UT Dallas|UT Dallas IRB DIrector|972-883-4506|amanda.boone@utdallas.edu|
20570046|NCT01880437|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20570047|NCT03713320|Viridian Therapeutics (formerly miRagen Therapeutics)|Regulatory Affairs|720-722-5917|clinicaltrials@viridiantherapeutics.com|
20570048|NCT00909532|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
20570049|NCT01209598|Memorial Sloan Kettering Cancer Center|Mark Dickson, MD|646-888-4164|dicksonm@mskcc.org|
20570050|NCT00085566|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|scherh@mskcc.org|
20570051|NCT02111863|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
20570052|NCT03772613|Mayo Clinic|Dr. Shahyar M. Gharacholou|904-956-8400|Gharacholou.Shahyar@mayo.edu|
20570053|NCT04594733|MUSC|Research Coordinator|843-792-1869|nitchie@musc.edu|
20570054|NCT02657954|VA San Diego Healthcare System|Dr Elizabeth Twamley|858-642-3848|elizabeth.twamley@va.gov|
20554027|NCT00423436|UT MD Anderson Cancer Center|Charles S Cleeland, PhD, Professor||asaleeba@mdanderson.org|
20554028|NCT03738865|Xeris Pharmaceuticals, Inc.|Chelsea Boundy|312-517-1466|cboundy@xerispharma.com|
20554029|NCT02212730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554030|NCT02691455|The University of Texas Health Science Center at Houston|Robert M. Feldman, MD|(713) 559-5239|Robert.M.Feldman@uth.tmc.edu|
20554031|NCT01257204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20554032|NCT02057757|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. John Beigel|301-451-9881|jbeigel@niaid.nih.gov|
20554033|NCT02514252|UT MD Anderson Cancer Center|Suresh K. Reddy, MD/Professor, Palliative Care Med|(713) 794-5362|sreddy@mdanderson.org|
20554034|NCT00723801|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
20554035|NCT02809976|Tufts Medical Center|David Romarin, MD Prinicpal Investigator|617 636 7462|drosmarin@tuftsmedicalcenter.org|
20554036|NCT00211081|Emory University|Dr. Willam Mahle|404-785-6000|wmahle@emory.edu|
20554037|NCT00113516|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20554038|NCT00047463|Vanderbilt University|Beth Malow/Principal Investigator|615-322-0283|beth.malow@vanderbilt.edu|
20554039|NCT02104557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554040|NCT00245557|McLean Hospital|Brent Forester MD|617-855-3622|bforester@mclean.harvard.edu|
20554041|NCT02709395|Wellspect HealthCare|Head of Medical Affairs, Markus Wittebo|+46 31 376 40 00|markus.wittebo@wellspect.com|
20554042|NCT01559311|St. Jude Medical (Hong Kong) Ltd|Clinical Project Leader Asia|29967605|lyim@sjm.com|
20554043|NCT05013905|Prometheus Biosciences, Inc.|Study Director|858-422-4300|mm@prometheusbiosciences.com|
20554044|NCT04942938|Centura Health|Dr. Courtney Ellerbusch|3039058272|courtneyellerbusch@centura.org|
20554045|NCT01849588|Massachusetts General Hospital|Dr. Andrew Zhu|617-724-4000|azhu@partners.org|
20554046|NCT01362907|Alcon Research|Joachim Nick, Dipl. Ing. (FH)|+49 6022 240 520|joachim.nick@cibavision.com|
20554047|NCT02978690|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554048|NCT01706250|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554049|NCT03286140|Imperial College London|Professor Alun Davies|+44 (0)20 3311 7309|a.h.davies@imperial.ac.uk|
20554050|NCT01826825|Brigham and Women's Hospital|Deborah J. Culley, M.D., Principal Investigator|6177327330|dculley@bwh.harvard.edu|
20554051|NCT00850031|AcuFocus, Inc|Eugenia Thomas, Director Clinical Trials|949/585-9511|nthomas@acufocus.com|129
20554052|NCT02281136|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Manager of Clinical Research|9147608796|Anna.Houlihan@sunpharma.com|
20554053|NCT05402995|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20554054|NCT00205712|Washington University School of Medicine|John Newcomer, MD|314-362-3153|newcomerj@wustl.edu|
20554055|NCT02188485|University of Rochester|Kim Van Orden, PhD|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
20554056|NCT00685932|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbank, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
20554057|NCT00096044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20570055|NCT03459612|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20570056|NCT01251887|NIAAA/NIA|Ramsden, Christopher|+1 410 558 8369|ramsdence@mail.nih.gov|
20570057|NCT00566345|Ology Bioservices|Sr. Manager, Clinical & Regulatory Operations|386-418-8751|angie.kimbler@ologybio.com|
20570058|NCT03049306|Johns Hopkins University School of Medicine|Jonathan Jun|410-550-0115|jjun2@jhmi.edu|
20570059|NCT03151551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20570060|NCT01639742|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20570061|NCT02531867|Alexion|Medical Director|(781) 357-9900|clinicaltrials@alexion.com|
20570062|NCT01266018|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20570063|NCT02370251|University of Oklahoma|Kimberly Ernst, MD|405-271-5215|kimberly-ernst@ouhsc.edu|42039
20570064|NCT04120376|Children's Hospital of Philadelphia|Dr. Cynthia Mollen|2153701217|mollenc@chop.edu|
20570065|NCT02053610|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20570066|NCT03427060|Akari Therapeutics|Chief Scientific Officer|+44 208 004 0261|miles.nunn@akaritx.com|
20538798|NCT01735708|Butler Hospital|Lisa Uebelacker|401-455-6381|luebelacker@butler.org|
20538799|NCT00276094|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20538800|NCT02759315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538801|NCT01689350|School of Pharmaceutical Sciences, Sun Yat-sen University|Lingyan CHEN, Master candidate|+8615018706960|chlingy@mail2.sysu.edu.cn|
20538802|NCT01406015|Brigham and Women's Hospital|Dr. Rajesh K. Garg||RGARG@bwh.harvard.edu|
20538803|NCT00787137|PanGenetics UK Limited|John Powell|+441763257869|info@pangenetics.com|
20538804|NCT00985907|University of California, San Francisco|Dr. Thomas Martin, MD|(415) 353-9365|Tom.Martin@ucsf.edu|
20538805|NCT00130923|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5747|mary.f.brunette@hitchcock.org|
20538806|NCT00554099|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20538807|NCT02075632|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538808|NCT03840525|Florida International University|Dr. Gladys Ibanez|305-348-4920|gibanez@fiu.edu|
20538809|NCT03464422|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
20538810|NCT01370837|Maastricht University Medical Center|Kristy Pickwell|+31433877019|k.pickwell@mumc.nl|
20538811|NCT04240093|Brown University|Jaclyn White Hughto, PhD, MPH|401-863-6580|jaclyn_hughto@brown.edu|
20538812|NCT02839902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20538813|NCT01628367|University of Michigan|Dr. Hom-Lay Wang|734-647-6175|homlay@umich.edu|
20554058|NCT03149237|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
20554059|NCT02442830|UMass Medical School|Principal Investigator|(774) 442-4098|David.Cave@umassmemorial.org|
20554060|NCT04587193|Virginia Commonwealth University|Brian Berman|800-762-6161|brian.berman@vcuhealth.org|
20554061|NCT01552772|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20554062|NCT00895180|Sidney Kimmel Comprehensive Cancer Center|Dr. Jaishri Blakely|(410) 955-8893||
20554063|NCT03851016|University of Houston|Dr. Theresa C. Chrisman|713-447-3334|tkchrisman@comcast.net|
20554064|NCT03878134|NIH Clinical Center|Dr. Elizabeth Jones Chief, Radiology and Imaging Sciences|3012634853|ejones@cc.nih.gov|
20554065|NCT00853658|Novartis Pharmaceuticals|Study Director|862-778-8300||
20554066|NCT00586469|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554067|NCT03090256|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20554068|NCT01227512|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20554069|NCT04150224|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
20554070|NCT04055116|Geisinger|Gayatri Malik, MD|15702716355|gmalik1@geisinger.edu|
20554071|NCT02774681|Northwestern University|Massimo Cristofanilli, MD|312-503-5488|Massimo.cristofanilli@nm.org|
20554072|NCT01394926|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|Paulsherwin@ge.com|
20554073|NCT02556710|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20554074|NCT02139644|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20554075|NCT02192684|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
20554076|NCT03189914|Rexahn|Doug Swirsky/ Chief Executive Officer|12402685300|swirskyd@rexahn.com|
20554077|NCT01076400|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554078|NCT02080091|Alimera Sciences, Ltd.|Andrew Joyson - Associate Director, Clinical Operations Europe|+44 1252 354 026|Andrew.Joyson@alimerasciences.com|
20554079|NCT03143829|University of Central Floroda|Victoria Loerzel|407-823-0762|victoria.loerzel@ucf.edu|
20554080|NCT00158379|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
20554081|NCT02391948|University of Washington|Sarah Westcott McCoy PT, PhD, FAPTA|206-616-8601|westcs@uw.edu|
20554082|NCT02181530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20554083|NCT01353339|St Paul's Hospital|Dr. John S. Gill|604-806-8970|jgill@providencehealth.bc.ca|
20554084|NCT01529645|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20554085|NCT01326780|Valeant|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
20554086|NCT00274716|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554087|NCT01602315|Novartis Pharmaceuticals|Study Director|862-778-8300||
20554088|NCT04193202|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554089|NCT00593372|UAMS Medical Center|Gary McCullough|501-852-7886|garyhmccullough@uams.edu|
20554090|NCT00127790|Universityy of Rochester|Wilfred Pigeon, PhD|(585) 275-3374|wilfred_pigeon@urmc.rochester.edu|
20554091|NCT00975975|IndianaU|Dr. Robert Nelson|317-944-0920|ronelson@iu.edu|
20554092|NCT00961259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20554093|NCT00843791|OREGON HEALTH & SCIENCE UNIVERSITY|Dr. Jonathan Q Purnell|5034941056|purnellj@ohsu.edu|
20554094|NCT01252251|Memorial Sloan Kettering Cancer Center|Dr. Michael Postow, MD|646-888-4589|PostowM@mskcc.org|
20554095|NCT01324024|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
20554096|NCT05711069|Hacetepe University|Ceyda Sofuoğlu M.Sc.|+905338557742|ceyda_sofuoglu@hotmail.com|
20554097|NCT03755765|Department of Family Medicine, Georgetown University Medical Center|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu|
20554098|NCT03091751|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
20554099|NCT04455893|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
20554100|NCT01158222|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
20554101|NCT01161329|UppsalaU|Karin Hellström|+46184714762|karin.hellstrom@neuro.uu.se|
20554102|NCT00111228|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20554103|NCT00962429|Oregon Health and Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
20554104|NCT03161314|Physical Therapy Faculty, Mahidol University|Asst.Prof.Dr. Sunee Bovonsunthonchai|024415450|sunee.bov@mahidol.edu|20804
20554105|NCT02464969|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20554106|NCT00724451|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20507820|NCT01361919|St. Michael's Hospital|Dr. Paul Dorian|416-864-5104|dorianp@smh.ca|
20525853|NCT00940823|Prism Eye Institute|Dr. Iqbal Ike K. Ahmed|905-456-3937|ike.ahmed@utoronto.ca|
20554107|NCT01599650|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20554108|NCT00720876|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
20570067|NCT00781937|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20570068|NCT02431052|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20570069|NCT02094898|Mayo Clinic|William V. Bobo, M.D.|507-538-9041|Bobo.William@mayo.edu|
20570070|NCT03305809|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20570071|NCT04014790|REGiMMUNE|Chief Executive Officer|+81-80-7022-7536|kenzo@regimmune.com|
20570072|NCT00816556|Mayo Clinic|Maire Brid MacBride MB BCh|507-538-2271|MacBride.Maire@mayo.edu|
20570073|NCT03065933|McLean Hospital|Elizabeth S. Liebson, M.D.|617-855-2284|eliebson@partners.org|
20538814|NCT03353922|Neurana Pharmaceuticals|Judy Caron, Chief Operating Officer|(617) 640-5043|jcaron@neuranapharma.com|
20538815|NCT00740714|Weill Medical College of Cornell University|M. Flint Beal, MD|212-746-6575|fbeal@med.cornell.edu|
20538816|NCT03688555|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
20538817|NCT00612508|Women's Health Research Unit|Oregon Health & Science University|503-494-3666|whru@ohsu.edu|
20538818|NCT02008357|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20538819|NCT05044104|Mayo Clinic|Dr. Vinay Chandrasekhara|207-284-2687|Chandrasekhara.Vinay@mayo.edu|
20538820|NCT01442064|Genentech|Genentech||ctg-post-d@gene.com|
20538821|NCT02312219|Mass General Hospital|Ahmed Tawakol, MD|617-726-0791|atawakol@mgh.harvard.edu|
20538822|NCT02153346|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538823|NCT00957333|WanFangH|Ruei-Ming Chen|02-27361661|rmchen@tmu.edu.tw|3222
20538824|NCT00858897|Nemours Children's Clinic|Dr. Dominique Darmaun|904-697-3863|ddarmaun@nemours.org|
20538825|NCT03697993|Vaccine Treatment Evaluation Unit (VTEU)|Nadine Rouphael, MD, MSc|(404) 822-1411|nroupha@emory.edu|
20538826|NCT02248740|Virginia Commonwealth Univeristy|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
20538827|NCT03582813|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
20538828|NCT01048866|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
20538829|NCT04765644|Imperial College London|Dr Ricky Vaja|020 7589 5111|r.vaja@imperial.ac.uk|
20538830|NCT02366767|Stanford School of Medicine|Bruce Buckingham|650-725-9549|buckingham@stanford.edu|
20538831|NCT00579995|University of Nebraska Medical Center|Scott Shurmur, M.D.|402-559-6463|sshurmur@unmc.edu|
20538832|NCT01258153|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it|
20538833|NCT02230683|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20538834|NCT00456599|University of Michigan|Mark Zalupski, MD|734-615-3969|zalupski@med.umich.edu|
20538835|NCT00260065|Eisai Inc.|Eisai Call Center|888-422-4743||
20538836|NCT02410577|Memorial Sloan Kettering Cancer Center|Dr. Joseph Osborne, MD, PhD|212-639-7788|osbornej@mskcc.org|
20538837|NCT04573881|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
20538838|NCT00664326|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20538839|NCT03809910|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20538840|NCT04787055|Sonova US Corporate Services, LLC|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20538841|NCT03647267|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
20538842|NCT05079477|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
20538843|NCT04948307|Orexo US, Inc.|David Capano|9085079909|david.capano@orexo.com|
20538844|NCT00734071|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20538845|NCT03654885|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20538846|NCT02384434|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20538847|NCT05264116|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
20538848|NCT06034652|Integra LifeSciences Corporation|Andrew Tummon, Director, Global Clinical Operations|609-936-5490|andrew.tummon@integralife.com|
20538849|NCT00583791|Abbott|Maren Wagner|6517565585|maren.wagner@abbott.com|
20538850|NCT00203021|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20538851|NCT01330966|George Clinical|Lindsey Munn|901-350-8801|lmunn@georgeclinical.com|
20538852|NCT02080260|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20538853|NCT03204890|Boston Medical Group|Dr. José Pablo Saffon|+573208899777|jsaffon@bostonmedical.com.co|
20538854|NCT03769311|University of Wisconsin Carbone Cancer Center|Justine Bruce, MD|608-262-4961|jybruce@medicine.wisc.edu|
20538855|NCT02853435|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20538856|NCT03627065|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20538857|NCT04562597|Medical University of South Carolina|Dr. Sylvia Wilson|843-792-2322|wilsosh@musc.edu|
20538858|NCT00996801|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clincaltrialsdisclosure@merck.com|
20538859|NCT00289198|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538860|NCT04172467|Hematology Oncology Kaiserslautern|Prof. Hartmut Link|0631|praxis-link@kabelmail.de|3503709
20538861|NCT03369431|University College London|Susan Simmons|+44 7952961881|susan.simmons.16@ucl.ac.uk|
20538862|NCT01062061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538863|NCT00524589|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20538864|NCT00490776|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20538865|NCT00046930|ECOG Statistical Office|Study Statistician|617-632-3012||
20538866|NCT01657760|Harbor-UCLA Department of Psychiatry|Todd Zorick|310-781-3400|tzorick@mednet.ucla.edu|
20538867|NCT01694108|Rigshospitalet|Lone Graff Stensballe, Research leader, Pediatrician, PhD|+0045 35459727|lone.graff.stensballe@regionh.dk|
20538868|NCT02506660|Hospital of Special Surgery|Dr. Richard Kahn|212-774-7274|KahnR@HSS.EDU|
20538869|NCT02151331|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
20554109|NCT03304379|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20554110|NCT02873104|Cutera|Lourdes Moldre, NP|415-971-5118|lmoldre@cutera.com|
20538870|NCT01113580|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20538871|NCT06687824|Manipal University College Malaysia|Heng Sy Xuan|+601110752589|hengsyxuan@hotmail.com|
20554111|NCT03402243|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20538872|NCT01145053|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20538873|NCT01146652|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20538874|NCT03294135|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20538875|NCT03523273|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
20538876|NCT00273754|University of Texas Medical School/ Houston|Samia Khalil, M.D./ Professor|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
20538877|NCT02763254|Cell Medica|Dr. Kurt Gunter (Chief Medical Officer)|832-581-4480|Kurt.Gunter@cellmedica.com|
20538878|NCT02963987|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
20538879|NCT03684304|University Hospitals|University Hospitals|216-844-1000|info@uhhospitals.org|
20538880|NCT01146288|Rabin Medical Center|Dr Boris Zingerman||borisz@clalit.org.il|
20538881|NCT00353431|Intern Medicine Solothurn, Switzerland|Robert Thomann, MD|+41326274501|endodiab.bss@bluewin.ch|
20538882|NCT00706329|Children's Hospital Boston and South Shore Hospital|Dr. Neil Feins|6173556915||
20538883|NCT03532932|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20538884|NCT02255565|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
20538885|NCT00931801|Community Research Initiative of New England|Calvin J. Cohen MD, MSc, Director of Research|617-502-1700|ccohen@crine.org|
20538886|NCT01174004|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
20538887|NCT00933244|University of Wisconsin - School of Medicine & Public Health|Dr. Karen E Hansen|608-265-8162|keh@medicine.wisc.edu|
20538888|NCT02227836|Mayo Clinic|Karthik Ravi, MD|507-284-4824|Ravi.Karthik@mayo.edu|
20538889|NCT02944565|The Ohio State University Comprehensive Cancer Center|Hallie Barr, PharmD BCOP|614-685-5803|Hallie.Barr@osumc.edu|
20538890|NCT02956850|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20538891|NCT01920152|University of Colorado, Denver|Omer Mei-Dan, MD|3033159900|omer.meidan@cuanschutz.edu|
20538892|NCT02165462|Universidad Católica San Antonio de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
20538893|NCT00183963|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|Victoria.Soto@med.usc.edu|
20538894|NCT00886119|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20538895|NCT00394901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20538896|NCT03002623|National Cancer Institute|Dr. Naris Nilubol|301- 451-2355|niluboln@nih.gov|
20538897|NCT02256267|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20538898|NCT05260333|Baylor College of Medicine|Dr. Leah Antoniewicz, MD-PI|832-8267458|leah.antoniewicz@bcm.edu|
20538899|NCT00462735|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
20538900|NCT00376805|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
20538901|NCT01352741|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223||
20538902|NCT00259298|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20538903|NCT00645528|Hunter Holmes McGuire VA Medical Center|Sonja K Fredrickson, MD|804-675-5151|sonja.fredrickson@va.gov|
20538904|NCT05445206|Analog Devices, Inc.|Emily Wycallis|9784351644|emily.wycallis@analog.com|
20538905|NCT03131596|Fuxing Hospital, Capital Medical University, Beijing, China|Dr. Shi Xiaoyu|+86 18618496384|petershi1990@163.com|
20538906|NCT01838785|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
20538907|NCT04332614|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20538908|NCT00004445|Louis Stokes Cleveland VAMC|Lisa Lombardo, MPT|216-791-3800|lisa.lombardo2@va.gov|4909
20538909|NCT02753127|Sumitomo Dainippon Pharma Oncology|Keiichi Saito|+1 (617)674-6800|keiichi.saito@SDPOncology.com|
20538910|NCT00940485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20538911|NCT02936284|Children's Mercy Hospital, Kansas University|Kai Ling Kong, PhD|816-731-7239|kkong@cmh.edu|
20538912|NCT04912895|Emory University|Larry Anderson, MD|404-727-1746|larry.anderson@emory.edu|
20538913|NCT03859739|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538914|NCT02088073|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20538915|NCT02785458|Northwestern University|Dr. Michael S. Wolf, PhD MPH|312-503-5592|mswolf@northwestern.edu|
20525854|NCT01082211|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20525855|NCT04999163|Procyrion, Inc.|Sr. Director, Clinical Affairs|650-208-1118|tami@procyrion.com|
20525856|NCT00811317|Massachusetts General Hospital|Steven Russell|6177261848|sjrussell@mgh.harvard.edu|
20525857|NCT01168908|Kennedy Krieger Institute|Kathryn Wagner, MD, PhD|443-923-9525|wagnerk@kennedykrieger.org|
20525858|NCT01275755|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20525859|NCT03653351|Washington University in Saint Louis|Eric Lenze MD|314-362-5154|lenzee@wustl.edu|
20525860|NCT00174967|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20525861|NCT04420585|Montefiore Medical Center|Dr. Kerry Morrone|718-741-2342|kmorrone@montefiore.org|
20525862|NCT00477750|Mayo Clinic|Dr. Vivek Roy||roy.vivek@mayo.edu|
20525863|NCT03558152|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20538916|NCT00733135|Covidien|Director of Medical Communications|763-591-3047|jean.ahlstrom@covidien.com|
20525864|NCT00601172|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525865|NCT02219581|Emory University|Thomas L. Bradbury, MD|404-759-3912|tombradburymd@gmail.com|
20525866|NCT04434469|Genetech|Medical Communications|800-821-8590|genentech@druginfo.com|
20538917|NCT02981524|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
20538918|NCT00520013|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
20538919|NCT02118597|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20538920|NCT02499692|The General Hospital of ShenYang Military|Dr Hanyaling|02428851876|hanyl@medmail.com.cn|
20538921|NCT02590562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20538922|NCT00824005|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
20538923|NCT02677844|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20538924|NCT03458702|Texas Tech University|Dr. Jacalyn McComb|806-834-6306|jacalyn.mccomb@ttu.edu|
20538925|NCT01697462|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20538926|NCT00168103|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
20538927|NCT00545532|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20538928|NCT03630302|Abbott neuromodulation|Erika Ross|972-526-8207|erika.ross@abbott.com|
20538929|NCT05268744|UCSF|Dr. Robert Hendren|(415) 476-7500|robert.hendren@ucsf.edu|
20538930|NCT01133275|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
20538931|NCT01143896|Michael E. DeBakey VA Medical Center|Fasiha Kanwal, MD, MSHS|(713) 440-4495|Fasiha.Kanwal@va.gov|
20538932|NCT01318070|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20538933|NCT01556061|University of Texas at Houston Medical School/ Dept. of Anesthesiology|Dr. Davide Cattano MD PhD|713-500-6235|davide.cattano@uth.tmc.edu|
20538934|NCT04375397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20507821|NCT03001843|University of Florida|Joshua Sappenfield, MD|352-273-5259|jsappenfield@anest.ufl.edu|
20538935|NCT02568449|Karmanos Cancer Instiute|Dr. Dipesh Uprety|313-576-8722|upretyd@karmanos.org|
20538936|NCT05545644|University of New Mexico|Dr. Barbara McCrady|505-925-2388|bmccrady@unm.edu|
20538937|NCT00610441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20538938|NCT05810714|The Ohio State University Comprehensive Cancer Center|Dr. Mira Katz|614-293-6603|Mira.katz@osumc.edu|
20538939|NCT00334282|GlaxoSmithKline|GSK Response Center|866-435-7343||
20538940|NCT00506597|The University of Texas (UT) MD Anderson Cancer Center|Robert J. Wells, MD / Professor||CR_Study_Registration@mdanderson.org|
20538941|NCT05242354|Biruni University|Dr Mustafa YILMAZ|+90 533 7129952|myilmaz@biruni.edu.tr|
20538942|NCT01511809|Ospedale San Raffaele|Dr. Antonella Castagna|00390226437934|castagna.antonella1@hsr.it|
20538943|NCT04957758|Oyster Point Pharma Inc|Marian Macsai, MD|312-259-2477|mmacsai@oysterpointrx.com|
20538944|NCT01685983|Janssen R&D BE|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20538945|NCT00686842|AMC|Susan Krown, MD, Protocol Chair|301-251-1161|amcpm@emmes.com|
20538946|NCT03035773|Johns Hopkins School of Public Health/SKCCC|Dr. Katherine C. Smith|443.927.3350|ksmit103@jhu.edu|
20538947|NCT02818114|Minneapolis VA Health Care System|J. Irene Harris|612-467-1654|jeanette.harris2@va.gov|
20538948|NCT01335750|Erdy/Searcy Group|Dr. Gary Andrasko, MS|(614) 459-3363|gandrask@columbus.rr.com|
20538949|NCT01167907|Wake Forest School of Medicine|Robert S. Weller, MD|336-716-7150|rweller@wakehealth.edu|
20507822|NCT01681576|Novartis|Study Director|862-778-8300||
20538950|NCT05182580|Orbis International|Dr. Nathan Congdon, Director of Research|646-674-5514|ncongdon1@gmail.com|
20538951|NCT01886690|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20538952|NCT02916407|Inje University, Haeundae Paik hospital|Dr Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
20538953|NCT03077698|Xenetic Biosciences Inc|Dr. Curtis Lockshin|781-778-7720|info@xeneticbio.com|
20507823|NCT01770691|ConTIPI LTD.|Dr. Elan Ziv|972-4-627-6066|eziv@contipi.com|
20538954|NCT03461406|Instituto Grifols, S.A.|Sandra Camprubi Gimenez|+34670923160|sandra.camprubi@grifols.com|
20507824|NCT03543358|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20538955|NCT01140568|UCSD - Moores Cancer Center|Lara Rose|858-822-6575|ljrose@ucsd.edu|
20538956|NCT03618628|Washington University School of Medicine|Dr. Mary Hastings|3142861433|hastingsmk@wustl.edu|
20538957|NCT01969500|University of Washington|Dror Ben-Zeev|(206) 685-9655|dbenzeev@uw.edu|
20507825|NCT00178464|St. Christopher's Hospital for Children|Dr. Norma B. Lerner|215 427-5261|norma.lerner@drexelmed.edu|
20538958|NCT01893359|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
20538959|NCT01873729|Pediatric Psychopharmacology at Massachusetts General Hospital|Dr. Thomas Spencer|6177243883|tspencer@partners.org|
20507826|NCT04111107|Tulane University|Stefan Grant, MD|504-988-5800|sgrant6@tulane.edu|
20538960|NCT02463032|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
20538961|NCT01741532|ApoPharma Inc.|Caroline Fradette|416-401-7543|cfradett@apopharma.com|
20538962|NCT01066780|Advanced Bionics, LLC|Kenneth Ripley, Director of Clinical Research|1.661.362.1400|clinical.research@advancedbionics.com|
20507827|NCT03956225|Alcon Research, LLC|Sr. CDMA Project Lead, Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
20507828|NCT02260648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20507829|NCT00321269|Iowa City VA Health Care System|Carolyn Turvey|319 338 0581|Carolyn-Turvey@uiowa.edu|7714
20538963|NCT00613080|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
20507830|NCT00805545|University of Florida|Patrick Duff, M.D.|352 273 7673|duffp@ufl.edu|
20507831|NCT01606735|Icon Bioscience, Inc|Wendy Murahashi, MD|6503694049|wendymurahashi@iconbioscience.com|
20507832|NCT00413335|Yale University School of Medicine|Dr. Sonia Caprio, Principal Investigator|203-785-5692|Sonia.Caprio@yale.edu|
20507833|NCT05128682|Beaumont Hosptials|Jennifer Giordano CRM|248-551-3517|jennifer.giordano@corewellhealth.org|
20507834|NCT02995330|Johns Hopkins University|"Dr. Samuel R. Denmeade Professor of Oncology| Director Genitourinary Oncology"|410-502-8341|DENMESA@jhmi.edu|
20507835|NCT05515952|University of Arizona|Lisbeth Haaheim|520-626-7755|lhaaheim@arizona.edu|
20507836|NCT03095053|Antalya IVF|Kevin Coetzee|090 530 764 3135|kevincoetzee61@yahoo.co.nz|
20507837|NCT01054976|Jan-Cil Korea|Business Unit Director|82 2 2094-4537||
20538964|NCT02360293|VA ORD|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
20538965|NCT02226549|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20554112|NCT01121211|Massachusetts General Hospital|Dr. Anne Klibanski|6177263870|aklibanski@partners.org|
20507838|NCT01641991|Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center|David Bernstein, MD, MA|513-636-7625|david.bernstein@cchmc.org|
20538966|NCT04983797|Biosense Webster, Inc.|Associate Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20554113|NCT01649856|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20554114|NCT00179647|Celgene Corporation|Robert D. Knight, M.D.|908-673-9749|rknight@celgene.com|
20554115|NCT00622635|Novartis Pharmaceuticals|Study Director|862 778-8300||
20554116|NCT00281840|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
20554117|NCT00835406|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20554118|NCT00733343|Department of Cardiology, Imperial College London, Dovehouse St., London SW3 6LY, United Kingdom|Martin R. Cowie, MD|+44 (0)20 7589 0|m.cowie@imperial.ac.uk|5111
20554119|NCT02138214|University of Wisconsin, Madison|Dr. Rebecca Sippel|608-263-1387|sippel@surgery.wisc.edu|
20554120|NCT02185768|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20554121|NCT03383588|Montefiore Medical Center|Dr Catherine Igel|718-405-8200|cigel@montefiore.org|
20554122|NCT04524962|Cartesian Therapeutics, Inc.|Hafsa Kamboh|4127585340|hafsa@cartesiantx.com|
20554123|NCT02550652|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
20554124|NCT03027466|National Cancer Institute|William Klein|2402766972|kleinwm@mail.nih.gov|
20554125|NCT02158039|Mayo Clinic|Dr. Mark Topazian|507-284-7602|topazian.mark@mayo.edu|
20554126|NCT01196871|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20554127|NCT01744730|Duke Clinical Research Institute, Duke University School of Medicine|Kevin Watt, MD|919-668-8556|kevin.watt@dm.duke.edu|
20554128|NCT03062891|University of Notre Dame|Dan Denis|6178066484|ddenis@nd.edu|
20554129|NCT03678181|University of Pennsylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
20525867|NCT01579045|Vistakon/Johnson & Johnson Vision Care|Katherine Osborn Lorenz, OD MS|904-443-3123|kosborn@its.jnj.com|
20554130|NCT00333606|Ernst Moritz Arndt University of Greifswald|Taras Usichenko, director of the trial|+493834865828|taras@uni-greifswald.de|
20554131|NCT01079234|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20525868|NCT00840307|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20554132|NCT01037790|University of Pennsylvania|Jennifer Louie, Program Manager|267-414-6179|Jennifer.Louie2@pennmedicine.upenn.edu|
20554133|NCT01485601|Medytox Inc.|Young Ryu|+82-2-6901-5890|young.ryu@medytox.com|
20554134|NCT03509948|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20554135|NCT03221257|University of California, Los Angeles|Dr. Michael D. Roth|3102067389|mroth@mednet.ucla.edu|
20554136|NCT02047604|Valeant Pharmaceuticals|VP Clinical Services|9089271162|christine.hnatko@valeant.com|
20554137|NCT02517905|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20554138|NCT04114058|Cedar Sinai -Kerlan Jobe|Dr. Michael Banffy|(310) 665-7200|Michael.Banffy@cskerlanjobe.org|
20554139|NCT01994395|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
20554140|NCT02710526|Braeburn Inc|Sonnie Kim|6104678718|sonnie@braeburnrx.com|
20554141|NCT01940705|VA RR&D National Center for Rehabilitative Auditory Research|Gabrielle Saunders, PhD|503-220-8262|Gabrielle.Saunders@va.gov|56210
20554142|NCT00459134|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20525869|NCT04184362|SFVA|Joannalyn Delacruz, Ph.D.|415-375-5748|Joannalyn.Delacruz@va.gov|
20507839|NCT05055570|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Dr. Jun Ma|13370103671|majun@mail.ccmu.edu.cn|
20507840|NCT02396342|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20525870|NCT01470651|New York State Psychiatric Institute-Research Foundation for Mental Hygene|Judith Rabkin|646-774-8075|jgr1@cumc.columbia.edu|
20525871|NCT01936181|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
20525872|NCT00900757|Duke University Medical Center|Mary Lou Affronti|919-684-6239|mary.affronti@dm.duke.edu|
20525873|NCT02064270|University of Missouri, Department of Orthopaedic Surgery|Stacee Clawson, Research Manager|5738849017|clawsons@health.missouri.edu|
20525874|NCT01949844|Cedars-Sinai Medical Center|Dr. Behzad Sharif, Assistant Professor|310-423-7758||
20525875|NCT00823069|Medicis|Mary Sanstead|480-291-5926|msanstead@medicis.com|
20525876|NCT00712881|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20525877|NCT02879617|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Specialist Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20525878|NCT02222545|Omeros Corporation|Clinical Trial Manager|(206) 676-5000|ctinfo@omeros.com|
20525879|NCT02651155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20525880|NCT00537316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20525881|NCT04533412|Icahn School of Medicine at Mount Sinai|Alex D. Federman, MD, MPH|(212) 824-7565|alex.federman@mountsinai.org|
20538967|NCT03099148|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20538968|NCT01269385|Mayo Clinic|Stephen M. Ansell MD||Ansell.Stephen@mayo.edu|
20507841|NCT01164865|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
20538969|NCT01842594|Shin Kong Wu Ho-Su Memorial Hospital|Kwan-Hwa Chi|+886-28332211|M006565@ms.skh.org.tw|2612
20538970|NCT02741570|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20507842|NCT00750165|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|cpaptrial@fphcare.co.nz|7044
20507843|NCT00599027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507844|NCT00171314|Novartis Pharamaceuticals|Novartis Pharmaceuticals|862-778-8300||
20507845|NCT00475540|MedStar Health Research Institute|Allie Moses, Manager, Clinical Research Systems and Recruitment Center|301-560-7353|Allison.E.Moses@MedStar.net|
20507846|NCT00377429|Fresenius Biotech|Anne Kuan|781 699 4618|anne.kuan@fresenius-biotech.com|
20507847|NCT02618343|UT Health San Antonio|David Wampler, PhD, LP|210-414-9548|wamplerd@uthscsa.edu|
20507848|NCT02394795|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20507849|NCT05202223|University of Kentucky|Dr. Elizabeth Rhodus|859-257-5562|elizabeth.rhodus@uky.edu|
20507850|NCT02939599|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20538971|NCT01498185|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20507851|NCT01669811|Clinical Statistics & Programming Department, Clinical Science Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
20538972|NCT00946322|Trauma Recovery Center, Cincinnati VA Medical Center|Jeremiah A. Schumm, PhD, Associate Director|859-572-6717|Jeremiah.Schumm@va.gov|
20507852|NCT03337139|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
20538973|NCT01710527|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507853|NCT03288493|Poseida Therapeutics|Rajesh Belani, MD, Vice President Clinical Development|858-779-3100|rbelani@poseida.com|
20538974|NCT01075971|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20507854|NCT01871896|University of California San Francisco|Matthew Lin|415 353 2161|Matthew.Lin@ucsf.edu|
20507855|NCT02415439|ReveraGen BioPharma, Inc.|Eric P. Hoffman, PhD|301-962-1578|eric.hoffman@reveragen.com|
20507856|NCT02373371|CHU de Limoges|Project Manager|0555058616|abdeslam.bentaleb@chu-limoges.fr|+33
20538975|NCT02367391|Penn State College of Medicine|Project Coordinator|7175310003|jyingst@phs.psu.edu|289511
20507857|NCT00453180|Cincinnati Childrens Hospital|Craig Erickson|513-636-6258|craig.erickson@cchmc.org|
20538976|NCT01688921|PharmaJet, Inc.|Tara Miller, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
20538977|NCT00884910|Netherlands Cancer Institute|Prof Dr FJM Hilgers|+31 20 512 2550|f.hilgers@nki.nl|
20507858|NCT03380026|Rochester Skin Lymphoma Medical Group|Clinical Research Coordinator|(585)364-1188|scarroll@roclymphoma.com|
20538978|NCT01213823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507859|NCT00562640|Memorial Sloan Kettering Cancer Center|Dr. Roisin O'Cearbhaill, MD|646-888-4227|ocearbhr@mskcc.org|
20538979|NCT04384107|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507860|NCT01412151|Massachusetts General Hospital|Steven M. Hersch, MD, PhD|617-726-1254|hersch@helix.mgh.harvard.edu|
20507861|NCT03127852|Centre for Global eHealth Innovation|Dr. Patrick Ware|1 (416) 340 4800|Patrick.Ware@uhn.ca|4765
20538980|NCT00459537|Novartis Pharmaceuticals|Study Director|862 778-8300||
20507862|NCT01824693|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20507863|NCT02150213|Novartis|Study Director|862-778-8300||
20507864|NCT00656084|New York Oncology Hematology|Dr. Lawrence E. Garbo|(518) 489-0044|Lawrence.Garbo@usoncology.com|
20507865|NCT01184456|AIDS Healthcare Foundation - Public Health Division|Adam Sukhija-Cohen|(323) 436-8900|adam.cohen@aidshealth.org|
20538981|NCT04559022|UT Southwestern|Research Coordinator|2146458907|jennifer.barillas@utsouthwestern.edu|
20507866|NCT00525785|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|jajani@mdanderson.org|
20525882|NCT05113979|OnPointVision|Lynne Archer|949-749-4170|larcher@onpoint-vision.com|
20525883|NCT02048826|University of California at Irvine|Prof. David Reinkensmeyer|949-824-5218|dreinken@uci.edu|
20554143|NCT00829621|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
20554144|NCT01755416|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
20507867|NCT04150562|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
20507868|NCT01306032|National Cancer Institute|Dr. Alice Chen|301-435-0517|chenali@mail.nih.gov|
20554145|NCT01976845|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Dr. Ronald H Wender|3104231682|ronald.wender@cshs.org|
20507869|NCT00835003|Aarhus University Hospital, Dep. Obstetrics and Gynecology, Aarhus, Denmark|MD, PhD Julie Glavind|+4578450000|julie.glavind@dadlnet.dk|
20554146|NCT05419947|Instituto de Investigación Biomédica de Salamanca (IBSAL)|Dr. Luis Muñoz Bellvís|0034 923 29 11 00|luismb@usal.es|
20554147|NCT01157533|The University of Texas (UT) MD Anderson Cancer Center|Ara Vaporciyan, MD, BS/ Professor||CR_Study_Registration@mdanderson.org|
20507870|NCT03859960|Fatih Sultan Mehmet Education and Research Hospital|MD. Arzu Atici|+905335621208|arzususinatici@gmail.com|
20554148|NCT00441337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20525884|NCT01098500|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554149|NCT03655236|Sun Pharma Advanced Research Company Limited|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
20554150|NCT03042312|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20554151|NCT01856140|Seoul National University College of Medicine|Dr. Sang Yoon Lee|028702673|rehabilee@gmail.com|
20554152|NCT04258839|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20554153|NCT02293005|UT MD Anderson Cancer Center|Dr. Anne Tsao, MD- VP, Academic Affairs, CAO Office|(713) 792-6363|astsao@mdanderson.org|
20554154|NCT04331366|Emory University|Jeffery Miller, MD|404-778-7200|jeffrey.miller@emory.edu|
20554155|NCT01043874|Novartis Pharmaceuticals|Study Director|862-778-8300||
20554156|NCT02277626|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
20554157|NCT02648698|Department of Hysteroscopic Centre, Fuxing Hospital, the Eighth Clinical Medical College, Capital Medical University, Beijing, China|Dr. Dongmei Song|13651294056|echosdm@163.com|86
20554158|NCT00966940|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
20554159|NCT01774903|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
20554160|NCT00924950|UCSF|Tina Bhutani|4154763396|tinabhutanimd@gmail.com|
20554161|NCT00982319|Sidney Kimmel Comprehensive Cancer Center|Dr. Kala Visvanathan|410-614-1112|kvisvan1@jhu.edu|
20554162|NCT03779997|University of Washington|Judith I. Tsui|206-744-1835|tsuij@uw.edu|
20554163|NCT03603964|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20554164|NCT00563797|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
20554165|NCT00530023|Director, Program Management, Clinical Research|Harold Torunsky|8185765445|harold.torunsky@medtronic.com|
20554166|NCT00982189|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
20554167|NCT02863354|Retina Consultants of Houston|Dr. Charles C. Wykoff|713-524-3434|ccwmd@houstonretina.com|
20554168|NCT01591746|Mayo Clinic|Dr. Valerie Lemaine, MD, MPH|507-284-2736|lemaine.valerie17@gmail.com|
20554169|NCT01611571|Columbia University Medical Center|Marcella Walker MD|212-342-5351|mad2037@columbia.edu|
20554170|NCT05051241|Zhejiang GenFleet Therapeutics Inc.|Yuting Peng|+86 21 6882 1388|ytpeng@genfleet.com|
20554171|NCT00286949|Michael E. DeBakey VA Medical Center|Laura Marsh, M.D., Principal Investigator|713-794-8907|laura.marsh2@va.gov|
20554172|NCT01298063|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554173|NCT04632940|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-094DMDStudy@fibrogen.com|
20554174|NCT02737566|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
20554175|NCT05038137|Medical University of South Carolina|Dr. Karanchi|(843) 792-2529|karanchi@musc.edu|
20525885|NCT03452488|Biophytis S.A.|Cendrine Tourette|+331 44 27 33 00|cendrine.tourette@biophytis.com|
20525886|NCT04016779|Supernus|Joseph Hull, Ph.D., Director Clinical research|240-403-5324|jhull@supernus.com|
20525887|NCT00330343|JHU|Myron Yaster|9552393|myaster1@jhmi.edu|
20525888|NCT00281632|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525889|NCT06586788|Indiana School of Medicine|Dr. Rebecca McNally Keehn|(317) 274-2121|mcnallyr@iu.edu|
20525890|NCT02691936|Cleveland Clinic Foundation|Dr. Marie Fidela Paraiso|216-444-3428|PARAISM@ccf.org|
20525891|NCT01876784|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20525892|NCT01878084|Alexandria University|Prof. Mona K. Marei|002-03-4858353|mona.marei@gmail.com|
20525893|NCT00749684|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20525894|NCT03696108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525895|NCT02643849|SRS Medical|Director of Clinical Trials|800-345-5642|info@srsmedical.com|
20525896|NCT05239494|University of Alabama at Birmingham|Andrew Pucker, OD, PhD|920-579-2900|andrewpucker@hotmail.com|
20525897|NCT04798989|Tisento Therapeutics|Clinical Research|1-857-259-5371|hello@tisentotx.com|
20525898|NCT02581475|Shandong University Qilu Hospital|Dr. Yanqing Li|+86-531-82169236|liyanqing@sdu.edu.cn|
20525899|NCT02737631|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20525900|NCT04603482|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
20525901|NCT00732758|Children's Hospital of Pittsburgh|Kumaravel Rajakumar|412-692-5822|rajakumark@upmc.edu|
20525902|NCT03382834|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|3016283313|ACTGCT.Gov@s-3.com|
20525903|NCT02693171|United Therapeutics Corp.|Odette Jordan, MD, PMP|919-425-5606|ojordan@unither.com|
20525904|NCT01167881|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20525905|NCT01992653|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20525906|NCT00977314|Sonitus Medical, Inc.|Clinical Trials Manager|8668162076|lily@sonitusmedical.com|
20525907|NCT02107859|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20525908|NCT01303406|National Hospital for Neurology and Neurosurgery|Dr Paola Giunti|020 3448 3141|violet.le-fevre@uclh.nhs.uk|
20525909|NCT02344251|MUSC|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
20525910|NCT00671528|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20525911|NCT03767153|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
20525912|NCT00556933|Wright State University, Dayton, Ohio|R. Brian Stevens, MD, PhD|937-545-4817|rbstevens1@icloud.com|
20525913|NCT03887442|TTCC Grupo Español de Tratamiento de Tumores de Cabeza y Cuello|Carmen Montalbán, Manager|+34676154172|ttccmanager@yahoo.com|
20525914|NCT06343467|TRIA Orthopedic Center|Megan Reams; Director of Orthopaedic Research|(952) 806-5329|megan.reams@tria.com|
20525915|NCT00022698|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20525916|NCT03318497|UT Southwestern Medical Center|Kelli Key, PhD|214-648-8152|Kelli.Key@UTSouthwestern.edu|
20525917|NCT01628198|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20525918|NCT01743560|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20525919|NCT03425396|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20525920|NCT03033602|VA Boston Healthcare System & Boston University School of Medicine|Dr. Denise Sloan, Professor of Psychiatry|857-364-6333|dsloan@bu.edu|
20525921|NCT01441765|Beth Israel Deaconess Medical Center|Dr. David Avigan, Principal Investigator|617-667-9920|davigan@bidmc.harvard.edu|
20525922|NCT00170625|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
20525923|NCT03527264|Brown Oncology Research Group|Don S. Dizon, MD|4018633000|BrUOG@Brown.edu|
20525924|NCT00784550|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525925|NCT00743288|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
20525926|NCT00688701|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20525927|NCT00029536|Beth Israel Deaconess Medical Center|Dr. Andrew G. Herzog|781-431-0277|aherzog@bidmc.harvard.edu|
20525928|NCT02715700|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20525929|NCT01346189|University of Pennsylvania and Department of Veteran Affairs|Dr. Kevin G. Volpp||volpp70@wharton.upenn.edu|
20525930|NCT00697541|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20525931|NCT03320850|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20525932|NCT00068367|SWOG Statistical Center|Study Statistician|206-667-4623|sarcoma@crab.org|
20525933|NCT03781583|University of Michigan Medical School|James Weiland|734-764-9793|weiland@umich.edu|
20525934|NCT01938430|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20525935|NCT00976820|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525936|NCT00968981|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20525937|NCT02233296|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20525938|NCT01489254|Synthon BV|VP Clinical Development|+3124727700|clinicaltrials@synthon.com|
20525939|NCT02233101|Rush University Medical Center|Craig J. Della Valle, MD|312-432-2350|craigdellavalle@rushortho.com|
20525940|NCT01302444|Rhode Island Hospital|James R Klinger, MD||jklinger@lifespan.org|
20525941|NCT01194531|Natera (formerly Gene Security Network)|Nina Wemmer, MS,CGC, Study Coordinator|650-249-9090|nwemmer@natera.com|
20525942|NCT03891862|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20525943|NCT02822573|Wake Forest NCORP Research Base|Lead Biostatistician (Emily Dressler, PhD)|336-716-0891|NCORP@wakehealth.edu|
20525944|NCT01053962|Synergy Pharmaceuticals Inc|Dr. Laura Barrow/Senior Vice President Clinical Development|212-297-0020|lbarrow@synergypharma.com|
20525945|NCT04143594|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20525946|NCT00308087|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
20525947|NCT01044290|HSRD, Durham VAMC|Karen Steinhauser, PhD|919 668-2148|karen.steinhauser@duke.edu|
20525948|NCT04323306|MMV|Benoit Bestgen|+41 79 765 18 68|bestgenb@mmv.org|
20525949|NCT01878812|GlaxoSmithKline|GSK Response Center|866-435-7343||
20525950|NCT01646021|Janssen-Cilag International NV|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20525951|NCT00438100|The University of Tokyo|Tempei Miyaji|+81-3-5800-9086|tmiyaji@m.u-tokyo.ac.jp|
20538982|NCT02218593|Nemours Children's Health|Director of Clinical Trials|4076507652|kristen.gibbs@nemours.org|
20538983|NCT00528996|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20538984|NCT01307462|FHCRC|Guang-Shing Cheng MD|206-667-7074|gcheng2@fhcrc.org|
20538985|NCT02831933|Houston Methodist Neal Cancer Center|Eric Bernicker|713.790.3333|ccresearch@houstonmethodist.org|
20538986|NCT03875664|Atrium Health|Dr. Sarah Evans|704-304-1660|sarah.evans@atriumhealth.org|
20538987|NCT04129411|Mayo Clinic|Dr. Marius Stan|507-284-2463|stan.marius@mayo.edu|
20538988|NCT05065190|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20538989|NCT02943915|Moss Rehabilitation Research Institute, Elkins Park, PA, USA|Dylan Edwards|215-663-6554|dylan.edwards@jefferson.edu|
20538990|NCT04973696|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Dr. Ana-Maria Vranceanu|617-724-4977|avranceanu@mgh.harvard.edu|
20554176|NCT02181231|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
20554177|NCT02520531|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
20554178|NCT02442700|Ramathibodi Hospital, Mahidol University|Asita Wongprikorn, MD|664236949|wongprikorn@yahoo.com|
20554179|NCT01723904|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20554180|NCT00752908|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20554181|NCT00059475|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-6375|nciirbadmin@mail.nih.gov|
20554182|NCT00887341|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20554183|NCT02015234|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|212 980 9155|greg.sullivan@tonixpharma.com|117
20554184|NCT01752933|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20554185|NCT01591681|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|jdrfapp2@jaeb.org|
20554186|NCT03282955|B. Braun Melsungen|Study Manager|05661/71|studies@bbraun.com|0
20554187|NCT00832429|M D Anderson Cancer Center|Sara Hull|713-563-4598|sehull@mdanderson.org|
20554188|NCT00627406|Fertility Clinic Regional Hospital Skive|Dr. Peter Humaidan|+45 78 44 57 60|peter.humaidan@viborg.rm.dk|
20554189|NCT02486406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20554190|NCT01858194|Icahn School of Medicine at Mo|Betsy Ellsworth, Research Program Director|212 824 8902|betsy.ellsworth@mountsinai.org|
20554191|NCT00235989|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20554192|NCT04796831|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20554193|NCT01129141|NCRAR, VA RR&D|James A. Henry, Ph.D.|503.220.8262|james.henry@va.gov|57466
20554194|NCT00178191|University of Rochester|Michael Flynn|585-273-3232|Michaelk_flynn@urmc.rochester.edu|
20554195|NCT00495716|University of Washington Virology Research Clinic|Clinic Director|206-520-4340|vrc@uw.edu|
20570074|NCT02007200|University of Michigan Comprehensive Cancer Center|Gregory T. Wolf, M.D.|800-865-1125|gregwolf@umich.edu|
20570075|NCT03598699|AxeroVision, Inc.|Dr. Achim Krauss|+1 (484) 238-6255|achim.h.krauss@gmail.com|
20570076|NCT02330562|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20570077|NCT04182113|Indiana University|Clinical Research Manager|3178808495|iupdp@iupui.edu|
20570078|NCT01496365|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20570079|NCT01015677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20570080|NCT01646385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570081|NCT02706951|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20570082|NCT02489734|Children's Hospital of Fudan University|Dr. Xuan Wang|021-18017591058|13818318679@139.com|
20570083|NCT04294667|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20570084|NCT01841697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20570085|NCT04198948|University of Sarajevo|Associate Professor Tanja Dujic, PhD|+38733586194|tanja.dujic@ffsa.unsa.ba|
20570086|NCT00233389|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20570087|NCT04962698|Georgia Institute of Technology|Prof. Minoru Shinohara|404-894-1030|shinohara@gatech.edu|
20570088|NCT02312206|Prothena Biosciences|Wendy Curlin|(650) 837-8550|clinicaltrials@prothena.com|
20570089|NCT00585975|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
20570090|NCT04915131|Bloom Technologies NV|Managing Director|+14156038067|julien@bloomlife.com|
20570091|NCT03082612|Emory University|Dr. Jill Hamilton|404-727-8749|jill.b.hamilton@emory.edu|
20570092|NCT01006616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20570093|NCT04974723|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
20570094|NCT00736125|Duke University Medical Center|Dr. Terri Monk|919-286-6938|terri.monk@duke.edu|
20570095|NCT02877732|Stanford Concussion and Brain Performance Center/ Stanford Emergency Medicine|Dr. Jamshid Ghajar|(650) 725-5562|jghajar@stanford.edu|
20570096|NCT00992992|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570097|NCT00952848|Virginia Commonwealth University|Thomas J. Smith, MD, FACP|410-955-2091|tsmit136@jhmi.edu|
20570098|NCT00217022|Mayo Clinic, Rochester MN|Dr. Darrell Pardi|507-538-1231|pardi.darrell@mayo.edu|
20570099|NCT00458393|University of California, San Francisco|David Glidden|415-514-8009|david.glidden@ucsf.edu|
20570100|NCT02625571|Penn State College of Medicine|Dr. Brian Allen|717-531-4100|ballen1@pennstatehealth.psu.edu|323492
20570101|NCT05178979|Boston College|Katelyn Sileo|617-552-3205|sileoka@bc.edu|
20570102|NCT02299427|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu|
20570103|NCT03035318|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
20538991|NCT02559414|New York University School of Medicine|Jeffrey Berger, MD|212 263 4004|Jeffrey.Berger@nyumc.org|
20538992|NCT01670565|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu|
20538993|NCT01410812|University of Pennsylvania|Katherine L. Milkman, Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
20538994|NCT04555837|The University of Texas MD Anderson Cancer Center|Faye Johnson, MD|(713) 792-6363|fmjohns@mdanderson.org|
20538995|NCT06250738|Rollins School of Public Health|Dr. Andrea Lopez-Cepero|404-727-3956|andrea.a.lopez-cepero@emory.edu|
20538996|NCT00419315|Philadelphia VA Medical Center|David Oslin|215 823 5894|dave.oslin@va.gov|
20538997|NCT04979910|Icahn School of Medicine at Mount Sinai|Esther Lee|212-585-6133|esther.lee@mssm.edu|
20538998|NCT00293709|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20538999|NCT00086502|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20539000|NCT01304329|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539001|NCT01797380|Duke University Health Systems|Harold Goforth, M.D.|216-636-3999|goforth@ccf.org|
20539002|NCT03028987|Stanford University School of Medicine, Dept. of Pediatrics|Cornelia Dekker, MD|6507244437|cdekker@stanford.edu|
20539003|NCT01842581|Bausch Health Americas, Inc.|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20539004|NCT01287195|Brigham and Women's Hospital|Scott B. Snapper, M.D., Ph.D.|617-919-4973|ssnapper@partners.org|
20539005|NCT01995552|India Medtronic Pvt. Ltd.|Vinay Rajan Ph.D|+91 22.3307.4700|vinay.rajan@medtronic.com|
20539006|NCT03562793|Richard L. Roudebush VA Medical Center|Dr. Marianne Matthias|317-988-4514|Marianne.Matthias@va.gov|
20539007|NCT00885768|Kidney Reasearch Center, Tehran University of Medical Sciences|Mohammad Reza Khatami MD|00982161192659|khatami@hbi.ir|
20539008|NCT02068118|CDM e-Health|Clinical Development Physician|33 (0) 1 39 07 62 86|fralsi-ctpublication@airliquide.com|
20539009|NCT00140842|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
20539010|NCT00283868|University of California, San Diego|Brett C. Meyer, MD|619-543-7760|bcmeyer@ucsd.edu|
20539011|NCT01515475|Jaeb Center for Health Research|Ray Kraker M.S.P.H.|813-975-8690|rkraker@jaeb.org|
20539012|NCT01968057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539013|NCT01420627|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
20539014|NCT00837876|Vanderbilt-Ingram Cancer Center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
20539015|NCT03558074|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20539016|NCT00453973|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20539017|NCT01996592|Wake Forest School of Medicine|Jessica L. Booth, MD|336-718-8278|jbooth@wakehealth.edu|
20539018|NCT00870194|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20539019|NCT00707746|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20539020|NCT01656629|Johns Hopkins University|Dr. Suzanne Jan De Beur|410-550-0100|sjandebe@jhmi.edu|
20539021|NCT01219933|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20539022|NCT01902888|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.208.3365|artscott@wlgore.com|
20539023|NCT03149003|Sumitomo Pharma Oncology|Sheila Dhaskali|617-674-6800|Sheila.dhaskali@oncology.sumitomo-pharma.com|
20539024|NCT01443130|University of Maryland School of Medicine|Miriam K. Laufer, MD, MPH|410-706-5333|mlaufer@medicine.umaryland.edu|
20539025|NCT00685373|Novartis Pharmaceuticals|Study Director|862-778-8300||
20539026|NCT00364533|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-6780||
20539027|NCT00582738|Pharmaceuticals|Novartis|41613241111||
20539028|NCT02758301|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|6123003066|lindsay.k.werder@medtronic.com|
20539029|NCT02228343|University of New Mexico Health Sciences|Hadya Khawaja|505-272-7028|hkhawaja@salud.unm.edu|
20539030|NCT02642965|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20539031|NCT03412097|Parker University|Dr. Katherine A Pohlman|972 438 6932|kpohlman@parker.edu|7148
20539032|NCT04557787|Coloplast A/S|Vice President, Medical Affairs|+454911 1111|clinical-studies@coloplast.com|
20539033|NCT01827332|MUSC|Aimee McRae-Clark|843-792-5216|mcraeal@musc.edu|
20539034|NCT02700165|Zeltiq Aesthetics|Kerrie Jiang, Exective Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20539035|NCT00276614|David Geffen School of Medicine at UCLA|Matthew Rettig, M.D.|310-794-3565|mrettig@mednet.ucla.edu|
20539036|NCT01522404|Emory University|Allan I. Levey, MD, PhD|404-727-7220|alevey@emory.edu|
20539037|NCT05714943|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
20539038|NCT01557881|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
20539039|NCT00737594|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20539040|NCT01831817|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539041|NCT00958217|VA San Diego Healthcare System/UCSD|Susan R. Tate, Ph.D., Clinical Psychologist|619-426-9402|srtate@ucsd.edu|
20539042|NCT01685021|MorphoSys AG|Dr. Sumeet Ambarkhane, Director, Clinical Program Leader|004989899270|sumeet.ambarkhane@morphosys.com|
20539043|NCT02198235|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
20539044|NCT03052530|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
20539045|NCT01999218|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539046|NCT00546260|Portola Pharmaceuticals Inc.|Kevin Romanko, Senior Director Clinical Operations|650-246-7305|kromanko@portola.com|
20539047|NCT03780959|Amgen Inc.|Study Director|866-572-6436||
20570104|NCT03845075|Saniona A/S|Janus Schreiber Larsen|7070 5225|janus.larsen@saniona.com|+45
20539048|NCT03681678|William Beaumont Hospital|Jennifer Giordano|248-551-3517|jennifer.giordano@corewellhealth.org|
20507871|NCT02855450|Dompè|Flavio Mantelli, MD, PhD|+39 02583831|info@dompe.com|
20507872|NCT05159362|Q2i, LLC|Steven Jenkins, CEO Q2i|646-660-2151|sjenkins@q2i-group.com|
20507873|NCT01376245|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507874|NCT02171819|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
20539049|NCT04619004|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|9089926400|CTRinfo@dsi.com|
20570105|NCT02564718|Bayer|Therapeutic Area Head|+1-888-84-22937|clinical-trials-contact@bayer.com|
20570106|NCT03269695|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570107|NCT00104637|Columbia University|David J. Lederer, MD|212-305-7771|dl427@columbia.edu|
20570108|NCT01313624|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20570109|NCT00857233|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20570110|NCT05043883|CathVision|Mads Matthiesen|+4531470730|mem@cathvision.com|
20570111|NCT02980705|Sun Pharma Advanced Research Company Limited|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
20570112|NCT00263575|Strakan Pharmaceuticals Ltd|Fiona Miller|01896 66868|fiona.miller@prostrakan.com|
20570113|NCT02669615|Medical College of Wisconsin|Parameswaran Hari|4148054600|phari@mcw.edu|
20570114|NCT02271230|Brigham and Women's Hospital|Dr. Luc Djousse|617-525-7591|ldjousse@rics.bwh.harvard.edu|
20570115|NCT01130168|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20570116|NCT01305473|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
20570117|NCT01283022|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20539050|NCT04030962|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20539051|NCT00306475|Vanderbilt Psychiatric Hospital|Herbert Meltzer, M.D.|615-327-7049|herbert.meltzer@vanderbilt.edu|
20539052|NCT05991934|Johns Hopkins Bloomberg School of Public Health|Johannes Thrul, PhD|(443) 318-6633‬|jthrul@jhu.edu|
20539053|NCT05621239|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20539054|NCT06504524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539055|NCT04424225|University of Minnesota|Jessica Nielson|714-904-7939|jnielson@umn.edu|
20539056|NCT05288166|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20539057|NCT01114360|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-2590|frahbar@emory.edu|
20539058|NCT01804582|University of Maryland, Baltimore|Gloria M. Reeves, M.D.|410-328-3522|greeves@psych.umaryland.edu|
20539059|NCT00159913|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20539060|NCT03455829|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20539061|NCT03040414|HealthPartners Institute|Amy Becker LaFrance, Sr. Manager, Research Project Management Office|952.967.5079|Amy.B.LaFrance@healthpartners.com|
20539062|NCT01305655|NOPHO|Dr Jesper Heldrup|+46705172389|jesper.heldrup@skane.se|
20539063|NCT00689793|Departement of ambulatory care and community medicine, University of Lausanne, Switzerland|Dr Bernard Favrat MD|+41795566183314|Bernard.favrat@chuv.ch|
20539064|NCT00875056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539065|NCT00357656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20539066|NCT02573246|Duke University Health System|Dr. Andrada D. Neacsiu|919-684-6714|andrada.neacsiu@duke.edu|
20539067|NCT00701636|LA BioMed at Harbor-UCLA Medical Center|Loren Miller MD|310-222-3813|Lgmiller@ucla.edu|
20539068|NCT01011933|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20539069|NCT01439074|Changhai Hospital of Shanghai|Prof Xia, Zhaofan|+86 2181873471||
20539070|NCT00815191|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
20525952|NCT01967706|Philip Morris Products S.A.|Christelle HAZIZA|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20539071|NCT02639338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20539072|NCT03094286|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
20539073|NCT00493636|ACORN Research, LLC|Study Chair|901-435-5570|lschwartzberg@acornresearch.net|
20539074|NCT02900170|Albert Einstein Medical Center|Basma Abdulhadi|215456500|abdulhab@einstein.edu|
20539075|NCT01291836|Alere San Diego|William Arnold|858-505-2000|william.arnold@alere.com|
20539076|NCT00201123|NYU School of Medicine|William Rom MD|212 263-6479|William.Rom@nyumc.org|
20539077|NCT01814670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20525953|NCT00725608|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
20525954|NCT01021761|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
20525955|NCT03047720|Indiana University|Dr Benjamin Whittam|317.944.8896|bwhittam@iupui.edu|
20525956|NCT00614120|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20525957|NCT02223546|Medical University of Graz|Gerald Seidel, MD|+43 316 385 12394|gerald.seidel@medunigraz.at|
20525958|NCT00179673|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
20525959|NCT02388815|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
20525960|NCT00319592|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20525961|NCT01512446|Ruhr-Universität Bochum|Johannes Pfeilschifter, MD||Johannes.Pfeilschifter@rub.de|
20525962|NCT03421145|3M Health Care Business Group|Manager of Biostatistics|6518152737|swalters@mmm.com|
20525963|NCT01820572|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20525964|NCT00288600|Fundação Oswaldo Cruz|Maria Elisabeth Moreira|552125541911|bebeth@iff.fiocruz.br|
20525965|NCT03600194|Philips|Jeff Jasko|412-542-3836|jeff.jasko@philips.com|
20525966|NCT04439214|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
20525967|NCT02235077|Duke Clinical Research Institute|Adrian Hernandez, MD|919 668 7515|adrian.hernandez@duke.edu|
20539078|NCT02012686|Department of Anesthesiology and Pain Medicine, Gangnam Severance Hospital, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Republic of Korea|Dr Dong Woo Han|82-2-2019-3549|HANESTH@yuhs.ac|
20539079|NCT02945553|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
20539080|NCT01703065|University of Washington|Dr. Celestia Higano, MD|206-606-1152|thigano@u.washington.edu|
20539081|NCT01005212|Houston Methodist Research Institute - Heart Center Research|Bevin Lopez, Clinical Trials Manager|7134413912|balopez@houstonmethodist.org|
20539082|NCT00624416|Pennington Biomedical Research Center|Leanne Redman|225-763-0947|Leanne.Redman@pbrc.edu|
20539083|NCT03352453|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20539084|NCT02827500|Duke Clinical Research Institute|Dr. Robert Mentz|919-668-7121|robert.mentz@duke.edu|
20539085|NCT01241760|Janssen Infectious Diseases BVBA|Compound Development Team Leader|32 14 64 13 70||
20539086|NCT02725593|Study Information Center|Global Clinical Lead|+1-887-240-9479|information.center@astrazeneca.com|
20525968|NCT03852628|RTI International|PASA Core Leadership|919-541-6002|shirsch@rti.org|
20525969|NCT02964208|Abbott|Ryan Gage|+1 612 805 6398|ryan.gage@abbott.com|
20525970|NCT02119455|University of Connecticut- Division of Orthodontics|Dr. Flavio Uribe|8606792550|furibe@uchc.edu|
20507875|NCT00764946|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507876|NCT01162304|University of Rochester|Joel Kent, MD|585-273-2972|joel_kent@urmc.rochester.edu|
20507877|NCT01996904|CM Chungmu Hospital|Sang-Hoon Lhee|+82(2)2068/4525|cmirb@naver.com|
20507878|NCT00585923|Biomet|Jacquelyn Hughes|973-299-9300|jacquelyn.hughes@biomet.com|3075
20507879|NCT01324622|DePuy Synthes|Allyson Morris|610-719-5298|amorris5@its.jnj.com|
20507880|NCT02219087|OhioHealth|Sara Jordan Clinical Pharmacist for Surgery Services|614-461-8174|sara.jordan@ohiohealth.com|
20507881|NCT00618449|University of California, San Francisco|Julius Schachter, PhD / Emeritus Professor of Laboratory Medicine|+1 (415) 824-5115|Julius.Schachter@ucsf.edu|
20507882|NCT00138424|Collaborative Antiviral Study Group|Penelope Jester, BSN,MPH,CCRC|(205) 877-975-7280|PJester@peds.uab.edu|
20525971|NCT00877487|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20525972|NCT01516008|Janssen Research & Development, L.L.C.|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20525973|NCT02118727|University of Missouri Health Care|Richard Barohn, MD|573-882-3693|rbarohn@health.missouri.edu|
20525974|NCT01217476|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
20525975|NCT03129945|University of California, Irvine|Judith Chung|714-456-8695|judithc@hs.uci.edu|
20525976|NCT00813813|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
20525977|NCT00986921|Boston University Department of Obstetrics and Gynecology|Director of Clinical Research|617-414-5175|rstudy@bmc.org|
20525978|NCT01758731|University of Colorado, Denver|Dr. David Raben|303-724-3027|david.raben@ucdenver.edu|
20525979|NCT04445714|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20525980|NCT02805660|Mirati Therapeutics|Tavette Neskorik, Senior Director, Clinical Science|858-332-3552|neskorikt@mirati.com|
20525981|NCT01923298|The University of Arizona Cancer Center|Dr. Pavani Chalasani|520-626-0191|pchalasani@uacc.arizona.edu|
20525982|NCT02572076|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
20525983|NCT06137131|Ghent University|Dr. Iris Meerschman|+32499294636|iris.meerschman@ugent.be|
20525984|NCT01684943|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
20525985|NCT04223635|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20525986|NCT04965311|OHSU Knight Cancer Institute|Dr. Brett Sheppard|503-494-9169|sheppard@ohsu.edu|
20525987|NCT01672710|Institute for Health and the Environment, University at Albany|David O. Carpenter MD|518-525-2660|dcarpenter@albany.edu|
20525988|NCT02122887|Bar Ilan University|Moran Influs|972-35317943|moran.influs@gmail.com|
20525989|NCT03725761|Wisconsin Institutes for Medical Research|Joshua M Lang, MD, MS|(608) 265-8131|jmlang@medicine.wisc.edu|
20525990|NCT03055494|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20525991|NCT05443594|Boston Scientific|Thomas Stoltz|651-582-4000|Thomas.Stoltz@bsci.com|
20525992|NCT05129293|Trinity Health Of New England|Mandell Center Research Team|860-714-3005|MSResearch@TrinityHealthOfNE.org|
20525993|NCT05903924|Vanda Pharmaceuticals|Vanda Pharmaceuticals|2027343400|clinicaltrials@vandapharma.com|
20525994|NCT04166591|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
20525995|NCT03192995|University of California at San Francisco|Dr. Glenn-Milo Santos, Associate Professor|415-867-1151|glenn-milo.santos@ucsf.edu|
20525996|NCT03506568|Devers Eye Institute|Dr. Robert Kinast|503-413-8202|robertkinast@gmail.com|
20525997|NCT05210101|Brigham and Women's Hospital|Sophia Koo, MD|6175258418|skoo@bwh.harvard.edu|
20525998|NCT01424514|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539087|NCT00514020|Vanderbilt-Ingram Cancer Center|Laura Goff, MD|615-936-0059|laura.goff@vanderbilt.edu|
20539088|NCT04064346|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
20539089|NCT01667146|ANZIC - RC, Monash University|Prof Carol Hodgson|+61 (3) 99030598|carol.hodgson@monash.edu|
20539090|NCT01428336|Cleveland Clinic Foundation|Seenia Peechakara|216 4105901|peechas@ccf.org|
20539091|NCT02423122|EIP Pharma|John Alam||jalam@eippharma.com|
20525999|NCT01286168|Mayo Clinic|Dr. Amy C. Degnim|507-284-6357|Degnim.Amy@mayo.edu|
20526000|NCT06207149|Vanderbilt University|Meghan Burke|6153431014|meghan.burke@vanderbilt.edu|
20526001|NCT02487771|University of Kansas Medical Center|Susan Carlson, PhD|(913) 588-5359|SCARLSON@kumc.edu|
20526002|NCT02002533|University of Rochester|Gary Morrow|585-275-9961|gary_morrow@urmc.rochester.edu|
20526003|NCT04598451|Argenx|Regulatory Manager|Please email:|regulatory@argenx.com|
20526004|NCT02147522|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
20526005|NCT03796442|Seoul National University Hospital|Prof. Ho Young Hwang|00-82-2-2072-3020|scalpel@snu.ac.kr|
20526006|NCT02893553|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
20526007|NCT01429064|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
20526008|NCT01871402|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
20526009|NCT04594941|GE HealthCare|Francois Tranquart, M.D., Ph.D|447775543206|francois.tranquart@ge.com|
20526010|NCT00231114|Asthmatx, Inc.|Narinder S Shargill, PhD|408-419-0100||
20526011|NCT02031640|Teva Branded Pharmaceutical Products, R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20526012|NCT02005692|Leaf Healthcare, Inc.|Barrett Larson, MD, Chief Medical Officer|650-701-3652|barrett.larson@leafhealthcare.com|
20539092|NCT02378207|Desmond Tutu HIV Foundation, Cape Town, South Africa|Dr. Linda-Gail Bekker|+27214066959|linda-gail.bekker@hiv-research.org.za|
20539093|NCT01985763|Icahn School of Medicine at Mount Sinai|Dr. Sofya Pintova|212-824-8461|Sofya.Pintova@mountsinai.org|
20539094|NCT00552448|TexasTech|Dr. Adaobi Kanu|806 743 7336|adaobi.kanu@ttuhsc.edu|
20539095|NCT00316524|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20539096|NCT00167661|University of Wisconsin - Madison|Dr. Sharon Bartosh|(608) 265-6020|smbartosh@wisc.edu|
20539097|NCT03306641|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
20539098|NCT01490294|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20539099|NCT02789410|Mayo Clinic|Dr. Hans P. Sviggum|507-284-9697|sviggum.hans@mayo.edu|
20539100|NCT01751776|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539101|NCT00160654|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20539102|NCT01902459|Ethicon, Inc|Richard Kocharian, MD, PhD|+1 908-218-2013|rkochar1@its.jnj.com|
20539103|NCT00831701|Department of Urology, University Hospital Zürich, Switzerland|Räto T. Strebel|0041-44-2551111|raeto.strebel@ksgr.ch|
20539104|NCT02117349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20570118|NCT04354168|Boston University Chobanian & Avedisian School of Medicine, Family Medicine|Brian Jack, MD|617-414-6207|brian.jack@bmc.org|
20570119|NCT01781832|Cincinnati Children's Hospital Medical Center|Ethan Smith, MD|513 636-4200|Ethan.Smith@cchmc.org|
20570120|NCT00087555|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
20570121|NCT05523219|SERF|Sponsor|+33 4.72.05.60.10|clinical@serf.fr|
20570122|NCT00661713|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20526013|NCT01194999|Barrie Urology Associates - The Male/Female Health and Research Centre|Joseph A Zadra, MD CM FRCSC|705-727-0551|joezadra@rogers.com|
20526014|NCT01892709|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
20526015|NCT05356533|University of Washington|Jennifer Cadigan|206-543-5689|cadiganj@uw.edu|
20526016|NCT00635453|Universidade Federal de Ciências da Saúde de Porto Alegre|Dr. Marcia Vitolo|+555133038798|marciavitolo@hotmail.com|
20526017|NCT02091375|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20526018|NCT02682823|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20526019|NCT05896527|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20526020|NCT03085238|MTrap|Vice President, RA/QA/CA|3013258537|cmitchell@m-trap.com|
20526021|NCT01279070|Parc Sanitari Sant Joan de Déu|Dr. Aida Farreny|+34 936406350|afarreny@pssjd.org|2373
20526022|NCT03261674|VA Palo Alto|Dr Ansgar Furst; Rayma Williams|(650) 339-4015|ansgar.furst@va.gov; rayma.williams@va.gov|
20526023|NCT01883817|University of Cincinnati|Director Clinical Research Management|513-558-8621|gayathri.kavikondala@uc.edu|
20526024|NCT00623935|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
20526025|NCT00782184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526026|NCT03330262|Barron Associates|Principal Research Scientist|434-973-1215|barron@barronassociates.com|125
20526027|NCT00205868|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20526028|NCT01154088|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526029|NCT05010512|Alcon Research, LLC|Associate Director, Clinical Projects - CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20526030|NCT05129137|Unither Pharmaceuticals|Non-Clinical and Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
20526031|NCT01084668|Abbott|Global Medical Services|800-633-9110||
20539105|NCT01440881|University of Florida|Dr. Thomas Beaver|352-273-5501|thomas.beaver@surgery.ufl.edu|
20570123|NCT01482429|Federal University of Uberlândia|Liliane Barbosa da Silva Passos|553432182150|lilibsp@yahoo.com.br|
20570124|NCT04522206|NYU LAngone Health - Long Island|Muhammad B. Tariq, M.D|602-363-1134|Muhammad.Tariq2@nyulangone.org|
20526032|NCT01118624|Spectrum Pharmaceuticals|Pankaj Sharma, MD|949-743-9264|pankaj.sharma@sppirx.com|
20526033|NCT01869699|University of California, San Francisco|Dr. Hildy Schell-Chaple|415-353-1039|hildegarde.schell-chaple@ucsf.edu|
20526034|NCT05028075|Center for Digital Health|Director of Research|2674280125|digitalhealth@uphs.upenn.edu|
20526035|NCT01475851|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526036|NCT01576276|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|jkong2@mgh.harvard.edu|
20526037|NCT02447497|3M|Nancy Klinger|651 491 9433|nmklinger@mmm.com|
20526038|NCT01552915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20526039|NCT06191393|Aptitude Medical Systems, Inc|Brad Killingsworth|2814674855|brad.killingsworth@aptitudemedical.com|
20526040|NCT01023841|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20539106|NCT02242981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539107|NCT02033213|KBC Zagreb|Maja Karaman Ilić, MD PhD|00385 1 2385 122|majakilic1@gmail.com|
20539108|NCT02535416|Arrowhead Pharmaceuticals, Inc.|James Hamilton, MD|626-696-3400|jhamilton@arrowheadpharma.com|
20526041|NCT04240457|ChicagoArbor Eye Care|David Lubeck, MD|708-798-6633|david.lubeck@chicagoarboreye.com|
20526042|NCT02858180|Duke University|Andrew Muir, MD|919-684-2052|muir0002@duke.edu|
20526043|NCT00844480|Northwestern University|Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
20526044|NCT00979420|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526045|NCT01570634|Salient Pharmaceuticals Incorporated|Richard scruggs|7135899859|rscruggs@salientpharmaceuticals.com|
20526046|NCT01054196|Weill Cornell Medicine|Roger Pearse, M.D. PhD|646-962-6500|rnp2001@med.cornell.edu|
20526047|NCT01295827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526048|NCT01668173|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal|212-639-2194|RampalR@mskcc.org|
20526049|NCT00684320|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|(619) 229-3740|namir@mail.sdsu.edu|
20526050|NCT02439814|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
20526051|NCT04679311|Washington University School of Medicine|Steven Weintraub MD|314-652-4100|weintraub@wustl.edu|55298
20526052|NCT02778074|Linkoping University|Dr Peter Johansson|0460700896548|peter.b.johansson@liu.se|
20526053|NCT03699280|Imperial College London|Ms Nandita Deo|07939360357|nandita.deo@gmail.com|
20526054|NCT02396420|South Florida Medical Imaging|Cynthia Toot ARNP|954-267-6626|cynthia.toot@holy-cross.com|
20526055|NCT00569673|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
20526056|NCT03518619|Butler Hospital|Ana M. Abrantes, Ph.D.|401-455-6440|Ana_Abrantes@Brown.edu|
20526057|NCT01273623|Boston Scientific|Susanna Kennedy|763.494.2601|susanna.kennedy@bsci.com|
20526058|NCT01640379|Johns Hopkins University|Dr. Maria Trent|4109552910|mtrent2@jhmi.edu|
20526059|NCT01493284|St Jude Medical|Sr Clinical Scientist|4159179696|alicia.kimber@abbott.com|
20526060|NCT03489707|Medical College of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
20526061|NCT00325156|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526062|NCT04064411|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
20526063|NCT03395184|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526064|NCT03053063|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20526065|NCT02060058|Kaohsiung Medical University Hospital|Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine|+886-7-3121101|hsmonyan@gmail.com|6770
20526066|NCT01188876|Massachusetts General Hospital|Marcela del Carmen, MD, MPH|617-724-4800|MDELCARMEN@mgh.harvard.edu|
20526067|NCT03963232|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20526068|NCT00356135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20526069|NCT03617770|University of Illinois at Chicago|Dr. Pamela Martyn-Nemeth|3129967903|pmartyn@uic.edu|
20526070|NCT03512210|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|301-628-3348|ACTGCT.gov@fstrf.org|
20526071|NCT02551770|GWD Consult|Dr. Manfred Klasser|+49 6108 825 65 20|manfred.klasser@gwd-consult.de|
20526072|NCT00321698|Portland VAMC|Dr. Mark Garzotto|541-728-0665|garzotto@ohsu.edu|
20526073|NCT05033262|The University of Pennsylvania School of Nursing|Emily Summerhayes|6099233786|esummer@nursing.upenn.edu|
20526074|NCT05270395|University of Kentucky|Dr. McLouth|859-562-2526|laurie.mclouth@uky.edu|
20526075|NCT03960021|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20526076|NCT03030989|University of Chicago|Randee Estes, Study Coordinator|773-702-1209|restes@medicine.bsd.uchicago.edu|
20526077|NCT02730377|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20526078|NCT02706886|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20526079|NCT03917472|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20526080|NCT01154296|Department of Sociomedical Sciences/Mailman School of Public Health/Columbia University|Lisa Metsch, PhD, Stephen Smith Professor and Chair of Sociomedical Sciences|212-305-3577|lm2892@columbia.edu|
20526081|NCT02759055|HealthPartners Institute|Patrick J O'Connor|952-967-5034|Patrick.J.OConnor@HealthPartners.Com|
20526082|NCT02203851|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20526083|NCT04934189|Hunter College of the City University of New York|Danielle S. Berke, Ph.D.|212-772-5550|db2800@hunter.cuny.edu|
20526084|NCT03309657|University of Queensland Center for Clinical Research|Prof. Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
20539109|NCT03474081|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20539110|NCT00693654|Wake Forest University Health Sciences|Alan Fleischer, Jr., MD|336-716-7753|afleisch@wfubmc.edu|
20539111|NCT01977690|Johann Wolfgang Goethe University|Stephan Duetzmann|001491781470479|stephan.duetzmann@gmail.com|
20539112|NCT01176955|Wake Forest Baptist Medical Center|Brad Yentzer|336-716-4735|byentzer@wakehealth.edu|
20539113|NCT01058941|Oregon Health & Science University|Dr. Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
20539114|NCT02644356|Collinge and Associates, Inc.|William Collinge, PhD, MPH|541-632-3502|william@collinge.org|
20539115|NCT02210091|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20539116|NCT02739321|The Cleveland Clinic|Dr. Thomas Frazier||fraziet2@ccf.org|
20539117|NCT01711866|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20539118|NCT00897390|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20539119|NCT03159104|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20539120|NCT01742065|Kaiser Permanente Center for Health Research|Gloria D. Coronado|503 335 2427|Gloria.D.Coronado@kpchr.org|
20539121|NCT02440789|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20539122|NCT02382848|Penn State University College of Medicine|Dr. Fauzia Mahr|717 531-8133|fmahr@pennstatehealth.psu.edu|
20539123|NCT01858753|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
20539124|NCT04938037|ErciyesU|Dr. Isa Cuce|+905056263723|dr.icüce@hotmail.com|
20539125|NCT03350906|Mayo Clinic|Ian R. Lanza, Ph.D.|507-255-8147|Lanza.Ian@mayo.edu|
20539126|NCT04872998|University of Utah|Principal Investigator Joel Trinity Associate Professor|801-582-1565|joel.trinity@utah.edu|
20539127|NCT05160766|University Hospital Cologne|Prof. Dr. med. Oliver A. Cornely|0049 221 478 85523|oliver.cornely@uk-koeln.de|
20539128|NCT02654236|IU School of Medicine|Dr. Suthat Liangpunsakul|(317) 988-3232|sliangpu@iu.edu|
20539129|NCT01549873|Nationwide Children's Hospital|David Martin, MD|614-722-4200|David.Martin@nationwidechildrens.org|
20539130|NCT00877370|University of Michigan|Bruce A. Mueller|(734) 615-4578|muellerb@umich.edu|
20539131|NCT02733653|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
20539132|NCT05251753|Wake Forest School of Medicine|Caleb Suggs|3367164171|csuggs@wakehealth.edu|
20539133|NCT04271475|Actelion Pharmaceuticals Ltd|Clinical Science Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20539134|NCT00890682|Pacira Pharmaceuticals, Inc|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20539135|NCT02212678|University of Minnesota|Lisa Coles, MS, PhD|4109264788|durh0016@umn.edu|
20539136|NCT02337634|University of Chicago|Dr. Jon Grant|7738341325|jgrant4@bsd.uchicago.edu|
20539137|NCT03493607|Icahn School of Medicine at Mount Sinai|Christina Layton|212-241-6231|christina.layton@mssm.edu|
20539138|NCT02046070|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20539139|NCT01818284|UT MD Anderson Cancer Center|Chitra Hosing, MD/Professor, Stem Cell Transplantation|713-792-7734|cmhosing@mdanderson.org|
20539140|NCT05601102|University of Stirling|Professor Anna C. Whittaker|0178646|a.c.whittaker@stir.ac.uk|7816
20539141|NCT04284813|McLean Hospital/Harvard Medical School|Julie M. McCarthy, PhD|6178553521|jmccarthy@mclean.harvard.edu|
20539142|NCT03106415|Mayo Clinic|Saranya Chumsri MD|904-953-2000|Chumsri.Saranya@mayo.edu|
20539143|NCT03476876|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20539144|NCT00385723|Institute for Behavioral Medicine Research, Ohio State University College of Medicine, OH, USA|Dr. Janice K. Kiecolt-Glaser|+1 614 293 3499|Janice.Kiecolt-Glaser@osumc.edu|
20539145|NCT01390779|UCSD|Mona Moshtaghi|858 534-6290|momoshta@ucsd.edu|
20539146|NCT03689712|Galera Therapeutics|Megan Holm|484-615-2036|mholm@galeratx.com|
20539147|NCT01189292|Department of General, Abdominal and Transplant Surgery, University of Heidelberg|Dr. Ignazio Tarantino||ignazio.tarantino@med.uni-heidelberg.de|
20539148|NCT00353873|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539149|NCT03743064|Helsinn Healthcare SA|Florin Muraru|+41 91985 21 21|florin.muraru@helsinn.com|
20539150|NCT01483209|Duke University Medical Center|Dr. Cynthia Shortell|919-681-2223|cynthia.shortell@duke.edu|
20539151|NCT00660985|Galderma|Michael Graeber, MD, Head of Global Clinical Project Management and US Development|609-860-8201|michael.graeber@galderma.com|
20539152|NCT00180297|Boston Scientific|Elisabeth Mouton - Clinical Trial Manager|+33 1 39 30 11 90|elisabeth.mouton@bsci.com|
20539153|NCT00973102|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
20539154|NCT00966719|Children's Hospital of Eastern Ontario|Dr Catherine Pound|613-737-7600|cpound@cheo.on.ca|
20554196|NCT04519658|CinCor Pharma|Yuan-Di Halvorsen|617-675-8126|yhalvorsen@cincor.com|
20539155|NCT04941807|Weill Cornell Medicine|Dr. Shari Lipner|6469623376|shl9032@med.cornell.edu|
20539156|NCT03553498|Albert Einstein College of Medicine|Polly Bijur|718-430-4217|polly.bijur@einsteinmed.org|
20539157|NCT01100567|Boston Children's Hospital|Dr. Amy DiVasta, PI|6173553792|amy.divasta@childrens.harvard.edu|
20539158|NCT00160199|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
20539159|NCT02124772|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20539160|NCT02713529|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20539161|NCT03343080|Mayo Clinic|Dr. Troy Seelhammer|507-255-6051|seelhammer.troy@mayo.edu|
20539162|NCT03089944|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20539163|NCT01636713|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539164|NCT03689244|Actelion Pharmaceuticals Ltd|Senior Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20539165|NCT04498377|Evive Biotech|Jianmin Chen|6095124566|jianmin.chen@evivebiotech.com|
20539166|NCT01739803|University of Tennessee College of Pharmacy|Marie Chisholm-Burns|901-448-7141|mchisho3@uthsc.edu|
20539167|NCT00915148|Stavanger UH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
20539168|NCT03283436|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
20539169|NCT03759041|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
20539170|NCT00525824|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20539171|NCT02645617|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
20539172|NCT02525094|MedImmune, LLC|Rene van der Merwe|301-398-2532|information.center@astrazeneca.com|
20539173|NCT00969436|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539174|NCT01018095|Tulane University|Patricia Kissinger, PhD|5049887320|kissing@tulane.edu|
20539175|NCT00054028|The Ohio State University Comprehensive Cancer Center|Maryam Lustberg, MD|614-293-0066|Maryam.Lustberg@osumc.edu|
20539176|NCT01274611|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20539177|NCT02290938|RAND|Elizabeth D'Amico|310-393-0411|damico@rand.org|6487
20539178|NCT03172130|University of Utah|Krishna Sundar|801-581-7806|krishna.sundar@hsc.utah.edu|
20539179|NCT02349685|SeoulNUBH|Nayoung Kim|+ 82-31-787-7008|nayoungkim49@empas.com|
20539180|NCT01350115|Novartis Pharmaceuticals|Study Director|862-778-8300||
20539181|NCT00168454|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20539182|NCT05565937|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20539183|NCT04544683|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Aaron Conger, MD|801-587-1493|u6007025@umail.utah.edu|
20539184|NCT00541346|University of Oklahoma Health Sciences Center|Thomas M. Lock, M.D.|405-271-5700|Thomas-Lock@ouhsc.edu|45167
20539185|NCT04253587|UCSF Dept of Neurology|Peter Wais, Principal Investigator|415-502-1212|peter.wais@ucsf.edu|
20539186|NCT03323736|Smith+Nephew|Laura England, PhD|(650) 223-6909|laura.england@smith-nephew.com|
20539187|NCT01806064|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|233
20539188|NCT01286077|Janssen-Cilag Greece|EMEA Medical Affairs Director|+30 210 8090738||
20539189|NCT00701805|Abbott|Global Medical Services|800-633-9110||
20539190|NCT00418977|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|katharine.loeb@mssm.edu|
20539191|NCT01733771|Bnai Zion Medical Center|Dr. Samuel Attias|+972524707304|samuel.attias@b-zion.org.il|
20539192|NCT02262078|Mayo Clinic|Barry A. Borlaug, MD||Borlaug.Barry@mayo.edu|
20539193|NCT02804750|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20539194|NCT00167388|University of Pittsburgh|Dr. Toby Yanowitz|412-641-4111|yanotd@mail.magee.edu|
20539195|NCT04144959|Penumbra, Inc.|Erin Archard, Senior Director of Clinical Research, Vascular|+1 802 377 9715|earchard@penumbrainc.com|
20539196|NCT01973608|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20539197|NCT05501795|Bismarck Lasik|Dr Stephen Wexler|701-222-2020|drwexler@bismarcklasik.com|
20539198|NCT05970120|Biosense Webster, Inc.|Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20539199|NCT02797184|Washington University in St. Louis|Dr. Lauren Park|3143633915|l.park@wustl.edu|
20539200|NCT04692077|HPTN Statistical & Data Management Center|HPTN Statistical Manager|+1 (206) 667-4004|HPTN-Data-Access@scharp.org|
20539201|NCT05149313|Almirall S.A|Head of Global Clinical Development|+34932913000|gco@almirall.com|
20539202|NCT04831424|Columbia University|Martin Picard|6467748967|mp3484@columbia.edu|
20539203|NCT03199391|Zimmer Biomet|Madison Murphy|5745262059|madison.murphy@zimmerbiomet.com|
20539204|NCT01867086|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
20539205|NCT04243330|VA Rocky Mountain MIRECC|Nazanin Bahraini, PhD|720-723-6490|Nazanin.Bahraini@va.gov|
20539206|NCT04927663|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-7171|rahul.aggarwal@ucsf.edu|
20539207|NCT03826342|University of Michigan|Golfo Tzilos Wernette|734-988-3424|gtzilos@med.umich.edu|
20539208|NCT01727011|Centre Antoine Lacassagne|Professeur JM Hannoun-Levi|04.92.03.12.60|jean-michel.hannoun-levi@nice.unicancer.fr|
20539209|NCT03007745|Corporal Michael J. Crescenz VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov|
20539210|NCT03921554|Children's Hospital of Philadelphia|Dr. Adeline Vanderver|215-590-1719|vandervera@chop.edu|
20539211|NCT00431951|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
20539212|NCT03446053|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
20507883|NCT04311177|University of Minnesota|Christopher Tignanelli|612-626-1968|ctignane@umn.edu|
20507884|NCT01912716|Indiana University|Dr. Evan Fogel|317-944-2816|efogel@iu.edu|
20539213|NCT01789138|Department of Public Health, University of Tartu, ESTONIA|Prof. Anneli Uusküla|+372 7374195|anneli.uuskula@ut.ee|
20539214|NCT01224444|White River Junction VA|Heiko Pohl|802-295-9363|heiko.pohl@dartmouth.edu|5595
20539215|NCT01342549|Michael E. DeBakey VAMC|Dr. Ricardo Jorge|713-794-7010|ricardo.jorge@va.gov|
20539216|NCT01299571|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539217|NCT02459275|University of Miami|Dr. D. Dante Yeh|305-585-1822|dxy154@med.miami.edu|
20539218|NCT00708734|Tampa VA Hospital|Tatjana Bulat|8135583932|tatjana.bulat@va.gov|
20539219|NCT02942654|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539220|NCT01777945|Hoffmann-La Roche|Medical Communications|1-800-821-8590||
20539221|NCT02634606|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|x61987
20539222|NCT01173029|Universidade Gama Filho|Paulo Robeto Benchimol Barbosa|+55-21-95320182|ecgar@yahoo.com|
20539223|NCT01012921|Institut Straumann AG|Julia Dorn|0041619651111|julia.dorn@straumann.com|
20539224|NCT05432167|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20539225|NCT01267175|Medtronic Diabetes|Harold Torunsky|(818) 576 5445|harold.torunsky@medtronic.com|
20539226|NCT00895661|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
20539227|NCT02006069|Abbott|Kwangdeok Lee PhD|+19725269673|kwangdeok.lee@abbott.com|
20539228|NCT00958932|National Jewish Health|Dr. Bruce Bender|303-398-1697|benderb@njhealth.org|
20539229|NCT02553538|Massachusetts General Hospital|Dr. Sanja Percac-Lima|617-643-6980|spercaclima@partners.org|
20539230|NCT02276547|Neovasc|Lisa Read, Clinical Study Manager|8558025180|lread@neovasc.com|323
20539231|NCT00791557|University Hospitals of Cleveland|Dr. Amanda Suggs, MD|216-844-7546|Amanda.suggs@uhhospitals.org|
20539232|NCT00853840|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20539233|NCT01439126|Concordia Pharmaceuticals Inc.|John AR McCleery, CPA, CA, Managing Director and CFO|1-246-256-1861|jmccleery@concordiarx.com|
20539234|NCT03242018|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20539235|NCT00687609|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539236|NCT02635347|Rutgers-NJ Medical School|Baburao Koneru, MD, MPH|973-972-9599|koneruba@njms.rutgers.edu|
20539237|NCT02308488|NYU Langone Health - Perlmutter Cancer Center|Carmen A. Perez, M.D., Ph.D.|212-731-5003|Carmen.Perez@nyulangone.org|
20539238|NCT01541917|Children's Mercy Hospital|Mark Connelly, PhD (Principal Investigator)|816-234-3000|mconnelly1@cmh.edu|3193
20539239|NCT02011490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507885|NCT02391350|University of Utah|Dr. Julie Fritz|8015872237|julie.fritz@utah.edu|
20539240|NCT01244633|Psyadon Pharmaceuticals|Dr. Richard Chipkin|3019192020|rchipkin@psyadonrx.com|
20539241|NCT01565564|Tianjin Medical University|Dr. Xilin Yang|+86 22 83336727|yangxilin@tijmu.edu.cn|
20539242|NCT02449018|Novartis Pharmaceuticals|Study Director|8627781873||
20539243|NCT03995355|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO - Sr. Principal Research Optometrist|1-800-843-2020|MBishop4@its.jnj.com|
20539244|NCT03335254|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
20554197|NCT00298831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554198|NCT00437034|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20554199|NCT04409041|Washington University|Dr. Caroline Mann|(314) 996-8010|cmann@wustl.edu|
20554200|NCT01978184|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
20554201|NCT03837496|Massachusetts General Hospital|Jamie Jacobs, PhD|617-643-1777|jjacobs@mgh.harvard.edu|
20554202|NCT03146650|Northwestern University, Feinberg School of Medicine|Young Kwang Chae, MD, MPH, MBA|312-926-4248|YCHAE@nm.org|
20554203|NCT00931307|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20554204|NCT01815671|Specialists in Gastroenterology, LLC|Leonard Weinstock, MD|314-997-0554|lw@gidoctor.net|102
20554205|NCT00691210|Columbia University Medical Center|Owen A. O'Connor, MD, Ph.D.|212-326-5720|oo2130@cumc.columbia.edu|
20554206|NCT01130740|Center for Health Services Reserach in Primary Care, Durham VAMC|Kelli D. Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
20554207|NCT01767792|The University of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.4010|bkorf@uabmc.edu|
20554208|NCT01208233|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554209|NCT00983814|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20554210|NCT01181895|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554211|NCT02707640|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20554212|NCT05789875|UCSF|Dr. Parya Saberi|415-502-1000|parya.saberi@ucsf.edu|17171
20554213|NCT00023452|CDC|Dr Elsa Villarino|404-639-5340|mev1@cdc.gov|
20554214|NCT02287415|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20554215|NCT04551105|Virginia Tech|Study Director of Clinical Trials|+1 (301) 820-5225|dcben0@gmail.com|
20539245|NCT01355796|University of Iowa|Janice Launspach|319-356-2047|janice-launspach@uiowa.edu|
20539246|NCT01965899|Medtronic, plc|CRHF Clinical Research|800-328-2518|MedtronicCRMtrials@medtronic.com|
20539247|NCT00535821|Loma Linda University|H. Bryant Nguyen|909-558-4000|hbnguyen@llu.edu|44023
20539248|NCT02698371|University Fernando Pessoa|Prof. Patricia Manarte-Monteiro; Associate Professor|+351 225 071 300|patmon@ufp.edu.pt|
20539249|NCT02138240|Johns Hopkins University School of Medicine|Kimberly Gudzune|443-287-7238|gudzune@jhu.edu|
20539250|NCT01122108|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|kschmitz@lmarc.com|
20539251|NCT03295396|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
20539252|NCT01825941|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
20539253|NCT03495102|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20539254|NCT01161537|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20539255|NCT00520910|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
20539256|NCT02769962|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
20539257|NCT00151372|Weill Cornell Medical College|George S. Alexopoulos, M.D.|914-997-5767|gsalexop@med.cornell.edu|
20539258|NCT02706197|Program for Clinical Oximetry and Imaging Geisel School of Medicine & Dartmouth Health; Dartmouth College|Periannan (Kupps) Kuppusamy MS, PhD|603-646-5490|Periannan.Kuppusamy@dartmouth.edu|
20539259|NCT02783170|Duke University|Dr. Geeta Swamy|919-681-5220|geeta.swamy@duke.edu|
20539260|NCT04638127|University of Cincinnati|Principal Investigator: Ashley Weber, PhD, RN, RNC-NIC|513-5580132|ashley.weber@uc.edu|
20539261|NCT01282294|Synthes GmbH|Clinical Research Scientist|0041 32 720 44 65|clinicalaffairs.emea@synthes.com|
20539262|NCT02408523|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20539263|NCT03344172|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20539264|NCT04495868|Emory University|Brian Bobzien, MD|404-616-4226|brian.patrick.bobzien@emory.edu|
20554216|NCT03995758|Indiana University School of Medicine|Dr. Marcelino Rivera|3179622485|maeriver@iu.edu|
20554217|NCT01818336|AllerQuest|Dr. Franklin Adkinson Jr., MD-Vice President, Chief Medical Officer|410-550-2051|fadkinson@allerquest.com|
20554218|NCT00320281|Craig Hospital|Dr. Gary Maerz|303-789-8220|adannels@craighospital.org|
20554219|NCT03328897|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20554220|NCT00608829|W.L. Gore and Associates|Abe Letter|928 864 3113|aletter@wlgore.com|
20554221|NCT02805257|University of California, San Francisco|Ying Han, MD, PhD|415-476-3321|ying.han@ucsf.edu|
20554222|NCT00612066|University of California, Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
20554223|NCT00672477|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
20539265|NCT00300677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20539266|NCT01300351|AstraZeneca China|Guofei Dai|+86 21 60301242|guofei.dai@astrazeneca.com|
20507886|NCT00413062|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20507887|NCT02176291|University of Pittsburgh|Dr. Jordan F. Karp|412-246-6048|karpjf@upmc.edu|
20507888|NCT02431468|Neurotrope BioScience, Inc.|David Crockford, Vice President, Regulatory Affairs|(973)242-0005|dcrockford@neurotropebioscience.com|
20507889|NCT00006604|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20507890|NCT00736580|West Virginia University|Michael Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
20507891|NCT03589885|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20507892|NCT01583452|ITESM - Pediatrics Division|Gabriela López Jaimez|+527211476044|gabylopez7@gmail.com|
20507893|NCT02157506|Bristol-Myers Squibb International Corporation|EU Study Start-Up Unit||clinical.trials@bms.com|
20507894|NCT03448224|University of Kentucky|Dr. Jerod Stapleton|859.562.2802|jerod.stapleton@uky.edu|
20507895|NCT03103906|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20507896|NCT00764478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507897|NCT02763072|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20539267|NCT02811913|VA Northeast Ohio Healthcare System|Dr. Svetlana Pundik|(216)791-3800|svetlana.pundik@va.gov|
20539268|NCT00343863|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20526085|NCT01470781|McLean Hospital/Harvard Medical School|Dr. Kathryn Lewandowski|617-855-2886|klewandowski@mclean.harvard.edu|
20526086|NCT00765895|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
20526087|NCT00970632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20526088|NCT02653170|Michigan State University|Dr. Mathew Reeves|517-353-8623|reevesm@msu.edu|
20526089|NCT02086448|University of Pittsburgh|Dr. Francesca Facco|412-641-1220|Faccof@upmc.edu|
20526090|NCT01968356|3M Health Care|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
20526091|NCT02161484|University of Pittsburgh|Dr. Rita Merman, P.I.|41256322137|MermanRB@upmc.edu|
20526092|NCT01895270|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
20526093|NCT05139303|University of Kentucky College of Dentistry Division of Orofacial Pain|Dr. Isabel Moreno Hay|8593233440|imo226@uky.edu|
20554224|NCT03266588|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20554225|NCT00736242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554226|NCT02886572|Duke University Health System|Joan Cahill BNS OCN CCRP|(919) 668-5211|joan.cahill@duke.edu|
20554227|NCT03264157|Bio Products Laboratory|Head of Medical Affairs|1-844-4BPLUSA|MedInfo@bpl-us.com|
20554228|NCT00009737|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20554229|NCT01734746|MaastrichtUMC|R.F.P.M. Kruitwagen|+31433874767|r.kruitwagen@mumc.nl|
20554230|NCT01163682|Columbia University Irving Medical Center|Dawn Hershman|212-342-5162|dlh23@cumc.columbia.edu|
20554231|NCT01931839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20554232|NCT03224468|Massachusetts General Hospital|Jodi Gilman, PhD|617-643-7293|jgilman1@mgh.harvard.edu|
20554233|NCT01978119|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554234|NCT00812812|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554235|NCT03095417|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
20570125|NCT03561597|KKWCH|Dr Chew Chu Shan Elaine|63946042|elaine.chew.c.s@singhealth.com.sg|
20570126|NCT04887506|Tavanta Therapeutics|Head, Clinical Development|+1 833776 8963|info@tavanta.com|
20570127|NCT03506347|Mayo Clinic|Dr. Mark Spangehl|480-342-2948|Spangehl.Mark@mayo.edu|
20539269|NCT00096018|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20539270|NCT00673881|Radiant Research|Michael H. Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|2220
20539271|NCT01221194|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20539272|NCT03968159|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
20539273|NCT02674425|PolyPhotonix|Dr|00441740625|duncan@polyphotonix.com|557
20539274|NCT00413010|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20539275|NCT00443781|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20539276|NCT00430937|Novartis Pharmaceuticals|Study Director|862-778-8300||
20539277|NCT02688868|Shanghai Microport Medicine|HT Zhang|+862138954600|zhanght@microport.com|8552
20539278|NCT02989805|Emory University|Benjamin Druss, MD, MPH|404-712-9602|bdruss@emory.edu|
20539279|NCT00286221|Johns Hopkins School of Medicine|Dr. Bradford Winters|4109559080|bwinter1@jh.edu|
20539280|NCT00875342|Weil Cornell Medical College|Program director|212 821 0783|jdifede@med.cornell.edu|
20539281|NCT02771626|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
20539282|NCT02690649|Parkview Health|Julie Hughbanks|260-266-1444|julie.hughbanks@parkview.com|
20539283|NCT00106691|GTx, Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com|
20570128|NCT01437488|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jean Hoffman-Censits|215 955-8874|jean.hoffman-censits@jefferson.edu|
20570129|NCT04562896|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
20570130|NCT06124131|Tulane University|Laura Perry|504-988-8906|lperry5@tulane.edu|
20570131|NCT01024036|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
20570132|NCT02176837|Hope Pharmaceuticals|Craig Sherman, MD|4806071970|sherman@hopepharm.com|
20570133|NCT00691678|Columbia University|Dawn L. Hershman, MD|212-305-1945|dlh23@cumc.columbia.edu|
20570134|NCT01190449|Weill Cornell Medicine Cornell University|Cara Rosenbaum, MD|(646) 962-6500|car9156@med.cornell.edu|
20570135|NCT04811339|University of Cincinnati|Dr. Bruce Yacyshyn|513-633-8715|yacyshbr@ucmail.uc.edu|
20570136|NCT03972397|The University of Texas Health Science Center at Houston|Anthony L Estrera, MD|713-486-5100|anthony.l.estrera@uth.tmc.edu|
20570137|NCT05896696|A.Stein Regulatory Affairs Consulting Ltd.|Ahava Stein|+972-9-7670002|ahava@asteinrac.com|
20526094|NCT03875482|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20526095|NCT00949403|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20526096|NCT00507819|The Children's Hospital of Philadelphia|David J. Goldberg, MD|267-426-8143|goldbergda@email.chop.edu|
20526097|NCT01945970|Unilever R&D Research Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@gmail.com|
20526098|NCT00979875|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
20526099|NCT02738879|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526100|NCT00890084|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526101|NCT01438294|Universidade Nove de Julho|Evelim Leal de Freitas Dantas Gomes, PhD PT|5511976333349|evelimfreitas@hotmail.com|
20526102|NCT01075646|Department of Anesthesia, Reanimation Bellvitge University Hospital|Noelia Fustran|932607323|nfustran@bellvitgehospital.cat|
20526103|NCT01520558|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
20526104|NCT01730534|AstraZeneca|Global Study Leader|+49 4103 708 3792|Sandra.ranft@astrazeneca.com|
20526105|NCT01676896|UTexasAustin|Sharon Horner|512-471-7951|shorner@mail.nur.utexas.edu|
20526106|NCT01647516|Celgene Corporation|Anne McClain, Senior Manager|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
20526107|NCT01323595|Weill Cornell Medical College|Chairman, Department of Urology|212 746-5491|pnschleg@med.cornell.edu|
20526108|NCT01613222|GEHealthcare|Jeffrey Conner|414-477-8374|Jeffrey.Conner@ge.com|
20526109|NCT01895608|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
20526110|NCT03505593|ENvizion Medical|Clinical Director|+972-72-2288240|anath@envizionmed.com|
20526111|NCT02319174|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
20526112|NCT00405522|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
20526113|NCT02855359|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20526114|NCT03155178|3M|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
20526115|NCT01023256|MorphoSys|Roman Korolkiewicz|+498989927|Roman.Korolkiewicz@morphosys.com|208
20526116|NCT02833844|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20526117|NCT04712019|3M|Biostatistics Manager|651-382-2876|swalters@mmm.com|
20526118|NCT04525079|Celltrion Inc|JiWoong Lim|82-32-850-5806|jiwoong.lim@celltrion.com|
20526119|NCT02195310|KCI Europe Holding B.V.|Daniela Weichert, PhD|+353 (0) 860436155|daniela.weichert@acelity.com|
20526120|NCT02541669|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20526121|NCT04739722|Geneoscopy Inc.|Chief Medical and Science Officer|314-887-7777|contact@geneoscopy.com|
20526122|NCT03729570|Emory University|Aaron Siegler, PhD|404-712-9733|asiegle@emory.edu|
20526123|NCT00631410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526124|NCT03998163|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20526125|NCT03419598|University of Bath|Professor Richie Gill|01225 383627|r.gill@bath.ac.uk|
20526126|NCT01322035|University of South Alabama, Department of Surgery|Dr. William O. Richards|251-471-7993|brichards@health.southalabama.edu|
20526127|NCT04569968|Bolu Abant İzzet Baysal University|Tamer ÇANKAYA|5335519171|tamercankaya@hotmail.com|+90
20526128|NCT00727844|Tuberculosis Research Section, LCID, NIAID, NIH|Dr. Clifton Barry|301-451-9554|cbarry@niaid.nih.gov|
20526129|NCT03912818|Stanford University|Sandy Srinivas|650-725-2078|sandysri@stanford.edu|
20507898|NCT00643604|United Therapeutics Corporation|Remodulin Program Leader|919-485-8350|clinicalrecordsmanagement@unither.com|
20526130|NCT03861871|NYU Langone Health|Latoya King|646 558 083|latoya.king@nyulangone.org|
20507899|NCT02702011|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20507900|NCT02029495|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
20526131|NCT00570349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20507901|NCT03498287|Pressure Profile Systems|Clinical Trials Manager|310.641.8100|research@wrist-aid.com|
20526132|NCT00985959|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
20526133|NCT04676451|Penn State Hershey Medical Center|Amy Longenecker|717-531-1513|alongenecker@pennstatehealth.psu.edu|
20507902|NCT03450915|BiondVax Pharmaceuticals ltd.|Chief Scientific Officer & Clinical Management|+97289302529|benyedidia@BiondVax.com|5103
20539284|NCT01754194|Medtronic MITG|Maria Young - Clinical Research Manager|+353 (0)1 4381611|maria.young@medtronic.com|
20539285|NCT00530920|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539286|NCT00907296|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20539287|NCT03208530|Brigham and Women's Hospital|Kei Ouchi, MD, MPH|(617) 732-5640|kei_ouchi@dfci.harvard.edu|
20539288|NCT02066129|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
20539289|NCT02392403|Cochlear|Chris James|+33 534 638 584|cjames@cochlear.com|
20539290|NCT00678834|The Ohio State University Wexner Medical Center|Dr. Chandan K. Sen, PhD. Professor and Associate Dean|614-247-7658|chandan.sen@osumc.edu|
20539291|NCT02322190|National Cancer Institute|Dr. Ronald Gress|240-760-6167|rg26g@nih.gov|
20539292|NCT01264614|UNION COLLEGE|Cay Anderson-Hanley, PhD|518-388-6355|andersoc@union.edu|
20570138|NCT00903760|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|713-745-3428|ggarciam@mdanderson.org|
20539293|NCT04904809|Abbott Vascular|Sandeep Pingle|858-222-9673|sandeep.pingle1@abbott.com|
20539294|NCT02776033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20539295|NCT01403376|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
20539296|NCT00316888|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
20539297|NCT02616393|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
20539298|NCT02314364|Massachusetts General Hospital|Henning Willers, MD|617-726-5184|hwillers@mgh.harvard.edu|
20539299|NCT01302054|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539300|NCT00857948|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
20526134|NCT00471718|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
20539301|NCT00084149|University of California, San Diego|Dr. Florin Vaida|619 543-8045|fvaida@ucsd.edu|
20539302|NCT03123614|University of Utah Moran Eye Center|Mark Mifflin, MD|801-213-4152|Mark.Mifflin@hsc.utah.edu|
20539303|NCT03757130|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20539304|NCT03619135|University of Iowa College of Dentistry|Dr. Kyle Stein|319-384-5105|kyle-stein@uiowa.edu|
20539305|NCT02968914|AstraZeneca Clinical Study Information Center|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20539306|NCT02144155|UCSD|David Feifel||dfeifel@kadimanp.com|
20539307|NCT01617447|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20526135|NCT04257032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539308|NCT00576472|St. Jude Children's Research Hospital|Heather Conklin PhD|1-866-278-5833|info@stjude.org|
20539309|NCT00780273|University if Rochester Medical Center|Dr. George Romanos|585-276-4149|GeorgiosRomanos@urmc.rochester.edu|
20539310|NCT00121641|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20570139|NCT01177956|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20570140|NCT02330276|Va San Diego Healthcare System|Robert R. Henry, MD|8585528585|rrhenry@outlook.com|3648
20570141|NCT01256671|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
20570142|NCT04411186|Medical University of South Carolina|Dr. David Gutman, M.D., MBA, Associate Professor of Anesthesiology|843-792-5454|gutman@musc.edu|
20526136|NCT00602459|Ohio State University|John Byrd, M.D.||john.byrd@osumc.edu|
20526137|NCT00746564|St. Jude Medical|Director, Clinical Studies|1-800-733-3455|tshipman@sjm.com|
20539311|NCT00047619|University of Calgary|Dr. Chester Ho|(403) 944 4620|chester.ho@albertahealthservices.ca|
20539312|NCT04468074|University of Colorado, Boulder|Marta Ceko|443-835-6587|Marta.Ceko@colorado.edu|
20554236|NCT02571452|San Francisco VA Healthcare System|Dr. Shira Maguen|415-221-4810|Shira.Maguen@va.gov|22511
20570143|NCT03167151|Oxford University Hospitals NHS Foundation Trust|Dr Andrew S Protheroe|01865 253275|andrew.protheroe@oncology.ox.ac.uk|
20570144|NCT01458522|Duke University|Aatif M. Husain, M.D.|919-668-8700|aatif.husain@duke.edu|
20526138|NCT00322231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526139|NCT02640677|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20526140|NCT02036840|Nationwide Children's Hospital|Ralph Beltran, MD|614-722-4200|Ralph.Beltran@nationwidechildrens.org|
20526141|NCT00957268|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20526142|NCT02255305|NorthShore UH|Jennifer Grant|847-570-2420|jgrant@northshore.org|
20526143|NCT01817582|Bausch & Lomb Incorporated|Director of Clinical Operations||Jon.Williams@bauschhealth.com|
20526144|NCT03197467|AIO-Studien-gGmbH|AIO-Studien-gGmbH Help Desk|0049-30-8145344|info@aio-studien-ggmbh.de|31
20526145|NCT06229132|Columbia University|Corina Lelutiu-Weinberger, PhD|(212) 342-1502|cl4265@cumc.columbia.edu|
20526146|NCT01515462|Fondazione Telethon ETS|Sean Russell|+39 02 2022 17210|srussell@telethon.it|
20526147|NCT01296542|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
20526148|NCT04338269|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20526149|NCT03339726|JNJWorldwide|Steven Sacavage, PharmD, Associate Director, Global Pain & Allergy Clinical Research|215 273-8568|ssacavag@its.jnj.com|8568
20526150|NCT02210247|Pacira Pharmaceuticals Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20526151|NCT03681990|3M|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
20539313|NCT00094107|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539314|NCT01184417|Alameda County Medical Center|Jonathan Rosenson MD|510-407-6743|jonrosenson@yahoo.com|
20539315|NCT00860015|Columbia University|Rober Taub, MD - Vivian and Seymour Milstein Family Prof. of Clinical Medicine||rntaubipod@gmail.com|
20539316|NCT00128713|New England Research Institutes|Susan Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
20539317|NCT00424190|Cerexa|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
20539318|NCT01672866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20539319|NCT00424268|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20539320|NCT00358436|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20539321|NCT04327024|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20539322|NCT00668811|MedStar Washington Hospital Center|Dr Kenneth D. Burman|202-877-8109|kenneth.d.burman@medstar.net|
20539323|NCT03938324|Duke University|Sharron Docherty, PhD|919-668-3836|sharron.docherty@duke.edu|
20539324|NCT01266590|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539325|NCT04558359|University of Kentucky|Alexander Flannery, PharmD, PhD|859-562-2766|alexander.flannery@gmail.com|
20539326|NCT02008773|Indiana University Psychotic Disorders Program|Alan Breier, MD|317-880-8495|abreier@iupui.edu|
20539327|NCT04732949|Synairgen|Brooke Clarke, SVP, Head of Communications|02380 512 800|info@synairgen.com|
20539328|NCT03046225|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
20539329|NCT04256512|Mayo Clinic|Pooja P. Advani, MBBS|904-953-7291|Advani.Pooja@mayo.edu|
20539330|NCT04435600|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20507903|NCT01740388|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
20507904|NCT04142216|Demiroglu bilim University|Assistant Professor Nurten Ozen|+905334509382|ozenurten@yahoo.com.tr|
20507905|NCT02555657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507906|NCT01948141|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20507907|NCT01578785|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20507908|NCT00895193|University of Kansas Medical Center|Julie-Ann Dutton, MS, RD|(913) 588-4064|jdutton@kumc.edu|
20507909|NCT00904995|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
20507910|NCT01476748|BWH|Dr. JI Einarsson|617-525-8582|jeinarsson@partners.org|
20507911|NCT02714504|Univ Fed Rio de Janeiro|Dr Marcio Nucci|552139382463|mnucci@hucff.ufrj.br|
20507912|NCT02392494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507913|NCT02443571|Blue Earth Diagnostics Ltd.|Chief Medical Officer|+44 (0) 1865 784 186|contact@blueearthdx.com|
20507914|NCT01214317|Isfahan University of medical sciences|Director of clinical trial|+983136202020|etemadifar.m@gmail.com|
20507915|NCT00587769|Mayo Clinic|Jon O. Ebbert|507-284-2511|ebbert.jon@mayo.edu|
20507916|NCT00505895|University of Texas MD Anderson Cancer Center|Muzaffar Qazilbash, MD / Professor, Stem Cell Transplantation|713-745-4371|CR_Study_Registration@mdanderson.org|
20507917|NCT05351710|Florida State University|Dr. Jesse Cougle|8506458729|cougle@psy.fsu.edu|
20539331|NCT03133221|University of Maryland Greenebaum Comprehensive Cancer Center|Jean Yared, MD|410-328-1230|jyared@umm.edu|
20539332|NCT03298841|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
20539333|NCT05824936|Nemours Children's Hospital|Dr. Abigail Strang|3026516400|astrang@nemours.org|
20539334|NCT03119389|University of Maryland|Kerri Thom|410-706-6124|kthom@som.umaryland.edu|
20539335|NCT02258529|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20539336|NCT01533922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539337|NCT02648217|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20539338|NCT02657564|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
20539339|NCT04135859|Nationwide Children's Hospital|Jamie Jackson, Ph.D.|614-722-3585|jamie.jackson2@nationwidechildrens.org|
20539340|NCT04047420|University of Pittsburgh|Sharon Riddler, MD, MPH|4123831741|riddler@pitt.edu|
20539341|NCT02641522|Benaroya Research Institute|Sarah Robinson/ Administrative Assistant|(206) 342-6931|diabetes@benaroyaresearch.org|
20507918|NCT00676793|LSU Health, Shreveport|Dr. Jerry w. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
20539342|NCT03262116|Massachusetts General Hospital|Dr Steven J. Russell, MD, PhD|617.726.1848|sjrussell@mgh.harvard.edu|
20554237|NCT01877421|Oral Health Research Institute, Indiana University School of Dentistry|Domenick T. Zero, DDS, MS|240-457-0668|dzero@iu.edu|
20526152|NCT01579084|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20526153|NCT01482065|Johns Hopkins University|Dr. Seva Polotsky, M.D., PhD|410-550-6386|vpolots1@jhmi.edu|
20526154|NCT01942486|University of Utah|Bradley Katz|8015871079|bradley.katz@hsc.utah.edu|
20526155|NCT03728426|Brigham and Women's Hospital/Dana-Farber Cancer Institute|Dr. Amy Sherman|6175253575|acsherman@bwh.harvard.edu|
20526156|NCT02424630|Chuncheon Sacred Heart Hospital|Dr Jung-Taek Hwang|82 33 240 5197|drakehjt@hanmail.net|
20526157|NCT02637895|University of Miami Miller School of Medicine|Dr. Philip Harvey|305 243 4094|pharvey@med.miami.edu|
20526158|NCT01741792|Amgen, Inc.|Study Director|866-572-6436||
20526159|NCT00761280|Isarna Therapeutics GmbH, formerly Antisense Pharma GmbH|Medical Officer|+49-89-890831|info@isarna-therapeutics.com|0
20526160|NCT02355821|RGNKC|Ekaterina Dudinskaya, head of age-related metabolic and endocrine disorders laboratory|+79031914690|katharina.gin@gmail.com|
20526161|NCT01187771|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
20526162|NCT02045862|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0) 20 3379 8000|astellas.resultsdisclosure@astellas.com|
20526163|NCT03961061|Wake Forest Health Sciences|Justin B. Moore, PhD|336-716-3702|jusmoore@wakehealth.edu|
20526164|NCT04507256|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20526165|NCT02360631|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
20539343|NCT01727791|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539344|NCT03923582|University of Minnesota|Gudrun Kilian|612-624-0358|kilian@umn.edu|
20539345|NCT02608450|Cassiopea SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20539346|NCT00635089|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20539347|NCT01304407|Baylor College of Medicine|Dr. Steven Abrams|512-495-4700|sabrams@bcm.edu|
20539348|NCT01848847|namik kemal university|cem celik|905324205365|cemcel@yahoo.com|
20539349|NCT01283542|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20539350|NCT02636946|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20539351|NCT05059977|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20539352|NCT03833713|Stanford University|Brian Suffoletto|4129016892|suffbp@stanford.edu|
20539353|NCT04285489|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|8029
20570145|NCT00516139|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570146|NCT00416598|The Ohio State University|William Blum, M.D.||William.Blum@osumc.edu|
20570147|NCT01226732|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20570148|NCT02166476|The Medicines Company|Global Health Science Center|888-977-6326|medical.information@themedco.com|
20570149|NCT05155566|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570150|NCT03752177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20539354|NCT04405245|EyePoint Pharmaceuticals, Inc|David Bauer|8573410747|dbauer@eyepointpharma.com|
20570151|NCT04367480|University of Rochester NCORP Research Base|Jennifer Gewandter, PhD|585-275-2141|Jennifer_Gewandter@urmc.rochester.edu|
20570152|NCT03382561|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20570153|NCT01131104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539355|NCT03443427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20539356|NCT02576860|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20539357|NCT00477269|Novartis Pharmaceuticals|Study Director|862-778-8300||
20539358|NCT02391961|Louis Stokes VAMC|Alessandro Serra|2167913800|Alessandro.Serra@va.gov|
20539359|NCT03263780|Cedars-Sinai Medical Center|Timothy Daskivich, M.D.|310-423-4700|timothy.daskivich@cshs.org|
20539360|NCT01792518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539361|NCT04807387|Baylor College of Medicine|Dr Julie Hakim|832-826-7464|julie.hakim@bcm.edu|
20539362|NCT01014455|Mayo Clinic|David O. Warner MD|5072846277|warner.david@mayo.edu|
20539363|NCT00249613|UCLA Integrated Substance Abuse Programs|Michael Prendergast|310-267-5503|mlp@ucla.edu|
20539364|NCT00806442|Brigham and Women's Hospital|Elliot Israel, MD|617-732-2801|eisrael@partners.org|
20539365|NCT02621398|Cancer Institute of New Jersey|Salma Jabbour, MD|732-235-8675|jabbousk@cinj.rutgers.edu|
20539366|NCT04728594|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20539367|NCT01497613|University of Miami Miller School of Medicine|Dr. Sara J. Czaja|305-355-9068|sczaja@med.miami.edu|
20539368|NCT01455220|University of South Florida|Dr.Tuan Vu/ Dr. Derrick Robertson|813-974-6378|droberts@health.usf.edu|
20539369|NCT00267150|Novartis Pharmaceuticals|Study Director|862-778-8300||
20539370|NCT02718040|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
20539371|NCT04881747|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20539372|NCT00475215|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539373|NCT00699218|UC Davis|Guohua Xia|916-734-3574|gxia@ucdavis.edu|
20539374|NCT00351273|University of South Florida|John D. Carter, M.D.|(813) 974-2681|jocarter@health.usf.edu|
20570154|NCT01076244|Center for Pain Relief|Timothy Deer|(304) 347-6144|Diana.tolentino@stfh.net|
20570155|NCT04469465|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20570156|NCT01165177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20570157|NCT03520075|Taiho Oncology, Inc|Taiho|609-250-7336|clinicaltrialinfo@taihooncology.com|
20570158|NCT05146206|Community and Patient Preference Research (CaPPRe)|Dr Lili Toh|+61 452551409|lili.toh@cappre.com.au|
20570159|NCT03546816|Menlo Therapeutics Inc.|Iain Stuart, PhD|1- 800-775-7936|Iain.Stuart@foamix.com|
20570160|NCT02270671|University College Dublin|Dr Amanda Fitzgerald|+35317168541|amanda.fitzgerald@ucd.ie|
20570161|NCT01657799|AbbVie|Global Medical Services|800-633-9110||
20570162|NCT01777126|Pharmacy Department, University Hospitals Leuven & Department of Pharmaceutical and Pharmacological Sciences, KULeuven, Belgium|Peter Declercq|003216342340|peter.declercq@uzleuven.be|
20570163|NCT00565266|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
20570164|NCT04611347|University of Virginia|Brent DeGeorge, MD|434.982.4263|BD6U@uvahealth.org|
20570165|NCT00611715|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
20570166|NCT00727415|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
20539375|NCT01378429|Sunovion|Respiratory Medical Director|866-503-6351||
20539376|NCT00619489|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20570167|NCT01624298|Johns Hopkins University|Stephanie Skavenski|+260966674841|sskavenski@yahoo.com|
20539377|NCT02356887|Toronto western Hospital/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
20539378|NCT02544373|University of Michigan|Tiffany J. Braley, MD, MS, Associate Professor of Neurology|734-936-6267|tbraley@med.umich.edu|
20539379|NCT02273960|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20570168|NCT00345800|Cares|UCB|+1 844 599|UCBCares@ucb.com|2273
20526166|NCT02256982|Massachusetts General Hospital|Ted Hong, MD|617-726-6050|tshong1@partners.org|
20526167|NCT03614078|PRCL Research Inc|Caroline Fortier|1-514-708-4417|caroline.fortier@prclresearch.com|
20570169|NCT02113410|Florida Atlantic University|Dr. Juyoung Park|561-297-4537|jpark14@fau.edu|
20570170|NCT03634306|Mercy Hospital St. Louis|David Levine, MD|314-251-7650|David.Levine@Mercy.net|
20570171|NCT03414047|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20570172|NCT04593823|scPharmaceuticals|Dr. John Mohr, PharmD; Sr VP Clinical Development and Medical Affairs|7813017220|jmohr@scpharma.com|
20570173|NCT02250534|University of Vermont|Stephen T. Higgins, PhD, Professor, Department of Psychiatry|802-735-6267|stephen.higgins@uvm.edu|
20570174|NCT03197025|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@mail.nih.gov|
20570175|NCT01253447|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
20570176|NCT02108652|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20570177|NCT03311269|Vascular Inisights, LLC|Ms. Lorraine Hanley, MBA|617-519-1109|lorraine.hanley@merit.com|
20570178|NCT01560871|Texas Woman's University|Dr. Suh-Jen Lin|214-689-7718|slin@twu.edu|
20526168|NCT03886519|University of North Carolina at Chapel Hill|Emily Gower, PhD|919-966-1420|egower@unc.edu|
20526169|NCT04964544|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20526170|NCT03875274|BPKIHS|Dr. Pankaj Baral|9856037077|pankajbaral7@gmail.com|
20526171|NCT03829618|Penn State Hershey Medical Center|Zoulfira Nisnevitch-Savarese, M.D.|717-531-6597|znisnevitchsavarese@pennstatehealth.psu.edu|
20526172|NCT02777970|Menarini Ricerche|Dr. Angela Capriati (Clinical Sciences Director)|+39 055 5680|acapriati@menarini-ricerche.it|9933
20526173|NCT02319967|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|chicagotrial@uic.edu|
20526174|NCT02347891|Northwell Health|Principal Investigator|5167082550|gmarder@northwell.edu|
20526175|NCT00834639|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20526176|NCT01968707|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
20526177|NCT01104246|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
20526178|NCT01083186|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20526179|NCT01783639|Gardia Medical|Dr. Vardit Segal|+972-4-6277166|Vardit@Gardiamedical.com|106
20526180|NCT04789291|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526181|NCT03783130|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
20526182|NCT00805870|Western Michigan University|Dr. Christopher C. Cheatham|269-387-2542|chris.cheatham@wmich.edu|
20526183|NCT01867294|Mayo Clinic|Aminah Jatoi, M.D.|507.284.1623|jatoi.aminah@mayo.edu|
20526184|NCT00278148|Case Comprehensive Cancer Center|Dr. Nathan Pennell|21684459281|penneln@ccf.org|
20526185|NCT02083185|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20526186|NCT00380081|Purdue Pharma LP|Clinical Leader|800-733-1333||
20526187|NCT02017912|Brainstorm Cell Therapeutics|Chief Medical Officer|+1-201-488-0460|ClinicalTrial@brainstorm-cell.com|
20526188|NCT01446237|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526189|NCT01931956|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
20526190|NCT02847494|Montefiore Health|Benjamin W. Friedman, MD|17189206626|befriedm@montefiore.org|
20526191|NCT02294175|James A. Haley Veterans Hospital and Clinics|Dr. Linda Cowan|813-558-3932|linda.cowan@va.gov|
20526192|NCT02468154|Istituto Ortopedico Rizzoli|Luisa Veronesi|0516366694|cristiana.forni@ior.it|0039
20526193|NCT02548351|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20526194|NCT01901653|AbbVie Stemcentrx|Senior Director, Clinical Operations|(650) 827-4879|isobel.lakatos@abbvie.com|
20526195|NCT01744184|University Hospitals Dorset NHS Foundation Trust|Dr Simon McLaughlin|01202303626|Simon.McLaughlin@uhd.nhs.uk|
20526196|NCT00792688|Glycotex, Inc.|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
20526197|NCT00072280|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20526198|NCT03226769|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20526199|NCT00537576|University of California, San Francisco|Anke Hemmerling, Project Director|415-597-4963|ahemmerling@globalhealth.ucsf.edu|
20526200|NCT04553471|Washington University School of Medicine|Pamela Samson, M.D.|314-747-1786|psamson@wustl.edu|
20526201|NCT05152966|FARAPULSE|Christopher (Kit) Schneider|6176867661|christopher.schneider@bsci.com|
20526202|NCT01340027|Astellas Pharma Europe, B.V.|Medical Director||Astellas.resultsdisclosure@astellas.com|
20526203|NCT02496091|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20526204|NCT02272842|Innlandet Hospital Trust|Tor Strand|+4790971086|tors@me.com|
20526205|NCT02663102|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20526206|NCT05685264|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526207|NCT02342197|Kasr El-Aini Hospital|Nawara Mohamed|0223654060|nawaram@kasrelaini.edu.eg|002
20526208|NCT02341495|Loyola University Medical Center|Dr. Elizabeth Henry|708-327-3153|ehenry@lumc.edu|
20526209|NCT04089904|University of Chicago|Theodore Karrison (Research Professor)|7737029326|tkarrison@health.bsd.uchicago.edu|
20526210|NCT02017717|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20539380|NCT01789606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539381|NCT04350307|Yale University|Dr. Robin Raju|203-688-8800|robin.raju@yale.edu|
20539382|NCT01105377|Johns Hopkins Oncology Center|Nilofer S. Azad, M.D.||nazad2@jhmi.edu|
20539383|NCT01120990|Hypertension Center, Third University Department of Medicine, University of Athens|George S Stergiou, MD|+30 210 7763117|gstergi@med.uoa.gr|
20539384|NCT01280695|Metabolic Solutions Development Company|Jerry Colca, PhD|269.343.6732|jcolca@msdrx.com|
20539385|NCT05011513|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539386|NCT03667690|Cidara Therapeutics, Inc.|Taylor Sandison, M.D., MPH|858-888-7868|clinicaltrialinfo@cidara.com|
20539387|NCT04802187|Massachusetts General Hospital|Madeline Davies|617-726-6653|medavies@mgh.harvard.edu|
20539388|NCT05101798|Icahn School of Medicine at Mount Sinai|Orli Weiss|9086700847|orli.weiss@icahn.ismms.edu|
20539389|NCT00837759|NIDDK, National Institutes of Health|Dr. Rana Malek|3015945288|malekr@mail.nih.gov|
20539390|NCT01073930|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20539391|NCT01192568|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20539392|NCT03459365|Cleveland Clinic|Carlos Higuera|954 659-5430|higuerc@ccf.org|
20539393|NCT00599755|Merck Sharp and Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539394|NCT04037254|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20539395|NCT03320330|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20539396|NCT02198794|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20539397|NCT01885910|DermResearch, PLLC|Dr. Leon Kircik|502-451-9000|wedoderm@yahoo.com|
20539398|NCT01306656|Columbia University|Shonni Silverberg, MD|212-305-6291|sjs7@cumc.columbia.edu|
20539399|NCT01778426|Medtronic|Neuromodulation, Clinical Study Management||medtronicneurotrials@medtronic.com|
20539400|NCT00477152|Baxter Halthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
20539401|NCT01023672|Mayo Clinic|Dr. Bradley F. Boeve|507-266-4106|bboeve@mayo.edu|
20539402|NCT01918332|Yonsei University Healthcare System Severance Hospital|Prof. YangSoo Jang|82-2-6924-3109|yejung@lgls.com|
20539403|NCT02905006|Cares|UCB|+1877 822|UCBCares@ucb.com|9493
20539404|NCT05063539|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20539405|NCT01751139|GlaxoSmithKline|GSK Response Center|435-7343|GSKClinicalSupportHD@gsk.com|866
20539406|NCT04736628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539407|NCT00759525|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
20539408|NCT02428205|University of Missouri|Dr David Beversdorf|5738826081|beversdorfd@health.missouri.edu|
20539409|NCT00527319|Oxford Pharmaceutical Resources, Inc.|Dr. Richard Guarino|973-256-0600|Guarino@oxfordpharm.com|
20539410|NCT04908280|University of Rochester|Christopher T Richardson MD, PhD|585 - 275 - 7546|crichardson@urmc.rochester.edu|
20539411|NCT00680368|Loma Linda VA Healthcare System|T. Michael Kashner, PhD, PI|909 825-7084|michael.kashner@va.gov|2853
20539412|NCT00483041|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
20539413|NCT03779503|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20539414|NCT00864851|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20539415|NCT02066415|Amgen Inc.|Study Director|866-572-6436||
20539416|NCT00889200|Butler Hospital|Linda Carpenter, MD|401 455 6349|Linda_Carpenter_MD@Brown.edu|
20539417|NCT03973905|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20539418|NCT04094584|University of California, San Francisco|Ralph Wang|(415) 353-4890|ralph.wang@ucsf.edu|
20539419|NCT00110461|Otsuka Pharmaceutical Development & Commercialization, Inc.|Andy Forbes||andy.forbes@otsuka-us.com|
20539420|NCT00537407|Debiopharm International S.A.|Jean-Maurice Dumont, Vice President Medical Affairs|4121 321 01 11|jean-maurice.dumont@debiopharm.com|
20539421|NCT02713867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20539422|NCT01600053|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
20539423|NCT02715726|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20539424|NCT02445573|Guang'anmen hospital of China Academy of Chinese Medical Sciences|Dr. Huanfang Xu|+86 10 8800 1124|huanfang_xu@126.com|
20539425|NCT01565941|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
20539426|NCT03230292|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20539427|NCT02855944|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20539428|NCT01639755|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20539429|NCT01581008|VA Eastern Colorado Health Care System|David Bekelman, MD, MPH|720-857-5088|david.bekelman@va.gov|
20539430|NCT03629912|Western Kentucky University|Dr. Matthew Shake|270-745-3918|matthew.shake@wku.edu|
20539431|NCT02282904|NIAID|Elizabeth Kang|3014027567|ekang@niaid.nih.gov|
20539432|NCT01852383|New York State Psychiatric Institute|Dr. D.P. Devanand|(646) 774-8658|dpd3@columbia.edu|
20570179|NCT00537329|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20539433|NCT02365285|Vanderbilt University Medical Center|Cyndya Shibao, MD|615-322-2318|cyndya.shibao@vumc.org|
20539434|NCT02404649|Harvard School of Dental Medicine|Dr. Kevin Guze|6177210707|kevin_guze@hsdm.harvard.edu|
20570180|NCT00243022|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Glen Stevens||steveng@ccf.org|
20570181|NCT01390441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539435|NCT04208087|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8593|722_clinical_project_team@seikagaku.co.jp|
20539436|NCT00408590|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-2511|galanis.evanthia@mayo.edu|
20554238|NCT00908960|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
20554239|NCT02821104|Nationwide Children's Hospi|Robert Hoffman|614-722-4425|robert.hoffman@nationwidechildrens.org|
20554240|NCT01158924|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
20554241|NCT03795922|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
20554242|NCT04165291|Yale University Child Study Center|Carla Stover|12037853486|carla.stover@yale.edu|
20554243|NCT02248922|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20554244|NCT01416805|University of South Florida|Dr. Eric Storch|727-767-8230|Eric.Storch@bcm.edu|
20554245|NCT05468398|University of California, Irvine|Navid Alem, MD / Principal Investigator|(949) 413-4950|alemn@hs.uci.edu|
20554246|NCT00684424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20554247|NCT01071512|University of Chicago|Dr. Adil Javed|773.834.0558|ajaved@neurology.bsd.uchicago.edu|
20554248|NCT01427296|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
20554249|NCT03367312|Duke University School of Medicine|Dr. Sudarshan Rajagopal|919-684-6237|sudarshan.rajagopal@duke.edu|
20554250|NCT05267171|Universidad de Oviedo|Claudia Leirós Díaz|663571819|claudia_leiros@hotmail.com|
20554251|NCT02076412|Rigel|Anne-Marie Duliege, MD|6506241100|clinicaltrials@rigel.com|6506241100
20554252|NCT00958880|Southern Methodist University|Jasper Smits, Ph.D.|214-768-4310|jsmits@smu.edu|
20554253|NCT01971346|University of Michigan|Heather Chubb|734-936-6394|hdchubb@med.umich.edu|
20554254|NCT01122511|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20554255|NCT04187196|Atrium Health|Elijah Beaty, MD, MPH, FACC|704-403-6100|Elijah.Beaty@atriumhealth.org|
20554256|NCT01687166|Boston Scientific|Clinical Trial Manager|617-218-3849|weismanm@bsci.com|
20554257|NCT02755831|Naval Medical Center San Diego|CAPTAIN Dennis Spence, NC, USN, PhD, CRNA|6199161680|dennis.l.spence.mil@mail.mil|
20554258|NCT02316717|Immuron|Neta Tobis, Clinical Director|+972549277334|neta@immuron.com|2549277334
20554259|NCT00183872|USC/Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
20554260|NCT01516879|Amgen Inc.|Study Director|866-572-6436||
20554261|NCT01720069|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
20554262|NCT04568122|Stanford University BioEngineering|Manu Prakash, PhD|(650) 725-3731|manup@stanford.edu|
20554263|NCT00594256|Nathan Kline Institute|Joshua Kantrowitz MD|845-398-5503|jkantrowitz@nki.rfmh.org|
20554264|NCT01910064|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
20554265|NCT00595582|LSU Health Sciences Center, Shreveport LA|Dr. James Patterson/Professor|318-813-2070|jpatte@lsuhsc.edu|
20554266|NCT02002494|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
20554267|NCT02460224|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20554268|NCT02797262|University of California, Los Angeles|Research Scientist|3105917541|statue22@gmail.com|
20554269|NCT01600586|Vanderbilt University|Olena Chorna|850-508-5571|olena.chorna@vanderbilt.edu|
20554270|NCT04160260|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20554271|NCT01974050|Columbia University|Melissa S. Stockwell|212-342-5732|mss2112@cumc.columbia.edu|
20554272|NCT00236938|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
20554273|NCT02460198|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554274|NCT00965848|Medical Affairs, Janssen-Cilag Ltd.,Thailand|Medical Affairs Director|662-792-7200||
20554275|NCT00813761|Vistakon|Kristy Canavan, OD|1-904-443-1474|kcanava2@its.jnj.com|
20554276|NCT01891734|Department of Veterans Affairs San Diego|Kathleen Grubbs|808-383-9757|kathleen.grubbs@va.gov|
20554277|NCT00555438|CHU SAINT-ETIENNE|Pr patrick MISMETTI|33(1)477127788|patrick.mismetti@chu-st-etienne.fr|
20554278|NCT01578044|VA Eastern Colorado Health Care System|P. Michael Ho|720-857-2115|michael.ho@va.gov|
20554279|NCT02758236|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
20554280|NCT02447991|Mayo Clnic|Jeffrey Staab, MD|507-293-9438|staab.jeffrey@mayo.edu|
20554281|NCT01693601|Icahn School of Medicine at Mount Sinai|John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
20554282|NCT01003418|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507919|NCT02133742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507920|NCT03479216|Derince Training and Research Hospital|Dr. Hande Aytuluk|00905336515650|handegrbz@gmail.com|
20554283|NCT02770391|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Moshe Ornstein,|18662238100|taussigresearch@ccf.org|
20554284|NCT00019682|Indiana University Health|Dr Douglas Schwartzentruber|317-948-6873|dschwart@iuhealth.org|
20539437|NCT01605942|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20539438|NCT03028636|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
20539439|NCT01012323|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
20539440|NCT00558272|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20539441|NCT02920957|CooperVision Inc|Sr.Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20539442|NCT01969435|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
20539443|NCT01706588|The School of Dentistry, University of Birmingham|Prof. Thomas Dietrich|+44-121-46 65494|t.dietrich@bham.ac.uk|
20539444|NCT00582998|University of Alabama at Birmingham|Asya Love, RN|205-996-6781|asyalove@uab.edu|
20539445|NCT01597635|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539446|NCT01882868|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20539447|NCT00652951|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554285|NCT03333486|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20554286|NCT01612546|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20554287|NCT02276495|UC Irvine Health Department of Anesthesiology & Perioperative Care|Dr. Joseph Rinehart|714-456-7415|jrinehar@hs.uci.edu|
20539448|NCT02593825|Duquesne University|Regina Harbourne, Primary Investigator|4026570538|harbourner@duq.edu|
20539449|NCT01022424|Otsuka Pharmaceutical Co.,Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20539450|NCT06359080|JelikaLite Corp|Katya Sverdlov, Chief Operating Officer|9175668151|katya@jelikalite.com|
20539451|NCT00511134|Yale University|Andrea H. Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
20539452|NCT01949090|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539453|NCT03826199|UCLA|Dvora Joseph Davey|3107011526|dvoradavey@ucla.edu|
20539454|NCT03242252|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20539455|NCT01116427|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20539456|NCT01079936|University of Texas (UT) MD Anderson Cancer Center|Muzaffar H. Qazilbash, Professor, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
20539457|NCT03344640|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20539458|NCT00657371|UT MD Anderson Cancer Center|Robert S. Bresalier, MD / Professor||CR_Study_Registration@mdanderson.org|
20539459|NCT00652899|University of Minnesota, Dept. Ob/Gyn|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
20539460|NCT03984487|Cincinnati Children's Hospital|Dr. Amie Duncan|513-803-2416|Amie.Duncan@cchmc.org|
20539461|NCT03544307|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3774|song-youngpark@unomaha.edu|
20539462|NCT01365624|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|610-650-4200|dbregman@lpicrd.com|828
20539463|NCT03426631|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
20539464|NCT00654004|Oregon Health & Science Univeristy|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
20539465|NCT04971941|Harvard School of Dental Medicine|Dr. Jeffry R Shaefer|(781) 718-6793|jeffry_shaefer@hms.harvard.edu|
20539466|NCT00444067|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
20539467|NCT00710385|Substance Abuse|Sandra D. Comer|646-774-6146|sdc10@columbia.edu|
20539468|NCT01264770|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20539469|NCT01325714|Houston Center for Innovations in Quality, Effectiveness, and Safety|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
20539470|NCT04039867|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20539471|NCT00521222|Columbia University Irving Medical Center|Marjorie Slankard, MD|212-326-8410|ms53@columbia.edu|
20539472|NCT00499408|Comprehensive Cancer Center of Wake Forest University|K.C. Balaji, MD|336-716-5690|kbalaji@wakehealth.edu|
20539473|NCT02241187|Memorial Sloan Kettering Cancer Center|Dr. Kenneth Yu, MD|646-888-4188|YuK1@mskcc.org|
20539474|NCT00199888|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20554288|NCT04176796|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
20539475|NCT01020903|Staten Island University Hospital|Michael Silverberg/Principal Investigator|718-226-6629|msilverberg@siuh.edu|
20539476|NCT05216627|University of Pennsylvania|Daniel Blumenthal|215-746-7155|daniel.blumenthal@pennmedicine.upenn.edu|
20539477|NCT02504931|UT Health San Antonio|Dr. John Roache|210-562-5406|roache@uthscsa.edu|
20539478|NCT04075409|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20539479|NCT00162266|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
20539480|NCT01839656|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20539481|NCT01595581|University of Southern California|Edward Schroeder|323-442-2498|eschroed@usc.edu|
20539482|NCT02621073|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
20539483|NCT00495755|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
20539484|NCT02265796|Malcom Randall VA Medical Center|Dr. Anthony Bavry|352-376-1611|anthony.bavry@va.gov|6325
20539485|NCT03449433|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20539486|NCT00569868|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|5015266990|pettynathanm@uams.edu|2461
20539487|NCT01291277|Yale School of Medicine|Dr. Loren Laine|203-937-3462|loren.laine@yale.edu|
20539488|NCT00849108|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|cesare.orlandi@lantheus.com|
20539489|NCT02963701|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539490|NCT01548742|Minneapolis VA Medical Center|Kelvin O. Lim, MD (Principal Investigator)|612-467-3323|kolim@umn.edu|
20539491|NCT00637572|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20539492|NCT01345682|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539493|NCT00896649|Boston Medical Center|Gustavo Mercier, House Radiologist|617-638-6610|gustavo.mercier@bmc.org|
20539494|NCT00795288|Washington University|Michael Diringer|314-362-2999|diringerm@wustl.edu|
20539495|NCT03180307|On Target Laboratories|Tommy Lee, MSHS, Vice President, Clinical Operations|765-588-4547|Tlee@ontargetlabs.com|
20539496|NCT00428207|Joslin Diabetes Center|Howard Wolpert, MD|6173092665|howard.wolpert@joslin.harvard.edu|
20539497|NCT01294163|Radboudumc, Department of Anaesthesiology|Dr. Jan HOFLAND|+31243611111|Jan.Hofland@radboudumc.nl|3658
20539498|NCT01563172|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539499|NCT01075984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539500|NCT02495454|Fondazione Italiana Linfomi ONLUS|Dr. Luigi Marcheselli - FIL statistician|059 4223873|lmarcheselli@filinf.it|
20539501|NCT03652675|Columbia University / New York State Psychiatric Institute|Jennifer C Elliott, PhD|646 774 7953|jce2130@cumc.columbia.edu|
20539502|NCT01638559|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20539503|NCT00712582|Memorial Sloan Kettering Cancer Center|Dr. Andrew Zelenetz, MD, PhD|646-608-3728|zeleneta@mskcc.org|
20570182|NCT00621192|Eunice Kennedy Shriver National Institute of Child Health and Human Development|David Siegel, MD|301-595-8670|siegelda@mail.nih.gov|
20570183|NCT04706793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570184|NCT00823836|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570185|NCT02725528|McMaster University|Dr. Achilles Thoma|905-523-0019|athoma@mcmaster.ca|
20570186|NCT02287233|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20570187|NCT02804399|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001800781021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570188|NCT02058836|Wake Forest University Health Sciences|Dr. Ryan Terlecki|336-716-2011|rterlecki@wakehealth.edu|
20570189|NCT05702541|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20570190|NCT01774305|Yonsei Univ. Health System, Gangnam Severance Hospital|Dr. Jeongsoo Lee|+82-2-2019-6092|ration99@yuhs.ac|
20570191|NCT02168478|Medimetriks|Noah L. Rosenberg, MD, Chief Medical Officer|2019194083|Noahrosie@yahoo.com|
20570192|NCT01157377|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20570193|NCT01324700|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD, Professor of Psychiatry|214-645-6950|sherwood.brown@utsouthwestern.edu|
20570194|NCT05479747|Faculty of Dentistry, Ain Shams University|Dr|+11112228724|AlaaMahmoud@dent.asu.edu.eg|
20570195|NCT01795859|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20570196|NCT00904722|The University of Texas (UT) MD Anderson Cancer Center|Sattva S. Neelapu, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
20570197|NCT01743976|Wake Forest School of Medicine|James C. Eisenach|336-716-4182|jimeisenach@gmail.com|
20570198|NCT02072421|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
20570199|NCT01801982|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570200|NCT00727506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20570201|NCT02650466|Alfred E. Mann Insitute at the University of Southern California|Cesar E. Blanco,PhD; Sr Director R&D|2138211619|cblanco@usc.edu|2138211619
20570202|NCT01214421|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20570203|NCT03545412|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20570204|NCT03783689|SPR Therapeutics, Inc|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
20570205|NCT04795336|NYU Langone Health|Joshua C Rozell, MD|212-598-6000|Joshua.rozell@nyulangone.org|
20570206|NCT01638390|Carl Zeiss Meditec, Inc.|Todd Otani, Senior Clinical Research Scientist|925-557-4513|todd.otani@zeiss.com|
20570207|NCT00158197|Friends Research Institute|Joy Chudzynski|323-333-8122|joychud@ucla.edu|
20539504|NCT02539511|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
20539505|NCT00483002|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539506|NCT02014584|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539507|NCT01181674|McMaster University|Dr. Natalia McInnes (nee Yakubovich)|905-521-2100|natalia.mcinnes@mcmaster.ca|
20539508|NCT03442296|Johns Hopkins University School of Medicine|Dr. Carrie Nieman|410-502-6965|cnieman1@jhmi.edu|
20539509|NCT01555125|Novartis Pharmaceutical|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20539510|NCT02651220|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20539511|NCT00447122|BrUOG|Howard Safran, MD|4018633000|BrUOG@brown.edu|
20539512|NCT01447121|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3062|carmine.greene@ascensia.com|
20539513|NCT01274429|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20539514|NCT01399008|Metabolex|Mary Jean Stempien, M.D., Acting Chief Medical Officer|510-293-8800|mjstempien@metabolex.com|
20539515|NCT03907033|Mayo Clinic|Dr. Johnny Yi|480-342-0612|Yi.Johnny@mayo.edu|
20539516|NCT01439373|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539517|NCT00370838|Johns Hopkins University|Dr. Harvey Singer|410-955-7212|hsinger@jhmi.edu|
20539518|NCT04046250|Tosk, Inc.|Emile Youssef, MD, PhD|312.244.0068|eyoussef@tosk.com|
20539519|NCT00007644|Minneapolis VA Medical Center|Timothy Wilt, MD|612-467-2158|timothy.wilt@va.gov|
20539520|NCT00709878|Northwestern University|Mario Lacouture, MD|212-610-0079|LacoutuM@mskcc.org|
20539521|NCT04576897|Indiana University|Samer Gawrieh|317-278-9326|sgawrieh@iu.edu|
20539522|NCT03834220|Debiopharm International S.A.|Head Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20539523|NCT00574548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539524|NCT02593318|University of Kansas Medical Center|Russell H. Swerdlow, MD|9135885000|rswerdlow@kumc.edu|
20539525|NCT02020408|UCSD Department of Psychiatry|Walter H. Kaye, MD|858-534|wkaye@ucsd.edu|8019
20539526|NCT03684694|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
20554289|NCT02927691|Teachers College, Columbia University|Michelle Troche|212-678-3953|mst2139@tc.columbia.edu|
20554290|NCT04356716|Columbia University|Suzanne Daly, RN, BSN|212 305 9535|sd2798@cumc.columbia.edu|
20554291|NCT03574129|University of Washington|Dr. Irene Njuguna|2065191275|irenen@uw.edu|
20554292|NCT00524134|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20554293|NCT01577706|McLean Hospital|Dr. J. Eric Jensen|617-855-3366|ejensen@mclean.harvard.edu|
20554294|NCT01782131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554295|NCT01627249|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrstat2@jaeb.org|
20554296|NCT00796718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20554297|NCT02627677|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20554298|NCT00317772|UT MD Anderson Cancer Center|Diane C Bodurka,Chief Education & Training Ofc, Education & Training|(713) 745-3358|dcbodurka@mdanderson.org|
20554299|NCT04175262|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554300|NCT02451748|University of Illinois at Chicago|Shiva Shahrara, PhD|312-413-7529|shahrara@uic.edu|
20554301|NCT03087591|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-5772|ptriozzi@wakehealth.edu|
20554302|NCT01176591|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
20554303|NCT01073618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554304|NCT02696850|WashingtonU|Dr. Jay F. Piccirillo, Principal Investigator|(314) 362-8641|piccirij@wustl.edu|
20554305|NCT00673049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554306|NCT02621606|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554307|NCT01175824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20554308|NCT03455855|Boston Scientific|Dr Haotian Zhang|+8617621154031|haotian.zhang@bsci.com|
20554309|NCT02979535|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20554310|NCT01519713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20554311|NCT04820673|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20554312|NCT00587587|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
20554313|NCT01162005|Seoul National University Children's Hospital|Hee Gyung Kang|+82-2-2072-0658|pedneph@snuh.org|
20554314|NCT03226067|Calliditas Therapeutics|Richard Philipson, MD Chief Medical Officer|Desk: +46 556659-9766|richard.philipson@calliditas.com|
20554315|NCT00875394|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20554316|NCT01933334|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20554317|NCT00767000|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554318|NCT03103282|3-D Matrix Europe SAS|Florian REBECA|+33617587769|frebeca@puramatrix.com|
20554319|NCT02039505|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20554320|NCT00693992|University of Pittsburgh|Mark A. Socinski, M.D.||socinskima@upmc.edu|
20570208|NCT04012619|West China Hospital, Sichuan University|Prof. You Lu|13398179653|radyoulu@hotmail.com|
20554321|NCT01343082|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20554322|NCT04265755|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20570209|NCT01536587|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570210|NCT02666664|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20554323|NCT00856024|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClincialTrialsDisclosure@merck.com|
20539527|NCT00575965|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617 632 5880|steven_treon@dfci.harvard.edu|
20539528|NCT03268941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20539529|NCT01216683|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20539530|NCT02100969|University of Kansas Medical Center|Dr. Mazen Dimachkie|913-588-6970|mdimachkie@kumc.edu|
20539531|NCT01629953|VA North Texas Health Care System|James LePage, Ph.D. Chief Research and Development|214-857-0240|james.lepage@va.gov|
20539532|NCT00720343|Stanford University|Pamela Flood, M.D.|201-370-3933|pflood@stanford.edu|
20539533|NCT00707954|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20539534|NCT01085435|Boston Scientific|Jens Goetzke|1-800-227-3422|jens.goetzke@bsci.com|
20539535|NCT04279613|Yale University|Dr. Kevan Herold|203-785-6507|kevan.herold@yale.edu|
20539536|NCT02478164|Dana-Farber Cancer Institute|Eudocia Q. Lee, MD, MPH|617-632-2166|eqlee@partners.org|
20539537|NCT02888743|Department of Data Science, Dana-Farber Cancer Institute|Anita Giobbie-Hurder, MS (Study biostatistician)|617-632-2193|agiohur@ds.dfci.harvard.edu|
20539538|NCT01424566|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
20539539|NCT05138549|Prisma Health|Harley T. Davis|8032969533|pamela.davis2@prismahealth.org|
20539540|NCT00450073|Emory University|Vin Tangpricha|4047277254|vin.tangpricha@emory.edu|
20539541|NCT01100528|Cleveland Clinic, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|866-223-8100|CancerCenterResearch@ccf.org|
20539542|NCT03842683|Steno Diabetes Center North Denmark|Dr. Morten Hasselstrøm Jensen|+4522226964|mhj@hst.aau.dk|
20539543|NCT03675516|Momentum Data|Dr Andrew McGovern|+447531221970|andy.mcgovern@momentumdata.co.uk|
20539544|NCT02211313|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
20539545|NCT00551291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20539546|NCT01943552|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539547|NCT01177969|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
20539548|NCT00996346|University of New Mexico Cancer Center|Monte Shaheen, MD / Study Principal Investigator|505-925-0404|MoShaheen@salud.unm.edu|
20539549|NCT01475162|Medical College of Wisconsin|William R. Drobyski|414-456-4941|wdrobysk@mcw.edu|
20539550|NCT00490022|University of Washington|Dr. Stephanie Page, PhD, MD|206.616.0483|page@u.washington.edu|
20539551|NCT02478580|University Of Texas Southwestern Medical Center|Dr. Enas Kandil|214-590-8509|Enas.Kandil@UTSouthwestern.edu|
20539552|NCT02358044|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539553|NCT02768753|General Hospital of Jinan Military Area|Dr.Qing Qing He，Dr.Gao Feng Ni|15653853675|m15653853675@163.com|
20570211|NCT04596995|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20539554|NCT01504204|Wake Forest University Health Sciences|Irma M Richardsom, MHA|336-716-2903|irichard@wakehealth.edu|
20539555|NCT00903331|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
20539556|NCT00906958|ResMed Ltd|Alison Wimms|+44 7901332675|alison.wimms@resmed.com|
20539557|NCT01571453|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20539558|NCT00129961|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20539559|NCT01985360|NYU Langone Health|Sripal Bangalore|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
20539560|NCT03691779|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20539561|NCT02528357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20539562|NCT03897036|Senhwa Biosciences|Jason Huang, MD / Chief Medical Officer and Acting Chief Executive Officer|(858) 552-6808|jasonhuang@senhwabio.com|112
20570212|NCT02783573|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
20570213|NCT00589303|Mayo Clinic|Dr. Win K. Shen|480-342-0348|wshen@mayo.edu|
20570214|NCT01780454|Massachusetts General Hospital|Dr. David Sachs|617-726-4065|David.Sachs@tbrc.mgh.harvard.edu|
20539563|NCT00721539|Stanford|Edward Damrose, MD, associate professor|650-725-6500|edamrose@stanford.edu|
20539564|NCT04054999|Mayo Clinic|Sher-Lu Pai, M.D.|904-956-3327|Pai.SherLu@mayo.edu|
20539565|NCT03869333|PATH|Rahsan Erdem|+1 202 540 4546|rerdem@path.org|
20539566|NCT01927055|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
20539567|NCT02598128|Alcresta Therapeutics, Inc.|Russell G. Clayton, D.O., Chief Medical Officer|215.813.5100|rclayton@alcresta.com|
20539568|NCT03002454|Winnipeg Regional Health Authority|Dr. Sandor Demeter|1 (204) 787-3375|sdemeter@hsc.mb.ca|
20539569|NCT02030288|VA Boston Healthcare System|Nicholas Livingston|857-364-6360|nicholas.livingston@va.gov|
20539570|NCT05219669|Opiant Pharmaceuticals|Clinical Director|18043791090|PatientSafetyNA@Indivior.com|
20539571|NCT03134183|Virginia Commonwealth University|Frances Casey, MD|804-828-5076|frances.casey@vcuhealth.org|
20539572|NCT03274804|Universitätsklinikum Heidelberg, NCT|Dr. Georg Martin Haag|+49 (0) 6221 56|GeorgMartin.Haag@med.uni-heidelberg.de|4801
20539573|NCT00845065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20539574|NCT02299076|VAL HEALTH, LLC|Daniel Astrachan|2033769388|dastrachan@valhealth.com|
20539575|NCT01198509|New York University School of Medicine|Steven B. Abramson, MD|212-263-8003|StevenB.Abramson@nyumc.org|
20539576|NCT00330668|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
20539577|NCT00181610|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
20539578|NCT01994993|Duke University Medical Center|Michael Cohen-Wolkowiez, M.D|9196688812|michael.cohenwolkowiez@duke.edu|
20539579|NCT00499746|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
20539580|NCT02228096|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20539581|NCT01969721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539582|NCT00790478|University of Tennessee|Paul Terry|(865) 305-9341|pterry@utmck.edu|
20526211|NCT04488419|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
20526212|NCT04161079|Medtentia International Ltd Oy|Olli Keränen / Chief Executive Officer|+358 50 3567090|ok@medtentia.com|
20526213|NCT02515994|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., F.A.A.O. Principle Research Optometrist|904-443-1474|KCANAVA2@its.jnj.com|
20526214|NCT00326781|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
20526215|NCT04045132|The Children's Hospital of Philadelphia|Dr. James Guevara|2155901130|guevara@chop.edu|
20526216|NCT04630249|The Medical University of South Carolina|Constance Guille|843-792-6489|guille@musc.edu|
20526217|NCT01131884|University of Rochester|K.Rao Poduri, M.D., Chair of Physical Medicine & Rehab|585-275-6978|kr_poduri@urmc.rochester.edu|
20526218|NCT05129475|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526219|NCT01899742|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526220|NCT02662764|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20526221|NCT00387751|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
20526222|NCT04874233|Prism Clinical Research|Amy Eastenson, MD|1-651-641-2900|aeastenson@prismresearchinc.com|
20526223|NCT02809859|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|7044
20526224|NCT00089778|National Cancer Institute (NCI), National Institutes of Health (NIH)|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
20526225|NCT00177307|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
20526226|NCT02523924|Johns Hopkins University|Steven Rowe, MD|4105028052|srowe8@jhmi.edu|
20526227|NCT02677038|M D Anderson Cancer Center|Dr. Milind Javle|713-792-5434|mjavle@mdanderson.org|
20526228|NCT01460654|Massachusetts General Hospital|Dr. Benjamin Leder|6177266723|bzleder@partners.org|
20526229|NCT00742872|American University of Beirut Medical Center|Dr. Ala Sharara|+961-3-350000|as08@aub.edu.lb|
20526230|NCT01917812|Johns Hopkins University School of Medicine|Dr. Seth S Martin|410-955-7376|smart100@jhmi.edu|
20526231|NCT03640481|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20526232|NCT00535847|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
20526233|NCT05007041|Duke University|Dr. Kenneth Schmader|919-660-7572|kenneth.schmader@duke.edu|
20526234|NCT04889157|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526235|NCT01546168|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20526236|NCT02850016|The Rockefeller University|Marina Caskey|212-327-7396|mcaskey@rockefeller.edu|
20526237|NCT01902758|University of Montana|Director of the Montana Center for Work Physiology and Exercise Metabolism|406-243-2117|brent.ruby@mso.umt.edu|
20526238|NCT00423189|Retina Consultants of Houston|David M. Brown|713-524-3434|dmbmd@houstonretina.com|
20526239|NCT01844206|Columbia University|Dr. Allison Lee|305-582-6077|al3196@cumc.columbia.edu|
20526240|NCT05028413|University of Pennsylvania|Associate Professor Mucio C. Delgado, MD, MS|215-74-826|mucio.delgado@pennmedicine.upenn.edu|
20526241|NCT00070018|SWOG Statistical Center|Study Statistician|206-667-4623||
20526242|NCT02747849|UPittsburgh|Rajeev Chaudhry, MD|412-692-7932|rajeev.chaudhry@chp.edu|
20526243|NCT04756128|Methodist Hospital|Daniel Delaney, PharmD|952-993-5442|daniel.delaney@parknicollet.com|
20526244|NCT03488849|InnoVital Systems|Chief Medical Officer|2022862328|amit@innovitalsystems.com|
20526245|NCT00574249|Abbott|Medical Information Specialist|1-800-633-9110||
20526246|NCT00669552|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
20526247|NCT03197870|EyePoint Pharmaceuticals, Inc|David Bauer|8573410747|dbauer@eyepointpharma.com|
20526248|NCT01618019|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
20526249|NCT01542034|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20526250|NCT03845491|Stryker Neurovascular|Sr. Clinical Project Manger|510-413-2500|lisa.park@stryker.com|
20526251|NCT01508130|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20526252|NCT01680159|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20526253|NCT02200536|Damascus University|Assistant Professor Easter Joury|00963955650456|easterjoury@icloud.com|
20526254|NCT02783729|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20526255|NCT05600270|Lahey Hospital and Medical Center|Neev Mehta|781-744-1933|neev.n.mehta@lahey.org|
20526256|NCT02288091|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
20526257|NCT04021121|University of California, San Francisco|Dr. Felicia Chow|(628) 206-4449|felicia.chow@ucsf.edu|
20526258|NCT02458768|LG Life Sciences|Jonghee Jin|82-2-6924-3122|jonghee@lgls.com|
20526259|NCT02773212|University of Illinois at Chicago|Dr. Margaret Wardle|(312)413-5564|mwardle@uic.edu|
20526260|NCT00978250|National Cancer Institute|Dr. James Doroshow|240-781-3320|jim_doroshow@nih.gov|
20526261|NCT01330394|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
20526262|NCT03843632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526263|NCT03403751|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
20526264|NCT05036668|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20526265|NCT02105246|San Francisco VA Healthcare System|Dr. Mary Whooley|415-221-4810|mary.whooley@va.gov|
20526266|NCT01623037|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulaory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20526267|NCT00387010|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20526268|NCT02071810|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20526269|NCT00520481|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539583|NCT01102894|University of Minnesota|Dr. Joanne Slavin|612-624-7234|jslavin@umn.edu|
20539584|NCT04023682|University of Iowa Hospitals and Clinics|Sundara Reddy, MBBS|(319) 356-2108|sundarareddy-durgempuditripura@uiowa.edu|
20539585|NCT01599741|Philips|Thijs Grunhagen|+31 6 11645166|thijs.grunhagen@philips.com|
20539586|NCT02745535|Institute of Human Virology, University of Maryland|Dr. Eleanor Wilson|1(410)706-1710|eleanor.wilson@ihv.umaryland.edu|
20539587|NCT00440830|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
20539588|NCT02145351|Mayo Clinic|Barry A. Borlaug, M.D.|507-255-4152|Borlaug.Barry@mayo.edu|
20539589|NCT00716742|Allergan, Inc.|Vice President, Global Health Outcomes Strategy and Research|714-246-4500|clinicaltrials@allergan.com|
20539590|NCT03480009|University of Pittsburgh|Principal Investigator, MD MPH|412-641-5496|fpr@upmc.edu|
20539591|NCT00491374|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20539592|NCT04268745|New York University|Dr. Anat Lubetzky|2129989195|anat@nyu.edu|
20539593|NCT01086852|Bio Products Laboratory|Miranda Norton|020 8 957 2661|miranda.norton@bpl.co.uk|
20539594|NCT01174173|Northwestern University|Sanjiv J. Shah, MD|3129262926|sanjiv.shah@northwestern.edu|
20539595|NCT00527332|Deptartment of Obstetrics and Gynecology, University Hospital, Linköping, Sweden|Dr Preben Kjolhede|+46101030000|Preben.Kjolhede@lio.se|3187
20539596|NCT00528801|Children's Hospital of Oakland and Research Institute|Elliott Vichinsky, MD|510-428-3651|evichinsky@mail.cho.org|
20539597|NCT01364740|Stanford University|Clete A. Kushida, MD, PhD|650-721-7560|clete@stanford.edu|
20539598|NCT05532891|Imperial College London|Dr Emma Rose McGlone|07949565678|e.mcglone@ic.ac.uk|
20539599|NCT02504580|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
20539600|NCT01329848|Western University of Health Sciences|Dr. Chris Chase|909 706-3882|cchase@westernu.edu|
20539601|NCT00789672|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
20539602|NCT04473664|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20539603|NCT02252965|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20539604|NCT01387464|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
20539605|NCT02429791|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20539606|NCT02615691|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20539607|NCT00881504|Georgetown University Medical Center|Dr. John L Marshall|202-444-7064|marshalj@georgetown.edu|
20539608|NCT01276223|Alcon Research|Director of Alcon Clinical|1-888-451-3937||
20539609|NCT02017522|University of Michigan|Venkatesh Murthy, MD||vlmurthy@umich.edu|
20539610|NCT05856227|Basilea Pharmaceutica International Ltd, Allschwil|Marc Engelhardt, MD, Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
20539611|NCT02596230|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539612|NCT01571232|Retina Macula Institute|Ron P. Gallemore M.D., Ph.D.|310-944-9393|rongallemoremd@gmail.com|
20539613|NCT01854268|University of Florida|Alexandra E. Brandimore, M.A. CCC/SLP|352-273-3711|aessman@ufl.edu|
20539614|NCT02704689|Stryker|Jennifer Warnke|(201) 749-8000|jennifer.warnke@stryker.com|
20539615|NCT00802893|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20539616|NCT03123328|Masimo Corporation|Director, Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
20539617|NCT02251938|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
20539618|NCT04051827|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20539619|NCT04909229|Yale University|Joseph Ross, MD, MHS|203-785-2987|joseph.ross@yale.edu|
20507921|NCT01265420|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|317-875-9105|tdk@hand.md|
20507922|NCT02554253|Mayo Clinic|Erica Wittwer|5072559814|wittwer.erica@mayo.edu|
20539620|NCT02484950|Rush University Medical Center|Brian Cole|(312) 432-2818|Brian.cole@rushortho.com|
20539621|NCT01646203|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20539622|NCT01557959|Wake Forest Baptist Health|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
20539623|NCT02717130|Thriving Mind South Florida|John W. Newcomer, M.D., President & CEO|305-860-0653|jnewcomer@thrivingmind.org|
20539624|NCT02335424|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20570215|NCT04836559|Janssen Research & Development, LLC|Executive Medical Director Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20539625|NCT00548717|Dana Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|Corey_Cutler@dfci.harvard.edu|
20539626|NCT02712424|Geisel School of Medicine|Dr C Fordham von Reyn|6036505000|fvr@dartmouth.edu|
20539627|NCT02809053|Archigen Biotech Ltd|Medical Director|+44 (0)20 3749 5000|info@archigenbio.com|
20539628|NCT02411929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539629|NCT01722435|Centre for Interdisciplinary Addiction research of Hamburg University ZIS|Prof. Dr. Jens reimer|+4940741057900|reimer@uke.de|
20539630|NCT00908037|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539631|NCT02565810|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
20570216|NCT00730015|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
20570217|NCT04978350|UNC Lineberger Comprehensive Cancer Center|Angelo Navas|919-445-1128|angelo_navas@med.unc.edu|
20507923|NCT03558191|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Project manager|0518-82342973|linan.wang@hengrui.com|
20507924|NCT01736254|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20570218|NCT00013611|University of Minnesota|Gary Collins, M.S.|612-626-9006|gary-c@ccbr.umn.edu|
20539632|NCT02723175|Medical University of South Carolina|Jeffrey Borckardt|843-792-3295|borckard@musc.edu|
20539633|NCT04109976|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20507925|NCT02559206|Ironwood Pharmaceuticals, Inc.|Nick Omniewski, MPH|(617) 621-8454|nomniewski@ironwoodpharma.com|
20526270|NCT04586634|Coloplast|Director of Clinical Strategy|+4549111111|clinical-studies@coloplast.com|
20526271|NCT00789256|Dartmouth-Hitchcock Medical Center|Marc Gautier, MD - Principal Investigator|603-650-5529|marc.gautier@hitchcock.org|
20526272|NCT00381043|University of North Carolina at Chapel Hill|Dr. J.C. Garbutt|919-966-4652|jc_garbutt@med.unc.edu|
20526273|NCT02880865|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
20526274|NCT03951064|University of North Carolina at Chapel Hill|Jackson Pettee|984-215-6872|jackson_pettee@med.unc.edu|
20526275|NCT00796705|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20526276|NCT01565369|Avid Radiopharmaceuticals|Chief Medical Officer|215-798-0700|clinicaloperations@avidrp.com|
20526277|NCT02841280|Indiana University|Dr. Rajiv Agarwal|3179882241|ragarwal@iu.edu|
20526278|NCT00833482|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20526279|NCT01290978|cyberDERM Clinical Studies|Dr. Gary Grove|610-325-0112||
20526280|NCT01746420|Wright Medical|Justin Moss|615-236-4984|justin.moss@wright.com|
20526281|NCT02600845|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20526282|NCT03666533|Department of Veterans Affairs Northeast Ohio Healthcare system|Dr. Svetlana Pundik|216-791-3800|svetlana.pundik@va.gov|63732
20526283|NCT04240886|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
20526284|NCT01089933|OHRI|Dr Michelle Chiu|613-798-5555|mchiu@toh.ca|14169
20526285|NCT04743804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20526286|NCT01632150|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20570219|NCT05382039|Loma Linda University|Eric Johnson|9095584632|ejohnson@llu.edu|47471
20570220|NCT01432626|University of Pittsburgh|Dr. Prem Soman|412 647 3435|somanp@upmc.edu|
20570221|NCT01642147|Huashan Hospital Fudan University|Xiao-Yu Yang|086-021-52889999|xiaoyuyangfudan@gmail.com|7693
20570222|NCT02577003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Dvelopment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20570223|NCT02786004|GE Healthcare|Beth Heckel|262-312-7269|beth.heckel@med.ge.com|
20570224|NCT04351269|Aziyo Biologics, Inc.|Associate Director of Clinical Operations|470-514-4085|clinical@aziyo.com|
20570225|NCT03210519|Department of Nutrition, Chung Shan Medical University|Dr. Nae-Cherng Yang|886-0936810214|naeman@csmu.edu.tw|
20570226|NCT00476242|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
20570227|NCT04486313|Romark|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
20570228|NCT00126659|UT MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor||caperez@mdanderson.org|
20570229|NCT00174447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20570230|NCT02643225|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20570231|NCT01013961|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20570232|NCT01667406|Imperial College London|Professor Waljit Dhillo|442083833242|w.dhillo@imperial.ac.uk|
20570233|NCT03865953|Lateral Pharma Pty Ltd|Mr David Kenley|+61 (0)400 151 490|dk@lateral-pharma.com|
20570234|NCT02229578|University of Florida|Brenda Fahy, MD|859-402-4360|bfahy@anest.ufl.edu|
20570235|NCT00943787|University of Virginia|Mary Oliveri|434-982-0602|mc7m@virginia.edu|
20570236|NCT03017937|Cincinnati Chidren's Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
20570237|NCT04883060|University of Iowa|Matthew Howard III|(319) 356-8468|matthew-howard@uiowa.edu|
20570238|NCT01777334|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570239|NCT03603639|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20570240|NCT02440334|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. John Eisenbrey|(215) 503-5188|john.eisenbrey@jefferson.edu|
20570241|NCT00756457|Ithaca College|Jeff Houck, PhD|585-340-9619|jhouck@ithaca.edu|
20570242|NCT01973062|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-444-6145|ahluwam@ccf.org|
20570243|NCT02413593|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20570244|NCT00409409|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20570245|NCT01818427|University of Pittsburgh|Dr. Jason Sperry|412 6922850|sperryjl@upmc.edu|
20570246|NCT03599622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20570247|NCT02420041|Naval Medical Center San Diego|LCDR Ian M Fowler, MD|619-532-8954|ian.m.fowler.mil@mail.mil|
20570248|NCT01278615|University of Chicago|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
20570249|NCT00905359|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20570250|NCT02138253|Conatus Pharmaceuticals, Inc.|Steven Mento, Ph.D., CEO|858-376-2622|smento@conatuspharma.com|
20570251|NCT01918371|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20570252|NCT01006889|University of Florida|Dr. Kenneth Cusi|352-273-8661|kcusi@ufl.edu|
20570253|NCT02085473|MedImmune, LLC|Meena Jain|+44 (0) 1223 895966|jainm@medimmune.com|
20570254|NCT04438382|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20570255|NCT01099579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20570256|NCT02446613|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570257|NCT02706847|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20570258|NCT03432390|Anesthesiology Unit, Teaching Hospital of the Federal University of Pernambuco, Recife, Pernambuco, Brazil|Dr. Jayme Marques dos Santos Neto|5581996212977|jaymemed@yahoo.com.br|
20526287|NCT05027048|Stanford|Dr. Jessica Ansari|650-723-5349|jansari@stanford.edu|
20526288|NCT02143791|Abbott|Devyani Nanduri|+1 510 561 4328|devyani.nanduri@abbott.com|
20526289|NCT04112160|UT Southwestern Dept of Urology|Dr. Brett Johnson|214-645-3526|brett.johnson@utsouthwestern.edu|
20570259|NCT00835185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20570260|NCT01087814|University of Minnesota|Ann Seguin|612-625-7472|segu0017@umn.edu|
20539634|NCT00491608|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
20570261|NCT01427738|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20570262|NCT05314374|Mayo Clinic|Andres Acosta|507-266-6931|acosta.andres@mayo.edu|
20554324|NCT01531959|Beth Israel Deaconess Medical Center|Matthias Eikermann|6176327034|meikerma@bidmc.harvard.edu|
20554325|NCT03614793|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Zachary McCormick, MD|801-587-1493|u6014808@umail.utah.edu|
20554326|NCT02082522|At the request of Concordia Laboratories Inc.|Dr. Michelle Depot||michelle.depot@advanzpharma.com|
20554327|NCT01863446|Mass General Hospital|Elizabeth Klerman|617-643-2424|ebklerman@hms.harvard.edu|
20554328|NCT00633984|Boston University|Dr. Stefan G. Hofmann|617 353 9233|shofmann@bu.edu|
20554329|NCT02554773|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20554330|NCT02496884|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20554331|NCT00097591|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20554332|NCT02312310|Columbia University Medical Center|Scott A. Small, MD|212-305-1269|sas68@columbia.edu|
20554333|NCT01168999|University of Florida|Dr. Joel Bialosky|352-273-8636|bialosky@phhp.ufl.edu|
20554334|NCT04317586|Stryker|Kevin Barga|2018315073|kevin.barga@stryker.com|
20554335|NCT00491244|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-2-23123456|jacque_liu@mail2000.com.tw|63572
20554336|NCT01276327|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554337|NCT00807092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20554338|NCT01794949|Emory University|Henry Liberman, MD|404-686-2503|hliberm@emory.edu|
20570263|NCT02658175|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20570264|NCT01966978|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20570265|NCT02918292|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20570266|NCT01351337|Huashan Hospital|Dr Jinsong Wu|862152888771|wjsongc@126.com|
20570267|NCT02392104|William S. Middleton Memorial Veterans Hospital|Andrea Porter, PharmD|608-890-0742|andrea.porter@wisc.edu|
20570268|NCT01963169|University of Maryland, Baltimore|Eun-Shim Nahm|410-706-4913|enahm@son.umaryland.edu|
20570269|NCT02636608|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20570270|NCT03912532|NGM Biopharmaceuticals, Inc|VP, Clinical Operations|650-243-5555|ngm282@ngmbio.com|
20570271|NCT04913948|Ottawa Hospital Research Institute|Dr. Darine El-Chaar|(613) 737-8899|delchaar@toh.ca|78797
20570272|NCT00815919|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|John_Koreth@dfci.harvard.edu|
20554339|NCT03766646|University Hospital Southampton|Dr Patrick Butler|81205662|patrick.butler@uhs.nhs.uk|+44 (0)23
20526290|NCT03051516|Fred Hutchinson Cancer Center|Margaret M. Madeleine, PhD|206-667-4630|mmadelei@fredhutch.org|
20570273|NCT03522389|Mahidol University|Sunee Bovonsunthonchai|66855926144|sunee.bov@mahidol.ac.th|
20570274|NCT00589836|Cleveland Clinic|Zoran Popovic MD|216 444-9242|popoviz@ccf.org|
20570275|NCT04599907|Candesant Biomedical|Erin Tims, VP of Clinical Affairs|19255776863|etims@candesant.com|
20570276|NCT03780010|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
20570277|NCT00966264|Helsinki University|Ritva Hurskainen|+23845872267|ritva.hurskainen@hus.fi|
20570278|NCT00487825|Novartis Pharmaceuticals|Study Director|862-778-8300||
20570279|NCT01473745|ChangGungMH|Dr. Yi Hsuan Chen|+886227135211|acantehr@gmail.com|3533
20570280|NCT01986114|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20570281|NCT01190644|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20570282|NCT02366143|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20570283|NCT02172911|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20570284|NCT01589926|Children's Hospital at Montefiore|Kerry Morrone, MD, Asst Prof of Pediatrics|718-741-2342|kmorrone@montefiore.org|
20570285|NCT00575042|University of Miami|Dr. Cynthia Levy|305-243-2330|clevy@med.miami.edu|
20570286|NCT00566813|University of Illinois at Chicago|Jose Oberholzer, MD|312-996-6771|jober@uic.edu|
20570287|NCT01271504|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20570288|NCT03745794|UT MD Anderson Cancer Center|Dr. Ching-Wei D. Tzeng, MD/Associate Professor, Surgical Oncology|(713) 792-0386|cdtzeng@mdanderson.org|
20570289|NCT02768597|Mayo Clinic|Dr. Mark E. Morrey|507-284-2511|morrey.mark@mayo.edu|
20570290|NCT00940875|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20570291|NCT00490945|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marelene.dressman@vandapharma.com|
20570292|NCT00567840|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
20570293|NCT03064152|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
20570294|NCT02309346|Hospital de Clínicas de Porto Alegre|Ricardo Francalacci Savaris|+55 51 33596042|rsavaris@hcpa.edu.br|
20570295|NCT03721705|Renew Research|Billy Tally, CEO|949-545-8466|bill2@stage2innovations.com|
20570296|NCT01162135|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
20570297|NCT01951768|Geneva University Hospitals, Balgrist University Hospital|Dr. med. Ilker Uçkay|+41 44 386 11 11|ilker.uckay@balgrist.ch|
20570298|NCT01181492|Huazhong University of Science&Technology|Zhang Xianwei|027 83662853|ourpain@163.com|
20570299|NCT00485953|University of Pittsburgh|Dr. Susan Greenspan|412-692-2476|greenspn@pitt.edu|
20570300|NCT01216072|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20570301|NCT04070768|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20570302|NCT00720369|McLean Hospital|Cara McCabe, BA|617-855-2410|cfmccabe@partners.org|
20570303|NCT02947100|Nemours/AI duPont Hospital|Dr Robin Miller|302-651-5500|rmiller@nemours.org|
20570304|NCT00822770|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PhD / Associate Professor|713-794-1628|mkonople@mdanderson.org|
20570305|NCT02402322|Universitat Autonoma de Barcelona|Dr. Pablo Oromendia|+34 665175467|p.oromendia@gmail.com|
20570306|NCT02818998|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20570307|NCT00926380|Massachusetts General Hospital|Natalie David||ndavid2@mgh.harvard.edu|
20570308|NCT01080326|Mayo Clinic|Juliane Bingener-Casey, M.D.|507-538-9007|BingenerCasey.Juliane@mayo.edu|
20570309|NCT04919070|University of Rochester|Dr. Sally Norton|5852759814|sally_norton@urmc.rochester.edu|
20570310|NCT01296555|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20570311|NCT03563313|University of Virginia|Sue Brown, MD|434-962-0602|sab2f@virginia.edu|
20570312|NCT01182181|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20570313|NCT01704547|UMGCCC|Elizabeth M. Nichols, MD|410-328-2324|enichols1@umm.edu|
20570314|NCT01101061|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20570315|NCT01200498|The University of Texas MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Assistant Professor|713-745-4009|eharriso@mdanderson.org|
20570316|NCT01586975|Northwestern University|Northwestern University|312.503.4394|r-bernstein@northwestern.edu|
20570317|NCT02569957|Sidney Kimmel Cancer Center at Thomas Jefferson University|Russell Schilder|215-503-3057|russell.schilder@jefferson.edu|
20570318|NCT02635386|Woman's Hospital|Dr Karen Elkind-Hirsch|2252315278|karen.elkind-hirsch@womans.org|
20570319|NCT00745498|Seoul National University Bundang Hospital Department of Ophthalmology|Dr. Se Joon Woo|+82-31-787-7377|sejoon1@hanmail.net|
20570320|NCT03174782|University of California, San Francisco- Fresno|Kamell Eckroth-Bernard|559-431-6226|kamell.eckroth-bernard@ucsf.edu|
20570321|NCT00778921|Novartis Pharmaceuticals|Study Director|862-778-8300||
20570322|NCT03178045|Memorial Sloan Kettering Cancer Center|Robert Allen Jr., MD|646-608-8041|allenr1@mskcc.org|
20570323|NCT03636373|Rutgers, The State University of New Jersey|Naomi Schlesinger, MD|732 235 6117|Naomi.Schlesinger@hsc.utah.edu|
20570324|NCT00572533|University of Louisville|Adam E Gaweda|502-852-0766|adam.gaweda@louisville.edu|
20570325|NCT01078922|Oncology Specialists, SC|Research Manager|847-410-0658|ktolzien@oncmed.net|
20570326|NCT02353468|University of Colorado|Choon-kee Lee, MD|7208489252||
20570327|NCT00003477|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20570328|NCT00267098|Medtronic CRDM Clinical|BLOCK HF Clinical Trial Leader|763-526-2729|medtroniccrmtrials@medtronic.com|
20570329|NCT01575873|Amgen Inc.|Study Director|866-572-6436||
20570330|NCT00798304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570331|NCT02031536|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20570332|NCT04069585|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
20570333|NCT04211389|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20570334|NCT00980590|Cleveland Clinic|Dr. Daniel Sessler|216-445-6500|sessled@ccf.org|
20570335|NCT00547534|University of Rochester Medical Center|Dr. Jonathan Friedberg|585-275-4911|Jonathan_Friedberg@urmc.rochester.edu|
20570336|NCT03850275|Clarkson University|Ali Boolani|3152681663|aboolani@clarkson.edu|
20570337|NCT02688530|Hospital for Special Surgery|Meghan Kirksey, MD, PhD|212-606-1206|Kirkseym@hss.edu|
20570338|NCT00725543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20570339|NCT03200444|Coloplast A/S|Director of Pre-Clinical Research|49111111|dklfn@coloplast.com|+45
20570340|NCT01062971|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20570341|NCT01530087|Hollister Incorporated|Director, Global Clinical Affairs|847.918.3467|Stacy.Haddad@hollister.com|
20570342|NCT01182207|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20570343|NCT00762645|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20570344|NCT04996940|University of Kansas Medical Center|Leah Lambart Graduate Research Assistant|9139457862|llambart@kumc.edu|
20570345|NCT03947918|University of California, San Francisco|Suzanna Martinez|415-476-2300|suzanna.martinez@ucsf.edu|
20570346|NCT03783871|Ethicon|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
20570347|NCT05990387|Indiana University|Dr. Blair Johnson|8128558699|bj33@iu.edu|
20570348|NCT00604188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20570349|NCT04680637|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20570350|NCT02242643|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570351|NCT04243512|University of Maryland Baltimore|Amber Kleckner|410-706-5961|amber.kleckner@umaryland.edu|
20570352|NCT01103232|Vakif Gureba Training and Research Hospital|ILHAN KARACAN|+ 90 212 4531700|ilhankaracan@hotmail.com|
20570353|NCT03500835|Children's Hospital Los Angeles|Alaina Vidmar|323-361-4606|avidmar@chla.usc.edu|
20570354|NCT00443599|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
20570355|NCT05093504|CytoSorbents|Weihong Fan|1 732-329-888|wfan@cytosorbents.com|
20570356|NCT02272244|Thomas Jefferson Universiy|Ronald Myers(Priniciple Investigator)|215-5034085|ronald.myers@jefferson.edu|
20570357|NCT03733899|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
20570358|NCT03526679|National Taiwan University Hospital|Dr. Tom Wei-Wu Chen|+886-2-23123456|tomwchen@ntuh.gov.tw|66002
20570359|NCT03415243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20570360|NCT04916002|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20570361|NCT05923112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570362|NCT03118050|University of Texas Medical Branch|Elena Volpi, MD, PhD|210-562-6139|volpi@uthscsa.edu|
20570363|NCT05781750|Kezar Life Sciences, Inc.|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
20570364|NCT05621252|Pliant Therapeutics|Pliant Therapeutics Medical Monitor|650-481-6770|clintrials@pliantrx.com|
20570365|NCT01234883|Baxter Healthcare|Drew Jones, M.D.|224-270-2659|Drew_Jones@baxter.com|
20570366|NCT04889118|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20570367|NCT05147350|Repare Therapeutics INC|Repare Therapeutics Medical Monitor|857-340-5402|clininfo@reparerx.com|
20570368|NCT06576674|University of North Carolina at Chapel Hill|Michael Bremmer, PhD|301-827-0566|mbremmer@unc.edu|
20570369|NCT06136897|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20570370|NCT02472145|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20570371|NCT00632021|Vanderbilt University Medical Center|Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
20570372|NCT02025855|Frederick Health|Thomas Smoot|2405663250|tlsmoot@frederick.health|
20570373|NCT01628692|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20570374|NCT02437071|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
20570375|NCT03101033|Xijing Hospital, the Fourth Military Medical University|Dr yan lu|029-84775337|yanlu001@fmmu.edu.cn|029-847753
20570376|NCT01587118|Tuscaloosa Research and Education Advancement Corp|Sandra Creel|205-554-2000|sandra.creel@va.gov|1-2840
20570377|NCT01640171|Retina Vitreous Associates of Florida|Steven Cohen|7274459110|scohen@health.usf.edu|
20570378|NCT03802617|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
20570379|NCT00020722|Barbara Ann Karmanos Cancer Institute|Lawrence G. Lum, M.D., D.Sc|(313) 576-8326|luml@karmanos.org|
20570380|NCT03042299|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20570381|NCT04788511|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20570382|NCT00672451|Wake Forest University Health Sciences|Dr. John Burkart|33671662958|jburkart@wakehealth.edu|
20570383|NCT01031498|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
20570384|NCT01658020|Asan Midical Center|Principal Investigator|+82-2-3010-3136|ymoh55@amc.seoul.kr|
20570385|NCT04206085|Viveve|Vice President, Clinical & Medical Affairs|720-696-8100|clinicalaffairs@viveve.com|
20570386|NCT02760485|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20570387|NCT03845023|Apnimed, Inc|Clinical Trials|6015008880|clinicaltrials@apnimed.com|
20570388|NCT02353871|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20570389|NCT02526186|MOMH|Amanda Crawford|7025633583|amanda.j.crawford.ctr@health.mil|
20570390|NCT03180008|University of Illinois at Chicago|Andrew DeMott, MPH|312-355-3174|ademot1@uic.edu|
20570391|NCT06638840|Oticon medical|Director of Clinical Affairs|+46 31 748 61 00|studyinfor@oticonmedical.com|
20570392|NCT04750577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20570393|NCT04980378|Globus Medical|Jessica Fulwider, Lead Clinical Project Manager|703-772-1455|jfulwider@globusmedical.com|
20570394|NCT02647645|Nova Southeastern University|Raymond L Ownby, MD, PhD|9542621481|ro71@nova.edu|
20570395|NCT01688310|Catholic University of Mozambique Medical School|Dr. Peter Millard|2078663503|pmillard@mac.com|
20570396|NCT03371823|University of Delaware|Dr. Megan Wenner|302-831-7343|mwenner@udel.edu|
20570397|NCT00311246|UIC|Nadera J Sweiss|312-996-5723|nsweiss@uic.edu|
20570398|NCT01466790|Janssen Research & Development, LLC|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
20570399|NCT00356811|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570400|NCT02386839|Shire (Note: This product was divested to Oak Hill Bio in 2022)|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20570401|NCT01939301|Indiana University|Jeffrey A. Kline, MD|317-880-3900|jefkline@iu.edu|
20570402|NCT00212992|Ottawa Hospital Research Institute|Dr. Ian G. Stiell, Senior Scientist|613-798-5555|istiell@ohri.ca|18683
20570403|NCT05347485|Janssen Scientific Affairs, LLC|Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20570404|NCT04369053|Freenome|Director of Clinical Development|(650)446-6630|medicalaffairs@freenome.com|
20570405|NCT05064488|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20570406|NCT04986566|City of Hope Medical Center|Dr, Laleh Melstrom|626-359-8111|lmelstrom@coh.org|
20570407|NCT04090528|University of Wisconsin - Madison|Douglas G. McNeel, MD PhD|(608) 263-4198|dm3@medicine.wisc.edu|
20570408|NCT04082429|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20570409|NCT04991766|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20570410|NCT05499130|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20570411|NCT04464421|University of Tennessee Health Science Center|Karen Derefinko, PhD|9014482526|kderefin@uthsc.edu|
20570412|NCT06533527|Cleveland Clinic Florida (Weston Hospital)|Dr. Tilak Shah|954-659-5646|shaht3@ccf.org|
20570413|NCT04590404|Vanderbilt University Medical Center|Dr. Hilary Tindle|(615) 875-9726|hilary.tindle@vumc.org|
20570414|NCT05903183|Icosavax Inc.|Icosavax Clinical Operations|206-737-0085|clinops@icosavax.com|
20570415|NCT03698019|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
20570416|NCT00569127|SWOG|SWOG Statistician|206-667-4408||
20570417|NCT05147272|Repare Therapeutics|Repare Therapeutics Medical Monitor|857-340-5402|clininfo@reparerx.com|
20570418|NCT03172975|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
20570419|NCT05238103|Johns Hopkins University|Lena Mathews, MD MHS|410-502-0469|lmathew6@jhmi.edu|
20570420|NCT05739994|Indiana University Bloomington|Dr. Hannah Block|8128555390|hjblock@iu.edu|
20570421|NCT03299959|Smith+Nephew, Inc|Senior Manager Clinical Compliance|07811407089|datasharing.gcs@smith-nephew.com|
20570422|NCT03735121|Hoffman-La-Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20570423|NCT03725605|Lytix Biopharma AS|Director Scientific Research Baldur Sweinbjornsson|+47 413 44 682|Baldur.Sveinbjornsson@lytixbiopharma.com|
20570424|NCT03668223|Dana Farber Cancer Institute|Dr. Abby Rosenberg|617-632-5286|abbyr_rosenberg@dfci.harvard.edu|
20539635|NCT00025155|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20539636|NCT04897607|Christiana Care Health System|Dr. Scott Siegel|302-623-4500|ssiegel@christianacare.org|
20539637|NCT03781791|Enterin|Richard Larson, MD Chief Medical Officer|505-469-2670|r.larson@enterininc.com|
20539638|NCT05086510|AinShamsU|Dr. Mohammad Gamal|2001114115331|mdgamal92@gmail.com|
20539639|NCT00413374|Brigham and Women's Hospital|Research Coordinator|617-732-6984|arao2@partners.org|
20539640|NCT00552760|Lehigh Valley Hospital|Edward R. Norris, MD|(610) 402-5766|Edward.Norris@lvh.com|
20539641|NCT03022981|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20539642|NCT01944345|Wenzel Spine, Inc.|Director, Quality & Regulatory Affairs|5123148271|bnowatzke@wenzelspine.com|
20539643|NCT03615066|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20539644|NCT04079881|Wash Univ School of Medicine|Janet McGill, MD|(314) 362-8681|jmcgill@wustl.edu|
20539645|NCT00924404|University of Iowa|Lakshmi Durairaj|319-353-7968|lakshmi-durairaj@uiowa.edu|
20539646|NCT00721175|Khon Kaen University|Assist. Prof. Apichat Sangchan|66850004651|apichaz@yahoo.com|
20539647|NCT03294629|Sleep Center, Taoyuan Chang Gung Memorial Hospital|Ning-Hung, Chen|+886-3-3281200|ninghung@yahoo.com.tw|2281
20539648|NCT01008969|University of California, San Francisco|Youngho Seo, PhD|415-353-9464|youngho.seo@ucsf.edu|
20539649|NCT01848366|William Beaumont Hospital|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.org|
20539650|NCT01175395|University of Illinois at Chicago|Jennifer I Lim MD|312-413-0704|jennylim@uic.edu|
20539651|NCT00225784|Dartmouth-Hitchcock|J. Marc Pipas, MD|603-650-9474|J.Marc.Pipas@hitchcock.org|
20539652|NCT01459913|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20539653|NCT01064687|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539654|NCT02966015|Clinical operations,Medical Affairs|Head of clinical operations|+45 49113267|dkphl@coloplast.com|
20539655|NCT00509171|London Health Sciences Centre|Emil H. Schemitsch, MD, FRCS|5196633349|emil.schemistch@lhsc.on.ca|
20539656|NCT02177838|Rutgers Cancer Institute of New Jersey|Sung Kim, MD|732-235-3986|sk1375@cinj.rutgers.edu|
20539657|NCT04040621|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539658|NCT02383433|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Davendra Sohal|+1 216-444-8258|sohald@ccf.org|
20539659|NCT02208349|St Vincent Hospital|Jestin Carlson|8144525000|jcarlson@svhs.org|
20539660|NCT02477553|Indiana University|Peter H. Schwartz, M.D., Ph.D.|317-278-4037|phschwar@iu.edu|
20539661|NCT04311463|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20539662|NCT00952614|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
20539663|NCT00737633|Vivus, Inc|Wesley W Day, PhD|650-934-5200|day@vivus.com|
20539664|NCT00377364|UT Southwetern Medical Center at Dallas|E.Sherwood Brown, M.D., Ph.D.|214-645-6950|Sherwood.Brown@utsouthwestern.edu|
20539665|NCT02986854|GlaxoSmithKline|GSK Response Center|866-435-7343|mb116236@gsk.com|
20539666|NCT02530996|Salt Lake VAMC and University of Utah|Dr. Tracy Frech|801 213 2312|tracy.frech@hsc.utah.edu|
20539667|NCT00695864|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
20539668|NCT01403116|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
20539669|NCT02409342|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20539670|NCT00279812|Institute of Food Research|Dr Charlotte Armah|01603 255 000|charlotte.armah@ifr.ac.uk|5360
20539671|NCT05327361|University of Miami|Enzo Berardesca|3052434472|exb743@med.miami.edu|
20539672|NCT02107157|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20539673|NCT05498467|Department of Dermatology and Allergy - Herlev-Gentofte Hospital|Kelvin Yeung|38673243|kelvin.yeung@sund.ku.dk|0045
20539674|NCT02069119|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20539675|NCT02720692|Baudax Bio Inc.|Development|484-395-2440|info@baudaxbio.com|
20539676|NCT02503501|HealthPartners Neuroscience Research|Clinical Research Manager|651-495-6363|aleta.l.svitak@healthpartners.com|
20539677|NCT01740401|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
20539678|NCT03878758|Becton Dickinson|Michael Gibney|201-847-6170|michael.gibney@bd.com|
20539679|NCT01769196|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20539680|NCT00765063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539681|NCT03614325|Beth Israel Deaconess Medical Center|Dr. Brian P. O'Gara|6177543189|bpogara@bidmc.harvard.edu|
20539682|NCT00321464|Amgen Inc.|Study Director|866-572-6436||
20539683|NCT00119366|Fred Hutchinson Cancer Research Center|Johnnie Orozco, MD, PhD|(206) 667-4102|jorozco@fredhutch.org|
20539684|NCT01673620|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554340|NCT00759967|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@ohri.ca|82534
20554341|NCT01229228|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
20554342|NCT04479618|BenskinL|Linda Benskin, PhD, RN, Independent Researcher|+1 (512) 659-0812|lindabenskin@utexas.edu|
20554343|NCT04023695|Vanderbilt University|Brian Drolet, MD|(615) 322-2350|brian.c.drolet@vumc.org|
20554344|NCT04627727|BIDMC|Judy Nee, mD|617-667-2193|jnee@bidmc.harvard.edu|
20539685|NCT01206582|Mayo Clinic|Dr. Adil E. Bharucha|507-284-6439|bharucha.adil@mayo.edu|
20539686|NCT02522325|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
20539687|NCT01755455|Dartmouth-Hitchcock Medical Center|Alex H. Gifford, M.D.|603-650-5533|alex.h.gifford@hitchcock.org|
20554345|NCT01260922|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20570425|NCT01503086|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
20570426|NCT05502783|National Heart, Lung, and Blood Institute (NHLBI) at National Institutes of Health (NIH)|Dr. Georg Aue|301.547.9490|aueg@nhlbi.nih.gov|
20570427|NCT04870957|University of Michigan|Afton Hassett, PsyD|734-763-5226|afton@med.umich.edu|
20570428|NCT05970640|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20570429|NCT04340843|Washington University in St. Louis School of Medicine|Dr. Mia Weiss|3147473096|m.c.weiss@wustl.edu|
20507926|NCT03862131|Washington University School of Medicine|Dr. Joshua Mitchell|314-362-1291|jdmitchell@wustl.edu|
20507927|NCT02024204|NYU Langone|Joan Reibman, MD|212-263-6479|joan.reibman@nyumc.org|
20507928|NCT00937794|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20570430|NCT00310180|ECOG-ACRIN Cancer Research Group|ECOG-ACRIN statistician|617-632-3000|eatrials@jimmy.harvard.edu|
20570431|NCT01090011|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20570432|NCT01641653|Rutgers-New Jersey Medical School|Vasanti Tilak, MD|973 972-7477|tilakva@njms.rutgers.edu|
20570433|NCT02852356|Ovation Fertility|Director|5126107474|tex@ovationfertility.com|
20507929|NCT00597935|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20570434|NCT00321685|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20570435|NCT00624910|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20570436|NCT01730950|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20570437|NCT03023722|Yale University|Stacey Stein, MD|203 737-1600|stacey.stein@yale.edu|
20570438|NCT03616964|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20570439|NCT00129935|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20570440|NCT03445793|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|taylorcousarj@njhealth.org|
20570441|NCT03020069|NYU Langone Health|Jeniece Ilkowitz RN, MA, CDE|212-263-9910|Jeniece.ilkowitz@nyulangone.org|
20570442|NCT02056626|University of Rochester|John Bisognano|585-341-7800|john_bisognano @ urmc.rochester.edu|
20570443|NCT03809000|American College of Radiology|Wendy Seiferheld|2155743208|wseiferheld@acr.org|
20570444|NCT05765435|Cionic|Rebecca Webster|888-481-3724|rebecca@cionic.com|
20570445|NCT01952847|UT MD Anderson Cancer Center|Aung Naing, MD-Professor, Invest. Cancer Therapeutics|(713) 563-3885|anaing@mdanderson.org|
20570446|NCT01585441|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
20570447|NCT00882115|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
20570448|NCT01850589|Staten Island University Hospital|Dr. Jonathan Deitch, PI, Director of Vascular Surgery|718-226-9000|jonathan_deitch@siuh.edu|1278
20570449|NCT01843777|National Center for Rehabilitative Auditory Research|M. Samantha Lewis, PhD|503-220-8262|Michele.Lewis3@va.gov|51996
20570450|NCT01449149|Department of Radiation Oncology, PENN MEDICINE|Michelle Alonso-Basanta, MD PhD|215 615 3782|michelleab@uphs.upenn.edu|
20570451|NCT03721172|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20570452|NCT01318876|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
20570453|NCT01653210|Univerisity of Virginia|Sue Brown, MD||sab2f@virginia.edu|
20570454|NCT00224029|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20570455|NCT03513068|ResMed|Maureen Crocker, Sr. Manager Market Access|+65 9815 2195|maureen.crocker@resmed.com|
20570456|NCT00513747|The Arthur James Comprehensive Cancer Center|John Byrd, MD|614-293-9869|john.byrd@osumc.edu|
20570457|NCT01236352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20570458|NCT01827046|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
20570459|NCT02357264|Maimonides Medical Center|Eitan Dickman, MD|718-283-6057|edickman@maimonidesmed.org|
20570460|NCT03623373|Washington University School of Medicine|Brad S. Kahl, M.D.|314-273-3591|bkahl@wustl.edu|
20570461|NCT02282917|Mass General Brigham|Matthew E Stenerson, MSc, Clinical Research Project Manager|7155721100|matthew_stenerson@meei.harvard.edu|
20570462|NCT02581059|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20570463|NCT03149029|Massachusetts General Hospital Cancer Center|Ryan J. Sullivan, MD|617-643-3614|RSULLIVAN7@mgh.harvard.edu|
20570464|NCT02176863|Instituto Grifols, S.A.|Sandra Camprubi, PhD/Senior Director, Clinical Operations|+34 67 0923160|sandra.camprubi@grifols.com|
20570465|NCT06077773|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20570466|NCT02473042|The University of Texas MD Anderson Cancer Center|Alicia Kowalski, MD|(713) 563-5614|amkowalsk@mdanderson.org|
20570467|NCT02037256|Barbara Ann Karmanos Cancer Institute|Dr. Divaya Bhutani|501-680-9229|db3203@cumc.columbia.edu|
20570468|NCT03007732|University of California, San Francisco|Dr. David Oh, MD, PhD|(415) 476-1000|David.Oh@ucsf.edu|
20570469|NCT02101983|University of Rochester|Deborah Mulford|585-275-5823|deborah_mulford@urmc.rochester.edu|
20570470|NCT02634814|University of North Carolina at Chapel Hill|Brian Pietrosimone, PhD|919-962-3617|brian@unc.edu|
20570471|NCT06017050|Center for Innovative Public Health Research|Michele Ybarra|8773026858|michele@innovativepublichealth.org|801
20570472|NCT06862154|Marmara University School of Medicine|Dr. Emre Kudu|+902166254545|dr.emre.kudu@gmail.com|
20570473|NCT03459846|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20570474|NCT00001481|National Institute of Mental Health (NIMH)|Dr. Peter Schmidt|+1 301 496 6120|peterschmidt@mail.nih.gov|
20570475|NCT02911805|Atlanta VA|Jeffrey H. Boatright, PhD|404-321-6111|jeffrey.boatright@va.gov|
20570476|NCT03987295|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
20570477|NCT00826228|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
20570478|NCT01246999|University of Rochester|John Treanor MD, Professor of Medicine|585-275-5871|John_Treanor@urmc.rochester.edu|
20570479|NCT04650698|NYU Langone|Arthur Hertling, MD|212-598-6085|Arthur.Hertling@nyulangone.org|
20570480|NCT00307047|Abbott Vascular|Ellen Travis|408-845-1512|ellen.travis@av.abbott.com|
20570481|NCT00379769|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570482|NCT03778294|Mayo Clinic|Dr Sujay Vora|480-342-1262|Vora.Sujay@mayo.edu|
20570483|NCT02825251|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20570484|NCT01197612|University of Michigan|Garrett Griffin, MD||ggriffin@mw-fp.com|
20570485|NCT00349466|Can-Fite Biopharma|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
20570486|NCT01689363|Amphastar Pharmaceuticals, Inc.|Gisela Sharp|(909) 980-9484|GiselaS@amphastar.com|2016
20570487|NCT02104505|Center for Environmental Medicine, Asthma and Lung Biology; University of North Carolina, Chapel Hill|Allison Burbank, MD|919-843-2714|allison_burbank@med.unc.edu|
20570488|NCT01845805|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
20570489|NCT02859064|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20570490|NCT00127842|Amgen Inc.|Study Director|866-572-6436||
20570491|NCT00667459|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20570492|NCT02568397|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
20570493|NCT02354651|University of Florida|Dr. Barbara Smith|3522945315|bksmith@ufl.edu|
20570494|NCT00581893|University of Iowa|Erik St. Louis|507-266-7456|StLouis.Erik@mayo.edu|
20570495|NCT00590564|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng|646-888-0841|dengg@mskcc.org|
20570496|NCT00656201|Brigham and Women's Hospital|Elena Yanushpolsky, MD|617-732-4648|lgreenberg@partners.org|
20570497|NCT01377389|UT MD Anderson Cancer Center|Aparicio,Ana,M.D. / Genitourinary Medical Oncology|713-792-7734|AAPARICIO@MDANDERSON.ORG|
20570498|NCT01434680|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20570499|NCT01012245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20570500|NCT00725712|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570501|NCT01515943|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20570502|NCT02684123|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman-Yassky|(212) 241-9728|Emma.Guttman@mountsinai.org|
20570503|NCT05224843|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
20570504|NCT02120001|Massachusetts General Hospital|Robert Kacmarek, Director Respiratory Care|(617) 726-2000|rkacmarek@mgh.harvard.edu|
20570505|NCT02037477|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20570506|NCT01245140|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570507|NCT02635360|University of Virginia|Dr. Linda R. Duska|434-944-9135|LRD5D@uvahealth.org|
20570508|NCT00334542|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
20570509|NCT02078726|University of California, San Francisco|John Cello, MD|628-206-4767|John.Cello@ucsf.edu|
20570510|NCT02833805|Johns Hopkins University|Dr. Amy DeZern|410-502-7208|adezerb1@jhmi.edu|
20570511|NCT00535938|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20570512|NCT03182998|Mayo Clinic|Dr. Jon C. Tilburt, MD, MPH|480-301-3401|tilburt.jon@mayo.edu|
20570513|NCT00777634|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
20570514|NCT00872001|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20570515|NCT03178344|Department of Psychiatry, UNC Chapel Hill|Jhana Parikh|919-966-9929|jhana_parikh@med.unc.edu|
20570516|NCT00996502|Columbia University|CU PRS Administrator|212-342-1643|ClinicalTrialsGov@cumc.columbia.edu|
20570517|NCT03218566|Penumbra, Inc.|Erin Archard, Sr. Clinical Study Manager|+1 510 995 9801|earchard@penumbrainc.com|
20570518|NCT00443209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20570519|NCT01728623|Eisai Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
20570520|NCT01791413|Mahidol University|Dr. Weena Krutsawad|66812070264|vna_fe2@hotmail.com|
20570521|NCT00521976|Stavanger University Hospital|Dennis W.T. Nilsen MD PhD FESC FAHA|+4705151|nide@sus.no|9455
20570522|NCT00133575|Brigham and Women's Hospital|Lindsey R. Baden, M.D.|617-732-6801|LBaden@partners.org|
20570523|NCT01280604|Mercer University/ Kaiser Permanente|Kendra Manigault, PharmD, BCPS, BCACP, CDE|678-547-6216|manigault_kr@mercer.edu|
20570524|NCT04016272|Florida State University|Dr. Hyochol Ahn|850-644-2647|hahn@fsu.edu|
20526291|NCT03408444|Johnson & Johnson Vision Care, Inc.|Xu Cheng - Sr. Principal Clinical Scientist|1-800-843-2020|xcheng6@its.jnj.com|
20570525|NCT00825305|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
20526292|NCT04984681|University of Alabama at Birmingham|Crystal Chapman Lambert|205-934-3481|cclamber@uab.edu|
20526293|NCT01214252|Covidien|Annie Choi|781-839-1756|annie.choi@covidien.com|
20526294|NCT04327661|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|2027343400|clinicaltrials@vandapharma.com|
20526295|NCT02817698|Yale University|Marc Grasso|2037377074|marc.grasso@yale.edu|
20526296|NCT03391232|Treos Bio|Chef Scientific Officer|+3615500826|eniko.toke@treosbio.com|
20539688|NCT02081599|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20539689|NCT01840527|Massachusetts General Hospital Cancer Center|Ryan Sullivan|6177244000|rsullivan7@mgh.harvard.edu|
20539690|NCT02146001|University of Pittsburgh|Dr. Bethany Barone Gibbs|412-383-4002|bbarone@pitt.edu|
20539691|NCT01356628|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Avnish Bhatia|215-955-8874|avnish.Bhatia@jefferson.edu|
20539692|NCT00306527|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20539693|NCT00785980|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20539694|NCT00344500|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
20539695|NCT02207491|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20539696|NCT00126776|Minneapolis VAMC|Kathryn Rice MD|612 725 2000|kathryn.rice@va.gov|4400
20539697|NCT00417963|C.R. Bard Inc.|Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|2644
20539698|NCT03603106|Guerbet|Jing Hao, MD|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20539699|NCT00448747|Aeterna Zentaris|Nicola Ammer|+496942602|nammer@aezsinc.com|3472
20539700|NCT00387725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539701|NCT02692755|Georgetown University|Nicole Swanson|2026879194|ns1209@georgetown.edu|
20539702|NCT04201093|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20539703|NCT00007020|Retrophin, Inc.|Retrophin Medical Information|+1 8776595|medinfo@retrophin.com|518
20539704|NCT05011058|Viracta Therapeutics|Dr. Darrel Cohen|858-400-8470|ClinicalTrials@Viracta.com|
20539705|NCT03908476|Abbott|Marie Fahey|+15122864398|Marie.fahey@abbott.com|
20539706|NCT05194267|UCSD|Jean-Phillipe Miron|514-890-8000|jmiron@health.ucsd.edu|26489
20539707|NCT00320424|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539708|NCT03270891|University of Michigan|Laurie Buis|734-998-5694|buisl@med.umich.edu|
20539709|NCT02540668|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
20539710|NCT05779007|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20539711|NCT06225466|University of Texas Southwestern Medical Center|Dr. Proshad Efune|2144566393|proshad.efune@utsouthwestern.edu|
20539712|NCT06328660|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
20539713|NCT03194438|State University of New York at Buffalo School of Nursing|Tania Von Visger, APRN, PhD, PCCN|7168292201|Taniavon@buffalo.edu|
20539714|NCT05147662|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20539715|NCT04394715|Yale University|Nihar Desai|203-767-6399|nihar.desai@yale.edu|
20554346|NCT02708745|Seattle Children's Hospital|Dr. Doug Opel|206-987-2000|douglas.opel@seattlechildrens.org|
20554347|NCT03653429|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|212-523-4000|poonam.paibantwalhebbalasankatte@mountsinai.org|
20554348|NCT01700946|St. Jude Children's Research Hospital|Sima Jeha, MD|(901) 595-3901|sima.jeha@stjude.org|
20554349|NCT01168934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554350|NCT02480621|Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital|Dr. Adam Driesman|2033315938|Adam.Driesman@nyumc.org|
20554351|NCT02617589|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20554352|NCT01975389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554353|NCT01331694|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554354|NCT01334866|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
20554355|NCT00955266|Brigham & Women's Hospital|Michael Nurok|617-899-5961|mnurok@gmail.com|
20554356|NCT02296112|Vanderbilt University Medical Center|Douglas Johnson, MD|(615) 936-8422|douglas.b.johnson@vumc.org|
20554357|NCT02052466|Cleveland Clinic Foundation|Dr. Eric Ricchetti|2164456915|ricchee@ccf.org|
20554358|NCT00508742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554359|NCT01613339|Orebro county council|Dr. Anette Forsberg|+46-19-602 5788|anette.forsberg@orebroll.se|
20554360|NCT01228929|University of Rochester|Dr. James V. Aquavella|585-275-8944|james_aquavella@urmc.rochester.edu|
20554361|NCT03246529|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
20554362|NCT02283528|Emory University|Dr. Gary Francis Bouloux|404-778-4500|gfboulo@emory.edu|
20554363|NCT03136068|UCSF|Director of Clinical Trials|414-206-8715|abby.sokoloff@ucsf.edu|
20554364|NCT01071395|Rush University of Medical Center|Dr. Christopher G. Goetz|312-942-8016|cgoetz@rush.edu|
20554365|NCT01946711|Pari Pharma|Friedrich gruber|+4989742846|friedrich.gruber@pari.com|76
20554366|NCT01337089|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
20554367|NCT04419493|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554368|NCT01040871|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
20554369|NCT03041415|Stanford University|Principal Investigator|6507235082|king@stanford.edu|
20554370|NCT02044510|Lawson Research Institute|Mary McKibbon|5196466367|mary.mckibbon@sjhc.london.on.ca|
20554371|NCT02652780|GenSight Biologics|Regulatory Affairs|176217220|ipengue@gensight-biologics.com|0033
20554372|NCT01172938|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|clinicaltrialdisclosure@celgene.com|
20554373|NCT01033747|Novartis Pharmaceuticals|Study Director|862 778-8300||
20554374|NCT00003498|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20554375|NCT02956629|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554376|NCT04188041|Kent Hospital|Daria Szkwarko, PI|401-921-7981|szkwarkd@gmail.com|77981
20554377|NCT04177693|Yale University|Dr. Heping Zhang|2037855185|heping.zhang@yale.edu|
20554378|NCT00618657|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20554379|NCT00365859|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20554380|NCT04713748|Duke Clinical and Translational Science Institute|Douglas Wixted|919-668-0515|douglas.wixted@duke.edu|
20554381|NCT00995449|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
20554382|NCT00406029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554383|NCT01557946|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
20554384|NCT04067141|CooperVision, Inc.|Jose A. Vega, O.D., MSC., FAAO|9256213761|javega@coopervision.com|
20554385|NCT01219738|University of Miami|Eliana Mendes|(305) 243-2568|e.mendes@miami.edu|
20554386|NCT02639884|Masimo Corporation|Vikram Ramakanth|9492977416|vramakanth@masimo.com|
20554387|NCT01831089|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology Business Unit.|+34 91 846 60 00|clinicaltrials@pharmamar.com|
20554388|NCT00889421|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
20554389|NCT01958918|Novartis Pharma AG|Study Director|+41613241111|Novartis.email@novartis.com|
20554390|NCT01597687|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554391|NCT02114892|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
20554392|NCT01243450|Cu-Tech, LLC|William J. Cunningham, MD|(973) 331-1620|wcunningham@cu-tech.com|
20554393|NCT02013765|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20554394|NCT02061345|Imperial College, London|Prof Pat Price|02075895111|p.price@imperial.ac.uk|
20554395|NCT01134900|The University of Texas Health Science Center at Houston (UTHealth)|Allison B. McCoy, PhD|713-500-6931|allison.b.mccoy@uth.tmc.edu|
20554396|NCT00659269|University of New Mexico|Zoneddy Dayao, MD|5059250404|zdayao@salud.unm.edu|
20554397|NCT02832674|ThermiGen LLC|Toni Fournier, Sr. VP New Products|214-888-0634|TFournier@Thermi.com|
20554398|NCT00718042|Abbott Laboratories|Associate Director Clincal Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
20554399|NCT04327934|John B. Pierce Laboratory/Yale School of Medicine|Nina Stachenfeld|203 562 9901|nina.stachenfeld@yale.edu|219
20554400|NCT02443298|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
20507930|NCT04777214|University of Pennsylvania|Samuel Cason|215-573-4336|sacason@pennmedicine.upenn.edu|
20539716|NCT00231413|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20507931|NCT01064076|Cameron Health, Inc. a subsidiary of Boston Scientific|Michael Husby, Clinical Studies Manager|312-402-1877|michael.husby@bsci.com|
20507932|NCT00547898|Valeant Pharmaceuticals|Johnson Varughese|9089271162|christine.hnatko@valeant.com|
20507933|NCT03326869|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
20507934|NCT01874119|Saint Louis University|Dr. John Richart|314-577-8854|richartj@slu.edu|
20507935|NCT01002742|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20507936|NCT05263921|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507937|NCT02670928|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20507938|NCT02678312|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20507939|NCT04507776|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20507940|NCT00393068|Sarah Cannon Research Institute|Johanna C. Bendell, MD|615-329-7274|jbendell@tnonc.com|
20507941|NCT01136746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20507942|NCT00700063|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20507943|NCT03154294|Avera Cancer Institute|Dr. Casey Williams|605-322-3588|Casey.Williams@avera.org|
20507944|NCT00223652|Northwestern University|David C. Mohr|312- 503-1403|d-mohr@northwestern.edu|
20507945|NCT00092677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20507946|NCT02966353|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20507947|NCT00873288|Northwestern University|Bonnie Spring|312-908-2293|bspring@northwestern.edu|
20507948|NCT00749268|Covidien|Jessica Carlson, Clinical Project Manager|(203) 821-4734|jessica.carlson@covidien.com|
20507949|NCT00081328|TODAY Coordinating Center at George Washington University Biostatistics Center|Dr. Kathryn Hirst, Coordinating Center PI|301-881-9260|khirst@bsc.gwu.edu|8025
20507950|NCT02814448|Cleveland Clinic|Dr. Miriam Cremer|216-312-0618|cremerm@ccf.org|
20507951|NCT00093470|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
20507952|NCT00010803|University of Virginia|Steven T. DeKosky MD|434-924-5118|SD3ZC@hscmail.mcc.virginia.edu|
20507953|NCT05905601|University of Washington / University of North Carolina at Chapel Hill|Benjamin Buck, Ph.D.|(919) 445-4330|ben.buck@med.unc.edu|
20507954|NCT02514772|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
20507955|NCT00877006|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20507956|NCT04671342|Philips|Bill Hardy|412-874-2710|bill.hardy@philips.com|
20507957|NCT03583606|Cincinnati Children's Hospital|Paul Spearman, MD|513-636-4509|paul.spearman@cchmc.org|
20507958|NCT04131933|Ottawa Hospital Research Institute|Dr. Mark Clemons|+1-613-737-7700|mclemons@toh.ca|70170
20507959|NCT00817206|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
20507960|NCT00126581|Dana-Farber Cancer Institute|Pasi Janne, MD, PhD||pjanne@partners.org|
20507961|NCT00793182|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
20507962|NCT01754207|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20507963|NCT03728140|Reproductive medcine of Jinan central hospatil|Dr. bin wu|+86 053185695203|wb0538@163.com|
20507964|NCT01188096|Atrium Health|Donald L. Durden, MD, PhD|980-442-2048|donald.durden@atriumhealth.org|
20507965|NCT00851253|Boston Medical Center|Dr. Minh Tam Truong|617-638-7070|Minh-Tam.Truong@bmc.org|
20507966|NCT00806078|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
20507967|NCT02236273|Columbia University|Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
20507968|NCT02487277|University of California, San Francisco|Dr. Andrew Ko|(415) 353-7286|Andrew.Ko@ucsf.edu|
20539717|NCT02708485|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
20507969|NCT05859971|University of Wisconsin School of Medicine and Public Health|Heather Neuman, MD, MS, FACS|(608) 262-9060|neuman@surgery.wisc.edu|
20507970|NCT00109005|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
20507971|NCT03004976|Duke University|Emily Poehlein, MB|919-668-8473|emily.poehlein@duke.edu|
20507972|NCT02786836|UT Southwestern Medical Center at Dallas|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
20507973|NCT01143714|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
20507974|NCT01106391|Cordis Corp.|Brandy Maschhaupt, Clinical Project Manager|847-887-5744|brandy.maschhaupt@cardinalhealth.com|
20539718|NCT01659255|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20539719|NCT03316950|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20539720|NCT00549770|Novartis Pharmaceuticals|Study Director|862-778-8300||
20570526|NCT03617289|Henry Ford Health System|Dr. Jason Muir|517-861-6451|jmuir1@hfhs.org|
20570527|NCT00884897|Maryland Psychiatric Research Center|Deanna L. Kelly Pharm.D., BCPP|410-402-96860|dkelly@mprc.umaryland.edu|
20570528|NCT00153985|Dana-Farber Cancer Institute|Catherine Wu, MD|617-632-5943|cwu@partners.org|
20570529|NCT01715883|University of Pittsburgh|Matthew Morrell, MD|412-647-8477|morrellmr@upmc.edu|
20570530|NCT01850030|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
20570531|NCT00246090|Eisai Call Center|Eisai Inc.|888-422-4743||
20570532|NCT03053453|NYU Langone Health|Dr. Arthur Hertling|2125986085|Arthur.Hertling@nyulangone.org|
20507975|NCT00150345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20554401|NCT01047683|Amarin Pharma, Inc.|Alex Giaquinto|+1 908 326 1324|alex.giaquinto@amarincorp.com|
20570533|NCT00763451|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20570534|NCT00763490|University of Michigan Comprehensive Cancer Center|Dr. Daniel Couriel, M.D.|734-936-8785|dcouriel@umich.edu|
20554402|NCT04847050|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
20570535|NCT01473992|University of South Florida|M. Jason Highsmith|8139743806|mhighsmi@health.usf.edu|
20526297|NCT00552032|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20570536|NCT05594589|Eisai Korea Inc. Medical department|Serena SoYoun Kwon|+82-2-3451-5533|s-kwon@eisaikorea.com|
20570537|NCT00115336|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
20570538|NCT02554383|University of Pittsburgh|Nader Shaikh|412-692-8111|nader.shaikh@chp.edu|
20570539|NCT02482610|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
20570540|NCT03272711|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
20570541|NCT01536197|University of Illinois at Urbana Champaign|M. Yanina Pepino|217-300-2374|ypepino@illinois.edu|
20570542|NCT00715117|Pennsylvania State University|Jill P Smith, MD Professor Emeritus of medicine|717-531-3694|jsmith2@psu.edu|
20570543|NCT01999777|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
20570544|NCT03569891|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20570545|NCT00796627|Johns Hopkins University|Dr. John Harmon|410-550-0405|jharmon@jhmi.edu|
20570546|NCT01527162|Seattle Children's Research Institute|Kristie Bjornson, PhD, PT|206 884-2066|kristie.bjornson@seattlechildrens.org|
20570547|NCT01310699|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
20570548|NCT00926575|Soligenix, Inc.|Dhara Patel, Clinical Coordinator|609-538-8200|dpatel@soligenix.com|
20570549|NCT02035696|Seqirus|Clinical Trial Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20570550|NCT01882413|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20570551|NCT01867047|Duke University Medical Center|Michael Bolognesi, MD||michael.bolognesi@duke.edu|
20570552|NCT01454739|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
20570553|NCT02367352|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20570554|NCT02866669|University of Alabama at Birmingham|Dr. Andrea Cherrington|205-996-2885|acherrington@uabmc.edu|
20570555|NCT01437423|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20570556|NCT01375751|Amgen Inc.|Study Director|866-572-6436||
20570557|NCT02980523|Laboratorios Sophia|Clinical pharmacologist|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20570558|NCT00633945|University of Pennsylvania|Dr. Victoria Werth|215-898-0168|werth@mail.med.upenn.edu|
20570559|NCT02552147|Vanderbilt University Medical Center|Alan Lewis, MD, PhD|(615) 936-4997|alan.s.lewis@vumc.org|
20570560|NCT03792347|Ruijin Hospital, Shanghai JiaoTong University School of Medicine|Prof. Hecheng Li, Chair of Thoracic Surgery|(86)13917113402|lihecheng2000@hotmail.com|
20570561|NCT02743897|Perelman School of Medicine|Dr. Peter Reese|215-900-3782|amussell@upenn.edu|
20570562|NCT01573949|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
20570563|NCT02229227|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20526298|NCT02091960|Astellas Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
20526299|NCT04777201|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20526300|NCT02697890|TuftsUSDM|Y. Natalie Jeong|6176366531|natalie.jeong@tufts.edu|
20526301|NCT02691013|University of California San Diego|Dr. Robert Owens|858-657-5258|rowens@ucsd.edu|
20526302|NCT06017752|Boise State University|Dr. Aida Midgett|2084261219|aidamidgett@boisestate.edu|
20526303|NCT02357706|Charite Department of Sleepmedizin|Prof Dr med Ingo Fietze|+49 30 450 513 122|ingo.fietze@charite.de|
20526304|NCT02111785|Department of Neurosurgery, University of Virginia Health System|Dr. Daniel Raper|4349823244|raper@virginia.edu|
20526305|NCT02327403|Massachusetts General Hospital|Dr. Leonardo V Riella, MD, PhD|6176436266|LRIELLA@MGH.HARVARD.EDU|
20526306|NCT00880230|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
20526307|NCT02275780|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20526308|NCT03960866|Ocuphire Pharma, Inc.|Mina Sooch|248-681-9815|msooch@ocuphire.com|
20526309|NCT03369067|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20526310|NCT01054300|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526311|NCT00981045|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20526312|NCT00135798|University Colorado, Denver|Gregory T. Everson, M.D., Director of Hepatology|720-848-2245|greg.everson@UCDenver.edu|
20526313|NCT00738881|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D|507/538-1760|alex.adjei@roswellpark.org|
20526314|NCT00759785|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526315|NCT02416193|Loyola University Chicago|Mary Byrn, R.N., Ph.D.|(773) 508-8973|mbyrn@luc.edu|
20526316|NCT01282164|Cleveland Clinic|Dr. Amir H. Hamrahian|216-445-8555|hamraha@ccf.org|
20526317|NCT03671564|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
20526318|NCT04521621|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20526319|NCT01663779|Yale School of Medicine|Kevin M. Schuster|203-785-2572|kevin.schuster@yale.edu|
20526320|NCT02609100|Washington University School of Medicine in St. Louis|Dr. Vladimir M. Kushnir|314-362-3685|vkushnir@wustl.edu|
20526321|NCT05845567|Italfarmaco SpA|Maurizio Caserini, MD|+ 39 02 64431|m.caserini@italfarmacogroup.com|
20526322|NCT03409107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20526323|NCT00916344|BIOTRONIK SE & Co.KG|Dr. Evelyn Diessel|+49 (0) 30 68905|evelyn.diessel@biotronik.com|1231
20507976|NCT05034614|Mayo Clinic|Danielle J. O'Laughlin, P.A.-C., M.S.|507-284-5164|OLaughlin.Danielle@mayo.edu|
20526324|NCT01013844|Northwestern University Department of Dermatology|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
20526325|NCT02062944|Northwestern University|Josh Levitsky|312 695 4413|josh.levitsky@nm.org|
20539721|NCT01395277|University of Texas at Austin|Dr. R. Matthew Brothers|512-232-6016|r.m.brothers@austin.utexas.edu|
20539722|NCT05375214|Johns Hopkins University|Kevin Li|443-475-0671|kevinli@jhmi.edu|
20539723|NCT00628147|SF VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
20539724|NCT02636712|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
20539725|NCT04596085|Natural Supplements LLC|Dr. Mahir Abduldaim|+966557880299|maherdaim@yahoo.com|
20570564|NCT01580904|Universidade Estadual da Paraíba|Impacto da Atenção Farmacêutica em pacientes diabéticos (IPCD)|558387010977|patriciatrindad@yahoo.com.br|
20570565|NCT02018653|University of Texas (UT) MD Anderson Cancer Center|Sai-Ching J. Yeung, MD||CR_Study_Registration@mdanderson.org|
20570566|NCT02677870|UHCMC|Dr. Lori-Anne Schillaci|216-844-3936|lori-anne.schillaci@uhhospitals.org|
20570567|NCT01607879|Froedtert and the Medical college of Wisconsin|Kathryn Bylow, MD|414-805-4600|kbylow@mcw.edu|
20570568|NCT04468230|Virginia Commonwealth University|Renato Martins, MD|804-828-1965|MasseyCPC@vcu.edu|
20570569|NCT03714659|New Jersey Regenerative Institute|Dr. Gerard Malanga|9739988301|gmalangamd@hotmail.com|
20570570|NCT03845140|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20570571|NCT05020145|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570572|NCT01592045|United Therapeutics Corporation|Allison Lim|919-425-8799|alim@unither.com|
20570573|NCT04560374|Marmara University Faculty of Health Sciences Department of Pediatric Nursing|Dr. Çağrı Çövener Özçelik|009-0216-777-57-00|ccovener@gmail.com|5773
20570574|NCT02239744|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
20570575|NCT00148668|Dana-Farber Cancer Institute|Dr Eric Winer|617-632-2335|eric_winer@dfci.harvard.edu|
20526326|NCT01740128|James J. Peters VAMC|Noam Y. Harel, MD, PhD|718-584-9000|noam.harel@va.gov|1742
20526327|NCT01223469|St. Jude Medical/Endosense|Hendrik Lambert PhD, VP of Clinical and Regulatory Affairs||Hendrik.Lambert@endosense.com|
20526328|NCT02658734|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20526329|NCT02231879|LMI/NIAID/NIH|Dr. David H. McDermott|301-761-6647|dmcdermott@niaid.nih.gov|
20526330|NCT00189306|Graceway Pharmaceuticals|Medical Director|267-984-0400|jim.lee@gracewaypharma.com|
20526331|NCT00459706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526332|NCT02939716|University of Nottingham|Robin Spiller|01158231090|robin.spiller@nottingham.ac.uk|
20526333|NCT00976209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20526334|NCT01252563|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526335|NCT00901017|Institut Straumann AG|Marc Quirynen, Professor|+4161965|michael.hotze@straumann.com|1235
20526336|NCT03826628|AFT Pharmaceuticals Ltd.|Ioana Stanescu|+64 9 488 0232|ioana.stanescu@aftpharm.com|712
20526337|NCT02029989|UMN, College of Pharmacy|Dr. Mark E. Schneiderhan|8452540458|meschnei@d.umn.edu|
20526338|NCT00271011|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
20526339|NCT02224820|Dept of Transplant Surgery, Uppsala University Hospital|Dr. Tomas Lorant|+46 70 677 29 01|tomas.lorant@surgsci.uu.se|
20526340|NCT00756561|University of Washington, Dept. of Medicine|Mara Roth, MD|(206) 221-0519|mylang@u.washington.edu|
20526341|NCT03045276|Children's Hospital of Philadelphia|Dr. Sandra Amaral|2678443097|amarals@chop.edu|
20526342|NCT03724877|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526343|NCT03492398|Seoul National University Hospital|Inseung Jeon|82-2-2072-1920|isjeon0127@snu.ac.kr|
20526344|NCT04383938|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20526345|NCT05072106|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar's Oncology, Business Unit,|0034918466000|AEincoming@pharmamar.com|
20526346|NCT00771264|Uroplasty, Inc.|Susan Holman, Cheif Operating Officer|952-426-6143|susan.holman@uroplasty.com|
20526347|NCT01944670|Skeletal Dynamics, LLC|Ana Escagedo|305-596-7585|AEscagedo@SkeletalDynamics.com|
20526348|NCT02879994|Jonsson Comprehensieve Cancer Center|Dr. Edward Garon|(310)586-2098|egaron@mednet.ucla.edu|
20526349|NCT01272141|Emory University School of Medicine|William Read, MD|1-888-946-7447|william.l.read@emory.edu|
20526350|NCT04063657|University of California, Davis|Dr. Christopher Kreulen|(916) 734-6805|ckreulen@ucdavis.edu|
20526351|NCT01473394|Forest Research Institute, Inc.|Carl Gommoll|201 427-8000||
20526352|NCT04178824|Icahn School of Medicine at Mount Sinai|Allan Geliebter PhD|212-523-4574|Allan.Geliebter@mountsinai.org|
20526353|NCT03794661|Abbott Medical Devices Neuromodulation|Binith Cheeran|+15122864262|binith.cheeran@abbott.com|
20526354|NCT04810247|The Miriam Hospital|Dr. KayLoni Olson|401-793-8971|kayloni.olson@lifespan.org|
20526355|NCT01995175|GlaxoSmithKline|GSK Response Center|866-435-7343|lr24921@gsk.com|
20526356|NCT00984061|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20526357|NCT00535782|Hoffman-LaRoche|Medical Communications|800-821-8590||
20526358|NCT01185509|Dana-Farber Cancer Institute|Ian Krop, MD, PhD|617.632.6973|Ian_Krop@dfci.harvard.edu|
20526359|NCT02946073|Braeburn|Susan Franks, SVP, Head of Regulatory Affaires|6104678719|sfranks@braeburnrx.com|
20526360|NCT05803096|Beth Israel Medical Center|Dr. Heidi Rayala|16176673739|hrayala@bidmc.harvard.edu|
20526361|NCT05178641|Procter & Gamble Co.|Dr. Susanna Brink, Clinical Scientist|+49 6196 89 4474|brink.s@pg.com|
20526362|NCT01588457|UT Health San Antonio|Charles Bowden, MD|2105675393|bowdenc@uthscsa.edu|
20539726|NCT02049138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20539727|NCT00257660|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
20539728|NCT02437084|Stanford University School of Medicine|Dr Joshua W. Knowles, MD, PhD; Assistant Professor, Cardiovascular Medicine|650-723-1431|knowlej@stanford.edu|
20539729|NCT03945019|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
20539730|NCT01462877|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20539731|NCT03332160|Tactile Medical|Heather Smith|612.800.5539|HSmith@tactilemedical.com|
20539732|NCT04598269|Aclaris Therapeutics, Inc.|Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
20539733|NCT03101085|University of Kansas Medical Center|Dr. Russell Swerdlow|913-588-0970|rswerdlow@kumc.edu|
20539734|NCT01154751|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
20539735|NCT00718770|University of Colorado School of Medicine|Joshua Klopper, MD|303-724-3921|joshua.klopper@ucdenver.edu|
20539736|NCT04484207|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
20539737|NCT00772109|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20539738|NCT01624090|National Cancer Institute|Dr. David S. Schrump|240-858-7000|schrumpd@nih.gov|
20539739|NCT01895309|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
20539740|NCT04232215|Mayo Clinic|Yvonne S. Butler Tobah, M.D.|507-284-0210|ButlerTobah.Yvonne@mayo.edu|
20539741|NCT02454153|Johns Hopkins University|Naresh M. Punjabi|410-550-6487|npunjabi@jhmi.edu|
20539742|NCT00626405|Mayo Clinic|Svetomir Markovic, M.D., Ph.D.|5072840527|markovic.svetomir@mayo.edu|
20539743|NCT02666105|University of Minnesota|Manish Patel, DO|612-625-2654|patel069@umn.edu|
20539744|NCT02147769|Stanford University|Valerie Chock, MD|650-723-5711|vchock@stanford.edu|
20539745|NCT01264419|Silk Road Medical, Inc.|Richard Ruedy, Exec VP Clinical Affairs|408-828-7281|ric@silkroadmed.com|
20539746|NCT02100475|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20539747|NCT03109184|NORTHEASTERN UNIVERSITY|DR. CHRISTIE RIZZO|(617) 373-2486|C.RIZZO@NORTHEASTERN.EDU|
20539748|NCT02885246|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
20539749|NCT01237613|Orthopedic Foot and Ankle Center|Terrence M. Philbin, DO|614-895-8747|ofacresearch@orthofootankle.com|111
20539750|NCT02806960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20539751|NCT01041287|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
20539752|NCT01209078|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539753|NCT00924508|UCSF|John Koo, MD|415-476-6281|john.koo@ucsfmedctr.org|
20539754|NCT00372697|Novartis Pharmaceuticals|Study Director|862 778-8300||
20539755|NCT00901199|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|510-428-3172|ashutosh.lal@ucsf.edu|
20539756|NCT03221842|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20539757|NCT00704288|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20539758|NCT01055314|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20539759|NCT00527982|UT MD Anderson Cancer Center|Waun K. Hong, MD/Professor||CR_Study_Registration@mdanderson.org|
20539760|NCT01939366|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20539761|NCT00680797|VA Greater Los Angeles|Dr. Cathy Lee|310-478-3711|cathy.lee2@va.gov|42627
20539762|NCT04724967|University of Miami|Robert Kirsner|305-689-2646|rkirsner@med.miami.edu|
20539763|NCT02781480|MeiraGTx|Chief Medical Officer|+1 973 609-2156|robert.zeldin@meiragtx.com|
20539764|NCT03950492|WVU Rockefeller Neuroscience Institute|James Mahoney, PhD|304-293-5323|james.mahoney@hsc.wvu.edu|
20539765|NCT01272869|Coloplast A/S|Director Medical Affairs|4549111111|dkbir@coloplast.com|
20539766|NCT00771615|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539767|NCT02455076|Emory University|Guillermo Umpierrez|(404)778-1665|geumpie@emory.edu|
20539768|NCT01192412|St. George's, University of London|Dr. Laura A. Magee|+442086729944|LMagee@sgul.ac.uk|52621
20539769|NCT00859937|University of Chicago Comprehensive Cancer Center|Dr. Stuart Wong|773-702-9311|swong@mcw.edu|
20539770|NCT00151476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20539771|NCT00383942|Loyola University|Scott Graziano, M.D.|708-216-6288|sgrazia@lumc.edu|
20539772|NCT03433417|Cutera, Inc.|Margot Doucette|(415) 657-5518|mdoucette@cutera.com|
20539773|NCT02917733|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539774|NCT04099511|University of Missouri|Dr. Gregory Petroski|(573) 884-2119|petroskig@health.missouri.edu|
20570576|NCT00983853|Vertex Pharmaceuticals Incorporated|Medical Monitor|1-617-444-6777|medicalinfo@vrtx.com|
20570577|NCT00325598|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
20570578|NCT05034939|VentureMed Group, Inc.|Vice President, Clinical, Regulatory & Quality|763-296-2021|jschweiger@venturemedgroup.com|
20570579|NCT05288829|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20570580|NCT02599688|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
20570581|NCT03016598|Portland VA|Delaney.McKechnie@va.gov|360-696-4061|Delaney.McKechnie@va.gov|32017
20570582|NCT05400837|Johns Hopkins University|Nino Isakadze|443-997-0270|nisakad1@jh.edu|
20570583|NCT02049515|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20570584|NCT00820664|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20570585|NCT02872012|University of Michigan Kellogg Eye Center|Dr. Anjali Shah|734-763-8122|arshah@med.umich.edu|
20539775|NCT02868229|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20539776|NCT06151288|Vaxcyte, Inc.|Study Director: Clinical Development|650-585-0029|clinicaltrialsgov@vaxcyte.com|
20539777|NCT00759408|Brigham and Women's Hospital|Anju Nohria, MD|617-525-6852|ANOHRIA@PARTNERS.ORG|
20539778|NCT00687102|Wake Forest University Health Sciences|Sally A. Shumaker, PhD|336-71696934|sshumake@wakehealth.edu|
20539779|NCT03157583|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20539780|NCT03096873|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20539781|NCT05236712|Univcersity of Washington|Oleg Zaslavsky|2068493301|ozasl@uw.edu|
20539782|NCT01581619|Massachusetts General Hospital|Alphonse Taghian, MD, PhD|617-726-7559|ATAGHIAN@mgh.harvard.edu|
20539783|NCT00290498|U.T. MD Anderson Cancer Center|Dr. Luis E. Fayad / Lymphoma/Myeloma|7137922860|lefayad@mdanderson.org|
20539784|NCT04122170|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
20539785|NCT04268173|University of Wisconsin-Madison|Dr. Ryan Westergaard|(608) 265-7927|rpw@medicine.wisc.edu|
20539786|NCT00869401|Mayo Clinic|Nadia Laack M.D.|5072844561|laack.nadia@mayo.edu|
20539787|NCT03233438|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20539788|NCT02219503|AbbVie|Global Medical Services|800-633-9110||
20539789|NCT02925741|Cleveland Clinic|Mary Montague|216-444-1878|montagm@ccf.org|
20539790|NCT01786252|Michigan State University|Dr. Asgerally Fazleabas|(517) 884-6031|asgi@hc.msu.edu|
20539791|NCT00494507|University of Rochester|Robert Griggs, MD|585-275-3707|robert_griggs@urmc.rochester.edu|
20539792|NCT03831945|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
20539793|NCT00109577|University of Calgary|Dr. Bonnie Kaplan|403-955-7363|kaplan@ucalgary.ca|
20539794|NCT00587847|North Shore-Long Island Jewish Health System|Kanti Rai, MD|(718) 470-4050|krai@nshs.edu|
20539795|NCT02613169|University of Washington|Dr. Sylvia M. LaCourse|206-616-5978|sylvial2@uw.edu|
20539796|NCT00343382|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-1623|cloprinzi@mayo.edu|
20539797|NCT04032080|Baylor Scott & White Health|Joyce O'Shaughnessy, MD|214-818-8472|joyce.oshaughnessy@usoncology.com|
20539798|NCT02337725|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20539799|NCT01407523|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20539800|NCT00141115|New York State Psychiatric Institute|John J. Mariani|2125435987|jm2330@columbia.edu|
20539801|NCT00084487|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
20539802|NCT01561963|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20539803|NCT01008462|Fred Hutchinson Cancer Research Center|Dr. Mohamed L. Sorror|(206) 667-6298|msorror@fredhutch.org|
20539804|NCT01915823|Meda Pharmaceuticals|Dr.Nancy Ruiz,MD|7325642390|nancy.ruiz@meda.us|
20539805|NCT03040986|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|udo.rudloff@nih.gov|
20539806|NCT00803062|NRG Oncology Statistics and Data Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20539807|NCT02925728|Centre Hospitalier Départemental Vendée|Sylvie VERBRUGGHE|0251446161|sylvie.verbrugghe@ght85.fr|
20539808|NCT00752726|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539809|NCT00042666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539810|NCT02039856|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|(818) 891-7711|elizabeth.yano@va.gov|36031
20539811|NCT02540291|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20539812|NCT00896441|Stanford University|Mike Greicius|650-723-8331|greicius@stanford.edu|
20539813|NCT01304589|University of Tennessee Health Science Center|Dr. Candace Brown|901-412-4341|csbrown@uthsc.edu|
20539814|NCT01441466|Princess Amlia Children's Clinic, Isala|Jolita Bekhof|+31384245050|j.bekhof@isala.nl|
20539815|NCT02048371|SARC|SARC|734-930-7600|sarc@sarctrials.org|
20539816|NCT02423980|Xeris Pharmaceuticals, Inc.|Martin Cummins, VP Drug Development|512-498-2675|mcummins@xerispharma.com|
20539817|NCT01879072|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20539818|NCT01776723|H Lee Moffitt Cancer Center & Research Institute|Eric Padron, MD|813-745-3907|Eric.Padron@Moffitt.org|
20539819|NCT00602420|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20539820|NCT01735981|The Ohio State University|Anne Kloos|614-688-5942|kloos.4@osu.edu|
20539821|NCT00767806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539822|NCT01815840|Hoffmann-La Roche|Medical Communications|800 821-8590||
20539823|NCT00568126|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
20539824|NCT04395690|Aula Dental Avanzada|G. Esteve-Pardo|965215755|guillem@clinicaesteve.com|
20539825|NCT03909152|Memorial Sloan Kettering Cancer Center|Dr. Rachel Grisham, MD|646-888-4653|grishamr@mskcc.org|
20539826|NCT05346653|University of Chicago|Sr. Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
20539827|NCT04541628|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20539828|NCT00597493|Duke University Health System|David Reardon, MD|617-632-2166|David_Reardon@DFCI.harvard.edu|
20539829|NCT00308074|University of Massachusetts Medical School|Dr. Jean A. Frazier|508-856-5896|ChildResearch@umassmed.edu|
20539830|NCT03002311|WASHINGTON UNIVERSITY MEDICAL SCHOOL|Brian F. Gage, MD|3144548697|bgage@wustl.edu|
20539831|NCT03722524|AO Servier|Natalya LOGUNOVA|+7 495 9370700|Natalya.LOGUNOVA@servier.com|
20539832|NCT00687674|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20539833|NCT04369950|The University of Texas Health Science Center at Houston|Linden Lee, MD, Assistant Professor|(713) 500-6200|Linden.O.Lee@uth.tmc.edu|
20539834|NCT02408263|HSS|Dr. Gungor|212.606.1206|GungorS@hss.edu|
20539835|NCT00612560|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20539836|NCT01240200|Emory University School of Medicine|Christopher Newton, MD|404-355-4393|cnewton@atlantadiabetes.com|
20539837|NCT00765570|Summa Health System|Tracy Mondello, MS|330-375-6131|mondellot@summahealth.org|
20539838|NCT01529034|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
20539839|NCT04676867|DalCor Pharmaceuticals|David Kallend|+1 514-508-5099|dkallend@dalcorpharma.com|
20539840|NCT02387294|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
20526363|NCT03991013|University of Cape Town|Prof Graeme Meintjes|+27 (0) 21 4066075|Graeme.Meintjes@uct.ac.za|
20526364|NCT00343785|Fred Hutchinson Cancer Research Center|Dr. Rainer Storb, Director Transplantation Biology|2066676839|rstrob@fredhutch.org|
20570586|NCT03000348|NovaBiotics Ltd|Dr Deborah O'Neil, CEO|01224 711 377|deborah@novabiotics.co.uk|
20526365|NCT00108485|Diabetes Research Institute|Dr. Ronald Goldberg|305-243-6574|RGoldber@med.miami.edu|
20526366|NCT00828074|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
20526367|NCT00655733|Hutchison MediPharma|Hua Mu,Senior Vice President of Clinical Research and Development|861 3564487805|huam@hmplglobal.com|
20526368|NCT01608815|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20526369|NCT02035748|Alcon, a Novartis company|EMEA Medical Affairs Lead, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20526370|NCT02122770|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20526371|NCT02474589|SIGA Technologies|Dennis E Hruby, PhD, Chief Scientific Officer|541-753-2000|dhruby@siga.com|
20570587|NCT01667549|Monell Chemical Senses Center|Julia A. Mennella, PhD; Study Principal Investigator|267-519-4880|mennella@monell.org|
20526372|NCT01041976|Edith Nourse Rogers Memorial VA|Lisa Mueller|781-687-3192|Lisa.Mueller@va.gov|
20526373|NCT00705718|Medtronic|Karla Betz, Principal Clinical Research Specialist|763-526-2737|karla.h.betz@medtronic.com|
20526374|NCT02954653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526375|NCT03054064|Parker Hannifin Corporation|Ryan J. Farris, Ph.D., P.E.|2168963335|ryan.farris@parker.com|
20526376|NCT00711828|Mayo Clinic|Craig B. Reeder, M.D.||Reeder.Craig@mayo.edu|
20526377|NCT01890226|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
20526378|NCT01459718|Novartis Pharmaceuticals|Study Director|862-778-1873||
20526379|NCT00715728|Vienna General Hospital/University of Vienna|Olga Plattner, Medical Doctor|43-1-40-400-4103|olga.plattner@meduniwien.ac.at|
20526380|NCT01258075|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20526381|NCT00785213|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20526382|NCT01500213|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|862.228.2483|mhuber@tesarobio.com|
20570588|NCT01407276|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526383|NCT02386345|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
20570589|NCT01807182|Fred Hutchinson Cancer Center|Dr. Sylvia Lee|206-606-2274|smlee@fredhutch.org|
20570590|NCT04947514|Montefiore Medical Center|Dr. Amy Yao|7189204800|amyao@montefiore.org|123
20570591|NCT00478205|Eisai Call Center|Eisai Inc.|888-422-4743||
20526384|NCT02612610|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526385|NCT04150705|Washington University School of Medicine|Tyler Fraum, M.D.|314-362-2928|tylerjfraum@wustl.edu|
20526386|NCT01546571|Polynoma|Clinical Program Director|5418405451|karihatten@polynoma.com|
20526387|NCT05127304|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526388|NCT01421186|MorphoSys AG|Dr Winrich Rauschning, Clinical Project Lead (external)|+4989 89927|winrich.rauschning@external.morphosys.com|0
20526389|NCT01866657|University Hospitals Cleveland Medical Center|Dr. Edwin Avery|440-391-0690|Edwin.avery@uhhospitals.org|
20526390|NCT01880086|Weill Cornell Medical College|Dr. Peter N. Schlegel|2127465491|pnschleg@med.cornell.edu|
20526391|NCT04360174|Ocular Therapeutix|Chief Medical Officer|7813574000|clinicalaffairs@ocutx.com|
20526392|NCT00214149|UW Hospital and Clinics|Diana Trask, research coordinator for study|608-263-9528|trask@humonc.wisc.edu|
20526393|NCT03973918|ABTC Consortium|Director of ABTC Consortium|410-955-8837|jfisher@jhmi.edu|
20526394|NCT02951533|Janssen-Cilag GmbH|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20526395|NCT00896181|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
20570592|NCT00696488|Wake Forest University Health Sciences|Steve Feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
20570593|NCT04092452|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570594|NCT01367444|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20526396|NCT03338803|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526397|NCT05168878|University of Colorado|Dr. Maya Haasz|7204789231|maya.haasz@childrenscolorado.org|
20526398|NCT03376256|University of Miami|Dr. Ralf Gebhard|3055858365|rgebhard@med.miami.edu|
20526399|NCT02251106|University of Alberta|Dr. Greg Kawchuk|780-492-6891|greg.kawchuk@ualberta.ca|
20570595|NCT01012947|Ajou University|Dr. Kang Soo Lee|821087812077|kpsimon@hanmail.net, antiaging@ajou.ac.kr|
20570596|NCT02127125|San Antonio Geriatric Research, Education, and Clinical Center|Dr. Nicolas Musi|(210) 562-6140|musi@uthscsa.edu|
20570597|NCT03332784|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20570598|NCT03306420|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20570599|NCT01545557|Galderma|Clinical project manager|817-961-5655|aestheticclinicaltrials@galderma.com|
20570600|NCT01018732|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20570601|NCT01536171|University of Florida|Dr. Heather K. Vincent, PhD|352-273-7410|vincehk@ortho.ufl.edu|
20526400|NCT02375555|Dana Farber Cancer Institute|Ajantha Nithi|857-215-2829|ajantha_nithi@dfci.harvard.edu|
20536565|NCT03645096|UT Southwestern Medical Center|Dr. Sherwood Brown|214-645-6950|Sherwood.Brown@utsouthwestern.edu|
20536566|NCT03520920|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536567|NCT00988052|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20536568|NCT02997865|Washington University School of Medicine in St. Louis|Kenneth E. Freedland, PhD|314-286-1311|freedlak@wustl.edu|
20536569|NCT01119066|Memorial Sloan Kettering Cancer Center|Richard O'Reilly, MD|646-888-2157|oreillyr@MSKCC.ORG|
20539841|NCT00997620|Westernsky|Lyndon E Mansfield, MD|915-544-2557|immunman@westernskymed.com|
20539842|NCT01554514|Washington University|Dr. Elaine Majerus|314-362-8866|emajerus@wustl.edu|
20539843|NCT01423916|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20539844|NCT02903394|Duke University|Kengyeh Chu|919-681-2093|ken.chu@duke.edu|
20539845|NCT02294734|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539846|NCT01141478|Loma Linda University Medical Center|Diane Scavone, research coordinator|909 558-3636|dscavone@llu.edu|33670
20539847|NCT02250664|University of Vermont|Stephen T. Higgins, PhD, Professor|802-735-6267|stephen.higgins@uvm.edu|
20539848|NCT03957876|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Sudipto Mukherjee, MD, PhD, MPH|216-444-0506|mukhers2@ccf.org|
20539849|NCT03847909|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20539850|NCT00975143|Cipher Pharmaceuticals Inc.|Julia Chan, RAC|905-602-5840|jchan@cipherpharma.com|326
20539851|NCT01147900|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539852|NCT01375608|NIH, NHLBI, MCHB|Dr Matthew Hsieh|301-402-7687|matthewhs@nhlbi.nih.gov|
20539853|NCT03129360|NYU Langone Health|Donald Goff, MD|646.485.4843|Donald.Goff@nyulangone.org|
20539854|NCT00545103|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20539855|NCT01953913|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20539856|NCT05026853|University of Michigan|Dr. Dinesh Khanna|734-763-7182|khannad@med.umich.edu|
20539857|NCT03836677|AstraZeneca AB|AstraZeneca AB|1-877-240-9479|information.center@astrazeneca.com|
20539858|NCT01353911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539859|NCT01732913|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20539860|NCT03249103|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
20539861|NCT00295932|Memorial Sloan Kettering Cancer Center|Dr. Carol Portlock|212-639-8109|portlocc@mskcc.org|
20539862|NCT00884832|Mayo Clinic|Dr. Adil E. Bharucha|507-266-9156|bharucha.adil@mayo.edu|
20539863|NCT04891107|Boston University Department of Physical Therapy & Athletic Training|Terry Ellis PT, PhD, FAPTA|617-353-7571|tellis@bu.edu|
20539864|NCT03098745|CooperVision Inc.|Dr.Jose A.Vega O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20539865|NCT00500760|Amgen Inc.|Study Director|866-572-6436||
20539866|NCT01600092|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539867|NCT00614484|Professor of Radiation Medicine, Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@llu.edu|
20539868|NCT02914561|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20539869|NCT01300455|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539870|NCT00565136|Boston Urogynecology Associates|Peter Rosenblatt, MD; Director of Urogynecology|(617) 354-5452|prosenbl@mah.harvard.edu|
20539871|NCT01399268|HSS|Dr. Jules|212.606.1206|JulesK@hss.edu|
20539872|NCT02438813|Allergan, Inc|Medical Director/ Epidemiologist|714-246-4500|clinicaltrials@allergan.com|
20539873|NCT00694304|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20539874|NCT03135210|University of Minnesota|Amanda Sharp|(612) 626-4691|sharp@umn.edu|
20539875|NCT03445390|Stanford University|Dr. Mark Burbridge|(650) 353-8484|markburb@stanford.edu|
20539876|NCT00552409|University of Washington|Dr. Ian de Boer|206-616-5403|deboer@u.washington.edu|
20539877|NCT04018313|Celltrion. Inc|Keumyoung Ahn/Head of Clinical Planning 2 Department|+82 32 850 4190|Keumyoung.ahn@celltrion.com|
20539878|NCT01805037|Northwestern University, Feinberg School of Medicine|Barbara Pro, MD|312-695-6180|barbara.pro@northwestern.edu|
20539879|NCT01270256|University of Chicago|Dr. Robert M Naclerio|773-702-0080|rnackeri@surgery.bsd.uchicago.edu|
20539880|NCT02879578|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20539881|NCT02964585|George Washington University Medical Faculty Associates|Dr. Sabyasachi Sen|202-741-2233|ssen1@email.gwu.edu|
20539882|NCT03517566|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20539883|NCT04566692|Grifols Therapeutics LLC|Rhonda Griffin|+1 919 757 1744|rhonda.griffin@grifols.com|
20539884|NCT01183468|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20539885|NCT00303511|Emory University|Dr. Wendy Book|404-778-5545|wbook@emory.edu|
20539886|NCT00454649|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539887|NCT04042727|Stony Brook University|Andreas KAlogeropoulos|4045124463|Andreas.Kalogeropoulos@stonybrookmedicine.edu|
20539888|NCT01181258|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
20539889|NCT02102399|Federal University of Bahia|Lilian Paternostro|+55 (71) 8191-9730|lilian_fono@hotmail.com|
20539890|NCT03385330|Children's Hospital of Philadelphia|Dr. Sara DeMauro|445-225-6400|demauro@chop.edu|
20539891|NCT00971295|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20539892|NCT00955513|Novartis Consumer Health|Clinical Project Leader Pain category|+41223635528||
20539893|NCT00086411|University of Pennsylvania|Peter Gariti, Ph.D.|215-222-3200|gar1iti@mail.med.upenn.edu|0
20539894|NCT00375167|Queens University|Dr. Terry Krupa|613-533-6236|terry.krupa@queensu.ca|
20539895|NCT00410605|Univerisity of Wisconsin Carbone Cancer Center|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
20570602|NCT02165826|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20570603|NCT00873327|Duke University Medical Center|Brian Smith, MD. MPH|919-668-8951|brian.smith@duke.edu|
20539896|NCT04836247|University of Delaware|Valerie Earnshaw|302-831-4772|earnshaw@udel.edu|
20539897|NCT00988364|Baylor College of Medicine|Dr. Chu-Huang Chen|832-355-9026|chu-huang.chen@bcm.edu|
20539898|NCT01887353|Intermountain Healthcare|T. Jared Bunch|8015074701|jared.bunch@imail.org|
20539899|NCT00609739|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
20539900|NCT01729494|University of Cincinnati|Rita R. Alloway, Pharm.D., Director of Clinical Trials|513-558-1568|rita.alloway@uc.edu|
20539901|NCT02108691|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
20539902|NCT01078168|Clinic of Psychiatry and Psychotherapy, University Medical Center JGU Mainz|Prof. Dr. Andreas Fellgiebel|+49-6131-17-7363|Andreas.Fellgiebel@unimedizin-mainz.de|
20539903|NCT01962870|Stanford University|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
20539904|NCT00649428|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
20539905|NCT02315560|University of Pittsburgh|Dr. Heidi Stephany|412-692-7932|heidi.stephany@chp.edu|
20539906|NCT02008227|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20539907|NCT02702180|Savara Inc|Raymond D. Pratt, MD, PACP - Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
20539908|NCT03267888|Emory University|Mohammad K Khan|404-778-3473|m.k.khan@emory.edu|
20539909|NCT02241343|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20539910|NCT04680975|Sanofi (Kadmon, a Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20539911|NCT00753454|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
20539912|NCT02702414|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539913|NCT00615030|Novartis Pharmaceuticals|Study Director|862-778-8300||
20539914|NCT03446456|University of Maryland School of Nursing|Rachel Massalee|4107068244|rmassalee@umaryland.edu|
20539915|NCT03781505|Aga Khan University|Dr. Muhammad Saad Yousuf|+92213486|saad.yousuf@aku.edu|4253
20539916|NCT00989963|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director||info@lungbiotechnology.com|
20539917|NCT04588389|UMass Chan Medical School|Dr Alexander Chan for Eman Nada, MD|7743030338|alexander.chan@umassmemorial.org|
20539918|NCT00658814|SWOG|Study Statistician|206-667-4623||
20539919|NCT02911142|National Cancer Institute|Dr. Ramya Ramaswami|240-506-1088|ramya.ramaswami@nih.gov|
20539920|NCT01178099|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20539921|NCT02703480|Tufts University School of Dental Medicine|Associate Professor|6176366659|yumi.ogata@tufts.edu|
20539922|NCT02473367|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539923|NCT04816721|Enanta Pharmaceuticals, Inc.|Medical Monitor|+1 6176070800|enquiries@enanta.com|
20539924|NCT02466009|University of Rochester|Aram Hezel|585-275-5823|Aram_Hezel@urmc.rochester.edu|
20539925|NCT02176161|NYU Langone Health|Aaron Katz, MD|516-535-1900|Aaron.Katz@nyulangone.org|
20539926|NCT01286740|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20539927|NCT02435706|Columbia University College of Dental Medicine|Elena Sanz Miralles, DDS, PhD|212-342-3008|ecs2181@cumc.columbia.edu|
20539928|NCT00847015|Memorial Sloan Kettering Cancer Center|Dr. M. Catherine Pietanza|646-888-4203|pietanzm@mskcc.org|
20539929|NCT01641822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20539930|NCT03222414|Vanderbilt University Medical Center|Laura Sorabella||laura.sorabella@vumc.org|
20570604|NCT01191008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570605|NCT00978562|OHSU KCI|Edward Neuwelt, MD|503-494-5626|huddlesa@ohsu.edu|
20570606|NCT03786744|Samara Medical Center Dinasty|Volchkov Stanislav|+78469564455|quality@cordbank.ru|
20570607|NCT02394665|University of Miami|Fazilat Ishkanian MD, PhD|305-243-4200|f.ishkanian@med.miami.edu|
20570608|NCT02145169|Albert Einstein Medical Center|Kamran Mohiuddin. Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EISNTEIN.EDU|
20570609|NCT02923193|Shockwave Medical|Birgit Greschner|650-575-6199|bgreschner@shockwavemedical.com|
20570610|NCT01907269|University of Alabama at Birmingham|Dr. Elizabeth J. Rahn|2059966552|rahneli@uab.edu|
20570611|NCT00490698|The University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD / Professor||CR_Study_Registration@mdanderson.org|
20570612|NCT02201901|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20570613|NCT00668785|West Coast Retina Medical Group, Inc.|J. Michael Jumper, MD|415-972-4600|jmjumper@westcoastretina.com|
20570614|NCT03766373|Novus Therapeutics|Clinical Director|949-679-1110|study004@novustherapeutics.com|
20570615|NCT00738283|Baylor College of Medicine|Steven A. Abrams, MD|713-798-7164|sabrams@bcm.edu|
20570616|NCT03595878|University of North Carolina Lineberger Comprehensive Cancer Center|Colette Shen|+1 984-974-0400|cjshen@email.unc.edu|
20570617|NCT00469859|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20570618|NCT03494985|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20536570|NCT01945996|University of Southern California|Elizabeth Burner|3232266667|eburner@usc.edu|
20536571|NCT01736267|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
20536572|NCT00271856|UCSF Osher Center for Integrative Medicine|Patricia Moran, PhD|415.353.9745|moranp@ocim.ucsf.edu|
20536573|NCT04599803|Verily Life Sciences LLC|Gabriel Kowalsky|9709011616|gabekowalsky@verily.com|
20536574|NCT01509846|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20536575|NCT03115411|Stanford University School of Medicine|Dr. Subhas Banerjee, MD|650-723-2623|sbanerje@stanford.edu|
20536576|NCT04677543|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
20536577|NCT01539070|Instituto Mexicano del Seguro Social|MPH. Gloria Oliva Martínez Andrade|5556059862|gloria_olivam@hotmail.com|21075
20536578|NCT01437111|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20536579|NCT03162796|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536580|NCT01176617|Hospital of the University of Pennsylvania|Dr. Sanjay Dixit|215-615-4337|sanjay.dixit@uphs.upenn.edu|
20539931|NCT02981966|UTexas_SanAntonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu|
20539932|NCT00082381|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20539933|NCT02345330|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
20539934|NCT03077204|Ascension Texas Spine and Scoliosis|Devender Singh, Research Scientist|512 324 3580|dpsingh@ascension.org|15916
20539935|NCT00454181|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
20539936|NCT03729245|Nektar Therapeutics|Study Director|4154825300|StudyInquiry@nektar.com|
20539937|NCT03322423|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-904-443-3402|TKarkkai@its.jnj.com|
20539938|NCT02096263|GlaxoSmithKline|GSK Response Center|866-435-7343||
20539939|NCT01054625|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20539940|NCT03178669|InDex Pharmaceuticals|Karin Arnesson, Clinical Trial Manager|+46 8 122 038 57|karin.arnesson@indexpharma.com|
20539941|NCT02976103|Dana-Farber Cancer Institute|Donna Berry, PhD, RN|617-632-1909|donna_berry@dfci.harvard.edu|
20539942|NCT00079677|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20539943|NCT03074682|Yale University|Dr. Marc Auerbach|203-688-3333|marc.auerbach@yale.edu|
20539944|NCT01218399|Astra Zeneca|Elena Pizzi|+1 302 885 2677|Elena.Pizzi@astrazeneca.com|
20539945|NCT00412074|Medical University of South Carolina|Carol Wagner|18437922112|wagnercl@musc.edu|
20539946|NCT00576576|Emory|Dr. Habib Samady|4047781237|hsamady@emory.edu|
20539947|NCT00671437|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
20539948|NCT03927404|University of Pittsburgh|Dr. Sashwati Roy|412-648-8297|sar453@pitt.edu|
20539949|NCT01229449|Reckitt Benckiser Healthcare International|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20539950|NCT03203291|Columbia University Irving Medical Center|Sunil Agrawal, PhD|(212) 854-2841|sunil.agrawal@columbia.edu|
20539951|NCT05098509|Radius Pharmaceuticals, Inc.|Ellie Ratigan|617-444-1800|scout015@radiuspharm.com|
20539952|NCT04033068|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539953|NCT02540265|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
20539954|NCT03157037|Linköping University|Professor Mårten Segelmark|+46 70 287 19 44|marten.segelmark@liu.se|
20539955|NCT00324233|Coloplast A/S|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
20539956|NCT01972789|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
20539957|NCT01707381|Bausch + Lomb|Heleen DeCory, Ph.D.|(585) 338-8161|Heleen.DeCory@bausch.com|
20539958|NCT01704456|UBC|Dr Lori Brotto|604-875-4111|lori.brotto@vch.ca|68898
20539959|NCT04016077|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539960|NCT02474407|SK Bio-pharmaceuticals Co, Ltd|Lee Min Jae, Associate Manager||minj.lee@sk.com|
20539961|NCT00671606|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, ND/Assistant Professor||tjohnsto@mdanderson.org|
20539962|NCT04667104|Janssen Research & Development, LLC|Clinical Registry Group|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20539963|NCT02933502|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20539964|NCT02126839|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20539965|NCT00422383|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20539966|NCT00411632|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
20539967|NCT05399290|Michigan State University|Erika Malana|5173038716|malanaer@msu.edu|
20539968|NCT00761527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20539969|NCT00592124|Johns Hopkins University|Craig W. Hendrix, MD|1 410 955-9707|chendrix@jhmi.edu|
20539970|NCT04599465|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20539971|NCT00742417|Instituto Grifols S.A.|Mireia Torres|+34935710500|mireia.torres@grifols.com|12273
20539972|NCT00627367|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
20539973|NCT00258817|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20539974|NCT00965575|Cincinnti Childrens|Sejal Jain|513-636-4222|sejal.jain@cchmc.org|
20539975|NCT00757822|Central Arkansas Veterans Healthcare System|Dr. Muhammad Jaffar|501-688-9310|Muhammad.Jaffar@va.gov|
20539976|NCT03775512|Biosense Webster, Inc.|Franchise Medical Manager|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20539977|NCT00495625|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
20539978|NCT02629822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20539979|NCT01912339|Boston Scientific Corporation|Kevin Hagelin, Clinical Program Manager|(800) 328-3881|kevin.hagelin@bsci.com|
20539980|NCT00856726|University of Alabama at Birmingham|Orlando Gutierrez|205-996-2736|ogutierrez@uabmc.edu|
20526401|NCT02267772|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD, Associate Professor|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
20526402|NCT02091986|AstraZeneca|Global Clinical Lead Göran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
20526403|NCT00125242|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@health.utah.edu|1363
20526404|NCT00606554|Boston University School of Medicine|Allan Walkey, MD, MSc|617-638-4860|alwalkey@bu.edu|
20526405|NCT01664949|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20526406|NCT02727777|UT MD Anderson Cancer Center|Dr. Jason R. Westin/Lymphoma/Myeloma|713-792-3750|jwestin@mdanderson.org|
20526407|NCT01738503|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20539981|NCT03464019|Milestone Pharmaceuticals Inc.|Cameron Szakacs_PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
20539982|NCT01754493|New York State Psychiatric Institute|Roberto Lewis-Fernandez|646-774-8102|rlewis@nyspi.columbia.edu|
20539983|NCT02489942|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0217|clintriage.rdg@boehringer-ingelheim.com|
20539984|NCT00858208|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20539985|NCT01272635|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
20539986|NCT04996251|Northwell Health (previously) now at Advocate Aurora Health|Dr. Vini Chopra Konowitz|859-905-8782|vinichopra924@gmail.com|
20539987|NCT01543776|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20539988|NCT02397057|American Regent, Inc|Mark A. Falone, MD MPH|6317723544|mfalone@americanregent.com|61844
20539989|NCT02893917|Yale School of Medicine: Medical Oncology|Joseph Kim, MD|(203) 200-4822|joseph.w.kim@yale.edu|
20539990|NCT00679172|Emergent Product Development Gaithersburg|Dr. Tim Babinchak|(240) 631-3585||
20539991|NCT00793169|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
20539992|NCT00434642|Hoffman-LaRoche|Medical Communications|800-821-8590||
20539993|NCT04512976|University of Texas Southwestern Medical Center|Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
20539994|NCT03392649|Univerisity of Chicago Medicine|Dr. Gaurav Upadhyay|773-702-9461|gupadhyay@medicine.bsd.uchicago.edu|
20539995|NCT00414518|University of Colorado Denver|Michelle A. Barron|303-724-4939|michelle.barron@ucdenver.edu|
20539996|NCT05249569|UT Southwestern Medical Center|Dr. David Hsieh|214/648-4180|david.hsieh@utsouthwestern.edu|
20539997|NCT03927144|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20539998|NCT03858530|Children's Mercy Kansas City|Dr. Sherwin Chan|816-234-3273|sschan@cmh.edu|
20539999|NCT01463072|City of Hope|Dr. Mina Sedrak|626-359-8111|msedrak@coh.org|
20540000|NCT02271945|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
20507977|NCT01803854|Department of Veterans Affiairs, Office of Research and Development|Dr. Christina D. Williams, Acting Director of Cooperative Studies Program Epidemiology Center Durham|919-286-0411|christina.williams4@va.gov|175464
20507978|NCT03646760|Henry Ford Health|Steven Keteyian, PhD|313-972-1920|sketeyian1@hfhs.org|
20507979|NCT05224076|University of Kansas School of Nursing|Dr. Barbara Polivka|6142049915|bpolivka@kumc.edu|
20507980|NCT01807949|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20507981|NCT04325906|Rush University|Jie Li, PI|3125634643|jie_li@rush.edu|
20507982|NCT02666508|UIC College of Dentistry|Kimberly Fasula RDH, MS, MPH|(312) 996-5513|kfasul1@uic.edu|
20507983|NCT00555568|CHOIR (Center for Healthcare Organization & Implementation Research|Susan V. Eisen|781-687-2858|susan.eisen@va.gov|
20507984|NCT01588353|XIA Project, Pharmaceuticals Sales Division, Asahi Kasei Pharma Corporation|Norihiro Tateishi, Manager|+81-3-3296-3641|xia_project@om.asahi-kasei.co.jp|
20507985|NCT01409993|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
20507986|NCT02677220|Cochlear|Director of Clinical Research|3032647180|loneill@cochlear.com|
20507987|NCT00965146|Stryker Orthopaedics®|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
20507988|NCT01148693|Tehran medical university of science|Dr. Rasoul sotoudehmanesh|(+98 21) 82414000|r.sotudemanesh@gmail.com|82415000
20507989|NCT01504971|ChinaPLAGH|Dr. Weifeng Wang|0086-13911952018|wangwf301@hotmail.com|
20507990|NCT04581863|University of Pennsylvania|Mucio Delgado, MD, Principal Investigator|215-746-8256|mucio.delgado@pennmedicine.upenn.edu|
20507991|NCT00225212|Stanford University Medical Center|Neal Birkett, MS, RAC|650-723-6456|nbirkett@stanford.edu|
20507992|NCT01519063|Yale University|Dana Cavallo, Assistant Professor|203974-7607|dana.cavallo@yale.edu|
20507993|NCT01335698|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20507994|NCT01357889|GlaxoSmithKline|GSK Response Center|866-435-7343||
20507995|NCT01170221|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|Philippe.Prokocimer@cubist.com|241
20507996|NCT00739960|UIC|Nadera J Sweiss, MD|312-996-5723|nsweiss@uic.edu|
20507997|NCT01714817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20507998|NCT00798577|Alcon Labs|Alcon Clinical|1.888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20507999|NCT02031432|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20540001|NCT00652080|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
20526408|NCT04687072|Argenx|Regulatory manager|Please email|regulatory@argenx.com|
20526409|NCT01662791|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|DiBaise.John@mayo.edu|
20526410|NCT03626363|Michigan Technological University|Kelly Kallio, Assistant Vice President of Sponsored Programs|9064872226|kmkallio@mtu.edu|
20526411|NCT01187498|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
20526412|NCT01970475|Amgen Inc.|Study Director|866-572-6436||
20526413|NCT00960986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20526414|NCT01984892|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
20526415|NCT04464720|University of California San Francisco|Dr. Stephanie M Holm|415-514-0878|stephanie.holm@ucsf.edu|
20526416|NCT00342563|Yale University School of Medicine|Dr. Elizabeth Ralevski|+1 203-932-5711|elizabeth.ralevski@yale.edu|x4282
20526417|NCT02156895|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526418|NCT02234596|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,|646-888-4186|janjigiy@mskcc.org|
20554403|NCT03835260|Pivot Health Technologies Inc.|Senior Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
20570619|NCT04124471|Children's Hospital of Philadelphia|Ignacio Tapia, MD|(267) 426-5842|tapia@chop.edu|
20554404|NCT02822794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20554405|NCT04788147|RefleXion|Debradenise Brooks|16504828435|dbrooks@reflexion.com|
20554406|NCT00466323|VA VISN 5 Mental Illness Research, Education and Clinical Center|Amy Drapalski, Ph.D.|410-637-1855|amy.drapalski@va.gov|
20554407|NCT00293540|International Breast Cancer Research Foundation|Richard R. Love, MD|608-698-7881|richardibcrf@gmail.com|
20554408|NCT00781326|University of Pittsburgh|Ellen Whyte, MD|412 246 5066|whyteem@upmc.edu|
20554409|NCT03732248|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
20554410|NCT05101252|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen, OD, MS, FAAO|(904)254-0152|TKarkkai@its.jnj.com|
20554411|NCT01243944|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20554412|NCT01166984|AtoxBio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
20554413|NCT01384539|University of Colorado|Dr. Jessica Kendrick|303-602-5012|Jessica.Kendrick@ucdenver.edu|
20554414|NCT01714024|UNC School of Dentistry|Steven Offenbacher, DDS, PhD, MMSc|919-537-3205|steven_offenbacher@unc.edu|
20554415|NCT01731171|Sheppard Pratt Health System|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
20554416|NCT01736852|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20554417|NCT00403546|Massachusetts General Hospital|Donald C. Goff, MD||Donald.Goff@nyumc.org|
20554418|NCT01814722|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554419|NCT02604589|William Beaumont Hospital|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
20554420|NCT04408963|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20554421|NCT00793910|Carl R. Darnall Army Medical Center|Matthew Kuhnle, DO|216-965-3518|matthew.kuhnle@us.army.mil|
20554422|NCT01504438|Duke University|James Nunley II, M.D.|919-684-4033|james.nunley@duke.edu|
20554423|NCT01070810|BIDMC|Michael W Donnino|617-754-2295|mdonnino@bidmc.harvard.edu|
20554424|NCT02418546|Massachusetts General Hospital|Dr. Anne-Marie Wills|6177265532|awills@mgh.harvard.edu|
20554425|NCT05061446|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570620|NCT02282059|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570621|NCT02394925|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
20570622|NCT03670277|Johnson & Johnson Vision Care|Xu Cheng, MD, PhD, FAAO - Sr. Principal Clinical Scientist|1-800-843-2020|xcheng6@its.jnj.com|
20570623|NCT02660112|Mayo Clinic|Ralitza H. Gavrilova, M.D.|507-293-1283|Gavrilova.Ralitza@mayo.edu|
20570624|NCT02774668|University of Missouri|Elizabeth Parks, Professor of Nutrition and Exercise Physiology|573-882-5864|parksej@missouri.edu|
20570625|NCT04886518|Harmony Biosciences|Sharon Wolfe-Schwartz, Executive Director, Medical and Regulatory Writing|267-965-0270|swolfe-schwartz@harmonybiosciences.com|
20570626|NCT02358668|The Chinese University of Hong Kong|Dr Andrea Luk|852-26324276|andrealuk@cuhk.edu.hk|
20570627|NCT02419417|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20570628|NCT01240551|National Cancer Institute|Dr. Karen Kurdziel|301-443-0622|kurdziek@mail.nih.gov|
20570629|NCT04403542|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20570630|NCT03325790|Sound Pharmaceuticals, Inc.|Dr. Jonathan Kil|206-634-2559|info@soundpharma.com|
20570631|NCT02737826|Medical University of South Carolina|Dr. Kelly Barth|843-792-0686|stephen@musc.edu|
20570632|NCT00078377|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20570633|NCT01385748|Onxeo|Berangere Vasseur, MD|+33 (0)1 45 58 76 00|b.vasseur@onxeo.com|
20570634|NCT01317875|Incyte Corporation|Incyte Corporation Call Center, Study Director|1-855-463-3463|medinfo@incyte.com|
20570635|NCT01381575|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20570636|NCT00159263|Imperial College London|Peter Barnes|+44 (0)20 7594 7959|p.j.barnes@imperial.ac.uk|
20570637|NCT01200342|UT MD Anderson Cancer Center|Sapna P. Patel, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20570638|NCT02748889|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
20570639|NCT04546217|University of Alabama at Birmingham|Dr. Sarah dos Anjos|2059347323|smanjos@uab.edu|
20570640|NCT02550938|Align Technology, Inc.|Allison Mossing, Sr. Clinical Research Associate|4084701046|amossing@aligntech.com|
20570641|NCT01367847|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-3995|djjones@email.unc.edu|
20570642|NCT03305887|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
20570643|NCT01439867|Amgen Inc.|Study Director|866-572-6436||
20570644|NCT00863512|Duke University Medical Center|David Harpole, M.D.||david.harpole@duke.edu|
20570645|NCT03121820|GEROPHARM|GEROPHARM Clinical Leader|+7(812) 703-79-75|inform@geropharm.ru|
20508000|NCT01617187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526419|NCT05013788|The University of Texas Health Science Center at Houston|Monica Kodakandla, MD|713-500-5666|RMonica.Kodakandla@uth.tmc.edu|
20526420|NCT04852679|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20526421|NCT03728985|W.L. Gore and Associates|Rizwan Afzal|1-623-234-5408|rafzal@wlgore.com|
20526422|NCT00688935|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
20526423|NCT01294696|Merck Sharp & Dohme Corp|Vice President, Late Stage Group Development Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20540002|NCT02227394|Zambon S.p.A.|Luca Raiteri, MD|+39 02 6652461|luca.raiteri@zambongroup.com|
20526424|NCT05633992|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20526425|NCT00197002|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526426|NCT02345265|Dana-Farber Cancer Institute|Dr. Joyce Liu|617-632-5269|Joyce_Liu@dfci.harvard.edu|
20526427|NCT03569293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20526428|NCT04843761|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
20526429|NCT03839459|University of Rochester Medical Center|Brea Lipe, MD|(585) 275-4099|Brea_Lipe@URMC.Rochester.edu|
20526430|NCT00258349|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20526431|NCT01088243|National Jewish Health|Dr. Lisa A. Maier|303-398-1983|MaierL@NJHealth.org|
20526432|NCT02262000|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20526433|NCT02370667|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
20540003|NCT00663403|University of Michigan College of Pharmacy|Bruce A. Mueller|7347636629|muellerb@umich.edu|
20540004|NCT00719680|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20540005|NCT04071158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540006|NCT03445559|VA New York Harbor Healthcare System|Dr. Danil V. Makarov|212-686-7500|Danil.Makarov@Va.gov|
20526434|NCT00371644|VA North Texas Health Care System|Dr. Alina Suris|2148572312|alina.suris@va.gov|
20526435|NCT04060199|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
20526436|NCT00478699|Fundación GECP|Eva Pereira|+34 934302006|epereira@gecp.org|
20526437|NCT01005888|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20526438|NCT01043705|Medtronic plc|Lynn Landborg, Clinical Research Manager|763 526 2877|lynn.landborg@medtronic.com|
20526439|NCT00669019|University of Chicago|Dr. Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
20526440|NCT02003963|Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632729|amanda.staiano@pbrc.edu|
20526441|NCT01801280|Charité University Hospital - Department of Nephrology|Olesja Rissling|+49 30 450 514 153|olesja.rissling@charite.de|
20526442|NCT00581542|University of Rochester, Strong Mem orial Hospital|Franci Gigilotti|585 275-0588|francis_gigilotti@urmc.rochester.edu|
20526443|NCT00176644|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20526444|NCT05020366|University of Pittsburgh|Dr. Angela Caldwell|412-383-7231|arl78@pitt.edu|
20526445|NCT00392496|Sunnybrook Health Sciences Centre|Dr. Rena Buckstein|416-480-5847|rena.buckstein@sunnybrook.ca|
20526446|NCT01065714|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
20526447|NCT01260272|L-MARC Research center|Kathy Schmitz, Site Manager|502 214 3990|kschmitz@lmarc.com|
20526448|NCT01629290|University of Michigan School of Dentistry|Danika Downey, DDS|330-877-8783|danika.downey@gmail.com|
20554426|NCT03056690|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20554427|NCT01159067|City of Hope National Medical Center|Dr. Vinod Pullarkat|626-256-4673|vpullarkat@coh.org|82405
20554428|NCT03074734|TobaccoFree Research Institute Ireland|Professor Luke Clancy|+353868364337|lclancy@tri.ie|
20554429|NCT05580575|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD, MS|614-292-0882|fogt.78@osu.edu|
20554430|NCT02610140|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20554431|NCT00861341|University of Rochester, Wilmot Cancer Center|Charles Francis, MD|585-275-3761|Charles_Francis@urmc.rochester.edu|
20554432|NCT02127307|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-5431347|jose.zubeldia@ge.com|
20554433|NCT03333746|The Ohio State University Comprehensive Cancer Center|Dr. Yvonne Efebera|614-293-7243|Yvonne.Efebera@osumc.edu|1278
20554434|NCT01312961|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20554435|NCT01825408|UNC Department of Otolaryngology|Dr. Adam Zanation||adam_zanation@med.unc.edu|
20554436|NCT01514318|DJO Surgical|Dr. Jane M. Jacob|512-834-6323|jane.jacob@djoglobal.com|
20554437|NCT01337297|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
20554438|NCT02778204|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20554439|NCT04122443|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20554440|NCT03362515|Thomas Jefferson University|Dr. Mindy Rabinowitz|215-955-6784|mindy.rabinowitz@jefferson.edu|
20554441|NCT02755935|Cochlear Americas|Ginger Grant, AuD|410-375-0883|ggrant@cochlear.com|
20554442|NCT04523129|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
20554443|NCT02143518|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
20554444|NCT00452335|Sucampo Pharma Americas, Inc.|VP, Clinical Development|301-961-3400|info@sucampo.com|
20554445|NCT01343160|W.L. Gore & Associates|Rizwan Afzal|623-234-5408|rafzal@wlgore.com|
20554446|NCT03047447|Bristlecone Health, Inc,|Dr. Kelly Gibas, Director or Clinical Trials|(763) 424-2474|kgibas@bristleconefitness.com|
20554447|NCT00432380|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554448|NCT02669329|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20554449|NCT03704376|The University of Texas Health Science Center at Houston|Lane Bailey, PhD, PT|713-704-6794|lane.bailey@uth.tmc.edu|
20554450|NCT03422003|Dana-Farber Cancer Institute|Dr. Rinaa Punglia|617-632-3591|rpunglia@mgb.org|
20554451|NCT01404312|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20554452|NCT02744534|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
20554453|NCT03821376|Indiana University|Jordan Swensson, MD|317-944-1831|jswensso@iu.edu|
20554454|NCT00071487|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554455|NCT02391402|Portland VA|Megan Callahan|503-220-8262|megan.callahan@va.gov|50525
20554456|NCT03971617|Stony Brook University Medical Center|Sandra Skinner|631-444-7513|sandra.skinner@stonybrookmedicine.edu|
20554457|NCT00581945|Study Director|Novartis Pharmaceuticals|862-778-8300||
20554458|NCT02840877|Boston Medical Center|Karen Jacobson, MD MPH|617-414-5213|karen.jacobson@bmc.org|
20554459|NCT03003676|Targovax|Dr. Lone H. Ottesen, Chief Development Officer|+44 7920567911|lone.ottesen@targovax.com|
20554460|NCT05209191|REAL Prevention LLC|Dr. Michael L. Hecht|18143601893|HECHTPSU@GMAIL.COM|
20570646|NCT03941600|Washington University School of Medicine|Dr. Kerri Morgan|314-286-1659|morgank@wustl.edu|
20570647|NCT00580489|Metrohealth Medical Center|Charles Emerman|2167783577|cemerman@metrohealth.org|
20570648|NCT01673022|Indiana University School of Medicine|Research Coordinator|317-944-2654|jmvinter@iupui.edu|
20570649|NCT00983749|Department of Emergency Medicine, University of California San Diego Health System|Kama Guluma, M.D.|619-543-6463|kguluma@ucsd.edu|
20570650|NCT04292470|University of California Davis|Dr. Michelle Dossett|916-734-5367|mdossett@ucdavis.edu|
20570651|NCT00283283|Walter Reed National Vaccine Healthcare Center Network|COL Renata J. M. Engler, MD|202-782-9461|renata.engler@na.amedd.army.mil|8819
20570652|NCT00867100|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
20570653|NCT02906020|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20570654|NCT01597843|Clement J Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
20570655|NCT02701062|AtriCure|Nfii Ndikintum, VP Clinical Affairs and Biometrics|(513) 644-8192|nndikintum@atricure.com|
20570656|NCT01375673|WJB Dorn VAMC (VHA)|Andrea M. Boyd, PhD, Asscoaite Nurse Executive, Research/Education|803.776.4000|andrea.boyd@va.gov|5654
20570657|NCT04698915|Galera Therapeutics|Judy Schnyder, Sr. Vice President Clinical Operations and Data Management|484-870-9625|jschnyder@galeratx.com|
20570658|NCT00979953|Cubist Pharmaceuticals|VP of Clinical Research|(781) 860-8660||
20570659|NCT01124097|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
20570660|NCT03023553|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20570661|NCT00399841|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20570662|NCT04829747|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20570663|NCT02330094|Mayo Clinic|Dr. William D. Freeman|904-953-7103|freeman.william1@mayo.edu|
20554461|NCT03021759|University of Pennsylvania|Rebecca Pepe|215-360-0951|peper@pennmedicine.upenn.edu|
20526449|NCT01323010|University of Sao Paulo|Dr Fabio Pereira Muchão|+5511 983835563|fabiomuchao@gmail.com|
20554462|NCT04279925|Plastic Surgery Division of Surgery Department of Cipto Mangunkusumo Hospital Jakarta / Faculty of Medicine Universitas Indonesia|Prasetyanugraheni Kreshanti, MD|08158732424|pras_md@yahoo.com|
20554463|NCT00803023|Jazz Pharmaceuticals|Director of Clinical Development|650-496-3777||
20526450|NCT05174949|University of Oklahoma Health Sciences Center|Dr. Yuan Yang (Principal Investigator) C/o Dr. Shirley James (Project Biostatistician)|4052712131|shirley-james@ouhsc.edu|46812
20554464|NCT00701389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554465|NCT02647658|University of Pittsburgh|Dr. Charity Patterson|412-383-4812|cgp22@pitt.edu|4123834812
20554466|NCT01542528|Yale University|Dr. James Leckman|203-785-5880|james.leckman@yale.edu|
20554467|NCT05282004|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20554468|NCT04808609|Columbia University|Dr. Rebecca Schnall, RN, MPH, PhD, Professor of Disease Prevention and Health Promotion (in Nursing)|212-342-6886|rb897@cumc.columbia.edu|
20554469|NCT02202135|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
20554470|NCT01993719|National Cancer Institute|Dr. Stephanie L. Goff|240-760-6214|stephanie.goff@nih.gov|
20554471|NCT02256111|Duke University|Michael Harrison, MD|919-668-4615|michael.harrison@duke.edu|
20554472|NCT04382326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554473|NCT02710630|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554474|NCT02461589|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20554475|NCT01038921|Emory University|Dr. Abinav Goyal|404-727-8758|agoyal4@emory.edu|
20526451|NCT04351373|Mayo Clinic|Dr. Matthew Carlson|507-284-8532|Carlson.Matthew@mayo.edu|
20526452|NCT04537910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20554476|NCT01709227|Stanford University|David Kwiatkowski|650-721-3290|david.kwiatkowski@stanford.edu|
20554477|NCT04695691|Cutera|Director Clinical Research|415-657-5518|mdoucette@cutera.com|
20554478|NCT00559897|Barbara Ann Karmanos Cancer Institute|Dr. Shirish Gadgeel|313-576-8753|gadgeels@karmanos.org|
20554479|NCT03295201|Marmara University|Dr. Kardelen Gencer Atalay|5324404887|kardelengencer@gmail.com|532
20554480|NCT00572572|Hoosier Cancer Research Network|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20526453|NCT01123941|Novartis Vaccines Institute for Global Health|Dr. Audino Podda, MD|+39 0577 243496|audino.podda@novartis.com|
20554481|NCT02828111|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|clinical@pellepharm.com|
20526454|NCT00351741|USAISR|Principal Investigator|210-916-3054|kevin.chung@us.army.mil|
20554482|NCT04096560|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20570664|NCT00708851|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel, MD|609-443-4501|dreamacres1@aol.com|
20526455|NCT04050124|NYU Langone Health|Scott Gorenstein, MD|5166638498|Scott.Gorenstein@nyulangone.org|
20526456|NCT04281901|Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia. Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.|Domen Vozel, M.D., Saba Battelino, M.D., PhD.|+386 (0)1 522 83 07|domen.vozel@kclj.si|
20526457|NCT04601103|3M Health Care Business Group|Brenda Coalwell, Clinical Affairs Manager|16517362456|bccoalwell1@mmm.com|
20526458|NCT05083923|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20570665|NCT01535001|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
20570666|NCT05878873|Colorado State University|Dr. Brett Fling|(970) 491-3451|brett.fling@colostate.edu|
20570667|NCT01383447|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Patrick Brown|410-614-4915|pbrown2@jhmi.edu|
20570668|NCT00577135|Duke University|Jeff Sharp|919.668.7086|jeff.sharp@dm.duke.edu|
20570669|NCT02375347|University of Florida|Volker Mai, PhD, MPH|3522739398|vmai@epi.ufl.edu|
20570670|NCT00193479|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
20570671|NCT00425607|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
20570672|NCT00079339|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
20570673|NCT02563548|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
20570674|NCT00559377|UWMC Dept of Radiology|Joseph G Rajendran|206-221-4421|rajan@u.washington.edu|
20570675|NCT04312256|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
20570676|NCT00590226|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
20570677|NCT01547598|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20540007|NCT02678923|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
20570678|NCT00371176|Boston VA Healthcare System|Dr. Brett Litz|857 364 4131|brett.litz@va.gov|
20570679|NCT00203047|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20540008|NCT00455143|Icahn School of Medicine at Mount Sinai|Department of Anesthesiology|212-241-7473||
20540009|NCT03266172|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20540010|NCT04921332|University of Pittsburgh|Erica Osborn DNP, CRNP|814-282-9793|elo25@pitt.edu|
20540011|NCT02004977|University of Minnesota|Dr. Susie Nanney|612-626-6794|msnanney@umn.edu|
20540012|NCT05222555|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20540013|NCT00300365|University of Pennsylvania|Dr. Richard L. Dunbar|(215) 315-3378|richard.dunbar@uphs.upenn.edu|
20570680|NCT00340704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20570681|NCT04071301|Essity Hygiene and Health|Fredrik Agholme, Clinical Trials Manager, Clinical Affairs|+46 73 0323634|Fredrik.AGHOLME@essity.com|
20570682|NCT00121667|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20570683|NCT01453023|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554483|NCT00534352|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
20526459|NCT01203826|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
20554484|NCT04071951|Cedars-Sinai Medical Center|Joshua Pevnick|310.423.4683|pevnickj@cshs.org|
20554485|NCT03735420|National University of Natural Medicine|Ryan Bradley, ND, MPH|5035521862|rbradley@nunm.edu|
20554486|NCT00833924|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
20554487|NCT01485861|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20554488|NCT01144338|Astrazaneca Inc.|Peter Ohman|1(301)398-0120|Peter.Ohman@astrazeneca.com|
20554489|NCT02266381|The First Affiliated Hospital of Guangzhou Medical University|Dr. Guohua Zeng|0086-20-34294163|gzgyzgh@vip.sina.com|
20554490|NCT00096941|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20554491|NCT02401672|Medical University of South Carolina|Xingbao Li, MD|843-792-5729|lixi@musc.edu|
20554492|NCT04796610|RAND Corporation|Laura Bogart|3103930411|lbogart@rand.org|7281
20554493|NCT01459796|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20554494|NCT00733824|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
20554495|NCT00701051|Baltimore VA Medical Center|Steven J. Prior, PhD|410-605-7000|steven.prior@va.gov|4129
20554496|NCT02658851|Apyx Medical|Kari Larson|8012440058|kari.larson@apyxmedical.com|
20554497|NCT01410110|Yale University School of Medicine|Morris Bell, Ph.D.|203-932-5711|morris.bell@yale.edu|2281
20526460|NCT02751879|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526461|NCT01537068|NYSPI|David Hellerstein MD|646-774-8000|desdesk@nyspi.columbia.edu|
20526462|NCT06011161|VISN 2 Center of Excellence for Suicide Prevention|Dev Crasta|585-364-8119|Dev.Crasta@va.gov|
20526463|NCT04442269|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20526464|NCT03802565|Neurana Pharmaceuticals, Inc.|Randall Kaye, MD - Chief Medical Officer|858-732-0708|rkaye@neuranapharma.com|
20526465|NCT03559868|Yale University, Yale School of Medicine|Mehal Wajahat MD, DPhil|877.925.3637|wajahat.mehal@yale.edu|
20526466|NCT00430352|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20526467|NCT03099694|Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Pediatrics in Chongqing|Prof. Shi Yuan|13508300283|15084335697@163.com|
20526468|NCT04326439|Emory University|Dr. Himalee Sabnis|404-727-3285|hsabnis@emory.edu|
20526469|NCT05805085|CooperVision Inc.|José A. Vega OD, MSc, PhD, FAAO|+19256213761|jvega2@coopervision.com|
20526470|NCT02291601|Bioscience Labs|C Beausoleil|460-782-5498|cbeausoleil@biosciencelabs.com|
20526471|NCT05870956|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526472|NCT04065451|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
20526473|NCT01597375|Brigham and Women's Hospital|Tanya Laidlaw|617-525-1034|tlaidlaw@bwh.harvard.edu|
20526474|NCT00347919|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526475|NCT00624195|UCSD|Dr. Ron Ellis|619-543-5079|roellis@ucsd.edu|
20526476|NCT01190267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526477|NCT04017832|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20526478|NCT01419080|Saint Luke's Hospital of Kansas City|John Spertus|816-932-8270|jspertus@saint-lukes.org|
20526479|NCT02046395|Tulane University|Vechi Batuman|(504)988-5346|vbatuma@tulane.edu|
20526480|NCT01996410|OhioHealth|John Elliott|614-566-3643|John.Elliott@ohiohealth.com|
20526481|NCT04654754|Rush University|Dr. Jie Li|3125634643|jie_li@rush.edu|
20526482|NCT03641326|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
20526483|NCT00794040|Mood, Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health|Dr Argyris Stringaris|(301) 443-8019|argyris.stringaris@nih.gov|
20526484|NCT04696354|Philips|Danielle Op den Kamp, Sr Manager Clinical Operations|+31 (0)627218737|Danielle.op.den.kamp@philips.com|
20526485|NCT03005327|X4 Pharmaceuticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
20526486|NCT01263782|UT MD Anderson Cancer Center|Dr. George Simon, Thoracic/Head & Neck Med Onc|713-794-4740|GSIMON@MDANDERSON.ORG|
20526487|NCT00915876|University of Michigan|Amy Pai|7346470005|amypai@med.umich.edu|
20526488|NCT01490073|University of Washington|Elizabeth Micks|206-616-4939|emicks@uw.edu|
20554498|NCT03634579|Emory University|Sherif Nour|404-778-3800|sherif.nour@emoryhealthcare.org|
20554499|NCT04111497|Fred Hutchinson Cancer Center|Dr. Stephanie Lee|206-667-6190|sjlee@fredhutch.org|
20526489|NCT02782065|Boston Children's Hospital|Leah Abecassis|6173552299|leah.abecassis@childrens.harvard.edu|
20540014|NCT01274520|Columbia University College of Physicians and Surgeons - Center for Liver Disease and Transplantation|James V. Guarrera, MD, FACS|(212)305.3839|jjg46@cumc.columbia.edu|
20540015|NCT01966445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20540016|NCT01374178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20540017|NCT00524017|SKCCC|Dr. Zubair Khan|4109553157|zkhan@jhmi.edu|
20540018|NCT04856904|Galderma R&D, Inc.|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20540019|NCT01422824|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20540020|NCT00902174|Novartis Pharmaceuticals|Study Director|862-778-8300||
20540021|NCT00454584|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215-793-7612||
20554500|NCT02661828|Emory University|Boadie Dunlop, MD|404-727-8474|vcruz@emory.edu|
20554501|NCT05857527|Medical University of South Carolina|Kelly McGloon|8437926443|mcgloon@musc.edu|
20540022|NCT02760810|Johnson & Johnson Vision Care Inc.|Andrea Le, OD, MBA - Manager, Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
20570684|NCT05186311|Becton, Dickinson and Company|Clinical Program Manager|9292850651|Pierre.Asselin@bd.com|
20540023|NCT02421601|Seikagaku Corporation|Clinical Development Department|(81)3-5220-8948|kyoichi.osano@seikagaku.co.jp|
20540024|NCT01716104|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Director of Clinical Research and Medical Information|+74952761571|PutilovskiyMA@materiamedica.ru|302
20540025|NCT00117793|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
20540026|NCT00581360|Clinical Research Services, UPCI|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
20540027|NCT02895945|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20540028|NCT04003987|Indiana University School of Medicine|Yar Yeap|(317) 274-0275|yyeap@iupui.edu|
20540029|NCT01946126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20540030|NCT03429543|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20540031|NCT01818492|Sobi AB|Carl Johan Treutiger|46 76 00 11 815|CarlJohan.Treutiger@sobi.com|
20540032|NCT02025439|Edward Hines VA Hospital|Theresa Bender-Pape|708-202-4953|Theresa.BenderPape@va.gov|
20540033|NCT00989781|UCSD|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
20540034|NCT01026220|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20540035|NCT00651625|University of New Mexico|Wilmer L. Sibbitt, MD, Principal Investigator|505 272-4761|wsibbitt@salud.unm.edu|
20540036|NCT00409344|Massachusetts General Hospital|Ulrich Schmidt, MD PhD|617-724-6490|uschmidt@partners.org|
20540037|NCT05096312|East Avenue Medical Center|Dr. Monqiue Lianne Lim-Ang|0287100957|moniquelianne.lim@gmail.com|
20540038|NCT02641067|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20540039|NCT00534833|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20540040|NCT00498355|University of California San Francisco|Dr. Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
20540041|NCT01178268|Abbott Vascular|Dana Haudek|928-925-4054|dana.haudek@av.abbott.com|
20540042|NCT01593592|Tropical Medicine Departement, Faculty of Medicine, Zagazig University, Egypt|Dr Mohamed Emara|+2 0100 272 4482|emara_20007@yahoo.com|
20540043|NCT02814175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20540044|NCT01971008|Innsbruck Medical University|Prof. Dr. Klaus Seppi|004351250481498|klaus.seppi@tirol-kliniken.at|
20540045|NCT00244101|Vermont Oxford Network|Roger F. Soll, MD|802 865 4814|roger.soll@uvmhealth.org|212
20540046|NCT03679624|Weill Cornell Medicine|Dr. John Allan, Associate Professor of Medicine|2127463481|joa9069@med.cornell.edu|
20540047|NCT02870101|UCLA David Geffen School of Medicine and Fielding School of Public Health|Jeffrey D. Klausner, MD, MPH|310-557-2273|JDKlausner@mednet.ucla.edu|
20540048|NCT04120363|Pennington Biomedical Research Center|Jennifer C Rood, PhD|225-763-2524|jennifer.rood@pbrc.edu|
20540049|NCT04532931|Shin Poong Pharm. Co., Ltd.|Shin Poong Pharm. Co., Ltd.|82-2-2189-3478|bwon@shinpoong.co.kr|
20540050|NCT00065806|Duke University Medical Center|Laura Schanberg, MD|919-684-6575|laura.schanberg@duke.edu|
20540051|NCT00581867|University of Kansas Medical Center|Dr. Jeffrey Burns|(913) 588-0555|jburns2@kumc.edu|
20540052|NCT02092311|OMID FERTILITY CENTER|Dr.Navid Pooyan|00989124474032|navidpooyan@yahoo.com|
20540053|NCT01329939|North Shore - Long Island Jewish Health System; Hofstra North Shore-LIJ School of Medicine|Dr. Sherry Farzan, Attending Physician, Assistant Professor of Medicine and Pediatrics|5166225070|sfarzan@nshs.edu|
20540054|NCT02522442|Sleep Therapy & Research Center|Eric Powell, Ph.D.|(210) 614-6000|powell.eric@sleeptrc.com|
20540055|NCT01753401|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20540056|NCT00470418|James J Peters VA Medical Center|Dr. Hillel Grossman|718-584-9000|hillel.grossman2@va.gov|5752
20540057|NCT00599638|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540058|NCT01463202|Center for Family Planning Research|Principal Investigator|412-641-5496|fpr@upmc.edu|
20540059|NCT02825212|Icahn School of Medicine at Mount Sinai|Dr. Peter D. Gorevic|212-241-0968|peter.gorevic@mountsinai.org|
20540060|NCT03006887|Eisai, Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
20540061|NCT00462748|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20540062|NCT01729208|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
20540063|NCT02428413|Teleflex|Thomas Philbeck, PhD, MBA, Senior Director of Global Research and Scientific Services|210-581-7778|thomas.philbeck@teleflex.com|
20540064|NCT03286283|Apyx Medical (formerly Bovie Medical Corporation)|Shawn Roman/Vice President of Research and Development|1-727-384-2323|shawn.roman@apyxmedical.com|
20540065|NCT03688100|Cedars-Sinai Medical Center|Dr. Waguih IsHak|310-423-3515|Waguih.IsHak@cshs.org|
20540066|NCT04882787|Sonova|Jinyu Qian, Director Innovation Centre Toronto|905-677-1167|jinyu.qian@sonova.com|5873
20540067|NCT04783077|University of Minnesota|Susan Telke|6125902697|telke001@umn.edu|
20540068|NCT01141491|MabVax Therapeutics, Inc.|Dave Hansen|858.259.9405|dhansen@mabvax.com|301
20570685|NCT02879383|Fractyl Laboratories, Inc.|Sarah Hackett, Director of Clinical Operations|(781) 902-8840|shackett@fractyl.com|
20570686|NCT00980642|Cleveland Clinic|Dr. Andrea Kurz|216 445-9924|KURZA@ccf.org|
20570687|NCT02125279|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20570688|NCT01392703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20570689|NCT01236378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570690|NCT03724253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20570691|NCT03343093|University of Minnesota|Gudrun Kilian|612-626-9568|kilian@umn.edu|
20570692|NCT01790295|Icahn School of Medicine at Mount Sinai|Dr. John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
20540069|NCT02453555|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540070|NCT03045341|Yale University|Dr Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
20540071|NCT03689855|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-747-7948|danielmorgensztern@wustl.edu|
20540072|NCT02409719|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
20540073|NCT02479139|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
20540074|NCT00764673|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
20540075|NCT01438177|Perlmutter Cancer Center|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
20540076|NCT01727336|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20540077|NCT00849862|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20540078|NCT00619099|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
20540079|NCT00885482|Catholic University of S. Heart|Andrea De Luca|+390630155366|deluca.andrea@fastwebnet.it|
20540080|NCT00084656|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20540081|NCT02772978|University of California at San Francisco|Andrew Kayser, MD PhD|415-502-7332|Andrew.Kayser@ucsf.edu|
20540082|NCT04684992|Cairn Diagnostics|Chief Scientist and Compliance Officer|615-376-5464|cwilliams@cairndx.com|
20540083|NCT03776461|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20540084|NCT02163421|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20540085|NCT01389323|BristolMyers Squibb|BristolMyers Squibb Study Director||Clinical.Trials@bms.com|
20540086|NCT03040115|University of Cincinnati|Elizabeth Kopras, Senior Research Associate|513-558-7205|koprasej@uc.edu|
20540087|NCT02851823|Izmir Katip Celebi University, Dentistry Faculty|Assoc.Prof.Dr. Mehmet Sağlam|+90 530 324 99 48|dtmehmetsaglam@gmail.com|
20540088|NCT02533726|Stanford University School of Medicine|Dr David Pickham|650 701 6830|dpickham@stanford.edu|
20540089|NCT04349033|Wayne State University|Dr. Mark A. Lumley, Professor|3135772247|mlumley@wayne.edu|
20540090|NCT01417455|Instituto de Medicina Molecular|João Eurico Fonseca|+351217999544|jecfonseca@gmail.com|47221
20540091|NCT02837042|UAB|Gurudatta Naik, Scientist 3|205-996-5530|alkanand@uab.edu|
20540092|NCT03596450|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20540093|NCT04583956|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20540094|NCT01069705|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20540095|NCT00915551|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
20540096|NCT04390841|Biotronik (Beijing) Medical Device Limited|Senior Clinical Study Project Manager|+86 10 6522 3851-863|lan.chen@biotronik.com|
20540097|NCT02999633|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20540098|NCT02607228|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20540099|NCT01204216|Research Service, Cincinnati VA Medical Center|Robert M Cohen, MD, Physician,|5136748676|robert.cohen@uc.edu|
20540100|NCT04775264|AtriAN Medical Ltd|Barry O'Brien|+353872934292|barry.obrien@atrianmedical.com|
20540101|NCT03665688|UTMB Galveston|Antonio Saad Director of Clinical Research Division|409 772 0982|afsaad@utmb.edu|
20540102|NCT01196416|Memorial Sloan Kettering Cancer Center|Dr. Mark Dickson|646-888-4164|DicksonM@mskcc.org|
20540103|NCT03908970|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20540104|NCT04407234|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20540105|NCT02280317|Valirx plc|Dr Suzanne Dilly|+44 2476796496|suzanne.dilly@valirx.com|
20540106|NCT00727558|Vistakon|Kurt Moody OD, FAAO/ Director|904-443-3088|kmoody1@its.jnj.com|
20540107|NCT01717326|Merck Sharp & Dohme Corp.|Results Point of Contact* Name or Official Title Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20540108|NCT00771056|Northwell Health (formerly North Shore LIJ Health System)|Kanti R Rai, MD|(718)470-4050|krai@nshs.edu|
20540109|NCT04943432|University of North Carolina at Chapel Hill|Catherine Paquette, MA, MPS|919-962-5082|cpaq@live.unc.edu|
20540110|NCT01123707|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20540111|NCT02986802|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3755|De-Kun.Li@kp.org|
20540112|NCT03281304|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540113|NCT00428844|Cubist Pharmaceuticals, Inc.|Ed Campanaro, VP Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
20540114|NCT02684188|University of Montana|Tom Seekins, Ph.D.|2432654|TOm.Seekins@UMontana.edu|406
20540115|NCT00488826|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20540116|NCT01549977|Takeda|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20540117|NCT00006400|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
20540118|NCT01705106|University of Chicago|Manish R. Sharma, MD|773-834-0312|msharma@bsd.uchicago.edu|
20540119|NCT03208088|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen SR Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20540120|NCT00605345|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20540121|NCT01108523|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20540122|NCT03210961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540123|NCT00301418|Feinstein Institute for Medical Research|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu|
20540124|NCT03831100|Medical University of South Carolina|Evan Graboyes|843-792-0719|graboyes@musc.edu|
20540125|NCT04566601|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540126|NCT02625844|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20540127|NCT01248741|British Columbia Cancer Agency|Dr Juanita Crook|2507123958|jcrook@bccancer.bc.ca|
20540128|NCT03047031|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540129|NCT00860171|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
20540130|NCT03304119|Hôpital Privé Antony|V Chassaing|+33 1 46 74 37 00|vchassaing92@gmail.com|
20540131|NCT00666224|Teva Pharmaceutical Industries, Ltd.|Yossi Gilgun, PhD, Global Clinical Leader|972-9-863-1491|yossi.gilgun@teva.co.il|
20540132|NCT01450098|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20526490|NCT04545567|University of Virginia|Mark DeBoer|1 434 924 0123|mdd5z@virginia.edu|
20526491|NCT03979807|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526492|NCT04009668|University of Michigan|Dr. Zubin Modi|(734) 232-6798|modiz@med.umich.edu|
20526493|NCT02419612|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
20526494|NCT00533702|Eli Lilly and company|Chief Medical Officer|800-545-5979||
20526495|NCT01095978|Abbott|Global Medical Services|1-800-633-9110||
20526496|NCT00965341|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO / Assistant Professor|713-745-4192|HMoreno@mdanderson.org|
20526497|NCT02807506|Penn Medicine Center for Physical Medicine and Rehabilitation|Dr. Michelle J. Johnson|4148130128|johnmic@pennmedicine.upenn.edu|
20526498|NCT04413552|Indivior, Inc.|Global Director, Clinical Development|804-594-4488|TrialDisclosure@Indivior.com|
20526499|NCT03476174|Hoosier Cancer Research Network|Jeff Smith|317-634-5842|jsmith@hoosiercancer.org|41
20526500|NCT03955081|OLYMPUS EUROPA SE & CO. KG|Peter Teichmann, PhD|+49 40 23773|peter.teichmann@olympus.com|7835
20526501|NCT01794793|RECORDATIGROUP|Mario Maldonado, MD / Head of Clinical Development Global Endocrinology|+41798030344|maldonado.m@recordati.com|
20526502|NCT02417961|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
20526503|NCT05079750|University of Oxford|Dr. Paola Cicconi|01865 611425|paola.cicconi@ndm.ox.ac.uk|
20526504|NCT05091346|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20526505|NCT03036098|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20526506|NCT01632904|Incyte Corporation|Study Director|855 463-3463||
20526507|NCT02956447|Massachusetts General Hospital|Dr. Stephanie Seminara|617-724-5390|MGHKisspeptinResearch@partners.org|
20526508|NCT04769466|LifeBio|Lisbeth Sanders|937-303-4574|beth@lifebio.com|
20526509|NCT04542499|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20526510|NCT02142361|Optometry Research Group (GIO)|Robert Montés-Mico O.D., MPhil, PhD Optometry|34-9635-44764|robert.montes@uv.es|
20526511|NCT04281784|University of Washington|Janaki Torrence, Research Coordinator|206-402-7357|jtorrenc@uw.edu|
20526512|NCT04035434|CRISPR Therapeutics AG|Annie Weaver, PhD: Study Director|+1 617-315-4600|info@crisprtx.com|
20526513|NCT04488497|Weill Cornell Medicine|Dr. Iris Navarro Millan|646-962-7875|vam4007@med.cornell.edu|
20526514|NCT02111746|The University of Texas Health Science Center at Houston|Dr. Kristofer M Charlton-Ouw|(713) 486-5100|Kristofer.CharltonOuw@uth.tmc.edu|
20526515|NCT01849068|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
20526516|NCT02210286|Stanford University|Alison Myoraku|6507244559|myoraku@stanford.edu|
20526517|NCT05185622|Santhera|Dr Shabir Hasham|+41 61 906 89 50|Shabir.Hasham@santhera.com|
20526518|NCT01877551|Washington University School of Medicine|Dr. Dominic Reeds|3143628430|dreeds@wustl.edu|
20526519|NCT00348790|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
20526520|NCT02614222|The Cooper Health System|Dr. Ronak Desai|856-342-2000|desai-ronak@cooperhealth.edu|
20526521|NCT03602391|University of Texas at Arlington|JEREMY A FORSBERG|8172722105|ogcs@uta.edu|
20540133|NCT01128192|Veterans Medical Research Foundation|Principal Investigator|858-552-8585|rrhenry@ucsd.edu|
20540134|NCT05443256|University of New Mexico|Dr. James F. Cavanagh|5052773890|jcavanagh@unm.edu|
20540135|NCT03335774|Nivagen Pharmaceuticals|Dr Vishal S Narang|+919820020278|vnarang@nivagen.com|
20540136|NCT00482625|Weill Cornell College of Medicine|Dr. Steven Lipkin|212-774-7160|stl2012@med.cornell.edu|
20540137|NCT01078363|Stanford University|William F. Fearon, M.D.|650 725-2621|wfearon@stanford.edu|
20540138|NCT03828617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540139|NCT00610311|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20554502|NCT02799082|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
20526522|NCT00984139|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526523|NCT02725580|Amicus Therapeutics|Amicus Therapeutics Patient Advocacy|+1 609-662-2000|clinicaltrials@amicusrx.com|
20526524|NCT00878969|Vanderbilt University|T. Alp Ikizler, MD|615-343-6104|alp.ikizler@vanderbilt.edu|
20540140|NCT03354273|GE HealthCare|Francois Tranquart, M.D., Ph.D|447775543206|francois.tranquart@ge.com|
20540141|NCT03828331|VA Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
20540142|NCT00746863|UNC Hospitals|Gena Dunivan, MD|919-966-4717|gdunivan@med.unc.edu|
20540143|NCT03229109|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
20540144|NCT03653988|University of Iowa Hospitals and Clinics|Melinda Seering, M.D.|(319) 384-8466|melinda-seering@uiowa.edu|
20540145|NCT04207749|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20540146|NCT00655629|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20540147|NCT05126836|University of Minnesota|Dr. Markus Meyer|612.625-9538|meye3249@umn.edu|
20540148|NCT03416127|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20540149|NCT02277925|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
20540150|NCT00705367|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20540151|NCT01959139|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
20540152|NCT01610336|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20540153|NCT00741013|Washington University School of Medicine|Delphine L. Chen|314-362-7029|chend@mir.wustl.edu|
20540154|NCT01559675|Cedars Sinai Medical Center|Dr. Phillip Fleshner|310-289-9224|pfleshner@aol.com|
20540155|NCT00082407|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20540156|NCT00567359|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|LVSEQUIST@PARTNERS.ORG|
20540157|NCT02352753|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20540158|NCT00539305|University of Washington|Monique Cherrier PhD.|206-277-3594|cherrier@u.washington.edu|
20540159|NCT00607867|Minneapolis VA Health Care System, Metabolic Research Labortory|Mary C. Gannon, Ph.D.|6124672895|ganno004@umn.edu|
20540160|NCT03626545|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20540161|NCT04274556|Demiroglu Bilim University|Nurten OZEN|+90 212 213 64 86|ozenurten@yahoo.com.tr|
20540162|NCT00793325|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540163|NCT01440816|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
20540164|NCT03387020|St. Jude Children's Research Hospital|Dr. Arzu Onar-Thomas|901-595-5499|arzu.onar@stjude.org|
20540165|NCT01452919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20540166|NCT02421588|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
20540167|NCT01359943|Novartis Pharmaceuticals|Study Director|862-778-8300||
20540168|NCT02516592|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20540169|NCT00510744|University of Pittsburgh|Stephen O'Keefe|412 648 7217|sjokeefe@pitt.edu|
20540170|NCT01110382|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
20540171|NCT00098306|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540172|NCT00360568|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20540173|NCT01431391|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
20540174|NCT01114438|GI Dynamics|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
20540175|NCT00753363|Baltimore VAMC|Dr. Alice Ryan|410-605-7851|aryan@grecc.umaryland.edu|
20554503|NCT02543346|Kingston General Hospital|Dr. Anne Ellis|6135482336|ellisa@kgh.kari.net|
20554504|NCT00006411|JCHR|Roy W. Beck, MD, PhD|813-975-8690|cds@jaeb.org|
20508001|NCT00538824|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
20508002|NCT03828149|Novus Therapeutics|Clinical Director|949-679-1110|study001@novustherapeutics.com|
20508003|NCT04430283|Faraday Pharmaceuticals, Inc.|Clinical Trial Manager|206-492-5310|info@faradaypharma.com|
20508004|NCT02664532|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
20508005|NCT01998269|University of North Carolina at Chapel Hill|Dr. Stacy Bailey|919-843-9834|scbailey@unc.edu|
20508006|NCT01561560|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20508007|NCT00800865|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508008|NCT01738737|University of Sao Paulo|Sarah Rubia Ferreira de Meneses|+55(11)470898-71|sarah.meneses@usp.br|
20508009|NCT05406440|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20540176|NCT02292706|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20540177|NCT01229722|Dimagi Inc.|Dr. Vikram Kumar|6176492214|information@dimagi.com|
20540178|NCT02725866|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20526525|NCT01152359|VA Medical Center|William S. Yancy, Jr.|919-286-0411|william.yancy2@va.gov|7770
20526526|NCT01007136|University of Texas Southwestern|Timea Hodics, M.D.||Timea.Hodics@UTSouthwestern.edu|
20526527|NCT01230424|Tufts Medical Center|Dr. Timothy McAlindon|6176365610|tmcalindon@tuftsmedicalcenter.org|
20526528|NCT01128218|SIU Medicine|Barbara Lokaitis, BA, CCRP / Senior Clinical Research Coordinator|217.545.9737|blokaitis@siumed.edu|
20526529|NCT04495816|Icahn School of Medicine at Mount Sinai|Dr. David Lerner|212-241-9410|david.lerner2@mountsinai.org|
20526530|NCT06137703|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526531|NCT02160847|Georgia State University|Dr. Jenelle Shanley Chatham|404-413-1340|jshanley@gsu.edu|
20526532|NCT04329091|UNIVERSITY OF CHICAGO|Al McAuley, Clinical Research Manager|7738343274|amcauley1@bsd.uchicago.edu|
20526533|NCT00741091|Boston Scientific Corporation|Todd Kornmann, Specialist, Prin Reg Affairs|763-494-1348|Todd.Kornmann@bsci.com|
20526534|NCT01801358|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
20526535|NCT03787303|Aultman Hospital|Shruti Trehan MD|3303634162|trehanshruti4@gmail.com|
20526536|NCT01527487|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20526537|NCT00108342|Department of Veterans Affairs - VAGLA|Nina G. Schneider, Ph.D., Principle Investigator|310-268-3059|ngs@ucla.edu|
20526538|NCT01210495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526539|NCT01695330|Oncotherapeutics|Dr. James Berenson|310-420-9649|jberenson@berensonocology.com|
20526540|NCT01826370|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526541|NCT01575275|Cleveland Clinic|Dr. Michael Vogelbaum|2164448564|vogelbm@ccf.org|
20526542|NCT00640653|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
20526543|NCT00597506|Duke University Medical Center|Herbert Hurwitz, MD|919-668-1861|herbert.hurwitz@duke.edu|
20526544|NCT02961062|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20526545|NCT03199612|Montefiore Einstein|Omar Saeed|718-920-2626|osaeed@montefiore.org|
20526546|NCT02938949|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
20526547|NCT00526331|UT MD Anderson Cancer Center|Gabriel Mena, MD / Professor||CR_Study_Registration@mdanderson.org|
20526548|NCT01259375|Huntsman Cancer Institute|Dr. Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
20526549|NCT00628095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526550|NCT03124121|Guy's & St Thomas' Hospital|Dr Mark Samaan|07740637713|mark.samaan@gstt.nhs.uk|
20526551|NCT03336268|Chestnut Health Systems|Dr. Dennis Watson|312-274-5316|dpwatson@chestnut.org|
20526552|NCT04424966|Ivy Brain Tumor Center|Dr. Nader Sanai|602-406-8605|research@ivybraintumorcenter.org|
20526553|NCT02738255|Brigham and Women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
20526554|NCT01508052|Gachon University|Dr.Kwak|82324603400|hyun615@gilhospital.com|
20526555|NCT04535531|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20526556|NCT02225366|UT MD Anderson Cancer Center|Dr. Rodabe Amaria,MD, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|rnamaria@mdanderson.org|
20526557|NCT04616573|Sight Sciences, Inc.|Kavita Dhamdhere, MD, PhD|877-266-1144|kdhamdhere@sightsciences.com|
20526558|NCT02537431|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
20526559|NCT03003494|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526560|NCT03040804|Montefiore Medical Center|Steven R. Cohen, MD, MPH|7189208352|srcohen@montefiore.org|
20526561|NCT02266472|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20526562|NCT01077739|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20526563|NCT00877071|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
20526564|NCT05723328|Hackensack Meridian Carrier Clinic|Zachary D. Fischer PhD, MT-BC|908-281-1324|Zachary.Fischer@hmhn.org|
20526565|NCT05537792|Georgia Institute of Technology|Dr. Aaron Young|404.385.5306|aaron.young@me.gatech.edu|
20526566|NCT03495154|Medtronic|Alyssa Sutch, Senior Clinical Research Specialist|612-214-9756|alyssa.m.sutch@medtronic.com|
20526567|NCT00538512|University of Michigan School of Public Health|Arnold S. Monto, MD|734-764-5453|asmonto@umich.edu|
20540179|NCT01990612|Northwestern University|Dr. William Grobman|312-472-4661|w-grobman@northwestern.edu|
20540180|NCT02413047|Indiana University|Dr. Matthew Bohm, DO (Principal Investigator)|3179485136|mbohm@iu.edu|
20540181|NCT03595527|Centre hospitalier de l'Université de Montréal|Valréie Martel-Laferrière, MD|5148908000|valerie.martel-laferriere.med@ssss.gouv.qc.ca|
20540182|NCT02188849|Institute of Nutrition and Food Technology University of Chile|Sandra Hirsch MD|+56 229781485|shirsch@inta.uchile.cl|
20540183|NCT04365452|Indiana Univiersity|Theresa Joyce, Quality Improvement Consultant, Research Complaince|3172921882|tajoyce@iu.edu|
20540184|NCT02508324|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
20540185|NCT00123604|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20540186|NCT02577016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20540187|NCT00812565|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201-604-1155|michael.eppolito@octapharma.com|
20540188|NCT01369732|Yonsei University College of Medicine|Dr. Yon Hee Shim|82220193547|tren125@yuhs.ac|
20540189|NCT00566254|Eisai Call Center|Eisai Inc.|888-422-4743||
20540190|NCT01793883|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
20540191|NCT00687531|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20540192|NCT02353728|Weill Cornell Medical College|Dr.Ellen K.Ritchie|646-962-2700|ritchie@med.cornell.edu|
20540193|NCT02301624|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20540194|NCT00895310|University of California Davis|Analyst|9167340294|pkaujla@ucdavis.edu|
20540195|NCT00659230|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|3819
20540196|NCT05066165|Intellia Therapeutics|Trial Manager|833-888-0387|clinicalscience@intelliatx.com|
20540197|NCT02467582|SAKK|Regulatory affairs|+41 31 389 91 91|regulatory@sakk.ch|
20540198|NCT01370265|Mayo Clinic|Dr. Panithaya Chareonthaitawee|507-284-1648|chareonthaitawee.panithaya@mayo.edu|
20540199|NCT03343626|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20540200|NCT00703924|Institute Pasteur Tunisia|Afif Ben Salah, MD, PhD|216-71-792-429|afif.bensalah@pasteur.rns.tn|
20540201|NCT05388617|Cynosure|Jamie Trimper|9782564200|jamie.trimper@cynosure.com|
20540202|NCT01031979|Ralph H. Johnson VAMC|Dr. Peter Tuerk|(843) 789-6188|peter.tuerk@va.gov|
20540203|NCT03592368|University of Colorado, Anschutz Medical Campus|Joel Stoddard|(720) 777-5702|joel.stoddard@cuanschutz.edu|
20540204|NCT01107665|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20540205|NCT02566590|University of Utah|Micah Drummond|8015877764|micah.drummond@hsc.utah.edu|
20540206|NCT00680459|Baystate Medical Center|Dr. Christine McKiernan|413-794-5370|Christine.McKiernan@bhs.org|
20540207|NCT02376179|Nationwide Children's Hospital|Kris Jatana, MD|614-722-6032|Kris.Jatana@nationwidechildrens.org|
20540208|NCT02454478|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20540209|NCT02227667|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
20540210|NCT00389493|New York State Psychiatric Institute|Dr. Helen Blair Simpson|646-774-7000|kimeldo@nyspi.columbia.edu|
20540211|NCT01732770|Amgen Inc.|Study Director|866-572-6436||
20540212|NCT00791089|University of Michigan|Hakan Oral|734 936-6868|oralh@med.umich.edu|
20540213|NCT01959841|Maruho Co.,Ltd. Kyoto R&D Center|linical Development Dept.|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20540214|NCT00780416|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20540215|NCT02170870|Mayo Clinic|Dr. Adil E. Bharucha, Principal Investigator|507-284-2687|bharucha.adil@mayo.edu|
20540216|NCT03521141|Vanderbilt University Medical Center|Stephen King|615-875-9394|stephen.king@vumc.org|
20540217|NCT00125957|McLean Hospital|Dr. Beth Murphy|617-855-2000|bmurphy5@partners.org|2297
20540218|NCT01721226|George Washington University|Dr. Irene Kuo|202-994-0367|ikuo@gwu.edu|
20540219|NCT01193114|The Ohio State University|Dr. Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
20540220|NCT01496469|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20540221|NCT00077649|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20540222|NCT01532869|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20540223|NCT01331291|Massachusetts General Hospital|Tracy T. Batchelor, MD|617-643-1938|tbatchelor@mgh.harvard.edu|
20540224|NCT00778895|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540225|NCT02953886|University of Michigan|Emily Yanca|734-763-3988|emthorpe@umich.edu|
20540226|NCT02647346|Podimetrics Inc|Brian Petersen|860-558-9204|brian@podimetrics.com|
20540227|NCT01192828|University of Colorado Denver|Dr. Johan Van Hove, Primary Investigator|303-724-2338|johan.vanhove@childrenscolorado.org|
20540228|NCT00820222|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20540229|NCT00590577|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader, Paliperidone|609-730-4530||
20540230|NCT02690714|Prometic Biotherapeutics Inc.|Senior Director, Clinical Development|301-549-9761|clinical@prometic.com|
20540231|NCT01300260|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20540232|NCT02128074|Keryx Biopharmaceuticals, Inc|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
20540233|NCT00439374|Northwestern University Medical School|William Grobman, MD|312-472-4661|w-grobman@northwestern.edu|
20540234|NCT00293020|BioDelivery Sciences International|Andrew Finn, Pharm.D.|919-582-9050|AFinn@bdsi.com|
20540235|NCT01147848|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540236|NCT00908466|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
20540237|NCT01919216|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
20540238|NCT00418574|Menarini Ricerche SpA|Clinical Research Director||abagovomab@menarini-ricerche.it|
20540239|NCT01894022|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540240|NCT03001778|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
20540241|NCT02013245|Centre Hospitalier Universitaire Vaudois (CHUV)|Dr. François Spertini, Associate Professor, Division Immunology & Allergy|+41 21 31 40 799|Francois.Spertini@chuv.ch|
20508010|NCT00859573|University of Arkansas for Medical Sciences|Michael J. Mancino, M.D.|501-526-8442|mjmancino@uams.edu|
20508011|NCT03488238|Masimo Corporation|Cristina Johnson|949-297-7000|clincalresearchdept@masimo.com|
20508012|NCT01316939|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526568|NCT01390428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526569|NCT00642603|Genentech, Inc.|Medical Communications|800-821-8590||
20526570|NCT05897827|University of Pittsburgh|Robert W. S. Coulter|412-624-0647|robert.ws.coulter@pitt.edu|
20526571|NCT05376241|University of Colorado|Laura Scherer|303-724-5749|laura.scherer@cuanschutz.edu|
20526572|NCT05773781|University of Liverpool|Mr Jason Fleming|0151 529 5259|Jason.Fleming@liverpool.ac.uk|
20526573|NCT02276053|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20526574|NCT00715104|Dendreon Corporation|Lynn Ngo|206-274-6763|lngo@dendreon.com|
20526575|NCT02059434|AstraZeneca|AstraZeneca Clinical Study Information Center||ClinicalTrialTransparency@astrazeneca.com|
20526576|NCT01004406|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
20526577|NCT02928770|Stanford University|Clete A. Kushida, M.D., Ph.D.|6507217560|clete@stanford.edu|
20526578|NCT00929474|St. Jude Medical|Manager of Clinical Studies|818-493-2522|klee3@sjm.com|
20526579|NCT03201874|Seattle Children's Hospital|Tonya Palermo, Professor, Anesthesiology and Pain Medicine, Seattle Children's Hospital|206-884-4208|tonya.palermo@seattlechildrens.org|
20526580|NCT02907593|Oregon Health & Science University|Dr. Cindy McEvoy|5034945598|mcevoyc@ohsu.edu|
20526581|NCT03050541|University of Chicago|Office of Clinical Research|(773) 834-1238|tkyeo@bsd.uchicago.edu|
20526582|NCT01752634|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20526583|NCT01196936|University of Alabama at Birmingham|Dr. Smita Bhatia|(205) 638-2120|sbhatia@peds.uab.edu|
20526584|NCT06474078|Chang Gung Memorial Hospital|Dr. Chun Bing Chen|03-3281200|chunbing.chen@gmail.com|8494
20526585|NCT05562934|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20526586|NCT04216784|Rush University Medical Center|Lance Lineberger|312-942-5126|Lance_Lineberger@rush.edu|
20526587|NCT00962949|Vanderbilt University Medical Center|Hossam Mustafa|615-343-6499|adcresearch@vanderbilt.edu|
20526588|NCT05103176|University of Michigan|Dr. Michael Vesia, Assistant Professor|734 763-3905|mvesia@umich.edu|
20526589|NCT04644185|Sinocelltech Ltd.|Dr.|13522038372|yuanxin_chen@sinocelltech.com|
20526590|NCT05128773|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20526591|NCT04697056|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20526592|NCT04322539|HUTCHMED International|William Schelman, MD, PhD|+1-973-306-4490|williams@hutch-med.com|
20526593|NCT03617861|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
20526594|NCT01702532|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526595|NCT00623597|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20526596|NCT01451164|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
20526597|NCT03790618|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20526598|NCT01846221|Columbia University|Allison Lee, MD - Assistant Professor of Anesthesiology|212-342-2028|al3196@cumc.columbia.edu|
20526599|NCT02659514|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|9497886700|shanta.chawla@sppirx.com|
20526600|NCT05283135|Oregon Medical Research Center, PC|Benjamin Ehst, MD, PhD|5032451525|behst@oregonmedicalresearch.com|
20526601|NCT04186806|3M Health Care|Elaine Egging/Project Manger|651-737-0263|eegging@mmm.com|
20526602|NCT03687372|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
20526603|NCT02174913|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
20554505|NCT00433992|Case Western Reserve University|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
20554506|NCT03735862|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
20508013|NCT01432457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526604|NCT03536949|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
20526605|NCT02901275|Johns Hopkins University School of Medicine|Dr. Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
20526606|NCT04106089|Rutgers University Camden|Dr. Lauren Daniel|856-225-6535|lauren.daniel@rutgers.edu|
20526607|NCT03502018|Maimonides Medical Center|Dr. Kevin Kang|718-283-8805|kkang@maimonidesmed.org|
20526608|NCT01384019|Seoul national university Bundang hospital|Dr. Chang-Hwan Yoon|+82-31-787-7052|changhwanyoon@snubh.org|
20526609|NCT03141983|University of Pennsylvania|Natalie Kuzla|2672524208|nkuzla@pennmedicine.upenn.edu|
20526610|NCT00767039|Boston Medical Center|Alan Fujii MD (PI)|617-4414-3735|Alan.Fujii@bmc.org|
20526611|NCT03932331|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20526612|NCT03379753|TriHealth Inc.|Rachel Pauls, MD|513-463-4300|Rachel_Pauls@trihealth.com|
20526613|NCT01032239|Medtronic Clinical Neuromodulation|Alessandra Calabrese, PhD||alessandra.calabrese@medtronic.com|
20526614|NCT00654992|Seoul National University Bundang Hospital|Effect of erythropoietin in kidney after cardiac surgery|82-31-787-7014|kyna@snubh.org|
20526615|NCT04713592|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20526616|NCT03782298|Smtih + Nephew, Inc|Judith Horner|+44 1482 673251|Judith.horner@smith-nephew.com|
20526617|NCT01056198|Healthpoint Biotherapeutics|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
20526618|NCT01382225|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20526619|NCT01797081|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20526620|NCT02426749|University of Manitoba|Dr Zahra Moussavi|204 474 7023|Zahra.Moussavi@umanitoba.ca|
20526621|NCT00359736|Miami VAHS|Dr. Robert M Jackson, ACOS/R|305-575-3548|robert.jackson4@va.gov|
20526622|NCT01852201|Medical University of SC|Jonathan Lena, MD|843-792-9226|lena@musc.edu|
20526623|NCT02513498|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
20526624|NCT02057419|The Miriam Hospital|Dr Kate Guthrie, Principal Investigator, Project WISH Lead Investigator|401-793-8180|kate.guthrie@brownhealth.org|
20526625|NCT02767492|Hawkins Foundation|Kyle Adams|864 454-7458|kyle.adams@hawkinsfoundation.com|
20526626|NCT01793688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526627|NCT02484651|Universidade Aberta, Mathematics Section|Prof. Catarina S Nunes|+351 300 001 705|cnunes@bio-mathematics.org|
20526628|NCT03649178|Vanderbilt University Medical Center|C. Michael Stein MD|615-936-3420|michael.stein@vumc.org|
20526629|NCT02251548|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
20526630|NCT00954512|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526631|NCT05685732|Corium, LLC|Ronald Tashjian|6172337474|rtashjian@corium.com|
20526632|NCT02640404|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20526633|NCT05250102|Medline Industries, LP|Julie J. Finley|(800) 633-5463|jjfinley@medline.com|
20526634|NCT04908202|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20526635|NCT05397171|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20526636|NCT02100670|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526637|NCT05409131|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20526638|NCT04250714|Boston Scientific|Nele Cielen - Clinical Trial Manager|0032470991143|nele.cielen@bsci.com|
20526639|NCT01668966|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20526640|NCT04599933|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
20526641|NCT05098067|Women and Infants Hospital|Dr. Lauren Murphy|2107222589|lmmurphy@wihri.org|
20526642|NCT00842075|UColorado|Dr. H. Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
20526643|NCT00546455|UCSD|MARIO CHOJKIER|858-552-8585|mchojkier@gmail.com|7283
20526644|NCT00345878|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526645|NCT02102100|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehemt.sofuoglu@yale.edu|4809
20526646|NCT06303167|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20526647|NCT03506945|University of California San Diego|Brent Mausbach|8588227529|bmausbach@ucsd.edu|
20526648|NCT04076059|Astellas Pharma China, Inc|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|China only
20526649|NCT02677896|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
20526650|NCT03902522|CytoDyn|Joseph Meidling|13609808524|jmeidling@cytodyn.com|
20526651|NCT02729038|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20526652|NCT05363072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526653|NCT03719287|3M|Helen Han|651-737-9234|mhan3@mmm.com|
20526654|NCT03385304|University of Maryland, Baltimore|Research Administrator|410-706-6823|ahowe@som.umaryland.edu|
20540242|NCT04058886|University of North Carolina at Chapel Hill|Kim Faurot, PhD|919-966-8586|faurot@med.unc.edu|
20540243|NCT03624127|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20540244|NCT03036189|Montana State University|Suzanne Held|4069946321|suzanne@montana.edu|
20540245|NCT01545050|CSL behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20540246|NCT03262441|Fred Hutchinson Cancer Research Center|Dr. Joshua Schiffer|(206)667-7359|jschiffe@fredhutch.org|
20540247|NCT03235089|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
20540248|NCT01860950|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
20540249|NCT03238924|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
20540250|NCT00559988|Biotronik, Inc|Crystal Miller|503-451-8051|crystal.miller@biotronik.com|
20540251|NCT02891382|Universidad Peruana Cayetano Heredia|Dr. J Jaime Miranda|+511 241 69 78|Jaime.Miranda@upch.pe|
20540252|NCT01455194|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20540253|NCT02516228|Philips|Sr. Clinical Operations Manager|3034753417|pat.olsen@philips.com|
20540254|NCT03916484|University of North Carolina at Chapel Hill|Kate Muessig, PhD|850-644-3299|kmuessig@fsu.edu|
20540255|NCT05090852|UPenn|Natasha Mirza, MD|215 662 2979|natasha.mirza@pennmedicine.upenn.edu|
20540256|NCT00504894|Weill Cornell Medicine|Kane Pryor|(212) 746-2953|kap9009@med.cornell.edu|
20540257|NCT03050320|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
20540258|NCT04356040|Abbott|Anne Sarver|6517563813|anne.sarver@abbott.com|
20540259|NCT00788710|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20540260|NCT01008904|Virginia Commonwealth University|Thomas J. Smith, MD|410-955-2091|tsmit136@jhmi.edu|
20540261|NCT02518191|Shanghai 6th People's Hospital Affiliated to Shanghai Jiao Tong University|Dr. ZONG|86 (21) 24058549|tigerzong@msn.com|
20540262|NCT01008449|UAB|Principal Investigator|205-934-3411|dana_figueroa_marzilli@hotmail.com|
20540263|NCT01220180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540264|NCT01990859|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20540265|NCT02262754|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540266|NCT01067469|UT MD Anderson Cancer Center|Dr. John F de Groot/Chair Ad Interim, Neuro-Oncology|713- 745-3072|jdegroot@mdanderson.org|
20540267|NCT01338857|New York University Langone Medical Center|Matthias A. Karajannis, MD|212-263-9630|matthias.karajannis@nyumc.org|
20540268|NCT01727414|Cincinnati Children's Hospital|Tanya Froehlich|5136361154|tanya.froehlich@cchmc.org|
20540269|NCT04079114|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
20540270|NCT04016844|University of Iowa|Dr.Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
20540271|NCT01364389|Novartis Pharmaceuticals|Study Director|862-778-8300||
20540272|NCT01227005|University of Texas Health Science Center-Houston|Bryan A. Cotton, MD, MPH|713-500-7354|bryan.a.cotton@uth.tmc.edu|
20540273|NCT00629798|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|646-608-3738|tamarir@mskcc.org|
20540274|NCT02554981|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20540275|NCT00241904|Johns Hopkins University|Dr. Jerilyn Allen|410-614-4882|jallen1@jhu.edu|
20540276|NCT03968848|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20540277|NCT01959243|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
20540278|NCT01345669|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540279|NCT00516165|Massachusetts General Hospital|Dr.Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
20540280|NCT01549925|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
20540281|NCT00554372|SillaJen Biotherapeutics, Inc.|Manager, IP, Contracts, Translational Research|415 281 8886|tchiaverotti@sillajen.com|
20540282|NCT00547521|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20540283|NCT02175979|Catharina Hospital|dr Misha Luyer|+31402399111|misha.luyer@catharinaziekenhuis.nl|
20540284|NCT01487265|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
20540285|NCT02291419|Cleveland Clinic|Dr. Venu Menon|216-445-5390|menonv@ccf.org|
20540286|NCT01115673|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20540287|NCT03043391|Istari Oncology|W. Garret Nichols, MD MS|919-245-7662|info@istarioncology.com|
20540288|NCT01350232|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|jef001@jefferson.edu|
20540289|NCT00491491|Chaim Sheba Medical Center|Dr Avichai Shimoni|972 3 530 5303|ashimoni@sheba.health.gov.il|
20540290|NCT01271725|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540291|NCT03251937|Boston Scientific|Director of Clinical Sciences|661 949 4350|roshini.jain@bsci.com|
20540292|NCT03121365|The Children's Hospital of Phiadelphia|Dr. James Guevara|215-590-1130|Guevara@email.chop.edu|
20540293|NCT00303485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20540294|NCT02133781|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20540295|NCT01378325|AUBMC|Sahar Siddik-Sayyid|9611350000|ss01@aub.edu.lb|6380
20540296|NCT00635167|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edouard Trabulsi|215-955-1000|edouard.trabulsi@jefferson.edu|
20540297|NCT01963845|University of California, San Diego|Rohit Loomba, MD professor of Medicine|858-543-2230|roloomba@ucsd.edu|
20540298|NCT00193180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20540299|NCT03274414|Memorial Sloan Kettering Cancer Center|Dr. Marc Cohen, MD|212-639-3769|cohenm2@mskcc.org|
20540300|NCT00891228|NICHD|H. Trent MacKay, MD, MPH|301-435-6988|mackayt@mail.nih.gov|
20540301|NCT02381015|Wake Forest University Health Sciences|Dr. Aubrey R. Turner|336-918-3585|aubreyturner@gmail.com|
20540302|NCT00118742|Hoffmann-La Roche|Medical Communications|800-821-8590||
20540303|NCT00904488|UNC Eshelman School of Pharmacy|Dr. Jo Ellen Rodgers|(919) 962-2249|jerodgers@unc.edu|
20540304|NCT02688985|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20540305|NCT02445326|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
20540306|NCT00930553|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20540307|NCT01964963|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20540308|NCT01726582|Froedtert and the Medical College of Wisconsin|Susan Tsai, MD|414-955-1412|stsai@mcw.edu|
20540309|NCT01235234|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
20540310|NCT02630472|UPenn|Nithin D. Adappa, Principal Investigator|215-662-2360|Nithin.Adappa@uphs.upenn.edu|
20540311|NCT00921843|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20540312|NCT01393639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540313|NCT01832155|University of Minnesota|Corjena Cheung, Assistant Professor|612-624-5198|corjena@umn.edu|
20540314|NCT01279616|Nationwide Children's Hospital|Kristy Ott|614-722-6313|kristy.ott@nationwidechildrens.org|
20540315|NCT00972530|Department of Research and Development County Council of Gavleborg/Uppsala University|Dr Tomas Weitoft|+46 26 154388|tomas.weitoft@lg.se|
20540316|NCT00183625|Semel Institute at UCLA|Stephen R. Marder, M.D.|310-268-3647|marder@ucla.edu|
20540317|NCT05979922|Photozig, Inc.|Bruno Kajiyama|6506947595|info@photozig.com|
20540318|NCT01369641|Thomas Jefferson University|David Cognetti, MD|215-955-6670|David.Cognetti@jefferson.edu|
20540319|NCT00842543|Nemours Children's Clinic|J. Atilio Canas MD|9046973600|jcanas@nemours.org|3674
20540320|NCT03738891|Zeltiq Aesthetics|Lori Brandt, Director, Clinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
20540321|NCT01483183|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20540322|NCT00239928|Pfizer, Inc.|Pfizer Clinical Trails.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20540323|NCT03276546|Queen's University, Belfast|Professor Margaret Cupples|07714233204|m.cupples@qub.ac.uk|
20540324|NCT02718716|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20540325|NCT02942485|University of Helsinki|Dr. Svetlana Vakkilainen|+358407693375|svetlanakostjukovitch@gmail.com|
20540326|NCT03041896|MCRA|Glenn Stiegman|2025525800|gstiegman@mcra.com|
20540327|NCT01317901|Aptevo Therapeutics|Scott C. Stromatt|206-859-6675|sstromatt@apvo.com|
20540328|NCT01991522|St. Michael's|Dr. Samir C. Grover|416-864-5628|samir.grover@utoronto.ca|
20540329|NCT04869358|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20540330|NCT04047979|Emory University|Dr. Nadine Rouphael|404-712-1435|nroupha@emory.edu|
20540331|NCT03068754|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20540332|NCT00129467|Portland Veterans Affairs Medical Center|Dr. Linda Ganzini|(503) 220-8262|linda.ganzini@va.gov|56492
20540333|NCT01009086|Janssen Research & Development, LLC|Director, Clinical Research|1-800-526-7736||
20540334|NCT01424228|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20540335|NCT00881465|University of South Florida|Eric Storch, Ph.D.|7277678230|estorch@health.usf.edu|
20540336|NCT04373746|Nationwide Children's Hospital|Dr. Joseph D. Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
20540337|NCT03037983|Palo Alto VA|Jong Yoon|510-220-7086|jhyoon1@stanford.edu|
20540338|NCT02697188|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|212
20540339|NCT04496453|Emory University|Lavanya Vasudevan, Ph.D., M.P.H., C.P.H.|404-727-3956|lavanya.vasudevan@emory.edu|
20540340|NCT01399866|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
20540341|NCT05392803|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|baabdullah@health.ucsd.edu|
20540342|NCT00235716|Dept. of Veterans Affairs Cooperative Stduies Program|Peter Guarino, PhD, Director WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
20540343|NCT03576716|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
20540344|NCT02249182|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20540345|NCT00148941|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20554507|NCT01072201|Colgate Palmolive Co|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
20540346|NCT03244826|Dana-Farber Cancer Institute|Dr. Gregory Abel (Principal Investigator)|617-632-1906|gregory_abel@dfci.harvard.edu|
20540347|NCT02673684|Defense and Veterans Center for Integrative Pain Management|Mary McDuffie|301-400-4242|mmcduffie@dvcipm.org|
20540348|NCT01092663|KineMed, Inc.|Carine Beysen, PhD|510-655-6525|cbeysen@kinemed.com|123
20540349|NCT00223704|Vanderbilt University|Mias Pretorius, Associate Professor of Anesthesiology and Clinical Pharmacology|615-8757402|mias.pretorius@vanderbilt.edu|
20540350|NCT01534195|Ora|Keith Lane|9786896500|klane@oraclinical.com|
20540351|NCT02974842|nVision Medical|Surbhi Sarna|408 655 3577|surbhi@nvisionmedical.com|
20540352|NCT00360724|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
20540353|NCT01368081|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540354|NCT00061633|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20540355|NCT03253328|Washington University School of Medicine|Mohamed A Zayed|314-362-5648|zayedm@wustl.edu|
20540356|NCT02964767|SinghRK|Dr. Ranjan K Singh|91+9431263911|dr_ranjankumarsingh@yahoo.com|
20540357|NCT02611817|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20540358|NCT02950480|University of California, San Francisco|Dr. Pamela Munster|(415) 885-7810|pamela.munster@ucsf.edu|
20540359|NCT01363661|ECSOR|Jacques Bruhwyler, Project Manager|3267444093|Jacques.Bruhwyler@ecsor.com|
20540360|NCT01835223|Roswell Park Cancer Institute|Katy Wang, Statistician, M.A.|716-845-1300|katy.wang@roswellpark.org|6269
20540361|NCT03149055|Memorial Sloan Kettering Cancer Center|Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
20540362|NCT00630344|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
20540363|NCT00413036|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20540364|NCT03250182|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
20540365|NCT03400163|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20540366|NCT00896025|University of Texas Southwestern Medical Center|William M. Lee, MD|214-645-6111|william.lee@utsouthwestern.edu|
20554508|NCT00360334|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20554509|NCT01916304|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20554510|NCT01898793|Washington University School of Medicine|Amanda Cashen, M.D.|314-434-8323|acashen@wustl.edu|
20554511|NCT04666441|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20554512|NCT00766415|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
20554513|NCT01114516|Northwestern University Feinberg School of Medicine|Dr. Emily Miller|3124724685|emily-miller-1@northwestern.edu|
20554514|NCT00061048|National Cancer Institute, National Institutes of Health|Thomas A. Waldmann, M.D.|301-496-6653|Thomas.Waldmann2@nih.gov|
20554515|NCT01632579|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20554516|NCT03779841|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20554517|NCT00898677|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554518|NCT00234884|Abbott|Global Medical Services|1-800-633-9110||
20554519|NCT01016834|Zogenix|Judith Myers, Senior Director Clinical Operations|510-550-8300|jmyers@zogenix.com|
20554520|NCT00836875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554521|NCT06748040|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
20526655|NCT01097421|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526656|NCT02634268|VA Puget Sound Health Care System|Margaret Collins|206.764.2085|margaret.collins@va.gov|
20526657|NCT01120249|SWOG|Melissa Plets|206.667.2707|mplets@fredhutch.org|
20526658|NCT01701193|University of Saskatchewan|Roger Pierson, PhD|306-884-1059|roger.pierson@usask.ca|
20526659|NCT02720744|Flamel Ireland Limited|Jennifer Gudeman|+1 (314) 750-2751|jgudeman@avadel.com|
20526660|NCT01482962|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20526661|NCT02407457|Endologix, Inc.|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
20526662|NCT04416737|Stanford University|Dr. Rayhan Lal|650-725-2908|inforay@stanford.edu|
20526663|NCT03332628|University of Iowa|Nicole Brogden, Associate Professor|(319) 335-8752|nicole-brogden@uiowa.ed|
20526664|NCT01472757|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
20526665|NCT02619396|John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust|Dr Milena Leo|0186522055|milena.leo@ouh.nhs.uk|
20540367|NCT03100058|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20554522|NCT04621500|Medical University of South Carolina|Stephen J. Savage, MD|18437925787|savages@musc.edu|
20526666|NCT02865590|Department MESVA - University of L'Aquila|Enrico Marchetti DDS, PhD|+39862433304|enrico.marchetti@univaq.it|
20540368|NCT03194646|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20540369|NCT02141360|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
20540370|NCT04302545|King Edward Medical University, Lahore, Pakistan|Shazia Saaqib|+92-3214708583|shaziasaaqib@gmail.com|
20540371|NCT03550404|Pacific Institute for Research and Evaluation|Cathleen Willging|505-765-2328|cwillging@pire.org|
20540372|NCT00932165|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20540373|NCT01336023|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20540374|NCT00666965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20540375|NCT01122849|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540376|NCT01361178|University of Pittsburgh|Andrej Petrov, MD|412-648-6215|petrovaa@upmc.edu|
20540377|NCT04294147|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20540378|NCT00881647|University of California, San Francisco|Thomas C. Neylan, MD|415-750-6961|thomas.neylan@ucsf.edu|
20540379|NCT02726022|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20540380|NCT01124955|Federal University of São Paulo|Tatiana Molinas Hasegawa|55 115576 4239|tatianamolinas@hotmail.com|
20540381|NCT03274518|University of São Paulo|Dr. Bruno Caldin da Silva|+5511997620521|bruno.caldin@hc.fm.usp.br|
20540382|NCT00692419|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Steven D. Weisbord MD|412-360-3911|steven.weisbord@va.gov|
20540383|NCT02456857|MD Anderson Cancer Center|Dr. Clinton Yam|(832) 589-8343|cyam@mdanderson.org|
20540384|NCT00781859|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
20540385|NCT05546229|Cari Health Inc.|Chief Medical Officer|619 2343725|drcarr@carihealth.com|
20540386|NCT01983774|Columbia University|Emily DiMango, MD|212-305-0631|ead3@cumc.columbia.edu|
20508014|NCT04134728|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508015|NCT02911818|The University of Pennsylvania Center for Weight and Eating Disorders|Dr. Thomas Wadden|215-746-5046|wadden@pennmedicine.upenn.edu|
20508016|NCT01175590|Bausch & Lomb Inc.|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20508017|NCT01019252|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@mgh.harvard.edu|
20508018|NCT01779648|SMG-SNU Boramae Medical Center|Principal Investigator|+82-10-9988-2691|turejsreal@hanmail.net|
20508019|NCT02384395|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-6712|cynthia_gay@med.unc.edu|
20508020|NCT03351478|Lexicon Pharmaceuticals, Inc|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20508021|NCT03154307|Miami Neuroscience Institute|Clinical Research Administrator|17865961825|starlieb@baptisthealth.net|
20508022|NCT01618422|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
20508023|NCT03485222|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|(212) 241-8484|juan.badimon@mssm.edu|
20508024|NCT03657810|Charleston Laboratories, Inc.|Bernard P. Schachtel, MD, Chief Scientific Officer|561.379.8726|bschachtel@charlestonlabs.com|
20508025|NCT03911869|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508026|NCT03554850|Stryker Neurovascular|Fei Qin|+8613524821775|fei.qin@stryker.com|
20508027|NCT00756678|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20508028|NCT00985738|University of Colorado Hospital|Dr. Al Baha Barqawi|303-724-2722|AL.BARQAWI@UCDENVER.EDU|
20508029|NCT00367341|Emory University School of Medicine|Helen Mayberg, MD|404-727-6740|hmayber@emory.edu|
20508030|NCT03325556|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-|medicalinformation@acadia-pharm.com|2897
20508031|NCT01705587|University of Pittsburgh|Susan Greenspan, MD|412-692-2477|greenspn@pitt.edu|
20508032|NCT02227849|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20508033|NCT02119026|Medical University Vienna, Internal Med. I, Dep. of Oncology|Werner Scheithauer, MD|+43 1 40400|werner.scheithauer@meduniwien.ac.at|54620
20508034|NCT00812604|University of Hong Kong|Dr. Ricky Wing Kit Wong, Associate professor in orthodontics|852-2859 0554|fyoung@hkucc.hku.hk|
20508035|NCT01373918|University of California, Los Angeles|Dr. Kara L. Calkins|310 825-9330|KCalkins@mednet.ucla.edu|
20508036|NCT00340834|Novartis Pharmaceuticals|Study Director|862-778-8300||
20508037|NCT00762268|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
20508038|NCT00291499|IBSA Institut biochimique|Project Leader|0041 58360100|rd@ibsa.ch|
20508039|NCT00129740|The University of Texas MD Anderson Cancer Center|Cortes,Jorge E, MD./Professor|713-794-5783|jcortes@mdanderson.org|
20508040|NCT00081939|The Myeloma Institute, University of Arkansas for Medical Sciences|Director of Clinical Trials and Regulatory Affairs|501-526-6990|npetty@uams.edu|
20508041|NCT02451488|Mayo Clinic|Dr. James Jakub|507-284-3629|Jakub.James@mayo.edu|
20508042|NCT04897594|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
20508043|NCT01387074|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20508044|NCT02849184|Jichi Medical University School of Medicine|Professor Kazuomi Kario|+81-285-58-7538|kkario@jichi.ac.jp|
20508045|NCT04426890|Celltrion. Inc|Yunju Bae/Head of Clinical Planning 1 Department|+82 32 850 4160|Yunju.bae@celltrion.com|
20508046|NCT02373163|PREVENCION|Josefina Medina-Lezama|+5154251269|jmedinal2911@gmail.com|
20508047|NCT04526067|University of Texas Health Science Center in San Antonio|Dawn Velligan, PhD|210-567-5508|velligand@uthscsa.edu|
20508048|NCT01532570|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20508049|NCT03892707|Woerwag Pharma LLC|Anna Shagako, Clinical Trials Manager/ Authorized Person of Pharmacovigilance|+7 (495) 382 85 56|anna.shagako@woerwagpharma.ru|
20540387|NCT01339897|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
20540388|NCT01138501|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20554523|NCT00734305|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20508050|NCT04263363|UCLA|Dr. Eilon Gabel, MD|310-267-8693|EGabel@mednet.ucla.edu|
20508051|NCT04190186|University of Rochester|David Huang, MD|585 275 5391|david_huang@urmc.rochester.edu|
20508052|NCT02141217|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508053|NCT03515213|University of California, Irvine|Leslie Thompson|9498243990|lmthomps@hs.uci.edu|
20508054|NCT01457924|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508055|NCT01665768|Johns Hopkins University|Douglas Gladstone, MD|4109558781|dgladst1@jhmi.edu|
20508056|NCT01329341|James A Haley Veterans Hospital|Stephanie McGovern|813-558-3964|stephanie.mcgovern@va.gov|
20508057|NCT00448760|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD, Professor|305-243-4909|bardalan@med.miami.edu|
20508058|NCT01226706|Gynecology, Regina Qu'Appelle Health Region|Dr. Corrine Jabs|(306) 586-3120|corrinejabs@hotmail.com|
20508059|NCT03017846|Albert Einstein College of Medicine|Anthony Guzman, MD|7189208352|anguzman@montefiore.org|
20508060|NCT04603391|University of Florida|John S. Markowitz, Pharm.D.|(352) 273-6262|jmarkowitz@cop.ufl.edu|
20526667|NCT04489381|Romark, L.C.|Jessica Fulgencio|8132828544|jessica.fulgencio@romark.com|
20526668|NCT02505334|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20526669|NCT02833935|McGill University|Shane Sweet|514-398-4184|shane.sweet@mcgill.ca|09903
20508061|NCT01899677|Zeynep Kamil Maternity and Children's Education Training Hospital|Ozge Serce (Investigator, MD)|+905323270375|ozge_serce@hotmail.com|
20508062|NCT03123055|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
20508063|NCT05067452|University of California San Francisco|Dr. Kartika Palar|415-502-8492|kartika.palar@ucsf.edu|
20526670|NCT01549041|DukeUMC|Joseph P McEvoy, MD|9198199295|JPMCEVOY@DUKE.EDU|
20526671|NCT02543892|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20508064|NCT00067470|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
20508065|NCT01135017|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
20508066|NCT03688685|Cadent Therapeutics (A Novartis Company)|Cadent Therapeutics (A Novartis Company)|1-888-669-6682|Novartis.email@novartis.com|
20508067|NCT00050622|Florida International University|William E. Pelham, Jr.|305-348-3002|wpelham@fiu.edu|
20570693|NCT01908751|McMaster University|Dr. Mohit Bhandari|9055274322|bhandam@mcmaster.ca|
20508068|NCT02703987|Danone Nutricia Research|Danone Nutricia Research||register.clinicalresearchnutricia@danone.com|
20508069|NCT00936117|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-745-2723|CR_Study_Registration@mdanderson.org|
20508070|NCT01803711|UConn Health Center|Jayesh Kamath MD PhD|8606796727|jkamath@uchc.edu|
20508071|NCT02693691|Abbott|Dr. Marie-Elena Brett|7815283613|marieelena.brett@abbott.com|
20508072|NCT02727660|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
20508073|NCT01200160|Abbott Laboratories de México|Carlos A Gonzalez MD, PhD|(5255) 5809-|carlos.gonzalez@abbott.com|7576
20508074|NCT01567891|Adaptimmune|Clinical Trials Management|215-825-9302|clinicaltrials@adaptimmune.com|6302
20508075|NCT04569799|Penn State Health College of Medicine|Kathryn McGillen, M.D.|717-531-0003|kmcgillen@pennstatehealth.psu.edu|
20508076|NCT01192204|The Ohio State University|Susan R, Mallery DDS, PhD|614 292-5892|mallery.1@osu.edu|
20508077|NCT03454412|International Clinic of Rehabilitation|Oleh Kachmar|+380324765200|okachmar@ic.reha.lviv.ua|
20508078|NCT01167582|Rutgers University|Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu|
20508079|NCT01928485|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Lee Ponsky|+1 216-844-4831|lee.ponsky@uhhospitals.org|
20526672|NCT00081731|University of Toledo|Christopher Cooper, MD|419-383-6297|christopher.cooper@utoledo.edu|
20526673|NCT02335749|Zeltiq Aesthetics|Kerrie Jiang, Director Clinical Affairs|925-621-7462|kerrie.jiang@allergan.com|
20570694|NCT01821105|The Ohio State University|Edward Martin, MD|614-293-8843|Edward.Martin@osumc.edu|
20570695|NCT00420784|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
20570696|NCT02417441|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20570697|NCT03080142|UC Davis Medical Center, Department of Anesthesiology|Jon Zhou MD|9167035028|jonzhou@ucdavis.edu|
20570698|NCT00607672|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
20570699|NCT04937920|DermBiont, Inc|Emma Taylor, MD (Chief Medical Officer)|510-607-8155|emma@dermbiont.com|
20570700|NCT00723125|BrUOG|William Sikov, MD|4018633000|Roxanne_Wood@brown.edu|
20570701|NCT00813982|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20570702|NCT00855413|The University of North Carolina|Dr. Cynthia Gay|9198432726|cynthia_gay@med.unc.edu|
20570703|NCT03382769|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
20570704|NCT00675584|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
20570705|NCT02493946|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
20570706|NCT00869947|Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
20570707|NCT02559310|Nabriva Therapeutics US, Inc.|Jennifer Schranz, MD, Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
20570708|NCT02633397|Dean, University of Maryland School of Medicine, Vice President for Medical Affairs, University of Maryland, Baltimore|Mark Gladwin|410-706-7410|mgladwin@som.umaryland.edu|
20570709|NCT03036124|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|information.center@astrazeneca.com|
20570710|NCT04021043|MD Anderson Cancer Center|Joe Chang, MD|(713) 563-2337|jychang@mdanderson.org|
20570711|NCT04441905|Pharmaceutical Product Development (PPD), part of Thermo Fisher Scientific|Kristie Miller, MD|512-747-1504|kristie.miller@ppd.com|
20570712|NCT02562235|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20570713|NCT03945773|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20570714|NCT01920932|St. Jude Children's Research Hospital|Matt Ehrhardt, MD|(901) 595-5913|matt.ehrhardt@stjude.org|
20540389|NCT00365274|The University of Texas (UT) MD Anderson Cancer Center|Michelle Fanale, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
20540390|NCT03696589|Teachers College, Columbia University|Lori Quinn|212-678-3424|lq2165@tc.columbia.edu|
20540391|NCT04534881|Saint Louis University|Sandeep Dhindsa|13149774911|sandeep.dhindsa@health.slu.edu|
20540392|NCT03657095|Lung Biotechnology PBC Study Director|Lung Biotechnology PBC|301-608-9292|info@lungbiotechnology.com|
20540393|NCT00761202|Allergan, Inc.|Vice President Medical Affairs - Europe|(714)246-4500|clinicaltrials@allergan.com|
20540394|NCT00348309|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554524|NCT03809182|Pontificia Universidad Católica de Chile|Mauricio Ibacache MD|+56984421425|mibacach@med.puc.cl|
20554525|NCT03794089|VA Center for Integrated Healthcare|Dr. Robyn L. Shepardson|315-425-4400|Robyn.Shepardson@va.gov|53956
20554526|NCT00116805|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20554527|NCT01760954|AbbVie|Global Medical Services|800-633-9110||
20554528|NCT01159938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20554529|NCT02487563|Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University|Yaqiong Tang|+86 18896588075|tangyaqiong@suda.edu.cn|
20554530|NCT02621983|Atlanta VA Medical Center|Dr. Erica Duncan|404-321-6111|erica.duncan@va.gov|207532
20554531|NCT02032901|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20554532|NCT00982020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508080|NCT00039741|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20540395|NCT00622388|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540396|NCT01894243|AstraZeneca|Anitra Fielding - Senior Research Physician||ClinicalTrialTransparency@astrazeneca.com|
20540397|NCT01743040|UCLA Biomed|Joseph Thomas, MD|310-222-2544|jthomas@labiomed.org|
20540398|NCT02713659|The Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
20540399|NCT00828750|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540400|NCT04006392|Erchonia Corporation|Clinical Affiairs|888.242.0571|tsammons@erchonia.com|501
20540401|NCT01299116|FHI 360|Dr. David Hubacher|919 544 7040|dhubacher@fhi360.org|11223
20540402|NCT00492336|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
20540403|NCT03043651|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
20540404|NCT01630889|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|059study@fibrogen.com|
20540405|NCT02980133|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20540406|NCT01854281|University Hospital Motol|Jakub Honek, MD|+42022443|jakub.honek@gmail.com|4901
20540407|NCT01000324|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540408|NCT01068158|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
20540409|NCT02355210|University of Nebraska-Lincoln|Heather Rasmussen, Assistant Professor|402-472-1373|hrasmussen2@unl.edu|
20540410|NCT02596945|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20540411|NCT01853605|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20540412|NCT01424033|University of Michigan|Jan Stevens|7349365566|janstev@med.umich.edu|
20554533|NCT01722331|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
20570715|NCT04024462|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20570716|NCT05274750|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20570717|NCT06193967|University of Tennessee, Knoxville|Dr. Hollie Raynor|865-974-9126|hraynor@utk.edu|1
20570718|NCT04328623|Centre Hospitalier Départemental Vendée|Adeline TROJET-BOSSARD|251446572|adeline.trojet-bossard@ght85.fr|+33
20570719|NCT05687032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570720|NCT02134717|University of Pittsburgh|Kevin Gibson MD|412-624-7095|gibsonkf@upmc.edu|
20570721|NCT04982588|Medtronic, Inc.|Fairy Liu|+86-02120325765|rs.evolutprochinaclinicalstudy@medtronic.com|
20570722|NCT03912662|Medtronic|Marion Blanc|+33 4 74 08 90 00|marion.blanc@medtronic.com|
20570723|NCT02224469|University Medical Center Utrecht|Dr E.J. Aarnoutse|+31887555123|e.j.aarnoutse@umcutrecht.nl|
20570724|NCT03880019|Columbia University Medical Center|Matthew Ingham, MD|646-317-7141|mi2337@cumc.columbia.edu|
20570725|NCT03934099|LG Chem|Younghwan Jang|02-6987-4154|younghj@lgchem.com|
20570726|NCT05628285|Oticon Medical AB|Director of Clinical Affairs|0046-31-7486100|studyinfo@oticonmedical.com|
20570727|NCT02339506|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
20570728|NCT02869867|Centre Hospitalier Départemental Vendée|Dr Yves-Marie PLUCHON|251446248|yves-marie.pluchon@chd-vendee.fr|+33
20540413|NCT00238238|Meyer Cancer Center, Weill Cornell Medical College|John P Leonard, M.D.||jpleonar@med.cornell.edu|
20540414|NCT01007838|UWalesBangor|Danielle Kirkman|00 44 1248 388254|pepa03@bangor.ac.uk|
20540415|NCT04517643|Johns Hopkins Medicine|Robert Hobbs|410-502-1229|rhobbs3@jhmi.edu|
20540416|NCT04978818|Johns Hopkins School of Public Health|Dr. Laura Hammit|4436510000|lhammitt@jhu.edu|
20540417|NCT02277119|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
20540418|NCT04699461|ADC Therapeutics|Contact ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20540419|NCT02478255|Duke University|Bastiaan Driehuys, PhD (Professor of Radiology)|919 684-7786|bastiaan.driehuys@duke.edu|
20540420|NCT00767767|Weill Cornell Medicine|Kane Pryor|(212) 746-2969|kap9009@med.cornell.edu|
20540421|NCT03068767|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|Chief of internal medicine department|+886-2-6628-9779|uld888@yahoo.com.tw|2317
20540422|NCT01730586|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-7734|MOverman@mdanderson.org|
20540423|NCT01431963|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540424|NCT02566317|Arizona State University|Matthew Buman, PhD|602-827-2289|mbuman@asu.edu|
20540425|NCT03077919|RTI International|Kristine L. Rae Olmsted, MSPH|919-541-8035|krolmsted@rti.org|
20540426|NCT03738618|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20540427|NCT00826618|University of Miami|Thomas A. Albini, MD|3054825006|talbini@med.miami.edu|
20540428|NCT01332253|Senior Manager, Clinical Operations|Byron Kaelin|615-255-0068|bkaelin@cumberlandpharma.com|250
20540429|NCT03499314|NYU Langone Health|Leigh Charvet, PhD|(929) 455-5141|Leigh.Charvet@nyulangone.org|
20540430|NCT01618695|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
20540431|NCT00952081|UMDNJ|Alex Bekker, MD, PhD|973-972-5007|bekkeray@umdnj.edu|
20540432|NCT00439296|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20540433|NCT00931606|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20540434|NCT00871338|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540435|NCT01016600|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20540436|NCT00872599|Vanderbilt University|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
20540437|NCT04794270|Johnson & Johnson VIsion Care, Inc.|Benjamin Straker - Principal Research Optometrist|1-904-312-0604|bstraker@its.jnj.com|
20540438|NCT01937260|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
20540439|NCT00801229|Massachusetts General Hospital|Joseph Biderman, MD|617-726-1746||
20540440|NCT03826186|University of Iowa Hospitals and Clinics|Vice Chair for Research|319-335-9595|donna-hammond@uiowa.edu|
20540441|NCT03032263|Wake Forest University Health Sciences|Dr. Thomas Templeton|336-716-4285|ttemplet@wakehealth.edu|
20540442|NCT02510001|University of Oxford Clinical Trials and Research Governance (CTRG)|Heather House|01865 572245|heather.house@admin.ox.ac.uk|
20540443|NCT06831513|UT Southwestern Medical Center - School of Health Professions|Dara Spivey, CPO, LPO|(214) 645-8250|dara.spivey@utsouthwestern.edu|
20540444|NCT05148806|NHS Blood and Transplant|Gillian Powter Trial Manager|44 7590 353091|gillian.powter@nhsbt.nhs.uk|
20540445|NCT00724984|Pharmacyclics|Dr. Thorsten Graef|855-427-8846|pharmacyclics@medcomsol.com|
20540446|NCT01468350|Acorda Therapeutics, Inc.|Vice President - Clinical Development & Medical Affairs|914-347-4300|hhenney@acorda.com|
20540447|NCT04120402|Eupraxia Pharmaceuticals Ltd.|Chief Scientific Officer|250-590-3968|amalone@eupraxiapharma.com|
20540448|NCT04648683|Vanderbilt University Medical Center|Carrie Brintz|615-875-9885|carrie.brintz@vumc.org|
20540449|NCT01357551|Durham VA Medical Center|Dr. Corrine Voils|9192860411|corrine.voils@va.gov|5196
20540450|NCT01626092|Masonic Cancer Center, University of Minnesota|Weston P Miller, MD|612-626-2778|mill4991@umn.edu|
20540451|NCT02219334|Baylor College of Medicine|Shabana Yusuf/Associate Professor of Pediatrics|832-824-5388|syusuf@bcm.edu|
20540452|NCT05362058|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20540453|NCT06292130|Pro-Change Behavior Systems, Inc.|Sara Johnson, PhD|401.360.2980|sjohnson@prochange.com|
20540454|NCT00711971|University of Michigan|Ellen Mozurkewich, Adjunct Assistant Professor|(734) 546-2772|emozurkewich@salud.unm.edu|
20540455|NCT03606187|SGX Medical|VP of Clinical Affairs|6613108409|wpark@sgxmedical.com|
20540456|NCT03704688|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Arbour|646-608-3792|arbourk@mskcc.org|
20540457|NCT01566500|Columbia University|Marie Chesaniuk|212-854-0127|mc3333@columbia.edu|
20540458|NCT04774926|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20540459|NCT00787189|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20540460|NCT03397342|Montefiore Medical Center|Dr. Madhur Garg|718-920-4140|mgarg@montefiore.org|
20540461|NCT01068769|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
20540462|NCT01458418|Children's Mercy Hospital|Corey Schurman|8162343000|crschurman@cmh.edu|
20540463|NCT02524158|VA San Diego|Dr. Erik J. Groessl|858-552-8585|erik.groessl@va.gov|6347
20540464|NCT03671304|UT Southwestern Medical Center|Dr. Muhammad Beg|214-648-4180|muhammad.beg@utsouthwestern.edu|
20540465|NCT00596830|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540466|NCT02638168|Penn State Health Milton S Hershey Medical Center|Raman Baweja, MD, MS|7175318134|rbaweja@pennstatehealth.psu.edu|
20540467|NCT00887926|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20540468|NCT02097030|CooperVision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
20570729|NCT05218499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20540469|NCT04865237|Imperial College London|Professor Christopher Chiu|02083832301|c.chiu@imperial.ac.uk|
20540470|NCT00773773|Memorial Sloan Kettering Cancer Center|Dr. Paul Tempst, PhD|212-639-8923|liljah@mskcc.org|
20508081|NCT00946881|STEBA Biotech|Bertrand Gaillac International Project Leader|+ 33 974197905|b.gaillac@stebabiotech.com|
20508082|NCT02407041|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
20508083|NCT03700970|Vanderbilt university medical center|Dr. Galen Perdikis|+1 (615) 936-0198|galen.perdikis@vumc.org|
20508084|NCT02608229|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
20508085|NCT00476996|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20508086|NCT00675558|Columbia University Medical Center|Paul D. Berk, MD|2120-305-4491|pb2158@columbia.edu|
20508087|NCT04218799|University of Maryland School of Medicine|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
20508088|NCT01769469|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20508089|NCT02750267|Center for Diabetes Technology|Dr. Daniel R. Chernavvsky|4342431395|drc2v@virginia.edu|
20508090|NCT04152642|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
20526674|NCT02635542|University of Chicago|Rebecca M Gerlach, MD|773-702-6700|rgerlach@dacc.uchicago.edu|
20526675|NCT00656851|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
20526676|NCT03584464|Medtronic, plc|Alissa Anderson, Clinical Study Manager|7075912434|alissa.anderson@medtronic.com|
20526677|NCT00742508|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526678|NCT02431806|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20526679|NCT05513703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20526680|NCT04120584|Inmode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
20526681|NCT03619902|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20526682|NCT04450407|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20526683|NCT04542421|u of colorado|Dr Anna Maw|720-848-4289|anna.maw@cuanschutz.edu|
20526684|NCT05238025|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20526685|NCT01638312|Kaohsiung Medical University Chung-Ho Memorial Hospital|JihJin Tsai, MD|886-7-3121101|jijits@cc.kmu.edu.tw|6358
20526686|NCT02336360|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20526687|NCT02754674|Samsung Medical Center|Wang, JoonHo|82-2-3410-3507|mdwang88@gmail.com|
20570730|NCT06476834|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20526688|NCT03814720|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Alicia T Widge, M.D.|301-451-8715|alicia.widge@nih.gov|
20526689|NCT03083561|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20526690|NCT00474045|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20526691|NCT02135107|Eisai Co., Ltd. and EA Pharma Co., Ltd.|Public Relations Group (EA Pharma Co., Ltd.)|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
20526692|NCT02009397|University of Louisville, James Graham Brown Cancer Center|Dr. Jason Chesney|502-562-3429|jason.chesney@louisville.edu|
20526693|NCT00581347|University of Rochester Medical Center|Peter Szilagyi|585-275-5798|peter_szilagyi@urmc.rochester.edu|
20526694|NCT05523011|Paracrine Therapeutics Private Limited|Lai Ruenn Chai|+6593375977|ruennchai.lai@paracrinetherapeutics.com|
20526695|NCT02987374|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20526696|NCT02278120|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20526697|NCT00287989|MSKCC|Charles M. Rudin, MD, PhD.|646-888-4527|rudinc@mskcc.org|
20526698|NCT03197324|Theracos Sub, LLC|Albert Collinson, Ph.D.|508-688-4221|acollinson@theracos.com|
20526699|NCT00102531|Insmed|Margaret Galluzzi|(908) 977-9900|Margaret.Galluzzi@Insmed.com|
20526700|NCT00288067|University of Washington|Dr. Ajay Gopal|206-288-2035|agopal@uw.edu|
20526701|NCT06350461|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
20526702|NCT00514904|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526703|NCT03430895|Memorial Sloan Kettering Cancer Center|Dr. Samuel Funt, MD|646-888-4770|funts@mskcc.org|
20526704|NCT00084318|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20526705|NCT01317797|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20526706|NCT03597009|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20526707|NCT01550705|University of Utah|John D. Phillips, Ph.D.|801-581-6650|john.phillips@hsc.utah.edu|
20526708|NCT01378377|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20526709|NCT04676412|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20526710|NCT05741346|BioCryst Pharmaceuticals Inc.|Study Director|+001 919859 1302|clinicaltrials@biocryst.com|
20526711|NCT03711058|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|610-614-9169|nazad2@jhmi.edu|
20526712|NCT05573672|Canadian College of Naturopathic Medicine|Monique Aucoin|416 498 1255|maucoin@ccnm.edu|223
20526713|NCT04765722|McMaster University|Dr. Imran Satia|905 5212100|satiai@mcmaster.ca|76228
20526714|NCT03596671|BlueWind Medical|Medical Affairs|612-203-5739|peter.rodine@bluewindmedical.com|
20526715|NCT05175131|Abbott|Suntje Sander-Struckmeier, PhD|+49 (0) 511 6750 3254|suntje.sander@abbott.com|
20526716|NCT05906836|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20526717|NCT04982575|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20526718|NCT05711381|Hanmi Pharmaceutical Co., Ltd.|Moon Hee Lee, MD|+82 2 410 9062|mhlee7@hanmi.co.kr|
20526719|NCT02407132|University of Arkansas for Medical Sciences|Dr. Pearl McElfish|479-713-8680|pamcelfish@uams.edu|
20526720|NCT02672332|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20526721|NCT01458951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540471|NCT00844558|University of Iowa|Neil Segal|3193560737|segal-research@uiowa.edu|
20540472|NCT00588094|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
20540473|NCT01868334|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
20540474|NCT03777319|The Abigal Wexner Research Institute at Nationwide Children's Hospital|Dr. Kevin Flanigan|614-722-5615|kevin.flanigan@nationwidechildrens.org|
20540475|NCT02951429|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20540476|NCT03514433|Boston Medical Center|Tracy A Battaglia, MD, MPH|617 638 7428|Tracy.Battaglia@bmc.org|
20540477|NCT04569357|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20540478|NCT01457846|Astrazeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
20540479|NCT01846741|Cyberonics, Inc.|Bita Najimipour, Clinical Study Manager|(281) 228-7370|bita.najimipour@cyberonics.com|
20540480|NCT01853878|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540481|NCT00383162|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540482|NCT01623739|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
20540483|NCT03029091|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513 636-7177|marc.rothenberg@cchmc.org|
20540484|NCT00465647|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
20540485|NCT03916081|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20540486|NCT01240135|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20540487|NCT04038567|Duke University|Christopher Cox|919-681-7232|christopher.cox@duke.edu|
20540488|NCT04450329|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20540489|NCT03937960|University of Alabama at Birmingham|Dr. Bhuvana Sunil|2056389107|dr.bhuvana.s@gmail.com|
20540490|NCT02561221|Pennington Biomedical Research Center|Dr. Peter T. Katzmarzyk, Associate Executive Director of Population and Public Health Sciences|225-763-2536|doctors@pbrc.edu|
20540491|NCT02841241|Intermountain Medical Center|Office of Research|8015077000|officeofresearch@imail.org|
20540492|NCT02387008|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidget_jenkins@unc.edu|
20540493|NCT03368235|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20540494|NCT02828020|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20526722|NCT03384784|University of Pennsylvania|Rebecca Ashare|215.746.7143|rlashare@pennmedicine.upenn.edu|
20526723|NCT00585013|Baylor College of Medicine|Paul Checchia MD|832-826-5011|checchia@bcm.edu|
20526724|NCT02872857|The University of Texas Health Science Center at Houston|HuiMahn Alex Choi, Associate Professor|713-500-5638|Huimahn.A.Choi@uth.tmc.edu|
20526725|NCT02663752|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20526726|NCT01779167|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
20526727|NCT04392167|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
20526728|NCT02963558|Wake Forest University School of Medicine|D Clark Files, MD|336-716-8898|dfiles@wakehealth.edu|
20526729|NCT01573767|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526730|NCT02339155|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526731|NCT00850096|CPEX Pharmaceuticals, Inc.|Chief Medical Officer|603-658-6100||503
20526732|NCT02176083|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
20526733|NCT03226678|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20526734|NCT01371877|University of Nebraska Medical Center|Dr. Jill Poole|402-559-4087|japoole@unmc.edu|
20526735|NCT01279564|Rambam Health Care Campus|Dr. Michal Barak|972 4 8542487|m_barak@rambam.health.gov.il|
20526736|NCT05932225|Alcon Research, LLC|Clinical Trial Lead, CDMA Trial Management Operations|1-888-451-3937|alcon.medinfo@alcon.com|
20526737|NCT03427268|Pharmamar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology, Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
20526738|NCT03117881|University of Alabama at Birmingham|Dr. Tapan Mehta|205) 975-9171|tapan@uab.edu|
20526739|NCT01813734|Massachusetts General Hospital|Dr. Alice Shaw|617-724-4000|ASHAW1@mgh.harvard.edu|
20526740|NCT04946552|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
20526741|NCT00308750|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20526742|NCT01358578|Novartis|Study Director|862-778-8300||
20526743|NCT01643798|Medical University of South Carolina|Joseph Taylor|8437295729|taylorjj@musc.edu|
20526744|NCT03605849|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20526745|NCT03327948|Axonics, Inc.|Gita Ghadimi|9497516412|gita.ghadimi@axonics.com|
20526746|NCT02304380|University of North Carolina at Chapel Hill|Renée Ferrari, PhD|(919) 843-1341|rferrari@unc.edu|
20526747|NCT01027897|Grady Health System|Prasad Abraham|404-616-3246|pabraham@gmh.edu|
20526748|NCT00328094|Beth Israel Deaconess Medical Center, Boston, MA|Dr. Balachundhar Subramaniam, MD MPH|6177542675|bsubrama@bidmc.harvard.edu|
20526749|NCT01911780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20526750|NCT03870529|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
20526751|NCT02045732|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526752|NCT02667626|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
20526753|NCT00473824|ADMA Biologics, Inc.|Rebecca Avila|561-989-5853|reavila@admabio.com|
20526754|NCT02560623|Mayo Clinic|Dr. Prasad G. Iyer|507-293-7911|iyer.Prasad@mayo.edu|
20526755|NCT01349322|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20526756|NCT05014815|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20526757|NCT04247880|University of Washington|Dr. Marissa Baker|206 616 4709|bakermg@uw.edu|
20540495|NCT03688620|GlaxoSmithKline|Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccines|877-379-3718|GSKClinicalSupportHD@gsk.com|
20540496|NCT04356352|Wake Forest University Health Sciences|Michael Norton, MD|336-716-8791|mnorton@wakehealth.edu|
20540497|NCT01515046|The University of Iowa|Joseph J. Cullen, MD, FACS|319-353-8297|joseph-cullen@uiowa.edu|
20540498|NCT01183065|Memorial Sloan Kettering Cancer Center|Ho, Alan, MD, PhD (Assistant Attending)|+1646-888-4235|HoA@mskcc.org|
20540499|NCT00416455|NRG Oncology Statistics and Data Management Center|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20540500|NCT04254666|University of Massachusetts Chan Medical School|Carol Curtin|774-455-6527|carol.curtin@umassmed.edu|
20540501|NCT02798978|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20540502|NCT02475278|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20540503|NCT02391363|Baylor College of Medicine|Melinda A. Stanley, PhD|713-794-8841|mstanley@bcm.edu|
20540504|NCT00954993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20540505|NCT00704938|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20540506|NCT00265317|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
20540507|NCT02300259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20540508|NCT02737475|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20540509|NCT04042324|Rockwell Medical, Inc|Raymond Pratt, MD|248 960 9009|rpratt@rockwellmed.com|405
20540510|NCT00385138|The Medicines Company|Meredith Todd|973.290.6088|meredith.todd@themedco.com|
20540511|NCT01504841|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20540512|NCT04756804|Zurex Pharma, Inc.|VP, Reg Affairs|608.203.9090|customercare@zurexpharma.com|
20540513|NCT04440813|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
20508091|NCT02790463|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
20508092|NCT02726113|Medical University of South Carolina|Sebastiano Gattoni-Celli, M.D.; Professor of Radiation Oncology|843-876-5103|gattonis@musc.edu|
20508093|NCT01770145|US WorldMeds|Regulatory Associate, Clinical Operations|5028158130|rgerlach@usworldmeds.com|
20508094|NCT01789346|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20508095|NCT02759861|University of Nebraska Medical Center|Mark Mailliard|402-559-8126|mark.mailliard@unmc.edu|
20508096|NCT02151682|Grünenthal GmbH|Clinical Trial Helpdesk|+49-(0)241-569|clinical-trials@grunenthal.com|3223
20508097|NCT00618995|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508098|NCT02988219|Warsaw Medical University|Dr. Karolina Dobronska|48 22 502 17 21|karolinapladzyk@gmail.com|
20508099|NCT01213264|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508100|NCT02375984|Saint John's Cancer Institute (formerly John Wayne Cancer Institute)|Lisa van Kreuningen|3105827053|lisa.vankreuningen@providence.org|
20508101|NCT01522443|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20508102|NCT03260894|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20508103|NCT00706394|Endologix|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
20508104|NCT00290589|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
20508105|NCT05014542|Family Medicine Practice Svijetlana Perculija Durdevic, MD, Ninska 10, Sesvete|Svijetlana Perculija Durdevic, MD, family medicine specialist, acupuncturist|00385913302507|svijetlana.perculija.durdevic@outlook.com|
20508106|NCT01438307|UAB|Francisco Robert, MD|205-934-5077|paco@uab.edu|
20508107|NCT02378883|Medtronic Neurovascular|Darren Lacour, Sr. Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
20508108|NCT00318565|Biosense Webster|Christine Liu|9098398608|cliu10@its.jnj.com|8608
20508109|NCT00691093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20508110|NCT00493467|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma|713-563-1509|fsamaniego@mdanderson.org|
20508111|NCT06444165|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
20508112|NCT03814005|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20508113|NCT00810810|Bloodworks Northwest (formerly Puget Sound Blood Center)|Karen Nelson, PhD., Vice President Laboratories|206-689-6549|knelson@bloodworksnw.org|
20508114|NCT01896856|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Nilofer Azad|410-614-9169|nazad2@jhmi.edu|
20508115|NCT04446299|Braintree Laboratories, Inc.|Head of R&D, GI|7819646710|studydirector@sebelapharma.com|
20540514|NCT02255461|St. Jude Children's Research Hospital|Jie Huang|9015955750|jie.huang@stjude.org|
20540515|NCT01362894|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
20540516|NCT00291018|DePuy Synthes Spine|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
20540517|NCT01015781|VA RR&D, NCRAR|James A. Henry, Ph.D., Principal Investigator|5032208262|james.henry@va.gov|57466
20540518|NCT02967510|ITF Research Pharma SLU|Javier Suárez Almarza|+34 916572323|jsuarez@itfsp.com|
20540519|NCT01177189|Salt Lake City VAMC|Van Reese|801 582 1565|van.reese@hsc.utah.edu|
20540520|NCT01336413|VHA Durham|Christine E. Marx, MD MA|9192860411|christine.marx@va.gov|3626
20540521|NCT00847886|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug Safety|281-863-3000||
20540522|NCT02462720|BTG International Inc.|Lynn Allen|425-410-3152|lynn.allen@btgplc.com|
20540523|NCT04240574|Rosalind Franklin University|Jacque Ortiz|847-578-8423|jacquelyn.ortiz@rosalindfranklin.edu|
20540524|NCT03668613|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20540525|NCT02106494|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
20540526|NCT01858740|Fred Hutchinson Cancer Center|Marie Bleakley, MD|206-667-6572|mbleakle@fredhutch.org|
20526758|NCT04516343|Biomotum|Chief Science Officer|(800) 566-2531|zach@biomotum.com|
20526759|NCT03833804|UW School of Medicine and Public Health|Majid Afshar, MD|608-263-1792|mafshar@medicine.wisc.edu|
20526760|NCT00250458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20526761|NCT00667186|University of Cincinnati College of Medicine|Michael S. Lyons|513-558-0890|lyonsme@ucmail.uc.edu|
20526762|NCT00480493|University of Massachusetts, Worcester|Susan Sullivan-Bolyai|508-856-4185|susan.sullivan-bolyai@umassmed.edu|
20526763|NCT04027075|Oregon Research Behavioral Intervention Strategies, Inc.|Dana Smith|541-484-2123|dana.smith@influentsin.com|
20526764|NCT03207074|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
20526765|NCT00455520|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
20526766|NCT00109876|Rhode Island Hospital/Alpert Medical School|Damian E. Dupuy, MD|401 - 444 - 5184|ddupuy@lifespan.org|
20526767|NCT02560324|University of Pennsylvania|Principal Investigator|215-746-5789|rlashare@pennmedicine.upenn.edu|
20526768|NCT01455181|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20554534|NCT02855060|Atrium Health|Rachel Seymour|74-355-6969|rachel.seymour@atriumhealth.org|
20526769|NCT01068626|University of Gothenburg|Kristjan Karason|+46 31 342 7554|kristjan.karason@gu.se|
20554535|NCT04088097|Yale University|Dr Janet Lydecker|2037374299|janet.lydecker@yale.edu|
20554536|NCT01126593|Orlando Orthopaedic Center|Dr. Randy Schwartzberg|(407) 254-2500|orlandosportsdoc@yahoo.com|
20526770|NCT01785849|Amgen Inc.|Study Director|866-572-6436||
20526771|NCT03098498|Department of Periodontology, University Hospital Wuerzburg|Dr. Yvonne Jockel-Schneider|49-931-201-72620|jockel_y@ukw.de|
20526772|NCT00808639|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard.edu|
20540527|NCT03386487|Yale University|Dr. Deepak Cyril D'Souza, M.D.|203-932-5711|deepak.dsouza@yale.edu|2594
20540528|NCT00734968|University of Missouri|Daniel Jackson MD|573 499 6041|jacksondl@health.missouri.edu|
20540529|NCT02920749|Department of Anaesthesiology and Intensive Therapy, University of Pecs|Dr. Timea Bocskai|36 72 507374|bocskai.timea@pte.hu|
20540530|NCT00286494|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20540531|NCT04776317|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
20540532|NCT04207060|Mayo Clinic|Dr. Santhi Swaroop Vege|(507) 266-6931|vege.santhi@mayo.edu|
20540533|NCT05438576|Mayo Clinic|Demilade Adedinsewo, M.B, Ch.B.|904-953-0859|adedinsewo.demilade@mayo.edu|
20540534|NCT01067144|Stanford University|Dr. Ian Carroll|(650) 723-6411|ic38@stanford.edu|
20540535|NCT01871441|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Neal Flomenberg|215 955-0182|dolores.gross@jefferson.edu|
20540536|NCT01835158|Harvard|Toni K. Choueiri, MD|(617) 632-5456|toni_choueiri@dfci.harvard.edu|
20540537|NCT00296140|Roudebush VA Medical Center|Dr. Linda Williams|317-988-2715|Linda.Williams6@va.gov|
20540538|NCT01856582|Cincinnati Children's Hospital Medical Center|Rebecca Marsh, MD/Associate Professor of Pediatrics|513-803-9063|Rebecca.Marsh@cchmc.org|
20540539|NCT00475904|EpiCept Corporation|Chief Medical Officer|914-606-3500|sallard@epicept.com|
20540540|NCT00880191|Mayo Clinic|Debra L. Barton RN, PhD, AOCN|507/284-1623|barton.debra@mayo.edu|
20540541|NCT01635881|Boston Scientific|Andrey Nersesov, Clinical Trial Manager|1-508-683-4988|Andrey.Nersesov@bsci.com|
20540542|NCT00939562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20540543|NCT00774800|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
20540544|NCT01919801|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20540545|NCT01843062|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20540546|NCT01059994|University of Texas Medical Branch|Melinda Sheffield-Moore|4097728126|melmoore@utmb.edu|
20540547|NCT01677858|Amgen Inc.|Study Director|866-572-6436||
20540548|NCT01331109|Forest Research Institute|Robert Palmer, MD|1-201-427-8200|robert.palmer@frx.com|8218
20540549|NCT00066963|Professor, S/D- PREV/REST|Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
20540550|NCT00988091|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20540551|NCT00773747|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20540552|NCT02669212|National Institutes of Health|Dr. Brian Walitt|202-549-7669|brian.walitt@nih.gov|
20540553|NCT03549104|University of Illinois at Chicago|Pamela Martyn-Nemeth|312-996-7903|pmartyn@uic.edu|
20540554|NCT01973998|Lewis Katz School of Medicine Temple University|Michael R. Jacobs - Director of Research Development|2157072242|michael.jacobs@tuhs.temple.edu|
20540555|NCT00646399|Biosynexus|Irwin Scher, MD|301-330-5800|irwinscher@biosynexus.com|
20540556|NCT04493203|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20540557|NCT04016259|The University of Texas Health Science Center at Houston|"Hyochol Brian Ahn, PhD, RN, MSN, Associate Professor"|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
20540558|NCT04929249|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20540559|NCT02540993|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20540560|NCT01620528|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20540561|NCT02202538|Parker Hannifin Corporation|Ryan Farris|(216) 896-3335|ryan.farris@parker.com|
20508116|NCT02563925|Memorial Sloan Kettering Cancer Center|Dr. Shanu Modi, MD|646-888-5243|modis@MSKCC.ORG|
20526773|NCT02776644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526774|NCT02089334|Rexahn Pharmaceuticals Inc.|Doug Swirsky/ Chief Executive Officer|240-268-5300|swirskyd@rexahn.com|
20526775|NCT00655473|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20526776|NCT00710684|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540562|NCT03997825|Relievant Medsystems|Diane Sahr, VP of Clinical Research|(650) 368-1000|dsahr@relievant.com|
20540563|NCT00767819|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20540564|NCT01153698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540565|NCT01323140|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
20540566|NCT00604045|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
20540567|NCT02332291|Vanderbilt University Medical Center|Warren D. Taylor, MD, MHSc|615-322-1073|warren.d.taylor@vumc.org|
20540568|NCT00699335|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20526777|NCT04778059|US Biotest, Inc.|Dr. Gere diZerega|8055951300|gere.dizerega@usbiotest.com|
20526778|NCT02832375|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526779|NCT01312233|Spine Institute for Quality|Christine M Goertz, DC, PhD (Study Principal Investigator)|301-335-0071|cgoertz@spineiq.org|
20526780|NCT01645891|EO2 Concepts|Dr. Mark Q Niederauer|2103387703|m.niederauer@eo2.com|
20526781|NCT00754520|Zimmer Biomet|Clinical Project Lead|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
20526782|NCT03026530|Region Ostergotland|Dr. Kihlstedt Pasquier|0046101041000|ebba.kihlstedt.pasquier@regionostergotland.se|
20508117|NCT01700985|Therapeutics Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
20526783|NCT00138073|Massachusetts General Hospital|Jaime Chang|617-726-9069|jchang4@partners.org|
20526784|NCT03301740|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|(919) 445-2656|jflythe@med.unc.edu|
20508118|NCT00134017|Johns Hopkins University|Leo Luznik, MD|4105027732|luznile@jhmi.edu|
20526785|NCT02584998|CMC VAMC|Emily Carter Paulson, MD MSCA|215-823-5880|emily.paulson@va.gov|
20540569|NCT04118595|University of North Carolina at Chapel Hill|Michelle Meyer, PhD|919-966-6539|mlmeyer@unc.edu|
20508119|NCT01342952|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508120|NCT04024072|Padagis LLC|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
20508121|NCT00426556|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20508122|NCT02584868|Centre Hospitalier Universitaire Brugmann|Philippe Van der Linden, MD, PhD|+32 2 477 23 30|philippe.vanderlinden@chu-brugmann.be|
20508123|NCT02494440|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20508124|NCT03970824|CELLTRION, Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
20508125|NCT00416312|Johns Hopkins University, School of Medicine|George Sgouros, Ph.D.|410 614 0116|gsgouros@jhmi.edu|
20526786|NCT01173055|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
20526787|NCT04814368|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20526788|NCT04530591|Hospital of the University of Pennsylvania|Jacob Brenner, Assistant Professor of Medicine|215-662-2222|Jacob.Brenner@pennmedicine.upenn.edu|
20526789|NCT04216589|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20540570|NCT04146935|Yale School of Medicine|Dr. Karl Insogna|203-785-3272|karl.insogna@yale.edu|
20540571|NCT01371305|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20540572|NCT02220712|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20540573|NCT03533244|Allgenesis Biotherapeutics|Tan Nguyen|+886-2-8787-1232|tan.nguyen@allgenesis.com|
20540574|NCT00760838|Ghent University Hospital|dr. Brusselle Guy|003293322604|guy.brusselle@uzgent.be|
20540575|NCT01817959|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20540576|NCT02019875|University of Washington|Kenneth Thummel|206-543-0819|thummel@u.washington|
20540577|NCT01628965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20540578|NCT00330681|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20540579|NCT03597061|University of Cincinnati|Cathleen Stough, Ph.D.|513-556-5589|odarcc@ucmail.uc.edu|
20540580|NCT02160145|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Devlopment|609 524 6788|clinicaltransparency@otsuka-us.com|
20540581|NCT02006979|University of Alberta|Dr. Amy Kirkham, Postdoctoral Research Fellow|7804926874|amy.kirkham@ualberta.ca|
20540582|NCT03170193|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20540583|NCT00375518|Memorial Sloan Kettering Cancer Center|Dr. David Amar|212-639-6798|amard@mskcc.org|
20540584|NCT00894361|PI/study coordinator retired due to personal family health matters and study sponsor then withdrew funding. Study terminated and no data was collected or analyzed from any participant.|Terence J. Gioe, M.D.||tjgioe@gmail.com|
20540585|NCT02881762|University of Maryland, Baltimore|Dr Lydia Tang|14107066567|lydiatang@ihv.umaryland.edu|
20540586|NCT00465088|Abbott|Global Medical Services|800-633-9110||
20540587|NCT00626444|Thomas Jefferson University|Daniel Monti, MD|215-955-4410|Daniel.Monti@jefferson.edu|
20540588|NCT04054375|Northwestern University School of Medicine|Dr. Senda Ajroud-Driss|(312) 944-0063|s-ajroud@northwestern.edu|
20540589|NCT02932748|University of Kansas Medical Center|Anna M. Gorczyca, PhD|913-588-9077|agorczyca@kumc.edu|
20540590|NCT04260347|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540591|NCT00994422|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
20540592|NCT01806675|Stanford University|Sanjiv Sam Gambhir, Professor for Clinical Investigation in Cancer Research and Professor|650-725-6175|sgambhir@stanford.edu|
20540593|NCT03078855|University of Rochester|Michael Brady, PhD|585-275-5830|michael_brady@urmc.rochester.edu|
20540594|NCT00391027|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20540595|NCT03422536|University of Arizona Cancer Center|Rachel Jarrett|5206260375|rjarrett@email.arizona.edu|
20540596|NCT00532298|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540597|NCT00479856|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540598|NCT01578577|Northwestern University|Dr. Stephen Persell|312-503-6464|spersell@nm.org|
20540599|NCT01763606|Memorial Sloan Kettering Cancer Center|Dr. Lisa DeAngelis, MD|212-639-8000|deangell@mskcc.org|
20540600|NCT04406649|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
20540601|NCT04164732|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20540602|NCT00661622|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu|
20540603|NCT04067609|Yale School of Medicine|Dr Audrey Merriam|203-785-7813|audrey.merriam@yale.edu|
20540604|NCT04765202|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20540605|NCT05758402|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20540606|NCT01636986|Alcon Research, Ltd.|Jami Kern, PhD|1-888-452-3937|alcon.medinfo@alcon.com|
20540607|NCT04867733|University of Iowa|Nicole Brogden|319-335-8752|nicole-brogden@uiowa.edu|
20540608|NCT00395850|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
20540609|NCT00820872|Mayo Clinic|Alvaro Moreno-Aspitia, M.D.|(904) 953-7291|morenoaspitia.alvaro@mayo.edu|
20540610|NCT03197922|Emory University|Nathan Call, PhD|404-785-9428|ncall@emory.edu|
20540611|NCT01987583|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
20540612|NCT01620762|Circassia Ltd|VP Clinical Operations|+44 1865 405560||
20540613|NCT00705146|VIHA|Helia Sillem MScOT|2507557611|helia.sillem@viha.ca|
20540614|NCT00095173|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20540615|NCT01623869|Memorial Sloan-Kettering Cancer Center|Sandra Pierina D'Angelo, M.D.||dangelos@mskcc.org|
20540616|NCT01436266|Boston Medical Center|Sarita Sonalkar, MD|617 414 7304|sarita.sonalka@bmc.org|
20540617|NCT03256253|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
20540618|NCT02161757|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
20540619|NCT00391625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20540620|NCT03664765|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
20540621|NCT01496846|University of Michigan|Dr Tatiana Botero, Director of Postgraduate Program in Endodontics|734-936-2526|tbotero@umich.edu|
20540622|NCT01772576|Boston Scientific|Ursula Appl|003224167213|ursula.appl@bsci.com|
20540623|NCT00923845|National Cancer Institute|Dr. Daniel Fowler|301-435-8641|fowlerda@mail.nih.gov|
20540624|NCT00379912|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20540625|NCT02578186|Procter & Gamble|Andrew L. Carr, PhD|513-622-0928|carr.an@pg.com|
20540626|NCT02873338|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20540627|NCT00847197|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526790|NCT03721835|Smith+Nephew, Inc.|Karlie Morgan|+1.512.496.7507|Karlie.Morgan@smith-nephew.com|
20526791|NCT01690910|St. Joseph Mercy Hospital|Amy Burghardt|734-712-2027|amy.burghardt@stjoeshealth.org|
20526792|NCT01254851|Loyola University Medical Center|Linda Brubaker|708-216-4033|lbrubaker@lumc.edu|
20540628|NCT01620944|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20540629|NCT04378114|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
20540630|NCT00830180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540631|NCT01366885|OHSU|Dr. Gene Stubbs|503-939-7351|stubbsgene@comcast.net|
20540632|NCT01832532|Cincinnati Children's Hospital Medical Center|Raouf Amin, MD|(513) 636-7945|Raouf.Amin@cchmc.org|
20526793|NCT01306045|National Cancer Institute|Dr. Arun Rajan|240-760-6236|rajana@nih.gov|
20526794|NCT04198584|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-966-6732|donna_evon@med.unc.edu|
20526795|NCT02000882|US Oncology Research|Taqi Mohammad|7138702175|taqi.mohammad@mckesson.com|
20526796|NCT04550832|LigaChem Bioscience, Inc.|Seonghye Cheon|+82)02-6952-0689|scheon@ligachembio.com|
20526797|NCT04823130|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20526798|NCT03312595|Acera Surgical, Inc.|Chief Science Officer|844-879-2237|information@acera-surgical.com|
20526799|NCT03315455|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20526800|NCT04439357|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20526801|NCT04527003|MSHersheyMC|Dr. Kristin Riley|7175316647|kriley1@pennstatehealth.psu.edu|
20526802|NCT00985426|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
20526803|NCT02052596|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526804|NCT00558896|Mayo Clinic|Dr. Martha Lacy||lacy.martha@mayo.edu|
20526805|NCT00182728|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20526806|NCT02657577|Pennington Biomedical Research Center|Leanne Redman, Principal Investigator|2257630947|Leanne.Redman@pbrc.edu|
20526807|NCT00230022|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
20526808|NCT00723190|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20526809|NCT00454818|Celladon Corporation|Jeffrey J. Rudy, Vice President|1 858-366-4288|jrudy@celladon.net|
20526810|NCT03181503|Galderma|Clinical Operations|(0) 4 93 95 70 70|Clinical.Studies@galderma.com|+33
20540633|NCT00392990|Northwestern University|Leo Gordon, MD||l-gordon@northwestern.edu|
20526811|NCT00001656|National Institute of Mental Health|Judith L. Rapoport, M.D.|301-496-6080|rapoporj@mail.nih.gov|
20540634|NCT04331002|University of Kentucky|Dr. Austin Stone|859-218-3131|austin.stone@uky.edu|
20540635|NCT03845738|Dentsply IH AB d.b.a Dentsply Sirona Implants|Director Center of Clinical Research, AnnaKarin Lundgren|+46 31 376 30 00|annakarin.lundgren@dentsplysirona.com|
20540636|NCT00825812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20508126|NCT01488409|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
20540637|NCT01078844|Johns Hopkins University School of Medicine|Eric Samstad, MD|410-550-0171|esamsta1@jhmi.edu|
20540638|NCT00991406|Cleveland VAMC|Elizabeth Hardin|216-791-3800|Elizabeth.HardinvandenBogert@va.gov|4698
20540639|NCT03824587|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20540640|NCT01300572|Fred Hutchinson Cancer Research Center|Brenda Sandmaier, MD|(206) 667-4961|bsandmai@fredhtuch.org|
20540641|NCT00986362|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
20540642|NCT06037408|Emphycorp, Inc.|Dr. Alain Martin|(908) 237-1561|al.martin.hq@emphycorp.com|
20540643|NCT03052816|UH Hospitals Cleveland Medical Center/MetroHealth Medical Center at time of study protocol|Andrey Petrikovets MD|323 243 9091|andrepetrikovets@yahoo.com|
20540644|NCT01211340|University of Missouri|Debra Parker Oliver|573-884-5301|oliverdr@missouri.health.edu|
20540645|NCT03755661|Boston University|LaNeia Thomas|617-358-6346|laneia@bu.edu|
20540646|NCT00895453|Vienna Medical School|Armin Witt MD|+43140400|armin.witt@meduniwien.ac.at|2821
20540647|NCT01736618|Boston Scientific - Rhythm Management|Clinical Trial Manager or Director of Clinical Trials (Cardiology Rhythm Management)|1-800-227-3422|jill.leigh@bsci.com|
20540648|NCT04167137|Synlogic|Aoife Brennan, MB, BCh, BAO, MMSc|(857) 999-0767|aoife@synlogictx.com|
20540649|NCT02634827|Mayo Clinic|Aref Al-Kali, MD|507-538-0871|AlKali.Aref@mayo.edu|
20540650|NCT01748825|National Cancer Institute|Dr. Naoko Takebe|240-781-3320|takeben@nih.gov|
20540651|NCT01849419|University of Chicago|Dr. Harriet de Wit|(773) 702-3560|hdew@uchicago.edu|
20540652|NCT02714283|Oregon Health & Science University|Emily Henkle, PhD, MPH|503-494-6226|henkle@ohsu.edu|
20540653|NCT02461745|Southern California Permanente Medical Group|Division of Clinical Trials Research|(626) 564-5667|clinical.trials@kp.org|
20540654|NCT00211887|Icahn School of Medicine at Mount Sinai|Dr. Fred D. Lublin|212-241-6854|fred.lublin@mssm.edu|
20540655|NCT00965419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20540656|NCT00997594|Mie University|Dr. Koichiro Yamakado|+81-59-231-5029|yama@clin.medic.mie-u.ac.jp|5630
20540657|NCT01946152|UT MD Anderson Cancer Center|Michael Wang,MD/ Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
20540658|NCT03712787|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20540659|NCT01865448|Unidad de Apoyo a la Investigacion. Hospital Rio Hortega|Dr. Daniel de Luis|983420400|dadluis@yahoo.es|83523
20540660|NCT04255862|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20540661|NCT05111249|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20540662|NCT05128578|University of Pittsburgh|Shari Rogal|412-360-6177|rogalss@upmc.edu|
20540663|NCT02346461|National Human Genome Research Institute|Carrillo, Nuria|+1 301 402 2324|nuria.carrillo@nih.gov|
20540664|NCT03004911|School of Medicine at the University of Sao Paulo|Amélia Pasqual Marques|+55 11 3091 7451|pasqual@usp.br|
20540665|NCT00799266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20540666|NCT01702025|Department of Health and Exercise Science|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
20540667|NCT02679755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540668|NCT01061359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540669|NCT00725049|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20540670|NCT02610777|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20540671|NCT00732875|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20540672|NCT02324283|Juntendo University|Dr. Izumi Kawagoe|+81338133111|ikawago@juntendo.ac.jp|
20540673|NCT03688074|AstraZeneca|Globall Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
20540674|NCT03928717|Providence College|Dr. Nick Tarantino|4018651612|ntaranti@providence.edu|
20540675|NCT00660179|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
20540676|NCT00581581|University of Rochester|Ronnie Guillet, MD, PhD|585-275-6209|ronnie_guille@urmc.rochester.edu|
20540677|NCT03056339|The University of Texas MD Anderson Cancer Center|Dr. Loretta Nastoupil, M.D. / Stem Cell Transplantation and Cellular Therapy Department|713-792-2860|lnastoupil@mdanderson.org|
20540678|NCT05224453|Prince Sattam bin Abdulaziz University|Dr. Gopal Nambi|0501878382|physio_gopal@rediffmail.com|
20540679|NCT04171219|M.D. Anderson Cancer Center|Aung Naing, MD|713-563-3885|anaing@mdanderson.org|
20540680|NCT02380443|Mirror Biologics, Inc|Dr. Michael Har-Noy|7602167494|harnoy@mirrorbio.com|
20540681|NCT02974257|BIDMC|Dr. Katherine Berg|617-754-2281|kberg@bidmc.harvard.edu|
20540682|NCT00398567|Puma Biotechnology, Inc|Senior Director, Clinical Operations|+1 424 248 6500|clinicaltrials@pumabiotechnology.com|
20540683|NCT01363908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20540684|NCT02551822|University of New Mexico Health Sciences Center, Department of Obstetrics & Gynecology, Division of Urogynecology|Dr. Yuko Komesu, MD|505-272-6382|YKomesu@salud.unm.edu|
20540685|NCT01703507|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
20540686|NCT04878211|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20540687|NCT04273893|University of Virginia|UVA Radiation Oncology Clinical Research Coordinator|434-243-0008|UVARADONCClinicalTrials@uvahealth.org|
20540688|NCT00328614|Thomas Jefferson University|Edouard Trabulsi, MD|215-955-1000|Edouard.Trabulsi@jefferson.edu|
20540689|NCT05613257|Cedars Sinai Medical Center|Joel Arnold|310-423-9839|joel.arnold@cshs.org|
20540690|NCT05380505|NYU Langone Health|Marie Bragg, PhD|646-501-2717|Marie.Bragg@nyulangone.org|
20540691|NCT00694018|VA Ann Arbor Center for Clinical Management Research|Sarah L. Krein, PhD, RN|734-845-3621|sarah.krein@va.gov|
20554537|NCT03556761|University of Pennsylvania|Dr Lisa Levine|215-662-6913|lisa.levine@pennmedicine.upenn.edu|
20508127|NCT00105560|Massachusetts General Hospital|Dr. Nancy Tarbell, Pediatric Radiation Oncologist|617-724-1836|NTARBELL@mgh.harvard.edu|
20508128|NCT00425100|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20508129|NCT01315847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508130|NCT00979017|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
20540692|NCT00856544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540693|NCT01036321|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
20540694|NCT01687101|Thomas Jefferson University, Jefferson Headache Center|Stephen D Silberstein, MD|215-955-2243|bruce.smith@jefferson.edu|
20540695|NCT05274269|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20508131|NCT03086317|Emory University|Dr. Wissam Jaber, Assistant Professor|4046861000|wissam.jaber@emory.edu|
20508132|NCT03699631|Froedtert and the Medical College of Wisconsin|William Drobyski, MD|414-805-6700|wdrobyski@mcw.edu|
20540696|NCT02206035|Froedtert and the Medical college of Wisconsin|William Drobyski, MD|414-456-4941|wdrobysk@mcw.edu|
20540697|NCT02936843|The University of Michigan|Rodica Pop-Busui, MD, PhD|Phone 734-647-9809|rpbusui@med.umich.edu|
20540698|NCT01077401|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
20540699|NCT01511068|Cincinnati Children's Hospital Medical Center|Dr. Bruce Trapnell|513636-6361|Bruce.Trapnell@cchmc.org|
20540700|NCT01824355|Ascensia Healthcare|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20540701|NCT04124705|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20540702|NCT02093962|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
20540703|NCT01716455|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20540704|NCT03521479|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
20540705|NCT02275156|Amgen Inc.|Study Director|866-572-6436||
20540706|NCT03929640|Milton S. Hershey Medical Center|Serdar Ural|717-531-6209|sural@pennstatehealth.psu.edu|
20540707|NCT02106403|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540708|NCT00639626|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
20540709|NCT00177255|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
20540710|NCT02038075|University of Utah|Dr. Craig Bryan|8015877978|craig.bryan@utah.edu|
20508133|NCT02940626|X4 Pharmaceuticals (merged with Arsanis)|Vice President, Clinical Operations|(857) 529-8300|rnd@x4pharma.com|
20508134|NCT03488914|Hunter College|Dr. Tyrel Starks|212-772-5550|tstarks@hunter.cuny.edu|
20508135|NCT02559713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20508136|NCT01767519|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20508137|NCT00293423|University of California, Davis|Dr. Orin Bloch||obloch@ucdavis.edu|
20508138|NCT00964158|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508139|NCT00507416|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
20508140|NCT04428359|BP Koirala Institute of Health Sciences|Dr. Bibisha Baaniya|9841744777|cul.bibisha@gmail.com|+977
20508141|NCT01182337|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
20508142|NCT03101514|the first affiliated hospital of Harbin medical university|Dr. Zhi-Ping Liu|+8613936034546|as150001@aliyun.com|
20508143|NCT01021813|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508144|NCT03571256|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20508145|NCT02270684|University of Southern California|Dr Christopher Powers|3234422900|powers@usc.edu|
20508146|NCT00868452|Sunovion|Medical Director, CNS|1-866-503-6351||
20508147|NCT01673191|Retinal Consultants of Arizona|Dr. Pravin Dugel|602-222-2221|PDugel@gmail.com|
20508148|NCT03141372|Cleveland Clinic Florida|Sara Farag, Fellow in Minimally Invasive Gynecologic Surgery|8147691904|faragsara@gmail.com|
20508149|NCT02247401|AbbVie|Global Medical Services|800-633-9110||
20508150|NCT03418051|University of North Carolina at Chapel Hill|Erik Wikstrom|9199622260|wikstrom@unc.edu|
20540711|NCT04000581|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
20540712|NCT03477838|Virginia Commonwealth University|Evan Sisson, PharmD|804-828-8076|emsisson@vcu.edu|
20540713|NCT01931163|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
20540714|NCT02519595|Children's Hospital of Michigan|Nirupama Kannikeswaran|313-745-5260|nkannike@dmc.org|
20540715|NCT00387036|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20540716|NCT00850538|New England Baptist Hospital|Carl Talmo|617-724-5474|ctalmo@nebh.org|
20540717|NCT03139344|University of Iowa Department of Physical Therapy and Rehabilitation Science|Dr. Richard K. Shields|319-335-9791|richard-shields@uiowa.edu|
20540718|NCT03188510|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20508151|NCT03695393|Boston Medical Center and BU School of Medicine|Karsten Lunze, MD|617-638-6933|lunze@bu.edu|
20508152|NCT02486211|University of Pittsburgh|Dr. Jon Rittenberger|4126479489|rittjc@upmc.edu|
20540719|NCT04182672|The University of Texas Health Science Center at Houston|Pritish Bawa, MD|713-500-7702|Pritish.Bawa@uth.tmc.edu|
20540720|NCT05261009|Wake Forest School of Medicine|Daryl Henshaw, MD|336-716-4498|dhenshaw@wakehealth.edu|
20554538|NCT03057119|Florida State University|Katie Kloss|9045716395|katie.kloss@med.fsu.edu|
20508153|NCT04169061|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
20508154|NCT04585451|PainQx|VP R&D|6179817753|bd@painqx.com|
20540721|NCT02762331|Virginia Commonwealth University|Donald Brophy, PharmD|(804) 827-1455|dbrophy@vcu.edu|
20540722|NCT01088399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20540723|NCT03637517|Medicines for Malaria Venture|Stephan Chalon, MD|+41 22 555 0369|chalons@mmv.org|
20540724|NCT00400569|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
20540725|NCT02921087|SUNY College of Optometry Clinical Vision Research Center|Danielle Iacono, OD|212-938-5936|diacono@sunyopt.edu|
20540726|NCT00852241|Loyola Medicine|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedicine.org|
20540727|NCT03848949|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
20540728|NCT02524418|University of Florida|Dr. Peter V. Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
20540729|NCT00619307|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20540730|NCT00928694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20540731|NCT00118430|Indiana University|Kurt Kroenke|3172749046|kkroenke@regenstrief.org|
20540732|NCT02147288|Yale University|Dr. Marc Walker||marc.walker@yale.edu|
20540733|NCT00669383|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
20540734|NCT03223337|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20540735|NCT01362608|Novartis|Clinical Disclosure Office|862-778-8300||
20540736|NCT00889824|WashingtonU|Joel Goebel, MD|(314) 362-7344|goebelj@ent.wustl.edu|
20540737|NCT01504412|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
20540738|NCT03437577|University of Minnesota|Susan Marino|612-624-2964|marin007@umn.edu|
20540739|NCT00536471|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20540740|NCT00381693|Mayo Clinic|Dr. Ruben A. Mesa|507-284-3533|mesa.ruben@mayo.edu|4-3533
20540741|NCT00345865|Masonic Cancer Center, University of Minnesota|Dr.Veronika Bachanova|612-625-5469|bach0173@umn.edu|
20540742|NCT05651867|Quantum Surgical|Marion Chassouant|0033781425198|m.chassouant@quantumsurgical.com|
20540743|NCT02553395|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
20540744|NCT02159976|Department of Internal Medicine, Seoul National University Bundang Hospital|Nayoung Kim, M.D., Ph.D.|+ 82-31-787-7008|nayoungkim49@empas.com|
20540745|NCT02003534|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20540746|NCT02546492|University of MAryland sSchool of Medicine|A Haririan|410-328-5720|ahariria@som.umaryland.edu|
20508155|NCT00493974|University of Minnesota|Sarah Lindberg|612-626-9011|slindberg@umn.edu|
20540747|NCT03920254|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20540748|NCT03040674|Lung Health Institute|Melissa Rubio, PhD, APRN|2145042117|pidallas@thelunghealthinstitute.com|
20540749|NCT01934010|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
20540750|NCT01393821|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-7202|Jatoi.Aminah@mayo.edu|
20540751|NCT05419232|Nationwide Children's Hospital|Jason Newland|6147223416|jason.newland@nationwidechildrens.org|
20540752|NCT02608463|University of Arkansas for Medical Sciences|Dr. Shona Ray-Griffith|501-526-8428|slray@uams.edu|
20540753|NCT00377858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20540754|NCT03534141|University of California, San Francisco|Dr. Michael P. Bokoch, Principal Investigator|415-476-8389|Michael.Bokoch@ucsf.edu|
20540755|NCT00517361|The University of Chicago|Dr. Rita Nanda|773-834-2756|rnanda@medicine.bsd.uchicago.edu|
20540756|NCT00709618|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540757|NCT01854034|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|lvsequist@partners.org|
20540758|NCT04042909|Brown University|Kate B. Carey|4018636558|kate_carey@brown.edu|
20540759|NCT04303572|University of Pittsburgh|Dr. Margaret Ragni, Principal Investigator|412-209-7288|ragni@pitt.edu|
20540760|NCT06312592|Washington University in St. Louis|Dr. Lindsay Stark|314-935-4747|lindsaystark@wustl.edu|
20540761|NCT04428619|UCLA|Lin Chang|310-206-0192|linchang@mednet.ucla.edu|
20540762|NCT03785405|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20540763|NCT01948063|BIDMC|Michael W Donnino|617-754-2341|mdonnino@bidmc.harvard.edu|
20540764|NCT01858766|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20540765|NCT05234957|Benha University|Dr. Mohamed Farid|00201003354636|mohamed.farid@fmed.bu.edu.eg|
20508156|NCT02807363|Enteris Biopharma Inc.|Paul Shields, Ph.D|9734533520|pshields@enterisbiopharma.com|
20508157|NCT02188719|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20508158|NCT00966693|UT MD Anderson Cancer Center|Weber,Donna M.,M.D. / Lymphoma/Myeloma|713-792-2860|dmweber@mdanderson.org|
20508159|NCT00192036|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20540766|NCT03517228|Memorial Sloan Kettering Cancer Center|Dr. Mario Leitao, MD|212-639-3987|leitaom@mskcc.org|
20540767|NCT00887510|University of Florida|Rhonda M Cooper-DeHoff|352 273-6184|dehoff@cop.ufl.edu|
20540768|NCT01340053|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
20540769|NCT03781414|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20540770|NCT01028846|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-839-7975|meredith.hawkins@einsteinmed.edu|
20508160|NCT03371732|Institute Bergonie|Dr. Marion Barrault Couchouron, Coordinating Investigator|0556337805|m.barrault@bordeaux.unicancer.fr|
20508161|NCT01861054|Dompé Farmaceutici|Pier Adelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
20540771|NCT00156390|University of Pittsburgh|Dr. Samir Saba|412-802-3372|sabas@upmc.edu|
20540772|NCT00245037|Oregon Health and Science University|Richard T. Maziarz, MD|503-494-6345|maziarzr@ohsu.edu|
20540773|NCT04752358|Adaptimmune|Clinical Trials Management|+1 (215) 825-9260|clinicaltrials@adaptimmune.com|
20540774|NCT00555672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540775|NCT01053988|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540776|NCT01922271|Novartis Pharmaceuticals|Study Director|862-778-8300||
20540777|NCT00719355|University of Illinois at Chicago|Eileen G. Collins PhD, RN|312-413-5621|ecollins@uic.edu|
20526812|NCT01892085|University of Florida|Leslie Parker|352 215 9360|Parkela@ufl.edu|
20526813|NCT01573325|Northwestern Memorial Hospital|Rebecca Duke DNP, MSN, NP-BC Transplant Surgery Nurse Practitioner|3126951686|rduke@nmh.org|
20526814|NCT00201240|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20526815|NCT01135069|Spear Pharma|K.L. Spear M.D.|239-433-3442|spear@spearpharma.com|
20526816|NCT01629823|ALA-ACRC|Janet T Holbrook, PhD, MPH|443-287-3170|jholbro1@jhu.edu|
20526817|NCT03258008|UT MD Anderson Cancer Center|Dr. John Heymach, PHD-Chair, Thoracic-Head & Neck Med Onc|(713) 792-6363|jheymach@mdanderson.org|
20526818|NCT01199822|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20526819|NCT00525902|Oregon Health & Science University|Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
20526820|NCT02258542|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
20526821|NCT02844907|Durham VAMC|David D'Alessio, MD|919-684-5778|david.dalessio2@va.gov|
20526822|NCT00550862|Intercept Pharmaceuticals|Dr. David Shapiro|858-652-6800|dshapiro@interceptpharma.com|
20526823|NCT00033657|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20526824|NCT01683422|Loma Linda University Health|Gary Yang|909 558 4000|gyang@llu.edu|88056
20526825|NCT00986986|University of Hawaii at Manoa|Dominic Chow|(808)737-2751|dominicc@hawaii.edu|
20526826|NCT02303990|University of Pennsylvania|Dr. Amit Maity|215) 662-3759|maity@uphs.upenn.edu|
20526827|NCT03235115|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20526828|NCT01928797|Brigham and Women's Hospital|Dr. Bhavani Kodali|617-732-8220|BKODALI@BWH.HARVARD.EDU|
20526829|NCT04631107|Apnimed, Inc.|Clinical Trials|617-500-8880|clinicaltrials@apnimed.com|
20526830|NCT02525536|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20526831|NCT01797159|The SKCCC at Johns Hopkins|The SKCCC at Johns Hopkins|4109556980|kjansen3@jhmi.edu|
20526832|NCT00475878|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.edu|
20526833|NCT00096993|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20526834|NCT03280225|Central Arkansas Veterans Healthcare System|Dr. Sara J. Landes|501-257-3385|sara.landes@va.gov|
20526835|NCT01828216|Chinese University of Hong Kong|David SC Hui|852 2632 2211|dschui@cuhk.edu.hk|
20526836|NCT01440569|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20526837|NCT00435487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20526838|NCT00835679|Vanderbilt-Ingram Cancer Center|Emily Chan, MD|615-343-4677|emily.chan@vanderbilt.edu|
20526839|NCT02719938|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
20526840|NCT00955968|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20526841|NCT05020899|Boston Medical Center|Lisa Quintiliani, PhD|617-638-2777|lisa.quintiliani@bmc.org|
20526842|NCT00565669|Carolina Eye|Helga Sandoval||hps@cepmd.com|
20526843|NCT01940900|Ophthotech Corp.|Denise Teuber||denise.teuber@ophthotech.com|
20526844|NCT01177709|Nathan Kline insistute for Psychiatric Research|Robert C smith MD|845-298-6531|rsmith@nki.rfmh.org|
20526845|NCT03596723|Kala Pharmaceuticals, Inc|VP Clinical Development|781-996-5252|Results010@kalarx.com|
20526846|NCT04972968|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20526847|NCT01698879|CETLAM|Dr. Jordi Sierra|+34 93 434 44 12|jsierra@santpau.cat|
20540778|NCT01415401|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader|1-888-451-3937|alcon.medinfo@alcon.com|
20540779|NCT02465372|Wake Forest University Health Sciences|Dr. Justin Moore|336-716-3702|jusmoore@wakehealth.edu|
20540780|NCT00836186|Johns Hopkins University|Jean Wright, MD PI|410-614-3950|jwrigh71@jhmi.edu|
20540781|NCT02186665|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
20540782|NCT01151371|Vistakon|Kathy Lorenz-Osborn, OD|+1 904 443-1032|kosborn@its.jnj.com|
20540783|NCT04210622|Medtronic, Inc|Clinical Research Specialist|800-328-2518|medtroniccastrials@medtronic.com|
20540784|NCT04427072|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20540785|NCT05232864|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20540786|NCT02023996|Memorial Sloan Kettering Cancer Center|Dr. Neeta Pandit-Taskar, MD|212-639-3046|pandit-n@MSKCC.ORG|
20540787|NCT01844778|Novartis|Study Director|862-778-8300||
20540788|NCT02211456|Oxford University Hospitals NHS FT|Dr James Gamble|00441865221012|james.gamble@ouh.nhs.uk|
20540789|NCT03605914|The University of Texas Health Science Center at Houston|Martin J. Citardi, MD, Professor and Chair, Department of Otorhinolaryngology|(713) 500-5410|Martin.J.Citardi@uth.tmc.edu|
20540790|NCT02652468|University of Madison Carbone Cancer Center|Vaishalee Kenkre|(608) 263-1699|vpkenkre@medicine.wisc.edu|
20540791|NCT02910102|Axovant Sciences, Inc.|Director, Clinical Development|1-833-296-8268|clinicaltrials@axovant.com|
20540792|NCT00328861|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20540793|NCT01130896|Johns Hopkins University|Henry Halperin, MD|410-955-2412|nsaju1@jhmi.edu|
20540794|NCT02024724|Northwestern University, Feinberg School of Medicine|Antoun Nader, M.D.|312-695-4814|a-nader2@northwestern.edu|
20540795|NCT00961714|Alphatec Spine, Inc.|Glen Seidner, Clinical Affairs|760-494-6789|gseidner@alphatecspine.com|
20540796|NCT01128946|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526848|NCT00191282|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20526849|NCT01717482|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-8462|Wigle.Dennis@mayo.edu|
20540797|NCT00145574|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20540798|NCT00621140|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540799|NCT00527904|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
20526850|NCT04756154|3M|Linda Olson|651-736-3586|lkolson2@mmm.com|
20526851|NCT03589976|NYU Langone Health|Jose-Alberto Palma, MD, PhD|212-263-7225|JoseAlberto.PalmaCarazo@nyulangone.org|
20540800|NCT03323801|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
20540801|NCT02669121|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20540802|NCT04405076|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20540803|NCT04310566|Johnson & Johnson Vision Care|Thomas Karkkainen - Sr.Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20540804|NCT02110264|UCLA|David Farabee|3109630009|dfarabee@mednet.ucla.edu|
20540805|NCT00620113|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20540806|NCT04412707|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
20540807|NCT00571974|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
20540808|NCT02813889|Penn Medicine Center for Physical Medicine and Rehabilitation|Dr. Michelle J. Johnson|4148130128|johnmic@pennmedicine.upenn.edu|
20540809|NCT00555880|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20540810|NCT00941915|Assistant Research Practice Manager|Joan Cahill, BSN RN OCN CCRP|(919) 668-5211|joan.cahill@duke.edu|
20540811|NCT04014062|Lambda Therapeutic Research Ltd.|Dr. Anshul Attrey, M.D. Principal Investigator|+91-79-40202020|anshulattrey@lambda-cro.com|
20540812|NCT00546000|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
20540813|NCT00726414|Mutual Phrmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20540814|NCT00721188|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20540815|NCT01336140|Rush University Medical center|Rami Doukky|312-942-4655|rami_doukky@rush.edu|
20540816|NCT01048658|Oregon Health & Science University|Dr. Rosenne Botha|503-494-3666|whru@ohsu.edu|
20540817|NCT00939536|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
20540818|NCT04784143|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20540819|NCT04809285|Medtronic|Binh Ngo (Clinical Research Director)|9492027218|binh.ngo@medtronic.com|
20540820|NCT02837029|Northwestern University, Feinberg School of Medicine|Aparna Kalyan, MBBS, FRACP|312 926 4291|Aparna.kalyan@northwestern.edu|
20540821|NCT02644343|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
20540822|NCT03370042|Kamineni Institute of dental sciences|Dr. Raga Bindu|09849441800|ragha.j16@gmail.com|
20540823|NCT02034877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540824|NCT01013194|ISMETT-UPMC|Dr Giada Pietrosi|+390912192111|gpietrosi@ismett.edu|
20540825|NCT00526591|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
20540826|NCT02461927|VA CT Healthcare System, Yale University|Dr. Gihyun Yoon|(203) 932-5711|gihyun.yoon@yale.edu|7421
20540827|NCT02783599|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20540828|NCT00783614|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
20540829|NCT01564732|Duke University Medical Center|Dana Portenier, M.D.|919-470-7031|dana.portenier@duke.edu|
20540830|NCT01159015|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20540831|NCT04808141|Sword Health Inc|Fernando Dias Correia|+1 (646) 379-6751|fcorreia@swordhealth.com|
20540832|NCT02598297|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20540833|NCT01401517|TheraVasc Inc.|Tony Giordano|318-349-3851|tgiordano@theravasc.com|
20540834|NCT00394706|University of Washington|Siobhan Brown, PhD-Biostatistician|206-685-1302|spes@uw.edu|
20540835|NCT04846322|Yale University|Ula Hwang, MD|+1 (203) 7371774|ula.hwang@yale.edu|
20540836|NCT03369249|New York State Psychiatric Institute|Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
20540837|NCT00887549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20540838|NCT04112303|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20540839|NCT05173012|Sage Therapeutics|Carrie Vaudreuil|(857) 259-4766|carrie.vaudreuil@sagerx.com|
20540840|NCT00100789|SWOG Statistical Center|Study Statistician|206-667-4623||
20540841|NCT03472950|University of Kansas Medical Center|Jeffrey Statland, MD|913-945-9933|Jstatland@kumc.edu|
20540842|NCT01318408|Drexel University College of Medicine|Carol Lippa, MD|215-762-7090|clippa@drexelmed.edu|
20540843|NCT00972725|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540844|NCT02506192|Minneapolis VA Health Care System|Ronald R Bach, PhD, Principal Investigator|(612)467-6315|ronald.bach@va.gov|
20540845|NCT01685697|Univeristy of Alberta|Georg Schmolzer|7807354660|georg.schmoelzer@me.com|
20540846|NCT02703324|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20540847|NCT02096549|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
20540848|NCT03705559|University of Kentucky|Shanna Babalonis, Ph. D.|859-257-1881|babalonis@uky.edu|
20540849|NCT00195091|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina MD|646-888-4558|trainat@MSKCC.ORG|
20540850|NCT01543074|Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston TX|Rod Dashwood|7136777806|rdashwood@ibt.tamhsc.edu|
20540851|NCT00945256|University of Texas Medical Branch|Dr Melinda Sheffield-Moore, Professor of Medicine|409-772-8707|melmoore@utmb.edu|
20540852|NCT01979952|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540853|NCT00795236|Oregon Health & Science University|Alfred Lewy|(503) 494-7746|lewy@ohsu.edu|
20540854|NCT01439594|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
20540855|NCT01821859|Oregon Health and Science University|Tanja Pejovic|503-494-5125|pejovict@ohsu.edu|
20540856|NCT00203424|Translational Oncology Research International|Dr. Fairooz F. Kabbinavar, Chief Medical Officer|310-824-1934|FKabbina@mednet.ucla.edu|
20540857|NCT00475709|St Jude Medical|Kelly Erickson|16517566580|kaerickson@sjm.com|
20540858|NCT04759157|University of Utah|Dr. Kelly Baron|801-585-7588|kelly.baron@utah.edu|
20540859|NCT04491539|Florida State University|Henna Budhwani|(850) 644-3296|hbudhwani@fsu.edu|
20540860|NCT04477759|Medical College of Wisconsin|Musaddiq Awan, MD|414-805-4497|mawan@mcw.edu|
20540861|NCT03364738|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20540862|NCT03245398|Swiss Tropical and Public Health Institute|Dr Jennifer Keiser|+41 61 284 8218|jennifer.keiser@swisstph.ch|
20540863|NCT01938833|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maysa Abu-Khalaf|215 503-4685|maysa.abu-khalaf@jefferson.edu|
20540864|NCT04079816|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
20540865|NCT01702246|UCSF Benioff Children's Hospital Oakland|Dr. Carolyn Hoppe|(510)428-3193|choppe@mail.cho.org|
20540866|NCT02687581|State University of New York College of Optometry|Dr. Jingyun Wang|212-938-5759|jwang@sunyopt.edu|
20540867|NCT00835341|Peking University School of Oncology|Department of Etiology|+8610-88196752|dengdajun@bjmu.edu.cn|
20540868|NCT01340573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20540869|NCT03301298|Promentis Pharmaceuticals|Dean Brostowin|617-300-6172|dbrostowin@promentispharma.com|
20540870|NCT02560012|The University of Texas Health Science Center, Houston|Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
20540871|NCT00714311|Medical University of Vienna|Stephan Doering|+43140400|stephan.doering@meduniwien.ac.at|25190
20540872|NCT02218008|Alkermes, Inc.|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
20540873|NCT01278797|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554539|NCT00353704|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
20554540|NCT02525133|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20554541|NCT01154166|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554542|NCT01375049|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20554543|NCT01575561|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20554544|NCT01037309|Prosensa|Fiona Lawrence|+31(0)713322100|f.lawrence@prosensa.nl|
20570731|NCT05555615|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|844-422-2342|medicalinformation@acadia-pharm.com|
20570732|NCT03635086|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20570733|NCT02196077|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
20570734|NCT02046512|Washington University in St. Louis School of Medicine|Kimberly Reske, Research Coordinator|3147474041|kreske@wustl.edu|
20570735|NCT03482752|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
20570736|NCT02844777|Vidac Pharma|Max Herzberg|0544257381|maxherzberg@gmail.com|
20570737|NCT04458818|Combined Military Hospital Kharian, Punjab Pakistan|Dr Muhammad Noman Karim|+923313358884|f9noman@gmail.com|
20570738|NCT00150618|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20570739|NCT00762476|University of Virginia|Dr. Ronald Turner|(434) 243-9864|RBT2N@hscmail.mcc.virginia.edu|
20570740|NCT00965497|University of South Carolina School of Medicine|Meera Narasimhan, MD|803-434-1100|shardeman@uscmed.sc.edu|
20570741|NCT02878603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20570742|NCT01055704|Mayo Clinic|Dr Michael Camilleri|5072662305|camilleri.michael@mayo.edu|
20570743|NCT02037776|Osaka Medical College|Kazunari Tominaga, M.D., Ph. D.|+81-72-683-1221|in2139@osaka-med.ac.jp|8096
20570744|NCT03928392|Loma Linda University|Dr. Dragana Krpalek|9095584328|dkrpalek@llu.edu|41340
20570745|NCT02781311|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20570746|NCT04115189|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570747|NCT02562898|University of California, San Francisco|Dr. Margaret Tempero|415-353-7528|Margaret.Tempero@ucsf.edu|
20570748|NCT01936467|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
20570749|NCT01774045|Taipei Veterans General Hospital|Dr. Cheng-Ta Li|886-2-2871-2121|on5083@msn.com|7027
20570750|NCT04547023|Stanford University|Yair Blumenfeld, MD|650-498-4069|yairb@stanford.edu|
20570751|NCT00250432|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20570752|NCT01011868|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20570753|NCT01262092|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
20570754|NCT03784820|University of North Carolina at Chapel Hill|Hunna Watson, PhD|984-974-5217|hunna_watson@med.unc.edu|
20570755|NCT01255761|UCB Clinical Trial Call Center|(UCB) Study Director|+1 887 822 9493||
20570756|NCT02336425|Novartis Pharmaceuticals|Study Director|862-778-8300||
20570757|NCT00658606|Astellas Pharma Canada, Inc.|Director, Scientific Affairs||ClinicalTrials@us.astellas.com|
20570758|NCT04905849|UC San Francisco|Dr. Joaquin A. Anguera, Associate Professor|415 502 7322|joaquin.anguera@ucsf.edu|
20570759|NCT05010850|SafeHeal|Heather Cronin, VP Clinical Affairs|5184289593|hcronin@safeheal.com|
20570760|NCT03981939|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20570761|NCT01056263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570762|NCT02037620|University of Louisville|Dr. Susan Harkema|502-581-8675|susan.harkema@louisville.edu|
20540874|NCT02069392|University of Maryland School of Medicine|Britta Hahn, Ph.D.|4104026112|bhahn@som.umaryland.edu|
20540875|NCT00269633|Thomas Jefferson University|Roseann Talarico|215 503 4743|roseann.talarico@jefferson.edu|
20540876|NCT03058692|Baylor College of Medicine|Robert L. Atmar, M.D.|713-798-6849|ratmar@bcm.edu|
20540877|NCT02477124|Duke University|Jennifer Gallagher|9199701551|jennifer.gallagher@duke.edu|
20540878|NCT03038126|University of Maryland Baltimore|Jeffrey C. Fink, MD MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
20540879|NCT02451917|Endocrinology Division, University of São Paulo Medical School,|Marcia Silva Queiroz, MD, PhD|+ 5511 26616293|marcia.queiroz@hc.fm.usp.br|
20540880|NCT01724866|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
20540881|NCT01340586|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20508162|NCT02581982|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|mgoodman@wakehealth.edu|
20526852|NCT00456508|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20526853|NCT04253782|Yale School of Medicine|Daniel Joseph, MD|(203) 785-4404|daniel.joseph@yale.edu|
20526854|NCT02294461|Astellas Pharma Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
20526855|NCT02389374|Menzies School of Health Research|Benedikt Ley|889468643|benedikt.ley@menzies.edu.au|
20526856|NCT00908596|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20526857|NCT02949908|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20526858|NCT01143064|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
20526859|NCT01661933|The Prince Charles Hospital|Dr John Croese. The Chief Investigator|+61733716164|jcroese@bigpond.com|
20526860|NCT01967641|New York State Psychiatric Institute|Dr. Maria A. Sullivan, M.D., Ph.D|646-774-6152|mas23@columbia.edu|
20526861|NCT03448939|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
20526862|NCT02332239|Department of Emergency Medicine, Alpert Medical School, Brown University|Megan L. Ranney, MD, MPH, FACEP|401-444-2557|megan_ranney@brown.edu|
20526863|NCT03488225|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD./ Professor|713-792-4764|ejabbour@mdanderson.org|
20526864|NCT01541839|University of Alberta|Dr. Erin Wright|780-407-7656|erin.wright@me.com|
20526865|NCT01472965|St. Jude Children's Research Hospital|Joshua Wolf, MBBS, BA|901-595-1475|joshua.wolf@stjude.org|
20526866|NCT01576003|Cincinnati Children's Hospital Medical Center|Conrad R. Cole, MD|513-636-6155|conrad.cole@cchmc.org|
20540882|NCT00411671|University of Texas (UT) MD Anderson Cancer Center|George Blumenschein, MD / Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
20540883|NCT01424501|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540884|NCT01980095|RedHill Biopharma|Dr. Ira Kalfus|1-917-817-7517|ira@redhillbio.com|
20540885|NCT04737278|BDL Biochemistry, consultant for Mitosynergy|Dr Barbara Leinweber, PhD|(520)334-5444|barb@bdlbiochem.com|
20540886|NCT03671213|Moximed, Inc.|Rose Weinstein, Director of Clinical Affairs|415-312-0255|rsweinstein@moximed.com|
20540887|NCT00889512|University Reproductive Associates|Dr. Peter G. McGovern|201-288-6330|mcgovepg@uranj.com|
20540888|NCT02363621|Sierra Eye Associates|Dr. Arshad Khanani|775-329-0286|Arshad.Khanani@gmail.com|
20540889|NCT01128244|University of Florida|Dr. Jesse F. Gregory|(352) 392-1991|jfgy@ufl.edu|225
20540890|NCT05690555|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
20540891|NCT03974945|Rocky Mountain Regional Department of Veterans Affairs|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
20540892|NCT04506502|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20540893|NCT01449006|St Vincent's Hospital, Sydney, Australia|Prof. Bruce Brew|61 2 8382 1111|bruce.brew@svha.org.au|4100
20540894|NCT03350815|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20540895|NCT03526146|San Francisco Veterans Affairs Health Care System, San Francisco, CA|Linda L. Chao|415-221-4810|linda.chao@ucsf.edu|24386
20540896|NCT03571555|Royal Holloway University of London|Dr. Michael Evangeli|00447801543681|michael.evangeli@rhul.ac.uk|
20540897|NCT01898429|Dartmouth Hitchcock Medical Center|Paul E. Holtzheimer, MD|603-650-4914|Paul.E.Holtzheimer@hitchcock.org|
20540898|NCT03829449|Akari Therapeutics Plc|Dr Wynne Weston-Davies|0208 004 6106|wynne.weston-davies@akaritx.com|
20540899|NCT03724890|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20554545|NCT02530619|Northwestern University, Feinberg School of Medicine|Brady L. Stein, MD|312-695-6832|bstein@nmff.org|
20554546|NCT01282710|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
20554547|NCT00786916|Akron Children's Hospital|Michael D. Reed, Pharm.D.|330-543-3193|MReed@chmca.org|
20570763|NCT00838929|Thomas Jefferson University|Wenyin Shi, MD, PhD|215-955-4111|Wenyin.Shi.@jefferson.edu|
20570764|NCT04101565|Johns Hopkins Dept of Pediatrics / Division of Adolescent/Young Adult Medicine|Dr. Arik Marcell|4432878946|amarcell@jhu.edu|
20570765|NCT04461158|Medical University of South Carolina|Dr. Jim C. Oates, MD, Rheumatology Division Director|843-792-1991|oatesjc@musc.edu|
20570766|NCT00699842|Thomas Jefferson University|Emmanuel Besa, MD|215-955-8874|Emmanuel.Besa@jefferson.edu|
20570767|NCT03595124|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
20570768|NCT04075903|University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology|Lesley Jackson, MD, MSPH|205-934-1779|lejackson@uabmc.edu|
20570769|NCT03607422|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20570770|NCT04832971|Arrowhead Pharmaceuticals, Inc.|Patrick O'Brien, Chief Operating Officer|626-304-3400|PObrien@arrowheadpharma.com|
20570771|NCT03584152|Stanford University|Sam P. Most, MD, MBA|(650) 724-8019|smost@stanford.edu|
20570772|NCT01351805|Brigham and Women's Hospital/ Harvard Medical School|Karen Costenbader|16177326088|kcostenbader@bwh.harvard.edu|
20570773|NCT00433511|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20570774|NCT02312557|Oregon Health & Science University|Rachel Slottke|503-494-6117|slottker@ohsu.edu|
20570775|NCT00742326|NIAID|Colleen Hadigan MD MPH|301-594-5754|hadiganc@niaid.nih.gov|
20570776|NCT00894504|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20570777|NCT06733103|University of East Anglia|Sophie Livsey|07947272186|sophie.livsey1@nhs.net|
20570778|NCT03698994|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20570779|NCT04620369|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu|
20570780|NCT03316807|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
20570781|NCT04042077|Menarini Ricerche S.p.A.|Corporate Director of Clinical Sciences|0555680|acapriati@menarini-ricerche.it|9990
20570782|NCT01080300|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
20570783|NCT01776008|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@dom.wustl.edu|
20570784|NCT01163474|Houston VA HSR&D|Donna Smith/Project Coordinator|(713)440-4423|Donna.Smithd19d7@va.gov|
20570785|NCT04530604|University of Michigan|Principal Investigator, Dr. Greg Yanik|734 232-9335|gyanik@med.umich.edu|
20570786|NCT02689453|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
20570787|NCT01162486|Johns Hopkins University School of Medicine|Dr. Kelly E. Dooley|410-955-3100|kdooley1@jhmi.edu|
20570788|NCT00953615|Mayo Clinic|Keith D. Lindor, M.D.|507-284-2969|lindor.keith@mayo.edu|
20570789|NCT03434028|Massachusetts General Hospital|PETAL Clinical Coordinating Center PI|617-872-2882|tthompson1@mgh.harvard.edu|
20570790|NCT02498236|University of California, Los Angeles|Dr. Stephen R. Marder|3104783711|SMarder@mednet.ucla.edu|83647
20570791|NCT02296892|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
20570792|NCT00585078|Beth Israel Deaconess Medical Center Beth Israel Deaconess|Rebecca Miksad MD MPH|617.667.2100|rmiksad@bidmc.harvard.edu|
20570793|NCT04198571|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570794|NCT01814072|Northwestern University Feinberg School of Medicine|Bonnie Spring, PhD, ABPP|312-908-2293|bspring@northwestern.edu|
20570795|NCT00383123|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570796|NCT04253119|MSD Pharmaceuticals LLC|Vladimir Achikyan, Medical Affairs Manager|79161981264|vladimir.achikyan@merck.com|
20570797|NCT03566979|Johnson & Johnson Worldwide|Steven Sacavage, Associate Director Clinical Research|215-273-8568|SSacavag@its.jnj.com|
20554548|NCT01807585|Medtronic Endovascular|Melissa Hasenbank, Clinical Research Director|707-525-0111|melissa.hasenbank@medtronic.com|
20554549|NCT02504645|ImmuPharma|CEO|+33 6 18 22 16 50|robert.zimmer@immupharma.com|
20554550|NCT01854554|UT MD Anderson Cancer Center|Dr. Caroline Chung, MD- VP, Chief Data Officer, Data Impact & Governance|(713) 745-5422|cchung3@mdanderson.org|
20554551|NCT02819726|Archigen Biotech Ltd|Medical Director|+44(0)20 3749 5000|info@archigenbio.com|
20554552|NCT00359762|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20554553|NCT02829034|University of Pennsylvania|Yuchi Han, PI of the study|215-615-3417|yuchi.han@uphs.upenn.edu|
20554554|NCT02613481|Yardley Dermatology Associates, PC|Director of Clinical Trials|2155796155|rfried@yardleyderm.com|
20554555|NCT01762761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20554556|NCT02317575|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20554557|NCT03465540|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20554558|NCT00088218|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
20554559|NCT01385059|City of Hope Medical Center|Dr. Sumanta Kumar Pal|626-359-8111|SPal@coh.org|
20554560|NCT01592708|UNC Chapel Hill|Dr. Jay Anderson, PI|919-966-5136|janderson@aims.unc.edu|
20554561|NCT02141516|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20554562|NCT03169153|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20554563|NCT02678039|Dartmouth-Hitchcock|Mark P. Yeager, MD|603-650-5922|mark.p.yeager@hitchcock.org|
20554564|NCT00658112|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
20554565|NCT01603875|Queen Saovabha Memorial Institute|Dr. Terapong Tantawichien|66225201614|terapong_tantawichien@hotmail.com|125
20554566|NCT01652716|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
20554567|NCT03390907|Penn State Milton S. Hershey Medical Center|Dr. John Levenick|717-531-3834|jlevenick@pennstatehealth.psu.edu|
20554568|NCT03077165|IlkosTherapeutic Inc.|Monique Champagne|450-680-3381|mchampagne@ilkostherapeutic.com|2910
20554569|NCT04028388|Modra Pharmaceuticals|M. Keessen|+31202050188|info@modrapharmaceuticals.com|
20554570|NCT02841644|Atrium Health|Vice Chair of Research|7043552000|Rachel.Seymour@atriumhealth.org|
20554571|NCT02584309|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-8475|bvantine@wustl.edu|
20554572|NCT00389818|AMC|Ronald Mitsuyasu, MD|310-557-1803|rmitsuya@mednet.ucla.edu|
20554573|NCT02430077|UT Southwestern Medical Center|Abhimanyu Garg|2146482895|Abhimanyu.garg@utsouthwestern.edu|
20554574|NCT02752048|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3294-4527|toiawase@taiho.co.jp|
20554575|NCT01312467|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
20554576|NCT00132769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554577|NCT01431508|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554578|NCT00129259|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20554579|NCT01092195|National Institutes of Health|Pamela Stratton MD|301-435-4068|strattop@mail.nih.gov|
20554580|NCT01609556|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20554581|NCT00139997|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
20554582|NCT02199691|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext 1#|Contact-US@sanofi.com|
20554583|NCT02969928|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
20554584|NCT04286594|McLean Hospital|Dr. Staci Gruber|617-855-2762|gruber@mclean.harvard.edu|
20554585|NCT00774995|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554586|NCT01736566|Brigham and Women's Hospital|Carrie Blout, Genetic Counselor Project Manager|617-264-5837|carrie.blout@gmail.com|
20554587|NCT01209624|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554588|NCT03117387|LUMC|Maarten Honing|+31715264038|g.h.m.honing@lumc.nl|
20554589|NCT03403634|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kristopher.Attwood@Roswellpark.org|
20554590|NCT03964454|RTI International|Yukiko Washio|9194852794|ywashio@rti.org|
20554591|NCT05955560|Becton, Dickinson & Company|Director of Clinical Affairs|551-225-1164|kirsten.hammitt@bd.com|
20554592|NCT01539291|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20554593|NCT04450264|Icahn School of Medicine at Mount Sinai|Dr. Jamilia Sly|212-824-7813|jamilia.sly@mssm.edu|
20554594|NCT01543256|Boston Scientific|Evelyne Ho|+1 508-683-4140|Evelyne.Ho@bsci.com|
20554595|NCT00822510|University of Arizona College of Nursing|Terry Badger, PhD, PMHCNS-BC, FAAN|520-626-6058|tbadger@email.arizona.edu|
20554596|NCT03985423|Sobi|Radmila Kanceva, MD|+4686972000|radmila.kanceva@sobi.com|
20554597|NCT03119766|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20554598|NCT02562755|SillaJen Biotherapeutics Inc.|Kyoung Soo Ha, Senior Medical Director|+1-415-281-8886|ksha@kr.sillajen.com|
20554599|NCT02034578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20554600|NCT01045447|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20554601|NCT00129987|Imperial College London|Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
20554602|NCT02318329|Five Prime Therapeutics|Medical Lead|415-365-5600|FPA144@fiveprime.com|
20554603|NCT01138124|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554604|NCT00466193|Purdue Pharma LP|Clinical Leader|800-733-1333||
20554605|NCT01614210|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
20554606|NCT01181921|Jan-Cil Spain|COUNTRY MEDICAL DIRECTOR|+34 91 7228043||
20570798|NCT04147858|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
20570799|NCT00794170|University of Pennsylvania|Karen Glanz|215-898-0613|kglanz@upenn.edu|
20540900|NCT02123823|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540901|NCT01870505|Memorial Sloan Kettering Cancer Center|Dr. Sarat Chandarlapaty, MD, PhD|646-888-4311|ChandarS@MSKCC.ORG|
20570800|NCT02615938|LMU/ Haunersches Kinderspital|Prof. Matthias Griese|+498944000|matthias.griese@med.uni-muenchen.de|57870
20570801|NCT06173687|Cochlear Limited|PRS Specialist|+612 9428 6555|cltd-prs-admin@cochlear.com|
20570802|NCT04121897|University of North Carolina at Chapel Hill|Dana McCarty, PT, DPT|919-843-8792|dana_mccarty@med.unc.edu|
20570803|NCT02810873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Mathew Thakur|215-503-7874|mathew.thakur@jefferson.edu|
20570804|NCT04683510|University of Tennessee Health Science Center|Principle investigator|(901)448-2383|mmart126@uthsc.edu|
20570805|NCT03771638|Bridge HIV, San Francisco Department of Public Health|Dr. Susan Buchbinder|628.217.7479|susan.buchbinder@sfdph.org|
20570806|NCT03375320|Dana-Farber Cancer Institute|Jennifer A. Chan, MD, MPH|617-632-6315|jang@partners.org|
20570807|NCT03348631|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20570808|NCT03388632|National Cancer Institute|Dr. Jiran Ahmed|240-781-4042|jibran.ahmed@nih.gov|
20570809|NCT01068210|Memorial Sloan Kettering Cancer Center|Dr. Lee Jones, PhD|646-888-8103|jonesl3@mskcc.org|
20540902|NCT02687139|Johns Hopkins University|Mohamad Allaf, MD|410-502-7710|mallaf@jhmi.edu|
20570810|NCT04556305|University of Illinois Chicago|Dr. Shannon Halloway|(312) 996-7800|sthallow@uic.edu|
20570811|NCT06314438|University of Washington|Principal Investigator|206-221-3595|stonew@uw.edu|
20570812|NCT05190770|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2342|markovaa@mskcc.org|
20570813|NCT03692052|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
20570814|NCT02325830|Cardiac Dimensions|Vice President of Clinica Affairs|425-605-5922|aswenson@cardiacdimensions.com|
20570815|NCT01806389|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
20570816|NCT04596540|Swedish Orphan Biovitrum AB (publ)|Blank Clinical Study Physician, MD|+46 8 697 20 00|medical.info@sobi.com|
20570817|NCT02950259|Earle A. Chiles Research Institute, Providence Cancer Institute|Dr. David B. Page|503-215-6588|david.page2@providence.org|
20570818|NCT04526665|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20570819|NCT05752474|Hebrew Rehabilitation Center, Hebrew SeniorLife|Dae Hyun Kim|6179715362|daehyunkim@hsl.harvard.edu|
20526867|NCT01393132|Wayne State Univeristy, Detroit, MI|Gabriel Sosne, MD|248-594-6702|gsosne@med.wayne.edu|
20526868|NCT00087126|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
20540903|NCT03254940|Duke University|Dr. Gary G. Bennett (PI/Dean of Trinity College of Arts & Sciences)|(919) 808-7821|gary.bennett@duke.edu|
20526869|NCT01432275|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
20526870|NCT01839799|University of Pennsylvania|Jennifer Louie, Program Manager|215-220-9668|Jennifer.Louie2@pennmedicine.upenn.edu|
20526871|NCT01935700|Kaohsiung Medical University Hospital|Dr. Zu-Yau Lin|88677317123|linzuyau@yahoo.com.tw|
20526872|NCT01935128|University of Toledo Medical Center|Michael A. Rees, MD, PhD|419 383-3961|michael.rees2@utoledo.edu|
20540904|NCT01350245|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
20526873|NCT00231283|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
20526874|NCT00772005|Cephalon, Inc.|Vice President, Clinical Research, CNS/Pain|1-800-896-5855||
20526875|NCT02203162|Montefiore Medical Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
20526876|NCT01044758|Johns Hopkins University School of Medicine|Gregory Krauss, M.D.|(410) 955-2822|gkrauss@jhmi.edu|
20526877|NCT02584959|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20526878|NCT00492817|The University of Texas MD Anderson Cancer Center|Amol J. Ghia, MD|(832) 628-7357|ajghia@mdanderson.org|
20526879|NCT02978859|Columbia University|Benjamin Izar|212 304 5871|bi2175@cumc.columbia.edu|
20540905|NCT01561053|Grifols|AMBAR clinical manager|+34 935712200|AMBARclinical@grifols.com|
20540906|NCT02104947|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540907|NCT01090063|Tufts Medical Center|Dr. Alice Gottlieb|617-636-7462|Agottlieb@tuftsmedicalcenter.org|
20540908|NCT02326233|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
20540909|NCT02484222|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|18017591058@163.com|
20540910|NCT03202134|AZSintJanAV|Jan Mulier|003250452490|jan.mulier@azsintjan.be|
20540911|NCT04698993|Draegerwerk AG & Co. KGaA|Dr Rainer Polzius|+498824514429|rainer.polzius@draeger.com|
20540912|NCT01298765|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
20540913|NCT02467842|SK bioscience|Hayoung Lee|+82-2-2008-2552|haylee@sk.com|
20540914|NCT03216746|UFParaná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
20540915|NCT00635882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20540916|NCT01320202|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
20540917|NCT04090242|Becton Dickinson|Edward Mahoney|978-901-7248|Edward.Mahoney@bd.com|
20540918|NCT02305238|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20540919|NCT02513472|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20540920|NCT01019369|Baylor College of Medicine|Anitra Beasley, MD, MPH|832-826-7318|anitra.beasley@bcm.edu|
20540921|NCT03747640|Florida State University|Hyochol Ahn, PhD, MSN, MS-ECE, MS-CTS, APRN, ANP-BC, FAAN|850-644-2647|hahn@fsu.edu|
20540922|NCT01711645|Vanderbilt Medical Center|Kathryn M. Edwards, MD|615-322-3078|Kathryn.edwards@vanderbilt.edu|
20570820|NCT00551746|Intermountain Healthcare|Benjamin D Horne, PhD, MPH|801-507-4708|Benjamin.Horne@imail.org|
20508163|NCT00405821|NIAID|Steven Reynolds|256-772-220-087|sjreynolds@niaid.nih.gov|
20508164|NCT02372097|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20508165|NCT04962503|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager|Tel: +61 3 9660 4900|mail@clinuvel.com|
20508166|NCT02148211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508167|NCT01425229|University of Heidelberg|Prof. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
20508168|NCT03148756|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20508169|NCT01376362|National Institutes of Health|Hatice Nida Sen, Principal Investigator, National Eye Institute|(301) 402-3254|senh@nei.nih.gov|
20508170|NCT00638924|Unicamp|Juliana Gomes Zabatiero||juzabatiero@yahoo.com.br|
20508171|NCT03788967|Senior Vice President Clinical Development|Angela Talley|857-242-1575|atalley@sperotherapeutics.com|
20526880|NCT00204477|University of Texas Medical Branch Galveston|Leejane W. Lu|(409)772-1011|llu@utmb.edu|
20540923|NCT02815644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540924|NCT00384332|University of Alabama at Birmingham|Candace Cromer|2059753442|clreed@uab.edu|
20540925|NCT00408434|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20540926|NCT00588354|Mayo Clinic|Dr. Marc A. Huntoon|(507) 284-2511|huntoon.marc@mayo.edu|
20540927|NCT01811186|Asan Medical Center|Hoseong Lee|82-2-3010-3521|hosng@amc.seoul.kr|
20540928|NCT02973516|Guerbet|Jing Hao, MD, Head of Global Medical Affairs and Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20540929|NCT02268994|Keryx Biopharmaceuticals, Inc.|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
20540930|NCT03850535|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20540931|NCT04230213|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540932|NCT00524472|Cleveland Clinic|Andra Duncan, MD|216 445-2372|DUNCANA@ccf.org|
20554607|NCT01992536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20554608|NCT03669081|University of Utah|Eryberto Martinez|801-581-2563|eddie.martinez@utah.edu|
20554609|NCT00389324|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
20554610|NCT02519504|Emory University|Judith Fridovich-Keil, PhD|404-727-3924|jfridov@emory.edu|
20554611|NCT02548962|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
20554612|NCT04831736|NYU Langone Health|Lisa Doan, MD|212-201-1004|Lisa.Doan@nyulangone.org|
20554613|NCT00652457|University of California, San Diego|Jody Corey-Bloom, MD, PhD|858-249-0574|jcoreybloom@ucsd.edu|
20554614|NCT03551938|University of Michigan|Dr. Rob Stephenson|734-763-1188|rbsteph@med.umich.edu|
20554615|NCT01925183|Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna|Markus Peck-Radosavljevic (Principal Investigator)|+43 1 40400|markus.peck@meduniwien.ac.at|47440
20554616|NCT01046110|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20554617|NCT00905580|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
20554618|NCT02159482|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
20554619|NCT01233817|Department of Physical Medicine and Rehabilitation, School of Medicine, University of Utah|Aga Lewelt MD, Principal Investigator|801-518-4572|aga@genetics.utah.edu|
20554620|NCT02753751|Yale University|Francis P. Wilson|2037376095|francis.p.wilson@yale.edu|
20554621|NCT01854827|University of Michigan|DCC PI|734-936-3585|mageej@med.umich.edu|
20554622|NCT00736996|University of Colorado|Robert S. Schwartz, M.D.|303-724-1919|robert.schwartz@ucdenver.edu|
20554623|NCT02667912|Tomsk National Research Medical Center of the Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
20554624|NCT04443218|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20554625|NCT02660944|Resolve Therapeutics LLC|James Posada|(208)7277010|jp@resolvebio.com|
20554626|NCT02843568|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
20554627|NCT03586999|University of Colorado|Brad Haverkos, MD|7208488698|brad.haverkos@cuanschutz.edu|
20554628|NCT01701375|Johns Hopkins University|Ivana Gojo, MD|410-502-7726|Igojo1@jhmi.edu|
20554629|NCT02807597|UT Southwestern Medical Center|Dr. Samuel Achilefu|314-362-8599|Samuel.Achilefu@UTSouthwestern.edu|
20554630|NCT02187016|Silverstone Research Group|Pejjmon Amini, DMD|702-901-444||
20554631|NCT02059148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20554632|NCT01525082|Stanford University|Shaheen Shagufta, Clinical Assistant Professor|650-725-6454|sshaheen@stanford.edu|
20554633|NCT04689737|Fundació de Lluita contra la SIDA, les Malalties Infeccioses i la Promoció de la Salut i La Ciència|Dr. Jose Molto Marhuenda|+34 934657897|jmolto@lluita.org|
20554634|NCT03880578|Klinikum Lüdenscheid|Professor Rolf Larisch, Director|‭+49 2351 46|rolf.larisch@klinikum-luedenscheid.de|3311
20554635|NCT04934670|Xenikos BV (no longer in business)|Ypke van Oosterhout, custodian of Sponsor|+31 611 0177 611|ypke@me.com|
20554636|NCT02921412|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|JVega2@coopervision.com|
20554637|NCT01528228|A.T. Still University|Corey Luebbering|660.626.2147|coreyluebbering@atsu.edu|
20526881|NCT00150800|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20526882|NCT03660475|Penn State Hershey Medical Center|Joseph Sassani, MD, MHA|717 531 8783|jsassani@pennstatehealth.psu.edu|
20526883|NCT01966068|Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|267-426-2304|fiks@email.chop.edu|
20526884|NCT02345460|Case Comprehensive Cancer Center|Dr. Davendra Sohal|216-444-8258|sohald@ccf.org|
20526885|NCT01790828|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540933|NCT01979133|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
20540934|NCT00486824|Stanford University|Dr. Deirdre Lyell|6507255720|dlyell@stanford.edu|
20540935|NCT02748070|Stanford University|Michael Chang|(650) 725-6500|michael.t.chang@stanford.edu|
20540936|NCT00240500|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540937|NCT00801398|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
20540938|NCT00534976|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20540939|NCT00861471|New York University Cancer Institute|Anna Ferrari, MD|212-731-5389|anna.ferrari@nyumc.org|
20540940|NCT02092025|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20540941|NCT02927938|Levine Cancer Institute|Dr. James Symanowski; Chair, Department of Cancer Biostatistics|9804422371|james.symanowski@atriumhealth.org|
20540942|NCT00264537|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
20540943|NCT02476006|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20540944|NCT01704404|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20540945|NCT03621657|University of Wisconsin-Madison|Dr. Nasia Safdar|608-263-1545|ns2@medicine.wisc.edu|
20540946|NCT02222610|Retina Consultants of Texas|Dr. Amy C. Schefler|(713) 524-3434|acsmd@retinaconsultantstexas.com|
20540947|NCT00615017|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
20540948|NCT00806988|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
20540949|NCT02232022|Northwell Health|Jeffrey M. Katz|516-562-3062|jkatz2@northwell.edu|
20540950|NCT04775953|Duke University|Thomas L. Holland, MD|919-613-4268|thomas.holland@duke.edu|
20540951|NCT01698814|Alcon Research, Ltd.|Terri Pasquine, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20540952|NCT03777059|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20540953|NCT00855959|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20540954|NCT05589610|Equillium, Inc.|Clinical Trial Manager|8582401200|clinicaltrials@equilliumbio.com|
20540955|NCT02607618|Motif BioSciences|Stephanie Noviello|908-432-7802|stephanie.noviello@motifbio.com|
20540956|NCT00368641|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20540957|NCT02214290|Texas Tech University|Dr. Arturo Figueroa|8068345587|arturo.figueroa@ttu.edu|
20540958|NCT02517541|Scientific and Regulatory affairs|Zenia M Størling|+45 49111869|dkzenst@coloplast.com|
20540959|NCT00699608|GlaxoSmithKline|GSK Response Center|866-435-7343||
20540960|NCT01136408|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20540961|NCT02828436|University of Minnesota|Manda Keller-Ross|612-625-3175|kell0529@umn.edu|
20540962|NCT04220554|University of Southern Denmark|Consultant, MD, PhD Mathias Tiedemann Svendsen|0045 61265827|mtsvendsen@health.sdu.dk|
20540963|NCT00566462|Eisai Call Center|Eisai Inc.|888-422-4743||
20540964|NCT03078556|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20540965|NCT03782701|Bascom Palmer Eye Institute|Dr. Wendy Lee|(305) 243-2020|wlee@med.miami.edu|
20540966|NCT04421482|NYU Langone Health|Nazeeh Hanna, MD|516-663-3853|Nazeeh.hanna@nyulangone.org|
20540967|NCT03010319|Integra LifeSciences|Andrew Tummon Director, Global Clinical Affairs|609-936-5490|andrew.tummon@integralife.com|
20540968|NCT02128724|University of Oxford|Stasya Ng|+441865 617083|octo-BKM120@oncology.ox.ac.uk|
20540969|NCT01442714|Stanford University|Dr. Bruno Medeiros|650-723-5007|brunom@stanford.edu|
20540970|NCT04306510|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20540971|NCT06068426|Cincinnati Children's|Dr. David Vitale|(513) 517-7040|David.Vitale@cchmc.org|
20540972|NCT04720417|Thomas Jefferson University|Rino Seedor, MD|215-955-8874|Rino.Seedor@Jefferson.edu|
20540973|NCT03329092|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20540974|NCT03314987|University of Louisville|Dr. Timothy O'Toole Associate Professor|15024190808|tim.otoole@louisville.edu|
20540975|NCT03574779|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20540976|NCT02751580|Sidney Kimmel Cancer Center at Thomas Jefferson University|Nicole Simone, MD|215-955-6702|nicole.simone@jefferson.edu|
20540977|NCT02588261|Astellas Pharma Global Development, Inc.|Senior Medical Director|1800 888-7704|astellas.resultsdisclosure@astellas.com|
20540978|NCT01915173|Massachusetts General Hospital|Michelle L. Dossett, MD, PhD, MPH|617-643-6034|mdossett@mgh.harvard.edu|
20540979|NCT03755882|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO- Director of clinical Sciences|904 443-1290|BPALL@its.jnj.com|
20540980|NCT00412243|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
20540981|NCT01073449|Dept. of Arrhythmology - Cliniche Humanitas Gavazzeni|Dr. Giosue Mascioli|+39 035 4204159|giosuemascioli@mac.com|
20540982|NCT01137032|Fougera Pharmaceuticals Inc.|Angela C. Kaplan, Associate Director Clinical Development|631-659-2256|angela.kaplan@sandoz.com|
20540983|NCT01746368|Tuscaloosa VA Medical Center (Retired)|Ann Mahaney-Price, DNP|205-409-8301|amparnp@yahoo.com|
20540984|NCT05636852|GE HealthCare|Paul Sherwin, MD, PhD|+1 (609) 510-3686|PaulSherwin@gehealthcare.com|
20540985|NCT01664182|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA 96161|Thomas J Semrad, MD, MAS|+1 530 582 6450|tsemrad@tfhd.com|
20540986|NCT01076036|Corindus, Inc|Michail M. Pankratov, MD, PhD, Vice President of Clinical & Regulatory Affairs|508-653-3335|Michail.Pankratov@Corindus.com|206
20540987|NCT02221674|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
20540988|NCT05292131|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20554638|NCT02255110|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20540989|NCT02557542|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
20540990|NCT04390880|VA Greater Los Angeles Healthcare System|Gholam Berenji, M.D.|310-268-3547|Gholam.Berenji@va.gov|
20508172|NCT04268303|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
20508173|NCT00355134|Novartis Pharmaceuticals|Study Director|862-778-8300||
20508174|NCT02979444|Northwestern University Feinberg School of Medicine|Darius Tandon, PhD|410-852-0399|dtandon@northwestern.edu|
20508175|NCT00741104|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20508176|NCT04306900|Trishula Therapeutics, Inc.|Executive Director|1-650-509-5732|info@trishulatx.com|
20508177|NCT03621189|Chang Gung Memorial Hospital|Dr. Hsing Chang Ni|886975365663|alanni0918@yahoo.com.tw|
20508178|NCT01135394|University of Maryland School of Medicine|Soren Snitker, MD, PhD|4107061511|ssnitker@som.umaryland.edu|
20508179|NCT04432376|Hill Dermaceuticals|Dr. Rosario G Ramirez, Medical Director|4073231887|nini.ramirez@hillderm.com|
20508180|NCT05742841|Wake Forest School of Medicine|Nick Ashburn|336-716-4646|n.ashburn@wakehealth.edu|
20508181|NCT02088541|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20508182|NCT00379236|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20508183|NCT00110591|CytoDyn, Inc.|Joe Meidling|360-980-8524|jmeidling@cytodyn.com|
20508184|NCT00801892|University of Pittsburgh|E. Chasens, PhD|412-624-9380|chasense@pitt.edu|
20526886|NCT00129727|Massachusetts General Hospital|Richard T Penson MD MRCP|617-726-5867|rpenson@partners.org|
20526887|NCT01553240|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
20526888|NCT00754208|University of Nebrasa Medical Center|Joan Daughton|402-552-6006|jdaughton@childrensomaha.org|
20526889|NCT01239212|Cincinnati Children's Hospital Medical Center|Dr. Stephanie Merhar|513-636-4200|stephanie.merhar@cchmc.org|
20526890|NCT00334633|University of Alabama at Birmingham|jane R Schwebke, MD|205-975-5665|schwebke@uab.edu|
20526891|NCT00656487|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20526892|NCT02637713|Montefiore Medical Center|Dr. Erin Moran-Atkin|718-920-4800|emoran2@montefiore.org|
20526893|NCT02847182|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
20526894|NCT02345889|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
20526895|NCT04325698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526896|NCT00962091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20526897|NCT00003910|ECOG Statistical Office|Study Statistician|617-632-3012||
20526898|NCT02326298|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20526899|NCT01768845|West Virginia Universtiy|Michael Craig, MD|304-293-4980|craigm@wvumedicine.org|
20526900|NCT02086682|Mayo Clinic|Dr. Marie Hogan|507-266 -1963|Hogan.Marie@mayo.edu|
20526901|NCT02044874|Arena Pharmaceuticals, Inc|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
20526902|NCT02889835|UAB School of Dentistry|Nathaniel Lawson DMD PhD|205-975-8302|nlawson@uab.edu|
20526903|NCT02987972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526904|NCT03153982|University of California, San Francisco|WIlliam Ryan, MD|(415) 502-1877|William.Ryan@ucsf.edu|
20526905|NCT01328548|McMaster University|Dr. Mark Loeb|905 515 9140|loebm@mcmaster.ca|26679
20526906|NCT03800836|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20526907|NCT00549601|Novartis Pharmaceuticals|Study Director|862-778-8300||
20526908|NCT00224406|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20526909|NCT01842906|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
20526910|NCT01556997|Symplmed Pharmaceuticals LLC|Jeff Feldstein, Sr. Vice President and CMO|888-552-9769|feldstein@symplmed.com|
20526911|NCT01010009|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
20526912|NCT01361113|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20526913|NCT01250171|Novartis Pharmaceuticals|Study Director|862 778-8300||
20526914|NCT03309696|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
20526915|NCT05070468|Alborz University of Medical Sciences|Dr. Masoumeh Farahani|09123783823|drfarahani73@yahoo.com|
20526916|NCT02607280|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20526917|NCT00078949|NCIC|Seninor Biostatistician for LY12|613-533-6000|bechen@ctg.queensu.ca|77703
20526918|NCT00577005|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
20526919|NCT01004432|Janssen Scientific Affairs, LLC|Study Director|215-325-4209|rdehorat@its.jnj.com|
20526920|NCT00590538|The Children's Hospital of Philadelphia|Ronald Rubenstein, MD, PhD|1-215-590-1281|rubensteinr@email.chop.edu|
20526921|NCT02309723|Tufts Medical Center|Dr.Yue Zhong, Project Director of Center for the Evaluation of Value and Risk in Health|6176361424|yzhong@tuftsmedicalcenter.org|
20526922|NCT01125813|Octapharma AG|Dr Sigurd Knaub|41 55 451 21 41|sigurd.knaub@octapharma.ch|
20526923|NCT05216991|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|renew.j@mayo.edu|
20526924|NCT02453282|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20526925|NCT02327013|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20526926|NCT00323037|CTI Clinical Trial and Consulting Services|Sandy Stagge, RN, BSN|513-619-1837|sstagge@ctifacts.com|
20526927|NCT02380859|Dartmouth-Hitchcock Medical Center|Stephen L. Lee, MD PhD|603-650-5104|stephen.l.lee@hitchcock.org|
20526928|NCT01565668|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
20526929|NCT04258254|University of Delaware|Anjana Bhat, Study PI|4435238680|abhat@udel.edu|
20526930|NCT02255552|Sarepta Therapeutics, Inc.|Medical Director|+1-800-690-2003|clinicaltrials@sarepta.com|
20526931|NCT01447446|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20526932|NCT02063178|University of Tennessee Health Science Center|Rebecca Krukowski|9014482426|rkrukows@uthsc.edu|
20526933|NCT04829331|Acera Surgical|Matthew MacEwan|440-477-1890|macewan@acera-surgical.com|
20540991|NCT01345188|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633242828|shammas@mchsi.com|
20540992|NCT00684775|"Johns Hopkins School of Medicine: Department of Psychiatry"|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20540993|NCT06041919|Thirty Respiratory Ltd|Inva Hoti|+44 (0) 1235 431200|Inva.Hoti@30.technology|
20540994|NCT04526145|Ohio State University|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
20540995|NCT04211441|Medtronic, Inc|Director of Clinical Research|800-328-2518|medttroniccastrials@medtronic.com|
20540996|NCT00577824|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20540997|NCT04531241|Johnson & Johnson Vision Care, Inc.|Meredith Bishop, OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
20540998|NCT02576795|BioMarin (UK) Ltd|Konstantia-Maria Chavele, PhD, Director, Clinical Sciences|+44 207-4203351|KonstantiaMaria.Chavele@bmrn.com|
20540999|NCT01635855|Merz Pharmaceuticals North America|Merz Pharmaceuticals North America|800-334-0514|clinicaltrials@merzusa.com|
20541000|NCT03190460|University of Washington School of Nursing|Dr. Hilaire Thompson|2066165641|hilairet@uw.edu|
20541001|NCT03400176|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20541002|NCT00966550|Illinois Institute of Technology|Dr. Britt Burton-Freeman|312-567-5307|bburton@iit.edu|
20541003|NCT01371734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541004|NCT00206440|Baylor College of Medicine|Mothaffar Rimawi|713 798 1999|rimawi@bcm.tmc.edu|
20541005|NCT00958165|CardioFocus, Inc|Burke T. Barrett|508 658-7200|bbarrett@cardiofocus.com|
20541006|NCT03565237|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20541007|NCT02021955|VA Puget Sound Health Care Sysem|Margaret Collins|206.764.2085|margaret.collins@va.gov|
20541008|NCT01140061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20570821|NCT04949802|ViaLase Inc.|Melvin Sarayba, MD|9494662856|melvin.sarayba@vialase.com|
20570822|NCT03267810|University of Miami|Elizabeth Felix|305-243-4497|efelix@med.miami.edu|
20541009|NCT00952393|University of Colorado|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
20570823|NCT00233480|Ahmanson-UCLA Cardiomyopathy Center|Tamara B Horwich, MD|310-825-8676|thorwich@mednet.ucla.edu|
20541010|NCT00428389|Novartis Pharmaceuticals|Study Director|862-778-8300||
20541011|NCT00766051|University of Utah at the time of the study|Lynne La Corte, PhD, OTR/L, OTD|970 4330981|lflacorte@independence.net|
20541012|NCT02708355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541013|NCT01098305|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
20541014|NCT01957410|Janssen Research & Development, LLC|Director||ClinicalTrialDisclosure@its.jnj.com|
20541015|NCT01746173|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
20541016|NCT03771274|Carolina Eyecare Physicians, LLC|Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
20541017|NCT01173601|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20541018|NCT05258149|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
20541019|NCT00476827|Duke University|Kimberly Blackwell, MD|919-668-1748|kimberly.blackwell@duke.edu|
20541020|NCT01466127|Massachusetts General Hospital|Elizabeth Hoge, M.D.|617-724-0859|ehoge@mgh.harvard.edu|
20541021|NCT00108862|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20541022|NCT03124836|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20541023|NCT01625000|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20541024|NCT00566852|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20541025|NCT01147055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541026|NCT01518374|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20541027|NCT00465452|The University of Toledo|Julia Spears|419-383-6728|julia.spears@utoledo.edu|
20541028|NCT03828019|JHSPH Center for Clinical Trials|Elizabeth E. Sugar|410-614-7837|esugar2@jhu.edu|
20541029|NCT05715242|Stanford University School of Medicine|Michele L. Patel, PhD|650-549-7047|michele.patel@stanford.edu|
20541030|NCT02343406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20541031|NCT04384523|Wuhan Healthgen Biotechnology Corp.|Daichang Yang|18602708398|dyang@oryzogen.com|
20541032|NCT00195663|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20541033|NCT03214406|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20541034|NCT04560075|University of Pittsburgh|Dr. Tina Goldstein|(412) 246-5604|goldtr@upmc.edu|
20541035|NCT04551950|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20541036|NCT04565951|Center to Improve Veteran Involvement in Care (CIVIC), HSR&D Center of Innovation, VA Portland Health Care System|Dr. Alan Teo|503-220-8262|alan.teo@va.gov|52461
20541037|NCT02748928|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
20541038|NCT03182907|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541039|NCT00429169|Columbia University/NYSPI|Michael F. Grunebaum, MD|212-543-5842|mfg14@columbia.edu|
20570824|NCT01443403|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20570825|NCT03258723|Yale School of Medicine|Marcella Nunez-Smith, MD, MHS|(203) 785-6454|marcella.nunez-smith@yale.edu|
20570826|NCT01107899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20570827|NCT00953771|Mount Sinai Beth Israel|Dr. Ilan Shapira|212-844-8948|Ilan.Shapira@mountsinai.org|
20541040|NCT02109809|Wake Forest University Health Sciences|Dr. Gordon Phillips|336-716-0659|gophilli@wakehealth.edu|
20541041|NCT01041521|Tufts University|Christine Wanke, Principal Investigator||christine.wanke@tufts.edu|
20541042|NCT03691662|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20541043|NCT00147316|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20541044|NCT00172042|Novartis Pharmaceuticals|Study Director|862-778-8300||
20541045|NCT01771250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20541046|NCT02058563|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541047|NCT01180296|Fetal Medicine Foundation?USA|David McKenna|937-208-4005|dsmckenna@mvh.org|
20541048|NCT00166439|Mayo Clinic|Patrick B. Johnston, M.D., Ph.D.|507/284-5362|johnston.patrick@mayo.edu|
20541049|NCT00483938|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20541050|NCT01718444|UIC|Albert Asante, MD MPH|3123552634|akdasante@yahoo.com|
20541051|NCT01511081|UT MD Anderson Cancer Center|Joe Chang, MD/Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
20541052|NCT00106353|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541053|NCT04039217|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
20541054|NCT01371552|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
20541055|NCT03364309|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20541056|NCT00615992|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20541057|NCT02328027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20541058|NCT03319212|Johnson & Johnson Vision Care, Inc.|Elizabeth Dow, OD, FAAO - Principal Research Optometrist|904-443-1061|edow1@its.jnj.com|
20541059|NCT00349778|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
20541060|NCT02465203|Novartis|Study Director|+41613241111||
20541061|NCT02387554|Bundang Seoul National University Hospital|Principal Investigator||mekka@snu.ac.kr|
20541062|NCT04072887|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20541063|NCT03193736|iSTAR Medical|Zubair Hussain, VP Clinical and Regulatory Affairs|+3210771658|zubair@istarmed.com|
20541064|NCT00856297|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20541065|NCT03369236|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|1 855-752-2356|clinicaltrials@alexion.com|
20541066|NCT02248636|Puget Sound VA|William Banks, Associate Chief of Staff for Research|206 764-2701|william.banks4@va.gov|
20541067|NCT00423449|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541068|NCT03294850|AdventHealth Translational Research Institute|Dr. Karen Corbin|(407) 303-7100|Karen.Corbin@AdventHealth.com|
20541069|NCT03334812|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20541070|NCT01153724|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20541071|NCT02697435|VAPHS|Debra Kaye Weiner, M.D.|412-360-2920|Debra.Weiner@va.gov|
20541072|NCT00870545|Memphis VAMC|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
20541073|NCT02178696|University of Michigan|Jon-Kar Zubieta||JONKAR.ZUBIETA@hsc.utah.edu|
20541074|NCT02508428|Anderson Orthopaedic Research Institute|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
20541075|NCT02859441|National Institutes of Health|Henry E Wiley, M.D., Principal Investigator, NEI|301-496-6583|wileyhe@nei.nih.gov|
20541076|NCT04338971|Neurolutions|Director of Clinical Affairs|831-316-5466|lsouders@neurolutions.com|
20541077|NCT04371666|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-093DMDStudy@fibrogen.com|
20541078|NCT03228212|Johnson & Johnson Vision Care Inc.|John Buch -SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
20541079|NCT00999544|University of Kentucky|Dr. Sharon Walsh|859-257-6485|sharon.walsh@uky.edu|
20541080|NCT01392547|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20541081|NCT02936635|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
20541082|NCT00447226|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541083|NCT02309944|Masonic Cancer Center, University of Minnesota|Deanna GK Teoh|612-626-3111|dkteoh@umn.edu|
20541084|NCT03049917|University of Washington|Dr.|206-422-5564|jsyker@uw.edu|
20541085|NCT00584012|Holden Comprehensive Cancer Center|Cena Jones-Bitterman|319-353-4596|cena-jones@uiowa.edu|
20541086|NCT04404556|Cincinnati Children's Hospital Medical Center|Avani Modi, Ph.D.|513-636-4864|avani.modi@cchmc.org|
20541087|NCT02871635|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20541088|NCT00502671|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20554639|NCT02328326|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Dr. Ann-Marie Rosland|4123602259|Ann-Marie.rosland@va.gov|
20554640|NCT01194674|National Institutes of Health|H. Nida Sen, Principal Investigator, National Eye Institute|301-402-3254|senh@nei.nih.gov|
20554641|NCT01748994|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
20554642|NCT03433456|University of Alabama at Birmingham|Dr. Gareth Dutton|205.934.6876|gdutton@uabmc.edu|
20554643|NCT04496258|University of Denver|Kateri McRae|3038713632|Kateri.McRae@du.edu|
20570828|NCT00974259|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
20541089|NCT00681629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20541090|NCT03796637|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
20541091|NCT01510158|Ardea Biosciences, MD|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
20570829|NCT03991741|University of California, San Diego|Gregory Daniels, MD, PhD|(858) 822-5354|CancerCTO@health.ucsd.edu|
20541092|NCT00832416|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20526934|NCT02718248|Ottawa Hospital Research Institute|Sarah MacLean|6137378899|samaclean@ohri.ca|73011
20526935|NCT01313494|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20554644|NCT03251924|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20554645|NCT00153101|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554646|NCT03424681|Mind Research Network|Dr. Claire Wilcox|5052725028|cwilcox@mrn.org|
20554647|NCT01175226|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
20554648|NCT01440946|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
20554649|NCT03299192|Kaiser Permanente|Rene Hawkes, Project Manager|206-287-2073|rene.j.hawkes@kp.org|
20554650|NCT03291613|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
20554651|NCT00983580|Mayo Clinic|Frank A. Sinicrope, M.D.||sinicrope.frank@mayo.edu|
20554652|NCT04737538|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20554653|NCT01218997|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
20554654|NCT04382612|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
20554655|NCT01328002|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20554656|NCT03149328|University of Alberta|Dr. Kara Schick-Makaroff|1-780-492-9043|kara.schickmakaroff@ualberta.ca|
20554657|NCT01222585|Duke Clinical Research Institute|Michael Cohen-Wolkowiez, MD|919668-8812|michael.cohenwolkowiez@dm.duke.edu|
20554658|NCT01443442|SCCO at MBKU|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
20554659|NCT01306617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20554660|NCT01578551|Johns Hopkins University|David Ettinger, MD|410-955-8847|ettinda@Jhmi.edu|
20554661|NCT02780349|Gardia Medical|Vardit Segal Ph.D|972-4-6277166|vardit@gardiamedical.com|
20554662|NCT05204134|Tandem Diabetes Care|Supervisor Clinical Operations|+18778016901|clinicalaffairs@tandemdiabetes.com|
20554663|NCT02788175|NIAID|Dr. Michael C. Sneller|301-496-0491|MSNELLER@niaid.nih.gov|
20554664|NCT00162136|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20554665|NCT00818441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554666|NCT03320070|Mallinckrodt|Medical Information Call Center|1-800-844-2830|medInfo@mnk.com|
20554667|NCT02212028|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
20554668|NCT00272168|VA Central Office|Wendy Tenhula, Ph.D.|202-461-4167|Wendy.Tenhula@va.gov|
20526936|NCT02604550|Emory University|John Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
20526937|NCT01404208|MGH|Dr. Daniel Geller|617 724 5141|dan.geller@mgh.harvard.edu|
20526938|NCT03747302|Norris Cotton Cancer Center|Dr. Ardis Olson|603-643-2385|Ardis.Olson@dartmouth.edu|
20526939|NCT01032070|Astellas Pharma Global Development, Inc|Senior Medical Director, Medical Oncology||ClinicalTrials.Disclosure@us.astellas.com|
20526940|NCT00583375|Wright Medical|Stephen Roach|615-656-7466|Stephen.Roach@wright.com|
20526941|NCT03769675|Mayo Clinic|Narayan R. Kissoon, M.D.|507-284-4961|Kissoon.Narayan@mayo.edu|
20526942|NCT02772276|MediBeacon|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
20526943|NCT00738062|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20526944|NCT01099774|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20526945|NCT02248974|Baylor College of Medicine|Dr. Jennifer Blumenthal-Barby|(713) 798-3785|jennifer.blumenthal-barby@bcm.edu|
20526946|NCT00894790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20526947|NCT04093492|Medical College of Wisconsin|Dr. Mir A Basir|414-266-6820|mbasir@mcw.edu|
20526948|NCT02945254|Brigham and women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
20526949|NCT00783224|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20526950|NCT01711619|Medtronic|Global Clinical Study Manager||medtronicneurotrials@medtronic.com|
20541093|NCT02114606|University of North Carolina at Chapel Hill|Evan Dellon, MD|919-966-2511|evan_dellon@med.unc.edu|
20541094|NCT05786508|University of Minnesota|Brent Leininger|6126266477|lein0122@umn.edu|
20541095|NCT04426318|Center for Healthy Minds|Matthew Hirshberg|608-262-0035|hirshberg@wisc.edu|
20541096|NCT04829916|Guard Therapeutics|Head of Clinical Operations|+46733319438|trials@guardtherapeutics.com|
20541097|NCT01761019|Department of Dermatology, University of Pittsburgh School of Medicine|Laura K. Ferris, MD, PhD|412-647-2013|ferrlk@upmc.edu|
20541098|NCT03781778|Fred Hutchinson Cancer Research Center|Marian L. Neuhouser, PhD|2066674797|mneuhous@fredhutch.org|
20541099|NCT02287467|NIAID|Dr. Richard Davey|301-496-8029|rdavey@niaid.nih.gov|
20541100|NCT03106636|University of Oregon|Dr. Philip Fisher|541-346-4968|philf@uoregon.edu|
20541101|NCT00225498|Feinstein Institute for Medical Research, Zucker Hillside Hospital|Anil K. Malhotra, MD|718-470-8012|malhotra@lij.edu|
20541102|NCT02152761|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20554669|NCT01075321|Mayo Clinic|Craig B. Reeder MD|480.301.8000|Reeder.Craig@mayo.edu|
20554670|NCT00262834|SKCCC|Vered Stearns|4432876489|vstearn1@jhmi.edu|
20554671|NCT01800877|Centre de Recherche du CHUS|Marie-Hélène Masse|819-346-1110|marie-helene.masse3@usherbrooke.ca|14173
20526951|NCT00334802|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20526952|NCT03422159|Community Medical Center Department of Critical Care, Department of Nephrology|Jose Iglesias, DO|732-557-8070|jiglesias23@gmail.com|
20554672|NCT00003457|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20526953|NCT03436199|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
20526954|NCT04742309|University of California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
20526955|NCT00503997|Vanderbilt-Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
20526956|NCT01195844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526957|NCT01118988|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|310-825-0731|LZeltzer@mednet.ucla.edu|
20526958|NCT01836809|Virginia Commonwealth University|Keyur Shah, MD|804-828-4571|kshah@mcvh-vcu.edu|
20526959|NCT01225289|Tehran University of Medical Sciences|The Study of the Effects of Vitamin A Supplementation on Immune System and Th1/Th2 Balance in Patien|+98 912 2182815|sjafarirad@gmail.com|
20526960|NCT00336323|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Name/Official Title: Adam Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
20526961|NCT01037127|GlaxoSmithKline|GSK Response Center|866-435-7343||
20526962|NCT01834716|Mayo Clinic|Neill Graff-Radford|9049537103|graffradford.neill@mayo.edu|
20526963|NCT05072964|FARAPULSE|Allison Anderson|651-582-5077|Allison.Anderson@bsci.com|
20526964|NCT01726036|TriHealth|Rachel G. Sinkey MD - PI|513-862-6918|pam_plummer@trihealth.com|
20526965|NCT01047332|Brigham and Women's Hospital|Dr. David L. Carr-Locke, MD, FRCP||dcarrlocke@chpnet.org|
20526966|NCT00291161|Houston HSRD Center of Excellence|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
20526967|NCT03521817|Pennington Biomedical Research Center|John W Apolzan|225-763-2827|john.apolzan@pbrc.edu|
20526968|NCT00778102|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20526969|NCT04149574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20526970|NCT04506905|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526971|NCT00073983|SARC|SARC Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
20526972|NCT04010747|Boston Medical Center & BU Chobanian & Avedisian School of Medicine|Emily R Kline, PhD|401-206-0586|emily.kline@bmc.org|
20526973|NCT03976323|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20526974|NCT03200847|University of Colorado Hospital|Dr. Martin McCarter|13037242725|martin.mccarter@cuanschutz.edu|
20526975|NCT02554318|Medical Faculty Wijaya Kusuma Surabaya|Dr. Budhi Setiawan|+6287751644522|nehesa@gmail.com|
20526976|NCT05765253|Argon Medical Devices|Danyel Carr|469-731-1421|Danyel.Carr@argonmedical.com|
20526977|NCT00085098|Children's Oncology Group|Results Coordinator|(626) 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20526978|NCT01886781|University of Stellenbosch, South Africa|Cheryl Stevenson|0827514411|cheryl@retaildc.co.za|
20526979|NCT04812795|University of Pennsylvania|Dr. Andy Tan|2157466546|andy.tan@asc.upenn.edu|
20526980|NCT03887117|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20526981|NCT03526055|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
20526982|NCT00513357|University of Texas MD Anderson Cancer Center|Dr. Egidio Del Fabbro|713-563-4157|ammarin@mdanderson.org|
20526983|NCT01162122|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20526984|NCT02020512|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20526985|NCT01001806|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
20526986|NCT00878605|VA Greater Los Angeles Healthcare System|Dr. Zhaoping Li, Section Chief|310-268-3528|zhaoping.li@va.gov|
20526987|NCT02787057|Peking University First Hospital|Dr. Jie Dong|+86 010 66551708|jie.dong@bjmu.edu.cn|
20526988|NCT03442699|Hartford Hospital/Institute of Living|David Tolin, Ph.D.|860-545-7685|david.tolin@hhchealth.org|
20526989|NCT03301844|NTC srl|Alessandro Colombo|+39 02 4385 0490|alessandro.colombo@ntcpharma.com|
20526990|NCT05087966|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
20526991|NCT01914159|Dept of Ophthalmology, University of Bonn, Bonn, Germany|Tim U. Krohne, MD, FEBO|+49 228 287|krohne@uni-bonn.de|15505
20526992|NCT02292186|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20554673|NCT02246998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20554674|NCT02473614|University of California at Irvine|Dr. Kelli Sharp|9495107968|ksharp@uci.edu|
20554675|NCT01075074|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
20554676|NCT02416791|Neurostimulation Laboratory, Hospital das Clínicas/São Paulo University, Brazil|Professor Adriana Bastos Conforto|+55 11 2661-7955|adriana.conforto@hc.fm.usp.br|
20554677|NCT01054729|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20554678|NCT00844194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554679|NCT00562159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20554680|NCT00659165|Univ NM|Mark Burge|505-272-4658|mburge@salud.unm.edu|
20554681|NCT03907501|UCSD School of Medicine|Dr. Christine Tara Peterson|7033959377|chpeterson@health.ucsd.edu|
20554682|NCT03326999|Icahn School of Medicine at Mount Sinai|Dr. Christina Jeng|212-241-6426|christina.jeng@mountsinai.org|
20554683|NCT01659021|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20554684|NCT04729803|palo alto university|Dr. Mikael Rubin|650-433-3805|mrubin@paloaltou.edu|
20554685|NCT01114646|Hartford Hostpial|Arben Ademi, CCRP|860-972-3561|arben.ademi@hhcealth.org|
20554686|NCT05734846|CooperVision Inc.|Percy Lazon de la Jara BOptom PhD|+1-925-251-6682|PLazon@coopervision.com|
20541103|NCT04343755|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20541104|NCT03101254|Dana-Farber Cancer Institute|Dr. Elizabeth Buchbinder|6176325055|elizabeth_buchbinder@dfci.harvard.edu|
20541105|NCT01290757|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20541106|NCT00352001|CCCC|Dr. Mikkael Sekeres|216-445-9353|sekerem@ccf.org|
20541107|NCT02021643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20541108|NCT00900666|Mary Free Bed Rehabilitation Hospital|Krisanne B. Chapin, PhD|616-493-9831|krisanne.chapin@maryfreebed.com|
20541109|NCT05280717|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20541110|NCT01588444|UT Health Sci Ctr San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
20541111|NCT05888181|UZ Leuven|Patrick Verschueren|003216342541|patrick.verschueren@uzleuven.be|
20541112|NCT01070173|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
20541113|NCT04300309|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20541114|NCT03035331|Mayo Clinic|Yi Lin|507-293-5189|Lin.Yi@mayo.edu|
20541115|NCT02314221|VA RR&D National Center for the Medical Consequences of Spinal Cord Injury|Ann M. Spungen, EdD|718-584-9000|ann.spungen@va.gov|5814
20541116|NCT05725746|Washington University in St. Louis|Cindy Schwarz|314-935-3063|cschwarz@wustl.edu|
20541117|NCT04607837|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
20541118|NCT02362464|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|maengh@mail.nih.gov|
20541119|NCT03453489|Barbara Ann Karmanos Cancer Institute|Anthony F. Shields, MD, PhD|313-576-8735|shieldsa@karmanos.org|
20541120|NCT03375489|Massachusetts General Hospital|Jennifer Temel, MD|617-724-4000|jtemel@mgh.harvard.edu|
20541121|NCT04030520|University of California San Francisco|Dr Rachel King|+256785304516|rachel.king@ucsf.edu|
20541122|NCT04209205|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20541123|NCT03427749|University of Ottawa Heart Institute|Dr. Terrence Ruddy|613-696-7267|truddy@ottawaheart.ca|
20541124|NCT05747027|Endeavor Health|Urogynecology Research Coordinator|847-570-4729|JLee5@northshore.org|
20541125|NCT03071393|University of Florida|Emily Fox, Principal Investigator|904-742-2500|ejfox@phhp.ufl.edu|
20541126|NCT03657849|Regions Hospital|Meghan O'Brien / Study Coordinator|612-437-1141|meghan.e.obrien@healthpartners.com|
20541127|NCT00048347|NIAID|Peter Mannon, MD|205-934-4726|pmannon@uab.edu|
20541128|NCT00548145|Osaka University Hospital|Hiroaki Kazui,Ph.D.|81-6-6879-3051|kazui@psy.med.osaka-u.ac.jp|
20541129|NCT00874848|Biothera|Jamie Lowe, Vice President, Clinical Development|651-256-4653|jlowe@biothera.com|
20541130|NCT03089541|Yale School of Medicine|Dr. Deepa Camenga, Principal Investigator|12037378310|deepa.camenga@yale.edu|
20541131|NCT02324816|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20541132|NCT05169424|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20541133|NCT00858637|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20541134|NCT01380834|Children's Hospital of UPMC|Dr. Mihaela Visoiu|412-692-5260|visoium@upmc.edu|
20541135|NCT00604695|Brigham & Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
20541136|NCT01898013|Durham VA Medical Center|Jennifer C. Naylor, PhD|9192860411|jennifer.naylor2@va.gov|
20541137|NCT01100775|University of Maryland Baltimore|Ms. Dawn Detamore|410 402 6820|DDetamore@som.umaryland.edu|
20541138|NCT04677504|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20541139|NCT00112125|Impulse Dynamics (USA) Inc|Angela Stagg, Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
20541140|NCT00167310|UPittsburgh|Dr. Jeffrey K. Yao, Research Professor|412-360-6781|jkyao@pitt.edu|
20541141|NCT04522141|Lucerne University of Applied Sciences and Arts|Dr. Mirjam Stieger|0041798852810|mirjam.stieger@hslu.ch|
20541142|NCT03052049|Northwestern Medical Group|Jennifer Karp RN|312-926-5289|jkarp@nm.org|
20541143|NCT03304873|NYU Grossman School of Medicine|Jennifer Lighter, MD|212-263-5454|Jennifer.Lighter@nyulangone.org|
20541144|NCT01895959|University of California, San Francisco|Xiaojuan Li, PhD|415-353-4909|Xiaojuan.li@ucsf.edu|
20541145|NCT01868477|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20541146|NCT00042991|Operations and Biostatistics Center for Pediatric Brain Tumor Consortium (PBTC)|Mehmet Kocak|9015952947|mehmet.kocak@stjude.org|
20541147|NCT02022436|University of Pittsburgh Medical Center|Rabih Chaer|4128023025|chaerra@upmc.edu|
20541148|NCT00367835|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20541149|NCT01574651|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20541150|NCT03887221|Zambon S.p.A.|Valentina Zanin|+39 02 665241|valentina.zanin@zambongroup.com|
20541151|NCT00445770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541152|NCT00947115|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20541153|NCT03274856|GLWL Research Inc|Caroline Fortier|1.514.708.4417|caroline.fortier@glwlresearch.com|
20541154|NCT02123576|The Pennsylvania State University Division of Gastroenterology and Hepatology Milton S. Herhsey Medical Center|Dr. Jonathan G. Stine|717-531-0003|jstine@pennstatehealth.psu.edu|28-9478
20541155|NCT02395614|Vanderbilt university medical center|Dr. Kent K. Higdon|615-936-0160|kent.hidgon@vumc.org|
20541156|NCT00934128|The University of Texas (UT) MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC||HMoreno@mdanderson.org|
20541157|NCT04649177|BostonSight|Daniel Brocks, MD|(781)726-7337|ecrowley@bostonsight.org|
20541158|NCT01985425|Population Health Research Institute|Dr. Philip Devereaux|905-527-4322|philipj@mcmaster.ca|40654
20541159|NCT02834247|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20541160|NCT01807299|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
20541161|NCT00811174|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
20541162|NCT01938040|Rutgers/State University of New Jersey (NJMS)|Alex Bekker, MD, PhD|973 972-5007|bekkeray@njms.rutgers.edu|
20541163|NCT02029911|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
20541164|NCT00763386|Zimmer|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
20541165|NCT01402817|Indiana University School of Medicine - Pediatrics|Chie-Schin Shih, MD|317-948-8568|shih2@iu.edu|
20541166|NCT00412893|Astellas Pharma Global Development, Inc.|Medical Head Immunology, Transplant and Infectious Disease Therapeutic Area||resultsdisclosure@astellas.com|
20541167|NCT00853151|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20541168|NCT01751984|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20541169|NCT02274792|Amgen Inc.|Study Director|866-572-6436||
20541170|NCT01999400|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
20541171|NCT01023711|University of Rochester|John Treanor, M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
20541172|NCT04587050|Imperial College london|Dr Tamara Elliott|02075946230|te04@ic.ac.uk|
20541173|NCT01957202|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541174|NCT01456169|Takeda GlobalResearch and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20541175|NCT02292446|Novaratis Pharmaceuticals|Study Director|888-669-6682|novartis.email@novartis.com|
20541176|NCT00935311|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20541177|NCT02652156|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
20541178|NCT01822457|Imperial Vascular Unit|Mr Pasha Normahani|+44 (0) 20 759 48904|pnormahani@gmail.com|
20541179|NCT02223338|Loma Linda University|Dr. David Sierpina|9095582154|dsierpina@llu.edu|
20541180|NCT00496080|Ethicon|Piet Hinoul MD|908-218-2585|phinoul@its.jnj.com|
20541181|NCT04098809|Benaroya Research Institute at Virginia Mason|Dr. Andrew Stamm|206-223-6772|Andrew.Stamm@virginiamason.org|
20541182|NCT01200368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541183|NCT00570310|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541184|NCT00759161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541185|NCT00479336|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20541186|NCT02741596|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20541187|NCT03329846|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20541188|NCT03066193|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
20541189|NCT02631551|Glenmark Pharmaceuticals Ltd.|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20541190|NCT02859246|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-4331|Reza_Dana@meei.harvard.edu|
20541191|NCT00080301|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20541192|NCT01196026|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570830|NCT01007110|University of Kansas Medical Center|Kathleen Gustafson, Ph.D.|(913) 588-0065|kgustafson@kumc.edu|
20570831|NCT03377361|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20570832|NCT00794924|Kaplan-Harzfeld Geriatric Medical Center|Hilla Zaharoni|97288595350|hilla_z@clalit.org.il|
20570833|NCT03274895|SIFI SpA|Dr. Jelle Kleijn|+31615643708|jelle.kleijn@sifigroup.com|
20570834|NCT01294436|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20570835|NCT02389764|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
20570836|NCT01267240|Princess Margaret Cancer Centre|Dr.Eric Chen, Principal Investigator|416-946-4501|eric.chen@uhn.ca|2263
20570837|NCT04674189|CureVac SE|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
20570838|NCT01637077|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-1623|loprinzi.charles@mayo.edu|
20570839|NCT02638103|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20570840|NCT01358331|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure||ClinicalTrialsDisclosure@merck.com|
20570841|NCT04907357|Medical University of South Carolina|Kathleen Brady, MD, PhD|843-792-5205|bradyk@musc.edu|
20570842|NCT03342196|University Hospitals, Case Comprehensive Cancer Center|Principle Investigator|216-844-0139|Leland.Metheny@uhhospitals.org|
20570843|NCT00546078|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570844|NCT02121912|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|
20570845|NCT03995225|Yale School of Medicine|Kathleen A Garrison|415-260-8618|kathleen.garrison@yale.edu|
20570846|NCT03358238|University of Wisconsin-Madison|Amy Cochran|608-262-0772|cochran4@wisc.edu|
20570847|NCT01431950|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570848|NCT01210651|UCSF|Sudha Prathikanti, MD|415-516-3867|sudha.prathikanti@gmail.com|
20570849|NCT01740154|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
20570850|NCT05723263|University of North Carolina at Chapel Hill|Joseph Tucker, MD, PhD|919-966-2536|jdtucker@med.unc.edu|
20570851|NCT03358472|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20570852|NCT03974022|Dizal Pharmaceuticals|Li Zheng|862161097899|clinicaltrials@dizalpharma.com|
20570853|NCT04013971|Emory University|Trisha Kesar, PT, PhD|404-712-5803|tkesar@emory.edu|
20508185|NCT00962754|Princess Amalia Children's Clinic, Isala Klinieken|Dr. J. Bekhof|0031-38-4245050|j.bekhof@isala.nl|
20508186|NCT01711541|Alliance for Clinical Trials in Oncology|Everett E. Vokes, M.D.|773-702-9306|evokes@medicine.bsd.uchicago.edu|
20508187|NCT00728936|Idera Pharmaceuticals, Inc|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20508188|NCT00438464|University of Texas (UT) MD Anderson Cancer Center|Jeri Kim, MD / Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
20570854|NCT02520310|Abbott Structural Heart|Sripad Bellary|650-353-1726|sripad.bellary@abbott.com|
20508189|NCT03943446|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20570855|NCT01340014|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20570856|NCT05032066|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20541193|NCT04034004|UC San Diego|Dr. Fadel Zeidan|858-246-8342|zeidanlaboratory@ucsd.edu|
20541194|NCT02486016|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchomb (PI)|410-706-2646|astinchc@rx.umaryland.edu|
20541195|NCT04317040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541196|NCT03672292|Scynexis|David Angulo|201-884-5471|David.Angulo@scynexis.com|
20541197|NCT00799903|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541198|NCT02518971|Michigan Medicine|Andrew Urquhart|734-936-6636|andrewu@med.umich.edu|
20541199|NCT03088917|Radboudumc|Prof. dr. J.P.H. Drenth|0031243613999|joost.drenth@radboudumc.nl|
20541200|NCT00757237|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
20541201|NCT00947271|The Miriam Hospital|Dr. Michael Carey|401-793-8218|michael_carey@brown.edu|
20541202|NCT00490269|Uniformed Services University for the Health Sciences|Dr. Lou Cantelina|301-295-3240|louis.cantelina@usuhs.edu|
20541203|NCT05150990|University of California Santa Barbara|Dr. Nancy Collins|805-568-0042|ncollins@ucsb.edu|
20541204|NCT00779025|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20541205|NCT01022138|Karmanos Cancer Institute|Dr. Abhinav Deol|313-576-8093|deola@karmanos.org|
20541206|NCT01397461|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
20541207|NCT05139927|NYU|Marya Gwadz, PhD|917-863-2125|mg2890@nyu.edu|
20541208|NCT05729568|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20541209|NCT04181762|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20541210|NCT00632619|Florida International University|James G Waxmonsky|305 348 3258|jwaxmons@fiu.edu|
20541211|NCT02440685|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
20541212|NCT01221350|Centro Universitario de Ciencias de la Salud, Mexico|Fernando R Siller Lopez, Ph.D.|523310585200|fsiller@cucs.udg.mx|33723
20541213|NCT01514201|St. Jude Children's Research Hospital|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
20541214|NCT02352844|Washington University School of Medicine|Saiama Waqar, M.D.|314-362-5737|saiamawaqar@wustl.edu|
20541215|NCT00590863|Univeristy of Texas Southwestern Medical Center, Dallas|Madhukar H. Trivedi, M.D.|214-648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
20541216|NCT02735343|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20541217|NCT03054649|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20541218|NCT00637416|University of Kansas Medical Center|Director, ENT Clinical Research|(913) 588-7154|ksykes@kumc.edu|
20541219|NCT03318016|University of Colorado Hospital|Daniel Pollyea, MD Associate Professor|720-848-8084|daniel.pollyea@cuanschutz.edu|
20541220|NCT01717001|University of Tennessee|Rebecca Robertson|865-974-2093|rrober28@utk.edu|
20541221|NCT02534909|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20541222|NCT01804881|North York Family Health Team|Principal Investigator|4164943003|dsouthgate@nyfht.com|130
20541223|NCT00132808|Novartis Pharmaceuticals|Study Director|862-778-8300||
20541224|NCT03165916|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
20541225|NCT02403999|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20541226|NCT03830359|Laboratoires Thea|ESTRADE|0635156453|marielle.estrade@theapharma.com|
20541227|NCT02715609|Washington University School of Medicine|Dr. Jiayi Huang|314-362-8516|jiayi.huang@wustl.edu|
20541228|NCT00362648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541229|NCT02204072|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20541230|NCT03983304|Zeltiq Aesthetics|Lori Brandt, Director, Clinical Trial Management|925 621-7460|lori.brandt@abbvie.com|
20541231|NCT00310817|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20541232|NCT00799435|Baylor|David Aguilar, MD|713-798-0280|daguilar@bcm.edu|
20541233|NCT03319134|UT Dallas|Clinical Trial Manager|9723337277|Sarah.McLeod@utdallas.edu|
20541234|NCT01587040|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20541235|NCT00432341|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20541236|NCT04346654|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20541237|NCT05870865|TrialSpark|TrialSpark|Please Email|soothe.info@trialspark.com|
20541238|NCT01594931|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
20541239|NCT04683835|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
20541240|NCT02407223|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20570857|NCT05564637|Mayo Clinic|Yogesh Reddy, M.B.B.S.|507-284-2904|reddy.yogesh@mayo.edu|
20570858|NCT04577573|James J. Peters VA Medical Center|Noam Y. Harel, MD, PhD|718-584-9000|noam.harel@va.gov|1742
20570859|NCT04297618|Centre for Ocular Research and Education|Jill Woods|(519) 888-4567|jwoods@uwaterloo.ca|36743
20570860|NCT04704219|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20570861|NCT00217737|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20570862|NCT04581343|PanCAN|Samantha Pedersen, Sr. Director Clinical Operations|310.706.3726|spedersen@pancan.org|
20570863|NCT03213704|Children's Oncology Group|Results Reporting Coordinator|(626) 241-1500|resultsreportingcoordinator@childrensoncologygroup.org|
20570864|NCT02259621|Johns Hopkins SKCCC Clinical Research Office Coordinating Center|Jasmine Brooks|6673068335|jbrook54@jhmi.edu|
20541241|NCT00597402|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
20541242|NCT04864639|Duke University|Leonor Corsino, MD, MHS|919-684-4005|leonor.corsinonunez@duke.edu|
20541243|NCT03449758|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20541244|NCT01860287|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20541245|NCT02848222|University of Alabama at Birmingham|Dr Jason Nichols|205-975-3497|jjn@uab.edu|
20541246|NCT01606709|UConnHealth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
20541247|NCT01478971|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20541248|NCT05561582|University of Central Florida|Abigail Wilson|407-823-1026|Abigail.Wilson@ucf.edu|
20541249|NCT03937713|VA ORD|Associate Chief of Staff for Research|716-862-6528|ali.el-solh@va.gov|
20541250|NCT00988013|University of Illinois at Chicago|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
20541251|NCT01101035|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20541252|NCT00922623|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
20541253|NCT03633344|Omnifarma Kyiv LLC|Oleg Kurchenko|+380503319653|Kurchenko@omnifarma.kiev.ua|
20541254|NCT01764711|Vanderbilt Universtiy|Alfredo Gamboa|6158751003|alfredo.gamboa@vumc.org|
20541255|NCT00950846|Baylor College of Medicine/Texas Children's Hospital|Dr. Caridad A. Martinez|832-824-4692|camartin@texaschildrens.org|4670
20541256|NCT01717872|Women and Children's Hospital of buffalo|Dr. Jerrold Lerman|716 878 7701|jerrold.lerman@gmail.com|
20541257|NCT01799226|UMichigan|Janet Kinney|734-615-5452|kinneyj@umich.edu|
20541258|NCT02178995|Stanford University|Jesse Adams, MD|2069144771|jadamsuw@stanford.edu|
20541259|NCT00587158|Mayo Clinic|Hatem Amer, MD, FASN; Assistant Professor of Medicine; Division of Nephrology and Hypertension|507-256-1963|amer.hatem@mayo.edu|
20541260|NCT00981461|Lexington International, LLC|David Michaels|5614170200|dm@hairmax.com|
20541261|NCT00483405|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20541262|NCT00571038|Clement J. Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
20541263|NCT01797263|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; matthew.bair@va.gov|
20541264|NCT02342223|VA Northern California Health Care System|Jared Jagdeo, MD, MS|917-837-9796|jrjagdeo@gmail.com|
20541265|NCT02947646|Actuated Medical|Director Quality Assurance & Regulatory Affairs|814-355-0003|medical.affairs@actuatedmedical.com|
20541266|NCT04854551|University of Colorado Anschutz Medical Campus|Joshua Gowin|3037243769|joshua.gowin@cuanschutz.edu|
20541267|NCT01284517|Sunovion|Medical Director, CNS|1-866-503-6351||
20541268|NCT01165541|Geisel School of Medicine At Dartmouth|Mary Brunette, MD|603-271-7642|mary.brunette@dartmouth.edu|
20541269|NCT00181766|Massachusetts General Hospital|Joseph Biederman, MD|617-726-1743|jbiederman@partners.org|
20541270|NCT00687804|Novartis Pharmaceuticals|Study Director|862 778-8300||
20541271|NCT04390243|Cedar Sinai Medical Center|Andrew Hendifar, M.D.|310-423-2217|Andrew.Hendifar@cshs.org|
20541272|NCT03838978|Moximed, Inc.|Alexandra Kraenzlin, Director of Clinical Affairs|+41 44 515 62 06|akraenzlin@moximed.com|
20541273|NCT02915978|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20541274|NCT03402035|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
20541275|NCT03559933|Stimdia Medical, Inc.|Tim Miller|612.940.3454|tmiller@stimdia.com|
20541276|NCT02451124|Case Comprehensive Cancer Center|Amitabh Chak|2168443217|axc22@cwru.edu|
20541277|NCT03301350|University of Wisconsin Carbone Cancer Center|Kari Wisinski, MD|608-262-2876|kbwisinski@medicine.wisc.edu|
20541278|NCT01248949|MedImmune, LLC|Mohammed Dar, MD|301-398-0000|information.center@astrazeneca.com|
20541279|NCT00286429|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20541280|NCT01973413|Univeristy of VIrginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20541281|NCT01746225|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
20541282|NCT03508609|Caladrius Biosciences, Inc.|William Sietsema|9495352391|bsietsema@caladrius.com|
20541283|NCT00999518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541284|NCT00122369|Beth Israel Deaconess Medical Center (at time of study); now Hypnalgesics, LLC|Elvira V. Lang, MD|978 404 9724|elang@bidmc.harvard.edu|
20541285|NCT00250276|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541286|NCT01546688|Eisai Call Center|Eisai Inc.|888-422-4743||
20508190|NCT00905268|The National Hospital, University College London|Prof. Nicholas William Wood|020 7837 3611|n.wood@ucl.ac.uk|
20541287|NCT00667849|Bioventus LLC|Peter Heeckt, MD (CMO)|1-800-396-4325|peter.heeckt@bioventusglobal.com|
20541288|NCT00782483|University of Arkansas for Medical Sciences/Arkansas Children's Hospital|Dr. Gal Shafirstein|501-364-7546|jboswell@uams.edu|
20541289|NCT03543137|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20541290|NCT01135095|Department of Medicine, Cardiology Division, Columbia University Medical Center and New York Presbyterian Hospital, New York|Dr. Andrew J. Einstein|+1 212 305-4275|Andrew.einstein@columbia.edu|
20541291|NCT01052077|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20541292|NCT01445080|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20508191|NCT01281189|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
20541293|NCT02487030|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20541294|NCT03857542|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20541295|NCT01525615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20541296|NCT04050618|CooperVision, Inc.|Jose A. Vega, O.D., MSc, FAAO|925-621-3761|javega@coopervision.com|
20541297|NCT01026012|University of Maryland Cardiology|Dr. Scott Jerome|410-876-0086|sjerome@medicine.umaryland.edu|
20541298|NCT00948753|University of Pennsylvania Abramson Cancer Center|David Porter|215-662-2862|david.porter@pennmedicine.upenn.edu|
20541299|NCT00655538|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20541300|NCT02451943|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20541301|NCT03652181|University of Chicago, Medicine and Biological Sciences Division|Agnieszka Stadnik|(773) 702-8996|astadnik@bsd.uchicago.edu|
20541302|NCT00859547|ZymoGenetics|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
20541303|NCT01473732|Montefiore Medical Center|Dr. Enver Akalin, Medical Director Kidney Transplant|718-920-4815|eakalin@montefiore.org|
20541304|NCT02279667|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20541305|NCT00786799|University of California, San Francisco|Robert L. Hendren, D.O.|415-476-7198|robert.hendren@ucsf.edu|
20541306|NCT01641601|UCSF|Kirsten Salmeen|628-213-5314|kesalmeen@gmail.com|
20541307|NCT03187119|West Virginia University|Dr. Christina Duncan|304-293-1289|Christina.Duncan@mail.wvu.edu|
20541308|NCT03361293|University of Minnesota|Jeffrey Wozniak, PhD, LP|612-273-9741|jwozniak@umn.edu|
20541309|NCT01426958|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20541310|NCT02968368|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
20541311|NCT00040443|RespireRx Pharmaceuticals|Richard Purcell|732-492-1797|rpurcell@respirerx.com|
20541312|NCT03071887|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
20541313|NCT03393494|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20541314|NCT00061893|Children's Oncology Group|Results Reporting Coordinator||resultsreportingcoordinator@childrensoncologygroup.org|
20541315|NCT01526213|UNC-Chapel Hill|Mary F. Paine, RPh, PhD|919-966-9984|mpaine@unc.edu|
20541316|NCT01314001|University of Pennsylvania|Paul M. Sanborn, M.S.|215-746-7150|sanborn@mail.med.upenn.edu|
20541317|NCT01521507|TearScience, Inc.|Study Director|919-467-4007|cstevens@tearscience.com|
20541318|NCT03188432|Wake Forest Baptist Comprehensive Cancer Center|Principal investigator|3367135440|Michael.G.Kelly@advocatehealth.org|
20541319|NCT04498143|University of Denver|Dr. Kathryn Fox|3015202715|Kathryn.Fox@du.edu|
20541320|NCT06260670|Ablacon, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
20541321|NCT00413218|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
20541322|NCT00206336|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
20541323|NCT00195039|Weill Cornell Medicine|Scott Tagawa, MD||guonc@med.cornell.edu|
20541324|NCT01843023|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
20541325|NCT00466921|Northwestern University|Clinical Trials Office|312-695-1301||
20541326|NCT00587678|University of Virginia|Dr Christopher Kramer|434-243-0736||
20541327|NCT05282927|Durham VA Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Dr. Kelli Allen|919-286-0411|Kelli.Allen@va.gov|177090
20541328|NCT02741635|Fisher & Paykel Healthcare Ltd.|Christine Lambert|+64 9 574 0123|christine.lambert@fphcare.co.nz|7172
20541329|NCT02727907|BIOCAD|Linkova Yuliya|+7(495)9926628|linkova@biocad.ru|930
20541330|NCT01427933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20541331|NCT01643382|University of California, San Francisco|Justin Parekh, MD, MAS|415-595-3707|justin.parekh@ucsfmedctr.org|
20541332|NCT01633541|University of Michigan Rogel Cancer Center|Dr. Paul Swiecicki|734-647-1017|pswiecic@med.umich.edu|
20541333|NCT03472326|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20541334|NCT05447663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20541335|NCT01128426|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541336|NCT01592071|University of Miami|Dr. John Lewis|(305) 243-6227|jelewis@miami.edu|
20541337|NCT01100320|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
20541338|NCT04980612|University of California San Francisco|Wolf Mehling, MD|415|wolf.mehling@ucsf.edu|9021331
20541339|NCT00666406|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20541340|NCT01502228|IndianaU|Dr. Theodore Logan|(317) 948-7449|tlogan@iu.edu|
20570865|NCT03660826|NRG Oncology|Helen Huang on behalf of Danielle Enserro, PhD.|(716) 845-1300|huangh@nrgoncology.org|2318
20570866|NCT04978129|University of Texas at Arlington|Melissa Lewis|817-272-9833|Melissa.Lewis@uta.edu|
20541341|NCT05730387|Institute for Global Health at BC Children's Hospital and BC Women's Hospital + Health Centre|Matthew O. Wiens|6048292562|matthew.wiens@bcchr.ca|
20541342|NCT02728089|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541343|NCT04669301|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
20541344|NCT05049850|Hansa Biopharma AB|Study Director|+46 46 16 56 70|clinicalstudyinfo@hansabiopharma.com|
20541345|NCT04137731|Joint Replacement Center of Montefiore Medical Center|Clinical Research Director|9292466352|sereffer@montefiore.org|
20541346|NCT05919888|SSMHealth SLUCare Physician Group|Dr. Randall Otto|314-614-2970|randall.otto@slucare.ssmhealth.com|
20541347|NCT05236257|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20541348|NCT04752332|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20541349|NCT01895946|AstraZeneca UK Limited|Dr Justin P. O. Lindemann, MBChB MBA, Medical Science Director, AZD5363|(0)7920 250301|Justin.Lindemann@astrazeneca.com|+44
20541350|NCT00924443|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20541351|NCT02863328|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20541352|NCT00942825|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
20541353|NCT00595478|Dartmouth College|Catherine Stanger, Ph.D.|603-646-7023|catherine.stanger@dartmouth.edu|
20541354|NCT03245775|University of Virginia|Dr. Jamie Zoellner, Professor of Public Health Sciences|4349624488|jz9q@virginia.edu|
20541355|NCT03401671|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20541356|NCT02713828|ECOG Stats Center|Dr Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
20541357|NCT02451514|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541358|NCT03302247|Fox Chase Cancer Center|Martin Edelman|215-728-5682|Martin.Edelman@fccc.edu|
20541359|NCT03197376|PATH|Dr. Steve Lamola|+ 1 206.302.6067|slamola@path.org|
20541360|NCT01092910|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
20541361|NCT01773187|CTI BioPharma Corp.|Beth Ziemba|206-272-4347|bziemba@ctibiopharma.com|
20541362|NCT02978833|Hospital for Special Surgery|Jennifer Cheng|6467146870|chengj@hss.edu|
20541363|NCT01123395|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20541364|NCT00186901|St. Jude Children's Research Hospital|Sue Kaste, DO|866-278-5833|referralinfo@stjude.org|
20541365|NCT03868254|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20541366|NCT02420379|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
20541367|NCT03795116|SUNY Downstate Health Sciences University|Jared Jagdeo MD, MS|347-466-9263|jared.jagdeo@downstate.edu|
20541368|NCT00977171|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20541369|NCT01410890|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20541370|NCT00217425|ECOG Statistical Office|Study Statistician|617-632-3012||
20541371|NCT03951077|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20541372|NCT00681889|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|Cornea_Research@meei.harvard.edu|
20541373|NCT00086047|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|Susmita.Kashikar-Zuck@cchmc.org|
20541374|NCT01395901|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
20541375|NCT03923790|The University of Texas Health Science Center at Houston|Anjail Sharrief, MD, MPH, Associate Professor|713-500-6538|anjail.z.sharrief@uth.tmc.edu|
20541376|NCT03271424|University of North Carolina Chapel Hill|Dr. Audrey Pettifor|919-966-7439|apettif@email.unc.edu|
20541377|NCT01798966|Hamilton Glaucoma center|Anjali Parekh|+1858 822-1553|anjalism@gmail.com|
20541378|NCT01165983|Beth Israel Deaconess Medical Center|Aristidis Veves, Research Director|617-632-7075|aveves@bidmc.harvard.edu|
20541379|NCT01217944|Novartis Pharmaceuticals|Study Director|862-778-8300||
20541380|NCT03579940|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20541381|NCT00671034|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20541382|NCT00997035|University of California, San Francisco|Kathryn Ray|415-514-3227|kathryn.ray@ucsf.edu|
20541383|NCT03726489|University of Pennsylvania|Brooke Bishop|215-615-0523|brooke.bishop@pennmedicine.upenn.edu|
20541384|NCT00713544|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20541385|NCT00269919|Janssen Korea Ltd., Korea|Medical CRA|+82-2-2094-4804||
20541386|NCT00797277|National Taiwan University Hospital|Dr. Tzung-Jeng Hwang|+886-2-23123456|tjhwang@ntu.edu.tw|66792
20541387|NCT02471014|University of Florida|Mathew Sebastian, PhD|8644901978|mathewsebastian@ufl.edu|
20541388|NCT02544503|Emory University|Cathrin Buetefisch, MD, PhD|404-712-5507|cathrin.buetefisch@emory.edu|
20541389|NCT02380287|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20508192|NCT05355818|LEO Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20508193|NCT01090102|University of California, San Francisco|Dr. Ma Somsouk|415-206-6480|somsoukma@medsfgh.ucsf.edu|
20570867|NCT03931746|Northwell Health Department of Dermatology|Sr. Clinical Data Analyst|516-321-8508|astrunk1@northwell.edu|
20570868|NCT05454813|Medline Industries, L:P|Julie Miller|630-418-6891|jamiller@medline.com|
20508194|NCT01601704|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
20508195|NCT03518034|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20508196|NCT00546429|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
20541390|NCT04473963|Ablacon, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
20541391|NCT04640311|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20541392|NCT02123849|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
20541393|NCT03315572|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20541394|NCT00991939|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
20541395|NCT01461707|University of California, San Francisco|JiWon Choi|415-514-2534|jiwon.choi@ucsf.edu|
20541396|NCT01450761|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20541397|NCT00535002|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
20541398|NCT01327677|Johns Hopkins University School of Medicine|Athir Morad, M.D.|4109552611|morada@jhmi.edu|
20541399|NCT01220739|University of California, San Diego|Dr. Thomas Hemmen|858-657-7190|themmen@ucsd.edu|
20541400|NCT02073682|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
20541401|NCT03801174|University of Wisconsin - Madison|Corrine Voils, PhD|608-262-9636|voils@surgery.wisc.edu|
20541402|NCT00855816|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
20541403|NCT01965704|Stanford University|David Drover|650-725-0364|ddrover@stanford.edu|
20541404|NCT03573323|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20541405|NCT03869008|UTMC|Bashar Kahaleh, MD|4193834271|bashar.kahaleh@utoledo.edu|
20541406|NCT01687296|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541407|NCT04912583|The University of Texas Health Science Center at Houston|Radha Korupolu, MD|713-797-5233|Radha.korupolu@uth.tmc.edu|
20541408|NCT01290614|University of Minnesota|Paul Drawz, MD|6126255423|draw0003@umn.edu|
20541409|NCT01479868|Janssen Research & Development|Director & Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
20541410|NCT01177007|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20541411|NCT01155336|University of Rochester|Dr. Robert Block|585 275-3356|robert_block@urmc.rochester.edu|
20541412|NCT02336230|Mesoblast, Inc.|Christopher James, VP Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
20541413|NCT02524171|Center for Innovation to Implementation, VA Palo Alto|Daniel M. Blonigen, PhD|650-493-5000|daniel.blonigen@va.gov|27828
20541414|NCT02526277|The Ohio State University|Ariane Park, MD|614.293.4969|Ariane.Park@osumc.edu|
20541415|NCT01379183|Mayo Clinic|Dr. Jeff L. Fidler|507-284-5010|fidler.jeff@mayo.edu|
20541416|NCT01695135|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20541417|NCT02507388|Alcon, A Novartis Division|Global Program Clinical Head, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
20541418|NCT02753946|Nabriva Therapeutics plc|Chief Medical Officer|(610) 816-6640|officeUS@nabriva.com|
20541419|NCT00216671|Janssen Cilag Spain|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
20541420|NCT02714569|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20541421|NCT01219985|Centre Hospital-Universitaire d'Amiens|Pr. Marc-Etienne Meyer|+33 3 22 45 59 64|meyer.marc-etienne@chu-amiens.fr|
20541422|NCT00596752|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20541423|NCT01870726|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20541424|NCT03691571|The Hospital of the University of Pennsylvania|Dr. Cory M. Tschabrunn|215-614-0482|coryt@pennmedicine.upenn.edu|
20541425|NCT00746694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20541426|NCT00555217|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Linda Fried, MD, MPH|412-360-3930|Linda.Fried@va.gov|
20541427|NCT00983385|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
20541428|NCT00900029|Smith & Nephew, Inc.|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20541429|NCT02709330|Duke University|Richard Bedlack, MD, PhD|919-668-2839|richard.bedlack@duke.edu|
20541430|NCT02587819|Biosceptre UK|Dr Shaun McNulty|01223496092|shaun.mcnulty@biosceptre.com|
20541431|NCT00511238|Onyx Pharmaceuticals|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
20541432|NCT03152591|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20541433|NCT01227980|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|301-451-6960|melanies@mail.nih.gov|
20541434|NCT00330759|Amgen Inc.|Study Director|866-572-6436||
20541435|NCT03110471|swansea university|sue jordan|+44 (0) 1792 518541|s.e.jordan@swansea.ac.uk|
20541436|NCT00972335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20541437|NCT04070989|JnJ MedTech|Mary Panozzo|+15744049398|MPanozzo@its.jnj.com|
20541438|NCT06083987|University of Pittsburgh|Dr. Ana Radovic|4126927227|anr94@pitt.edu|
20541439|NCT04685798|Washington University School of Medicine|Gloria J. Guzman Pérez-Carrillo, M.D.|314-362-5950|guzman.gloria@wustl.edu|
20541440|NCT01908530|Imperial College London|Prof Nick Oliver|07957163617|nick.oliver@imperial.ac.uk|
20541441|NCT00287222|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
20541442|NCT00592904|Eisai Call Center|Eisai Inc.|888-422-4743||
20541443|NCT01388907|Sofradim Production COVIDIEN|Patrice BECKER, Global Director, Clinical Affairs|+33 4 74 08 92 38|patrice.becker@covidien.com|
20541444|NCT01910402|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20541445|NCT00824473|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
20541446|NCT01359904|MUHC|Sameena Iqbal|5149341934|sameena.iqbal@mcgill.ca|44034
20541447|NCT02660853|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20541448|NCT03594773|University of Pittsburgh School of Medicine|Holly Swartz, MD|4122465588|SwartzHA@upmc.edu|
20541449|NCT03191630|The Ohio State University|Dr. Tara O'Brien|6142928045|obrien.782@osu.edu|
20541450|NCT01550757|US Department of Veterans Affairs|Thomas O'Toole, MD|(401) 273-7100|thomas.otoole@va.gov|6359
20541451|NCT02707146|Division of Research, Kaiser Permanente Northern California|Dr. Richard Grant|510-891-5993|Richard.W.Grant@kp.org|
20541452|NCT00193206|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20541453|NCT01433016|Exalenz Bioscience|Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
20541454|NCT02148523|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
20541455|NCT01631994|NYU Winthrop Hospital, Dep't of Gastroenterology|David Friedel, MD|(516) 663-2528|DFriedel@nyuwinthrop.org|
20541456|NCT00714415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541457|NCT03315039|Moleculin Biotech Inc|Chief Scientific Officer|862-273-1432|DPicker@moleculin.com|
20541458|NCT00740584|Starpharma Pty Ltd|Clinical Development Manger|+61 3 9532 2700|clare.price@starpharma.com|
20541459|NCT01582139|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
20541460|NCT02794766|Universidade de Passo Fundo|Prof. Fernando Fornari|+555433168395|fernandofornari@gmail.com|
20541461|NCT00123123|University at Buffalo|Frank A. Scannapieco|716-829-3373|fas1@buffalo.edu|
20541462|NCT00337207|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
20541463|NCT00452868|Wake Forest Baptist Health|Dr. Janet Tooze|336-716-0286|jtooze@wakehealth.edu|
20541464|NCT01618669|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Medical Affairs||Astellas.resultsdisclosure@astellas.com|
20541465|NCT03259087|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541466|NCT05202418|Emory University|Dr. Bonney Reed|404-727-8312|ebreed@emory.edu|
20541467|NCT02562716|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|smcdonou@fredhutch.org|
20541468|NCT00684996|SWOG Statistical Center|Study Statistician|206-667-4623||
20541469|NCT02519439|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20541470|NCT01775371|Albert Einstein College of Medicine|Dr. Polly Bijur|718-430-4217|polly.bijur@einsteinmed.edu|
20541471|NCT04400058|CRMG|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
20541472|NCT01078441|ECOG Statistical Office|Study Statistician|617-632-3012||
20541473|NCT02868554|University of North Carolina at Chapel Hill|Ching-Chang Ko, DDS, PhD|919-537-3763|ching-chang_ko@unc.edu|
20541474|NCT04915729|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20541475|NCT04961541|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20541476|NCT01684202|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20541477|NCT00191308|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20541478|NCT00851279|Stereotaxis Inc.|Dr Qun Sha, MD, Director of Clinical Trials|314 678 6143|qun.sha@stereotaxis.com|
20541479|NCT03305770|Alcon, A Novartis Division|Sr Director Project Leadership|1-888-451-3937|alcon.medinfo@alcon.com|
20541480|NCT03539601|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541481|NCT03710642|Alzheimer's Disease Cooperative Study (ADCS)|Clinical Operations|858-246-1333|alzinfo@ucsd.edu|
20541482|NCT01970306|Memorial Sloan Kettering Cancer Center|Dr. Vivian Strong, MD|212-639-5056|strongv@mskcc.org|
20541483|NCT00226811|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20541484|NCT01010971|Sunovion|Respiratory Medical Director|1-866-503-6351||
20541485|NCT03386721|Hoffmann-La Roche|Medical Communications|08008218590|genentech@druginfo.com|
20541486|NCT03676972|Peking University Third Hospital|Dr. Lulin Ma|13701010872|malulin@medmail.com.cn|+86
20541487|NCT00700713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20541488|NCT00550953|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20541489|NCT03797586|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Dr.Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
20541490|NCT01369784|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea (GELTAMO)|Dr. Carlos Panizo|+ 34 948 25 54 00|cpanizo@unav.es|
20541491|NCT02680665|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541492|NCT02905266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20541493|NCT04797780|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|info@syros.com|
20541494|NCT02921490|Mayo Clinic|Vance Lehman|1-507-284-2511|lehman.vance@mayo.edu|
20541495|NCT01802710|Hospital Galdakao-Usansolo|Dra Miren Orive|0034 944007105|miren.orivecalzada@osakidetza.net|
20541496|NCT02528786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20541497|NCT01099397|University of Florida|Mariellen Moore|352-273-6381|marielm@ufl.edu|
20541498|NCT02363959|Duke University|Scott Shofer MD, PhD|919-668-2402|scott.shofer@duke.edu|
20541499|NCT02696759|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
20541500|NCT00950248|National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Bibiana Bielekova|(240) 669-2724|bibi.bielekova@nih.gov|
20541501|NCT00003199|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20541502|NCT00940498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541503|NCT00650845|Guerbet|Pierre Desché, MD - VP Development, Medical and Regulatory Affairs.|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20541504|NCT03761810|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
20541505|NCT00869518|University of California, San Francisco|Brian S. Schwartz, MD|415-476-5767|brian.schwartz@ucsf.edu|
20541506|NCT04178720|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20541507|NCT02663622|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541508|NCT00662545|UCSF SFGH|Anne Luetkemeyer|415 476 4082|aluetkemeyer@php.ucsf.edu|130
20541509|NCT00930930|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
20541510|NCT04618744|Oramed, Ltd.|Chief Scientific Officer|+97225660001|miriam@oramed.com|
20541511|NCT03678311|Cleveland Clinic|Dr. Reena Mehra|216-444-2165|mehrar@ccf.org|
20541512|NCT02744092|Dana-Farber Cancer Institute|Dr. Jean Connors|(617) 632-3000|jconnors@bwh.harvard.edu|
20541513|NCT01633788|Allergan plc|Ronald Bradford|1-714-846-5486|Bradford_Ron@allergan.com|
20541514|NCT01929226|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
20541515|NCT03310723|BC Women's Hospital, Department of Anesthesia|Research Assistant|604-875-2424|james.taylor1@phsa.ca|6076
20541516|NCT02098746|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20541517|NCT01072188|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20541518|NCT02640547|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20541519|NCT03018691|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20541520|NCT01172535|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20541521|NCT03461146|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
20541522|NCT02501590|Head of The Pediatric Neurology and Developmental Unit|Aviva Mimouni-Bloch|97297709048|abloch@clalit.org.il|
20541523|NCT02545608|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
20541524|NCT00945282|ViiV Healthcare|GSK Response Center|866-435-7343||
20541525|NCT02915263|Beth Israel Deaconess Medical Center|Christopher Gibbons MD|617-632-8454|cgibbons@bidmc.harvard.edu|
20541526|NCT02478463|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20541527|NCT01879683|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20541528|NCT01825187|New Hanover Regional medical Center|Dr. William Hope|(910)667-9233|william.hope@nhrmc.org|667
20541529|NCT01508169|Hospital de Clinicas da Universidade Estadual de Campinas (Unicamp)|Cecilia de Morais Barbosa|+55-19-35217113|cecimbarbosa@gmail.com|
20541530|NCT01698502|University of Copenhagen|Michael Lund|+45 3532 7519|michaeltl@sund.ku.dk|
20541531|NCT00004092|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626) 256-4673|pfrankel@coh.org|65265
20541532|NCT01961271|Mundipharma Pte Ltd|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
20541533|NCT03600740|Mayo Clinic|Erik H. Middlebrooks, M.D.|904-953-6696|Middlebrooks.Erik@mayo.edu|
20541534|NCT01702558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20541535|NCT01680666|Stanford University|Matias Bruzoni, MD|650-723-6439|mbruzoni@stanford.edu|
20541536|NCT02396212|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20541537|NCT01623115|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20541538|NCT04950465|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20541539|NCT04308941|BostonSight|Dr. Daniel Brocks|(781) 726-7506|ecrowley@bostonsight.org|
20541540|NCT02230566|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
20541541|NCT06309953|Bausch & Lomb|Jason Vittitow, PhD|908-541-3060|jason.vittitow@bausch.com|
20541542|NCT00940901|Johns Hopkins University, School of Medicine|Dr. Arthur L. Burnett, Director of Sexual Medicine Fellowship Program|410-614-3986|aburnett@jhmi.edu|
20541543|NCT01338818|Novartis Pharmaceuticals|Study Director|8627788300||
20541544|NCT01620086|University of Arkansas for Medical Sciences|Erik Messias, MD|501-526-8142|emessias@uams.edu|
20541545|NCT00740207|Bracco Diagnostics Inc.|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
20541546|NCT05065905|Saint-Petersburg State Medical Academy n.a. I.I.Mechnikov of Ministry of Health, Saint-Petersburg, Russia, 195067|Dr. med. Sc., Prof. Tamara Sologub|+78125439609|mechnik@mail.ru|
20541547|NCT00580723|University of California, Irvine|Brian Swasdibutra, Clinical Research Coordinator|9498247103|bswasdib@uci.edu|
20541548|NCT00556998|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541549|NCT00895284|Mayo Clinic|Dr. Rosanne Kho|408-301-5811|kho.rosanne@mayo.edu|
20541550|NCT01425801|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20541551|NCT03066596|Montefiore Medical Center|Marina Reznik, MD, MS|718-741-2494|mreznik@montefiore.org|
20541552|NCT02330055|Beth Israel Deaconess Medical Center|Dr. Matthias Eikermann|6176673364|meikerma@bidmc.harvard.edu|
20526993|NCT01443494|Intensive Care Unit, Zhongda Hospital, Southeast University|Jingyuan Xu|86-025-83262550|xujingyuanmail@163.com|
20541553|NCT02959437|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20541554|NCT02864901|Office of Regulated Activities|Emily Badraslioglu, Senior Regulatory Advisor & FDA Sponsor Representative|(301) 619-6828|emily.d.badraslioglu.civ@health.mil|
20541555|NCT01951651|Baylor|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
20541556|NCT00782717|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937 and 817.568.6725|medinfo@alconlabs.com|
20541557|NCT02446717|AbbVie|Global Medical Services|800-633-9110||
20541558|NCT04871425|University of Washington|Complex Family Planning Division|206.221.9074|uwfp@uw.edu|
20541559|NCT03149172|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
20541560|NCT02292719|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20541561|NCT02538042|Duke University|Dr. F. Joseph McClernon|9196682963|joseph.mcclernon@duke.edu|
20541562|NCT02940496|MD Anderson Cancer Center|Ahmed Kaseb, MD|(713) 792-2828|akaseb@mdanderson.org|
20541563|NCT02586727|Murray Ocular Oncology & Retina|Dr. Timothy Murray|3054877470|tmurray@murraymd.com|
20541564|NCT05973006|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20541565|NCT05167825|Janssen Pharmaceutical K.K.|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20541566|NCT04289311|Medical University of South Carolina|Shannon Phillips, PhD, RN, Associate Professor|843-792-9379|phillipss@musc.edu|
20541567|NCT02481297|The University of Texas MD Anderson Cancer Center|Dr. Nitin Jain/Associate Professor|713-745-6080|njain@mdanderson.org|
20541568|NCT05431478|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20541569|NCT02326597|Emory University|Lakshmanan Krishnamurti, MD|4047270710|lkrishn@emory.edu|
20541570|NCT02286921|SKCCC at JHU|Dr. Samual Denmeade|410-955-8875|denmesa@jhmi.edu|
20541571|NCT04089761|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical and Regulatory Affairs|+972723909755|daganh@theranica.com|
20541572|NCT00770601|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
20541573|NCT00676013|University of Texas Medical Branch|David Herndon, MD|409-770-6731|dherndon@utmb.edu|
20541574|NCT00428948|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
20541575|NCT02506634|FirstSunYetSen|Dr. Niandi Tan|+86 15989117039|tanniandi@126.com|
20541576|NCT03884790|GreenBone Ortho SpA|Senior Clinical Affairs Manager|+393479747691|sonia.granados@greenbone.it|
20541577|NCT03201419|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20541578|NCT05907395|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541579|NCT04544956|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20541580|NCT02119663|Incyte Corporation|Study Director|855 463-3463||
20541581|NCT00892775|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541582|NCT00699660|Veterans Affairs at TVHS|Theodore Speroff PhD|615-636-9476|ted.speroff@va.gov|
20541583|NCT00103740|Novartis Pharmaceuticals|Study Director|862-778-8300||
20541584|NCT02771197|The Blood and Marrow Transplant Group of Georgia/Northside Hospital|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
20541585|NCT02155920|University of Texas Southwestern Medical School|Daniel C. Bowers, MD|214-648-3896|Daniel.Bowers@utsouthwestern.edu|
20554687|NCT01381172|Impulse Dynamics (USA) Inc|Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
20526994|NCT00483704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20526995|NCT03604705|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
20526996|NCT03689543|National Institute of Mental Health|Dr. Peter Schmidt|+1 301 496 6120|peterschmidt@mail.nih.gov|
20526997|NCT05619536|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
20526998|NCT05727306|University of Sheffield|Andrew G. Messenger|+44 114 222 2000|a.g.messenger@sheffield.ac.uk|
20526999|NCT00885742|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20527000|NCT01319851|Emory University|Dr. John Horan|404-785-1272|jthoran@emory.edu|
20527001|NCT00819780|Amgen Inc.|Study Director|866-572-6436||
20527002|NCT00948506|University of Pennsylvania|Joy Wan|2157466364|joy.wan@uphs.upenn.edu|
20527003|NCT03912428|National Institute of Mental Health|Dr. Robert Innis|+1 301 594 1368|robert.innis@nih.gov|
20527004|NCT03233204|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20541586|NCT02137096|University of Florida|John Fort, MD|352-273-9120|john.fort@ufl.edu|
20541587|NCT01223183|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
20541588|NCT00163020|Obstetrix Medical Group, Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@pediatrix.com|
20541589|NCT04437485|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, PhD., Principal Investigator|317-274-6761|jstew@iupui.edu|
20541590|NCT03553758|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
20541591|NCT02986711|Penn State University College of Medicine|Jessica Yingst|7175310003|jmy5048@psu.edu|289511
20541592|NCT01454791|MS Center at Evergreenhealth Care|Theodore R, Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
20541593|NCT01467505|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20541594|NCT02807623|Defense Health Agency Immunization Healthcare Division South Atlantic Region Vaccine Safety hub|Laurie Housel|910-432-4015|laurie.a.housel.civ@mail.mil|
20541595|NCT03811340|TriHealth Inc.|Rachel Pauls, MD|513-463-4300|Rachel_Pauls@trihealth.com|
20541596|NCT05104450|Veterans Health Administration|Dr. Lucas Donovan|206-277-6783|Lucas.Donovan@va.gov|
20541597|NCT00769886|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20541598|NCT04367831|Columbia University|Sahil A. Parikh, MD|212-305-3617|sap2196@cumc.columbia.edu|
20541599|NCT04662359|University of Pennsylvania|Dr. Michael George|215-662-2454|michael.george@pennmedicine.upenn.edu|
20541600|NCT04057807|Yale School of Medicine|Adam Mecca|203.764.8100|adam.mecca@yale.edu|
20541601|NCT01080807|Cephalon, Inc.|Vice President, Medical Affairs|610-727-6353||
20541602|NCT02271698|Duke University Health System|Dr. Stuart Alan Grant|919-681-6437|stuart.grant@duke.edu|
20541603|NCT04472611|Yale University School of Medicine|Dr. Alexandra Lansky|203 737 2142|alexandra.lansky@yale.edu|
20541604|NCT00984308|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
20541605|NCT02045095|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20541606|NCT02525588|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
20541607|NCT02459119|Dana Farber Cancer Institute|Dr. Guru Sonpavde, MD|617-632-2429|gsonpavde@gmail.com|
20541608|NCT03618420|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
20541609|NCT03369418|UCLA|Kirsten Tillisch|1 310 208-5400|ktillisch@mednet.ucla.edu|
20541610|NCT01485094|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20541611|NCT05413668|Quotient Sciences|Jeffrey Levy|+44 (0)115 974 9000|jeffrey.levy@quotientsciences.com|
20541612|NCT01588561|McLean Hospital|Scott Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
20541613|NCT01818596|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20541614|NCT01740414|New York State Psychiatric Institute|Dr. Sandra Comer|646-774-6146|comersd@nyspi.columbia.edu|
20541615|NCT01337336|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541616|NCT03081156|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|William Stringer, MD|424-571-7626|stringer@ucla.edu|
20541617|NCT03767257|Memorial Sloan Kettering Cancer Center|Dr. Malin Hultcrantz, MD, PhD|646-608-3714|hultcram@mskcc.org|
20541618|NCT04435366|Astellas Pharma Global Development, Inc|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
20541619|NCT04502290|University of Pittsburgh|Amit Sethi|4123836619|asethi@pitt.edu|
20541620|NCT04112810|Medical College of Wisconsin|William R Drobyski, MD, FACP, FASTCT|414-456-4941|wdrobysk@mcw.edu|
20541621|NCT00837213|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541622|NCT02293798|Mark Mofid, M.D.|Dr. Mark Mofid|8589099000|drmofid@drmofid.com|
20541623|NCT04497116|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
20541624|NCT02698826|Cooper University Health Care|Brian Roberts, MD/ REOX Study Director|856-342-2352|roberts-brian-w@cooperhealth.edu|
20541625|NCT03782233|The First Affiliated Hospital of Nanjing Medical University|Dr. He Huang|13852476684|hh19871117@126.com|
20541626|NCT04524858|Aclaris Therapeutics, Inc.|Ajay Aggarwal|484-540-6296|Clintrials@aclaristx.com|
20541627|NCT03507036|UT Southwestern|Jennifer Barillas|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20541628|NCT01788566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20541629|NCT03967054|Colorado State University|Brian D. Foy, PhD.|970-491-3470|Brian.Foy@colostate.edu|
20541630|NCT04739436|Duke University Medical Center|Sherri L. Smith, PhD, AuD, CCC-A|(919) 684-2426|sherri.smith@duke.edu|
20541631|NCT03622814|Medical University of South Carolina|Teresa Kelechi|843-810-3157|kelechtj@musc.edu|
20541632|NCT03269994|Memorial Sloan Kettering Cancer Center|Dr. Michael D'Angelica, MD|212-639-3226|dangelim@mskcc.org|
20541633|NCT04417361|UCSF|Jeffrey D. Sharon|4153532757|jeffrey.sharon@ucsf.edu|
20541634|NCT01862536|VA Boston Healthcare System|Dr. Ronald Goldstein|857-203-6578|Ronald.Goldstein@va.gov|
20541635|NCT04661150|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20541636|NCT02701283|Medtronic Structural Heart & Aortic Clinical Research & Medical Science|Kristin Smith, Clinical Research Manager|763-526-3095|kristin.m.smith@medtronic.com|
20541637|NCT02777827|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20541638|NCT00398320|Stanford University School of Medicine|Pamela L Kunz, MD|650-725-8738|pkunz@stanford.edu|
20508197|NCT02273037|The Hospital for Sick Children|Dr. Diego G. Bassani|+14168137654|diego.bassani@sickkids.ca|303033
20508198|NCT02062398|BlueWind Medical|Amit Korner, VP Clinical Research|+972.74.7218905|amit.korner@bluewindmedical.com|
20508199|NCT00601146|DFCI|Andrea Ng|617-732-6310|ang@lroc.harvard.edu|
20508200|NCT00415519|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20570869|NCT01183390|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20570870|NCT00474526|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20570871|NCT02763215|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20570872|NCT02277054|Filatov Institite of Eye Diseases and Tissue Therapy of the NAMS of Ukraine|Dr. Oleksiy Buznyk|+380487181548|a_buznik@bk.ru|
20570873|NCT00592293|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
20570874|NCT01606319|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
20570875|NCT05330988|Department of Veterans Affairs|Dr. John H. Kindred|8437924328|john.kindred1@va.gov|
20570876|NCT01784523|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
20570877|NCT02179177|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
20570878|NCT00022659|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20570879|NCT04340947|University of Oklahoma Health Sciences|Professor of Pediatrics|405-271-1903|heal-lab@ouhsc.edu|
20570880|NCT02349152|University of Pittsburgh|Dr. Kathirvel Subramaniam, MD, MPH|412-647-5635|subramaniamk@upmc.edu|
20570881|NCT01907906|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832||
20570882|NCT00884650|Children's Hospital Colorado|Dr. Frank Chang|720-777-6900|Chang.Frank@tchden.org|
20570883|NCT00880022|vanderbilt university|sheila h ridner|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
20570884|NCT01634269|Medttronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
20570885|NCT02154906|UT Health Science Center San Antonio|Brian L. Mealey|210-567-3567|mealey@uthscsa.edu|
20570886|NCT04646369|University of Pittsburgh|Oliver Lindhiem|4122465909|lindhiemoj@upmc.edu|
20570887|NCT04052425|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20570888|NCT04334278|University of Kentucky|Caitlin Conley|8592571939|caitlin.conley2@uky.edu|
20570889|NCT01821937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20570890|NCT00732992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570891|NCT02838134|Radboud University Medical Center|Dr M.C. Warlé|+31-24362415333|Michiel.Warlé@radboudumc.nl|
20570892|NCT01969851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20570893|NCT03037203|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2159707145|ClinicalTrialDisclosure@JazzPharma.com|
20570894|NCT02332902|The University of Texas Health Science Center at Houston|Dr. Mary Kay Koenig||Mary.K.Koenig@uth.tmc.edu|
20570895|NCT01245374|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20570896|NCT02266342|W.L. Gore & Associates|Charee Robe, Biostatistician|928-864-4048|crobe@wlgore.com|
20570897|NCT02353312|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100|wen-chih.wu@va.gov|16237
20570898|NCT04199052|University of California San Diego|Dr. Jamila K. Stockman, Professor|(858) 822-4652|jstockman@health.ucsd.edu|
20570899|NCT04946942|Weill Medical College of Cornell University|Catherine Riffin, PhD|(203) 303-4904|acr2213@med.cornell.edu|
20570900|NCT00365547|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
20570901|NCT03170518|Janssen Research & Development, LLC|Director Clinical Leader Internal Medicine|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20541639|NCT00064792|NICHD, NIH|Dr. Forbes Porter, Clinical Director, NICHD|301-435-4432|fdporter@mail.nih.gov|
20541640|NCT03137225|Virginia Commonwealth University|Henry J. Rozycki, MD|8048289602|henry.rozycki@vcuhealth.org|
20570902|NCT02257918|Louisiana State University Health Sciences Center|Stephanie N. Taylor, MD|(504) 658-2622|staylo2@lsuhsc.edu|
20570903|NCT03023423|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20570904|NCT03512197|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20570905|NCT03842436|Brigham and Women's Hospital|Peter R. Chai, MD, MMS|617-732-5640|pchai@bwh.harvard.edu|
20570906|NCT01948076|Brigham and Women's Hospital|Maria Yialamas|617-732-5500|myialamas@partners.org|
20570907|NCT01151423|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
20570908|NCT01263054|Halyard Health, Inc.|Mark Lavigne|508-837-1427|mark.lavigne@hyh.com|
20570909|NCT00936598|University of Pittsburgh|Professor|412-623-5965|bovbjergdh@upmc.edu|
20570910|NCT00681668|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20508201|NCT01619488|Nemours Childrens Health Delaware|Kirk W Reichard, MD, MBA, Surgical Director|302-651-5999|kreichar@nemours.org|
20570911|NCT01654068|University of Kentucky|Ronal McGarry|859-323-6486|rcmcga2@email.uky.edu|
20570912|NCT01227616|AMAG Pharmaceuticals|Medical Information||CTInterest@covispharma.com|
20570913|NCT04277507|Aerin Medical|Director of Clinical Operations|650-518-9624|alaborde@aerinmedical.com|
20570914|NCT00920647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20570915|NCT00569192|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20570916|NCT00691600|Baylor College of Medicine|Andrea T. Cruz, MD, MPH|832-824-5582|acruz@bcm.edu|
20570917|NCT00583947|Sepracor Inc|Respiratory Medical Director|866-503-6351||
20570918|NCT02314689|University of Mississippi Medical Center|Suvankar Majumdar MD|6019845220|smajumdar@umc.edu|
20508202|NCT00510484|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
20508203|NCT01590212|University of Glasgow|Prof. Phil Wilson|+44 (0)1463 255892|p.wilson@abdn.ac.uk|
20508204|NCT02533401|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20508205|NCT01324128|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
20508206|NCT03819764|The Cleveland Clinic Foundation|Dr. Susan Linder, PT, DPT, PhD|216-445-9815|linders@ccf.org|
20508207|NCT00881361|Mayo Clinic|Judy C. Boughey, MD|507-284-3629|boughey.judy@mayo.edu|
20508208|NCT01978600|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20508209|NCT02307318|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
20508210|NCT06000501|NYU Langone Health|Lenard Adler, MD|212-263-3580|Lenard.Adler@nyulangone.org|
20508211|NCT03496662|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
20508212|NCT01707368|LEO Pharma GmbH|Tobias Anger, Medical Advisor|+49 610 220 1258|TANDE@leo-pharma.com|
20508213|NCT03819478|Wake Forest University Health Sciences|Ashley Weaver, PhD|336-716-0944|asweaver@wakehealth.edu|
20508214|NCT00282867|University of Virginia|Karen C. Johnston, MD, MSc|434 924-5323|kj4v@virginia.edu|
20508215|NCT01074658|Medronic Bakken Research Center|Hanne Gonnissen|+3143356|hanne.gonnissen@medtronic.com|6734
20508216|NCT00091962|University of Pittsburgh School of Medicine|Dr. Bruce L Rollman, Principal Investigator|(412) 692-2659|rollmanbl@upmc.edu|
20508217|NCT00432562|Adventrx Pharmaceuticals|Chief Executive Officer|858-768-6325|culley@adventrx.com|
20508218|NCT02146248|OHSU|Jeffrey T. Jensen|503-629-4058|jensenje@ohsu.edu|
20508219|NCT04406389|Weill Cornell Medicine|Dr. Maria T. DeSancho|646-962-2065|mtd2002@med.cornell.edu|
20508220|NCT03539861|University of Michigan|Lenar Yessayan|734-763-9041|lenar@med.umich.edu|
20508221|NCT01374217|Carolinas HealthCare System|Nilanjan Ghosh, MD|9804422000||
20508222|NCT00555906|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508223|NCT01033487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508224|NCT00862654|Galderma|Farzi Sidou, Clinical Project Manager|+33 4 93 95 70 51|farzaneh.sidou@galderma.com|
20508225|NCT03219567|Duke University|Anthony Kuo, M.D.|919-684-3799|anthony.kuo@duke.edu|
20508226|NCT00889681|Medtronic- AF Solutions|Dana Wigert- Sr. Clinical Research Specialist|763-526-2802|dana.wigert@medtronic.com|
20508227|NCT04176445|Hospital Moinhos de Vento|PT Douglas Neves|(51) 9.98975514|nevesfisioup@gmail.com|
20508228|NCT01829217|Dana-Farber Cancer Institute|Principal Investigator: Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
20508229|NCT04377672|Johns Hopkins University|Sanjay K. Jain|4105028241|sjain5@jhmi.ed|
20570919|NCT00486252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20541641|NCT03160898|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
20541642|NCT02601833|University of Michigan School of Dentistry|Emily Yanca Project and Data Manager|734-763-3988|emthorpe@umich.edu|
20541643|NCT03405818|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541644|NCT04441255|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20541645|NCT01971385|Massachusetts General Hospital|Dr. Maria Alora-Palli|6177265066|mpalli@mgh.harvard.edu|
20541646|NCT00291486|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20541647|NCT04408040|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com|
20541648|NCT03421106|University of Connecticut|Caitlin Caspi|(860) 486-2834|caitlin.caspi@uconn.edu|
20541649|NCT02919072|Sintetica SA|Anna Guaita|+41 (0)91640 42 50|aguaita@sintetica.com|
20541650|NCT02578199|YALE|Dr. Rachel Barnes|203-785-6395|rachel.barnes@yale.edu|
20541651|NCT01657292|Birken AG|Head of pharmaceutical development|+49 7233 97490|t.zahn@birken.eu|
20541652|NCT02424175|Brigham and Women's Hospital|Dr. Jessica Allegretti|6177325500|jallegretti@bwh.harvard.edu|
20541653|NCT01900652|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20541654|NCT02267538|Peking University First Hospital|Dr. Dong-Xin Wang,PHD,the director of department of Anesthesiology and Critical Care Medicine|+8613910731903|wangdongxin@hotmail.com|
20541655|NCT03932760|University of Utah|Gwen Latendresse|801-587-9636|Gwen.Latendresse@nurs.utah.edu|
20541656|NCT02774148|Spectrum Health|Andrea Mantel|616-486-2051|andrea.mantel@spectrumhealth.org|
20541657|NCT03922620|Geisinger Medical Center|Dr. Gerard Cush|5702716700|MSKIresearch@geisinger.edu|
20541658|NCT03566082|Smith + Nephew|Fleur Derdeyn, Principal Clinical Study Manager|0032 497 60 20 32|fleur.derdeyn@smith-nephew.com|
20541659|NCT04725500|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
20541660|NCT00857857|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541661|NCT03772665|Acucela, dba Kubota Vision|Dr. Jeff Gregory|2068058310|clinicaltrials@acucela.com|
20541662|NCT01412164|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
20541663|NCT01848158|Seattle Children's Hospital|Jane Di Gennaro, MD MS|206-987-6988|jane.digennaro@seattlechildrens.org|
20541664|NCT01389882|Seoul National University Hospital|Dr. Juyoung Lee|lamb4122@snu.ac.kr|lamb4122@snu.ac.kr|
20541665|NCT03790111|TerSera Therapeutics Inc.|Janine North, Executive Director-Clinical Development|888 600 8116|jnorth@tersera.com|
20541666|NCT03074409|University of Electronic Science and Technology of China|Dr. Shuxia Yao|+8618111297596|yaoshuxia@uestc.edu.cn|
20541667|NCT00280917|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
20541668|NCT03529110|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20541669|NCT01584232|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20541670|NCT05904470|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
20541671|NCT01380769|Cerulean Pharma Inc.|Adrian Senderowicz|617 551 9600|asenderowicz@ceruleanrx.com|
20541672|NCT00742183|Mölnlycke Health Care|Viktoria Ahlenius Körner|+46-31-722 32 46|viktoria.ahleniuskorner@molnlycke.com|
20541673|NCT02430090|Ankara Numune Training and Research Hospital|Dr. Müge Çakırca|+905054433177|mugeturkoglu81@hotmail.com|
20541674|NCT00764699|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
20541675|NCT02107703|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20541676|NCT03906071|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20541677|NCT01556451|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541678|NCT04152772|Butler Hospital|Mascha van 't Wout-Frank|401-680-4198|Mascha_vant_Wout@brown.edu|
20541679|NCT05963022|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20541680|NCT02109640|University of Edinburgh|Hugh M Paterson|44 131 537 1000|hugh.paterson@ed.ac.uk|
20541681|NCT03740659|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
20541682|NCT03030417|National Cancer Institute|Dr. Alice P. Chen|240-781-3320|chenali@mail.nih.gov|
20541683|NCT01539759|University of North Carolina|Erika Levi, MD and Gretchen Stuart, MD|(919) 843-5633|Erika.Levi@gmail.com|
20541684|NCT02175017|Ono Pharmaceutical Co., Ltd.|Medical Information Center||clinical_trial@ono-pharma.com|
20541685|NCT02491983|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
20541686|NCT03575403|University of Kentucky|Dr. Craig R. Rush, Ph.D.|8592575388|crush2@uky.edu|
20541687|NCT00773513|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
20541688|NCT02946034|Massachusetts General Hospital|Dr. Raymond Chung|617-726-5925|Chung.Raymond@mgh.harvard.edu|
20541689|NCT04544358|University of Illinois at Chicago|Dr. David X Marquez|312.996.1209|marquezd@uic.edu|
20541690|NCT03359174|Yale Univeristy|Clinical Research Coordinator|203 737 6839|laura.cusack@yale.edu|
20570920|NCT01261247|Mayo Clinic Cancer Center|Patrick Johnston, MD, PhD|507-284-2511|johnston.patrick@mayo.edu|
20570921|NCT05226130|VA San Diego Healthcare System, San Diego, CA|Ruth Klaming, PhD|858-552-8585|rklaming@health.ucsd.edu|
20570922|NCT03811002|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20570923|NCT05853900|Click Therapeutics|Clinical Development|347-460-8607|click_ct_contact@clicktherapeutics.com|
20570924|NCT02706249|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
20570925|NCT02884492|Columbia University Medical Center (Taub Institute)|William C. Kreisl, MD|212-305-9194|wck2107@cumc.columbia.edu|
20570926|NCT05101993|AtriCure|Randall Lee, VP Medical Affairs, Clinical Affairs|650-347-0419|RLee@atricure.com|
20570927|NCT01124838|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20570928|NCT02065882|Biotest AG|Dr. Christina Erb|00496103801|christina.erb@biotest.com|0
20570929|NCT04680533|University of Rochester|Jennifer Gewandter|(585) 276-5661|jennifer_gewandter@urmc.rochester.edu|
20570930|NCT03816761|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20570931|NCT02560753|T3DTherapeutics|John Didsbury, PhD|9199490517|didsj919@t3dtherapeutics.com|
20570932|NCT04057573|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20570933|NCT04991753|Janssen Research & Development|Medical Director Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20570934|NCT05609604|UBuffalo|Paresh Dandona|17168818924|ghanim@buffalo.edu|
20570935|NCT02797522|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20570936|NCT03299049|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20570937|NCT04486625|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570938|NCT02980042|University of Colorado Anschutz, Neurology Department|Dr. Timothy Vollmer|3037242187|timothy.vollmer@ucdenver.edu|
20570939|NCT00725270|Stanford University|Alan Schatzberg|650-723-8331|afschatz@stanford.edu|
20570940|NCT00769600|MSKCCC|Charles Rudin, MD|646-888-4336|rudinc@mskcc.edu|
20570941|NCT02460575|Tulane University|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
20527005|NCT02814227|University of Michigan|J. Todd Arnedt, PhD|734-615-8666|tarnedt@med.umich.edu|
20527006|NCT02520427|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20554688|NCT02334800|Pfizer Inc.|Pfizer ClinicalTrail.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554689|NCT00575588|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20554690|NCT01430130|Neodyne Biosciences|Kristin Prosak|650-543-7129|kprosak@neodynebio.com|126
20554691|NCT03525834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20554692|NCT02703844|University of Kent|David Wilkinson|+44 (0)1227 824772|d.t.wilkinson@kent.ac.uk|
20554693|NCT00801684|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
20554694|NCT01184014|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
20554695|NCT00614939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20527007|NCT00793624|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508230|NCT03954444|Teva Pharmaceuticals Development Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20554696|NCT00840970|Intersect ENT|Chris Lewis, VP Clinical Affairs|423-598-6681|clewis@intersectent.com|
20554697|NCT00504829|Life Cycle Pharma|H. Eugene Griffin, MS, DVM|646-200-8505|ggr@lcpharma.com|
20554698|NCT01645709|CaloSyn Pharma Inc.|Stephen Snowdy, PhD|404-863-8892|ssnowdy@ansleyvc.com|
20554699|NCT03054844|Columbia University|Dr. Daniel Tsze|212-305-9825|dst2141@columbia.edu|
20554700|NCT02673697|Corcym|Elisa Cerutti|+39 3459182413|elisa.cerutti@corcym.com|
20554701|NCT00437489|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20554702|NCT01286818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20554703|NCT03321981|Merus N.V.|Executive Director Clinical Trials|+16174014499|USenquiries@merus.nl|
20554704|NCT03321019|University of Florida|Dr. Karen Hegland|3522948366|kwheeler@ufl.edu|
20554705|NCT03259035|Canadian Cancer Trials Group|Dr. Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
20554706|NCT03895853|UT MD Anderson Cancer Center|Joseph L. Nates, Professor, Critical Care& RespiratoryCare|(713) 792-5040|jlnates@mdanderson.org|
20554707|NCT03473886|Massachusetts General Hospital|Rachel A. Millstein|617-724-2047|RAMILLSTEIN@mgh.harvard.edu|
20527008|NCT00157248|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554708|NCT02056301|Baylor College of Medicine|Chris Glover, MD, MBA|832-824-5800|cdglover@bcm.edu|
20554709|NCT02209324|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20554710|NCT03105362|Boston Children's Hospital|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
20554711|NCT01242527|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20554712|NCT01198600|Alcon Research|R. Alan Landers, O.D., M.S., F.A.A.O.|1-800-241-7629||
20554713|NCT01785602|Novartis|Study Director|862-778-8300||
20554714|NCT02749903|Memorial Sloan Kettering Cancer Center|Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
20554715|NCT04177108|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20554716|NCT03127228|University of Michigan|Dr. Chin-Wei Wang|734-763-2105|jeffwa@umich.edu|
20554717|NCT02041429|Dana-Farber Cancer Institute|Beth Overmoyer, MD|617.632.380|Beth_Overmoyer@DFCI.HARVARD.EDU|
20554718|NCT01427712|Medical affairs|Medical affairs manager|+81-3-5656-0516|takumi.kanzo@viatris.com|
20554719|NCT00784043|MED-EL Corporation|Jennifer Bulls|1-888-633-3524|research.us@medel.com|
20554720|NCT01143259|Intermountain Healthcare|Matthew Peters RN MS|801-442-3703|matthew.peters@imail.org|
20554721|NCT03791398|BrUOG|Brown University Oncology Research Group|401-863-3000|BrUOG@Brown.edu|
20554722|NCT03176693|University of California Los Angeles|Masha Livhits, MD|310-206-0585|mlivhits@mednet.ucla.edu|
20554723|NCT00766376|Palomar Medical Technologies, Inc.|Director of Regulatory Affairs|781-993-2414|stimberlake@palomarmedical.com|
20554724|NCT02207829|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554725|NCT00101101|H. Lee Moffitt Cancer Center and Research Institute|Sophie Dessureault, M.D., Ph.D.|813-745-1965|sophie.dessureault@moffitt.org|
20527009|NCT03191864|Ellodi Pharmaceuticals (Formerly Adare Pharmaceuticals)|Senior Director Clinical Operations and Medical Affairs|(609) 450-1312|karol.knoop@ellodipharma.com|
20554726|NCT01800903|Coloplast A/S|Trine Møller Senior Clinical Manager|+45 4911 2174|dktrm@coloplast.com|
20554727|NCT02116322|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
20554728|NCT00852397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554729|NCT01751022|Medtronic|Shelby Li|+17635262704|shelby.li@medtronic.com|
20527010|NCT01447927|University Hospitals of Cleveland, Case Medical Center|Dr. Amitabh Chak|216-844-5385|Amitabh.chak@case.edu|
20527011|NCT02342548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554730|NCT03861000|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
20554731|NCT01968434|Clalit HS|Prof. Herman Avner Cohen|00972 3-939-8203|hermanc@clalit.org.il|
20554732|NCT00428610|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20554733|NCT02280044|Johns Hopkins Bloomberg School of Public Health|David A Sack|443 287 8795|dsack1@jhu.edu|
20554734|NCT02105116|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
20554735|NCT04837482|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20554736|NCT00987467|Johns Hopkins University, Wilmer Eye Institute|Esen Akpek, MD, Associate Professor of Ophthalmology, Wilmer Eye Institute|410-955-5214|esakpek@jhmi.edu|
20554737|NCT02646423|University of California, San Francisco|Miriam Kupperman, PhD, MPH|415-502-4089|miriam.kupperman@ucsf.edu|
20554738|NCT00086346|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20554739|NCT01790750|University of Florida|Curt DeGroff|(352) 273-7831|degroffc@peds.ufl.edu|
20554740|NCT03017508|Yale University|Angeli Landeros|203-737-4809|angeli.landeros@yale.edu|
20554741|NCT02352493|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|Clinicaltrials@alnylam.com|
20554742|NCT02162810|UPMC Children's Hospital of Pittsburgh|Karen Kenyon, research coordinator|4126923058|kenyonkl@upmc.edu|
20554743|NCT00706121|SWOG Statistical Center|SELECT/S0000D Statistician|206-667-4623||
20554744|NCT02546544|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
20554745|NCT01921348|University of MS Medical Center|Gailen D. Marshall, Jr., MD, PhD, Director, Division of Clinical Immunology and Allergy|6018155527|gmarshall@umc.edu|
20554746|NCT02223390|Duke University (Currently at Columbia University)|Kathleen Sikkema, PhD|212-305-8236|ks3364@cumc.columbia.edu|
20554747|NCT01465334|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
20554748|NCT01994486|UNIVERSITY OF FLORIDA|Giuseppe (Joseph) Morelli, MD|352-273-9467|GIUSEPPE.MORELLI@MEDICINE.UFL.EDU|
20554749|NCT03963895|Aronora, Inc.|Norah Verbout, Ph.D.|503-964-0250|norah.verbout@aronorabio.com|
20554750|NCT00795600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20554751|NCT03936244|Hospital Universitario Fuenlabrada|Dr. Hugo Otaola Arca|+56 9 4108 9452|hugotaolarca@hotmail.com|
20554752|NCT01248884|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554753|NCT01202773|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20554754|NCT00462384|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20554755|NCT01131312|National Cancer Institute|Dr. Mark Schiffman|240-276-7259|schiffmm@nih.gov|
20554756|NCT01984398|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20554757|NCT03834194|University of Virginia, School of Medicine|Dr. Rebecca Krukowski|9014482426|wae4mq@virginia.edu|
20554758|NCT03879798|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
20554759|NCT01343407|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554760|NCT03526900|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20554761|NCT04079933|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
20554762|NCT01986829|Washington University School of Medicine|Brian Van Tine, M.D.|314-362-5817|bvantine@wustl.edu|
20554763|NCT02504866|Clinical Center|Damiano, Diane|+1 301 451 7544|damianod@cc.nih.gov|
20554764|NCT01229436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554765|NCT01775137|Novartis Pharmaceuticals|Study Director|862-778-8300||
20554766|NCT02073968|Montefiore Medical Center / Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
20554767|NCT03231371|University of Michigan|Bryan Goldstein||Bryan.Goldstein@cchmc.org|
20554768|NCT00877448|BiondVax Pharmaceuticals Ltd.|Tamar Ben-Yedidia, PhD|972-8-9302529|benyedidia@BiondVax.com|
20554769|NCT00022516|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
20554770|NCT03067441|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20554771|NCT02291718|Duke University Medical Center|Dr. Lynne Koweek|919-684-8111|lynne.koweek@duke.edu|
20554772|NCT04289753|Northwestern University|Stephen D. Persell, MD, MPH, FACP|3125036464|spersell@nm.org|
20554773|NCT02096055|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair|713-792-7026|hkantarjian@mdanderson.org|
20554774|NCT01985126|Janssen Research & Development, LLC|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20554775|NCT00366626|Medical University of South Carolina|Dr. Raymond F. Anton, Distinguished University Professor|843-792-1226|antonr@musc.edu|
20554776|NCT05799495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20554777|NCT03373591|Montefiore Medical Center|Diego Camacho, MD|718-920-4800|dicamach@montefiore.org|
20554778|NCT03694548|Emory University|Dr. Nitya Bakshi|404-727-3149|nitya.bakshi@emory.edu|
20554779|NCT00439777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20527012|NCT04231396|BioSpeech|K. Lindaas, Principal Investigator|(503) 522-6276|kirstylindaas@biospeech.com|
20554780|NCT00661492|US Oncology|Dr. Mark T. Fleming|757-827-9400|Mark.Fleming@USONCOLOGY.COM|
20554781|NCT01024387|Dana-Farber Cancer Institute|Matthew H. Kulke, MD|617.632.5136|Matthew_Kulke@dfci.harvard.edu|
20554782|NCT03855189|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554783|NCT00099983|VA Connecticut HCS|John Krystal, MD|203-937-4790|john.krystal@yale.edu|
20554784|NCT02641080|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
20554785|NCT00803634|The Medicines Company|Jason Campagna|973-290-6199|jason.campagna@themedco.com|
20554786|NCT03835533|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
20554787|NCT03115424|Mayo Clinic|Adrian Vella, M.D.|507-266-1387|vella.adrian@mayo.edu|
20554788|NCT01418209|Brigham and Women's Hospital|Hadine Joffe, MD, MSc|617-732-4906|hjoffe@partners.org|
20554789|NCT01976416|Indiana University|Dr Chandy John|317-274-8940|chjohn@iu.edu|
20554790|NCT01110239|University Miami|Sebastian Koch|305 243-6733|skoch@med.miami.edu|
20554791|NCT00080223|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20554792|NCT01127438|Eisai Call Center|Eisai Inc.|888-422-4743||
20554793|NCT03099382|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Shiwei Sun; Project Manager|+86-18036618554|shiwei.sun@hengrui.com|
20554794|NCT00499369|SWOG|Study Statistician|206-667-4623||
20554795|NCT02939105|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20554796|NCT01898195|Department of Population Health, New York University School of Medicine|Donna Shelley, MD, MPH/ Vice Chair for Research; Associate Professor of Population Health and Medici|646-501-2526|Donna.Shelley@nyumc.org|
20554797|NCT01802411|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|Pacira Pharmaceuticals, Inc.|MedInfo@pacira.com|
20554798|NCT03930745|University of Alabama at Birmingham School of Medicine|Jeanne Marrazzo, MD, MPH|205-975-5500|jmarrazzo@uabmc.edu|
20554799|NCT01337245|University of Arizona|Senior Regulatory Coordinator|520-621-6417|regulatory@arizona.edu|
20554800|NCT02670629|"Servicio de Ortopedia y Traumatología . Hospital Universitario José Eleuterio González"|Dr. Adriana Hernández|8112901288|adrianahl@gmail.com|
20554801|NCT04095858|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554802|NCT04292301|SpinTech MRI|Rana El Hachem|2487126789|rana@spintechmri.com|
20554803|NCT03154710|Weprom|Dr Katell LE DU|241682940|k.ledu@cjb72.org|0033
20554804|NCT01203189|Saint Louis Univ Hospital|Aibing Mary Guo, M.D., Assistant Professor|3142563430|aguo@slu.edu|
20570942|NCT02521363|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina, MD|646-888-4558|trainat@MSKCC.ORG|
20554805|NCT02055352|Novartis Pharmaceuticals|Study Director|862-778-8300||
20554806|NCT02180646|University of Missouri|Dr Jill Kanaley|573-882-2519|kanaleyj@missouri.edu|
20554807|NCT05349617|Bavarian Nordic A/S|Medical Information|1-844-422-8274|medical.information_na@bavarian-nordic.com|
20554808|NCT00746954|Louis Stokes DVA Medical Center|Kingman P. Strohl MD|216-7913800|kingman.strohl@va.gov|
20554809|NCT00993447|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20554810|NCT01763567|Medtronic, Inc.|Julie Sekella|818-576-5000|Julie.Sekella@medtronic.com|
20554811|NCT03082963|University of Miami|Dr Jeffrey Goldberger|305-243-4356|j-goldberger@miami.edu|
20554812|NCT00970502|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
20554813|NCT01863680|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20554814|NCT00566228|Mayo Clinic|Luis F. Porrata, M.D.|507/284-2511|Porrata.Luis@mayo.edu|
20554815|NCT02740127|UT MD Anderson Cancer Center|Bobby Bellard, Assistant Professor, Anesthesiology & PeriOper Med|(713) 794-1461|bbellard@mdanderson.org|
20554816|NCT02041195|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20554817|NCT02707055|National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Lorenzo Leggio, M.D., PhD|+1 443 740 2801|lorenzo.leggio@nih.gov|
20554818|NCT03564496|NYU Langone|Matthew Lustberg|929 455 5090|matthew.lustberg@nyulangone.org|
20554819|NCT00674986|Hoffman-LaRoche|Medical Communications|800-821-8590||
20554820|NCT01880424|AstraZeneca|Peter Zeng|+86 21 6030 1867|peter.zeng@astrazeneca.com|
20554821|NCT01787617|Pennington Biomedical Research Center|Dr. Robert Newton|225-763-3034|Robert.Newton@pbrc.edu|
20554822|NCT03521635|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554823|NCT00414700|TiGenix n.v.|Nel Van Lommel, MSc, Manager Clinical Operations Europe, TiGenix n.v.|+3216396060|nel.vanlommel@tigenix.com|
20554824|NCT00902304|Novartis Pharmaceuticals|Study Director|862-778-8300||
20554825|NCT02492100|Massachusetts General Hospital|Areej El-Jawahri|248-763-3912|ael-jawahri@partners.org|
20554826|NCT05706506|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20554827|NCT04564833|Renibus Therapeutics|Stacey Ruiz, PhD / VP, Drug Development|424-209-2734|sruiz@renibus.com|
20554828|NCT02807948|Abbott|Adam M.Cline, MD, MSc.- Principal Scientist|818-493-2025|adam.cline@abbott.com|
20554829|NCT01303627|Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital 1. Anesthesiology|Derya Özkan MD|0903125962553|derya_z@yahoo.com|
20554830|NCT00440050|Oregon Health and Sciences University/Portland VA Medical Center, Portland, Oregon.|Joseph Quinn, MD|503-494-6976|quinnj@ohsu.edu|
20554831|NCT01576536|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|mike.stein@vanderbilt.edu|
20554832|NCT02066857|Emory University|Claude Jarrett, M.D.|404-778-8099|CJarrett@wilmingtonhealth.com|
20554833|NCT01175382|University of Alabama at Birmingham|Dr. Kathryn Burgio|205-558-7064|kburgio@uabmc.edu|
20554834|NCT02203019|Texas Tech University|Dr Kenneth Nugent|18067436847|kenneth.nugent@ttuhsc.edu|
20554835|NCT02377986|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
20554836|NCT04450823|Global Surgery Amsterdam|Dr Matthijs Botman|0031648073683|matthijsbotman@gmail.com|
20554837|NCT04495712|VA Portland Health Care System|Merritt Raitt MD|503-220-8262|merritt.raitt@va.gov|57571
20554838|NCT02511431|NIDDK|Christopher Koh, MD|301-443-9402|christopher.koh@nih.gov|
20554839|NCT02942160|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
20541691|NCT00239733|Weill Cornell|Kristen Marks|212-746-4177|markskr@med.cornell.edu|
20541692|NCT03715803|Universidad de Buenos Aires|Dr. Agustín Sampietro|+5491158336327|asampietro@live.com.ar|
20541693|NCT01332994|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20570943|NCT04896008|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
20570944|NCT03430583|Mezzion Pharmaceuticals|Dr. Scott Oglesby|919-260-5782|Oglesby@granzer.biz|
20570945|NCT04201288|Brown University|Ethan Moitra, Associate Professor of Psychiatry and Human Behavior|401-444-1949|ethan_moitra@brown.edu|
20570946|NCT00944229|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20570947|NCT01270828|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20570948|NCT06456385|Medical University of South Carolina|Dr. Xiaolong Peng|8437928642|pengxi@musc.edu|
20570949|NCT01810939|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20570950|NCT02963090|Duke Cancer Institute|Thomas Stinchcombe, MD|(919) 668-6688|thomas.stinchcombe@duke.edu|
20570951|NCT04400487|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20570952|NCT01677299|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
20570953|NCT02153905|National Cancer Institute|Dr. Steven Rosenberg|240-858-3080|sr78a@nih.gov|
20570954|NCT00520845|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn|615-322-4967|leora.horn@vanderbilt.edu|
20570955|NCT01189110|VAMC St. Louis MO|Deborah Fritz FNP PhD|314-652-4100|deborah.fritz@va.gov|53692
20570956|NCT00351377|Novartis Pharmaceuticals|Study Director|862-778-8300||
20570957|NCT01732549|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20570958|NCT01516749|University of California, San Francisco|Kieron S. Leslie, MD|415-206-4777|lesliek@derm.ucsf.edu|
20570959|NCT02030002|University of Minnesota|Thorsten Gruenheid|612-625-3903|tgruenhe@umn.edu|
20570960|NCT00566540|The Ohio State University Comprehensive Cancer Center|Enzer Ozer, MD|614-293-8074|enver.ozer@osumc.edu|
20570961|NCT03994731|Horizon Therapeutics USA, Inc.|Medical Monitor|866-479-6742|clinicaltrials@horizontherapeutics.com|
20570962|NCT01150461|Massachusetts General Hospital|Michael A. Fifer, MD|617 726-1832|mfifer@partners.org|
20570963|NCT01681992|GlaxoSmithKline|GSK Response Center|866-435-7343||
20570964|NCT01100606|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20570965|NCT01415934|University of Colorado|Carrie Brill|303 808 9708|CARRIE.BRILL@UCDENVER.EDU|
20570966|NCT02406248|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
20570967|NCT04148989|Intermountain Health|Director, Office of Research|(801) 408-1991|officeofresearch@imail.org|
20570968|NCT03329300|University of Alabama at Birmingham Department of Pediatrics|Marissa Gowey, PhD|2056386618|marissa.gowey.phd@gmail.com|
20570969|NCT00786643|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20570970|NCT04805073|University of Florida Health Gainesville|Adam Wendling, MD, Division Chief Obstetric Anesthesiology|3528707461|Awendling@anest.ufl.edu|
20570971|NCT00405938|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20570972|NCT02526498|Cancer Institute of New Jersey|Bruce Haffty|732-235-5203|hafftybg@cinj.rutgers.edu|
20570973|NCT05000047|Sonova USCS|Principal Investigator, Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20570974|NCT03017742|Masimo Corporation|Cristina Johnson|(949) 297-7000|clinicalresearchdept@masimo.com|
20570975|NCT01093469|Wake Forest|Dr Alan Fleischer|336-716-3775|adclark@wakehalth.edu|
20570976|NCT02694445|Department of Neurology, Xuan Wu Hospital,Beijing,China|Jianping Jia|010-63150669|jiajp@vip.126.com|
20570977|NCT01584518|Creighton University|Dr Anjan Talukdar|402-280-3586|talukdar.anjan@gmail.com|
20570978|NCT04529005|University of Illinois Chicago College of Pharmacy|Scott Benken|3123554107|benken@uic.edu|
20570979|NCT01782690|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20570980|NCT06719986|Purdue Pharma|Clinical Leader|1-888-726-7535|Purduemedinfo@pharma.com|
20570981|NCT00554996|Barbara Trautner, MD, PhD|Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
20570982|NCT02473965|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20570983|NCT01475305|Medimmune, LLC|Hasan Jafri, Medical Director|301-398-4431|jafrih@medimmune.com|
20570984|NCT00132678|Johnson & Johnson Pharmaceutical Research and Development|Director of Clinical Research|609 730-4576||
20570985|NCT03222505|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
20570986|NCT00953147|Sunovion|Respiratory Medical Director|1-866-503-6351||
20570987|NCT01484431|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20570988|NCT02224404|Universitair Ziekenhuis Gent|Dr. Hilde Beele|09/332 22 87|Hilde.Beele@uzgent.be|
20570989|NCT01251770|Hospital General de Niños Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
20570990|NCT02113124|The Transitional Learning Center at Galveston|Dr. Brent Masel|409-762-6661|bmasel@tlcgalveston.org|411
20570991|NCT02514239|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20570992|NCT01901419|Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan|Dr. Tso-Chou Lin|+886-2-87927128|tclin@mail.ndmctsgh.edu.tw|
20570993|NCT01888874|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
20570994|NCT05302440|University of Hong Kong|Dr. Derek Yee Tak CHEUNG|3917 6652|derekcheung@hku.hk|
20570995|NCT00475644|Eli Lilly and Company|Cheif Medical Officer|800-545-5979||
20570996|NCT01411241|Sanofi Pasteur|Director||Contact-US@sanofi.com|
20570997|NCT01976273|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20570998|NCT02301377|University of Michigan|Dr. Aarti Shakkottai|734-764-4123|aartik@med.umich.edu|
20570999|NCT03466047|Imperial College London|Carel le Roux|7970719453|c.leroux@imperial.ac.uk|
20554840|NCT01751568|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 544-7040|mallen@fhi360.org|11246
20554841|NCT03447769|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20554842|NCT04040985|Smith and Nephew|Michael Howarth|07540268240|michael.howarth@smith-nephew.com|+44
20554843|NCT03264989|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20554844|NCT00797667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554845|NCT03029208|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20554846|NCT01863017|University of Kansas Medical Center|Merlin G Butler|9135881800|mbutler4@kumc.edu|
20554847|NCT03207750|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20554848|NCT02334748|Novartis Pharma AG|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
20554849|NCT02493361|University of California, San Francisco|Dr. Katy Tsai|(415) 402-5483|katy.tsai@ucsf.edu|
20554850|NCT00289341|Rockefeller University|Mayu Frank|212-327-7443|frankm@rockefeller.edu|
20554851|NCT03893448|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554852|NCT02785406|The University of Texas Health Science Center at Houston|Scott Lane|713-486-2535|Scott.D.Lane@uth.tmc.edu|
20554853|NCT00583492|Henry Ford Health System|Benjamin Movsas|313-516-2319|bmovsas1@hfhs.org|
20554854|NCT01351740|British Columbia Centre for Excellence in HIV/AIDS|Dr Marianne Harris|1-604-806-8771|mharris@cfenet.ubc.ca|
20554855|NCT01568047|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
20554856|NCT00817089|UPENN|David Oslin|215 823 5894|oslin@upenn.edu|
20554857|NCT03783923|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
20554858|NCT00723177|NYSPI/Columbia University|Sandra Comer PhD|646 774-6146|SDC10@columbia.edu|
20554859|NCT00856583|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20554860|NCT01944046|Duke University|Linmarie Sikich, M.D.|919-681-0026|linmarie.sikich@duke.edu|
20554861|NCT00823082|GrifolsTherapeutics Inc.|Michael Ken Woodward, BSc, M.Sc|+1 919-316-6675|michael.woodward@grifols.com|
20554862|NCT03023891|Vanderbilt University Medical Center|Vivian Kawai|(615) 322-3304|vivian.k.kawai@vumc.org|
20554863|NCT03452917|University of Washington|Francis Kim|206-897-5264|fkim@u.washington.edu|
20554864|NCT01767116|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20554865|NCT04307186|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20554866|NCT01757964|University of Washington|David Suskind MD Professor of Pediatrics|206-987-2521|Jani.Klien@seattlechildrens.org|
20554867|NCT02854540|Stanford School of Medicine|Dr. Marlyanne Pol-Rodriguez|650-721-7144|mpr@stanford.edu|
20554868|NCT00754845|Canadian Cancer Trials Group|Senior Biostatistician|6135336430|dtu@ctg.queensu.ca|
20554869|NCT03238001|Digital Cognition Technologies|SVP, Clinical Affairs|6174331777|aholway@digitalcogtech.com|
20554870|NCT02582905|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD PhD MBA|214-645-6950|sherwood.brown@utsouthwestern.edu|
20554871|NCT01866709|ZS Pharma, Inc|Henrik Rasmussen, MD, PhD|443-699-5230|hrasmussen@zspharma.com|
20554872|NCT00499889|UT MD Anderson Cancer Center|Richard E. Champlin, MD/Professor|713-792-8848|pmcadams@mdanderson.org|
20554873|NCT00345397|Medical College of Wisconsin and Zablocki VAMC Milwaukee, WI|Mary F. Otterson, MD; Professor of Surgery|414-384-2000|Motterso@mcw.edu|4-1619
20554874|NCT05003791|University of Illinois Chicago|Dr. Madison Goodyke|6166446417|mbuurs2@uic.edu|
20554875|NCT01422070|Università degli Studi di Ferrara|Dr Maurizia Capuzzo|+393355932642|cpm@unife.it|
20554876|NCT03191903|Anika|Carol Pekar, VP Clinical Affairs|781-457-9218|cpekar@anikatherapeutics.com|
20508231|NCT02447458|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
20508232|NCT03162458|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761571|PutilovskiyMA@materiamedica.ru|302
20554877|NCT00503685|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20554878|NCT00927927|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
20554879|NCT01027793|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
20554880|NCT02379585|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
20554881|NCT02897141|Columbia University|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
20554882|NCT02936076|The Miriam Hospital|Dr. Jessica Unick|401-793-8966|junick@lifespan.org|
20554883|NCT03135522|The Johns Hopkins University School of Medicine|Dr. Robert A. Wise, M.D.|410-905-5688|rwise@jhmi.edu|
20554884|NCT01344460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20554885|NCT01343706|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554886|NCT03483623|David Grant Medical Center, Clinical Investigation Facility, Travis AFB, CA|Lt Col Laurie Migliore|707-423-7280|laurie.a.migliore.mil@mail.mil|
20554887|NCT00560833|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527013|NCT00787917|Novartis Pharmaceuticals|Study Director|862 778-8300||
20527014|NCT02172040|Kitov Pharmaceuticals, Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
20527015|NCT01463267|Kent State University|Joel Hughes|3306727721|jhughes1@kent.edu|
20527016|NCT05670314|University of Nottingham|Dr Afroditi Kouraki|0115 8231676|afroditi.kouraki1@nottingham.ac.uk|+44
20527017|NCT03334422|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20527018|NCT01472939|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20527019|NCT02539134|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20527020|NCT01675154|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-8295|abhimanyu.garg@utsouthwestern.edu|
20527021|NCT02971800|CHU de Québec|Dr Philippe Laberge|+1(418)525-4444|philippe.laberge@fmed.ulaval.ca|
20527022|NCT05323994|Sevier|Denis Morozov|8-495-93707-00|denis.morozov@servier.com|
20527023|NCT01253668|Merck|Dr. Stephen Keefe|215-220-9693|stephen.keefe@merck.com|
20527024|NCT00595114|Brigham and Women's Hospital|Dr. Bruce D. Levy|617-525-5407|blevy@partners.org|
20527025|NCT00616603|Loma Linda University Department of Anesthesiology|Patricia Moore, CCRP|909-558-8493|pamoore@llu.edu|
20527026|NCT04108988|Yale School of Medicine|Dr. Kimberly Hieftje|(203) 737-3301|kimberly.hieftje@yale.edu|
20527027|NCT00176436|Maryland Psychiatric Research Center|M. Patricia Ball, R.N., C.,M.S.|410-402-7663|pball@mprc.umaryland.edu|
20527028|NCT04566133|National Cancer Institute|Dr. Tim F. Greten|2407606114|gretentf@mail.nih.gov|
20527029|NCT00355706|Pain Management Center of Paducah|Laxmaiah Manchikanti, MD|2705548373|drm@asipp.org|100
20527030|NCT03180515|Stanford School of Medicine|Bronte-Stewart Lab|6507236709|hbsmovlab@gmail.com|
20527031|NCT04395391|Exact Sciences|Alexandra Massoud, Vice President of Clinical Affairs|608-284-5700|clinicaltrials@exactsciences.com|
20527032|NCT03435224|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
20527033|NCT02523235|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
20527034|NCT00367484|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Bettina Stubinski/Senior Medical Director|+49 6151 72 5200|service@merckgroup.com|
20527035|NCT04472026|University Of Florida|Naykky Singh Ospina|352) 273-8656|naykky.singhospina@medicine.ufl.edu|
20527036|NCT02570139|3M Critical and Chronic Care Solutions Division|Anne Swearingen, Manager, Clinical Operations|651 736 7826|aswearingen@mmm.com|
20527037|NCT00908076|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu|
20527038|NCT02609724|UZ Leuven|Prof. Nele Devoogdt|0032 16 34 25 15|nele.devoogdt@uzleuven.be|
20527039|NCT02382796|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527040|NCT03077659|NanOlogy, LLC|Gere S. diZerega, MD|805-595-1300|gere.dizerega@usbiotest.com|
20527041|NCT02570321|UCSF, Proctor Foundation|Sarah Abedelrahman, Research Data Analyst|2135093817|sarah.abdelrahman@ucsf.edu|
20527042|NCT04007107|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20527043|NCT04526574|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527044|NCT04068688|Duke University|Lauren Franz MBChB, MPH|919-681-0023|lauren.franz@duke.edu|
20527045|NCT04679051|Texas Tech University|Joaquin U Gonzales|806 834 5944|joaquin.gonzales@ttu.edu|
20527046|NCT00006305|University of Pittsburgh|Dr. Maria Brooks|4126241618|brooks@edc.pitt.edu|
20527047|NCT00662558|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20527048|NCT00329641|SWOG Statistical Office|SWOG Melanoma Statistician|206-667-4408||
20527049|NCT01075399|Certus International, Inc.|Edward M. Aten, MD, President|603.627.1212|eaten@certusintl.com|
20527050|NCT00396877|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
20527051|NCT02470403|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20527052|NCT02348359|Brace Pharma Capital|Vice President, Clinical and Regulatory|240-403-7153|info@Tyrogenex.com|
20527053|NCT01881087|Fundación Valle del Lili|Dr. Fredy Ariza, MD., MSc., PhD(a).|+57 3319090|fredyariza@hotmail.com|4122
20527054|NCT02631070|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20527055|NCT02669914|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovindan@wustl.edu|
20527056|NCT00980018|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20527057|NCT00987402|University Hospital, Geneva|Stephan Harbarth MD|+41-22-372.3357|stephan.harbarth@hcuge.ch|
20527058|NCT01985958|University of Pennsylvania|Edgar Ben-Josef, M.D.|215-662-3932|Edgar.Ben-Josef@uphs.upenn.edu|
20527059|NCT01362517|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20527060|NCT03878875|Imperial|Hemna Santilale|020|hemna.santilale@nhs.net|
20541694|NCT04170543|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20541695|NCT04628780|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541696|NCT05315479|Baudax Bio|Development|484-395-2440|info@baudaxbio.com|
20541697|NCT04303559|University of Pittsburgh|Dr. Margaret Ragni, Principal Investigator|412-209-7288|ragni@pitt.edu|
20541698|NCT00592488|Vanderbilt University|Todd Rice, MD|615 322-3412|todd.rice@vanderbilt.edu|
20541699|NCT01987102|Isofol Medical AB|Chief Medical Officer|+46 (0)702433750|karin.ganlov@isofolmedical.com|
20541700|NCT04378270|University of Pittsburgh|Jeffrey Gusenoff, MD|(412) 641-3960|gusenoffja@upmc.edu|
20541701|NCT01327599|Alcon Research, Ltd.|Doug Hubatsch, Therapeutic Unit Head, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20541702|NCT01132313|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20541703|NCT01156714|VAORD|Fred Ivey|410-605-7000|Frederick.Ivey@va.gov|6582
20541704|NCT01236521|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; Matthew.Bair@va.gov|
20541705|NCT03946748|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20541706|NCT02052752|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541707|NCT00165672|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
20541708|NCT04854694|FaceView Mask, LLC|Jeanne Hahne, MSN, RN|4155188574|jeannehahne@gmail.com|
20541709|NCT02784171|Canadian Cancer Trials Group|Dr. Lesley Seymour|613533600|lseymour@ctg.queensu.ca|75544
20541710|NCT04965688|Inova Health System|Adam Cohen, MD|7035767279|adam.cohen@inova.org|
20541711|NCT04266795|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20541712|NCT03043872|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20541713|NCT03868943|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-7548|rstrowd@wakehealth.edu|
20541714|NCT04551066|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20541715|NCT00369577|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20541716|NCT03915470|Destiny Pharma|Clinical Project Manager|+44 (0)1273-704440|info@destinypharma.com|
20541717|NCT00434109|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
20541718|NCT02937558|Xeris Pharmaceuticals, Inc.|Khaled Junaidi|312-517-1461|xerisclintrials@xerispharma.com|
20541719|NCT01463306|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541720|NCT03790917|National Medical Research Center for Preventive Medicine|professor Sergey Yu. Martsevich|89161643690|sergeymartsevich@mail.ru|
20541721|NCT04186871|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20541722|NCT00121186|SWOG Statistical Center|Study Statistician|206-667-4623||
20541723|NCT02682992|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, Regulatory Specialist Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20541724|NCT03274063|University of Edinburgh|Dr Philip Riches|07944625313|priches@staffmail.ed.ac.uk|
20541725|NCT01045694|University of Missouri-Columbia|Stephen Colbert|573-882-2275|colberts@health.missouri.edu|
20541726|NCT02679170|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541727|NCT01408459|University of Illinois at Chicago|Dr. Phyllis E. Bowen|708-524-0586|pbowen@uic.edu|
20541728|NCT00992459|Hyperion Therapeutics|Bruce Scharschmidt, MD, SVP, Chief MedicaL & Development Officer|650-745-7851|bruce.scharschmidt@hyperiontx.com|
20541729|NCT01511016|Baylor College of Medicine|Leanne Scott, PhD, Director of Sponsored Programs|713-798-6978|lbscott@bcm.edu|
20541730|NCT01023724|Bucci Laser Visiosn|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
20541731|NCT01025830|University of California Berkeley|Jayne Byakika Tusiime|1 510 219 7567|tusiimej@berkeley.edu|
20541732|NCT00543387|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541733|NCT00549445|University of Alabama at Birmingham|J. Edwin Blalock, PhD|205-934-6439|blalock@uab.edu|
20541734|NCT02373774|Columbia University Medical Center|Raquel Schrager|(212) 305-4687|rs3823@cumc.columbia.edu|
20541735|NCT00513435|Memorial Sloan-Kettering Cancer Center|Matthew Fury, MD|646-888-4233|furym@mskcc.org|
20541736|NCT02614729|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
20541737|NCT02467179|University of California San Diego|Dr. Gregory Feld|(858) 246-2972|gfeld@ucsd.edu|
20541738|NCT02796677|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20541739|NCT03798717|University of Portsmouth|Dr. Ant Shepherd|02392845289|ant.shepherd@port.ac.uk|
20541740|NCT00942903|The Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
20541741|NCT04002960|Masimo|Chelsea Frank|949-297-7000|studies@masimo.com|
20541742|NCT00961181|University Medical Center, Freiburg i.Br., Germany|Prof. Dr. Christoph Hehrlein|+49 761 270|christoph.hehrlein@uniklinik-freiburg.de|6095
20554888|NCT01085318|EMD Serono, Inc.|Fernando Dangond, MD FAAN|781-681-2348|fernando.dangond@emdserono.com|
20541743|NCT01045967|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20541744|NCT01777308|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541745|NCT03410628|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20541746|NCT03212326|Weill Cornell Medical College|Dr. Christopher Liu|212-746-2655|chl7001@med.cornell.edu|
20541747|NCT02918617|University of Texas Health San Antonio|Bennett Amaechi, DDS|210-567-3185|amaechi@uthscsa.edu|
20541748|NCT03057496|Schepens Eye Research Institute of Massachusetts Eye and Ear|Alex Bowers|617 912 2512|alex_bowers@meei.harvard.edu|
20541749|NCT02040623|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20541750|NCT03689582|University of Michigan Rogel Cancer Center|Morand Piert, MD|734-936-5388|mpiert@med.umich.edu|
20541751|NCT01790594|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20541752|NCT00381004|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
20541753|NCT01560286|BioMarin Pharmaceutical Inc|Sr. Medical Director, Clinical Science|415-475-5854|Ari.Gershman@bmrn.com|
20541754|NCT00404651|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20541755|NCT02785185|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20541756|NCT01364584|University of Colorado School of Medicine|Judith G Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
20541757|NCT00181363|Maastro Radiation Oncology|J. Buijsen,|+31 (0)88-44-55-666|jeroen.buijsen@maastro.nl|
20541758|NCT02372877|Fresenius Kabi|Jason Friedmann|847-550-2365|jason.friedmann@fresenius-kabi.com|
20541759|NCT02362321|CHU de Québec|Principal Investigator|418-649-0252|michel.prudhomme.chuq@gmail.com|
20541760|NCT03273673|Virginia Tech|Dr. Robin Queen|(540) 231-3134|rmqueen@vt.edu|
20541761|NCT01982123|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
20541762|NCT04363879|AtriumHealth|Dr. Brad Hurst, Director of Assisted Reproduction Program|7043553153|Brad.Hurst@atriumhealth.org|
20541763|NCT01822197|Nationwide Childrens Hospital|Dr Ben Kopp|6147224766|benjamin.kopp@nationwidechildrens.org|
20541764|NCT01132807|Alliance for Clinical Trials in Oncology|David J. Straus, MD|212-639-8365|strausd@mskcc.org|
20541765|NCT00763412|Washington University in St Louis|Ana Maria Arbelaez|314-286-1138|arbelaez_a@kids.wustl.edu|
20541766|NCT05030350|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
20554889|NCT01059617|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554890|NCT02331992|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 5740123|cpaptrial@fphcare.co.nz|
20554891|NCT01688336|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20554892|NCT00612313|UT Southwestern Medical Center|Dr. Graham Emslie and Dr. Betsy Kennard|214-456-5900|beth.kennard@utsouthwestern.edu|
20554893|NCT05932290|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554894|NCT03864614|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20554895|NCT00910481|King's College London|Professor Divaka Perera|02071887188|divaka.perera@kcl.ac.uk|
20566957|NCT00822900|Emergency Neurosciences, Emergency Medicine, Emory University|David W. Wright, Associate Professor, Department of Emergency Medicine, Emory University|404-778-1709|david.wright@emory.edu|
20566958|NCT00701415|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20566959|NCT02106884|UZ Leuven|Prof. Dr. Eric Van Cutsem|0032 16 344418|eric.vancutsem@uzleuven.be|
20566960|NCT01868230|UMass Amherst|Dr. Lisa Chasan-Taber, Principal Investigator|4135451664|lct@umass.edu|
20566961|NCT00109031|Swedish Orphan Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
20566962|NCT01822756|Incyte Corporation|Study Director|1-855-463-3463||
20566963|NCT02208843|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566964|NCT04899999|University of Rochester|Dr. Francisco Cartujano Barrera, M.D|(585) 273-1646|francisco_cartujano@urmc.rochester.edu|
20527061|NCT01133288|Kennedy Krieger Institute|Eric Levey, M.D.|443-923-9148|levey@kennedykrieger.org|
20527062|NCT00551161|North Shore-LIJ Health System|Marc L. Gordon,MD|516-562-3492|MLGordon@nshs.edu|
20527063|NCT00934856|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20527064|NCT01273155|National Cancer Institute|Naoko Takebe, M.D., Ph.D.|240-781-3398|Takeben@mail.nih.gov|
20527065|NCT01256385|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
20527066|NCT01438814|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20527067|NCT01666210|Ocular Therapeutix, Inc.|Eric Ankerud|781-357-4013|eankerud@ocutx.com|
20527068|NCT00404924|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20527069|NCT03887429|Promentis Pharmaceuticals|Chad Beyer|(414) 238 2992|cbeyer@promentispharma.com|
20527070|NCT03303391|University of Texas Southwestern Medical Center|Peter Van Buren|214-645-8293|peter.vanburen@utsouthwestern.edu|
20527071|NCT00195494|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20527072|NCT03019003|Massachusetts General Hospital Cancer Center|Dr. Sara Pai, MD, PhD|6178779118|sara.pai@mgh.harvard.edu|
20527073|NCT00926536|Stanford University|Dr Nishita Kothary|6504986020|kothary@stanford.edu|
20527074|NCT01267201|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527075|NCT00501059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20527076|NCT02124759|UTHSC San Antonio|Dr. Nicolas Musi|630-5001|musi@uthscsa.edu|210
20527077|NCT03653091|Fractyl Health, Inc.|Sarah Hackett, Sr. Director of Clinical Operations|(781) 902-8840|shackett@fractyl.com|
20527078|NCT04249622|Mayo Clinic|Saranya Chumsri, MD|904-953-2000|Chumsri.Saranya@mayo.edu|
20571000|NCT03211234|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
20571001|NCT01020877|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20571002|NCT00790400|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
20571003|NCT01997905|Methodist Hospital Houston|Basel Ramlawi, MD|713-441-5200|basel.ramlawi@gmail.com|
20571004|NCT01006980|Hoffman-LaRoche|Medical Communications|800-821-8590||
20571005|NCT01483144|Cancer Prevention Pharmaceuticals|Michelle Boytim|520-908-7774|mboytim@canprevent.com|
20541767|NCT00178477|University of Rochester Medical Center|Walter O'Dell, Ph.D.|585-275-9996|walter_odell@urmc.rochester.edu|
20571006|NCT04307940|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20541768|NCT03654690|Brown University|Dr. Tyler Wray|4018636659|tyler_wray@brown.edu|
20541769|NCT02711137|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20571007|NCT05543174|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20541770|NCT00203229|Thomas Jefferson University|M. Alan Stiles|215-955-6215|Alan.Stiles@Jefferson.edu|
20541771|NCT03477396|City of Hope|Dr. MIna Sedrak|626-359-8111|msedrak@coh.org|
20541772|NCT00068341|Jonsson Comprehensive Cancer Center|Helena Chang, M.D., Ph.D., Revlon/UCLA Breast Center|310-794-5640|hchang@mednet.ucla.edu|
20541773|NCT03922581|Emory University|Abigail Lott, PhD|404-712-0159|abigail.lott@emoryhealthcare.org|
20541774|NCT05098028|Bausch Health Americas, Inc|Varsha Bhatt|7072301712|varsha.bhatt@bauschhealth.com|
20541775|NCT01508312|Memorial Sloan Kettering Cancer Center|Dr. Alison Moskowitz|212-639-4839|moskowia@mskcc.org|
20541776|NCT02223715|Otsuka Pharmaceutical Co., LTD.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
20541777|NCT02222558|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
20541778|NCT01745367|Aveo Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
20541779|NCT00896298|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
20541780|NCT02322281|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
20541781|NCT00494585|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
20541782|NCT01507688|VA HSRD PRIS-M QUERI and CHIC HSRD Centers|Teresa Damush Ph.D.|317-988-4277|Teresa.Damush@va.gov|
20541783|NCT02163824|Kala Pharmaceuticals, Inc|VP, Clinical Development||Results001@kalarx.com|
20541784|NCT00936702|Mayo Clinic|Matthew P. Goetz, M.D.|507 284-2511|goetz.matthew@mayo.edu|
20541785|NCT00790192|Sunovion|Josephine Cucchiaro, PhD, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20541786|NCT00354679|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
20541787|NCT03456076|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20541788|NCT00466440|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20541789|NCT01844388|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20541790|NCT03187132|CedarsSinaiMC|R. Brennan Spiegel|310-423-6784|Brennan.Spiegel@cshs.org|
20541791|NCT01837277|Federal University of Bahia|Professor Carlos Brites|+5555992329552|crbrites@hotmail.com|
20541792|NCT02541812|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
20541793|NCT01020786|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20541794|NCT05350163|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
20541795|NCT03609177|Dana Farber Cancer Institute|James Tulsky, MD, Chair of Suppportive Oncology Department|617-582-9201|JamesA_Tulsky@dfci.harvard.edu|
20541796|NCT01358825|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541797|NCT00113841|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-9660|xzhou@mdanderson.org|
20541798|NCT02366195|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20541799|NCT01076959|Abbott|Global Medical Services|800-633-9110||
20541800|NCT02452424|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20541801|NCT04266925|University of Alabama at Birmingham|Dr David Schwebel,|205-934-4068|schwebel@uab.edu|
20541802|NCT01059318|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20541803|NCT00386243|Center on Implementing Evidence Based Practice|Matthew J. Bair, MD MS|317-988-2058|mbair@iupui.edu|
20541804|NCT02781610|Seattle Children's|Michelle Skalland (Biostatistician)|206-884-7519|michelle.skalland@seattlechildrens.org|
20541805|NCT00176462|Rutgers Cancer Institute of New Jersey|Richard Drachtman, MD|732-235-8675|drachtri@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
20541806|NCT01840345|Virginia Commonwealth University|Dr. Dace Svikis|(804) 827-1184|dssvikis@vcu.edu|
20541807|NCT01150097|Novartis Pharmaceuticals|Study Director|862-778-8300||
20541808|NCT01301833|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20541809|NCT01792115|NIDDK|Dr. Yaron Rotman|301-451-6553|rotmanyaron@mail.nih.gov|
20541810|NCT02302365|Terumo BCT|Isobelle Galeon, MD, MPH, MSCS, Medical Monitor Clinical Safety|+1 303 542-5166|Isobelle.Galeon@Terumobct.com|
20541811|NCT02719171|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20541812|NCT00227721|Barbara Ann Karmanos Cancer Institute|Robert Morris, M.D.|313-576-9436|rmorris@med.wayne.edu|
20541813|NCT01083849|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20571008|NCT02356705|Bassett Healthcare|Dr. David Ullman|585-750-7510|doccfi@hotmail.com|
20541814|NCT04456634|Medicines for Malaria Venture (MMV)|Jacques Herve|+41 79 370 40 63|hervej@mmv.org|
20541815|NCT05298202|University of Montana|Dustin Slivka|(406) 243-2389|dustin.slivka@umontana.edu|
20541816|NCT01875159|Uniformed Services University|Carl E. Hunt, M.D.|240-694-2676|carl.hunt@usuhs.edu|
20541817|NCT01253642|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
20541818|NCT02539797|University of California, Los Angeles|Dr. Yuri Rassovsky|3104783711|yurir@ucla.edu|
20541819|NCT01432405|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
20541820|NCT01139814|Catheter Robotics, Inc.|Vice President, Clinical and Regulatory Affairs|973-426-0300|research@catheterrobotics.com|
20541821|NCT02752880|Chang Gung Memorial Hospital|Dr. YH Huang|+886975360240|igighuang@gmail.com|
20541822|NCT01609348|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
20541823|NCT03430791|Miami Cancer Institute at Baptist Health, Inc.|Yazmin Odia|786-596-2000|YazminO@baptisthealth.net|
20541824|NCT00383786|Baylor College of Medicine|Sanjay Mathew, MD/PI|7137985439|sjmathew@bcm.edu|
20541825|NCT00531284|Amgen, Inc.|Study Director|866-572-6436||
20541826|NCT00291135|University of Kansas Medical Center Research Institute|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
20541827|NCT02219464|Vanderbilt University Medical Center|Cindy Pastern, RN BSN CCRP|615-343-0259|cindy.pastern@vanderbilt.edu|
20541828|NCT03270943|University of North Carolina at Chapel Hill|Christine Lathren, MD, MPH|919-966-8586|lathren@email.unc.edu|
20541829|NCT02981368|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
20541830|NCT02544321|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20541831|NCT03493945|National Cancer Institute|Dr. James L. Gulley|301-480-7164|gulleyj@mail.nih.gov|
20541832|NCT01517750|HELIOS-Klinik Ambrock|Dr Georg Nilius|+492331-9742005|klinik-ambrock.pneumo@t-online.de|
20541833|NCT01307319|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20541834|NCT02735239|Ludwig Institute for Cancer Research|Jonathan Skipper|212-450-1539|jskipper@lcr.org|
20541835|NCT02719535|The Hong Kong Polytechnic University|Dr. Andrew Lam|85227666109|andrew.kc.lam@polyu.edu.hk|
20541836|NCT02152631|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20541837|NCT02038153|Montefiore|Dr. Ira Braunschweig|718 920-4826|ibraunsc@montefiore.org|
20541838|NCT02647281|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541839|NCT00666666|Rutgers Cancer Institute of New Jersey|Robert DiPaola, MD|732-235-8675|zelinsta@cinj.rutgers.edu, dipaolrs@cinj.rutgers.edu, rizzoji@cinj.rutgers.edu|
20541840|NCT03347123|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20541841|NCT00754377|Louis Stokes VA Medical Center|Dr. David Aron|(216) 791-2300|david.aron@va.gov|5836
20541842|NCT03985761|Rutgers The State University of NJ|Dr. Gerard G Fluet DPT, PhD|(973) 972-8529|fluetge@shp.rutgers.edu|
20541843|NCT02532465|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
20541844|NCT02493036|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
20541845|NCT02420093|University of Michigan Health System|Patricia Connors, PT, DScPT, OMPT|734-763-6464|pattyconnors219@gmail.com|
20541846|NCT01495286|University of Arkansas|Anita Mitchell PhD, coinvestigator|501-686-7021|AMitchell@uams.edu|
20541847|NCT03001557|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20541848|NCT01794000|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20541849|NCT00965081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20541850|NCT00964496|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
20541851|NCT01367834|UNC Chapel Hill|Rebecca Knickmeyer Santelli|9199662216|rebecca_knickmeyer@med.unc.edu|
20541852|NCT00255190|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20541853|NCT02513121|University of California, San Diego|Dr. Jeffrey Schwimmer|858-966-8907|jschwimmer@ucsd.edu|
20541854|NCT02609308|Universidad Autónoma de Nuevo León|Carlos Acosta-Olivo, PhD|+52 81 8347-3056|dr.carlosacosta@gmail.com|
20541855|NCT03392935|University of Utah Dermatology|Dr. Karen Stolman, Assistant Professor, Dermatology|8015816465|ks@checkmateproductions.com|
20541856|NCT04537793|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20541857|NCT00988598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541858|NCT01303939|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
20541859|NCT00256724|Advanced Circulatory|Nathan Burkhart|651.403.5600|nburkhart@advancedcirculatory.com|
20541860|NCT01217463|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
20541861|NCT02197702|StJustineH|Dr Francine Ducharme|5143454931|Francine.m.ducharme@umontreal.ca|4398
20541862|NCT01569841|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20541863|NCT00706446|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
20541864|NCT02485561|Washington University in St. Louis|Amy McQueen|3142862016|amcqueen@wustl.edu|
20541865|NCT01141712|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20541866|NCT01012258|Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd.|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
20541867|NCT01814527|East Carolina University|Joseph Armen DO|252-744-3212|armenj@ecu.edu|
20541868|NCT03742973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20541869|NCT03571204|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|msneller@niaid.nih.gov|
20541870|NCT00857285|Daiichi Sankyo, Inc.|Senior Director, Regulatory Operations|732-590-5000|hmkessler@dsus.com|
20541871|NCT01126723|Institute for Aging Research, Hebrew SeniorLife|Dr. Lewis Lipsitz|617-971-5318|lipsitz@hsl.harvard.edu|
20541872|NCT03081884|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
20541873|NCT03948334|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20541874|NCT05114473|University of Valencia|Dr. Borja Perez-Dominguez|697464680|f.borja.perez@uv.es|34
20541875|NCT00279916|Mayo Clinic|Dr. Laura Orvidas|507-284-3410|orvidas.laura@mayo.edu|
20541876|NCT01807598|Stanford University|Jason R. Gotlib|650-736-1253|jason.gotlib@stanford.edu|
20541877|NCT00731679|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
20541878|NCT03384940|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20541879|NCT04184297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20541880|NCT02412098|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20541881|NCT03089580|University of Michigan / Kellogg Eye Center|Sarah Wood|734-615-2479|skwood@med.umich.edu|
20541882|NCT03087513|Toronto Western Hospital/University Health Network|Study Coordinator|416-603-5800|emad.alazazi@uhnresearch.ca|6237
20541883|NCT01288989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508233|NCT03094832|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508234|NCT03812588|New York State Psychiatric Institute|Dr. Bret Rutherford|646-774-8660|bret.rutherford@nyspi.columbia.edu|
20508235|NCT00442767|Montefiore Medical Center|Dr. Rubina Heptulla|718-920-4664|rheptull@montefiore.org|
20541884|NCT03890588|HealthPartners Institute|JoAnn Sperl-Hillen, MD, Senior Clinical Investigator|952-967-5009|joann.m.sperlhillen@healthpartners.com|
20541885|NCT05017701|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20541886|NCT04896593|Anxiety Disorders Center|David Tolin, Ph.D.|860-545-7685|david.tolin@hhchealth.org|
20541887|NCT00452790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541888|NCT05551611|Kocaeli University|Dr. Suzi ÖZDEMİR|05548488674|suzi.ozdemir@gmail.com|
20541889|NCT00985673|GlaxoSmithKline|GSK Response Center|866-435-7343||
20541890|NCT02252146|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20541891|NCT05736874|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20541892|NCT00984256|US Army Medical Materiel Development Activity (USAMMDA)|Michelle Mathers|301-619-8061|Michelle.mathers@us.army.mil|
20541893|NCT00246519|University of Florida|Julie A. Johnson|352-273-6007|johnson@cop.ufl.edu|
20541894|NCT01131507|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20541895|NCT04388111|Houston Methodist Hospital|Research Coordinator|346 238 1603|tsullivan@houstonmethodist.org|
20541896|NCT03776747|University of Iowa|Dr. Eric Hoffman|(319) 356-1381|eric-hoffman@uiowa.edu|
20541897|NCT00527735|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20541898|NCT01855412|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
20541899|NCT01293825|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|(216) 844-2808|martha.sajatovic@uhhospitals.org|
20541900|NCT01302483|Department of Periodontics & Endodontics, School of Dental Medicine, University of Buffalo, SUNY|Dr. Sebastian Ciancio|(716) 829-3848|ciancio@buffalo.edu|
20541901|NCT02960516|Vanderbilt university medical center|Dr. Wesley Thayer|+1 (615)936-3759|wesley.thayer@vumc.org|
20541902|NCT00669214|Genentech, Inc.|Medical Communications|800-821-8590||
20541903|NCT01121146|AORI|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
20541904|NCT00346216|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541905|NCT01276639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541906|NCT03431441|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|904-443-1396|mbishop4@its.jnj.com|
20508236|NCT01181778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20508237|NCT02674685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508238|NCT02713789|Urovant Sciences GmbH|JP Nicandro, PharmD|833-219-5557|clinicaltrials@urovant.com|
20541907|NCT03999515|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
20508239|NCT04491240|MC Dinasty|Tyumina Olga|+78462039808|centr123@bk.ru|201
20541908|NCT03400852|Mallinckrodt|Medical Information Call Center|1-800-844-2830|MedInfo@mnk.com|
20541909|NCT01285401|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20571009|NCT06024278|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
20508240|NCT01305213|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
20508241|NCT01293084|Johns Hopkins Univeristy|Beth Laube Professor|410-502-5791|blaube@jhmi.edu|
20571010|NCT03104075|The Jackson Laboratory|Dr. Jacques Banchereau|860-837-2443|jacques.banchereau@jax.org|
20571011|NCT01933243|Nationwide Children's Hospital|Andrea Bonny|614-722-2458|andrea.bonny@nationwidechildrens.org|
20571012|NCT00015847|OHSU Knight Cancer Institute|Dr. Brian Druker|503-494-7999|trials@ohsu.edu|
20571013|NCT00709228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20571014|NCT02870972|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20571015|NCT04497389|University of Utah|Joseph Tonna, MD|801-587-6271|joseph.tonna@hsc.utah.edu|
20571016|NCT05646719|Opus Genetics|Sarah Callahan|984-884-6030|Scallahan@opusgtx.com|
20571017|NCT01594827|Johns Hopkins Unviversity School of Medicine|Dr. Mark Jennings|410-502-7044|mjenni15@jhmi.edu|
20571018|NCT02484664|Brigham and Women's Hospital|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
20571019|NCT03445533|Idera Pharmaceuticals, Inc.|Head of Clinical Operations|484-348-1605|lcolfer@iderapharma.com|
20571020|NCT02615509|Philips AB|Daniel Stenströmer|+46 708 303 767|daniel.stenstromer@philips.com|
20571021|NCT03334253|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|8139758690|rkraker@jaeb.org|
20571022|NCT03274453|New York University School of Medicine|Kirsten Boenigk|212 598 6085|Kirsten.Boenigk@nyumc.org|
20571023|NCT00703339|Lung Rx|Rosa Negro-Vilar|240-821-1881|rnegrovilar@lungrx.com|
20571024|NCT00945672|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571025|NCT00968526|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571026|NCT00584077|University of Texas-Galveston|Alexander Duarte, MD|409-772-2436|aduarte@utmb.edu|
20571027|NCT02106962|California Insitute of Renal Research, Inc.|Mark M. Boiskin, M.D.|858-637-4600|mboiskin@bnmg.org|
20571028|NCT05569421|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20527079|NCT03627416|Jagiellonian University Medical College|Dr. Jakub Antczak|+48 795 421 153|jantczak@uj.edu.pl|
20527080|NCT00875433|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20527081|NCT02923245|Brown University|Almaz Dessie, MD||almaz@brown.edu|
20527082|NCT05530980|University of South Carolina College of Nursing|Dr. Demetrius Abshire|803-576-6262|abshired@mailbox.sc.edu|
20527083|NCT00684749|University of Minnesota|Umar Choudry/Bruce Cunningham|6126250697|choud008@umn.edu|
20527084|NCT02093390|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20527085|NCT02824562|UAB|Jessica Merlin|2059967894|jmerlin@uabmc.edu|
20527086|NCT03246061|Relievant Medsystems|Chris Hilker, Sr. Director Clinical Affairs|(650) 368-1000|chilker@relievant.com|
20527087|NCT00401401|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20527088|NCT02864316|Sidney Kimmel Comprehensive Cancer Center|Patrick Forde, MBBCh|410-955-3974|pforde1@jhmi.edu|
20527089|NCT04710368|Mount Sinai Hospital|Annapoorna S Kini, M.D.|(212) 241-4181|annapoorna.kini@mountsinai.org|
20527090|NCT05459558|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
20527091|NCT03278847|Imperial College London|Dr Chris Gale, Reader in Neonatal Medicine|+44 203 3153519|christopher.gale@imperial.ac.uk|
20527092|NCT01887288|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
20527093|NCT01092637|National Perinatal Epidemiology Unit, University of Oxford|Clinical Trials Unit|+44 1865 289700|ctu@npeu.ox.ac.uk|
20527094|NCT02921750|Mölnlycke Health Care|Maria Åberg Håkansson|+46 31722 3000|maria.aberghakansson@molnlycke.com|
20541910|NCT02366312|NYU College of Dentistry|Dr. Brian Schmidt|212-998-8900|brianl.schmidt@nyu.edu|
20541911|NCT05200143|Providence Portland Medical Center|Dr. Matthew Taylor|503-215-1979|canrsrchstudies@providence.org|
20541912|NCT03719131|Emory University|Kavita Dhodapkar, MD|404-785-1112|kavita.dhodapkar@emory.edu|
20508242|NCT02259127|MRC CTU at UCL|Prof Diana M Gibb (Chief Investigator)|+44 (0) 207 670 4700|diana.gibb@ucl.ac.uk|
20541913|NCT01544920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541914|NCT00411749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20541915|NCT02525653|Memorial Sloan Kettering Cancer Center|Dr. Paul Paik, MD|646-608-3759|paikp@mskcc.org|
20541916|NCT03170661|LUMC|Drs. Maarten Honing|0715264038|g.h.m.honing@lumc.nl|
20541917|NCT03244917|Hebrew SeniorLife|Susan Mitchell MD, MPH|6172813669|smitchell@hsl.harvard.edu|
20541918|NCT01272232|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20541919|NCT01147666|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
20541920|NCT00796666|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541921|NCT02159066|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-102|ClinicalTrials.gov_Inquiries@pfizer.com|
20541922|NCT01135134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20541923|NCT00631358|Alcon Labs|Alcon Clinical|1-888-451-3937; 1-817-568-6725|medinfo@alconlabs.com|
20541924|NCT04140396|Stanford University|Chi-Ho Ban Tsui|(650) 200-9107|bantsui@stanford.edu|
20541925|NCT01156480|NorthShore University HealthSystem|Dr. Brandy Frost|847-570-2033|bfrost@northshore.org|
20541926|NCT05470387|Palisade Bio|Mitchell Jones, CMO|858-704-4900|mitchell.jones@palisadebio.com|
20541927|NCT01255423|Novartis Consumer Health|Clinical Project Leader|0041223635528||
20541928|NCT03367858|University of Rhode Island|Dr. Sarah Feldstein Ewing|401-874-4251|feldsteinewing@uri.edu|
20541929|NCT03831477|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20541930|NCT01176058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541931|NCT02254473|TRIA Orthopaedic Center|Megan Reams|952-806-5329|megan.reams@tria.com|
20541932|NCT01858363|Spectranetics|Nicolas Aguirre|+1-312-297-6655|nicolas.aguirre@philips.com|
20541933|NCT01859923|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20541934|NCT00429949|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20541935|NCT03148613|Carrot Inc.|Director Clinical Affairs|650-906-4255|craig@carrot.co|
20541936|NCT02878317|University of Nottingham|Professor Maarten Taal|01332 224618|m.taal@nottingham.ac.uk|
20541937|NCT00057863|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20541938|NCT00764361|Nanotherapeutics, Inc.|John Abernethy, MD - Medical Director|386-462-9663|jabernethy@nanotherapeutics.com|326
20541939|NCT02090426|Massachusetts Institute of Technology|Amy Finkelstein, PhD|6173246995|jgubb@mit.edu|
20541940|NCT02462148|Wake Forest Baptist Health|Dr. Jimmy Turner|3368064498|jturner@wakehealth.edu|
20541941|NCT02079038|Vertiflex|Steve Reitzler|442-325-5934|Stephen.reitzler2@bsci.com|
20541942|NCT03480152|National Cancer Institute|Dr. Steven Rosenberg|240-858.3080|steven-rosenberg@nih.gov|
20541943|NCT01308736|Rutgers Robert Wood Johnson Medical School|Dr. Marc Steinberg|7322354341|marc.steinberg@rutgers.edu|
20541944|NCT03634085|Venn Life Sciences|Simone van Broekhoven / Clinical Trial Manager|+310765480625|simone.vanbroekhoven@vennlife.com|
20541945|NCT04276233|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20541946|NCT03246789|Weill Cornell Institute of Geriatric Psychiatry|Dr. Patricia Marino|(914) 997-8691|pam2029@med.cornell.edu|
20541947|NCT01946139|Emmes Company, LLC|Kimberly Mosby-Griffin|301 251-1161|kmosby@emmes.com|10158
20541948|NCT01191723|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20541949|NCT03101566|University of Michigan Rogel Cancer Center|Vaibhav Sahai, MBBS, MS|734-936-4991|vsahai@med.umich.edu|
20541950|NCT00488488|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527095|NCT04703270|St George's, University of London|Dr Sarah Sturrock|020 8672 9944|ssturroc@sgul.ac.uk|
20527096|NCT00114738|National Cancer Institute|Dr. Wyndham Wilson|301-435-2415|wyndham_wilson@nih.gov|
20527097|NCT01149421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20527098|NCT03738800|Mayne Pharma|Mayne Pharma|1 252 752 3800|us.medicalinformation@maynepharma.com|
20527099|NCT00766467|Dana-Farber Cancer Insitute|Eudocia Quant Lee, MD|617-632-2166|eqlee@partners.org|
20527100|NCT02777944|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
20527101|NCT02223819|Columbia University|Shaheer A. Khan, DO|212-342-5162|sk4488@cumc.columbia.edu|
20527102|NCT00624559|University of Delaware|Dr. William Farquhar|302-831-6178|wbf@udel.edu|
20527103|NCT01678885|Pennington Biomedical Research Center|Corby Martin, Ph.D.|225-763-2585|corby.martin@pbrc.edu|
20527104|NCT05873335|Gabi SmartCare|Edouard Carton|472537844|edouard.carton@gabismartcare.com|
20527105|NCT01153620|B. Braun Medical, Centre of Excellence|Medical Affairs Manager|+41 58 258 55 47||
20527106|NCT03329248|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20527107|NCT01522235|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|6176328454|rfreeman@bidmc.harvard.edu|
20527108|NCT03769194|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
20527109|NCT01996657|Wuhan Asia Heart Hospital|Dr.Litao Zhang|+862765796888|zhengleetau@qq.com|8204
20527110|NCT03000530|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20527111|NCT01523704|Fujita Health University School of Medicine|Eiichi Watanabe, MD, PhD|+81-562-93-2312|enwatan@fujita-hu.ac.jp|
20527112|NCT01430624|Medical University of South Carolina|Heidi Resnick, Ph.D.|843-792-2945|resnickh@musc.edu|
20527113|NCT00798018|Department of Anesthesiology, West China Second Hospital|Han Huang|80-028-8550-3753|huanghan1981@hotmail.com|
20527114|NCT02565706|William Paterson University|Jennifer Di Noia|973.720.3714|dinoiaj@wpunj.edu|
20527115|NCT00416793|UT MD Anderson Cancer Center|Gauri Varadhachary, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
20541951|NCT03435185|University of Health Sciences Dr. Lütfi Kırdar Kartal Training and Research Hospital|Dr. Cem Bölük|+902164413900|cem.boluk@sbu.edu.tr|
20541952|NCT03901144|Perrigo/ACO Hud Nordic|Dr Tina Holm|+46732744113|tina.holm@perrigo.com|
20541953|NCT04936061|CoolTech|Clinical Trial Manager|570-228-8140|jholland@cooltechcorp.com|
20541954|NCT04445662|Massachusetts General Hospital|Travis P Baggett MD MPH|617-643-9314|tbaggett@mgh.harvard.edu|
20541955|NCT01451385|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20541956|NCT01598922|McLean Hospital|Dr.Isabelle Rosso|6178552607|irosso@partners.org|
20541957|NCT02488005|Icahn School of Medicine at Mount Sinai|Becky Phan|212-824-7785|becky.phan@mssm.edu|
20541958|NCT05864586|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20541959|NCT03635424|Medtronic Coronary and Structural Heart Clinical|Hatice Bilgic Lim, PhD; Principal Clinical Research Specialist|763-526-1018|hatice.bilgic.lim@medtronic.com|
20541960|NCT05081219|Atrium Health Wake Forest Baptist|Suzanne Craft, PhD|336.713.8846|Suzanne.Craft@advocatehealth.org|
20541961|NCT06019728|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20554896|NCT00136955|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20541962|NCT00543777|UT MD Anderson Cancer Center|Haesun Choi, MD/Professor, Abdominal Imaging Department|(713) 745-4693|hchoi@mdanderson.org|
20541963|NCT02110095|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20541964|NCT01604291|Hoffmann-La Roche|Medical Communications|800-821-8590|Genentech@druginfo.com|
20541965|NCT01050634|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541966|NCT01702844|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20541967|NCT03956550|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20541968|NCT00876200|Hospices Civils de Lyon|Dr Behrouz KASSAI-KOUPAI|472116911|behrouz.kassai-koupai@chu-lyon.fr|+33
20541969|NCT04154943|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20541970|NCT00296816|Sanofi|Trial Trans[parency Team||Contact_us@sanofi.com|
20541971|NCT01363700|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20541972|NCT00148759|Emory University|Ighovwerha Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
20541973|NCT01454596|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
20541974|NCT00230126|The Ohio State University|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
20541975|NCT00434226|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20541976|NCT02721875|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20541977|NCT03483896|University of Southern California|Prof. Kyle Konis, Ph.D|(213) 740-2723|kkonis@usc.edu|
20541978|NCT02052544|DSM Nutritional Products Ltd Branch Pentapharm|Anne Brisset|41 61 706 4837|Anne.Brisset@pentapharm.com|
20541979|NCT02888106|Hepatera LLC|Yana Deloveri|+7 495 762 52 53|deloveri@hepatera.ru|42-14
20541980|NCT02314936|KGK Synergize Inc.|Dr. Tetyana Pelipyagina|5194389374|drtetyana@kgksynergize.com|
20541981|NCT00430716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20541982|NCT00837200|Milton S Hershey Medical Center|Joseph J Drabick, MD|717-531-5911|jdrabick@hmc.psu.edu|
20541983|NCT00675909|Seattle Children's Hospital|Eileen Klein, MD, MPH|206-987-2599|eileen.klein@seattlechildrens.org|
20541984|NCT01329978|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20541985|NCT02451995|Imperial College Healthcare|Dr Vishal Luther|07828913612|v.luther14@imperial.ac.uk|
20541986|NCT01887132|National Institute of Mental Health (NIMH)|Ashura W Buckley|(301) 496-5190|shu.buckley@nih.gov|
20541987|NCT00287716|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
20541988|NCT05006261|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|pbonato@mgh.harvard.edu|
20541989|NCT00431626|Northwestern U|Borko D. Jovanovic, MS, PhD|312 503 2008|borko@northwestern.edu|
20541990|NCT02927392|University of Colorado Anschutz Medical Campus|Edward L. Melanson, PhD|303-724-0935|ed.melanson@cuanschutz.edu|
20541991|NCT01708317|Washington University School of Medicine|Dr. Fahd A Ahmad|314-286-0298|ahmad_f@kids.wustl.edu|
20541992|NCT02401347|Stanford Medicine at Stanford University|Melinda L Telli, MD|(650) 724-9533|mtelli@stanford.edu|
20541993|NCT01685567|Silk Road Medical, Inc.|Linda Ruedy. Sr. Director, Clinical and Regulatory Affairs|(408) 585-2113|lruedy@silkroadmed.com|
20541994|NCT02354534|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|CervixDoctor@jhmi.edu|
20541995|NCT03259555|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20541996|NCT02800863|Abbott Vascular|Nicole Harbert|(972) 526-4841|Nicole.harbert@abbott.com|
20541997|NCT03957551|University of Iowa|John Rieth, MD|(319) 356-1616|john-rieth@uiowa.edu|
20541998|NCT00607087|sanofi-aventis|Medical Affairs Study Director||publicregistryGMA@sanofi-aventis.com|
20541999|NCT02021669|Washington University School of Medicine|Robert M. Carney, Ph.D|314-286-1305|carneyr@wustl.edu|
20542000|NCT04532034|Temple University|Elizabeth THomas|215-204-1699|tug66715@temple.edu|
20542001|NCT02717494|Westat|Lauren Laimon, Senior Study Director|240-453-2987|LaurenLaimon@westat.com|
20542002|NCT01887184|The University of Hong Kong|Professor Chi Wai Cheung|22553303|cheucw@hku.hk|
20542003|NCT00154297|Novartis Pharmaceuticals|Study Director|862-778-8300||
20554897|NCT02239510|TriHealth Hatton Research Institute|Jenni Steinbrunner|513-862-4033|jenni_steinbrunner@trihealth.com|
20554898|NCT01787604|MeshalkinRI|Dmitry|+79069090505|dmhvan@mail.ru|
20554899|NCT00527566|National Jewish Health|Michael Wechsler|617-285-4987|wechslerm@NJHealth.org|
20571029|NCT00874731|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571030|NCT01528319|Johnson & Johnson K.K. Medical Company|Department Chief, Clinical Development & PMS|+81-3-4411-6789|yikeda5@its.jnj.com|
20571031|NCT01736540|Novartis|Study Director|862-778-8300||
20571032|NCT04079634|Northwestern University|Nishant Verma, MD|3129262148|nishant.verma@nm.org|
20554900|NCT00074282|ECOG-ACRIN Statistical Office|Study Statistician|617 632 3012|eatrials@jimmy.harvard.edu|
20571033|NCT03812029|ENYO Pharma SA|Pietro Scalfaro|+33437700219|ps@enyopharma.com|
20571034|NCT00479882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571035|NCT00581477|Vanderbilt University Medical Center|Alfredo Gamboa MD|6158751003|alfredo.gamboa@vumc.org|
20571036|NCT03106753|Icahn School of Medicine at Mount Sinai|Dr. Natalie Porat|973-919-6166|poratnat@gmail.com|
20571037|NCT02977286|Tufts Medical Center|Erik Garpestad, M.D.|617-636-5388|egarpestad@tuftsmedicalcenter.org|
20571038|NCT03933462|Philips|Sara Garbin|724-787-8550|sara.garbin@philips.com|
20571039|NCT03937141|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
20571040|NCT02975102|Bausch + Lomb|Associate Director, Global Clinical Operations|+49 30 330 93|natasa.orlic-pleyer@bausch.com|318
20571041|NCT04148651|Candela Corporation|Medical Director|+1 949.599.7657|konikap@candelamedical.com|
20571042|NCT00594022|R.P. Chiacchierini & Associates|R.P. Chiacchierini & Associates|(240) 683-3738|rpc@rpcaconsulting.com|
20571043|NCT03392168|Arcutis|Study Inquiry|650-847-4115|studyinquiry@arcutis.com|5
20571044|NCT02609672|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
20571045|NCT03519204|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20571046|NCT04591171|The University of Texas Health Science Center at Houston|Joyce P Samuel, MD, MS|713-500-6708|joyce.samuel@uth.tmc.edu|
20571047|NCT02597712|Trio Medicines Ltd|Dr Malcolm Boyce|+44 20 8961 4130|mboyce@triomedicines.com|
20571048|NCT02614690|Connecticut Children's Medical Center|Dr, Mark Lee|860-837-7421|Mlee01@connecticutchildrens.org|
20571049|NCT01441635|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20571050|NCT02600897|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20571051|NCT05304117|Western Carolina University|Dr. R Turner Goins|828.227.3515|rtgoins@wcu.edu|
20571052|NCT02614183|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20571053|NCT05992922|Iacta Pharmaceuticals|Chief Operating Officer|714-330-8532|sj@iactapharma.com|
20571054|NCT00699153|Bausch & Lomb, Inc.|Laura Trusso, MS.|(585) 338-5561|laura.trusso@bausch.com|
20571055|NCT03054051|Emory University|Kate Winskell Enger PhD|404-727-5286|swinske@emory.edu|
20571056|NCT00078338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20571057|NCT04996004|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571058|NCT03412916|Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital|Ana-Maria Vranceanu|(617) 724-3953|avranceanu@mgh.harvard.edu|
20571059|NCT06476548|Moffitt Cancer Center|Dr. Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
20571060|NCT04595682|University of Kentucky|Dr. Mark Fillmore|8592574728|fillmore@uky.edu|
20571061|NCT06490302|CooperVision, Inc.|Jose A. Vega,OD,MSc, PhD|9256213761|javega@coopervision.com|
20571062|NCT01877148|Universidade Federal de Pernambuco|Kátia Monte-Silva|+ 55 (81) 2126-7579|monte.silvakk@gmail.com|
20571063|NCT00789360|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20571064|NCT03559062|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20571065|NCT05890027|Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida|Dr. Sara T. Wester|(305)-243-2020|swester2@med.miami.edu|
20571066|NCT03926195|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20571067|NCT00447590|Apollo Endosurgery|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
20571068|NCT01967069|Promius Pharma|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
20571069|NCT00609947|Medtronic CardioVascular|Lynda Chaplin - Study Manager|(707) 543-5459|lynda.chaplin@medtronic.com|
20571070|NCT00504075|Bio Products Laboratory Limited|Tim Aldwinckle, MD|+44 2089572565|Tim.Aldwinckle@bpl.co.uk|
20571071|NCT01186705|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
20571072|NCT01689857|Seoul National University Bundang Hospital|Dr. Chanyeong Heo|82317877222|lionheo@snu.ac.kr|
20571073|NCT05105087|Thomas Jefferson University|Ji-Bin Liu, MD|215-955-4862|jxl120@jefferson.edu|
20554901|NCT00464542|University of Pittsburgh|Thomas Cherpes|412 692 5930|cherpestl@upmc.edu|
20554902|NCT01319396|ResMed|Paul Phillips|+353 1 716 3755|paul.phillips@resmed.com|
20554903|NCT01773226|Zimmer Biomet|Linda Korthout, Scientific Affairs Specialist|+31.610.072.853|Linda.Korthout.external@zimmerbiomet.com|
20554904|NCT04401579|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20554905|NCT00489970|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554906|NCT01438411|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
20554907|NCT00618514|Image Guided Surgery Associates|Robert Worthington-Kirsch|(610) 327-7236|kirsch@igsapc.com|
20554908|NCT01093794|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20554909|NCT02053350|UVirginia|Dr. Cirle Warren|(434) 924-5242|CA6T@hscmail.mcc.virginia.edu|
20508243|NCT00462488|Sesen Bio|Rachelle Dillon, Ph.D.|204-452-7126|rachelle.dillon@sesenbio.com|308
20554910|NCT02244944|University of Kentucky|Gregory Graf|8592574749|Gregory.Graf@uky.edu|
20542004|NCT01550809|Departamento de Endocrinología y Nutrición, Hospital Clínico Universitario de Valencia, Universitat de València, Valencia, Spain|Francisco Javier Ampudia Blasco|+34 96 3862665|Francisco.J.Ampudia@uv.es|
20542005|NCT01125800|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20542006|NCT01168726|University of Missouri|Dr. Matthew P. Martens, Professor; Division Executive Director|573-882-3382|martensmp@missouri.edu|
20542007|NCT03370718|M.D. Anderson Cancer Center|Mouhammed A. Habra, MD|713-792-2841|mahabra@mdanderson.org|
20542008|NCT00214539|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412-716-0717|Mark.Grubb@bsci.com|
20542009|NCT04106609|Maple Tree Cancer Alliance|Dr. Karen Wonders|937-477-8213|karen.wonders@mapletreecanceralliance.org|
20542010|NCT03095248|Cincinnati Children's Hospital Medical Center|Senior Regulatory Specialist|15135350640|andrea.bidwell@cchmc.org|
20542011|NCT03775486|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20542012|NCT05477485|Virginia Commonwealth University|Dr. April D. Kimmel|(804) 628-6273|adkimmel@vcu.edu|
20542013|NCT01572480|National Cancer Institute|Dr. Elizabeth Hill|240-760-6183|Elizabeth.Hill@nih.gov|
20542014|NCT04194944|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20542015|NCT00801216|IRCCS Ospedale San Raffaele|Dr. Andrés José Maria Ferreri|022643 7649|ferreri.clinicaltrials@hsr.it|
20542016|NCT05214768|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20542017|NCT05481359|Cortex, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
20542018|NCT03066063|Barron Associates, Inc.|Richard Adams|434-973-1215|adams@bainet.com|
20542019|NCT03741088|HistoSonics, Inc.|Clinical Affairs Manager|651.398.7586|christine.sullivan@histosonics.com|
20542020|NCT06235905|Navitorpharma|Senior Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
20542021|NCT05579977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542022|NCT01406990|Creighton University|Dr. Katie Packard, PharmD|402-280-4566|kathleenpackard@creighton.edu|
20542023|NCT01611194|Intermountain Healthcare|Lindell Weaver, MD, FACP, UHM|801-408-3623|lindell.weaver@imail.org|
20542024|NCT02918357|University of California, San Francisco|Dr. Thomas Hope|(415) 221-4810|thomas.hope@ucsf.edu|2264
20542025|NCT00348673|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542026|NCT02756572|University of Washington/Seattle Cancer Care Alliance|Mary-Elizabeth Percival, MD, MS|206-606-1320|mperciva@seattlecca.org|
20542027|NCT00319254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542028|NCT00794950|University of Michigan|Alon Z. Weizer, MD, MS|734-615-6662|aweizer@umich.edu|
20542029|NCT02485704|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
20542030|NCT03145259|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20542031|NCT04177212|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20542032|NCT01279681|Mayo Clinic|Joleen M. Hubbard, M.D.|507 284-3121|hubbard.joleen@mayo.edu|
20542033|NCT02831764|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20542034|NCT04104256|University of California Los Angeles, Division of General Internal Medicine and Health Services Research|Project Manager|310-825-8253|cvillaflores@mednet.ucla.edu|
20542035|NCT03174366|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
20542036|NCT00101686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20542037|NCT00985465|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542038|NCT01054456|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20542039|NCT03880058|Scarless Labs Inc.|Dr. Elisabeth Leeflang|213-788-2128|Clin_Info@scarlesslabs.com|
20542040|NCT00687401|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20542041|NCT02336607|Astrazeneca|BP of Astrazeneca|+86 21 60302288|aztrial_results_posting@astrazeneca.com|
20542042|NCT02119871|Department of Cardiothoracic Surgery, Lund University|Maya Landenhed Smith|+4646173639|maya.landenhed_smith@med.lu.se|
20542043|NCT02643459|Herlev Hospital, Department of Cardiology|Dr. Martin Schultz|004538683868|martin.schultz@regionh.dk|
20554911|NCT01747772|Division of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital|Anthony E. Samir MD||asamir@partners.org|
20554912|NCT00492349|University of Maryland|L. Elliot Hong, M.D.|410-402-6828|ehong@mprc.umaryland.edu|
20542044|NCT00961311|Medtronic Cardiovascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20542045|NCT00721396|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20542046|NCT01721161|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20542047|NCT00271375|Atlanta VAMC|Patricia Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
20542048|NCT02365649|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20542049|NCT03476135|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20542050|NCT04142034|University of Arkansas for Medical Sciences|Jeannette Lee|5015266712|jylee@uams.edu|
20542051|NCT03865446|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542052|NCT04875806|NextCure, Inc|Senior VP, Clinical and Translational Development|240-399-4900|NCClin@nextcure.com|
20542053|NCT02952365|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
20542054|NCT02021565|Atlanta VA Medical Center|Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
20542055|NCT03324802|Mayo Clinic|Carlos E. Vargas, M.D.|4803421262|Vargas.Carlos@mayo.edu|
20542056|NCT01188772|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20542057|NCT01433172|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jhanelle Gray|813-745-3050|jhanelle.gray@moffitt.org|
20542058|NCT00104650|Amgen Inc.|Study Director|866-572-6436||
20542059|NCT02294058|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|AMcClain@celgene.com|
20542060|NCT01894607|University of Texas (UT) MD Anderson Cancer Center|Ott Le, MD/Associate Professor, Diagnostic Radiation Body Imaging||CR_Study_Registration@mdanderson.org|
20542061|NCT03084796|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20542062|NCT04388254|Cassava Sciences|Sr. Associate Director|5125013180|bmurray@cassavasciences.com|
20542063|NCT00512876|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
20542064|NCT00700440|Cancer Center, Sun Yat-sen University|Dr. Lu Tai-xiang|86-20-87343372|lutx@mail.sysu.edu.cn|
20542065|NCT00650767|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
20542066|NCT02093793|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
20542067|NCT01808196|Cincinnati Children's Hospital Medical Center|Pablo Abonia, MD|513-636-|pablo.abonia@cchmc.org|
20542068|NCT00479713|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542069|NCT00141102|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542070|NCT03061201|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542071|NCT06172348|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542072|NCT03116685|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
20542073|NCT05274958|Carilion Clinic|Director Psychiatry Clinical Research|540-527-4900|askablinger@carilionclinic.org|
20542074|NCT03400475|University of Iowa|Dr. Ahmed Mahrous|3193336517|ahmedmohamed-mahrous@uiowa.edu|
20542075|NCT02647723|University of Chicago|Dr. Kate Keenan|773-702-4449|kekeenan@uchicago.edu|
20542076|NCT05524220|The University of Texas Health Science Center at Houston|Erikka Washington, MD|713-500-6202|Erikka.L.Washington@uth.tmc.edu|
20542077|NCT04894669|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20542078|NCT00866814|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
20542079|NCT04491136|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20542080|NCT00848783|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
20542081|NCT01505374|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD|212-606-1206|memtsoudiss@hss.edu|
20542082|NCT02360228|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
20542083|NCT01712204|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
20542084|NCT02315534|Sumitomo Dainippon Pharma Oncology|Connor Marshall|843-364-8039|cmarshall@bostonbiomedical.com|
20542085|NCT02464410|Veterans Health Administration|Amy Bohnert|734-845-3638|amybohne@med.umich.edu|
20542086|NCT02679287|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
20542087|NCT01114828|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20542088|NCT01777776|Array BioPharma, Inc.|Study Director|303-381-6604|info@arraybiopharma.com|
20542089|NCT03628976|Georgia Institute of Technology|Dr. Minoru Shinohara|404-894-1030|shinohara@gatech.edu|
20542090|NCT00851786|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20542091|NCT01137370|Department of Medicine and Lung Institute, Seoul National University College of Medicine|Jae-Joon Yim|+82-2-2072-2059|yimjj@snu.ac.kr|
20542092|NCT01943591|Centre hospitalier de l'Université de Montréal Research Centre|Dr. Jean Raymond|514-890-8000|jraymond.nri@gmail.com|27235
20542093|NCT00865345|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
20542094|NCT01519323|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20542095|NCT03858049|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20542096|NCT02079740|Massachusetts General Hospital|Ryan Corcoran, MD PhD|617-724-4000|rbcorcoran@mgb.org|
20542097|NCT04617782|Corium, Inc.|Ronald Tashjian, Sr. Director of Clinical Operations|6172337474|rtashjian@coriumintl.com|
20542098|NCT01147042|NIH CC|Dr. John Gallin|301-827-5428|jgallin@cc.nih.gov|
20542099|NCT00915954|Cedars-Sinai Medical Center|Dr. Odelia Cooper|310-423-2830|coopero@cshs.org|
20542100|NCT00599872|Greer Laboratories|Bob Esch, VP Research & Development|828.759.7845|esch@greerlabs.com|
20542101|NCT00387881|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542102|NCT03052101|University of Cincinnati|Elizabeth Kopras|513-558-4831|koprasej@uc.edu|
20542103|NCT05473026|University of Florida|Lakeshia Cousin, PhD, APRN, AGPCNP-BC|352-273-6318|lakeshiacousin@ufl.edu|
20542104|NCT00496015|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542105|NCT01116401|Brigham & Women's Hospital|Hadine Joffe|617-732-4906|hjoffe@partners.org|
20542106|NCT01535807|Inova Heart and Vascular Institute|Lisa Fornaresio, PhD|703-776-7071|lisa.fornaresio@inova.org|
20542107|NCT01590979|Staten Island University Hospital, Northwell Health|Soad Bekheit, MD|718-226-6629|msills@northwell.edu|
20542108|NCT02730728|University of Pennsylvania|Dr Nabil Elkassabany|2156628000|nabil.elkassabany@uphs.upenn.edu|
20542109|NCT01521026|UCSD|Elizabeth Twamley, PhD|6195436684|etwamley@ucsd.edu|
20542110|NCT00934635|Janssen Cilag|Medical Development Manager; Medical and Scientific Affairs|0049-2137-955-1240||
20542111|NCT02193776|TB Alliance|Almari Conradie, Director, Clinical Operations|+27 12 991 6328|almari.conradie@tballiance.org|
20542112|NCT00914186|Taisho Pharmaceutical R&D Inc.|Fred Henry MS, MPH,|973-898-6200|F-Henry@taihso-rd.com|
20542113|NCT03788057|The Regional Public Hospital in Lesko, Poland|Dr. Janusz Ciółkowski|+48 134698071|ciolkowski.janusz@gmail.com|
20542114|NCT00248495|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20542115|NCT03812380|UT Southwestern Medical Center|Khashayar Sakhaee, MD|214-648-0324|Khashayar.Sakhaee@UTSouthwestern.edu|
20542116|NCT00981149|ECU SODM|Sharon Gordon, DDS|2527377125|gordons@ecu.edu|
20542117|NCT02341235|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
20542118|NCT03518294|The Penn State College of Medicine|Dr. Jonathan Stine|7175311017|jstine@pennstatehealth.psu.edu|
20542119|NCT04115384|HealthPartners Institute|Manager Research Operations|651-495-6363|ClinicalTrials@HealthPartners.com|
20542120|NCT04244253|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20542121|NCT00619515|Case Comprehensive Cancer Center|Dr. Lee Ponsky|216-844-4831|lee.ponsky@uhhospitals.org|
20542122|NCT03294590|Boston University Henry M. Goldman School of Dental Medicine|Belinda Borrelli, PhD|617-358-3358|belindab@bu.edu|
20542123|NCT02531217|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
20542124|NCT00474955|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20542125|NCT02576639|Novartis Pharmaceuticals|Study Director|862-778-8300||
20542126|NCT00628030|Virginia Commonwealth University|Suzanne E Mazzeo, Professor of Psychology|804-827-9211|semazzeo@vcu.edu|
20542127|NCT04177706|Medical University of South Carolina|Prinicipal Investigator|8438761199|JONJEN@musc.edu|
20542128|NCT03004365|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
20542129|NCT01619839|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
20542130|NCT03822897|Canadian Cancer Trials Group|Dr. Wendy Ranjana Parulekar|613 533 6430|wparulekar@ctg.queensu.ca|
20542131|NCT04701333|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20542132|NCT01292187|Tarsa Therapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
20542133|NCT02920892|Rush University Medical Center|Elizabeth Berry-Kravis, MD PhD|312-942-4036|Elizabeth_Berry-Kravis@rush.edu|
20542134|NCT03827655|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20542135|NCT01092728|The University of Texas (UT) MD Anderson Cancer Center|Kevin Kim, MD/Melanoma Medical Oncology|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
20542136|NCT03649217|Moterum Technologies, Inc.|Brianne Darcy|(864) 659-3180|brie@moterumtechnologies.com|
20542137|NCT02520726|University of Utah|Brent Kious, MD|801-585-1418|brent.kious@hsc.utah.edu|
20542138|NCT02552966|Northwestern University|Dr. John Pandolfino, Principal Investigator|3126950182|j-pandolfino@northwestern.edu|
20542139|NCT01216202|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
20542140|NCT02851303|Brown Family Medicine|Dr. Mary Beth Sutter|401-921-7981|marybeth_sutter@brown.edu|
20542141|NCT01774799|Hebrew SeniorLife|Dr. Susan Mitchell|617-971-5326|smitchell@hsl.harvard.edu|
20542142|NCT04332107|University of California, San Francisco FI Proctor Foundation|Dr. Thomas Lietman, Director of the UCSF FI Proctor Foundation|415-476-1442|tom.lietman@ucsf.edu|
20542143|NCT00717249|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S. Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
20554913|NCT01928719|Penn State College of Medicine|Nicolle Krebs|717-531-5673|nkrebs@pennstatehealth.psu.edu|
20571074|NCT02132832|The University of Texas Health Science Center at Houston|Scott D. Lane, PhD|(713) 486-2535|Scott.D.Lane@uth.tmc.edu|
20571075|NCT02874014|Mayo Clinic|Dr. C. Richard Choo|507-284-3261|Choo.C@mayo.edu|
20527116|NCT01672294|VA HSRD Durham VA Medical Center|Karen Steinhauser, PhD|9196682148|karen.steinhauser@va.gov|
20527117|NCT03379792|AdventHealth Translational Research Institute|Richard E. Pratley|407-303-2519|richard.pratley.md@adventhealth.com|
20527118|NCT01285492|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20527119|NCT03646149|VA Greater Los Angeles|Sonya Gabrielian, MD, Investigator|310-478-3711|sonya.gabrielian@va.gov|49853
20527120|NCT01121536|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20527121|NCT00401960|Weill Medical College|K Rhee|6469626224|kyr9001@med.cornell.edu|
20527122|NCT02649426|ReCor Medical Inc.|Chief Clinical Officer|+1-650-420-8048|hreeve-stoffer@recormedical.com|
20527123|NCT01606202|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20527124|NCT00306787|Novartis Pharmaceuticals|Study Director|862-778-8300||
20527125|NCT02273908|Medical Affairs, Pfizer Japan Inc.|Study Director : Koichi Fujii, MD|81-3-5309-9370|koichi.fujii@pfizer.com|
20527126|NCT00369161|Novartis Pharmaceuticals|Study Director|862-778-8300||
20527127|NCT04908475|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20527128|NCT01440387|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527129|NCT01870297|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
20527130|NCT01739764|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20554914|NCT03832010|Cutaneous Translational Research Program|Ruizhi Wang|4105027546|rwang@jhmi.edu|
20554915|NCT01230593|Icahn School of Medicine at Mount Sinai|Albert Wu MD PhD|2125184524|albert.wu@mssm.edu|
20554916|NCT04495374|Universidade Federal de Alfenas|Profa. Dra. Larissa Helena Lobos Torres Pacheco|3537011805|larissa.torres@unifal-mg.edu.br|55
20554917|NCT03727750|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554918|NCT03523533|University of New Mexico Health Sciences Center (HSC)|Dr. Tim Petersen|5052722610|timpetersen@salud.unm.edu|
20554919|NCT00111657|Duke University Medical Center|John S. Sundy, MD, PhD|919-684-2347|john.sundy@duke.edu|
20554920|NCT01054820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554921|NCT00321919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20554922|NCT02624804|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20554923|NCT02590354|Institute of Tropical Medicine Antwerp|Dr. Eric Florence|+32 3 247 66 42|eflorence@itg.be|
20554924|NCT00996996|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554925|NCT00760929|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
20554926|NCT01666002|Stanford University|Jean Tang MD PhD, assistant professor|650-723-6316|tangy@stanford.edu|
20554927|NCT05053087|Mayo Clinic|Benjamin K. Wilke, M.D.|904-953-2405|Wilke.Benjamin@mayo.edu|
20554928|NCT04171700|University of Pennsylvania|Kim Reiss Binder|1 215 360 0735|Kim.ReissBinder@uphs.upenn.edu|
20554929|NCT01452269|University of Rochester|Dr. Steven Barnett||steven_barnett@urmc.rochester.edu|
20554930|NCT02585895|Amgen Inc.|Study Director|866-572-6436||
20554931|NCT01243333|Huntsman Cancer Institute Research Compliance Officer|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
20554932|NCT01169467|Duke University Medical Center|Dr. Keith Dombrowski|(919)|keith.dombrowski@dm.duke.edu|
20554933|NCT03108924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554934|NCT02127164|University of Arizona|Andrew Tang, MD|520-626-5056|traumaresearch@arizona.edu|
20554935|NCT01173848|Cleveland Clinic|Dr. James Simon|216-445-4891|simonj2@ccf.org|
20554936|NCT01255358|EryDel spa|Clinical Study Coordinator|+39 02 36504470|guenter.janhofer@erydel.com|
20554937|NCT03950739|United Therapeutics Corp.|United Therapeutics Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20554938|NCT03625570|Louisiana State University Health Sciences Center - New Orleans|Dr. Noelle G. Moreau|504-568-4291|nmorea@lsuhsc.edu|
20554939|NCT03370887|AstraZeneca|Global Clinical LEad|1-877-240-9479|information.center@astrazeneca.com|
20554940|NCT01343056|University of Pittsburgh|Linda Siminerio, PhD|412-864-0158|simineriol@upmc.edu|
20554941|NCT00345579|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554942|NCT01732835|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
20554943|NCT01046643|The University of Michigan|Dr. Yolanda Smith|(734) 936-7401|ysmith@med.umich.edu|
20554944|NCT03009110|Indiana University School of Medicine|Graham Hogg|317-962-0415|gahogg@iu.edu|
20554945|NCT02388321|Maimonides Medical Center|Sergey Motov, MD (Prinicipal Investigator)|718-283-8693|smotov@maimonidesmed.org|
20554946|NCT01776645|Stanford University|Dr. Sean Mackey|650-724-2795|smackey@pain.stanford.edu|
20554947|NCT01175668|Baystate Medical Center|Rachana Singh, MD|413-794-2400|rachana.singhmd@bhs.org|
20554948|NCT02937545|Duke University School of Medicine|Susanne B Haga|919-684-0325|susanne.haga@duke.edu|
20554949|NCT02626715|UPMC Children's Hospital of Pittsburgh|Dr. Randy Windreich|412-692-5055|randy.windreich@chp.edu|
20508244|NCT02061748|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554950|NCT02007577|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
20554951|NCT02504294|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
20542144|NCT01670721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20542145|NCT03799341|VA Pittsburgh Healthcare System|Sarah Forster, PhD|412-209-9208|sarah.forster2@va.gov|
20542146|NCT04037891|Akari|Wynne H Weston-Davies|+44(0)7801 281283|wynne.weston-davies@akaritx.com|
20542147|NCT02511379|Alcon, A Novartis Division|Study Director Med Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20542148|NCT03446313|University of California, San Francisco|Linda Park, Principle Investigator|415-502-6616|linda.park@ucsf.edu|
20542149|NCT03100149|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20542150|NCT01857297|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20542151|NCT03213834|University of Florida|Erin Silverman, Research Coordinator|352-273-5870|erin.silverman@medicine.ufl.edu|
20542152|NCT01855360|Brigham and WQomen's Hospital|Rodney H Falk|6175257053|rfalk@bwh.harvard.edu|
20542153|NCT01871519|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20542154|NCT00320515|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20542155|NCT01063153|Massachusetts General Hospital|Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD|(617)-724-0006|jbiederman@partners.org|
20542156|NCT00350844|Ann and Robert H. Lurie Children's Hospital of Chicago|Dr. Robert I. Liem|312-227-4842|Rliem@luriechildrens.org|
20542157|NCT01420926|Weill Medical College of Cornell University|Gail Roboz, M.D||gar2001@med.cornell.edu|
20542158|NCT01232868|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20542159|NCT03737123|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20542160|NCT04290039|BARDA|Brenda Wolling, Regulatory SME|(202) 692-4763|Brenda.Wolling@hhs.gov|
20542161|NCT03439280|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20542162|NCT01459588|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20542163|NCT02777021|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
20542164|NCT01474317|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20542165|NCT01914003|QOL Medical, LLC|Heather Smith, Director of One Patient Services|919-832-4949|hsmith@onepatientservices.com|
20542166|NCT00453154|Duke University Medical Center|Dr. Neal Ready||ready001@mc.duke.edu|
20542167|NCT03629886|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20542168|NCT03291067|Mitsubishi Tanabe Pharma Development America, Inc.|Clinical Trials, Information Desk|Please e-mail|information@mt-pharma-us.com|
20542169|NCT03683173|Washington University School of Medicine|Diana Parra Perez, Ph.D.|314-286-1426|parrad@wustl.edu|
20542170|NCT03016312|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20542171|NCT02123134|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
20542172|NCT00904813|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
20542173|NCT02995980|University of Alabama at Birmingahm|Rachael Lancaster, MD|205-934-4080|mvetrano@uabmc.edu|
20542174|NCT03714178|Farapulse|Kit Schneider|617-686-7661|kschnieder@farapulse.com|
20542175|NCT01731912|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20542176|NCT01169103|Massachusetts General Hospital|Madhusmita Misra|617-724-5602|mmisra@partners.org|
20542177|NCT02043938|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20542178|NCT03010527|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20542179|NCT01458639|Cyclomedica Australia Pty Ltd|Gary Somerville, Quality and Regulatory Manager|+61 (0)2 9541 0411|gsomerville@cyclomedica.com.au|
20542180|NCT02656017|University of Pittsburgh|Dr. Kyongtae Bae|412-647-3500|baek@upmc.edu|
20542181|NCT01755234|Northwestern University|Gildasio De Oliveira|312-695-4858|g-jr@northwestern.edu|
20542182|NCT00622505|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20542183|NCT01839058|Western University|Keith McIntosh|519-646-6100|keith.mcintosh@sjhc.london.on.ca|61312
20542184|NCT01441843|Erasmus University Medical Centre|Dr. M. Klimek|+31107033713|m.klimek@erasmusmc.nl|
20542185|NCT01332123|university of pittsburgh|Goeran Fiedler|4126246475|gfiedler@pitt.edu|
20542186|NCT01775774|University of California San Francisco|Michael A. Matthay, MD|415-353-1206|michael.matthay@ucsf.edu|
20542187|NCT00614380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542188|NCT01506271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542189|NCT01391663|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20542190|NCT00462306|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
20542191|NCT03515824|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542192|NCT00920855|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20542193|NCT02303093|Octapharma Pharmazeutika Produktionsgesm.b.H.,|Dr. Bernhard Rohrbacher|+431610324182|bernhard.rohrbacher@octapharma.com|
20542194|NCT00510835|UPittsburgh|Derek C. Angus, MD, MPH, FRCP|(412) 647-6965|angusdc@ccm.upmc.edu|
20542195|NCT01787461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542196|NCT00152503|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20542197|NCT06098937|Bausch & Lomb|Jeffery Schafer, OD, MS Director, Clinical Research|585-338-5664|jeffery.schafer@bausch.com|
20542198|NCT04816214|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20542199|NCT03649074|Akili Interactive|Clinical Operations and Research Manager|8572543399|dfarlow@akiliinteractive.com|
20542200|NCT04487106|The University of Texas MD Anderson Cancer Center|Nichols Short MD/Associate Professor|713-563-4485|NShort@mdanderson.org|
20542201|NCT04393493|hospital civil de guadalajara|Dr Jonathan Chavez Iñiguez|3313299609|jonarchi_10@hotmail.com|
20542202|NCT02910466|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20542203|NCT04037865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527131|NCT03008278|Yale School of Medicine|Michael Cecchini, MD|(203) 200-4422|michael.cecchini@yale.edu|
20527132|NCT01074255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542204|NCT00965250|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
20542205|NCT02537717|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20542206|NCT05051579|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20542207|NCT02221869|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
20542208|NCT00055692|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20542209|NCT00066677|Fox Chase Cancer Center|Steven J. Cohen|215-728-2450|s_cohen@fccc.edu|
20542210|NCT00271102|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
20542211|NCT03492125|MingSight Pharmaceuticals|Kai Zhang|8582055958|kzhang@mingsight.com|
20542212|NCT00932321|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20542213|NCT04481243|Mayo Clinic|Ana L. Creo, M.D.|507-284-3300|Creo.Ana@mayo.edu|
20542214|NCT04564846|Oramed, Ltd.|Chief Scientific Officer|+97225660001|miriam@oramed.com|
20542215|NCT00445549|National Cancer Institute, National Institutes of Health|Elise C. Kohn, M.D.|301-496-4916|kohne@mail.nih.gov|
20542216|NCT06039579|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20542217|NCT04073186|Johnson & Johnson Vision Care|Thomas Karkkainen- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20542218|NCT02349633|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542219|NCT00558246|Ethicon|Phyllis Britnell|1 908 218-3060|pbritnel@its.jnj.com|
20542220|NCT00303823|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
20542221|NCT01220167|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
20542222|NCT05552027|Children's Hospital of Philadelphia|Morgan O'Donald|267-499-4114|ODONALDM@chop.edu|
20554952|NCT00144339|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554953|NCT00305058|Montefiore Medical Center|Andrew Chang, MD|718-920-6626|achang3@yahoo.com|
20554954|NCT04102501|Retrotope|Mark G. Midei, MD, VP Medical Affairs|4103715357|mark@retrotope.com|
20554955|NCT03329352|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
20554956|NCT02338362|Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada|Dr. Graham Trope|1-416-603-5117|graham.trope@uhn.ca|
20554957|NCT01669343|Princess Margaret Hospital|Dr. David Cescon|416-946-2000|dave.cescon@uhn.on.ca|
20554958|NCT02371369|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
20554959|NCT06281548|University of North Carolina-Chapel Hill|Adams Sibley|423-227-9198|asibley@live.unc.edu|
20554960|NCT01618838|Georgetown University Hospital|Dr. Sean Collins|202-444-3062|spc9@gunet.georgetown.edu|
20554961|NCT01587651|Daiichi Sankyo Medical Affairs|Fred Lipkin|973-944-2216|flipkin@dsi.com|
20554962|NCT00586105|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20554963|NCT02679690|University of Pittsburgh|Sheryl Ondrejko, DNP||sherylannmarieo@gmail.com|
20554964|NCT01286259|University of California, San Francisco|Steven G. Deeks|(415) 476-4082|Steven.Deeks@ucsf.edu|
20554965|NCT00127673|Case Western Reserve University|Dr. Norah C Feeny|2163682695|ncf2@case.edu|
20554966|NCT00358735|Medical Compression Systems|Clifford W Colwell, M.D Scripps Clinic|972-4-6266630|Jbarak@mcsmed.com|412
20566965|NCT03822832|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566966|NCT00243867|American Regent Inc.|Manager Medical Writing|631-772-3555|HRathfon@americanregent.com|
20527133|NCT04250298|Medical University Graz|Dr. Camilla Drexler-Helmberg|0043316385|camilla.drexler@uniklinikum.kages.at|83066
20527134|NCT01451632|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20527135|NCT00932451|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527136|NCT04891406|Imperial Tobacco Ltd|Simon McDermott|+44 (0)117 332 0225|simon.mcdermott@uk.imptob.co|
20527137|NCT00585715|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
20527138|NCT01634659|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20527139|NCT02968433|Stanford University|Dr. Helen Bronte-Stewart|650-723-6709|hbsmovlab@gmail.com|
20527140|NCT01294371|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20527141|NCT00637806|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
20527142|NCT04272606|University of Iowa|Catherine Olinger|319-384-5892|catherine-olinger@uiowa.edu|
20527143|NCT00725101|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20527144|NCT00622336|Celgene Corporation|Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
20527145|NCT00824382|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20527146|NCT02680834|TactileMedical|Clinical Research Director|612-540-5267|astone@tactilemedical.com|
20527147|NCT00415597|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
20542223|NCT00667628|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
20542224|NCT04663321|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20542225|NCT03360682|Hospital Clínic/IDIBAPS, University of Barcelona|Jose M. Miro Meda (PI), MD, PhD, Consultant, Infectious Diseases Service|93 227 54 30|JMMIRO@clinic.cat|
20542226|NCT03232346|NYS Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|adam.bisaga@nyspi.columbia.edu|
20542227|NCT01962441|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20527148|NCT01043562|Vanderbilt University (current institution)|Dr. Andrew E. Radbill|615-322-7447|andrew.radbill@vanderbilt.edu|
20527149|NCT04102865|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20542228|NCT04862065|Abbott Laboratories|Tuan Bui (Manager Clinical Research)|224-668-4702|tuan.l.bui@abbott.com|
20542229|NCT01453140|Hackensack University Medical Center|Dr. Michele Donato, MD|551-996-2000|MDonato@hackensackumc.org|3524
20542230|NCT02634333|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|mhuggins@jaeb.org|
20542231|NCT02611479|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
20542232|NCT00743249|Alcon Research, Ltd.|Theresa A. Landry, Ph.D.|1-888-451-3937|alcon.medinfo@alcon.com|
20542233|NCT03936608|The University of Kansas|Amit Noheria|9135889757|amit.noheria@gmail.com|
20542234|NCT02748863|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20542235|NCT00231777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542236|NCT03275740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542237|NCT00890825|AstraZeneca|Tracy Cunningham|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
20542238|NCT00844376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20542239|NCT00988884|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542240|NCT04621448|University of California, San Francisco|Dr. Deborah Barnes|415-502-2943|deborah.barnes@ucsf.edu|
20542241|NCT03022396|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20542242|NCT02972931|AIDS Research Institute IrsiCaixa|Dr. Judith Dalmau|934656374|jdalmau@irsicaixa.es|161
20542243|NCT02519023|University of Minnesota|Dr. Jacob Hutchins|6122505535|hutc0079@umn.edu|
20542244|NCT00468299|University of Rochester|Dr. Sarah Betstadt|585-276-5368|sarah_betstadt@urmc.rochester.edu|
20542245|NCT03546621|Hepatera LLC|Dr.Alexander Alexandrov|+7 (495) 726-52-53|alexandrov@myr-pharma.com|42-03
20542246|NCT00646646|University of Alabama at Birmingham|Dr. Michael Froelich|205-934-4711|froelich@uab.edu|
20542247|NCT00226590|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., Ph.D., c/o Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
20542248|NCT00660192|Yale School of Medicine|Baman,Jabbari M.D. Porfessor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
20542249|NCT00377520|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20542250|NCT02111447|GLA|Research Coordinator|7163236570|tgensler@greatlakesanes.com|
20542251|NCT00973752|Massachusetts General Hospital|Dr. Amir Fathi|617-724-1124|afathi@partners.org|
20542252|NCT04908397|Vanderbilt University Medical Center|Anna R. Hemnes|615-343-8227|anna.r.hemnes@vumc.org|
20527150|NCT01764997|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20527151|NCT00082017|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
20527152|NCT01313221|Amgen Inc.|Study Director|866-572-6436||
20527153|NCT00994214|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20527154|NCT02020837|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
20527155|NCT01777139|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527156|NCT04987931|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527157|NCT01692002|Imperial College London|Prof Gary Frost Head of Section for Nutrition Research|07872850308|g.frost9296@gmail.com|
20527158|NCT03292458|Massachusetts Eye and Ear|Prof. Kristina Simonyan|617-573-6016|kristina_simonyan@meei.harvard.edu|
20542253|NCT03318549|University of Miami|Vice Chair of Research|305-326-6373|fmedeiros@med.miami.edu|
20542254|NCT00539994|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542255|NCT02673918|University of British Columbia|Bolette Rafn|604-827-1914|bolette.rafn@ubc.ca|
20542256|NCT02021942|Klinik und Poliklinik für Neurologie der Universitaet Regensburg|Prof. Dr. Berthold Schalke|+49 941 941|berthold.schalke@medbo.de|3010
20542257|NCT05470985|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20542258|NCT01917747|UK Dept. of Otolaryngology Head and Neck Surgery|Dr. Matthew L. Bush|859-218-2168|matthew.bush@uky.edu|
20542259|NCT06451965|University of East Anglia|Ercan Hassan (Trainee Clinical Psychologist)|07496337806|nue22cyu@uea.ac.uk|
20542260|NCT02870283|Universidade Federal do Rio Grande do Sul|Dra. Ana Flávia Silva Lima|+5551999185180|afbslima@gmail.com|
20542261|NCT02741245|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542262|NCT02997501|Astrazeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20542263|NCT03253679|M D Anderson Cancer Center|Dr. Siqing Fu|713-792-4318|siqingfu@mdanderson.org|
20542264|NCT02586623|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
20542265|NCT01116648|Dana-Farber Cancer Institute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
20542266|NCT04539938|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542267|NCT00990106|VA Puget Sound Health Care System|Murray Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
20542268|NCT01663012|Stanford University School of Medicine650-|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
20542269|NCT02926638|SWOG|Lung Committee Statistician|2066677733|kmini@fredhutch.org|
20542270|NCT00791908|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
20542271|NCT01650298|ABBOTT|Grant Kim|818-493-3147|gkim@sjm.com|
20542272|NCT02849418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20542273|NCT01405768|Washington University School of Medicine|L. Stewart Massad, M.D.|314-362-3181|massadl@wudosis.wustl.edu|
20542274|NCT03692208|The University of Chicago|Dr. Elbert Huang|(773) 834-9143|ehuang@medicine.bsd.uchicago.edu|
20542275|NCT00882440|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20542276|NCT01342913|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542277|NCT05295849|University of Connecticut|Sherry Pagoto, PhD|860-486-5917|sherry.pagoto@uconn.edu|
20542278|NCT01381016|University of Colorado Denver|Associate Professor|(303) 724-2037|alex.polotsky@ucdenver.edu|
20542279|NCT05482308|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542280|NCT04319198|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20542281|NCT00905450|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20542282|NCT05801991|Southern California College of Optometry|Erin Rueff, OD, PhD (Principal Investigator)|714-463-7586|erueff@ketchum.edu|
20542283|NCT00467077|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20542284|NCT01451723|Louisiana Health Sciences Center-New Orleans|Jesus Lovera MD|50-903 9302|jlover@lsuhsc.edu|
20542285|NCT01378988|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
20542286|NCT01631435|Given Imaging- Covidien|Ravit Peled , Clinical trials manager|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
20542287|NCT01421017|NYU Langone Health|Sylvia Adams|212-731-5795|sylvia.adams@nyumc.org|
20542288|NCT00833040|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
20542289|NCT02313766|CaenUH|Pr Jean-Luc Hanouz|33 2 31 06 47 36|hanouz-jl@chu-caen.fr|
20542290|NCT02542046|UCaliforniaSF|Dr. Benjamin Yeh|4155149318|ben.yeh@ucsf.edu|
20542291|NCT04233008|Brigham and Women's Hospital|Sarah Little|617-732-5452|selittle@bwh.harvard.edu|
20542292|NCT00416624|Mayo Clinic|Charles L. Loprinzi, M.D.|507-266-6247|loprinzi.charles@mayo.edu|
20542293|NCT01893801|Cancer Research and Biostatistics|Adam Rosenthal|(206) 839-1797|adamr@crab.org|
20542294|NCT03489863|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
20542295|NCT01005251|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20542296|NCT02754570|University of Colorado|Rachel Gerle|720-848-5096|rachel.gerle@ucdenver.edu|
20542297|NCT00962208|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
20542298|NCT00657540|Rocky Mountain Poison and Drug Center|Victoria Anderson - Research Projects Manager|303-389-1236|victoria.anderson@rmpdc.org|
20542299|NCT00141453|Daiichi Sankyo, Inc|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20542300|NCT04375150|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20542301|NCT04245111|Dartmouth Health Orthopaedics|Dr. Ida Leah Gitajn|(603) 650-5133|Ida.Leah.Gitajn@hitchcock.org|
20542302|NCT02039115|Center for Interventional Endoscopy|Robin (Barron-Nelson) Kangas|407.303.5503|Robin.Barron@flhosp.org|
20542303|NCT02843165|University of California, San Diego|Andrew Sharabi|(858) 822-5354|CancerCTO@health.ucsd.edu|
20542304|NCT04755816|University of Michigan College of Pharmacy|Dr. MICHAEL DORSCH|734/647-1452|mdorsch@umich.edu|
20542305|NCT02792231|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20542306|NCT05196828|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
20542307|NCT00473434|Jan-Cil Australia|Regional Medical Affairs Therapeutic Lead Immunol|61 2 88753219||
20542308|NCT00423657|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
20542309|NCT02422498|Memorial Sloan Kettering Cancer Center|Dr. Simon Powell, MD|212-639-3639|powells@mskcc.org|
20542310|NCT02653326|Universidad de Valparaiso|Carla Taramasco|2508306|carla.taramasco@uv.cl|+56 32
20542311|NCT02855203|Peter MacCallum Cancer Centre|Office of Cancer Research|+61 3 85597364|OCR@petermac.org|
20542312|NCT01752426|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
20542313|NCT03650088|University of North Carolina at Chapel Hill|Deborah F. Tate, PhD|919-966-5851|dtate@unc.edu|
20542314|NCT03206216|Stanford University Medical Center|Seema Nagpal, MD|650-725-8630|snagpal@stanford.edu|
20542315|NCT00657046|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20542316|NCT04864249|University of Pittsburgh Medical Center, Magee-Womens Hospital|Dr. Alisse Hauspurg|412-641-1381|janickia@upmc.edu|
20542317|NCT03192826|Patras Medical School|OPHTHALMOLOGY PATRAS|6975801961|cgeorg@upatras.gr|
20542318|NCT00499681|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD, Principal Investigator|615-936-2033|ingrid.mayer@vanderbilt.edu|
20542319|NCT00739401|Endologix|Elisa Hebb, VP Clinical Affairs|949-598-4628|ehebb@endologix.com|
20542320|NCT04575155|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
20542321|NCT05748275|Multack Eye Care|Dr Sam Multack|815-889-3333|smultack@mecvision.com|
20542322|NCT03915717|Sonavex|Katy Feeny|443-862-2024|kfeeny@sonavex.com|
20542323|NCT03808090|University of Alabama at Birmingham|Dr Kyle Wood|205-996-2295|kylewood@uabmc.edu|
20542324|NCT01239381|Massachusetts General Hospital|Theodore S Hong, MD, physician radiation oncology|617-726-6050|TSHONG1@mgh.harvard.edu|
20542325|NCT06237049|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
20542326|NCT03748823|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20542327|NCT02525471|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
20542328|NCT04678115|VA Central Western Massachusetts|Kevin Houston|781-588-7674|kevin.houston2@va.gov|
20542329|NCT02738008|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20542330|NCT04486235|Corporal Michael J. Crescenz VA Medical Center|Jocelyn Remmert, PhD|215-823-5800|jocelyn.remmert@va.gov|
20542331|NCT04590014|Vapotherm Inc|Katherine Gerich|5854696753|kgerich@vtherm.com|
20542332|NCT03935126|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542333|NCT00982735|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542334|NCT01091675|Unidad de Reumatología, Hospital Parc Tauli de Sabadell. Institut Universitari UAB|Dr. Jordi Gratacós Masmitjá|937.23.10.10|jgratacosmas@gmail.com|
20542335|NCT02794207|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
20542336|NCT00948064|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
20542337|NCT02722564|St. Luke's University Health Network|Holly Stankewicz, D.O.|484-526-4000|holly.stankewicz@gmail.com|
20542338|NCT01782898|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
20542339|NCT02426580|The Nephrology Department, the Chengdu Second Affiliated Hospital of Chongqing Medical University, the Third Peoples's Hospital of Chengdu|Dr. Gong Rong, Dr. Han Tianzhao, Dr. Leonard Stern|+86 028-61318708|gongr2006@sina.com|
20542340|NCT01572207|Case Western Reserve University|Matthew Plow|216-368-8969|map208@case.edu|
20542341|NCT00383552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20542342|NCT03096834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20542343|NCT00966654|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20542344|NCT00575185|University of Minnesota|Hank Balfour MD|(612) 626-5670|balfo001@umn.edu|
20542345|NCT01393158|Oregon Health & Science University|Dr. Eric Simpson,|503-494-2121|simpsone@ohsu.edu|
20542346|NCT02413918|University of Texas HEalth Science Center San Antonio|Charles Bowden, MD|210-567-5405|BowdenC@uthscsa.edu|
20542347|NCT00762359|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20542348|NCT03397264|Opthea|Director of Clinical Research|+61 3 9826 0399|info@opthea.com|
20542349|NCT02682381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20542350|NCT02891174|University of Michigan|Dr. Elizabeth Langen|734-764-3406|elangen@med.umich.edu|
20542351|NCT01693029|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|004980244760|biopharma.clinicaltrials@sandoz.com|
20542352|NCT01329263|University of Pennsylvania|Dr. Andrew Strasser|2157465788|strasse3@mail.med.upenn.edu|
20542353|NCT01366872|Orthopaedic Associates of Michigan, PC|Dr. John G. Anderson|616-459-7101|John.Anderson@oamichigan.com|797
20542354|NCT00308139|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
20542355|NCT02152826|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20542356|NCT01173016|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
20542357|NCT02469623|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|442232608-|steven.mcquillan@acutus.com|
20542358|NCT03309878|Johns Hopkins University|Grants Administrative Manager|443-927-3568|JHCCCRO@jhmi.edu|
20542359|NCT01096316|Dept Psychiatry & Behavioral Sciences University of Washington|Jurgen Unutzer MD MPH MA, Professor and Chair|206-543-3752|unutzer@uw.edu|
20542360|NCT01884077|Washington University School of Medicine - Dept of Orthopaedic Surgery|Dr. Aaron Chamberlain|314-362-9283|chamberlaina@wudosis.wustl.edu|
20542361|NCT02836652|Abbott|Poornima Sood|7818528334|poornima.sood@abbott.com|
20542362|NCT03679975|Aquestive Therapeutics|Gary Slatko, Chief Medical Officer|908-941-7050|clinicaltrials@aquestive.com|
20542363|NCT02648204|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20542364|NCT00659802|Hutchison Medipharma|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
20542365|NCT01008943|Cook Medical|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
20542366|NCT02356159|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
20542367|NCT00861705|Warren Alpert Medical School of Brown University, Department of Medicine|William M. Sikov, M.D.|401-793-7151|wsikov@lifespan.org|
20542368|NCT06418152|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
20542369|NCT05789745|Nucleus Network|Trisha Shamp, Ph.D|651-641-2925|t.shamp@nucleusnetwork.com|
20542370|NCT05108246|SUNY at Buffalo|Nikhil Satchidanand|7168162884|ns1@buffalo.edu|
20542371|NCT02055898|Imperial College London|Keith Boland||k.boland@imperial.ac.uk|
20542372|NCT01500772|Debiopharm International S.A.|Vice President, Clinical Research and Development|4121 321 01 11|info-international@debiopharm.com|
20542373|NCT00718510|Department of Psychiatry, University of Alberta|Dr. Serdar Dursun|(780) 492-7319|dursun@ualberta.ca|
20542374|NCT02201524|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20542375|NCT02314052|Dicerna Pharmaceuticals|Ralf Rosskamp|617-621-8097|rrosskamp@dicerna.com|
20542376|NCT02795117|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20542377|NCT01960140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20542378|NCT04551989|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20542379|NCT02694744|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20542380|NCT00686777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20542381|NCT00883779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20542382|NCT00399516|Boston Scientific|Brad Hershey, MS|(661) 949-4828|Brad.Hershey@bsci.com|
20542383|NCT03040141|Visterra Inc.|Head of Regulatory Affairs|+1 617-498-1070|info@visterrainc.com|
20542384|NCT04879628|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20542385|NCT02348593|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
20542386|NCT05675046|Sonex Health, Inc.|Amy Stegner, Vice President Clinical Affairs|(888) 518-8780|astegner@sonexhealth.com|
20542387|NCT00871871|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20542388|NCT03863509|University of Wisconsin-Madison|Dr James H. Stein|608-262-2075|jhs@medicine.wisc.edu|
20542389|NCT03861273|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20554967|NCT03864900|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
20542390|NCT01673828|Department of Neurology, School of Medicine, University of California, Davis|Dr. Michael Rogawski|916-734-6285|rogawski@ucdavis.edu|
20542391|NCT00191334|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20542392|NCT03064490|Duke University Health System (DUHS)|Linda Kaltenbach/Regulatory Coordinator|(919) 668-3726|linda.kaltenbach@duke.edu|
20542393|NCT06319898|Atrium Health Wake Forest Baptist|Dr. Erin Franks|7043041160|erin.franks@atriumhealth.org|
20542394|NCT02775916|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20542395|NCT00960622|St Luke's Roosevelt Hospital New York|Dr. Donald Phillip Kotler|212 523 3670|dkotler@chpnet.org|
20542396|NCT04046328|Pharmascience Inc.|Clinical Study Manager|514-340-9800|researchsupport@pharmascience.com|
20542397|NCT01195701|TriHealth Hatton Research Institute|Academic Clinical Research Supervisor|513-862-2330|Angie_Fellner@trihealth.com|
20542398|NCT01600326|University of Michigan|Jon Jacobson|734 936-4365|jjacobsn@umich.edu|
20542399|NCT04456504|University of Wisconsin School of Pharmacy|Mary Hayney, PharmD, MPH, FCCP, BCPS|608-265-4666|mary.hayney@wisc.edu|
20508245|NCT02848313|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20508246|NCT03510910|NYU Langone Health|Thomas Youm, MD|212-348-3636|Thomas.Youm@nyulangone.org|
20508247|NCT01673490|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508248|NCT03382262|Flexion Therapeutics|Scott Kelley MD, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
20527159|NCT02542293|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20527160|NCT03030118|Penn State Hershey College of Medicine|Nancy J Olsen MD, Professor of Medicine|717-531-4921|nolsen@pennstatehealth.psu.edu|
20527161|NCT04529850|Galera Therapeutics|Judy Schnyder|484-870-9625|jschnyder@galeratx.com|
20527162|NCT00310466|ALK-Abelló A/S|Kim Simonsen, Senior Director|+4545747576||
20527163|NCT00593606|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20527164|NCT02278367|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20527165|NCT00810017|MedStar Health Research Institute|Scientific Center Administrator, Oncology Research|(301) 560-7300|Research@MedStar.net|
20527166|NCT04643964|The Ohio State University|Dr. Daniel Strunk|6146884891|strunk.20@osu.edu|
20527167|NCT02638129|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
20527168|NCT00869557|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20527169|NCT02397291|"University of Colorado Denver | Anschutz"|Henry Galan|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20527170|NCT01048905|Emory University School of Medicine|Claudia R. Morris MD, FAAP|404-727-5500|claudia.r.morris@emory.edu|
20508249|NCT04914819|University of Pennsylvania|Dr. Jennifer Lewey|215-662-7700|jennifer.lewey@pennmedicine.upenn.edu|
20508250|NCT02715804|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
20508251|NCT03961295|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20508252|NCT01625611|Yale University|Dr. Krishnan-Sarin|203.974.7595|nicholas.franco@yale.edu|
20508253|NCT00948194|University of Colorado Denver|Nick Naughton|303-724-0833|nick.naughton@cuanschutz.edu|
20508254|NCT00233324|University of Alabama|Waldemar A. Carlo, M.D|(205) 934-4680|wcarlo@peds.uab.edu|
20508255|NCT01759160|First Affiliated Hospital of Sun Yat-sen University|Dr. Xia Feng|008613688877856|fengxiar@yahoo.cn|
20527171|NCT02368210|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
20527172|NCT01492101|Nektar|Alison Hannah, MD||AHannah@nektar.com|
20527173|NCT00316914|Mayo Clinic|Dr. Axel Grothey|507-184-2779|grothey.axel@mayo.edu|
20527174|NCT00676572|Imperial College London|Professor Kian Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20527175|NCT01966419|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
20527176|NCT04339179|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
20527177|NCT00259285|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20527178|NCT01917344|Boston Children's Hospital|Susan Waisbren, P.h.D|617-355-7346|susan.waisbren@childrens.harvard.edu|
20527179|NCT02956057|Tomas Bata Hospital|Kojecky Vladimir|+420577552512|kojecky@bnzlin.cz|
20527180|NCT00565916|Washington University School of Medicine|Dr. Robert Gropler MD|314-747-3878|groplerr@mir.wustl.edu|
20527181|NCT00985517|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
20527182|NCT00943670|Hoffman-LaRoche|Medical Communications|800-821-8590||
20527183|NCT01777295|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527184|NCT00426660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508256|NCT02905825|Exalenz Bisocience|Avraham Hershkowitz|972-8-9737513|avrahamh@exalenz.com|
20527185|NCT00980174|Amgen Inc.|Study Director|866-572-6436||
20542400|NCT04233801|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20554968|NCT02308033|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
20508257|NCT00662389|Apsara Medical Corporation|Eve Conner, Ph.D. Consultant|510 566-2495|eaconner@sbcglobal.net|
20527186|NCT00337779|Teva Pharmaceutical Industries, Ltd.|Chen Duksin, MD|972-9-863-4642|chen.duksin@teva.co.il|
20542401|NCT02173769|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542402|NCT01419795|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
20542403|NCT01391364|Bausch Health|Study Director||robert.steffen@bausch.com|
20542404|NCT01690052|Indiana University School of Dentistry|Juan F. Yepes DDS, MD, MPH, MS, DrPH, Associate Professor|317-944-9601|jfyepes@iupui.edu|
20542405|NCT01453049|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542406|NCT02421172|Novartis Pharmaceuticals|Study Director|8627788300||
20542407|NCT00928486|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
20542408|NCT01841281|UC Davis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
20542409|NCT00683878|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20542410|NCT03112681|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
20542411|NCT02869633|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20542412|NCT04024891|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
20542413|NCT02041325|BVARI|Dr. Nikhil C. Munshi|857-203-6172|nikhil_munshi@va.gov|
20542414|NCT03287791|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20542415|NCT03441477|NIDEK Co., LTD.|Tadakazu Ichimura|+81-533-67-8904|tadakazu_ichimura@nidek.co.jp|
20542416|NCT03095651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542417|NCT01048879|University of Michigan|Bruce A. Mueller|7346154578|muellerb@umich.edu|
20542418|NCT00851357|UCSD|Principal Investigator|858-300-1056|szhu@ucsd.edu|
20542419|NCT02210000|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542420|NCT02660788|BC Cancer|Dr. Alan Nichol|604-877-6046|anichol@bccancer.bc.ca|
20542421|NCT00791388|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
20542422|NCT02690181|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542423|NCT00443040|Tioga Pharmaceuticals|Dr. Allen Mangel, Chief Medical Officer|919-485-5668|mangel@tiogapharma.com|
20542424|NCT03585660|Department of Radiology, University of Chicago|Dr. Aytekin Oto, MD, MBA|1-773-702-8553|aoto@bsd.uchicago.edu|
20542425|NCT02763644|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20542426|NCT05757648|University Hospitals Cleveland Medical Center|Dr. Ying An|(216)368-3277|Ying.An@UHhospitals.org|
20542427|NCT05256901|Emory University|Viola Vaccarino, MD, PhD, Principal Investigator|404-727-8710|lvaccar@emory.edu|
20542428|NCT03255902|William Beaumont Hospitals|Donna Marvicsin, Nurse Practitioner, Pediatric Endocrinology|248-568-6932|donna.marvicsin@beaumont.org|
20542429|NCT02646826|Wellesley Pharmaceuticals, LLC|David Dill|2154930168|ddill@wellesleypharma.com|
20542430|NCT00702468|GW Pharma Ltd|Richard Potts Clinical Operations Director|+44 1353 616600|rp@gwpharm.com|
20554969|NCT02358889|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
20542431|NCT00472108|Galderma R&D SNC|CTA Coordinator|+33 493 95 70 85|cta.coordinator@galderma.com|
20542432|NCT00716963|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
20542433|NCT00005906|TMB/NHLBI|Joel Moss|301-496-1597|mossj@nhlbi.nih.gov|
20542434|NCT04201431|University of Oxford|Dr. Angela Minassian|01865611425|angela.minassian@ndm.ox.ac.uk|
20542435|NCT01945021|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542436|NCT02163902|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
20542437|NCT00983346|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
20542438|NCT00099372|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
20542439|NCT00003468|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20542440|NCT02903160|Icahn School of Medicine at Mount Sinai|Dr. Bobby Liaw|212-604-6010|bobby.liaw@mountsinai.org|
20542441|NCT01838317|University of Texas Southwestern Medical Center|Dr. Muhammad Shaalan Beg|214-648-4180|muhammad.beg@utsouthwestern.edu|
20542442|NCT01664910|The University of Texas MD Anderson Cancer Center|Dr. Issa Khouri, MD/Stem Cell Transplantation and Cellular Therapy Department|713-745-0049|ikhouri@mdanderson.org|
20542443|NCT02527681|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
20542444|NCT02374164|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20542445|NCT00867165|Merck Sharp & Dohme.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542446|NCT03550378|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
20542447|NCT00756106|Massachusetts General Hospital|Dr. Elizabeth Gerstner||EGERSTNER@mgh.harvard.edu|
20542448|NCT00837902|Vanderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
20542449|NCT00689390|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542450|NCT02343263|Indiana University|Bruce H. Matt, MD, MSc|3172781215|bmatt@iupui.edu|
20542451|NCT01384734|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20542452|NCT00647296|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
20542453|NCT02922725|University of Utah|Brent M. Kious|801-585-1418|brent.kious@hsc.utah.edu|
20542454|NCT01300234|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542455|NCT00360412|Eisai Call Center|Eisai Inc.|888-422-4743||
20542456|NCT04612725|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20542457|NCT03349723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542458|NCT03409796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20542459|NCT00837252|National Eye Institute|Catherine M. Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
20542460|NCT00644423|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
20542461|NCT01414634|Neuroimmunology and MS Research, Department of Neurology, University Hospital Zürich, 8091 Zürich, Switzerland|Roland Martin|044 255 11 25|roland.martin@usz.ch|
20542462|NCT03270436|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
20542463|NCT02985827|Ora|Senior Director of Research and Development|9786858900|klane@oraclinical.com|
20542464|NCT01977547|Washington University School of Medicine|Dr. Philip C. Spinella|3142860858|pspinella@wustl.edu|
20542465|NCT02714400|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|62155
20542466|NCT04235140|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20542467|NCT01751061|Duke University|Dr. Christopher Cox|9196817232|Christopher.cox@duke.edu|
20542468|NCT04673214|MEXICAN SOCIAL SECURITY INSTITUTE|Dr. GILBERTO CRUZ ARTEAGA|55 87 44 22|gilberto.cruz@imss.gob.mx|15320
20542469|NCT00866177|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
20554970|NCT03285477|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20508258|NCT01709708|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
20542470|NCT05635461|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
20542471|NCT01620060|Sunovion|Medical Director, CNS|1-866-503-6351||
20542472|NCT02269124|Massachusetts Eye and Ear|Dr. Michael S. Cohen, MD|6175733190|Michael_Cohen@MEEI.HARVARD.EDU|
20542473|NCT03776864|University of Washington|Dr. Ryan Lynch|206-606-1739|rclynch@uw.edu|
20542474|NCT03452540|Afimmune|Study Director|+353 1 2946380|regulatory.afimmune@afimmune.com|
20542475|NCT01582061|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20542476|NCT05075746|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
20542477|NCT01045460|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
20508259|NCT01527110|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542478|NCT04664153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542479|NCT00097500|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20542480|NCT03388346|UIHC|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
20542481|NCT00189098|Wilhelmina Children's Hospital, University Medical Center Utrecht|Prof. A. Schilder|0031 302504580|A.Schilder@umcutrecht.nl|
20542482|NCT00524485|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20542483|NCT01600885|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu|
20542484|NCT00474123|Heart Institute (InCor) Hospital of the Faculty of Medicine, University of São Paulo (HCFMUSP)|Comparison of Antiplatelet and Anti-inflammatory Effects of High Dose Statin Monotherapy Versus Mode|55-11-30695058|eduardopesaro@hotmail.com|
20542485|NCT01889667|Oramed|Chief Scientific Officer|+972-2-566-0001|aviva@oramed.com|
20542486|NCT00642356|Novartis Pharmaceuticals|Study Director|862 778-8300||
20542487|NCT02767271|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
20542488|NCT01009060|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542489|NCT02726620|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
20542490|NCT04055675|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
20542491|NCT00088530|CTIBioPharma Corp.|Simran Bedi Singh|(206) 272-4000|ssingh@ctibiopharma.com|
20542492|NCT00300755|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20542493|NCT04571944|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542494|NCT00966186|Seoul National University Bundang Hospital|Jung-Won Hwang|82-31-787-7499|jungwon@snubh.org|
20542495|NCT00667888|UT MD Anderson Cancer Center|Karen Huffman, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2339|khoffman1@mdanderson.org|
20542496|NCT00626275|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
20542497|NCT01362348|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542498|NCT02734693|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20542499|NCT00758771|UCSF|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
20542500|NCT00960063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542501|NCT00539981|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20542502|NCT02675907|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
20542503|NCT01611792|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|802 847-6733|Sharon.Henry@uvm.edu|
20542504|NCT03360903|University of Chicago|Aaron Fox|(773) 702-0021|aaronfox@uchicago.edu|
20542505|NCT04097431|Mount St Mary's University|Dr. Griffin Rooker|(301) 447-5143|g.w.rooker@msmary.edu|
20542506|NCT01759420|Carl R Darnall Army Medical Center|Peter Moffett MD|254-288-8302|peter.m.moffett.mil@mail.mil|
20542507|NCT01422161|New York University School of Medicine|Preeti Raghavan, MD|212 598 6206|raghap01@nyumc.org|
20542508|NCT01129622|Mount Sinai Hospital|Robert F Casper|416-972-0777|casper@lunenfeld.ca|
20542509|NCT02051764|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20542510|NCT00591006|The University of Texas Southwestern Medical Center|E. Sherwood Brown|214 645 6950|sherwood.brown@utsouthwestern.edu|
20542511|NCT02898454|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20542512|NCT02570503|Virginia Commonwealth University|Teresa Potter|804-828-6749|teresa.potter@vcuhealth.org|
20542513|NCT04731636|LifeTechScientific|Clinical manager|15695219339|Xuwei@lifetechmed.com|
20542514|NCT04264442|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
20542515|NCT01623479|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20542516|NCT01290523|University of California San Francisco Department of Radiology|Dr Nicholas Fidelman|(415) 353-1300|Nicholas.Fidelman@ucsf.edu|
20542517|NCT03071263|Vifor Pharma Inc.|Clinical Support & Regulatory Intelligence, Regulatory Affairs Director|+1 250 708 4296|Clive.Burge@viforpharma.com|
20542518|NCT00732212|CURE Digestive Diseases Research Center|Dennis M. Jensen, M.D.|310-268-3569|djensen@mednet.ucla.edu|
20542519|NCT01991808|University of Pennsylvania|Lilie Lin, MD|215-622-6515|lin@uphs.upenn.edu|
20542520|NCT03289208|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml@ml.mt-pharma.co.jp|
20542521|NCT00662207|Hines VA Hospital, Research Service|James S. Walter, Ph.D.|708-202-5805|James.Walter@va.gov|
20542522|NCT02354235|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20542523|NCT03069352|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20542524|NCT02621424|VA Palo Alto|Jauhtai Cheng, MD, Staff Neurologist|650-493-5000|jauhtai.cheng2@va.gov|63617
20542525|NCT05626673|Pray.com|Breanne Laird|9095574002|breanne.laird@pray.com|
20542526|NCT05148234|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
20542527|NCT01928927|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20542528|NCT05550779|University of Colorado Colorado Springs|Dr. Lori James|7192554172|ljames@uccs.edu|
20542529|NCT00179621|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20542530|NCT05622734|University of Washington School of Nursing|Oleg Zaslavsky|2068493301|ozasl@uw.edu|
20542531|NCT01273766|Comprehensive Cancer Center of Wake Forest University|Dr. Mary Ann Knovich|336-716-7973|mknovich@wakehealth.edu|
20542532|NCT01941485|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Refractive, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
20542533|NCT00262860|University of Rochester|Jonathan W. Friedberg|585-273-4150|jonathan_friedberg@urmc.rochester.edu|
20542534|NCT02973100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20542535|NCT01419236|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20542536|NCT00281463|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
20542537|NCT01364896|University of Pittsburgh|Ross Cranston|412-383-1675|rdc27@pitt.edu|
20542538|NCT03224130|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
20542539|NCT00414635|Community Research Initiative of New England (CRINE)|Calvin Cohen, MD|617 502 1700|ccohen@crine.org|
20542540|NCT02764385|Oregon Health & Science University|Sue Flocke|5034946697|flocke@ohsu.edu|
20508260|NCT02007252|Novartis Pharmaceuticals|Study Director|862-778-8300||
20508261|NCT02657434|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20508262|NCT01858597|The first Affiliated Hospital of Sun-Yat Sen University|Director of Clinical Trials|86-020-28823388|zsyyyb@mail.sysu.edu.cn|
20508263|NCT00511108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20508264|NCT02698566|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20508265|NCT02147691|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
20508266|NCT04866823|Wake Forest School of Medicine|Morgana Mongraw-Chaffin|13367133108|mmongraw@wakehealth.edu|
20508267|NCT01392742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20508268|NCT01998958|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20508269|NCT02432703|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20508270|NCT02137837|SWOG Statistics and Data Management Center|Breast Committee Statistician|2066674623|dlew@fredhutch.org|
20508271|NCT01181141|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
20508272|NCT01628393|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20508273|NCT03395223|Provepharm SAS|Emilie HUYGHUES|+33 6 20 58 28 27|emilie.huyghues@provepharm.com|
20508274|NCT00763243|Indiana University School of Medicine|William Kronenberger, Ph.D.|317-944-8162|wkronenb@iupui.edu|
20508275|NCT03005041|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508276|NCT01248364|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508277|NCT02682030|Cedars Sinai Medical Center - 8700|Dr. Ashraf Elsayegh|3105560335|ashraf.elsayegh@cshs.org|
20508278|NCT00673894|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
20508279|NCT02193828|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20508280|NCT04046341|Children's Hospital of Philadelphia|Marsha Wallace|2155900119|wallacem@chop.edu|
20508281|NCT00405652|Novartis Pharmaceuticals|Study Director|862-778-8300||
20508282|NCT01637870|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbanks, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
20508283|NCT05109702|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
20508284|NCT01392378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508285|NCT02322411|University of Wisconsin - Madison|Dr. Nicole Pulia|6082561901|npulia@wisc.edu|11697
20508286|NCT02679807|University of Virginia|Ronald Turner|434-981-9141|rbt2n@virginia.edu|
20508287|NCT04350905|NIH|Jessica Manning|+85561856557|Jessica.manning@nih.gov|
20508288|NCT01285791|Hadassah Medical Organization|Dr Ido Mizrahi|+972-2-5844550|idomiz17@gmail.com|
20542541|NCT03598036|Aurinia Pharmaceuticals Inc.|Clinical Trial Support|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20542542|NCT01314313|Edwards Lifesciences|Tenley Koepnick||Tenley_Koepnick@edwards.com|
20508289|NCT02671461|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20508290|NCT01412060|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20508291|NCT00629525|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
20508292|NCT00004732|Mayo Clinic|Thomas G. Brott, MD - Principal Investigator|904-953-0556|Brott.thomas@mayo.edu|
20508293|NCT01183312|Emory University School of Medicine|Dr. Lynn Marie Trotti|404-728-4752|lbecke2@emory.edu|
20508294|NCT01688635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20571076|NCT06381986|Sunhawk Vision Biotech|President|+886-72222660|hjuo@shvbiotech.com|
20508295|NCT02661464|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20508296|NCT00367432|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20571077|NCT03149042|University at Buffalo|Dr. Ciprian Ionita|7164004283|cnionita@buffalo.edu|
20571078|NCT01643044|Wayne State University|Steven Ondersma, PhD|313-444-9797|sondersm@med.wayne.edu|
20571079|NCT01434745|Washington State University|Dr. jean-Baptiste Roullet|5093587666|j.roullet@wsu.edu|
20571080|NCT02470780|University of Cincinnati/UC Health|Hilary Perez PhD|5135582577|perezhe@ucmail.uc.edu|
20571081|NCT00790205|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571082|NCT02643628|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
20571083|NCT02362503|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20542543|NCT04124939|Urology Department, Wake Forest University|Sachin N. Vyas, Research Manager|336-713-4098|svyas@wakehealth.edu|
20542544|NCT04494841|MMJ Labs|Dr. Amy Baxter|1 877 805 2899|abaxter@mmjlabs.com|
20542545|NCT03893396|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, clinical research manager|+33516494246|caroline.allix-beguec@ght-atlantique17.fr|
20527187|NCT00422422|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
20542546|NCT04607668|G1 Therapeutics, Inc|Clinical Trial Info|+1 9192139835|clinicalinfo@g1therapeutics.com|
20542547|NCT02250326|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20542548|NCT04516746|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20542549|NCT00322777|Canadian Institute of Natural and Integrative Medicine|Dr. Badri Rickhi|403-220-0022|b.ricki@cinim.org|0
20542550|NCT00503750|Emory University|Dr. Ruth O'Regan|404-778-8808|roregan@emory.edu|
20542551|NCT00768989|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20542552|NCT01194830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542553|NCT05626738|ENDOSTART SRL|Alessandro Tozzi|0571843033|a.tozzi@endostart.com|0039
20542554|NCT04951115|Weill Cornell Medicine|Ashish Saxena|646-962-2066|ahs9018@med.cornell.edu|
20542555|NCT02681809|ThromboGenics|Global Clinical Development|+3216751310|info@oxurion.com|
20542556|NCT00435409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542557|NCT05120713|University of Southern California|Dr. Andy Kim|213-740-5156|andyk@usc.edu|
20542558|NCT03316196|VA San Diego Healthcare System|Dr. Jessica Bomyea|8585528585|jessica.bomyea@va.gov|1416
20542559|NCT03631940|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
20542560|NCT03562195|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20542561|NCT02529852|M D Anderson Cancer Center|Jason Westin|(713) 792-3750|jwestin@mdanderson.org|
20542562|NCT00117637|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20542563|NCT00614575|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542564|NCT03119259|Indiana University|Dr. Richard Holden|812-586-1965|rjholden@iu.edu|
20542565|NCT03535974|Fundatia Bio-Forum|Dr. Felician Stancioiu|+40727500402|felicians11@gmail.com|
20542566|NCT04059549|UW Madison|Olivia Vjorn|6084772614|ocody@wisc.edu|
20542567|NCT02639494|Mayo Clinic|Dr. Rajiv Gulati|507-538-6325|Gulati.Rajiv@mayo.edu|
20542568|NCT01919229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20542569|NCT01011673|Montefiore Medical Center, Albert Einstein College of Medicine|Benjamin Friedman, MD|718-920-6626|BEFRIEDM@montefiore.org|
20542570|NCT04368260|University of Virginia|Dr. Amy Mathers|434-924-9678|ajm5b@virginia.edu|
20542571|NCT00549640|Mayo Clinic|Dr. Richard D. Hurt|507-266-1944|nicotineresearch@mayo.edu|
20542572|NCT00803283|Janssen Taiwan|Medical Advisor|886-2-23762158||
20542573|NCT03261336|Inova Schar Cancer Institute|Stephanie Van Bebber, Sr. Director Clinical Trials|5714720213|Stephanie.VanBebber@inova.org|
20542574|NCT03174353|University of Washington|Dr. Venu Pillarisetty|206-616-4924|vgp@uw.edu|
20542575|NCT00292942|Uniformed Services University of the Health Sciences|Louis Cantilena, Jr., MD, PhD|301-295-0016|lcantilina@usuhs.mil|
20542576|NCT00644358|Allergan, Inc.|Therapeutic Area Head|1-877-277-8566|IR-CTRegistration@allergan.com|
20542577|NCT03180385|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
20542578|NCT02732600|VISN 5 Mental Illness Research, Education, and Clinical Center|Richard Goldberg|410-637-1851|Richard.Goldberg@va.gov|
20542579|NCT03324776|MODEL Clinical Research LLC|Philip Levin, MD|4102413438|pal3420@yahoo.com|
20542580|NCT00651924|VA Connecticut Healthcare System|Robert Kerns, Ph.D.|203-932-5711|robert.kerns@va.gov|3841
20542581|NCT00550407|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542582|NCT00584415|University of Oklahoma Health Sciences Center|Sunny Po, MD., Study Principal Investigator|405-271-9696|sunny-po@ouhsc.edu|
20542583|NCT00556894|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
20542584|NCT03883581|NOVA Southeastern University|Lauren Tabor Gray|954-914-5447|Lauren.taborgray@nova.edu|
20542585|NCT03332459|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20542586|NCT05190120|University of California San Francisco|Dr. Pedram Aleshi|(415) 271-1627|pedram.aleshi@ucsf.edu|
20542587|NCT02099864|Oregon Health & Science University|Dr. Alexandra Sokolova, M.D.|(503) 494-4396|sokolova@ohsu.edu|
20542588|NCT03062358|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542589|NCT04750642|Cochlear|Aaron Parkinson|13039414951|aparkinson@cochlear.com|
20527188|NCT01389258|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20542590|NCT01697397|G-Tech Medical|Steve Axelrod, PhD, CEO|650-269-1479|steve.axelrod@gtechhealth.com|
20542591|NCT01650194|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20542592|NCT04158583|Hoffman-La-Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20542593|NCT03043885|UCSF|Daniel Clark|415.476.1101|daniel.clark@ucsf.edu|
20542594|NCT02649556|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
20542595|NCT00399308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20542596|NCT00740220|Wake Forest University|Arjun Chatterjee, MD, MS, FCCP|336.716.4649|achatter@wfubmc.edu|
20542597|NCT01602224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20542598|NCT00633477|Takeda|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
20542599|NCT02539823|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212 824 9314|yasmin.hurd@mssm.edu|
20542600|NCT00770653|Takeda Pharma GmbH, Aachen (Germany)|Medical Director|+49 800 8253325|clinicaltrialregistry@tpna.com|
20542601|NCT00289653|Centre for Addiction and Mental Health|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|36859
20542602|NCT01962792|Pharmacyclics LLC|Thorsten Graef, Head of Clinical Development|+1 (408) 215-3127|tgraef@pcyc.com|
20542603|NCT04906499|University of North Carolina at Chapel Hill|Caroline Lisee, PhD|919-962-2025|liseecar@email.unc.edu|
20542604|NCT01908426|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20542605|NCT03346434|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20542606|NCT03525444|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20542607|NCT03240601|Shepherd Center|Dr. Edelle Field-Fote|4046034274|edelle.field-fote@shepherd.org|
20542608|NCT02741128|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20542609|NCT01419769|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
20542610|NCT00878501|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20542611|NCT04416204|University of Alabama at Birmingham|Dr. Rita Basu|2059341200|rbasu@uabmc.edu|
20542612|NCT00812708|University of California Los Angeles|Kevin M. Miller, MD|(310) 206-9951|millerpatients@jsei.ucla.edu|
20542613|NCT01183689|Wake Forest University School of Medicine|Mark Espeland|336-716-2826|mespelan@wakehealth.edu|
20542614|NCT01959503|C.R. Bard|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
20542615|NCT03965130|Yale|Dr. Kitt Falk Petersen|203 737 1942|kitt.petersen@yale.edu|
20542616|NCT04346745|Columbia University|Associate Professor|2128512246|jl4658@columbia.edu|
20542617|NCT01838694|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
20542618|NCT00945958|SPARC|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
20542619|NCT02587520|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20542620|NCT00672555|Department of surgery, Cantonal hospital of St. Gallen|Lukas Marti; principal investigator|0041794120153|lukas.marti@kssg.ch|
20542621|NCT02780401|University of Washington Medical Center|Jennifer S. Childs|2066162305|childj@u.washington.edu|
20542622|NCT00350025|Fox Chase Cancer Center|Dr. Yu-Ning Wong|215-728-3889|yu-ning.wong@fccc.edu|
20542623|NCT02153086|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20542624|NCT00446849|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20542625|NCT03115359|Pennsylvania State University|Aleksandra E. Zgierska, MD, PhD|717-531-8187|azgierska@pennstatehealth.psu.edu|
20542626|NCT01815918|Hospital for Special Surgery|Kethy Jules-Elysee, MD|212-606-1206|JulesElyseeK@HSS.EDU|
20542627|NCT04682197|Atrium Wake Forest Baptist Health|Dr. Charles H. Tegeler|336-716-9447|BBRP@wakehealth.edu|
20542628|NCT03285724|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
20542629|NCT02412306|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20542630|NCT04231669|Washington University in St. Louis|Dr. Ozge Sensoy Bahar|314-935-9403|ozge.sensoybahar@wustl.edu|
20542631|NCT03480048|Michigan State University|Jean Kerver, PhD, MSc, RD, Assistant Professor|231-392-8227|jkerver@epi.msu.edu|
20542632|NCT03793751|Tata Main Hospital, Tata Steel|Dr.Deb Sanjay Nag|+91-9431166582|debsanjay@gmail.com|
20542633|NCT03661723|Dana-Farber Cancer Institute|David A. Reardon, MD (Clinical Director, Center for Neuro-Oncology)|617-632-2166|david_reardon@dfci.harvard.edu|
20542634|NCT04019379|University of Minnesota|Kathleen M. Hill Gallant, PhD|612-625-5285|hillkm@umn.edu|
20542635|NCT04750824|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542636|NCT00807911|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
20542637|NCT04175730|University of Illinois at Chicago|Dr. Michael Abern|312-996-9330|mabern1@uic.edu|
20542638|NCT04851691|University of California Los Angeles, Division of General Internal Medicine and Health Services Research|Project Manager|310-825-8253|cvillaflores@mednet.ucla.edu|
20542639|NCT03532542|Sarepta Therapeutics, Inc.|Medical Director|1-888-727-3782|SareptAlly@sarepta.com|
20542640|NCT00836589|BIOTRONIK, INC|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
20542641|NCT03324607|Duke University Medical Center|Yuh-Chin T. Huang, MD, MHS|9196843069|huang002@mc.duke.edu|
20542642|NCT01814774|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20542643|NCT02914639|OcuTerra Therapeutics, Inc.|Chief Medical Officer|(617) 701-7382|info@ocuterratx.com|
20542644|NCT01018030|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542645|NCT00436332|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fhcrc.org|
20542646|NCT01924845|BioMarin Pharmaceuticals|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
20542647|NCT00062439|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
20527189|NCT02477709|Afferent Pharmaceuticals, Inc.|Chief Medical Officer|650-286-1276|info@afferentpharma.com|
20554971|NCT03283670|Washington University|Ben Palanca, MD PhD|314 273-9076|palancab@wustl.edu|
20542648|NCT00286442|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20542649|NCT02140047|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608|cti-inq-ml@ml.mt-pharma.co.jp|
20542650|NCT02174731|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20542651|NCT00079040|ECOG Statistical Office|Study Statistician|617-632-3012||
20542652|NCT00325897|Denver Health Medical Center|Dr. Richard Albert|303-436-6900|ralbert@dhha.org|
20542653|NCT04079296|Astellas Pharma Global Development Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
20542654|NCT01317472|Indiana University|Terese Stevens, Dept administrator|317-278-3187|tstevens@iupui.edu|
20542655|NCT03804840|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20542656|NCT00910104|Boston Children's Hospital|Mark Puder MD PhD|617-355-1838|mark.puder@childrens.harvard.edu|
20542657|NCT03583099|Weill Cornell Medicine|Fernando J. Martinez, MD, MS|646-962-2370|fjm2003@med.cornell.edu|
20542658|NCT04890652|Department of Psychiatry, Yale University School of Medicine|Dongju Seo, Associate Professor|475-441-3457|dongju.seo@yale.edu|
20542659|NCT04364386|InPress Technologies Inc|Jan Segnitz, MD|(408) 238-9279|jsegnitz@gmail.com|
20542660|NCT03859024|University of Alabama at Birmingham|Dr. Adam Baumgarten|205-996-6769|abaumgarten@uabmc.edu|
20542661|NCT00907426|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20542662|NCT03192176|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20542663|NCT05796557|Yale|Oliver Karam|203-785-4651|oliver.karam@yale.edu|
20542664|NCT00442169|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20542665|NCT01890343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20542666|NCT02399215|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@Roswellpark.org|
20542667|NCT00772538|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542668|NCT00189540|AnGes|Director of Clinical Operations|240-780-9031|information@anges-mg.com|
20542669|NCT01089504|University of Rochester|Ronnie Guillet|585-275-6209|ronnie_guillet@urmc.rochester.edu|
20542670|NCT00001832|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20542671|NCT00713609|GlaxoSmithKline|GSK Response Center|866-435-7343||
20542672|NCT01903356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542673|NCT04529083|VA North Texas Health Care System|Dr. James Le Page|214-857-1437|james.lepage@va.gov|
20542674|NCT00060528|National Cancer Instititute (NCI), National Institutes of Health (NIH)|James L. Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
20542675|NCT04196686|Lucile Packard Children's Hospital Stanford|Samuel Rodriguez, MD|(650)723-6412|sr1@stanford.edu|
20542676|NCT04701814|Pharos university in Alexandria|P.T Moataz Abdelaal|1060081213|moataz.abd.student@pua.edu.eg|+20
20542677|NCT01995708|Memorial Sloan Kettering Cancer Center|Dr. David Chung, MD, PhD|646-608-3770|ChungD1@MSKCC.ORG|
20542678|NCT00265564|Office of Mental Health Operation, Veterans Health Administration|Jodie Trafton, Director Program Evaluation and Resource Center|650-493-5000|Jodie.Trafton@va.gov|22474
20542679|NCT00119847|Stony Brook University|Dr. Eric J. Rashba|631-444-3575|eric.rashba@stonybrookmedicine.edu|
20542680|NCT01553084|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
20542681|NCT04698343|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
20542682|NCT05139680|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542683|NCT03581279|MDC Associates, Inc.|Manager, Regulatory and Clinical Affairs|9787055012|t2@mdcassoc.com|
20542684|NCT02756338|BIOTRONIK, Inc.|Crystal Miller|800-547-0394|crystal.miller@biotronik.com|
20542685|NCT04309110|Firstkind Ltd|Dr Kieron Day|+44 (0) 1494 572040|kieron.day@firstkindmedical.com|
20542686|NCT01339689|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20542687|NCT00659061|Aga Khan University|Professor Zulfiqar Ahmed Bhutta|4930051|zulfiqar.bhutta@aku.edu|4782
20542688|NCT01856270|University of Washington|Dr. Jeanne Hoffman|206-221-6511|jeanneh@uw.edu|
20542689|NCT00590187|Cyclacel Pharmaceuticals|Julius, Huang, PhD.|760-877-2708|jhuang@cyclacel.com|
20542690|NCT00467740|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542691|NCT00475670|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20542692|NCT00730158|UPMC Hillman Cancer Center|Edward Chu, MD|(412) 648-6589|chue2@upmc.edu|
20542693|NCT01168349|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20542694|NCT02678351|Stanford Medicine at Stanford University|Andrea Otte|650-736-4183|anotte@stanford.edu|
20542695|NCT01632020|University of Arkansas for Medical Sciences|Daisy Wade|5016868274|dewade@uams.edu|
20542696|NCT04999839|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20542697|NCT03740048|Wake Health|Dr Zhidong Lin|3367138720|zlin@wakehealth.edu|
20542698|NCT00526292|Memorial Sloan Kettering Cancer Center|Dr. Katherine Hsu|646-888-2667|hsuk@mskcc.org|
20542699|NCT01476722|alcon Blobal Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
20542700|NCT00528957|Gilead Sciences|Clinical Trial Disclosures & Transparency||GileadClinicalTrials@gilead.com|
20542701|NCT01636765|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20542702|NCT02654782|Mayo Clinic|Dr. William C. Oliver, Jr.|507-255-4240|oliver.william@mayo.edu|
20542703|NCT03111875|Cleveland Clinic|Daniel I. Sessler, MD|216-444-4900|sessled@ccf.org|
20542704|NCT03273426|Seoul National University Hospital|Dr. Wonshik Han|+82-2-2072-1958|hanw@snu.ac.kr|
20542705|NCT03485924|Johns Hopkins Medical Institute|Dr. Eun Ji Shin|4106140950|eshin3@jhmi.edu|
20542706|NCT05288816|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20542707|NCT03416868|Massachusetts General Hospital; Harvard Medical School|Jarrad Van Stan, PhD, CCC-SLP|617-643-8410|jvanstan@mgh.harvard.edu|
20542708|NCT01323582|University of Florida|Baharak Moshiree MD|305-243-2515|bmoshiree@med.miami.edu|
20542709|NCT00564681|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20542710|NCT00988832|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20542711|NCT03174184|Vanderbilt University Medical Center|Kelly Dooley, MD, PhD|6153228972|kelly.e.dooley@vumc.org|
20542712|NCT01969708|The Emmes Corporation|Principal Investigator of the SCORE2 Data Coordinating Center|301-251-1161|score2@emmes.com|
20542713|NCT00392392|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
20542714|NCT00409539|Sunovion|Medical Director, Urology|1-866-503-6351||
20542715|NCT01239511|Sinphar Pharmaceutical Co., Ltd.|Melanie Huang|886-2-27603688|wthuang@sinphar.com.tw|2190
20542716|NCT02588599|Arizona Institute of Footcare Physicians|Kerry Zang DPM|480-834-8804|kerryzang@aol.com|
20542717|NCT03353675|Transgene|Director of Medical Affairs|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
20542718|NCT00402168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20542719|NCT01128049|University of Rochester Medical Center, Flaum Eye Institute|James Aquavella, MD|585-275-8944|James_Aquavella@URMC.Rochester.Edu|
20542720|NCT00582361|UAB|Research Nurse Coordinator|205-996-6781|Talyor.vlack@ortho.uab.edu|
20542721|NCT02370420|Universidad Autonoma de Nuevo Leon|Felix Vilchez Cavazos|811 049 80 70|vilchez.doctor@hotmail.com|
20542722|NCT05790460|Abramson Cancer Center at the University of Pennsylvania|Charu Aggarwal, MD, MPH|215-662-6318|charu.aggarwal@pennmedicine.upenn.edu|
20542723|NCT00410956|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-7601|jarnagiw@mskcc.org|
20542724|NCT04388683|Tufts Medical Center|Dr. Marvin Konstam|617-636-6293|mkonstam@tuftsmedicalcenter.org|
20542725|NCT00880698|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20542726|NCT00904943|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20542727|NCT04861597|Montefiore Medical Center|Ruby Greywoode M.D. M.S., Assistant Professor of Medicine|347-671-8205|rgreywoode@montefiore.org|
20542728|NCT03284710|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20542729|NCT04992312|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20542730|NCT05546476|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542731|NCT02498925|McLean Hospital|Christian Webb, PhD|6178554429|cwebb@mclean.harvard.edu|
20542732|NCT03760029|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542733|NCT03137654|UFlorida|Ben Lewis, Assistant Professor, UF Department of Psychiatry|3522948724|benlewis@ufl.edu|
20542734|NCT04709068|Current Health|Clinical Research Lead|617-208-4239|study.team@currenthealth.com|
20542735|NCT01706458|UWCCC|Mary Jane Staab - Program Manager|608-262-4304|mjs@medicine.wisc.edu|
20542736|NCT04854135|Washington University in St. Louis|Paulina Cruz Bravo, MD|314-922-8620|pcruz@wustl.edu|
20542737|NCT05875532|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542738|NCT00072462|Queen Mary University of London|Professor Jack Cuzick|+442078823504|j.cuzick@qmul.ac.uk|
20542739|NCT02384551|VA ORD|Heidi J Silver|615-875-9355|heidi.j.silver@vumc.org|
20542740|NCT04349891|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
20542741|NCT05164120|MedStar Health Georgetown Transplant Institute|Alexander Kroemer, MD; Khalid Kahn, MD|202-444-3700|Alexander.Kroemer@gunet.georgetown.edu; Khalid.M.Khan@gunet.georgetown.edu|
20542742|NCT03448406|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542743|NCT00087152|SWOG|Lead Statistician - Breast Cancer Committee|(206) 839-1761|williamb@crab.org|
20542744|NCT01292486|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
20542745|NCT04369404|Massachusetts General Hospital|Karen Sepucha, PhD|617-724-3350|ksepucha@mgh.harvard.edu|
20542746|NCT03130738|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|407-323-1887|nini.ramirez@hillderm.com|
20542747|NCT04602390|Anokion US|Medical Director|+1 857.320.6607|clinicaltrials@anokion.com|
20542748|NCT03043534|WakeForest|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
20542749|NCT03882021|Abbott|Laura Zitella Verbick|+1-612-961-7336|laura.zitellaverbick@abbott.com|
20542750|NCT01546857|Rutgers-New Jersey Medical School|Jean Daniel Eloy|9739721470|eloyje@njms.rutgers.edu|973
20542751|NCT03582215|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.strauss@fda.hhs.gov|
20542752|NCT04913610|Drugs for Neglected Diseases initiative|Clinical Trial Data|41 22 906 9230|ctdata@dndi.org|
20508297|NCT00903370|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
20542753|NCT01210716|Fenwal, Inc|Sr. Mgr. Clinical Affairs|847-550-5620|carrie.pineda@fenwalinc.com|
20542754|NCT03186209|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20542755|NCT01277744|UT MD Anderson Cancer Center|Andrea Hayes-Jordan M.D. / Surgical Oncology|713-794-4616|AHJORDAN@MDANDERSON.ORG|
20554972|NCT01165281|Janssen Pharm KK Japan|Medical Director|＋81-3-5509||
20508298|NCT00744848|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20527190|NCT02943785|Daiichi Sankyo|Contact for Clinical Trial Information|+ 1 908-992-6400|CTRinfo@dsi.com|
20554973|NCT01307501|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
20554974|NCT00724347|VANCHCS|David L. Woods, Ph.D.|925-372-2571|David.Woods@va.gov|
20554975|NCT03859323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20554976|NCT01429259|Hartford Hospital|Joseph L. Kuti, Pharm.D.|860-972-3612|joseph.kuti@hhchealth.org|
20554977|NCT01682460|CCLR|Research Manager|519-888-4742|cclr2@sciborg.uwaterloo.ca|
20542756|NCT01791244|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20527191|NCT03313310|UNC Chapel Hill, ATN Coordinating Center|Betty Rupp|919-962-6603|brupp@email.unc.edu|
20527192|NCT01281956|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
20527193|NCT03170609|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527194|NCT01361867|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
20527195|NCT01593254|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20527196|NCT00456261|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20527197|NCT03083769|Southern Medical University|Dr. Liang Li|86 20 61648510|liliang@smu.edu.cn|
20527198|NCT01904903|MedStar|Allison Moses|301-256-2728|Allison.E.Moses@medstar.net|
20527199|NCT00719914|Brigham and Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
20527200|NCT00634049|Astellas Pharma Global Development, Inc.|Vice President, Medical Head ID/IM/TX|(224) 205-8800|Astellas.resultsdisclosure@astellas.com|
20527201|NCT00314132|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20527202|NCT01260584|Daiichi Sankyo|Brian Baker|973-944-2712|bbaker@dsi.com|
20527203|NCT05708703|University of Minnesota, Masonic Cancer Center|Dr. Rachel Vogel|612-624-6928|isak0023@umn.edu|
20527204|NCT02918552|University of Pittsburgh|Tara Sheila Stakich|412-864-2082|tss54@pitt.edu|
20527205|NCT04395274|Ohio State University Comprehensive Cancer Center|Dr. Alayna Tackett|614-558-2679|alayna.tackett@osumc.edu|
20527206|NCT01592292|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20527207|NCT03482167|University of Delaware|Christopher R. Martens, Ph.D.|302-831-7270|cmartens@udel.edu|
20527208|NCT02167815|Nemocnice Podlesí|MuDr Jan Stryja|+420 558 304 111|Jan.stryja@atlas.cz|
20527209|NCT04612777|New York State Psychiatric Institute|Dr. Michael Compton|4043759231|mtc2176@cumc.columbia.edu|
20527210|NCT05497960|IMPACTIV (Vivo)|Eric Levitan|770-331-3208|eric@teamvivo.com|
20527211|NCT04148287|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
20527212|NCT01131065|Instituto Grifols, S.A.|Michael Woodward, BSc, M.Sc|+34 935712200|michael.woodward@grifols.com|
20527213|NCT02240069|University of Montana|Curtis Noonan|406-243-4957|curtis.noonan@umontana.edu|
20527214|NCT01362244|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20527215|NCT02681757|Children's Hospital Colorado|Choi Young Mee MD|7207770859|youngmeeyoungmee@gmail.com|
20527216|NCT02407054|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20527217|NCT01650545|University of Maryland|Aldo Tullio Iacono|410 328 4351|aiacono@umm.edu|
20542757|NCT04657679|Georgetown University|Sandra Swain, MD,|(202) 687-8487|sandra.swain@georgetown.edu|
20542758|NCT03853473|Medical College of Wisconsin|Matthew J. Durand, Ph.D., Principal Investigator|414-955-5619|mdurand@mcw.edu|
20542759|NCT05468814|Hospital Universitario Reina Sofía|Ms. Irene Calzado Álvarez de Lara|+34618093419|ircaalla@gmail.com|
20542760|NCT01983228|Minneapolis Veterans Affairs Health Care System|Dr. Diana Burgess, Principal Investigator|612-467-1591|diana.burgess@va.gov|
20542761|NCT02955589|Huya Japan G.K.|Huya Japan clinical development||japanclinical@huyabio.com|
20542762|NCT04716426|ELJ Consultancy|Ernesto Cesar Pinto Leal Junior|+55 11 975222856|ceo@eljconsultancy.com|
20542763|NCT02987231|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@unesp.br|
20542764|NCT01046565|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20527218|NCT02539654|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20527219|NCT04438499|Laborie Medical Technologies|Adele Campbell|16032558251|ACampbell@laborie.com|
20527220|NCT02168777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20527221|NCT01663857|Eli Lilly and Company|Chief Medical Officer|800-575-5979|Clinicaltrials.gov@lilly.com|
20527222|NCT01709864|Novartis Pharmaceuticals|Study Director|862-778-8300||
20527223|NCT02517021|Helsinn Healthcare SA|Dr. Ruben Giorgino|+41 91 985 2121|ruben.giorgino@helsinn.com|
20527224|NCT01172808|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20527225|NCT03529799|University of Miami|Michael Hoffer|305 243-1484|michael.hoffer@miami.edu|
20527226|NCT03315962|UCSF|Gabe Chamie|(415) 476-4082|gabriel.chamie@ucsf.edu|
20527227|NCT01066793|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20527228|NCT01520519|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
20527229|NCT01911793|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
20527230|NCT03774394|University of Florida|Francesco Franchi, MD|+1-904-244-2060|francesco.franchi@jax.ufl.edu|
20527231|NCT02697916|Duke University; Duke Clinical Research Institute|W. Schuyler Jones, MD|919-668-8917|schuyler.jones@duke.edu|
20527232|NCT03959488|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20527233|NCT00290693|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
20527234|NCT05625477|Zhuhai Trinomab Pharmaceutical Co., Ltd.|Wenxi Xiang|18083065921|xiangwenxi@trinomab.com|
20527235|NCT04849416|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20527236|NCT01450072|UBNS|Dr. Ellen Carl|716-218-1000|ecarl@ubns.com|7260
20527237|NCT02370056|Cleveland Clinic|Dr. Emre Gorgun|216 444-1244|GORGUNE@ccf.org|
20527238|NCT03749499|University of Chicago Illinois|Heather M. Prendergast MD, MS, MPH, Professor, Department of Emergency Medicine|3124131214|hprender@uic.edu|
20527239|NCT02667587|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20527240|NCT05940077|Tufts University|Dr. Evan Papa|617-636-4056|evan.papa@tufts.edu|
20527241|NCT00388297|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
20527242|NCT01463358|Casa di Cura san Pio XI|Massimo Santini MD FESC FACC|+390666494491|m.santini@rmnet.it|
20527243|NCT03570554|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20527244|NCT01642485|Richmond Pharmacology Ltd|Dr Jorg Taubel|+44(0)2086645200|j.taubel@richmondpharmacology.com|
20527245|NCT02719353|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20527246|NCT01420679|Spectrum Pharmaceuticals, Inc|Gajanan Bhat|949-743-9219|gajanan.Bhat@sppirx.com|
20527247|NCT03956615|Vrije Universiteit Brussel|Dr. Matthias D'Huyvetter|+3224776013|afspraak_nucleaire@uzbrussel.be|
20527248|NCT00412217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20527249|NCT01069419|UCB Clinical Trial Call Center|UCB (Study Director)|+1887 822 9493||
20527250|NCT00956631|Vertos Medical|VP of Clinical, Regulatory and Quality|9493490008|cmyers@vertosmed.com|216
20527251|NCT00365209|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
20527252|NCT03114657|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20527253|NCT00115037|UPENN|David Oslin, MD|215-823-5894|oslin@upenn.edu|
20527254|NCT01179737|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20527255|NCT01546038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527256|NCT01398410|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
20527257|NCT04245202|Ege University Medical Faculty Hospital|Dr. Aykut Eşki|05303009760|aykuteski1984@gmail.com|
20527258|NCT00717275|University of Florida|Dr. Erin M. Dunbar|352-273-9000|edunbar@neurosurgery.ufl.edu|
20554978|NCT02062502|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20554979|NCT03811912|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20554980|NCT03586648|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
20554981|NCT02099838|Huazhong University of Science and Technology|Dr. Yu|027-83662883|xfyu188@163.com|
20554982|NCT01227889|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554983|NCT04121962|Johns Hopkins Bloomberg School of Public Health|Dr. Karin Tobin|4105025368|ktobin2@jhu.edu|
20554984|NCT00774787|Rigel Dermatology|Darrell Rigel|212-684-5964|dsrigel@prodigy.net|
20554985|NCT02019719|GlaxoSmithKline|GSK Response Center|866-435-7343||
20554986|NCT04535037|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20527259|NCT00231309|Emory University|Kuang-Yueh Chiang, MD|404-785-1441|kuang-yueh.chiang@choa.org|
20527260|NCT03515629|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20527261|NCT00424021|Gilead Sciences, Inc.|Karen L Miller, PhD|650-524-3892|KarenL.Miller@gilead.com|
20527262|NCT01254721|SM&M Korea|Hui Jung Sin / Clinical Project Leader|82-2-2188-2165|ClinicalTrialTransparency@astrazeneca.com|
20527263|NCT02600767|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
20527264|NCT03597022|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20508299|NCT00976248|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
20542765|NCT01650558|University of Maryland School of Medicine|Miriam K. Laufer, M.D., M.P.H.|410-706-5333|mlaufer@som.umaryland.edu|
20542766|NCT02960217|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20542767|NCT01069484|Norwegian School of Sport Sciences, Department of Sports Medicine, Oslo, Norway|Dr. Gunvor Hilde|+47 41366045|gunvor.hilde@gmail.com|
20542768|NCT00079326|Dana-Farber Cancer Institute|Craig Bunnell|617-632-3800|cbunnell@partners.org|
20542769|NCT02978417|Duke University|Michele Easter, Ph.D.|919-385-0862|michele.easter@duke.edu|
20542770|NCT05083351|Masimo|Director, Clinical Lab Operations|(949) 297-7000|studies@masimo.com|
20542771|NCT04326920|UZ Gent|Cedric Bosteels|+3293325909|cedric.bosteels@ugent.be|
20542772|NCT02970799|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20542773|NCT00083889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20542774|NCT00960375|V Maryland Healthcare System|Dr. Melanie Bennett, Research Health Scientist|410-637-1859|Melanie.Bennett@va.gov|
20542775|NCT03019406|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20542776|NCT03668873|Cleveland Clinic Foundation|Cynthia R. Johnson, PhD|216 448-6440|johnsoc@ccf.org|
20542777|NCT04267380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20542778|NCT03473236|GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|R. Aranda M.D. / Senior Vice President of Clinical Development|(858) 684-1300|raranda@gossamerbio.com|
20542779|NCT03138369|Neurovalens Ltd|Paul McGeoch, MD|858-232-3312|paul.mcgeoch@neurovalens.com|+1
20542780|NCT02228681|GOG Foundation|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
20542781|NCT03155724|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
20542782|NCT00525512|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542783|NCT04258423|Indiana University|Dr. Chandrashekhar Kubal|317-312-2601|sakubal@iupui.edu|
20542784|NCT01784991|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
20542785|NCT01601535|New Approaches to Neuroblastoma Therapy|NANT Medical Director|323-361-5687|nantops@chla.usc.edu|
20542786|NCT03309020|National Institutes of Health|Teresa Magone, MD, Principal Investigator, NEI|301-435-4562|teresa.magonedequadroscosta@nih.gov|
20542787|NCT00601835|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20542788|NCT00880620|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|908-307-2234|kaihong.jiang@amneal.com|
20542789|NCT02856412|San Francisco Veterans Health Care System|Thomas Neylan, MD|415-750-6961|Thomas.Neylan@va.gov|
20542790|NCT05893862|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542791|NCT01400698|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
20542792|NCT02919761|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20542793|NCT05086705|The Ohio State University Comprehensive Cancer Center|Dr. Sagar Sardesai|614-293-6401|sagar.sardesai@osumc.edu|
20542794|NCT04972162|WSAUDAS|Dr. Veronika Littmann|+4991313080|veronika.littmann@wsa.com|
20542795|NCT01352117|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20542796|NCT01766050|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20542797|NCT02081677|Johnson & Johnson Vision Care Inc.|Tawnya Wilson, Principal Research Optometrist|904-443-1834|TWilson@ITS.JNJ.com|
20542798|NCT03406377|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20542799|NCT00385671|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20542800|NCT00717574|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
20542801|NCT03037385|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20542802|NCT04515771|Richard L. Roudebush VA Medical Center|Dr. Johanne Eliacin|317-988-5000|Johanne.Eliacin@va.gov|
20542803|NCT00278343|Juarvinski Cancer Centre|Dr. Hal Hirte|905-387-9495|hirteh@hhsc.ca|
20542804|NCT01021020|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
20542805|NCT02535481|UCL|EPIGRAAFT Trial team|020 7679 2000|epigraaft@gmail.com|
20542806|NCT04273737|Columbia University Irving Medical Center|Dr. Heakyung Kim|212-305-9416|hk2641@cumc.columbia.edu|
20542807|NCT05543265|Massachusetts General Hospital|Mark Clapp, MD|617-724-2000|mark.clapp@mgh.harvard.edu|
20542808|NCT02766023|University of California San Francisco|Craig Cohen, MD, MPH|(415) 476-5874|Craig.Cohen@ucsf.edu|
20542809|NCT03359629|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
20542810|NCT00286468|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20542811|NCT02953652|Huya Japan G.K.|Huya Japan Clinical Development||japanclinical@huyabio.com|
20542812|NCT03679247|Brigham and Women's Hospital|Lipika Samal|6177327063|lsamal@bwh.harvard.edu|
20542813|NCT02927301|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
20542814|NCT04742556|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542815|NCT03035032|Astellas Pharma Sinagpore Pte Ltd|Clinical Trial Disclosure|+65 6500 9330|astellas.resultsdisclosure@astellas.com|
20542816|NCT03789669|Johnson & Johnson Surgical Vision|Brian Pall, Dr.|+1 904 6292289|bpall@its.jnj.com|
20542817|NCT01809938|GuysThomasNHSTrust / Rockingham General Hospital|Dr. Sam Hillyard|+61424055820|sghillyard@yahoo.co.uk|
20542818|NCT02595983|Alnylam Pharmaceuticals Inc|Chief Medical Office|866.330.0326|Clinicaltrials@alnylam.com|
20542819|NCT03550118|University of Washington|Daniel Ballesteros|206-221-5873|danieb25@uw.edu|
20542820|NCT01187017|NIHNHLBI|Bhavisha Patel, MD|301.402.3477|bhavisha.patel@nih.gov|
20542821|NCT00524511|UMass Memorial Medical Center|Dawn Tasillo, MD|5083346255|tasillod@ummhc.org|
20542822|NCT03617172|Vanderbilt University Medical Center|Sr. Clinical Trials Operations Manager|6159360815|stephanie.anne.smith@vumc.org|
20542823|NCT03305666|Denver Health and Hospital Authority|Dr. Fredric Pieracci|(303) 436-4029|Fredric.Pieracci@dhha.org|
20542824|NCT02051452|Harvard Medical School|Dr. Ken Solt, MD, Associate Professor of Anaesthesia|6177264359|ksolt@mgh.harvard.edu|
20542825|NCT01166139|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu|
20542826|NCT02587221|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20542827|NCT02546609|Nusirt Biopharma Inc.|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
20542828|NCT02212015|Universität Heidelberg/Universitätsmedizin Mannheim|Prof. Dr. med. Peter Hohenberger|+49 0621 383 2609|peter.hohenberger@umm.de|
20542829|NCT01048593|Eyepoint Pharmaceuticals, Inc.|Regulatory Affairs Specialist|6179726318|dbauer@eyepointpharma.com|
20542830|NCT03780452|UAB Department of Orthopaedic Surgery|Dr. Ashish Shah|(205) 930-8339|ashishshah@uabmc.edu|
20542831|NCT00914849|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8304|jdipersi@dom.wustl.edu|
20542832|NCT01001221|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
20542833|NCT02388269|electroCore LLC|Clinical Affairs Department electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
20542834|NCT05106959|University of New Mexico South West Clinical Trials Network|Cade Arnink|505-918-0341|clarnink@salud.unm.edu|
20542835|NCT02689427|The University of Texas MD Anderson Cancer Center|Clinton Yam, MD|(832) 589-8343|cyam@mdanderson.org|
20542836|NCT03988400|Ralph H. Johnson VA|Jesse Dean|8437929566|deaje@musc.edu|
20542837|NCT02542865|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20542838|NCT00375999|Gangnam Severance Hospital, Yonsei University College of Medicine|Dr. Jae Yong Cho|82-2-2019-4363|chojy@yuhs.ac|
20542839|NCT05005260|Mayo Clinic|Johar Paul|5072556804|Paul.Johar@mayo.edu|
20542840|NCT03164668|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20542841|NCT02240485|Université du Québec à Trois-Rivières|Dr. Joël Tremblay|4186592170|joel.tremblay@uqtr.ca|2820
20542842|NCT04038359|Secura Bio, Inc.|Ohad Bentur, MD, MHA, MSc|1-702-254-0011|obentur@securabio.com|
20542843|NCT00703014|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542844|NCT02004236|BrainMech Foundation|Moises Domingo president of Brainmech Foundation|+441615312645|moises@bigdata4brain.co.uk|
20542845|NCT04949191|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20542846|NCT05121766|Hackensack Meridian Health|Arunima Sarkar, MD|5519961140|arunima.sarkar@hmhn.org|
20542847|NCT03259230|Swedish Orphan Biovitrum|Medical Director|+4686972000|clinical@sobi.com|
20542848|NCT01033240|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20542849|NCT02913482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20542850|NCT02005016|VA Pittsburgh Healthcare System|Dr. Michael Dickey|412-360-6467|michael.dickey@va.gov|
20542851|NCT00625131|VA Medical Center, Durham, NC|Angela Kirby, MS; Regulatory Coordinator|9192860411|angela.kirby@va.gov|5526
20542852|NCT01003301|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
20542853|NCT00918281|GE Healthcare|Matthew Miller|011-44-1494-543981|matthew.miller@ge.com|
20542854|NCT03624881|Biosense Webster, Inc.|Senior Safety Officer CSS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20542855|NCT00168844|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542856|NCT01026844|Massachusetts General Hospital|Lecia Sequist, MD|617-724-4000|lvsequist@partners.org|
20542857|NCT03557970|Oregon Health and Science University|Elie Traer, MD PhD|5034943553|traere@ohsu.edu|
20542858|NCT01260649|MGH|Dr. Cristina Cusin|617 726 64221|ccusin@mgh.harvard.edu|
20542859|NCT02138890|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
20542860|NCT00112736|Adult Brain Tumor Consortium (ABTC)|Dr. Patrick Y Wen||pwen@partners.org|
20542861|NCT05435339|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
20542862|NCT01446159|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
20542863|NCT00537394|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)628-3313|ACTGCT.Gov@s-3.com|
20542864|NCT01283139|MedImmune, LLC|Gabor Illei, MD, Senior Director, Clinical Development|301-398-0000|IlleiG@Medimmune.com|
20542865|NCT00004563|University of Texas Health Science Center at Houston|Maureen Mayes, MD|+1 (713) 500-6900|Maureen.D.Mayes@uth.tmc.edu|
20542866|NCT00995761|Gyeongsang National University Hospital|Gyeong-Won Lee M.D.Ph.D.|82-55-750-8066|brightree@lycos.co.kr|
20542867|NCT00593346|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
20542868|NCT04875013|DR. EYTAN A. DAVID, MD, Otolaryngologist|Dr. Eytan David|(604) 988-0598|dr.david@shaw.ca|
20542869|NCT00849940|Duke University Medical Center|David MacLeod, M.B.|919-681-3551|david.macleod@dm.duke.edu|
20542870|NCT03577275|NorthSea Therapeutics BV|Dr Patrick Round|+44(0)7979502770|patrick.round@northseatherapeutics.com|
20542871|NCT02994108|Florida State University College of Medicine|Mary Gerend|8506451541|mary.gerend@med.fsu.edu|
20542872|NCT00089297|ECOG Statistical Office|Study Statistician|617-632-3012||
20542873|NCT00904969|American Medical System|Laura Olson, Clinical Project Manager|952-930-6000|laura.olson2@bsci.com|
20542874|NCT01097668|Apitope Technology (Bristol) Ltd|Chief Executive Officer|+44(0)117 3707720|keith.martin@apitope.com|
20542875|NCT04396756|Pliant Therapeutics, Inc.|Gregory P. Cosgrove, MD, Vice President, Clinical Development|1-650-481-6770|GCosgrove@pliantrx.com|
20542876|NCT00574197|Cedars-Sinai Medical Center|Ernst Schwarz, MD, PhD|(310) 840-7089|Ernst.Schwarz@cshs.org|
20542877|NCT01910298|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20542878|NCT00948246|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
20542879|NCT00148317|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
20542880|NCT04199351|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20542881|NCT03623243|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20542882|NCT03007966|Wake Forest University Health Sciences|Christopher Edwards|336-716-4498|chedward@wakehealth.edu|
20542883|NCT03365102|Brown University|Richard Jones|401-444-1943|rich_jones@brown.edu|
20542884|NCT00474487|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
20542885|NCT01428258|University of Wisconsin-Madison|Dr. Denise M Ney|608-262-4386|ney@nutrisci.wisc.edu|
20542886|NCT00419393|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20542887|NCT00979901|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20542888|NCT00681044|Boston Medical Center|Dr. Vaishali Sanchorawala, Director of Stem Cell Transplant Program|617-637-7017|vaishali.sanchorawala@bmc.org|
20542889|NCT03924622|University of Washington|Becky Ostrem CIP Compliance Administrator, Regulatory Affairs|2066858138|bostrem@uw.edu|
20542890|NCT02994238|Northwestern University|Kathy Boon- Clinical Research Associate|312-503-4687|kathy.boon@northwestern.edu|
20542891|NCT05941702|University of Manchester|Krishna Panchmatia|07857543272|krishna.panchmatia@postgrad.manchester.ac.uk|
20542892|NCT02814916|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20542893|NCT04392739|SIGA Technologies|Emily Blum, Assoc. Director of Clinical Research|541-224-1305|eblum@siga.com|
20542894|NCT05316597|University of Washington|Dr. Gregory Bratman|2065437591|bratman@uw.edu|
20542895|NCT03547518|William Beaumont Hosptial|Jennifer Giordano, RN BSN Clinical Research Manager|248-551-3517|jennifer.giordano@corewellhealth.org|
20542896|NCT02887820|University of Pittsburgh|Amy Monroe|412-623-6382|monroeal@upmc.edu|
20542897|NCT04247347|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
20542898|NCT02923726|Boston Scientific|Jacqueline Beaulieu, Sr. Clinical Trial Manager|1-800-227-3422|jacqueline.beaulieu@bsci.com|
20542899|NCT04386291|NYS Psychiatric Institute|Dr. Brian A Fallon|646-774-8052|baf1@cumc.columbia.edu|
20542900|NCT00671658|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD./ Chair|713-792-7026|eharriso@mdanderson.org|
20542901|NCT03098641|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Philippe Ferry|+33 5 46 45 50 50|philippe.ferry@ch-larochelle.fr|
20542902|NCT01469221|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20542903|NCT00790803|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skk@retinacenterspc.com|
20542904|NCT04205240|The Ohio State University Comprehensive Cancer Center|Dr. Srinivas Devarakonda|614-293-3196|Srinivas.Devarakonda@osumc.edu|
20542905|NCT01490151|Stanford University|Dr. Bruce Buckingham, MD|408-356-0911|buckingham@stanford.edu|
20542906|NCT05467007|The George Washington University|Dr. Andrew C. Meltzer|202-741-2952|Ameltzer@mfa.gwu.edu|
20542907|NCT02358473|Kyowa Kirin Pharmaceutical Development, Inc.|Regional_Program Lead|1-609-919-1000|clinical.info@kyowa-kirin-pharma.com|
20542908|NCT00953667|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
20542909|NCT02970981|NYU Langone Health - Perlmutter Cancer Center|Jeffrey S. Weber, MD, PhD|212 731 6262|Jeffrey.Weber@nyulangone.org|
20542910|NCT04797585|Cleveland Clinic Foundation|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
20542911|NCT00918385|Duke University|Dr. Daniel George|(919) 668 4615|daniel.george@duke.edu|
20542912|NCT03207126|Imperial College London|Diana Marcus|07525133957|diana.marcus@nhs.net|
20542913|NCT02296164|Helsinn Therapeutics (U.S.), Inc.|Bill Bailey|+1 732 603 2848|bill.bailey@helsinn.com|
20542914|NCT04576988|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20542915|NCT01938079|Columbia University|Amy L. Dzierba, Pharm.D., BCPS, BCCCP, FCCM|212-305-5852|ald9012@nyp.org|
20542916|NCT03371836|KennedyKrieger|Project Director|443-923-7600|Salpekar@kennedykrieger.org|
20542917|NCT04897711|Utah State University|Stephanie Borrie|435-797-1388|stephanie.borrie@usu.edu|
20542918|NCT03218384|NYU Langone Health|Stuart Katz, MD|2122633946|Stuart.Katz@nyulangone.org|
20542919|NCT02362724|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20542920|NCT02025179|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
20542921|NCT00556075|Repros Therapeutics Inc.|Jennifer L. Wike|2817193402|jwike@reprosrx.com|
20542922|NCT01854359|National Institutes of Allergy and Infectious Diseases|Dr. Peter Kosa (Staff Scientist)|(301) 731-6444|peter.kosa@nih.gov|
20542923|NCT02485691|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20542924|NCT01927497|Academic medical center|prof. dr. P.J. Tanis|0031205669111|g.d.musters@amc.nl|
20542925|NCT00395746|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20542926|NCT04528641|Reithera|Medical Director|06 99775|roberto.camerini@reithera.com|352
20542927|NCT00517296|Vanderbilt University Medical Center|David A. Schwartz, MD|615-322-4643|david.a.schwartz@vanderbilt.edu|
20542928|NCT04764162|Virginia Tech|Dr. Kevin Davy|(540)231-3487|kdavy@vt.edu|
20542929|NCT03361137|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20542930|NCT00791934|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
20542931|NCT05358366|University of North Carolina at Chapel Hill|Natalia Villegas Rodriguez, PhD|919-966-4260|navilleg@email.unc.edu|
20542932|NCT05556265|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20542933|NCT02787564|University of Hohenheim|Prof. Dr. Nanette Ströbele-Benschop|+49711 459 24260|N.Stroebele@uni-hohenheim.de|24260
20542934|NCT03724942|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
20542935|NCT02429830|Torax Medical, Inc|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20542936|NCT02608684|Cedars-Sinai Medical Center|Bobbie J. Rimel, MD|310-423-1126|Bobbie.Rimel@cshs.org|
20542937|NCT00558142|University of Edinburgh|Prof M Eddleston|01312426776|m.eddleston@ed.ac.uk|
20542938|NCT01176032|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20542939|NCT01149096|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20542940|NCT06047210|Swedish Orphan Biovitrum|Medical Director|+4686972000|clinical@sobi.com|
20542941|NCT06133816|University of Pennslyvania|Katharine Rendle, PI|215-349-5442|katharine.rendle@pennmedicine.upenn.edu|
20542942|NCT04819945|GATT Technologies B.V.|Dr Stuart Head, MD, PhD, Chief Medical Officer|+31645306042|s.head@gatt-tech.com|
20542943|NCT03521570|Emory University|Nabil F. Saba MD, FACP|404-778-0278|nfsaba@emory.edu|
20542944|NCT00322881|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
20542945|NCT01667900|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20542946|NCT00468169|University of Chicago|Everett E Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
20542947|NCT00784563|Veterans Affairs Medical Center of Iowa City|Ergun Y. Uc, MD|319-356-8753|ergun-uc@uiowa.edu|
20542948|NCT02946580|Massachusetts General Hospital|Dr. Kyle Staller|617-724-7556|kstaller@mgh.harvard.edu|
20542949|NCT03896438|University of Minnesota|Melanie Stimac|612-301-2449|stima011@umn.edu|
20542950|NCT00685165|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20542951|NCT01336933|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
20542952|NCT00321789|Veterans Affairs Medical Center|Corrine I. Voils|919-286-0411|corrine.voils@va.gov|5196
20542953|NCT00534365|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
20542954|NCT04292535|Michigan State University|Matthew B. Pontifex|517-432-5105|pontifex@msu.edu|
20542955|NCT00310765|retired|Dr. Ann Silverman||anngimd@icloud.com|
20542956|NCT03542812|University of Utah|Candice Fike|801-587-7804|candice.fike@hsc.utah.edu|
20542957|NCT01420861|Oncternal Therapeutics|Mary Breitmeyer|8582092082|mbreitmeyer@oncternal.com|208
20542958|NCT00829738|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20542959|NCT03413891|University Hospitals Leuven|Mrs. Barbara Debaveye|003216 341463|barbara.debaveye@uzleuven.be|
20542960|NCT04905134|Duke University|Walter T. Lee, MD, MHS|919-613-6407|walter.lee@duke.edu|
20542961|NCT03009058|Immodulon Therapeutics Ltd|Chief Medical Odfficer|+44 (0)20 3137 6346|info@immodulon.com|
20542962|NCT03137992|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
20542963|NCT02103309|Alcon Japan, Ltd.|Director of Clinical Trials|1-888-451-3937|alcon.medinfo@alcon.com|
20542964|NCT03077542|National Heart, Lung, and Blood Institute at National Institutes of Health|Courtney Fitzhugh, M.D.|301.402.6496|fitzhughc@nhlbi.nih.gov|
20542965|NCT04359810|Columbia University Irving Medical Center|Max O'Donnell, MD|212-305-5794|mo2130@columbia.edu|
20542966|NCT03221556|Boston Medical Center|Caroline Kistin, MD MSc|(617) 414-3638|caroline_kistin@brown.edu|
20542967|NCT04760782|University of Vermont|Dr. David Lunardini|(802) 847-2663|david.lunardini@uvmhealth.org|
20542968|NCT00795704|University of Mississippi Medical Center|Daniel Riche|601-984-2640|driche@umc.edu|
20542969|NCT03980730|vTv Therapeutics LLC|VP Clinical Operations|3368410300|jfreeman@vtvtherapeutics.com|
20542970|NCT01300728|Sutter Neurology Medical Group|Shawn Kile, MD|(916) 454-6850|KileS@sutterhealth.org|
20542971|NCT01486966|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20542972|NCT02392806|Saint Louis University|Noah Hillman|3145779292|noah.hillman@health.slu.edu|
20542973|NCT04076540|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20542974|NCT03125226|University of Washington School of Medicine|Dr. Jing Zeng|2065985998|jzeng13@uw.edu|
20542975|NCT00301808|Barbara Ann Karmanos Cancer Institute|Shrish Gadgeel, M.D.|(313) 556-8820|sgadgee1@hfhs.org|
20542976|NCT02234843|Therapeutic Area Head|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20542977|NCT01319981|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD./ Professor|713-792-4764|ejabbour@mdanderson.org|
20542978|NCT01607957|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
20542979|NCT04570930|University of Michigan|Dr. Noelle E Carlozzi|734-764-0644|PMR-CODAlab@med.umich.edu|
20542980|NCT04972786|University of New Mexico|Dr. Jeremy Hogeveen|773-941-2182|jhogeveen@unm.edu|
20542981|NCT01001975|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20542982|NCT00844844|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc.||clinicaltrials@alxn.com|
20542983|NCT03905096|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20542984|NCT01943344|Vivasure Medical|Dr Chris Martin|+353 9 395 440|chris.martin@vsuremed.com|
20542985|NCT02016781|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20527265|NCT00312572|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20542986|NCT05460754|Montana State University|Dr. Mary P Miles|406 994-6678|mmiles@montana.edu|
20542987|NCT00945009|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20554987|NCT01319318|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20542988|NCT04886154|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20542989|NCT05305443|University of Illinois Urbana Champaign|Dr. Liliane Windsor|217-300-1782|lwindsor@illinois.edu|
20542990|NCT03919773|UT Southwestern Medical Center|Dr. Steven Vernino|214-648-8816|steven.vernino@utsouthwestern.edu|
20542991|NCT02977403|Eunice Kennedy Shriver National Institute of Health, NIH|Dr. Jack Yanovski|301-496-0858|jy15i@nih.gov|
20542992|NCT04659044|Perlmutter Cancer Center at NYU Langone Health|Catherine Diefenbach M.D.|(212) 731-5670|Catherine.diefenbach@nyulangone.org|
20542993|NCT02891447|University of M D Anderson Cancer Center|Dr. Brian Badgwell|713-745-7351|bbadgwell@mdanderson.org|
20542994|NCT04966013|EmitBio Inc|Chief Medical Officer|919.321.1734|info@emitbio.com|
20542995|NCT04875975|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20542996|NCT03960541|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20542997|NCT00781768|Loyola University Medical Center|Patrick Stiff, M.D.|708-327-3148|pstiff@lumc.edu|
20542998|NCT02458313|University of Colorado School of Medicine|Dr. Kristina Legget|3037245809|kristian.legget@cuanschutz.edu|
20542999|NCT03414983|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20543000|NCT00751296|University Health Network - Princess Margaret Cancer Centre|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
20543001|NCT00755183|Andover Eye|Dr. Mark Abelson|9784750705||
20543002|NCT01280903|University of Pittsburgh|Elizabeth A. Schlenk|412-624-4103|els100@pitt.edu|
20543003|NCT03453164|Fukushima medical university of medicine|Prof. Koji Kono|+81245471259|kojikono@fmu.ac.jp|
20543004|NCT00874510|Center for Health Incentives and Behavioral Economics|Kevin Volpp, MD, PhD|215.573-0270|volpp70@exchange.upenn.edu|
20543005|NCT02177695|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
20543006|NCT03904017|University of Colorado|Layne Dylla|303-724-1716|layne.dylla@cuanschutz.edu|
20543007|NCT00248625|University of Pittsburgh|Robert H. Squires, Jr.|412-692-8648|squiresr@upmc.edu|
20543008|NCT02464540|Federal University of Pelotas|Dr Noéli Boscato|5553999530000|noeliboscato@gmail.com|
20543009|NCT01074502|UNC Chapel Hill|Aida Lugo-Somolinos MD-PI|919-843-9447|alugosom@med.unc.edu|
20543010|NCT01691534|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
20543011|NCT02220920|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20543012|NCT00834977|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20543013|NCT02047032|Gunang'anmen Hospital|Zhishun Liu|86 88002331|liuzhishun@aliyun.com|
20543014|NCT05719311|Entero Therapeutics|VP, Regulatory, QA & Compliance|9194491484|AChandler@Enterothera.com|
20543015|NCT05176314|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20543016|NCT05753449|Allegheny Health Network|Megan Hendricks, regulatory Specialist|412-330-6206|megan.hendricks@ahn.org|
20543017|NCT02118584|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20543018|NCT04204447|University at Buffalo|Andrew Talal|7168884737|ahtalal@buffalo.edu|
20543019|NCT03103542|Swedish Orphan Biovitrum AB|Medical Information|+468 6972000|medical.info@sobi.com|
20543020|NCT03557294|Arizona State University|Scott Leischow, PhD|602-496-3300|scott.leischow@asu.edu|
20543021|NCT02939287|Rush University Medical Center|Danielle Murphy, PharmD, BCOP, BCPS|3129472401|danielle_murphy@rush.edu|
20543022|NCT00989911|Ahamanson/UCLA ACHDC|Dr. Jamil Aboulhosn|3108255950|jaboulhosn@mednet.ucla.edu|
20543023|NCT02918370|UT Southwestern|E. Sherwood Brown MD PhD MBA|214-645-6950|sherwood.brown@utsouthwestern.edu|
20554988|NCT02731131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20543024|NCT00322855|University of New Mexico|Christine M. Gan, Ph.D|5059250387|cgan@salud.unm.edu|
20543025|NCT03402217|Ci3 at the University of Chicago|Ellen McCammon|773-834-8462|emccammon@bsd.uchicago.edu|
20543026|NCT01680341|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20543027|NCT02005549|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20543028|NCT00499486|The Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins|Dr. Hidalgo||mhidalgo@cnio.es|
20543029|NCT00333775|Hoffmann-La Roche|Medical Communications|800 821-8590||
20543030|NCT02968134|The University of Queensland|Prof. Jason Roberts|+61 7 3646 4108|j.roberts2@uq.edu.au|
20543031|NCT01383928|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20543032|NCT01349543|Imperial College London|Prof Peter JM Openshaw|07973820801|p.openshaw@imperial.ac.uk|
20543033|NCT04914364|Duke University|Ashley Poole|919-538-6272|ashley.poole@duke.edu|
20543034|NCT01263769|UT MD Anderson Cancer Center|Dr. Jose Karam, MD, Associate Professor, Urology|(713) 745-0374|jakaram@mdanderson.org|
20543035|NCT05058365|The University of Hong Kong|Professor Lam Shui-fong|85239172388|lamsf@hku.hk|
20543036|NCT05444855|Children's Mercy Hospitals and Clinics|Melissa Miller MD|816234300|mmiller@cmh.edu|
20543037|NCT00702702|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
20543038|NCT01500733|National Heart Lung and Blood Institute|Ahn, Inhye|+1 301 827 1203|inhye.ahn@nih.gov|
20543039|NCT00551759|ECOG Statistical Office|Study Statistician|617-632-3012||
20543040|NCT03279081|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20543041|NCT05379179|University of Arizona|Jessica Winters|520-780-1882|jwinters1@arizona.edu|
20543042|NCT00214045|University of Wisconsin School of Medicine and Public Health|Dr. Stephen Nakada|(608)263-1359|nakada@urology.wisc.edu|
20543043|NCT01283555|PATH|Jessica Cohen|206-285-3500|jcohen@path.org|
20543044|NCT00762164|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
20543045|NCT02954536|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,MD|646-888-4186|janjigiy@mskcc.org|
20543046|NCT00568022|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20543047|NCT03025282|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20543048|NCT01377584|University of Pittsburgh|Faith Luyster, PhD|412-624-7910|fsl3@pitt.edu|
20543049|NCT05135871|Shanghai LianBio Development Co., Ltd|Brianna Sun|+862123081188|brianna.sun@lianbio.com|
20543050|NCT01576341|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
20543051|NCT00617734|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20543052|NCT01844765|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20554989|NCT02509624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20554990|NCT02348216|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20554991|NCT01055639|VA San Diego Healthcare System|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
20554992|NCT00765245|Vanderbilt-Ingram Cancer Center|Dr. Nishitha Reddy|800-811-8480|nishitha.reddy@vanderbilt.edu|
20554993|NCT04483479|Enterin|Dr. Richard Larson, Chief Medical Officer|5054692670|r.larson@enterininc.com|
20554994|NCT01197950|Universty of Skovde|Professor Lena Mårtensson|+46500448000|lena.martensson@his.se|
20554995|NCT02553330|Incyte Organization|Study Director|855-463-3463|medinfo@incyte.com|
20554996|NCT02896855|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20554997|NCT02169674|Vaccine Evaluation Center|Director of Vaccine Evaluation Center|604-845-2422||
20554998|NCT04634604|Jaeb Center for Health Research|Ray Kraker|8139758690|rkraker@jaeb.org|
20554999|NCT02265705|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20555000|NCT04030416|seca gmbh & co. kg|Kristin Klückmann|+49(40)200000|kristin.klueckmann@seca.com|232
20555001|NCT00346034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20555002|NCT04000165|The National Institutes of Health / The National Heart, Lung, and Blood Institute|Dr. Swee Lay Thein, Chief of Sickle Cell Branch|301.402.6699|sweelay.thein@nih.gov|
20555003|NCT03660683|George Washington University Medical Faculty Associates|Dr. Sabyasachi Sen|301-461-6676|ssen1@email.gwu.edu|
20555004|NCT00941603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20555005|NCT02079805|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20555006|NCT01753193|MedImmune, LLC|Raj Tummala|+1 301-398-0548|information.center@astrazeneca.com|
20555007|NCT00383435|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20555008|NCT00583557|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555009|NCT02682264|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20555010|NCT02347761|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20555011|NCT00874029|Halt Medical, Inc|Laura Kemp, Sr. VP Clinical Affairs|408-375-1465|lkemp@haltmedical.com|
20555012|NCT00283504|CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS|MARIPAZ MORALES MD|7576688255|MARIPAZ.MORALES@CHKD.ORG|
20555013|NCT03198000|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD, MPH|(973) 255-8701|AParikh1@its.jnj.com|
20555014|NCT01761747|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-6335|phammerman@partners.org|
20555015|NCT00864032|University of California Davis Comprehensive Cancer Center|Dr. Robert J. Canter|916-734-5907|robert.canter@ucdmc.ucdavis.edu|
20555016|NCT01059760|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
20555017|NCT02252211|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20555018|NCT00659633|University of Alabama at Birmigham|Dr. Michael Froelich|205-975-3328|mfroelich@uabmc.edu|
20555019|NCT00968669|MedImmune|Joe Parker, MD|301-398-0000|parkerJ@medimmune.com|
20555020|NCT01953926|Puma Biotechnology, Inc.|Sr Director, Clinical Operations|4242486500|clinicaltrials@pumabiotechnology.com|
20555021|NCT03836287|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20555022|NCT00986999|University of Hawaii|Cecilia M. Shikuma M.D.|808 692-1328|shikuma@hawaii.edu|
20555023|NCT02255175|UNC School of Medicine|Crystal Edler Schiller, PhD|919-966-4810|crystal_schiller@med.unc.edu|
20555024|NCT01276587|Columbia University|Margaret Lee, MD|212-305-6290|ml653@cumc.columbia.edu|
20555025|NCT01949480|University of Pittsburgh|Dr. Anna Uskova, Principal Investigator|412) 623-2167|UskoAA@anes.upmc.edu|
20555026|NCT02100072|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20543053|NCT03914417|Icahn School of Medicine at Mount Sinai|Dr. Sharon Rose|212-241-3288|sharone.rose@gmail.com|
20543054|NCT02747186|University of North Carolina at Chapel Hill|Raymond P. White Jr., DDS, PhD|919-537-3944|ray_white@unc.edu|
20543055|NCT03836625|Vanderbilt University|Kate Clouse|(615) 343-5351|kate.clouse@vanderbilt.edu|
20543056|NCT01897025|National University Hospital|Dr Effie Chew|65-67726198|effie_chew@nuhs.edu.sg|
20543057|NCT01247324|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20543058|NCT00506350|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543059|NCT03474588|Yale University Department of Psychiatry|Dr. Brian Kiluk, Ph.D.|203-737-1544|brian.kiluk@yale.edu|
20543060|NCT03902418|University of CApe Town|Landon Myer|0829430578|landon.myer@uct.ac.za|
20543061|NCT01691794|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20555027|NCT04798586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543062|NCT05010707|Washington University in St. Louis, School of Medicine|Thomas Baranski, MD, PhD|314-747-3997|baranski@wustl.edu|
20543063|NCT01740713|Consorzio per Valutazioni Biologiche e Farmacologiche|Clinical Research Coordinator|0039 0382 25075|mariagraziafelisi@cvbf.net|
20543064|NCT02336282|St. Jude Children's Research Hospital|Kevin Krull, PhD|(901) 595-5891|kevin.krull@stjude.org|
20543065|NCT04084171|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20543066|NCT03563209|İzmir Katip Çelebi University, Faculty of Medicine|ilker şengül|05337333698|ilkrsngl@gmail.com|
20543067|NCT01404039|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526156|felipe.fregni@ppcr.hms.harvard.edu|
20543068|NCT05472090|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 799-8599|greg.sullivan@tonixpharma.com|
20543069|NCT03863795|National Cancer Institute|Annette Kaufman|301-467-8521|kaufmana@mail.nih.gov|
20543070|NCT01395797|New York State Psychiatric Institute|Sandra Comer PhD|646 774-6146|sdc10@columbia.edu|
20543071|NCT04567628|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20543072|NCT00199381|Kyowa Hakko Kirin Pharma, Inc.|Director of Clinical Trials|609-919-1100|mcantillon@kyowa-kirin-pharma.com|
20543073|NCT00603408|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wudosis.wustl.edu|
20543074|NCT02892344|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20543075|NCT01295814|IC Study, LLC|Philip C. Bosch, MD|760-743-3135|pboschmd@gmail.com|
20543076|NCT02958917|National Jewish Health|Dr. Evans Fernández|303-388-4461|fernandezevans@njheallth.org|
20543077|NCT00181168|Johns Hopkins Univ|Paul W. Ladenson, MD, Professor and PI|4109553663|ladenson@jhmi.edu|
20543078|NCT01775501|Massachusetts General Hospital|Dr. Lipika Goyal|617-724-4000|LGOYAL@PARTNERS.ORG|
20543079|NCT02318706|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
20543080|NCT01702311|Emory University|Guillermo Umpierrez, MD|404-778-1663|geumpie@emory.edu|
20543081|NCT02170376|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20543082|NCT04106557|Ovid Therapeutics|Todd F. Baumgartner, M.D., MPH|802-752-5168|tbaumgartner@ovidrx.com|
20508300|NCT05567393|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20543083|NCT02326155|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
20543084|NCT05024032|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20543085|NCT02166346|Johns Hopkins University|Michael Levy, Principal Investigator|443-287-4412|mlevy@jhmi.edu|
20543086|NCT01209689|Hoffmann-La Roche|Medical Communications|800 821-8590||
20543087|NCT03780244|QMedAB|Clinical Project Manager|817-961-5000|aestheticclinicaltrials@galderma.com|
20543088|NCT03175367|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20543089|NCT02670811|Centro de Investigación en Alimentación y Desarrollo, A.C.|Dr. Belinda Vallejo Galland|526622892400|vallejo@ciad.mx|365
20543090|NCT03937570|Division of Cardiac Surgery, Department of Surgery - University of Verona|Marzia Lilliu, MD, PhD|+39 3281383539|marzialilliu@gmail.com|
20543091|NCT03714672|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
20543092|NCT03629535|NYU Langone Health|Greta Piper, MD|212-263-4778|Greta.Piper@nyulangone.org|
20543093|NCT00809185|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|216-445-9354|advania@ccf.org|
20543094|NCT02364700|New York University|Grace Kim PhD, OTR/L|121-998-5846|gjk207@nyu.edu|
20543095|NCT01054885|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543096|NCT00804908|AbbVie|Global Medical Information|800-633-9110||
20543097|NCT03649646|Boryung Pharm. CO., LTD|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
20543098|NCT03085095|Myovant Sciences GmbH|Clinical Trials at Myovant|650-278-8743|ClinicalTrials@Myovant.com|
20543099|NCT02770014|Dana-Farber Cancer Institute|Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
20543100|NCT03459079|University of Florida|Kenneth Cusi|352-505-9060|kcusi@ufl.edu|
20543101|NCT00674817|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543102|NCT02379728|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
20543103|NCT00976183|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
20543104|NCT04945733|Janssen Pharmaceutical K.K.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20543105|NCT00726063|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20543106|NCT02007096|Division of General Surgery, Department of Surgery, The Mount Sinai Medical Center|Dr. Celia M Divino|212-241-5499|Celia.Divino@mountsinai.org|
20543107|NCT01231984|Becton Dickinson|Laurence Hirsch, MD|201-847-6513|Laurence_Hirsch@bd.com|
20543108|NCT01968447|LUMC|Albert Dahan|+31 71 52 62301|a.dahan@lumc.nl|
20543109|NCT02182895|Brigham and Women's Hospital|Dr. Rajesh Garg, MD|617-732-5584|rgarg@partners.org|
20543110|NCT00821795|Lexington VAMC|Dennis G Karounos, MD Principal investigator|859 233-4511|dennis.karounos@va.gov|4430
20543111|NCT01827137|Sellas Life Sciences|Dragan Cicic|646-200-5278|info@sellaslife.com|
20543112|NCT03566511|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-839-7975|meredith.hawkins@einsteinmed.edu|
20543113|NCT04196777|Iowa City VA Health Care System|Daniel Livorsi|319-688-3871|daniel.livorsi@va.gov|
20543114|NCT00981656|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20543115|NCT04026113|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20543116|NCT00687596|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
20543117|NCT04613362|Richard L. Roudebush VA Medical Center|Dr. Teresa Damush|317-988-4277|teresa.damush@va.gov|
20543118|NCT02903771|Kazia Therapeutics Ltd|Jeremy Simpson|+61 400410974|Jeremy.simpson@kaziatherapeutics.com|
20543119|NCT02218372|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20543120|NCT02753283|University of Pittsburgh|Dr. Susan Greenspan|+14126922477|greenspn@pitt.edu|
20543121|NCT03406780|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
20543122|NCT04090203|Cleveland Clinic|Dr. Jaclyn Bjelac|216 445-1449|bjelacj2@ccf.org|
20543123|NCT03299556|Purdue Pharma L.P.|Thomas Alfieri, PhD - Director, Medical Affairs Strategic Research|(475) 299-6085|thomas.alfieri@pharma.com|
20543124|NCT01488045|St. Joseph Mercy Hospital|Robert K. Cleary, MD|734.712.8150|Robert.Cleary@trinity-health.org|
20543125|NCT05043363|Imperial College London|Mr James Kinross|02033121947|j.kinross@imperial.ac.uk|
20543126|NCT05365217|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20543127|NCT02476617|AbbVie|Global Medical Services|800-633-9110||
20543128|NCT02491684|AstraZeneca|Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20543129|NCT01350947|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
20543130|NCT04739982|Stanford University|Kaiti Dunlap, Clinical Research Coordinator|650-497-9214|kdunlap2@stanford.edu|
20543131|NCT03651765|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20543132|NCT01346358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20543133|NCT02839096|University of Missouri School of Medicine|Research Success Core|(573) 817-3386|obgynresearchsuccesscore@health.missouri.edu|
20543134|NCT03496844|University of Arizona|Phillip Kuo, MD PhD|5206268318|pkuo@arizona.edu|
20543135|NCT00771914|University of Rochester Division of Epidemiology, Department of Community and Preventive Medicine|Robert Block, MD, MPH, FACP|585-275-3356|robert_block@urmc.rochester.edu|
20543136|NCT04372017|Sanford Health|Dr. Susan Hoover|605-328-8120|Susan.Hoover@sanfordhealth.org|
20543137|NCT01521117|Oregon Health & Science University|Amie Hiller, MD|503 721 1091|peterami@ohsu.edu|
20543138|NCT01056822|Pharmaceuticals|Novartis|+1 (862) 778-8300||
20543139|NCT03638453|Dana Farber Cancer Institute/Boston Children's Hospital|Dr. Kira Bona, MD, MPH|617-632-4688|kira.bona@childrens.harvard.edu|
20543140|NCT01527149|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20543141|NCT03331315|University of Tennessee - West Cancer Center|Michael Ulm|404-281-9480|mulm@westclinic.com|
20543142|NCT02230410|Mayo Clinic|Dr. Kenneth K. Wang|507-293-7911|wang.kenneth@mayo.edu|
20543143|NCT02135861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20543144|NCT04614363|Houston Methodist|Dr. Brian Miles|713-441-8113|bjmiles@houstonmethodist.org|
20543145|NCT02992288|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20543146|NCT00656513|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20543147|NCT04558125|Cedars-Sinai Medical Center|Victor Tapson, MD|919-971-6441|Victor.Tapson@cshs.org|
20543148|NCT01748292|Retina Consultants of Houston|Charles C. Wykoff, MD, PhD|713-524-3434|ccwmd@houstonretina.com|
20543149|NCT00771277|VA Medical Center Memphis|Dr. Linda O. Nichols|901 523-8990|linda.nichols@va.gov|5082
20543150|NCT03199976|Helsinki University Central Hospital|Dr Anne Kotaniemi-Syrjänen|+35894711|anne.kotaniemi-syrjanen@hus.fi|
20543151|NCT02392637|UT MD Anderson Cancer Center|Dr. Milind Javle, Professor, GI Medical Oncology|(713) 792-5434|mjavle@mdanderson.org|
20543152|NCT01761877|Stony Brook University|Dr. Alison T Stopeck|5206476982|Alison.Stopeck@stonybrookmedicine.edu|
20543153|NCT03913455|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20543154|NCT03962491|Virginia Commonwealth University|Kathryn Polak, PhD|(804) 827-1184|polakkm@vcu.edu|
20543155|NCT03020667|Uwatoko Clinic|Kunihiko Uwatoko, MD|+81-52-991-4602|uwatoko.clinic@gmail.com|
20543156|NCT03697252|Karuna Therapeutics, Inc.|Stephen Brannan|857-449-2234|sbrannan@karunatx.com|
20543157|NCT03288103|Cincinnati Childrens Hospital Medical Center|Dr. Philippe Backeljauw, MD|15136368444|Philippe.backlejauw@cchmc.org|
20543158|NCT03796728|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20543159|NCT03165617|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20543160|NCT05236270|University of Oklahoma Health Sciences|Dr. Amanda Janitz|405-271-2229|amanda-janitz@ouhsc.edu|48081
20543161|NCT03926208|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
20543162|NCT01499940|West Virginia Universtiy|Gerald Higa, PharmD|(304) 293-1461|ghiga@hsc.wvu.edu|
20543163|NCT03694678|Massachusetts General Hospital|Ana-Maria Vranceanu|6178931664|avranceanu@mgh.harvard.edu|
20543164|NCT02435212|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@novartis.com|
20543165|NCT05249582|Palo Alto University|Erick Kim|(510) 457-1584|ekim@paloaltou.edu|
20543166|NCT03267277|National Institute of Environmental Health Sciences|Dr. Adam Schiffenbauer|+1 301 451 6270|adam.schiffenbauer@nih.gov|
20543167|NCT00135226|Nuffield Department of Population Health|Prof Jane Armitage|+44 (0)1865 743743|ascend@ndph.ox.ac.uk|
20543168|NCT04689139|Petrovsky NRCS|Dr. Artem Gubko|+79684241490|gubko@artvig.ru|
20543169|NCT02380573|University of Texas Health Science Center at San Antonio|Dr. Peter Fox|210-567-8150|fox@uthscsa.edu|
20543170|NCT01184898|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
20543171|NCT02893293|Stanford University|Heike Daldrup-Link, MD|(650) 725-2548|mairead@stanford.edu|
20543172|NCT04076696|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20543173|NCT04531176|The Cleveland Clinic Foundation|Kim Jenkins|216-445-4791|jenkink@ccf.org|
20543174|NCT02151487|UT Southwestern Medical Center|Dawood Nasir|214-590-5352|Dawood.Nasir@UTSouthwestern.edu|
20543175|NCT00561652|Minneapolis VA Medical Center|Dr. Howard Fink|612-467-3304|howard.fink@va.gov|
20543176|NCT04842747|Veru|Gary Barnette PhD CSO|800-606-9382|veruclinicaltrials@verupharma.com|
20543177|NCT01743469|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20543178|NCT00317473|USAMRU-K|Mark A. Withers, MD PhD|+254-722-449-357|aodika@wrp-ksm.org|
20543179|NCT02285855|UT MD Anderson Cancer Center|Stephen Chun/Assistant Professor, Radiation Oncology|713- 563-9600|sgchun@mdanderson.org|
20543180|NCT04643808|Medical Univesristy of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
20543181|NCT04484961|Houston Methodist Hospital|Bradley Lambert, PhD|8326872483|bslambert@houstonmethodist.org|
20543182|NCT00388349|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
20543183|NCT01345240|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555028|NCT00298233|Oxford University Clinical Research Unit|Dr. Jeremy Farrar|+84 839237954|info@oucru.org|
20555029|NCT00819182|Indiana University|Janet S Carpenter, PhD, RN, FAAN|317-278-6093|carpentj@iupui.edu|
20555030|NCT04773015|GE Healthcare|Paul Sherwin, MD, PhD|609 510 3686|PaulSherwin@ge.com|
20543184|NCT04011540|University of Pennsylvania|Lauren Southwick|267-428-0125|lauren.southwick@pennmedicine.upenn.edu|
20555031|NCT02908269|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20555032|NCT00142909|Yale University School of Medicine|Rajita Sinha, Ph.D|203-737-5805|rajita.sinha@yale.edu|
20543185|NCT01468558|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20543186|NCT01259063|Memorial Sloan Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|dalbagng@mskcc.org|
20543187|NCT03710187|University of Tennessee Medical Center|Pharm D, Pharmacist Specialist, Critical Care|865-305-9134|swinters@utmck.edu|
20543188|NCT01339832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20543189|NCT00774046|University of Chicago|Dr. Lucy A. Godley|773-702-4140|lgodley@medicine.bsd.uchicago.edu|
20543190|NCT01126749|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20543191|NCT00599014|Emory University|Dr. Javed Butler|404-778-5136|jbutle4@emory.edu|
20543192|NCT00976274|Department of Family Medicine, Yonsei University College of Medicine|Dr. Jae-Yong Shim|(+82) 2-2019-3480|hope@yuhs.ac|
20543193|NCT02183675|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20543194|NCT00627393|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
20543195|NCT05328102|Xencor, Inc|Michael Chiarella|858-945-2415|mchiarella@xencor.com|
20543196|NCT01668784|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20543197|NCT02657889|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20543198|NCT00795535|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-355-4960|kproctor@med.miami.edu|
20543199|NCT00464698|Massachusetts General Hospital|Darin D. Dougherty, MD|617-724-6300|ddougherty@partners.org|
20543200|NCT02855281|Hospital Bethanien Solingen, Clinic of Pneumology and Allergology, Center for Sleep Medicine and Respiratory Care, Solingen, Germany|Dr. Lars Hagmeyer|0212636004|institut@klinik-bethanien.de|
20543201|NCT00374140|University of Pittsburgh|Ahmad Tarhini, MD, PhD|(412) 648-6578|tarhiniaa@upmc.edu|
20543202|NCT00604565|Rockwell Medical|Ajay Gupta, MD|248-960-9009|rd@rockwellmed.com|
20543203|NCT04756427|Washington University|Darla Shores|314-454-6173|shores@wustl.edu|
20543204|NCT03341299|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20543205|NCT04609319|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543206|NCT03804528|University of Miami|Joyce Gomes-Osman|305-284-2632|j.gomes@miami.edu|
20543207|NCT04607005|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20543208|NCT04825574|Blueprint Medicines|Blueprint Medicines Medical Information|1-888-258-7768|medinfo@blueprintmedicines.com|
20543209|NCT03518086|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20543210|NCT00668148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20543211|NCT02702492|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20543212|NCT01243190|The university of Texas MD Anderson Cancer Center|William Wierda MD./Professor|713-745-0428|wwierda@mdanderson.org|
20543213|NCT04944992|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543214|NCT00303069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
20543215|NCT00758667|Vanderbilt University|R. Bruce Shack, MD|615-936-0160|bruce.shack@vanderbilt.edu|
20543216|NCT04295720|University of Arizona|Phillip H. Kuo, MD, PhD|520-626-1957|pkuo@arizona.edu|
20543217|NCT04328077|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
20543218|NCT01456039|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20543219|NCT04936945|Soahg University|Dr. Magdy Mohamed Amien|0934602963|portal@med.sohag.edu.eg|
20543220|NCT00335777|Jefferson Headache Center|Stephen D. Silberstein, MD|215-955-2243|stephen.silberstein@jefferson.edu|
20543221|NCT02798627|University of Pennsylvania Perelman School of Medicine|Kyle Kampman, MD|2157462764|kampman@pennemdicine.upenn.edu|
20543222|NCT03821402|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20543223|NCT00578539|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
20543224|NCT00939393|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
20543225|NCT02851615|Cincinnati Children's Hospital Medical Center|Dr. Lori Crosby|513-636-5380|Lori.Crosby@cchmc.org|
20527266|NCT00904839|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20543226|NCT00313014|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20543227|NCT01843621|Dept of Pediatrics, Pharmongkutklao Hospital, Bankok, Thailand|Sriluck Simasathien, MD|66-2-644-8971|ssriluck@yahoo.com|
20543228|NCT00371150|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20543229|NCT02345070|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20555033|NCT03971643|InflaRx|Prof. Dr. Niels C. Riedemann|+49-(0) 3641-508 180|niels.riedemann@inflarx.de|
20508301|NCT00358501|Jazz Pharmaceuticals|Head of Clinical Development|650.496.3777||
20543230|NCT03081117|Johns Hopkins University|Dr. Leah Rubin, Associate Professor of Neurology, Psychiatry, and Epidemiology|410-955-7311|lrubin@jhu.edu|
20543231|NCT05660577|Bausch & Lomb|Study Director|5102595284|aloncaric@bausch.com|
20543232|NCT04723056|Stanford University|Linda Nguyen|650-736-0431|nguyenlb@stanford.edu|
20543233|NCT05106894|Children's Hospital Los Angeles|Dr. Beth A. Smith|3233614670|bsmith@chla.usc.edu|
20543234|NCT04441138|Rush University Medical Center|Dr. Gaurav Marwaha|3129424399|Gaurav_Marwaha@Rush.edu|
20543235|NCT03363841|Scynexis|David Angulo|201-884-5471|David.Angulo@scynexis.com|
20543236|NCT02156076|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
20543237|NCT03431285|King Fahd University Hospital- Imam Abdulrahman Bin Faisal University|Dr. Muhammed Alshahrani|+966138966666|msshahrani@iau.edu.sa|2002
20543238|NCT06271993|Covalon Technologies Inc.|Director of Regulatory Affairs|888-236-4944|customerservice@covalon.com|
20543239|NCT00481832|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
20543240|NCT02558894|AstraZeneca|Global Clinical Lead|+1 301-398-0000|ClinicalTrialTransparency@astrazeneca.com|
20543241|NCT00581308|W. L. Gore & Associates|Jay Donosky|(800) 437-8181|jdonosky@wlgore.com|
20543242|NCT03379818|University of Birmingham|Dr Andrea Krott|+44 (0)121 414 4903|a.krott@bham.ac.uk|
20543243|NCT01310777|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20543244|NCT00003475|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20543245|NCT00106704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543246|NCT01780506|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
20543247|NCT00643864|CarolinasHS|Dr. Mark Hirsch, Senior Scientist|704 355 7673|mark.hirsch@carolinashealthcare.org|
20543248|NCT01096875|Ankara University Medical Faculty, Department of Cardiovascular Surgery|Prof. A. Ruchan Akar MD., FRCS(CTh).|+90 533 646 06 84|akarruchan@gmail.com|
20543249|NCT01867671|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20543250|NCT02967991|University Hospitals Case Western Reserve|Shaffer Mok|4404065500|Shaffer.Mok@UHHospitals.org|
20543251|NCT01440959|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20543252|NCT03486912|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20543253|NCT00412984|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20543254|NCT02199184|The University of Texas MD Andeerson Cancer Center|Elias Joseph Jabbour|713-792-4764|ejabbout@mdanderson.org|
20543255|NCT04097678|Twin Cities Spine Center|Clinical Research Director|612-775-6222|jmdawson@tcspine.com|
20543256|NCT02453737|Mayo Clinic|Dr. Robert W. Mutter|507-284-3191|Mutter.Robert@mayo.edu|
20543257|NCT04711850|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
20543258|NCT03844997|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Sudipto Mukherjee, MD, PhD|866-223-8100|TaussigResearch@ccf.org|
20543259|NCT00965354|Imperial College|Openshaw, Peter J M|07973 820 801|p.openshaw@imperial.ac.uk|
20543260|NCT04552301|Icahn School of Medicine at Mount Sinai|Dr. Juan Wisnivesky|(212) 241-2125|juan.wisnivesky@mountsinai.org|
20543261|NCT00074165|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
20543262|NCT02516696|Weill Cornell Medicine|Multiple Myeloma Program Manager|646.962.9376|hyk4001@med.cornell.edu|
20543263|NCT01260493|Vårdalinstitute, University of Gothenburg|Professor Synneve Dahlin-Ivanoff ( Research leader)|+46 31 7865733|synneve.dahlin-ivanoff@gu.se|
20543264|NCT02718898|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20543265|NCT01451606|University of Maryland, Baltimore|Dr. Joel Greenspan|4107067090|jgreenspan@umaryland.edu|
20543266|NCT02989493|University of Wisconsin|John Curtin|608-262-0387|jjcurtin@wisc.edu|
20543267|NCT01808755|Divisione Urologia IRCCS Policlinico San Matteo Pavia, Italy|D. Porru|39-0382-503868/503872|danieleporru@tin.it|
20543268|NCT01502293|OncoSec Medical Incorporated|Kellie Malloy, Chief Clinical Development Officer|858-375-9989|kmalloy@oncosec.com|
20543269|NCT02673372|Maimonides Medical Center|Sergey Motov, Director of Research|718-283-8693|smotov@maimonidesmed.org|
20543270|NCT00231816|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543271|NCT01075243|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543272|NCT03337308|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20543273|NCT01569191|Aston University|Prof James Wolffsohn|+44(0)1212044140|j.s.w.wolffsohn@aston.ac.uk|
20543274|NCT01614249|University of Nairobi|Mrs. Rose Okoyo Opiyo|+254 020 2726300|roseopiyo@uonbi.ac.ke|43481
20543275|NCT05498649|Scripps Optometric Group|Dr Keith Wan|858-530-2800|keithmwan@gmail.com|
20543276|NCT02731469|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
20543277|NCT02761330|Washington Universtiy School of Medicine|Alyssa Labonte|314-273-7338|alabonte@wustl.edu|
20543278|NCT00888134|Massachusetts General Hospital|Donald P. Lawrence|617-643-3614|dplawrence@mgh.harvard.edu|
20543279|NCT03183869|Lawson Health Research Institute|Chantelle Graf, RN|519-685-8500|chantelle.graf@sjhc.london.on.ca|35352
20543280|NCT03043313|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20543281|NCT00286728|VAHSRD|Christine Timko|650-617-2746|Christine.Timko@va.gov|
20543282|NCT03050801|National Institutes of Health|Dr. Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
20543283|NCT00584948|University of California, Davis Medical Center|Randi J Hagerman, MD|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
20543284|NCT03735875|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Professor|713-794-4392|NDaver@mdanderson.org|
20543285|NCT02711891|Rush University Medical Center|Kathleen C. Heneghan, RN, PhD|3123395943|kheneghan@facs.org|
20543286|NCT05856422|Clinimark|Associate Researcher|833 373 0998|Carolyn.Cohen@element.com|1
20543287|NCT02677493|IL-YANG PHARM.|Clinical Research Manager|+82-70-7165-7316|hlpark@ilyang.co.kr|7316
20543288|NCT03204188|National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)|Adrian Wiestner, M.D., Ph.D., Principal Investigator|301-594-6855|wiestnea@nhlbi.nih.gov|
20543289|NCT03593044|The Ohio State University College of Optometry|Dr. Jeffrey Walline|(614) 247-6840|walline.1@osu.edu|
20543290|NCT03531112|University of North Carolina at Chapel Hill|Rachel Goode, PhD|919-962-6429|rwgoode@email.unc.edu|
20543291|NCT01972217|AstraZeneca|Medical Director|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
20543292|NCT03829228|USANA Health Science|Dr. Junqiang Tian|8019547462|jeremy.tian@usanainc.com|
20543293|NCT02844569|University of North Carolina at Chapel Hill|Dr. Thiago Morelli|919-537-3727|thiago_morelli@unc.edu|
20543294|NCT02443688|Celtaxsys, Inc.|Director, Clincal Operations|4702060153|sbirnbaum@celtaxsys.com|123
20543295|NCT00242502|University of Texas MD Anderson Cancer Center|Ahmed Kaseb, MD/ Professor||MJLim@mdanderson.org|
20543296|NCT01112917|BRIGHT Research Partners|Andrea Fenton Abbs - Study Director|612-298-7460|andrea@brightresearchpartners.com|
20543297|NCT05101122|Apnimed|Clinical Trials|6015008880|clinicaltrials@apnimed.com|
20543298|NCT04135417|Humacyte Inc.|Shamik Parikh, Chief Medical Officer|919-313-9633|sparikh@humacyte.com|130
20543299|NCT01635504|University of British Columbia|Dr. Shannon Humphrey|(604) 714-0222|shannon@carruthers-humphrey.com|
20543300|NCT00616759|Loma Linda University|Ronald L. Warnell, M.D.|909-558-9551|rwarnell@llu.edu|
20543301|NCT02177123|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
20543302|NCT02437344|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
20543303|NCT04538989|Rezolute|Chief Medical Officer (Dr. Brian Roberts)|650-206-4507|brian@rezolutebio.com|
20543304|NCT02878343|UPenn|Dr. Karen Glanz||kglanz@pennmedicine.upenn.edu|
20543305|NCT05172128|Duke University Medical Center|Dr. P. Murali Doraiswamy|9196845933|murali.doraiswamy@duke.edu|
20543306|NCT00837434|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20543307|NCT01709721|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
20543308|NCT02006472|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
20543309|NCT00886379|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-7929|jr33@partners.org|
20543310|NCT03137381|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20543311|NCT01684917|Imperial College London|Professor Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
20543312|NCT01980017|University of Ottawa Heart Institute|Dr. Robert Reid|6136967393|breid@ottawaheart.ca|
20543313|NCT03044106|University of North Carolina at Chapel Hill|Nicholas Wise, DC|(864) 494-1001|nicholas_wise@med.unc.edu|
20543314|NCT03848325|University of Pittsburgh|Sanjay R. Patel MD, MS|412-383-0607|patelsr2@upmc.edu|
20543315|NCT01207414|Novartis Pharmaceuticals|Study Director|862-778-8300||
20543316|NCT02057250|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20543317|NCT03520998|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20543318|NCT01435382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543319|NCT03367793|Ohio State University College of Optometry|Dr. Heather Anderson, Study PI|614-247-5825|anderson.3881@osu.edu|
20543320|NCT00423579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20543321|NCT00260533|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
20543322|NCT04682366|Wake Forest|Majid Mirzazadeh|336-716-4131|mmirzaza@wakehealth.edu|
20543323|NCT03125395|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20543324|NCT02383576|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20555034|NCT01870843|Xian-Janssen Pharmaceutical Ltd|Associate TA Manager||ClinicalTrialDisclosure@its.jnj.com|
20555035|NCT03325712|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20555036|NCT02265237|AbbVie|Global Medical Information|800-633-9110||
20543325|NCT04218240|University of Pennsylvania|Kyle M. Kampman, MD|2157462764|kampman@pennmedicine.upenn.edu|
20543326|NCT05179785|University of Pittsburgh|Mary Phillips|4123838206|fmristudies@upmc.edu|
20543327|NCT03292926|Hospital for Special Surgery, Anesthesiology|Dr. Jonathan Beathe|2126061036|beatheJ@hss.edu|
20555037|NCT00650546|Department of Gastroenterology, San Antonio Uniformed Services Health Consortium|Patrick R Kenney, DO||pat.kenney@us.army.mil|
20543328|NCT04852302|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
20543329|NCT04393935|Emory University|Natalie Crawford, PhD|404-712-9445|ndcrawford@emory.edu|
20543330|NCT02163538|University Louisville|Dr. Resad Pasic|502-561-7465|resad.pasic@louisville.edu|
20543331|NCT01063049|Gastroenterology Services|Dr. David Gerard|630 969 1167|davidpgerard@comcast.net|
20543332|NCT03656939|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543333|NCT03094416|IBSA|Claudia Scarsi|+41583601000|claudia.scarsi@ibsa.ch|
20543334|NCT00979940|Indiana University School of Medicine|Dr. Rolf Kreutz|3179620500|rkreutz@iu.edu|
20543335|NCT02158442|Osprey Medical|Michele Shepard|952.955.8236|mshepard@ospreymed.com|
20543336|NCT05386329|Massachusetts General Hospital, Department of Psychiatry|Director, Center for OCD and Related Disorders|617-724-6146|swilhelm@mgh.harvard.edu|
20543337|NCT03600909|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad, MD|1-833-MSK-KIDS|bouladf@MSKCC.ORG|
20543338|NCT02651675|Regenxbio Inc.|Clinical Development Lead|240-552-8968|srastogi@regenxbio.com|
20543339|NCT03816696|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20543340|NCT05712460|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543341|NCT05135767|Brown University|Hayley Treloar Padovano, PhD|4018636623|hayley_treloar@brown.edu|
20543342|NCT04363320|University of Wisconsin - Madison|Todd Molfenter, PhD|608-262-1685|tdmolfenter@wisc.edu|
20543343|NCT02260934|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20543344|NCT01436526|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20543345|NCT01235897|University of California, San Francisco|Jo Chien, MD|415-885-7577|crss@ucsf.edu|
20543346|NCT05421624|Boston University|Franchino Porciuncula, EdD, PT, DScPT|(617) 353-7525|fporciun@bu.edu|
20543347|NCT03755206|Johns Hopkins Center for Indigenous Health|Dr. Emily E. Haroz, Associate Professor|4109556931|eharoz1@jhu.edu|
20543348|NCT05194124|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20543349|NCT03642873|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20543350|NCT05737069|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20543351|NCT02532517|Cerenovus|Christopher Hendricks|415-656-6565|CHendric@its.jnj.com|
20527267|NCT05385224|EnteraSense Ltd.|David Collins, Director of Technical Operations|091 750 246|david@enterasense.com|
20543352|NCT03312231|Kaiser Permanente Washington Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|lisa.a.jackson@kp.org|
20543353|NCT05178173|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD|919-966-9731|ljacox@live.unc.edu|
20543354|NCT00453895|University of Würzburg|Prof. Dr. Martin Fassnacht|+49-931-201-39201|fassnacht_m@medizin.uni-wuerzburg.de|
20543355|NCT03157830|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
20543356|NCT03694353|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr. Director, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
20543357|NCT00498940|Columbia University Medical Center|Santos Cabreriza/ Associate Scientist|212-305-9515|sc45@cumc.columbia.edu|
20543358|NCT05138653|Cerevel Therapeutics|Cerevel Central Contact|8572500977|info@cerevel.com|
20543359|NCT02331134|University of Colorado Hospital|Antonio Jimeno, MD, PhD|3037242478|antonio.jimeno@cuanschutz.edu|
20543360|NCT05967260|Oregon Health & Science University|Clara Mosquera-Lopez|503--418-4129|mosquera@ohsu.edu|
20543361|NCT02845297|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivana Gojo|410-502-8775|igojo1@jhmi.edu|
20555038|NCT01178853|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
20555039|NCT03550313|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555040|NCT00839072|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20555041|NCT01297062|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20555042|NCT01682837|UT Southwestern Medical Center at Dallas|John Poindexter|2146486857|john.poindexter@utsouthwestern.edu|
20555043|NCT04782323|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20555044|NCT04369469|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20555045|NCT02863991|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
20555046|NCT01154634|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
20555047|NCT00364858|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20555048|NCT00558285|Novartis Pharmaceuticals|Study Director|862-778-8300||
20555049|NCT02596451|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20555050|NCT03151434|Indiana University Department of Anesthesiology|Dr. Yar Luan Yeap|3172740275|yyeap@iupui.edu|
20555051|NCT02345512|National Health Service Greater Glasgow & Clyde|Ms Jennifer Crockett|0141 276 4900|jennifer.crockett@ggc.scot.nhs.uk|4912
20555052|NCT01660906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20555053|NCT01538745|SAUSHEC|Josh Miller|210-916-7111|joshmillersr@gmail.com|
20555054|NCT03478891|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
20555055|NCT03823651|Duke University Medical Center|Dr. Anthony Sung|919-668-1000|anthony.sung@duke.edu|
20555056|NCT01850004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20555057|NCT04827576|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20555058|NCT04745169|Baylor College of Medicine|Elizabeth Lorenz, MD|713-798-2694|elizabeth.lorenz@bcm.edu|
20527268|NCT01069315|McMaster University|Paula McKay, Manager|9055274322|mckayp@mcmaster.ca|44131
20527269|NCT01688141|University of Leicester|Professor Nigel Brunskill|+44 116 258 8043|njb18@le.ac.uk|
20527270|NCT04521114|CytoDyn Inc.|Joseph Meidling, Senior Director - Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
20543362|NCT00079417|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20543363|NCT01615939|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
20543364|NCT04671017|Valneva Austria GmbH|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
20543365|NCT01586364|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20543366|NCT00091949|Yale School of Medicine|Walter N. Kernan|203-764-7000|walter.kernan@yale.edu|
20543367|NCT01520506|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20543368|NCT00425269|University of Oslo|Victoria Telle Hjellset|0047 22 85 06 12|t.v.t.hjellset@medisin.uio.no|
20543369|NCT01084655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20543370|NCT05366738|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
20543371|NCT00906204|Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA|Dr. R. Brian Stevens, MD, PhD, FACS|937-545-4817|rbstevens1@icloud.com|
20543372|NCT02231086|Amsterdam UMC|Prof. dr. P.J. Tanis|+31-20-4444444|p.j.tanis@amsterdamumc.nl|
20543373|NCT00732030|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20543374|NCT02151058|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20543375|NCT00124943|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20543376|NCT03337477|AstraZeneca Clinical|Study Information Center|+1 877 240 9479|information.center@astrazeneca.com|
20543377|NCT03304626|University of Cincinnati|Khurram Bari|513-558-2898|khurram.bari@uc.edu|
20543378|NCT00744497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20543379|NCT03027609|Aridis Pharmaceutical Inc|Lynne Deans|001-925200|deansl@aridispharma.com|3089
20543380|NCT03298035|The University of Texas Health Science Center at Houston|Catherine C. Beaullieu, MD|(713) 500-6044|Catherine.C.Beaullieu@uth.tmc.edu|
20543381|NCT03182374|Zimmer Biomet|Clinical Project Lead|+41791522905|miguelcorreatapia@zimmerbiomet.com|
20543382|NCT01698333|Therapeutics Inc.|Clinical Research|858-571-1800|clinicalresearch@therapeuticsinc.com|
20543383|NCT00408317|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20543384|NCT01462370|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543385|NCT02092610|Radboud University Hospital Nijmegen Medical Centre|Dr. Myrthe Hol|(024) 36 14934|Myrthe.Hol@radboudumc.nl|
20543386|NCT03198715|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20543387|NCT03651479|Eastern Mediterranean University|Asst. Prof. Dr. Gozde Iyigun|+903926303011|gozde.iyigun@emu.edu.tr|
20543388|NCT00853307|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20527271|NCT00553358|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@Novartis.com|
20543389|NCT00473564|University of Alabama at Birmingham|William Carroll, MD|205-934-9767|wcarroll@uabmc.edu|
20543390|NCT02135432|University of Alabama at Birmingham|Steven M. Rowe|205-975-6385|smrowe@uab.edu|
20543391|NCT00914316|William Beaumont Hospital|Barbara Higgins, RN|248 551-1535|Barbara.Higgins@beaumont.org|
20543392|NCT03131219|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20543393|NCT01528332|Philips Consumer Lifestyle|Dr. Elke Naujokat|+31 (0) 631974213|elke.naujokat@philips.com|
20543394|NCT02399163|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543395|NCT03163303|University of California, San Francisco|Dr. Derek Satre|(415) 476-7382|derek.satre@ucsf.edu|
20543396|NCT00600080|Johnson & Johnson Vision Care|Kurt Moody, OD|+1 904 443-3088|kmoody1@its.jnj.com|
20543397|NCT04163952|Cancer Institute of New Jersey Rutgers|Dr. Adam Berger|732-235-8675|ab2047@cinj.rutger.edu|
20543398|NCT01391546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543399|NCT03961672|City of Hope Medical Center|Dr. Alexey Danilov, MD|626-359-8111|adanilov@coh.org|
20543400|NCT02988466|University of Minnesota, Masonic Cancer Center|Mark Juckett, MD|(612) 626-5654|juck0001@umn.edu|
20543401|NCT04225897|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543402|NCT00074711|Creighton University|Robert P Heaney, MD|402 280 4029|rpheaney@creighton.edu|
20543403|NCT03466658|Penn State Health|Dr. Hyunmin Kim|717-531-4826|hkim2@pennstatehealth.psu.edu|
20543404|NCT01921205|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20543405|NCT00360230|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543406|NCT00456846|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
20543407|NCT03416985|University of California Los Angeles|Joan Pi Anfruns, DMD|310-825-0834|jpianfruns@dentistry.ucla.edu|
20543408|NCT03219723|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20543409|NCT00459316|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20543410|NCT00910650|University of California at Los Angeles, Jonsson Comprehensive Cancer Center|Ignacio Baselga|310 206-2090|ibaselga@mednet.ucla.edu|
20543411|NCT03542877|University of Colorado|Dr. Wells Messersmith|303-724-0747|wells.messersmith@cuanschutz.edu|
20543412|NCT01028820|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
20543413|NCT04543279|Washington University School of Medicine|Dr. Amy Zhou|314-362-8814|a.zhou@wustl.edu|
20543414|NCT00929695|Fred Hutchinson Cancer Research Center|Marco Mielcarek|206-667-2827|mmielcar@fhcrc.org|
20543415|NCT01436149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20543416|NCT00573508|Astellas Pharma Global Development|Astellas Medical Monitor||clinicaltrials@us.astellas.com|
20543417|NCT00528112|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20543418|NCT01590264|Washington University in Saint Louis|Dr. Jay F. Piccirillo|314-362-8641|piccirilloj@ent.wustl.edu|
20543419|NCT02559622|Novartis Pharmaceuticals|Study Director|862--778--8300||
20543420|NCT01069003|Medtronic|Sidney Cohen, Sr. Clinical Medical Advisor|707-591-7277|sidney.a.cohen@medtonic.com|
20543421|NCT01318577|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
20543422|NCT03593902|Northwestern University|Kathleen Quigley|312-695-8192|kathleen.quigley@nm.org|
20543423|NCT02246530|University of Alabama at Birmingham|Dr. Breanna Willeford, DO|205-934-4131|breannawilleford@uabmc.edu|
20543424|NCT01506596|Vector Oncology LLC|Dr. Mark Walker, VP of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
20543425|NCT05810740|Pierre Fabre Médicament|Ana Catarina Pinto, Responsible Medical Officer|5 3450 6059|ana.catarina.pinto@pierre-fabre.com|
20543426|NCT01488890|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
20543427|NCT05560425|University of North Carolina at Chapel Hill|Elena Vidrascu, PhD, MSc|919-843-9193|elena91@live.unc.edu|
20543428|NCT04408989|mabxience Research SL|Susana Millan|+3491771500|susana.millan@mabxience.com|
20543429|NCT02694185|Rocky Mountain Regional VA Medical Center|Elizabeth Cheng|720-857-5101|elizabeth.cheng@va.gov|
20543430|NCT05082857|Wake Forest University School of Medicine|Anna Miller-Fitzwater, MD, MPH|336-713-0630|amillerf@wakehealth.edu|
20543431|NCT03475004|University of Colorado|Dr. Christopher Lieu|303-724-6390|christopher.lieu@cuanschutz.edu|
20543432|NCT03645122|VA Pittsburgh Healthcare System|Assistant Director for Clinical and Regulatory Affairs|412-822-3669|Nikitha.Deepak@va.gov|
20543433|NCT03605667|Biohaven Pharmaceuticals, Inc|Chief Medical Officer|+1 203-404-0410|clinicaltrials@biohavenpharma.com|
20543434|NCT05632211|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
20543435|NCT04366349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20543436|NCT03253393|University of New South Wales|Dr Jacqueline Tan|+612 9385 6551|jacqueline.tan@unsw.edu.au|
20543437|NCT03641937|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20543438|NCT01350999|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20543439|NCT02121535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20543440|NCT00092417|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20543441|NCT01256788|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Douglas Wyland|864-454-7422|dwyland@ghs.org|
20543442|NCT00696072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20543443|NCT01597596|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
20543444|NCT01601236|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20543445|NCT00992108|UCLA Neurology|Marisa Chang, MD|310-794-1870|marisachang@mednet.ucla.edu|
20543446|NCT02189317|Emory University|John W Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
20543447|NCT00535496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20543448|NCT01074814|Translational Drug Development|Linda Vocila, Executive Director Clinical Strategy|6023588311|lvocila@td2inc.com|
20543449|NCT01083771|Brown University Oncology Research Group (BrUOG)|Anthony Mega, MD|4018633000|kayla_rosati@brown.edu|
20543450|NCT02208310|University of Michigan|Peter Higgins|7346472964|phiggins@umich.edu|
20543451|NCT03181932|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
20543452|NCT02584686|Department of Andrlolgy, Sexology & STDs, Cairo University|Prof. Dr. Hussein Ghanem, Chairman of Andrology Department|00201001176111|hmhghanem@gmail.com|
20543453|NCT02461758|University of Wisconsin School of Medicine and Public Health|FREDDY CALDERA, ASST PROFESSOR , GASTROENTEROLOGY|(608) 263-1995|fcaldera@medicine.wisc.edu|
20543454|NCT04030143|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20543455|NCT03216226|Zealand Pharma A/S|Kim Mark Knudsen|+45 50603780|KMKnudsen@zealandpharma.com|
20543456|NCT05966142|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
20543457|NCT04849364|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20543458|NCT05261386|ADS Therapeutics LLC|Dr. Rong Yang|9496798408|rong_yang@cloudbreaktherapeutics.com|
20543459|NCT02738801|Galapagos NV|Evelyn Fox|003215342900|evelyn.fox@glpg.com|3215342900
20543460|NCT01643668|Massachusetts General Hospital|Yi-Bin Chen, MD|617-726-0187|YCHEN6@PARTNERS.ORG|
20543461|NCT04771455|Northwestern University|Dr. Andrea Graham|312-503-5266|andrea.graham@northwestern.edu|
20543462|NCT03253796|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543463|NCT00894803|University of Cincinnati|Dr Arthur Pancioli|513-558-8087|arthur.pancioli@uc.edu|
20543464|NCT00449696|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
20543465|NCT01033019|Novartis|Study Director|862-778-8300||
20543466|NCT03431259|Massachusetts General Hospital|Marilyn Heng, Principal Investigator|6176430149|mheng@mgh.harvard.edu|
20543467|NCT00347022|GUERBET|Corinne DUBOURDIEU|+33.1.45.91.50.00|corinne.dubourdieu@guerbet-group.com|
20543468|NCT01409707|University of Mississippi Medical Center|Dr. Scott Coffey|601-815-5588|scoffey@umc.edu|
20543469|NCT03094325|NYU Langone Health|Daniel Swistel, MD|646-754-7217|Daniel.Swistel@nyulangone.org|
20543470|NCT01903460|Mirum|Study Physician|+1 650-667-4085|medinfo@mirumpharma.com|
20543471|NCT03104868|Northwestern University|Dr. Michael Wolf|312-503-5592|mswolf@northwestern.edu|
20543472|NCT01292135|Pharmacyclics|Thorsten Graef, MD|855.427.8846|medinfo@pcyc.com|
20543473|NCT00521079|EnteroMedics Inc|Senior Vice President of Clinical|651-634-3209|ktweden@enteromedics.com|
20543474|NCT04986904|University of Virginia|Dr. Kelly Shaffer|434-982-1022|kshaffer@virginia.edu|
20543475|NCT02867436|Motol University Hospital|Zdeněk Šumník, PI|+420702000087|zdenek.sumnik@lfmotol.cuni.cz|
20543476|NCT01551186|Washington University School of Medicine, St. Louis, Missouri|Dr. Erik Dubberke, MD, MSPH|314-454-8354|edubberk@wustl.edu|
20543477|NCT02018562|Johns Hopkins University|Vinciya Pandian PhD, MSN, RN, ACNP-BC, FAAN|4436553482|vpandia1@jhu.edu|
20543478|NCT04080505|Columbia University|Jennifer Kuo, MD|212-305-6969|jhk2029@cumc.columbia.edu|
20543479|NCT03175679|BeijingYouanH|Dr. LJUN|861366138148|lujun98@ccmu.edu.cn|
20543480|NCT05494385|Indiana University School of Medicine|Dr. Anna Guanzon|2197651884|amguanzon89@gmail.com|
20543481|NCT03108131|The University of Texas MD Anderson Cancer Center|Dr. Kanwal Raghav|(917) 733-0356|kpraghav@mdanderson.org|
20543482|NCT01253291|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20543483|NCT02920632|Amsterdam UMC, Vrije Universiteit|Dr. Chris Vriend|+31625694912|c.vriend@amsterdamumc.nl|
20543484|NCT01838395|BioLineRx Ltd.|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
20543485|NCT00723736|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20543486|NCT01723384|San Francisco Department of Public Healt|Dr. Glenn-Milo Santos|415-437-6231|glenn-milo.santos@ucsf.edu|
20543487|NCT04309396|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
20543488|NCT05720897|Indiana University|Stuart Schrader|3172781409|sschrade@iu.edu|
20543489|NCT00400179|Taiho Pharma USA, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
20543490|NCT04780061|Patterson Institute for Integrative Oncology Research|Clinical Trial Coordinator|6137921222|mlegacy@thechi.ca|1
20543491|NCT04050553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20543492|NCT02086175|Dana-Farber Cancer Institute|Caron A. Jacobson, MD|617-632-6404|cajacobson@partners.org|
20543493|NCT05430854|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20543494|NCT00734149|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|gaspa001@mc.duke.edu|
20543495|NCT04314284|Washington University School of Medicine|Mary Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
20543496|NCT03353688|University of Alabama at Birmingham|Program Manger|(205) 934-0683|clg17@uab.edu|
20543497|NCT00938704|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20543498|NCT01652235|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20543499|NCT03205709|Columbia University Medical Center|D.P. Devanand, M.D.|774-8658|dpd3@cumc.columbia.edu|646
20543500|NCT02023086|Université de Montréal|Langis Michaud|5149166312|langis.michaud@umontreal.ca|
20543501|NCT04760613|NYU Langone health|Stephen Ross, MD|212-263-6289|Stephen.ross@nyulangone.org|
20527272|NCT01797094|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20543502|NCT03589859|VA Northeast Ohio Healthcare System|Dr. Mark Walker|216-791-3800|mark.walker5@va.gov|65229
20543503|NCT04671901|Memorial Sloan Kettering Cancer Center|Dr. Michael Ortiz MD|212-639-6057|ortizm2@mskcc.org|
20543504|NCT05565742|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20543505|NCT04163341|University of Alabama at Birmingham|Dr. Michael Mugavero|202-966-5822|mmugavero@uab.edu|
20543506|NCT05417438|UMass Chan Medical School|Reem Najjar|7742750890|Reem.najjar@umassmed.edu|
20543507|NCT04272242|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20543508|NCT04053036|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20543509|NCT02681523|Imperial College London|Laura Kenny|+44 (0)20 7594 2806|l.kenny@imperial.ac.uk|
20543510|NCT05291520|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20543511|NCT01347112|Mayo Clinic|Dr. Richard Hurt|507-284-7313|rhurt@mayo.edu|
20543512|NCT04639245|Fred Hutchinson Cancer Center|Dr. Damian Green|(855) 557-0555|dgreen@fredhutch.org|
20543513|NCT02419001|Synthetic Biologics Inc.|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
20543514|NCT03591406|Vifor (International) Inc.|VIT-IRON-2011-004 Clinical Study Team|+41 58 851 80 00|VIT-IRON-2011-004.study@viforpharma.com|
20543515|NCT04082819|SE Health|SE Research Centre|N/A|research@sehc.com|
20543516|NCT02505919|PROCEPT BioRobotics Corporation|Angela Lee|6502327215|a.lee@procept-biorobotics.com|
20543517|NCT01122238|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
20543518|NCT01537666|Savara Inc.|Taneli Jouhikainen, MD, MBA; Chief Operating Officer|(888) 302-4876|info@savarapharma.com|
20543519|NCT02703597|University of Florida|Assistant Professor|3526279467|gkhalil@ufl.edu|
20543520|NCT01614886|Novartis Pharmaceuticals|Study Director|862-778-8300||
20543521|NCT02191111|University of Mississippi|Dr. Meagen Rosenthal|662-915-2475|mmrosent@olemiss.edu|
20543522|NCT01834911|New York Medical College|Dr. Robert Fekete|9143451313|robert_fekete@nymc.edu|
20543523|NCT02224560|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20543524|NCT01523366|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
20543525|NCT01352715|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20543526|NCT00765206|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20543527|NCT02416206|The Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
20543528|NCT05131308|Kansas City Heart Rhythm Institute|Dhanunjaya Lakkireddy|913-449-1297|dhanunjaya.lakkireddy@hcahealthcare.com|
20543529|NCT01690143|University of Alabama at Birmingham|Luciano J Costa, Principal Investigator|205-209-6038|ljcosta@uabmc.edu|
20543530|NCT04757766|Servier|olga linnik|8-495-93707-00|olga.linnik@servier.com|
20543531|NCT01710345|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20543532|NCT01766440|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
20543533|NCT01052493|Imperial College London|Dr Tricia Tan|020 83838038|t.tan@imperial.ac.uk|
20527273|NCT02366403|War Related Illness and Injury Study Center, VA Palo Alto Healthcare System|Peter Bayley, PhD|650 493-5000|peter.bayley@va.gov|68653
20527274|NCT03013985|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
20527275|NCT04482036|Eskenazi Health|Jessica Broughton|317-903-6276|jessica.broughton@eskenazihealth.edu|
20527276|NCT02322333|Clinvest Research|Jim Sly MS|4178413673|jsly@clinvest.com|
20527277|NCT00076999|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20527278|NCT04964986|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
20527279|NCT01217385|American College of Radiology|Donna Hartfeil, Director Protocol Management|215-717-2765|dhartfeil@acr.org|
20527280|NCT01432561|University of California San Diego|Dr. Ranjan Dohil, P.I.|619-471-9554|rdohil@ucsd.edu|
20527281|NCT00586508|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20527282|NCT02079636|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20527283|NCT03434249|SOFAR S.p.A|LAURA PATRUCCO|+390202 909 362291|laura.patrucco@sofarfarm.it|
20527284|NCT03325894|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20527285|NCT01294007|ATEC Spine|Saba Pasha, Director Clinical Research & Data Science|760-356-6639|spasha@atecspine.com|
20527286|NCT00602290|University of California, Los Angeles|Dr. Helen Lavretsky|310-794-4619|hlavretsky@mednet.ucla.edu|
20527287|NCT00441363|VeroScience|Donna Cowan|401 816-0525|donna_cowan@veroscience.com|
20527288|NCT01043094|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
20527289|NCT02437188|Baylor College of Medicine|Dr. Lilian Dindo, Assistant Professor|713-440-4637|lilian.dindo@bcm.edu|
20527290|NCT00499343|U.T. M.D. Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor|713-792-8750||
20527291|NCT02598778|MMC - Dentistry|Kakanantadilok, Nuntiya|(888) 700-6623|nkakanan@montefiore.org|
20527292|NCT02290925|Faculty of Medicine & Allied Sciences, Rajarata University of Sri Lanka|Professor Sisira Siribaddana|+94777326940|sisira.siribaddana@gmail.com|
20527293|NCT01716520|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527294|NCT00791037|University of Washington|Dr. Mary L. Disis|206-543-8557|ndisis@u.washington.edu|
20527295|NCT00998205|University of Missouri-Columbia|Anand Chockalingam|573-882-2296|chockalingama@missouri.edu|
20527296|NCT02635009|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20527297|NCT00981058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20543534|NCT02105740|Universidade de Brasília|Gil Montenegro|556181487323|prof.gilmontenegro@gmail.com|
20543535|NCT03931941|Clinical Development|Clinical Development|651-705-8778|US8-Studyinfo@ferring.com|
20543536|NCT03944577|University of Nebraska Medical Center|Douglas Stoller|402-559-0815|douglas.stoller@unmc.edu|
20543537|NCT00551642|Mallinckrodt|Medical Information Call Center|800-556-3314|medinfo@mnk.com|
20555059|NCT00639717|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik|734-764-3243|jelevine@umich.edu|
20555060|NCT00724282|University of Chicago|Andrea Eiring|773-702-3657|aeiring@bsd.uchicago.edu|
20555061|NCT01615731|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20555062|NCT04396834|UNC-Chapel Hill|Christian Hendershot|(919) 962-5565|christian_hendershot@med.unc.edu|
20555063|NCT01024569|University of Illinois at Chicago|Judith A Cook|312-355-3921|jcook@uic.edu|
20555064|NCT02367911|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
20555065|NCT00263666|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555066|NCT00896168|Xian-Janssen Pharmaceutical Ltd|Director of Medical Affairs|(8610) 5821 8359||
20555067|NCT01490632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20555068|NCT00352365|SWOG|Study Statistician|206-667-4623||
20555069|NCT02811861|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20555070|NCT04743908|The University of Chicago|Dr. John Schneider|(773) 702-2453|jschnei1@uchicago.edu|
20555071|NCT00512135|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20555072|NCT03422250|IRCCS Centro San Giovanni di Dio Fatebenefratelli|Michela Pievani|+39 030 35011|mpievani@fatebenefratelli.eu|
20555073|NCT03812146|VA Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400|Kyle.Possemato@va.gov|53551
20555074|NCT00377819|Amgen Inc.|Study Director|866-572-6436||
20555075|NCT03388619|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
20555076|NCT00467870|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20555077|NCT01917526|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
20555078|NCT02261363|University of Nevada, Reno|Jennifer Pearson|7756825005|jennipearson@unr.edu|
20555079|NCT01517802|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20555080|NCT01206738|University of Aberdeen|Prof Shaun Treweek||streweek@mac.com|
20555081|NCT03774186|Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus|Dr. Sarit Polsky|303-724-8575|sarit.polsky@cuanschutz.edu|
20555082|NCT03268811|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20555083|NCT02031276|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
20555084|NCT01148810|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20555085|NCT01235910|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
20555086|NCT02880852|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555087|NCT02165722|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
20555088|NCT05423509|University of New Mexico Health System|Selina Silva, MD|505-272-4107|ssilva@salud.unm.edu|
20555089|NCT06390098|Asceneuron SA|Asceneuron Clinical Research|+ 41 21 353 8245|clinicaltrials.gov@asceneuron.com|
20555090|NCT02417246|UF|Dr. Larisa H Cavallari|352-273-8245|lcavallari@cop.ufl.edu|
20555091|NCT03535649|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20555092|NCT00317239|Luitpold Pharmaceuticals, Inc.|Mark Falone|610-650-4200|mfalone@luitpold.com|
20555093|NCT04408469|Yale University School of Public Health|Dr. Danielle Chiaramonte|646-429-9407|danielle.chiaramonte@yale.edu|
20555094|NCT04321460|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20555095|NCT01308749|Duke University Center for Autism and Brain Development|Linmarie Sikich, MD|9196810026|linmarie.sikich@duke.edu|
20555096|NCT01301963|CCCC|Hien Duong, MD|216-445-5531|duongh@ccf.org|
20555097|NCT02824913|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
20555098|NCT01205685|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
20555099|NCT03058679|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|lewisjd@pennmedicine.upenn.edu|
20555100|NCT00574080|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|PettyNathanM@uams.edu|2461
20555101|NCT01098006|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555102|NCT00784810|Napp Pharmaceuticals Ltd|Director of Medical Affairs|01223 424444||
20555103|NCT04137380|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20555104|NCT06027216|Schepens Eye Research Institute, Mass Eye and Ear|Eli Peli|617-912-2597|eli_peli@meei.harvard.edu|
20555105|NCT02745626|University of Connecticut Health|Dr. Madhur Upadhyay, Director Orthodontic Clinic, Assistant Professor|860-679-3729|maupadhyay@uchc.edu|
20555106|NCT03646513|Smith+Nephew, Inc.|Andrew Copey|+61.490.503.157|andrew.copley@smith-nephew.com|
20555107|NCT04644328|Massachusetts Institute of Technology|Esther Duflo|617-258-7013|eduflo@mit.edu|
20555108|NCT03330834|Sun Yat-sen University Cancer Center|Dr.Yuxiang Ma|86 020 87343894|mayx@sysucc.org.cn|
20555109|NCT00968617|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20555110|NCT04433767|Vanderbilt University Medical Cdenter|Warren Taylor, MD, Director of the DIvision of Geriatric Psychiatry|615-322-1073|warren.d.taylor@vumc.org|
20555111|NCT00167544|Nationwide Children's Hospital Clinical Research Institute|Dr. Nehal Parikh|614-355-6657|nehal.parikh@nationwidechildrens.org|
20527298|NCT05916131|University of Michigan|Yu Kuei Lin, MD|734-232-1573|yuklin@med.umich.edu|
20527299|NCT02305446|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20555112|NCT02388633|OregonHSU|Jonathan Lindner, MD|5034949191|lindnerj@ohsu.edu|
20555113|NCT00288587|Cleveland Clinic Foundation|Leighann Cesar, RN|216-445-6551|cesar1@ccf.org|
20555114|NCT01434602|National Cancer Institute|Dr. Mark R. Gilbert|240-760-6023|mark.gilbert@nih.gov|
20527300|NCT03933020|The University of Texas Health Science Center at Houston|Rohini D. Samudralwar, MD|(832) 325-7077|Rohini.D.Samudralwar@uth.tmc.edu|
20543538|NCT00391586|Dana Farber Cancer Institute|Dennie Jones, MD|617-632-6478|DennieV_Jones@DFCI.HARVARD.EDU|
20543539|NCT00198822|Center for Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health|Prof. Keith P West, Jr., Principal Investigator|410-955-2061|kwest@jhsph.edu|
20543540|NCT03011099|UT health PM&R|Chang, Shuo-Hsiu, PT, PhD|713-799-7016|Shuo-Hsiu.Chang@uth.tmc.edu|
20543541|NCT02968758|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
20543542|NCT00129246|Associate Professor of Psychiatry and Program Director, Smoking Cessation Service at Smilow Cancer Hospital at Yale-New Haven|Benjamin A. Toll, PhD|(203) 974 5767|benjamin.toll@yale.edu|
20543543|NCT02252666|University of Wisconsin - Madison|Dr. Mitchell Tyler|(608) 262-5112|metyler1@wisc.edu|
20543544|NCT00283296|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
20543545|NCT01353898|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527301|NCT02696434|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20543546|NCT02668653|Daiichi Sankyo Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20543547|NCT03558737|University of Utah|Bradley Yoder|801-581-7052|bradley.yoder@hsc.utah.edu|
20543548|NCT01294553|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543549|NCT01217229|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20543550|NCT01032538|Martina Hansens Hospital|Tor Kjetil Nerhus|+47 93409934|kjnerhus@gmail.com|
20543551|NCT00453206|Wake Forest University Health Sciences|David Hurd, MD|336-716-2843|dhurd@wakehealth.edu|
20543552|NCT02784548|VA San Diego Healthcare System|Dr. Thomas Rutledge|8585528585|thomas.rutledge@va.gov|7273
20543553|NCT00577889|Mayo Clinic Cancer Center|Robert McWilliams, M.D.||McWilliams.robert@mayo.edu|
20543554|NCT03041181|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
20543555|NCT03536572|VA San Diego Healthcare System|Carl J. Stepnowky, Deputy ACOS R&D|858-642-3269|carl.stepnowsky@va.gov|
20543556|NCT00005780|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
20543557|NCT04973449|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20543558|NCT01467960|Villa Melitta|Sarah Dassati|+39 0471 471|sarahdassati@yahoo.it|471
20543559|NCT00888173|NRG Oncology|Linda Gedeon For Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
20543560|NCT03529669|Oxford University Hospitals NHS Trust|Dr Somnath Mukherjee|01865 617018|Somnath.Mukherjee@ouh.nhs.uk|
20543561|NCT03955146|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|zephyrus@fibrogen.com|
20543562|NCT04798183|Pusan National University Yangsan Hospital|Sungchul huh, M.D., Ph.D.||dr.huhsc@gmail.com|0553604250
20543563|NCT02628873|Wright State University|Steven Lindheim|858-740-1083|doclalalindheim@gmail.com|
20543564|NCT02560038|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
20543565|NCT03597347|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
20543566|NCT00107653|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20543567|NCT02961894|Rex Medical|Colin Valentis|610-629-6051|cvalentis@rexmedical.com|
20555115|NCT01835626|University of California, San Francisco|Dr. Sue Yom|(415) 353-9893|Sue.Yom@ucsf.edu|
20555116|NCT01108081|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
20543568|NCT00541658|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20543569|NCT01074970|Hoosier Cancer Research Network|Director of Clinical Data Management|317-634-5842|jsmith@hoosiercancer.org|41
20555117|NCT01764945|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508302|NCT02540772|San Rafael University Hospital|Monica Triviño Mosquera|34958275700|monica.trivino@sjd.es|
20508303|NCT02177175|Memorial Sloan Kettering Cancer Center|Dr. Anthony Yu, MD|212-639-7932|yua3@mskcc.org|
20527302|NCT01586871|University of Minnesota|Aaron Kelly PhD|612-626-3492|kelly105@umn.edu|
20543570|NCT00626106|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20543571|NCT03472885|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20543572|NCT01664975|Zhengzhou University|Mingzhi Zhang|0371-66295564|mingzhi_zhang@126.com|
20543573|NCT02201953|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20543574|NCT04743778|University of Michigan, School of Social Work|Dr. Jaclynn Hawkins|(734) 615-2817|jachawk@umich.edu|
20543575|NCT01181349|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20543576|NCT01533207|NRG Oncology|Linda Gedeon on behalf of Danielle Enserro, PhD|716-845-1169|linda.gedeon@roswellpark.org|
20543577|NCT00321620|Amgen Inc.|Study Director|866-572-6436||
20543578|NCT01887327|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|ClinicalTrials@mnk.com|5
20543579|NCT00874094|NY Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
20543580|NCT01747876|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20543581|NCT01047358|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543582|NCT00129402|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20543583|NCT03041038|Northwestern University|Dr. Amy Paller|3126953721|NUderm-research@northwestern.edu|
20543584|NCT02121158|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Michael T. Wininger, Ph.D., Study Biostatistician|203-932-5711|michael.wininger@va.gov|3262
20543585|NCT02131259|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20543586|NCT02796170|Tulane University|Dragana Lovre|(504)988-9928|dlovre@tulane.edu|
20543587|NCT01527370|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543588|NCT04843007|NanoAlvand|Dr. Hamidreza kafi|9129232594|Kafi.h@orchidpharmed.com|+98
20543589|NCT01472289|TotipotentSC|Dr. Venkatesh Ponemone|+91-124-4976860|venkatesh.ponemone@totipotentsc.com|
20543590|NCT04004988|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20543591|NCT03873116|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20543592|NCT02989597|Montefiore Medical Center|Dr. Andrew J. Kobets|718-920-7400|akobets@montefiore.org|
20543593|NCT02531802|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20543594|NCT04454918|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20543595|NCT00425802|Memorial Sloan Kettering Cancer Center|Hugo Castro-Malaspina, MD|212-639-8197|castro-h@mskcc.org|
20543596|NCT03131570|ROCKEFELLER UNIVERSITY|Dr. James G. Krueger|2123277409|KRUEGEJ@MAIL.ROCKEFELLER.EDU|
20543597|NCT04596267|Boston Medical Center|Dr. Eric Devine|617-418-7888|eric.devine@bmc.org|
20543598|NCT00071058|National Cancer Institute, National Institutes of Health|Antonio Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
20543599|NCT02000440|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543600|NCT00871975|LABORIE|Clinical Research Administrator|905 612 1170|acampbell@laborie.com|2274
20543601|NCT02698215|University of California Los Angeles|Lara Ray, PhD|310-794-5383|lararay@psych.ucla.edu|
20543602|NCT01210313|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
20543603|NCT02226367|VA Puget Sound Health Care System|Murray Raskind, MD|(206) 277-3797|Murray.Raskind@va.gov|
20543604|NCT00870740|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20527303|NCT01004718|University of Pennsylvania|Ellen Napier, CRNP|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
20527304|NCT04103034|Band Therapeutics|Tia DeFeo-Fraulini|7819186561|tia.defeo-fraulini@bandtherapeutics.com|
20527305|NCT01522131|The University of Texas Health Science Center at Houston|Rosemary Thomas, DMD, MS|713-486-4074|rosemary.thomas@uth.tmc.edu|
20527306|NCT04105010|Dizal Pharmaceuticals|Rika Chen|862161095875|clinicaltrials@dizalpharma.com|
20527307|NCT01211483|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20527308|NCT03724084|The Ohio State University Comprehensive Cancer Center|Dr. James Blachly|614-293-7484|James.Blachly@osumc.edu|
20527309|NCT01810705|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
20527310|NCT00427999|Novartis Pharmaceuticals|Study Director|862-778-8300||
20527311|NCT02284568|Teva Pharmaceutical Industries Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20527312|NCT00460265|Amgen Inc.|Study Director|866-572-6436||
20527313|NCT03209518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20527314|NCT01832818|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
20527315|NCT00236899|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20527316|NCT02854605|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20527317|NCT00568334|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527318|NCT01897571|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
20527319|NCT03217968|CEFALY Technology|Clinical Trial Department director|+3243676722|info@cefaly.com|
20527320|NCT00625404|FHI 360|Jennifer Deese, Principal Investigator|919-544-7040|jdeese@fhi360.org|11292
20527321|NCT05268016|Meiji Pharma USA Inc.|Meiji Pharma USA Inc. Study Lead|+1 201-777-7133|mpu.contact@meiji.com|
20527322|NCT00821015|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20527323|NCT01897792|UAB Department of Anesthesiology|Jean-Francois Pittet, MD|205-996-4755|jpittet@uabmc.edu|
20527324|NCT05656885|CooperVision Inc.|Dr. Jose A Vega OD, MSc, FAAO|+19256213761|javega@coopervision.com|
20527325|NCT03411902|Wake Forest School of Medicine|Kristen Beavers|336-758-5855|beaverkm@wfu.edu|
20527326|NCT00791492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527327|NCT05821296|Dermosciences France|Sara Bayo Rodriguez|638966321|clinicaltrials@dermaceutic.com|0033
20527328|NCT00090987|AMC|Jeannette Y. Lee, Director of Statistical Center|(501) 526-6712|jylee@uams.edu|
20527329|NCT00713661|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
20527330|NCT00990665|St. Jude Medical|Clay Cohorn: Director, Clinical Study Management|972 309 8087|ccohorn@sjm.com|
20527331|NCT02603562|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
20527332|NCT00270231|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
20527333|NCT00796744|US Biotest|Dr. Shelagh Verco|805-595-1300|shelagh.verco@usbiotest.com|
20527334|NCT01534208|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20527335|NCT04208321|ICON Early Phase Services, LLC|Dr. Cassandra Key, Senior Medical Director|210-283-4120|Cassandra.key@iconplc.com|
20527336|NCT02046772|Hospital Universitario Príncipe de Asturias|Antonio Rodríguez Miguel|+34 91 887 81 00|antonio.hupa@gmail.com|2610
20527337|NCT00574795|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20527338|NCT00672841|University of Utah|Kimberly E. Hanson, MD, MHS|801.585.2867|kim.hanson@hsc.utah.edu|
20527339|NCT02638259|Sandoz|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
20527340|NCT02569086|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45|krisoebr@rm.dk|78452845
20527341|NCT03578146|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20527342|NCT04299048|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527343|NCT01717391|The University of Iowa|John M. Buatti, MD|319-356-2699|john-buatti@uiowa.edu|
20527344|NCT05972941|The Ohio State University College of Public Health|Dr. Joanne G. Patterson|614-247-1780|patterson.1191@osu.edu|
20543605|NCT04006288|University of Florida|Dr. Dominick J Angiolillo. Professor of med University of Florida College of Medicine-Jacksonville|904-244-3378|dominick.angiolillo@jax.ufl.edu|
20543606|NCT03592186|Brown University School of Public Health|Sara Becker, Ph.D, Principal Investigator|4018636604|sara_becker@brown.edu|
20527345|NCT00106639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527346|NCT01876979|OMFS & HD|Department Chair|302-320-6458|dmeara@christianacare.org|
20543607|NCT00307801|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20543608|NCT01498068|Janssen Belgium|Compound Development Team Leader|32 14 64 13 70||
20543609|NCT02596867|TTUHSC-EP|Zeina Nahleh|9152155195|zeina.nahleh@ttuhsc.edu|
20543610|NCT03058146|University of California, San Diego|Dr. Zvinka Zlatar|858-822-7737|zzlatar@health.ucsd.edu|
20543611|NCT00632229|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
20543612|NCT02323217|Imperial College London|Dr Robin J Tyacke|(0)20 7594 7096|r.tyacke@imperial.ac.uk|+44
20543613|NCT03224819|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20543614|NCT03542487|Office of Evaluation Sciences, General Services Administration|Mattie Toma|859-621-0517|mattie.toma@gsa.gov|
20543615|NCT00737672|W.L. Gore and Associates, Inc.|Clinical Project Manager|928-864-3771|cavery@wlgore.com|
20543616|NCT01539824|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0)20 3137 6346|info@immodulon.com|
20543617|NCT02735863|ABIVAX|Sharon Skare|+33153830961|sharon.skare@abivax.com|
20543618|NCT00829426|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20527347|NCT01096589|Centre for Reasearch and Implementation of Clinical Practice (CRICP)|Prof. Christine Moffatt, Principal Investigator|+44 20 73 51 14 11|christine.moffatt@cricp.org.uk|
20527348|NCT02202044|University of Colorado|Tracey MacDermott|303-724-2757|Tracey.MacDermott@ucdenver.edu|
20527349|NCT00232596|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527350|NCT01712334|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20527351|NCT01253174|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20527352|NCT02919267|Institut universitaire de cardiologie de de pneumologie de Québec|Dr Jean Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
20527353|NCT03467763|Memorial Sloan Kettering Cancer Center|Dr. James Flory|6468883790|floryj@mskcc.org|
20527354|NCT01863498|Children's Mercy Kansas City|Dr. Shawn St. Peter|816-234-3575|sspeter@cmh.edu|
20527355|NCT00932698|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20527356|NCT04608344|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20527357|NCT00131365|InSightec|Nadir Alikacem|214.630.2000|nadira@insightec.com|
20527358|NCT05249127|Clarity Pharmaceuticals|Dr Othon Gervasio, Chief Medical Officer|+61 2 9209 4037|info@claritypharmaceuticals.com|
20527359|NCT02908074|Mereo BioPharma Group|Jackie Parkin|+44 (0) 333 023 7300|enquiries@mereobiopharma.com|
20527360|NCT02073565|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
20527361|NCT02436031|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
20527362|NCT02227368|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
20527363|NCT03765229|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
20527364|NCT00525876|UT MD Anderson Cancer Center|Issa F. Khouri, MD/ Professor||celsaenz@mdanderson.org|
20527365|NCT00693485|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20527366|NCT03282591|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
20527367|NCT00888290|Albert Einstein College of Medicine|Michal Melamed|718-430-2496|michal.melamed@einsteinmed.org|
20527368|NCT06046209|CooperVision, Inc.|Lee Hall|+19252516684|lhall@coopervision.com|
20527369|NCT04525131|University of Kansas Medical Center|Dr. John A Taylor|9135888170|jtaylor27@kumc.edu|
20527370|NCT06226649|National Cheng Kung University|Mr. Chun-Yi Ho|886-6-2353535|eggman0011@gmail.com|5852
20543619|NCT00311766|RegeneRx Biopharmaceuticals, Inc.|Study Director, David R. Crockford|617-285-5588|dcrockford@regenerx.com|
20543620|NCT02002598|Columbia University|Suzanne Lentzsch, MD|646-317-4840|sl3440@cumc.columbia.edu|
20543621|NCT04672239|Recovery Research Institute, Department of Psychiatry, Massachusetts General Hospital|Bettina B. Hoeppner, Ph.D., MS|617-643-1988|bhoeppner@mgh.harvard.edu|
20543622|NCT00537134|Centre Hospitalier de l'Université de Montréal (CHUM)|Ruby Klink|(514) 890-8000|ruby.klink.chum@ssss.gouv.qc.ca|27235
20543623|NCT04606134|University of Rochester Medical Center|Mara Weinstein MD|(585) 275-7546|Mara_Weinsteinvelez@URMC.Rochester.edu|
20543624|NCT01099267|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20543625|NCT03373240|Yale University|Dr. Arielle Baskin-Sommers|203-432-9257|arielle.baskin-sommers@yale.edu|
20543626|NCT04123470|Lokon Pharma|Angelica Loskog CEO|+46 18-50 74 44|angelica.loskog@lokonpharma.com|
20543627|NCT04029883|Cedars-Sinai Medical Center|Dr. Joseph Ebinger|424-315-2284|cda-research@cshs.org|
20543628|NCT04876521|All India Institute of Medical Sciences|Dr. Biswa Ranjan Mishra|09438884220|psych_biswa@aiimsbhubaneswar.edu.in|
20543629|NCT05972993|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20543630|NCT04792645|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu|
20543631|NCT03866577|Momenta Pharmaceuticals, Inc.|Senior Director Clinical Development Head Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20543632|NCT05530252|BeijingSHCMU|Dr.Nannan Han|15701545851|qhddenver@126.com|
20543633|NCT04825678|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20543634|NCT04370873|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20555118|NCT00648908|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
20555119|NCT05077267|Bavarian Nordic A/S|Bavarian Nordic Call Center|+1-844-422-8274|medical.information_us@bavarian-nordic.com|
20555120|NCT02944877|University of California, Irvine|Dr. Sean Young|714-413-2347|syoung5@hs.uci.edu|
20555121|NCT04747977|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
20527371|NCT05869864|American University|Caroline Kuo, DPhil, MPhil|2028857385|ckuo@american.edu|
20527372|NCT01973335|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge, researcher|0473924199|frederik.verbrugge@zol.be|+32
20543635|NCT00651742|Taiho Oncology, Inc|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
20543636|NCT02344108|Mass General Brigham|Matthew E Stenerson, MS, Clinical Research Project Manager|7155721100|matthew_stenerson@meei.harvard.edu|
20543637|NCT01535040|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20543638|NCT00911170|Amgen Inc.|Study Director|866-572-6436||
20543639|NCT01824836|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20543640|NCT02638220|Travere Therapeutics, Inc.|Cheryl Wong Po Foo/Director, Clinical Development|8889697879|cheryl.wongpofoo@travere.com|
20543641|NCT04051996|Yale University|Dr. Amer Zeidan|(203) 200-4363|amer.zeidan@yale.edu|
20543642|NCT02153632|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|9088091357|gwagner@osmotica.ccom|
20543643|NCT04323124|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543644|NCT06904586|Duzce University|Assistant Professor|+905059313588|gizem123demir@hotmail.com|
20543645|NCT01710501|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543646|NCT02536976|Struthers Parkinson's Center|Dr. Sotirios Parashos|001-952-993-5495|sotirios.parashos@parknicolet.com|
20543647|NCT02144610|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
20543648|NCT02169427|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20543649|NCT01354899|Molnlycke Health Care AB|Tina Kjellen|+46317223098|tina.kjellen@molnlycke.com|
20543650|NCT00463567|Novartis Pharmaceuticals|Study Director|862-778-8300||
20543651|NCT03881852|Axsome Therapeutics, Inc.|Caroline Streicher, Executive Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
20543652|NCT00641667|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
20543653|NCT01421719|Stanford University|Rodney U. Anderson, MD|6504984240|rua@stanford.edu|
20543654|NCT01124006|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
20543655|NCT00565084|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20543656|NCT01712399|MedImmune, LLC.|Marius Albulescu, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
20543657|NCT01357850|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543658|NCT04610281|Ullo World|Dr. Brigitte Laurent|+33782096875|brigitte@ullo.fr|
20543659|NCT02648919|University of Hawaii Cancer Center|Stacy Mercado, IIT/ Education Manager|8084404561|smercado@cc.hawaii.edu|
20543660|NCT05887388|University of North Carolina at Chapel Hill|Mark Toles, PhD|919-966-5684|mtoles@email.unc.edu|
20543661|NCT03824769|University of Connecticut|Zeely Denmat|860-455-3842|zeely.denmat@uconn.edu|
20543662|NCT03537404|R-Pharm|Emiliya Krasavina, Medical Adviser|0074959567937|krasavina@rpharm.ru|
20543663|NCT00842335|Jubilant Clinsys Inc.|Jane Fisher, Senior Manager, Regulatory Affairs|+1 (919) 518-8786|jfisher@clinsys.com|
20543664|NCT01271946|Arstasis|Debra Cogan, Director of Quality, Regulatory and Clinical|650-261-8073|dcogan@arstasis.com|
20543665|NCT02435992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20543666|NCT00907335|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
20543667|NCT03879772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571084|NCT05143138|WL Gore|Cinzia Santin, Clinical Study Mgt, Gore Medical Products|+393463645539|csantin@wlgore.com|
20571085|NCT03632083|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20543668|NCT00912808|Oregon Health & Science University|Kathryn Chung, MD|503 220 8262|chungka@ohsu.edu|51091
20543669|NCT00767364|Wayne State University School of Medicine, Children's Hospital of Michigan|Eric McGrath, MD|313-745-5863|emcgrath@med.wayne.edu|
20543670|NCT03345784|University Health Network, Princess Margaret Cancer Centre|Dr. Stephanie Lheureux, PI|416-946-2818|stephanie.lheureux@uhnresearch.ca|
20543671|NCT03415685|Lutronic|Alexander Denis, Global Manager of Clinical Research|9788959206|adenis@lutronic.com|
20543672|NCT02512783|Children's Hospitals and Clinics of Minnesota|Angela Doucette|6128137144|angela.doucette@childrensmn.org|
20543673|NCT00482053|Stanford University Medical Center|Wen-Kai Weng, Assistant Professor of Medicine|650-723-7689|wkweng@stanford.edu|
20543674|NCT03611829|McGill University|Mallory Frayn, PhD (c)|514-398-1399|mallory.frayn@mail.mcgill.ca|
20543675|NCT00728689|Siga Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
20543676|NCT03941288|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
20543677|NCT02415608|Stanford University Medical Center|Jason Robert Gotlib, MD; Professor of Medicine (Hematology)|650-498-6000|C.Langford@stanford.edu|
20543678|NCT02871934|VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA|Dr. Jason Vassy|857-364-2561|jvassy@partners.org|
20543679|NCT00389610|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
20543680|NCT00538902|Abbott|Global Medical Services|800-633-9110||
20543681|NCT00887809|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
20543682|NCT01615484|University of North Carolina at Chapel Hill|Thomas Egan, MD, MSc, FACS|919-966-3381|thomas_egan@med.unc.edu|
20543683|NCT00497081|San Francisco Department of Public Health|Glenn-Milo Santos, MPH|415.437.6231|glenn-milo.santos@sfdph.org|
20543684|NCT04109547|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20543685|NCT01550003|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20543686|NCT05567783|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20543687|NCT05005182|Mayo Clinic|Abhishek Mangaonkar|507-538-0173|Mangaonkar.Abhishek@mayo.edu|
20543688|NCT03675126|Sarepta Therapeutics, Inc.|Medical Director|1-888-727-3782|SareptAlly@sarepta.com|
20543689|NCT00001959|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
20543690|NCT03982355|IMperial COllege London|Dr SImon Dryden|+447828464949|simon.dryden@imperial.ac.uk|
20543691|NCT03773978|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20543692|NCT03113487|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20543693|NCT03777982|Dana Farber/Mass General Brigham Cancer Care|Anthony D'Amico|857-215-1489|adamico@bwh.harvard.edu|
20543694|NCT02958995|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20543695|NCT03995368|VA Greater Los Angeles Healthcare System|Dr. Jonathan K. Wynn|3104783711|Jonathan.Wynn@va.gov|44957
20543696|NCT00817843|UMC Utrecht|Professor F.L.J. Visseren, MD PhD|0031-88-7555555|f.l.j.visseren@umcutrecht.nl|
20508304|NCT01924299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508305|NCT00605072|University of Southern California|Dr. Ihab Hajjar|323-226-6720|ihajjar@usc.edu|
20508306|NCT05064332|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508307|NCT00141037|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20527373|NCT00506714|Arthritis Foundation|Meika A. Fang, MD|310-478-3711|meika.fang@va.gov|84503
20527374|NCT02454075|Trio Medicines|Dr Malcolm Boyce|020 8961 4130|mboyce@hmrlondon.com|
20543697|NCT03755934|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20543698|NCT04266717|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu|
20543699|NCT00361296|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
20543700|NCT00940771|Bill Holt Clinic, Phoenix Children's Hospital|Janice Piatt, MD, Medical Director|602-933-0955|jpiatt@phoenixchildrens.com|
20543701|NCT04351334|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543702|NCT00963859|The University of Texas (UT) MD Anderson Cancer Center|John W. Davis, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20543703|NCT02072668|University of Tennessee Center for the Heath Sciences|Dr. Kenneth Ataga|901.448.3181|kataga@uthsc.edu|
20543704|NCT05523089|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
20543705|NCT02514083|National Heart Lung and Blood Institute (NHLBI)|Inhye Ahn, M.D.|301-827-1203|inhye.ahn@nih.gov|
20543706|NCT01899040|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
20543707|NCT01350258|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
20543708|NCT01582477|St. Elizabeth's Medical Center|Andrew Sternlicht, MD|617-789-2777|andrew.sternlicht@steward.org|
20543709|NCT02083354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20527375|NCT02651415|BC Cancer|Dr. Barbara Melosky|604-877-6000|bmelosky@bccancer.bc.ca|
20527376|NCT04344535|Stony Brook University|Elliott Bennett-Guerrero|6314446026|elliott.bennett-guerrero@stonybrookmedicine.edu|
20527377|NCT02614131|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20527378|NCT02603107|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20527379|NCT00032630|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-393-2863|Frederick.Grover@ucdenver.edu|
20527380|NCT04103515|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
20543710|NCT01148979|McLean Hospital|J. Alexander Bodkin, MD|617-855-3186|abodkin@mclean.harvard.edu|
20543711|NCT00777153|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20543712|NCT00554216|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
20543713|NCT01615120|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
20543714|NCT02393378|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20543715|NCT05764785|University of Massachusetts Boston|Dr. Jean Rhodes|(617) 620-9147‬|jean.rhodes@umb.edu|
20543716|NCT00071890|INSERM U897 Bordeaux FRANCE|Pr G. Chene|557571392|genevieve.chene@isped.u-bordeaux2.fr|+33
20543717|NCT01389596|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543718|NCT01671319|University of Wisconsin Carbone Cancer Center|Dr. Amyé Tevaarwerk|608-262-2837|at4@medicine.wisc.edu|
20543719|NCT01550224|Stanford University Medical Center|Steven Edward Coutre, MD; Professor of Medicine (Hematology)|650-725-4040|coutre@stanford.edu|
20543720|NCT01424215|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
20543721|NCT02993107|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20543722|NCT03038100|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20543723|NCT01198795|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|58124
20543724|NCT01116986|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
20555122|NCT00690521|University of New Mexico Health Sciences|Joe Anderson|505-272-3664|janderson@salud.unm.edu|
20543725|NCT03250273|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
20543726|NCT04154904|Oregon Health and Science University|Jessica Castle|1503-494-7072|castleje@ohsu.edu|
20543727|NCT02392624|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20543728|NCT00936715|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20543729|NCT03819114|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20543730|NCT03841604|Zambon SpA|Elena Tiberio, BSc|+39 02665241|clinicaltrials@zambongroup.com|
20543731|NCT02492763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543732|NCT03877510|Impax Laboratories, LLC|Pamela Fitzpatrick, Senior Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
20543733|NCT01337960|VA Maryland Health Care System|Larry Forrester, PhD|410-637-3241|Larry.Forrester@va.gov|
20543734|NCT01772316|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20543735|NCT00267059|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Associate Professor|713-792-2063|eharriso@mdanderson.org|
20543736|NCT02085161|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20543737|NCT01213316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543738|NCT04591353|University of Alabama at Birmingham|Promil Kukreja|205-934-4042|Pkukreja@uab.edu|
20543739|NCT01936870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543740|NCT04790916|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20543741|NCT00832299|Beth Israel Medical Center|Peter Kozuch, MD||pkozuch@chpnet.org|
20543742|NCT02930824|University of Florida|Dr. Larisa Cavallari|(352) 273-8245|LCavallari@cop.ufl.edu|
20543743|NCT00628108|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20543744|NCT03848832|GW Research Ltd|Medical Enquiries|1-833-424-6724|medinfo@gbio.com|
20543745|NCT02494323|Bet-Loewenstein|Dr.Yaron Sacher|97297709918|ysacher@clalit.org.il|
20543746|NCT00719472|Genentech, Inc.|Medical Communications|800-821-8590||
20543747|NCT02086500|University of Pittsburgh|Dr. Jason Sperry MD, MPH|4128028270|sperryjl@upmc.edu|
20543748|NCT00711191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543749|NCT02633306|University of Minenesota|Stephen Haines, MD|612 624-6666|shaines@umn.edu|
20543750|NCT01744977|Durham Veterans Affairs Medical Center|Hayden Bosworth, PhD|919-286-6936|hayden.bosworth@va.gov|
20543751|NCT01213472|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
20543752|NCT03774576|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20543753|NCT00089752|University of Pennsylvania School of Nursing|Terri E. Weaver, PhD, RN, FAAN|215-898-2992|tew@nursing.upenn.edu|
20543754|NCT00930046|Boston Children's Hospital|Dr. Navil Sethna|781-216-1650|navil.sethna@childrens.harvard.edu|
20543755|NCT01598532|Spaulding Rehabilitation Hospital|Ross D. Zafonte, DO|617-952-5227|rzafonte@partners.org|
20543756|NCT03429270|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
20543757|NCT01967940|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
20543758|NCT04189952|University of Miami|Craig Moskowitz, MD|305-243-9009|chm78@med.miami.edu|
20543759|NCT04475081|Louisiana State University Health - New Orleans|Associate Dean for Research|9858693445|pfidel@lsuhsc.edu|
20543760|NCT04298697|Emory University|Colleen Kelley, MD, MPH|404-712-1823|colleen.kelley@emory.edu|
20543761|NCT00904982|University of Pennsylvania Perelman School of Medicine|Stephen E. Kimmel, MD, MSCE/Director, Clinical Epidemiology|(215) 898-1740|stevek@mail.med.upenn.edu|
20543762|NCT02593006|Hackensack University Medical Center|Yukiko Kimura MD|551-996-5306|yukiko.kimura@hackensackmeridian.org|
20543763|NCT02054689|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20543764|NCT03678493|University of Minnesota, Masonic Cancer Center|Armin Rashidi, MD, PhD|(612) 273-8383|arashidi@umn.edu|
20543765|NCT02431637|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
20543766|NCT01352793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543767|NCT00656448|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
20543768|NCT01929317|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543769|NCT04322526|University of Pittsburgh|Dr. Marta Pecina|734-945-2473|pecinam@upmc.edu|
20543770|NCT03146585|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
20543771|NCT01716234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543772|NCT02667119|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
20543773|NCT01523756|Coloplast A7S|Marianne Raff|+45 4911 2562|dkmr@oloplast.com|
20543774|NCT00993967|Santhera Pharmaceuticals|Thomas Meier, PhD|+41 61 906 89 50|thomas.meier@santhera.com <Thomas.Meier@santhera.com>|
20543775|NCT03994081|University of North Carolina at Chapel Hill|Tobias Schwippel, MD|919-966-9929|tobias_schwippel@unc.edu|
20543776|NCT03783078|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20555123|NCT03819660|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|3054203200|gingenito@catalystpharma.com|
20508308|NCT00888615|NRG Oncology|Christopher Purdy on behalf of James Kauderer|(716)845-1300|purdyc@nrgoncology.org|2296
20508309|NCT00637377|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20508310|NCT04186663|University of California San Francisco|Dr. Hellene Ellenikiotis|408-313-0166|hellene.ellenikiotis@ucsf.edu|
20508311|NCT00719862|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|WWheeler@medapharma.us|
20508312|NCT01184846|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20508313|NCT01999946|NYU Langone Health|Joshua Lee, MD MS|646-501-3552|joshua.lee@nyulangone.org|
20508314|NCT00719953|Sourazky Tel-Aviv Medical Center|Professor N. Vaisman|972-3-6974807|vaisman@tasmc.health.gov.il|
20543777|NCT02758210|Emory University|Mikhael El Chami, MD|404-686-2504|melcham@emory.edu|
20543778|NCT00474812|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Charles Nock MD|216-844-3862|charles.nock@uhhospitals.org|
20543779|NCT02620774|Center for Anti-infective Research and Development|David Nicolau|860-972-3941|david.nicolau@hhchealth.org|
20543780|NCT02059278|Point Guard Partners LLC|Jeremy Brace|727-458-2823|jbrace@pointguardllc.com|
20543781|NCT02180100|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86755-83923333|fanshangrong@163.com|5502
20543782|NCT05452486|University of Arkansas for Medical Sciences|Dr. Caitlin Price|(501) 686-8125|CEPrice@uams.edu|
20543783|NCT05408429|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543784|NCT03435211|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
20543785|NCT02195518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20543786|NCT03818256|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
20543787|NCT03111121|West Virginia University|Pavithra Ranganathan Ellison, MD|3045984122|pavithra.ellison@hsc.wvu.edu|
20543788|NCT03043794|Johns Hopkins University, Department of Radiation Oncology|Dana Baker Kaplin, MPH|410-614-3950|dkaplin1@jhmi.edu|
20543789|NCT04223479|The University of Jordan|Lana M. Agraib|+962|lanamg2007@yahoo.com|00000
20543790|NCT03205423|New York State Psychiatric Institute|Jermaine Jones|7577533212|jermaine.jones@NYSPI.Columbia.edu|
20543791|NCT02749422|NYU Langone Health|Anli Liu|929-455-2340|Anli.Liu@nyulangone.org|
20543792|NCT02594124|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20543793|NCT03712358|Istari Oncology|Lisa Franklin|919-245-7662|lfranklin@istarioncology.com|
20543794|NCT00595088|Bnai Zion Medical Center|Dr. Sarel Halachmi|+97248359542|sarel.halachmi@b-zion.org.il|
20543795|NCT00735436|Duke University Medical Center|Annick Desjardins, MD, FRCPC||annick.desjardins@dm.duke.edu|
20543796|NCT04586205|University of Pennsylvania|Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
20543797|NCT03312634|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20543798|NCT04828343|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20543799|NCT02937116|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
20543800|NCT02079246|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20543801|NCT04040933|Johnson & Johnson Consumer Inc. (J&JCI)|Robin Mathew|908-904-5034|rmathew1@its.jnj.com|
20543802|NCT02066181|Memorial Sloan-Kettering Cancer Center|Mrinal Murugesan Gounder M.D.|646-888-4167|gounderm@mskcc.org|
20543803|NCT00354978|UT MD Anderson Cancer Center|Scott Kopetz, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
20543804|NCT00775190|Beaumont Health System|Evie Russell, RN|248-898-5388|Evie.Russell@beaumont.org|
20543805|NCT02141295|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20543806|NCT01709084|Janssen R&D US|Director, R&D, Medical Departement||ClinicalTrialDisclosure@its.jnj.com|
20543807|NCT00214201|UW Madison|Director of Clinical Trials|608-263-2565||
20543808|NCT01432730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543809|NCT01235741|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20543810|NCT02696967|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20543811|NCT01803607|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543812|NCT00632814|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20543813|NCT00706238|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543814|NCT00753506|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
20543815|NCT04441892|Mayo Clinic|Dr. Michael J. Ackerman|507-284-8900|ackerman.michael@mayo.edu|
20543816|NCT00384670|Department of Pediatrics, Pharamongkutklao Hospital|Sriluck Simasathien ; Infectious Disease Consultant|66-2-644-8971||
20543817|NCT03763877|Poxel|Director, Medical Operations|+33 (0)4 37 37 20 10|carole.thang@poxelpharma.com|
20543818|NCT03906448|University of Florida|David Tran, MD, PhD|352-273-9000|david.tran@neurosurgery.ufl.edu|
20543819|NCT01774721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543820|NCT01222689|university of california san francisco|Dr. Andrew Ko, MD|415-353-7286|Andrew.Ko@ucsf.edu|
20543821|NCT01600716|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20543822|NCT00248040|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20543823|NCT01760733|Telemark Hospital Trust|MD, PhD Kristian Heldal|+4790018417|hkri@ous-hf.no|
20543824|NCT02282605|Destiny Pharma|Director of Projects|+44 (0) 1273 704440|medinfo@destinypharma.com|
20543825|NCT03926611|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20543826|NCT03543878|Georgia Institute of Technology|Annabelle C. Singer, PhD|510-501-9659|asinger@gatech.edu|
20543827|NCT00836693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20555124|NCT01136291|Department of Obstetrics and Gynecology - University of Campinas|Fernanda Garanhani de Castro Surita|+551935219304|surita@unicamp.br|
20555125|NCT02545907|Leeds Institute of Clinical Trials Research|Alexandra Pitchford|0113 343 9077|medcatal@leeds.ac.uk|
20555126|NCT01573702|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20555127|NCT03165045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20555128|NCT00759109|Merck Sharp and Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20555129|NCT01827904|Insightec|Nadir Alikacem, SVP Global Regulated Clinical Affairs|214-360-9900|nadira@insightec.com|
20555130|NCT00780962|Beth Israel Deaconess Medical Center|Nathan I. Shapiro, MD, MPH|617-754-2323|nshapiro@bidmc.harvard.edu|
20555131|NCT01660763|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20555132|NCT01910519|Emory University|Nadine Rouphael MD|404-712-1435|nroupha@emory.edu|
20555133|NCT04266028|Desentum Oy|Head of Clinical Operations|+358400224892|Info@desentum.fi|
20555134|NCT00952653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555135|NCT00380068|Gilead Sciences Inc|Martine Allard, PhD; Senior Clinical Research Scientist|650-524-3898|martine.allard@gilead.com|
20555136|NCT01915563|Althaia Xarxa Assistencial Universitaria de Manresa|Dr Rafael Fernandez|34.8732550|rfernandezf@althaia.cat|3730
20555137|NCT02259608|Radboud UMC|Rob Arts|0031 24|rob.jw.arts@radboudumc.nl|36 67206
20555138|NCT01812044|Duke University Medical Center|Laura Enyedi, M.D.|919-684-2038|laura.enyedi@dm.duke.edu|
20555139|NCT02720484|Northwestern University|Devalingam Mahalingam|312.472.0564|mahalingam@northwestern.edu;|
20555140|NCT05070897|Hôpital Européen Georges Pompidou|Pr Elena Paillaud|0156093310|elena.paillaud@aphp.fr|
20555141|NCT01617629|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
20555142|NCT02715765|University of Minnesota|Kelvin Lim|612-273-9803|kolim@umn.edu|
20555143|NCT01884350|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20555144|NCT03510481|NIAID/LMIV|Dr. Patrick Duffy|301-761-5089|patrick.duffy@nih.gov|
20555145|NCT00363766|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20555146|NCT01489579|Kaiser Permanente|Alicia Cymbala|303-972-5384|Alicia.A.Cymbala@kp.org|
20555147|NCT04295564|OHSU|Dr. Cindy McEvoy|503-494-0223|mcevoyc@ohsu.edu|
20555148|NCT04537923|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20555149|NCT01261611|Ipsen Innovation|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20555150|NCT02527798|Duke University|Leigh Gosnell|919-668-1280|leigh.gosnell@duke.edu|
20555151|NCT04690855|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
20555152|NCT01808690|University of Colorado Denver/Children's Hospital Colorado|Dr. Kristen J Nadeau|720-777-2855|Kristen.Nadeau@childrenscolorado.org|
20555153|NCT02395120|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu|
20555154|NCT00377234|Hoffmann-LaRoche|Medical Communications|800-821-8590||
20555155|NCT01997398|Barrow Neurlogical Institute / St. Joseph's Hosptial & Medical Center|Francisco A. Ponce, MD|602-406-3242||
20555156|NCT00626522|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
20555157|NCT01159691|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20555158|NCT00381966|Johns Hopkins University|Daniel Song|401-502-5875|dsong2@jhmi.edu|
20555159|NCT05732454|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571086|NCT04245345|Medtronic|Rachel Vasseur, Sr. Clinical Research Specialist|6123550360|rachel.s.vasseur@medtronic.com|
20555160|NCT01153633|B. Braun Medical AG|Medical Scientific Affairs Manager|+41 58 258 55 47||
20571087|NCT01834586|EvergreenHealth Multiple Sclerosis Center|Theodore Brown|425-8995350|trbrown@evergreenhealth.com|
20555161|NCT00384085|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
20508315|NCT01549223|Brigham and Women's Hospital|Lawrence Tsen, MD|617-732-8216|ltsen@partners.org|
20508316|NCT01987349|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20508317|NCT04021706|Tufts University|Bess Dawson-Hughes|6175563066|bess.dawson-hughes@tufts.edu|
20508318|NCT01375647|University of Vermont|Dorothy M Dickson, MSc|802 656 9296|dorothy.dickson@med.uvm.edu|
20508319|NCT04884945|Indiana University School of Medicine, Pediatrics|Stacy Keller|3172786127|stasulli@iu.edu|
20543828|NCT03938259|Baylor College of Medicine7|Dr. Adam Adler|832-824-5801|Adam.adler@bcm.edu|
20543829|NCT02612779|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20508320|NCT02332798|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20543830|NCT02004041|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
20508321|NCT00595868|University of Vermont|John R. Hughes, MD|802-656-3195|john.hughes@uvm.edu|
20508322|NCT02688153|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
20508323|NCT00107172|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
20508324|NCT01102140|University of Michigan|Dr. Jennifer Cowger|7345464911|jennifercowger@gmail.com|
20508325|NCT02354092|Oregon Health & Science University|Ob/Gyn Regulatory Specialist, Women's Health Research Unit|503-494-3666|whru@ohsu.edu|
20508326|NCT00713284|California Pacific Medical Center|Dr. V. Ram Peddi|415-600-1000|peddir@sutterhealth.org|
20508327|NCT03140722|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
20543831|NCT03910244|Cleveland Clinic|Keith McCrae, MD|216-445-7809|mccraek@ccf.org|
20508328|NCT05711862|The University of Texas Health Science Center at Houston|Heather Webber, PhD|713-486-2723|Heather.E.Webber@uth.tmc.edu|
20543832|NCT01101867|The Ohio State University|Dr. Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
20508329|NCT01742091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20543833|NCT01746901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508330|NCT00612339|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
20508331|NCT03750240|NYU Langone Health|Guillaume Madelin, PhD|(212) 263-3343|guillaume.madelin@nyulangone.org|
20543834|NCT02683577|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
20508332|NCT03706040|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20508333|NCT00927758|Sandoz|Study Director|609-627-8889|yaping.zhu@sandoz.com|
20543835|NCT03594110|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20543836|NCT00763035|Wake Forest University Health Sciences|Gregory Hundley|+1 (336) 716-0607|ghundley@wakehealth.edu|336
20508334|NCT00439725|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20543837|NCT00702221|BTG International Inc.|SVP, Clinical Development|610-278-1660|thomas.king@btgplc.com|
20508335|NCT01544478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508336|NCT03788616|Faculty of dentistry, Ain Shams University|Dr. Marina Fakhry assistant lecturer of pediatric dentistry|01273731722|Dr.marina.fakhry@gmail.com|+02
20543838|NCT03856788|Icahn School of Medicine at Mount Sinai|Christina Jeng, MD, FASA|212) 241-6426|christina.jeng@mountsinai.org|
20508337|NCT00212758|Oregon Health & Science University|Dr. Amira Al-Uzri|503-494-7327|aluzria@ohsu.edu|
20543839|NCT03769519|Duke|Isaretta L. Riley, MD, MPH|919-286-0411|isaretta.riley@duke.edu|
20508338|NCT02574481|Boston Scientific|Nicole Kilburn|970-294-4082|Nicole.Kilburn@bsci.com|
20508339|NCT03062267|University of Washington|Principal Investigator|(206) 685-9655|dbenzeev@uw.edu|
20508340|NCT02940860|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
20543840|NCT04798196|UW-Madison|Gina Landucci|(608) 890-1440|gina.landucci@wisc.edu|
20543841|NCT01249261|Warner Chilcott|Grexan J. Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20508341|NCT03404219|Boston University|Dr. Daniel Fulford|(617) 358-6723|dfulford@bu.edu|
20508342|NCT03300258|University of Wisconsin, Madison|Peter Adamczyk|(608) 263-3231|peter.adamczyk@wisc.edu|
20555162|NCT03846024|University of Vermont|Ethan Jones|802-656-9437|ethan.d.jones@med.uvm.edu|
20508343|NCT04209530|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
20543842|NCT03114683|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
20555163|NCT03725982|Institute of Occupational and Social Medicine and Health Services Research|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
20508344|NCT00646581|UMass Medical School|Matthew Goodnow|508-856-2494|matthew.goodnow@umassmed.edu|
20508345|NCT00527072|Janssen Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-5711||
20508346|NCT00608881|Massachusetts General Hospital|Dr. Merit Cudkowicz|617-726-0813|mcudkowicz@partners.org|
20543843|NCT01055197|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20543844|NCT04916587|University of Colorado, Denver|Dr. Monica Perez Jolles|303-724-0829|monica.jolles@cuanschutz.edu|
20543845|NCT04355169|Shionogi Inc.|Shionogi Clinical Trials Administrator Clinical Support Help Line|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20555164|NCT03319277|Cleveland Clinic|Emily RW Davidson, M.D.|812-272-2380|dr.emily.rose@gmail.com|
20527381|NCT01887678|Biologische Heilmittel Heel GmbH|Christine Frank, PhD, Global Clinical Project Manager|+49 7221 501 3188|christine.frank@heel.com|
20508347|NCT02954952|Masimo Corporation|Director of Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
20527382|NCT02410213|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
20527383|NCT03677934|Hoffmann-La Roche|Medical Communications|800 821-8590|global-roche-genentech-trials@gene.com|
20508348|NCT00724815|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
20508349|NCT00810043|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
20555165|NCT02346383|CCAMP|J Kelby Hutcheson MD|8642956399|khutchesonmd@carolinapain.com|
20543846|NCT01658436|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|trialandresults.registries@novartis.com|
20543847|NCT00686712|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
20543848|NCT01151189|Aeras|Product Director; Bernard Landry|301-547-2919|blandry@aeras.org|
20543849|NCT01318915|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20543850|NCT00926237|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
20543851|NCT04119414|University of Miami|Stephen Weiss|7862108684|sweiss2@med.miami.edu|
20543852|NCT01342211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543853|NCT05378672|Zealand Pharma A/S|Clinical Operations|+45 88 77 36 00|clinicaltrials@zealandpharma.com|
20543854|NCT01588522|BPGbio Inc.|Bing Nie|617-588-1002|bing.nie@bpgbio.com|
20543855|NCT04504253|University of Utah|Brent Kious, MD|8015851418|brent.kious@hsc.utah.edu|
20543856|NCT02855125|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
20543857|NCT04467905|Milestone Pharmaceuticals Inc.|Leonid Kokovin-Sher|1 450-912-6783|lkokovin-sher@milestonepharma.com|
20543858|NCT00664443|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
20543859|NCT05370495|Seinda|Jing-Feng Huang, Ph.D.|1.858.254.9188|jfhuang@SeindaPharm.com|
20543860|NCT03894124|Chelsea and Westminster NHS Foundation Trust|Research Operations Manager|+442033156825|chelwest.research@nhs.net|
20555166|NCT01944631|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508350|NCT02001688|Kamada Ltd|Head of Clinical Operations|+972-72-2219172|sharonc@kamada.com|
20555167|NCT00838110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527384|NCT02952872|Wayne State University|Dr. Emily Grekin|313-577-2820|grekine@wayne.edu|
20527385|NCT04769739|Evergreen General Hospital|Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
20527386|NCT00045734|Adult Brain Tumor Consortium (ABTC)|Patrick Wen, MD|410-955-8837|jfisher@jhmi.edu|
20527387|NCT02069093|Novartis Pharmaceuticals|Study Director|862-778-8300||
20527388|NCT02624388|UVA Health|William Petersen|434-924-8499|wcp3g@uvahealth.org|
20527389|NCT03290547|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20543861|NCT04684836|Vanderrbilt University|Jessica Ancker, MS, PhD|(615) 322-5000|jessica.s.ancker@vumc.org|
20527390|NCT00561470|sanofi-aventis|International Clinical Development Study Director||contact-us@sanofi.com|
20527391|NCT02315872|Providence Health & Services|Lynette Currie|503-216-1034|lynette.currie@providence.org|
20527392|NCT00335959|SWOG Statistical Center|Study Statistician|206-667-4623||
20527393|NCT01889355|AgaMatrix, Inc|Senior Clinical Research Technician|603-328-6035|krocha@agamatrix.com|
20543862|NCT02786394|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
20527394|NCT02028169|AbbVie|Global Medical Services|800-633-9110||
20527395|NCT01001598|Boston Children's Hospital|Colin A. Sieff|617 919-4241|colin.sieff@childrens.harvard.edu|
20527396|NCT00737893|Johns Hopkins Brady Urological Institute|Dr. Hiten Patel|410-502-7710|hiten.patel@lumc.edu|
20527397|NCT02450552|Massachusetts General Hospital - Neurological Clinical Research Institute|Protocol Investigator|617-726-2000|Brian.Wainger@MGH.HARVARD.EDU|
20543863|NCT01833247|Stanford University Department of Neurology|Robert S. Fisher, MD, PhD|650-7215289|robert.fisher@stanford.edu|
20527398|NCT02722837|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20527399|NCT04877535|Washington University School of Medicine|Christopher King|(314) 362-8649|christopherking@wustl.edu|
20543864|NCT02230995|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20527400|NCT00925652|Dana-Farber Cancer Institute|Erica Mayer MD MPH|617-632-2335|emayer@partners.org|
20527401|NCT01969084|Beth Israel deaconess Medical Center|Aristidis Veves|617 632 7075||
20527402|NCT01343667|W. L. Gore & Associates|Bryan Randall, Clinical Biostatistician|928-864-4832|BRandall@WLGore.com|
20527403|NCT00810446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527404|NCT05079230|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20527405|NCT01524783|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20543865|NCT01679314|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
20571088|NCT03443414|Verona Pharma|Brian Maurer, Senior Clinical Operations Director|(914) 767-5037|brian.maurer@veronapharma.com|
20571089|NCT01512797|Columbia University Medical Center|Dr. Blandine Laferrere|212-851-5562|bbl14@columbia.edu|
20527406|NCT00100841|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
20527407|NCT03164265|University of Pittsburgh|Dr. Angus Thomson|(412) 624-6392|thomsonaw@upmc.edu|
20571090|NCT03325777|The University of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
20527408|NCT00824434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
20543866|NCT05462756|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20543867|NCT03666663|UCSF|Dr.Nina Riggins|7028064831|Nina.Riggins7@gmail.com|
20543868|NCT02409277|University of Utah|Flory Nkoy|801-662-3660|flory.nkoy@hsc.utah.edu|
20543869|NCT00420771|NYSPI|John J. Mariani, MD|212-543-5987|jm2330@columbia.edu|
20543870|NCT00959985|Massachusetts General Hospital|Dr. Alphonse G Taghian, MD PhD|617-726-6050|ataghian@partners.org|24369
20543871|NCT01942837|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
20543872|NCT01298648|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20543873|NCT03252431|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
20543874|NCT03077412|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20543875|NCT02812342|Yale Dermatology - Middlebury|Brett King, MD, PhD, BA, Associate Professor of Dermatology|(203) 737-4825|brett.king@yale.edu|
20543876|NCT02266888|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20543877|NCT02351856|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543878|NCT04939714|Emory University|Carolyn Clevenger, DMP, APRN|404-712-2394|carolyn.clevenger@emory.edu|
20543879|NCT01458392|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543880|NCT03762993|Purdue University|Preeti Sivasankar|765-494-3788|preeti@purdue.edu|
20543881|NCT01281124|The Ohio State University Comprehensive Cancer Center|Greg Otterson|614-293-2887|Greg.Otterson@osumc.edu|
20543882|NCT00918255|Abbott|Global Medical Services|800-633-9110||
20543883|NCT02038933|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20543884|NCT04226742|University of California, Irvine|Stephen Schueller|949-824-3850|s.schueller@uci.edu|
20543885|NCT01635439|NWAFH|Ahmed Abdelaziz|0096644411088|webmaster@nwafh.med.sa|
20543886|NCT01193244|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20543887|NCT01417377|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20543888|NCT02113982|Stemline Therapeutics, Inc.|Ira Gupta, MD|877-332-7967|clinicaltrials@menarinistemline.com|
20543889|NCT01394003|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20543890|NCT03040336|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
20543891|NCT01647217|Tissuetech Inc|Hosam El Sheha, MD, PhD|305-274-1299|hsheha@tissuetechinc.com|
20543892|NCT00068692|ECOG-ACRIN statistical office|Statistician||eatrials@jimmy.harvard.edu|
20543893|NCT00779155|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303-795-3222|abraswell@pico-tesla.com|
20543894|NCT03481595|Cleveland Clinic Florida|Carlos Higuera|9546595430|higuerc@ccf.org|
20543895|NCT03557034|Cleveland Clinic|Khaldoun Tarakji, MD, MPH|216-445-9225|TARAKJK@ccf.org|
20555168|NCT01003899|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571091|NCT02103114|Duke University|Dr. Edmund Jooste|919-681-4877|edmund.jooste@duke.edu|
20527409|NCT00721279|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20543896|NCT02540629|Seoul National University Hospital|Dr. Jeong Ho Park|+821035426282|timthe@gmail.com|
20543897|NCT01759446|Acura Pharma|Dr. Al Brzeczko|847-705-7709|abrzeczko@acurapharm.com|
20543898|NCT00815659|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20543899|NCT03847896|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
20527410|NCT03673345|University of Rochester|Jennifer Nayak, MD, PI|5852750526|Jennifer_nayak@urmc.rochester.edu|
20543900|NCT02395471|Medtronic MITG Gastrointestinal & Hepatology|Dr.Jaime Kean|303-882-6759|Jaime.M.Kean@medtronic.com|
20543901|NCT00118417|Massachusetts General Hospital|Naomi M. Simon, MD|617-726-7913|nsimon@partners.org|
20543902|NCT02978781|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20543903|NCT00785785|Novartis Pharmaceuticals|Study Director|862-778-8300||
20543904|NCT02453321|University of Pittsburgh Medical Center|Kevin King, DO - Clinical Asst. Professor|412 748-5589|kingkk@upmc.edu|
20543905|NCT01244893|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Senior Research Optometrist|(904) 443-1290|BPALL@its.jnj.com|
20543906|NCT00357552|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20543907|NCT00976404|Northwestern University|Baiba Berzins, MPH|312-695-5012|baiba@northwestern.edu|
20543908|NCT00521404|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20543909|NCT03089281|Boston Scientific|Clinical Trial Manager|1-800-227-3422|Sara.Veraghtert@bsci.com|
20543910|NCT02301416|Wake Forest School of Medicine|Jamy Ard|336-716-9837|jard@wakehealth.edu|
20543911|NCT00882557|Cubist Pharmaceuticals, Inc.|Ed Campanaro/Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
20543912|NCT00842296|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
20543913|NCT01528969|Kuwait University, Faculty of Dentistry|Prof. Eino Honkala|+965 65638938|eino.honkala@hsc.edu.kw|
20543914|NCT01908062|Oregon Health & Science University|Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
20543915|NCT01383356|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20543916|NCT03584789|HealthPartners Institute|D. Brad Rindal, DDS, Associate Dental Director Research|952-967-5026|donald.b.rindal@healthpartners.com|
20543917|NCT01357525|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
20543918|NCT02035267|Allergan, Inc|Beta Bowen|1-714-246-4446|Bowen_Beta@allergan.com|
20543919|NCT04646044|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20543920|NCT04803396|Dompé farmaceutici SpA|dr. Mauro P. Ferrari|+39 02 583831|clinops@pec.dompe.it|
20543921|NCT04827680|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20543922|NCT03038880|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20543923|NCT02803580|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20543924|NCT02054104|National Cancer Institute|Dr. David Schrump|240-858-7000|schrumpd@mail.nih.gov|
20543925|NCT03134703|Johns Hopkins All Children's Hospital|Sandra Brooks, MD|727-767-4313|sbrook36@jhmi.edu|
20543926|NCT00084136|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20527411|NCT05153148|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20543927|NCT02230670|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20543928|NCT01524796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20543929|NCT00080535|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
20543930|NCT01374438|Metabolic Solutions Development Company|Dr. Jerry Colca|269.343.8732|jcolca@msdrx.com|
20543931|NCT02202759|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20543932|NCT01646125|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20543933|NCT03124342|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
20543934|NCT00904033|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
20543935|NCT02201394|Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon||Juan.Badimon@mssm.edu|
20543936|NCT00865566|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20543937|NCT00602472|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20543938|NCT02885025|VA Greater Los Angeles Healthcare System|Joseph Yusin Chief division Allergy Immunology|3104783711|joseph.yusin2@va.gov|40230
20543939|NCT00823615|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20543940|NCT02404025|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
20543941|NCT00955916|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, M.D.|813-745-4291|rami.komrokji@moffitt.org|
20543942|NCT00956007|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20543943|NCT01750229|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
20543944|NCT03734692|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20543945|NCT05571605|University of North Texas|Dr. Justin Sprick|940-565-2226|justin.sprick@unt.edu|
20543946|NCT00419952|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20543947|NCT03126591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20543948|NCT02085460|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20543949|NCT01285323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20543950|NCT00217399|Georgetown University|Dr. Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
20543951|NCT02158546|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
20543952|NCT02376998|University Magna Graecia of Catanzaro|Prof. Raffaele Serra|+3909613647380|rserra@unicz.it|
20543953|NCT02351817|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
20543954|NCT01194856|Cleveland Clinic|Marisa Tungsiripat|2164442037|tungsim@ccf.org|
20571092|NCT00980746|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20543955|NCT00803569|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20543956|NCT02488915|Neuravi Ltd|Mairsíl Claffey|0035391394123|mclaffey@neuravi.com|
20543957|NCT00885170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543958|NCT03771664|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20543959|NCT01011894|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|212-639-7053|brentjer@mskcc.org|
20543960|NCT03418714|Johns Hopkins University|Frederick Barrett|4105509777|fbarret2@jhmi.edu|
20543961|NCT01208207|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543962|NCT03122509|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
20543963|NCT04041414|University of Southern California|Jeremy Goldbach, PhD, LMSW|(213) 821-6460|goldbach@usc.edu|
20543964|NCT00665652|Dartmouth Hitchcock Medical Center|Elijah Stommel|603-650-5104|elijah.w.stommel@hitchcock.org|
20543965|NCT01749215|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki|415-221-4810|steven.batki@ucsf.edu|23671
20543966|NCT02382705|University of British Columbia|Dr. Robert Enns|604 688 6332|cgalorport@gmail.com|
20543967|NCT01526577|LG Life Sciences|Dong Yeop Shin|82 2 6924 3114|dongyeopshin@lgls.com|
20543968|NCT02900378|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20543969|NCT01807624|Jean Brown Research Center|Dr. Derek Muse|(801) 261-2000|participate@jeanbrownresearch.com|
20543970|NCT01134055|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543971|NCT03060096|Wake Forest NCORP Research Base|Dr. Emily Dressler|336-716-0891|NCORP@wakehealth.edu|
20543972|NCT01441076|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Grayson, Peter|+1 301 827 9187|peter.grayson@nih.gov|
20543973|NCT00380367|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571093|NCT02335905|Baylor College of Medicine|Sheldon L. Kaplan|832-824-4330|skaplan@bcm.edu|
20571094|NCT01436305|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20571095|NCT03563066|McMaster University|Gail Gauvreau|9055259140|gauvreau@mcmaster.ca|22791
20543974|NCT01605799|San Francisco VA Medical Center|Dr. Shira Maguen|415-221-4810|shira.maguen@va.gov|22511
20543975|NCT01559857|Stanford University|Dr. Natalie Rasgon|6507249694|natalie.rasgon@stanford.edu|
20543976|NCT00734539|Duke Univiersity Medical Center|Daniel K. Benjamin Jr|919-668-7081|danny.benjamin@dm.duke.edu|
20543977|NCT02504151|Yale|Dr. Mohini Ranganathan|(203)932-5711|mohini.ranganathan@yale.edu|2546
20543978|NCT05038982|Johns Hopkins University|Shawn Kwatra|410-502-7546|skwatra1@jhmi.edu|
20543979|NCT00472576|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
20543980|NCT04170608|FARAPULSE|Christopher Schneider|617-686-7661|kschneider@farapulse.com|
20543981|NCT01454102|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20543982|NCT04355143|University of California Los Angeles|Reza Ardehali, MD, PhD|310-825-5280|rardehali@mednet.ucla.edu|
20543983|NCT02148874|The Ohio State University Wexner Medical Center|Lisa Christian, PhD|614-293-0936|lisa.christian@osumc.edu|
20543984|NCT03739203|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20543985|NCT01782378|VA Boston Healthcare System, Jamaica Plain Campus, Boston, MA|Margaret Naeser, PhD|857-364-4030|Margaret.Naeser@va.gov; mnaeser@bu.edu|
20543986|NCT00830440|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
20543987|NCT02592798|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20543988|NCT00705016|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20543989|NCT02233517|VAORD|Elizabeth Van Voorhees|(919) 286-0411|elizabeth.vanvoorhees@va.gov|6435
20543990|NCT00942604|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
20543991|NCT01663103|University of Colorado Anschutz Medical Campus|Dr. Kristen Nowak|303-724-4842|Kristen.Nowak@ucdenver.edu|
20527412|NCT02267135|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|trialandresults.registries@novartis.com|
20543992|NCT01656408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20543993|NCT00363480|GlaxoSmithKline|GSK Response Center|866-435-7343||
20543994|NCT04008745|University of Sao Paulo|Isabel de Camargo Neves Sacco|+551130918426|icnsacco@usp.br|
20543995|NCT05465317|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20543996|NCT00385216|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
20543997|NCT02420821|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20543998|NCT00999102|NY Presbyterian Hospital - Weill Cornell Medical Center|Dr. Samuel Mann, PI|212-746-2200|sjmann@med.cornell.edu|
20543999|NCT01808456|Inova Fairfax Hospital|Dr. Ravinder Wali|7037764001|ravinder.wali@inova.org|
20544000|NCT02708186|Axovant Sciences GMBH|Senior Director of Clinical Research|1-833-296-8268|clinicaltrials@axovant.com|
20544001|NCT00888940|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
20544002|NCT03507569|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20544003|NCT03815929|Principle Investigator|Dr. Ekta Kapoor|507 538-7103|kapoor.ekta@mayo.edu|
20544004|NCT03313037|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544005|NCT02760498|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20544006|NCT02205736|Levine Cancer Institute at Carolinas Healthcare System|Dr. James Symanowski|9804422371|james.symanowski@carolinashealthcare.org|
20544007|NCT02529072|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
20544008|NCT02105662|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20544009|NCT02118441|Department of Anesthesia, St. Paul's Hospital|S. K. W. Schwarz, MD, PhD|604-806-8337|stephan.schwarz@ubc.ca|
20544010|NCT02042274|University of Guelph|Dr. David Mutch, Associate Professor|519-824-4120|dmutch@uoguelph.ca|53322
20544011|NCT00990704|Abbott|Global Medical Services|800-633-9110||
20544012|NCT03403283|University of Alabama at Birmingham|maria grant|13528714314|mariagrant@uabmc.edu|
20544013|NCT03252925|The First Affiliated Hospital of Soochow University|Yue Han|13901551669|hanyue@suda.edu.cn|
20544014|NCT04816552|Johns Hopkins School of Public Health|Dr. Christine Marie George|(202) 657-5798|cmgeorge@jhu.edu|
20527413|NCT00900731|Novartis Pharmaceuticals|Study Director|862 778-8300||
20527414|NCT03806231|Intermountain Healthcare|Molly Adams, Clinical Research Project Coordinator|(801)507-7030|molly.adams@imail.org|
20527415|NCT03646305|York University|Keisha C. Gobin, MA|416-736-2100|kgobin@yorku.ca|33153
20527416|NCT01554176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527417|NCT02678000|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20527418|NCT03053427|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
20527419|NCT03816644|Albert Einstein College of Medicine|Dr. Joe Verghese|7184303808|joe.verghese@einsteinmed.edu|
20527420|NCT02607306|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20527421|NCT00756600|Boston Children's Hospital Anesthesia Foundation|Dr Mary Ellen McCann|6173557737|mary.mccann@childrens.harvard.edu|
20527422|NCT03240406|Albert Einstein College of Medicine|Dr. Yasmin Mossavar-Rahmani|718-430-2136|yasmin.mossavar-rahmani@einsteinmed.edu|
20544015|NCT00194532|University Of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
20544016|NCT01908803|Alcon Research, Ltd.|Sr Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20544017|NCT00098813|Memorial Sloan-Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
20555169|NCT01262651|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
20544018|NCT01002339|Hospital Universitario de Canarias. Universidad de La Laguna. Spain|Dr. Armando Torres Ramírez|+34630989515|atorres@ull.es|
20544019|NCT01907854|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20544020|NCT02215252|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544021|NCT00892099|Massachusetts General Hospital|Dr. Ishir Bhan|617-726-3934|ibhan@mgh.harvard.edu|
20527423|NCT02360475|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527424|NCT00463840|New York University Cancer Institute|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
20527425|NCT01653327|Dartmouth-Hitchcock Medical Center|Dr. Thomas Davis|1-603-650-8626|Thomas.H.Davis@hitchcock.org|
20527426|NCT04284930|Cleveland Clinic|Risal Djohan|216 312-6146|djohanr@ccf.org|
20527427|NCT02301039|Sarcoma Alliance for Research Through Collaboration|Research Manager|734-930-7600|sarc@sarctrials.org|
20527428|NCT03850691|Masonic Cancer Center, University of Minnesota|Evidio Domingo-Musibay, MD|612-625-9604|musib024@umn.edu|
20544022|NCT01657019|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20527429|NCT01160380|Oncotherapeutics|Director of Clinical Operations|310-623-1200|lthulin@oncotherapeutics.com|
20527430|NCT02510820|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20527431|NCT03046056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20527432|NCT03089853|University of Alabama at Birmingham|Surya P Bhatt|205-934-5555|sbhatt@uabmc.edu|
20527433|NCT00642954|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527434|NCT02913105|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20527435|NCT01317004|Novartis Pharmaceuticals|Study Director|862-778-8300||
20527436|NCT05243563|USA Health|Catera Duhon|251-415-1598|cduhon@health.southalabama.edu|
20527437|NCT04114656|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20527438|NCT00703326|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20527439|NCT03364036|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20527440|NCT02661061|Trinity College Dublin|Dr Martha Finnegan|0863638264|mfinneg@tcd.ie|
20527441|NCT01393106|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20527442|NCT03052920|Washington University in St. Luis|Jill B Firszt, PI|314-362-4760|FirsztJ@wustl.edu|
20527443|NCT01980628|Pharmacyclics, LLC|Isaiah Dimery, MD, Senior Medical Director|408-215-3579|idimery@pcyc.com|
20527444|NCT02578940|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
20527445|NCT02217800|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
20527446|NCT01698268|Beaumont Health|Kaveh Aslani, MD|248-898-81905|kaslani@beaumont.org|
20527447|NCT04757805|Nationwide Children's Hospital|Giorgio Veneziano, MD|614-722-4200|Giorgio.Veneziano@nationwidechildrens.org|
20527448|NCT03341936|Dana Farber Cancer Institute|Glenn J. Hanna, MD|6176326799|GJHANNA@partners.org|
20527449|NCT02485418|University of Texas Southwestern|Deryk Walsh, MD|2144566393|deryk.walsh@utsouthwestern.edu|
20527450|NCT00858468|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20527451|NCT02131636|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20527452|NCT02173379|Abbott Vascular|Kelly A. Stockelman, PhD|720-951-8649|Kelly.Stockelman@abbott.com|
20527453|NCT00674479|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD/Professor|713-745-0394|fravandi@mdanderson.org|
20544023|NCT02346721|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20571096|NCT02097303|Carolina Research Professionals, LLC|Dr. Neal D. Shore, MD, FACS, CPI|843-449-1010|nshore@carolinaresearchprofessionals.com|243
20571097|NCT00780455|Bayer Healthcare AG|Medical Affiars Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20571098|NCT05262751|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571099|NCT03690427|University of California, Los Angeles|Mary Rezk-Hanna, PhD|3102068654|mrhanna@mednet.ucla.edu|
20571100|NCT01721954|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
20571101|NCT00727740|Yale University School of Medicine|Priya Jamidar, MD|203-785-6228|priya.jamidar@yale.edu|
20571102|NCT02956837|GlaxoSmithKline|GSK Response Center|866-435-7343|shm60684@gsk.com|
20527454|NCT04997265|Vanderbilt University Medical Center|Whitney Gannon|6109095789|whitney.gannon@vumc.org|
20527455|NCT04767529|Akero Therapeutics, Inc.|Kitty Yale|(650) 487-6488|harmonystudies@akerotx.com|
20527456|NCT01056913|St John of God Hospital Vienna|Bernhard Dauser (MD)|+43121121|bernhard.dauser@gmail.com|5098
20544024|NCT00790842|PrECOG|PrECOG Statistician|978-835-3516|jbmanola@gmail.com|
20544025|NCT02968004|OPKO Health, Inc.|OPKO Health, Inc.|3055754100|contact@opko.com|
20544026|NCT05029362|The University of Texas Health Science Center at Houston|Irene Tami-Maury, DMD, MSc, DrPH|(713) 500-9234|Irene.M.Tami-Maury@uth.tmc.edu|
20544027|NCT02115048|Translational Research In Oncology (TRIO)|Director, Project Management|+33 1 58 10 09 09|TRIO020.contact@trioncology.org|
20544028|NCT03722238|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544029|NCT02606643|Saint Louis University|Gary Furhman|314-977-2090|jathompson@slu.edu|
20544030|NCT00093041|Genmab A/S|VP Clinical Operations Eva Järlid Westerberg|+45 7020 2728|E.Westerberg@genmab.com|
20544031|NCT03216512|Duke University|Dr Scott Kollins|919-681-0014|scott.kollins@duke.edu|
20544032|NCT03408392|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20544033|NCT00561925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20544034|NCT00417417|NHLBI/NIH|Richard O. Cannon III, MD|301-496-9895|cannonr@nih.gov|
20544035|NCT00684021|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
20544036|NCT00891904|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20544037|NCT01046396|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20544038|NCT02177032|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20544039|NCT02161016|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
20544040|NCT02556177|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
20544041|NCT04320316|University of Alabama at Birmingham|M.D|12056389107|hdabdullatif@uabmc.edu|
20544042|NCT03818321|TriHealth|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
20544043|NCT00571493|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
20544044|NCT00847210|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20544045|NCT01187355|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20544046|NCT01188343|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20544047|NCT01143246|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20544048|NCT04634253|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20544049|NCT01499355|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20544050|NCT02048670|Mayo Clinic|Dr. Devin L. McCaslin|507-284-3410|mccaslin.devin@mayo.edu|
20544051|NCT00722072|OHSU Knight Cancer Institute|Dr. Stephen Chui|503-494-8534|chuis@ohsu.edu|
20544052|NCT01457703|University of Colorado Denver|Clinical Research Regulatory Manager|303-724-6501|Chanel.mansfield@ucdenver.edu|
20544053|NCT03987503|University of California, San Francisco|Dr. Meghan D. Morris, Associate Professor|415-574-0651|meghan.morris@ucsf.edu|
20544054|NCT02911844|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
20544055|NCT00454324|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20544056|NCT03000608|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@santalispharmaceuticals.com|101
20544057|NCT03133793|Sponsored Programs Adminstration (SPA)|Dr. Mario Medina, Director of Sponsored Programs Administration|913-588-5724|mmedina3@kumc.edu|
20544058|NCT03486834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20544059|NCT00702299|University of Arizona|Dr. Setsuko Chambers|520/626.0950|schambers@azcc.arizona.edu|
20544060|NCT03714880|University of Pittsburgh|Suji Uhm, MD, MPH|412-641-4590|uhms@upmc.edu|
20544061|NCT03352609|MUSC|Dr Friedrich|843-792-9888|friedric@musc.edu|
20544062|NCT02379091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20544063|NCT02053376|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20544064|NCT03326713|Rutgers Cancer Institute|Anita Y. Kinney, PhD|(732) 865-3375|anita.kinney@rutgers.edu|
20544065|NCT00771758|Ortho-McNeil Janssen Scientific Affair, LLC.|Senior Director of Clinical Development, Pain|(908)927-5465||
20544066|NCT03067077|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
20544067|NCT00935584|VA san Diego Healthcare System|Dr. Zia Agha|8586421295|zia.agha@va.gov|
20544068|NCT01624350|Medtronic|Medtronic (Sponsor)|508.452.4095|michelle.v.disalvo@medtronic.com|
20544069|NCT02546388|University of Pennslyvania|Paco Bravo, MD|1-215-220-9494|Paco.Bravo@pennmedicine.upenn.edu|
20544070|NCT03801408|University of Arkansas for Medical Sciences|Sara Jones, Principal Investigator|501-526-7846|sljones@uams.edu|
20544071|NCT01662765|Bahcesehir University, School of Medicine|Dr. Mehmet Kaplan|+905056268899|dr.kaplan27@gmail.com|
20544072|NCT01394016|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20544073|NCT02530515|UT MD Anderson Cancer Center|Dr. Chitra Hosing / Stem Cell Transplantation|(713) 745-3219|cmhosing@mdanderson.org|
20555170|NCT02692248|MFAR|Responsable person designated by the sponsor|+34934344412|investigacion@mfar.net|
20555171|NCT01512225|Sunnybrook Research Institute|Dr. Elizabeth Asztalos|416-480-6100,|elizabeth.asztalos@sunnybrook.ca|87791
20555172|NCT04969783|Masonic Cancer Center|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
20555173|NCT02489500|Boston Medical Center|Vaishali Sanchorawala, MD|6176388261|sfenness@bu.edu|
20555174|NCT03489304|Perelman School of Medicine|Dr. Matthew Kayser|215 898 8298|kayser@pennmedicine.upenn.edu|
20555175|NCT02239679|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|Anna.Houlihan@sunpharma.com|
20555176|NCT02716974|Johns Hopkins University School of Medicine|Kenneth Pienta|410-502-3137|kpienta1@jh.edu|
20555177|NCT02605954|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20555178|NCT03740490|Stephenson Cancer Center, University of Oklahoma Health Sciences|Michael Businelle|405-271-8001|michael-businelle@ouhsc.edu|50460
20555179|NCT00599326|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
20555180|NCT03434119|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20555181|NCT03421197|Dr Reddy's Laboratories|Srinivas Sidgiddi, Sr Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
20555182|NCT00779246|Christiana Care Health System|Marci Drees, MD, MS|302-733-5602|mdrees@christianacare.org|
20555183|NCT00148343|Case Western Reserve University/MetroHealth Medcial Center|Lynne Sheffler, MD|216-957-3570|lsheffler@metrohealth.org|73556
20555184|NCT03579459|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555185|NCT04153409|Lateral Pharma Pty Ltd|Mr David Kenley|+61400151490|dk@lateral-pharma.com|
20555186|NCT04844281|The Ohio State University College of Optometry|Jennifer Fogt, OD MS|16142928858|OPTEyeStudies@osu.edu|
20555187|NCT02844946|Baylor College of Medicine|Dr. Lilian Dindo|713-440-4637|lilian.dindo@bcm.edu|
20555188|NCT02806986|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20555189|NCT00407537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555190|NCT01380327|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20555191|NCT05046795|Viatris|Dik WH Ng, PhD|+44 (0)1304 626895|dik.ng@viatris.com|
20555192|NCT01127178|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20555193|NCT05348681|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
20555194|NCT01040130|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20555195|NCT00782340|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20555196|NCT01805297|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6060|sonny-icks@dmei.org|
20555197|NCT02952924|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20555198|NCT01226745|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20555199|NCT01435577|Grünenthal GmbH|Director of Clinical Trials|+241 569 3223||
20555200|NCT01458574|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555201|NCT02125786|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|8662785833|referralinfo@stjude.org|
20555202|NCT02279641|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
20555203|NCT04964089|Kodiak Sciences Inc|Pablo Velazquez-Martin|1 (650) 281-0850|ClinOps@kodiak.com|
20555204|NCT01494051|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
20555205|NCT01365494|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20555206|NCT01664078|Cordis US Corp|Jennifer Lee|+1-669-699-6851|jennifer.lee02@cordis.com|
20555207|NCT03351049|University of Pittsburgh|David Brienza|412.624.6383|dbrienza@pitt.edu|
20555208|NCT02877485|Stanford Facial Plastic and Reconstructive Surgery|Sam P. Most MD|650-736-3223|smost@stanford.edu|
20555209|NCT01700816|Massachusetts General Hospital|Carlos Fernandez Robles MD|6176432410|cfernandez-robles@mgh.harvard.edu|
20555210|NCT05039268|Macquarie University|Richard Gan|+61 2 9812 3739|richard.gan@mq.edu.au|
20555211|NCT02838017|NorthShore University HealthSystem|Lena Braginsky|2245952705|lena.braginsky.mfm@gmail.com|
20555212|NCT05350449|University of Nevada Las Vegas|Dr. Nirmala Lekhak|702-895-5983|nirmala.lekhak@unlv.edu|
20555213|NCT03581305|NIH/CC|Dima Hammoud, Senior investigator|3014023041|hammoudd@cc.nih.gov|
20555214|NCT01798927|UT Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
20555215|NCT02250612|Sylentis|Clinical Trials Department||info@sylentis.com|
20555216|NCT03822533|Region Västra Götaland, Närhälsan|Chan-Mei Ho-Henriksson, PhD-student, RPT|+46709892821|chan-mei.ho@vgregion.se|
20544074|NCT00174187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544075|NCT05069948|The University of Edinburgh and NHS Lothian|Aimun Jamjoom|0131 536 1000|v1ajamjo@ed.ac.uk|
20544076|NCT01198977|Rehabilitation Care Services; MS Center of Excellence (MSCOE), VA Puget Sound Health Care System|Aaron Turner, PhD, Director, Rehabilitation Psychology; Asst Director Research, MSCOE|206-277-6134|Aaron.Turner@med.va.gov|
20544077|NCT01285557|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
20544078|NCT04410367|Blue Earth Diagnostics, Ltd.|Chief Medical Officer|+44 (0)1865 784 186|contact@blueearthDx.com|
20544079|NCT01899521|Atlanta VA Medical Center|Dr. Ashish Mehta|404-321-6111|Ashish.Mehta@va.gov|207133
20544080|NCT06482125|Universitas Pelita Harapan|Dr. Corry Quando Yahya|2181383190900|corry.yahya@lecturer.uph.edu|
20544081|NCT05353777|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20544082|NCT04701762|Cleveland Clinic|Kurt Ruetzler|216 407-4108|ruetzlk@ccf.org|
20544083|NCT05786651|Lehigh University|Nancy Carlisle|610-758-5122|nbc415@lehigh.edu|
20544084|NCT01987453|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20544085|NCT01590888|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
20544086|NCT04953728|University of Michigan|Jiande Chen|734-764-3880|cjiande@med.umich.edu|
20544087|NCT02331277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20544088|NCT04375085|Elixir Medical Corp|Candace Elek, EVP Clinical Research|4086362000|celek@elixirmedical.com|
20544089|NCT01399372|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20544090|NCT01376804|Hoffman-LaRoche|Medical Communications|800-821-8590||
20544091|NCT01071798|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20544092|NCT01732718|University of North Carolina at Chapel Hill|Kenneth Ataga, MD|901-448-2813|kataga@uthsc.edu|
20544093|NCT00847509|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
20544094|NCT02653417|Radius Pharmaceuticals, Inc.|Clinical Operations|617-551-4000|clinopsinfo@radiuspharm.com|
20544095|NCT01705509|Cardiovascular Institute of the South|Agostino Ingraldi, MD, FACC|337-988-1585|Agostino.Ingraldi@cardio.com|
20544096|NCT02736890|Icahn School of Medicine at Mount Sinai|Dr. Thomas Bryce|212-241-6321|thomas.bryce@mountsinai.org|
20544097|NCT02904954|Weill Cornell Medicine|Cathy Spinelli, RN BSN|212-746-3328|caf2007@med.cornell.edu|
20544098|NCT05097963|Mayo Clinic|Vinay Chandrasekhara, M.D.|507-284-2687|Chandrasekhara.Vinay@mayo.edu|
20544099|NCT00214890|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
20544100|NCT01554241|University of California, San Francisco|Janice B.Schwartz, M.D., Professor of Medicine|(415) 406-1573|janice.schwartz@ucsf.edu|
20544101|NCT02118961|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk / Clinical Development counter||cti-inq-ml@ml.mt-pharma.co.jp/clinicaldevelopment@mail.biken.or.jp|
20544102|NCT02745119|Hoffmann-La Roche|Medical Communications|616878333|global.trial_information@roche.com|+41
20544103|NCT00432172|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20544104|NCT02536963|Rebiscan|CEO|857-600-0982|jgshaka@rebiscan.com|
20544105|NCT00687193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544106|NCT02129699|European Thoracic Oncology Platform|European Thoracic Oncology Platform|+41 31389 93 91|SPLENDOUR@etop-eu.org|
20544107|NCT02447003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20544108|NCT03534804|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20544109|NCT04161157|University of Kentucky|Dr. Laurie McLouth|859-562-2526|laurie.mclouth@uky.edu|
20544110|NCT03752567|Farmacia La Regina|Dr. Raffaele La Regina|+393389066138|raffaele.laregina@gmail.com|
20544111|NCT03529695|USC Center for Economic and Social Research|Kayla De La Haye, PhD, Research Scientist|323-442-8228|delahaye@usc.edu|
20544112|NCT05174416|Peking Union Medical College Hospital|Prof. Shuyang Zhang|+86 13911667211|shuyangzhang103@163.com|
20544113|NCT02582775|University of Minnesota, Masonic Cancer Center|Dr. Christen Ebens|(612) 626-5654|ebens012@umn.edu|
20544114|NCT01648751|University of PIttsburgh|Pamela Moalli MD PHD|412-641-6052|moalpa@upmc.edu|
20544115|NCT02833233|Memorial Sloan Kettering Cancer Center|Dr. Elizabeth Comen|646-888-4525|comene@mskcc.org|
20544116|NCT05673876|Genentech Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
20571103|NCT01824589|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
20544117|NCT03529422|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
20544118|NCT02000115|Abbott Structural Heart|Daniella Corporan|779-220-7309|daniella.corporan@abbott.com|
20544119|NCT04815824|VA Eastern Colorado Health Care System|Dr. Sarah Wherry|303-704-8054|sarah.wherry@va.gov|
20544120|NCT05006573|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20544121|NCT04377659|Memorial Sloan Kettering Cancer Center|Dr. Boglarka Gyurkocza, MD|646-608-3768|gyurkocb@mskcc.org|
20544122|NCT05030129|Rush University Medical Center|Elizabeth Berry-Kravis, MD PhD|312-942-4036|Elizabeth_Berry-Kravis@rush.edu|
20544123|NCT02484391|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-7970|bpowell@wakehealth.edu|
20544124|NCT02538510|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
20544125|NCT04922216|University of North Carolina at Chapel Hill|Brooke Nezami, PhD|919-966-5852|bnezami@unc.edu|
20544126|NCT04949490|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20544127|NCT03278249|University of Cincinnati Cancer Center|Rekha Chaudhary, MD, Adjunct-Associate Professor of Medicine|513-558-2119|Rekha.chaudhary@uc.edu|
20571104|NCT01727505|University of Miami School of Medicine, Dept. of Pediatrics - Div. of Neonatology|Nelson Claure, MSc, PhD, Director Neonatal Pulmonary Research Lab|305 585 6408|nclaure@miami.edu|
20571105|NCT02627118|UConn Health|Andre Kaplan, MD||kaplan@uchc.edu|
20571106|NCT02637323|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20571107|NCT01825577|Saint Louis University|Dr. Ahsan Khan|314-977-4826|khanay@slu.edu|
20571108|NCT00358644|Eisai Inc.|Eisai Call Center|888-422-4743||
20571109|NCT00513708|SUNY Buffalo|Schieder, Jeffrey|716-645-2977|jss10@buffalo.edu|
20571110|NCT03327831|UC Irvine|Christopher Zachary|949-824-5515|czachary@uci.edu|
20571111|NCT00368875|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
20571112|NCT01564277|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20571113|NCT02595372|IndianaU|Dr. Kathy Miller|(317) 948-3855|kathmill@iu.edu|
20571114|NCT02588872|Rush University Medical Center|Mukesh Ahuja|312-432-2380|cole.research@rushortho.com|
20571115|NCT01594970|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20571116|NCT00401258|McLean Hospital|Brian Brennan, M.D.|617-855-2911|bbrennan@partners.org|
20571117|NCT01427725|Medical affairs|Medical affairs manager|+81-3-5656-0516||
20571118|NCT01299480|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571119|NCT01661764|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
20571120|NCT01430468|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-445-5151|iannotj@ccf.org|
20544128|NCT02017405|Entera Health, Inc.|Audrey L. Shaw, Ph.D.|919 971 8000|audrey.shaw@enterahealth.com|
20544129|NCT00811590|Huntsman Cancer Institute|Dr. Randall Burt|801-585-3281|randall.burt@hci.utah.edu|
20544130|NCT06714682|Ain Shams university|Dr. Mohamed Ibrahim , Lecturer of anesthesia|01115560811|T.majestic@hotmail.com|002
20544131|NCT00905164|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20544132|NCT04730804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20544133|NCT03349034|Icahn School of Medicine at Mount Sinai|Dr. Brett Miles|(212) 241-9410|brett.miles@mountsinai.org|
20544134|NCT01039376|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20527457|NCT03706469|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20544135|NCT00123422|Edward Hines Jr. ,VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
20544136|NCT04555616|University of Kentucky|Elizabeth Rhodus|859-257-5567|elizabeth.rhodus@uky.edu|
20544137|NCT01938716|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|713-792-2828|gvaradha@mdanderson.org|
20544138|NCT05488535|Advanced Bionics|Emily Cardenas, Au.D.|16616785405|Emily.Cardenas@advancedbionics.com|
20544139|NCT04455815|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20544140|NCT03219528|University of Michigan|Allen Lee|734-936-4785|allenlee@med.umich.edu|
20544141|NCT02120898|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20544142|NCT00927953|MacroGenics, Inc.|Medical Officer||info@macrogenics.com|
20544143|NCT00724698|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20544144|NCT04048356|University of New Mexico|Peter Jeppson, site contact for study|505-967-8428|pjeppson@salud.unm.edu|
20544145|NCT05021978|Praxis Precision Medicines|Charmaine Manilay|2243996121|cmanilay@praxismedicines.com|
20544146|NCT00196313|Duramed Research|Duramed Research Protocol Chair|215-293-7279|role_medical_affairs@tevapharm.com|
20544147|NCT02690948|Stanford University|Anne Lynn S. Chang, Associate Professor of Dermatology|650-721-7151|alschang@stanford.edu|
20544148|NCT01411891|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
20544149|NCT04592887|Varian, a Siemens Healthineers Company|Senior Manager, Clinical Trials|437-991-3496|ClinOps@varian.com|
20544150|NCT00414596|NEMA Research, Inc|Jospeph V Pergolizzi, MD|239-597-3564|nemaresearch@aol.com|
20544151|NCT04614974|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
20544152|NCT00658359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544153|NCT02558296|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20544154|NCT02832115|Aultman Hospital|Dr. Prabhakaran Gopalakrishnan|3304548076|prab.gopalakrishnan@aultman.com|
20544155|NCT02919995|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|
20544156|NCT02245217|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
20544157|NCT03967444|Galderma Research & Development, Aesthetics|Director of Clinical Operations|817-961-5655|aestheticclinicaltrials@galderma.com|
20544158|NCT02369796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20544159|NCT01821118|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544160|NCT00318643|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
20555217|NCT02863926|Indiana University School of Medicine|Kristen Wanczyk / Certified Clinical Research Nurse Coordinator|317-7988-9548|keevans@iu.edu|
20555218|NCT02061384|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
20544161|NCT01812252|Fred Hutch Cancer Center|Bart Lee Scott M.D.|(206)909-0977|bscott@fredhutch.org|
20544162|NCT02557139|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
20544163|NCT01378871|Albert Einstein College of Medicine|Dr, Amit Verma||amit.verma@einsteinmed.edu|
20544164|NCT01519921|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20544165|NCT01216189|Karolinska Institutet|Professor Anna Martling|+46851770000|anna.martling@ki.se|
20544166|NCT01146795|Columbia University|Jason Wright, MD|212-305-3410|jw2459@cumc.columbia.edu|
20527458|NCT01636947|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527459|NCT02289105|Fostering Improvement in End-of-Life Decision Science Program|Dr. Scott Halpern|215-5739461|shalpern@exchange.upenn.edu|
20527460|NCT00935064|University of Delaware/Christiana Care Health System|Dr. Raelene E. Maser|302-831-8400|rmaser@udel.edu|
20527461|NCT00445744|FHCRC|H. Joachim Deeg MD|206 667 4409|jdeeg@fhcrc.org|
20527462|NCT03943823|The University of Texas Health Science Center at Houston|Sunbola Ashimi, PhD|713-500-6410|Sunbola.S.Ashimi@uth.tmc.edu|
20527463|NCT01955109|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
20527464|NCT01167634|University of Pennsylvania School of Medicine|Laurie Norton|2155738799|lanorton@mail.med.upenn.edu|215
20527465|NCT00911586|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
20527466|NCT00939471|Acclarent, Inc.|Laura England, Manager-Clinical|650-687-4466|lenglan1@its.jnj.com|
20527467|NCT00310076|Comprehensive Cancer Center of Wake Forest University|Greg Russell, MS|336-716-5449|grussell@wakehealth.edu|
20527468|NCT02555930|Imperial College London|Dr Harriet Kemp|+44 20 3315 8816|h.kemp@imperial.ac.uk|
20527469|NCT01010399|Franco Felizarta, MD|Franco Felizarta, MD|661-324-3128|felizarta@pol.net|
20527470|NCT03003000|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20527471|NCT04933617|National Cancer Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
20527472|NCT00089635|Amgen Inc.|Study Director|866-572-6436||
20527473|NCT01044589|Cleveland Clinic|Dr. Massarat Zutshi|(216) 444-3540|zutshim@ccf.org|
20527474|NCT00419159|Novartis Pharmaceuticals|Study Director|862-778-8300||
20527475|NCT02648477|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20527476|NCT04292639|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
20527477|NCT01605032|Albert Einstein College of Medicine/Montefiore Medical Center|Ira Braunschweig, MD|718-920-4057|IBRAUNSC@montefiore.org|
20527478|NCT02920177|University of Michigan|Jordyn Sessel|734-615-0934|jsessel@med.umich.edu|
20527479|NCT04907227|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527480|NCT03723070|Boston Scientific|Clinical Trial Manager|+32 470 991143|nele.cielen@bsci.com|
20527481|NCT01801241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
20527482|NCT00316862|Memorial Sloan-Kettering Cancer Center|David H. Ilson, M.D., Ph.D.||ilsond@mskcc.org|
20527483|NCT03759366|Alexion Pharmaceuticals Inc.|Alexion Europe SAS European Clinical Trial Information|7 87148158|clinicaltrials.eu@alexion.com|
20527484|NCT00539032|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20527485|NCT00986947|Johns Hopkins University School of Medicine|Andrew Singer, MD|410-550-6484|registerclinicaltrials@jhmi.edu|
20527486|NCT02978885|Columbia University|Gebhard Wagener, MD|212-305-6494|gw72@cumc.columbia.edu|
20527487|NCT01669785|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|260-755-1099||
20527488|NCT00866333|Syndax Pharmaceuticals, Inc.|Michael L. Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
20527489|NCT02669082|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20527490|NCT04918355|University of Colorado|Heather Tolle|303-724-9924|heather.tolle@cuanschutz.edu|
20527491|NCT04683939|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20527492|NCT03041467|Medtronic|Phally Roffe, Clinical Study Manager|763.526.0350|phally.s.roffe@medtronic.com|
20527493|NCT02732015|UT MD Anderson Cancer Center|Saroj Vadhan,MD-Clinical Professor, Cytokine & Supportive Oncology|713-792-7966|svadhanr@mdanderson.org|
20527494|NCT01084148|Orfagen|Clinical Project Manager|0033 5 34 50 64 62|caroline.miklaszewski@orfagen.com|
20527495|NCT04513899|University of California, Irvine, Sue & Bill Gross School of Nursing|Dr Adeline Nyamathi|(949) 824-8932|anyamath@hs.uci.edu|
20527496|NCT01937715|Pfizer Inc.|Pfizer ClincialTrials.gov Call Center|+18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527497|NCT00632632|Weill Cornell Medical College|JoAn Difede, PhD|212 746 3079|jdifede@med.cornell.edu|
20527498|NCT00298363|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20527499|NCT00135356|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20527500|NCT00153816|Geisel School of Medicine at Dartmouth|Leila A. Mott, Statistical Analyst|603-650-3447|Leila.A.Mott@Dartmouth.EDU|
20527501|NCT01533688|UOklahoma|Dr. Mohammad Madhoun|405-456-326-|mohammad-madhoun@ouhsc.edu|
20527502|NCT02263729|University of Pittsburgh|James J. Irrgang|412-383-9865|jirrgang@pitt.edu|
20527503|NCT04591015|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
20527504|NCT02509078|Mass General Hospital (PETAL Clinical Coordinating Center)|Katie Oldmixon|617-726-4777|coldmixon@mgh.harvard.edu|
20544167|NCT05375760|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20544168|NCT03853109|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20544169|NCT01721044|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20555219|NCT02301143|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20527505|NCT02686814|Medtronic|Jessica Halverson, Clinical Research Director|(800) 633-8766|rs.perigonjapantrial@medtronic.com|
20544170|NCT03102437|Impulse Dynamics|Angela Stagg|18453592389|astagg@impulsedynamics.com|
20544171|NCT04032093|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544172|NCT03129568|Okayama University Hospital|Dr. Hidemasa Oh|086-235-6506|hidemasa@okayama-u.ac.jp|6506
20544173|NCT01356277|McGill University Health Centre|Dr. Bethany Foster|514-412-4461|bethany.foster@mcgill.ca|
20544174|NCT02535806|Children's Mercy Hospital|Dr. Keith August|816-302-6808|kjaugust@cmh.edu|
20544175|NCT00960999|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20544176|NCT00515619|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20544177|NCT00658385|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-6684|bouladf@mskcc.org|
20544178|NCT03052829|Medical College of Wisconsin|Amberly Anger|414-955-6708|aanger@mcw.edu|
20544179|NCT03123731|University of California, San Diego|Dr. Brook Henry|619-543-4737|blhenry@ucsd.edu|
20544180|NCT03397966|Vanderbilt University Medical Center|Alp Ikizler, Catherine McLaughlin Hakim Chair in Vascular Biology, Professor of Medicine|615-343-7592|alp.ikizler@vumc.org|
20544181|NCT04721977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544182|NCT02864394|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20544183|NCT02374450|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20544184|NCT03207763|Emory University|Evan Anderson, MD|404-727-1746|evanderson@emory.edu|
20544185|NCT00921895|Rapid Pathogen Screening, Inc.|Robert Sambusky, MD|941-556-1853|sambursky@rpsdetectors.com|
20544186|NCT01177397|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20544187|NCT01189409|BC Cancer|Dr. Philippa Hawley|607-877-6000|PHawley@bccancer.bc.ca|67-2707
20544188|NCT01358721|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20544189|NCT01765972|Johnson & Johnson Vision Care Inc.|Katherine Osborn Lorenz, OD, MS|614 459-9477|KOSBORN@its.jnj.com|
20544190|NCT02446899|AstraZeneca AB|Global Clinical Lead|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20544191|NCT01943903|HeartFlow|VP, Clinical|408-314-2335|smullen@heartflow.com|
20544192|NCT01051518|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
20544193|NCT04287036|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
20544194|NCT01106690|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20544195|NCT00998296|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20544196|NCT04396639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544197|NCT01544335|Massachusetts General Hospital|Associate Director, Lymphedema Research Program|6177240127|cbrunelle@mgh.harvard.edu|
20544198|NCT04211909|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20544199|NCT02106390|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544200|NCT00124514|cincinnatichildrens|Hermine Brunner|5136367982|hermine.brunner@cchmc.org|
20544201|NCT03977818|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
20544202|NCT03809104|Ci-Shan Hospital, Health and Welfare of Minister, Taiwan|Ms. Chia-Yu Wei|+886-7-6615523|ivywei@chis.mohw.gov.tw|1729
20555220|NCT03214367|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20555221|NCT03555396|Columbia University|Dr. Alissa Davis|212-851-2224|ad3324@columbia.edu|
20555222|NCT00511862|BTG International Canada Inc.|Director of Clinical Operations|613-801-1880|TheraSphereClinical@btgplc.com|
20555223|NCT04726709|University of Idaho|Dr. Rajal Cohen|2088856324|rcohen@uidaho.edu|
20555224|NCT00085410|Fox Chase Cancer Center|Assistant Professor, Medical Oncology|215-214-1676|crystal.denlinger@fccc.edu|
20555225|NCT01286779|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20555226|NCT04827212|Northeastern University|Dr. Dinesh John|(801) 230-6320|d.john@northeastern.edu|
20555227|NCT04360824|University of Iowa Hospitals & Clinics|Dr. Usha Perepu|1-319-356-2195|usha-perepu@uiowa.edu|
20555228|NCT00304070|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20555229|NCT00320216|Centocor Research & Development, Inc.|Senior Director Clinical Research|1-800-457-6399||
20555230|NCT00377676|VeroScience|Richard Scranton|401 816-0525|richard_scranton@veroscience.com|
20555231|NCT00353275|UT Health Science Center at Houston|Dr. Lillian S. Kao|713-566-5095|Lillian.S.Kao@uth.tmc.edu|
20555232|NCT01617421|Clinical Center|Middleton, Kimberly|+1 301 496 9083|middletonk@mail.nih.gov|
20555233|NCT01754714|Abbott|Associate Director Clinical Services|+31 29-44-79-196|taco.baardman@abbott.com|
20555234|NCT02528214|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20555235|NCT02384759|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20555236|NCT01605617|Mayo Clinic|Dr. Jeffrey L. Cornella|480-342-2867|cornella.jeffrey@mayo.edu|
20555237|NCT00347308|The New York Eye & Ear Infirmary|Anthony P. Sclafani, MD|212-979-4200|asclafani@nyee.edu|
20555238|NCT02014116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20555239|NCT00121238|University of Michigan Comprehensive Cancer Center|Maha Hussain, M.D.|(734)936-8906|mahahuss@med.umich.edu|
20555240|NCT01540851|Brigham and Women's Hospital|Elena Losina, PhD|617-732-6928|elosina@partners.org|
20555241|NCT00325468|Amgen Inc.|Study Director|866-572-6436||
20544203|NCT01532986|VA Greater Los Angeles Healthcare System|Eric M Cheng|3102067671|echeng@mednet.ucla.edu|
20544204|NCT04313244|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20544205|NCT02976038|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20544206|NCT04069702|Duke University|Sarah Kelleher, PhD|9194163405|sarah.kelleher@duke.edu|
20544207|NCT03096288|University of Florida College of Medicine - Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
20544208|NCT02551887|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
20544209|NCT02004093|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20544210|NCT04085289|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20544211|NCT01995838|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20544212|NCT03588884|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20544213|NCT00275509|New York University Langone Transplant Institute|Robert Montgomery, MD|646-501-2418|Robert.Montgomery@nyumc.org|
20544214|NCT01967576|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
20544215|NCT03449667|University of California San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
20544216|NCT02819804|Northwestern University|Shira Dinner, MD|312-695-6180|shira.dinner@nm.org|
20544217|NCT03196349|Duke University|Dr. Thomas Ortel|919-684-5350 ext 3|thomas.ortel@duke.edu|
20544218|NCT01963078|MUSC|Dr. Megan Moran-Santa Maria|843-817-6233|moranm@musc.edu|
20544219|NCT03388164|Laureate Institute for Brain Research|Teresa Victor|918-502-5108|tvictor@laureateinstitute.org|
20544220|NCT02210039|Massachusetts General Hospital|Guillermo Tearney, PI|617-724-2979|gtearney@partners.org|
20544221|NCT00345358|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544222|NCT01385293|Duke University|Andrew J. Armstrong, MD ScM FACP|919 668 4667|andrew.armstrong@duke.edu|
20544223|NCT02892448|The Ottawa Hospital Research Institute|Dr. Paul E Beaule|613-737-8899|pbeaule@toh.ca|73265
20544224|NCT00499083|University of Nebraska Medical Center|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
20544225|NCT01254422|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
20544226|NCT00643162|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
20544227|NCT03066947|BriaCell Therapeutics Corporation|Dr. William Williams|1-888-485-6340|williams@briacell.com|
20544228|NCT04587661|University of Pittsburgh|Dr. Charles Jonassaint|+14125869850|cjonassaint@pitt.edu|
20544229|NCT01942694|Division of Endocrinology, Diabetes, and Metabolism, Tufts Medical Center|Dr. Anastassios Pittas|617-636-3232|apittas@tuftsmedicalcenter.org|
20544230|NCT00949702|Hoffmann-La Roche|Medical Communications|800-821-8590||
20544231|NCT01654302|Northwestern University|Julia Marks, CRC|312-503-1215|julia.marks@northwestern.edu|
20544232|NCT01569607|Emory University|Dr. Cathrin Buetefisch|404-712-5507|cathrin.buetefisch@emory.edu|
20544233|NCT04539795|University of Alabama at Birmingham (UAB)|Dr. Wells (Study PI)|205-934-5555|LungHealth@uabmc.edu|
20544234|NCT04139018|Washington University School of Medicine Department of Otolaryngology - Head and Neck Surgery|Jay Piccirillo, M.D., Vice Chair for Research|314-362-8641|piccirij@wustl.edu|
20544235|NCT02565108|GW Research Ltd.|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20544236|NCT03614156|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20544237|NCT01310075|UT MD Anderson Cancer Center|Dr. Mark W Clemens, Associate Professor, Plastic Surgery|713-794-1247|mwclemens@mdanderson.org|
20544238|NCT00646048|Boston Scientific|Colleen Holthe, Clinical Project Manager|651-581-4632|Colleen.Holthe@bsci.com|
20544239|NCT01587924|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544240|NCT01696188|Sidney Kimmel Medical College at Thomas Jefferson University|Dr. Eric Schwenk|215-955-6161|Eric.Schwenk@jefferson.edu|
20544241|NCT02668393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20544242|NCT02141204|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20544243|NCT02139007|UAB|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
20544244|NCT01607255|VA Northern California Healthcare Systems - Mather|Joseph W. Leung, MD, Chief of Gastroenterology|916-366-5339|Joseph.Leung2@va.gov|
20544245|NCT03848728|University of California, San Francisco|Douglas Black|4158063016|douglas.black@ucsf.edu|
20544246|NCT05720312|Stanford University|Gregory Sahlem, MD|(650) 434-7844|gsahlem@stanford.edu|
20544247|NCT00536744|SANUWAVE, Inc.|Dr. Daniel Jorgensen, MD|678-578-0116|daniel.jorgensen@sanuwave.com|
20544248|NCT02581410|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544249|NCT00670748|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
20544250|NCT02876601|Medical University of Vienna|Univ.Prof. Dr. Bernd Jilma|+4314040029810|bernd.jilma@meduniwien.ac.at|
20544251|NCT03863080|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
20544252|NCT04194437|TransMedics, Inc.|VP Cliinical Affairs|978-552-0900|ldamme@transmedics.com|
20544253|NCT02991768|University of Kansas Medical Center|Clinical Research Coordinator|913-588-3520|edelaney2@kumc.edu|
20571121|NCT01281839|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20571122|NCT01305239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571123|NCT04176731|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20527506|NCT01888653|Columbia University Medical Center/New York State Psychiatric Institute|Yuval Neria|6467748092|yuval.neria@nyspi.columbia.edu|
20544254|NCT03467750|Emory University|Dr. Laura Gilbertson|404-785-6670|laura.gilbertson@emory.edu|
20544255|NCT02248246|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20544256|NCT00742235|Massachusetts General Hospital|Principal Investigator|617-726-3934|ibhan@partners.org|
20544257|NCT00433004|University of Pennsylvania|Arden McAllister|215-662-3532|arden.mcallister@uphs.upenn.edu|267
20544258|NCT05661409|Emory University|Dr. Matthew K. Whalin|404-616-5014|mwhalin@emory.edu|
20544259|NCT04730271|DePuy Synthes|Ian Leslie|N/A|ileslie1@its.jnj.com|
20571124|NCT03518567|Brown University|Elizabeth Aston, PhD|401-863-6668|elizabeth_aston@brown.edu|
20571125|NCT01754753|The University of Sheffield|Daniel Hind - Assistant Director Sheffield Clinical Trials Research Unit|441142220707|d.hind@sheffield.ac.uk|
20571126|NCT00344032|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571127|NCT01754987|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
20571128|NCT03746509|University of Minnesota|Juergen Konczak|612-624-4370|jkonczak@umn.edu|
20571129|NCT05131477|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|contact-us@saonofi.com|6
20571130|NCT02194829|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20571131|NCT06915285|VisionQuest Biomedical Inc|Vinayak Joshi|3054845674|vjoshi@visionquest-bio.com|
20571132|NCT06840769|Helsinn Healthcare SA|Tulla Spinelli|+41.91.985.21.21|Tulla.Spinelli@helsinn.com|
20571133|NCT02726945|GID Bio|Director of Clinical Operations|3039524901|s.samudre@gidbio.com|105
20571134|NCT03085836|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20571135|NCT03374488|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20571136|NCT02493062|St. Louis Fetal Care Institute|Dr. Laura Vricella|3146784488|fetalcare@ssmhealth.com|
20571137|NCT03054337|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
20571138|NCT01327612|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20571139|NCT02838979|University of Washington|Ernest Ayers|206-685-1423|ayerse@uw.edu|
20571140|NCT01762904|Universidad de Guanajuato|Alejandro E. Macías|+52 477 7 14 58 59|aaeemmhh@yahoo.com|4644
20571141|NCT01028677|UNC_ChapelHill|Dr. Cort Pedersen|919 966-4447|cort_pedersen@med.unc.edu|
20571142|NCT00775411|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20571143|NCT00387244|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20571144|NCT01016262|Forest Laboratories|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20571145|NCT03470740|Chang Gung University of Science and Technology|Su-Hui Chen|886-3-2118999|sophee@mail.cgust.edu.tw|3216
20571146|NCT01730378|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571147|NCT02451176|Cleveland Clinic Foundation|Dr. Michael Rosen|12164453441|rosenm@ccf.org|
20527507|NCT02368886|Mayo Clinic Arizona|Tanios Bekaii-Saab, M.D.|507/266-0800|Bekaii-Saab.Tanios@mayo.edu|
20527508|NCT00631163|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20527509|NCT00253370|ECOG Statistical Office|Study Statistician|617-632-3012||
20527510|NCT02553798|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
20527511|NCT00983541|Huntsman Cancer Institute|Christopher Anker, MD|801-213-4241|candace.larson@hci.utah.edu|
20527512|NCT01937884|University of Arizona|Dr. Katri Typpo|5206265485|ktyppo@email.arizona.edu|
20527513|NCT00004088|City of Hope|Brenda Williams, Senior Director, Clinical Trials Office|626-218-2702|bwilliams@coh.org|
20527514|NCT00894244|Northwestern University|Dr. Murad Alam|(312) 695-6785|m-alam@northwestern.edu|
20527515|NCT02826577|University of Chicago|Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
20527516|NCT01853696|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
20527517|NCT01656187|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
20555242|NCT03593655|Stellenbosch University, Centre for Medical Ethics and Law|Gonasagrie Nair|27-21-938-7050|gnair@sun.ac.za|
20555243|NCT03732209|Fralin Biomedical Research Institute at VTC|Jeffrey Stein|540-526-2124|jstein1@vtc.vt.edu|
20555244|NCT05857163|TenNor Therapeutics (Suzhou) Limited.|Guozhu Geng|0512-86861990|guozhu.geng@tennorx.com|
20555245|NCT00413413|Novartis Pharmaceuticals|Study Director|862 778-8300||
20555246|NCT01470027|Weill Cornell Medicine|Dr. Dikoma C. Shungu, Professor of Physics in Radiology|2127462481|dcs7001@med.cornell.edu|
20555247|NCT04174521|Vanderbilt University Medical Center|Bryan Shepherd|615-343-3496|bryan.shepherd@vumc.org|
20555248|NCT01972061|University of Pittsburgh|Dr. Christopher Chermansky|412-6418385|chermanskycj2@upmc.edu|
20571148|NCT00659880|RTI Surgical|Robin Waite, RN|386-418-8888|rwaite@rtix.com|
20571149|NCT01853475|Medicines for Malaria Ventire (MMV)|Dr Thomas Rueckle|+41 22 799 4567|ruecklet@mmv.org|
20544260|NCT02350296|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20544261|NCT02223858|Veterans Affairs Pittsburgh Healthcare System|Dr. Leslie R.M. Hausmann|412-360-2112|leslie.hausmann@va.gov|
20544262|NCT03198507|Redhill Biopharma Inc.|June Almenoff, Chief Scientific Officer|(984) 444 7010|jalmenoff@redhillus.com|
20544263|NCT00241839|University of Florida|Mark S. Segal, MD, PhD; Assistant Professor and Chief, Division of Nephrology|352-273-8821|Mark.Segal@medicine.ufl.edu|
20544264|NCT04954833|Johnson & Johnson Vision Care, Inc. (JJVC)|Xu Cheng|1-800-843-2020|xcheng6@its.jnj.com|
20544265|NCT05050227|VA Greater Los Angeles Healthcare System, UCLA David Geffen School of Medicine|Lucinda B. Leung, MD, PhD, MPH|310-478-3711|lleung@mednet.ucla.edu|
20544266|NCT04288661|1st Propaedeutic Surgery Department,Hippocration Hospital,University of Athens, Greece|Dr Maria Malvina Eleftheriou|+30 6945176503|malvina_el@hotmail.com|
20544267|NCT00831181|Beth Israel Medical Center|Dr Peter Kozuch|212 844-8282|pkozuch@chpnet.org|
20544268|NCT00043979|National Cancer Institute, National Institutes of Health|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
20544269|NCT04639258|Medtronic Structural Heart & Aortic|Robert Waltonen|763-526-0424|robert.waltonen@medtronic.com|
20544270|NCT01924949|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20544271|NCT01635153|Dartmouth-Hitchcock|Dr C Fordham von Reyn|6036507167|fvr@dartmouth.edu|
20544272|NCT00831480|Baylor College of Medicine|Dr. Gilad E. Amiel|713-798-4079|lhiggins@bcm.edu|
20544273|NCT02560558|Emory University|Dr. Idelberto Badell|404-712-6562|ibadell@emory.edu|
20544274|NCT00533117|NYSPI|Barbara Stanley|6467747582|bhs2@columbia.edu|
20544275|NCT01189032|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20544276|NCT01470326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544277|NCT01166282|AbbVie|Global Medical Information|800-633-9110||
20544278|NCT02577718|MD Anderson Cancer Center|Dr. A M Chaftari|7137923491|achaftar@mdanderson.org|
20544279|NCT00346697|Johns Hopkins University|Dr Todd Brown, Associate Professor of Medicine and Epidemiology|410-502-2327|tbrown27@jhmi.edu|
20544280|NCT00686686|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20544281|NCT01012440|University of Chicago|Dr. Kirti Kulkarni|(773) 702-2781|kkulkarni@radiology.bsd.uchicago.edu|
20544282|NCT01278212|Medical University of South Carolin|Harriet Eldredge-Hindy|8437926382|eldredge@musc.edu|
20544283|NCT00131248|UT Houston Medical School|Kathleen A. Kennedy, MD, MPH|713 500-6708|kathleen.a.kennedy@uth.tmc.edu|
20544284|NCT00272311|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
20544285|NCT01052701|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410) 614-8762|ejfuchs@jhmi.edu|
20544286|NCT00477386|IndianaU|Daniela Matai, MD|317-944-0920|dmatai@iupui.edu|
20544287|NCT02691507|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
20544288|NCT03023397|University of North Carolina at Chapel Hill|Allison Burbank, MD|919-962-5136|allison_burbank@med.unc.edu|
20544289|NCT02387502|Govt. Medical College, Haldwani.|Dr. Geeta Bhandari|8958267145|bhandari_geetantl@rediff.com|
20544290|NCT02284243|Recro Pharma|Randall Mack|484-395-2470|rmack@recropharma.com|2406
20544291|NCT01227993|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
20544292|NCT00541385|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
20544293|NCT01733680|SUNy Upstate Medical University|Gail P DePalma|3154643260|depalmag@upstate.edu|
20544294|NCT01932437|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
20544295|NCT05126953|Bausch + Lomb Incorporated|Schafer, Jill|0000000|Jill.Schafer@bausch.com|
20544296|NCT06404021|University of Calabria|Antonio Curcio|+390984681889|antonio.curcio.cardio@unical.it|
20544297|NCT04269889|National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|David J. Young, MD, PhD|301.827.7823|david.young2@nih.gov|
20544298|NCT01526733|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|858-794-8889||
20544299|NCT04987333|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20544300|NCT01167504|Institute of Food Research|Professor Peter Wilde|+441603255258|peter.wilde@ifr.ac.uk|
20544301|NCT02699749|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20544302|NCT02377817|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
20544303|NCT02839200|Idorsia Pharmaceuticals|Clinical Trial Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
20544304|NCT02952820|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20544305|NCT02364570|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
20544306|NCT00298558|New England Research Institutes|Sharon L. Tennstedt, PhD|617-972-3362|stennstedt@neriscience.com|
20544307|NCT01108185|Abbott|Global Medical Services|1-800-633-9110||
20544308|NCT01393392|Rutgers Robert Wood Johnson Medical School|Dr. Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
20544309|NCT02908672|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20544310|NCT01424072|University of São Paulo|Leonice Fumiko Sato Kurebayashi|5511 991126023|fumie_ibez@yahoo.com.br|
20544311|NCT01185080|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20544312|NCT00759941|Alcon Research, Ltd.|Head, Global Medical Affairs|800-862-5266|medinfo@alconlabs.com|
20544313|NCT01322945|Barrow Neurological Institute|Andrew S. Little, MD|602-406-3181|heidi.jahnke@dignityhealth.org|
20544314|NCT01781728|Johns Hopkins University, Department of Radiation Oncology|Dr. Amol Narang|410-913-3559|anarang2@jhmi.edu|
20555249|NCT01866410|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20555250|NCT00553267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20544315|NCT05615922|NYU Langone Health|Leigh Charvet, PhD|929-455-5141|Leigh.Charvet@nyulangone.org|
20544316|NCT06083506|WestVirginiaU|Arif Salman Abdul Shakore|304-293-5831|arifsalman.abdulshakore@hsc.wvu.edu|
20544317|NCT04858035|Montclair State University|Elaine R. Hitchcock|9732293797|hitchcocke@montclair.edu|
20544318|NCT05307692|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20544319|NCT04500158|Virginia Commonwealth University|Dr. Caroline Carrico|(804) 828-8328|ckcarrico@vcu.edu|
20544320|NCT01967238|Stanford University|Taia Wang|5103873941|taiawang@stanford.edu|
20544321|NCT04364867|Orthopedic Institute, Norton Healthcare|Ryan Krupp MD|502-394-6341|Ryan.Krupp@nortonhealthcare.org|
20544322|NCT04774094|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20544323|NCT02433366|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20544324|NCT05232682|Brown University|Mollie Monnig, PhD|4018633491|mollie_monnig@brown.edu|
20544325|NCT04098237|Cedars-Sinai Medical Center|Dr. Andrew Hendifar, MD|310-423-2217|andrew.hendifar@cshs.org|
20544326|NCT05358353|Reflow Medical|Carolyn Mascho|949-481-0399|cmascho@reflowmedical.com|
20544327|NCT02064582|UT Southwestern Medical Center|Kevin Courtney, MD|214-648-4180|Kevin.Courtney@utsouthwestern.edu|
20544328|NCT01136980|EndoGastric Solutions|Adrain Lobontiu|+16504749259|alobontiu@endogastricsolutions.com|
20544329|NCT02605122|Cempra Pharmeuticals, a wholly owned subsidary of Melinta Therapeutics, Inc.|Melissa Allaband|9199140822|mallaband@melinta.com|
20544330|NCT03751657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1)866-867-7178|clinicaltrials@novonordisk.com|
20544331|NCT00842751|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
20544332|NCT02139592|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20544333|NCT01014351|SCRI Development Innovations LLC|John D. Hainsworth, M.D.|615-329-7274|asksarah@scresearch.net|
20544334|NCT02223702|Kocaeli University|Chair and Associate Professor of Periodontology|+902623442222|esragd@yahoo.com|5102
20544335|NCT01219881|The Ohio State University|Dr. Joseph Werner|614-293-8487|Joseph.Werner@osumc.edu|
20544336|NCT02754440|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
20544337|NCT01059435|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20544338|NCT00297258|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544339|NCT01263197|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20544340|NCT00473382|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20544341|NCT03155841|University of Pennsylvania|Jose Bauermeister|215-898-9993|bjose@upenn.edu|
20544342|NCT02481219|Given Imaging (a Medtronic company)|Liron Bar Yaakov|+97249097946|liron.bar-yaakov@covidien.com|
20544343|NCT03070964|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
20544344|NCT01094119|Cleveland Clinc|Daniel Sessler|216-444-4900|DS@OR.org|
20544345|NCT00834093|Dana-Farber Cancer Institute|Dr. Glenn Hanna|617.632.6799|GJHANNA@PARTNERS.ORG|
20544346|NCT01626872|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20544347|NCT01578486|UMass Medical School|Xiaoduo Fan, MD, MPH|508-856-3881|xiaoduo.fan@umassmed.edu|
20544348|NCT02425943|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20544349|NCT05503823|University of Manitoba|Dr. Zahra Moussavi|204 474-7023|zahra.moussavi@umanitoba.ca|
20544350|NCT01106248|Eisai|Dr. Peter Tarassoff|888-422-4743||
20544351|NCT00357903|Amgen Inc.|Study Director|866-572-6436||
20544352|NCT00606593|Actelion Pharmaceuticals Ltd|Pascal Charef/Clinical Trial Leader|+41 61 565 65 65||
20544353|NCT03181529|Johns Hopkins University|Dr. Roland Griffiths|410-550-0034|rgriff@jhmi.edu|
20544354|NCT01600170|University of Pennsylvania School of Medicine|Ronald G Collman|215-898-0913|collmanr@pennmedicine.upenn.edu|
20544355|NCT01209325|University of California, San Francisco|Dr. Joel M. Palefsky|415-476-1574|jpalefsky@medicine.ucsf.edu|
20544356|NCT00607373|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20544357|NCT02773576|Braeburn Inc|Christine Kampf|6104678728|ckampf@braeburnrx.com|
20544358|NCT01160822|Novartis Pharmaceuticals|Study Director|862-778-8300||
20544359|NCT04772560|University of Houston|Kathryn Richdale OD, PhD|713-743-1974|richdale@uh.edu|
20544360|NCT00314795|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20544361|NCT03962062|Medicines Development for Global Health|Sally Kinrade, Vice President, Project Leader, Onchocerciasis & Lymphatic Filariasis|+61 3 9912 2400|sally.kinrade@medicinesdevelopment.com|
20544362|NCT02170077|BIAL - Portela & Cª, SA|Head of Clinical Research|+351 22 9866100|clinical.trials@bial.com|
20544363|NCT02015910|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
20544364|NCT04546672|Oregon Health & Science University|Dr. Brandon Togioka|503-494-4572|togioka@ohsu.edu|
20544365|NCT01780974|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
20544366|NCT01724346|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20544367|NCT03710577|Univerisity of Wisconsin-Madison|Dr. Kelli Koltyn|608-262-4234|koltyn@education.wisc.edu|
20544368|NCT00525161|University of Kentucky|Dr. Suleiman Massarweh|8593238043|massarweh@uky.edu|
20544369|NCT01076361|Medtronic|4968 Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
20544370|NCT01397968|SK Life Science|Chief Medical Officer|201-421-3830|mkamin@sklsi.com|
20544371|NCT02970162|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
20544372|NCT00750438|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
20544373|NCT00787644|University of Vermont|Dr. Anne Dixon|802 656 3525|anne.dixon@uvm.edu|
20544374|NCT02264249|Cleveland Clinic Florida|Dr. Alison Schneider|954-659-5646|schneia2@ccf.org|
20544375|NCT01642589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20555251|NCT04389840|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20555252|NCT02078284|Pugent Sound Blood Center|Sherrill Slichter|206-292-6541|sjslichter@psbc.org|
20555253|NCT00096135|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20555254|NCT02365467|Medtronic|Alexa Glandon, Medtronic Clinical Study Manager|12624087021|alexa.a.glandon@medtronic.com|
20555255|NCT00709722|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
20555256|NCT02043782|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
20555257|NCT04667117|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20555258|NCT01306162|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20555259|NCT01947946|AZ-PPD|Steven Fox|441480716682|steven.fox@ppdi.com|
20555260|NCT02830594|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20555261|NCT02232893|Tsumura USA Inc|Yu Tanaka|609-799-2083|Yu Tanaka <tanaka_yuu@mail.tsumura.co.jp>|
20555262|NCT01298128|Mount Sinai Hospital|Dr. Kimberly Liu|416-586-5367|kliu@mtsinai.on.ca|
20555263|NCT01090453|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555264|NCT02666950|Mayo Clinic|Lisa Sproat, M.D.|480/301-8000|Sproat.Lisa@mayo.edu|
20555265|NCT03867734|University of Washington|Lindley A. Barbee, MD, MPH|206-744-2595|lbarbee@uw.edu|
20555266|NCT00884585|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20555267|NCT03970109|National Institutes of Health|Dr. Daniel Falk|301-443-0788|falkde@mail.nih.gov|
20555268|NCT03832192|care.coach|Principal Investigator|8554374569|pi@care.coach|2
20555269|NCT02663128|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
20555270|NCT01253343|Cincinnati Children's Hospital Medical Center|Dr. Drew Barzman|513-636-4788|drew.barzman@cchmc.org|
20555271|NCT01663636|Center for Global Health, University of Colorado|Dr. Edwin J. Asturias|3037246282|edwin.asturias@ucdenver.edu|
20555272|NCT03832946|Galecto Biotech aps|Hans Schambye - Chief Executive Officer|+4526373726|info@galecto.com|
20555273|NCT02060890|University of California, San Francisco|Nicholas Butowski MD Professor of Neuro-Oncology|414-353-2966|Thelma.Munoz@ucsf.edu|
20555274|NCT01692197|UT MD Anderson Cancer Center|Borthakur,Gautam MD|713-563-1586|CR_Study_Registration@mdanderson.org|
20555275|NCT02120924|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
20555276|NCT02756624|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20555277|NCT03588572|Guangzhou General Hospital of Guangzhou Military Command|Dr.Yan Liu|0086-02088654756|yanliu@139.com|0086
20555278|NCT02267382|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@mycovia.com|
20555279|NCT02730819|Mayo Clinic|Dr. Jason Sluzevich|904-953-9453|Sluzevich.Jason@mayo.edu|
20555280|NCT02121847|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20555281|NCT02663817|University of Miami|Dr. Ivaylo Mihaylov|305-243-8223|i.mihaylov@med.miami.edu|
20555282|NCT02142049|Pharmacyclics, LLC|Director of Clinical Operations|408-774-0330|Clinical_Directors@pcyc.com|
20555283|NCT02099006|University of Rochester|Adrienne Bonham MD|(585) 273-3314|adrienne_bonham@urmc.rochester.edu|
20555284|NCT01410448|Novartis Pharmaceuticals|Study Director|862-778-8300||
20555285|NCT01308580|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20555286|NCT02535065|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
20555287|NCT03712917|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
20555288|NCT01781572|Pfizer|Study Director|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555289|NCT01438541|Molnlycke Health Care AB|Tina Kjellén|+46317223098|tina.kjellen@molnlycke.com|
20555290|NCT02091167|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios, Coordinator of Clinical Trials|+55 27 3335-7337|emnpalacios@gmail.com|
20555291|NCT00791765|Amgen Inc.|Study Director|866-572-6436||
20555292|NCT04575896|Johns Hopkins University|Niraj Desai, MD|410-614-8297|ndesai13@jhmi.edu|
20555293|NCT00924287|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
20555294|NCT02498483|Columbia University|Jennifer Woo Baidal|212-342-2962|jw3286@cumc.columbia.edu|
20555295|NCT04704375|LECOM|Dr. Santiago Lorenzo|941-782-5974|slorenzo@lecom.edu|
20555296|NCT01625897|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20555297|NCT00156065|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20555298|NCT01432366|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555299|NCT02891187|UNewMexico|Dr. Jennifer Thompson|16366790301|jthompson626@gmail.com|
20555300|NCT04546581|University of Minnesota|James Neaton|612-626-9040|neato001@umn.edu|
20555301|NCT02526693|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
20555302|NCT01275625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555303|NCT03009045|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Loren G. Miller|310-222-5623|lgmiller@ucla.edu|
20555304|NCT01585103|Mayo Clinic|Dr. Jeffrey Alexander|507-284-1825|Alexander.Jeffrey14@mayo.edu|
20555305|NCT01349569|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
20555306|NCT03165526|Abbott Medical Device|Courtney Weiler|224 430 4918|ClinicalTrials.gov_SH_Inquiries@abbott.com|
20555307|NCT04389762|Professor Lu Neurological Clinic|Professor Lu|+886-3-396-0388|lucs.clinic@gmail.com|
20555308|NCT00328510|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-7679|Maria.Werner-Wasik@jeffersonhospital.org|
20555309|NCT01412944|Novartis|Study Director|862-778-8300||
20555310|NCT01990950|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
20555311|NCT05356221|Oticon Medical|Dr. Nicole Amichetti|+1 609-366-0424|nitc@oticonmedical.com|
20555312|NCT03508843|University of Alabama at Birmingham|Dr David Schwebel|1-205-934-8745|schwebel@uab.edu|
20555313|NCT02536508|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
20555314|NCT01889420|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
20555315|NCT03073603|University of Colorado School of Medicine|John R. Corboy, MD|13037242187|john.corboy@cuanschutz.edu|
20555316|NCT02312739|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|HSC-familyplanningresearch@salud.unm.edu|
20555317|NCT00823719|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555318|NCT02357836|UT Southwestern Medical Center|Dr. David Gerber|214-648-4180|David.Gerber@UTSouthwestern.edu|
20555319|NCT04757649|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
20555320|NCT03750487|Partnership to End Addiction|Sarah Dauber, Vice President|212-841-5270|sdauber@toendaddiction.org|
20555321|NCT00344682|UMass Medical School|Dr. Kristina Deligiannidis|508-856-5928|kristina.deligiannidis@umassmemorial.org|
20555322|NCT00924885|Vitrolife|Director of clinical investigations|0046708228063|thardarson@vitrolife.com|
20555323|NCT02862106|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
20555324|NCT02508480|Boston University|Dr. Zlatka Russinova|617-353-3549|zlatka@bu.edu|
20555325|NCT02995967|UAB|Joseph Malek|2059965466|jmalek@uabmc.edu|
20555326|NCT04969250|University of Minnesota|Melissa Skeans, Statistician/Protocol Manager|612-626-9011|tico@insight-trials.org|
20555327|NCT03305016|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
20555328|NCT00563784|UT MD Anderson Cancer Center|Dr. Steven H. Lin/Radiation Oncology|713-563-8490|shlin@mdanderson.org|
20555329|NCT02119416|SUNYBuffalo|Jennifer Temple|716-829-5593|jltemple@buffalo.edu|
20555330|NCT02278328|Children's Hospital of Philadelphia|Timothy Roberts, Professor|267 426 0307|robertstim@email.chop.edu|
20555331|NCT03834779|UT Southwestern Medical Center|Dr. Ank Nijhawan|214-648-2777|ank.nijhawan@utsouthwestern.edu|
20555332|NCT04118348|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20555333|NCT03043664|Duke University Medical Center|Michael Morse, MD|919-668-1861|michael.morse@duke.edu|
20555334|NCT00093145|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20555335|NCT01310036|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20555336|NCT03359096|University of Pennsylvania|Raj C. Dedhia, MD, MSCR|215-349-5009|Raj.Dedhia@pennmedicine.upenn.edu|
20555337|NCT00833989|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555338|NCT02310750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20555339|NCT03085563|Children's Hospital Colorado|Paul Szefler, MD, FAAP|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20555340|NCT03447782|Boston Children's Hospital|Dr. Alyssa Lebel|7812161960|alyssa.lebel@childrens.harvard.edu|
20555341|NCT01934218|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|yuko.shibata@seikagaku.co.jp|
20555342|NCT03538626|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20555343|NCT01156701|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555344|NCT04575428|Duke University|Marat Fudim, MD, MHS|919-684-1284|marat.fudim@duke.edu|
20555345|NCT01308918|Institut universitaire de cardiologie et de pneumologie de Quebec|Nathalie Gagne|418 656-8711|nathalie.gagne@criucpq.ulaval.ca|2645
20555346|NCT02911948|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20555347|NCT00522275|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20555348|NCT03965052|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20555349|NCT04323436|Novartis|Study Director|862-778-8300|Novartis.email@novartis.com|
20555350|NCT03021187|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20555351|NCT03394924|Enanta Pharmaceuticals, Inc.|Nathalie Adda|+1 6176070705|nadda@enanta.com|
20555352|NCT01842789|Acessa Health, Inc.|Laura Kemp, Clinical Affairs Consultant|4083751465|lkemp@acessahealth.com|
20555353|NCT02276482|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20555354|NCT00450424|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|Kristen.Sorice@fccc.edu|
20555355|NCT02005471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20555356|NCT00801827|Vanderbilt_University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
20555357|NCT00627705|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
20555358|NCT04198662|University of California, San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
20555359|NCT03096782|University of Texas MD Anderson Cancer Center|Amanda Olson, MD / Stem Cell Transplantation|713-745-1505|alolson@mdanderson.org|
20555360|NCT03156023|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20555361|NCT05819749|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
20555362|NCT03843788|Rutgers, The State University of New Jersey|Dr. Adrienne Simonds|8565667190|simondad@shp.rutgers.edu|
20555363|NCT00932893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555364|NCT00443547|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
20555365|NCT02062632|Mayo Clinic|Terence T. Sio, MD, MS|507/284-2511|sio.terence@mayo.edu|
20555366|NCT02156674|Masonic Cancer Center, University of Minnesota|Elizabeth Braunlin MD, PhD|612 626 2755|braun002@umn.edu|
20555367|NCT01562756|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
20555368|NCT04579757|HUTCHMED Limited|Nicky Murray|+44 7738 881999|nicolam@hutch-med.com|
20544376|NCT03959176|Wake Forest University School of Medicine|Keith Walter, MD|336-716-2144|kwalter@wakehealth.edu|
20544377|NCT02736578|Stanford University|Eben Rosenthal|650-723-2967|elr@stanford.edu|
20544378|NCT02110069|Boston Children's Hospital|Dr. Denise M. Adans|617-919-6407|adamsdm@chop.edu|
20544379|NCT04400643|Hamilton Medical AG|Jean Michel Arnal|+33 1 84 04 97 58|jarnal@hamilton-medical.com|
20544380|NCT02819011|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
20544381|NCT02633059|Mayo Clinic|Dr. Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
20544382|NCT01442103|Molnlycke Health Care|Joan wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
20544383|NCT04603027|Evelo Biosciences, Inc.|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
20544384|NCT01213199|GALDERMA|Fabien AUDIBERT, CPM|+ 33 4 92 95 29 21|fabien.audibert@galderma.com|
20544385|NCT00807001|Idenix Pharmaceuticals, Inc.|John Z. Sullivan-Bolyai, MD, MPH|877-433-6491||
20544386|NCT01284335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20544387|NCT02269267|Medical College of Wisconsin|Ehab Atallah, MD|414-805-4600|eatallah@mcw.edu|
20544388|NCT03773796|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
20544389|NCT00590772|Penn State University|Timothy Craig|717-531-6525|tcraig@psu.edu|
20544390|NCT03805659|Medical College of Wisconsin|Peter Kraegel|414-955-0657|pkraegel@mcw.edu|
20544391|NCT01350401|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
20544392|NCT02273596|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20544393|NCT02604160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20544394|NCT01069900|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20544395|NCT00145158|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20544396|NCT06131476|Johnson & Johnson Vision Care|Principal Research Optometrist, Clinical Sciences|1 800-843-2020|njoshi30@its.jnj.com|
20544397|NCT02873702|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20544398|NCT03249116|Tufts University|Dr. Megan K Mueller|508-887-4543|megan.mueller@tufts.edu|
20544399|NCT03762317|Hennepin County Medical Center|Dr. Kunal Gupta|6128732677|kunal.gupta@hcmed.org|
20544400|NCT00221117|Toronto RI Institute|Dr. Milos Popovic|416-597-3422|milos.popovic@utoronto.ca|6305
20544401|NCT03108469|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
20508351|NCT00561340|University of Nebraska Medical Center|Christopher Kratochvil|402-552-6005|ckratoch@unmc.edu|
20544402|NCT01255436|University of the Philippines Manila|Dr. Lia M. Palileo|6325679740|liapalileo@gmail.com|
20544403|NCT04816669|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20544404|NCT01229267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20544405|NCT00001213|National Institutes of Health|Rachel J. Bishop, MD, Principal Investigator, National Eye Institute|301-402-3771|bishopra@nei.nih.gov|
20544406|NCT01742117|Mayo Clinic|Dr. Naveen L. Pereira|507-284-4441|Pereira.Naveen@mayo.edu|
20544407|NCT01499277|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
20544408|NCT00859456|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
20544409|NCT02636595|AbbVie|Global Medical Services|800-633-9110||
20544410|NCT00880919|University of Minnesota|Dr. S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
20544411|NCT01576809|Novartis Consumer Health|Clinical project Leader|41223633111||
20544412|NCT02015637|Melinta Therapeutics, Inc.|Susan K. Cammarata, M.D. (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
20544413|NCT01695304|Centers for Disease Control and Prevention|Ciara O'Reilly, PhD|404-639-1953|bwf1@cdc.gov|
20544414|NCT02297373|Ottawa Hospital|Dr Gregoire Le Gal|613-737-8899|glegal@toh.ca|
20544415|NCT05782179|MinervaX|Cornelia Oostvogels/Chief Medical Officer (CMO)|00491515092821|lio@minervax.com|
20544416|NCT06170242|Enanta Pharmaceuticals, Inc.|Medical Monitor|+1 6176070800|enquiries@enanta.com|
20544417|NCT02863419|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20544418|NCT02362282|North Florida/South Georgia Gainesville VA Medical Center|Janis J Daly, Ph.D., Director Brain Rehabilitation Research Center|352-548-6000|Janis.Daly@va.gov|6603
20544419|NCT02207088|AbbVie|Global Medical Services|800-633-9110||
20544420|NCT03511937|University of North Carolina at Chapel Hill|Anna Grummon, PhD|(617) 495-2021|agrummon@hsph.harvard.edu|
20544421|NCT02921841|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
20544422|NCT00074490|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
20544423|NCT04139798|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20544424|NCT02981446|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20544425|NCT04411667|Sharp HealthCare|Matthew Geriak, PharmD / Research Pharmacist|8589393717|matthew.geriak@sharp.com|
20544426|NCT00714870|St. Elizabeth's Medical Center|Dr. Shirley Gonzalez|617-926-0114|shirleyg2008@gmail.com|
20544427|NCT03399552|Memorial Sloan Kettering Cancer Center|Dr. Andreas Rimner, MD|646-608-2449|Rimnera@MSKCC.ORG|
20544428|NCT02357368|Emory University|Lisa Haddad, MD|404-778-1385|lisa.haddad@emory.edu|
20544429|NCT03895840|University of Kansas Medical Center|Neil Segal, MD|9135740961|segal-research@kumc.edu|
20508352|NCT01989754|Janssen Research & Development, LLC|Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20544430|NCT01931566|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20544431|NCT00411684|HRA Pharma|Paul Carter - Chief Scientific Officer|+33 1 40 33 11 30|p.carter@hra-pharma.com|
20508353|NCT02186457|Indiana University School of Medicine|Dr. Michael House|3179440113|michouse@iupui.edu|
20508354|NCT01369225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544432|NCT00760617|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544433|NCT04476797|Galera Therapeutics|Judy Schnyder|484-870-9625|jschnyder@galeratx.com|
20544434|NCT00638014|Duke University|Elliott Bennett-Guerrero|9196819660|benne011@mc.duke.edu|
20544435|NCT04625101|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
20544436|NCT02991040|Prollenium Medical Technologies Inc.|Mr. Ario Khoshbin|+1 (905) 508-1469|ario@prollenium.com|
20544437|NCT04287517|Istanbul University Faculty of Medicine Sports Medicine Department|Dr. Sergen Devran, Residency in Istanbul University Sports Medicine Department|00905377782594|sergendevran@gmail.com|
20544438|NCT00734500|Duke University|Michael Cohen-Wolkowiez|9196688812|michael.cohenwolkowiez@duke.edu|
20544439|NCT03857867|Stanford|Peter Tass|650-304-8849|ptass@stanford.edu|
20544440|NCT01869764|Wake Forest University Health Sciences|Edward Levine, MD|336-716-5440|elevine@wakehealth.edu|
20527518|NCT02798120|Novan|Cathy White, Vice President, Drug Development Operations|9194858080|clinical@novan.com|
20527519|NCT03292471|VA Pittsburgh/California State University, East Bay|Dr. Michelle Gravier|510 885-3215|michelle.gravier@csueastbay.edu|
20544441|NCT01286480|University of Alberta|Dr. Andrew Mackie|780-407-8361|andrew.mackie@ualberta.ca|
20544442|NCT01918306|Vanderbilt-Ingram Cancer Center|Dr. Vandana Abramson|800-811-8480|vandana.abramson@vanderbilt.edu|
20544443|NCT01237197|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20544444|NCT02506244|Scripps Research Translational Institute|Steven R. Steinhul, MD, Prinicipal Investigator|858-554-5757|steinhub@scripps.edu|
20544445|NCT01319552|Columbia University|Dr. Steven Spitalnik|2123425648|eldad.hod@gmail.com|
20544446|NCT04717336|The National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|Georg Aue, MD|301.451.7141|aueg@nhlbi.nih.gov|
20544447|NCT02039843|Tennesse Valley HCS|Joan Richerson|615-574-8198|joan.richerson@va.gov|
20544448|NCT01958164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20544449|NCT05522153|Virtua Medical Group, PA|Sean McMillan|908-812-7542|smcmillan@virtua.org|
20544450|NCT02807402|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20544451|NCT04983680|Massachusetts General Hospital/Harvard Medical School|Dr. Christina Luberto|617-643-9453|cluberto@mgh.harvard.edu|
20544452|NCT02102204|Amgen Inc.|Study Director|866-572-6436||
20544453|NCT03894813|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86-0755-83923333|fanshangrong@163.com|
20544454|NCT02656693|Brigham and Women's Hospital|Heather J. Baer, ScD|617-525-7503|hbaer@bwh.harvard.edu|
20544455|NCT03284307|University of Sydney|Robert Sanders, MBBS, PhD, FRCA|02 9036 3136|robert.sanders@sydney.edu.au|
20544456|NCT01404936|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
20527520|NCT03924505|RTI International|Dr. Barrot H Lambdin|628-200-6707|blambdin@rti.org|
20527521|NCT02447575|Baylor College of Medicine|Dr. Nicola Hanania|(713) 873-3454|hanania@bcm.edu|
20544457|NCT01596062|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20544458|NCT02255435|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20544459|NCT01745822|French National Research Institute for Sustainable Development (IRD)|Gonzague Jourdain|+66818830065|gonzague.jourdain@ird.fr|
20544460|NCT02741518|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
20544461|NCT00476008|Charles E. Schmidt College of Medicine, Florida Atlantic University|Peter Holland, MD|561-297-0164|holland@fau.edu|
20544462|NCT01227018|Vanderbilt-Ingram Cancer Center|Dr. Dana Cardin|615-936-8580|dana.cardin@vanderbilt.edu|
20544463|NCT02948634|UT Southwestern|Jason Zafereo|14-648-1002|jason.zafereo@utsouthwestern.edu|2146481002
20544464|NCT03007225|Ain Shams University|Dr Iman Montasser, Assistant professor of Tropical Medicine member of HCC clinic and group , Ain Sha|0020201065065333|imanfawzy2@gmail.com|
20544465|NCT00499616|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20544466|NCT00826462|University of Oslo|Professor Morten Lindbaek|+47-22850646|morten.lindbak@medisin.uio.no|
20544467|NCT00659737|Drexel university|Michael Green|215-762-1524|micheal.green@drexelmed.edu|
20544468|NCT03085797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20544469|NCT00867815|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20544470|NCT04050202|University of California, San Francisco|Danielle Roubinov, PhD|919-843-5898|danielle.roubinov@ucsf.edu|
20544471|NCT01614392|Jean Mayer USDA HNRCA, Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
20544472|NCT00372593|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20544473|NCT02974543|University of Michigan|Susan Shore, Professor of Otolaryngology|734 647-2116|sushore@umich.edu|
20544474|NCT03534180|City of Hope|Dr. Jasmine Zain, MD|6263598111|jazain@coh.org|
20544475|NCT00220636|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
20544476|NCT00539942|University of Alabama at Birmingham|Warner K. Huh, MD|205-996-4662|warner.huh@ccc.uab.edu|
20544477|NCT01237899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20544478|NCT00790088|Medtronic Int. Trading SaRL|Dr Odile Carrette|+41218038119|odile.osullivan@medtronic.com|
20544479|NCT04269265|University of Minnesota|Kevin Escandon, MD MS|612-626-9344|escan012@umn.edu|
20544480|NCT04439136|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20544481|NCT02910986|Mayo Clinic|Celine M. Vachon, Ph.D.|507 293-3247|Vachon.Celine@mayo.edu|
20544482|NCT04902924|Rehabilitation and Exercise Science Laboratory (RESlab), University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Vanessa Wellauer|0041 81 300 01 78|vanessa.wellauer@supsi.ch|
20544483|NCT04141839|University of Arizona|Mary Koss|5204818610|mpk@arizona.edu|
20544484|NCT03217058|University of California San Francisco|Dr. Derek Satre, Principal Investigator|415-476-7382|Derek.Satre@ucsf.edu|
20544485|NCT00614432|University of Hawaii|Investigator|808-203-6500|whrc@hawaii.edu|
20544486|NCT00343460|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
20544487|NCT03682770|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20544488|NCT01491607|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
20544489|NCT01317277|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
20544490|NCT00774566|Stardtisches Klinikum Karlsruhe, Medizinische Klinik IV|Dr. Armin Luik|0049-721974|armin.luik@klinikum-karlsruhe.de|2901
20544491|NCT02688777|North Florida/South Georgia Veteran's Health System|Dr. Dorian Rose|352-376-1611|dorian.rose@va.gov|105238
20544492|NCT02549365|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
20544493|NCT00912795|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1 - 801#
20544494|NCT04896073|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
20544495|NCT00176917|Masonic Cancer Center, University of Minnesota|Paul J. Orchard, M.D.|612-626-2313|orcha001@umn.edu|
20544496|NCT02454517|Fred Hutchinson Cancer Center|Jeannette M. Schenk, PhD|206-667-6860|jschenk@fredhutch.org|
20544497|NCT03565497|Boston University|Dr. Michael Otto|617-306-1836|mwotto@bu.edu|
20544498|NCT02999672|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20544499|NCT01075685|Inpes|Juliette Guillemont|+331 49 33 22 55|juliette.guillemont@inpes.sante.fr|
20544500|NCT00531661|CardioMEMS, Inc.|Jordan Bauman|4043458235|jbauman@cardiomems.com|
20544501|NCT02858362|Summit Therapeutics|Clinical Disclosure|Please Email|clinicaltrials@summitplc.com|
20544502|NCT03281200|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20544503|NCT02194985|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20544504|NCT00225732|Cumberland Pharmaceuticals Inc.|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
20544505|NCT02561832|AstraZeneca Pharmaceuticals LP|Carsten Goessl MD|+1 2404490654|Carsten.Goessl@astrazeneca.com|
20544506|NCT01155518|suny buffalo|sandeep dhindsa||sandhindsa@yahoo.com|
20544507|NCT02304367|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
20544508|NCT00594815|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212-639-7523|omuroa@mskcc.org|
20544509|NCT03527732|Swiss Tropical and Public Health Institute|Prof. Dr. Jennifer Keiser|+41 (61) 284 8218|jennifer.keiser@swisstph.ch|
20544510|NCT03599089|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
20544511|NCT03214666|GT Biopharma, Inc.|Dr. Gregory Berk|925-719-3531|gb@gtbiopharma.com|
20544512|NCT03417154|University of Minnesota, Masonic Cancer Center|Dr. Joseph Maakaron|(612) 626-5654|maaka001@umn.edu|
20544513|NCT02500797|Memorial Sloan-Kettering Cancer Center|Sandra P. D'Angelo, M.D.|646-888-4159|dangelos@mskcc.org|
20544514|NCT00060840|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20544515|NCT02983552|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20544516|NCT00357006|Monash Alfred Psychiatry Research Centre|Prof Jayashri Kulkarni|+61 390766924|j.kulkarni@alfred.org.au|66924
20544517|NCT00976560|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544518|NCT03710161|University of Nebraska Medical Center|Dr. Laura Graeff-Armas|402-559-6310|laura.armas@unmc.edu|
20544519|NCT03702283|VANDERBILT UNIVERSITY MEDICAL CENTER|Cosby A Stone, Jr. MD, MPH|6153223412|Cosby.a.stone@vumc.org|
20544520|NCT02902237|Department of Medicine A, University Hospital Muenster, Germany|Prof. Dr. Wolfgang Berdel, Professor of Medicine|+49 251 835|berdel@uni-muenster.de|2672
20544521|NCT04853017|Elicio Therapeutics, Inc.|Study Director|(857) 209-0050|info@elicio.com|
20544522|NCT01469377|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20544523|NCT04939415|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
20544524|NCT04308291|Medtronic Diabetes|Fabio Di Piazza|+393456172157|fabio.di.piazza@medtronic.com|
20544525|NCT00003469|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20544526|NCT00523302|Medical University of South Carolina|Edward B. Short|8437923295|shortb@musc.edu|
20544527|NCT03239106|Washington University School of Medicine|Brian Kim, Associate Professor of Medicine|314-273-1376|briankim@wustl.edu|
20544528|NCT01599637|Novartis Pharmaceuticals|Study Director|862-778-8300||
20544529|NCT03810105|Memorial Sloan Kettering Cancer Center|Dr. Karen Autio, MD|646-422-4632|autiok@mskcc.org|
20544530|NCT00354432|Wake Forest University School of Medicine|Dr. Doug Case|(336) 716-5425|dcase@wakehealth.edu|
20544531|NCT00802945|Nektar|Alison Hannah, MD||AHannah@nektar.com|
20544532|NCT03493464|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
20544533|NCT01788358|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20544534|NCT01168219|Washington University School of Medicine|Ravi Vij, MD||rvij@im.wustl.edu|
20544535|NCT01413204|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20544536|NCT00753649|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544537|NCT00333762|VA Pittsburgh Healthcare System|Dana Sinciline|412-822-3683|dana.sinciline@va.gov|
20544538|NCT04849559|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20544539|NCT01662102|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20544540|NCT02586207|Sanford Health|Steven F. Powell, MD|605-328-8000|Steven.Powell@sanfordhealth.org|
20544541|NCT00392769|UT MD Anderson Cancer Center|Judith Wolff, MD / Professor||CR_Study_Registration@mdanderson.org|
20544542|NCT00439517|Merck KGaA|Merck KGaA Communication Center|+49-6151-75-5200|service@merckgroup.com|
20544543|NCT02058303|Ochsner Health System|Ken Bode|504.842.1936|ken.bode@ochsner.org|
20544544|NCT01262989|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544545|NCT00470275|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20544546|NCT00526071|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20544547|NCT01339052|Dana-Farber Cancer Institute|Patrick Y. Wen, MD, Director, DFCI Center for Neuro-Oncology|617-632-2166|pwen@partners.org|
20544548|NCT02637037|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20544549|NCT03610269|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
20544550|NCT00659789|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
20544551|NCT00611026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544552|NCT02395081|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-8264|jr33@partners.org|
20544553|NCT02109497|Prana Biotechnology|Dr Caroline Herd|+6133494906|info@pranabio.com|
20544554|NCT01147874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544555|NCT01436435|Boston Scientific|DeeAnn Tinjum, Clinical Trial Manager|763-494-1927|deeann.tinjum@bsci.com|
20544556|NCT04150861|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20544557|NCT02721966|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
20544558|NCT03613519|Boston University School of Public Health|Lynn Rosenberg, ScD|617.734.6006|lrosenbe@bu.edu|
20544559|NCT02175030|University of Utah|David Turok, MD, PI|801-581-5160|david.turok@hsc.utah.edu|
20544560|NCT02533453|Astrazeneca, Korea|Hyun Jung Kang / Local Study Leader|82 2 2188 0846|hyunjung.kang@astrazeneca.com|0846
20544561|NCT02453711|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20544562|NCT03008369|Mayo Clinic|Ashish Vitthalrao Chintakuntlawar, MBBS, Ph.D.|5072930504|Chintakuntlawar.Ashish@mayo.edu|
20544563|NCT01292629|Hoya Surgical Optics, Inc.|Kees den Besten, Vice President Global Quality, Regulatory Affairs, and Clinical Research|+65 6681 0025|kees.denbesten@HOYA.com|
20544564|NCT03695367|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
20544565|NCT03519711|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
20544566|NCT00068419|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20544567|NCT04674761|Albireo AB|Albireo AB|medinfo@albireopharma.com|medinfo@albireopharma.com|
20544568|NCT02469870|Trifoia|Dr. Jordan Pennefather|1-877-874-3642|jordanp@trifoia.com|
20544569|NCT01974635|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
20544570|NCT00396253|Genentech, Inc.|Medical Communications|800-821-8590||
20555369|NCT02332720|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20555370|NCT02207816|GlaxoSmithKline|GSK Response Center|866-435-7343|cc781166@gsk.com|
20555371|NCT00780208|Medical University of South Carolina|Aimee McRae-Clark, Professor|843-792-5216|mcraeal@musc.edu|
20544571|NCT01594216|Abramson Cancer Center|Angela DeMichele, MD|215-615-5329|Angela.DeMichele@pennmedicine.upenn.edu|
20544572|NCT05340478|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|713 791-1414|Ellen.Teng@va.gov|
20544573|NCT00092443|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20544574|NCT01493167|Helsinki University Hospital|Dr Nina Linfors|358 9 4711|nina.c.lindfors@hus.fi|
20544575|NCT01721837|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20544576|NCT01951963|Health Partners|Dr. Aaron Burnett|651-254-5304|Aaron.M.Burnett@HealthPartners.Com|
20544577|NCT01500720|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20544578|NCT03830307|University of Pittsburgh|Dr. Grace Lim|412-641-4260|limkg2@upmc.edu|
20544579|NCT00740857|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20544580|NCT02963506|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20544581|NCT02284035|Hospital Clinic of Barcelona|Dr. Esteban Martínez|+34 93 227 54 00|ESTEBANM@clinic.cat|
20544582|NCT04845568|Washington University|Ellen Fitzsimmons-Craft|3142862074|fitzsimmonse@wustl.edu|
20544583|NCT00630838|University of Michigan|Daniel Teitelabum|734-936-8464|dttlbm@umich.edu|
20544584|NCT00928408|Amgen Inc.|Study Director|866-572-6436||
20544585|NCT00256997|Janssen Inc. Toronto, Ontario, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
20544586|NCT02538354|Universy Medical Center Groningen|dr. J.Z.H. von Martels|0031503616161|j.z.h.von.martels@umcg.nl|
20544587|NCT03843541|Zambon S.p.A.|Valentina Zanin|+39026652441|valentina.zanin@zambongroup.com|
20544588|NCT05978713|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20544589|NCT04163016|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20544590|NCT04693767|Penumbra Inc.|Brooke Lawson|+15109952183|blawson@penumbrainc.com|
20544591|NCT04301193|University of Maryland|Division Chief of Obstetric Anesthesiology|(410) 328-4229|bkodali@som.umaryland.edu|
20544592|NCT02930018|NoNO Inc.|Michael Tymianski, MD PhD|4165831687|mtymianski@nonoinc.ca|
20544593|NCT01104311|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
20544594|NCT02587637|Abbott|Robyn Capobianco|+1 512 286 4274|robyn.capobianco@abbott.com|
20544595|NCT04193189|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20544596|NCT02042872|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
20544597|NCT00684060|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
20544598|NCT00702715|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20544599|NCT01677377|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20544600|NCT02260180|Aclaris Therapeutics, Inc.|Judith Schnyder, Senior Director of Clinical Operations|1-484-329-2144|jschnyder@aclaristx.com|
20544601|NCT03059355|University of Miami, Miller School of Medicine - Interdisciplinary Stem Cell Institute (ISCI)|Joshua M Hare, MD|305 243 5579|JHare@med.miami.edu|
20544602|NCT01079299|Center for Curative and Palliative Wound Care Calvary Hospital|Oscar M. Alvarez / Principal Investigator|718-518-2577|oalvarez@calvaryhospital.org|
20544603|NCT03544333|University Hospital of Psychiatry Zurich, Switzerland|Stephanie Homan, PhD|0041 44 384|stephanie.homan@bli.uzh.ch|28 02
20544604|NCT05844007|Montana State University|Dr. Lauren Davis|828-773-6328|lauren.davis6@montana.edu|
20544605|NCT02810509|Ilsan Paik Hospital Inje University|Keun-Sik Hong, MD, PhD, Prof|82-31-910-7680|nrhks@paik.ac.kr|
20544606|NCT00243269|University of Rochester|Joseph Roscoe PhD|585 275-9962|joseph_roscoe@urmc.rochester.edu|
20544607|NCT01837823|Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai|Dr. Annapoorna Kini|212-241-4181|annapoorna.kini@mountsinai.org|
20544608|NCT00555061|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544609|NCT01864603|University of California, San Francisco|Tamara Clark|628-206-8790|Tamara.Clark@ucsf.edu|
20544610|NCT03848182|Montefiore Medical Center; 1695 Eastchester Road|Dr. Jennifer Chuy, Co-Investigator, Assistant Professor (Oncology)|718-405-8505|jchuy@montefiore.org|
20544611|NCT05801341|UW School of Medicine and Public Health|Ellen Wald, MD|(608) 263-8558|erwald@pediatrics.wisc.edu|
20544612|NCT00673738|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
20544613|NCT03830892|Virginia Commonwealth University|Dr. Andrew J. Barnes|804-827-4361|abarnes3@vcu.edu|
20544614|NCT00330967|Phoenix VA Health Care System|Charles Oh|602-277-5551|charles.oh@va.gov|1-5127
20555372|NCT02349295|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20544615|NCT00337675|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20544616|NCT02136069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20544617|NCT04693234|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20544618|NCT05814367|Johnson & Johnson Vision Care, Inc. (JJVC)|Nabin Joshi|1-800-843-2020|njoshi30@its.jnj.com|
20544619|NCT02578706|Icahn School of Medicine at Mount Sinai|Dr. Meagan O'Brien||Meagan.O'Brien@mssm.edu|
20544620|NCT00408200|University of Pennsylvania|Anthony Killian|215-615-5299|tony.killian@uphs.upenn.edu|
20508355|NCT00118911|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@partners.org|
20508356|NCT05507580|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20508357|NCT01555905|University of Florida|D. Barbara Smith|3522945315|bksmith@ufl.edu|
20544621|NCT00921518|Wilkes University|Judith Kristeller|570-408-4272|judith.kristeller@wilkes.edu|
20544622|NCT04103749|Boston Scientific Corporation|Victoria Lazzari|508-382-9132|victoria.lazzari@bsci.com|
20544623|NCT03048578|NYU Langone Health - Weight Management Program|Holly F. Lofton, MD|(212) 263-3166|Holly.Lofton@nyulangone.org|
20544624|NCT00459186|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-632-3237|Mary_Taplin@dfci.harvard.edu|
20544625|NCT02920242|Novartis Pharmaceuticals|Study Director|862-778-1873|novartisemail@novartis.com|
20544626|NCT01409811|City of Hope|Carolyn Behrendt, Ph.D.|626-218-1148|cbehrendt@coh.org|
20544627|NCT00634101|Johnson & Johnson Vision|DIR CLINICAL NEW PRODUCT DEVELOPMENT|1-800-843-2020|KMoody1@its.jnj.com|
20544628|NCT01543633|Neuroscience Statistics Research Laboratory, Massachusetts General Hospital|Dr. Emery N. Brown|(617) 726-8786|enb@neurostat.mit.edu|
20544629|NCT03306173|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas-Lemos|540 526 2106|rflemos@vtc.vt.edu|
20544630|NCT00573144|Mayo Clinic|Dr. Horng H. Chen|507-284-1644|chen.horng@mayo.edu|
20544631|NCT03051178|University of Florida|Dr. Aysegul Gunduz|3522736877|agunduz@bme.ufl.edu|
20544632|NCT02813577|Becton Dickinson|Anna Lovas|763-445-2385|anna.lovas@bd.com|
20544633|NCT03210337|Aclaris Therapeutics|Executive Director, Clinical Operations|4843292144|jschnyder@aclaristx.com|
20544634|NCT00125164|Ipsen|Medical Director, Pediatric Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20544635|NCT01470118|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20544636|NCT03339219|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20544637|NCT01497496|Moffitt Cancer Center|Celeste Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
20544638|NCT02023697|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20544639|NCT03937999|Montefiore Medical Center|Paul Riska, MD|718-920-6494|priska@montefiore.org|
20555373|NCT06111742|Boston Children's Hospital, Harvard Medical School|Harrison Pravder|516-426-8166|hpravder@meei.harvard.edu|
20555374|NCT01914926|Maimonides Medical Center|Christian Fromm, MD; Director of Research|718-283-6391|cfromm@maimonidesmed.org|
20555375|NCT04717596|Abigail Wexner Research Institute|Dr. Elise Berlan|6147222458|elise.berlan@nationwidechildrens.org|
20555376|NCT02473952|Grifols Therapeutics, LLC|Rhonda Griffin, BSN|919-316-6693|Rhonda.Griffin@Grifols.com|
20555377|NCT02606838|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20555378|NCT00237744|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|jjd17@case.edu|6603
20555379|NCT03204279|Helsinn Healthcare SA|Edwin de Wit - Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
20555380|NCT01064739|Vanderbilt University|Dr. Emily Garland|615 936 1748|emily.garland@vanderbilt.edu|
20555381|NCT02962687|Durham VA HSR&D|Susan N Hastings|919-286-6986|susan.hastings@va.gov|
20555382|NCT04258020|OhioHealth|Dr. Kiran Devulapally|614-566-9143|kiran.devulapally@ohiohealth.com|
20555383|NCT02097472|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20555384|NCT04004611|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20555385|NCT04323852|Shahid Beheshti Medical School|Dr. ََAfshin Zarghi|021-22439781|Mpajouhesh@sbmu.ac.ir|
20555386|NCT04022668|Yeditepe University|Emre Aslanger|0216578000|mr_aslanger@hotmail.com|4240
20555387|NCT00130533|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20555388|NCT01059565|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20555389|NCT00574587|Montefiore Medical Center|Markenya Mirander|718-862-8840|MMIRANDE@montefiore.org|
20555390|NCT02040116|Wake Forest Baptist Medical Center|LeAnne Kennedy|336-713-3400|lakenned@wakehealth.edu|
20555391|NCT01592435|Carestream Health, Inc.|Susan Pate, MS, RN, RAC, Senior Manager, Clinical Affairs|585-627-6557|susan.pate@carestream.com|
20555392|NCT03927950|Department of Psychiatry, University of Tartu|Eduard Maron|+3727318812|eduard.maron@kliinikum.ee|
20555393|NCT03263429|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20508358|NCT02293096|"University of Colorado Denver | Anschutz"|Andrew Monte, MD, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20508359|NCT01117012|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
20544640|NCT01354314|The Johns Hopkins University|Dr. Ned Sacktor|410-550-1045|sacktor@jhmi.edu|
20544641|NCT00478023|Grunenthal GmbH|Claudia Leinweber|49 241 569 2509|claudia.leinweber@grunenthal.com|
20544642|NCT02622178|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
20544643|NCT05019521|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20544644|NCT00885534|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
20544645|NCT01273519|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20544646|NCT04292899|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20544647|NCT05307965|John Radcliffe Hospital|Giovanni Luigi De Maria|+441865228364|GiovanniLuigi.DeMaria@ouh.nhs.uk|
20544648|NCT04672655|Stanford University|Molly Tanenbaum, PhD|(650) 725-3955|mollyt@stanford.edu|
20555394|NCT02864082|Timber Pharmaceuticals|Alan Mendelsohn, MD|2673004249|amendelsohn@timberpharma.com|
20555395|NCT04139317|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20555396|NCT03621696|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
20555397|NCT00412087|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
20555398|NCT01618864|Iluminage|Director of Clinical Affairs|+972 547 800 260|doranr@iluminagebeauty.com|
20555399|NCT01109992|Brigham and Women's Hospital|Sharmila Dorbala|617-732-6215|sdorbala@partners.org|
20555400|NCT00690755|James A. Haley VA Research Department|Robert Farese, MD|813-972-2000|Robert.Farese@va.gov|
20508360|NCT03219892|Xuanwu Hospital|Piu Chan|010-83198677|pbchan@hotmail.com|
20508361|NCT03796182|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20508362|NCT05425719|MediBeacon, Inc.|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
20508363|NCT04682353|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20508364|NCT02849626|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20508365|NCT03258632|Department of Veterans Affairs|Christine Timko|650-493-5000|Christine.Timko@va.gov|23336
20508366|NCT03505749|VA Portland Health Care System|Dr. Vanessa Somohano, Postdoctoral Research Fellow|503-220-8262|vanessa.somohano@va.gov|
20508367|NCT01151540|Eisai Co., Ltd.|Customer Joy Department. EJ|8133817-3700|_ML_CLNCL@hhc.eisai.co.jp|
20508368|NCT03846219|Immunic AG|Andreas Muehler, MD|+4917678738359|andreas.muehler@imux.com|
20508369|NCT00180271|Boston Scientific|Jill Leigh|800 227 3422|jill.leigh@bsci.com|
20508370|NCT02261883|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20508371|NCT04199793|Vanderbilt University Medical Center|Sandip Zalawadiya, MBBS|6159368187|sandip.k.zalawadiya@vumc.org|
20508372|NCT01011218|Stanford University Medical Center|Oxana RG Palesh, MD, PhD; Assistant Professor of Psychiatry and Behavioral Sciences|650-725-7011|oxana.palesh@stanford.edu|
20508373|NCT03820726|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508374|NCT00628758|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
20508375|NCT01938001|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20508376|NCT00877604|Fondazione Istituto Neurologico Carlo Besta|Alberto Albanese|+39 02 2392 4552|alberto.albanese@unicatt.it|
20508377|NCT02025829|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
20508378|NCT01495923|The Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
20544649|NCT03892967|Mayo Clinic|Andrea L. Cheville, MD|507-284-1402|Cheville.Andrea@mayo.edu|
20555401|NCT04287920|Mayo Clinic|Douglas (Doug) A. Simonetto, M.D.|507-284-4824|Simonetto.Douglas@mayo.edu|
20555402|NCT00958035|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20555403|NCT03585244|Foundation for Prader-Willi Research|Theresa Strong, PhD - Director of Research Programs|888-322-5487|theresa.strong@fpwr.org|702
20555404|NCT02955511|Cedars Sinai Medical Center|Dr. Ofelia Loani Elvir Lazo, Research Project Advisor|3104231682|ofelia.elvir-lazo@cshs.org|
20555405|NCT03273946|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555406|NCT01220557|Forschungsinstitut der Diabetes Akademie Mergentheim|Norbert Hermanns, PhD|+49 7931 594|hermanns@diabetes-zentrum.de|553
20555407|NCT00430768|UMASS Medical School|Dr. Terry Flotte|(508) 856-2107|Terry.Flotte@umassmed.edu|
20555408|NCT00762320|Phoenix Children's Hospital|Laura Clarke-Steffen, PhD, RN|602-933-0234|lclarke@choenixchildrens.com|
20555409|NCT02199028|Stanford University|Dr Bruce Buckingham|(408) 356-0911|buckingham@stanford.edu|
20555410|NCT01881126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20544650|NCT03387085|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20544651|NCT01077050|SciBase|Director of Clinical Operations|+46841062001|per.svedenhag@scibase.se|
20544652|NCT05475483|SOM Innovation Biotech SA|Chief Medical Officer|+41 79 552 15 78|medori@sombiotech.com|
20527522|NCT00466206|UCSF-Benioff Children's Hospital|Michael Harrison, MD|415 476-2538|pedsurg@ucsfmedctr.org|
20544653|NCT01006291|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20544654|NCT02641561|Cooper University Hospital|Shaffer R. S. Mok, M.D., M.B.S.|6099804564|mok.shaffer@gmail.com|
20527523|NCT02191046|Thammasat university|Dr.Araya Satdhabudha|0813414900|araya221@gmail.com|662
20544655|NCT00479687|Bioventus LLC|Regulatory and Clinical Affairs|18003964325|CT.gov@bioventusglobal.com|
20544656|NCT02565784|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
20544657|NCT03180840|Protalix Ltd.|Sari Alon|+972-4-9028100|sari@protalix.com|215
20544658|NCT02933450|Emergency Department, Baylor College of Medicine|Dr Zubaid Rafiue|7138732626|zubaidrafique@gmail.com|
20527524|NCT01964716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544659|NCT01812668|Barbara Ann Karmanos Cancer Institute|Dr. Elisabeth Heath|313-576-8734|heathe@karmanos.org|
20544660|NCT01089517|Ophthotech|Jeffrey Nau|646-573-7045|jeff.nau@ophthotech.com|
20527525|NCT02147067|Emory University|Habib Samady, MD|(404) 778-1237|hsamady@emory.edu|
20544661|NCT01675544|Creighton University School of Medicine|Dr. Venkata M. Alla|(402) 280-4292|venkataalla@creighton.edu|
20544662|NCT00689260|EMD Serono, Inc.|Sanja Dragnic, MD|781-681-2337|sanja.dragnic@emdserono.com|
20544663|NCT05780424|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
20544664|NCT01170247|University of Iowa|Brett Faine|319-310-8067|brett-faine@uiowa.edu|
20544665|NCT01934647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20544666|NCT00662298|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20544667|NCT03126344|Shanghai ninth people's hospital|Sun Yu|13611895542|dr_sunyu@163.com|+86
20544668|NCT01715857|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20544669|NCT01373671|Siemens Medical Solutions USA, Inc.|Director of Clinical Affairs|610-448-6468|lesley.ewing@siemens.com|
20544670|NCT01027273|Icahn School of Medicine at Mount Sinai|Carol R Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
20544671|NCT04657094|City of Hope Medical Center|Dr. Alexey Danilov|6263598111|adanilov@coh.org|
20544672|NCT02563067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20544673|NCT00839319|University of Washington|Mara Roth, MD|206-221-0519|mylang@u.washington.edu|
20544674|NCT00774267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544675|NCT01039519|Synta Pharmaceuticals|VP Clinical Research|781-541-7156|aoneill@syntapharma.com|
20544676|NCT03062540|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
20544677|NCT00808080|UC San Diego Moores Cancer Center|Dr. Thomas Lane, Stem Cell Lab Director|858-822-5364|jreiner@Ucsd.edu|
20544678|NCT01330108|University of Alabama at Birmingham|Robert C Bourge|205-934-3624|bbourge@uab.edu|
20544679|NCT00423917|Mayo Clinic|Winston Tan MD|507/284-1159|tan.winston@mayo.edu|
20544680|NCT03052400|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
20544681|NCT02936648|Department of Veterans Affairs, CHOIR and BridgeQUERI|Vera Yakovchenko|781.687.3374|vera.yakovchenko@va.gov|
20544682|NCT02914301|George Washington University School of Medicine & Health Sciences- Department of Emergency Medicine|Dr. Andrew C. Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
20544683|NCT00485134|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
20544684|NCT00970684|Case Comprehensive Cancer Center|Nathan Pennell MD|216-445-9285|penneln@ccf.org|
20544685|NCT04294680|Campbell Clinic|Principal Investigator|9017595522|tbrolin@campbellclinic.com|
20544686|NCT00475306|Montefiore Medical Center|Dr. BW Friedman|718-920-6626|befriedm@montefiore.org|
20544687|NCT02950467|UCSF|Michelle Matvey|4152214810|michelle.matvey@ucsf.edu|24117
20544688|NCT03565328|National Heart Lung and Blood Institute (NHLBI)|Michael Sack, M.D. Principal Investigator, NIH, NHLBI|301.402.9259|sackm@nhlbi.nih.gov|
20544689|NCT03656562|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20544690|NCT00905645|Sientra|Chief Technology Officer|(805) 562-3500|denise.dajles@sientra.com|
20544691|NCT00578292|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
20544692|NCT01485172|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544693|NCT01587014|Medical Center of the Rockies|Dr. Julie Dunn|970-624-1680|julie.dunn@uchealth.org|
20544694|NCT02028208|Allerdern (dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|7208
20544695|NCT03021343|Khalidi Hospital & Medical Center|Dr. Ramzi Tabbalat|00962795535522|ramzi_md@yahoo.com|
20544696|NCT04995419|Astellas Pharma China, Inc.|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
20544697|NCT00838513|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
20544698|NCT02416622|AGTC|Dr. Matt Feinsod|386-462-2204|mfeinsod@agtc.com|7202
20544699|NCT00139477|Nemours Children's Clinic|Dr. Nelly Mauras, Chief, Division of Endocrinology|904-697-3674|nmauras@nemours.org|
20544700|NCT01491984|IWK Health Centre|Dr. Ronald George|902-470-6627|rbgeorge@dal.ca|
20544701|NCT00441064|Novartis Pharmaceuticals|Study Director|862-778-8300||
20544702|NCT00953056|Merck Sharp and Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20544703|NCT03962504|National Center for PTSD at VA Boston Healthcare System|Dr. Denise Sloan|857-364-6333|denise.sloan@va.gov|
20544704|NCT01388335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20544705|NCT01243580|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
20544706|NCT03111628|JohnsHopkinsU|Sarbjit S. Saini|410550-2129|ssaini@jhmi.edu|
20544707|NCT00067002|UT MD Anderson Cancer Center|Simrit Parmar, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|SParmar@mdanderson.org|
20544708|NCT01004991|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
20544709|NCT01627288|Duke University Health System|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
20555411|NCT00867217|University of Kansas Medical Center|Dr. Bruce Kimler|(913) 588-4523|bkimler@kumc.edu|
20555412|NCT05045625|Albany Medical College|Clinical Research Coordinator|518-262-2367|khazeno@amc.edu|
20555413|NCT00718718|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20527526|NCT02572856|University of Washington Medical Center|David Flum, MD|206 616-5440|daveflum@uw.edu|
20544710|NCT01032889|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20544711|NCT03523988|University of Washington|Lead Investigator|4254668544|akeith@uw.edu|
20544712|NCT03433040|University of South Florida|Wendy Duncan, QA/QI Research Compliance Manager|8139747454|wduncan3@usf.edu|
20544713|NCT03532451|ECOG Stats Center|Xiangying Chu|3472770190|xchu@ds.dfci.harvard.edu|
20544714|NCT02527421|Prosoft Clinical|Robert Babilon President|484 320 2068|b.babilon@prosoftclinical.com|
20544715|NCT02541604|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20544716|NCT01369888|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20544717|NCT05220436|South London & Maudsley NHS Foundation Trust|Dr Emilie Bourke|07702686322|emilie.bourke@slam.nhs.uk|
20544718|NCT02840461|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20544719|NCT01287741|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20544720|NCT03217071|University of California, San Francisco|Dr. Sue Yom, MD, PhD|(415) 353-9893|Sue.Yom@ucsf.edu|
20544721|NCT04434937|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20544722|NCT05603312|MeiraGTx, LLC|Program Manager|646-860-7982|patients@meiragtx.com|
20544723|NCT01865552|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
20544724|NCT01027806|School of Medicine, University of Missouri Health|Leila Kheirandish-Gozal, M.D., M.Sc.|(573) 884-3229|gozall@health.missouri.edu|
20544725|NCT03079102|Baylor College of Medicine|Cameron Dezfulian|832-826-6210|cameron.dezfulian@bcm.edu|
20544726|NCT02923921|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20544727|NCT03083873|Iovance|Sr. Medical Director, Rana Fiaz|661-645-3572|rana.fiaz@iovance.com|
20544728|NCT00295880|Masonic Cancer Center, University of Minnesota Blood and Marrow Transplant Program|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
20544729|NCT01474239|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20544730|NCT01264705|UT Southwestern Medical Center|Adam Yopp, MD|214-648-5870|adam.yopp@utsouthwestern.edu|
20544731|NCT00854113|Theracos|Yuan-Di Halvorsen|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
20544732|NCT02082119|Humanitas Cancer Center|Dr. Marta Scorsetti|+390282248524|marta.scorsetti@hunimed.eu|
20544733|NCT00796419|Emory University|Greg Martin, MD, MSc|404-616-0148|greg.martin@emory.edu|
20544734|NCT00539864|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20544735|NCT01250145|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20544736|NCT04683887|Azienda Unità Sanitaria Locale di Piacenza|Massimo Guasconi|+39-0523-303853|m.guasconi2@ausl.pc.it|
20544737|NCT02840799|University of Pennsylvania|Hannah Maynard|215-662-7580|hannah.maynard@pennmedicine.upenn.edu|
20544738|NCT02642315|University of Missouri Columbia|Pradeep Sahota MD|573-882-6402|sahotap@missouri.edu|
20544739|NCT01760785|Denver Research Institute|Dr. Thomas Beresford|303-399-8020|thomas.beresford@ucdenver.edu|3732
20544740|NCT02687191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544741|NCT00943072|Regeneron Pharmaceuticals|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
20508379|NCT01999348|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20508380|NCT01569087|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
20508381|NCT01626989|Philips|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
20508382|NCT02437487|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|(617) 945-9626|mtrucksis@serestherapeutics.com|
20508383|NCT02293902|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20508384|NCT03801356|Cleveland Clinic|Dr. Michael Steinmetz|216-445-5754|STEINMM@ccf.org|
20508385|NCT02947022|UNC Chapel Hill, Department of Radiology|Clinical Research Manager|919-966-4997|rad_research@med.unc.edu|
20508386|NCT03125018|Masimo|Tala Harake||studies@masimo.com|
20508387|NCT01089751|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20508388|NCT01229891|National nutrition and food technology institute|T Neyestani|0982122376471|neytr@yahoo.com|
20508389|NCT00105183|Fresenius Biotech|Regulatory Affairs|781 699 4618|anne.kuan@fresenius-biotech.com|
20508390|NCT00792701|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
20508391|NCT01788150|Svelte Medical|Betsy Lowry|19082642181|blowry@sveltemedical.com|
20508392|NCT02135900|Staten Island University Hospital|Michel Chalhoub, MD|7182269000|chalhoubmichel@gmail.com|
20508393|NCT04702984|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20508394|NCT03167541|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research|+44 (0) 1482326151|clinicalrequests@rb.com|
20508395|NCT00615914|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508396|NCT01467661|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20508397|NCT03673956|Mayo Clinic|Dr. Garret W. Choby|507-284-2533|Choby.Garret@mayo.edu|
20508398|NCT02021071|Philips|Rami Nachabe, PhD|+1-513-926-1486|Rami.Nachabe@philips.com|
20508399|NCT03037307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20544742|NCT01349049|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20508400|NCT00270998|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20508401|NCT01118715|Athens Orthopedic Clinic|Dr. Michael Shuler|706-549-1663|mshuler@athensorthopedicclinic.com|
20508402|NCT01902004|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Helen Lavretsky|(310)794-4619|hlavretsky@mednet.ucla.edu|
20544743|NCT01170533|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
20544744|NCT00552188|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
20508403|NCT04075396|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20555414|NCT02467777|Fox Valley Orthopaedic Institute|Vishal Mehta|6305841400|vmehta@fvortho.com|
20544745|NCT03887702|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|adarke@fredhutch.org|
20544746|NCT04432727|Tactile Medical|Michelle Wetherby|612-230-4576|mwetherby@tactilemedical.com|
20544747|NCT01193257|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20544748|NCT02881567|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20544749|NCT02405442|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20544750|NCT00373113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544751|NCT02078960|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20544752|NCT03275350|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
20544753|NCT02173509|University Aveiro|Teresa Herdeiro|+351234370200|teresaherdeiro@ua.pt|
20544754|NCT04661579|PATH|Christian F. Ockenhouse, MD, PhD|1 (206) 285-3500|cockenhouse@path.org|
20544755|NCT01396447|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20544756|NCT01743859|University of Colorado|Dr. Daniel Pollyea||daniel.pollyea@ucdenver.edu|
20544757|NCT01402102|Clinical trial center for Functional Food in Chonbuk Nat'l University Hospital|Dr. Dal-Sik Kim|82-63-250-1793|dskim@chonbuk.ac.kr|
20544758|NCT01386970|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
20544759|NCT01056302|Department of Veterans Affairs|Dr. Rebeka Silva|415-221-4810|rebeka.silva@va.gov|22784
20544760|NCT04881942|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
20544761|NCT02948088|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20544762|NCT00975780|Yale University School of Medicine|Vincent James Quagliarello MD, Professor of Medicine (Infectious Diseases); Clinical Chief, Infectio|(203) 785-7571|vincent.quagliarello@yale.edu|
20544763|NCT01056016|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
20544764|NCT01077076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20544765|NCT02289157|UTSW Medical Center|Dr. Scott Roberts|214-648-3113|scott.roberts@utsouthwestern.edu|
20544766|NCT01976741|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20544767|NCT01415882|Mayo Clinic|Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
20544768|NCT00670306|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
20544769|NCT01301027|University of Utah|Srinivansan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
20544770|NCT00845897|Washington University School of Medicine|Mary Hastings PT, DPT, ATC|314 286 1433|hastingsmk@wustl.edu|
20544771|NCT02722499|Medical College of Wisconsin|Jennifer A. Campbell|414-955-8829|jacampbell@mcw.edu|
20544772|NCT01009619|Katholieke Universiteit Leuven and University Hospital Leuven|Prof. Dr. GM Verleden|+32 16 34 68 08|geert.verleden@uzleuven.be|
20544773|NCT01620216|OHSU|Dr. Stephen Spurgeon|5034948950|spurgeos@ohsu.edu|
20544774|NCT03566485|Vanderbilt-Ingram Cancer Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
20544775|NCT00369265|Philadelphia ENT Associates|Robert T. Sataloff, M.D., D.M.A., FACS|215-545-3322|rtsataloff@phillyent.com|
20544776|NCT01192191|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544777|NCT01047553|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20544778|NCT01072643|The Children's Hospital of Philadelphia|Dr. Aruna T. Nathan|215-590-1858|aruna.nathan@gmail.com|
20544779|NCT02817464|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20544780|NCT00828204|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
20544781|NCT06139887|White River Junction VA Medical Center|Dr. Natalie Riblet|1-802-295-9363|natalie.riblet@va.gov|5893
20544782|NCT03801044|Sisli Hamidiye Etfal Training and Research Hospital|Mustafa Sevinc|00905309291239|musevinc@hotmail.com|
20544783|NCT01615029|Janssen Research & Development, LLC|Senior Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20544784|NCT05064358|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20544785|NCT04421027|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20544786|NCT02285439|Children's Hospital Los Angeles|Dr. Nathan Robison|323.361.2121|mek162@chla.usc.edu|
20544787|NCT05186805|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20544788|NCT00481091|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20544789|NCT03010488|New York State Psychiatric Institute|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
20544790|NCT00975689|National Institute of Child Health and Human Development; NIH|Dr. Forbes D Porter, Senior Investigator|(301) 435-4432|fdporter@mail.nih.gov|
20544791|NCT02423902|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
20544792|NCT04329806|Vanderbilt University Medical Center|Dr. Alfredo Gamboa|615 875 1003|alfredo.gamboa@vumc.org|
20544793|NCT04838626|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20544794|NCT02867384|Dana-Farber Cancer Institute|Corey Cutler, MD|6176323470|corey_cutler@dfci.harvard.edu|
20544795|NCT03901469|Zenith Epigenetics|Zenith Study Team|587-390-7865|ZEN003694-004@zenithepigenetics.com|
20544796|NCT01349959|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Clinical Research Office|410-955-8866|jhcccro@jhmi.edu|
20544797|NCT02675634|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com|
20544798|NCT01652534|Northwestern University|Dr. Tanya Simuni|312-503-2970|tsimuni@nm.org|
20544799|NCT03710083|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
20555415|NCT01311102|Harbor-UCLA Medical Center|Dr. Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
20544800|NCT01727024|Novartis Pharmaceuticals|Study Director|862-778-8300||
20544801|NCT01847027|University of North Texas Health Science Center|Meharvan Singh, PhD|8177355429|meharvan.singh@unthsc.edu|
20544802|NCT00467753|UMDNJ|Sherie Novotny, MD|(732) @35-4119|novotnsl@rutgers.edu|
20544803|NCT02037230|University of Michigan Rogel Cancer Center|Theodore Lawrence, M.D., Ph.D.|734-647-9955|tsl@umich.edu|
20544804|NCT00948441|University of Pittsburgh|Judith M. Martin, MD|412-692-7028|judy.martin@chp.edu|
20544805|NCT04473469|University of Michigan|Timothy Bruns|(734) 647-8727|bruns@umich.edu|
20544806|NCT00104520|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
20544807|NCT01026324|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617-632-5053|stephen_hodi@dfci.harvard.edu|
20544808|NCT02442804|Brown University|John Bellone, Ph.D.|4012737100|john_bellone@brown.edu|6168
20544809|NCT01640834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20544810|NCT02624986|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20544811|NCT02116205|WRAIR Clinical Trials Center|Dr. Kristin Mills, Principal Investigator|301-319- 2039|Kristin.t.mills.ctr@mail.mil|
20544812|NCT02561338|Hua Medicine|Yi Zhang|+86-21-58869997|yzhang@huamedicine.com|3269
20544813|NCT04200352|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20544814|NCT00993148|Northwestern University|Dr. Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
20544815|NCT00806819|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20544816|NCT02373683|Case Western Reserve University|Katherine Slain|12168443310|katherine.slain@uhhospitals.org|
20544817|NCT01737502|Mayo Clinic in Florida|Yanyan Lou, MD|904-953-0315|lou.yanyan@mayo.edu|
20544818|NCT01326104|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
20544819|NCT04073225|Johns Hopkins University|Michelle Carlson|(410) 790-8205|mcarlso2@jhu.edu|
20544820|NCT05407064|Mind Medicine Inc|Medical Affairs|1-332-245-4732|MedAffairs@mindmed.co|
20544821|NCT06019611|Mayo Clinic|Dr. Kristin Zhao, Director of the Assistive and Restorative Technologies Laboratory|507-284-8942|zhao.kristin@mayo.edu|
20544822|NCT02219659|MemorialCare Long Beach|Division of Pulmonary and Critical Care|(562) 933-2000|mtanios@yahoo.com|
20544823|NCT00124306|University of Pennsylvania|J. Richard Landis, PhD|215-5734922|hultman@upenn.edu|
20544824|NCT00427765|UT MD Anderson Cancer Center|Partow Kebriaei, MD/Associate Professor||celsaenz@mdanderson.org|
20544825|NCT00560352|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20544826|NCT00487461|University of Illinois at Chicago|Ali Alaraj, MD|312-996-4842|alaraj@uic.edu|
20544827|NCT05767749|Weill Cornell Medicine|Dr. Kira Minkis|(646) 962-3376|kim9036@med.cornell.edu|
20544828|NCT00114517|University of Southern California|Howard N. Hodis, M.D., Director, Atherosclerosis Research Unit|323-442-1478|athero@usc.edu|
20544829|NCT03760718|Oregon Health & Science University|Brandon Togioka, MD|503-494-4572|togioka@ohsu.edu|
20544830|NCT03568461|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20544831|NCT04695977|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20544832|NCT02685267|PCCTC|Jake Vinson|646-422-4383|vinsonj@mskcc.org|
20544833|NCT00611403|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20544834|NCT00578734|Penn State Children's Hospital|Dr. Neal J. Thomas|717-531-5337|nthomas@hmc.psu.edu|
20544835|NCT04990804|Vanderbilt University Medical Center|Research Coordinator|615-936-7107|kennadie.long@vumc.org|
20544836|NCT04202419|Miami Dermatology and Laser Institute|Dr. Jill Waibel|(305) 615-2393|info@miamidermlaser.com|
20544837|NCT00662675|Johnson & Johnson Pharmaceutical Research & Development, LLC|Director, Clinical Team Leader|609-730-3158||
20544838|NCT01717053|Duke University|Dr. Bridget Koontz|919-668-5213|bridget.koontz@duke.edu|
20544839|NCT04681352|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20544840|NCT03860818|Ralph H. Johnson VA Healthcare System|Dr. David J. Taber|843.789.6624|David.Taber2@va.gov|
20544841|NCT00792571|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
20544842|NCT02600819|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20544843|NCT00505778|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20544844|NCT04857320|LANGFORD RESEARCH INSTITUTE|Managing Director|5614296429|KKirby@Langfordresearch.org|150
20544845|NCT03790696|Washington University School of Medicine|Jennifer Harper / Clinical Research Coordinator|314-286-2697|jenniferharper@wustl.edu|
20544846|NCT04216264|Duke University|Dr. Charles Wood|919-620-4772|charles.wood@duke.edu|
20544847|NCT03291964|Oregon Health and Science university|David Sheridan Assistant Prof|5034941691|sheridda@ohsu.edu|
20544848|NCT00811018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544849|NCT01976091|Sarepta Therapeutics, Inc|Medical Information|1-800-690-2003|SareptAlly@sarepta.com|
20544850|NCT02722304|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20544851|NCT00934362|University of North Carolina at Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
20544852|NCT02566369|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
20544853|NCT01092117|Endologix|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
20544854|NCT04380519|R-Pharm|Sergey Grishin, Head of Scientific Affairs Department|0074959567937|sa.grishin@rpharm.ru|1506
20508404|NCT01156532|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20544855|NCT03656380|University of North Carolina at Chapel Hill|Lindsay Cortright, MA|919-445-4911|lindsay_cortright@med.unc.edu|
20544856|NCT02283827|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20544857|NCT02147561|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20544858|NCT05300763|Johnson & Johnson Vision Care, Inc.|John R. Buch, Senior Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
20544859|NCT04625517|UT Southwestern Medical Center|Kelli Key, Ph.D.|214-648-8152|Kelli.Key@UTSouthwestern.edu|
20544860|NCT01598506|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
20544861|NCT02100696|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20544862|NCT05626322|Pfizer Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544863|NCT02879812|Emory University|Dr. Rachel Patzer|404-727-6047|rpatzer@emory.edu|
20544864|NCT04059159|Spinal Singularity|Derek Herrera|949-436-7974|dherrera@urodevmedical.com|
20544865|NCT00048074|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20544866|NCT02873377|University of Miami|Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
20544867|NCT04518358|Guiding Technologies Corp.|John Nosek|609-605-9273|john.nosek@guidingtechnologies.com|
20544868|NCT01583296|Ferkauf Graduate School of Psychology, Yeshiva University|Jonathan M. Feldman|6465924508|jonathan.feldman@einstein.yu.edu|
20544869|NCT01063283|Inova|Michael Maitland, MD, PhD|571-472-4724|Michael.Maitland@inova.org|
20544870|NCT00356304|VA New Jersey Healthcare System|Alejandro Interian, Principal Investigator|908-647-0180|alejandro.interian@va.gov|4617
20544871|NCT02504216|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20544872|NCT00223080|Department of Disease Control, Ministry of Public Health|Dr. Supachai Rerks-Ngarm|66-2-590-3006|supachai@health.moph.go.th|
20544873|NCT02598583|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20544874|NCT03237286|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
20544875|NCT03193593|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
20544876|NCT02792829|Eisai Inc.|Eisai Medical Research Inc.|1-888-422-4743|esi_medinfo@eisai.com|
20544877|NCT02797613|Memorial University|Peter Daley|7097250240|pkd336@mun.ca|
20544878|NCT01262820|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20544879|NCT01151904|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20544880|NCT01010867|Columbia University Medical Center|Monica Bhatia, MD|2123055808|mb2476@cumc.columbia.edu|
20544881|NCT02302339|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
20544882|NCT03564678|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Professor|713-792-4764|ejabbour@mdanderson.org|
20544883|NCT04420325|UZ Leuven|Lennert Minten|+32496397568|lennert.minten@gmail.com|
20544884|NCT04016623|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20544885|NCT02752165|University of Rochester|Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
20544886|NCT00826202|Nathan Kline Institute|Daniel Javitt MD, PhD|845-398-6534|javitt@nki.rfmh.org|
20544887|NCT01704599|Dept. Dermatology Wayne StateUniversity|Peter J. Aronson, MD|(313)_745-7845|paronson@med.wayne.edu|
20544888|NCT02267837|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
20544889|NCT00912197|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
20544890|NCT00756613|VA|Tamara Paine|7082028387|tamara.paine@va.gov|25785
20544891|NCT04901715|University of North Carolina at Chapel Hill|Kelli Sullivan, MPH|919-962-9786|kelli_sullivan@med.unc.edu|
20544892|NCT04022499|Denver Health and Hospital Authority|Rocio Pereira, Medical Director, Community Integrated Health Care|303-436-6000|rocio.pereira@dhha.org|
20544893|NCT00494676|Schepens Eye Research Institute|Alex Bowers|617-912-2512|alex_bowers@meei.harvard.edu|
20544894|NCT05036733|University of Michigan|Yvonne J Huang MD|734-936-5047|yvjhuang@med.umich.edu|
20544895|NCT04075812|The Ohio State University|Marcia Bockbrader MD PhD|6142933127|bockbrader.13@osu.edu|
20544896|NCT01322841|Indiana University School of Medicine|Aaron Carroll|3172789616|aaecarro@iu.edu|
20544897|NCT01077921|Duke University Medical Center|Laura De Castro, MD, MHSc|(412) 623-7026|laura.decastro@dm.duke.edu|
20544898|NCT01505764|Department of Veterans Affairs|Jose M Garcia MD, PhD, Clinician Investigator|206-7642984|jose.garcia@va.gov|
20544899|NCT01256294|Novartis Pharmaceuticals|Study Director|862-778-8300||
20544900|NCT01643772|Mundipharma (China) Pharmaceutical Co.Ltd|Ms. Dan Zhu, Clinical operation and quality lead of the study|+8610 6563 6891|dan.zhu@mundipharma.com.cn|
20544901|NCT00724711|Gilead Sciences|Dara Wambach, MA, Associate Director, Regulatory Affairs|650 522 5163|Dara.Wambach@gilead.com|
20544902|NCT01139008|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20544903|NCT02631590|Moffitt Cancer Center|Richard Kim, MD, Principal Investigator|813-745-1277|Richard.Kim@moffitt.org|
20544904|NCT01088048|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20544905|NCT01621802|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544906|NCT01149148|UmichiganHS|Dr. Wei C. Lau|734 9369479|weiclau@med.umich.edu|
20544907|NCT03436082|Yale School of Medicine|Joseph Ross, MD, MHS|203-785-2987|joseph.ross@yale.edu|
20544908|NCT00950859|ViiV Healthcare|GSK Response Center|866-435-7343||
20544909|NCT04896086|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20544910|NCT02917642|University of São Paulo|Dr. Ericka T. Pinheiro|551126488293|erickapinheiro@usp.br|
20544911|NCT02249832|Feinstein Institutes for Medical Research|Bruce T. Volpe, MD|(516) 562-3384|bvolpe1@northwell.edu|
20544912|NCT02516969|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MSCR, CCRP|412-647-5554|stadtermanbm@upmc.edu|
20544913|NCT00857714|IndianaU|Sunil Badve, MD|317-491-6417|sbadve@iupui.edu|
20544914|NCT00545272|Novartis Pharmaceuticals|Study Director|862-778-8300||
20544915|NCT00724867|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544916|NCT01175083|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544917|NCT04027608|University at Buffalo|Jennifer Temple, Principle Investigator|7168295593|jltemple@buffalo.edu|
20544918|NCT00093379|The University of Texas (UT) MD Anderson Cancer Center|Cathy Eng, MD/ Professor||CR_Study_Registration@mdanderson.org|
20544919|NCT01737593|UCLA|Dr. Wendy Ren|310.267.8678|wren@mednet.ucla.edu|
20544920|NCT04335136|APEIRON Biologics AG|Dr. Romana Gugenberger|+4366488506236|romana.gugenberger@apeiron-biologics.com|
20544921|NCT00771953|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
20544922|NCT03328208|Hypnalgesics, LLC|Elvira V. Lang, MD, CEO|6177349087|drevlang@comforttalk.com|
20544923|NCT00947193|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20544924|NCT04364984|Medical Practice Prof D.Ivanov|Prof Dmytro Ivanov|0504448788|drivanovdd@gmail.com|+38
20544925|NCT01941186|Child Health Institute of New Jersey|Manuel Jimenez, MD, MS|732-235-6230|jimenema@rwjms.rutgers.edu|
20544926|NCT02105961|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20544927|NCT03860259|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
20544928|NCT02283762|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
20544929|NCT02367833|Penn State University|Dr. Mary Jane De Souza|8148630045|mjd34@psu.edu|
20544930|NCT02268175|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mary_taplin@dfci.harvard.edu|
20544931|NCT00889720|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20544932|NCT00775593|GIMEMA|Edoardo La Sala|+39 06 70390524|e.lasala@gimema.it|
20544933|NCT02067676|Enteric Disease Department, Naval Medical Research Center|Ramiro Gutierrez, MD|301-319-3193|ramiro.l.gutierrez.mil@mail.mil|
20544934|NCT00996333|Columbia University|Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
20544935|NCT01327482|Massachusetts General Hospital|Dr. Caroline Mitchell|617-724-2182|caroline.mitchell@mgh.harvard.edu|
20544936|NCT00476229|UT MD Anderson Cancer Center|Chitra M. Hosing, MD/Associate Professor||gmccormi@mdanderson.org|
20544937|NCT02164461|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|Sheeri@advaxis.com|
20544938|NCT01814241|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20544939|NCT02471326|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
20544940|NCT00078897|University of Arizona|Dr. Elizabeth Jacobs|(520) 626-0341|jacobse@email.arizona.edu|
20544941|NCT03865381|Verily Life Sciences|Head of Clinical Science|(650) 253-0000|info@verily.com|
20544942|NCT04999852|Indiana University|Clarissa Tokash|(812) 855-7686|catokash@iu.edu|
20544943|NCT03776812|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20544944|NCT04950816|The University of Texas Health Science Center at Houston|Diane Santa Maria, DrPH|713-500-2187|diane.m.santamaria@uth.tmc.edu|
20544945|NCT04758637|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
20544946|NCT05110872|Fralin Biomedical Research Institute at Virginia Tech Carilion|Dr. Freitas-Lemos|540-526-2106|rflemos@vtc.vt.edu|
20544947|NCT03350672|Philadelphia FIGHT Community Health Centers|Linden Lalley-Chareczko|2155258695|lchareczko@fight.org|
20544948|NCT00452361|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20544949|NCT02282514|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20544950|NCT03043105|Peking Union Medical College Hospital|Dr. Jian Li|86-010-69155027|lijian@pumch.cn|
20544951|NCT01668589|Amgen Inc.|Study Director|866-572-6436||
20544952|NCT01120964|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
20544953|NCT04198714|MetroHealth Medical Center|Dr. Jeffrey Mangel|216-778-5595|jmangel@metrohealth.org|
20544954|NCT04238819|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20544955|NCT02529553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20544956|NCT04917757|University Hospital Würzburg|Prof Dr. Martin Fassnacht|4993120139021|fassnacht_m@ukw.de|
20544957|NCT03704389|Northwestern University|Stephen D. Persell, MD, MPH, FACP|312-503-6464|spersell@nm.org|
20544958|NCT04549545|Aerin Medical|Tien Dang Sr. Clinical Affairs Manager|669-256-6596|tdang@aerinmedical.com|
20544959|NCT03390114|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
20544960|NCT03036215|HealthPartners Institute|James Fricton, DDS, Senior Research Investigator|6126191678|james.r.fricton@healthpartners.com|
20544961|NCT01395524|AstraZeneca|Mark Sostek||aztrial_results_posting@astrazeneca.com|
20544962|NCT01657461|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949 297 5494|manish.s.gupta@medtronic.com|
20544963|NCT01868542|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20544964|NCT00130247|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D., Principal Investigator|(216) 368-1949|jlj@case.edu|
20544965|NCT01574183|MUSC|Aimee McRae-Clark, PharmD|843-792-5216|mcraeal@musc.edu|
20544966|NCT02609113|Wake Forest Baptist Health|Vanessa Baute, MD|336-716-8140|vbaute@wakehealth.edu|
20544967|NCT00843284|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20544968|NCT00147069|Imperial College London|Professor Louise Donnelly|+44 (0)20 7594 7895|l.donnelly@imperial.ac.uk|
20544969|NCT04458090|University of Colorado Anschutz Medical Campus|Dr. Channing Tate, Assistant Professor|3037248985|channing.tate@cuanschutz.edu|
20544970|NCT02175199|Alcon Research, Ltd.|Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20544971|NCT00122980|Baylor College of Medicine|Russell E. Ware, MD, PhD, Director, Texas Children's Hematology Center|(832) 824-1368|reware@bcm.edu|
20544972|NCT00459732|Children's Hospital & Research Center, Oakland|Ellen Fung, PhD RD CCD|510-428-3885|efung@mail.cho.org|4939
20544973|NCT01124864|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20544974|NCT01243242|Alcobra|Dr Yaron Daniely CEO|972-072-2204662|yaron@alcobra-pharma.com|
20544975|NCT03093662|Brooke Army Medical Center|Dr. Derek Brown|2109160808|Derek.J.Brown1.mil@mail.mil|
20544976|NCT05480111|The University of Texas Health Science Center at Houston|Randa J Jalloul, MD|713-566-5749|Randa.J.Jalloul@uth.tmc.edu|
20544977|NCT03983317|TheraNova, LLC|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
20544978|NCT01761162|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
20544979|NCT00436345|GlaxoSmithKline|GSK Response Center|866-435-7343||
20544980|NCT01296672|UT Health|Jonathan Gelfond|210 567-0836|gelfondjal@uthscsa.edu|
20544981|NCT01716052|UTHSCSA @CTRC|Dr. Kenneth Kist|210-450-5600|KIST@UTHSCSA.EDU|
20544982|NCT04248491|Beaumont Health|Director Urology Research|2485511488|bernadette.zwaans@Corewellhealth.org|
20544983|NCT01068964|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20544984|NCT01311024|head of Clinical Research Unit, National Institute for Health and Welfare|Arto Palmu, MD, PhD Research manager,|+358295247910|arto.palmu@thl.fi|
20544985|NCT00787618|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20544986|NCT01652469|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
20544987|NCT01305577|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20544988|NCT00796978|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Cynthia Owusu|+1 216-844-7670|cynthia.owusu@uhhospitals.org|
20544989|NCT02834793|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20544990|NCT02364336|NIDDK|Dr. Marc Ghany|301-402-5115|mg228m@nih.gov|
20544991|NCT01731938|Grifols Therapeutics, Inc.|Henry Li, PhD, RAC|1-919-316-6042|Henry.Li@Grifols.com|
20544992|NCT01049009|Emory University School of Medicine|Dr. Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
20544993|NCT03179202|SPR Therapeutics|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
20544994|NCT00859638|McMaster University|Dr. Julie Richardson|(905) 525-9140|jrichard@mcmaster.ca|27811
20544995|NCT02910505|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20544996|NCT02969408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20544997|NCT01147627|The Third Affiliated Hospital of Sun Yat-sen University|Dr. Jianping Weng|86-20-85253162|wjianp@mail.sysu.edu.cn|
20544998|NCT04643158|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20544999|NCT01092546|GE Healthcare|Paul Sherwin, M.D.|609-514-6820|Paul.Sherwin@ge.com|
20545000|NCT02197078|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545001|NCT00622440|University of California, San Francisco|Naomi Jay, PhD|415-353-7443|Naomi.Jay@ucsf.edu|
20545002|NCT02223377|Department of Anesthesia, McMaster University, Canada|Dr. Thuvaraha Vanniyasingam|(905) 525-9140|tvanniya@stjosham.on.ca|21736
20545003|NCT04154189|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20545004|NCT02280408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20545005|NCT01068600|Novartis Pharmaceuticals|Study Director|862-778-8300||
20545006|NCT02474069|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20545007|NCT04173494|Sierra Oncology LLC - a GSK company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20545008|NCT01623050|SinuSys Corporation|Janie Mandrusov, Director of Pre-Clinical and Clinical Development|4084104411|emandrusov@sinusys.com|
20545009|NCT01191762|Kenneth R. Phelps, M.D.|Kenneth R. Phelps, M.D.|518-626-5641|kenneth.phelps@va.gov|
20545010|NCT03898557|University of Pennsylvania|Alison M. Buttenheim, PhD MBA|215.573.5314|abutt@nursing.upenn.edu|
20545011|NCT01519869|University of Kentucky|Rachel Miller|859-323-2169|raware00@uky.edu|
20545012|NCT03023813|Cleveland Clinic|Glen Taksler PhD|216-445-7499|taksleg@ccf.org|
20545013|NCT00393861|IndianaU|Lawrence H. Einhorn, M.D.|(317) 944-0920|leinhorn@iu.edu|
20545014|NCT00974480|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
20545015|NCT01421355|Brigham and Women's Hospital|Joshua Beckman, MD|617-732-6320|jbeckman@partners.org|
20545016|NCT00202878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20545017|NCT02123472|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545018|NCT01474018|Baylor Endocrine Center|Dr. Erin D. Roe|214-820-3466|edr@roemd.com|
20545019|NCT00577798|University of Nebraska Medical Center|Thomas Porter, MD|+1 (402) 559-8150|trporter@unmc.edu|
20545020|NCT02433080|University College London|Dr Anne Lanceley|+442076796807|a.lanceley@ucl.ac.uk|
20545021|NCT03563183|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20545022|NCT03801031|University of Iowa|David Bender, MD|319-356-2015|david-bender@uiowa.edu|
20545023|NCT01594528|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
20545024|NCT00486291|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
20545025|NCT01209702|Hoffman-LaRoche|Medical Communications|800-821-8590||
20545026|NCT00528450|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
20545027|NCT00126490|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-8311|mayer.fishman@moffitt.org|
20545028|NCT04036292|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20545029|NCT03462511|Columbia University School of Nursing|Arlene Smaldone, PhD, RN|212-342-3048|ams130@columbia.edu|
20545030|NCT02925416|Melinta Therapeutics|Study Director|1-844-633-6568|medinfo@melinta.com|
20545031|NCT00200356|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20545032|NCT02577445|Livanova|Clinical Project Manager|0032498644704|renske.dezwaef@livanova.com|
20545033|NCT02355184|CytoDyn|Joseph Meidling|(360) 980-8524|jmeidling@cytodyn.com|
20545034|NCT01856218|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
20545035|NCT03718091|Massachusetts Genera Hospital|Gregory M Cote MD PhD|6177244000|gcote@partners.org|
20545036|NCT02490670|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545037|NCT02160899|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20545038|NCT04129151|Dana-Farber Cancer Institute|David S Shulman, MD|617-632-6670|david_shulman@dfci.harvard.edu|
20545039|NCT02603666|Karolinska University Hospital, Huddinge, 141 86 Stockholm|Ferenc Karpati M.D., Ph.D., Senior Consultant|+46858580000|ferenc.karpati@karolinska.se|81656
20545040|NCT01588418|University of Texas Health Science Center at San Antonio|Dr. Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
20545041|NCT01463007|BrUOG-Brown University Oncology Research Group|Dr. Jaroslaw Hepel|4018633000|kristen_mitchell@brown.edu|
20545042|NCT01320137|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545043|NCT02314637|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20545044|NCT02934503|NYU Langone|Dr. Joshua Sabari|212-731-6363|Joshua.Sabari@nyulangone.org|
20545045|NCT03110770|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20545046|NCT01667419|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20545047|NCT00856518|North Florida/South Georgia Veterans Health System|Dr. Janis Daly|352-376-1611|janis.daly@neurology.ufl.edu|5223
20545048|NCT02082340|American University of Armenia|Dr. Harutyunyan||aharutyunyan@aua.am|
20545049|NCT00536913|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20545050|NCT04195893|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20545051|NCT06026124|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
20545052|NCT03001817|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20545053|NCT03855059|University of Arizona/Deptartment of Anesthesiology|Peter Lichtenthal, MD|5206267221|plich@arizona.edu|
20545054|NCT00035932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20545055|NCT01805791|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
20545056|NCT04413617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545057|NCT03152929|Spectrum Health|Marianne Melnik|616-486-6333|marianne.melnik@corewellhealth.org|
20545058|NCT02511106|AstraZeneca AB|Global Clinical Leader|+447920183730|ClinicalTrialTransparency@astrazeneca.com|
20545059|NCT01015638|GlaxoSmithKline|GSK Response Center|88-435-7343||
20545060|NCT00984620|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545061|NCT04296448|Johns Hopkins University Department o Peidaitrics Division of Pediatric Emergency Medicne|Dr. Therese Canares|(410) 955-6146‬|therese.canares@jhmi.edu|
20545062|NCT00947167|Stanford University School of Medicine|Pamela L. Kunz, MD, Leader GI Oncology Research Group|650-725-8738|pkunz@stanford.edu|
20545063|NCT01719744|Princess Margaret Cancer Centre|Dr. ALBIRUNI RAZAK|416-586-4800|Albiruni.Razak@uhn.ca|5371
20545064|NCT05854784|CLINUVEL UK LTD|Director, Global Clinical Affairs|+4401372860765|mail@clinuvel.com|
20545065|NCT01703754|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
20545066|NCT05487196|UPMC Magee Women's Hospital|Dr. Grace Lim, MD, MSc|412-641-1778|limkg2@upmc.edu|
20545067|NCT01459497|University of Texas Southwestern Medical Center|Dr. Puneeth Iyengar|214-645-7603|puneeth.iyengar@utsouthwestern.edu|
20545068|NCT03530124|Duke University|Dr. Rachel Greenberg|919 668 4725|rachel.greenberg@duke.edu|
20545069|NCT03179319|Brown University|Katie Biello|401-863-3082|katie_biello@brown.edu|
20545070|NCT01120717|Novartis Pharmaceuticals|Study Director|862 778-8300||
20545071|NCT03117140|Univesity of Iowa Hospitals and Clinics|Melinda Seering|3193561616|melinda-seering@uiowa.edu|
20545072|NCT00947882|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20545073|NCT05188053|Mayo Clinic|Gabriel Schouten - Clinical Research Coordinator|507-266-5895|schouten.gabriel@mayo.edu|
20545074|NCT00794313|Oregon Health & Science Universtiy|Kathyrn Chung MD|503 721 - 1091|chungka@ohsu.edu|
20545075|NCT02379637|Novartis|Dr Marianna Armogida Director Clinical Research Innovation|+41223635182|marianna.armogida@novartis.com|
20545076|NCT03849118|Telix Pharmaceuticals (Innovations) Pty Ltd|Dr. Kavita Vadali, Sr. Clinical Project Manager|+1 919-924-8887|kavita.vadali@telixpharma.com|
20545077|NCT06057727|University of Pennsylvania|Dr. Shivan Mehta|2679726027|shivan.mehta@pennmedicine.upenn.edu|
20545078|NCT01561313|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20545079|NCT04535453|Janssen Vaccines & Prevention B.V.|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20545080|NCT02695420|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20545081|NCT04449263|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256402964|javega2@coopervision.com|
20545082|NCT02929407|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20545083|NCT01742286|Study Director|Study Director|862-778-8300|novartis.email@novartis.com|
20545084|NCT04530136|Pharming Technologies BV|Anurag Relan, MD|0031 (0)71 5247400|a.relan@pharming.com|
20545085|NCT02878798|Virginia Commonwealth University|Dr. A. Gordon Smith|801-828-9869|gordon.smith@vcuhealth.org|
20545086|NCT01309282|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20545087|NCT02087423|AstraZeneca|Phillip Dennis, MD, PhD|+1 301 398-5549|ClinicalTrialTransparency@astrazeneca.com|
20545088|NCT01387542|Janssen-Cilag Ltd.: 106 Moo 4 Lad Krabang Industrial Estate, Chalongkrung Rd., Lamplatew, Lad Krabang, Bangkok 10520|Medical Affairs Director|+66 2 7397200||5888
20545089|NCT03601117|Stanford University|Dr Nolan Williams|(650)800-6920|nolanw@stanford.edu|
20545090|NCT02762370|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20545091|NCT03632954|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
20545092|NCT02954172|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
20545093|NCT01519167|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
20545094|NCT00556504|TCM Biotech International|Dr. Ya-Chun Wang, EVP/CSO|886-2-26581677|yachunwang@tcmbio.com|733
20545095|NCT00233064|MedImmune, LLC|Hasan S. Jafri, MD|301-398-0000||
20545096|NCT04393454|Albert Einstein College of Medicine|Dr. Chaoyuan Kuang|718-430-3516|chaoyuan.kuang@einsteinmed.edu|
20545097|NCT01003769|Mayo Clinic|Asher Alban Chanan-Khan, M.D.|(716) 845-3221|chanan-khan.asher@mayo.edu|
20545098|NCT03304249|University of Kansas Medical Center|Megan Olalde|913-588-2042|molalde@kumc.edu|
20545099|NCT04976192|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20545100|NCT02621151|NYU Langone Health|Minas Economides, MD|2127315413|minas.economides@nyulangone.org|
20545101|NCT00924027|National Cancer Institute|Dr. Deborah E. Citrin|240-760-6206|citrind@mail.nih.gov|
20545102|NCT02635425|Ain Shams university|Dr. Ahmad Hussieny Salama|00201223114626|ahmdhsf@hotmail.com|
20545103|NCT04236141|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20545104|NCT01925131|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|amoseley@fredhutch.org|
20545105|NCT03278067|GlaxoSmithKline|GSK Response Center|866-435-7343|emily.p.lu@gsk.com|
20545106|NCT01217307|University Medical Center Groningen|Dr. I.C.C. van der Horst||i.c.c.van.der.horst@umcg.nl|
20545107|NCT01303224|Menarini Ricerche S.p.A.|Angela Capriati MD PhD, Corporate Director of Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9933
20545108|NCT01888432|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20545109|NCT03054129|Dr. İsmail Atabek Physical Therapy and Rehabilitation Center|Ertan Şahinoğlu, PT, PhD|+90 5326478653|ertan.sahinoglu@hotmail.com|
20545110|NCT03844945|Aerie Pharmaceuticals Ireland Limited, Japan Branch|Clinical Research, Japan|+81-3-6860-8410|JapanCS208@aeriepharma.com|
20545111|NCT01696929|Georgia Regents University|Dr. Brian Miller|706-721-4445|brmiller@gru.edu|
20545112|NCT03159260|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
20545113|NCT01043939|Masonic Cancer Center, University of Minnesota|Cindy K. Blair, MPH|612-624-9668|blair016@umn.edu|
20545114|NCT02726542|Massachusetts General Hospital|Takara Stanley, MD|617-726-5312|tstanley@mgh.harvard.edu|
20545115|NCT01954927|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
20545116|NCT02156271|Duke University Medical Center|Dr. Andrew Krystal|919-681-8742|andrew.krystal@duke.edu|
20545117|NCT00588159|Mayo Clinic|Dr. Michelle A. O. Kinney|507-266-9877|kinney.michelle@mayo.edu|
20545118|NCT00375609|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20545119|NCT01368562|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20545120|NCT02491944|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20545121|NCT00727441|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
20545122|NCT01239992|University Munich|Klaus G. Parhofer|+49-89-7095-3010|klaus.parhofer@med.uni-muenchen.de|
20545123|NCT00535288|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20545124|NCT02810444|Biotest AG|Dr. med. Andrea Wartenbrg-Demand|+49 6103 801|andrea.wartenberg-demand@biotest.com|0
20545125|NCT00745849|University of Texas Southwestern|Ganesh Shanmugam, MD|9797036112|ganesh01@yahoo.com|
20545126|NCT05111301|Tandem Diabetes Care|Supervisor, Clinical Operations|(877) 801-6901|clinicalaffairs@tandemdiabetes.com|
20545127|NCT01754727|AbbVie|Global Medical Information|800-633-9110||
20545128|NCT02785770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545129|NCT03968939|UMissouri - Missouri Orthopaedic Institute|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20545130|NCT04838977|University of Utah|Heather Keenan|8015877567|heather.keenan@hsc.utah.edu|
20545131|NCT04126278|NYU Langone Health|Mehul Shah|616-501-7223|Mehul.Shah@nyulangone.org|
20545132|NCT01421472|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20545133|NCT00856232|UMDNJ|Dr. Boris Veysman|732-235-8717|veysmabo@umdnj.edu|
20545134|NCT00621348|AIIMS|Rakesh Lodha|91 11 26593621|rakesh_lodha@hotmail.com|
20545135|NCT02453347|Audie L. Murphy Veterans Administration Hospital|Dr. Carlos Jaramillo|210-617-5300|jaramilloc3@uthscsa.edu|15773
20545136|NCT02597478|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
20545137|NCT05043142|Yuria-Pharm|Tetiana Sprynsian|+380665134849|Tetiana.Sprynsian.pm@pharmaxi.com.ua|
20545138|NCT01256190|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20545139|NCT04931888|Yale University|Julia Rosenberg, MD MHS|2037777411|julia.rosenberg@yale.edu|
20545140|NCT02350478|Medical University of Graz|Assoz.-Prof. Dr. Harald Sourij|+43316385|ha.sourij@medunigraz.at|81310
20545141|NCT02779556|University of Arkansas for Medical Sciences|Kristie Hadden, PhD/Associate Professor|501-993-3178|KBHADDEN@uams.edu|
20545142|NCT03364270|Cedars-Sinai Medical Center|Balaji Tamarappoo, MD|3104232219|Balaji.Tamarappoo@cshs.org|
20545143|NCT04915950|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20545144|NCT02644109|Nutrition and Food Technology Institute, University of Chile|Dr. Sandra Hirsch|+56229781495|shirsch@inta.uchile.cl|
20545145|NCT00918736|Veterans General Hospital, Kaohsiung, Taiwan|Shu-Fen Sun|886-73422121|sfsun.tw@yahoo.com.tw|4210
20545146|NCT01942733|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
20545147|NCT02625909|The Kirby Institute|Pip Marks, Clinical Trials Manager|+61 2 9385 0886|pmarks@kirby.unsw.edu.au|
20545148|NCT01980589|Amgen, Inc.|Study Director|866-572-6436||
20545149|NCT04080167|St. Jude Children's Research Hospital|Jane Hankins, MD|(901) 595-4974|jane.hankins@stjude.org|
20545150|NCT02167139|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534|dh01.shin@samsung.com|
20545151|NCT01297491|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20545152|NCT00518089|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20545153|NCT00312195|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
20545154|NCT00324961|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545155|NCT00344487|University of Maryland Institute of Human Virology|Charles E. Davis, Jr. MD|410-706-1684|cdavis@ihv.umaryland.edu|
20545156|NCT01247272|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20545157|NCT01966718|Arthritis Treatment Center|Dr. Nathan Wei|301-694-5800|nwei@arthritistreatmentcenter.com|
20545158|NCT02791763|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|7343
20545159|NCT03686007|City of Hope Medical Center|Dr. Virginia Sun|626-359-8111|VSun@coh.org|
20545160|NCT01456897|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
20545161|NCT01400880|University of Florida|Dr. Tony Gregg|352-265-0111|greggar@ufl.edu|
20545162|NCT01396070|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
20545163|NCT04254913|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20545164|NCT01396057|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20545165|NCT01761240|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20545166|NCT01233232|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20545167|NCT00268853|Institut de Recherches Internationales Servier|Anton Egorov, Associate Project Director Clinical Development|+33 1 55 72 31 94|anton.egorov@servier.com|
20545168|NCT02917122|National Cheng Kung University|Dr. Kao Chin Chen|+886-6-2353535|andchen@mail.ncku.edu.tw|5213
20545169|NCT03574181|Boston Medial Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
20545170|NCT01708902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545171|NCT00442364|BTG International Inc|David DI Wright MB BS|610-278-1660|david.wright@btgplc.com|
20545172|NCT02633020|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20545173|NCT00934440|University of Kansas Cancer Center|Dr. Peter Van Velduizen|(913) 945-5059|SWILLIAM@kumc.edu|
20545174|NCT05661851|Johnson & Johnson Vision Care, Inc. (JJVC)|Principal Research Optometrist|(347) 903-5029|njoshi30@its.jnj.com|
20555416|NCT03277313|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20508405|NCT01855945|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20555417|NCT03431168|UAB|Dr. Jodie Dionne|2059756530|jdionne@uabmc.edu|
20545175|NCT00530816|Onyx Pharmaceuticals, Inc.|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
20555418|NCT03708198|UVA Health|William Manson, MD|4349242283|wcm6m@virginia.edu|
20508406|NCT02156804|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20545176|NCT02152956|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20545177|NCT01014910|Children's Mercy Hospital Kansas City|Dr. Russell McCulloh|816-234-3061|rmcculloh@cmh.edu|
20545178|NCT02445794|Retrotope, Inc|Frederic Heerinckx/VP Clinical Operations|650-437-0700|frederic@retrotope.com|109
20545179|NCT01136785|The University of Chicago|Dr. Eve Van Cauter/Dr. Babak Mokhlesi|773-702-0169 or 773-702-2181|evcauter@medicine.bsd.uchicago.edu; bmokhles@medicine.bsd.uchicago.edu|
20545180|NCT01388985|Institute of Tropical Medicine Antwerp|Dr. Patrick Soentjens|+32 3 247 66 41|psoentjens@itg.be|
20545181|NCT03761368|Medical University of Łódź|Karolina Stokfisz|+48422014260|stokfisz.karolina@gmail.com|
20545182|NCT02654769|Teva Pharmaceuticals Inc., USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
20545183|NCT01794338|Carolinas HelathCare System|Research Director|704-355-3168|Amy.Lincourt@carolinashealthcare.org|
20545184|NCT04473235|Universidade Federal de Minas Gerais|Elisa de Paula França Resende|+55 31 3307 9417|elisa.resende@gbhi.org|
20545185|NCT01754402|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
20545186|NCT01282463|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545187|NCT00798759|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20545188|NCT03320824|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
20545189|NCT00955305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20545190|NCT00109590|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20545191|NCT02123251|University of Hawaii, Center on Disability Studies|Dr. Chuan Chinn|8089565379|chuanc@hawaii.edu|
20545192|NCT01221285|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20545193|NCT03387111|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20545194|NCT00407381|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
20545195|NCT01945710|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20545196|NCT02730195|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
20545197|NCT02338882|University of Plymouth|Dr Phillip Buckhurst|01752 588884|phillip.buckhurst@plymouth.ac.uk|
20545198|NCT01328405|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
20545199|NCT01904773|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicines Unit|Joel Posener, MD - Head, Early Clinical Development||ClinicalTrialTransparency@astrazeneca.net|
20545200|NCT04518995|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20545201|NCT03390101|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
20545202|NCT01511055|Mayo Clinic|Sean C. Dowdy, M.D.|507-266-0225|Dowdy.Sean@mayo.edu|
20545203|NCT00480987|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
20545204|NCT00813943|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20545205|NCT01235598|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
20545206|NCT02151773|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
20545207|NCT02551991|Ipsen Bioscience, Inc.|Medical Director|see email|clinical.trials@ipsen.com|
20545208|NCT00395343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20545209|NCT00265148|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545210|NCT03101111|Themis Bioscience|Christiane Thomasser|01 236 7151|christiane.thomasser@themisbio.com|
20545211|NCT02507960|University of Maryland Medical Center|Elizabeth Nichols|4103287586|enichols1@umm.edu|
20545212|NCT05525078|Medical University of South Carolina|Tracy Smith, PhD|843 792 5164|smithtra@musc.edu|
20545213|NCT00942994|Novartis Pharmaceuticals|Study Director|862-778-8300||
20545214|NCT03583385|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20545215|NCT04780919|Charles University, 2nd Faculty of Medicine|Jakub Katolicky|+420 739 081 676|jakub@katolicky.eu|
20545216|NCT00095940|Pediatric Brain Tumor Consortium|Assistant Director Operations and Biostatistics Center|901-595-2617|dana.wallace@stjude.org|
20545217|NCT00387790|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20545218|NCT04491604|Krystal Biotech|Dr. Hubert Chen, MD, Senior Vice President of Clinical Development|(412) 586-5830|inquiries@krystalbio.com|
20545219|NCT00296296|Stanford University|Stephan Busque, MD|650-498-6189|sbsuque@stanford.edu|
20545220|NCT01874340|Novartis|Study Director|862-778-8300||
20545221|NCT03029988|Navidea Biopharmaceuticals|Bonnie Abbruzzese Senior Director|614.793.7500|babbruzzese@navidea.com|147
20545222|NCT03539549|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20545223|NCT00641641|University of New South Wales|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
20545224|NCT01290913|Boston Children's Hospital|Clinical Coordinator|6173556127|sara.little@childrens.harvard.edu|
20545225|NCT03241030|Baylor College of Medicine|Nidhi Singh, MD|832-824-2771|nidhi.singh@bcm.edu|
20545226|NCT02864862|The University of Texas Health Science Center at Houston|Chun-Teh Lee|713-486-4384|Chun-Teh.Lee@uth.tmc.edu|
20545227|NCT04605991|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20545228|NCT02191865|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20545229|NCT01523275|University of California, San Francisco|Jolie Chang|415-353-2203|jolie.chang@ucsf.edu|
20545230|NCT03263702|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
20545231|NCT03598114|Washington University School of Medicine|Sarah Moreland-Russell, Ph.D., MPH|314-935-8382|smoreland-russell@wustl.edu|
20545232|NCT02527200|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20545233|NCT00689117|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545234|NCT01206322|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
20545235|NCT00444678|NYU Langone Health|Deirdre Cohen, MD|212-731-5656|Deirdre.Cohen@nyulangone.org|
20545236|NCT01324518|Orion Global Clinical Operations|Clinical Study Director||jutta.hanninen@orionpharma.com|
20545237|NCT03236662|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
20545238|NCT05573386|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
20545239|NCT03646123|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545240|NCT00332722|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|101
20545241|NCT02657408|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545242|NCT02447302|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20545243|NCT05334212|University Hospitals Cleveland Medical Center|Dr. Gabriel Smith|(440)827-5088|Gabriel.Smith@UHhospitals.org|
20545244|NCT00910299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545245|NCT02428478|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
20545246|NCT01442844|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
20545247|NCT01430169|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20545248|NCT01057589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545249|NCT03098615|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
20545250|NCT02281383|Memorial Sloan Kettering Cancer Center|Dr. Harry Herr, MD|646-422-4411|herrh@MSKCC.ORG|
20545251|NCT01215097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545252|NCT02252939|Massachusetts General Hospital|Rachel Gottlieb, Research Coordinator|617-726-1569|rgottileb3@mgh.harvard.edu|
20545253|NCT01516034|Dr David Friedman Laser & Skin Center|David J. Friedman, Principal Investigator|+972-2-5635673|drfriedmanlaser@gmail.com|
20545254|NCT01033448|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20545255|NCT00870584|Novartis Pharmaceuticals|Study Director|862-778-8300||
20545256|NCT01497366|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20545257|NCT03911102|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20545258|NCT00419445|CoMentis (formerly Athenagen)|Carl Grove|650-869-7600|cgrove@comentis.com|
20545259|NCT03508908|Aurum Institute|Dr. Eduard Sanders|254723593762|ESanders@auruminstitute.org|
20545260|NCT01881828|Jaeb Center for Health Research|Kellee Miller|15310 Amberly Drive|t1dstats@jaeb.org|
20545261|NCT00472030|University of Iowa|Janet Fairley, M.D.|319-384-8560|janet-fairley@uiowa.edu|
20545262|NCT00829504|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20545263|NCT04189224|Johnson & Johnson Vision Care, Inc.|Thomas R Karkkainen.|1-800-843-2020|tkarkkai@its.jnj.com|
20545264|NCT05283031|Imperial College Ophthalmology Research Group|Jamie Spofforth|020 3312 6666|Jamiespofforth@nhs.net|
20545265|NCT03254459|Insys Therapeutics, Inc.|Director, Clinical Development|4805003105|gdecastro@insysrx.com|
20545266|NCT04540510|Nuvance Health (formerly Western Connecticut Health Network)|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
20545267|NCT01129583|Columbia University Medical Center|TTC research fellow|212-305-3912|ttc@gmail.com|
20545268|NCT04672954|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545269|NCT00830869|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20545270|NCT00395057|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20545271|NCT00281658|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20545272|NCT00669409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545273|NCT04590248|AstraZeneca Clinical Study Information Centre|Global Clinical Head|+1-877-240-94 79|information.center@astrazeneca.com|
20545274|NCT01109056|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20545275|NCT02052414|The Center for Clinical Research|James M. North MD|3367656181|jnorth1@ccrpain.com|
20545276|NCT01816711|Aarhus University Hospital|Mette Abildgaard Pedersen|31411180|meabpe@rm.dk|
20545277|NCT01303003|Steward St. Elizabeth's Medical Center|Meghan Cashman, IRB Manager|617-789-2804|meghan.cashman@steward.org|2804
20545278|NCT05011279|Dana-Farber Cancer Institute|Catherine Marinac|617-632-4703|CatherineR_Marinac@dfci.harvard.edu|
20545279|NCT05367492|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
20545280|NCT00353470|Albert Einstein College of Medicine|Barbara Milrod, M.D., PI|212-595-0806|bmilrod@montefiore.org|
20545281|NCT04978454|Duke University Medical Center|Christopher Woods|919-684-7916|chris.woods@duke.edu|
20545282|NCT01971086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508407|NCT01112982|University of South Florida|John Carter, M.D|813-974-2473|mpatelli@health.usf.edu|
20545283|NCT01343693|Zimmer Biomet Spine|Zimmer Biomet Spine Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
20545284|NCT02891070|Baxter Healtcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20545285|NCT02704143|Changhai Hospital affiliated to Navy Medical University|Dr. Huojun Zhang|86-021-31162207|chyyzhj@163.com|
20545286|NCT00260962|Ottawa Hospital Research Institute|Dr. Hany Bissada|613-798-5555|hbissada@ottawahospital.on.ca|78042
20545287|NCT01179113|Cedars Sinai Medical Center|Dr. Roya Yumu', Anesthesiology Program Director|310-423-1682|Roya.Yumul@cshs.org|
20545288|NCT02888119|NYU Langone Health|Dr. Ravinder Regatte|(212) 263-4857|Ravinder.Regatte@nyulangone.org|
20545289|NCT01767142|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20545290|NCT04726969|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
20545291|NCT04975230|Case Western Reserve University|Stephanie Griggs|404-544-9915|stephanie.griggs2@emory.edu|
20545292|NCT01996839|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20545293|NCT00926029|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20545294|NCT02471612|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
20545295|NCT03206788|Kansas University Medical Center|Dr. Matthias Salathe|913 588 6045|msalathe@kumc.edu|
20545296|NCT00833417|Genentech, Inc.|Medical Communications|800-821-8590||
20545297|NCT03330002|Essential Medical, a wholly owned subsidiary of Teleflex, Inc.|Darra Bigelow, Clinical Trials Manager|610-331-7299|darra.bigelow@teleflex.com|
20545298|NCT01625260|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20545299|NCT03899805|Dana Farber Cancer Institute|Suzanne George MD, PI|6176326826|suzanne_george@dfci.harvard.edu|
20545300|NCT05246514|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20545301|NCT02209532|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
20545302|NCT01802073|Stanford University|Dr. Kenneth Cox|(650) 723-5070|KCox@stanfordchildrens.org|
20545303|NCT02291016|University of Tennessee Graduate School of Medicine|Clinical Trials Coordinator|865-305-7975|jferris@utmck.edu|
20545304|NCT01776307|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
20545305|NCT03236155|Rush University Medical Center|Anne DeBenedetti, CRC|3124322468|anne.debenedetti@rushortho.com|
20545306|NCT02745145|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20545307|NCT03083990|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
20545308|NCT01018810|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545309|NCT02424578|Iroko Pharmaceuticals|SVP Medical Affairs, Pharmacovigilance and Medical Information|2675463003|eoimagosie@iroko.com|3182
20545310|NCT02902484|UT Southwestern Medical Center|Dr. Salwan Al Mutar|214-648-4008|salwan.almutar@utsouthwestern.edu|
20545311|NCT05871450|German University of Health and Sports|Wolfgang Ruf|+49 (030) 577 97 37 370|wolfgang.ruf@dhgs-hochschule.de|
20545312|NCT02872935|University of Iowa|Dr. Kokila Thenuwara|319-384-5876|kokila-thenuwara@uiowa.edu|
20545313|NCT05343624|University Hospitals Cleveland Medical Center|Dr. Tanureet Arora|(440)892-6424|Tanureet.Arora@UHhospitals.org|
20545314|NCT00862082|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
20545315|NCT05405257|Baylor College of Medicine|Keren Machol|7137987359|machol@bcm.edu|
20545316|NCT01901250|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu|
20545317|NCT00916929|St Jude Medical|Tamara Shipman|408 522-6410|tshipman@sjm.com|
20545318|NCT02645019|Nationwide Children's Hospital|Mineto Kamada|6147224200|mineto.kamata@gmail.com|
20545319|NCT00782834|Fox Chase Cancer Center|Margaret von Mehren, M.D., Director of Sarcoma Oncology|215-728-2814|margaret.vonMehren@fccc.edu|
20545320|NCT02055118|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20545321|NCT01955629|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20545322|NCT00580671|Geisel School of Medicine at Dartmouth|Alan J. Budney, PhD|855-290-2822|alan.j.budney@dartmouth.edu|
20545323|NCT01221311|Medical University of South Carolin|Gregory Cote|843-876-4261|cotea@musc.edu|
20545324|NCT02560025|Massachusetts General Hospital|Amir Fathi, MD|617-724-1124|AFATHI@mgh.harvard.edu|
20545325|NCT02703337|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545326|NCT03800420|Clinical Trials_inquiries|Clinical Trials_inquiries|+82-31-8092-3280|clinicaltrials.gov_inquiries@bridgebiorx.com|
20545327|NCT00746512|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20545328|NCT02745080|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20545329|NCT00282308|Genentech, Inc.|Medical Communications|800 821-8590||
20545330|NCT00329524|UAMS Department of Otolaryngology|John Dornhoffer, MD|501-686-7000|dornhofferjohnl@uams.edu|
20545331|NCT05073432|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
20545332|NCT01001325|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
20545333|NCT02758184|Duke University|Sergio Mendoza Lattes, M.D.|919-684-2023|sergio.mendoza@duke.edu|
20545334|NCT01584440|Avanir Pharmaceuticals, Inc.|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
20545335|NCT04237116|Novartis Pharma GmbH|Study Director|(862) 778-8300|novartis.email@novartis.com|
20545336|NCT00899431|The University of Texas MD Anderson Cancer Center|Dr. Issa F. Khouri, MD/Professor, Stem Cell Transplantation|713- 745-0049|ikhouri@mdanderson.org|
20571150|NCT03199469|Astellas Pharma Global Development, Inc. (APGD)|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20508408|NCT00389441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545337|NCT03212144|Columbia University|Dr. Richard Sloan|6467748947|rps7@columbia.edu|
20545338|NCT00661427|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
20545339|NCT00599339|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20545340|NCT05564052|Janssen Research & Development, LLC|Sr. Director Clinical Sciences Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20545341|NCT01821560|University of Pennsylvania|Dr. Teresa R. Franklin|215-746-1883|teresafr@pennmedicine.upenn.edu|
20545342|NCT01338298|Maryland Psychiatric Research Center|AnnMarie Kearns, MS|4104066854|akearns@som.umaryland.edu|
20545343|NCT00531427|Purdue Pharma|Clinical Leader, Executive Medical Director|800-733-1333||
20545344|NCT02712047|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20545345|NCT02051933|CarolinasHS|Christine Churchill|704-355-6947|christine.churchill@carolinashealthcare.org|
20545346|NCT00594945|Jazz Pharmaceuticals, Inc.|Executive Director, Clinical Development|650 496 3777||
20545347|NCT00588861|Biomet Manufacturing|Nick Higdon, Clinical Research Specialist|1-800-348-9500|nicholas.higdon@biomet.com|3047
20545348|NCT02438358|Lumicell|Jorge Ferrer, Ph.D.|617-571-0592|jmferrer@lumicell.com|
20545349|NCT00923949|National Cancer Institute|Giuseppe Giaccone M.D.|301-496-4916|giacconeg@mail.nih.gov|
20545350|NCT02165839|Stanford University|Oxana Palesh, Associate Professor of Psychiatry and Behavioral Sciences|(650) 725-7011|oxana.palesh@stanford.edu|
20545351|NCT02848729|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20545352|NCT03861988|Stanford University|Boris Heifets, MD, PhD|(650) 497-8057|bheifets@stanford.edu|
20545353|NCT02617485|Mabion S.A.|Adam Tuszyner|+48504441105|a.tuszyner@mabion.eu|
20545354|NCT00220779|Talecris Biotherapeutics|Ralph Kantor, PhD|1-800-520-2807|ralph.kantor@talecris.com|
20545355|NCT00791076|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20545356|NCT04434846|NIH|Jessica Manning|+85561856557|Jessica.manning@nih.gov|
20545357|NCT01049945|Mayo Clinic|Shaji K. Kumar, M.D.||kumar.shaji@mayo.edu|
20545358|NCT02248675|VA Center of Excellence for Suicide Prevention|Wilfred R. Pigeon, PhD|(585) 393-7945|wilfred.pigeon2@va.gov|
20545359|NCT04565327|University of California, San Francisco|Dr. Zhen Wang, MD|(415) 476-3767|Zheng.Wang@ucsf.edu|
20545360|NCT02506985|University of Kentucky|Susan Smyth|859-323-2274|susansmyth@uky.edu|
20545361|NCT03745820|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20545362|NCT00507728|UT MD Anderson Cancer Center|Paul M Cinciripini, MD, Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
20545363|NCT03619811|UCSD|Clinical Research Coordinator|858-246-5236|mgreytak@ucsd.edu|
20545364|NCT01734889|Swedish Orphan Biovitrum|Medical Director|+46 8 697 20 00|erik.brouwer@sobi.com|
20545365|NCT00966875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545366|NCT00802113|Columbia University|Prakash Satwani, MD|(212) 305-0223|ps2087@cumc.columbia.edu|
20545367|NCT01589653|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20545368|NCT01536067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20545369|NCT02747433|MGH Institute of Health Professions|Susan Fasoli, ScD OTR/L, Associate Professor|617-643-4777|sfasoli@mghihp.edu|
20545370|NCT02386189|Iowa City VA Health Care System|Dr. Carolyn Turvey|319 358 9501|carolyn.turvey@va.gov|7714
20545371|NCT04657666|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20545372|NCT00606905|University of Chicago|Mary D. Stephenson, M.D. MSc|773 834-1167|mstephen@babies.bsd.uchicago.edu|
20545373|NCT03120351|ClevelandCF|Bruce Vrooman|216-444-2200|vroomab@ccf.org|
20545374|NCT01651806|Rush University Medical Center|Brett Levine, MD|708.236.2664|levine.research@rushortho.com|
20545375|NCT01790243|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
20545376|NCT01558128|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
20545377|NCT04250077|We The Village|Jane Macky, CEO|9176844267|jane@wethevillage.co|
20545378|NCT01022398|Creighton University|Cardiology Research Manager|402-280-4566|tammyburns@creighton.edu|
20545379|NCT04693052|Northwestern University|Dr. Jeffrey Rado, MD,MPH,FAPA|312-695-5060|jeffrey.rado@nm.org|
20545380|NCT03319745|The University of Texas MD Anderson Cancer Center|Dr. Neema Navai|(713) 792-3250|nnavai@mdanderson.org|
20545381|NCT01317550|MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|713-563-2300|zliao@mdanderson.org|
20545382|NCT00870103|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20545383|NCT03255629|Joslin Diabetes Center|Mary Elizabeth Patti, MD|(617) 309-2635|MaryElizabeth.Patti@joslin.harvard.edu|
20545384|NCT04540198|Baylor Scott & White Health Research Institute|Dr. Alan Stevens|254-215-9885|alan.stevens@bswhealth.org|
20545385|NCT04075734|Rutgers Cancer Institute of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
20545386|NCT01137604|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20545387|NCT01584544|Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College|Dr. Jing Jin|8601087788122|jingjin1025@163.com|
20545388|NCT01024309|OrthoCarolina Research Institute|Dr. Susan Odum|704.323.2265|Susan.Odum@OrthoCarolina.com|
20545389|NCT00329797|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20545390|NCT01472718|Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana,|Marco De Carlo, MD, PHD|+39 050995326|marcodecarlo@gmail.com|
20545391|NCT02093819|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545392|NCT01469715|University of Virginia|Stacey Anderson, MD||sg4c@virginia.edu|
20545393|NCT00862641|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20545394|NCT03179605|Prosoft Clinical|Robert Babilon President|4843202068|b.babilon@prosoftclinical.com|
20545395|NCT00635999|Penn State University|Michelle G. Newman|814-863-1148|mgn1@psu.edu|
20545396|NCT00711477|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
20545397|NCT03037580|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
20545398|NCT03500224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20545399|NCT01324401|Harvard Medical School / Massachusetts General Hospital|Wayne Shreffler|617-726-6147|wshreffler@mgh.harvard.edu|
20545400|NCT00335764|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-3657|jfisher@jhmi.edu|
20545401|NCT00499590|OPKO Health, Inc.|Jane Hsiao, PhD, MBA|305-575-6004|jhsiao@opko.com|
20545402|NCT01980485|Penn State University|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
20545403|NCT02873429|University of Pittsburgh|Carol M. Greco, Associate Professor of Psychiatry|412-623-6873|grecocm@upmc.edu|
20545404|NCT00612807|Duke University Medical Center|Jill Compton, Ph.D.|919-416-2089|compton@duke.edu|
20545405|NCT03435783|Brown University School of Public Health|Tyler Wray|401-863-6659|tyler_wray@brown.edu|
20545406|NCT00744042|Alexion Pharma GmbH|Alexion Pharma GmbH||ClinicalTrials@alxn.com|
20545407|NCT01567839|The Ohio State University, Division of Endodontics|Dr. John Nusstein|614-292-9412|nusstein.1@osu.edu|
20545408|NCT00853567|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20545409|NCT02259088|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20545410|NCT00932828|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20545411|NCT01818752|Amgen Inc.|Study Director|866-572-6436||
20545412|NCT04270370|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20545413|NCT01324141|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
20545414|NCT02872285|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
20545415|NCT06457204|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20545416|NCT03524729|VA|Dr. Sangeorzan|206-516-3261|bruce.sangeorzan@va.gov|
20545417|NCT01031836|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20545418|NCT00490529|Stanford University|Ronald Levy|650-725-6452|levy@stanford.edu|
20545419|NCT04507373|UT Southwestern Medical Center|Dr. Zahid Ahmad|214/648-2377|ZAHID.AHMAD@UTSouthwestern.edu|
20545420|NCT02793856|West China Hospital, Sichuan University|You Lu|+862885423571|283494287@qq.com|
20545421|NCT00617669|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20545422|NCT01410357|Case Western Reserve University School of Medicine and Neurological Institute|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org|
20545423|NCT03630770|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org|
20545424|NCT01710137|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
20545425|NCT04620213|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
20545426|NCT03467152|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20545427|NCT00945906|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20545428|NCT04583709|Geisinger Heart Institute|Pugazhendhi Vijayaraman|5708085444|pvijayaraman1@geisinger.edu|
20545429|NCT01086358|Cleveland Clinic Foundation|Jennifer Kriegler, MD|216-444-8265|krieglj@ccf.org|
20545430|NCT03317405|Northwestern University|Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
20545431|NCT01999517|Mount Sinai Medical Center|Gervasio Lamas, MD|305-674-2162|gervasiolamas@gmail.com|
20545432|NCT00591318|New York State Psychiatric Institute|Brian Fallon|646-774-8052|brian.fallon@nyspi.columbia.edu|
20545433|NCT01743001|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
20545434|NCT03194737|Teleflex/NeoTract|Emily Friedland, Director, Global Clinical Operations|925.387.6014|emily.friedland@teleflex.com|
20545435|NCT03052426|West Virginia University|Dr. Brandy Brown|304-293-1955|bkenned2@hsc.wvu.edu|
20545436|NCT03764293|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Yongli Xie|18581831003|yongli.xie@hengrui.com|
20545437|NCT05051631|Vanderbilt University Medical Center|Dr. Lucy Spalluto|615-875-5649|lucy.b.spalluto@vumc.org|
20508409|NCT00305604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20545438|NCT03679754|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
20545439|NCT00964171|Institut Bergonié|Dr Marianne Fonck|05.56.33.32.42|m.fonck@bordeaux.unicancer.fr|
20555419|NCT01218438|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20555420|NCT01932164|Hospital Sirio Libanes|Dra Daniela Franco Bueno|+5511997900159|dbuenousp@gmail.com|
20555421|NCT00045110|Adult Brain Tumor Consortium|Lauren E Abrey, MD|410-955-8837|jfisher@jhmi.edu|
20555422|NCT03662750|Imperial College London|Prof Roland Veltkamp|020 3311 7296|r.veltkamp@imperial.ac.uk|
20555423|NCT01496352|Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD, VP, Drug Development|609-375-9855|kallenby@drreddys.com|
20555424|NCT05872035|Apple|Rajiv Kumar, MD|8669055303|htclinicalquestions@apple.com|
20555425|NCT01760239|HealthPartners Institute|Elyse Kharbanda, MD MPH|952-967-5038|Elyse.O.Kharbanda@healthpartners.com|
20555426|NCT01983293|Abbott|Clay Cohorn|1 972 309 8087|clay.cohorn@abbott.com|
20555427|NCT03147248|Celltrion. Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
20555428|NCT03750552|Theravance Biopharma Inc|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20555429|NCT00773968|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20555430|NCT02241967|Ralph H. Johnson VA Medical Center|Jeffrey Borckardt, Ph.D|843-792-3295|Jeffrey.Borckardt@va.gov|
20555431|NCT03929029|Dana Farber Cancer Institute|Dr. Patrick A. Ott|6175829030|patrick_ott@dfci.harvard.edu|
20555432|NCT04517396|University of Pennsylvania|Katherine Greene|215-662-7580|katherine.greene@pennmedicine.upenn.edu|
20555433|NCT02008890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20555434|NCT02522494|Jesse Brown VA Medical Center|Howard S. Gordon, MD|(312) 569-7331|howard.gordon2@va.gov|
20555435|NCT03240588|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20555436|NCT01449305|isRed Pharma & Biotech Research Corporation|Mirror Hsieh|886-8-7628188|mingrong@bioisred.com|
20555437|NCT02091726|University of New England|Peter S. Millard, MD, PhD|2072992131|pmillard@mac.com|
20555438|NCT01780922|Washington State Unviversity|Boon P. Chew|5093351427|boonchew@wsu.edu|
20545440|NCT00080899|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|: 60094
20555439|NCT01227681|Buddhist Tzu Chi General Hospital Hualien|Dr. Chen Shin-Yuan|+886-3-8561825|william.sychen@msa.hinet.net|2151
20555440|NCT02047045|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
20555441|NCT04066114|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20545441|NCT04615832|Fisher & Paykel Healthcare Ltd.|Bhavi Ogra|+64 9 574 0123|bhavi.ogra@fphcare.co.nz|7882
20545442|NCT02640508|UT Health San Antonio|Virginia Kaklamani, MD|210-450-3838|kaklamani@uthscsa.edu|
20545443|NCT00776919|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545444|NCT03116152|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
20545445|NCT02410343|Teva Branded Pharmaceutical Products|Director of Clinical Trials|215-591-3000|Public_CTD@tevapharm.com|
20545446|NCT02036853|Cook Children's Health Care System|Director of Research Operations|682-885-2103|CookChildrensResearch@cookchildrens.org|
20545447|NCT02692391|Ohio State University|Georgios Papachristou, MD PhD|6142836255|georgios.papachristou@osumc.edu|
20545448|NCT00800254|University of Colorado Denver|Jennifer Stevens-Lapsley, PhD|303-724-9170|jennifer.stevens-lapsley@ucdenver.edu|
20545449|NCT02660983|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
20545450|NCT01224145|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20545451|NCT02902146|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
20555442|NCT00803647|NSABP Foundation|Diana Gosik, Director Department of Site and Study Management|412-339-5333|diana.gosik@nsabp.org|
20555443|NCT00856856|Abbott Vascular International BVBA|Susan Veldhof|31653428610|susan.veldhof@av.abbott.com|
20555444|NCT00728819|Penn Medicine|Associate Professor of Radiology|2156627892|ITKINMAX@GMAIL.COM|
20555445|NCT00434057|Electro-Optical Sciences, Inc.|Joanna Adrian / Director, Clinical Operations and Medical Affairs|(914)591-3783|adrian@eosciences.com|732
20555446|NCT00455195|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20508410|NCT00636441|Duke University Medical Center|P. Kelly Marcom, M.D.|919-684-3877|marco001@mc.duke.edu|
20508411|NCT00049504|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.gov|
20545452|NCT01253577|Intersect ENT|James Stambaugh, Vice President Clinical Affairs|650-641-2103|jstambaugh@intersectent.com|
20555447|NCT02117570|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
20555448|NCT02148250|University of Minnesota|Elizabth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
20545453|NCT00721968|Glaukos|Jeff Wells. Sr VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
20545454|NCT05601544|Johnson & Johnson Vision Care, Inc. (JJVC)|Senior Principal Research Optometrist|904-608-7238|jbuch@its.jnj.com|
20545455|NCT04303195|Neurogastrx|Chief Scientific Officer|17817304040|info@neurogastrx.com|
20545456|NCT01064947|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
20545457|NCT02970942|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20545458|NCT00508196|University of Dundee|DR Anna Maria Choy|01382 383482|a.choy@dundee.ac.uk|
20545459|NCT01065454|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20545460|NCT00773604|University of California, San Francisco|Jill Ostrem|415-353-7885|Jill.Ostrem@ucsf.edu|
20545461|NCT01601652|UC Davis|Arthur J de Lorimier, Director of Pediatric Gastroenterology|916-734-3112|adelorimier@ucdavis.edu|
20545462|NCT05688670|Duke University Medical Center|Lisa Einhorn, M.D.|(919) 668-4000|lisa.einhorn@duke.edu|
20545463|NCT00273793|UTexas_SanAntonio|Dr. RJ Lamb|210-567-5480|lamb@uthscsa.edu|
20545464|NCT00488683|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20545465|NCT01548833|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20545466|NCT03818035|Janssen Research & Development LLC|GUIDE-Study Responsible Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20545467|NCT00982423|Mayo Clinic|Dr. Horng Chen|507-538-2354|chen.horng@mayo.edu|
20545468|NCT03374202|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20545469|NCT05286749|UW School of Medicine and Public Health|Tana Chongsuwat, MD, MPH|224-260-1666|tana.chongsuwat@fammed.wisc.edu|
20545470|NCT03680742|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
20545471|NCT01248104|Loma Linda University Medical Center|Dr. Jason Gatling|909-558-4475|jgatling@llu.edu|44475
20545472|NCT02894502|University of Rome Tor vergata, Rome, Italy|Dr. Ercole Vellone|+393387491811|ercole.vellone@uniroma2.it|
20545473|NCT00615901|Memorial Sloan Kettering Cancer Center|Dr. Pamela Drullinksy|516-256-3955|drullinp@mskcc.org|
20545474|NCT03700684|University of Massachusetts Amherst|Kelly Richardson|413-545-2007|krichardson@umass.edu|
20545475|NCT01120782|Johnson & Johnson Vision Care|Ross Franklin, OD|1-904-443-1379|RFrankl1@its.jnj.com|
20545476|NCT04140227|Bausch and Lomb|Johnson Varughese VP Clinical Services|908-927-1162|johnson.varughese@bausch.com|
20545477|NCT00635219|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20545478|NCT02420015|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|175526
20545479|NCT00796445|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545480|NCT02737891|Saniona A/S|Kim Krogsgaard|20148384|kim.krogsgaard@saniona.com|0045
20545481|NCT00388583|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20545482|NCT05194579|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545483|NCT01988584|The University of Texas Health Science Center at Houston|Charles S. Cox, MD, Professor|713-500-7300|charles.s.cox@uth.tmc.edu|
20545484|NCT03595228|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422|medical.information_us@bavarian-nordic.com|8274
20545485|NCT01639729|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
20545486|NCT03232333|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
20545487|NCT01253811|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20545488|NCT01087736|University of California, San Francisco|David L. Pennington, PhD (Research Psychologist II)|415-221-4810|david.pennington2@va.gov|4504
20545489|NCT00759564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545490|NCT03495856|University of North Carolina School of Medicine|Carrie Brintz|919-445-6109|carrie_brintz@med.unc.edu|
20545491|NCT00435045|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545492|NCT00567255|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
20545493|NCT05037578|University of Kansas Alzheimer's Disease Research Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
20545494|NCT05387434|University of Kansas Medical Center|Dr. Anna Gorczyca|913-588-9077|agorczyca@kumc.edu|
20545495|NCT04233918|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20545496|NCT01853839|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545497|NCT04145219|ALK-Abelló A/S|Vice President, Clinical Operations Strategy|+45 4574 7576|clinicaltrials@alk.net|
20545498|NCT01640314|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20545499|NCT03672097|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20545500|NCT01290796|Bard Medical Division|Jaime Ritter, MPH, CCRP, CIC|770-784-6437|jaime.ritter@crbard.com|
20545501|NCT01632267|AssureRx|Joel Winner, MD|513-234-0510|jwinner@assurerxhealth.com|
20545502|NCT02709538|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20545503|NCT05099263|Aerin Medical|Anais Laborde, Sr. Director of Clinical Operations|6505189624|alaborde@aerinmedical.com|
20545504|NCT00835211|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20545505|NCT01838980|Motus GI Medical Technologies Ltd.|Medical Consultant|+972-4-6214446|rose@motusgi.com|104
20545506|NCT02343549|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20545507|NCT03087617|Imbio, Inc|Director of Engineering|612520360|laurenkeith@imbio.com|2142
20545508|NCT01896206|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
20545509|NCT02160041|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|novartis.email@novartis.com|
20545510|NCT01403948|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545511|NCT04450381|Masimo Corporation|Vikram Ramakanth|949-297-7000|clincalresearchdept@masimo.com|
20545512|NCT01090323|Novartis Pharmaceuticals|Study Director|862-778-8300||
20545513|NCT05498701|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545514|NCT01864005|Astrazeneca|Judith Hsia|1-301-398-0102|judithhsia@astrazeneca.com|
20545515|NCT03899467|Suzhou Kintor Pharmaceuticals,Inc.|Millie Gu|+8651262639938|PR@kintor.com.cn|
20545516|NCT01962961|Indiana University School of Medicine|Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
20545517|NCT00763698|St. Jude Medical|Director, Clinical Affairs|(408) 522-6410|tshipman@sjm.com|
20545518|NCT02184572|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545519|NCT02495038|Yonsei University Wonju college of medicine|Dr. Wooyoung Park|563664250|wongulung28@gmail.com|971
20545520|NCT00006409|University of North Carolina - Chapel Hill|June Stevens|919-966-7218|june_stevens@unc.edu|
20545521|NCT01454258|University Hospital Frankfurt|Prof Dr Dr Kai Zacharowski, FRCA|004969630186668|kai.zacharowski@kgu.de|
20545522|NCT02636361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545523|NCT02448641|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
20545524|NCT02413151|University of Lisbon|Maria Helena Santa-Clara Pombo Rodrigues|00351917377277|santaclara@fmh.ulisboa.pt|
20527527|NCT01693185|Konkuk University Medical Center|Dr. Tae-Yop Kim, Professor of Anesthesiology|82-2-2030-5445|taeyop@gmail.com|
20527528|NCT00462449|Department of Physical Medicine and Rehabilitation University of Pittsburgh|Dr. Michael C. Munin|412-648-6848|muninm@upmc.edu|
20545525|NCT00228553|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20545526|NCT02663934|Washington University in St. Louis|Brittany Nelson, Senior Clinical Research Coordinator|314-747-8425|bmnelson@wustl.edu|
20545527|NCT04556383|GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB004, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
20545528|NCT00884741|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20545529|NCT00238355|OHSU Knight Cancer Institute|Dr. Lynne Strasfeld|503-494-1551|strasfel@ohsu.edu|
20545530|NCT02537015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20545531|NCT04219085|Yale University|Audrey Merriam|203-785-7813|audrey.merriam@yale.edu|
20545532|NCT04469998|AxeroVision, Inc.|Dr. Houman Hemmati|+1 (310) 600-4123|houman@axerovision.com|
20545533|NCT01097005|Mylan EPD Japan|Takao Miki, Medical Affairs||takao.miki@mylan.com|
20545534|NCT04627285|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20527529|NCT01017601|Mayo Clinic|Julian Molina, M.D, Ph.D.|507-284-1328|Molina.julian@mayo.edu|
20545535|NCT01948193|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20527530|NCT03292614|Dietrich-Bonhoeffer-Klinikum|Ulrike Holland|+49 395 775 3427|aug-st2@dbknb.de|
20527531|NCT00187278|St Jude Medical|Pascale Ducloux, Clinical Manager|+3227746709|pducloux@sjm.com|
20527532|NCT01857102|Johnson and Johnson Vision Care Inc.|Kathrine E. Osborn, OD, MS, FAAO- DIRECTOR GLOBAL STRATEGIC CLAIMS|904-443-1032|KOSBORN@its.jnj.com|
20527533|NCT01115556|Vitreous Retina Macula Consultants of New York|K. Bailey Freund, MD (or Galyna Ganieva, Research Manager)|212-861-9797|gganieva@vrmny.com|6929
20527534|NCT05604794|University of Toronto|Dr Chris Lo|65 6709 3003|chris.lo@utoronto.ca|203
20527535|NCT00090584|New England Research Institutes|Anne Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
20527536|NCT02735096|Innervo Technology|Dr. Hui Tang|5732896776|htang@innervotech.com|
20527537|NCT00497770|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20545536|NCT03338959|University of Washington|Lee Cranmer, MD, PhD, Sarcoma Program Director|206-606-7439|ldcranme@fredhutch.org|
20527538|NCT00438802|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
20527539|NCT01080391|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20527540|NCT04493151|Center for Anti-Infective Research and Development, Hartford Hospital|Dr. Joseph L. Kuti, PharmD, FIDP, FCCP|(860) 972-3612|Joseph.Kuti@hhchealth.org|
20545537|NCT00409331|UT MD Anderson Cancer Center|Mark Chambers, DMD / Associate Professor|713-745-2672||
20545538|NCT02184455|DeCell Technolpogies Inc.|Dr. Paul F. Gratzer, CSO|902-223-2179|pfgratzer@decelltechnologies.com|
20545539|NCT04601454|Medtronic|DTM-LE Clinical Research Study Team|763-514-4000|rs.scsresearch@medtronic.com|
20545540|NCT01491113|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
20545541|NCT00668733|Graceway Pharmaceuticals|Sharon F. Levy, MD / Sr. VP, Clinical Product Development|267-948-0400|sharon.levy@gracewaypharma.com|
20545542|NCT00538785|MedImmune, LLC|Pamela Griffin, Senior Director, Clinical Development|301 398 0000|griffinp@medimmune.com|
20545543|NCT01331213|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
20545544|NCT03897439|University of Kanas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
20545545|NCT03124927|Masimo Corporation|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20545546|NCT02047344|Golden Biotechnology Corp.|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
20545547|NCT05315908|University of California San Diego|Dr. Jesse Nodora|(858) 822-3686|jnodora@health.ucsd.edu|
20545548|NCT00294762|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
20527541|NCT05749068|Silicon Valley Gastroenterolgy|Dr. George Triadafilopoulos|(650) 988-7530|info@siliconvalleygi.com|
20527542|NCT02117713|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20527543|NCT01094782|Massachusetts General Hospital|Dr. Lucy Chen|6177246102|mghpainresearch@partners.org|
20527544|NCT01712308|The University of Texas MD Anderson Cancer|Prithviraj Bose MD/Associate Professor|713-792-7747|PBose@mdanderson.org|
20527545|NCT00678470|University of California at San Francisco|John Koo MD|4154764701|john.koo@ucsfmedctr.org|
20527546|NCT02503254|Philip Morris Products S.A.|Cam Tuan Tran|+41 (58) 242 2620|CamTuan.Tran@pmi.com|
20545549|NCT02937584|AstraZeneca|Stephan Stenglein, MD|+46 (0)31 776 1000|stephan.stenglein@astrazeneca.com|
20545550|NCT00280384|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|81-3-3817-5235|h3-shimizu@hhc.eisai.co.jp|
20545551|NCT02238080|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20545552|NCT01738646|Duke Univeristy Medical Center|Katherine Peters|919 684-3914|katherine.peters.@dm.duke.edu|
20545553|NCT01598129|Oncos Therapeutics|Director, Clinical Operations||info@oncos.com|
20545554|NCT00505076|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
20545555|NCT02250703|University of Mississippi Medical Center|Madhankumar Sathyamoorthy. PI|6018157066|msathyamoorthy@umc.edu|
20545556|NCT04093024|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545557|NCT03145818|Providence VA Medical Center|James Rudolph, MD, Principal Investigator|401-273-7100|James.Rudolph@va.gov|6406
20545558|NCT00647270|Abbott|Global Medical Services|800-633-9110||
20555449|NCT00958919|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
20555450|NCT00922428|Pascoe pharmazeutische Präparate GmbH|Anja Braschoss|0049 641 7960100|KlinischeForschung@pascoe.de|
20555451|NCT03403725|Menarini Ricerche SPA|Corporate Director of Clinical Sciences|+39 055 56809933|acapriati@menarini-ricerche.it|
20555452|NCT03701555|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20555453|NCT00546728|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20555454|NCT00373334|Braintree Laboratories, Inc.|Clinical Operations Manager|781-843-2202|jmcgowan@braintreelabs.com|
20555455|NCT02508311|James J Peters VA Medical Center|Gregory Schilero|7185849000|gregory.schilero@va.gov|6701
20555456|NCT02370602|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20555457|NCT03349710|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20555458|NCT04256733|University of Montana|Dr. Laurie Slovarp|406-243-2107|laurie.slovarp@umontana.edu|
20555459|NCT04955639|Pivot Health Technologies Inc.|Craig Fujii, Sr. Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
20527547|NCT00957905|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-422-4491|feldmand@mskcc.org|
20555460|NCT04447404|DURECT Corporation|Executive Director, Regulatory Affairs|408-777-1417|jill.burns@durect.com|
20555461|NCT02539342|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
20555462|NCT01369342|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
20555463|NCT04723576|RAND|Lisa S. Meredith|310.393.0411|seidel@rand.org|7365
20555464|NCT02727894|Institution for Clinical and Experimental Medicine|Jan Král|+420605273008|jan.kral@centrum.cz|
20555465|NCT04320069|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20555466|NCT00454051|Novartis Pharmaceuticals|Study Director|862-778-8300||
20555467|NCT01571362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555468|NCT03966157|Saint Louis University|Dr. Samuel J. Burton|3147500811|s.burton.1818@gmail.com|
20555469|NCT01519206|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20555470|NCT01491854|Novartis Pharma AG|Study Director|862-778-8300|novartis.email@novartis.com|
20555471|NCT01026974|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20555472|NCT05725005|Asceneuron SA|Asceneuron Clinical Research|+ 41 21 353 8245|clinicaltrials.gov@asceneuron.com|
20555473|NCT03579563|The University of Iowa|Dr. Yu-Hsiang Wu|319-3359758|yu-hsiang-wu@uiowa.edu|
20555474|NCT05177770|Coherus BioSciences|Allison Intondi, Vice President, Clinical Operations|800-794-5434|ClinicalTrials@Coherus.com|
20555475|NCT01390246|University of Texas Medical Branch|Dr. Tatiana Nanovskaya, PhD|409-772-3908|tnnanovs@utmb.edu|
20555476|NCT00214136|University of Wisconsin Carbone Cancer Center|Dr. Mark A. Ritter|608-263-8500|ritter@humonc.wisc.edu|
20555477|NCT02105948|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555478|NCT01140191|Walter Reed National Military Medical Center (WRNMMC)|COL Glenn W. Wortman|301-295-6400|glenn.wortmann@amedd.army.mil|
20555479|NCT02558010|Medical College of Wisconsin|Keri R. Hainsworth, PhD|414-266-6306|khainswo@mcw.edu|
20555480|NCT04072159|Arizona State University, College of Health Solutions|Dr. Alexis Koskan (Assistant Professor)|602-827-2792|alexis.koskan@asu.edu|
20555481|NCT01177904|IVI Madrid|Dr. Graciela Kohls|91 180 29 00|graciela.kohls@ivi.es|
20555482|NCT00695669|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555483|NCT03421691|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20555484|NCT03980470|University Hospital Zurich|Dr Ronny R. Buechel|+41442551059|ronny.buechel@usz.ch|
20555485|NCT01196975|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555486|NCT03738150|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20555487|NCT03762135|University of Michigan|Dr. Susan Woolford|734-615-8214|swoolfor@med.umich.edu|
20555488|NCT01462344|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555489|NCT05244525|The University of Texas Health Science Center at Houston|James M. Gregory, MD|(713) 486-7500|James.M.Gregory@uth.tmc.edu|
20555490|NCT00581529|University of Michigan Comprehensive Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
20555491|NCT00253864|Ottawa Hospital Research Institute|Clinical Research Coordinator|613-737-8899|kmcilquham@ohri.ca|79839
20555492|NCT04697758|AsclepiX Therapeutics|Dr A Shojaei|8005723545|ashojaei@asclepix.com|
20555493|NCT00360529|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
20555494|NCT01629329|EINSTEIN MEDICAL CENTER|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
20555495|NCT01592643|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
20555496|NCT00110617|Novartis Pharmaceuticals|Study Director|862-778-8300||
20555497|NCT04764396|University of Michigan|Eileen Carpenter|734-615-3948|eicarpen@med.umich.edu|
20555498|NCT02657226|The University of Pittsburgh|Dr. John Kellum|4123834202|kas287@pitt.edu|
20555499|NCT03230916|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20555500|NCT00383448|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
20555501|NCT01128413|Washington University School of Medicine|Dr. Chris Holthaus|314-747-5994|holthauscv@wustl.edu|
20555502|NCT00722761|MGH Curtis|Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
20555503|NCT03680755|Temple University Kornberg School of Dentistry|Associate Dean for Research & Chair Department of Oral Health Sciences|215-707-1773|marisol.tellez.merchan@temple.edu|
20555504|NCT00660010|Abbott Laboratories|Global Medical Services|800-633-9110||
20555505|NCT01177098|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20555506|NCT03069482|Duke University Psychiatry & Behavioral Sciences|Dr. Roger Vilardaga|9196813441|roger.vilardaga@duke.edu|
20555507|NCT01461668|University of California Irvine|Raveena Singh|949-824-9285|ravsingh@uci.edu|
20555508|NCT01009931|Rutgers Cancer Institute of New Jersey|Tatiana Zelinskaya|(732) 235-9837|zelinsta@cinj.rutgers.edu|
20555509|NCT02434692|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
20555510|NCT00581230|UT Medical School at Houston|Carin A. Hagberg|713-500-6222|carin.a.hagberg@uth.tmc.edu|
20555511|NCT05912400|University of Arkansas for Medical Sciences|I-Shin Wen|5016868274|IWen@uams.edu|24024
20555512|NCT01843192|Ethicon, part of Johnson & Johnson|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20555513|NCT05645354|The University of Texas Health Science Center at Houston|Irene Tami-Maury, DMD,MSc,DrPH-NHSN|713-500-9234|Irene.M.Tami-Maury@uth.tmc.edu|
20555514|NCT03248739|Wake Forest University School of Medicine|Kyle Fargen|336-716-8641|kfargen@wakehealth.edu|
20555515|NCT01259713|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20555516|NCT03461003|The University of Texas Health Science Center at Houston|Joyce P Samuel, MD, MS|713-500-6708|joyce.samuel@uth.tmc.edu|
20555517|NCT00620750|New York University School of Medicine|Marc Gourevitch, MD, MPH|212-263-8553|marc.gourevitch@nyumc.org|
20571151|NCT03836859|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 513831|clinical.trials@dompe.com|
20571152|NCT01023958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571153|NCT02159040|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20571154|NCT04646291|Mosie Baby (Consultant)|Karina Loyo, Ph.D., MBA, CCDM|512-563-1393|karina@drkarina.com|
20571155|NCT01031628|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
20571156|NCT01304498|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571157|NCT03080493|University of California, Davis|Mitchell Creinin, MD|916-734-6670|mdcreinin@ucdavis.edu|
20571158|NCT00759642|University of Kansas Cancer Center|Priyanka Sharma, MD|913-945-5059|PSHARMA2@kumc.edu|
20545559|NCT01565343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20545560|NCT01012674|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20571159|NCT00755417|Depomed|Head of Research & Development|650-462-5900|msweeney@depomed.com|108
20545561|NCT00638183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545562|NCT02059291|Novartic Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20571160|NCT02676843|Columbia University|William Kreisl, MD|212-342-2380|wck2107@cumc.columbia.edu|
20571161|NCT02803593|Emory University|Dr. Eun Ok Im|404-712-9805|eun.ok.im@emory.edu|
20545563|NCT03180619|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20571162|NCT01993849|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20571163|NCT01895036|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
20571164|NCT03004404|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571165|NCT01937975|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571166|NCT02522728|Stryker Orthopaedics|Eric Garling, PhD Snr. Director Medical & Scientific Affairs Europe|+31 6 467 135 18|Eric.Garling@stryker.com|
20571167|NCT02028325|Indiana University|Aaron Cohen-Gadol, MD, MSc|317-362-8760|acohen@goodmancampbell.com|
20571168|NCT04210843|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20571169|NCT01099917|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
20571170|NCT01266161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545564|NCT01433289|Baylor|Supriya Parikh|832-824-2589|supriya.parikh@bcm.edu|
20545565|NCT00729469|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20545566|NCT00514852|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20545567|NCT00470834|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545568|NCT00244140|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20545569|NCT02673541|Dartmouth-Hitchcock Medical Center|Dr Jeffrey Adler|603-650-5261|Jeffrey.m.adler@hitchcock.org|
20571171|NCT02990468|BioMimetix JV LLC|Director of Clinical Operations|303-862-7268|contact@bmxpharma.com|
20527548|NCT02083653|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
20545570|NCT05408637|Massachusetts General Hospital and Harvard Medical School|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
20545571|NCT01989208|Sulfagenix|President and CEO|1-318-349-3851|tgiordano@sulfagenix.com|
20545572|NCT04975438|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20545573|NCT04973436|Duke University School of Medicine|Tamara Somers, PhD|9194163408|tamara.somers@duke.edu|
20545574|NCT02693132|University of Colorado Denver|Seth Creasy|720-848-6477|seth.creasy@ucdenver.edu|
20545575|NCT03048006|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
20545576|NCT01462253|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
20545577|NCT01276054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
20545578|NCT04343235|Wright State University|Sheela Barhan, MD|937-208-2850|sheela.barhan@wright.edu|
20545579|NCT00787267|Duke University Medical Center|Michael Kelley , MD|919-286-0411|kelleym@duke.edu|7326
20545580|NCT01763996|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20545581|NCT00865280|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20545582|NCT01168986|University of Florida|Joel Bialosky, PT, PhD|352-273-8636|jbialosky@phhp.ufl.edu|
20545583|NCT02246413|Univeristy of Illinois, Chicago|Nan Lv, PhD, Research Scientist|312-802-1072|lvn2017@uic.edu|
20545584|NCT02371941|The University of Tennessee Health Science Center|Dr. Jay Lieberman|901-287-7337|jlieber1@uthsc.edu|
20545585|NCT01788215|University of Rochester|Kathleen Hoeger MD MPH|585-275-7891|kathleen_hoeger@urmc.rochester.edu|
20545586|NCT02751385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545587|NCT02299791|KaiserPermanente Center for Health Research|Rachel Gold|503-528-3902|rachel.gold@kpchr.org|
20545588|NCT03091348|Men|Abraham Morgentaler|617-277-5000|research@menshealthboston.com|
20545589|NCT04534686|University of Illinois at Chicago|Tanvi Bhatt|3123554443|tbhatt6@uic.edu|
20545590|NCT01419197|Hoffmann-La Roche|Medical Communications|800 821-8590||
20571172|NCT01160237|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545591|NCT00146848|Clinical Affairs|Kira Stolen|1 800 CARDIAC|cshd@bsci.com|
20555518|NCT00852631|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
20571173|NCT03355209|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20571174|NCT01081886|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20571175|NCT02567708|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571176|NCT00706654|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
20571177|NCT01151215|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
20571178|NCT02251236|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
20571179|NCT01154140|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571180|NCT02378038|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20571181|NCT03697122|Duke University|Negmeldeen Mamoun, M.D.|919-681-3551|negmeldeen.mamoun@duke.edu|
20571182|NCT02079025|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
20571183|NCT04276051|Emory University|Alexandra Migdal, MD|404-778-3280|alexandra.love.migdal@emory.edu|
20571184|NCT01374568|UAB|Dr. Amy Warriner|2059964004|awarriner@uabmc.edu|
20571185|NCT01912404|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20571186|NCT02269423|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571187|NCT04379011|University of Minnesota|Dr. Ricardo Battaglino|612-625-2661|rbattagal@umn.edu|
20571188|NCT00617929|Masonic Cancer Center, University of Minnesota|Jakub Tolar, MD|612-624-7180|tolar003@umn.edu|
20571189|NCT03229486|Pusan National University Yangsan Hospital|Professor|0553602756|anesktk@pusan.ac.kr|
20571190|NCT02078492|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
20571191|NCT00856245|University of Kansas Cancer Center|Siddhartha Ganguly, MD|(913) 588-6030|sganguly@kumc.edu|
20571192|NCT05672771|University of Illinois|Dr. Elizabeth A L Stine-Morrow|217-244-2167|eals@illinois.edu|
20571193|NCT02080546|Duke University Medical Center|Dr Paula S Lee|919-684-3765|paula.s.lee@duke.edu|
20571194|NCT00760747|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20555519|NCT00765843|Rosalind Franklin University of Medicine and Science|Ryan Crews|847-578-8437|ryan.crews@rosalindfranklin.edu|
20555520|NCT04829344|American Genomics, LLC|Michelle Widmann|919-600-1819|mwidmann@calclinicalsolutions.com|
20555521|NCT02564523|Janssen Vaccines & Prevention B.V|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20555522|NCT03814889|Stanford University|Allison Okamura|(650) 723-3148|aokamura@stanford.edu|
20555523|NCT00448539|Eisai Inc.|Eisai Medical Information|1 8882472378|esi_medinfo@eisai.com|
20555524|NCT04862143|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20555525|NCT02103439|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
20555526|NCT00695903|Cubist Pharmaceuticals|Medical Director||ellie.hershberger@cubist.com|
20555527|NCT02696317|Alcon, A Novartis Division|Sr. Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20555528|NCT01343368|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-8094|smith719@umn.edu|
20555529|NCT04542343|CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE|DR. MOHSEN BAZARGAN|323-357-3655|mohsenbazargan@cdrewu.edu|
20555530|NCT01816594|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20555531|NCT00413153|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
20555532|NCT03117738|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
20555533|NCT01669629|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|904 443-1032|kosborn@its.jnj.com|
20555534|NCT01221597|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20555535|NCT02504073|Kantonsspital Baselland Standort Bruderholz|Alexandra Bellwald|0041797429755|alexandra.bellwald@ksbl.ch|
20555536|NCT04420689|Alume Biosciences|Chief Medical Officer|858-922-3966|brett.berman@alumebiosciences.com|
20555537|NCT01347333|Mercy Research|Michelle McFarland, MPH, CHRC|314-251-8827|michelle.mcfarland@mercy.net|
20555538|NCT02366338|Mugla Sitki Kocman University|Ozcan Basaran|+902522120724|basaran_ozcan@yahoo.com|
20571195|NCT01443923|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
20545592|NCT01798849|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20545593|NCT00743106|Cleveland Clinic Foundation|Jerome O'Hara, MD|216-444-8278|oharaj@ccf.org|
20545594|NCT00850421|Park Nicollet Institute|Park Nicollet Institute|952-993-3123||
20545595|NCT00824733|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
20545596|NCT01146457|BIDMC|Philip Hess|617-667-3353|phess@bidmc.harvard.edu|
20545597|NCT00597597|Rush University Medical Center|Ruta Rao|312-942-3324|ruta_d_rao@rush.edu|
20545598|NCT00145977|The University of Chicago|Tamara Vokes, MD|773-702-1465|tvokes@medicine.bsd.uchicago.edu|
20545599|NCT03060551|Department of Plastic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea|Suk-Ho Moon|821090803527|nasuko@catholic.ac.kr|
20545600|NCT04629066|Duke Clinical Research Institute|Marjan Cobbaert|919-668-9740|mr157@duke.edu|
20545601|NCT05225805|Nabriva Therapeutics US, Inc.|Christine Guico-Pabia, MD, MBA, MPH|610-981-2874|christine.guico-pabia@nabriva.com|
20571196|NCT01426230|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
20545602|NCT02369172|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20545603|NCT00610480|UT Southwestern Medical Center|Peter Chen|214-648-3837|peter.chen@utsouthwestern.edu|
20545604|NCT05477108|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-94 79|information.center@astrazeneca.com|
20545605|NCT04410133|Blue Earth Diagnostics|Head of Research and Development|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
20545606|NCT00334113|VA Boston Healthcare System|Dr. DeAnna Mori|857-364-4121|deanna.mori@va.gov|
20545607|NCT02083861|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
20545608|NCT03376295|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545609|NCT00893815|Henry Jackson Foundation|Infectious Diseases Clinical Research Program||contactus@idcrp.org|
20545610|NCT02509026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545611|NCT04947085|Maimonides Medical Center|Sergey Motov|718-283-6000|smotov@maimo.org|
20545612|NCT00167219|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan, MD|+1 612-626-2961|macmi002@umn.edu|
20545613|NCT00243841|Indiana University|Amy Miller Research Manager|317 944 1242|amym@iu.edu|
20545614|NCT01808092|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.wilson2@astrazeneca.com|
20545615|NCT02204124|Washington University School of Medicine|William Hawkins, M.D.|314-286-0702|hawkinsw@wustl.edu|
20545616|NCT02908490|University of Pittsburgh|Kimberly P. Liang, MD, MS|412-586-3550|liangkp@upmc.edu|
20545617|NCT02248688|Dayton Interventional Radiology-Research|Mubin Syed, MD|937-215-0878|mubinsyed@aol.com|
20545618|NCT04144127|Emory University|Dr. Felipe Lobelo|(770) 488-5737|felipelobelo@emory.edu|
20545619|NCT04586387|Virginia Commonwealth University|Carrie Peterson|804 827 5270|clpeterson@vcu.edu|
20545620|NCT00945295|New Mexico VA Healthcare System|JoAnn Harnar, Research Nurse|505-256-5701|Joann.Harnar@va.gov|
20545621|NCT03615040|University of Leicester|Professor Chris Brightling|+44 116 250 2704|ceb17@le.ac.uk|
20545622|NCT01541397|The University of Texas Health Science Center at Houston|Heather Saavedra|713-500-7098|Heather.Saavedra@uth.tmc.edu|
20545623|NCT02317744|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
20545624|NCT02365480|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
20545625|NCT00706342|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20545626|NCT01034670|Stanford University|Shai Friedland, MD|(650) 617-2732|shaif@stanford.edu|
20545627|NCT04762719|Mayo Clinic|Madhusudan (Madhu) Grover, M.B.B.S.|507-293-2698|Grover.Madhusudan@mayo.edu|
20545628|NCT01781299|University of Pittsburgh Plastic Surgery|Kenneth Shestak|412-641-1487|shestakkc@upmc.edu|
20545629|NCT03163017|The University of Texas Health Science Center at Houston|Joshua Gary, MD|713-486-6500|Joshua.L.Gary@uth.tmc.edu|
20545630|NCT01099449|Mayo Clinic|Charles Loprinzi, M.D.|(507) 284-3731|cloprinzi@mayo.edu|
20545631|NCT02032238|OD-OS GmbH|Ulrike Weber|+49 332831282|ulrike.weber@od-os.com|100
20545632|NCT00653939|OXiGENE, Inc.|Chief Executive Officer|650-635-7000|info@oxigene.com|
20545633|NCT00717236|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20545634|NCT00612105|Valeant Pharmaceuticals International, Inc.|Associate Director Clinical Operations|919-294-3080|david.lineberry@valeant.com|
20545635|NCT01105767|USUHS|LTC Michael Ellis|301-295-2254|Michael.Ellis@usuhs.edu|
20545636|NCT00475982|VA Medical Center Greater Los Angeles Healthcare System|William Aronson, MD|3102683446|waronson@ucla.edu|
20545637|NCT00993226|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20545638|NCT00817596|Medasys, Inc.|Clinical Trials Manager|973-426-9229|jarrambide@medasyspumps.com|
20545639|NCT00271505|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
20545640|NCT00119678|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20545641|NCT02720042|Becton, Dickinson and Company|Sandra van Guldener|+31 6 46900840|sandra.vanguldener@bd.com|
20545642|NCT03704636|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
20545643|NCT00791817|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
20545644|NCT02356900|Duke University Medical School|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
20545645|NCT01134705|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20545646|NCT00509145|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20545647|NCT00246740|Departments of Pediatrics and Pharmacology, University of Alberta|Dr Richard Schulz|780-492-6581|richard.schulz@ualberta.ca|
20545648|NCT00125528|Northwestern Universiyt|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
20545649|NCT00101452|Massachusetts General Hospital|Maurizio Fava|617-724-2513|mfava@partners.org|
20545650|NCT01994889|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545651|NCT02969655|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20545652|NCT01510769|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6671|mfung@ardeabio.com|
20545653|NCT02674204|Cedars-Sinai Medical Center|Marc Goodman, PhD|310-423-6188|Marc.Goodman@cshs.org|
20545654|NCT02646371|LimmaTech Biologics AG|Director of Clinical Trials|+41 44 733 8585|info@lmtbio.com|
20545655|NCT02466659|Indiana University|Daniel Neely|3172741214|deneely@iupui.edu|
20545656|NCT00929643|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545657|NCT01536392|UT MD Anderson Cancer Center|Michael Frumovitz, Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
20545658|NCT02874144|Northwestern|Anju Peters|3126950513|anju.peters@northwestern.edu|
20545659|NCT00574236|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
20555539|NCT01292928|Boston Scientific Corporation|Philip Ghizoni, Clinical Trial Manager|763-255-0036|Philip.Ghizoni@bsci.com|
20555540|NCT04530448|West Virginia University|Ankit Sakhuja, MD|304.598.6092|ankit.sakhuja@hsc.wvu.edu|
20555541|NCT02212574|Johns Hopkins University|Dr. Kenneth Cohen|(410) 614-5055|kcohen@jhmi.edu|
20555542|NCT02898974|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
20555543|NCT01631630|National Institute on Alcohol Abuse and Alcoholism|Diazgranados, Nancy|+1 301 435 9386|nancy.diazgranados@nih.gov|
20555544|NCT02162420|Masonic Cancer Center|Christen Ebens, MD, MPH|612-624-4511|ebens012@umn.edu|
20555545|NCT03638141|Sidney Kimmel Comprehensive Center|Ana De Jesus-Acosta|4432870411|adejesu1@jh.edu|
20555546|NCT03759873|University of Texas Medical Branch, Division of Cardiovascular Medicine|Dr. Diann Gaalema|409-772-1533|digaalem@utmb.edu|
20555547|NCT04420221|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555548|NCT00511004|NIAID|Thomas B. Nutman|301-496-5398|tnutman@niaid.nih.gov|
20555549|NCT00990652|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
20555550|NCT04618718|Protembis GmbH|Karl von Mangoldt|+49 241 9903 3621|kvm@protembis.com|
20555551|NCT02388386|Scripps Clinic Medical Group|Sanjeev Bhavanni MD|6196601842|bhavnani.sanjeev@scrippshealth.org|
20555552|NCT01673802|University of Alabama at Bimringham|John V. Thomas, MD; Principal Investigator|205-996-4132|jvthomas@uabmc.edu|
20555553|NCT04159688|Yale University|Dr. Ansel Hillmer|203-737-6400|ansel.hillmer@yale.edu|
20555554|NCT01988246|Cole Eye Institute - Cleveland Clinic|Rishi Singh, MD|216-445-9497|singhr@ccf.org|
20555555|NCT02935062|Federal University of Santa Maria|Márcia Keske-Soares|55 55 999726370|marcia-keske.soares@ufsm.br|
20555556|NCT02384954|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20555557|NCT02372396|Veterans Medical Research Foundation|Dr. Ariel Lang|858-552-8585|ajlang@ucsd.edu|5359
20555558|NCT04313634|Mayo Clinic|Sundeep Khosla, M.D.|507-255-6663|khosla.sundeep@mayo.edu|
20555559|NCT05219877|Department of Urology, Faculty of Medicine University of Indonesia - Cipto Mangunkusumo General Hospital|Prof. dr. Harrina Erlianti|+62 816-825-226|harrinaerlianti@gmail.com|
20555560|NCT01201629|OKC VA Medical Center|Dr. Meheroz H. Rabadi|405-456-5298|meheroz.rabadi@va.gov|
20555561|NCT00680316|Genentech, Inc.|Medical Communications|800-821-8590||
20555562|NCT00047879|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
20555563|NCT01548690|University of Texas Southwestern Medical Center|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
20555564|NCT01117311|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
20555565|NCT00105027|The EMMES Corporation|Paul C. VanVeldhuisen, Ph.D.|301-251-1161|score@emmes.com|
20555566|NCT04558346|University of Kansas Medical Center|Dr. Michael Rippee|913-945-7486|mrippee@kumc.edu|
20555567|NCT03086447|Johnson & Johnson Vision|Kristy Canavan- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1474|KCANAVA2@its.jnj.com|
20555568|NCT00809757|Sunovion|Respiratory Medical Director|1-866-503-6351||
20555569|NCT00659334|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
20555570|NCT01174342|Meir Medical Center|Amit Meshi|+972523580222|amitmeshi@gmail.com|
20555571|NCT02587351|University of Minnesota|John Connett|612-626-9010|john-c@umn.edu|
20555572|NCT01218646|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20555573|NCT02693665|Children's National Medical Center|Dr. Maureen E. Lyon, PhD, Professor of Pediatrics, Principal Investigator|703-346-2873|mlyon@childrensnational.org|
20555574|NCT02075593|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555575|NCT02010060|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virginia.edu|
20555576|NCT04414696|Kaiser Permanente|Lyndsay Avalos|5108210300|lyndsay.a.avalos@kp.org|
20555577|NCT00726752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555578|NCT04560166|Y-mAbs Therapeutics|Chief Operating Officer|+4570261414|clinicaltrials@ymabs.com|
20555579|NCT00976599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555580|NCT00844857|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20555581|NCT00570674|Dana-Farber Cancer Institute|Roy B. Tishler, MD|617.632.5734|RTISHLER@LROC.HARVARD.EDU|
20555582|NCT01641978|Hospital Universitario de Getafe|Susana Arias Rivera|+34916839360|susana.arias@salud.madrid.org|2459
20555583|NCT02358603|Department of Cardiology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine|Dr. Zhao, Jianrong||drzjr@126.com|
20555584|NCT03576547|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD./Professor|713-745-0394|fravandi@mdanderson.org|
20555585|NCT01912612|University of Michigan Rogel Cancer Center|Lynn Henry, MD, PhD|734-936-9868|norahh@med.umich.edu|
20555586|NCT01588184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20555587|NCT00907153|Penn State Hershey Medical Center|Dr. Nazia Raja-Khan|717-531-8395|nrajakhan@psu.edu|
20555588|NCT00778648|Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie , Charité - Universitätsmedizin Berlin, Germany|Dr. Stephanie Roll|+49 30 450 529023|stephanie.roll@charite.de|
20555589|NCT02120027|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
20555590|NCT01002872|Northshore University Healthsystem|Dr Stuart Sprague|847-570-1761|ssprague@northshore.org|
20555591|NCT01092338|Children's Hospital of Philadephia|Virginia Stallings|215-590-1664|stallingsv@email.chop.edu|
20555592|NCT03393000|Diffusion Pharmaceuticals Inc|Vice President of Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
20555593|NCT01773070|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20527549|NCT02073656|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20527550|NCT01938989|Alcon Research, Ltd.|Melvin Sarayba, Franchise Head Cataract, GMA|1-888-451-3937|alcon.medinfo@alcon.com|
20527551|NCT02638051|Clifford Hospital|Prof. Clifford LK Pang, President of Clifford Hospital|(8620) 34710038|cpang@cliffordgroup.com|
20527552|NCT00428922|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-0066|Bhuvaneswari.Ramaswamy@osumc.edu|
20527553|NCT04164004|Stanford University|Alexander Sandhu|9097671214|ats114@stanford.edu|
20527554|NCT02054910|University of Alabama at Birmingham|Jaypal Ramesh|205-975-9564|jramesh@uab.edu|
20527555|NCT00432276|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20527556|NCT00207727|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
20527557|NCT05362695|Ironwood Pharmaceuticals, Inc|Ironwood Study Chair|617-621-7722|info@ironwoodpharma.com|
20527558|NCT03557684|UCLA|Joshua H. Cho, MD, PhD|3104286218|hjcho@mednet.ucla.edu|
20527559|NCT03611582|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20527560|NCT01783821|Mayo Clinic|Dr. Emir Festic|904-953-9758|Festic.Emir@mayo.edu|
20527561|NCT02333383|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20527562|NCT04459598|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20545660|NCT01748240|academic group|Groupe Francophone des Myelodysplasies|+ 33 (0)1 71 20 70 59|fatiha.chermat@aphp.fr|
20545661|NCT00486811|Grünenthal GmbH|Claudia Leinweber|+49 241 569 2509|claudia.leinweber@grunenthal.com|
20545662|NCT03753789|Ethicon|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
20545663|NCT01012089|University of Oklahoma College of Pharmacy|Teresa Lewis Pharm D|405-271-2859|Teresa-Lewis@ouhsc.edu|
20545664|NCT02975557|Ophthalmology and Visual Sciences, University of Illinois, Chicago, IL|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
20545665|NCT02037555|Grifols Therapeutics, LLC|Miquel Barceló, PhD|+34 935.712.368|Miquel.Barcelo@grifols.com|
20545666|NCT01578850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545667|NCT00601952|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
20527563|NCT04852276|National Institute of Allergy and Infectious Diseases (NIAID)|Emily Ricotta, PhD|240-550-3474|emily.ricotta@nih.gov|
20527564|NCT04542278|University of Wisconsin - Madison School of Medicine and Public Health|Dawn Elfenbein, MD, MPH, FACS|(608) 263-1387|elfenbein@surgery.wisc.edu|
20527565|NCT01859949|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545668|NCT01573052|VA Salt Lake City Medical Center|Dr. Christopher Stock|801-582-1565|christopher.stock@va.gov|1172
20545669|NCT01711216|Abbott|Senior Global Medical Director|+49 160 749 0615|Claire.Pexman-Fieth@abbott.com|
20545670|NCT02929498|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20545671|NCT03562988|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|609-806-1200|annahita.ghassemi@churchdwight.com|
20545672|NCT00750152|Merz Pharmaceuticals, LLC|Merz Pharmaceuticals, LLC|800-334-0514||
20545673|NCT01030666|JWGUniversity|Prof. Dr. Peter Eickholz|+496963015642|eickholz@med.uni-frankfurt.de|
20545674|NCT03456882|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Elisabetta Pupillo|+390239014605|elisabetta.pupillo@marionegri.it|
20555594|NCT01471054|Oncology Service, Wills Eye Hospital|Arman Mashayekhi, MD|215-928-3105|arman_mash@yahoo.com|
20555595|NCT01559844|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20555596|NCT02181803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20555597|NCT00951041|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555598|NCT01578993|Semprus BioSciences|Ulla Wallin, Director of Clinical Research|1-617-577-2205|ulla.wallin@semprusbio.com|
20555599|NCT02388724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20555600|NCT01795833|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
20555601|NCT01217073|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20555602|NCT04477187|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20527566|NCT01890759|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20545675|NCT04002908|Ariadne Labs|Katherine Semrau|6177805311|ksemrau@ariadnelabs.org|
20545676|NCT03698591|Duke University|Dr. Kevin LaBar, PhD.|(919)668-2424|klabar@duke.edu|
20545677|NCT01254760|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
20545678|NCT04359901|VA Boston Healthcare System|Westyn Branch-Elliman, MD, MMSc|857-203-5116|westyn.branch-elliman@va.gov|
20545679|NCT01909011|Mount Sinai Beth Israel|Igor Galynker MD PhD|212-420-4535|igalynke@chpnet.org|
20527567|NCT01344759|Cincinnati Children's Hosptial Medical Center|Dr. Mohamed Mahmoud|513-636-4408|Mohamed.Mahmoud@cchmc.org|
20527568|NCT01080976|BIDMC|Charles Safran|617-278-8170|csafran@bidmc.harvard.edu|
20527569|NCT01238341|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
20527570|NCT05437640|University of Alabama at Birmingham|Dr. Christine Ferguson|205-934-7773|cfergus2@uab.edu|
20527571|NCT02474355|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20527572|NCT05206734|Royal Hospital for Children and Young People, Edinburgh|Richard K Russell|0131 312 0431|richard.russell@nhs.scot|
20527573|NCT04228965|Medical University of South Carolina|Erin A. McClure, Principal Investigator|843-792-7192|mccluree@musc.edu|
20527574|NCT02330172|Seoul national university Bundang Hospital|Eunsu Choi|821032990658|potterydoll@hanmail.net|
20527575|NCT00734656|University of Connecticut Health Center|Jonathan Covault|860-679-7560|jocovault@uchc.edu|
20527576|NCT02287688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20527577|NCT03214679|University School of Medicine, New York|Ben Eckhardt|212-562-1000|benjamin.eckhardt@nyumc.org|
20527578|NCT01601067|VA San Diego|Sonya Norman, PhD|858-552-8585|sonya.norman@va.gov|
20527579|NCT03015194|National Heart Lung and Blood Institute (NHLBI)|Robert Lederman, M.D. Principal Investigator, NIH, NHLBI|301.402.6769|ledermar@nhlbi.nih.gov|
20527580|NCT02707172|Kaohsiung Medical University|Dr. Ming-Tsang Wu|+886-7-3121101|e_encourage@yahoo.com|2315
20527581|NCT03083353|The University of Texas at Austin|Sara Reedy|512-232-4319|Sarah.Fella@austin.utexas.edu|
20527582|NCT05251064|University of Virginia|Dr. Mark Miller|(434) 243-7778|mdm3p@uvahealth.org|
20527583|NCT01754766|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20527584|NCT02469168|Walter Reed National Military Medical Center|Jody Richardson, MSN, RN|301-295-7798|jody.richardson.ctr@usuhs.edu|
20527585|NCT00433017|Novartis Pharmaceuticals|Study Director|862 778-8300||
20527586|NCT01306214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20527587|NCT01760447|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527588|NCT02030886|Yale School of Medicine|Dr James Liu|+1 203 785 2020|liu.ji@yale.edu|
20527589|NCT03742258|Northwestern University|Dr. Reem Karmali, MD|(312) 695-0711|reem.karmali@northwestern.edu|
20527590|NCT01380691|Eli Lilly Company|Chief Medical Officer|800-545-5979||
20527591|NCT02536781|Khon Kaen University|Faculty of Pharmaceutical Science|+66-43-362092|lsucharat@gmail.com|
20527592|NCT03423147|Icahn School of Medicine at Mount Sinai|Nicola Tavella|212-241-3888|nicola.tavella@mssm.edu|
20527593|NCT01048099|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20527594|NCT00508157|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20545680|NCT03425253|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20545681|NCT00695097|University of California, San Francisco|Flavio Vincenti|415-353-1322|flavio.vincenti@ucsfmedctr.org|
20545682|NCT04614324|Aerin Medical|Anais Laborde Sr. Director of Clinical Affairs|650-518-9624|alaborde@aerinmedical.com|
20527595|NCT01987232|Amgen Inc.|Study Director|866-572-6436||
20527596|NCT02910726|Memorial Sloan Kettering Cancer Center|Neeta Pandit-Taskar, MD|1-833-MSK-KIDS|pandit-n@mskcc.org|
20545683|NCT02695160|Sangamo Therapeutics|Medical Monitor|+1 510 307 7266|clinicaltrials@sangamo.com|
20555603|NCT02460991|Boston Scientific|Kristi Winterfeldt|763-494-1165|kristi.winterfeldt@bsci.com|
20555604|NCT01552213|Stanford University, School of Medicine|Anna Girsen, Research Operations Manager|(650) 725-5720|agirsen@stanford.edu|
20555605|NCT01296568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20555606|NCT00321854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20555607|NCT03905655|Romark Laboratories, L.C.|Jessica Fulgencio|813-282-8544|jessica.fulgencio@romark.com|
20555608|NCT02566031|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20555609|NCT02277106|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20555610|NCT03317002|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20555611|NCT00303966|University of Chicago|Dr. Wendy Stock|773-834-8982|wstock@medicine.bsd.uchicago.edu|
20555612|NCT03280121|Daniel and Daniel Consulting, LLC|Cynthia Harris, Director of Clinical Trials|775-392-2975|cindy@clinregconsult.com|
20555613|NCT02297308|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
20555614|NCT01981564|Johns Hopkins University School of Medicine, Department of Pediatrics|Dr. Arlene Butz|410-614-5963|abutz@jhmi.edu|
20555615|NCT04738643|University of Pennsylvania|Robert Schnoll, PhD|215-746-7143|schnoll@pennmedicine.upenn.edu|
20555616|NCT03996473|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20555617|NCT04597190|University of Washington|John Fortney|2066856955|fortneyj@uw.edu|
20555618|NCT04349553|Prokarium|Kristen Albright|+44 (0) 7375 124 275|kristen.albright@prokarium.com|
20555619|NCT03526250|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20555620|NCT01715805|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20555621|NCT04936230|Weill Cornell Medicine|Himanshu Nagar, MD|212-746-3704|hnagar@med.cornell.edu|
20555622|NCT02219932|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20555623|NCT00233493|University Hospitals Cleveland Medical Center Center for Medical Mycology|Dr. Mahmoud Ghannoum|216-844-8580|Mahmoud.Ghannoum@case.edu|
20555624|NCT01391962|National Cancer Institute|Dr. Alice P. Chen|240-781-3320|chenali@mail.nih.gov|
20555625|NCT01672801|Boston IVF|Alan Penzias|781-434-6500|apenzias@bostonivf.com|
20555626|NCT06476366|Department of Dermatology, Emirates Military Hospital|Dr Ahsan Tameez-ud-din|051-9293480|ahsantameezuddinmalik@gmail.com|312
20555627|NCT03726346|Fisher & Paykel Healthcare Ltd.|Bhavi Ogra|+64 9 574 0123|bhavi.ogra@fphcare.co.nz|7675
20555628|NCT00054353|Fred Hutch|Marco Mielcarek, MD||mmielcar@fredhutch.org|
20555629|NCT01692340|The Ohio State University|Steven K. Clinton, MD PhD|614-293-2886|steven.clinton@osumc.edu|
20555630|NCT01733056|Emory University|Dr. Robert Swerlick|404-727-3669|rswerli@emory.edu|
20555631|NCT01546194|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
20555632|NCT00836641|Goethe University Childrens Hospital|Prof Markus Rose|0049-696301|Markus.Rose@kgu.de|5754
20555633|NCT02890381|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20555634|NCT03543826|University of Washington|Adrienne James|206-744-4634|ajames1@uw.edu|
20555635|NCT01272934|Novartis Consumer Health|Clinical Project Leader|0041223635228||
20555636|NCT03449030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20555637|NCT03825380|Laboratoires Théa|Corentin LE CAMUS|0473981414|Corentin.LECAMUS@theapharma.com|
20555638|NCT01762046|Massachusetts General Hospital|Jose C. Florez, MD, PhD|6176433308|jcflorez@partners.org|
20555639|NCT03595904|Icahn School of Medicine at Mount Sinai|Dr. Sarah Miller|212-824-7783|Sarah.Miller@mssm.edu|
20555640|NCT01581281|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
20555641|NCT02087163|Align Technology|Allison Mossing|4084701056|amossing@aligntech.com|
20555642|NCT00388414|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
20555643|NCT03282890|UConn|Dr. Michael Copenhaver|860-208-3632|michael.copenhaver@uconn.edu|
20555644|NCT00700401|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20555645|NCT01650259|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20555646|NCT00626431|Abbott|Global Medical Services|800-633-9110||
20555647|NCT01683864|University Clinic of Tübingen|Prof. Alfred Königsrainer|0049 7071 2983290|silvia.wagner@med.uni-tuebingen.de|
20555648|NCT00355082|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555649|NCT02576067|Icahn School of Medicine at Mount Sinai|Zahi Fayad, PhD|212-824-8471|zahi.fayad@mssm.edu|
20555650|NCT02726451|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20555651|NCT03570619|University of Michigan Rogel Cancer Center|University of Michigan Cancer Center Admin|7349369499|ClinicalTrialsgov_CCAdmin@umich.edu|
20555652|NCT02522715|Oregon Health & Science University|Rachel Slottke, Program Manager|503-494-6117|slottker@ohsu.edu|
20571197|NCT00844597|Sarepta Therapeutics|Edward M. Kaye, MD, Interim CEO, SVP & Chief Medical Officer|617-274-4003|EKaye@Sarepta.com|
20527597|NCT01731470|Beaumont Hospital, Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.edu|
20527598|NCT01952080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20527599|NCT02258334|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20527600|NCT05822648|Stanford University|Dr. Eric Stice|650-723-7885|estice@stanford.edu|
20527601|NCT03564795|KeraNetics|Luke Burnett|336.725.0621|lburnett@keranetics.com|
20527602|NCT00862459|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20527603|NCT00770133|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20527604|NCT00564395|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
20527605|NCT02208050|St. Vincent's University Hospital|Professor Christopher McGuigan|+35312214209|C.McGuigan@svhg.ie|
20527606|NCT02770768|University of Chicago|Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
20545684|NCT00336856|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
20545685|NCT02720107|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20545686|NCT02522624|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
20545687|NCT01325337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20545688|NCT03483922|HKG Epitherapeutics|David Cheishvili|5142601972|david.cheishvili@hkgepitherapeutics.com|
20545689|NCT04313647|Ruijin Hospital , Shanghai Jiao Tong University School of Medicine|Dr. Qu|(+86)2164370045|jmqu0906@163.com|
20545690|NCT00843778|UCB|UCB Clinical Trial Call Center|+1 877 822||9493
20545691|NCT03381742|Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China|Dr. Yue Li|86-451-85555673|ly99ly@vip.163.com|
20545692|NCT02933671|Duke University|W. Michael Bullock, MD, PhD|919-668-2024|william.bullock@duke.edu|
20545693|NCT00730028|San Francisco General Hospital, UCSF|Henry F. Chambers, MD|(415) 206 - 5437|hchambers@medsfgh.ucsf.edu|
20545694|NCT01964755|University of Miami|Juan C. Ramos MD|305-243-1326|jramos2@med.miami.edu|
20545695|NCT02870933|National Cardiovascular Center Harapan Kita|Tri Wisesa Soetisna, M.D, MHA, PhD|+62215684093|tricts2000@yahoo.com|
20545696|NCT01250496|Rush University Medical Center|Dr. Rami Doukky; Director of Nuclear Cardiology|312-942-4655|rami_doukky@rush.edu|
20545697|NCT00003590|SWOG Statistical Center|Study Statistician|(206)667-4623||
20545698|NCT01425463|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20545699|NCT01332799|University of Iowa|Dr. Roberto Kalil|319-355-6564|roberto-kalil@uiowa.edu|
20545700|NCT01236547|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20545701|NCT04022733|Ajou University|Associate professor in Anesthesiology Department|82-31-2195689|beye98@aumc.ac.kr|
20545702|NCT00576680|Dana-Farber Cancer Institute|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
20545703|NCT04941443|Boston Medical Center, Department of Anesthesiology|Rachel Achu, MD|(617) 414-2000|rachel.achu@bmc.org|
20545704|NCT00361634|Amgen Inc.|Study Director|866-572-6436||
20555653|NCT01808313|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508412|NCT00334204|University of Mississippi|Tibor Fulop, M.D./Associate Professor of Medicine|601 984-5670|tfulop@umc.edu|
20508413|NCT03332303|Prasco LLC|Senior Director, Quality Assurance|513-618-3333|b.inskeep@prasco.com|
20527607|NCT00477607|VA RR&D National Center for Rehbilitative Auditory Research|Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
20527608|NCT00467961|NIH NHLBI|Minocher Battiwalla, MD|301-827-0939|minoo.battiwalla@mail.nih.gov|
20508414|NCT00983359|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
20508415|NCT03495817|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
20545705|NCT01566084|University of Colorado Denver|Dr. Kristen Jablonski|303-724-4842|KRISTEN.NOWAK@UCDENVER.EDU|
20545706|NCT01128621|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545707|NCT00807560|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|Katharine.Loeb@mssm.edu|
20545708|NCT00233454|Stanford University Medical Center|Jason R Gotlib, MD, Associate Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
20545709|NCT00583713|Braintree Laboratories, Inc.|Russell Pelham, PhD|781-843-2202|rpelham@braintreelabs.com|
20545710|NCT04224688|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20545711|NCT04074161|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20545712|NCT00864916|Indiana University School of Medicine|Samir K. Gupta, MD|317-274-7926|sgupta1@iu.edu|
20545713|NCT03816709|North Dakota State University|Kara Gange, Associate Professor|701-231-5777|kara.gange@ndsu.edu|
20545714|NCT01950013|Indiana University, Dept of Speech & Hearing Sci|Larry Humes|812-855-3507|humes@indiana.edu|
20545715|NCT00275340|University of Toronto|Monica Parry, RN, PhD, CCN(C)||parrym@kgh.kari.net|
20545716|NCT02778113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20545717|NCT00783198|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20545718|NCT00539188|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
20545719|NCT04784442|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
20545720|NCT00852371|Makerere University Kampala|Nankabirwa Joaniter|+256772676429|jnankabirwa@yahoo.co.uk|
20545721|NCT02756806|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20545722|NCT03158285|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20545723|NCT03753113|Tabriz University of Medical Sciences|Dr. Farid Masoud|+989036859062|faridmasoud@gmail.com|
20545724|NCT02228980|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20545725|NCT01642615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20545726|NCT02744040|Fred Hutchinson Cancer Research Center|Ann C Duerr, MD, PhD, MPH, Member|206-667-7938|aduerr@fredhutch.org|
20545727|NCT01008423|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20545728|NCT01809639|Spartanburg Regional Healthcare System|John Lucas|423-309-5646|jlucas@srhs.com|
20545729|NCT02453672|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
20545730|NCT01028300|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
20545731|NCT02140593|Herlev and Gentofte Hospital University of Copenhagen|Dr. Matias Vested Madsen|+4538683868|matias.vested.madsen@regionh.dk|
20545732|NCT00715910|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545733|NCT04166240|VAORD|Hardeep Singh|713 7948515|hardeep.singh@va.gov|
20545734|NCT00946153|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20545735|NCT02973438|University of Miami|Mark S. Nash, Ph.D.|3052433628|mnash@med.miami.edu|
20545736|NCT02465099|Ethicon Inc|Jason Waggoner|(513) 337-8130|jwaggon1@its.jnj.com|
20545737|NCT01675167|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20508416|NCT02781454|University of Washington|Dr. Michael D. Weiss|206-598-7688|mdweiss@uw.edu|
20545738|NCT01165216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20545739|NCT06221826|Pharmasoft|Meshcherskiy Y.E., Medical director|+7(495)626-47-55|meshcherskiy_y@pharmasoft.ru|140
20545740|NCT01379508|Novartis|Clinical Disclosure Office|862-778-8300||
20545741|NCT04180540|Emory University|Michael lloyd|404-712-4063|mlloyd@emory.edu|
20545742|NCT03952039|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20545743|NCT02626624|CarboFix Orthopedics Ltd.|Dvir Sherpsky, Director of Clinical Trials|+972-54-770-9920|dvir@carbo-fix.com|
20545744|NCT04174365|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20545745|NCT03472547|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
20545746|NCT05141448|Johnson & Johnson Vision Care, Inc. (JJVC)|Principal Research Optometrist|614-531-6781|anixon1@its.jnj.com|
20545747|NCT00856414|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20545748|NCT02208063|Cumberland Pharmaceuticals Inc.|Senior Director of Clinical and Regulatory Affairs|615-255-0068|ahaeberle@cumberlandpharma.com|
20545749|NCT00913458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545750|NCT03595618|Galapagos NV|Galapagos Medical Information|+32 15342900|medicalinfo@glpg.com|
20545751|NCT02279407|AstraZeneca|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
20545752|NCT02500056|Tartu University Hospital|Ceith Nikkolo|+37253319082|ceith.nikkolo@kliinikum.ee|
20545753|NCT03890666|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20545754|NCT01816945|Yale University|Megan Smith Associate Professor|203 764 8655|megan.smith@yale.edu|
20545755|NCT02331095|The Ohio State University|Dr. Tzu-Fei Wang|614-366-8366|tzufeiwang@gmail.com|
20545756|NCT01155011|UCSD|Jacqueline Kerr|858-534-9305|jkerr@ucsd.edu|
20545757|NCT01323855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20545758|NCT02122783|MossRehab|Mukul Talaty|2156636682|mctalaty@einstein.edu|
20545759|NCT00329849|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20545760|NCT00618098|CRMG|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
20545761|NCT00740376|Corin|Global Regulatory Affairs and Clinical Director|+44 (0)1285 659866||
20545762|NCT00653432|Anika Therapeutics, Inc.|Kara Mezger, Exec Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20545763|NCT05277337|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20545764|NCT01214057|The University of Texas Health Science Center at Houston|Davide Cattano, MD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
20545765|NCT00322621|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20545766|NCT04987788|Icahn School of Medicine at Mount Sinai|Sarah Miller|(212) 824-7783|sarah.miller@mssm.edu|
20545767|NCT00357760|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20545768|NCT01038869|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
20545769|NCT02238067|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20545770|NCT00700141|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20545771|NCT02010151|Seoul National University Hospital|Dr. Sun Young Lee|+82-10-9269-2376|sy2376@gmail.com|
20545772|NCT02213133|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20545773|NCT02350764|Memorial Sloan Kettering Cancer Center|Dr. Adam Schoenfeld, MD|646-608-4042|schoenfa@mskcc.org|
20545774|NCT03726996|Yale University|Yong-Hui Jiang, MD, PhD|203-785-2660|yong-hui.jiang@yale.edu|
20508417|NCT00326417|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20508418|NCT00844285|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20508419|NCT01586806|Hospital for Special Surgery|Dr. Mary Chisholm|2126061206|chisholmm@hss.edu|
20508420|NCT01185704|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20508421|NCT01313208|Amgen Inc.|Study Director|866-572-6436||
20508422|NCT01957787|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
20508423|NCT00187889|University of Florida|Dr. Carl J. Pepine|352-273-9082|carl.pepine@medicine.ufl.edu|
20508424|NCT00435994|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
20508425|NCT03096444|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
20508426|NCT03288324|Cincinnati Childrens Hospital Medical Center|Hermine Brunner|(513) 636-6320|hermine.brunner@cchmc.org|
20508427|NCT00788697|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
20508428|NCT01998880|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20508429|NCT02248857|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
20508430|NCT01664858|University of Leeds|Professor John P Greenwood|+44 (0)113 3925481|j.greenwood@leeds.ac.uk|
20508431|NCT03549117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508432|NCT00014911|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20508433|NCT00345540|Novelos Therapeutics, Inc.|Vice President, Clinical Development|617-244-1616|hpalmin@novelos.com|
20508434|NCT00861380|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508435|NCT04179786|VBI Vaccines|Dr. Francisco Diaz-Mitoma|1 613 297 3304|fdiazmitoma@vbivaccines.com|
20508436|NCT03310580|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director, Global Clinical Operations|(908) 947-3543|nramirez@aeriepharma.com|
20508437|NCT00089102|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20508438|NCT01269047|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
20508439|NCT01576120|Given Imaging|"Ravit Peled | Clinical Trials Manager"|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
20508440|NCT03205982|Columbia University|Rebecca Schnall, PhD, MPH|212-342-6886|rb897@columbia.edu|
20508441|NCT00994162|Smith+Nephew|Rachael Winter|+44 1482 673475|rachael.winter@smith-nephew.com|
20508442|NCT02983799|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20545775|NCT01328444|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508443|NCT00607126|DAvdi Geffen School of Medicine at UCLA|Barbara Giesser,MD|310-825-7313|bgiesser@mednet.ucla.edu|
20508444|NCT02677623|Columbia University|Nisha Philip, Clinical Research Manager|212-305-4973|np2173@cumc.columbia.edu|
20508445|NCT00795509|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508446|NCT00970268|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20508447|NCT03136367|Dartmouth College|Marie-Anne Durand|603-667-8601|marie-anne.durand@dartmouth.edu|
20508448|NCT00201760|The Ohio State University Comprehensive Cancer Center|Kari Kendra, MD|614-293-7956|Kari.Kendra@osumc.edu|
20508449|NCT02320214|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20508450|NCT03175562|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508451|NCT02146833|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20508452|NCT03030183|Ra Pharmaceutical, Inc|Sponsor Ra Pharmaceutical, Inc|1 617 401 4060|trials@rapharma.com|
20508453|NCT01461824|The Research Institute at Nationwide Children's Hospital|Dr. Andrea Bonny|614-722-2450|andrea.bonny@nationwidechildrens.org|
20508454|NCT01105936|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545776|NCT03531632|MacroGenics, Inc.|Stephen Eck, M.D., Chief Medical Officer|301 251-5172|ecks@macrogenics.com|
20508455|NCT01563107|Vanderbilt University Medical Center|Alfredo Gamboa MD|6158751003|alfredo.gamboa@vumc.org|
20508456|NCT02707601|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20508457|NCT01769612|Institut Pasteur of Tunis|Afif Gen Salah, MD, PhD|011-216-71-792-429|noemailavailable@no.com|
20508458|NCT03907969|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20508459|NCT00247273|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20508460|NCT03276572|Weill Cornell Medicine|Dr. Scott Tagawa|646-962-2027|stt2007@med.cornell.edu|
20508461|NCT02580240|Subei People's Hospital|QQLv|18051063899|bonhomie2014@163.com|
20508462|NCT00607919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508463|NCT01660230|ZZ Biotech, LLC|Kent Pryor, PhD, MBA, Chief Operating Officer||kpryor@zzbiotech.com|
20508464|NCT02100410|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20508465|NCT01707095|University of Colorado|Thomas Robinson|303-724-2728|thomas.robinson@ucdenver.edu|
20508466|NCT03744598|patientMpower Ltd|Chief Scientific Officer|353872599131|colin@patientmpower.com|
20545777|NCT02743611|Bellicum|Contact for Clinical Trials|(832) 384-1100|clinicaltrials@bellicum.com|
20545778|NCT00600119|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
20545779|NCT00561977|UMass Medical School|Barbara Olendzki, RD MPH LDN|508-856-5195|barbara.olendzki@umassmed.edu|
20545780|NCT00977080|Abbott|Global Medical Services|800-633-9110||
20545781|NCT00566696|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
20545782|NCT01534897|Massachusetts General Hospital Cancer Center|Dr. Lori J. Wirth|617 724 4000|lwirth@mgh.harvard.edu|
20545783|NCT01518270|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20545784|NCT01616693|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20545785|NCT02395172|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20545786|NCT00597896|Mount Sinai School of Medicine|Katherine E. Burdick, PhD||katherine.burdick@mssm.edu|
20545787|NCT00946985|Ortho-McNeil Janssen Scientific Affairs, LLC|Clinical Project Scientist|609-730-3229||
20545788|NCT01546623|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
20545789|NCT02369744|Albert Einstein Medical Center|Kamran Mohiuddin; Director ED Clinical Research|2154562313|MOHIUDDK@EISNTEIN.EDU|
20545790|NCT01590758|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
20545791|NCT04525885|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20545792|NCT02717832|University of Michigan|Dr. Jeffrey Horowitz|734-647-1076|jeffhoro@umich.edu|
20545793|NCT00096356|Wake Forest University Comprehensive Cancer Center|Dr. Glenn Lesser|(336) 713-5440|glesser@wakehealth.edu|
20545794|NCT02878057|Department of Breast Oncology, Peking University Cancer Hospital and Institute|Dr. Huiping Li|86-10-88196739|huipingli2012@hotmail.com|
20545795|NCT00978757|Francisco C. Bonofiglio|MD|541149590200|francisco.bonofiglio@hospitalitaliano.org.ar|4949
20545796|NCT00402740|Abbott Vascular|Ellen Travis, MS, NFP|408 845-1512|Ellen.Travis@av.abbott.com|
20545797|NCT03009396|Redhill Biopharma|Reza Fathi, Sn. VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
20545798|NCT02043808|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20545799|NCT00582075|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
20545800|NCT00557856|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545801|NCT03255083|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20545802|NCT00363545|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545803|NCT01457352|Sun Pharma Advanced Research Company Limited|SPARC|912266455645|Clinical.Trials@Sparcmail.com|
20545804|NCT02957968|Virginia Commonwealth University Massey Cancer Center|Massey CTO Breast Team|804-628-6430|masseyctbrst@vcu.edu|
20545805|NCT03865316|Masimo Corporation|Cristina Johnson|949-297-7000|ClinicalResearchDept@masimo.com|
20545806|NCT04084561|Center for Asian Health, Temple University|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
20545807|NCT03137069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20545808|NCT02600871|University of Texas Health San Antonio|Dr. Adriana Segura Olson|2152649796|adriana.s.olson@gmail.com|
20545809|NCT01604278|Novartis Pharmaceuticals|Study Director|862-778-8300||
20545810|NCT03035487|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
20545811|NCT00640224|Children's Hospital of Pittsburgh of UPMC|Dr. Silva Arslanian|412-692-6935||
20545812|NCT00422513|Hoffman-LaRoche|Medical Communications|800-821-8590||
20545813|NCT03135119|Penn State College of Medicine|Dr. Brian Allen|7175314100|ballen1@pennstatehealth.psu.edu|
20545814|NCT01478048|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20545815|NCT00955201|Edward Hines Jr. VA Hospital|Evan Stubbs|708-202-3507|evan.stubbs@va.gov|
20545816|NCT01252667|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
20545817|NCT04644315|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20545818|NCT03032380|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20545819|NCT01836276|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
20545820|NCT01561898|Janssen Pharm KK Japan|Medical Director|03-4411-5067||
20545821|NCT01847131|Faculty of Medicine Siriraj Hospital, Mahidol University|Torpong Thongngarm, M.D.|66-2-419-8263|torpong.tho@mahidol.ac.th|
20545822|NCT00331552|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20545823|NCT01445548|National Eye Institute|Wai T. Wong, MD, PhD|301-496-7566|wongw@nei.nih.gov|
20545824|NCT01883453|Umeå University|Dr Krister Tano|0046705569043|krister.tano@umu.se|
20545825|NCT02204761|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
20545826|NCT01707238|Visioncare Research Ltd.|Graeme Young|01252 718719|g.young@visioncare.co.uk|207
20545827|NCT04497038|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20545828|NCT03642132|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545829|NCT04493892|Columbia University|Jasmine A. McDonald|12123053586|jam2319@cumc.columbia.edu|
20545830|NCT02577887|Abbott (previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim@abbott.com|
20545831|NCT02267317|University of Texas Health San Antonio|Hanyu Liang|210-617-5300|liangh0@uthscsa.edu|15197
20545832|NCT00947791|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
20545833|NCT02366091|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
20545834|NCT02338232|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
20545835|NCT01105065|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
20545836|NCT00422084|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
20545837|NCT03996369|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20545838|NCT01782469|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20545839|NCT02614469|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-764-9611|michaels@helix.mgh.harvard.edu|
20545840|NCT02535572|Medical University of South Carolina|Morgan Dancy|843-876-5141|maddoxm@musc.edu|
20571198|NCT04160988|Acer Healthcare Inc.|Regulator Manager|886-6-26963131|Johnny.Lu@acer.com|5789
20545841|NCT04620798|Indiana University Bloomington School of Public Health|Molly Rosenberg, MPH, PhD|(812) 856-2509|rosenmol@indiana.edu|
20545842|NCT00568633|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation)|650-725-8950|rlowsky@stanford.edu|
20545843|NCT01224782|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20545844|NCT01960907|RESTECH srl|Dr. Pasquale Pio Pompilio, R&D manager|+39 02 3659 3690|p.pompilio@restech.it|
20545845|NCT00324259|Washington University School of Medicine|Dr. Matthew Ellis|314-362-8866|mjellis@bcm.edu|
20545846|NCT00441116|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545847|NCT02925338|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545848|NCT01332461|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545849|NCT00029146|University of North Carolina at Chapel HIll|William J. Powers, MD||powersw@neurology.unc.edu|
20545850|NCT01765218|University of California, Davis|Kristin Hoffman, MD|916-205-2755|krhoffman@ucdavis.edu|
20545851|NCT00313781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545852|NCT03567343|The University of Arizona|Dr Michael Grandner|15206266346|grandner@email.arizona.edu|
20545853|NCT02057081|VISN 5 Mental Illness Research, Education, and Clinical Center|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
20545854|NCT03288142|Northwestern University Feinberg School of Medicine|Stephen D. Persell, MD, MPH, FACP|312-503-6464|spersell@nm.org|
20545855|NCT01094522|Stanford University School of Medicine|Dr. Gregory Hammer|6507367359|ham@stanford.edu|
20545856|NCT01214395|PathWest Laboratory Medicine WA|Dr Kerry Carson Trial Manager|+61 8 93464092|kerry.carson@uwa.edu.au|
20545857|NCT01185353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545858|NCT01294098|Washington University School of Medicine|Lauren Westlund|314-454-5345|davislauren@wustl.edu|
20545859|NCT02270944|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545860|NCT01699867|Johns Hopkins Medicine|Lisa K. Jacobs, M.D.|410-502-0880|ljacob14@jhmi.edu|
20545861|NCT00183729|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
20545862|NCT00796926|Singapore National Eye Center|Dr Louis Tong|65 62277255|Louis.tong.h.t@snec.com.sg|
20545863|NCT03512457|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
20545864|NCT04160975|Harvard University|Dr. Marcella Alsan|617-496-1770|marcella_alsan@hks.harvard.edu|
20545865|NCT00530504|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20545866|NCT00006289|National Institute of Nursing Research|Dr. Leorey Saligan (Principal Investigator, former PI: Dr. Raymond Dioone)|301-451-1685|saliganl@mail.nih.gov|
20545867|NCT04096482|Emory University|Joshua M Levy|(404) 778-3381|joshua.levy2@emory.edu|
20545868|NCT00576420|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
20545869|NCT03225859|Minneapolis VA Medical Center|Shannon Kehle-Forbes, PhD|612-467-4772|Shannon.Kehle-Forbes@va.gov|
20545870|NCT03521102|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|bfriedm@montefiore.org|
20545871|NCT02043899|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20545872|NCT03254108|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20545873|NCT01771809|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20545874|NCT00362180|Kastle Therapeutics, LLC|Christopher Bryant, Ph.D.|8152633913|cbryant@kastletx.com|
20545875|NCT01106092|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545876|NCT03930264|Nova Laboratories Limited|Dr Hussain Mulla|+44 (0)116 223 0100|hussain.mulla@novalabs.co.uk|
20545877|NCT01371032|Cedars Sinai Medical Center|Dr. Roya Yumul, MD, PhD|310-423-1682|Roya.Yumul@cshs.org|
20545878|NCT02434471|Duke University|Mustafa R. Bashir, M.D.|919-684-7366|mustafa.bashir@duke.edu|
20545879|NCT01473368|Beth Israel Deacones Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
20545880|NCT00369629|Northwestern University|Barbara Pro||barbara.pro@nm.org|
20545881|NCT04839562|Massachusetts General Hospital|Dr. Craig Surman|6176808489|csurman@partners.org|
20545882|NCT00911443|R&D Department - Sigma-Tau SpA|Roberto Camerini|+390691393562|roberto.camerini@sigma-tau.it|
20545883|NCT00762424|WellSpan Health|Barbara Stahlman MS, Clinical Research Associate|717-851-2450|bstahlman@wellspan.org|
20545884|NCT01347580|AstraZeneca|Dr Tomas Andersson MD|00 46 31 77 61966|tomas.lg.andersson@astrazeneca.com|
20545885|NCT01949337|Memorial Sloan-Kettering Cancer Center|Michael J. Morris, MD|646-422-4469|morrism@mskcc.org|
20545886|NCT00003472|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20545887|NCT01012219|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20555654|NCT00477191|Department of Dermatology, Mass General Hospital|Alexa Boer Kimball, MD MPH|617-726-0149|akimball@partners.org|
20555655|NCT01289067|Icahn School of Medicine at Mount Sinai|Dr. Bobby Liaw|(212) 604-6010|bobby.liaw@mountsinai.org|
20555656|NCT04656847|Sevier|Medical manager - Yuriy Burtsev|8-495-93707-00|Yuriy.Burtsev@servier.com|
20555657|NCT03301051|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
20545888|NCT00874939|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20545889|NCT01909791|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
20545890|NCT02168387|Duke University Medical Center|Ira M. Cheifetz, MD, FCCM, FAARC|919-681-4080|ira.cheifetz@dm.duke.edu|
20555658|NCT02073331|Aziyo Biologics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
20527609|NCT00326170|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
20527610|NCT02429310|Imperial College London|Professor Alun Davies|02033117320|a.h.davies@imperial.ac.uk|
20527611|NCT00394433|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
20555659|NCT01359735|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20555660|NCT03006328|NYU Langone Health|Sandra Wittleder, PhD|212-263-4149|sandra.wittleder@nyulangone.org|
20555661|NCT01358526|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20555662|NCT01778465|Western University|Clinical Trials Program Coordinator|+15196466100|taciano.rocha@sjhc.london.on.ca|61125
20555663|NCT00724971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555664|NCT01003249|Wake Forest University Health Sciences|Dr. Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
20555665|NCT01962974|Janssen Pharmaceuticals|STRATEGIC LEAD||ClinicalTrialDisclosure@its.jnj.com|
20555666|NCT00147966|UCSD|Arthur Kavanaugh|858-657-7040|akavanaugh@ucsd.edu|
20555667|NCT00955877|Washington University in St. Louis School of Medicine|Diego Morales|3144544688|d.morales@wustl.edu|
20555668|NCT02132611|Cardiovascular Systems, Inc.|Clinical Project Manager|651-259-1600|clinicaltrials_csi@csi360.com|
20555669|NCT02298192|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20555670|NCT01995123|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health; William S Middleton Memorial Veterans Hospital|Jessica Cook, PhD|608-265-9775|jwcook@ctri.wisc.edu|
20555671|NCT01913600|Medtronic, Coronary & Structural Heart Clinical|Lisa Bousquette, Clinical Research Director|707-591-2967|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20555672|NCT06167031|Tzu Chi University|Associate professer Mei-Lin Hsieh|886933513291|shaer@gms.tcu.edu.tw|
20555673|NCT02979639|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555674|NCT01429532|SunYat-senU|Prof. Yizhi Liu|+86-20-87330341|Reviewborad_SYsU@163.com|
20555675|NCT01877408|University of New England|Dr. Peter Millard|2078663503|pmillard@mac.com|
20555676|NCT00240487|The Children's Hospital of Philadelphia|Richard Lin|2155905505|linr@email.chop.edu|
20555677|NCT02621931|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20555678|NCT00920426|ViiV Healthcare|GSK Response Center|866-435-7343||
20555679|NCT01292603|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20555680|NCT03282981|VA Northern California Health Care System|Dr. Sara Dahle and Dr. Rosyln Rivkah Isseroff|916-843-7151|sara.dahle@va.gov|
20555681|NCT03870763|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20555682|NCT02345031|Autifony Therapeutics Ltd|Clinical Project Manager|+44 1438 906860|info@autifony.com|
20555683|NCT01096992|The University of Texas MD Anderson Cancer Center|William Wierda, MD./Professor|713-745-0428|CR_Study_Registration@mdanderson.org|
20555684|NCT03031938|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555685|NCT02479412|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20555686|NCT01877538|Department of Nuclear Medicine & PET Center, Aarhus University Hospital|Dr. Per Borghammer|+0045 23818581|perborgh@rm.dk|
20555687|NCT02732938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555688|NCT01613248|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20555689|NCT01636882|Viralytics Ltd|Mark Grose|1 647 821 7673|mark.grose@viralytics.com|
20555690|NCT02703350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20555691|NCT06116591|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555692|NCT05585307|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20555693|NCT02647359|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
20555694|NCT04642638|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20555695|NCT00319098|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555696|NCT00965523|Eisai|Tatsuo Watanabe, Study Director|+81-3-3817-5252||
20555697|NCT02415400|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20555698|NCT02270450|SWOG Statistics and Data Management Center|Palliative and End of Life Care Committee Statistician|2066674623|karnold@fredhutch.org|
20555699|NCT02363738|University Health Network|Dr. Roger McIntyre|416-603-5279|roger.mcintyre@uhn.ca|
20545891|NCT01659554|Columbia University Medical Center|Reena M. Vattakalam, CCRP|212-342-6895|rmv2110@cumc.columbia.edu|
20545892|NCT01561703|University of Missouri - Department of Otolaryngology - Head and Neck Surgery|Research Coordinator|5738822549|schneiderri@health.missouri.edu|
20545893|NCT00522925|Ligand Pharmaceuticals, Inc.|Ram Kapil, PhD/ Sr. Director, Clinical Pharmacology|858-550-7603|rkapil@ligand.com|
20545894|NCT00918931|Organization: The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
20545895|NCT01350544|RAND Corporation|Laura M. Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
20545896|NCT01444092|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
20545897|NCT02396160|University of Queensland|Dr Niikee Schoendorfer|0413122076|n.schoendorfer@uq.edu.au|
20545898|NCT01328366|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20545899|NCT00594425|Virginia Clinical Research, Inc|David Pariser MD|757-625-0151|dpariser@pariserderm.com|
20545900|NCT02558829|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
20545901|NCT00097981|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Director|1 215 325-5329||
20545902|NCT00412373|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136|jhulihan@its.jnj.com|
20545903|NCT01002820|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20545904|NCT01673347|William Beaumont Hospital|Erin Baker, PhD|248-551-1816|erin.baker@beaumont.org|
20545905|NCT01031420|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
20545906|NCT02528721|Exalenz Bioscience|VP of Clinical Affairs|972-8-9737502|melinaa@exalenz.com|
20545907|NCT00813176|University of Iowa|Dr Javier H Campos|3193567208|javier-campos@uiowa.edu|
20545908|NCT00895011|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|medaffairs@vivus.com|
20545909|NCT03774823|Venus Concept Ltd.|Director, Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20545910|NCT01568528|Emory University|Dr. Erica Duncan|404-321-6111|eduncan@emory.edu|
20545911|NCT03241368|Medtronic GIH|Amanda Wenisch, Clinical Resaerch Coordinator / Study Manager|1-206-225-4025|amanda.m.wenisch@medtronic.com|
20545912|NCT04740905|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20545913|NCT04821362|Ege University|Dr. Sercan Yalçınlı|+90 505 537 41 01|sercan.yalcinli@ege.edu.tr|
20545914|NCT01054183|Akron Children's Hospital|Michael T. Bigham, MD|330-543-8639|MBigham@chmca.org|
20545915|NCT00065429|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20555700|NCT00601926|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|614-293-2886|Paul.Monk@osumc.edu|
20545916|NCT02080819|Virginia Commonwealth University|Dr. Liangsuo Ma|8048282871|liangsuo.ma@vcuhealth.org|
20545917|NCT00548184|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
20545918|NCT00636363|Bausch & Lomb|Robert Steffen|(585) 338-6399|robert.steffen@bausch.com|
20545919|NCT00280748|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20545920|NCT02034409|VA Salt Lake City Health Care System|Daniel Clegg, MD|801-582-1565|daniel.clegg@va.gov|
20545921|NCT01144299|GlaxoSmithKline|GSK Response Center|866-435-7343||
20545922|NCT03353233|Duke University Medical Center|W. Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
20545923|NCT02342418|University of Michigan|Manjunath Pai, Associate Professor|7346470006|amitpai@med.umich.edu|
20545924|NCT04255394|Zimmer Biomet|Linda Meijer|+31627933741|linda.meijer@zimmerbiomet.com|
20545925|NCT00428584|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|fernando.dangond@emdserono.com|
20545926|NCT00528541|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20545927|NCT00985829|skin research center|Zohreh Tehranchi-nia, assist. prof|+989121029415|zohreh_tehranchi@yahoo.com|
20545928|NCT02390791|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20545929|NCT03612856|Aronora, Inc.|Christina U. Lorentz|503-964-0250|christina.lorentz@aronorabio.com|
20545930|NCT01181986|Phoenix VA Health Care System|Dr. Juraj Koska|602-277-5551|juraj.koska@va.gov|7685
20545931|NCT01011309|IDRI|Jill Ashman, MSc, Associate Director of Clinical Operations|206-858-6041|jill.ashman@idri.org|
20545932|NCT01085006|Tehran University of Medical Sciences|Dr. Laleh Eslamian|+982184902415|leslamian@tums.ac.ir|
20545933|NCT00831493|UT MD Anderson Cancer Center|Sunil Krishnan, MD / Associate Professor||mclemons@mdanderson.org|
20545934|NCT00548652|VANebraska|Cyrus Desouza|4023468800|cyrus.desouza@va.gov|5506
20545935|NCT00222131|Texas Tech|Jerzy Sarosiek, MD, PhD, AGAF, FACG|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
20545936|NCT04784065|Baylor College of Medicine|Dr. Grace Lo, Associate Professor of Medicine|713-791-1414|ghlo@bcm.edu|227804
20545937|NCT05092360|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
20545938|NCT01525225|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20545939|NCT01182844|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
20508467|NCT01089569|International Diabetes Center|Dr. Richard M. Bergenstal|952-993-1913|richard.bergenstal@parknicollet.com|
20508468|NCT00445341|National Cancer Institute, National Institutes of Health|Kieron Dunleavy, M.D.|301-435-1007|DunleavK@mail.nih.gov|
20508469|NCT03051217|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20508470|NCT02864706|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20508471|NCT00641706|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|Galanis.evanthia@mayo.edu|
20508472|NCT01675141|National Cancer Institute|Dr. Dickran Kazandijian|301-451-2677|kazandijiandg@nih.gov|
20508473|NCT02057276|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
20508474|NCT00109772|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20508475|NCT02516150|Massachusetts General Hospital|Courtney Balliro|617-726-1242|cballiro@partners.org|
20508476|NCT00813917|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
20508477|NCT05441540|UNC School of Medicine|Benjamin Succop|8284439726|benjamin_succop@med.unc.edu|
20508478|NCT01359046|Mayo Clinic|Dr. John Gebhart|507-266-7711|gebhart.john@mayo.edu|
20508479|NCT01498588|Emory University|Keerthi Gogineni, MD, MSHP|404-778-1801|keerthi.gogineni@emory.edu|
20508480|NCT03168841|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
20508481|NCT01349972|University of North Carolina, Lineberger Comprehensive Cancer Center|Joshua Zeidner|(919) 962-5164|Joshua_Zeidner@med.unc.edu|
20508482|NCT03364491|George Washington University Biostatistics Center|Principal Investigator, MFMU|301-881-9260|mfmudatasets@bsc.gwu.edu|
20508483|NCT04539262|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20508484|NCT03228394|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20508485|NCT02157103|Emory University|William L. Read, MD, Principal Investigator|404-778-1900|william.l.read@emory.edu|
20508486|NCT01921452|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|49-6151-72-5200|service@merckgroup.com|
20545940|NCT03048383|University of Utah|Dr. P. Daniel Ward|801-581-8471|PDanielWard@hsc.utah.edu|
20545941|NCT05009979|National Cancer Institute|Dr. Esther Mena Gonzalez|240-760-6111|esther.menagonzalez@nih.gov|
20545942|NCT01330017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20545943|NCT01221272|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20545944|NCT02656680|University of Connecticut|Dr. Sherry Pagoto|8604868979|sherry.pagoto@uconn.edu|
20545945|NCT01215929|UAMS|Michael J Mancino MD|501-526-8440|mjmancino@uams.edu|
20545946|NCT01246466|AtriCure|Vice President, Clinical Affairs and Biometrics|1-513-644-8192|nndikintum@atricure.com|
20545947|NCT00877773|University of Texas (UT) MD Anderson Cancer Center|Daniel Karp, MD / Professor, Investigational Cancer Therapeutics||CR_Study_Registration@mdanderson.org|
20545948|NCT00603590|Tehran University of Medical Sciences|Mansoor Rastegarpanah|+989121255960|rastegar@sina.tums.ac.ir|
20545949|NCT00910624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20545950|NCT01122264|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545951|NCT03005873|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
20545952|NCT04585009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20545953|NCT01713933|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20545954|NCT00918125|Duke University Medical Center|Dr. Kevin Thomas|919-668-7857|kevin.thomas@dm.duke.edu|
20545955|NCT02882152|University of São Paulo|Dr. Joaquim Edson Vieira|+55 11 3061 8716|joaquimev@usp.br|
20545956|NCT02871882|Mayo Clinic|Andres Acosta|15072666931|acosta.andres@mayo.edu|
20545957|NCT01009840|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
20545958|NCT00791973|University of Chicago|Dr. Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
20545959|NCT04240678|UC Davis Medical Center|Eric Chak|916-734-3751|echak@ucdavis.edu|
20545960|NCT01104376|Indiana University|Zeruesenay Desta, PhD|317-630-8860|zdesta@iupui.edu|
20545961|NCT00797966|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20545962|NCT00541190|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
20545963|NCT00732901|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
20545964|NCT01486043|Children's Hospital Los Angeles|Dr. Jamie Wood|323-361-7388|jawood@chla.usc.edu|
20545965|NCT01514786|UMichigan|Dr. Masahito Jimbo|734-998-7120|mjimbo@med.umich.edu|
20545966|NCT01430754|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
20545967|NCT02617901|Sheffield Children's NHS Foundation Trust|Dr Amaka C Offiah|0114 271 7557|a.offiah@sheffield.ac.uk|
20545968|NCT00177047|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
20545969|NCT02661178|Drugs for Neglected Diseases initiative|Sophie Delhomme|+41229069230|sdelhomme@dndi.org|
20545970|NCT01408329|Stanford University|Anne L Friedlander|650-725-7531|afriedlanderCW@gmail.com|
20545971|NCT03859973|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508487|NCT05097157|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20508488|NCT01525667|Pluristem Ltd.|Dr.Esther Lukasiewicz Hagai|+972-972-74-710-8600|estherl@Pluristem.com|694
20545972|NCT02855541|University of Colorado Boulder|James Peterman, PhD|303-735-0358|james.peterman@colorado.edu|
20545973|NCT01242813|Novartis Pharmaceuticals|Study Director|862-778-8300||
20508489|NCT00770224|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
20545974|NCT02766582|Medical College of Wisconsin|D. Denise Uyar|414-805-6606|duyar@mcw.edu|
20545975|NCT01910311|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20545976|NCT00701662|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20545977|NCT01839604|AstraZeneca Pharmaceuticals LP|Martin Scott, MD/PhD|Martin.Scott@astrazeneca.com|Martin.Scott@astrazeneca.com|
20545978|NCT03337490|Mayne Pharma LLC|Associate Director, Clinical Operations|9195737948|phoevos.hughes@maynepharma.com|
20545979|NCT03560518|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20545980|NCT01363349|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
20545981|NCT00917644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20545982|NCT00766753|University of Pittsburgh Cancer Institute|Frank Lieberman|(412) 648-6507|liebermanf@upmc.edu|
20545983|NCT00924040|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitman@mail.nih.gov|
20545984|NCT00362128|Albert Einstein College of Medicine|Judith Wylie-Rosett|718-430-3345|Judith.Wylie-Rosett@einstein.yu.edu|
20545985|NCT01579812|UPMC Hillman Cancer Center|Dr. Ronald Buckanovich, MD, PhD|412-641-4721|buckanovichrj@mwri.magee.edu|
20545986|NCT05168501|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
20545987|NCT01133990|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20545988|NCT03271983|University of Maryland, Baltimore|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20545989|NCT02282345|UT MD Anderson Cancer Center|Dr. Jennifer Litton,VP, Clinical Research, VP Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
20545990|NCT01185301|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20545991|NCT02683746|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20545992|NCT01213576|University of Liverpool|Professor Neil French|+441517959630|french@liv.ac.uk|
20545993|NCT04987944|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20545994|NCT00606047|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8920|pbeaule@toh.ca|
20545995|NCT00345332|University of Rochester|Division of Urogynecology|585-273-3232|amy_keller@urmc.rochester.edu|
20545996|NCT04121078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20555701|NCT01968213|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20555702|NCT02187991|Sarah Cannon Development Innovations, LLC|Taqi Mohammad|713-870-2175|taqi.mohammad@scri.com|
20555703|NCT01392560|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20555704|NCT02081846|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
20555705|NCT00875836|MUSC|Dr. Aimee McRae-Clark|843.792.5216|mcraeal@musc.edu|
20555706|NCT01939028|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Chad Michener|216-444-6601|michenc@ccf.org|
20555707|NCT03282227|Zosano Pharma Corporation|Donald Kellerman, PharmD, Sr. VP, Clin Dev and Med Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
20555708|NCT01404572|Bristol-Myers Squibb (BMS)|BMS Study Director||Clinical.Trials@bms.com|
20555709|NCT00682734|Montefiore Medical Center|Benjamin Friedman|718 920 6626|befriedm@montefiore.org|
20555710|NCT00295750|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20555711|NCT00322348|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20555712|NCT01289912|Boston Children's Hospital|Dr. Mustafa Sahin|617-355-8994|Mustafa.Sahin@childrens.harvard.edu|
20555713|NCT00802854|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555714|NCT02293044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20555715|NCT00989287|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555716|NCT02512575|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20555717|NCT01047839|Valneva Austria GmbH|Senior Scientist Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
20555718|NCT01857531|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
20555719|NCT00572234|University of Nebraska Medical Center|Kathleen Grant|402-995-4347|kathleen.grant2@va.gov|
20555720|NCT03858803|Portland State University|Dr. Janet S. St. Lawrence|971-978-7801|janetsstlawrence@gmail.com|
20555721|NCT03736434|The Ohio State University College of Nursing|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
20555722|NCT04598152|The Ohio State University College of Medicine|Jay Fournier, PhD|614-293-9600|jay.fournier@osumc.edu|
20555723|NCT00746603|Weill Cornell Medicine|Jennifer Levine, MD|212-305-9770|jel9022@med.cornell.edu|
20555724|NCT00435370|Baylor College of Medicine|Dr. Thomas R. Kosten|(713) 794-7032|kosten@bcm.edu|
20555725|NCT01965834|University of Miami|Denise Pereira MD|305-243-4909|dpereira2@med.miami.edu|
20545997|NCT04136444|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20571199|NCT01250509|University of California, San Francisco|Jennifer Daubenmier, PhD|415-514-8601|jennifer.daubenmier@ucsf.edu|
20571200|NCT01228175|University of Colorado Boulder|Dr. Kent Hutchison|303-492-8163|kent.hutchison@colorado.edu|
20571201|NCT01292304|University of Florida|Giuseppe (Joseph) Morelli, MD|352-273-9508|giuseppe.morelli@medicine.ufl.edu|
20571202|NCT00243074|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fredhutch.org|
20571203|NCT02506933|City of Hope Medical Center|Dr. Ryotaro Nakamura, MD|6263598111|RNakamura@coh.org|
20571204|NCT03939689|Lantheus|June Li, Vice President, Biometrics and Data Sciences|978-671-8107|lij@lantheus.com|
20571205|NCT04427280|The Royal Marsden NHS Foundation Trust|Senior Trial Manager (for the CARDS study)|020 8642 6011|gi.trials@rmh.nhs.uk|3807
20571206|NCT05310201|Medical University of South Carolina|Angela Moreland, PhD|8437928209|moreland@musc.edu|
20571207|NCT04944290|Padagis LLC|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
20571208|NCT03388268|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
20571209|NCT02296502|University of Pittsburgh|Benjamin L Handen, PhD|412-235-5445|handenbl@upmc.edu|
20571210|NCT02412735|Mesoblast, Inc.|Christopher James, VP Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
20527612|NCT00093847|Massachusetts General Hospital|Dr George Papakostas, M.D.|6177266697|gpapakstas@partners.org|
20545998|NCT01844479|University of Michigan|James Wrobel, DPM, MS|734-647-4940|jswrobel@med.umich.edu|
20545999|NCT02012582|vasopharm GmbH|Dr. Reinhard Schinzel|+49 931 359099|schinzel@vasopharm.de|115
20546000|NCT03207438|University of Saskatchewan|Evyn Peters|13068441312|evyn.peters@usask.ca|
20546001|NCT03051620|Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark|Anne Sophie Sølling|+45 78 45 54 75|annesoel@rm.dk|
20546002|NCT01073462|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20546003|NCT03554486|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
20546004|NCT02992197|The University of Vermont College of Medicine|Benjamin Lee|8026567748|blee7@uvm.edu|
20546005|NCT02509117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20546006|NCT00832624|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546007|NCT05396599|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
20527613|NCT00594386|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20571211|NCT01228318|Emory University|Igho Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
20546008|NCT02199717|Hospital for Sick Children|Vanessa Bouskill NP|4168135871|vanessa.bouskill@sickkids.ca|
20546009|NCT00684541|SDSU|Professor Nader Amir|6192293744|namir@mail.sdsu.edu|
20546010|NCT00934843|Medical University of South Carolina|Dr. Eric Graham|843-792-8704|grahamem@musc.edu|
20546011|NCT03259620|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20546012|NCT01576159|Middle East Technical University|Ozgur Celik PhD.|+903122104016|ozgur@udel.edu|3663
20546013|NCT01055067|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20527614|NCT03417024|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
20527615|NCT02604173|Stanford University|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
20546014|NCT03602560|CymaBay Therapeutics, Inc.|Elaine Watkins, DO, MSPH, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
20546015|NCT03658876|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
20546016|NCT02616146|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546017|NCT02000154|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
20546018|NCT01340872|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
20546019|NCT01502332|USaoPaulo|Dr Alcino Costa Leme|55 11 989044014|costaleme@uol.com.br|
20546020|NCT03039621|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20546021|NCT02361476|Rigshospitalet|Mogens Ydemann, MD|+45 35455620|mogens@ydemann.dk|
20546022|NCT01142089|Cosmo Technologies Ltd.|Richard Jones|+35318170370|RJones@cosmopharma.com|
20555726|NCT00158743|BTG International Inc|Suzanne Ward Pharm D|610-278-1660|suzanne.ward@btgplc.com|
20555727|NCT03943095|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555728|NCT03674177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555729|NCT03387852|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20546023|NCT01145638|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
20546024|NCT00789074|Queen Mary University of London|Professor Peter Hajek|+44 207 882 8231|p.hajek@qmul.ac.uk|
20546025|NCT01974765|Memorial Sloan Kettering Cancer Center|Dr. Rachel Grisham, MD|646-888-4653|grishamr@mskcc.org|
20546026|NCT00925938|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20546027|NCT00052442|Memorial Sloan-Kettering Cancer Center|Owen A. O'Connor, MD, PhD|212-639-8889|oo2130@columbia.edu|
20546028|NCT05338671|University of Washington|Avina Paranjpe|206-543-5044|avina@uw.edu|
20546029|NCT01733212|New York Methodist Hospital|Sandip Darji|718/780-3779|darji_sandip2005@yahoo.com|
20546030|NCT03085914|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20546031|NCT01369329|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
20546032|NCT00159822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20546033|NCT01689532|Janssen Pharmaceutical K.K.|Senior Manager||ClinicalTrialDisclosure@its.jnj.com|
20546034|NCT01958489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20546035|NCT02307253|Fondazione Policlino Universitario A Gemelli IRCCS|Dr Alberto Larghi|0630156580|alberto.larghi@yahoo.it|
20546036|NCT00275821|Novartis Pharmaceuticals|Study Director|862-778-8300||
20546037|NCT01215916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20546038|NCT00915499|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
20546039|NCT00958438|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20546040|NCT01410344|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20546041|NCT02788279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20546042|NCT02353143|Menarini Ricerche|Director of Clinical Sciences|003905556809990|acapriati@menarini-ricerche.it|
20546043|NCT01280201|Group for Neuroendocrine Tumors (GETNE)|Dr. Enrique Grande (Hospital Universitario Ramón y Cajal)|931780742|getne@getne.org|201
20546044|NCT00253708|Beth Israel Deaconess Medical Center|Russell S. Phillips, MD|6174322222|Russell_phillips@hms.harvard.edu|
20546045|NCT02095132|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20546046|NCT01981057|Medical University of Vienna|Nadja Haiden M.D.|+4314040032320|nadja.haiden@meduniwien.ac.at|
20546047|NCT04905498|University of Kansas Medical Center|Amanda S. Bruce|4014990576|abruce2@kumc.edu|
20546048|NCT01029405|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546049|NCT00409175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546050|NCT00430183|Memorial Sloan-Kettering Cancer Center|James A. Eastham, MD|646-422-4390|easthamj@mskcc.org|
20546051|NCT02599051|Cleveland Clinic Florida|G W Davila|9546595559|davilag@ccf.org|
20546052|NCT02946931|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546053|NCT03492840|Raziel Therapeutics|Racheli Gueta|97289126941|racheli@raziel-therapy.com|
20546054|NCT00869778|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
20546055|NCT03339297|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
20546056|NCT02126748|Vrije Universiteit Brussel|Filip Van Ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
20546057|NCT01976988|Cedars Sinai Medical Center|Phillip Fleshner MD|310-289-9224|pfleshner@aol.com|
20546058|NCT03316911|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
20546059|NCT01119937|Novartis Pharmaceuticals|Study Director|862-778-8300||
20546060|NCT01270802|Indiana University School of Medicine|Dr. Samir K. Gupta, Principal Investigator|317-274-7926|sgupta1@iu.edu|
20546061|NCT01512667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508490|NCT00047853|National Institute of Mental Health|Pao, Maryland|+1 301 435 5770|paom@mail.nih.gov|
20546062|NCT01883856|University of Virginia|Peter A. Netland, MD, PhD|4349821086|pan9c@virginia.edu|
20546063|NCT01566214|Iowa City VA Health Care System|Mark Vander Weg|319-338-0581|mark.vanderweg@va.gov|7717
20546064|NCT04132804|Massachusetts General Hospital|Dr. Kyle Staller|617-726-5565|kstaller@mgh.harvard.edu|
20508491|NCT00294684|NIDDK|Ed Doo||dooe@niddk.gov|
20546065|NCT00393510|Institute of Chinese Medicine, Chinese University of Hong Kong|Prof. Leung Ping Chung|(852)2252 8863|pingcleung@cuhk.edu.hk|
20546066|NCT02700334|INSTITUTO DE TERAPUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20546067|NCT01534182|Novartis|Study Director|+1 (862) 778-8300||
20546068|NCT03077087|Regions Hospital|Joshua S Rosenzweig / Study Coordinator|651-254-3351|joshua.s.rosenzweig@healthpartners.com|
20546069|NCT00770146|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20546070|NCT01023477|Inova Health Care|Kirsten Edmiston, MD|703-850-9555|Kirsten.edmiston@inova.org|
20546071|NCT02412488|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
20546072|NCT01989468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20546073|NCT01640327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20546074|NCT01967784|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20546075|NCT03222492|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20546076|NCT00674154|Aarhus University Hospital|Lars Rolighed|004520677876|larsrolighed@gmail.com|
20546077|NCT00816023|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD, MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
20546078|NCT01525901|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|(212) 659-9134|alexander.kolevzon@mssm.edu|
20546079|NCT02312882|Stanford University|Anthony E Oro, M.D., Ph.D.||oro@stanford.edu|
20546080|NCT01229462|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20546081|NCT04449029|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20546082|NCT01476202|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546083|NCT00641316|University of Alabama at Birmingham|Nicolaas Geurs, DDS,MS|2059344506|ngeurs@uab.edu|
20546084|NCT02025556|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20546085|NCT02189954|DorkuzEU|Anaesthesiology and Reanimation, Dr. Sule Ozbilgin|0905055252901|ozbilginsule@gmail.com|
20546086|NCT02112045|Washington University School of Medicine|Meagan Jacoby, M.D., Ph.D.|314-454-8304|mjacoby@wustl.edu|
20546087|NCT00627445|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20546088|NCT02775240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20546089|NCT01126671|Boston Children's Hospital|Dr. Sarah Pitts|617-355-3732|sarah.pitts@childrens.harvard.edu|
20546090|NCT00247611|Center for Health, Intervention & Prevention|Dr. Jeffrey Fisher, Principal Investigator|(860) 486-4940|jeffrey.fisher@uconn.edu|
20546091|NCT05395091|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
20546092|NCT04114617|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
20546093|NCT00568386|Alcon Research|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20546094|NCT01433250|Novartis Pharmaceuticals|Study Director|862-778-8300||
20546095|NCT03148691|Aclaris Therapeutics|Executive Director, Clinical Operations|4843247933|jschnyder@aclaristx.com|
20546096|NCT02930980|Medtronic EMEA RCC|Valentina Amori, Medical Writer|+39 06 32814236|valentina.amori@medtronic.com|
20546097|NCT02596750|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
20546098|NCT00968032|pfm medical ag|Christof Schmeer|+49 6873 9011|christof.schmeer@pfmmedical.com|41
20546099|NCT00081861|U.T. M.D. Anderson Cancer Center|Barbara Pro, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
20546100|NCT01544088|VA Boston Healthcare System|Denise Sloan, Ph.D.|(857) 364-6333|denise.sloan@va.gov|
20546101|NCT00445588|Adult Brain Tumor Consortium|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
20546102|NCT01509053|Otsuka Pharmaceutical Development & Commercialization, Inc.|Medical Affairs|800-562-3974||
20546103|NCT01764919|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
20546104|NCT00796991|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20546105|NCT00171834|Novartis Pharmaceuticals|Study Director|862-778-8300||
20546106|NCT00834080|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
20546107|NCT03467685|UPMC Dermatology|Dr. Rashek Kazi|5167105208|kazir@upmc.edu|
20546108|NCT03396952|University of California, San Francisco|Dr. Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
20546109|NCT04345367|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546110|NCT00796523|University of Toledo|Jonna M. McRury, M.D.|419-389-1118|jmcrury@aol.com|
20546111|NCT02252744|Western University of Health Sciences|Jasmine Wong Yumori OD FAAO|(909) 706-3886|jyumori@westernu.edu|
20546112|NCT01876329|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
20546113|NCT02431260|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20546114|NCT00321646|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
20546115|NCT03208985|HRA Pharma|Christine VENARD|+33184139244|c.venard@hra-pharma.com|
20546116|NCT01522937|University of Michigan Comprehensive Cancer Center|Dr. Kyle Cuneo, M.D.|734-936-4300|kcuneo@umich.edu|
20508492|NCT04206670|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
20508493|NCT02443805|Stallergenes Greer|Martine Le Gall, Director of Clinical Development|+33 1 55 59 25 56|martine.legall@stallergenesgreer.com|
20508494|NCT00961116|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20546117|NCT03774719|Washington University in Saint Louis|Gonzalo Matzumura|3143627211|g.matzumuraumemoto@wustl.edu|
20546118|NCT00781885|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
20546119|NCT02576145|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20546120|NCT01227824|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546121|NCT01755026|west virginia university|michael stitely|304-293-5631|mstitely@hsc.wvu.edu|
20546122|NCT00875589|Daroff-Dell'Osso Ocular Motility Laboratory|Jonathan Jacobs, PhD|216-791-3800|jxj24@case.edu|2947
20546123|NCT00392379|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
20546124|NCT01700387|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-883-7889|rcady@banyangroupinc.com|
20546125|NCT02184624|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546126|NCT03417713|Hamilton General Hospital|Dr. Theodore Rapanos|905-521-2100|rapanost@mcmaster.ca|44652
20546127|NCT01295879|Brigham and Women's Hospital|David E. Leaf, M.D., Renal Fellow|617-732-5951|DELEAF@partners.org|
20546128|NCT02730793|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
20546129|NCT02365233|University of Texas Medical Branch|Nicola Abate, MD - Professor and Director of Endocrinology Division|409 772 1922|niabate@utmb.edu|
20546130|NCT00995566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546131|NCT01059929|University of Chicago|John Kress|773-702-6790|jkress@medicine.bsd.uchicago.edu|
20546132|NCT01264601|University of Michigan|Matthew Greenhawt, MD, MBA|734/936-5634|mgreenha@umich.edu|
20546133|NCT01375075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20546134|NCT00384111|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
20546135|NCT00545129|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546136|NCT00821509|National Institute for Health and Welfare|Tapani Hovi, Project Leader|+358 400 517299|tapani.hovi@thl.fi|
20546137|NCT03678870|Vanderbilt University Medical Center|Sarah Osmundson, Assistant Professor of Obstetrics and Gynecology|(615) 343-7869‬|sarah.osmundson@vumc.org|
20546138|NCT03127098|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20546139|NCT03104816|USCalifornia|Eugenia Ayrian|8186363161|eayrian@med.usc.edu|
20546140|NCT01894568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20546141|NCT00807573|Memorial Sloan Kettering Cancer Center|Dr. Maria Pietanza, Assistant Attending|+1646-888-4203|PietanzM@mskcc.org|
20571212|NCT03011567|NYU Langone Health|Christina Penfield, MD, MPH|646-754-2700|christina.penfield@gmail.com|
20546142|NCT01426789|Novartis Pharmaceuticals|Study Director|862-778-8300||
20571213|NCT00603525|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571214|NCT00770029|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
20571215|NCT02124811|Emory University|Robert Cotes, MD|(404) 616-4752|robert.o.cotes@emory.edu|
20571216|NCT04043143|"University of Colorado Denver | Anschutz"|Karsten Bartels, MD, PhD, MBA|303-724-1111|karsten.bartels@cuanschutz.edu|
20571217|NCT03480932|Johns Hopkins Bloomberg School of Public Health|Dr. Shruti Mehta|4432873837|smehta@jhu.edu|
20571218|NCT02734498|Wake Forest School of Medicine|James Kimball, MD|336-716-9702|jkimball@wakehealth.edu|
20571219|NCT04624243|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571220|NCT03065075|University of Massachusetts|Dr. Tania Sierra|508-334-9840|tania.sierra@umassmemorial.org|
20571221|NCT03322540|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20571222|NCT00583466|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20571223|NCT00168389|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20571224|NCT01294397|Amgen Inc.|Study Director|866-572-6436||
20571225|NCT01661205|AtriCure, Inc.|Vice President, Clinical Operations|513-755-4562|SZink@AtriCure.com|
20571226|NCT00426127|University of Iowa|Daniel Berg, MD|319-353-7800|daniel-j-berg@uiowa.edu|
20571227|NCT00346905|Boston Scientific|Director, Endoscopy Clinical Affairs|1-508-333-1015||
20546143|NCT04054947|White River Junction VA Medical Center|Dr. Brian Shiner|802-295-9363|brian.shiner@va.gov|6070
20571228|NCT04191421|Emory University|Dr. Olatunji Alese, MD|404-778-6639|olatunji.alese@emory.edu|
20571229|NCT03111095|University of Wisconsin School of Medicine and Public Health|Kara Hoppe, DO|(206) 371-4014|khoppe2@wisc.edu|
20571230|NCT02413645|Hospital Clinic-HIVACAT|Dr. Felipe Garcia|932275400|fgarcia@clinic.cat|2844
20571231|NCT00955708|Boston Scientific|Director of Clinical Trial Management - cRM franchise|1-800-227-3422|elaine.larson@bsci.com|
20571232|NCT03738475|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20571233|NCT00737477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20571234|NCT01132820|NRG Oncology /GOG|Linda Gedeon for Michael Sill, PhD|716 845-1169|lgedeon@gogstats.org|
20571235|NCT01370655|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571236|NCT01048697|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
20571237|NCT05138289|HeartFlow|Saba Mirza|650-241-1221|smirza@heartflow.com|
20571238|NCT01735175|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
20571239|NCT04692467|Weill Cornell Medicine|Dr. Margaret McNairy|646-962-8140|mam9365@med.cornell.edu|
20571240|NCT01485120|GE Healthcare|Jeff Conner|414-721-2423||
20571241|NCT00422734|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20546144|NCT00311584|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20571242|NCT02344342|University of Michgan Health Systems|Todd Koelling, MD|734-936-5265|tkoellin@med.umich.edu|
20571243|NCT00848484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571244|NCT03151746|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20571245|NCT01059305|The University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD/Professor, Thoracic/Head & Neck Med Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20571246|NCT02670122|Ramon y Cajal University Hospital. Vascular and Interventional Radiology Service|Jose Urbano Garcia, MD, PhD, EBIR, FCIRSE|+ 34 606 31 84 30|jurbano34@gmail.com ; jurbano@salud.madrid.org|
20571247|NCT03321253|Necip Fazil City Hospital|Dr. Bunyamin Kutluksaman|903442282800|bkutluksaman@gmail.com|
20571248|NCT01262547|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
20571249|NCT02781649|Johns Hopkins University|Christine Durand, MD|410-955-5684|cdurand2@jhmi.edu|
20571250|NCT02762903|Columbia University|William N. Levine, MD|212-305-0998|wnl1@cumc.columbia.edu|
20571251|NCT01889069|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20546145|NCT03720652|University of North Carolina at Chapel Hill|Philip D. Sloane, MD, MPH|+1 (919) 966-4439|philip_sloane@med.unc.edu|
20546146|NCT00620503|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20546147|NCT03073733|jCyte, Inc.|Robert Beathard|9492430687|rob.beathard@jcyte.com|
20546148|NCT01454778|Sanford Health|Dr. Patrick Kelly|605-312-7300|Patrick.Kelly@SanfordHealth.org|
20571252|NCT00108745|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20571253|NCT03168542|Johnson & Johnson Vision Care, Inc.|Tom Karkkainen, OD MS, FAAO - Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
20571254|NCT00723749|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
20571255|NCT01426347|Johns Hopkins University|Uzma Jalal Haque|410-550-0578|uhaque@jhmi.edu|
20571256|NCT00664534|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20571257|NCT03041792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571258|NCT01715207|SamsungMC|Prof Duk-Kyung Kim|01099333413|dukkyung.kim@samsung.com|
20571259|NCT00561145|Wageningen University|Dr Lisette de Groot|+31-317482220|lisette.degroot@wur.nl|
20571260|NCT01691950|Imperial College London|Mr Richard M Kwasnicki PhD MRCS|+44 (0) 20 759 48904|rmk107@ic.ac.uk|
20571261|NCT00402051|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20571262|NCT00305344|University of Florida|Dr Michael Haller|352.273.9264|hallemj@peds.ufl.edu|
20571263|NCT00277095|Uromedica|Sabitha R Shriram|763-694-9880|sshriram@uromedica-inc.com|216
20571264|NCT01956097|Ewha Brain Institute, Ewha W. University|Soonhyun Ban, RN, MS|+82-2-3277-6550|soonhyun.s.ban@gmail.com|6554
20546149|NCT00835731|Planned Parenthood League of Massachusetts|Principal Investigator|6176161600||
20546150|NCT00348881|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20546151|NCT00575146|Dr. Senckenberg Institute of Neurooncology|Dr. Johannes Rieger|+49 69 6301|johannes.rieger@med.uni-frankfurt.de|87711
20546152|NCT01227629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546153|NCT03207035|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
20527616|NCT01324570|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stacy.baldridge@pharma.com|
20546154|NCT00645450|Manchester VA Medical Center|Dr. Scott P. Orr|603-624-4366|scott.orr@va.gov|6565
20546155|NCT01588470|UT Health Science, San Antonio|Dr. Muhammad Abdul-Ghani, MD|210-567-6691|abdulghani@uthscsa.edu|
20546156|NCT03708393|Seno Medical|Shaan Schaeffer VP of Clinical Operations|610-698-3259|sschaeffer@senomedical.com|
20546157|NCT00881868|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20546158|NCT01981551|National Cancer Institute|Dr. Geraldine H O'Sullivan Coyne|240-781-3371|osullivancoyngh@nci.nih.gov|
20546159|NCT02880956|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20546160|NCT00833664|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20546161|NCT02055365|Icahn School of Medicine at Mount Sinai|Brad Rosenberg, MD, PhD||brad.rosenberg@mssm.edu|
20546162|NCT00678743|Biofortis Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
20546163|NCT00002931|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
20546164|NCT02907892|University of Minnesota|Dr. Rachel Vogel|6513345982|isak0023@umn.edu|
20546165|NCT04531462|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546166|NCT04175509|Aultman Hospital|Dr. Michaela Beynon|2488218826|michaelabeynon@gmail.com|
20546167|NCT00348933|University of California and Rady Children's Hospital, San Diego|Lynne M. Bird, MD|858-966-5840|Lbird@rchsd.org|
20546168|NCT01264081|National Cancer Institute|Dr. Udo Rudloff'|301-496-3098|rudloff@nih.gov|
20546169|NCT01489111|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20546170|NCT02716896|University of Texas Health San Antonio|Dharam Kaushik|210-567-5676|kaushik@uthscsa.edu|
20546171|NCT01727700|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20546172|NCT01546402|Post Graduate Institute of Medical Education and Research|Aniruddha Agarwal|+911722756111|aniruddha9@gmail.com|
20546173|NCT01631656|WakeForest University Health Sciences|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
20546174|NCT01757691|Novartis|Study Director|862-778-8300||
20546175|NCT02641483|VAORD|Dennis Bourbeau|2167913800|dennis.bourbeau@va.gov|
20546176|NCT02484859|Recep Tayyip Erdoğan Üniversitesi|Dr. Başar Erdivanlı|04642130491|berdivanli@gmail.com|2128
20546177|NCT02054481|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546178|NCT02320903|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|grants@ebpi.org|
20546179|NCT02564432|Department of Veterans Affairs|James Peter Beck|801-231-6309|james.beck@hsc.utah.edu|
20546180|NCT01011478|NSABP Foundation|Director, Department of Regulatory Affairs|412-339-5300||
20546181|NCT04575597|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546182|NCT02921061|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
20546183|NCT02108262|CSLBehring|Trial Registration Coordinator|610-878-4000|clinicaltrials@cslbehring.com|
20546184|NCT05027971|Boston Scientific|Winnie Chen|952-930-6000|FlexivaPulseRegistry@bsci.com|
20546185|NCT02486627|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
20546186|NCT01238588|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-5500|kzandinejad@partners.org|34769
20546187|NCT03192358|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
20546188|NCT01915303|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20546189|NCT00637780|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546190|NCT01251536|UZ Leuven|Prof Dr Eric Van Cutsem|003216344218|eric.vancutsem@uzleuven.be|
20546191|NCT00439738|Novartis Pharmaceuticals|Study Director|1-862-778-8300||
20555730|NCT02194621|RBHS-Rutgers School of Dental Medicine, Oral Biology Department|Daniel Fine, DMD|973-972-3728|finedh@sdm.rutgers.edu|
20546192|NCT00400803|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
20555731|NCT04631666|Institute of Virology|Prof. Florian Klein|49221478|florian.klein@uk-koeln.de|85800
20555732|NCT02493127|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
20555733|NCT02763384|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-747-8439|guy@wustl.edu|
20555734|NCT00714168|University of Pittsburgh|John M. Jakicic, PhD|412-383-4001|jjakicic@pitt.edu|
20555735|NCT02037347|Yale University|Brett King MD|203-785-4092|brett.king@yale.edu|
20555736|NCT04988308|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20555737|NCT02096900|Loma Linda University|Amgad H. Hanna, MD|909-558-4475|ahanna@llu.edu|
20555738|NCT00670774|Mayo Clinic|Dr. Mark D. Stegall|507-284-6275|Stegall.Mark@mayo.edu|
20555739|NCT03143218|London School of Hygiene and Tropical Medicine|Professor Brian Greenwood|+442072994707|brian.greenwood@lshtm.ac.uk|
20555740|NCT02474927|University of Pittsburgh|John McDyer|(412) 624-8915|mcdyerjf@upmc.edu|
20555741|NCT00866840|Rutgers Cancer Institute of New Jersey|James Goydos, MD|(732) 235-7593|goydosjs@cinj.rutgers.edu|
20555742|NCT02599194|Stanford University|Andrei H. Iagaru|(650) 725-4711|aiagaru@stanford.edu|
20555743|NCT03034577|The University of Melbourne|Prof Colin Royse|+61408467548|Colin.Royse@unimelb.edu.au|
20555744|NCT03919422|Department of Anesthesiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital|Dr. Junfen Zhang, director of the clinical trial|+8618930173689|zhangjunfeng@sjtu.edu.cn|
20555745|NCT04177758|Rush University Medical Center|Anne DeBenedetti, MSc|312-432-2468|anne.debenedetti@rushortho.com|
20555746|NCT02625623|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20555747|NCT00744653|Copenhagen University Hospital Herlev|MD Louise Wichmann Matthiessen|+ 45 38 68 98 58|louise.wichmann.matthiessen@gmail.com|
20555748|NCT00374842|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555749|NCT00808808|MedImmune, LLC|Seth Toback, MD|301-398-0000|tobacks@medimmune.com|
20555750|NCT01681589|NYU Langone Health|Prin Amorapanth, MD, PhD|212-263-6037|Prin.Amoropanth@nyulangone.org|
20555751|NCT02352948|AstraZeneca|Medical Science Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20555752|NCT00679939|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555753|NCT01428765|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20555754|NCT02653482|Saint Luke's Hospital of Kansas City|Program Manager, Cardiometabolic Research|8166957561|DEFINE-HF@saint-lukes.org|
20555755|NCT04657211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555756|NCT05054816|Sonova Canada|Jinyu Qian, PhD; VP Sonova Innovation Centre Toronto|647-262-4826|jinyu.qian@sonova.com|
20555757|NCT06273774|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20555758|NCT03910413|The University of Alabama at Birmingham|Andrew Smith|205-934-4080|andrewdennissmith@uabmc.edu|
20555759|NCT04098939|Aarhus University Hospital|Søren Helbo Skaarup|+4528911869|soeska@rm.dk|
20555760|NCT01911403|Hospital de Sao Joao, E.P.E.|Dr. Paulo Morgado|+351 22 551 2100|vilaresmorgado@iol.pt|
20555761|NCT02062359|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20555762|NCT02985866|University of Virginia Center for Diabetes Technology|Boris Kovatchev, PhD|434-982-0602|mc7m@virginia.edu|
20555763|NCT01949311|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|1-844-734-6643|clinicaltrials@regeneron.com|
20555764|NCT02338154|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
20555765|NCT03272633|Cancer Institute of New Jersey Rutgers|Roger K. Strair, MD|732-235-4523|strairrk@cinj.rutgers.edu|
20555766|NCT04279314|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
20555767|NCT00692094|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
20555768|NCT03166618|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20555769|NCT00798720|University of Wisconsin|Abigail Mapes, Thoracic Oncology Research Program Manager|(608) 262-8158|acmapes@medicine.wisc.edu|
20555770|NCT03137303|University of Illinois at Chicago|Min J. Joo, MD MPH|312-996-8039|joo@uic.edu|
20555771|NCT03561090|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
20555772|NCT00373399|New York State Psychiatric Institute|Margaret Haney|646-774-6153|mh235@cumc.columbia.edu|
20555773|NCT03663231|University of Rochester|Ralph Saunders|585-275-1141|ralph_saunders@urmc.rochester.edu|
20555774|NCT05762835|University of California at Davis|Dr. Jennifer Rosenthal|9167344719|rosenthal@ucdavis.edu|
20555775|NCT02007291|Federal University of Minas Gerais|Luís Felipe José Ravic de Miranda|55-31-3225-2337|ravicmiranda@gmail.com|
20555776|NCT04386096|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20555777|NCT00485485|UT MD Anderson Cancer Center|Anne Tsao, M.D. / Associate Professor|713-792-6363|mejprice@mdanderson.org|
20555778|NCT05457608|CooperVision|Jose A. Vega,OD,MSc,FAAO|9256213761|jvega2@coopervision.com|
20555779|NCT04402866|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20555780|NCT03667053|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
20555781|NCT00515502|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555782|NCT03647501|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
20555783|NCT01043432|Rocky Mountain MIRECC|Lisa A. Brenner|303-399-8020|lisa.brenner@va.gov|2571
20555784|NCT03152526|Miltenyi Biotec|Clinical Project Manager|617-218-0055|lorenb@miltenyibiotec.com|
20555785|NCT02807558|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|tcrowell@syros.com|
20555786|NCT01362140|Amgen Inc.|Study Director|866-572-6436||
20546193|NCT01284491|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20546194|NCT01978938|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
20546195|NCT02694757|11 Health|Michael Seres|+16572660570|michael@11health.com|
20546196|NCT02395302|Tactile Medical|Clinical Research Manager|(612)355-5123|mbroich@tactilemedical.com|
20546197|NCT02650921|Galderma Research & Development, LLC|Assoc Director of Clinical Operations|817-961-5000|courtney.maguire@galderma.com|
20546198|NCT00783302|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
20546199|NCT00160667|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20546200|NCT00200343|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20546201|NCT01806662|Rockefeller University|James Krueger|2123278333|gilleap@mail.rockefeller.edu|
20546202|NCT00043550|Adelphi University, The Derner Institute of Advanced Psychological Studies|Jacques P.Barber, PhD, Dean and Professor|516.877.4807|jbarber@adelphi.edu|
20546203|NCT01479426|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jong-Kwan Park, MD|82-63-276-8284|rain@chonbuk.ac.kr|
20546204|NCT00300430|Abbott|Medical Information Specialist|800-633-9110||
20546205|NCT01917656|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20546206|NCT02285062|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20546207|NCT02015221|Tactile Medical|Director of Clinical Research|6123555121|shoy@tactilemedical.com|
20546208|NCT01306929|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
20546209|NCT01905423|Washington University in St Louis Medical School|Peter Fischer|+1 (314) 747-5198|pufischer@wustl.edu|
20546210|NCT03709576|Penn State Cancer Institute|Michelle Stojanovic|7175310003|mstojanovic1@pennstatehealth.psu.edu|287412
20546211|NCT00270842|James A. Haley VA|Dr. Patricia A. Quigley|8135583912|patricia.quigley@va.gov|
20546212|NCT01143701|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
20546213|NCT00368290|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
20546214|NCT03041129|University of Colorado|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
20571265|NCT05415748|UCSF|Dr. Scott Bauer|650-515-2879|scott.bauer@ucsf.edu|
20571266|NCT03075527|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
20571267|NCT05985538|University of North Carolina at Chapel Hill|Dr. Seth M. Noar|9192607269|noar@unc.edu|
20571268|NCT04363957|University of California, San Diego|Dr. Jyoti Mayadev|(858) 822-5354|CancerCTO@health.ucsd.edu|
20571269|NCT06534671|Vanderbilt University Medical Center|Prince J. Kannankeril, MD, MSCI|(615) 322-7447|prince.kannankeril@vumc.org|
20571270|NCT00921947|VaxInnate|Dr. David N.Taylor|609-860-2260|david.taylor@vaxinnate.com|
20571271|NCT02209181|McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.|Joseph Aquilina, MD, Senior Director, Clinical Research|(215) 273-8025|JAquilin@its.jnj.com|
20571272|NCT02281500|Instituto Grifols S.A.|Jordi Navarro Puerto|+34 935712200|jordi.navarro@grifols.com|
20571273|NCT01976572|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20571274|NCT00388804|UT MD Anderson Cancer|Andrew Lee, MD / Professor||lhamblin@mdanderson.org|
20571275|NCT04463680|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
20571276|NCT02592707|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
20571277|NCT02998476|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20571278|NCT04855734|Children's National Hospital|Dr. Maureen E. Lyon, Clinical Health Psychologist, Professor of Pediatrics|703-346-2873|mlyon@childrensnational.org|
20571279|NCT03832595|University of Pittsburgh|Dr. Manisha Jhamb|4126477062|jhambm@upmc.edu|
20546215|NCT03608150|Luminopia, Inc.|VP of Clinical Development|9788067080|endri@luminopia.com|
20555787|NCT01910129|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20555788|NCT04458948|UNM HSC|Cristina Beato|505-272-1734|CBeato@salud.unm.edu|
20555789|NCT02491671|Hospital Universitario de Salamanca|Dr. Marcelo Jiménez|923291100|mfjl@usal.es|
20555790|NCT00535730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20555791|NCT00936858|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
20555792|NCT05525494|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20555793|NCT00584727|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
20555794|NCT02464449|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
20555795|NCT00729833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555796|NCT00092131|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20555797|NCT02341417|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20555798|NCT04773587|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20555799|NCT02372409|Washington University School of Medicine|Andrew Cluster, M.D.|314-454-6018|acluster@wustl.edu|
20555800|NCT00622167|Massachusetts General Hospital|Iris McNulty, RN|617 726 2612|imcnulty@partners.org|
20555801|NCT02820623|Northwestern University|Rinad Beidas, PhD|312-503-0546|rinad.beidas@northwestern.edu|
20555802|NCT05893992|Sonova|Dr. Jonathan Vaisberg|9057456785|jonathan.vaisberg@sonova.com|
20555803|NCT01954017|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director of Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
20555804|NCT03346759|University of Michigan|Jason Bell, MD|7342323897|jasonbel@med.umich.edu|
20555805|NCT03341910|Dr. Reddy's Laboratories, Inc|Dr. Srinivas Sidgiddi, Sr. Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
20555806|NCT03826667|Smith+Nephew, Inc.|Judith Horner|+44 1482 673251|Judith.horner@smith-nephew.com|
20555807|NCT01680328|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20555808|NCT00596440|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
20555809|NCT00074035|The Ohio State University Medical Center|Sherif S. Farag, M.D., Ph.D.||farag-1@medctr.osu.edu|
20555810|NCT01453595|Memorial Sloan Kettering Cancer Center|Dr. Martin Voss|646-422-4631|vossm@mskcc.org|
20555811|NCT03077724|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
20555812|NCT02313428|University of Pittsburgh|Sashwati Roy|412-648-8297|sar543@pitt.edu|
20555813|NCT05374421|Erchonia Corporation|Clinical Affairs Manager|864-531-0064|tsammons@erchonia.com|501
20555814|NCT04370054|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20555815|NCT05672628|The University of Texas Health Science Center at Houston|Seema S Aggarwal, PhD, APRN, AGNP-C|713-500-9946|Seema.S.Aggarwal@uth.tmc.edu|
20555816|NCT06660823|Ain Shams University|Dr.Mohammed Abd Al Jawad,Professor of cardiac surgery|+201111219461|mohammed_abdaljawad@med.asu.edu.eg|
20555817|NCT00593567|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20555818|NCT02993445|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
20555819|NCT01946542|Duke University Medical Center|William Kraus|919-684-2063|william.kraus@duke.edu|
20555820|NCT00871689|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
20555821|NCT00590902|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
20555822|NCT00785291|UCSF Comprehensive Cancer Center|Hope Rugo, M.D.||hrugo@medicine.ucsf.edu|
20555823|NCT02119260|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555824|NCT05183022|University of Alabama at Birmingham|Andrew D. Pucker, OD, PhD|1-920-579-2900|apucker@uab.edu|
20555825|NCT02057874|Vanderbilt University Medical Center|Professor of Surgery and Cancer Biology|615-936-2956|lee.gorden@vanderbilt.edu|
20555826|NCT00799292|Mt Sinai School of Medicine, Department of Obstetrics and Gynecology|Charles Ascher-Walsh MD, MPH|212-241-2827|charles.ascher-walsh@mssm.edu|
20555827|NCT01738984|University of Hawaii, School of Nursing and Dental Hygiene|Cheryl Albright|8089569716|cherylal@hawaii.edu|
20555828|NCT00610116|Department of Cardiology and Rhythmology, Augusta Hospital, Duesseldorf, Germany.|Joachim Winter, MD|+49 (0) 2118|joachim.winter@uniklinik-duesseldorf.de|1173
20555829|NCT03100617|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
20555830|NCT03912259|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20555831|NCT00360308|Eisai Call Center|Eisai Inc.|888-422-4743||
20555832|NCT04786444|Valneva Austria GmbH|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
20555833|NCT00386880|Doylestown Hospital|Abraham A. Ashkenazi, MD-Principal Investigator|215-625-2894|aashkenazi2001@yahoo.com|
20555834|NCT01433354|Novartis Pharmaceuticals|Study Director|862--778--8300||
20546216|NCT00510653|The University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD / Professor||CR_Study_Registration@mdanderson.org|
20546217|NCT04355728|University of Miami|Camillo Ricordi|305-243-6913|ricordi@miami.edu|
20546218|NCT00483756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546219|NCT00710762|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546220|NCT00436501|UT MD Anderson Cancer Center, Office of Multicenter Clinical Research|Robert Coleman, MD / Professor||RColeman@mdanderson.org|
20546221|NCT00495040|UT MD Anderson Cancer Center|Chang,Joe Y.,M.D. / Radiation Oncology|713-563-2337|jychang@mdanderson.org|
20555835|NCT05098054|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20555836|NCT01016769|Memorial Sloan Kettering Cancer Center|Dr. David Pfister, MD|646-888-4237|pfisterd@mskcc.org|
20555837|NCT02015676|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20555838|NCT01618162|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20546222|NCT01390064|University of Arkansas for Medical Sciences|Dr. Laura Hutchins|5016868274|hutchinslauraf@uams.edu|
20546223|NCT04157673|University at Buffalo|Leonard H. Epstein, PhD|7168293400|lhenet@buffalo.edu|
20546224|NCT02452931|Tolmar, Inc.|Vice President of Clinical Development|970-212-4500|info@tolmar.com|
20546225|NCT03011892|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20546226|NCT02282293|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
20546227|NCT00562315|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
20546228|NCT03381729|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
20546229|NCT02000908|University of Minnesota|Peter Argenta MD|612-626-3111|argenta@umn.edu|
20546230|NCT01551420|Providence VA Medical Center|Linda Resnik, Research Career Scientist|401-273-7100|Linda.Resnik@va.gov|2368
20546231|NCT00169442|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546232|NCT01155167|UCSF|Andrew Boyle MD|4153533817|aboyle@medicne.ucsf.edu|
20546233|NCT01252732|Melinta Therapeutics, Inc.|Karen Fusaro|6098270956|kfusaro@melinta.com|
20546234|NCT00336583|Asan Medical Center|Cheolwon Suh|82 2 3010 3209|csuh@amc.seoul.kr|
20546235|NCT02248558|UNC Project-China|Weiming Tang|+86-15920567132|weimingtangscience@gmail.com|
20546236|NCT01258998|The University of Texas (UT) MD Anderson Cancer Center|Christopher R Flowers,Chair, Lymphoma-Myeloma|713- 745-6095|crflowers@mdanderson.org|
20546237|NCT01143389|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
20546238|NCT04966910|University of Washington|Michael Pullmann|206-685-0408|pullmann@uw.edu|
20546239|NCT00636701|Atlanta VA Medical Center|Dr. Andrew Butler|404-413-1415|andrewbutler@gsu.edu|
20546240|NCT02276027|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20546241|NCT03224598|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
20546242|NCT01845103|CryoLife, Inc.|Scott Capps, MS/ Vice President, Clinical Research|800-438-8285|clinicaltrialregistration@cryolife.com|
20546243|NCT00830791|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|(800) 672-6372|ClinicalTrialsDisclosure@merck.com|
20546244|NCT02446171|AstraZeneca AB|Ian Wogan|+1 301 398 0670|ClinicalTrialTransparency@astrazeneca.com|
20546245|NCT00456807|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546246|NCT03328182|Hollister Incorporated|Director Global Clinical Affairs|8476802837|stacy.haddad@hollister.com|
20546247|NCT00504582|UT MD Anderson Cancer Center|Dr. Paul F Mansfield, Professor, Surgical Oncology|(713) 794-5499|pmansfie@mdanderson.org|
20546248|NCT03384693|University of California, San Francisco|Dr. Christine Higham|415-476-2188|christine.higham@ucsf.edu|
20546249|NCT02415842|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20546250|NCT00883688|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Multicenter coordinating for Collaborative Ependymoma Research Network Study (CERN)||CR_Study_Registration@mdanderson.org|
20546251|NCT00178503|University of Texas Medical School at Houston|Deborah A. Pearson, Ph.D.|713-486-2588|Deborah.A.Pearson@uth.tmc.edu|
20546252|NCT00464490|University of California San Francisco|Julin F. Tang, MD, MS|415-206-5274|tangj@anesthesia.ucsf.edu|
20546253|NCT03188042|NYU Langone Health|Joel Schuman, MD, FACS|929-455-5030|Joel.Schuman@nyu.edu|
20546254|NCT01634256|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
20546255|NCT00528970|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20546256|NCT01440543|Digestive Diseases Center, Vitkovice Hospital, Ostrava, Czech Republic|Premysl Falt MD|+420602689561|faltprem@centrum.cz|
20546257|NCT03860935|Eidos Therapeutics, Inc., a BridgeBio Company|VP, Clinical Operations|415-887-1471|info@bridgebio.com|
20546258|NCT03616223|Frequency Therapeutics|Carl LeBel, PhD, CDO|781-315-4600|clinicaltrialsinformation@frequencytx.com|
20546259|NCT03086967|Atrium Health|Dr. Susan Bliss|(704)562-4860|Susan.Bliss@atriumhealth.org|
20546260|NCT01556347|Tim Icenogle MD PLLC|Timothy B Icenogle MD|509-220-1900|timicenogle@comcast.net|
20546261|NCT01475071|Galderma|Cyril Moulin|+33 4 92 38 30 14|cyril.moulin@galderma.com|
20546262|NCT01752036|SKCCC|Terrence Caldwell|443-287-1889|caldwte@jhmi.edu|
20546263|NCT02230527|Cleveland Clinic|Joseph Campbell, MD|216-444-9836|campbej10@ccf.org|
20546264|NCT04461600|Ayala Pharmaceuticals|Chief Medical Officer|+1-857-444-0553|info@ayalapharma.com|
20546265|NCT01020006|Pharmacyclics|Dr. Laurence Elias|855-427-8846|pharmacyclics@medcomsol.com|
20546266|NCT01661088|University of Michigan Rogel Cancer Center|Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
20546267|NCT02278471|UT southwestern|Dr. Thomas J Wang|6159361717|thomas.wang@UTsouthwestern.edu|
20546268|NCT01437995|Johns Hopkins University|Alexis Rea|4432878496|area5@jhu.edu|
20546269|NCT04618770|Stryker|Kevin Barga|2018315073|kevin.barga@stryker.com|
20546270|NCT04456673|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20546271|NCT04391049|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20546272|NCT03874429|Laboratoires Thea|Corentin Le Camus|0680382020|corentin.lecamus@theapharma.com|+33
20546273|NCT00636220|Chembio Diagnostic Systems, Inc.|Javan Esfandiari|(631) 924-1135|jesfandiari@chembio.com|112
20546274|NCT01101308|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
20546275|NCT02280122|JWGUniversity|Prof. Dr. Peter Eickholz|+49696301|eickholz@med.uni-frankfurt.de|5642
20546276|NCT00711516|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
20546277|NCT01895361|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20546278|NCT04964193|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
20546279|NCT01037192|Fraser Health Authority|Anna Yuen, BSc. Pharm|604-520-4005|anna.yuen@fraserhealth.ca|
20555839|NCT04794803|Dompé Farmaceutici|Dr Maria De Pizzol, BSc|+39 02 583831|clinops@pec.dompe.it|
20546280|NCT00095147|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20546281|NCT01779219|Wroclaw University Hospital, Department of Neurosurgery|Dr. Marcin Czyz|+48 734-34-00|mt.czyz@gmail.com|
20546282|NCT00906971|Universidade Federal de Pernambuco|Carlos André Gomes Silva|+55 83 9913-4949|carlosandrejpa@hotmail.com|
20546283|NCT00223236|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
20546284|NCT04463069|Hong Kong Baptist University|Dr. Yang Gao|+852 3411 3082|gaoyang@hkbu.edu.hk|
20546285|NCT03976648|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20546286|NCT00960570|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20546287|NCT01451437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546288|NCT03050775|Mayo Clinic|Jean M. Guyer, DNP|507-255-5716|guyer.jean@mayo.edu|
20546289|NCT03603509|Mayo Clinic|Richard Kennedy, PhD|507-284-0708|Kennedy.Rick@mayo.edu|
20546290|NCT02197455|Yale Univ School of Medicine|Brett King, MD|2037854092|brett.king@yale.edu|
20546291|NCT00773383|Hoffman-LaRoche|Medical Communications|800-821-8590||
20546292|NCT03386253|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20546293|NCT03493815|The Pennsylvania State Univ College of Medicine, The Milton S. Hershey Medical Center|Stephanie Estes, M.D.|717-531-8478|sestes@pennstatehealth.psu.edu|
20546294|NCT03811093|Vidantis Technologies, Inc|Thomas A. Namynanik - Consultant to invisa-RED Technologies|404 915-5938|andyn997@vidantis.com|
20546295|NCT01095094|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
20546296|NCT00874614|Progenics Pharmaceuticals, Inc|Jessica D Jensen, MPH|646-975-2513|jjensen@progenics.com|
20546297|NCT03699475|Bellicum|Contact for Clinical Trial Information|(832) 384-1100|clinicaltrials@bellicum.com|
20546298|NCT00137839|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
20546299|NCT01122394|VA New York Harbor Healthcare System|Jennifer Friedberg, Ph.D.|212-951-3314|jennifer.friedberg@va.gov|
20546300|NCT00775203|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20546301|NCT04896229|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
20546302|NCT00045942|Novartis|Study Director|862-778-8300||
20546303|NCT00880464|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
20546304|NCT01887743|Children's Mercy Kansas City|Valentina Shakhnovich, MD|816-302-3068|vshakhnovich@cmh.edu|
20546305|NCT02692651|University of Michigan|Krishna Rao|734 615-9730|krirao@med.umich.edu|
20546306|NCT03490981|VA Center for Integrated Healthcare|Dr. Gregory P. Beehler, Associate Director of Research|716-862-7934|gregory.beehler@va.gov|
20546307|NCT02324543|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20546308|NCT02480712|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20546309|NCT01860846|AbbVie|Global Medical Services|800-633-9110||
20546310|NCT05463198|Zynex Monitoring Solutions|ZMS Clinical|800-495-6670|clinical@zynexmonitoring.com|
20546311|NCT01856764|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20555840|NCT00476476|Dana-Farber Cancer Institute|Neil Horowitz MD|617.732.8843|NHOROWITZ@mgh.harvard.edu|
20555841|NCT01426191|xiangbei welman pharmacuticol CO.,LTD|Directer of clinical trials|020-38868707|gap@welman.com.cn|
20555842|NCT04149405|OndokusMU|Feyza Otan Özden|+905322535106|feyza_otan@yahoo.com|
20555843|NCT00971048|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20555844|NCT01189279|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20555845|NCT03321396|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|6202
20555846|NCT02964416|Aga Khan University|Dr Asma Abdus Salam|+92-21-34864715|asma.salam.azhar@gmail.com|4639
20555847|NCT03806270|Yeditepe U|Dr. Ferda F. Kartufan|+902165784000|ferdasozer@gmail.com|4754
20555848|NCT00845663|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20555849|NCT02633137|Memorial Sloan Kettering Cancer Center|Dr. Anita Kumar, MD|646-608-3780|kumara2@mskcc.org|
20555850|NCT04307004|University of Alabama at Birmingham|Emily B. Levitan, Professor and Vice Chair|(205) 975-7680|elevitan@uab.edu|
20555851|NCT05545072|Emory University|Thomas S Edwards, MD Assistant Professor, Rhinology and Skull Base Surgery Division|4045017710|thomas.edwards@emory.edu|
20555852|NCT02395042|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20555853|NCT01324271|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20555854|NCT01972841|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|astellas.resultsdisclosure@astellas.com|
20555855|NCT01360606|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20555856|NCT03256162|Trinity College Dublin|Dr Bronagh Gallagher|01 249|bgallag@tcd.ie|3200
20555857|NCT01869491|Reckitt Benckiser|Clinical Data Controller||clinicaldatacontroller@reckitt.com|
20555858|NCT01270347|Horizon Pharma USA, Inc|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
20555859|NCT04818346|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20555860|NCT05553808|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555861|NCT02273141|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
20508495|NCT00968708|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20555862|NCT00492284|QLT Inc.|Medical Information Department|1-800-663-5486|medaff@qltinc.com|
20555863|NCT02734212|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
20546312|NCT02239120|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546313|NCT00466687|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
20546314|NCT01535976|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
20555864|NCT04313881|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20555865|NCT00727272|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20555866|NCT00651664|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20555867|NCT00688636|Univerisity of Pittsburgh|Research Coordinator|412-648-9173|goldbyreffnerka@upmc.edu|
20555868|NCT01572727|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20555869|NCT04053764|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20555870|NCT04732286|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20555871|NCT01474681|Novartis Pharmaceuticals|Study Director|862-778-8300||
20555872|NCT01972516|Dana-Farber Cancer Institute|Susana Campos, MD|617-632-5269|susana_campos@dfci.harvard.edu|
20555873|NCT02195986|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
20555874|NCT02571218|IRCCS Policlinico San Donato|Giuseppe Ciconte|+39 02 52 77 42 60|g.ciconte@gmail.com|
20555875|NCT02834780|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20555876|NCT03150056|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555877|NCT03335033|Mayo Clinic|Matthew W. Urban|507-284-3703|Urban.Matthew@mayo.edu|
20555878|NCT00395876|Genentech, Inc.|Medical Communications|800-821-8590||
20546315|NCT00853996|University of Kansas Mecical Center|Bruce F. Kimler Ph.D|913-588-4523|bkimler@kumc.edu|
20546316|NCT02158364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20546317|NCT01944839|Ophthotech|Denise Teuber||denise.teuber@ophthotech.com|
20546318|NCT00609362|University of Aarhus|Torben Harsløf, MD|+4589497681|torbhars@rm.dk|
20546319|NCT05093790|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20546320|NCT01087788|Cares|UCB|+1877 822||9493
20546321|NCT00927940|Medtronic Japan Co.,Ltd|Hiroko Okubo|+81-3-6430-7017|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20546322|NCT03007888|Impax Laboratories, LLC|Pamela Fitzpatrick, Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
20546323|NCT03471624|Stanford University|Mindie H Nguyen, Professor of Medicine, GI & Hepatology, Liver Transplant|650-498-6084|mindiehn@stanford.edu|
20546324|NCT00827931|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546325|NCT01870076|Shriners Hosptials for Children|Laura Fowler/Clinical Research Coordinator|513-872-6000|lfowler@shrinenet.org|6249
20546326|NCT00492063|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20546327|NCT01402427|State Health Center, Hungary|Istvan Hizoh, MD, PhD / Senior Consultant|+36 1 4651800|ihizoh@web.de|71773
20546328|NCT00890045|Houston Methodist Hospital|George M. Nassar M.D.|713-790-1963|georgemnassar@gmail.com|
20546329|NCT01947855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546330|NCT01872325|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
20546331|NCT00621621|Medtronic- AF Solutions|Adam Cline, MD, MSc.- Sr. Clinical Research Specialist|763-526-9601|adam.cline@medtronic.com|
20546332|NCT00608569|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20546333|NCT04456153|UT Southwestern Medical Center|Dr. Mamta K. Jain|2140648-9914|mamta.jain@utsouthwestern.edu|
20546334|NCT01453387|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20546335|NCT02312687|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20546336|NCT03985878|Sarepta Therapeutics, Inc.|Medical Director|1-888-SAREPTA (1-888-727-3782)|SareptAlly@sarepta.com|
20546337|NCT00878436|NYU Langone Medical Center|Fraustina Hsu|646 754 712|fraustina.hsu@nyumc.org|
20546338|NCT04545944|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
20546339|NCT00599131|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
20546340|NCT01514370|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20546341|NCT00123643|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20546342|NCT02103153|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20546343|NCT03068091|University of Missouri|Talissa Altes|573 882 1026|ALTEST@HEALTH.MISSOURI.EDU|
20546344|NCT01439815|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
20546345|NCT00129311|Yale Unviersity|Dr. Andrea Weinberger|203-974-7598|andrea.weinberger@yale.edu|
20546346|NCT00534599|AstraZeneca|Gerard Lynch||AZtrial_results_posting@astrazeneca.com|
20546347|NCT01543581|Loma Linda University Health, Department of Dermatology|Dr. Abel Torres, PI|(909) 558-2055|atorres@llu.edu|
20546348|NCT01634191|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20555879|NCT02937168|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20555880|NCT02154763|The Ottawa Hospital|Dr.Joseph Mamazza|613-798-5555|jmamazza@toh.on.ca|
20555881|NCT02251990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546349|NCT03645434|AstraZeneca AB|AstraZeneca AB|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
20546350|NCT00167778|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
20546351|NCT02654717|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759900|srinivassidgiddi@drreddys.com|
20546352|NCT02491359|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
20546353|NCT02081859|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
20546354|NCT02404532|Otsuka Pharmaceutical Development & Commercialization, Inc|Tim Peters-Strickland|800 562-3974||
20546355|NCT00003830|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
20546356|NCT05347147|Executive Director Invex Australia|Tom Duthy|+61 (08) 6382 0137|tduthy@invextherapeutics.com|
20546357|NCT00266851|Wisconsin Resaerch & Education Network|Dr. David Hahn|608-234-3212|dlhahn@wisc.edu|
20546358|NCT03739242|A. Menarini Industrie Farmaceutiche Riunite SrL|Dr Paolo Fabrizzi Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
20546359|NCT00039871|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20546360|NCT02446743|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546361|NCT03361176|Maryland Laser Skin and Vein|Robert A. Weiss, MD|4106662839|cmyers@mdlsv.com|
20546362|NCT02478398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546363|NCT02531971|University of Maryland, Baltimore|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20546364|NCT02013141|Cumberland Pharmaceuticals Inc|Clinical Scientist|615-255-0068|bgibson@cumberlandpharma.com|229
20546365|NCT02713256|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20546366|NCT00923364|National Cancer Institute|Dr. Dennis Hickstein|301-594-1718|hicksted@mail.nih.gov|
20546367|NCT00357032|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20546368|NCT03023046|University of Washington|Ryan Cassaday, MD|2066061202|cassaday@seattlecca.org|
20546369|NCT01205581|St. Jude Children's Research Hospital|Jon McCullers, MD|866-278-5833|info@stjude.org|
20546370|NCT00640835|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
20546371|NCT00704522|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20546372|NCT04395001|Wake Forest School of Medicine|Dennis C. Ang|3367058701|dang@wakehealth.edu|
20546373|NCT04418661|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20546374|NCT01203644|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20546375|NCT00992589|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
20546376|NCT05508074|InFlectis Bioscience|Beatrice Lejeune|+33 668919060|beatricelejeune@inflectisbioscience.com|
20546377|NCT02142387|Laboratory of Emergency Medical Services, Seoul National University Hospital Biomedical Research Institute|Dr. Gwan Jin Park|82-10-7477-3293|pkj83531@naver.com|
20546378|NCT02984943|David Grant Medical Center, Travis Air Force Base|Dr. Michelle Sit|707-423-3875|michelle.t.sit.mil@mail.mil|
20546379|NCT01431209|University of Nebraska Medical Center|Dr. Julie M. Vose|402-559-3848|jmvose@unmc.edu|
20546380|NCT01268579|Memorial Sloan Kettering Cancer Center|Dr. David Pfister MD|646-888-4237|pfisterd@MSKCC.ORG|
20546381|NCT01209832|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20546382|NCT00046891|Mayo Clinic|Debra L. Barton, R.N., Ph.D.|507-266-6247|barton.debra@mayo.edu|
20546383|NCT01982968|University of California, San Francisco|Harold Collard, MD|415 4761000|Harold.Collard@ucsf.edu|
20546384|NCT00420641|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546385|NCT01653028|Memorial Sloan Kettering Cancer Center|Mark Andrew Dickson M.D.|6468884164|dicksonm@mskcc.org|
20546386|NCT03459690|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|617-634- 2721|bsubrama@bidmc.harvard.edu|
20546387|NCT02586506|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546388|NCT00684047|Grifols Biologicals Inc.|Paul Pinciaro|443-375-8825|Paul.Pinciaro@grifols.com|
20546389|NCT01367080|Dong Wha Pharm. Co. Ltd.|Cheol-Hee Lim. Clinical Research Manager (CRM)|+82-2-2021-9300|cheolhee.lim@dong-wha.co.kr|551
20546390|NCT02536404|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20546391|NCT01911910|Queen Mary University London/ Barts Health NHS Trsut|Dr Mohammed Khanji|020 7363 8079|m.khanji@qmul.ac.uk|
20546392|NCT01381562|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546393|NCT02971033|Edward Hines Jr. Veterans Administration Hospital|Susan L. Uprichard|(336) 402-1086|susan.uprichard@va.gov|
20546394|NCT00308581|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20546395|NCT00952380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546396|NCT03400956|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20546397|NCT03235180|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
20546398|NCT02048241|New York State Psychiatric Institute|Stephen J. Donovan, MD|646-774-8078|sd45@columbia.edu|
20546399|NCT00534313|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20546400|NCT03044574|Pirogov Russian National Researching Medical University|Dr. Kirill Lobastov, Associated professor at the Department of General Surgery and Radiology|+7-985-211-63-31|lobastov_kv@hotmail.com|
20546401|NCT01816451|University of Trás-os-Montes and Alto Douro|Ph.D. Laura Castro de Garay|+55 21 22275084|laura@virtualsoftware.com.br|
20546402|NCT00592774|Eisai Call Center|Eisai Inc.|888-422-4743||
20546403|NCT01892384|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20555882|NCT03265600|Cambridge Health Alliance|Dr. Zev Schuman-Olivier|617-591-6132|zschuman@cha.harvard.edu|
20571280|NCT03277352|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20571281|NCT03790306|Genesee Orthopedic & Hand Surgery Associates, P.C.|Andrew Wickline, MD|315-735-4496|awickline23@gmail.com|
20571282|NCT01769430|University of Maryland, College Park|Professor & Director PHAB Lab|424-246-8358|phablab@umd.edu|
20571283|NCT04535544|Janssen Research & Development, LLC|Senior Director Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20571284|NCT03429166|VA HSR&D|Amanda Borsky, PhD|2024435739|amanda.borsky@va.gov|
20571285|NCT01920477|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
20571286|NCT01681277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571287|NCT01667926|Massachusetts General Hospital|Dr. Cristina Cusin|6177263855|ccusin@mgh.harvard.edu|
20571288|NCT03838731|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20571289|NCT04227145|Children's Mercy Kansas City|Emily Hurley|(816) 731-7093|eahurley@cmh.edu|
20571290|NCT02271984|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20571291|NCT01088984|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20571292|NCT03312023|Institute of Human Virology, University of Maryland Baltimore|Dr. Joel V. Chua|1-410-706-5704|jchua@ihv.umaryland.edu|
20571293|NCT01182441|Boston Scientific|WATCHMAN Trial Manager|1-800-227-3422||
20571294|NCT04079868|Durham VA Geriatric Research Education and Clinical Center|Dr. Cathleen Colon-Emeric|9192860411|cathleen.colon-emeric@va.gov|6932
20571295|NCT05620108|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|renew.j@mayo.edu|
20571296|NCT02038842|Service d'immunologie clinique - Hôpital Henri Mondor|Pr. Jean-Daniel Lelièvre|+33 1 49 81 24 55|jean-daniel.lelievre@hmn.aphp.fr|
20571297|NCT05504954|Department of Medicine, Center for Dissemination and Implementation Science, University of Illinois Chicago|Dr. Geri Donenberg|312-996-8602|gerid@uic.edu|
20571298|NCT01757197|Weill Cornell Medicine|Usama Gergis, MD|(212) 746-2119|usg2001@med.cornell.edu|
20571299|NCT05332912|University of Alabama, Tuscaloosa|Professor Emeritus|2052002183|emerrill@ua.edu|
20571300|NCT01174446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20571301|NCT01128270|University of Florida|Peter W. Stacpoole,MD|(352) 273-9023|pws@ufl.edu|
20571302|NCT05000216|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20571303|NCT04076943|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-092Study@fibrogen.com|
20571304|NCT03119233|Endologix|Tammy Stiver, Manager, Clinical Affairs|5136731452|tstiver@endologix.com|
20571305|NCT00509249|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20571306|NCT02224703|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
20571307|NCT02057575|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
20571308|NCT00863681|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20571309|NCT03596762|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20571310|NCT03842228|The University of Texas MD Anderson Cancer Center|Dr. Timothy Yap|(713) 839-5458|tyap@mdanderson.org|
20571311|NCT02195479|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20571312|NCT01263509|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20571313|NCT05071053|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20571314|NCT03993210|DFCI|Clare Tempany|617-732-7858|ctempany@bwh.harvard.edu|
20571315|NCT01193010|Massachusetts General Hospital|Rachel Gottlieb, Clinical Research Coordinator|617.724.4985|rgottlieb3@mgh.harvard.edu|
20571316|NCT01445327|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
20571317|NCT01602510|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571318|NCT01001390|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-966-5934|info@stjude.org|
20571319|NCT00895895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571320|NCT01261000|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org|
20571321|NCT03019640|Yago Nieto, PhD / Stem Cell Transplantation Department|UT MD Anderson Cancer Center|713-792-8750|ynieto@mdanderson.org|
20571322|NCT01016847|Duke Asthma Allergy and Airway Center|Monica Kraft, M.D.|9194790719|denise.beaver@dm.duke.edu|
20571323|NCT01621776|University of Florida|Janet Silverstein, MD|352-334-1390|silvejh@peds.ufl.edu|
20571324|NCT01495572|National Cancer Institute|Udai Kammula M.D.|301-435-8606|kammulau@mail.nih.gov|
20571325|NCT04916730|University of California, San Diego|Michael J. Wilkinson, MD|(858)246-2510|mjwilkinson@health.ucsd.edu|
20571326|NCT00455741|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
20571327|NCT02138097|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571328|NCT04978090|University of Kentucky|Dr. Andrew Bernard|859-257-3253|andrew.bernard@uky.edu|
20546404|NCT01700439|Edwards Lifesciences, LLC|Jennifer Currin, Senior VP of Medical and Clinical Affairs, Surgical Structural Heart|949-250-2500|Jennifer_Currin@edwards.com|
20546405|NCT00714571|VA Ann Arbor Healthcare System|Dr. Benjamin M. Hampstead|734-763-9259|Benjamin.Hampstead@va.gov|
20546406|NCT01829243|Duke University Medical Center|Ashwin A. Patkar, MD|919-668-3626|ashwin.patkar@duke.edu|
20571329|NCT03745898|Brigham and Women's Hospital|Dr. Susan Redline|(617) 732-5500|sredline@bwh.harvard.edu|
20546407|NCT03445156|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
20571330|NCT04263987|Vanderbilt University Medical Center|Nicholas kavoussi|615-322-7401|nicholas.l.kavoussi@vumc.org|
20546408|NCT03758755|Inova Health System|Dr. Edward Chang|571-472-0464|edward.chang@inova.org|
20546409|NCT00266877|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20571331|NCT00935532|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20546410|NCT03848871|Skin Sciences, PLLC|Maureen McAllister|5024519000|mmdermresearch@yahoo.com|
20546411|NCT03705273|Vanderbilt University School of Medicine|Donald H. Arnold, MD, MPH|16155790516|don.arnold@vumc.org|
20546412|NCT00830076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546413|NCT01254942|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
20546414|NCT01077375|Forest Research Institute|Allan Spera, Director, Clinical Development|(201) 427-8399|Allan.Spera@frx.com|
20546415|NCT01924429|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Newcorn|212-659-8775|Jeffrey.newcorn@mssm.edu|
20546416|NCT00729846|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
20546417|NCT02162576|Propeller Health|Dr. Meredith Barrett|415-409-9258|meredith.barrett@propellerhealth.com|
20546418|NCT01089361|Beth Israel Deaconess Medical Center|Dr. Daniel Talmor|617-754-2675|dtalmor@bidmc.harvard.edu|
20546419|NCT01606878|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20546420|NCT01159431|UCLA|Dr. Christopher DeGiorgio|310-206-3753|cmd@mednet.ucla.edu|
20546421|NCT03353740|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|
20546422|NCT01484288|CVRx|Vice President, Global Clinical Research|763-416-2876|egalle@cvrx.com|
20546423|NCT00604214|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20546424|NCT05486416|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|858-263-4239|yuling.lai@haisco-usa.com|
20546425|NCT02076425|Early Emotional Development Program at Washington University School of Medicine|Dr. Joan Luby|3142862730|lubyj@wustl.edu|
20546426|NCT00156936|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
20546427|NCT00853970|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
20546428|NCT04133064|Pivot Health Technologies Inc.|VP of Clinical and Medical Affairs|415-757-7696|marler@pivot.co|
20546429|NCT01397825|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20546430|NCT01931670|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20546431|NCT04352127|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
20546432|NCT01992159|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20546433|NCT02160002|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
20546434|NCT00635024|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20546435|NCT03442868|Texas Woman's University|Hui-Ting Goh|2146897723|HGoh1@twu.edu|
20546436|NCT00713310|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20546437|NCT00329901|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20546438|NCT05028361|Duke Human Vaccine Institute|Emmanuel Walter|919 620 5346|chip.walter@duke.edu|
20546439|NCT00779259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20546440|NCT00799773|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
20546441|NCT00282464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20546442|NCT01214174|Icon Bioscience, Inc.|Wendy Murahashi, MD|650-369-4049|wendymurahashi@iconbioscience.com|
20546443|NCT05072470|Sonova USCS|Research Audiologist|630-821-5000|phonakaudiologyresearch@gmail.com|
20546444|NCT03723603|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
20546445|NCT02963831|Ludwig Institute for Cancer Research|Jonathan Skipper|12124501539|jskipper@lcr.org|
20546446|NCT01966432|Duke University, Dept. of Psychiatry and Behavioral Sciences|Dr. Li-Tzy Wu, Professor in Psychiatry|(919) 889-9369|litzy.wu@duke.edu|
20546447|NCT00181623|Massachusetts General Hospital|Corrine Welt, MD|617-716-8437|cwelt@partners.org|
20546448|NCT02815280|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20546449|NCT00603642|Amgen Inc.|Study Director|866-572-6436||
20546450|NCT00654147|University of Miami School of Medicine|Director AIDS Clinical Research Unit|305-243-3838|mfischl@med.miami.edu|
20546451|NCT01230177|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546452|NCT02538783|UPenn|Catherine Reale|215-746-4009|catherine.reale@uphs.upenn.edu|
20546453|NCT02514473|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20546454|NCT01607203|AZ JAN PALFIJN|dr.Decleer Wim|+32 9 325 92 20|wim.decleer@janpalfijngent.be|092248851
20546455|NCT04381988|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@MSKCC.ORG|
20546456|NCT03915860|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20546457|NCT01178827|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20546458|NCT01107379|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
20571332|NCT02227992|Ethicon, Inc.|Senior Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20571333|NCT00996606|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20571334|NCT00281320|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20546459|NCT04559529|Vanderbilt University Medical Center|Stephan Heckers, MD; Principal Investigator|6153222665|stephan.heckers@vumc.org|
20571335|NCT00475228|University o Pittsburgh|Heather Hohmann, MD|412-641-1441|hhohmann@mail.magee.edu|
20571336|NCT01447576|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20571337|NCT00338988|University Texas MD Anderson Cancer Center|Melanie Thomas, MD/Assistant Professor|713-794-4869|mjlim@mdanderson.org|
20571338|NCT00975676|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director Dr. Heidi Roschitzki-Voser Organization|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
20571339|NCT02548078|GlaxoSmithKline|GSK Response Center|866-435-7343|aal77632@gsk.com|
20571340|NCT02579772|Queen's University|Dr. J. Alberto Neder|613-548-2255|nederalb@gmail.com|
20571341|NCT03128671|University of Miami|Cindy Munro|305-284-2107|cmunro@miami.edu|
20571342|NCT04072445|Mayo Clinic|Dr. Amit Mahipal|507-293-0487|Mahipal.Amit@mayo.edu|
20571343|NCT04641962|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20571344|NCT00862836|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20571345|NCT02171247|Duke University Medical Center|Daniel T Boll, MD|919-684-2711|daniel.boll@duke.edu|
20571346|NCT02222870|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20571347|NCT05472740|Duke University|Amelia Scott, Research Program Leader|(919) 613-4584|amelia.lorenzo@duke.edu|
20571348|NCT02942004|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
20571349|NCT05627258|Vaccine Research Center Clinical Trials Program, NIAID|Lesia K. Dropulic, M.D./Principal Investigator; Laura Novik, R.N., M.A./Study Coordinator|301-451-8717|lesia.dropulic@nih.gov; laura.novik@nih.gov|
20571350|NCT04517669|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
20571351|NCT02138786|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20571352|NCT02088957|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20571353|NCT01541384|University of Pennsylvania|Dr. Peter Reese|215-898-6086|peter.reese@uphs.upenn.edu|
20571354|NCT01923662|VAORD|Ronald J Triolo|216-791-3800|Ronald.Triolo@va.gov|64138
20571355|NCT03296800|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
20571356|NCT00677534|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-3867|jstubbs@kumc.edu|
20571357|NCT02687035|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
20571358|NCT01102764|Medical University of South Carolina|Ron Acierno, PhD|843-792-2949|acierno@musc.edu|
20571359|NCT00667394|National Cancer Institute, National Institutes of Health|Dr. Katherine Warren|301-435-4683|warrenk@box-w.nih.gov|
20571360|NCT03165747|Emory University|Roberto Pacifici, MD|404-712-8420|roberto.pacifici@emory.edu|
20571361|NCT02160730|Cedars-Sinai Medical Center|Dr. Ning-Ai Liu|310-423-7382|ning-ai.liu@cshs.org|
20571362|NCT05214378|Cleveland Department of Veterans Affairs|Dennis Bourbeau|216-791-3800|dennis.bourbeau@va.gov|
20571363|NCT04638660|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
20571364|NCT04028921|Children's Mercy Kansas City|Dr. Robin Shook, PhD|(816) 234-9443|rpshook@cmh.edu|
20571365|NCT04481373|Baylor College of Medicine|Thomas Giordano|7137988918|tpg@bcm.edu|
20508496|NCT02708966|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
20546460|NCT01009281|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20546461|NCT00548405|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20546462|NCT00924170|National Cancer Institute|Dr. Robert Kreitman|301-496-6947|Robert_Kreitman@nih.gov|
20546463|NCT00579436|University of Kentucky|Phillip Kern|859 323 4933|pake2222@uky.edu|
20546464|NCT01624870|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|maarten.hollander@medtronic.com|
20546465|NCT03901456|University of Minnesota|Joseph Gaugler, PhD|612-626-2485|gaug0015@umn.edu|
20546466|NCT00625703|University of Texas Southwestern Medical Center|Lus Stella Muniz, MD|214-648-3111|irb@utsouthwestern.edu|
20546467|NCT04098224|ART MEDICAL|Mrs. Shirly Steinlauf|972-54-5804242|Shirly@artmedical.com|
20546468|NCT02548728|University of North Carolina at Chapel Hill|Cort Pedersen, MD|919-923-3284|cort_pedersen@med.unc.edu|
20546469|NCT05478681|The University of Texas Health Science Center at Houston|Kendra M Anderson, PhD|713-486-0513|Kendra.M.Anderson@uth.tmc.edu|
20546470|NCT06054269|CDC|Perrine Marcenac|6782830242|pmarcenac@cdc.gov|
20546471|NCT01587898|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546472|NCT01738477|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546473|NCT00502203|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD / Professor||CR_Study_Registration@mdanderson.org|
20546474|NCT01302834|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20546475|NCT00899392|Children's Hospital of Philadelphia/OHSU/Doernbecher Children's Hospital|Joel A Friedlander|503-494-1078|friedlan@ohsu.edu|
20546476|NCT02437110|National Institutes of Health|Dr. Avi Nath|301-496-1561|natha@mail.nih.gov|
20546477|NCT01431638|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20546478|NCT01261780|University of Wisconsin Carbone Cancer Center|Toby Campbell|608-263-3962|tcc@medicine.wisc.edu|
20546479|NCT01239732|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20546480|NCT03836001|Stanford University|Albert Chiou|(650) 721-8418|achiou@stanford.edu|
20571366|NCT00332462|Novartis Pharmaceuticals|Study Director|862-778-8300||
20571367|NCT01476449|Retina Vitreous Associates of Florida|David Eichenbaum, MD|727-323-0077|deichenbaum@retinavitreous.com|
20546481|NCT04876690|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20546482|NCT02660138|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
20571368|NCT02922023|University of Florida Colleges of Pharmacy and Medicine|Katherine Vogel Anderson, Pharm.D., BCACP, FCCP|352-273-6240|kvanderson@cop.ufl.edu|
20555883|NCT02293538|Alcon Research, Ltd.|Global Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20555884|NCT03166761|Vanderbilt University Medical Center|Byron Schneider|(615)936-7708|byron.j.schneider@vumc.org|
20555885|NCT03969654|Zimmer Biomet, Inc.|Director of Clinical Operations|8006136131|Clinicaloperations@zimmerbiomet.com|
20555886|NCT02269670|Emory University|Dr. Suchita Pakkala|404-686-3496|suchita.pakkala@emoryhealthcare.org|
20555887|NCT05023304|Vance Thompson Vision|Director of Clinical Trials|1-605-371-7075|keeley.boever@vancethompsonvision.com|
20555888|NCT01962493|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555889|NCT00003508|Burzynski Research Institute, Inc|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20555890|NCT02160314|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
20555891|NCT03576768|Medical University of South Carolina|Colleen Hanlon, PhD|843-792-9888|hanlon@musc.edu|
20555892|NCT01698684|Vivus, Inc.|Wesley W Day, PhD|650-934-5200||
20555893|NCT02925455|Case Western Reserve University and MetroHealth System|Michael Fu|215-368-0355|mjf24@case.edu|
20555894|NCT01514448|Novartis Pharmaceuticals|Study Director|862-778-8300||
20555895|NCT02314624|Evidence Based Practice Institute|Linda Dimeff, PhD|206-384-7371|linda.dimeff@jasprhealth.com|
20555896|NCT03595579|Axsome Therapeutics, Inc.|Amanda Jones, PharmD, Senior Vice President of Clinical Development|212-332-3223|ajones@axsome.com|
20555897|NCT01718028|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D.|1-888-451-3937|alcon.medinfo@alcon.com|
20555898|NCT01925950|Soligenix, Inc.|Dr. Richard Straube|609-538-8200||
20555899|NCT03162224|Global Clinical Lead|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20555900|NCT00725452|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20555901|NCT00324870|Johns Hopkins University|Michael Carducci, MD|410-614-6337|carducci@jhmi.edu|
20555902|NCT02723864|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
20555903|NCT03148470|University of Fribourg|Prof. Dr. Jean-Marie Annoni|++4126 306 3802|jean-marie.annoni@unifr.ch|
20555904|NCT00713648|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20555905|NCT00082173|Johns Hopkins University|Dr. Richard Chaisson|410-955-1755|rchaiss@jhmi.edu|
20555906|NCT01733732|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20555907|NCT01738750|University of Utah|Dr. Eric Scaife|801-662-2950|eric.scaife@imail2.org|
20555908|NCT00464815|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555909|NCT02526654|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
20555910|NCT02633800|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|CTRinfo@DSI.com|
20555911|NCT01402141|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Baek-Hwan Cho, MD|82-63-250-1579|chobh@jbnu.ac.kr|
20555912|NCT01030861|Benaroya Research Institute|Carla Greenbaum, MD|206-342-6933|cjgreen@benaroyaresearch.org|
20555913|NCT00254982|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20555914|NCT00000392|NIMH|Benedetto Vitiello, MD - Supervisory Medical Officer|301-443-3357|bvitiell@mail.nih.gov|
20555915|NCT02836418|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
20555916|NCT03430674|Indiana University|Jamie Renbarger, MD|317-944-8784|jarenbar@iu.edu|
20555917|NCT02071173|Boston Scientific|Kelly Aspinwall|1-800-CARDIAC|kelly.aspinwall@bsci.com|
20527617|NCT01093651|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
20555918|NCT02436265|Indiana University|Aali shah MD|317-944-9981|ashah9@iuhealth.org|
20555919|NCT01507220|The Ohio State University|Sergio Bergese, MD|(614) 293-9027|bergese.1@osu.edu|
20555920|NCT01654549|Tehran University of Medical Sciences|Dr Raika Jamali|982163120000|jamalira@tums.ac.ir|411
20546483|NCT01642732|University of Michigan Hospital|Dr. Daniel Hamstra, Associate Professor of Radiation Oncology|734-936-4300|dhamm@umich.edu|
20546484|NCT02438475|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
20546485|NCT00899353|Marshall University Joan C. Edwards School of Medicine|Dr. W. Elaine Hardman|304-696-3721|hardmanw@marshall.edu|
20546486|NCT01247298|University of Alabama at Birmingham (UAB)|Rojymon Jacob, MD|205-975-9704|rjacob@uabmc.edu|
20546487|NCT04475198|SiteOne Therapeutics|John Mulcahy|+1 (650) 392-0419|john.mulcahy@site1therapeutics.com|
20546488|NCT02489422|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
20546489|NCT04604132|Basilea Pharmaceutica International Ltd, Allschwil|Manuel Häckl, MD|+41 76 302 53 10|manuel.haeckl@basilea.com|
20546490|NCT00402233|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546491|NCT03493932|Emory University|Edjah K. Nduom, MD, FAANS|404-778-5770|edjah.k.nduom@emory.edu|
20546492|NCT02589600|University of Pittsburgh|Susan Greenspan|4126922477|greenspn@pitt.edu|
20546493|NCT04850781|Johns Hopkins University|Kali Thomas|(410) 955-4766|kali.thomas@jhu.edu|
20546494|NCT00053898|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
20546495|NCT00056498|Maryland Psychiatric Research Center|Robert W. Buchanan, MD|410-402-7876|rwbuchanan@mprc.umaryland.edu|
20546496|NCT01007253|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
20546497|NCT02232880|Vanderbilt University|David Harrison||david.g.harrison@Vanderbilt.Edu|
20546498|NCT01481129|Centre Léon Bérard (now CHLS)|Dr Hervé Ghesquieres|0426556824|herve.ghesquieres@chu-lyon.fr|
20546499|NCT04085367|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20546500|NCT03274999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20546501|NCT00130442|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
20546502|NCT00814333|University of Kansas Medical Center|Kevin Sykes, PhD|913-588-7154|ksykes@kumc.edu|
20546503|NCT01752712|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
20546504|NCT01527357|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20546505|NCT02233946|Boston Children's Hospital|Dr. Sion Kim Harris|8572184304|sion.harris@childrens.harvard.edu|
20555921|NCT00937924|University of California, Irvine|Dr. Kenneth Chang|714-456-6187|kchang@uci.edu|
20546506|NCT00910247|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20546507|NCT01879579|New York University School of Medicine|Dr. Natalie Levy|2122638924|Natalie.Levy@nyumc.org|
20546508|NCT02927067|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20546509|NCT01695668|University of Michigan|Dr Shahzad Mian|734-647-8397|smian@med.umich.edu|
20546510|NCT02292784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20546511|NCT00134784|Institute for Neurodegenerative Disorders|Principal Investigator|203 401 4300|kmarek@indd.org|
20546512|NCT02519855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546513|NCT03621475|University of Vermont|Renee Stapleton, MD, PhD|(802) 656-7975|renee.stapleton@med.uvm.edu|
20546514|NCT01842633|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546515|NCT03565367|Stanford University|Lawrence Recht, MD|(650) 725-8630|lrecht@stanford.edu|
20546516|NCT02057042|VA Center for Clinical Managment Research|Paul Pfeiffer|7348453649|paul.pfeiffer@va.gov|
20546517|NCT01206387|Taro Pharmaceuticals U.S.A., Inc|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
20546518|NCT00920907|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20546519|NCT01275339|Washington University School of Medicine|Brian R. Lindman, MD|615-936-5949|brlindman@wustl.edu|
20546520|NCT04389970|University of Alabama at Birmingham|Brooks Wingo|2059345982|bcwingo@uab.edu|
20546521|NCT01555957|University of Rochester|Sanjiv Amin|585-273-2696|sanjiv_amin@urmc.rochester.edu|
20546522|NCT00718081|AcelRx|Dr. Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
20546523|NCT00815516|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
20546524|NCT03042702|Innovation Pharmaceuticals|Arthur P. Bertolino MD, PhD, MBA|9789214125|abertolino@IPharmInc.com|
20546525|NCT00976508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546526|NCT01198158|Georgetown University Hospital|George Philips MBBS, MD, MPH, FACP|202-444-2198|George.K.Philips@gunet.georgetown.edu|
20546527|NCT05478174|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|858-263-4239|yuling.lai@haisco-usa.com|
20546528|NCT05822531|Penn State College of Medicine|Ian Paul|(717) 531-8006|ipaul@pennstatehealth.psu.edu|
20546529|NCT03702244|Heartflow Inc|Director, Clinical Operations|877-478-3569|whuey@heartflow.com|
20546530|NCT01993836|Duke University|Miles Berger, MD, PhD|919-684-8679|miles.berger@duke.edu|
20546531|NCT02195687|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20546532|NCT00686634|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
20546533|NCT02288377|FFCD|Karine Le Malicot|+ 33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20546534|NCT02296138|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546535|NCT04369924|University of Miami|Amanda Jensen-Doss|3052848332|ajensendoss@miami.edu|
20546536|NCT01653132|Beth Israel Deaconess Medical center|Dr. Pushpa Narayanaswami|617-667-8130|pnarayan@bidmc.harvard.edu|
20555922|NCT01763931|SKCCC at Johns Hopkins|Vered Stearns, MD|410-614-1361|HopkinsBreastTrials@jhmi.edu|
20555923|NCT04650555|Humanetics Corporation|Michael D Kaytor, PhD|952-400-0405|mkaytor@humaneticscorp.com|
20555924|NCT04460742|University of Rochester|Adam Simning|585-474-9534|adam_simning@urmc.rochester.edu|
20546537|NCT03312751|Swedish Orphan Biovitrum AG|Radmila Kanceva, MD, Medicine Development Lead|+41 793048899|Radmila.Kanceva@sobi.com|
20546538|NCT00475423|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20546539|NCT01499862|Department of Physical Therapy and Rehabilitation, University of California San Francisco|Dr. Nancy N. Byl|415-514-4816|byln@ptrehab.ucsf.edu|
20546540|NCT02217527|Univ of Pittsburgh|Dr. Kenneth A. Perkins, Prof of Psychiatry|412-246-5395|perkinska@upmc.edu|
20546541|NCT02181517|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
20546542|NCT01203852|University of Florida|Dr. Julie A. Johnson|(352) 273-6309|johnson@cop.ufl.edu|
20546543|NCT00787904|Emory University|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
20508497|NCT01515488|Maricopa Integrated Health System|Madhumita Sinha, MD, MHSM|602-344-5404|madhumita_sinha@dmgaz.org|
20546544|NCT02582684|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20546545|NCT01878149|Baxano Surgical®|Sr. Director of Clinical Affairs|919.899.9760|teresa.schroeder@baxsurg.com|
20546546|NCT04672252|NYU Langone Health|Michael J. Alaia, MD|(646) 501-7223|Michael.Alaia@nyulangone.org|
20546547|NCT01431300|Duke University Medical Center|Charles Kim|919-684-7284|charles.kim@duke.edu|
20546548|NCT06390839|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20546549|NCT01495676|INSTITUT REGIONAL DU CANCER DE MONTPELLIER|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
20546550|NCT02720094|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
20546551|NCT02055638|Azevan Pharmaceuticals, Inc.|Dr. Neal Simon, CEO|(610) 419-1057|ngsimon@azevan.com|
20546552|NCT01903252|Tillotts Pharma AG|Dr. Robert Hofmann, MD PhD|+4161 935 27 14|robert.hofmann@tillotts.com|
20546553|NCT03735238|Baylor College of Medicine|Jasvinder Singh, MD, MPH; Senior Faculty and Chief of Immunology, Allergy, and Rheumatology|713.798.1365|jasvinder.md@gmail.com|
20546554|NCT02805504|Loma Linda University Health|Duane Baldwin, MD Director of Urologic Research|909 558 4196|dbaldwin@llu.edu|
20546555|NCT03562767|Emory University|Dr. Ambar Kulshreshtha|(404) 686-2410|akulshr@emory.edu|
20546556|NCT02004288|Sestre milosrdnice University Hospital Center Vinogradska 29, Zagreb, Croatia|Orjena Žaja, MD MSc PhD primarius Ass Prof Pediatrics, Pediatric gastroenterologist|P:+38513787342 M:+3859937872|Orjena Žaja <orjenazf@yahoo.com>|
20546557|NCT01230125|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20546558|NCT01138917|AVITA Medical|Director of Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
20546559|NCT02819908|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
20546560|NCT04658940|Acutus Medical|Karen Stephens, Director Clinical Affairs|442-232-6080|karen.stephens@acutus.com|
20546561|NCT00821327|US Oncology Research, McKesson Specialty Health|Dr. Matthew D. Galsky|212-659-5412|matthew.galsky@mssm.edu|
20546562|NCT02119676|Incyte Corporation|Study Director|855 463-3463||
20546563|NCT04268823|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20546564|NCT02919969|Dana Farber Cancer Institute|James Cleary|617-632-6073|james_cleary@dfci.harvard.edu|
20546565|NCT02093351|AstraZeneca Pharmaceuticals|Dr Carsten Goessl, Indication Lead||clinicaltrialtransparency@astrazeneca.com|
20546566|NCT01099709|Purdue Pharma LP|Stephen C. Harris, MD|203-588-7592|Stephen.Harris@pharma.com|
20546567|NCT00706849|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20546568|NCT01611454|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute|786-596-3505|raulh@baptisthealth.net|
20546569|NCT02616601|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20546570|NCT03718299|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trials@sunpharma.com|5689
20546571|NCT01343823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20546572|NCT02153476|Allegro Ophthalmics, LLC|Director of Clinical Research|949-444-5722|lkarageozian@allegroeye.com|
20546573|NCT01689909|Medical College of Georgia; Augusta University|William Vaughn McCall|706-721-6719|WMCCALL@augusta.edu|
20546574|NCT00244842|Aurinia Pharmaceuticals Inc.|Robert Huizinga|250-708-4322|rhuizinga@auriniapharma.com|
20546575|NCT02415855|University of Alberta|Dr. Kenneth Butcher|780-407-4366|ken.butcher@ualberta.ca|
20546576|NCT01236118|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20546577|NCT04535167|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546578|NCT03404960|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20546579|NCT00075270|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546580|NCT00246571|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546581|NCT03422627|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20546582|NCT02455557|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20546583|NCT03390842|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
20546584|NCT04656899|Washington State University Elson S. Floyd College of Medicine, Analytics and PsychoPharmacology Laboratory (APPL)|Dr. Crystal Smith (backup: Dr. Sterling M. McPherson)|(509) 368-6876|crystal.lederhos@wsu.edu|
20546585|NCT01848782|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
20546586|NCT02409914|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
20546587|NCT03513848|University of California, Irvine|Alyson Zalta|949-824-3409|azalta@uci.edu|
20546588|NCT03828370|Klein Buendel Inc.-|Dr. W. Gill Woodall, Ph. D.|5053829796|gwoodall@kleinbuendel.com|
20546589|NCT02677324|DFCI|Jorge J. Castillo|617-632-2681|jorgej_Castillo@dfci.harvard.edu|
20546590|NCT00461331|Tulane University Health Sciences Center|Tina K. Thethi, MD, MPH|504-988-5044|tthethi@tulane.edu|
20546591|NCT00761150|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20546592|NCT00290407|James Graham Brown Cancer Center|Roger H Herzig, MD|502/396-3119|rhherz01@louisville.edu|
20546593|NCT01076296|GE Healthcare|Anita Johnson|262-548-2825|Anita.Johnson@ge.com|
20546594|NCT01925989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20546595|NCT00868517|Department of Veterans Affairs|Michelle Kennedy Prisco|202-745-8000|michelle.prisco@va.gov|56235
20546596|NCT02496676|National Institute of Allergy and Infectious Diseases|Ravell Aumaitre, Juan|+1 301 761 6669|juan.ravell@nih.gov|
20546597|NCT05442775|Cytokinetics|Cytokinetics MD|650-624-2929|medicalaffairs@cytokinetics.com|
20546598|NCT04739865|COMPASS Pathways|Chief Medical Officer|07443136539|info@compasspathways.com|
20546599|NCT01361854|CHU St Pierre|Dr Marie Bruyneel|003225354219|Marie_BRUYNEEL@stpierre-bru.be|
20546600|NCT00040846|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20546601|NCT02830438|AlbertEHN|Mario Naranjo-Tovar|2157965542|mario.edu6@hotmail.com|
20546602|NCT02106923|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546603|NCT03734705|Stanford University|Katie Fracalanza, PhD|408-769-0589|kfracalanza@stanford.edu|
20546604|NCT03579602|Blaze Bioscience|Dr. Kristi Harrington|206-535-8144|Clinical.trials@blazebioscience.com|
20546605|NCT03720392|Massachusetts General Hospital|Zachariah DeFilipp, MD|617-643-3944|ZDEFILIPP@MGH.HARVARD.EDU|
20546606|NCT02581839|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
20546607|NCT02889562|Sanford Health|Todd Chapin PharmD|701-417-2351|todd.chapin@sanfordhealth.org|
20546608|NCT01943474|C. R. Bard|Gina Gilbert|407-489-0835|gina.gilbert@crbard.com|
20546609|NCT01470989|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20546610|NCT00969280|Korea Institute of Oriental Medicine|Tae-Hun Kim, Researcher|82-10-6532-5524|rockandmineral@gmail.com|
20546611|NCT00217464|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20546612|NCT00459979|CCCC|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
20555925|NCT04969198|University of Wisconsin-Madison|Jesse Kaye|608-262-8885|jtkaye@ctri.wisc.edu|
20555926|NCT04391023|University of Iowa|Dr. Alexandra Courtney Fietsam|N/A|alexandra-fietsam@uiowa.edu|
20555927|NCT03074630|AmsterdamUMC|Erik van Bommel|+31 20 4444444|e.vanbommel@amsterdamumc.nl|
20555928|NCT02189798|Advanced Bionics|Michelle Caulfield, Senior VP, Global Quality Assurance and Regulatory Affairs|6613621400|clinicalresearch@advancedbionics.com|
20555929|NCT03842995|Hudson Alpha Institute for Biotechnology|Greg Cooper, PhD|2563279490|gcooper@hudsonalpha.org|
20555930|NCT01518868|Bausch Health|Study Director||robert.steffen@bausch.com|
20555931|NCT00529399|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
20555932|NCT03695172|Duke University Medical Center|Amanda Kumar, MD|919-681-4607|amanda.kumar@duke.edu|
20555933|NCT02672111|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
20555934|NCT02486328|Ufuk University Faculty of Medicine|Dr Perihan Ekmekçi|+903122044000|erdogduperi@gmail.com|
20555935|NCT06242444|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20555936|NCT02076152|Massachusetts General Hospital|Elizabeth Gerstner, MD|617-724-2887|EGERSTNER@PARTNERS.ORG|
20555937|NCT03317977|Wayne State University|Deborah Ellis, Ph.D.|313-577-1055|dellis@med.wayne.edu|
20555938|NCT02635880|Cutera|Ginger Pocock|4156575702|gpocock@cutera.com|
20555939|NCT02046980|Daegu Kyungbook Dizziness society|Dr. Hyun Ah Kim|+82-53-250-7475|kha0206@dsmc.or.kr|
20555940|NCT01483924|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
20555941|NCT00003298|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20555942|NCT00335322|Kirby Institute|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
20555943|NCT03369444|University College London|Pratima Chowdary|+44(0)20 7472 6835|p.chowdary@ucl.ac.uk|
20555944|NCT04330638|UZ Gent|Anja Delporte|+3293320228|anja.delporte@uzgent.be|
20555945|NCT00856050|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
20555946|NCT02439710|Institute for Policy Advancement Ltd|Mark W Skinner|+1-202-253-8342|mskinnerdc@gmail.com|
20555947|NCT01410773|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20571369|NCT00558844|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
20571370|NCT01146600|Emory University School of Medicine|Lynn Marie Trotti, MD, MSc|404-728-4752|lbecke2@emory.edu|
20571371|NCT02579135|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
20571372|NCT04076787|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571373|NCT02766777|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20571374|NCT01886287|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
20571375|NCT02593123|Virginia Commonwealth University Massey Cancer Center|Dr. Amir Toor, Principal Investigator|804 828 5116|amir.toor@vcuhealth.org|
20571376|NCT00504777|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20571377|NCT03514277|Reconstructive Orthopedics|Robert Greenleaf|609-267-9400|bob.greenleaf1@gmail.com|
20571378|NCT01195623|Uppsala UH|Lena Blomgren MD PhD|+46851774173|lena.blomgren@karolinska.se|
20571379|NCT02278484|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|952
20571380|NCT00534495|Children's Hospital at Montefiore|Dr.Norman T.Ilowite|718-696-2602|NILOWITE@montefiore.org|
20571381|NCT01572740|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20571382|NCT00478192|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20571383|NCT00214019|UW Madison|Gina Crisafi|6082654554|gmc@medicine.wisc.edu|
20571384|NCT00477490|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20571385|NCT00137969|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20571386|NCT01346072|University of North Carolina Chapel Hill|Kirkwood F. Adams, Jr., MD|919-966-2877|kfa@med.unc.edu|
20571387|NCT01465763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571388|NCT01646177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20571389|NCT00668265|Beth Israel Medical Center|Igor Galynker, MD|212 420 4535|igalynke@chpnet.org|
20571390|NCT02920970|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
20571391|NCT01711853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571392|NCT04191616|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20571393|NCT04230122|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20546613|NCT00989573|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20546614|NCT01629771|Northwestern University|Clinical Trials Unit Coordinator|312-695-6829|j-bae@northwestern.edu|
20546615|NCT00278915|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20546616|NCT05214573|Mayo Clinic|Rozalina McCoy, M.D., M.S.|507-538-7955|mccoy.rozalina@mayo.edu|
20546617|NCT00814801|Janssen Pharm KK Japan|Director|81-3-4411-5717||
20546618|NCT04148872|University of Wisconsin - Madison|Scott Chaiet, MD|608-263-0192|chaiet@surgery.wisc.edu|
20546619|NCT02486718|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20546620|NCT02520089|Universidad Autonoma de Nuevo Leon|Dr. Carlos Alberto Acosta-Olivo|+528183476698|dr.carlosacosta@gmail.com|
20571394|NCT04910139|Sound Health Systems|Paramesh Gopi|408-316-3631|pgopi@soundhealth.life|
20546621|NCT02081248|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20546622|NCT01037088|UCaliforniaDavis|Dr. Barth Wilsey, MD|916-843-9082|blwilsey@ucdavis.edu|
20546623|NCT03351101|Bausch Health|Study Director|+1 (585) 338-6399|Robert.Steffen@bausch.com|
20546624|NCT02216812|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
20546625|NCT00873873|National Jewish Health|Head, Pediatric Clinical Pharmacology|303-398-1193|szeflers@njhealth.org|
20546626|NCT00527488|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20571395|NCT00604708|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
20571396|NCT03697551|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20571397|NCT01277887|Yale University School of Medicine|Lisa Fucito, PhD|203 974-5759|lisa.fucito@yale.edu|
20571398|NCT01371708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
20546627|NCT01958827|AbbVie|Global Medical Information|800-633-9110||
20571399|NCT02514551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20571400|NCT02142153|F2G|Dr Anthony Kennedy|0044 161 785 1273|TKennedy@f2g.com|
20571401|NCT00167206|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
20571402|NCT01791972|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|1-215-591-3000|ustevatrials@tevapharm.com|
20571403|NCT00632502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571404|NCT04954326|Institut de Recherches Internationales Servier|Therapeutic Area in Oncology|+33155724366|clinicaltrials@servier.com|
20546628|NCT03036800|University of Leicester|Prof Melanie Davies|0116 258 6481|melanie.davies@uhl-tr.nhs.uk|
20546629|NCT01278927|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20546630|NCT00721253|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20546631|NCT02829944|Duke University Medical Center|Emily Barney|9709031869|ezb2@duke.edu|
20546632|NCT06372782|Q-Med AB|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20508498|NCT02260388|University of Kansas Medical Center|Dr. Richard Barohn|9139459943|rbarohn@kumc.edu|
20546633|NCT01730937|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20546634|NCT03875235|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20546635|NCT06447688|Medicalpark Hospital|Sefa SURAL|+90 532 565 0160|sesural@hotmail.com|
20546636|NCT01395784|New York State Psychiatric Institute|Jermaine Jones, PhD|646 774-6113|jonesje@nyspi.columbia.edu|
20546637|NCT00622739|Baylor College of Medicine|Kirti Saxena|832-822-4065|kxsaxen1@texaschildrens.org|
20546638|NCT04179409|Abigail Wexner Research Institute, Nationwide Children's Hospital|Dr. Kevin Flanigan, Center for Gene Therapy Director|614-722-5615|kevin.flanigan@nationwidechildrens.org|
20546639|NCT02155946|VA Ann Arbor|Dr. Benjamin Hampstead|734-763-9259|bhampste@med.umich.edu|
20546640|NCT02873585|University of North Carolina at Chapel Hill|Angela Broome, DDS, MS|9195373160|abroome@unc.edu|
20546641|NCT01276197|CHOIR|Dr. Thomas K. Houston|781-687-2884|thomas.houston2@va.gov|
20546642|NCT03123185|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546643|NCT01545843|University of Michigan|Dr. J. Todd Arnedt|734-764-1234|tarnedt@med.umich.edu|
20546644|NCT03468543|Lyndra|Andrew Bellinger, MD, PhD|857-302-7878|abellinger@lyndra.com|
20546645|NCT00470158|AHRQ|Stephanie Chang|301 427-1490|stephanie.chang@ahrq.hhs.gov|
20546646|NCT01249118|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20546647|NCT00880685|University of Chicago|Dr. Jon Grant|773-834-1326|jongrant@uchicago.edu|
20546648|NCT04179890|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546649|NCT01063712|"Cardiology Medical Center Kardiozentrum"|Alexandra Heath MD Ph.D|005912 2785037|draheath@gmail.com|
20546650|NCT00978432|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
20546651|NCT02579928|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
20546652|NCT04972630|Medical University of South Carolina|Dr. Suparna Qanungo|(843) 876-1125|qanungo@musc.edu|
20546653|NCT02642744|University of Pennsylvania|Laura Stein|215-662-6214|laura.stein@pennmedicine.upenn.edu|
20546654|NCT06312462|Jiangsu Institute of Parasitic Diseases|Dr. Huang Yuzheng|19941716698|huangyuzheng@jipd.com|
20546655|NCT05247398|University of Minnesota|Corey McGee|612-626-5645|mcge0062@umn.edu|
20546656|NCT04251156|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20546657|NCT04656275|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546658|NCT00300742|UVA Center for Addiction Research and Education|Dr. Nassima Ait-Daoud|434-243-0541|uvacare@virginia.edu|
20546659|NCT05954143|Bolt Biotherapeutics, Inc.|Director of Clinical Development Operations|1-650-434-8640|clinicaltrials@boltbio.com|
20546660|NCT01129024|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20546661|NCT05293392|Nemours Children's Health|Thao-Ly Phan, MD, MPH|302-331-7342|thaoly.phan@nemours.org|
20546662|NCT00934648|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20546663|NCT02361580|Massachusetts Generla Hospital|Taylor Pong, Research Coordinator||tpong1@partners.org|
20546664|NCT02047318|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20546665|NCT01857310|NICHD|Dr. Enrique Schisterman|3014356893|schistee@mail.nih.gov|
20546666|NCT00998764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546667|NCT04761627|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20546668|NCT01933789|University of Washington|Dr. J. Randall Curtis|206-744-3356|jrc@uw.edu|
20546669|NCT00723203|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
20546670|NCT01514162|St Jude Medical|Jennifer Johnson|6517566803|jjohnson101@sjm.com|
20546671|NCT03935399|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
20546672|NCT01323920|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
20546673|NCT03103061|Medical University of South Carolina|Hunter Gray, Program Coordinator|843-876-3185|grayhu@musc.edu|
20546674|NCT03102190|Massachusetts Eye and Ear Infirmary|Project Manager, Clinical Trials|617-573-6981|elizabeth_grimm@meei.harvard.edu|
20546675|NCT06400251|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20546676|NCT02891603|Moffitt Cancer Center|Joseph Pidala, MD, PhD|813-745-2556|Joseph.Pidala@moffitt.org|
20546677|NCT02067975|Maryland Psychiatric Research Center|Sam Kane-Gerard|410-402-6120|SGerard@som.umaryland.edu|
20546678|NCT00732940|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546679|NCT00938886|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
20508499|NCT01981109|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
20546680|NCT01233518|Heartflow, Inc.|Whitney Huey|650.257.6697|whuey@heartflow.com|
20555948|NCT01041638|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20555949|NCT03152552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20555950|NCT00567242|University of Florida|Bruce Crosson, PhD / Professor|352-273-6617|nossorc1@phhp.ufl.edu|
20555951|NCT04084314|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20555952|NCT03336619|Romark|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
20555953|NCT01300546|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
20555954|NCT02271386|The Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|2674262304|fiks@email.chop.edu|
20555955|NCT01316926|GlaxoSmithKline|GSK Response Center|866-435-7343||
20555956|NCT02649868|Clinical Center|Wood, Bradford|+1 301 496 7739|bwood@mail.cc.nih.gov|
20555957|NCT00765193|Department of Dermatology, Medical University of Graz-Austria|Iris Zalaudek, MD|+436763328269|iris.zalaudek@medunigraz.at|
20555958|NCT01864564|University of Texas at Austin|Lorie M. Harper, MD, MSCI|512-324-7036|lorie.harper@austin.utexas.edu|
20555959|NCT03373604|Columbia University|Patrick Lao, PhD|212-342-1399|pjl2133@cumc.columbia.edu|
20555960|NCT00710424|GW Pharm Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20555961|NCT01986881|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20555962|NCT01760889|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20555963|NCT01466985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20555964|NCT00955357|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20555965|NCT01258608|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555966|NCT04205630|Byondis B.V.|Clinical Development|0031246795101|clinicaltrials@byondis.com|
20555967|NCT00676182|James A. Haley Veterans' Hospital|Dr. Kris Siddharthan|813-558-3950|Krishnaswami.Siddharthan@va.gov|
20555968|NCT04250727|Yale School of Medicine|Lisa Fucito, PhD: Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry|(203) 688-1878|lisa.fucito@yale.edu|
20555969|NCT01393782|George Washington University Medical Faculty Associates|Clinical Trials Unit, Department of Anesthesiology and Critical Care Medicine|202-715-4750|mseneff@mfa.gwu.edu|
20555970|NCT02943408|Veterans Affairs Rocky Mountain (VISN 19) Mental Illness Research Education and Clinical Center (MIRECC)|Dr. Samantha Hack|720-234-2017|samantha.hack@va.gov|
20555971|NCT01106833|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20555972|NCT01621126|Massachusetts General Hospital|Dr. Jon J.P. Warner, Chief of Shoulder Service MGH, Harvard Professor of Orthopaedics.|617-724-3140|jwarner@mgh.harvard.edu|
20555973|NCT00886340|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
20555974|NCT03224182|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
20555975|NCT02481310|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@northwestern.edu|
20555976|NCT04953390|Sonova USCS|Principal Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
20555977|NCT00643916|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20555978|NCT03035292|Cambridge University Hospitals NHS Trust|Dr Stephen Kelleher, Director of R&D|01223 217418|r&denquiries@addenbrookes.nhs.uk|
20555979|NCT01808950|Galderma Spirig|Dr. Francine Santoro|+41623878720|francine.santoro@galderma.com|
20555980|NCT01907191|Saint Francis Hospital and Medical Center|Sanjay Sinha, MD|860-714-6654|ssinha3300@gmail.com|
20555981|NCT00686166|SWOG Statistical Center|SWOG Statistician|206-667-4408||
20555982|NCT01549613|University of Cincinnati, Dept. of Emergency Medicine|George J. Shaw, MD, PhD|513-558-8098|shawge@ucmail.uc.edu|
20555983|NCT02131272|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20555984|NCT00381940|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20555985|NCT04162769|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20555986|NCT02163733|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20555987|NCT00746590|BTG International Ltd.|Claire Daugherty|+1 801 556 8882|claire.daugherty@btgplc.com|
20555988|NCT00209417|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
20555989|NCT02794285|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20555990|NCT04052204|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials_gov_Inquiries@pfizer.com|
20555991|NCT00363675|Shrines Hospitals for Children - Boston|Mary Jo Baryza, Diredtor of Therapeutic Services|617-371-4749|mbaryza@shrinenet.org|
20555992|NCT01803074|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20555993|NCT04124926|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
20555994|NCT01250977|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|215-746-7173|albeldab@pennmedicine.upenn.edu|
20555995|NCT02578238|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20555996|NCT02167074|Erasmusm MC University Medical Center Rotterdam|Dr. P. van Riet|0031648237608|p.vanriet@erasmusmc.nl|
20555997|NCT02013622|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20555998|NCT04224155|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
20555999|NCT03644186|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki|+41 31 511 94 00|TOUCH-monitoring@etop.ibcsg.org|
20556000|NCT03712891|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20556001|NCT02701985|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20556002|NCT04009291|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
20556003|NCT02085408|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20571405|NCT01213524|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
20571406|NCT00630734|University of Colorado Denver|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
20571407|NCT06411613|VA Puget Sound Health Care System|Dawn Bates|206-277-3012|dawn.bates@va.gov|
20571408|NCT02519348|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20571409|NCT05239598|Penn Dental Medicine|Dr. Pat Corby|215-898-1162|patcorby@upenn.edu|
20571410|NCT05855967|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20571411|NCT04147195|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20571412|NCT04092530|University of Illinois at Chicago|Kristin Rankin|708-710-8411|krankin@uic.edu|
20571413|NCT04707664|Partner Therapeutics, Inc.|Medical Information|1-888-479-5385|PartnerTx@medcomminc.com|
20571414|NCT05817383|Hebrew Rehabilitation Center|Dr. Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
20571415|NCT02354820|Indiana University School of Medicine|William E. Bennett, Jr. Principal Investigator|3172786928|webjr@iu.edu|
20571416|NCT02706405|Fred Hutchinson Cancer Center|Dr. Jordan Gauthier|2066672713|jgauthier@fredhutch.org|
20571417|NCT02304705|University of Kentucky|Dr. Maya Guglin|859-323-4738|maya.guglin@uky.edu|
20571418|NCT01195948|National Institutes of Health|Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
20571419|NCT03140280|Medical College of Wisconsin|Ehab Atallah, MD|414-805-4600|eatallah@mcw.edu|
20571420|NCT02981108|Jiangsu Hansoh Pharmaceutical Group Co., Ltd.|Alison Li|86-21-51211850|Alison.li@hspharm.com|
20571421|NCT00954187|Loma Linda University|Julio Narvaez, MD|9095589408|thamilton@llu.edu|
20571422|NCT05577715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20571423|NCT03412773|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20571424|NCT03317990|University College London|Professor Greg Shaw|+44 (0)20 7679 2000|ncita.neurosafe@ucl.ac.uk|
20571425|NCT01656252|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
20571426|NCT02643303|Ludwig Institute for Cancer Research|Jonathan Skipper|12124501539|jskipper@lcr.org|
20571427|NCT00974818|Memorial Slaon Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|Dalbagng@mskcc.org|
20571428|NCT04440839|UNIVERSITY OF CALIFORNIA DAVIS|Misty Humphries|9167342028|mdhumphries@health.ucdavis.edu|
20571429|NCT00929253|Virginia Tech|Dr. Warren K. Bickel|540-526-2015|wkbickel@vt.edu|
20571430|NCT03057847|University of Pittsburgh|Dr. Elizabeth Krans|412-641-3532|kransee@upmc.edu|
20571431|NCT00448201|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
20571432|NCT03301155|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20571433|NCT02769442|University of Maryland School of Medicine, Department of Emergency Medicine|Siamak Moayedi Md|4103288025|smoayedi@em.umaryland.edu|
20571434|NCT01706705|UT MD Anderson Cancer Center|Dr. Ann Klopp / Associate Professor, Radiation Oncology|713-563-6930|aklopp@mdanderson.org|
20571435|NCT03510455|National Institute of Dental and Craniofacial Research|Rachel I. Gafni|301-594-9924|gafnir@mail.nih.gov|
20571436|NCT04958642|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
20571437|NCT01199068|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20571438|NCT01250925|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-3313|cornea_research@meei.harvard.edu|
20546681|NCT02518464|Columbia University Medical Center|Robert Sommer, MD|212-305-7060|rs2463@cumc.columbia.edu|
20571439|NCT00678301|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571440|NCT03338296|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20571441|NCT01939353|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20571442|NCT00458952|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
20571443|NCT03573947|Duke Cancer Institute|Dr. Jeffrey Clarke|9196819509|jeffrey.clarke@duke.edu|
20571444|NCT03237377|Johns Hopkins SKCCC CRO Coordinating Center|Jasmine Brooks, Senior Research Program Coordinator|667-306-8335|jbrook54@jhmi.edu|
20571445|NCT04421950|University of Arkansas for Medical Sciences and Arkansas Children's Nutrition Ce|Eva C. Diaz, Principal Investigator|5013643056|ecdiazfuentes@uams.edu|
20571446|NCT05048238|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20571447|NCT00186017|Stanford University School of Medicine|Dr. Terence A. Ketter, MD.|6507232507|tketter@stanford.edu|
20571448|NCT03289351|Phoenix Children's|Dr. Justin Lee|6029330016|jlee8@phoenixchildrens.com|
20571449|NCT00335140|Johns Hopkins Cancer Center|Lode Swinnen, MD|(410) 955-8603|lswinne1@jhmi.edu|
20571450|NCT02204657|University Malaya Medical Centre|Dr Sharmila SP|60379492299|sharmsp13@gmail.com|
20571451|NCT01038427|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20571452|NCT03285555|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
20571453|NCT02221557|Sunstar Americas, Inc.|Akane Takemura, R&D Senior Manager|847-794-4276|akane.takemura@us.sunstar.com|
20571454|NCT01137578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20571455|NCT01361594|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20546682|NCT00481507|GEORGETOWN UNIVERSITY|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu|
20546683|NCT01120067|VA Boston Healthcare System|John Otis|857-364-5740|john.otis@va.gov|
20546684|NCT00819793|Abbott|Poornima Sood||psood@sjm.com|
20546685|NCT04711837|Haisco USA Pharmaceutical Inc.|Yu-Ling Lai Senior Director Clinical Operations|1 732-26-4759|Yuling.lai@Haisco-usa.com|
20571456|NCT00415051|US Army Medical Research Institute of infectious Diseases (USAMRIID)|COL Phillip R. Pittman, MD, MPH|301-619-4994|phillip.pitman@amedd.army.mil|
20571457|NCT03651700|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
20546686|NCT01150474|Mayo Clinic|Dr. Kristina A. Butler|480-301-5934|butler.kristina@mayo.edu|
20571458|NCT03874754|Johns Hopkins School of Nursing|Nada Lukkahatai|2407509867|nada.lukkahatai@jhu.edu|
20571459|NCT05479734|University of Oklahoma Health Sciences|David Bard, Director of EmBRACER Center|4052718001|David-Bard@ouhsc.edu|
20571460|NCT03945825|University of Iowa Carver College of Medicine|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
20571461|NCT00600613|Memorial Sloan Kettering Cancer Center|Dr. Yoshiya Yamada|212-639-2950|yamadaj@mskcc.org|
20571462|NCT02623998|McMaster University|Dr. Natalia McInnes|19055212100|natalia.mcinnes@mcmaster.ca|73794
20571463|NCT01509547|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20571464|NCT01399918|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-888-4740|Feldmand@MSKCC.ORG|
20571465|NCT03197766|BioMarin Pharmaceutical Inc.|Alice Huntsman Labed|+44 207 4203392|alice.huntsmanlabed@bmrn.com|
20546687|NCT03021564|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Maxime Leloup|+33 (0)5 46 45 66 09|maxime.leloup@ght-atlantique17.fr|
20571466|NCT00570908|Baylor Coolege of Medicine|Dr. Mothaffar Rimawi|7137981811|rimawi@bcm.edu|
20571467|NCT01110408|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
20571468|NCT00669877|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, Assistant Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20571469|NCT03635099|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571470|NCT04103892|Clexio Biosciences Ltd|Regulatory Affairs Lead|972-733318704|myriam.belahcen@clexio.com|
20571471|NCT03008005|Wayne State University|Dr. Christine Rabinak, Principal Investigator|(313) 577-9875|rabinak@wayne.edu|
20546688|NCT01947907|Ascendis Pharma A/S|VP Clinical Development|+49 172 155 2596|mb@ascendispharma.com|
20571472|NCT07025837|Citruslabs|Patrick Renner|4242450285|hello@citruslabs.com|
20571473|NCT01435772|BioMarin Pharmaceutical Inc.|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
20571474|NCT03238963|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571475|NCT06926673|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20571476|NCT05823012|Xeris Pharmaceuticals, Inc.|Valentina Conoscenti, MD|1-877-XERIS-37|Clinicaltrials@xerispharma.com|
20571477|NCT01424813|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20571478|NCT05899413|University of California, San Francisco|Dr. Yoobin Park|6289461325|yoobin.park@ucsf.edu|
20571479|NCT01555489|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
20571480|NCT07149155|Dell Medical School, The University of Texas at Austin|Project Coordinator|NA|SFA@austin.utexas.edu|
20571481|NCT03345576|Richmond VAMC|Ashraf S. Gorgey|8046755000|ashraf.gorgey@va.ogv|3386
20571482|NCT04854850|University of Pittsburgh|Robyn T. Domsic|412-383-8000|rtd4@pitt.edu|
20546689|NCT01077154|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20508500|NCT03407170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546690|NCT02207946|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20546691|NCT02545543|Seqirus|Seqirus Clinical Trial Disclosure Lead|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20546692|NCT05744258|UZ Brussel|prof. dr. Sebastien Kindt|+32 2 477 60 11|sebastien.kindt@uzbrussel.be|
20546693|NCT04675151|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
20546694|NCT04035486|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20546695|NCT03947684|UT southwestern medical center|Dr. Yasin Dhaher|2146450064|yasin.dhaher@utsouthwestern.edu|
20556004|NCT01904448|University of North Carolina at Chapel Hill|Craig A. Buchman, MD, FACS|314-362-7395|buchmanc@wustl.edu|
20556005|NCT01556438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556006|NCT03819491|Consult Med Iasi|Dr. Delia Reurean-Pintilei|+40232233387|drdeliapintilei@gmail.com|
20556007|NCT01506193|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556008|NCT01388816|Proprietary Products, Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD|609-375-9855|kallenby@drreddys.com|
20556009|NCT03206203|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20556010|NCT03160027|University of California, San Francisco & San Francisco VA Medical Center|Dr. Linda Chao|14152214810|linda.chao@ucsf.edu|24386
20556011|NCT01386528|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20556012|NCT01798550|Emory University|Christine Kempton MD, MSc|404-778-1900|ckempto@emory.edu|
20556013|NCT01953081|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
20556014|NCT01687257|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20556015|NCT03776136|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20556016|NCT02258477|University of Colorado, Anschutz Health and Wellness Center|Dr. James Hill|303-724-9974|james.hill@ucdenver.edu|
20556017|NCT01839734|The Ruth M. Rothstein CORE Center|Dr. Gregory Huhn|312-572-4575|ghuhn@cookcountyhhs.org|
20556018|NCT05245864|UAMS|Arny A. Ferrando|501-526-5711|AFerrando@uams.edu|
20556019|NCT00184548|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20556020|NCT00160680|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20556021|NCT00985725|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20556022|NCT02216123|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556023|NCT05159622|George Washington University|Uriyoan Colon-Ramos|202994 1899|uriyoan@gwu.edu|
20556024|NCT03643952|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556025|NCT01358968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556026|NCT00487162|UMDNJ-NJMS|J. Jeffrey Freda, MD, MBA|973 972-5007|jjfreda@umdnj.edu|
20556027|NCT00815295|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
20508501|NCT00587834|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
20546696|NCT02104739|The University of Texas Health Science Center at Houston|Absalon D Gutierrez, MD|(713) 500-6641|Absalon.D.Gutierrez@uth.tmc.edu|
20546697|NCT05772702|Pulvinar Neuro|Dr. Christopher Walker|8043173403|chris.walker@pulvinarneuro.com|
20546698|NCT00884377|Walter Reed Army Medical Center|Dr. Naomi Aronson, Principal Investigator|202-782-8691|naronson@usuhs.mil|
20546699|NCT02352922|Center for Advanced Gynecology, PLLC|Dr. Kenneth I Barron|5088876896|kenneth.barron.md@gmail.com|
20546700|NCT04300751|University of Kentucky|Director for the Center on Drug and Alcohol Research|859-257-6485|Sharon.Walsh@uky.edu|
20546701|NCT05033002|Duke University School of Nursing|Michael Relf, Ph.D.|919-684-9219|michael.relf@duke.edu|
20546702|NCT02311582|Washington University School of Medicine|Milan G. Chheda, M.D.|314-747-2712|mchheda@wustl.edu|
20546703|NCT05204381|University of North Carollina at Chapel Hill|Zachary Stewart|919-966-9929|zachary_stewart@med.unc.edu|
20546704|NCT04214288|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20546705|NCT00807027|GREEN CROSS CELL|CRA of Clinical Trial|82-2-2101-0665|a1pole@greencrosscell.com|665
20546706|NCT03997383|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20546707|NCT00924781|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20546708|NCT00708201|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20546709|NCT00761748|Coloplast A/S|Director of Medical Outcome||dkbir@coloplast.com|
20546710|NCT02554279|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20546711|NCT00812487|Ohio State University|Kathleen Dungan, MD, MPH|614-685-3333|kathleen.dungan@osumc.edu|
20546712|NCT01995045|Emory University|Dr. Timothy Olsen|404-778-4996|tolsen@emory.edu|
20546713|NCT02757950|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
20546714|NCT03398278|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
20546715|NCT01117792|Boston Scientific|Tom Stoltz, Clinical Trial Manager|1-800-227-3422|thomas.stoltz@bsci.com|
20546716|NCT00274924|ECOG Statistical Office|Study Statistician|617-632-3012||
20546717|NCT01055496|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546718|NCT00584740|Novartis|Study Director|862-778-8300||
20546719|NCT01698710|Massachusetts General Hospital|Dr. William Brugge|6173083532|Brugge.William@mgh.harvard.edu|
20546720|NCT01673282|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20546721|NCT03485495|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20546722|NCT02915874|University of Iowa|Jess G Fiedorowicz, MD, PhD|319-384-9267|jess-fiedorowicz@uiowa.edu|
20546723|NCT01325792|W. L. Gore & Associates, Inc., Sponsor|Lori Norton, PhD|800-437-8181|lnorton@wlgore.com|
20546724|NCT05318183|The Ohio State University|Richard Bruno|614.292.5522|bruno.27@osu.edu|
20546725|NCT03681288|PROVIDENCE VAMC/ BROWN UNIVERSITY|Erica Eaton, Ph.D.|14012737100|erica_eaton@brown.edu|13428
20546726|NCT02751931|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
20546727|NCT03615508|Denver Health|Dr. Ifantides|303-602-0156|cristos.ifantides@dhha.org|
20546728|NCT03473548|Washington University|Dr. David Leonard|314-454-6162|dsleonard@wustl.edu|
20546729|NCT02233478|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|61987
20556028|NCT03252587|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20556029|NCT00789438|Institut für Anästhesiologie und Operative Intensivmedizin, Universitätsklinukum Schleswig-Holstein, Campus Kiel|Christoph Ilies M.D.|+49-431-597|christoph.ilies@anaesthesie.uni-kiel.de|2991
20556030|NCT05130970|CSL Behring LLC|Trial Registration Coordinator|610 878 4000|clinicaltrials@cslbehring.com|+1
20556031|NCT01640808|Pharmaceutical Division, Clinical Administration Dept.|Administrator of clinical trial information||ctrdinfo@kowa.co.jp|
20556032|NCT03896035|VANTHCS|Una Makris, MD (PI)|2148570240|una.makris2@va.gov|
20556033|NCT00743366|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|reslabsurc@gmail.com|
20556034|NCT03998618|Indiana University|Dr. Catherine Mosher|317-274-6769|cemosher@iu.edu|
20556035|NCT02308748|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
20556036|NCT00675766|West Los Angeles Veterans Association|Dr. Charles Hinkin|310-478-3711|chinkin@ucla.edu|44214
20556037|NCT01749982|Columbia University|Megan N Hall|212-305-3161|mh2825@columbia.edu|
20556038|NCT01625221|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
20556039|NCT01988779|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
20556040|NCT00377403|Washington University in St Louis|Jane Garbut,MD|314-454-8613|jgarbutt@dom.wustl.edu|
20556041|NCT01284426|Division of Allergy and Immunology, Department of Pediatrics, Siriraj Hospital, Mahidol University|Professor Orathai Jirapongsananuruk, Director of Clinical Trials|024197000|siojr@mahidol.ac.th|
20556042|NCT00417079|sanofi-aventis|International Clinical Development Study Director||GV-Contact-us@sanofi-aventis.com|
20556043|NCT00694603|Massachusetts General Hospital|Dr. Lecia Sequist|617-724-4000|lvsequist@partners.org|
20556044|NCT00969501|Georgia Institute for Clinical Research, LLC|Arnold Weil, MD|770-421-2030|research@lowbackpain.com|
20556045|NCT01922076|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20556046|NCT01022762|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20556047|NCT00802074|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
20556048|NCT00827918|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556049|NCT02979262|Yale University Child Study Center|Dr. Carla Stover|2037853486|carla.stover@yale.edu|
20556050|NCT03743038|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20556051|NCT01565707|Astellas Pharma Europe B.V.|Medical Director, Medical Science - Urology||Astellas.resultsdisclosure@astellas.com|
20556052|NCT05207813|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20556053|NCT00617344|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
20546730|NCT01986933|Chugai Pharmaceutical|Clinical trials information||clinical-trials@chugai-pharm.co.jp|
20546731|NCT00811642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20546732|NCT06432088|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20546733|NCT01006603|AstraZeneca|Boaz Hirshberg , MSD||ClinicalTrialTransparency@astrazeneca.com|
20546734|NCT06661954|University of Alabama at Birmingham|Rachel Cowan, PhD|205-934-5034|recowan@uabmc.edu|
20546735|NCT02964078|Moffitt Cancer Center|Jad Chahoud MD, MPH|813-745-6926|Jad.Chahoud@moffitt.org|
20546736|NCT01892722|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20546737|NCT04153149|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20546738|NCT02003365|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20546739|NCT00625742|University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Med||CR_Study_Registration@mdanderson.org|
20546740|NCT02316548|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
20546741|NCT00371761|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20546742|NCT00334074|Baylor University Medical Center|Dr. Edward Agura|214-818-8472|Sandyli@baylorhealth.edu|
20546743|NCT02607514|Massachusetts General Hospital|Maren Nyer|6072796290|mnyer@partners.org|
20546744|NCT05171816|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20546745|NCT02937571|Memorial Sloan Kettering Cancer Center|Dr. Neha Korde, MD|646-608-3708|korden@mskcc.org|
20546746|NCT03675321|Medical College of Wisconsin|Clinical Research Manager|4142666131|ksiegel@mcw.edu|
20546747|NCT04391569|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20546748|NCT04641221|Butler Hospital|Lisa Uebelacker, PhD|401-455-6381|luebelacker@butler.org|
20546749|NCT00997113|Minneapolis Medical Reseach Foundation|James Miner|6128738791|miner015@umn.edu|
20546750|NCT06165627|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20546751|NCT00219544|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20546752|NCT01163032|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
20546753|NCT01464723|University of California San Diego Shiley Eye Center|Dr. Stuart Brown|(858) 822-2585858-246-0814|sibrown@ucsd.edu|
20546754|NCT01683825|Brigham and Women's Hospital|Sharmila Dorbala, Director Nuclear Cardiology|617-732-6290|sdorbala@bwh.harvard.edu|
20546755|NCT03624517|Medical University of South Carolina|Dr. Don Rockey|(843) 792-6982|rockey@musc.edu|
20546756|NCT04030026|Trevi Therapeutics, Inc.|Thomas Sciascia, MD, Chief Scientific Officer|203-304-2499|info@trevitherapeutics.com|
20546757|NCT04155567|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20546758|NCT03764033|San Francisco VA Health Care System|Shira Maguen, PhD|415-221-4810|Shira.Maguen@va.gov|22511
20546759|NCT05856760|Travere Therapeutics, Inc.|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
20546760|NCT03375788|Massachusetts General Hospital|Dr. Takara Stanley|617-724-9109|tstanley@mgh.harvard.edu|
20546761|NCT02477696|Acerta Pharma BV|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20546762|NCT07123272|University of Michigan|Anna Kratz|734-647-5982|alkratz@med.umich.edu|
20546763|NCT02278341|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
20546764|NCT04902326|University of Michigan Medical School|Jeffrey Kullgren|734-845-3613|jkullgre@med.umich.edu|
20546765|NCT02397564|University of Louisville|W. James Tidwell|5025831749|wjamestidwell@gmail.com|
20546766|NCT01487577|Children's Hospital of Pittsburgh of UPMC|Randy M. Windreich, MD|412-692-5225|randy.windreich@chp.edu|
20546767|NCT05048082|OncoNano Medicine, Inc|Vice President, Clinical Operations|(682) 285-1411|trials@onconanomed.com|
20546768|NCT00634270|The Univ of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.5140|kcole@uab.edu|
20546769|NCT01479985|Washington University in St. Louis|Dr. Tessa Madden, MD, MPH|314-747-6495|maddent@wudosis.wustl.edu|
20546770|NCT01653782|Karolinska Institute|Dr. Irene Jensen|+46852483218|irene.jensen@ki.se|
20546771|NCT05765227|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20546772|NCT02777749|Columbia University Medical Center|Dr. Matthew Grosso|2123058193|mgrosso13@gmail.com|
20546773|NCT01155479|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546774|NCT02360605|LSUShreveport|Dr. Connie Arnold|318-675-4324|carnol@lsuhsc.edu|
20546775|NCT00689091|University of Michigan|Dr. George A Mashour|734-936-4280|gmashour@med.umich.edu|
20546776|NCT05867342|Stanford University|Peter H. Hwang, MD|(650) 725-6500|hwangph@stanford.edu|
20546777|NCT01721577|Rush University Medical Center|Crista Brawley|312-563-2312|crista_brawley@rush.edu|
20546778|NCT02497976|IC Study LLC|Philip C. Bosch, MD|760 743-3135|pboschmd@gmail.com|
20546779|NCT01410552|LivaNova|Scientific Communication manager|33146013082|Anne.rousseauplasse@sorin.com|
20546780|NCT01277081|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546781|NCT01903525|Scottish Rite for Children|Dr. Shane Miller|469-515-7222|shane.miller@tsrh.org|
20546782|NCT03977454|Yale School of Medicine: Anesthesiology|Jinlei Li, MD, PhD|(203) 785-2802|jinlei.li@yale.edu|
20556054|NCT03591068|Optinose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
20556055|NCT00833638|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556056|NCT00490646|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20556057|NCT01178086|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20556058|NCT02137369|Emory University|Dr. Dunlop|404-727-8969|bdunlop@emory.edu|
20556059|NCT04184791|Feinstein Institute for Medical Research at Northwell|Dr. Ritesh Ramdhani|516-325-7000|rramdhani@northwell.edu|
20556060|NCT01400503|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20556061|NCT00983073|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
20556062|NCT01417026|Children's Hospital of Philadelphia|Robert Schultz, PhD|267-426-7540|schultzrt@email.chop.edu|
20556063|NCT01669122|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556064|NCT02959996|Massachussetts General Hospital|Malavika Prabhu|6177249028|mprabhu@mgh.harvard.edu|
20556065|NCT03762473|University of Alabama at Birmingham|Graham Towns, MD|(205)934-1801|gtowns@uabmc.edu|
20556066|NCT02962908|PepTcell Ltd (trading as SEEK)|Dr Olga Pleguezuelos, Chief Scientific Officer|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
20556067|NCT03543254|St. Olavs Hospital HF|Knut Hagen|+4795401579|knut.hagen@ntnu.no|
20556068|NCT02077166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20556069|NCT01261338|University of Cincinnati|Ronald J. Jandacek, PhD, Principal Investigator|513-558-5492|ronald.jandacek@uc.edu|
20556070|NCT03519854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556071|NCT00234065|Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd.|Masahiko Abe, Director Cardiovascular Projects|+81-6-6943-7722|abems@otsuka.jp|2545
20556072|NCT00126438|GE Healthcare|Jose Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
20556073|NCT01420848|University of São Paulo|Leonice Fumiko Sato Kurebayashi|(5511 991126023)|fumie_ibez@yahoo.com.br|
20556074|NCT05132699|University of Texas Health Science Center at San Antonio|Casey Straud|210-562-6742|straud@uthscsa.edu|
20556075|NCT02899728|Dana- Farber Cancer Institute|Jacob Sands, MD|617-632-6049|Jacob_Sands@DFCI.HARVARD.EDU|
20556076|NCT05557942|Aerovate Therapeutics|Toll Free Number|(888) 373-8110|clinicaltrials@aerovatetx.com|
20556077|NCT00127608|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556078|NCT05520138|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556079|NCT01329029|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20556080|NCT06854601|Pharmasoft|Y.E. Meshcherskiy, Medical Director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
20556081|NCT04133831|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
20556082|NCT00680407|Meda Pharmaceuticals, Inc.|Associate Director, Clinical Research and Operations||michael.purzycki@meda.us|
20556083|NCT01751126|Santen Inc|R&D Quality Manager|4152689199|evelyn.chikere@santen.com|
20556084|NCT01253525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556085|NCT03078270|George Washington University|Daniel Lieberman, M.D.|202-741-2899|dlieberman@mfa.gwu.edu|
20556086|NCT00447057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556087|NCT00440531|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20556088|NCT00385580|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20556089|NCT00677833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556090|NCT02606279|Wake Forest University Health Sciences|Katherine Schafer, Assistant Professor Internal Medicine|13367166342|kschafer@wakehealth.edu|336
20556091|NCT00746122|Imperial College London|Professor Janet Powell|44-2033117312|j.powell@imperial.ac.uk|
20556092|NCT02184611|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20556093|NCT04493216|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20556094|NCT02172755|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
20556095|NCT00993655|Canadian Cancer Trials Group|Senior Biostatistician|6135336430||
20556096|NCT03151005|Department of Endocrinology, Xinqiao Hospital, Army Military Medical University|Min Long, MD|023-68763255|longmin_casper@163.com|
20556097|NCT03318523|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20556098|NCT02858050|Saint Michael's Medical Center|Jihad Slim, MD|9738772663|jsmdsmmc@gmail.com|
20571483|NCT04683627|Noven Pharmaceutical|Robert Kirshoff|5512332668|clinicaltrials@noven.com|
20571484|NCT00282672|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
20571485|NCT02525718|Northwestern Memorial Hospital|Dr. Mohammed Alghoul||malghoul@nm.org|
20571486|NCT06149104|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20571487|NCT05241314|University of Minnesota|Sarah Hoffman|612-625-0606|hoff0742@umn.edu|
20571488|NCT00626197|F. Hoffmann-La Roche Ltd/Genentech Inc.|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20571489|NCT04833127|NYS Psychiatric Institute and Columbia University|Dr. Susie Hoffman|718 744 7686|sh51@cumc.columbia.edu|
20571490|NCT04339959|University of New Mexico|Dr. Cindy Blair|15059257907|CiBlair@salud.unm.edu|
20571491|NCT04335591|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20571492|NCT05282121|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571493|NCT05530577|University of Southern California|Christian Hendershot, PhD|323-442-1082|christian.hendershot@usc.edu|
20571494|NCT00561431|University of Alabama at Birmingham|Ashita Tolwani, M.D.|2059752021|atolwani@uab.edu|
20571495|NCT05467293|Yuyu Pharma, Inc.|Robert Wonsang Yu|+82 2 6972 9062|wsyu@yuyu.co.kr|
20571496|NCT06264128|SleepRes|Bernie Hete|+1 615-921-2406|bhete@sleepres.com|
20571497|NCT01077128|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20571498|NCT00847626|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20571499|NCT02190903|University of Pennsylvania School of Medicine|Mark D Neuman|2157467468|neumanm@mail.med.upenn.edu|
20571500|NCT00384189|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20571501|NCT04546425|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571502|NCT03882177|Johns Hopkins University School of Medicine|Petros C. Karakousis, MD|410-502-8233|petros@jhmi.edu|
20571503|NCT01254552|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
20571504|NCT02979249|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-659-8512|hetanshi.naik@mssm.edu|
20571505|NCT01125046|Northwestern University|Priya Kumthekar, MD||Priya.Kumthekar@nm.org|
20571506|NCT01685229|Acclarent Inc.|Clinical Manager|949-453-6408|PChen126@ITS.JNJ.com|
20571507|NCT01012362|Masonic Cancer Center, University of Minnesota|Dr. Arkadiusz Dudek|651-254-3321|Arkadiusz.Z.Dudek@HealthPartners.com|
20571508|NCT01399697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20571509|NCT02964325|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
20571510|NCT03079284|Maine Medical Center|Dr. Alexa Craig|207-396-7337|craiga@mmc.org|
20571511|NCT03085225|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20571512|NCT00967005|Yale University|Dr. Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
20571513|NCT01371825|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20571514|NCT04606901|Temple University Hospital|Dr. Ellen Hauck|2674438719|ellen.hauck@tuhs.temple.edu|
20571515|NCT04868539|Brigham and Women's Hospital|Dr. Charles Czeisler, Ph.D., M.D.|617-732-4013|cacadmin@partners.org|
20571516|NCT01401153|Research Institute of Child Nutrition|Prof. Dr. Mathilde Kersting|+49-231-792210-18|kersting@fke-do.de|
20571517|NCT05486728|Sunhawk Vision Biotech|President|+886-7-2222660|hjuo@shvbiotech.com|
20571518|NCT01818531|Wake Forest University Health Sciences|Dr. Daryl Henshaw|3367166344|dhenshaw@wakehealth.edu|
20571519|NCT01677767|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20571520|NCT02807272|Kura Oncology Inc.|Clinical Operations|+1 617 588-3755|KO-TIP-004@kuraoncology.com|
20571521|NCT01162863|University of Michigan|Dr. Richard J Saad|734-936-4780|rsaad@umich.edu|
20571522|NCT00588692|Mayo Clinic|Dr. Barry A. Borlaug|507-284-4442|borlaug.barry@mayo.edu|
20546783|NCT04365257|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Chetan Bettegowda|4109558620|cbetteg1@jhmi.edu|
20546784|NCT02129777|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20546785|NCT02301611|Lumabridge, LLC|Marsha Greene|(484) 319-1117|mgreene@lumabridge.com|
20546786|NCT01609478|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
20546787|NCT05040971|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20546788|NCT05622604|Pray.com|Breanne Laird, PhD|9095574002|breanne.laird@pray.com|
20546789|NCT01351896|The Ohio State University Comprehensive Cancer Center|Dr. Kerry Rogers|614-293-3873|Kerry.Rogers@osumc.edu|
20546790|NCT01589770|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|michael.stein@vanderbilt.edu|
20546791|NCT02283177|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20546792|NCT01101191|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
20546793|NCT03761797|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546794|NCT02995369|Montefiore Medical Center|Nuntiya Kakanantadilok|718-405-8057|nkakanan@montefiore.org|
20546795|NCT02387476|FRESCA Medical|Robert Lahaderne|949-542-3535|rlahaderne@frescamed.com|
20546796|NCT00879879|SunCoast CCOP Research Base|Dr. Jeffrey Krischer, Principal Investigator|813-396-9245|ccop@epi.usf.edu|
20546797|NCT00645788|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20546798|NCT00495079|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
20546799|NCT00327470|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546800|NCT02290431|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20546801|NCT02197234|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20546802|NCT03783702|Stanford University School of Medicine|Noel Ayoub|3109407055|nfa@stanford.edu|
20546803|NCT02274038|University of Pennsylvania Perelman School of Medicine|Dr. Sharyn Katz, Principal Investigator|215-662-4000|sharyn.katz@pennmedicine.upenn.edu|
20546804|NCT02361346|Molecular Templates, Inc.|Study Director|512 930-0304|trials@mtem.com|
20546805|NCT01163318|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20546806|NCT03666676|University of Rochester|Dr. Laurel H. Carney|585-276-3948|Laurel_Carney@URMC.Rochester.edu|
20546807|NCT04445792|Duke Clinical Research Institute|Kady-Ann Steen-Burrell, Ph.D.|919-668-8300|kady.ann.steen.burrell@duke.edu|
20546808|NCT03587727|University of Colorado|Yesenia Garcia Reyes|720-777-6984|Yesenia.GarciaReyes@childrenscolorado.org|
20546809|NCT05797974|University of Florida|Dr. Jana Sacco|904-244-7418|Jana.Sacco@jax.ufl.edu|
20546810|NCT05618782|Levicept|Iwona Bombelka|0000000000|info@levicept.com|
20546811|NCT00562627|Baerum Hospital|Ulrich Johannes Spreng|004798499184|ulispreng@hotmail.com|
20546812|NCT00997438|VA Portland Health Care System|Dr. Sonemany Salinthone|5032208262|salintho@ohsu.edu|54394
20546813|NCT04393298|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20546814|NCT04633460|Hospital of the University of Pennsylvania|Payman Zamani|(215) 662-4000|payman.zamani@pennmedicine.upenn.edu|
20546815|NCT03754972|Medical Metrics, Inc|Trevor Grieco|713-850-7500|tgrieco@medicalmetrics.com|247
20546816|NCT04911426|Texas Christian University Institute of Behavioral Research|Dr.Jennifer Pankow|8172577226|j.pankow@tcu.edu|6475
20546817|NCT05128929|Stanford University School of Medicine|Roham Zamanian, MD|650-725-5495|zamanian@stanford.edu|
20546818|NCT02651714|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
20546819|NCT01515540|Northwestern University|Javeria Ali Hashmi|3125037991|j-hashmi@northwestern.edu|
20546820|NCT04704154|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20546821|NCT03469570|Edwards Lifesciences|Edwards Critical Care Clinical Affairs|(949) 250-7169|afmidestudy@edwards.com|
20546822|NCT02604017|AbbVie|Global Medical Services|800-633-9110||
20546823|NCT01634178|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20546824|NCT03115580|Icahn School of Medicine at Mount Sinai|Annapoorna S. Kini, MD|212-241-4181|annapoorna.kini@mountsinai.org|
20546825|NCT00926588|VA HSRD|Dr. Kurt Kroenke|317-988-3476|kkroenke@regenstrief.org|
20546826|NCT00058539|Hoffmann-LaRoche|Medical Communications|: 800-821-8590|genentech@druginfo.com|
20546827|NCT02524977|University of Cincinnati Health|VP Research UC Health|513-558-6937|christopher.lindsell@uc.edu|
20546828|NCT00963677|The Second Xiangya Hospital of Central South University|Ru-Ping Dai, B.Sc(Med), PhD, Associate Professor|86-731-85295970|Ruping_dai@yahoo.com.cn|
20546829|NCT02483533|Neothetics|Director of Clinical Trials|8585501900||
20546830|NCT01112683|University of Colorado School of Medicine|Dr. Alberto Costa|303-724-6007|Alberto.Costa@ucdenver.edu|
20546831|NCT00781508|MetroHealth Medical Center|Robert C. Bahler, MD|216 778-2431|rbahler@metrohealth.org|
20546832|NCT03116347|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20556099|NCT03232983|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20556100|NCT01615328|Seoul National University Bundang Hospital|Jin-Sup Yeom|82-31-787-7190|highcervical@gmail.com|
20556101|NCT02261493|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
20556102|NCT01597050|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20556103|NCT00483184|Nobel Ilac San ve Tic. A.S.|Hasan Zeytin MD., Ph.D.|+90 216 6336012|hasan.zeytin@nobel.com.tr|6012
20556104|NCT01992380|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20556105|NCT02065336|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20556106|NCT01515410|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
20546833|NCT01255787|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20546834|NCT00476047|Fred Hutchinson Cancer Research Ctr|Mazyar Shadman, MD|2066675467|mshadman@fredhutch.org|
20546835|NCT04966741|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20571523|NCT00820170|Memorial Sloan Kettering Cancer Center|Dr. Monica Fornier|646-888-4563|fornierm@mskcc.org|
20571524|NCT03995316|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
20571525|NCT02202785|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20571526|NCT02180243|War Related Illness and Injury Study Center|Matthew Reinhard, PsyD|202-745-8000|matthew.reinhard@va.gov|55785
20571527|NCT01461005|MCRA|Justin Eggleton, Senior Director, Spine Regulatory Affairs|2025525804|jeggleston@mcra.com|
20571528|NCT01436253|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571529|NCT06285240|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20571530|NCT05380362|UBNS|Dr. Ellen Carl|716-218-1000|ecarl@ubns.com|7260
20571531|NCT04844879|Medacta International SA|Medical Affairs Department|+41 91 696 60 60|myclinicaldata@medacta.ch|
20571532|NCT05140915|University of Massachusetts Chan Medical School|Dr. Rajani Sadasivam|(508) 856-8923|rajani.sadasivam@umassmed.edu|
20571533|NCT04520659|Johns Hopkins University Bloomberg School of Public Health|Suzanne Woods, CRNP-P, CCRP, Manager, RSVPeds Team|(443) 813-0697|swoods12@jhu.edu|
20571534|NCT04430439|University of California, Irvine|Karen Lindsay|949-824-0148|kllindsa@hs.uci.edu|
20571535|NCT04485611|Durham VA Health Care System|Dr. Atilio Barbeito, Chief, Anesthesiology Service|(919) 286-6938|atilio.barbeito@va.gov|177150
20571536|NCT04879849|Takeda|Medical Director|+1-877-825-3327|Trialdisclosures@takeda.com|
20571537|NCT03361865|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20571538|NCT03603002|Johns Hopkins University, Department of Radiation Oncology|Dr. K. Ranh Voong|410-550-6597|kvoong1@jhmi.edu|
20571539|NCT03852719|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20571540|NCT04201262|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20571541|NCT05619575|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20546836|NCT03835728|UT Southwestern, Dept of Neurology|Dr. Steven Vernino|214-645-8800|steven.vernino@utsouthwestern.edu|
20546837|NCT03964337|Duke University|Michael Harrison, M.D.|919-668-8108|michael.harrison@duke.edu|
20546838|NCT03160859|Veterans Administration Greater Los Angeles Healthcare System|Felix W. Leung, M.D, Staff Gastroenterologist|818-891-7711|felix.leung@va.gov|32520
20546839|NCT02241889|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
20546840|NCT00773838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546841|NCT02502006|University of Pennsylvania|Katherine N. Theken, PharmD, PhD|2158987470|ktheken@upenn.edu|
20546842|NCT00509262|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546843|NCT01853618|National Cancer Institute|Dr. Tim F. Greten|(301) 451-4723|tim.greten@nih.gov|
20546844|NCT00558571|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546845|NCT02398227|University of Akron|Dawn M Johnson, Ph.d|3309722505|johnsod@uakron.edu|
20546846|NCT01715129|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20546847|NCT02009384|University of Louisville|Jason Chesney|502-562-3429||
20546848|NCT01146860|ENT practice|Dr. Rainer Jund, Specialist in Otorhinolaryngology|+49 89 804880|RainerJund@gmx.de|
20546849|NCT01092832|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20546850|NCT02674854|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
20546851|NCT03149848|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20546852|NCT00400153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257 Option 4|clintriage.rdg@boehringer-ingelheim.com|
20546853|NCT00330161|University of Michigan Comprehensive Cancer Center|Erin Sargent|(734) 936-3348|esargent@umich.edu|
20546854|NCT00002975|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20546855|NCT04738318|Vanderbilt University Medical Center|Dr. Jed Maslow|615-936-7846|jed.i.maslow@vumc.org|
20546856|NCT01226121|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|3178759105|tdk@hand.md|
20546857|NCT04231981|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
20546858|NCT00378079|Friends Research Institute|Dr. Timothy Kinlock|(410) 837-3977|tkinlock@friendsresearch.org|224
20546859|NCT02581943|Wake Forest Baptist Comprehensive Cancer Center|Assistant Director of Clinical Research Operations|336-713-6913|mebrown@wakehealth.edu|
20546860|NCT01233687|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
20546861|NCT00432601|VA HSRD|Dr. Angela Fagerlin|801-587-1694|angie.fagerlin@hsc.utah.edu|
20546862|NCT00829985|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20546863|NCT04473482|University of Michigan|Jessica Mellinger|734-232-0284|jmelling@umich.edu|
20546864|NCT03122301|Northwestern Medicine|David Walega, MD|13129271345|d-walega@northwestern.edu|
20546865|NCT00453388|Fred Hutchinson Cancer Research Center|Dr. Hans-Peter Kiem|206-667-4425|hkiem@fredhutch.org|
20546866|NCT00745615|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20546867|NCT00570232|University of Alabama at Birmingham|Eben Rosenthal,MD|2059349713|erosenthal@uabmc.edu|
20546868|NCT01076075|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546869|NCT03114059|Dietrich-Bonhoeffer-Klinikum|Ahmed Medra|+49 395 775 13483|a.medra@live.com|
20546870|NCT04466228|University of California, San Francisco|Wan-Yu Hsu|+14153531140|wanyuhsu3@gmail.com|
20546871|NCT05038904|Johns Hopkins University School of Medicine|Melanie C. Dispenza, MD, PhD|410-550-2301|mdispen1@jhmi.edu|
20546872|NCT01445886|Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Keelung, Taiwan|Yin-Ku Lin|886-2-2431-3131|lin1266@adm.cgmh.org.tw|2127
20546873|NCT01602666|Children's Oncology Group|Results Reporting Coordinator|626 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20546874|NCT03576274|Johns Hopkins School of Nursing|Dr.Nada Lukkahatai,|410-614-5297|nada.lukkahatai@jhu.edu|
20546875|NCT02935543|Univ. of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20546876|NCT03387150|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20546877|NCT04078178|MGH|Kayla McEachern|617-643-5265|kmceachern2@mgh.harvard.edu|
20546878|NCT04006119|Alaunos Therapeutics, Inc|Jaymes Holland, Clinical Consultant|6502732627|jholland@alaunos.com|
20546879|NCT04617795|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20546880|NCT00472459|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20546881|NCT04850313|University of Arkansas for Medical Sciences|Dr. David Warner|501-686-5822|DBwarner@uams.edu|
20546882|NCT04999982|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Andrea Spencer|3122273402|aspencer@luriechildrens.org|
20546883|NCT03269552|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
20546884|NCT02186301|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
20546885|NCT01285947|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20546886|NCT00095238|Britol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20546887|NCT03505671|Wake Forest Baptist Comprehensive Cancer Center|Nancy Avis, PhD|336-713-5440|navis@wakehealth.edu|
20546888|NCT00586729|Maricopa Integrated Health System|Karen Richey, RN|602-344-5125|karen.richey@mihs.org|
20546889|NCT02038829|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20546890|NCT00749580|USF Health|Charurut Somboonwit, MD|813 3078067|csomboon@health.usf.edu|
20546891|NCT05283928|The University of Texas Health Science Center at Houston|Popi Stylianou, DDS,MS|713-486-4048|Popi.Stylianou@uth.tmc.edu|
20546892|NCT05803603|University of Maryland School of Social Work|Jay Unick|410-706-3735|junick@ssw.umaryland.edu|
20546893|NCT03544775|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20546894|NCT06460493|Verona Pharma|Clinical Development|844-341-9901|clinicaltrials@veronapharma.com|
20546895|NCT02987660|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20546896|NCT03707184|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|8012136110|sam.mitchell@hci.utah.edu|
20546897|NCT04950608|Dana-Farber Cancer Institute|Dr. Yvan Beaussant|617-582-9318|patresearch@dfci.harvard.edu|
20546898|NCT05007717|University of Washington|Data Analyst|7347809402|wenwenj@uw.edu|
20546899|NCT03553836|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20546900|NCT03220438|University of Maryland Baltimore|Dr Laura Rowland|410-402-6073|lrowland@som.umaryland.edu|
20546901|NCT04062123|University of Pittsburgh|Keith Vogt, MD, PhD|4126473147|vogtkm@upmc.edu|
20546902|NCT04111939|RTI International|Charles Knott|9195416294|cknott@rti.org|
20546903|NCT02339376|Beth Israel Deaconess Medical Center|Bernard S. Chang, M.D.|617-632-8930|bchang@bidmc.harvard.edu|
20546904|NCT04626310|University of Massachusetts Amherst|Katherine Dixon-Gordon, PhD|413-545-0226|katiedg@umass.edu|
20546905|NCT01850602|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20571542|NCT01647542|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20546906|NCT00367770|Actelion Pharmaceuticals Ltd.|Loïc Perchenet, Head of Global Post-Approval Studies|+41 61 565 64 57|loic.perchenet@actelion.com|
20546907|NCT01315236|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
20546908|NCT00287079|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20546909|NCT01778179|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|doris@hexsel.com.br|
20546910|NCT01282203|AbbVie (prior sponsor Abbott)|Global Medical Services|1-800-633-9110||
20546911|NCT03282565|University of Michigan|Dr. Riann Palmieri-Smith|734-615-3154|riannp@umich.edu|
20546912|NCT00740051|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20546913|NCT02011893|St. Jude Medical|Roni Diaz, Director Clinical Studies|972-309-8601|RDiaz@sjm.com|
20546914|NCT00930982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20546915|NCT00991952|Memorial Sloan-Kettering Cancer Center|Dr. Yelena Janjigian|646-888-4186|janjigiy@mskcc.org|
20546916|NCT00518973|UCSD Eating Disorders Treatment and Research Center|Walter H. Kaye|858-534-3951|wkaye@ucsd.edu|
20546917|NCT03452527|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
20546918|NCT00582816|University of Wisconsin Carbone Cancer Center|Dr. Ken DeSantes|608-263-8563|kbdesantes@pediatrics.wisc.edu|
20546919|NCT03239665|Rutgers University Center for Health Outcomes, Policy, & Economics|Laura T. Pizzi, PharmD, MPH|8484456825|laura.pizzi@rutgers.edu|
20546920|NCT01931709|University of Washington|Jennifer Specht, MD|206-288-6889|jspecht@uw.edu|
20546921|NCT01565499|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20546922|NCT03170232|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20546923|NCT01658813|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
20546924|NCT00618839|Stratatech Corporation|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
20546925|NCT00722371|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556107|NCT04235036|The Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
20556108|NCT00989768|Brazilian Center for Studies in Dermatology|Juliana de Souza|+55 51 3026 2633|pesquisa@cebd.org.br|
20556109|NCT02192502|Cleveland Clinic|Dr. Andra Duncan|216-538-6944|duncana@ccf.org|
20556110|NCT01381692|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20556111|NCT04575467|Caliway Biopharmaceuticals Pty Ltd|Candra Chou|886226971355|candra.chou@caliway.com|1317
20556112|NCT01994954|University of Massachusetts Medical School|Dr. Lawrence Rhein|508-334-6206|Lawrence.Rhein@umassmemorial.org|
20556113|NCT00449176|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20556114|NCT02576678|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20556115|NCT02472964|Mylan Inc|Clinical Program Manager|412-651-9530|gail.tribble@mylan.com|
20556116|NCT02045238|Hospital Universitario - Sao Paulo University|Dr. Mateus Deckers Leme|X551130919200|mateusdl@gmail.com|9451
20556117|NCT01454583|Foundation Stiftung Institut fuer Herzinfarktforschung Ludwigshafen, Germany|Professor Dr. Uwe Zeymer|+49 621 503 2813|Uwe.Zeymer@t-online.de|
20556118|NCT04434560|Duke University|Sarah Sammons, MD|919-684-4563|sarah.sammons@duke.edu|
20556119|NCT01967732|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20556120|NCT00452387|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20556121|NCT04403698|Study Principal Investigator Ghent Universitary Hospital|Prof. dr. Ruth Wittoek|+329 332 25 20|Ruth.Wittoek@Ugent.be|
20556122|NCT00977665|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20556123|NCT01181050|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
20556124|NCT01018394|Mayo Clinic|Dr. Jon Ebbert|507-266-1944|nicotineresearch@mayo.edu|
20556125|NCT03792126|University Hospitals Dorset NHS Foundation Trust|Louise Johnson|0300 019 4473|Louise.Johnson@uhd.nhs.uk|
20556126|NCT00683644|University of Iowa|richard tyler|319 356 2471|rich-tyler@uiowa.edu|
20556127|NCT04322682|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514 376-3330|jean-claude.tardif@icm-mhi.org|3612
20556128|NCT01027000|Dana Farber Cancer Institute|Edwin P. Alyea, MD||edwin_alyea@dfci.harvard.edu|
20556129|NCT04123067|Penn State Hershey Medical Center|Dr. Kerstin Bettermann|717-531-1803|kbettermann@pennstatehealth.psu.edu|
20556130|NCT02238379|Yale University|Dr. Helena Rutherford|203-737-3408|helena.rutherford@yale.edu|
20556131|NCT00441090|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20556132|NCT01441102|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
20556133|NCT03085485|University of Alabama at Birmingham|Bo Liu|(205) 975-7868|boliu@uabmc.edu|
20556134|NCT00605280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556135|NCT01302119|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
20556136|NCT01662882|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20556137|NCT01775904|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556138|NCT00518115|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556139|NCT02235493|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
20556140|NCT01055769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556141|NCT01662310|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20556142|NCT01212770|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20556143|NCT02243943|LUMC|Prof Dr A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
20556144|NCT00829387|VA Connecticut Healthcare System|Rebecca Czlapinski|203-932-5711|rebecca.czlapinski@va.gov|3357
20556145|NCT03036163|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
20556146|NCT00707031|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20556147|NCT02747238|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
20556148|NCT00541450|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||clinicaltrialsdisclosure@spcorp.com|
20556149|NCT03195010|FHCRC|Dr Bethany Samuelson Bannow|5034949925|samuelsb@ohsu.edu|
20556150|NCT02680054|Oxford University Hospitals NHS Trust|Dr Rachel Besser|01865 741741|rachel.besser@ouh.nhs.uk|
20556151|NCT02626780|The GID Group|Director of Clinical Affairs|3039524901|GIDAA-01@thegidgroup.com|
20556152|NCT04304833|University of Arkansas for Medical Sciences|Judith Weber|5012961982|weberjudithl@uams.edu|
20556153|NCT01951625|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20556154|NCT01116934|JWGUniversity|Prof. Dr. Peter Eickholz|+49-69-6301|eickholz@med.uni-frankfurt.de|5642
20556155|NCT00613951|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20556156|NCT01437449|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
20556157|NCT00655980|University of Chicago Medicine|Principal Investigator|7737022544||
20556158|NCT01367262|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556159|NCT02858895|Medicenna Therapeutics Inc|Rosemina Merchant - Chief Development Officer|604-340-3081|nmerchant@medicenna.com|
20556160|NCT05540522|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556161|NCT03163758|Peking Union Medical College Hospital|Dr. Weihong Zhang|01069159581|ZhangWeiHong@pumch.cn|
20556162|NCT03754803|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20556163|NCT05338333|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20556164|NCT04951336|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
20556165|NCT04348604|Case Western Reserve University|Joy Yala, Data Manager|216-368-0783|jxy790@case.edu|
20556166|NCT02097108|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
20556167|NCT06675500|Ain Shams University|Dr.Sarah Elghareeb,lecturer of Anesthesia and ICU|+201012434690|Sarahhamdy@med.asu.edu.eg|
20556168|NCT01475136|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556169|NCT03962894|University of Florida|Jennifer Fishe|904-244-4046|Jennifer.Fishe@jax.ufl.edu|
20556170|NCT00506493|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
20556171|NCT04171102|University of Cagliari|Prof. Dr. Giuseppe Amato|337963197|amatomed@gmail.com|
20556172|NCT01712009|Amgen Inc.|Study Director|866-572-6436||
20556173|NCT00265980|Professor of Pediatrics and Medicine at the Columbia University|Michael Rosenbaum, MD|212-305-9949|mr475@cumc.columbia.edu|
20556174|NCT04050865|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
20556175|NCT00857207|Malcom Randall VAMC|Julia Kay Waid-Ebbs, Health Science Specialist|352-871-0282|Julia.Waid-Ebbs@va.gov|
20556176|NCT01332227|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20556177|NCT01100255|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
20556178|NCT03751631|Eyenovia, Inc.|VP, Development|714-269-8838|gclasby@eyenoviabio.com|
20556179|NCT03073148|Tangible Science|Director of Research and Development|650-241-1045|kelly@tangiblescience.com|108
20556180|NCT02822222|RMJ Holdings LLC d/b/a RMJH Rx|Russell Jaffe, M.D., Chief Executive Officer|(703) 840-4440|rjaffe@rmjholdings.com|
20556181|NCT01143688|National Jewish Health|Michael E. Wechsler M.D.|617-285-4987|wechslerm@NJHealth.org|
20556182|NCT00428090|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556183|NCT00361140|Moffitt Cancer Center|Dr. Teresa Field|(813) 745-7202|Teresa.Field@moffitt.org|
20556184|NCT02690974|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20556185|NCT05276830|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
20556186|NCT05090709|Edinburgh Napier University|Dr Rebecca Hamilton|0131455|rebeccaisabel.hamilton@napier.ac.uk|2350
20556187|NCT01922115|UNC Chapel Hill|Dr. Elizabeth Geller|919-966-4717|elizabeth_geller@med.unc.edu|
20556188|NCT04977050|University of New Mexico|Dr. Akshay Sood|505-272-4751|ASood@salud.unm.edu|
20556189|NCT00863655|Novartis Pharmaceuticals|Study Director|862-778-8300||
20556190|NCT02548455|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
20556191|NCT00530855|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20556192|NCT01627327|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556193|NCT04294966|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20556194|NCT01137474|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
20556195|NCT03901326|People's Liberation Army General Hospital|Dr Junjie Yang|13581662680|fearlessyang@126.com|86
20556196|NCT02525874|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20556197|NCT01692782|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20556198|NCT02161133|Veterans Affairs New Jersey Healthcare System|Lisa McAndrew|862-400-3317|lisa.mcandrew@va.gov|
20556199|NCT03945188|Arena Pharmaceuticals, a wholly owned subsidiary of Pfizer|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20556200|NCT02081573|University of Pittsburgh School of Nursing|Judith A. Callan|412-383-5321|callanja@pitt.edu|
20556201|NCT00423176|Merck, Sharp & Dohme Corp.|Senior Vice Presdient, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20556202|NCT05554237|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556203|NCT02477111|Cordis, A Cardinal Health Company|Jennifer Lee, Clinical Project Manager|669-699-6851|jennifer.lee02@cordis.com|
20556204|NCT01328574|National Cancer Institute|Dr. Andrea Apolo|301-451-1984|apoloab@mail.nih.gov|
20556205|NCT01152580|Duquesne University|Dr. Paula Witt-Enderby, Professor of Pharmacology and Toxicology|412-396-4346|wittp@duq.edu|
20556206|NCT01570829|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20556207|NCT03028974|Stanford University|Cornelia Dekker, MD|650-724-4437|cdekker@stanford.edu|
20556208|NCT02654808|Columbia University|Dr. Timothy Ryntz|212-305-4973|ter2111@cumc.columbia.edu|
20508502|NCT00126672|Dana-Farber Cancer Institute|Dabora Sandra L MD|(617) 732-5500|sandy.dabora@gmail.com|
20508503|NCT01001234|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508504|NCT00125372|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@hitchcock.org|
20508505|NCT01851863|Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, China|Sheng-Liang Chen, MD|86-21-58752345|slchenmd@hotmail.com|
20508506|NCT02076334|University University Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu|
20508507|NCT03379376|Wake Forest University Health Sciences|Meg O'Mara - Study Coordinator|336-716-5440|megreen@wakehealth.edu|
20508508|NCT01611298|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
20508509|NCT00753623|MGH Center for Translational Pain Research|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org|
20508510|NCT00996593|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508511|NCT00871572|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508512|NCT02026206|Pusan Natinal University Yangsan Hospital|Professor Yong-Il Shin|82-55-360-2872|rmshin01@gmail.com|
20508513|NCT00735670|University of Michigan Spinal Cord Injury System|Dr. Denise G Tate|734 763-0971|dgtate@umich.edu|
20508514|NCT01686958|Profound Medical|Mathieu Burtnyk|647-476-1350|mburtnyk@profoundmedical.com|408
20508515|NCT02486367|University Hospitals Cleveland Medical Center|Dr. David Zidar|216-791-3800|daz21@case.edu|
20508516|NCT04197986|QED Therapeutics, Inc.|Acting Chief Medical Officer|1-877-280-5655|Proof302.ct@qedtx.com|
20508517|NCT01078558|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20508518|NCT00411086|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20508519|NCT04294095|Colorado School of Public Health|Jenn Leiferman|303-724-4386|jenn.leiferman@cuanschutz.edu|
20508520|NCT00992602|University of Washington|Maciej M. Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
20508521|NCT02629614|Cala Health|Sr. Director of Clinical Operations|6506515296|vivien@calahealth.com|
20546926|NCT01075191|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20508522|NCT02224638|Swedish Covenant Hospital|Nancy Chaiken|847-372-3500|nchaiken@comcast.net|
20508523|NCT01406652|Geneva University Hospitals|Dr.med Ilker Uçkay|+412237123311|ilker.uckay@hcuge.ch|
20508524|NCT01230749|Janssen R&D US|Director, Translational Medicine|1 908 927-7881||
20508525|NCT03366844|Cedars-Sinai Medical Center|Stephen Shiao, MD, PhD|310-423-2836|Stephen.Shiao@cshs.org|
20508526|NCT01060098|Imperial College London|Sonya Abraham|+44 (0)20 3313 4114|s.abraham@imperial.ac.uk|
20508527|NCT02480998|The catholic university of Korea, Seoul ST. Marry's Hospital|Dr.Dong-suck Lim, CI|+82-2-2258-7327||
20508528|NCT02687711|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20508529|NCT00191386|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508530|NCT03077243|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
20508531|NCT03984812|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508532|NCT01826448|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20508533|NCT04038385|William Paterson University, Sociology Department|Jennifer Di Noia, PhD, Principal Investigator|19737203714|dinoiaj@wpunj.edu|
20508534|NCT05302804|University of Montana|Dustin Slivka|(406) 243-2389|dustin.slivka@umontana.edu|
20508535|NCT02971007|Matinas Biopharma|Director Clinical Development|9082953235|jjohnson@matinasbiopharma.com|
20508536|NCT01807611|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|866-278-5833|referralinfo@stjude.org|
20508537|NCT02038790|Indivior, Inc.|Global Director Clinical Development|804-379-1090||
20508538|NCT02431793|Northwestern University|Dr. Danielle McCarthy|312-926-7532|d-mccarthy2@northwestern.edu|
20508539|NCT01818986|University of Texas Southwestern Medical Center Dallas|Dr. Raquibul Hannan|214-645-7696|raquibul.Hannan@UTSouthwestern.edu|
20546927|NCT00133978|Clinical Evaluation Research Unit|Dr. Daren Heyland|613-549-6666|dkh2@queensu.ca|4847
20508540|NCT02286726|The University of Texas MD Anderson Cancer Center|Ghayas Issa C. MD./Assistant Professor|713-745-6798|GCIssa@mdanderson.org|
20508541|NCT02683707|JohnsHopkinsU|Dr J William McEvoy|4109555000|jmcevoy1@jhmi.edu|
20508542|NCT03537092|University Of Pittsburgh|Leslie Meyn, PhD|412-641-4233|meynla@mwri.magee.edu|
20508543|NCT03170258|Duke University|R. Alison Adcock, MD, PhD|919-681-7486|alison.adcock@duke.edu|
20546928|NCT00718237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20546929|NCT02128100|University of Louisville|Dr. Neal Dunlap|502-561-2700|neal.dunlap@louisville.edu|
20546930|NCT02635646|University of Guanajuato|Dr. Rodolfo Guardado-Mendoza||guardamen@gmail.com|
20546931|NCT00913692|National Institute of Allergy and Infectious Diseases, Laboratory of Infectious Diseases|Jeffrey I. Cohen, MD|(301) 496-5265|jcohen@niaid.nih.gov|
20546932|NCT03769376|"University of Colorado Denver | Anschutz"|Kerri Font, DDS, MS|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20546933|NCT01486810|New York Psychiatric Institute|Dr. John Mariani|646-774-8181|John.mariani@nyspi.columbia.edu|
20546934|NCT00971620|National Cancer Institute|Dr. Edward Cowen|301-496-4299|cowene@mail.nih.gov|
20546935|NCT01423604|Incyte Corporation|Study Director|1-855-463-3463||
20508544|NCT01333098|Washington University School of Medicine|Eric Lenze, MD|314-362-5154|lenzee@wustl.edu|
20546936|NCT03324581|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20546937|NCT01120834|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
20556209|NCT00113568|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20508545|NCT01391468|China Medical University|II-Kuan Wang|88975681050|ikwang@seed.net.tw|
20508546|NCT00063986|ECOG Statistical Office|Study Statistician|617-632-3012||
20556210|NCT01680848|Dental PBRN Japan|Director of the Dental PBRN Japan|+81-93-285-3022|info@dentalpbrn.jp|
20546938|NCT00586664|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
20546939|NCT04856865|Alladapt Immunotherapeutics|Chief Medical Officer|650-420-3900|info@alladapt.com|
20546940|NCT04721067|Indiana University|Dr. Samir K. Gupta|3172747926|sgupta1@iu.edu|
20546941|NCT02625389|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20546942|NCT03070444|Folktandvården Gävleborg AB|Anke Krämer|+4625155680|anke.kramer@regiongavleborg.se|
20546943|NCT01373489|Medical College of Wisconsin|Jennifer Campbell|4149558829|jacampbell@mcw.edu|
20546944|NCT04285580|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20546945|NCT02582255|FIDEC|Ricardo Rüttimann|+13058540075|rruttimann@fidec-online.org|
20546946|NCT04854642|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20546947|NCT00847171|Johns Hopkins University|Dr. Leisha Emens||emensle@jhmi.edu|
20546948|NCT04509739|University of Washington|Christina Zhao|206-221-6415|zhaotc@uw.edu|
20546949|NCT01709578|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20546950|NCT04050371|UCSF|Robert Grant|415-323-6658|robert.grant@ucsf.edu|
20546951|NCT00597701|Essentia Health|Charles E Gessert, MD, MPH|218-786-8176|cgessert@eirh.org|
20556211|NCT02275065|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20556212|NCT02186210|Seoul National University Hospital Dept of Anesthesiology|Dr Yunseok Jeon|82-2-2072-2465|jeonyunseok@gmail.com|
20556213|NCT01826812|The Wilmer Eye Institute, Johns Hopkins|Dr. Esen K. Akpek|410-955-5214|esakpek@jhmi.edu|
20556214|NCT01684748|Virginia Polytechnic Institute & State University|Elaina Marinik, Ph.D.|5402318299|emarinik@vt.edu|
20556215|NCT01955954|Palo Alto Health Sciences, Inc|Debra Reisenthel|9255948404|debra@pahealthsciences.com|
20556216|NCT01921296|University of Michigan Hospital|Dr. Norah Lynn Henry, Associate Professor of Internal Medicine|734-936-4991|norahh@umich.edu|
20546952|NCT01107418|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20546953|NCT00988325|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20546954|NCT01155219|Laboratoires Thea|Dr Pascale Pouliquen|0473981436|p.pouliquen@laboratoires-thea.fr|
20546955|NCT02670343|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Christina Wang, MDAssociate Director UCLA Clinical and Translational Science Institute|1-310-222-1888|wang@labiomed.org|
20546956|NCT01314911|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D|301-451-9881|jbeigel@niaid.nih.gov|
20546957|NCT00306202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20546958|NCT00814879|Yale University School of Medicine: Internal Medicine: Infectious Diseases: AIDS Care Program / Viral Hepatitis Program|Dr. Michael J. Kozal|(203)737-4040|michael.kozal@yale.edu|
20546959|NCT01277042|GlaxoSmithKline|GSK Response Center|866-435-7343||
20546960|NCT01490723|U.T. MD Anderson Cancer Center|Issa F. Khouri, M.D., Stem Cell Transplantation|(713) 745-0049|ikhouri@mdanderson.org|
20546961|NCT03560739|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20546962|NCT01362595|Feinstein Institutes for Medical Research|Dr. Adrianna Vlachos|516-562-1504|avlachos@northwell.edu|
20546963|NCT00959374|Covidien|Amy Pollack M.D. Vice President Medical Affairs, STI|203-821-4719|amy.pollack@covidien.com|
20546964|NCT02448680|LFB USA, Inc.|Kerry Biron, Director US Clinical Operations|508-370-5166|kerry.biron@lfb-usa.com|
20546965|NCT04243421|Medical University of Białystok|Małgorzata Pietruska|+48606461092|mpietruska@wp.pl|
20546966|NCT01741012|Wayne State University School of Medicine|Dr. J. Patricia Dhar, MD, Principal Investigator|313-577-6011|pdhar@med.wayne.edu|
20546967|NCT04123665|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20546968|NCT04396496|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
20546969|NCT01711879|University of Colorado School of Medicine|Rachel Gerle|720-848-2020|rachel.gerle@ucdenver.edu|
20546970|NCT00958789|Stryker Orthopaedics|Ellen Axelson, Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
20546971|NCT02464917|Memorial Health Systems|Michael Nageotte, MD|562-933-2748|mnageotte@memorialcare.org|
20546972|NCT00478881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20546973|NCT01466179|Amgen Inc.|Study Director|866-572-6436||
20546974|NCT03028350|Cumberland Pharmaceuticals|Senior Clinical Scientist|6154257644|bgibson@cumberlandpharma.com|
20546975|NCT01083173|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20546976|NCT03410823|University of Maryland School of Medicine|Denise Orwig|410-706-2406|dorwig@som.umaryland.edu|
20546977|NCT00792077|UT MD Anderson Cancer Center|Sriram Yennu, MD- Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20546978|NCT04565236|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20546979|NCT01041495|SUNY Upstate MEdical Univ|thomas schwartz|3154643166|schwartt@upstate.edu|
20546980|NCT03584373|Montefiore Medical Center|Dr. Kara Watts, Associate Professor, Department of Urology|718-920-4531|kwatts@montefiore.org|
20546981|NCT03780400|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
20546982|NCT00057681|Washington University in St. Louis|Barbara Geller, M.D.|314-747-3657|gellerb@wustl.edu|
20546983|NCT03127956|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20546984|NCT00470184|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20546985|NCT04163822|CHCMU|no sponsor, PI: Yuan Shi|13508320283|shiyuan@hospital.cqmu.edu.cn|
20546986|NCT01923168|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20546987|NCT00768469|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20546988|NCT00957593|Lehigh Valley Health Netword|Joanne N. Quinones MD MSCE|6104021221|joanne_n.quinones@lvhn.org|
20546989|NCT05780268|University of Minnesota|Birgit Grund|612- 626-8622|birgit@ccbr.umn.edu|
20546990|NCT00459056|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20546991|NCT02522871|TransMedics|Laura Damme|978-552-0910|LDamme@TransMedics.com|
20546992|NCT00573287|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|6036507549|alan.i.green@dartmouth.edu|
20546993|NCT01222403|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20546994|NCT00725842|Merck Sharp & Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20546995|NCT00947505|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
20546996|NCT02793622|University of California, San Francisco|Grant Dorsey, MD|628-206-4680|grant.dorsey@ucsf.edu|
20546997|NCT03442400|Cleveland Clinic|Samir Kapadia, MD|216-444-6735|kapadis@ccf.org|
20546998|NCT02068768|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
20546999|NCT01262352|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20547000|NCT01185834|Alcon Research, Ltd.|Sameena Haque-Khan, PhD, BSc(Hons)Optom, MCOptom, FAAO|1-800-241-7629||
20547001|NCT03189381|Indiana University (IU)|Dr. Kevin Shiue|317 944 2524|kshiue@iupui.edu|
20547002|NCT01401959|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20547003|NCT02925793|DS Biopharma|Study Director|+35312933590|regulatory.dsbiopharma@dsbiopharma.com|
20547004|NCT01244490|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20547005|NCT03020446|University of Toledo|Munier Nazzal, MD|419-383-3576|Munier.Nazzal@utoledo.edu|
20547006|NCT01115582|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
20547007|NCT00321893|University of Texas MD Anderson|Powel H. Brown, MD, PhD/Professor of Medicine and Cancer Prevention||CR_Study_Registration@mdanderson.org|
20547008|NCT03455764|Dana-Farber Cancer Institute|Dr. Elizabeth Buchbinder|6176325055|elizabeth_buchbinder@dfci.harvard.edu|
20547009|NCT01585584|University of Calgary|Dr. Samuel Lee|403-220-8457|samlee@ucalgary.ca|
20547010|NCT00686998|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20547011|NCT05985980|Istanbul Medeniyet University|Mehmet Agirbasli MD|+902166065200|agirbasli@gmail.com|
20547012|NCT01394718|Children's Hospital of Philadelphia|Athena Zuppa, MD, MSCE|267-426-7359|zuppa@email.chop.edu|
20547013|NCT04478123|Memorial Sloan Kettering Cancer Center|Dr. Michael Scordo, MD|646-608-3771|scordom@mskcc.org|
20547014|NCT02395016|Biotech Pharmaceutical Co., Ltd.|Director of Clinical Trials|010-51571020|lucy_he@biotechplc.com|8753
20547015|NCT04444895|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20547016|NCT01547780|National Institute of Mental Health|Robert Innis|+1 301 594 1368|innisr@mail.nih.gov|
20547017|NCT00719264|Novartis Pharmaceuticals|Study Director|862-778-8300||
20547018|NCT02195414|The General Hospital of Shenyang Military Region|Yaling Han, Study Chair of Clinical Trials|+86-024-28856123|hanyaling@263.net|
20547019|NCT00588952|Yale University|Ismene Petrakis|203-932-5711|Ismene.petrakis@yale.edu|2244
20547020|NCT01461057|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20547021|NCT01288976|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
20547022|NCT04198818|Haihe Biopharma Co., Ltd|Medical Officer|86-(021)-20568888|fugen.li@haihepharma.com|8988
20547023|NCT00642473|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20547024|NCT01680549|Texas Tech University Health Sciences Center|Nancy Swinford|806-743-2569|nancy.swinford@ttuhsc.edu|
20547025|NCT02547714|Novartis Pharmaceuticals|Study Director|862-778-8300||
20547026|NCT00740246|Luitpold Pharmaceuticals, Inc.|Mark A Falone|610-650-4200|mfalone@americanregent.com|844
20547027|NCT03535571|KGK Science Inc.|Dr. Mal Evans|519-438-9374|mevans@kgkscience.com|
20547028|NCT00662532|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
20547029|NCT00366340|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547030|NCT00442468|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547031|NCT00589784|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|KaleyT@mskcc.org|
20547032|NCT03823378|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20547033|NCT01606254|Janssen Pharm KK Japan|Medical Director|81-3-4411||5509
20547034|NCT01001299|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20547035|NCT00977808|University of Virginia|Boris Kovatchev, Ph.D./Principal Investigator|434-982-6479|pcm9b@virginia.edu|
20547036|NCT02195011|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20547037|NCT00174291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547038|NCT00450112|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
20547039|NCT03418571|Ablynx NV|Medical Monitor|+32 9 262 00 00|clinicaltrials@ablynx.com|
20547040|NCT03882008|University of Washington|Bobby Kwanghoon Han|206-685-9950|hank4@uw.edu|
20547041|NCT01582854|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20547042|NCT04068896|NGM Biopharmaceuticals|VP Clinical Operations|(650)243-5555|ngm120@ngmbio.com|
20547043|NCT02953509|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20547044|NCT00484185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547045|NCT00251004|Novartis Pharmaceuticals|Study Director|862-778-8300||
20547046|NCT02051816|LSU School of Medicine New Orleans|David Janz, MD, MSc|504-568-3167|djanz@lsuhsc.edu|
20547047|NCT02694718|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20547048|NCT00824070|Bausch & Lomb Inc|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
20547049|NCT02045303|Texas Health Resources Presbyterian Hospital of Dallas|Lisley Viana, Physical Therapist|214-345-4334|lisleyviana@texashealth.org|
20547050|NCT00256282|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
20547051|NCT00667446|AbbVie, (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20547052|NCT02829983|Universidade Estadual Paulista Júlio de Mesquita Filho|Mauro Pedrine Santamaria|3947-9033|mauro.santamaria@ict.unesp.br|
20547053|NCT00591578|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20547054|NCT04644783|University of Michigan|Mohamad El Zaatari|734-647-2954|mohamade@med.umich.edu|
20547055|NCT01723696|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
20547056|NCT02380690|VA ORD|Robert O'Brien|2024435741|Robert.O'Brien2@va.gov|
20556217|NCT01569438|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20547057|NCT00727532|Northwestern University|Results Entry Administrator|312-695-1301|croqualityassurance@northwestern.edu|
20571543|NCT02819024|Barbara Ann Karmanos Cancer Institute|Anthony F. Shields, MD, PhD|3135768735|shieldsa@karmanos.org|
20571544|NCT05576662|Stanford University|Linda N. Geng, MD, PhD|650-723-4000|geng@stanford.edu|
20571545|NCT02902770|Maimonides Medical Center|Antonios Likourezos|7182836896|alikourezos@maimonidesmed.org|
20571546|NCT05217641|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20571547|NCT05292586|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20571548|NCT02755129|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
20571549|NCT02645123|University of Ioannina School of Medicine|Dr. Georgios Krekoukias|00306934609400|gkrekos@gmail.com|
20527618|NCT00505661|UT MD Anderson Cancer Center|John Kavanagh, MD / Professor|713-792-2933||
20547058|NCT00829933|Daiichi Sankyo.,LTD|So Yoshino, Manager|81-90-8024-0742|yoshino.so.ej@daiichisankyo.co.jp|
20547059|NCT03687970|Washington University|Simon Haroutounian, PhD. Assistant Professor,|314-286-1715|simon.haroutounian@wustl.edu|
20547060|NCT02300727|Aurora Health Care - Bay Area Medical Center|Dhimant Patel, MD|920-288-4123|dhimant.patel@aurora.org|
20547061|NCT00523367|University of Florida|Juan Munoz, MD|904-633-0089|juan.munoz@jax.ufl.edu|
20571550|NCT03633799|Sebela Women's Health|Elizabeth Gray, Manager, Clinical Operations|760-593-8383|Elizabeth.gray@sebelapharma.com|
20547062|NCT01848041|RVL Pharmaceuticals|Sr. Director, Clinical Development|908-809-1423|mvelasco@osmotica.com|
20571551|NCT00777764|Genentech, Inc.|Medical Communications|800-821-8590||
20547063|NCT00356122|Sanofi-Aventis|Trial Transparency Team||Contact-Us@sanofi.com|
20547064|NCT00491556|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20547065|NCT00782795|University of Michigan|Matthew DiMagno||mdimagno@umich.edu|
20571552|NCT02397447|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
20571553|NCT02994069|University of Kentucky|Dr. Susanne Arnold|859-323-6522|susanne.arnold@uky.edu|
20508547|NCT03669146|The Ohio State University College of Optometry|Ann Morrison|614-570-3416|morrison.421@osu.edu|
20508548|NCT01488188|International Vaccine Institute|Dr. Jae Seung Yang|82-2-881-1198|jsyang@ivi.int|
20508549|NCT01783470|NIDDK / NIH|Aaron M. Cypess, MD, PhD, MMSc|301-435-9267|aaron.cypess@nih.gov|
20508550|NCT01419015|Edwards Lifesciences|Aya Saeki||Aya_Saeki@edwards.com|
20508551|NCT02911519|SAMEIN|Dr. Jenny Garcia|+57 4 219 6014|jenny.garcia@udea.edu.co|
20508552|NCT01237223|Novartis Pharmaceuticals|Study Director|862-778-8300||
20508553|NCT00443846|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508554|NCT03437044|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
20508555|NCT01659268|College of Nursing at Ribeirão Preto, University of Sao Paulo|Cesar Eduardo Pedersoli|55(16)3602-3421|cesinhajardel@ig.com.br|
20508556|NCT03043807|Johns Hopkins University|Kenneth Pienta|4105023137|kpienta1@jh.edu|
20508557|NCT02665468|VA-CHOIR|Dr. Timothy P. Hogan|781-687-3181|timothy.hogan@va.gov|
20508558|NCT00802867|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20508559|NCT01809197|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20547066|NCT04480424|Scientific Innovation Office (SIO) Clinical Program Leader/Director Bioscience Clinical & Pharmacovigilance|Rhonda Griffin|+1 919 316 6693|Rhonda.griffin@grifols.com|
20547067|NCT04461509|Cedars-Sinai Medical Center|Laura Sarmiento|310-423-4295|Laura.sarmiento@cshs.org|
20547068|NCT01683019|NeoSync, Inc.|Dr. Bill Phillips|949-333-2906|bill@neosync.com|
20547069|NCT00543855|Eisai Co., Ltd.|Masaki Nakagawa, Study Director|+81-3-3817-5245||
20547070|NCT00076024|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547071|NCT02417844|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20547072|NCT00902161|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20547073|NCT01785095|IBSA Institut Biochimique SA|IBSA Clinical Research Manager|+41583601000|rd@ibsa.com|
20571554|NCT04193826|Conformal Medical, Inc|Aly Dechert / Manager of Clinical Operations|(603) 718-8742|adechert@conformalmedical.com|
20508560|NCT02256345|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
20547074|NCT00301821|Mayo Clinic|Ivana N. M. Micallef, M.D.|507-284-4642|micallef.ivana@mayo.edu|
20547075|NCT02294773|Midwest Fertility Specialists or St. Vincent Women's Hospital|Dr. Matt Will or Dr. Lauren Messinger|317-415-7528|laurenmessinger@gmail.com|
20547076|NCT03052764|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20547077|NCT03150485|Johnson & Johnson Vision|Thomas Karkkainen - SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
20547078|NCT02097537|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group||clinical@santen.co.jp|
20547079|NCT05828095|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20547080|NCT01981759|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
20547081|NCT03206073|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
20547082|NCT00403403|Genentech, Inc.|Medical Communications|800-821-8590||
20547083|NCT00096954|Hoffman-LaRoche|Medical Communications|800-821-8590||
20547084|NCT03034200|Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Peter Anderson|216-308-2706|andersp@ccf.org|
20547085|NCT01739400|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
20547086|NCT01736657|Terumo BCT, Inc.|Ray Goodrich, Phd, VP Scientifc and Clinical Affairs|303-205-2680||
20547087|NCT03350984|University of Guanajuato|Dra. Paulina Crespo Morfin|+52 4431300112|pb.crespomorfin@outlook.es|
20547088|NCT01347307|Mercy Research|Lead Regulatory Coordinator - Investigator Initiated Trials|314-251-8827|michelle.mcfarland@mercy.net|
20547089|NCT02876640|University of Wisconsin - Madison|Lisa Barroilhet, MD, MS|608-264-3204|barroilhet@wisc.edu|
20547090|NCT00920829|Medical University of South Carolina|Dr. Raymond Anton|843-792-1226|antonr@musc.edu|
20527619|NCT01907217|St Patrick's University Hospital|Prof Declan McLoughlin|+353 1 2493343|d.mcloughlin@tcd.ie|
20527620|NCT01764659|UMMC MSGCC|Howard Zhang, PhD|(410)706-6510|hzhang@umm.edu|
20527621|NCT01210352|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
20527622|NCT00422292|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20527623|NCT02440854|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20547091|NCT04533880|NYU Langone Health|Larry Chen|(646) 501-7200|Larry.Chen@nyulangone.org|
20547092|NCT02284178|University of Central Florida|Mary Lou Sole|407-823-5496|mary.sole@ucf.edu|
20547093|NCT02260531|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
20547094|NCT00073073|Georgetown University|Dr. Claudine Isaacs|(202)444-3677|isaacsc@georgetown.edu|
20547095|NCT05959200|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20547096|NCT03954041|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20547097|NCT02090075|Los Angeles Biomedical Research Institute at Harbo|Dr Matthew Budoff|3102224107|mbudoff@labiomed.org|
20547098|NCT03868124|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
20547099|NCT04177355|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20547100|NCT03981822|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
20547101|NCT02742246|Yale University School of Medicine|Dr. Brian Kiluk, Associate Professor of Psychiatry|203-737-1544|Brian.kiluk@yale.edu|
20547102|NCT03489551|University of Iowa|Michelle Weckmann|319-384-7538|michelle-weckmann@uiowa.edu|
20547103|NCT02519387|Mundipharma Pharmaceuticals Sdn Bhd|Elayne Chan|+60 122162170|Elayne.Chan@mundipharma.com.my|
20547104|NCT00054717|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20527624|NCT02243046|Global Research Consultants|Dr. Franklin Garcia-Godoy|954-888-9102|fgarciagodoy@gmail.com|
20547105|NCT01896479|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20547106|NCT03139604|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20547107|NCT00585559|Vanderbilt University Medical Center|Dr. Matthew Fusco|615-322-1054|matthew.r.fusco@vumc.org|
20547108|NCT02882074|Cleveland Clinic|Dr. Marta Kelava|2162133218|kelavam@ccf.org|
20547109|NCT01117051|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20547110|NCT03190369|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20547111|NCT04543409|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20547112|NCT02093026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20547113|NCT04081233|The University of Texas Health Science Center at Houston|David E. Meyer, MD, MS, FACS|713-500-7244|David.E.Meyer@uth.tmc.edu|
20547114|NCT01056380|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
20527625|NCT01908582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20547115|NCT00586326|Hologic, Inc.|Nancy Chenette, Director, Clinical Affairs|508-263-8770|nancy.chenette@hologic.com|
20547116|NCT03595774|Indiana University Purdue University Indianapolis|Dr. Andrew R. Coggan|3172740656|acoggan@iu.edu|
20547117|NCT04831788|University of Novi Sad, Faculty of Medicine|Prof. Vladimir Petrovic|+381648028800|vladimir.petrovic@izjzv.org.rs|
20547118|NCT03519386|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
20547119|NCT02783469|University of Dundee|Professor Blair H. Smith|01382383795|b.h.smith@dundee.ac.uk|
20547120|NCT03101267|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20547121|NCT00555425|Yale University|Dr. David Fiellin|203-688-2471|david.fiellin@yale.edu|
20547122|NCT00393042|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
20547123|NCT00829283|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
20547124|NCT02431247|Janssen Sciences Ireland UC|Clinical Registry Group|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20547125|NCT00322153|Forest Research Institute|Stephen M Graham, PhD|201-427-8156|Stephen.Graham@frx.com|
20547126|NCT02414139|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20547127|NCT03523000|University Hospitals Cleveland Medical Center|Dr. Salim Hayek|216-844-2685|salim.hayek@uhhospitals.org|
20547128|NCT00772070|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
20547129|NCT01309308|Baskent University|Ayse Parlakgumus|00903224586868|ayseparlakgumus@yahoo.de|2102
20547130|NCT00495131|National Taiwan University Hospital|Chen-Hua Liu, MD|886223123456|jacque_liu@mail2000.com.tw|63572
20547131|NCT02750215|Massachusetts General Hospital|Rebecca Suk Heist, MD|617-726-8033|RHEIST@PARTNERS.ORG|
20547132|NCT01307020|Menarini Ricerche S.p.A.|Dr Angela Capriati, Corporate Clinical Research Director|+39 055 5680 9933|acapriati@menarini-ricerche.it|
20547133|NCT00266864|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
20547134|NCT02338336|Norwarta|Peggy Hagerty|267-240-4010|hagertymws@comcast.net|
20547135|NCT04647890|Certa Therapeutics Pty Ltd|Prof Darren Kelly, CEO|+61 3 9657 0700|dkelly@certatherapeutics.com|
20547136|NCT01952470|Alfred Health|Benjamin James Tarrant|+61404455658|b.tarrant@alfred.org.au|
20547137|NCT01094561|Columbia University|Elizabeth Hecht, MD|(212)305-6510|eh2560@cumc.columbia.edu|
20547138|NCT01909453|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547139|NCT01994590|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-2830|PCorn@mdanderson.org|
20547140|NCT00255801|Memorial Sloan Kettering Cancer Center|Dr. David Straus|212-639-8365|strausd@mskcc.org|
20547141|NCT03332771|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
20547142|NCT03442764|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20547143|NCT01966692|Unversity of Florida|Dr Yuanyuan Jiao|(407) 313-7014|yyjiao@cop.ufl.edu|
20547144|NCT01823510|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|212-241-8484|juan.badimon@mssm.edu|
20547145|NCT05523323|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20547146|NCT02469038|University of Chicago|Melanie Norstrom|773-702-1991|mnorstrom@medicine.bsd.uchicago.edu|
20547147|NCT03435640|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20547148|NCT00636987|St Jude Medical|Sr. Clinical Manager|6517566803|jjohnson101@sjm.com|
20547149|NCT01251146|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20547150|NCT05654441|University of North Carolina at Chapel Hill|Keely Muscatell, PhD|919-843-5467|kmuscatell@unc.edu|
20547151|NCT01955980|PARI Pharma|Friedrich Gruber|+4989742846|friedrich.gruber@pari.com|10
20508561|NCT02052141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20547152|NCT00053365|Gynecologic Oncology Group|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20547153|NCT01483690|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
20547154|NCT04534465|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20547155|NCT02239224|aTyR Pharma|Gennyne Walker|858 731 8389|clinicaltrials@atyrpharma.com|
20547156|NCT03718871|Weill Cornell Medicine|Dr. Radhika Sundararajan|(646) 962-4654|ras9199@med.cornell.edu|
20547157|NCT03183778|NYU Langone Health|David Goldfarb, MD|212-263-0744|David.Goldfarb@nyulangone.org|
20547158|NCT00737464|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20547159|NCT01885871|Cutera, Inc|Clinical Research Department|1-888-428-8372|gweiss@cutera.com|
20547160|NCT00905827|Department of Veteran Affairs|Kathryn Magruder|843-789-7280|Kathryn.Magruder@va.gov|
20547161|NCT00872027|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
20547162|NCT00509392|VNUS Medical Technologies / Covidien (sponsor)|Eppie Chang, MS; Director Clinical Research|408-360-7200|eppie.chang@covidien.com|
20547163|NCT05386823|HighField BioPharmaceuticals Corporation|Dr. Yuhong Xu|+86-571-86961869|yhxu@hf-biopharm.com|
20547164|NCT03007407|NSABP Foundation|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
20547165|NCT03228420|Nevro Corp.|Donald Middlebrook|(650) 433-2218|don.middlebrook@nevro.com|
20547166|NCT02266914|The Ohio State University Wexner Medical Center|Tamara McMath, MPH|614-293-8082|tamara.mcmath@osumc.edu|
20547167|NCT00206076|Drexel University College of Medicine|David Reich, MD|215-762-7143|David.Reich@DrexelMed.edu|
20547168|NCT01060345|University of Chicago|Nora Jaskowiak, MD|773-702-2048|njaskowi@surgery.bsd.uchicago.edu|
20547169|NCT00427960|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20547170|NCT01142128|University of Florida|Phillip Toskes, M.D.|352-273-9493|phillip.toskes@medicine.ufl.edu|
20547171|NCT03355664|Mahidol Oxford Tropical Medicine Research Unit (MORU)|Thomas Peto|(+66) 802 187 460|tom@tropmedres.ac|
20556218|NCT01207102|Duke University Medical Center|Dr Kimberly Blackwell|919-6681748|black034@mc.duke.edu|
20556219|NCT00736645|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20556220|NCT01330433|Loma Linda University, Dept of Cardiovascular and Thoracic Surgery|Research Coordinator|909-558-4355|vayermiller@llu.edu|
20527626|NCT03594955|Sanofi-Aventis Research & Development|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20556221|NCT03084666|University of Alabama at Birmingham|Brant Wagener, MD, PhD|12059346007|bwagener@uabmc.edu|
20556222|NCT01201057|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
20556223|NCT04259086|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20556224|NCT04899349|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20556225|NCT03240692|Stanford University|Dr. Nolan Williams|650-800-6920|nolanw@stanford.edu|
20527627|NCT01829997|RTI Surgical|Kristina Shine|386-418-8888|kshine@rtix.com|4404
20547172|NCT01337687|Montefiore Medical Center, Albert Einstein College of Medicine|Casara Jean Ferretti|3472499694|cferrett@montefiore.org|
20508562|NCT00268463|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
20571555|NCT01876082|Department of Medical Oncology, Institut bergonié|Pr Antoine Italiano, coordinating investigator|05.47.30.60.88|a.italiano@bordeaux.unicancer.fr|
20571556|NCT03829501|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20571557|NCT02964013|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571558|NCT01123070|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8270|USMedInfo@tevapharm.com|
20571559|NCT04942366|Ziauddin University|Mubarra Rao|03343088915|mubarrar@gmail.com|
20571560|NCT03284229|Spectranetics Corporation|Spectranetics Corporation|719-447-2211|Ami.Sood@philips.com|
20571561|NCT03554629|Clinical Research Program Manager|Kathleen H. Niebel RN BSN BSME|978-549-9325|kathleen.h.niebel@gmail.com|
20571562|NCT00663702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20571563|NCT01977677|Stanford University School of Medicine|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
20571564|NCT01498887|Novartis Pharmaceuticals|Study Director|862-778-8300||
20571565|NCT01151852|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20571566|NCT03079297|University of Texas Southwestern|Maria Monastirsky|214-648-0174|Maria.Monastirsky@utsouthwestern.edu|
20571567|NCT00667225|University of North Carolina, Chapel Hill|Dean Morrell|919-843-5539|morrell@med.unc.edu|
20571568|NCT03056300|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20571569|NCT03733990|Faron Pharmaceuticals Ltd|Chief Medical Officer|+35824695151|info@faron.com|
20571570|NCT05262517|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571571|NCT05602727|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571572|NCT02187159|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
20571573|NCT04325282|Stanford University|Fiona Baumer, MD, MS|(650) 723-0993|fbaumer@stanford.edu|
20571574|NCT00465998|Stavanger University Hospital|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
20571575|NCT05520775|University of North Carolina at Chapel Hill|Christian Hendershot|(213) 821-0769|christian.hendershot@usc.edu|
20571576|NCT04020185|ImmuneSensor Therapeutics Inc.|Vice President of Clinical Operations and Project Management|210-380-5164|tmooneyham@immunesensor.com|
20571577|NCT04414202|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
20571578|NCT04087811|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
20571579|NCT00527787|POZEN Inc|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
20571580|NCT01238536|University of Washington|Janna Friedly M.D.|206-744-3664|friedlyj@uw.edu|
20571581|NCT00441259|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20571582|NCT01229878|VA Providence Healthcare System|Kel Morin|347-346-0380|kel.morin@va.gov|
20571583|NCT01840410|Novartis|Study Director|862-778-8300||
20571584|NCT00839956|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20571585|NCT04041037|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
20571586|NCT01460225|Dartmouth-Hitchcock Medical Center|Dr. Brian Lacy|603-650-5215|brian.e.lacy@hitchcock.org|
20571587|NCT01495598|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
20571588|NCT03083665|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20571589|NCT01289210|VentiRx Pharmaceuticals Inc.|Kristi Manjarrez, Vice President, Clinical Affairs|206-689-2259|kmanjarrez@ventirx.com|
20571590|NCT01647945|Stanford University|Dr. Edda Spiekerkoetter|650-724-1493|eddas@stanford.edu|
20571591|NCT01744704|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20571592|NCT01040169|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20571593|NCT00350727|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571594|NCT03564353|UT Dallas|Clinical Trial Manager|972-883-7277|Sarah.McLeod@utdallas.edu|
20571595|NCT05371665|Montana State University|Brandon Scott|(406) 994-5218|brandon.scott2@montana.edu|
20571596|NCT03551691|Children's Hospital of Philadelphia|Dr. Virginia Stallings|267-425-1633|stallingsv@chop.edu|
20571597|NCT02367040|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20571598|NCT02477618|Sage Therapeutics|Helen Colquhoun, MD - Vice President, Medical Science|(617) 229-5234|Helen@sagerx.com|
20571599|NCT02446821|Sebela Women's Health Inc.|Elizabeth Gray, Manager, Clinical Operations|760-593-8383|elizabeth.gray@sebelapharma.com|
20571600|NCT03007420|Boston Children's Hospital|Pradeep Dinakar, MD|857-218-3556|Pradeep.Dinakar@childrens.harvard.edu|
20571601|NCT01655251|Connecticut Children's Medical Center|Dr. Sharon R. Smith|860-545-9000|srsmith@connecticutchildrens.org|
20571602|NCT02638883|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
20571603|NCT02284009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20571604|NCT06532357|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571605|NCT00747227|Abbott medical Optics, Inc.|Nicholas Taranatino, O.D., Head, Global Clinical Research & Devlopment|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
20571606|NCT00685139|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20571607|NCT03789175|NHLBI, NIH|Dr. Paul Hwang|3014353068|hwangp@mail.nih.gov|
20571608|NCT02420951|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177329501|wfitz@partners.org|
20571609|NCT00814177|McMaster University|Sam Schulman, MD|1-905-5270271|schulms@mcmaster.ca|44479
20571610|NCT02952534|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20508563|NCT03000686|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20571611|NCT00225017|Northwestern University|Robert Murphy|312-503-9000|r-murphy@northwestern.edu|
20571612|NCT02993406|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20571613|NCT03563157|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20571614|NCT02248818|AstraZeneca LP|Joel Posner MD||ClinicalTrialTransparency@astrazeneca.com|
20571615|NCT02942277|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
20571616|NCT02441985|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
20571617|NCT02783027|University of Pittsburgh|Dr. Daniel Patterson|412-864-3830|pdp3@pitt.edu|
20571618|NCT00461981|MedImmune, LLC|Christopher Ambrose, MD|301-398-0000|ambrosec@medimmune.com|
20571619|NCT02863289|NHS Tayside|Mr Benedict Clift|01382 660111|ben.clift@nhs.net|35160
20571620|NCT01876901|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20571621|NCT01562041|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20571622|NCT03031496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20571623|NCT02339545|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
20571624|NCT03868787|Northwestern University Feinberg School of Medicine|Ashley Turner, MD Assistant Professor of Obstetrics and Gynecology|2316200549|ashley.turner1@nm.org|
20571625|NCT04313608|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20571626|NCT02510040|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|813-975-8690|rkraker@jaeb.org|
20571627|NCT01712061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571628|NCT00758342|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20571629|NCT00879775|Department of Family Medicine, Dongguk University Ilsan Hospital, Republic of Korea|Sang-Yeon Suh, M.D.,Ph.D|0082-031-961-7490|fmmodel@gmail.com|
20571630|NCT00842244|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556226|NCT02300220|Imperial College London|Professor Jadwiga Wedzicha|02075947947|j.wedzicha@imperial.ac.uk|
20556227|NCT04891419|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20508564|NCT02920450|University of Florida Heath Cancer Center|Protocol Development Manager|352-273-8128|clh1230@ufl.edu|
20556228|NCT00127101|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20556229|NCT02291614|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20556230|NCT00843167|Oregon Health & Science University|Dr. Jackilen Shannon|541-706-6861|shannoja@ohsu.edu|
20556231|NCT01159054|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-6660|kzandinejad@partners.org|34769 page
20556232|NCT03088826|Maimonides Medical Center|Sergey Motov|718283600|smotov@maimonidesmed.org|
20556233|NCT00683826|Columbia University Medical Center|Henry N. Ginsberg MD, Gissette Reyes Soffer MD|2123059298|gr2104@columbia.edu|
20556234|NCT02432105|Alcon, A Novartis Division|Clinical Scientific Director, GCRA - Global Clinical Development|1-888-451-3937|alcon.medinfo@alcon.com|
20556235|NCT04365660|Stanford University|Dr. Kristen Ganjoo, MD|650-498-6000|kganjoo@stanford.edu|
20556236|NCT04302350|The First Affiliated Hospital of Nanjing Medical University|Dr.cunming Liu|13951890866|cunmingliu@njmu.edu.cn|
20556237|NCT01311674|Emergent Biosolutions|Christine Hall, Sr. Director Clinical Research||chall@ebsi.com|
20556238|NCT02012491|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|Courtney.Schreiber@uphs.upenn.edu|
20556239|NCT02430194|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
20556240|NCT05608629|Icahn School of Medicine at Mount Sinai|Dr. Benjamin H Natelson|(212) 844-6665|Benjamin.Natelson@mountsinai.org|
20556241|NCT03969719|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556242|NCT02130193|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556243|NCT01266642|UT MD Anderson Cancer Center|Dr. Benjamin Smith, Professor, Radiation Oncology Department|(713) 563-2380|bsmith3@mdanderson.org|
20556244|NCT03854461|Queen's University Belfast|Prof. Jayne Woodside|+44 (0)28 9097 8942|j.woodside@qub.ac.uk|8942
20556245|NCT01323530|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20556246|NCT04918784|Acera Surgical, Inc.|Matthew MacEwan|440-477-1890|macewan@acera-surgical.com|
20556247|NCT00915031|University of California, Irvine|Linda Huynh|7144567354|lindamh@uci.edu|
20556248|NCT01835262|Maimonides Medical Center|Antonios Likourezos|718-283-6896|alikourezos@maimonidesmed.org|
20556249|NCT01266850|Vanderbilt University Medical Center|Kathryn M. Edwards, MD|615-322-3078|kathryn.edwards@vanderbilt.edu|
20556250|NCT01437124|Wirral NHS Trust|Hussain Kazi|0151 678 6111|hussainkazi@nhs.net|
20556251|NCT04128293|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20556252|NCT02035332|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
20571631|NCT01068665|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20571632|NCT01373580|ReVision Optics|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
20571633|NCT00858689|FRAXA Research Foundation|Michael R. Tranfaglia MD|978-462-1990|info@fraxa.org|
20547173|NCT01960387|University of Pittsburgh Cancer Institute|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
20547174|NCT04218123|Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina|Habib Rizk, MD, MSc|8438760112|rizkh@musc.edu|
20547175|NCT04163718|Moffitt Cancer Center|Javier Pinilla, MD, PhD|813-745-8212|javier.pinilla@moffitt.org|
20547176|NCT01289782|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20547177|NCT02131532|University of Edinburgh|Dr Simiao Wu|0044-131-242-6371|simiao.wu@ed.ac.uk|26371
20547178|NCT04499599|L-Nutra, Inc.|Dr. Min Wei|323.791.2426|mwei@l-nutra.com|
20571634|NCT02992691|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20547179|NCT03742440|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20547180|NCT00055224|National Institute of Mental Health|Dr Maryland Pao|(301) 435 5770|paom@mail.nih.gov|
20547181|NCT03436810|Mahidol University|Sunee Bovonsunthonchai|024415450|sunee.bov@mahidol.edu|
20547182|NCT00121173|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
20547183|NCT01754909|Baltimore VAMC|Dr Eric Cohen|410 605 7000|eric.cohen@va.gov|5/7182
20547184|NCT01677312|Center for Interventional Endoscopy, Florida Hospital|Dr. Shyam Varadarajulu, MD|407-303-2570|svaradarajulu@yahoo.com|
20547185|NCT04291001|University of Utah|Lori Gawron, MD|801-213-4989|lori.gawron@hsc.utah.edu|
20547186|NCT03794882|University of Wisconsin-Madison|Dr Kristin Bevil|6082638100|kbevil@wisc.edu|
20547187|NCT01569464|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
20547188|NCT01376557|Lexicon Pharmaceuticals, Inc.|Dr. Paul Strumph|(281) 863-3302|pstrumph@lexpharma.com|
20547189|NCT01642407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547190|NCT03063203|Washington University School of Medicine|John Welch, M.D., Ph.D.|314-362-2626|jwelch@wustl.edu|
20547191|NCT01856023|Clinigen|Head of Medical Affairs|8323263256|nancy.gregory@clinigengroup.com|
20547192|NCT00424255|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547193|NCT03004248|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
20547194|NCT02632838|School of Nursing, Rutgers, the State University of New Jersey|Dr. Peijia Zha|7327637412|peijiaz@sn.rutgers.edu|
20547195|NCT03631355|NYU Langone Health Orthopedic Hospital|Dr. Michael J. Alaia|6465017223|michael.alaia@nyulangone.org|
20547196|NCT02810340|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20547197|NCT01412918|Medical College of Wisconsion|Dr. David Friedland|414-805-|dfriedland@mcw.edu|
20547198|NCT03945175|NYU Langone Health|Terry Leon|646 754 4837|terry.leon@nyulangone.org|
20547199|NCT02797054|University of Colorado|Julie A Maertens|303-724-7319|julie.maertens@ucdenver.edu|
20547200|NCT00870233|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi ME|212-639-5016|chid@mskcc.org|
20547201|NCT03221764|University of Louisville|Dr. Victor van Berkel|502-588-7600|victor.vanberkel@ulp.org|
20547202|NCT00769483|UT MD Anderson Cancer Center|Milind Javle, MD/Professor, GI Medical Oncology|713-792-2828|mjavle@mdanderson.org|
20547203|NCT01306877|Covidien|Tam LaFleur, Clinical Project Manager|203-821-4744|tam.lafleur@covidien.com|
20547204|NCT00939952|Albany College of Pharmacy and Health Sciences|Katie Cardone|518-694-7875|katie.cardone@acphs.edu|
20547205|NCT04697381|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547206|NCT01057901|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20547207|NCT00999921|Medical College and Hospital Kolkata|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
20547208|NCT02495103|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
20547209|NCT00704808|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20547210|NCT01654796|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|MFAVA@mgh.harvard.edu|
20547211|NCT00473746|Janssen R&D US|Sr. Director, Clinical Research|(310)914-2917||
20556253|NCT05616962|Primus Pharmaceuticals, Inc.|Director of Clinical Trials|480-483-1410|info@primusrx.com|
20556254|NCT04177680|Matinas BioPharma|Dr. James J Ferguson, MD|(908) 505-0964|jferguson@matinasbiopharma.com|
20556255|NCT04924283|Medical University of South Carolina|Christine Hahn|843-518-2875|hahnc@musc.edu|
20556256|NCT02030015|University of Minnesota|Jeanine Jarnes, PharmD|612-626-5131|utzx0002@umn.edu|
20556257|NCT00365391|Wayne State University|Philip A. Philip, M.D., Ph.D., F.R.C.P.||philipp@karmanos.org|
20556258|NCT03014674|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20556259|NCT00514943|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20556260|NCT03764449|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20556261|NCT05745142|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556262|NCT00833560|Jan-Cil Germany|Therapeutic Areas Director|+49 2137 955-492||
20571635|NCT05071586|University of Wisconsin - Madison|Bernadette Gillick|608-381-2699|bgillick@wisc.edu|
20547212|NCT01962922|Veloxis Pharmaceutical|Leslie Callahan|732-321-3221|lca@veloxis.com|
20547213|NCT00744471|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547214|NCT03224546|University of Kentucky|William W. Stoops|859-257-5383|william.stoops@uky.edu|
20547215|NCT04706416|Valley Baptist Medical Center|Dr. Ameer Hassan|973-303-8146|ameerehassan@gmail.com|
20547216|NCT00970736|University of Florida|Karen Hegland|352 359-1830|kwheeler@ufl.edu|
20547217|NCT01616082|Translational Research Institute for Metabolism and Diabetes|Dr. Steven R. Smith|407-303-7115|steven.r.smith.md@flhosp.org|
20547218|NCT04705363|Mayo Clinic of Jacksonville|Dr. Janice Krieger|904-953-6160|krieger.janice@mayo.edu|
20547219|NCT00976573|Mayo Clinic|Robert R. McWilliams, MD|507/284-8432|mcwilliams.robert@mayo.edu|
20547220|NCT02117427|Aevi Genomic Medicine|Garry A Neil|610-254-4208|garry.neil@aevigenomics.com|
20547221|NCT02730208|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20547222|NCT00055471|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20556263|NCT00499031|NRG Oncology Statisics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gmail.com|
20556264|NCT00414817|Kaiser Permanente, Center for Health Research|Dr. William Vollmer, Senior Investigator|503-335-6755||
20556265|NCT00477230|CardioFocus, Inc.|Burke T. Barrett, Study Director|508 658-7200|bbarrett@cardiofocus.com|
20556266|NCT03382782|Illinois Institute of Technology|Dr. Lindsay Sheehan, Co-Investigator|312-567-7983|lsheehan@iit.edu|
20556267|NCT01316510|UC Davis|Mark Underwood|916-734-8672|munderwood@ucdavis.edu|
20556268|NCT01785680|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manary@kids.wustl.edu|
20556269|NCT01791725|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
20556270|NCT02583425|Dr. Reddy's|Director, Clinical Development|609-375-9900||
20556271|NCT01644734|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20556272|NCT02450331|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20556273|NCT01040858|Portland VA Healthcare System|Dr. Daniel Storzbach|503-220-8262|Daniel.Storzbach@va.gov|56497
20556274|NCT02606903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20556275|NCT02157779|Providence VA Medical Center|M. Tracie Shea, PhD|401-273-7100|MaryTracie.Shea@va.gov|6248
20556276|NCT01291498|Oxford University Hospitals NHS Trust|Mr Radu Mihai||radu.mihai@ouh.nhs.uk|
20556277|NCT01292876|University of Pittsburgh|Maria Alexander, Office Manager|412-624-5308|alexanderm3@upmc.edu|
20556278|NCT01175850|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
20556279|NCT04528069|Alcon Research, LLC|Director of Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20556280|NCT01814371|Washington University School of Medicine|Stephanie Fritz, MD, MSCI|3144544115|fritz.s@wustl.edu|
20556281|NCT04158050|Helsinki University Hospital|Dr Paula Kauppi|+358504286802|paula.kauppi@hus.fi|
20556282|NCT01016938|Universtity of Maryland School of Medicine|Warren D'Souza, PhD, MBA|410-328-7159|wdsouza@umm.edu|
20556283|NCT01982240|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
20556284|NCT04341116|I-Mab Biopharma US Ltd|Claire Xu|3177558242|Claire.Xu@i-mabbiopharma.com|
20556285|NCT00868439|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20556286|NCT04109703|Soovu Labs|Charles Chabal, MD|206-579-4910|Chuck@Soovu.com|
20556287|NCT00338884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556288|NCT03871595|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20556289|NCT00224874|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20556290|NCT00911534|Eisai Call Center|Eisai Inc.|888-422-4743||
20556291|NCT02355002|Massachusetts General Hospital|Drs. Joan Camprodon and Sabine Wilhelm|6177265340|jcamprodon@mgh.harvard.edu|
20556292|NCT05072080|Bavarian Nordic|Medical Information|1-844-422-8274|medical.information_na@bavarian-nordic.com|
20556293|NCT04322604|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20556294|NCT04867369|NYU Langone Health|Arthur Hertling, MD|212-598-6085|arthur.hertling@nyulangone.org|
20556295|NCT02921997|Vanderbilt Vaccine Research Program|C. Buddy Creech, MD, MPH|615-343-0332|buddy.creech@vanderbilt.edu|
20556296|NCT01839110|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
20556297|NCT00930293|University of Pittsburgh|Jill M. Cyranowski, PhD|412-246-5588|cyranowskijm@upmc.edu|
20556298|NCT00850473|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20556299|NCT02677116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20556300|NCT03342638|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20556301|NCT00554970|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20556302|NCT01292239|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
20556303|NCT03213158|University of Wisconsin - Madison|Fahid Aziz, MD|(608) 262-5420|faziz@wisc.edu|
20556304|NCT03649230|Purdue Pharma (Canada)|Graeme Donnelly|905.837-6498|graeme.donnelly@purdue.ca|
20556305|NCT01693068|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20556306|NCT00579280|University of South Florida College of Medicine|David V. Sheehan, MD, MBA|813-974-4544|dsheehan@health.usf.edu|
20556307|NCT04126408|northwell health|northwell health|5165620100|trebeiz@northwell.edu|
20556308|NCT00295022|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20556309|NCT01551199|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 791-1414|ellen.teng@va.gov|25513
20556310|NCT00734630|Forest Laboratories, Inc.|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
20556311|NCT01239030|Rhodes Pharmaceuticals|Akwete Adjei, PhD|401-202-9408|Akwete.Adjei@pharma.com|
20556312|NCT03156660|University of Virginia|Dr. Rebecca Krukowski|4349245303|wae4mq@virginia.edu|
20571636|NCT00392925|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20556313|NCT01302847|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|MPAACT.ctgov@fstrf.org|
20556314|NCT01371851|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
20527628|NCT02065518|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
20527629|NCT01110967|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
20527630|NCT01066663|Dana-Farber Cancer Institute|Jennifer R Brown MD PhD|l 617-632-4894|Jennifer_Brown@dfci.harvard.edu|
20527631|NCT01090050|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
20527632|NCT03539484|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20527633|NCT02232061|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20527634|NCT00571103|University of Iowa Carver College of Medicine|Dr. Donald W Black|319-3534431|donald-black@uiowa.edu|
20527635|NCT03735407|CheckCap|Clinical Director|972-4-8303401|daniella.bleistein@check-cap.com|
20527636|NCT00564278|Columbia Univ Med Center and New York State Psychiatric Institute|Roberto Lewis-Fernandez, MD, Professor of Psychiatry CUMC - NYSPI|646-774-8102|rlewis@nyspi.columbia.edu|
20527637|NCT00560703|Organization: Galderma R&D, Inc|Michael Graeber|609-409-7701|clinicaltrials@galderma.com|
20527638|NCT06439095|Van Yuzuncu Yil University Faculty of Dentistry|Dr. Burçin Avcı, Assistant Professor|+90 5359558140|burcinavci@yyu.edu.tr|
20527639|NCT02339974|Henry Ford Health|Dr. Brian O'Neill|313-970-6483|boneil3@hfhs.org|
20527640|NCT03484403|Dallas VA Medical Center|Dr Thiru Annaswamy|214-857-0273|thiru.annaswamy@va.gov|
20527641|NCT04278924|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20547223|NCT03437512|University of Michigan|Emily O. Garnett, PhD, CCC-SLP|734-232-3371|emilyog@med.umich.edu|
20547224|NCT01897714|Oncopeptides AB|Eva Nordström|+4686152040|trials@oncopeptides.com|
20547225|NCT01801072|University of Michigan|Dr. Aditya Pandey, Chair, Department of Neurosurgery|734-936-7010|adityap@umich.edu|
20547226|NCT03693170|Pierre Fabre Medicament|Isabelle Klauck, MD|+33149108018|isabelle.klauck@pierre-fabre.com|
20547227|NCT03581786|Shanghai Junshi Bioscience Co., Ltd.|Xiaojun Wang|86-021-50796193|xiaojun_wang@junshipharma.com|
20547228|NCT00510874|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547229|NCT00775944|University of Nottingham|Graeme Docherty|01158321380|graeme.docherty@nottingham.ac.uk|
20547230|NCT01583543|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
20547231|NCT00721123|Hoffmann-La Roche|Medical Communications|800 821-8590||
20547232|NCT00397943|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547233|NCT06053463|The Ohio State University College of Optometry|Jennifer Fogt|614-292-0882|fogt.78@osu.edu|
20547234|NCT03436563|M D Anderson Cancer Center|Dr. Van Morris|713-792-2828|vkmorris@mdanderson.org|
20547235|NCT02806973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20547236|NCT02840240|Cleveland Clinic|Fabio Rodriguez|216444-9950|rodrigf3@ccf.org|
20547237|NCT04209426|Medextens SARL|Frederic C Daoud, M.D., M.Sc., Epidemiologist-Biostatistician|+33964281703|fcdaoud@medextens.com|
20547238|NCT01617148|Cleveland Clinic Foundation|Dr. Rishi Singh|330-888-4000|singhr@ccf.org|
20547239|NCT02145507|Haemonetics (trial sponsor)|Adrian Orr, Clinical Research Director|781.356.9647|aorr@haemonetics.com|
20547240|NCT00423670|Merck, Sharp and Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20547241|NCT00900601|Oslo University Hospital|Thomas Kibsgård|99030831|kibsgard@gmail.com|+47
20547242|NCT01654861|Eastern Regional Medical Center|Eiko Klimant, MD|215-537-7400|eiko.klimant@ctca-hope.com|
20547243|NCT03727373|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
20547244|NCT00413478|University of Texas (UT) MD Anderson Cancer Center|Zeev Estrov, MD/Professor, Leukemia|713-794-1675|CR_Study_Registration@mdanderson.org|
20547245|NCT01082380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547246|NCT01052844|Faculdade de Medicina do ABC|Felipe Melo Cruz|+55+11+27595914|felipemcruz@yahoo.com.br|
20547247|NCT01241240|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20547248|NCT01466595|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20547249|NCT02313454|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20547250|NCT02376829|Align Technology Inc|Sherri Wilson-Lopes|408-470-1032|swilson@aligntech.com|
20547251|NCT01439347|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
20556315|NCT00450411|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20556316|NCT05725317|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20556317|NCT00941330|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
20556318|NCT01194570|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20556319|NCT01377480|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556320|NCT00876915|University of Rochester|Charles Francis, MD|(585) 275-5823|charles_francis@urmc.rochester.edu|
20556321|NCT02673398|City of Hope|Dr. Yuan Yuan|626-359-8111|Yuyuan@coh.org|
20556322|NCT01111123|Mount Siani School of Medicine Department of Dermatology|Jason Emer, MD|2122413288|jason.emer@mssm.edu|43288
20556323|NCT04333420|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
20556324|NCT01203930|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20556325|NCT00289887|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556326|NCT03409666|Zimmer Biomet|Lisette Smid|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
20556327|NCT00512148|Tengion declared bankruptcy in 2014|Tengion declared bankruptcy and there is no results contact|There is no Tengion phone||
20556328|NCT01866943|Hospital for Special Surgery|Research Fellow|917-843-6655|berlinerz@hss.edu|
20556329|NCT01355588|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
20556330|NCT01666951|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
20556331|NCT02366910|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
20556332|NCT02623322|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
20556333|NCT03284788|University of Florida|Dr. Michelle Cardel, Adjunct Professor|352-273-8811|mcardel@ufl.edu|
20556334|NCT03563716|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20556335|NCT03775200|Compass Pathways|Medical Director|07443136539|info@compasspathways.com|
20556336|NCT04605978|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
20556337|NCT03813238|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20556338|NCT03104699|Agenus, Inc.|Clinical Trial Information|1-781-674-4265|clinicaltrialinfo@Agenusbio.com|
20556339|NCT01690130|Medical University of South Carolina|TMS in Nicotine Craving|8437925729|lixi@musc.edu|
20556340|NCT02462876|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
20547252|NCT04115644|UT Southwestern Medical Center|Dr. Michael Khazzam|214/645-8917|michael.khazzam@utsouthwestern.edu|
20547253|NCT02325791|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20556341|NCT01786512|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20556342|NCT00605293|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20556343|NCT03581981|Atlanta VAHCS|Sheila Rauch|404-321-6111|sheila.rauch@va.gov|203122
20547254|NCT01298193|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20547255|NCT00107952|Theravance Biopharma Antibiotics, Inc.|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20547256|NCT01975831|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20547257|NCT03475875|Johnson & Johnson Vision|John Buch - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
20547258|NCT04025710|BIOTRONIK SE & Co.KG|Senior Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20547259|NCT00006389|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20547260|NCT01958112|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
20547261|NCT01085500|Mayo Clinic|Benjamin Zendejas, MD|507-538-5413|zendejas.benjamin@mayo.edu|
20547262|NCT01781169|Shenzhen Center for Chronic Disease Control|Dr. Ji-Chang Zhou|86-755-25503842|jichangzhou@gmail.com|
20547263|NCT06309407|Oregon Health and Science University|Dr. Sandy Christiansen|2038092318|chrissan@ohsu.edu|
20547264|NCT04811573|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20547265|NCT04812080|University of California Davis|Dr. Moon Chen|916-734-1191|mschenjr@ucdavis.edu|
20547266|NCT02096575|U of New Mexico - Dept of OBGYN/Family Planning|Michel Paves, HS Research Specialist|505-272-9703|MDaliva@salud.unm.edu|
20547267|NCT01987401|Department of Veterans Affairs, Office of Research and Development|Dr. Nicholas L. Smith, Director of Seattle Cooperative Studies Program|2067642773|nicholas.smith@va.gov|
20547268|NCT02376283|The Royal Wolverhampton NHS Trust|Prof James Cotton|01902307999|jamescotton@nhs.net|
20547269|NCT05074173|Tulane University School of Medicine|Keith Ferdinand|504-988-5492|kferdina@tulane.edu|
20547270|NCT00633867|NHS Grampian|W Brampton||william.brampton@nhs.net|
20547271|NCT00439465|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603-650-6432|Kenneth.R.Meehan@hitchcock.org|
20556344|NCT02080871|W.L. Gore & Associates|Hector R Novoa|928-864-3867|hnovoa@wlgore.com|
20547272|NCT01827358|University of Maryland Medical Center|Karen Kotloff, MD|410-706-5328|kkotloff@medicine.umaryland.edu|
20547273|NCT02691962|Becton Dickinson and Company|Dawn Heimer|+1-401-825-8681|Dawn.Heimer@bd.com|
20547274|NCT00596362|Memorial Sloan Kettering Cancer Center|Dr. David Abramson|212-639-7232|abramsod@mskcc.org|
20547275|NCT00817479|The University of Chicago, Department of Medicine|Dr. Gini Fleming, MD|(773) 702-6149|gfleming@medicine.bsd.uchicago.edu|
20547276|NCT02793128|UroGen Pharma Ltd.|Madlen Malinowski|6467689533|madlen.malinowski@urogen.com|
20547277|NCT02355977|Zhejiang University|Dr. Ying Wang|86-571-87217437|wyi1006@sina.com|
20547278|NCT02359851|Vanderbilt-Ingram Cancer Center|Principal Investigator|615-936-7423|douglas.b.johnson@vanderbilt.edu|
20547279|NCT01854944|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20547280|NCT05419999|University of Texas Health Science Center at San Antonio|Casey Straud|210-562-6700|straud@uthscsa.edu|
20547281|NCT00282347|Genentech, Inc.|Medical Communications|800-821-8590||
20547282|NCT02101112|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20547283|NCT02782923|NYU Langone Madison Avenue Orthopaedics|Yong H. Kim, MD|212-427-3986|Yong.Kim@nyulangone.org|
20547284|NCT02418156|Aziyo Biolgics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
20547285|NCT03368118|Abivax|Vice President Clinical Operations|01 53 83 08 41|paul.gineste@abivax.com|
20547286|NCT01445626|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20547287|NCT00993044|Children's Hospital Los Angeles|Rajkumar Venkatramani|3233615504|rvenkatramani@chla.usc.edu|
20547288|NCT04894916|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
20547289|NCT00734747|Medigus Ltd|Aviel Roy-Shapira, MD|+972 8646 6880|avrish@gmail.com|
20547290|NCT03642327|University of Maryland School of Medicine|Howard Dubowitz, MD, Professor of Pediatrics|4107066144|hdubowitz@som.umaryland.edu|
20547291|NCT05063318|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar's Oncology, Business Unit|0034918466000|clinicaltrials@pharmamar.com|
20547292|NCT03287635|Toyos Clinic|Dr.|9137064408|mtoyos@toyosclinic.com|
20547293|NCT00323869|Stanford University Medical Center|Heather A Wakelee, MD, Associate Professor of Medicine (Oncology)|650-498-6000|hwakelee@stanford.edu|
20547294|NCT01865084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20547295|NCT02285283|The University of Texas Health Science Center at Houston|Amber U. Luong, MD, PhD|713-486-5000|Amber.U.Luong@uth.tmc.edu|
20547296|NCT03682809|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
20547297|NCT02661711|Moorfields Eye Hospital|Tumelo Kaminskas|02072533411|moorfields.resadmin@nhs.net|2036
20547298|NCT01751802|Psyadon Pharmaceuticals|President/CEO|301-919-2020|info@psyadonrx.com|
20547299|NCT00521001|Mayo Clinic|Svetomir Markovic, MD, PhD|507/284-1370|markovic.svetomir@mayo.edu|
20547300|NCT02821910|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20547301|NCT01082640|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20547302|NCT03577171|Assembly Biosciences|Linda Baher, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
20547303|NCT01056328|St. Jude Medical|Nicole Glowacki, Clinical Project Manager|651-756-3432|NGlowacki@sjm.com|
20547304|NCT01770652|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
20547305|NCT01025154|The University of Texas MD Anderson Cancer Center|Stefan Faderl, MD / Associate Professor|713-745-4613|eharriso@mdanderson.org|
20547306|NCT01810432|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556345|NCT00234052|Northwestern University|Clinical Trials Office|312-695-1301||
20547307|NCT00057954|ECOG Statistical Office|Study Statistician|617-632-3012||
20547308|NCT00559754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20547309|NCT01264016|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20547310|NCT02117414|Medtronic, Inc|Evera MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
20547311|NCT01629706|Alcon Research, Ltd.|Alan Landers, Project Head, Vision Care R&D|1-888-451-3937|alcon.medinfo@alcon.com|
20571637|NCT03552523|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
20547312|NCT00701376|Cleveland Clinic|Brian Parker, MD|216-444-9950|parkerb1@ccf.org|
20547313|NCT02537574|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20547314|NCT02663687|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20547315|NCT01151098|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333 OR 800-745-7445||
20547316|NCT01593722|Laboratory of Parasitic Diseases, NIAID, NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
20547317|NCT03343067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20547318|NCT00542451|Dana Farber Cancer Institute|SARA TOLANEY, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
20571638|NCT03538938|University of Wisconsin School of Medicine and Public Health|Danielle McCarthy|6082655949|demccarthy@ctri.wisc.edu|
20571639|NCT00755105|USDA Grand Forks Human Nutrition Research Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
20571640|NCT02985840|OhioHealth Research Institutute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
20571641|NCT04145700|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20571642|NCT03398902|Rory Meyers College of Nursing, New York University|Dr. Susan Malone|212-992-7047|sm7760@nyu.edu|
20571643|NCT01518153|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-8750|CR_Study_Registration@mdanderson.org|
20571644|NCT02775071|Temple University|David Sarwer|215-707-8632|dsarwer@temple.edu|
20571645|NCT01327846|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20571646|NCT00203268|Thomas Jefferson University|Stephen D. Silberstein, MD|215-955-2243|Stephen.Silberstein@Jefferson.edu|
20571647|NCT00847522|Huntsman Cancer Institute|Mark Wade|8012135746|mark.wade@hci.utah.edu|
20571648|NCT00594880|the Wistar Institute|Luis Montaner|215 898 3934|montaner@mail.wistar.org|
20571649|NCT02523690|Johns Hopkins University|Dr. Dale Needham|410-287-3343|dale.needham@jhmi.edu|
20571650|NCT01254747|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
20571651|NCT00245960|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571652|NCT00737698|Imperial College London|Dr Samantha Amanda Sathyapala|+442073518029|s.sathyapala@imperial.ac.uk|
20571653|NCT01067846|Brain Imaging Research Center|Clint Kilts, PhD|526-8163|CDKilts@uams.edu|
20571654|NCT02817906|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20571655|NCT00672737|Stanford University|Anthony Doufas, MD, PhD|(650) 498-7699|agdoufas@stanford.edu|
20571656|NCT01675453|Academician EN Meshalkin State Budget Research Institute of Circulation Pathology|Dr. Evgeny Fominskiy|+79139538754|evfominskiy@gmail.com|
20571657|NCT01868425|University of Wisconsin - Madison|John Shepler|608-263-8100|jashepler@wisc.edu|
20571658|NCT00972322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571659|NCT04958200|Boston University|Tibor Palfai, PhD|6173539345|palfai@bu.edu|
20571660|NCT02387970|Columbia University|Panos N. Papapanou, DDS, PhD|(212) 342-3008|pp192@cumc.columbia.edu|
20571661|NCT00671177|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
20571662|NCT01310231|Mount Sinai Hospital|Pamela Goodwin/PI|416 586-8211|Pamela.goodwin@sinaihealth.ca|
20527642|NCT04847232|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20527643|NCT02476916|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
20547319|NCT00116168|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
20547320|NCT05153473|CHU de Poitiers|Dr Louis Etienne GAYET|+33(0)5.49.44.44.92|Louis-Etienne.GAYET@chu-poitiers.fr|
20571663|NCT04662060|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
20571664|NCT03086655|University of California San Francisco|Dr. Maria Ekstrand|+1 (415) 502-1000|Maria.Ekstrand@ucsf.edu|17142
20571665|NCT03841526|Xeris Pharmaceuticals|Dawn Harper, VP Clinical Devlopment|1-877-XERIS-37|clinicaltrials@xerispharma.com|
20556346|NCT01410474|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20556347|NCT02428296|Children's National Medical Center|Dr. Kim Keppler-Noreuil|2024766287|kkepplerno@childrensnational.org|
20556348|NCT03384173|University of Wisconsin, Madison|Matthew Harer|608-417-6236|mwharer@wisc.edu|
20556349|NCT00828984|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
20556350|NCT03509974|Cochlear|George Cire|+13038855440|gcire@cochlear.com|
20556351|NCT00464646|NSABP Foundation, Inc.|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
20556352|NCT00420199|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20566967|NCT01321073|The University of Alabama at Birmingham|Robert Bourge, M.D., Professor of Medicine, Radiology, and Surgery|(205)934-7400|bbourge@uab.edu|
20508565|NCT02291445|Maastricht University (Medical Center)|Z. Weerts||z.weerts@maastrichtuniversity.nl|
20566968|NCT03212638|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20566969|NCT02831816|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
20566970|NCT02686658|IVERIC Bio, Inc.|Medical Director|609-474-6755|info@ivericbio.com|
20566971|NCT00758550|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20566972|NCT05250206|Indizen Optical Technologies (Madrid), Universidad Complutense de Madrid|Director of Clinical Trials|+34 (91) 833 37 86|evachamorro@iot.es|
20566973|NCT02581137|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
20566974|NCT03476798|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
20566975|NCT06269003|University of Hawaii Cancer Center|Donghee Nicole Lee, Assistant Professor|8084418184|nlee@cc.hawaii.edu|
20566976|NCT05865392|University of Colorado|Dr. Danielle M. Ostendorf|3037249203|danielle.ostendorf@cuanschutz.edu|
20566977|NCT04162873|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20566978|NCT04447027|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
20566979|NCT04118894|Stryker|Jennifer Seidman, Manager, Clinical Research|9016338616|jennifer.seidman@stryker.com|
20566980|NCT03496766|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20566981|NCT03187223|Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland|Prof Dr. Thomas Pabst|+41 31 63 2 84 30|Thomas.Pabst@insel.ch|
20566982|NCT04700904|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
20566983|NCT02808468|University of Washington|Dr. Michele Bedard-Gilligan|206-616-4215|mab29@uw.edu|
20571666|NCT04897841|University of Wisconsin - Madison|Sharon Blohowiak|608-417-6957|sblohowiak@wisc.edu|
20571667|NCT02603328|University of Chicago, Medicine and Biological Sciences Division|Agnieszka Stadnik|773-702-8996|astadnik@bsd.uchicago.edu|
20571668|NCT00918879|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20571669|NCT00357110|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20571670|NCT03425097|Stanford University|Thomas A Zikos, MD|(408) 426-5599|zikosta@stanford.edu|
20571671|NCT03339245|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
20571672|NCT00515671|IUPUI|Michelle Salyers|317-274-2904|mpsalyer@iupui.edu|
20571673|NCT00288639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20571674|NCT01283152|Baylor University Medical Center|Robert S. Rahimi, M.D., M.S.C.R. Assistant Professor, Department of Medicine|214-820-8500|Robert.Rahimi@Baylorhealth.edu|
20571675|NCT00567567|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
20571676|NCT03433677|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20571677|NCT03330405|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571678|NCT01736189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20571679|NCT04210427|Saint Louis University|Purnima Modi|3149772029|purnima.modi.1@slu.edu|
20571680|NCT03512964|Johns Hopkins University School of Medicine, Division of Infectious Diseases|Joyce Jones, MD|443-287-8530|jjone154@jhmi.edu|
20571681|NCT01499303|AstraZeneca|Bernadette Weidman|800-456-3669|ClinicalTrialTransparency@astrazeneca.com|
20571682|NCT00608868|Medical, Astrazeneca Korea|Hui Jung Sin||huijung.sin@astrazeneca.com|
20571683|NCT00626626|Penn State Hershey Medical Center|Dr David Claxton|717-531-8401|dclaxton@hmc.psu.edu|
20571684|NCT00702962|MSHERSHEY MC|Dr. C. Belani|717-531-1078|cbelani@psu.edu|
20571685|NCT02476175|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
20571686|NCT01252355|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20571687|NCT02175641|Washington Universtiy in St. Louis|Leopoldo J. Cabassa, Associate Professor|314-935-2829|ljcabassa@wustl.edu|
20571688|NCT02931253|The Donald Guthrie Foundation for Education and Research|Pramod Deshmukh, MD|570 887 2284|Pramod.Deshmukh@guthrie.org|
20571689|NCT05435482|University of California, San Francisco|Ji Won Choi|415.340.1434|jiwon.choi@ucsf.edu|
20571690|NCT01923467|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
20571691|NCT02242097|Northwestern University, Feinberg School of Medicine|Dr. Reem Karmali|(312) 695-0990|reem.karmali@northwestern.edu|
20571692|NCT03435692|Seattle Children's Hospital|David E. Liston, MD, MPH|206-987-3996|david.liston@seattlechildrens.org|
20571693|NCT01145898|Indiana University|Alon Harris|317-278-00177|alharris@indiana.edu|
20571694|NCT02440425|Moffitt Cancer Center|Robert M. Wenham, MD, MS, FACOG, FACS|813-745-5739|Robert.Wenham@moffitt.org|
20571695|NCT01701102|Hospital for Special Surgery|Jennifer Cheng|212-774-7377|chengj@hss.edu|
20571696|NCT03750786|Isofol|Karin Gedda|+46 (0) 729 9453 37|karin.gedda@isofolmedical.com|
20571697|NCT00780559|University of Maryland School of Medicine|Clinical Research Coordinator|(410) 328-6583|inmed@som.umaryland.edu|
20571698|NCT04462289|Minneapolis VA Health Care System|Dr. Anne Melzer|6124674413|anne.melzer2@va.gov|
20547321|NCT02788474|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20547322|NCT00755911|University of Michigan|Darnell Kaigler|734-998-1468|dkaigler@umich.edu|
20547323|NCT00245583|Icahn School of Medicine at Mount Sinai|Dr. Heather Berlin|212-241-4761|heather.berlin@mssm.edu|
20547324|NCT04718103|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20547325|NCT01343901|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20547326|NCT01369485|Ethicon Surgical Care|John Lombard, Manager Clinical Research|908 218 2877|Jlombar8@its.jnj.com|
20547327|NCT02721979|University of Washington|Dr. Michael Schweizer|(206) 606-6252|schweize@uw.edu|
20547328|NCT02764190|Seattle Children's Research Institute|Cari McCarty|206-884-8243|Carolyn.McCarty@seattlechildrens.org|
20547329|NCT01484938|Alcon Research, Ltd.|Jami Kern, Ph.D., Global Medical Affairs|800-862-5266||
20547330|NCT00708071|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
20547331|NCT02140775|New York State Psychiatric Institute|Dr. Martin McElhiney|646.774.8035|mcelhin@nyspi.columbia.edu|
20547332|NCT03696927|Abilitech Medical|Director of Clinical and Product Management|833.225.3123|info@abilitechmedical.com|
20547333|NCT02942576|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
20547334|NCT00945854|Federico II University|Riccardi Gabriele|+390817462117|riccardi@unina.it|
20571699|NCT01766713|UCSD|Rohit Loomba|858-534-2624|roloomba@ucsd.edu|
20547335|NCT00938964|Duke University Health System|Joseph Mathew, M.D|919-681-6646|joseph.mathew@duke.edu|
20571700|NCT02205034|CHU Toulouse|Pr Maithe Tauber|+33534558551|tauber.mt@chu-toulouse.fr|
20571701|NCT04343976|Massachusetts General Hospital|Sponsor-Investigator|617-724-3836|chung.raymond@mgh.harvard.edu|
20571702|NCT02807883|University of Texas MD Anderson Cancer Center|Partow Kebriaei, MD / Stem Cell Transplantation Department|713-745-0663|pkebriae@mdanderson.org|
20571703|NCT00694109|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20571704|NCT00846807|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571705|NCT00201877|The Ohio State University Comprehensive Cancer Center|Kristie Blum, MD|614-293-4519|Kristie.Blum@osumc.edu|
20547336|NCT01765803|University of New Mexico|Stuart Winter, MD|505-272-4461|SWinter@salud.unm.edu|
20547337|NCT01227564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547338|NCT04650854|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20547339|NCT00194675|VA Puget Sound Health Care System|Alvin M. Matsumoto, MD|(206) 764-2760|alvin.matsumoto@med.va.gov|
20547340|NCT05308290|Stanford University|Charles Brown, MD PhD|6504983512|chbrown@stanford.edu|
20547341|NCT01285960|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
20547342|NCT00667420|MassGH|David P. Ryan|617-724-0245|dpryan@partners.org|
20547343|NCT04867434|Raziel Therapeutics|Dr. Racheli Gueta, Director of Clinical Trials|97289124670|racheli@raziel-therapy.com|
20547344|NCT00586196|BIDMC|Edward R Marcantonio|617-754-1405|emarcant@bidmc.harvard.edu|
20547345|NCT01490788|Tonix Pharmaceuticals, Inc.|Greg Sullivan, MD||greg.sullivan@tonixpharma.com|
20547346|NCT00995865|GE Healthcare- Life Sciences|Amanda Culliton|1-508-683-2232|Amanda.Culliton@ge.com|
20547347|NCT00410202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20547348|NCT00144027|Central Arkansas Veterans Healthcare System|Jeff Pyne|501-257-1083|jeffrey.pyne@va.gov|
20547349|NCT05080660|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20547350|NCT01520454|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
20547351|NCT04221230|Neumora Therapeutics, Inc.|Study Contact|+1- (857) 760-0900|clinicaltrials@neumoratx.com|
20547352|NCT00048893|National Cancer Institute (NCI), National Institutes of Health (NIH)|Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
20547353|NCT03119701|Faron Pharmaceuticals Ltd|Chief Medical Officer|+3584005529411|medical@faron.com|
20547354|NCT02043379|UAB Pediatric Cardiac Critical Care Medicine|Jeffrey Alten, MD|(205) 975-3123|jalten@peds.uab.edu|
20547355|NCT02125604|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20547356|NCT04340063|Edward Hines Jr. VA|Dr. Keith Gordon|(312) 503-3339|keith.gordon2@va.gov|
20547357|NCT01030783|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|617-588-1960|Clinical@aveooncology.com|
20547358|NCT05824741|Penn State College of Medicine|Ian Paul|(717) 531-8006|ipaul@pennstatehealth.psu.edu|
20547359|NCT00911742|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20547360|NCT03670836|Columbia University Medical center|Rachana Gavara|914-356-2730|rg2460@cumc.columbia.edu|
20571706|NCT02193490|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
20571707|NCT02299414|University of Alabama at Birmingham|Dr. Alan Tita|(205) 934-9616|atita@uabmc.edu|
20571708|NCT03686423|NYU Langone Health|Ryan Brown, PhD|2122633396|Ryan.Brown@nyulangone.org|
20547361|NCT00396032|Genentech, Inc.|Medical Communications|800-821-8590||
20547362|NCT00572897|Univeristy of Illinois Hospital & Health Sciences System|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
20571709|NCT04608773|University of Pittsburgh|Anne Fisher|4126479665|amf91@pitt.edu|
20547363|NCT00606944|Seoul National University Bundang Hospital|Sung-Bum Kang|+82-31-787-7093|kangsb@snubh.org|
20547364|NCT03875118|National Taipei University of Nursing Health and Sciences|Director of Nursing Department|886-2-28227101|tsaejyy@ntunhs.edu.tw|3118
20547365|NCT02237911|University of Pittsburgh|Dr. Sara Piva|(412) 383-6712|spiva@pitt.edu|
20547366|NCT02423109|CooperVision|Myhanh Nguyen, OD|9257306716|mnguyen@coopervision.com|
20547367|NCT02428608|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
20547368|NCT04521777|UT MD Anderson Cancer Center|An T Ngo-Huang, Assistant Professor, Rehabilitation Medicine|(713) 745-2327|ango2@mdanderson.org|
20547369|NCT04060862|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20547370|NCT02477423|Neonatology, Department of Pediatrics, University of Chicago|Dr. Christina S. Kim|773-702-6210|christinakim13@gmail.com|
20547371|NCT01143207|FHI 360|Vera Halpern, MD|919-54-7040|vhalpern@fhi360.org|11390
20547372|NCT01813110|Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
20547373|NCT00048061|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20547374|NCT03555435|National Center for PTSD|Eve Carlson|6504935000|eve.carlson@va.gov|24058
20547375|NCT01828515|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
20547376|NCT00992927|Seoul National University Hospital|Sun Gun Chung/Professer|+82-2-2072-3954|suncg@snu.ac.kr|
20547377|NCT01601431|Baylor College of Medicine|Mohamed Othman, M.D.|713 798 0947|mohamed.othman@bcm.edu|
20547378|NCT02169284|University of Wisconsin Carbone Cancer Center|Dr. Tracy Downs|608-263-9534|downs@urology.wisc.edu|
20547379|NCT04341662|University of Birmingham|Dr Adam Devall|+447971823452|a.j.devall@bham.ac.uk|
20547380|NCT05014490|"PrJSC Pharmaceutical Firm Darnytsia"|Andrii Doroshenko, PhD, MD|+38 044 207 73 53|a.doroshenko@darnytsia.ua|
20547381|NCT05078138|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@health.mil|
20547382|NCT02273739|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20547383|NCT01309893|Bausch & Lomb|Dr. Robert Steffen|585 338-6399|robert.steffen@bausch.com|
20547384|NCT01879540|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20547385|NCT03370289|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20547386|NCT00922701|University G. D'Annunzio|Mario Bonomini, M.D.|+39 0871 540120|m.bonomini@nephro.unich.it|
20547387|NCT00873860|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
20547388|NCT00236951|Luitpold Pharmaceuticals|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
20547389|NCT01858636|St. Jude Medical|Andrew Campbell|+1.651.756.5538|acampbell2@sjm.com|
20547390|NCT02139800|Children's Hospital of Philadelphia (CHOP)|Dr. Haresh Kirpalani|215-590-2455|kirpalanih@email.chop.edu|
20547391|NCT02862600|Heart Metabolics, Ltd.|Mark G. Midei, MD, Executive Director and Head of Cardiology|4103715357|markgmidei@gmail.com|410
20547392|NCT04859114|Medical College of Wisconsin|Mir A Basir|4142666820|mbasir@mcw.edu|
20547393|NCT02378025|Veterans Affairs Palo Alto Healthcare System|Dr. Peter Bayley|650 493-5000|peter.bayley@va.gov|
20547394|NCT01017575|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
20547395|NCT04437368|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20547396|NCT03500679|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20547397|NCT04186481|Smith+Nephew, Inc.|Alison Walker, Regional Operation Manager ANZ|+61 466 322 200|Alison.walker@smith-nephew.com|
20547398|NCT00095628|London Regional Cancer Centre|Dr. Eric Winquist|519-685-8600|eric.winquist@lhsc.on.ca|53243
20547399|NCT04271280|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20547400|NCT02280473|Allergan plc|Michael Robinson|1-714-246-6415|Robinson_Michael@Allergan.com|
20547401|NCT01388920|Theratechnologies|Senior Medical Advisor|514-336-7800|jmamputu@theratech.com|
20547402|NCT02034422|Salt Lake City VAMC|Joel Trinity, PhD|801-582-1565|joel.trinity@va.gov|1794
20547403|NCT01280955|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|mitchel.horwitz@duke.edu|
20547404|NCT03014492|Cincinanti Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
20547405|NCT01484054|Johnson & Johnson Vision Care|Michael Mayers, OD, FAAO|904-443-3252|mmayers@its.jnj.com|
20547406|NCT01539317|Oregon Health and Science University|Dr. Martha Goetsch|503-494-3666|whru@ohsu.edu|
20547407|NCT04223232|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
20547408|NCT00364130|Children's Hospital of Philadelphia|Mary Leonard, MD, MSCE|215-590-0874|leonard@email.chop.edu|
20547409|NCT05281601|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20547410|NCT00901927|The University of Texas (UT) MD Anderson Cancer Center|Nathan Fowler/Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
20547411|NCT01860573|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org|
20547412|NCT04490239|University of Mississippi|Dr. Joshua Sharp|662-915-1758|jsharp@olemiss.edu|
20547413|NCT01352468|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
20547414|NCT01178073|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547415|NCT01674634|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20556353|NCT05095272|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Patrick E. Duffy; Lab Chief|240.381.1317|patrick.duffy@nih.gov|
20556354|NCT03610464|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
20547416|NCT00937391|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20571710|NCT02833077|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20571711|NCT01077518|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20571712|NCT03524092|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20571713|NCT04303780|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20571714|NCT05718466|Henry Ford Health System|Marissa Gilbert|313-556-8422|mgilber6@hfhs.org|
20571715|NCT00387426|UT MD Anderson Cancer Center|Srdan Verstovsek, MD / Associate Professor||eharriso@mdanderson.org|
20571716|NCT01253135|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20571717|NCT01901432|ITALFARMACO S.p.A.|Medical Expert|+39 026443 258|p.bettica@italfarmaco.com|
20571718|NCT00379288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20571719|NCT01015560|SWOG Statistical Center|Study Statistician|206-667-4623||
20571720|NCT03149809|Atlanta VA Health Care System|E. Camille Vaughan, MD, MS|404 315 4100|elizabeth.vaughan2@va.gov|373100
20571721|NCT01692951|Cleveland Clinic Foundation|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
20571722|NCT01174576|Harokopio University|Dr. Mary Yannakoulia|00302109549175|myianna@hua.gr|
20571723|NCT01255631|CUMC Plastic Surgery|Christine Rohde|212-342-3707|chr2111@cumc.columbia.edu|
20571724|NCT00384774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20571725|NCT02815579|University of California, San Francisco|Dr. Sheri Weiser|(628) 206-2427|Sheri.Weiser@ucsf.edu|
20571726|NCT00264303|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20571727|NCT02389452|Sanofi|Trial Transparency Team||Contact --US@Sanofi.com|
20571728|NCT02311673|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20571729|NCT02385240|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20571730|NCT01006252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20571731|NCT01014208|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571732|NCT02566044|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
20571733|NCT02683772|ResMed|Maureen Crocker, Manager Medical Affairs|8588366653|maureen.crocker@resmed.com|
20547417|NCT04533685|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20547418|NCT05223335|Mayo Clinic|Mandeep Singh, M.D.|507-255-2398|Singh.Mandeep@mayo.edu|
20571734|NCT00769652|Rutgers Cancer Institute of New Jersey|Dr. Elizabeth Poplin, MD (sub-investigator)|732-235-8675|poplinea@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20571735|NCT00414908|Abbott Products|Sven Voet - Global Communication|+41 61 487 08 56|sven.voet@abbott.com|
20571736|NCT01076153|Abbott|Global Medical Services|1-800-633-9110||
20571737|NCT04165031|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20571738|NCT00818168|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20571739|NCT04045964|The University of Texas Health Science Center at Houston|Angela Stotts, PhD|(713) 500-7590|Angela.L.Stotts@uth.tmc.edu|
20571740|NCT03809039|Mitsubishi Tanabe Pharma Europe Ltd|Clinical Trials, Information Desk|Please e-mail|regulatory@mt-pharma-eu.com|
20571741|NCT02658877|NYU Langone Health|Joan Reibman|212 263 6479|Joan.Reibman@nyulangone.org|
20571742|NCT03853551|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|8772409479
20571743|NCT03417544|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-3800|Nancy_Lin@dfci.harvard.edu|
20571744|NCT00818779|Texas Tech University Health Sciences Center School of Medicine|Gary Meyerrose|806-743-3150|gary.meyerrose@ttuhsc.edu|
20571745|NCT00743431|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20571746|NCT03309813|Insightec|Nadir Alikacem, VP Global Regulated Clinical Affairs|214-630-9900|NadirA@Insightec.com|
20571747|NCT04978493|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571748|NCT01128114|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
20571749|NCT02206061|University of Rochester|Jill Halterman, MD|5852755798|jill_halterman@urmc.rochester.edu|
20571750|NCT04187326|UMass Chan School of Medicine|Dr. Elliot Edmiston, Associate Professor of Psychiatry & Behavioral Sciences|5088566480|kale.edmiston@umassmed.edu|
20571751|NCT02654652|Universidade Federal de Minas Gerais|Dr. Maria Isabel Correia|+55 31 34098033|isabel_correia@uol.com.br|
20571752|NCT02738853|Medtronic|Phuong-Uyen Le|763-526-0989|phuong-uyen.n.le@medtronic.com|
20571753|NCT01390870|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571754|NCT00316017|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
20571755|NCT04157400|MUSC|Nathan Rowland|843-792-6590|rowlandn@musc.edu|
20571756|NCT01809834|School of Optometry, University of Waterloo|Lyndon Jones, PhD, FCO|519-888-4742|ljones@uwaterloo.ca|
20571757|NCT03599687|Yorkshire Ambulance Service NHS Trust|Richard Pilbery|+447463734823|r.pilbery@nhs.net|
20571758|NCT01800890|Coloplast A/S|Marian Sinvani|+45 4911 2356|dkmards@coloplast.com|
20571759|NCT01803282|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20571760|NCT01949389|VA Connecticut Healthcare system|Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
20547419|NCT00245219|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|Scheier@cmu.edu|
20547420|NCT00723931|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20547421|NCT01232205|Dept Obstetrics Gynecology Indonesia University|Yuditiya Purwosunu|+44 753 870 6897|yudi@med.showa-u.ac.jp|
20571761|NCT02671500|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20571762|NCT01807000|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20547422|NCT02945787|Moffitt Cancer Center|Thomas H. Brandon PhD|813 745-1750|Thomas.Brandon@moffitt.org|
20547423|NCT02021656|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20547424|NCT00510952|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20547425|NCT01604109|ThammasatU|Thanya Sitthisettapong|6629869213|thanyasang@yahoo.com|7150
20547426|NCT04808999|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20547427|NCT03172910|Apollo Investment Management|Scientific Advisor|+352 2088 1301|rchari@kaiperheathcare.com|
20547428|NCT04070144|Injeq|Chief Scientific Officer|+358405805944‬|info@injeq.com|
20547429|NCT01659658|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20547430|NCT01847001|Columbia University Medical Center|Dr. Kevin Kalinsky|212-305-1925|cancerclinicaltrials@cumc.columbia.edu|
20547431|NCT04233034|Jaeb Center for Health Research|Colleen Bauza|813-975-8690|cbauza@jaeb.org|
20547432|NCT02247531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20547433|NCT03347188|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20547434|NCT03468985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20547435|NCT00842764|Department of Otolaryngology/UCI|Brian J Wong, MD, PhD|7144565753|bjwong@uci.edu|
20547436|NCT01278303|Johns Hopkins Hospital|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
20547437|NCT01869725|University of Iowa|M. Sue O'Dorisio, MD, PhD|319-335-7234|sue-odorisio@uiowa.edu|
20547438|NCT04457973|University of Arizona|Dr. Hyochol Ahn|520-626-1769|hbrian@arizona.edu|
20547439|NCT02960997|Stanford University|Joyce Teng, MD, PhD|(650) 724-9627|jteng3@stanford.edu|
20547440|NCT04824365|Emphycorp/Cellular Sciences, inc.|Dr. Alain Martin|9082371561|dr.martin@erols.com|
20571763|NCT02870049|UC San Diego|Samir Gupta, MD|07/09/2018|s1gupta@health.ucsd.edu|
20547441|NCT03416374|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20547442|NCT03463031|Glenmark Pharmaceuticals Ltd|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20547443|NCT01068652|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20547444|NCT00417482|New York State Psychiatric Institute|Davangere P. Devanand, MD|212-543-5612|dpd3@columbia.edu|
20547445|NCT03739840|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20547446|NCT01323946|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547447|NCT01058265|Mayo Clinic in Arizona|Larry Bergstrom, MD|480-301-7108|bergstrom.larry@mayo.edu|
20547448|NCT01243671|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20547449|NCT02869438|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
20547450|NCT02962765|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
20527644|NCT04400656|Imperial College London|Ms Puja Jadav|0203 311 5473|p.jadav@imperial.ac.uk|
20527645|NCT05600036|Alumis Inc.|SVP, Development Operations|(650) 231-6625|clinicaltrials@alumis.com|
20527646|NCT06010732|Indiana University School of Dentistry|Domenick T. Zero|3179877507|dzero@iu.edu|
20547451|NCT03583073|Brown U|Anthony Spirito|4013692435|anthony_spirito@brown.edu|
20547452|NCT02964507|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20547453|NCT02340715|Medical College of Wisconsin|Ergun Ahunbay|4148057898|eahunbay@mcw.edu|
20547454|NCT05323656|Calliditas Therapeutics AB|Head of Clinical Operations|+4684113005|info@calliditas.com|
20547455|NCT02495233|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20547456|NCT03880461|Kaiser Permanente Northern California|Monique Hedderson, Ph.D.|925-520-0785|monique.m.hedderson@kp.org|
20547457|NCT00672204|University of Minnesota|Bernhard J. Hering, M.D.|612-626-5735|bhering@umn.edu|
20547458|NCT03862040|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20547459|NCT01028378|Clinical Research Consultants, Inc.|Barbara S. Fant, Pharm.D.|513-961-8200|bsfant@crc-regulatory.com|
20547460|NCT00645710|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20547461|NCT01115803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20547462|NCT00064298|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20547463|NCT03614975|University of Pittsburgh, Department of Family Medicine|Richard Zimmerman, MD|412-383-2354|zimmrk@upmc.edu|
20547464|NCT00450385|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
20547465|NCT01390220|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
20547466|NCT03533686|University of Miami|Dr. Hillary Snapp|305-243-4611|hsnapp@med.miami.edu|
20547467|NCT00136604|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547468|NCT02017171|Joslin Diabetes Center|Dr. Alessandro Doria (Sponsor and PI of the study)|617-319-0970|alessandro.doria@joslin.harvard.edu|
20547469|NCT01562873|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|Nancy_Lin@dfci.harvard.edu|
20547470|NCT02398409|VHA|Dr. Virginia (Daggett) Wilder|307-675-3659|virginia.wilder@va.gov|
20547471|NCT02536833|Samumed|Christopher Swearingen, PhD, VP of Clinical Outcomes and Analytics|858.926.2952|chris@samumed.com|
20527647|NCT03699540|University of Kentucky|Shanna Babalonis, Ph.D.|859-257-1881|babalonis@uky.edu|
20547472|NCT02220998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20547473|NCT01172275|Yale University|Dr. Michael H. Bloch|203-737-4809|michael.bloch@yale.edu|
20527648|NCT02066727|Tianjin Medical University General Hospital|Dr Yuechun LU|15902233666|luyuechun@sina.com|
20547474|NCT01158703|BROOKE ARMY MEDICAL CENTER|AHMAD M. SLIM, MD, LTC, MC|210-916-4717|AHMAD.SLIM@US.ARMY.MIL|
20527649|NCT05460078|Atrium Health|Dr. Jason Roberge|7043550268|jason.roberge@atriumhealth.org|
20547475|NCT02239627|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20556355|NCT03294330|Penn State College of Medicine|Colette Pameijer|717-531-5272|cpameijer@pennstatehealth.psu.edu|
20547476|NCT00413166|The University of Texas (UT) MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, Professor, Leukemia|7137927734|fravandi@mdanderson.org|
20571764|NCT05686122|Duke University School of Medicine|Sarah Kelleher, PhD|919-416-3405|sarah.kelleher@duke.edu|
20547477|NCT04638673|Medical University of South Carolina|Dr. Mark S. George|843-876-5142|georgem@musc.edu|
20571765|NCT05235269|Attralus|Scott Stephens, Senior Director Clinical Operations|321-228-7400|sstephens@attralus.com|
20547478|NCT01977937|OHSU|Dr Elizabeth Pedigo|5039705211|pedigo@ohsu.edu|
20571766|NCT05511038|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20571767|NCT03746392|University of Washington|Program Coordinator (Elizabeth Nielsen)|206-744-9516|eniels9@uw.edu|
20571768|NCT05543187|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20571769|NCT03810235|School of Medicine and Public Health University of Wisconsin-Madison|Kathleen M. Antony, M.D, M.S.C.I|608-417-6099|kantony@wisc.edu|
20571770|NCT04777864|Seattle Children's Research Institute|Dr. Emily Kroshus|206-884-5326|Emily.Kroshus@seattlechildrens.org|
20571771|NCT01198067|M.D. Anderson Cancer Center|Sheeba K. Thomas, MD|713-792-2860|sthomas@mdanderson.org|
20571772|NCT00798434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571773|NCT04522921|Department of Clinical Medicine, Aarhus University / Steno Diabetes Center Aarhus, Aarhus University Hospital|Dorthe Dalstrup Pauls|+45 28256406|dorthedalstrup@clin.au.dk|
20571774|NCT01217437|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20571775|NCT00871286|Northwestern|Rakesh Chandra|312-695-8182|rchandra@nmff.org|
20571776|NCT03682185|University of Pennsylvania|Dr. Nancy A. Hodgson|215-573-7387|hodgsonn@nursing.upenn.edu|
20571777|NCT04908631|Duke University|Howard W. Francis, MD|919-681-8069|howard.francis@duke.edu|
20571778|NCT00558792|Bracco Diagnostics Inc|Usha Halemane, Executive Director of Medical Biometrics and Medical Writing|609-514-2578|usha.halemane@diag.bracco.com|
20571779|NCT02336451|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20571780|NCT00462605|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
20571781|NCT03548220|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
20547479|NCT00392821|Sarah Cannon Research Institute|John D Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20547480|NCT03004443|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
20547481|NCT00828854|Syndax Pharmaceuticals, Inc.|Michael Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
20547482|NCT00915356|AstraZeneca|Gerard Lynch||clinicalTrialTransparency@astrazeneca.com|
20547483|NCT01782833|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
20547484|NCT03425019|The University of Texas Health Science Center at Houston|Hyochol Ahn|(713) 500-2179|hahn@fsu.edu|
20547485|NCT00191646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20547486|NCT02595996|Columbia University Irving Medical Center|June K. Wu, MD|212-342-3704|jw92@cumc.columbia.edu|
20547487|NCT03194490|Loma Linda University|Dr. Everett Lohman III|(909) 558-4632|elohman@llu.edu|83171
20547488|NCT01505647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20547489|NCT01574079|University of Mississippi Medical Center|Principle investigator|601-984-6369|lbarnes@umc.edu|
20547490|NCT00406718|UT_SanAntonio UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
20547491|NCT05032859|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20547492|NCT02153710|University of Washington|Diane Kendall|2066160537|dkendall@uw.edu|
20547493|NCT01927341|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547494|NCT01397201|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20547495|NCT04088656|University of Washingtion|Carmen Hazim|4042451459|chazim@uw.edu|
20547496|NCT00451451|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20547497|NCT00122278|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
20547498|NCT01002482|CH Chartres|Dr. Pierre Kalfon|003323730303073|pkalfon@ch-chartres.fr|
20547499|NCT03861611|Montefiore Medical Center|Eddie Irizarry, MD|718-904-2104|eddiriza@montefiore.org|
20547500|NCT01948310|Duke Medical Center|Leslie Willis|9196606782|leslie.willis@duke.edu|
20547501|NCT01557894|Babes-Bolyai University|Bogdan Tudor Tulbure|+40745753061|btulbure@gmail.com|
20547502|NCT03402659|EIP Pharma|Jennifer Conway, Associate Director of Clinical Development|(617) 744-4400|jconway@eippharma.com|
20547503|NCT00695578|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
20571782|NCT03446001|TauRx Therapeutics Management Ltd.|Sotereos Gates, PhD|+44 (0) 7771 570707|s.gates@taurx.com|
20547504|NCT01442038|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20547505|NCT00089284|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
20547506|NCT03956056|Washington University School of Medicine|William Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
20571783|NCT01736943|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20547507|NCT02128828|University of Hawaii|Dr. Cecilia Shikuma|808 692-1328|shikuma@hawaii.edu|
20547508|NCT00090051|Hoffmann-La Roche|Medical Communications||global.clinical_trial_registry@roche.com|
20547509|NCT01298531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547510|NCT01229397|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20547511|NCT00608543|UT Southwestern Medical Center|Dr.Prabha Sunderajan|214-648-0156|prabha.sunderajan@utsouthwestern.edu|
20547512|NCT03051646|Columbia University Medical Center|Victoria M. Leavitt|212 342 1351|vl2337@cumc.columbia.edu|
20547513|NCT01742936|Nationwide Children's Hospital|Vidya Raman, MD|614-722-4200|Vidya.Raman@nationwidechildrens.org|
20547514|NCT01251744|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547515|NCT00214500|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20547516|NCT02147184|Baylor College of Medicine|Dr. Chadi Calarge|832-824-4764|chadi.calarge@bcm.edu|
20547517|NCT01880047|Weill Cornell Medicine|Sujit Sheth|2126463400|shethsu@med.cornell.edu|
20547518|NCT06400979|University of California, Davis Medical Center|Carolyn Mofidi, RN-BC, BSN, MS-L|(916) 734-3333|cmofidi@ucdavis.edu|
20547519|NCT01287078|National Heart Lung and Blood Institute|Dr Richard Childs|301-451-7128|childsr@nhlbi.nih.gov|
20547520|NCT00117286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20547521|NCT02343081|FLENI- mrc (FLENI Multi-specialty Research Center)|Dr. Alejandro Muggeri (Principal Investigator)|54-11-5777 3200|alemuggeri@hotmail.com.ar|2020
20547522|NCT06207435|University of Pennsylvania|Dr. Farouk Dako|2673091241|farouk.dako@pennmedicine.upenn.edu|
20547523|NCT00750880|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20547524|NCT01257802|University of Michigan|W Joseph McCune MD Professor of Rheuntic Diseases University of Michigan|734 936 5560|jmccune@med.umich.edu|
20547525|NCT02675231|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20571784|NCT00890695|KEMRI/Wellcome Trust Research Programme|Dr James Berkley|+254 41 522535|jberkley@kilifi.kemri-wellcome.org|
20571785|NCT01802151|Department of Food Science and Human Nutrition, University of Florida|Dr. Wendy Dahl|352-392-1991|wdahl@ufl.edu|224
20571786|NCT00129480|Portland VA Medical Center|Steven K. Dobscha MD|503-220-8262|steven.dobscha@va.gov|52207
20571787|NCT00926497|Children's Hospital of Lucerne|Martin Stocker, MD|0041412051288|martin.stocker@ksl.ch|
20571788|NCT00833261|UT Southwestern Medical Center|Dr. Lucien Nedzi|214-645-7653|lucien.nedzi@utsouthwestern.edu|
20571789|NCT03439254|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20571790|NCT00837694|University at Buffalo|Jennifer L. Temple|716-829-5593|jltemple@buffalo.edu|
20571791|NCT01008553|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
20571792|NCT01663922|St Stephens AIDS Trust|Dr Akil Jackson|0203 315 6503|akil.jackson@chelwest.nhs.uk|
20571793|NCT02324608|Cancer Institute of New Jersey Rutgers|Dr. Adam Berger|732-235-8675|ab2047@cinj.rutger|
20547526|NCT01525173|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20547527|NCT02961218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20547528|NCT04616027|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571794|NCT03482466|Baylor College of Medicine; Michael E. DeBakey VA Medical Center; Menninger Clinic|Ramiro Salas|7137983502|rsalas@bcm.edu|
20571795|NCT04552899|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20571796|NCT00673959|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20571797|NCT00731133|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
20547529|NCT01462227|Yale University|Robert Stanley Sherwin, MD|203 737 1932|robert.sherwin@yale.edu|
20547530|NCT00591266|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20547531|NCT01234207|UCaliforniaBerkeley|Andrew D. Graham|510-643-9252|agraham@berkeley.edu|
20571798|NCT02383940|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20508566|NCT04737759|Boston College|Dr. Karen Lyons|6175526379|karen.lyons@bc.edu|
20508567|NCT01484561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508568|NCT03371251|Boston Pharmaceuticals, Inc.|Etienne Dumont, MD|(484) 986 8699|clinicaltrials@bostonpharmaceuticals.com|
20508569|NCT04362813|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20508570|NCT02023268|Laboratoires Théa|Dr Pascale Pouliquen|04 73 98 14 36|p.pouliquen@laboratoires-thea.fr|
20508571|NCT00660075|Laval University|Patrick Couture|418-654-2106|patrick.couture@crchul.ulaval.ca|
20527650|NCT02697591|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20547532|NCT00586846|Memorial Sloan Kettering Cancer Center|Dr. Paul Meyers|212-639-5952|meyersp@mskcc.org|
20547533|NCT03737851|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20547534|NCT05298306|Lateral Pharma|Dr Stuart Mudge|+61424588904|sm@lateral-pharma.com|
20547535|NCT01482351|George Mason University|Dr. Kathy C. Richards|(703) 946-3725|kricha11@gmu.edu|
20547536|NCT03497676|Family Health International (FHI 360)|IMPAACT ClinicalTrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20508572|NCT01150760|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20547537|NCT03496571|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20547538|NCT00484718|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547539|NCT01226043|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20547540|NCT02204007|Cleveland Clinic Foundation|Dr. Carlos A Higuera, MD|2166361136|higuerc@ccf.org|
20547541|NCT01702571|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20547542|NCT00910988|Washington University|Julie Schweiger/Michael Yingling|3143623153/5735791412|schweigj@psychiatry.wustl.edu/yinglinm@psychiatry.wustl.edu|
20547543|NCT00322101|Fred Hutchinson Cancer Research Center|Bart Lee Scott|206-667-1990|bscott@fhcrc.org|
20547544|NCT01753739|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20547545|NCT05211284|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
20547546|NCT03911843|Azienda Ospedaliero-Universitaria di Novara, Italy|Dr. Francesco Cadario, Head of the Pediatric Diabetology service|+39 347 226 6507|francesco.cadario@gmail.com|
20547547|NCT01907100|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20547548|NCT02865343|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
20547549|NCT00667602|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20547550|NCT01594385|St. Luke's University Health Network|Stanislaw P. Stawicki, M.D.|484-526-4426|stanislaw.stawicki@sluhn.org|
20547551|NCT00285467|Indiana University School of Medicine|Sharon Moe, MD|317-278-2868|smoe@iupui.edu|
20547552|NCT03640559|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|189
20547553|NCT01436162|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20547554|NCT01888003|University of Alabama at Birmingham Department of Anesthesiology and Perioperative Medicine|Dr. Thomas Vetter|205.934.6501|tvetter@uab.edu|
20547555|NCT03187756|Perlmutter Cancer Center, NYU Langone Health|David Kaminetzky, MD|212-731-5855|David.Kaminetzky@nyulangone.org|
20547556|NCT01535664|Acorda Therapeutics, Inc.|Gustavo Suarez, MD|(914) 326-5394|gsuarez@acorda.com|
20547557|NCT01931202|New York State Psychiatric Institute|Bret R. Rutherford|6467748660|bret.rutherford@nyspi.columbia.edu|
20547558|NCT04597918|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20547559|NCT00395538|Rho, Inc|Robert James|(919) 595-6468|robert_james@rhoworld.com|
20547560|NCT01876810|Centre for Addiction and Mental Health|Bernard LeFoll|416-535-8501|bernard.lefoll@camh.ca|34772
20547561|NCT01069185|Pablo Tobon Uribe Hospital|Dr.Jorge Donado Research Unit Chief|+574459753|jdonado@hptu.org.co|
20547562|NCT01857583|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
20547563|NCT03120624|Mayo Clinic|Jamie N Bakkum-Gamez MD|507-284-2511|bakkum.jamie@mayo.edu|
20547564|NCT04571515|MEDA Pharma GmbH & Co. KG (A Viatris Company)|Susanne Vogt|+49 (0) 172 19 20 321|susanne.vogt@viatris.com|
20547565|NCT05140382|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20547566|NCT00931879|Eastern Virginia Medical School|Dr. Henri Parson|(757)446-7976|parsonhk@evms.edu|
20547567|NCT00401531|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20547568|NCT02437513|Protip Medical|Linda Nicolini CEO|0033388103068|l.nicolini@protipmedical.com|
20547569|NCT03092024|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
20547570|NCT03403374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20547571|NCT04879225|Wake Forest University School of Medicine|Emily Harwood|8284067599|eaharwoo@wakehealth.edu|
20547572|NCT03257696|Groupe Hospitalier de la Rochelle Ré Aunis|Dr. Camille Bonnin|+0546455050|camille.bonnin@ght-atlantique17.fr|
20547573|NCT00736957|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K. 5-2, Nishi-kanda 3-chome, Cyiyoda-ku, Tokyo 101-0065 JAPAN|Medical Director|+81-3-4411-5509||
20547574|NCT01092507|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20547575|NCT03646643|University of Pennsylvania|Dr. Saman Nazarian|215-615-5220|Saman.Nazarian@pennmedicine.upenn.edu|
20547576|NCT04882501|InovaHCS|Principal Investigator Inova Fair Oaks Hospital|703 391-4892|Laura.McNicholl@inova.org|
20556356|NCT00617981|Celsion Corporation|Nicholas Borys, M.D. Senior Vice President and Chief Medical Officer|609-896-9100|nborys@celsion.com|
20556357|NCT02123108|University of California Los Angeles|Dr. Fady M. Kaldas|310-825-8138|FKaldas@mednet.ucla.edu|
20556358|NCT00716092|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20547577|NCT05314478|Liverpool University Hospitals NHS Foundation Trust|Dr Tristan Payne|01517064553|tristan.payne@liverpoolft.nhs.uk|
20547578|NCT04629508|1-855-463-3463|Study Director|1-855-463-3463|medinfo@incyte.com|
20508573|NCT01170949|University Charité Berlin|Markus Magerl|+4930450618304|markus.magerl@charite.de|
20508574|NCT01202760|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508575|NCT01654523|University of Michigan|Joseph Himle - Professor|7343303258|himlej@umich.edu|
20508576|NCT04354155|Johns Hopkins All Children's Hospital|Anthony Alexander Sochet|17277672912|anthony.sochet@jhmi.edu|
20508577|NCT03380624|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|fogt.78@osu.edu|
20508578|NCT03644108|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20508579|NCT00971633|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20527651|NCT02722746|University of Florida, College of Medicine|Dr. Terrie Vasilopoulos|3522738910|tvasilopoulos@anest.ufl.edu|
20556359|NCT02219048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556360|NCT02436330|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-624-9188|alc@uic.edu|
20556361|NCT02054806|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556362|NCT01132326|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20556363|NCT00781391|Daiichi Sankyo, Inc.|James Hanyok, Sr. Director|732-590-5000|jhanyok@dsi.com|
20556364|NCT04535947|SilkTech Biopharmaceuticals|Brian Lawrence|6172720691|brianlawrence@silk-tech.com|
20556365|NCT00995501|Cleveland clinic|Daniel Sessler, MD|216-445-4900|sesseld@ccf.org|
20556366|NCT03616184|University of Nebraska Medical Center|Vijaya Bhatt|402-559-8008|vijaya.bhatt@unmc.edu|
20556367|NCT02396745|Allegheny Singer Research Institute|Mara Yerk, Administrative Director|412-389-3059|mara.yerk@ahn.org|
20556368|NCT04111757|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
20556369|NCT02133534|Duke University Medical Center|Research Practice Manager|919 681 6819|bixby001@duke.edu|
20556370|NCT04321239|University of Michigan|Mary Janevic|734 647 3194|mjanevic@umich.edu|
20556371|NCT04575051|University of Pittsburgh|Dr. Catherine Palmer|412-383-6565|cvp@pitt.edu|
20556372|NCT00526123|Tufts Medical Center|Dr. Klemens B. Meyer|617-636-9421|kmeyer@tuftsmedicalcenter.org|
20556373|NCT03182868|University of Miami|Michael Hoffer|305 243-1484|michael.hoffer@miami.edu|
20556374|NCT02958969|BWH|Gregory Piazza|6177326984|gpiazza@bwh.harvard.edu|
20556375|NCT00668902|Indiana University School of Medicine|Zeruesenay Desta|+1 (317) 274-2823|zdesta@iu.edu|
20556376|NCT03030222|Saint Luke's Hospital of Kansas City|Study Manager|816-932-9858|EMBRACE-HF@saint-lukes.org|
20556377|NCT01830127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20527652|NCT01939223|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
20556378|NCT02813070|GE Healthcare|Paul Sherwin, M.D., PhD|+1-774-843-3888|PaulSherwin@ge.com|
20556379|NCT03645759|Michael E. Debakey VA Medical Center|Dr. Gina Evans|832-269-3048|gina.evans@va.gov|
20527653|NCT05053035|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
20556380|NCT00818753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20556381|NCT01389973|Janssen, R&D, LLC, Spring House, PA|Senior Director, Clinical Development, Immunology||ClinicalTrialDisclosure@its.jnj.com|
20556382|NCT00725296|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20556383|NCT02693743|University of Arkansas for Medical Sciences|Favrin Smith|1 (501) 526-8488|SmithFavrinM@uams.edu|
20556384|NCT03360942|Dartmouth-Hitchcock Medical Center|Cristina Ferrazzano Yaussy, MPH, CCRP, Research Regulatory Affairs Specialist|603-650-5333|Cristina.Ferrazzano.Yaussy@hitchcock.org|
20556385|NCT04907942|Click Therapeutics|Shaheen Lakhan, MDPhD, FAAN Study Chair|Not applicable|Science@clicktherapeutics.com|
20556386|NCT00254202|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20556387|NCT02459574|Imperial College London|Prof. Prapa Kanagaratnam|02033123783|p.kanagaratnam@imperial.ac.uk|
20556388|NCT01735201|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20556389|NCT02063230|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
20556390|NCT01826227|Memorial Sloan Kettering Cancer Center|Dennis Chi, MD|212-639-5016|chid@mskcc.org|
20556391|NCT04139564|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
20556392|NCT01624948|UCSF|Allison Webber MD|415 353 8382|allison.webber2@ucsf.edu|
20556393|NCT02249819|Northwell Health|Johanna Chang, Senior Research Coordinator|(516)562-3646|jchang14@northwell.edu|
20556394|NCT00002558|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
20556395|NCT01260350|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20556396|NCT03046212|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
20556397|NCT00558428|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20556398|NCT00626028|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20556399|NCT05224050|Rutgers, The State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
20556400|NCT00850889|Allergan, Inc.|Steven P. James, MD, VP, Global Medical Affairs|714-246-4500|james_steven@allergan.com|
20556401|NCT00420992|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
20556402|NCT02003352|Brain Synergy Institute|Frederick R Carrick|321-868-6464|drfrcarrick@post.harvard.edu|
20556403|NCT00053989|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716084505819|theresa.hahn@roswellpark.org|
20556404|NCT03205371|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20556405|NCT01851174|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
20556406|NCT03786952|Ohio Northern University|Phillip Zoladz|419-772-2142|p-zoladz@onu.edu|
20527654|NCT01294748|Micell Technologies|Jeffrey Mifek, VP Clinical Affairs|919-313-2102|jmifek@micell.com|
20556407|NCT04918147|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20547579|NCT03288454|Apollo Investment Management|Scientific Advisor|+352 2088 1301|rchari@kaiperheathcare.com|
20547580|NCT04073368|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
20547581|NCT00145600|St. Jude Children's Research Hospital|Jamie Flerlage, MD|1-866-278-5833|info@stjude.org|
20547582|NCT00920231|Baltimore VA MC|Dr Cha-Min Tang|410 706-2347|ctang@som.umaryland.edu|
20547583|NCT00147251|MedStar Research Institute|Barbara V Howard|301-560-7305|barbara.v.howard@medstar.net|
20547584|NCT05402020|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20547585|NCT04865640|"Medical Products Group | Analog Devices Inc."|Tony Akl|781-937-1665|tony.akl@analog.com|
20547586|NCT02694523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20547587|NCT01086423|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547588|NCT04505540|University of Vermont|Dr. Scott Mackey, PhD|8028478767|msmackey@uvm.edu|
20547589|NCT01367119|Mayo Clinic|Dr. Keith G. Rassmussen|507-284-2933|rasmussen.keith@mayo.edu|
20547590|NCT05342532|Icahn School of Medicine at Mount Sinai|Gres Karim|212-241-2499|gres.karim@mountsinai.org|
20547591|NCT02808871|Baylor College of Medicine|Ivan O. Rosas, MD|617-510-9910|Ivan.Rosas@bcm.edu|
20547592|NCT02057393|Penn State Hershey Medical Center|Colette Pameijer, Associate Professor of Surgery|717-531-5272|cpameijer@pennstatehealth.psu.edu|
20547593|NCT03180684|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20547594|NCT04847622|Research Organisation King's Cross (KC) Ltd.|Toni Sobande, Clinical Project Manager|447494 795 982|toni.sobande@rokcservices.com|
20547595|NCT02652767|GenSight Biologics|Magali Taiel CMO|1 76 21 72 26|mtaiel@gensight-biologics.com|0033
20547596|NCT03953183|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20547597|NCT01130103|Research Foundation for Mental Hygiene|Franklin Schneier MD|212-543-5368|frs1@columbia.edu|
20547598|NCT03839082|University of California Los Angeles|Monica Tincopa|310 825-2631|mtincopa@mednet.ucla.edu|
20547599|NCT03367247|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-632-2334|alexi_wright@dfci.harard.edu|
20547600|NCT00887744|Medtronic Spinal & Biologics Europe and Central Asia|E. Wülfert, Medical Affairs & Clinical Operations Director||inca.studyregistration@medtronic.com|
20547601|NCT03091777|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
20547602|NCT02314143|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20547603|NCT02354482|University of Kentucky|Jessica Clouser|8593230284|jess.clouser@uky.edu|
20547604|NCT00089674|Amgen Inc.|Study Director|866-572-6436||
20547605|NCT03963401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547606|NCT01194427|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
20547607|NCT00832390|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20547608|NCT01528215|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
20547609|NCT01476644|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
20547610|NCT01610271|Baylor College of Medicine|Rabih Darouiche, MD|713.799.5088|sdself@gmail.com|
20547611|NCT02393690|Academic and Community Cancer Research United (ACCRU)|Alan Ho, M.D.|212-639-7202|hoa@mskcc.org|
20547612|NCT03488927|University of Nebraska-Lincoln|Katie Edwards|402-472-2223|katie.edwards@unl.edu|
20547613|NCT00237185|Novartis|Study Director|862-778-8300||
20547614|NCT04350606|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547615|NCT00252629|Northport, VAMC|Mohammad M. Amin, MD|6312614400|mohammad.amin2@va.gov|2469
20547616|NCT00972088|bikur holim hospital|samuel n adler md, director of clinical trial|972 2 6464206|nasnadler@gmail.com|
20547617|NCT02819518|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20547618|NCT00880165|Philadelphia VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov|
20547619|NCT01758289|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20547620|NCT02658097|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nathan Pennell|1-866-223 8100|TaussigResearch@ccf.org|
20556408|NCT04273139|Dana-Farber Cancer Institute|Jorge J. Castillo, Md|617-632-2681|jorgej_castillo@dfci.harvard.edu|
20556409|NCT04212091|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20556410|NCT03492281|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20556411|NCT03624504|Medtronic (Shanghai) Management Co., Ltd.|Weifan Sun, Clinical Study Manager|021-20325267|weifan.sun@medtronic.com|86
20556412|NCT00951483|Loyola University Chicago|Angelos Halaris, MD, PhD|708-216-3275|ahalaris@lumc.edu|
20556413|NCT03565887|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
20556414|NCT03364751|Philip Morris Products S.A.|Christelle Haziza, Director Clinical Science & Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20556415|NCT02975973|Baylor College of Medicine|Raymond Cho|713-798-7781|Raymond.Cho@bcm.edu|
20547621|NCT03552965|University of Arkansas for Medical Sciences|Rashad Perry|501-686-8274|Rperry3@uams.edu|
20547622|NCT01711372|CogCubed|Dr Monika Roots, Chief Medical Officer|6173082009|monika@cogcubed.com|
20547623|NCT00309738|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
20547624|NCT00729924|Vanderbilt University|David W. Haas, MD|615-936-8594|david.w.haas@vanderbilt.edu|
20547625|NCT01104701|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTrasparency@astrazeneca.com|
20547626|NCT04382391|Allegheny Health Network (AHN)|Tariq Cheema, MD, Vice President and Medical Director AHN Research Institute|412-321-3344|tariq.cheema@ahn.org|
20547627|NCT02171065|Lund University|Principal Investigator: David Erlinge, MD, PhD|+46-733746165|david.erlinge@gmail.com|
20547628|NCT00518687|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20547629|NCT02598960|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20547630|NCT01614600|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20547631|NCT02231918|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20547632|NCT03714620|Trinity Health, Loyola University Medical Center, Stritch School of Medicine|Shannon Lovett, MD, Associate Professor of Emergency Medicine|7082168705|slovett@lumc.edu|
20547633|NCT00547196|City of Hope|Dr. Anna Pawlowska, MD|626-359-8111|apawlowska@coh.org|
20547634|NCT00137631|Department of Human Development, State University of New York at Binghamton|Leo Wilton, PhD|607-777-9215|lwilton@binghamton.edu|
20547635|NCT00085709|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
20547636|NCT00293215|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20547637|NCT02213042|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20547638|NCT04622735|Unither Pharmaceuticals|Non Clinical & Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
20547639|NCT02007512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547640|NCT04087213|DEKA Research|Clinical Research Manager|(603) 669-5139|clinical@dekaresearch.com|
20547641|NCT01134315|AbbVie|Global Medical Services|800-633-9110||
20547642|NCT03126370|University of Colorado Anschutz Medical Campus|Jennifer Kiser, PharmD, PhD|3037246131|jennifer.kiser@cuanschutz.edu|
20547643|NCT02545075|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20547644|NCT03090412|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-6269|Chong.Wang@roswellpark.org|
20547645|NCT01669096|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547646|NCT03923738|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20547647|NCT02751788|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20547648|NCT05246397|University of Washington|Andrew Bowdle MD, PhD, FASE|206-979-0477|bowdle@u.washington.edu|
20547649|NCT01684020|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20547650|NCT03583164|F2G Ltd|Daniela Zinzi|43 664 3582281|dzinzi@f2g.com|
20547651|NCT01952600|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
20547652|NCT01272661|UHospitalsCleveland; Rainbow Babies and CHildren's Hospital|Lydia Furman MD, PI|216-844-8260|Lydia.Furman@uhhospitals.org|
20547653|NCT01417936|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
20547654|NCT00984568|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20547655|NCT00573248|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
20547656|NCT02791594|Abramson Cancer Center|Dr. Michael Farwell|215-662-7750|michael.farwell@pennmedicine.upenn.edu|
20547657|NCT00805948|Medtronic, Inc|Michael McGuffey, Clinical Research Director|707-591-7126|michael.mcguffey@medtronic.com|
20547658|NCT04508140|Highlight Therapeutics S.L.|Marisol Quintero|+34 961 10 99 55|mquintero@highlighttherapeutics.com|
20547659|NCT03059446|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20547660|NCT01982331|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20547661|NCT04105543|University of Wisconsin Carbone Cancer Center|Justine Bruce, MD|(608) 262-4961|jybruce@medicine.wisc.edu|
20547662|NCT00586066|Massachusetts General Hospital|Andrew Nierenberg, Principal Investigator|6177240837|anierenberg@partners.org|
20547663|NCT02676466|University of Florida|ENRGISE Coordinating Center Project Manager|352-294-5800|ENGISEACC@aging.ufl.edu|
20547664|NCT01016561|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
20547665|NCT02103218|UNC Greensboro|Lisa Goble Director Office of Research Integrity|336-256-1173|lagoble@uncg.edu|
20547666|NCT00908011|St. Paul's Hospital/University of B.C.|Dr. Greg Bondy|604-806-8192|gbondy@providencehealth.bc.ca|
20547667|NCT02325856|Department of Nephrology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan|Lim Paik-Seong|886-4-26581919|jamespslim@gmail.com|
20547668|NCT06352060|Kansas City Heart Rhythm Institute|Dhanunjaya Lakkireddy|913-934-4300|dlakkireddy@gmail.com|
20547669|NCT04192370|Brigham and Women's Hospital|Joji Suzuki, MD|617-455-7981|Jsuzuki2@bwh.harvard.edu|
20547670|NCT02301988|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20547671|NCT02745210|Loma LInda University Medical Center|Brenda Bartnik Olson|1-909-558-4000|BBartnik@llu.edu|85216
20547672|NCT02891161|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20547673|NCT02750943|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547674|NCT00990938|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20547675|NCT01074047|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20547676|NCT04669535|UMass Chan Medical School|Dr. Terence Flotte|508-856-8992|terry.flotte@umassmed.edu|
20547677|NCT01298544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547678|NCT05169567|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20547679|NCT02211638|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20571799|NCT02308787|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|(303) 231-4357|Ray.Goodrich@terumobct.com|
20571800|NCT01240915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571801|NCT04297631|Washington University|Venessa Riegler|3143621721|rieglerv@wustl.edu|
20571802|NCT01598662|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
20571803|NCT01720277|Brown University and Providence VA Medical Center|Dr. Stefan Gravenstein|401-863-3172|Stefan_gravenstein@brown.edu|
20571804|NCT02574845|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571805|NCT01867333|National Cancer Institute|Ravi A. Madan|301-480-7168|rm480i@nih.gov|
20571806|NCT01249027|Abbott Vascular|Leong Roy|8133 7475|roy.leong@abbott.com|+65
20571807|NCT03878277|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
20571808|NCT00968071|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur M.D./Associate Proffesor|713-563-1586|eharriso@mdanderson.org|
20571809|NCT01696045|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20571810|NCT01559129|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20571811|NCT03525392|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
20571812|NCT03262662|University at Buffalo|Larry Hawk, PhD|716-829-2323|lhawk@buffalo.edu|
20571813|NCT00831129|University of Chicago|Dr. George Bakris|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
20571814|NCT01333813|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571815|NCT02917603|UMissouri|Debra Parker Oliver; PI|573-356-6719|oliverdr@missouri.edu|
20571816|NCT03291288|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20508580|NCT01998399|Vanderbilt University|Gordon Bernard, Professor of Medicine, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@Vanderbilt.Edu|
20508581|NCT00376246|UCSD Medical Center|Ori Ben-Yehuda, MD|619-543-2814|obenyehuda@ucsd.edu|
20508582|NCT02690168|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
20508583|NCT02762708|Mayo Clinic|Meera Shah, MB, ChB|507-284-0106|Shah.Meera@mayo.edu|
20508584|NCT01062009|UCSF Benioff Childrens Hospital Oakland|Natalie Cvijanovich, MD|510-428-3784|NCvijanovich@mail.cho.org|
20508585|NCT01961089|Ziemer Ophthalmic Systems AG|Dr. Gregor Schmid|+41323327154|gregor.schmid@ziemergroup.com|
20508586|NCT01468701|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508587|NCT04644484|Synermore Biologics Co., Ltd.|Director of Clinical Trials|+86-512-87658266|xjli@synermore.cn|8077
20508588|NCT04366713|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|1-424-248-6500|clinicaltrials@pumabiotechnology.com|
20508589|NCT00156013|Oncology Specialists|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
20508590|NCT00631540|Cook Incorporated|Scott Snyder, PhD|765-463-7537|ssnyder@medinst.com|
20508591|NCT00677560|Queen Mary University of London|Dr Harpal Singh Kalsi|07872492181|h.kalsi@qmul.ac.uk|
20508592|NCT01079195|Abbott|Global Medical Services|1-800-633-9110||
20508593|NCT03984838|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
20508594|NCT04034043|IRCSS Istituto Ortopedico Rizzoli|Federico Giardina|+390516366418|federico.giardina@ior.it|
20508595|NCT00523614|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
20508596|NCT03700736|University of Connecticut|Dr. Molly Waring|860-486-1446|molly.waring@uconn.edu|
20508597|NCT03726333|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials_gov_Inquiries@pfizer.com|
20508598|NCT02935595|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|(713) 486-2500|Sudhakar.Selvaraj@uth.tmc.edu|
20508599|NCT00402285|University of California, San Francisco|Peter Carroll, MD|415-353-7098|pcarroll@urology.ucsf.edu|
20508600|NCT00784459|Washington University|Dr Jonathan Green|314-747-3591|jgreen@wustl.edu|
20508601|NCT02431702|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20508602|NCT00671970|Dana Farber Cancer Institute|Dr. David Reardon|(617) 632-2166|David_Reardon@DFCI.HARVARD.EDU|
20508603|NCT01510028|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20508604|NCT00633893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20508605|NCT02741310|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20508606|NCT05091918|Stryker|Kevin Barga|+12018315073|Kevin.Barga@stryker.com|
20508607|NCT01766986|University Hospital Hamburg-Eppendorf|Dr. Matthias Reeh|+49015222816521|m.reeh@uke.de|
20508608|NCT01784211|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508609|NCT00239356|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20571817|NCT04276415|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20508610|NCT03417505|Tangible Science|Dr. Kelly Mabry|650-241-1045|kelly@tangiblescience.com|108
20571818|NCT00208325|DePuy International|Kimberly Dwyer, Ph.D, CCRA||kdwyer2@its.jnj.com|
20571819|NCT02145468|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571820|NCT00586612|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571821|NCT00422812|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20571822|NCT00623805|Hoffmann-La Roche|Medical Communications|800 821-8590||
20571823|NCT00635128|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571824|NCT02906007|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20571825|NCT03520712|BioMarin Pharmaceutical (UK) Ltd.|Konstantia-Maria Chavele, PhD, Director, Clinical Sciences|+44207|KonstantiaMaria.Chavele@bmrn.com|4203351
20571826|NCT05570630|University of Rochester|Cynthia Rand, PI|5852759316|cynthia_rand@urmc.rochester.edu|
20571827|NCT04531982|Acadia Pharmaceuticals Inc.|Senior Director, Medical Information|8444222342|medicalinformation@acadia-pharm.com|
20571828|NCT06655558|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20571829|NCT04839185|UW School of Medicine and Public Health|Dinesh Shah, MD|608-417-6099|dmshah@wisc.edu|
20571830|NCT03468478|Hospital do Rim - Fundação Oswaldo Ramos|Dr. Helio Tedesco Silva Junior|55 11 50878113|heliotedesco@medfarm.com.br|
20571831|NCT06988800|Muvik|Dr. Chelsea Gordon|9063990332|chelsea@muviklabs.io|
20571832|NCT02344290|REPRIEVE Clinical Coordinating Center|REPRIEVE Project Manager|617-724-9109|mghreprievetrial@mgb.org|
20571833|NCT04998812|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20571834|NCT03898778|Minnesota Medical Technologies Corporation|VP of Regulatory Affairs|507-533-0366|rmanglin@mnmedicaltechnologies.com|
20571835|NCT04893460|Oregon Research Behavioral Intervention Strategies Inc.|Dr. Dana Smith|541-484-2123|danas@ori.org|
20571836|NCT04746846|Virginia Commonwealth University|Ingrid Pretzer-Aboff, Ph.D., RN , FGSA, FAAN|804-828-3340|iaboff@vcu.edu|
20571837|NCT03578887|University of Washington|Ellen Schur, MD, MS|206-543-8433|ellschur@uw.edu|
20571838|NCT04500769|University of Kentucky|Douglas Long|859-323-5438|delong2@uky.edu|
20571839|NCT00568178|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571840|NCT01332630|UT MD Anderson Cancer Center|Ibrahim,Nuhad K.,M.D. / Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20571841|NCT01534143|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kahdimi, M.D.|(313) 576-8022|zalkadh@emory.edu|
20571842|NCT01008410|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20571843|NCT02988050|Menoufia University|Professor Ezzeldin Ibrahim, Professor of Anaesthesia|00201006303178|ezzeldin7@yahoo.com|
20571844|NCT04143945|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20571845|NCT02787044|Brigham and Women's Hospital|Dr. Scott Solomon|857-307-1960|ssolomon@bwh.harvard.edu|
20571846|NCT03889704|University of Pittsburgh|Dr. Edward Burton|4126924670|eab25@pitt.edu|
20571847|NCT02591953|Rush|Dr. Jeremy Alland|3124322434|jeremy.alland@rushortho.com|
20571848|NCT01517295|International Clinical Research Institute|Srinivas Nalamachu|913.317.5300|nalamachu@yahoo.com|
20571849|NCT02672852|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20571850|NCT03248882|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571851|NCT04308590|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20571852|NCT02734576|North Shore University Hospital Northwell Health|Dr. Athos Patsalides|516-562-2244|apatsalides@northwell.edu|
20571853|NCT01156376|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20571854|NCT01493427|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20571855|NCT00565773|Duke University|Allan D. Kirk, MD, PhD|919-681-1400|allan.kirk@duke.edu|
20571856|NCT01725126|GlaxoSmithKline|GSK Response Center|866-435-7343||
20571857|NCT01734239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571858|NCT01075958|Northumbria University|Dr Philippa Jackson|+44 191 204 8818|philippa.jackson@northumbria.ac.uk|
20571859|NCT01021618|Hartford Hospital|Gary V Heller, MD, PhD|860-545-5527|aahlber@harthosp.org|
20571860|NCT03151993|Federal Center for Brain and Neurotechnology|Dr. Eugene I. Gusev, President of the Federal Center for Brain and Neurotechnology|495-280-01-74|egusev2339@gmail.com|+7
20571861|NCT02781090|Montefiore Medical Center|Dr. Jonathan Shuter|718-920-7845|jshuter@montefiore.org|
20571862|NCT02075073|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
20571863|NCT04481568|Northwell Health|Dr. Liron Sinvani, Principal Investigator|646-766-7169|ldanay@northwell.edu|
20571864|NCT00416195|Eisai Call Center|Eisai Inc.|888-422-4743||
20571865|NCT01882764|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
20571866|NCT00414167|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
20571867|NCT03101462|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
20571868|NCT00795275|University of Colorado Anschutz Medical Campus|Leigh Perreault, MD|303-249-7732|leigh.perreault@ucdenver.edu|
20571869|NCT02530970|Aziyo Biologics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
20571870|NCT02119442|UCLA|Soraya Sadeghi|3108255950|smsadeghi@mednet.ucla.edu|
20571871|NCT00827099|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
20571872|NCT03846453|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
20571873|NCT00468143|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
20571874|NCT01681121|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
20571875|NCT03478904|National Cancer Institute|William D. Figg, Pharm.D.|240-760-6179|figgw@mail.nih.gov|
20571876|NCT00886795|Johns Hopkins University|Clifton O. Bingham III, M.D.|410-550-0578|cbingha2@jhmi.edu|
20571877|NCT02297100|Wake Forest University Health Sciences|Dr. Robert Evans|336-713-0320|revans@wakehealth.edu|
20571878|NCT01669577|University of São Paulo|Luiz Guilherme Villares da Costa, MD|5511985584737|lgvc76@yahoo.com.br|
20571879|NCT01283516|Novartis Pharmaceuticals|Study Director|862-778-8300||
20571880|NCT01098318|University of Pennsylvania|Dr. Jun Mao, Associate Professor|215-746-2481|jun.mao@uphs.upenn.edu|
20571881|NCT00860847|Los Angeles Biomedical Research Inst.|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
20571882|NCT00444275|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20571883|NCT00132873|Jazz Pharmaceuticals, Inc.|Mortimer Mamelak, MD|650 496 3777|roman.skowronski@jazzpharma.com|
20571884|NCT03030859|University of Pennsylvania School of Nursing|Jie Deng, PhD, PI|215-573-2393|jiedeng@nursing.upenn.edu|
20571885|NCT01204710|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20571886|NCT01896726|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20571887|NCT02539459|Fox Chase Cancer Center|Robert Uzzo, M.D.|215-728-3096|robert.uzzo@fccc.edu|
20571888|NCT01012297|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Administration and Operations|(716) 845-5702|kurasa@nrgoncology.org|
20547680|NCT04382755|UZ Gent|Anja Delporte|+3293320228|anja.delporte@uzgent.be|
20547681|NCT01510457|Rehabilitation Institute of Chicago Center for Pain Studies|Dr. R. Norman Harden|312.238.5654|centerforpainstudies@ric.org|
20547682|NCT00859027|University of Connecticut Health Center|Pamela Taxel MD|860-679-4743|taxel@nso.uchc.edu|
20547683|NCT02775903|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20547684|NCT04041700|Cochlear|Johan Blechert|+46766498632|jblechert@cochlear.com|
20547685|NCT03173534|Cleveland Clinic|Samir Kapadia, MD Chairman Cardiovascular Medicine|216 444-6735|KAPADIS@ccf.org|
20547686|NCT00458536|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
20547687|NCT04468321|Yale University|Joseph Ross, MD, MHS|2037852987|joseph.ross@yale.edu|
20547688|NCT00285207|TigrisPharmaceuticals|Chief Medical Officer||info@tigrispharma.com|
20547689|NCT03237871|Johns Hopkins Bloomberg School of Public Health|Principal Investigator|410-955-3537|ljennin6@jhu.edu|
20547690|NCT06120777|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20547691|NCT05419908|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20547692|NCT02981940|Dana-Farber Cancer Institute|Eudocia Q Lee, MD MPH|617.632.2166|eudocia_lee@dfci.harvard.edu|
20547693|NCT05069259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547694|NCT00814788|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
20547695|NCT00084838|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
20547696|NCT00683085|Research Hospital, The Institute of Medical Science, The University of Tokyo|Hitomi Nagayama, M.D., Ph.D. / Project Lecturer|+81-3-3443-8111|zephyrus@ims.u-tokyo.ac.jp|
20547697|NCT01846104|Department of Clinical Research Division of Medicine USAMRIID|Matthew Chambers, MD|301-619-6731|matthew.s.chambers@mail.mil|
20547698|NCT00851630|Duke University Medical Center|Dr. Nathan Thielman|919-6687174|n.thielman@duke.edu|
20547699|NCT00398411|University of Cologne|Prof. Dr. Oliver A. Cornely|+49 221 478 88794|oliver.cornely@zks-koeln.de|
20547700|NCT01397162|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20547701|NCT01409434|University of Florida|Dr. Rhonda Cooper-DeHoff|352-273-6184|dehoff@cop.ufl.edu|
20547702|NCT05015530|BG ClinicalS|Dr Bernard Gout|+33 (0)561 531 944|b.gout@bgclinicals.com|
20547703|NCT04735536|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
20547704|NCT03026088|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20547705|NCT00761579|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
20547706|NCT03611010|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Development|6155642188|imaciasperez@cumberlandpharma.com|
20547707|NCT00504985|UT MD Anderson Cancer Center|Xin Shelley Wang, MD, MPH / Associate Professor|713-745-3504||
20547708|NCT00950911|Amgen Inc.|Study Director|866-572-6436||
20547709|NCT00438451|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|C. Ruckes|+49 (0) 6131 17|ruckes@izks-mainz.de|9919
20547710|NCT01288027|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20547711|NCT02413372|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20547712|NCT01550471|Allegheny Health Network|Deborah Gentile, Principal Investigator|412-359-4099|dgentile@wpahs.org|
20547713|NCT00760214|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20547714|NCT00994318|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
20547715|NCT04157621|MUSC|Vanessa Hinson|843-876-0829|hinsonvk@musc.edu|
20547716|NCT03960554|Columbia University Irving Medical Center|Thomas L. Nickolas MD|212-305-5020|tln2001@cumc.columbia.edu|
20571889|NCT05543707|Pardes Biosciences|Vice President, Quality|4042815163|jenna.tagliaferri@pardesbio.com|
20547717|NCT04587271|University of Kentucky|Dr. Suzanna Attia|859-323-6211|suzanna.attia@uky.edu|
20547718|NCT00736879|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
20547719|NCT02360111|Memorial Sloan Kettering Cancer Center|Dr. Ann Jakubowski, Ph.D., MD|212-639-5013|jakubowa@mskcc.org|
20547720|NCT00718302|Boston Medical Center|Paul Tornetta, III, MD|617-414-6295|tornetta@bu.edu|
20547721|NCT00735254|Arizona Dermatology and Cosmetic|Edward Galiczynski, MD|(602) 277-1449|egaliczynski@arizonaderm.com|
20547722|NCT00315146|Wake Forest Universtiy Baptist Medical Center|Stephen Kritchevsky|336-713-8548|skritche@wakehealth.edu|
20547723|NCT01031381|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
20547724|NCT00751621|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20547725|NCT01272284|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
20547726|NCT04489732|University of Wisconsin Carbone Cancer Center|Randy Kimple, MD, PhD, FASTRO|608-263-5361|rkimple@humonc.wisc.edu|
20547727|NCT05619523|University of Maryland, College Park|Dr. Melanie Killen|(301) 405-3176|mkillen@umd.edu|
20547728|NCT04007198|Equillium|Clinical Operations|8582401200|clinicaltrials@equilliumbio.com|
20547729|NCT06138145|University of Pennsylvania|Dr. Kevin B. Johnson|215-573-5885|Kevin.Johnson1@Pennmedicine.upenn.edu|
20547730|NCT03660488|University of Southern California|Jeffrey D Klausner MD MPH, Clinical Professor of Population and Public Health Sciences|4158768901|jdklausner@med.usc.edu|
20547731|NCT01822678|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20547732|NCT01200862|Mereo BioPharma|Dr. Jackie Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
20547733|NCT01336296|UCincinnati|Research Associate Professor|5135852145|adele.rike@uc.edu|
20547734|NCT00249288|Schizophrenia Program, Massachusetts General Hospital|Michelle Hill|617-912-7846|michelehill1@gmail.com|
20547735|NCT03309046|MemphisVAMC|Dr. Linda Olivia Nichols|901 523-8990|linda.nichols@va.gov|5082
20547736|NCT01070043|Novartis Pharmaceuticals|Study Director|862 - 778- 8300||
20547737|NCT01721070|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20547738|NCT02047227|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20547739|NCT01721473|VA San Diego Healthcare System|Arthur Brody|8585528585|arthur.brody@va.gov|
20547740|NCT01302379|University of San Diego, California|Ruth Patterson|8585349235|repatterson@ucsd.edu|
20547741|NCT04181320|Mölnlycke|Vice President Corporate Clinical & Medical Affairs CMO & RQA|+46317223045|jane.clark@molnlycke.com|
20547742|NCT01090973|H. Lee Moffitt Cancer Center and Research Institute|Celeste Bello, M.D.|813-745-8623|celeste.bello@moffitt.org|
20547743|NCT00445978|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
20547744|NCT02766465|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20547745|NCT02435069|Nemours Children's Clinic|Kimberly S. Jarczyk, PhD, C-PNP|9044611730|jarczykks@gmail.com|
20547746|NCT03112590|Moffitt Cancer Center|Hyo S. Han, MD|813-745-4933|Hyo.Han@moffitt.org|
20547747|NCT00590889|St.Jude Medical|Heidi Hinrichs, VP of Clinical Study Management, St. Jude Medical||hhinrichs@sjm.com|
20547748|NCT02059005|Treatment Research Institute|Adam Brooks, PhD|215-399-0980|abrooks@tresearch.org|128
20547749|NCT00739596|Novartis Pharmaceuticals|Study Director|862-778-8300||
20547750|NCT02520661|UW School of Medicine and Public Health|Manish N. Shah, MD, MPH|608-263-6690|mnshah@medicine.wisc.edu|
20547751|NCT00843726|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
20547752|NCT03374631|The University of Texas at Dallas|Dr. Amy Pinkham|(972) 883-4462|amy.pinkham@utdallas.edu|
20547753|NCT02443519|Yeshiva University & Albert Einstein College of Medicine|Dr. Elizabeth Seng|646-592-4368|elizabeth.seng@yu.edu|
20547754|NCT02176343|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20547755|NCT00760084|Eisai Inc.|Yufang Lu, MD, PhD|888-422-4743||
20547756|NCT02567552|IVI Barcelona|Evelin Lara Molina|+34 93 531 63 00|Evelin.Lara@ivi.es|27503
20547757|NCT03309150|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20547758|NCT00171054|Novartis Pharmaceuticals|Study Director|862-778-8300||
20547759|NCT03861702|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20547760|NCT02900560|Translational Research In Oncology (TRIO)|Director, Project Management|33 158 10 09 09|026@trioncology.org|
20547761|NCT02037607|Indiana University|Heather Cero, Research Nurse Manager|317-396-1298|hcero@iupui.edu|
20547762|NCT01828320|University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
20547763|NCT02160782|Mirum Pharmaceuticals|Mirum Clinical Trials|1 650-667-4085|medinfo@mirumpharma.com|
20547764|NCT00413400|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
20547765|NCT00891462|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20547766|NCT00970073|Cleveland Clinic|Bijan Eghtesad|2164029954|eghtesb@ccf.org|
20547767|NCT00423722|UT MD Anderson Cancer Center|Dr. Eduardo Bruera, MD / Professor|713-792-6085|ebruera@mdanderson.org|
20547768|NCT00215683|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20547769|NCT01083485|Mundipharma Research|Maggie Wilson|+ 4401223 424444||2303
20547770|NCT00674973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20547771|NCT00763048|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
20547772|NCT05108922|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20547773|NCT05036369|VibrantGastro|Clinical trials manager|+972 046663322|service@vibrantgastro.com|
20556416|NCT02413580|Grifols Therapeutics LLC|Rhonda Griffin|9193166693|Rhonda.Griffin@grifols.com|
20556417|NCT03804710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20556418|NCT04542018|University of Michigan|Prashant Singh, MBBS|734-647-1191|singhpr@med.umich.edu|
20556419|NCT03583554|Baylor College of Medicine and Michael E. DeBakey VA Medical Center|Dr. Marijn Lijffijt, Assistant Professorq|713-798-5642|marijn.lijffijt@bcm.edu|
20556420|NCT03178266|ZipLine Medical|Wendy Winters, Clinical Project Manager|4085061866|wwinters0@gmail.com|
20556421|NCT01215292|University of Washington|Mara Roth, MD|206-221-0519|mylang@uw.edu|
20556422|NCT00689221|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20556423|NCT01029054|University of Michigan Hospital|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
20556424|NCT01812655|Arkansas Children's Hospital|Debra Jeffs, PhD, RN, Principal Investigator|501-364-3239|jeffsda@archildrens.org|
20556425|NCT00036569|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@mail.nih.gov|
20556426|NCT02363946|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|6263043400||
20556427|NCT00262821|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20556428|NCT04435665|NFlection|Director of Clinical Operations|7078532199|comara@nflectionrx.com|
20547774|NCT02260440|UPMC Hillman Cancer Center|Anuradha Krishnamurthy, MD|412-623-3283|krishnamurthya2@upmc.edu|
20556429|NCT00765388|Coloplast A/S|Seema Suchdev Wrisberg|+4549113519|dkssw@coloplast.com|
20547775|NCT02349061|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20547776|NCT01956435|University of Texas at Austin Medical School and Seton Family of Hospitals|Ammar Ahmed, MD|512-504-0855|amahmed@seton.org|
20547777|NCT02095223|University of Miami|Christopher Kuenze|5174325018|kuenzech@msu.edu|
20547778|NCT01564914|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
20547779|NCT01507298|Imperial College London|Dr. Richard Mark Kwasnicki|07851759471|rmk107@ic.ac.uk|
20547780|NCT03906461|Abbott|Clinical Research Scientist|16517563101|laura.zitellaverbick@abbott.com|
20547781|NCT04925271|Thomas Jefferson University|Anand Kumar, Associate Professor of Medicine|215-955-8900|anand.kumar@jefferson.edu|
20547782|NCT00426231|Johns Hopkins University|Dhananjay Vaidya|410-6142307|dvaidya1@jhmi.edu|
20547783|NCT01795638|University of Cincinnati Medical Center|Barbara Isemann|513-584-5060|barbara.isemann@uchealth.com|
20547784|NCT03061097|Microbiome Health Research Institute|Majdi Osman, MD, MPH|617-575-2201|majdi@openbiome.org|
20547785|NCT01043146|Corimmun, GmbH|Gary Peters, MD, Managing Director|001-215 628-5257|gpeters7@its.jnj.com|
20547786|NCT00595465|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
20547787|NCT00107783|NHGRI|William Gahl, MD/Clinical Director|301-402-2739|gahlw@mail.nih.gov|
20547788|NCT02360995|Loma Linda University School of Dentistry|Yiming Li, DDS|909-558-8069|yli@llu.edu|
20547789|NCT00331864|Novartis Pharmaceuticals|Study Director|862-778-8300||
20547790|NCT02611960|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20547791|NCT02395666|Beat Childhood Cancer|Dr. Giselle Sholler|704-381-9900|Giselle.Saulniersholler@atriumhealth.org|
20547792|NCT00994929|The University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
20547793|NCT00351000|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
20547794|NCT04131556|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20547795|NCT01229371|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20547796|NCT02106910|University of North Carolina at Chapel Hill|Nicholas J. Shaheen, MD|919-966-7655|nicholas_shaheen@med.unc.edu|
20547797|NCT02476422|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20547798|NCT01859143|MedImmune, LLC|Raburn Mallory, MD/Senior Director, Clinical Development|301-398-0000|malloryr@medimmune.com|
20547799|NCT00700570|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20547800|NCT00093782|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
20547801|NCT02563990|University of Miami|Andres Missair|3055857037|amissair@miami.edu|
20547802|NCT01431131|University of Louisville|Dr. Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
20547803|NCT01933217|Children's Hospital Medical Center, Cincinnati|Brad Kurowski, MD, MS|513-803-3655|brad.kurowski@cchmc.org|
20527655|NCT01618916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20547804|NCT02180165|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20547805|NCT02861131|Oregon Health & Science University|Brandon Togioka|5034944572|togioka@ohsu.edu|
20547806|NCT00267189|Novartis Pharmaceuticals|Study Director|862-778-8300||
20547807|NCT00745940|Lakehead University|Dr. Michel Bédard|807-343-8630|mbedard@lakeheadu.ca|
20547808|NCT04137224|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20547809|NCT00925990|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|858-457-7227|mhuyghe@conatuspharma.com|
20547810|NCT01368432|Johns Hopkins University & school of Medicine|Vani Rao|410-550-2288|vrao@jhmi.edu|
20547811|NCT02310321|Astellas Pharma Inc.|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
20547812|NCT04950166|OncoNano Medicine, Inc|Vice President, Clinical Operations|(682) 285-1411|trials@onconanomed.com|
20547813|NCT01698905|Novartis|Study Director|862-778-8300|novartis.email@novartis.com|
20547814|NCT05896748|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20547815|NCT03207555|The University of Texas MD Anderson|Jan Burger, MD/Professor|713-563-1487|jaburger@mdanderson.org|
20547816|NCT01729247|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
20547817|NCT00857415|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20547818|NCT00764504|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
20556430|NCT01846182|Central Texas Veterans Health Care System|Charles J. Foulks, M.D., ACOS/R|254 743 2643|Charles.Foulks@va.gov|
20556431|NCT03923933|Head of Nephrology Hospital General de México|Rafael Vadez-Ortiz M.D. PhD|+52 2789-2000|rafavaldez@gmail.com|1253
20527656|NCT03004924|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20547819|NCT04795622|Merz Aesthetics|Public Disclosure Manager|+49 69 1503|Aesthetic.Trials@merz.com|1
20547820|NCT00337350|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
20547821|NCT01437878|Actelion Pharmaceutical Ltd|Maziar Assadi Gehr|+41 61 565 5525|maziar.assadi-gehr@actelion.com|
20547822|NCT01369615|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20547823|NCT04263454|University of Alabama at Birmingham|Jarred Younger|205-975-5821|youngerlab@uab.edu|
20547824|NCT00986479|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
20547825|NCT02035475|OhioHealth|Dr. Ronney Abaza|614-544-8104|ronney.abaza@ohiohealth.com|
20547826|NCT01460368|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20547827|NCT02322021|Eisai Medical Information|Eisai Ltd.|+1-888-274-2378|esi_medinfo@eisai.com|
20547828|NCT04493333|University of Arkansas for Medical Sciences|I-Shin Wen|5016868274|iwen@uams.edu|24024
20547829|NCT02791399|VA Portland Health Care System|Benjamin Morasco, PhD|5032208262|benjamin.morasco@va.gov|
20547830|NCT00414271|Johns Hopkins Singapore|Prof Alex Chang|+65 68802220|alexchang@imc.jhmi.edu|
20547831|NCT00704912|Penn State College of Medicine, Penn State Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rsl1@psu.edu|
20547832|NCT02793921|University of Pittsburgh|Dr. Catherine Bender, Principal Investigator|412-624-3594|cbe100@pitt.edu|
20547833|NCT01920555|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
20547834|NCT00422097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20547835|NCT02572388|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|adrian.hill@ndm.ox.ac.uk|
20547836|NCT01051466|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20547837|NCT00810108|University of California San Diego|Dr. Brookie M. Best, Associate Professor|858-822-5550|brookie@ucsd.edu|
20547838|NCT04839146|Radboudumc|Benjamin Mordmüller (Principal investigator)|+31 (0)24 3619499|benjamin.mordmueller@radboudumc.nl|
20547839|NCT00841971|University of Pittsburgh|Dr Nina Singh|412 360-1688|nis5@pitt.edu|
20547840|NCT01420653|AFT Pharmaceuticals Ltd.|Jennifer Zhang|+ 64 9 488 0232|jenniferz@aftpharm.com|710
20547841|NCT01539642|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20547842|NCT02600351|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20547843|NCT02521766|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20547844|NCT00567593|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
20547845|NCT00739999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20547846|NCT01146275|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
20547847|NCT02943460|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20547848|NCT03875768|Duke University|Gary G. Bennett, PhD|919-684-4510|gary.bennett@duke.edu|
20547849|NCT01925274|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547850|NCT00922233|FHI360|Dr. Vera Halpern|9195447040|vhalpern@fhi360.org|
20547851|NCT04327674|Department of Respiratory Diseases and Allergy. Aarhus University Hospital. Denmark.|Søren Helbo Skaarup|28911869|soeska@rm.dk|
20547852|NCT00723398|Milton S. Hershey Medical Center|Dr. Andrea Manni|717-531-8395|amanni@pennstatehealth.psu.edu|
20547853|NCT03153956|NYU Langone Health|Dennis A. Cardone, DO|+1 646 501 7223|Dennis.Cardone@nyulangone.org|
20547854|NCT04396665|University of Oviedo|Vicerrectorado de investigación|+34985104190|viceinvestigacion@uniovi.es|
20547855|NCT00559936|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|cornea_research@meei.harvard.edu|
20547856|NCT01225887|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
20547857|NCT00566501|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20547858|NCT00835159|NYU Langone Medical Center|ALEXANDER ZASLAVSKY|212-263-5569|michael.haile@nyumc.org|
20547859|NCT00749515|St. Jude Children's Research Hospital|Ellis Neufeld, MD, PhD|901-595-7509|ellis.neufeld@stjude.org|
20547860|NCT01270542|Doheny Eye Institute/USC/University of Iowa|Dr. Elliott Sohn|319-356-3185|elliott-sohn@uiowa.edu|
20547861|NCT00277446|Northwestern University|Lewis J. Smith|312-503-0501|ljsmith@northwestern.edu|
20547862|NCT01680887|Perelman School of Medicine|Kyle Kampman|215 746 2764|kampman@pennmedicine.upenn.edu|
20547863|NCT03686514|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20547864|NCT01400815|22nd Century Group, Inc.|Karen Delaney|716-270-1523|kdelaney@xxiicentury.com|
20547865|NCT01123850|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
20547866|NCT02234986|CASI Pharmaceuticals, Inc.|Dr. Alexander Zukiwski|+1 240 864 2888|alexz@casipharmaceuticals.com|
20547867|NCT02456103|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20556432|NCT02454101|AinShamsU|ahmed kotb|0100868199|ahmedmkotp@hotmail.com|+2
20556433|NCT01813474|AstraZeneca|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
20556434|NCT01011829|University of California, Los Angeles|Steve Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
20547868|NCT02448810|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20556435|NCT00587964|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Beal|212-639-5159|bealk@mskcc.org|
20547869|NCT05708586|University of Michigan|Dr. Noelle Whyte|734 936-5780|whyteno@umich.edu|
20547870|NCT00470847|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-2335|nlin@partners.org|
20547871|NCT01810588|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
20547872|NCT00568685|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20547873|NCT01231230|University of Miami|Adam Wanner, MD|(305)243-2568|awanner@med.miami.edu|
20547874|NCT01267656|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20547875|NCT00467610|Rush university medical center|Jamile shammo|312-942-5157|jamile_shammo@rush.edu|
20547876|NCT04398316|Hennepin County Medical Center, Department of Emergency Medicine|Elliott Chinn, DO|612-873-3508|elliott.chinn@hcmed.org|
20547877|NCT02001181|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547878|NCT01842815|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20547879|NCT05466448|Raziel Therapeutics|Racheli Gueta|97289126941|racheli@raziel-therapy.com|
20547880|NCT01945112|Stanford Department of Emergency Medicine|Grant Lipman|415-290-9286|gslipman@stanford.edu|
20547881|NCT01483807|VA SALT LAKE CITY HEALTHCARE SYSTEM|Dr. Julie Wambaugh|8015821565|julie.wambaugh@health.utah.eduj|1363
20547882|NCT03643159|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20547883|NCT03438383|Department of Vascular Surgery, Korgialeneio-Benakeio Hellenic Red Cross Hospital, Athens, Greece|Dr. Konstantinos Roditis, Study Chair|+306976686951|roditis.k@gmail.com|
20547884|NCT01528033|Witten/Herdecke University|Dörthe Seidel|00492219895731|Doerthe.Seidel@uni-wh.de|
20547885|NCT01498601|Fraser Health|Trudy Robertson RN, MSN, CNN(c)|604-520-4715|Trudy.Robertson@fraserhealth.ca|
20547886|NCT03170856|Boston Children's Hospital|Dr. William Meehan|781-216-1328|william.meehan@childrens.harvard.edu|
20547887|NCT02780609|Moffitt Cancer Center|Taiga Nishihori, MD|813-745-1856|Taiga.Nishihori@moffitt.org|
20547888|NCT02898116|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20547889|NCT03635788|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20547890|NCT05521906|University of Nebraska-Lincoln, Department of Educational Psychology/Interpersonal Violence Research Laboratory|Katie M Edwards, PhD|402-472-2448|katie.edwards@unl.edu|
20571890|NCT00542542|University of Texas MD Anderson Cancer Center|Dr. Farzin Goravanchi, Professor, Anesthesiology & Perioperative Medicine|713-563-5613|CR_Study_Registration@mdanderson.org|
20571891|NCT05430815|Emory University|Anne Dunlop, MD, MPH|404-712-8520|amlang@emory.edu|
20571892|NCT04047862|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20547891|NCT03803683|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@cumc.columbia.edu|
20547892|NCT00492050|UT MD Anderson Cancer Center|Sheeba Thomas, MD-Professor, Lymphoma-Myeloma|(713) 792-2860|sthomas@mdanderson.org|
20547893|NCT00282412|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
20547894|NCT01854658|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20547895|NCT03911713|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20547896|NCT00145704|Upstate Orthopedics|Timothy A. Damron|315-464-8602|damront@upstate.edu|
20556436|NCT04557930|Dartmouth-Hitchcock|Dr. Amber E. Barnato|603-646-5609|Amber.Barnato@dartmouth.edu|
20508611|NCT03551626|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20556437|NCT02732366|University of Pittsburgh, Department of Physical Therapy|Christine M. McDonough, Assistant Professor of Physical Therapy|4123834603|cmm295@pitt.edu|
20556438|NCT01297959|Excited States/Exoxemis, Inc|Jackson T Stephens, Jr|(402) 884-2316|sstephens@exoxemis.com|
20556439|NCT00344461|University of Maryland, Institute Of Human Virology|Charles E. Davis, Jr., MD|410-706-4608|cdavis@ihv.umaryland.edu|
20556440|NCT01667432|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20556441|NCT02339831|Brigham and Women's Hospital|Wolfgang Fitz MD|617-732-9500|wfitz@partners.org|
20556442|NCT00671931|Cincinnati Children's Hospital|Mohamed Mahmoud, MD Principal Investigator|513 636-7426|mohamed.mahmoud@cchmc.org|
20556443|NCT00951275|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20556444|NCT04427202|University of Chicago Medicine|Mai T. Pho, MD MPH|773-834-3689|mpho@bsd.uchicago.edu|
20556445|NCT00251745|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20556446|NCT05501860|American Genomics, LLC|Michelle Widmann|919-600-1819|mwidmann@calclinicalsolutions.com|
20556447|NCT00636649|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
20571893|NCT03826030|Duke University|Wayne Feng, MD|919-681-1700|wayne.feng@duke.edu|
20571894|NCT06122870|Johns Hopkins University|Dr. Kawsar Talaat|410-336-9164|ktalaat@jhu.edu|
20571895|NCT04015869|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski|203-932-5711|Elizabeth.Ralevski@yale.edu|1-4282
20571896|NCT06748729|Össur Iceland ehf.|Laurine Roussillon|+3548221812|lroussillon@ossur.com|
20571897|NCT06118957|University of Utah Obgyn|Elizabeth Turner, MPH, Senior Regulatory Coordinator|8012018929|elizabeth.e.turner@hsc.utah.edu|
20527657|NCT02867202|the 1st affiliated hospital of Wenzhou Medical University.|the 1st affiliated hospital of Wenzhou Medical University.|0886-0577-88069525|zfy983023@hotmail.com|
20508612|NCT00653328|Vanderbilt-Ingram Cancer Center|Marta Crispens, M.D.|800-811-8480|marta.crispens@vanderbilt.edu|
20571898|NCT03986944|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20571899|NCT03002220|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
20556448|NCT04508699|San Diego State University|AVP for Research Support Services|619-594-5938|rss@sdsu.edu|
20556449|NCT04866017|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20556450|NCT01321554|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20556451|NCT01865708|Children's Healthcare of Atlanta|Dr. Jana Stockwell|404-785-1868|jana.stockwell@choa.org|
20556452|NCT02355067|Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
20556453|NCT01553318|Wake Forest Baptist|dennis ang|336-716-4209|dang@wakehealth.edu|
20556454|NCT02238925|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency||tom.chmielewski@jazzpharma.com|
20556455|NCT02178059|AstraZeneca R&D|Göran Eckerwall, Medical Science Director|1-800-236-9933|Goran.Eckerwall@astrazeneca.com|
20556456|NCT03040713|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20508613|NCT03967847|University Hospitals Cleveland Medical Center|John Strony, MD|908-268-3663|john.strony@uhhospitals.org|
20508614|NCT01017549|iCAD, Inc. Xoft, Inc|Michael A. Patz MBA, RAC, Senior Director Clinical Affairs|603-882-5200|mpatz@icadmed.com|7308
20508615|NCT05686044|Annovis Bio, Inc.|Matthew Peterson, PhD|484-875-3192|peterson@annovisbio.com|
20508616|NCT00364819|University of California Davis|Christopher L. Bowlus, MD|916-734-8986|clbowlus@ucdavis.edu|
20508617|NCT03304262|University of New Mexico|Sarah Pirio Richardson|505-272-3342|spiriorichardson@salud.unm.edu|
20508618|NCT00391807|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20508619|NCT02351739|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20508620|NCT02980692|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
20508621|NCT03943888|Seoul National University Hospital|Dr. Sang-Hwan Ji|+82-2-2072-3661|taepoongshin@gmail.com|
20508622|NCT01998438|Fuwai Hospital|Dr. Hongwen Ji|+86 13701229553|jihongwen@hotmail.com|
20508623|NCT03725293|Beaumont Hospitals|Amit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
20508624|NCT02143141|Wake Forest School of Medicine|Dr. Jessica Booth|3367188278|jbooth@wakehealth.edu|
20508625|NCT03862495|Skin Disease Hospital of Southern Medical University|Deputy Chief Physician Li Changchang|18585239166|lichch8@mail2.sysu.edu.cn|
20508626|NCT00064077|NRG Oncology|Angela Kuras on behalf of Michael Sill and Helen Huang|716-845-5702|kurasa@nrgoncology.org|
20508627|NCT04397796|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20508628|NCT01057862|Yale University|Dr. Marc N Potenza|2037373553|marc.potenza@yale.edu|
20508629|NCT01661946|Queen's University Department of Ophthalmology|Dr. Sanjay Sharma|613-544-3400|sanjay_sharma60@hotmail.com|2227
20508630|NCT03363165|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
20508631|NCT02255760|MedImmune LLC|Hasan S. Jafri, MD, Senior Director, Clinical Development|301-398-0000|jafrih@medimmune.com|
20508632|NCT00003838|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator, NIH, NHLBI|301.451.7128|childsr@nhlbi.nih.gov|
20508633|NCT00618813|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20508634|NCT00425113|National Institute of Allergy and Infectious Diseases|Ray Chen|301-443-5816|ray.chen@nih.gov|
20508635|NCT00879437|Baylor College of Medicine|Jack Su|8328224306|jmsu@txch.org|
20508636|NCT00291187|Vanda Pharmaceuticals Inc.|Marlene Dressman, PhD.|202-734-3462|marlene.dressman@vandapharma.com|
20556457|NCT02565914|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20556458|NCT00361374|Massachusetts General Hospital|Dr David Mischoulon, Director of Research, Depression Clinical and Research Program|617-724-5198|dmischoulon@partners.org|
20556459|NCT02258139|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
20556460|NCT03338894|Atlantic Children's Health/Atlantic Health Outpatient|Dr. Alycia Leiby|973--971-5676|alycia.leiby@atlantichealth.org|
20556461|NCT04465357|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
20556462|NCT04452292|University of Kentucky|Dr. Charles Kunos|859-323-2354|charles.kunos@uky.edu|
20556463|NCT01782443|DFCI|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
20556464|NCT03039595|Oxford Univeristy Hospitals NHS Foundation Trust|Dr Helen Jones|01865 235657|helen.jones3@ouh.nhs.uk|
20556465|NCT02570126|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556466|NCT01335204|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20556467|NCT04385368|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20556468|NCT00677235|Bard Peripheral Vascular|John Van Vleet|1-800-321-4254|John.VanVleet@CRBard.com|
20508637|NCT01153672|University of Washington|Hannah M. Linden, MD|206-288-6989|hmlinden@u.washington.edu|
20508638|NCT00615459|Novartis Pharmaceuticals|Study Director|862-778-8300||
20527658|NCT00438256|Massachusetts General Hospital|Theodore Hong, MD|617-724-1159|TSHONG1@mgh.harvard.edu|
20556469|NCT00952367|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556470|NCT02230956|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20547897|NCT02203071|University of Missouri|Research Project Analyst|573-882-7583|jonesvicki@health.missouri.edu|
20547898|NCT01845818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20547899|NCT00195273|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20547900|NCT01680965|Moffitt Cancer Center|Joseph Pidala, M.D., PhD|813-745-2069|Joseph.Pidala@moffitt.org|
20547901|NCT02595970|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|Novartis.email@novartis.com|
20547902|NCT01886716|Miami University|Dr. Elise Clerkin|513-529-2483|clerkiem@miamioh.edu|
20547903|NCT02367131|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20547904|NCT02570074|University of Illinois at Chicago|Keith A. Rodvold, PharmD, FCCP, FIDSA|312-996-3341|kar@uic.edu|
20556471|NCT00382824|Lahey Hospital & Medical Center|Jordan Jara|7817442958|jordan.jara@lahey.org|2958
20571900|NCT03795753|Emory University|Dr. Nancy Collop|404-712-7533|nancy.collop@emory.edu|
20571901|NCT02225132|National Heart Lung and Blood Institute|Fitzhugh, Courtney|+1 301 402 6496|courtney.fitzhugh@nih.gov|
20571902|NCT01202903|Novartis Pharmaceuticals|Study Director|862-778-8300||
20547905|NCT05061966|University of Pensylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
20547906|NCT03793556|Sofar Spa|Dr Francesca Baldan|0039 02 909362|francesca.baldan@sofarfarm.it|1
20547907|NCT04416633|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20547908|NCT02923427|DorkuzEU|Anaesthesiology and Intensive Care, Sule Ozbilgin|905055252901|ozbilginsule@gmail.com|
20547909|NCT01325623|Cyberonics Europe BVBA|Wim Van Grunderbeek, Clinical Operations Manager Cyberonics Europe|+32 2 720 95 93|wim.vangrunderbeek@cyberonics.com|312
20547910|NCT00598702|Mallinckrodt Pharmaceuticals|Lawrence Hill, VP Clinical Development|908-238-6370|lawrence.hill@mallinckrodt.com|
20571903|NCT01302080|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547911|NCT02063880|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
20571904|NCT01318018|Dept. of Anesthesiology and Intensive Care Medicine|Prof. Dr.Martin Soehle|++49-228-287-|martin.soehle@ukb.uni-bonn.de|11378
20547912|NCT00611533|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
20571905|NCT02334982|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20571906|NCT00921687|Louis Stokes Cleveland VA Medical Center|Paul Drawz, MD, MHS, MS|6126255423|draw0003@umn.edu|
20571907|NCT02124603|Casa di Cura Di Stefano|Dr.Marcello Santocono|+393356070002|santocono.m@alice.it|
20547913|NCT01924988|Georgetown University Medical Center|James B. Spies MD MPH|202-444-3450|spiesj@gunet.georgetown.edu|
20571908|NCT01507987|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
20547914|NCT01359007|University of Oklahoma|Ingrid Block - CTO Directo|405-271-8777|ingrid-block@ouhsc.edu|
20547915|NCT01072669|Cleveland Clinic|Dr. Soumya Chatterjee|216-444-9945|chattes@ccf.org|
20547916|NCT01461980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547917|NCT04171765|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20547918|NCT00122109|VA Pacific Islands Healthcare System|Leslie A. Morland, PsyD, Principal Investigator|(808) 566-1934|leslie.morland@va.gov|
20571909|NCT00297427|University of Pittsburgh|Dr. Sandra Engberg|412-624-6616|sje1@pitt.edu|
20571910|NCT01127893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547919|NCT03584100|Stanford University|Jeffrey Yao|650-723-5643|jyao@stanford.edu|
20547920|NCT02540226|Hospital for Special Surgery|Dr. Kethy Jules-Elysee|212-606-1206|JulesElyseeK@HSS.EDU|
20571911|NCT01262677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547921|NCT00809354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547922|NCT03028103|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
20571912|NCT04512703|ZOLL Medical Corporation|Mike Osz|4129683333|mosz@zoll.com|14104
20547923|NCT01480089|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
20547924|NCT00783965|ChildrensHRCOakland|Raj Prasad|510-450-7602|rprasad@chori.org|7602
20547925|NCT00365144|UCaliforniaSF|Andrew Ko, MD|415-353-9888|andrewko@medicine.ucsf.edu|
20571913|NCT00597246|Memorial Sloan Kettering Cancer Center|Ronald Blasberg, MD|646-888-2211|blasberr@mskcc.org|
20547926|NCT01439568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20547927|NCT01578330|Novartis|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20547928|NCT01134731|UAB|Dr. Richard Shelton|205-934-2484|rshelton@uab.edu|
20547929|NCT01669928|Imperial College London|Professor Neil Poulter|+44 20 7594 3446|n.poulter@imperial.ac.uk|
20571914|NCT03283254|Columbia University|Elizabeth Werner, Ph.D.|646-774-8945|ew150@cumc.columbia.edu|
20571915|NCT02055781|CTI BioPharma Corp.|Beth Ziemba||bziemba@ctibiopharma.com|
20571916|NCT02060370|University of Texas MD Anderson Cancer Center|Dr. Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-2830|ejonasch@mdanderson.org|
20571917|NCT01896557|Heart Institute of University of Sao Paulo Medical School|Remo Holanda de Mendonca Furtado|+5511 26615058|remo_holanda@hotmail.com|
20571918|NCT03098563|Johns Hopkins University|Claudia Campbell|4105507989|ccampb41@jhmi.edu|
20547930|NCT01631110|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20571919|NCT02182947|Children's Mercy Hospital|Nadia Hijaz|3139204958|nmhijaz@cmh.edu|
20547931|NCT01954342|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|Leanne.Redman@pbrc.edu|
20547932|NCT02409810|The Ohio State University|Judy Opalek Director, Research Administration|6147789696|judy.opalek@osumc.edu|
20547933|NCT00437320|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20547934|NCT02148107|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571920|NCT00356408|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20571921|NCT05487586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571922|NCT00919191|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
20571923|NCT02757872|NYU Langone|Dr. Michal Melamed|212-263-0705|michal.melamed@nyulangone.org|
20571924|NCT01072630|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20571925|NCT04246021|King Hussein Cancer Center|Dr. Hikmat Abdel-Razeq|0096265300460|habdelrazeq@khcc.jo|1403
20547935|NCT00762216|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20547936|NCT01199731|ViiV Healthcare|GSK Response Center|866-435-7343||
20547937|NCT03194503|The Children's Hospital of Philadelphia|Dr. Akira Nishisaki|267-426-0665|NISHISAKI@email.chop.edu|
20547938|NCT04231318|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20547939|NCT00846287|UMass Medical School|Dr. Mitchell Albert|(807) 684-7270|albertmi@tbh.net|
20547940|NCT00542971|The University of MD Anderson Cancer Center|Farhad Ravandi-Kashani, M.D./Associate Professor|713-745-0394|fravandi@mdanderson.org|
20547941|NCT01638819|Sutter Health|Michael Chez, MD|(916) 773-8711|ChezM@sutterhealth.org|
20547942|NCT00979069|Atlanta VAMC|Dr. Joe Nocera|404 321 6111|joe.nocera2@va.gov|6354
20547943|NCT00471146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508639|NCT00918346|Santen Oy|Auli Ropo|+358405012416|auli.ropo@santen.fi|
20547944|NCT03538431|Massachusetts General Hospital|Dr. Joseph Biederman|6177261743|biederman@helix.mgh.harvard.edu|
20547945|NCT01212107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20547946|NCT00706810|Huntsman Cancer Institute|Dr. Randy Jensen|801-581-6908|randy.jensen@hci.utah.edu|
20547947|NCT01414608|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|gedeonl@nrgoncology.org|
20547948|NCT05156073|Johns Hopkins University School of Medicine|Dr. Ariel Green|(410) 550-6733|ariel@jhmi.edu|
20547949|NCT00973349|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
20547950|NCT01015131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508640|NCT03238352|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508641|NCT04153929|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20571926|NCT00643617|Accuray, Inc.|Director of Clinical Affairs|608-824-3421|sgodbold@accuray.com|
20547951|NCT05430022|University of Southern California|Dr. Jessica Schwartzman, Assistant Professor|3232075910|jstrendlab@gmail.com|
20547952|NCT02452697|Duke University|Cristina Gasparetto, MD|919-668-1000|cristina.gasparetto@duke.edu|
20571927|NCT03894618|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
20571928|NCT02551653|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20571929|NCT02683785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20547953|NCT03148275|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20571930|NCT01305408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20571931|NCT02770612|Brigham and Women's Hospital|Brian T Bateman|617-278-0930|bbateman@partners.org|
20571932|NCT02233803|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547954|NCT05098938|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20547955|NCT01262131|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
20547956|NCT00866788|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20547957|NCT02339285|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
20547958|NCT02053051|Imperial College London|Prof Nick Oliver|02075941862|nick.oliver@imerial.ac.uk|
20508642|NCT04083794|Spaulding Rehabilitation Hospital Cambridge|Dr. Adina E. Draghici|617-758-5508|adraghici@mgh.harvard.edu|
20547959|NCT00537238|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547960|NCT03538678|University of Pittsburgh|Kar-Hai Chu|412-692-2578|chuk@pitt.edu|
20571933|NCT01606670|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20571934|NCT02636725|University of Miami|Jonathan Trent MD|305-243-2581|JTrent@med.miami.edu|
20571935|NCT05254080|Medical University of South Carolina|Dr. Christopher W. Austelle|843-792-2872|austelle@musc.edu|
20571936|NCT03653208|ImmuneMed Inc.|Byoungok Ahn|+82-2-527-8391|ahnbo@immunemed.co.kr|
20571937|NCT00368927|National Jewish Health|James R. Jett, M.D.|303-270-2601|JettJ@NJHealth.org|
20571938|NCT01152814|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20571939|NCT03284203|University of Chicago|Mary Akel|773-834-4489|makel@medicine.bsd.uchicago.edu|
20571940|NCT01877239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20571941|NCT04368364|The University of Texas Health Science Center at Houston|Sudipta Sen, MD, Assistant Professor|713-500-6200|Sudipta.Sen@uth.tmc.edu|
20571942|NCT04561778|Geisinger Health System|Dr Pugazhendhi Vijayaraman|5708086020|pvijayaraman1@geisinger.edu|5444
20571943|NCT04662931|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20571944|NCT02406677|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD, VP, CVMD TA|302-886-5526|Naeem.Khan@astrazeneca.com|
20571945|NCT01114880|Abbott|Global Medical Services|1-800-633-9110||
20571946|NCT01533753|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-263-7107|jybruce@medicine.wisc.edu|
20571947|NCT04531098|VBI Vaccines|Dr. Francisco Diaz-Mitoma|1 613 297 3304|fdiazmitoma@vbivaccines.com|
20571948|NCT04531904|CERENOVUS|Cerenovus Clinical Research Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20571949|NCT00283244|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20571950|NCT02628028|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20571951|NCT02839889|Four Seasons Compassion for Life|Janet Bull, MD|8286926178|jbull@fourseasonscfl.org|302
20571952|NCT03519997|University Texas Southwestern Medical Center|David Hsieh|214/648-4180|David.Hsieh@UTSouthwestern.edu|
20571953|NCT03361605|University of Michigan|Amy McKinney|734-647-8129|adrongo@med.umich.edu|
20571954|NCT00186888|St. Jude Children's Research Hospital|Ibrahim Qaddoumi MD|1-866-278-5833|info@stjude.org|
20571955|NCT02108964|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20571956|NCT03006848|St Jude Children's Research Hospital|Dr. Michael Bishop|866-278-5833|referralinfo@stjude.org|
20571957|NCT04372121|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20571958|NCT02745353|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
20571959|NCT05014568|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20571960|NCT03820947|Medtronic|Wendy Moeyersons, Clinical Research Specialist|+32486313172|wendy.moeyersons@medtronic.com|
20571961|NCT01967147|Alcon Research, Ltd.|Global Brand Med Affairs Lead, GCRA, GMA Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20571962|NCT03843554|University of Pittsburgh|Associate Vice Chancelor, Clinical Trials Operations|412-383-2561|pat.corby@pitt.edu|
20571963|NCT02896075|University of Texas at Austin|Stephanie Lapierre|512-471-8594|stephlap1116@gmail.com|
20571964|NCT02218606|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin, MD, PhD|646-422-4472|slovins@MSKCC.ORG|
20571965|NCT03203473|Dana Farber Cancer Institute|Toni K Choueiri, MD|(617) 632-5456|toni_choueiri@dfci.harvard.edu|
20571966|NCT01882543|Department of Urology, Queens University, Ontario|J. Curtis Nickel|613-548-2497|jcn@queensu.ca|
20571967|NCT04420949|University of Wisconsin - Madison|Dr. Kreg Gruben|608 262 2711|kreg.gruben@wisc.edu|
20571968|NCT01325311|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
20571969|NCT02314780|Medical University of Vienna|Dr. Martin Andreas|+ 43 1 40400|martin.andreas@meduniwien.ac.at|69660
20571970|NCT02083107|AinShams University|Dr. Mohamed S. Sweed, Dr.Mourad M.El-Said, Dr.Amgad E. Abou-Gamrah, Dr.Mohamed M. Abd-El-Hamid|01001222047|drmsweed@gmail.com|+2
20571971|NCT01077271|Abbott|Global Medical Services|1-800-633-9110||
20547961|NCT01193660|CHA Bundang Medical Center, CHA University|Minyoung Kim, MD, PhD|82-31-780-1872|kmin@cha.ac.kr|
20547962|NCT02841189|Indiana University|Nicole Horn MD|317-944-9981|nhorn@iupui.edu|
20571972|NCT00979550|University of Kentucky Healthcare|Henry C. Vasconez, MD|8593236328|betsy.fink@uky.edu|
20571973|NCT04396366|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20571974|NCT00550589|Statistical Center of AIDS Malignancy Consortium|Jeannette Lee|(501) 526-6712|jylee@uams.edu|
20571975|NCT00166712|Comprehensive Transplant Center, Northwestern University|Joseph Leventhal, MD, PhD, Associate Professor|(312) 695-1703|jleventh@nmh.org|
20571976|NCT04684394|Gemini Therapeutics, Inc.|Gemini Therapeutics, Inc.|617-401-4401|clinicaltrials@geminitherapeutics.com|
20571977|NCT02548845|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
20571978|NCT00482690|University of Nebraska Medical Center|Stephen Rennard|402-559-7313|srennard@unmc.edu|
20571979|NCT00640133|Butler Hospital|Dr. Benjamin Greenberg|(401) 455-6602|be3ngreenb@gmail.com|26602
20571980|NCT01183260|Cleveland Clinic|Alison Klika, Research Program Manager|216-444-4954|klikaa@ccf.org|
20571981|NCT00128102|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20571982|NCT01531673|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20571983|NCT04370548|Dare Bioscience, Inc.|VP, Clinical Operations|858-926-7655|nzack@darebioscience.com|109
20571984|NCT04476251|National Cancer Institute|Scott M. Norberg D.O.|301-275-9668|scott.norberg@nih.gov|
20571985|NCT03446781|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
20571986|NCT02060539|CooperVision|Cheryl McKinnon|925-251-2034|cmckinnon@coopervision.com|
20571987|NCT02093949|Saint joseph hospital|Dr Julien Seitz|+330491807044|jseitz@hopital-saint-joseph.fr|
20571988|NCT02796300|UCLA Medical Center|Principal Investigator|310-267-8771|EdwardLee@mednet.ucla.edu|
20571989|NCT05141500|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
20571990|NCT01638429|Cedars-Sinai Medical Center|Dr Ruchi Mathur|310-423-4774|Ruchi.Mathur@cshs.org|
20571991|NCT01470001|University at Buffalo|Dr Tova Ablove|716-878-7138|tablove@buffalo.edu|
20571992|NCT03268603|Mayo Clinic|Nathan Staff, M.D., Ph.D.|507-293-1283|Staff.Nathan@mayo.edu|
20571993|NCT04786964|Checkpoint Therapeutics|James Oliviero|212-574-2830|jfo@checkpointtx.com|
20571994|NCT01066520|Biologische Heilmittel Heel GmbH|Dr. Istvan Zatik|+4972215013192|istvan.zatik@heel.com|
20571995|NCT03896152|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20571996|NCT04939701|Astellas Pharma Global Development Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20571997|NCT02236988|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20571998|NCT05775991|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
20571999|NCT01461811|Alcon Research, Ltd.|Mary Fahmy, OD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20572000|NCT03733314|EA Pharma Co., Ltd|Corporate Communication Dept.|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
20572001|NCT04514510|National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)|Arun Shet, MD, PhD|301.827.6808|arun.shet@nih.gov|
20572002|NCT01693900|Beaumont Health|Randy Fayne, DO|248-898-1905|rfyane@beaumont.org|
20572003|NCT01353118|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20572004|NCT00864253|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
20572005|NCT01111240|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20572006|NCT01989169|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20572007|NCT01585155|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20572008|NCT00515723|Washington University School of Medicine and Florida Atlantic University|John Newcomer, M.D.|561-297-0252|jnewcomer@fau.edu|
20572009|NCT02235311|University of Missouri - Columbia|Ashley McCormick, PharmD, BCPS|573-771-7798|ausmusash@health.missouri.edu|
20572010|NCT04655027|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-94 79|information.center@astrazeneca.com|
20572011|NCT00658788|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
20572012|NCT00653523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20572013|NCT03898167|The University of Texas MD Anderson Cancer Center|Dr. Jane Montealegre|713-792-0919|jrmontealegre@mdanderson.org|
20572014|NCT01937026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572015|NCT00994175|National Heart Lung and Blood Institute|Levine, Stewart|+1 301 402 1448|levines@nhlbi.nih.gov|
20547963|NCT02436304|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20547964|NCT01237821|Penn State Hershey Medical Center|Diane Thiboutot|717-531-1513|dthiboutot@pennstatehealth.psu.edu|
20547965|NCT00785928|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20547966|NCT03764007|University of California, San Francisco|Dr. Thomas A. Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
20547967|NCT04465162|UT MD Anderson Cancer Center|Dr. Bouthaina S Dabaja, MD-Professor, Radiation Oncology Department|(713) 563-2406|bdabaja@mdanderson.org|
20547968|NCT01675427|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20547969|NCT02556203|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20547970|NCT01892267|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
20547971|NCT05021081|Johnson & Johnson Vision Care, Inc. (JJVC)|John R. Buch, O.D., M.S., F.A.A.O.|1-800-843-2020|jbuch@its.jnj.com|
20572016|NCT04696653|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20527659|NCT02005627|Imperial College London|Stephen R Durham|+44207-351-8024|s.durham@imperial.ac.uk|
20527660|NCT03743402|University of Washington|Dr. Mark Sullivan|2066853184|sullimar@uw.edu|
20527661|NCT03611101|Exalenz Bioscience|Clinical Trial Manager|+972-8-9737513|avrahamh@exalenz.com|
20527662|NCT03838510|San Francisco Department of Public Health, University fo California San Francisco|Phillip Coffin, MD, MIA|628-217-6282|phillip.coffin@sfdph.org|
20527663|NCT02540161|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
20527664|NCT03913104|University of California, San Francisco|Natalie Morris|(415) 353-4724|natalie.morris@ucsf.edu|
20527665|NCT01370616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527666|NCT01084538|Abbott|Global Medical Services|1-800-633-9110||
20527667|NCT03780972|ONL Therapeutics|Director of Clinical Operations|(734) 412-8787|info@onltherapeutics.com|
20527668|NCT00803205|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20527669|NCT03973697|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20527670|NCT01490697|Massachusetts General Hospital|Roger K. Pitman, MD|617-726-5333|roger_pitman@hms.harvard.edu|
20508643|NCT02801006|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20508644|NCT00224003|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com|
20527671|NCT00379808|University of Florida|Dr Julie Johnson, PI|352-273-6007|johnson@cop.ufl.edu|
20527672|NCT03409120|University of Alabama at Birmingham|Christopher Gonzalez|2059753732|clg17@uab.edu|
20547972|NCT01967433|University of Oklahoma Health Sciences Center and VAMC, Oklahoma City|Salman Nusrat|4052715428|salman-nusrat@ouhsc.edu|
20547973|NCT00100178|Barbara Davis Center for Childhood Diabetes, Health Sciences Center, University of Colorado|Peter Gottleib, MD|303-724-6714|Peter.Gottleib@uchsc.edu|
20547974|NCT02477839|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20547975|NCT02781779|Kansas City Heart Rhythm Institute|Donita Atkins|816-651-1969|donita.atkins@hcahealthcare.com|
20547976|NCT00631696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547977|NCT01050543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20572017|NCT04348435|Hope Biosciences Stem Cell Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
20572018|NCT00848588|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
20572019|NCT01099215|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20572020|NCT01732822|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
20572021|NCT00215137|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
20572022|NCT03333876|Philips Respironics|Noah Papas|4122776436|Noah.Papas@philips.com|
20572023|NCT00336700|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
20572024|NCT00095498|Amgen Inc.|Study Director|866-572-6436||
20527673|NCT04779606|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
20527674|NCT03725033|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20527675|NCT01313351|Rapid Pathogen Screening, Inc|Robert Sambursky, MD|9415581853|rob.sambursky@lumosdiagnostics.com|
20527676|NCT02906033|Helsinki University Hospital|MNSc Maria Pulkkinen|+358 50 427 2678|maria.pulkkinen@hus.fi|
20527677|NCT00687882|Johns Hopkins All Children's Hospital|Dr. Neil A Goldenberg, Associate Dean of Research|727-767-3674|neil@jhmi.edu|
20527678|NCT01625689|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
20527679|NCT01236326|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-0727|mea9008@med.cornell.edu|
20527680|NCT00889187|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon, MD, PhD|617-732-8564|HMAMON@LROC.HARVARD.EDU|
20527681|NCT03092934|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20527682|NCT01782352|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|VITAL Study Director|1-800-388-3963|vitalstudy@partners.org|
20547978|NCT02657538|Department of Preventive, Restorative and Pediatric Dentistry, University of Bern|PD Dr. Klaus Neuhaus|+41 (0)31 632 49 74|klaus.neuhaus@zmk.unibe.ch|
20547979|NCT02439879|Universidad Popular Autonoma del Estado de Puebla|Dr. Hector Garcia Alcala|+522222299400|hector.garcia@upaep.mx|7466
20547980|NCT02315989|Linkou Chang Gung Memorial Hospital|Hong, Ji-Hong M.D.|03-3281200|jihong@cgmh.org.tw|2600
20572025|NCT05020327|University Hospitals Cleveland Medical Center|Dr. Ankita Desai|216-844-3645|Ankita.Desai@UHhospitals.org|
20572026|NCT00591370|Memorial Sloan-Kettering Cancer Center|Dr. Paul Chapman|212-639-7357|chapmanp@mskcc.org|
20572027|NCT03232580|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20572028|NCT00095056|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20572029|NCT02654691|Aarhus University|Nanna Finnerup|0045 78463382|finnerup@clin.au.dk|
20572030|NCT04019990|Hacetepe University|Ceyda Sofuoğlu M.Sc.|+905338557742|ceyda_sofuoglu@hotmail.com|
20572031|NCT00306670|Georgetown University|Craig M Kessler, MD|202-444-8676|kesslerc@georgetown.edu|
20572032|NCT00503139|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572033|NCT01827475|Emergency Medicine, Stony Brook U|Dr. Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
20572034|NCT02735577|New York State Psychiatric Institute|Nasir Naqvi, MD|6467748181|nasir.naqvi@nyspi.columbia.edu|
20572035|NCT00833833|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20572036|NCT02040259|Stryker Neurovascular|Minyi Ji, Biostatistician, Clinical Evidence|+1 (510) 980-5689|minyi.ji@stryker.com|
20572037|NCT00316602|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20572038|NCT01142232|IndianaU|Dr. Attaya Suvannasankha|(317) 278-9306|asuvanna@iu.edu|
20572039|NCT00626990|EORTC|Dr. Thierry Gorlia|027741652|thierry.gorlia@eortc.org|
20572040|NCT04138576|ServierRussia|Medical Manager-Olga Linnik|8-495-93707-00|olga.linnik@servier.com|1316
20572041|NCT01994837|AbbVie|Global Medical Services|800-633-9110||
20572042|NCT01951352|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
20572043|NCT00574873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572044|NCT00581555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572045|NCT05816330|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter D Crompton|301-761-5042|pcrompton@niaid.nih.gov|
20572046|NCT00201643|Obstetrix Medical Group, Inc.|Kimberly A. Maurel, MSN, CNS|714-593-9171|kimberly_maurel@pediatrix.com|
20572047|NCT02885324|Indiana University|Dr. Scott Coven|317-944-8784|scoven@iu.edu|
20572048|NCT01802567|Penn State Health Children's Hospital|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
20572049|NCT01940939|Dr.LIU|ShanghaiMHC|862134773775|erliu110@126.com|
20572050|NCT01895101|Amphia Hospital|Dr. Thierry V Scohy|0031765955570|tscohy@amphia.nl|
20572051|NCT00370682|Phramongkutklao Hospital, Bangkok, Thailand|Verrachai Watanaveeradej, MD|662-644-8971|veerachaiw@yahoo.com|
20572052|NCT03167359|Emory University|Dr. Mylin Torres|404-778-3473|matorre@emory.edu|
20572053|NCT03339583|I.M. Sechenov First Moscow State Medical University|Polina Pchelina|+79036701725|polbox@mail.ru|
20572054|NCT00943852|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20572055|NCT00734591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572056|NCT01656200|University of Liverpool|Dr Lance Turtle|+44 151 795 9626|lance.turtle@liverpool.ac.uk|
20572057|NCT00730275|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20572058|NCT01652495|Istituto Ortopedico Rizzoli|Milva Battaglia, Director of Clinical Trials|0516366026|milva.battaglia@ior.it|0039
20572059|NCT00821951|Yale University|Dr. Roy H Decker, MD PhD|203 737-2758|roy.decker@yale.edu|
20572060|NCT05187364|Medical University of South Carolina|Dr. Amber Jarnecke|843-876-3115|jarnecka@musc.edu|
20572061|NCT00338962|Yale University|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
20572062|NCT03046121|Penn State University|Marie Boltz PhD|215-962-9712|mpb40@psu.edu|
20572063|NCT03214640|Wake Forest Health Science|Peter Pan, MD|336-716-1228|ppan@wakehealth.edu|
20572064|NCT04155047|Sunovion Respiratory Development Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20572065|NCT04091061|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572066|NCT00821587|University of Florida|Roberto J. Firpi-Morell, MD|352-273-9500|firpirj@medicine.ufl.edu|9466
20572067|NCT04488770|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20572068|NCT03547739|University of Alabama at Birmingham|Janet M. Turan, PhD, MPH|2059757770|jmturan@uab.edu|
20572069|NCT01208103|UT MD Anderson Cancer Center|Dr. Michael Overman/Gastrointestinal Medical Oncology|713-745-4317|MOverman@mdanderson.org|
20572070|NCT04678505|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20572071|NCT00403767|Johnson & Johnson Pharmaceutical Research & Development L.L.C.|Head of Development, CV & UROL|1 908-927-7767||
20572072|NCT05330676|University of Pennsylvania|John C. Greenwood, MD, MS|856-816-7172|john.greenwood@pennmedicine.upenn.edu|
20572073|NCT02741323|University of California, San Francisco|Clinical Research Manager|415-595-1226|Rodney.Rogers@ucsf.edu|
20572074|NCT02045875|Asthma Management Systems|Andrew G Weinstein MD|302 893 5455|agwmd@aol.com|
20572075|NCT01276379|GEMCAD|Joan Maurel Santasusana|+ 34 93 434 44 12|JMAUREL@clinic.cat|
20572076|NCT01743989|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20572077|NCT02245022|University of Liverpool|Catriona Waitt|0778288217|cwaitt@liverpool.ac.uk|
20572078|NCT05384938|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20572079|NCT01187381|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20572080|NCT00384397|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20572081|NCT01525238|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20572082|NCT01214642|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572083|NCT01946529|St. Jude Children's Research Hospital|Sara Federico, MD|901-595-2220|sara.federico@stjude.org|
20556472|NCT03574597|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20556473|NCT00673309|University of Texas Medical Branch|Tina Mack-Moshay- ClinicalTrials.gov Administrator|409-266-6917|tlmackmo@utmb.edu|
20556474|NCT02355743|BloodCenter of Wisconsin, Medical College of Wisconsin|Lynn Malec|414-257-2424|lynn.malec@bcw.edu|
20556475|NCT02712905|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20556476|NCT03721965|Incyte Corporation|Incyte Corporation Call Center|(0)330 100 3677|globalmedinfo@incyte.com|
20556477|NCT02862457|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556478|NCT04085328|Alcon Research, LLC|Expert CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20556479|NCT04496219|University of Washington|Dr. Sarah Psutka, MD, MS|206-598-4294|spsutka@uw.edu|
20556480|NCT00419263|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|(919) 859-1302||
20556481|NCT02342886|TB Alliance|Leandra Lombard, Director, Clinical Operations|+27 87 700 3900|Leandra.Lombard@tballiance.org|
20556482|NCT01328080|Johns Hopkins Dermatology|Ginette Okoye, MD, Director of Ethnic Skin Program|410-502-7546|ctrep@jhmi.edu|
20556483|NCT02191267|Brigham and Women's Hospital|Dr. Martha Shenton|617-699-6152|shenton@bwh.harvard.edu|
20556484|NCT00765674|Novartis Pharmaceuticals|Study Director|862 778-8300||
20556485|NCT03015402|University of Pittsburgh|Dr. Michael Risbano, Director of Advanced Cardiopulmonary Exercise Testing Program|412-692-2210|risbanomg@upmc.edu|
20556486|NCT03138096|Radboud University Medical Center|Dr. M.B.B. McCall|+31642166480|Matthew.McCall@radboudumc.nl|
20556487|NCT00316082|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20556488|NCT02216773|Imperial College London|Professor Long Jiao|+44 2033133937|l.jiao@imperial.ac.uk|
20556489|NCT00528775|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20556490|NCT01995461|Marshfield Clinic Research Foundation|Dr. Rachel Stankowski|715-389-3442|stankowski.rachel@mcrf.mfldclin.edu|
20556491|NCT00540124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556492|NCT02671032|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
20556493|NCT01163097|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
20556494|NCT04540874|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20556495|NCT00796302|Ohio State University|Michael Aman|614-688-4196|Aman.1@osu.edu|
20556496|NCT01777854|UH|Carissa Wentland DO|320-392-4737|carissa.wentland@gmail.com|
20556497|NCT02652481|Boston Scientific|Clinical Trial Manager|+32479983495|anneleen.viville@bsci.com|
20556498|NCT02510144|University of Maryland Baltimore|Dr. Mohit Gilotra|(301) 502-4102|mgilotra@som.umaryland.edu|
20556499|NCT02124265|Johns Hopkins University School of Medicine|Carisa Cooney|443-287-4629|ccooney3@jhmi.edu|
20556500|NCT01939548|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556501|NCT03311373|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
20556502|NCT02080468|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
20556503|NCT02115633|RxFunction, Inc.|Lars Oddsson, PhD|8572340382|loddsson@rxfunction.com|
20556504|NCT00205348|University of Wisconsin-Madison|Dr. Herbert Chen|608-263-1387|chen@surgery.wisc.edu|
20556505|NCT00374322|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556506|NCT00182754|Mayo Clinic|Aminah Jatoi, M.D|507-284-4918|jatoi.aminah@mayo.edu|
20556507|NCT00553696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556508|NCT01054768|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|5104283172|ashutosh.lal@ucsf.edu|
20556509|NCT00686881|Merck Sharp & Dohme Corp..|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20556510|NCT02471651|California Retina Consultants|Dr. Gabriel Gordon|8059631648|gabe@californiaretina.com|3034
20556511|NCT02085252|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20556512|NCT01460940|The Ohio State University Comprehensive Cancer Center|Dr. Kristie Blum|614-293-4590|Kristie.Blum@osumc.edu|
20527683|NCT01333956|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
20572084|NCT02954198|Medical University of South Carolina|Dr. David Taber|843-792-4003|taberd@musc.edu|
20547981|NCT01465191|Columbia University|Richard Smiley, MD|212-342-2742|rms7@cumc.columbia.edu|
20572085|NCT00682851|Magee-Womens Research Institute|Lorna Rabe|412-641-6042|lrabe@mwri.magee.edu|
20527684|NCT02134353|Pharmaxis|Dr Brett Charlton|+61 2 9454 7200|Brett.Charlton@pharmaxis.com.au|210
20547982|NCT00943124|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527685|NCT01953432|Michael E. DeBakey VA Medical Center|Daryl Shorter, MD|713-798-4870|shorter@bcm.edu|
20547983|NCT04010539|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20547984|NCT02992132|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20547985|NCT01687036|Medical University Innsbruck, Department of Internal Medicine III, Cardiology|Markus Stühlinger, MD|+43 512 504|markus.stuehlinger@uki.at|81 320
20508645|NCT01614912|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20508646|NCT02481596|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
20508647|NCT02228564|Becton Dickinson|Spark Yamanoglu|480-597-8604|Spark.yamanoglu@bd.com|
20508648|NCT01216397|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508649|NCT01875510|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
20508650|NCT02281344|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
20508651|NCT01360229|University of Colorado School of Medicine|Dr. Benzi Kluger|3037242194|benzi.kluger@ucdenver.edu|
20508652|NCT01455415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20547986|NCT00179127|Vanderbilt University Medical Center|Sheila McMorrow|615-343-8332||
20508653|NCT00587301|NYU Langone Health|Christine Ren Fielding, MD|2122633166|christine.ren-fielding@nyulangone.org|
20508654|NCT00351819|Brigham and Women's Hospital|Dr. Shehzad Basaria|617-525-9150|sbasaria@partners.org|
20508655|NCT02867163|University of New Mexico|Dr. David Siegel|505-272-2610|dsiegel@salud.unm.edu|
20508656|NCT01400139|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20508657|NCT00418717|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20508658|NCT00249795|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
20508659|NCT01804114|NSUHS|Michael Ujiki, MD|8475701700|rpulido@northshore.org|
20508660|NCT00719537|William Beaumont Hospital|John Uckele|2485510610|john.uckele@beaumont.edu|
20508661|NCT01142193|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|Bob.Anders@upsher-smith.com|
20508662|NCT03380000|Penn State University|David N. Proctor|8145715234|dnp3@psu.edu|
20508663|NCT03549429|Tufts Medical Center|Dr. Dan Drzymalski|‪617-913-8168|ddrzymalski@tuftsmedicalcenter.org|
20508664|NCT02910219|Georgetown University|Sandra M. Swain, MD, FACP, FASCO|202-687-4600|Sandra.Swain@georgetown.edu|
20508665|NCT01425749|University of Virginia|Craig L Slingluff Jr|434-924-1730|cls8h@virginia.edu|
20508666|NCT02096042|The University of Texas (UT) MD Anderson Cancer Center|Nitin Jain, MD/Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20508667|NCT03406715|Moffitt Cancer Center|Alberto A. Chiappori, MD|813-745-4541|Alberto.Chiappori@moffitt.org|
20508668|NCT00845507|University of Cincinnati|Dr. DelBello|513-558-2989|Melissa.Delbello@uc.edu|
20508669|NCT05200455|Dartmouth-Hitchcock Medical Center|Dr. Barbara Jobst|6036505000|Barbara.C.Jobst@hitchcock.org|
20508670|NCT00771173|Loyola University Chicago|Dr. Linda Brubaker|708-216-3960|lbrubaker@lumc.edu|
20508671|NCT00807014|GlaxoSmithKline|GSK Response Center|866-435-7343||
20547987|NCT00457366|USC|Dr George Simpson|7604687106|gsimpson@usc.edu|
20508672|NCT02091921|University of Southern California|Leonardo Clavijo, MD|3234426130|lclavijo@usc.edu|
20508673|NCT03307629|Noxopharm|Lorena Figueroa, Director clinical Operations|+612 9144 2223|lorena.figueroa@noxopharm.com|
20508674|NCT02483078|CytoDyn|Joseph Meidling Senior Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
20508675|NCT03296787|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20508676|NCT02853032|University of Texas Health -- San Antonio|Felipe S. Salinas, Ph.D.|210-567-8214|salinasf@uthscsa.edu|
20508677|NCT04876599|Massachusetts General Hospital|Dr. Daniel Hall|‭+1 (704) 517-7273‬|dhall7@mgh.harvard.edu|
20508678|NCT01379924|Boston Children's Hospital|Dr. Joanne Cox|6173557701|joanne.cox@childrens.harvard.edu|
20508679|NCT04532918|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20508680|NCT01280812|UC San Francisco|Yoshimi Fukuoka, PhD, RN, FAAN|415-476-8419|yoshimi.fukuoka@ucsf.edu|
20508681|NCT03682055|Cullinan Oncology|Phill Gallacher|+1 617 710 9127|pgallacher@cullinanoncology.com|
20547988|NCT00381381|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical team manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
20572086|NCT02731690|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20508682|NCT00880100|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 263||
20508683|NCT02225925|Johns Hopkins University|Daniel Song|410-502-5875|dsong2@jhmi.edu|
20508684|NCT03424044|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
20572087|NCT04142359|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20572088|NCT03568318|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20572089|NCT02898077|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20572090|NCT04410523|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20572091|NCT00794144|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20572092|NCT00490490|Stanford University Medical Center|Susan J. Knox, MD, Associate Professor of Radiation Oncology|(650) 725-2720|sknox@stanford.edu|
20572093|NCT03207451|Inova Health System|Director of Clinical Trials|443-244-1497|kevin.bliden@inova.org|
20572094|NCT02040584|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20572095|NCT00996476|Janssen Pharmaceutical K.K., Japan|DIrector|81 3 44115639||
20572096|NCT00436852|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20572097|NCT02141620|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
20572098|NCT01519089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572099|NCT03199118|Cairo University|Sarah Elbanna, assistant lecturer at the Oral Medicine and Periodontology department|+201000760002|srhelbanna@gmail.com|
20572100|NCT01353859|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20572101|NCT01659853|Galerma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
20572102|NCT06612255|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
20572103|NCT03921723|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20572104|NCT03015129|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
20572105|NCT05032872|Brandeis University|Xin Yao Lin|6462583562|xylin@brandeis.edu|
20572106|NCT00910039|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
20572107|NCT00406692|Boston University|Clifford Knapp, PhD|617-414-1990|cknapp@bu.edu|
20572108|NCT04928287|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
20572109|NCT01744392|Health Services Research & Development, Durham VAMC|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
20572110|NCT00472849|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
20572111|NCT02369068|Beaumont Hospital, Royal Oak|Deborah Hasenau RN, Director, Urology Research|248-551-0804|Deborah.Hasenau@Beaumont.org|
20572112|NCT04664075|Imperial College London|Senior Clinical Research Nurse|02083833231|flu-rsv-study@imperial.ac.uk|
20572113|NCT02033083|Planned Parenthood of New York City|Director of Clinical Training and Research|212-274-7340|ctri@ppnyc.org|
20572114|NCT01696955|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20572115|NCT00799981|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
20572116|NCT01641159|University of Cincinnati College of Medicine; Department of Psychiatry|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
20572117|NCT00798590|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20572118|NCT01404429|PGIMER, India|Varun Dhir, Assistant Professor, Internal Medicine|+91-8872229998|varundhir@gmail.com|
20572119|NCT01280357|Monica Healthcare Ltd|Ian How|+44 (0)115912|ianhow@monicahealthcare.com|4540
20572120|NCT00688870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572121|NCT00992225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572122|NCT03466073|BioAegis Therapeutics Inc.|Mark DiNubile MD|609-706-5866|mdinubile@bioaegistx.com|
20572123|NCT00744757|Medical Affairs, Janssen Taiwan|Medical Director|+886-2-23761255||
20572124|NCT00532493|VA Puget Sound Health Care System|Dr. Murray Rasknd|(206) 764-2702|Murray.Raskind@va.gov|
20572125|NCT05833100|i-SENS, Inc.|Moon Hwan Kim|+82 (0)2 910 0521|mhkim@i-sens.com|
20572126|NCT00707759|FONDECYT|Maria Angela Delucchi|56-2-25755972|madelucchi@gmail.com|
20572127|NCT00841555|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
20572128|NCT03459443|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|1.855.752.2356|clinicaltrials@alexion.com|
20572129|NCT00888927|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20572130|NCT02153073|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20572131|NCT03702231|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
20572132|NCT05745701|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572133|NCT01607476|Mayo Clinic|Dr. Val Lowe|507-255-3616|vlowe@mayo.edu|
20572134|NCT04445987|Arcutis Biotherapeutics|Arcutis Medical Information|+1 844 692-6729|medinfo@arcutis.com|
20572135|NCT00749957|Applied Genetic Technologies Corporation|Chief Medical Officer|386-462-2204|jchulay@agtc.com|7205
20572136|NCT01170390|Oregon Health & Science University|Dr. Alison Edelman|503.418.2585|edelmana@ohsu.edu|
20572137|NCT00680992|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20556513|NCT03260868|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20572138|NCT03568643|UCSF FI Proctor Foundation|Dr Catherine Oldenburg|(415) 502-8843|catherine.oldenburg@ucsf.edu|
20572139|NCT02425904|Dana-Farber Cancer Institute/Boston Children's Hospital|Barbara Degar, MD|617-632-5186|Barbara_Degar@dfci.harvard.edu|
20547989|NCT01916967|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20547990|NCT02759354|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20547991|NCT01104155|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
20547992|NCT00975637|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
20547993|NCT03799211|NYU Langone Health|Mia Minen, MD, MPH|212-263-7744|Mia.Minen@nyulangone.org|
20547994|NCT00764491|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|651-256-8503|Rgriffith@spineology.com|
20556514|NCT02925676|UNEEG medical|Clinical Research Associate|+45 25657550|clinical@uneeg.com|
20572140|NCT03842358|Washington University School of Medicine|Debbie Bennett, M.D.|314-454-7696|debbie.bennett@wustl.edu|
20572141|NCT02626455|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
20572142|NCT05148962|Gritstone bio, Inc.|Elizabeth Martin, Vice President, Clinical Development Infectious Disease|+1 (877) 520-2233|clinicalstudies@gritstone.com|
20572143|NCT06665919|Tbilisi State Medical University|Konstantine Liluashvili , MD., PH.D.|+995599908899|k.liluashvili@tsmu.edu|
20572144|NCT01200290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572145|NCT01144377|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508685|NCT04839393|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508686|NCT00994760|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666|clinicaltrials@nycomed.com|0
20508687|NCT01100658|Masonic Cancer Center, University of Minnesota|Alicia Kunin-Batson|612-624-6931|kunin003@umn.edu|
20508688|NCT02668952|Dept of Anesthesiology, University of New Mexico|Neal Gerstein, MD|5052722610|ngerstein@salud.unm.edu|
20508689|NCT01001572|Novartis Pharmaceuticals|Study Director|862 778-8300||
20508690|NCT01094808|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
20508691|NCT00369278|Novartis Pharmaceuticals|Study Director|862-778-8300||
20508692|NCT02044822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20508693|NCT02967172|University of Iowa|Michael Willey, MD|319-384-8452|michael-willey@uiowa.edu|
20508694|NCT02025530|University of Manchester|Professor Alexander Heazell|+441612766484|alexander.heazell@manchester.ac.uk|
20508695|NCT05364437|Imperial College London|Gary Frost|07872850308|g.frost@imperial.ac.uk|
20508696|NCT01040845|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20508697|NCT04965116|University of California, San Diego|Dr. Sarah Averbach, MD, MAS|858-329-4464|familyplanningresearch@health.ucsd.edu|
20508698|NCT01732107|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20508699|NCT04445688|Apnimed, Inc|Clinical Trials|617-500-8880|clinicaltrials@apnimed.com|
20556515|NCT00981084|University of Missouri - Kansas City|Dr. Jared Bruce|401-499-4043|brucejm@umkc.edu|
20556516|NCT02291679|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
20556517|NCT02048072|Cantonal Hospital of St. Gallen|Jochen Vehoff|0041714941111|jochen.vehoff@kssg.ch|
20556518|NCT01112579|Medtronic Cardiac Rhythm and Heart Failure|DEFEAT-HF Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
20556519|NCT01648270|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20556520|NCT00902694|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20572146|NCT05820295|Weill Cornell Medicine|Lisa Kern, MD, MPH|646-962-5889|lmk2003@med.cornell.edu|
20572147|NCT00905515|East Carolina University|Director of Clinical Trials|252-744-0671|bryantw@ecu.edu|
20572148|NCT02980731|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20572149|NCT03918499|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20572150|NCT03828747|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20572151|NCT00772330|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
20572152|NCT00127205|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
20572153|NCT00307684|Janssen-Cilag G.m.b.H.|European Medical Affairs Director Neurology|+49 2137 955258|bschaeu2@its.jnj.com|
20572154|NCT02580305|Suven Life Sciences|Ramakrishna Nirogi, PhD|+9140 2319 3956|nvsrk@suven.com|
20547995|NCT00923936|National Cancer Institute|Dr. Robert Yarchoan|301-496-0328|yarchoanr@pop.nci.nih.gov|
20572155|NCT00224887|Stanford University|Dr. Donna Matheson|650-723-5895|donna.matheson@stanford.edu|
20527686|NCT01732471|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20527687|NCT00474786|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527688|NCT03426436|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
20527689|NCT02892513|Medical College of Wisconsin|Carrie Y. Peterson, MD, MS|414-955-5783|cypeterson@mcw.edu|
20527690|NCT00358956|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20527691|NCT00655681|University of New Mexico Carrie Tingley Hospital|Elizabeth A. Szalay MD|505 272-5214|eszalay@salud.unm.edu|
20527692|NCT05011890|University of North Carolina Lineberger Comprehensive Cancer Center|Gita Mody|+1 919-966-3382|gita_mody@med.unc.edu|
20527693|NCT04776018|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20527694|NCT03168919|St. Jude Children's Reaserch Hospital|Asim K. Bag, MD Bag|9015953347|asim.bag@stjude.org|
20527695|NCT01085136|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20527696|NCT02195427|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
20572156|NCT04343287|BRIM Biotechnology, Inc.|Erin Chang, Vice President of Portfolio Management Department|0226598779|erin.chang@brimbiotech.com|119
20527697|NCT03260426|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
20527698|NCT00083720|ImClone, LLC|Chief Medical Officer||ClinicalTrials@imclone.com|
20527699|NCT01210144|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20527700|NCT00386425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20527701|NCT02655419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527702|NCT04226495|University of Nebraska Medical Center|Jeffrey Songster|308-520-2847|jeffrey.songster@unmc.edu|
20527703|NCT00435019|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20527704|NCT03338569|University of Minnesota|Ronald Reilkoff, MD|612-624-0999|rreilkof@umn.edu|
20527705|NCT04607980|Amgen Inc.|Study Director|8665726436|medinfo@amgen.com|
20527706|NCT01854879|Cochlear Americas|Lori O'Neill Director of Research|(303) 790-9010|loneill@cochlear.com|
20527707|NCT02012959|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20527708|NCT00810498|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
20527709|NCT04494425|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20527710|NCT01270321|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
20527711|NCT03151083|VA Connecticut Healthcare System|Dr. Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
20527712|NCT04003623|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20527713|NCT02918097|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|5551999185180|afbslima@gmail.com.br|
20527714|NCT04640038|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
20527715|NCT02242019|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
20527716|NCT04316260|Medical University of South Carolina|Noelle Natale|843-876-2426|natalen@musc.edu|
20572157|NCT03527550|McLean Hospital|Dr. Andrew Peckham|617-855-2946|adpeckham@mclean.harvard.edu|
20572158|NCT01085968|VA Overton Brooks|Elizabeth Disbrow|318-6757184|edisbr@lsuhsc.edu|
20572159|NCT03053518|NYU Langone Health|Mary Sevick, MD|646-501-2621|Mary.Sevick@nyulangone.org|
20572160|NCT02683876|MEBO Research|Maria De la Torre|7862286880|maria.delatorre@meboresearch.org|
20572161|NCT00939822|University of Wisconsin School of Medicine and Public Health|Dr. Cynthia M. Carlsson|608-256-1901|cmc@medicine.wisc.edu|11691
20572162|NCT02147899|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
20572163|NCT01143870|University of Pennsylvania|Anjali Gopalan|575-640-3893|agopalan@upenn.edu|
20572164|NCT01911390|Department of Environmental and Radiological Health Sciences|Dr Elizabeth Ryan|970-491-1536|E.P.Ryan@colostate.du|
20572165|NCT00400725|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20572166|NCT05731999|Kontigo Care AB|Markku Hämälainen, CSO|+46 (0)76 947 3132|markku.hamalainen@kontigocare.com|
20508700|NCT00299416|UT-Houston Health Science Center, Department of Neurology|James C. Grotta, MD|713-500-7088|james.c.grotta@uth.tmc.edu|
20527717|NCT01744483|Oregon Health Science & Science University|Dr Miriam Treggiari|(503) 494-8311|treggiar@ohsu.edu|
20527718|NCT01190189|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20572167|NCT04073446|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
20572168|NCT01480219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527719|NCT03915626|University of Maryland, Baltimore School of Pharmacy|Dr. Audra L. Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20572169|NCT02638597|University of Texas Southwestern Medical Center|Principal Investigator|2146480188|madhukar.trivedi@UTSouthwestern.edu|
20572170|NCT00951015|ViiV Healthcare|GSK Response Center|866-435-7343||
20572171|NCT01167452|Texas Tech University Health Sciences Center|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
20572172|NCT03819634|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
20572173|NCT00757627|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20572174|NCT00635661|New York University,. Rusk Institute|Dr. Irene Ward|212-263-6073|Irene.ward@nyumc.org|
20572175|NCT03192475|University of Pittsburgh|Elizabeth Mary Venditti PhD, Associate Professor of Psychiatry and Epidemiology|(412) 647-1027|vendittiem@upmc.edu|
20572176|NCT03417570|Washington University School of Medicine|Vladimir M. Kushnir, M.D.|314-454-5960|vkushnir@wustl.edu|
20572177|NCT00573859|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
20572178|NCT02818244|Cleveland Clinic|Marc Gillinov MD|216 445-8841|GILLINOM@ccf.org|
20572179|NCT02229851|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20572180|NCT03541200|Mitsubishi Tanabe Pharma Development America|Clinical Trials, Information Desk|Please email|information@mt-pharma-us.com|
20572181|NCT03682302|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20572182|NCT01769326|University of California Irvine|Steven Cramer, M.D.|(949) 824-8748|scramer@uci.edu|
20572183|NCT01413503|University of California, San Francisco|Paul A. Fitzgerald, MD|415-665-1136|Paul.Fitzgerald2@ucsf.edu|
20572184|NCT00293059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20572185|NCT02001064|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
20572186|NCT01609062|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
20572187|NCT03772587|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20572188|NCT01821352|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
20572189|NCT05260021|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20572190|NCT00607724|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20572191|NCT00151281|Weill Cornell Medical College|Dr. Jia Ruan|646-962-2068|jruan@med.cornell.edu|
20572192|NCT01717742|Hospital for Sick Children|Dr. Eyal cohen|416-813-7654|eyal.cohen@sickkids.ca|
20572193|NCT04150068|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20572194|NCT05316701|Orca Biosystems, Inc.|Chief Medical Officer|530-414-9743|info@orcabio.com|
20572195|NCT04679935|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20572196|NCT03960047|University Of Guelph|Professor Barbara A. Morrongiello|5195461637|bmorrong@uoguelph.ca|
20572197|NCT04362189|Hope Biosciences Stem Cell Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
20572198|NCT02111681|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum, MD|914-367-7273|gelblumd@mskcc.org|
20572199|NCT05116540|Hope Biosciences Research Foundation|Maureen Gerwin|(346) 900-0340|maureen@hopebio.org|
20572200|NCT04349631|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
20572201|NCT00775463|United Therapeutics Corporation|Oral Treprostinil Program Head|919-485-8350|klaliberte@unither.com|
20572202|NCT00091169|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20572203|NCT00660543|Oregon Health and Science University|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
20572204|NCT00661479|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20572205|NCT03786042|Dartmouth college|Research Scientist|603-646-5408|john.brand@dartmouth.edu|
20572206|NCT05263388|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
20572207|NCT02366468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20572208|NCT03651622|University of North Carolina at Chapel Hill|Elizabeth Mayer-Davis, PhD|919-966-7218|mayerdav@email.unc.edu|
20572209|NCT03582943|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
20572210|NCT01153321|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
20572211|NCT02071290|St. Michael's Hospital|Dr. Ori Rotstein|416-864-6060|rotsteino@smh.ca|5304
20572212|NCT01232738|UKansasMCRI|Yunxia Wang|913-588-6970|ywang@kumc.edu|
20556521|NCT04969263|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|extension
20572213|NCT00488475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572214|NCT00942305|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20572215|NCT04850794|University of North Carolina at Chapel Hill|Kelsey Thompson, MS|919-966-1007|kelsey_thompson@med.unc.edu|
20572216|NCT00267085|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
20572217|NCT01227382|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
20572218|NCT02797080|Horizon Pharma Ireland, Ltd, Dublin, Ireland|Julie Ball, MS, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
20572219|NCT00299494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572220|NCT01538966|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org|
20547996|NCT05394350|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20547997|NCT03530800|University of Chicago|Dr. Jon E. Grant|7738341325|jgrant4@bsd.uchicago.edu|
20547998|NCT01385371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20547999|NCT00292318|Greater Los Angeles VA Medical Center|Felix W. Leung, MD|818-891-7711|felix.leung@va.gov|9403
20548000|NCT02027376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20548001|NCT03171051|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20548002|NCT00304239|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20548003|NCT02979197|Kitov Pharma Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
20548004|NCT02436681|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
20548005|NCT02030938|Sofregen|Clinical Project Manager|4029991564|fjawed@sofregen.com|
20548006|NCT01599832|University of Chicago Comprehensive Cancer Center|Walter Stadler|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
20548007|NCT03954132|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20548008|NCT02949700|Baylor College of Medicine|Dr. Vlad Sandulache|713-798-7218|Vlad.Sandulache@bcm.edu|
20548009|NCT03763318|Equillium|Clinical Operations|858-240-1200|clinicaltrials@equilliumbio.com|
20548010|NCT05597020|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
20548011|NCT03029702|University of Pittsburgh|Maisa Feghali|412 641 1000|feghalim@upmc.edu|
20548012|NCT05595382|Rutgers University Associate Professor|Dr. Lauren Daniel|856-225-6535|lauren.daniel@rutgers.edu|
20548013|NCT02422940|Acorda Therapeutics|Holy Roberts, Executive Medical Director - Medical Affairs|914-326-5224|hroberts@acorda.com|
20548014|NCT00560885|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
20548015|NCT03722173|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20572221|NCT01417104|The Ohio State University|Sanjay Rajagopalan, MD|614-247-7760|sanjay.rajagopalan@osumc.edu|
20572222|NCT01416389|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572223|NCT01365481|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20572224|NCT00047697|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
20572225|NCT02946853|University of Rochester|Dr. Jonathan Steinberg|9734364155|jsteinberg@summithealth.com|
20572226|NCT00958841|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20572227|NCT02402153|UNEEG medical A/S|Clinical Manager|+45 41414244|lybl@UNEEG.com|
20572228|NCT01125514|Novartis Pharmaceuticals|Study Director|862-778-8300||
20572229|NCT00858364|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20572230|NCT03980808|Georgia Institute of Technology|Salimah LaForce, M.S.|404-385-4614|salimah@cacp.gatech.edu|
20572231|NCT00632489|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20572232|NCT00436605|Yale University School of Medicine|Harriet Kluger|203-737-2572|Harriet.Kluger@yale.edu|
20572233|NCT03014011|Bispebjerg Hospital|MD Malin Nilsson|50595861|mnil0028@regionh.dk|0045
20572234|NCT02755818|University of California, Davis|George Kaysen MD - Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
20572235|NCT00929110|Novartis Pharmaceuticals|Study Director|862 778-8300||
20548016|NCT04128579|Equillium, Inc.|Clinical Trial Manager|8582401200|clinicaltrials@equilliumbio.com|
20508701|NCT00442260|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20572236|NCT03794700|University of Colorado Anschutz Medical Campus|Channing Tate, PHD Assistant Professor|3037248985|channing.tate@cuanschutz.edu|
20572237|NCT02416453|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20572238|NCT01163292|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20572239|NCT02535091|SK Life Science, Inc.|Medical Director|402-835-5977|smisra@sklsi.com|
20548017|NCT02887859|Humacyte Inc.|Dr. Shamik Parikh, MD, CMO|919-313-9633|sparikh@humacyte.com|
20572240|NCT05319912|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20572241|NCT01143181|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20548018|NCT06624449|University of Cincinnati|Fahad Alanezi|5138845844|alanezfz@mail.uc.edu|
20548019|NCT01554397|UCSD Moores Cancer Center|Dr. Loren Mell|858-246-4071|lmell@health.ucsd.edu|
20548020|NCT02875132|The Chinese University of Hong Kong|Dr. Herbert Ho Fung LOONG|35052166|h_loong@clo.cuhk.edu.hk|
20548021|NCT00257608|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20548022|NCT01896050|University of Michigan Comprehensive Cancer Center|Norah Lynn Henry, MD|734-936-4991|norahh@med.umich.edu|
20548023|NCT02206048|UT MD Anderson Cancer Center|Dr. Kathleen M. Schmeler, MD|713-745-3518|kschmele@mdanderson.org|
20548024|NCT02925923|University of Alabama at Birmingham|Leah Pogwizd|(205) 996-4410|leahpogwizd@uabmc.edu|
20508702|NCT02074904|UPENN|Timothy Pond, MPH|215-746-1959|timpond@pennmedicine.upenn.edu|
20508703|NCT01363258|UAB School of Nursing|Rita Jablonski|205-975-9019|rjablonski@uabmc.edu|
20548025|NCT03265665|University of Illinois at Chicago|Dr. Sharmilee Nyenhuis|3124131655|snyenhui@uic.edu|
20572242|NCT03223662|National Cancer Institute|Caryn Steakley|240-858-3749|steaklec@nih.gov|
20572243|NCT01259089|Northwestern University|Clinical Trials Office|312-695-1301||
20572244|NCT01258595|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20572245|NCT01140295|The Children's Hospital of Philadelphia|Petar Mamula|215-590-9146|mamula@email.chop.edu|
20572246|NCT01489891|Hospital Universitario Infanta Cristina|Dr. Felipe de la Morena|0034659716030|felipe_de_la_morena@hotmail.com|
20572247|NCT00948766|Novartis Pharmaceuticals|Study Director|862 778-8300||
20572248|NCT01036438|Molnlycke Health Care AB|Ann Larkö|+46 722 3338|ann.larko@molnlycke.com|
20572249|NCT00777088|Medtronic|Darren LaCour|949-680-1274|darren.j.lacour@medtronic.com|
20572250|NCT01278173|Lundbeck|H||LundbeckClinicalTrials@Lundbeck.com|
20572251|NCT03592745|Feinstein Institutes for Medical Research at Northwell Health|Senior Research Coordinator|5165623646|jchang14@northwell.edu|
20572252|NCT00421954|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
20572253|NCT02729831|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.harvard.edu|
20572254|NCT02091206|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20572255|NCT03970538|LimFlow|Director, Clinical Affairs|559-970-1012|kmccaffrey@limflow.com|
20572256|NCT05597787|University of Delaware|Valerie Earnshaw|(302) 831-6500|earnshaw@udel.edu|
20572257|NCT01241604|Philips Respironics|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
20572258|NCT01593787|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
20572259|NCT01133418|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
20572260|NCT00452023|The University of Texas MD Anderson Cancer Center|Lucia Masarova MD/Assistant Professor|832-750-4211|LMasarova@mdanderson.org|
20572261|NCT03621787|co-PI|Kathleen Sienko|734647249|sienko@umich.edu|
20572262|NCT00969709|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20572263|NCT03037931|American Regent, Inc.|Elizabeth Ernst, Global Executive Director of Regulatory Affairs|631-605-5753|eernst@americanregent.com|3551
20572264|NCT02075476|Hospital Gregorio Marañón|Dr. Carlos Álvarez|0034915868000|calvargon@gmail.com|
20572265|NCT02081443|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
20572266|NCT01789567|Medtronic Bakken Research Center|Kitty Schapira|+31433566802|kitty.schapira@medtronic.com|
20572267|NCT02914275|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20572268|NCT00872989|SWOG Statisticial Center|Lung Committee Statistician|206-667-4623||
20572269|NCT02407990|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20572270|NCT00923260|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Miguel F Herrera|(+52) 55 54870208|miguelfherrera@gmail.com|
20572271|NCT02699086|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
20572272|NCT03900416|Lawrence University|Dr. Lori Hilt|920-832-7050|lori.m.hilt@lawrence.edu|
20572273|NCT00836745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572274|NCT05540717|Allergy Therapeutics (UK) Ltd.|Pieter-Jan De Kam, Clinical Director|+44 (0) 1903 844 700|pieter-jan.dekam@allergytherapeutics.com|
20572275|NCT03377699|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20572276|NCT03784001|University of California, Los Angeles|Tanera van Diggelen|4086231219|tvandiggelen@gmail.com|
20572277|NCT02440659|Arbor Research Collaborative for Health|Francesca Tentori|734-665-4108|christina.pustulka@arborresearch.org|
20572278|NCT00774930|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20572279|NCT01181323|Cincinnati Children's Hospital Medical Center|Mark Steinhoff, MD|513-636-2791|Mark.steinhoff@cchmc.org|
20572280|NCT01177800|Beijing, China R&D|Senior Therapeutic Area Physician|+86 010 58218358||
20572281|NCT04032613|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|919-445-2656|jflythe@med.unc.edu|
20572282|NCT00424385|Oncology Specialists, SC|Sigrun Hallmeyer, MD Director of Research; Chadi Nabhan, MD FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
20572283|NCT03535506|Georgetown University|Nicole Swanson|2026879194|ns1209@georgetown.edu|
20572284|NCT05126563|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
20572285|NCT05560243|University of Alabama at Birmingham|Isabel Scarinci, Principal Investigator|2059757177|scarinci@uab.edu|
20572286|NCT05870228|University of Strathclyde|Stephanie McCrory|07538376660|stephanie.mccrory@strath.ac.uk|
20572287|NCT02503852|Kerastem|Eric Daniels, M.D., Chief Medical Officer|858.348.8050|edaniels@puregraft.com|
20572288|NCT03231800|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20572289|NCT00859222|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|Patrick_Wen@dfci.harvard.edu|
20572290|NCT04075994|University of Pittsburgh|Dr. Jared Magnani|(412)383-0611|magnanij@pitt.edu|
20572291|NCT01247285|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20572292|NCT01141647|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli-slone@va.gov|
20572293|NCT01941719|TUSPM|Dr. Jinsup Song|2157775872|jsong@temple.edu|
20572294|NCT04035499|University of Rochester Medical Center|Dr. Kah Poh Loh|585-276-4353|kahpoh_loh@urmc.rochester.edu|
20572295|NCT00357331|Weill Medical College|Assistant Professor of Medicine|212-746-1670|sinhana@med.cornell.edu|
20572296|NCT02120287|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
20572297|NCT00359983|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572298|NCT02643472|Children's National Health System|Dr. Karen Fratantoni|202-476-4793|kfratant@childrensnational.org|
20572299|NCT01215188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556522|NCT03456700|Mayo Clinic|Aminah Jatoi MD|507/284-2511|Jatoi.Aminah@mayo.edu|
20556523|NCT04154787|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20556524|NCT03053050|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20556525|NCT03703466|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20556526|NCT03355326|Indiana University, School of Medicine|Dr. Alan Ladd, Principle Investigator|317-274-4606|aladd@iupui.edu|
20556527|NCT01602536|University of California, Irvine|Cornelia Pechmann|310-892-0619|cpechman@uci.edu|
20556528|NCT00175825|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20556529|NCT04098406|Clene Nanomedicine|Jeremy Evan, PA-C|5419086335|jeremy@clene.com|
20556530|NCT02001194|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
20556531|NCT00522301|Memorial Sloan Kettering Cancer Center|Dr. William Tew|646-888-4220|teww@mskcc.org|
20556532|NCT01490502|The Johns Hopkins University School of Medicine|Sandra D. Cassard, ScD|443-287-4353|scassar1@jhmi.edu|
20556533|NCT02281448|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20556534|NCT04186780|Universidade de Sorocaba|Dr. Luciane Cruz Lopes|+ 55 15 2101-7104|luciane.lopes@prof.uniso.br|
20556535|NCT01699022|SPARC|Dr. Shravanti Bhowmik|02266455645|shravanti.bhowmik@sparcmail.com|5626
20556536|NCT00772590|Kirby Institute, University of New South Wales|Sean Emery|+612 938509900|semery@kirby.unsw.edu.au|
20508704|NCT00928512|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20508705|NCT01963780|TransMedics, Inc.|VP, Clinical Affairs|978.552.0900|ldamme@transmedics.com|
20556537|NCT02066402|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
20548026|NCT01858376|The Ohio State University|Chandan K. Sen|6142477786|chandan.sen@osumc.edu|
20548027|NCT00509041|University of Minnesota Masonic Cancer Center|Arkadiusz Dudek, MD, PhD||dudek002@umn.edu|
20548028|NCT00108433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548029|NCT02910362|Arizona Eye Consultants|Sean McCafferty, MD|(520) 791-7401|sjmccafferty66@hotmail.com|
20548030|NCT01012167|Maryland Psychiatric Research Center|William Carpenter, Jr.|410-402-7101|wcarpent@mprc.umaryland.edu|
20548031|NCT00161473|VA Puget Sound Healthcare System|Lucy Y. Wang, M.D.|206-277-5089|wanglucy@u.washington.edu|
20548032|NCT03326726|Medline Industries|Sr. Regulatory Affairs Specialist|847-643-3515|aminarcik@medline.com|
20548033|NCT01006369|Rutgers Cancer Institute of New Jersey|Elizabeth Poplin MD|732-235-7620|poplinea@cinj.rutgers.edu|
20548034|NCT04806503|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20548035|NCT03589469|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
20548036|NCT02219438|UCSD|Dr Brian Ilfeld|(619) 543-5560|bilfeld@ucsd.edu|
20548037|NCT01182610|Accelerated Community Oncology Research Network, Inc.|Vice Presidnet of Scientific Affairs||mwalker@acorncro.com|
20548038|NCT00809848|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20548039|NCT01824342|Amgen Inc.|Study Director|866-572-6436||
20548040|NCT01871142|Colorado State University|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
20548041|NCT02006888|IconBioscience|Howard Franklin|2153961332|hfranklin@iconbioscience.com|215
20548042|NCT03485391|Ralph H. Johnson VA Health Care System|Stephanie Hart|843-577-5011|Stephanie.Hart4@va.gov|205103
20548043|NCT01137396|Yale University|Peter Morgan|203-974-7560|peter.morgan@yale.edu|
20548044|NCT02754557|Emory University|Negar Fani, PhD|404-712-0354|nfani@emory.edu|
20548045|NCT00734474|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20548046|NCT00942448|IBSA Institut Biochimique|Barbara Gugliotta|+41 58 360 1000|barbara.gugliotta@ibsa.ch|
20556538|NCT00152464|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20556539|NCT04493931|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20556540|NCT00378352|National Institute on Aging, NIH|Edward Lakatta, M.D.|410-558-8218|lakattae@grc.nia.nih.gov|
20556541|NCT00266825|University of Kansas Medical Center|Dr. Susan Carlson|913-588-5359|SCARLSON@kumc.edu|
20556542|NCT00430248|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20556543|NCT00917579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20556544|NCT00754338|Centre for Contact Lens Research|Craig A Woods, Research Manager|1 519 888 4567|cawoods@sciborg.uwaterloo.ca|36547
20556545|NCT04208516|UPMC|Jeremy Kearns, MD|412-623-5296|kearnsjt@upmc.edu|
20556546|NCT00831779|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20556547|NCT04020341|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20556548|NCT05763628|CooperVision Inc.|José A. Vega OD, PhD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
20556549|NCT02872701|On Target Laboratories|Tim Biro|216-533-3082|tbiro@ontargetlabs.com|
20556550|NCT00187226|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|901-595-3604|thomas.merchant@stjude.org|
20556551|NCT04683926|Syntrix Pharmaceuticals|Aaron Schuler|253-833-8009|aschuler@syntrixbio.com|21
20556552|NCT00941993|Acclarent|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
20556553|NCT00319748|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
20556554|NCT04721925|University of Michigan|Erin Bonar|7347647936|erinbona@med.umich.edu|
20556555|NCT01040260|University of California, San Francisco|Dr. Timothy Carmody|(415) 221-4810|Timothy.Carmody@ucsf.edu|26344
20556556|NCT00885092|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20556557|NCT05120115|MetroHealth Hospital|James Sulzer|5125419036|jss280@case.edu|
20556558|NCT01113502|Abramson Cancer Center of the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
20556559|NCT01144026|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
20556560|NCT03002610|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
20548047|NCT03089320|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu|
20556561|NCT01970982|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20548048|NCT00231842|Montefiore Medical Center|Mark Einstein, MD, MS|718-405-8082|meinstei@montefiore.org|
20556562|NCT01146496|University of Edinburgh|Michael Eddleston|01312426776|m.eddleston@ed.ac.uk|
20572300|NCT01012414|Thomas Jefferson University|David Whellan MD|215 955 5050|david.whellan@jefferson.edu|
20548049|NCT00313300|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20548050|NCT00639678|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548051|NCT01973569|Contact for Clinical Trial Information|Daiichi Sanyko|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
20548052|NCT04644003|STALICLA SA|Eric Painbeni, PhD - Head of Clinical Operations|+41 (0)79 918 33 16|clinical@stalicla.com|
20548053|NCT05027464|Veterans Affairs San Francisco HCS|Nicole McCamish|415-221-4810|nicole.mccamish@va.gov|24284
20548054|NCT01348607|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Administrator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
20548055|NCT03572244|University of Iowa|Dr. Chris Barwacz|3193843002|chris-barwacz@uiowa.edu|
20548056|NCT04172623|Yale School of Medicine|Krysten Bold, PhD|2039747603|krysten.bold@yale.edu|
20548057|NCT04066647|Cedars Sinai Medical Center|Kacey Haptonstall|424-315-4489|kacey.haptonstall@cshs.org|
20548058|NCT02651467|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548059|NCT00573937|Mayo Clinic|Donald Northfelt, MD|480-301-8335|northfelt.donald@mayo.edu|
20548060|NCT00333801|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-3819|lori.davis@va.gov|
20548061|NCT03633617|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20548062|NCT00149734|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20572301|NCT02601300|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20548063|NCT00580970|Virginia Commonwealth University/Massey Cancer Center|Mitchell S. Anscher, M.D. Professor and chairman|804-828-7238|mitchell.anscher@vcuhealth.org|
20548064|NCT03161093|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20548065|NCT00570765|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20548066|NCT01031706|University of North Carolina at Chapel Hill|Dr. Scott H. Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
20548067|NCT03114488|University of Minnesota|Elias Boroda|763-498-4176|borod002@umn.edu|
20548068|NCT03711266|Michigan Medicine|Rebecca Sripada|734-222-7432|rekaufma@med.umich.edu|
20548069|NCT01646073|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20548070|NCT04558281|University of California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
20548071|NCT00057876|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20548072|NCT01393301|Massachusetts General Hospital|Dr. Conall O'Cleirigh, PI|(617) 643-0385|cocleirigh@mgh.harvard.edu|
20548073|NCT02758171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20548074|NCT01999114|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stephen.harris@pharma.com|
20548075|NCT02437383|University of North Carolina at Chapel Hill|Dr. Inna E. Tchivileva|1 919 537 3291|inna_tchivileva@unc.edu|
20548076|NCT03342963|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20548077|NCT01309165|Sunnybrook Research Institute|Dr. Sara McEwen|4162266780|sara.mcewen@sunnybrook.ca|7957
20548078|NCT01649609|Columbia University Medical Center|Sumit Mohan, MD|2123053273|sm2206@cumc.columbia.edu|
20548079|NCT01739309|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20548080|NCT01289457|The University of Texas M D Anderson Cancer Center|Jabbour,Elias Joseph, M.D./Associate Professor|713-792-4764|CR_Study_Registration@mdanderson.org|
20548081|NCT02787551|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20548082|NCT00620464|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20548083|NCT02038452|Keele University|Dr Edward Roddy|01782 734715|e.roddy@keele.ac.uk|
20548084|NCT03139279|Department of Anesthesiology, SUNY Downstate Medical Center|Dennis Dimaculangan, MD|718-270-3765|dennis.dimaculangan@downstate.edu|
20548085|NCT01336569|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Medical Affairs Leader, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20548086|NCT02337738|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20548087|NCT03911154|University of Pennsylvania|Dr. David Dinges|215-898-9665|dinges@pennmedicine.upenn.edu|
20572302|NCT02310100|Abbott|Lori Rusch, Ph.D.|1-651-756-2668|lori.rusch@abbott.com|
20572303|NCT01127763|Mt Sinai School of Medicine|Amy Tiersten, MD|212-249-3300|amy.tiersten@mssm.edu|
20548088|NCT00406354|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20548089|NCT01231347|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20548090|NCT01224665|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|ctangen@fredhutch.org|
20548091|NCT02080637|Duke University|Kevin Hill, M.D.|919-668-8305|kevin.hill@duke.edu|
20548092|NCT01626495|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20548093|NCT01565642|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
20548094|NCT01934972|The Ohio State University|Nicholas Breitborde, PhD|614-685-6052|nicholas.breitborde@osumc.edu|
20548095|NCT01278160|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20548096|NCT01631812|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20548097|NCT02856698|Hospital Universitario de Canarias|Alberto Dominguez Rodriguez. MD, PhD, FESC|+34 922678000|adrvdg@hotmail.com|
20556563|NCT00708916|New York University School of Medicine|Andrew Franks, MD, Principal Investigator|212-263-5244|andrew.franks@nyumc.org|
20572304|NCT00528931|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20556564|NCT04270292|Demiroglu Bilim University|Nurten OZEN|+90 (212) 275 75 82|ozenurten@yahoo.com.tr|
20556565|NCT01133158|GELTAMO|Francisco Javier Peñalver|91 621 98 24|fjpenalver@fhalcorcon.es|
20572305|NCT00477659|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20548098|NCT00932737|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20548099|NCT02401022|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
20548100|NCT02718300|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20548101|NCT03673046|Massachusetts General Hospital, Department of Psychiatry|Director, Center for OCD and Related Disorders|617-724-6146|swilhelm@mgh.harvard.edu|
20548102|NCT03817879|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
20548103|NCT03693300|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20548104|NCT00697073|Santhera|Dr Thomas Meier|+41 61 906 8964|thomas.meier@santhera.com|
20548105|NCT03150160|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
20548106|NCT03894046|Entasis Therapeutics|Dr. David Altarac - Chief Medical Officer|+1 781 810 0120|david.altarac@entasistx.com|
20548107|NCT00082342|NINDS, NIH|Mark Hallett, MD, Chief|301-496-9526|hallettm@ninds.nih.gov|
20548108|NCT02202837|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548109|NCT02160990|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20548110|NCT04195906|Sanifit Therapeutics S. A.|Peter Szecsödy|+41588529079|clinicaltrials@cslbehring.com|
20548111|NCT02486302|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548112|NCT01601860|University of São Paulo|Dra. Alessandra Cristina Marcolin|+55(16)36022813|dralemar@uol.com.br|
20548113|NCT00385762|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
20548114|NCT02422303|University of Texas Health Science Center San Antonio|Bonnie Gillis|210-567-4500|gillis@uthscsa.edu|
20548115|NCT03481907|George Washington University|Dr. Adam Friedman|214 235 7381|ajfriedman@mfa.gwu.edu|
20548116|NCT00428792|Novartis Pharmaceuticals|Study Director|862 778-8300||
20548117|NCT00850343|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
20548118|NCT00371826|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20548119|NCT02710396|Columbia University Herbert Irving Comprehensive Cancer Center|Catherine Shu|212 305 3997|cas2145@cumc.columbia.edu|
20548120|NCT04612790|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20548121|NCT03053271|Millendo Therapeutics|Clinical Trial Information|+1 734 845-9000|millendo@millendo.com|
20572306|NCT02571153|Pontificia UCSP|Eduardo Toshiyuki Moro||eduardo_moro@terra.com.br|
20548122|NCT02654314|Yale Center for Analytical Sciences|Jesse S Reynolds|(203) 785-5445|jesse.reynolds@yale.edu|
20548123|NCT02124161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548124|NCT02517866|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20548125|NCT01436006|Università di Palermo|Sergio Salerno|00390916552315|sergio.salerno@unipa.it|2315
20548126|NCT05095454|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
20548127|NCT00679055|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548128|NCT00853073|Wills Eye Hospital|Marlene R. Moster, MD|215-928-3123|marlenemoster@gmail.com|
20548129|NCT01008150|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|judy.langer@nsabp.org|
20548130|NCT01497275|Duke University Medical Center|Anne Beaven, MD|919-668-1211|anne.beaven@duke.edu|
20548131|NCT01950169|Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden|Dr. Lena Flodin|Mobile: 0701910300|lena.flodin@sll.se|
20548132|NCT01938573|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20548133|NCT03420625|Karolinska University Hospital|Dr. Paul Ackermann|+46 8 517 700 00|paul.ackermann@sll.se|717 34
20548134|NCT02617888|Ft. Belvoir Community Hospital|Michael K. Cheezum, MD|571-231-2159|Michael.k.cheezum.mil@mail.mil|
20572307|NCT03835351|Cleveland Clinic Foundation|Dr. Michael Rosen|12164453441|rosenm@ccf.org|
20572308|NCT01253018|VA Maryland Health Care System|Dr. Christopher T. Bever, Jr. MD, MBA|(410) 605-7000|christopher.bever@va.gov|7130
20572309|NCT02935660|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20572310|NCT00291642|UCB S.A.|UCB|+1844 599|UCBCares@ucb.com|2273
20572311|NCT00735475|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20572312|NCT00939159|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
20572313|NCT02338973|National Institutes of Health|Wadih Zein, MD, Principal Investigator, NEI|301-496-8118|zeinw@nei.nih.gov|
20572314|NCT01472549|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
20572315|NCT02327351|National Research Center for Pediatric Hematology , Moscow, Russian Federation|Balashov Dmitriy, head of HSCT department|84956647078|Dmitriy.Balashov@fccho-moscow.ru|6534
20572316|NCT03189745|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572317|NCT05086276|Frequency Therapeutics|Director of Clinical Trials|781-315-4600|clinicaltrialsinformation@frequencytx.com|
20572318|NCT03367429|Weill Cornell Medicine|Michael O'Dell, M.D.|19175495179|mio2005@med.cornell.edu|
20572319|NCT05907707|University of North Carolina at Chapel Hill|Andrea Seiler, MD|+41 316322111|andrea.seiler@insel.ch|
20527720|NCT05025332|Neuren Pharmaceuticals|Chief Medical Officer|+61 (3) 9092 0480|MedicalInformation@neurenpharma.com|
20508706|NCT01749800|Spaulding Rehabilitation Hospital|Paolo Bonato|+1-617-952-6319|pbonato@partners.org|
20548135|NCT00737438|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
20548136|NCT02410551|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
20548137|NCT04137627|Universitas Indonesia|Dr. dr. Diani Kartini, Sp.B-K(Onk)|+628122684919|d.kartini@gmail.com|
20548138|NCT05085730|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20548139|NCT05447897|General Internal Medicine, University of Colorado School of|Dr. Gina Kruse, PI|303-724-4811|gina.kruse@cuanschutz.edu|
20548140|NCT04553679|University of Southern California|Marika Demers, PhD, OT, post-doctoral research fellow|13234421196|demers@pt.usc.edu|
20548141|NCT01649804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20548142|NCT03719586|NIAID/NIH|Dr. Richard T. Davey, Jr., M.D., U.S. study PI|301-496-8029|rdavey@niaid.nih.gov|
20548143|NCT00178633|University of Texas Medical School at Houston|Heinrich Taegtmeyer, MD, DPhil, Principal Investigator|713 500-6569|heinrich.taegtmeyer@uth.tmc.edu|
20548144|NCT03845543|iD3 Medical|Clinical Research Professional|+32 (0)52252745|office@iD3medical.com|
20548145|NCT04242173|Moffitt Cancer Center|Christine Chung|1-813-745-5061|Christine.Chung@moffitt.org|
20527721|NCT02081014|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP Drug Development|512-498-2675|mjcummins@xerispharma.com|
20548146|NCT04429243|WL Gore|Charee Robe|9288644048|crobe@wlgore.com|
20548147|NCT03649867|NHS Tayside - Dundee Adult Psychological Therapies Service|Dr Lucie Bartoskova|00441382346556|lucie.bartoskova@nhs.net|
20548148|NCT02028871|University of Illinois at Chicago|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
20548149|NCT02907268|ICLS|Shantel Demay|905-842-2262|s.demay@icls.ca|
20548150|NCT02633501|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20548151|NCT00390234|Princess Margaret Hospital|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
20548152|NCT00240227|VA Puget Sound Health Care System|Andrew J. Saxon, M.D.|206-764-2782|andrew.saxon@va.gov|
20548153|NCT02963935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20548154|NCT01209923|University of Southern California|Edward Schroeder|323-442-2498|eschroed@usc.edu|
20548155|NCT00725504|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
20548156|NCT00771316|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548157|NCT03648827|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
20548158|NCT02955797|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
20548159|NCT01881373|University of Hawaii|Rachel Novotny|808-956-3848|novotny@hawaii.edu|
20548160|NCT02906332|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20548161|NCT02046902|Saint Luke's Mid America Heart Institute|Carole Decker|(816) 932-5440|c1decker@saint-lukes.org|
20548162|NCT04176705|Wake Forest University Health Sciences|John Bailey, MD|(336) 716-8002|jkbailey@wakehealth.edu|
20548163|NCT03805646|University of California Los Angeles|Dr. Catherine Juillard|310-267-9609|cjuillard@mednet.ucla.edu|
20548164|NCT00392015|United States Military Malaria Vaccine Program Naval Medical Research Center|Dr. Judith Epstein|301-252-9026|judith.epstein@med.navy.mil|
20548165|NCT02614092|VISN 21 MIRECC, VA Palo Alto Health Care System|Dr. Kaci Fairchild|6504935000|jenniferkaci.fairchild@va.gov|63432
20548166|NCT02742441|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
20548167|NCT01854242|University of Florida|David A. Weinstein, MD, MMSc|3522650855|weinsda@peds.ufl.edu|
20548168|NCT03789396|University of Colorado|Adit Ginde, MD, MPH|720-848-6777|ADIT.GINDE@CUANSCHUTZ.EDU|
20548169|NCT00546104|Duke University Health System|Kimberly Blackwell, MD|919-668-1478|kimberly.blackwell@duke.edu|
20556566|NCT01984684|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
20556567|NCT02681614|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Bryan Traughber|+1 216-884-2516|bryan.traughber@uhhospitals.org|
20556568|NCT04886479|CooperVision Inc.|Director Global Clinical Affairs|+19256213761|jvega2@coopervision.com|
20556569|NCT04555096|Galera Therapeutics|Judy Schnyder, SVP Clinical Operations and Data Management|2155937119|jschnyder@galeratx.com|
20556570|NCT02835339|Oregon Health and Science University|Kathleen Brookfield, MD, PhD, MPH|503-494-2101|brookfie@ohsu.edu|
20527722|NCT01026818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20527723|NCT04575584|Merck Sharp & Dohme, LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527724|NCT02634801|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20527725|NCT03678675|Tufts Medical Center|Jean Hostage|617-636-4549|jeanhostage@gmail.com|
20527726|NCT00940576|University of Jena, Institute of Nutrition, Department of Nutritional Physiology Jena, Thuringia, Germany|Gerhard Jahreis, Prof. Dr.|+(49)3641/949610|gerhard.jahreis@uni-jena.de|
20527727|NCT04392219|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
20556571|NCT01077544|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
20527728|NCT02335346|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20527729|NCT01548768|Columbia University Irving Medical Center|Dr. Joan Bathon, MD|212-305-6327|jmb2311@cumc.columbia.edu|
20548170|NCT02281773|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20548171|NCT02104752|VA Greater Los Angeles Healthcare System/UCLA|Jonathan K. Wynn, Ph.D.|(310) 478-3711|jkwynn@ucla.edu|44957
20548172|NCT01126801|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
20548173|NCT02899299|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20548174|NCT03423641|Kaiser Permanente|Elizabeth McGlynn, Ph.D.|6265643807|Elizabeth.A.Mcglynn@kp.org|
20548175|NCT02497612|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20548176|NCT02239354|ViaCyte|Corporate Communications|858-207-0500|info@viacyte.com|
20548177|NCT00369122|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20548178|NCT00004635|National Cancer Institute, National Institutes of Health|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
20548179|NCT00408629|Abbott|Global Medical Services|800-633-9110||
20548180|NCT00191906|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20548181|NCT01890746|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20548182|NCT02059902|Health Partners|Dr. William J Mohr|(651)454-5304|William.J.Mohr@healthpartners.com|
20548183|NCT00777205|Veterans Affairs Healthcare System|Marcia Valenstein, MD|734-845-3649|marcia.valenstein@va.gov|
20548184|NCT03257371|University of Missouri|Dr. James Cook|573-882-7189|cookjl@health.missouri.edu|
20548185|NCT02268955|Maricopa Integrated Health System|Dan Quan, DO|602-344-5058|dany_quan@dmgaz.org|
20548186|NCT04046055|University of Iowa|Dr. Craig D. Workman|319-467-0746|craig-workman@uiowa.edu|
20548187|NCT01784848|HCor|Dr Carlos Schiavon|1130536611|schiavon.ca@gmail.com|8201
20548188|NCT03198078|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20548189|NCT02607930|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20548190|NCT01676727|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|Maarten.Hollander@medtronic.com|
20556572|NCT03923959|LancasterGH|Halle Becker|7175441401|halle.becker@pennmedicine.upenn.edu|
20556573|NCT01362439|Janssen-Cilag SpA, Cologno Monzese, Milan - Italy|Therapeutic Area Medical Manager|+39 0225101||
20556574|NCT03575325|Moffitt Cancer Center|Bijal D. Shah, MD, MS|813-745-4294|Bijal.Shah@moffitt.org|
20556575|NCT05711641|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|Dr. Tatiane Vacaro Campos|+551126617585|tati_vacaro@hotmail.com|
20556576|NCT04040751|Emory University|Sarah Blanton, PT, DPT|404-712-2222|sblanto@emory.edu|
20556577|NCT00762450|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
20556578|NCT03905330|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20556579|NCT02612311|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20556580|NCT01596582|Boston Medical Center|Paul C. Schroy III, MD, MPH|671-638-8335|paul.schroy@bmc.org|
20548191|NCT03387683|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20556581|NCT01428076|BTG International Inc.|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
20556582|NCT00387673|Miami VA Healthcare System|Kristina Beekhuizen|305-575-7000|Kristina.Beekhuizen@va.gov|
20556583|NCT00862134|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
20556584|NCT00101933|Medtronic Neuromodulation|Jim Vollhaber, Clinical Study Manager|763-526-8093|medtronicneurotrials@medtronic.com|
20556585|NCT04510675|Princeton Consumer Research Corp.|Principal Investigator|727-576-7300|bd@princetonconsumer.com|
20556586|NCT00976352|University of Florida|Dr. Barry Byrne, Professor and Associate Chair|352-273-6563|bbyrne@ufl.edu|
20556587|NCT01494584|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556588|NCT01522417|Medicure|Kyle Brown|204-594-3411|kbrown@medicure.com|
20556589|NCT00058123|North American Brain Tumor Consortium|Susan Chang, MD|410-955-8837|jfisher@jhmi.edu|
20556590|NCT00506064|UT MD Anderson Cancer Center|Una Srejic, MD / Professor|713-792-6914|CR_Study_Registration@mdanderson.org|
20556591|NCT02460692|University of California, San Diego|Thomas D. Marcotte, PhD|619-543-5044|tmarcotte@health.ucsd.edu|
20556592|NCT01298999|Columbia University Medical Center|Julian A Abrams, MD|2123059541|ja660@cumc.columbia.edu|
20556593|NCT02151266|Emory University|Dr. Gary|404-727-8360|ragary@emory.edu|
20556594|NCT03987841|University of Alabama at Birmingham|Caroline Presley|205-934-7609|capresley@uabmc.edu|
20556595|NCT04839965|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
20556596|NCT02170025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20556597|NCT01077830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556598|NCT01337674|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556599|NCT02543658|First affilitated hospital of Nanchang university|Wenhua He|+8613879182642|hewenhua@ncu.edu.cn|
20556600|NCT00949884|Daiichi Sankyo, Inc.|Robert Dubiel, PharmD|973-944-2963|bdubiel@dsi.com|
20556601|NCT03717402|Dana-Farber Cancer Institute|Andrea C. Enzinger, MD|617-582-7335|Andrea_Enzinger@DFCI.HARVARD.EDU|
20556602|NCT02565901|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20556603|NCT01857882|University Health Network|Dr. Toni Zhong|416-340-3858|toni.zhong@uhn.ca|
20572320|NCT05051462|University of Toronto|Barna Konkoly-Thege|+1 (705) 549 3181|konkoly.thege.barna@gmail.com|2614
20572321|NCT05452278|Imperial Brands PLC|Libby Clarke|+44 (0117) 3320221|libby.clarke@impbrands.com|
20572322|NCT03663257|Philips Medical Systems Nederland B.V.|Joris de Groot|+31621949619|joris.ah.de.groot@philips.com|
20548192|NCT00629772|Innovaderm Research|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
20548193|NCT03840174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548194|NCT00722423|VA San Diego Healthcare System|Dr. Samuel B. Ho|8586423280|Samuel.Ho2@va.gov|
20548195|NCT04040244|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
20572323|NCT01022112|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20572324|NCT01238900|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
20572325|NCT03241927|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
20572326|NCT01198756|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572327|NCT04004936|Atlanta VAHCS|Dr. Elizabeth Camille Vaughan/ Atlanta Site Section Chief Birmingham/Atlanta GRECC|404 315 4100|elizabeth.vaughan2@va.gov|373118
20572328|NCT02915302|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
20572329|NCT02062593|Imperial College London|Rasha Al-Lamee|+447976276923|r.al-lamee13@imperial.ac.uk|
20572330|NCT00591721|University of Illinois at Chicago|Marcia Finlayson, PhD|312-996-4603|marciaf@uic.edu|
20572331|NCT03809429|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20572332|NCT01244529|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|kosborn@its.jnj.com|
20572333|NCT00941070|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
20572334|NCT03174431|The Ohio State University|Silpa Nekkanti|614-293-4643|silpa.nekkanti@osumc.edu|
20572335|NCT02111187|Associate professor of oncology and urology|Emmanuel Antonarakis|443-287-0553|eantona1@jhmi.edu|
20572336|NCT00252577|VA San Diego Healthcare System|John Kelsoe|858-552-8585|john.kelsoe@va.gov|5704
20572337|NCT01655693|ONXEO|Olivier De Beaumont; Chief Medical Officer|+33 (0) 1 45 58 95 33|o.debeaumont@onxeo.com|
20572338|NCT01680640|University of Southampton|Christopher D Byrne|44 (0)23 8120 8818|cdtb@soton.ac.uk|
20572339|NCT03122223|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20572340|NCT01820585|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
20572341|NCT00548262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572342|NCT02285153|Medical University of Vienna|Bernd Jilma|+434040029180|bernd.jilma@meduniwien.ac.at|
20572343|NCT00684723|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20572344|NCT04535310|The Ohio State University College of Optometry|Jennifer Fogt|16142928858|OPT-EyeStudies@osu.edu|
20572345|NCT02544451|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20572346|NCT00924118|Johns Hopkins Hospital|Steven P. Schulman, MD|4109557378|sschulma@jhmi.edu|410
20572347|NCT01390077|University of California, San Diego|William Leo Nyhan, M.D., Ph.D.|(619)543-5337|wnyhan@ucsd.edu|
20572348|NCT03590366|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20572349|NCT03358251|Prudentix Ltd.|Head of QA/RA|+972-72-394-22-24|tsipi@prudentix.com|
20572350|NCT05017103|M D Anderson Cancer Center|Neeta Somaiah, MD|713-792-3626|nsomaiah@mdanderson.org|
20572351|NCT02656329|GE Healthcare|Francois Tranquart, M.D., Ph.D.|0-44-1494-543037|francois.tranquart@ge.com|
20572352|NCT03699826|University of Iowa|Aaron Boes|319-353-8587|aaron-boes@uiowa.edu|
20572353|NCT01081665|Abbott|Global Medical Services|1-800-633-9110||
20572354|NCT01630694|University of Rochester|Jacek Wojtczak|585-273-2972|jacek_wojtczak@urmc.rochester.edu|
20572355|NCT03796962|Xenon Pharmaceuticals Inc.|Medical Affairs|+1-604-484-3300|medicalaffairs@xenon-pharma.com|
20572356|NCT00719329|Johns Hopkins Bloomberg School of Public Health|Dr. Luke Mullany|410-502-2626|lmullany@jhsph.edu|
20572357|NCT03211117|Mayo Clinic|Ashish V. Chintakuntlawar, MBBS, Ph.D.|(855) 776-0015|Chintakuntlawar.Ashish@mayo.edu|
20572358|NCT01118013|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD||abashey@bmtga.com|
20572359|NCT01747551|Dana-Farber Cancer Institute|Peter Enzinger|617-632-3029||
20572360|NCT03916458|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548196|NCT05143541|Kantonsspital St. Gallen|Dr. André E. Dutly|071 494 9944|andre.dutly@kssg.ch|
20548197|NCT04926077|Philips|Bill Hardy|412-874-2710|bill.hardy@philips.com|
20548198|NCT05012657|Point Designs|Director of Clinical Research|7206004753|research@pointdesigns.com|
20548199|NCT03789214|The Johns Hopkins University School of Medicine|Andrew S. Huhn, Ph.D.|410-550-1971|ahuhn1@jhu.edu|
20572361|NCT02546921|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20572362|NCT01373151|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20572363|NCT02186600|University of Nebraska Medical Center|Laura Bilek|402-559-6923|lbilek@unmc.edu|
20572364|NCT01504477|Georgetown University|Michael Pishvaian|202-444-2223|pishvaim@georgetown.edu|
20572365|NCT01546675|Department of Veterans Affairs|Linda Resnik, PT, PhD|401-273-7100|linda.resnik@va.gov|2368
20548200|NCT01349231|Yale University, Connecticut Mental Health Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
20548201|NCT00590460|BAYLOR|Malcolm Brenner, MD|832-824-4663|mbrenner@bcm.edu|
20527730|NCT03300050|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
20548202|NCT01986140|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
20572366|NCT03381339|Marquette Univeristy|Associate Dean|4142885944|andrew.dentino@marquette.edu|
20572367|NCT03230877|Fisher & Paykel Healthcare Ltd.|Sarah Gunson|+64 9 574 0123|sarah.gunson@fphcare.co.nz|7675
20572368|NCT02387268|M.C.Carmel|Dr.Kobie Dickstein|048250055|kobiedi@clalit.org.il|
20548203|NCT01484132|New England Research Institutes|Felicia Trachtenberg, Principal Research Scientist|617-972-3120|ftrachtenberg@neriscience.com|
20548204|NCT01912963|Dana-Farber Cancer Institute|Rachel Freeman MD|617.632.3000|Rachel_Freedman@dfci.harvard.edu|
20572369|NCT03117998|REMD Biotherapeutics, Inc|"Dung Zung Thai, MD, PhD"|415-225-9338|zungthai@remdbio.com|
20527731|NCT02907619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527732|NCT03326518|Lument AB|Dr Thomas Fork|+46 705336996|thomas.fork@lumentab.com|
20572370|NCT01253070|Washington University School of Medicine|Geoffrey Uy, MD||guy@dom.wustl.edu|
20548205|NCT03616171|Emory University|Ashley Coombe, PhD|404-712-9313|ashley.coombe@emory.edu|
20548206|NCT03139318|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
20548207|NCT01833546|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20548208|NCT01069627|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20548209|NCT00464269|UCB|Clinical Trial Call Center|+1 877 822 9493||
20548210|NCT00747461|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
20548211|NCT02149875|Shanghai Sixth People's Hospital|Dr. Hao Chen|02164369181|chenhao_316@aliyun.com|8405
20548212|NCT05055453|Sonova|Jean Anne Schnittker, Research Audiologist|+41 58 928 01 01|jeananne.schnittker@sonova.com|
20548213|NCT00299182|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7966|CR_Study_Registration@mdanderson.org|
20548214|NCT04102956|Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.|Xiaoyun Liu PhD|+8613191887318|audrey-l@163.com|
20572371|NCT01468181|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572372|NCT04828837|NTUNHS|Wang Szu-Yi|886-97140315|jachiex@gmail.com|
20572373|NCT01397422|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
20572374|NCT00545753|ParaPRO LLC|Director of Quality and Regulatory|317-810-6205|kerrym@parapro.com|
20572375|NCT04664400|Dartmouth College|Tor D Wager, PhD|(603)-646-2196|Tor.D.Wager@Dartmouth.edu|
20572376|NCT00636805|Duke University Medical Center|Mary Lou Affronti|919-6846239|mary.affronti@dm.duke.edu|
20572377|NCT03491891|First Hospital of Jilin University|Xiang Wang|+86-13504321434|jdwxiang123@126.com|
20572378|NCT00710905|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20572379|NCT01011153|MELA Sciences, Inc.|Joanna Adrian, Director of Clinical Operatons and Medical Affairs|914-591-3783|adrian@melasciences.com|732
20572380|NCT03776539|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
20572381|NCT01081132|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20572382|NCT02297139|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20572383|NCT02577822|Northwestern University|David Manning, MD|312-695-6800|david.manning@nm.org|
20572384|NCT02101385|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20572385|NCT03691909|Hope Biosciences Stem Cell Research Foundation|Linette Rehkopf RPh|346-900-0340|linette@hopebio.org|102
20572386|NCT01982448|Dana-Farber Cancer Institute|Clinical Trials Office|617-632-5313|ctopm@dfci.harvard.edu|
20572387|NCT02158052|Massachusetts General Hospital|Thomas Spitzer, MD|6177241124|tspitzer@mgh.harvard.edu|
20572388|NCT03695237|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20572389|NCT00055601|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20572390|NCT04461483|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20572391|NCT02217332|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
20572392|NCT04343872|University of Alabama at Birmingham|Dr. Andrea L. Cherrington|205-996-2885|acherrington@uabmc.edu|
20572393|NCT01850446|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20572394|NCT03725085|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20572395|NCT02704754|Howard University|Thomas A Mellman|12022575961|TMellman@Howard.edu|
20572396|NCT02716818|Diurnal Limited|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
20572397|NCT01597141|Maine Medical Center Research Institute|William R. McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
20572398|NCT03646656|Department of Veterans Administration|Dr. Karen Goldstein|919.826.0411|karen.goldstein@va.gov|1707764
20572399|NCT03507777|Abbott Vascular|Jana Buccola, Director Clinical Programs|+1-408-845-1049|jana.buccola@abbott.com|
20572400|NCT02245737|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
20572401|NCT03866798|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
20572402|NCT02551718|University Of Washington|Dr. Percival|206-606-1320|mperciva@seattlecca.org|
20572403|NCT00446043|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20572404|NCT00359216|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20572405|NCT00692276|Vertiflex|Steve Reitzler|442-325-5934|sreitzler@vertiflex.com|
20572406|NCT01033422|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
20572407|NCT01144052|Ospedale Civico|Claudio Globbi, Dr. med.|+41 91 811 6921|claudio.gobbi@eoc.ch|
20572408|NCT00105001|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20572409|NCT03836716|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
20572410|NCT01879722|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20572411|NCT00697697|MAP Pharmaceuticals, Inc. a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20572412|NCT04988867|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
20572413|NCT01327495|University of Washington|Stephanie Page, MD, PhD|206-616-0483|page@uw.edu|
20572414|NCT03385343|Mayo Clinic|Kevin Buller Clinical Research Coordinator|507-255-4803|Buller.Kevin@mayo.edu|
20572415|NCT03307005|Johns Hopkins University|Rashmi Nisha Aurora, MD, MHS|443-513-6535|rnaurora@jhmi.edu|
20572416|NCT00294515|Hoffmann-La Roche|Medical Communications|800-821-8590||
20572417|NCT00560066|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20548215|NCT03131453|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20572418|NCT00506441|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20572419|NCT00673400|Cantonal Hospital St. Gallen, Department of Surgery|Ulrich Beutner PhD|+41 71 494 1111|ulrich.beutner@kssg.ch|
20572420|NCT01151410|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20572421|NCT01712659|National Cancer Institute|Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
20572422|NCT00844532|Abbott Vascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
20572423|NCT02270515|University of Illinois, Chicago|Dr. Denise M. Hynes, Professor, College of Medicine|312-355-0083|dhynes@uic.edu|
20572424|NCT00738894|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
20572425|NCT03026075|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
20572426|NCT04927247|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572427|NCT00878826|Stanford University|Dr. Deirdre Lyell|650-736-1191|dlyell@stanford.edu|
20572428|NCT04540887|Wake Forest Institute for Regenerative Medicine|Dr. Stephen Walker|33-713-7272|swalker@wakehealth.edu|
20572429|NCT02688218|Oregon Health and Science University|Joseph El Youssef|503-418-5128|elyoussj@ohsu.edu|
20572430|NCT04512430|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20572431|NCT05061472|University of Colorado Anschutz Medical Campus|Adnin Zaman, MD|5852761001|adnin.zaman@cuanschutz.edu|
20572432|NCT03670004|Jesse Brown VA Medical Center|Dr. Matthew Major|312-503-5731|matthew.major2@va.gov|
20572433|NCT00383110|Ralph H. Johnson VAMC|Leonard Egede, MD, MS|843-789-6670|leonard.egede@va.gov|
20572434|NCT02489968|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20572435|NCT03738423|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20572436|NCT04577001|Mayo Clinic|Dr. Hilary DuBrock|(507) 284-2957|DuBrock.Hilary@mayo.edu|
20572437|NCT00588900|UNC Lineberger Comprehensive Cancer Center|Bert O'Neil, M.D.||bert_oneil@med.unc.edu|
20572438|NCT02299089|Camurus AB|Clinical Trial Manager|+46 46 2876 530|Info@Camurus.com|
20572439|NCT04949243|Duke University|Saira Siddiqui, MPH|919-688-8464|saira.siddiqui@duke.edu|
20572440|NCT01728337|CBED|Dr Doris Hexsel|30262633|cbed@cbed.com.br|
20572441|NCT01865747|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20572442|NCT04625413|University of Rochester Medical Center|Dr. Kah Poh Loh|585-276-4353|kahpoh_loh@urmc.rochester.edu|
20572443|NCT03981861|ChildrensMHC|Tania Burgert|203 676 4545|tsburgert@cmh.edu|
20572444|NCT05618912|Indiana University School of Medicine|Dr. Syril Keena T. Que|317-944-7744|ques@iu.edu|
20572445|NCT03973931|University of Colorado|Dr. Michael Ho|303-590-5969|michael.ho@cuanschutz.edu; p.michael.x-ho@kp.org|
20572446|NCT00925353|St. Luke's Mountain States Tumor and Medical Research Institute|Colleen K. Lambertz, MBA, MSN, FNP|208 463 6018|lambertc@slhs.org|
20572447|NCT02199743|UT Southwestern Medical Center|Debra Bushong, MS, LPC|214-648-4653|debra.bushong@utsouthwestern.edu|
20572448|NCT02516332|Duke University|Patrick Smith, Ph.D.|919-681-3006|patrick.j.smith@duke.edu|
20572449|NCT00452426|Ethicon Endo-Surgery|James Martin, PhD|513 337-7000||
20572450|NCT03541174|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58844 1977|idorsiaclinicaltrials@idorsia.com|
20572451|NCT00605215|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20572452|NCT00275262|Abbott|Global Medical Services|800-633-9110||
20572453|NCT02002650|Xijing hospital of digestive diseases|Hui Luo|862984771536|fmmulh@163.com|
20572454|NCT05130047|Mayo Clinic|Michael Camilleri, M.D., D.Sc.|507-284-2687|camilleri.michael@mayo.edu|
20527733|NCT01375374|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20527734|NCT03108066|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20572455|NCT01546636|NorthShore University HealthSystem|Glenn Murphy, MD, Director of Clinical Research|847-570-2760|gmurphy@northshore.org|
20572456|NCT01302067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572457|NCT00834626|Kirloskar Hospital|Dr. Neeraj Gupta|+91-40-23296241|drugale@kirloskarhospital.com|
20572458|NCT02738203|Stanford University, Department of OB/GYN|Research Manager|6507211562|familyplanningresearch@stanford.edu|
20572459|NCT00266227|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20572460|NCT03573583|University of Florida|Todd Manini|(352) 273-5914|tmanini@ufl.edu|
20572461|NCT00670631|University of Iowa|Guido Tricot, MD, PhD||guido-tricot@uiowa.edu|
20572462|NCT01290315|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@luitpold.com|811
20572463|NCT02295553|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
20572464|NCT00423943|University of California, Los Angeles|Michael Minzenberg|310-825-7642|MMinzenberg@mednet.ucla.edu|
20572465|NCT02134977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20572466|NCT04464954|Mike O'Callaghan Military Medical Center|Amanda Crawford|7026532067|amanda.j.crawford.ctr@health.mil|
20572467|NCT00538915|DallasAllergyImmunology|Richard L. Wasserman, M.D., Ph.D.|(972) 566-7788|drrichwasserman@gmail.com|
20572468|NCT00901186|Novartis Pharmaceuticals|Study Director|1-862-778-8300||
20572469|NCT02383056|University of Miami|Dr. Keyvan Nouri|305-243-3380|Knouri@med.miami.edu|
20572470|NCT01658150|Icahn School of Medicine at Mount Sinia|Dr. Katherine Burdick|212-659-8841|katherine.burdick@mssm.edu|
20572471|NCT04187989|University of Michigan|Dr. Erin Bonar|7347647936|erinbona@med.umich.edu|
20572472|NCT03602066|University of Arizona Cancer Center|Jared Robbins, MD|520-626-6724|jrobbins@arizona.edu|
20572473|NCT01239043|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20572474|NCT02929329|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20572475|NCT02121301|Ciurem Pharma Inc|Gosse B. Bruinsma|613-866-9609|gbb@CIUREM.COM|
20572476|NCT00353522|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20572477|NCT00037830|Thomas Jefferson University|Dr. Jay Schneider|215-503-0370|jay.schneider@jefferson.edu|
20572478|NCT00831753|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20572479|NCT01639560|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
20572480|NCT01467882|Debiopharm International, S.A.|Eija Lundström|:+41 21 3210111|eija.lundstrom@debiopharm.com|
20572481|NCT01631227|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20572482|NCT00766363|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
20572483|NCT03292432|University of North Carolina at Chapel Hill|Rachel Goolsby - Research Manager|9198430685|rwgoolsby@unc.edu|
20572484|NCT03020576|Columbia University Medical Center/ Dept. of Rehabilitation & Regenerative Medicine|Lauri Bishop, PT, DPT Research Physical Therapist|212-305-6095|LB2413@cumc.columbia.edu|
20572485|NCT01841931|Maimonides Medical Center|Director of Research, Department of Psychiatry|718-283-7162|tjacob@maimonidesmed.org|
20548216|NCT01532973|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20572486|NCT03398213|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
20572487|NCT00700427|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572488|NCT01767701|Queen Mary University of London|Professor Gavin Giovannoni||g.giovannoni@qmul.ac.uk|
20548217|NCT04432272|Beaumont Hospitals|Matthew Sims, MD|248-551-0027|matthew.sims@beaumont.org|
20548218|NCT02024555|Vanderbilt University Medical Center|Wonder Drake, MD|(615) 322-2035|wonder.drake@vumc.org|
20548219|NCT04916769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548220|NCT03772678|Arch Biopartners Inc.|Richard Muruve|(647) 428-7031|info@archbiopartners.com|
20548221|NCT05736224|Yale University Department of Dermatology|Kacie Carlson, Physician Assistant|203 785 7432|Kacie.carlson@yale.edu|
20548222|NCT04526509|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20548223|NCT03806491|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
20548224|NCT03950791|Stanford University School of Medicine|Maisa Ziadni, PhD|(650) 724-9143|mzaidni@stanford.edu|
20548225|NCT03448653|Centre Hospitalier Départemental Vendée|Dr. Vincent MACE|0251446572|vincent.mace@ght85.fr|+33
20548226|NCT02719327|Madison Veterans Affairs Geriatrics Research, Education & Clinical Center (GRECC)|Cynthia Carlsson, MD, MS; Professor of Medicine (Geriatrics)|608-280-7000|cynthia.carlsson@va.gov|
20548227|NCT04340193|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20548228|NCT06350474|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
20548229|NCT00717093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548230|NCT00721500|Vistakon|Kurt Moody OD FAOO / Director|904-443-3088||
20548231|NCT01543698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548232|NCT00217620|SWOG Statistical Center|Study Statistician|206-667-4623||
20548233|NCT00418015|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|3129269015|r-mccarthy@northwestern.edu|
20548234|NCT00089414|Behavioral Endocrinology Branch/National Institute of Mental Health/NIH|Pedro E. Martinez, M.D., Principal Investigator|301-402-0615|martinep@mail.nih.gov|
20548235|NCT01517074|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
20548236|NCT01863953|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20548237|NCT01797731|Hospital for Special Surgery|David Mayman|2127742024|maymand@hss.edu|
20548238|NCT01453725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556604|NCT03896009|Axsome Therapeutics, Inc.|Caroline Streicher, Executive Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
20556605|NCT00437645|Novartis Pharmaceuticals|Study Director|862 778-8300||
20556606|NCT00662857|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20556607|NCT03966053|Feinstein Institutes for Medical Research|Adrianna Vlachos, MD|5165623757|avlachos@northwell.edu|
20556608|NCT00989092|Amgen Inc.|Study Director|866-572-6436||
20572489|NCT02796625|University of Maryland Baltimore|Dr. David Seminowicz|14107063476|dseminowicz@umaryland.edu|
20548239|NCT03945214|University of California San Francisco|Dr. Rachel Radin|845-641-9569|rachel.radin@ucsf.edu|
20548240|NCT02391701|Hospital Clínico Universitario de Santiago|Dr. María del Mar Calvo Malvar|34 981950395|mariadelmar.calvo.malvar@sergas.es|
20548241|NCT01955564|Newron Pharmaceuticals S.p.A.|Dr. Ravi Anand|+39 026103461|ravi@anand.ch|
20572490|NCT02057523|Loyola University Medical Center|Sanjeev Akkina|7082166389|sanjeev.akkina@lumc.edu|
20572491|NCT00355199|Ospedale Papa Giovanni XXIII, Bergamo|Alessandro Rambaldi|0352673684|arambaldi@asst-pg23.it|+39
20572492|NCT04245228|Mayo Clinic|Dr. Cassie Kennedy, PI|1-507-284-2511|kennedy.cassie@mayo.edu|
20572493|NCT00964886|VA San Diego Healthcare System|Joseph H. Atkinson MD|858 552 8585|joseph.atkinson@va.gov|2568
20572494|NCT02758847|University of Pittsburgh|Dr Rabih Chaer|4128023333|chaerra@upmc.edu|
20572495|NCT04587752|Yale University|Dr. Janet Lydecker|2037374299|janet.lydecker@yale.edu|
20572496|NCT02006251|Cleveland Clinic|Wael Barsoum|2164444954|barsouw@ccf.org|
20572497|NCT03500159|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|604-629-9223|clinical@aqxpharma.com|
20572498|NCT03535597|Memorial Healthcare Systerm|Dr. Jianli Niu|954-265-6653|jniu@mhs.net|
20572499|NCT03412747|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20572500|NCT03484273|University of Calgary|Dr. Satish R. Raj|403-210-6152|satish.raj@ucalgary.ca|
20572501|NCT01426867|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20572502|NCT00468104|Midwest Pulmonary and critical care|George Thommi|402 206 7372|tommi4@cox.et|
20572503|NCT01263665|W.L. Gore & Associates|Keli Sapp|9288643964|kesapp@wlgore.com|
20572504|NCT00461513|Veterans Health Administration|Dr. Meg Plomondon|303-370-75770|Meg.Plomondon@va.gov|
20572505|NCT02706899|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20572506|NCT00324675|"University Hospital Carl Gustav Carus, Dresden"|Dr. Frank Pistrosch|0049 351 4400580|frank.pistrosch@uniklinikum-dresden.de|
20572507|NCT00381615|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20572508|NCT00371683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20572509|NCT02601976|Getz Pharma|Mr. Jaffer Bin Baqar|111111511|jaffer.baqar@getzpharma.com|2710
20572510|NCT03181789|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20572511|NCT01131182|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20572512|NCT04602221|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20572513|NCT03001076|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20572514|NCT02576587|Cleveland Clinic|Dr. Reena Mehra|216-444-4946|mehrar@ccf.org|
20572515|NCT01080716|Vaccine Trial Treatment Center, Mahidol University|Punnee Pitisutithum, MBBS, DTM&H, FRCPT|66-2-643-5599|tmppt@mahidol.ac.th|
20527735|NCT03798327|Icahn School of Medicine at Mount Sinai|Dr. Nathan Goldstein|212-844-1712|Nathan.goldstein@mssm.edu|
20527736|NCT04401202|King Abdulaziz University|Dr. Abdulrahman Koshak|0543292333|aekoshak@kau.edu.sa|
20527737|NCT03491397|University of California Los Angeles|Siddharth A. Padia, MD|310-825-2992|SPadia@mednet.ucla.edu|
20527738|NCT02714036|MEDICINOVA, INC|Director, Research and Development|858-373-1500|clinicaltrialinfo@medicinova.com|
20527739|NCT03141034|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
20548242|NCT02480920|Department of Cardiology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey|Volkan Emren||vemren@hotmail.com|
20548243|NCT01436396|Sanofi Pasteur|Director||Contact-US@sanofi.com|
20548244|NCT00875979|Hoffmann-La Roche|Medical Communications|800 821-8590||
20548245|NCT00216476|Janssen Cilag European Medical Affairs|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
20548246|NCT00303901|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
20556609|NCT03586583|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20556610|NCT02832622|Abbott|Kwangdeok Lee, PhD|1-972-526-9673|kwangdeok.lee@abbott.com|
20556611|NCT04149925|Lexington Medical Inc.|Annette Dunn|480-313-8505|annette@lexington-med.com|
20556612|NCT02586025|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20556613|NCT02713711|UC de Maule|Professor Gabriel Nasri Marzuca Nassr|56 71 203463|gmarzuca@gmail.com|
20556614|NCT04586569|Boston Children's Hospital|Dr. Linda Bulich|617-355-7737|linda.bulich@childrens.harvard.edu|
20556615|NCT00998400|University of Bologna|Professor Chiara Rafanelli|0039 051 2091847|chiara.rafanelli@unibo.it|
20556616|NCT03704584|Emory University|Dr. Charles Daly|404-919-6168|charles.a.daly@emory.edu|
20556617|NCT03185832|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
20556618|NCT03675451|Weill Cornell Medicine|Junaid Niaz|212.746.5793|mjn3001@med.cornell.edu|
20556619|NCT02127372|Duke University Medical Center|Gordana Vlahovic, MD|919-681-4047|Gordana.vlahovic@dm.duke.edu|
20556620|NCT02173548|Virginia Commonwealth University|Antonio Abbate, MD, PhD|(804) 828-0513|antonio.abbate@vcuhealth.org|
20556621|NCT03597568|University of I|Dr. Diana Jalal|319-338-0581|diana-jalal@uiowa.edu|
20556622|NCT04141774|UW School of Medicine and Public Health|Dr. Vivek Prabhakaran, MD, PhD|(608) 265-5269|vprabhakaran@uwhealth.org|
20556623|NCT03722927|Wake Forest Baptist Health|Dr. Christopher Runyan|336-716-4171|crunyan@wakehealth.edu|
20556624|NCT03548207|Janssen Research & Development, LLC|Vice President Research and Development, Cellular Therapy|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20556625|NCT01756352|Brigham and Women's Hospital|Marcelo DiCarli, MD|(617) 732-6290|mdicarli@bwh.harvard.edu|
20556626|NCT03822117|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20572516|NCT01056718|Mercy Hospital East Communities|Denise Janosik, MD|314-251-3920|Denise.Janosik@mercy.net|
20556627|NCT00415610|University of Minnesota|Adnan I Qureshi, MD|612-624-2431|qureshai@gmail.com|
20556628|NCT01610427|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572517|NCT01139580|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572518|NCT00633880|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20572519|NCT00700778|Fox Chase Cancer Center|Dr. Jose Russo|215-728-4782|Jose.Russo@fccc.edu|
20572520|NCT00350103|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20572521|NCT02842151|Alcon, A Novartis Division|Senior Global Brand Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20572522|NCT02559895|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20572523|NCT01305200|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
20572524|NCT00432666|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
20572525|NCT00978627|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20572526|NCT00565851|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20572527|NCT04058366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20572528|NCT01342341|Ernest Gallo Clinic and Research Center|Dr. Jennifer Mitchell, Clinical Project Director|510-985-3921|jmitchell@gallo.ucsf.edu|
20572529|NCT00705679|University of Washington|Jeanne Marrazzo, MD, MPH, FACP, FIDSA|206-744-3679|jmm2@uw.edu|
20572530|NCT03730480|Ascensia Diabetes Care|Pragathi Shelat|1 (862) 229-6679|pragathi.shelat@ascensia.com|
20572531|NCT03356626|Seoul National University Hospital, Seoul National University College of Medicine|Seong-Ho Kong|+82-2-2072-4199|seongho.kong@snu.ac.kr|
20572532|NCT01164644|University of Wisconsin School of Medicine and Public Health|Dr. Scott R. Chaiet|(608) 263-1092|scottchaiet@yahoo.com|
20572533|NCT00621777|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|a_eden_evins@hms.harvard.edu|
20572534|NCT01008319|University of Oklahoma|LaTasha Craig, MD|405-271-8787|latasha-craig@ouhsc.edu|
20572535|NCT00704379|Baylor College of Medicine|Dr. Ricardo Jorge|713-794-7010|Ricardo.Jorge@bcm.edu|
20572536|NCT04513652|American Genomics, LLC|Martin Uram, MD|848-444-0665|martin@amgenomics.net|
20572537|NCT02663518|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572538|NCT01983254|Duke University|Christopher Cox, PI|9196817232|christopher.cox@duke.edu|
20572539|NCT01954966|University of Pennsylvania|Claudia Iannelli|6104424426|Claudia.iannelli@pennmedicine.upenn.edu|
20572540|NCT00434213|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
20572541|NCT01253304|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572542|NCT01699503|Indiana University|Dr. Nicole Fowler|317-274-9021|fowlern@iupui.edu|
20572543|NCT01534689|Regulatory Insight, Inc.|Clinical Consultant|6157129743|elvira@reginsight.com|
20572544|NCT00006011|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20572545|NCT03178643|DCRI|Dr. Steve Taylor|9198245232|steve.taylor@duke.edu|
20572546|NCT02015455|University of Washington|Dr. Sandra K Johnston, PhD, RN Executive Administrative Director- CLEAR Center|206-221-7444|stonesk@uw.edu|
20572547|NCT03909529|CMP Pharma|Paul Sudhakar|816-507-8249|pauls@ptspharma.com|
20572548|NCT01090479|Northwestern University|Michael Murray, MD|312-926-4444|m.murray8278@gmail.com|
20572549|NCT00911937|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572550|NCT04560010|NYU Langone|Arthur Hertling, MD|212-263-5072|Arthur.hertling@nyulangone.org|
20572551|NCT01871805|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20572552|NCT03097484|University of Kentucky|John Bauer, MD|859-218-2927|john.bauer@uky.edu|
20572553|NCT01670760|3M|Terri White|651-733-0228|twhite3@mmm.com|
20572554|NCT02335710|University of Tennessee|Richard D. Komistek, Ph. D.|8659742093|rkomiste@utk.edu|
20572555|NCT01435616|Eli Lilly and Company|Chief Medical Officer|800 545 5979||
20572556|NCT04860297|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20572557|NCT04771611|Mayo Clinic|James L. Kirkland, M.D., Ph.D.|507-538-3817|Kirkland.James@mayo.edu|
20572558|NCT00396019|AstraZeneca|Dr. Regina Jakacki||regina.jakacki@astrazeneca.com|
20572559|NCT03992131|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
20572560|NCT04811131|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20572561|NCT04718779|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20572562|NCT00741390|Becton Dickinson|Kenneth Kassler-Taub, VP Medical Affairs|201-847-7009|kenneth_kassler_taub@bd.com|
20572563|NCT00003453|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20572564|NCT00620282|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20572565|NCT02217475|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20572566|NCT02615002|Neurim Pharmaceuticals|Tali Nir, DVM, VP Clinical and Regulatory Affairs|+972-3-7684902|talin@neurim.com|
20572567|NCT04738292|Froedtert / Medical College of Wisconsin|Sailaja Kamaraju, MD, MS|414-805-4600|skamaraju@mcw.edu|
20556629|NCT00999466|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20556630|NCT01357616|Alcon Research, Ltd.|Mandy Ye, Head, Clinical Trial Management, Asia|1-888-451-3739|alcon.medinfo@alcon.com|
20556631|NCT05443659|Theranica|Dr Dagan Harris, VP Clinical and Regulatory Affairs|+972542220121|daganh@theranica.com|
20556632|NCT03255824|Montefiore Medical Center|Dr. Patrick Nolan|718-405-8195|pnolan@montefiore.org|
20556633|NCT05072457|Hearts for Hearing|Lead Investigator|405-548-4335|phonakaudiologyresearch@gmail.com|
20556634|NCT01091155|novoGI|Eran Choman, VP Clinical Affairs & Statistics|+972 9 8603000|eran.choman@novogi.com|
20572568|NCT02971761|Department of Medical Oncology, City of Hope|Yuan Yuan, MD, PhD.|626-256-4673|yuyuan@coh.org|89200
20527740|NCT00715520|Emory University|Dr. Cathrin Buetefisch|4047121894|cathrin.buetefisch@emory.edu|
20572569|NCT02442336|Fox Chase Cancer Center|Carolyn Fang|215-728-4062|carolyn.fang@fccc.edu|
20556635|NCT03432364|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
20572570|NCT01237587|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20572571|NCT01142115|Clinical Regulatory Development, Global R&D|Trine Møller Kruse|+4549112174|dktrm@coloplast.com|
20572572|NCT03208036|Minneapolis VA Health Care System|Tasha Nienow|612-467-1004|tasha.nienow@va.gov|
20572573|NCT00453193|The University of Texas M D Anderson Cancer Center|Farhad Ravandi-Kashani MD/Associate Professor|713-745-0394|eharriso@mdanderson.org|
20572574|NCT01879553|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20572575|NCT00320528|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572576|NCT01030406|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
20572577|NCT00760474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20572578|NCT00513305|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
20572579|NCT01262027|The University of Texas (UT) MD Anderson Cancer Center|Vicente Valero, MD/Professor, Breast Medical Oncology|713-792-7734|vvalero@mdanderson.org|
20572580|NCT03014479|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20572581|NCT00610740|Masonic Cancer Center, University of Minnesota|Levi Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
20572582|NCT00531453|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
20572583|NCT03419832|Wake Forest School of Medicine|Joseph E. Andrews, Jr., PhD, CIP, CCRP|336-716-7658|jandrews@wakehealth.edu|
20572584|NCT01394978|Davol, Inc.|Dawn Heimer, PhD|+1-401-825-8681|Dawn.Heimer@CRBard.com|
20572585|NCT02217501|UT Southwestern Medical Center|Subhash Banerjee, MD|214-857-1608|Subhash.Banerjee@utsouthwestern.edu|
20572586|NCT02019667|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
20572587|NCT03748992|Medical University of South Carolina|Patrick Flume, MD|843-792-3167|flumepa@musc.edu|
20572588|NCT02432196|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
20572589|NCT01905150|Hirschfeld Oncology|Dr. Azriel Hirschfeld|718-732-4050|ah@honcology.com|
20572590|NCT02592876|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20572591|NCT01464775|MercyMC|Dr. Fermin Barrueto|410-321-8452|fbarrueto@mdmercy.com|
20572592|NCT00611975|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
20572593|NCT02594163|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20572594|NCT04497142|Brigham and Women's Hospital|Steven Tobochnik, MD|617-732-7432|stobochnik@bwh.harvard.edu|
20572595|NCT02233543|Novartis Pharmaceuticals|Study Director|862-778-8300||
20572596|NCT00603304|University of Alabama at Birmingham|Dr. Alan Cantor|(205) 934-6887|acantor@uab.edu|
20572597|NCT01076192|AbbVie|Global Medical Information|800-633-9110||
20572598|NCT01034176|Brigham and Women's Hospital|Dr. Anil Chandraker|617-525-8203|achandraker@partners.org|
20572599|NCT00715962|Birmingham VAMC|Cynthia J. Brown, MD, MSPH|205-933-8101|cynthia.brownd44b2@va.gov|7300
20572600|NCT05087979|Virginia Commonwealth University|Vishal Yajnik, MD, MS|804-663-3519|vishal.yajnik@vcuhealth.org|
20572601|NCT01119105|Nabriva Therapeutics|Jennifer Schranz, M.D., Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
20572602|NCT01639495|Biosense Webster, Inc.|Robert Stagg, PhD, Manager, Clinical Franchise|(949) 450-7779|rstagg@its.jnj.com|
20572603|NCT03296033|Wake Forest School of Medicine|Daryl Henshaw, MD|336-716-6344|dhenshaw@wakehealth.edu|
20572604|NCT04214600|Cairo University|Dr. Nadine Mansour|(+2)01001482455- 01001465719|lotfynadine@gmail.com|
20572605|NCT02935452|University of Southampton|Ms Lindsay Welch|07881205106|lw13e14@soton.ac.uk|
20572606|NCT01635920|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
20572607|NCT00210470|University of Michigan Hospital|Gregory T. Wolf||gregwolf@umich.edu|
20572608|NCT00686725|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20527741|NCT01006590|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20527742|NCT03332095|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20527743|NCT00178646|UTHealth|Gerard E. Francisco|7137975246|Gerard.E.Francisco@uth.tmc.edu|
20572609|NCT00092495|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20572610|NCT02778932|University Hospital Schleswig-Holstein, Campus Kiel|Priv.-Doz. Dr. med. Axel Fudickar|0049500|axel.fudickar@uksh.de|20801
20572611|NCT01587027|Medical Center of the Rockies|Gary Luckasen, M.D.|(970)624-1686|gary.luckasen@uchealth.org|
20572612|NCT04772898|Creighton University|Anastasia Kyvelidou|4022805749|aky61380@creighton.edu|
20572613|NCT03250234|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
20572614|NCT01004848|Icahn School of Medicine at Mount Sinai|Carol R. Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
20572615|NCT00768079|MedImmune, LLC|Joseph M. Parker, Director, Clinical Development|+1 301-398-4095|information.center@astrazeneca.com|
20572616|NCT01498679|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572617|NCT02483000|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
20572618|NCT00795366|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-585-1178|kproctor@med.miami.edu|
20572619|NCT00158860|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572620|NCT03047395|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20572621|NCT01145209|National Heart Lung and Blood Institute|Wiestner, Adrian MD, PhD|+1.301.594.6855|wiestnea@nhlbi.nih.gov|
20572622|NCT01146782|ApniCure, Inc.|Andrea Brown, Director, Clinical Affairs|650-361-9000|abrown@apnicure.com|122
20572623|NCT02414932|Trinity College Dublin|Dr Martha Finnegan|0035312493385|mfinneg@tcd.ie|
20572624|NCT00470366|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, MD|646-422-4491|feldmand@mskcc.org|
20572625|NCT01011387|Mölnlycke Health Care AB|Jenny Thorell|0046 31 7223000|jenny.thorell@molnlycke.com|
20572626|NCT03661762|Norfolk and Norwich University Hospitals NHS Foundation Trust|Mr John Phillips|: +44 1603 593054|john.phillips@mac.com|
20572627|NCT00438672|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
20572628|NCT01099475|Maastricht University Medical Centre|Dr. MAJ van den Broek, MD|31 43 3884502|m.vandenbroek@maastrichtuniversity.nl|
20572629|NCT01781078|Boston Scientific|Kelly Aspinwall|651-582-4560|Kelly.Aspinwall@bsci.com|
20572630|NCT04887064|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20572631|NCT03924765|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
20572632|NCT03417895|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Yuanchao Wang; SPM|86-18036618707|yuanchao.wang@hengrui.com|
20572633|NCT01942785|Email contact via H. Lundbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
20572634|NCT05121246|mAbxience Research S.L.U.|Dr. Susana Millán|+34 682821346|susana.millan@mabxience.com|
20572635|NCT05038163|NBER|Sarah Holmes Berk|617-588-1445|sholmes@nber.org|
20572636|NCT05453201|James J. Peters Veterans Affairs Medical Center|Dr. Marianne Goodman|6462457071|mggoodman2001@yahoo.com|
20572637|NCT03562975|University Of South Florida|Clinical Research Manager|18139749423|amjackson@usf.edu|
20572638|NCT01934790|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20572639|NCT04688320|"LLC SuperGene"|Dr. Sergey Markin|(495) 287-98-07|info@supergene.ru|+7
20572640|NCT03798691|UW School of Medicine and Public Health|Freddy Caldera, DO|608-628-8201|fcaldera@medicine.wisc.edu|
20572641|NCT00552929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20572642|NCT04548544|University of California, San Francisco|Olga Tymofiyeva|415-514-4870|Olga.Tymofiyeva@ucsf.edu|
20572643|NCT00728910|University of Pennsylvania|Richard Dunbar MD|215-662-9024|richard.dunbar@uphs.upenn.edu|
20572644|NCT04155203|Padagis|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
20572645|NCT02368457|Oral and Maxillofacial Surgeon|Dr. Miriam Martos|+34932746179|miryam.martos@gmail.com|
20572646|NCT00669279|University of Florida|Dr. Benjamin J Epstein|3523590945|epstein@cop.ufl.edu|
20572647|NCT01147536|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
20548247|NCT01076231|University of Pennsylvania|Dr. Jacob Shabason|215-662-3998|susan.mazzoni@uphs.upenn.edu|
20572648|NCT00835900|Roswell Park Cancer Institute|Dr. Martin Mahoney|7168452300|martin.mahoney@roswellpark.org|
20572649|NCT01758900|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
20572650|NCT03122691|Johns Hopkins University School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20572651|NCT03762200|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
20572652|NCT00935818|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
20572653|NCT01846494|Duke Clinical Research Institute|Allison DeLong|919-668-6855|allison.delong@duke.edu|
20572654|NCT00867308|Johns Hopkins University|Amy DeZern, MD|4105027208|adezern1@jhmi.edu|
20572655|NCT00604825|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572656|NCT03465904|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|ClinicalTrial@cefaly.com|
20548248|NCT03417804|Centro Hospitalar do Porto|Dr. Simão Esteves|+351222077549|simao.esteves@me.com|
20548249|NCT00369707|Northwestern University|Leo Gordon, MD|312-695-4520|l-gordon@northwestern.edu|
20572657|NCT01506453|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
20572658|NCT00117845|National Cancer Institute, National Institutes of Health|Thomas Waldmann, M.D.|301-496-6656|tawald@mail.nih.gov|
20572659|NCT00616902|Abbott|Global Medical Services|800-633-9110||
20572660|NCT01135537|Sickkids|Dr Tal Schechter-Finkelstein|4168136906|tal.schechter-finkelstein@sickkids.ca|
20572661|NCT02680002|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
20572662|NCT00645801|retired|Director of Gastrointestinal Research||anngimd@icloud.com|
20572663|NCT00759915|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
20572664|NCT03527173|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20572665|NCT02856828|Duke University Health Systems|Dr. Rachel Reilly|919-668-0291|rachel.reilly@duke.edu|
20572666|NCT01248780|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
20572667|NCT04097301|AGC Biologics|Anna Stornaiuolo|0221277440|astornaiuolo@agcbio.com|
20572668|NCT01227577|Novartis|Study Director|862-778-8300||
20572669|NCT00107120|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Daniel Ventura, PhD|201-427-8252|daniel.ventura@frx.com|
20572670|NCT03241225|Weill Cornell Medicine|Dr. Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
20572671|NCT00852540|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572672|NCT03076333|Joint UNC/NC State Department of Biomedical Engineering|David S Lalush|919-513-7671|dslalush@ncsu.edu|
20572673|NCT00896051|Tibotec|Senior Director|+32 (0) 14 641 265||
20572674|NCT00435591|Astellas Pharma Global Development|Senior Medial Director, Medical Affairs||clinicaltrials@us.astellas.com|
20572675|NCT02618915|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
20572676|NCT01813929|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20572677|NCT00007345|National Cancer Institute|Dr. Kieron Dunleavy|301-435-1007|DunleavK@mail.nih.gov|
20572678|NCT04433585|Nektar Therapeutics|Study Director|8554828676|StudyInquiry@nektar.com|
20572679|NCT02074553|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20572680|NCT00194987|Weill MC|Dr James Bussel|917-291-5091|jbussel@med.cornell.edu|
20572681|NCT01664598|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20572682|NCT02342743|CEFALY Technology|Clinical Trials Department director|+3243676722|info@cefaly.com|
20572683|NCT04875676|Vaxart|Vice President Regulatory|(650) 747-6028|mdrayton@vaxart.com|
20572684|NCT02454179|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20572685|NCT03182725|University of California - San Diego Health|Dr. Pam Taub|858-246-2342|ptaub@health.ucsd.edu|
20572686|NCT03103763|Penobscot Bay Medical Center|Caroline Knight, RN, Clinical Research Manager|207-301-8959|cknight@pbmc.org|
20572687|NCT00938470|Mayo Clinic|Steven R Alberts MD MPH|507-284-4918|alberts.steven@mayo.edu|
20508707|NCT01296698|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20508708|NCT01975675|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20508709|NCT03639987|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20508710|NCT02157168|University of Arizona|Dr. Ada Wilkinson-Lee, Co-Investigator|(520) 626-7766|adaw@email.arizona.edu|
20508711|NCT02971293|AstraZeneca|Dr Ioannis Psallidas, MD, PhD|1-877-240-9479|Information.centre@astrazeneca.com|
20508712|NCT03104985|State Scientific Center of Laser Medicine, Russia, Moscow|Sergey Moskvin|+7-905-770-1860|7652612@mail.ru|
20508713|NCT00729326|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20508714|NCT01235728|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508715|NCT02810951|Castle Creek Biosciences|Chief Medical Officer|(484) 713-6000|medinfo@castlecreekbio.com|
20508716|NCT03199638|Nemours Children's Health|Dr Dominique Darmaun, PI|904 6973674|ddarmaun@nemours.org|
20508717|NCT01575899|Buddhist Tzu Chi General Hospital|Dr. Ming-Cheh, Chen|+886-910-521003|MingCheh_chen@tzuchi.com.tw|
20508718|NCT02807844|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20508719|NCT03097029|Children's Hospital of Philadelphia|Dr. Nina Sainath|267.426.1736|sainathn@email.chop.edu|
20508720|NCT00709124|Johns Hopkins University School of Medicine|Dr Dale Needham|(410) 955-3467|dale.needham@jhmi.edu|
20508721|NCT00373490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508722|NCT01669642|washington university in st louis|SRI SANKAR CHINTA PI|3144544661|schinta@wustl.edu|
20508723|NCT00753688|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508724|NCT00108953|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20508725|NCT01854593|Department of Ophthalmology, Surugadai Hospital of Nihon University|Dr. Ayumu Manabe|+81-3-3293-1711|ayumu.m76@gmail.com|429
20508726|NCT01125293|Dana-Farber Cancer Institute|Irene Ghobrial|617-632-4101|irene_ghobrial@dfci.harvard.edu|
20508727|NCT00936299|University of Colorado Denver|Paula Riggs, MD|303.724.2235|paula.riggs@ucdenver.edu|
20508728|NCT00659126|Oregon Health and Science University|Amy Huddleston|5034945626|huddlesa@ohsu.edu|
20572688|NCT03245151|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20572689|NCT00936741|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20548250|NCT03594435|University of California Los Angeles|Dr. Lara Ray|310-206-6756|lararay@psych.ucla.edu|
20548251|NCT02394548|Massachusetts General Hospital|Dr. Henning Willers|617-726-5184|hwillers@mgh.harvard.edu|
20572690|NCT01970345|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
20572691|NCT01552603|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
20572692|NCT00618618|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20572693|NCT01488877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572694|NCT00955253|Imperial College London|Dr Paresh Malhotra|0208 846 1234|p.malhotra@imperial.ac.uk|
20572695|NCT04797650|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20572696|NCT00309959|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
20572697|NCT02470910|DFCI/BWH|Anthony D'Amico|8572151489|adamico@bwh.harvard.edu|
20572698|NCT02947087|MUSouthCarolina|Hongjun Wang, PhD|8437921800|wangho@musc.edu|
20572699|NCT00560560|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572700|NCT01854138|ProMedica|Karl J. Beer, MD|419-578-4260|karl.beer@promedica.org|
20572701|NCT01160289|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572702|NCT01236534|University of Rochester|Andrew Goodman, MD|585-275-7854|andrew_goodman@urmc.rochester.edu|
20572703|NCT01844687|Columbia University Medical Center|Margaret Haney, PhD., Professor|(646) 774-6153|mh235@columbia.edu|
20572704|NCT01963923|Complejo Hospitalario Universitario A Coruña|Esther Gimenez Moolhuyzen|679336288|raquel.sebio@udc.es|
20572705|NCT00635427|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20572706|NCT00564889|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20572707|NCT02624791|UVa Center for Behavioral Medicine Research|Project Coordinator|434-924-8656|tab2v@hscmail.mcc.virginia.edu|
20572708|NCT00998790|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
20572709|NCT01993927|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20572710|NCT00287690|Imperial College London|Dr Carolyn Webb|+44 3301288121|c.webb@imperial.ac.uk|
20572711|NCT02478710|Premier Health|Director of Clinical Research|19374747850|jllader@premierhealth.com|
20572712|NCT04822597|University of Wisconsin School of Medicine and Public Health|Heather B Neuman, MD, MS, FACS|(608) 263-7064|neuman@surgery.wisc.edu|
20572713|NCT03406078|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
20572714|NCT00591851|Memorial Sloan-Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
20572715|NCT03387137|Johns Hopkins University Bloomberg School of Public Health|Suzanne Woods, CRNP-P, CCRP, Manager, RSVPeds Team|(410) 614-1880|swoods12@jhu.edu|
20572716|NCT05593445|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20572717|NCT05559476|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20572718|NCT05110690|Washington University School of Medicine|Michael Avidan, MBBCh, FCASA|314-273-4136|avidanm@wustl.edu|
20572719|NCT03647488|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20572720|NCT00812331|Janssen Research & Development United States|Global Clinical DVLP Manager||ClinicalTrialDisclosure@its.jnj.com|
20572721|NCT03694275|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20572722|NCT01783847|Iran university of Medical Sciences|Mohsen Bahmani Kashkouli|00989121777003|mkashkouli2@gmail.com|
20572723|NCT00153062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20572724|NCT01304238|GlaxoSmithKline|GSK Response Cente|866-435-7343||
20572725|NCT02340767|National Dental PBRN|Dr. Sonia Makhija|2059965298|smakhija@uab.edu|
20572726|NCT01589237|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20572727|NCT01621737|UCSD|David Feifel|(858) 412-4130|dfeifel@kadimanp.com|
20572728|NCT01022268|Imperial College London|Dr Jethro Herberg|+44 - 0207 594 3990|j.herberg@imperial.ac.uk|
20572729|NCT00734097|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20572730|NCT00910689|Ohio University|Kenneth Holroyd|(740) 593-1085|holroyd@ohio.edu|
20572731|NCT01764685|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
20572732|NCT03207009|bluebird bio, Inc|Study Medical Director|+1-833-999-6378|clinicaltrials@bluebirdbio.com|
20572733|NCT01877837|Hackensack Meridian Health|Elana Smilow|5519965673|Elana.Smilow@hmhn.org|
20572734|NCT04259645|UPMC Department of Anesthesiology and Perioperative Medicine|Anna Uskova, MD|412-623-2167|uskoaa@upmc.edu|
20572735|NCT00932113|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
20572736|NCT01773291|Kaohsiung Chang Gung Memorial Hospital|Wen-Long Hu, Deputy Director, Department of Chinese Medicine|+886-7-7317123|oolonghu@gmail.com|2334
20572737|NCT02480153|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572738|NCT01403610|UT Health San Antonio|Andrew Brenner|210-450-1000|regulatoryaffairs@uthscsa.edu|
20572739|NCT00203476|TuscaloosaREAC|Raela Williford, PharmD|(205) 554-2000|Raela.Williford@va.gov|2433
20572740|NCT01190514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20548252|NCT04562792|Children's Mercy|Dr. Alan Gamis|816-302-6808|agamis@cmh.edu|
20572741|NCT02080312|UCSD|Julie Bykowski|619-543-6766|jbykowski@ucsd.edu|
20572742|NCT02550470|Rutgers - New Jersey Medical School|Dr. Eloy, PI|973 972 5007|eloyje@njms.rutgers.edu|
20548253|NCT03605212|Menarini Group|Angela Capriati, MD PhD - Corporate Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
20548254|NCT01254292|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20548255|NCT02083081|Mayo Clinic|Christi Patten PhD|507-538-7370|patten.christi@mayo.edu|
20572743|NCT01775475|AIDS Malignancy Consortium Statistical and Data Analysis Center|Study Statistician|(212) 659-9558|amcpm@emmes.com|
20572744|NCT01346475|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
20572745|NCT00703937|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20572746|NCT03840915|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20572747|NCT00700258|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572748|NCT00473265|Columbia University Medical Center|John P. Bilezikian MD|212-305-2663|jpb2@columbia.edu|
20572749|NCT01156792|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548256|NCT02263131|The Catholic University of Korea, Seoul St. Mary's Hospital|Dr. Kang Jin Han|+82-10-4251-8375|kjhan@catholic.ac.kr|
20548257|NCT01230710|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20572750|NCT01097707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572751|NCT03212989|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-6712|cynthia_gay@med.unc.edu|
20572752|NCT02876159|Emory University|Dr. Mark J. Mulligan, M.D., F.I.D.S.A|404-712-1370|mmulli2@emory.edu|
20572753|NCT02235831|Alcon Research, Ltd.|Sr. Global Brand Lead, GCRA, Vision Care|1-888-451-3937||
20572754|NCT02029872|Johns Hopkins University School of Nursing|Dr. Jason Farley|4105027563|jfarley1@jhu.edu|
20572755|NCT03699085|University of Washington|Lauren Whiteside, Primary Investigator|206-744-8464|laurenkw@uw.edu|
20572756|NCT03568331|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
20572757|NCT04638920|University Hospital Zurich|Prof. Malcolm Kohler, Sponsor-Investigator|+41442551111|malcolm.kohler@usz.ch|
20572758|NCT05383508|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20572759|NCT03139669|University of Virginia|Dr. Emma Mitchell Associate Professor|4342433962|emm6z@virginia.edu|
20572760|NCT03775434|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20572761|NCT01621568|National Cancer Institute|Dr. Arun Rajan|240-760-6236|rajana@mail.nih.gov|
20572762|NCT01859988|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
20572763|NCT02065687|NRG Oncology|Christopher Purdy on behalf of Michael Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20572764|NCT00580645|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
20572765|NCT01157676|University of Miami|Dipen Parekh, MD|305 243 6591|parekhd@miami.med.edu|
20572766|NCT00682890|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
20572767|NCT01721460|University od Wisconsin - Madison|Dr. Aeyal Raz|608-263-8100|raz@wisc.edu|
20572768|NCT03028220|Imperial College London|Prof Nick Oliver|02075942460|nick.oliver@imperial.ac.uk|
20572769|NCT00141219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20572770|NCT01506609|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20572771|NCT01710891|MinneapolisMRF|Brian Driver|6128739528|Brian.Driver@hcmed.org|
20527744|NCT04942210|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
20527745|NCT03688802|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20572772|NCT02261597|Beth Israel Deaconess Medical Center, Harvard Medical School|Dr. Monika Haack|617-667-5234|mhaack@bidmc.harvard.edu|
20527746|NCT05697627|University of Michigan|Hannah Becker|(734) 764-2580|hcbecker@umich.edu|
20572773|NCT01324440|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20572774|NCT02884908|University of Maryland School of Medicine|Dr. Melanie Bennett|4107060892|mbennett@som.umaryland.edu|
20572775|NCT00938860|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20572776|NCT01605019|Houston Methodist Research Institute|Raquel R Bunge|713-441-3912|rrbunge2@houstonmethodist.org|
20572777|NCT01464840|University of Alabama at Birmingham|Amelia Sutton, M.D., Ph.D.|205-934-5612|alsutton@uab.edu|
20572778|NCT00468559|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20572779|NCT00324116|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20556636|NCT00337272|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20556637|NCT03043079|University of Pennsylvania|Dr. John P Fischer|2156627300|john.fischer2@uphs.upenn.edu|
20556638|NCT04539821|VA Connecticut Healthcare System|Dr. Brent Moore|203-435-2243|brent.moore@va.gov|
20556639|NCT04635579|University of Washington|Dr Scott Telfer|2062292022|telfers@uw.edu|
20556640|NCT01127646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556641|NCT03466086|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
20556642|NCT01754467|Northwestern University|Christine Pellegrini, PhD|312-503-1395|c-pellegrini@northwestern.edu|
20556643|NCT01970462|Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
20556644|NCT00162370|Lantheus Medical Imaging|Director, Clinical Operations|978-671-8118|Sandra.Monte@lantheus.com|
20556645|NCT00774579|Imperial College Healthcare London|Prof. Desmond Johnston|020 3312 1253|desmond.johnston@imperial.ac.uk|
20556646|NCT01499082|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20556647|NCT01786967|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
20556648|NCT05380947|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20556649|NCT01563536|AbbVie|Global Medical Services|800-633-9110||
20556650|NCT01270126|Otto-von-Guericke University of Magdeburg, Medical Faculty, Institute of Medical Psychology, Magdeburg, Germany|Prof. Bernhard A. Sabel|0049 3916721800|bernhard.sabel@med.ovgu.de|
20556651|NCT01188109|Emory University|Shishir K. Maithel, MD|404-778-1900|smaithe@emory.edu|
20556652|NCT00538590|Hospital of Universität Köln|Thomas Dietlein, Ph. D., MD|+49 221 4785862|thomas.dietlein@uk-koeln.de|4300
20556653|NCT06030414|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
20556654|NCT01352598|Mercy|Jaymeson Stroud, MD|314-251-6844|Jaymeson.Stroud@mercy.net|
20556655|NCT01723722|Eastern Maine Medical Center|Dr Mark S Brown|207-973-8670|mbrown@emh.org|
20556656|NCT01169675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20556657|NCT02354664|University of Florida|Barbara Smith, Assistant Professor|352-294-5315|bksmith@phhp.ufl.edu|
20556658|NCT02816138|Vanderbilt University Medical Center|Warren D. Taylor, MD|6153221073|warren.d.taylor@vanderbilt.edu|
20556659|NCT02355028|Alcon, A Novartis Division|Clinical Scientist, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
20556660|NCT02276222|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20556661|NCT04102579|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20556662|NCT05899686|UCaliforniaSF|Pekka Talke|4153063602|pekka.talke@ucsf.edu|
20556663|NCT00572195|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
20556664|NCT01525602|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20556665|NCT02412137|Texas Scottish Rite Hospital for Children|Dr. Brandon Ramo|2145597755|brandon.ramo@tsrh.org|
20556666|NCT04913363|University of Virginia|Jennifer Roe|434-982-4567|jjr4b@virginia.edu|
20556667|NCT04506970|Mayo Clinic|Mauro Schenone|5072840210|schenone.mauro@mayo.edu|
20556668|NCT02532179|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20556669|NCT00806234|Johns Hopkins University|Dr. Mark Riddle|410-302-6120|mriddle1@jhmi.edu|
20556670|NCT02240108|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
20556671|NCT00789815|Chung Gung Memorial Hospital|Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
20556672|NCT00119405|Case Western Reserve University|Grace McComsey|216-844-3607|mccomsey.grace@clevelandactu.org|
20556673|NCT00800839|The University of Texas (UT) MD Anderson Cancer Center|Amin M. Alousi, MD/Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
20556674|NCT04676425|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556675|NCT04958785|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230|GileadClinicalTrials@gilead.com|GILEAD-0
20556676|NCT01224925|UiT The Arctic University of Norway (Tromsø university)|Associate professor Rita Kundzina|+4777649118|rita.kundzina@uit.no|
20556677|NCT00791843|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
20556678|NCT02018445|SeaSpine|Sara Tish Mikoczi|760-216-5652|tish.mikoczi@seaspine.com|
20556679|NCT00245102|Memorial Sloan-Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
20572780|NCT02703259|Christiana Care Health Systems|Dr. Terri Huynh|302-623-4410|terri.huynh@christianacare.org|
20556680|NCT01139190|PLx Pharma LLC|Ronald Zimmerman, CEO & President|713-842-1249|ron.zimmerman@plxpharma.com|205
20556681|NCT02293395|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20556682|NCT04639193|University of California San Diego|Dr Chris Schmickl|8582462154|cschmickl@health.ucsd.edu|
20572781|NCT00662818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20572782|NCT01642251|ECOG-ACRIN Cancer Research Group|Study Statistician||eatrials@jimmy.harvard.edu|
20572783|NCT01302860|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20572784|NCT00895154|Washington University|Dr. Allison King|314-454-4291|king_a@wustl.edu|
20572785|NCT03988920|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20572786|NCT01605916|Biometrics Department, Science Affairs Division, R&D, Astrazeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
20572787|NCT00540046|Basic Health International|Miriam Cremer MD MPH|(646) 593-8694|miriam.cremer@gmail.com|
20572788|NCT01021215|University of Texas (UT) MD Anderson Cancer|Dr. Powel H. Brown, MD Anderson Phase I/II Prevention Consortium|(713) 745-3672|CR_Study_Registration@mdanderson.org|
20572789|NCT01103362|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20572790|NCT02533531|LifeWatch Services, Inc.|Paul Hanneman|1 847 720 2231|Phanneman@gobio.com|
20572791|NCT02047903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20572792|NCT01942590|Duke University Health System|Dwight Koeberl, M.D., Ph.D.|919-684-2036|dwight.koeberl@duke.edu|
20572793|NCT01688830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20572794|NCT01285609|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20572795|NCT02502799|Florida International University|Dr. William E. Pelham Jr.|305-348-3002|wpelham@fiu.edu|
20572796|NCT03706313|Duke University|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
20572797|NCT00690040|Hemek Medical center|Dr. Raed Salim|97246494031|salim_ra@clalit.org.il|
20572798|NCT03029351|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
20572799|NCT01290029|Amgen Inc.|Study Director|866-572-6436||
20572800|NCT02924428|Venus Concept Ltd.|Director, Clinical Affairs|416-222-6144|mgronski@venusconcept.com|517
20572801|NCT00504660|UT MD Anderson Cancer Center|Charles A. Conrad, MD / Professor|713-745-1896|skang@mdanderson.org|
20572802|NCT00512317|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20572803|NCT01491672|Novartis|Study Director|862-778-8300||
20572804|NCT04390022|Barcelona Institute for Global Health|Carlos Chaccour|0034666293112|carlos.chaccour@isglobal.org|
20572805|NCT03064035|Methodist Hospital|Zachary Stoecker, PharmD|952-977-5520|Zachary.Stoecker@parknicollet.com|
20572806|NCT01143038|Amgen Inc.|Study Director|866-572-6436||
20572807|NCT02336178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572808|NCT00618982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20572809|NCT03310268|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20572810|NCT03346161|Washington University School of Medicine|Mary C. Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
20572811|NCT01197833|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
20572812|NCT00706433|Dusa Pharmaceuticals, Inc.|Anna Houlihan||houlihana@dusapharma.com|
20572813|NCT01035073|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
20572814|NCT01236365|Nemours Children's Clinic|Nelly Mauras, MD|904-697-3674|nmauras@nemours.org|
20572815|NCT04289051|Sunstar Americas, Inc.|Akane Takemura|18477944276|akane.takemura@us.sunstar.com|
20572816|NCT01183234|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20572817|NCT00822172|CPC Clinical Research|William Hiatt, MD, President|3038609900|william.hiatt@cpcmed.org|
20572818|NCT00545051|Hoffmannb-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20572819|NCT01375114|UT MD Anderson Cancer Center|Dr. Sriram Yennu, MD-Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20572820|NCT01888900|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Marc Ghany|301-402-5515|marcg@mail.nih.gov|
20572821|NCT03271021|Foamix Pharmaceuticals|Senior Director, Clinical Operations|9089630117|kendra.gulbronson@foamix.com|
20572822|NCT04955444|The Methodist Hospital Research Institute|Elsie Rizk|7134412557|erizk@houstonmethodist.org|
20572823|NCT03606668|NYU Langone Health|Leigh Charvet, PhD|(929) 455-5141|Leigh.Charvet@nyulangone.org|
20572824|NCT00952120|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
20572825|NCT00495586|CAMFIC|Carl Llor|+34 3011777|carles.llor@urv.cat|
20572826|NCT03038438|Medtronic|Stephanie Cihlar|763.258.9524|stephanie.a.cihlar@medtronic.com|
20572827|NCT03215810|Moffitt Cancer Center|Ben Creelan, MD|813-745-4541|ben.creelan@moffitt.org|
20572828|NCT00992433|Baylor College of Medicine|Hana El Sahly, MD|713-798-2058|hanae@bcm.edu|
20572829|NCT02038543|Mayo Clinic|Dr. John C. Lieske|507-284-2064|Lieske.John@mayo.edu|
20572830|NCT03406260|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20572831|NCT02647866|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20572832|NCT03098420|University of Alabama at Birmingham|Dr. Joel Feinstein|205-934-4696|jfeinstein@uabmc.edu|
20572833|NCT01029652|Novartis Pharmaceuticals|Study Director|862 778-8300||
20572834|NCT02318992|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
20572835|NCT02313233|Kaohsiung Municipal TA- TUNG Hospital|Dr. Ching- Chia Li|886-7-291-1101||
20572836|NCT02095951|Wayne State University School of Medicine - Children's Hosp. of Michigan|Eric McGrath, MD|313-745-5862|emcgrath@med.wayne.edu|
20572837|NCT03618823|UPMC Children's Hospital of Pittsbugh|Senior Research Associate|1412-692-9879|nelsonjl2@upmc.edu|
20572838|NCT02399254|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD|860-714-4055|RZuWalla@TrinityHealthOfNE.org|
20527747|NCT02570750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572839|NCT02930226|University of Cincinnati|Jose A. Cancelas, M.D., Ph.D.|513-558-1324|Jose.Cancelas@cchmc.org|
20572840|NCT01096823|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|(310) 825-0731|LZeltzer@mednet.ucla.edu|
20527748|NCT04122625|Debiopharm International S.A.|Head Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20527749|NCT01410240|Baxter BioScience|Maurice Bagot D'Arc, MD, Sr Medical Director Medical Affairs , BioSurgery||maurice_bagot_d'arc@baxter.com|
20527750|NCT04348500|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
20527751|NCT02776670|Alcon, A Novartis Division|Head, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20527752|NCT00895934|Fred Hutchinson Cancer Research Center|Roland B. Walter, MD, PhD|206-667-3599|rwalter@fhcrc.org|
20527753|NCT02636699|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
20527754|NCT00624832|Novartis Pharmaceuticals|Study Director|862-778-8300||
20527755|NCT04379700|NYU Langone Health|Bedros Taslakian, MD|212-263-5898|bedros.taslakian@nyulangone.org|
20527756|NCT04595279|Johns Hopkins University|Matthew Johnson|410-550-0056|mwj@jhu.edu|
20527757|NCT03624569|The Ohio State University|Richard Bruno, Principal Investigator|6142925522|bruno.27@osu.edu|
20527758|NCT00957424|Roswell Park Cancer Institute|Richard O'Connor|716-845-4517|richard.oconnor@roswellpark.org|
20527759|NCT01038752|Optimum Therapeutics|Dr. M. Guillaume Wientjes||gwientjes@optimumtx.com|
20527760|NCT02053259|Arizona State University|Dr. Marc Adams|602-827-2470|marc.adams@asu.edu|
20527761|NCT00703118|Tibotec|Medical Leader|1 609 730-3174||
20527762|NCT00591019|University of Arkansas for Medical Sciences (UAMS)|Dr John Dornhoffer|501 686-5140|dornhofferjohnl@uams.edu|
20527763|NCT03714776|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
20527764|NCT00212264|University of Alabama at Birmingham|Patricia S Goode, MD|2055587064|pgoode@uabmc.edu|
20527765|NCT02051335|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20527766|NCT00595101|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20527767|NCT01578499|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20527768|NCT04100590|New York State Psychiatric Institute|Caroline A Arout, PhD|646-774-6167|caroline.arout@nyspi.columbia.edu|
20508729|NCT00260429|Auxilium Pharmaceuticals, Inc.|Greg Kaufman, MD; Senior Director of Clinical Development|484 321 5900|gkaufman@auxilium.com|5920
20508730|NCT01324687|University of Rochester|Manish N. Shah|585-276-6565|manish_shah@urmc.rochester.edu|
20527769|NCT03884985|University of Rochester|Martina Poletti|(585) 275-4801|martina_poletti@urmc.rochester.edu|
20527770|NCT02664922|University of California, Los Angeles|Jennifer Scovotti|310.206.4484|jscovotti@mednet.ucla.edu|
20572841|NCT00577473|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20572842|NCT01580423|Dartmouth-Hitchcock Medical Center|Donald A. Mahler|603 650-5533|Donald.a.mahler@hitchcock.org|
20572843|NCT02595073|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20572844|NCT01990560|Ichan School of Medicine at Mount Sinai|Dr. Alice C. Levine|212-241-1500|alice.levine@mountsinai.org|
20572845|NCT00732225|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20572846|NCT01801735|Iroko Pharmaceuticals, LLC|Alexis Gomez, Director of Clinical Operations|267-546-1426|agomez@iroko.com|
20572847|NCT02084056|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20572848|NCT04080908|NYU Langone Health|Stuart Katz|2122633946|Stuart.Katz@nyulangone.org|
20572849|NCT01293487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572850|NCT01975974|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
20572851|NCT01153958|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20572852|NCT03954392|Vanderbilt University|Judy Garber, Ph.D., Professor of Psychology and Human Development|16153305605|judy.garber@vanderbilt.edu; jgarber.vanderbilt@gmail.com|
20572853|NCT01226095|Abbott|Global Medical Services|800-633-9110||
20572854|NCT03283072|University of Florida|Mark Bishop|3522736112|bish@ufl.edu|
20572855|NCT02552368|Washington University School of Medicine - Department of Neurology|Dr. Thy Huskey|314-362-4503|huskeyt@wustl.edu|
20572856|NCT00911768|Kyung Hee East-West Neo Medical Center|Jae-Woo Park, KMD, PhD|+082-02-440-6219|pjw2907@khu.ac.kr|
20572857|NCT02734953|Allegheny Health Network|Dr Raymond Benza|412-359-3131|raymond.benza@ahn.org|
20572858|NCT00467350|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343000|mmiller@cmh.edu|
20572859|NCT03616977|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20572860|NCT00515853|University of Southampton|Sophie A. Pilkington|+44 (0)23 8059 5058|rgioinfo@soton.ac.uk|
20572861|NCT04041453|Universidad Nacional de Salta|Alejandro J Krolewiecki|+54 911 3183-8673|alekrol@hotmail.com|
20572862|NCT02819557|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20572863|NCT02631577|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20572864|NCT00979134|AstraZeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
20572865|NCT01007643|University of Manitoba|Dr Erika Persson|780-492-4752|epersson@ualberta.ca|
20572866|NCT01710332|Mid Atlantic Retina|Allen C. Ho, MD|215-459-0477|mformoso@midatlanticretina.com|
20572867|NCT02359877|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20572868|NCT02110147|Wellstat Therapeutics Corporation|Wellstat Medical Information|800.914.0071|medinfo@wellstat.com|
20572869|NCT00189488|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
20572870|NCT02349425|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20572871|NCT02186223|Bio2 Medical, Inc.|Chief Medical Officer|720-833-5675|langel@bio2medical.com|
20572872|NCT00252733|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
20572873|NCT00717067|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20572874|NCT02090959|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20572875|NCT03480217|Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center|Ian Kronish|212-342-1335|ik2293@columbia.edu|
20572876|NCT02808143|Northwestern University Feinberg School of Medicine|Joshua Meeks, MD, PhD|312-363-8959|Joshua.meeks@northwestern.edu|
20572877|NCT00522873|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20572878|NCT00657020|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572879|NCT02190045|CAVHS/ UAMS|Kalpana Padala, MD|501-257-1000|kppadala@uams.edu|
20572880|NCT02029846|Johns Hopkins University|Dr. Hsin-Chieh Yeh|410-614-4316|hyeh1@jhmi.edu|
20572881|NCT02966301|MEDSENIC|RIEGER François - CEO - Scientific Director|+33671733159|fr@medsenic.org|
20572882|NCT02561754|University of Kansas Medical Center|Dr. Joseph Donnelly|785-864-3880|jdonnelly@ku.edu|
20572883|NCT02349646|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
20572884|NCT00832637|University of New Mexico|Yehuda Patt, MD|5059250405|yzpatt@salud.unm.edu|
20572885|NCT00370331|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572886|NCT01874431|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20572887|NCT02367820|Nektar Therapeutics|Medical Affairs|855-482-8676|StudyInquiry@nektar.com|
20572888|NCT01336803|Stanford University|Heike Daldrup-Link|650-723-8996|heiked@stanford.edu|
20572889|NCT02937454|Vifor (International) AG.|FER-CARS-06 Clinical Study Team|+41 588 518 000|FER-CARS-06.study@viforpharma.com|
20572890|NCT01879059|University of Kansas Medical Center|John P. Thyfault, PhD|913-588-1790|jthyfault@kumc.edu|
20572891|NCT01474434|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20572892|NCT02192879|Duke University Medical Center|Elizabeth Malinzak, MD|919-681-9660|elizabeth.malinzak@duke.edu|
20572893|NCT00993668|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
20572894|NCT02207569|Medtronic|Kristin Smith|763-526-3095|kristin.m.smith@medtronic.com|
20572895|NCT01833845|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|104
20572896|NCT01014143|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20572897|NCT00944073|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
20572898|NCT00523640|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20508731|NCT03383627|Northwell Health|Lubaina Presswala, DO|516-708-2540|lpresswala@northwell.edu|
20572899|NCT00652327|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20572900|NCT01076647|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20548258|NCT02905149|Instituto de Investigación Sanitaria La Fe|Maria Cortell|961246611|investigacion_clinica@iislafe.es|
20548259|NCT03277690|Cortendo AB|Xeris Medical Director|+1 610-254-9200|LOGICS@cortendo.com|
20548260|NCT00747812|Boston Scientific|Lyn Pimentel, Clinical Project Manager|(661) 949-4174|Lyn.Pimentel@bsci.com|
20548261|NCT01708161|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
20548262|NCT04856891|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20548263|NCT01147172|Anika Therapeutics|Adrian Orr, Director Clinical Affairs|781.457.9000|aorr@anikatherapeutics.com|
20572901|NCT00920075|Medical University of South Carolina|Deborah A Bowlby, Asst.Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
20548264|NCT04048122|Washington University School of Medicine|Dr. Erin Foster|314-286-1638|erfoster@wustl.edu|
20548265|NCT02484287|University of Oklahoma Health Science Center|Blair Apple|4052714658|Blair-Apple@ouhsc.edu|1
20572902|NCT04595318|Montefiore Health System|Dr. Shadi Nahvi|718 920 5379|snahvi@montefiore.org|
20572903|NCT03814031|Henry Ford Hospital|Yoshihisa Morita|3059784358|YOSHIHISA.MORITA@JEFFERSON.EDU|
20572904|NCT02081417|Department of Psychiatry and Behavioral Sciences, University of New Mexico|Annette Crisanti, PhD|505-850-7430|acrisanti@salud.unm.edu|
20548266|NCT04209348|The University of Tennessee, Knoxville|Dr. Samantha Ehrlich|510 299 8747|sehrlic1@utk.edu|
20572905|NCT00297596|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
20572906|NCT01577745|MedImmune, LLC|Mohammed Dar|301-398-1008|information.center@astrazeneca.com|
20572907|NCT02450799|Alcon, A Novartis Division|Phase IV, Clinical and Regulatory Affairs, Alcon Japan|1-888-451-3937|alcon.medinfo@alcon.com|
20572908|NCT00862719|IndianaU|Dr. Sherif Farag|317-944-0920|ssfarag@iu.edu|
20572909|NCT01737827|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20572910|NCT01451827|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20572911|NCT01856868|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
20572912|NCT01034163|Novartis|Study Director|862-778-8300||
20572913|NCT02424734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572914|NCT00528645|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
20572915|NCT01445301|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572916|NCT00752557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572917|NCT02150343|Circassia Ltd|VP Clinical Operations|+44 1865 405560|kirsten.evans@circassia.com|
20572918|NCT02729753|C2 Therapeutics|Marcia Wachna, Director of Clinical Research||marcia@c2therapeutics.com|
20572919|NCT01090427|Janssen Research & Development, LLC|VICE PRESIDENT IMMUNOLOGY||ClinicalTrialDisclosure@its.jnj.com|
20572920|NCT01154010|Massachusetts Eye and Ear Infirmary|Director of the Ocular Immunology and Uveitis Service|617-573-5549|George_Papaliodis@meei.harvard.edu|
20572921|NCT03294148|Weill Cornell Medicine|Dr. Yoni Ashar|(646) 962-2820|joa9188@med.cornell.edu|
20572922|NCT02073747|University Medical Center of Southern Nevada|Emergency Department Research Coordinator|702-224-7124|wesley.forred@umcsn.com|
20572923|NCT02413333|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20572924|NCT01465347|Diffusion Pharmaceuticals Inc|Chief Executive Officer|(434) 220-0718|DKalergis@diffusionpharma.com|
20572925|NCT02996474|National Heart Lung and Blood Institute|Christopher Hourigan|+1 301 451 0257|christopher.hourigan@nih.gov|
20572926|NCT04493502|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20572927|NCT02891837|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
20572928|NCT01588431|UT Health San Antonio|Anand Karnad, MD|210-450-1267|karnad@uthscsa.edu|
20572929|NCT02632526|AstraZeneca AB|A study to assess the safety, tolerability, pharmacokinetics & dynamics of AZD5718 in healthy male||ClinicalTrialTransparency@astrazeneca.com|
20572930|NCT01048671|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20572931|NCT00060424|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
20572932|NCT00312923|Rush University Medical Center|Barbara Swanson|312-942-8977|barbara_a_swanson@rush.edu|
20572933|NCT03538301|Nitto Denko Corporation|Nitto Denko Corporation Study Director|858-255-3010|clinicaltrialinfo005@nitto.com|
20572934|NCT03965351|Cincinnati Children's Hospital Medical Center|Mary Banks|513-636-2147|mary.banks@cchmc.org|
20572935|NCT00943111|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20572936|NCT02859324|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20572937|NCT05652647|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548267|NCT02396251|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
20548268|NCT02617784|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20556683|NCT01023568|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20556684|NCT00224770|Johns Hopkins University|Dr. Daniel F. Hanley|(410) 614-6996|dhanley@jhmi.edu|
20556685|NCT01106430|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20556686|NCT01341977|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20556687|NCT00297115|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20556688|NCT02124889|WakeForest|Dr. Adolfo Fernandez|336-716-6099|afernand@wakehealth.edu|336
20556689|NCT02472652|Thomas D Gazda MD PC|Thomas D Gazda MD|480 518 6299|goodgazda@yahoo.com|
20556690|NCT01083641|University of Wisconsin Carbone Cancer Center|Dr. Kari Wisinski|608-262-2876|kbwisinski@medicine.wisc.edu|
20556691|NCT03439189|Exalenz Bioscience|Clinical trial manager|00 972 546605412|avrahamh@exalenz.com|
20556692|NCT03412812|University of Alabama at Birmingham|Dr. John Fiveash|205-975-0224|jfiveash@uabmc.edu|
20556693|NCT01777321|GlaxoSmithKline|GSK Response Center|866-435-7343||
20572938|NCT05326815|The Cleveland Clinic Foundation|Kim Jenkins|216-445-4791|jenkink@ccf.org|
20572939|NCT05917470|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
20572940|NCT00715754|University of Utah|Laurie Moyer-Mileur|801/587-7488|Laurie.Moyer-Mileur@hsc.utah.edu|
20572941|NCT02334423|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
20572942|NCT02765802|Eiger BioPharmaceuticals, Inc|SVP, Clinical Development|1-650-618-1621|info@eigerbio.com|
20572943|NCT02926898|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20572944|NCT02292927|Imperial Colege London|Colin Bicknell|02033126072|alison.deslandes@imperial.nhs.uk|
20572945|NCT00568802|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
20572946|NCT01039792|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
20572947|NCT01656733|University of Connecticut School of Medicine|Cheryl Oncken, MD, MPH|860-679-3425|oncken@uchc.edu|
20572948|NCT01065844|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
20572949|NCT02224690|GW Research Ltd.|Medical Enquires||medinfo.USA@gwpharm.com, medinfo@greenwichbiosciences.com|
20548269|NCT05055128|Cinclus Pharma Holding AB|Kajsa Larsson, MD, PhD|+46 70 675 01 28|kajsa.larsson@cincluspharma.com|
20572950|NCT00825916|Capstone Therapeutics|Denise Lamon, Director of Regulatory Affairs|800-937-5520|dlamon@capstonethx.com|5206
20572951|NCT02962960|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
20572952|NCT02054741|University of Rochester, Medical Center|Dr. Supriya Mohile, Professor of Medicine|585-275-0394|URCC_GAP70@urmc.rochester.edu|
20572953|NCT02489123|University of Washington|Ajay K. Gopal, MD|206-606-2037|agopal@uw.edu|
20572954|NCT04299438|University of Pennsylvania|Dr. Jennifer McCoy|215 662 4000|jennifer.mccoy@pennmedicine.upenn.edu|
20548270|NCT00273910|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20548271|NCT00936611|Dana-Farber Cancer Institute|Irene Ghobrial|6176324101|irene_ghobrial@dfci.harvard.edu|
20548272|NCT01783054|Medical University of South Carolina|Eric Kimchi, MD|842-792-4271|kimchi@musc.edu|
20548273|NCT02497300|University of Alabama at Birmingham|Eric Judd|205 934-9509|ejudd@uab.edu|
20548274|NCT01822496|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20548275|NCT02081183|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20548276|NCT00543543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548277|NCT04308304|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548278|NCT00945555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548279|NCT00834678|The Ohio State University Comprehensive Cancer Center|Rachel Layman, MD|614-366-8541|Rachel.Layman@osumc.edu|
20548280|NCT04502979|University of North Carolina at Chapel Hill|Eric A Hodges, PhD, FNC-BC, FAAN|919-966-0534|eahodges@email.unc.edu|
20548281|NCT03318900|M D Anderson Cancer Center|Amir A. Jazaeri, MD|713-792-2921|aajazaeri@mdanderson.org|
20548282|NCT00772304|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20548283|NCT00165984|Emory University|Paul Kirshbom|404-785-6330|pkirshb@emory.edu|
20548284|NCT03945266|Pennsylvania State University|Dr. Abigail Pauley|814-863-7354|amp34@psu.edu|
20548285|NCT01686828|University of Washington|Dr. Katya Rubinow|206-7543-3470|rubinow@uw.edu|
20548286|NCT03750461|Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH Geisel School of Medicine, Hanover, NH|Matthew Z. Wilson, MD MSc FACS FASCRS|(603) 650-8113|Matthew.Z.Wilson@hitchcock.org|
20572955|NCT04223830|Boston Scientific|Victoria Lazzari|508-382-9132|victoria.lazzari@bsci.com|
20548287|NCT01736124|James J. Peters Veterans Affairs Medical Center|Dr. Jeremy Silverman|718-584-9000|jeremy.silverman@va.gov; jeremy.silverman@mssm.edu|1700
20548288|NCT02734433|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20548289|NCT02628769|Imperial College London|Louise Donnelly|+44 02075947895|l.donnelly@imperial.ac.uk|
20548290|NCT03242824|Mayo Clinic|Nadia N. Laack, MD, MS|507/284-2511|Laack.Nadia@mayo.edu|
20548291|NCT03882788|Research Office|Clinical Trials Manager|650-724-1720|clinicaltrials-gov@stanford.edu|
20548292|NCT03698331|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20548293|NCT06033521|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548294|NCT01467583|Harper University Hospital|Krista Wahby, Critical Care Pharmacist in the Medical ICU|313-745-2711|kwahby@dmc.org|
20548295|NCT02130024|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20548296|NCT03727425|Auris Health, Inc.|Scott Rehage|9256832590|scott.rehage@aurishealth.com|
20548297|NCT02717273|University of Virginia|Robert Sawyer|4349821632|rws2k@virginia.edu|
20548298|NCT05274165|Sonova USCS|Senior Research Audiologist|630-821-5000|phonakaudiologyresearch@gmail.com|
20548299|NCT02127723|Q-Med AB|Q-Med AB|+46 18 474 9000|medicalinfo.q-med@alderma.com|
20548300|NCT04294277|EAU Research Foundation|Dr. Wim Witjes|31263890677|w.witjes@uroweb.org|
20548301|NCT03350620|Vyluma, Inc|VP of Clinical Development|9083677400|info@vyluma.com|
20572956|NCT01806623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556694|NCT03837509|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20556695|NCT04280653|Mati Therapeutics Inc.|Deepank Utkhede|778-991-3301|dutkhede@matitherapeutics.com|
20556696|NCT00455975|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
20556697|NCT05131165|RAND Corporation|Sebastian Linnemayr|310-393-0411|slinnema@rand.org|6734
20556698|NCT01267292|The University of Texas Health Science Center at Houston|Scott Lane, PhD|713-486-2535|Scott.D.Lane@uth.tmc.edu|
20556699|NCT01478009|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Chang-Seop Lee|82-63-276-8284|lcsmd@jbnu.ac.kr|
20556700|NCT02298361|OCHIN, Inc.|Jennifer E. DeVoe, MD, DPhil|503-943-2618|devoej@ohsu.edu|
20556701|NCT01798394|University of Minnesota|Nicole Tosun|612-624-5439|tosun004@umn.edu|
20548302|NCT03507400|Practice for Neurology and Ludwigs-Maximilians-Universitiy Munich|Dr. Monika Empl|+4989500598710|dr.empl@dr-empl-neurologie.de|
20556702|NCT03247790|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20548303|NCT01555983|UC Davis (currently at UC San Diego)|Barth Wilsey MD|916-402-2270|bwilsey@ucsd.edu|
20548304|NCT02353754|Pacira Pharmaceuticals Inc.|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
20548305|NCT02475031|Indiana University School of Medicine - Anesthesia Division|Dr. Yar Yeap|317-274-0275|yyeap@iupui.edu|
20548306|NCT02495831|CROSS REsearch SA|Dr. Milko Radicioni|+41.91.63.00|clinic@croalliance.com|510
20548307|NCT02008318|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20548308|NCT00573183|Univerity of Washington Alcohol & Drug Abuse Institute|Dr. Dennis Donovan|206-543-0937|ddonovan@u.washington.edu|
20548309|NCT05439941|Evelo Biosciences, Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
20548310|NCT02336373|Baylor College of Medicine|Vivien Sheehan, MD, PhD|(832) 824-4459|vxsheeha@txch.org|
20548311|NCT00726375|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-615-5707|sungchoi@umich.edu|
20548312|NCT02022020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20548313|NCT01926015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548314|NCT01364649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20548315|NCT00902668|Virginia Commonwealth University|Laurie W. Cuttino, MD|804-828-7232|LCuttino@mcvh-vcu.edu|
20548316|NCT01788046|Amgen Inc.|Study Director|866-572-6436||
20548317|NCT02765269|Xinhua Translational Institute for Cancer Pain, Shanghai|Gang Ding|021-69691540||
20548318|NCT01147640|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
20548319|NCT03711318|NYS Psychiatric Institute|Dr. Adam Bisaga, study PI|646-774-6155|adam.bisaga@nyspi.columbia.edu|
20548320|NCT00091442|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Director Medical Leader|908 218 7361||
20556703|NCT02650219|St Joseph Hospital Marseille|Dr Christine Serratrice|0041798731474|cserratrice@hotmail.fr|
20556704|NCT01291784|Icahn School of Medicine at Mount Sinai|Dr. John O. Mascarenhas|212-241-6756|john.mascarenhas@mssm.edu|
20556705|NCT04504331|Stanford Medicine at Stanford University|Jennifer Lee Caswell-Jin, MD|1-310-332-6541|caswell@stanford.edu|
20556706|NCT04570436|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
20556707|NCT03802123|ImaginAb|Director, Regulatory Affairs|: +1.310.730.5869|ethomas@imaginab.com|
20556708|NCT01274182|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
20556709|NCT01822587|MUSC|Michael Saladin|843-792-5306|saladinm@musc.edu|
20556710|NCT01701414|Dept of Emergency Medicine, Rhode Island Hospital|Francesca Beaudoin MD, MS|401-444-2577|fbeaudoin@lifespan.org|
20556711|NCT00117676|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20556712|NCT00594854|Pozen Inc.|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
20556713|NCT03172702|AstraZeneca|Global Clinical Lead|+18772409479|information.center@astrazeneca.com|
20548321|NCT00917501|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu|
20556714|NCT03292146|Massachusetts General Hospital|Karen K. Miller, MD|617-724-7388|KKMILLER@mgh.harvard.edu|
20556715|NCT02954354|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20548322|NCT02175628|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|9199664997|rad_research@med.unc.edu|
20556716|NCT03468933|Tulane University|Dr. Fayez Kheir|504-988-3541|fkheir@tulane.edu|
20556717|NCT06134180|Case Western Reserve Unviersity|Kylie Meyer|2163681928|knm77@case.edu|
20572957|NCT01964924|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
20572958|NCT01528345|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20572959|NCT02141451|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
20572960|NCT00190749|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20572961|NCT00439231|NHLBI/NIH|Georg Aue|301.451.7141|AueG@nhlbi.nih.gov|
20572962|NCT00709852|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20572963|NCT03814187|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20548323|NCT03534362|Saint Louis University|Joe D Brunworth, MD|314-577-8884|joe.brunworth@health.slu.edu|
20548324|NCT03656107|University of Leicester|Dr Lucy Beishon|0116252|lb330@le.ac.uk|3134
20548325|NCT04517500|Mayo Clinic|Roberto P. Benzo, M.D.|507-284-0561|Benzo.Roberto@mayo.edu|
20548326|NCT00986830|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20548327|NCT01495975|MGH Diabetes Center|Nancy Wei, MD|617-724-7597|ncwei@mgh.partners.org|
20548328|NCT01954160|Duke Clinical Research Institute|Kathy Moore|919-668-8065|kathy.moore@dm.duke.edu|
20548329|NCT00808483|University of Oslo|Professor Anne Marit Mengshoel|004790036933|a.m.mengshoel@medisin.uio.no|
20548330|NCT02038881|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20548331|NCT00333840|Novartis Pharmaceuticals|Study Director|862-778-8300||
20556718|NCT04475549|Cyclerion Therapeutics, Inc.|Cyclerion Clinical Development|1-857-327-8778|info@cyclerion.com|
20556719|NCT04852055|Brown University|Project Director|(401) 863-7345|ellen_mccreedy@brown.edu|
20556720|NCT05163418|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20556721|NCT04495179|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
20556722|NCT00569582|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20556723|NCT02676375|Department of Psychiatry, University of California San Diego|Dr. Arthur Brody|8585528585|abrody@ucsd.edu|3775
20556724|NCT04559568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20556725|NCT03678545|Cincinnati Children's Hospital Medical Center|Regina Yearout|513-517-2108|regina.yearout@cchmc.org|
20556726|NCT05608499|Icahn School of Medicine at Mount Sinai|Giselle Singer|212-241-3288|giselle.singer@mssm.edu|
20556727|NCT01422408|Knight Cancer Institute, Oregon Health & Science University|Emile Latour|503-418-9601|latour@ohsu.edu|
20556728|NCT01936857|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
20556729|NCT00490282|The University of Texas (UT) MD Anderson Cancer Center|Adam Garden, MD/Radiation Oncology Department|(713) 563-2300|agarden@mdanderson.org|
20556730|NCT02963974|University of North Carolina at Chapel Hill|Lisa Park, AuD, CCC-A|984-215-2871|lisa_park@med.unc.edu|
20572964|NCT00296400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20572965|NCT03901482|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
20548332|NCT01904058|Mirum|Study Physician|1-650-667-4085|medinfo@mirumpharma.com|
20548333|NCT03096483|GE Healthcare|Beth Heckel|2623127269|beth.heckel@ge.com|
20548334|NCT02664610|University of Michigan|Lesli Skolarus|734-936-9075|lerusche@umich.edu|
20548335|NCT04810481|Medtronic|Keith Holloman|6126707136|keith.holloman@medtronic.com|
20548336|NCT01318642|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|866-572-6436|Bobby.Reddy@Immunitybio.com|
20548337|NCT06448078|Ege University|Gizem Kececi Ozgur|+90 506 678 71 28|gizem.kececi.1991@gmail.com|
20548338|NCT05835323|Johnson & Johnson MedTech Surgery|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20548339|NCT03557853|MSD Pharmaceuticals LLC|Vladimir Achikyan|+74959167100|vladimir.achikyan@merck.com|
20548340|NCT02808650|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20548341|NCT02927262|Astellas Pharma Global Development, Inc|Clinical trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20548342|NCT04141046|University of North Carolina at Chapel Hill|Saira Sheikh, MD|919-966-0545|szsheikh@email.unc.edu|
20548343|NCT02503410|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
20548344|NCT03467048|Cleveland Clinic|Dr. Kurt Ruetzler|216-445-8105|ruetzlk@ccf.org|
20548345|NCT04043728|Rush University Medical Center|Dr. Amanda Mathew|13125631273|amanda_mathew@rush.edu|
20548346|NCT03841448|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20548347|NCT00072176|Princess Margaret Hospital, Toronto, Canada|Dr. Amit M. Oza|416 946 4501|amit.oza@uhn.ca|2818
20548348|NCT02000180|St. Michael's|Dr. Samir C. Grover|4168645628|samir.grover@utoronto.ca|
20548349|NCT04128371|National Institute of Allergy and Infectious Diseases|Dr. Paneez Khoury|+1 301 402 3673|paneez.khoury@nih.gov|
20548350|NCT01739361|LSU Health Sciences Center New Orleans|Dr. David R Janz, MD, MSc, Assistant Professor of Medicine|504-568-3167|djanz@lsuhsc.edu|
20548351|NCT00968864|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
20548352|NCT00586625|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
20548353|NCT03353246|Duke University Medical Center|Michael Haglund, M.D., Ph.D.|919-684-6936|haglu001@mc.duke.edu|
20548354|NCT04032652|NorthShore University HealthSystem|Asst Director Research Compliance|2243647975|rpulido@northshore.org|
20548355|NCT02423772|Queen's University of Belfast|Kevin Vowles|+44 (0)28 9097 5445|k.vowles@qub.ac.uk|
20548356|NCT03672643|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548357|NCT01470859|Department of Neurology, Huashan Hospital affiliated to Fudan University.|Dr. Jian Wang|+86-13321934789|wangjian336@hotmail.com|
20548358|NCT01066000|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20548359|NCT03001882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20548360|NCT01386008|Clinical Research Center (CRC) UC Berkeley School of Optometry|Meng Lin, OD, PhD|(510) 642-9731||
20548361|NCT00566111|Yale University Department of Psychiatry|Dr. Gerard Sanacora|(203) 974-7535|gerard.sanacora@yale.edu|
20548362|NCT04449861|Jilin Cancer Hospital|Ying Cheng, MD|NA|jl.cheng@163.com|
20548363|NCT05268055|UMass Chan Medical School|Melissa L. Anderson, PhD|508-856-5820|melissa.anderson@umassmed.edu|
20548364|NCT00289718|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548365|NCT03319173|Bristlecone Health, Inc.|Dr. Kelly J. Gibas|763-913-4600|kelly-gibas@bethel.edu|
20548366|NCT03428932|Nemours Children's Health|Nelly Mauras, MD|904-697-3674|Nelly.Mauras@nemours.org|
20548367|NCT02160535|University of Washington|Dr. Sylvia Lucas, MD, PhD|206-598-9260|lucass@uw.edu|
20548368|NCT01191333|Director, VISN21 MIRECC, Department of Veterans Affairs|Jerome Yesavage, MD|650-852-3287|Jerome.Yesavage@va.gov|
20548369|NCT02468232|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20548370|NCT01826604|Saint Louis University|Dr. Katherine M. Scolari Childress|314-977-2090|scolarik@slu.edu|
20548371|NCT00615108|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20548372|NCT01914757|AstraZeneca|Mitchell Goldman, Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
20548373|NCT03509883|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20548374|NCT02024529|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20548375|NCT00354614|ResMed|VP Medical Affairs|858 836 6782|ResmedScienceCenter@resmed.com.au|
20548376|NCT02476201|Abbott Medical|Pilar Santamaria|+34 917 278 964|pilar.santamaria@abbott.com|
20548377|NCT03650556|Abbott Medical|Amber Miller|(612) 413-7236|amber.miller@abbott.com|
20548378|NCT02585843|Columbia University|A. Reshad Garan|(917) 374-3346|arg2024@cumc.columbia.edu|
20548379|NCT01856907|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5278|karen.elkind-hirsch@womans.org|
20548380|NCT01102270|Brigham and Women's Hospital|Atul Malhotra|6177326488|amalhotra1@partners.org|
20548381|NCT02191137|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20548382|NCT00694707|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
20548383|NCT02556736|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20548384|NCT02046733|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|STIMULI@etop-eu.org|
20548385|NCT01191411|University of Texas Southwestern Medical Center|Keith E. Argenbright, MD|817-288-9898|keith.argenbright@utsouthwestern.edu|
20548386|NCT04041375|Michael E. DeBakey VAMC|Dr. Natalie E. Hundt|713-791-1414|natalie.hundt@va.gov|10315
20556731|NCT02574910|UT Southwestern Medical Center|Dr Perrin White|2146489246|perrin.white@utsouthwestern.edu|
20556732|NCT00810264|BIOTRONIK|Clinical Studies Engineer Group Manager|800-547-0394|celestial@biotronik.com|
20556733|NCT04653766|Bioxodes|Medical Writer|+32 (0)71 239 602|stephanie.demoulin@bioxodes.com|
20556734|NCT01256567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556735|NCT02563496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20556736|NCT00567190|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20556737|NCT02306759|The Brooklyn Hospital Center|Director, Emergency Medicine Clinical Research Program|718-250-6250|bsin@tbh.org|
20556738|NCT00636610|Genentech, Inc.|Medical Communications|800-821-8590||
20556739|NCT00313820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20556740|NCT02721082|U. Kansas Medical Center|Dr. Kimber Richter|9134490157|krichter@kumc.edu|
20556741|NCT00251862|Boston Medical Center|Dr. Paul C. Schroy III|617-638-8335|paul.schroy@bmc.org|
20556742|NCT02453685|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20556743|NCT02925611|PGIMER|Dr. Steve Joys|7087617352|stevejoys@gmail.com|91
20556744|NCT00416182|Vermont Children's Hospital at Fletcher Allen Health Care|Dr. Thomas Lahiri, Principal Investigator|802-847-8600|thomas.lahiri@vtmednet.org|
20556745|NCT00522626|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
20556746|NCT03076970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20556747|NCT00838682|The Catholic University of Korea, Uijeongbu St. Mary's Hospital|Hiun-Suk Chae|82-31-820-3019|chs@catholic.ac.kr|
20556748|NCT00990964|Medtronic, Inc.|Attain Success Clinical Trial Leader|800-328-2518|medtronicCRMtrials@medtronic.com|62864
20556749|NCT03202472|Jonsson Comprehensive Cancer Center|Mark Glover|310 794-8742|mglover@mednet.ucla.edu|
20556750|NCT03364348|Stanford Medicine at Stanford University|Sinyoung Park|650-721-4485|sinyoung@stanford.edu|
20556751|NCT01768832|Washington University in St. Louis|Dr. Gammon M. Earhart|314-286-1407|earhartg@wustl.edu|
20556752|NCT03315143|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20572966|NCT01014533|University of Michigan|Kirk Brower||kbrower@med.umich.edu|
20572967|NCT00669682|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
20572968|NCT00412061|Novartis Pharmaceuticals|Study Director|862-778-8300||
20572969|NCT02689518|University of California San Diego|Professor Michael Goldbaum|858 534 3516|mgoldbaum@ucsd.edu|
20572970|NCT05332145|HealthPartners Institute|Stephanie Hooker, PhD, MPH|952-967-5056|stephanie.a.hooker@healthpartners.com|
20572971|NCT04555031|Bausch & Lomb|Study Director|5853386399|robert.steffen@bausch.com|
20572972|NCT02433340|AbbVie|Global Medical Services|800-633-9110||
20572973|NCT01178385|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
20572974|NCT03032393|Youngstown State University|Associate Professor|330941-2702|wge@ysu.edu|
20572975|NCT00857272|Braintree Laboratories, Inc.|John McGowan, Associate Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
20572976|NCT00985946|University of Wisconsin Carbone Cancer Center|Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
20572977|NCT03002753|Christoph-Dornier-Stiftung Münster|Christian Rupp, M. Sc.|00492514183440|rupp@cds-muenster.de|
20572978|NCT02679508|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20572979|NCT03103490|Professor of Radiology (Nuclear Medicine)|Andrei Iagaru|(650) 725-4711|aiagaru@stanford.edu|
20572980|NCT03456427|GE Healthcare|Beth Heckel|1-262-312-7269|beth.heckel@med.ge.com|
20572981|NCT00928018|Dana Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
20572982|NCT02665338|Medical University of South Carolina|Dr. Xingbao Li|843 7925729|lixi@musc.edu|
20572983|NCT02008877|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
20572984|NCT01049217|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572985|NCT00998335|University of Florida|Dr. Kenneth Cusi|352-273-7236|KCusi@ufl.edu|
20572986|NCT03149549|CytomX Therapeutics|Monika Vainorius|(650) 515-3185|clinicaltrials@cytomx.com|
20572987|NCT03136445|NHS Blood and Transplant|A/Prof Lise Estcourt|44 1865 387789|Lise.Estcourt@nhsbt.nhs.uk|
20572988|NCT01892540|University Hospitals|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
20572989|NCT01370590|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20572990|NCT05172050|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20572991|NCT02909764|Monell Chemical Senses Center|Julie A. Mennella|2675194880|mennella@monell.org|
20572992|NCT06298669|Rutgers|Maya Guglin|9085968459|maya.guglin@rutgers.edu|
20572993|NCT04617275|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20572994|NCT04227704|Washington University School of Medicine|Dr. David Monks|314-323-1845|dmonks@wustl.edu|
20572995|NCT02437253|Los Angeles Biomedical Research Institute at Harbor-UCLA|Dr. Lynda Polgreen (PI)|310-222-1961|lpolgreen@labiomed.org|
20572996|NCT00133809|Emory University|Nicole Turgeon MD|404-727-3257|nturgeo@emory.edu|
20572997|NCT02317432|Disparities Research Unit, MGH|Margarita Alegria, PI|617-724-1237|malegria@mgh.harvard.edu|
20572998|NCT01533597|Soonchunhyang Bucheon Hospital|Dr. Kwang-Woo Lee|+82 32 621 5465|urolkw@schmc.ac.kr|
20556753|NCT03320018|Stony Brook Medicine|Christine Pol|6314449083|christiana.pol@stonybrookmedicine.edu|
20572999|NCT04807582|Imperial College London|Professor Eric Aboagye|0203 313 3720|eric.aboagye@imperial.ac.uk|
20573000|NCT01111474|Federal University of São Paulo|Dr. Olga Dumont Flecha - PHD student|38 35326082|olgaflecha@gmail.com|
20573001|NCT02564354|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
20548387|NCT01967342|University of Alabama|Beverly E. Thorn, Ph.D.|(205) 348-8024|bthorn@ua.edu|
20548388|NCT01986946|Duke University Hospital|Dr. Erin Manning|919-681-3551|erin.manning@duke.edu|
20548389|NCT04674644|Suleyman Demirel University|Dr Esra Oz|05326788040|esrakaraagac@sdu.edu.tr|
20573002|NCT04101318|Coloplast|Vice President, Medical Affairs|+45 4911 1111|clinical-studies@coloplast.com|
20573003|NCT00558259|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573004|NCT04609306|University of Orthopaedics|Jonathan Wright, MD|(352) 273-7001|wrightjo@ortho.ufl.edu|
20573005|NCT00156819|Johns Hopkins Center for Clinical Trials|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
20573006|NCT03718533|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20573007|NCT00888628|Massachusetts General Hospital|James F. Markmann, M.D. Ph.D - Chief, Division of Transplant Surgery|617-643-4087|kcrisalli@mgh.harvard.edu|
20573008|NCT02370810|Anglia Ruskin Univeristy|Eldre Beukes|1223698847|eldre.beukes@anglia.ac.uk|2847
20548390|NCT01268150|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20548391|NCT00395733|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20548392|NCT03725852|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20548393|NCT04981392|UMass Chan Medical School|Kimberly Fisher, MD|5088561975|kimberly.fisher2@umassmed.edu|
20548394|NCT03072732|ZOLL|Project Manager|14127216444|moszm@yahoo.com|
20548395|NCT01419639|NYU Langone Medical Center|Matthias A. Karajannis|212 263 9959|matthias.karajannis@nyumc.org|
20548396|NCT01672736|University Health Network - Princess Margaret Cancer Centre|Dr. Suzanne Trudel|416-946-4501|Suzanne.Trudel@uhn.ca|4566
20548397|NCT01697358|Medtronic Restorative Therapies Group - Pain Stim|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
20548398|NCT02387710|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
20548399|NCT02853344|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
20548400|NCT02913612|Duke Clinical Research Institute|Kanecia Zimmerman, MD, PhD, MPH|919-668-8651|kanecia.zimmerman@duke.edu|
20548401|NCT00669396|University of Utah|David Turok, MD|801-581-7647|david.turok@hsc.utah.edu|
20548402|NCT01262573|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
20548403|NCT04251273|Truth Initiative|Amanda L. Graham, PhD, Principal Investigator|(202) 525-6473‬|vapestudy@truthinitiative.org|
20548404|NCT04402060|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20548405|NCT00810693|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20548406|NCT04836312|University of Pennsylvania|Alexander Fanaroff, MD|215-615-7674|alexander.fanaroff@pennmedicine.upenn.edu|
20548407|NCT03860597|University of California, San Diego|Neal Swerdlow, M.D., Ph.D.|(619) 543-6270|nswerdlow@ucsd.edu|
20548408|NCT02507973|The R Adams Cowley Shock Trauma Center|Dr Deborah Stein|410-328-3495|dstein@umm.edu|
20548409|NCT00331422|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu|
20548410|NCT02345226|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20548411|NCT01848704|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
20548412|NCT01710046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548413|NCT00989157|NRIFargo|Dr. James Roerig|701 365 4919|jroerig@nrifargo.com|
20548414|NCT03386474|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20548415|NCT01021306|Palmer Center for Chiropractic Research, Palmer College of Chiropractic|Dr. James DeVocht|563.884.5150|james.devocht@palmer.edu|
20548416|NCT02282358|Memorial Sloan Kettering Cancer Center|Dr. Andrew Zelenetz, MD, PhD|646-608-3728|zeleneta@mskcc.org|
20548417|NCT01898208|Mayo Clinic|Ritu Banerjee, M.D., Ph.D.|507-284-6904|banerjee.ritu@mayo.edu|
20548418|NCT01498978|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
20556754|NCT00715650|Yale University|Dr. Marc Rosen|203-932-5711|marc.rosen@yale.edu|2575
20556755|NCT02641392|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|amcclain@celgene.com|
20556756|NCT02691182|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni/ Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
20556757|NCT03026790|University of Minnesota|Erin Krebs|612-629-7558|Erin.Krebs@va.gov|
20556758|NCT02563002|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20556759|NCT03856515|M.D. Anderson Cancer Center|Jason Robinson|713-792-2265|nicotinestudy@mdanderson.org|
20556760|NCT03518125|BARDA|Susan Hollingsworth/Regulatory Operations Specialist|202-691-2040|Susan.Hollingsworth@hhs.gov|
20556761|NCT04452877|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20556762|NCT05453110|Baylor University Keller Army Community Hospital Division 1 Sports Physical Therapy Fellowship|Dr. Kelly M. Scott|509-595-7263|kmsid119@gmail.com|
20556763|NCT05906368|UPMC, University of Pittsburgh|Dr. Katherine Grace Lim|412-641-1778|limkg2@upmc.edu|
20556764|NCT02799784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20556765|NCT03387579|Indiana University School of Medicine|Dr. Katie Huff|3179449395|huffka@iupui.edu|
20556766|NCT01050816|Eulji General Hospital|Lee Gyeong Tae|+82-11-214-3323|lkt2408@hanmail.net|
20556767|NCT02360319|Vanguard Research Group|Patrica Marcy|3474398035|pmarcy@northwell.edu|
20556768|NCT00948298|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
20556769|NCT02403180|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20556770|NCT01445652|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20556771|NCT00929162|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20556772|NCT00952822|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20548419|NCT00961649|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20548420|NCT02155881|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20548421|NCT02711345|Novartis Pharma AG|Study Director|862 778-8300|Novartis.email@novartis.com|
20548422|NCT04357782|Central Virginia VA Health Care System|Dr. Brian Davis|804-675-5000|Brian.Davis5@va.gov|
20548423|NCT01786148|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
20548424|NCT00675259|The Ohio State University|Ewa Mrozek, MD|614-293-0066|Ewa.mrozek@osumc.edu|
20548425|NCT03780543|Assembly BioSciences Inc.|Chief Development Officer|415-855-3006|manderson@assemblybio.com|
20548426|NCT01033851|Massachusetts General Hospital|Dr. Elizabeth Hoge|6177240859|ehoge@partners.org|
20548427|NCT00066729|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20548428|NCT02349542|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
20556773|NCT00658567|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
20556774|NCT01755702|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556775|NCT00691938|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
20556776|NCT01319799|Sahlgrenska University Hospital,Cardiothoracic Anesthesia, 41345 Gothenburg ,SWEDEN|Dr Bjorn Reinsfelt|0046702954263|bjorn.reinsfelt@gu.se|
20556777|NCT04860518|Faron|Dr Juho Jalkanen|+358407071046|juho.jalkanen@faron.com|
20556778|NCT01965782|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556779|NCT03882879|Rush University Medical Center|Dr. Jori Fleisher|13125632900|jori_fleisher@rush.edu|
20556780|NCT01250990|University of Pennsylvania|Richard L Dunbar|215-662-9024|richard.dunbar@uphs.upenn.edu|
20556781|NCT03039023|Cleveland Clinic Foundation|Jennifer Wilcox|216-636-6153|kirsopj@ccf.org|
20556782|NCT03701399|Biohaven Pharmaceuticals|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20556783|NCT03440372|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20556784|NCT00448448|University of Iowa Dept of Orthopaedics and Rehabilitation|Dr. Lori A. Dolan|319-356-1075|lori-dolan@uiowa.edu|
20556785|NCT02340026|The Children's Hospital of Philadelphia|Laura A. Prosser, PT, PhD|215-590-2495|ProsserL@chop.edu|
20556786|NCT03945292|Arrowhead Pharmaceuticals, Inc.|Patrick O'Brien, Chief Operating Officer|626-304-3400|PObrien@arrowheadpharma.com|
20556787|NCT02684006|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556788|NCT04642898|University of Kentucky|Dr. Sauer-Zavala|859-562-1571|ssz@uky.edu|
20556789|NCT04280562|David Putrino|Icahn School of Medicine at Mount Sinai|212-824-8369|david.putrino@mountsinai.org|
20556790|NCT02968420|Vaccine Evaluation Center|Dr. Manish Sadarangani|604-875-2422|msadarangani@bcchr.ubc.ca|
20556791|NCT01368965|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20556792|NCT05103384|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
20556793|NCT00514735|Medtronic|Linda Nelson, Director of Clinical Research|763-526-2891|linda.k.nelson@medtronic.com|
20556794|NCT05417620|Johns Hopkins Bloomberg School of Public Health|Dr. Sheree Schwartz|443-983-2564|sschwartz@jhu.edu|
20556795|NCT00771810|Tarix Pharmaceuticals|Elizabeth Wagner|6178760223|elizabeth.wagner@tarixpharma.com|
20556796|NCT00765232|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
20556797|NCT00226239|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
20556798|NCT02660827|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
20556799|NCT04672941|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20556800|NCT02038894|Cincinnati Children's Hospital Medical Center|Dr. Mario Patino|5132538190|mario.patino@cchcm.org|
20556801|NCT03124979|Masimo|Tala Harake||studies@masimo.com|
20556802|NCT00045305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20556803|NCT04274894|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20556804|NCT02279043|University of California, San Francisco|Edith Fox|4152062544|edith.fox@ucsf.edu|
20556805|NCT02386995|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
20556806|NCT06213701|Center for Healthy Minds|Simon Goldberg|(608) 265-8986|sbgoldberg@wisc.edu|
20556807|NCT00453986|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556808|NCT04450108|Bosch Healthcare Solutions|Dr. Klaus Müller, Study director|+49 160 90816081|klaush.mueller@de.bosch.com|
20556809|NCT01031810|New York State Psychiatric Institute|Dr. Patrick J. McGrath|(646) 774-8076|mcgrath@nyspi.columbia.edu|
20556810|NCT01024608|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20556811|NCT02669784|Milton S. Hershey Medical Center|Rekha Cherian, M.D.|717-531-6735|rcherian@pennstatehealth.psu.edu|
20556812|NCT04648150|Hopital fondation Rothschild|Dr Amélie YAVCHITZ|+33148036454|ayavchitz@for.paris|
20556813|NCT01880723|University of Arizona|Courtney Wheatley|507-266-2696|wheatley.courtney@mayo.edu|
20556814|NCT02821403|The Hong Kong Polytechnic University|Dr. Tsz Wing Leung|27664268|jeffrey.TW.leung@polyu.edu.hk|
20556815|NCT03289234|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml@ml.mt-pharma.co.jp|
20556816|NCT04295005|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20556817|NCT00608582|VA Boston Healthcare System and Boston University School of Medicine|Margaret Naeser, PhD|857-364-4030|mnaeser@bu.edu|
20556818|NCT00939484|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
20556819|NCT04233372|Hospital Clínic of Barcelona|Dr. Alexy Inciarte|+34932275400|ajinciar@clinic.cat|
20556820|NCT03938454|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20556821|NCT01090310|Novartis|Study Director|862-778-8300||
20556822|NCT00695786|UT MD Anderson Cancer Center|Felipe Samaniego,MD/Professor, Lymphoma-Myeloma|(713) 745-6824|fsamaniego@mdanderson.org|
20573009|NCT04601870|University of Wisconsin-Madison School of Medicine and Public Health Center for Tobacco Research and Intervention|Mark Zehner|16082627568|mark.zehner@ctri.wisc.edu|
20573010|NCT04193436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573011|NCT00321373|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573012|NCT01774487|Baylor College of Medicine and Texas Children's Hospital|Sanjiv Harpavat|832-824-2099|harpavat@bcm.edu|2144
20573013|NCT00477334|Novartis Pharmaceuticals|Study Director|862-778-8300||
20573014|NCT02418676|State University of Maringá - Paraná - Brazil|Dra. Graciette Matioli|55 44 3011-3868|gmatioli@uem.br|
20573015|NCT01028937|NTK Enterprises, Inc.|Nancy Lockerman|831-869-1384|nlockerman@opti-k.com|
20573016|NCT02354508|Novartis Pharmaceuticals|Study Director|826-778-8300|novartis.email@novartis.com|
20573017|NCT03587974|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
20573018|NCT02585232|Tuscaloosa VA Medical Center|Dr. Michelle Hilgeman|205-554-2000|Michelle.Hilgeman@va.gov|3278
20508732|NCT02633046|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20556823|NCT01410058|University of Zimbabwe College of Health Sciences|Tsitsi G Monera-Penduka|307148|moneratg@yahoo.co.uk|
20556824|NCT03027414|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
20556825|NCT01364922|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20556826|NCT02542839|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
20556827|NCT04244396|Abbott_Medical_Devices|Emily Jesser Clinical Research Scientist II|6514482520|emily.jesser@abbott.com|
20556828|NCT01787097|Imperial College|Dr Omar S Usmani|+44 (0)20 7351 8051|o.usmani@imperial.ac.uk|
20556829|NCT05178121|University of Washington|Doyanne Darnell|206-744-9108|darnelld@uw.edu|
20556830|NCT01953003|Institut de Recherche Pierre Fabre, Toulouse France|Karim Keddad, Head of Medical Unit|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
20556831|NCT02512679|Children's Hospital Los Angeles|Neena Kapoor, M.D.|343-361-2434|nkapoor@chla.usc.edu|
20556832|NCT00553501|University of Vermont, Vermont Cancer Center|Barbara Grant, MD||barbara.grant@vtmednet.org|
20556833|NCT02597907|Kyungpook National University|Dr Younghoon Jeon|82534205871|jeon68@gmail.com|
20556834|NCT03701295|Johns Hopkins University|ETCTN Grants Administrative Manager|410-955-4044|jmurra33@jhmi.edu|
20556835|NCT01464021|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20556836|NCT04672096|Neuronoff, Inc.|Jasmine Wilson|408-858-2612|jasmine@neuronoff.com|
20556837|NCT03391765|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20556838|NCT00944658|Imperial College London|Peter Taylor|+44 (0) 2075941872|jrco@imperial.ac.uk|
20556839|NCT01255592|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20556840|NCT01272960|University of Alabama School of Medicine|Dr. Lorie Harper|205-975-0515|lmharper@uabmc.edu|
20556841|NCT00963911|Institut Bergonié|Pr Pierre Soubeyran|33(0)556333333|p.soubeyran@bordeaux.unicancer.fr|
20556842|NCT03496974|XBiotech|Ashley Otero, Corporate and Clinical Relations Manager|512-386-2930|aotero@xbiotech.com|
20556843|NCT04682119|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20556844|NCT03928028|Children's Hospital of Philadlephia|C. Alix Timko|2674265467|timkoc@chop.edu|
20556845|NCT02802501|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20556846|NCT02012192|Medical University of Innsbruck|Prof. Dr. Nicole Concin|+43 512 504|nicole.concin@i-med.ac.at|81433
20556847|NCT04525547|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20556848|NCT00800202|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20556849|NCT01580072|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
20556850|NCT01207570|The Hong Kong Polytechnic University|Dr. Marco Pang|85227667156|Marco.Pang@inet.polyu.edu.hk|
20556851|NCT01705496|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
20556852|NCT01746095|Savara Inc.|Head of Clinical Development|+45 7930 1414|info@savarapharma.com|
20573019|NCT00760006|Chilsren's Hospital of Pittsburgh of UPMC|Dr. Joseph E. Losee|412-692-6203|joseph.losee@chp.edu|
20573020|NCT00461032|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573021|NCT00297232|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20573022|NCT02257567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20573023|NCT02350777|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|212-639-5987|tamarir@mskcc.org|
20573024|NCT01878214|Washington University School of Medicine in St. Louis|Jaime Strickland, MA|314-454-7337|jstrickl@dom.wustl.edu|
20573025|NCT00946101|MedImmune, LLC an affiliate of AstraZeneca AB|Elissa Malkin, D.O.|301-398-0000|malkine@medimmune.com|
20573026|NCT01174160|Cardiome Pharma|Jonathan Mather, Director, Head of Regulatory Affairs|+44 (0)7581148916|jmather@cardiome.com|
20573027|NCT06377488|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|RFrankl1@its.jnj.com|
20573028|NCT03625895|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20573029|NCT01288521|University of Iowa|Sony Tuteja, Pharmd|215-573-7834|sony.tuteja@gmail.com|
20573030|NCT00552240|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20548429|NCT02215096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20548430|NCT01011738|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20548431|NCT00200161|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
20548432|NCT03896165|Ohio State University College of Nursing|Assistant Professor|614-292-5684|thrane.2@osu.edu|
20548433|NCT00691301|Gynecologic Oncology Group|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
20548434|NCT02642029|McLean Hospital|Ann Shinn, MD|617-855-3053|akshinn@partners.org|
20573031|NCT02679573|Melinta Therapeutics, Inc.|Sue Cammarata|312-724-9401|scammarata@melinta.com|
20573032|NCT01415531|Forest Research Institute|Tatjana Lukic, MD, MSc|(201) 427-8649|tanya.lukic@frx.com|
20573033|NCT05753670|Endeavor Health|Dr. Ghazaleh Rostami Nia|847-570-4729|GRostamiNia@northshore.org|
20573034|NCT00122460|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
20573035|NCT02483585|Amgen Inc.|Study Director|866-572-6436||
20573036|NCT01935180|VA Medical Center|Dr. Heiko Pohl|8022959362|heiko.pohl@dartmouth.edu|5595
20573037|NCT04196101|Enanta Pharmaceuticals, Inc|Guy De La Rosa, MD Senior Director, Infectious Diseases|(617) 607-0800|gdelarosa@enanta.com|
20573038|NCT02684851|CarolinasHS|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
20573039|NCT03430531|Penn State Hershey Medical Center|Dr. Verghese Cherian|7175318521|vcherian@pennstatehealth.psu.edu|
20573040|NCT02325557|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
20573041|NCT01502631|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20573042|NCT02534038|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|sdube@avanir.com|
20573043|NCT01488487|Div. of Hematology and Oncology, Univ. of North Carolina at Chapel Hill|Dr. Hanna Sanoff|919-966-4431|hanna_sanoff@med.unc.edu|
20573044|NCT00395460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20573045|NCT02943226|The University of Texas Health Science Center at Houston|Joseph P. Hasapes, M.D.|(713) 566-5440|Joseph.P.Hasapes@uth.tmc.edu|
20573046|NCT00250926|Dana Farber Cancer Institute|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
20573047|NCT02354443|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
20573048|NCT02319525|UAB|Dr. Jasvinder Singh, Principal Investigator|2059343235|jasvinder.md@gmail.com|
20573049|NCT01808326|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573050|NCT01200589|Novartis Pharmaceuticals|Study Director|862-778-8300||
20573051|NCT01590082|The University of Texas (UT) MD Anderson Cancer Center|Sapna P. Patel, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|sppatel@mdanderson.org|
20573052|NCT01853644|Northwestern University|Daniela Matei|312.472.4684|daniela.matei@northwestern.edu|
20573053|NCT02891408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20573054|NCT00185965|School of Medicine, Stanford University|Ronald Levy, MD / Robert K and Helen K Summy Professor of Medicine|650-725-6452|levy@stanford.edu|
20573055|NCT01853774|Arizona State University|Professor, College of Nursing and Health Innovation|6024960740|linda.larkey@asu.edu|
20573056|NCT01920854|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
20573057|NCT01043393|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
20573058|NCT03797677|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20573059|NCT03265938|Icahn School of Medicine at Mount Sinai|Dr. Samuel DeMaria|(212) 241-1518|samuel.demaria@mountsinai.org|
20573060|NCT03143166|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573061|NCT02673515|Medical University of Graz|Assoc.-Prof.Dr. Harald Sourij|+43 316 385|norbert.tripolt@medunigraz.at|78038
20573062|NCT03683823|The University of Texas at Austin|Dr. Michael Telch|512-560-4100|telch@austin.utexas.edu|
20573063|NCT00994682|University of Florida|Dr. Kenneth Cusi|352-273-8662|kcusi@ufl.edu|
20573064|NCT01323972|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573065|NCT02677428|VA Connecticut Healthcare System|Marc Rosen|203-932-5711|marc.rosen@va.go|2112
20573066|NCT03539887|The University of Texas Health Science Center at Houston|Rodrigo Machado-Vieira, MD, PhD, MSc|(713) 741-5000|Rodrigo.MachadoVieira@uth.tmc.edu|
20573067|NCT01946438|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20573068|NCT00589121|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20573069|NCT02412371|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20573070|NCT00847808|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20573071|NCT01116102|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
20548435|NCT01823146|University of Florida|Dr. Natalie Ebner|203 691 0371|natalie.ebner@ufl.edu|
20548436|NCT00463580|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
20548437|NCT00676338|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20548438|NCT02122458|VA Pittsburgh Healthcare System|Sheila R. Pratt, Ph.D.|412-979-3157|Sheila.Pratt@va.gov|
20548439|NCT00412542|UT MD Anderson Cancer Center|Vinay Puduvalli, MD / Associate Professor|713-745-5769|kuhunter@mdanderson.org|
20548440|NCT02833350|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20548441|NCT01188421|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
20548442|NCT02927327|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
20548443|NCT01604408|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20548444|NCT00075218|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20548445|NCT02509481|Colorado State University|Dr. Brian D. Foy, Professor|970-491-3470|Brian.Foy@colostate.edu|
20548446|NCT01189604|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20548447|NCT03626168|The University of Alabama|Dr. Amy Ellis, principal investigator|205-348-8128|aellis@ches.ua.edu|
20548448|NCT02357979|University of California at San Francisco|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
20548449|NCT00392860|Human Engineering Research Laboratories|Michael L Boninger|412-822-3700|boninger@upmc.edu|
20548450|NCT00843531|University of California, San Francisco|Emily Bergsland, MD|(415) 514-6520|Emily.Bergsland@ucsf.edu|
20548451|NCT01772160|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548452|NCT01573260|McGill University|Dr.Ronald B Postuma|514-934-8026|ron.postuma@mcgill.ca|
20548453|NCT01332331|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20573072|NCT05000931|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20573073|NCT00925132|University of Iowa|Mohammed Milhem|319-356-2324||
20573074|NCT02545933|University of Florida|Dr. Dominick Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
20573075|NCT03141905|University of Maryland, Baltimore|Jeffrey C. Fink MD, MS (Principal Investigator)|410-328-4822|jfink@som.umaryland.edu|
20573076|NCT01134952|LondonHSC|Dr Vivian McAlister|5196632920|vmcalist@uwo.ca|
20573077|NCT05180500|University of Pittsburgh|Dr. Sharon Hillier, PhD|412-641-6435|hillsl@mwri.magee.edu|
20573078|NCT04927884|CSSIFM|Chaitali Nangia, MD Oncologist|855-797-9277|Chaitali.nangia@cssifm.org|
20573079|NCT00727311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclsoure@merck.com|
20573080|NCT03992846|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20573081|NCT00729378|University of Arizona|Dr. Scott Going, Ph.D.|520-626-3432|going@u.arizona.edu|
20573082|NCT01586910|Medtronic, Inc.|Peggy Yunker|763-514-4000|surtavi@medtronic.com|
20573083|NCT03224351|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20573084|NCT01328717|Ascensia Diabetes Care|Dr. Daniel Brown|574-256-7754|daniel.brown@ascensia.com|
20548454|NCT00538291|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
20548455|NCT01696695|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20556853|NCT00526630|University of Cincinnati|Alberto Espay, MD|513-403-4600|alberto.espay@uc.edu|
20573085|NCT00346268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573086|NCT00031551|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
20573087|NCT01672723|University of California, Los Angeles|Dr. Naomi Eisenberger|310-267-5196|neisenbe@ucla.edu|
20573088|NCT01966380|Sahlgrenska university hospital|Prof. Jan Faergemann|031-3421000|jan.faergemann@derm.gu.se|
20573089|NCT04487834|Calisia University, Kalisz, Poland|Jacek Piatek|+48883389788|drpiatek@interia.eu|
20573090|NCT00484289|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20573091|NCT00192647|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20573092|NCT01828073|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20573093|NCT00690443|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
20573094|NCT03057977|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573095|NCT00953407|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20573096|NCT02502097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573097|NCT00876928|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
20573098|NCT02874924|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
20573099|NCT01689337|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20573100|NCT03834051|Vancouver Island Health Authority|Dr. Christine Lee|250 519 1898|christine.lee@viha.ca|
20573101|NCT00642772|Center for Health Services Research in Primary Care, Durham VA Medical Center|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
20573102|NCT05877508|University of California San Francisco|Michael Peluso|(415) 502-2449|michael.peluso@ucsf.edu|
20573103|NCT01147601|Oregon Health & Science University|Dr. Alfons Krol|503-494-9993|krola@ohsu.edu|
20573104|NCT04800432|University of South Florida|Tatyana Harris|(813) 974-7454|trharris1@usf.edu|
20573105|NCT05398237|University of Arizona Cancer Center|Clara Curiel-Lewandrowski, MD|(520) 626-5351|ccuriel@arizona.edu|
20573106|NCT01529203|Galderma|Clinical Project Manager|(33) 4 92 38 67 33|may.ma@galderma.com|
20573107|NCT01312857|Memorial Sloan Kettering Cancer Center|Dr. Nancy Kemeny, MD|646-888-4180|kemenyn@MSKCC.ORG|
20573108|NCT01248065|Penn State University Dept. of Public Health Sciences|Tonya S. King, PhD|717-531-7178|tking@psu.edu|
20573109|NCT02234687|New York University School of Medicine|Charles Marmar, MD|646 754 4855|Charles.Marmar@nyumc.org|
20573110|NCT00893984|Minneapolis Heart Institute Foundation|Chief Medical Officer|612-863-3900|scott.sharkey@allina.com|
20573111|NCT01762501|Sogo Rinsho Medefi Co., Ltd|Naoyuki Takano|+81-3-6901-6079|takano.naoyuki@sogo-medefi.jp|
20573112|NCT02781844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20573113|NCT02725801|University of Kentucky Division of Plastic Surgery|Lesley Wong|859-323-7505|lesley.wong@uky.edu|
20573114|NCT02518490|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20573115|NCT04256629|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20573116|NCT01383499|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573117|NCT00346632|Kyowa Kirin Pharmaceutical Development, Inc.|Project Leader|6099191100|clinical.info@kyowakirin.com|
20573118|NCT02572882|University of Pennsylvania|Natalie Kuzla|215-573-2935|nkuzla@pennmedicine.upenn.edu|
20573119|NCT04275089|Reia, LLC|Kaitlin Maier|2032742886|kaitlin@reiahealth.com|
20573120|NCT02469389|VISN 5 MIRECC|Dr. Melanie Bennett|(410) 637-1850|Melanie.Bennett@va.gov|
20573121|NCT01079663|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
20573122|NCT01847469|Yale University School of Medicine, VA Connecticut Healthcare System|Dr. Ismene Petrakis|(203) 932-5711|ismene.petrakis@yale.edu|
20573123|NCT04447846|Kenndey Krieger Institute|Dr. Anne Comi|443-923-9127|comi@kennedykrieger.org|
20573124|NCT00180323|Rigshospitalet, Copenhagen Unviversity Hospital, Denmark|Dr. Jesper Hastrup Svendsen||jesper.hastrup.svendsen@rh.regionh.dk|
20573125|NCT03486457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573126|NCT01590017|AMC Statistical Center|Jeannette Lee, PhD.|501-526-6712|jylee@uams.edu|
20573127|NCT00093808|Mayo Clinic|Winston Tan, MD|904-953-7290|Tan.Winston@mayo.edu|
20573128|NCT00871780|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20573129|NCT02527343|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20573130|NCT00701220|The Ohio State University|Philip F. Binkley, MD, MPH|(614) 293-3956|binkley.2@osu.edu|
20573131|NCT05767021|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20573132|NCT03575754|London Health Sciences Centre|Dr. Derek Cool|519-685-8500|derek.cool@lhsc.on.ca|54965
20573133|NCT01485055|Nationwide Childrens Hospital|Rajinder Bajwa|6147222000|rajinder.bajwa@nationwidechildrens.org|
20573134|NCT00912301|Mayo Clinic|Michael L. Camilleri, MD|507-266-2306|camilleri.michael@mayo.edu|
20573135|NCT01236339|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.234.5263|artscott@wlgore.com|
20573136|NCT02344004|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
20573137|NCT01945060|University of Virginia|Marc D Breton|14349826484|mb6nt@virginia.edu|
20573138|NCT01708213|TauTona Group|Ann Thomas|650-331-2461|athomas@tautonagroup.com|
20573139|NCT00116753|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20573140|NCT00986973|The Children's Hospital of Philadelphia|Dr. Can Ficicioglu|2155905876|ficicioglu@email.chop.edu|
20548456|NCT02640716|Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China|Dr. Yi Tang|+86 10 83199456|tangyi@xwhosp.org|
20548457|NCT04081324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20573141|NCT00578461|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
20548458|NCT01464996|University of North Carolina at Chapel Hill School of Dentistry|Dr. Andre Ritter, Professor and Chair|919-537-3987|andre_ritter@unc.edu|
20573142|NCT02009761|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20548459|NCT00739050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548460|NCT01756053|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
20548461|NCT00285818|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
20548462|NCT02404220|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20548463|NCT01259596|Wake Forest School of Medicine|Gretchen A. Brenes, Ph.D.|336-716-4551|gbrenes@wakehealth.edu|
20548464|NCT05280782|Washington University School of Medicine|Dr. Pamela K. Woodard|314-362-7100|woodardp@wustl.edu|
20548465|NCT01024231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20548466|NCT01163266|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20548467|NCT02586064|Providence VA Medical Center|Dr. Tracie Shea|401-273-7100|MaryTracie.Shea@va.gov|6248
20573143|NCT00950950|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20573144|NCT01809002|Axogen|Stacy Arnold, VP of Clinical Research|770-833-2570|sarnold@axogeninc.com|
20573145|NCT00757783|Johnson & Johnson Pharmaceutical Research & Development|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
20573146|NCT02372136|Gerber Foundation, UT Southwestern Med Ctr, Children's Medical Center|National Grant Gerber Foundation) (LPB); George L. MacGregor Professorship (CRR); National Children'|214-648-3903|luc.brion@utsouthwestern.edu|
20573147|NCT00743275|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20573148|NCT00575029|University of Arkansas|Dr. Donald Bodenner|501-526-5710|bodennerdonald@uams.edu|
20573149|NCT00850603|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
20573150|NCT02831387|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
20573151|NCT01592500|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20573152|NCT00118755|Hoffmann-La Roche|Medical Communications|800-821-8590||
20573153|NCT02204176|Wayne State University and Michigan State University|Dr. Phuong Vo|616-634-0566|votrucph@msu.edu|
20573154|NCT00292162|NHS|Michael MacDonald|01412112000|michael.macdonald@nhs.net|
20573155|NCT01016977|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573156|NCT02394951|Washington University in Saint Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
20573157|NCT05081388|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20573158|NCT01776541|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20573159|NCT04279392|University of Nebraska Medical Center|Laura Bilek|402-690-3524|lbilek@unmc.edu|
20548468|NCT02919696|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
20548469|NCT03181893|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548470|NCT02158975|University of Michigan Comprehensive Cancer Center|Dr. Ryan Wilcox, M.D.|734-615-1482|rywilcox@umich.edu|
20548471|NCT01706822|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
20548472|NCT02840721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548473|NCT01967173|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
20556854|NCT02052310|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1200|063study@fibrogen.com|
20556855|NCT02094443|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20556856|NCT00595504|Massachusetts General Hospital|David C. Henderson, M.D.|617-912-7800|dchenderson@partners.org|
20556857|NCT01949870|AstraZeneca|Dr Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
20556858|NCT00293267|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556859|NCT01804816|Cleveland Clinic Foundation|Dr. W.H. Wilson Tang, MD|(216) 444-2121||
20556860|NCT03086330|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20556861|NCT02182973|University of Louisville|Paula Radmacher|5028525532|paula.radmacher@louisville.edu|
20556862|NCT01235546|University of Alabama at Birmingham, Maternal & Fetal Medicine|Alan Tita, MD|205-934-9616|atita@uab.edu|
20556863|NCT01123382|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
20556864|NCT02740049|Imperial College London|Dr Coen Wiegman|+44(0)2075947846|c.wiegman@imperial.ac.uk|
20556865|NCT01256411|Novartis Pharmaceuticals|Study Director|862-778-8300||
20556866|NCT02274857|Abbott|Clinical Program Director|651-756-6717|kristin.ruffner@abbott.com|
20556867|NCT00834106|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556868|NCT00330915|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20556869|NCT00645164|DFB Pharmaceuticals|Herbert B. Slade MD, FAAAAI|817.302.3919|bert.slade@dfbpharmaceuticals.com|
20556870|NCT04225533|Serpin Pharma, LLC|Dr. Cohava Gelber|7033433258|cgelber@serpinpharma.com|
20556871|NCT02643862|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
20573160|NCT01171807|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
20548474|NCT01346969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548475|NCT02096679|AstraZeneca|Dr Mireille Cantarini||ClinicalTrialTransparency@astrazeneca.com|
20548476|NCT02002832|Sumitomo Pharma (Suzhou) Co., Ltd.|Chief Medical Officer|+86-10-57322070|luo@dsmpharm.com.cn|
20548477|NCT03540030|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
20548478|NCT03666624|University of Washington|Karen Fredriksen Goldsen|206-543-5722|fredrikk@uw.edu|
20548479|NCT03329508|Pharma 2B LTD|Pninit Litman study director|+972 8 9472672|pninit@pharma2b.com|
20548480|NCT03225599|Northwell Health|Administrative Director, Clinical Research|(516) 881-7064|dcannone1@northwell.edu|
20548481|NCT04815031|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548482|NCT03021304|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20548483|NCT02308189|Ohio University|Brian Clark, PhD|740-593-2354|clarkb2@ohio.edu|
20548484|NCT03022435|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
20548485|NCT00397215|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548486|NCT02959983|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20573161|NCT01901341|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20548487|NCT00484094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573162|NCT01981473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548488|NCT02728596|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|karnold@fredhutch.org|
20548489|NCT03221270|University of North Carolina at Chapel Hill|Rachel Force, PhD|984-974-6239|rachel_force@med.unc.edu|
20573163|NCT00738582|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20548490|NCT03439657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20548491|NCT00193258|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20573164|NCT00757588|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20548492|NCT00370071|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20573165|NCT00549783|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20573166|NCT00624923|Joslin Diabetes Center|Dr. Allison Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
20573167|NCT00799513|San Raffaele Hospital IRCCS|Principal Investigator|0226437649|ferreri.andres@hsr.it|
20548493|NCT03572972|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573168|NCT05062759|AstraZeneca Clinical Study Information Center|Global Clinical Head|+187724094 79|information.center@astrazeneca.com|
20548494|NCT01558739|Novartis Pharmaceuticals|Study Director|862-778-8300||
20573169|NCT00903006|University of Texas MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD / Associate Professor, Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
20548495|NCT01771952|University of Virginia, Kinesiology|Joe Hart|4349246187|jmh3zf@virginia.edu|
20548496|NCT04266769|LightForce Orthodontics|Kelsey Fafara|7329775646|kelsey@lightforceortho.com|
20548497|NCT01193842|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
20573170|NCT01749904|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
20548498|NCT00894127|bioAffinity|Maria Zannes|505-400-9747|mz@bioaffinitytech.com|
20573171|NCT03536143|Krystal Biotech|Dr. Hubert Chen, MD, Senior Vice President of Clinical Development|(412) 586-5830|inquiries@krystalbio.com|
20573172|NCT03476707|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20573173|NCT04055090|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20548499|NCT02484690|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20573174|NCT04745026|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20548500|NCT02612129|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
20573175|NCT05478499|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20573176|NCT04426851|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573177|NCT03256851|Wayne State University|Dr. Nora Fritz|(313) 577-1096|nora.fritz@wayne.edu|
20548501|NCT02557295|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
20548502|NCT00589290|National Institutes of Health (NIH), National Cancer Institute (NCI)|Arun Rajan, M.D.|301-594-5322|rajana@mail.nih.gov|
20548503|NCT01067976|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20573178|NCT01944371|University of California, San Francisco|Steven G. Deeks|4156064082|Steven.Deeks@ucsf.edu|404
20548504|NCT00976677|ECOG Statistical Office|Study Statistician|617-632-3012||
20548505|NCT00485433|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20548506|NCT03487549|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
20548507|NCT03948698|Elizabeth Glaser Pediatric AIDS Foundation|Shirin Kakayeva|2404377929|skakayeva@pedaids.org|
20548508|NCT00150709|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20573179|NCT00801931|Columbia University|Prakash Satwani, MD|212-305-0223|ps2087@cumc.columbia.edu|
20573180|NCT02476279|Division of Gastroenterology & Hepatology, Medical University of South Carolina|Dr. B. Joseph Elmunzer|8437926982|elmunzer@musc.edu|
20548509|NCT04092582|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20548510|NCT01805440|Department of Psychiatry|Douglas Kondo, MD|801-583-2500|doug.kondo@hsc.utah.edu|
20548511|NCT02903355|Southern Illinois University School of Medicine|Gary Fifer, MSHI|217-545-7823|gfifer@siumed.edu|
20548512|NCT04667481|University of Washington|Dr. Kerryn Reding, Study Principal Investigator|206-221-1571|kreding@uw.edu|
20548513|NCT03689114|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Giorgia Giussani|0239014604|giorgia.giussani@marionegri.it|
20548514|NCT01313858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548515|NCT04021771|Thomas Jefferson University|Dr. Kristin Rising|215-503-5507|Kristin.Rising@jefferson.edu|
20548516|NCT02609204|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
20548517|NCT03095885|Allena Pharmaceuticals, Inc|Allena Medical Affairs|6174674577|AllenaMedInfo@allenapharma.com|
20548518|NCT03642457|Icahn School of Medicine at Mount Sinai|Poonam Pai|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
20548519|NCT01392443|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20548520|NCT01895062|5i Sciences|Dr. Richard Rose|858-759-2205|rrose@5isciences.com|
20548521|NCT03019575|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548522|NCT01134276|Seoul National University College of Medicine|Sun-Whe Kim|+82-2-2072-2315|sunkim@plaza.snu.ac.kr|
20548523|NCT01935791|Imperial College London|Dr Chioma Izzi-Engbeaya|02075942454|c.izzi@imperial.ac.uk|
20573181|NCT00116337|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
20548524|NCT01626456|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823|usmedinfo@alkermes.com|
20548525|NCT01816074|Dept of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
20548526|NCT00320931|University of Maryland, Baltimore|Vasken Dilsizian, MD|410-328-6890|vdilsizian@umm.edu|
20548527|NCT05203289|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20548528|NCT00752102|Joslin Diabetes Center|Dr. Sylvia Rosas|617-309-2477|sylvia.rosas@joslin.harvard.edu|
20548529|NCT03270644|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20548530|NCT00333177|University of California, Los Angeles|Keith H. Nuechterlein, Ph.D., Principal Investigator|(310) 825-0036|keithn@ucla.edu|
20548531|NCT00736944|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
20508733|NCT02766907|TissueTech|VP Medical Affairs|8882968858|hsheha@tissuetechinc.com|
20556872|NCT01281644|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20548532|NCT01426438|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20573182|NCT03545503|New Hanover Regional Medical Center|William F. Powers, IV, MD, FACS|910-667-9232|william.powers@nhrmc.org|
20573183|NCT02128542|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20548533|NCT01500031|Boston Scientific|Director Clinical Trials|708-771-4737|Pamela.Grady@bsci.com|
20548534|NCT03643575|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20548535|NCT00845858|Evoke Pharma|Marilyn R. Carlson|858-345-1494|mcarlson@evokepharma.com|
20573184|NCT01098097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20548536|NCT01927627|Case Comprehensive Cancer Cent|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
20573185|NCT00394082|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20548537|NCT00910273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548538|NCT03488355|Memorial University of Newfoundland|Dr. Peter Daley|7097772089|pkd336@mun.ca|
20548539|NCT00338104|Northwestern University|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu|
20548540|NCT00633750|Vanderbilt-Ingram Cancer Center|Carlos Arteaga, M.D.|(615) 936-1919||
20548541|NCT00968890|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548542|NCT02362269|University of Wisconsin|Dr. Corinne D. Engleman|(608) 265-5491|cengelman@wisc.edu|
20548543|NCT00423514|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad, MD|1-833-MSK-KIDS|bouladf@MSKCC.ORG|
20548544|NCT01361568|Cara Therapeutics|Frédérique Menzaghi, PhD; Vice President, Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
20573186|NCT00402597|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|VP FRANCHISE MED LDR|1 908 927 7767||
20573187|NCT01831856|Institut de Recherche Pierre Fabre|Karim KEDDAD, MD, PhD Head of Medical Unit|+33 5 34 50 61 69|Karim.keddad@pierre-fabre.com|
20548545|NCT01433731|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|jeffrey.skolnik@tetralogicpharma.com|
20548546|NCT01254630|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548547|NCT02020577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573188|NCT05208866|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
20573189|NCT00298090|UTHSCSA|Jane Youngers|210-567-2340|youngers@uthscsa.edu|
20548548|NCT01999868|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20573190|NCT02996565|HealthPartners Institute|Karen Margolis, MD MPH|952-967-7301|Karen.L.Margolis@HealthPartners.com|
20548549|NCT00761631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548550|NCT00502944|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
20548551|NCT00310401|Vanderbilt University|Lorraine B. Ware M.D.|615 322 8614|lorraine.ware@vanderbilt.edu|
20548552|NCT00289016|Amgen, Inc.|Study Director|866-572-6436||
20548553|NCT00319501|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548554|NCT00561457|Bard Peripheral Vascular|Director of Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
20548555|NCT00667875|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
20548556|NCT00450255|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20548557|NCT01892865|Michael E. DeBakey VAMC|Panos Kougias MD MSc|713.794.7700|panagiotis.kougias@va.gov|
20548558|NCT03553927|Imperial College London|Channa Jayasena|02083833242|c.jayasena@imperial.ac.uk|
20548559|NCT01441180|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
20548560|NCT01402011|University of British Columbia Department of family practice|Dr. Helene Bertrand, M.D., CCFP, LM|604-985-5381|dr.hbertrand@gmail.com|
20548561|NCT00142298|Novartis Pharmaceuticals|Study Director|862-778-8300||
20548562|NCT03630042|Oxford University Hospital NHS Trust|Jaimal Kothari|NA|Jaimal.Kothari@ouh.nhs.uk|
20548563|NCT03360747|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20548564|NCT01759511|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20548565|NCT02569671|Institut Straumann|Mustapha El Amrani|0041619651741|mustapha.elamrani@straumann.com|
20548566|NCT01757535|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinica.Trials@bms.com|
20548567|NCT06238362|SleepRes|Bernard Hete|+1 615-921-2406|bhete@sleepres.com|
20548568|NCT02637622|Johns Hopkins Bloomberg School of Public Health|John FP Bridges|614-685-2543|john.bridges@osumc.edu|
20548569|NCT04638400|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Paresh Dandona|7169574325|pdandona@kaleidahealth.org|
20548570|NCT04508335|Reia, LLC|Chief Medical Officer|603 715-7017|paul@reiahealth.com|
20548571|NCT03366012|Columbia University|Julian Abrams, MD, MPH|212-305-1909|ja660@cumc.columbia.edu|
20548572|NCT01484041|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
20548573|NCT02675114|Edwards Lifesciences|Research Director|949-250-2500|THV_CT.gov@Edwards.com|
20548574|NCT02027883|Wellmont CVA Heart Institute|Terrie Walker, Director of Clinical Research|423-230-5643|twalker@mycva.com|
20548575|NCT00531934|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20548576|NCT02323113|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20548577|NCT00316719|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548578|NCT00690274|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
20527771|NCT00094536|Cooper Surgical|Chief Medical Officer|203-601-5200|Robert.Auerbach@coopersurgical.com|
20548579|NCT02280304|Michael E. DeBakey VA Medical Center|Dr. Mary Newsome|713-791-1414|mary.newsome@va.gov|25947
20548580|NCT02975336|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20548581|NCT00928395|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
20548582|NCT03689530|University of Michigan|Michele Heisler|(734) 845-3504|mheisler@med.umich.edu|
20548583|NCT01977794|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20573191|NCT00577577|Insmed|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
20548584|NCT00533897|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20548585|NCT02515825|AUM Cardiovascular|Marie Johnson, PhD|612.799.2511|mariej@aumcv.com|
20548586|NCT00713323|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20548587|NCT01925677|University of Maryland, Baltimore|Dr. Rolf Barth|4103286020|rnbarth@som.umaryland.edu|4103286020
20548588|NCT00491075|U.T. MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|guclinicaltrials@mdanderson.org|
20548589|NCT01603355|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
20548590|NCT03792191|Mansoura University|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
20548591|NCT03423082|University of Pittsburgh|Nghi C. Nguyen, MD, PhD|412-647-0104|nguyennc@upmc.edu|
20548592|NCT00246753|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20548593|NCT03921073|Moffitt Cancer Center|Dr. John Mullinax|813-745-1867|John.Mullinax@moffitt.org|
20548594|NCT00545766|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20548595|NCT03643796|University of Arkansas for Medical Sciences|Mohamed Abdeldayem|2244279747|Maabdeldayem@uams.edu|
20548596|NCT00270790|University of Maryland School of Medicine|Mohan Suntharalingam|410-328-2328|msuntha@umm.edu|
20548597|NCT04075279|Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health|Dr. Tyler Quinn|412-386-4450|yhh7@cdc.gov|
20548598|NCT00608972|Rutgers Cancer Institute of New Jersey|Deborah L Toppmeyer, M.D.|732-235-6789|toppmede@cinj.rutgers.edu|
20548599|NCT01303861|Duke University Medical Center - Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@dm.duke.edu|
20548600|NCT02234570|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
20548601|NCT00659360|Cross Cancer Institute|Dr. Margaret Von Mehren|215-214-1663|margaret.vonmehren@fccc.edu|
20548602|NCT02056639|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
20548603|NCT01868503|Stanford University|Dr. Kathleen Horst|6507360921|kateh@stanford.edu|
20548604|NCT00398918|Boston University|Ofra Sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
20548605|NCT03917459|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20548606|NCT00567307|Wake Forest School of Medicine, Winston Salem, NC|Dr. Elsayed Z Soliman, Director of the Epidemiological Cardiology Research Center|336-716-8632|esoliman@wakehealth.edu|
20548607|NCT00131508|St Jude Children's Research Hospital|Winfred Wang|1-866-278-5833|info@stjude.org|
20548608|NCT01330030|Stanford University|Dr Joel D Killen|650-723-5895|jkillen@stanford.edu|
20548609|NCT02980783|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20548610|NCT00850070|The Children's Health Council|Glen R. Elliott, Ph.D., M.D.|650.688.3649|gelliott@chconline.org|
20548611|NCT05047770|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20548612|NCT03758443|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20548613|NCT01522248|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
20548614|NCT01360593|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor, MPH, CCRP|412-647-5554|stadtermanbm@upmc.edu|
20548615|NCT00696800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548616|NCT05224141|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20548617|NCT01296360|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
20548618|NCT02956070|Universidade Federal Fluminense|Dr. Luiz Augusto Poubel|55 21 981113344|luizpoubel@id.uff.br|
20548619|NCT02390908|Hunter College|Dr. Tyrel J. Starks|212-772-5550|tstarks@hunter.cuny.edu|
20556873|NCT03673306|IRCCS Ospedale Policlinico San Martino, Genoa, Italy|Matteo Lambertini|+39 010 555 4254|matteo.lambertini@unige.it|
20556874|NCT04026529|Omaha VA Medical Center|Dr. Debra Romberger|4025597539|debra.romberger@va.gov|
20556875|NCT03338829|University of Minnesota|Sarah A. Wernimont MD, PhD|612-301-3408|swernimo@umn.edu|
20556876|NCT02618967|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20556877|NCT03628287|City University of New York, School of Public Health|Denis Nash, PhD|347-331-6554|denis.nash@sph.cuny.edu|
20556878|NCT05656040|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20556879|NCT04393441|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20556880|NCT04003610|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20573192|NCT00232544|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20573193|NCT00598273|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20573194|NCT00906945|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
20573195|NCT02434497|AstraZeneca Plc|Robin Mukherjee|+46317761000|robin.mukherjee@astrazeneca.com|
20573196|NCT01210664|University of California San Francisco Diabetes Center|Jeffrey Bluestone, PhD|415-502-5677|jeff.bluestone@ucsf.edu|
20573197|NCT01054170|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20573198|NCT02951767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20573199|NCT02751320|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573200|NCT02549196|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20573201|NCT01442779|Texas Tech University Health Sciences Center|Lorenz Lutherer, MD, PhD|806-743-2532|Lorenz.Lutherer@ttuhsc.edu|
20548620|NCT01479127|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20548621|NCT00515177|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
20548622|NCT00199875|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20548623|NCT01869439|WoundVision LLC|Dr. James G. Spahn, M.D.|(317) 775-6080|brett@woundvision.com|
20548624|NCT02737397|Clinilabs, Inc|Magdy Shenouda, MD|201-417-7765|Jackie@sen-jam.com|
20548625|NCT03469934|AnaptysBio, Inc|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
20548626|NCT03569033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548627|NCT01691898|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20548628|NCT01013350|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20548629|NCT00624234|Vanderbilt University|Dr. Laurie Cutting|615-875-1054|Laurie.Cutting@Vanderbilt.Edu|
20548630|NCT02019277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20548631|NCT04738734|Pulse Biosciences, Inc.|William A. Knape, VP Clinical, Regulatory, and Quality Affairs|510-906-4649|bknape@pulsebiosciences.com|
20548632|NCT02256072|Northwestern University Feinberg School of Medicine|Dr. Lee A. Lindquist|312-503-3916|LAL425@md.northwestern.edu|
20548633|NCT03212690|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20548634|NCT01297920|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20548635|NCT00474760|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548636|NCT01546207|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y. Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20548637|NCT00506662|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20548638|NCT03019185|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20548639|NCT02764333|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner, MD|848-225-6530|konnerj@MSKCC.ORG|
20548640|NCT03355365|Tisch MS Research Center of New York|Saud Sadiq|212-265-8070|ssadiq@tischms.org|
20548641|NCT04622306|Sagami|Mr Grant R Burt|+33 607 54 52 41|grantburt@sagami-europe.com|
20548642|NCT00617851|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
20548643|NCT01200524|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
20548644|NCT02758132|University of Hawaii Cancer Center|Stacy Mercado|8084404561|smercado@cc.hawaii.edu|
20548645|NCT00723580|Child Psychopharmacology Institute|Bill J. Duke, Ph.D.|701-241-9281|bduke@ChildPsychopharmacologyInstitute.org|2
20548646|NCT03273543|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20548647|NCT00697788|Mass General Hospital for Children|Erik Shank, MD|6177242250|eshank@partners.org|
20548648|NCT03228433|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20548649|NCT00689078|ORA|Paul Gomes|9786858900|pgomes@oraclinical.com|
20548650|NCT03289858|University of Massachusetts, Worcester|Eric Swart|503-880-7125|eric.swart@umassmemorial.org|
20548651|NCT01365052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20548652|NCT05294640|Moyes Eye Center|Meleha Ahmad|401-523-5911|meleha.ahmad@gmail.com|
20548653|NCT05981391|The University of Texas Health Science Center at San Antonio|Dr. John Moring|210-562-6716|moringj@uthscsa.edu|
20548654|NCT04460937|The Ohio State University Comprehensive Cancer Center|Dr. Eric Miller|614-293-8595|eric.miller@osumc.edu|
20548655|NCT03225573|AIn Shams University|Professor Ali Gamal Zohni|+2 01004931448|zohniali@gmail.com|
20548656|NCT04515394|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20548657|NCT01058655|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942||
20548658|NCT03881670|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
20548659|NCT00914485|Southeast Louisiana Veterans Health Care System|P. Adam Kelly, PhD, MBA|504-988-6630|peter.kelly@va.gov|
20548660|NCT02435147|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
20548661|NCT02939079|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
20548662|NCT04093414|Beaumont Hospitals|Diedre Brunk|248-898-5580|Diedre.Brunk@beaumont.org|
20548663|NCT04889222|Masimo Corporation|Ahmed Alghazi|949-297-7437|aalghazi@masimo.com|
20508734|NCT02758613|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
20527772|NCT01900431|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20548664|NCT01485393|MGH|Dr. Johnson-Akeju|6177247200|ojohnsonakeju@partners.org|
20548665|NCT02639546|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20548666|NCT02478372|Golden Jubilee National Hospital|David McDonald|07914861078|david.mcdonald@nhs.net|
20573202|NCT05249829|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20573203|NCT00513604|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20527773|NCT00624650|OHSU|Samantha Ruimy|5034940724|ruimy@ohsu.edu|
20556881|NCT05198466|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20556882|NCT02865720|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20556883|NCT02953938|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20556884|NCT03848403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20556885|NCT00168038|CSL Behring|Clinical Trial Disclosure Manager||clinicaltrials@cslbehring.com|
20556886|NCT00490256|Emory University|Paul Kirshbom, MD|404-785-6330|pkirshb@emory.edu|
20556887|NCT04198805|Indiana University School of Medicine|Naga Chalasani, MD|(317) 278-0414|nchalasa@iu.edu|
20556888|NCT04188067|Massachusetts General Hospital|Dr. Alexandra Touroutoglou PhD|6176436348|ATOUROUTOGLOU@mgh.harvard.edu|
20556889|NCT03599349|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 865|clinicaltrials@merz.com|
20556890|NCT04209075|NIDDK|Dr. Stephanie Chung|301-402-2122|Stephanie.Chung@NIH.gov|
20556891|NCT04639128|The Permanente Medical Group|Dr. Adrian Hinman|510-454-7292|adrian.d.hinman@kp.org|
20556892|NCT02638948|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
20556893|NCT05007392|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
20556894|NCT06821412|Liberating Technologies, Inc.|Jen Johansson|774-233-0874|jen.johansson@liberatingtech.com|
20556895|NCT01352585|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20556896|NCT03135535|Baylor College of Medicine|Prof.|17137987536|bijan.najafi@bcm.edu|
20556897|NCT02459262|MinervaX ApS|Per Fisher DPhil|+45 20 25 20 38|pbf@minervax.com|
20556898|NCT01904864|Baylor College of Medicine|Jacquelyn M. Powers, MD||jacquelyn.powers@bcm.edu|
20556899|NCT03724487|Case Western Reserve University|Dr. Carolyn Still, Assistant Professr|216-368-6338|cwh11@case.edu|
20556900|NCT00832767|Covidien|Jessica Carlson|203-821-4734|jessica.carlson@covidien.com|
20556901|NCT00549757|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20556902|NCT01964326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556903|NCT02347657|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20556904|NCT04647032|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
20556905|NCT03708588|Aurora Health Care|Suhail Allaqaband, MD|414-469-3491|suhail.allaqaban@aah.org|
20556906|NCT02093663|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20556907|NCT00508404|Amgen Inc.|Study Director|866-572-6436||
20556908|NCT01505387|Analyze & Realize|Felix Alt|+49 30 40008100|Falt@a-r.com|
20556909|NCT01424930|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20556910|NCT01301391|CLIOSS S.r.l.|Dr. Davite Cristina|+39 0031 58|regulatory@clioss.com|1482
20556911|NCT02629991|Albert Einstein College of Medicine|Bonnie Taylor|7188397530|botaylor@montefiore.org|
20556912|NCT01621880|Sun Yat-sen Memorial Hospital, Sun Yat-sen University|Yamei Tang|08613556001992|yameitang@hotmail.com|
20556913|NCT01662063|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20556914|NCT01422135|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
20556915|NCT01477853|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556916|NCT00677352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556917|NCT01814748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556918|NCT05288660|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20556919|NCT03088267|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
20556920|NCT01895972|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
20556921|NCT02782169|University of Hawaii|Family Planning Department|808-983-6000|hawaiimedab@gmail.com|
20556922|NCT04751942|Univeristy Hosptials Cleveland Medical Center|Rachael Kilkenny|216-545-4850|Rachael.Kilkenny@UHhosptials.org|
20556923|NCT02954523|Georgetown University|Chul Kim|12024442223|Chul.Kim@gunet.georgetown.edu|
20556924|NCT03531320|InnoPharmax Inc.|Staff of Medical Affairs|886-2-8797-7607|yuan.lin@innopharmax.com|
20556925|NCT03365154|Libra Medical|Phil Zhang, MD|6692039308|pzhang@libramed.com|
20556926|NCT00724152|VA Connecticut Healthcare System|Dr. Caroline Schmidt, Co-investigator|203-932-5711|Caroline.Schmidt@va.gov|3391
20556927|NCT00386022|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
20556928|NCT03371082|Gan & Lee Pharmaceuticals USA Corp.|Jia Lu, MD, PhD Executive Director of US Clinical Sciences|+1 888-288-5395|Jia.Lu@ganlee.us|
20556929|NCT03266770|University Hospitals Cleveland Medical Center|Dr. Kyle Scarberry|(216)844-3009|Kyle.Scarberry@UHhospitals.org|
20556930|NCT02440633|Otsuka Pharmaceutical Co., Ltd.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
20556931|NCT01160848|Photocure ASA|Project Director|+47 22062210|pf@photocure.no|
20556932|NCT02657031|University Medical Center Emergency Department|Dr. Tony Zitek|7022247124|zitek10@gmail.com|
20556933|NCT03078816|UCSF Movement Disorders|Aaron Viser|415 353 9453|aaron.viser@ucsf.edu|
20556934|NCT02114151|Janssen Infectious Diseases - Diagnostics BVBA|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20556935|NCT01218126|GlaxoSmithKline|GSK Response Center|866-435-7343||
20556936|NCT02411565|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hye Sook Chon|813-745-7205|hyesook.chon@moffitt.org|
20548667|NCT00113087|New England Research Institute|Lynn Sleeper|617-972-3235|lsleeper@neriscience.com|
20548668|NCT03452228|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20548669|NCT00386607|Novartis Pharmaceuticals|Study Director|862-778-8300||
20548670|NCT02761733|Felton Institute & Palo Alto University|Joyce Chu (Principal Investigator)|650-814-8376|jchu@paloaltou.edu|
20548671|NCT02713204|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20548672|NCT01222884|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
20548673|NCT02350569|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20548674|NCT04569253|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20548675|NCT04206800|Boston IVF|Kristin Rooney|781-434-6470|krooney@bostonivf.com|
20548676|NCT00788073|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
20548677|NCT03608254|The University of Alabama|Dr. Amy Ellis|2053488128|aellis@ches.ua.edu|
20548678|NCT00660673|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20548679|NCT03208127|Massachusetts General Hospital|Raymond Chung, MD|617-724-7562|chung.raymond@mgh.harvard.edu|
20548680|NCT01713608|Medicines for Malaria Venture|Dr Fiona Macintyre|+41 22 799 4078|macintyref@mmv.org|
20548681|NCT03505190|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20548682|NCT03476278|Derince Eğitim Ve Araştırma Hastanesi|Dr. Hande Aytuluk|5336515650|handegrbz@gmail.com|
20548683|NCT01903031|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20548684|NCT03000569|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20548685|NCT02298023|, Seoul National University Hospital|Dr. Sun G. Chung|+82-2-2072-2560|chung60611@gmail.com|
20548686|NCT01811680|Tan Tock Seng Hospital|Dr Karen Chua|65 68894580|karen_chua@ttsh.com.sg|
20548687|NCT00569270|Arthur F Gelb MD|Arthur F Gelb MD Principal Investigator|562-633-2204|afgelb@msn.com|
20548688|NCT00447005|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548689|NCT00492531|Professor of Medicine: Chief, Pulmonary, Allergy and Critical Care Medicine: Director, Hemostasis and Vascular Biology Research Institute; University of Pittsburgh School of Medicine|Mark Gladwin|412-692-2117|gladwinmt@upmc.edu|
20548690|NCT04122534|Montana State University|Dr. Kelly E. Knight|303-819-6997|kelly.knight3@montana.edu|
20548691|NCT01469234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20548692|NCT00644189|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
20548693|NCT00579878|University of Nebraska Medical Center|James O'Dell|402 559-7288|jrodell@unmc.edu|
20548694|NCT02128932|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20548695|NCT03685123|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virginia.edu|
20548696|NCT03451578|Duke Eye Center|Dr. Sharon Fekrat|919-681-3937|sharon.fekrat@duke.edu|
20548697|NCT04584970|University of North Carolina at Chapel Hill|Jacob Nelson|704-677-3801|jacob14@live.unc.edu|
20548698|NCT03113916|Kaiser Permanente Center for Health Research|Nangel Lindberg|503 528 3961|Nangel.M.Lindberg@kpchr.org|
20548699|NCT01758523|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
20548700|NCT01893203|Helsinki university hospital|Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
20548701|NCT04729621|Teva Pharmaceuticals|US Medical Affairs|1-888-483-8279|usmedinfo@tevapharm.com|
20548702|NCT02663908|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20548703|NCT03308786|Case Western Reserve University|Michael M. Lederman MD|2168448786|MXL6@CASE.EDU|
20548704|NCT02004522|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20548705|NCT01787331|University of California, San Francisco|Rahul Aggarwal, MD|877-827-3222|cancertrials@ucsf.edu|
20548706|NCT03175978|IGF Oncology, LLC|Hugh McTavish|651-207-8270|hmctavish@igfoncology.com|
20548707|NCT03281577|Takeda|Medical Director|+1-877-825-3327|takedadisclosures@takeda.com|
20548708|NCT01897454|NYU Langone|Dr. Jennifer Chuy|646-501-0194|jennifer.chuy@nyulangone.org|
20548709|NCT04015336|National Cancer Institute|Dr. Scott Norberg, D.O.|301-275-9668|scott.norberg@nih.gov|
20548710|NCT00491764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548711|NCT00894166|Duke University Medical Center|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu|
20548712|NCT05350410|Alzheimer's Disease Cooperative Study|Sara Moukarzel, PhD, Program Manager|(858) 432-8828|smoukarzel@health.ucsd.edu|
20548713|NCT01601132|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20548714|NCT00354887|UT MD Anderson Cancer Center|Robert Wolff, MD / Professor|713-792-2828|mjlim@mdanderson.org|
20548715|NCT02110238|Seikagaku|Junko Takamura||junko.takamura@seikagaku.co.jp|
20548716|NCT01024335|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
20548717|NCT01479478|Stanford University|Dr. Natali Aziz, MD|650-725-5720|mfmresearch@stanford.edu|
20573204|NCT00196976|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548718|NCT00142935|The Miriam Hospital/Brown University|Josiah D. Rich, MD, MPH|401-793-4770|jrich@lifespan.org|
20548719|NCT03055156|Stanford University|Dr. Seiji Nishino|650-725-8602|nishino@stanford.edu|
20548720|NCT00129272|The University of Tennessee|Uma Rao, MD|615-794-3351|urao@utk.edu|
20548721|NCT01550731|Veterans Administration|Dr. Rebecca Sudore|(415) 221-4810|Rebecca.Sudore@va.gov|23475
20548722|NCT04269707|American Regent, Inc.|Mark A. Falone, MD|631.772.3544|mfalone@americanregent.com|
20548723|NCT01146912|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
20548724|NCT00074984|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20548725|NCT03080454|Feinstein Institute for Medical Research at Northwell Health|Bruce Volpe|516-562-3384|bvolpe1@northwell.edu|
20548726|NCT02202980|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20548727|NCT01952145|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20548728|NCT03441269|Maimonides Medical Center|Sergey Motov, MD|718-283-8693|alikourezos@maimonidesmed.org|
20548729|NCT01216761|University of Michigan Health System|Laraine Washer, MD|734-936-5205|laraine@med.umich.edu|
20548730|NCT04138810|University of Pennsylvania, Department of Urogynecology|Dr. Lily Arya|215-662-4147|larya@pennmedicine.upenn.edu|
20548731|NCT00591344|Northwestern University|Daniel Corcos, PhD|708-214-5454|daniel.corcos@northwestern.edu|
20548732|NCT03779711|Mayo Clinic|Clint Hagen|(507) 577-1764|hagen.clint@mayo.edu|
20548733|NCT01457573|Houston Methodist Hosptial System|Timothy Boone, MD, PhD, Principal Investigator|713-441-6455|tboone3@houstonmethodist.org|
20548734|NCT00413244|Icahn School of Medicine at Mount Sinai|Dr. Mary Ann McLaughlin|(212) 241-3340|maryann.mclaughlin@mountsinai.org|
20548735|NCT02653872|AstraZeneca AB|AZD7986 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20548736|NCT00619177|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20548737|NCT01609231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548738|NCT01180647|NYU School of Medicine|Joshua D. Lee|212-263-4242|joshua.lee@nyumc.org|
20548739|NCT04873700|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20548740|NCT01044706|Kremers Urban Development Company|Bang Qian Xu, Ph.D., Director of Biopharmaceutics|812-523-5453|Bang.xu@ucb.com|
20548741|NCT01561378|Montefiore Medical Center|Daniel Ceusters|718-920-2956|dceuster@montefiore.org|
20548742|NCT00071396|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Assistant Professor|713-745-4613|eharriso@mdanderson.org|
20548743|NCT04545554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20548744|NCT00116428|Biosense Webster|Melissa Schultz, Project Manager, Regulatory Affairs|800-729-9010|mschult1@its.jnj.com|8787
20548745|NCT01032174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548746|NCT03783975|University of Maryland Baltimore|Dr. Amber Beitelshees|410-706-0118|abeitels@som.umaryland.edu|
20548747|NCT03998566|Boston Scientific|Jeya Satheesh|6124490870|jeya.satheesh@bsci.com|
20548748|NCT02572609|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20548749|NCT04295772|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548750|NCT02635776|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20548751|NCT01811225|University of Minnesota|Dr. Sharon Allen|612-624-2446|allen001@umn.edu|
20548752|NCT00287365|University of North Carolina at Chapel Hill|David B. Peden, MD, MS|919-966-0768|dpeden@med.unc.edu|
20548753|NCT00400764|Hoffman-LaRoche|Medical Communications|800-821-8590||
20548754|NCT00737243|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20548755|NCT02925117|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20548756|NCT00601198|University of Cincinnati|Alison Kastl, Director of Clinical Trials|813-584-0436|kastla@ucmail.uc.edu|
20548757|NCT03113071|Fox Chase Cancer Center|Dr. Henry Fung|215-728-2674|Henry.Fung@tuhs.temple.edu|
20548758|NCT01682954|Ohio State University|Dr. Carla Miller|614-292-1391|miller.4453@osu.edu|
20548759|NCT00579137|Baylor|Robert Krance, MD|832-824-4661|rkrance@bcm.edu|
20548760|NCT00302107|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-2000|lori.davis@va.gov|
20548761|NCT00437983|Sourazky Tel-Aviv Medical Center|Prof. A. Korczyn|972-3-6974229|amosk@tasmc.health.gov.il|
20548762|NCT00621959|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20548763|NCT04721171|Medical College of Wisconsin|Thangam Venkatesan|262-226-9632|tvenkate22@gmail.com|
20548764|NCT00594659|Geisel School of Medicine at Dartmouth College|Alan J. Budney, PhD Principal Investigator|855-290-2822|Alan.J.Budney@dartmouth.edu|
20548765|NCT04439201|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20548766|NCT03320057|University of California San Francisco|Shelly Kaller|510-986-8945|shelly.kaller@ucsf.edu|
20548767|NCT00403234|Purdue Pharma L.P.|Clinical Leader, Director of Clinical Research|800-733-1333||
20548768|NCT02468674|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20548769|NCT00956020|NYEEI Department of Otolaryngology|Anthony Sclafani, MD|212-979-4200|asclafani@nyee.edu|
20573205|NCT01535560|Alcon Research, Ltd.|Sally Schieb, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20548770|NCT01644565|Enteric Diseases Department, Naval Medical Research Center|Ramiro L. Gutierrez, MD, MPH|301-319-3193|ramiro.gutierrez@med.navy.mil|
20548771|NCT01550289|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20548772|NCT00814970|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
20548773|NCT00541931|Stanford University|Dr. Anne Chang, MD|(650)721-7151|alschang@stanford.edu|
20548774|NCT05154578|MinervaX|Cornelia Oostvogels/Chief Medical Officer (CMO)|00491515092821|lio@minervax.com|
20548775|NCT03930680|University of Arkansas for Medical Sciences|Hui-Ming Chang, MD, MPH|501-686-7575|hchang@uams.edu|
20548776|NCT03260881|University of Miami Miller School of Medicine|Dr Gianluca Iacobellis MD PhD Professor of Medicine|3052433636|giacobellis@med.miami.edu|
20548777|NCT02050841|Octapharma|Michael Eppolito|2016041155|michael.eppolito@octapharma.com|
20548778|NCT00815698|Herlev Hospital, dept. of Surgery|Jacob Rosenberg|+45 26237323|jacob.rosenberg@regionh.dk|
20548779|NCT02432742|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
20548780|NCT01180985|Johnson & Johnson Vision Care|John Buch, OD, MS, FAAO|1 904 443-1707|jbuch@its.jnj.com|
20548781|NCT00705289|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20548782|NCT01030536|MedImmune LLC, Milstein Building, Granta Park, Cambridge, CB21 6GH, United Kingdom|Edward Bradley, MD|+44 (0)1223 895997||
20548783|NCT03473171|The University of Texas Health Science Center at Houston|James M. Stark, MD|713-500-5650|James.M.Stark@uth.tmc.edu|
20548784|NCT02601027|Stanford University|Gordon Kwanlyp Lee, Professor of Surgery (Plastic and Reconstructive Surgery)|650-723-5824|glee@stanford.edu|
20548785|NCT01419626|Johnson & Johnson Consumer and Personal Products Worldwide|DIRECTOR ORAL HEALTH, MEDICAL AFFAIR & CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20548786|NCT02577549|Wake Forest University|Dr. Stephen Messier|336-758-5849|messier@wfu.edu|
20548787|NCT02248701|North Florida/South Georgia Veterans Health System|Joshua Yarrow, MS, PhD|(352) 548-6477|Joshua.Yarrow@va.gov|
20548788|NCT01145625|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
20548789|NCT04289623|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20548790|NCT01101880|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
20548791|NCT00762385|Vistakon|Kurt Moody, OD FAAO|904-443-3088||
20548792|NCT01540838|University of Helsinki, Children´s Hospital, Helsinki University Hospital|Dr. Okko Savonius, PhD candidate|+358456731185|okko.savonius@helsinki.fi|
20548793|NCT02130570|Brigham and Women's Hospital|Dr. Jeffrey L Schnipper, MD, MPH, FHM|617-732-7063|jschnipper@partners.org|
20548794|NCT04424888|Pendulum Therapeutics|James Bullard, PhD, Chief Technical Officer|(844) 912-2256|james.bullard@pendulum.co|
20548795|NCT00493025|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Rosalyn Juergens, MD.|410-908-7829|rjuerge1@jhmi.edu|
20548796|NCT03863197|KU Leuven|Dr. Britta Hanssen|+3216341295|britta.hanssen@kuleuven.be|
20548797|NCT01065597|Department of Psychiatry, University of Maryland School of Medicine|William T. Regenold, MDCM|410-328-6511|wregenol@psych.umaryland.edu|
20548798|NCT01781975|University of South Florida|Melissa Parker|8133969378|MELISSA.PARKER@EPI.USF.EDU|
20548799|NCT01622231|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548800|NCT04545060|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20548801|NCT02509767|Planned Parenthood Federation of America|Julia Kohn|2122614636|julia.kohn@ppfa.org|
20548802|NCT00973674|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
20548803|NCT02100579|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
20548804|NCT01440452|Johns Hopkins Hospital|Daniel Becker|4108284629|db@inirehab.com|
20548805|NCT03082261|Abbott|Robyn Capobianco|+15129343941|robyn.capobianco@abbott.com|
20548806|NCT00839852|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
20548807|NCT02068027|BDSI|Vice President Clinical Operations|919-582-0294|twarneke@bdsi.com|
20548808|NCT00494299|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20548809|NCT01281137|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director: Dr. Heidi Roschitzki-Voser|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
20548810|NCT01581710|CHA UNIVERSITY|Dr. HAN, MAN YONG|82-31-780-6262|drmesh@gmail.com|
20548811|NCT01986907|Novartis Pharmaceuticals|Study Director|+41613241111|trialandresults.registries@novartis.com|
20548812|NCT03800173|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20548813|NCT02846324|Global Blood Therapeutics|Nick Vlahakis|1 650 8228756|nvlahakis@gbt.com|
20548814|NCT00579098|Mayo Clinic|Paul A. Friedman, MD|507-255-2398|friedman.paul@mayo.edu|
20548815|NCT01254331|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20548816|NCT05213481|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20548817|NCT03273270|Medical University of South Carolina|Gonzalo Revuelta|7927262|revuelta@musc.edu|
20548818|NCT00722800|MGH|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
20548819|NCT02850601|BWH|Dr. Herve Sroussi|617 5256864|hsroussi@bwh.harvard.edu|
20548820|NCT01533077|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20548821|NCT02130297|Icahn School of Medicine at Mount Sinai|Dr. Hooman Khorasani|347-574-8500|hooman.khorasani@mountsinai.org|
20548822|NCT00347360|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548823|NCT01449539|University of Arkansas for Medical Science-MIRT|Sarah Waheed, MD|501-686-8230|mirt@uams.edu|
20548824|NCT05004077|University of Kentucky|Dr. Kevin Hatton|859-218-0365|kevin.hatton@uky.edu|
20548825|NCT01187433|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20548826|NCT00144391|Charles R. Drew University of Medicine and Science|Dr. Theodore Friedman|310-668-5197|theodorefriedman@cdrewu.edu|
20548827|NCT01790932|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|nlin@partners.org|
20548828|NCT04223973|Medtrum France|Mrs Melanie MARMOUNIER-WILHLEM- Commercial DIrector|+33620591224|melanie.marmounier@medtrum.com|
20548829|NCT00880997|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
20548830|NCT01267045|VA Puget Sound Health Care System|David J. Kearney, MD|206-277-1445|David.Kearney@VA.gov|
20548831|NCT00300274|Novartis Pharmaceuticals|Study Director|862-778-8300||
20548832|NCT00242216|The University of Texas Health Science Center at Houston|Dr. Roberto C. Arduino, Professor of Medicine|713-500-6731|roberto.c.arduino@uth.tmc.edu|
20527774|NCT03782974|USANA Health Sciences|Dr. Jeremy Tian|01-801-954-7658|jeremy.tian@usanainc.com|
20527775|NCT00714753|Mayo Clinic|Thomas M. Pisansky, M.D.||Pisansky.Thomas@mayo.edu|
20527776|NCT03704948|University of Iowa|Lisa S. Segre|13193357079|lisa-segre@uiowa.edu|
20527777|NCT01726621|Medtronic MiniMed, Inc|Clinical Research Manager|8185765171|julie.sekella@medtronic.com|
20548833|NCT00394147|University of Maryland|Dr. Ranee Mehra|410-328-7904|rmehra@umd.edu|
20548834|NCT00678080|UT Health|Dr. Jerrie Refuerzo, M.D.|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
20548835|NCT03569618|University of California, San Francisco|Riley Bove, MD MSc|415.502.7209|riley.bove@ucsf.edu|
20548836|NCT03105479|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
20548837|NCT05136690|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527778|NCT04504175|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
20573206|NCT02740374|The Ohio State University Wexner Medical Center - Department of Anesthesiology|Alberto Uribe|6142933559|alberto.uribe@osumc.edu|
20573207|NCT02842827|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573208|NCT01815138|UConn Helth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
20573209|NCT00825825|Steward St. Elizabeth's Medical Center|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
20573210|NCT02697292|Mayo Clinic|Sean J. Pittock, M.D.|507-2084-4741|Pittock.Sean@mayo.edu|
20573211|NCT00609765|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
20573212|NCT00882687|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20573213|NCT00577356|Virginia Mason Medical Center|Jacqueline Vuky, MD|(206) 223-6193|Jacqueline.Vuky@vmmc.org|32246
20573214|NCT02649946|BD/Bard|Heather Lam, Associate Project Manager, Clinical Affairs|(763) 390-8616|heather.lam@bd.com|
20573215|NCT00491829|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
20573216|NCT01047293|Huntsman Cancer Institute|Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
20573217|NCT02054520|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
20573218|NCT01272804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573219|NCT03801915|National Cancer Institute|Dr. Jonathan Hernandez|240-760-6072|jonathan.hernandez@nih.gov|
20573220|NCT01588496|Amgen Inc.|Study Director|866-572-6436||
20573221|NCT01551212|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20508735|NCT04128527|Ambu|Signe Toräng|31267089|sito@ambu.com|
20508736|NCT01496274|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20508737|NCT00721617|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20573222|NCT05924945|Masimo Corporation|Chelsea Frank|9492977000|clinicalresearchdept@masimo.com|
20508738|NCT01225172|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20556937|NCT02134587|School of Pharmaceutical Scientes of Universidade Estadual Paulista Júlio de Mesquita Filho, Araraquara, SP (Brazil)|Fabiana Rossi Varallo|5516997629496|varallo.f.r@gmail.com|
20573223|NCT02471833|Emory University|Whitney Wharton, PhD|404-712-7359|w.wharton@emory.edu|
20556938|NCT00265889|Case Comprehensive Cancer Center|Brian Bowell, MD|216-444-6922|bolwelb@ccf.org|
20556939|NCT00303862|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20556940|NCT02778100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20556941|NCT05238233|Prisma Health|Aimee Hanvey|864-760-7350|aimee.hanvey@prismahealth.org|
20556942|NCT00825266|Stanford University|Roham Zamanian|650-725-5495|roham.zamanian@stanford.edu|
20573224|NCT01775124|Novartis|Study Director|862-778-8300||
20573225|NCT02164383|University of Wisconsin Center for Tobacco Research and Intervention|Tanya Schlam, PhD|608-262-4149|trschlam@ctri.wisc.edu|
20573226|NCT01350336|Boston Scientific Corp.|G Mark Grubb|(412) 716-0717|grubbm@bsci.com|
20573227|NCT04964388|UNIVERSITY OF MISSISSIPPI MEDICAL CENTER|Amy Wigglesworth|6018153164|ajwigglesworth@umc.edu|
20573228|NCT01093521|University of Washington|Christopher H. Goss, MD MSc|206-543-3166|goss@u.washington.edu|
20573229|NCT02563522|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20573230|NCT01052103|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20573231|NCT04874415|University of Pittsburgh|Dr. Mary Ellen Vajravelu|412-692-6533|MaryEllen.Vajravelu@pitt.edu|
20573232|NCT03405792|University of Florida|Ashley Ghiaseddin, MD|352-273-9000|ashley.ghiaseddin@neurosurgery.ufl.edu|
20573233|NCT00918580|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573234|NCT00372229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20573235|NCT01347762|Beth Israel Deaconess Medical Center|Kevin P. Hill, M.D., M.H.S., Principal Investigator|617 667 1597|khill1@bidmc.harvard.edu|
20573236|NCT03235284|Federal University of Bahia - FUBA|Dr.Pietro Araújo|71992520519|pietro.araujo@ufba.br|
20556943|NCT00860379|Shriners Hospitlas for Children|Maggie Dylewski Begis|617-872-8567|mdylewski@shrinenet.org|
20573237|NCT00310037|University of California, San Francisco|Lawrence D. Kaplan, MD||lkaplan@medicine.ucsf.edu|
20573238|NCT02700945|Medtronic|Carola Alfaro Vives|763-526-1539|carola.alfaro.vives@medtronic.com|
20573239|NCT01382706|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
20573240|NCT05559099|National Institute of Allergy and Infectious Diseases|Lori Dodd|2406695247|doddl@niaid.nih.gov|
20573241|NCT04018092|University of Florida - Norman Fixel Brain Institute|Dr. Dawn Bowers|3522220100|dawnbowers@phhp.ufl.edu|
20573242|NCT01984671|Duke University School of Medicine|Tamara Somers, PhD|919-416-3408|tamara.somers@duke.edu|
20573243|NCT02208999|CEMKA|Stéphane Bouée, Medical director|331.41.87.95.25|stephane.bouee@cemka.fr|
20573244|NCT00319839|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
20573245|NCT04494256|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20573246|NCT00262951|University of Minnesota, Masonic Cancer Center|Edward Greeno, M.D.|612-626-6418|green049@umn.edu|
20573247|NCT01778023|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20573248|NCT00903630|University of Minnesota, Dept. of OBGYN|Dr. Levi Downs, Jr|612-626-3111|downs008@umn.edu|
20556944|NCT01515748|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20556945|NCT03221387|Lewis Katz School of Medicine at Temple University|Adam Nester, JD, MS|215-707-1986|coisom@temple.edu|
20556946|NCT00803452|University of Louisville|Professor Douglas Borchman|502 852 7435|borchman@louisville.edu|
20556947|NCT01774149|Norwegian Center for Integrated Care and Telemedicine|Dr. Stein Olav Skrøvseth|+4795805841|stein.olav.skrovseth@telemed.no|
20556948|NCT00657618|WRAIR|Roseanne A. Resnner, MD|301-295-6400|rose.resnner@us.armyh.mil|
20573249|NCT04025580|National Institutes of Health|Rachel Sparks|240-292-4642|rachel.sparks@nih.gov|
20573250|NCT03086213|Shenzhen Third People,s Hospital|Thoracic surgical department|13823135410|daoren_000113@126.com|
20573251|NCT01768117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573252|NCT01616056|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
20573253|NCT02939170|Alcon, A Novartis Division|Clinical Project Lead, Clinical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20573254|NCT01249274|Yale University|Kimberly A. Yonkers, M.D.|203-764-6621|kimberly.yonkers@yale.edu|
20573255|NCT01000636|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|
20573256|NCT00138671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20573257|NCT03658668|NYU Langone Health|Mathew Lustberg, MA|929 445 5090|Matthew.Lustberg@nyulangone.org|
20573258|NCT04634825|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20573259|NCT02777385|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20573260|NCT04129216|Johns Hopkins University|Dr. Mehran Habibi|4105505522|mhabibi2@jhmi.edu|
20573261|NCT02581631|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20573262|NCT00705523|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@mail.med.upenn.edu|152
20573263|NCT01013285|UCLA Neuro-Oncology Program|Albert Lai|310-825-5321|albertlai@mednet.ucla.edu|
20573264|NCT04619251|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573265|NCT01986075|New York State Psychiatric Institute|Kenneth Carpenter, PhD|646-774-8181|kenneth.carpenter@nyspi.columbia.edu|
20573266|NCT02003573|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573267|NCT00803751|UT Medical School, Houston|Maria Matuszczak|713-498-2768|maria.matuszczak@uth.tmc.edu|
20556949|NCT01659151|Moffitt Cancer Center|Amod Sarnaik, M.D.|813-745-8581|Amod.Sarnaik@moffitt.org|
20556950|NCT05774197|Harvard Medical School|Desiree Azizoddin, PsyD|4052718001|desiree_azizoddin@dfci.harvard.edu|50516
20556951|NCT05460325|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20556952|NCT01387139|Ucolorado|Keith Weisz|303-724-2592|keith.weisz@childrenscolorado.org|
20556953|NCT05073133|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20556954|NCT05878197|Ghent University|drs. Anke Adriaansen|0471028622|anke.adriaansen@ugent.be|
20556955|NCT05002218|Columbia University Irving Medical Center|Scott Barbuto, MD|518-275-9588|sb3779@cumc.columbia.edu|
20556956|NCT04120233|University of Kentucky|Dr. Linda J. Van Eldik|1-859-257-5566|linda.vaneldik@uky.edu|
20556957|NCT06223373|Wake Forest University Health Sciences|Kristen Faith Nicholson, PhD|704-355-2000|Kristen.Nicholson@advocatehealth.org|
20573268|NCT03102645|Department of Clinical Pharmacology, University Hospital Bispebjerg and Frederiksberg|Jonatan Kornholt|+4538635604|jonatan.kornholt@regionh.dk|
20573269|NCT01413087|Anchiano Therapeutics Israel Ltd.|Dr. David Kerstein|857-259-4626|david.kerstein@anchiano.com|
20573270|NCT02232243|University of Kentucky|Peng Wang|(859) 257-4488|p.wang@uky.edu|
20573271|NCT05026710|University of Michigan|Khurshid Ghani, MD|734-763-2797|kghani@med.umich.edu|
20573272|NCT00490724|Clinical Science Initiative Dept. Janssen Pharmaceutical K.K./ Tokyo Japan|Manager|+81.3.4411.5653||
20573273|NCT01395888|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573274|NCT03218397|Duke University|Vance Fowler, MD, MHS|919-613-5678|vance.fowler@duke.edu|
20573275|NCT01796548|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
20573276|NCT00126503|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
20573277|NCT02457559|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20573278|NCT00974376|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20573279|NCT02374671|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
20573280|NCT00903682|Janssen-Cilag EMEA|EMEA Medical Affairs Director Virology|+31 6 542 454 37||
20573281|NCT00462332|GIMEMA Foundation Data Center|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
20573282|NCT03866473|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
20573283|NCT02495792|Brooke Army Medical Center|MAJ Jamie Morris|210-221-3700|jamie.b.morris.mil@mail.mil|
20573284|NCT00600886|Novartis Pharmaceuticals|Study Director|862-778-8300||
20573285|NCT02523599|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20573286|NCT05590884|Guerbet|Frantz Hebert, Global Head of Clinical Development|+33 680249334|frantz.hebert@guerbet.com|
20573287|NCT04308395|Sol-Gel Technologies, Ltd.|VP Clinical & Regulatory Affairs|+972-73-3729453|Ofra.Levy-Hacham@sol-gel.com|
20573288|NCT04443153|UVA Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|marc.breton@virginia.edu|
20573289|NCT05182125|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20573290|NCT02760277|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
20573291|NCT04763421|Ethicon Endo-Surgery|Senior Director of Clinical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20573292|NCT04134845|Vanderbilt University Medical Center|Dr. William Stevenson|615-322-2318|William.g.stevenson@vumc.org|
20573293|NCT03110224|Zimmer Biomet|Annette Tieu|971-482-9622|annette.tieu@zimmerbiomet.com|
20573294|NCT05328167|Thomas Jefferson University|Dr. John Eisenbrey, Associate Professor|215-503-5188|john.eisenbrey@jefferson.edu|
20573295|NCT05195489|NYU Langone Health|Kimberly Hoagwood, PhD|240-401-4289|Kimberly.Hoagwood@nyulangone.org|
20573296|NCT05406752|Unither-Pharmaceuticals|Non-Clinical & Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
20573297|NCT03440320|Colorado State University|Dr Arlene Schmid|970-491-7562|arlene.schmid@colostate.edu|
20573298|NCT01201343|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20573299|NCT01919814|Pennington Biomedical Research Center|Frank Greenway, MD|2257632578|frank.greenway@pbrc.edu|
20573300|NCT00185679|Stanford Cancer Institute|Ginna G Laport, MD|650-723-8222|ginna.laport@stanford.edu|13911
20573301|NCT01440374|Novartis Pharmaceuticals|Study Director|862-778-8300||
20573302|NCT01036763|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573303|NCT00619762|LifeCell|Director of Clinical Operations|908.809.7856|djacobs@lifecell.com|
20573304|NCT04812548|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20573305|NCT01980654|Pharmacyclics|Dr. Jutta Neuenburg|408-215-3735|jneuenburg@pcyc.com|
20573306|NCT01845220|Johns Hopkins University|Jed W. Fahey, Sc.D.|4106142607|jfahey@jhmi.edu|
20573307|NCT02673151|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|(650) 725-4711|aiagaru@stanford.edu|
20573308|NCT02141984|AbbVie|Global Medical Services|800-633-9110||
20573309|NCT01177722|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20556958|NCT03520322|University of Rochester Medical Center|Otolaryngology Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
20573310|NCT02049151|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Centre|496151725200|service@merckgroup.com|
20573311|NCT01201317|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
20573312|NCT02079610|University of Pittsburgh School of Medicine|Kymberly Young, PhD|412-648-6179|youngk@pitt.edu|
20556959|NCT03764774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20573313|NCT00861263|University of FLorida|Dr. Peter Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
20573314|NCT02080221|Brown University Oncology Research Group|Howard Safran, MD|4018633000|BrUOG@BROWN.EDU|
20573315|NCT04005053|University of Minnesota|Kathryn Cullen|612-273-9732|rega0026@umn.edu|
20573316|NCT03184870|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20573317|NCT02978144|Columbia University|Gebhard Wagener, MD|(212) 305-6494|gw72@cumc.columbia.edu|
20573318|NCT01285843|Medacta International|Ing. Elisa Bonacina, Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
20573319|NCT00250679|Sepracor Inc.|Respiratory Medical Director|1-866-503-6351||
20573320|NCT00448279|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20573321|NCT03907410|Children's Hospital of Philadelphia|Chen Kenyon|2674266339|kenyonc@chop.edu|
20573322|NCT04776148|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20573323|NCT02440451|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
20573324|NCT01749605|University of Iowa|Brett Faine, PI|319-310-8067|brett-faine@uiowa.edu|
20527779|NCT00448812|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|+1 (412) 716-0717|grubbm@bsci.com|
20527780|NCT01687283|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527781|NCT02092649|University of Guelph|Sebastian Jannas-Vela MSc|(519)-824-4129|sjannas@uoguelph.ca|53907
20527782|NCT01533948|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20548838|NCT03730012|Astellas Pharma Global Development, Inc|Clinical trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20548839|NCT00443261|University of Kansas Cancer Center|Dr. Stephen Williamson|9139455059|swilliam@kumc.edu|
20548840|NCT02025621|Duke Clinical Research Institute|Rajendra Mehta, MD Study Principal Investigator|919-668-8971|raj.mehta@dm.duke.edu|
20548841|NCT00739674|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20548842|NCT02373852|Gardia Medical Ltd|Dr Vardit Segal|972-52-4579178|vardit@gardiamedical.com|
20548843|NCT00990236|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|traumare@ohsu.edu|
20548844|NCT01560403|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20548845|NCT00539656|Johns Hopkins University School of Medicine|Allen Chen, MD,PhD,MHS|410-614-4434|chenal@jhmi.edu|
20548846|NCT01519271|University of Pennsylvania|Daniel Weintraub, MD|215-349-8207|Daniel.Weintraub@UPHS.UPENN.EDU|
20548847|NCT01337700|Montefiore Medical Center, Albert Eins|Eric Hollander, MD|7189204287|eholland@montefiore.org|
20548848|NCT01947582|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
20548849|NCT00064337|SWOG Statistical Center|Study Statistician|206-667-4623||
20548850|NCT02911857|Novartis Pharmaceuticals|Study Director|862-778-1873|Novartis.email@novartis.com|
20548851|NCT00899574|NYU Cancer Institute|Sylvia Adams, MD|212-263-6485|sylvia.adams@nyumc.org|
20548852|NCT01397890|AstraZeneca|Nongluk Yimsuan|66 2 7397400|ClinicalTrialTransparency@astrazeneca.com|429
20548853|NCT00434954|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20548854|NCT02329080|International Extranodal Lymphoma Study Group (IELSG)|Scientific and Medical Director|+41 58 666|ielsg@ior.usi.ch|7321
20548855|NCT01704521|University of Cincinnati|Kenneth E. Sherman, MD. PhD|513-558-3918|kenneth.sherman@uc.edu|
20548856|NCT01961362|National Jewish Health|Dr. Jeffrey J. Swigris|303-398-1621|swigrisj@njhealth.org|
20548857|NCT00120523|MEDA Pharma GmbH & Co. KG|Clinical Research|+49 6172 888|clinical.research@medapharma.de|01
20548858|NCT01313312|Ipsen Innovation|Medical Director, Neurology.||clinical.trials@ipsen.com|
20548859|NCT00147212|MGH Cancer Center|M. Dror Michaelson, MD PhD|6177261594|dmichaelson1@partners.org|
20548860|NCT01761175|CHU de Québec, Département d'Anesthésie-Réanimation de l'Hôpital de l'Enfant-Jésus|Dre Marie-Josée Nadeau|418 649-5807|marie-josee.nadeau@fmed.ulaval.ca|
20548861|NCT02640573|Baylor College of Medicine|Vivien Sheehan|832 824 4459|vsheehan@bcm.edu|
20548862|NCT00784641|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20548863|NCT01206166|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
20548864|NCT00932126|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548865|NCT02716805|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20548866|NCT00066365|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20548867|NCT04288752|J3 Bioscience, Inc|R. Tyler McCabe, Ph.D.|801-550-9956|tmccabe@j3bio.com|
20548868|NCT00467857|Kimberly-Clark Health Care|Dr. Shu-Ping Yang|770-587-7267|Shu-Ping.Yang@kcc.com|
20548869|NCT02605304|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20548870|NCT00787761|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD, Principal Investigator|404-255-1930|abashey@bmtga.com|
20548871|NCT03576495|Brigham and Women's Hospital|Dr. Douglas S. Smink|617-983-7260|dsmink@bwh.harvard.edu|
20548872|NCT02867150|Optimal Health and Weight Center|Dr. Ellyn Levine M.D.|(619) 567-6914|dr.levine@teamtsfl.com|
20548873|NCT01216748|University of Miami|Matthias Salathe, MD|(305)243-2568|msalathe@med.miami.edu|
20548874|NCT03638622|Massachusetts General Hospital, Boston|Tayyaba Hasan|617-726-6996|thasan@mgh.harvard.edu|
20548875|NCT00098956|The Ottawa Hospital|Dr. Glenwood Goss|613-737-7700|ggoss@ottawahospital.on.ca|56708
20548876|NCT00516074|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20548877|NCT01589978|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
20548878|NCT04010695|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
20548879|NCT01216631|University of Leeds|Professor Philip Conaghan|+44 113 3924884|p.conaghan@leeds.ac.uk|
20548880|NCT03822182|AHNI Orthopedics|Brian Badman|3178328800|bbadman@gmail.com|
20548881|NCT00810355|Richard L. Roudebush VA Medical Center|Dr. Paul Lysaker|317-988-2546|paul.lysaker@va.gov|
20548882|NCT01749631|AbbVie|Global Medical Information|800-633-9110||
20548883|NCT01612858|Tufts Medical Center|Rakhi Kohli MD MS|617-636-4709|rkohli@tuftsmedicalcenter.org|
20548884|NCT01484275|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20548885|NCT03558087|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20548886|NCT03943160|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
20548887|NCT01387789|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20548888|NCT00913380|Seoul National University Bundang Hospital|Kyoung Ho Lee|82-31-787-7607|kholeemail@gmail.com|
20548889|NCT02187744|Pfizer, Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548890|NCT00134030|MRC Clinical Trials Unit at UCL|Prof Matt Sydes||mrcctu.euramos@ucl.ac.uk|
20548891|NCT01788228|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548892|NCT02358681|Columbia University|Daniel Tsze MD MPH|212-317-0997|dst2141@cumc.columbia.edu|
20548893|NCT00828412|Promius Pharma|Joanne Fraser|908 429-4504|joannefraser@promiuspharma.com|
20573325|NCT00666679|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20556960|NCT04922554|Paratek Pharmaceuticals Inc|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20556961|NCT01345630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556962|NCT04737109|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20556963|NCT03092375|UF Hepatology Research at CTRB|Lauren Morelli|3522739508|LAUREN.MORELLI@MEDICINE.UFL.EDU|
20556964|NCT01289418|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
20556965|NCT00551070|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20556966|NCT00605202|Oulu University Hospital, Department of Internal Medicine|Janne Hukkanen|+358-8-315 6212|janne.hukkanen@oulu.fi|
20556967|NCT03122119|Star Spine and Sports|Dr. Douglas Hemler, Prinical Investigator|3035701834|dhemler@starcolorado.com|
20556968|NCT01920282|Virginia Tech|Dr. Kevin Davy|(540) 231-3487|kdavy@vt.edu|
20556969|NCT02803125|VA Boston Healthcare System|Anica Pless Kaiser, PhD|857-364-5309|Anica.PlessKaiser@va.gov|
20556970|NCT04372628|Vanderbilt University Medical Center|Clinical Trials Operations Manager|(615) 875-3080|kelly.walsh@vumc.org|
20556971|NCT01493687|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
20556972|NCT05067439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20556973|NCT00705133|UC Los Angeles|Rajan Saggar|310-206-6766|rsaggar@mednet.ucla.edu|
20556974|NCT02323646|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20556975|NCT00521144|Memorial Sloan-Kettering Cancer Center|Dr. Lee Krug|646 888 4201|krugl@mskcc.org|
20556976|NCT01370525|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
20556977|NCT04791761|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|4126926874|shafferad@upmc.edu|
20556978|NCT01559948|Texas Woman's University|Dr. Kelli Brizzolara|214-689-7722|kbrizzolara@twu.edu|
20556979|NCT00180479|Abbott Vascular|Ellen Travis, Clinical Science|408-845-1512|Ellen.Travis@av.abbott.com|
20556980|NCT05168579|University of Pittsburgh|Dr. Deepika Mohan|404-375-9325|dem73@pitt.edu|
20556981|NCT00105235|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20556982|NCT02416492|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
20556983|NCT03685396|Azienda Ospedaliera San Paolo - Università degli Studi di Milano|Dr.Fulvio Gatti|3396441920|fudy@libero.it|
20556984|NCT01197508|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20556985|NCT01078155|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20556986|NCT03286751|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20556987|NCT00248781|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20556988|NCT01532128|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20556989|NCT00580814|UCaliforniaIrvine|Tim Wigal, Ph.D., director UCI CHild Development Center|949-824-1812|tlwigal@uci.edu|
20556990|NCT04044456|Malcom Randall VAMC|Health Science Specialist|352-376-1611|julia.waid-ebbs@va.gov|105224
20556991|NCT01972529|Eisai Inc|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
20556992|NCT00939874|St Vincents Hospital|Professor Andrew Carr|+61 2 8382 3359|andrew.carr@svha.org.au|
20556993|NCT00330174|Medical University of South Carolina|Susan Sonne, PharmD, BCPP|843.792.5221|sonnesc@musc.edu|
20556994|NCT01032733|University of Florida|Stephen Anton|352-273-7514|santon@ufl.edu|
20556995|NCT02316769|Vanderbilt University|Bret Alvis|6159365836|bret.d.alvis@vanderbilt.edu|
20556996|NCT01201811|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20556997|NCT03477279|University of North Carolina at Chapel Hill|Nora Rosenberg, PhD, MSPH|919-843-6580|nora_rosenberg@unc.edu|
20556998|NCT02277990|Medtronic|Daniel Lexcen, Sr. Clinical Program Manager|+17635269702|daniel.lexcen@medtronic.com|
20556999|NCT00946296|UMass Medical School|Dr. Giles Whalen|508-334-5202|Giles.Whalen@umassmemorial.org|
20557000|NCT04283448|Montana State University|Mary P Miles|406 994-6678|mmiles@montana.edu|
20508739|NCT01068717|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20573326|NCT00691327|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
20573327|NCT04882995|UMass Chan Medical School|Dr. Deepali Maheshwari|4137948764|deepali.mahesh@gmail.com|
20573328|NCT04371198|Duke University Health System|Joan Cahill BNS OCN CCRP|(919) 668-5211|Joan.Cahill@duke.edu|
20573329|NCT02579174|Northwestern University|Melissa Shauver, MPH|312-472-6024|melissa.shauver1@nm.org|
20573330|NCT00655486|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
20573331|NCT02136420|Massachusetts Eye and Ear Infirmary|Faisal Karmali|617-573-5593|faisal_karmali@meei.harvard.edu|
20573332|NCT00440999|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
20573333|NCT04218084|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573334|NCT01100034|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573335|NCT04756960|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20573336|NCT04578574|University of Miami|Eva Widerstrom-Noga, PhD; Roberta Vastano, PhD|305243-7125; 305243-8847|ewiderstrom-noga@med.miami.edu; Rxv331@med.miami.edu|
20573337|NCT00828841|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20573338|NCT00836095|Penn State Milton S. Hershey Medical Center|Sonia Vaida MD, Professor of Anesthesiology|7175318433|svaida@hmc.psu.edu|
20573339|NCT03609853|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20573340|NCT01602562|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573341|NCT04964414|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
20573342|NCT01718353|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20573343|NCT00509587|Princess Margaret Cancer Centre|Dr. Natasha Leighl|416-946-2399|natasha.leighl@uhn.ca|
20573344|NCT03572387|Icahn School of Medicine at Mount Sinai|Vaibhav Patel, MD|212-659-5511|vaibhav.patel@mountsinai.org|
20573345|NCT00968227|Washington University|Michael Diringer PI|314-362-2999|diringerm@wustl.edu|
20573346|NCT01981772|The Ohio State University College of Dentistry|Sara Fowler|6142923596|fowler.276@osu.edu|
20573347|NCT02411357|University of Vermont|Sarah H. Heil, PhD|802-656-8712|sarah.heil@uvm.edu|
20573348|NCT00001984|NIDDK, NIH|Dr. Alan Kirk||allank@intra.niddk.nih.gov|
20573349|NCT03333837|Wake Forest University School of Medicine|Christina Hugenschmidt, PhD|336-713-8116|chugensc@wakehealth.edu|
20573350|NCT02112838|Rigel Pharmaceuticals|Sandra Tong|1-650-624-1207|stong@rigel.com|
20573351|NCT03519971|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20573352|NCT02549014|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573353|NCT06729606|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
20573354|NCT04849507|Medical University of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
20573355|NCT05929339|Wake Forest University School of Medicine|James C. Eisenach, MD|336716-4182|jimeisenach@gmail.com|
20573356|NCT00409773|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573357|NCT03572478|University of Chicago|Walter STadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
20573358|NCT02401867|Fenway Community Health|Sari Reisner, ScD|617-927-6017|sari.reisner@childrens.harvard.edu|
20573359|NCT04234425|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
20573360|NCT02315352|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20573361|NCT02795429|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20573362|NCT03719170|VA Ann Arbor Healthcare System|Dr. Sameer Saini|734-845-3504|sameer.saini@va.gov|
20573363|NCT05220254|Stanford University|Judith Prochaska|(650) 724-3608|jpro@stanford.edu|
20573364|NCT03794908|University of Michigan|Helen Burgess|734-615-8303|bhelen@umich.edu|
20573365|NCT03786783|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20573366|NCT04363801|Leap Therapeutics, Inc.|Douglas Onsi / President and CEO|617-218-1116|donsi@leaptx.com|
20573367|NCT04754477|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20573368|NCT05041101|The University of Texas MD Anderson Cancer Center|Sadia Saleem, MD|(281) 566-1900|ssaleem@mdanderson.org|
20573369|NCT00249002|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20573370|NCT00069108|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20573371|NCT01853137|Osama AlAli|Dr.|00963992262582|osama-alali@hotmail.com|
20573372|NCT03401229|AstraZeneca|Maria Jison, MD Global Clinical Head, FASENRA, Late-stage R&I|+13013980340|Maria.Jison@astrazeneca.com|
20573373|NCT00690820|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
20573374|NCT05333224|Istanbul Medeniyet University|Ayca Evkaya Acar|+905544263263|ayca.evkaya@gmail.com|
20573375|NCT00585377|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
20557001|NCT03434678|Memorial Sloan Kettering Cancer Center|Dr. Florence Grant, MD|212-639-8829|moses-gf@mskcc.org|
20557002|NCT05735587|Hebrew Rehabilitation Center|Dr. Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
20557003|NCT06060457|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20557004|NCT02061202|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|212-241-3650|jeffrey.glassberg@mountsinai.org|
20557005|NCT01533493|Massachusetts General Hospital|Joseph Biederman|617-724-1743|jbiederman@partners.org|
20557006|NCT01860703|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
20557007|NCT00072761|Vanderbilt University School of Medicine|Michael R. DeBaun, MD, MPH|615-875-3040|m.debaun@vanderbilt.edu|5-3040
20557008|NCT02532556|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20557009|NCT00696410|University of Michigan|Jennifer Cowger, MD, Assistant Professor|734 936-5265|jennmatt@med.umich.edu|
20557010|NCT04898231|UCSD|Dr. Adriana Tremoulet|858-246-0012|atremoulet@health.ucsd.edu|
20557011|NCT03184792|University of Washington|Dr. Fatma Inanici|2067872692|finanici@uw.edu|
20557012|NCT02495025|University of California Los Angeles|Principal Research Manager, Health Services Research Program|310-825-8624|lindseythompson@mednet.ucla.edu|
20557013|NCT03818672|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
20557014|NCT01001052|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20557015|NCT02365519|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
20557016|NCT01971723|Florida State University|Dr. Michael J. Ormsbee|(850) 644-4793|mormsbee@fsu.edu|
20557017|NCT02073461|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
20557018|NCT03657277|University of Iowa|Nicole Brogden|3193358752|nicole-brogden@uiowa.edu|
20557019|NCT00566579|Department of OBGYN, Faculty of Medicine, Khon Kaen University, 40002, THAILAND|Bandit Chumworathayi|66818733327|bunchu@kku.ac.th|
20573376|NCT01411215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573377|NCT03451162|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20573378|NCT03305731|University of Illinois at Chicago|Dr. Emily Kringle|312-996-9665|kringle@uic.edu|
20573379|NCT01136772|Columbia University|T. Scott Stroup|646-774-8435|stroups@nyspi.columbia.edu|
20573380|NCT01498653|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573381|NCT04409886|Maimonides Medical Center|Gene Sobol|718-283-6000|gsobol@maimonidesmed.org|
20573382|NCT03881553|University of Pittsburgh School of Medicnie|Elisabeth Salisbury, PhD|412-246-5378|salisburye2@upmc.edu|
20573383|NCT00455325|Washington University School of Medicine|Janet McGill, MD|(314) 362-8688|jmcgill@wustl.edu|
20573384|NCT01651442|National Jewish Health|Bryan Simmons|303-398-1850|simmonsb@njhealth.org|
20573385|NCT01759368|VTT Technical Research Centre of Finland|Anna-Leena Orsama|+358408485966|anna-leena.orsama@vtt.fi|
20573386|NCT01313689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20573387|NCT01768637|University of Arkansas for Medical Sciences|Nishank Jain, MD|5016865295|njain2@uams.edu|
20573388|NCT03426605|OrphAI Therapeutics|Esther Nkrumah|2675121750|enkrumah@orphai-therapeutics.com|
20573389|NCT02666846|Futura Medical Developments Limited|Director of Clinical Development|01483685683|tim.holland@futuramedical.com|
20573390|NCT03386110|Hunter College|Tyrel J. Starks|212-206-7919|tstarks@hunter.cuny.edu|
20573391|NCT02684253|Memorial Sloan Kettering Cancer Center|Dr. Sean McBride, MD, MPH|646-608-2450|mcbrides@mskcc.org|
20573392|NCT01001559|Red Oak Psychiatry Associates|Dr. Lawrence Ginsberg|281-893-4111|larrydg@earthlink.net|151
20573393|NCT00419666|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20573394|NCT02308020|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
20573395|NCT01211288|University of Alabama at Birmingham|Dr. Toni Tien Neumeier|205-934-5459|neumeier@uab.edu|
20527783|NCT03307837|Concentric Analgesics|Dr. John Donovan, President and Founder|415-676-8940|JOHN@CONCENTRICANALGESICS.COM|
20573396|NCT01270971|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
20573397|NCT04217590|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astazeneca.com|
20573398|NCT03324451|College of Nursing,Kaohsiung Medical University|Ruey-Hsia Wang|886-3-3121101|wrhsia@kmu.edu.tw|2641
20573399|NCT00704405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573400|NCT03169101|University of Pennsylvania|Rebecca Ashare, PhD|7168296273|rlashare@pennmedicine.upenn.edu|
20573401|NCT02641496|Veterans Affairs Palo Alto Health Care System|Lisa Kinoshita, Ph.D. (Principal Investigator)|650-493-5000|Lisa.Kinoshita@va.gov|65633
20548894|NCT00508755|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
20548895|NCT00945893|MedImmune, LLC|Raburn Mallory, MD Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
20548896|NCT01435603|Northwestern University|Research Project Manager|312-503-3359|emily.anderson1@northwestern.edu|
20548897|NCT01602120|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
20548898|NCT00775346|Covidien|Manager, Clinical Affairs|303 305 2591|Norma.Prince@Covidien.com|
20548899|NCT02012283|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
20548900|NCT02764697|Tampa Bay Uveitis Center, LLC|Dr. Grace Levy Clarke|855 798 8393|grace@tampabayuveitis.com|
20548901|NCT00074269|UCSD|Dr. Edward Ball, Director BMT Program|858-822-6600|tball@ucsd.edu|
20573402|NCT01028027|Bausch & Lomb Incorporated|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
20573403|NCT01321151|UT Southwestern Medical Center|Megan Marks, Ph.D.|214-648-0882|megan.marks@utsouthwestern.edu|
20573404|NCT03801473|Sultan Abdulhamid Han Training and Research Hospital|Tugba Ozsoy|+902165422020|tugbaozsoyy@gmail.com|3876
20573405|NCT02775695|Froedtert and the Medical College of Wisconsin|Susan Tsai, MD|414-805-9720|stsai@mcw.edu|
20573406|NCT04546789|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20573407|NCT00790751|Vivus, Inc|Wesley W Day PhD|650-934-5200||
20573408|NCT00286078|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
20573409|NCT04016558|University of California, San Francisco|Danielle Hessler|415-476-6196|danielle.hessler@ucsf.edu|
20573410|NCT02572843|Swiss Cancer Institute|Regulatory Affairs|+41 31 389 91 91|regulatory@swisscancerinstitute.ch|
20573411|NCT04118374|Vanderbilt University Medical Center|Justin M Gregory, MD, MSCI|(615) 322- 7427|metabolism@vumc.org|
20573412|NCT01078454|ECOG Statistical Office|Study Statistician|617-632-3012||
20573413|NCT05227703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20573414|NCT03464097|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20573415|NCT03035201|Wake Forest University School of Medicine|Mark Espeland, PhD; Multiple Principal Investigator|336-716-2826|mespelan@wakehealth.edu|
20573416|NCT02390050|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20573417|NCT01522469|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20573418|NCT00112047|Gilead Sciences|Dara Wambach MA, Associate Director, Regulatory Affairs|650-522-5163|dara.wambach@gilead.com|
20573419|NCT03727438|Department of Veteran Affairs ADAPT|Jennifer Zervakis|919 286-0411|jennifer.zervakis@va.gov|17 6174
20548902|NCT04547712|Medtronic Neuromodulation|Helen Berrier|763-526-8178|helen.berrier@medtronic.com|
20573420|NCT03170349|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20573421|NCT02491632|UT MD Anderson Cancer Center|Sriram Yennu,MD- Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20573422|NCT00235547|University of Washington|Dr. Sarah Prager|415-206-8715|pragers@uw.edu|
20573423|NCT01912456|CSL Behring GmbH|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20548903|NCT03298867|Horizon Pharma USA, Inc.|Suzy Hammel|866-479-6742|clinicaltrials@horizontherapeutics.com|
20573424|NCT03442985|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20548904|NCT01995825|U of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
20548905|NCT01798004|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20573425|NCT01640054|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20548906|NCT04680052|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20548907|NCT01367002|Yale School of Medicine|Alessandro Santin, MD|(203) 200-4176|alessandro.santin@yale.edu|
20573426|NCT00029172|Roudebush VAMC Center of Excellence|Dr. Linda Williams|317-988-3337|linda.williams6@va.gov|
20573427|NCT01620255|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20573428|NCT03077360|"University of Colorado Denver | Anschutz"|Bryan Bergman|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20573429|NCT01557283|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573430|NCT01716117|Stryker Neurovascular|Scott Courts, Clinical Program Manager|5104132170|scott.courts@stryker.com|
20573431|NCT03645057|University of Rochester|Julie Ryan|(585) 276-3862|Julie_Ryan@URMC.Rochester.edu|
20573432|NCT01206777|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-688-7942|Jeffrey.Jones@osumc.edu|
20573433|NCT03607539|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
20573434|NCT04187053|University of Texas Health Science Center at Houston|Srinivas Ayilavarapu, BDS, DSc, MDS|713-486-4390|srinivas.ayilavarapu@uth.tmc.edu|
20573435|NCT01155375|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com|
20573436|NCT00975507|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573437|NCT01295034|Icahn School of Medicine at Mount Sinai|Andrea D. Branch PhD|212 659 8371|andrea.branch@mssm.edu|
20573438|NCT03818204|VA Central Western Massachusetts|Kevin Houston|781-588-7674|kevin.houston2@va.gov|
20573439|NCT00887250|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20573440|NCT05754333|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20573441|NCT03864146|Minneapolis VAHCS|Eric Dieperink, MD|612-467-4010|eric.dieperink@va.gov|
20548908|NCT06956170|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20573442|NCT00824161|The University of Texas M.D. Anderson Cancer Center|Scott Kopetz, MD|713-792-2828||
20573443|NCT04981366|University of São Paulo|Prof. Hamilton Roschel|+55 11 30618789|hars@usp.br|
20573444|NCT01112306|Actelion Pharmaceuticals Ltd|Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20573445|NCT00881608|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
20573446|NCT03214094|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20573447|NCT00848926|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20573448|NCT02832154|Wake Forest University Health Sciences|Study coordinator|336-713-5061|drlittle@wakehealth.edu|
20573449|NCT00966277|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20573450|NCT03339570|Hospital Gregorio Maranon|Dr. Mikel Aburto|34915868000|mikelaburto@hotmail.com|7007
20573451|NCT01952054|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
20573452|NCT03421431|Enanta Pharmaceuticals|Kristin Sanderson|617-607-0775|ksanderson@enanta.com|
20573453|NCT00141726|University of Michgan Comprehensive Cancer Center|Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
20573454|NCT04147650|Aurinia Pharmaceuticals|Clinical Trial Support|(250) 744-2487|clinicaltrials@auriniapharma.com|
20573455|NCT01959516|Novartis Pharmaceuticals|Study Director|862-778-8300||
20573456|NCT01477333|United Therapeutics Corp.|Kevin LaLiberte, PharmD|919-425-8176|KLaliberte@unither.com|
20573457|NCT01178671|Research Foundation for Mental Hygiene|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
20573458|NCT02435966|Physios & Universidad Europea de Madrid|Gracia M. Gallego, M.Sc.|+34 609036607|gracia.maria.gallego@gmail.com|
20548909|NCT01516437|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548910|NCT01332500|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548911|NCT01650844|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
20573459|NCT04620811|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20573460|NCT01078675|AstraZeneca, R&D, B&I|Niklas Berglind, GPS|+46317766310|niklas.berglind@astrazeneca.com|
20573461|NCT02501538|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20573462|NCT01366495|Friends Research Institute|Dr. Michael S. Gordon, Senior Research Scientist|410-837-3977|mgordon@friendsresearch.org|251
20573463|NCT01765465|DongGuk University Ilsan Hospital|Dr. In Woong Han||cardioman76@gmail.com|
20573464|NCT03311334|Sumitomo Pharma America|Mimi M. Lee, MSW, CCRP|617-674-6800|mimi.lee@oncology.sumitomo-pharma.com|
20573465|NCT01804062|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
20573466|NCT02745392|Zosano Pharma Corporation|Dr. Donald Kellerman|(510) 745-4004|dkellerman@zosanopharma.com|
20573467|NCT02513303|Vascular Therapies, Inc.|Rakesh Raghubanshi|9176204369|rakesh@vasculartx.com|
20573468|NCT02004353|Cochlear|Jasmin Kaur|+41612058238|jakaur@cochlear.com|
20573469|NCT01691768|CAPRISA|Nonhlanhla Yende-Zuma|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
20573470|NCT04023110|University of Pennsylvania|Bonnie Ky, MD, MSCE|215-573-6606|bonnie.ky@pennmedicine.upenn.edu|
20573471|NCT00819390|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20573472|NCT01191268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20573473|NCT00336895|UPittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
20573474|NCT01959334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20573475|NCT03362879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20573476|NCT01007448|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
20573477|NCT02481947|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
20573478|NCT01337115|Centro Hospitalar do Porto|Dr Raul Carvalho|+351226176114|raul@meo.pt|
20573479|NCT03426267|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
20573480|NCT02094755|University of Southern California|Dr. Leonardo Clavijo|3234426130|lclavijo@usc.edu|
20573481|NCT00527592|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
20573482|NCT01636960|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573483|NCT01209780|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20573484|NCT02464033|Linkoeping University|Johnny Ludvigsson, MD, PhD, Prof Linkoeping University|+46 13 28 68 54|Johnny.Ludvigsson@liu.se|
20573485|NCT02112708|Institut Català de la Salut|Principal Investigator: Carme Rovira Aler|+34686838979|crovira.bcn.ics@gencat.cat|
20573486|NCT03110185|Washington University School of Medicine Department of Anesthesiology|Dr. Ben Palanca|314-273-9076|palancab@wustl.edu|
20573487|NCT02250092|University of Minnesota|Bernadette Gillick|612-626-6415|gillick@umn.edu|
20573488|NCT03075410|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20573489|NCT02053792|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20573490|NCT01427751|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20573491|NCT04948333|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20573492|NCT03804502|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
20573493|NCT05330312|Vicore Pharma|Director Clinical Operations|+46317880560|info@vicorepharma.com|
20573494|NCT05849103|Vanderbilt University Medical Center|Sarah Osmundson, MD, MS|6158752231|sarah.osmundson@vumc.org|
20573495|NCT05572021|Atrium Health|Greg Scarola, MS, MBA|704-355-5766|Gregory.Scarola@advocatehealth.org|
20548912|NCT01687998|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20573496|NCT03432260|DURECT Corporation|Director of Regulatory Affairs|408-777-1418|jill.burns@durect.com|
20573497|NCT02186847|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20573498|NCT01307579|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20573499|NCT02871258|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20573500|NCT05370521|Spruce Biosciences|Chief Medical Officer|415-655-4169|clinicaltrials@sprucebio.com|
20573501|NCT04873232|Helixmith, Co., LTD|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
20573502|NCT03938545|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
20573503|NCT01060540|Durham VA Medical Center|Corrine Voils, PhD|919-286-0411|corrine.voils@va.gov|5196
20573504|NCT04262947|Lahey Hospital and Medical Center|Thomas Schnelldorfer|781-744-5100|thomas.schnelldorfer@lahey.org|
20573505|NCT01222507|Washington University|Dr. Jay Piccirillo|314-362-7508|piccirilloj@ent.wustl.edu|
20573506|NCT02647320|Daiichi Sankyo|Daiichi Sankyo Contact for Clinical Trial Information|+81-3-6225-1111(M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
20573507|NCT00596427|Kinemed, Inc|Carine Beysen, PhD|5106556525|cbeysen@kinemed.com|123
20573508|NCT00320541|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20573509|NCT01605292|Long Beach VA Medical Center|Arnold Seto, MD, MPA|(562) 826-8000|arnold.seto@va.gov|5486
20573510|NCT03836989|Oregon Health and Science University|Dr. Myriam Loyo|503-494-8510|loyo@ohsu.edu|
20573511|NCT01650246|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6721|mfung@ardeabio.com|
20548913|NCT01663532|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20548914|NCT02432729|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|christelle.haziza@pmi.com|
20548915|NCT04805541|Akdeniz University|Prof.Dr. Ahmet Burak Bilgin|5465473336|gozdrburakbilgin@gmail.com|
20548916|NCT03695250|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20548917|NCT03243071|NYU Langoen Health|Girardin Jean-Louis, PhD|646-501-3431|Girardin.Jean-Louis@nyulangone.org|
20548918|NCT03542474|Northwestern University|Dr. Daniel Corcos|312-908-6792|daniel.corcos@northwestern.edu|
20573512|NCT04281004|University of Utah|Mark Mifflin, MD|801-583-4152|mark.mifflin@hsc.utah.edu|
20573513|NCT00701779|Deaconess Clinic, Inc.|Paul F. Siami, MD CPI|812-426-9576|research.paul.siami@deaconess.com|
20548919|NCT02958293|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
20548920|NCT02195583|GlaxoSmithKline|GSK Response Center|866-435-7343||
20548921|NCT00354744|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20548922|NCT00983437|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20548923|NCT00094172|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20548924|NCT01020981|VHA HSR&D|Marcia Valenstein, MD|7349453649|marcia.valenstein@va.gov|
20548925|NCT00993200|University of Utah|Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
20548926|NCT00289133|DePuy Orthopaedics, Inc.|Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
20548927|NCT01691339|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20573514|NCT02482870|Recep Tayyip Erdogan University School of Medicine|Dr. Başar Erdivanlı|+904642130491|berdivanli@gmail.com|2128
20548928|NCT02555683|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20573515|NCT01322048|Vanderbilt University Medical Center|Mayur B. Patel|6153225000|mayur.b.patel@vanderbilt.edu|
20548929|NCT00612040|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20573516|NCT01873495|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
20548930|NCT00827502|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20573517|NCT00876694|Novartis Pharmaceuticals|Study Director|862-778-8300||
20573518|NCT00288509|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
20548931|NCT02614586|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20548932|NCT02924571|NYU Langone Health|Themistocles Protopsaltis|646-501-7200|themistocles.protopsaltis@nyulangone.org|
20573519|NCT02382016|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
20548933|NCT03783949|UZLeuven|Ellen Reynders, SC|+3216342996|ellen.reynders@uzleuven.be|
20548934|NCT00002651|SWOG Statistical Center|Study Statistician|206-667-4623||
20548935|NCT00944671|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20573520|NCT00084266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20548936|NCT03750955|University of Washington|Dr. Diane Daubert|206-685-3766|ddaubert@uw.edu|
20548937|NCT00304746|McLean Hospital|Harrison G Pope Jr., M.D.|617-855-2911|hpope@mcLean.harvard.edu|
20573521|NCT01535014|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20548938|NCT01431989|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573522|NCT00730171|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
20573523|NCT02047643|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
20573524|NCT04256603|MetroHealth|c. kim|216 778 7800|ckim3@metrohealth.com|
20573525|NCT01386788|EKoch|Ernst Koch|++49 6257 1788|Ernst.MW.Koch@t-online.de|
20573526|NCT00120406|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
20573527|NCT00762970|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
20573528|NCT00879762|Saint Louis University Medical Center|Sharon E. Frey, M.D.|315-977-5500|sharon.frey@health.slu.edu|
20573529|NCT01115660|Wake Forest School of Medicine|Dr. Cheryl Bushnell|(336) 716-2357|cbushnel@wakehealth.edu|
20573530|NCT01313637|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573531|NCT01274585|Massachusetts General Hospital|Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients|617-643-0541|lsavitt@partners.org|
20573532|NCT00676065|Center for Epidemiology and Health Research Germany|Juergen Dinger, MD, PhD|+49 30 945 101 20|dinger@zeg-berlin.de|
20573533|NCT00795951|Rady Children's Hospital, San Diego, CA|SE Jacob, MD and L Eichenfield, MD|858-576-1700|leichenfield@rchsd.org|4825
20573534|NCT00427336|UT MD Anderson Cancer Center|Paolo Anderlini, MD / Professor||mvpacheco@mdanderson.org|
20573535|NCT00816348|NSLIJ Health System|Cindy Haller MD|516-472-3650|challer@lij.edu|
20573536|NCT04572841|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20573537|NCT06469242|Alcon Research, LLC|Sr. Principal, Clinical Project Management, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20573538|NCT01205152|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
20573539|NCT05093699|Mayo Clinic|Dr Robert Anderson|507-284-4341|anderson.robert2@mayo.edu|
20573540|NCT00211185|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20573541|NCT02783768|CUIMC|Elizabeth C. Oelsner, MD, MPH|212-305-9056|eco7@cumc.columbia.edu|
20573542|NCT01323647|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573543|NCT00986674|ECOG Statistical Office|Study Statistician|617-632-3012||
20573544|NCT01468831|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
20573545|NCT00842985|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20573546|NCT01037244|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20573547|NCT02203695|Johns Hopkins University, School of Medicine|Dr. Daniel Song|410-502-5875|dsong2@jh.edu|
20548939|NCT02763462|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
20548940|NCT02100514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573548|NCT04316182|APICES|Juan Luis Sanz (MW)|+34 918166804|juanluis.sanz@apices.es|103
20573549|NCT01127139|Abbott|Global Medical Services|1-800-633-9110||
20573550|NCT02959450|INCMNSZ|Dr. Aurora Serralde|+52-55-54870900|aurora.serraldez@incmnsz.mx|2193
20573551|NCT02070588|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
20573552|NCT02388646|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
20573553|NCT02216357|Cumberland Pharmaceuticals Inc.|Senior Manger, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|250
20573554|NCT00972205|National Cancer Institute (NCI), National Institutes of Health (NIH)|Susan S. Bates, M.D.|301-402-0984|Batess@mail.nih.gov|
20573555|NCT00235326|McMaster University|John Marshall|9055212100|marshllj@mcmaster.ca|76782
20573556|NCT01849822|California Institute of Technology|Dr. Richard Andersen|16263958336|andersen@vis.caltech.edu|
20573557|NCT02316366|Nationwide Children's Hospital|Dr. Renee Quarrie, fellow|2037136871|reneepetagae@gmail.com|
20573558|NCT00928746|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573559|NCT02955147|Mass General Hospital|Dr. Sebastian Unizony|(617) 726-7938|sunizony@mgh.harvard.edu|
20573560|NCT02294227|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
20573561|NCT00887432|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
20573562|NCT00899548|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Antonio C. Wolff, M.D.|410-614-4192|awolff@jhmi.edu|
20573563|NCT00551460|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
20573564|NCT01580969|Huntsman Cancer Institute|Josiah Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
20573565|NCT01745848|University of Pittsburgh|Dr. Jessica Bon Field|412-648-6494|bonjm@upmc.edu|
20573566|NCT03463161|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
20573567|NCT02027623|Washington University|Linda van Dillen, PT, PhD, FAPTA; Research Division Director|314-286-1427|vandillenl@wustl.edu|
20573568|NCT05007808|Buzzz Pharmaceuticals Limited|Deirdre O'Keefe, PhD, Head of IP and Portfolio Management|+447733104786|deirdre@hotmail.co.uk|
20573569|NCT01886378|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20573570|NCT01736865|Tufts Medical Center|Dr. Anastassios Pittas|617-636-5694|apittas@tuftsmedicalcenter.org|
20573571|NCT00815685|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D., via Moffitt Cancer Center|813-745-6885|nagi.kumar@moffitt.org|
20573572|NCT03143816|Barbara Davis Center for Diabetes, University of Colorado|Satish Garg MD|3037246713|satish.garg@ucdenver.edu|
20527784|NCT03525808|Boston Scientific|Ornela Gjata|(508)-683-4155|Ornela.Gjata@bsci.com|
20527785|NCT00904917|Children's Hospital of Philadelphia|Rhonda C. Boyd, Ph.D.|215-590-3945|boydr@email.chop.edu|
20527786|NCT00762034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20527787|NCT02442206|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20527788|NCT00497146|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20527789|NCT01471444|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
20548941|NCT00319553|Sanofi Pasteur Inc.|Medical Director||RegistryContactUS@sanofipasteur.com|
20548942|NCT02673138|Yale Pediatric Diabetes|Neha S. Patel, DO|203-764-6747|neha.patel@yale.edu|
20548943|NCT00885846|Bastyr University|Guan-Cheng Sun, PhD|425-602-3389|gsun@bastyr.edu|
20548944|NCT00880542|University of Calicornia Los Angeles (UCLA)|William Tap, MD|888-798-0719|wtap@mednet.ucla.edu|
20573573|NCT02656160|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
20573574|NCT03513588|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573575|NCT00505284|Eisai Call Center|Eisai Inc.|888-422-4743||
20573576|NCT00940108|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20573577|NCT01275131|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|(858)794-8889||
20573578|NCT02292654|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20573579|NCT01740323|Emory University|Andrew Miller, MD|404-727-8260|amill02@emory.edu|
20573580|NCT02858349|University of Cincinnati|Pierce Boyne|5135587499|Pierce.Boyne@uc.edu|
20573581|NCT06172881|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD, MS|614-292-0882|fogt.78@osu.edu|
20573582|NCT01911065|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20573583|NCT02594826|Fox Chase Cancer Center|Dr. Carolyn Fang|1-888-369-2427|carolyn.fang@fccc.edu|
20573584|NCT01422226|University of Colorado Denver|Christina Gavito|303-724-5559|christina.gavito@ucdenver.edu|
20573585|NCT00709696|University of Minnesota|Dr. Marc Mooney|612-991-6875|moon0078@umn.edu|
20573586|NCT00001962|NIH National Heart, Lung and Blood Institute|Neal Young MD|301-496-5093|youngns@nhlbi.nih.gov|
20573587|NCT00171704|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
20573588|NCT00231153|Cadence Pharmaceuticals, Inc.|Catherine Hardalo, MD Vice President Anti-Infectives, Clinical Development|858-436-1439|chardalo@cadencepharm.com|
20573589|NCT00081770|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20573590|NCT02268474|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20573591|NCT03435497|RAND Corporation|Laura Bogart, PhD|3103930411|lbogart@rand.org|7281
20573592|NCT00362453|Tufts Medical Center|Chenchen Wang, MD, MSc, Associate Professor|617-636-3251|cwang2@tuftsmedicalcenter.org|
20573593|NCT01217957|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20573594|NCT01765192|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20573595|NCT01146054|Stanford University Comprehensive Cancer Center|Albert C. Koong, M.D., Ph.D., Sue and Bob McCollum Professor, Associate Chair of Radiation Onocology|650-498-7703|akoong@stanford.edu|
20573596|NCT00388453|Vanderbilt University|Michael Vaezi, MD, PhD|615.322.3739|michael.vaezi@vanderbilt.edu|
20508740|NCT01822223|University of Alabama at Birmingham|Michael S. Reddy, DMD, DMSc|2059344720|mreddy@uab.edu|
20508741|NCT02758119|iLumens|David Drummond|0033144494848|david.drummond@ilumens.org|6
20508742|NCT02679781|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+97226776135|fuxavia@gmail.com|
20508743|NCT04209400|VBI Vaccines Inc.|Dr Francisco Diaz-Mitoma|613-297-3304|fdiazmitoma@vbivaccines.com|
20508744|NCT03404518|Loma Linda University Health System|Khanh Nguyen, MD|909-558-8558|khanguyen@llu.edu|
20573597|NCT02901041|Boston University|Dr. Todd Farchione|(617) 353-9610|tfarchio@bu.edu|
20573598|NCT01480674|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20573599|NCT03249714|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20508745|NCT01602549|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557020|NCT01165775|Stanford School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
20557021|NCT04981678|MaineHealth, Department of Anethesiology|Lead Research Coordinator|207-662-2862|janelle.richard@mainehealth.org|
20573600|NCT01996813|Loyola University Medical Center|Douglas Evans, M.D.|708-216-2523|devans@lumc.edu|
20573601|NCT00605644|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20573602|NCT00655863|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20573603|NCT05580588|Shanghai Pharma Biotherapeutics USA Inc.|CSO|8587755354|kenneth@sphbio.com|
20573604|NCT05103228|Dunamenti REK IVF Center (former Kaali Institute)|Dr Peter Kovacs|+3612022802|peterkovacs1970@hotmail.com|
20573605|NCT00712673|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20573606|NCT03603028|UAB|David A. Brown|205-975-2788|dbrownpt@uab.edu|
20573607|NCT02963610|Fox Chase Cancer Center|Hossein Borghaei, DO, MS|215-214-4297|Hossein.Borghaei@fccc.edu|
20573608|NCT00063154|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20573609|NCT01122862|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573610|NCT01222273|Children's Hospital of Pittsburgh of UPMC|Joseph M. Pilewski, MD|(412) 692-2164|pilewskijm@upmc.edu|
20573611|NCT00846391|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573612|NCT02924064|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
20573613|NCT02699983|Rutgers Robert Wood Johnson Medical School|Jeanne Ferrante|848-932-5252|jeanne.ferrante@rutgers.edu|
20573614|NCT03575143|University of California San Diego|Robert L. Owens, MD|8586575258|rowens@health.ucsd.edu|
20573615|NCT02566265|Yale University School of Medicine|Andrew Branagan, MD|617-459-5234|andrew.branagan@yale.edu|
20573616|NCT02875977|Loyola University Medical Center|Cynthia Brincat, M.D., Ph.D.|708-216-2180|cbrincat@lumc.edu|
20573617|NCT04040400|University of Louisville Brown Cancer Center|Shiao Woo, MD Principal Investigator|502-562-4360|shiao.woo@louisville.edu|
20573618|NCT01790126|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20573619|NCT00700973|VA Palo Alto Health Care System|Christine Timko|650-617-2746|Christine.Timko@va.gov|
20573620|NCT02145247|UCSDMED|R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
20573621|NCT02269332|Mike O'Callaghan Military Medical Center|Senior Research Associate/Research Manager|7026533583|amanda.j.crawford.ctr@health.mil|
20573622|NCT00610467|University of California Irvine|Professor|949-824-6001|msu@uci.edu|
20557022|NCT03421808|Medical University of South Carolina|Mark S. George, MD|18438765142|georgem@musc.edu|
20573623|NCT04781387|Crestone, Inc.|Vice President, Clinical Development|(609) 900-5733|lboccumini@crestonepharma.com|
20573624|NCT00679627|Johnson & Johnson Pharmaceutical Research & Development|Director, Clinical Research|1 609-730-7674||
20573625|NCT00448123|William Beaumont Hospital|Robert Swor, DO|248-89-81970|raswor@beaumont.edu|
20557023|NCT04574882|University of Pennsylvania|Director of Research|2674280125|digitalhealth@pennmedicine.upenn.edu|
20573626|NCT02318797|University of Pittsburgh Department of Psychiatry|Charles Reynolds, MD|412-246-6414|reynoldscf@upmc.edu|
20573627|NCT00645047|University of California San Diego|Zia Agha|858-552-8585|zagha@ucsd.edu|
20548945|NCT03719612|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
20573628|NCT01105754|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
20573629|NCT00511472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573630|NCT01079741|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
20573631|NCT02709096|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
20573632|NCT00446992|University of Nevada School of Medicine|Dr. Brian Kirkpatrick|775-682-8459|bkirkpatrick@medicine.nevada.edu|
20573633|NCT00406653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20573634|NCT00818649|Masonic Cancer Center, University of Minnesota|Erica Warlick, M.D.|612-625-5467|ewarlick@umn.edu|
20573635|NCT06338462|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
20573636|NCT00390182|University of Maryland Baltimore|Nancy Kennedy|410-328-2513|nkennedy@umm.edu|
20573637|NCT02791945|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
20573638|NCT00069238|National Cancer Institute|Dr. Wyndham WIlson|301-435-2415|wilsonw@mail.nih.gov|
20573639|NCT01001832|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20548946|NCT05091047|Erchonia Corporation|Clinical Affairs Manager|888.242.0571|tsammons@erchonia.com|
20548947|NCT01496248|Krea University College of Medicine|Young-Hoon Ko|+82-31-412-5140|korean@chol.com|
20548948|NCT02127710|AstraZeneca|Senior Medical Director, Savolitinib||ClinicalTrialTransparency@astrazeneca.com|
20548949|NCT04718961|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20548950|NCT02727842|Cochlear Americas|Kimberly Nix, Clinical Project Manager|303-264-2340|knix@cochlear.com|
20548951|NCT00003487|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20548952|NCT03407625|University of Texas Southwestern Medical Center|Emily Adhikari, MD|214-648-7825|emily.adhikari@utsouthwestern.edu|
20548953|NCT02197273|OhioHealth|Deborah Napier|614-566-5575|Deborah.Napier@ohiohealth.com|
20548954|NCT04154930|Galderma|Clinical Project Manager|817-961-5655|aestheticclinicaltrials@galderma.com|
20548955|NCT00657358|UAB|Dr. Michael Froelich|205-975-0145|froelich@uab.edu|
20573640|NCT02453360|University of Wisconsin School of Medicine|Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
20508746|NCT01962688|Icahn School of Mediine at Mount Sinai|Dr. Jagat Narula|212-241-4122|jagat.narula@mountsinai.org|
20548956|NCT00515411|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
20548957|NCT02628938|Riyadh Colleges of Dentistry and Pharmacy|Dr. Mohammad Rayyan|00966508821318|mohammadrayyan1979@gmail.com|
20573641|NCT00953745|Washington University School of Medicine|Dr. Charles R. Conway, MD|314-362-7566|conwayc@psychiatry.wustl.edu|
20573642|NCT03527238|University of Florida|Ali Zarrinpar|352-265-0606|ali.zarrinpar@surgery.ufl.edu|
20573643|NCT03063125|University of Kansas Medical Center|Katie Glavin|913-588-8721|kglavin@kumc.edu|
20573644|NCT01427595|University of Virginia Center for Research in Reproduction|Dr. Christine Burt Solorzano|4342436911|pcos@virginia.edu|
20573645|NCT02427464|Helixmith Co., Ltd.|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
20573646|NCT00557947|Ethicon Inc|John Lombard|908-218-2877|Jlombar8@its.jnj.com|
20573647|NCT03756129|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20573648|NCT04576455|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20573649|NCT01340196|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573650|NCT03660553|The Lundquist Research Institute|Rajesh Garg|310-222-1968|rajesh.garg@lundquist.org|
20573651|NCT01709747|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
20573652|NCT04109196|Rush University Medical Center|Dr. Philip Held|312-942-1423|philip_held@rush.edu|
20573653|NCT00604279|Xian-Janssen Pharmaceutical Ltd|Local Trial Manager|86-10-5821 8213||
20573654|NCT00816400|MedImmune|A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575|1-877-240-9479|information.center@astrazeneca.com|
20573655|NCT00601419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573656|NCT01786174|Massachusetts General Hospital|James D. Berry, MD, MPH|617-726-5097|jdberry@mgh.harvard.edu|
20573657|NCT01614197|Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL)|Roy Leong|323-361-5132|rleong@chla.usc.edu|
20573658|NCT01824160|Johns Hopkins University|RICHARD RINGEL|410-714-6745|rringel@jhmi.edu|
20573659|NCT03628898|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
20573660|NCT02245672|Mylan Pharma UK Ltd|Dik Ng, PhD|+44-7467-941703|dik.ng@mylan.co.uk|
20573661|NCT00971932|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20573662|NCT04344600|Johns Hopkins School of Medicine|Mark Sulkowski|410-955-7538|msulkowski@jhmi.edu|
20573663|NCT01729156|Department of Nuclear Medicine & PET Centre, Aarhus University Hospital|Lars C. Gormsen, Consultant|004578456260|lars.christian.gormsen@clin.au.dk|
20573664|NCT01215422|UNIVERSITY OF ALBERTA|DR. JOAN ROBINSON|780-248-5540|jr3@ualberta.ca|
20573665|NCT06336603|Regulatory Affairs|Head|9122 66455645|Clinical.Trial@sunpharma.com|
20573666|NCT05398016|University of Nevada Las Vegas|Dr. Brenna Renn, PI|7028950569|brenna.renn@unlv.edu|
20573667|NCT04335812|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
20573668|NCT02113241|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20573669|NCT03890419|Duke University|Padma Gulur|919-681-4660|padma.gulur@duke.edu|
20573670|NCT02169453|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20573671|NCT02434939|Makerere University ,College of Health Sciences, Department of Anesthesia and Critical care|Dr.Lubega Felix Anthony|+256777756571|falubega@chs.mak.ac.ug|
20573672|NCT03581825|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
20548958|NCT02058693|Collaborative Behavioral Health|Michael Topel PsyD|847-922-3253|michaeltopel@gmail.com|
20573673|NCT01668667|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20573674|NCT00979810|Memorial Sloan Kettering Cancer Center|Michelle Bradbury, MD, PhD|646-888-3373|bradburm@mskcc.org|
20573675|NCT06020118|Duke University|Dr. Emmanuel Walter|919 620 5346|chip.walter@duke.edu|
20573676|NCT03562247|Vanderbilt University Medical Center|Lisa Lancaster, MD|615-322-2386|lisa.lancaster@vumc.org|
20573677|NCT03525431|University of California, San Francisco|Mary Norton|(415) 476 4080|mary.norton@ucsf.edu|
20573678|NCT01723254|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573679|NCT01564628|Acarix A/S|Claus Christensen|+45 29724411|dkcbc@acarix.com|
20573680|NCT04640077|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20573681|NCT01257425|Ipsen|Director, Uro-oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20573682|NCT01822301|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
20573683|NCT04262817|Yale School of Medicine|Asti Jackson, Ph.D.|475-241-4904|asti.jackson@yale.edu|
20573684|NCT03430206|Stanford University|Thomas Caruso, MD, MEd|(626) 275-0341|tjcaruso@stanford.edu|
20573685|NCT00368992|SWOG|Lung Committee Statistician|206-667-4623||
20573686|NCT04877730|University of Virginia|Sue Brown|434-982-0602|sab2f@virginia.edu|
20573687|NCT02668185|Imperial College London|Professor Wajit Dhillo|+44 (0)20 7594 2489|w.dhillo@imperial.ac.uk|
20573688|NCT01013597|University of Wisconsin Carbone Cancer Center|Abigail Mapes, Thoracic Oncology Research Program Manager|608-262-8158|acmapes@medicine.wisc.edu|
20573689|NCT00427895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573690|NCT02953860|University of Colorado|Professor Anthony Elias|720-848-0347|anthony.elias@cuanschutz.edu|
20573691|NCT00585195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573692|NCT00603720|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20548959|NCT00241358|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@wustl.edu|
20573693|NCT02796560|University of Sherbrooke|Dr Marjorie Carbonneau|819-346-1110|Marjorie.Carbonneau@USherbrooke.ca|22180
20573694|NCT03534284|University of Washington|Dr. Raj Mehrotra|206-221-7138|rmehrotr@uw.edu|
20573695|NCT04737187|Taiho Oncology, Inc.|Taiho|+1-844-878-2446|medicalinformation@taihooncology.com|
20573696|NCT03373201|Vanda Pharmaceuticals|Medical Director|202-734-3400|clinicaltrials@vandapharma.com|
20548960|NCT00843856|Imperial College NHS Trust|Dr Megan Griffith|02083835272|megan.griffith1@nhs.net|
20548961|NCT03855228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548962|NCT00590135|Cleveland Clinic|Brian Griffin MD|216-444-6812|Griffib@ccf.org|
20548963|NCT03104543|Fred Hutchinson Cancer Center|Dr. Eric Chow|206-667-7724|ericchow@uw.edu|
20548964|NCT01219673|University of Texas (UT) MD Anderson Cancer Center|Dr. David Rosenthal Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
20573697|NCT02656823|DENTSPLY IH AB,|Ulrika Bonander|31 376 30 68|ulrika.bonander@dentsplysirona.com|+46
20548965|NCT02564497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20548966|NCT01972568|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20548967|NCT02059408|University of California, San Francisco|Carmen Peralta, Professor of Medicine|415-221-4810|carmenalicia.peralta@ucsf.edu|23678
20573698|NCT00822523|Loma Linda University|Gordon Perterson, MD|909-558-4000|gpeterson@llu.edu|
20548968|NCT00957580|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20548969|NCT01468675|Brigham and Women's Hospital|Jennifer Haas, M.D.|617-525-6652|jhaas@partners.org|
20548970|NCT01540266|University Hospital Basel|Dr. med. Roland Bingisser|+41 61 265 58 30|roland.bingisser@usb.ch|
20573699|NCT01009580|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20573700|NCT01439360|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573701|NCT00345293|Rockefeller University|Mayu Frank, MS, ANP, Clinical Research Nurse Practitioner|212-327-7443|frankm@rockefeller.edu|
20573702|NCT03319849|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20573703|NCT03045068|The University of Texas Health Science Center at Houston|Nischal K Gautam, MD|713-500-6200|Nischal.K.Gautam@uth.tmc.edu|
20573704|NCT01122160|USDA|Beverly Clevidence|301-504-8367|beverly.clevidence@ars.usda.gov|
20573705|NCT00355056|St. Jude Medical|Director, Global Clinical Affairs|818-493-3648|aoza@sjm.com|
20573706|NCT01072877|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
20573707|NCT00995020|Affiliation: Oswaldo Cruz Foundation|Investigator: MJCamargo [Camargo Maria José] Official Title: PHD|00552199777009|mariaj.camargo@hotmail.com|
20573708|NCT03290196|Andrews Research and Education Foundation|Jessica Truett|8509168570|jessica.truett@andrewsref.org|
20573709|NCT02986334|Northwestern University|Apkar Vania Apkarian|312-503-0404|a-apkarian@northwestern.edu|
20573710|NCT04142450|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20573711|NCT03008707|University of Pusa|Dario Tartaglia|+393334491229|dario261184@gmail.com|
20573712|NCT01138007|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573713|NCT03548987|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20573714|NCT04661878|Duke University School of Nursing|Dr. Marta Mulawa|(919) 684-9555|marta.mulawa@duke.edu|
20573715|NCT03867175|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367130031|mfarris@wakehealth.edu|
20573716|NCT01990209|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20573717|NCT02768870|Edwards Lifesciences, LLC|Sabrina Hundt, Director, Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
20573718|NCT01774110|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
20573719|NCT00640016|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
20573720|NCT01287065|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573721|NCT01259726|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20573722|NCT00490009|Stanford University Medical Center|Susan J Knox, MD, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
20573723|NCT01211197|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573724|NCT00261846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573725|NCT00959166|Imperial College London|Prof Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
20573726|NCT02618031|Cleveland Clinic Akron General|John Elias|330-344-6176|eliasj@ccf.org|
20573727|NCT01426763|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20573728|NCT00928447|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
20573729|NCT01259284|UT MD Anderson Cancer Center|Ara Vaporciyan, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
20573730|NCT02271425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20573731|NCT03318809|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20573732|NCT00307125|DAIT/NIAID|Director, Clinical Research Operations Program (CROP)|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20573733|NCT01134016|Golden Biotechnology Corp.|Dr. Howard Cheng, Director of clinical trials|886-2808-6006|howard@goldenbiotech.com.tw|
20573734|NCT00051363|Stanford University|Deborah A. Nichols|208-908-7364|dnichols@cableone.net|
20573735|NCT00926211|Restoration Robotics|Miguel Canales, M.D.|650-965-3612|miguel@restorationrobotics.com|206
20573736|NCT01032382|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
20573737|NCT01242800|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
20573738|NCT04176848|Canadian Cancer Trials Group|Dr. Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
20573739|NCT02640157|AbbVie|Global Medical Services|800-633-9110||
20573740|NCT00710021|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20573741|NCT01679405|University Medical Center Mainz|Prof. Dr. Markus Moehler|0049613117|Markus.Moehler@unimedizin-mainz.de|7275
20573742|NCT01536015|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20573743|NCT04508023|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20573744|NCT02341859|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
20573745|NCT00511901|University of Medicine and Dentistry of New Jersey|Jeffrey L Carson, MD|732-235-7122|carson@umdnj.edu|
20573746|NCT02447172|Innocoll|Charlene A. Tucker MS, Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20573747|NCT01204398|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573748|NCT03261700|National Center for PTSD, located at the VA Boston Healthcare System|Dr. Katherine Iverson, PI|857-364-2066|katherine.iverson@va.gov|
20573749|NCT00770341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com|
20573750|NCT03995667|Oregon Health & Science University|Dr. Timur Mitin, MD, PhD|503-494-8756|mitin@ohsu.edu|
20573751|NCT02533570|Seattle Genetics, Inc|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20573752|NCT00529958|University of Calgary Sport Medicine Centre|ACL RCT Research Coordinator|403-220-8944|aclstudy@ucalgary.ca|
20573753|NCT03816332|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20573754|NCT04947527|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
20573755|NCT03316300|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20573756|NCT03164564|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
20573757|NCT01910181|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20573758|NCT01340651|Incyte Corporation|Study Director|855 463-3463||
20573759|NCT01315353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20573760|NCT03567434|Baylor University|Dr. Jason Carter|254-710-4499|jason_carter1@baylor.edu|
20573761|NCT04469270|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20573762|NCT01607112|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573763|NCT05269355|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20573764|NCT01050790|Virginia Commonwealth University/Massey Cancer Center|Amir A. Toor, MD, Associate Professor of Medicine|804-828-4360|atoor@mcvh-vcu.edu|
20508747|NCT04482244|Dana-Farber Cancer Institute|Dr. Manan Nayak|617-632-5096|manan_nayak@dfci.harvard.edu|
20508748|NCT02823080|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
20508749|NCT00676208|Louis Stokes VA Medical Center|Michelle Davidson|(216) 791-2300|michelle.davidson@va.gov|2338
20508750|NCT03906136|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20508751|NCT04772469|University of California San Francisco|Dr. Carol Camlin|5109679558|Carol.Camlin@ucsf.edu|
20508752|NCT00878644|University of Utah|Marianne Gildea, BSN, MS; Director of THAPCA Trials|801-608-4907|marianne.gildea@hsc.utah.edu|
20508753|NCT01389076|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
20573765|NCT01880528|Mayo Clinic|Terence T Sio, MD, MS|480/301-7050|Sio.Terence@mayo.edu|
20548971|NCT00190671|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20548972|NCT04502433|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20573766|NCT00081497|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20573767|NCT02254278|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@gmail.com|
20548973|NCT02699593|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO -Sr. Principal Research Optometrist|904 443-1290|BPALL@its.jnj.com|
20548974|NCT01681472|Isofol Medical|Anders Rabbe|+46 (0)707 64 65 00|anders.rabbe@isofolmedical.com|
20548975|NCT00795145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20548976|NCT02556554|Regents of the University of Colorado|Sarit Polsky, MD, MPH|3037248575|sarit.polsky@ucdenver.edu|
20548977|NCT01696071|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573768|NCT06609135|UMASS Chan Medical School|Dr. Lawrence Rhein, Chair of Pediatrics at UMASS Chan Medical School|5083346581|lawrence.rhein@umassmemorial.org|
20573769|NCT05437510|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20548978|NCT04203797|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20573770|NCT03573401|Biofrontera Bioscience GmbH|Research and Development|+49 214 876 32|regulatory@biofrontera.com|66
20548979|NCT01999179|Versiti|Dr Lisa Baumann Kreuziger|414-937-6826|lisakreuziger@versiti.org|
20548980|NCT01752985|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20573771|NCT02884427|Universidad Andrés Bello|Professor Hernán Andrés de la Barra O., DC,PT,Mg|56226618402|quiropraxiayequilibrio@gmail.com|
20573772|NCT04878731|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573773|NCT01097785|University of Missouri|Paul Fadel|1-573-884-5220|fadelp@health.missouri.edu|
20573774|NCT05779397|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
20573775|NCT02730988|Wake Forest University|Kristen Beavers|3367585855|beaverkm@wfu.edu|
20573776|NCT01256658|Novartis|Study Director|41 61 324 1111||
20573777|NCT03330457|Portola Pharmaceuticals|Head of Clinical Development|650-246-7000|ClinicalTrials@Portola.com|
20527790|NCT01225926|Alcon Research, Ltd.|Manoj Venkiteshwar, Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20573778|NCT00719563|University of Michigan School of Nursing|Debra L. Barton, RN, PhD, AOCN, FAAN|734-763-3868|debbartn@umich.edu|
20573779|NCT00294554|Johns Hopkins University School of Medicine|Laura Marsh, MD|713-794-8907|laura.marsh2@va.gov|
20527791|NCT03972501|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
20527792|NCT01709409|OHRI|Dr. Brigitte Lemyre|613-737-8899|blemyre@toh.on.ca|71882
20527793|NCT01741350|University of Connecticut|Dr. Michael M. Copenhaver, Ph.D.|860 208-3632|michael.copenhaver@uconn.edu|
20527794|NCT02412878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20527795|NCT02190721|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|USMedInfo@tevapharm.com|
20527796|NCT04571385|Acesion Pharma|Birgitte Vestbjerg|+45 20772575|bve@acesionpharma.com|
20527797|NCT04046263|"University of Colorado Denver | Anschutz"|Jessica Kendrick, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20527798|NCT04676152|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20527799|NCT01928199|Washington University in St. Louis|Rowena Delos Santos|314-362-8351|delossantos@wustl.edu|
20527800|NCT00755261|SKCCC, Johns Hopkins University|Christian Meyer, M.D., Ph.D.|4105025940|cmeyer13@jhmi.edu|
20527801|NCT02107313|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
20573780|NCT00462865|BrUOG|Bachir Sakr, MD|4018633000|kayla_rosati@brown.edu|
20527802|NCT02830074|John D. Dingell VA Medical Center|Dr. M.Safwan Badr, MD, Ph.D.|3135763548|m.badr@va.gov|
20573781|NCT02864381|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20527803|NCT01031004|Vistakon|John Buch/Principal Research Optometrist|904-443-1707||
20527804|NCT02788188|National Institute of Allergy and Infectious Diseases|Davey, Richard|+1 301 496 8029|rdavey@niaid.nih.gov|
20527805|NCT01214668|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20527806|NCT02815267|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20527807|NCT01108237|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
20527808|NCT01681095|William Beaumont Hospital|Marc P. Sakwa, M.D.|248/898-0123|marc.sakwa@beaumont.org|
20573782|NCT02120625|Nimbus Concepts, LLC|J. Scott Bainbridge, MD (PI)|303-522-5219|jscottbainbridge@gmail.com|
20573783|NCT01917513|Helios Dr. Horst Schmidt Kliniken, Wiesbaden, Germany|Prof. Ralf Kiesslich||ralf.kiesslich@hsk-wiesbaden.de|
20573784|NCT00887679|Duke University Medical Center|Dr. Ashwin A Patkar Associate Professor|919-668-3626|ashwin.patkar@duke.edu|
20573785|NCT02683941|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20573786|NCT03136328|Montefiore Medical Center|Charito Love, MD|718-406-8462|clove@montefiore.org|
20573787|NCT00325039|New England Research Institutes, Inc.|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
20573788|NCT02287376|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
20573789|NCT01009203|University of Pittsburgh Medical Center|Julie E. Bauman, MD|4126486507|baumanje@upmc.edu|
20573790|NCT01776424|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20573791|NCT00426153|Mayo Clinic|Marie Hogan, MD, PhD, Assistant Prof of Medicine, College of Medicine|507-266-9364|hogan.marie@mayo.edu|
20573792|NCT00615836|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20573793|NCT01630434|TransMedics, Inc.|VP, Clinical Affairs|978.552.0900|ldamme@transmedics.com|
20573794|NCT00687973|Novartis Pharmaceuticals|Study Director|862 778-8300||
20573795|NCT03554954|National University of Singapore|Dr. Kim Jung Eun|65161136|fstkje@nus.edu.sg|+65
20573796|NCT02121834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20573797|NCT02578862|Ochsner Medical Center|Edward D McCoul, MD, MPH|504-842-4080|edward.mccoul@ochsner.org|
20573798|NCT01110876|University of Texas (UT) MD Anderson Cancer Center|John de Groot, MD/Associate Professor, NEURO-ONCOLOGY|(713) 745-3072|jdegroot@mdanderson.org|
20573799|NCT04465760|OREGON HEALTH & SCIENCE UNIVERSITY|Joseph Shatzel MD MCR|5034948311|shatzel@ohsu.edu|
20573800|NCT03128008|Duke University Health System|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
20573801|NCT01768520|Hanlim Pharm|Clinical Trial Unit|82234896297|yrsong@hanlim.com|2234896297
20573802|NCT02075541|GlaxoSmithKline|GSK Response Center|866-435-7343|lp542096@gsk.com|
20573803|NCT00343252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20573804|NCT02076178|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573805|NCT00731120|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20573806|NCT03975595|University of Virginia|Dr. Patrick Finan|(720) 244-1702|tpx4xe@virginia.edu|
20573807|NCT02019927|Will Eye Hopsital|Ann Murchison MD|267-733-9617|Visionresearch@willseye.org|
20573808|NCT00394953|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20573809|NCT03181451|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
20573810|NCT00604812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20548981|NCT06934993|Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine|Dr. Abdulgani Orhun YENİGÜN|+90 05346214600|orhunyenigun@gmail.com|
20548982|NCT05147428|UMass Chan Medical School|Jerry H. Gurwitz, MD|508-856-3085|jerry.gurwitz@umassmed.edu|
20548983|NCT02823431|Duke Biomedical Engineering|Warren Grill PhD|(919) 660-5276|warren.grill@duke.edu|
20548984|NCT00544466|City of Hope Medical Center|Dr. Jeffrey Wong, MD|6263598111|JWong@coh.org|
20548985|NCT01385566|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573811|NCT01610011|McLean Hospital|Marc J. Kaufman, Ph.D., Principal Investigator|617-855-3469|kaufman@mclean.harvard.edu|
20527809|NCT02178358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20548986|NCT00825682|Sheba Medical Center|Dr Dorit Gamus|+972-3-5303956|dorit.gamus@sheba.health.gov.il|
20573812|NCT02335125|University of Washington Harborview Medical Center|Douglas Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
20573813|NCT00690833|Wake Forest University Health Sciences|Dr Steve feldman|336-716-3775|sfeldman@wakehealth.edu|
20573814|NCT01592864|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573815|NCT01326533|University of Pittsburgh|Frederico Toledo|412-692-2848|.toledofs@upmc.edu|
20573816|NCT00982995|University of Michgan Comprehensive Cancer Center|Susan Urba|734-615-4762|surba@umich.edu|
20573817|NCT04677179|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20573818|NCT04819776|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20573819|NCT04845633|Damascus University|Dr. Line Droubi|00963966896989|droubiline@gmail.com|
20573820|NCT03598088|Dare Bioscience, Inc.|Jessica Hatheway VP, Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
20573821|NCT02988622|Univeristy of Iowa, Hospitals and Clinics|Dr. Marta VanBeek|(319) 384-6012|marta-vanbeek@uiowa.edu|
20573822|NCT00983931|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20573823|NCT02409368|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20573824|NCT01296347|ImperialNHSTrust|Dr Gillian Chumbley|+44 203 311 1000|gillian.chumbley@imperial.nhs.uk|Bleep 5865
20573825|NCT03343301|Amgen|Study Director|866-572-6436|medinfo@amgen.com|
20573826|NCT02041520|Instituto Mexicano del Seguro Social, UMAE HE No. 1 Bajio|Dr. Norma Amador|+524777174800|norma.amador@imss.gob.mx|31315
20573827|NCT04633551|University of South Carolina|Abbi Lane-Cordova|8037777568|lanecord@mailbox.sc.edu|
20573828|NCT01000285|Washington University School of Medicine|Lee Ratner, M.D., Ph.D.|314-362-8836|lratner@dom.wustl.edu|
20573829|NCT03705832|Columbia University|Emily DiMango, MD|212-305-0631|ead3@columbia.edu|
20573830|NCT05203068|"Federal State Budgetary Institution National Medical Research Center of Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation"|Dr. Kazakov Aleksey Vladimirovich, principal investigator|+79254666638|alexeykazakov1982@yandex.ru|
20573831|NCT06729593|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
20573832|NCT05677893|Oneness Biotech Co., Ltd.|Director of Clinical Research|+886-2-2703-1098|Jessica.Ho@onenessbio.com.tw|
20573833|NCT01101477|Chang Gung Memorial Hospital|Dr. Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
20573834|NCT00720941|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
20573835|NCT00420017|Purdue University|James E Tisdale PharmD|317-613-2315|hwroblew@iupui.edu|306
20573836|NCT01128738|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573837|NCT02673203|Yale University School of Medicine|Renata Belfort De Aguiar, MD, PhD; Assistant Professor of Medicine (Endocrinology)|(877) 925-3637|renata.aguiar@yale.edu|
20573838|NCT02796001|University of Virginia School of Medicine|Ronald Turner, MD|4349819964|rbt2n@virginia.edu|
20573839|NCT00892723|Capstone Therapeutics|Denise Lamon|800-937-5520|dlamon@capstonethx.com|5206
20573840|NCT04388774|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
20573841|NCT01026454|University of Washington|Connie Celum, MD, MPH|206-520-3800|ccelum@uw.edu|
20573842|NCT01142596|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573843|NCT00927160|Icahn School of Medicine at Mount Sinai|Dr. William Hung|718-584-9000|william.hung@mssm.edu|
20573844|NCT00710996|Alcon Research, Ltd.|Rick Potvin|817-551-4815|Rick.Potvin@alconlabs.com|
20573845|NCT03021954|Dr Cipto Mangunkusumo Hospital|dr. Fernandi Moegni|+62-82298111778|fernandi71@ui.ac.id|
20573846|NCT02917278|Purdue University|Kathleen Hill Gallant|765-494-0101|hillgallant@purdue.edu|
20573847|NCT02196714|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20573848|NCT02120716|University of Michigan|Golfo Tzilos, PhD|7349987120|gtzilos@med.umich.edu|
20573849|NCT04079803|Cassava Sciences, Inc.|Nadav Friedmann, PhD, MD, Chief Medical Officer|512-501-1900|nfriedmann@cassavasciences.com|
20573850|NCT03353350|Hanmi Pharmaceutical Co., Ltd.|Sujin Jung|+82-2-410-0473|sujin.jung@hanmi.co.kr|
20573851|NCT03037619|University of South Carolina|Christine Pellegrini|803-777-0911|cpellegrini@sc.edu|
20573852|NCT00759330|Teikoku Pharma USA, Inc.|Director of Clinical Trials|408-501-1821||
20573853|NCT01881750|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
20573854|NCT01519466|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
20573855|NCT00807235|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
20573856|NCT01210079|School of Nursing, University of California, Los Angeles|Margaret (Peggy) Compton, RN PhD|(310) 206-2825|pcompton@sonnet.ucla.edu|
20573857|NCT01012713|University of California San Francisco|Dr. John Koo|4154764701|john.koo@ucsfmedctr.org|
20573858|NCT01596621|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20573859|NCT00178126|University of PIttsburgh|David Brienza|(412) 624-6383|DBrienza@pitt.edu|
20573860|NCT04009850|Yale School of Medicine|Dr. Krysten Bold|203-974-7603|krysten.bold@yale.edu|
20573861|NCT01281969|NIMH|Dr. David I. Driver|301.496.1683|david.driver@nih.gov|
20573862|NCT01201265|Hoffmann-La Roche|Medical Communications|800-821-8590||
20573863|NCT01575028|Nationwide Children's Hospital|Tarun Bhalla|(614) 722-4200|Tarun.Bhalla@NationwideChildrens.org|
20573864|NCT02240693|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573865|NCT01585987|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20573866|NCT00413972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20573867|NCT01992393|Case Western Reserve University|Joy Yala, Data & Regulatory Coordinator II|216-368-0783|jxy790@case.edu|
20548987|NCT01696084|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|2158709177|tom.chmielewski@jazzpharma.com|
20573868|NCT02520284|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20573869|NCT01898923|Oneness Biotech Co., Ltd.|Henry Chang, Associate Director of Clinical Research|+886 2 2703 1098|henry.chang@onenessbio.com.tw|366
20573870|NCT03087019|Dana-Farber Cancer Institute|Jonathan Schoenfeld, MD, MPH|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
20573871|NCT02678247|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
20573872|NCT01907360|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
20573873|NCT02279394|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|Irene_Ghobrial@dfci.harvard.edu|
20573874|NCT00723021|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573875|NCT00282282|Dana-Farber Cancer Institute|Vincent T. Ho, MD Associate Professor of Medicine, Harvard Medical School|(617) 632-5938|vincent_ho@dfci.harvard.edu|
20573876|NCT02739360|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20573877|NCT00637923|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
20573878|NCT01163916|Abbott|Global Medical Services|800-633-9110||
20573879|NCT00026208|Stanford Univeristy Medical Center|Jessica C Lam, BS|650-723-0437|jclam11@stanford.edu|
20573880|NCT05462886|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20573881|NCT04002401|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20573882|NCT00423930|Memorial Sloan Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
20573883|NCT02337751|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20573884|NCT02618642|Rzeszow University|Jolanta Zwolińska PhD|48 505095199|jolantazwolinska@op.pl|
20573885|NCT02181387|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
20573886|NCT02880540|Children's National Hospital|Janelle Vaughns MD|202-476-2025|jvaughns@childrensnational.org|4165
20573887|NCT02881957|University of Utah|Dr. Michael Karsy|801-581-6908|michael.karsy@hsc.utah.edu|
20573888|NCT04485858|CorNeat Vision|Clinical Research Associate|0586753739|talia@corneat.com|
20573889|NCT03413735|The Ohio State University|Dr. Richard Bruno|614-292-5522|bruno.27@osu.edu|
20573890|NCT02390245|Wills Eye Hospital|Dr. L. Jay Katz|215-825-4713|jmolineaux@willseye.org|
20573891|NCT01078220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573892|NCT00959647|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20573893|NCT02101034|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-362-4471|dadkins@wustl.edu|
20573894|NCT03081052|Duke University|Kamrouz Ghadimi, M.D., M.H.Sc.|919-681-6532|kamrouz.ghadimi@duke.edu|
20548988|NCT01925534|Tufts Medical Center|Dr. Nicholas Hill|(617) 636-6377|nhill@tuftsmedicalcenter.org|
20548989|NCT03811028|Sobi|Global Communication|+4686972000|info@sobi.com|
20548990|NCT00560105|VA WNY Health Care System|Dr. S. Sethy|716-862-7875|ssethi@buffalo.edu|
20548991|NCT02400333|AstraZeneca AB|Brilinta Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20548992|NCT02785432|UT Southwestern|Jason Zafereo|146481002|jason.zafereo@utsouthwestern.edu|146481002
20548993|NCT03663816|University of Florica|Sharareh Sharififar|352-273-7410|sharareh75@phhp.ufl.edu|
20548994|NCT00871260|The University of Chicago|Dr. Amit Patel|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
20548995|NCT03539081|University of Iowa|Marshall Holland, MD|205-934-2654|mtholland@uabmc.edu|
20548996|NCT00283400|Baylor College of Medicine|Jose I Suarez, MD, Professor of Neurology|713-798-8472|jisuarez@bcm.edu|
20548997|NCT01292746|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
20548998|NCT01259128|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20548999|NCT03372096|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20549000|NCT00040365|National Cancer Institute (NCI), National Institutes of Health (NIH)|Kevin A. Camphausen|301-496-5457|camphauk@mail.nih.gov|
20549001|NCT00680017|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
20549002|NCT02840097|University of California, Davis|Daniel Nishijima, Study Co-PI|916.734.3884|dnishijima@ucdavis.edu|
20557024|NCT05809596|Boston Scientific|Nicole Kelly, Clinical Trial Manager|1-800-CARDIAC|Nicole.Kelly2@bsci.com|
20573895|NCT02720536|Novartis Pharmaceuticals|Study Director|888-778-8300|Novartis.email@novartis.com|
20573896|NCT01028222|Study Director|Novartis|862-778-8300||
20573897|NCT00146328|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573898|NCT00300781|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20573899|NCT01708122|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Urology|Richard Reznichek|3102222724|RReznichek@dhs.lacounty.gov|
20573900|NCT01717989|Amgen Inc.|Study Director|866-572-6436||
20573901|NCT03224325|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|+1
20573902|NCT02525861|Baxalta|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20573903|NCT02544217|Khondrion B.V.|Edwin Spaans, PharmD.|+31654997700|spaans@khondrion.com|
20573904|NCT00819260|Dartmouth-Hitchcock|Carolyn L. Kerrigan MD|603-650-5148|carolyn.kerrigan@hitchcock.org|
20573905|NCT00667355|Abbott|Global Medical Services|1-800-633-9110||
20573906|NCT03278106|Mayo Clinic|Amit Mahipal MBBS|+1 (507) 293-0487|Mahipal.amit@mayo.edu|
20573907|NCT02175004|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20573908|NCT01137955|Celiac Disease Center at Columbia University|Dr. Peter Green|(212) 305-5590|mtm2111@columbia.edu|
20573909|NCT00756470|University of Texas (UT) MD Anderson Cancer Center|Ricardo Alvarez, MD/Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
20573910|NCT00820027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573911|NCT01978262|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
20573912|NCT02982187|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20573913|NCT02604433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20573914|NCT03285178|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
20573915|NCT01128894|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573916|NCT03437278|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20573917|NCT00973362|Hologic, Inc.|Vice President Clinical Affairs|858-410-8000|rainer.ziermann@hologic.com|
20573918|NCT05116046|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20573919|NCT02168842|University of Rochester Medical Center, Department of Biostatistics and Computational Biology|David Oakes, PhD|5852752405|david_oakes@urmc.rochester.edu|
20573920|NCT02147353|Icahn School of Medicine at Mount Sinai|Dr. Shelbi C. Jim On|212-241-6500|shelbi.jimon@mountsinai.org|
20573921|NCT02974088|Medical Entomology Centre|Ian Burgess|+44 1223 810070|ian@insectresearch.com|
20573922|NCT00150969|University Health Network|Dr. Angela M Cheung|416-340-4841|jscher@uhnresearch.ca|
20573923|NCT02019888|NCRAR|M. Patrick Feeney|503-273-5306|Patrick.Feeney@va.gov|
20549003|NCT03513328|University of Florida|Biljana Horn, MD|352-273-9121|biljana.horn@ufl.edu|
20549004|NCT02279420|USGI Medical|Senior Director of Clinical Research|9493693890|samlung@usgimedical.com|
20549005|NCT01153347|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20549006|NCT02835820|University of Alabama at Birmingham|Shannon Morrison|12059967841|samorris@uab.edu|
20549007|NCT03554746|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
20549008|NCT01539694|Bausch Health|Study Director||robert.steffen@bausch.com|
20573924|NCT02893930|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20573925|NCT01054846|Parkview Health|Thein Zhu|260-266-1279|thein.zhu@parkview.com|
20573926|NCT01614743|DeNova Research|Steven H Dayan, MD|312-335-2070|sdayan@drdayan.com|
20573927|NCT02446886|Weill Cornell Medicine|Research Coordinator|6469625736|liz4005@med.cornell.edu|
20573928|NCT04384848|Northwestern University|David Cella|312-503-1725|d-cella@northwestern.edu|
20573929|NCT00256451|University of Pennsylvania|David Oslin, MD|2158235894|oslin@upenn.edu|
20573930|NCT01762722|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
20573931|NCT04318951|Medical School Berlin|Prof. Dr. Benjamin Stahl|+49 30 7668 375 708|benjamin.stahl@medicalschool-berlin.de|
20573932|NCT01294683|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573933|NCT01290601|WRAIR|Shirley Lee-Lecher|301-251-5000|usarmy.detrick.medcom-wrair.mbx.ocid@mail.mil|
20573934|NCT02571049|Dr. Reddy's|Director of Clinical Development|609-375-9900|cfritz@drreddys.com|
20573935|NCT00985153|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20573936|NCT03552822|University of Alabama at Birmingham|Dr. Mark Powell|2059346007|mfpowell@uabmc.edu|
20573937|NCT00865969|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20573938|NCT03370471|Atlanta VA Health Care System|Amy D Rodriguez, PhD|404-321-6111|amy.rodridguez@va.gov|204201
20573939|NCT00561951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20573940|NCT01765179|Clarus Therapeutics|Sr. VP Clinical and Medical Affairs|847-562-4300|tdanoff@clarustherapeutics.com|
20573941|NCT02903368|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
20573942|NCT03824639|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
20508754|NCT00394277|Hoffmann-La Roche|Medical Communications|800-821-8590||
20549009|NCT05096221|Sarepta Therapeutics Inc.|Sarepta Therapeutics Inc.|1-888-727-3782|SareptAlly@sarepta.com|
20549010|NCT02061774|TTUHSC CRI|Cathy Lovett|806-743-4222|cathy.lovett@ttuhsc.edu|
20573943|NCT03454828|Yale University School of Medicine: Pediatrics Endocrinology|Nicola Santoro|2037376356|nicola.santoro@yale.edu|
20549011|NCT02478632|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20573944|NCT06515483|Loops, LLC|Steven Kayser, President|360-366-3009|stevenkayser@flossloops.com|
20549012|NCT04678661|University of Pittsburgh|Dr. Linda Siminerio|412-559-0359|similx@upmc.edu|
20549013|NCT01086033|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20573945|NCT05959629|University of Pennsylvania School of Dental Medicine|Dr. Bekir Karabucak|215-898-4927|bekirk@upenn.edu|
20557025|NCT06916468|University Hospitals Cleveland Medical Center|Dr. Bryan Carroll|(216)844-8200|Bryan.Carroll@UHhospitals.org|
20557026|NCT03770494|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20557027|NCT00791323|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20557028|NCT04620681|Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
20557029|NCT01984697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557030|NCT01936896|Virginia Commonwealth University|Antonio Abbate|8048280513|antonio.abbate@vcuhealth.org|
20557031|NCT03810534|University of North Carolina at Chapel Hill|Mark Toles, MPH|919-966-5684|mtoles@email.unc.edu|
20557032|NCT00949715|Medtronic CRDM|Rachael Rose|763-526-2332|rachael.k.rose@medtronic.com|
20557033|NCT02287350|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
20573946|NCT03722407|Moffitt Cancer Center|Eric Padron, MD|813-745-2864|eric.padron@moffitt.org|
20573947|NCT02788903|Penn State College of Medicine|Jennifer Kraschnewski|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
20573948|NCT00147823|SUNY Upstate Medical University|Timothy A. Damron, MD|315-464-8604|damront@upstate.edu|
20557034|NCT01582789|CooperVision, US|Don Siegel, OD|623-544-3877|dsiegel@coopervision.com|
20549014|NCT03094169|Formation Biologics|Sandra Sinclair|8326221699|sandra@forbius.com|
20549015|NCT04645953|Alexza Pharmaceuticals Inc.|Dan Myers, PhD, VP Product & R&D|(650) 210-6164|dmyers@alexza.com|
20549016|NCT00864721|Ocala Oncology, Ocala, FL, USA|Dr. Craig Reynolds|352-732-4032|Craig.Reynolds@USOncology.com|
20549017|NCT00187200|St. Jude Medical|Ashish Oza|(818) 493-3648|aoza@sjm.com|
20549018|NCT01705730|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20549019|NCT01773733|"FEDERAL STATE BUDGETARY INSTITUTION ENDOCRINOLOGY RESEARCH CENTRE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION"|Prof. Ivan I . Dedov, Director of the Endocrinology Research Centre|+7 499 124 4300|dedov@endocrincentr.ru|
20549020|NCT03741062|University of Manitoba|Dr. Brian Wiens|613-809-4501|wiensb3@myumanitoba.ca|
20549021|NCT01315665|Riley Hospital for Children|James Chmiel|317-948-7180|jfchmiel@iu.edu|
20549022|NCT04755790|Point Designs|Director of Clinical Research|7206004753|research@pointdesignsllc.com|
20549023|NCT03417219|VA Palo Alto Health Care System|Dr. Blake Scanlon|6504935000|blake.scanlon@va.gov|65316
20549024|NCT03345914|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20549025|NCT00261807|U. of Maryland Medical Systems, R Adams Cowley Shock Trauma Center|Dr. Manjari Joshi|410-328-3656|mjoshi@som.umaryland.edu|
20549026|NCT01706146|Northwestern University|Adin-Cristian Andrei, Ph.D.|312-694-0509|Adin-Cristian.Andrei@nm.org|
20549027|NCT03992014|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20549028|NCT00675948|GW Pharma LTD.|Mr Richard Potts, Clinical Operations Director|00 44 1223 266 800|rp@gwpharm.com|
20549029|NCT02527161|Stryker SP|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
20549030|NCT00762229|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
20549031|NCT02218320|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|919 966-9998|akashuba@unc.edu|
20549032|NCT02609828|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549033|NCT02096731|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549034|NCT01896102|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
20549035|NCT01751178|GlaxoSmithKline|GSK Response Center|866-435-7343||
20549036|NCT02747875|Children's National Hospital|Dr. Andrew Waberski, Assistant Professor|2024762025|awabersk@childrensnational.org|
20549037|NCT03285984|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20549038|NCT02693119|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-(617) 600-6888|jim.carr@stealthbt.com|
20549039|NCT01719783|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20549040|NCT01833988|Massachusetts General Hospital Diabetes Research Center|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
20549041|NCT02149719|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
20549042|NCT02805972|University of California San Francisco|Ashley Mason, PhD|415 514 6820|ashley.mason@ucsf.edu|
20549043|NCT00939640|University of Michigan|Dr. Scott Hummel|734-998-7991|scothumm@med.umich.edu|
20549044|NCT02121522|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549045|NCT01202565|AbbVie|Global Medical Services|800-633-9110||
20549046|NCT02169479|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20549047|NCT00892047|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
20549048|NCT05306977|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
20549049|NCT00369824|GlaxoSmithKline|GSK Response Center|866-435-7343||
20549050|NCT00415168|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549051|NCT02106975|Virginia Commonwealth University School of Medicine|Alpha A Fowler, III, MD|804-828-9071|alpha.fowler@vcuhealth.org|
20549052|NCT00806351|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549053|NCT00306189|Amgen Inc.|Study Director|866-572-6436||
20549054|NCT00087607|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20549055|NCT02015754|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20549056|NCT01234831|Massachusetts General Hospital|Dr. Erica S. Shenoy|617-726-2036|eshenoy@partners.org|
20549057|NCT03763175|MAST Program|Director of Clinical Trials|(310) 423-0617|GroupMedicineMAST@cshs.org|
20573949|NCT03217266|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20573950|NCT01390181|Grand Traverse Heart Associates|Anna Booher|231 935-5800|annabooher3@gmail.com|
20573951|NCT00955487|University of Colorado School of Medicine/Children's Hospital Colorado|Dr. John Kinsella|(303) 724-2853|john.kinsella@ucdenver.edu|
20549058|NCT00672646|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20573952|NCT00792805|Novartis Pharmaceuticals|Study Director|862 778-8300||
20573953|NCT02598557|UT MD Anderson Cancer Center|Parijatham S. Thomas, MD., Associate Professor, Clinical Cancer Prevention|(713) 745-1075|psthomas@mdanderson.org|
20573954|NCT01213589|Medtronic|Richard Jonkers, PhD|800-217-1617|richard.jonkers@medtronic.com|3727
20573955|NCT02072434|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@dsi.com|
20573956|NCT01810692|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20573957|NCT00402363|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573958|NCT02090374|Imperial College London|Professor Trevor Hansel|+44 (0)20 3312 5733|t.hansel@imperial.ac.uk|
20573959|NCT00937833|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
20573960|NCT01707225|Virginia Commonwealth University|Rajiv Malhotra, DO|804-828-9071|rajiv.malhotra@vcuhealth.org|
20573961|NCT01942720|Medtronic|Clinical Trials Manager|+972-4-9097952|michal.kedar-datel@medtronic.com|
20573962|NCT01607554|University of New Mexico Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
20573963|NCT00162032|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|Cesare.Orlandi@lantheus.com|
20573964|NCT03952806|Biohaven Pharmaceuticals, Inc|Chief Medical Officer|+1 203-404-0410|clinicaltrials@biohavenpharma.com|
20573965|NCT00818389|Massachusetts General Hospital|Elizabeth Simpson|617-726-3430|esimpson1@partners.org|
20573966|NCT05195814|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573967|NCT04823221|Boao Yiling Life Care Center|Dr. Ming Liu|139 1103 6970|liuming9876@yeah.net|+86
20573968|NCT02027701|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20573969|NCT00146757|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20573970|NCT00550368|Stanford University|Dr. Julie Parsonnet|(650) 725-4561|parsonnt@stanford.edu|
20573971|NCT00759291|UT Southwestern|Dr. Joshua Beckman|214-648-3100|joshua.beckman@utsouthwestern.edu|
20573972|NCT02349360|University of Florida|Wendy Dahl Associate Professor|3522943707|wdahl@ufl.edu|
20573973|NCT03586687|Penn State Hershey Medical Center|Cayce Onks, DO|7175317127|conks@pennstatehealth.psu.edu|
20573974|NCT04250987|Coloplast|Vice President, Medical Affairs|+45 4911 1111|clinical-studies@coloplast.com|
20573975|NCT02919657|Medfit Rx|David Michael|9196109893|dmichael@medfitrx.net|
20573976|NCT03478163|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
20573977|NCT01971203|Icahn School of Medicine at Mount Sinai|Cindy J. Aaronson, MSW, PhD|212-241-3169|cindy.aaronson@mssm.edu|
20573978|NCT01285050|Johns Hopkins University|David Thomas|410-502-6043|dthomas@jhmi.edu|
20573979|NCT01498289|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
20573980|NCT01794923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20573981|NCT01423253|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20573982|NCT04071795|NYU Langone Health|Erin Rogers|6465012544|Erin.Rogers@nyulangone.org|
20573983|NCT00752622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20573984|NCT00576836|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
20573985|NCT00392327|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20573986|NCT03267940|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
20573987|NCT01074216|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
20573988|NCT01401907|MGH|Jennifer Temel MD|617-724-4000|jtemel@partners.org|
20573989|NCT01323634|GlaxoSmithKline|GSK Response Center|866-435-7343||
20573990|NCT05056987|Alcon Research, LLC|Senior Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20573991|NCT01182194|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20573992|NCT01948908|Columbia University College of Physicians and Surgeons|Daniel S. Tsze|212-305-9825|dst2141@columbia.edu|
20573993|NCT00796120|PharmaMar SA Av de los Reyes 1, Poligono Industrial La Mina 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
20573994|NCT02197767|Mayo Clinic|Dr. Stephen B. Erickson|507-284-4083|Erickson.Stephen@mayo.edu|
20573995|NCT01280110|Departamento de Oftalmologia - Universidade Estadual de Campinas - Campinas - Brazil|Vital Paulino Costa|55-19-35217396|vp.costa@uol.com.br|
20573996|NCT03737474|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20508755|NCT02371980|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20508756|NCT00547729|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
20549059|NCT00289783|GlaxoSmithKline|GSK Response Center|866-435-7343||
20549060|NCT02963649|Medtronic|Giulia Gatta, Clinical Study Manager|+310629467793|giulia.gatta@medtronic.com|
20549061|NCT01453361|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
20549062|NCT03128047|Hackensack Meridian Health|Jeanette Haugh|5519963457|Jeanette.haugh@hmhn.org|
20549063|NCT01594281|Novartis Pharmaceuticals|Study Director|1-862-778-8300|Novartis.email@novartis.com|
20549064|NCT01871532|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20549065|NCT00289471|Durham VAMC|John W. Williams|919-286-6963|jw.williams@duke.edu|
20573997|NCT00971243|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20557035|NCT00861614|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20557036|NCT05050578|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20557037|NCT02243280|AbbVie|Global Medical Services|800-633-9110||
20557038|NCT03276637|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
20557039|NCT04082442|Johns Hopkins University|Thorsten Leucker, MD|410-502-0469|tleucke1@jhmi.edu|
20557040|NCT02710292|Alcon Japan Ltd.|Clinical Manager|1-888-451-3937|alcon.medinfo@alcon.com|
20557041|NCT02364180|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
20557042|NCT01783418|Ste-Justine's Hospital|Catherine Malboeuf-Hurtubise, Post-doctoral fellow|514-343-6111|catherine.malboeuf-hurtubise@umontreal.ca|4594
20557043|NCT00089141|Fred Hutchinson Cancer Research Center (FHCRC)|Paul J. Martin, M.D.|206-667-4798|pmartin@fhcrc.org|
20557044|NCT00508261|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557045|NCT01242748|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20573998|NCT00803270|New England Resesarch Institutes|Anne M. Stoddard|617-972-3331|astoddard@neriscience.com|
20573999|NCT02737917|Lincoln Medical Center|Dr. Nicholas Caputo|718-579-6010|ncaputo.md@gmail.com|
20574000|NCT03349892|University of California, Los Angeles|Robert K. Chin, MD, PhD , Assistant Clinical Professor|(310) 825-9771|rkchin@mednet.ucla.edu|
20574001|NCT02265367|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20574002|NCT02370043|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
20574003|NCT01231516|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20574004|NCT05266586|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20574005|NCT02225353|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
20574006|NCT01193920|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20574007|NCT04195958|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20574008|NCT04683731|Trustees of Indiana University|Dr. Peter H. Schwartz, MD, PhD|317-278-4037|phschwar@iu.edu|
20574009|NCT02910739|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574010|NCT02513719|Abbott Vascular|Kusano Hajime|408-645-1626|hajime.kusano@av.abbott.com|
20549066|NCT01673867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20549067|NCT02048891|Rambam health Care campus|Shahar Kol Director IVF Unit|97247773232|skol@rambam.health.gov.il|
20549068|NCT02550106|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
20549069|NCT03166735|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549070|NCT01543958|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20549071|NCT04019288|M.D. Anderson Cancer Center|Amir A Jazaeri|713-745-1613|aajazaeri@mdanderson.org|
20549072|NCT04538430|University of Utah|Shellie Cunningham|801-587-5488|shellie.cunningham@hsc.utah.edu|
20549073|NCT01112358|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20549074|NCT00726986|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
20549075|NCT02577978|Northwestern Medicine|David W Manning|3124726023|David.Manning@nm.org|
20549076|NCT01803204|USP|Cristina Sousa|+5511996017972|crissousa@usp.br|
20549077|NCT04613375|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549078|NCT03019783|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-5500|joshua.a.beckman@vanderbilt.edu|
20549079|NCT02589405|Galderma R&D|Stephanie Leclerc|492386706|stephanie.leclerc@galderma.com|+33
20549080|NCT04208997|Vanderbilt University Medical Center|Dr Giovanni Davogustto|6159361720|giovanni.e.davogustto@vumc.org|
20549081|NCT00408460|University of Washington|Renato G Martins, MD|206-288-2048|rgmart@uw.edu|
20549082|NCT02264639|Apellis Pharmaceuticals, Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20549083|NCT02506465|Medi-Tate / Olympus|Sivan Baker|+97247701839|sivan.baker@olympus.com|
20549084|NCT01117948|JSW-Lifesciences|Director of Clinical Trials|0043316 258111|office@jsw-lifesciences.com|310
20549085|NCT01172522|ConnecticutSC|Edward M. Lane|2033720009|EMLMD@msn.com|
20549086|NCT01350492|William S. Middleton Memorial Veterans Hospital|Aaron J. Stegner, Ph.D.|608-262-1290|aaron.stegner@va.gov|
20549087|NCT02319837|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549088|NCT00753766|VA Boston Healthcare System|Paul R. Conlin, M.D.|8572035111|paul.conlin@va.gov|
20549089|NCT00702689|National Institute of Arthritis and Musculoskeletal and Skin Diseases|Edward Cowen, M.D.|301-827-2328|cowene@mail.nih.gov|
20549090|NCT03993132|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20549091|NCT02713373|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@RoswellPark.org|
20549092|NCT00239590|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
20549093|NCT01252147|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20549094|NCT03698409|SUNY Upstate medical University|Assistant Profressor|3154644243|zidan@upstate.edu|
20557046|NCT00840801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574011|NCT05312151|Compass Pathways|Chief Medical Officer|07443136539|info@compasspathways.com|
20557047|NCT00335452|sanofi-aventis|Trial Information Transparency Team||GV-Contact-us@sanofi-aventis.com|
20549095|NCT02993757|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20549096|NCT03351933|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20549097|NCT01611155|Mayo Clinic|Charles L. Loprinzi, MD|507-284-3731|cloprinzi@mayo.edu|
20549098|NCT02369016|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20549099|NCT02229383|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20549100|NCT00672932|UCSF|Richard W. Price, M.D.|415-206-4487|rwprice@sfgh.ucsf.edu|
20549101|NCT02403986|Q-Med AB|Cecilia Skoglund, Manager Study strategy and publications|46 18 474 9000|cecilia.skoglund@galderma.com|
20549102|NCT05248867|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20549103|NCT03704467|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20549104|NCT00660699|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@dom.wustl.edu|
20549105|NCT05263895|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549106|NCT05764408|Prisma Health|Dr. Melissa Wise|8644551600|melissa.wise2@prismahealth.org|
20549107|NCT00967668|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
20549108|NCT04096963|Boston Scientific Corperation|Associate Clinical Trial Manager|+861085742971|yifan.zhao@bsci.com|
20549109|NCT01542125|Alberta Health Services|Research Coordinator|780-492-2398|manu.saraswat@albertahealthservices.ca|
20549110|NCT01709513|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator||clinicaltrials@regeneron.com|
20549111|NCT01034631|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20549112|NCT01431170|NJMS, Rutgers University|Suqin Guo, MD|973-972-2031|guos1@njms.rutgers.edu|
20549113|NCT01193530|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Medicine|713-792-6085|rdev@mdanderson.org|
20549114|NCT04218695|BIDMC|Dr. Zachary Fricker|6176321070|zfricker@bidmc.harvard.edu|
20549115|NCT01890473|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20549116|NCT00934089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549117|NCT01945281|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549118|NCT00799383|Baylor College of Medicine|Chadi Calarge, MD|832-824-4764|chadi.calarge@bcm.edu|
20549119|NCT00926328|Colgate Palmolive|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
20549120|NCT00681083|Fisher & Paykel Healthcare|Hansinie Laing|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|8601
20549121|NCT03119831|Department of Periodontology, School of Dentistry, National and Kapodistrian University of Athens, Greece|Dr. Anastasios M. Gkatzonis|6976486314|gkatzonis.tasos@gmail.com|0030
20549122|NCT02767843|California Center for Sleep Disorders|Jerrold Kram, MD|510.263.3300|info@californiasleepcenters.com|
20549123|NCT01023620|UT Southwestern Medical Center|Dr. Michael Limerick|214-590-0611|Michael.Limerick@UTSouthwestern.edu|
20549124|NCT01434667|Brigham and Women's Hospital|Kurt Christensen, PhD|(617) 264-5883|kchristensen@bwh.harvard.edu|
20549125|NCT02647203|University of Talca|Dr. Rodrigo Giacaman|+56712201546|giacaman@utalca.cl|2654
20549126|NCT02165215|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20549127|NCT05074667|Stanford University|Sejal Shah, MD|650-498-7351|sshah2@stanford.edu|
20549128|NCT01948947|VA San Diego Healthcare System|Valerie Metzger Smith, Study Coordinator|858-750-0274|valerie.metzgersmith@va.gov|
20549129|NCT03535844|National University of Singapore|Dr. Kim Jung Eun|+6565161136|fstkje@nus.edu.sg|
20549130|NCT00297830|Columbia University|Dr. Elizabeth Shane|2123056289|es54@columbia.edu|
20549131|NCT00003473|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20549132|NCT04401423|Columbia University Irving Medical Center|Dr. Jeanine D'Armiento / Principal Investigator|212-305-3745|jmd12@cumc.columbia.edu|
20549133|NCT01548651|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
20549134|NCT00779701|Temple University Hospital|Dr. Nina Gentile|215-707-2000|ngentile@temple.edu|8402
20549135|NCT02193867|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20549136|NCT01867424|National Cancer Institute|Dr. Ismail Baris Turkbey|301-443-2315|turkbey@nih.gov|
20549137|NCT01921387|Seattle Cancer Care Alliance|Ajay Kumar Gopal, MD, Director of Clinical Research|(206) 606-2037|agopal@uw.edu.org|
20549138|NCT02582983|Hoffmann-La Roche|Medical Communications|800-821-8590||
20549139|NCT05209360|The University of Iowa|Jason M Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
20549140|NCT03416946|Orthopaedic Innovation Centre|Trevor Gascoyne|204-926-1235|tgascoyne@orthoinno.com|
20549141|NCT02021331|University of Michigan|Dr. Robert Eber|734-647-4023|reber@umich.edu|
20549142|NCT02114216|Seoul National University Hospital|Dr. Jinjoo Kim|82-10-6261-6483|jjkim0727@gmail.com|
20549143|NCT01439633|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
20549144|NCT00469274|Vanderbilt University Medical Center|Dr. Thomas R. Talbot|615-322-2789|tom.talbot@vanderbilt.edu|
20549145|NCT02983825|University of Pennsylvania|Nicolas Bamat, MD MSCE|2155904010|bamatn@email.chop.edu|
20549146|NCT01776840|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20549147|NCT03641339|National Institutes of Health|Matthew J. Memoli, MD, MS|301-443-5971|memolim@niaid.nih.gov|
20508757|NCT00789724|VCU Pauley Heart Center|Antonio Abbate, MD, PhD|8048280513|aabbate@mcvh-vcu.edu|
20574012|NCT03226275|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20549148|NCT02989545|Shaare Zedek Medical Center|Dr. Dan Livovsky|+972525622398|danlivo@szmc.org.il|
20549149|NCT04457336|Spruce Biosciences|Dina Ayala-Jones, Associate Director, Clinical Development Operations|424.558.1211|djones@sprucebio.com|
20549150|NCT00446251|University of Washington|Dr. Connie L. Davis|206-598-6079|cdavis@u.washington.edu|
20549151|NCT02581787|Stanford University|Maximilian Diehn, MD, PhD|(650) 721-1550|diehn@stanford.edu|
20549152|NCT00381550|Sidney Kimmel Comprehensive Cancer Center|Michael McDevitt, MD PhD|410-955-9175|mmcdev1@jhmi.edu|
20549153|NCT01416272|Bausch & Lomb / Valeant Pharmaceuticals|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
20549154|NCT02217878|Collegium Medicum, Nicolaus Copernicus University|Prof. Jacek Kubica|+485854023|jkubica@cm.umk.pl|
20574013|NCT03769181|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20574014|NCT03971422|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20508758|NCT00959894|UNC School of Medicine|Michelle Floris-Moore, M.D., M.S.|919-966-2537|mfloris@med.unc.edu|
20574015|NCT04596384|City of Hope|Virginia Sun, Professor|+16269888652|VSun@coh.org|
20574016|NCT04751656|University of Florida|Megan McVay|352-294-1638|megan.mcvay@ufl.edu|
20574017|NCT03253926|New York State Psychiatric Institute|Margaret Haney|646-774-6153|mh235@cumc.columbia.edu|
20574018|NCT01485354|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
20574019|NCT03566810|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20508759|NCT00922974|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20508760|NCT00323310|Bracco Diagnostics Inc|Usha Halemane/Executive Director|609-514-2578|usha.halemane@diag.bracco.com|
20508761|NCT00446641|Asan Medical Center, University of Ulsan College of Medicine|Professor Sun U. Kwon|82-2-3010-3960|sukwon@amc.seoul.kr|
20508762|NCT01689324|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20508763|NCT03565991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508764|NCT00681291|LifeCell|Donna Jacobs|908-809-7856|djacobs@lifecell.com|
20508765|NCT00086385|University of California, San Francisco|Sharon M. Hall, PhD|415-476-7574|sharon.hall@ucsf.edu|
20508766|NCT00899600|Dartmouth-Hitchcock Medical Center|Dr. Randy Loftus|6036504642|randy.w.loftus@hitchcock.org|
20508767|NCT01149772|Michael E. DeBakey VA Medical Center|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
20508768|NCT00442611|Stanford University|Dr. Lorinda Chung|(650)493-5000|shauwai@stanford.edu|6242
20508769|NCT01376388|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508770|NCT03542149|Medicines for Malaria Venture (MMV)|Dr. Helen Demarest|: +41 22 555 03 24|demaresth@mmv.org|
20508771|NCT02009930|David Grant Medical Center, Travis Air Force Base|Dr. Elijah Burton|707-423-7950|elijah.j.burton2.mil@mail.mil|
20508772|NCT02108223|Sisli etfal training anf research hospital|Fatma yazıcı yılmaz|+905079234033|fatmayazc@gmail.com|
20508773|NCT02468804|University of Colorado Denver|Isabelle Buard, PhD|(303)472-5973|Isabelle.Buard@cuanschutz.edu|
20508774|NCT02252068|McLean Hospital|Dr. R. Kathryn McHugh|617-855-2000|kmchugh@mclean.harvard.edu|
20508775|NCT02568852|Haseki-156|Dr.Turgut Donmez|00905347400967|surgeont73@hotmail.com|
20508776|NCT02471586|Abbott|Kristina M Gibbens, Senior Clinical Project Manager|+1 651-756-3859|Kristina.gibbens@abbott.com|
20508777|NCT06103591|EmStop, Inc.|Phil Ebeling, CEO|763-227-9954|phil.ebeling@emstopeps.com|
20508778|NCT01510834|Pacific Health Research and Education Institute|Laurel King, PhD|808-564-5711|laurel.king@va.gov|
20508779|NCT00488059|Hoffmann-La Roche|Medical Communications|800-821-8590||
20508780|NCT03235726|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508781|NCT00563368|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
20508782|NCT01784614|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508783|NCT00114218|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|lgedeon@gogstats.org|
20508784|NCT01927887|Massachusetts General Hospital|Mukesh Harisinghani|6176432009|mharisinghani@partners.org|
20508785|NCT01505114|Fred Hutchinson cancer Research center|Chunyuan Wu|206-667-5567|cwu@scharp.org|
20508786|NCT03168555|Zealand University Hospital|Dr. Christian Borup, coordinating investigator|+4523328035|chrbo@regionsjaelland.dk|
20508787|NCT02165072|Texas Tech university Health Sciences Center, Lubbock, TX|Dr Kenneth Nugent|(806) 743-6847|Kenneth.nugent@ttuhsc.edu|
20508788|NCT03882723|Rush University Medical Center|Dr. David Vines|3129424408|David_Vines@rush.edu|
20508789|NCT00466661|Medical University of South Carolina|Bryan K. Tolliver, M.D., Ph.D. (Principal Investigator)|(843) 792-4869|tollive@musc.edu|
20508790|NCT00661570|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
20508791|NCT02754661|Medtronic GIH (Given Imaging LTD)|Liron Bar Yaakov, Senior Manager Clinical Affairs|972-526060466|liron.baryaakov@medtronic.com|
20508792|NCT01000025|NCIC Clinical Trails Group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
20549155|NCT02718157|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
20549156|NCT01201785|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
20574020|NCT01103245|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|james.luther@vanderbilt.edu|
20574021|NCT00826111|Steward St. Elizabeth's Medical Center of Boston, Inc.|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
20508793|NCT04423757|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508794|NCT02738580|IVIValencia|DR. ERNESTO BOSCH|+34 963050900|Ernesto.Bosch@ivirma.com|
20508795|NCT00158223|Icahn School of Medicine at Mount Sinai|Dr. Joseph I. Friedman|631-761-3607|joseph.friedman@mssm.edu|
20549157|NCT02151110|MedImmune LLC|David Howe, MBChB, MD, MRCOG|+44 (0) 1223 895980|information.center@astrazenea.com|
20574022|NCT02805725|Institut Bergonie|Pr Antoine Italiano|+ 33 5 47 30 60 88|a.italiano@bordeaux.unicancer.fr|
20574023|NCT01195545|University of Washington|Brant Oelschlager, MD|206-543-3518|brant@uw.edu|
20574024|NCT01837069|NYU Langone Health|Jeffrey Berger|212 263 4004|Jeffrey.Berger@nyulangone.org|
20574025|NCT04968197|Mayo Clinic|Gaurav N. Pradhan, Ph.D.|(480) 301-5351|Pradhan.Gaurav@mayo.edu|
20508796|NCT01250756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508797|NCT02999100|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508798|NCT00293241|Medtronic Bakken|Lidwien Vainer|+31 433566752|lidwien.vainer@medtronic.com|
20508799|NCT03803202|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508800|NCT03595384|Emory University|Jennifer K Frediani PhD, RD|404-727-3766|jfredia@emory.edu|
20508801|NCT00583661|Berlin Heart Inc.|Robert Kroslowitz, CEO|1-281-863-9700|kroslowitz@berlinheart.com|
20508802|NCT01367860|IOT/HC University of SãoPaulo|Dr. Alexandre Cristante Fogaça|+55 11 2661-6951|aacristante@uol.com.br|
20557048|NCT02943941|Medtronic Inc|Verla Laager|(800) 328.2518|verla.l.laager@medtronic.com|
20508803|NCT01270958|GlaxoSmithKline|GSK Response Center|866-435-7343||
20549158|NCT01064310|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20549159|NCT00001880|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator, NIH, NHLBI|301.451.7128|childsr@nhlbi.nih.gov|
20549160|NCT02639065|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20549161|NCT00481078|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20549162|NCT01289080|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20549163|NCT00873015|University of Virginia Medical Center|Dr. Edward Oldfield|(434) 982-0059|EHO4U@hscmail.mcc.virginia.edu|
20549164|NCT03128411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549165|NCT00345839|Amgen Inc.|Study Director|866-572-6436||
20549166|NCT03928353|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
20549167|NCT01960400|Université de Sherbrooke|Dr Yannick Tousignant-Laflamme|819-821-8000|Yannick.Tousignant-Laflamme@USherbrooke.ca|72912
20549168|NCT05544734|Weill Cornell Medicine|Dr Shari Lipner|6469623376|shl9032@med.cornell.edu|
20549169|NCT02989714|University of Michigan Rogel Cancer Center|Ajjai Alva, MD|734-936-0091|ajjai@umich.edu|
20549170|NCT02914119|Herlev Hospital, research unit, anesthesia|Dr. JLD Thomsen|004538633863|prs@demants.dk|
20549171|NCT04659928|The University of Texas Health Science Center at Houston|Claudia Ruiz Brisuela, DDS|713-486-4138|Claudia.RuizBrisuela@uth.tmc.edu|
20549172|NCT03749447|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20549173|NCT00259649|University of Pittsburgh|Dawn marcus|412-953-4797|marcusd@upmc.edu|
20508804|NCT02142504|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20508805|NCT03124901|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20508806|NCT00617591|H. Lee Moffitt Cancer Center and Research Institute|Rachid Baz, M.D.|813-745-8212|rachid.baz@moffitt.org|
20508807|NCT04114539|Emalex Biosciences, Inc.|Sr. Director of Clinical Operations|1847|dkim@emalexbiosciences.com|7150562
20508808|NCT01711658|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20508809|NCT02918656|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
20508810|NCT03094611|The University of Texas MD Anderson Cancer Center|Elias Jabbour, MD./ Professor, Leukemia|713-792-4764|ejabbour@mdanderson.org|
20508811|NCT02186561|Medtronic Neurovascular, Clinical Affairs|Senior Project Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
20508812|NCT04285853|Emory University|Dr. John Xerogeanes|404-778-7202|jxeroge@emory.edu|
20508813|NCT01877941|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|art.wallace@va.gov|3732
20508814|NCT03179410|Duke University|Andrew Armstrong, M.D.|919-668-8797|andrew.armstrong@duke.edu|
20508815|NCT02460978|AstraZeneca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20508816|NCT02562989|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508817|NCT00588523|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley, MD|212-639-7523|kaleyt@mskcc.org|
20508818|NCT01459068|Johns Hopkins Bloomberg School of Public Health|Courtland Robinson|4104155266|crobinso@jhsph.edu|
20508819|NCT00841269|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu|
20508820|NCT00088972|SWOG|Study Statistician|206-667-4623||
20508821|NCT02023112|AbbVie|Global Medical Information|800-633-9110||
20508822|NCT00701441|Ohio State University|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
20508823|NCT00537680|Santhera Pharmaceuticals|Dr Thomas Meier|+41619068964|thomas.meier@santhera.com|
20508824|NCT00360685|Moffitt Cancer Center|Janelle Perkins, PharmD|813-745-7226|Janelle.Perkins@moffit.org|
20508825|NCT03001310|MeiraGTx|Program Manager|0044 (0)20 3866 4320|CNGB3@meiragtx.com|
20508826|NCT01347632|CONRAD|Andrea Thurman|757-446-7444|thurmaar@evms.edu|
20508827|NCT03693404|NYU Langone Health|Philipp Leucht, MD|646-501-0291|philipp.leucht@nyulangone.org|
20508828|NCT01576406|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508829|NCT00651313|Columbia Laboratories, Inc.|George W. Creasy, MD Vice President, Clinical Research|973-486-8797|gcreasy@columbialabs.com|
20508830|NCT03328624|SALSA@USC|Research Coordinator|323-442-5528|dhuyvett@usc.edu|
20508831|NCT00892957|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
20508832|NCT01760187|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|8572425142|alison.long@aegerion.com|
20549174|NCT01433991|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20549175|NCT00787891|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
20549176|NCT01258582|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
20549177|NCT01227434|University of California San Francisco|Michael Prados, MD|4154767217|pradosm@neurosurg.ucsf.edu|
20549178|NCT03486223|Vanderbilt University Medical Center|Dr. James M Luther|6153223353|james.luther@vumc.org|
20549179|NCT01819831|Loma Linda University Health|Gary Yang, Professor, Chair of Radiation Medicine|909 558 4444|gyang@llu.edu|
20549180|NCT02034110|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20527810|NCT03297021|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@mountsinai.org|
20574026|NCT03511053|Dallas VA Medical Center|Dr. Thiru M. Annaswamy, Staff Physician, PM&R Service|2148570273|thiru.annaswamy@va.gov|
20527811|NCT00948922|H. Lee Moffitt Cancer Center and Research Institute|Dr. Melissa Alsina|813-745-7202|melissa.alsina@moffitt.org|
20527812|NCT02734862|Cidara Therapeutics, Inc.|Taylor Sandison, M.D., MPH|858-888-7868|clinicaltrialinfo@cidara.com|
20574027|NCT02425644|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20527813|NCT02343380|University of Turin|Dr Simona Bo|0039116335543|simona.bo@unito.it|5541
20527814|NCT02700698|University of Arkansas for Medical Sciences; Arkansas Children's Research Institute|Elisabet Borsheim, PhD|501-364-3053|EBorsheim@uams.edu|
20527815|NCT04165135|Hoffmann-La Roche|Medical Communications|800 821 8590|genentech@druginfo.com|
20574028|NCT00567268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549181|NCT02587234|University of Kentucky|Lumy Sawaki, MD, PhD||lumy.sawaki@uky.edu|
20549182|NCT01877265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549183|NCT01738321|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
20549184|NCT01468012|New York State Psychiatric Institute|Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
20574029|NCT03599557|University of California, Los Angeles|Principal Investigator|(310) 206-6328|pszilagyi@mednet.ucla.edu|
20574030|NCT00888433|Baker IDI Heart and Diabetes Institute|Murray Esler, Principal Investigator||murray.esler@bakeridi.edu.au|
20574031|NCT03312348|Sheffield Children's NHS Trust|Dr Shammi Ramlakhan - Chief Investigator|+44 1142262331|shammi.ramlakhan@sch.nhs.uk|
20574032|NCT02202551|Adamas Pharmaceuticals, Inc.|Reed Johnson|510-450-3500|rjohnson@adamaspharma.com|
20574033|NCT02349451|AbbVie|Global Medical Services|800-633-9110||
20574034|NCT02311998|The University of Texas MD Anderson Cancer Center|Nitin Jain MD/Associate Professor|713-745-6080|njain@mdanderson.org|
20574035|NCT02064855|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
20574036|NCT00186069|Stanford University|Anna Girsen, Manager of Research Operations|(650) 725-5720|agirsen@stanford.edu|
20574037|NCT01176773|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
20508833|NCT05151367|Columbia University|Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
20508834|NCT00669032|Tedec-Meiji Farma, S.A.|R&D Director|918870980|m.gimeno@tedecmeiji.com|
20508835|NCT00642018|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508836|NCT01607073|Gillette Children's Specialty Healthcare|Beverly Wical, MD|(651) 229-3870|BWical@gillettechildrens.com|
20508837|NCT01410799|University of Pennsylvania|Dr. Anne Cappola|215-573-5359|acappola@upenn.edu|
20508838|NCT02564029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508839|NCT04126031|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508840|NCT00617656|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
20508841|NCT01946412|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20508842|NCT00131664|Dr. Anatoly Langer, Chair CHRC, Canadian Heart Research Centre|Dr. Robert Josse|416-977-8010|langera@chrc.net|
20527816|NCT00530790|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527817|NCT00423358|University of Wisconsin|Karen E Hansen, MD, MS|608-263-3457|keh@medicine.wisc.edu|
20527818|NCT00915603|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20527819|NCT03319810|Sutter Institute for Medical Research|Carol Parise, PhD, Research Scientist|(916) 887-4744|PariseC@sutterhealth.org|
20527820|NCT04000360|The Cleveland Clinic Foundation|Dr. Jay L. Alberts|440-708-3735|albertj@ccf.org|
20527821|NCT02865811|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
20527822|NCT03014622|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
20527823|NCT01687387|Innate Pharma|Director Clinical Operations|+33043030|info@innate-pharma.fr|30
20527824|NCT03760458|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20527825|NCT01660802|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20527826|NCT01119846|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527827|NCT01243294|Coloplast A/S|Pia Nordmand, Clinical Trial Manager|+4549113250|dkpialn@coloplast.com|
20527828|NCT00048997|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20527829|NCT03763058|Centre d'Evaluation et Traitement de la Douleur|Dr Guilhem Parlongue|00262262912037|guilhem_parlongue@hotmail.com|
20549185|NCT00590720|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
20549186|NCT00528788|Duke University Medical Center|Jula Inrig, MD|919-660-6882|Jula.Inrig@duke.edu|
20549187|NCT03039283|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
20549188|NCT01056653|University of Calgary, Faculty of Nursing|Dr. Karen Benzies|403-220-2294|benzies@ucalgary.ca|
20549189|NCT01847274|GSK|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20549190|NCT02569658|Rush University Medical Center|Yale Fillingham|3095310220|yale.fillingham@gmail.com|
20574038|NCT01862133|Regenstrief Institute|William M. Tierney, MD|(317) 274-9094|wtierney@regenstrief.org|
20574039|NCT00078754|The University of Chicago|Dr. Emil F. Coccaro, MD|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
20549191|NCT01081678|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20527830|NCT02759835|National Cancer Institute|Azam Ghafoor|240-858-3289|azam.ghafoor@nih.gov|
20527831|NCT01404949|Memorial Sloan Kettering Cancer Center|Dr. Jae Park, MD|646-608-3743|parkj6@mskcc.org|
20549192|NCT00727636|Children's Hospital Boston|Dr. Athos Bousvaros|617-355-2962|athos.bousvaros@childrens.harvard.edu|
20549193|NCT00695409|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
20557049|NCT02736825|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20557050|NCT00790452|UT MD Anderson Cancer Center|Victor A Levin, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
20574040|NCT04668586|Haukeland University Hospital|Øyvind Ulvik|+47 97 50 00|doc.ulvik@online.no|
20574041|NCT02804178|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
20574042|NCT03057808|University of Virginia|Dr. Rebecca Krukowski|4349245303|wae4mq@virginia.edu|
20574043|NCT01581541|Stanford University School of Medicine|Dr. Shivaani Kummar|650-724-9084|skummar@stanford.edu|
20574044|NCT04329832|Intermountain Healthcare|Naresh Kumar|8013827483|naresh.kumar@imail.org|
20574045|NCT00287339|UNC_ChapelHill|Dr Nicholas Shaheen|919 9667047|nshaheen@med.unc.edu|
20574046|NCT00564018|UT Southwestern Medical Center|Soumya Adhikari, MD|214 456 5959|soumya.adhikari@utsouthwestern.edu|
20574047|NCT00986440|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20574048|NCT01869075|Sunnybrook HSC|Artemis Diamantouros|416-480-6100|artemis.diamantouros@sunnybrook.ca|3654
20574049|NCT00388154|University of Texas (UT) MD Anderson Cancer Center|Jubilee Brown, MD/Associate Professor, Gynecology Oncology & Reproductive Medicine|713-745-8837|CR_Study_Registration@mdanderson.org|
20574050|NCT00421707|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574051|NCT03291587|Wake Forest NCORP Research Base|Lead Biostatistician|3367160891|NCORP@wakehealth.edu|
20574052|NCT01759407|Nationwide Children's Hospital|Nicole Elsey, MD|614-722-4200|Nicole.Elsey@nationwidechildrens.org|
20574053|NCT01477320|University of Louisville|Dr. Mohamed Saad|5028525841|mohamed.saad@louisville.edu|
20574054|NCT02513745|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
20574055|NCT01116882|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
20574056|NCT00547365|University of Tennessee Graduate School of Medicine|Alan Solomon, MD|865-305-9167|asolomon@utmck.edu|
20574057|NCT01139658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20574058|NCT03933774|St. Vincent's Hospital|Dr. Jung Min Bae|82-31-881-8982|jminbae@gmail.com|
20574059|NCT00504881|UCB Clinical Trial Call Center|UCB (Study Director)|+1 877 822 9493||
20574060|NCT01777269|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574061|NCT00352911|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
20574062|NCT03717129|Johns Hopkins University|Dr. Craig Hendrix|4109559707|chendrix@jhmi.edu|
20574063|NCT01783041|Children's Hospital at Montefiore, Albert Einstein College of Medicine|Mamta Fuloria|718-904-4105|mfuloria@montefiore.org|
20574064|NCT03796260|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20574065|NCT00753272|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574066|NCT00742053|C.R. Bard|Christopher DiMatteo/Clinical Scineces Manager|801-522-5487|chris.dimatteo@crbard.com|
20549194|NCT00900237|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20574067|NCT02092220|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
20549195|NCT01619423|PledPharma AB|Stefan Carlsson, MD, PhD, Chief Medical Officer|+46 8 679 72 10|stefan.carlsson@pledpharma.se|
20549196|NCT01281865|Memorial Sloan-Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|keohanm@mskcc.org|
20549197|NCT05673889|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574068|NCT00960531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549198|NCT03478657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20574069|NCT00593957|Kennedy Krieger Institute|Dr Sakkubai Naidu Professor of Neurology and Pediatrics|443-923-2778|naidu@kennedykrieger.org|
20549199|NCT02590003|Yale University|Rogerio C. Lilenbaum, MD, Professor of Medicine (Medical Oncology); Chief Medical Officer of Smilow|(203) 200-5864|rogerio.lilenbaum@yale.edu|
20574070|NCT03481023|Riverside Medical Center|Dr. Brad Suprenant|(815) 939-9400|blsuprenant@comcast.net|
20574071|NCT02411578|Jaeb Center for Health Research|Stephanie DuBose|813-975-8690|t1dstats2@jaeb.org|
20574072|NCT00494481|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20574073|NCT01030198|Cynosure, Inc.|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20574074|NCT00332189|BioMarin Pharmaceutical, Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
20574075|NCT03707925|UT MD Anderson Cancer Center|Roberto Casal, MD/ Associate Professor, Pulmonary Medicine|713-745-2645|rfcasal@mdanderson.org|
20574076|NCT03099005|UCSD|Brook Henry|(619) 543-4737|blhenry@ucsd.edu|
20574077|NCT02876835|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20574078|NCT01117857|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
20574079|NCT02791737|The Ohio State University Comprehensive Cancer Center|Dr. Ashley Rosko|614-293-3196|Ashley.Rosko@osumc.edu|
20574080|NCT00883051|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20574081|NCT01411839|University of California, San Francisco|Dr. John A. Sauceda|415-460-6045|john.sauceda@ucsf.edu|
20574082|NCT03282240|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20574083|NCT01675479|Abbott Medical Optics|Head of Clinical Science|714-247-8613|khileman@its.jnj.com|
20574084|NCT04223856|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20574085|NCT03442114|Cincinnati Children's Medical Center|Dr. Lori Crosby|5136365380|Lori.Crosby@cchmc.org|
20574086|NCT03620890|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD, Assistant Professor|713-500-6421|Michal.F.Bartal@uth.tmc.edu|
20574087|NCT05640466|Sohag University|Hussien Sedik Mohamed, Orthopedic Surgery Resident, Sohag University|+20-1065840049|hussien_sediek_post@med.sohag.edu.eg|
20527832|NCT01267422|Department of Ophthalmology, Tongji Hospital Tongji Medical College, Huazhong University of Science and Technology|Bin Li|+86-13638673626|libin-12@163.com|
20574088|NCT01444651|Massachusetts General Hospital|Dr. Jennifer Ho|617-726-6411|jho1@partners.org|
20574089|NCT02445196|Stanford University|Dr. C. Barr Taylor|415-987-1810|btaylor@stanford.edu|
20574090|NCT03338192|Washington University Pain Center in St. Louis|Burel Goodin|3142736403|burel@wustl.edu|
20574091|NCT00733993|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
20574092|NCT01929980|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-9063|Pooja.Khandelwal@cchmc.org|
20574093|NCT03236246|Keryx|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
20574094|NCT00619190|UNC Chapel Hill|Linmarie Sikich, MD|919-972-7499|lsikich@med.unc.edu|
20574095|NCT02952001|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20574096|NCT00389857|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
20574097|NCT02276872|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
20574098|NCT04175808|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20574099|NCT00281021|James Graham Brown Cancer Center, University of Louisville|Dr. Goetz Kloecker|502-562-4358|ghkloe01@exchange.louisville.edu|
20574100|NCT06078579|Cairo university|Dr. Bahaa Mahmoud Fawzy|+201033559646|bahaamust66@gmail.com|
20574101|NCT05972733|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
20574102|NCT02158520|Mayo Clinic|Svetomir N. Markovic MD, PhD|507/266-0800|markovic.svetomir@mayo.edu|
20574103|NCT01637623|University of Wisconsin School of Pharmacy|John M. Dopp|608-265-9352|john.dopp@wisc.edu|
20574104|NCT01570036|Cancer Insight|Program Director, Karen Arrington, RN, BSN|210-243-5711|karrington@cancerinsight.com|
20574105|NCT00969878|Baylor|Thomas Kosten|7137947032|kosten@bcm.edu|
20574106|NCT00568321|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574107|NCT01859078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20574108|NCT00823901|MGH CURTIS|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
20574109|NCT01369511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20574110|NCT05057923|DreamTec Research Limited|Keith Kwong|+85237052355|keithkwong@dreamtec.hk|
20574111|NCT01376349|Alliance for Clinical Trials in Oncology|Debra Barton, R.N., Ph.D.||debbartn@med.umich.edu|
20557051|NCT02901626|Christiana Care Health System, Department of Obstetrics & Gynecology|Matthew Hoffman, MD, MPH|(302) 301-3350|mhoffman@christianacare.org|
20549200|NCT01517711|University of Cincinnati College of Medicine|Dr. Thomas Geracioti, Principle Investigator|513-748-9825|thomas.geracioti@uc.edu|
20549201|NCT03733470|University of Iowa|Eric Hoffman, PhD|319-365-1381|eric-hoffman@uiowa.edu|
20574112|NCT01176968|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549202|NCT01786668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549203|NCT04891978|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20557052|NCT04082884|Yale School of Medicine|Laura Marie Nally, MD|(877) 925-3637|laura.nally@yale.edu|
20549204|NCT03570697|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20549205|NCT01849783|University of Iowa|Margarida Magalhaes-Silverman, MD|319-384-9156|margarida-silverman@uiowa.edu|
20549206|NCT03948581|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20557053|NCT01007656|PingTung Christian Hospital Ruiguang Branch|Dr. Choo-Aun Neoh|886-8-736-8686|neohca@gmail.com|5310
20557054|NCT02940574|KU Leuven|Prof. Dr. Kaat Alaerts|16 37 64 46|kaat.alaerts@kuleuven.be|+32
20557055|NCT03687190|Changhua Christian Hospital|Chung-Min Chiu|*886-982-506-067|shongdiah@gmail.com|
20557056|NCT00659490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20557057|NCT05674890|University of Iowa Hospitals and Clinics Department of Ophthalmology and Visual Sciences|Dr. Andrew Pouw|3193562928|andrew-pouw@uiowa.edu|
20557058|NCT00827541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557059|NCT01649232|Spanish Neurometrics Foundation|Dr. Moises Aguilar-Domingo, Chairman of Spanish Neurometrics Foundation|+34 634548720|moises.aguilar@gmail.com|
20557060|NCT01750879|Massachusetts General Hospital|Dr. Wayne Shreffler|617-726-6147|WSHREFFLER@mgh.harvard.edu|
20557061|NCT02421666|Center for Asian Health, Lewis Katz School of Medicine, Temple University|Dr. Grace X. Ma|2157078823|grace.ma@temple.edu|
20557062|NCT04810221|Life Meter Srl|Dr. Fernando De Benedetto/President|+39 391 4334 090|fernando.debenedetto@lifemetersrl.com|
20557063|NCT03642938|Duquesne University (now at University of Texas at Dallas)|Benedict Kolber|972-883-7225|Benedict.kolber@utdallas.edu|
20557064|NCT01566331|University of Padua|Dr. Erich Cosmi|+393398146745|ecosmi@hotmail.com|
20557065|NCT01119768|AstraZeneca|Gerard Lynch||az_trials_posting@astrazeneca.com|
20557066|NCT01059643|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20557067|NCT00246337|Merck Sharp & Dohme Corp|Vice President of Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
20557068|NCT00338598|Yale University|Elizabeth Ralevski Assistant Professor of Psychiatry|+1 203-932-5711|elizabeth.ralevski@yale.edu|4282
20557069|NCT03525548|Vertex Pharmaceuticals Incorporated|Medical Monitor|617 341 6777|medicalinfo@vrtx.com|
20557070|NCT01226511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20557071|NCT02032212|Imperial Tobacco Group|Tanvir Walele|0044 177 933 7589|tanvir.walele@uk.imptob.com|
20557072|NCT02579876|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
20574113|NCT00718640|Janssen Inc., Canada|Director, Medical Affairs Oncology|416-382-5078||
20574114|NCT00819286|Biomet Microfixation|Brian Hatcher|904-741-4400|brian.hatcher@biomet.com|
20574115|NCT04263909|BWH Anesthesia|Linda S. Aglio, MD MS|6177328480|laglio@bwh.harvard.edu|33328
20574116|NCT00068588|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20574117|NCT05193500|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
20574118|NCT03840486|Emory University|Steven Lindsey, MD|913-706-0232|steven.m.lindsey@emory.edu|
20574119|NCT04098068|Sidney Kimmel Comprehensive Center at Johns Hopkins University|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20574120|NCT03871829|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574121|NCT02993523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20574122|NCT03694418|Montana State University|Dr. Elizabeth Rink|4066000297|elizabeth.rink@montana.edu|
20574123|NCT01806129|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20574124|NCT04288778|Janssen Research & Development, LLC|Medical Advisor|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20549207|NCT02000583|University of Kansas Medical Center|Jeffrey M. Burns MD|913-588-0555|jburns2@kumc.edu|
20549208|NCT03068455|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20549209|NCT01876420|Medtronic|Terry Noel|763-526-0309||
20549210|NCT03173313|ZOLL Circulation, Inc.|Vice President of Clinical Affairs|(408) 541-2140|jcreech@zoll.com|
20557073|NCT03821337|VA Medical Center|Program Manager|843-792-0476|lisa.nunn@va.gov|
20557074|NCT01456299|Ajou University|Dr.Kim|82-32-460-3400|kjyeop@ajou.ac.kr|
20557075|NCT00525525|University of California San Francisco|Michael D. Prados, MD, FACP|415-353-2383|pradosm@neurosurg.ucsf.edu|
20574125|NCT04442737|Janssen Scientific Affairs, LLC|Vice President Medical Affairs Infectious Disease and Vaccines (IDV)|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20508843|NCT00937326|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508844|NCT00790218|Can-Fite BioPharma|Sari Fishman, Director of Clincal Trials|972528998666|sari@canfite.co.il|
20508845|NCT00405275|VA Nebraska-Western Iowa Health Care System|James R. O'Dell, MD|402-559-7288|jrodell@unmc.edu|
20508846|NCT00088595|Novartis Pharmaceuticals|Study Director|862-778-8300||
20508847|NCT03180294|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20508848|NCT02058706|Karmanos Cancer Institute|Dr. Elisabeth Heath|313.576.8734|heathe@karmanos.org|
20549211|NCT04461210|University at Buffalo|Director of the Clinical and Translational Science Institute|7168884850|vmbarnab@buffalo.edu|
20574126|NCT00744523|Medtronic Aortic and Peripheral Vascular|Arslan Malik, Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
20508849|NCT03870893|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
20574127|NCT01139021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20574128|NCT01720173|NRG Oncology|Angela Kuras on behalf of Wei Deng, PhD|716-845-5702|kurasa@nrgoncology.org|
20574129|NCT00784693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574130|NCT05458479|Massachusetts General Hospital Lurie Center for Autism|Dr. Robyn Thom|7818601700|rthom@mgh.harvard.edu|
20574131|NCT03673865|Emory University|Dina Amin|404-251-8895|dina.amin@emory.edu|
20574132|NCT03588728|University of Pittsburgh|Cynthia Conklin, Ph.D.|4125869840|conkca@upmc.edu|
20574133|NCT01388790|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20574134|NCT00195507|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20574135|NCT00528866|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20574136|NCT02888665|Northwestern University|Seth Pollack, MD, Director of Sarcoma Program|312-503-5320|seth.pollack@northwestern.edu|
20574137|NCT00993915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574138|NCT01386658|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20574139|NCT00592761|UAMS Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
20574140|NCT02465463|Emory|Dr. Tanvi Dhere|404-686-1000|tdhere@emory.edu|
20574141|NCT01368809|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Paul F White|214-7703775|paul.white@cshs.org|
20574142|NCT01087931|Vanderbilt University|Kevin O'Neill|615-936-5677||
20574143|NCT00696761|the Department of Urology, Asan Medical Center, University of Ulsan College|Kanghyon Song, Myung-Soo Choo, Kyu-Sung Lee, Ji-Yeon Han, Young-Suk Lee,|82-2-3010-3735|mschoo@amc.seoul.kr|
20574144|NCT00769860|University of Kansas Medical Center|Dr. Richard Barohn|(913) 588-6094|RBAROHN@kumc.edu|
20574145|NCT00934141|University of Wisconsin - Madison|Dr. David H Gustafson|608-890-1436|dhgustaf@wisc.edu|
20574146|NCT00412971|Fredriksberg hospital|Gregers G. Hermann|(+45) 38163536|gregershermann@hotmail.com|
20574147|NCT01106404|Neuromodulation Emerging Therapy Clinical Research, Medtronic, Inc|Mark Sun, Senior Clinical Research Manager|763-526-8098|mark.sun@medtronic.com|
20574148|NCT00775450|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20574149|NCT01749540|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574150|NCT01055262|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
20574151|NCT00894686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574152|NCT03482583|University of Florida|Dr. Ramzi Salloum, Assistant Professor|352-294-4997|rsalloum@ufl.edu|3522944994
20574153|NCT01209143|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20574154|NCT01145755|AstraZeneca|Gerard Lynch|645895|aztrial_results_posting@astrazeneca.com|+44 1509
20574155|NCT02460666|University of California, Los Angeles|Helen Lavretsky, MD|(310) 794-4619|HLavretsky@mednet.ucla.edu|
20574156|NCT05245097|ActiveProtective|Dr Rebecca J Tarbert|267-242-6125|Rebecca@activeprotective.com|
20574157|NCT04770493|Brown University|Dr. Robert Miranda Jr.|401-863-6658|Robert_Miranda_Jr@brown.edu|
20574158|NCT00692978|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
20574159|NCT03231943|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20574160|NCT01572922|St. Jude Children's Research Hospital|Jane Hankins, MD|866-278-5833|Jane.Hankins@stjude.org|
20574161|NCT04821869|Pulmonary Research Institute of Southeast MIchigan|Gary T Ferguson, MD, Director|248-478-6908|garytferguson@msn.com|
20574162|NCT03444324|Biotest AG|Dr. Christina Erb|00496103801|christina.erb@biotest.com|0
20574163|NCT01117454|Vanderbilt University Medical Center|Dr. Prince J. Kannankeril, MD, MSCI|615 322-7447|prince.kannankeril@vanderbilt.edu|
20574164|NCT01774851|Merrimack Pharmaceuticals|MM-111 Medical Director|617-441-1000||
20574165|NCT01794520|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20574166|NCT04796896|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20574167|NCT02021292|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
20574168|NCT04356183|Duke University|Kim Huffman, MD, PhD|919-613-7797|kim.huffman@duke.edu|
20574169|NCT01177787|Gachon University of Medicine and Science|Dr. Kyu Rae LeeMD.PhD.|8232-770-1215|baria07@daum.net|
20574170|NCT02824263|Johns Hopkins University School of Medicine|Jonathan Jun|410-550-0115|jjun2@jhmi.edu|
20574171|NCT00980681|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20574172|NCT00992511|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557076|NCT05614089|University of Pittsburgh|Dr. Jing Luo, MD, MPH, Associate Professor of Medicine|412-383-3559|luoj@pitt.edu|
20557077|NCT02499679|HeartFlow|Sarah Mullen|650-241-1221|smullen@heartflow.com|
20557078|NCT05701995|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20557079|NCT00715429|University of Wisconsin School of Pharmacy|Dr. Mary Elliott|608-695-7501|meelliott@pharmacy.wisc.edu|
20557080|NCT00406133|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D., Director|813-975-8690|rbeck@jaeb.org|
20557081|NCT04899245|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
20557082|NCT04880395|Fundación Huésped - Buenos Aires|Dr. María Inés Figueroa|+54 11 2120-9999|maria.figueroa@huesped.org.ar|
20574173|NCT01676909|Department of Veterans Affairs, VAMHCS MIRECC|Mary Brighid Walsh|410-637-1860|marybrighid.walsh@va.gov|
20574174|NCT04615247|Principal Investigator|Alison Huang, MD|415-353-7900|alison.huang@ucsf.edu|
20574175|NCT00247377|UCI|Ninh Nguyen|714-456-8598|ninhn@uci.edu|
20574176|NCT02743377|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
20574177|NCT02076113|Lahey Hospital & Medical Center|Zoher Ghogawala, MD|781-744-8984|zoher.ghogawala@lahey.org|
20574178|NCT01180998|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
20574179|NCT05664763|Yale University|Stephen R Baldassarri, M.D.|203-785-3627|stephen.baldassarri@yale.edu|
20574180|NCT04231539|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20574181|NCT04092101|University of Vermont|Stacey C. Sigmon, PhD|802-656-9987|stacey.sigmon@uvm.edu|
20574182|NCT05057247|Dana-Farber Cancer Institute|Glenn J. Hanna, M.D.|617-632-309|glenn_hanna@dfci.harvard.edu|
20574183|NCT01067326|Mayo Clinic|Dr. Amir Lerman|507-255-4152|lerman.amir@mayo.edu|
20574184|NCT01629784|Northwestern University|Hae Bae, CRCC|312-695-6829|j-bae@northwestern.edu|
20574185|NCT02430051|University of Southern California|Dr. Leah Stein Duker|(323)442-0371|lstein@chan.usc.edu|
20574186|NCT03681886|Alcon, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20574187|NCT02198430|Real Fundación Victoria Eugenia|Dr. Rubén Cuesta-Barriuso|+34913146508|ruben.cuestab@gmail.com|
20574188|NCT03272763|Fisher & Paykel Healthcare Ltd.|Rebecca Thomson|+64 9 574 0123|Rebecca.Thomson@fphcare.co.nz|7675
20574189|NCT01050907|Fast-Track Drugs and Biologics, LLC|Jonathan D. Berman|301-922-2097|jberman@fasttrackresearch.com|
20574190|NCT02030405|Stanford University Medical Center|Bruno Carneiro de Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
20574191|NCT04526197|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20574192|NCT00381303|Tibotec Therapeutics Clinical Affairs (TTCA), Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
20574193|NCT00267631|Maimonides Medical Center|Dr. Estevan Garcia, MD; Principal Investigator|718-283-6352|EsGarcia@maimonidesmed.org|
20574194|NCT01136811|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
20574195|NCT01211522|Vanderbilt University Medical Center|E Wesley Ely|‭(615) 936-3395‬|wes.ely@vumc.org|
20574196|NCT02441062|University of Iowa, Holden Comprehensive Cancer Center|M.Sue O'Dorisio|(319) 335-7234|sue-odorisio@uiowa.edu|
20574197|NCT02740972|NS Pharma, Inc.|Medical Affairs|(201) 986-3860|trialinfo@nspharma.com|
20574198|NCT00372385|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
20574199|NCT01966471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20574200|NCT02279862|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20574201|NCT03431857|Zimmer Biomet|Emilie Rohmer, Clinical Ops manager|+41588548210|emilie.rohmer@zimmerbiomet.com|
20574202|NCT01323621|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574203|NCT00651157|Mayo Clinic Cancer Center|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
20574204|NCT01721603|University of California, San Francisco|Alain Algazi, MD|(415) 353-7552|Alain.Algazi@ucsf.edu|
20574205|NCT01119001|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
20574206|NCT04343248|Romark, L.C.|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
20574207|NCT04931836|University of Minnesota|Mark Pereira, PhD|612-624-4173|map@umn.edu|
20574208|NCT03604523|UMass Medical School|Dr. David Cave|508-856-8399|david.cave@umassmemorial.org|
20574209|NCT00458341|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20574210|NCT05461794|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20574211|NCT02083705|University of Alberta|Georg Schmölzer|7807354647|georg.schmoelzer@me.com|
20574212|NCT01162317|Atlanta VAMC|Wei Huang (PI)|404-321-6111|wei.huang@va.gov|6517
20574213|NCT00810394|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
20574214|NCT00467285|Samuel Stratton VAMC|Dr. Subhashini Yaturu|518-626-5642|Subhashini.Yaturu@va.gov|
20574215|NCT03891524|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574216|NCT03019796|University of Castilla-La Mancha|Proffessor|925268800|ricardo.mora@uclm.es|
20549212|NCT05338216|Northeastern University|Dr. Erin Meier|1 (617) 373-7438|e.meier@northeastern.edu|
20549213|NCT01554683|Beth Israel Deaconess Medical Center|Dr. Daniel Press|617-667-4074|dpress@bidmc.harvard.edu|
20549214|NCT02498132|University of Kansas|Professor Carl Lejuez|240-535-0467|clejuez@ku.edu|
20549215|NCT00692341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|ClinicalTrials.gov_Inquiries@pfizer.com|
20549216|NCT04600375|University of Arkansas for Medical Sciences|Dr. Vivian Shi|5015266994|VYShi@uams.edu|
20549217|NCT03330288|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20549218|NCT04447794|University of Alaska Anchorage|Dr. Patrick Dulin|(907) 786-1653|pldulin@alaska.edu|
20549219|NCT01042678|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20549220|NCT02284516|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20549221|NCT00205881|Advanced Bionics, LLC|Kenneth Ripley|(661) 362-4572|Kenneth.Ripley@advancedbionics.com|
20549222|NCT03463512|Abbott|Suntje Sander|+495116750|suntje.sander@abbott.com|3254
20549223|NCT04789499|Washington University in Saint Louis|Research Statistician|3143621077|kallogjerid@wustl.edu|
20549224|NCT04203498|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20549225|NCT00644657|University of Oklahoma Health Sciences Center|Eliot Schechter, MD|405-456-5378|eliot-schechter@ouhsc.edu|
20549226|NCT01235689|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20549227|NCT01443078|Memorial Sloan Kettering Cancer Center|Chaft, Jamie, MD|646-888-4545|ChaftJ@mskcc.org|
20549228|NCT00578383|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
20549229|NCT01809106|Mario Negri Institution|Dr. Oscar Corli|+390239014564|oscar.corli@marionegri.it|
20549230|NCT01706978|The Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|78377
20549231|NCT00005044|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20549232|NCT03546062|"Università degli studi della Campania luigi Vanvitelli"|Raffaele Marfella|+390815665110|raffaele.marfella@unicampania.it|
20549233|NCT00181155|Johns Hopkins University|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
20549234|NCT02572401|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
20549235|NCT01548287|AstraZeneca Pharmaceuticals LP, Neuroscience iMed|Joel Posener, MD||clinicaltrialtransparency@astrazeneca.net|
20549236|NCT01957930|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
20549237|NCT00353795|NIH|David Bluemke|301 402 1854|bluemked@nih.gov|
20549238|NCT00259610|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis,|205-934-7733|jcurtis@uab.edu|
20549239|NCT02028754|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20549240|NCT01090492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549241|NCT01768286|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20549242|NCT02083965|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
20549243|NCT00929383|Stryker Neurovascular|David Hess, Manager Clinical Affairs|1-510-413-2642|david.hess@stryker.com|
20549244|NCT00868608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549245|NCT00365508|University of Pennsylvania|Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
20549246|NCT00981370|Childrens Hospital Los Angeles|Thomas Coates, MD|323-361-2352|tcoates@chla.usc.edu|
20549247|NCT02538029|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
20549248|NCT04147221|Center for Anti Infective Research and Development|Dr. Joseph L. Kuti|860-972-3612|joseph.kuti@hhchealth.org|
20549249|NCT00666029|University Hospital Southampton|Professor Christopher Byrne|+44 238120 5006|cdtb@soton.ac.uk|
20549250|NCT01218113|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527833|NCT00284154|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20549251|NCT00115739|University of Michigan Comprehensive Cancer Center|Frances Worden, M.D.|(734) 615-6633|fworden@umich.edu|
20549252|NCT00595530|Connecticut Children's Medical Center|Dr. William T. Zempsky|860-837-5207|wzempsk@ConnecticutChildrens.org|
20549253|NCT01055171|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
20549254|NCT00745823|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1- 800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574217|NCT00475033|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20549255|NCT01337739|Northwestern University|Paul Fitzgerald|312-472-3539|p-fitzgerald2@northwestern.edu|
20549256|NCT00651794|University of Texas HSC-Houston|Dr. Eric Thomas|713-500-7958|Eric.Thomas@uth.tmc.edu|
20549257|NCT01206660|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
20549258|NCT01633853|Peking University Internetional Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
20549259|NCT01661621|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
20549260|NCT00300391|UPittsburgh|Barb Early, RN, BSN, CCRC|(412) 647-9745|earlybj@upmc.edu|
20549261|NCT00290888|Pan Am Clinic|Dr. Peter MacDonald|204-925-7480|pmacdonald@panamclinic.com|
20549262|NCT00842608|Regenstrief Institute, Inc.|Dr. Malaz Boustani|(317) 274-9235|mboustan@iu.edu|
20549263|NCT01335191|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
20549264|NCT01513343|Baylor College of Medicine|Dr. Sheryl O. Hughes, Associate Professor|713-798-7017|shughes@bcm.edu|
20549265|NCT01270516|University of Kentucky|Emily Bradford, Clinical Trial Compliance Administrator|859) 323-2973|emily.bradford@uky.edu|
20549266|NCT05166824|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20549267|NCT02417831|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549268|NCT00905151|Tufts Medical Center|Associate Professor|617-636-2569|linker@tuftsmedicalcenter.org|
20549269|NCT01001377|Amgen Inc.|Study Director|866-572-6436||
20549270|NCT00964860|Procter and Gamble|Holly Eynon|513-622-2920|eynon.ha@pg.com|
20549271|NCT00867568|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
20549272|NCT02683161|Johns Hopkins University|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
20549273|NCT03727230|Guangzhou Blood Center|Director of Clinical Trials|+86-20 83595049|fuyongshui1969@yahoo.com|
20549274|NCT02124083|National Institute of Child Health and Human Development|Porter, Forbes|+1 301 435 4432|fdporter@mail.nih.gov|
20549275|NCT02059395|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
20549276|NCT04377620|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20549277|NCT00134082|Johns Hopkins University|Richard Ambinder, MD|4109558839|rambind1@jhmi.edu|
20549278|NCT00724932|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20549279|NCT00289991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20549280|NCT01610570|National Cancer Institute|Dr. Brigitte Widemann|301-496-7387|widemanb@mail.nih.gov|
20549281|NCT00961233|University of North Carolina School of Medicine|Evan S. Dellon, MD MPH|919-966-2511|edellon@med.unc.edu|
20508850|NCT02650193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549282|NCT01529502|Massachusetts General Hospital|Dr. Lorenzo Berra|617 724 1901|LBERRA@MGH.HARVARD.EDU|
20574218|NCT04484831|University of Florida|Dr. Michelle Cardel, Adjunct Professor|352-273-8811|mcardel@ufl.edu|
20508851|NCT01308853|Akademikliniken, Stockholm, Sweden|Dr. Per Hedén|+46 8 614 54 00|per.heden@ak.se|
20574219|NCT02577601|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|503-494-0757|mccrimmo@ohsu.edu|
20508852|NCT01951326|RedHill Biopharma|Reza Fathi, Senior VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
20574220|NCT02818920|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
20508853|NCT03689699|Columbia University|Mark N. Stein, MD|212 305 5874|mns2146@cumc.columbia.edu|
20508854|NCT02959970|Almirall LLC|Ayman Grada|610-840-7107|ayman.grada@almirall.com|
20508855|NCT00666536|Novartis Pharmaceuticals|Study Director|862-778-8300||
20508856|NCT03300427|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20508857|NCT00693420|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20557083|NCT04686422|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20557084|NCT00227617|UCSF Helen Diller Family Comprehensive Cancer Center|Dr. Emily Bergsland|415-885-7810|Emily.Bergsland@ucsf.edu|
20557085|NCT03063294|Veterans Affairs Greater Los Angeles Healthcare System|David Avram Ganz, MD, PhD|310-478-3711|David.Ganz@va.gov|
20557086|NCT05340855|Mayo Clinic|Christi A Patten, Ph.D.|507-266-2554|patten.Christi@mayo.edu|
20557087|NCT03407794|University of North Florida|Andrea Arikawa|9044798995|andrea.arikawa@unf.edu|
20557088|NCT01811212|The Ohio State University Compreshive Cancer Center|Manisha Shah, MD|614-366-6994|manisha.shah@osumc.edu|
20557089|NCT03779906|Bracco Diagnostics Inc.|Maria Luigia Storto, MD, Executive Director Medical Planning and Management X-ray products|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
20557090|NCT02235545|Abbott|Nicole Harbert, Program Director|1 972-526-4841|nicole.harbert@abbott.com|
20557091|NCT02276066|University of Florida Board of Trustees Contracts & Grants|Mark S. Segal|352-273-5357|segalms@medicine.ufl.edu|
20557092|NCT05377359|Sonova|Bilal Sheikh, Research Audiologist|2268083260|bilal.sheikh@sonova.com|
20557093|NCT03386032|The Procter & Gamble Company|Laurie Moulton, M.S., Statistical Group Scientist|+1-513-544-3636|moulton.lt@pg.com|
20557094|NCT01807156|Emory University|Bassel El-Rayes, MD|404-778-1900|bassel.el-rayes@emoryhealthcare.org|
20557095|NCT04857034|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
20574221|NCT01335009|Eisai Inc.|Eisai Medical Information|18882742378|esi_medinfo@eisai.com|
20574222|NCT00445068|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20574223|NCT04824521|University of Montana|Dr. Sarah Reese|7313940288|Sarah.reese@mso.umt.edu|
20574224|NCT01598311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574225|NCT00658684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574226|NCT00688103|School of Medicine, Toho University|Dr. Hideto Kameda|+81-3-3468-1251|hideto.kameda@med.toho-u.ac.jp|2326
20574227|NCT06605391|Emory University|Fayron Epps, PhD, RN|678-723-8188|fepps@emory.edu|
20574228|NCT03144804|Massachusetts General Hospital|Aparna Parikh, MD|617-339-8452|aparna.parikh@mgh.harvard.edu|
20574229|NCT04417127|Brown University School of Public Health|Omar Galarraga, PhD (Study Contact PI)|+1 (401) 863-2331|omar_galarraga@brown.edu|
20574230|NCT06060717|Fisher & Paykel Healthcare Ltd|Kelly Tay|+64 9-282-9734|kelly.tay@fphcare.co.nz|5634
20574231|NCT06018844|Children's Mercy Research Institute|Priscilla Connell|8166014543|Endocrine-RisingT1deAlliance@cmh.edu|
20574232|NCT05591274|University of Miami, Miller School of Medicine|Russell Saltzman|3052431152|R.Saltzman@med.miami.edu|
20574233|NCT02087748|Lotus Clinical Research, LLC|Anne Arriaga, VP of Clinical Operations|626-397-3412|anne@lotuscr.com|
20574234|NCT03219320|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
20508858|NCT02853123|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20574235|NCT00509665|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20574236|NCT03078907|Actelion Pharmaceuticals Ltd|Clinical Registry group|844-434-4210|clinical-trials-disclosure@its.jnj.com|
20574237|NCT01955122|UMC Utrecht|Prof. Peter Siersema|+31 88 7559338|P.D.Siersema@umcutrecht.nl|
20574238|NCT01672788|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20574239|NCT03874325|Moffit Cancer Center|Hung Khong, MD|813-745-3828|hung.khong@moffitt.org|
20574240|NCT03329196|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
20574241|NCT01128361|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu|
20574242|NCT00985166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574243|NCT02464228|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|KO-TIP-002@kuraoncology.com|
20574244|NCT00530868|UAB|Lisle Nabell|205 934-3061|Lnabell@uabmc.edu|
20574245|NCT00148954|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
20574246|NCT01681628|Thought field Therapy Foundation UK Ltd.|Dr R H Robson|+44 (0)1952550688|r.robson2@btinternet.com|
20574247|NCT00257686|Kowa Research Institute|Bill Arana|9194331600|barana@kowaus.com|
20574248|NCT00846651|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
20574249|NCT01566682|ProLung|Michael Garff, Chief Operating Officer|8012049625|mag@prolunginc.com|
20574250|NCT04229472|Oxford University Hospitals NHS Foundation Trust|Timothy R Betts|+44 (0)1865 220256|timothy.betts@cardiov.ox.ac.uk|
20574251|NCT05787782|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20574252|NCT05736211|Wake Forest University School of Medicine|Dr. Parissa Ballard|704-355-2000|parissa.ballard@advocatehealth.org|
20574253|NCT02634346|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20574254|NCT03260595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574255|NCT04485104|Jazz Pharmaceuticals, Inc.|Director Clinical Trial Disclosure & Transparency|+1 215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20574256|NCT00908232|Janssen-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492||
20574257|NCT00132496|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
20574258|NCT01222260|Columbia University Medical Center|Suzanne Lentzsch, M.D., PhD.|212-304-5485|sl3440@cumc.columbia.edu|
20574259|NCT05062083|National Institute of Mental Health (NIMH)|Dr. Robert Innis|301-594-1368|robert.innis@nih.gov|
20574260|NCT03170154|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20574261|NCT01163721|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20574262|NCT00680823|Children's Hospital of Pittsburgh|Dr. Robert Hickey|412 692 7692|robert.hickey@chp.edu|
20574263|NCT00954421|University of Florida|Dr. Kelly Foote|352-273-5550|foote@neurosurgery.ufl.edu|
20574264|NCT01891721|VA Greater Los Angeles Healthcare System|Dr. Carol Jahchan|310-478-3711|carol.jahchan@va.gov|42953
20574265|NCT02979925|VA San Diego Healthcare System|Albert Leung, MD|858-552-8585|albert.leung@va.gov|3866
20574266|NCT05629962|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
20574267|NCT05640648|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
20574268|NCT06389838|Kranus Health GmbH|Director of Clinical Trials|+491756939818|medical@kranushealth.com|
20574269|NCT01005459|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
20574270|NCT02271477|Ente Ospedaliero Cantonale|Dr. med. Andrea Saporito, Vice-Director of Anaesthesiology|091/811.89.78|andrea.saporito@eoc.ch|
20574271|NCT03254485|Akebia Therapeutics|Akebia Therapeutics|6178446128|trials@akebia.com|
20574272|NCT01104116|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20574273|NCT02958267|OhioHealth|Joseph J Ruane, DO|614-566-3810|joseph.ruane@ohiohealth.com|
20574274|NCT00777946|Novartis Pharmaceuticals|Study Director|862-778-8300||
20574275|NCT00763867|Duke University|Jenny Ibarra|919.236.3291|jenny.ibarra@duke.edu|
20574276|NCT03645954|Lithuanian Univrsity of Health Sciences|Principal Investigator Inna Jaremko|+37064857386|inna.jaremko@kaunoklinikos.lt|
20574277|NCT01377753|National Cancer Institute|Dr. Peter Pinto|240-760-6249|pintop@mail.nih.gov|
20574278|NCT00508352|Ottawa Hospital Research Institute|Dr. Jean-Michel Caudrelier|613-737-8899|jcaudrelier@toh.ca|70216
20574279|NCT02244996|Hong Kong Polytechnic University|Dr. Henry Chan|85227667937|henryhl.chan@polyu.edu.hk|
20574280|NCT00174265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20574281|NCT01473160|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
20574282|NCT00047320|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
20574283|NCT03471871|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20574284|NCT03040622|Inova Heart and Vascular Institute|Kevin Bliden|443-244-1497|kevin.bliden@inova.org|
20574285|NCT03434353|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20574286|NCT00234494|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20574287|NCT01831544|Medtronic|Methee Schreuder|+31611597388|methee.schreuder@medtronic.com|
20574288|NCT01521897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574289|NCT02194062|Yale School of Medicine|Paul Neubauer|2037855430|paul.neubauer@yale.edu|
20574290|NCT03422172|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508859|NCT03250624|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20508860|NCT00179998|Nationwide Children's Hospital|Dr. Robert Castile|614-355-6670|robert.castile@nationwidechildrens.org|
20508861|NCT02933372|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
20508862|NCT03008187|Menarini Ricerche|Angela Capriati, MD|+39 055 56 80 9990|acapriati@menarini-ricerche.it|
20508863|NCT03805971|Centre hospitalier universitaire de Liège|Dr Olivier Bonhomme|003243667881|obonhomme@chuliege.be|
20508864|NCT01155193|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20549283|NCT04159571|Wake Forest University School of Medicine|Merideth Addicott, PhD|336-716-7792|maddicot@wakehealth.edu|
20574291|NCT04533451|Mayo Clinic|Dr. Aminah Jatoi|507-266-9160|Jatoi.Aminah@mayo.edu|
20574292|NCT00293722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574293|NCT00538304|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20574294|NCT04658186|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20574295|NCT03153137|Actelion Pharmaceuticals Ltd|Senior Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574296|NCT01821378|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20574297|NCT02267356|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@viamet.com|
20574298|NCT00559585|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20574299|NCT00867113|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20574300|NCT04044183|Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital|Ana-Maria Vranceanu|(617) 724-3953|avranceanu@mgh.harvard.edu|
20574301|NCT01230788|Emory University|Dr. Todd Cooper|404-785-3000|tmcoope@emory.edu|
20574302|NCT00323297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574303|NCT01633814|University of Missouri|Principal Investigator|573-884-5220|fadelp@health.missouri.edu|
20574304|NCT01774084|Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden;|Thomas Nyström MD, PhD|+4686163211|thomas.nystrom@ki.se|
20574305|NCT02973048|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
20574306|NCT01906346|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
20574307|NCT04226833|Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
20574308|NCT02088788|Geisinger|Melissa Troup|570-214-5433|matroup@geisinger.edu|
20574309|NCT03510988|Weill Cornell Medicine|Katerina Dodelzon, MD|646 962 9650|kad9090@med.cornell.edu|
20574310|NCT01786239|Northwell Health|Delbert Robinson MD|7184708195|drobinso@northwell.edu|
20574311|NCT01050205|University of Pittsburgh|Dr. Andrea Kriska|412-383-1286|aky@pitt.edu|
20508865|NCT03613818|Boise State Universtiy|Dr. Diana Doumas|2084261219|dianadoumas@boisestate.edu|
20508866|NCT03012594|Northwell health|Dr.Larry Miller|5165620334|lmiller7@northwell.edu|
20508867|NCT01480232|Massachusetts General Hospital-Center for Addiction Medicine|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
20508868|NCT03962634|Virginia Commonwealth University|Parthasarathy Madurantakam|804-828-4953|madurantakap@vcu.edu|
20508869|NCT01843205|University of Kentucky|Craig R. Rush, Ph.D.|(859) 257-5388|crush2@email.uky.edu|
20508870|NCT00517413|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20549284|NCT01158157|Cangene Corporation|Christine Hall, Ph.D. Director Clinical|204-275-4248|chall@ebsi.com|
20574312|NCT00364156|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
20527834|NCT04527978|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20527835|NCT00055497|Abbott|Global Medical Services|800-633-9110||
20549285|NCT00444912|Genzyme|Medical Information||medinfo@genzyme.com|
20549286|NCT01606007|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
20549287|NCT03758066|Dimagi, Inc.|Y. Xian Ho|617-649-2214|yho@dimagi.com|63
20549288|NCT00332163|Amgen Inc.|Study Director|866-572-6436||
20549289|NCT02340975|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
20549290|NCT01007812|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20549291|NCT04353271|University of South Alabama|Office of Research Complaince|2514607573|swhite@southalabama.edu|
20549292|NCT01091974|University of Rochester Medical Center|Joseph A. Roscoe Ph.D.|(585) 275-9962|Joseph_Roscoe@URMC.Rochester.edu|
20549293|NCT01979445|The Medicines Company|Global Health Science Center, The Medicines Company|1-888-977-6326|medical.information@themedco.com|
20549294|NCT05379231|National Centre for Audiology|Dr. Susan Scollie|519 661-2111|scollie@nca.uwo.ca|88948
20549295|NCT01004705|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
20549296|NCT01496807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Andrew Brohl|813-745-3242|andrew.brohl@moffitt.org|
20549297|NCT00959764|Tarsa Theapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
20549298|NCT03095612|University of Texas Southwestern Medical Center|Dr. David Gerber|214-648-4180|david.gerber@utsouthwestern.edu|
20549299|NCT01390649|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20549300|NCT00389597|LDR Spine|Noah Bartsch, VP, Clinical,Regulatory,Quality|512-344-3319|noah.bartsch@ldrspine.com|
20549301|NCT02762578|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20549302|NCT02935842|University Hospital Basel|Prof. Peter Fuhr|0041 61 265|peter.fuhr@usb.ch|41 66
20549303|NCT00911547|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549304|NCT03344796|Northwestern Univ|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
20549305|NCT01199965|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20549306|NCT00939770|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20549307|NCT01146665|University of Alberta|Dr. Amanda Newton|780-248-5581|an6@ualberta.ca|
20549308|NCT00758836|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549309|NCT02929667|University of Iowa|Dr. Rup Sainju|319-356-4337|rup-sainju@uiowa.edu|
20549310|NCT00566995|National Cancer Institute|Dr. W. Marston Linehan|301-496-6353|linehanm@mail.nih.gov|
20527836|NCT02104167|Zimmer Biomet|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
20574313|NCT01472380|Mutual Pharmaceutical Company, Inc.|VP, Clinical Development and Medical Affairs|215-697-1743|clinicaltrials@urlmutual.com|
20527837|NCT00048165|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20527838|NCT00731731|Mayo Clinic|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
20549311|NCT00404235|Mayo Clinic|Svetomir N. Markovic, MD, Ph.D|(507) 284-1370|markovic.svetomir@mayo.edu|
20574314|NCT02511678|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
20549312|NCT00688753|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20527839|NCT02112877|Boston Scientific|Nancy O'Connell, Sr. Clinical Research Manager|763-494-2706|nancy.oconnell@bsci.com|
20527840|NCT02379273|Cochlear Americas|Aaron J Parkinson, PhD, Principal Clinical Project Manager|3035242563|aparkinson@cochlear.com|
20527841|NCT01051440|Steward St. Elizabeth's Medical Center|Tara Lauriat|617-789-2404|tara.lauriat@steward.org|
20574315|NCT00324701|Ralph H. Johnson VAMC|Leonard E. Egede, MD, MS|843-789-6670|Leonard.Egede@va.gov|
20574316|NCT01295281|Wellspect HealthCare|Dikran Shamoun|+46313764275|dikran.shamoun@wellspect.com|
20574317|NCT00292461|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
20574318|NCT05090995|Yale University School of Medicine|Lisa Fucito, PhD|203-200-1470|Lisa.fucito@yale.edu|
20574319|NCT02730598|University of Kansas Medical Center|Neil Segal|(913) 945-8985|segal-research@kumc.edu|
20574320|NCT04893577|University of Utah MidValley Dermatology|Christopher Hull, MD|801-213-0375|adrianne.evans@hsc.utah.edu|
20574321|NCT01210118|Hellenic Anticancer Society|Professor Panagiotis Behrakis|00302106470056|pbehraki@hsph.harvard.edu|
20574322|NCT03221192|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20574323|NCT05066724|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20574324|NCT01491893|Istari Oncology|Garrett Nichols, MD|(919) 245.7662|gnichols@istarioncology.com|
20574325|NCT02069353|University of Pittsburgh|Jonathan Elmer|412-647-9489|elmerjp@upmc.edu|
20574326|NCT01389765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20574327|NCT03877432|Taipei Medical University|Dr. Chih-Wei Peng|886-2-27361661|cwpeng@tmu.edu.tw|3070
20574328|NCT01696942|Milton S. Hershey Medical Center|Dr. David Stewart|717-531-0003|dstewart@pennstatehealth.psu.edu|
20574329|NCT01422850|CytoVac A/S|Christer Lundell-Ek, Project Manager - Clinical Development||cle@cytovac.dk|
20574330|NCT02673619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20574331|NCT03834038|Vancouver Island Health Authority|Dr. Christine Lee|250-519-1898|christine.lee@islandhealth.ca|
20574332|NCT00724308|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
20574333|NCT01313117|Northwestern University|Jeffrey Allen M.D.|312-695-8636|jallen1@nmff.org|
20574334|NCT01786187|Michigan State University|Amy Hoffman, RN, PhD|517 355 8348|amy.hoffman@ht.msu.edu|
20574335|NCT01350453|University of Southampton|Jane Burridge|+44(0)2380 598 885|jhb1@soton.ac.uk|
20574336|NCT03602261|OPKO Health|Akhtar Ashfaq|305-575-423|AAshfaq@opko.com|
20574337|NCT05772156|NewYork-Presbyterian Hospital, Columbia University Irving Medical Center|Intramuscular Methylergonovine to Decrease Blood Loss During Cesarean Delivery for Twins: A Triple-B|877-843-2229|hbg2115@cumc.columbia.edu|
20574338|NCT02960113|Rutgers Robert Wood Johnson Medical School|Shaul Cohen, MD|732-235-8717|chohensh@rwjms.rutgers.edu|
20574339|NCT03157232|Masimo|Tala Harake||studies@masimo.com|
20574340|NCT04697264|University of Surrey|Miss Irene Ray|07490749704|i.ray@surrey.ac.uk|
20574341|NCT01990534|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20574342|NCT05344092|Department of Veterans Affairs|Dr. Erin Reilly|781-687-2000|Erin.Reilly@va.gov|4191
20574343|NCT04498169|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. VP, Clinical Development and Medical Affairs.|+1 908-947-3551|msenchyna@aeriepharma.com|
20574344|NCT01383161|University of California, Los Angeles|Gary Small, MD|310-825-0291|gsmall@mednet.ucla.edu|
20574345|NCT03942406|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
20574346|NCT01207596|International Clinical Research Institute|Srinivas Nalamachu|913-317-5300|nalamachu@yahoo.com|
20574347|NCT00216203|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20574348|NCT06069778|BioNTech SE|BioNTech clinical trials patient information|+49 61319084|patients@biontech.de|0
20574349|NCT02856893|EORTC|Yassin Pretzenbacher|+32 2 774 1365|yassin.pretzenbacher@eortc.org|
20549313|NCT05996718|Georgia State University|Candace L. Kemp|404-413-5216|ckemp@gsu.edu|
20549314|NCT01713686|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20549315|NCT00809276|SKCCC|Leo Luznik, MD|410-502-7732|lluznik2@jhmi.edu|
20549316|NCT02885012|Medical University of South Carolina|John Terrill Huggins|(843) 792-2296|hugginjt@musc.edu|
20549317|NCT03187197|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549318|NCT02385045|Imperial College London|Professor Julian Teare|02033126666|j.teare@ic.ac.uk|
20549319|NCT01637935|Takeda|Head, Pharmacoepidemiology|+1-877-825-3327|trialdisclosures@takeda.com|
20549320|NCT02200211|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20549321|NCT00381485|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@spcorp.com|
20549322|NCT01235351|TIMI Study Group|Jessica L. Mega, MD, MPH|6172780145|jmega@partners.org|
20549323|NCT00126191|DFCI|Ann LaCasce, MD|617-632-5959|ALACASCE@PARTNERS.ORG|
20549324|NCT00307294|University of Pittsburgh|Rita Johnson RN BSN CCRC|412-647-8571|johnsonr1@upmc.edu|
20549325|NCT02519036|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20549326|NCT02955602|CymaBay Therapeutics, Inc.|Elaine Watkins, DO, MSPH, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
20549327|NCT02980601|Wake Forest Baptist Health|Joseph Molnar|336-716-4171|jmolnar@wakehealth.edu|
20549328|NCT01575769|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
20549329|NCT01619982|Stanford University|Chandra Ramamoothy|650-723-5728|chandrar@stanford.edu|
20549330|NCT01144286|Privatni gynekologicka ambulance|Vladimir Dvorak|+420 542 221 661|ssgcr@ti.cz|
20549331|NCT03068130|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20549332|NCT01966159|Shenyang Northern Hospital (The General Hospital of Shenyang Military Region)|Dr. Hanyaling|024-28897310|hanyl@medmail.com.cn|
20549333|NCT02643381|UT-Southwestern Medical Center|Gerald Matchett|214-648-6400|gerald.matchett@utsouthwestern.edu|
20549334|NCT02732119|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20549335|NCT05275400|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20549336|NCT02585960|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20549337|NCT03639935|University of Michigan Rogel Cancer Center|ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20549338|NCT00541593|Baystate Medical Center|Dr. John R. Romanelli|(413) 794-3175|john.romanelli@bhs.org|
20549339|NCT04930965|Tulane University|Erin Peacock|504-988-1075|epeacoc@tulane.edu|
20549340|NCT02849678|University of Pittsburgh Medical Center Department of Anesthesiology|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
20549341|NCT00288054|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
20549342|NCT02249585|Seoul National University Hospital|Dr Kook Hyun Lee, MD, PhD|82-2-2072-2467|leekh@snu.ac.kr|
20574350|NCT03801902|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20574351|NCT03952585|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20574352|NCT02310672|Actelion Pharmaceuticals Ltd|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574353|NCT03258554|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20574354|NCT04704336|NYU Langone Health|Olugbenga Ogedegbe, MD|646-501-3435|Olugbenga.Ogedegbe@nyulangone.org|
20574355|NCT03118674|Wake Forest School of Medicine|Herbert L. Bonkovsky, MD|3367137341|hbonkovs@wakehealth.edu|
20574356|NCT02260882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574357|NCT02119325|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574358|NCT01063829|AiCuris Anti-infective Cures GmbH|Chief Medical Officer|004920231763|info@aicuris.com|0
20574359|NCT05073679|Penn State College of Medicine|Dr. Rosemary Claire Roden|717-531-1383|rroden@pennstatehealth.psu.edu|
20574360|NCT00533468|Children's Hospital of Philadelphia|Dr James Reingold|6027516093|reingoldj@email.chop.edu|
20574361|NCT00954174|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
20574362|NCT02234323|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
20574363|NCT04209621|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Sun, Clare, M.D. Principal Investigator, NIH, NHLBI|301.402.1806|clare.sun@nih.gov|
20574364|NCT02249767|Spear Pharmaceuticals|Dr. Spear|239-560-2411|spear@spearpharm.com|
20574365|NCT01372410|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574366|NCT02644941|Humacyte Global Inc|Shamik Parikh, Chief Medical Officer|919-313-9633|sparikh@humacyte.com|130
20574367|NCT04585646|CooperVision, Inc|Lee Hall, PhD|(925) 251 6684|lhall@coopervision.com|
20574368|NCT01145495|Weill Cornell Medical College|Peter Martin, M.D.||pem9019@med.cornell.edu|
20574369|NCT00706550|Michael E. DeBakey Veterans Affairs Medical Center|Dr. Maria C. Rodriguez-Barradas|713-794-7384|Maria.Rodriguez-Barradas2@va.gov|
20574370|NCT01886313|Winston Pharmaceuticals|Dr. Scott B. Phillips|8473628200|scott@winstonlabs.com|
20574371|NCT04614662|The Hospital for Sick Children|Lillian Sung|4168135287|lillian.sung@sickkids.ca|
20574372|NCT01207726|SKCCC|Charlie Rudin, MD|646.888.4527|rudinc@mskcc.org|
20574373|NCT04325308|University of Alabama at Birmingham|Ariel Salas|2059344680|asalas@uab.edu|
20574374|NCT04884763|Indiana University School of Dentistry|Dr. Domenick Zero|3179877507|dzero@iu.edu|
20574375|NCT01387230|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574376|NCT02097641|University of California San Francisco|Michael A. Matthay, MD|415-502-7434|michael.matthay@ucsf.edu|
20574377|NCT02340091|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
20574378|NCT00688181|Boston Scientific Corporation|Director, Clinical Operations|(952) 930-6300|Teresa.Takle-Flach@bsci.com|
20574379|NCT00403754|Novartis Pharmaceuticals|Study Director|862 778-8300||
20574380|NCT00633061|Univesity of Oklahoma College of Medicine|Janna Journeycake, MD||janna-journeycake@ouhsc.edu|
20574381|NCT02000427|Amgen Inc.|Study Director|866-572-6436||
20574382|NCT02208297|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20574383|NCT02708095|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20574384|NCT05125679|Janssen-Cilag Limited|Senior EMEA Medical Advisor Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574385|NCT03829319|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20574386|NCT04498832|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20574387|NCT05359003|Wake Forest University School of Medicine|Halley Alexander, MD, MS, FACNS|336-716-6898|halley.alexander@advocatehealth.org|
20574388|NCT03140423|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Susan S. Huang, MD, MPH|(714) 456-5047|sshuang@hs.uci.edu|
20574389|NCT05101707|Medical University of South Carolina|Dr Dorothea Jenkins|(843)792-2112|jenkd@musc.edu|
20574390|NCT00607022|University of Iowa|Clark Stanford|319-335-7381|CStanford@uiowa.edu|
20574391|NCT04540133|UCSF|Dr. Alessandro Villa|415-476-2045|Alessandro.Villa@ucsf.edu|
20574392|NCT06268288|Mayo Clinic|Lytitia Shea, M.D.|507-422-9847|shea.lytitia@mayo.edu|
20574393|NCT03049735|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
20574394|NCT02146326|Indiana University|Michelle Salyers, PhD / Professor, Department of Psychology|317-274-2904|mpsalyer@iupui.edu|
20549343|NCT03988088|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20549344|NCT00781274|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20574395|NCT03153111|Actelion|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574396|NCT04225221|University of North Carolina at Chapel Hill|Jessica Baker, PhD|984-235-0858|jhbaker@med.unc.edu|
20574397|NCT02684357|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20574398|NCT01079130|Novartis Pharmaceuticals|Study Director|862-778-8300||
20574399|NCT01853982|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
20574400|NCT00390910|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574401|NCT01839487|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
20574402|NCT03714425|Brigham and Women's Hospital|Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
20574403|NCT03622619|Eye Research Group, SOVS, UNSW Sydney|Dr Jacqueline Tan|02 9385 6551|jacqueline.tan@unsw.edu.au|
20574404|NCT04585776|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20574405|NCT01658826|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
20574406|NCT06071754|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20574407|NCT04567615|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20574408|NCT05028517|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|241
20574409|NCT00909792|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20574410|NCT04964960|University of Kentucky|Dr. John Villano|859-323-0405|jlvillano@uky.edu|
20574411|NCT02960854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
20574412|NCT00221195|Tulane University|Cindy Leissinger|504-988-5433|cleissi@tulane.edu|
20574413|NCT01247571|NRG Oncology|Linda Gedeon for William Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
20574414|NCT00833911|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20574415|NCT02431650|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
20574416|NCT01736085|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
20574417|NCT01423812|The Ruth M. Rothstein CORE Center|Gregory Huhn, MD|312-572-4575|ghuhn@cookcountyhhs.org|
20574418|NCT01621230|UTexasSouthwestern|Margaret Craig, MD|2142638919|maggieanes@gmail.com|
20574419|NCT02596620|Chang Gung Memorial Hospital, Taiwan|Dr. Wei-Chen Tai|886-975056026|luketai1019@gmail.com|
20574420|NCT03155373|Imperial College Healthcare NHS Trust|Jonathan Afoke|02033132026|j.afoke@nhs.net|
20574421|NCT01054144|Moffitt Cancer Center|Rachid Baz, MD|813-745-3163|Rachid.Baz@moffitt.org|
20574422|NCT02616614|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20574423|NCT02748018|Medtronic Diabetes|Colleen Haberman, Sr. Clinical Research Manager|6127503275|colleen.p.haberman@medtronic.com|
20574424|NCT01662115|Cleveland Clinic Florida|Chief Academic Office|9546595278|weisse@ccf.org|
20574425|NCT02691260|University of Wisconsin-Madison|Corrine Voils|608-262-9636|voils@surgery.wisc.edu|
20574426|NCT01324323|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20574427|NCT00537485|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
20574428|NCT01284062|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574429|NCT05361668|Crinetics Pharmaceuticals, Inc.|Study Director|(858) 450-6464|medinfo@crinetics.com|
20574430|NCT00642382|Cartiva, Inc|Director Clinical Operations|770-754-3805|rtownsend@cartiva.net|
20574431|NCT01236105|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20574432|NCT01603082|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9393|ClinicalTrialTransparency@astrazeneca.com|
20574433|NCT04086433|Regulatory Mark|Alison Sathe|5133047971|alison@regulatorymark.com|
20574434|NCT00852592|UPittsburgh|Assistant Professor of Psychiatry|412-246-5248|sitdk@upmc.edu|
20574435|NCT05467774|MetroHealth Hospital/Case Western Reserve University|Dr. James Sulzer|5125419036|jss280@case.edu|
20574436|NCT00634010|The University of Texas (UT) MD Anderson Cancer Center|Eduardo Bruera, MD, Chair, Palliative Care Medicine||CR_Study_Registration@mdanderson.org|
20574437|NCT01026142|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20574438|NCT01452854|UCSF|Dr. Mitchell Rosen|415-353-7394|thomas.remble@ucsfmedctr.org|
20574439|NCT00846885|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20574440|NCT01862640|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|DT-inquiry@otsuka.jp|
20574441|NCT01019317|University of Texas (UT) MD Anderson Cancer Center|Elias Joseph Jabbour MD/Assistant Professor|713-792-4764|eharriso@mdanderson.org|
20574442|NCT02178553|Mayo Clinic Rochester|Dr. James D. Hannon|507-284-7289|hannon.james@mayo.edu|
20574443|NCT05085665|Washington University in St. Louis|Dr. Philip Budge|314-747-5532|pbudge@wustl.edu|
20574444|NCT00695253|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Rodney A. White, M. D.|310 963-5230|rawhite@ucla.edu|
20574445|NCT01641809|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20574446|NCT03030235|Saint Luke's Hospital of Kansas City|PRESERVED-HF Study Manager|816-932-9858|PRESERVED-HF@saint-lukes.org|
20574447|NCT03294109|university of Californiia|Siamak Rahman, MD|310 2678839|sirahman@mednet.ucla.edu|
20527842|NCT01153009|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20527843|NCT00410072|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20574448|NCT03690141|Effector Therapeutics|Mark Densel, Vice President Development Operations|8589258215|mdensel@effector.com|
20574449|NCT04744285|Roswell Park Comprehensive Cancer Center|Kris Attwood|877-275-7724|askroswell@roswellpark.org|
20527844|NCT01291264|University of California, San Francisco|Dr. Julius Schachter, Professor of Laboratory Medicine|415 824 5115|julius.schachter@ucsf.edu|
20527845|NCT02232477|Lundquist Institute|Dr. Agnes Chen|424-306-7635|ahchen@lundquist.org|
20527846|NCT01212159|Temple University School of Medicine|Alfred A. Bove|215-707-9259|alfred.bove@tuhs.temple.edu|
20508871|NCT00136357|The Center for Mind-Body Medicine|Dr. James Gordon|202-966-7338|jgordon@cmbm.ort|
20527847|NCT01641471|Cleveland Clinic - Section of Adult Reconstrution|Research Program Manager|216-444-4954|klikaa@ccf.org|
20574450|NCT01717768|TesoRx Pharma LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
20574451|NCT00448435|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574452|NCT00809523|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
20574453|NCT04195581|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|925-621-3761|JVega2@coopervision.com|
20574454|NCT00821431|ConvaTec|Kim Peters, Director of Clinical Affairs|07889841338|kim.peters@convatec.com|
20574455|NCT03712189|Children's Hospital Los Angeles|Dr Todd P Chang|13233612109|tochang@chla.usc.edu|
20574456|NCT03026127|Weill Cornell Medicine|Dr. Dimitris Kiosses|914-997-4381|dkiosses@med.cornell.edu|
20574457|NCT04561765|Yale University|Ondrej Blaha|203.737.4468|ondrej.blaha@yale.edu|
20574458|NCT01182766|University of Virginia School of Medicine|Dr. Nassima Ait-Daoud Tiouririne|(434) 243-0570|NAT7B@uvahealth.org|
20574459|NCT03027557|Aalborg University Hospital|Professor Peter Vestergaard|+45 97 66 36 00|p.vestergaard@rn.dk|
20574460|NCT03270332|University of Miami|Dr. Adam Wanner|3053010563|awanner@miami.edu|
20574461|NCT01699789|RAND Corporation|Kenneth B. Wells|310-794-3728|kwells@mednet.ucla.edu|
20574462|NCT01009554|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20574463|NCT01605253|Rush University Medical Center|Mark Pollack, MD|3129425372|mark_pollack@rush.edu|
20574464|NCT02554903|Actelion Pharmaceuticals US, Inc|Medical Affairs Associate Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574465|NCT00822588|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
20574466|NCT04427501|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20574467|NCT04974515|University of Miami, Miller School of Medicine|Naresh M. Punjabi, MD, PhD|305-243-6388|npunjabi@miami.edu|
20574468|NCT04936841|University of Wisconsin School of Medicine and Public Health|Zachary Morris, MD, PhD|(608) 263-2603|zmorris@humonc.wisc.edu|
20574469|NCT00639223|U. of Pennsylvania Health System|Steven Halbert MD, MSCE|215 510 2221|shalbert@mail.med.upenn.edu|
20574470|NCT01244451|GIMEMA|Alfonso Piciocchi|+39 06 70390528|a.piciocchi@gimema.it|
20574471|NCT01444209|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|robert.timmerman@utsouthwestern.edu|
20574472|NCT04145544|Nurami Medical Ltd|Dr. Amir Bahar (COO & Clinical Director)|+972-747408888|Amir@nurami-medical.com|
20574473|NCT04201821|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20574474|NCT00408603|Sunesis Pharmaceuticals, Inc.|Dr. Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
20574475|NCT02075411|Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|215-590-1858|gurnaney@email.chop.edu|
20574476|NCT02846532|Janssen Research & Development, LLC|SR DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20527848|NCT02784288|University of Michigan|Paul Swiecicki|734-647-1017|pswiecic@med.umich.edu|
20527849|NCT02757625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527850|NCT02131233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527851|NCT00645671|Bausch & Lomb|Dr. Tuyen Ong|(973) 360-6389|Tuyen.Ong@bausch.com|
20527852|NCT02095197|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu|
20527853|NCT05114564|CooperVision|José A. Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com|
20527854|NCT00493311|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
20527855|NCT02779075|Mayo Clinic|Adrian Vella|507-202-8490|vella.adrian@mayo.edu|
20527856|NCT00790556|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527857|NCT00255840|CIPRA-SA|Dr Ian Sanne|+27 11 276 8800|isanne@witshealth.co.za|
20527858|NCT03247322|Medical University of South Carolina|David Taber, PharmD, MS|843-792-3368|taberd@musc.edu|
20527859|NCT00339833|National Institutes of Health|Jonathan Krakoff, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|6022005217|jkrakoff@mail.nih.gov|
20527860|NCT02829047|Vibrant Gastro|Clinical trials manager|046663322|service@vibrantgastro.com|
20527861|NCT02020135|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
20527862|NCT01005901|Novartis Pharmaceuticals|Study Director|862-778-8300||
20527863|NCT01597492|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527864|NCT00162097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20574477|NCT04484259|University of Florida College of Medicine Jacksonville|Francesco Franchi, MD|904-244-5515|francesco.franchi@jax.ufl.edu|
20574478|NCT03951220|University of Oxford|Gaurav Agarwal|07826636655|gaurav.agarwal@medsci.ox.ac.uk|
20574479|NCT04908189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20574480|NCT01306890|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
20574481|NCT02217436|Rady Children's Hospital San Diego|Dr. Amy Williams Bryl|8589668036|abryl@rchsd.org|
20574482|NCT02656420|JHSPH|Dr. Thomas W. Kensler|410-955-1292|tkensle1@jhu.edu|
20574483|NCT01088464|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20574484|NCT01611948|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20574485|NCT01890148|AstraZeneca|Larsson, Bengt|+46 (0) 317064277|ClinicalTrialTransparency@astrazeneca.com|
20574486|NCT01215175|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574487|NCT03872453|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20574488|NCT01678209|Icahn School of Medicine at Mount Sinai|Beth Krone, PhD|212-241-8014|beth.krone@mssm.edu|
20574489|NCT03756350|Venus Concept|Dr. Matthew Gronski|(888) 907-0115|mgronski@venusconcept.com|
20574490|NCT04283981|The University of Texas Health Science Center at Houston|Simon Young|(713) 486-2568|simon.young@uth.tmc.edu|
20574491|NCT01096342|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
20574492|NCT03739762|Kaiser Permanente|Dori Rosenberg, Principal Investigator|206-287-2532|dori.e.rosenberg@kp.org|
20574493|NCT00607880|Mayo Clinic|Albert G. Hakaim, M.D.||Hakaim.Albert@mayo.edu|
20574494|NCT01281007|EMS|Manager of Clinical Trials|+5501938874176|pesquisa.clinica@ems.com.br|
20574495|NCT01426516|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
20574496|NCT05104476|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20574497|NCT03865940|Vanderbilt University Medical Center|Shelby Meier, PhD - Senior Scientific Project Manager|6159369228|shelby.meier@vumc.org|
20574498|NCT02170389|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20574499|NCT01008696|Medical Affairs, Seoul, Korea|Clinical Research Associate|82-2-2094-4835||
20574500|NCT02366728|Duke University|Mustafa Khasraw, M.D.|919-668-6688|mustafa.khasraw@duke.edu|
20574501|NCT03083847|National Institute of Allergy and Infectious Diseases|Patrick Duffy|(301) 761-5089|Patrick.Duffy@nih.gov|
20574502|NCT01627002|ProtAffin Biotechnologie AG|ProtAffin Biotechnologie AG||office@protaffin.com|
20574503|NCT01601847|Case Western Reserve University|Dr. Anna Maria Hibbs|216-844-3387|annamaria.hibbs@cwru.edu|
20574504|NCT01807923|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20574505|NCT02403622|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|mosman@openbiome.org|
20574506|NCT03836807|Dompé farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20574507|NCT00685685|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20574508|NCT04029116|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
20574509|NCT03531788|University of Pittsburgh|Roxanna M. Bendixen, Principal Investigator|4123836603|bendixen@pitt.edu|
20574510|NCT02469896|Barrow Neurological Institute|Shafeeq Ladha, MD|602-406-8989|Shafeeq.Ladha@Barrowneuro.org|
20574511|NCT02510560|Elgan Pharma Ltd.|Miki Olshansky, Chief Executive Officer|972-4-6098626|Miki@elganpharma.com|
20574512|NCT00882310|Columbia University|Paul Oberstein, MD|212-305-0592|po2178@cumc.columbia.edu|
20574513|NCT04722250|Medtronic Cardiovascular|Myra Fan Director|763 514 4000|rs.smarttrial@medtronic.com|
20574514|NCT01464229|MGH|Esther Howe|617-726-8895|ehowe3@partners.org|
20574515|NCT04233164|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Franco, Luis|+1 240 220 4366|luis.franco@nih.gov|
20574516|NCT00717054|Drexel University College of Medicine|Michael Green, DO|215-762-7798|michael.green@drexelmed.edu|
20574517|NCT04556396|Loyola University Medical Center|Kristin Baldea|708-216-9000|kbaldea@lumc.edu|
20574518|NCT01405937|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574519|NCT01868139|University of Maryland School of Medicine|Dr. Bruce Greenwald|4103288731|bgreenwa@medicine.umaryland.edu|
20574520|NCT02540538|MaastrichtUMC|Astrid ML Oude Lashof, MD, PHD|0031433876644|a.oudelashof@mumc.nl|
20574521|NCT01557348|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20574522|NCT05103280|University of Nebraska at Omaha|Sara A. Myers, PhD - Professor|(402) 554-3246|samyers@nebraska.edu; ffallahtafti@unomaha.edu|
20574523|NCT05649657|New Taipei Municipal Tucheng Hospital, Chang Gung Memorial Hospital|Dr. Shu-Chun Huang|0952818169|h0711@ms13.hinet.net|
20574524|NCT04598477|Argenx|Regulatory Manager|Please email:|regulatory@argenx.com|
20574525|NCT05183360|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20574526|NCT05579990|University of Alabama at Birmingham|Dr. Camille Worthington|205-975-7274|cschneid@uab.edu|
20574527|NCT05118204|Albert Einstein College of Medicine|Aaron Fox|718-920-7173|adfox@montefiore.org|
20574528|NCT06263582|UNC Lineberger Comprehensive Cancer Center|Sorgi Kate|919-966-5280|kasorgi@email.unc.edu|
20574529|NCT01313650|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574530|NCT03454308|Medical University of South Carolina|Dr. Jessica Chandler|843-792-1928|chandlje@musc.edu|
20574531|NCT05393037|MSD|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20574532|NCT01012739|Novartis Pharmaceuticals|Study Director|862 778-8300||
20527865|NCT01204918|Yale University|Gerard Sanacora, PhD, MD: Professor of Psychiatry; Director, Yale Depression Research Program|(203) 974-7535|gerard.sanacora@yale.edu|
20527866|NCT00004500|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
20574533|NCT04029480|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20574534|NCT04786119|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20527867|NCT01963091|MUSC|Dr. Moran-Santa Maria|843-792-8187|moranm@musc.edu|
20574535|NCT06132763|Virginia Commonwealth University|Sarah Farthing|804-527-4756|sarah.malone@vcuhealth.org|
20574536|NCT02593786|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20574537|NCT03857321|Atrium Health Wake Forest|Suzanne Craft, PhD|336-713-8846|suzcraft@wakehealth.edu|
20574538|NCT00012298|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
20574539|NCT02383589|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20574540|NCT01829399|Anesthesiology Department, University of NC at Chapel Hill|Randall F. Coombs, M.D.|919-966-5136|rcoombs@aims.unc.edu|
20574541|NCT01703663|University of Michigan|Devin L. Brown, MD, MS|734-936-9075|devinb@umich.edu|
20574542|NCT02408861|Icahn School of Medicine at Mount Sinai|Dr Himanshu Joshi MBBS MPH PhD|2126599635|Himanshu.Joshi@mountsinai.org|
20574543|NCT03808688|Aerie Pharmaceuticals|VP, Medical Affairs|949-246-8731|jmwilliams@aeriepharma.com|
20574544|NCT03998176|University of Nebraska Medical Center|Josh Havens|402-559-2674|jhavens@unmc.edu|
20574545|NCT04612036|University of Tennessee|Michael LaCour|865-974-9376|mlacour@utk.edu|
20574546|NCT01974089|Centre for Clinical Research, North Denmark Regional Hospital, Hjoerring, Denmark|Dorte Melgaard|+4526281086|dmk@rn.dk|
20574547|NCT04641299|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20574548|NCT03018587|Cutera, Inc.|Margot Doucette|(415) 657-5518|mdoucette@cutera.com|
20574549|NCT03662139|Department of PM&R, Marmara University School of Medicine|Naime Evrim Karadag-Saygi, Prof. Dr.|00902166570606|evrimkaradag4@hotmail.com|1628
20574550|NCT02137512|Jaeb Center for Health Research|John Lum, Artificial Pancreas Project Director|8139758690|jlum@jaeb.org|
20574551|NCT01940354|Hospital of the University of Pennsylvania|Scott Trerotola, MD|215-662-6983|scott.trerotola@uphs.upenn.edu|
20574552|NCT02020863|University of California, Irvine Health|Maxime Cannesson, PhD|714- 456-5059|mcanness@uci.edu|
20574553|NCT00352885|Emory University|Bobbi Woolwine|404-712-9620|bwoolwi@emory.edu|
20574554|NCT01920594|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574555|NCT00928564|UC Irvine|Dr. Felicia Lane|17144566155|kbacca@uci.edu|
20574556|NCT04906616|University of California, San Francisco|Dr. Amy Conroy|415-476-6021|Amy.Conroy@ucsf.edu|
20574557|NCT00929656|Malcom Randall VAMC|Dr. Dorian Rose, Research Health Scientist|352-376-1611|Dorian.Rose@va.gov|5238
20574558|NCT00390611|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20574559|NCT00385203|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20574560|NCT03308942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20574561|NCT01131351|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20574562|NCT04147234|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|001
20574563|NCT02496897|Altimmune|Stephanie Holland, Clinical Project Manager|240-654-1450|SHolland@Altimmune.com|40
20574564|NCT00140231|BIDMC|Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
20574565|NCT01524133|Atlanta VAMC|Sheila Rauch|404-321-6111|sheila.rauch@va.gov|3122
20574566|NCT01346488|AbbVie|Global Medical Information|800-633-9110||
20574567|NCT04344860|University Of Pittsburgh|Nicoletta Machin|(412) 209-7280|machinnc2@upmc.edu|
20574568|NCT05352048|University of Kentucky|Dr. Francis Farhadi|859-323-5661|francis.farhadi@uky.edu|
20574569|NCT01214187|Brigham and Women's Hospital|Ivan Rosas, MD|617-278-0434|irosas@rics.bwh.harvard.edu|
20574570|NCT01233869|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574571|NCT02967354|Uppsala University Hospital|Dr Per-Ola Carlsson|+46184714425|per-ola.carlsson@mcb.uu.se|
20574572|NCT01158651|UAB|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
20574573|NCT01191541|Department of pediatrics, Institute of Hematology and Blood Diseases Hospital.|xiaofan Zhu|+86 22 23909001|xfzhu@ihcams.ac.cn|
20574574|NCT00631189|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20549345|NCT00282984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20549346|NCT00191269|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20574575|NCT04464265|University of Michigan Medical School|Zirui Huang, PhD|734-615-2875|huangzu@med.umich.edu|
20574576|NCT00974090|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20574577|NCT00056862|National Institute of Diabetes and Digestive and Kidney Diseases|Jay H. Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
20574578|NCT01822522|AMC Operations and Data Management Cener|Kim Mosby-Griffin|301-251-1161|kmosby@emmes.com|10158
20527868|NCT03517449|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20574579|NCT04721821|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574580|NCT01272947|Novartis Consumer Health S.A.|Clinical Project Leader|+41 22 3635528||
20574581|NCT02019420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574582|NCT01093625|Vistakon|Katherine E. Osborn||clinicalstudies@its.jnj.com|
20574583|NCT02756351|CytaCoat AB|Dr Jacob Odeberg|+46 (0) 70 2087571|jacob.odeberg@scilifelab.se|
20574584|NCT01843218|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20574585|NCT01431534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574586|NCT02742766|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20574587|NCT01959048|Hadassah-Hebrew University|Jacob Strahilevitz|972508946353|jstrahilevitz@hadassah.org.il|
20574588|NCT01395316|University of Chicago|Dr. Adil Javed||ajaved@neurology.bsd.uchicago.edu|
20574589|NCT00617188|Masonic Cancer Center, University of Minnesota|Peter Argenta, M.D.|612-626-6037|argenta@umn.edu|
20574590|NCT01554488|William S. Middleton Memorial VA Hospital|Mihaela Teodorescu, MD-Principle Investigator|(608)2561901|mt3@medicine.wisc.edu|11080
20574591|NCT01474863|Vanderbilt University Medical Center|Todd Rice, MD|6153223412|todd.rice@vanderbilt.edu|
20574592|NCT00708175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20574593|NCT03196232|Stanford University|George A Fisher, Colleen Haas Chair in the School of Medicine|650) 725-9057|georgeaf@stanford.edu|
20574594|NCT02038920|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20574595|NCT00866697|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20574596|NCT02906787|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
20574597|NCT00447382|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20574598|NCT03823768|Medical University of South Carolina|Professor|8437922724|taberd@musc.edu|
20574599|NCT03901053|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
20574600|NCT04600336|Mayo Clinic|Bradley J. Stish, MD|507-538-6120|stish.bradley@mayo.edu|
20574601|NCT03706417|MaineHealth|Principal Investigator|207-396-6920|alexa.craig@mainehealth.org|
20574602|NCT05938998|University of Kansas Medical Center|Dr. Amy Bodde|913-588-7983|abodde@kumc.edu|
20574603|NCT04313153|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|6178446128|trials@akebia.com|
20574604|NCT00523718|Yale University|Christopher Pittenger|(203) 974-7675|christopher.pittenger@yale.edu|
20574605|NCT01436071|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527869|NCT05835063|University of Michigan|Melissa Cousino|(734) 936-4220|melcousi@med.umich.edu|
20574606|NCT01194453|Sun Yat-sen University Cancer Center|Dr. Li Zhang|87342288|zhangli6@mail.sysu.edu.cn|
20574607|NCT00749879|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20574608|NCT02348775|Baylor College of Medicine|R. V. Sekhar M.D.|713-798-3908|rsekhar@bcm.edu|
20574609|NCT03335163|University of Colorado Anschutz Medical Campus|Dr. Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
20574610|NCT04650282|University of Michigan|Michael Popovich|(734) 936-1808|mipopovi@med.umich.edu|
20574611|NCT01016964|Lexington International, LLC|David Michaels|5614170200|las@hairmax.com|
20574612|NCT03873493|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20574613|NCT00863109|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574614|NCT00702845|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574615|NCT00682565|Cytokinetics, Inc.|Medical Director|650-624-3053||
20574616|NCT01244243|University of California, Irvine|Steve Cramer|7144566876|scramer@uci.edu|
20574617|NCT01448213|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
20574618|NCT00454532|Bionovo|Mary Tagliaferri, MD|5106012000|clinicaltrials@bionovo.com|
20574619|NCT04606771|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20574620|NCT00786825|University of Minnesota|Elizabeth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
20574621|NCT04682977|University of Illinois Chicago|Dr. Mansha Mirza|312-355-5427|mmirza2@uic.edu|
20574622|NCT00733304|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574623|NCT01187550|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20574624|NCT00129623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20574625|NCT02445755|Stanford University School of Medicine|Vinod K. Bhutani, MD|(650) 723-5711|bhutani@stanford.edu|
20574626|NCT03189862|University of Michigan|Leah E. Robinson|(734) 647-7645|lerobin@umich.edu|
20574627|NCT05341700|Virginia Tech|Dr. Enette Larson-Meyer|5402311025|enette@vt.edu|
20557096|NCT00387894|University of California San Francisco|Michael Prados, MD|415-353-7500|PradosM@neurosurg.ucsf.edu|
20557097|NCT03662074|Wake Forest Baptist Comprehensive Cancer Center|Study Nurse|336-716-0230|saverill@wakehealth.edu|
20557098|NCT02923739|M D Anderson Cancer Center|Dr. Anil Sood|713-745-5266|asood@mdanderson.org|
20574628|NCT03974334|University of Massachusetts Medical School|Dr. Paula Gardiner|7744416716|paula.gardiner@umassmed.edu|
20574629|NCT03326895|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
20574630|NCT01109173|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
20574631|NCT02252536|NIAAA|Megan Ryan|3014434225|mryan1@mail.nih.gov|
20574632|NCT00729781|Medtronic Xomed, Inc.|David Hodge, Project Manager|(+1-904) 281-2774|david.l.hodge@medtronic.com|
20574633|NCT01438151|Mount Sinai|Dr. Shradha Agarwal|212-659-9261|shradha.agarwal@mssm.edu|
20574634|NCT02340728|Memorial Sloan Kettering Cancer Center|Mark Schattner, MD|212-639-3148|schattnm@mskcc.org|
20574635|NCT01836042|Glaukos|Jeff Wells, PharmD, MBA, RAC|949-367-9600|jwells@glaukos.com|227
20574636|NCT02822950|Michigan State University|Gary Stein|517-353-5126|steing@msu.edu|
20574637|NCT00006392|SWOG Statistical Center|Study Statistician|2066674623||
20574638|NCT02459769|University of Rochester|Charles Kamen, PhD|585-275-9958|charles_Kamen@urmc.rochester.edu|
20574639|NCT02378220|Harding University College of Pharmacy / Unity Health - White County Medical Center, Searcy, Arkansas, USA|Lindsay Elliott|5012794800|lselliott@harding.edu|
20574640|NCT05105789|UW School of Medicine and Public Health|Ellen Wald, MD|(608) 263-8558|erwald@pediatrics.wisc.edu|
20574641|NCT01271803|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20574642|NCT02616523|University Clinical Center Ljubljana|dr. Lea Andjelković|0038615223810|lea.andjelkovic@gmail.com|
20574643|NCT01975428|Scripps Translational Science Institute|Eric J. Topol, M.D.|858-554-5708|etopol@scripps.edu|
20574644|NCT00628251|AstraZeneca|Paula del Rosario|+44 7884 735492|ClinicalTrialTransparency@astrazeneca.com|
20574645|NCT00728481|Mayo Clinic|Dr. Amy Foxx-Orenstein, D.O., Associate Prof. of Medicine, College of Medicine|480-301-8806|foxx-orenstein.amy@mayo.edu|
20574646|NCT02545322|Department of Therapeutic Radiology and Oncology, Medical University of Graz|Peter Winkler, PhD (Head of Medical Physics)|+43 316 385|peter.winkler@medunigraz.at|83193
20574647|NCT00041067|SWOG|Study statistician|206-667-4623||
20574648|NCT00778622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20574649|NCT01463384|Huntington Medical Research Institutes|Principal Investigator|6263975840|mrs@hmri.org|
20574650|NCT01251120|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20574651|NCT01968070|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20574652|NCT00890929|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
20574653|NCT00108069|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@box-w.nih.gov|
20574654|NCT02558231|Actelion Pharmaceuticals Ltd.|Principal Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574655|NCT00995007|National Cancer Institute|Dr. Katherine E. Warren|301-435-4683|warrenk@box-w.nih.gov|
20574656|NCT03933397|Duke Clinical Research Institute - Duke University Medical Center|Huiman Barnhardt, PhD|919-668-7313|huiman.barnhart@duke.edu|
20574657|NCT03367715|NYU Langone Health - Perlmutter Cancer Center|Sylvia Kurz, MD, PhD|212-731-6267|Sylvia.Kurz@nyulangone.org|
20574658|NCT01078207|Covidien|Fran Haury, RRT Research Coordinator, Clinical Affairs|303 305-2314|fran.haury@covidien.com|
20574659|NCT02257957|Universidad Nacional de Colombia|Dr Marcel Y Avila|+5713165000|myavilac@unal.edu.co|15119
20574660|NCT02066051|Mayo Clinic|Dr. Joanne F. Shen|480-301-8377|shen.joanne@mayo.edu|
20574661|NCT01237340|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20574662|NCT01610687|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20574663|NCT02401412|Hollister Incorporated|Stacy Haddad, Global Clinical Affairs Director|847-680-2837|stacy.haddad@hollister.com|
20574664|NCT02374398|Eastern Maine Medical Center|Dr. Alexandru Seviciu|207-973-5918|aseviciu@emhs.org|
20574665|NCT02014740|University of Miami|Prof Gianluca Iacobellis|3052433636|giacobellis@med.miami.edu|
20574666|NCT03684642|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20574667|NCT01643525|Johns Hopkins University|Dr. Paul Nyquist||pnyquis1@jhmi.edu|
20574668|NCT06154213|University of Connecticut|Sherry Pagoto, PhD|(860) 486-5917|sherry.pagoto@uconn.edu|
20574669|NCT01840605|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20574670|NCT03739437|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
20574671|NCT01351623|Memorial Sloan Kettering|Nikoletta Lendvai, MD|(212) 639-3368|lendvain@mskcc.org|
20574672|NCT01130974|Bausch & Lomb Inc.|Robert Steffen|(585) 338-6399|robert.steffens@bausch.com|
20574673|NCT03359590|Profil Institut für Stoffwechselforschung GmbH|Dr. Christoph Kapitza|+49 2131 4018|christoph.kapitza@profil.com|157
20574674|NCT06132425|University of California, Los Angeles|Nora Barnes-Horowitz|(310) 825-2961|nbarneshorowitz@ucla.edu|
20574675|NCT06308666|Centre for Ocular Research and Education|Jill Woods|(519) 888-4567|jwoods@uwaterloo.ca|36743
20574676|NCT00835120|University Hospitals Case Medical Center|Carla Conroy|216-844-2871|carla.conroy@Uhhospitals.org|
20574677|NCT01019980|Novartis Pharmaceuticals|Study Director|862-778-8300||
20574678|NCT03747419|Dana-Farber Cancer Institute|Kent Mouw|6176325734|kent_mouw@dfci.harvard.edu|
20574679|NCT04275297|Osher Center for Integrative Health|A. Gracie Kelly, MS, Research Assistant|6153431554|gracie.kelly@vumc.org|
20574680|NCT05564299|Massachusetts General Hospital|Ingrid V Bassett|617-724-3341|ibassett@mgh.harvard.edu|
20574681|NCT04435782|Actelion Pharmaceuticals Ltd|Study Responsible Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574682|NCT03672461|University of California, San Francisco|Alison Huang, MD|415-353-7900|Alison.Huang@ucsf.edu|
20574683|NCT04225806|InterVene, Inc|Clinical Affairs|6509957137|ClinSupport@intervene-med.com|
20574684|NCT00805038|Case Western Reserve University|Ash Sehgal|216-778-7728|axs81@cwru.edu|
20574685|NCT00315939|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
20574686|NCT04890054|Oregon Rural Practice Research Network|Robert Durr, M.P.H.|503-418-3592|durrr@ohsu.edu|
20574687|NCT05586269|Boston Children's Hospital|Dr. Allison Wu|6173556058|allison.wu@childrens.harvard.edu|
20574688|NCT04752475|Associate Professor of Prenatal Pediatrics at CUIMC|Russell Miller, MD|212-305-3151|rsm20@cumc.columbia.edu|
20574689|NCT04532372|City of Hope Medical Center|Dr. Sanjeet Dadwal|626-359-8111|sdadjeet@coh.org|
20574690|NCT03435003|Stony Brook University|Dr. Konstantinos Spaniolas|631-444-8330|konstantinos.spaniolas@stonybrookmedicine.edu|
20574691|NCT03746951|Nationwide Children's Hospital|Dr. Senthil Krishna|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
20574692|NCT02113579|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20574693|NCT00726622|Mayo Clinic|Tonia M. Young-Fadok, M.D.||youngfadok.tonia@mayo.edu|
20574694|NCT04085341|Graybug Vision|Director, Global Clinical Development Operations|5622098872|bpatel@graybug.vision|
20574695|NCT00440700|University of Minnesota|Dr. Linda Chlan|612-624-6658|chlan001@umn.edu|
20574696|NCT02973425|UMass Chan Medical School|Rajani Sadasivam|15088568923|Rajani.Sadasivam@umassmed.edu|
20574697|NCT02393677|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|(05946)-228393|bikramjit_81@rediff.com|
20574698|NCT00813319|Emory University Rollins School of Public Health|Dr. Ralph DiClemente, Principal Investigator|404-727-0237|rdiclem@emory.edu|
20574699|NCT02645760|Khonkaen University|Rungthip Chalermsan|+66 835603675|chalermsanrungthip@gmail.com|
20574700|NCT02267603|Cancer Immunotherapy Trials Network|Administrative Director|206-667-6609|citn.core.reg@hvtn.org|
20574701|NCT04621734|University of Texas Health Science Center at San Antonio|Dr. Veronica Armijo-Garcia|210-274-8969|mirelesv@uthscsa.edu|
20574702|NCT01754857|University of Wisconsin Carbone Cancer Center|Julie Chang, MD|800-622-9822|clinicaltrials@cancer.wisc.edu|
20574703|NCT03632109|University of Washington|Dr. Lindley Barbee, Principal Investigator|206.744.2595|lbarbee@u.washington.edu|
20574704|NCT00966823|Rhode Island Hospital|Francois I. Luks, MD, PhD|401-228-0556|Francois_Luks@brown.edu|
20574705|NCT00059839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20574706|NCT03842163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574707|NCT01636414|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2265|susan.odum@orthocarolina.com|
20574708|NCT03829241|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20574709|NCT00698451|Janssen Services, LLC|Senior Director|1 215 325-5329|tmcgowan@its.jnj.com|
20557099|NCT02573402|The University of Texas Health Science Center at Houston|Argyrios Stampas, MD|(713) 797-5007|Argyrios.Stampas@uth.tmc.edu|
20557100|NCT00948974|Drexel University|Evan Forman|215.553.7113|evan.forman@drexel.edu|
20557101|NCT00053495|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
20557102|NCT02231177|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20557103|NCT00409682|Abbott|Global Medical Services|800-633-9110||
20557104|NCT03581084|UCSF Airway Clinical Research Center|Ariana Lowman|14155141539|ariana.baum@ucsf.edu|
20557105|NCT05711537|Wake Forest School of Medicine|Heather Columbano, MD|336-716-4498|hcolumba@wakehealth.edu|
20557106|NCT01896869|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
20557107|NCT01691833|Carolinas Healthcare System|Dr. Rachel Seymour|704-355-2000|Rachel.Seymour@carolinas.org|
20557108|NCT00252538|VA Long Beach Healthcare System|Peter Hauser|562 826 8000|peter.hauser2@va.gov|2629
20557109|NCT03319537|Memorial Sloan Kettering Cancer Center|Dr. Marjorie Zauderer, MD|646-608-3790|zauderem@mskcc.org|
20557110|NCT04710927|University Malaya Kuala Lumpur, Malaysia|Dr Tengku Nurfarhana Nadirah Tengku Hamzah|0379674802|tengkunurfarhana@um.edu.my|4865
20574710|NCT01292447|Women and Infants Hospital|Rebecca Allen|4012741122|rhallen@wihri.org|
20508872|NCT01355497|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
20508873|NCT01502761|University of Southern California|Dr. William J Mack|323 442 7512|william.mack@med.usc.edu|
20508874|NCT01838655|National Institutes of Health|Brian Brooks, MD, PhD, Principal Investigator, NEI|301-451-2238|brian.brooks@nih.gov|
20557111|NCT00801801|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
20557112|NCT00118716|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557113|NCT00855062|Harvard School of Public Health|Sachiko Miyahara|617-432-2837|miyahara@sdac.harvard.edu|
20557114|NCT03357614|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
20557115|NCT00530062|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20574711|NCT02224599|Kiromic|CMO and Head of Clinical Operations|(832) 968-4888|sdahlbeck@kiromic.com|
20574712|NCT00596934|University of Michigan|Dr. Elif A. Oral|734-615-7271|eliforal@med.umich.edu|
20574713|NCT05178134|Scandinavian Biopharma Holding AB|Head of Clinical Development|+4684705600|info@scandinavianbiopharma.se|
20574714|NCT02315898|University of Michigan|Dr. Kathleen Stringer|734-647-4775|stringek@med.umich.edu|
20574715|NCT01330914|San Francisco Veterans Affairs Medical Center|Dr. Anne Schafer|(415) 221-4810|anne.schafer@va.gov|24895
20574716|NCT04504357|Boston University School of Public Health, Departments of Global Health and Epidemiology|Jacob Bor, ScD SM|(617) 358-2176|jbor@bu.edu|
20574717|NCT01660607|Stanford University|Dr. Everett Meyer|650-725-5816|evmeyer@stanford.edu|
20574718|NCT00998426|Johns Hopkins Medicine|Kirti Shetty, MD|202 660 5555|kshetty1@jhmi.edu|
20574719|NCT02308007|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
20574720|NCT00528567|Hoffman-LaRoche|Medical Communications|800-821-8590||
20574721|NCT00467389|Substance Abuse Research Laboratory, Kansas City VA Medical Center|Kenneth Grasing|(816) 922-2756|kenneth.grasing@va.gov|
20574722|NCT03352011|VA Center for Integrated Heathcare|Dr. Kyle Possemato|315-425-4400|kyle.possemato@va.gov|53551
20574723|NCT03085758|Adrenomed AG|Jens Zimmermann|+49 (0) 3302 20 77 810|jzimmermann@adrenomed.com|
20574724|NCT01122576|Bausch & Lomb Incorporated|Quintus Ngumah, OD, PhD|(973) 360-6450|Quintus.Ngumah@bausch.com|
20574725|NCT05696236|University of Michigan|Charles Schuler|734-232-2154|schulerc@med.umich.edu|
20574726|NCT01829360|University of Kansas|Holly Storkel|7858640099|hstorkel@ku.edu|
20574727|NCT02024165|Winnie Palmer Hospital for Women and Babies|John Busowski, MD|407-435-1485|john.busowski@orlandohealth.com|
20574728|NCT03574441|Augusta University|Efrain Riveros Perez|7067217361|eriverosperez@augusta.edu|
20574729|NCT00931944|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
20574730|NCT03610399|Acre Health State Secretariat|Suiane Negreiros|55 68 9983 1266|omsvalle@hotmail.com|
20574731|NCT01132612|Novartis Pharmaceuticals|Study Director|862-778-8300||
20574732|NCT00859950|Weill Cornell Medical College|Dr. Ana Krieger|646-962-7378|ack2003@med.cornell.edu|
20574733|NCT03838198|University of Michigan|Ewa Czyz|734-764-9466|ewac@umich.edu|
20574734|NCT00578786|Gilead Sciences, Inc.|Hunter Gillies, MD, DSEM|650-522-1214|hunter.gillies@gilead.com|
20574735|NCT00312221|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20574736|NCT02060721|Actelion Pharmaceuticals Ltd.|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574737|NCT00866723|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos|(617) 632-5269|panagiotisa_konstantinopoulos@dfci.harvard.edu|
20574738|NCT00038727|George Washington University|Marinella Temprosa, PI of Coordinating Center|3018819260|ella@bsc.gwu.edu|
20574739|NCT04178967|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20574740|NCT03078595|Johann Wolfgang Goethe-University Frankfurt|Prof. Dr. med. dent. Peter Eickholz|+4915112433230|eickholz@med.uni-frankfurt.de|
20574741|NCT02608879|NYU Langone Medical Center|Patricia Corby, Principal Investigator|646-501-2615|patricia.corby@nyumc.org|
20574742|NCT00223678|Vanderbilt Medical Center|Dr. Anthony Langone|615-936-1179|anthony.langone@vanderbilt.edu|
20574743|NCT04409353|Cedars-Sinai Medical Center|Samuel Eberlein|310-423-6721|samuel.eberlein@cshs.org|
20574744|NCT02767128|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
20574745|NCT02499770|G1 Therapeutics|Chandra Lovejoy|001 9192991250|clovejoy@g1therapeutics.com|
20574746|NCT02564926|Astrazeneca, Korea|EunYoung Kim / Local Study Specialist|82 2 2188 0946|EunYoung.Kim@astrazeneca.com|0946
20574747|NCT03610165|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
20574748|NCT01351753|University of Iowa|Gary Pierce, PhD|13193359487|gary-pierce@uiowa.edu|
20557116|NCT03059901|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
20557117|NCT04209725|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20557118|NCT02857426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20557119|NCT02634788|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20557120|NCT01238640|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhaue@its.jnj.com|
20557121|NCT03467932|Oramed Pharmaceuticals|Miriam Kidron, Ph.D.|+972-2-566-0100|miriam@oramed.com|
20557122|NCT01780935|Novartis Pharmaceuticals|Study Director|862-778-8300||
20557123|NCT02831257|Massachusetts General Hospital|Scott Plotkin|617-724-5369|splotkin@mgh.harvard.edu|
20557124|NCT00855595|Intendis GmbH|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20557125|NCT01844284|Abbott Vascular|Hajime Kusano|408-845-1626|hajime.kusano@av.abbott.com|+1
20557126|NCT00611858|Dana-Farber Cancer Institute|Jeffrey Meyerhardt, MD, MPH|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
20574749|NCT00671554|Greenville Hospital System|Joe Stephenson, MD|864-455-3600|joe.stephenson@usoncology.com|
20574750|NCT02204566|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
20574751|NCT00977574|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
20574752|NCT04223791|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574753|NCT04667247|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
20574754|NCT05460273|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20574755|NCT04124614|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20574756|NCT05749952|University of Pittsburgh|Sashwati Roy|412 624 0422|sasr453@pitt.edu|
20574757|NCT03022318|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
20574758|NCT03047551|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
20574759|NCT02462928|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20574760|NCT00395863|Bracco Diagnostics Inc.|Gianpaolo Pirovano, MD, Executive Director, Head Corporate Medical Development|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
20574761|NCT03503513|University of Michigan|Dr. Denise Tate|(734) 647-5195|dgtate@umich.edu|
20574762|NCT01170039|Emory University|Jennifer Christie|404-778-4594|jchris6@emory.edu|
20574763|NCT00727649|Birmingham VA Medical Center|Dr. Alayne Markland, PI of this clinical trial|205-933-8101|alayne.markland@va.gov|6365
20574764|NCT01826851|URochester|Peter A. Knight, MD|(585) 275-6340|Peter_Knight@URMC.Rochester.edu|
20574765|NCT02953639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20574766|NCT01830855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574767|NCT00699803|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20574768|NCT00295633|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20574769|NCT01798992|University of Colorado, Denver|Dr. Michael Bristow, MD PhD|303-724-5453|Michael.Bristow@ucdenver.edu|
20574770|NCT02294682|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574771|NCT01516970|Janssen-Cilag GmbH|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
20574772|NCT00434421|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20574773|NCT02334787|Otsuka Pharmaceutical Co., LTD.|Study Director, Department of Clinical Management|+81-3-6361-7366||
20574774|NCT00931242|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
20574775|NCT00892177|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-7733|galanis.evanthia@mayo.edu|
20574776|NCT01446016|Houston Methodist|Dr. Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
20574777|NCT02525055|hVIVO Services Limeted|Dr Nicolas Noulin|+442077561365|n.noulin@hvivo.com|
20574778|NCT00404066|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
20574779|NCT01296035|Women & Infants Hospital|Director of Clinical Trials|401-274-1122|jmari@wihri.org|
20574780|NCT01674712|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20574781|NCT01186796|Mayo Clinic|Johannes. D. Veldhuis, M.D.|507-255-0902|Veldhuis.Johannes@mayo.edu|
20574782|NCT01049243|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-1877|sfeldman@wfubmc.edu|
20574783|NCT01287364|Sunovion|Respiratory Medical Director|1-866-503-6351||
20574784|NCT01936909|Virginia Commonwealth University|Benjamin Van Tassell|8048284583|bvantassell@vcu.edu|
20574785|NCT00744211|University of South Carolina SOM|Francis G. Spinale|803-777-3964|cvctrc@uscmed.sc.edu|
20574786|NCT00000125|Washington University School of Medicine|Michael Kass MD|314-362-5713|kass@vision.wustl.edu|
20574787|NCT05372653|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
20574788|NCT02797067|Changhai Hospital|Yangyang Qian|13818040017|919835863@qq.com|
20574789|NCT01003990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20574790|NCT01829425|University of New Mexico|Dr. Yuko Komesu|5052490726|ykomesu@salud.unm.edu|
20574791|NCT05211739|Alcon Research, LLC|Clinical Project Lead, CRD Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20574792|NCT03606980|Children's Hospital of the King's Daughters|Dana Reesman, PT, DPT|757-668-4894|dana.reesman@chkd.org|
20574793|NCT01294150|NeoTract|Emily Hergenreter Director of Clinical Affairs|650-739-5570|ehergenreter@neotract.com|
20574794|NCT03675776|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20574795|NCT00999713|Penn State College of Medicine|Neal J. Thomas, M.D.|717-531-5337|nthomas@psu.edu|
20574796|NCT00690235|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
20574797|NCT01416987|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20574798|NCT03427125|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20574799|NCT02876302|Dana-Farber Cancer Institute|Dr. Filipa Lynce, MD, Principal Investigator|617-632-3800|Filipa_Lynce@dfci.harvard.edu|
20574800|NCT05390580|Washington University School of Medicine - Neurology Department|Dr. Osvaldo J. Laurido-Soto, PI|314-362-7382|ojlaurido-soto@wustl.edu|
20574801|NCT04014361|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20574802|NCT05225103|Duke University|David Goldston|919-681-1100|david.goldston@duke.edu|
20574803|NCT01130051|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20574804|NCT05315947|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20574805|NCT04252287|Janssen Scientific Affairs, LLC|Director CVM Health Equity|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574806|NCT01080677|Stanford University School of Medicine|Professor of Neurology|650-723-5184|chos@stanford.edu|
20574807|NCT01544023|University of Rostock, Klinikum Südstadt der Hansestadt Rostock, Frauenklinik|Dr. Max Dieterich|+4938144016145|max.dieterich@uni-rostock.de|
20574808|NCT02129205|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508875|NCT00441727|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20508876|NCT02133001|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20508877|NCT04211961|University of Galway|Dr. Alberto Alvarez-Iglesias|+35391524411|alberto.alvarez-iglesias@universityofgalway.ie|
20549347|NCT00941005|University of Wisconsin - Madison|Jeffrey Larson, MD|(608) 417-6175|larsonjef@surgery.wisc.edu|
20549348|NCT02774954|USCalifornia|Ricky Bluthenthal|3234428236|rbluthen@usc.edu|
20549349|NCT02168361|Center for Hepatitis C|Dr. Brian Pearlman|4042651044|brianpearlman3@hotmail.com|
20549350|NCT01804465|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
20549351|NCT02516046|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20549352|NCT00674362|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20549353|NCT02653183|Universitair Ziekenhuis Gent|Prof. Dr. Hilde Beele|+32 9 332 21 11|Hilde.Beele@uzgent.be|
20549354|NCT00923156|Novartis Pharmaceuticals|Study Director|862-778-8300||
20549355|NCT04066023|Zosano Pharma Corporation|Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
20549356|NCT04665856|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20549357|NCT03386448|The Taub Group|Neal Taub MD|7044429805|nealtaub@gmail.com|
20549358|NCT03338010|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20549359|NCT01211730|Northwestern University Feinberg School of Medicine|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu|
20549360|NCT02564796|UC San Diego|Dr. David Werho|(858) 966-5855|dwerho@rchsd.org|
20549361|NCT00816595|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
20549362|NCT00293033|Meda Pharmaceuticals Inc.|Larry Gever, PharmD, Director, Medical Affairs|732-564-2400|larry.gever@meda.us|
20549363|NCT03583697|BioMarin Pharmaceutical Inc.|Alice Huntsman Labed|+44 792-756-5104|alice.huntsmanlabed@bmrn.com|
20549364|NCT00453063|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20549365|NCT00114530|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20549366|NCT01586065|Nemours Children's Health|Larry A Fox, MD|9046973600|larry.fox@nemours.org|
20549367|NCT01577108|China Medical University Hospital|Ming Ho, MD|886422052121|mi.ho@msa.hinet.net|2063
20549368|NCT03724032|University of Michigan|Jacqueline Dobson|734-763-8469|contactHOPE@umich.edu|
20549369|NCT00751933|Haukeland University Hospital|Gunnar Nysæter or Solomon Tefera or Jan Hatlebakk|+47 55972900|jhat@helse-bergen.no|
20549370|NCT02450591|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
20549371|NCT01817530|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20549372|NCT00072566|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20549373|NCT00679432|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|mhuang@santarus.com|
20549374|NCT01558271|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549375|NCT01084083|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
20549376|NCT00228384|W. L. Gore & Associates, Inc.|Chad Badorek|800/437-8181|cbadorek@wlgore.com|
20549377|NCT00873912|MedImmune, LLC|Elissa Malkin, DO|301-398-0000|malkine@medimmune.com|
20549378|NCT01466153|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenca.com|
20549379|NCT01213329|Northwestern University|Dr. Lorenzo Gallon|312-695-8900|l-gallon@northwestern.edu|
20549380|NCT03483740|University of Toronto|Andrew Eaton|4169788895|andrew.eaton@utoronto.ca|
20549381|NCT03261973|Massachusetts General Hospital|Grace Ha|617-643-1697|gha2@mgh.harvard.edu|
20549382|NCT03000283|Allina Health|Dr. Jesse Corry|651-241-6550|Jesse.Corry@allina.com|
20549383|NCT04543838|UPMC|Parthasarathy Thirumala, MD|412-648-4208|thirumalapd@upmc.edu|
20549384|NCT05695209|Indiana University|Principal Investigator|317-278-3154|mmatthia@iu.edu|
20549385|NCT03802227|Nektar Therapeutics|Study Director|415-482-5416|medicalaffairs@nektar.com|
20549386|NCT04362072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549387|NCT04731363|Cleveland Clinic Foundation|Dr. Stanley Hazen, MD|216-444-9426|hazens@ccf.org|
20549388|NCT01918774|Richard L. Roudebush VA Medical Center|Marina Kukla|317-988-3330|marina.kukla2@va.gov|
20549389|NCT01606800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549390|NCT01135420|Department of Veterans Afairs|Christine Timko|650-493-5000|Christine.Timko@va.gov|
20549391|NCT01182675|UCSF|Christopher C. Dvorak, MD|415-476-2188|dvorakc@peds.ucsf.edu|
20549392|NCT01811654|NYU Langone Health|Dennis Cardone, DO|212-460-0176|ariel.aponte@nyumc.org|
20549393|NCT02501473|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549394|NCT02551757|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
20549395|NCT01473836|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549396|NCT00599924|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20549397|NCT01806298|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20549398|NCT03229278|Cancer Institute of New Jersey Rutgers|Dr. Biren Saraiya - Associate Professor of Medicine Medical Director, Office of Human Research Servi|732-235-5773|saraiybi@cinj.rutgers.edu|
20549399|NCT00980057|Medtronic, Inc|Adaptive CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|
20549400|NCT04980040|Takeda|Medical Director|+1 877-825-3327|trialdisclosures@takeda.com|
20549401|NCT01874132|University of Trás-os-Montes e Alto Douro|Professor Nelson Sousa|259350756|nelsons@utad.pt|+351
20549402|NCT00691015|Barbara Ann Karmanos Institute|Zaid Al-Kadhimi, M. D.|(404) 778-1900|zalkadh@emory.edu|
20549403|NCT02139228|Novartis Vaccines and Diagnostics Srl|Posting Director||RegistryContactVaccinesUS@novartis.com|
20549404|NCT04160195|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
20549405|NCT00706823|University of Texas Medical School at Houston|Carin A. Hagberg, MD|713-500-6222|carin.a.hagberg@uth.tmc.edu|
20549406|NCT00592384|University of Washington|Dr. Jesse R. Fann|206 6854280|fann@uw.edu|
20549407|NCT06333613|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|osova@its.jnj.com|
20549408|NCT01373242|University of North Carolina at Chapel Hill|Edwin Kim, MD; Director UNC Food Allergy Initiative|919-537-3193|edwinkim@email.unc.edu|
20549409|NCT02499783|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20549410|NCT01243892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20549411|NCT03675477|ReistoneBiopharma|Roger Liu, Medical Director|+8613917512446|roger.liu@reistonebio.com|
20549412|NCT00730405|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574809|NCT01578967|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20574810|NCT04376060|Saint Joseph University|Dr Sarah Khalil|0096170322739|sarahfkhalil2@gmail.com|
20574811|NCT04115878|University of Arizona|Daniel Combs, MD|520-626-7780|combs89@arizona.edu|
20574812|NCT07052682|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20574813|NCT01310803|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20574814|NCT00332839|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
20574815|NCT00789867|Imperial College|Samia Soussi|0207 594 7980|s.soussi@imperial.ac.uk|
20574816|NCT01999569|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
20574817|NCT00594516|Johnson & Johnson Pharmaceutical Research & Development|Mila Etropolski, MD Clinical Leader|609-730-4537|metropol@its.jnj.com|
20574818|NCT01493557|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20574819|NCT02592551|Baylor College of Medicine|Bryan Burt, MD|713-798-6376|burt@bcm.edu|
20574820|NCT00521924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20574821|NCT01876251|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574822|NCT00982865|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20574823|NCT01355484|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
20574824|NCT02460497|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20574825|NCT03876171|University of Miami|Louis Herns Marcelin, Ph.D.|3052848493|lmarcel2@miami.edu|
20574826|NCT02012296|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20574827|NCT04321980|Orpheris, Inc.|Jeffrey L Cleland, PhD, Executive Chair|650-505-5048|cleland@orpheris.com|
20574828|NCT00908583|University of Cincinnati|E. Steve Woodle|513-558-6001|woodlees@ucmail.uc.edu|
20574829|NCT00993954|University of Alberta|Dr Andrew Dixon|780-492-3553|andrew.dixon@albertahealthservices.ca|
20574830|NCT00860951|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
20574831|NCT01681810|University of Pittsburgh|Dr. Kara Hughan|4126925173|kara.hughan@chp.edu|
20574832|NCT01667081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574833|NCT03034460|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20574834|NCT01205438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20574835|NCT03823404|Quince Therapeutics, Inc.|Dr. Karen Smith|650 722 9813|ksmith@quincetx.com|
20574836|NCT03631667|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
20574837|NCT01087957|Innovative Neurotronics|Helen Rogers PT, PhD|512-721-1922|hrogers@ininc.us|
20574838|NCT01002456|Dept. of Veterans Affairs|Dr. Madeline McCarren|708 786 7987|madeline.mccarren@va.gov|
20574839|NCT01399190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20574840|NCT04216251|Massachusetts General Hspital|Andrew T. Chan, MD, MPH|617-726-3212|achan@partners.org|
20574841|NCT01835015|Alcon Research, Ltd.|Director, Translational Medicine Expert, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
20574842|NCT03239483|"Fundacio Lluita Contra la Sida, Hospital Universitari Germans Trias | Pujol"|Dr. Ross D. Cranston|34-934-657-897|rdcranston@outlook.com|
20574843|NCT01178333|New England Research Institutes|Dr. Susan Assmann, Principal Research Scientist|617-972-3048|sassmann@neriscience.com|
20574844|NCT03678103|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
20574845|NCT04214301|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20574846|NCT01241552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557127|NCT01820559|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20557128|NCT01069354|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
20574847|NCT00201838|The Ohio State Unversity Comprehensive Cancer Center|Miguel Villalona-Calero, MD|614-293-5484|Miguel.Villalona@osumc.edu|
20574848|NCT05395104|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20574849|NCT00381563|New England Baptist Hospital|Director of Clinical Trials|(617)754-6602|pmccree@caregroup.harvard.edu|
20574850|NCT00024167|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD/Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
20574851|NCT00072358|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|1-833-MSK KIDS|kushnerb@MSKCC.ORG|
20574852|NCT03568045|Yale School of Medicine|Dr. Melissa Knauert|203-785-4162|melissa.knauert@yale.edu|
20574853|NCT00770770|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
20574854|NCT01761279|Portsmouth Hospitals NHS Trust|Dr Pete Basford, Endoscopy Research Fellow|+447890990445|petebasford@hotmail.com|
20574855|NCT00117507|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20574856|NCT01505010|University of Leuven|Dr. Jan A. Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
20574857|NCT03837379|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
20574858|NCT02354781|Nationwide Children's Hospital|Dr. Jerry Mendell|1-614-722-4877|Jerry.Mendell@nationwidechildrens.org|
20574859|NCT00626210|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
20574860|NCT04553068|Evofem|Catherine Maher|8585501900|cmaher@evofem.com|
20574861|NCT02218190|Washington University School of Medicine|Michael P. Kelly, MD, MSc|314-747-2511|kellymi@wustl.edu|
20574862|NCT04513665|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
20574863|NCT01368042|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20574864|NCT02663271|University of Florida|David Tran, MD, PhD|352-273-9000|david.tran@neurosurgery.ufl.edu|
20574865|NCT01572675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574866|NCT00460551|Genmab A/S|Eva Järlid Westerberg PhD|+45 7020 2728|E.Westerberg@genmab.com|
20574867|NCT02966223|Indiana University|Mark Tann, MD|317- 948-8782|matann@iupui.edu|
20574868|NCT01326728|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
20574869|NCT02536755|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20574870|NCT02499081|University of Arkansas for Medical Sciences|Maurizio Zangari, MD|501-686-8274|MZangari@uams.edu|
20574871|NCT01667107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574872|NCT00972777|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20574873|NCT01093326|Actelion Pharmaceuticals Ltd|Director Clinical Leader Neuroscience|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574874|NCT06950879|Ghent University|Ruth Van der Looven|003293324237|ruth.Vanderlooven@uzgent.be|
20574875|NCT05868811|Children's Mercy Hospital|Dr. Kai Ling Kong|5157712880|kkong@cmh.edu|
20574876|NCT05162027|University of Maryland, School of Dentistry|Dr. Marcela Romero Reyes|4107067168|mromero@umaryland.edu|
20574877|NCT02553265|NYU Langone Health|Horacio C Kaufmann, MD|212-263-7225|Horacio.Kaufmann@nyulangone.org|
20574878|NCT02039726|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
20574879|NCT04415658|Washington University in St. Louis School of Medicine|Dr. Rajat Dhar|3143622999|dharr@wustl.edu|
20574880|NCT01025492|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
20574881|NCT01650285|BrUOG|Dr. Anthony Mega|4018633000|kayla_rosati@brown.edu|
20574882|NCT00659529|National Jewish Health|Jennifer L. Taylor-Cousar, MD|(303) 270-2764|Taylor-CousarJ@NJHealth.org|
20574883|NCT00916539|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
20574884|NCT02023242|Ivantis, Inc.|Richard Hope|949-333-1310|rhope@ivantisinc.com|
20574885|NCT01950247|American Regent, Inc.|Mark Falone, MD.|631.772.3544|mfalone@americanregent.com|
20574886|NCT00763971|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20574887|NCT03498131|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
20574888|NCT03383289|Columbia University in the City of New York|Jeanne Teresi, EdD, PhD|212-305-9379|jat61@cumc.columbia.edu|
20574889|NCT00832117|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20574890|NCT02606461|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20574891|NCT02764164|Cincinnati Childrens Hospital Medical Center|Dr. Ernest Pedapati|5137361901|ernest.pedapati@cchmc.org|
20574892|NCT00789750|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400||
20574893|NCT03740997|GE HealthCare|David Thompson, MD, PhD|+44 7775 543206|david.thompson1@gehealthcare.com|
20574894|NCT01750931|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574895|NCT00928174|The Queen's Medical Center|Sandi Kwee, Principal Investigator|808-691-5466|skwee@queens.org|
20574896|NCT03681951|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20574897|NCT02187809|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
20574898|NCT01020448|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20574899|NCT01230554|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
20557129|NCT01591382|Brigham and Women's Hospital|Dr. Srdjan S. Nedeljkovic||snedeljkovic@partners.org|
20557130|NCT05887947|University of Kansas Medical Center|Eleanor Leavens|913-945-7875|eleavens@kumc.edu|
20574900|NCT02080455|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-242-5142|alison.long@aegerion.com|
20574901|NCT01006265|Actelion Pharmaceuticals Ltd.|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20574902|NCT00307333|University of Virginia|Joseph R. Moorman, MD|434-982-3367|rm3h@virginia.edu|
20549413|NCT00000371|Freedom Clinic Trail, Massachusetts General Hospital|Dr. Donald Goff|617-921-7899|goff@psych.mgh.harvard.edu|
20549414|NCT00963937|GlaxoSmithKline|GSK Response Center|866-435-7343||
20574903|NCT01245387|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574904|NCT02232282|Loyola University Chicago|Larissa Bresler, MD|7086433827|lbresler@lumc.edu|
20549415|NCT00334958|Eisai Medical Services|Eisai Inc.|1-888-422-4743|esi_medinfo@eisai.com|
20527870|NCT01280682|Department of Endocrinology, First Affiliated Hospital of Nanjing Medical University|Yang Tao|+86-13851498409|dryangtao@sina.com|
20549416|NCT04431453|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20574905|NCT02101021|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20549417|NCT00622401|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
20574906|NCT01621542|Sunovion Pharmaceuticals Inc.|WT2725 Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20574907|NCT03694613|Fundacion Santa Fe, Bogotá, Colombia|Dr. Sergio Lerma|+57 3017752726|serlerma@gmail.com|
20574908|NCT02632721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20574909|NCT02221349|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20574910|NCT04207801|Aurigene Discovery Technologies Limited|Divyesh Mandavia|9427181182|divyesh_m@aurigene.com|
20574911|NCT00544648|Vanderbilt-Ingram Cancer Center|Vicki Keedy, MD|615-936-3524|vicki.keedy@vanderbilt.edu|
20574912|NCT04166383|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|gretentf@mail.nih.gov|
20574913|NCT03346057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20574914|NCT01184053|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20574915|NCT02939989|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20574916|NCT03785678|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20574917|NCT04399122|Joint Warfighter Refractive Surgery Center, Wilford Hall Ambulatory Surgical Center|Dr. Jose E. Capo-Aponte|(210) 292-2554|Jose.E.CapoAponte.ctr@mail.mil|
20574918|NCT01083628|University of California, Berkeley|Dr. Adrian Aguilera|510-642-8564|aguila@berkeley.edu|
20574919|NCT03620019|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|Melahat_Canter@med.unc.edu|
20574920|NCT05426759|AtriAN Medical Ltd|Barry O'Brien PhD|+353872934292|barry.obrien@atrianmedical.com|
20574921|NCT01174238|University of California, San Francisco|Adil Daud, MD|415-353-7392|adaud@medicine.ucsf.edu|
20574922|NCT02301936|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20574923|NCT02322229|Alcon, A Novartis Division|Worldwide Medical Affairs Director, GMA Retina Lucentis|1-888-451-3937|alcon.medinfo@alcon.com|
20574924|NCT00705432|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20574925|NCT01102803|Southern Methodist University|Dr. Jasper Smits|214-768-4125|jsmits@smu.edu|
20574926|NCT00521053|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|1-865-769-4011|wachter@pvct.com|23
20574927|NCT00375219|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20549418|NCT01194466|Mount Mercy University/The University of Iowa|Dr. Jen Lee|3193231623|jlee@mtmercy.edu|
20574928|NCT00824824|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
20549419|NCT01323959|GlaxoSmithKline|GSK Response Center|866-435-7343||
20549420|NCT00223262|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146456950|sherwood.brown@utsouthwestern.edu|
20549421|NCT03834441|MGH|Margaret Samuels-Kalow|617-726-8340|msamuels-kalow@partners.org|
20549422|NCT02021773|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20549423|NCT01481376|Surgical Department of the Protestant Hospital|Docteur Dieter BIRK|06332 422120||
20549424|NCT02243696|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
20549425|NCT01534962|Menarini Ricerche S.p.A|Angela Capriati MD PhD, Head of Corporate Clinical Research|00390555680|acapriati@menarini-ricerche.it|9933
20574929|NCT02281357|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
20549426|NCT00622284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549427|NCT00457301|Lung transplant program, University of Alberta Hospital|Maria Jose Santana|780-441-1661|msantana@ualberta.ca|
20549428|NCT01745133|DermResearch PLLC|leon kircik|5023965310|wedoderm@yahoo.com|
20549429|NCT00915278|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549430|NCT01919606|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20549431|NCT01086761|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20549432|NCT05399641|Scynexis|David Angulo|201-884-5471|david.angulo@scynexis.com|
20574930|NCT02684279|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20549433|NCT02094677|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
20549434|NCT03408483|UAB|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
20574931|NCT01162239|University of California, San Francisco|Dr. Gary Humfleet, PhD|(415) 476-7674|Gary.Humfleet@ucsf.edu|
20549435|NCT00478231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549436|NCT01300650|Virginia Commonwealth University|Benjamin Van Tassell|8049820997|bvantassell@vcu.edu|
20549437|NCT01702961|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
20549438|NCT00727220|IndianaU|Linda A DiMeglio|317-944-3889|dimeglio@iu.edu|
20549439|NCT01899261|Montefiore Medical Center and Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nohri@montefiore.org|
20549440|NCT00084383|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
20549441|NCT01201850|Children's Hospital Colorado|Margaret Macy, MD|720-777-5877|margaret.macy@childrenscolorado.org|
20549442|NCT03137537|Dana Farber Cancer Institute|Dr. Anju Nohria|6175257052|anohria@partners.org|
20549443|NCT01552694|Washington University School of Medicine|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
20549444|NCT00672243|The Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|(919) 668-1409|reard003@mc.duke.edu|
20549445|NCT00191139|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549446|NCT02465515|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20527871|NCT01918072|VA Greater Los Angeles Healthcare System, West Los Angeles, CA|Donna L. Washington, MD, MPH|310-478-3711|donna.washington@va.gov|49479
20527872|NCT02893423|Maimonides Medical Center|Kalpana Tyagaraj|718-283-1753|KTyagaraj@maimonidesmed.org|
20527873|NCT04677387|University of North Carollina at Chapel Hill|Delesha Carpenter, PhD, MSPH|828-250-3916|dmcarpenter@unc.edu|
20549447|NCT03846804|Indiana University School of Medicine|James Wood, MD|317-944-7260|woodjb@iu.edu|
20549448|NCT00824720|Vistakon|Brian Schwam MD/Director Clinical Affairs & Ocular Sciences|904-443-1482||
20549449|NCT02339584|Enter Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA, GDD|1-888-451-3937|alcon.medinfo@alcon.com|
20549450|NCT02610725|Massachusetts General Hospital|Louisa G. Sylvia, Ph.D.|617-643-4804|lsylvia2@mgh.harvard.edu|
20549451|NCT04094883|University of North Carolina at Chapel Hill|Joseph Duncan, MD, PhD|919-966-2536|joseph_duncan@med.unc.edu|
20549452|NCT00743483|Swedish Orphan Biovitrum|Maria Öhman, TA Clinical Head Neonatology|+46 70 694 81 61|maria.ohman@sobi.com|
20549453|NCT01273597|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20549454|NCT03100500|Novartis Pharmaceuticals|Director|862-778-8300|novartis.email@novartis.com|
20574932|NCT00228566|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20574933|NCT05180279|Medical University of South Carolina|Dr Garth Swanson|843-876-2152|swansong@musc.edu|
20549455|NCT02352974|4Pharma AB|Åsa Carlsheimer|+4672244516|asa.carlsheimer@4pharma.com|
20549456|NCT02151383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20574934|NCT04448756|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20549457|NCT01785069|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20549458|NCT01088997|Children's Hospital of Philadelphia|Haresh Kirpalani, MD, MSc|215-590-2455|kirpalanih@email.chop.edu|
20549459|NCT02383498|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20549460|NCT01703039|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
20549461|NCT05570500|Ain Shams University|Dr. Omar Alaa Taqa|01001454416|o.a.taqa@hotmail.com|
20549462|NCT00147446|Northwestern University|David C. Mohr|312-503-3128|m.lisetteluistro@northwestern.edu|
20549463|NCT02302807|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20549464|NCT01980940|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549465|NCT03432897|Brown Oncology Research Group|BrUOG|4018633000|BrUOG@Brown.edu|
20549466|NCT05358444|Johns Hopkins University Schoo of Medicine|Maya Venkataramani MD, MPH|4109559869|mvenkat2@jh.edu|
20549467|NCT00895232|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
20574935|NCT02733185|Mount Sinai Medical Center of Florida|Dr. Gervasio Lamas|305-674-2162|Gervasio.Lamas@msmc.com|
20574936|NCT01624259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549468|NCT05372419|Chief Medical Officer|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20549469|NCT02761252|Menarini International Operations Luxembourg SA|Medical Director|+352 2649761|aconte@menarini.lu|
20549470|NCT01133522|Amgen Inc.|Study Director|866-572-6436||
20549471|NCT03835780|Centre for Musculoskeletal Research|Maya H Buch|+441613066000|maya.buch@manchester.ac.uk|
20574937|NCT01298518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549472|NCT02342327|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20574938|NCT00782288|Johns Hopkins University|Pamela L. Zeitlin, M.D., Ph.D., Professor and Director of SOM Pediatric Pulmonary|443-287-8981|pzeitlin@jhmi.edu|
20549473|NCT01700725|University of Wisconsin - Madison|David Rabago, MD|608-843-0850|david.rabago@fammed.wisc.edu|
20549474|NCT03192462|Baylor College of Medicine|Dr. Benjamin Musher|(713)798-3750|blmusher@bcm.edu|
20549475|NCT04840615|National Cancer Institute|Dr. Raffit Hassan|240760-6232|rh276q@nih.gov|
20549476|NCT00717197|University of Florida|Erin M. Dunbar, MD|(352) 273-9000|edunbar@neurosurgery.ufl.edu|
20549477|NCT00982137|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20549478|NCT03003390|Yale University|Dr. E. Vincent S Faustino|203-785-4651|vince.faustino@yale.edu|
20549479|NCT01648101|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508878|NCT03210220|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82-32-460-3636|jjchoi2@gilhospital.com|
20508879|NCT04586673|University of Oxford|Dr Paola Cicconi|01865611425|paola.cicconi@ndm.ox.ac.uk|
20508880|NCT01444898|Children's Hospital Los Angeles|Dr. Mitchell Geffner|323-361-7032|mgeffner@chla.usc.edu|
20508881|NCT04583969|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20508882|NCT01061567|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508883|NCT01831804|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508884|NCT01819506|Ralph H Johnson VAMC|Michelle Woodbury|843-792-1671|Woodbuml@musc.edu|
20508885|NCT02420990|Center on Addiction|Dr. Aaron Hogue|212-841-5278|ahogue@centeronaddiction.org|
20508886|NCT03326583|George Washington Medical Faculty Associates|Dominic Raj|(202) 741-2296|draj@mfa.gwu.edu|
20508887|NCT01592006|University of Chicago Medical Center|Dr. Helen S. Te|773-702-2395|hte@medicine.bsd.uchicago.edu|
20508888|NCT03447821|Cosmo Technologies Ltd.|Richard Jones|+353 18170370|RJones@cosmopharma.com|
20508889|NCT00228943|Indiana University|Janet S. Carpenter|317-278-6093|carpentj@iupui.edu|
20508890|NCT04685538|Sintetica SA|Anna Guaita|+41 (0)91 640 42 50|aguaita@sintetica.com|
20508891|NCT00176878|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
20508892|NCT02475629|TaiMed Biologics USA Corp.|Manager - Clinical Services|(949) 331-3225|bbell@taimedbio.com|
20549480|NCT01340885|Oregon Health & Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
20549481|NCT02140372|NYU School of Medicine|Binita Shah|212-263-4235|binita.shah@nyumc.org|
20549482|NCT03000439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574939|NCT02877927|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
20549483|NCT00634166|Mylan Pharmaceuticals Inc.|Eric Davis, M.D.|304.554.6503|eric.davis@mylan.com|
20574940|NCT00601250|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549484|NCT02370160|Masonic Cancer Center at University of Minnesota|Dr. Veronika Bachanova|612-625-8287|pham0179@umn.edu|
20574941|NCT01810016|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20549485|NCT01308060|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
20549486|NCT00872534|PLx Pharma|Ronald Zimmerman, CEO & President|1-713-842-1249|ron.zimmerman@plxpharma.com|205
20549487|NCT01581931|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549488|NCT02734940|Virginia Commonwealth University|Dr. Jessica Potter|(804) 828-2755|jessica.potter@vcuhealth.org|
20574942|NCT01791803|North Shore Medical Center|Dr. Faysal M. Hasan|978-741-1200|fhasan@partners.org|4901
20549489|NCT02954237|Abbott|Jordan Anderson, Clinical Scientist|651-756-3360|ClinicalTrials.gov_SH_Inquiries@abbott.com|
20549490|NCT01244724|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
20549491|NCT01508650|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-2227|dkitzman@wakehealth.edu|
20549492|NCT00160693|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20549493|NCT04566302|Massachusetts General Hospital|Guillermo Tearney, MD, PhD|617-724-2979|gtearney@mgb.org|
20549494|NCT05988619|Pomona College|Dr. Benjamin Rosenberg|408-458-5375|benjamin.rosenberg@pomona.edu|
20574943|NCT04572854|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20549495|NCT04538261|AdventHealth Orlando|D. Ashley Hill, MD|407-303-1444|Ashley.Hill.MD@AdventHealth.com|
20549496|NCT00587054|Memorial Sloan-Kettering Cancer Center|Dr. Ann Jakubowski|212-639-5013|jakubowa@mskcc.org|
20549497|NCT05873257|Coloplast A/S|Clinical Strategy Project Manager: Johanne Louise Gotfredsen|004549113350|dkjoat@coloplast.com|
20549498|NCT00726232|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20549499|NCT01651039|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
20549500|NCT00709761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20549501|NCT03600818|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20574944|NCT01330134|University of Chicago|John P. Kress, MD|773-702-1000|jkress@medicine.bsd.uchicago.edu|
20549502|NCT01488370|Loma Linda University Department of Anesthesiology|Elizabeth Ghazal, MD|909-558-4475|EGhazal@llu.edu|
20549503|NCT03355820|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20549504|NCT03478930|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20549505|NCT04189081|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
20549506|NCT00044083|Office of the Clinical Director-NIMH-NIH-HHS|Jose A. Apud|3015946561|apudj@mail.nih.gov|
20549507|NCT00553644|Veterans Affairs Medical Center/University of Minnesota|Vicki Morrison, M.D.||morri002@umn.edu|
20549508|NCT00705484|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549509|NCT00977860|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MCCR|412-647-5554|stadtermanbm@upmc.edu|
20549510|NCT00851747|Loyola Medical Center|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedical.org|
20549511|NCT02621060|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
20549512|NCT04003012|CAMC Institute of Academic Medicine|Dr. Stephanie Thompson|304-388-9911|stethompson@camc.org|
20549513|NCT02228460|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20549514|NCT00119106|CDC|Dr. Michael Martin|662 580 0669|ZND9@CDC.GOV|
20549515|NCT01010061|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20549516|NCT01866293|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|212-639-6009|GiraltS@mskcc.org|
20549517|NCT03066804|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20549518|NCT00740831|PregLem SA|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
20549519|NCT03050554|UC San Diego Moores Cancer Center|Dr. Andrew Sharabi|858-534-4808|ansharabi@health.ucsd.edu|
20549520|NCT00555971|Cleveland Clinic|David M. Lang|216-444-6933|langd@ccf.org|
20549521|NCT03470441|Faraday Pharmaceuticals, Inc|Clinical Trials Manager|206-492-5310|info@faradaypharma.com|
20549522|NCT03982368|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20549523|NCT00518284|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20574945|NCT02246582|Medtronic Diabtes|Smita Barua, Clinical Trial Manager|818.576.5534|smita.barua@medtronic.com|
20549524|NCT03768414|SWOG Statistics and Data Management Center|Gastrointestinal Committee Statistician|2066674623|scolby@fredhutch.org|
20549525|NCT01152697|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
20574946|NCT02229539|Mayo Clinic|Robert C. Miller, MD, MS|904-953-1003|miller.robert@mayo.edu|
20549526|NCT02571777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20549527|NCT03706079|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
20549528|NCT00329238|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20574947|NCT02899078|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20527874|NCT00269477|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20527875|NCT00431067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549529|NCT00801632|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20549530|NCT03652012|University of Arizona|Dr Ying-hui Chou|5206217447|yinghuichou@arizona.edu|
20549531|NCT01288235|Massachusetts General, Hospital|Torunn I. Yock, MD|6177262000|tyock@mgh.harvard.edu|
20549532|NCT03292562|The University of Texas Health Science Center at Houston|Amir Khan, MD|713-500-5519|Amir.M.Khan@uth.tmc.edu|
20549533|NCT00764738|Retina Macula Institute|Dr. Ron Gallemore||rongallemoremd@gmail.com|
20549534|NCT01203098|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
20508893|NCT01421069|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508894|NCT01641081|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20508895|NCT03383614|DNDi|Jean Yves Gillon|+41.22.906.92.32|jygillon@dndi.org|
20508896|NCT01511640|University of Kentucky College of Medicine|Joshua Lile, Ph.D., Professor|8593236034|jalile2@uky.edu|
20508897|NCT03297944|University of Kentucky|Marion Coe|859-257-6488|mcoe07@gmail.com|
20508898|NCT02925312|Medstar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
20508899|NCT02352103|Vattikuti Urology Institute, Henry Ford Hospital|Deepansh Dalela, MD|3139162600|ddalela1@hfhs.org|
20508900|NCT00444964|Children's Mercy Hospital|Jaylene Weigel|816-701-1359|jweigel@cmh.edu|
20508901|NCT00166517|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20508902|NCT00842361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20508903|NCT01072448|Novartis Pharmaceuticals|Study Director|862 778-8300||
20508904|NCT02119468|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|62405
20508905|NCT01015820|Mayo Clinic|Dr. Michael B. Wallace|904-953-6970|wallace.michael@mayo.edu|
20508906|NCT01313078|National Cancer Institute, National Institutes of Health|Elise Kohn, M.D.|301-496-9336|kohne@mail.nih.gov|
20508907|NCT03136484|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20508908|NCT04399980|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
20508909|NCT01449955|UT Southwestern/VA North Texas|Dr. Alina Suris|214-857-0334|alina.suris@va.gov|
20508910|NCT01601470|Novartis Pharmaceuticals|Study Director|862-778-8300||
20508911|NCT01203787|UNIVERSITY OF FLORIDA|Roniel Cabrera, MD|352-273-9468|RONIEL.CABRERA@MEDICINE.UFL.EDU|
20508912|NCT00044655|NYSPI|Nancy H. Covell, Ph.D.|6469450227|covelln@nyspi.columbia.edu|
20527876|NCT00938587|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527877|NCT00849290|Dendreon Corporation|Director, Clinical Operations|206-455-2476|clinical@dendreon.com|
20527878|NCT00548249|Rockwell Medical|Richard C. Yocum, MD|858-229-8585|ryocum@rockwellmed.com|
20549535|NCT02650856|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
20549536|NCT02197520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549537|NCT00913497|Corewell Health|Esther Peariso|6164860358|esther.peariso@corewellhealth.org|
20549538|NCT03385564|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549539|NCT03087643|University of Verona|Dr. Massimo Venturelli|00390458415114|massimo.venturelli@univr.it|
20549540|NCT00113022|Experimental Therapeutics and Pathophysiology Branch, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
20549541|NCT01427972|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549542|NCT01095731|Columbia University Irving Medical Center|E. Sander Connolly Jr., MD|212-305-0376|esc5@cumc.columbia.edu|
20549543|NCT02578316|Eisai Inc.|Eisai Medical Services|888-||
20549544|NCT04997304|University of Michigan|Njira Lugogo|734-647-6477|nlugogo@med.umich.edu|
20549545|NCT00940225|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20549546|NCT02469298|GlaxoSmithKline|GSK Response Center|866-435-7343||
20549547|NCT04249583|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
20549548|NCT03311724|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20508913|NCT02079519|Hoffmann-La Roche|Medical Communications|800 821-8590||
20508914|NCT01176240|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20527879|NCT01912352|Seoul National University|Dr. Jae-Won Kim|822-2072-3648|adore412@paran.com|
20549549|NCT03576976|New York State Psychiatric Institute|Dr. Alice Medalia|646-774-8482|am2938@cumc.columbia.edu|
20527880|NCT01178814|Columbia University Irving Medical Center|Mark Heaney, MD|646-317-5199|mlh2192@cumc.columbia.edu|
20527881|NCT01464619|The Children's Hospital of Philadelphia|James Guevara, MD, MPH|215-590-1130|guevara@email.chop.edu|
20527882|NCT00750919|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549550|NCT04666051|Menoufia Univeristy|M. Ashraf BAlbaa|+20482224216|mohamed.balbaa@med.menofia.edu.eg|
20549551|NCT02957305|Dep. of Obstetrics and Gynecology, Universidade Federal do Rio Grande do Sul, Porto Alegre - RS - Brazil|Ricardo Francalacci Savaris|+5551997781966|rsavaris@hpca.edu.br|
20549552|NCT00674700|Stallergenes|Michel Roux, Medical Director|+33 1 55 59 2970|mroux@stallergenes.com|
20549553|NCT00395304|Penn State Hershey College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
20549554|NCT01749137|Rhythm Pharmaceuticals, Inc|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20549555|NCT00621985|Children's Hospital Boston|Joseph Majzoub|617-355-7476|joseph.majzoub@childrens.harvard.edu|
20549556|NCT01408485|St. Jude Medical|Nancy Ouch, Senior Clinical Project Manager|949-769-5000|NOuch@sjm.com|
20549557|NCT01397084|AstraZeneca|James Armbrust||aztrial_results_posting@astrazeneca.com|
20549558|NCT03130257|Kaiser Permanente Washington Health Research Institute|Beverly B. Green, MD, MPH|206-287-2997|Bev.B.Green@kp.org|
20549559|NCT01751867|Janssen R&D US|SR DIR COMPD DEV TM LDR|1 908 704-5197||
20549560|NCT04932096|Oregon Health & Science University|Dr. Cydni Williams|5034945522|willicyd@ohsu.edu|
20549561|NCT02064894|CHU Ste-Justine Hospital|Dr. Sylvie Le May|514-343-6384|sylvie.lemay@umontreal.ca|
20557131|NCT05163522|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20549562|NCT01396148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549563|NCT02536040|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
20549564|NCT03095066|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20549565|NCT03766581|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20549566|NCT03716024|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20549567|NCT04343261|Saint Francis Hospital and Medical Center|Latha Dulipsingh, MD|860-714-4402|Latha.Dulipsingh@trinityhealthofne.org|
20549568|NCT02123121|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
20549569|NCT02837328|University of Minnesota|Pamela Lutsey, PhD MPH|612-624-5812|lutsey@umn.edu|
20549570|NCT01112865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549571|NCT02197247|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20549572|NCT00790985|Primus Pharmaceuticals|Robert Levy, MD., Director of Clinical Development|480-483-1410|Rlevy@primusrx.com|
20549573|NCT00244010|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
20549574|NCT03851705|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20549575|NCT02478775|University of Colorado School of Medicine|Dr. Alex Polotsky|303-704-8221|ALEX.POLOTSKY@CUANSCHUTZ.EDU|
20549576|NCT01964430|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20549577|NCT02591290|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20549578|NCT02571075|Womack Army Medical Center|Anthony Plunkett|910-643-2324|anthony.r.plunkett.civ@mail.mil|
20557132|NCT01712477|Michigan State University|Chet A Morrison, M.D.|9897901001|chet.morrison@cmich.edu|
20557133|NCT02521285|UT MD Anderson Cancer Center|Robert S. Bresalier, MD- Professor, Gastroenterology Hepat & Nutr|(713) 745-4340|rbresali@mdanderson.org|
20557134|NCT01398280|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
20557135|NCT01542957|Universitat de Barcelona|Prof. Guillem Feixas|0034 933125100|gfeixas@ub.edu|
20557136|NCT00689026|Georgia Regent University|Dr. Sherman M. Chamberlain, Professor of Medicine|706-721-2238|schamberlain@gru.edu|
20527883|NCT02612688|Brown University|Jessica A. Ogarek, Senior Biostatistician|401-863-9356|jessica_ogarek@brown.edu|
20557137|NCT01666808|Emory University|Dr. Ashesh Jani|404-778-3827|abjani@emory.edu|
20527884|NCT04006509|University of Florida|Leslie A. Parker|352 273 6384|parkela@ufl.edu|
20557138|NCT03933826|University of Washington|Dr. John Gore|206-543-9926|cistopm@uw.edu|
20557139|NCT04992546|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20557140|NCT04506775|UMass Chan Medical School|J. Aaron Scott, DO|774-303-4156|jamesaaron.scott@umassmemorial.org|
20557141|NCT02703922|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, clinical research manager|+33516494246|caroline.allix-beguec@ght-atlantique17.fr|
20557142|NCT03934736|Dynavax Technologies Corporation|Robert Janssen, MD, Senior Vice President & Chief Medical Officer|5106650414|rjanssen@dynavax.com|1414
20557143|NCT00818116|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20557144|NCT01648348|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-1370|galanis.evanthia@mayo.edu|
20557145|NCT03419364|University of North Carolina at Chapel Hill|Kim Boggess, MD|919-966-1601|kboggess@med.unc.edu|
20557146|NCT00552084|Vanderbilt University Medical Center|Dr. C Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
20557147|NCT01338025|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20557148|NCT03188055|University of Wisconsin, Madison|Margaret Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
20557149|NCT03017079|THE SECOND AFFILIATED HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE|Dr|18817821529|hm198699@126.com|
20557150|NCT04349280|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20557151|NCT04549363|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20557152|NCT02286089|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20557153|NCT01266447|NRG Oncology|Linda Gedeon, Clinical Data Coordinator|716-845-1169|lgedeon@gogstats.org|
20557154|NCT00847405|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20557155|NCT01728792|Takeda|Takeda Study Registration Call Center, Central Contact|+1-877-825-3327|medicalinformation@tpna.com|
20557156|NCT03559218|KeraNetics|Ryan Clohessy, PhD|4102513940|rclohessy@keranetics.com|
20557157|NCT04277455|Mercy Research|Dr. Johnson Thomas|417-888-5660|johnson.thomas@mercy.net|
20557158|NCT02760056|OHSU|Anna Orban|503-494-3549|orban@ohsu.edu|
20557159|NCT01679301|Philips Respironics|Chuck Cain|+1 724 7335835|chuck.cain@philips.com|
20557160|NCT02259517|Duke University|Jonathan Posner, MD|1 919 684 2403|jonathan.posner@duke.edu|
20557161|NCT02305381|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20574948|NCT02060383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20527885|NCT00080483|University of Pennsylvania|Peter J. Snyder M.D.|215-898-0208|pjs@mail.med.upenn.edu|
20574949|NCT03441334|Texas Woman's University|Hui-Ting Goh, Assistant Professor|2146897723|HGoh1@twu.edu|
20549579|NCT03190915|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20549580|NCT02933606|Bionomics Limited|VP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
20549581|NCT00183677|Massachusetts General Hospital|Dan Iosifescu, MD, MSc||diosifescu@partners.org|
20549582|NCT02083783|Tris Pharma, Inc.|Antonio Pardo MD|732-823-4755|apardo@trispharma.com|
20549583|NCT01546883|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
20549584|NCT02256631|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20549585|NCT00530946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20549586|NCT04545385|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20549587|NCT01128842|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20549588|NCT04528732|Washington University in St. Louis|Dr. Proscovia Nabunya|3149359087|nabunyap@wustl.edu|
20549589|NCT00255125|Kansas City VA Medical Center|Dr. Peter Van Veldhuizen|816-861-4700|peter.vanveldhuizen@va.gov|
20549590|NCT00668707|The Centre for Health Innovation|Mark Legacy, Clinical Trial Coordinator|613-792-1222|mlegacy@thechi.ca|1
20549591|NCT00834171|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20549592|NCT03943147|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20549593|NCT00418457|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
20549594|NCT00629707|University of California, Davis|Dr. Nicole Glaser|916-734-7098|nsglaser@ucdavis.edu|
20549595|NCT02267083|Gem Pharmaceuticals, LLC|Elizabeth Moore, Regulatory Affairs Agent|8583532019|elizabethmoore109@comcast.net|
20549596|NCT00968201|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20549597|NCT02619175|Loewenstein Rehabilitation Hospital|Mrs. Shirley Handelzalts|972-9-7709010|peregshir@gmail.com|
20549598|NCT02784431|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
20549599|NCT02657369|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20549600|NCT00361569|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
20549601|NCT02605824|UCSF Airway Clinical Research Center|Fahy Research Manager|415-514-1539|ariana.baum@ucsf.edu|
20549602|NCT04875195|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@msd.com|
20549603|NCT00826943|Vanderbilt University|Douglas Tzanetos|615-942-7971|dtzanetos@hotmail.com|
20549604|NCT00074152|International Breast Cancer Study Goup|Barbara Ruepp|+4131 3899222|barbara.ruepp@ibcsg.org|
20549605|NCT01382212|AbbVie|Global Medical Information|800-633-9110||
20549606|NCT03715530|University of Iowa|Dr. Mark Santillan|319-356-3180|mark-santillan@uiowa.edu|
20549607|NCT01072331|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20549608|NCT01594762|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
20549609|NCT03288129|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20549610|NCT00650260|University of South Florida Dept of Surgery/Anesthesiology|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
20549611|NCT02777333|University of Oxford|Mr P Garfjeld Roberts|01865 227374|patrick.garfjeldroberts@ndorms.ox.ac.uk|
20549612|NCT00837811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549613|NCT03307967|Yale University|Christina Lazar, Project Director|203-932-5711|christina.lazar@yale.edu|4833
20549614|NCT02065375|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20549615|NCT03268954|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20549616|NCT02159560|Beth Israel Deaconess Medical Center|Philip Hess|6176673112|phess@bidmc.harvard.edu|
20549617|NCT02993146|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
20549618|NCT04524689|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20549619|NCT03128424|Endologix|Mohamed Moawad|949-595-7244|mmoawad@endologix.com|
20549620|NCT01511315|UCSF Psoriasis Center|Mio Nakamura, MD|4154764701|mio.nakamura@ucsf.edu|
20549621|NCT01898806|Columbia University|Grace Ulerio|212-305-6953|gu2102@cumc.columbia.edu|
20549622|NCT03156543|University of Michigan Medical School|Bethany Ruffino|734 615-0768|bruffino@med.umich.edu|
20549623|NCT02356575|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao, MD, MSCE|646-888-0866|maoj@mskcc.org|
20549624|NCT00903396|Mayo Clinic|Michele Halyard, M.D.|4803014567|mhalyard@mayo.edu|
20549625|NCT01389817|Medical College of Wisconsin|Harry T. Whelan M.D.|414-266-3466|hwhelan@mcw.edu|
20549626|NCT01758432|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20549627|NCT02966028|Sanifit|SVP Clinical Development Operations|18582815976|Claire.Padgett@sanifit.com|
20549628|NCT00036738|Fred Hutchinson Cancer Research Center|Dr. George Georges|206-667-6886|ggeorges@fredhutch.org|
20549629|NCT01089062|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20549630|NCT02577510|CF|Gaurav Gupta|6139451601|gaurav00gupta@gmail.com|
20549631|NCT03052725|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20549632|NCT04592874|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
20557162|NCT01042509|Hospital Universitario|Dr. David Gomez-Almaguer|5281-83488510|hematohu@yahoo.com|
20549633|NCT01976338|Novartis|Study Director|862-778-8300||
20574950|NCT04946825|University of Vermont|Elias Klemperer, PhD|802-656-1641|elias.klemperer@med.uvm.edu|
20549634|NCT03616600|Hong Kong Polytechnic University|Dr. Henry Chan|+85227667937|henryhl.chan@polyu.edu.hk|
20549635|NCT03897465|Lohmann & Rauscher GmbH & Co. KG|Dr Daria Trofimenko, Senior Manager Clinical Regulatory Affairs|+49 (0) 2631 99 6385|Daria.Trofimenko@de.LRMed.com|
20549636|NCT00621582|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549637|NCT03617185|University of Michigan|Brian Callaghan, MD|7349367183|Bcallagh@med.umich.edu|
20549638|NCT04672993|Coloplast|Senior Scientific Manager Marianne Raff Dambæk|004549112562|dkmr@coloplast.com|
20549639|NCT01387932|Merit Medical Systems, Inc.|Vicky Brunk RN, Vice President, Medical Affairs, Merit Medical|+1 (717) 873-3309|vicky.brunk@merit.com|
20549640|NCT04092439|Pennington Biomedical Research Center|Tim Allerton, Ph.D.|225-763-2940|timothy.allerton@pbrc.edu|
20549641|NCT00864383|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
20574951|NCT01932242|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
20549642|NCT02801396|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
20549643|NCT01306942|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20549644|NCT02899793|Yale University School of Medicine|Dr. Alessandro Santin|203-737-4450|alessandro.santin@yale.edu|
20549645|NCT02423993|Endocrinology Research Centre, Moscow|Dr. Lyudmila Ibragimova|+7 9266180811|doc_mila@mail.ru|
20549646|NCT01146834|Weill Cornell Medicine|Ruben Niesvizky, MD|646-962-9376|run9001@med.cornell.edu|
20549647|NCT03685968|The University of Texas Health Science Center at Houston (UTHealth)|Elizabeth M. Gendel|+1 (713) 500-3587|Elizabeth.M.Gendel@uth.tmc.edu|
20549648|NCT03965039|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20549649|NCT02771093|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20574952|NCT03426787|Washington University in St. Louis School of Medicine|Dr. Mary C Politi|3147471967|mpoliti@wustl.edu|
20549650|NCT03322631|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20549651|NCT02412618|VCU Medical Center|Dr. Frances Casey|804-828-7877|frances.casey@vcuhealth.org|
20549652|NCT01646762|Mayo Clinic|Dr. Rafael Fonseca|480-301-4280|fonseca.rafael@mayo.edu|
20549653|NCT02378961|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20549654|NCT01253408|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
20549655|NCT02557555|Rutgers New Jersey Medical School|Assistant Professor|4133869415|ajantoni@gmail.com|
20549656|NCT04338074|University of Alabama at Birmingham|Dr. Timothy J Ness|205-975-9643|tness@uabmc.edu|
20549657|NCT02051686|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
20549658|NCT00335478|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
20549659|NCT04967443|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549660|NCT02405780|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|0044 1896 668 173|Clinical-Trials@fk-b.com|
20527886|NCT02819440|Vanderbilt University Medical Center|Evan Brittain|6153224382|evan.brittain@vumc.org|
20549661|NCT01654536|Sunovion|Respiratory Medical Director|1-866-503-6351||
20549662|NCT02494297|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
20549663|NCT01996852|Case Comprehensive Cancer Center|Dr. Amy Zhang|+1 216-368-0968|amy.zhang@case.edu|
20549664|NCT04502693|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20574953|NCT00316355|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org|
20549665|NCT00602797|University of Nebraska Medical Center|Apar Ganti|402-559-5622|aganti@unmc.edu|
20574954|NCT01653288|Children's Hospital of Philadelphia|Dr. Nancy Kassam-Adams|2155903118|adamsn@email.chop.edu|
20549666|NCT03736447|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20549667|NCT00363883|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20549668|NCT02389361|ASTES|Dr. DEFLANDRE Eric|0032477764241|eric.deflandre@gmail.com|
20549669|NCT03547583|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20549670|NCT00382252|Institut Bergonie|Dr Françoise Bonichon||F.Bonichon@bordeaux.unicancer.fr|
20527887|NCT01701505|Big Grins Pediatric Dentistry|Dr. Gregory D. Evans, DDS|970-407-1020|greg@biggrinswithdrgreg.com|
20549671|NCT01600638|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20549672|NCT03338998|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20549673|NCT00039130|Duke University Medical Center|David Rizzieri, M.D.||rizzi003@dm.duke.edu|
20549674|NCT02657915|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20549675|NCT05853185|Liaquat University of Medical and Health Sciences|Dr. Sarang Suresh|03154044802|hotchandanisarang@gmail.com|
20549676|NCT00701675|Ralp H. Johnson VA Medical Center|Olga Brawman-Mintzer, MD|8437242302|mintzero@musc.edu|2834
20549677|NCT01744197|Evergreen Hematology and Oncology|Melanie Matson, RN, BSN|5094642873|mmatson@evergreen4cure.com|
20549678|NCT04706091|Massachusetts General Hospital|John W Winkelman, MD PhD|617-724-7426|jwwinkelman@mgh.harvard.edu|
20549679|NCT01063868|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20549680|NCT01949506|Froedtert and the Medical college of Wisconsin|Meena Bedi, MD|414-805-4400|mbedi@mcw.edu|
20527888|NCT00602446|Masonic Cancer Center, University of Minnesota|Linda J. Burns, MD|612-624-8144|burns019@umn.edu|
20549681|NCT01446289|Novartis vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20549682|NCT03329573|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20549683|NCT02915016|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20549684|NCT02166905|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-2300|chong.wang@roswellpark.org|
20549685|NCT02617628|University of Pennsylvania Office of Research Services|W. Stuart Watson|215-573-6707|wswatson@upenn.edu|
20549686|NCT05243641|M D Anderson Cancer Center|Rachel M. Layman, MD|713) 745-8401|rlayman@mdanderson.org|
20549687|NCT04785677|Florida State University|Stephen Tripodi|850-645-1572|stripodi@fsu.edu|
20574955|NCT00713817|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20549688|NCT05169437|Tempus AI, Inc|Virginia Rhodes, MD|(800) 976-5448|support@tempus.com|
20549689|NCT05405309|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20574956|NCT02053909|Boca Raton Regional Hospital|Dr. Alexander Kulik|561-955-6300|alex_kulik@yahoo.com|
20574957|NCT03627767|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549690|NCT05438888|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549691|NCT04698187|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20549692|NCT03820986|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20549693|NCT02284126|Columbia University Irving Medical Center|Dr. E. Sander Connolly Jr.|2123054118|esc5@cumc.columbia.edu|
20549694|NCT00607815|Cincinnati VA Medical Center|Dr. Kathleen M. Chard|859-572-6741|Kathleen.Chard@va.gov|
20549695|NCT02513394|Dana-Farber Cancer Institute|Erica L. Mayer, MD, MPH|617-632-3800|emayer@partners.org|
20549696|NCT04487730|Weill Cornell Medicine|Dr. Nili Solomonov|212-746-5886|nis2051@med.cornell.edu|
20549697|NCT00907777|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20549698|NCT03875885|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-0677|radellin@wakehealth.edu|
20527889|NCT00002525|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20574958|NCT00907257|Valeant Pharmaceuticals International, Inc|David Lineberry|949-973-1153|David.Lineberry@valeant.com|
20574959|NCT04163900|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
20549699|NCT03364023|Medtronic Neurovascular Clinical Affairs|Medtronic Neurovascular Clinical Affairs|9498373700|rs.nvclinicalprospr-sea@medtronic.com|
20574960|NCT00283049|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
20549700|NCT02891850|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20549701|NCT02674529|University of Pittsburgh|Project Research Coordinator|412-376-3913|neppacham@upmc.edu|
20527890|NCT03304184|University of Michigan|Elizabeth Van Tubergen|2487045640|evantub@umich.edu|
20527891|NCT01505179|UCSD MED CLINICAL TRIALS|Denise Barnard, MD|858 246-2996|dbarnard@ucsd.edu|
20549702|NCT01651195|Helsinki University Central Hospital|Prof. Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
20549703|NCT03797014|Institute of Human Virology, University of Maryland Baltimore|Dr. Joel Chua|14107065704|jchua@ihv.umaryland.edu|
20549704|NCT01970397|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20549705|NCT03903874|University of Alabama at Birmingham|Dr. Dori Pekmezi|205-975-8061|dpekmezi@uab.edu|
20549706|NCT03305575|Tufts Medical Center|Alaa Basura, MD|6176365000|abasura@tuftsmedicalcenter.org|6208
20557163|NCT01163643|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20557164|NCT01564368|American College of Radiology|Senior Director Clinical Research Administration|215-574-3150|info@acr.org|
20574961|NCT01628107|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20574962|NCT03523728|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20574963|NCT02230254|Second Affiliated Hospital of Zhejiang University|Dr. Wang Jian'an|010-85216440|Yuwei.Zhang@bsci.com|
20574964|NCT00621751|Atrium Health; Currently at Indiana University School of Medicine|Flora Hammond, MD|317-292-6781|flora.hammond@rhin.com|
20574965|NCT02528370|Hospital Galdakao-Usansolo|Dr Cristobal Esteban|0034 94 400 7000|cristobal.estebangonzalez@osakidetza.eus|7002
20574966|NCT01667536|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
20574967|NCT00419120|Tengion, Inc.|Sunita Sheth, MD - Chief Medical Officer|267-960-4805|sunita.sheth@tengion.com|
20574968|NCT01831921|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolin@wakehealth.edu|
20574969|NCT01069120|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20574970|NCT02251379|Johns Hopkins University|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
20574971|NCT01655329|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
20574972|NCT03349775|Beth Israel Deaconness Medical Center|Dr. Jennifer Ho|617-735-4102|jho@bidmc.harvard.edu|
20574973|NCT00884325|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
20574974|NCT04439071|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20574975|NCT01186939|Celgene Corporation|CL Beach||CLBeach@celgene.com|
20574976|NCT01817855|AstraZeneca|Naimish Patel|+1 781 839 4061|Naimish.Patel@astrazeneca.com|
20574977|NCT03945591|NYU Langone Health|Ahmad Al-Homsi|6465017621|Samer.Al-Homsi@nyulangone.org|
20574978|NCT03938038|The University of Texas Health Science Center at Houston|Gabrielle Hatton, MD|713-500-7211|gabrielle.e.hatton@uth.tmc.edu|
20574979|NCT00698204|University of Connecticut Health Center|Dr. Rajesh V. Lalla|860-679-8007|lalla@uchc.edu|
20574980|NCT01179672|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20574981|NCT01949155|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20574982|NCT00314249|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
20574983|NCT04667377|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20574984|NCT02316340|UT Health San Antonio|Dr. Sukeshi Arora|2104502872|ARORAS@UTHSCSA.EDU|
20574985|NCT04004429|SynAct Pharma|Thomas Jonassen, Chief Scientific Officer|+45 4015 6669|tj@SynActpharma.com|
20574986|NCT02092350|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20574987|NCT00729482|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20574988|NCT02448225|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20574989|NCT00806676|Johns Hopkins University School of Medicine|Dr. Jeffrey Fadrowski|410-955-2467|jfadrow1@jhmi.edu|
20574990|NCT04234672|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20574991|NCT00962390|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
20574992|NCT04422990|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20574993|NCT00713479|University of California, Los Angeles|Dr Edythe London|(310) 825-0606|elondon@mednet.ucla.edu|
20574994|NCT00113230|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Associate Professor|713-792-2933||
20574995|NCT02224313|Eastern Virginia Medical School|Dr.David Archer|7574467444|archerdf@evms.edu|
20574996|NCT02486653|University of Wisconsin - Madison|Dr. Evie Carchman, MD|608-263-2521|carchman@surgery.wisc.edu|
20574997|NCT00800436|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20574998|NCT04808622|Diffusion Pharmaceuticals|Chris Galloway, MD (Chief Medical Officer)|(434) 220-0718|cgalloway@diffusionpharma.com|
20574999|NCT00711529|Stanford Hospital|Shannon MacLaughlan, MD|650-724-0456|smaclaug@stanford.edu|
20575000|NCT05417607|Duke University|Lauren Franz MBChB, MPH|919-681-0023|lauren.franz@duke.edu|
20575001|NCT01673568|Hvidovre Hospital University of Copenhagen|Mette W. Christoffersen|38625826|mette.willaume@gmail.com|
20575002|NCT02518997|Stanford University|Melissa Scala|650-723-5711|mscala@stanford.edu|
20575003|NCT01343485|Planned Parenthood Federation of America|Zoe Unger, Research Program Coordinator|212-261-4702|zoe.unger@ppfa.org|
20575004|NCT00698932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20575005|NCT00757003|Stanford University|Dr. Daniel Sze, Principal Investigator|650-723-0728|dansze@stanford.edu|
20575006|NCT00601705|Cleveland Clinic|Dr. David Adelstein|216 444-9310|ADELSTD@ccf.org|
20575007|NCT01653964|Mayo Clinic|Dr. Carrie Hruska|5072663991|hruska.carrie@mayo.edu|
20575008|NCT02146599|Abbott Medical Optics|Anne Buteyn; Manager, Clinical Research|949-505-2029|anne.buteyn@abbott.com|
20508915|NCT01115517|Robert Cizik Eye Clinic|Dr. Nan Wang|713-559-5200|nwang@cizikeye.org|
20508916|NCT03627494|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508917|NCT02314598|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
20508918|NCT02578992|Tri-Service General Hospital|Dr. Wei-Hung Chan|+886-2-87927128|whcken@gmail.com|
20508919|NCT02443155|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20508920|NCT00505518|Massachusetts General Hospital|Albert Yeung|617-724-5138|ayeung@partners.org|
20549707|NCT00105469|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575009|NCT04246801|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
20575010|NCT02743351|Fate Therapeutics|Executive Director, Clinical Operations|858.875.1800|info@fatetherapeutics.com|
20575011|NCT03044886|Department of Stomatology, Beijing Chao-yang Hospital, Capital Medical University|Dr. Wang Zuomin|+86-010-85231492|wzuomin@sina.cn|
20508921|NCT00302055|Northwestern University|Dr. Ronald T Ackermann|(312) 503-6400|r.ackermann@northwestern.edu|
20575012|NCT02921269|Johns Hopkins University|ETCTN Grants Administrative Manager|443-927-3568|jmurra33@jhmi.edu|
20575013|NCT00703053|Saint Louis University|Robert Belshe, MD|314-977-9030|belsherb@slu.edu|
20575014|NCT00387764|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575015|NCT03065023|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575016|NCT05975840|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20575017|NCT00683163|UNIVERSITY OF CALIFORNIA, SAN FRANCISCO|Dr. Dennis Black|415-514-8159|dblack@psg.ucsf.edu|
20575018|NCT00088907|ECOG Statistical Office|Study Statistician|617-632-3012||
20575019|NCT00682448|Rush University Medical Center|Stephanie Cavanaugh, MD||Stephanie_Cavanaugh@rush.edu|
20575020|NCT00829049|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20575021|NCT04050670|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20575022|NCT00268437|Mayo Clinic|Aminah Jatoi, M.D.|507/284-4918|jatoi.aminah@mayo.edu|
20575023|NCT00761306|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20575024|NCT00525044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575025|NCT00483561|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
20575026|NCT01817907|Brigham and women's Hospital|D. Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
20575027|NCT02982239|Sleep and Health Research Program - University of Arizona|Dr. Michael Grandner|5206260105|grandner@psychiatry.arizona.edu|
20575028|NCT00880555|Department of Veterans Affairs|Dr. David Glenn Clark|843-792-7446|clarkda@musc.edu|
20575029|NCT01651104|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20575030|NCT04296877|The Ohio State University College of Optometry|Jennifer Fogt|16142928858|OPT-EyeStudies@osu.edu|
20575031|NCT01873417|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20575032|NCT00785044|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
20575033|NCT01086410|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575034|NCT04196803|Vanderbilt University Medical Center|Dr. Qi Dai|615)936-0707|qi.dai@vanderbilt.edu|
20575035|NCT01022996|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
20575036|NCT02767323|Duke University|Dr. Lysianne Beynel|9193386273|lysianne.beynel@gmail.com|
20575037|NCT00930722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575038|NCT00710879|Bausch & Lomb Incorporated|Joseph Barr, OD, MS|(585) 338-6439|joseph.t.barr@bausch.com|
20575039|NCT01809132|UTexas Southwestern Medical Center|Dr. Mack C. Mitchell|2146485036|mack.mitchell@utsouthwestern.edu|
20575040|NCT04854434|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20575041|NCT00760019|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-6186|jbeckman@partners.org|
20575042|NCT02667275|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
20575043|NCT01756040|University of Maryland Baltimore|Rose Marie Viscardi, M.D.|410-328-6003|rviscard@som.umaryland.edu|
20575044|NCT01274715|Michael DeBakey VAMC|Aanand Naik, MD|713-794-8541|anaik@bcm.edu|
20575045|NCT04479436|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|9089926400|CTRinfo@dsi.com|
20575046|NCT02022085|Radboud University Medical Centre, Nijmegen, The Netherlands|Professor Emmanuel Mylanus|+31 24 361 1111|Emmanuel.Mylanus@radboudumc.nl|
20575047|NCT02713542|Arthrex|Clinical Affairs Manager|2395984302|INC_ClinicalResearch@arthrex.com|
20575048|NCT02357134|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
20575049|NCT03583450|University of California, San Francisco|Dr. Jina Sinskey|857-998-0137|jina.sinskey@ucsf.edu|
20575050|NCT05097716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575051|NCT00791258|Daiichi Sankyo, Inc|John Raia|(973) 944-2683|jraia@dsi.com|
20575052|NCT00210184|Institut Bergonie|Pr Marianne Fonck|+33556333333||
20575053|NCT03923556|University of Colorado School of Medicine|Dr. Ana Fernandez-Bustamante|720-848-6744|ana.fernandez-bustamante@cuanschutz.edu|
20575054|NCT01690897|University of British Columbia|Dr. Lori Brotto|604 875 4111|Lori.Brotto@vch.ca|68901
20575055|NCT01118325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20575056|NCT03334409|Mayo Clinic, Rochester|Lance Pagliaro, M.D.|(507)293-0566|Pagliaro.lance@mayo.edu|
20575057|NCT00975715|Novartis|Study Director|41 61 324 1111||
20575058|NCT00418951|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
20575059|NCT02563093|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20575060|NCT02150499|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclousre@sunovion.com|
20575061|NCT05215262|Mount Sinai Adolescent Health Center|Sarah Wood, MD, MSHP|(332) 227-4355|Sarah.Wood@mountsinai.org|
20575062|NCT00588536|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
20575063|NCT03496324|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20575064|NCT00239226|Medtronic BRC - Medtronic Italia SpA|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
20575065|NCT00646906|University of Pennsylvania|Tilo Grosser, MD|215-573-7600|tilo@pennmedicine.upenn.edu|
20575066|NCT00956657|NHS Greater Glasgow & Clyde|Gavin H. Taylor, Clinical Psychologist|0141 211 2134|gavin.taylor@ggc.scot.nhs.uk|
20575067|NCT01303965|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
20575068|NCT04060563|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20575069|NCT00851682|Washington University|Robert Grubb, III|314 454-7185|grubbr@wudosis.wustl.edu|
20575070|NCT01892306|Massachusetts General Hospital|Kristen Ellard, PhD|617-726-6422|kellard@partners.org|
20575071|NCT01534013|Imperial College London|Prof Nick Oliver|02075942433|nick.oliver@imperial.ac.uk|
20575072|NCT03633526|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
20575073|NCT01379573|NYU Langone Health|Jill Buyon|+1 212 263 0746|Jill.Buyon@nyulangone.org|
20549708|NCT03444961|Cleveland Clinic|Dr. Aleksandra Rachitskaya|216-445-9519|rachita@ccf.org|
20575074|NCT02871778|Parion Sciences|Karl Donn|919 313 1185|kdonn@parion.com|
20575075|NCT02945150|Massachusetts General Hospital|Dr. Raymond Chung|617-724-7562|Chung.Raymond@mgh.harvard.edu|
20575076|NCT02653300|Oramed Pharmaceuticals|Miriam Kidron, Ph.D.|+972-2-566-0100|miriam@oramed.com|
20575077|NCT03530917|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20575078|NCT02289352|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20575079|NCT01390272|Durham VA Medical Center, Durham, NC|Dr. George Lee Jackson, PhD MHA|919-286-0411|George.Jackson3@va.gov|7091
20575080|NCT01177384|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575081|NCT01849497|Amgen Inc.|Study Director|866-572-6436||
20575082|NCT02715466|B. Braun Melsungen AG|Study Manager|00495661/71|studies@bbraun.com|0
20575083|NCT00823303|Washington University School of Medicine|Dr. Daniel W. Coyne|3143627211|dcoyne@dom.wustl.edu|
20575084|NCT00591825|Laureate Institute for Brain Research (LIBR)|Robin Aupperle, PhD|(913) 588-9078|raupperle@laureateinstitute.org|
20575085|NCT04311697|Applied Pharma Rersearch|Paola Prina|4847169881|paola.prina@apr.ch|
20575086|NCT01540825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575087|NCT01641237|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575088|NCT01301456|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575089|NCT01383096|Nucleus Network|Peter Hodsman|+ 613 9076 8900|businessdevelopment@nucleusnetwork.com.au|
20575090|NCT04872348|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
20575091|NCT01509079|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
20575092|NCT01338415|Actelion Pharmaceuticals Ltd|Principal Clinical Scientist||ClinicalTrialDisclosure@its.jnj.com|
20575093|NCT03000088|Ajou University School of Medicine|Dr. Jiyoung Lee|82-31-219-5689|leejiyoung0616@gmail.com|667
20575094|NCT00233363|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20575095|NCT00874770|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
20575096|NCT04880447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575097|NCT00718549|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20575098|NCT01576172|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
20575099|NCT02137122|University of Florida|Adam Woods|352-294-5842|ajwoods@phhp.ufl.edu|
20575100|NCT01033552|University of Minnesota, Masonic Cancer Center|Dr. Jakub Tolar|(612) 626-5654|tolar003@umn.edu|
20575101|NCT01958788|Concordia University|Elizabeth Hebert|1-514-848-2424|el_heber@live.concordia.ca|2199
20575102|NCT02613884|Kate Farms|Vanessa Millovich|3522634409|vannanole@gmail.com|
20575103|NCT00433914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20575104|NCT02844920|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
20575105|NCT04534491|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20575106|NCT00240981|Brigham & Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
20575107|NCT00766090|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575108|NCT03331861|Columbia University Irving Medical Center|Barry Fine, MD|212-305-5755|bmf2002@cumc.columbia.edu|
20575109|NCT00528580|University of Chicago|Millie Maleckar|773-702-1472|mmalecka@bsd.uchicago.edu|
20575110|NCT03024970|CooperVision, Inc.|Myhanh Nguyen, OD, FAAO|925-730-6716|mnguyen@coopervision.com|
20575111|NCT00131469|OHSU|Eric Orwoll|15034940225|orwoll@ohsu.edu|
20575112|NCT01170546|Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital|Shih-Wei Chou, MD, PhD|88633281200|h0711@ms13.hinet.net|3846
20575113|NCT01727765|University of Portsmouth|Dr Mitch Lomax|02392845297|mitch.lomax@port.ac.uk|
20575114|NCT00736034|Sourazky Tel-Aviv Medical Center|Dr. V. Vakhapova|972-3-6973698|vedanicek@gmail.com|
20575115|NCT01910116|Seoul National University Hospital|Prof. Eun Bong Lee|822-2072-3944|leb7616@snu.ac.kr|
20575116|NCT01196533|Morristowm Memorial Hospital|Dr. Frank Smart|973-214-2601|frank.smart@atlantichealth.org|
20575117|NCT04458103|Massachusetts General Hospital|David D'Alessandro|617-726-8841|DADALESSANDRO@mgh.harvard.edu|
20557165|NCT01802437|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
20557166|NCT01861574|Medical University of South Carolina|JEFFREY J BORCKARDT|(843)792-3295|borckard@musc.edu|
20557167|NCT04538144|Institute for Exercise and Environmental Medicine|Dr. Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
20549709|NCT02871297|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20549710|NCT01509950|Stanford University|Research Operations Manager|6507255720|agirsen@stanford.edu|
20549711|NCT04115839|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20549712|NCT03808545|University of Alabama at Birmingham|Brooks Wingo, Associate Professor|2059345982|bcwingo@uab.edu|
20549713|NCT02820753|Northwestern University|Stephanie Batio|312-503-4684|stephanie.batio@northwestern.edu|
20575118|NCT01983839|Aarhus University Hospital, Department of infectious diseases|Dr Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
20527892|NCT03420222|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20575119|NCT00911625|Rush University Medical Center|David Baldwin, MD|312-942-2813|david_baldwin@rush.edu|
20557168|NCT00429663|Boston Medical Center|Paul Tornetta III, MD|617-414-6295|paul.tornetta@bmc.org|
20557169|NCT03420781|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20557170|NCT02162680|Duke University Medical Center|Julia Aucoin, DNS|1 919 613 6406|julia.aucoin@dm.duke.edu|
20557171|NCT02313909|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20557172|NCT01583686|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
20575120|NCT00590044|Emory University SOM|Guillermo Umpierrez|4047781663|geumpie@emory.edu|
20575121|NCT01514136|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1990|dkbir@coloplast.com|
20575122|NCT03945357|Prisma Health|Aimee Hanvey|864-760-7350|aimee.hanvey@prismahealth.org|
20575123|NCT03422679|Cellestia Biotech AG|Maria Bobadilla, Chief Development Officer|+41616332957|maria.bobadilla@cellestia.com|
20575124|NCT00955279|Johnson & Johnson Pharmaceutical Research & Development|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20575125|NCT01235793|Cedars-Sinai Medical Center|Yuliya Linhares, MD|310-423-4646|Yuliya.Linhares@cshs.org|
20575126|NCT01692691|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
20575127|NCT01159912|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575128|NCT01883986|VA Puget Sound Health Care System|Lynn F. Reinke, PhD, ARNP|206-277-4186|lynn.reinke1@va.gov|
20575129|NCT02456662|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5367|sarah_betstadt@urmc.rochester.edu|
20557173|NCT00643123|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
20557174|NCT05292534|Sonova|Dr. Ieda Ishida|6472847562|ieda.ishida@sonova.com|
20557175|NCT01538472|University of Texas (UT) MD Anderson Cancer Center|Issa Khouri, MD / Professor, Stem Cell Transplant|713-745-2803|CR_Study_Registration@mdanderson.org|
20557176|NCT02309112|University of Oxford|Marcy McCall, Lead Researcher|+441865 289300|marcy.mccall@kellogg.ox.ac.uk|
20557177|NCT02133872|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
20557178|NCT02623855|UCSF Benioff Children's Hospital Oaland|Dr. Nooshin Razani, Principal Investigator|415-428-3129|nrazani@mail.cho.org|
20557179|NCT01446666|Asan Medical Center, University of Ulsan College of Medicine|Professor Young-Suk Lim|+82-02-3010-5933|limys@amc.seoul.kr|
20557180|NCT00238433|Oregon Health & Science University|Richard Maziarz, MD|503-494-6365|maziarzr@ohsu.edu|
20557181|NCT00454571|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
20557182|NCT01376323|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557183|NCT04681729|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20557184|NCT02436811|Universidade Federal do Paraná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
20557185|NCT03595332|Northern Arizona University|Dr. Hendrik de Heer|9285231499|dirk.deheer@nau.edu|
20557186|NCT02227875|Mylan, Inc.|Keri L. Vaughan, Director Global Clinical Operations, General Medicine||keri.vaughan@mylan.com|
20557187|NCT01804101|Fred Hutchinson Cancer Center|Dr. Roland B. Walter|206-667-3599|rwalter@fredhutch.org|
20557188|NCT02657317|University of Texas Health Science Center at San Antonio|Donald McGeary, PhD|210-567-5454|mcgeary@uthscsa.edu|
20557189|NCT02856113|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20557190|NCT03494166|University of Arizona College of Nursing|Terry Badger, PhD (MPI) and Alla Sikorskii, PhD (MPI)|520-626-6058|tbadger@arizona.edu|
20557191|NCT01960725|Duke University School of Medicine|Dr. Dennis Clements|919-684-7790|dennis.clements@duke.edu|
20557192|NCT01155154|SUNY Downstate Medical Center|Shahriar Zehtabchi|718-245-2973|shahriar.zehtabchi@downstate.edu|
20557193|NCT02470494|Earlens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650-739-4447|Suzanne.Levy@Earlens.com|
20557194|NCT00758459|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20557195|NCT00723099|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.org|
20557196|NCT01058304|Health Services Research & Development, Durham VAMC|Kelli D. Allen|919-286-0411|kelli.allen@va.gov|7090
20557197|NCT02755597|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20557198|NCT02496767|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
20557199|NCT00166296|Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona|Crisanto Diez-Quevedo|+34934978814|cdiezquevedo.germanstrias@gencat.cat|
20557200|NCT04035200|Imbrium Therapeutics|Medical Information|1-888-726-7535|Purduemedinfo@pharma.com|
20557201|NCT03351738|MedImmune, LLC|Richard George|+1-301-398-5681|information.center@astrazeneca.com|
20557202|NCT03997513|VA Pittsburgh Healthcare System|Dr. Jessica Bon Field|412-360-6823|jessica.field@va.gov|
20557203|NCT05479604|Mayo Clinic|Amar Miglani, M.D.|4803422929|miglani.amar@mayo.edu|
20575130|NCT00822354|Northwestern University|Clinical Trials Coordinator|312-695-6829|j-bae@northwestern.edu|
20575131|NCT02374021|Brigham and Women's Hospital|Dr. Daniel Solomon|617-732-5356|dsolomon@bwh.harvard.edu|
20575132|NCT00982007|Luitpold Pharmaceuticals, Inc.|Mark A. Falone|610-650-4200|mfalone@luitpold.com|
20575133|NCT00504153|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
20575134|NCT04411953|Cycle Pharmaceuticals|Head of Global Regulatory Affairs and Clinical Development|+441223803635|claudia.percivalle@cyclepharma.com|
20575135|NCT00732251|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
20557204|NCT02202746|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20557205|NCT03138733|Basilea Pharmaceutica|Dr Marc Engelhardt, MD|+41 79 701 0551|marc.engelhardt@basilea.com|
20557206|NCT01089374|Dartmouth-Hitchcock Medical Center|Dr. Richard Barth|603-650-9479|Richard.J.Barth.Jr@hitchcock.org|
20557207|NCT02969837|University of Chicago|Member of the Biostatistics Lab|773.702.2453|slee@health.bsd.uchicago.edu|
20557208|NCT02098538|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
20557209|NCT04723823|University of Pittsburgh|Debbie Harrington, CCRP|412-383-1355|debbie.harrington@pitt.edu|
20557210|NCT05107960|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20557211|NCT04179032|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20557212|NCT06289192|Johns Hopkins University|Alejandra Ellison-Barnes|n/a|aelliso6@jhmi.edu|
20557213|NCT03459287|Cerus Corp|Richard Benjamin, M.D., Ph.D.|925 288 6000|rbenjamin@cerus.com|
20557214|NCT04421092|Medical University of South Carolina - Department of Otolaryngology|Shaun A. Nguyen, MD - Director of Clinical Research|8437921356|nguyensh@musc.edu|
20557215|NCT03641313|Vanderbilt-Ingram Cancer Center|Jordan Berlin|6153434128|jordan.berlin@vumc.org|
20557216|NCT03033225|Mayo Clinic|Kenneth K. Wang, MD|507-284-2511|wang.kenneth@mayo.edu|
20557217|NCT00057551|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
20557218|NCT03371940|Indiana University School of Medicine|Dr. Mary de Groot|317-278-1965|mdegroot@iu.edu|
20557219|NCT05099926|Columbia University Irving Medical Center|Dr. Andrea T. Duran|212-342-4491|atd2127@cumc.columbia.edu|
20557220|NCT04475432|Tarsus Pharmaceuticals, Inc.|Mark Holdbrook, Senior Vice-President of Clinical Development|408-431-6613|mark@tarsusrx.com|
20557221|NCT00031486|University of Alabama at Birmingham|Penny Jester|(877) 975-7280|pjester@peds.uab.edu|
20557222|NCT01685138|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20557223|NCT02068495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20557224|NCT03988166|Teleflex|Ricardo De Medeiros, Director Scientific Clinical Affairs|612.812.5008|ricardo.demedeiros@teleflex.com|
20557225|NCT00500903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20557226|NCT05096156|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD MS, Principal Investigator|16142928858|OPT-EyeStudies@osu.edu|
20557227|NCT00717860|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20557228|NCT04058353|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20557229|NCT00995072|ECIR|Benjamin Epstein, PharmD|904-854-1354|benjamin.epstein@eastcoastresearch.net|
20557230|NCT01951638|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20557231|NCT01349920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549714|NCT00790023|Sunovion|Respiratory Medical Director|1-866-503-6351||
20549715|NCT00331682|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
20549716|NCT00573469|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20549717|NCT01338792|USC Norris Comprehensive Cancer Center|Jacek Pinski, MD|323-865-3900|pinski_j@ccnt.usc.edu|
20549718|NCT00618072|New York Medical College|Harriette R. Mogul MD MPH|914-594-2278|Harriette_Mogul@NYMC.edu|
20549719|NCT03719885|Penn Medicine|Research Coordinator|215-662-9393|jonathan.lilley@pennmedicine.upenn.edu|
20549720|NCT02151591|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Lisa Fucito|203-200-1470|Lisa.fucito@yale.edu|
20549721|NCT03644212|Maimonides Medical Center|Sara Meeder|7182837253|smeeder@maimonidesmed.org|
20549722|NCT00187486|University of California San Francisco|Michael Prados, MD|415 353 2076|PradosM@neurosurg.ucsf.edu|
20549723|NCT00684593|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549724|NCT02599129|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
20575136|NCT00805025|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20575137|NCT04029961|Medical College of Wisconsin|John LaDisa|414-288-6739|jladisa@mcw.edu|
20575138|NCT02347488|UCLA Department of Anesthesiology|Nir Nahum Hoftman, MD|310-267-8679|nhoftman@mednet.ucla.edu|
20575139|NCT05314712|Center for American Indian and Rural Health Equity|Vernon Grant|406-531-9310|vernon.grant@montana.edu|
20575140|NCT03007979|Washington University School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
20575141|NCT00232141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20575142|NCT02273726|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|064study@fibrogen.com|
20575143|NCT01479829|Loyola University Medical Center|Dr. Angelos Halaris|708-216-3272|ahalaris@luc.edu|
20575144|NCT00846547|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
20549725|NCT01896544|Massachusetts General hospital|Tiffany M.N. Otero|4074950753|totero@partners.org|
20508922|NCT02279160|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
20508923|NCT00189436|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|412-359-4099|dskoner@hsc.wvu.edu|
20508924|NCT00731666|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
20508925|NCT00053014|SWOG statistical office|SWOG leukemia statistician|206-667-4408||
20508926|NCT01473355|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20508927|NCT00106249|CUNY|Dr. Antonio Mantovani|212-650-5417|amantovani@med.cuny.edu|
20508928|NCT01810289|University of California at San Francisco|Dr. Elvin Geng|415-476-4082|elvin.geng@ucsf.edu|409
20508929|NCT00509028|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20508930|NCT00948428|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20508931|NCT04241120|HabitAware|Sameer Kumar|2489904720|sameer@habitaware.com|
20508932|NCT01495689|Ottawa Hospital Research Institute|Smita Pakhale|613-737-8899|spakhale@ohri.ca|79428
20508933|NCT05516134|Hopeful Aging|Michael Skrajner|4404777881|mike@hopefulaging.com|
20508934|NCT00254163|Ocala Oncology|Dr. Craig Reynolds|(352) 732-4032|Craig.Reynolds@USOncology.com|
20549726|NCT05526716|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClincalTrialsDisclosure@msd.com|
20549727|NCT04213079|Icahn School of Medicine at Mount Sinai|Sergei Yakushin|212-241-9349|sergei.yakushin@mssm.edu|
20549728|NCT00844714|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|phsue@medsfgh.ucsf.edu|
20549729|NCT00520936|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549730|NCT02010840|The Hog Kong Polytechnic University|Vivian Ngai|2766|vivian.ngai@polyu.edu.hk|6775
20549731|NCT04182763|Oregon Health & Science University|Allison Gregory, MS CGC, Project Manager|503-494-4344|gregorya@ohsu.edu|
20549732|NCT03984994|University of Maryland|Dr. Steven J. Prior|301-405-2483|sprior@umd.edu|
20549733|NCT03010176|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549734|NCT04220866|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549735|NCT01903187|St. Jude Medical, Inc.|Steven Madej|651-756-2230|smadej@sjm.com|
20549736|NCT02535312|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20549737|NCT03739593|Aerie Pharmaceuticals, Inc|Kevin Kerr, Director of Clinical Development|(949) 526-8701|kkerr@aeriepharma.com|
20549738|NCT01471171|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20549739|NCT00378378|Merck, Sharp & Dohme Corp.|Senior Vice Presiden, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20549740|NCT00407797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549741|NCT01812174|Artivion, INC|Erica Troup , Clinical Project Manager|706-409-5974|erica.troup@artivion.com|
20549742|NCT02713347|VA|Dr. David Bekelman|7207236388|david.bekelman@va.gov|
20549743|NCT04950998|University of Southern California|Dr. Stacey Schepens Niemiec|3234422069|schepens@usc.edu|
20549744|NCT05973981|RAND|William Shadel|412-683-2300|shadel@rand.org|4489
20549745|NCT03132220|University of Colorado School of Medicine|Dr. Meredith Mealer|303-724-6857|Meredith.Mealer@cuanschutz.edu|
20549746|NCT00601458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20549747|NCT00370032|GlaxoSmithKline|GSK Response Center|866-435-7343||
20549748|NCT00518986|Cephalon, Inc.|Medical monitor|1-800-896-5855||
20549749|NCT05683249|Neurocentria Inc.|Clinical Development|925-954-4868|info@neurocentria.com|
20549750|NCT05469178|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
20549751|NCT05393895|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
20549752|NCT00968513|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu|
20549753|NCT01328431|Yale University|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
20549754|NCT00018031|NIAID/NIH|Dr. Shyam Kottilil|301-435-036|skottilil@niaid.nih.gov|
20549755|NCT01521546|The Ohio State University|Subha V. Raman, MD|(614)293-8963|raman.1@osu.edu|
20549756|NCT02158273|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20549757|NCT02446483|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575145|NCT04263896|University of Chicago|Dr. Sandra Laveaux|773-702-6118|slaveaux@bsd.uchicago.edu|
20575146|NCT06291831|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575147|NCT01944293|Columbia University Medical Center - NY State Psychiatric Institute|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
20575148|NCT00311376|Allergan, Inc.|Therapeutic area Head|714-246-4500|clinicaltrials@allergan.com|
20575149|NCT00257166|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575150|NCT02142738|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575151|NCT03688880|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
20575152|NCT01704287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575153|NCT03713034|Yale University|Tyra Pendergrass Boomer|(203) 737-6101|tyra.pendergrass@yale.edu|
20575154|NCT04968041|Florida State University|Julia Sheffler|850-644-4199|julia.sheffler@med.fsu.edu|
20575155|NCT01847430|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575156|NCT02709694|Hospital for Special Surgery|Dr. Lisa Mandl|(212) 774-2960|mandll@hss.edu|
20575157|NCT02247765|Medtronic|Michael Luna-Victoria|3034068955|michael.luna-victoria@medtronic.com|
20575158|NCT02716675|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20557232|NCT03479697|Atrium Wake Forest Baptist Health School of Medicine|Charles Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
20557233|NCT00766675|Janssen Pharmaceutics Taiwan|Medical Affairs Director|+886-2-23762155||
20557234|NCT03308825|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
20557235|NCT05418777|William Beaumont Hospitals|Maureen Cooney, RN Clinical Research Manager|2485510099|maureen.cooney@corewellhealth.org|
20557236|NCT03935217|Lupin Pharmaceuticals|Director of Clinical Operations|443-301-3146|jackieshaw@lupin.com|
20557237|NCT01782742|Cleveland Clinic Lou Ruvo Center for Brain Health|Jeffrey Cummings, MD, ScD|702.483.6029|cumminj@ccf.org|
20557238|NCT02882282|MD Anderson Cancer Center|Renata Ferrarotto, MD|713-792-6363|rferrarotto@mdanderson.org|
20557239|NCT00514683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20557240|NCT02487498|Novartis Pharmaceuticals|Study Director|862-778-1873||
20557241|NCT00676130|Brigham and Women's Hospital|Daniel J. Pallin, MD, MPH|617-525-6614|dpallin@partners.org|
20557242|NCT00691808|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug safety|281-863-3000||
20557243|NCT02228967|San Diego State University Research Foundation|Mark B. Reed/Professor and Interim Associate Dean|619-594-6664|mreed@sdsu.edu|
20557244|NCT00520975|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
20557245|NCT01181726|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20557246|NCT04998604|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20557247|NCT00642902|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20557248|NCT05383417|University of California San Diego Health|Dr. Andrew Vahabzadeh-Hagh|858-249-4070|avahabz@health.ucsd.edu|
20557249|NCT02466646|Marmara University Faculty of Dentistry, Department of Periodontology|Prof. Dr. Basak Dogan|00905332621170|basak.sdogan@gmail.com|
20557250|NCT03953898|Yale School of Medicine|Rory Shallis, MD|(203) 200-4363|rory.shallis@yale.edu|
20557251|NCT03261271|University of Kansas Medical Center|Dr. Jill Hamilton-Reeves|913-588-7650|jhamilton-reeves@kumc.edu|
20557252|NCT00229957|McMaster University|Dr. Julie Richardson|905-525-9140|jrichard@mcmaster.ca|27811
20557253|NCT01222195|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
20557254|NCT02696564|School of Medicine, Johns Hopkins University|Robert A. Wise, M.D.|410-550-0545|rwise@jhmi.edu|
20557255|NCT05267600|argenx BV|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20557256|NCT04067401|University of Rochester Medical Center, Psychiatry Dept|Dr. Peter Wyman|5852733372|peter_wyman@urmc.rochester.edu|
20557257|NCT01537302|Austin Heart|Matthew Selmon, MD|512-788-2692|matthew.selmon@hcahealthcare.com|
20557258|NCT00106184|University of Pittsburgh|Chester V. Oddis, MD|412-383-8861|cvo5@pitt.edu|
20557259|NCT01722162|Washington University School of Medicine|Manik A. Amin, M.D.|314-362-9115|manikamin@wustl.edu|
20557260|NCT02167217|Washington University School of Medicine|Anne M. Connolly, MD FAAN|314-362-6981|connollya@wustl.edu|
20557261|NCT01889186|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20557262|NCT02110901|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
20549758|NCT01805154|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
20557263|NCT04711603|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
20557264|NCT03643224|Medtronic CAS|Josman Suri|7635050262|josman.suri@medtronic.com|
20557265|NCT04252742|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20575159|NCT01172197|NHS Tayside|Dr G McLeod|+44 1382 7974440848|g.a.mcleod@dundee.ac.uk|
20575160|NCT00616434|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20575161|NCT00467779|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20575162|NCT00436618|Mayo Clinic|Thomas E. Witzig M.D.|(507) 284-0527|witzig.thomas@mayo.edu|
20575163|NCT01994382|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20575164|NCT02428855|Massachusetts General Hospital|Dr. Bruce Giantonio|617-724-4000|BGIANTONIO@mgh.harvard.edu|
20575165|NCT02066311|The Feinstein Institute for Medical Research|Dr. Meggan Mackay|516-562-3838|mmackay@northwell.edu|
20575166|NCT04353596|Medizinische Universität Innsbruck/ Medical University Innsbruck|Prof. Dr. Axel Bauer|0043 512 504 25621|Axel.Bauer@i-med.ac.at|
20575167|NCT05418673|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20575168|NCT00866749|The University of Texas MD Anderson Cancer Center|Michael Andreeff MD./Professor|713-792-7261|mandreeff@mdanderson.org|
20575169|NCT02170779|VA Research and Development|Cinda Hugos, Physical Therapist|503-220-8262|hugosc@ohsu.edu|52338
20575170|NCT00935272|Medicis Global Services|Heather M Corey|480-291-5981|hcorey@medicis.com|
20575171|NCT02017379|Texas Tech University Health Sciences Center at El Paso|Research Compliance Officer|915-215-4814|jackie.roberts@ttuhsc.edu|
20575172|NCT01478360|Novartis Pharmaceuticals|Study Director|862-778-8300||
20575173|NCT01772004|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20575174|NCT01688856|The MetroHealth System|Dr. Jayme Knutson|216-957-3557|jsk12@case.edu|
20575175|NCT01561495|AbramsonCC Radiation Oncolocy|Susan Prendergast, RN|215-662-4267|susan.prendergast@pennmedicine.upenn.edu|
20575176|NCT04666350|PATH|Chris F Ockenhouse, MD, PhD|+1 (202) 716-5849|cockenhouse@path.org|
20575177|NCT00888381|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20575178|NCT02729740|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
20575179|NCT00531882|University Hospitals Case Medical Center|Michael W Konstan, MD|2168445267|michael.konstan@uhhospitals.org|
20575180|NCT05144113|Spaulding Rehabilitation Hospital|Dr. J.Andrew Taylor|616-758-5503|jandrew_taylor@hms.harvard.edu|
20575181|NCT00175877|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20575182|NCT04267770|Imperial College London|Nick Oliver|+44 20 7594 1796|nick.oliver@imperial.ac.uk|
20575183|NCT03061175|Rutgers Cancer Institute of New Jersey|Dr. Sharon Manne, Associate Director, Population Science|732-235-6759|mannesl@cinj.rutgers.edu|
20575184|NCT00995475|University of Dundee|Professor Brian J Lipworth|+44 1382 383188|b.j.lipworth@dundee.ac.uk|
20527893|NCT00459368|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454||
20575185|NCT02431897|University of Texas Southwestern Medical Center Dallas|Dr. David D. Rahn|12146486430|david.rahn@utsouthwestern.edu|
20575186|NCT03044249|Mediti Pharma Inc.|Chief Executive Officer|1-514-993-7207|ivan.shaw@meditipharma.com|
20575187|NCT00760669|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
20575188|NCT01560923|Masonic Cancer Center, University of Minnesota|Dr.Gautam Jha|612-624-5373|jhaxx014@umn.edu|
20575189|NCT01995578|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari MD|646-608-3738|tamarir@mskcc.org|
20575190|NCT03142438|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
20575191|NCT04411628|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20575192|NCT03734016|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20575193|NCT01979835|principal investigator|Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
20575194|NCT00314353|NSABP Foundation, Inc.|Diana Gosik|412-330-4692|diana.gosik@nsabp.org|
20575195|NCT01428661|Vanda Pharmaceuticals Inc.|Curt Wolfgang, Ph.D.|202-734-3400|curt.wolfgang@vandapharma.com|
20575196|NCT03828292|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20575197|NCT01444456|Amgen Inc.|Study Director|866-572-6436||
20549759|NCT03310021|Portola Pharmaceuticals|Head of Clinical Development|6502767153|ClinicalTrials@Portola.com|
20575198|NCT01744353|Brown Oncology Research Group|Helena Lau|4018633000|helena_lau@brown.edu|
20575199|NCT00121836|Hoffmann-LaRoche|Medical Communications|800-821-8590||
20575200|NCT00382720|sanofi-aventis|International Clinical Development Clinical Study Director||contact-us@sanofi-aventis.com|
20549760|NCT04087096|Massachusetts General Hospital|Dr. Elaine Yu|617-643-6353|EWYU@mgh.harvard.edu|
20549761|NCT00702923|University of Wisconsin Carbone Cancer Center|Douglas McNeel, M.D., Ph.D.|(608) 263-4198|dm3@medicine.wisc.edu|
20549762|NCT02002091|Algiers' university -1- Benyoucef Benkhedda, Faculty of Medicine Meherzi, Algiers.|Dr Wafia- Nadia Nibouche-Hattab|+213771810932|wani16000@yahoo.fr|
20549763|NCT02846714|Huntsman Cancer Institute University of Utah|Dr. Yelena Wu|8012135653|yelena.wu@utah.edu|
20557266|NCT02597036|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20557267|NCT06351371|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20557268|NCT03759834|Mayo Clinic|Matthew Carlson, M.D., M.B.A.|507-284-8532|Carlson.Matthew@mayo.edu|
20557269|NCT01849263|Washington University School of Medicine|Nancy L. Bartlett, M.D.||nbartlet@dom.wustl.edu|
20575201|NCT02414399|University of Washington|Dr. Patricia Pavlinac|206 616-8326|ppav@uw.edu|
20575202|NCT02737852|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annhita.ghassemi@churchdwight.com|
20575203|NCT05745675|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20575204|NCT04042740|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20549764|NCT02467075|University of Michigan, Department of Radiology|Matthew Davenport, MD|734-232-2095|matdaven@med.umich.edu|
20549765|NCT01434030|University of Virginia|Boris P Kovatchev, Ph.D.|434-924-5592|bpk2u@virginia.edu|
20549766|NCT00393029|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven Rosenberg, M.D., Ph.D.|301-496-4164|Steven.Rosenberg@nih.gov|
20549767|NCT02612727|Minnesota Medical Research Foundation (now Hennepin Healthcare) and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
20549768|NCT03396367|Hunter College|Dr. Tyrel Starks|212-772-5550|tstarks@hunter.cuny.edu|
20549769|NCT04292743|Lombardi Comprehensive Cancer Center|Marcus Noel|202-444-2223|Marcus.S.Noel@gunet.georgetown.edu|
20575205|NCT03042780|H Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
20575206|NCT04024228|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20575207|NCT02982590|HOSPITAL UNIVERSITI SAINS MALAYSIA|DR W YUS HANIFF W ISA|09-767 3000|wyhaniff@usm.my|
20575208|NCT00886704|Ludwig Maximilians-University Munich|Clemens von Schacky, Head, Preventive Cardiology, University of Munich|+498951600|clemens.vonschacky@med.uni-muenchen.de|2165
20575209|NCT01168973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20575210|NCT00415506|Oregon Health & Science University|Dr. Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
20575211|NCT02163187|Memorial Sloan Kettering Cancer Center|Dr. Martin Weister, MD|212-639-6698|weiser1@mskcc.org|
20575212|NCT03281668|University of North Carolina at Chapel Hill/Thurston Arthritis Research Center|Yvonne Golightly, PhD|919-966-0566|golight@email.unc.edu|
20575213|NCT01901575|NYU Langone Medical Center|Avrimin M. Kogan, MD|(212) 263-5072|Avrimin.Kogan@nyumc.org|
20575214|NCT04774250|Washington University in St. Louis|Dr. Craig Buchman, Lindburg Professor & Chair, Department of Otolaryngology-Head & Neck Surgery|314-362-2914|buchmanc@wustl.edu|
20575215|NCT01871220|University of Iowa College of Dentistry|Dr. Christopher Barwacz|3193843002|chris-barwacz@uiowa.edu|
20575216|NCT00709111|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20575217|NCT00623974|UT MD Anderson Cancer Center|Mimi Hu, MD / Professor||CR_Study_Registration@mdanderson.org|
20575218|NCT00290290|Baylor College of Medicine|Rabih Darouiche, M.D.|713-794-8858|rabihd@bcm.edu|
20575219|NCT02015442|Imperial College London|Prof Gary Frost|020 7594 0959|g.frost@imperial.ac.uk|
20575220|NCT03374995|Wake Forest University Health Sciences|Principal investigator|336-716-5440|kwinkfie@wakehealth.edu|
20575221|NCT00393796|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|1-800-865-1125|mahahuss@umich.edu|
20575222|NCT04013789|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20575223|NCT03319407|Mayo Clinic|Robert L. McClain, M.D.|904-956-1728|Mcclain.Robert@mayo.edu|
20575224|NCT00119041|Louis Stokes VA Medical Center|David C. Aron, MD, MS|(216) 791-2300|david.aron@va.gov|5702
20575225|NCT05111041|Duke University|Devon Noonan, Ph.D.|919-684-3786|devon.noonan@duke.edu|
20575226|NCT00041080|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20575227|NCT01011439|CLIOSS S.r.l.|Dr. Cristina Davite|+39 0031 58|regulatory@clioss.com|1482
20575228|NCT00058552|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20575229|NCT00359021|Tibotec|SENIOR DIRECTOR R&D|1 609 730-7548||
20575230|NCT03861936|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20575231|NCT00006151|University of Pennsylvania|Peter Gariti||gar1iti@mail.med.upenn.edu|
20575232|NCT00702364|Craig Hospital|Cynthia Harrison-Felix, PhD|303-789-8565|charrison-felix@craighospital.org|
20575233|NCT01312038|Middle Ear Physiology Laboratory|Ellen Mandel, MD|412-692-6214|mandele@pitt.edu|
20575234|NCT03198520|Solvay® Dental 360|Tim Shary Compliance and Product Specialist|770-772-8665|Tim.shary@solvay.com|
20549770|NCT05766423|Northwestern University|Research Assistant Professor|312-503-0274|allison.pack@northwestern.edu|
20549771|NCT02161731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549772|NCT02381288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20549773|NCT02468414|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
20549774|NCT00004978|Division of Biostatistics, University of Minnesota|James Neaton, PhD|612-626-9040|jim@ccbr.umn.edu|
20549775|NCT01044862|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
20549776|NCT01652703|Amgen Inc.|Study Director|866-572-6436||
20549777|NCT00062374|Memorial Sloan-Kettering Cancer Center|Dr. David P. Kelsen|646-888-4179|kelsend@mskcc.org|
20549778|NCT02155608|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
20549779|NCT03555591|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20549780|NCT01532414|Repros Therapeutics Inc.|Jennifer L Wike, Director of Regulatory Affairs|281-719-3402|jwike@reprosrx.com|
20549781|NCT02728050|University of Washington|Anna Halpern, MD|206-606-1978|halpern2@uw.edu|
20549782|NCT02380677|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
20549783|NCT05426902|Duke University|Amanda Eudy, MSPH, Ph.D.|919-681-1811|amanda.eudy@duke.edu|
20549784|NCT02584673|The Cooper Health System|Irwin Gratz|856-968-8527|gratz-irwin@cooperhealth.edu|
20549785|NCT00617773|Recepta Biopharma|Dr. Oren Smaletz, M.D., Medical Director|55 11 3709-2140|oren.smaletz@receptabiopharma.com.br|
20549786|NCT03217175|MGH Diabetes Research Center|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
20549787|NCT01223001|The Rehabilitation Hospital of Indiana|Dr. Lance Trexler|(317)879-8940|lance.trexler@rhin.com|
20549788|NCT02552199|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20557270|NCT04130802|Oculis SA|Chief Development Officer|0041 21 711 39 70|info@oculis.com|
20557271|NCT03937219|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20557272|NCT02515279|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20557273|NCT01800968|Duke Clinical Research Institute|Adrian Hernandez, MD|919-668-7515|adrian.hernandez@duke.edu|
20557274|NCT02257099|UBMD Orthopaedics and Sports Medicine|John Marzo, MD|7168292982|jmmarzo@buffalo.edu|
20557275|NCT04987762|Purdue Pharma L.P.|Clinical Leader|1-800-745-7445|nelson.sessler@imbriumthera.com|
20557276|NCT03185481|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557277|NCT02303184|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20557278|NCT02620917|University of Padova|Daniela Bruttomesso|0039 049/8212183|daniela.bruttomesso@unipd.it|
20557279|NCT02044991|Loyola University|Colleen Fitzgerald, M.D., M.S.|708-216-2180|cfitzgerald@lumc.edu|
20557280|NCT00701038|The Ohio State Universtiy|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
20557281|NCT02362048|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20557282|NCT00504426|Headwuarters of New Product Evaluation and Development, Otsuka Pharmaceutical Co., Ltd.|IMAOKA, Kyoji, Operatin Officer, Gemeral Manager|+81-3-6361-7366||
20557283|NCT04029129|UConnHealth|Dr. Douglas Brugge|860-679-8814|brugge@uchc.edu|
20557284|NCT02003508|Melbourne Sexual Health Centre|A/Prof Marcus Chen|+613 93416260|mchen@mshc.org.au|
20557285|NCT03685591|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557286|NCT01714804|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
20575235|NCT01670539|West Virginia University|Georgia L Narsavage|304-293-6729|gnarsavage@hsc.wvu.edu|
20575236|NCT02783443|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
20575237|NCT01986920|Aclaris Therapeutics|Christopher Powala, Chief Operating Officer|484-324-7933|cpowala@aclaristx.com|
20575238|NCT03023059|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
20575239|NCT03781323|University of Rochester|Richard Dunne|585-275-5823|Richard_Dunne@urmc.rochester.edu|
20575240|NCT01495858|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20575241|NCT01526551|University of Kentucky College of Public Health|Dr. Robin Vanderpool|859-218-2102|robin@kcr.uky.edu|
20575242|NCT01364623|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
20575243|NCT01353508|Novartis|Study Director|862-778-1873||
20575244|NCT01614821|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
20575245|NCT02902081|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20575246|NCT00619970|CHLA|Brynie Slome Collins MD|323 361 2181|bcollins@chla.usc.edu|
20557287|NCT00438880|Mayo Clinic Cancer Center|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
20557288|NCT00944047|University of Kansas Cancer Center|Dr. Qamar Khan|(913) 588-6029|ctnursenav@kumc.edu|
20557289|NCT02220894|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557290|NCT05390970|University of Iowa Healthcare|Dr. Annah J. Vollstedt|712-253-1627|annah-vollstedt@uiowa.edu|
20557291|NCT04098250|Mayo Clinic|Todd Schwedt, M.D.|480-301-9721|Schwedt.Todd@mayo.edu|
20557292|NCT00633464|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20557293|NCT00394355|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20557294|NCT04278625|Nationwide Children's Hospital|Dr. Peter Winch|614-722-5936|peter.winch@nationwidechildrens.org|
20557295|NCT02612064|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557296|NCT00079001|Massachusetts General Hospital|Matthew Smith, MD, PhD||smith.matthew@mgh.harvard.edu|
20557297|NCT05070416|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20557298|NCT03538015|University of Utah|Dr. Owen Chan|801-581-7755|ochan@u2m2.utah.edu|
20557299|NCT00698646|Novartis Pharmaceuticals|Study Director|862-778-8300||
20557300|NCT00985010|Materno-Perinatal Hospital of the State of Mexico|Hugo Mendieta Zerón|+52-722-2176605|mezh_74@yahoo.com|
20557301|NCT00316173|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575247|NCT04792567|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20575248|NCT01127659|University of Buffalo|Paresh Dandona|716) 961-9900|pdandona@kaleidahealth.org|
20575249|NCT00496730|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20557302|NCT05650164|Merck Healthcare KGaA, DarmstadtGermany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20557303|NCT02044848|Novartis Pharmaceuticals|Study Director|862-778-8300||
20557304|NCT00045708|Johns Hopkins - Adult Brain Tumor Consortium (ABTC)|Director Adult Brain Tumor Consortium|410-955-8837|jfisher@jhmi.edu|
20575250|NCT01314963|Stanford Univeristy Medical Center|Craig Levin, PhD; Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine)|650-736-0449|cslevin@stanford.edu|
20575251|NCT03769246|Columbia University Medical Center|Dr. Anna-Christina Bevelaqua|(212) 342-0085|ab3302@cumc.columbia.edu|
20575252|NCT00113074|University of Iowa|Mark Vander Weg|319-338-0581|mark-vanderweg@uiowa.edu|7717
20575253|NCT00889226|CMC|Dr. Hoyoung Sohn|82-2-222-2222|abc@snu.ac.kr|3333
20557305|NCT00278538|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20575254|NCT01106027|Mayo Clinic|Dr. Mark Stegall|507-284-6275|Stegall.Mark@mayo.edu|
20575255|NCT00369785|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20575256|NCT00800683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575257|NCT01365585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575258|NCT00356889|University of Wisconsin Cancer Center|William Schelman, M.D.||wrs@medicine.wisc.edu|
20575259|NCT02678416|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20575260|NCT01848353|University of Oklahoma Health Sciences Center|Kevin Short, PhD, Associate Professor|(405) 271-8001|kevin-short@ouhsc.edu|43094
20575261|NCT00953719|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|shimden@its.jnj.com|
20557306|NCT00685945|Vanderbilt University|Dr. Mias Pretorius|615-343-0665|mias.pretorius@vanderbilt.edu|
20557307|NCT03183388|Yale School of Medicine|Dr. Hilary Blumberg|203-785-6180|hilary.blumberg@yale.edu|
20557308|NCT04716413|Montefiore Medical Center|Dr. Naum Shaparin|718-920-4316|nshapari@montefiore.org|
20557309|NCT01493960|Index Pharmaceuticals|Dr Thomas Knittel|0046 8 508 847 31|thomas.knittel@indexpharma.com|
20557310|NCT00249249|Kowa Research Europe, Ltd.|Dr Neil Hounslow|+44 118 922 9004|nhounslow@kowa.co.uk|
20557311|NCT01679236|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
20557312|NCT00284141|Sanofi|Trial Transparency Team||Contact-Us@Sanofi.com|
20557313|NCT00201864|The Ohio State University|Ewa Mrozek|614-293-7956|Ewa.Mrozek@osumc.edu|
20557314|NCT00071721|Alzheimer's Disease Cooperative Study|Paul Aisen|858-622-2028|paisen@ucsd.edu|
20557315|NCT02882711|The University of Texas Health Science Center at Houston|Salih Selek, M.D.|713-741-3936|salih.selek@uth.tmc.edu|
20557316|NCT02597790|David Geffen School of Medicine at UCLA|Kara Chew, MD, MS|310-825-0796|kchew@mednet.ucla.edu|
20557317|NCT00299000|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
20557318|NCT02412501|Medtronic Coronary/Structural Heart|Beth Moe, Clinical Study Manager|763-526-1184|beth.moe@medtronic.com|
20557319|NCT01160484|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
20557320|NCT00803101|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20557321|NCT01909570|University Hospital Virgen de las Nieves|Dr. Ana Clavero|0034958020482|anaclaverogilabert@gmail.com|
20557322|NCT01529008|Bone Therapeutics|Chief Medical Officer|+32 493 09 73 66|Regulatory@bonetherapeutics.com|
20557323|NCT00332332|Amgen Inc.|Study Director|866-572-6436||
20557324|NCT01382602|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
20557325|NCT03091673|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
20557326|NCT02790073|Sanifit|Rekha Garg MD MS|18582815978|rekha.garg@sanifit.com|
20557327|NCT04170686|University of Pennsylvania|Dr. Melissa G. Hunt|610-529-8055|mhunt@psych.upenn.edu|
20557328|NCT03328143|Aurora Neuroscience Innovation Institute|Richard A Rovin, MD|4143851922|richard.rovin@aurora.org|
20557329|NCT04389333|National Clinical Research Center for Digestive Diseases Department of Gastroenterology|Dr. Zhuan Liao|21-31161004|liaozhuan@smmu.edu.cn|+86
20557330|NCT00331344|Oakland Medical Center|Andrea Harzstark, M.D.|510-752-6789|andrea.l.harzstark@kp.org|
20557331|NCT01342458|University of Sao Paulo|Dr. Francis Trombini-Souza|55 11 3091 8426|trombinisouza@usp.br|
20557332|NCT03633929|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
20557333|NCT02487810|Fostering Improvement in End-of-Life Decision Science (FIELDS) Program|Beth Cooney, Assistant Director of FIELDS Program|215-573-9461|elcooney@exchange.upenn.edu|
20557334|NCT02489110|Photozig, Inc.|Bruno Kajiyama|6506947595|info@photozig.com|
20557335|NCT02889133|Columbia University Medical Center|Dr. Eldad Hod|212-305-4109|eh2217@cumc.columbia.edu|
20557336|NCT04359784|Fred Hutchinson Cancer Center|Jordan Gauthier|206-667-2713|jgauthier@fredhutch.org|
20557337|NCT02753595|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20557338|NCT02453581|Qeensland Institute of Medical Research|Dr James McCarthy|+61 7 3845 3796|James.McCarthy@qimr.edu.au|
20508935|NCT01952288|VA Puget Sound Health Care System|Rebekah J. Rein, JD|206-764-2711|rebekah.rein@va.gov|
20557339|NCT03899753|Montefiore Medical Center|Konrad Gruson, MD|3475774412|kgruson@montefiore.org|
20557340|NCT03034018|Brigham and Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
20557341|NCT04859660|University of Arizona|Martina Gabra|520-626-6636|mgabra2@gmail.com|
20557342|NCT03217747|M D Anderson Cancer Center|Aung Naing|713-563-1930|anaing@mdanderson.org|
20575262|NCT03492554|Apple|Health Technology Clinical Operations|1-866-905-5303|htclinicalquestions@apple.com|
20557343|NCT03996291|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20575263|NCT01289821|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20575264|NCT03591354|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
20575265|NCT01010633|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20575266|NCT04376827|Janssen Research & Development, LLC|Senior Director Clinical Research MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20575267|NCT05907213|University of Pittsburgh, UPMC Department of Anesthesiology & Perioperative Medicine|Dr. Katherine Grace Lim, Chief of the Division of OB & Women's Anesthesiology|412-641-1778|limkg2@upmc.edu|
20575268|NCT02615470|Auburn University|Salisa Westrick|3348448314|westrsc@auburn.edu|
20575269|NCT02000596|University of Maryland Greenebaum Comprehensive Cancer Center|Kate Tkaczuk|410-328-7394|ktkaczuk@umm.edu|
20575270|NCT01717287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575271|NCT04490395|Duke University|Jennifer Plumb Vilardaga, PhD|919-668-6123|jennifer.plumb.vilardaga@duke.edu|
20575272|NCT01861028|Conformis|Director of Clinical and Technical Research|781-345-9103|sumesh.zingde@conformis.com|
20575273|NCT02650999|University of Pennsylvania, Clinical Research Unit|Ellen Napier, Nurse Pracitioner|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
20575274|NCT00388505|Novartis Pharmaceuticals|Study Director|862-778-8300||
20575275|NCT05092919|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
20575276|NCT00618436|University of Pittsburgh|Dr. Lori Shutter|1-412-647-8410|shutterla@upmc.edu|
20575277|NCT01490684|King Abdulaziz Medical City|Dr Hasan Al-Dorzi|966535888632|aldorzih@yahoo.com|
20557344|NCT03248375|Icahn School of Medicine at Mount Sinai|Dr. Edward Kim|(212) 241-7409|Edward.Kim@mountsinai.org|
20549789|NCT03487276|InflaRx N.V.|Dr. Korinna Pilz, MD, MSc|+49 89 414 189 78 00|Korinna.Pilz@InflaRx.de|
20549790|NCT05035550|Michigan State University|Dr. Jason Moser|517-355-2159|jmoser@msu.edu|
20549791|NCT01438957|Pfizer|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549792|NCT00224042|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20549793|NCT00840450|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
20549794|NCT01354990|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549795|NCT02170298|UC Davis|Julie B Schweitzer|916-703-0294|jschweitzer@UCDAVIS.EDU|
20549796|NCT00777608|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20549797|NCT01448486|St. Vincent's Hospital, Sydney|Prof. Bruce Brew|61 2 8382 1111|b.brew@unsw.edu.au|4100
20549798|NCT02853604|Advaxis, Inc.|Surya Vangala|609-423-2528|vangala@advaxis.com|
20549799|NCT00975650|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
20549800|NCT01061177|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
20549801|NCT03858309|Oregon Health & Science University (OHSU)|Selda Yildiz, PhD|(503) 494-7219|yildiz@ohsu.edu|
20549802|NCT01539538|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
20549803|NCT00847379|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20549804|NCT04390191|Icahn School of Medicine at Mount Sinai|Dr. Neomi Shah|212-241-6286|neomi.shah@mssm.edu|
20549805|NCT03978832|Indivior Inc|PERSERIS Medicines Development Lead and Head Global Clinical Operations and Development|804 379-1090|regan.fong@indivior.com|
20549806|NCT00003499|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20549807|NCT01744574|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
20549808|NCT02864498|DS Biopharma|Study Director|+353 1 2933590|regulatory.dsbiopharma@DSBiopharma.com|
20549809|NCT01256008|Wenzhou Medical University|Director of Clinical Trials|+86 0577 55579363|hjc@wmu.edu.cn|
20549810|NCT02256189|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
20549811|NCT02248103|Faculty of Oral and Dental Medicine Cairo University|Ass. Prof. Dr. Noha Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
20549812|NCT03250845|UZ Leuven|Datamanager|+3216346880|jonas.vanham@uzleuven.be|
20549813|NCT02019693|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
20549814|NCT03822078|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20549815|NCT01854710|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
20549816|NCT00730132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20549817|NCT02227758|St Jude Medical/Abbott|Clinical Study Director||rdiaz@sjm.com|
20549818|NCT02296320|MedImmune, LLC|Hasan S. Jafri|301-398-4431|information.center@astrazeneca.com|
20549819|NCT03282682|Comenius University in Bratislava|Doc. Mgr. Milan Sedliak, PhD.|+421918340671|milan.sedliak@uniba.sk|
20549820|NCT05466682|NYU Langone Health|Mia T Minen, MD|212-263-7744|mia.minen@nyulangone.org|
20549821|NCT01930123|Duke University|Brian J. Soher, Ph.D.|919-684-7350|brian.soher@duke.edu|
20549822|NCT02695329|Zimmer Biomet G.K.|Clinical Affairs Senior Manager|+81-6402-6777|takahito.nakai@zimmerbiomet.com|
20549823|NCT01348165|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549824|NCT01929343|UT Southwestern Medical Center|Josh Becker|2146485277|joshua.becker@utsouthwestern.edu|
20549825|NCT01269463|Rhodes Pharmaceuticals L.P.|Inder Chaudhary, PhD|401-262-9272|inder.chaudhary@rhodespharma.com|
20549826|NCT01125605|Pascoe pharmazeutische Praeparate GmbH|Director of Clinical Trials|0049 641 7960100|klinische.forschung@pascoe.de|
20549827|NCT02549937|HUTCHMED Limited|Martin Benes|+1.973.306|martinb@hutch-med.com|4490
20575278|NCT00625989|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
20549828|NCT03199274|Thomas Jefferson University|John Eisenbrey, PhD|(215) 503-5188|john.eisenbrey@jefferson.edu|
20575279|NCT01180478|CROES|J. de la Rosette, chairman CROES|+31 20 5666030|info@croesoffice.org|
20508936|NCT00606177|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20549829|NCT03278873|MeiraGTx|Program Manager|0044 (0)20 3866 4320|ocularinfo@meiragtx.com|
20575280|NCT03785925|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20575281|NCT02091778|Podiatry and Foot health, Stott Lane Salford ,UK|Paul Chadwick|0161 206 4710|paul.chadwick@salford.nhs.uk|
20575282|NCT00677820|MedImmune LLC, an affiliate of AstraZeneca|Raburn Mallory, MD/ Sr Dir Clinical Development|301-398-0000|malloryr@medimmune.com|
20575283|NCT01673919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20549830|NCT01886794|University of Texas Medical Branch|Kathleen L. Vincent, M.D.|409-772-2610|klvincen@utmb.edu|
20575284|NCT00986544|"Department of Surgery, Hospital P. Colombo, Via Orti Ginnetti 7, 00049 Velletri (Rome), Italy"|Marcello Picchio|+39696102228|marcellopicchio@libero.it|
20549831|NCT05670236|Cleveland Clinic Foundation|Dr. Patrick Corrigan|216-618-9932|corrigd4@ccf.org|
20549832|NCT04518306|George Medicines Pty Limited|Anthony Rodgers (Principal Investigator)|+44 7983 578 290|arodgers@georgeinstitute.org|
20549833|NCT02801331|University of Pittsburgh School of Medicine|Elisabeth B Salisbury, PhD|14122465378|salisburye2@upmc.edu|
20549834|NCT02443987|Gloucestershire Hospitals NHS Foundation Trust|Dr Sharan Athwal|0300 422 2222|sharan.athwal@glos.nhs.uk|
20549835|NCT01352546|Plastic Surgery Professional Association|Peter T. Pacik, MD, FACS|603 387 7735|ptpacik@verizon.net|
20549836|NCT00946478|UCSD Dermatology|Dr. Tissa Hata|858-657-8390|ucsddermstudies@gmail.com|
20549837|NCT00887653|THE MIRIAM HOSPITAL|Aadia Rana|4017934680|arana@lifespan.org|
20549838|NCT03069378|Memorial Sloan Kettering Cancer Center|Dr. Ciara Kelly, MD|646-888-4312|Kellyc1@mskcc.org|
20549839|NCT01397708|Alaunos Therapeutics, Inc|Jaymes Holland Clinical Consultant|6502732627|jholland@alaunos.com|
20549840|NCT04334902|Heuron|Yoomi Kim_Clinical Research Team Leader|01035173212|yoomi_kim@iheuron.com|
20549841|NCT01638546|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
20549842|NCT05231954|Indiana University|Katrina Coppedge|317-278-1602|kcoppedg@iu.edu|
20549843|NCT05947643|Washington University, Department of Otolaryngology - Head and Neck Surgery|Dorina Kallogjeri, Assoc.Professor of Otolaryngology|314-362-1077|kallgjerid@wustl.edu|
20549844|NCT01354977|Albert Einstein College of Medicine|Dr. Meredith Hawkins|7184302903|meredith.hawkins@einstein.yu.edu|2903
20549845|NCT00612690|University of Illinois at Chicago|Marc S. Atkins, Ph.D.|312-413-1048|atkins@uic.edu|
20549846|NCT01664533|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20549847|NCT04869644|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
20549848|NCT00844831|University of Louisville|John M. Wo, MD|502-852-6991|johnwogi@gmail.com|
20549849|NCT05255068|The University of Iowa|Wen Liu|3193557104|wen-liu-1@uiowa.edu|
20549850|NCT00680862|VHA|Henry Anaya|310-478-3711|henry.anaya@va.gov|48488
20549851|NCT00540514|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20549852|NCT03291808|Johns Hopkins University|Gem Roy|4432875796|groy2@jhu.edu|
20549853|NCT04988646|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
20549854|NCT02129725|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
20549855|NCT02543437|Stryker Japan|Yasuyuki Inatsugu, Associate manager of clinical affairs|81 3 6894 8394|yasuyuki.inatsugu@stryker.com|
20549856|NCT02397278|Stanford University|Michael Fadell II|3037241111|mfadell@stanford.edu|
20549857|NCT01304316|University of Pennsylvania|Dr. Elliot V. Hersh|215-898-9686|evhersh@pobox.upenn.edu|
20549858|NCT01315678|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
20549859|NCT02471430|Massachusetts General Hospital|Mathias Lichterfeld|617-726-2000|mlichterfeld@mgh.harvard.edu|
20549860|NCT00869349|Brigham and Women's Hospital|Nancy A. Shadick|617-732-5266|nshadick@partners.org|
20549861|NCT00429273|University of California, Los Angeles|James T. McCracken, M.D.|310-825-0470|jmccracken@mednet.ucla.edu|
20549862|NCT00144963|Talon Therapeutics|VP, Regulatory Affairs|650-228-5066|ttarlow@talontx.com|
20549863|NCT04251169|SOLTI|Sara Cano|34 664 449 862|info@gruposolti.org|
20549864|NCT03210376|UT MD Anderson Cancer Center|Dr. Wendell H. Williams III / Anesthesiology & Perioperative Medicine|713-563-0034|WHWilliams@mdanderson.org|
20549865|NCT00521014|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
20575285|NCT01688596|Penn State Milton S. Hershey Medical Center|Dr. Matthew F. Davies, M.D.|7175310003|mdavies@hmc.psu.edu|283519
20575286|NCT04746833|VA Connecticut Healthcare System|Dr. Brent A. Moore|2034352243|brent.moore@yale.edu|
20575287|NCT00915772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575288|NCT04747834|Regulatory Pathways Group, Inc.|Gretchen Neumann|19494667124|gneumann@regulatorypathways.com|
20549866|NCT00603889|Albert B. Sabin Vaccine Institute|Dr. David Diemert, Director of Clinical Trials|202-842-5025|david.diemert@sabin.org|
20549867|NCT03208244|Massachusetts General Hospital|Raymond Chung, MD|617-724-7562|Chung.Raymond@mgh.harvard.edu|
20549868|NCT02856035|Department of Veterans Affairs, N Fl/S Georgia VA Medical Center|Dr. Janis J Daly|216 402 8940|jjd17@case.edu|
20549869|NCT01233258|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20549870|NCT00390468|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|caperez@mdanderson.org|
20549871|NCT01049308|VA Loma Linda Healthcare System|Dr Helme Silvet|9095836097|helme.silvet@va.gov|
20549872|NCT03845985|UMass Chan Medical School|Melissa L. Anderson, Associate Professor of Psychiatry|508-856-5820|melissa.anderson@umassmed.edu|
20575289|NCT01488279|Frist Clinic Endocrinology|Dr. Annis Marney|615-403-8398|annis.marney@hcahealthcare.com|
20549873|NCT01318993|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575290|NCT03593850|Universidad del Rosario|Dr. Juan Sebastian Martin Saavedra|2672200532|juans.martin@urosario.edu.co|
20549874|NCT03334539|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
20549875|NCT02457260|University of Pittsburgh|Daniel E. Forman - Chief of a section of Geriatrics Cardiology|412-864-2507|formand@pitt.edu|
20575291|NCT02490475|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20549876|NCT04974697|Johnson & Johnson Vision Care (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
20549877|NCT03706456|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20549878|NCT03302234|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575292|NCT04748653|University of California San Francisco|Alison El Ayadi, Associate Professor|415-476-5877|alison.elayadi@ucsf.edu|
20549879|NCT03889444|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20575293|NCT01701999|California Department of Public Health|Dr. Jessica Khouri|510-231-7600|Jessica.Khouri@cdph.ca.gov|
20557345|NCT05805657|University of California, Berkeley|Dr. Allison Harvey, Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
20557346|NCT01345721|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20575294|NCT01195090|Department of Internal Medicine, Mackay Memorial Hospital|Dr. Sung-Chen Liu|886-2-2543-3535|pine3.tw@yahoo.com.tw|2174
20575295|NCT04912245|Wake Forest University Health Sciences|Tele Voice|336.716.8028|jgabbard@wakehealth.edu|
20575296|NCT01205230|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575297|NCT02319668|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575298|NCT01372150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575299|NCT01236573|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20575300|NCT02665052|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Susan S. Conroy|(410) 637-3213|susan.conroy@va.gov|
20575301|NCT00823823|Children's Hospital Boston|Dr. Donald Bae|617-355-6808|donald.bae@childrens.harvard.edu|
20575302|NCT02234284|University of California San Francisco|Dr. David Thom|415-206-2278|David.Thom@UCSF.edu|
20575303|NCT00536809|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575304|NCT04569032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557347|NCT02390531|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|8139758690|rkraker@jaeb.org|
20557348|NCT00511875|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
20557349|NCT02618616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20557350|NCT03764072|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20557351|NCT02080780|Ventrus Biosciences|Ventrus|646-706-5208|VEN307@ventrusbio.com|
20549880|NCT02644135|UHCMC|Dr. Robert Salata|2168443293|robert.salata@uhhospitals.org|
20557352|NCT00459342|The University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, MD / Associate Professor|713-792-7734|fmjohns@mdanderson.org|
20549881|NCT02795832|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20557353|NCT02686034|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
20557354|NCT00542880|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20557355|NCT00696384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20557356|NCT01678131|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557357|NCT04251884|Ospedale Regionale di Lugano|Dr. Francesco Mongelli|+41764706297|francesco.mongelli@mail.com|
20557358|NCT04179721|Northwell Health|Dr. Liron Sinvani, Principal Investigator|646-766-7169|ldanay@northwell.edu|
20557359|NCT04225988|Cedars Sinai Medical Center|Dr. Edmund Huang, MD|310-423-2641|edmund.huang@cshs.org|
20557360|NCT05361655|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20557361|NCT04839354|Emory University|Claudia Morris, MD|404-785-7141|claudia.r.morris@emory.edu|
20557362|NCT07069764|National Institute of Laser Enhanced Sciences (NILES), Cairo University|DR.hala shaaban attiyah|01012894478|std.halashaaban@niles.edu.eg|
20557363|NCT03284112|Columbia University|Dr. James M. Noble|212-342-4126|jn2054@columbia.edu|
20557364|NCT04425902|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20557365|NCT01191840|Duke University Health System|Vance Fowler|919-668-8044|fowle003@mc.duke.edu|
20557366|NCT04669600|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
20557367|NCT01544998|Mayo Clinic|Horng Chen, MD, Professor of Medicine|507-284-8846|chen.horng@mayo.edu|
20557368|NCT02128646|University of Kansas Medical Center|Michael Moncure, MD|913-588-1240|mmoncure@kumc.edu|
20557369|NCT06369779|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20557370|NCT01682213|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman, MD|646-888-4162|chapmanp@mskcc.org|
20557371|NCT01264380|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20557372|NCT01860586|Mid-Atlantic Retina|Dr. Jason Hsu, Principal Investigator|215-928-3092|jshu@midatlanticretina.com|
20557373|NCT00530803|Montefiore Medical Center|Associate Professor, Dept of Pediatrics|718-741-2460|cskae@montefiore.org|
20549882|NCT04112784|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
20575305|NCT00324753|Center for Health Equity Research and Promotion (VAPHS)|Maria K. Mor|(412) 360-2240|maria.mor@va.gov|
20557374|NCT03474107|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20557375|NCT01932697|Mayo Clinic|Daniel J. Ma, M.D.|507/284-3261|Ma.Daniel@mayo.edu|
20557376|NCT01916655|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
20557377|NCT01330316|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20557378|NCT01337986|Washington Univerisity St. Louis|Robert Naismith, MD|314-747-5576|naismithr@wustl.edu|
20557379|NCT00141739|Blood and Marrow Transplant Program, University of Michigan|Dr. John E. Levine|734-936-8456|jelevine@med.umich.edu|
20557380|NCT01520402|Mount Sinai School of Medicine|Dr. Daniella Kadian-Dodov|(212) 241-9454|daniella.kadian-dodov@mssm.edu|
20508937|NCT02603172|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20508938|NCT00927576|VANCHCS|Dr. David L. Woods|925-372-2571|dlwoods@ucdavis.edu|
20508939|NCT05935982|University of Alabama at Birmingham (UAB)|Byron Lai, PhD|205-638-9790|byronlai@uab.edu|8-9725
20508940|NCT00420342|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20508941|NCT00839436|NIAID|Dr. Virginia Sheikh|3014357939|sheikhv@niaid.nih.gov|
20508942|NCT01440972|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
20508943|NCT03933215|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20508944|NCT05784129|Janssen Pharmaceuticals, Inc, US Medical Affairs|Medical Director Gastroenterology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20508945|NCT00407550|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
20508946|NCT02238782|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
20508947|NCT02580591|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20508948|NCT01801124|Maimonides Medical Center|Mark Kronefeld, MD|(718) 283-8816||
20508949|NCT00810095|MindFrame, Inc .|Dr. Thomas J. McCarthy|949-204-0806|tmccarthy@mindframeinc.com|
20508950|NCT05301803|CathVision ApS|Clinical Research Manager|+4531324745|kpf@cathvision.com|
20508951|NCT01599806|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
20508952|NCT02023918|UCSF|Dr. Ethan Weiss|4155140819|ethan.weiss@ucsf.edu|
20549883|NCT00496808|UT MD Anderson Cancer Center|Raphael E Pollock,PHD/Professor Emeritus, Surgical Oncology|(713) 792-6928|CR_Study_Registration@mdanderson.org|
20549884|NCT01845831|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20549885|NCT00221403|Ohio State Medical Center/Nationwide Children's Hospital|Robert Kowatch, MD, PhD|(614) 355-2872|Robert.Kowatch@nationwidechildrens.org|
20549886|NCT00779285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20549887|NCT00256750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20549888|NCT01003288|University of Bergen|Professor Rebecca Cox|+4755974668|rebecca.cox@uib.no|
20549889|NCT04659161|Karuna Therapeutics, Inc.|Inder Kaul, VP Clinical Development|1-888-783-0380|medinfo@karunatx.com|
20508953|NCT01263314|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549890|NCT00901316|Texas Children's Hospital|Sheldon L. Kaplan, MD|832-824-4330|skaplan@bcm.edu|
20508954|NCT03436147|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
20508955|NCT00282568|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
20508956|NCT03006926|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
20508957|NCT03689972|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20549891|NCT02197130|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549892|NCT02615145|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20549893|NCT00592943|Massachusetts General Hospital; Harvard Medical School|Thomas J. Spencer, MD|(617) 726-1731|tspencer@partners.org|
20549894|NCT00565045|MetroHealth Medical Center|Dr. Jayme Knutson|216-778-8364|jsk12@case.edu|
20549895|NCT03648983|Montefiore Medical Center|Lisa Wiechmann||lwiechma@montefiore.org|
20549896|NCT03129178|University of Portsmouth|Dr Anthony Shepherd|02392 84|ant.shepherd@port.ac.uk|5289
20557381|NCT02287584|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20557382|NCT02269371|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|7026533298|jill.clark.3.ctr@us.af.mil|
20557383|NCT01492686|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20557384|NCT04711356|London School of Hygiene & Tropical Medicine|Dr Daniela Manno, clinical trial coordinator and responsible physician|+44 20 7927|daniela.manno@lshtm.ac.uk|2092
20557385|NCT03086018|Bernafon AG|Julie Tantau|+41 31 998 1646|juta@bernafon.com|
20557386|NCT01892345|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20557387|NCT02080195|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Javier Bolaños Meade, MD|410-614-6398|fbolano2@jhmi.edu|
20557388|NCT01257880|Swedish Medical Center|Jill T. Jesurum, Ph.D.|206-683-1505|jill.jesurum@swedish.org|
20557389|NCT00077064|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20575306|NCT00303979|Medtronic Cardiac Rhythm Disease Management|IMPROVE HF, Clinical Research Specialist||medtronicCRMtrials@medtronic.com|
20575307|NCT04366050|UCSD|Rohit Loomba, MD, MHSc|858-246-2201|roloomba@ucsd.edu|
20575308|NCT02367066|AstraZeneca|Dr. Stanko Skrtic, MD, PhD||ClinicalTrialTransparency@astrazeneca.com|
20575309|NCT02247960|University of Rochester|Jean Joseph|585-341-7795|jean_joseph@urmc.rochester.edu|
20575310|NCT01591317|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20508958|NCT00324272|John Radcliffe Hospital|Mr. Henk Giele, Consultant Plastic & Reconstructive Surgeon|01865 231 056|henk.giele@orh.nhs.uk|
20508959|NCT02417064|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20575311|NCT03123250|PROCEPT BioRobotics Corporation|Angela Lee|650-232-7215|a.lee@procept-biorobotics.com|
20575312|NCT02361944|Vanderbilt University|Frederic T. BIllings IV|6159368487|frederic.t.billings@vumc.org|
20575313|NCT04340557|Sharp HealthCare|Matthew Geriak, PharmD|858-939-3717|matthew.geriak@sharp.com|
20575314|NCT00773136|University of Miami|Dr. Sara Wester|305-326-6132|swester2@med.miami.edu|
20575315|NCT01210170|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
20575316|NCT02032550|University of Pennsylvania|Ravishankar Jayadevappa|215-898-3798|jravi@pennmedicine.upenn.edu|
20575317|NCT02463071|AstraZeneca|Torbjorn Lundstrom, MD, PhD|+46 31 706 4100|torbjorn.lundstrom@astrazeneca.com|
20575318|NCT03086057|Brown University|Dr. Katie Biello|401-863-3082|katie_biello@brown.edu|
20575319|NCT02941926|Novartis Pharmaceuticals|Study director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20575320|NCT04305275|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20575321|NCT02705807|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575322|NCT00199836|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20575323|NCT02243865|Chordate|Dr Jan-Åke Åkesson|+46 8 40015586|info@chordate.com|
20575324|NCT00053703|UNC Chapel Hill|Linmarie Sikich, MD|919-972-9744|lsikich@med.unc.edu|
20575325|NCT03098836|Duke University Medical Center|Daniel George, MD|(919) 668-8108|daniel.george@duke.edu|
20575326|NCT03986866|University of Arkansas for Medical Sciences|Johnathan Goree, MD|(501) 686-8818|JHGoree@uams.edu|
20575327|NCT01500525|Capital Institute of Pediatrics|Ling Cao，MD,Pulmonologist, Professor|86-13910610319|caoling9919@163.com|
20575328|NCT02003014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20575329|NCT01660451|Bayer|Therapeutic Area Head|+1-888-8422937|clinical-trials-contact@bayer.com|
20575330|NCT05093322|HUTCHMED Limited|Nick Lawn|+44 7826 422448|nickl@hutch-med.com|
20575331|NCT00898443|UAB|Marsha Wakefield, M.D.|205-934-4696|mwakefield@uab.edu|
20575332|NCT03880032|Johns Hopkins Bloomberg School of Public Health|Pamela Surkan|4105027396|psurkan@jhu.edu|
20575333|NCT00407654|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
20575334|NCT00074581|Fred Hutchinson Cancer Research Center|Dr. Deborah Donnell|2066675661|deborah@scharp.org|
20575335|NCT03613662|Scilex Pharmaceuticals, Inc.|Associate Director Clinical Operations|6503866709|cambrose@scilexpharma.com|
20575336|NCT01708291|University of Rochester|Sandra Jee|585-273-4657|sandra_jee@urmc.rochester.edu|
20557390|NCT00621543|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5368|sarah_betstadt@urmc.rochester.edu|
20575337|NCT00617604|Astellas Pharma Europe B.V|Senior Director Medical Science||Astellas.resultsdisclosure@astellas.com|
20575338|NCT03250832|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20575339|NCT02303704|Ch. Pervaiz Elahi Institute of Cardiology, Multan, Pakistan.|Dr. Muhammad Sher-i-Murtaza|0333-6107570|sherm.cpeic@gmail.com|
20575340|NCT01034540|Biofortis Clinical Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
20575341|NCT02232126|University of Southern California|Dr. Susan Enguidanos|213-740-9822|enguidan@usc.edu|
20575342|NCT02336763|UCLA|Mitchell Kamrava, MD|310-825-9775|mkamrava@mednet.ucla.edu|
20575343|NCT01353079|GREER Laboratories, Inc.|Terrance Coyne, M.D., Executive Vice President of Research & Development; Chief Medical Officer|(828) 759-7495|tcoynemd@greerlabs.com|
20575344|NCT03982342|Nationwide Children's Hospital|Carl Backes, MD|1-614-355-6729|Carl.Backes@nationwidechildrens.org|
20575345|NCT03086265|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
20575346|NCT05293743|The Hospital for Sick Children|Dr. Maryse Bouchard|4168137654|maryse.bouchard@sickkids.ca|224522
20575347|NCT02064920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575348|NCT00916279|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
20575349|NCT00310804|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20575350|NCT03598647|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
20575351|NCT00688155|Wake Forest School of Medicine|Mark Espeland, PhD|336-761-2826|mespelan@wakehealth.edu|336
20575352|NCT04310085|Medicines for Malaria Venture|Dr Stephan Chalon|+41 22 555 0379|chalons@mmv.org|
20575353|NCT01292798|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
20575354|NCT01499953|University Hospital Dresden, Centre for Vascular Medicine|PD Dr. med. Jan Beyer-Westendorf|+49-351-4582899|Jan.Beyer@uniklinikum-dresden.de|
20575355|NCT03548285|University of Texas Southwestern Medical Center|David Sher, MD|214-645-8525|david.sher@utsouthwestern.edu|
20575356|NCT03697720|NorthShore University HealthSystem|Kevin Hellman, Research Associate Professor|847-570-2622|khellman@northshore.org|
20575357|NCT01183143|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20575358|NCT04096274|Boise State University|Dr. Nathaniel Williams|2084263145|natewilliams@boisestate.edu|
20575359|NCT01942148|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
20575360|NCT02248259|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575361|NCT02807480|Laureate Institute for Brain Research|Robin Aupperle|918-502-5744|raupperle@laureateinstitute.org|
20575362|NCT02369848|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
20575363|NCT01979159|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@va.gov|1363
20575364|NCT02114164|OhioHealth|Dr. Oscar Martinez|(614) 544-8104|oscar.martinez@ohiohealth.com|
20575365|NCT00096785|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20575366|NCT00257725|New York State Psychiatric Institute|Laurence Greenhill, MD|212-543-5340|GREENHIL@nyspi.columbia.edu|
20575367|NCT02573870|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575368|NCT01858532|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20575369|NCT00514514|Novartis|Study Director|862-778-8300||
20575370|NCT01575106|Massachusetts General Hospital|Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
20575371|NCT02829307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20575372|NCT01408992|Khon Kaen University|Dr. Kwanchanok Yimtae|66-43348396|kwayim@kku.ac.th|
20575373|NCT01206062|Wake Forest University Health Sciences|David Reboussin|336-716-6844|drebouss@wakehealth.edu|
20575374|NCT00957528|The University of Texas Medical Branch at Galveston|Randall Urban, M.D., Professor of Medicine|409- 772-1176|rurban@utmb.edu|
20575375|NCT01021956|STEBA Biotech|Bertrand Gaillac International Project Leader|+33 9 74 19 79 05|b.gaillac@stebabiotech.com|
20575376|NCT02081534|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20575377|NCT00762892|UT Health Science Center Houston|Tanvir Bell, MD|713-500-6759|Tanvir.K.Bell@uth.tmc.edu|
20575378|NCT00338039|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Professor||CR_Study_Registration@mdanderson.org|
20575379|NCT02234479|University of Maryland|Elizabeth Nichols, MD|410-328-2324|enichols1@umm.edu|
20575380|NCT03947983|The University of Texas Austin|Kavita Radhakrishnan|5124717936|kradhakrishnan@mail.nur.utexas.edu|
20575381|NCT05506956|Johns Hopkins University|Kristen Murray, Program Manager|410-614-6707|kmeckel2@jhmi.edu|
20575382|NCT01841749|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20575383|NCT02285920|University of Pennsylvania|Laura M. Dember, MD|215-573-5264|ldember@pennmedicine.upenn.edu|
20575384|NCT01825057|Yale School of Medicine|Steve Martino|203-932-5711|steve.martino@yale.edu|7418
20575385|NCT01480284|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575386|NCT00066742|SWOG Statistical Center|Lung Committee Statistician|206-652-2267||
20575387|NCT02809131|Vanderbilt University Medical Center|Christopher R. Ellis, MD, FACC, FHRS|(615)-936-2523|Christopher.ellis@vumc.org|
20575388|NCT01211535|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
20575389|NCT05368961|Cleveland Clinic|Michelle Levay, Nurse Research Manager|216-445-4749|levaym@ccf.org|54749
20575390|NCT00549939|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20575391|NCT00003895|Providence Cancer Center, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center|Walter J. Urba, MD, PhD; Physician Director of Research|503-215-5696|Walter.Urba@providence.org|
20575392|NCT00415857|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/792-7305|eharrison@mdanderson.org|
20575393|NCT01735279|Department of Psychobiology, Universidade Federal de São Paulo (UNIFESP), Rua Napoleão de Barros, São Paulo , Brazil|Md PhD José Carlos F. Galduróz|+55 11 2149 0000|galduroz@unifesp.br|
20575394|NCT01380730|Amgen Inc.|Study Director|866-572-6436||
20575395|NCT04130633|Johns Hopkins University School of Medicine|C. Austin Zamarripa, PhD|410-550-6969|czamarr2@jh.edu|
20575396|NCT05686928|Galderma|Thu Q. Nguyen, PhD|8179615495|thu.nguyen@galderma.com|
20575397|NCT00922480|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
20527894|NCT02334384|Eastern Virginia Medical School|Kenji Cunnion|7574465125|cunniokm@evms.edu|
20575398|NCT04784897|Innovation Pharmaceuticals Inc.|Senior Vice President, Clinical Sciences|978-921-4125|info@ipharminc.com|
20575399|NCT02446314|The University of Reading|Prof Claire Williams|0118 378 7540|claire.williams@reading.ac.uk|
20575400|NCT00550654|National Cancer Institute, National Institutes of Health|Deborah Citrin, M.D.|301-496-5457|citrind@mail.nih.gov|
20575401|NCT04754802|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
20575402|NCT00701090|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575403|NCT00873366|Mayo Clinic|Dr. Matthew P. Goetz|507-284-2511|goetz.matthew@mayo.edu|
20575404|NCT01970488|Amgen Inc.|Study Director|866-572-6436||
20575405|NCT02201420|Navidea Biopharmaceuticals, Inc.|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
20527895|NCT02651688|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20575406|NCT01490814|Medtronic|Ralf Meyer|+49215981490|ralf.meyer@medtronic.com|
20575407|NCT01537198|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20575408|NCT01299376|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575409|NCT03680911|University of Miami|Roy R. Casiano, MD|305-243-5290|rcasiano@med.miami.edu|
20575410|NCT03962738|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20575411|NCT00574288|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20575412|NCT01898689|UC San Diego|Dr. Brian Ilfeld|(858) 444-5949|bilfeld@ucsd.edu|
20575413|NCT03716050|Wake Forest Baptist Health|Ivo Pestana|336-716-4171|ipestana@wakehealth.edu|
20575414|NCT01221727|Amgen Inc.|Study Director|866-572-6436||
20575415|NCT00529451|Novartis Pharmaceuticals|Study Director|862-778-8300||
20575416|NCT02566577|Emory University|Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
20527896|NCT00625183|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20575417|NCT00097773|Seattle Childrens Hospital|Bonnie Ramsey, MD|206-987-5725|bonnie.ramsey@seattlechildrens.org|
20575418|NCT01009034|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
20575419|NCT01494350|Institut Pasteur of Tunis|Afif Ben Salah, MD, PhD|011-216-71-792-429|afif.bensalah@pasteur.rns.tn|
20575420|NCT01786603|University of Kansas Medical Center|Dr. Richard Barohn|913-945-9944|rbarohn@kumc.edu|
20575421|NCT03700320|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20575422|NCT03654976|ALK-Abelló A/S|Senior Director Global Clinical Development|0045 45747576|clinicaltrials@alk.net|
20575423|NCT02179671|AstraZeneca|Phillip Dennis|1 + 301-398-5549|Phillip.Dennis@astrazeneca.com|
20575424|NCT01775735|Boston Scientific|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
20575425|NCT02054325|UPECLIN|Dr. Matheus Bertanha|+55 14 38116305|matheus.fameca@ig.com.br|
20527897|NCT01429441|ThromboGenics N.V.|Dr. Petra Kozma-Wiebe|+32 16 751 497|petra.kozma@thrombogenics.com|
20549897|NCT00456014|Stony Brook University School of Medicine|Ramin V. Parsey, MD, PhD|631-444-3084|Ramin.Parsey@stonybrookmedicine.edu|
20549898|NCT04404361|CTI BioPharma Corp.|John Volpone|206-351-7663|jvolpone@ctibiopharma.com|
20549899|NCT03480646|Constellation, Inc.|Clinical Program Lead|1-844-667-1992|medinfo@morphosys.com|
20549900|NCT05330702|University of Iowa|Shaoping Zhang|(319) 335-7386|shaoping-zhang@uiowa.edu|
20549901|NCT02881554|University of Washington|Dr. Smith Apisarnthanarax, Principal Investigator|+1 206 598-4100|apisarn@uw.edu|
20549902|NCT00638378|Incyte Corporation|Study Director|1-855-463-3463||
20549903|NCT02417974|Boston Medical Center and BU School of Medicine|Alan Moss, MD, PhD|617-638-6116|alan.moss@bmc.org|
20549904|NCT01892293|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
20549905|NCT03602482|Pennsylvania State University College of Medicine|Dr. Amanda J. Miller|7175317676|aross1@pennstatehealth.psu.edu|
20549906|NCT02114814|The Ohio State University|Dr. Jie Hu|6146880394|hu.1348@osu.edu|
20549907|NCT02601469|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20549908|NCT05276401|Lakewood Amedex|Dr. Adam Ruskin|941-225-2514|ARuskin@LakewoodAmedex.com|
20549909|NCT01411774|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
20549910|NCT00056316|University of Missouri-St. Louis|Ann M. Steffen, PhD, Associate Professor|314-516-5382|ann_steffen@umsl.edu|
20575426|NCT04688775|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
20575427|NCT00932425|University of California San Francisco|Wade Smith, MD, PhD|415-353-8897|smithw@neurology.ucsf.edu|
20527898|NCT01606748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549911|NCT04617509|Gesynta Pharma AB|Charlotte Edenius|+46733864246|charlotte.edenius@gesynta.se|
20575428|NCT01721876|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575429|NCT01200238|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
20575430|NCT02717754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20575431|NCT00482703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20575432|NCT05834348|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20575433|NCT00891319|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|216
20575434|NCT04631796|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20575435|NCT05714982|UNC|Principal Investigator|(919) 966-3282|ntb@unc.edu|
20575436|NCT03677596|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575437|NCT00806195|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20575438|NCT02752035|Astellas Pharma Global Development, Inc.|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
20575439|NCT01161043|Medtronic Diabetes|Suiying Huang|8185763319|suiying.huang@medtronic.com|
20575440|NCT01621633|Novartis Pharmaceuticals|Study Director|862-778-8300||
20575441|NCT01131676|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20575442|NCT01231659|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20575443|NCT00509067|Department of Psychiatry Georgetown University Medical School|Dr. Stephen I. Deutsch|757.446.5888|DeutscSI@EVMS.EDU|
20575444|NCT02901574|Johns Hopkins University School of Medicine|Rajani Sebastian, PhD|410-502-5012|rsebast3@jhmi.edu|
20575445|NCT02887404|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
20575446|NCT00749476|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20575447|NCT01937598|Div. Diabetology, Med. Dep. I, St. Josef-Hospital (Ruhr-Univeristy Bochum), change of address 01.01.20015|Prof. Dr. M. A. Nauck, Principle Investigator|+49-234-509|michael.nauck@rub.de|6332
20575448|NCT01022242|Uppsala University Hospital|Monica Wiig||monica.wiig@akademiska.se|
20575449|NCT00117598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575450|NCT00545064|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20575451|NCT01770912|University of Florida|Charles G. Widmer, Associate Professor|352-273-5696|widmer@dental.ufl.edu|
20575452|NCT03407651|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
20575453|NCT01380639|Schön Klinik Berchtesgadener Land|Dr. Klaus Kenn|+49 8652 931541|kkenn@schoen-kliniken.de|
20575454|NCT01536951|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20575455|NCT00351416|Massachusetts General Hospital|Janet Hall|617-877-1112|jehall@partners.org|
20575456|NCT01843972|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575457|NCT00615472|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
20549912|NCT03633695|AcuFocus, Inc.|Magda Michna, PhD., Chief Global Clinical, Medical and Regulatory Affairs Officer|(949) 585-9511|mmichna@acufocus.com|
20549913|NCT00684307|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20549914|NCT02515058|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
20549915|NCT03808493|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20549916|NCT01029795|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20549917|NCT01806545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20549918|NCT00884312|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20549919|NCT00617123|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549920|NCT00461045|Triphase Accelerator|Associate Director of Clinical and Regulatory Operations|858-295-4337|jennifer.ki@triphaseco.com|
20549921|NCT00133952|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
20549922|NCT00314093|University of Texas Southwestern Medical Center|Dr. Ellen Vitetta|214-648-1200|ELLEN.VITETTA@UTSouthwestern.edu|
20549923|NCT03809117|George Washington University|Dr. Andrew Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
20549924|NCT05048784|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20549925|NCT01603056|ALK-Abelló A/S|Vivian Wang, Sr. Medical Affairs Manager|86 - 10 5166 8198|Vivian.Wang@alk.net|
20549926|NCT02270957|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405 822 2336|joan-merrill@omrf.org|
20549927|NCT03291054|Northwell|Richard Carvajal, MD|516-734-8900|rcarvajal2@northwell.edu|
20549928|NCT01246401|Yale University|Dr. Sandra Springer||sandra.springer@yale.edu|
20549929|NCT03462082|University of Rochester|Karlo J Lizarraga, MD, MS / Assistant Professor of Neurology|585-341-7500|karlo.lizarraga@gmail.com|
20549930|NCT00919724|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iu.edu|
20549931|NCT01391559|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
20549932|NCT00166114|University of Miami School of Medicine|Dominique Musselman, MD, MSCR|404-723-8361|dmusselman@med.miami.edu|
20549933|NCT02335294|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20549934|NCT00545168|ParaPRO LLC|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
20549935|NCT00960778|Medical University of South Carolina|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
20549936|NCT00743340|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20549937|NCT03508921|Vanderbilt Medical Center|Melissa Kaufman, MD, PhD Professor of Urology|615-322-3807|melissa.kaufman@vumc.org|
20549938|NCT00859053|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20549939|NCT03266107|Relievant Medsystems Inc.|VP Clinical Affairs|(650) 368-1000|dsahr@relievant.com|280
20549940|NCT01898611|University of Pennsylvania|Anne Cappola, MD|215-573-5359|acappola@mail.med.upenn.edu|
20575458|NCT01854645|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20575459|NCT02774616|Biotronik SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20575460|NCT04261504|Arizona State University|Yi-Yuan Tang|4807903577|yiyuan@asu.edu|
20575461|NCT00430482|Boston University Charles River Campus|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
20575462|NCT00545402|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20575463|NCT01817751|Virginia Commonwealth University Massey Cancer Center|Massey Cancer Center CTO Operations Managers|877-4627739|ctoclinops@vcu.edu|
20575464|NCT00555477|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@umich.edu|
20549941|NCT02548650|University of Florida College of Medicine - Jacksonville|Dominick J Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
20549942|NCT00426855|Kantonsspital Aarau|Dr. Peter Moosmann|+41 62 838 60 51|peter.moosmann@ksa.ch|
20549943|NCT02128113|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20549944|NCT00299104|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20549945|NCT03680105|Reven Pharmaceuticals|Head, Global Clinical Affairs|13036691336|kristina.cabala@reven.com|
20549946|NCT03814356|Massachusetts General Hospital|Brian L. Edlow, M.D.|617-724-6352|bedlow@mgh.harvard.edu|
20549947|NCT01312272|VISN 22 Mental Illness Research, Education, and Clinical Center|Dr. Michael C. Davis|3104783711|mcdavis@mednet.ucla.edu|49234
20549948|NCT02244606|SCYNEXIS|Dr. David Angulo|(201) 884 - 5471|david.angulo@scynexis.com|
20549949|NCT01402492|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
20549950|NCT04866225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549951|NCT00982878|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
20549952|NCT03722966|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|
20549953|NCT01336764|National Center for PTSD|Steven H. Woodward, PhD|650-493-5000|steve.woodward@va.gov|22111
20549954|NCT01626391|TauRx Therapeutics Ltd|Dr. Jiri Hardlund|+44 (0)1224438550|JHH@taurx.com|
20549955|NCT02573311|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20549956|NCT05537883|Wake Forest University Health Sciences|Selwan Barbat, MD|704-355-2000|Selwan.Barbat@atriumhealth.org|
20549957|NCT02099708|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20549958|NCT05229406|Center for Healthy Minds, University of Wisconsin - Madison|Simon B. Goldberg, PhD|608-265-8986|sbgoldberg@wisc.edu|
20549959|NCT04026308|UAMS|Michael Wilson|501-686-8729|MPWilson@uams.edu|
20549960|NCT04171050|University of California, Los Angeles|Tamara Grisales, MD|310-983-1023|tgrisales@mednet.ucla.edu|
20575465|NCT00397033|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
20575466|NCT03519867|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575467|NCT00382018|SWOG|Breast Committee Statistician|2066675712|jmiao@fredhutch.org|
20575468|NCT01252810|GE Healthcare|Ruben Sheng, M.D.|609-514-6899|Rubin.Sheng@ge.com|
20575469|NCT01721057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20575470|NCT01020591|CDHA|Wendy Jardine|902 429 6218|wendymjardine@gmail.com|
20575471|NCT01202279|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
20575472|NCT03805750|University of California San Diego|F.B. Nahab MD|858-822-6683|fnahab@health.ucsd.edu|
20575473|NCT01984164|Emory University|Dr. Hajjar|404-712-2036|ihabhajjar@emory.edu|
20575474|NCT02811549|Advanced Bionics|Ankur Kaushal, VP of Global Regulatory Affairs|661 362 1400|clinicalresearch@advancedbionics.com|
20575475|NCT03472924|Oregon State University|Marc Norcross, PhD, ATC|541-737-6788|marc.norcross@oregonstate.edu|
20575476|NCT02219321|University of Texas Southwestern Medical Center|Enas Kandil|214-648|Enas.Kandil@UTSouthwestern.edu|9374
20575477|NCT03057613|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Shlomo Koyfman|1-866-223-8100|TaussigResearch@ccf.org|
20575478|NCT02546765|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|6176320706
20575479|NCT05082376|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20575480|NCT00493220|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
20575481|NCT02109562|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20575482|NCT00445224|University of Kentucky|Dr. Tim L. Uhl Principal Investigator|859-323-1100|tluhl2@uky.edu|80858
20575483|NCT00068575|UT MD Anderson Cancer Center|Peter Pisters, MD / Professor||asanmigu@mdanderson.org|
20575484|NCT01590550|Loma Linda University|Rita Sheth, MD|909-558-8242|rsheth@llu.edu|
20575485|NCT04136184|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20575486|NCT04887155|UCLA Semel Institute|Marc Weintraub|3108251300|mjweintraub@mednet.ucla.edu|
20575487|NCT03318978|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
20575488|NCT02844816|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|ctangen@fredhutch.org|
20575489|NCT00667823|Actelion Pharmaceuticals Ltd|Senior Clinical Leader PH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20575490|NCT04633174|Dartmouth-Hitchcock Medical Center|Dr. Nicholas Daniel, Staff Physician, Emergency Services|(603) 650-7254|Nicholas.Daniel@hitchcock.org|
20575491|NCT02592018|UCSF Department of Dermatology|Dr. Wilson Liao|415-476-4701|wilson.liao@ucsf.edu|
20575492|NCT03372928|US Army Research Institute of Environmental Medicine|Jess Gwin|508-206-2300|jessica.a.gwin.ctr@mail.mil|
20575493|NCT06156215|University of California San Francisco|Dr Melanie Molina|512.294.4366|melanie.molina@ucsf.edu|
20575494|NCT04890314|Weill Cornell Medicine|Dr. Jim C. Hu|(646) 962-6363|jch9011@med.cornell.edu|
20549961|NCT01370356|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575495|NCT04456764|University of Pittsburgh|P. Daniel Patterson|412-647-3078|pdp3@pitt.edu|
20575496|NCT05050318|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20575497|NCT04360551|University of Hawaii at Manoa John A Burns School of Medicine|Cecilia M. Shikuma MD|808 692-1328|shikuma@hawaii.edu|
20575498|NCT05338515|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20575499|NCT03496012|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20575500|NCT02322125|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
20575501|NCT01463670|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun MD|646-608-3718|hassounh@mskcc.org|
20575502|NCT03029715|Menoufia Univeristy|Dr Ezzeldin Ibrahim|0021006303178|ezzeldin7@yahoo.com|
20575503|NCT00520884|University of Pennsylvania, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism|Anne Cappola, M.D., Sc.M.|215-573-5359|ACappola@mail.med.upen.edu|
20575504|NCT03427047|Medacta USA|Rena Mandino, Director, Clinical Research|352-359-3581|rmandino@medacta.us.com|
20575505|NCT00766038|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
20575506|NCT04701138|University of North Carolina at Chapel Hill|Saame Shaikh, PhD|919-843-4348|shaikhsa@email.unc.edu|
20575507|NCT03138538|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20575508|NCT01798589|Dermatology Specialists|Joseph Fowler, MD|502-583-7546|fowlerjoe@msn.com|
20575509|NCT01524198|King Saud University|Dr. Abdullah Alangari|966506287276|alangari100@gmail.com|
20575510|NCT02232802|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
20575511|NCT03650842|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-5817|Joseph.Tobias@nationwidechildrens.org|
20575512|NCT00634634|Cancer Institute of New Jersey|Dr. Deborah Toppmeyer|732-235-5203|toppmede@cinj.rutgers.edu|
20575513|NCT01973777|University of British Columbia|Dr Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
20575514|NCT00885703|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20575515|NCT05745662|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20575516|NCT05030454|Washington University School of Medicine|Pamela Samson, M.D., MPHS|314-747-1786|psamson@wustl.edu|
20575517|NCT01490450|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20575518|NCT00404820|Novartis Pharmaceuticals|Study Director|862 778-8300||
20575519|NCT00938717|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
20575520|NCT00998049|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20575521|NCT01462435|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
20575522|NCT03600142|University of Utah|Dr. Melissa Watt|8015817201|melissa.watt@hsc.utah.edu|
20575523|NCT03887533|National Institute of Child Health and Human Development (NICHD)|Dr. Forbes Porter|301-435-4432|fdporter@mail.nih.gov|
20575524|NCT01543152|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
20575525|NCT04639973|Baylor College of Medicine|Cara Buskmiller, MD|832-824-1000|cara.buskmiller@bcm.edu|
20575526|NCT02053168|BD Interventional - Surgery|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
20575527|NCT00636675|University of North Carolina Chapel HIll|Ruth A. Anderson|919-966-8785|rutha@email.unc.edu|
20575528|NCT00857532|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20575529|NCT02687542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549962|NCT01658072|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
20549963|NCT00040664|GlaxoSmithKline|GSK Response Center|866-435-7343||
20549964|NCT02334358|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
20549965|NCT03953820|Aquestive Therapeutics|Denis Scheper, Director of Portfolio Management and Clinical Operations|(908)941-1887|denis.scheper@aquestive.com|
20549966|NCT05451225|Columbia University|Dr. Michael Compton|646-774-8476|mtc2176@cumc.columbia.edu|
20549967|NCT04746963|AsclepiX Therapeutics|Dr A Shojaei|800-572-3545|info@asclepix.com|
20549968|NCT00799422|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20549969|NCT04456959|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20549970|NCT00545662|Columbia University|Dr. William Friedewald|212-305-3017|wtf1@columbia.edu|
20575530|NCT01838616|Grünenthal GmbH|Study Director|+49 241 569|Clinical-Trials@grunenthal.com|3223
20549971|NCT00583778|MetroHealth Medical Center|Dr. Rita Cydulka|216-778-7800|rcydulka@gmail.com|
20549972|NCT00441883|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20549973|NCT03292588|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20549974|NCT03761277|Medtronic Neuromodulation Clinical Research|Pain Therapies Clinical Research Director|763-514-4000|rs.embracetdd@medtronic.com|
20549975|NCT00759031|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20549976|NCT00543140|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20549977|NCT00578812|NuVasive, Inc|Julie Pairamore, Sr. Manager, Clinical Affairs|858-320-5258|jpairamore@nuvasive.com|
20549978|NCT01804296|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
20549979|NCT00309387|University of Parma|Giovanni Maraini, MD|+39 0521 238527|maraini@unipr.it|
20549980|NCT04532164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20549981|NCT02483520|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588-1673|Kwilliams1@kumc.edu|
20549982|NCT01104493|MedImmune, LLC|Dr. Robert Gasser|301-398-0000|gasserr@medimmune.com|
20549983|NCT00208091|Clinical Motor Physiology Laboratory|Dr. Seth Pullman|212-305-3808|sp31@columbia.edu|
20549984|NCT01342796|Novartis Vaccines and Diagnostics|Posting Director||Novartis.email@novartis.com|
20575531|NCT01848288|Alcon Research, Ltd.|Doug Fanney, Director, Global Medical Affairs, Cataract Instrumentation|1-888-451-3937|alcon.medinfo@alcon.com|
20575532|NCT01007032|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20575533|NCT01101438|Canadian Cancer Trials Group|Professor Bingshu Chen|+16135336000|bechen@ctg.queensu.ca|77703
20575534|NCT05335356|Biocon Biologics Limited|Dr Sarika D|080 2808|Sarika.Deodhar@biocon.com|5302
20575535|NCT00791336|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
20575536|NCT03634397|Penn State College of Medicine|Dr Candice Maenza|7175310003|cmaenza@pennstatehealth.psu.edu|283146
20575537|NCT04223843|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575538|NCT03901105|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20575539|NCT00914927|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20575540|NCT00357214|Tufts University|Bess Dawson-Hughes|617 556 3066|bess.dawson-hughes@tufts.edu|6175100519
20575541|NCT01519934|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20575542|NCT01687179|Brigham and Women's Hospital|Elizabeth P. Henske, MD|857-307-0782|ehenske@bwh.harvard.edu|
20575543|NCT02164929|Duke University Medical Center|Timothy Miller, MD||timothy.miller2@duke.edu|
20575544|NCT03496220|Angulus|Dr. Perry Dubin|‪(917) 426-5911‬|perry@angulus.us|
20575545|NCT00365456|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
20575546|NCT02475070|Lund University|Dr Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
20575547|NCT01846728|University of Colorado Anschutz Medical Campus|Edward Melanson, PhD|303-724-0935|ed.melanson@cuanschutz.edu|
20575548|NCT02161575|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20575549|NCT00714285|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575550|NCT02138617|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|Melahat_Canter@med.unc.edu|
20575551|NCT00702754|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
20575552|NCT01085786|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
20575553|NCT00112671|Princess Margaret Phase II Consortium|Dr. Srikala Sridhar|416-946-4501|srikala.sridhar@uhn.ca|2662
20575554|NCT01286454|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575555|NCT00702325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20575556|NCT00814671|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
20575557|NCT04556136|Madigan Army Medical Center|Dr. Mary McCarthy|253-968-3695|mary.s.mccarthy1.civ@health.mil|
20575558|NCT01507779|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20575559|NCT01022502|Chang Gung Memorial Hospital|Yin-Ku Lin, MD. PhD.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
20575560|NCT00861913|Karmanos Cancer Institute, Wayne State University|Amy M. Weise, D. O.|313-576-8952||
20575561|NCT02101515|George Washington University School of Medicine and Health Sciences|Alexis Gimovsky, MD|2027412603|agimovsk@mfa.gwu.edu|
20575562|NCT01751399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20575563|NCT00073528|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20575564|NCT02937194|The University of Hong Kong|Prof Wong, May Chun Mei|852-28590422|mcmwong@hku.hk|
20575565|NCT00003702|NRG Oncology|Angela M. Kuras on behalf of Virginia Filiaci|7168455702|kurasa@nrgoncology.org|
20575566|NCT02790138|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20575567|NCT03199040|Washington University School of Medicine|Williams Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
20575568|NCT01226459|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
20575569|NCT00474708|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20575570|NCT03770091|UPMC|John Fowler|412-605-3245|fowlerjr@upmc.edu|
20575571|NCT02132884|Fox Chase Cancer Center|Dr. Hossein Borghaei|215-2141515|Hossein.Borghaei@fccc.edu|
20575572|NCT00698997|University California Davis|Dr. Sally Rogers|916-703-0264|sjrogers@ucdavis.edu|
20575573|NCT00475722|University of Michigan|Dr. Zora Djuric|734-615-6210|zoralong@umich.edu|
20575574|NCT01889238|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575575|NCT01054742|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20575576|NCT03116997|Memorial Sloan Kettering Cancer Center|Dr. German Echeverry, MD|212-639-8865|echeverg@mskcc.org|
20575577|NCT00574145|Vanderbilt-Ingram Cancer Center|Nancy Wells, DNSc., R.N|615-322-6184|nancy.wells@vanderbilt.edu|
20575578|NCT03227471|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20575579|NCT00449670|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575580|NCT04183790|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20575581|NCT01251653|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575582|NCT03197493|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
20575583|NCT02329964|Korea University Anam Hospital|Seolju Park|+82-10-6314-6013|gursla2@naver.com|
20575584|NCT00176605|Rutgers Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20575585|NCT00833053|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
20575586|NCT01033734|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20575587|NCT02865018|Icahn School of Medicine at Mount Sinai, Corrine Goldsmith Dickinson Center for MS|Ilana Katz Sand|212-241-6854|ilana.katzsand@mssm.edu|
20575588|NCT00139776|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20575589|NCT02210065|U.T. MD Anderson Cancer Center|Dr. Betul Oran / Associate Professor, Stem Cell Transplantation|713-745-2820|BOran@mdanderson.org|
20575590|NCT00674583|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575591|NCT00111800|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575592|NCT03442036|University of California San Diego|John J. Finneran IV, MD|4083073004|jfinneran@ucsd.edu|
20575593|NCT00971178|Department of Anaesthesiology, the University of Hong Kong|Clinical Assistant Professor|852-22553303|cheucw@hku.hk|
20575594|NCT00326209|Bausch Health Americas, Inc.|Director of Clinical Operations||lindsey.mathew@bauschhealth.com|
20575595|NCT04109222|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20575596|NCT02577406|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20575597|NCT05143489|Maimonides Medical Center|Director of Research Administraton|7182836896|alikourezos@maimo.org|
20575598|NCT04630171|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20575599|NCT01111851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20575600|NCT05807464|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20575601|NCT00125762|BIDMC|Nezam Afdhal|6176321118|nafdhal@bidmc.harvard.edu|
20575602|NCT01816061|DCVAMC|Dr.Joel Scholten|2027458000|joel.scholten@va.gov|55099
20575603|NCT01961349|CO RI&A TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
20575604|NCT00731055|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|amb107@columbia.edu|
20575605|NCT05525689|Northwestern University|Dr. David Mohr|312-503-1403|d-mohr@northwestern.edu|
20575606|NCT01353196|VA Medical Center VA Maryland Health Care System, Baltimore, MD|Brajesh K. Lal, MD|410-605-7000|blal@som.umaryland.edu|
20575607|NCT01671111|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20575608|NCT02343159|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20575609|NCT03959332|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20575610|NCT01978535|Mayo Clinic|Dr. Amie Jones|507-284-6063|Jones.Amie@mayo.edu|
20575611|NCT01092143|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575612|NCT01506960|Massachusetts General Hospital|Iris McNulty|617 726 2612|imcnulty@partners.org|
20575613|NCT01846624|Stanford University Medical Center|David Joseph Iberri, MD; Clinical Assistant Professor (Hematology)|650-498-6000|diberri@stanford.edu|
20575614|NCT04702737|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20575615|NCT03574753|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20575616|NCT01177683|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20575617|NCT00580372|University of Arkansas for Medical Science|Dr. Bart Barlogie|501-526-2873||
20575618|NCT00617539|University of California San Francisco|Michelle Melisko, MD|415-353-7070|Michelle.Melisko@ucsf.edu|
20575619|NCT04743921|University of Alabama at Birmingham Department of Orthopaedic Surgery|Dr. Amit Momaya|205-975-2663|amomaya@uabmc.edu|
20575620|NCT00427349|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20575621|NCT01908972|Seoul National University College of Medicine|Prof. Tae Hyun Choi|82-10-5595-5829|psthchoi@snu.ac.kr|
20575622|NCT01977820|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
20575623|NCT01660321|ParaPro|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
20575624|NCT03491007|Durham VA Healthcare Center|Susan O'Loughlin|919-286-0411|susan.o'loughlin@va.gov|
20575625|NCT02568475|Florida Atlantic University|Ruth M. Tappen, Principal Investigator|561-297-2613|rtappen@health.fau.edu|
20575626|NCT02625233|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
20575627|NCT02426476|Columbia VA Health Care System, Virginia Commonwealth University, University of South Carolina|James Burch, MS, PhD, Professor|803-404-1552|burch@mailbox.sc.edu|
20575628|NCT02504554|Arizona State University|James Adams|480 965 3316|jim.adams@asu.edu|
20575629|NCT03023930|Yale University|Dr. Gail D'Onofrio|(203) 785-7059|gail.donofrio@yale.edu|
20575630|NCT04425720|Montefiore Medical Center|Dr. Jonathan Leff|7189204316|jleff@montefiore.org|
20575631|NCT00290186|Dayton Children's Hospital|Daniel J. Lacey, MD, PhD|937-641-3080|LaceyD@childrensdayton.org|
20575632|NCT01771055|University of Louisville|Dr. Jason Smith|502-852-5675|josmit19@louisville.edu|
20575633|NCT04391036|University of Pittsburgh Medical School|Dr. Leslie Meyn|412-641-4233|meynla@mwri.magee.edu|
20575634|NCT03184077|Virginia Commonwealth University|Lindsay Morrell, MD|410-823-1120|lmorrellmcv@gmail.com|
20575635|NCT01675635|Mundipharma (China) pharmaceutical Co, LTD.|Ms. Dan Zhu, Clinical operation and quality lead of the study|0086-10-65636800|medical.mcpc@mundipharma.com.cn|
20575636|NCT00262522|Abbott|Global Medical Services|800-633-9110||
20575637|NCT04272892|University of Oxford|Dr Melanie Fleming|+441865611461|melanie.fleming@ndcn.ox.ac.uk|
20575638|NCT06557122|Encoll Corp|Dr. Subramanian Gunasekaran, PhD|+1 (510) 396-8581|guna@encoll.com|
20575639|NCT02072928|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20575640|NCT02269787|Department of Veterans Affairs|Dr. Christine Timko, Research Career Scientist|6504935000|Christine.Timko@va.gov|23336
20575641|NCT00687440|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20575642|NCT03366298|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
20575643|NCT02481921|Providence VA Medical Center|Dr. Wen-Chih Wu|401-273-7100|wen-chih.wu@va.gov|16237
20575644|NCT00736255|DukeUMC|Scott Kollins, PhD|9196810014|kolli001@mc.duke.edu|
20575645|NCT02833974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20575646|NCT01439282|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20575647|NCT04419610|Imperial College|Dr David Owen|07575089144|d.owen@imperial.ac.uk|
20575648|NCT00751777|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
20575649|NCT00675922|University of Texas Medical Branch|Tina Mack-Moshay, ClinicalTrials.gov Administrator|409-266-6917|tlmackmo@utmb.edu|
20575650|NCT01502709|University of North Carolina|Dr Asma Khan|919 537 3389|asma_khan@dentistry.unc.edu|
20575651|NCT02722863|Korea Otsuka Pharmaceutical Co.,Ltd.|Huiyeong,Shim/Associate CTM for LPS & ISS|02-3287-9220|hyshim@otsuka.co.kr|
20575652|NCT00586261|Mayo Clinic|Dr. Patricia Best|507-284-4441|best.patricia@mayo.edu|
20575653|NCT03703882|Astria Therapeutics, Inc|Andrew Nichols, PhD - Chief Scientific Officer|617-349-1971|anichols@astriatx.com|
20575654|NCT02013180|Catalca Ilyas Cokay State Hospital|Dr. Mustafa Zafer Temiz|+90 212 787 19 12|dr_mustafazafertemiz@hotmail.com|1178
20575655|NCT01535573|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD, Professor and Director of Center For Neurobehavioral Research On Addictions||Joy.M.Schmitz@uth.tmc.edu|
20575656|NCT00457015|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20575657|NCT03670953|Impax Laboratories, LLC|Pamela Fitzpatrick, Senior Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
20575658|NCT04179734|Imperial College London|Professor Waljit S. Dhillo, Principal Investigator|00442075943487|w.dhillo@imperial.ac.uk|
20575659|NCT00290615|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
20575660|NCT00937937|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
20575661|NCT02966509|Stanford University and VA Palo Alto Health Care System|Dr. Manali Patel|650-723-4000|manalip@stanford.edu|
20575662|NCT02877693|Abbott|Grant Kim, Director Clinical Programs|818-493-3147|grant.kim1@abbott.com|
20575663|NCT01227187|George Washington University|Lakhmir Chawla|202-715-4752|lchawla@mfa.gwu.edu|
20575664|NCT01566773|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20575665|NCT02187471|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
20575666|NCT02236520|Vanderbilt University Medical Center|Alp Ikizler|(615) 343-7592|alp.ikizler@vumc.org|
20575667|NCT01785160|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575668|NCT02318667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575669|NCT04814342|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20575670|NCT05102344|University of California, Irvine|Sabrina E.B. Schuck, Ph.D.|9495335465|sabrina@uci.edu|
20575671|NCT01489670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20575672|NCT01365039|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|(585) 338-6399|robert.steffen@bausch.com|
20575673|NCT00867789|Children's Mercy Hospital|Dr. Joan Giovanni|8162343430|gegiovanni@cmh.edu|
20575674|NCT03807349|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574-371-9784|ryan.boylan@zimmerbiomet.com|
20575675|NCT00294060|Medtronic CRDM|P3 Study Team|800-328-2518|medtroniccrmtrials@medtronic.com|
20575676|NCT00187096|St. Jude Children's Research Hospital|Jeffrey Rubnitz, MD|1-866-278-5833|info@stjude.org|
20575677|NCT00330876|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
20575678|NCT03329911|Bio-Thera Solutions Ltd.|Yufeng Zhang|+86 2038251386|yfzhang@bio-thera.com|
20575679|NCT01263483|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20575680|NCT05500274|The University of Chicago|Dr. John Schneider|(773) 702-2453|jschnei1@uchicago.edu|
20575681|NCT04252859|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
20575682|NCT01555151|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
20575683|NCT03596866|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20575684|NCT00829179|Duke University Medical Center|John S. Sundy M.D. PhD|(919) 668-2169|john.sundy@duke.edu|
20575685|NCT03000179|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20575686|NCT00635479|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
20575687|NCT00258011|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20575688|NCT03269435|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20575689|NCT02512809|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|joseph.tobias@nationwidechildrens.org|
20575690|NCT02047253|University of Alabama at Birmingham|Pam Dixon, RN, BSN, OCN|205-975-9875|pamdixon@uab.edu|
20575691|NCT04085523|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ads@ascendispharma.com|
20557391|NCT02206217|School of Optometry, The Hong Kong Polytechnic University|Prof. Carly Sin Yin Lam|2766 6091|carly.lam@polyu.edu.hk|
20575692|NCT05318937|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
20575693|NCT04722042|University of North Carolina at Chapel Hill|Margaret Dillon, AuD, PhD|919-966-5251|mdillon@med.unc.edu|
20575694|NCT02454140|University of California, San Diego|Dr. James D. Murphy|(858) 822-6040|j2murphy@health.ucsd.edu|
20575695|NCT05359679|Kaiser Permanente Washington|Lorella Palazzo PhD|206-287-2900|lorella.g.palazzo@kp.org|
20575696|NCT01877915|Janssen Research & Development, LLC|SENIOR DIRECTOR, CLINICAL LEADER CV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20575697|NCT01449461|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20575698|NCT05314517|Kinevant|Study Director|(+1) 646-494-6491|kinevant.resolve-lung@kinevant.com|
20575699|NCT04714073|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575700|NCT02710136|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20575701|NCT00450242|University of North Carolina, Dept. of Obstetrics and Gynecology|Denniz Zolnoun, MD, MPH|919-966-7764|denniz_zolnoun@med.unc.edu|
20575702|NCT00798135|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
20575703|NCT02228720|Intersect ENT|James Stambaugh|6506412103|jstambaugh@intersectent.com|
20575704|NCT01401842|University of South Florida|John M. Mayer, DC, PhD / Study Director|813-974-3818|jmayer2@health.usf.edu|
20575705|NCT03337542|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20575706|NCT00290199|UAB|Dr. Alan Tita|205-934-9616|atita@uab.edu|
20575707|NCT00282295|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575708|NCT02786134|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6290|mdicarli@bwh.harvard.edu|
20575709|NCT05470465|U.S. Food and Drug Administration|Jeffry Florian|301-796-4847|Jeffry.Florian@fda.hhs.gov|
20575710|NCT00232583|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20575711|NCT04702451|Volta Medical|Paola Milpied|+33768025499|paola.milpied@volta-medical.com|
20575712|NCT03996980|Universidad de Sevilla|Dr. Manuel Pabón-Carrasco|954 350 997|mpabon2@us.es|+34
20575713|NCT00583024|University of Iowa/Holden Comprehensive Cancer Center|David Lubaroff, PhD|(319) 335-8423|david-lubaroff@uiowa.edu|
20575714|NCT04347226|Columbia University|Mark N. Stein, MD|917-658-2771|mns2146@cumc.columbia.edu|
20575715|NCT03977974|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20575716|NCT00095875|Dana Farber Cancer Institute|Robert I Haddad, MD|617-632-3090|rihaddad@partners.org|
20575717|NCT03743311|AO Servier|Olga Linnik|+7 495 9370700|olga.linnik@servier.com|
20575718|NCT00847145|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20575719|NCT00307151|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20575720|NCT00346073|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575721|NCT02204150|Mass General Hospital|Gary Tearney|617-724-2979|gtearney@partners.org|
20575722|NCT02701868|Pennington Biomedical Research Center|Abby Altazan|2257632801|Abby.Altazan@pbrc.edu|
20575723|NCT00980200|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575724|NCT01617460|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20575725|NCT00984490|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
20575726|NCT00054704|NIMH, DIRP, Experimental Therapeutics and Pathophysiology Branch|Dr. Carlos Zarate|3014510861|zaratec@mail.nih.gov|
20575727|NCT00362414|University of California Irvine|Dr. Steven Cramer|(714) 456-6876|scramer@uci.edu|
20575728|NCT02603120|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20575729|NCT04467424|University Hospital of Split|Dr. Ana Nevescanin Biliskov, pediatric anesthesiologist|00385912508001|anevescanin@gmail.com|
20575730|NCT01469182|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20575731|NCT01114503|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575732|NCT00366275|Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia|Luca Arcaini MD|+390382501308|luca.arcaini@unipv.it|
20575733|NCT01321710|University of California, San Francisco|Kathryn Lee, RN, PhD|415-476-4442|kathryn.lee@nursing.ucsf.edu|
20575734|NCT03370536|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|(212) 241-7114|vivek.reddy@mountsinai.org|
20575735|NCT01761292|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
20575736|NCT00916357|Halozyme|Vice President, Endocrinology Clinical Development|858-794-8889||
20575737|NCT03577730|University of Michigan|Phillip Vlisides|734-936-4280|pvliside@umich.edu|
20575738|NCT00003535|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20575739|NCT02289742|Alcon Research, Ltd.|Global Medical Affairs, Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20575740|NCT01360554|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575741|NCT01911442|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20575742|NCT00309465|Beaumont Health System|Tamra Dukatz, CRNA, MSN|248 992-4741 (pager)|tdukatz@beaumont.edu|
20575743|NCT03668600|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20575744|NCT01925573|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
20575745|NCT00424749|Mayo Clinic|Dr. Fernando C. Fervenza||fervenza.fernando@mayo.edu|
20575746|NCT04451161|University of Washington|Dr. Aaron Lyon|(206) 221-8604|lyona@uw.edu|
20575747|NCT00454857|Amgen Inc.|Study Director|866-572-6436||
20575748|NCT00596947|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark, Clinical Transplant Research Pharmacist|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
20575749|NCT02114268|MedImmune, LLC|M. Pamela Griffin, MD, Senior Director|301-398-0000|information.center@astrazeneca.com|
20575750|NCT01921751|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20575751|NCT01075412|The University of Iowa|Sarah McGuire, PhD|214-645-7613|Sarah.McGuire@utsouthwestern.edu|
20575752|NCT00865904|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20575753|NCT01431274|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20557392|NCT02192970|University of Wisconsin - Madison|Michael M Altaweel, MD|(608) 263-7290|mmaltaweel@wisc.edu|
20557393|NCT00792103|NuPathe Inc.|Mark Pierce, MD PhD|484-567-0130|mpierce@nupathe.com|
20557394|NCT03745222|Celgene Corporation|Anne McClain|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
20575754|NCT01378858|Albert Einstein College of Medicine|Shadi Nahvi, MD, MS|718 920 5379|snahvi@montefiore.org|
20575755|NCT02664272|Smith & Nephew, Inc.|Vice President of Medical Affairs|+41 41 7662222|luca.orlandini@smith-nephew.com|
20575756|NCT03073980|Massachusetts General Hospital|John C. Petrozza, M.D.|617-726-8868|jpetrozza@mgh.harvard.edu|
20575757|NCT01358760|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
20575758|NCT01806857|Center for Neurological Study|Richard Smith, MD|858-455-5463|cnsonline@ymail.com|
20575759|NCT01034592|Stanford University Medical Center|Jason R Gotlib, MD, Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
20575760|NCT00832520|UNM Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
20575761|NCT00789880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20575762|NCT01379469|Washington University School of Medicine|David Rudnick MD, PhD- Associate Professor|314-286-2832|rudnick_d@wustl.edu|
20575763|NCT00912002|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575764|NCT00609986|Medical University of South Carolina|Dr. Kathie Hermayer|843-792-2529|hermayer@musc.edu|
20575765|NCT03159091|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20575766|NCT04814823|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20575767|NCT02044133|Centre hospitalier départemental Vendée|Dr Yves BLEHER|0251446572|yves.bleher@ght85.fr|
20575768|NCT02247245|University of Leeds|Dr Haqeel Jamil|0113 343 3241|haqeel.jamil@nhs.net|
20575769|NCT05678257|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
20575770|NCT02046096|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20575771|NCT03520959|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557395|NCT02252432|Cedars Sinai Medical Center|Ofelia Loani Elvir Lazo, MD|310-423-1682|Loani.Elvir-Lazo@cshs.org|
20557396|NCT01281202|National Institute on Drug Abuse|David McCann, Ph.D.|301-443-2999|dmccann@nida.nih.gov|
20557397|NCT04708223|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20557398|NCT02063828|Wake Forest NCORP Research Base|Emily Dressler, PhD|336 716-0891|ncorp@wakehealth.edu|
20557399|NCT03483038|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20557400|NCT01064297|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557401|NCT01091948|Cleveland Clinic Foundation|Dr. Basem Abdelmalak|216-444-3746|abdelmb@ccf.org|
20557402|NCT03210155|Texas A&M University Corpus Christi|Dr. Christina Murphey|316.825.3747|christina.murphey@tamucc.edu|
20557403|NCT00755040|Vanderbilt Ingram Cancer Center|Madan Jagasia, M.D.|(615) 936-8422|madan.jagasia@vanderbilt.edu|
20557404|NCT00586170|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
20557405|NCT01089231|Leibniz Universität Hannover|M. Sc. Simone Schmidt|+49 (511) 762 5931|Schmidt@nutrition.uni-hannover.de|
20557406|NCT00558064|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20557407|NCT04552743|Stanford Medicine at Stanford University|Khanh Nguyen|650-721-2372|khanhpn@stanford.edu|
20557408|NCT03152084|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20557409|NCT02027402|Seoul St Mary's hospital|Teaho Hong|821052065266|gshth@catholic.ac.kr|
20557410|NCT03513757|Medical College of Wisconsin|Susan Taylor MD|414-266-3560|sutaylor@mcw.edu|
20557411|NCT00982930|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20557412|NCT00941798|Novartis Pharmaceuticals|Study Director|862-778-8300||
20557413|NCT04108000|Emory University|Professor Mi-Kyung Song, PhD, RN|404-727-3134|mi-kyung.song@emory.edu|
20557414|NCT04411849|Ohio State University|Dr. Paul Reiter|614-292-4803|reiter.36@osu.edu|
20557415|NCT03904043|Washington University School of Medicine|Dr. Michael Waters|314-747-7236|m.r.waters@wustl.edu|
20557416|NCT05559866|Mayo Clinic|Dr. Omar Ghanem|507-284-2095|ghanem.omar@mayo.edu|
20557417|NCT03750006|VA Kansas City Healthcare System|Bruce Troen|913-574-4896|bruce.troen@va.gov|
20557418|NCT05619003|Coloplast|Senior Scientific Manager|+45 49112880|dkcpov@coloplast.com|
20557419|NCT03538951|Vidac Pharma|Max Herzberg|0544257381|maxherzberg@gmail.com|
20575772|NCT00487396|Given Imaging|Director, Clinical Affairs|+972-4-9097777|Hila.Debby@givenimaging.com|
20575773|NCT04969276|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20575774|NCT04551677|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20575775|NCT01777412|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
20575776|NCT00943579|Children's Health Council|Glen R. Elliott, Ph.D., MD|650.688.3649|gelliott@chconline.org|
20575777|NCT05097144|CooperVision Inc.|José A. Vega OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
20575778|NCT00418665|Amgen Inc.|Study Director|866-572-6436||
20575779|NCT01140360|Indiana University|Dr. Kent Robertson|317-944-4969|krobert@iu.edu|
20575780|NCT00840086|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20575781|NCT03332498|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@moffitt.org|
20575782|NCT02554019|Biotest AG|Dr. Peter Röttgen|+496103801|peter.roettgen@biotest.com|803
20575783|NCT02463409|Vanderbilt University Medical Center|Dr. Ashley Shoemaker|615-343-8816|ashley.h.shoemaker@vanderbilt.edu|615
20575784|NCT02538016|Boston Children's Hospital|Alyssia Venna|617-919-6352|Alyssia.Venna@childrens.harvard.edu|
20575785|NCT02634151|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
20575786|NCT02347098|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
20575787|NCT01444742|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|CR_Study_Registration@mdanderson.org|
20575788|NCT02187172|University of Pennsylvania|Dr. Joel Gelfand|215-662-3514|joel.gelfand@pennmedicine.upenn.edu|
20575789|NCT02181816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20575790|NCT02830880|Emory University|David Schuster, MD|(404) 712-4859|dschust@emory.edu|
20575791|NCT05400213|University of Texas Health Science Center at San Antonio|Brian Mealeey, DDS, MS|210-450-8736|mealey@uthscsa.edu|
20575792|NCT02349048|Janssen R&D BE|Associate Director, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
20575793|NCT02219282|DorkuzEU|Semih Kucukguclu|902324125707|semih.kucukguclu@gmail.com|
20575794|NCT00094770|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20575795|NCT00871845|Allegheny Singer Research Institute|Hossam Kandil||Hossam.KANDIL@ahn.org|
20575796|NCT00253643|Oregon Health & Science University|Dr. Jackilen Shannon|503-220-8262|shannoja@ohsu.edu|54868
20575797|NCT00825500|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
20575798|NCT01368536|Novartis Pharmaceuticals|Study Director|862-778-8300||
20575799|NCT01035099|Weill Cornell Medicine|Rodriq Stubbs|646-962-3276|res2011@med.cornell.edu|
20575800|NCT00383084|Johns Hopkins University|Kevin Fontaine, PhD|443-449-4314|kfontai1@jhmi.edu|
20575801|NCT02113436|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575802|NCT01648790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20575803|NCT01486927|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20575804|NCT04075721|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20575805|NCT02159729|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
20575806|NCT02636582|UT MD Anderson Cancer Center|Dr. Isabelle Bedrosian, MD, Professor, Breast Surgical Oncology|(713) 563-1872|ibedrosian@mdanderson.org|
20575807|NCT00573430|AstraZeneca|Gerard Lynch|+44 7780 956181|aztrial_results_posting@astrazeneca.com|5895
20575808|NCT01278745|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20575809|NCT01148537|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
20575810|NCT00896779|Stanford University|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
20575811|NCT01843842|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
20575812|NCT02953340|Spectrum Pharmaceuticals Inc. Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
20575813|NCT01376778|The George Washington University Biostatistics Center|Dr. Rebecca Clifton, MFMU Principal Investigator|301-881-9260|rclifton@bsc.gwu.edu|
20575814|NCT01197521|AstraZeneca|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20575815|NCT01543828|Novartis Pharmaceuticals|Study Director|862-778-8300||
20575816|NCT01069172|AMO Development, LLC|Luis Atiles, Manager, Clinical Research|214 537-6784|luis.atiles@amo.abbott.com|
20575817|NCT00827606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575818|NCT03437564|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20575819|NCT00243386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20575820|NCT04037748|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20549985|NCT01599234|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20549986|NCT03684811|Forma Therapeutics, Inc.|Medical Affairs|(617) 679-1970|medicalinformation@formatherapeutics.com|
20549987|NCT02033694|Infraredx, A Nipro Company|Priti Shah|781-345-9646|pshah@infraredx.com|646
20549988|NCT00786682|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20549989|NCT03489720|Vanderbilt University Medical Center|Dr. Uma Shastri|615-936-3198|uma.shastri@vumc.org|
20549990|NCT00846430|Corewell Health|Dr. Albert Cornelius|616-391-2086|albert.cornelius@helendevoschildrens.org|
20549991|NCT01148940|Albert Einstein College of Medicine|Dr. Henny Billett|718-430-2186|hbillett@montefiore.org|
20549992|NCT03143894|Johns Hopkins University|Tracy Vannorsdall, PhD|410-502-3701|TVannor1@jhmi.edu|
20575821|NCT04995055|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
20575822|NCT01017003|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20575823|NCT04695392|UPENN|Martha A.Q. Curley, RN, PhD|2155739449|curley@nursing.upenn.edu|
20575824|NCT01412554|Oslo University Hospital Ullevål, Norway|MD PhD Tonje Amb Aksnes|+22119101|tonjeaksnes@hotmail.com|47
20575825|NCT00450723|UM/Sylvester Comprehensive Cancer Center|Eli Avisar MD|305-243-4902|eavisar@med.miami.edu|
20575826|NCT01987960|A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
20575827|NCT00807742|Brown University|Damaris Rohsenow, Ph.D.|401-863-6648|damaris_rohsenow@brown.edu|
20575828|NCT03834519|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|Clinicaltrialsdisclosure@msd.com|
20575829|NCT04655144|University of Miami|Prasoon Mohan, MD|7736563386|prasoonpm@gmail.com|
20575830|NCT01484977|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
20575831|NCT00853749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575832|NCT00591214|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20575833|NCT00841204|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
20575834|NCT04857996|Unity Biotechnology, Inc.|Study Director|650-513-0096|UBX1325_medicalmonitor@unitybiotechnology.com|
20575835|NCT01129921|Napa Pain Institute|Eric Grigsby, MD|707-252-9660|egrig@aol.com|
20575836|NCT01392677|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20575837|NCT01181076|Oslo University Hospital|Kristin Skaarud|4723070000|kskaarud@ous-hf.no|
20575838|NCT02726971|Department of Hysteroscopic Center, Fuxing Hospital, Capital Medical University, Beijing, China|Dr. YH Liu|8618301474064|emmagj@126.com|
20575839|NCT01380379|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
20575840|NCT02324075|Stanford University|Prof. Stephen P. Luby, MD|+1-650-723-4129|sluby@stanford.edu|
20575841|NCT01538628|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
20575842|NCT01357577|VA National Center for PTSD|Jessica L. Hamblen, PhD|8022965132|jessica.hamblen@va.gov|
20575843|NCT00909181|Antares Pharma|Kaushik Dave|609 359 3020|kdave@antarespharma.com|
20575844|NCT01875783|Joslin Diabetes Center|Dr. Jennifer Sun|617-209-2554|jennifer.sun@joslin.harvard.edu|
20575845|NCT00754832|Oregon Health & Science University|Dr. Michelle Cameron|503-418-1971|cameromi@ohsu.edu|
20575846|NCT02375724|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20575847|NCT04712110|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20557420|NCT06238999|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20557421|NCT06615544|Ivoclar Vivadent AG|Head of Department Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20557422|NCT00811382|BIOTRONIK|Mathias Freudigmann|+49(0)30 68905 - 1248|mathias.freudigmann@biotronik.com|
20557423|NCT07018999|Department of Anaesthesiology & Perioperative Medicine, Hong Kong Children's Hospital|Dr. Vansie Kwok, Consultant|+852-96737367|kv314@ha.org.hk|
20575848|NCT01517893|University of Massachusetts Medical School|John E. Harris, MD, PhD|508-856-1982|john.harris@umassmed.edu|
20575849|NCT03462576|Exalenz Bioscience|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737513|avrahamh@exalenz.com|
20575850|NCT00271596|University of Iowa; Elks Rehab Hospital|Leigh Beglinger, PhD|319-353-4489|leigh-beglinger@elksrehab.org|
20575851|NCT01063075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20575852|NCT01329679|DavidGrant|Sachin Shah|707-423-3277|sshah@pacific.edu|
20575853|NCT05032612|The University of Texas Health Science Center at Houston|Timothy Kirkpatrick, DDS|713-486-4227|timothy.c.kirkpatrick@uth.tmc.edu|
20575854|NCT00941668|Colgate Palmolive|Willliam DeVizio-DMD|732-878-7901|William_DeVizio@colpal.com|
20575855|NCT01396226|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20575856|NCT04206605|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20575857|NCT01651351|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20575858|NCT02225080|Integra LifeSciences Corporation|Director, Global Clinical Affairs|609-936-5490|andrew.tummon@integralife.com|
20575859|NCT00585611|UW-Madison at time of study|Nancy Sweitzer||nancysweitzer@shc.arizona.edu|
20575860|NCT05879107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20575861|NCT03901079|BSC|Chenchen FAN|+861085216427|chenchen.fan@bsci.com|
20575862|NCT01748942|Oregon Health and Science University|Daniel Clayburgh, MD PhD|503-494-8510|clayburg@ohsu.edu|
20575863|NCT00589420|Abramson Cancer Center|Ravi Amaravadi|2156622222|ravi.amaravadi@pennmedicine.upenn.edu|
20575864|NCT00133991|Johns Hopkins University|Yvette Kasamon, MD||ykasamon@jhmi.edu|
20575865|NCT01953575|Mayo Clinic|David A. Katzka|507-284-4824|Katzka.David@mayo.edu|
20575866|NCT02662036|Washington University School of Medicine|Terence Myckatyn, M.D.|314-996-8800|myckatyn@wustl.edu|
20575867|NCT00942175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20575868|NCT03113656|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20575869|NCT01940471|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20575870|NCT02973087|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20575871|NCT04311216|University of Liverpool|Dr Fraser Philp|01517942000|f.philp@liverpool.ac.uk|
20575872|NCT03710486|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20575873|NCT00445705|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20575874|NCT01279850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575875|NCT01131520|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|
20575876|NCT01147744|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575877|NCT04118270|University of Massachusetts Medical School|Alok Kapoor|917-856-4538|alok.kapoor@umassmed.edu|
20575878|NCT01555567|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
20575879|NCT01439672|University of Virginia|Sue Brown, MD||sab2f@virginia.edu|
20575880|NCT01436084|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
20575881|NCT03497585|Pennine Acute NHS Trust|Dr Deborah Antcliff|0161 7242168|Deborah.Antcliff@pat.nhs.uk|
20575882|NCT01744665|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20575883|NCT03803059|Crown Laboratories, Inc|Thomas Hitchcock, PhD.|8883723982|THitchcock@crownlaboratories.com|
20575884|NCT02904915|The University of Texas Health Science Center at Houston|Pamela D. Berens, MD|713-500-6471|Pamela.D.Berens@uth.tmc.edu|
20575885|NCT03067571|The University of Texas MD Anderson Cancer Center|Gautam Borthakur MD/Professor|713-563-1586|gborthak@mdanderson.org|
20575886|NCT03497806|Finch Therapeutics|Dr. Shrish Budree|(857) 322-4646|sbudree@finchtherapeutics.com|646
20575887|NCT02090413|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20575888|NCT01045798|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575889|NCT05419128|CHESS - University of Wisconsin--Madison|Kasey Thompson|608-590-7821|kfwagner@wisc.edu|
20575890|NCT05248295|MGH IHP|Lauryn Zipse|6176433245|lzipse@mghihp.edu|
20575891|NCT04066491|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20575892|NCT04490018|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20575893|NCT01839396|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
20575894|NCT02321930|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
20575895|NCT01293968|Qazvin University of Medical Sciences|Dr.Katayun Borhanmojabi|09127841440|ka.mojabi@yahoo.com|
20575896|NCT01133379|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20575897|NCT00255970|RTI Biologics|Clinical Projects, Director|386-418-8888|rparkhurst@rtix.com|
20575898|NCT00121108|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20575899|NCT03080883|Mayo Clinic|Dr. Robert McBane|(507)266-3964|mcbane.robert@mayo.edu|
20575900|NCT00388973|AstraZeneca|Medical Science Director, Seroquel||AZTrial_Results_Posting@astrazeneca.com|
20575901|NCT02562924|University of Vermont Medical Center|Dr. Daniel Gerges|8028474535|daniel.gerges@uvmhealth.org|
20575902|NCT01258504|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
20575903|NCT02530528|MicroBioTest|Dr. MH Bashir|7039250100|muhammad.bashir@microbac.com|
20575904|NCT00075400|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20575905|NCT01652885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575906|NCT01183559|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|215 728-3135|Igor.Astsaturov@fccc.edu|
20575907|NCT03723707|NYU Langone Health|Mauricio Arcila-Mesa|646-501-4660|Mauricio.arcila-mesa@nyulangone.org|
20575908|NCT00075023|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
20575909|NCT04342871|UNC Lineberger|Eliza Park|919-966-3494|leeza_park@med.unc.edu|
20575910|NCT03382665|Zimmer Biomet|Fabrizio Lucchini, Clinical Jr.Project Lead|0041798575924|Fabrizio.Lucchini@zimmerbiomet.com|
20575911|NCT00666458|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20575912|NCT02611154|Sports Medicine Research & Testing Laboratory|Dr. Geoffry Miller|801-994-9519|gmiller@smrtl.org|
20575913|NCT04682405|Washington University School of Medicine|Keith Stockerl-Goldstein, M.D.|314-747-7859|ksgoldstein@wustl.edu|
20575914|NCT02982954|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20575915|NCT01429584|University of Utah Department of Anesthesiology|Dr. Elizabeth Thackeray|(801) 581-6393|elizabeth.thackeray@hsc.utah.edu|
20575916|NCT04002037|UMissourri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20575917|NCT00747643|H. Lee Moffitt Cancer Center and Research Institute|Thomas H. Brandon, Ph.D.|813-745-1750|thomas.brandon@moffitt.org|
20575918|NCT00750698|Syndax Pharmaceuticals|Syndax Pharmaceuticals|781-419-1400|clinicaltrials@syndax.com|
20575919|NCT00516048|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20575920|NCT02263079|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20575921|NCT03557281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20575922|NCT00402649|University of Maryland Center for Vaccine Development|Ina Stephens, MD|410-706-1123|istephen@medicine.umaryland.edu|
20575923|NCT01999465|University of Michigan|Dr. Lynda Yang|7349365017|bpclinic@umich.edu|
20575924|NCT05030012|Vapotherm|Katherine Gerich|5854696753|kgerich@vtherm.com|
20575925|NCT02628236|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|8452681943|Anna.Houlihan@sunpharma.com|
20575926|NCT04203745|Candela Medical|Dr. Konika Patel Schallen|508-358-0357|konikap@candelamedical.com|
20575927|NCT01523496|University Hospitals Cleveland Medical Center|Dr Grace McComsey|216-844-2739|Grace.McComsey@UHhospitals.org|
20575928|NCT02605187|Stanford University School of Medicine|Dr. Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
20575929|NCT04329702|Duke University|Christopher Cox|9196817232|christopher.cox@duke.edu|
20575930|NCT00766532|University of Wisconsin|Dr. Karen Hansen|608-263-0517|keh@medicine.wisc.edu|
20575931|NCT01438489|MedImmune, LLC|Gabor Illei, MD, Senior Director|301-398-0000|illeig@Medimmune.com|
20575932|NCT03451786|Carl Zeiss|Michael Bonilla|+1 925-557-4100|michael.bonilla@zeiss.com|
20575933|NCT01761084|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
20575934|NCT00940589|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
20575935|NCT03719690|Kura Oncology, Inc.|Clinical Operations|617-588-3755|KO-TIP-007@kuraoncology.com|
20575936|NCT01471015|University of Utah|Dr. Mariana Baserga|801-581-7052|mariana.baserga@hsc.utah.edu|
20575937|NCT00988143|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20575938|NCT03672370|Zimmer Biomet|Clinical Project Lead, Sandra Rosser|+41 (0)58 854 84 09|sandra.rosser@zimmerbiomet.com|
20575939|NCT00928889|Novartis Pharmaceuticals|Study Director|862 778-8300||
20575940|NCT00632099|New York State Psychiatric Institute|Dr. Suzette Evans|646-774-6136|se18@columbia.edu|
20575941|NCT02006342|The University of Texas Health Science Center at Houston|Dr. Pratik B. Doshi|713-608-6537|Pratik.B.Doshi@uth.tmc.edu|
20575942|NCT01118273|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20575943|NCT02684604|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
20575944|NCT04490863|Masimo Corporation|Vikram Ramakanth|949-297-7000|ClinicalResearchDept@masimo.com|
20575945|NCT01496131|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20575946|NCT00761007|Menarini Group- Clinical Research|Angela Capriati MD PhD, Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
20575947|NCT04707157|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20575948|NCT01409213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20575949|NCT03625687|Massachusetts General Hospital|Raymond Chung, MD|6177247562|Chung.Raymond@mgh.harvard.edu|
20575950|NCT00711425|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
20575951|NCT00843518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20575952|NCT01252745|Acerus Pharmaceuticals Corporation|Vice President|(416) 679-0776|nbryson@aceruspharma.com|
20575953|NCT01342484|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20575954|NCT01840579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20549993|NCT02442869|University of Nevada, Reno|Dr. Jacqueline Pistorello|775-784-4648|pistorel@unr.edu|
20549994|NCT02269241|Exeltis|Dr. Enrico Colli, Chief Scientific Officer|+34917711500|enrico.colli@exeltis.com|
20549995|NCT03020160|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20575955|NCT01058070|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
20575956|NCT03302975|Univeristy of British Columbia|Chris Napier|604-721-1310|chris.napier@ubc.ca|
20549996|NCT01513473|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20575957|NCT04506086|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20575958|NCT05599672|University of Utah|Gerald (Jerry) Cochran, PhD|801-213-0654|jerry.cochran@hsc.utah.edu|
20575959|NCT03996876|University of California, San Francisco|Aoife O'Donovan, Associate Professor of Psychiatry|4152214810|aoife.odonovan@ucsf.edu|x24959
20575960|NCT02971631|University of Cambridge|Mr Geoffrey Roberts|01223767176|geoffroberts@cantab.net|
20575961|NCT04090580|"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Vasco de Quiroga 15, Belisario Domínguez Secc 16, Tlalpan, 14080, CDMX, Mexico. Department of endocrinology and lipid metabolism"|Miguel Ángel Gómez Sámano|+52 1 55 59939816|miguel.gomezs@incmnsz.mx|
20575962|NCT00597753|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20575963|NCT02222207|BAYER|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
20575964|NCT01199042|Bethesda North Hospital|Dr. Shahrokh Javaheri|513-793-7378|shahrokhjavaheri@icloud.com|
20575965|NCT01584479|University of Michigan|William Giannobile, Principal Investigator|734-764-1562|wgiannob@umich.edu|
20575966|NCT01423162|Food and Nutrition Research Institute|Trinidad P. Trinidad|6328372071|trinidadtp@yahoo.com.ph|2281
20575967|NCT01308008|VA GRECC|Neil Alexander MD|734-845-3048|nalexand@umich.edu|
20575968|NCT01239342|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|EJonasch@mdanderson.org|
20575969|NCT02325219|Janssen Pharmaceutical K.K., Japan|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20575970|NCT04036708|Michigan State University|Michael J Boivin|1-517-884-0281|boivin@msu.edu|
20575971|NCT02918864|Rush University Medical Center|Dr. Latha Valluripalli Soorya|(312) 942-6238|latha_soorya@rush.edu|
20575972|NCT03289650|Northwestern University|Lorenzo Gallon|312 695 4457|l-gallon@northwestern.edu|
20575973|NCT01656031|Comprehensive Cancer Center of Wake Forest University|Dr. Bayard Powell|336-716-7970|bpowell@wakehealth.edu|
20549997|NCT04166435|Yale University|Dr. Michael Cecchini|(203) 737-3472|michael.cecchini@yale.edu|
20549998|NCT01218204|GlaxoSmithKline|GSK Response Center|866-435-7343||
20549999|NCT00127660|University of Minnesota|Lisa Harnack, DrPH|612-626-9398|harna001@umn.edu|
20550000|NCT01833520|UT MD Anderson Cancer Center|Vivek Subbiah,Associate Professor, Invest. Cancer Therapeutics|(713) 563-0393|vsubbiah@mdanderson.org|
20550001|NCT00489541|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
20550002|NCT05131646|Clearside Biomedical, Inc.|Susan Coultas, PhD|678.270.3639|susan.coultas@clearsidebio.com|
20550003|NCT04028700|University of North Carollina at Chapel Hill|Matthew S. Karafin MD MS|984-974-1583|matthew.karafin@unchealth.unc.edu|
20550004|NCT03784729|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
20550005|NCT01191801|Sunesis Pharmaceuticals, Inc|Judy Fox, Chief Scientific Officer|(650) 266-3736|jfox@sunesis.com|
20550006|NCT00003479|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20550007|NCT03348956|Dartmouth Hitchcock Medical Center|Victoria Lawson|(603) 650-5104|victoria.h.lawson@hitchcock.org|
20550008|NCT02042183|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-844-2830|clinicaltrials@mnk.com|5
20550009|NCT01192516|Veterans Affairs--Ann Arbor Health Care System|Research Health Science Specialist|734-936-2123|sumurphy@umich.edu|
20550010|NCT02254252|Mashhad University of Medical Sciences|Pouya Nezafati|00989151578421|nezafatip871@mums.ac.ir|
20550011|NCT02321800|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20550012|NCT01051323|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550013|NCT01193868|The University of Texas MD Anderson Cancer Center|George Blumenschein, MD / Professor|713-792-2734|CR_Study_Registration@mdanderson.org|
20550014|NCT03647033|National University Hospital|Dr. David Chen|+6594550281|david_chen@nuhs.edu.sg|
20550015|NCT04605484|AlloVir, Inc.|Richard Riese|617-433-2605|rriese@allovir.com|
20550016|NCT04171531|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
20550017|NCT00265798|University of Chicago|Dr. Hedy L. Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
20550018|NCT01401582|Geman Centr for Neurodegenerative Diseases (DZN)|PD Dr. JR Thyrian|+49383486|rene.thyrian@dzne.de|7592
20550019|NCT04862585|Ohio State University|Mike Berger, PharmD|614-366-0556|michael.berger@osumc.edu|
20550020|NCT04124757|LUMC|Martijn Boon MD PhD|003171522301|m.boon@lumc.nl|
20550021|NCT03366337|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20550022|NCT00880009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550023|NCT01217801|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
20550024|NCT04584645|Evidation Health|Director, Enterprise Research Design|650-389-9550|results@evidation.com|
20550025|NCT01146418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550026|NCT03926169|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20550027|NCT03789474|ALL INDIA INSTITUTE OF MEDICAL SCIENCES,RISHIKESH,UTTARAKHAND,INDIA.|Dr M KESARI|7093005219|kesyellow@yahoo.com|
20550028|NCT03708328|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20550029|NCT04523220|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20550030|NCT00571948|Research Institute of Child Nutrition|Dortmund Intervention Trial for Optimization of Infant Nutrition|0049 231 7922100|kersting@fke-do.de|
20550031|NCT02006719|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20550032|NCT03123913|University of Rochester Medical Center|Chad Heatwole, MD, MS-CI|585-275-7867|dystrophy_registry@urmc.rochester.edu|
20575974|NCT02257372|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550033|NCT02517567|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20550034|NCT02439138|Dana-Farber Cancer Institute|Jorge J. Castillo|617-632-6045|jorgej_castillo@dfci.harvard.edu|
20550035|NCT03727347|Aerin Medical, Inc.|Anais Laborde|(650) 518-9624|alaborde@aerinmedical.com|
20550036|NCT02320669|Seattle Childrens hospital|Michael A Portman|206-987-1014|michael.portman@seattlechildrens.org|
20550037|NCT00006237|SWOG statistical office|SWOG Melanoma Statistician|206-667-4408||
20550038|NCT00585247|University of Ccalifornia, Irvine. Beckman Laser Institute|Dr. Kristen Kelly|949.824.7997|kmkelly@uci.edu|
20550039|NCT01257087|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20550040|NCT01846416|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550041|NCT00558558|UT MD Anderson Cancer Center|Ying Guo, MD - Associate Professor|713-745-2327|jaallo@mdanderson.org|
20550042|NCT00217594|NHLBI, NIH|Chris Hourigan MD|301-451-0257|hourigancs@mail.nih.gov|
20550043|NCT00317356|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20550044|NCT02812160|Spatz FGIA Inc.|Jeffrey Brooks MD|1-516-303-0613|jeff@spatzmedical.net|
20550045|NCT05980182|Virginia Commonwealth University|Dr. Maria Thomson|804-628-2640|mthomson2@vcu.edu|
20550046|NCT04492618|Mayo Clinic|Aaron R. Mangold, M.D.|480-301-4256|Mangold.Aaron@mayo.edu|
20550047|NCT02511184|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550048|NCT02111772|University of Virginia|Dr. Peter W. Heymann|434-242-8209|pwh5a@virginia.edu|
20550049|NCT01824901|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20550050|NCT02950025|Washington University School of Medicine|Michael C. Roach, M.D.|314-747-1786|roachm@wustl.edu|
20550051|NCT00869206|Christiana Care Health System|Andrew L. Himelstein, MD|(302) 366-1200|ahimelstein@cbg.org|
20550052|NCT00085631|Duke University Medical Center|Dr Mark Dewhirst|919 6683726|joan.cahill@dm.duke.edu|
20550053|NCT01349790|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
20550054|NCT03902574|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20550055|NCT03521934|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20550056|NCT00727025|Dartmouth-Hitchcock|Dr. Carolyn Kerrigan|603 650-5148|carolyn.l.kerrigan@hitchcock.org|
20550057|NCT02101060|Salem VA Medical Center|Dr. Krisann Oursler|540-982-2463|krisann.oursler@va.gov|4981
20550058|NCT00038857|MDAnderson Cancer Center|Dr. Richard E. Champlin|713-792-8750|celsaenz@mdanderson.org|
20550059|NCT03729960|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
20550060|NCT00799604|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
20527899|NCT00006110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20550061|NCT01425281|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
20550062|NCT05288062|Mayo Clinic|Wilson I. Gonsalves, MD|507-266-5947|Gonsalves.Wilson@mayo.edu|
20550063|NCT00769392|Lahey Clinic|Gregory Blaha, MD|781-744-2580|christine.gould@lahey.org|
20550064|NCT01667029|Massachusetts General Hospital|Dr. Brian Wainger|617-726-8810|Brian.Wainger@mgh.harvard.edu|
20550065|NCT01025752|VA Connecticut Healthcare System|Dr. Alicia Heapy|203-932-5711|alicia.heapy@va.gov|2299
20550066|NCT01537393|CaseWestern|Dr. Jonathan Lass|2168448368|Jonathan.Lass@UHhospitals.org|
20550067|NCT01697566|M.D. Anderson Cancer Center|Karen H. Lu, MD|713-745-8902|khlu@mdanderson.org|
20550068|NCT00459953|Stanford University|Joel D Killen|(650) 723-5895|jkillen@stanford.edu|
20550069|NCT01447433|Changhai Hospital|Prof. Donglian Cai|86 21 81873168|nutrition1226@126.com|
20550070|NCT00036270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550071|NCT01578187|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
20550072|NCT04518293|George Medicines Pty Limited|Anthony Rogers (Principal Investigator)|+44-7983 578 290|arodgers@georgeinstitute.org|
20550073|NCT02516163|Stryker SP|Holly Solomon|+61 2 9467 1072|Holly.Solomon@stryker.com|
20550074|NCT03170401|University of Washingtion|Dr. Grant E O'Keefe|206-744-8016|gokeefe@uw.edu|
20550075|NCT01709162|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20550076|NCT01874054|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20550077|NCT02010775|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20550078|NCT03936985|University of Utah|Gerald (Jerry) Cochran, PhD|801-213-0654|jerry.cochran@hsc.utah.edu|
20550079|NCT02030041|PGIMER|Anil Bhansali|01722756583|ashuendo@gmail.com|
20550080|NCT00843024|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550081|NCT01032837|Hoffman-LaRoche|Medical Communications|800-821-8590||
20550082|NCT05201703|University of Florida - Jacksonville|Dr. Katherine Zarroli|3025615456|katherine.zarroli@jax.ufl.edu|
20550083|NCT00787852|BrUOG|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
20550084|NCT01737697|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20550085|NCT01372462|Clinical Research Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
20557424|NCT03444376|Clinical Development|• Project Lead|+82-2-6098-2756|yoonjeong.choi@genexine.com|
20557425|NCT04081220|UT HEALTH MAYS CANCER CENTER|Dr Zohra Nooruddin|2013362409|nooruddinz@uthscsa.edu|
20557426|NCT03171480|The Ohio State University|Kara Rood, MD|440-321-0264|kara.rood@osumc.edu|
20557427|NCT01373931|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550086|NCT01866930|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
20550087|NCT00750815|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
20550088|NCT02288897|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|865-769-4011|wachter@pvct.com|23
20575975|NCT04325542|Medical Mission Institute|Dr Christa Kasang||christa.kasang@medmissio.de|
20550089|NCT02521870|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
20550090|NCT02579239|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
20550091|NCT00279305|Type 1 Diabetes TrialNet|Carla Greenbaum, MD||cjgreen@benaroyaresearch.org|
20575976|NCT01849874|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20575977|NCT02104583|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20575978|NCT04640272|Ribomic, Inc.|Dr. Yoshikazu Nakamura|81-3-3440-3303|yoshi@ribomic.com|
20575979|NCT04673292|Johns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University School of Nursing|Jacky Jennings,PhD, MPH; Shruti Mehta, PhD, MPH; Jason Farley, PhD, MPH, ANP-BC, FAAN|410-550-4132|jennings@jhmi.edu; smehta@jhu.edu; jfarley1@jhu.edu|
20575980|NCT00880399|GlaxoSmithKline|GSK Response Center|866-435-7343||
20575981|NCT03045861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20575982|NCT02933034|Stanford University|Phillip C. Yang|(650) 498-8008|phillip@stanford.edu|
20575983|NCT03709654|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
20575984|NCT01902966|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD, Professor, Gynecologic Oncology & Reproductive Medicine|713-745-0307|lramonde@mdanderson.org|
20575985|NCT01549275|Kaohsiung Medical University Hospital|Dr. Zu-Yau LIn|886-7-323-4553|linzuyau@yahoo.com.tw|
20550092|NCT02862171|International Partnership for Microbicides|Dr John Steytler|+27 21 8602300|jsteytler@ipmglobal.org|
20550093|NCT03930797|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
20550094|NCT00662012|Uniformed Services University of Health Sciences (USUHS)|Naomi Aronson, MD|(301) 295-3621|naomi.e.aronson.civ@mail.mil|
20550095|NCT01893632|NYSPI|john mariani, md|646-774-6140|john.mariani@nyspi.columbia.edu|
20550096|NCT02144012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20550097|NCT00753415|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550098|NCT04212650|Steadman Philippon Research Institute|Suzanne Liv Page, JD|970-401-8770|spage@sprivail.org|
20550099|NCT04936256|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
20550100|NCT04656691|UnitedHealth Group/Optum Labs|Tracy Ziolek , Vice President, Human Research Affairs|215-868-3114|tracy_ziolek@uhg.com|
20575986|NCT03448068|Mayo Clinic|Dr. Andrew W. Gorlin|480-342-2446|Gorlin.Andrew@mayo.edu|
20550101|NCT03779724|Aksaray University Training and Research Hospital|The principal investigator|905555289493|mlk.aykut@gmail.com|
20550102|NCT02846779|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
20550103|NCT02959307|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
20550104|NCT01753856|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550105|NCT00887978|United Therapeutics Corporation|Kevin Laliberte, PharmD|919-425-8350|klaliberte@unither.com|
20557428|NCT01995539|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
20557429|NCT01147822|Novartis Pharmaceuticals|Study Director|1-862-778-8300|Novartis.email@Novartis.com|
20557430|NCT01751230|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|leanne.redman@pbrc.edu|
20527900|NCT00621517|East Tennessee State University|Max Bayard MD|802-524-8805|mmbayard3@gmail.com|
20508960|NCT00990249|The University of Texas (UT) MD Anderson Cancer Center|Partow Kebriaei, MD/Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
20508961|NCT01548417|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
20508962|NCT00602771|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
20508963|NCT00732641|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20508964|NCT02873208|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
20508965|NCT00415584|Montefiore Medical Center|Dr. Maria Coco|718-920-4136|mcoco@montefiore.org|
20575987|NCT04773106|Implandata Ophthalmic Products GmbH|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
20557431|NCT00261495|Janssen Pharmaceutica NV|EMEA Medical Affairs Director Analgesia|+49 4107 312356|kpappert@its.jnj.com|
20557432|NCT04207840|Amphastar Pharmaceuticals, Inc.|Amphastar Pharmaceuticals, Inc.|(909) 980-9484|info@amphastar.com|
20557433|NCT03243422|University of North Carolina, Chapel Hill|Lisa Gravens-Mueller, Biostatistician/Supervisor|919 962-3098|lgravens@email.unc.edu|
20557434|NCT02173054|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Papapit Tuchinda|+662-419-4333|papapitt@gmail.com|
20557435|NCT00817999|Creighton University|Tammy Burns, PharmD|402-280-4292|TammyBurns@creighton.edu|
20557436|NCT03430063|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20557437|NCT03124199|Hospital Universitario de la Princesa|Mercedes Ramas|913093911|mercedesramas@gmail.com|
20557438|NCT02798211|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20557439|NCT01782872|Hospital for Special Surgery|Dr. Jacques YaDeau|212774224|yadeauj@hss.edu|
20557440|NCT04219618|The University of Texas Health Science Center at Houston|Igor D. Gregoric, MD|713-486-6714|Igor.D.Gregoric@uth.tmc.edu|
20575988|NCT00291447|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20575989|NCT06243198|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20575990|NCT02819635|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20575991|NCT04172714|Emory University|Nima Kokabi, MD|(404) 778-4747|nima.kokabi@emory.edu|
20575992|NCT03179891|Aquestive Therapeutics|Director of Clinical Operations|908-941-1900|clinicaltrials@aquestive.com|
20557441|NCT00659984|NANT Consortium|NANT Operations Center|323-361-5687|nantops@chla.usc.edu|
20557442|NCT01005303|Belfast Health and Social Care Trust|Dr Nick McKeag|02895048487|nick.mckeag@belfasttrust.hscni.net|
20557443|NCT04026165|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20557444|NCT01059630|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
20557445|NCT03170375|VA Ann Arbor Health System|Scott Hummel|734-845-5283|scott.hummel@va.gov|
20557446|NCT00441701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557447|NCT05028426|Groupe Hospitalier de la Rochelle Ré Aunis|Dr. Vivien Fontaine|+33546455050|recherche.clinique@ght-atlantique17.fr|
20557448|NCT03155932|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20557449|NCT03607825|Minnetronix Neuro|Director of Clinical Trials|651-917-4060|info@cerevention.com|
20557450|NCT01287611|DrLutfi|Dr. Cem Turan|00905323513423|cemturan@gmail.com|
20557451|NCT00763958|University of Alabama at Birmingham|Dr. Karen Cropsey|205-917-3786|kcropsey@uab.edu|205
20557452|NCT04074590|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20557453|NCT00828308|BrUOG|Anthony Mega, MD|4018633000|BrUOG@brown.edu|
20557454|NCT03299686|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20557455|NCT02709005|University of Iowa Hospitals and Clinics|Patricia Winokur, MD|319-384-4590|patricia-winokur@uiowa.edu|
20557456|NCT02348684|Medical College of Wisconsin|Dr. Carmen Bergom|414-805-4365|cbergom@mcw.edu|
20557457|NCT03720938|Abant Izzet Baysal University|Dr. Halil Ibrahim Atasoy|90 532 599 89 53|halilibrahimatasoy@gmail.com|
20557458|NCT03532308|Yale University School of Medicine|Michael S. Leapman, MD|(203) 785-2815|michael.leapman@yale.edu|
20557459|NCT00499863|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
20557460|NCT02535364|Juno Therapeutics|Dr. Nikolaus Trede|206-566-5886|Nick.Trede@junotherapeutics.com|
20557461|NCT00571701|Northwell Health (previously known as NorthShore-LIJ Health System)|Dr. Bettie Steinberg|516-562-1159|bsteinbe@northwell.edu|
20557462|NCT04707196|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20557463|NCT01862796|National Institute of Diabetes Digestive and Kidney Diseases/NIH|Dr. Marci E. Gluck|602-200-5317|gmarci@mail.nih.gov|
20557464|NCT01462162|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20557465|NCT03485911|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20557466|NCT03333928|HighTide Therapeutics|Dr. Adrian Di Bisceglie, CMO|314-791-0593|adibisceglie@hightidetx.com|
20557467|NCT02881008|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
20557468|NCT04037436|University of Waterloo|The MoveStrong program for promoting balance and functional strength training and adequate protein i|519-888-4567|lmgiangr@uwaterloo.ca|46357
20557469|NCT01375205|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-3968|simpsone@ohsu.edu|
20557470|NCT01674621|Radius Health Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
20557471|NCT01148862|Medtronic|Thomas P Troub|818-576-3142|thomas.troub@medtronic.com|
20557472|NCT05031078|Emory University|Dr. Erin Scherer|404-712-6904|erin.margaret.scherer@emory.edu|
20557473|NCT05398796|Vaccine Research Center Clinical Trials Program, NIAID|Lesia K. Dropulic, M.D./Principal Investigator; Laura Novik, R.N., M.A./Study Coordinator|301-451-8717|lesia.dropulic@nih.gov; laura.novik@nih.gov|
20557474|NCT06199934|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557475|NCT04270747|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20575993|NCT02833922|Institute for Reproductive Health|Dr. Victoria Jennings|2026871392|Victoria.Jennings@georgetown.edu|
20575994|NCT00530894|Edwards Lifesciences|Tenley Koepnick|949-250-6504|tenley_koepnick@edwards.com|
20575995|NCT01349465|Janssen Research & Development, LLC|Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
20575996|NCT02969187|Cleveland Clinic|Dr. Philip R. Schauer|216-444-4794|schauep@ccf.org|
20575997|NCT01372384|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20557476|NCT01220869|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20575998|NCT03129321|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
20508966|NCT02640755|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
20508967|NCT00444080|University of Virginia|Peter A. Netland, MD, PhD|434-982-1086|pan9c@virginia.edu|
20508968|NCT03979872|University of Utah|Dr. Yelena Wu|801-213-5653|yelena@utah.edu|
20508969|NCT01192100|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
20508970|NCT02057068|Atlanta Department of Veterans Affairs Medical Center CVNR|Patricia C. Griffiths, PhD|6783615462|pcgriff@emory.edu|
20508971|NCT00865046|VA Pittsburgh Healthcare System|Dr. Debra K. Weiner|412-360-2920|debra.weiner@va.gov|
20508972|NCT02959190|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20508973|NCT01522768|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
20550106|NCT02136810|Yale School of Medicine|Dr. Robert Schonberger, PI|203-785-2802|robert.schonberger@yale.edu|
20508974|NCT01235507|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20508975|NCT01082588|Massachusetts General Hospital|Dr. David Henderson|617-912-7800|dchenderson@partners.org|
20508976|NCT02017704|SKCCC @ Johns Hopkins Medicine|Amol Narang, MD|410-955-7390|anarang2@jhmi.edu|
20508977|NCT01587274|Montefiore Health|Benjamin W. Friedman, MD|7189206626|befriedm@montefiore.org|
20508978|NCT00643097|Duke University Medical Center|Dr. John H. Sampson|919-684-9041|john.sampson@duke.edu|
20508979|NCT01095666|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20508980|NCT00588380|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
20508981|NCT03034057|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508982|NCT02917629|UW Carbone Cancer Center|Dr. Howard Bailey|800-622-8922|clinicaltrials@cancer.wisc.edu|
20508983|NCT00718523|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+331 58 10 08 89|matthieu.rupin@trioncology.org|
20508984|NCT03271307|University of California Los Angeles|Dr. Kathryn Dovel|7143303416|KDovel@mednet.ucla.edu|
20508985|NCT00910728|AstraZeneca|Dr Gregory Curt, MD|+1 301 398 0109|Gregory.Curt@astrazeneca.com|
20508986|NCT05041062|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20508987|NCT04454138|Prism Eye Institute|Ronaldo Santiago|905-456-3937|ronaldo.santiago@prismeye.ca|267
20508988|NCT04821960|Northwestern University|James W. Griffith|3125035345|j-griffith@northwestern.edu|
20508989|NCT03032250|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-1432|cnightin@wakehealth.edu|
20508990|NCT03561246|Brooks Rehabilitation Clinical Research Center|Mark G. Bowden - PI|904-345-6626|mark.bowden@brooksrehab.org|
20508991|NCT03619837|University of Southern California|Norah Terrault|323-442-5100|terrault@usc.edu|
20508992|NCT01696396|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20527901|NCT01863732|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20508993|NCT00983242|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlpharma.com|
20508994|NCT01731990|Novartis Pharmaceuticals|Study Director|862-778-8300||
20550107|NCT05284656|Al-Azhar University|Amira Reda Muhammad|0106 822 0389|amira.reda89@hotmail.com|
20550108|NCT00858130|University of North Carolina at Chapel Hill|Dr. Stephan Moll, Professor of Hemology/Oncology|919-966-3311|stephan_moll@med.unc.edu|
20575999|NCT02576444|Yale School of Medicine: Medical Oncology|Joseph Paul Eder, MD|(203) 737-6980|joseph.eder@yale.edu|
20576000|NCT00842231|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20576001|NCT03503877|University of California, San Francisco|Mitchell Rosen|415-353-7475|Mitchell.Rosen@ucsf.edu|
20576002|NCT03370120|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20576003|NCT04962022|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576004|NCT02888093|University of Iowa Hospitals and Clinics|Dr. Joseph Kowalski|3193561616|joseph-kowalski@uiowa.edu|
20576005|NCT04416555|Cleveland Clinic|Dr. Sabry Ayad|216.476.7052|Saayad@ccf.org|
20576006|NCT03972969|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20576007|NCT00445484|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
20576008|NCT04251910|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
20576009|NCT04607148|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20576010|NCT00804570|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20576011|NCT00290342|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576012|NCT00916149|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
20576013|NCT02997735|Children's Hospital of Philadelphia|Brian Jenssen, MD MSHP|215-554-4390|JenssenB@email.chop.edu|
20576014|NCT00912028|University of Campinas, Brazil|Carlos E Leite Arieta MD, PhD||ra-visus-clnclstds@its.jnj.com|
20576015|NCT00841568|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20576016|NCT03002155|University of Washington (affiliation)|Sara Morgan, PhD|651-229-1719|sjmorgan@uw.edu|
20576017|NCT00978029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20576018|NCT02830776|Formerly - Tulane University Department of Dermatology. Currently - Suzanne Bruce and Associates, PA|Megan Couvillion, MD, FAAD|504-473-2915|megan.couvillion@gmail.com|
20576019|NCT02242578|The University of Texas at Austin|Robert J Buchanan, MD|512-324-7991|robertbuchanan@utexas.edu|
20576020|NCT01820364|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
20576021|NCT01793142|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576022|NCT03451084|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
20576023|NCT01087775|San Francisco VA Medical Center|Dr. Karen Seal|4152214810|Karen.Seal@va.gov|24852
20576024|NCT03418129|Duke University|Eric Elbogen, Ph.D.|919-684-9983|eric.elbogen@duke.edu|
20576025|NCT02087956|University of Rochester|Dr. Ellen Poleshuck|585-275-3138|ellen_poleshuck@urmc.rochester.edu|
20576026|NCT01066585|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
20576027|NCT00884273|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20576028|NCT00258674|Baylor Research Institute|Baylor Research Institute|214-820-9991|Elizabeth.Cothran@baylorhealth.edu|
20576029|NCT03715153|Institut de Recherches Internationales Servier (I.R.I.S.)|Dr. Pierre-François PENELAUD|+ 33 1 55 72 68 58|pierre-francois.penelaud@servier.com|
20576030|NCT00353834|Joslin Diabetes Center|Edward S. Horton, MD|6173091995|edward.horton@joslin.harvard.edu|
20550109|NCT02700815|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20550110|NCT04023526|OncoVerity|Clay Smith, MD Chief Medical Officer|7204981136|csmith@oncoverity.com|
20550111|NCT00040937|SWOG|Robert Z. Orlowski, MD,PhD|(713) 792-2860|rorlowsk@mdanderson.org|
20550112|NCT02470234|Rhodes Pharmaceuticals L.P.|Dr. Akwete Adjei|401-262-9408|akwete.adjei@rhodespharma.com|
20550113|NCT00806390|UMaryland|Stephen Gottlieb|410-328-8788|sgottlie@medicine.umaryland.edu|
20550114|NCT04567225|The Cleveland Clinic Foundation|Dr. Mohammed Al-Jaghbeer|216-476-7983|ALJAGHM@ccf.org|
20550115|NCT00345345|National Heart Lung and Blood Institute|Stefan F Cordes, Principal Investigator, M.D., Ph.D.|+1 240 383 6460|stefan.cordes@nih.gov|
20550116|NCT02324569|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20550117|NCT02016560|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20550118|NCT01943292|Verastem|Lou Vaickus, MD, FACP/Chief Medical Officer|781-292-4200|lvaickus@verastem.com|
20550119|NCT00911820|Dana-Farber Cancer Insitute|Peter Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
20550120|NCT00996216|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550121|NCT05519540|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20550122|NCT02804932|University of Iowa|Dr. Darren Casey|13193841009|darren-casey@uiowa.edu|
20550123|NCT03825315|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20550124|NCT01693653|NYU Langone Medical Center, Center for Musculoskeletal Care|Yusuf Yazici|646-501-7400|yusuf.yazici@nyumc.org|
20550125|NCT00963547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550126|NCT00279591|University of Arkansas for Medical Sciences|Dr. Michael Stroud|501-364-1861|StroudMichaelH@uams.edu|
20550127|NCT02038023|AUERBACH HEMATOLOGY ONCOLOGY ASSOC|Dr Michael AUERBACH|410-780-4050|MAUERBACHMD@ABHEMONC.COM|
20550128|NCT00903695|UOklahoma Health Sciences Center|Marilee Monnot, PhD|405-456-5773|marilee-monnot@ouhsc.edu|5773
20550129|NCT04882540|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20550130|NCT02430311|Astrazeneca|Gershon Locker|+1 773 868 0184|Gershon.Locker@astrazeneca.com|
20550131|NCT02113592|Kaiser Permanente Washington Health Research Institute|Lynn DeBar, PhD, MPH, Principal Investigator|206-287-2900|lynn.debar@kp.org|
20550132|NCT02495168|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20557477|NCT01784068|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20576031|NCT04018794|University of California, San Francisco|Dr. Melissa Dvorsky|4154767167|melissa.dvorsky@ucsf.edu|
20557478|NCT04954586|McMaster University|Dr. Lisa Carlesso|9055259140|carlesl@mcmaster.ca|23811
20557479|NCT00532155|Sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
20557480|NCT02134925|University of Pittsburgh|Robert E. Schoen, M.D., M.P.H|412-864-7078|rschoen@pitt.edu|
20557481|NCT04027348|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
20576032|NCT00432042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20501732|NCT00984204|St. Jude Medical|Nabil Kanaan|949-769-5000|nkanaan@sjm.com|
20501735|NCT02787863|Samara State Medical University, Institute of Sera and Vaccines RAS|Professor Andrei Dmitrievich Protasov, Professor Mikhail Petrovich Kostinov|+79277444126|crosss82@mail.ru|
20501740|NCT00252057|Boston Medical Center|Brian Jack PI|617-414-44675|brian.jack@bmc.org|
20576033|NCT00492752|BAYER|Therapeutic Area Head|<not disclosed>|clinical-trials-contact@bayerhealthcare.com|
20501756|NCT00393874|University of Pittsburgh|Dr. Anne Germain|412-383-2150|GERMAX@upmc.edu|
20501757|NCT00511355|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20501759|NCT01632566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20501763|NCT02158091|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
20527902|NCT03084315|University of Minnesota|Anne Joseph, MD, MPH|612-625-3789|lagre010@umn.edu|
20527903|NCT00395642|BIOTRONIK, Inc.|Katerina de Metz (Director, Clinical Studies)|800-547-0394|katerina.demetz@biotronik.com|
20527904|NCT02993354|Montefiore Medical Center|Dr. Peter Bernstein|718-904-2767|pbernste@montefiore.org|
20576034|NCT01357655|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20576035|NCT05003622|Pierre Fabre Medicament|Jean Claude Vedovato|+33 609828746|jean.claude.vedovato@pierre-fabre.com|
20576036|NCT00390546|University of British Columbia|Dr. Shubhayan Sanatani|604-875-2345|ssanatani@cw.bc.ca|7955
20501764|NCT03977467|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
20576037|NCT03357731|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20576038|NCT01417195|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20576039|NCT01773109|University of Pennsylvania (Abramson Cancer Center)|Dr. Charu Aggarwal|2156624000|charu.aggarwal@pennmedicine.upenn.edu|
20576040|NCT03118232|University of California, Irvine|Dr. Susan Huang|714-456-5047|sshuang@hs.uci.edu|
20576041|NCT04766021|Indiana University|Dr. Blair Johnson|8128558699|bj33@indiana.edu|
20576042|NCT03303950|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
20576043|NCT01733472|Region Skane|Andreas Harsten|46708870567|andreas.harsten@skane.se|
20576044|NCT02535715|University of Texas Health San Antonio|Curtis Triplitt, PharmD|210-358-7228|triplitt@uthscsa.edu|
20576045|NCT04353284|Yale School of Medicine|Geoffrey Chupp, MD Professor of Medicine (Pulmonary); Director, Yale Center for Asthma and Airways D|(203) 785-3627|geoffrey.chupp@yale.edu|
20576046|NCT01040351|Cairo university|Usama M.Fouda, M.D, PhD|+20123595106|umfrfouda@yahoo.com|
20576047|NCT01230307|University of Michigan|Barry Bleske|734-763-3232|bbleske@umich.edu|
20576048|NCT02387359|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
20576049|NCT00122681|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576050|NCT01422356|Melbourne Sexual Health Centre, Alfred Health|Associate Professor Marcus Chen|+61 3 9341 6260|mchen@mshc.org.au|
20576051|NCT02256540|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau|303-724-1914|kerrie.moreau@cuanschutz.edu|
20576052|NCT01230242|MaineHealth|Clinicaltrials.gov Administrator|207.396.8228|llemire@mmc.org|
20576053|NCT05433571|Johnson & Johnson Vision Care (JJVC)|Ross Franklin|1-800-843-2020|RFRANKL1@its.jnj.com|
20576054|NCT03923426|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrialsgov_Inquiries@Pfizer.com|
20576055|NCT01476475|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20576056|NCT00751400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20576057|NCT00676676|Massachusetts General Hospita|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
20576058|NCT00429403|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
20576059|NCT01918007|National and Kapodistrian University of Athens School of Medicine and Aghia Sophia Children's Hospital, Athens, Greece|Dr. Athanasios Kaditis, Head, Division of Pediatric Pulmonology, First Department of Pediatrics|+302132013000|akaditis@med.uoa.gr|
20576060|NCT01261507|Georgetown University Medical Center|Matthew T. Freedman, MD|4105429680|freedmmt@georgetown.edu|
20576061|NCT00441974|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576062|NCT01977599|UCL|Dr Robert Kerrison, Senior Research Fellow|02076798268|Robert.kerrison.13@ucl.ac.uk|
20576063|NCT04206020|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
20576064|NCT02700412|University of Alabama at Birmingham|Dr. Jerzy Szaflarski, MD, PhD|205-934-3866|jszaflarski@uabmc.edu|
20576065|NCT02310776|Northwestern Medicine|Ellen B. Mendelson, MD, FACR, Lee F. Rogers Professor of Medical Education in Radiology, Profess|3124720436|emendels@nm.org|
20576066|NCT00530270|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
20576067|NCT03782402|CUIMC|Diana Martinez|646-774-6160|dm437@cumc.columbia.edu|
20576068|NCT01923285|Abbott|Robyn Capobianco|512-286-4274|robyn.capobianco@abbott.com|
20576069|NCT01517529|University of Cincinnati|Dr. Mohamed Tarek M Shata|(513) 558-6110|mohamed.shata@uc.edu|
20576070|NCT03374189|St. Vincent's Hospital|Dr. Hee Youn Kim|82-31-249-7473|khyoun10589@gmail.com|
20576071|NCT00330382|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
20576072|NCT01356407|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20576073|NCT04512040|VA Palo Alto Health Care System|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
20576074|NCT01309659|Duke University Medical Center|Harvey J Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
20576075|NCT02018822|University of Rochester|Hans Malmstrom|585-275-5087|hans_malmstrom@urmc.rochester.edu|
20576076|NCT02285777|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576077|NCT03201458|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
20576078|NCT01785459|Carolinas Medical Center|Dr. Sean Fox|704-355-3181|Sean.Fox@atriumhealth.org|
20576079|NCT00715026|Zimmer|Director, Clinical Affairs|574-371-8019|erin.osborn@zimmer.com|
20527905|NCT02061683|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20527906|NCT03489941|Bausch & Lomb|Heleen DeCory|(585) 338-8161|heleen.decory@bausch.com|
20576080|NCT00552175|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20576081|NCT00750737|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|CR_Study_Registration@mdanderson.org|
20576082|NCT05112536|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20576083|NCT01389752|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20576084|NCT03259074|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20576085|NCT02184195|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|information.center@astrazeneca.com|
20576086|NCT03341975|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343430|mmiller@cmh.edu|
20576087|NCT01056510|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20527907|NCT01421147|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550133|NCT02376361|Albany Medical College|Loay Salman, MD|518-262-5176|SalmanL@amc.edu|
20550134|NCT00284050|Novartis Pharmaceuticals|Study Director|862 778-8300||
20550135|NCT02573350|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20576088|NCT02285998|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20576089|NCT00545298|Nitric BioTherapeutics Inc|Frank J. McCaney, CEO Sponsor|215-788-6200|fmccaney@nbtherapeutics.com|
20576090|NCT00685880|Mayo Clinic|Dr. Jeffrey S. Brault|507-284-1643|brault.jeffrey@mayo.edu|
20576091|NCT03339206|University of North Carolina at Chapel Hill|Adam O. Goldstein|984-974-0210|adam_goldstein@med.unc.edu|
20576092|NCT03029143|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20576093|NCT02668874|University of Iowa College of Dentistry|Director of Clinical Research|319-467-1398|dentistry-research@uiowa.edu|
20576094|NCT00974675|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
20576095|NCT01394627|Brigham and Women's Hospital|Gail Adler|617-732-5661|gadler@partners.org|
20576096|NCT04744207|Gesynta Pharma AB|Study Director|+46 73 386 4246|ctg@gesynta.se|
20576097|NCT01617070|USC/Keck School of Medicine|Shoji Yano|323-226-3816|syano@usc.edu|
20576098|NCT00974246|Valley Medical Research|Meenakshi Patel, MD|937-208-8298|mpatelmd@ymail.com|
20576099|NCT00573989|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
20576100|NCT04544475|NYU Langone Health|Lila Nachtigall|2122636361|Lila.Nachtigall@nyulangone.org|
20576101|NCT00808236|BeneChill, Inc.|Becky Inderbitzen, Vice President of Clincial Affairs|858-695-8118|binderbitzen@benechill.com|
20576102|NCT00777101|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20576103|NCT00961220|Case Comprehensive Cancer Center|Dr. Kevin Cooper|216-844-3111|kevin.cooper@uhhospitals.org|
20576104|NCT05376215|Phonak Audiology Research Center|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20576105|NCT02031770|University of Colorado Denver|Dr. Jessica Kendrick|3037244837|Jessica.Kendrick@ucdenver.edu|
20576106|NCT00282334|Dept. of Medical Research, Holstebro Hospital|Line Bille Madsen|+45 99125421|linemads@rm.dk|
20576107|NCT01947816|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20576108|NCT00471705|Universidad de Antioquia - Colombia|Iván Darío Vélez Bernal|574 + 219 6501 - 02|idvelez@pecet-colombia.org|
20576109|NCT01301950|DePuy Synthes|Sam Himden, Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
20576110|NCT04041284|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20576111|NCT00825162|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20576112|NCT03455491|PHARMENTERPRISES LLC|CEO Vladimir Nebolsin|+7 (985) 728-75-72|ph@pharmenterprises.ru|
20576113|NCT01784770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576114|NCT01391286|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20576115|NCT01671423|Einstein Medical Center|Scott Goldstein|2154561836|goldstes@einstein.edu|
20576116|NCT04093843|West Virginia University|Amelia Adcock, MD|304-598-6127|akadcock@hsc.wvu.edu|
20576117|NCT02037295|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Jonathan Krakoff, M.D.|(602) 200-5217|jkrakoff@mail.nih.gov|
20576118|NCT01140451|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20576119|NCT02152085|University of Colorado Boulder|Roger Enoka|3034927232|enoka@colorado.edu|
20550136|NCT02708121|Department of Health Education and Behavior, College of Health and Human Performance, University of Florida|Dr. Megan McVay|(352)294-7029|megan.mcvay@ufl.edu|
20550137|NCT01987505|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20550138|NCT03454997|Johns Hopkins University School of Medicine|Gail Daumit MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20550139|NCT01111149|University of Minnesota|Dr. S. Hossein Fatemi|612-626-3633|fatem002@umn.edu|
20550140|NCT02221947|Neurotrope BioScience, Inc|Vice President, Regulatory Affairs|973-826-5109|dcrockford@neurotropebioscience.com|
20550141|NCT04677374|University of North Carolina at Chapel Hill|Mitch Matoga, MD, MS|00265 1 755056|mmatoga@email.unc.edu|
20550142|NCT03857243|UTSW|Timea Hodics, M.D.|(240)-423-2741|Timea.Hodics@UTSouthwestern.edu|
20550143|NCT03765918|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20550144|NCT04202965|Protagonist Therapeutics, Inc|Clinical Study Director|1-888-899-1543|ptgxclintrials@ptgx-inc.com|
20550145|NCT04394286|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20550146|NCT02794883|Northwestern University, Feinberg School of Medicine|Karan Dixit, MD|312-503-4724|karan.dixit@northwestern.edu|
20550147|NCT00187369|Sunnybrook Health Sciences Center|Dr Jon Barrett||jon.barrett@sunnybrook.ca|
20550148|NCT01774604|Penn State Hershey Medical Center/Dartmouth-Hitchcock Medical Center|John M. Levenick|603-667-1332|jlevenick@hmc.psu.edu|
20550149|NCT01484197|Novartis Pharmaceuticals|Study Director|862-778-8300||
20550150|NCT01727297|Medtronic, Inc.|Medtronic Cardiac Rhythm and Heart Failure clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
20550151|NCT00586001|Boston University Charles River Campus|Todd Farchione|(617) 353-9610|tfarchio@bu.edu|
20550152|NCT02348606|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20550153|NCT00814164|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20550154|NCT01980992|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
20550155|NCT00299975|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
20550156|NCT03012165|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20550157|NCT04380116|Yale University|Dr. Frank Buono|2037795799|frank.buono@yale.edu|
20550158|NCT01746745|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550159|NCT01169493|Duke University Medical Center|Brett D. Atwater, MD|9196848111|brett.atwater@duke.edu|
20550160|NCT05228132|Becton Dickinson|Joshua Black, Clinical Project Manager|520-599-6124|joshua.black@bd.com|
20550161|NCT03284398|Fresenius Kabi Deutschland, GmbH|Prof. Dr. med. Martin Westphal|+49 6172 686-7348|martin.westphal@fresenius-kabi.com|
20550162|NCT05883449|Affimed GmbH|Clinical Operations|+49 621 560030|trials@affimed.com|
20550163|NCT01044771|Metropolis Medical|Dr. Fritz Bredeek|415 292 5477|fritz@doctor.com|
20576120|NCT00067028|The University of Texas M. D. Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
20576121|NCT00661531|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
20576122|NCT03134599|CooperVision|Jose Vega, O.D., MSc., FAAO|9252516213761|javega@coopervision.com|
20576123|NCT03070470|U.S. Food and Drug Administration|Jose Vicente, PhD|301-796-8442|Jose.VicenteRuiz@fda.hhs.gov|
20576124|NCT03078075|UT Southwestern Medical Center|Dr. Madhukar Trivedi|214/648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
20576125|NCT03962101|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20576126|NCT02614859|Fox Chase Cancer Center|Dr. Daniel Geynisman|215-728-3889|Daniel.Geynisman@fccc.edu|
20576127|NCT00732303|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20576128|NCT00397813|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
20576129|NCT04784182|Auburn University|Drew Frugé|3348448433|adf0003@auburn.edu|
20576130|NCT01399788|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576131|NCT01441037|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
20576132|NCT02919436|Maine Medical Center|Dr. Anand Rughani|207-885-0011|arughani@mmc.org|
20576133|NCT00283595|Massachusetts General Hospital|Anne Klibanski, MD|617-726-3870|aklibanski@partners.org|
20576134|NCT02459795|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20576135|NCT03699007|Stanford University Medical School|Dr. Laura Simons|(650) 736-0838|lesimons@stanford.edu|
20576136|NCT04718974|Infectious Diseases Institute, College of Health Sciences, Makerere University|Dr. Agnes Bwanika Naggirinya|+256752521570|anaggirinya@idi.co.ug|
20576137|NCT01594515|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576138|NCT00053417|Acorda Therapeutics|Andrew Blight, PhD|914-347-4300|ablight@acorda.com|102
20576139|NCT02409290|MRC CTU at UCL, University College London, London UK|Dr Ruth Goodall|+44 2076704728|r.goodall@ucl.ac.uk|
20576140|NCT01713621|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 03 00|moehrlej@mmv.org|
20576141|NCT00705783|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
20557482|NCT02158884|Major Extremity Trauma and Rehabilitation Consortium|Susan Collins (Study Manager)|410 502 8966|scolli21@jhu.edu|
20576142|NCT02327052|Hospital São Rafael|Dr. Milena Botelho Pereira Soares|+557132816455|milenabpsoares@gmail.com|
20576143|NCT01722604|Bausch & Lomb|Daniel Donatello|(585) 338-5306|Daniel.Donatello@bausch.com|
20576144|NCT02121262|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20576145|NCT03300674|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
20576146|NCT01553188|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
20576147|NCT02445625|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
20576148|NCT02829138|University of Guelph|Dr. David M Mutch|+1-519-824-4120|dmutch@uoguelph.ca|53322
20576149|NCT02588976|Triemli City Hospital|Director Clinical Trial|+41 44 416 25 52|christoph.hofer@triemli.stzh.ch|
20576150|NCT03096730|Tianjin Medical University General Hospita|Dr. Guolin Wang|13002211205|1464322162@qq.com|
20576151|NCT05289570|Duke University|Ian Welsby, MD|919-681-6752|ian.welsby@duke.edu|
20576152|NCT03223428|TerSera Therapeutics LLC|Noran Osman, PharmD, MHS, Associate Director, External Research and Medical|+1-224-754-4605|nosman@tersera.com|
20576153|NCT02777268|Simbec Research Limited|Dr Girish Sharma|+44 1443 690977||
20576154|NCT02230384|University of Pittsburgh|K.N. Roy Chengappa, MD / Principal Investigator|412-246-5006|chengappakn@upmc.edu|412
20576155|NCT02651584|Braeburn Pharmaceuticals|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
20576156|NCT01024010|Mayo Clinic|Tait D. Shanafelt, M.D.||shanafelt.tait@mayo.edu|
20576157|NCT01071538|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
20576158|NCT00841789|Seattle Childrens hospital|Michael A Portman|2069871014|michael.portman@seattlechildrens.org|
20576159|NCT00964743|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
20576160|NCT03317795|Mayo Clinic|Dr. Shannon K. Laughlin-Tommaso|507-538-5783|LaughlinTommaso.Shannon@mayo.edu|
20576161|NCT00939783|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576162|NCT00455689|Brigham & Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
20576163|NCT01664559|BWH|Dr. Lynn Ngo, Lead Study Coordinator/investigator|(617)732-8798|llngo@partners.org|
20576164|NCT06290206|University of Utah|Kaila Christini, MsPH, MS|801-587-4565|Kaila.Christini@hci.utah.edu|
20508995|NCT04374149|Prisma Health|Dr. Julie Martin, Director of Cancer Research|(864) 455-3667|julie.martin@prismahealth.org|
20576165|NCT03631732|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20501793|NCT05593016|Duke University School of Medicine|Caroline Dorfman, PhD|919-416-3473|caroline.dorfman@duke.edu|
20501794|NCT06523491|RCBIOFORM|Julia Melentyeva Commercial Director|84952237095|md@bioform.ru|
20501795|NCT00598975|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
20501796|NCT05159557|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
20501797|NCT01790503|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20501798|NCT00748579|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
20501799|NCT02322710|Mylan Medical SAS|Rafik NAMANE MD.|0033146258607|rafik.namane@mylan.com|
20501800|NCT02848079|Yale University|Dr. Jeremy Kortmansky|1 (203) 407-8002|jeremy.kortmansky@yale.edu|
20501801|NCT00122135|Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), MEDVAMC, Houston, TX|Dr. Ursula Braun|832 687 1645|ubraun@bcm.edu; ursula.braun@va.gov|
20501802|NCT01707472|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20501803|NCT02770326|Memorial Sloan Kettering Cancer Center|Dr. Robin Mendelsohn, MD|212-639-8286|mendelsr@mskcc.org|
20501804|NCT03790683|Sidney Kimmel Medical College, Thomas Jefferson University and Hospitals|Marc C. Torjman, Ph.D.|(215) 955-5275|Marc.Torjman@Jefferson.edu|
20501805|NCT01629797|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
20501806|NCT01411345|University of Miami|Matthew Abramowitz MD|305-243-4200|mabramowitz@med.miami.edu|
20501807|NCT02479802|Grifols Bioscience Industrial Group|Miquel Barcelo, PhD|+34 935.712.368|Miquel.Barcelo@Grifols.com|
20501808|NCT03124784|Masimo Corporation|Tala Harake|949-297-7000|studies@masimo.com|
20501809|NCT05702515|Duke University|Deborah Hutch Allen|919-681-4719|hutch.allen@duke.edu|
20501810|NCT02162732|Penn State Health Children's Hospital|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
20501811|NCT03757988|University of North Carolina at Chapel Hill|Tonya Elliott|919-966-3915|tonya_elliott@med.unc.edu|
20501812|NCT01202656|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
20501813|NCT02507011|University of Minnesota|Thenappan Thenappan, MD|612-625-2191|cvheart@umn.edu|
20501814|NCT01121393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20501815|NCT04372927|University of Washington School of Medicine|Dr. Jing Zeng|206-598-4115|jzeng13@uw.edu|
20501816|NCT00577993|UT MD Anderson Cancer Center|Nathan Fowler,MD, Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
20501817|NCT00883246|Medtronic|Clinical Program Manager|763-398-7000|michael.p.swierzewski@medtronic.com|
20501818|NCT01077973|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20501819|NCT02679469|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20501820|NCT00119158|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
20501821|NCT00608985|Actelion Pharmaceuticals Ltd|Ouali Berkani/Clinical Trial Leader|+41 61 565 5342||
20501822|NCT03033745|CSL Behring|Trial Registration Coordinator|610 878-4000|clinicaltrials@cslbehring.com|
20501823|NCT02706730|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
20501824|NCT02499029|MUSC|Sudie Back, PhD|843-792-9383|backs@musc.edu|
20501825|NCT01999582|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20501826|NCT01014741|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20501827|NCT01081795|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
20501828|NCT02462473|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
20501829|NCT00661271|Johns Hopkins School of Medicine|Erica Sibinga|410-550-4134|esibinga@jhmi.edu|
20501830|NCT01243320|University of Utah|Mark A. Munger, Pharm.D.|8015816165|mmunger@hsc.utah.edu|
20501831|NCT00953758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20501832|NCT01707693|University of Arkansas for Medical Sciences|Leanne L. Lefler, PhD, APN, RN Principal Investigator|5012961939|LeflerLeanne@uams.edu|
20501833|NCT04336995|VUMC|Ken Monahan|6153222318|ken.monahan@vanderbilt.edu|
20501834|NCT03115151|UT Southwestern Medical Center|Dr. Enas Kandil|214/648-9374|Enas.Kandil@UTSouthwestern.edu|
20501835|NCT03403205|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20501836|NCT00706030|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20501837|NCT05779072|Coopervision|Paul Chamberlain|9257306754|pchamberlain@coopervision.com|
20501838|NCT03713944|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20501839|NCT03847610|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
20501840|NCT03298022|AltruBio|Vice President of Clinical Operations|17142150224|simona.reed@altrubio.com|
20501841|NCT01445769|Incyte Corporation|Study Director|855 463-3463||
20501842|NCT04906980|Janssen Research & Development, LLC|GLOBAL MEDICAL LEADER RESPIRATORY INFEC|+12153252489|ClinicalTrialDisclosure@its.jnj.com|
20501843|NCT01539590|Yale University Medical Center|Dr. Joesph Brennan|(203) 483-8300|Brennan.Joesph@yale.edu|
20501844|NCT00487539|Janssen Research & Development|Senior Director|215-793-7540||
20501845|NCT02695628|Stanford University|Rajesh Shah|650-723-0728|rajshah@stanford.edu|
20501846|NCT02751502|NYU Langone Health|Renat Sukhov, MD|347-377-5138|Renat.Sukhov@nyulangone.org|
20501847|NCT02678390|Research Centre on Aging|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20501848|NCT00852995|Smith & Nephew|Jamie E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20501849|NCT00720109|Children's Oncology Group|Results Reporting Coordinator|626-241-1546|resultsreportingcoordinator@childrensoncologygroup.org|
20501850|NCT03595553|Summit Therapeutics|Katie Tran|408 677 6503|Katie.Tran@Summitplc.com|
20501851|NCT03467958|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20501852|NCT02692209|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20501853|NCT02925156|Loyola University Chicago|Amy Luke, Ph.D.|(464) 220-9243|aluke@luc.edu|
20501854|NCT01141595|Arkansas Children's Hospital Reseach Insitute|Richard Frye|501-364-5465|REFrye@uams.edu|
20557483|NCT00462280|University of California, Irvine|Dr. Kenneth G. Linden|714-456-3719|kglinden@uci.edu|
20501855|NCT00361595|Cleveland Clinic|Chad Deal|216-444-6575|dealc@ccf.org|
20501856|NCT01844895|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20501857|NCT02772432|Mass General Hospital|Elyse Park|6177246836|epark@mgh.harvard.edu|
20501858|NCT03208231|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20501859|NCT03321097|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
20501860|NCT03861143|NImmune Biopharma, Inc.|Clinical Development|(540) 218-2262|info@nimmunebio.com|
20501861|NCT04947800|Dartmouth-Hitchcock|james stahl|6036502000|james.e.stahl@hitchcock.org|
20501862|NCT06485479|UNC|Principal Investigator|(919) 966-3282|ntb@unc.edu|
20501863|NCT06142643|Kylane Laboratoires|Basste Hadjab, Sponsor|0225889611|compliance@kylane.com|
20501864|NCT04982250|Fred Hutchinson Cancer Center|Katrina F Ortblad, ScD, MPH|2066677267|kortblad@fredhutch.org|
20501865|NCT03430921|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20501866|NCT01489527|H. Lee Moffitt Cancer Center and Research Institute|Anna R. Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
20501867|NCT00700271|Novartis Pharmaceuticals|Study Director|862-778-8300||
20501868|NCT01411085|Geisel School of Medicine at Dartmouth|Alan I Green, MD|603-650-7549|alan.i.green@dartmouth.edu|
20501869|NCT03784079|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20501870|NCT04440592|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|Please email|information@mt-pharma-us.com|
20501871|NCT03845582|Alkeus Pharmaceuticals, Inc.|Meena Venugopal|877-255-7476|mvenugopal@alkeus.com|
20501872|NCT02028455|Seattle Children's Therapeutics|Dr. Colleen Annesley|206-987-7122|ICC-PLAT@seattlechildrens.org|
20501873|NCT02396589|Washington University in St. Louis School of Medicine|Dr. Susan Stark|3142734114|sstark@wustl.edu|
20501874|NCT04705051|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20501875|NCT01178138|University of Arkansas for Medical Sciences|W. Brooks Gentry, MD|501 686 6119|gentrywilliamb@uams.edu|
20501876|NCT01241708|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
20501877|NCT02968810|Northwestern University|Dr. Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
20501878|NCT02040298|UCSF|Tracy Tran, BA|415-353-2707|tracy.tran@ucsf.edu|
20501879|NCT04183335|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20501880|NCT00049673|Canadian Cancer Trials Group|Director of Clinical Trials|613-533-6340|jdancey@ctg.queensu.ca|
20501881|NCT01535729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20501882|NCT02787850|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director of Clinical, Regulatory and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20557484|NCT04843930|Weill Cornell Medicine|Lindsay Victoria, PhD|646-962-3973|liv3002@med.cornell.edu|
20557485|NCT00947661|Sun Pharma Advanced Research Company|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
20557486|NCT01489189|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
20557487|NCT00112580|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20557488|NCT02624739|ResMed|Paul Phillips|01 906 8861|paul.phillips@resmed.com|
20557489|NCT05597722|University of Pittsburgh|Dr. Eva Szigethy|412-667-0416|szigethye@upmc.edu|
20557490|NCT00404495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557491|NCT00856167|University of Arizona|Dr. Cheryl Ritenbaugh, Principal Investigator|520-822-6710|ritenbau@email.arizona.edu|
20557492|NCT06027619|Cleveland Clinic, Dermatology and Plastic Surgery Institute, Case Comprehensive Cancer Center|Edward V Maytin|(216) 445-6676|maytine@ccf.org|
20557493|NCT01108458|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
20557494|NCT01486615|B. P. Koirala Institute of Health Sciences|Dr Krishna Pokharel|0977-9841986321|drkrishnapokharel@gmail.com|
20501883|NCT02326805|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
20501884|NCT03733392|Abbott|Emily Jesser, Ph.D.|763-954-1350|emily.jesser@abbott.com|
20501885|NCT02168686|Adverum Biotechnology, Inc.|Chief Development Officer|650-649-1413|sseyedkazemi@adverum.com|
20557495|NCT01686165|University of Arizona Cancer Center|Daniel Persky, M.D.|520-626-8908|dpersky@uacc.arizona.edu|
20501886|NCT02803164|Mayo Clinic|Dr. Mathew Thomas|904-953-2000|thomas.mathew@mayo.edu|
20501887|NCT04415073|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD|+1-781-419-1400|kmadigan@syndax.com|
20557496|NCT03921346|University Hospitals of Geneva|Dr Johan N. Siebert|+41795534072|Johan.Siebert@hcuge.ch|
20501888|NCT00808444|GlaxoSmithKline|GSK Response Center|866-435-7343||
20501889|NCT00618748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20501890|NCT03269344|Henry Ford Cancer Institute|Dr. Andrew Cook|3135568400|acook11@hfhs.org|
20501891|NCT04401267|St. Jude Children's Research Hospital|Seth Karol, MD|(901) 595-1716|seth.karol@stjude.org|
20501892|NCT01846455|RECKITT BENCKISER PHARMACEUTICALS, INC.|Reckitt Benckiser Pharmaceuticals, Inc.|804-379-1090||
20501893|NCT01449708|Coastal Anesthesiology|Patrick Ziemann-Gimmel, MD|904-819-4478|pziemann@yahoo.com|
20501894|NCT02392013|Washington University in St. Louis|Dr. Susy Stark|3142734114|sstark@wustl.edu|
20501895|NCT04294459|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20501896|NCT04033367|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20501897|NCT01191697|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|(877) 442-3342|peter_enzinger@dfci.harvard.edu|
20501898|NCT01882907|Pusan National University Hospital|In Joo Kim|+82-51-240-7224|injkim@pusan.ac.kr|
20501899|NCT01784965|Stanford Universtiy|Gerald Reaven, Professor Emeritus|650-724-3416|greaven@stanford.edu|
20501900|NCT04580290|Xiros Ltd|Tracey Oxley|07810337555|Tracey.Oxley@xiros.co.uk|
20501901|NCT01467492|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20501902|NCT02450487|Bauru School of Dentistry University of Sao Paulo|Dr. Adriana Calvo|+551432358200|birinjela@yahoo.com.br|
20501903|NCT01491178|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20501904|NCT03132636|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20501905|NCT01415752|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20501906|NCT03286842|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20501907|NCT01391507|Janssen Research & Development, LLC|Associate Director Biostatistics||ClinicalTrialDisclosure@its.jnj.com|
20501908|NCT00857727|Mount Sinai St. Luke's|Dr. Jinu Kim|212-523-6121|JiKim@chpnet.org|
20501909|NCT01445028|MidAtlantic Retina|Richard Kaiser, MD|215-928-3092|research@midatlanticretina.com|
20501910|NCT01285908|National Institute of Neurological Disorders & Stroke|Dr. David S. Goldstein||david.goldstein1@nih.gov|
20501911|NCT01562548|GlaxoSmithKline|GSK Response Center|866-435-7343||
20501912|NCT02926209|GI View Ltd.|CEO, Dr. Tal Simchony|+97235753199|tal@giview.com|
20501913|NCT01239160|Tactile Medical|Director of Clinical Research|612-540-5267|astone@tactilemedical.com|
20501914|NCT00825565|Northwestern University|Stephanie Rangel|312-503-5942|stephanie.rangel@northwestern.edu|
20501915|NCT01415427|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|pslasor@bmrn.com|
20501916|NCT04781816|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20501917|NCT01789970|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20501918|NCT02123485|Department of Affective Disorder, Aarhus University Hospital, Denmark|Dr Poul Erik Buchholtz|21474299|Buchholtz.Hansen@ps.rm.dk|
20501919|NCT03423342|University of Washington|Dr. Kevin O'Brien, Study PI|206-529-7802|cardiac@uw.edu|
20501920|NCT01347034|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
20501921|NCT02574637|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20501922|NCT01536860|RSSL|Rungano Munyuki|+44 118 918 4166|rungano.munyuki@rssl.com|
20501923|NCT01164722|AIDS Malignancy Consortium|Group Statistician|1-501-526-6712|jylee@uams.edu|
20501924|NCT03138876|Mayo Clinic|Dr. William O. Tatum|904-953-2498|tatum.william@mayo.edu|
20501925|NCT02682901|Eastern Virginia Medical School|Henri Parson|7574467976|parsonhk@evms.edu|
20501926|NCT03870555|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20501927|NCT04926779|Quality Research and Invention LLC|Zanetta Malanowska-Stega|6462718593|jstega@optonline.net|
20501928|NCT02902120|Institute of Human Virology, University of Maryland School of Medicine|Lydia Tang|410-706-6567|LydiaTang@ihv.umaryland.edu|
20501929|NCT01787916|CHU de Quebec|Weisnagel|4185254444|john.weisnagel@crchul.ulaval.ca|47035
20501930|NCT03694925|Cleveland Clinic Arthroplasty Research Group|Alison Klika|4123017914|klikaa@ccf.org|
20501931|NCT03104725|National Institutes of Health/NINDS|Dr. David Goldstein|301-496-2103|goldsteind@ninds.nih.gov|
20501932|NCT01422239|Yale University School of Medicine|Andrea Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
20501933|NCT01639872|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5054|mary.f.brunette@hitchcock.org|
20501934|NCT02799069|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
20501935|NCT02171611|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20501936|NCT02065154|UAB|Omer Jamy|205-934-9294|omerjamy@uabmc.edu|
20501937|NCT03652662|MUSC|Sarah Miller, PhD, RN|8427921692|millesar@musc.edu|
20501938|NCT03499028|Cleveland Clinic|Anabelle Visperas|216-444-2416|vispera@ccf.org|
20501939|NCT01110200|GlaxoSmithKline|GSK Response Center|866-435-7343||
20501940|NCT01681433|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20501941|NCT00730639|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20501942|NCT00903929|University of Rochester|Jane L. Liesveld|585-275-5823|jane_liesveld@urmc.rochester.edu|
20501943|NCT02665286|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
20501944|NCT06245551|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20501945|NCT01318109|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20501946|NCT02177201|Adnan Menders University, Anesthesiology and Reanimation Department|Dr. Sinan Yılmaz|+905055954374|dr_snnylmz@hotmail.com|
20501947|NCT04338009|University of Pennsylvania|Dr. Jordana Cohen|215-662-4000|jco@pennmedicine.upenn.edu|
20501948|NCT01250379|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20527908|NCT00136214|BIDMC|Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
20576166|NCT00501007|Rutgers, The State University of New Jersey|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
20576167|NCT03917823|University of California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@health.ucsd.edu|
20576168|NCT00135668|Duke University Medical Center|Scott Schulman, MD|919-681-4877|schul003@mc.duke.edu|
20576169|NCT02424253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20576170|NCT03998046|Northwestern University|Ronald Ackermann, MD, MPH|(312)-503-3232|r.ackermann@northwestern.edu|
20576171|NCT02370615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20576172|NCT00075088|University of California, San Francisco|Barbara J Drew, PhD|415-476-4302|barbara.drew@nursing.ucsf.edu|
20576173|NCT00455013|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20576174|NCT01445951|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20576175|NCT03054922|Nationwide Children's Hospital|David P. Martin, MD|614-722-4200|david.martin@nationwidechildrens.org|
20576176|NCT04126083|Mayo Clinic|W. Michael Hooten, M.D.|507-266-9672|Hooten.William@mayo.edu|
20576177|NCT00578136|The Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|267-426-5850|gurnaney@email.chop.edu|
20576178|NCT00754793|University of Washington|Dr. Greg E. Davis, MD MPH|206-543-5230|gedavis@uw.edu|
20576179|NCT01585272|Novartis Pharmaceutical|Study Director|862-778-8300||
20576180|NCT00781911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20576181|NCT00891982|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576182|NCT02012621|University of Colorado-AMC|Dr. Jose Castillo-Mancilla|303-724-4934|jose.castillo-mancilla@cuanschutz.edu|
20576183|NCT00361270|Michael E DeBakey VAMC|Wright Williams, Ph.D., ABPP|713-794-7629|wright.williams@va.gov|
20576184|NCT01031550|UMDNJ|Yuriy Gubenko, MD|973 972-5007|yuriygubenko@yahoo.com|
20576185|NCT00820950|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
20576186|NCT02122198|University of Colorado Denver|Kerry Hildreth, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20576187|NCT02581202|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20576188|NCT04050982|Stanford University|Linda Ottoboni|(650) 498-5914|LOttoboni@stanfordhealthcare.org|
20576189|NCT05264740|McMaster University|Dr. Laura Anderson|N/a|ln.anderson@mcmaster.ca|
20576190|NCT05885737|CSL Behring|Clinical Study Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20576191|NCT00609791|City of Hope|Dr. Mina Sedrak|6263598111|msedrak@coh.org|
20576192|NCT04218201|NYU Langone Health|Rebecca Stone|646-754-5322|Rebecca.Stone@nyulangone.org|
20576193|NCT01265615|Ural Institute of Cardiology, Ural State Medical Academy|Dr. Alexander Kharlamov|+79638547663|drskharlamov@gmail.com|
20576194|NCT02841397|Masimo Corporation|Cristina Johnson|(949) 297-7000|clinicalresearchdept@masimo.com|
20576195|NCT01757678|HeartFlow|VP Clinical, Quality & Regulatory Affairs|650-241-1221|clinicalresearch@heartflow.com|
20576196|NCT03548935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20576197|NCT04677959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20576198|NCT00619255|University of Washington|Doug Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
20576199|NCT02716987|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20576200|NCT02086786|Rovi S.A. Laboratorios Farmacéuticos|Jordi Llaudó Garín ( Clinical Development Manager)|+34913756230|jllaudo@rovi.es|
20576201|NCT02189161|Laser Surgery Care|Dr. Stephen E. Goldstone, MD|212-242-6500|segmd@prodigy.net|
20576202|NCT00713427|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
20576203|NCT01923129|Cedars Sinai Medical Center|Dr. Phillip Fleshner|(310) 289-9224|Phillip.Fleshner@cshs.org|
20576204|NCT01298752|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20576205|NCT01549002|ColumbiaU|Dr. Daniel Fenster|212-305-9825|dbf2114@columbia.edu|
20576206|NCT00886600|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20527909|NCT00171158|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20527910|NCT02757352|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20550164|NCT00642460|Hoffman-LaRoche|Medical Communications|800-821-8590||
20550165|NCT01110434|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
20550166|NCT01191398|University of Texas Southwestern Dallas Medical Center|Craig J. Huang, MD|214-456-6371|craig.huang@utsouthwestern.edu|
20550167|NCT01844518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20550168|NCT02756013|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Peter Rose|+1 216-444-6601|ROSEP@ccf.org|
20550169|NCT01197560|Celgene|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20550170|NCT00211510|Medtronic, Inc|John Shin, PhD, MBA|818 576 4019|john.shin@medtronic.com|
20550171|NCT02216591|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
20550172|NCT00680706|Baystate Medical Center|Howard Smithline|413-794-3433|howard.smithline@baystatehealth.org|
20550173|NCT02854631|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20550174|NCT03844646|Stanford University|Sun H. Kim, MD, MS|650-723-8284|sunhkim@stanford.edu|
20550175|NCT00176228|Uillinois|Dr. Mani Pavuluri|312 4130064|mpavuluri@psych.uic.edu|
20550176|NCT00621153|AstraZeneca|Gerard Lynch|+44 1509 64589|aztrial_results_posting@astrazeneca.com|4589
20508996|NCT05569850|DIBINE, University of Bologna|Prof. Lorenzo Breschi|+393482210664|lorenzo.breschi@unibo.it|
20527911|NCT01268189|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
20576207|NCT01251367|Ipsen|Medical Director, Neurology,||clinical.trials@ipsen.com|
20576208|NCT02255409|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20576209|NCT00047060|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
20501949|NCT04899232|University of Miami|Enrique Ginzburg, MD|305-585-1178|eginzbur@med.miami.edu|
20501950|NCT01314716|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20501951|NCT00898560|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20501952|NCT01327157|Master-Pos graduação em Otorrinolaringologia|Dra Rosana de Queiroz Costa|55___11___98579-8799|rosanaqueiroz@msn.com|
20501953|NCT02926950|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20501954|NCT05036083|M.D. Anderson Cancer Center|Olena Weaver|713-471-3613|ooweaver@mdanderson.org|
20501955|NCT03087955|Drugs for Neglected Diseases|Sandra Rembry, PharmD|+41229077734|srembry@dndi.org|
20501956|NCT02392429|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20501957|NCT00482014|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20501958|NCT03686397|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
20501959|NCT02257580|Hospital for Special Surgery|Colson Zucker, Research Coordinator|6467146029|zuckerc@hss.edu|
20501960|NCT04137887|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20501961|NCT00898222|Brigham and Women's Hospital|Dr. Shamsah Kazani|617-732-8201|skazani@partners.org|
20501962|NCT03591380|University of Wisconsin - Madison|David Foley, MD|608-263-2527|foley@surgery.wisc.edu|
20576210|NCT01732809|Brazilian Center for Studies in Dermatology|Scientific Coordinator|+55 51 30262633|cientifico@cbed.org.br|
20501963|NCT05064059|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20501964|NCT02740478|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
20501965|NCT00741156|The Hospital for Sick Children|Dr. Kyong-Jin Lee|416-813-7326|kyong-jin.lee@sickkids.ca|
20501966|NCT02615990|University of Kentucky|Lisa Fryman|859 323 2060|lisa.fryman@uky.edu|
20501967|NCT04316585|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20501968|NCT03905863|Serena Group Inc|Dr Thomas Serena|671-945-5225|serena@serenagroups.com|
20501969|NCT03195517|University of Perugia - Italy|Dr. Rita Lombardini|+39 075 578 4027|rita.lombardini@unipg.it|
20501970|NCT01072344|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao|646-888-0866|maoj@mskcc.org|
20501971|NCT03312517|Henry Ford Sleep Research Center|Christopher Drake, PhD|248-344-6672|cdrake1@hfhs.org|
20501972|NCT01934140|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20501973|NCT01294384|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20576211|NCT02290873|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
20576212|NCT01378104|the Catholic University of Korea|Dr. Kwon|+82322805886|doctorkwon@catholic.ac.kr|
20576213|NCT00506883|AR Scientific, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20576214|NCT02870309|Grifols Therapeutics LLC|Susan Sorrells|919-316-6582|susan.sorrells@grifols.com|
20576215|NCT04901481|TheraNova, LLC|Director of Clinical|4159268616|clinicalstudy@theranova.com|
20576216|NCT00078325|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20576217|NCT01519765|Stanford University|Dr. Linh Tran|925-642-2241|lltran20@gmail.com|
20576218|NCT01473563|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20576219|NCT02739620|University of Vermont|Michael J. Toth|802-656-7989|michael.toth@med.uvm.edu|
20576220|NCT02354222|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20576221|NCT00730964|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|Rubin.Sheng@ge.com|
20576222|NCT02218242|University of Kentucky|Angela Mahan|859 257 4488|angela.mahan@uky.edu|
20576223|NCT02941705|Cedar Sinai|Russell Haber|(310) 967-8322|Russell.Haber@CSHS.org|
20576224|NCT03471975|Ajou University School of Medicine|Jihoon Hwang|+821093103304|kironojh@gmail.com|
20576225|NCT04402970|University of Missouri|Dr. Zach Holliday|5738829072|hollidayz@health.missouri.edu|
20576226|NCT03499509|The University of Alabama at Birmingham|Barbara Gower, PhD|205-934-4087|bgower@uab.edu|
20576227|NCT01475175|Medtronic CRDM|AdOpt CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62736
20576228|NCT02437864|University of New Mexico Health Sciences Center (HSC)|Dr. Codruta Soneru|5052722610|csoneru@salud.unm.edu|
20576229|NCT01892163|Moorfields Eye Hospital NHS Foundation Trust|Professor Sobha Sivaprasad|02072533411|sobha.sivaprasad@moorfields.nhs.uk|
20576230|NCT01080248|Washington University School of Medicine|Joel Picus, M.D.|314-362-5740|jpicus@dom.wustl.edu|
20576231|NCT02822885|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
20576232|NCT00645593|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|(734) 647-8903|mahahuss@umich.edu|
20576233|NCT03704142|University of Massachusetts Amherst Dept. of Communication Disorders|Dr. Karen Helfer|413-545-4014|khelfer@comdis.umass.edu|
20576234|NCT00993265|Yale University, Child Study Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
20576235|NCT03924752|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
20576236|NCT00533442|University of Miami|Dr. George W. Burke, III|305-355-5111|gburke@med.miami.edu|
20576237|NCT02258451|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20576238|NCT04048616|Tufts University and Tufts Medical Center|Lisa Ceglia, MD MS|(617) 636-8171|lisa.ceglia@tuftsmedicine.org|
20501974|NCT02944448|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20501975|NCT01461044|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20501976|NCT00716976|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20576239|NCT05815719|Instituto Bernabeu|Juan Carlos Castillo|+34965154000|jcastillo@institutobernabeu.com|
20576240|NCT04473690|KBio Inc|Katrina Whelan|2706893345|katrinaw@KBio.com|
20576241|NCT00517751|Medtronic Spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20501977|NCT00200850|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
20501978|NCT01282073|Kyungpook National University Hospital|Sun-Hee Park|+82532005547|sh-park@knu.ac.kr|
20501979|NCT03881007|Institute of Tropical Medicine Antwerp|Dr. Chris Kenyon|+32(0)32470786|ckenyon@itg.be|
20501980|NCT02889796|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20501981|NCT02421887|NICHD|Esther Eisenberg, NICHD Project Scientist|301-496-6516|esther.eisenberg@nih.gov|
20501982|NCT04269395|Galderma|Clinical Operations|8179615000|Clinical.Studies@galderma.com|1
20501983|NCT01764633|Amgen Inc.|Study Director|866-572-6436||
20501984|NCT02268058|McMaster Children's Hospital|Dr. Tina Petrelli|905-521-2100|petrelli@hhsc.ca|75162
20501985|NCT04142983|GCAM / Biomat USA - Grifols|Center Medical Director|956-729-7677|laredomedical@gcamplasma.com|
20501986|NCT00328770|Liver Transplant Program, University of Alberta Hospitals|Dr. Norman Kneteman|780-407-6168|norm.kneteman@albertahealthservices.ca|
20501987|NCT02062658|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
20501988|NCT00643994|Accuray, Inc.|Director of Clinical Affairs|608-824-3421|sgodbold@accuray.com|
20501989|NCT03382847|NYU LANGONE TRANSPLANT INSTITUTE|Dr. Bonnie Lonze|2122638365|Bonnie.Lonze@nyumc.org|
20501990|NCT03545906|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
20501991|NCT01847885|SPR Therapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
20501992|NCT01895127|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
20501993|NCT01568606|Ahmanson-UCLA Cardiomyopathy Center|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
20501994|NCT04016311|The University of Texas at Austin, School of Nursing|Gayle M. Timmerman PhD, Professor|5124719087|gtimmerman@mail.utexas.edu|
20501995|NCT04311086|Medtronic|Sara Dinkins SPYRAL DYSTAL Global Study Manager|303-840-4034|rs.spyraldystal@medtronic.com|
20501996|NCT04029519|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|, clinicaltrials@prolleniumus.com|
20501997|NCT00355394|CHOP|Dr. Nicholas Abend|215-590-1719|abend@email.chop.edu|
20576242|NCT03021499|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20576243|NCT01210690|UCB|UCB Cares|+1 877 822 9493||
20576244|NCT00495820|Central Arkansas Veterans Healthcare System|Prasad Padala, MD, MS, Associate Director for Clinical Programs, GRECC|5012572537|prasad.padala@va.gov|
20576245|NCT00470054|Wake Forest University|Antonius Miller||aamiller@wfubmc.edu|
20576246|NCT01878526|Khon Kaen University|Dr.Chingching Foocharoen|6643363746|fching@kku.ac.th|
20576247|NCT00528021|Boston Scientific Corporation|Jessie Stockwell|612-618-1136|jessie.stockwell@bsci.com|
20576248|NCT01246583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576249|NCT01423851|NS Pharma, Inc.|Medical Affairs|201-986-3860|trialinfo@nspharma.com|+1
20576250|NCT02901925|Dartmouth-Hitchcock|Dr. David Roberts|603-650-|David.W.Roberts@dartmouth.edu|
20576251|NCT00556452|University of Michigan Cancer Center|Dr. John Magenau|734/936-8785|johnmage@umich.edu|
20576252|NCT03077347|University of CA Davis Health|Tiffany T . Norris|916-703-9193|ttnorris@ucdavis.edu|
20576253|NCT05396742|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20576254|NCT02004262|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
20576255|NCT01146873|Columbia University|Louise Kuhn, PhD|212-305-2398|lk24@cumc.columbia.edu|
20576256|NCT04331795|University of Chicago, Department of Medicine Section of Rheumatology|Dr. Pankti Reid|773-702-6119|pankti.reid@uchospitals.edu|
20576257|NCT03200366|Indiana University|Susan M. Rawl, PhD, RN, FAAHB, FAAN|317-278-2217|srawl@iu.edu|
20576258|NCT00405067|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
20576259|NCT01224626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576260|NCT02055820|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20576261|NCT05074251|UCLA|Dr. Dvora Joseph Davey|310-701-1526|dvoradavey@ucla.edu|
20576262|NCT00930761|Instituto de Puericultura e Pediatria Martagão Gesteira - UFRJ|Dr. Arnaldo Prata Barbosa|+55 21 25904891|arnaldoprata@globo.com|
20576263|NCT00631020|UCLA Center for Health Promotion and Disease Prevention|Dr. Steven Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|225
20576264|NCT01468584|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20576265|NCT03571646|Medtronic|Geraldine Kelly|+353 879840223|geraldine.kelly@medtronic.com|
20501998|NCT00794560|Pharmaceutical Care Research Group, University of Basle, Switzerland|Dr. Seraina Mengiardi|061 267 15 29|seraina.mengiardi@unibas.ch|0041
20501999|NCT00756938|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502000|NCT04823949|The Medical University of South Carolina|Dr. Matthew Finneran|(843) 792-4500|finneram@musc.edu|
20502001|NCT00094055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502002|NCT01175902|Seoul St. Mary's Hospital|Chan Kee Park|82222586208|ckpark@catholic.ac.kr|
20502003|NCT02347176|MedImmune, LLC|Rene van der Merwe|301-398-4095|information.center@astrazeneca.com|
20502004|NCT00411554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20502005|NCT02556255|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
20502006|NCT01543087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502007|NCT04673786|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
20502008|NCT00143455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20502009|NCT01325428|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502010|NCT01298492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20502011|NCT02004873|Medtronic Cardiac Rhythm and Heart Failure|Micra Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
20576266|NCT01074190|Northwerstern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20502012|NCT01353703|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502013|NCT01337076|Mayo Clinic, Rochester|Dr. Colin Driscoll|507 266 1965|driscoll.colin@mayo.edu|
20502014|NCT01687712|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
20502015|NCT00512798|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
20502016|NCT00281879|OHSU Knight Cancer Institute|Dr. Richard Maziarz|503-494-1551|maziarzr@ohsu.edu|
20502017|NCT01984268|Dartmouth-Hitchcock Medical Center|Director, Office of Research Operations|(603) 650-6340|Barbara.A.Moskalenko@hitchcock.org|
20502018|NCT03505021|Orion Corporation|Director, Clinical Operations|358104261|clinicaltrials@orionpharma.com|
20502019|NCT03075085|University of Arkansas for Medical Sciences|Dr. Taren Swindle|870-236-0997|tswindle@uams.edu|
20502020|NCT00403260|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
20502021|NCT01664793|University of Pittsburgh|Richard K. Zimmerman|412-383-2355|zimmer@pitt.edu|
20502022|NCT05036681|The University of Texas MD Anderson Cancer Center|Dr. Siqing Fu|(713) 792-4318|siqingfu@mdanderson.org|
20502023|NCT03718143|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
20502024|NCT00805740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502025|NCT02066792|Institute for Mental Health Research and Department of Psychology, The University of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
20502026|NCT03660878|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20502027|NCT04288570|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20502028|NCT05227690|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20502029|NCT05499559|Arthro Therapeutics/Joint Academy|Study Director|+46708971677|leif@jointacademy.com|
20502030|NCT05022641|University of Michigan|Dr. Paul Gauger|734-936-0231|pgauger@med.umich.edu|
20502031|NCT00223496|UTHSCSA|Dr. Charles Bowden|210-567-5479|Bowdenc@uthscsa.edu|
20502032|NCT00847587|UUtah|Kirtly Parker Jones|801-581-3834|kirtly.jones@hsc.utah.edu|
20502033|NCT02971202|Vanderbilt University Medical Center|Justin M. Gregory MD MSCI|615-875-9669|justin.m.gregory.1@vumc.org|
20502034|NCT02723201|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
20502035|NCT04669678|University of Alabama at Birmingham|Rena C Patel|2059348145|renapatel@uabmc.edu|
20502036|NCT01414257|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502037|NCT01534676|Columbia University Medical Center|Eldad Hod, MD|212-342-5648|eh2217@cumc.columbia.edu|
20502038|NCT02634580|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20502039|NCT00540579|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20502040|NCT02908880|Essential Medical, Inc.|Sam Nardone|6105571009|sam@essmedclosure.com|
20502041|NCT03521505|Chang-Gung Memorial Hospital|Dr Ting-Yu Lin|886 3281200|yuebaoyuebao@gmail.com|8467
20502042|NCT01396005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
20502043|NCT02170662|Duke University Medical Center|Dr. Elise Olsen|919-668-5613|elise.olsen@dm.duke.edu|
20502044|NCT05159596|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
20502045|NCT05689047|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20502046|NCT01604512|Memorial Sloan Kettering Cancer Center|Dr. Robert Young, MD|212-639-8196|youngr@mskcc.org|
20502047|NCT03083886|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
20502048|NCT02261727|The George Institute for Global Health|Prof Christine Jenkins|+61280524300|christine.jenkins@sydney.edu.au|
20502049|NCT03178487|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20502050|NCT01453855|Alcon Research, Ltd.|Theresa A Landry, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20502051|NCT04161495|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20502052|NCT01262846|University of Pennsylvania|Pablo Tebas|215-6626932|pablo.tebas@uphs.upenn.edu|
20502053|NCT03529773|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502054|NCT03066102|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
20502055|NCT01496066|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
20502056|NCT00253630|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
20502057|NCT06219577|Scripps Optometric Group|Dr Jay Mashouf|18585302800|jaymashouf@gmail.com|
20502058|NCT00209339|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
20502059|NCT00429858|University of California, San Francisco|Dr. Andrew Ko, MD|(415) 353-7286|Andrew.Ko@ucsf.edu|
20502060|NCT01587079|Pearl Therapeutics, Inc|Colin Resiner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20502061|NCT03005054|Mallinckrodt|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
20502062|NCT02475655|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20502063|NCT00257010|Janssen-Ortho LLC|Vice President, Medical Affairs||ClinicalTrialDisclosure@its.jnj.com|
20502064|NCT00584480|UCSF|Robert L. Hendren, D.O.|415-476-7198|Robert.Hendren@ucsf.edu|
20502065|NCT02272686|UT MD Anderson Cancer Center|Issa F. Khouri, MD, Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
20502066|NCT01420146|Institut Jules Bordet|Dr Géraldine Gebhart|025413095|geraldine.gebhart@bordet.be|+32
20502067|NCT00441545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20502068|NCT03326141|University of Minnesota|Siobhan McMahon|612-625-3225|skmcmaho@umn.edu|
20576267|NCT00264875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20502069|NCT00236977|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20576268|NCT01500278|Cares|UCB|+1877 822||9493
20557497|NCT00939731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557498|NCT01392300|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20576269|NCT00734799|Durham VAMC|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
20576270|NCT00845728|Novartis Pharmaceuticals|Study Director|862-778-8300||
20576271|NCT01157364|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20576272|NCT01709435|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20576273|NCT01263639|Vanderbilt Medical Center|Dr. Brent J. Morris Orthopaedic Resident|615-835-0699|brent.j.morris@vanderbilt.edu|
20576274|NCT01576549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20576275|NCT02370875|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
20576276|NCT04081363|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20576277|NCT00586495|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20576278|NCT01707043|Wake Forest|Steve Feldman, MD|336-716-3775|sfeldman@wakehalth.edu|
20576279|NCT01765920|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20576280|NCT01081249|University of California, San Diego Medical Center, Department of Psychiatry|Dr. Kai MacDonald|619-203-7393||
20576281|NCT02025907|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20576282|NCT02017327|Laboratoires Thea|Director of medical operation|+473985089|J.auger@laboratoires-thea.fr|
20576283|NCT02153528|Institute of Tropical Medicine Antwerp|Clinical Trials Unit ITM|0032 32470778|jbuyze@itg.be|
20576284|NCT02411539|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20576285|NCT02189213|RFMH|Amir Levine|646 481 2566|amir.levine@nyspi.columbia.edu|
20576286|NCT03775421|Actelion Pharmaceuticals Ltd|Senior Clinical Leader PH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20576287|NCT02016820|Columbia University|Daniel E. Freedberg, MD, MS||def2004@cumc.columbia.edu|
20576288|NCT00473343|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20576289|NCT02008682|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20576290|NCT02431572|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
20576291|NCT02287623|University of Minnesota|Dr. Jacob Hutchins|612-624-9990|hutc0079@umn.edu|
20576292|NCT02700997|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
20576293|NCT02512224|The University of Tokyo Hospital|Dr. Sumito Ogawa|+81-3-5800-8830|suogawa-tky@umin.ac.jp|
20576294|NCT01441570|Brigham and Women's Hospital|Dr. Steven Gabardi|617-732-7658|sgabardi@partners.org|
20576295|NCT03610724|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20576296|NCT00786565|Bausch & Lomb|Jon Hayashida|(585) 338-6370|jon.hayashida@bausch.com|
20576297|NCT01699542|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
20576298|NCT02943564|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20576299|NCT00932360|University of Iowa|Dana Dailey|319-335-7149|dana-dailey@uiowa.edu|
20576300|NCT02536313|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20576301|NCT01924182|Medtronic Neuromodulation|Mary Markert Sr Prin Clinical Research Specialist|763-526-8162|mary.a.markert@medtronic.com|
20576302|NCT04143009|University of North Carolina at Chapel Hill|Brian Wells Pence, PhD|+1 919-966-7446|bpence@unc.edu|
20576303|NCT02577146|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
20576304|NCT00219284|Novartis Pharmaceuticals|Study Director|862-778-8300||
20576305|NCT01445821|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20576306|NCT02351505|The Ohio State University Comprehensive Cancer Center|Erin Bertino, MD|614-293-8054|Erin.Bertino@osumc.edu|
20576307|NCT04013529|Corporal Michael J. Crescenz VA Medical Center|Manik Chhabra|(215) 823-5800|manik.chhabra@va.gov|
20576308|NCT02958007|VA Maryland Healthcare System|Anjana Muralidharan|443-421-6275|anjana.muralidharan2@va.gov|
20576309|NCT02899689|UTMB|Antonio F Saad|4097720982|afsaad@utmb.edu|
20576310|NCT00359138|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20576311|NCT02116777|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20576312|NCT00733954|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20576313|NCT02663453|Thammasat University|Dr.Wilaiporn Techasatid|66890339442|wilaiporn66@gmail.com|
20576314|NCT03416153|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20576315|NCT04138017|University of Virginia|Eric McVey, Clinical Research Coordinator|434.243.5382|eric.mcvey@uvahealth.org|
20576316|NCT01292642|McLean Hospital|Kevin P Hill, MD, MHS|617-855-4501|khill@mclean.harvard.edu|
20502070|NCT00939692|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
20502071|NCT01891331|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
20502072|NCT00699907|University of Arizona|Dr. Setsuko K. Chambers|520-626-0950|schamber@uacc.arizona.edu|
20502073|NCT00430508|Daiichi Sankyo|James McCarthy / Director Regulatory Operations|732-590-3430|jmccarthy@dsus.com|
20502074|NCT01675960|Children's of Minnesota|Scott Schwantes|(612)813-7888|sschwantes@gillettechildrens.com|
20576317|NCT04649255|Sirtex Medical|Janet Bell|+ 888-474-7839|jbell@sirtex.com|
20576318|NCT02484911|First Affiliated Hospital of Harbin Medical University|Dr.Zhang|85555068|daxinmay@126.com|
20502075|NCT03889639|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20502076|NCT01703858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576319|NCT00218491|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
20576320|NCT04129528|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20576321|NCT00605423|Johns Hopkins University|Peter Campochiaro, M.D.||pcampo@jhmi.edu|
20576322|NCT01682135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20576323|NCT00490568|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576324|NCT01395394|Emory University|Kathryn Coakley|404-778-1286|kcoakle@emory.edu|
20576325|NCT01066364|UCSD|Rohit Loomba, MD|858-246-2201|roloomba@ucsd.edu|
20576326|NCT01157078|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20576327|NCT03402607|Duke University Health System|Linda Kaltenbach|919-681-6804|Linda.Kaltenbach@duke.edu|
20576328|NCT00789529|Manhattan Vision Associates / Institute for Vision Research|Dr. George Zikos|2126884277|gzikos@mvaivr.com|
20576329|NCT00129766|MedImmune|M. Pamela Griffin, Sr. Director, Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
20576330|NCT01081912|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
20576331|NCT02770547|Purdue University|Bruno Roseguini, Assistant Professor|(765) 496-2612|brosegui@purdue.edu|
20576332|NCT01324232|Avanir Pharmaceuticals|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
20576333|NCT05440539|Houston Methodist Hospital|Dr. Emily Rutledge|713-441-5800|erut@me.com|
20576334|NCT00393887|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
20576335|NCT01732796|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576336|NCT05626270|Erchonia Corporation|Travis Sammons|864-531-0064|tsammons@erchonia.com|
20576337|NCT00354770|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
20576338|NCT02324920|BIOTRONIK Italiy|Daniele Giacopelli|+39 3491712305|daniele.giacopelli@biotronik.com|
20576339|NCT00876187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576340|NCT01967628|University of Iowa|Dr. Alicia Gerke|319-356-1869|alicia-gerke@uiowa.edu|
20576341|NCT00838331|Emory University|John Roback, MD PhD|404-712-1774|jroback@emory.edu|
20576342|NCT01379274|Rush University Medical Center|Dr. Jamile Shammo|312-CANCER-1|jamile_shammo@rush.edu|
20576343|NCT03287219|Cosmo Technologies Ltd|R&D Manager||rjones@cosmopharma.com|
20576344|NCT01437852|Stratatech Corporation, a Mallinckrodt Company|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
20576345|NCT01628588|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20576346|NCT01970995|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20576347|NCT01780662|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20576348|NCT00595556|UCHC|Albert J. Arias, M.D.|8606794423|alarias@uchc.edu|4423
20576349|NCT02182687|Lahey Hospital & Medical Center|Julia Roache|781-744-3055|julia.roache@lahey.org|
20576350|NCT00794677|Children's Hospital Oakland Research Institute|Ronald M Krauss|510.450.7912|rkrauss@chori.org|
20576351|NCT05284760|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20576352|NCT05513625|AiCuris Anti-infective Cures AG|Information Desk|+4920231763|info@aicuris.com|0
20576353|NCT01073267|University of Texas (UT) MD Anderson Cancer Center|Bouthaina Dabaja, MD/Associate Professor, Radiation Oncology Department||CR_Study_Registration@mdanderson.org|
20576354|NCT04341441|Henry Ford Health System|John McKinnon, MD, MSc|313-916-8828|jmckinn3@hfhs.org|
20576355|NCT02039375|Johns Hopkins University School of Medicine|Victor C. Urrutia, MD|4109552228|vurruti1@jhmi.edu|
20576356|NCT03765138|Columbia University Medical Center/New York State Psychiatric Institute|Dr. Yuval Neria|646-774-8092|Yuval.Neria@nyspi.columbia.edu|
20576357|NCT03817775|• Department of Anaesthesia and Intensive Care, American Hospital of Paris|Dr Gilles BOCCARA|+33 1 46 41 25 25|gilles.boccara@ahparis.org|
20576358|NCT01624662|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
20576359|NCT01027819|Seoul National University Hospital|Dr. Dongwook Kim|821067395311|daljookim@gmail.com|
20576360|NCT01714687|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
20576361|NCT03116698|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759910|srinivassidgiddi@drreddys.com|
20576362|NCT00788372|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
20576363|NCT02572752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576364|NCT03921021|Weill Cornell Medicine|Manish Shah, MD|(646) 962-6200|mas9313@med.cornell.edu|
20576365|NCT03099187|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20576366|NCT01439555|UMass Medical School|Elizabeth DeGrush, DO|508-334-1000|elizabeth.degrush@umassmemorial.org|
20576367|NCT03310450|Universitas Negeri Semarang|Mahalul Azam|+628122853982|mahalul.azam@mail.unnes.ac.id|
20576368|NCT00868348|Aarhus University Hospital|Karen V Andersen|51263173|karenand@rm.dk|0045
20576369|NCT04869345|Cornell University|Dr. Anthony Ong|6072559993|anthony.ong@cornell.edu|
20576370|NCT01500759|ResMed Germany Inc|Medical Affairs CRS|089990100|ClinicalResearch&Strategy@ResMed.com|
20502077|NCT03506295|Vanderbilt University Medical Center|Dr. Fabien Maldonado|615-322-3412|fabien.maldonado@vumc.org|
20502078|NCT04600895|Appili Therapeutics Inc|Prasann Bavaniya, MS-BioTech|902-442-4655|pbavaniya@appilitherapeutics.com|5
20527912|NCT02135016|First Hospital of CMU|Dr. Jun Wang|8602483283100|wjun2000@hotmail.com|
20576371|NCT00616122|University of California, San Francisco|Hope S. Rugo|877-827-3222|clinicaltrials@ucsf.edu|
20576372|NCT04867473|Stanford University|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
20576373|NCT03921424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502079|NCT01665118|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20576374|NCT01143727|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
20576375|NCT05472012|Masimo|Chelsea Frank|949-297-7000|studies@masimo.com|
20576376|NCT05121480|Evelo Biosciences, Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
20576377|NCT02356562|AbbVie|Global Medical Services|800-633-9110||
20576378|NCT00412750|Novartis Pharmaceuticals|Study Director|862-778-8300||
20576379|NCT03787472|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
20576380|NCT00919035|Oncolgy Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
20576381|NCT01977781|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana, MD, MPH|617-573-4331|reza_dana@meei.harvard.edu|
20576382|NCT03955133|Swansea University|Professor Sue Jordan|+44 (0) 1792518541|s.e.jordan@swansea.ac.uk|
20576383|NCT00105443|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20576384|NCT02135692|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20576385|NCT03187769|Alkermes|Global Clinical Services|888-253-8008|clinicaltrials@alkermes.com|
20576386|NCT01623271|Massachusetts General Hospital|Jianren Mao, MD, PhD|617-724-6102|jmao@mgh.harvard.edu|
20576387|NCT01611974|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20576388|NCT01097746|UT MD Anderson Cancer Center|Dr. Anil K. Sood, MD/Professor, Gyn Onc & Reproductive Med|(713) 745-5266|asood@mdanderson.org|
20576389|NCT00522431|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20576390|NCT00772954|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20576391|NCT01093027|Mayo Clinic|Virgilio Evidente MD|480-301-8000|evidente.virgilio@mayo.edu|
20576392|NCT00665457|University of Nebraska Medical Center|Elizabeth Reed, M.D.|402-559-5388|ereed@unmc.edu|
20576393|NCT02495844|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20576394|NCT03927105|Hoosier Cancer Research Network|Adelai Neal|317-921-2053|aneal@hoosiercancer.org|
20576395|NCT01135498|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20576396|NCT02181829|Memorial Sloan Kettering Cancer Center|Suzanne Wolden, MD|212-639-5148|woldens@MSKCC.ORG|
20550177|NCT01179568|Columbia School of Social Work|M. Katherine Shear, MD|212-851-2176|ks2394@columbia.edu|
20576397|NCT02513329|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20576398|NCT00517595|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20576399|NCT00060346|ECOG Statistical Office|Study Statistician|617-632-3012||
20576400|NCT02083380|Medical University of Vienna, Division of Infectious Diseases and Tropical Medicine|Associate Professor Dr Michael Ramharter|+43140400-44400|michael.ramharter@meduniwien.ac.at|
20576401|NCT04091087|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576402|NCT03703102|Kyowa Kirin Co., Ltd.|Research & Development Planning Department, Research & Development Division|+81-3-5205-7200|clinical.info.jp@kyowakirin.com|
20576403|NCT00957008|University of South Carolina|Project director|8037773881|msui@mailbox.sc.edu|
20576404|NCT01118351|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
20576405|NCT02797808|University of Minnesota|Dr. Gail Bernstein|612-625-1632|berns001@umn.edu|
20576406|NCT03345108|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20576407|NCT02192827|Johns Hopkins all childrens hospital|Meghan Martin|9417373107|mmart163@jhmi.edu|
20576408|NCT01717209|Stanford University|Charles Hill|(650) 725-1930|chill1@stanford.edu|
20576409|NCT00708500|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20550178|NCT00598832|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
20576410|NCT03975920|The Restful Jaw Company, LLC|Dr. Eric Schiffman|(651)338-3344|schif001@umn.edu|
20550179|NCT01900704|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20550180|NCT01414010|Beth Israel Deaconess Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
20576411|NCT02788097|Antalya IVF|Kevin Coetzee|090 242 345 4700|kevincoetzee61@yahoo.co.nz|
20576412|NCT02631525|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
20576413|NCT03831971|Clinical Center|Masur, Henry|+1 301 496 9320|hmasur@cc.nih.gov|
20576414|NCT02863809|Massachusetts Eye and Ear|Odeta Dyrmishi & Joseph Ciolino|7742745014|Odeta_Dyrmishi@meei.harvard.edu; Joseph_Ciolino@meei.harvard.edu|
20576415|NCT01439204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20576416|NCT00336973|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20576417|NCT02445807|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
20576418|NCT01227044|Yale School of Medicine|Dr. Lynn Fiellin|203-737-3347|lynn.fiellin@yale.edu|
20576419|NCT04247061|Boston University|Director of Center for Behavioral Science Research|6173583358|belindab@bu.edu|
20576420|NCT00768521|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20576421|NCT01997411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20576422|NCT00205855|Boston Scientific Corporation|Natalie Bloom Lyons|763-228-9040|lyonsn@bsci.com|
20576423|NCT00917150|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20576424|NCT03891264|Massachusetts General Hospital|Dr. Jodi Gilman|617-643-7293|jgilman1@partners.org|
20576425|NCT01505634|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20576426|NCT01916928|Medstar Washington Hospital Center|Cecily A. Clark-Ganheart|202-877-3067|ganheartmd@gmail.com|
20576427|NCT04294719|Centre for Addiction and Mental Health|Courtney Brennan|4165358501|courtney.brennan@camh.ca|
20527913|NCT03488563|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20550181|NCT00357968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20576428|NCT00396201|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20576429|NCT00867321|Mayo Clinic|Steven R. Alberts, MD MPH|507/284-4918|Alberts.steven@mayo.edu|
20550182|NCT02970422|McGill University|Emilie Michalovic, Ph.D. Candidate|514-941-6450|emilie.michalovic@mail.mcgill.ca|
20550183|NCT02142959|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20550184|NCT00679302|Southern Illinois University, School of Medicine|Dr. Myto Duong, Pediatric Emergency Medicine Director|217-545-7409|myto_duong@yahoo.com|
20576430|NCT02330978|University São Paulo|Jayter Silva de Paula, MD, PhD|55 16 3602-2499|jspaula@fmrp.usp.br|
20550185|NCT03547687|Oregon Health Science University|Dr. Julia Durrant|503-494-0353|durrantj@ohsu.edu|
20550186|NCT00793403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550187|NCT02899988|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20576431|NCT00199914|Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand|Manee Rattanachaiyanont|+66-2419-4657|manee.rat@mahidol.ac.th|
20576432|NCT01733628|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20550188|NCT03848650|Columbia University|Manish Parikh, MD|212-326-8532|map2224@cumc.columbia.edu|
20550189|NCT01577329|University of Michigan|Roxane Raffin Chan|7344780170|roxchan@comcast.net|734
20550190|NCT02485301|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550191|NCT02041286|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20550192|NCT02461563|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550193|NCT01750242|Medtronic Neuromodulation|Stephanie Salisbury|763-526-8096|stephanie.salisbury@medtronic.com|
20550194|NCT01238471|Rambam Medical Center|Professor Imad Makhoul|972-4-8542219|makhoul@rambam.health.gov.il|
20576433|NCT02589496|Samsung Medical Center|Jeeyun Lee|82234101779|jyunlee@skku.edu|
20576434|NCT01934556|Palmetto Retina Center, LLC|John F. Payne, MD|(803) 931-0077|jpayne@palmettoretina.com|
20576435|NCT02813551|The University of Texas Health Science Center at Houston|Oscar Andres Viteri Molina, MD|(713) 500-6412|Oscar.A.ViteriMolina@uth.tmc.edu|
20576436|NCT00102960|Perinatal HIV Research Unit, Johannesburg and Children's Infectious Diseases Clinical Research Unit, Cape Town all in South Africa|Dr Avy Violari and Prof Mark Cotton|27 11 989 9702/27 21 938 4219|violari@mweb.co.za|9702/4219
20576437|NCT03471065|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
20550195|NCT03167411|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20576438|NCT05038020|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
20550196|NCT05374434|Lumendo|Mark Bispinghoff|+41 44 589 68 02|mark.bispinghoff@lumendo.ch|
20550197|NCT02627144|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20576439|NCT02909985|University of New Mexico|L. Olivia Hopkins|(505) 925-7769|LHopkins@salud.unm.edu|
20550198|NCT05820685|The University of Texas Health Science Center at Houston|John Harvin, MD, FACS|713-500-7244|John.Harvin@uth.tmc.edu|
20550199|NCT02651922|PASCOE Pharmazeutische Präparate GmbH|Dr. Inga Trompetter and Jennifer Lebert|0049-(0)641-7960-955|Jennifer.lebert@pascoe.de|
20550200|NCT01366209|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550201|NCT01053221|University of Wisconsin-Madison|William Burlingham, PhD|6082630119|burlingham@surgery.wisc.edu|
20550202|NCT02266225|University of Waterloo|Dr. Lora Giangregorio|519-888-4567|lora.giangregorio@uwaterloo.ca|36357
20550203|NCT00420927|Abbott|Global Medical Services|1-800-633-9110||
20550204|NCT03018704|Department of Veteran Affairs|David Oslin|215-823-5894|dave.oslin@va.gov|
20550205|NCT00320411|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576440|NCT03770260|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20550206|NCT04448171|Mayo Clinic|John Occhino, M.D., M.S.|507-538-5883|Occhino.John@mayo.edu|
20550207|NCT02088047|University of Arkansas for Medical Sciences|Betholyn Gentry|(501) 603-1010|bfgenry@uams.edu|
20550208|NCT01115101|University of Rostock|Dr. Max Dieterich|+493814401|max.dieterich@uni-rostock.de|4500
20550209|NCT00660309|Novartis Pharmaceuticals|Study Director|862-778-8300||
20550210|NCT02454296|University of Hawaii|Reni Soon, MD|808-203-6548|rsoon@hawaii.edu|
20550211|NCT00211809|Icahn School of Medicine at Mount Sinai|Dr. Andrea Allen|212-241-3176|andrea.allen@mssm.edu|
20550212|NCT01417234|KCI|VP, Global Clinical Development|12102555595|jane.hart@acelity.com|
20550213|NCT00023764|Memorial Sloan-Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
20576441|NCT02366611|University of Michigan, School of Dentistry|Alexandre DaSilva|7346153807|adasilva@umich.edu|
20550214|NCT01619774|University of Texas (UT) MD Anderson Cancer Center|Michael Davies, Associate Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20550215|NCT00496470|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20550216|NCT00729651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550217|NCT01218243|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@yahoo.com.cn|
20550218|NCT00823095|Loma Linda University Medical Center|Deborah Dodge|(909) 558-4000|ddodge@llu.edu|48500
20550219|NCT01525563|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20550220|NCT00291577|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20550221|NCT03473977|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
20550222|NCT03725098|Biom'up|William Spotnitz, MD, MBA|351-514-5009|w.spotnitz@biomup.com|
20550223|NCT03129100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20502080|NCT04438174|University of Utah|Dr. Giavonni Lewis|801-581-3050|giavonni.lewis@hsc.utah.edu|
20550224|NCT01587001|National Jewish Health|Nabeel Hamzeh|303-270-2613|hamzehn@njhealth.org|
20502081|NCT02340663|University of Michigan|Dr. Geoffrey Gerstner|734-763-7717|geger@umich.edu|
20550225|NCT01487200|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
20550226|NCT00833794|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20502082|NCT01459705|DCoE|Gregory A. Gahm, PhD|253-320-5772|gregory.a.gahm.civ@mail.mil|
20550227|NCT00663169|Novartis Pharmaceuticals|Study Director|862-778-8300||
20576442|NCT01394939|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
20550228|NCT02984709|Vanderbilt University Medical Center|Sarah Jaser|615-343-6775|sarah.jaser@vanderblit.edu|
20576443|NCT02831673|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20550229|NCT00496054|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20576444|NCT00150592|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20550230|NCT01362205|Denver Health Medical Center|Katie Overdier RN|303 602 1479|Katie.Overdier@dhha.org|
20550231|NCT02207244|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20550232|NCT01950741|Pusan National University Hospital|Ji Eun Lee, Assoicated professor|+82-51-240-7957|jlee@pusan.ac.kr|
20550233|NCT00508716|Griffin Hospital|Dr. Dorothea Wild|203 7327327|dwild@griffinhealth.org|
20550234|NCT00471328|Novartis Pharmaceuticals|Study Director|862-778-8300||
20576445|NCT00874120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20576446|NCT00477165|Stanford University|Uri Ladabaum, MD, MS||ladabau@stanford.edu|
20576447|NCT01823679|Stanford University Medical Center|Alexander Dimitrios Colevas, MD|650-724-9707|colevas@stanford.edu|
20550235|NCT00519831|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20550236|NCT04051008|SUNY Buffalo|Stephanie Anzman-Frasca|17168296692|safrasca@buffalo.edu|
20550237|NCT01962896|University of Texas Southwestern Medical Center|Theodore Laetsch, MD|214-648-5475|ted.laetsch@utsouthwestern.edu|
20576448|NCT03615183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20576449|NCT01659320|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
20550238|NCT02837783|Ironwood Pharmaceuticals, Inc.|Lara Lane|(617) 621-7722|llane@ironwoodpharma.com|
20576450|NCT01870401|Becton Dickinson|Lisa Erickson|763-463-2897|Lisa.Erickson@bd.com|
20550239|NCT03200860|University Medical Center Groningen - Department of Cardiology|Prof. dr. A.A. Voors|0031503616161|a.a.voors@umcg.nl|
20550240|NCT00844896|Massachusetts General Hospital|Frederick J. Stoddard Jr., M.D.,|(617) 371-4762|fstoddard@partners.org|
20550241|NCT04774328|Concentric Analgesics|Carrie Khouri, Associate Director of Clinical Operations|1-415-484-7921|ckhouri@concentricanalgesics.com|
20576451|NCT02289222|University of Maryland Greenebaum Comprehensive Cancer Center|Ashraf Badros M.B.Ch.B|410-328-1230|Abadros@umm.edu|
20576452|NCT01667471|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800-821-8590|genentech@druginfo.com|
20576453|NCT05634577|M D Anderson Cancer Center|Mouhammed Habra, MD|713-792-2841|mahabra@mdanderson.org|
20550242|NCT02233647|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
20550243|NCT00458211|Bronx Psychiatric Center|Nigel Bark MD|718 862 5429|Nigel.Bark@omh.ny.gov|
20576454|NCT01192022|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20576455|NCT01351389|Brown University, Center for Alcohol and Addiction Studies|Dr. Peter Monti|(401) 863-6661|peter_monti@brown.edu|
20576456|NCT04839978|Emory University|Kelli Komro, PhD|404-727-8742|kkomro@emory.edu|
20576457|NCT03239574|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20550244|NCT04342897|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20550245|NCT02634320|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
20550246|NCT00687323|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20576458|NCT00623480|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20576459|NCT03551509|Cleveland Clinic|Dr. Gregory Gilot|786 566-9176|gilotg@ccf.org|
20550247|NCT00838578|KYOWA KIRIN PHARMA|Project Leader|6099191100|clinical.info@kyowa-kirin-pharma.com|
20576460|NCT01594853|Kennedy Krieger Institute|Kathleen Zackowski|443-923-2716|zackowski@kennedykrieger.org|
20576461|NCT01515787|Memorial Sloan Kettering Cancer Center|Dr.Deborah Schrag|617-416-5194|schragd@mskcc.org|
20550248|NCT02465216|IDRI|Dr. Corey Casper|2063810883|corey.casper@idri.org|
20550249|NCT03919799|Kadmon (A Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20550250|NCT03898362|VA Pittsburgh Healthcare System|Dr. Brad Dicianno|412-822-3700|brad.dicianno@va.gov|
20550251|NCT05542576|Amydis, Inc.|Matthew Lehman|6463317899|matt.lehman@amydis.com|
20576462|NCT00769002|Hackensack University Medical Center|Dr. David Schwartz|551-996-2000|DSchwartz@hackensackumc.org|
20576463|NCT02868242|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20550252|NCT04600921|Department of Internal Medicine, Division of Cardiology, Medical University of Graz|Dr. Dirk von Lewinski|+4331638580684|dirk.von-lewinski@medunigraz.at|
20550253|NCT03631472|Gala Therapeutics|James Stambaugh SVP of Clinical Affairs|4087186834|jstambaugh@galatherapeutics.com|
20550254|NCT02267811|Biolux Research, Ltd.|Dr. Peter Brawn|6046690674|p.brawn@bioluxresearch.com|
20576464|NCT03776175|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576465|NCT00960661|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20576466|NCT02699892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20576467|NCT01981590|Medtronic Bakken Research Center|Lilian Kornet, Prin.Scientist|+31433566710|lilian.kornet@medtronic.com|
20502083|NCT03850912|Dana-Farber Cancer Institute|Michael Hassett|617-726-5200|michael_hassett@dfci.harvard.edu|
20550255|NCT02239978|Salt Lake City VA|Dr. Daniel Peterson|6028242279|daniel.peterson1@asu.edu|
20550256|NCT00602953|UT Southwestern Medical Center, Dallas, TX|Dr. ILDIKO LINGVAY|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20576468|NCT04677712|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
20576469|NCT00711100|University_of_Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
20576470|NCT00847912|Providence VA mendical Center|Martin Weinstock MD, PhD|401-457-3333|Martin.Weinstock@va.gov; Martin_Weinstock_MD@brown.edu|
20550257|NCT01850550|Penn State Hershey Medical Center|Jennifer Kraschnewski|717-531-8161|jkraschnewski@hmc.psu.edu|
20550258|NCT01852110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550259|NCT00218465|Center for Addiction Medicine|Sara Carlini|617-643-1990|scarlini@partners.org|
20576471|NCT00783094|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550260|NCT00410046|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20576472|NCT03808077|Memorial Sloan Kettering Cancer Center|Dr. Elizabeth Rieth, MD|212-639-5737|riethe@mskcc.org|
20576473|NCT00001379|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
20550261|NCT03909295|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20576474|NCT03405259|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20576475|NCT02311153|Vanderbilt University Medical Center|Justin H. Turner, MD, PhD||justin.h.turner@vanderbilt.edu|
20550262|NCT02066740|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20550263|NCT02141282|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20576476|NCT04086823|Raziel Therapeutics|Racheli Gueta , Director of Clinical trials|97289124670|racheli@raziel-therapy.com|
20550264|NCT02566083|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
20550265|NCT03312933|Brigham and Women's Hospital|Dr. Jeremy T. Smith|(617) 983-7295|jsmith42@bwh.harvard.edu|
20576477|NCT01650636|University of Miami|Dr. Michael Antoni|305-284-5466|mantoni@miami.edu|
20550266|NCT00875212|Federal University of Paraiba|Fabio Correia Sampaio (research leader)|+55 83 3216 7795|fabios@ccs.ufpb.br|
20576478|NCT01560780|VA North Texas Healthcare System|Shuaib Abdullah|214-857-1458|shuaib.abdullah@va.gov|
20576479|NCT01577186|Janssen Research & Development|Medical Director|886 2 23762155||
20576480|NCT00811135|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550267|NCT01752907|Amgen Inc.|Study Director|866-572-6436||
20550268|NCT03098550|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20550269|NCT01204853|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576481|NCT00518154|Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán|Dr. Carlos Aguilar Salinas, Director of Ethics in Human Research Committee|5554870900|carlos.aguilars@incmnsz.mx|4524
20550270|NCT01384760|ChineseUHK|Dr Susanna S Ng|(852) 98075787|drsssng123@yahoo.com.hk|
20576482|NCT01685463|Medical University of south Carolina|Dr. Xingbao Li|8437925729|lixi@musc.edu|
20550271|NCT00630396|Georgia Health Sciences University|David Hess, MD|706-721-1691|dhess@georgiahealth.edu|
20550272|NCT01479517|Rock Dental Clinic|Christina Sletten, DDS|719-599-9700||
20550273|NCT02990910|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|744734170@qq.com|
20576483|NCT00414453|University of Rochester|Robert H Dworkin|275-8214|robert_dworkin@urmc.rochester.edu|
20502084|NCT04116112|University of Cincinnati|Dr. Eva A. Mistry|513-558-1291|mistryea@ucmail.uc.edu|
20502085|NCT04520113|Johns Hopkins Bloomberg School of Public Health|Dr. Colleen Hanrahan|410-502-9289|chanrah1@jhu.edu|
20502086|NCT00516737|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502087|NCT00848354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502088|NCT03790280|University of California, Los Angeles (UCLA)|Angela Martinez, Research Manager|310-206-7630|angelamartinez@mednet.ucla.edu|
20502089|NCT00915343|Shire|Study Physician|1866-842-5335|clinicaltransparency@shire.com|
20502090|NCT00425386|OHSU Knight Cancer Institute|Dr. Christopher Ryan|5034946197|ryanc@ohsu.edu|
20502091|NCT00626093|St. Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
20502092|NCT00911989|Ethicon-Endo Surgery|Director of Clinical Operations|1.513.337.3079|SHelsing@its.jnj.com|
20502093|NCT03434977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20502094|NCT03064841|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502095|NCT04622046|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20502096|NCT04341948|SPR|Clinical Affairs|216-378-9106|support@SPRPainRelief.com|
20502097|NCT02192931|University of Utah|Danielle Boxer|801-587-1549|danielle.boxer@utah.edu|
20502098|NCT03266016|Children's Hospital Los Angeles|Dr. Robinder Khemani, MD. Medical Staff/USC Faculty|3233612376|rkhemani@chla.usc.edu|
20502099|NCT03160560|Center for Dental Research, Loma Linda University|Yiming Li, DDS, MSD, PhD, Professor and Associate Dean for Research|909-558-8069||
20502100|NCT01978093|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502101|NCT03193398|BlackThorn Therapeutics, Inc.|Jane Tiller, MD; Study Director|(415) 548-5313|jane.tiller@blackthornrx.com|
20502102|NCT02653768|Center to Accelerate Discovery and Practice Transformation, Durham VA|Kelli Allen, Associate Director|919-286-0411|kelli.allen@va.gov|177090
20502103|NCT00424827|Universiy of MA Medical School|Bilal Piperdi, MD|508-426-0442|UMMScommunications@umassmed.edu|
20502104|NCT00491179|National Taiwan University Hospital|Chen-Hua Liu|886223123456|jacque_liu@mail2000.com.tw|63572
20502105|NCT02298933|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
20527914|NCT01088711|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550274|NCT01206608|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20502106|NCT02009878|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20576484|NCT00822757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502107|NCT01583894|Boston Scientific Corporation|Nitzan Mekel-Bobrov, Director of Scientific Communications|6619494537|nitzan.mekel-bobrov@bsci.com|
20502108|NCT01790048|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454 2178|manarymj@wustl.edu|
20502109|NCT00584233|University of California Davis|Dr. John Boone|(916) 849-3580|jmboone@ucdavis.edu|
20502110|NCT00159432|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-226-6384|victoria.soto@med.usc.edu|
20502111|NCT01970176|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
20502112|NCT04537208|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20502113|NCT03655756|Morphogenesis, Inc|James Bianco, MD - Chief Executive Officer|8138756600|jbianco@morphogenesis-inc.com|104
20502114|NCT03237065|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
20502115|NCT02263833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502116|NCT00704964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20502117|NCT04317274|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
20502118|NCT03534427|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20502119|NCT02161211|University of Minnesota|Matt Kushner, Ph.D.|612-625-7546|kushn001@umn.edu|
20502120|NCT01307930|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
20502121|NCT04409873|University of California San Francisco|Dr. Stuart A. Gansky and Dr. Sepideh Banava|415-502-8094; 415-630-0094|stuart.gansky@ucsf.edu ; sepideh.banava@ucsf.edu|
20502122|NCT00492973|Lexington Clinic|Cale Jacobs, PhD|859-258-8238|cjaco@lexclin.com|
20502123|NCT03439033|Weill Cornell Medical College|Dr. Kritika Subramanian|212-746-6000|krs9089@nyp.org|
20502124|NCT01158521|Cleveland Clinic|Dr. Brian Rini|(216) 444-9567|rinib2@ccf.org|
20502125|NCT04173429|Qilu Hospital of Shandong University|Professor Gao Yanjing|18560086087|gaoyanjing@sdu.edu.cn|
20502126|NCT00993031|University of California, San Francisco|Diane V Havlir, MD|01-415-476-4082|dhavlir@php.ucsf.edu|400
20502127|NCT00465595|Johns Hopkins University School of Medicine|Roland R. Griffiths, Ph.D., Principal Investigator|4105500034|rgriff@jhmi.edu|
20502128|NCT01834729|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
20502129|NCT00288080|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20502130|NCT03403192|Wake Forest Health Science|Benjamin Morris, MD|336.716.6533|bmorris@wakehealth.edu|
20502131|NCT01269710|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
20502132|NCT02387580|Medicines for Malaria Venture (MMV)|Fiona Macintyre PhD|+41 22 555 0319|Macintyref@mv.org|
20502133|NCT00087646|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20502134|NCT01331304|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-724-0837|anierenberg@mgh.harvard.edu|
20502135|NCT06488157|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
20502136|NCT03033875|Emory University|Dr. Kenneth Hepburn|404-712-9286|khepbur@emory.edu|
20502137|NCT03650192|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20502138|NCT04925752|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20502139|NCT03726164|University College London|Prof Derek Hausenloy|+6584053767|d.hausenloy@ucl.ac.uk|
20502140|NCT02286947|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
20502141|NCT01145066|Wake Forest University Health Sciences|Dr. Michael Seeds|3367169811|mseeds@wakehealth.edu|
20502142|NCT03920670|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
20502143|NCT03436615|Novan|Cathy White, Vice President, Drug Development Operations|9194858080|clinical@novan.com|
20502144|NCT00573794|AbbVie|Global Medical Services|800-633-9110||
20502145|NCT01407094|University of Texas Southwestern Medical Center|Dr. Madhukar H. Trivedi|214-648-0188|madhukar.trivedi@UTSouthwestern.edu|
20502146|NCT05165654|BIDMC|Dr. Paulo Lizano|202-776-6708|lizanopl@gmail.com|
20502147|NCT04202679|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20502148|NCT05902364|Alcon Research, LLC|Clinical Project Lead, Dry Eye|1-888-451-3937|alcon.medinfo@alcon.com|
20502149|NCT02270242|Icahn School of Medicine at Mount Sinai|Dr. Roxana Mehran|212-659-9691|roxana.mehran@mountsinai.org|
20550275|NCT02893514|NYU Langone Health|Jennifer McNeely, MD, MS|(646) 501-3551|Jennifer.McNeely@nyulangone.org|
20550276|NCT00719134|Beth Israel Deacxoness Medical Center|Rami Burstein|617 735 2832|rburstei@bidmc.harvard.edu|
20550277|NCT00760578|Metabolic Solutions Development Company|Jerry Colca, PhD|269-343-6732|jcolca@msdrx.com|
20550278|NCT02989194|Visterra|Chief Medical Officer|617-498-1070|clinicaltrials@visterrainc.com|
20550279|NCT01549860|VP Medical Affairs|Pamela Unger|(952) 224-8755|punger@celleration.com|
20550280|NCT01366521|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550281|NCT00660023|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550282|NCT04180488|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20550283|NCT03506815|The Ottawa Hospital|Dr. Marc Carrier|613-737-8899|mcarrier@toh.ca|73034
20550284|NCT00471068|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20550285|NCT04160091|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
20550286|NCT04113304|Wayne State University|"Dr. Kathleen Lucy McGoron"|313.664.2500|Lucy.K.McGoron@wayne.edu|
20550287|NCT01011634|UCSF|Karen Meckstroth, MD|415 206-8713|meckstrothk@obgyn.ucsf.edu|
20502150|NCT02482129|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
20550288|NCT00616200|UNC Center for Functional GI & Motility Disorders|Stephan R. Weinland, Ph.D.|9198437828|stephan_weinland@med.unc.edu|
20502151|NCT01877083|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20550289|NCT00381095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557499|NCT05056870|Johnson & Johnson Vision Care, Inc.|Benjamin Straker-Principal Research Optometrist|1-800-843-2020|bstraker@its.jnj.com|
20557500|NCT00755222|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20557501|NCT03168295|University of Texas Health San Antonio|Carolina Solis-Herrera|(210) 567-6691|solisherrera@uthscsa.edu|
20557502|NCT01887470|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20557503|NCT01610154|Fuwai Hospital|Dr. Hui Wang|86-010-88396587|wh_endo@163.com|
20576485|NCT01780831|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20576486|NCT00183274|UPENN|Karl Rickels, M.D.|215-746-6417|krickels@mail.med.upenn.edu|
20576487|NCT02041377|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20576488|NCT01242267|Hackensack Meridan Health|Joshua Zenreich|5519964248|Joshua.Zenreich@hmhn.org|
20576489|NCT00371293|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
20576490|NCT02798536|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|hassanr@mail.nih.gov|
20576491|NCT03882970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20576492|NCT00607386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20576493|NCT01991990|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20576494|NCT03292809|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
20576495|NCT03362970|University of Calgary|Stephen Freedman|403-955-7740|stephen.freedman@ahs.ca|
20576496|NCT01265797|University of Toledo|Gretchen Tietjen, MD|419-383-3544|gretchen.tietjen@utoledo.edu|
20576497|NCT01422915|BrighamHospital|Dr. Peter V. Tishler|617-525-2123|repvt@channing.harvard.edu|
20576498|NCT02980224|Brace Consulting Group Inc.|Jeremy Brace, President|7274582823|jbrace@braceconsultinggroup.com|
20576499|NCT00583362|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576500|NCT00063570|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20576501|NCT02461550|Memorial Sloan Kettering Cancer Center|Dr. Stephen Solomon|212-639-5012|solomons@mskcc.org|
20576502|NCT00577642|Massachusetts General Hospital|Dr Noopur Raje|6177260711|nraje@partners.org|
20576503|NCT04770389|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20576504|NCT00794157|Novartis Pharmaceuticals|Study Director|862 778-8300||
20576505|NCT01692275|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|LONG_C@palmer.edu|
20576506|NCT04514523|Yale School of Medicine|Dr. Kasia Lipska|203-737-4853|kasia.lipska@yale.edu|
20576507|NCT00401375|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20576508|NCT02821715|Theranexus|Chief medical officer|+33680026779|werner.rein@theranexus.fr|
20576509|NCT00677014|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
20576510|NCT00640328|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576511|NCT02374099|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20576512|NCT01033825|Sunovion|Respiratory Medical Director|1-866-503-6351||
20576513|NCT03885089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576514|NCT06080451|University of Michigan|Dr. David Flood|734-647-2892|dcflood@umich.edu|
20576515|NCT03349099|Cleveland Clinic|Manoj Monga MD|216-445-8678|mongam@ccf.org|
20576516|NCT00278993|Eisai Call Center|Eisai Inc.|888-422-4743||
20576517|NCT02701387|UCLA School of Dentistry|Perry R. Klokkevold, DDS, MS, FACD|310-825-1927|pklokkevold@dentistry.ucla.edu|
20576518|NCT01290874|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
20576519|NCT03077685|NanOlogy, LLC|Mark Mitchell|8179004074|Mark.Mitchell@dfb.com|
20576520|NCT01979536|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20576521|NCT02408471|Smith+Nephew, Inc.|Belinda Larson, Director, Global Clinical Strategy (Trauma)||belinda.larson@smith-nephew.com|
20576522|NCT04194528|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|adarke@fredhutch.org|
20576523|NCT01076049|Irrimax Corporation|Chevy Brown, Clinical Trials Manager|770-807-3355|chevy.brown@irrisept.com|15
20576524|NCT05054114|SPP Pharmaclon Ltd.|Julia Isakova|81079055353311|isakova@pharmaclon.ru|
20576525|NCT01806779|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
20502152|NCT00762515|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
20550290|NCT04159025|Washington University School of Medicine|Alexander Chen, M.D.|314-454-8764|chenac@wustl.edu|
20550291|NCT02692716|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20550292|NCT03709771|Vanderbilt University Medical Center|Emily Shardelow|615-875-8949|emily.m.shardelow@vumc.org|
20550293|NCT02000973|First Hospital of China Medical University|Jun Wang|8602483283100|wjun2000@hotmail.com|
20550294|NCT00856284|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20550295|NCT01635101|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20550296|NCT01327885|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20550297|NCT03232801|University of Pittsburgh|Holly Thomas|412-586-9836|thomashn@upmc.edu|
20550298|NCT04271605|National Taiwan University BioMedical Park Hospital Chu-Tung Campus|Chirn-Bin Chang|0972654906|G03776@hch.gov.tw|
20550299|NCT03991715|University of North Carolina at Chapel Hill|Kelly Evenson, PhD|(919) 966-1967|kelly_evenson@unc.edu|
20550300|NCT01059825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557504|NCT00742079|Massachusetts General Hospital|Jennifer Gottlieb, PhD|617-912-7800|jgottlieb2@partners.org|
20576526|NCT01779024|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
20576527|NCT02595450|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20576528|NCT04294901|VA Boston Healthcare System|Amy Linsky, MD, MSc|857-364-2760|amy.linsky@va.gov|
20557505|NCT02243202|Janssen Research & Development, LLC|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20557506|NCT02337517|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
20557507|NCT04382924|Algernon Pharmaceuticals|Dr. Christopher Bryan|2045572308|cbryan@algernonpharmaceuticals.com|
20557508|NCT02659787|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20557509|NCT00582946|EarLens Corporation|Sunil Puria|650-366-9000|spuria@earlenscorp.com|
20557510|NCT01083654|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
20557511|NCT01114204|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20557512|NCT05582304|Johnson & Johnson Vision Care, Inc. (JJVC)|John R Buch|1-800-843-2020|jbuch@its.jnj.com|
20557513|NCT00991341|New England Research Institutes|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
20557514|NCT02401464|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20557515|NCT00215540|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
20557516|NCT03010462|Nexstim Plc|Vice President, Medical Affairs|+358927271710|jarmo.laine@nexstim.com|
20557517|NCT03505476|University of Iowa|Dr. Jennifer Hrabe Clinical Associate Professor|319-384-7359|jennifer-hrabe@uiowa.edu|
20576529|NCT00938314|Stem Cell Therapeutics Corp.|Chief Scientific Officer|403.245.5495|adavidoff@stemcellthera.com|226
20576530|NCT01964352|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576531|NCT01908101|Seattle Cancer Care Alliance|Stefanie Parker|206-889-0917|parkers@seattlecca.org|
20576532|NCT03379662|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
20576533|NCT00166205|Worldwide Clinical Operations|Sheryl Helsinger, Director|513-337-3079|shelsing@its.jnj.com|
20576534|NCT02227693|Eisai Inc.|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
20576535|NCT00141765|University of Michigan Cancer Center|Dr. John E. Levine, MD|734-936-8456|jelevine@umich.edu|
20576536|NCT03657368|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
20576537|NCT00631371|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576538|NCT03378076|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
20576539|NCT00590590|KV Pharmaceutical|Jim Joffrion, Sr. Director, Clinical Affairs|314-645-6600|jjoffrion@kvph.com|
20576540|NCT02145741|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576541|NCT03865706|Columbia University|Daniel E. Freedberg, MD, MS|857-998-9370|def2004@cumc.columbia.edu|
20576542|NCT02646982|University of Texas Southwestern|Ihab Hajjar, MD|214-645-9533|ihabhajjar@emory.edu|
20576543|NCT02095535|UBC Department of Anesthesia - BC Women's Hospital|Tashya De Silva|604-875-2158|tashya.desilva@cw.bc.ca|
20576544|NCT00713700|Abbott|Ashish Oza|1-818-493-3648|aoza@sjm.com|
20576545|NCT00781456|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20576546|NCT02631200|Queen's University Belfast|Dr Peter O'Halloran|02890972490|p.ohalloran@qub.ac.uk|
20502153|NCT00429585|Boston Medical Center|Paul Tornetta, MD|617-414-6295|paul.tornetta@bmc.org|
20502154|NCT01582308|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502155|NCT02017574|Baltimore Veterans Affairs|Jeremy Rietschel, PhD|410-605-7000|jeremy.rietschel@va.gov|3233
20502156|NCT03376477|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Syed Abbas Ali, MD- Assistant Professor- Division of Hematologic Malignancies|4432877104|sali35@jhmi.edu|
20502157|NCT01355705|Stanford University|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
20557518|NCT02748694|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20576547|NCT03174132|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
20576548|NCT01877187|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
20576549|NCT02340585|Stryker|Stacy Phung|678 469 2428|stacy.phung@stryker.com|
20576550|NCT03124823|Masimo|Tala Harake||studies@masimo.com|
20576551|NCT03273166|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
20576552|NCT01294670|Memorial Sloan Kettering Cancer Center|Tanya Trippett, MD|1-833-MSK-KIDS|trippet@mskcc.org|
20576553|NCT04152161|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20576554|NCT02412787|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20576555|NCT03246958|Dana Farber Cancer Institute (DFCI)|Dr. Kartik Sehgal|617-632-3090|kartik_sehgal@dfci.harvard.edu|
20576556|NCT05525533|University of California, San Francisco|Jenny Liu|6503800762|jenny.liu2@ucsf.edu|
20576557|NCT01032915|Novartis|Study Director|862-778-8300||
20576558|NCT03363321|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576559|NCT01897285|Arrowe Park Hospital|Mrs Gwenneth Lawrence|0151 678 5111|gwen.lawrence@nhs.net|8362
20576560|NCT03524339|Cleveland Clinic|Graham Chapman|440-312-2229|gchapman5@gmail.com|
20576561|NCT00714792|University of Rochester|Michael K. Flynn, MD|585-273-3232|michael_flynn@urmc.rochester.edu|
20576562|NCT00382993|Glaxo Smith Kline|GSK Response Center|1-866-435-7343||
20576563|NCT03196076|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20576564|NCT02461992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576565|NCT03341962|Immunic AG|Andreas Muehler, MD|004989|Andreas.Muehler@imux.com|20804770
20576566|NCT00524342|University of Pittsburgh|Dr. Margaret Ragni|412-209-7288|ragni@dom.pitt.edu|
20557519|NCT02007434|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20576567|NCT04474795|Washington University In St. Louis School of Medicine|Cynthia Herrick, MD, MPHS|3147470278|herrickc@wustl.edu|
20576568|NCT00814775|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20576569|NCT02941627|Oticon Medical|Clinical Research Director|+33 4 93 95 18 18|mhoe@oticonmedical.com|
20576570|NCT00606320|Otsuka Pharmaceutical Co, Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20576571|NCT00563186|University of Calgary|Dr. John Conly|403-944-8090|John.Conly@albertahealthservices.ca|
20576572|NCT04839380|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20576573|NCT00879645|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20576574|NCT00513500|Boston University|Kojo Yeboah-Antwi|617-414-1275|kyantwi@bu.edu|
20576575|NCT00749996|Medtronic Spinal & Biologics|Irène Ayer, Clinical research specialist|+41 21 803 84 27|irene.ayer@medtronic.com|
20576576|NCT00345176|The EMMES Corporation|Traci Clemons, PhD|301-251-1161|tclemons@emmes.com|212
20576577|NCT04377711|Covis Pharma|Clinical Trial Interest|1-877-374 -4177|CTInterest@covispharma.com|
20576578|NCT01225731|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20576579|NCT02613936|University of New Mexico|Dr. Davin Quinn|505-272-2223|dquinn@salud.unm.edu|
20576580|NCT01556425|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20576581|NCT01783080|NY State Psychiatric Institute|David J Hellerstein MD, Professor of Clinical Psychiatry, Columbia|646-774-8000|hellers@nypsi.columbia.edu|
20576582|NCT02076997|Baylor College of Medicine|Dr. Jennifer Foster|832-824-4646|jhfoster@texaschildrens.org|
20576583|NCT02533063|University of Wisconsin|Diane Krueger|6082656410|dckruege@wisc.edu|
20576584|NCT03873714|Medtronic Neurovascular|Director, Global Clinical Research|949.837.3700|rs.advance@medtronic.com|
20576585|NCT01970501|Arca biopharma Inc.|Dr. Michael Bristow|7209412100|Michael.Bristow@arcabio.com|
20576586|NCT01632995|Bridge HIV, San Francisco Department of Public Health|Dr. Albert Liu, Clinical Research Director|415-437-7408|albert.liu@sfdph.org|
20576587|NCT01811875|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 20 8957 2200|medinfo@bpl.co.uk|
20576588|NCT04486950|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20576589|NCT00950664|Seoul National University Hospital|BS Jeon|+82220722876|brain@snu.ac.kr|
20576590|NCT03115567|Northwestern University|Dermatology CTU|312-503-5944|NUderm-research@northwestern.edu|
20576591|NCT01326546|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
20576592|NCT03152019|Hospices Civils de Lyon|Dr Dupuis Girod|427856522|sophie.dupuis-girod@chu-lyon.fr|+33
20576593|NCT00755274|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20576594|NCT00350142|Stanford Cancer Center|Dr. Albert Koong|650-498-7703|akoong@stanford.edu|
20576595|NCT00081159|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20576596|NCT01548339|University Hospital Lausanne|Prof. N. Demartines||demartines@chuv.ch|
20576597|NCT00923130|National Cancer Institute|Dr. Ravi Madan|301-496-3493|madanr@mail.nih.gov|
20576598|NCT03693625|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20576599|NCT00684255|New York Medical College|Dr. Mitchell S. Cairo|914-594-3650|mitchell_cairo@nymc.edu|
20576600|NCT01464307|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20576601|NCT02911922|Weill Cornell Medicine - New York Presbyterian Hospital|Josephine Kang, M.D. Ph.D.|212-746-3607|jok9106@med.cornell.edu|
20576602|NCT03449095|University of Illinois at Urbana-Champaign|Dr. Catharine Fairbairn|215-300-5850|cfairbai@illinois.edu|
20576603|NCT02457637|Renji Hospital, Shanghai Jiao Tong University School of Medical|Professor Hai Li , Director of Clinical Trials|+86-13818525494|haili＿17@126.cpm|
20576604|NCT00159861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20508997|NCT02748785|Seoul National University Hospital|Eun Bong Lee|+82-2-2072-4399|leb7616@snu.ac.kr|
20550301|NCT00106392|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20550302|NCT00844051|Children's Hospital Los Angeles|Pia Pannaraj, MD, MPH|323-361-2509|ppannaraj@chla.usc.edu|
20550303|NCT03342690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550304|NCT03138889|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20550305|NCT00105482|Yale School of Medicine, Department of Psychiatry|Stephanie Samples O'Malley PhD, Director, Division of Substance Abuse Research|(203) 974-7590|stephanie.omalley@yale.edu|
20550306|NCT00411645|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20550307|NCT04016285|University of Kentucky Department of Orthopaedic Surgery & Sports Medicine|Dr. Stephen Duncan|859-218-3084|stephen.duncan@uky.edu|
20550308|NCT01929460|Kaiser Permanente, Los Angeles Medical Center|Karl Kwok, MD|800-954-8000|regional-research-committee@kp.org|
20550309|NCT01749514|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550310|NCT04648631|University of Miami|Hadar Lev-Tov, MD|305-689-2646|hlevtov@med.miami.edu|
20550311|NCT02368431|VA Connecticut Healthcare System West Haven Campus, West Haven, CT|Dr Albert Arias|804-828-5793|albert.arias@vcuhealth.org|
20550312|NCT00006903|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20550313|NCT01909674|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
20550314|NCT02969369|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltraildisclosure@sunovion.com|
20550315|NCT00589563|City of Hope Medical Center|Dr. Ryotaro Nakamura|626-256-4673|rnakamura@coh.org|65285
20550316|NCT01369758|Hologic, Inc|Christina Mastandrea|508-263-8772|Christina.Mastandrea@Hologic.com|
20550317|NCT01217814|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20550318|NCT04891874|Shanghai Eastern Hepatobiliary Surgery Hospital|Dr. SHI Changying|+86-021-81887735|nona-peach@hotmail.com|
20550319|NCT01637272|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20550320|NCT01496612|NIH/NINDS|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
20550321|NCT00830362|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
20576605|NCT04311502|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20576606|NCT01040052|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20576607|NCT02586675|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
20576608|NCT03186677|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
20576609|NCT03962439|University of Texas at Dallas|Joseph Hennessee|408-813-4488|joseph.hennessee@utdallas.edu|
20576610|NCT01661140|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20576611|NCT00513409|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576612|NCT01049035|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20576613|NCT02239939|WFSM|Dr. Barbara Nicklas|3367138569|bnicklas@wakehealth.edu|
20576614|NCT03678402|The Ohio State University Wexner Medical Center|Dr. Tammy Moore|6142937847|tammy.moore@osumc.edu|
20576615|NCT01526902|Indiana University|Pete Kollbaum, OD, PhD, FAAO, FBCLA, Principal Investigator|812-856-0108|kollbaum@indiana.edu|
20576616|NCT00812214|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|617-744-1310|Spierings@MedVadis.com|
20576617|NCT01514682|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
20576618|NCT00132132|SEMC|Dr. Shirley Gonzalez|617-926-0114|shirley.gonzalez@steward.org|
20576619|NCT03470493|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
20576620|NCT03605680|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20576621|NCT03189446|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
20576622|NCT00647556|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20576623|NCT05594173|University Health Network|Catriona Steele|4165973422|catriona.steele@uhn.ca|7802
20576624|NCT01692964|Rapid Pathogen Screening, Inc.|Robert Sambursky, MD|941-556-1853|rob.sambursky@lumosdiagnostics.com|
20576625|NCT01496885|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20576626|NCT04852848|University of Oregon|Anne Marie Mauricio, Research Associate Professor|602-920-7459|amariem@uoregon.edu|
20576627|NCT02915523|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
20576628|NCT00915681|Meda Pharma GmbH & Co KG (A Viatris company)|Baerbel Fingerhut|+49 6172 888|baerbel.fingerhut@viatris.com|1419
20576629|NCT00919100|MMJ Labs|Dr. Amy Baxter|877-805-2899|abaxter@mmjlabs.com|106
20576630|NCT03221751|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
20576631|NCT00919503|Fred Hutchinson Cancer Research Center|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
20576632|NCT01598779|University of Buenos Aires|Dr. Laura Fleider|541159508000|laurafleider@hotmail.com|8582
20576633|NCT04338815|University of Nebraska-Omaha|Philippe Malcolm|617-487-1148|pmalcolm@unomaha.edu|
20576634|NCT00535132|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
20576635|NCT02590588|Boston Medical Center|Mark Sloan MD|617-638-2367|mark.sloan@bmc.org|
20576636|NCT01751308|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20576637|NCT02918773|Emory University|Andi L Shane MD/MPH/MSc|404-727-9880|ashane@emory.edu|
20576638|NCT02559687|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20576639|NCT03504410|Cornerstone Pharmaceuticals Inc|Sanejev Luther|585-978-1351|sanjeev.luther@cornerstonepharma.com|
20576640|NCT02706873|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20576641|NCT05098041|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20576642|NCT05051904|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576643|NCT03824808|University of Missouri|Dr Boris Mraovic|5738822568|mraovicb@health.missouri.edu|
20576644|NCT00618410|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
20576645|NCT03958552|University of Maryland School of Nursing|Dr. Joan Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
20576646|NCT01297270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576647|NCT03015259|KINDEVA DRUG DELIVERY|Lester Harrison, PhD|6122714814|lester.harrison@kindevadd.com|
20576648|NCT01965262|Coopervision|Paul Chamberlain, BSc Honors, Sr. Manager Clinical Research|(925) 730-6754|pchamberlain@coopervision.com|
20576649|NCT01029366|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
20576650|NCT01479543|Hero Institute for Infant Nutrition|Esther Matencio Hilla|+0034 968 89 89 00|esther.matencio@hero.es|
20576651|NCT00906087|University of Michigan|Sayoko E. Moroi|734-763-3732|smoroi@med.umich.edu|
20576652|NCT00440947|ViiV Healthcare|GSK Response Center|866-435-7343||
20576653|NCT01827670|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576654|NCT01142401|Icahn School of Medicine at Mount Sinai|Joseph Sparano, MD|212-241-3300|joseph.sparano@mssm.edu|
20576655|NCT00689572|University of Virginia|Nassima Ait-Daoud Tiouririne, M.D.|(434)243-0570|nat7b@virginia.edu|
20576656|NCT00283075|The Rogosin Institute|Dr. Barry H. Smith, CEO|212-746-1551|bas2005@nyp.org|
20576657|NCT02813694|Nabriva Therapeutics US, Inc|Jennifer Schranz, M.D., Chief Medical Officer|610 981 2842|jennifer.schranz@nabriva.com|
20576658|NCT01236300|University of Chicago Medical Center|Dr. Vani J.A. Konda|773-702-1460|vkonda@medicine.bsd.uchicago.edu|
20576659|NCT01797575|The University of Texas Health Science Center at Houston|Jair C Soares, MD|713-486-2627|jair.c.soares@uth.tmc.edu|
20576660|NCT02671136|Loma Linda University Health|Ahmed Khocht|909 558 4000|akhocht@llu.edu|
20576661|NCT01152021|Department of Anesthesia, Perioperative and Pain Medicine|Rachel Dabek|857-218-5413|rachel.dabek@childrens.harvard.edu|
20527915|NCT01240902|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20576662|NCT02595723|UT Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
20576663|NCT04288154|Mayo Clinic|Amir Lerman, M.D.|507-255-2398|lerman.amir@mayo.edu|
20576664|NCT02223260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576665|NCT00996944|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576666|NCT01902290|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20576667|NCT00769184|NeoStrata Co., Inc.|Barbara Green, RPH, MS|(609) 520-0715|bgreen@neostrata.com|
20576668|NCT03042715|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
20576669|NCT00385255|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576670|NCT02250274|Marshfield Clinic Research Foundation|Director of the Center for Clinical Epidemiology & Population Health|715-389-3444|belongia.edward@mcrf.mfldclin.edu|
20576671|NCT00446511|Novartis Pharmaceuticals|Study Director|862-778-8300||
20576672|NCT01136655|AstraZeneca|Göran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
20576673|NCT02079987|University of Florida|Donna L. Carden, MD, MPH|352-265-5911|dcarden@ufl.edu|
20576674|NCT02873936|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20576675|NCT01015768|Southern California College of Optometry|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@scco.edu|
20576676|NCT02185404|University of South Florida|Kyle B. Reed|813-974-2385|kylereed@usf.edu|
20576677|NCT00542269|Novartis Pharmaceuticals|Study Director|862 778-8300||
20576678|NCT00708123|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576679|NCT02970292|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261-2897|medicalinformation@acadia-pharm.com|
20576680|NCT00845650|Emergent Product Development Gaithersburg, Inc.|Study Director||clinicalstudies@ebsi.com|
20576681|NCT00814892|Mayo Clinic|Dr. Manish Kohli|507-284-2511|kohli.manish@mayo.edu|
20576682|NCT01187953|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
20576683|NCT01848184|Medtronic|Michelle DiSalvo|774 284 6089|michelle.v.disalvo@medtronic.com|
20576684|NCT01553136|Yale University|Stephanie Samples O'Malley, PhD, Professor of Psychiatry|(203) 974-7590|stephanie.omalley@yale.edu|
20576685|NCT00254462|University of Nebraska Medical Center|Christopher J. Kratochvil|402-552-6005|ckratoch@unmc.ed|
20576686|NCT01014689|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
20576687|NCT02159703|University of Pennsylvania|Alexander Lin, MD|(215) 662-3198|alexander.lin@uphs.upenn.edu|
20576688|NCT05159648|Mayo Clinic|Dr Robert Anderson|507-284-4341|anderson.robert2@mayo.edu|
20576689|NCT03040999|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20576690|NCT03451773|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|rudloffu@mail.nih.gov|
20576691|NCT03468855|Aclaris Therapeutics, Inc.|David Gordon|484-540-6296|Clintrials@aclaristx.com|
20576692|NCT03657043|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20576693|NCT01197326|Philips Healthcare|Duane A Young-Kershaw RN, BSN, Clinical Researcher|508-817-7001|duane.young-kershaw@philips.com|
20576694|NCT02627495|Spaulding Rehabilitation Hospital|Prof. Felipe Fregni|+1 (617) 935-2743|Fregni.Felipe@mgh.harvard.edu|
20576695|NCT01979523|Memorial Sloan Kettering Cancer Center|Dr. Alexander Shoushtari|646-888-4161|shoushta@mskcc.org|
20576696|NCT04762537|New York Psychiatric Institute|Kenzie Potter|2535920386|kenzie.potter@nyspi.columbia.edu|
20576697|NCT02730884|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD/Professor|713-794-5783|jcortes@mdanderson.org|
20576698|NCT01339559|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20576699|NCT00971945|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20576700|NCT03354663|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
20576701|NCT01137773|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
20576702|NCT01500109|Loma Linda University|Chelan Nour, MD|909-558-8493|cnour@llu.edu|
20576703|NCT03548051|Hope Clinic of the Emory Vaccine Center|Nadine Rouphael|404-377-3719|nroupha@emory.edu|10
20576704|NCT03874377|Children's National Medical Center|Dr. Sarah Hornack|202-895-3860|shornack@childrensnational.org|
20576705|NCT03325673|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20576706|NCT03799458|University of New Mexico Health Sciences Center|Dr. Davin Quinn|505-272-2223|dquinn@salud.unm.edu|
20576707|NCT01485627|UNIVERSITY OF ROCHESTER DEPARTMENT OF FAMILY MEDICINE|Ronald Epstein MD|5855069484|ronald_epstein@urmc.rochester.edu|
20576708|NCT01784861|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@wustl.edu|
20576709|NCT00401752|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20576710|NCT02424526|Sacramento State|Katrin Mattern-Baxter, PT, DPT|19162785766|kbaxter@csus.edu|
20576711|NCT01850485|Medical Center Leeuwarden|Matty Koopmans, MSc|0031582866738|matty.koopmans@znb.nl|
20576712|NCT02681172|Piramal Imaging|Dr. Juergen Hirschfeld, Head of GRA & PV|+49 30461124615|Juergen.Hirschfeld@piramal.com|
20576713|NCT01046877|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20502158|NCT03631706|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20502159|NCT01841333|University of Colorado|Dr. Daniel Pollyea|720-848-8084|DANIEL.POLLYEA@cuanschutz.edu|
20502160|NCT00939198|George Washington University|Dr. David Diemert|2029942909|ddiemert@gwu.edu|
20502161|NCT00836355|New York University Langone Medical Center|Saran Jonas|212 263 7591|Saran.Jonas@nyumc.org|
20502162|NCT01636466|Emory University|Dr. Ashtar Chami|404-712-7735|ashtar.chami@emory.edu|
20502163|NCT01966770|Clinical Research Center-UC berkely|Meng C. Lin O.D., PhD, FAAO|510-643-9252|mlin@berkeley.edu|
20502164|NCT02594644|UC Davis Department of Dermatology|Tatyana Petukhova MD||tpetukhova@ucdavis.edu|
20576714|NCT03681119|NYU Langone Health|Abraham Brody, PhD, RN, FAAN|212-992-7341|Abraham.Brody@nyulangone.org|
20576715|NCT00549172|University of Helsinki|Dr. Teppo Järvinen, Head of study chair||teppo.jarvinen@helsinki.fi|
20576716|NCT01087905|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.medicine.wisc.edu|
20576717|NCT02248727|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
20576718|NCT04639583|University of New Mexico|Jessie Maxwell, MD, MBA|505-272-3967|JRMaxwell@salud.unm.edu|
20576719|NCT03711500|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|6467746738|Joshua.Kantrowitz@nyspi.columbia.edu|
20576720|NCT00517829|Texas Oncology, Tyler Cancer Center|Dr. Donald Richards|903-579-9800|donald.richards@usoncology.com|
20576721|NCT00586209|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
20576722|NCT02018627|Massachusetts General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
20576723|NCT01179009|Washington University|Michael Yingling|5735791412|yinglinm@wustl.edu|
20576724|NCT01618214|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20576725|NCT00835237|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576726|NCT03339921|MOMH|Amanda Crawford|7026533583|amanda.j.rawford.ctr@health.mil|
20576727|NCT01265550|Dallas VA Medical Center|Stuart Spechler||sjspechler@aol.com|
20502165|NCT01354028|University of Arkansas for Medical Sciences|Dr Richard W Hall MD, Professor of Neonatology|501-680-7894|HallRichardW@uams.edu|
20502166|NCT00975156|Mischer Neuroscience Institute, Memorial Hermann-TMC|Elizabeth Noser||elizabeth.noser@memorialhermann.org|
20502167|NCT00305578|Indiana University|Dr. Amit Anand||aanand@iupui.edu|
20502168|NCT03472560|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20502169|NCT01946178|Mirabilis Medica, Inc.|Director of Clinical Affairs|425-486-8230|patrick@mirabilismedica.com|
20502170|NCT05425563|Dartmouth College|Dr. Tor Wager, professor|603-646-2196|tor@dartmouth.edu|
20502171|NCT01087541|Jordi Gol i Gurina Foundation|Cecilia Borau|34 934824617|cborau@idiapjgol.org|
20502172|NCT02494596|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502173|NCT02222714|Cedars-Sinai Medical Center|Patrick Lyden, MD, FAAN, FAHA|(310) 423-5166|Patrick.Lyden@cshs.org|
20502174|NCT03470129|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20502175|NCT01340209|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502176|NCT01537211|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
20502177|NCT00653861|Allergan Medical|Therapeutic Area Head|(805) 961-5500|devicetrials@allergan.com|
20502178|NCT02161562|Novartis Pharmaceuticals|Study Director|862-778-8300||
20502179|NCT01394705|Boston Children's Hospial|Tracy Curran|617355-5445|tracy.curran@cardio.chboston.org|
20502180|NCT01877564|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
20502181|NCT01573273|MUSC|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
20502182|NCT00353418|Hoffmann-La Roche|Medical Communications|800-821-8590||
20502183|NCT02450578|Medicines for Malaria Venture|Jörg Möhrle|+41 22 555 0330|moehrlej@mmv.org|
20502184|NCT04428411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502185|NCT02918019|Hoffmann-La Roche|Medical Comunications|1-800-821-8590|genentech@druginfo.com|
20502186|NCT00662792|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502187|NCT01699087|Alcon, A Novartis Division|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20502188|NCT02582957|University of Colorado|Dr. Richard Albert|303-602-5011|RICHARD.ALBERT@cuanschutz.edu|
20502189|NCT00094757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502190|NCT03021642|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20502191|NCT03419078|Imperial College Healthcare NHS Trust|Julie Beckerson|02033131922|julie.beckerson@nhs.net|
20502192|NCT00090545|National Cancer Institute, National Institues of Health|William Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
20502193|NCT02474082|Novartis Pharmaceuticals|Study Director|862 -778- 8300||
20502194|NCT01463098|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20502195|NCT03452371|Boston Medical Center/ Boston University Schools of Medicine and Public Health|Karen Lasser|617-414-6688|karen.lasser@bmc.org|
20502196|NCT01528787|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20502197|NCT03433781|NYU Langone|Perla Arriola|347-630-0311|perla.arriola@nyulangone.org|
20502198|NCT00797823|Legacy Health System|W Kenneth Ward MD|503-413-5171|wardk@ohsu.edu|
20502199|NCT02809833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502200|NCT03285243|Baylor college of Medicine|Adam Adler|832-8245800|Adam.adler@bcm.edu|
20502201|NCT02971670|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
20502202|NCT02793232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502203|NCT04849780|Johnson & Johnson Vision Care, Inc.|John R. Buch, OD, MS, FAAO|1-800-846-2020|jbuch@its.jnj.com|
20502204|NCT03522441|Catawba|Zaidoon A. Al-Zubaidy|1-980-242-3977|Zaidoon@catawbaresearch.com|
20502205|NCT03365778|Wills Eye Hospital|Clinical Research Coordinator|215-928-3213|jtran@willseye.org|
20508998|NCT01957215|GlaxoSmithKline|GSK Response Center|866-435-7343||
20508999|NCT00698139|Columbia University|Dr. Paolo C. Colombo|212-305-2638|pcc2001@columbia.edu|
20576728|NCT01297335|The Center for Clinical Research|Medical Director|3367656181|rrauck@ccrpain.com|
20576729|NCT01627860|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
20509000|NCT03597503|Supernus|Gianpiera Ceresoli-Borroni/ Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
20509001|NCT02944513|Brigham and Women's Hospital|Dr. Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
20576730|NCT02511730|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20576731|NCT01119248|Rutgers/New Jersey Medical School|Anuradha Patel, MD Director of Pediatric Anesthesiology|973 972-1886|patelan@njms.rutgers.edu|
20576732|NCT01883635|University of Rochester|Dr. Charles Kamen|585-275-9958|charles_kamen@urmc.rochester.edu|
20550322|NCT02701400|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
20576733|NCT00761514|Abbott|Medical Information Specialist|1-800-633-9110||
20576734|NCT01100437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576735|NCT00894556|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20576736|NCT02587650|University of California, San Francisco|Dr. Adil Daud|(415) 353-7392|Adil.Daud@ucsf.edu|
20576737|NCT00939900|SeoulNUBH|Professor|82317877194|khkoo@snu.ac.kr|
20576738|NCT00805480|Novartis Pharmaceuticals|Study Director|862-778-8300||
20576739|NCT06706245|Brown University Health|Joshua Kemp, Assistant Professor|4014321466|joshua_kemp@brown.edu|
20576740|NCT02068547|Washington University St. Louis|Wilson Z. Ray, MD|314-362-9959|rayz@wustl.edu|
20576741|NCT04365465|UPMC Magee-Womens Hospital|Dr. Grace Lim, MD, MSc|412-641-2179|limkg2@upmc.edu|
20576742|NCT00479154|NINDS/NIH|Fatta Nahab|301-496-9526|nahabf@ninds.nih.gov|
20576743|NCT02404103|University Louisville|Nemr Eid, MD|502-852-3772|n.eid@louisville.edu|
20576744|NCT01995071|AbbVie|Global Medical Services|800-633-9110||
20576745|NCT02543528|Johnson & Johnson Vision|Elizabeth Dow -PRINCIPAL RESEARCH OPTOMETRIST|904-443-1061|edow1@its.jnj.com|
20576746|NCT01982292|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20576747|NCT00879229|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20576748|NCT00817531|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
20576749|NCT00539695|Texas Children's Hospital|Dr. Rayne Rouce|832-824-4716|rouce@bcm.edu|
20576750|NCT02669017|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20576751|NCT03621280|Cortendo AB|Valentina Conoscenti, MD|1-877-937-4737|OPTICS@cortendo.com|
20576752|NCT00763815|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20576753|NCT01968135|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
20576754|NCT04749459|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20576755|NCT00003460|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20576756|NCT03245450|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20576757|NCT02429414|UT MD Anderson Cancer Center|Jagtar S Heir, Professor, Anesthesiology & PeriOper Med|(713) 745-3793|jsheir@mdanderson.org|
20576758|NCT00267748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576759|NCT02214238|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
20576760|NCT04442230|Altimmune, Inc.|Sarah K. Browne, MD/Senior Director, Clinical Development|240-654-1450|sbrowne@altimmune.com|
20576761|NCT00464334|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20576762|NCT03948178|Orion Corporation|Head of Compliance and UK Study Management, Clinical Operations|+441159487100|clinicaltrials@orionpharma.com|
20576763|NCT02898259|Clevleland|Dr. Brian Hill|1-866-223-8100|TaussigResearch@ccf.org|
20576764|NCT00967551|Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brasil|Hugo Costa-Ribeiro||hugocrj@ufba.br|
20576765|NCT03350217|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
20576766|NCT03303794|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
20576767|NCT03016325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20576768|NCT03761615|Sansum Diabetes Research Institute|Dr. Kristin Castorino|805-682-7638|info@sansum.org|
20576769|NCT01347554|Yonsei University Wonju College of Medicine|Dr. Seung-Hwan Lee|+82-33-741-0920|carshlee@yonsei.ac.kr|
20576770|NCT00004259|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20576771|NCT00790907|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576772|NCT01888640|University of Iowa|Dr. Kathleen A. Sluka|319-335-9791|kathleen-sluka@uiowa.edu|
20576773|NCT03389854|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
20576774|NCT00109707|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20576775|NCT00907101|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
20576776|NCT02199080|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Antoine Milhem|+33546455050|antoine.milhem@ch-larochelle.fr|
20576777|NCT02443883|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20576778|NCT03436862|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20576779|NCT02937818|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20576780|NCT00606086|GlobeImmune, Inc.|Clinical Operations Manager|3036252700|Alicia.Mattson@globeimmune.com|
20576781|NCT01471457|University of New Mexico|Kate Meriwether|5052495967|meriwet2@salud.unm.edu|
20576782|NCT04352439|Duke University|Dr. Brittany Davidson|+1 919 684 0188|brittany.davidson@duke.edu|
20576783|NCT01929408|Fred Hutchinson Cancer Research Center|Mohamed Sorror, MD, MSc|(206) 667-6298|msorror@fredhutch.org|
20576784|NCT02692495|MEBO Research|Irene Gabashvili, Scientific Director|(408) 341-9355|irene.gabashvili@meboresearch.org|
20509002|NCT03690674|Seattle Children's Research Institute|Dr. Pooja Tandon|206-884-1130|pooja.tandon@seattlechildrens.org|
20509003|NCT02027272|University of Mississippi Medical Center|James N. Martin, Jr.|601-984-5358|jnmartin@umc.edu|
20527916|NCT00582426|Novartis|Study Director|1-800-778-8300||
20576785|NCT00391222|Janssen Cilag Spain|EMEA Medical Affairs Director|+34 91 7228043||
20576786|NCT00889265|Zimmer Dental|Dr Hai Bo Wen, Director of Research|760-929-4312|haibo.wen@zimmer.com|
20576787|NCT02069899|Sobi AG|Radmila Kanceva/Senior Medical Director Immunology|+ 41 22 551 91 63|Radmila.Kanceva@sobi.com|
20557520|NCT01321541|Institut de Recherches Internationales Servier|Anton Egorov, Associate Project Director Clinical Development|+33 1 55 72 31 94|anton.egorov@servier.com|
20557521|NCT01355458|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20557522|NCT06097676|Azurity Pharmaceuticals, Inc.|David Sequeira|(913) 389-7961|david.sequeira@azurity.com|
20557523|NCT00691132|University of Minnesota|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
20557524|NCT02660801|UQTR|Pr Martin Descarreaux|819-376-5011|martin.descarreaux@uqtr.ca|3791
20557525|NCT04766086|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20557526|NCT01959347|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20557527|NCT01923805|Cleveland Clinic|Alison Klika; Research Program Manager, Adult Reconstruction|216-444-4954|klikaa@ccf.org|
20557528|NCT03541044|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20557529|NCT00860067|MedImmune LLC, an affiliate of AstraZeneca AB|Judith Falloon, MD/ Sr. Dir. Clinical Development|301-398-0000|falloonj@medimmune.com|
20576788|NCT00531752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576789|NCT00490451|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20576790|NCT01181011|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257|clintriage.rdg@boehringer-ingelheim.com|Option 4
20576791|NCT00610987|University of Missouri, Department of Orthopaedics|Dr. Brett Crist|573-882-6562|cristb@health.missouri.edu|
20576792|NCT00254501|University of Florida|Dale Kraemer||Dale.Kraemer@jax.ufl.edu|
20576793|NCT00550680|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20576794|NCT01967550|Novartis Consumer Health|Clinical Project Leader pain category|+41223633111||
20576795|NCT01223703|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr Savina Nodari|00390303996|nodari@med.unibs.it|587
20576796|NCT04249687|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
20576797|NCT00250835|University of New Mexico|Fa-Chyi Lee, MD|5059250405|flee@salud.unm.edu|
20576798|NCT01550562|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20576799|NCT00106171|Johns Hopkins University|Dr. Joseph Margolick|410-955-1436|jmargoli@jhsph.edu|
20576800|NCT01836783|University of Alabama at Birmingham|Maninder Kaur, BDS, MPH, MS, Principal Investigator|205-9344506|maninder@uab.edu|
20576801|NCT00853671|Massachusetts General Hospital|Dr. Brian B. Ghoshhajra|617-726-3745|bghoshhajra@partners.org|
20576802|NCT01035905|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20576803|NCT01273883|Mayo Clinic|Dr. Michael J. Cevette|480-301-7020|mcevette@mayo.edu|
20576804|NCT04489888|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20576805|NCT01003275|University of Washington|Ian H. de Boer, MD, MS, Associate Professor of Medicine|2066165403|deboer@u.washington.edu|
20576806|NCT00631748|VA Puget Sound Health Care System|Andre Tapp, MD|253-589-4176|andre.tapp@va.gov|
20576807|NCT02549209|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
20576808|NCT00333359|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20576809|NCT01332357|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576810|NCT02867995|Boston Medical Center|Dr. Manishi Desai|671-414-8806|Manishi.Desai@bmc.org|
20576811|NCT01534533|Peking University|Dr. Zhiyong Zou|+8610-13581525193|harveyzou2002@bjmu.edu.cn|
20576812|NCT04099251|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20576813|NCT05032157|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20576814|NCT03368170|Integrative Research Laboratories AB|Joakim Tedroff/Chief Medical Officer|+ 46 707 601691|joakim.tedroff@irlab.se|
20576815|NCT00880893|Sanofi Pasteur|Director||Contact-US@sanofi.com|
20576816|NCT02164981|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
20576817|NCT01783678|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20576818|NCT01408147|Cal Poly|Suzanne Phelan|805 756 2087|sphelan@calpoly.edu|
20576819|NCT01761266|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20576820|NCT00112905|ECOG Statistical Office|Study Statistician|617-632-3012||
20576821|NCT01042600|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@mail.amc.edu|
20576822|NCT04541004|ALK-Abelló A/S|David Hal Mollerup, Senior Director|+45 45747576|ClinicalTrials@alk.net|
20576823|NCT00621504|Cerexa, Inc|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
20576824|NCT00731874|Weill Cornell Medical College/Division of Transplant Surgery|Dr. Meredith J Aull|(212) 746-0727|mea9008@med.cornell.edu|
20576825|NCT03257267|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20576826|NCT03445000|ETOP IBCSG Partners Foundation|Heidi Roschitzki-Voser|+41 31 511 94 00|ALERT-lung@etop.ibcsg.org|
20576827|NCT03311711|Emory University|Mi-Kyung Song, PhD|404-727-3134|mi-kyung.song@emory.edu|
20576828|NCT02229552|SUNY Buffalo|Leonard H Epstein|716-826-3400|ckk@buffalo.edu|
20576829|NCT02684981|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576830|NCT03300466|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
20576831|NCT00820898|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
20576832|NCT01000662|NYU Langone Medical Center|Dr. Silvia Formenti, Chairman, Department of Radiation Oncology|(212) 731-5039|silvia.formenti@nyumc.org|
20576833|NCT02921971|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20576834|NCT00452699|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576835|NCT01602692|University of Wisconsin - Madison|Dr. Venkat Rao|(608) 263-1223|rao@surgery.wisc.edu|
20557530|NCT01282801|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20576836|NCT00648375|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
20576837|NCT01695473|University of California, San Francisco|Dr. Won Kim, MD|877-827-3222|Won.Kim@ucsf.edu|
20576838|NCT03509350|Emory University|Jon Sevransky MD, MHS|404-778-5734|jonathan.sevransky@emoryhealthcare.org|
20576839|NCT01425203|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20576840|NCT02246062|Faculdade de ciências médicas da Santa Casa de São Paulo|Dr Débora de Oliveira Cumino|+55 11 33617333|comissaocientifica@fcmsantacasasp.edu.br|
20576841|NCT04951037|Emory University|Fayron Epps, PhD, RN|404-727-6936|fepps@emory.edu|
20576842|NCT05630937|Nerviano Medical Sciences S.r.l.|Alberto Ocana|39 0331 58 1111|DL-Clinicaltrials@nervianoms.com|
20576843|NCT01098071|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20576844|NCT00983983|Massachusetts General Hospital|Dr. Anne-Marie Wills|855-644-6387|awills@partners.org|
20576845|NCT01604265|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20576846|NCT01022190|Radboud University Nijmegen Medical Centre|Study director|+31 24 36 13918||
20576847|NCT01903837|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
20576848|NCT01857713|Somna Therapeutics, L.L.C.|James Miller|262-345-5553|jmiller@somnatherapeutics.com|102
20576849|NCT03759665|IntraBio Ltd.|Taylor Fields, Chief Product Development Officer|+44 8081|tfields@intrabio.com|641283
20576850|NCT02599961|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20576851|NCT02432235|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
20576852|NCT01895322|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
20576853|NCT05515250|Saint Louis University|Purnima Modi|3149772029|purnima.modi.1@slu.edu|
20576854|NCT04400474|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
20576855|NCT00143312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20576856|NCT01834274|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20576857|NCT03603496|Massachusetts General Hospital|Nancy Rigotti, MD|617-724-3548|nrigotti@partners.org|
20576858|NCT03594227|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
20576859|NCT00774345|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@BMS.com|
20576860|NCT02500628|Woodinville Psychiatric Associates|Jon Berner MD PhD|425-481-0429|jonbernermd@gmail.com|
20576861|NCT00440505|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
20576862|NCT04074928|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20576863|NCT00763750|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
20576864|NCT02054897|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20576865|NCT00960843|Ethicon Endo-Surgery Inc.|Michael Schwiers Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20576866|NCT00652366|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20576867|NCT00619073|Children's Hospital Boston|Alan D. Michelson, M.D.|617-919-2116|alan.michelson@childrens.harvard.edu|
20576868|NCT01967537|Principal Investigator|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
20576869|NCT04703075|Johns Hopkins University School of Medicine|Maria Beatriz Kohler, Senior Research Nurse|4104048921|bkohler@jhmi.edu|
20576870|NCT03730116|Sevier|Mrdical manager - Yuriy Burtsev|8-495-93707-00|Yuriy.Burtsev@servier.com|1389
20576871|NCT04011280|Pacific Treatment and Research Center|Dr. Benjamin McKenna|858-534-8817|bmckenna@health.ucsd.edu|
20576872|NCT04942925|Alcon Research, LLC|Sr. Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20576873|NCT03649061|UZLeuven|Prof. Dr. Patrick Verschueren|+3216342541|patrick.verschueren@uzleuven.be|
20576874|NCT02124564|Cares|UCB|+1844599|UCBCares@ucb.comTokyo|2273
20576875|NCT00802204|Vanderbilt University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
20576876|NCT02043548|University of Pittsburgh|Chester Oddis, MD|412-383-8861|cvo5@pitt.edu|
20576877|NCT00400881|Texas Tech University|Juan Figueroa-Casas|915 5456626|juan.figueroa@ttuhsc.edu|235
20576878|NCT00456989|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|ctobcc@louisville.edu|
20576879|NCT03829657|Theravance Biopharma Ireland Limited|Medical Monitor|855 633 8479|medinfo@theravance.com|+1
20576880|NCT04418076|Associate Director Domestic Projects|Natalie Kil|203.737.2883|natalie.kil@yale.edu|
20576881|NCT01295216|Institute of Nutrition of Central America and Panama|Manuel Ramirez-Zea|+502 24719913|mramirez@incap.int|
20576882|NCT01452152|University of Maryland School of Medicine|Dr. Alan R. Shuldiner|410-706-1623|ashuldin@medicine.umaryland.edu|
20576883|NCT02380716|W. L. Gore & Associates|Greg Miller|623-234-5910|gmiller@wlgore.com|
20576884|NCT03315871|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|m480i@nih.gov|
20576885|NCT04874194|The university of Texas MD Anderson Cancer Center|Courtney DiNardo MD, Professor|713-794-1141|cdinardo@mdanderson.org|
20576886|NCT03047980|Kennedy Krieger Institute|Research Assistant|443-923-9569|vedmurthyp@kennedykrieger.org|3-9569
20576887|NCT01736579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20550323|NCT01666782|Rochester General Hospital|Saad Jamshed, MD|585-922-4020|Saad.Jamshed@rochesterregional.org|
20550324|NCT00080470|Boston Scientific|Director of Clinical Operations|866-360-4747|Valerie.Lucero-Cimmarust@bsci.com|
20550325|NCT01112241|Azienda Ospedaliera Universitaria San Martino, Genova, Italy|Dr. Giovanni Barisione, MD|+39 010 5553367|giovanni.barisione@hsanmartino.it|
20550326|NCT03734055|University of Rochester|Dr. Edith Williams|5856020802|edith_williams@urmc.rochester.edu|
20550327|NCT05425745|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20550328|NCT00524368|Tibotec Pharmaceuticals, Ireland|Medical Leader|+32 015 461 497||
20550329|NCT00998660|Medtronic, Inc.|Todd Weaver, PhD|763-526-8130|todd.weaver@medtronic.com|
20576888|NCT03036293|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20576889|NCT05048719|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20576890|NCT03936387|BOSTON CHILDREN'S HOSPITAL|ROLAND BRUSSEAU MD|6173557737|roland.brusseau@childrens.harvard.edu|
20576891|NCT00616109|University of Michigan|Gregory Kalemkerian, M.D.|(734) 936-4991|kalemker@umich.edu|
20576892|NCT00706134|Novartis Pharmaceuticals|Study Director|862-778-8300||
20576893|NCT02532231|The University of Texas MD Anderson Cancer Center|Tapan Mahendra Kadia, MD/Professor|713-563-3534|tkadia@mdanderson.org|
20576894|NCT03354754|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20576895|NCT00691483|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576896|NCT00746252|University of Marylland, Baltimore|Gloria M. Reeves, M.D.|410-706-3522|greeves@psych.umaryland.edu|
20576897|NCT01391000|Istituto Ortopedico Rizzoli|Dr Roberta Monesi|0516366694|cristiana.forni@ior.it|0039
20576898|NCT00082888|Mayo Clinic|Thomas E. Witzig, M.D.|507-266-2040|witzig@mayo.edu|
20576899|NCT03860961|NRG Oncology|Wendy Seiferheld|(215) 574-3208|seiferheldw@nrgoncology.org|
20576900|NCT01069562|Post Graduate Institute of Medical Education and Research|Puri GD|91-9914209509|gdpuri007@hotmail.com|
20576901|NCT02105454|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20576902|NCT00272038|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD, FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
20576903|NCT00493870|US Oncology Research|Taqi Mohammad|281-863-6439|taqi.mohammad@mckesson.com|
20576904|NCT00883337|sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20576905|NCT00527605|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576906|NCT01480297|The University of Michigan|Rodica Pop-Busui, MD, PhD|734-763-3056|rpbusui@umich.edu|
20576907|NCT03126760|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20576908|NCT00763139|Vanderbilt|Dr. Charles Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
20576909|NCT04312009|University of Minnesota|Christopher Tignanelli|612-626-1968|ctignane@umn.edu|
20576910|NCT02111564|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20576911|NCT03468309|VA Puget Sound Health Care System|Dr. Amanda E. Wood; Clinical Research Psychologist, VA PSHCS|253-583-1652|amanda.wood@va.gov|71652
20576912|NCT02396732|University of Miami|Kenneth Proctor|305-585-1178|kproctor@med.miami.edu|
20576913|NCT04986202|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20576914|NCT03340610|Southeast Retina Center|Dr. Dennis Marcus|706650061|dmarcus@southeastretina.com|
20576915|NCT02698735|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
20576916|NCT03548558|University of Southern California|Dr. Jill Luoto|+1-213-764-1581|jluoto@usc.edu|
20576917|NCT01289015|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
20576918|NCT01709149|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
20576919|NCT06117319|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20576920|NCT00290433|The University of Texas (UT) MD Anderson Cancer Center|Christopher Flowers/Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
20576921|NCT03001674|Tufts Medical Center|Dr. Navin Kapur|617 636 0720|nkapur@tuftsmedicalcenter.org|
20576922|NCT00793650|Emory University|Dr. Sagar Lonial|404-727-5572|sloni01@emory.edu|
20576923|NCT01515657|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
20576924|NCT00797732|Dana-Farber Cancer Institute|Weidong Lu, PhD, MB, Lic.Ac.|617.632.4350|weidong_lu@dfci.harvard.edu|
20576925|NCT02615743|Children's Hospital of Philadelphia|Dr. Chen Kenyon, Faculty PolicyLab and Assistant Professor University of Pennsylvania|267-426-6339|kenyonc@email.chop.edu|
20576926|NCT01857869|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576927|NCT02465073|Southwest Regional Wound Care Center|Randall Wolcott|806-793-8869|randy@randallwolcott.com|
20576928|NCT01277549|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
20576929|NCT02228590|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|clinicaltrialdisclosure@sunovion.com|
20576930|NCT02109484|Chris Hani Baragwanath Academic Hospital|Michelle J. Groome, MD, PhD|+27 11 983 4283|groomem@rmpru.co.za|
20576931|NCT02111993|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
20576932|NCT01097863|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20576933|NCT00796315|Procter & Gamble|Guhan Balan|513.622.2657|balan.g@pg.com|
20576934|NCT01400451|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20576935|NCT02249143|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
20576936|NCT00689871|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
20576937|NCT03496428|Implantology Institute|Prof. Dr. Duarte Marques|+351217 210 980|d.marques@institutoimplantologia.com|
20576938|NCT01890642|Medical College of Wisconsin|Maren Lunoe|414-266-2625|mlunoe@mcw.edu|
20502206|NCT03979274|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20502207|NCT02302963|University of Virginia Center for Diabetes Technology|Director|434-924-5592|bpk2u@virginia.edu|
20502208|NCT00535925|University of Campania|Prof. Ferdinando Carlo Sasso. MD, PhD|+39-081-5665010|ferdinandocarlo.sasso@unicampania.it|
20502209|NCT02180893|NYU Langone Medical Center|Peter Neuberger|212 263 5821|Peter.Neuburger@nyumc.org|
20527917|NCT03543176|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20527918|NCT00662311|Departments of Radiation Oncology and Global Health University of Washington Medical Center|Shilpen Patel|206-598-4100|shilpenp@uw.edu|
20576939|NCT03028870|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
20509004|NCT00688623|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20576940|NCT00317109|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576941|NCT03124771|Masimo|Tala Harake||studies@masimo.com|
20576942|NCT01079182|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20576943|NCT01508702|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
20576944|NCT02425826|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-800-260-1599|ClinicalTrialDisclosure@celgene.com|
20576945|NCT02997904|Piedmont Pharmaceuticals|Dr. Kathy Palma|336 544 0320|kpalma@piedmontpharma.com|202
20576946|NCT00879697|University of São Paulo|Raphael Dias|55 81 9728 6878|raphaelritti@gmail.com|
20576947|NCT02500121|Hoosier Cancer Research Network|Clinical Trials Results Coordinator|317-634-5842|aneal@hoosiercancer.org|21
20576948|NCT03221738|Massachusetts General Hospital|Anna Schwartzberg|617-724-7161|aschwartzberg@mgh.harvard.edu|
20576949|NCT02866279|Montefiore Medical Center|Erika Levi|7184058200|elevi@montefiore.org|
20576950|NCT01430455|Depression Evaluation Service (New York State Psychiatric Institute)|Jonathan W. Stewart|646-774-8070|jws6@nyspi.columbia.edu|
20576951|NCT02553512|Proteus Digital Health|Lorenzo DiCarlo MD, Vice-President of Clinical and Medical Affairs|+1 650 637 6199|ldicarlo@proteus.com|
20576952|NCT01425008|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20576953|NCT00264238|Stanford University School of Medicine, Dept of Psychiatry|Dr John Barry, Professor|(650) 725-5588|jbarry@stanford.edu|
20576954|NCT00562588|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576955|NCT04527185|Yale School of Medicine|Terril Verplaetse|203-737-6496|terril.verplaetse@yale.edu|
20576956|NCT02240654|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20576957|NCT00328627|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20576958|NCT02049944|Memorial Care|Dr. Morgan Swank|5624808460|morganswankmd@gmail.com|
20576959|NCT01662440|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20576960|NCT02600507|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20576961|NCT01975922|Vanderbilt University|Ann Kaiser|615-322-8163|ann.kaiser@vanderbilt.edu|
20576962|NCT02643004|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20576963|NCT00605085|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
20576964|NCT00600015|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20502210|NCT01478854|Johns Hopkins University School of Medicine|Kristin Redmond, MD|410-955-6980|kjanson3@jhmi.edu|
20502211|NCT00603915|Univerisity Health Network|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.on.ca|
20502212|NCT03687502|Children's Mercy Hospital|Dr. Tolulope Oyetunji|816-234-3575|taoyetunji@cmh.edu|
20502213|NCT01724528|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
20502214|NCT00466310|DUMC|Rima Kaddurah-Douk, Associate Professor|919-684-2611|rima.kaddurah-daouk@duke.edu|
20502215|NCT05574062|MedtronicD|Fabio Di Piazza|+393456172157|fabio.di.piazza@medtronic.com|
20502216|NCT00289107|DePuy Orthopaedics|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
20502217|NCT04820309|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20502218|NCT06033079|Vanderbilt University Medical Center|Derek J. Williams, MD, MPH|615-322-2744|derek.williams@vumc.org|
20502219|NCT03512418|Brigham and Women's Hospital|Peter Chai|617-732-5640|pchai@bwh.harvard.edu|
20502220|NCT04811716|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20502221|NCT03864653|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D. [Research Scientist]|(323) 463-1601|jfletcher@friendsresearch.org|126
20502222|NCT03048422|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20502223|NCT01928381|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicine Unit|Joel Posener, MD - Head Early Clinical Development||CinicalTrialTransparency@astrazeneca.net|
20502224|NCT03406897|University of Miami, Diabetes Research Institute|Dr. David Baidal|305-243-7740|dbaidal@med.miami.edu|
20502225|NCT04484285|University of Florida|Eric Porges, Associate Profressor|(352) 294-5838|eporges@ufl.edu|
20502226|NCT03196180|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
20502227|NCT01227902|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550330|NCT01955733|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20550331|NCT02762266|Stanford University|Erqi Pollom, MD|(650) 498-0484|erqiliu@stanford.edu|
20550332|NCT03758274|University of Rochester|Kenneth R. Conner|585-275-1211|kenneth_conner@urmc.rochester.edu|
20550333|NCT01113983|Edwards Lifesciences|Shin Sakai, PhD||shin_sakai@edwards.com|
20550334|NCT02422511|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
20550335|NCT02961751|University of California, Los Angeles|Jeffrey D. Klausner, MD, MPH|310-267-0409|jdklausner@mednet.ucla.edu|
20550336|NCT00842712|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20550337|NCT02715076|Department of outcomes research Cleveland Ohio|Dr. Daniel I. Sessler||ds@or.org|
20550338|NCT02299479|Boston Children's Hospital|Garry Steil, PhD|617 355-6000|Garry.Steil@childrens.harvard.edu|
20550339|NCT02785354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20550340|NCT02310568|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550341|NCT02255604|Aarhus Universitets Hospital|Hans Jürgen Hoffmann|7845000|Hans.Jurgen.Hoffmann@ki.au.dk|
20550342|NCT00113217|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor|713-563-7232|ejonasch@mdanderson.org|
20550343|NCT03975790|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557531|NCT00560612|Durham VA Medical Center|Christine Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
20576965|NCT04872101|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20576966|NCT00264004|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20576967|NCT03691974|Regeneron Pharmaceuticals, Inc|Study Director|844-734-6643|clinicaltrials@regeneron.com|
20576968|NCT00439946|United Therapeutics|Remodulin Program Leader|(919) 485-8350|ClinicalRecordsManagement@unither.com|
20576969|NCT04623242|Washington University|Administrative Director|(314) 221-8344|DIAN-TUDataRequest@wustl.edu|
20576970|NCT03598166|VA|Anika Zaman|6464190648|anika.zaman@nyulangone.org|
20576971|NCT00326898|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20576972|NCT03847987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20576973|NCT02721355|Immunology Research Institute in Gifu|Dr. Van Sa Nguyen|+819068053288|nguyen@ew-nutrition.co.jp|
20576974|NCT00679952|Seoul National University College of Medicine|Clinical instructor|82-2-2072-2817|meejookang@gmail.com|
20576975|NCT01578980|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
20576976|NCT01652287|Georgetown University Medical Center, Department of Family Medicine|Director of Research Programs|202-687-1600|FamilyMedResearch@georgetown.edu|
20576977|NCT01535365|Stony Brook U|Adam Singer|631-444-7856|adam.singer@stonybrook.edu|
20576978|NCT01592760|Universtiy of Wisconsin School of Medicine and Public Health|Richard E. Galgon, MD, MS|608-263-8100|galgon@wisc.edu|
20576979|NCT02605642|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20576980|NCT01390909|GlaxoSmithKline|GSK Response Center|866-435-7343||
20576981|NCT00925015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20576982|NCT00179309|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D., Ph.D.|301-435-2956|gulleyj@mail.nih.gov|
20576983|NCT00488982|University of California, San Francisco|Dr. Rahul Aggarwal|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
20576984|NCT01484626|Loyola University Medical Center|Scott Smith, M.D., Ph.D.|708-327-3142|ssmith8@lumc.edu|
20576985|NCT02952222|Boston Children's Hospital|Dr. Keira Mason|(617) 355-7737|keira.mason@childrens.harvard.edu|
20576986|NCT05526833|New York State Psychiatric Institute|Michael Avissar|(646) 774-5431|MichaelAvissarMDPhD@gmail.com|
20576987|NCT00586573|Massachusetts General Hospital|Craig Surman, MD|617-503-1424|csurman@partners.org|
20576988|NCT04852120|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20576989|NCT00522795|BrUOG|Kayla Rosati|401-863-3000|Kayla_Rosati@brown.edu|
20576990|NCT05726318|University of Pittsburgh|Megan Bradley, MD|412-641-3189|bradleym4@upmc.edu|
20576991|NCT05882318|Valencia Technologies|Dylan Beyer|+1 (661) 775-1414|dbeyer@valenciatechnologies.com|
20576992|NCT04175626|Biotronik, Inc|Crystal Miller|1 800-547-0394|crystal.miller@biotronik.com|
20576993|NCT03494881|Mayo Clinic|Jason Sluzevich, M.D.|904-953-6192|sluzevich.jason@mayo.edu|
20576994|NCT00428974|Can-Fite BioPharma Ltd|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
20576995|NCT05980299|Miami University|Dr. Katherine Abbott|513-529-0869|abbottkm@miamioh.edu|
20576996|NCT02264990|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20576997|NCT03031301|Vibrantgastro|clinical trial manager|046663322|service@vibrantgastro.com|
20576998|NCT00876993|Johns Hopkins All Children's Hospital|Stacie Stapleton|727-767-4176|stacie.stapleton@jhmi.edu|
20576999|NCT01849172|Guang'an Men Hospital, China Academy of Chinese Medical Sciences|Dr.Zhishun Liu|+86 01088002331|liuzhishun@aliyun.com|
20577000|NCT00705939|Protalix Ltd.|Vice President Product Development|+(972) 4-9889488|einata@protalix.com|137
20577001|NCT05048342|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20577002|NCT00493038|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20577003|NCT01441063|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
20577004|NCT02164422|Yale School of Medicine|Dr. Sherry McKee|2037373529|sherry.mckee@yale.edu|
20577005|NCT02112370|Seoul National University Hospital Department of Surgery|Dr. Kyu Eun Lee|+82)-2-2072-2817|kyueunlee@snu.ac.kr|
20577006|NCT01558661|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
20577007|NCT04607733|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20577008|NCT01665807|Mount Sinai Hospital, IDERU|Brenda L. Coleman, PhD,|416-586-4800|bcoleman@mtsinai.on.ca|4538
20577009|NCT02501265|Duke University School of Medicine|Dr. James Davis|919-668-5055|james.m.davis@duke.edu|
20577010|NCT02728830|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
20577011|NCT03504397|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20577012|NCT05182554|MIT|LISA HO|5106505455|lisaho@mit.edu|
20577013|NCT03215771|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
20577014|NCT02685709|Amryt|Asi Haviv, VP Clinical development|972 8 9393888|Asi@amrytpharma.com|
20577015|NCT00574275|Sanofi|International Clinical Development Study Director||Contact-Us@sanofi.com|
20577016|NCT01618942|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
20577017|NCT02788747|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
20509005|NCT02667236|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
20527919|NCT02508103|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
20527920|NCT03738163|Mölnlycke Health Care|Sabrina Chowdhury|+44 (0)7769 907654|sabrina.chowdhury@molnlycke.com|
20550344|NCT00597545|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
20550345|NCT02289690|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20550346|NCT01170754|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
20550347|NCT00779467|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
20557532|NCT01060553|Veteran Affairs New Jersey Health Care System|Thomas W. Findley, MD, PhD|973-676-1000|thomas.findley@va.gov|2713
20557533|NCT03160287|University of Washington|Oleg Zaslavsky|2066163242|ozasl@uw.edu|
20502228|NCT05280756|University of Pittsburgh Medical Center|Dr. Alexandre Paim Diaz|(412) 624-1000|paimdiaza@upmc.edu|
20502229|NCT02363478|"Academic Department of Gastroenterology, LAIKON General Hospital"|Dr. George P. Karamanolis|+30.213.2061307|georgekaramanolis@yahoo.co.uk|
20502230|NCT00768898|Alcon Research, Ltd.|Alison Ramsey, O.D., Manager|817-551-6986|Alison.ramsey@alconlabs.com|
20502231|NCT02527707|Eiger BioPharmaceuticals, Inc.|SVP Clinical Development|1-650-272-6138|info@eigerbio.com|
20557534|NCT01498822|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20502232|NCT00930059|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502233|NCT01299766|Thomas Jefferson University|Robin Casten|215-503-1250|robin.casten@jefferson.edu|
20557535|NCT04581200|Duke University|Christopher Cox|9196817232|christopher.cox@duke.edu|
20557536|NCT03131960|MicroTransponder Inc.|Study Director|8556289375|studies@microtransponder.com|
20557537|NCT01625923|University of Michigan|Allen Lee|734-936-9454|allenlee@umich.edu|
20502234|NCT04002310|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20502235|NCT00542997|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
20502236|NCT00352534|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20502237|NCT02388568|The University of Pennsylvania's Center for Weight and Eating Disorders|Dr. Jena Shaw Tronieri|215-746-5045|jena.tronieri@pennmedicine.upenn.edu|
20502238|NCT00544869|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
20502239|NCT02303431|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20502240|NCT00619502|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20502241|NCT01777763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20502242|NCT03968419|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20502243|NCT02109159|London School of Hygiene and Tropical Medicine|Dr Junko Kiriya|+442076368636|junko.kiriya@lshtm.ac.uk|
20502244|NCT00935883|University of Miami Miller School of Medicine|Philip J Rosenfeld|305-326-6148|prosenfeld@med.miami.edu|
20502245|NCT03179085|University of New Mexico Health Sciences Center|Vallabh Shah, PhD. Principal Investigator|505-272-9615|VShah@salud.unm.edu|
20577018|NCT01026831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502246|NCT01641939|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502247|NCT02894840|Mahidol university|Prof.Punnee Pitisuttithum|662 6435599|punnee.pit@mahidol.ac.th|
20502248|NCT01815229|Washington University School of Medicine|Dr. Carlos Puyo|314-747-1709|cpuyo@wustl.edu|
20502249|NCT00804687|Janssen Research and Development|Senior Medical Director|858-784-3111||
20502250|NCT03037281|University of Leicester|Dr Christopher Hebbes|0116 252 2522|christopher.hebbes@le.ac.uk|
20502251|NCT01029730|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20577019|NCT04417894|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20577020|NCT03461757|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20577021|NCT02864368|Duke University Medical Center|Principal Investigator|(919) 684-5301|dukebrain1@duke.edu|
20577022|NCT03861559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20577023|NCT04036968|Johns Hopkins University School of Medicine|Kelly Dunn, Professor|410-550-2254|kdunn9@jhmi.edu|
20577024|NCT00970853|Children's Hospital of Philadelphia|Dr. Jerilynn Radcliffe|215-590-7446|radcliffe@email.chop.edu|
20577025|NCT00507559|Medtronic Endovascular|Kristin Schwartz|(763) 514-4000|kristin.schwartz@medtronic.com|
20577026|NCT00858858|VA|Stuart Spechler|214-857-1603|Stuart.Spechler@va.gov|
20577027|NCT01344876|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
20577028|NCT05107765|The University of Texas Health Science Center of Houston|Jin H Yoon, PhD|713-486-2800|jin.ho.yoon@uth.tmc.edu|
20577029|NCT01765673|James Madison University|Christy Ludlow|540-937-3007|ludlowcx@jmu.edu|
20577030|NCT02475681|Acerta Clinical Trials|Study Director|18882929613|acertamc@dlss.com|
20577031|NCT02323698|Spaulding Rehabilitation Hospital|Dr. Randy D Trumbower, PI|(617) 952-6953|randy.trumbower@mgh.harvard.edu|
20577032|NCT02025426|Duke University, School of Medicine, Department of Anesthesiology|Dr. Ashraf Habib|(919) 681-4544|ashraf.habib@duke.edu|
20577033|NCT00356278|Emory University|Barbara O. Rothbaum, PhD, ABPP|404-712-8866|brothba@emory.edu|
20577034|NCT01166230|The University of Texas|H. Barton Grossman, MD|713-563-7456|hbgrossman@mdanderson.org|
20577035|NCT01008280|VISN 22 Network Office|Peter Hauser, MD, VISN 22 Mental Health Services Lead|562 826 8000|peter.hauser2@va.gov|2629
20577036|NCT01363986|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20577037|NCT01637142|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20577038|NCT01869647|Yale Emergency Medicine|Dr. Chris L. Moore|(203)737-3313|chris.moore@yale.edu|
20577039|NCT02762513|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
20577040|NCT02165384|Preceptis Medical|CEO|6123274795|steve@preceptismedical.com|
20502252|NCT03720899|University of Alabama at Birmingham|Karen Cropsey|(205) 975-7809|kcropsey@uab.edu|
20557538|NCT02918500|University of Ottawa Heart Institute|Dr. Andrew Pipe|613-696-7000|apipe@ottawaheart.ca|
20557539|NCT04404478|Ohio State University|Dr. Holly Jones|760-415-6147|jones.7935@osu.edu|
20557540|NCT01215357|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
20577041|NCT00687362|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20557541|NCT01859793|Medical College of Wisconsin|Michael E. Widlansky|414-955-6806|mwidlans@mcw.edu|
20557542|NCT05414318|W.L. Gore & Associates|Charee Robe|928-864-4048|crobe@wlgore.com|
20577042|NCT02354703|University of Maryland School of Medicine|Dr. David Gorelick|410-408-6806|dgorelick@som.umaryland.edu|
20577043|NCT03438045|NYU Grossman School of Medicine|Mary E. Northridge, PhD, MPH, Director of Dental Research|(347) 377-4342|Mary.Northridge@nyulangone.org|
20577044|NCT01968460|Pharma 2B LTD|Pninit Litman study director|+972 8 9472672|pninit@pharma2b.com|
20577045|NCT01268293|Eisai Co., Ltd.|Tatsuya Sasaki|81-3-3817-5252||5252
20577046|NCT02597855|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
20577047|NCT01099202|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
20577048|NCT04681170|Amryt Pharmaceuticals DAC|Head of Clinical Operations|+35315180200|janet.boylan@amrytpharma.com|
20577049|NCT06414512|University of Minnesota|David Boulware|612-624-9996|idim@umn.edu|
20577050|NCT01394081|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|Lori.Davis@va.gov|3819
20577051|NCT01407926|McMaster University|Maureen Markle-Reid, Associate Professor and Canada Research Chair, School of Nursing|905-525-9140|mreid@mcmaster.ca|22306
20577052|NCT02814565|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20577053|NCT02468648|NIDDK|Marc Ghany, MD, MHSc|301-402-5115|marcg@intra.niddk.nih.gov|
20577054|NCT02118792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20577055|NCT05131204|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20577056|NCT04373369|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5817|danielmorgensztern@wustl.edu|
20577057|NCT01777152|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20577058|NCT03716869|MS Hershey MC|Deepa Sekhar, Associate Professor of Pediatrics, Executive Director Penn State PRO Wellness|7175310003|dsekhar@pennstatehealth.psu.edu|281334
20577059|NCT02363686|University of Colorado|Carrie Higgins|7205603037|carrie.higgins@cuanschutz.edu|
20577060|NCT02469090|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20577061|NCT02163434|University at Buffalo|Dr. Thomas Guttuso, Jr.|7169326080|tguttuso@gmail.com|
20577062|NCT03446885|Florida International University|Gregory A. Fabiano, Ph.D.|716-359-7823|gfabiano@fiu.edu|
20577063|NCT01390259|University of Virginia|Marc Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
20577064|NCT03823391|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20577065|NCT01833130|Allergan, Inc|Medical Director,||clinicaltrials@allergan.com|
20577066|NCT04283123|Washington University School of Medicine in St. Louis|Susan Stark, PhD, OTR/L, FAOTA|(314)273-4114|sstark@wustl.edu|
20577067|NCT03461445|UC Davis Health|Associate Professor of Medicine|916-734-5141|lxchen@ucdavis.edu|
20577068|NCT05030311|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20577069|NCT03042468|Weill Cornell Medicine|Dr. Scott Tagawa|646-962-2027|stt2007@med.cornell.edu|
20577070|NCT03557359|Columbia University|Fabio Iwamoto|212-342-0571|fi2146@cumc.columbia.edu|
20577071|NCT04589988|Washington University in St. Louis|Dr. Susy Stark|3142734114|sstark@wustl.edu|
20577072|NCT02128230|University of Arkansas for Medical Sciences|Frits Van Rhee, MD|501-526-2873|vanrheefrits@uams.edu|
20577073|NCT01662895|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-63208913|mselim@bidmc.harvard.edu|
20577074|NCT03345472|Medtronic Restorative Therapies Group, Spinal Cord Stimulation|Stacie Hallaway/Senior Clinical Research Specialist|763-526-3844|RS.VectorsPM@medtronic.com|
20577075|NCT01926782|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
20577076|NCT02275338|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20577077|NCT02154386|UT Health Science Center San Antonio (School of Dentistry)|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
20577078|NCT02482675|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
20577079|NCT02365714|Medstar Georgetown University Hospital|Sonali Rudra, M.D.|202-444-3320|sonali.rudra@gunet.georgetown.edu|
20577080|NCT00070941|NYU Parkinson and Movement Disorders Center|Dr. Alessandro Di Rocco|212-263-4838|Alessandro.Dirocco@nyumc.org|
20577081|NCT03099486|Fox Chase Cancer Center|Dr. Namrata Vijayvergia|215-214-4283|Namrata.Vijayvergia@fccc.edu|
20577082|NCT01232829|University of Colorado Cancer Center|Dr. Wells Messersmith|303-724-3808|wells.messersmith@ucdenver.edu|
20577083|NCT00684788|Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20577084|NCT00075504|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20577085|NCT00623428|Hoffman-LaRoche|Medical Communications|800-821-8590||
20577086|NCT01142726|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20577087|NCT00419380|University of Colorado School of Medicine - Department of Pediatric Otolaryngology|Kenny H. Chan, MD|7207774776|kenny.chan@childrenscolorado.org|
20577088|NCT03099707|Brigham and Women's Hospital|Ingrid T. Katz|617-525-8194|ikatz2@bwh.harvard.edu|
20577089|NCT03167073|Washington University of St Louis (where research was conducted). Now at Brown University|Dr. Adam Lewkowitz|401-274-1122|alewkowitz@kentri.org|47447
20577090|NCT00758745|Alcon Research, Ltd.|Director of Clinical Research|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20577091|NCT03127384|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
20577092|NCT02703311|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20577093|NCT02340338|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
20577094|NCT00343889|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20577095|NCT01951820|University of Michigan School of Dentistry|Dr. Carlos Gonzalez|734-763-3391|carlosgc@umich.edu|
20509006|NCT04037462|VA Ann Arbor Healthcare System|Dr. Nithya Ramnath|(734) 845-5800|Nithya.Ramnath@va.gov|
20527921|NCT01964989|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20557543|NCT03815019|University of Kansas Medical Center|Ann Davis, PhD, MPH, ABPP, Director, Center for Children's Healthy Lifestyles & Nutrition|(913) 588-1227|adavis6@kumc.edu|
20577096|NCT00558870|University of Texas (UT) MD Anderson Cancer Center|Sriram Yennurajalingam, Palliative Care & Rehabilitation Medicine||CR_Study_Registration@mdanderson.org|
20577097|NCT01294579|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20577098|NCT00137111|St. Jude Children's Research Hospital|Ching-Hon Pui|1-866-278-5833|info@stjude.org|
20577099|NCT00562354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20577100|NCT00784654|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20577101|NCT00262873|University of Rochester|Jane Liesveld, M.D.|585-275-4099|Jane_Liesveld@urmc.rochester.edu|
20577102|NCT03440814|Soleno Therapeutics, Inc.|C601 Project Manager|650-353-2051|C601ProjectManager@soleno.life|
20577103|NCT01437397|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20577104|NCT00903175|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20577105|NCT01785134|Karolinska Institutet|Dr Erik Näslund|+46812355017|Erik.Naslund@ki.se|
20577106|NCT03074474|TELA Bio|Neal Overbeck|484-802-9570|noverbeck@telabio.com|
20577107|NCT02987621|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
20577108|NCT03441178|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
20577109|NCT01358864|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20577110|NCT04209855|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20577111|NCT01284114|Division of Nephrology, Department of Internal Medicine, Jichi Medical University|Dr. Yoshiyuki Morishita|81-285-58-7346|ymori@jichi.ac.jp|
20577112|NCT03409744|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20577113|NCT02896595|Virginia Commonwealth University Health Department of Anesthesiology|Praveen Prasanna|804-828-2207|praveen.prasanna@vcuhealth.org|
20577114|NCT01745146|Moss Rehabilitation Research Institute|Dr. Tessa Hart, PhD|215-663-6153|thart@einstein.edu|
20577115|NCT04161131|Stanford University|Molly Tanenbaum|650-725-3955|mollyt@stanford.edu|
20577116|NCT01265459|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
20577117|NCT00699348|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20577118|NCT05362526|University of Florida|Ashleigh Wehy, MD|9042449440|amweyh@gmail.com|
20577119|NCT03522324|University of Colorado Boulder|Dr. L. Cinnamon Bidwell|3037355180|lcb@colorado.edu|
20577120|NCT03704194|Washington university in St.louis|Brittany Minor|314-273-4118|bminor@wustl.edu|
20577121|NCT03491384|University of Colorado Boulder|Dr. L. Cinnamon Bidwell|3037355180|CUChange@Colorado.edu|
20577122|NCT01368835|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20577123|NCT02754726|HonorHealth Research Institute|Erkut Borazanci, MD MS|4803231350|clinicaltrials@honorhealth.com|
20577124|NCT01885000|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20577125|NCT01272999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20577126|NCT02792842|Asahi Kasei Pharma Corporation|Contact for Clinical Trial Information|+81-3-6699-3600|ct-info@om.asahi-kasei.co.jp|
20577127|NCT03756038|University of Pittsburgh|Dr. Maria Pacella|412-647-3183|pacellam@upmc.edu|
20577128|NCT01789814|Tufts Medical Center|Carey Kimmelstiel, MD Director of the Adult Cardiac Catheterization Laboratory|617-636-4504|Ckimmelstiel@tuftsmedicalcenter.org|
20577129|NCT03806127|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20577130|NCT04302727|University of North Carolina at Chapel Hill|Thomas Keyserling, MD|984-974-4462|thomas_keyserling@med.unc.edu|
20577131|NCT05215600|Zimmer Biomet|Carina Hafner|+41797073093|carina.hafner@zimmerbiomet.com|
20577132|NCT03142321|Washington University School of Medicine GI Division|Dr. Parakkal Deepak|3143623201|nixd@wustl.edu|
20577133|NCT03092726|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20577134|NCT03988335|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
20577135|NCT02217566|Janssen Research & Development, LLC|Regional Medical Affairs Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20577136|NCT03950973|University of Michigan School of Public Health, Department of Health Behavior & Health Education|Minal R. Patel, Ph.D, M.P.H|(734) 763-0087|minalrp@umch.edu|
20577137|NCT02436876|Microbion Corporation|Brett Baker, President and Chief Innovation Officer|4065991190|bbaker@microbioncorp.com|
20577138|NCT00999908|Novartis Pharmaceuticals|Study Director|862 778-8300||
20577139|NCT01692301|Novartis Pharmaceuticals|Study Directors|862-778-8300|trialandresults.registries@novartis.com|
20577140|NCT01290692|Saint Lukes Hospital KC, Missouri and Washington University School of Medicine, St.Louis Missouri|Michael E. Salacz,MD and David Tran,MD, PH.D|9134922221|gwood@tvaxbiomedical.com|
20577141|NCT01568593|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
20577142|NCT03987854|University of Michigan|Laura Saslow|(734) 764-7836|saslowl@umich.edu|
20577143|NCT02780648|IndianaU|Dr. Robert Miller|317-944-1317|millro@iu.edu|
20577144|NCT00265538|Iowa City VA Health Care System|Dr. Peter Kaboli|319-338-0581|Peter.kaboli@va.gov|
20577145|NCT03557892|University of Florence Medical School and AOU Careggi|Dr Ilaria Dicembrini|+393387861041|Ilaria.dicembrini@unifi.it|
20577146|NCT00293579|Ohio State University Comprehensive Cancer Center|Anterpreet Neki|614-257-2900|Anterpreet.Neki@osumc.edu|
20577147|NCT01276236|University of California, San Francisco|Dr. Toby Maurer, MD|(628) 206-8680|Toby.Maurer@ucsf.edu|
20577148|NCT01097304|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
20577149|NCT04472429|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20557544|NCT05960097|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20577150|NCT01180660|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
20577151|NCT05130463|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20577152|NCT00844753|University of Pittsburgh|Ben Handen|412-235-5452|HandenBL@upmc.edu|
20577153|NCT00470600|Cumberland Pharmaceuticals|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
20577154|NCT00088374|National Cancer Institute, National Institutes of Health|William M. Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
20577155|NCT02189850|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20577156|NCT00371865|VA San Diego Healthcare System|Dr. Julie Wetherell, PI|858-552-8585|Julie.Wetherell@va.gov|2752
20577157|NCT04817111|Children's Hospital of Philadelphia|Dr. Shana McCormack|215-590-3174|mccormacks1@email.chop.edu|
20577158|NCT00713583|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
20577159|NCT05073458|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20577160|NCT01545700|NorthShore University HealthSystem|Glenn S. Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
20577161|NCT01227551|Viralytics|Mark Grose|1 647 821 7673|Mark.Grose@Viralytics.com|
20577162|NCT04230304|Mayo Clinic|Sikander Ailawadhi|904-953-2000|Ailawadhi.Sikander@mayo.edu|
20577163|NCT05721482|The Ohio State University College of Nursing|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
20577164|NCT01627899|LifeScan Scotland|Mike Grady|+44 01463 721000|MGRADY@its.jnj.com|
20577165|NCT03627403|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20577166|NCT04685876|University of Texas, Houston|Dr. Alparslan Turan|713-500-6279|Mehmet.A.Turan@uth.tmc.edu|
20577167|NCT04205409|University of Washington|Dr. Andrew Cowan|2066067348|ajcowan@fredhutch.org|
20577168|NCT02656485|AOBIOME|Masha Gaber|617-475-1605|mgaber@aobiome.com|
20577169|NCT00861744|GlaxoSmithKline|GSK Response Center|866-435-7343||
20577170|NCT04428424|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20577171|NCT03809611|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20577172|NCT02193074|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20577173|NCT03473145|UC San Diego|Sheri Hartman|(858) 534-9235|sjhartman@health.ucsd.edu|
20577174|NCT04179175|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20577175|NCT01262365|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20577176|NCT00494091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20577177|NCT00130832|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20577178|NCT00532480|Indiana University|Dr. Amit Anand|317-944-7422|aanand@iupui.edu|
20577179|NCT00559507|Memorial Sloan-Kettering Cancer Center|Clifford Hudis, MD|646-888-4551|hudisc@mskcc.org|
20577180|NCT04232696|Neuspera Clinical Research|Mark Vollmer|612-281-4875|mark.vollmer@neuspera.com|
20577181|NCT01678144|Medtentia International Ltd Oy|Olli Keränen / CEO|+358 50 3567090|ok@medtentia.com|
20577182|NCT03118297|WashingtonU|Intervention To End Recurrent Unscheduled bleeding Trial (INTERRUPT): A randomized-controlled trial|3143228697|rachelezig@gmail.com|
20577183|NCT04227899|Abbott|Karine Ruster|(408) 845-0764|karine.piard-ruster@abbott.com|
20577184|NCT01676714|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
20577185|NCT04735653|University of Michigan Medical School|Dr. Paula Anne Newman-Casey|734-763-6967|panewman@med.umich.edu|
20577186|NCT01084265|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20577187|NCT01294800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20577188|NCT03326843|Dova Pharmaceuticals|Associate Director, Clinical Operations|919-338-7864|clinical@dova.com|
20577189|NCT04418765|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20577190|NCT01100944|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
20577191|NCT04668352|Adicet Bio|Nick Harvey|857-315-5528|nharvey@adicetbio.com|
20577192|NCT02296242|BioMed Valley Discoveries|Dean Welsch, PhD|8163898831|dwelsch@biomed-valley.com|
20577193|NCT01639833|Covidien|Michael Rohan|781-839-1757|Michael.Rohan@Covidien.com|
20577194|NCT02064387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20577195|NCT00703664|Massey Cancer Center, Virginia Commonwealth University|Dr. Beata Holkova|804-628-2581|bholkova@mcvh-vcu.edu|
20577196|NCT03728309|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20577197|NCT01212302|Cardiology Dep, Ruhr-University Bochum|Dr Horst Neubauer|+49-234-509-2326|Horst.Neubauer@rub.de|
20577198|NCT02342015|University of Padova|Marcello Rattazzi|+300498211867|marcello.rattazzi@unipd.it|
20577199|NCT00927095|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
20577200|NCT01662583|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
20577201|NCT01849770|University of Washington|Michael D. Weiss, MD|206-598-7688|mdweiss@uw.edu|
20577202|NCT00044512|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20577203|NCT00866307|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20577204|NCT02573155|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20577205|NCT04397094|Faculty of Dentistry Ain Shams University|Dr. Mariem Wassel|+2 0064871416|mariem.wassel@dent.asu.edu.eg|
20550348|NCT00644995|Group Health Cooperative|Jennifer McClure, PhD|206-287-2737|mcclure.j@ghc.org|
20550349|NCT01427504|University of Colorado|Dr. Jennifer Kiser|303-724-6131|jennifer.kiser@ucdenver.edu|
20550350|NCT00865124|Brigham and Women's Hospital|Gail K. Adler|617-732-5661|gadler@partners.org|
20550351|NCT02743520|University of Miami, Miller School of Medicine|Alberto Ramos, MD, MSPH, FAASM|305-243-8393|a.ramos1@med.miami.edu|
20550352|NCT03247530|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
20577206|NCT02508194|MedImmune, LLC|Judith Falloon, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
20577207|NCT01031914|Philips|Dr. David P. White|724 387 4554|Dr.DavidWhite@philips.com|
20577208|NCT00454805|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20577209|NCT00217087|Mayo Clinic|Kenneth Wang MD|507-255-7495|wang.kenneth@mayo.edu|
20577210|NCT00802685|University of Miami|Ilene R. S. Sosenko, M.D.|305-585-6408|isosenko@miami.edu|
20577211|NCT05913232|D. Western Therapeutics Institute, Inc.|Shigenobu Nakazora|+81-52-218-8785|shinakazora@dwti.co.jp|
20577212|NCT01328951|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20577213|NCT05103332|Alnylam Pharmaceuticals|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20577214|NCT04428476|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
20577215|NCT06232317|Department of Surgery, Houston Methodist Hospital|Dr. Hina Faisal|713-714-4973|hfaisal@houstonmethodist.org|
20577216|NCT03485820|Washington University in St. Louis|Susy Stark|3142734114|sstark@wustl.edu|
20577217|NCT04289116|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
20577218|NCT03194373|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
20577219|NCT04042103|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20577220|NCT05853380|Mindset Medical|Jeremy Markovich|8583055323|jeremy@mindsetmedical.com|
20577221|NCT02289950|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
20577222|NCT04518462|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9729|MedInfo@Pacira.com|
20577223|NCT01003210|University of Washington|Dr. James Taylor|206-6165-1206|uncjat@uw.edu|
20577224|NCT00271817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20577225|NCT03963011|Children's Mercy Hospital|Erin Opfer, DO|816-324-3273|ekopfer@cmh.edu|
20577226|NCT00931359|Miramar Labs|Kathy O'Shaughnessy, PhD|408-940-8700|kathyo@miramarlabs.com|
20577227|NCT04153188|Candela Corporation|Medical Director|+1 904 6549629|konikap@candelamedical.com|
20577228|NCT03711578|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
20577229|NCT01471782|Amgen, Inc|Study Director|866-572-6436||
20577230|NCT00936208|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20577231|NCT04818593|NYU Langone Health|Rani Fritz, DO, PhD, FACOG|718-935-9766|rani.fritz@nyulangone.org|
20577232|NCT01564862|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20577233|NCT00313209|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20577234|NCT02600494|Intra-Cellular Therapies, Inc.|Vice President, Clinical Development|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20577235|NCT03124563|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
20577236|NCT02452528|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20577237|NCT05061719|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
20577238|NCT05429073|Regulus Therapeutics|Kristen Gillotti, Senior Director Clinical Operations|203-313-8185|kgillotti@regulusrx.com|
20577239|NCT04246372|Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz|Joaquin Espinosa|303-724-7389|joaquin.espinosa@cuanschutz.edu|
20577240|NCT04339140|Beth Israel Deaconess Medical Center|Dr. Rushad Patell|617-667-7000|rpatell@bidmc.harvard.edu|
20577241|NCT04121091|Unit of Biological and Precision Psychiatry|Dr Daniel Lindqvist|+4646173885|daniel.lindqvist@med.lu.se|
20577242|NCT01696435|Massachusetts General Hospital|Dr. Olivia Okereke/Study Principal Investigator|(617) 726-2000|olivia.okereke@mgh.harvard.edu|
20577243|NCT04266041|Dartmouth-Hitchcock Medical Center|Dr. Yinchen Song|603-650-5104|yinchen.song@hitchcock.org|
20577244|NCT02723773|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20577245|NCT05168774|Children's Hospital of Philadelphia|Dr. David Lynch|215-590-2242|lynch@chop.edu|
20577246|NCT03963531|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20577247|NCT04176497|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-966-4432|Melahat_Canter@med.unc.edu|
20577248|NCT01314703|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
20577249|NCT04063384|University of Texas at Austin|Dr. Elizabeth Lippard|512-495-5216|elizabeth.lippard@austin.utexas.edu|
20577250|NCT04417699|OHSU Knight-Legacy Health Cancer Collaborative|Dr. Hagen Kennecke|971-262-9600|kennecke@ohsu.edu|
20577251|NCT03940703|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20577252|NCT03215030|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20550353|NCT03950167|UFUK UNIVERSITY|DR MÜGE KESKİN|+905333522090|mugekeskin1@hotmail.com|
20550354|NCT02533427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20577253|NCT05416138|University of Minnesota|Alexander Opitz|612-624-1094|aopitz@umn.edu|
20577254|NCT01743131|Boston Children's Hospital|Dr. Leslie Kean|404-376-0187|leslie.kean@childrens.harvard.edu|
20550355|NCT02509156|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
20577255|NCT03676257|Institut Bergonié|Carine Bellera|+33556330495|C.Bellera@bordeaux.unicancer.FR|
20550356|NCT03042533|harborview medical center|julie agel|206.744.4113|bagel@uw.edu|
20502253|NCT02397473|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20502254|NCT01757717|Memorial Sloan Kettering Cancer Center|Josh Yamada, MD|212-639-2950|yamadaj@mskcc.org|
20502255|NCT00883675|Maestro|Michael Mann, MD|650-380-9579|michael.mann@ucsfmedctr.org|
20577256|NCT04699539|Changhai Hos|Xiaofei Zhu|86-021-31162222|zhuxiaofei_zxf@163.com|
20577257|NCT05804877|Chung Shan Medical University|Dr. Yun-Ling Chen|+886958226869|yunling.annie@gmail.com|
20527922|NCT02499263|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20577258|NCT03310957|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20557545|NCT01856530|Boston University|Dr. Stefan G. Hofmann|617-353-9233|shofmann@bu.edu|
20557546|NCT00728962|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20557547|NCT02487472|GlaxoSmithKline|GSK Response Center|866-435-7343|lzr30020@gsk.com|
20577259|NCT04999267|Duke University - Duke Human Vaccine Institute|Chip Walter|919 620 5346|chip.walter@duke.edu|
20577260|NCT04540497|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20577261|NCT05274815|AstraZeneca|Global Clinical Lead|8772409479|information.center@astrazeneca.com|
20577262|NCT06132659|University of Michigan|Dr. Stefanie Russman Block|734-232-0373|srblo@umich.edu|
20577263|NCT03914326|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20577264|NCT04478708|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20577265|NCT01314118|Janssen Services, LLC|Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20577266|NCT01869114|Thomas Jefferson University|Margaret T Kasner, MD|215-955-3202|Margaret.Kasner@jefferson.edu|
20577267|NCT03323502|Indiana University School of Nursing|Dr. Susan Hickman|317-274-0032|hickman@iu.edu|
20577268|NCT03615326|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20502256|NCT05325775|Acer Therapeutics Inc ( a wholly owned subsidiary of Zevra Therapeutics Inc|Chief Medical Officer|844-902-6100|aquartel@zevra.com|
20502257|NCT00343512|Vanderbilt-Ingram Cancer Center|Bapsi Chak, M.D.|615-322-2555||
20502258|NCT00323557|UT MD Anderson Cancer Center|Amar Safdar, MD/Professor||CR_Study_Registration@mdanderson.org|
20502259|NCT00197054|Kombewa Clinic, US Army Medical Research Unit, Kisumo Kenya|LTC Mark Polhemus MD, MC|877-379-3788|GSKClinicalSupportHD@gsk.com|
20502260|NCT00684515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502261|NCT01580397|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20527923|NCT02769312|Providence VA Medical Center, Center for Neurorestoration and Neurotechnology|Dr. Noah S. Philip|401-273-7100|noah.philip@va.gov|6235
20527924|NCT04126317|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20527925|NCT00424593|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20527926|NCT01602679|University of Virginia Center for Research in Reproduction|Dr. Christopher R. McCartney|4342430329|cm2hq@virginia.edu|
20527927|NCT02496039|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
20527928|NCT04096001|Stanford Prevention Research Center, School of Medicine, Stanford University|Judith J Prochaska, PhD|650-724-3608|jpro@stanford.edu|
20527929|NCT02693717|UT MD Anderson Cancer Center|Jianjun Gao, MD PHD, Associate Professor, Genitourinary Medical Oncology|(713) 563-4195|jgao1@mdanderson.org|
20527930|NCT00217581|Barbara Ann Karmanos Institute|Philip A. Philip, M.D., Ph.D., F.R.C.P|(313) 576-8746|philipp@karmanos.org|
20527931|NCT00496587|The University of Texas MD Anderson Cancer Center|Dr. Nazir Tannir/|713-792-7734|CR_Study_Registration@mdanderson.org|
20527932|NCT00482170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527933|NCT01134263|Sanofi Pasteur|Trial Transparency Team||Contact-US@sanofi.com|
20527934|NCT01557517|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
20527935|NCT02445859|The Universit yof Leeds|Andrew Kirby|0044 113 3923989|a.kirby@leeds.ac.uk|
20527936|NCT02007278|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20527937|NCT01557868|American Orthopaedic Society for Sports Medicine|Dr. Barton Mann|847-292-4900|bart@aossm.org|
20527938|NCT02740335|Clinical Research Management Group|Patrick Murphy|413-821-0022|p.murphy@crmg-usa.com|
20527939|NCT02279745|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20527940|NCT00380718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20527941|NCT01349933|Mayo Clinic|Brigette Buig-Yue Ma, MBBS, FRACP||brigette@clo.cuhk.edu.hk|
20527942|NCT02033200|Vivus Inc|VP of Development|650-934-5200||
20527943|NCT01706575|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20527944|NCT02912455|Cleveland Clinic|Dr. Sangeeta Kashyap|(216) 445-2679|kashyas@ccf.org|
20527945|NCT02670382|Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University|Dr. Stefania Lamon-Fava, Scientist I|617-556-3105|stefania.lamon-fava@tufts.edu|
20527946|NCT02230540|Rigshospitalet, Department of Urology|Per Bagi, MD|+45 3545 8310|Per.bagi@regionh.dk|
20527947|NCT03244618|Unilever|Dr Jane Matheson|+44 (0)1516413633|jane.matheson@unilever.com|
20527948|NCT03469999|Columbia University Irving Medical Center|Dr. Heakyung Kim|212-305-9416|hk2641@cumc.columbia.edu|
20527949|NCT02949141|Patan Academy of Health Science|Darlene R House, MD|+977 9810339799|dhouse@iupui.edu|
20527950|NCT02820181|The First Hospital of Shanxi Medical University|Dr.Jun Tian|+8618612270351|zguotian@126.com|
20527951|NCT04424914|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527952|NCT00460746|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488|rfalcon@its.jnj.com|
20527953|NCT00822328|Cheng Hsin Rehabilitation Medical Center|Dr.Yi-Hsien Lin|+886-2-28264400|d49311001@ym.edu.tw|5750
20527954|NCT00789685|Faron Pharmaceuticals Limited|Dr Ilse Piippo, MD|+358 2469 5151|ilse.piippo@faronpharmaceuticals.com|
20527955|NCT02791438|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20527956|NCT01428115|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20527957|NCT01810783|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
20527958|NCT02620384|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
20527959|NCT02071082|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20577269|NCT03794583|United Therapeutics|United Therapeutics Global Medical Information|1-240-821-1881|305PerfectOLEStudy@lungbiotechnology.com|
20509007|NCT04402385|Yale School of Medicine|Olga Grechukhina, MD: Assistant Professor of Obstetrics, Gynecology & Reproductive Sciences|(203) 785-3091|olga.grechukhina@yale.edu|
20509008|NCT01894555|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
20509009|NCT01235338|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20509010|NCT02809118|Auris Medical|RAM|0041 61 201 13|ra@aurismedical.com|50
20509011|NCT01597440|Children's National Health System|Dr. Mendel Tuchman||mtuchman@childrensnational.org|
20509012|NCT02918721|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20509013|NCT05283499|Rutgers University School of Dental Medicine|Cecile A. Feldman|973-972-4634|feldman@rutgers.edu|
20509014|NCT02436915|Institute for Aging Research, Hebrew SeniorLife|Brad Manor|617-971-5332|bradmanor@hsl.harvard.edu|
20509015|NCT04083404|Queen Margaret University|Dr Susan Prior|44 (0)131 474 0000|sprior@qmu.ac.uk|
20509016|NCT01518309|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20509017|NCT00863317|Richmond Emergency Physicians Inc|Frank Petruzella|773 447-2489|fpetruzella@gmail.com|
20509018|NCT04480749|LSHTM|Michael Marks|020 7636 8636|michael.marks@lshtm.ac.uk|
20509019|NCT00038142|The University of Texas (UT) MD Anderson Cancer Center|Dr. Eugenie S. Kleinerman, Professor, Pediatrics - Research|713-792-8110|ekleiner@mdanderson.org|
20509020|NCT00809614|Novartis|Study Director|862-778-8300||
20509021|NCT00762528|Colgate Palmolive Company|William DeVizio, DMD|732-878-7901|william_Devizio@colpal.com|
20509022|NCT00728728|VHA Durham|Christine E. Marx, MD|9192860411|christine.marx@va.gov|3626
20509023|NCT03434041|Janssen Research & Development, LLC|DIRECTOR CLINICAL LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509024|NCT00654420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509025|NCT00250497|University_of_Minnesota|Dr. Dianne Neumark-Sztainer, Professor|612-624-0880|neuma011@umn.edu|
20509026|NCT01577628|Innovaderm Research|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
20509027|NCT00841672|Novartis Pharmaceuticals|Study Director|862-778-8300||
20509028|NCT02709109|Parion Sciences|Alison Church|919-313-1183|achurch@parion.com|
20509029|NCT01787799|Boston Scientific|Peter Maurer, MPH; Director of Clinical Trials|508-683-6678|peter.maurer@bsci.com|
20509030|NCT01928082|The University of Chicago|Murray J. Favus|(773) 702-6138|mfavus@medicine.bsd.uchicago.edu|
20509031|NCT04010370|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
20509032|NCT00927264|Johns Hopkins University|Cynthia Rand, Ph.D.|410-550-0487|crand@jhmi.edu|
20509033|NCT01815580|Fred Hutchinson Cancer Center|Ann Duerr|206 667 7938|aduerr@fredhutch.org|
20509034|NCT02219997|Alcon Research, Ltd.|Global Brand Med Affairs Lead, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
20509035|NCT02573233|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20509036|NCT05103475|Veterans Health Administration|Bella Etingen, PhD|214-857-0240|Bella.Etingen@va.gov|
20509037|NCT00924729|Johns Hopkins University|Walter J. Stark, M.D./Professor of Ophthalmology|410-955-5490|wstark@jhmi.edu|
20509038|NCT00196196|Codman & Shurtleff, Inc.|Jandira Ramos, MPH|508-828-3127|jramos8@its.jnj.com|
20509039|NCT00214487|Dr. Thomas Aller, Optometrist Inc.|Dr. Thomas Aller|650 871-1816|cptreyes@earthlink.net|
20509040|NCT02228824|University of Pittsburgh|Dr. Saul Shiffman|412-567-1761|shiffman@pinneyassociates.com|
20509041|NCT01814826|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20509042|NCT03339401|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20509043|NCT01042938|University of Rochester Medical Center|Julie L Ryan, PhD, MPH (PI)|585-276-3862|julie_ryan@urmc.rochester.edu|
20509044|NCT03997760|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20509045|NCT00856986|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20509046|NCT03032510|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
20509047|NCT03061812|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20509048|NCT04018612|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
20509049|NCT00361218|Massachusetts General Hospital|John W. Denninger, MD, PhD|617-726-2985|jdenninger@partners.org|
20509050|NCT00136838|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
20509051|NCT01883804|Barbara Davis Center for Diabetes, University of Colorado School of Medicine|Dr. Aaron Michels|303-724-1923|aaron.michels@ucdenver.edu|
20509052|NCT02566109|Wake Forest University Health Sciences|Gregory Hundley, MD|336-716-0607|ghundley@wakehealth.edu|
20502262|NCT00693160|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
20502263|NCT01405053|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20502264|NCT00868101|Universidade de Sao Paulo|Marcos Alves Pavione|55 79 9199 9576|mapavione@hotmail.com|
20502265|NCT04063371|The Ohio State University|Dr. Douglas Scharre|614-293-4969|Doug.Scharre@osumc.edu|
20502266|NCT02082678|UT Southwestern|E. Sherwood Brown. MD, PhD, MBA|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
20502267|NCT01099969|The University of Texas Health Science Center at Houston|Dr. Davide Cattano|713.500.6235|davide.cattano@uth.tmc.edu|
20502268|NCT02882633|University of Pennsylvania|Ignacio Badiola|215-893-7251|Ignacio.Badiola@uphs.upenn.edu|
20502269|NCT00357500|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
20502270|NCT02301403|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
20502271|NCT01128829|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
20502272|NCT01060059|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20502273|NCT03528512|William Beaumont Hospitals|Dr. Margaret Menoch|2489897289|margaret.menoch@beaumont.edu|
20509053|NCT01802515|Yale University|Dr. Mehmet Sofuoglu, Principal Investigator|203 937-4809|mehmet.sofuoglu@yale.edu|
20550357|NCT02547649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20577270|NCT04986072|University of Rochester Medical Center|Dr. Paulo Lizano MD, PhD|(201) 776-6708|lizanopl@gmail.com|
20550358|NCT00571987|UAMS|Dr. Suzanne Klimberg|501-686-6504|klimbergsuzanne@uams.edu|
20550359|NCT02551731|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20550360|NCT00484874|Dana-Farber Cancer Institute|Heather Jacene, MD|617-632-3767|hjacene@partners.org|
20577271|NCT03963544|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trial Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20577272|NCT04266301|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
20550361|NCT00811798|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550362|NCT01678911|Rehabilitation Institute of Chicago|Director of the Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
20577273|NCT04079712|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20550363|NCT04649060|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
20550364|NCT02602496|University of Nebraska Lincoln|Dr. Devin Rose|402-472-2802|drose3@unl.edu|
20550365|NCT01906008|UT MD Anderson Cancer Center|Dr. James Yao, MD, Director of GI Medical Oncology|(713) 792-2828|jyao@mdanderson.org|
20550366|NCT02117648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20577274|NCT03371225|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526154|fregni.felipe@mgh.harvard.edu|
20550367|NCT01815515|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
20550368|NCT00171730|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20550369|NCT05025241|Neuren Pharmaceuticals|Chief Medical Officer|+61 (3) 9092 0480|MedicalInformation@neurenpharma.com|
20550370|NCT02670837|University of Minnesota, Masonic Cancer Center|Dr. Christen Ebens|(612) 626-5654|ebens012@umn.edu|
20550371|NCT01985867|The Medical University of Warsaw|Katarzyna Wojtyniak|+48 22 317 94 21|wojtyniakkasia@gmail.com|
20577275|NCT04798781|Cedars-Sinai Medical Center|Andrew Hendifar, MD, MPH|3104232217|andrew.hendifar@cshs.org|
20577276|NCT01794572|Institut de Cancérologie de l'Ouest|Pr Stéphane SUPIOT|(+33) 2406799 00|stephane.supiot@ico.unicancer.fr|
20550372|NCT02220205|Beth Israel Deaconess Medical Center|Siripanth Nippita|617-667-4165|snippita@bidmc.harvard.edu|
20550373|NCT01465997|Cares|UCB|+1844 599||2273
20550374|NCT02246660|Northwestern University|Dr. Mary McDermott|312-503-6419|mdm608@northwestern.edu|
20550375|NCT02397785|Cleveland Clinic Foundation|Erica Magelky, Principal Investigator|713-628-5357|magelke@ccf.org|
20550376|NCT02557646|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550377|NCT03944954|University of Kentucky|Dr. Michael J Wesley|8593230579|michael.wesley@uky.edu|
20550378|NCT03223246|Massachusetts General Hospital|Dr. Margaret Samuels-Kalow|6177262000|msamuels-kalow@mgh.harvard.edu|
20577277|NCT03708562|Becton Dickinson (BPV)|Courtney Rothwell|480-350-6037|courtney.rothwell@bd.com|
20577278|NCT05801809|Spaulding Rehabilitation Hospital|Felipe Fregni, PI|6179526158|fregni.felipe@mgh.harvard.edu|
20550379|NCT02268084|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
20577279|NCT05289830|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Jordan Winter|216-844-5777|Jordan.winter@uhhospitals.org|
20550380|NCT05227027|University of California, San Francisco|Dr. Justin White, Associate Professor|415-476-8045|justin.white@ucsf.edu|
20577280|NCT02699697|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367135440|Doris.R.Brown@advocatehealth.org|
20550381|NCT02911753|University of Arizona|David O. Garcia, PhD, FACSM|520-626-4641|davidogarcia@email.arizona.edu|
20550382|NCT01891695|University of Virginia|Paul Read, MD|434-924-5191|pwr3u@hscmail.mcc.virginia.edu|
20577281|NCT02362035|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20550383|NCT00855920|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20577282|NCT01046825|St. Jude Children's Research Hospital|Raul Ribeiro, MD|901-595-3694|raul.ribeiro@stjude.org|
20550384|NCT04786990|Supernus Pharmaceuticals|Joseph T. Hull, PhD|240-403-5324|jhull@supernus.com|
20550385|NCT03809052|Galecto BIotech|Dr Bertil Lindmark, Chief Medical Officer|+45 70 70 52 10|info@galecto.com|
20550386|NCT00923247|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
20577283|NCT03140254|Becton Dickinson|Erin Zook|201-847-5351|erin.zook@bd.com|
20550387|NCT01782222|UCB|UCB Cares|+1 877 822 9493||
20577284|NCT05587296|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20550388|NCT02071914|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
20550389|NCT01756898|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20577285|NCT05469113|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20577286|NCT03560752|City of Hope|Dr. Ryotaro Nakamura|626-359-8111|rnakamura@coh.org|
20550390|NCT01500694|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20550391|NCT02007109|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
20550392|NCT03791489|Stryker ENT|Pr. Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20550393|NCT01605877|Alcon Japan, Ltd.|Hiroshi Kodama, Group Manager|81-3-6899-5000||
20577287|NCT02847624|Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd|Investigator in charge|+81-6-6943-7722|komaniwa.satoshi@otsuka.jp|
20550394|NCT02818569|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|617-724-7200|ojohnsonakeju@partners.org|
20550395|NCT02154243|HSS|Dr. Haskins|(212) 606-1000|HaskinsS@hss.edu|
20502274|NCT01614093|Morgan State University|Kimberly R. Warren, Ph.D.|443-885-3492|kimberly.warren@gmail.com|
20502275|NCT01816243|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
20550396|NCT03158116|UCSF Benioff Children's Hospital Oakland|Rachna Wadia, MD|844-724-4140|rawadia@mail.cho.org|
20502276|NCT01920711|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20502277|NCT02838407|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502278|NCT03550066|Kaiser Permanente Northern California|Dr. Susan D. Brown|5108913544|susan.d.brown@kp.org|
20502279|NCT01493180|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20502280|NCT01777581|Duke University Medical Center|David Marks, MD|919 668-2859|d.marks@duke.edu|
20502281|NCT05702736|Ege University|Dr. Merve UGURYOL UNAL|+902323115545|merve.uguryol.unal@ege.edu.tr|
20502282|NCT02321436|Ipsen|Medical Affairs Director, Neurology||clinical.trials@ipsen.com|
20502283|NCT00546052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502284|NCT04663945|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|PT.studies@cuanschutz.edu|
20502285|NCT00772668|UM/Sylvester Comprehensive Cancer|Denise Pereira MD|305-243-9127|dpereira2@med.miami.edu|
20502286|NCT05442853|Malcom Randall VA Medical Center|Andrew J. Franck|3523761611|Andrew.Franck@va.gov|105771
20502287|NCT05027932|Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH|Luca Giurgea|301-538-5235|Luca.giurgea@nih.gov|
20502288|NCT00865020|Novartis Pharmaceuticals|Study Director|862-778-8300||
20502289|NCT03695913|University of Michigan|Spring Stonebraker|734-649-0219|sprstone@med.umich.edu|
20502290|NCT01001702|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affair|800 562-3974||
20502291|NCT03856255|NYU Langone Health|Mark Pochapin, MD|212-263-9177|Mark.Pochapin@nyulangone.org|
20502292|NCT02624492|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502293|NCT03244033|University of Illinois at Chicago|Dr. Saul Weiner|312-355-1700|sweiner@uic.edu|
20502294|NCT01163786|Northwestern University|Clinical Trials at Northwestern University|312-695-6180|cancertrials@northwestern.edu|
20502295|NCT00634569|Grifols|Paul J. Pinciaro, PhD|410-814-7617|paul.pinciaro@grifols.com|
20502296|NCT01212185|UNC_ChapelHill|Dr. Cort Pedersen|919-966-4447|cort_pedersen@med.unc.edu|
20502297|NCT02167945|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20502298|NCT01192347|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20502299|NCT02623335|University of Wisconsin, Madison|Gretchen Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
20502300|NCT00395967|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20502301|NCT02400255|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20502302|NCT02568046|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
20502303|NCT00523991|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502304|NCT03261531|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
20502305|NCT01700192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Corporate Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502306|NCT00363038|Northwestern University Department of Dermatology|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
20502307|NCT00744874|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA- AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
20502308|NCT00566930|UQTR|Martin Descarreaux|819 376-5011|martin.descarreaux@uqtr.ca|3077
20502309|NCT01727895|Radboud UMC|Drs. Jenneke Leentjens|0031-243668420|Jenneke.Leentjens@radboudumc.nl|
20502310|NCT00379795|Genentech|Genentech||ctg-post-d@gene.com|
20502311|NCT00763321|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20502312|NCT03175549|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
20502313|NCT02435849|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20502314|NCT02486757|Massachusetts General Hospital|Dr. Natalie Shaw||natalie.shaw@nih.gov|
20502315|NCT00725075|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502316|NCT00352105|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
20502317|NCT02979431|Ablynx NV|Medical Monitor|+32 (0)9262 00 00|clinicaltrials@ablynx.com|
20502318|NCT01656434|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502319|NCT01235962|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20502320|NCT02883244|Sunstar Americas, Inc.|Senior Manager of R&D|8477944276|akane.takemura@us.sunstar.com|
20502321|NCT01727258|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20557548|NCT02010632|Khon Kaen University|Miss Nontaya Nakkam|66862642540|nonna_na@hotmail.com|
20502322|NCT05787847|University of Vermont|Dr. Richard Rawson|‭+1 (310) 951-9091‬|richard.rawson@uvm.edu|
20502323|NCT06468059|Kennesaw State University|Mark Geil|(470) 578-4805|mgeil@kennesaw.edu|
20502324|NCT02199197|Huntsman Cancer Institute Research Compliance Office|Data Manager|801-585-0601|compliance@hci.utah.edu|
20502325|NCT06098729|Yale University|Garrett Ash|2034443079|garrett.ash@yale.edu|
20502326|NCT02129660|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
20502327|NCT00630955|Yale University|Dr. Suchitra Krishnan-Sarin, Associate Professor of Psychiatry|203-974-7595|suchitra.krishnan-sarin@yale.edu|
20557549|NCT01669798|Duke University Medical Center|Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
20557550|NCT01802086|SormlandCC|Beatrice Olsson Duse|0704948359|bod257@hotmail.com|
20557551|NCT03125005|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20557552|NCT05918978|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20502328|NCT00993928|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
20502329|NCT01665144|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20502330|NCT02067039|CDC|Robin MacGowan|404-639-1920|rmacgowan@cdc.gov|
20557553|NCT00622180|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
20502331|NCT01972074|Massachusetts General Hospital|Gagan Joshi, MD|(617) 724-1541|joshi.gagan@mgh.harvard.edu|
20502332|NCT02317562|LFB|Clinical Information Desk|0033169827010|supportqcm@lfb.fr|
20502333|NCT02319044|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
20502334|NCT03551743|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20502335|NCT03891901|Emory University|Dr. Cynthia Giver|404-778-5806|cgiver@emory.edu|
20502336|NCT02105415|Mayo Clinic|Dr. Nathan Smischney|507-255-4305|smischney.nathan@mayo.edu|
20502337|NCT02154087|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20502338|NCT01658657|UNC Chapel Hil|Anthony Viera|919-966-0758|viera@med.unc.edu|
20502339|NCT04949841|LEO Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
20502340|NCT01172652|VA Palo Alto Health Care System|Dr. Trisha Suppes, MD PhD|(650) 493-5000|tsuppes@va.gov|67576
20502341|NCT03502993|Imperial College London|Dr J Herberg|0207 594 3900|j.herberg@imperial.ac.uk|
20502342|NCT03382574|UT MD Anderson Cancer Center|Dr. Powel Brown, Chair, Clinical Cancer Prevention|(713) 745-3672|phbrown@mdanderson.org|
20502343|NCT03110900|University of Arkansas for Medical Sciences|Michael Wilson, M.D.|(501) 686-5515|mpwilso1@outlook.com|
20502344|NCT00644787|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
20502345|NCT03355300|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
20557554|NCT02280239|Providence Health Care|Vininder Kour Bains|604-682-2344|VBains@providencehealth.bc.ca|62207
20557555|NCT06387472|Mayo Clinic|Matthew Hall, M.D.|904-953-6412|Hall.Matthew@mayo.edu|
20557556|NCT02332590|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20557557|NCT00279201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20557558|NCT02202434|Boston Scientific|Amy Maurer|508-683-6647|amy.maurer@bsci.com|
20502346|NCT01680900|University of Pennsylvania|Dr. Ellen Freeman|215-662-3329|freemane@mail.med.upenn.edu|
20502347|NCT00502216|Yale University School of Medicine|Benjamin Toll, Ph.D.|203-974-5767|benjamin.toll@yale.edu|
20502348|NCT02549755|Indiana University School of Medicine|Justin Sims, M.D.|317 948-6340|simsjb@iupui.edu|
20502349|NCT01031446|Vanderbilt-Ingram Cancer Center|Ingrid A. Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
20502350|NCT00500682|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20502351|NCT02851173|University of Texas at Austin|Andreana Haley|512-232-0863|haley@austin.utexas.edu|
20502352|NCT02531646|Carestream Health, Inc.|Susan Pate, RN, MS, RAC, Senior Clinical Manager|585-627-6557|susan.pate@carestream.com|
20502353|NCT00578305|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20502354|NCT03344003|Octapharma AG|Dr. Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
20502355|NCT01182428|Abbott Vascular|Ellen Travis, Clinical Science|408-845-3000|Ellen.Travis@av.abbott.com|
20502356|NCT01879345|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20502357|NCT00684957|Columbia University|Pamela Freda, MD|212-305-3725|puf1@columbia.edu|
20502358|NCT06272370|DARTNet Institute|Wilson Pace, MD|800-434-0278|Wilson.pace@dartnet.info|12
20502359|NCT03303911|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20502360|NCT03064763|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20502361|NCT00680836|George E. Wahlen V.A. Medical Center, Salt Lake City, UT|Ashok Tuteja, M.D.|801-582-1565|ashok.tuteja@va.gov|4019
20502362|NCT03038308|Columbia University|Gabrielle Page-Wilson, MD|212-305-3725|gp2287@cumc.columbia.edu|
20502363|NCT01583179|University of Wisconsin-Madison|Melanie Donnelly|720-848-0000|melanie.donnelly@ucdenver.edu|
20502364|NCT01220414|University of Wisconsin-Madison|Kelli F. Koltyn|608 262-4234|kelli.koltyn@wisc.edu|
20502365|NCT00623831|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20502366|NCT00374803|University of Cincinnati|Rita Alloway, PharmD|5135581568|rita.alloway@uc.edu|
20502367|NCT00997516|University of California, San Francisco|Jonathan T. Carter, MD, FACS|415-476-0974|jonathan.carter@ucsfmedctr.org|
20502368|NCT00929071|Susan H. Weinkle, MD|Susan H. Weinkle, MD|941-794-5432|sweinkle@aol.com|
20502369|NCT03555266|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
20502370|NCT00510809|University of Kansas Medical Center|James Backes, PharmD|(913) 588-5324|JBACKES@kumc.edu|
20502371|NCT03370770|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502372|NCT00132730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502373|NCT00179959|Children's Memorial Hospital|Amy Paller, MD|312-695-6829|apaller@nmff.org|
20502374|NCT01262976|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502375|NCT00236080|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20502376|NCT01214044|Oregon Health & Science University and VA Portland Health Care System|Jonathan Emens, M.D.|503-220-8262|emensj@ohsu.edu|58490
20502377|NCT00408694|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20502378|NCT01961544|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20502379|NCT00193063|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20502380|NCT01127165|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
20502381|NCT01017952|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502382|NCT01064167|Cardiovascular Institute & Fuwai Hospital|Guyan Wang|86-10-88398377|guyanwang2006@163.com|
20502383|NCT02194439|IndianaU|Sophie Paczesny|317-278-5487|sophpacz@iu.edu|
20502384|NCT01983787|Aarhus University Hospital, Department of infectious diseases|Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
20502385|NCT03984305|Global Kinetics Corporation|Director of Clinical Affairs|612.240.2437|karen.krygier@globalkineticscorp.com|
20577288|NCT02872311|Marshfield Clinic Research Institute|Project Manager|715-389-5088|king.jennifer@marshfieldresearch.org|
20550397|NCT02132130|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20550398|NCT02760069|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April.mil@mail.mil|
20550399|NCT04748120|Cleveland Clinic Foundation|Dr. Clayton Petro|216-444-3501|petroc@ccf.org|
20550400|NCT00646776|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
20550401|NCT03305653|Children's Hospital Colorado|Dr. Calies Menard-Katcher|720-777-2318|calies.menard-katcher@childrenscolorado.org|
20577289|NCT04102098|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550402|NCT00705653|Progen Industries|Michael Fitzgerald|919-803-9988|michaelf@progen-pharma.com|
20550403|NCT04208698|CinDome Pharma, Inc.|Director of Clinical Trials|844-531-1834|info@cinrx.com|
20577290|NCT04373551|University of Alabama at Birmingham|Dr. Mirjam-Colette Kempf|205-934-9333|MKempf@uab.edu|
20577291|NCT05617911|Gaylord Hospital|John Corbett|203-294-3224|jcorbett@gaylord.org|
20550404|NCT03031678|MED-EL Corporation|Allison Racey|1-888-633-3524|research.us@medel.com|
20577292|NCT04507126|MGH|Research Operations Director|617-724-1992|jgerber2@mgh.harvard.edu|
20577293|NCT01440010|Medical Faculty Mannheim, Heidelberg University|PD Dr. med. Elena Sperk|+496213838624|elena.sperk@medma.uni-heidelberg.de|
20577294|NCT05979207|Medicines for Malaria Venture|Director, Program Leadership and Strategy|+41 22 555 03 00|info@mmv.org|
20550405|NCT00439244|Novartis Pharmaceuticals|Study Director|862-778-8300||
20577295|NCT03975647|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20550406|NCT00590005|Emory University Department of Pediatrics|Dr. Anne Fitzpatrick, Director, Emory Asthma Clinical Research Program|404-727-9112|anne.fitzpatrick@emory.edu|
20550407|NCT04557371|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20550408|NCT01154764|Asan Medical Center|Hyeong-Seok Lim MD, Ph.D|+82 2 3010 4613|mdihs@amc.seoul.kr|
20550409|NCT01482884|AstraZeneca|Mark Berner Hansen|+46 31 776 4794|Mark.Berner.Hansen@astrazeneca.com|
20550410|NCT02044393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20577296|NCT04868903|The University of Chicago|David Meltzer, MD, PhD|7737020836|dmeltzer@bsd.uchicago.edu|
20550411|NCT04419714|Wesper/Tatch|Amir Reuvent|5754482824|amir@wesper.co|
20502386|NCT03076983|Drägerwerk AG & Co. KGaA|Mr. Robin Hüwel|+49 451 882 6830|ClinicalAffairs@draeger.com|
20502387|NCT03543410|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20502388|NCT02435914|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20502389|NCT02642094|University of Texas Health Science Center|LUZHE SUN, Ph.D.|210-567-5746|sunl@uthscsa.edu|
20502390|NCT01818726|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20502391|NCT04871711|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20502392|NCT01913483|Miami Cardiac & Vascular Institute, Baptist Health South Florida|Chief Medical Executive|800-273-2700|MCVI@BaptistHealth.net|
20502393|NCT02420873|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/ Associate Professor|713-794-4392|ndaver@mdanderson.org|
20502394|NCT01469000|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20502395|NCT04033419|University of North Carolina at Chapel Hill, Department of Psychiatry|Zev Nakamura, MD|(984) 974-3829|zev_nakamura@med.unc.edu|
20502396|NCT00742469|Valeant Pharmaceuticals|Valeant Pharmaceuticals|(866) 246-8245||
20502397|NCT03618056|Fred Hutchinson Cancer Research Center|Jessica Andriesen|206-667-5812|jandries@fredhutch.org|
20502398|NCT02026063|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD|281-863-3000|plapuerta@lexpharma.com|
20502399|NCT00723788|Children's National Health System|Pranav Vyas, MD|2024760186|PVyas@childrensnational.org|
20502400|NCT00632853|Mayo Clinic|Dr. Steven Schild|480-301-9692|sschild@mayo.edu|
20502401|NCT03564626|Virginia Commonwealth University|Dr. Jasmohan Bajaj|(804) 828-4060|jasmohan.bajaj@vcuhealth.org|
20502402|NCT00486278|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20502403|NCT00931489|University of California Davis, Department of Ophthalmology & Vision Science|Lawrence S. Morse, MD, PhD|916 734 6074|lsmorse@ucdavis.edu|
20502404|NCT02183519|University of Florida Communicative Disorders|Karen Hegland, PhD|352-273-3710|kwheeler@ufl.edu|
20502405|NCT04556617|Opna Bio|Kerry Inokuchi|650-204-4065|info@opnabio.com|
20502406|NCT01211600|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
20502407|NCT05168267|University of Wisconsin Madison - Incarceration and Mental Health Lab|Michael Koenigs|(608) 263-1679|mrkoenigs@wisc.edu|
20502408|NCT02937350|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
20502409|NCT00695565|Arcion Therapeutics, Inc.|Dr. James Campbell|(410) 522-8701|jcampbell@arciontherapeutics.com|
20502410|NCT01462266|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502411|NCT01106846|Northwestern University|Shireen Ahmad, M.D.|321-472-3585|sah704@northwestern.edu|
20502412|NCT02288273|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|Sergey.Zhuplatov@astrazeneca.com|
20502413|NCT00494143|VA Puget Sound Health Care System|Dr. Joseph Czerniecki|206 277 5188|joseph.czerniecki@va.gov|
20502414|NCT04247425|Oregon Health & Science University|Lara Davis, MD|5034948423|davisla@ohsu.edu|
20502415|NCT02247193|The University of Texas Health Science Center at Houston|Matthew R. Greives, MD|713-500-7275|Matthew.R.Greives@uth.tmc.edu|
20502416|NCT00692211|New Mexico VA Health Care System|Richard Hoffman, MD|505-265-1711|richard.hoffman2@va.gov|5318
20502417|NCT04698629|University of Washington|Dr. Judith Tsui|206-744-1835|tsuij@uw.edu|
20502418|NCT02320487|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502419|NCT06228586|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20577297|NCT03449901|Washington University School of Medicine|Mia Weiss, M.D.|314-362-5737|m.c.weiss@wustl.edu|
20577298|NCT03150173|Montefiore Medical Center|Dr. Aaron D. Fox, Professor, General Internal Medicine|718-920-7173|adfox@montefiore.org|
20577299|NCT05444556|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20577300|NCT04939519|Huntsman Cancer Institute at University of Utah|Dr. David Wetter|801-213-6178|david.wetter@hci.utah.edu|
20577301|NCT03735667|Boston Scientific|Sarah Zanon|+41 79 840 7006|sarah.zanon@bsci.com|
20577302|NCT02523040|Dana-Farber Cancer Institute|Eric Jacobsen, MD|857-215-1405|eric_jacobsen@dfci.harvard.edu|
20577303|NCT02772562|Medical University of South Carolina|Dr. Michael Lilly|843-792-4271|lillym@musc.edu|
20577304|NCT03755791|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20577305|NCT03316573|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617-632-6633|edjacobsen@partners.org|
20577306|NCT04075890|UCLA|Reza Tadayon Nejad|3102066389|rtadayonnejad@mednet.ucla.edu|
20577307|NCT00799812|BD|Erin Zook|847-362-9047|erin.zook@bd.com|
20577308|NCT03599635|University of Minnesota|Jason Habeck|612-624-9990|habe0073@umn.edu|
20577309|NCT03109847|Thomas Jefferson University|Joseph Curry, MD|215-503-6828|joseph.curry@jefferson.edu|
20577310|NCT04976621|Corporal Michael J. Crescenz VA Medical Center|Helene Moriarty, PhD, RN|610-519-5735|helene.moriarty@va.gov|
20577311|NCT03212170|UW Carbone Cancer Center|Dr. Amy Fowler, MD, PhD|608-262-9186|afowler@wisc.edu|
20577312|NCT02759172|Michigan State University|Dr. Jennifer Johnson|810-730-6121|jjohns@msu.edu|
20577313|NCT03676010|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Dr Carine Bellera|+33 (0)5 56 33 33 33|c.bellera@bordeaux.unicancer.fr|4495
20577314|NCT03205995|Omeros Corporation|Dr. Andreas Grauer|206-676-5000|ctinfo@omeros.com|
20577315|NCT03892746|Cleveland Clinic|Ela Plow, Associate Professor|216-445-4589|plowe2@ccf.org|
20577316|NCT03851796|Virginia Commonwealth University|Dr. Melanie K Bean|804-527-4756|melanie.bean@vcuhealth.org|
20577317|NCT04068610|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20577318|NCT05535972|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20577319|NCT01366417|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
20577320|NCT03594994|Washington University|Joseph Beals|314-362-8199|bealsjw@wustl.edu|
20577321|NCT02649894|Becton Dickinson|Dawn Heimer|2018476800|dawn.heimer@bd.com|
20577322|NCT05363683|University of Nebraska Medical Center|Elizabeth Wellsandt|402-559-4309|elizabeth.wellsandt@unmc.edu|
20577323|NCT04590963|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20577324|NCT04430738|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20577325|NCT06007664|University of Michigan|Noah J. Webster|734-936-3075|njwebs@umich.edu|
20577326|NCT00309985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20577327|NCT05575063|Johnson & Johnson Surgical Vision|Brian Pall, Dr.|+1 904 6292289|bpall@its.jnj.com|
20577328|NCT03659916|Albireo, An Ipsen Company|Medical Director|see email|clinical.trials@ipsen.com|
20577329|NCT04941456|Gaylord Hospital, Inc.|Dr. Henry Hrdlicka|203-284-2864|hhrdlicka@gaylord.org|
20577330|NCT02296684|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-362-4471|dadkins@wustl.edu|
20577331|NCT03347838|Rocky Mountain Regional VA Medical Center / University of Colorado School of Medicine|Robert Keith, MD|720-857-5120|robert.keith@cuanschutz.edu|
20577332|NCT02682420|BD Peripheral Intervention|Courtney Rothwell, Clinical Project Manager|602-830-5544|courtney.rothwell@bd.com|
20577333|NCT04452344|Rutgers University School of Dental Medicine|Cecile A. Feldman, DMD|973-972-4634|feldman@rutgers.edu|
20577334|NCT03422198|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20577335|NCT05171777|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20577336|NCT02364713|Mayo Clinic|Evanthia Galanis|507-266-0584|galanis.evanthia@mayo.edu|
20577337|NCT04686786|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20577338|NCT05445843|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20577339|NCT05307679|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20577340|NCT05628103|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-800-441-6763|smb_clinicaltranspa@otsuka-us.com|
20577341|NCT04840888|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20577342|NCT04191187|Moffitt Cancer Center|Dr. Nelli Bejanyan|813-745-6008|Nelli.Bejanyan@moffitt.org|
20577343|NCT03924869|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20577344|NCT05224544|Coloplast, Clinical strategies|Malene Hornbak Landauro, Medical writer of Clinical strategies|+4549112057|dkmhla@coloplast.com|
20577345|NCT03359759|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
20577346|NCT06279871|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
20577347|NCT04706507|Fred Hutch Cancer Center|Dr. Michael J. Boeckh|2066676706|mboeckh@fredhutch.org|
20577348|NCT05568888|CSL Behring|Study Director|16108784000|clinicaltrials@cslbehring.com|
20577349|NCT03708770|Becton Dickinson (BPV)|Courtney Rothwell|480.350.6037|courtney.rothwell@bd.com|
20577350|NCT02406781|Institut Bergonie|Pr Antoine Italiano|0524071947|a.italiano@bordeaux.unicancer.fr|
20577351|NCT04905082|City of Hope|Stacy W. Gray, MD. AM.|626-715-4425|stagray@coh.org|
20577352|NCT04026711|University of Vermont|Anne Dixon, Professor of Medicine|802 847 0000|anne.dixon@uvmhealth.org|
20577353|NCT05486065|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20577354|NCT00854373|University of California, San Francisco|Mitchell P. Rosen, MD|415-353-7475|rosenm@obgyn.ucsf.edu|
20577355|NCT05985395|University of Nebraska Medical Center|Windy Alonso|814-577-2941|windy.alonso@unmc.edu|
20577356|NCT03360539|Harvard University|Dr. Margaret McConnell|6174321232|mmcconne@hsph.harvard.edu|
20577357|NCT03919162|Vivoryon Therapeutics N.V.|Study Director|0049 34555599|clinics@vivoryon.com|00
20557559|NCT03237858|Boston Scientific|Joe Hobbs, Clinical Trial Manager|612-206-4703|JOE.HOBBS@BSCI.COM|
20557560|NCT02623816|MetroHealth Medical Center|Nisheet Waghray|2167785736|nwaghray@metrohealth.org|
20577358|NCT04671615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20577359|NCT03471143|Washington University School of Medicine|Dr. Patricia Dickson|314-273-2943|pdickson@wustl.edu|
20577360|NCT04745689|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20577361|NCT05741528|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-800-441-6763|SMB_ClinicalTranspa@otsuka-us.com|
20577362|NCT06400745|Alcon Research, LLC|Director Clinical Trial Management, Surgical IOL|1-888-451-3937|alcon.medinfo@alcon.com|
20577363|NCT04102189|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20577364|NCT03401489|San Francisco VA Medical Center|Bruce Ovbiagele|415-750-2047|bruce.ovbiagele@va.gov|
20577365|NCT03774082|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
20577366|NCT05478252|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20577367|NCT02553460|Lucile Packard Children's Hospital|Tanja A. Gruber, MD, PhD|(650) 723-5535|tagruber@stanford.edu|
20577368|NCT07071129|Stanford University|Jeffrey Goldberg, MD, PhD|(650) 723-6137|eye-chair-office@stanford.edu|
20577369|NCT04823650|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20577370|NCT01844986|AstraZeneca|Elizabeth Lowe|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20577371|NCT04846881|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20577372|NCT04560998|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20577373|NCT04862949|CHA Bundang Medical Center|Hong Jae Chon|82-31-780-3928|minidoctor@cha.ac.kr|
20577374|NCT07099521|South China Normal University|Dr. Yuanyuan Wang|+86 13076729124|angelayuanyuanwang@gmail.com|
20577375|NCT01950390|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20577376|NCT05938920|InSilico Medicine Hong Kong Limited|Yujin Tian|+86-21-50831718|Insilico-Clinicaltrial@insilico.ai|
20577377|NCT01251861|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20557561|NCT03075501|University of Illinois at Chicago|Emma Childs|312-355-2726|echilds@uic.edu|
20577378|NCT07106489|Universidad Nacional de Colombia|Leidy Tatiana Reyes Vega|+573016971711|ltreyesv@unal.edu.co|
20577379|NCT06462014|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
20577380|NCT07170488|University of Pittsburgh|Martina Anto-Ocrah|4123352862|maa509@pitt.edu|
20577381|NCT04381650|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20502420|NCT05888103|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20557562|NCT01886963|Carolinas HealthCare System|Dr. Todd Heniford|7043551813|todd.heniford@carolinashealthcare.org|
20502421|NCT05900115|innovation Research & Training|Tracy Scull, PhD|9194937700|tscull@irtinc.us|
20502422|NCT02949128|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20502423|NCT01602341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502424|NCT02152345|Columbia University Irving Medical Center|Dr. Mark A. Hardy|(212) 305-5502|mah1@cumc.columbia.edu|
20502425|NCT01641120|Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital|Lindsay Tuttle, MPH|860-714-2149|LTuttle@stfranciscare.org|
20502426|NCT02554929|The Hospital for Sick Children|Dr. Suneeta Monga|416-813-8954|suneeta.monga@sickkids.ca|
20502427|NCT01916980|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502428|NCT02324270|Teva Pharmaceuticals USA, Inc|Senior Director, Global Gx Clinical R&D- PD/CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20502429|NCT00546364|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20502430|NCT03521791|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20502431|NCT02090855|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6489|Paul.Sherwin@ge.com|
20502432|NCT04024501|AstraZeneca|AstraZeneca information Centre|1-877-240-9479|information.center@astrazeneca.com|
20502433|NCT03786432|William Beaumont University Hospital|Grace San Agustin|248 551 6679|grace.sanagustin@beaumont.org|
20502434|NCT00388947|Whitinsville Medical Center|Dr Samuel Zylstra|508-243-6260|samuelzylstra@milreg.org|
20502435|NCT04187092|University of Virginia|Joe M Hart|434.243.0256|jmh3zf@virginia.edu|
20502436|NCT00278876|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20502437|NCT01475734|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502438|NCT00771472|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502439|NCT00845195|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20502440|NCT04793399|ZERO LMC|Valentín García|91 336 86 86|jvalentingg@gmail.com|
20502441|NCT03054363|University of Colorado Hospital|Elena Shagisultanova, MD, PhD|7208480300|elena.shagisultanova@cuanschutz.edu|
20502442|NCT00880750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20502443|NCT03242954|Indiana University School of Nursing|Amy Knopf|206-356-9430|asknopf@iu.edu|
20502444|NCT00483327|Perlmutter Cancer Center at NYU Langone|Stephanie Blank, MD|212-731-5705|stephanie.blank@nyumc.org|
20502445|NCT01390389|McLean Hospital|Cara McCabe|617-855-2410|cfmccabe@partners.org|
20502446|NCT03593915|Sumitomo Oncology|Holly Beever|210-365-9014|holly.beever@oncology.sumitomo-pharma.com|
20502447|NCT01246206|Barbara Ann Karmanos Cancer Institute|Dr. Zaid Al-Kadhimi|800-527-6266|zalkadh@emory.edu|
20502448|NCT02002975|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20502449|NCT04660643|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20502450|NCT03988907|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20502451|NCT04391959|Azura Ophthalmics|Chief Medical Officer|17145598435|charles.bosworth@azuraophthalmics.com|
20502452|NCT01276171|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|48517
20502453|NCT03609619|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
20502454|NCT05162066|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20502455|NCT00167245|University of Pennsylvania|Dr. Kyle Kampman|2152223200|kampman@mail.med.upenn.edu|109
20502456|NCT00568555|Stanford University School of Medicine|Jarred Younger, PhD|650-724-2795|jyounger@stanford.edu|
20502457|NCT01871090|St Jude Medical, Inc.|Todd Stirman, Clinical Manager|(972) 526-9625|Tstirman@sjm.com|
20502458|NCT01231555|ViiV Healthcare|GSK Response Center|866-435-7343||
20502459|NCT03562663|Moss Rehabilitation Research Institute|Dylan Edwards|(215) 663-6411|EdwardDy@einstein.edu|
20502460|NCT01773421|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20502461|NCT00688909|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20502462|NCT03502330|Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center|Harriet Kluger, MD|(203) 200-6622|harriet.kluger@yale.edu|
20502463|NCT01496157|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
20502464|NCT00445302|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
20502465|NCT00445887|NRG Oncology|Linda Gedeon for James Kauderer, MA|716-845-1169|lgedeon@gogstats.org|
20502466|NCT03065179|UT Southwestern Medical Center|Dr. Hans Hammers|214/645-7445|Hans.Hammers@UTSouthwestern.edu|
20502467|NCT02472847|University of Illinois at Chicago|Dr. K. Luan Phan|312-355-5954|klphan@psych.uic.edu|
20502468|NCT03793439|Oregon Health & Science University|Dr. Marcia Friedman|5034948637|friedmam@ohsu.edu|
20502469|NCT00669617|Novartis Pharmaceuticals|Study Director|862-778-8300||
20502470|NCT01276821|Department of Child Health, Tribhuvan University Teaching Hospital, Institute of Medicine.|Dr. Aayush Khanal|977-1-4421532|aayush_khanal@yahoo.com|
20502471|NCT03980938|EIP Pharma, Inc|Jennifer Conway|(617) 744-4400|jconway@eippharma.com|
20502472|NCT02939131|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20502473|NCT02408692|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
20502474|NCT03569202|Finnsusp Ltd.|Dr. Jarmo Laihia, Manager of Clinical & Formulation Development|358 50 377 1212|jarmo.laihia@piiloset.fi|
20502475|NCT00420511|Leadership Sinai Centre for Diabetes, Mount Sinai Hospital|Dr. Ravi Retnakaran|416-586-4800|rretnakaran@mtsinai.on.ca|3941
20502476|NCT02415712|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20502477|NCT01668654|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502478|NCT01175005|Phoenixchildrens|Amanda Kasem|6025461910|akasem@phoenixchildrens.com|
20502479|NCT00454779|Amgen Inc.|Study Director|866-572-6436||
20502480|NCT01337973|VA Ann Arbor|Stephen Chermack, Ph.D.|734 845-5046|chermack@umich.edu|
20502481|NCT03256045|University of Washington|Dr. Andrew Cowan|206-606-7348|ajcowan@seattlecca.org|
20502482|NCT05210504|VUMC|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vumc.org|
20502483|NCT02522767|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20502484|NCT03222427|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20502485|NCT00254566|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20557563|NCT00970216|Chang Gung Memorial Hospital|Chau-Ting Yeh|88633281200|chautingy@gmail.com|8121
20502486|NCT00548548|Hoffman-LaRoche|Medical Communications|800-821-8590||
20502487|NCT01940484|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502488|NCT00358657|Fred Hutchinson Cancer Research Center|Dr. Kanwaldeep Mallhi|206-667-2014|kmallhi@fredhutch.org|
20502489|NCT01044966|Medical University of South Carolina|Dr. Bruce Frankel|8437922052|frankel@musc.edu|
20502490|NCT01705691|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
20502491|NCT02658448|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
20502492|NCT00841763|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20502493|NCT03634800|Weill Cornell Medicine|Dr. Himanshu Nagar|212-746-3704|hnagar@med.cornell.edu|
20502494|NCT02876887|Northwestern University|Mary McDermott, MD, Jeremiah Stamler Professor|1 312 503 6419|mdm608@northwester.edu|6419
20502495|NCT00272987|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20502496|NCT00356031|Massachusetts General Hospital|Dr. Sam S. Yoon, Principal Investigator|617 643-9475|syoon@partners.org|
20502497|NCT01076348|Medtronic, Inc.|Stefanie Lorinser, Sr. Clinical Research Specialist|763-526-2742|stefanie.lorinser@medtronic.com|
20502498|NCT01872338|VA New Jersey Healthcare System|Alejandro Interian, PHD|908-647-0180|alejandro.interian@va.gov|4617
20502499|NCT01284504|Stanford University|Anthony Doufas, MD, PhD|1-650-498-7699|agdoufas@stanford.edu|
20502500|NCT03739528|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
20502501|NCT01109940|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20502502|NCT02419508|Alcon, A Novartis Division|Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
20502503|NCT02490293|SeoulStmary's hospital|Tae-ho Hong|010-5206-5266|gshth@catholic.ac.kr|
20502504|NCT05556525|Mayo Clinic|Dr. Sebastian Fernandez-Bussy|904-953-6320|Fernandez-Bussy.Sebastian@mayo.edu|
20502505|NCT03657459|Cleveland Clinic|Nancy M. Albert PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN|216-444-7028|albertn@ccf.org|47028
20502506|NCT02707770|Imperial college healthcare NHS trust|vijay padmanaban|02033122349|vijay.padmanaban@nhs.net|
20502507|NCT01748071|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
20502508|NCT03068325|New York State Psychiatric Institute|Yuval Neria|646-774-8092|ny126@cumc.columbia.edu|
20502509|NCT00066690|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki-Voser, Head Trial Activities/Deputy Director|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
20502510|NCT00700180|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502511|NCT01613326|Novartis Pharmaceuticals|Study Director|4 161 324 1111||
20502512|NCT02088385|Changi General Hospital|Dr Andrew Kwek Boon Eu|6788 8833|andrew_kwek@cgh.com.sg|
20502513|NCT00605267|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20502514|NCT04557384|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20502515|NCT01418001|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
20502516|NCT00168831|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502517|NCT01505894|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502518|NCT01622569|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
20502519|NCT04173741|Hacettepe University|Dr. Asli Melek|+905376636789|aslimelek121@gmail.com|
20502520|NCT00059202|Mayo Clinic|Dr. Keith Lindor|507-284-2511||
20550412|NCT04221009|James A Haley Veterans' Hospital|Dr. Marc A Silva|813-972-2000|marc.silva1@va.gov|5613
20502521|NCT03378479|UZ Leuven|Prof. Dr. Joost Wauters - Intensivist|016344275|joost.wauters@uzleuven.be|
20502522|NCT03106779|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20502523|NCT04088409|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20502524|NCT04233229|Air Liquide Santé International|Marie-Danielle MILCENT / Clinical Project Manager|+33 (0)1 84 76 42 39|fralsi-ctpublication@airliquide.com|
20502525|NCT02288247|Astellas Pharma Europe Ltd. (APEL)|Clinical Trial Disclosure|+44 (0) 20 3379 8000|astellas.resultsdisclosure@astellas.com|
20502526|NCT04652804|Johns Hopkins Bloomberg School of Public Health|Shruti H. Mehta|443-287-3837|smehta@jhu.edu|
20502527|NCT00584194|USAMRIID Medical Division|Janice Rusnak, MD|301-619-4156|janice.rusnak@amedd.army.mil|
20550413|NCT00793598|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20550414|NCT02154490|SWOG Statistics & Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20557564|NCT01746043|UT MD Anderson Cancer Center|Lin,Steven H,M.D. Ph.D. / Radiation Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20557565|NCT02938169|Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine|Dr. Juseok Ryu|+82-10-4382-2328|jseok337@snu.ac.kr|
20557566|NCT00710606|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
20557567|NCT05044325|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20557568|NCT03036384|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
20502528|NCT04093531|University of Rochester|Ummara Shah, MD|585-275-1643|ummara_shah@urmc.rochester.edu|
20502529|NCT03118596|University Hospitals Coventry & Warwickshire NHS Trust|Dr Cyprian Mendonca|02476964000|cyprian.mendonca@hotmail.com|25871
20502530|NCT00927368|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20502531|NCT03473561|Abbott Laboratories|Suntje Sander, PhD|0049 - 511 - 6750 3254|suntje.sander@abbott.com|
20502532|NCT00191451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20502533|NCT00964431|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
20502534|NCT01114529|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|trialandresults.registries@novartis.com|
20502535|NCT00305942|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20502536|NCT02614079|University of Toledo Medical Center|Joseph Atallah, MD|419-383-6699|joseph.atallah@utoledo.edu|
20502537|NCT03072160|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
20502538|NCT00820755|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20502539|NCT02211261|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502540|NCT02817087|Houston Methodist Neurological Institute|David Chiu, M.D.|713-441-5801|dmccane@houstonmethodist.org|
20502541|NCT03543085|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
20502542|NCT02251912|University of North Carolina at Chapel Hill|Dr. Cort Pedersen|919-923-3284|cort_pedersen@med.unc.edu|
20502543|NCT00480857|University of Michigan Comprehensive Cancer Center|Dr. Daniel Hamstra|(734) 936-4300|dhamm@umich.edu|
20502544|NCT02551159|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20502545|NCT00243659|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20502546|NCT00268242|The Cleveland Clinic|Anjali S. Advani, MD|216-445-5330|advania@ccf.org|
20502547|NCT02175680|CytoDyn Inc.|Joseph Meidling, Sr. Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
20502548|NCT00464178|Hackensack University Medical Center|Dr. David Siegel|551-996-2000|DSiegel@hackensackumc.org|
20502549|NCT02052557|Des Moines University|Grants and Contracts Manager|5152711657|mlyon@dmu.edu|
20550415|NCT02298803|Diabetes Centre, Royal Prince Alfred Hospital|Dr Ted Wu|61295155888|ted.wu@sswahs.nsw.gov.au|
20550416|NCT02373202|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20550417|NCT02144233|University of Santiago de Compostela. A Coruña. SPAIN|Professor Urbano Santana Penín|+34647344093|urbano.santana@usc.es|
20550418|NCT00482612|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20550419|NCT00464087|Medstar Health Research Institute|Ron Waksman, MD|202-877-2812|ron.waksman@medstar.net|
20550420|NCT00088985|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@UNC.med.edu|
20550421|NCT01224431|Phoenix Children's Hospital|Angelique Ferayorni|602-546-1910|aferayorni@phoenixchildrens.com|
20550422|NCT02056782|Cantex|CBertrand|954-315-3660|cbertrand@cantex.com|
20550423|NCT03654651|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
20550424|NCT01401283|Hamburg Eppendorf University Hospital|Daniel A. Reuter, MD|+49-40-7410-0|dreuter@uke.de|
20550425|NCT02433483|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
20502550|NCT04506294|Children's Hospital of Philadelphia|Nancy Kassam-Adams, PhD (Principal Investigator)|215-590-3118|adamsn@chop.edu|
20502551|NCT01465659|Northwestern University|Sheetal Kircher, MD|312-695-0990|sheetal.kircher@nm.org|
20550426|NCT02569723|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20550427|NCT01606436|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550428|NCT04488068|VA San Diego Healthcare System|Mahadevan Rajasekaran, Ph.D.|8585528585|Mahadevan.Rajasekaran@VA.gov|7114
20550429|NCT04294472|Vera Therapeutics Inc.|Isabel Gorham, Director of Clinical Operations|(910)200-0532|isabel.gorham@veratx.com|
20550430|NCT02603419|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550431|NCT03552198|KCL|Dr D D'Antoni|NA|donatella.d'antoni@kcl.ac.uk|
20550432|NCT06149247|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
20550433|NCT02289417|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20550434|NCT02725710|Duke University|Jeremy M. Weber|919-681-4561|jeremy.m.weber@duke.edu|
20550435|NCT03572062|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550436|NCT01858389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
20550437|NCT01691781|Brigham and Women's Hospital|Anand Vaidya|6175258285|avaidya1@partners.org|
20550438|NCT03978520|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20550439|NCT01918085|Coloplast|Henrik Sigaard Knoth|+ 45 4911 3469|dkhsk@coloplast.com|
20550440|NCT01118221|MVAHS|Robert M Jackson, MD|305-575-3548|robert.jackson4@va.gov|
20550441|NCT01580618|Kaiser Permanente|Hyo-Chun Yoon, MD, PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
20550442|NCT01593215|RegionSkane|Anders Rosengren|+4640391169|anders.rosengren@med.lu.se|
20550443|NCT01550302|University of Washington|Srdjan Jelacic|(206) 598-3777|sjelacic@uw.edu|
20550444|NCT00600483|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20550445|NCT02343627|Taro Pharmaceuticals U.S.A. Inc|Senior Director, Clinical|+1 914-345-900|Natalie.Yantovskiy@Taro.com|
20550446|NCT03501069|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20550447|NCT02547454|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20550448|NCT00580606|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
20550449|NCT00240162|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20550450|NCT01684007|Alcon Research, Ltd.|Magda Michna, Expert Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20550451|NCT03655691|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
20550452|NCT03159624|University of Alabama at Birmingham|Dr. Brad Woodworth|205-801-7858|bwoodworth@uabmc.edu|
20550453|NCT03694821|UConn Health|Director of Outcomes, Research & Quality|860-679-4932|mcote@uchc.edu|
20550454|NCT01317030|Bausch & Lomb Incorporated|Robert Steffen, O.D., M.S.|585-338-6399|Robert.Steffen@bausch.com|
20550455|NCT04102020|ABBVIE CALL CENTER|AbbVie|844-663-3742|abbvieclinicaltrials@abbvie.com|
20550456|NCT05109442|Affimed GmbH|Clinical Operations|+49 621 56003-0|trials@affimed.com|
20550457|NCT04216329|National Cancer Institute|Dr. Kevin A. Camphausen|240-760-6205|camphauk@mail.nih.gov|
20550458|NCT03918447|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20550459|NCT03278613|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20550460|NCT01405456|Massachusetts General Hospital|Dr. Steven K. Grinspoon|6177249109|sgrinspoon@mgh.harvard.edu|
20550461|NCT02299297|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
20550462|NCT01774968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550463|NCT05353985|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20550464|NCT01730833|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20550465|NCT04847557|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20550466|NCT01325584|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
20550467|NCT03010254|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20550468|NCT00848081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550469|NCT00187876|University of Florida|Peter Indelicato, MD|352-273-7017|wernegs@ortho.ufl.edu|
20550470|NCT02064868|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20550471|NCT00603993|Abbott|Global Medical Services|1-800-633-9110||
20502552|NCT03434379|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20550472|NCT01393704|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
20502553|NCT01698528|Joslin Diabetes Center|Dr William Hsu|617-309-5803|william.hsu@joslin.harvard.edu|
20502554|NCT03122431|Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo|Prof Eloisa Bonfa|551130617490|eloisa.bonfa@hc.fm.usp.br|
20550473|NCT00418314|St. Jude Medical|Sr. Director Clinical Studies|(408) 522-6410|tshipman@sjm.com|
20502555|NCT02558374|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20550474|NCT02057406|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|jiang001@mc.duke.edu|
20550475|NCT02782780|San Francisco VA Health Care System|Dr. Linda Chao|415-221-4810|linda.chao@va.gov|24386
20550476|NCT03562481|University of North Carolina at Chapel Hill|Jessica Lee, DDS, MPH, PhD|9195373955|jessica_lee@unc.edu|
20557569|NCT00864708|NF/SG VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
20557570|NCT03145766|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20557571|NCT01391325|Ardea Biosciences, Inc.|Vice President, Clinical Research and Development|858.652.6587|sbaumgartner@ardeabio.com|
20557572|NCT02799472|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20557573|NCT02801669|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20557574|NCT00615264|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
20557575|NCT00058422|Memorial Sloan Kettering Cancer Center|Paul A. Hamlin, M.D.|646-608-1667|hamlinp@mskcc.org|
20557576|NCT03863522|Johns Hopkins University|Dr. Sara Sukumar|4106142479|saras@jhmi.edu|
20557577|NCT02884414|Stanford University|Jennifer Hledik|650-493-5000|jerhart@stanford.edu|62388
20557578|NCT01982435|Cleveland Clinic Foundation|Dr. Justis Ehlers|216-636-0183|Ehlersj@ccf.org|
20557579|NCT00871403|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557580|NCT00304512|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20550477|NCT03824912|Encube Ethicals Pvt Ltd|Dr. Lalatendu Panigrahi, Chief Scientific Officer|+91-22-6264-7002|lalatendu.p@encubeethicals.com|
20550478|NCT02904512|Veterans Affairs Medical Center|Dr. Ilias (Elias) Spanakis|(617) 319-9731|ispanakis@som.umaryland.edu|
20550479|NCT03828357|Abbott|Grant Kim, Director Clinical Programs|8184933147|grant.kim1@abbott.com|
20550480|NCT03219294|Maine Medical Center|Research Coordinator|2076622862|richaj3@mmc.org|
20557581|NCT02569437|Icahn School of Medicine at Mount Sinai|Dr. Benjamin Malkin||Benjamin.D.Malkin@kp.org|
20557582|NCT00985985|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557583|NCT01856712|University of Wisconsin|Randall Brown|6082636558|rtbrown@wisc.edu|
20557584|NCT02255357|new york psychiatric institute|wilfrid raby, m.d.|2129233031|wilfrid.raby@nyspi.columbia.edu|
20557585|NCT00509236|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557586|NCT01247428|Micell Technologies|Dennis Donohoe, MD, Chief Medical Advisor|919-313-2102|ddonohoeconsult@gmail.com|
20557587|NCT01112228|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20557588|NCT00312702|Walter Reed Army Institute of Research|James F. Cummings, MD|301-319-9312|james.cummings@us.army.mil|
20550481|NCT03454581|Federal University of Rio Grande do Sul|PhD Manoela Domingues Martins|55-51-33085011|manomartins@gmail.com|
20557589|NCT02192775|University of Arkansas for Medical Sciences|Brittany Lehman|501-686-8274|blehman@uams.edu|
20557590|NCT02255032|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20557591|NCT02037438|Stanford University|Dr. Clete Kushida|650-721-7560|clete@stanford.edu|
20557592|NCT03056534|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20557593|NCT06131294|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20557594|NCT00125593|Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford|Professor Colin Baigent|+44 1865 743743|colin.baigent@ctsu.ox.ac.uk|
20557595|NCT04146896|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
20557596|NCT01597505|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557597|NCT02675465|Amicus Therapeutics, Inc.|MedInfo|001 609-662-2000|MedInfoUSA@amicusrx.com|
20557598|NCT04203537|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
20557599|NCT04543188|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557600|NCT02583763|Region Östergötland / University of Linköping|Olov Änghagen PhD student|+461047246|olov.anghagen@regionostergotland.se|
20557601|NCT05004688|Mass General|Kayla McEachern|617 643 5265|kmceachern2@mgh.harvard.edu|
20557602|NCT01313286|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20557603|NCT05158296|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
20557604|NCT02552238|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
20557605|NCT01986101|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20557606|NCT02036645|AstraZeneca Pharmaceuticals|Michael Pomfret, Project Director, IMED Neuroscience||Clinicaltrialstransparency@astrazeneca.net|
20557607|NCT04241094|Center for Care Delivery & Outcomes Research|Laura Meis, PhD|651-467-4516|laura.meis@va.gov|
20550482|NCT01963403|UC Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
20550483|NCT03395886|Zhongshan Hospital, Fundan university|Mr Zhe Luo|64041990|ec@zs-hospital.sh.cn|
20550484|NCT03836612|St Thomas' Hospital, London|Dr Peter Irving|020 7188 7188|peter.irving@gstt.nhs.uk|
20550485|NCT02557698|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
20550486|NCT00549302|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550487|NCT03585504|Medical University of South Carolina|Dr. Angela Dempsey|843-762-4500|dempsear@musc.edu|
20550488|NCT01414114|Amgen, Inc|Study Director|866-572-6436||
20557608|NCT02498834|University of North Carolina at Chapel Hill|Betsy Sleath, PhD|(919) 962-0079|betsy_sleath@unc.edu|
20557609|NCT04204200|Centre Hospitalier de Ham|Dr. Jean-Francois Cazeneuve, Surgeon|06 62 29 24 51|jfc.laon@gmail.com|0033
20557610|NCT01949779|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
20557611|NCT03466918|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
20557612|NCT02272725|Stanford University School of Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
20557613|NCT01061333|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557614|NCT04858802|Medtronic plc|Xiaomin Deng|707-566-1311|Xiaomin.deng@medtronic.com|
20557615|NCT02026232|Washington University School of Medicine|Dr. Janet McGill|314-273-3929|jmcgill@wustl.edu|
20557616|NCT03610737|Vertos Medical|Angie Lee|949-349-0008|alee@vertosmed.com|
20557617|NCT02714868|Department of Occupational Therapy, Boston University|Dr. Jessica Kramer, Assistant Professor, PI|617-353-2702|kramerj@bu.edu|
20557618|NCT02013388|Nivalis Therapeutics, Inc.|Nivalis Therapeutics, Inc. (Formerly N30 Pharma)|720-945-7700|steven.shoemaker@nivalis.com|
20550489|NCT01737944|Antares Pharma|Jonathan Jaffe, MD; Vice President Clinical Development|1-609-359-3020|jjaffe@antarespharma.com|324
20557619|NCT00571961|Yale University AIDS Program|R. Douglas Bruce, MD, MA, MSc|(203) 737-6133|robert.bruce@yale.edu|
20557620|NCT04461795|Clinvest Research|Jim Sly|417-841-3673|jsly@clinvest.com|
20557621|NCT00185640|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
20557622|NCT01134601|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citind@mail.nih.gov|
20557623|NCT01817374|UAB Radiology Research|Marianne Vetrano|205-934-4080|mvetrano@uabmc.edu|
20557624|NCT03154281|Avera Cancer Institute|Dr. Casey Williams|6053223588|Casey.Williams@avera.org|
20557625|NCT02396537|University of Alabama at Birmingham|Dr. Christopher Pruitt|2056389587|cpruitt@peds.uab.edu|
20557626|NCT00927355|Emory|Dr. George Beck|404-686-1000|gbeck@emory.edu|
20557627|NCT01572389|Department of Veteran Affairs|Aanand, Naik, MD|713-794-8541|anaik@bcm.edu|
20557628|NCT01153269|Abbott|Global Medical Services|1-800-633-9110||
20557629|NCT03315936|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20557630|NCT02635724|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20557631|NCT04048863|B. Braun Medical Inc.|Dr. Diana Valencia|610-596-2875|diana.valencia@bbraunusa.com|
20557632|NCT01159743|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20557633|NCT00100932|Eisai|Dr. Peter Tarassoff|888-422-4743||
20557634|NCT00829686|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
20557635|NCT02387996|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20557636|NCT02424591|NYU School of Medicine|John Ard, MD|212.263.5072|john.ard@nyumc.org|
20557637|NCT01446796|Duke University Medical Center|Michel Khouri, MD|919 684 8111|michel.khouri@duke.edu|
20557638|NCT00818363|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20557639|NCT00770432|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20557640|NCT01453348|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20557641|NCT00633919|ALK-Abelló S.A.|Santiago Martín - Trial Manager|+34 913276127|santiago.martin@alk-abello.com|
20550490|NCT05620563|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20550491|NCT01781403|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
20550492|NCT02085785|Department of Veterans Affairs|Dr. Alyson Littman, Research Health Scientist|206-277-4182|alyson.littman@va.gov|
20557642|NCT01673893|Cardiovascular Institute of the South Clinical Research Corporation|Deanna K. Benoit, LPN, CCRC|985-876-0300|deanna.benoit@cardio.com|5613
20557643|NCT02756832|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20557644|NCT01991821|Acacia Pharma|Dr Gabriel Fox|01223875130|GabrielFox@acaciapharma.com|149
20557645|NCT00632281|University of Florida|Bridget Fitzgerald, Clinical Research Coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
20557646|NCT00954733|Northwestern University|Gildaasio De Oliveira, M.D.|312-472-3573|gjr@northwestern.edu|
20557647|NCT03592277|Saint Francis Hospital and Medical Center|David Shapiro, MD, MHCM, FACS, FCCM CMO of Saint Francis Hospital and Medical Center|860-833-5673|dshapiro@trinityhealthofne.org|
20557648|NCT01566630|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20557649|NCT03579290|Yale University|Theresa Babuscio Data Manager|203-737-5430|theresa.babuscio@yale.edu|
20557650|NCT01781390|Mesoblast, Inc.|Kenneth Borow, MD (Lead, Global Cardiovascular Development)|(212) 880-2060|Ken.Borow@Mesoblast.com|7951
20557651|NCT00622713|Novartis Pharmaceuticals|Study Director|862-778-8300||
20557652|NCT00861601|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557653|NCT01719237|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu|
20557654|NCT02914314|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20557655|NCT01973036|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
20557656|NCT03728972|Memorial Sloan Kettering Cancer Center|Dr. Malin Hultcrantz MD, PhD|646-608-3714|hultcram@mskcc.org|
20557657|NCT00895622|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20550493|NCT03590041|University of Colorado Anschutz medical Campus|Dr. Bethany Kwan|303-724-5153|bethany.kwan@cuanschutz.edu|
20550494|NCT02692703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20550495|NCT04626297|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20557658|NCT03324880|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20557659|NCT00652938|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557660|NCT03020225|BGU|Prof. Iris Shai|+972 52-579-3040|irish@bgu.ac.il|
20557661|NCT01412801|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20557662|NCT01547299|Medivation, Inc.|William Novotny, MD, Sr. Director, Clinical Development|415- 983-3066|william.novotny@medivation.com|
20550496|NCT04118166|Stanford Medicine at Stanford University|Maria Ahern|650-725-6413|mahern@stanford.edu|
20550497|NCT03434275|Baudax Bio, Inc.|Development|484-395-2440|info@baudaxbio.com|
20550498|NCT03519932|CooperVision Inc.|Jose A.Vega OD, MSc., FAAO|9256213761|javega@coopervision.com|
20550499|NCT02254486|Norgine Ltd|Lucy Clayton|+44-1895-826669|lclayton@norgine.com|
20550500|NCT01350414|Boston Scientific|Narinder Shargill|408-635-3907|Narinder.Shargill@bsci.com|
20550501|NCT00460408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550502|NCT00936585|National Institute of Allergy and Infectious Diseases|Michael Yao, MD|301-594-0593|yaomic@niaid.nih.gov|
20550503|NCT01573572|Bausch Health|Study Manager|908-242-8287|sandra.narain@bauschhealth.com|
20550504|NCT02309489|King's College London, UK|Dr Marina Daniele|020 7836 5454|marina.daniele@kcl.ac.uk|
20557663|NCT00782496|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20557664|NCT00584935|UAB Department of Dermatology|Wendy Cantrell, CRNP|205-502-9960|wcantrell@uabmc.edu|
20557665|NCT01987817|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20557666|NCT02402296|Al-Azhar University- Faculty of dental medicine (Girls branch)|Professor Hala Helmi Hazzaa|00201014129297|hala.hazzaa@yahoo.com|
20557667|NCT01576718|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20557668|NCT01874145|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20557669|NCT04631705|Institute of Virology|Prof. Florian Klein|49221478|florian.klein@uk-koeln.de|85800
20557670|NCT05741385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20557671|NCT01742364|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
20557672|NCT02439749|Medtronic|Pamela McKenna, Sr. Principal Clinical Research Specialist|(773) 597-5241|pamela.m.mckenna@medtronic.com|
20557673|NCT00916032|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20557674|NCT01995487|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
20557675|NCT00140205|BIDMC|Dr. Christos mantzoros|6176671656|cmantzor@bidmc.harvard.edu|
20557676|NCT04226365|Penn Medicine / Lancaster General Hospital|Halle Becker, MPH, Research Project Manager|7175441777|Halle.Becker@pennmedicine.upenn.edu|
20557677|NCT06412146|Children's Mercy Research Institute|Sophie MacColl|8166011485|risingT1DE@cmh.edu|
20557678|NCT04739761|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20557679|NCT02584725|Columbia University Irving Medical Center|Robert Maniker, MD|212-305-9876|rm3046@cumc.columbia.edu|
20557680|NCT03881696|DAIT/NIAID|Director, Clinical Research Operations Program|202-604-9855|DAITClinicalTrialsGov@niaid.nih.gov|
20557681|NCT05690776|Zimmer Biomet|Julie Nicoux|+33672613502|julie.nicoux@zimmerbiomet.com|
20557682|NCT01816763|VA Palo Alto|Karl Lorenz MD MSHS, Principal Investigator|6504935000|kalorenz@stanford.edu|
20557683|NCT02783820|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
20502556|NCT00769119|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20557684|NCT01186328|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20557685|NCT02357290|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
20557686|NCT03941015|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Dr. Jun Ma|13370103671|18710168703@163.com|
20557687|NCT02207725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20557688|NCT03395808|Avenue Therapeutics|Micheal Ryan, VP Clinical|781-652-4514|mryan@avenuetx.com|
20550505|NCT03303079|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20550506|NCT00010374|Synapse Biomedical, Inc.|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
20550507|NCT06185374|NYU Langone Health|Peter Liang, MD|(212) 686-7500|peter.liang@nyulangone.org|5745
20550508|NCT00372112|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550509|NCT01426373|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
20550510|NCT02756689|UAB|Lorie Harper, MD|205-934-5611|lmharper@uabmc.edu|
20550511|NCT01574326|Genzyme Corporation|Trial Transparency Team||Contact-US@sanofi.com|
20550512|NCT03856164|University of Texas Southwestern|Dr. Olutoyosi Ogunkua|2145578873|olutoyosi.ogunkua@utsouthwestern.edu|
20550513|NCT01919723|University of Alabama at Birmingham|Mehak Goel ,PhD|205-975-4021|mehakgoel@uabmc.edu|
20550514|NCT04502589|Virginia Commonwealth University|Albert Arias, M.D.|(804) 828-5793|albert.arias@vcuhealth.org|
20550515|NCT00911053|Oregon Health and Science University|OHSU IRB|5034948849|irb@ohsu.edu|
20550516|NCT00137046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20550517|NCT01288469|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
20550518|NCT05860647|HealthPartners Institute Neuroscience Research Center|Bhavani Kashyap, MBBS, PhD|651-495-6565|bhavani.x.kashyap@healthpartners.com|
20550519|NCT00582166|University of Wisconsin Carbone Cancer Center|Lymphoma/Myeloma Disease Oriented Team|608-265-3794|barnstable@wisc.edu|
20557689|NCT01966003|Amgen Inc.|Study Director|866-572-6436||
20557690|NCT00674570|San Francisco VA Health Care System|Sabra Inslicht, Ph.D.|415-221-4810|sabra.inslicht@ucsf.edu|23341
20550520|NCT02859454|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@nih.gov|
20550521|NCT00110149|BIDMC|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
20550522|NCT03334448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20550523|NCT01767155|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
20550524|NCT02518750|St. Jude Children's Research Hospital|Sima Jeha, MD|901-595-3901|sima.jeha@stjude.org|
20550525|NCT01365910|Vanderbilt-Ingram Cancer Center|Dr. Jordan Berlin|615-343-4128|jordan.berlin@vanderbilt.edu|
20550526|NCT00371137|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
20550527|NCT02013791|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20550528|NCT03798483|Oxford University hospital foundation trust|Colin Forde|+441865221540|Colin.Forde@ouh.nhs.uk|
20550529|NCT01462097|University of Maryland School of Medicine|Stephen Seliger, MD MS|410-605-7000|sseliger@som.umaryland.edu|x55231
20550530|NCT01835587|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20550531|NCT01307007|Luitpold Pharmaceuticals, Inc.|Sumita Chowdhury, MD, MPH, FACC, MBA|610-650-4200|SChowdhury@lpicrd.com|
20550532|NCT03310775|Kyunghee university hospital, Seoul, South Korea|Dr. Miae Oh|82-10-8929-5048|miae612@naver.com|
20550533|NCT00126568|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Panayiotis Savvides|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
20502557|NCT00686647|AngioScore|Gary Gershony, MD/ Chief Medical Officer|510-933-7900|gary@angioscore.com|
20550534|NCT03064451|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
20550535|NCT05475236|Veterans Health Administration|Dr. Clayton Swanson|3523761611|clayton.swanson@va.gov|107583
20550536|NCT00477971|Mayo Clinic|Dr. Morie Gertz||gertz.morie@mayo.edu|
20550537|NCT05355805|Acelyrin|Donald Betah|(805) 419-3805|Donald.Betah@acelyrin.com|
20550538|NCT00609492|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550539|NCT04493281|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20550540|NCT02634684|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
20550541|NCT00589914|Johnson & Johnson Pharmaceutical Research & Development LLC|Clinical Leader Psychiatry|1 609 730-2324||
20550542|NCT01356966|Emory University|Dr. Jeanie Park|404-727-1386|jeanie.park@emory.edu|
20550543|NCT00103142|Duke University Medical Center|Dr. Michael Morse|919-684-5705|michael.morse@dm.duke.edu|
20550544|NCT02606604|Stony Brook University|Lori Hochman|631-444-1193|lori.hochman@stonybrook.edu|
20550545|NCT01830699|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
20550546|NCT03315208|Massachusetts General Hospital/Harvard Medical School|Dr. Kate Bentley|617-724-7741|kbentley@mgh.harvard.edu|
20550547|NCT03472469|The University of Texas Health Science Center at Houston|John A. Harvin, MD|(713) 500-7244|John.Harvin@uth.tmc.edu|
20550548|NCT05259696|Palleon Pharmaceuticals|Palleon Clinical Development|857-285-5900|clinical@palleonpharma.com|
20550549|NCT00982592|Perlmutter Cancer Center at NYU Langone|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
20550550|NCT01669915|Brigham and Women's Hospital;181 Longwood Ave; Boston, MA 02115|Jae Hee Kang|617-525-2022|nhjhk@channing.harvard.edu|
20502558|NCT02385279|European Cardiovascular Research Institute|Dr. E. Spitzer|+31102062828|E.Spitzer@ECRI-Trials.com|
20550551|NCT02706691|University of Chicago Comprehensive Cancer Center|Technical Director|773-702-0819|pccc_regulatory@bsd.uchicago.edu|
20502559|NCT00604968|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550552|NCT00356369|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550553|NCT03545165|Weill Cornell Medicine|Scott Tagawa MD, Principal Investigator|646-962-2072|guonc@med.cornell.edu|
20550554|NCT01830972|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
20550555|NCT02408315|Indiana University School of Medicine|Dr. David M. Haas|317-880-3949|dahaas@iu.edu|
20550556|NCT00673465|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550557|NCT01829191|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
20550558|NCT01276353|Clinical Development. JAC PCU. Eisai Co., Ltd.|Naoki Kubota|+81-3-3817-5245||
20502560|NCT01116544|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
20502561|NCT00578643|Baylor College of Medicine|Robert Krance, MD|(832) 824-4661|rakrance@txch.org|
20502562|NCT01725750|Icahn School of Medicine at Mount Sinai|Jacob Greisman|212-241-4886|Jacob.greisman@mountsinai.org|
20550559|NCT03546192|Sanofi Pasteur Inc.|Medical Director|800-633-1610 ext 1#|RegistryContactUs@sanofipasteur.com|
20550560|NCT01200602|Mayo Clinic|Vilmarie Rodriguez, MD|507-284-2695|rodriguez.vilmarie@mayo.edu|
20550561|NCT02648178|The Koop Institute at Dartmouth, Geisel School of Medicine|Dr James Sargent|603-653-9025|James.D.Sargent@dartmouth.edu|
20550562|NCT00553514|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20550563|NCT02205814|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
20550564|NCT04952402|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20550565|NCT00726661|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20550566|NCT03327649|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|14052714742|stavros-stavrakis@ouhsc.edu|
20550567|NCT00143403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502563|NCT01831960|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20502564|NCT03828487|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
20502565|NCT03042936|UTHSC|Joan Han|9012876408|jhan14@uthsc.edu|
20502566|NCT02022826|Medtronic|Michal Kedar-Datel|+972-4-9097952|michal.kedar-datel@medtronic.com|
20502567|NCT03179436|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502568|NCT02887521|Mayo Clinic|Roberto Benzo, MD, MSc|(507) 284-0561|benzo.roberto@mayo.edu|
20502569|NCT01119456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20502570|NCT01332071|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502571|NCT01634555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20502572|NCT02542761|Mayo Clinic|Kenton Kaufman, Ph.D.|507-266-0136|Kaufman.Kenton@mayo.edu|
20502573|NCT01738971|University of Edinburgh|Dr Lucy Michie|0131 5361542|michieluc@yahoo.co.uk|
20502574|NCT01821300|The Children's Hopsital of Philadelphia|Dr. Andrea Kelly|215590-3174|kellya@email.chop.edu|
20502575|NCT02065453|Saint Louis University|M. Brigid Holloran-Schwartz, MD|314-781-8605|holloran@slu.edu|1
20502576|NCT03267004|University of Tennessee|Hollie Raynor|865-974-6259|hraynor@utk.edu|
20502577|NCT03694392|Kaiser Permanente Vaccine Study Center|Amber Hsiao Hyman, Senior Research Project Manger|510-267-7517|Amber.Hyman@kp.org|
20502578|NCT00618722|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20502579|NCT00200057|Medtronic Neuromodulation|Chad Giese|763-377-5955|chad.giese@medtronic.com|
20502580|NCT05512949|St. Louis University|Sharon E. Frey, M.D.|314-977-5500|sharon.frey@health.slu.edu|
20502581|NCT02810964|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
20550568|NCT00587639|Mayo Clinic|Dr. Christopher Wall|5072843352|wall.chris@mayo.edu|
20550569|NCT01860651|Hvidovre University Hospital|Dr. Katrine Carlsen|26180513|katrinec@gmail.com|0045
20550570|NCT02695498|Atrium Health Wake Forest Baptist|Rebecca Wells, MD, MPH|336-716-2357|rewells@wakehealth.edu|
20550571|NCT00160251|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20550572|NCT03782272|PATH|Gwen Ambler, Clinical Research Officer|+1-206-285-3500|gambler@path.org|
20550573|NCT02245308|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
20550574|NCT02452398|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20550575|NCT04216017|University of Washington|Dr. Jonah Hebert-Davies|2067443466|jdavies2@uw.edu|
20502582|NCT03523351|Memorial Sloan Kettering Cancer Center|Dr. Divya Yerramilli, MD|646-449-1931|yerramid@mskcc.org|
20550576|NCT00748033|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
20550577|NCT01018186|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502583|NCT01430442|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20550578|NCT02925494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20550579|NCT02845453|Boston Medical Center|Amy Yule, MD|617-414-1936|amy.yule@bmc.org|
20550580|NCT03735433|The Ohio State University|Kara Rood, MD|614-293-8515|Kara.Rood@osumc.edu|
20550581|NCT04973826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550582|NCT00165776|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|+81-3-3817-5245||
20550583|NCT00492583|Georgetown University|Daniel J Merenstein, MD|202-687-2745|djm23@georgetown.edu|
20550584|NCT00387023|UT MD Anderson Cancer Center|Bita Esmaeli, MD / Professor||CR_Study_Registration@mdanderson.org|
20550585|NCT00064844|Yale University School of Medicine|Ned Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
20502584|NCT03363633|Duke University Medical Center|Ellen D. Dillavou, MD, FACS||ellen.dillavou@duke.edu|
20550586|NCT00750204|Johns Hopkins University School of Medicine|Roy Brower, M.D.|1 (410) 614-6292|rbrower@jhmi.edu|
20550587|NCT00434330|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20550588|NCT02421315|New York State Psychiatric Institute|Dr. Rachel Marsh|646-774-5774|rachel.marsh@nyspi.columbia.edu|
20509054|NCT01906476|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
20550589|NCT04853225|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20550590|NCT00850564|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
20550591|NCT00534430|Department of Hematology, City of Hope|Anthony Stein, MD, Clinical Professor|626-537-5748|astein@coh.org|
20550592|NCT01404325|Novartis Pharmaceuticals|Study Director|8627788300||
20550593|NCT02389088|University of California, San Diego|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
20550594|NCT01075204|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954|esther.oppermann@abbott.com|
20550595|NCT00945139|University of Vermont CC|Dr. Claire Verschraegen|802-656-5487|claire.verschraegen@vtmednet.org|
20550596|NCT01986855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550597|NCT04317066|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20550598|NCT00333814|Allergan, Inc|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20550599|NCT02825992|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|763-331-4344|steven.mcquillan@acutus.com|
20550600|NCT01780636|UC Irvine|Karen Noblett|714-456-6807|knoblett@uci.edu|
20550601|NCT00711711|HECVSanté|Pr. Claude Pichonnaz|++41213168126|claude.pichonnaz@hesav.ch|
20550602|NCT02279173|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20550603|NCT01129609|Medtronic|Rianna Rapson|763-526-2170|rianna.k.rapson@medtronic.com|
20550604|NCT01164956|Dana-Farber Cancer Institute|Christina K. Ullrich, MD, MPH|617.632.4997|Christina_Ullrich@dfci.harvard.edu|
20550605|NCT00720434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550606|NCT02425046|Center for Children's Healthy Lifestyles & Nutrition - Children's Mercy Hospital|Dr. Helena Laroche|(816) 234-9251|hhlaroche@cmh.edu|
20550607|NCT01571427|Oregon Health & Science University|Dr. Hiroko Dodge|(503) 494-6695|dodgeh@ohsu.edu|
20550608|NCT02106728|Toronto General Hospital|Dr. Gina Dimitropoulos|416-340-3749|gdimit@ucalgary.ca|
20550609|NCT00267046|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-7966|xzhou@mdanderson.org|
20550610|NCT02066233|Mayo Clinic|Dr. Prasad G. Iyer|507-284-6469|Iyer.Prasad@mayo.edu|
20550611|NCT01077856|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550612|NCT01979016|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20502585|NCT00772629|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20502586|NCT04866290|Merit Medical Systems, Inc.|Vicky Brunk RN, Vice President, Medical Affairs, Merit Medical|+1 (717) 873-3309|vicky.brunk@merit.com|
20502587|NCT04051957|The University of Texas Health Science Center at Houston|Jaya Kala, MD|713-500-6868|jaya.kala@uth.tmc.edu|
20502588|NCT01097629|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502589|NCT03760484|University of Alberta|Dr. Dina Kao|780-233-6025|dina.kao@ualberta.ca|
20502590|NCT05197803|Sonova AG|Study Manager|519 895 0100|carolina.rubiano@sonova.com|2135
20502591|NCT00132041|American College of Radiology Imaging Network|Donna Harfeil, Director of Protocol Management|215-717-2765|Donna Hartfeil <dhartfeil@acr.org>|
20502592|NCT01171820|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
20502593|NCT03969875|Icahn School of Medicine at Mount Sinai|Dr. Poonam Pai|212-523-4000|poonam.paibantwalhebbalasankatte@mountsinai.org|
20502594|NCT03856944|Gainesville Eye Associates|Clayton Blehm, MD|770-532-4444|claytonblehm@gmail.com|
20502595|NCT02327260|University of Missouri, Kansas City|Dr. Kym Bennett|816-235-6370|bennettkk@umkc.edu|
20502596|NCT01936389|NYGRI|Jessica Jasien, MEn|2124777540|jjasien.ganyresearch@gmail.com|371
20502597|NCT02804763|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20502598|NCT00793793|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502599|NCT00006227|NRG Oncology|Christopher Purdy on behalf of Mark Brady PhD|(716)845-1300|purdyc@nrgoncology.org|2296
20502600|NCT00840827|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
20502601|NCT01445535|National Cancer Institute|Dr. Wyndham Wilson|240-760-6092|wyndham_wilson@nih.gov|
20502602|NCT03216382|Ryerson University|Dr. Naomi Koerner|416-979-5000|naomi.koerner@ryerson.ca|ext. 5521
20502603|NCT05130008|Massachusetts General Hospital|Dr. Jocelyn Carter|617 724 9000|jcarter0@mgh.harvard.edu|
20502604|NCT00364689|University of Miami|Clinical Trial Disclosure Manager|305-243-0494|y.p.davis@med.miami.edu|
20502605|NCT03887299|University of Texas Medical Branch Galveston|Antonio F Saad|4097476646|afsaad@utmb.edu|
20502606|NCT00592475|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20502607|NCT00331409|Oregon Health and Science University|Christopher W. Ryan|503-494-1951|ryanc@ohsu.edu|
20502608|NCT01482910|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20502609|NCT04137783|Children's Hospital of Chongqing Medical University|Dr. Jianhui Wang|13678428167|wangjh@cqmu.edu.cn|
20550613|NCT04983264|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550614|NCT01124422|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550615|NCT01442493|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
20550616|NCT00938639|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20502610|NCT03222349|Aquestive Therapeutics|Director of Clinical Operations|908-941-1887|denis.scheper@aquestive.com|
20502611|NCT02769624|Cincinnati Children's Hospital Medical Center|Katy Fischesser|513-803-5191|katy.fischesser@cchmc.org|
20502612|NCT01552681|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20502613|NCT02769728|Medical University of Graz|Prof. Harald Sourij|0316 385 81310|ha.sourij@medunigraz.at|
20502614|NCT04139122|Senju Pharmaceutical Co. Ltd.|Director, Clinical Development|+81 078 777 1018|senju-clinicaltrials@senju.co.jp|
20502615|NCT01987908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20502616|NCT01869348|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
20502617|NCT03711604|Rhizen Pharmaceuticals AG|Dr.Prajak Barde|9820503970|pjb@rhizen.com|
20502618|NCT02789657|BrUOG|Brown University Oncology Research Group|4018633000|BrUOG@Brown.edu|
20502619|NCT00448708|Angiotech Pharmaceuticals|Dr. Trudy Estridge|604-221-7676|testridge@angio.com|
20502620|NCT04698525|Medicine Faculty, Universidad Autónoma de San Luis Potosi|Ildefonso Rodriguez-Leyva MD, PhD|4442043016|ildefonso.rodriguez@uaslp.mx|
20502621|NCT00923117|National Cancer Institute, National Institutes of Health|Dr. Teri Kreisl|301-402-3423|kreislt@mail.nih.gov|
20502622|NCT01731678|University of Calgary|Frank MacMaster, PI of the project|403-955-2784|fmacmast@ucalgary.ca|
20502623|NCT03715426|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
20502624|NCT03665285|NextCure, Inc.|Chief Medical Officer|(240) 399-4900|NCClin@nextcure.com|
20502625|NCT00354601|Wake Forest University Health Sciences|Doug Case Biostatistician|336-716-1048|dcase@wfubmc.edu|
20502626|NCT03603652|ETHICON|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
20502627|NCT02058147|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20502628|NCT03640832|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20502629|NCT01486199|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
20502630|NCT02063035|Massachusetts General Hospital, Boston, MA, USA|Dr. Kirkham B. Wood|617-726-2000|kbwood@stanford.edu|+1
20502631|NCT01893567|Galderma Laboratories, L.P.|Senior Clinical Project Manager|817-961-5000|jay.mashburn@galderma.com|
20502632|NCT00130286|Weill Cornell Medical College|Dr. Marshall J. Glesby|212-746-4177|mag2005@med.cornell.edu|
20502633|NCT03604445|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20502634|NCT01360645|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20502635|NCT00773279|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20502636|NCT01920802|New York State Psychiatric Institute|Jeffrey A. Lieberman, MD|646-774-8436|jlieberman@columbia.edu|
20502637|NCT01286493|Queen Saovabha Memorial Institute|Dr.Suda Sibunruang|+66 2 2520161|sudapunrin@gmail.com|125
20502638|NCT00611247|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
20502639|NCT01890421|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
20502640|NCT00956254|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
20502641|NCT03969888|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20502642|NCT00836433|Durham VA GRECC|Dr. Cathleen Colon-Emeric|9192860411|cathleen.colonemeric@va.gov|6777
20502643|NCT00946309|Fred Hutchinson Cancer Research Center|Dr. Daniel Lin|206-221-0797|dwlin@uw.edu|
20502644|NCT02986230|HealthPartners Institute|Dr. Tom Elliott|218-525-7268|elliottt793@gmail.com|
20502645|NCT00874250|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
20502646|NCT00282841|University of California San Diego|Thilo Hoelscher, MD|619-543-5251|thoelscher@ucsd.edu|
20502647|NCT00428597|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20502648|NCT02447848|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20502649|NCT02307370|Spectranetics, LLC now a part of Philips Image Guided Therapy Devices|Nicolas Aguirre, Senior Manager, Clinical Operations|612-297-6655|nicolas.aguirre@philips.com|
20502650|NCT01506882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20502651|NCT04320407|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20502652|NCT03219866|Wake Forest Health Science|Jill Ohar, MD|336-716-1210|johar@wakehealth.edu|
20502653|NCT01811147|Cleveland Clinic Foundation|Dr. Amit Anand|216-636-2840|ananda@ccf.org|
20550617|NCT04326231|Cognoa|Senior Director of Clinical Research|4082076659|minda.seal@cognoa.com|
20550618|NCT00759954|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
20550619|NCT03124875|LimFlow Inc.|Cecilia Petrella|(888) 478-7705|cpetrella@limflow.com|101
20550620|NCT01313936|UCSF Dept of Pediatrics|Steven DuBois, MD|415-476-3831|duboiss@peds.ucsf.ed|
20550621|NCT00449046|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550622|NCT02875860|Baylor College of Medicine|Dr. Michael Belfort|832-826-7375|belfort@bcm.edu|
20550623|NCT01741701|University of Kansas Medical Center|Dr. Rajesh Pahwa|913-588-6782|rpahwa@kumc.edu|
20550624|NCT04247581|Apple|Health Tech Clinical Operations|866-905-5303|htclinicalquestions@apple.com|
20502654|NCT05523973|University of Cincinnati|Dr. Brittany Krekeler, PI|5132272759|krekelby@ucmail.uc.edu|
20502655|NCT01903265|Tonix Pharmaceuticals|Gregory M. Sullivan, MD, Chief Medical Officer|212 980 9155|Gregory.Sullivan@TonixPharma.com|117
20502656|NCT04690699|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
20502657|NCT00667576|Abbott Japan Co., Ltd.|Global Medical Services|800-633-9110||
20502658|NCT02265913|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20502659|NCT00778830|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20502660|NCT01891643|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20502661|NCT00325078|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
20502662|NCT01307033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502663|NCT02274688|University of Washington|Douglas Zatzick|2067446701|dzatzick@uw.edu|
20502664|NCT01400932|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502665|NCT00860158|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20557691|NCT03645967|Medline Industries, LP|Keri Jorgenson|2243014670|kajorgenson@medline.com|
20557692|NCT01105702|Perlmutter Cancer Center at NYU Langone|Michael Gruber, MD|212-731-5577|michael.gruber@nyumc.org|
20557693|NCT00548132|Washington University School of Medicine|Bernard C. Camins, MD|3144548351|bcamins@dom.wustl.edu|
20557694|NCT01187914|Arrhythmia Research Center, University of Utah|Dr. Kavitha Damal, Clinical research Manager|8012133775|kavitha.damal@carma.utah.edu|
20557695|NCT02110732|Helsinki University Hospital|Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
20557696|NCT00633932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20557697|NCT00482274|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|503 494-2897|eilersk@ohsu.edu|
20557698|NCT04836858|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20557699|NCT03215901|Boston University|Jacob Bor, Assistant Professor|617-358-2176|jbor@bu.edu|
20557700|NCT04887948|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502666|NCT04656990|University of South Carolina|Director, USC Office of Research Compliance|803 777-6670|lisaj@mailbox.sc.edu|
20557701|NCT02948959|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20557702|NCT00787319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557703|NCT02312856|CERENOVUS|Christopher Hendricks|415-656-6565|chendric@its.jnj.com|
20557704|NCT04415151|Yale School of Medicine|Hyung Chun, MD, FAHA|(203) 785-6012|hyung.chun@yale.edu|
20557705|NCT00409786|University of Pittsburgh|Kathleen McTigue|412-692-2940|mctiguekm@upmc.edu|
20557706|NCT00638235|Eastern Virginia Medical School|Dr. James C Lukban, Professor & Director Division of urogynecology|7574467900|lukbanjc@evms.edu|
20502667|NCT03244059|University of Alabama at Birmingham|Mark Dransfield MD|205-934-5425|mdransfield@uabmc.edu|
20502668|NCT00806221|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-2121|simpsone@ohsu.edu|
20502669|NCT05499520|University of Pennsylvania|Andy Tan|2157466546|andy.tan@asc.upenn.edu|
20502670|NCT00282243|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
20502671|NCT00686127|University of California, San Francisco|Dr. Christine Miaskowski, PI|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
20502672|NCT05256888|University of Maryland School of Nursing|Amber Kleckner, PhD|410-706-5961|amber.kleckner@umaryland.edu|
20557707|NCT02211534|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
20557708|NCT02608905|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
20557709|NCT03802864|Weill Cornell Medicine|Russell Hayden|2127465566|rph9002@med.cornell.edu|
20557710|NCT01641926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557711|NCT00708435|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20557712|NCT01691521|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557713|NCT02343003|Halyard Health|David Curd|470-448-5178|david.curd@hyh.com|
20557714|NCT03954743|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20557715|NCT02281760|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
20557716|NCT04559282|Cochlear|Therese Agat|+46766498562|tagat@cochlear.com|
20557717|NCT01108757|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
20502673|NCT03588741|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20557718|NCT02299258|The First People's Hospital of Yuhang District|Dr.Ding Shi|+8657189369162|shidingyuhang@163.com|
20557719|NCT03982043|University of Pittsburgh|Tina R. Goldstein, Ph.D.|4122465604|goldtr@upmc.edu|
20557720|NCT03338621|TB Alliance|Morounfolu Olugbosi|1 212 227 7540|morounfolu.olugbosi@tballiance.org|
20557721|NCT00699140|Instituto Grifols, S.A|Marta Carretero, PhD, Clinical Project Leader|+ 34 93 571 22 00|marta.carretero@grifols.com|
20557722|NCT01725386|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20557723|NCT00879996|SUNY Buffalo|Dr. Richard Blondell|716-898-4971|blondell@buffalo.edu|
20557724|NCT02786264|Yale School of Medicine|Dr. Robert Schonberger|2037852802|robert.schonberger@yale.edu|
20557725|NCT00989586|The Ohio State University Comprehensive Cancer Center|Beth Christian|614-293-8858|beth.christian@osumc.edu|
20557726|NCT00993824|International Diabetes Center|Roger Mazze PhD|952-993-3796|rmazze@aol.com|
20557727|NCT03434457|Douglas Mental Health University Institute|Dr Patricia Pelufo Silveira|1514-761-6131|patricia.silveira@mcgill.ca|3928
20557728|NCT02413463|Faculty of Medicine, Cairo University|Ahmed Awadein, MD|201223911743|ahmedawadein@yahoo.com|
20557729|NCT04772053|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20557730|NCT02835846|Loyola University Chicago|Alan J Wolfe|7082165814|awolfe@luc.edu|
20557731|NCT05400746|University of Oxford|Dr. Angela M Minassian|01865611424|angela.minassian@bioch.ox.ac.uk|
20557732|NCT05375955|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20557733|NCT05454410|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@novartis.com|
20502674|NCT03580616|Dartmouth-Hitchcock Medical Center|Dr. Elijah Stommel|6036505104|elijah.w.stommel@hitchcock.org|
20502675|NCT02487108|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20502676|NCT00883493|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20502677|NCT00400400|Novartis Pharmaceuticals|Study Director|862-778-8300||
20502678|NCT00648167|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
20502679|NCT01688050|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20502680|NCT01110395|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20502681|NCT01016873|Oraya Therapeutics Inc.|Denis O'Shaugnessy, Ph.D.|917-417-3974|doshaughnessy@orayainc.com|
20502682|NCT00506857|UT MD Anderson Cancer Center|Richard E. Champlin/Professor||ytdinh@mdanderson.org|
20502683|NCT05099640|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20502684|NCT03501966|Jaeb Center for Health Research|Colleen Bauza|813-975-8690|cbauza@jaeb.org|
20502685|NCT00189462|West Penn Allegheny Health System|David Skoner, MD|4123594099|dskoner@wpahs.org|
20557734|NCT05261191|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20557735|NCT03724396|University of California San Diego|Dr. Dawn Eichen|858-249-1123|deichen@ucsd.edu|
20557736|NCT03879408|Johnson & Johnson Consumer, Inc.|ASSOCIATE DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20557737|NCT01320943|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20557738|NCT04616014|Oramed, Ltd.|Chief Scientific Officer|972-2-566-0001|miriam@oramed.com|
20557739|NCT02227316|UCLA Department of Radiological Sciences|Director of Clinical Research|310-794-8995|schaabane@mednet.ucla.edu|
20557740|NCT01081041|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20557741|NCT03489057|University of North Carolina Lineberger Comprehensive Cancer Center|Xianming Tan, PhD|+1 919-966-8450|xianming@email.unc.edu|
20557742|NCT02034708|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
20557743|NCT00654901|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20557744|NCT05076149|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20557745|NCT05096208|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557746|NCT01481545|National Cancer Institute of Naples|Dr. Antonio Avallone|+39 081 5903629|a.avallone@istitutotumori.na.it|
20557747|NCT00117156|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
20557748|NCT01919970|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
20502686|NCT00849667|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20557749|NCT04043962|Seattle Children's Hospital|Tonya Palermo, Professor, Anesthesiology and Pain Medicine, Seattle Children's Hospital|206-884-4208|tonya.palermo@seattlechildrens.org|
20557750|NCT00584402|University of Califonia, Davis|John McGahan, M.D.|(916)734-0519|john.mcgahan@ucdmc.ucdavis.edu|
20557751|NCT00975221|Amgen Inc.|Study Director|866-572-6436||
20557752|NCT00856934|CHUV - CPR|Dr. Wassim Raffoul|+41 21 314 25 05|Wassim.Raffoul@chuv.ch|
20557753|NCT01862991|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20557754|NCT02762981|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20557755|NCT02970032|University of Utah Health|Corinne Bertolaccini, PharmD|801-581-2167|Corinne.Bertolaccini@hsc.utah.edu|
20557756|NCT02796274|Santhera Pharmaceuticals|Vanessa Dos Reis Ferreira|+41 61 906 89 50|office@santhera.com|
20557757|NCT02392611|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20557758|NCT01250119|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20557759|NCT02670538|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20557760|NCT01213043|Grifols Therapeutics Inc.|Benjamin King, PhD||ben.king@grifols.com|
20557761|NCT01155830|University of Utah|Dr. Christian Yost|801/581-7052|christian.yost@hmbg.utah.edu|
20557762|NCT05648357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20557763|NCT00255346|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD/Department Chair|713-792-7026|hkantarjian@mdanderson.org|
20557764|NCT00674323|Novartis Pharmaceuticals|Study Director|862-778-8300||
20557765|NCT01678443|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
20557766|NCT01175148|Mary Babb Randolph Cancer Center|Pam Bunner, Clinical Research Specialist|304-598-4511|bunnerp@wvuhealthcare.com|
20557767|NCT00805493|Emotion and Development Branch, NIMH-IRP|Kenneth Towbin, M.D., Chief Clinical Child and Adolescent Psychiatry|301-402-4403|Kenneth.Towbin@nih.gov|
20557768|NCT01676532|St.Michael's Hospital|Sloane Freeman|416-864-6060|freemansl@smh.ca|77042
20557769|NCT01010477|Rutgers-Robert Wood Johnson Medical School|Jill Williams, MD, Principal Investigator|7322354341|Jill.williams@rutgers.edu|
20557770|NCT02045433|UT Southwestern/Simmons Cancer Center-Dallas|Dr.Kevin Albuquerque|2146458499|Kevin.Albuquerque@UTSouthwestern.edu|
20557771|NCT01559454|University at Buffalo|Dr. Ricahrd Blondell|716-816-7237|blondell@buffalo.edu|
20557772|NCT01932294|University of Alabama at Birmingham|RongBing Xie|205-975-3624|rongbingxie@uabmc.edu|
20557773|NCT01778946|Vanderbilt University Medical Center|Dr. Paul Newhouse|6159360928|paul.newhouse@vanderbilt.edu|
20557774|NCT02150837|Medifast|Chris Coleman|410-504-8161|ccoleman@choosemedifast.com|
20557775|NCT03075904|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20557776|NCT00597714|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20557777|NCT01350141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557778|NCT00810082|Dartmouth College|Dr. Jon D. Lurie, MD, MS|603-653-3575|Jonathan D. Lurie <Jonathan.D.Lurie@hitchcock.org>|
20557779|NCT01488708|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20557780|NCT01588990|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20557781|NCT02367716|Cardiac Rhythm Management, Abbott Medical Devices|Clay Cohorn, Clinical Program Director|+19723098087|clay.cohorn@abbott.com|
20557782|NCT01473381|Forest Research Institute|Suresh Durgam, MD Clinical Asset Lead for Vilazodone - Senior Director - Clinical Development|201 427-8000|suresh.durgam@frx.com|8172
20557783|NCT00539643|Memorial Sloan Kettering Cancer Center|Dr. Anne Covey, MD|212-639-6746|coveya@MSKCC.ORG|
20557784|NCT02228395|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20557785|NCT04343586|Northwestern University|Dermatology CTU|312-503-5944|NUderm-research@northwestern.edu|
20557786|NCT02648971|Wake Forest University|Dr. John Hubbard|336-998-1297|jhubbard@wakehealth.edu|
20557787|NCT01287520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20557788|NCT03587142|Temple University|Dr. Henry Parkman|(215) 707-7579|henry.parkman@temple.edu|
20557789|NCT02768662|Otonomy, Inc.|Otonomy Medical information Center|1-844-686-4636|medinfo@otonomy.com|
20557790|NCT01800201|University of Pennsylvania|Noora Marcus|215-746-4429|noora.marcus@uphs.upenn.edu|
20557791|NCT01737684|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557792|NCT03921190|University of Jordan|Dr. Ahmad El-Ma'aita|+9625355000|a.maaita@ju.edu.jo|
20557793|NCT05061537|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20557794|NCT01480596|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557795|NCT04503096|Medical University of South Carolina|Andreana Benitez PhD|(843) 876-8479|benitez@musc.edu|
20557796|NCT02924324|Memorial Sloan Kettering Cancer Center|Dr. Ellen Basu, MD, PhD|212-639-5204|BasuE@mskcc.org|
20557797|NCT01576367|Novartis Pharmaceuticals|Study Director|862-778-8300||
20557798|NCT00988221|Hoffman-La Roche|Medical Communications|800 821-8590||
20557799|NCT00595270|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar.kastner@intercell.com|0
20557800|NCT01346514|VA Puget Sound|Carol Malte|206.277.3780|carol.malte@va.gov|
20557801|NCT00909480|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20557802|NCT02481375|University of British Columbia|Crystal Karakochuk|604 822 0421|crystal.karakochuk@ubc.ca|
20557803|NCT03528174|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
20557804|NCT05436912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20557805|NCT01616576|Advanced Bionics, LLC|Cedric Navarro, Vice President of Regulatory/Clinical Affairs and Quality|(661) 362-1963|Clinical.Research@advancedbionics.com|
20557806|NCT00979602|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557807|NCT02904902|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20557808|NCT02712398|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
20557809|NCT04750655|University of California, San Francisco|Ying Han|(415) 353-2020|ying.han@ucsf.edu|
20557810|NCT00094211|Stanford University|Dr. Abby C. King|650-725-5394|king@stanford.edu|
20557811|NCT03564782|Istari Oncology|W. Garrett Nichols, MD MS|919-245-7662|info@istarioncology.com|
20557812|NCT01821417|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS MS|2059344506|ngeurs@uab.edu|
20557813|NCT02118337|MedImmune, LLC|Farzana Walcott|+1 301-398-3063|information.center@astrazeneca.com|
20557814|NCT03787680|University of Michigan Rogel Cancer Center|Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20557815|NCT01490125|Novartis|Study director|41 61 324 1111||
20557816|NCT04522180|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionisph.com|
20557817|NCT05807919|University of Mihcigan|Prashant Singh|734-647-9252|singhpr@med.umich.edu|
20557818|NCT06334042|Hacettepe University Department of Anesthesiology and Intensive Care|Oguzhan Kahveci, MD|+903123051207|kahveci.oguz@hotmail.com|
20557819|NCT04571099|Philips Clinical & Medical Affairs Global|Marijke van Vlimmeren|+31 6 31042408|marijke.van.vlimmeren@philips.com|
20557820|NCT03635489|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20557821|NCT01368900|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20557822|NCT02492854|Boston Medical Center|Jeffrey Siracuse, MD|617-638-8488|Jeffrey.Siracuse@bmc.org|
20502687|NCT00553462|Yale Cancer Center|Rogerio Lilenbaum, M.D.||Rogerio.lilenbaum@yale.edu|
20502688|NCT01262625|American College of Radiology|Director Clinical Research Administration|215-574-3150|info@acr.org|
20509055|NCT01240304|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
20557823|NCT01786902|Asan Medical Center|Dr. Hanwook Yoo|82-2-3010-3374|hwyoo@amc.seoul.kr|
20502689|NCT03075163|UC Davis Anesthesiology & Pain Medicine|Neal Fleming, MD, PhD|916 734-5046|nwfleming@ucdavis.edu|
20502690|NCT04398732|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502691|NCT00486447|GE Healthcare|Angela N. Johnson, Senior Manager Clinical Affairs Operations|262-226-9495|angela.johnson@ge.com|
20502692|NCT02055404|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|1-888-451-3937|alcon.medinfo@alcon.com|
20502693|NCT03882424|Zhejiang Teruisi Pharmaceutical Inc.|Yilin Li, Medical Director|13601247168|yilin.li@teruisipharm.com|
20502694|NCT00947284|UCaliforniaSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
20509056|NCT01041404|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550625|NCT03033394|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
20550626|NCT02927431|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20502695|NCT00602355|Women and Infants Hospital|Caron Zlotnick|401-455-6529|czlotnick@butler.org|
20502696|NCT02772757|Mountain Home VA Medical Center|Sherri L. Smith, Au.D., Ph.D.|423.926.1171|sherri.smith@va.gov|7569
20502697|NCT02086331|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20502698|NCT00510276|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20502699|NCT03329378|Icahn School of Medicine at Mount Sinai|Dr. Aarti Bhardwaj|(212) 824-8578|Aarti.Bhardwaj@mountsinai.org|
20502700|NCT03486392|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20502701|NCT01500057|Brooklyn Urology Research Group|Ivan Grunberger, M.D. Medical Director|718-230-7788|ivg9002@nyp.org|
20502702|NCT00441792|Advocate Christ Medical Center|Erik Kulstad, MD, MS|7086843889|kulstad@uic.edu|
20502703|NCT01225341|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20502704|NCT00888355|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20502705|NCT00880360|University of Texas Health Science Center at San Antonio|Dr. Tyler Curiel|210-450-1000|curielt@uthscsa.edu|
20502706|NCT00666926|Verastem, Inc.|Mitchell Keegan|617-252-9300|mkeegan@verastem.com|
20502707|NCT01960855|AbbVie|Global Medical Services|800-633-9110||
20502708|NCT01318122|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20502709|NCT02471716|FivePrime Theraputics|Medical|415-365-5600|nick.mahasuwan@fiveprime.com|
20502710|NCT01539980|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Professor Pornanong Aramwit, Pharm.D., Ph.D.|+66899217255|aramwit@gmail.com|
20502711|NCT00626743|INJE University Pusan Paik Hospital|Jae Gook Shin, MD,PhD|+82-51-890-8954|phshinjg@paik.ac.kr|
20502712|NCT01815645|Federal University of Sao Paulo|Andre Q. C. Miguel|005511 965884111|aqcmiguel@gmail.com|
20502713|NCT01014585|Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc.|Joel Trugman, MD|201-427-8681|joel.trugman@frx.com|
20502714|NCT02154425|Cares|UCB|+1877 822||9493
20502715|NCT01481896|Anderson Orthopaedic Research Institute|Robert H. Hopper, Jr., PhD|(703) 619-4411|research@aori.org|
20502716|NCT01649947|Rutgers Cancer Institute of New Jersey|Joseph Aisner, MD|732-235-7401|aisnerjo@cinj.rutgers.edu|
20502717|NCT01162421|AbbVie|Global Medical Information|800-633-9110||
20502718|NCT03336502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502719|NCT01054079|Comprehensive Cancer Center of Wake Forest University|Dr. K.C. Balaji|336-618-2272|kbalaji@wakehealth.edu|
20502720|NCT01750255|Universidad de Antioquia|Pedro Amariles Muñoz|57 4 2195456|pedro.amariles@udea.edu.co|
20502721|NCT01133171|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
20502722|NCT01446419|Relievant Medsystems, Inc.|V.P. of Clinical & Regulatory Affairs|650-261-2259|lhook@relievant.com|
20502723|NCT01557166|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20502724|NCT00374244|Yale University School of Medicine, Dept of Psychiatry|Handan Gunduz-Bruce MD|(203) 932-5711|handan.gunduz-bruce@yale.edu|4130
20502725|NCT02445586|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502726|NCT01583374|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20502727|NCT00670007|CSL Behring|Clinical Trial Disclosure Manager|Use Email contact|clinicaltrials@cslbehring.com|
20550627|NCT01285310|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
20509057|NCT01993667|University of Utah|Dr. Scott McIntosh, MD, MPH|801-581-2730|Scott.McIntosh@hsc.utah.edu|
20509058|NCT01931150|Memorial Sloan Kettering Cancer Center|Dr. Mario Lacouture|646-888-6014|LacoutuM@mskcc.org|
20509059|NCT01248585|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
20509060|NCT03140488|University of Arizona|Meghan Hill|+64273095220|meghan.hill@auckland.ac.nz|
20509061|NCT01131078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20509062|NCT00608244|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
20502728|NCT00624221|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
20509063|NCT04697888|Children's Mercy Hospital|Joel Lim, MD - Principal Investigator|(816)234-3000|jlim@cmh.edu|
20509064|NCT01977040|Mednax. Inc|Kimberly Maurel|714593-9171|kimberly_maurel@mednax.com|
20509065|NCT01685060|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20509066|NCT02000219|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
20509067|NCT01605890|Hopital Bichat-Claude Bernard, AP-HP, Paris, France|Pr Sophie Matheron|+33140257883|sophie.matheron@aphp.fr|
20509068|NCT01780324|Seattle Children's Hospital|Neil Uspal, MD|206-987-2599|neil.uspal@seattlechildrens.org|
20509069|NCT00608894|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
20509070|NCT02444936|Cleveland VA|Dr. David Canaday|216-368-8901|dxc44@case.edu|
20509071|NCT03552289|Cook Research Incorporated|Alan Saunders|765-463-7537|Alan.Saunders@CookMedical.com|
20509072|NCT00209092|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emory.edu|
20509073|NCT02408484|Octapharma|Sigurd Knaub|55 451 21 41|sigurd.knaub@octapharma.com|+41 (0)
20509074|NCT04830839|Cincinnati Children's Hospital Medical Center|Professor|+15136363370|shari.wade@cchmc.org|
20509075|NCT01117181|Johns Hopkins|Anne Casper, MA|410-955-8183|ashankli@jhsph.edu|
20509076|NCT00216086|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20509077|NCT01080625|SNUH|Chul-Woo Jung/ Assistant professor|82-2-2072-0640|spss@snuh.org|
20509078|NCT01224106|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20509079|NCT00446797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20509080|NCT02019758|University of North Carolina at Chapel Hill|Evan S. Dellon, MD MPH|919-966-2513|edellon@med.unc.edu|
20509081|NCT00364832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20509082|NCT03053401|Akron Children's Hospital|Dr. Rami Karroum|330-543-8823|rkarroum@akronchildrens.org|
20509083|NCT01973972|Duke University|William S. Yancy, Jr.|919-681-2863|yancy006@mc.duke.edu|
20557824|NCT00361439|University of Chicago|Jayant Pinto, MD|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
20557825|NCT00724464|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
20557826|NCT01931735|VA Palo Alto Research|Jessica Asay|650-493-5000|asay@stanford.edu|65971
20557827|NCT02719990|Aravive, Inc.|Chief Operating Officer|(936) 355-1910|clinicaltrials@aravive.com|
20557828|NCT00717314|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20557829|NCT02070484|OhioHealth|Josepha Shehadi, MD|614-220-5648|joseph@drshehadi.com|
20557830|NCT01521884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557831|NCT02821819|Instituto Bernabeu|Dr. Juan Carlos Castillo|+34650562634|jcastillo@institutobernabeu.com|
20557832|NCT00658138|University of Bologna, Italy|Professor Giovanni Dondi dall'Orologio|+39 051-2088132|gdondi@alma.unibo.it|
20557833|NCT04182880|Cali Biosciences|Chief Medical Officer|12038376500|e.onel@calibiosciences.com|
20557834|NCT03389477|Washington University School of Medicine|Douglas Adkins, M.D.|(314) 362-4471|dadkins@wustl.edu|
20557835|NCT03522077|Aurora Health Care|Dr. Muhammad Fuad Jan|414-649-3491|fuad.jan@aah.org|
20557836|NCT02239380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557837|NCT03857230|IVFarma LLC|General Manager|+7(499)6455342|info@ivfarma.ru|1
20557838|NCT01806584|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20557839|NCT03995784|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
20557840|NCT00311155|Daiichi Sankyo Pharma Development|Sr. Director, Regulatory Operations|732-590-5032|hmkessler@dsi.com|
20557841|NCT02241720|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
20557842|NCT02764775|Fort Worth Independent School district|Dr. Julie Brown|214-725-8232|jbrown18@twu.edu|
20557843|NCT00429494|The University of Texas (UT) MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD, PhD / Professor||CR_Study_Registration@mdanderson.org|
20502729|NCT00127127|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502730|NCT03652909|Ascending Hearing Technologies, LLC|Christina Runge|2623523478|chrunge@mcw.edu|
20502731|NCT01059448|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20502732|NCT01542307|Massachusetts General Hospital|Aneesh Singhal, MD|6177268459|asinghal@partners.org|4
20502733|NCT02591615|NorthShore Medical Group|Thomas Hensing|847.570.2112|thensing@northshore.org|
20502734|NCT04188197|Rose Research Center|Dr. Jed E. Rose|9193282345|jed.rose@roseresearchcenter.com|
20502735|NCT02863068|Albert Einstein College of Medicine|Dr. Caterina Minniti|240-498-8684|bloodconsultant@gmail.com|
20502736|NCT01734655|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
20502737|NCT01322022|Children's Hospital of Pittsburgh/University of Pittsburgh|Dr. Cynthia Johnson|412-692-8404|cynthia.rheney.johnson@gmail.com|
20509084|NCT04072575|Janssen Research & Development, LLC|Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20557844|NCT00976703|Metrohealth Medical Center|Kelly S Gibson, MD|216-778-5498|kgibson@metrohealth.org|
20509085|NCT01266070|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20557845|NCT03289481|Clinical Research|Caroline Knight|2079218959|CKnight@pbmc.org|
20557846|NCT01265030|Maine Medical Center|Dr. Aaron Weiss, Principal Investigator|2073967565|Aaron.Weiss@mainehealth.org|
20557847|NCT01992549|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
20557848|NCT01495221|Vitreous Retina Macula Consulatants of New York|Jason S. Slakter, MD|212-861-9797|mail@vrmny.com|
20557849|NCT02209636|Rocky Mountain VA Medical Center|Anna Jovanovich, MD|303-724-8677|anna.jovanovich@va.gov|
20557850|NCT00767104|Wake Forest University Health Sciences|Alan Fleischer, Jr. MD|336-716-3775|Afleisch@wfubmc.edu|
20557851|NCT00840996|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20557852|NCT04022889|Cerus Corporation|Carol Moore|9258766819|cmoore@cerus.com|
20557853|NCT01900054|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20557854|NCT03047174|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
20509086|NCT01838213|Vestre Viken Hospital Trust|Arne Søraas, PhD|+4790652904|arne@meg.no|
20509087|NCT04882072|Janssen Pharmaceutical K.K.|Senior Director GI Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20557855|NCT01108835|The Chinese University of Hong Kong|Fanny Ko|85226323133|fannyko@cuhk.edu.hk|
20557856|NCT03285295|Abbott Laboratories|George Chen (Associate Director Clinical Affairs)|224-668-9185|george.chen@abbott.com|
20557857|NCT02075021|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
20557858|NCT00957931|University of California, San Francisco|Dr. Sandhya Kharbanda, MD||Sandhya.Kharbanda@ucsf.edu|
20509088|NCT02918318|Janssen Pharmaceutical K.K., Japan|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509089|NCT03185819|Janssen-Cilag International NV|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509090|NCT03097133|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509091|NCT00371540|Indiana University School of Medicine|Kara Wools-Kaloustian|317-274-7936|kwools@iu.edu|
20557859|NCT00857805|Loma Linda University Health|David Bush, MD, Professor Radiation Medicine|909 558 1000|DBush@llu.edu|88056
20557860|NCT01289041|Novartis Pharmaceuticals|Study Director|862-778-8300||
20557861|NCT01129531|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20557862|NCT00981474|Northwestern University|Paul C. Fitzgerald RN, BSN, MS|312-695-1064|p-fitzgerald2@northwestern.edu|
20509092|NCT02910089|Astrazeneca Pharmaceuticals|Susan Thomas, MD|302-886-5589|Susan.Thomas2@astrazeneca.com|
20557863|NCT03800979|Institute of Dermatology|Dr. Chinmanat Lekhavat (My old last name is Tangjaturonrusamee.)|+660847607474|chinmanat@hotmail.com|
20557864|NCT00605319|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
20557865|NCT02419547|Brigham and Women's Hospital|Douglas Shook, MD, Chief, Divison of Cardiac Anesthesia|617-732-8219|dshook@bwh.harvard.edu|
20509093|NCT02939976|Duke University Medical Center|David Kong, M.D.|919-668-8946|David.F.Kong@duke.edu|
20557866|NCT02991482|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki|+41 31 511 94 00|Heidi.Roschitzki@etop-eu.org|
20557867|NCT02887989|Cedars-Sinai Health System|Garth Fuller|3236003890|garth.fuller@cshs.org|
20557868|NCT02949921|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20557869|NCT00519896|University of Washington|Renato G Martins|206-288-2048|rgmart@uw.edu|
20557870|NCT00750282|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
20557871|NCT02341456|AstraZeneca|Lone Ottesen|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
20557872|NCT02508532|Blueprint Medicines|Medical Information|1-888-258-7768|medinfo@blueprintmedicines.com|
20557873|NCT00500240|UT MD Anderson Cancer Center|Khanh D Vu, MD/ Associated Professor|713-745-4516|eharriso@mdanderson.org|
20557874|NCT00301080|Northwestern University|Clinical Research Office|312-695-1301|cancertrials@northwestern.edu|
20557875|NCT03673462|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20557876|NCT02352363|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
20557877|NCT03502616|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557878|NCT01581840|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20557879|NCT02917265|Oklahoma Medical Research Foundation|Aikaterini Thanou, MD|405-271-7805|aikaterini-thanou@omrf.org|
20527960|NCT00630747|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20557880|NCT03002038|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
20557881|NCT03885011|Orasis|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
20509094|NCT04080752|Janssen Research & Development, LLC|BE-R and D-Research Physician - Seni|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509095|NCT01585168|Yale University|Dr. Godfrey Pearlson|(860) 545-7757|Godfrey.Pearlson@hhchealth.org|
20509096|NCT01194414|Hoffman-LaRoche|Medical Communications|800-821-8590||
20509097|NCT03605836|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20509098|NCT00954824|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
20509099|NCT04146038|Cancer Institute of New Jersey Rutgers|Roger K. Strair, MD, PhD|732-235-4523|strairrk@cinj.rutgers.edu|
20509100|NCT01782885|Universidad Autónoma de Nuevo León|M Sc Mario Simental-Mendía|+52 (81) 8329 4174|mario.simental@gmail.com|
20509101|NCT01704976|BUAS|Slavko Rogan (Study Chair)|+41 31 848 35 56|slavko.rogan@bfh.ch|
20509102|NCT02977507|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20509103|NCT03011775|Ukrainian Medical Stomatological Academy|Prof. Igor Kaidashev|+380505858953|kaydashevip@gmail.com|
20509104|NCT00422669|Medtronic, Inc.|Optimize RV Trial Leader|1-800-328-2518|medtroniccrmtrials@medtronic.com|
20509105|NCT01351064|IUSM|Aaron Carroll|3172789696|aaecarro@iu.edu|
20509106|NCT02120352|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20509107|NCT02427100|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor, Associate Professor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
20509108|NCT01610206|University of Virginia|Linda Duska, MD|434-982-1719|lrd5d@virginia.edu|
20550628|NCT03530098|Stanford University|Safwan S Halabi, MD|(650) 721-2850|safwan.halabi@stanford.edu|
20509109|NCT03536923|Renovia, Inc|Chief Medical Officer, Dr. Samantha Pulliam|866-735-8424|sjpulliam@renoviainc.com|
20509110|NCT01929707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20509111|NCT00437203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509112|NCT01332097|Mereo BioPharma|Dr. Jackie Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
20509113|NCT00431496|Amgen Inc.|Study Director|866-572-6436||
20509114|NCT01915095|Hines VA|Audrey Wilson|3122383637|awilson03@sralab.org|
20509115|NCT02343952|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20509116|NCT02067533|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
20509117|NCT02671760|Sequential Medicine Ltd|Head of Product Development|617-818-2735|tadahl@outlook.com|
20509118|NCT02999191|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509119|NCT01745913|Weill Cornell Medical College|Koen van Besien, MD|2127462646|kov9001@med.cornell.edu|
20509120|NCT03418064|CooperVision|Jose A. Vega, O.D., MSc., FAAO|19256213761|jvega2@coopervision.com|
20509121|NCT04968353|Virginia Commonwealth University School of Dentistry, Orthodontics|Steven J Lindauer|8048289326|sjlindau@vcu.edu|
20509122|NCT00845845|The University of Illinois Chicago|Scott Cotler, M.D. Professor of Medicine|708-216-3789|scotler@lumc.edu|
20509123|NCT01685203|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20509124|NCT02896192|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20509125|NCT00383708|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
20509126|NCT00318370|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
20509127|NCT00464711|Massachusetts General Hospital|Dr. Dan Iosifescu||diosifescu@partners.org|
20509128|NCT00410904|Barbara Ann Karmanos Cancer Institute|Shirish M. Gadgeel, M.D.|313-576-8753|gadgeels@karmanos.org|
20509129|NCT01750840|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
20509130|NCT02650895|OncoImmune, Inc.|Dr. Pan Zheng|2027516823|pzheng@oncoimmune.com|
20509131|NCT02988401|Johns Hopkins University|Dr. Ellen Mowry|4106141522|Emowry1@jhmi.edu|
20509132|NCT00981682|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20509133|NCT04507360|University of Washington|Tim Althoff|206-543-4243|althoff@cs.washington.edu|
20509134|NCT01004159|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20509135|NCT02712008|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20509136|NCT02481440|The Third Affiliated Hospital of Sun Yat-sen University|Li-Min Rong M.D., Director of Clinical Trials|862085252900|ronglimin@21cn.com, ronglm@mail.sysu.edu.cn|
20509137|NCT04483544|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
20509138|NCT01199198|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante,MD/Chair, General Internal Med|(713) 745-4516|cescalan@mdanderson.org|
20509139|NCT04315298|Regeneron Pharmaceuticals, Inc.|Clinical Trials Adminstrator|844-734-6643|clinicaltrials@regeneron.com|
20509140|NCT00736385|Duke University Medical Center|Christopher Kigongo|919-668-6579|christopher.kigongo@duke.edu|
20509141|NCT01183104|Japan Association for Diabetes Education and Care|Prof. Yasuo Terauchi|+81-3-3514-1721|terauchi-tky@umin.ac.jp|
20550629|NCT01195415|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
20550630|NCT01442675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20550631|NCT00752232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550632|NCT00555321|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20550633|NCT00005937|NIH National Heart, Lung and Blood Institute|Neal S. Young MD|301-402-1806|youngns@nhlbi.nih.gov|
20550634|NCT01574612|Meda Pharmaceutical|David Ginsberg, DO|732 564 2200|ginsberg.david@gmail.com|
20550635|NCT02532972|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736981|Daniel_Lee@meei.harvard.edu|
20509142|NCT03267511|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20509143|NCT01594749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557882|NCT02002182|Baylor College of Medicine|Dr. Andrew Sikora|7137983909|Andrew.Sikora@bcm.edu|
20557883|NCT03107377|Evofem|Chief Medical Officer|858-550-1900|kculwell@evofem.com|
20557884|NCT02914379|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20557885|NCT00453102|University of Miami|Izidore S. Lossos|305-243-4785|ilossos@med.miami.edu|
20557886|NCT04296890|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20557887|NCT03154944|Coloplast|Head of Medical Writing and Biostatistics|49113143|dkpen@coloplast.com|+45
20557888|NCT01782963|Massachusetts General Hospital|Noopur Raje, MD|617-724-4000|NRAJE@mgh.harvard.edu|
20557889|NCT04249219|University of Massachusetts Chan Medical School|Elise Stevens|(774) 455-6684|elise.stevens@umassmed.edu|56684
20557890|NCT05652036|Houston Methodist Hospital Department of Urology|Dr. Rose Khavari|713-441-6455|rkhavari@houstonmethodist.or|
20557891|NCT02237508|Zambon SpA|Isabella Salerio, PhD|+39 02665241|clinicaltrials@zambongroup.com|
20557892|NCT01650519|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20557893|NCT05458024|University of North Carolina at Chapel Hill|Sam McLean, MD, MPH|+1 (919) 843-5931|samuel_mclean@med.unc.edu|
20557894|NCT04986085|Grupo Español de Tumores Neuroendocrinos y Endocrinos|A responsible Person Designated by the Sponsor|0034934344412|investigacion@mfar.net|
20557895|NCT02954458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20557896|NCT04000594|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20557897|NCT00747123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20557898|NCT03267680|University of Southern California|Tali Homsey|3238650430|tali.homsey@med.usc.edu|
20557899|NCT02277743|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20557900|NCT00674466|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
20557901|NCT01224158|Johnson & Johnson Consumer and Personal Products Worldwide|Director Oral Health, Medical Affair & Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20557902|NCT01622010|St. Boniface Hospital|Kelly Codispodi BMR PT|204-237-2138|kcodispodi@sbgh.mb.ca|
20557903|NCT03976466|ISSEMyM Instituto de Seguridad Social del Estado de Mexico y Municipios|Julio Carlos Vélez de Lachica, Head of the orthopedics department at Regional Hospital Tlalnepantla|5526269200|activeknee@gmail.com|2100
20557904|NCT02055157|BioMarin Pharmaceutical Inc.|Alice Hunstman-Labed|+44 207 4203392|alice.huntsmanlabed@bmrn.com|
20557905|NCT01557322|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509144|NCT00364351|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20509145|NCT01636453|Penumbra, Inc.|Michaella Corso|(510) 748-3200||
20509146|NCT00653068|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20509147|NCT02177786|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20509148|NCT01305941|UNC Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20509149|NCT03950440|University Hospitals Leuven|Dr. Danny Feike Hoogma|003216344270|danny.hoogma@uzleuven.be|
20509150|NCT02892734|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
20509151|NCT02043509|University of East Anglia|Dr Joanne Emery||joanne.emery@uea.ac.uk|
20509152|NCT04724291|George Washington University|Dr. Andrew C. Meltzer|2027412952|ameltzer@mfa.gwu.edu|
20509153|NCT03189563|Dong-A ST|Xiaofei Du|82-2-92-8457|duxiaofeicat@donga.co.kr|
20509154|NCT01670825|Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
20509155|NCT02613338|University of Tennessee|Adrija Sharma, Principal Investigator|8659747684|adrija.sharma@utk.edu|
20509156|NCT00634751|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
20509157|NCT03654560|United Health Products, Inc.|Gerard Abate, MD Chief Medical Officer|(386) 627-1598|G.Abate@unitedhealthproductsinc.com|
20509158|NCT03135262|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: BH39147|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
20509159|NCT02728206|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20509160|NCT02773368|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20509161|NCT03960658|Minneapolis VA Health Care System|Dr. Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
20509162|NCT00732238|Michael E DeBakey VA Medical Center-Baylor College of Medicine|Rabih Darouiche|713-841-3882|rdarouiche@aol.com|
20509163|NCT01188460|OHRI|Dr. Keith Wilson||kewilson@toh.ca|
20557906|NCT02247336|William S Middleton Memorial Veterans Hospital|Corrine Voils, PhD|608-256-1901|corrine.voils@va.gov|12208
20557907|NCT00943306|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
20557908|NCT00733499|DePuy Ortho Joint US|Tamiko Magee-Rodgers, PhD||TMageeRo@its.jnj.com|
20557909|NCT00733980|GlaxoSmithKline|GSK Response Center|866-435-7343||
20557910|NCT02739347|Baylor College of Medicine|Raymond Cho|7137987781|Raymond.Cho@bcm.edu|
20557911|NCT02404389|Novartis Pharmaceuticals|Study Director|862-778-8300||
20557912|NCT00335257|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|0049(0)30 945 10120|dinger@zeg-berlin.de|
20557913|NCT01126060|Samsung medical center|Dr. Man Ki Chung|82-2-3410-1845|manki.chung@samsung.com|
20557914|NCT02658630|VA Pittsburgh Healthcare System|George F. Wittenberg|412-648-4178|GeoWitt@Pitt.edu|
20557915|NCT01062763|Dept. of Endocrinology, Odense University Hospital|Dr. Ib A. Jacobsen|+45 27203135|ib.abildgaard@rsyd.dk|
20557916|NCT01403441|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
20557917|NCT03926065|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
20557918|NCT03260127|VA San Diego Healthcare System|Laura Crocker|8586426484|laura.crocker@va.gov|
20557919|NCT00369681|Johns Hopkins University|Dr. Yvette Kasamon|410-955-8839|ykasamon@jhmi.edu|
20557920|NCT00431184|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
20557921|NCT02387216|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
20557922|NCT04359771|faculty of medicine, Cairo University|Dr. Ahmed Abdelbaki|00201066642728|a.abdelbaki@kasralainy.edu.eg|
20557923|NCT04041440|Customized Learning Exercises for Aural Rehabilitation|Chief Operating Officer|314 399-9943|chris@amptify.com|
20557924|NCT02306265|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
20557925|NCT00517075|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
20557926|NCT01187329|Cleveland Clinic|Andra E. Duncan, M.D|216-445-2372|DUNCANA@ccf.org|
20557927|NCT01962025|Ottawa HRI|Dr. Deborah Zimmerman|613-722-7000|dzimmerman@toh.ca|
20557928|NCT05737433|Hepion Pharmaceuticals Inc|Jill Greytok|732-902-4000|jgreytok@hepionpharma.com|
20557929|NCT04251065|SC Ematologia - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - Trieste|Prof. Francesco Zaja|+ 39 040 3992015|francesco.zaja@asugi.sanita.fvg.it|
20557930|NCT01216163|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20557931|NCT03597035|University Hospitals Cleveland Medical Center|Sanjay Rajagopalan|216-844-5125|Sanjay.Rajagopalan@UHhospitals.org|
20557932|NCT01552954|Department of Internal Medicine, Seoul National University Bundang Hospital|Ho Jun Chin|+82-10-7360-7025|mednep@snubh.org|
20557933|NCT01778556|NIDDK|Dr. Rebecca Brown|301-594-0609|brownrebecca@mail.nih.gov|
20557934|NCT00070135|The Ohio State University|Steven Devine, MD||steven.devine@osumc.edu|
20557935|NCT00576732|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609 730 2317||
20557936|NCT00920023|Massachusetts General Hospital|Ralph Weissleder|6177268226|RWEISSLEDER@MGH.HARVARD.EDU|
20557937|NCT01235403|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20557938|NCT01769170|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20557939|NCT02978443|Georgetown University|Suthee Rapisuwon|202-877-6583|Suthee.Rapisuwon@medstar.net|
20557940|NCT02296190|Milestone Pharmaceuticals|Francis Plat _MD_Chief Medical Officer|514-336-0444|fplat@milestonepharma.com|225
20557941|NCT01472874|Yale|Dr. Schilsky|203-785-2565|michael.schilsky@yale.edu|
20557942|NCT02087501|Endospan|Jessica Kleine||j.Kleine@endospan.com|
20557943|NCT00094328|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20557944|NCT03682705|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20557945|NCT01483937|BalanceSense LLC|Karen L. Atkins PhD PT|407 625 9680|atkins.balancesense@gmail.com|
20557946|NCT02213328|Desmond Tutu HIV Foundation|Dr Katherine Gill|+2721 785 3121|katherine.gill@hiv-research.org.za|
20557947|NCT00265330|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20557948|NCT00990340|Teva Neuroscience|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
20557949|NCT04615182|TransMedics Inc.|Laura Damme, VP Clinical Affairs|9785520900|ldamme@transmedics.com|
20557950|NCT00402337|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
20557951|NCT03565068|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557952|NCT05778526|The Hong Kong Polytechnic University.|Dr. Ka Po Wong|64860214|portia.wong@polyu.edu.hk|
20557953|NCT01436201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20502738|NCT00956943|University of Pennsylvania|Robert A. Schnoll, Ph.D.|215-746-7143|schnoll@mail.med.upenn.edu|
20502739|NCT02613208|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20502740|NCT02663895|Stanford University|Dr. Lorinda Chung|(650) 723-6961|shauwei@stanford.edu|
20502741|NCT03057366|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20502742|NCT00809328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502743|NCT04201717|FIrst Hospital of Jilin University|Dr. Quan Wang|+86 ‭15843073207‬|wquan@jlu.edu.cn|
20502744|NCT02911688|Center for Environmental Medicine Asthma and Lung Biology|Carole Robinette Assistant Director of Clinical Research|919 966-5638|carole_robinette@med.unc.edu|
20502745|NCT00947531|EVERNeuro Pharma|Head of R&D|+43 7665 20555|stefan.winter@everpharma.com|0
20502746|NCT06441877|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20502747|NCT06062264|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20502748|NCT01072409|University of Michigan|Teresa Zwolan, Ph.D.|(313) 618-9669|zwolan@umich.edu|
20502749|NCT03706365|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20502750|NCT05195528|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
20502751|NCT01552902|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20502752|NCT02720757|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502753|NCT02631538|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20527961|NCT03858894|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
20502754|NCT01554579|Afferent Pharmaceuticals|Clinical Development|650-286-1276|info@afferentpharma.com|
20557954|NCT00263328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509164|NCT01098032|Clinica Mediterranea|Dr. Carlo Briguori, Principal Investigator|+390817259|carlobriguori@clinicamediterranea.it|764
20509165|NCT00481988|Division of Experimental Therapeutics, NY State Psychiatric Organization|Peter Bulow MD, Assistant Professor of Clinical Psychiatry|(212) 543 5664|pb2182@columbia.edu|
20509166|NCT03136913|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
20509167|NCT01673425|VA National Center for Occupational Health & Infection Control|Lewis Radonovich|352-376-1611|Lewis.radonovich@va.gov|4988
20509168|NCT01525420|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.||jbricker@fhcrc.org|
20509169|NCT00610207|Cook Biotech, Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
20557955|NCT01199926|Purdue University|Dr. Dorothy Teegarden|765-494-8791|teegarden@purdue.edu|
20557956|NCT01226914|Medical University of South Carolina - Department of Otolaryngology - Head and Neck Surgery|Shaun A. Nguyen, MD, FAPCR|8437921356|nguyensh@musc.edu|
20509170|NCT03241589|VHA|Sara Peracca|415-750-2091|sara.peracca@va.gov|
20509171|NCT02069704|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
20509172|NCT02242760|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20509173|NCT03378973|Hospital for Special Surgery|Ronald Emerson, MD|2127742742|emersonr@hss.edu|
20509174|NCT01478581|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
20509175|NCT00744692|Duke University Medical Center|Dr. Suhag Parikh|919-668-1100|suhag.parikh@dm.duke.edu|
20509176|NCT02809846|Scripps TSRI|Lase Ajayi|785.218.1643|tajayi@scripps.edu|
20557957|NCT02613221|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20557958|NCT01301274|Intensive Care Unit - Hospital Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
20557959|NCT01893827|NYU Langone Health|Mia Malone|646-501-3577|mia.malone@nyulangone.org|
20509177|NCT01594411|CardioDx, Inc.|EJ Fernandez, MD, CCRP - Sr. Manager Clinical Affairs|650-383-3350|jkuo@cardiodx.com|
20509178|NCT00356057|BIOTRONIK, Inc.|Katerina de Metz, Director Clinical Studies|5036752169|katerina.demetz@biotronik.com|
20509179|NCT01620593|UT Health San Antonio Cancer Center|Sukeshi Arora, MD|210-450-1015|aroras@uthscsa.edu|
20509180|NCT00838383|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509181|NCT01451398|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20509182|NCT01000818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20557960|NCT02917941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20557961|NCT00399763|Denver Health|Christian Thurstone, M.D.|303-436-6006|christian.thurstone@dhha.org|
20557962|NCT04064242|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20557963|NCT03879603|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Julie E. Ledgerwood, DO (Study Chair)|301-594-8502|ledgerwood@mail.nih.gov|
20557964|NCT03536546|Department of Veterans Affairs|Paul N Pfeiffer, MD MS|(734) 769-1000|Paul.Pfeiffer@va.gov|
20502755|NCT00234039|SWOG Statistical Center|Study Statistician|206-667-4623||
20502756|NCT00110019|ECOG Statistical Office|Study Statistician|617-632-3012||
20502757|NCT03897751|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bauschhealth.com|
20502758|NCT01046695|Mayo Clinic|Deborah J. Engen, OT, CMT|507-255-5504|engen.deborah@mayo.edu|
20557965|NCT00626366|University of Nebraska Medical Center|Erin K O'Brien|402-559-6463|irbora@unmc.edu|
20502759|NCT02239263|cochlear|Lori O'Neill Director of Research|8005235798|loneill@cochlear.com|
20502760|NCT04426695|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20502761|NCT04303000|University of Alabama at Birmingham|Melinda Clarke|205-975-7809|melindaclarke@uabmc.edu|
20557966|NCT00445679|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20502762|NCT00822107|Oregon Health & Science University|Dr. David H. Ellison|5034944465|ellisond@ohsu.edu|
20502763|NCT05655377|Flint Rehabilitation Devices|Ian Russell|9496670140|irussell@flintrehab.com|
20502764|NCT03653390|University of Washington|Dr. Ivan Molton, PhD|2065433602|imolton@uw.edu|
20502765|NCT03118947|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20557967|NCT00859651|Columbia University|Katherine Crew, MD|212-305-1732|kd59@cumc.columbia.edu|
20557968|NCT04366726|Radius Health, Inc.|Associate Director, Clinical Operations|(617) 551-4000|info@radiuspharm.com|
20557969|NCT01353222|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
20557970|NCT01654601|The Catholic university of Korea|Won-myung Bahk. M.D. PhD.|82-2-3779-1051|wmbahk@catholic.ac.kr|
20557971|NCT02636270|Cincinnati Childrens Hospital Medical Center|Philippe Backeljauw|513-636-8444|philippe.backeljauw@cchmc.org|
20557972|NCT01119898|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20557973|NCT01833143|Memorial Sloan Kettering Cancer Center|Gregory Riely, MD, PhD|646-608-3913|rielyg@mskcc.org|
20557974|NCT00909428|Loyola University Chicago|Mary P FitzGerald|708-216-2170|mfitzg8@lumc.edu|
20557975|NCT03021668|Johns Hopkins Hospital|Dr. Matthew J. Weiss|4106143368|mweiss5@jhmi.edu|
20557976|NCT02217280|Missouri Orthopaedic Institute|Dr. Christina Goldstein|573-884-9022|goldsteincl@health.missouri.edu|
20557977|NCT01933880|Xi'an Janssen Pharmaceutical Ltd.|Director - CNS & Pain, CDMA, China R&D and SA|+86 10 5821-8307||
20557978|NCT00510458|Stryker Orthopaedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
20557979|NCT02569710|Alios BioPharma, Inc|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20557980|NCT02907814|Rutgers New Jersey Medical School|Dr. Elliot Crane|973-972-2020|cranees@njms.rutgers.edu|
20557981|NCT01125722|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20557982|NCT00583622|The University of Texas MD Anderson Cancer|Yago Nieto, MD, PhD / Professor||celsaenz@mdanderson.org|
20557983|NCT00045435|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|206-667-4961|bsandmai@fhcrc.org|
20557984|NCT00051168|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20557985|NCT04236258|Brigham and Women's Hospital|Dr. Elizabeth Yoselevsky|314-413-1254|eyoselevsky@bwh.harvard.edu|
20557986|NCT00709059|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20557987|NCT01396317|Hospital for Special Surgery|Dr. Robert Spiera|212-774-2048|spierar@hss.edu|
20557988|NCT01786330|University of Kansas School of Medicine - Wichita|Zachary Kuhlmann, DO|316-685-7234|zkuhlmann@kumc.edu|
20557989|NCT02172625|Georgia State University|Dr. Gerald S. Zavorsky|404-413-1271|zavorsky@gsu.edu|
20557990|NCT03315130|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20557991|NCT02707692|UC San Diego|David (Davey) Smith|619-300-9638|d13smith@health.ucsd.edu|
20557992|NCT02914132|ExThera Medical Corporation|Sr. Director of Regulatory and Clinical Affairs|9258392079|erdie@extheramedical.com|
20557993|NCT02944656|Emory University|Tiffany Hailstorks, MD, MPH|404-778-1385|tiffany.p.hailstorks@emory.edu|
20557994|NCT02053077|MUG|Thomas Pieber|004331638512383|thomas.pieber@medunigraz.at|
20557995|NCT04834817|University of California, Irvine|Dr. Kristen Kelly, Professor and Chair, Dept. of Dermatology|949-824-5515|kmkelly@hs.uci.edu|
20557996|NCT02417532|The Chris Moody Centre|Nick Birch|+44 1604 215440|nickbirch@doctors.org.uk|
20557997|NCT00552786|National Taiwan University|Dr. Yue-Liang Guo|+886-2-33228216|leonguo@ntu.edu.tw|
20557998|NCT04684641|Yale University|Dr. Jonathan Koff|475-224-8167|jon.koff@yale.edu|
20557999|NCT03549234|University of California San Diego|Matthew Swisher, MD|415-314-4099|matthew.swisher@gmail.com|
20558000|NCT02243631|Zablocki VA Medical Center|Dr. Ann Rosenthal , MD ACOS/Research|414-384-2000|ann.rosenthal@va.gov|41430
20558001|NCT03117517|Khyber Medical University|Dr. Mohsin Shah (Associate Professor)|3429620074|mohsin.ibms@kmu.edu.pk|+92
20558002|NCT01959945|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20558003|NCT01590771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558004|NCT02019563|The Hospital for Sick Children|Trang Nguyen|6473300825|trang.nguyen@easternhealth.ca|
20558005|NCT01785628|China Medical University Hospital|The chief, Department of Neurology|8864-22052121|d8079@mail.cmuh.org.tw|5035
20558006|NCT03015116|Landstuhl Regional Medical Center|Dr. Ann Kobiela Ketz|8022656263|annketz@gmail.com|
20558007|NCT01015807|Univerisity of Washington|Dr. Laurent Bollag|+12063277328|bollag@uw.edu|
20558008|NCT02200939|Smith+Nephew, Inc.|Laura England, Sr. Director Global Clinical Strategy|+1 650 223 6941|Laura.England@smith-nephew.com|
20558009|NCT02687412|SichuanCHRI|Dr Cui Ling|+8618181422637|cuiling1985@qq.com|
20558010|NCT00553202|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20558011|NCT03239873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558012|NCT00612222|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20558013|NCT02169895|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20558014|NCT01567943|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu|
20558015|NCT00708526|University of Utah|Dwayne Westenskow, PhD|801-581-2478|Dwayne.Westenskow@hsc.utah.edu|
20558016|NCT00768430|Baylor College of Medicine|Dr. Sanjay Mathew|7137911414|sjmathew@bcm.edu|5439
20558017|NCT01478113|Massachusetts General Hospital|Maren Nyer|617-643-4897|mnyer@partners.org|
20558018|NCT01703702|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20558019|NCT03355755|Ekso Bionics|Leslie Van Hiel|4042268017|leslie.vanhiel@gmail.com|
20558020|NCT03585296|Aclaris Therapeutics|Executive Director Clinical Operations|4843242144|jschnyder@aclaristx.com|
20558021|NCT00041756|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
20558022|NCT03270514|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Kathirvel Subramaniam, MD, MPH, FASE|724-799-5852|subramaniamk@upmc.edu|
20558023|NCT00462670|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
20558024|NCT02002884|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20558025|NCT02966002|University of Michigan|Adam Lubert|734-764-5177|luberta@med.umich.edu|
20558026|NCT02291432|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
20558027|NCT02596022|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
20558028|NCT02145078|Barbara Ann Karmanos Cancer Institute|Gerold Bepler|(313)576-8670|beplerg@karmanos.org|
20558029|NCT03327402|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20558030|NCT02134119|University of Georgia|Jamie Cooper|7065424903|jamie.cooper@uga.edu|
20558031|NCT01454830|The Pennsylvania State University|Amy M. Sawyer, PhD|814-863-1020|ams24@psu.edu|
20558032|NCT01785563|University of Iowa|Tarah T. Colaizy|3193255640|tarah-colaizy@uiowa.edu|
20558033|NCT00628901|Boston Scientific|Ana Becker / Sr. Clinical Program Manager|651-581-4605|Ana.Becker@bsci.com|
20558034|NCT01616771|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
20558035|NCT00744328|Northwestern University|Research Study Coordinator|312-695-8441|emily.pinheiro@northwestern.edu|
20558036|NCT00815035|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20502766|NCT02266108|UCSDMED|Elizabeth Reed, Associate Professor|5082121517|elizared7@gmail.com|
20502767|NCT00531960|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502768|NCT02737163|Johns Hopkins All Children's Hospital|Gerald Tuite, MD|7277678181|gtuite1@jhmi.edu|
20558037|NCT01767935|Wake Forest University Health Sciences|Dr. David Childs|336-716-2471|dchilds@wakehealth.edu|
20558038|NCT02091739|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20558039|NCT01422369|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
20558040|NCT00868699|Sunovion|Medical Director, CNS|1-866-503-6351||
20558041|NCT01737281|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
20558042|NCT01905046|City of Hope|Victoria Seewaldt, M.D.|6262564674|vseewaldt@coh.org|67321
20558043|NCT05672680|Icahn School of Medicine at Mount Sinai|Celia Divino|(212) 241-3348|celia.divino@mountsinai.org|
20558044|NCT02201056|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20558045|NCT00779779|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558046|NCT01395823|Dialysis Clinic Inc|Karen Majchrzak|615-342-0483|karen.majchrzak@dciinc.org|
20558047|NCT03300570|Fox Chase Cancer Center|David Weinberg, M.D., M.Sc.|215-214-1424|david.weinberg@fccc.edu|
20558048|NCT00116272|Amgen Inc.|Study Director|866-572-6436||
20558049|NCT03188120|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558050|NCT03571737|Brody School of Medicine @ East Carolina University|Dr. Jennifer Stahl|2527442570|stahlj@ecu.edu|
20558051|NCT00280826|National Eye Institute|Robert Nussenblatt, MD, MPH|301-496-3123|drbob@intra.nei.nih.gov|
20558052|NCT02139358|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
20558053|NCT04485130|University of California, San Francisco|Dr. Sulggi Lee|415-735-5127|sulggi.lee@ucsf.edu|
20558054|NCT02178566|Inova Health Systems|Christopher King, MD|7037763067|christopher.king@inova.org|
20558055|NCT00682643|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558056|NCT01875185|Johns Hopkins University School of Medicine|RhondaLyn McLean|(215) 662-4949|rhondalyn.mclean@uphs.upenn.edu|
20558057|NCT00085202|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|info@stjude.org|
20558058|NCT03238300|Medical University of South Carolina|Lindsay M. Squeglia, PhD|843-792-5451|squegli@musc.edu|
20558059|NCT02081950|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
20558060|NCT00818961|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
20558061|NCT01286441|Santalis Pharmaceuticals|Dr. Paul Castella Ph.D.|210-399-2316|paulc@santalispharma.com|101
20558062|NCT00110890|Amgen Inc.|Study Director|866-572-6436||
20558063|NCT04512066|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20558064|NCT03403426|Reflow Medical|Isa Rizk|9494810399|info@reflowmedical.com|
20558065|NCT03520400|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
20558066|NCT01015976|University of North Dakota - Neuropsychiatric Research Institute|James L. Roerig PharmD, BCPP|701 365 4919|jroerig@nrifargo.com|
20558067|NCT00116844|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558068|NCT00524030|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558069|NCT04398537|University of Alabama at Birmingham|Stefanie Woodard|205-996-4132|swoodard@uabmc.edu|
20558070|NCT02134210|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
20558071|NCT01596283|Memorial Sloan Kettering Cancer Center|Dr. Mary Fischer MD|212-639-6745|fischerm@mskcc.org|
20558072|NCT03722264|Virginia Commonwealth University|Eser Tufekci, DDS, PhD|804-828-9326|etufekci@vcu.edu|
20558073|NCT01486758|Washington University in St. Louis|Dr. Avraham Beigelman (PI)|314-454-2694|beigelman_a@kids.wustl.edu|
20558074|NCT02608489|Soonchunhyang University Hospital|Dr. JinKwon Chung|82-2-709-9354|schcornea@schmc.ac.kr|
20558075|NCT01411501|Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences|Liu Zhishun|8610-010-88001124|liuzhishun@aliyun.com|
20558076|NCT03463915|University of Louisville|Sean Francis|502-561-7260|Sean.francis@louisville.edu|
20502769|NCT00638937|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@ottawahospital.on.ca|70175
20502770|NCT00579813|University of Arkansas for Medical Sciences|Robert E. McGehee Jr., Ph.D.|501-603-1998|rem@uams.edu|
20502771|NCT01290627|The University of Tennessee|Richard Komistek, Ph. D.|86598744159|rkomiste@utk.edu|
20502772|NCT02532855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502773|NCT00756548|Braintree Laboratories, Inc.|John McGowan, Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
20502774|NCT00820573|University of Texas HSC at San Antonio|Eugenio Cersosimo, MD PhD|210 358 7200|Eugenio.cersosimo@uhs-sa.com|
20502775|NCT02981069|University of Texas Health San Antonio|Professor|12103587200|cersosimo@uthscsa.edu|
20502776|NCT04178772|Johnson & Johnson VIsion Care, Inc.|Thomas Karkkanien - Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20502777|NCT01154933|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
20502778|NCT02808390|PPM Services|Salvatore Bellinvia|+41916961710|sbellinvia@ppmservices.ch|
20502779|NCT01558063|Columbia University|J. John Mann, MD|646-774-7553|jjm@columbia.edu|
20502780|NCT04897867|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20502781|NCT00508391|BIOTRONIK, Inc.|Clay Cohorn|503-387-2614|clay.cohorn@biotronik.com|
20502782|NCT00880256|VA Puget Sound Health Care System|Dr. David Kearney|206-764-2285|david.kearney@va.gov|
20502783|NCT00802360|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20502784|NCT02041962|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
20502785|NCT01916629|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
20502786|NCT00330187|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20502787|NCT02908516|Yale School of Medicine, Department of Orthopaedics and Rehabilitation|Dr. Michael P. Leslie|(203) 737-6358|michael.leslie@yale.edu|
20502788|NCT01225562|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20502789|NCT00165958|Emory University|Dr. Suephy Chen|4047783084|schen2@emory.edu|
20502790|NCT02601573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502791|NCT01107444|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20550636|NCT02407704|University of Pittsburgh|Dr. Kirk Erickson|412-624-4533|kiericks@pitt.edu|
20558077|NCT01334944|Cumberland Pharmaceutical Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
20550637|NCT01348347|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20550638|NCT03235154|Community Research Initiative of New England|Amy E. Colson, MD|6175021700|acolson@crine.org|
20550639|NCT03636061|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20550640|NCT01922089|Novartis Pharmaceuticals|Study Director|862-778-8300||
20550641|NCT02988843|Masonic Cancer Center, University of Minnesota|Dr. Shilpa Gupta|612 624 0123|guptash@umn.edu|
20550642|NCT01683383|Stanford University School of Medicine|Krisa P. Van Meurs, M.D.|+1 650 723 5711|vanmeurs@stanford.edu|
20550643|NCT00996307|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20550644|NCT02496611|University of Minnesota|Aaron Kelly PhD|6126253492|kelly105@umn.edu|
20550645|NCT02850965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20550646|NCT00001723|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief SGO, PDEGEN|301-496-4686|yanovskj@mail.nih.gov|
20550647|NCT02788357|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
20550648|NCT00536198|Yale University School of Medicine|Kimberly A. Yonkers, M.D.|203-764-5914|Kimberly.Yonkers@yale.edu|
20550649|NCT02170051|Professor of Psychiatry, UC San Diego|Elizabeth W Twamley, PhD|858-642-3848|etwamley@health.ucsd.edu|
20550650|NCT02643082|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|650-305-2600|creisner@pearltherapeutics.com|
20502792|NCT01948830|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20502793|NCT00928421|BTG International Inc|David Wright MB FRCS|610-943-3513|david.wright@btgplc.com|
20502794|NCT03310970|University of Iowa|Nicole Brogden, Associate Professor|319-335-8752|nicole-brogden@uiowa.ed|
20502795|NCT02526550|Siriraj Hospital|Prof.Kulkanya Chokephaibulkit|662 4195695|kulkanya.cho@mahidol.ac.th|
20502796|NCT03875950|University of Washington|Pamela Kohler|206.221.5746|pkohler2@uw.edu|
20502797|NCT01260454|University of Rochester|R. James White, MD, PhD|585-486-0869|jim_white@urmc.rochester.edu|
20502798|NCT04062214|Yale University|Marc Rosen, MD|2039325711|marc.rosen@yale.edu|12112
20502799|NCT00091832|Amgen Inc.|Study Director|866-572-6436||
20502800|NCT02604940|West Virginia University|Pavithra Ranganathan Ellison, MD|304-598-4929|pavithra.ellison@wvumedicine.org|
20502801|NCT02349178|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
20502802|NCT03357393|Region Östergötland|Lena Nilsson|+46 10 103 00 00|lena.nilsson@regionostergotland.se|1838
20502803|NCT02542072|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20502804|NCT03961360|The University of Texas Health Science Center at Houston|Farah Amro, MD|713-500-6421|farah.h.amro@uth.tmc.edu|
20502805|NCT00654498|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502806|NCT01990261|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20502807|NCT01609842|VHA Eastern Colorado Health Care System|Marina McCreight|720-857-2785|marina.mccreight@va.gov|
20502808|NCT00954109|Harry S Truman Memorial VA Hospital and University of Missouri|John Thyfault, Associate Professor|573-814-6000|thyfaultj@health.missouri.edu|53742
20502809|NCT02474329|Radboudumc|Marjan Meinders|+00000000|Marjan.Meinders@radboudumc.nl|
20502810|NCT01356589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502811|NCT04343651|CytoDyn Inc.|Dr. Scott Kelly, Chief Medical Officer|(360) 980-8524|skelly@cytodyn.com|
20502812|NCT04714372|University of Minnesota, Masonic Cancer Center|Dr. Joseph Maakaron|612-624-5109|maaka001@umn.edu|
20502813|NCT04025632|UCB BIOSCIENCES GmbH|Clin Trial Reg & Results Disclosure|Please email|clinicaltrials@ucb.com|
20502814|NCT00376961|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
20502815|NCT00925600|Amgen Inc.|Study Director|866-572-6436||
20502816|NCT04785612|hVIVO|Alex Mann|+44(0)7738321671|a.mann@hvivo.com|
20502817|NCT04047797|MD Anderson Cancer Center|Hun J Lee, MD|713-792-2860|hunlee@mdanderson.org|
20502818|NCT03932799|University of Washington|Andrea Elmore|206-685-7194|aelmore@uw.edu|
20502819|NCT01929057|UCSD Dermatology Clinical Trials|Dermatology Clinical Trial Manage|(858)657-8390|dermstudies@ucsd.edu|
20502820|NCT01793792|MicroVention, Inc|Anne Hurley|714-247-8000|anne.hurley@microvention.com|
20502821|NCT00709826|Tragara Pharmaceuticals|Tracy Parrott|760-208-6919|tparrott@tragarapharma.com|
20502822|NCT00851903|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
20502823|NCT00270894|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20502824|NCT01070329|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20502825|NCT02863848|Universitat Rovira i virgili|Dr. Joaquin Escribano|+ 34 977 759364|joaquin.escribano@urv.cat|
20502826|NCT03220412|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
20502827|NCT00289913|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20502828|NCT03822884|Biosidus S.A.|Clinical Trial Manager - Dr. Roberto A. Diez|+5411 4909 8000|r.diez@biosidus.com.ar|
20550651|NCT00881712|University of Florida Proton Therapy Institute|Bradford Hoppe, M.D.|904-588-1800|bhoppe@floridaproton.org|
20502829|NCT01989221|TempleU|Dr. Henry Parkman|2157072498|henry.parkman@temple.edu|
20502830|NCT00542620|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20502831|NCT02357420|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20502832|NCT03617705|University of Florida|Dr. Yan Wang|3522945942|ywang48@ufl.edu|
20502833|NCT00214461|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20502834|NCT01061008|UWalesBangor|Dr. Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
20502835|NCT01492673|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett, MD|212-639-8267|trippet1@mskcc.org|
20502836|NCT02024971|Takeda Pharmaceuticals Company Limited|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20502837|NCT02908100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20502838|NCT04933123|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20502839|NCT05254418|Vanderbilt University Medical Center|Dr. Talat Alp Ikizler|6159366646|alp.ikizler@vumc.org|
20502840|NCT00440726|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20502841|NCT01808612|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20502842|NCT03683394|The University of California, San Francisco|Dr. Kristine Yaffe|(415) 476-7307|kristine.yaffe@ucsf.edu|
20502843|NCT00559273|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502844|NCT04276207|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20550652|NCT01324999|University of North Carolina at Chapel Hill|H. James Ford, MD|(919) 966-2531|hjford@med.unc.edu|
20550653|NCT00276744|SKCCC|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
20550654|NCT01294267|Icahn School of Medicine at Mount Sinai, Helmsley Electrophysiology Center|Vivek Y. Reddy, MD|212-241-7114|vivek.reddy@mountsinai.org|
20502845|NCT01256177|AstraZeneca|Dhaval Desai (MSD, Seroquel)|+13028857643|aztrial_results_posting@astrazeneca.com|
20502846|NCT01261819|Florida Hospital|Katherine Kratz, M.D.||katiegoodrich@gmail.com|
20502847|NCT04451330|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20502848|NCT00553163|Barts Health NHS Trust|Prof D S Rampton|+442035943300|d.rampton@qmul.ac.uk|
20502849|NCT01925209|Novartis Pharmaceuticals|Study Director|862-778-8300||
20502850|NCT00110994|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20502851|NCT01299727|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20550655|NCT02784275|NovMetaPharma Co., Ltd|Peter Lee|+82 (0)2 538 1893|Peter@NovMeta.com|
20550656|NCT02505867|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
20550657|NCT00060008|Children's Hospital of Philadelphia|Dr. Michael Fisher|215 590 2800|fisherm@email.chop.edu|
20550658|NCT01307397|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20550659|NCT00560859|University of Pennsylvania|Dr. Susan S. Ellenberg|215-573-3904|sellenbe@upenn.edu|
20550660|NCT00230607|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20550661|NCT02860169|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20502852|NCT02395991|Seoul National University Hospital|Professor Jeong Min Lee|82-2-2072-3154|jmsh@snu.ac.kr|
20502853|NCT01727089|City of Hope|Jeff Longmate, Ph.D.|626-218-2478|jlongmate@coh.org|
20558078|NCT02254408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20558079|NCT01671839|Merz Pharmaceuticals|Public Disclosure Manager|+49 69 1503 0|clinicaltrials@merz.com|
20558080|NCT03980184|Yale University|Rajita Sinha, PhD, Study PI|203-737-5805|rajita.sinha@yale.edu|
20558081|NCT01662531|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20558082|NCT00584805|USAMRIID Medical Division|Anthony Cardile, D.O.|301-619-8833|anthony.cardile.mil@mail.mil|
20558083|NCT01077362|Janssen Research & Development, LLC|Senior Director, Clinical Research|1-800-526-7736||
20558084|NCT02294630|Wayne State University|Beena G. Sood, MD, MS|313-745-5638|bsood@med.wayne.edu|
20558085|NCT03097861|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20558086|NCT04399356|Tufts Medical Center|Dorothy Dulko, PhD - Research Project Director|(617) 636-5009|ddulko@Tuftsmedicalcenter.org|
20558087|NCT02247804|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20502854|NCT00384241|Medical College of Georgia, Georgia Regents University|Haidong Zhu MD, PhD, Assistant Professor|706 721 5470|hzhu@gru.edu|
20502855|NCT01349140|University California San Diego|Brian Ilfeld, MD, MS|1-858-444-5949|bilfeld@ucsd.edu|
20502856|NCT01175798|Icahn School of Medicine at Mount Sinai|Anita Mehrotra MD|2122415153|anita.mehrotra@mssm.edu|
20502857|NCT01564706|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20502858|NCT01242644|University of South Alabama|Office of Research Compliance|251-460-7573|swhite@southalabama.edu|
20502859|NCT03157531|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
20502860|NCT00331006|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-972-3048|sassmann@neriscience.com|
20502861|NCT03450083|Johns Hopkins University School of Medicine|Jody Tversky, MD|410-550-8017|hoddin1@jhmi.edu|
20502862|NCT00109473|Cincinnati Children's Hospital Medical Center|Lee A. Denson|513-636-7575|lee.denson@cchmc.org|
20502863|NCT03213366|Albert Einstein College of Medicine|Dr. Viraj V Patel|718.920-7102|vpatel@montefiore.org|
20502864|NCT01879410|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502865|NCT01012492|Emory University School of Medicine|Leslie S Kean|404-376-0187|Leslie.kean@emory.edu|
20502866|NCT03002974|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
20502867|NCT01737931|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20502868|NCT01573910|Alcon Research, Ltd.|Firoz Vohra, Project Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20502869|NCT00364182|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502870|NCT04244370|BD|Heather Vander Ploeg|602-751-3268|heather.vander.ploeg@bd.com|
20502871|NCT00989989|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
20502872|NCT02284165|Duke Clinical Resarch Institute|Janet Prvu Bettger, ScD|617-901-0277|janet.bettger@duke.edu|
20502873|NCT01578031|University of Pennsylvania|Samuel T. Kuna, MD|215-823-4400|skuna@mail.med.upenn.edu|
20502874|NCT03497845|BARDA|Silvija Tresnjak-Smith, Regulatory Operations Branch Chief, Regulatory and Quality Affairs Division|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
20502875|NCT01439945|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
20502876|NCT04082663|Washington University School of Medicine|Dr. Gammon Earhart|314-286-1407|earhartg@wustl.edu|
20502877|NCT00777179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20502878|NCT00705263|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20502879|NCT05501119|Medical University of South Carolina|Dr. Diana Layne|(843) 792-8515|layne@musc.edu|
20502880|NCT02730260|Washington University School of Medicine|Dr. Walton Sumner|314-454-8164|wsumner@dom.wustl.edu|
20502881|NCT01285427|Life Technologies|Deanna Vella, Staff Regulatory Engineer|760-918-3000|deanna.vella@lifetech.com|
20502882|NCT05032950|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502883|NCT02959814|Skejby University Hospital, Denmark|Niels Ramsing Holm, MD|004526849066|Niels.holm@clin.au.dk|
20502884|NCT03404648|Mayo Clinic|Dr. Ming Yang|480-342-0988|Yang.Ming@mayo.edu|
20502885|NCT01784796|Edward Hines VA Hospital|Karen Saban, PhD|708-202-5264|Karen.Saban@va.gov|
20502886|NCT05243628|Mannkind Corporation|Jennifer Pleitez, Director of Clinical Operations|818-661-5032|endocrineresearch@mannkindcorp.com|
20502887|NCT03120832|Senseibio|Ramzi Melhem MD Medical Director|9168336928|rmelhem@senseibio.com|
20502888|NCT01078805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20502889|NCT01445678|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
20502890|NCT01943565|Brigham and Women's Hospital|Dirk J Varelmann, MD|617-732-8280|dvarelmann@partners.org|
20550662|NCT01897402|JN-International Medical Corporation|Regulatory Affairs Director|4028843477|dr_orten@jn-vaccines.org|
20550663|NCT01648205|University of Rochester|Wojciech Zareba, MD, PhD|5852755391|wojciech_zareba@urmc.rochester.edu|
20550664|NCT01958008|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20550665|NCT01428453|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550666|NCT01996709|Alcon Research, Ltd.|Jessie Lemp, DrPH, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20550667|NCT02167893|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20550668|NCT01804075|Eastern Maine Medical Center|Dr. Mark Brown|207-973-9503|mbrown@emh.org|
20502891|NCT01265524|Sorbent Therapeutics|Howard Dittrich, MD FACC|858-405-1429|hdittrich@sorbent.com|
20558088|NCT01827254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558089|NCT01350505|VA Palo Alto Health Care System|Dr. Jamie Zeitzer|650-493-5000|jamie.zeitzer@va.gov|62410
20558090|NCT01834222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558091|NCT01054573|Janssen Research & Development, LLC|Medical Leader|1 609 730-3174||
20558092|NCT03812536|Ohio State University|Dr. Syed Husain|6142938772|syed.husain@osumc.edu|
20558093|NCT00152009|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20558094|NCT01306201|Covidien|Ulf Borg, Director of Clinical Affairs|303-305-2400|ulf.borg@covidien.com|
20558095|NCT04702568|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20558096|NCT00393523|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20558097|NCT02207439|University of Pennsylvania|Alexander Lin, MD|215-662-3198|alexander.lin2@pennmedicine.upenn.edu|
20558098|NCT03148236|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
20558099|NCT01735396|Tisch Cancer Center, Icahn School of Medicine at Mount Sinai|Dr. Matthew David Galsky|212-689-5412|matthew.galsky@mssm.edu|
20558100|NCT03452176|Massachusetts General Hospital|Dr. Michael Levy|617-726-0412|mlevy11@mgh.harvard.edu|
20558101|NCT00779558|Stanford University|Alan Schroeder|408 885-5260|alan.schroeder@hhs.sccgov.org|
20558102|NCT00423852|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, Assistant Attending|+1646-422-4491|Feldmand@mskcc.org|
20558103|NCT00980005|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558104|NCT00572624|Washington University School of Medicine|Dr. Linda Peterson, M.D.|314-362-4577|lpeterso@dom.wustl.edu|
20558105|NCT04145037|AVROBIO, Inc|AVROBIO MedInfo|617-914-8419|medinfo@avrobio.com|
20550669|NCT01438424|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20550670|NCT02927080|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550671|NCT01411228|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
20550672|NCT00664742|Novartis Pharmaceuticals|Study Director|862-778-8300||
20550673|NCT02670083|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20550674|NCT01938378|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
20550675|NCT01413191|UT MD Anderson Cancer Center|Dr. Sapna Patel, MD - Associate Professor, Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
20550676|NCT02564042|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550677|NCT00660530|University of Illinois College of Pharmacy|Dr. Alan Lau|(312) 996-0894|alanlau@uic.edu|
20550678|NCT01622699|Isala|Dr J Bekhof|0384247492|j.bekhof@isala.nl|+31
20550679|NCT02461355|Burke Neurological Institute|Tomoko Kitago, MD|914-368-3169|tok7002@med.cornell.edu|
20558106|NCT01756560|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
20502892|NCT01542645|NorthShore University HealthSystem|Glenn Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
20502893|NCT03116113|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20502894|NCT02159807|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
20502895|NCT00950170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502896|NCT02064764|Medtronic, Inc.|Vanessa DeBruin|6123607687|vanessa.debruin@medtronic.com|
20502897|NCT01254669|Boston Medical Center|Dr. Natalie Joseph|1-617-414-5202|napierre@bu.edu|
20502898|NCT00600171|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502899|NCT02367521|Johns Hopkins University School of Medicine|Vani Rao, MD|4105502288|vrao@jhmi.edu|
20502900|NCT02104414|Mount Sinai St. Luke's|Dr. Ali Shariat|914-409-5023|alishariatmd@gmail.com|
20502901|NCT00542191|Leo W. Jenkins Cancer Center|Dr. Paul Walker|252-744-1015|walkerp@ecu.edu|
20502902|NCT00469612|The Ohio State University|Dr. Don Mutti|614-247-7057|mutti.2@osu.edu|
20502903|NCT02932787|Sheffield Hallam University|Martin Lamb|01142552782|m.lamb@shu.ac.uk|
20502904|NCT02620904|Montefiore Einstein|Jessica Maria Atrio|7184058260|jatrio@montefiore.org|
20502905|NCT02633371|University of Colorado|Dr. Anna Bruckner|720-777-0955|anna.bruckner@ucdenver.edu|
20502906|NCT03990870|Posit Science Corporation|Dr. Kyu Lee|415-528-7235|kyu.lee@positscience.com|
20502907|NCT01279057|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20502908|NCT01196442|Virginia Commonwealth University|Dr. Craig W. Swainey|804-828-9723|cswainey@mcvh-vcu.edu|
20502909|NCT01427309|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20502910|NCT00849017|GlaxoSmithKline|GSK Response Center|866-435-7343||
20502911|NCT02913313|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20502912|NCT04130646|Medical University of South Carolina|Associate Professor-Faculty|(843) 792-6076|badran@musc.edu|
20502913|NCT06118385|Benevolent|Judit Molnar, MD, PhD|+44 20 3781 9360|judit.molnar.md@benevolent.ai|
20502914|NCT02411448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20502915|NCT01848145|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
20502916|NCT01577238|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
20502917|NCT01058096|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
20502918|NCT00536172|University of Nebraska|William Burke MD|4025526005|wjburke@Unmc.edu|
20502919|NCT02516670|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Channing Paller Associate Professor Urologic Oncology|4109558239|cpaller1@jhmi.edu|
20502920|NCT02690194|Boston Children's Hospital|Greggory Kobelski|7812161093|Greggory.Kobelski@childrens.harvard.edu|
20502921|NCT03624946|Emergent BioSolutions Canada Inc.|Jason Richardson, Senior Scientist, Clinical Research|204-275-4266|jrichardson@ebsi.com|
20502922|NCT01728779|Johns Hopkins University|Dana Kaplin|410-614-3950|dkaplin1@jhmi.edu|
20502923|NCT00624520|Department of Veterans Affairs|Dr Douglas C Russell|608-256-1901|Dcrussel@facstaff.wisc.edu|
20502924|NCT00675025|Eisai Inc|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20502925|NCT02002702|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20502926|NCT01589484|University of Sao Paulo Medical School|Dr. Fabio Torricelli|+55 11 94308951|fabio_torri@yahoo.com.br|
20502927|NCT00944034|Novartis Vaccines|Posting Director|+39 0577 245863|anh.phung@novartis.com|
20502928|NCT01596257|Memorial Sloan Kettering Cancer Center|Dr. Sergio Giralt, MD|646-608-3731|GiraltS@mskcc.org|
20502929|NCT01570244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502930|NCT00464204|Fresenius Kabi Aktiengesellschaft|Professor Dr. Martin Westphal|+49 6172 686|martin.westphal@fresenius-kabi.com|7280
20502931|NCT05384041|Climb Technologies, Inc.|Julia Lanoha|(925) 405-5458|julia@climb.care|
20502932|NCT03176316|Loyola University Medical Center|Russell Nockels, M.D.|847-618-9565|neurocare@nch.org|
20502933|NCT03062657|Medtronic|Rhys Jones, PhD; Senior Clinical Research Specialist|+44 7826874430|rhys.j.jones@medtronic.com|
20502934|NCT00238264|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20502935|NCT00713219|Memorial Sloan Kettering Cancer Center|Dr. Matthew Fury|646-888-4233|furym@mskcc.org|
20502936|NCT01814787|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
20502937|NCT01958645|AstraZeneca|Anders Berggren, MD, PhD||clinicaltrialtransparency@astrazeneca.com|
20502938|NCT03183128|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
20502939|NCT03773302|QED Therapeutics, Inc.|Acting Chief Medical Officer|1-877-280-5655|PROOF301.ct@qedtx.com|
20502940|NCT02978222|Marker Therapeutics|Gerald Garrett|713.400.6400|ggarrett@markertherapeutics.com|
20502941|NCT01686568|Mayo Clinic|Dr. Ian R. Lanza|507-255-8147|lanza.ian@mayo.edu|
20502942|NCT03258814|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20502943|NCT01413958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502944|NCT01900002|UT MD Anderson Cancer Center|Dr. Ahmed Kaseb, MD, Professor, GI Medical Oncology|(713) 792-2828|akaseb@mdanderson.org|
20502945|NCT03382509|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502946|NCT04591054|Penn State Hershey Medical Center|Seth Pantanelli MD|717-531-4696|spantanelli@pennstatehealth.psu.edu|
20502947|NCT01751971|Brigham and Women's Hospital|Scott Sands, PhD|6172780911|sasands@bwh.harvard.edu|
20502948|NCT00706628|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20502949|NCT02921425|University of Miami|Dr. Joseph Sharit|305-284-6472|jsharit@miami.edu|
20502950|NCT01145560|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
20502951|NCT00712348|Protalix Ltd.|VP Medical Affairs|+972-4-9028100|raul@protalix.com|
20502952|NCT02678429|VUMC|Fenna Phibbs|614-936-0060|fenna.phibbs@vumc.org|
20509183|NCT00741260|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20509184|NCT02565615|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509185|NCT03920865|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20509186|NCT05563714|University of Michigan|Dr. Jacob E. Kurlander, MD, MS|734-660-4883|jkurland@umich.edu|
20509187|NCT01262599|Columbia University Medical Center|Dr. Christine Rohde|(212) 342-3707|chr2111@columbia.edu|
20509188|NCT01983878|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20509189|NCT00479167|Rush University Medical Center|Stephanie Gregory, MD|312-942-5982|stephanie_gregory@rush.edu|
20509190|NCT02650440|Coordination of Improvement of Higher Level Personnel - CAPES|Thais A. Rodrigues, MS, PT.|55 (61) 2022-6002|faleconosco@capes.gov.br|
20509191|NCT01997281|Seoul National University College of Medicine|Youn Min Cho, M.D, PhD|+82-2-2072-1965|ymchomd@snu.ac.kr|
20509192|NCT02448914|LobSor Pharmaceutical AB|Roger Bolsöy, CEO|+46 (0) 72 222 44 08|roger.bolsoy@lsmgroup.se|
20509193|NCT00560794|Amgen Inc.|Study Director|866-572-6436||
20509194|NCT01237301|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
20509195|NCT02384993|University of Wisconsin - Madison|Ozioma C. Okonkwo|(608) 265-4479|ozioma@medicine.wisc.edu|
20509196|NCT01372813|National Cancer Institute, National Institutes of Health|Marston Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
20509197|NCT00880607|Children's Hospital of Colorado, University of Colorado|Mindy Cohen, MD FAAP, Assistant Professor, Department of Anesthesiology||Mindy.cohen@childrenscolorado.org|
20509198|NCT01628042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509199|NCT02828644|Akili Interactive Labs|Kathryn Jenkins|7742666693|kjenkins@akiliinteractive.com|
20509200|NCT02996110|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20509201|NCT01726504|Guang An Men Hosptial of China Academy of Chinese Medical Sciences|Liu Zhishun|86 13651016313|liuzhishun@hotmail.com|
20509202|NCT02037204|UMC Utrecht|Prof. Daniel Saris|000000000000000000|d.saris@umcutrecht.nl|
20509203|NCT01119963|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
20509204|NCT00524043|Johnson & Johnson Pharmaceutical Research & Development|Clinical Team Leader, Paliperidone|609 730-2436||
20509205|NCT03938636|Navidea Biopharmaceuticals|Chief Medical Officer|614-822-2320|mrosol@navidea.com|
20509206|NCT02579863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509207|NCT02253394|Brigham and Women's Hospital|Dr. Bradley Maron|617-525-4857|bmaron@bwh.harvard.edu|
20509208|NCT03531762|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20509209|NCT01092364|Duke University Medical Center|Dr. Laura P. Svetkey|919-660-6626|laura.svetkey@dm.duke.edu|
20509210|NCT00054756|NIDDK|Dr Joanna Klubo-Gwiezdzinska|301-496-1211|joanna.klubo-gwiezdzinska@nih.gov|
20509211|NCT02734849|Allakos, Inc.|Henrik Rasmussen, MD, PhD, Chief Medical Officer|1 6505975002|hrasmussen@allakos.com|
20509212|NCT04210232|Johnson & Johnson Surgical Vision|Eugenia K. Thomas|+1 657 2903260|EThoma39@its.jnj.com|
20509213|NCT01525745|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
20509214|NCT02458352|University Hospital Zurich|Dr. Ronny Buechel|0041442551059|ronny.buechel@usz.ch|
20509215|NCT02527564|Stanford University|Po W. Wang|650-723-2483|wangp0@stanford.edu|
20509216|NCT00257322|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
20509217|NCT00628134|University of Pittsburgh|Tim Corcoran, Ph.D.|412-624-8918|corcorante@upmc.edu|
20509218|NCT04097028|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
20509219|NCT02473289|Janssen Research & Development, LLC|ASSOCIATE DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509220|NCT01156363|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20509221|NCT00383266|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5740|mbaggstr@dom.wustl.edu|
20509222|NCT03285490|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20509223|NCT03745989|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509224|NCT04944758|University of British Columbia|Dr. Raymond Lam|6048227325|r.lam@ubc.ca|
20509225|NCT04989504|Mayo Clinic|Dr. Kimberly Corbin|855-776-0015|corbin.kimberly@mayo.edu|
20509226|NCT00617162|Abbott|Lyndahl Himes, Sr. Clinical Research Scientist|+1 214 998 1137|lyndahl.himes@abbott.com|
20509227|NCT00735072|University of California, San Francisco|Peter W. Hunt, MD|(415) 476-4082|phunt@php.ucsf.edu|345
20509228|NCT01620658|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute, Research and Outcomes|786-596-3505|raulh@baptisthealth.net|
20509229|NCT00911144|GlaxoSmithKline|GSK Response Center|866-435-7343||
20509230|NCT01291511|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20509231|NCT04521920|Duke University|Dr. Mehri McKellar|(919) 613-6129|mehri.mckellar@duke.edu|
20509232|NCT00047008|NRG Oncology|Wendy Seiferheld||SeiferheldW@nrgoncology.org|
20509233|NCT01929018|University of Colorado Denver, Anschutz Medical Campus|Dr. Cory Christiansen|303.724.9101|cory.christiansen@ucdenver.edu|
20509234|NCT01366534|GlaxoSmithKline|GSK Response Center|866-435-7343||
20509235|NCT00748865|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20509236|NCT02748525|The University of Texas Health Science Center at Houston|Isis Gayed, MD|713-704-1787|isis.w.gayed@uth.tmc.edu|
20509237|NCT01047436|Xidea Solutions Limited|Dr D Bendel||daryl@xideasolutions.com|
20502953|NCT01228903|University of Colorado|Diana Jalal|3037244867|diana.jalal@ucdenver.edu|
20502954|NCT02602223|Oregon Health & Sciences University|Dr. Sivaraman Prakasam|503-346-4711|prakasam@ohsu.edu|
20502955|NCT01375764|Amgen Inc.|Study Director|866-572-6436||
20502956|NCT02867761|University of Michigan|Meilan K. Han|734 615-9772|mrking@med.umich.edu|
20502957|NCT03595280|Georgetown University|Darren Mays|2026878937|dmm239@georgetown.edu|
20502958|NCT02292212|Asahi Kasei Medical Co., Ltd.|Masaharu Aritomi, Ph.D.||aritomi.mb@om.asahi-kasei.co.jp|
20502959|NCT02675075|James A. Haley VA Hospital|Dr. Sam Phillips|813 558 3995|samuel.phillips@va.gov|
20502960|NCT02411747|Copenhagen Academy for Medical Education and Simulation, Rigshospitalet, Copenhagen University Hospital|Dr. Sarah Bube, director of the CYSTOSIM project|+4561339183|sarahbube@gmail.com|
20502961|NCT02149810|London Health Sciences Centre|Dr. Akshya Vasudev|519-685-8500|akshya.vasudev@lhsc.on.ca|75504
20502962|NCT01176916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20502963|NCT00675597|Memorial Sloan Kettering Cancer Center|Dr. Mark G. Kris|646-888-4205|Krism@mskcc.org|
20502964|NCT01014403|UT Southwestern Medical Center|Dr. Herb Phelan|214-648-6841|herb.phelan@utsouthwestern.edu|
20502965|NCT03158220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502966|NCT00622895|Fred Hutchinson Cancer Research Center|George E. Georges MD|206-667-6886|ggeorges@fredhutch.org|
20558107|NCT01916941|University of New Mexico|Dr. Claire Wilcox|505-272-2333|cewilcox@salud.unm.edu|
20502967|NCT01974817|Michigan State University|Dr Subhashis Mitra|517-353-3128|mitrasub@msu.edu|
20558108|NCT00098254|National Cancer Institute|Giuseppe Giaccone, M.D., PH.D.|301-496-4916|giacconeg@mail.nih.gov|
20558109|NCT02224482|Fox Chase Cancer Center|Dr. Suzanne Miller|215-728-4069|Suzanne.Miller@fccc.edu|
20558110|NCT00744263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558111|NCT00910520|Allergan, Inc|Therapeutic Area Head,|714-246-4500 ext:|clinicaltrials@allergan.com|
20558112|NCT01121172|4th Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki|Assimina Galli-Tsinopoulou, As.Professor of Pediatric Endocrinology|00302310991537|agalli@auth.gr|
20558113|NCT01905254|Universitiy Clinic Hamburg eppendorf|PD Dr. Ulrike Denzer|040741055380|u.denzer@uke.de|
20558114|NCT01336621|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558115|NCT02934620|Ohio State University, College of Public Health|Maria Gallo|16146882145|gallo.86@osu.edu|
20558116|NCT04557826|EmitBio|Director of Clinical Trials|919-321-1734|info@emitbio.com|
20558117|NCT01474213|Department of Anaesthetics, Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine|Dr. Jiang Hong|86-21-13512122883|hr310@vip.sina.com.cn|
20558118|NCT02130284|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20558119|NCT01985828|Advocate Health|Geraldine Lara|8477238239|geraldine.lara@aah.org|
20558120|NCT00524225|University of Pittsburgh|Dr. Margaret Ragni, Professor of Medicine|412-209-7288|ragni@dom.pitt.edu|
20502968|NCT00937235|University of Pennsylvania|Dr. Edna Foa|2157463327|foa@mail.med.upenn.edu|
20550680|NCT04429061|University of Alabama at Birmingham|Dr Carolyn Bolton|966841034|Carolyn.Bolton@cidrz.org|
20502969|NCT02216695|Derby Teaching Hospital NHS Trust|Nitin V Kolhe|01332788266|nitin.kolhe@nhs.net|
20502970|NCT02923271|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
20502971|NCT00224016|Watson Laboratories, Inc|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20502972|NCT03021577|Columbia University Irving Medical Center|Ziad A. Ali, MD Assistant Professor of Medicine|212-305-7060|zaa2112@cumc.columbia.edu|
20502973|NCT01524991|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
20502974|NCT01678976|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
20502975|NCT05742984|Cinclus Pharma|Cinclus Pharma Holding AB|+46 8 13 33 10|gosta.hiller@cincluspharma.com|
20502976|NCT02162862|University of Pittsburgh Medical Center|Dr. Eva Szigethy|412-802-6696|szigethye@upmc.edu|
20502977|NCT00254410|The University of Texas MD Anderson Cancer Center|Wierda,William G, MD./Professor|713-745-0428|wwierda@mdanderson.org|
20502978|NCT01409928|UTSW|Olga T. Gupta|(214) 648-8718|olga.gupta@utsouthwestern.edu|
20502979|NCT03502187|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
20502980|NCT01841619|UC Irvine Dermatology Research Center|Sergei A. Grando|949 824 7103|sgrando@uci.edu|
20502981|NCT00701714|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
20502982|NCT01950819|Novartis Pharma|Study Director|8627788300|Novartis.email@novartis.com|
20502983|NCT00781365|HealthPartners Institute for Education and Research|Dr. Karen Margolis, MD MPH|952-967-7301|karen.l.margolis@healthpartners.com|
20502984|NCT02649634|University of Calgary|Dr. Kristin von Ranson|403.220.7085|kvonrans@ucalgary.ca|
20502985|NCT01662648|Janssen China|Regional Medical Franchis Director AP|+86 10 582 187 66||
20502986|NCT01261559|University of Washington|Dr. Claire Sandstrom|206-744-3561|cks13@uw.edu|
20502987|NCT02928952|VAPHS, Center for Heath Equity Research and Promotion|Monica DiNardo PhD, Primary Investigator|412 360-2262|monica.dinardo@va.gov|
20502988|NCT01850615|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20502989|NCT00974220|Queen's University, Kingston, ON, Canada|Dr. Denis O'Donnell|1-613-548-2339|odonnell@queensu.ca|
20502990|NCT01227967|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
20502991|NCT03403400|Advent Health|Amie Jasper|407-303-8626|amiemarie.jasper@adventhealth.com|42
20502992|NCT02266433|New York University School of Medicine - Division of Hand Surgery|Anthony Sapienza, MD / Assistant Professor|212 737 3301|Anthony.Sapienza@nyulangone.org|
20502993|NCT01273064|Conatus Pharmaceuticals Inc.|MiRa Huyghe, Vice President, Clinical Development|(858) 457-7227|mhuyghe@conatuspharma.com|
20502994|NCT01144598|Abbott|Global Medical Services|1-800-633-9110||
20502995|NCT00560755|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20502996|NCT00848120|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20502997|NCT02344225|SUNY Downstate Medical Center|Jacob V. Aranda, MD, PhD, FRCPC, Principal Investigator|718-270-1912|jaranda@downstate.edu|
20502998|NCT02525549|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20502999|NCT03219073|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
20503000|NCT01988090|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
20503001|NCT02238847|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
20503002|NCT01734317|Mölnlycke Health Care|Joan Wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
20509238|NCT05784103|University of Pittsburgh|Dr. Surya Gnyawali, PhD|6143712027|scg92@pitt.edu|
20503003|NCT01961115|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
20503004|NCT01083667|HSS/WCMC|Dale Lange|6467978917|langed@hss.edu|
20503005|NCT00360399|Emory University|Helen Mayberg|404-727-6740|hmayber@emory.edu|
20503006|NCT03887130|Pierre Fabre|Gustavo Villanova M.D|+33149108265|gustavo.villanova@pierre-fabre.com|
20503007|NCT02497001|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|1-877-240-9479|information.center@astrazeneca.com|
20503008|NCT01752023|SKCCC at Johns Hopkins|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
20503009|NCT02440581|University of Kentucky|Division Administrator|859-218-4943|daniel.ormond@uky.edu|
20503010|NCT03135249|UT Southwestern Medical Center|Dr. Olaf Stuve, Principal Investigator|12146484559|olaf.stuve@utsouthwestern.edu|
20503011|NCT01889602|University of Minnesota|Dr. Susan Marino|612-624-2964|marin007@umn.edu|
20503012|NCT00961961|UPenn|Dr. Robert J. DeRubeis|215-573-5804|derubeis@psych.upenn.edu|
20503013|NCT01245673|University of Pennsylvania|Liz Veloso|215|eveloso@pennmedicine.upenn.edu|
20503014|NCT04722991|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20503015|NCT03186989|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20503016|NCT03057795|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
20503017|NCT02246621|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20503018|NCT01292057|Medical University of South Carolina|Joseph Schacht, Ph.D.|(843) 792-7497|schacht@musc.edu|
20503019|NCT01459614|Sidney Kimmel Comprehensive Cancer Center|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
20503020|NCT04451707|Groupe Hospitalier La Rochelle Ré Aunis|Dr Florence Hoefler|+330546455050|florence.hoefler@ch-troyes.fr|
20503021|NCT02587338|Universitätsklinikum Würzburg|Prof. Dr. Martin Herrmann|+4993120176650|Herrmann_m@ukw.de|
20503022|NCT00630331|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20503023|NCT01302808|UT Southwestern Medical Center|David Gerber, MD|2146484180|david.gerber@utsouthwestern.edu|
20503024|NCT06120530|Indiana University School of Medicine|Jose Lazaro|7274241947|jlazarow@iu.edu|
20503025|NCT02425098|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20503026|NCT00821678|VA HSR&D|John Fortney|206.764.2821|john.fortney@va.gov|
20503027|NCT02078219|Study Information Center AstraZeneca|Fredrik Erlandsson, MD|+1 877-240-9479|information.center@astrazeneca.com|
20503028|NCT03036527|University of Louisville|Charles Hubscher|502-852-3058|charles.hubscher@louisville.edu|
20503029|NCT02761967|University of Granada|Dr. Rodríguez-Blanque|+34644322567|rarobla@gmail.com|
20503030|NCT03136107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20503031|NCT02281591|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20503032|NCT03641560|Astellas Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
20503033|NCT02237235|Northwestern University|Herbert Y. meltzer|312-503-0309|h-meltzer@northwestern.edu|
20503034|NCT04533711|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
20503035|NCT03219164|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20503036|NCT02689492|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503037|NCT02732951|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503038|NCT01750918|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20503039|NCT04585763|Shockwave Medical|Birgit Greschner|650-575-6199|bgreschner@shockwavemedical.com|
20503040|NCT00460993|Atlanta VA Medical Center|Dr. Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
20503041|NCT02561897|Electrophysiology Research Foundation|Sanjeev Saksena|7323029990|eprf@aol.com|
20503042|NCT00659295|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20503043|NCT04840667|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20503044|NCT00654927|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
20503045|NCT02828267|Duke University Medical Center|Catherine Staton|9196845537|catherine.staton@duke.edu|
20503046|NCT00110305|Janssen-Virco BE|Director|32 14 641418||
20503047|NCT03338556|PrEP Biopharm Limited|Chief Medical Officer|8666207176|info@prepbiopharm.com|0
20503048|NCT00961532|Northwestern Medicine|Andrew M Naidech|312-503-3335|a-naidech@northwestern.edu|
20503049|NCT02010203|Clinical Development|Lori McDermott|9197948950|lmcdermott@heatbio.com|9197948950
20503050|NCT01495819|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
20503051|NCT01805180|Terumo BCT|Raymond P. Goodrich, PhD / VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|303.205.2680|Ray.Goodrich@terumobct.com|
20503052|NCT01922921|University of Washington|Director of Clinical Operations|2066162305|childj@u.washington.edu|
20558121|NCT01435655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503053|NCT04574999|Italfarmaco|Dr. Concepción Nieto|+34 91 657 23 23|cnieto@itfsp.com|
20503054|NCT00391599|Edith Wolfson Medical Center|Investigator|+972-35028329|lurie@wolfson.health.gov.il|
20558122|NCT01686581|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20558123|NCT01975220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558124|NCT02839343|Mayo Clinic|Frank Sinicrope|5072664338|Sinicrope.Frank@mayo.edu|
20558125|NCT01870388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20558126|NCT01852058|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20558127|NCT00661661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558128|NCT01657266|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Clinical trials Director|52+ (33) 30 01 42 00|leopoldo.baiza@sophia.com.mx|
20558129|NCT03474549|Rapid-Medical|Dr. Walid Haddad- Chief Clinical Officer|+972 72 2503331|walid@rapid-medical.com|
20503055|NCT03631927|Tata Memorial Hospital|Dr. Jigeeshu Divatia|+919869077435|jdivatia@yahoo.com|
20503056|NCT00206726|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20503057|NCT00008385|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20503058|NCT05148884|Neurolixis|Adrian Newman-Tancredi, PhD, DSc, CEO|(+33) 605 14 09 64|contact@neurolixis.com|
20503059|NCT00582556|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
20503060|NCT00595231|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
20503061|NCT01993888|Ethicon, Inc.|Senior Director of Ethicon Clinical R&D|908-218-2492|jbatill2@its.jnj.com|
20503062|NCT01341457|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20503063|NCT00365989|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
20503064|NCT00999830|HOPITAL DE PURPAN Service Hematologie|Dr Michel ATTAL|+33 (0)5.61.77.77.84|attal.m@chu-toulouse.fr|
20503065|NCT00832819|Eisai Co., Ltd.|Wataru Yusa|+81 3-3817-5252||5252
20503066|NCT00317044|AstraZeneca|ClinicalTrialTransparency||ClinicalTrialTransparency@astrazeneca.com|
20503067|NCT04647110|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503068|NCT04317690|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
20503069|NCT02318095|Regulatory Coordinator|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
20503070|NCT01717638|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20503071|NCT04486560|Johns Hopkins University|Dr. Lonny Yarmus|410-502-5224|lyarmus@jhmi.edu|
20503072|NCT01719757|Suyoun Yang|CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
20503073|NCT02626338|AROG Pharmaceuticals Inc.|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20503074|NCT01099111|KFMC|Dr. Ahmed Al Omair|+96612889999|aalomair@kfmc.med.sa|8771
20503075|NCT03312218|McGill University|Dr. Roland Grad|514-947-3718|roland.grad@mcgill.ca|
20503076|NCT01901224|Brigham and Women's Hospital|Mark A. Creager, MD|603-650-8283|mark.a.creager@hitchcock.org|
20503077|NCT01910792|Vitamin D, Skin, and Bone Research Laboratory|Dr. Michael F Holick|6176384546|mfholick@bu.edu|
20503078|NCT06415305|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
20503079|NCT00103012|National Institutes of Health, Clinical Center, Department of Pharmacy|Scott Penzak|301-496-2997|spenzak@cc.nih.gov|
20503080|NCT03051633|Colorado State University|Dr. Meghan Crabtree|2105875584|meghan.crabtree@colostate.edu|
20503081|NCT05211336|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
20503082|NCT01790490|NYSPI|Elias Dakwar, MD|(646) 774-8728|dakware@nyspi.columbia.edu|
20503083|NCT00393718|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20503084|NCT04271761|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|3105
20503085|NCT01084551|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20503086|NCT04684420|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151 72 5200|service@emdgroup.com|
20503087|NCT00463476|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20503088|NCT04226469|University of Illinois Chicago|Phimon Atsawasuwan|3124132651|patsawas@uic.edu|
20503089|NCT00988247|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20503090|NCT01703000|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
20503091|NCT00434967|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20503092|NCT00956930|Northwestern University|Riad Salem MD|312-695-6371|rsalem1@nm.org|
20503093|NCT00544830|City of Hope|Dr. Cy Stein|626-359-8111||
20503094|NCT01963481|NYU Langone Health|Sylvia Adams|212 731 5795|Sylvia.Adams@nyulangone.org|
20503095|NCT01551693|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
20503096|NCT01838044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503097|NCT03670030|Ochsner Medical Center|Robert Ramirez, DO|504-464-8500|awendt@ochsner.org|
20503098|NCT03709602|Duke University|Dr. Lisa Mansfield|919-681-9198|lisa.mansfield@duke.edu|
20503099|NCT00737529|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
20503100|NCT00565617|Medical University of South Carolina|Gregory Sahlem|843-792-5716|sahlem@musc.edu|
20503101|NCT00125034|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
20503102|NCT04666038|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20503103|NCT02658812|UT MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD-Professor Breast Medical Oncology|713-792-8754|nueno@mdanderson.org|
20503104|NCT03400800|Novartis|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
20503105|NCT01512264|Universtiy of Alabama at Birmingham|Dr. Jerzy P. Szaflarski|205.975.5587|jszaflarski@uabmc.edu|
20503106|NCT01194440|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|HopkinsBreastTrials@jhmi.edu|
20503107|NCT01931059|Northwell Health|Dr. Miklos Argyelan|718-470-8175|margyela@northwell.edu|
20503108|NCT01239355|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20503109|NCT01859247|The University of New Mexico Health Sciences Center|Dr. Sarah Pirio Richardson, MD|505-272-3342|spiriorichardson@salud.unm.edu|
20503110|NCT04957290|Noxopharm|Lorena, Director Clinical Operations|+ 61 2 9144 2223|lorena.figueroa@noxopharm.com|
20503111|NCT00896532|Amgen Inc.|Study Director|866-572-6436||
20503112|NCT03686969|CRMG|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
20503113|NCT04870671|Eastern Virginia Medical School|Dr. Terry Jacot|757-446-7056|jacotta@evms.edu|
20550681|NCT02310464|OBI Pharma, Inc.|Chen-En Tsai, MD, PhD|886 2 27866589|chenentsai@obipharma.com|215
20550682|NCT01967121|Michigan State University|Tracey Covassin|517-353-2010|covassin@msu.edu|
20550683|NCT02289898|Mereo BioPharma Group Plc.|John, Lewicki, Chief Scientific Officer|+44333023300|John.Lewicki@mereobiopharma.com|
20503114|NCT02899156|University of California Davis Medical Center|Kendra Schomer, PharmD|916-734-2243|kjschomer@ucdavis.edu|
20503115|NCT01468987|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20503116|NCT03430986|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20503117|NCT03257189|MC10 Inc|Chief Medical Officer|8572145600|ACombs@mc10inc.com|
20503118|NCT00299988|Weill Cornell Medical College|Norman Relkin, MD, PhD|212-746-9882|nrelkin@med.cornell.edu|
20503119|NCT00484315|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
20503120|NCT00943683|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20503121|NCT03035760|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
20503122|NCT01552343|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20503123|NCT02153099|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20503124|NCT01370460|Henry Ford Health System|Andrew Georgiadis, MD|313-916-7520|ageorgi1@hfhs.org|
20503125|NCT04152824|Oregon Health & Science University|Dr. Leslie Hammer|503-494-9313|hammerl@ohsu.edu|
20503126|NCT03283085|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20503127|NCT02292771|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20503128|NCT01468311|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|gconlonkc@mail.nih.gov|
20503129|NCT05047523|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20503130|NCT03658889|ChugaiPF|Isabelle Idier, Rheumatology Medical Leader|+33 (0) 1 56 37 44 89|idier@chugai-pharm.fr|
20503131|NCT04646148|Butler Hospital|Dr. Lisa Uebelacker|401-455-6381|luebelacker@butler.org|
20503132|NCT04628936|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
20503133|NCT01676831|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|deborah.leahy@uphs.upenn.edu|
20503134|NCT02747927|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20503135|NCT04801758|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20503136|NCT00522392|ECOG Statistical Office|Study Statistician|617-632-3012||
20503137|NCT00687453|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
20503138|NCT00430755|Robert-Bosch-Hospital|Prof. Dr. Mark Dominik Alscher|+4971181013496|dominik.alscher@rbk.de|
20503139|NCT02472457|The Children's Hospital of Philadelphia|Ronen Stein, MD|215-590-7801|ibdresearch@email.chop.edu|
20503140|NCT01834235|Precision Biologics Inc.|Dr. Philip Arlen President and CEO|3015008646|philip.arlen@precision-biologics.com|
20503141|NCT03902080|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20503142|NCT03575104|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
20503143|NCT02661594|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
20503144|NCT01989130|University of California-Davis|Larissa May, MD|916-736-5010|lsmay@ucdavis.edu|
20503145|NCT01169779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20509239|NCT01789255|University of Michigan Comprehensive Cancer Center|Pavan Reddy, M.D.|734-647-5954|reddypr@umich.edu|
20509240|NCT02635867|University of Illinois at Chicago|Adriana Semprum-Clavier|312-966-3535|asemprum@uic.edu|
20509241|NCT02128958|Can-Fite BioPharma|Pnina Fishman, PhD, CEO|972-3-924-1114|pnina@canfite.co.il|
20509242|NCT02565576|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20509243|NCT00939341|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|28062
20509244|NCT04904640|IRCCS Istituto Ortopedico Rizzoli|Francesco Castagnini, MD|+390516366418|francesco.castagnini@ior.it|
20509245|NCT00564265|Hospital de La Serena|Dr. Marcelo A. Beltran|56 - 51 - 485923|beltran_01@yahoo.com|
20509246|NCT01131130|Bausch + Lomb|Dr. Robert Steffen|585-338-6399|robert.steffen@bausch.com|
20509247|NCT04254796|University of California, San Francisco|Olga Tymofiyeva|415-514-4870|olga.tymofiyeva@ucsf.edu|
20509248|NCT01976975|McLean Hospital|David Crowley|6178554432|djcrowley@mclean.harvard.edu|
20509249|NCT02463227|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s3.com|
20509250|NCT01933399|MUSC|David Morrisette, PhD|843-792-2940|morrisdc@musc.edu|
20509251|NCT01849562|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20509252|NCT00633360|Brigham & Women's Hospital|Dr Hadine Joffe|617-732-4906|hjoffe@partners.org|
20509253|NCT00638274|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-82748|ppan@wakehealth.edu|
20509254|NCT03634228|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/ Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
20509255|NCT03304912|Drexel University|Alexis Roth, PhD, MPH|267.359.6123|alexisroth@drexel.edu|
20509256|NCT01044056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503146|NCT01354132|Beth Israel Deaconess Medical Center|Larry Seidman, PhD|617 754-1238|lseidman@bidmc.harvard.edu|
20503147|NCT00582517|University of Alabama at Birmingham|Taylor Vlack, RN|205-996-6781|tmwebb@uabmc.edu|
20503148|NCT00928070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509257|NCT04095793|Theravance Biopharma|Medical Monitor|855 633 8479|medinfo@theravance.com|+1
20503149|NCT00191854|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20503150|NCT02360098|TORONTO WESTERN HOSPITAL/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
20503151|NCT04355013|University Hospital of Salamanca|Dr. José A. Sastre|+34923291100|jasastre@saludcastillayleon.es|55580
20503152|NCT01479348|National Cancer Institute|Dr. Karen Kurdziel|804-897-1207|kurdziek@nih.gov|
20503153|NCT00862251|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503154|NCT02796755|Emory University|Andrew H Miller, MD|404-727-8260|amill02@emory.edu|
20503155|NCT00556426|C.R. Bard|John Reviere, Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|
20503156|NCT02673333|Memorial Sloan Kettering Cancer Center|Diane Reidy-Lagunes, MD|646-888-4185|reidyd@mskcc.org|
20503157|NCT02347631|UT Southwestern Medical Center|Danielle Robertson|214-648-3416|danielle.robertson@utsouthwestern.edu|
20503158|NCT01509625|Hospital Clínico San Cecilio Granada|Dr Isabel Blancas|+34 958023498|blancaslb@hotmail.com|
20503159|NCT02318784|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20503160|NCT02304926|FISABIO-University Hospital Dr Peset|Dr Antonio Hernández|961622492|hernandez_antmij@gva.es|
20503161|NCT02388295|AstraZeneca Pharmaceuticals LP|Jamie Mullen MD||Clinicaltrialtransparency@astrazeneca.net|
20503162|NCT01510327|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
20503163|NCT03804684|Wills Eye Hospital|M. Reza Razeghinejad, MD|12159283197|reza@willseye.org|
20503164|NCT02429856|UAlberta|Director of NACTRC|780-407-8007|ron.welch@ahs.ca|
20503165|NCT03700047|QMedAB|Clinical Project Manager|(817) 961-500|aestheticclinicaltrials@galderma.com|
20503166|NCT04340050|University of Chicago|Leila Yazdanbakhsh|773-834-5087|leila.yazdanbakhsh@bsd.uchicago.edu|
20509258|NCT01947647|Ralph H. Johnson VAMC|Daniel Gros, PHD|843-789-7311|daniel.gros@va.gov|
20509259|NCT02224274|UMC Ljubljana|Marko Noc|+386 1 522 22 96|marko.noc@mf.uni-lj.si|
20509260|NCT00499460|Clinical Research Division, Fred Hutchinson Cancer Research Center|Danny D. Shen, Member (Retired)|206-685-2920|ds@uw.edu|
20509261|NCT00887068|UT MD Anderson Cancer Center|Dr. Richard E. Champlin, MD/ Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
20509262|NCT00901394|University of Chicago|Principal Investigator|7737022544||
20509263|NCT02290340|MedImmune, LLC|M. Pamela Griffin|301-398-4095|information.center@astrazeneca.com|
20509264|NCT04129086|The University of Texas Health Science Center at Houston|John Andrew Harvin, MD|713-500-7292|John.Harvin@uth.tmc.edu|
20509265|NCT00045487|University of Texas Health Science Center San Antonio|Alain Mita, MD|210-450-5094|goodwine@uthscsa.edu|
20509266|NCT00089999|GlaxoSmithKline|GSK Response Center|866-435-7343||
20509267|NCT01167153|Novartis Pharmaceuticals|Study Director|862-778-8300||
20509268|NCT02859558|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20509269|NCT01432756|Boston Children's Hospital|Laura Bogart|857-218-4073|laura.bogart@childrens.harvard.edu|
20509270|NCT01357720|Crucell Switzerland AG|Medical Affairs Director|+41(0)319086111|info@crucell.com|
20509271|NCT00098865|DFCI|Mark W. Kieran, MD, PhD|617-632-4907|mark_kieran@dfci.harvard.edu|
20509272|NCT03050307|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20509273|NCT00439309|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
20509274|NCT02145754|University Medical center Ljubljana, Infectious Diseases Department|Daša Stupica|+386 1 522 21 10|dasa.stupica@kclj.si|
20509275|NCT00430027|University of Colorado, Denver|Dr. Tracey Schefter|720-848-0100|Tracey.Schefter@ucdenver.edu|
20509276|NCT01998906|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20509277|NCT01572844|GW Medical Faculty Associates|Alison Ehrlich, MD, Chair of Department of Dermatology|202-741-2625|aehrlich@mfa.gwu.edu|
20509278|NCT05724069|Alfasigma|Sara Manzoni|3473778218|sara.manzoni@alfasigma.com|
20509279|NCT01536418|GlaxoSmithKline|GSK Response Center|866-435-7343||
20509280|NCT02658149|Beaumont Health|Dr. James Verner|1(248)551-9722|jverner1@aol.com|
20509281|NCT00711412|Northwestern University|Dr. Mary Mulcahy|312 695 6182|Mary.Mulcahy@nm.org|
20509282|NCT00794469|Hadassah Medical Organization|Gal Dubnov-Raz|+972+54-4570250|gal-d@bezeqint.net|
20509283|NCT04358991|University of Pittsburgh|Dr. Ryan Shields, Associate Professor of Medicine|412-864-3745|shieldsrk@upmc.edu|
20509284|NCT01680991|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20509285|NCT02498392|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509286|NCT06073054|University of Iowa|Linnea Polgreen|(319) 384-3024|linnea-polgreen@uiowa.edu|
20509287|NCT03687827|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20509288|NCT02244619|Kettering Health Network|Skip Hickman, RPH|(937) 762-1339|skip.hickman@ketteringhealth.org|
20509289|NCT00068822|Mayo Clinic|David F. Kallmes, M.D.|507-266-3350|kallmes.david@mayo.edu|
20509290|NCT02367859|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
20509291|NCT00429572|UT MD Anderson Cancer Center|Naoto Ueno, MD, PhD/Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
20503167|NCT04134494|BIDMC|Roger Lefevre|6176674070|rlefevre@bidmc.harvard.edu|
20509292|NCT01665872|Yale University|Dr. Megan Smith|2037648655|megan.smith@yale.edu|
20550684|NCT03267186|Stanford University|Andrew R. Rezvani, MD|650-725-4077|arezvani@stanford.edu|
20550685|NCT01402544|Univeristy of California, San Diego|Dr. Henry Ferreyra|858-822-7982|hferreyra@ucsd.edu|
20550686|NCT01828281|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
20558130|NCT03573908|Ironwood Pharmaceuticals, Inc.|Vanessa Chong|(617) 374-3923|vchong@ironwoodpharma.com|
20503168|NCT00763009|UCHC|Michael Azrin|8606793343|azrin@uchc.edu|
20509293|NCT00424099|UT MD Anderson Cancer Center|Dr. Eduardo Bruera, MD- Chair, Palliative Care Med|(713) 792-6084|ebruera@mdanderson.org|
20509294|NCT01408732|University of Minnesota|Holly Boyer, MD|612-725-2000|boyer011@umn.edu|
20503169|NCT01111604|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979||
20503170|NCT01355289|Eisai Call Center|Eisai Inc.|888-422-4743||
20558131|NCT04006925|Stanford University|Emmanuel During|212-844-8888|Emmanuel.During@mountsinai.org|
20558132|NCT02089230|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
20509295|NCT00764322|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20509296|NCT01989572|ECOG Statistical Office|Study Statistician|617-632-3012||
20509297|NCT00262639|Medical University of South Carolina|Raymond F. Anton, M.D.|843-792-1226|antonr@musc.edu|
20509298|NCT02280096|Instituto Mexicano del Seguro Social. Unidad de Investigación Médica en Enfermedades Neurológicas.|Dr. Israel Grijalva|(01152) 5555780240|igrijalvao@yahoo.com|
20558133|NCT00186498|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
20558134|NCT03469284|UT MD Anderson Cancer Center|Dr. Carlos Roldan, Associate Professor, Pain Medicine|(713) 563-7402|croldan@mdanderson.org|
20558135|NCT00386308|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20558136|NCT02746575|Washington University|Principal Investigator|7737022544||
20558137|NCT04567693|Montefiore Medical Center|Dr. Jonathan Ross|718-920-7064|joross@montefiore.org|
20558138|NCT00720902|Columbia University|Pamela Freda, MD|212-305-3725|puf1@columbia.edu|
20558139|NCT04867785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20558140|NCT02959671|University of Minnesota|Thorsten Gruenheid, DDS, PhD|612-625-3903|tgruenhe@umn.edu|
20503171|NCT01221857|Gamida Cell|Kelly Myers|+972-2-659-5631|clinicaltrials@gamida-cell.com|
20503172|NCT00481845|Stanford Cancer Institute, Stanford University|Mark Daniel Pegram; Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
20503173|NCT02706938|Universidad Nacional de Colombia|Dr. Ivan Mauricio Villamil Morales|+573178755369|imvillamilm@unal.edu.co|
20503174|NCT02507349|UPMC Center for High-Value Health Care|Kelly Williams, Program Administrator|412-454-1198|Williamsk17@upmc.edu|
20503175|NCT00754156|University of Kentucky Medical Center|Phillip Chang, M.D. PI or Anna Rockich, Pharm.D. GSRP Director|859-323-6346|arockich@uky.edu|247
20503176|NCT01614964|Tulane University|Jeffrey G Shaffer|504-988-1142|jshaffer@tulane.edu|
20503177|NCT00860470|JHSPH|Keith P. West, Jr.|4109552061|kwest@jhsph.edu|
20503178|NCT00348140|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503179|NCT00619957|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20503180|NCT00868790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503181|NCT01763164|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503182|NCT03377634|Wake Forest University School of Medicine|Amber Brooks, MD|336-716-4498|akbrooks@wakehealth.edu|
20503183|NCT01264939|Genentech, Inc.|Medical Communications|800 821-8590||
20503184|NCT01167608|Rutgers-Robert Wood Johnson Medical School|Dr. Roseanne Dobkin, Associate Professor of Psychiatry|732-235-4051|dobkinro@rutgers.edu|
20503185|NCT03384329|Institute of Physiology and Basic Medicine|Dr. Lyubomir Aftanas|+7-913-912-2228|liaftanas@gmail.com|
20503186|NCT03251326|New York State Psychiatric Institute|Margaret Haney, Ph.D.|646-774-6129|meg.haney@nyspi.columbia.edu|
20503187|NCT01384292|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20503188|NCT01171612|Corporacion Sanitaria y Universitaria Parc Tauli|Anna Rodriguez-Pont|0034937231010|anna.r.pont@gmail.com|21283
20503189|NCT00854828|Washington University|Keith H. Bridwell, MD|314-747-2655|bridwellk@wustl.edu|
20503190|NCT01282229|Millenium Dental Technologies, Inc|Dr. David Harris|510-502-3345|dharris@LANAP.com|
20503191|NCT00996203|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20503192|NCT01671280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503193|NCT01959165|Biometrics|Nii Masahiro|+81 6 7711 4571|Masahiro.Nii@astrazeneca.com|4571
20503194|NCT03094195|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20503195|NCT00927563|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
20503196|NCT00909155|University of Wisconsin|Dr. Michael Peterson|608 265 8130|mpeterson2@wisc.edu|
20503197|NCT00787787|Cancer Consortium|Medical Director, Clinical Research Support|206-667-5767|lmendels@fredhutch.org|
20503198|NCT02116621|University of California, Davis|Richard Kravitz, MD, MSPH|916-734-1248|rlkravitz@ucdavis.edu|
20503199|NCT01412957|Amgen Inc.|Study Director|866-572-6436||
20503200|NCT04492566|Sansum Diabetes Research Institute|Dr. Kristin Castorino|805-682-7638|info@sansum.org|
20503201|NCT01870739|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20503202|NCT01986062|Arbor Pharmaceuticals|Dr. Steve Caras|(470) 235-2327|scaras@arborpharma.com|
20503203|NCT03538743|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503204|NCT00524537|AbbVie|Global Medical Information|800-633-9110||
20503205|NCT01565980|Michigan State University College of Nursing|Rebecca H. Lehto, PhD, Assistant Professor|517-353-4757|rebecca.lehto@hc.msu.edu|
20503206|NCT05391438|Children's Hospital Los Angeles|Alaina Vidmar|3236614606|avidmar@chla.usc.edu|
20503207|NCT00895830|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
20503208|NCT01929135|Universidad de los Andes|Dra. Catherine Andrade|056-972862308|catherine.perio@gmail.com|
20503209|NCT01926626|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
20503210|NCT03639948|University of Kansas Medical Center|Dr. Priyanka Sharma|913-588-6029|psharma2@kumc.edu|
20503211|NCT04439279|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20503212|NCT02031679|Johns Hopkins University School of Medicine|Dr. Eric Oliver|410-550-2300|eolive15@jhmi.edu|
20503213|NCT02338843|La Jolla Pharmaceutical Company|George Tidmarsh, MD, PhD|858-207-4264|gtidmarsh@ljpc.com|
20550687|NCT00142584|Viatris Inc|M. Rachel Kirker, PhD, Director, Clinical Oversight & Inspection Readiness|724-485-6170|rachel.kirker@viatris.com|
20503214|NCT00023322|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Theo Heller, M.D.|(301) 402-7147|Theoh@mail.nih.gov|
20503215|NCT01609933|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20509299|NCT00246376|Baylor College of Medicine|Ashok Balasubramanyam, MD, Prinicipal Investigator|713-798-8654|ashokb@bcm.edu|
20509300|NCT01872897|Reckitt Benckiser|Clinical Data Controller||clinicaldatacontroller@reckitt.com|
20509301|NCT01024920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503216|NCT03802721|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
20503217|NCT02300129|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
20503218|NCT01887912|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
20503219|NCT02924896|Imperial College London|Prof Gary Frost|020 7589 5111|g.frost@imperial.ac.uk|
20503220|NCT00970606|Vanderbilt University Medical Center|Gordon R. Bernard, MD, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@vanderbilt.edu|
20503221|NCT01154101|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503222|NCT05019131|University of California, San Francisco|Dr. Patience Afulani|(415) 476-1000|Patience.Afulani@ucsf.edu|
20503223|NCT00432237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20503224|NCT00412529|Novartis Pharmaceuticals|Study Director|862-778-8300||
20503225|NCT01919307|Denver Health and Hospital Authority|Edward Maa|303-602-5099|Edward.Maa@dhha.org|
20503226|NCT03742427|Marmara University|Sinan KARACABEY|+902166254545|karacabeysinan@gmail.com|
20503227|NCT02348099|Gerontology Research Lab|Mr Boris Feldman, Research Associate|16048755115|boris.feldman@vch.ca|
20503228|NCT05023252|Veterans Health Administration, Greater Los Angeles Veterans Healthcare Center|Alexander Young MD|310-478-3711|alexander.young@va.gov|
20503229|NCT02157883|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20503230|NCT03155997|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20503231|NCT01551979|Beth Israel Deaconess Medical Center|Mark Halko|6176670367|mhalko@bidmc.harvard.edu|
20503232|NCT04067518|Institut de Recherches Internationales Servier|Clinical Studies Department|+33 1 55 72 43 66|scientificinformation@servier.com|
20503233|NCT02771522|Calcivis Ltd|Director of Clinical Research|+44 131 658 5152|mwillins@calcivis.com|
20503234|NCT01111305|NIAID/NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
20503235|NCT02371850|University of Maryland School of Pharmacy|Audra Stinchcomb, PharmD|410-706-2646|astinchc@rx.umaryland.edu|
20503236|NCT00934102|University of Waterloo|Craig Woods, PhD, FAAO / Research Manager|1-519-888-4742|cclr2@uwaterloo.ca|
20503237|NCT04258579|Weill Cornell Medical College|Dr. Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
20503238|NCT04007159|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20503239|NCT02076165|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|36080
20503240|NCT00486603|Adult Brain Tumor Consortium|Director of ABTC|410-955-3657|jfisher@jhmi.edu|
20503241|NCT02547623|Icon Bioscience, Inc.|Vice President, Quality and Compliance|510-933-8381||
20503242|NCT02849639|University of Kentucky|Daniela C Moga MD PhD, Associate Professor|859-323-9682|daniela.moga@uky.edu|
20503243|NCT01756456|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20503244|NCT01379625|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
20503245|NCT01647737|Georgia Regents University|Dr. Scot DeRossi, Chairman of the ORal Medicine & Diagnostic Sciences Department|706-721-2607|Sderossi@gru.edu|
20503246|NCT00495157|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
20503247|NCT00813995|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503248|NCT03618030|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|Sailaja.Bhaskar@ImbriumThera.com|
20503249|NCT03689192|National Center for Cancer Immune Therapy|Cathrine Lund Lorentzen|004538683868|cathrine.lund.lorentzen@regionh.dk|
20503250|NCT00888238|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20503251|NCT02700984|Alcon Research|Sr Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20503252|NCT03705481|Corindus, Inc.|John Van Vleet, VP Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
20503253|NCT01032629|Janssen- Cilag International NV|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20503254|NCT00516919|Yale University School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
20503255|NCT02868892|WRMC|Jessica L. Coats|6233417220|jessica.coats@ctca-hope.com|
20503256|NCT00723957|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20503257|NCT01007526|Samsung Medical Center|Won Seog Kim|82234106548|wskimsmc@skku.edu|
20503258|NCT01360996|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
20503259|NCT01454076|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20503260|NCT00291551|Paracor Medical, Inc.|Michael Kolber, General Manager, VP, Regulatory Affairs|408-734-6000|info@paracor.com|
20503261|NCT01015833|Memorial Sloan-Kettering Cancer Center|Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
20503262|NCT02844998|Ankara TRH|Dr. Muhammet Fatih Kilinc|+90 312 595 3700|mdfatihkilinc@yahoo.com|3724
20509302|NCT00329784|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20509303|NCT00926185|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20509304|NCT04599972|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
20509305|NCT00638690|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Research|310-914-2915||
20509306|NCT00554853|UMichigan|PPAR-gamma agonist, rheumatoid arthritis and cardiovascular disease|734-936-7905|makaplan@umich.edu|
20509307|NCT02861118|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20509308|NCT01452191|University of Nottingham|Professor Denise Kendrick||denise.kendrick@nottingham.ac.uk|
20503263|NCT01656772|Stereotaxis, Inc.|Qun Sha M.D. (Study Director)|314-678-6143|qun.sha@stereotaxis.com|
20503264|NCT01651780|The Medicines Company|Global Health Science Center|800-388-1183||
20503265|NCT03898063|University of Miami|Nick Carcioppolo|3052845633|n.carcioppolo@miami.edu|
20503266|NCT02949830|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20503267|NCT01290887|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20503268|NCT01628926|Otsuka Pharmaceutical Co, Lts.|Director of Clinical Research and Development|+81-3-6361-7366||
20503269|NCT03437447|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20503270|NCT02040142|Montefiore Medical Center|Dr. John McAuliffe, Associate Professor Department of Surgery and Department of Pathology|718-379-6865|jomcauli@montefiore.org|
20503271|NCT04752384|Medical College of Wisconsin|Stuart J. Wong, MD|414-805-4600|swong@mcw.edu|
20503272|NCT00413959|Oncology Specialists SC|Sigrun Hallmeyer, MD Director of Research|847-268-8200|shallmeyer@oncmed.net|
20503273|NCT01629615|SOLTI|Scientific Manager|(+34) 93 343 63 02|pamela.celiz@gruposolti.org|
20503274|NCT00288574|NYSPI|BT Walsh, MD|646-774-8066|edru@nyspi.columbia.edu|
20503275|NCT00382031|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20503276|NCT01817790|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503277|NCT01671345|Jesse Brown VA Medical Center|Howard S. Gordon, MD|312-569-7331|howard.gordon2@va.gov|
20503278|NCT03636906|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20503279|NCT00891202|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20503280|NCT05070338|RAND Corporation|Katherine E. Watkins|310-393-0411|kwatkins@rand.org|6509
20503281|NCT04596891|New York State Psychiatric Institute|Dr. Yuval Neria|646-774-8092|ny126@cumc.columbia.edu|
20503282|NCT03690869|Regeneron Pharmaceuticals Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20503283|NCT04981223|Stanford University|Dr. Geoffrey Sonn|(650) 498-6000|gsonn@stanford.edu|
20503284|NCT06001307|Illinois Institute of Technology|Arryn Guy|312-567-6467|aguy1@iit.edu|
20503285|NCT03532100|CLiMB|Glenn Klute, PhD|206.277.6724|Glenn.Klute@va.gov|
20503286|NCT03263806|Beaumont Hospitals|Korana Stakich-Alpirez|248 898 0315|Korana.Stakich-Alpirez@beaumont.org|
20503287|NCT04544566|Coloplast A/S|Head of Scientific Affairs|+45 4911 1111|clinicaltrialsgovSA@coloplast.com|
20503288|NCT00142506|MEMORIAL SLOAN KETTERING CANCER CENTER|MICHAEL J ZELEFSKY|+1212-639-6802|zelefskm@MSKCC.ORG|
20503289|NCT04246554|UH Cleveland Medical Center|Dr. Michael Karns|216-844-7200|srmengers@gmail.com|
20503290|NCT01252966|University of Pennsylvania (Perelman School of Medicine)|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
20503291|NCT03340350|VA Nebraska-Western Iowa Health Care System|Sriram Ramaswamy, MD|402-995-4712|Sriram.Ramaswamy@va.gov|
20503292|NCT03275870|Beth Israel Lahey Health|Dr. Elena Gonzalez Brant, PI|6173191221|emgbrant@gmail.com|
20503293|NCT01133639|Mount Auburn|Emily Cook|(617) 354-3131|ecook@mah.harvard.edu|
20503294|NCT05194345|University of South Florida|Heewon Gray|(813) 974-9881|hlgray@usf.edu|
20503295|NCT03890679|Tufts Medical Center|Dr. Jonathan Davis|6176365322|jdavis@tuftsmedicalcenter.org|
20503296|NCT04854499|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20503297|NCT05415449|Children's Medical Center|Maria Leal|2144560276|Maria.leal@childrens.com|
20503298|NCT05428332|Stanford University|Allen Seo|9254939732|allenseo@stanford.edu|
20503299|NCT03455673|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, manager of clinical trials|+33546455050|caroline.allix-beguec@ght-atlantique17.fr|
20503300|NCT02185521|Philips Healthcare|Dr. Szymon Bieganski|978-284-3271|szymon.bieganski@philips.com|
20503301|NCT00398112|Mayo Clinic|Tait Shanafelt||shanafelt.tait@mayo.edu|
20503302|NCT03932812|University of Iowa|Sato Ashida|319-384-1477|sato-ashida@uiowa.edu|
20503303|NCT00332709|Novartis Pharmaceuticals|Study Director|862-778-8300||
20503304|NCT03293654|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
20503305|NCT01933932|AstraZeneca Research and Development|Dr Gabriella Mariani|+44 (0)1763 263801|ClinicalTrialTransparency@astrazeneca.com|
20503306|NCT03289416|Andrews Research and Education Foundation|Jessica Truett|8509168570|jessica.truett@andrewsref.org|
20509309|NCT01347073|Hyperion Therapeutics, Inc.|Craig James R.N. Associate Dir. UCD Clinical Operations|(650) 745- 7480|craig.james@hyperiontx.com|
20509310|NCT00626340|University of Pennsylvania|Dr. Cynthia Neill Epperson|215-573-8871|cepp@mail.med.upenn.edu|
20509311|NCT03236506|University of Dundee|Professor John Dillon|01382 383017|j.f.dillon@dundee.ac.uk|
20509312|NCT00621244|Novartis Pharmaceuticals|Study Director|862-778-8300||
20509313|NCT00865202|University of Colorado|Thomas Robinson MD|303-724-2728|thomas.robinson@ucdenver.edu|
20509314|NCT02865928|Northwell Health|Louis Ballas|718-470-5827|lballas@northwell.edu|
20509315|NCT03531710|United Neuroscience|Medical Director|+1 (972) 809-0481|info@unitedneuroscience.com|
20509316|NCT01925014|The LOCAT Group|Kyoung Ho Lee|82317877607|kholeemail@gmail.com|
20509317|NCT01690988|Washington University School of Medicine|Dr. Michael Avidan|314-747-4155|avidanm@wustl.edu|
20503307|NCT04454489|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336 -713-5440|mporosnicu@wakehealth.edu|
20503308|NCT01323478|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20503309|NCT05617521|Hospital Central Norte PEMEX|Dr. Antonio Marmolejo|+526142231826|dr.marmolejo.ch@gmail.com|
20503310|NCT00891995|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
20503311|NCT02054702|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20503312|NCT01262898|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503313|NCT00680225|New England Retina Associates|Dr. Peter Liggett|203-288-2020|neretina@msn.com|
20503314|NCT02494570|Aadi Bioscience|Medical Information|1-888-246-2234|MedInfo@aadibio.com|
20503315|NCT01295125|University Hosptials Cleveland Medical Center|Dr. Michael Rosen|216-396-9937|rosenm@ccf.org|
20503316|NCT03838484|Vanderbilt University Medical Center|Alan S. Lewis, M.D., Ph.D.|615-875-4027|alan.s.lewis@vumc.org|
20503317|NCT02633540|Fox Chase Cancer Center|Dr. Thomas Galloway|215-728-5536|Thomas.Galloway@fccc.edu|
20503318|NCT00661583|University of Colorado Denver|Dr.Malik Kahook|720-848-2020|malik.kahook@ucdenver.edu|
20503319|NCT01231412|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20503320|NCT04964258|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20503321|NCT04525703|University of Wisconsin - Madison|Pajarita Charles, PhD|608-263-3834|paja.charles@wisc.edu|
20503322|NCT01285349|Social Intervention Group|Dr. Nabila El-Bassel|212-851-2391|ne5@columbia.edu|
20503323|NCT03040024|Emory University|Dr. Amit Prabhakar|404-686-2747|amit.prabhakar@emory.edu|
20503324|NCT00096161|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20503325|NCT02452762|Children's Hospital of Eastern Ontario|James Dayre McNally, Principal Investigator and Pediatric Intensivist|613-737-7600|dmcnally@cheo.on.ca|3553
20503326|NCT03682120|St Louis University School of Medicine|Sharon Frey, MD|314-997-5500|sharon.frey@health.slu.edu|
20503327|NCT02630953|Brown University|Dr. Bess Marcus, Principle Investigator|401-863-6950|bess_marcus@brown.edu|
20503328|NCT00650858|Johns Hopkins University|Daniel F. Hanley, MD|410-614-6996|dhanley@jhmi.edu|
20503329|NCT03633084|Ribomic USA|Yusuf Ali, Ph.D.|(707) 287-4313|yusuf.ali@ribomic.com|
20550688|NCT05081011|Stanford University|Ashwin K Nayak, MD|(650) 725-5071|aknayak@stanford.edu|
20550689|NCT01354951|Memorial Sloan Kettering Cancer Center|Dr. Michael Zelefsky, MD|212-639-6802|zelefskm@mskcc.org|
20550690|NCT02709785|Saint Louis University|D. Douglas Miley|314-977-8381|ddouglas.miley@health.slu.edu|
20550691|NCT01961323|Icahn School of Medicine at Mount Sinai|Dr. Partho Sengupta|212-659-8847|partho.sengupta@mountsinai.org|
20550692|NCT00473642|Retina Specialists of Michigan|Scott Westhouse, DO|616-954-2020|s.westhouse@gmail.com|
20550693|NCT01156311|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20550694|NCT06133348|University of Alabama at Birmingham Cancer Center|Gabrielle Rocque, MD, MSPH|205-996-9281|grocque@uabmc.edu|
20550695|NCT01025791|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550696|NCT00514540|University of Texas MD Anderson Cancer Center|Lisa Pruitt, Quality Assurance Specialist|713-792-0411|LPruitt@mdanderson.org|
20550697|NCT04468204|Department of Otolaryngology - Head and Neck Surgery|Director of Clinical Research|(843)792-1356|nguyensh@musc.edu|
20550698|NCT01996982|Ascension Seton|Research Enterprise Staff|512-3247991|ra@seton.org|
20550699|NCT02278250|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20558141|NCT00708721|Huntsman Cancer Institute|Dr. Paul Shami|801-585-0100|paul.shami@hci.utah.edu|
20503330|NCT01957137|Pelvic Health and Gastric Therapies|Rachael McNamara / Clinical Research Specialist|763.526.8107|rachael.m.mcnamara@medtronic.com|
20503331|NCT00054132|Memorial Sloan Kettering Cancer Center|Dr. Maura Dickler|646-888-4560|dicklerm@mskcc.org|
20558142|NCT02494921|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
20558143|NCT04105972|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20558144|NCT01449240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20558145|NCT00067990|University_of_Minnesota|Hassan N. Ibrahim, MD|(612) 624-9444|ibrah007@umn.edu|
20558146|NCT01200030|The Hong Kong Polytechnic University|Dr. Shamay Ng|(852) 2766-4889|Shamay.Ng@polyu.edu.hk|
20558147|NCT01749501|William Beaumont Hospital|Dr. Martin Espinosa|248-898-0633|Martin.espinosa@beaumont.edu|
20558148|NCT02265224|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
20509318|NCT02705352|Massachusetts Eye and Ear|Shyana Harper|6173915982|Shyana_harper@meei.harvard.edu|
20503332|NCT03359902|University of Florida|John Williamson|352-548-6920|john.williamson@ufl.edu|
20503333|NCT00323284|Glaukos|Jeff Wells, Sr. VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
20503334|NCT01272583|Academic Medical Center|Dr. Josefine E. Schopman|+31 20 5669111|j.e.schopman@amc.uva.nl|
20503335|NCT04828330|VA Puget Sound Health Care System|Dr. Pradeep Suri|207-762-1010|pradeep.suri@va.gov|
20503336|NCT02330419|Department of Community Health Systems, University of California at San Francisco|Glenn-Milo Santos, Associate Professor|(628) 2177-6231|glenn-milo.santos@ucsf.edu|
20503337|NCT02875223|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20503338|NCT01997463|University of Arizona|Clara Ehrman|520-621-5439|csehrman@email.arizona.edu|
20503339|NCT00667615|Memorial Sloan Kettering Cancer Center|David Straus MD|212-639-8365|strausd@mskcc.org|
20503340|NCT01110252|Labcel|João Tadeu Ribeiro Paes|55 18 3302 5800|labcel.tronco@gmail.com|5856
20503341|NCT01955707|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20503342|NCT01905956|InQpharm Europe Ltd|Pee-Win Chong|+603 6201 9690|pwchong@inqpharm.com|358
20503343|NCT03431467|The Hospital of the University of Pennsylvania|Dr. Christian Bermudez|2153165151|christian.bermudez@pennmedicine.upenn.edu|
20503344|NCT04280081|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20503345|NCT03812172|Columbia University Irving Medical Center|Mathew Maurer|2123058274|msm10@cumc.columbia.edu|
20503346|NCT03896581|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20503347|NCT04022343|Emory University|Mehmet Asim Bilen, MD|404-778-1900|mehmet.a.bilen@emory.edu|
20503348|NCT02029976|George Mason University, College of Health and Human Services|Dr. Martha Y Kubik, Professor and Director School of Nursing|703-993-1971|mkubik@gmu.edu|
20503349|NCT01445171|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
20503350|NCT02660580|Fresenius Kabi SwissBioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
20503351|NCT04462536|NoNO Inc.|Michael Tymianski|6472932232|mtymianski@nonoinc.ca|
20503352|NCT04033926|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
20503353|NCT00450580|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503354|NCT06331884|4TEEN4 Pharmaceuticals|Kathleen Richter|0049 1784027078|richter@4teen4.de|
20503355|NCT01499173|University of Michigan, Neurology|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
20503356|NCT03804671|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503357|NCT04091347|Johns Hopkins School of Nursing|Janiece Taylor|443-287-4503|jwalke90@jhu.edu|
20503358|NCT04572633|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
20503359|NCT03480802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503360|NCT00893516|Emergent Biosolutions|Clinical Development Representative||ctgov@ebsi.com|
20503361|NCT04439266|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20503362|NCT02354833|West Virginia University|Dr. Manuel C. Vallejo, Chair of Department of Anesthesiology|304-598-4929|mvallejo@wvumediciane.org|
20503363|NCT05424276|ABLi Therapeutics|Milton Werner|9174940831|info@ablitherapeutics.com|
20503364|NCT04526730|Moffitt Cancer Center|Ahmad Tarhini, MD, PhD|813-745-8581|Ahmad.Tarhini@moffitt.org|
20503365|NCT03049449|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
20503366|NCT00848744|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
20503367|NCT00792298|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503368|NCT04354428|University of Washington|Christine Johnston|206-520-4340|cjohnsto@uw.edu|
20503369|NCT00499109|H. Lee Moffitt Cancer Center and Research Institute|Charles C. Williams, M.D., Study Chair|813-745-7282|charles.williams@moffitt.org|
20503370|NCT03304522|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20503371|NCT00670709|UCLA|Jennifer Villalobos|310-825-3351|info@brain.ucla.edu|
20503372|NCT00863551|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20503373|NCT03954626|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
20503374|NCT03371355|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20503375|NCT01508455|Hospira|Dr. Marcelo Garcia da Rocha|224-212-4424|marcelo.rocha@hospira.com|
20503376|NCT02965378|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20503377|NCT02909153|Rockwell Medical|clinical project manager|248-960-9009|sgrimberg@rockwellmed.com|
20503378|NCT02278783|Huntsman Cancer Institute|Theresa Werner|801-587-3486|theresa.werner@hci.utah.edu|
20503379|NCT03056443|West Virginia University|Robert Stansbury, MD|304-293-4661|rstansbury@hsc.wvu.edu|
20503380|NCT01526148|University Hospitals Cleveland Medical Center|Keming Gao, MD, PhD|216-844-2865|keming.gao@UHhospitals.org|
20503381|NCT01173653|Vanderbilt University Emergency Medicine Department|Benjamin Heavrin, MD|615-936-0253-|benjamin.heavrin@vanderbilt.edu|
20503382|NCT00584870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503383|NCT00631137|Johns Hopkins|Jaishri Blakeley|410-955-8837|jblakel3@jhmi.edu|
20503384|NCT03308188|University of Cincinnati|T. John Winhusen, PhD.|513-585-8292|winhust@ucmail.uc.edu|
20503385|NCT00481065|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20503386|NCT00772447|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20503387|NCT02914509|Ocular Therapeutix, Inc.|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
20503388|NCT03529409|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
20503389|NCT01497262|Novartis Pharmaceuticals|Study director|862-778-8300||
20503390|NCT00454207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20558149|NCT03810313|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20558150|NCT00872430|Hospital de Clínicas de Porto Alegre|Dr. Paulo Dornelles Picon|55 xx 51 21018752|paulopicon@gmail.com|
20558151|NCT04048759|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
20558152|NCT00509002|The University of Texas (UT) MD Anderson Cancer Center|George R Blumenschein Jr, MD, Professor, Thoracic/Head & Neck Med. Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20503391|NCT01795547|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
20558153|NCT00247624|August Health University|Vaughn McCall|706-721-3141|wmccall@augusta.edu|
20558154|NCT01111838|Memorial Sloan Kettering Cancer Center|Dr. Andrea Cercek|646-888-4189|CercekA@mskcc.org|
20558155|NCT02567825|UPMC Children's Hospital of Pittsburgh|Alejandro Hoberman, MD|412-999-3277|hobermana@upmc.edu|
20558156|NCT02444663|University of Oxford|Thomas Hamilton, Clinical Research Fellow|01865227696|thomas.hamilton@ndorms.ox.ac.uk|
20558157|NCT03195465|Loma Linda University School of Allied Health Professions|Amy Sadek, PhD Rehabilitation Science|951-212-2104|asadek@llu.edu|
20558158|NCT00553098|Fred Hutch Cancer Research|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
20558159|NCT01299090|Moy, Fincher, Chipps Medical Group|Lisa Chipps, MD|(310) 274-5372|lchipps@ucla.com|
20558160|NCT01872910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20558161|NCT00154310|Novartis Pharmaceuticals|Study Director|862-778-8300||
20503392|NCT00151892|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20558162|NCT01540565|NRG Oncology|Christopher Purdy on behalf of Mike Sill|(716)845-1300|purdyc@nrgoncology.org|2296
20558163|NCT03469349|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20558164|NCT03771157|University of Rochester|Michael Brady|585-276-3203|michael_brady@urmc.rochester.edu|
20558165|NCT02086162|Dartmouth-Hitchcock|Dr. Mary F. Brunette|603-229-5419|mary.f.brunette@hitchcock.org|
20558166|NCT03447730|Synlogic|Andrew Marsh, Head Clinical Operations|617-401-9975|andrew.marsh@synlogictx.com|9135
20558167|NCT05266963|Vanderbilt University Medical Center|Dan Moore, M.D., Ph.D.|615-322-7247|daniel.moore@vumc.org|
20558168|NCT04091360|Verona Pharma|Medical Science Director|6464130307|margot.macdonald-berko@veronapharma.com|
20558169|NCT01458990|Hunter Holmes McGuire VA Medical Center|Jasmohan Bajaj|804 675 5802|jasmohan.bajaj@va.gov|
20558170|NCT05288023|University of California San Francisco|Kieran O'Brien|(415) 476-1442|kieran.obrien@ucsf.edu|
20558171|NCT02235701|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20558172|NCT00525265|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
20558173|NCT01107743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558174|NCT00308737|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20558175|NCT01913639|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
20558176|NCT01805882|National Institute of Allergy and Infectious Diseases|Shyam Kottilil MD|+1 410 706 4872|Skottilil@ihv.umaryland.edu|
20558177|NCT01225822|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558178|NCT00130793|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558179|NCT00211237|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20558180|NCT01290822|Columbia University|Henry M. Spotnitz, MD|(212) 305-6191|hms2@columbia.edu|
20558181|NCT01003639|University of Iowa Hospitals and Clinics|Dr. Michael Wall|319-353-3942|michael-wall@uiowa.edu|
20558182|NCT01515189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20558183|NCT04078035|University of Pittsburgh|Dr. Anna Marsland|14123705622|marsland@pitt.edu|
20558184|NCT03758118|IRCCS Fondazione Bietti|Dr, Vincenzo Parisi|+390686356727|vmparisi@gmail.com|
20558185|NCT05644353|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20509319|NCT03696576|Emory University|Sandeep Shelly|404-686-4206|SSHELLY@emory.edu|
20558186|NCT03500640|University of Pittsburgh School of Medicine|Elizabeth M. Venditti PhD, Associate Professor of Psychiatry and Epidemiology|4123025228|vendittiem@upmc.edu|
20509320|NCT01137006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20509321|NCT00312728|Hoffman-LaRoche|Medical Communications|800-821-8590||
20509322|NCT00552344|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20509323|NCT01975376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509324|NCT00179517|Beth Israel Deaconess Medical Center|Andrew G Herzog MD,MSc|781-431-0277|aherzog@bidmc.harvard.edu|
20509325|NCT00023712|Gynecologic Oncology Group(GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20509326|NCT00565812|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509327|NCT02667392|VAORD|Dr. Dorian Rose|352-376-1611|dorian.rose@va.gov; dkrose@phhp.ufl.edu|105238
20509328|NCT01570309|Jacobi Medical Center|Dr Seth I Sokol|718-918-5735|seth.sokol@nbhn.net|
20509329|NCT00614991|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
20509330|NCT04857892|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20509331|NCT01311895|Montefiore Medical Center|Dr. Andrew Chang|718-920-6626|achang3@yahoo.com|
20509332|NCT00655811|University of Miami|Gil Yosipovitch, MD, Professor|305-243-5121|gyosipovitch@med.miami.edu|
20509333|NCT00368472|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20509334|NCT00118404|The University of Texas Southwestern Medical Center|Dr. Robin B. Jarrett, Professor of Psychiatry|214-648-5345|Robin.Jarrett@UTSouthwestern.edu|
20509335|NCT02590640|"University of Colorado Denver | Anschutz"|Director, Research Services|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20509336|NCT03209362|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|taku.hosaka@seikagaku.co.jp|
20509337|NCT00251589|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509338|NCT00323427|Portland VA Medical Center|Mitchel Turbin, Ph.D.|503-220-8262|bonnie.becker@va.gov|54525
20509339|NCT02493868|Janssen Research & Development, LLC|Senior Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509340|NCT02407236|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509341|NCT05849441|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
20509342|NCT00093756|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507/284- 9265|alex.adjei@roswellpark.org|
20509343|NCT01627782|Janssen Research & Development, LLC|Senior Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20558187|NCT05777174|MediBeacon, Inc.|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
20558188|NCT01447849|TexasTech|Dr. Jerzy Sarosiek, Director, Mol. Medicine Research|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
20558189|NCT03929562|University of Michigan|Anne C. Fernandez|734-232-0521|acfernan@med.umich.edu|
20558190|NCT01970787|Laser Surgery Care|Stephen E Goldstone|212-242-6500|segmd@prodigy.net|
20558191|NCT01036022|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558192|NCT02101918|UT MD Anderson Cancer Center|Dr. Daniel M. Halperin/ GI Medical Oncology|713-792-2828|DMHalperin@mdanderson.org|
20558193|NCT01508013|East Tennessee State University|Dr. Joel Hillhouse|423-439-4332|hillhous@etsu.edu|
20558194|NCT02487095|National Cancer Institute|Dr. Anish Thomas|240-760-7343|thomasa6@nih.gov|
20509344|NCT00643448|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20509345|NCT02168660|UT Southwestern Medical Center|Dr Perrin C White, Professor of Pediatrics|2146486875|perrin.white@utsouthwestern.edu|
20509346|NCT02177812|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20558195|NCT03482505|Masimo|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
20509347|NCT03695471|Mayo Clinic|Jason Sluzevich|904-953-6402|Sluzevich.Jason@mayo.edu|
20509348|NCT00464620|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
20509349|NCT01193049|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509350|NCT04403802|Cedars-Sinai Medical Center|Dr. Arash Asher|310-423-1218|arash.asher@cshs.org|
20509351|NCT00911326|Navidea Biopharmaceuticals|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
20509352|NCT00864539|National Nutrition and Food Technology Research Institute|Dr. Tirang R. Neyestani|(+9821)22376471|neytr@yahoo.com|
20509353|NCT04283773|Assiut Univercity|Demonstrator at pathology department|00201033986747|omar011523@med.au.edu.eg|
20509354|NCT06048809|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20509355|NCT02784496|The University of MD Anderson Cancer Center|Prithviraj Bose, MD/Professor|713-792-7747|PBose@mdnaderson.org|
20550700|NCT03483051|University of Pennsylvania|Dr. Julio Chirinos|215-200-7779|juliochi@pennmedicine.upenn.edu|
20550701|NCT00533845|Maimonides Medical center|Danny A Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
20550702|NCT00345254|Edith Wolf son Medical Cemter|Samuel Lurie|+972-35028329|drslurie@hotmail.com|
20550703|NCT06316973|Clear Scientific|Piercen Oliver|617-621-8500|poliver@clearsci.com|
20550704|NCT03078647|Candela Corporation|Director of Clinical Marketing|(949) 599-7646|doranr@candelamedical.com|
20550705|NCT01250834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550706|NCT00563381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20550707|NCT01911689|Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College|Dr.XiaoMing Zhang|+86 817 2262218|cjr.zhxm@vip.163.com|
20550708|NCT01957644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503393|NCT02549716|Milton S. Hershey Medical Center|Sprague W. Hazard III, M.D.|717-531-0003|shazard@pennstatehealth.psu.edu|311253
20503394|NCT01551745|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
20503395|NCT02764541|Dana-Farber Cancer Institute|Otto Metzger|6176323800|otto_metzger@dfci.harvard.edu|
20503396|NCT00382148|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20503397|NCT00749190|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503398|NCT00784758|University of California, Los Angeles|Dr. Eric Kleerup|310-794-6593|ekleerup@mednet.ucla.edu|
20503399|NCT02797470|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
20503400|NCT05142826|Florida International University|Gregory A. Fabiano, Ph.D.|716-359-7823|gfabiano@fiu.edu|
20503401|NCT04439331|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20503402|NCT00888511|Odense University Hospital|Olfred Hansen|+45 2424 1588|olfred.hansen@rsyd.dk|
20503403|NCT03726268|Duke University|Evan Kharasch, MD, PhD|919-613-1154|evan.kharasch@duke.edu|
20503404|NCT04696861|Duke University School of Nursing|Brandon Knettel|1 919 660 1218|brandon.knettel@duke.edu|
20503405|NCT03952559|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20503406|NCT01827384|National Cancer Institute|Dr. Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
20503407|NCT03866200|The University of Texas Health Science Center at Houston|Karen Posey, PhD|713-500-5786|karen.posey@uth.tmc.edu|
20503408|NCT04291560|University of North Carolina at Chapel Hill|Jamie Crandell, PhD|919-966-5803|jcrandell@unc.edu|
20503409|NCT03498521|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20503410|NCT04167345|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20503411|NCT00960076|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20503412|NCT02511522|Canadian Cancer Trials Group|Dr. Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
20503413|NCT01028352|University of Michigan Comprehensive Cancer Center|Dr. Norah L. Henry|734-936-4991|norahh@umich.edu|
20503414|NCT02557178|Mayo Clinic|Johanna Hoult|507-293-1989|hoult.johanna@mayo.edu|
20503415|NCT05052723|University of Kentucky|Dr. Joseph Kim|859-257-4490|joseph.kim@uky.edu|
20503416|NCT06161012|Johnson & Johnson Vision Care, Inc. (JJVC)|David Murakami, OD, MPH, FAAO|1-800-843-2020|dmuraka2@its.jnj.com|
20503417|NCT02601950|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
20503418|NCT00408005|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20503419|NCT05113940|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20503420|NCT01701258|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
20503421|NCT02542267|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
20503422|NCT02073487|Houston Methodist|Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
20503423|NCT00442598|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
20503424|NCT00887458|Johns Hopkins University|Dr. Michael Carducci|410-614-3977|carducci@jhmi.edu|
20503425|NCT00501228|U.T. M.D. Anderson Cancer Center|Martin Korbling, MD / Professor|713-745-3219||
20503426|NCT02673229|The University of Kansas Health System|Suzanne Mitchell, PhD, ARNP, FNP-BC, CWS|913-588-5000|smitchell3@kumc.edu|6562
20503427|NCT01756274|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20503428|NCT01147926|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20558196|NCT03557086|Massachusetts General Hospital|Dr. Nneka Ufere|617-643-3408|nneka.ufere@mgh.harvard.edu|
20509356|NCT04960202|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509357|NCT02158728|Medtronic|Clinical Research Specialist L. Vainer|+31 43 3566752|lidwien.vainer@medtronic.com|
20509358|NCT01250899|University of California, Los Angeles|Dr Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
20509359|NCT01847560|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509360|NCT05129124|Bausch + Lomb Incorporated|Jill Schafer|0000000|Jill.Schafer@bausch.com|
20509361|NCT02234050|EORTC|Dr. Thierry Gorlia|027741652|thierry.gorlia@eortc.org|
20509362|NCT00592176|University of Alabama at Birmingham|Dr. Tyler Hall, M.D.|205-325-8310|tandrewhall@yahoo.com|
20509363|NCT03774875|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20509364|NCT02352090|Helsinki University Central Hospital|Oskari Heikinheimo|+358 50 4271533|oskari.heikinheimo@helsinki.fi|
20509365|NCT03630185|The University of Texas Health Science Center at Houston|Stuart A Harlin, MD|713-486-5131|Stuart.A.Harlin@uth.tmc.edu|
20509366|NCT00987727|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20509367|NCT01678313|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
20509368|NCT00981292|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
20509369|NCT03377452|VA Greater Los Angeles Healthcare System|Jennifer Martin, PhD|818-891-7711|jennifer.martin@va.gov|36080
20509370|NCT00796003|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
20509371|NCT05179057|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
20509372|NCT03345342|Janssen Research & Development, LLC|Compound Development Team Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509373|NCT01268943|Chinese Academic Medical Sciences|Dr. Jing Jin|010-87788503|tangyu.pumc@gmail.com|
20509374|NCT02437162|Johnson&Johnson|SENIOR DIRECTOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509375|NCT03981744|Janssen Pharmaceutical K.K.|PRODUCT DEVELOPMENT PORTFOLIO LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509376|NCT02782104|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509377|NCT03464136|Janssen Scientific Affairs, LLC|DIRECTOR MEDICAL AFFAIRS MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509378|NCT04338321|Janssen-Cilag International NV|Europe, Middle East, Africa (EMEA) Medical Advisor Spravato|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509379|NCT02438787|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509380|NCT03412565|Janssen Research & Development, LLC|GLOBAL MEDICAL HEAD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509381|NCT03375203|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509382|NCT03107793|Janssen-Cilag International N.V.|European Medicines Agency (EMEA) Advisor-Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509383|NCT03277105|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509384|NCT03321526|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509385|NCT02808507|Johns Hopkins Bloomberg School of Public Health|Colleen Hanrahan|410-502-9289|chanrah1@jhu.edu|
20509386|NCT06181708|Imperial College Healthcare NHS Trust|Emma Flint|02033117322|e.flint1@nhs.net|
20509387|NCT03733132|Mayo Clinic|K Sreekumaran Nair, M.D., Ph.D.|507-255-2415|Nair@mayo.edu|
20509388|NCT02418585|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509389|NCT02040857|Dana-Farber Cancer Institute|Project Manager|617-632-5313|ctopm@dfci.harvard.edu|
20509390|NCT04159701|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20509391|NCT02845440|Massachusetts General Hospital, Center for Addiction Medicine|A. Eden Evins|6177333131|aeevins@mgh.harvard.edu|
20509392|NCT01775800|The Rogosin Institute|Dr. Nathaniel Berman|212-746-9766|nab2009@nyp.org|
20509393|NCT00693693|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
20509394|NCT02348840|Emory University|Gari D. Clifford, DPhil|404-727-0229|gari.clifford@emory.edu|
20509395|NCT00373880|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
20509396|NCT01987752|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
20509397|NCT01466062|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20509398|NCT03152110|University of Pittsburgh|Alicia Koontz|412-822-3700|akoontz@pitt.edu|
20509399|NCT01922986|University of Minnesota|James R. Carey|612-626-2746|carey007@umn.edu|
20509400|NCT01634100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509401|NCT00471276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509402|NCT00744991|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20509403|NCT01662986|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509404|NCT01487863|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
20509405|NCT02564068|Medical Faculty Associates at The George Washington University|Dr. Vivek Jain|202-741-2676|vjain@mfa.gwu.edu|
20509406|NCT01819194|Vistakon|Daria Wicks|904-443-1391|RA-VISUS-ClnclStds@its.jnj.com|
20509407|NCT04449276|CureVac AG|Clinical Trial Information|+49 6976805870|clinicaltrials@curevac.com|
20509408|NCT04401904|UT Health San Antonio|Carolina Solis-Herrera, MD|210-567-4900|solisherrera@uthscsa.edu|
20509409|NCT01614795|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20550709|NCT04044716|Atrium Health Wake Forest Baptist|Dr. Carolyn Huffman|336.713.4018|cshuffma@wakehealth.edu|
20550710|NCT01957553|Coloplast|Dr. Birte P.Jakobsen|+45 4911 1395|dkbir@coloplast.com|
20509410|NCT00655057|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
20509411|NCT00701103|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509412|NCT03054740|Aultman Health Foundation|Jane Sewell|330 363 0000|Jane.Sewell@aultman.com|3334
20509413|NCT01378299|Michael E. DeBakey VA Medical Center|Reina Villareal, MD|713-794-7534|reina.villareal@va.gov|
20509414|NCT02046382|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
20509415|NCT00456885|BIDMC|Jody Dushay|6177353343|jdushay@bidmc.harvard.edu|617
20509416|NCT01448707|Janssen Research & Development, LLC|EMEA Medical Affairs Program Lead||ClinicalTrialDisclosure@its.jnj.com|
20509417|NCT01308294|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof. Olivier Michielin, MD PhD|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
20509418|NCT02820038|University of North Carolina at Chapel Hill|Susan J. Blalock, PhD|919-962-0080|s_blalock@unc.edu|
20509419|NCT00260195|RAND Corporation|Lisa Jaycox|703-344-8236|jaycox@rand.org|5118
20509420|NCT00946023|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
20509421|NCT01810380|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
20509422|NCT02623699|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20509423|NCT00033371|University of Texas (UT) MD Anderson Cancer Center|Patrick Lynch, MD/Professor, Gastroenterology/Hepatology|713-794-5073|plynch@mdanderson.org|
20509424|NCT01390038|Tornier/Wright Medical|Josh Myers|9529217119|josh.myers@wright.com|
20509425|NCT01922739|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20509426|NCT00044213|Mount Sinai Medical Center|Gervasio A. Lamas, M.D.|305-674-2162|Gervasio.Lamas@msmc.com|
20509427|NCT01154322|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
20509428|NCT00636155|Duke University Medical Center|Mark Lanasa, MD, PhD|919-286-6897|mark.lanasa@duke.edu|
20509429|NCT00766142|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
20527962|NCT04503668|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20509430|NCT03765736|Duke Cancer Institute|John Strickler, MD|(919) 668-6608|john.strickler@duke.edu|
20509431|NCT00863434|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
20509432|NCT01116661|University of California San Francisco|Mitch Berger, MD; Director of Neurosurgery|415-353-7500|Mtich.Berger@ucsf.edu|
20509433|NCT00638651|University of Miami|Dr. Keyvan Nouri|305-243-3380|knouri@med.miami.edu|
20509434|NCT05426460|University of Pittsburgh|Dr. Cynthia Conklin|4125869840|conkca@upmc.edu|
20509435|NCT02996305|Ovid Therapeutics|Adera Matthews, MD|570 620 6290|madera@ovidrx.com|
20509436|NCT02973997|University of Colorado, School of Medicine|Bryan Haugen, M.D.|507-266-0800|bryan.haugen@ucdenver.edu|
20509437|NCT01431521|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509438|NCT00444951|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20509439|NCT03637959|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
20509440|NCT00366444|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
20509441|NCT04984876|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20509442|NCT02204410|Massachusetts General Hospital|Dr. Timothy Wilens|(617)643-3481|twilens@mgh.harvard.edu|
20509443|NCT04829734|Multi Radiance Medical|Douglas Johnson, ATC, EES, CLS - Chief Science Officer, Clinical and Scientific Affairs|440-542-0761|info@multiradiance.com|
20527963|NCT03403621|Mayo Clinic|Dr. Alexander Meves|507-284-3668|Meves.Alexander@mayo.edu|
20503429|NCT01474590|University of Western Ontario and Windsor Clinical Research Inc., 2224 Walker Rd. Suite 300, Windsor, ON, Canada|Dr. Jerry Tan||jerrytan@bellnet.ca|
20503430|NCT01670994|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20503431|NCT00758784|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20503432|NCT00891735|Genentech, Inc.|Medical Communications|800-821-8590||
20503433|NCT02036320|Johnson and Johnson Vision Care Inc.|Meredith Jansen,O.D.,M.S., FAAO|904-443-3500|mjanse12@ITS.JNJ.com|1396
20503434|NCT00885365|Chiesi Farmaceutici S.p.A.|Chiesi Clinical Trials||clinicaltrials_info@chiesi.com|
20503435|NCT01824979|Fisher and Paykel Healthcare|Clinical Research Scientist|+ 64 09 574 0100|CPAPtrial@fphcare.co.nz|
20503436|NCT00004054|NRG Oncology|Wendy Seiferheld||wseiferheld@nrgoncology.org|
20503437|NCT01365156|UT MD Anderson Cancer Center|Michael Frumovitz,Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
20503438|NCT02198833|Baylor College of Medcine|Rabih Darouiche, MD|713-794-8858|rabihd@bcm.edu|
20503439|NCT03751111|Xiangya Hospital, Central South University|Dr. Minxue Shen|86-15973164022|shenmx1988@csu.edu.cn|
20503440|NCT05003115|Vanderbilt University Medical Center|Dr. Ebele Umeukeje|615-322-3221|ebele.m.umeukeje@vumc.org|
20503441|NCT03757039|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20503442|NCT03406962|Magenta Therapeutics|Medical Director|(857) 242-0170|clinicaltrials@magentatx.com|
20503443|NCT03853694|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20503444|NCT01791855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503445|NCT01672957|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20503446|NCT00591734|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20503447|NCT04336397|Alaska Native Tribal Health Consortium|Dr. Diana Redwood|907-729-3959|dredwood@anthc.org|
20503448|NCT04370509|University of California, San Francisco|Dr. David Oh, MD, PhD|(415) 476-1000|david.oh@ucsf.edu|
20503449|NCT00951821|Brown University|Anthony Spirito|401-444-1929|anthony_spirito@brown.edu|
20503450|NCT02612909|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
20503451|NCT02357992|UT MD Anderson Cancer Center|Dr. Jack Roth, MD- Professor, Thoracic & Cardio Surgery-Rsch|(713) 792-7664|jroth@mdanderson.org|
20503452|NCT00826748|Weill Cornell Medicine|Grace Mammen|646-962-2672|gwm2004@med.cornell.edu|
20503453|NCT05224258|Medtronic Diabetes|Thomas Troub, Sr Clinical Research Program Manager|8052089091|thomas.troub@medtronic.com|
20503454|NCT05067127|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20503455|NCT05540652|Brown University|Shufang Sun|401-863-5735|shufang_sun@brown.edu|
20503456|NCT03367871|University of Miami|Abdulrahman Sinno MD|+1 (305) 243-2233|ak.sinno@med.miami.edu|
20527964|NCT01078298|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527965|NCT00659776|Oregon Health and Science University|Amy Huddleston|503-494-2910|huddlesa@ohsu.edu|
20527966|NCT00742027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20527967|NCT00628927|University of Cincinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
20527968|NCT02798354|Children's Hospital at Montefiore and Albert Einstein College of Medicine|Dr. Michael Rinke|718-741-2597|mrinke@montefiore.org|
20527969|NCT01298141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20527970|NCT01833936|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|6148958747|ofacresearch@orthofootankle.com|
20527971|NCT02164318|Duke University Medical Center|Dr. Jeffrey Lawson|919-681-2533|lawso006@mc.duke.edu|
20527972|NCT05381454|University of Texas Southwestern Medical Center|Theodoros Kelesidis|2146488979|Theodoros.Kelesidis@UTSouthwestern.edu|
20527973|NCT01467271|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
20527974|NCT01411319|University of Miami|Alan Pollack, MD, PhD|305-243-4916|apollack@med.miami.edu|
20527975|NCT01579669|Portland State University|Christina Nicolaidis, MD, MPH|5037259603|nicol22@pdx.edu|
20527976|NCT03441685|Vanderbilt University Medical Center|Dr. C. Melanie Schuele|615-936-5256|melanie.schuele@vanderbilt.edu|
20527977|NCT04948827|Camino Pharma|Gonul Velicelebi|858-201-2901|gonul@caminopharma.com|
20527978|NCT00527124|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath|313-576-8715|heathe@karmanos.org|
20527979|NCT00660595|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20527980|NCT01148459|GlaxoSmithKline|GSK Response Center|866-435-7343||
20527981|NCT04854057|Spaulding Rehabilitation|Dr. Randy Trumbower|6179526822|randy.trumbower@mgh.harvard.edu|
20527982|NCT01679028|Tasly Pharmaceuticals, Inc.|Dr. Henry SUN|240-744-6225|henrysunusa@gmail.com|
20527983|NCT00177866|University of Pittseburgh|George Arnold, MD|412 621-2334|Arnoldgl@upmc.edu|
20527984|NCT00795769|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20527985|NCT04475718|Orange Square Designs|Lisa Marceau|4014284197|lisa@orangesquare.com|
20527986|NCT03230838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20527987|NCT00435188|Durham VA Research and Development|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
20527988|NCT00521885|Lehigh Valley Health Network|Leslie Baga, Director of Research|610 402 1285|Leslie.Baga@lvhn.org|
20527989|NCT01915771|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
20527990|NCT00497055|San Francisco Department of Public Health|Phillip O. Coffin, Director of Substance Use Research|415-437-6282|phillip.coffin@sfdph.org|
20527991|NCT00575510|Mayo Clinic|Dr. Carmen Radecki Breitkopf|507-266-0969|radeckibreitkopf.carmen@mayo.edu|
20527992|NCT02603926|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
20527993|NCT03439462|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
20527994|NCT01778751|Durham Veterans Affairs Medical Center|Dr Matthew J Crowley|919-286-6936|matthew.crowley@va.gov|
20527995|NCT03260790|Mayo Clinic|Avni Y. Joshi, M.D., M.S.|507-284-3165|Joshi.Avni@mayo.edu|
20527996|NCT02787681|Loma Linda University|H. Bryant Nguyen, MD|909-558-4000|hbnguyen@llu.edu|
20527997|NCT02669667|MedImmune|Rene van der Merwe|+44 (0)1223 898263|information.center@astrazeneca.com|
20527998|NCT01603394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20527999|NCT00840034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20528000|NCT01215435|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20528001|NCT05811026|Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan|Dr. Chang-Ming Huang|+886-2-23123456|daniel510791@gmail.com|262141
20558197|NCT03619590|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
20558198|NCT01279343|Washington University School of Medicine|Jeanine Carbone MD|314-362-8523|jfcarbone@hotmail.com|
20528002|NCT02870205|Glenmark Pharmaceuticals Ltd|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20528003|NCT00394771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20558199|NCT04534114|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20528004|NCT03383692|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20558200|NCT03287414|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20528005|NCT03557476|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20550711|NCT02730455|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20550712|NCT02733367|Diurnal|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
20550713|NCT05564429|National Institute of Mental Health (NIMH)|Dr Robert Innis|301-594-1368|robert.innis@nih.gov|
20550714|NCT02480439|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20550715|NCT03049280|Intuitive Surgical|Intuitive Surgical Clinical Affairs|408-523-2100|sylvie.akiel-fu@intusurg.com|
20550716|NCT02326025|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20550717|NCT01867021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20550718|NCT00640601|AstraZeneca|Gerard Lynch|441625 518062|aztrial_results_posting@astrazeneca.com|
20550719|NCT03681405|Wake Forest Baptist Comprehensive Cancer Center|Meg O'Mara|336-716-9055|megreen@wakehealth.edu|
20550720|NCT03178903|Butler Hospital|Ana M. Abrantes, Ph.D.|4014556440|Ana_Abrantes@Brown.edu|
20550721|NCT01209260|University of California San Diego|Jonathan Hsu, MD, MAS|415-476-5706|jonathan.hsu@ucsd.edu|
20550722|NCT00973739|New York University Langone Medical Center|Matthias Karajannis, MD|212-263-8400|matthias.karajannis@nyumc.org|
20550723|NCT00733408|University of Washington|Jennifer Specht, MD, Associate Professor|(206) 606-1000|jspecht@uw.edu|
20550724|NCT00531232|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20550725|NCT04232124|Vanderbilt University Medical Center|David G. Harrison|6158753049|david.g.harrison@vumc.org|
20550726|NCT02152696|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
20550727|NCT04812964|VA Greater Los Angeles Healthcare System|Dr. Jonathan Jacobs|310-478-3711|jonathan.jacobs2@va.gov|
20550728|NCT02329730|Shanghai Public Health Clinical Center|Shuihua Lu|021-37990333|tubercle@gmail.com|2582
20550729|NCT02423577|President and Chief Scientific Officer|Russell Wilson, PhD|504-896-2789|rbw@autoimmune.com|
20550730|NCT02345850|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20550731|NCT02758899|Washington University|Wilson Z. Ray|314-747-6145|rayz@wustl.edu|
20550732|NCT02392247|Virginia Commonwealth University|Dr.Bruce Spiess, Principal Investigator|804-828-2267|bruce.spiess@vcuhealth.org|
20550733|NCT01430091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550734|NCT01991067|Medical University of Vienna, Department of Medicine I, Division of Infectious Diseases|Assoc. Prof. Dr. Christina Bahrs|+4314040044400|christina.a.forstner@meduniwien.ac.at|
20550735|NCT03134989|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|
20550736|NCT00224055|Watson Pharmaceuticals, Inc|Naomi Dahl, PharmD Director, Clinical Affairs||Naomi.dahl@watson.com|
20558201|NCT01087996|The EMMES Corporation|Adam Mendizabal|301 251 1161|amendizabal@emmes.com|221
20558202|NCT04395183|University of Utah|Brent Kious, MD, PhD|801-585-1418|brent.kious@hsc.utah.edu|
20558203|NCT01008475|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20558204|NCT02668016|Imperial College London|Professor Darrel Francis|0207 594 9647|d.francis@imperial.ac.uk|
20558205|NCT01044576|Imperial College London|Professor Paolo Muraro|02075946670|p.muraro@imperial.ac.uk|
20503457|NCT03837184|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
20558206|NCT00971750|Gundersen Lutheran Health System|Dr. Shanu Kothari|608-775-2331|snkothar@gundluth.org|
20558207|NCT05093049|Apyx Medical|Senior Director of Clinical Affairs|801-244-0058|kari.larson@apyxmedical.com|
20558208|NCT01316770|NIDCR/NIH|Ilias Alevizos|3014966207|alevizosi@mail.nih.gov|
20558209|NCT02260401|University of Washington|Dr. Janna Friedly|206-744-3000|friedlyj@uw.edu|
20558210|NCT00834808|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20558211|NCT01755143|Medtronic Cardiac Rhythm and Heart Failure|5076MRI Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
20558212|NCT00674622|University of Pittsburgh School of Medicine Department of Psychiatry|Ronald Glick, MD|412-623-3023|glickrm@upmc.edu|
20558213|NCT00738101|Baylor College of Medicine|Dr. Muralidhar H Premkumar|8328267980|premkuma@bcm.edu|
20558214|NCT01292070|Tunitas Therapeutics|Nolan Sigal, MD, PhD, CEO, Tunitas Therapeutics|(650) 887-4747|nsigal@tunitastherapeutics.com|
20558215|NCT00855010|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20558216|NCT02969525|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20558217|NCT03445065|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20558218|NCT03535337|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
20558219|NCT01598298|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
20558220|NCT00976482|ospedale S Orsola- Malpighi, Bologna, Italy|dr Mauro Biffi|+393337661449|mauro.biffi@aosp.bo.it|
20558221|NCT03366220|The University of Texas Health Science Center at Houston|Dr. Lillian S Kao|(713) 500-6280|Lillian.S.Kao@uth.tmc.edu|
20558222|NCT03462706|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
20558223|NCT02341287|Weill Cornell Medicine|Matthew R. Ebben, Ph.D.|646-962-9313|mae2001@med.cornell.edu|
20558224|NCT01097395|University of Colorado|Jennifer Kiser|3037246131|jennifer.kiser@cuanschutz.edu|
20558225|NCT00584701|UCSF|Robert Hendren, DO|415-476-7198|robert.hendren@ucsf.edu|
20558226|NCT01161472|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558227|NCT02914184|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20503458|NCT02013544|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
20558228|NCT00798174|Washington University in St. Louis|Dr. Timothy W. Smith|314-286-1501|tsmith@wustl.edu|
20558229|NCT00802659|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8525|jbradley@radonc.wustl.edu|
20509444|NCT02000622|AstraZeneca|Medical Science Director|1-877-240-9479|clinicaltrialtransparency@astrazeneca.com|
20509445|NCT01405027|Chronic Liver Disease Foundation|Dr. Fred Poordad|732-381-8887|poordad@txliver.com|
20509446|NCT01462045|University of New Mexico|Sang Hwan Kim, PhD/Lead Investigator|5057954545|sanghk@gmail.com|
20509447|NCT05085327|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20509448|NCT02462122|Bausch Health|Study Director||anyaloncaric@bauschhealth.com|
20509449|NCT01938391|NYU Langone Medical Center|Anvar Babaev, MD, PHD, FACC, FSCAI|212-263-5656|anvar.babaev@nyumc.org|
20509450|NCT05241470|Stuart Therapeutics|Brian Del Buono, Executive Vice President|7034025866|brian@stuarttherapeutics.com|
20509451|NCT02334813|University Hospital Essen, Germany|Prof. Dr. Ulrich Dührsen|+49 201 723|ulrich.duehrsen@uk-essen.de|2417
20509452|NCT01077193|Ethicon-Endo Surgery, Inc.|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
20509453|NCT03558828|Rush University College of Nursing|Manju Daniel|312.942.3460|manju_n_daniel@rush.edu|
20509454|NCT02869451|Duke University Medical Center|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
20509455|NCT02968277|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
20509456|NCT02219516|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
20509457|NCT03146403|Genocea|Jennifer LaVin|617-876-8191|jennifer.lavin@genocea.com|
20509458|NCT00077922|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
20509459|NCT02182999|Department of Orthopedic Surgery, Medical University of Innsbruck|Dr. Matthias Braito|0043 512 504|matthias.braito@gmail.com|81214
20509460|NCT02252588|University of Minnesota|Christine Wendt, MD|612-624-0999|wendt005@umn.edu|
20509461|NCT05241288|University of North Carolina at Chapel Hill|Michael B Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
20509462|NCT00285649|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
20509463|NCT02465489|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
20509464|NCT02972593|Indiana University School of Medicine Department of Orthopaedic Surgery|Dr. Brian H. Mullis|317-963-1966|bmullis@iupui.edu|
20509465|NCT02203916|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20509466|NCT00338806|NYSPInstitute|Dr. Helen Verdeli|212 543 5262|verdelih@nyspi.columbia.edu|
20509467|NCT00438490|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
20550737|NCT02068443|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20550738|NCT02771990|Providence Veterans Affairs Medical Center|Benjamin Greenberg|4012737100|benjamin.greenberg@va.gov|
20550739|NCT02014597|Baylor College of Medicine|Dr. Benjamin Frankfort|713-798-3453|benjamin.frankfort@bcm.edu|
20550740|NCT05126901|Shield TX (UK) Ltd.|Clinical Operations, Shield TX (UK) Ltd.|+44 (0) 191 511 8500|info@shieldtherapeutics.com|
20550741|NCT00754624|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20550742|NCT04067544|University of Utah College of Nursing|Lisa Taylor-Swanson|801.585.5486|lisa.taylor-swanson@nurs.utah.edu|
20550743|NCT00931762|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20550744|NCT01320085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550745|NCT01702454|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550746|NCT00710710|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20550747|NCT03510884|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20550748|NCT02282020|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
20550749|NCT01500629|Johnson & Johnson Consumer and Personal Products Worldwide|Daniel Qi, MD, PhD, Director, Clinical Research|973 385-2260|dqi6@its.jnj.com|
20550750|NCT00249444|Columbia University|Dr Wilfrid Raby|212-923-3031|rabywil@nyspi.columbia.edu|
20550751|NCT01499667|Novartis Pharnaceuticals|Study Director|862-778-8300||
20550752|NCT02673489|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20550753|NCT00759863|Photozig, Inc.|Bruno Kajiyama|650-694-7496|lifezig@photozig.com|3
20550754|NCT02781051|UT Southwestern Medical Center|Chad Rethorst, Associate Professor|2146480153|chad.rethorst@utsouthwestern.edu|
20550755|NCT01549392|London Health Sciences Hospital|Barbara Fisher|519-685-8650|barbara.fisher@lhsc.on.ca|
20550756|NCT02743806|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20550757|NCT00849381|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550758|NCT00460031|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
20550759|NCT02618434|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
20550760|NCT01988103|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20550761|NCT02506153|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
20509468|NCT01395966|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
20509469|NCT00045630|SWOG Statistical Center|Study Statistician|206-667-4623||
20509470|NCT00981747|University of Iowa|Dr. Alicia Gerke|319-356-1616|alicia-gerke@uiowa.edu|
20509471|NCT03489850|University of California Los Angeles|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
20509472|NCT04266158|The Ohio University|College of Medicine Office of Research Compliance Team|6145886811|comresearchcompliance@osumc.edu|
20509473|NCT03595449|Mayo Clinic|Shari A. Ochoa, M.D.|480-301-6479|Ochoa.Shari@mayo.edu|
20509474|NCT03242590|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
20509475|NCT02033850|'L. Sacco' Department of Biomedical and Clinical Sciences University of Milan|Prof. Leonardo Pantoni, Principal Investigator|0039-02-50319865|leonardo.pantoni@unimi.it|
20509476|NCT03215667|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
20509477|NCT04319445|Wake Forest University Health Sciences|Rebecca E Wells, MD, MPH|336-716-2357|rewells@wakehealth.edu|
20509478|NCT00441480|The Institute for Lipid and Atherosclerosis Research and Internal Medicine C, Sheba Medical Center, Tel Hashomer|Prof. Dror Harats|972-3-5302940|dror@vbl.co.il|
20509479|NCT00422240|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20509480|NCT01927068|Spectranetics LLC, now part of Philips Image Guided Therapy|Associate Director, Clinical Operations|612-297-6655|nicolas.aguirre@philips.com|
20509481|NCT00441012|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509482|NCT04489940|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center,|+49 6151725200|service@emdgroup.com|
20509483|NCT01624467|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20509484|NCT02725268|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20509485|NCT04498468|Johns Hopkins Wilmer Eye Institute|Michael Lin, BA, Research coordinator|8653851192|mlin60@jhu.edu|
20509486|NCT01838304|University of Pennsylvania|Vice-Chair of Research|(215) 662-3766|roderic.eckenhoff@uphs.upenn.edu|
20509487|NCT03674541|Brigham and Women's Hospital|Dr. David Systrom|6175431554|dsystrom@bwh.harvard.edu|
20509488|NCT02104141|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
20509489|NCT00262314|EMD Serono, Inc.|Fernando Dangond, M.D., Medical Responsible|+1 781 681 2348||
20509490|NCT05104749|Sonoran University of Health Sciences|Elizabeth Rice Principal Investigator|4809700000|e.rice@sonoran.edu|
20509491|NCT03964493|TenNor Therapeutics Limited|Zhenkun Ma, PhD / CEO|+1(646) 775-1861|zhenkun.ma@tennorx.com|
20509492|NCT02963766|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20509493|NCT00814307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509494|NCT01256918|Dr. Ram Manohar Lohia Hospital|Dr. Praveen Kumar Malik|00919810405681|praveenk002@yahoo.com|
20509495|NCT03054298|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20509496|NCT03073200|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20509497|NCT01474889|UPenn|Cornelia V. Dalton Bakes|215-746-2085|corneliv@pennmedicine.upenn.edu|
20509498|NCT02482389|Duke University Health System|Joan Cahill|(919) 668-5211|joan.cahill@duke.edu|
20509499|NCT04964557|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|information.center@astrazeneca.com|
20509500|NCT01186003|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20509501|NCT00550290|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
20509502|NCT02569398|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509503|NCT02571972|Retina Service of Wills Eye Hospital, Mid Atlantic Retina|Dr. Jason Hsu|215-928-3092|jhsu@midatlanticretina.com|
20509504|NCT00695500|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
20509505|NCT03039192|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509506|NCT03559192|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509507|NCT03186261|Faculty of Dentistry, Cairo University|Ali Mostafa Shamaa|+201005276468|alishamaa@hotmail.com|
20509508|NCT04888507|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20509509|NCT00400946|Dana-Farber Cancer Institute|Lewis B. Silverman, MD|617.632.6191|Lewis_Silverman@dfci.harvard.edu|
20509510|NCT04685408|Case Western Reserve University|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org|
20509511|NCT05643170|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20509512|NCT00142818|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
20509513|NCT02358863|Lombardi Comprehensive Cancer Center (LCCC)|John Marshall, MD|202-444-7064|marshalj@georgetown.edu|
20509514|NCT00438191|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
20509515|NCT06436300|Washington State University|Clemma Muller|612-327-7237|clemma.muller@wsu.edu|
20509516|NCT00365872|H. Lee Moffitt Cancer Center and Research Institute|Scott J. Antonia, M.D., Ph.D.|813-745-3883|scott.antonia@moffitt.org|
20509517|NCT02632344|Massachusetts General Hospital|Dr. Sara Pai, Principal Investigator|617-726-5251|sarapaimdphd@gmail.com|
20509518|NCT00777257|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20509519|NCT04924114|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20509520|NCT00673816|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
20509521|NCT03008889|Emory University|Dr. Lawrence Scahill|404-785-9336|lawrence.scahill@emory.edu|
20509522|NCT01520688|Allegheny Health Network|Deborah Gentile, MD|412-359-4099|dgentile@ahn.org|
20509523|NCT00498368|Mayo Clinic|Dr. Fernando Fervenza|507-255-3712|Fervenza.Fernando@mayo.edu|
20528006|NCT01420016|HealthPartners Institute|Dr. Patrick O'Connor|952-967-5034|patrick.j.oconnor@healthpartners.com|
20509524|NCT02266004|University of Miami|Corneliu Luca, MD|305-243-6732|cluca@med.miami.edu|
20509525|NCT01791465|Vanderbilt University Medical Center|John Koethe MD|615-343-0533|john.r.koethe@vanderbilt.edu|
20509526|NCT03289052|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20509527|NCT00537771|AstraZeneca|James J. Armbrust|+44 1625 518062|ClinicalTrialTransparency@astrazeneca.com|
20509528|NCT02575300|H. Lee Moffitt Cancer and Research Center|Dr. Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
20509529|NCT02736929|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|175526
20509530|NCT01236768|Agile Therapeutics|Lisa Flood, Associate Director of Clinical Operations|609-683-1880|lflood@agiletherapeutics.com|
20509531|NCT00605358|Weill Cornell Medicine|Dr. Jo Anne Sirey|9149974333|jsirey@med.cornell.edu|
20509532|NCT01957085|Lewis Katz School of Medicine|Robert L. Bettiker, MD/MGA, Principle Investigator|215.707.1982|robert.bettiker@temple.edu|
20509533|NCT02128919|Nathan Kline institute for Psycghatric Research|Robert C Smith MD|845-398-6531|rsmiith@nki.rfmh.org|
20509534|NCT02108522|AlloVir|Iain Fraser, MD|833-409-2281|ClinicalTrials@allovir.com|
20509535|NCT02148952|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
20509536|NCT04007367|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20509537|NCT01764022|BIOCAD|Dr. Mariia Shustova|+7812380 49 33|shustova@biocad.ru|651
20509538|NCT00414973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20509539|NCT03813199|Abivax|Vice President Clinical Operations|01 53 83 08 41|paul.gineste@abivax.com|
20509540|NCT01501162|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
20509541|NCT01512693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509542|NCT03077711|Lehigh Valley Health Network|Dr. Carolyn Botros, DO|4845917480|carolyn.botros@lvhn.org|
20509543|NCT01526928|Clovis Oncology|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20509544|NCT02044367|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509545|NCT00491751|Boston University School of Medicine|Naomi M. Hamburg, MD|617-638-7462|nhamburg@bu.edu|
20509546|NCT04731922|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20509547|NCT04157751|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509548|NCT04238689|Radboudumc, Department of Medical Microbiology|Dr. Matthew B.B. McCall|+31 024 361 1111|matthew.mccall@radboudumc.nl|
20509549|NCT02901080|Electromedical Products International, Inc.|Science and Education Director|8174583295|josh@epii.com|
20509550|NCT01437267|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
20509551|NCT00838695|VAnderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
20509552|NCT03934203|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509553|NCT00333970|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|203-932-5711|joanna.fiszdon@va.gov|2231
20509554|NCT04925947|Weill Cornell Medicine|Barbara Ma|646-962-6444|btm9003@med.cornell.edu|
20509555|NCT02829775|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20509556|NCT00608842|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
20509557|NCT00899678|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20509558|NCT02150460|National Eye Centre, Kaduna. Nigeria|Dr Aminatu Ali AbdulRahman|+2348037878367|aaaminatu@yahoo.com|
20509559|NCT02699125|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
20509560|NCT03799627|Akebia Therapeutics, Inc|Akebia Therapeutics, Inc|617-844-6128|trials@akebia.com|
20509561|NCT02939651|Fox Chase Cancer Center|Namrata Vijayvergia|+1 215-214-4283|Namrata.Vijayvergia@fccc.edu|
20509562|NCT04445051|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
20509563|NCT02092324|OHSU|Dr. Kim-Hien Dao|503-494-5074|daok@ohsu.edu|
20509564|NCT02637804|CooperVision Inc.|Director, Professional Service|+81 3 5449 6619|Taku.Muraoka@jp.coopervision.com|
20509565|NCT03190967|National Cancer Institute|Dr. Stanley Lipkowitz, PhD|240-760-6129|lipkowis@navmed.nci.nih.gov|
20509566|NCT00815776|Ascentia Health, Inc.|Lawrence G. Clayton, M.A., Study Director|(815) 484-9258|LGClayton@aol.com|
20509567|NCT03991468|Hamamatsu Photonics, K.K.|MCG Manager|+81-53-435-1560|fujisaka@sys.hpk.co.jp|
20509568|NCT03039569|University of Nebraska-Lincoln|Weiwen Chai|402-472-7822|wchai2@unl.edu|
20509569|NCT00616772|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20509570|NCT00615420|BC Cancer|Dr. Philippa Hawley|(604) 877-6000|phawley@bccancer.bc.ca|67-2752
20509571|NCT01673373|Getinge|Sr. Clinical Trial Manager|603-864-5219|inka.vesela@getinge.com|
20509572|NCT04852666|University of North Carolina at Chapel Hill|Michael Kappelman, MD, MPH|919-843-5908|michael_kappelman@med.unc.edu|
20509573|NCT00424840|University of Massachusetts Medical School|Dr. William Walsh|508-334-5539|William.Walsh@umassmemorial.org|
20509574|NCT01145833|University of CA, San Diego Center for Healthy Eating and Activity Research|Kerri Boutelle, Principal Investigator|858-534-8037|kboutelle@ucsd.edu|
20509575|NCT04021628|St George's, University of London|Dr Shari Sapuan|02086729944|ssapuan@sgul.ac.uk|5382
20509576|NCT03671148|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20509577|NCT02855086|Stanford University Medical Center|Gordon Li, MD, Associate Professor of Neurosurgery|650-721-1020|gordonli@stanford.edu|
20509578|NCT00589602|Cleveland Clinic|Jarek Maciejewski, MD|216-445-5962|maciejj@ccf.org|
20509579|NCT01804842|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
20509580|NCT00413777|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20503459|NCT03514914|University of California San Diego|Dr. Anita Raj|(858) 246-0066|anitaraj@health.ucsd.edu|
20503460|NCT00473876|University of Dundee|Professor Chim C Lang|0044(0)1382 496375|c.c.lang@dundee.ac.uk|
20503461|NCT03952286|University of Arizona Asthma & Airway Disease Research Center|Dr. Ashley A. Lowe|5206268814|aaray@email.arizona.edu|
20503462|NCT03456115|Johns Hopkins University Hospital|Christopher Razavi, MD|410-955-2307|crazavi1@jhmi.edu|
20503463|NCT00755079|VAHSRD|Joshua Hobson, MS|(718) 584-9000|joshua.hobson@va.gov|3129
20503464|NCT01276288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503465|NCT03496701|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
20503466|NCT04552470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503467|NCT00620061|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
20503468|NCT00629083|Contura International A/S|Ieva Ankorina-Stark, Ph D, Chief Scientific Officer|011 45 8110 0900|ieva.ankorina-stark@contura.com|
20503469|NCT03401749|University of Alabama at Birmingham|Ashish Shah|205-930-6722|ashishshah@uabmc.edu|
20503470|NCT01193686|VA Puget Sound Health Care System|Rhonda Williams, Ph.D.|206-277-6290|Rhonda.Williams1@va.gov|
20503471|NCT03333577|Cochlear|George Cire|303 885 5440|gcire@msn.com|
20503472|NCT01818297|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
20503473|NCT04439344|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20503474|NCT03770403|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20503475|NCT03896295|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20503476|NCT00552110|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20503477|NCT00582894|University of Oklahoma Health Sciences Center|George Selby, MD|405/271-4022|george-selby@ouhsc.edu|
20503478|NCT03185546|Wake Forest School of Medicine|Eric Donny, PhD|336-713-1520|edonny@wakehealth.edu|
20528007|NCT02839876|Duke University Medical Center|Dr. Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
20503479|NCT03029832|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20503480|NCT01412229|UNC Lineberger|Robin Johnson|(919) 966-1125|Robin_V_Johnson@med.unc.edu|
20503481|NCT04373460|Johns Hopkins University Bloomberg School of Public Health|David J. Sullivan|410-502-2522|dsulliv7@jh.edu|
20503482|NCT02553135|University of Miami|Byron Lam , MD|305-326-6021|blam@med.miami.edu|
20503483|NCT01557790|University of Pennsylvania|Justin E. Bekelman, MD|(215)662-7292|bekelman@xrt.upenn.edu|
20503484|NCT00700804|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Reserch Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
20503485|NCT02901431|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20503486|NCT03440944|Boston University School of Medicine|Joseph Pare, MD|6174144925|Joseph.pare@bmc.org|
20503487|NCT04672083|Navigen, Inc.|Alan L. Mueller, VP Research|801-243-9703|amueller@nvgn.com|
20503488|NCT01661790|China PLA General Hospital|Dr. Nan Du|86-13911599657|dunan05@aliyun.com|
20503489|NCT02536248|Laval university|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
20503490|NCT02048904|University of Missouri|Principal Investigator|573-882-2273 lastrag@healt|lastrag@health.missouri.edu|
20503491|NCT02413203|Univesrity of Pennsylvania|Garret A. FitzGerald|215-898-1185|garret@upenn.edu|
20503492|NCT03832387|HOSPITAL GENERAL UNIVERSITARIO DE CASTELLÓN|Dr. ALBERTO BELENGUER MUNCHARAZ|96472500|belengueralberto8@gmail.com|
20503493|NCT05775289|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20503494|NCT01984515|Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400|kyle.possemato@va.gov|53551
20503495|NCT00490542|Tufts Medical Center|S. Nassir Ghaemi, MD, MPH|617-636-5735|nghaemi@tuftsmedicalcenter.org|
20503496|NCT04743856|University of Pittsburgh|Bonny Rockette-Wagner|4126240188|bjr26@pitt.edu|
20503497|NCT04439188|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20503498|NCT01438008|Children's Hospital of Eastern Ontario|Dr. Denise Harrison|6137377600|dharrison@cheo.on.ca|6045
20503499|NCT01813890|Janssen Research & Development, L.L.C.|Mila Etropolski, Clinical Leader|609-730-4537|MEtropol@its.jnj.com|
20503500|NCT04482647|UT MD Anderson Cancer Center|Santhosshi Narayanan, MD-Assistant Professor, Integrative Medicine Program|(346) 228-6676|snarayanan2@mdanderson.org|
20503501|NCT02921386|Clarus Therapeutics Inc.|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
20503502|NCT00046228|Centocor Inc.|Executive Director Clinical Research|1-800-972-9063|EBarnath@ITS.JNJ.COM|6171
20503503|NCT00655928|Imperial College LOndon|Mark J Griffiths|+44 (0) 2073518523|m.griffiths@imperial.ac.uk|
20503504|NCT01707992|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
20528008|NCT01945294|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503505|NCT04108429|Northwestern University|Dr. Emily Lattie|312-503-5509|emily.lattie@northwestern.edu|
20503506|NCT00998738|Mayo Clinic|Dr. Charles Loprinzi|507-266-6247|cloprinzi@mayo.edu|
20503507|NCT04211337|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20558230|NCT03093428|Dana Farber Cancer Institute|Atish Choudhury|617-632-6328|achoudhury@partners.org|
20503508|NCT04977037|The University of Texas Health Sciences Center at Houston|Nuray Yozbatiran, PhD, PT|7137975282|Nuray.Yozbatiran@uth.tmc.edu|
20503509|NCT04980391|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20503510|NCT05654714|Baxter|Jessica Gregory|N/A|jessica_gregory@baxter.com|
20503511|NCT03697564|University of California, San Diego|Dr. Hitendra Patel|(858) 822-5354|CancerCTO@health.ucsd.edu|
20503512|NCT05105243|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|Michelle.Charles@cerevance.com|
20528009|NCT02721017|University of California San Francisco Department of Surgery|Dr. Benjamin Padilla|415-476-3642|Benjamin.Padilla@ucsf.edu|
20509581|NCT03287830|Columbia University|Dr. Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
20509582|NCT00435929|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
20528010|NCT01156051|Children's Specialized Hospital|Thomas A Rugino MD|732-797-3826|trugino@childrens-specialized.org|
20528011|NCT03816007|VA San Diego Healthcare System|Dr. Erik Groessl|858-642-6347|erik.groessl@va.gov|
20528012|NCT01218971|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
20550762|NCT00885105|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20550763|NCT01493570|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20550764|NCT02772081|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20550765|NCT01141907|Johns Hopkins University|Dr. Cheryl Dennison|443-287-4174|cdennis4@jhu.edu|
20550766|NCT01214356|MUSC|Vanessa Diaz, MD MSCR|8438762923|diazva@musc.edu|
20550767|NCT02598076|Yale Comprehensive Epilepsy Center, Department of Neurology, Yale Univseristy School of Medicine|Benjamin Tolchin, MD, MS|347-721-8491|benjamin.tolchin@yale.edu|
20550768|NCT02959944|Pharmacyclics, LLC|Justin Wahlstrom MD|669-215-7210|jwahlstrom@pcyc.com|
20558231|NCT04042285|Hull University Teaching Hospitals NHS Trust|Louise Hitchman|01482 311925|l.hitchman@nhs.net|
20558232|NCT03349268|University of Michigan|Keith Kaye|732 235-9312|kk1116@rwjms.rutgers.edu|
20558233|NCT03820323|University of Washington|Rena C. Patel|206-520-3800|rcpatel@uw.edu|
20558234|NCT04785326|Dong-A ST|Clinical Research Manager|02-920-1111|imspring@donga.co.kr|
20558235|NCT02912468|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
20558236|NCT02641249|University of California|Dr. Kalpashri Kesavan|3108256304|KKesavan@mednet.ucla.edu|
20558237|NCT00692406|DukeUMC|Dr. F. Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
20558238|NCT02597933|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558239|NCT04205929|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|edelmana@ohsu.edu|
20558240|NCT00817804|Respironics California|Adam Seiver|760-703-6993|adam.seiver@philips.com|
20558241|NCT01617005|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20558242|NCT01097915|University of Cagliari|Iole Tomassini Barbarossa, Associate Professor|+390706754144|tomassin@unica.it|
20558243|NCT01320735|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20558244|NCT04599101|William Beaumont Hospitals|Christine Batchelder, Research Nurse Manager|2488981075|christine.batchelder@corewellhealth.org|
20558245|NCT02307513|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20558246|NCT01560260|Sarcoma Alliance for Research through Collaboration (SARC)|Kristen Nuyen, Research Project Manager|734-930-7600|sarc@sarctrials.org|
20558247|NCT05952297|University of Utah|Dr. Kelly Baron|8015857588|kelly.baron@utah.edu|
20558248|NCT02100722|Stanford University|William Fearon, MD|650-725-2621|wfearon@stanford.edu|
20558249|NCT02300285|Boston Children's Hospital|Michael SD Agus, MD|617 355-5849|michael.agus@childrens.harvard..edu|
20558250|NCT02541383|Intergroupe Francophone du Myélome|Chief Executive Officier|+33 1 40 21 24 02|ifmclinicaltrials@myelome.fr|
20558251|NCT05796518|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-0031|mnjenkin@wakehealth.edu|
20558252|NCT01535274|University of Michigan|Dr. Paul Picton|734-936-4280|ppicton@umich.edu|
20558253|NCT02690077|Advocate Aurora Health|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aah.org|
20558254|NCT00594217|University of Virginia Center for Research in Reproduction|Dr. Christopher R. McCartney|4342436911|cm2hq@virginia.edu|
20558255|NCT04186403|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20558256|NCT01407354|University Maryland Rehabilitation and Orthopaedic Institute|Paula Richley Geigle PT PhD|410 448 6773|pgeigle@umm.edu|
20558257|NCT03501043|MossRehab|Stella Lee|215-663-6665|leest@einstein.edu|6665
20558258|NCT00405639|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
20503513|NCT00162773|Johns Hopkins University School of Medicine|Clinical Trials Program JHU ICTR|410-550-6484|registerclinicaltrials@jhmi.edu|
20558259|NCT00612534|AcelRx|Pamela Palmer, MD PhD|650-216-3500|ppalmer@acelrx.com|
20503514|NCT03783195|University of North Carolina at Chapel Hill|Saroja Voruganti, PhD|704-250-5009|saroja@unc.edu|
20558260|NCT03108157|ProcreaTec|Dr. Alexandra Izquierdo, Medical and Scientific Director at ProcreaTec|0034651879266|endoscratchtrial@gmail.com|
20558261|NCT02223754|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optemtrist|904-443-3500|TKarkkai@its.jnj.com|3402
20558262|NCT01960530|Diurnal Limited|Dr John Porter|02920 682069|info@diurnal.com|
20503515|NCT00215150|Duke University Medical Center|Wei Zhang, MD|(919) 684 5645|wei.zhang@duke.edu|
20558263|NCT04472377|Hygeia Touch Inc.|Lance Yang|+886-3-6675616|cyyang@hygeiatouch.com|
20503516|NCT02240134|University of Montana|Curtis Noonan, PhD|406-243-4957|curtis.noonan@umontana.edu|
20503517|NCT01871506|Elyse Park|Associate Professor|617-724-6836|epark@mgh.harvard.edu|
20503518|NCT03124459|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503519|NCT01903876|Georgia State University|Dr. Laura Salazar|404-413-1396|lsalazar1@gsu.edu|
20503520|NCT03062917|Imperial College NHS trust|Study PI Simon Nadel|02033126202|s.nadel@imperial.ac.uk|
20503521|NCT00673855|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20503522|NCT00278629|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20503523|NCT04214080|Marmara University|Assoc. Prof Aysel Yıldız Ozer|5334674433|aysel.yildiz@marmara.edu.tr|+90
20503524|NCT02863263|Mundipharma Singapore Holding Pte. Limited|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
20503525|NCT00603239|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20503526|NCT02988856|Massachusetts Eye and Ear|Kevin Houston|617-573-4177|kevin_houston@meei.harvard.edu|
20503527|NCT01562028|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|belief@etop-eu.org|
20503528|NCT02516657|Jacobs School of Medicine and Biomedical Sciences, Department of Pediatrics|Lucy D. Mastrandrea|716-323-0170|ldm@buffalo.edu|
20503529|NCT00378326|Rockefeller University|Robert B. Darnell, MD, PhD|212-327-7474|darnelr@rockefeller.edu|
20503530|NCT03093402|DAIT/NIAID|Director, Clinical Research Operations Program|3015947669|DAITClinicalTrialsGov@niaid.nih.gov|
20503531|NCT00054847|Southern Arizona VA Health Care System|Steven Goldman, MD|(520) 792-1450|Steven.Goldman@va.gov|4624
20503532|NCT02731742|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503533|NCT01316042|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rlegro@hmc.psu.edu|
20503534|NCT00461175|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
20503535|NCT03093155|Yale School of Medicine/Yale Cancer Center|Alessandro Santin, MD|(203) 737-4450|alessandro.santin@yale.edu|
20509583|NCT02155712|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
20528013|NCT01897766|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528014|NCT02179749|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
20509584|NCT05180721|Yale|Robin Whittemore|203-432-7000|robin.whittemore@yale.edu|
20509585|NCT04288089|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20509586|NCT00976963|University of Washington|Ann Stapleton|‪(206) 880-3464‬|stapl@uw.edu|
20509587|NCT02951455|University of Illinois Urbana Champaign|Liliane Windsor|2173001782|lwindsor@illinois.edu|
20509588|NCT04246489|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20509589|NCT03039790|Takeda (Note: This product was divested to HilleVax in 2022)|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20509590|NCT00557323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20509591|NCT00058188|Northwestern University|Clinical Trials Office|312-695-1301||
20509592|NCT04246541|University Hospitals Cleveland Medical Center|Dr. Michael Karns|216-844-7200|michael.karns@uhhospitals.org|
20509593|NCT01744041|Washington University - School of Medicine|Dr. Shannon Lenze|3143622752|slenze@wustl.edu|
20509594|NCT03003130|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
20509595|NCT03949621|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20509596|NCT01855425|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
20509597|NCT01025232|Retinal Consultants of Houston|David M. Brown, MD Director of Clinical Research|713-394-7534|dmbmd@houstonretina.com|
20509598|NCT01600105|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
20509599|NCT01196091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20509600|NCT03645811|University of Health Science|Dr. Demet İnangil|+905303021160|demet.inangil@sbu.edu.tr|
20509601|NCT01215786|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20509602|NCT04555811|University of Minnesota, Masonic Cancer Center|Veronika Bachanova MD, PhD|612-625-5469|bach0173@umn.edu|
20509603|NCT04247828|Altec Inc.|Dr. Paola Contessa|508-545-8236|pcontessa@altecresearch.com|
20509604|NCT02324049|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
20509605|NCT02618512|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
20509606|NCT02159365|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20509607|NCT03198728|Marius Pharmaceuticals, LLC|Nita Nimmons|919-374-1913|Nita@mariuspharma.com|
20528015|NCT00793546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509608|NCT00285246|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley, Ph.D., Research Physiologist|781-687-2273|karen.quigley@va.gov|
20509609|NCT04051944|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20509610|NCT03083470|US Biotest, Inc.|Gere diZerega, MD; President & CEO|805-595-1300|gere.dizerega@usbiotest.com|
20503536|NCT04336163|University of California, Irvine|Kristen Kelly, MD|949-824-6550|kmkelly@uci.edu|
20503537|NCT01773473|Eli Lilly and Company|Medical Officer|800-545-5979||
20503538|NCT00826514|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503539|NCT01085682|The Catholic University of Korea|Kun-Ho Yoon, professor|82-2-2258-8281|yoonk@catholic.ac.kr|
20503540|NCT03926143|Bayer AG|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20503541|NCT00967941|CAMC Health System|Patrick Stone, MD|304-388-8250|pstone0627@yahoo.com|9901
20503542|NCT04579549|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
20503543|NCT01053312|GE Healthcare|Paul Sherwin, MD|1-609-514-6820|paulsherwin@ge.com|
20503544|NCT02639351|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
20503545|NCT02207907|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528016|NCT02101359|Laboratoires Thea|Medical director|33-4-73-98-14-36|p.pouliquen@laboratoires-thea.fr|
20503546|NCT00691665|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20503547|NCT02589977|Vanderbilt University Medical Center|Marvin Kronenberg, MD|615-322-2318|marvin.w.kronenberg@vumc.org|
20503548|NCT01025635|Bayer HealthCare Pharmaceuticals, Inc. (formerly Intendis GmbH)|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20503549|NCT02209506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20503550|NCT01755169|MUSC|Dr. Amy-Lee Bredlau|843-876-0444|bredlau@musc.edu|
20503551|NCT01834404|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20503552|NCT01499290|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
20503553|NCT02209766|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
20503554|NCT00327444|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20503555|NCT00805207|Washington University in St Louis|Gordon Smith, PhD|314-362-4375|gsmith@wustl.edu|
20503556|NCT00064701|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
20503557|NCT02249052|Dr. Zachary E. Gerut|Dr. Zachary E. Gerut, Sponsor/Investigator|516 295-2100|zger@optonline.net|
20503558|NCT04223609|Mayo Clinic|Gaurav N. Pradhan, PhD|480-301-5351|Pradhan.Gaurav@mayo.edu|
20503559|NCT00355121|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20503560|NCT03313050|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503561|NCT02963376|NuvOx Pharma|Evan Unger, MD|520-624-6688|eunger@nuvoxpharma.com|
20503562|NCT01291017|University of Florida|Priya K Gopalan, MD|352-273-8699|gopalpk@ufl.edu|
20503563|NCT02847598|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20503564|NCT02848833|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503565|NCT07145541|AION Biosystems|Samara Barend|9079024986|sam@aionbiosystems.com|
20503566|NCT04375761|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20503567|NCT03797001|Virginia Commonwealth University|Benjamin Van Tassell|8048284583|bvantassell@vcu.edu|
20503568|NCT05404776|University of Texas Medical Branch|Meagan Benson, DO|409-772-0982|meaganbenson88@gmail.com|
20503569|NCT05556616|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20503570|NCT04840836|Columbia University|Samantha Garbers, PhD, Principal Investigator|212-305-0123|svg2108@cumc.columbia.edu|
20503571|NCT00500266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503572|NCT01431287|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503573|NCT02251743|Ohio State University|Dr. L Eugene Arnold|614-685-6701|L.Arnold@osumc.edu|
20503574|NCT03198221|Cleveland Clinic|Dr. Carol Burke|216-444-6864|BurkeC1@ccf.org|
20503575|NCT02935738|Barz IVF Center for Embryo Research and Infertility Treatment|Dr. Saeeda A. Muhsen-Alanssari|9798201303|barzivfcenter@gmail.com|
20503576|NCT00469508|UCLA Center for Behavioral and Addiction Medicine|Steven Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
20503577|NCT03615222|CTX VA|Suzannah Creech|254-654-7241|suzannah.creech@va.gov|
20503578|NCT01552057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20503579|NCT00476086|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susanna_campos@dfci.harvard.edu|
20503580|NCT02900092|Massachusetts General Hospital|Karen K. Miller, MD|617-726-3870|KKMiller@mgh.harvard.edu|
20503581|NCT03895203|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20503582|NCT01389245|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20503583|NCT02292849|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
20503584|NCT04125680|University of Michigan|Emily Feuerherm|810-766-6725|feuerher@umich.edu|
20503585|NCT00097539|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20503586|NCT04938648|Johns Hopkins University|Dr. Ariel Green|(410) 550-6733|ariel@jhmi.edu|
20503587|NCT00364793|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20503588|NCT00391976|Novartis Pharmaceuticals|Study Director|862 778-8300||
20509611|NCT00736450|University of Nebraska Medical Center|Julie Vose|402-559-3848|jmvose@unmc.edu|
20550769|NCT02775162|OrganOx Ltd|Robert Bovy, VP of Regulatory Affairs, North America|608-556-4429|robert.bovy@organox.com|
20550770|NCT04876274|School of Pharmacy, Taipei Medical University|Professor Hsiang-Yin Chen|(02)2736-1661|shawn@tmu.edu.tw|6175
20550771|NCT03454893|AVROBIO, Inc|AVROBIO MedInfo|617-914-8419|medinfo@avrobio.com|
20503589|NCT05127486|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20528017|NCT00732680|Mayo Clinic|Rizwan Siwani, MBBS|507-284-9155|siwani.rizwan@mayo.edu|
20503590|NCT00049127|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072841370|jaecle.kurt@mayo.edu|
20503591|NCT00310310|VA San Diego Healthcare System|Carl J. Stepnowsky,PhD|858-642-1240|Carl.Stepnowsky@va.gov|
20503592|NCT02582515|Johns Hopkins University School of Medicine|Assistant Professor|443-287-5143|jfmcguire@jhmi.edu|
20503593|NCT02724033|Department of Otolaryngology, Indiana University School of Medicine|Dr. Charles Yates, Primary Investigator|317-278-1286|cwyates@iupui.edu|
20503594|NCT01287754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20503595|NCT03193866|Karolinska Institutet|Professor Fredrik Piehl|+46-(0)8-517 798 40|fredrik.piehl@ki.se|
20503596|NCT05027802|Ipsen Bioscience Inc.|Medical Director|see email|clinical.trials@ipsen.com|
20503597|NCT00001337|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
20503598|NCT03878147|Michigan State University|Michael J. Boivin|+15178840281|boivin@msu.edu|
20503599|NCT05817045|EmitBio|Director of Clinical Trials|919-321-1734|info@emitbio.com|
20503600|NCT02688647|Kadmon Corporation|Karin Herrera, Vice President, Clinical Operations|1-724-778-6134|karin.herrera@kadmon.com|
20503601|NCT03619213|AstraZeneca AB|AstraZeneca Clinical Study Information Center|877-240-9479|Information.center@astrazeneca.com|+1
20503602|NCT02886702|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
20503603|NCT01808560|TearScience, Inc.|Manager of Clinical and Medical Affairs|919-459-4842|LJi4@its.jnj.com|
20503604|NCT01147497|Emory University|Eva Lathrop, MD, MPH|404-778-1379|elathro@emory.edu|
20503605|NCT02991599|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
20503606|NCT04026568|Penn State Hershey Medical Center|Kenneth Taylor, MD, Professor of Orthopaedics and Rehabilitation|717-531-2948|ktaylor3@pennstatehealth.psu.edu|
20503607|NCT00331760|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20503608|NCT02514044|University of Texas Health Science Center at Houston (UTHealth)|Dr. Gerard E. Francisco, Chairman and Professor, Physical Medicine and Rehabilitation|713.797.5246|gerard.e.francisco@uth.tmc.edu|
20503609|NCT03417440|University of Southern California Chan Division of OS-OT|Stacey Schepens Niemiec|3234422069|schepens@usc.edu|
20503610|NCT02786901|Bausch Health|Study Manager|(908) 242-8287|sandra.narain@bauschhealth.com|
20509612|NCT00427791|UT MD Anderson Cancer Center|Dr. Partow Kebriaei, Associate Professor|713-792-2648|ytdinh@mdanderson.org|
20528018|NCT03040427|Cleveland Clinic Foundation|Dr. Wael A. Jaber|216.444.8305|jaberw@ccf.org|
20528019|NCT01841567|Klinik und Poliklinik für Orthopädie und Unfallchirurgie der Uniklinik Köln|Dr Kourosh Zarghooni|+49 2247887294|kourosh.zarghooni@uk-koeln.de|
20528020|NCT03755518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20503611|NCT01687790|University of Pittsburgh|Dr. Christiane Hakim|412-641-1965|chakim@magee.edu|
20503612|NCT00607048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503613|NCT00673595|Mayo Clinic|Dr. John H. Eisenach|507-266-8715|eisenach.john@mayo.edu|
20503614|NCT01451645|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
20503615|NCT03663166|Moffitt Cancer Center|Bradford A. Perez, MD|813-745-4380|bradford.perez@moffitt.org|
20503616|NCT04485455|University of North Carolina at Chapel Hill|Shahzad Ali, MD|984-974-0033|shali@med.unc.edu|
20503617|NCT01110187|University of Alabama at Birmingham|Jerzy P. Szaflarski, MD|205-934-3866|szaflaj@uab.edu|
20503618|NCT00422279|Nobel Biocare|Isabelle Arrighi, Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
20503619|NCT03862027|University of North Carolina at Chapel Hill|Amanda Kovacich, MD|919-966-2532|amanda.kovacich@unchealth.unc.edu|
20503620|NCT02561156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20503621|NCT01071070|Abbott|Global Medical Services|800-633-9110||
20503622|NCT00158184|Substance Use Research Center|Dr. Sandra D. Comer|212-543-5981|sdc10@columbia.edu|
20503623|NCT02393209|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20503624|NCT00727402|Case Western Reserve University Dept Ophthalmology & Visual Sciences|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
20503625|NCT03545282|University of Washington|India Ornelas|206-685-8887|iornelas@uw.edu|
20503626|NCT02582671|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20503627|NCT02537678|University of South Florida|Alison Salloum|8139741535|asalloum@usf.edu|
20503628|NCT01147809|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503629|NCT01307423|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20503630|NCT02500537|Medtronic|Michelle DiSalvo|774.284.6089|michelle.v.disalvo@medtronic.com|
20503631|NCT01587989|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20503632|NCT06119191|CooperVision, Inc.|Cameron Postnikoff|925-730-6734|postnikoff@coopervision.com|
20503633|NCT05630846|GlaxoSmithKline Biologicals SA|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20503634|NCT00608465|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
20503635|NCT01056107|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
20503636|NCT01225263|BIDMC|Catherine Buettner, MD MPH|617-754-9600|cbuettne@bidmc.harvard.edu|
20503637|NCT01380899|Facultad de Medicina, Universidad Autonoma de San Luis Potosi|Ildefonso Rodriguez-Leyva|+52 4442043016|ildefonso.rodriguez@uaslp.mx|
20503638|NCT02364778|Icahn School Of Medicine at Mount Sinai|Dr. Annapoorna Kini||annapoorna.kini@mountsinai.org|
20503639|NCT00496366|Rutgers Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-6789|toopmede@cinj.rutgers.edu|
20509613|NCT01302691|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20528021|NCT03172364|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20503640|NCT02718820|Medical University of Vienna|Thorsten Fuereder|+43140400|thorsten.fuereder@meduniwien.ac.at|44450
20503641|NCT02811744|Univerisity of Pennsylvania|Erin Schubert|215-573-6569|erin.schubert@pennmedicine.upenn.edu|
20503642|NCT00260208|Novartis Pharmaceuticals|Study coordinator|862-778-8300||
20550772|NCT03070782|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20509614|NCT03446612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20509615|NCT03787095|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20509616|NCT01451983|Cleveland Clinic Center for Autism|Thomas W. Frazier, PhD|216-448-6440|fraziet2@ccf.org|
20509617|NCT00570362|St.Mary's Hospital, College of Medicine, The Catholic University of Korea|Jung-Il Moon|82-2-3779-2114|jimoon@catholic.ac.kr|1243
20509618|NCT02512276|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
20509619|NCT03150199|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
20509620|NCT03148795|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550773|NCT02320149|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20509621|NCT03338036|University of Western Ontario|Dr Jim Dickey, Associate Professor|519-661-2111|jdickey@uwo.ca|87834
20509622|NCT00398138|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak, Attending|+1212-639-5518|maslakp@mskcc.org|
20509623|NCT03256136|Massachusetts General Hospital|Dr. Jessica Lin|617-724-1134|jjlin1@partners.org|
20509624|NCT04973085|University of Vermont|Adam Sprouse Blum, MD|8028478050|Adam.Sprouse-Blum@uvmhealth.org|
20509625|NCT03924427|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20509626|NCT03028467|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20509627|NCT02253160|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer - BBT|303-232-6800|Ray.Goodrich@terumobct.com|
20509628|NCT01316380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509629|NCT00149890|Novartis Pharmaceuticals|Study Director|862-778-8300||
20509630|NCT01387594|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20509631|NCT00712270|Kettering Health Network|Manager, Research Operations and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
20509632|NCT02574520|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20509633|NCT02550093|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu|
20509634|NCT01611311|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509635|NCT01365091|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20509636|NCT05116683|Columbia University|Benjamin Izar, MD|212-304-5871|bi2175@cumc.columbia.edu|
20509637|NCT01435122|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jonathan R. Strosberg|813-745-3636|jonathan.strosberg@moffitt.org|
20509638|NCT02209259|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
20509639|NCT03878160|Massachusetts General Hospital|Dr. Christina Luberto|617-643-9453|cluberto@mgh.harvard.edu|
20509640|NCT04193605|School of Nursing at the University of Alabama at Birmingham|Crystal Chapman Lambert|205-934-3481|cclamber@uab.edu|
20509641|NCT00533780|Stanford University|Kathy Turner, RN, NP|650-724-6850|kathyt@stanford.edu|
20509642|NCT03887052|Kestra Medical Technologies, Inc.|Laura Gustavson, VP Clinical Marketing|14255264759|laura.gustavson@kestramedical.com|
20558264|NCT01122381|Vetarans Administration Pittsburgh Healthcare System|Kathy Gardner MD|(412) 360-6185|kathy.gardner@va.gov|
20558265|NCT02395133|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20558266|NCT01583101|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
20558267|NCT00962247|SUNY Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
20558268|NCT01536184|Child Development Clinic SSCY Centre|Dr. Ana Hanlon-Dearman|204-258-6628|ahdearman@hsc.mb.ca|
20558269|NCT01974700|Indiana University|Dr. Aaron Cohen-Gadol|317-396-1300|ACohen@goodmancampbell.com|
20558270|NCT02946918|UT Southwestern Medical Center|Dr. Alex Tessnow-ASSOC PROFESSOR|214/648-3685|Alex.Tessnow@UTSouthwestern.edu|
20558271|NCT01861522|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20558272|NCT00069784|sanofi|Trial Transparency Team||Contact_US@sanofi.com|
20558273|NCT04466215|The Scripps Research Institute|Dr. Barbara J.. Mason, Ph.D.|(858) 784-7324|mason@scripps.edu|
20558274|NCT00402194|Indiana University|Dr. Kieren Mather|317-278-7826|kmather@iu.edu|
20558275|NCT01555164|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20558276|NCT00926003|Michigan State University|Dr. Michael J. Boivin|5174324204|Michael.Boivin@hc.msu.edu|
20558277|NCT03203694|University of Missouri|Jaume Padilla|(573) 882-7056|padillaja@missouri.edu|
20558278|NCT03443713|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
20509643|NCT02365506|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20509644|NCT05505734|Avillion Life Sciences|Chief Medical Officer|+44 (0)203 764 9530|contact@avillionls.com|
20558279|NCT04686279|Johns Hopkins University|Dr. Craig Hendrix|410-955-9707|chendrix@jhmi.edu|
20558280|NCT04255342|University of Iowa|Chris Barwacz|(319) 384-3002|chris-barwacz@uiowa.edu|
20550774|NCT00022633|Cleveland Clinic|Dr. Derek Raghavan|216-445-6888|raghavd@cc.ccf.org|
20503643|NCT02091440|Osaka University Hospital|Prof. Yoshiki Sawa|+81 668793160|sawa@surg1.med.osaka-u.ac.jp|
20550775|NCT02237950|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
20550776|NCT05989815|Federal University of São Carlos (UFSCar)|Italo Amaral de Oliveira, Principal Investigator|+55 19 99719-0361|italoao@estudante.ufscar.br|
20550777|NCT04583891|University of Virginia|Philip Chow|9146453458|pic2u@virginia.edu|
20550778|NCT02532933|University Of Denver|Kevin Shelburne|3039021249|kevin.shelburne@du.edu|
20550779|NCT01714635|Abbott Medical Optics|Kendra Hileman, Ph.D., Director, Clinical Research & Development|714-247-8613|kendra.hileman@amo.abbott.com|
20550780|NCT02503735|Massachusetts General Hospital|Dr. Meghan Sise|617-726-5050|MSise@partners.org|
20550781|NCT00824512|Ipsen|Medical Director, Primary Care|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20550782|NCT03358290|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
20550783|NCT00203996|The University of Chicago|David A. Ehrmann, MD|(773) 702-6138|dehrmann@medicine.bsd.uchicago.edu|
20550784|NCT00897104|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20550785|NCT01217840|Stanford University|Sejal Shah MD|6507211811|sshah2@stanford.edu|
20550786|NCT03789318|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
20550787|NCT01937559|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
20550788|NCT04818840|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20550789|NCT00407563|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20550790|NCT05040386|University of Alabama at Birmingham|Anand Iyer, MD, MSPH|2059341968|aiyer@uabmc.edu|
20550791|NCT00536601|Roswell Park Cancer Institute|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
20550792|NCT00386776|Beth Israel Deaconess Medical Center|Dr. Warner V. slack|617 278 8155|wslack@bidmc.harvard.edu|
20550793|NCT00588848|MetroHealth Medical Center|Dr. Dennis Auckley|216-778-7212|dauckley@metrohealth.org|
20550794|NCT00412854|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550795|NCT01484873|Vanderbilt University|Ashley Shoemaker|615-343-8116|ashley.h.shoemaker@vanderbilt.edu|
20550796|NCT00311623|Duke University|Andrew Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
20550797|NCT03414424|Bronx VA Medical Center|Noam Y. Harel|718-584-9000|Noam.harel@va.gov|1742
20550798|NCT00877877|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550799|NCT01083576|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
20550800|NCT03527966|Virtua Health Inc.|Jillian Hoopes|856-761-3904|jhoopes@virtua.org|
20550801|NCT01948050|Beth Israel Medical Center|Helena Knotkova, PhD|212-844-8541|hknotkov@chpnet.org|
20550802|NCT00558025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20550803|NCT02288559|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
20550804|NCT00449540|Neuralieve|Cynthia Merrell|408-245-6400|cmerrell@neuralieve.com|
20550805|NCT02135146|University of Colorado|Nick Naughton, Professional Research Assistant|3037200833|nick.naughton@cuanschutz.edu|
20550806|NCT01881776|StLukeNY|Dr.Admir Hadzic|212-665-1400|admir@nysora.com|
20550807|NCT00333866|Organization: Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20550808|NCT06073119|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20550809|NCT02036294|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
20550810|NCT02393547|Mayo Clinic|Ryan T. Hurt, MD|507-266-1944|nicotineresearch@mayo.edu|
20550811|NCT05185089|NeRRe Therapeutics Ltd|CMO|+44 (0)1438 906960|info@nerretherapeutics.com|
20550812|NCT01370174|University of Maryland|Dr. Vicki Gray Principal Investigator|4107063778|vicki.gray@som.umaryland.edu|
20550813|NCT04997161|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20550814|NCT01485770|Jazz Pharmaceuticals|Director, Disclosure & Transparency|(215) 970-7145|ClinicalTrialDisclosure@JazzPharma.com|
20550815|NCT02663232|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550816|NCT01408914|Harvard Medical School|Carole Mitnick|617-432-6018|Carole_Mitnick@hms.harvard.edu|
20550817|NCT01958320|University of California San Francisco|Ronald Clyman, MD PI|415-443-9305|clymanr@peds.ucsf.edu|
20550818|NCT00759811|Instituto de Cardiologia do Rio Grande do Sul|Daniel Medeiros Moreira, MD. MSc.|55 (51) 3219-2802|danielmedeirosmoreira@gmail.com|
20550819|NCT06112756|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20550820|NCT04551092|Quantum Applied Science & Research, QUASAR Inc.|Gayle Guy|858 412 1839|gayle@quasarusa.com|
20550821|NCT01712490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20550822|NCT02423876|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
20550823|NCT01966900|Imperial College London|Dr Tom Cole|+44(0)2033136198|t.cole@imperial.ac.uk|
20550824|NCT03060629|Janssen Vaccines & Prevention B.V|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20550825|NCT01862874|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550826|NCT03748758|Novus Therapeutics|Clinical Director|949-679-1110|study002@novustherapeutics.com|
20550827|NCT01932112|Seoul St Mary's hospital|Y. Oh, director of clinical trial|82-2-2258-1141|oys@catholic.ac.kr|
20550828|NCT01129960|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
20550829|NCT03672747|Boys Town National Research Hospital|Tony Wilson|531-355-8909|tony.w.wilson@gmail.com|
20550830|NCT03198234|Stanford|Rajni Agarwal, MD|650-725-9250|rajnia@stanford.edu|
20550831|NCT04285879|Connecticut Children's|Adam P. Weaver, PT, DPT|860-284-0246|Aweaver@connecticutchildrens.org|
20528022|NCT01714609|Yale University|Dr. Garcia-Tsao|(203) 737-6063|guadalupe.garcia-tsao@yale.edu|
20528023|NCT02732327|Allergan|David Melnick, MD|201-427-8554|Melnick_David@Allergan.com|
20528024|NCT02306694|Oregon Health & Science University|Dr. Jayson Taylor|503-494-8716|taylojas@ohsu.edu|
20528025|NCT00603382|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528026|NCT02183909|University of California, San Francisco|Janet Myers, PhD, MPH, MA|415-502-1000|janet.myers@ucsf.edu|14626
20528027|NCT02320227|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20528028|NCT01327313|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20528029|NCT01573754|University of Texas Medical Branch Galveston|Dr. Karl Anderson|409-772-4661|kanderso@utmb.edu|
20528030|NCT01665677|Medical College of Wisconsin|Dr. Medhi Hamadani|414-805-6800|mhamadani@mcw.edu|
20528031|NCT01180049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528032|NCT01738191|Medical University of South Carolina|Dr. Vanessa Hinson|843-792-9115|hinsonvk@musc.edu|
20528033|NCT02483572|University of Nebraska Medical Center|Wayne Fisher|4025598863|wfisher@unmc.edu|
20528034|NCT00350779|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclsoure@merck.com|
20528035|NCT00528372|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
20528036|NCT02006056|Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto|Dr. Edward Chow|416-480-4974|edward.chow@sunnybrook.ca|
20528037|NCT02770846|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
20558281|NCT01672853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20558282|NCT01620567|Tufts University|Elizabeth J. Johnson, PhD|617.556.3204|elizabeth.johnson@tufts.edu|
20558283|NCT02073097|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Dr. Brian T. Hill|1-866-223 8100|TaussigResearch@ccf.org|
20558284|NCT01517243|Dartmouth College|Lionel Lewis|1-603-650-8685|lionel.d.lewis@dartmouth.edu|
20558285|NCT00474929|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
20558286|NCT03029247|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
20558287|NCT02593305|University of Iowa|Dr. Darren P. Casey|3193841009|darren-casey@uiowa.edu|
20528038|NCT02432144|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20550832|NCT02032810|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nikhil I. Khushalani|813-745-3437|nikhil.khushalani@moffitt.org|
20509645|NCT03575351|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20528039|NCT02946489|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
20528040|NCT02109445|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550833|NCT01064713|University of Texas (UT) MD Anderson Cancer Center|Agop Y. Bedikian, MD/Professor||CR_Study_Registration@mdanderson.org|
20550834|NCT03228537|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org|
20550835|NCT01927367|QEII Health Sciences Centre, Halifax, Nova Scotia|Dr. Jafna L Cox|(902) 473-7811|jafna.cox@dal.ca|
20550836|NCT01161862|Department of Biomedical Engineering, Boston University, Boston, Massachusetts.|Edward R. Damiano|(617) 353-9493|edamiano@bu.edu|
20550837|NCT00071513|Univeristy of Washington|Elizabeth McCauley, PHD, Principal Investigator|206-987-2579|eliz@uw.edu|
20558288|NCT01993017|Center for Behavioral Cardiovascular Health|Ian Kronish, MD, MPH, Principal Investigator|212-342-1335|ik2293@columbia.edu|
20509646|NCT01328769|University of Utah|Paul Hopkins|801-585-8139|paul.hopkins@utah.edu|
20509647|NCT01688999|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
20509648|NCT02768103|VA Palo Alto Health Care System|Dr Johanson|408-250-1982|lisa.johanson29@gmail.com|
20509649|NCT02283840|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20509650|NCT03748420|HealthPartners Institute|Dr. Patrick O'Connor|952-967-5034|patrick.j.oconnor@healthpartners.com|
20509651|NCT01263444|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20509652|NCT01611662|Fox Chase Cancer Center|Elizabeth Plimack, MD|215-728-3889|Elizabath.Plimack@fccc.edu|
20509653|NCT01899768|GlaxoSmithKline|GSK Response Center|866-435-7343||
20509654|NCT04043416|The University of Ottawa|Katherine Reilly|613-562-5800|kreilly@uottawa.ca|8238
20509655|NCT04098016|Duke University|Dr. Melissa Kay|7812493062|melissa.kay@duke.edu|
20509656|NCT00372489|Affymax|VP, Clinical Development|650-812-8700|info@affymax.com|
20509657|NCT03733249|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384-1100|clinicaltrials@bellicum.com|
20509658|NCT04476108|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20509659|NCT00850135|Stanford University School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
20509660|NCT02253992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20509661|NCT02213081|Northwestern University|Dr. Serdar Bulun|312-472-3980|Serdar.Bulun@nm.org|
20509662|NCT00772889|GlaxoSmithKline|GSK Response Center|866-435-7343||
20509663|NCT03323086|The Miriam Hospital|Dr. Michael Carey|401 793 8218|michael_carey@brown.edu|
20509664|NCT02515851|University Louisville|Nancy Alsip|502-852-2610|nlalsi01@exchange.louisville.edu|
20509665|NCT00355615|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20509666|NCT03676465|University of Virginia|Dr. Mark DeBoer|(434) 924-5956|deboer@virginia.edu|
20509667|NCT01866306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509668|NCT00085644|Abbott|Global Medical Services|800-633-9110||
20509669|NCT04259346|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20509670|NCT03330106|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20509671|NCT01004874|Duke University Medical Center|Dr. Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
20509672|NCT03441594|Pennington Biomedical Research Center|Candice A. Myers|12257632849|candice.myers@pbrc.edu|
20509673|NCT00623766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20509674|NCT00486889|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20509675|NCT00893763|University of South Florida|Cindy L. Munro, APRN, PhD|813-974-7597|cmunro2@health.usf.edu|
20509676|NCT00796549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509677|NCT01836029|VentiRx|Kristi Manjarrez|206 689 2256|kmanjarrez@ventirx.com|
20509678|NCT00606229|Otsuka Pharmaceutical CO., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20509679|NCT03523715|University of Southern California|Begum Ozel, MD|562-657-2961|ozel@usc.edu|
20509680|NCT02139280|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603.650.4628|Kenneth.R.Meehan@hitchcock.org|
20536581|NCT02623205|Department of Psychiatry, Renaissance School of Medicine at Stony Brook University|Kathryn Hill|904-252-3449|kathryn.hill@stonybrookmedicine.edu|
20558289|NCT00068380|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20558290|NCT01976364|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558291|NCT02757521|Washington University|Ben J Palanca, MD PhD MSC|314-286-0132|palancab@wustl.edu|
20558292|NCT01190215|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503644|NCT00768222|J&J Medical, China Ltd.|Xiaowei SUN, MD PhD|86 10 5952 3103|xsun5@its.jnj.com|
20503645|NCT03576144|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503646|NCT03323749|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20503647|NCT01444716|The University of Texas MD Anderson Cancer Center|Allessandra Ferrajoli, MD./Professor|713-792-2063|aferrajo@mdanderson.org|
20503648|NCT03263091|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|082MDSstudy@fibrogen.com|
20509681|NCT01678560|Yale University|Meir Kryger, MD|203-815-0914|meir.kryger@yale.edu|
20509682|NCT02201472|Cincinnati Children's Hospital|Dr. Stephanie Merhar|513-803-5180|stephanie.merhar@cchmc.org|
20509683|NCT00117572|UC San Diego Moores Cancer Center|Dr. Ezra E.W. Cohen||ecohen@ucsd.edu|
20509684|NCT00997555|Hurley Medical Center|John Alfred Carr, MD|810-262-4993|heartandbones@yahoo.com|
20509685|NCT01188811|Oregon Health & Science University|Rebecca Spain, MD, MSPH|503-494-5759|spainr@ohsu.edu|
20509686|NCT00090766|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20509687|NCT01602744|Tel Aviv University|Dvora Frankenthal|0097235326835|shai_f@zahav.net.il|
20509688|NCT00654368|Amgen Inc.|Study Director|866-572-6436||
20509689|NCT00559013|Synovis|Lesa Hobright-Turner, Director of Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
20509690|NCT02583360|The Research Institute at Nationwide Children's Hospital|Sudarshan Jadcherla MD|614-355-6433|sudarshan.jadcherla@nationwidechildrens.org|
20509691|NCT04228445|Provepharm, Inc.|Senior Director of Clinical Operations|6106018605|todd.koch@provepharm.com|
20550838|NCT02622321|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550839|NCT00790855|The University of MD Anderson Cancer Center|Hagop M. Kantarjian, M.D.|713-792-7026|eharriso@mdanderson.org|
20550840|NCT00886899|BridgePoint Medical|VP, Clinical Affairs|763-225-8500|jschultz@bridgepointmedical.com|
20550841|NCT00965718|Yonsei university|Moonjae Chung, MD|82-2-2228-2274|MJCHUNG@yuhs.ac|
20550842|NCT00138203|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|(608) 262-8158|amt@medicine.wisc.edu|
20550843|NCT00241280|Johnson & Johnson Vision Care, Inc.|David C. Turner, Ph.D. GLOBAL PLATFORM SR DIRECTOR, R&D|904-443-3500|DTURNER2@its.jnj.com|3479
20550844|NCT01634360|Eisai Call Center|Eisai Inc.|888-422-4743||
20550845|NCT03667924|University of Minnesota|Joseph Gaugler, PhD|612-626-2485|gaug0015@umn.edu|
20550846|NCT02402127|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20550847|NCT02260921|Myoscience|Director of Clinical|5109331541||
20550848|NCT01244425|BAXTER INNOVATIONS GmbH|Ildiko Szabo, MD, MBA Medical Director, Biosurgery||ildiko_szabo@baxter.com|
20550849|NCT02743871|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550850|NCT02484729|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20550851|NCT03194698|Mayo Clinic|Joanne F. Shen, M.D.|480-301-8085|Shen.Joanne@mayo.edu|
20550852|NCT02480114|Vanderbilt University Medical Center|Derek Smith, DDS, PhD|6159367423|derek.k.smith@vumc.org|
20550853|NCT01535053|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-845-1169|lgedeon@gogstats.org|
20550854|NCT01031069|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550855|NCT00512707|Brigham and Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
20550856|NCT01317160|Karolinska university Hospital|Dr. Paul W. Ackermann|+46851770000|paul.ackermann@karolinska.se|
20550857|NCT05286281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550858|NCT03032705|Tufts University School of Dental Medicine|Dr Gerard Kugel|(617) 636-0870|Gerard.Kugel@tufts.edu|
20550859|NCT03482440|University of Iowa|Anna Stanhewicz|3194671732|anna-stanhewicz@uiowa.edu|
20550860|NCT04405037|Cleveland Clinic Foundation|Dr. Scott Steele|216-444-4715|steeles3@ccf.org|
20550861|NCT01705288|Masonic Cancer Center at University of Minnesota|Dr. Peter Argenta|612-626-6283|argenta@umn.edu|
20550862|NCT02835274|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
20550863|NCT01182493|CHU Caen|Prof. Yves Reznik|+33231064585|reznik-y@chu-caen.fr|
20550864|NCT01853826|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20550865|NCT05661942|Advocate Health|Michael Cirone, MD|7086841710|michael.cirone@aah.org|
20550866|NCT01134783|University of North Carolina, Chapel Hill|Dr. Leslie A. Lytle|919-843-8171|llytle@email.unc.edu|
20550867|NCT04346537|Boston Scientific|Gena Kantor|1-800-227-3422|gena.kantor@bsci.com|
20550868|NCT01148745|Dialysis Clinic, Inc.|Dr. Toros Kapoian, M.D., F.A.C.P.|732-940-8368|Toros.Kapoian@dciinc.org|
20550869|NCT00397982|University of Virginia|Craig Slingluff|434 924 1730|cls8h@virginia.edu|
20550870|NCT02450903|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20550871|NCT00967798|Emory University|Arlene Stecenko, MD|404-712-2657|astecen@emory.edu|
20550872|NCT01432886|Eisai Co., Ltd.|Tadashi Nakanishi|81-3-3817-5252||5252
20550873|NCT01409564|Seoul National University Hospital|Prof. Jung Seok Choi|82-2-870-3461|choijs@neuroimage.snu.ac.kr|
20550874|NCT00225251|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
20550875|NCT02664441|Seattle Children's Hospital|Christian L. Roth, MD|206-987-5428|christian.roth@seattlechildrens.org|
20550876|NCT03045328|Stanford University|Steven Edward Coutre, Professor of Medicine (Hematology)|650-498-6000|coutre@stanford.edu|
20550877|NCT02070692|Oregon Health & Science University|Dr. Katharine Simmons|404-718-6619|simmonka@ohsu.edu|
20550878|NCT04615923|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
20550879|NCT02560584|Regional Hospitals & Family Health Centers|Dr. J. Stephen Jones|+1-216-442-5060|joness7@cff.org|
20550880|NCT00715078|Dendreon|Shabnam Vaziri|206-455-2323|Svaziri@Dendreon.com|
20558293|NCT00003511|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20503649|NCT03026803|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|62478
20503650|NCT01821963|University of Texas (UT) MD Anderson Cancer Center|Harrys A. Torres, MD/Assistant Professor, Infectious Diseases|(713) 792-6503|htorres@mdanderson.org|
20503651|NCT00783289|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
20503652|NCT00506389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503653|NCT03739619|Emory University|Jonathon Cohen, MD|404-778-2214|jonathon.cohen@emory.edu|
20503654|NCT04053387|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20503655|NCT03095703|Amsterdam UMC, location Academic Medical Center|Prof. dr. Evelien Dekker|+3120-5663534|e.dekker@amsterdamumc.nl|
20503656|NCT03539432|The Mind Research Network|Dr. Eric Claus|5055151556|eclaus@mrn.org|
20503657|NCT01381094|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|+1 617-844-6128|trials@akebia.com|
20503658|NCT03370757|Duke University School of Nursing|Dr. Debra Brandon|919-681-3813|debra.brandon@duke.edu|
20503659|NCT04092257|UNC Lineberger Comprehensive Cancer Center|Melahat Garipagaoglu|919-962-0000|Melahat_Canter@med.unc.edu|
20503660|NCT02443402|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20503661|NCT00318292|Mayo Clinic|Michaele Menghini|480-301-6651|menghini.michaele@mayo.edu|
20503662|NCT02241486|Loyola University Medical Center|Dr. Joseph R. Holtman|7082168563|jholtman@luc.edu|
20503663|NCT01934504|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20503664|NCT02770521|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20503665|NCT02665689|Charité University, Berlin|Prof. Dr. Antonia Joussen|+49 30 84452331|antonia.joussen@charite.de|
20503666|NCT00824564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503667|NCT00775021|Vistakon|Kurt Moody, Director Design R&D|904-443-3088||
20503668|NCT00363415|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20503669|NCT04802837|Summit Therapeutics|Katie Tran|4086776503|Katie.Tran@Summitplc.com|
20503670|NCT03464045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503671|NCT03826875|University of Washington|Professor of Neurological Surgery|2067449330|mlevitt@uw.edu|
20503672|NCT01506141|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20503673|NCT04889209|Baylor College of Medicine|Dr. Robert L. Atmar|713-798-6849|ratmar@bcm.edu|
20503674|NCT04607408|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|2066675812|hvtn.covpn.sdmc@hvtn.org|
20503675|NCT02148029|Veterans Administration of Baltimore Maryland|Dr. Brajesh K. Lal|410-328-5840|blal@som.umaryland.edu|
20503676|NCT04586504|Columbia University|Daniel Tsze MD MPH|212-317-0997|dst2141@cumc.columbia.edu|
20503677|NCT03905928|Pennsylvania State University College of Medicine|Andrea Hobkirk|717-531-7279|alh98@psu.edu|
20503678|NCT01725165|M D Anderson Cancer Center|Dr, Chad Tang|(713) 745-7179|ctang1@mdanderson.org|
20503679|NCT05039086|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20503680|NCT02725788|3M|Laura Rutledge|651-733-5394|lfrutledge1@mmm.com|
20503681|NCT05590377|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20503682|NCT00382967|GE Healthcare|Igor Grachev, MD|1-609-514-6857|igor.grachev@ge.com|
20503683|NCT01276184|University of Maryland School of Medicine|Dr. J. Kathleen Tracy, PhD|410-706-1205|ktracy@som.umaryland.edu|
20503684|NCT01748799|Centre for Addiction and Mental Health (CAMH)|Bernard Le Foll|416.535.8501|bernard.lefoll@camh.ca|34772
20503685|NCT02620020|Regeneron Pharmaceuticals|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20558294|NCT00462722|University of Colorado Anschutz Medical Campus|Catherine Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
20558295|NCT03472287|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman/Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
20558296|NCT01395043|Aalborg Hospital|Dr Nils Bjerregaard|004522860649|niheb@rn.dk|
20558297|NCT02342314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20558298|NCT01683994|National Cancer Institute|Dr. William Dahut|240-760-6070|william_dahut@nih.gov|
20558299|NCT00999661|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20558300|NCT00917267|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20558301|NCT03728153|Massachusetts General Hospital|Farrah Mateen|16177248653|fmateen@mgh.harvard.edu|
20558302|NCT00312858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558303|NCT03638635|Inova Health System|Erica Emery|703-776-7615|erica.emery@inova.org|
20503686|NCT00195650|Abbott|Global Medical Services|800-633-9110||
20503687|NCT01478958|University of Reading|Professor Julie Lovegrove|+44 (0)118 3786418|j.a.lovegrove@reading.ac.uk|
20503688|NCT01709331|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503689|NCT02305563|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20558304|NCT01603420|The Proton Collaborative Group|Corey Woods|630-836-8668|cwoods@pcgresearch.org|
20558305|NCT02318719|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20558306|NCT00252590|VA San Diego Healthcare/University of California, San Diego|Dr. Susan Tate|619-426-9402|srtate@ucsd.edu|
20558307|NCT00432835|University of Mississippi Medical Center|Thomas L. Abell, MD, Professor of Medicine|6019844540|tabell@umc.edu|
20558308|NCT00289770|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558309|NCT00423293|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20558310|NCT02430818|Washington University School of Medicine|Evan Schwarz|3147473690|schwarze@wustl.edu|
20558311|NCT00674115|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20558312|NCT05340751|Hospital for Special Surgery|Dr. Friedrich Boettner|2127742127|BoettnerF@hss.edu|
20509692|NCT00606294|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@mskcc.org|
20509693|NCT03418376|Hasselt University|Dr. Charly Keytsman|+32477611122|charly.keytsman@uhasselt.be|
20550881|NCT00592839|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
20550882|NCT01313767|Clinical Development Team of Medytox Inc.|Medytox Inc.|82-70-8666-6911|hgpark@medytox.com|
20550883|NCT00157950|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20550884|NCT01529346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550885|NCT01531374|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20550886|NCT02892760|The University of Texas Health Science Center at Houston|Gerard Francisco, MD|713-797-7636|Gerard.E.Francisco@uth.tmc.edu|
20550887|NCT00258882|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
20550888|NCT04867850|Abramson Cancer Center|Dr. Samuel Takvorian|267-438-8269|Samuel.takvorian@pennmedicine.upenn.edu|
20550889|NCT00082355|NIHCC|Dr Richard Chang|301-402-0256|rchang@cc.nih.gov|
20550890|NCT02233309|University of Nebraska Children's Hospital & Medical Center|Jessica K. Goeller, DO|(402) 955-4303|JGoeller@childrensOmaha.org|
20550891|NCT02328755|University of Michigan|John Magenau|734 936-8785|johnmage@med.umich.edu|
20550892|NCT00232817|Columbia University|Dr. Pamela Flood|201-370-3933|pamelaflood181@gmail.com|
20558313|NCT01014975|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
20528041|NCT01037816|Hisamitsu Pharmaceutical Co., Inc.|Yoshinobu Higashi, Section Manager, International Regulatory Affairs|+81-3-5293-1712|Yoshinobu_Higashi@hisamitsu.co.jp|
20528042|NCT00727090|Northwestern University|Andrew M Naidech|312-503-3592|a-naidech@northwestern.edu|
20528043|NCT00966355|Korea University College of Medicine|Prof. Soon Ho Um|+82-2-920-5019|umsh@korea.ac.kr|
20528044|NCT00958412|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20528045|NCT02552888|Tulane School of Medicine|Dr. Jing Chen|5049886110|jchen@tulane.edu|
20528046|NCT02371668|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
20536582|NCT02342288|West Virginia University|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
20536583|NCT02371785|Corindus Vascular Robotics|Vice President, Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
20536584|NCT01667133|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20536585|NCT01181804|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20558314|NCT00936481|Vanderbilt Universit|Kanika Bagai, MD, Assistant Professor|6153220283|kanika.bagai@vanderbilt.edu|
20558315|NCT01336634|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20558316|NCT02406885|The Johns Hopkins University School of Medicine|Dr. Brent Petty|410-955-8181|bpg@jhmi.edu|
20558317|NCT02176421|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20558318|NCT01971580|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
20558319|NCT02632786|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
20558320|NCT04250337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20558321|NCT00136812|Stanord University|Judith Prochaska, PhD, MPH; Associate Professor|650-724-3608|JPro@stanford.edu|
20558322|NCT02006420|University of Michigan|Dinesh Khanna|734-763-7182|khannad@umich.edu|
20558323|NCT02951351|Mayo Clinic|Margaret M. Reynolds, MD|507-284-2733|margaretmmreynolds@gmail.com|
20558324|NCT00474175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558325|NCT01619787|SUNYBuffalo|Leonard H. Epstein|716-829-3400|ckk@buffalo.edu|
20558326|NCT03101241|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
20558327|NCT01003184|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20558328|NCT04848662|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
20558329|NCT03501693|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20558330|NCT00284089|Novartis Pharmaceuticals|Study Director|862 778-8300||
20558331|NCT00089895|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20503690|NCT02643095|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|Fogt.78@osu.edu|
20503691|NCT02930174|University of Michigan Health System|Carl Haas|734-936-5234|chaas@med.umich.edu|
20503692|NCT04640766|NYU Langone Health|Lenard Adler, MD|212-263-3580|Lenard.Adler@nyulangone.org|
20503693|NCT04906707|Emory University|Dr. Nadine Matthie|404-712-8449|nadine.matthie@emory.edu|
20503694|NCT01976806|Beth Israel Deaconess Medical Center|Dr. Kenneth Mukamal|617-754-1401|kmukamal@bidmc.harvard.edu|
20503695|NCT01106040|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
20503696|NCT01041248|Childrens Hospital of Eastern Ontario|Dr Johannes Roth|6137377600|jroth@cheo.on.ca|1015
20503697|NCT04551014|Stanford University|Shai Friedland, MD|650-723-4000|shaif@stanford.edu|
20503698|NCT02654002|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20503699|NCT01946516|SWOG Statistics and Data Management Center|Cancer Care Delivery Committee Statistician|2066674623|karnold@fredhutch.org|
20503700|NCT00963807|Washington University in St. Louis|John P Crandall|(314) 747 - 5561|jcrandall@wustl.edu|
20503701|NCT01587950|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503702|NCT03128957|University of Michigan|Dr. Paul Picton|734 615 9864|ppicton@med.umich.edu|
20503703|NCT00684177|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503704|NCT05818124|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20503705|NCT00075881|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20503706|NCT02224664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503707|NCT03019549|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20503708|NCT00371267|San Francisco VA Medical Center|Timothy P. Carmody, Ph.D.|415-221-4810|Timothy.Carmody@va.gov|6344
20503709|NCT04030195|Precision BioSciences|Michael Karg, Senior Director, Clinical Operations|919-324-5512|michael.karg@precisionbiosciences.com|1574
20503710|NCT01412879|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
20558332|NCT01013792|HCA Retreat Hospital, Institute of Plastic and Reconstructive Surgery|Joseph V. Boykin, Jr., MD|804-353-8100|joseph.boykin@HCAhealthcare.com|
20558333|NCT02667886|X4 Pharmaceuticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
20503711|NCT02109029|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20558334|NCT02778399|Clinical Operations|Medical Responsible|+41 (0)22 552 1560|clinicaltrials@obseva.ch|
20550893|NCT00799487|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
20503712|NCT03195894|KontigoCare AB|Markku Hämäläinen, Research Director|0769 47 31 32|markku.hamalainen@kontigocare.com|
20503713|NCT01575912|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
20503714|NCT00486902|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
20503715|NCT01035151|University of South Caroina|Jeannette Andrews|803 777 3862|j.andrews@sc.edu|
20503716|NCT01217606|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20503717|NCT04178590|Department of Periodontology and Oral Medicine, School of Dental Medicine, University of Belgrade|Dr Mila Vuckovic|+381637060694|jovanovic.dr.mila@gmail.com|
20503718|NCT00996840|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503719|NCT00474240|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
20503720|NCT00809133|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503721|NCT00833092|USDA Grand Forks Human Nutrition ResearchCenter|Forrest H Nielsen, PhD|701-790-8455|forrest.nielsen@ars.usda.gov|
20503722|NCT00619229|UCB|UCB Clinical Trial Call Center|+ 1 877 822 9493 (UCB)||
20503723|NCT01700829|NY State Psychiatric Institute-Columbia University Medical Center|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
20503724|NCT01075178|Abbott|Global Medical Services|800-633-9110||
20503725|NCT02983604|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20503726|NCT00316264|MedImmune|Pamela Griffin|301 398 0000|clinicaltrialenquiries@medimmune.com|
20503727|NCT00355264|BioMarin Pharmaceutical Inc.|Joshua Lilienstein|651-523-0310|MEDINFO@bmrn.com|
20503728|NCT00699192|Novartis Pharmaceuticals|Study Director|862 778-8300||
20503729|NCT04927312|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503730|NCT03424161|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20503731|NCT04919564|National Cardiovascular Center Harapan Kita Jakarta|Prieta Adriane, MD|+62 852-2004-0006|prietaadriane@gmail.com|
20503732|NCT03624816|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
20503733|NCT00929240|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20503734|NCT01287104|National Cancer Institute|Dr. Nirali N. Shah|301-451-0390|shahnn@nih.gov|
20503735|NCT00296322|Asan Medical Center, University of Ulsan College of Medicine|Dr. Yoon-Koo Kang|+82-2-3010-3230|ykkang@amc.seoul.kr|
20503736|NCT00098787|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20503737|NCT02203149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503738|NCT00278525|Northwestern University|Dr. Richard Burt|312-908-0059|rburt@northwestern.edu|
20503739|NCT00684814|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20503740|NCT00446030|sanofi-aventis|Trial Transparency Team||Contact-us@sanofi-aventis.com|
20503741|NCT00608140|Duke University|Mary Ann Sellers|919-668-8544|maryann.sellers@duke.edu|
20503742|NCT03168867|Wayne State University|Deborah Ellis, Ph.D.|313-577-1055|dellis@med.wayne.edu|
20503743|NCT04348851|North Florida/South Georgia Veterans Health System|Dr. Constance Uphold|352-548-6000|connie.uphold@va.gov|106893
20503744|NCT00858832|USF Health Department of Obstetrics and Gynecology|Patrick Teefey MD|813-259-8680|ObGynClinicalResearch@health.usf.edu|
20503745|NCT05292755|University of Florida|Dr. Yujia Zhou|3053429166|yzhou1996@ufl.edu|
20503746|NCT00432809|Cleveland Clinic|Dr. Philip Schauer|216-444-4794|schauep@ccf.org|
20503747|NCT04052139|Boston Medical Center|Dr. Jeffrey H. Samet|617-414-7288|jsamet@bu.edu|
20503748|NCT04433117|University of Kentucky|Dr. Mohanad Al-Sabbagh|859-257-3003|malsa2@email.uky.edu|
20503749|NCT00707577|Massachusetts General Hospital|Dr. Anne Thorndike|617-724-4608|athorndike@mgh.harvard.edu|
20503750|NCT00190775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20503751|NCT01794780|Novartis Pharmaceutical|Study Director|862-778-8300||
20503752|NCT00519077|The University of Chicago|Tanguy Lim-Seiwert|773-702-2452|seiwert@uchicago.edu|
20503753|NCT01967225|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20503754|NCT01207466|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|joseph.rappon@cibavision.com|
20503755|NCT00642642|Biologics Consulting Group|Dr/ Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
20503756|NCT00332202|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20503757|NCT00957853|UT MD Anderson Cancer Center|Dr. Maura Gillison, PHD/Professor, Thoracic-Head & Neck Med Onc|713-792-6363|mgillison@mdanderson.org|
20503758|NCT02901314|Cleveland Clinic|Nancy M. Albert, PhD, CCNS, CCHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN|216-444-7028|albertn@ccf.org|47028
20503759|NCT02495948|Alcon, A Novartis Division|Global Medical Affairs Brand Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20503760|NCT00100048|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503761|NCT01701622|University of Mississippi Medical Center|Debbie Minor|601-984-6888|DMinor@umc.edu|
20503762|NCT01822561|Tufts Medical Center|Andre Witkin|6176367950|awitkin@tuftsmedicalcenter.org|
20503763|NCT05087030|Gedeon Richter Plc.|Medical Information Scientific Service|+36 1 505 70 32|medinfo@richter.hu|
20503764|NCT02722044|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
20503765|NCT03658954|Yale University School of Medicine|Lisa Fucito, PhD|(203) 200-1470|lisa.fucito@yale.edu|
20503766|NCT00818259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503767|NCT00741819|United Therpaeutics Corporation|Inhaled Treprostinil Program Head|919-485-8350|clinicalrecordsmanagment@unither.com|
20503768|NCT02863198|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
20550894|NCT03263442|University of North Carolina - Chapel Hill|Zev Nakamura|984-974-3829|zev_nakamura@med.unc.edu|
20503769|NCT00609622|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558335|NCT00578721|UC Irvine Health - Chao Family Comprehensive Cancer Center|Jason Zell, DO, MPH, MS|714-456-5153|jzell@hs.uci.edu|
20509694|NCT02774291|Albert Einstein College of Medicine/Montefiore medical center|Braunschweig, Ira|718-798-7474|ibraunsc@montefiore.org|
20509695|NCT00471315|Medical University of South Carolina|Peter Cotton, MD|(843) 792-6999|CottonP@MUSC.edu|
20509696|NCT00108277|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
20509697|NCT00460525|Department of Epidemiology of Parasitic Diseases, University of Bamako|Mahamadou A. Thera, MD, MPH|223-222-8109|mthera@mrtcbko.org|
20509698|NCT04757376|CELLTRION, Inc.|Head of Clinical Planning Department|+82 32 850 4167|jeehye.suh@celltrion.com|
20509699|NCT00609167|Mayo Clinic|Dr. A. Keith Stewart||stewart.keith@mayo.edu|
20509700|NCT01307046|Merch Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20528047|NCT00385827|Janssen Research & Development|Director||ClinicalTrialDisclosure@its.jnj.com|
20558336|NCT02081456|Cayuga Medical Center|Dr. Michael Costello, PT, DSc, OCS, MTC|607-252-3500|mcostellopt@gmail.com|
20558337|NCT02117934|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
20528048|NCT04378569|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20528049|NCT01048944|Southern Illinois University Carbondale|David G. Gilbert, Ph.D.|618-45303558|dgilbert@siu.edu|
20528050|NCT01844817|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
20528051|NCT04227405|University of Maryland|Dr. Mariana Falconier, Associate Professor|301-405-4004|marianak@umd.edu|
20528052|NCT04985942|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
20528053|NCT01305772|Duke University Medical Center|Neal Ready,MD|919-681-6932|neal.ready@dm.duke.edu|
20528054|NCT01290952|Azienda Ospedaliera Luigi Sacco|Dr. Massimo Lemma|0039 0239042876|lemma.massimo@hsacco.it|
20558338|NCT03245255|Thomas Jefferson University|Jaydev Dave|2158684795|dave.jaydev@mayo.edu|
20558339|NCT01298921|Geisinger Health System|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
20558340|NCT01022073|San Francisco VA Medical Center|William J. Marks, Jr., M.D.|415-750-2100|William.Marks@va.gov|
20509701|NCT03898323|University of California, San Francisco/San Francisco VA Health Care System|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
20558341|NCT00515437|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
20558342|NCT04999644|Johns Hopkins University School of Medicine|Justin Strickland|4105501975|jstric14@jhmi.edu|
20558343|NCT00736489|AstraZeneca|Carin Jorup, MSD||ClinicalTrialTransparency@astrazeneca.com|
20558344|NCT02205801|The University of Chicago Medicine & Biological Sciences|Dr. Raymond H. Grogan|773-702-7125|rgrogan@surgery.bsd.uchicago.edu|
20558345|NCT01373450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558346|NCT02234063|Icahn School of Medicine at Mount Sinai|Dr. Carol R. Horowitz|212-659-9564|carol.horowitz@mssm.edu|
20509702|NCT01547806|National Cancer Institute|Dr. Jennifer Kanakry|301-451-3787|kanakryja@nih.gov|
20509703|NCT00886691|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
20509704|NCT00392951|Children's Hospital of Philadelphia|David T. Teachey, MD|267-426-5802|teacheyd@email.chop.edu|
20509705|NCT03298048|UTexas_Houston|Dr. Herbert DuPont|713-500-9366|herbert.l.dupont@uth.tmc.edu|
20509706|NCT01251315|Charles R Drew University of Medicine and Science|Dr .Naureen Tareen|323-568-3359|aaant@aol.com|
20509707|NCT03935594|Vanderbilt university medical center|Dr. Salam AlKassis|(615)322-2350|salam.al.kassis@vumc.org|
20509708|NCT03954704|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20509709|NCT03017040|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
20509710|NCT00985140|Stanford University Cancer Center|Richard T. Hoppe, MD Henry S. Kaplan Harry Lebeson Professor of Cancer Biology|(650) 723-5510|hoppe@stanford.edu|
20509711|NCT00802880|Washington University School of Medicine|Brian Van Tine, M.D., Ph.D.|314-362-5817|bvantine@dom.wustl.edu|
20509712|NCT02406027|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509713|NCT01990703|University of Utah, Department of OBGYN|Dr. David Turok|801-581-6170|david.turok@hsc.utah.edu|
20509714|NCT03277794|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
20509715|NCT05166603|US Department of Veterans Affairs|Dawn M. Bravata, MD|3179882676|dawn.bravata2@va.gov|
20509716|NCT03979495|Massachusetts General Hospital|Dr. Jennifer Haas|617-724-1832|jhaas@mgh.harvard.edu|
20509717|NCT04969900|Principal Investigator|Dr. Leanne Free|303-724-8576|leanne.free@cuanschutz.edu|
20509718|NCT03691649|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20509719|NCT03537937|Pragmatic Critical Care Research Group|Chair of the Steering Committee|(615) 322-3412|matthew.w.semler@vumc.org|
20509720|NCT00425945|Stanford University School of Medicine|Dr. Randall Stafford|650-724-2400|rstafford@stanford.edu|
20509721|NCT02881151|Stanford University School of Medicine|Dr. Jaimie Henderson|+1 (650) 723-5574|henderj@stanford.edu|
20509722|NCT03315702|Department of Anesthesia, Xinhua hospital affiliated to Shanghai Jiaotong University School of medicine|Dr. Lai Jiang|021-25078999|jianglaimz@sina.com|
20509723|NCT03258593|National Cancer Institute|Dr. Raju Chelluri|240-858-3700|raju.chelluri@nih.gov|
20509724|NCT00732654|Johns Hopkins University|Corinne Keet|4109555883|pediatricallergy@jhmi.edu|
20509725|NCT05618808|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20509726|NCT05706623|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
20509727|NCT03728881|Division of Cancer Epidemiology and Genetics, NCI|Aimée R. Kreimer, PhD|240.276.7102|kreimera@mail.nih.gov|
20509728|NCT05379686|Steno Diabetes Center Copenhagen|Dr|+45 39 68 08 00|SDC-FP-Stenoinfo@regionh.dk|
20509729|NCT04517253|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20509730|NCT04428580|Stanford University|James Lock, MD, PhD|(650) 498-9111|jimlock@stanford.edu|
20509731|NCT04574570|IRCCS Istituto Ortopedico Rizzoli|Dr Stefano Zaffagnini|+3905163665706366111|stefano.zaffagnini@unibo.it|
20509732|NCT04651777|Western Universtiy|Dr. Grace E Parraga|519-931-5365|gparraga@robarts.ca|
20509733|NCT06048367|West China Hospital of Sichuan University|Professor. Yongsheng Wang|18980602258|wangys@wchscu.cn|
20509734|NCT04088331|Boston Scientific|Winnie Chen|952-930-6000|Winnie.Chen@bsci.com|
20509735|NCT01994109|Solstice Neurosciences|Regulatory Affairs Associate||regulatoryaffairs@usworldmeds.com|
20509736|NCT00576147|Baylor College of Medicine|Claudia Robertson|(713) 798-8932|claudiar@bcm.edu|
20509737|NCT02136134|Janssen R&D US|Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509738|NCT05674838|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20509739|NCT03070119|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20509740|NCT03137888|Emory University|Dr. Hui-Kuo Shu|4047781900|hgshu@emory.edu|
20509741|NCT02974621|Massachusetts General Hospital|Isabel Arillaga-Romany, MD PhD|877-442-3324|iarrillaga@mgh.harvard.edu|
20509742|NCT00732472|GlaxoSmithKline|GSK Response Center|866-435-7343||
20509743|NCT02159768|National University Hospital|Senior Consultant|+65 67724200|eugene_liu_hc@nuhs.edu.sg|
20558347|NCT02716038|Columbia University Irving Medical Center|Catherine A. Shu, MD|212-305-3997|cas2145@cumc.columbia.edu|
20558348|NCT02654990|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
20558349|NCT02669095|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
20558350|NCT03621202|Saranas, Inc.|Zaffer Syed|833-375-9273|zaffer@saranas.com|
20558351|NCT00697190|Vistakon|John Buch OD|904-443-1707||
20558352|NCT00886639|Schön Klinik BGL|Dr. Klaus Kenn|0865293|iheinzelmann@schoen-kliniken.de|1540
20558353|NCT01871558|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20558354|NCT01986361|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
20558355|NCT01709305|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558356|NCT03518658|CRHF Clinical|Keith Holloman|763-526-1545|keith.holloman@medtronic.com|
20558357|NCT00649389|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20558358|NCT04662671|EmitBio, Inc.|Chief Scientific Officer|(919) 321-1734|nstasko@emitbio.com|
20558359|NCT00453310|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
20503770|NCT00686543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20503771|NCT00825370|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|7189207464|achang@montefiore.org|
20503772|NCT01237951|UT MD Anderson Cancer Center|Dr. Nieto, Yago, M.D./Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
20528055|NCT03536663|Fresenius Medical Care North America|Senior Director of Statistics and Data Management|781-699-4203|ChiangHong.Ho@fmc-na.com|
20558360|NCT01806740|Guerbet|Corinne Dubourdieu, Head of Clinical Projects|+33145915000|corinne.dubourdieu@guerbet.com|
20558361|NCT04666922|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558362|NCT02444988|Vanderbilt University Medical Center|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
20558363|NCT01382940|Hoffmann-La Roche|Medical Communications|800 821-8590||
20558364|NCT04551196|Washington University School of Medicine|David Leonard, MD, Principal Investigator|314-454-2136|dsleonard@wustl.edu|
20558365|NCT00244374|University of California, San Francisco|Dr. Paula J. Lum|415-476-4082|plum@php.ucsf.edu|411
20558366|NCT00983489|Deen Dayal Upadhaya Hospital, New Delhi|Dr Kanchan Sharma|919417938224|psaiims@yahoo.co.in|
20558367|NCT02105636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20558368|NCT00291655|UCB Pharma|UCB Clinical trial call center|+1 877 822 9493||
20558369|NCT02010697|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
20558370|NCT00819403|Univ Maryland|Dr Michael Miller|410 328-6299|mmiller@medicine.umaryland.edu|
20558371|NCT03661996|Centrexion Therapeutics Corporation|Clinical Operations|617-837-6911|info@centrexion.com|
20558372|NCT03321513|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|mhuggins@jaeb.org|
20558373|NCT02960763|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
20558374|NCT02250521|The University of Texas Health Science Center at Houston|Carin A. Hagberg, MD|713-500-6200|Carin.A.Hagberg@uth.tmc.edu|
20558375|NCT01863043|University of Florida|Dr. Leslie Parker|352 215 9360|parkela@ufl.edu|
20558376|NCT03377790|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
20558377|NCT01928225|University of Colorado|Cynthia Frinhaber|720-848-0000|cynthia.firnhaber@cuanschutz.edu|
20558378|NCT01231841|Cleveland Clinic Foundation|Jaroslaw Maciejewski, MD PhD, Principal Investigator|216-445-5962|maciejj@ccf.org|
20558379|NCT02674490|Johns Hopkins University School of Medicine|Dr. Argye Hillis, MD|4109552228|argye@jhmi.edu|
20558380|NCT02440594|University of Pennsylvania|Shahrzad Mavandadi|215-823-5211|shahrzad.mavandadi@va.gov|
20558381|NCT00152763|University Health Network, Toronto General Hospital|Dr. Jane Irvine|(416) 736-5115|jirvine@yorku.ca|22444
20558382|NCT04741802|Duke University|Nia S. Mitchell, MD, MPH|919-668-7202|nia.s.mitchell@duke.edu|
20558383|NCT04498247|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558384|NCT00669903|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20558385|NCT01678820|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509744|NCT02559115|Memorial Sloan Kettering Cancer Center|Dr. Hebert A. Vargas Alvarez , MD|646-888-5410|vargasah@mskcc.org|
20550895|NCT01084174|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
20550896|NCT00708643|Vistakon|Kurt Moody, O.D. FAOO|904-443-3088||
20550897|NCT01594125|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20550898|NCT01843751|University of Wisconsin|Randall Brown|608-263-6558|rtbrown@wisc.edu|
20550899|NCT05492942|Boston Medical Center, Internal Medicine|Emily Hurstak, MD MPH|(617) 414 5951|emily.hurstak@bmc.org|
20550900|NCT00176826|University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
20550901|NCT01946425|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20550902|NCT04585022|Copenhagen University Hospital Hvidovre, Orthopaedic Department|MD Peter Nyby Hersnaes|+45 40104845|pnhersnaes@gmail.com|
20550903|NCT03103919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20550904|NCT05682326|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20550905|NCT03998189|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-4550|aohlmans@wakehealth.edu|
20550906|NCT02051608|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20558386|NCT01381874|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20558387|NCT04488003|Biomed Valley Discoveries|Caroline Emery, PhD|816-960-4615|cemery@biomed-valley.com|
20558388|NCT00058019|University of Chicago Medical Center|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
20558389|NCT01248962|Memorial Sloan Kettering Cancer Center|Dr. Roisin O'Cearbhaill, MD|646-888-4227|ocearbhr@mskcc.org|
20558390|NCT00985543|St Stephens Centre, Chelsea and Westminster Hospital|Dr Marta Boffito|+44 2088 466 507|marta.boffito@chelwest.nhs.uk|
20558391|NCT00245856|University of Oklahoma Health Sciences Center|Suman Rathbun MD|4052714742|suman-rathbun@ouhsc.edu|44773
20558392|NCT00557622|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558393|NCT01539863|Karolinska Institutet|Ass professor Iben Axén|+46704400618|iben.axen@ki.se|
20558394|NCT02693834|Baylor Institute for Rehabilitation|Priya Karakkattil, PT PhD|469-888-5172|Pjke7991@gmail.com|
20558395|NCT01468922|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
20558396|NCT01923389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558397|NCT02551744|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20558398|NCT02991144|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20558399|NCT03662997|Molnlycke Health Care|David Pham|678-231-9655|david.pham@molnlycke.com|
20558400|NCT00007475|National Institute of Diabetes & Digestive & Kidney Diseases|Jeffrey B. Kopp, MD|+1 (301) 594-3403|jbkopp@nih.gov|
20558401|NCT01719224|Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital|Matthias Eikermann, MD, PhD|617-643-7735|meikermann@partners.org|
20558402|NCT00258180|Johns Hopkins School of Medicine|Maria Oliva-Hemker MD|410-955-8769|moliva@jhmi.edu|
20558403|NCT00152971|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558404|NCT00675506|Massachusetts General Hospital|Steven K. Grinspoon MD|617-726-3890|sgrinspoon@partners.org|
20558405|NCT03151395|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20558406|NCT04475848|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20558407|NCT02494206|Memorial Sloan Kettering Cancer Center|Dr. Babak Mehrara MD|212-639-3099|mehrarab@mskcc.org|
20503773|NCT00682630|Shin Poong Pharmaceutical Co., Ltd.|Jansik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
20503774|NCT03481270|Stanford University|Marcella Alsan, Associate Professor of Medicine|(650) 721-1352|malsan@stanford.edu|
20503775|NCT02226965|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20503776|NCT00924703|BioMarin Pharmaceutical Inc.|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
20503777|NCT00666562|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
20503778|NCT01523873|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
20503779|NCT02570672|UT Health San Antonio|Sara Espinoza|210 617 5197|Sara.Espinoza@cshs.org|
20503780|NCT04429022|University at Buffalo|Dr Sarah Andres, PI|7163230631|seandres@buffalo.edu|
20503781|NCT00275561|Mayo Clinic|Jeffrey A. Alexander, MD, Assistant Professor of Medicine|507-538-2403|alexander.jeffrey14@mayo.edu|
20503782|NCT01530243|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
20503783|NCT01769105|Department of ophthalmology, University of Duesseldorf|Dr. David Finis|+49 211 8117320|David.Finis@med.uni-duesseldorf.de|
20503784|NCT00407355|Wilmer Eye Institute|Peter Campocahiro|: 410-955-5106|pcampo@jhmi.edu|
20503785|NCT02108457|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
20503786|NCT03551028|University of Virginia|Emma Mitchell|4342433962|emm6z@virginia.edu|
20503787|NCT00377962|Novartis Pharmaceuticals|Study Director|862 778-8300||
20503788|NCT00686205|Abbott Diagnostics Division|Peggy Moreno|847-937-2044|Peggy.Moreno@abbott.com|
20503789|NCT04504318|Stanford University|Dr. Arash Momeni|650-723-6189|amomeni@stanford.edu|
20503790|NCT01217749|Pharmacyclics, Inc.|Dr. Jutta K. Neuenburg|877-877-3536|medinfo@pcyc.com|
20503791|NCT00810797|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20503792|NCT02635204|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
20503793|NCT02216136|Washington University School of Medicine|Terence M. Myckatyn, M.D.|314-996-3873|myckatyn@wustl.edu|
20503794|NCT01159262|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
20503795|NCT03075839|Yale University|Krysten Bold|203-974-7603|Krysten.bold@yale.edu|
20503796|NCT02469246|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20503797|NCT00885079|Otsuka Pharmaceutical Co., Ltd.|Mr. Kyoji Imaoka|-81-6-6943-7722||
20503798|NCT04214652|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
20503799|NCT02107755|The Ohio State University Comprehensive Cancer Center|Dr. Jose Bazan|614-688-7040|Jose.Bazan2@osumc.edu|
20503800|NCT03303989|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|2059966086|pjfoster@uabmc.edu|
20558408|NCT04394845|Hoffmann-La Roche|Medical Communications|800 821-8590|global-roche-genentech-trials@gene.com|
20558409|NCT03961009|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
20558410|NCT04986982|BIAL - Portela & Ca, SA|Responsible of Clinical Operations|+351229866100|clinical.trials@bial.com|
20558411|NCT05229653|NYU Langone Health|Kathy Huang, MD|(212) 545-5400|Kathy.Huang@nyulangone.org|
20558412|NCT01845974|Advocate Medical Group Cardiology|Scott M. Miller MD|847-698-5500|scott.miller@advocatehealth.com|
20558413|NCT02759185|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
20558414|NCT04765735|Medtronic|Janelle Blum|262-289-8419|janelle.blum@medtronic.com|
20503801|NCT01658514|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
20503802|NCT01275222|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20503803|NCT02823457|GV Sonny Montgomery VAMC|Mary Jane Burton|6013624471|mary.burton2@va.gov|
20503804|NCT00144170|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503805|NCT00518349|NorwegianDohsa|Dr. Geir Hoff|+4791866762|hofg@online.no|
20503806|NCT03871491|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
20503807|NCT05202808|RxSight, Inc.|Director, Clinical Trials|9494215463|dgoffredo@rxsight.com|300
20503808|NCT04996797|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20503809|NCT04091217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20503810|NCT03878485|Washington University School of Medicine|Dr. Clifford Robinson|314-362-8567|clifford.robinson@wustl.edu|
20503811|NCT02747004|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20503812|NCT01444300|Oregon Health & Science University|Dr. Michelle Cameron|503-218-1971|cameromi@ohsu.edu|
20503813|NCT04826900|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
20503814|NCT04885257|Birmingham VA Medical Center|Research Compliance Officer|205-933-8101|latanya.higginbottom@va.gov|336885
20503815|NCT02597062|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
20503816|NCT03372941|Washington University School of Medicine|Stephen Liang|3017470750|syliang@wustl.edu|
20503817|NCT01708057|AstraZeneca|Carin Jorup||aztrial_results_posting@astrazeneca.com|
20503818|NCT01697345|Creighton University|Dr. Melissa A Dahir|402-657-2847|melissadahir@creighton.edu|
20503819|NCT02970929|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1 866-503-6351|clinicaltrialdisclosure@sunovion.com|
20503820|NCT00291343|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503821|NCT04188730|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
20503822|NCT01245647|University of Florida|Dr. Bob Cook|352-273-5869|cookrl@ufl.edu|
20503823|NCT02370121|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
20503824|NCT00342355|National Institute of Allergy and Infectious Diseases, Dvision of Clinical Research|Michael A Polis, MD, MPH|301-496-8027|mpolis@niaid.nih.gov|
20503825|NCT03929250|Oregon Health & Science University|Dr. Amala Soumyanath|503-494-6878|soumyana@ohsu.edu|
20503826|NCT03971721|The Ohio State University|Dr. Ulysses Magalang|(614) 293-4925|Ulysses.Magalang@osumc.edu|
20503827|NCT05262764|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20503828|NCT01392183|UT MD Anderson Cancer Center|Amado J. .Zurita-Saavedra, MD/ Associate Professor, Genitourinary Medical Oncology|713- 563-6966|azurita@mdanderson.org|
20503829|NCT05198713|Sonova US Corporate Services, LLC|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20503830|NCT02093702|Barrie and Community Family Health Team|Dr. Andrew Wozniak|(705) 728-2618|andrew.wozniak@barriefht.ca|
20503831|NCT01024244|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20503832|NCT01232946|Indiana University|Kieren J. Mather MD|317-278-7826|kmather@iu.edu|
20503833|NCT01587963|Rutgers RWJMS|Vincente Gracias|732-235-7920|graciavh@rwjms.rutgers.edu|
20503834|NCT00265941|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20503835|NCT02677779|AOU Careggi|Dr. Matteo Monami, Director Diabetic Foot Unit|00390557946563|matteo.monami@unifi.it|
20503836|NCT02432807|Eyevance Pharmaceuticals|Mark Jasek|817-677-6127|mjasek@eyevance.com|
20503837|NCT03976401|Akero Therapeutics, Inc.|Brittany de Temple, Senior Director Clinical Operations|(650) 868-7935|brittany@akerotx.com|
20503838|NCT02966314|University of Wisconsin - Madison|Ravi Viswanathan|(608) 263-1081|rviswanathan@medicine.wisc.edu|
20503839|NCT00828464|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503840|NCT00502840|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20503841|NCT02197377|DorkuzEU|Anaesthesiology and Reanimation|0905055252901|ozbilginsule@gmail.com|
20503842|NCT01974323|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20503843|NCT01057277|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
20503844|NCT00466505|Vanderbilt-Ingram Cancer center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
20503845|NCT00605826|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20550907|NCT01986985|GE Healthcare|Terri Hanlon, Clinical Affairs Project Manager|609-578-0173|terri.hanlon@GE.com|
20503846|NCT02351115|Engage Therapeutics, Inc|Chief Medical Officer||studydirector@engagetherapeutics.com|
20503847|NCT01241786|Hackensack University Medical Center|Dr. Anthony Mato|551-996-2000|AMato@hackensackumc.org|
20503848|NCT02886715|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
20503849|NCT00503399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20503850|NCT01676961|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
20503851|NCT03812510|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
20503852|NCT01172067|CRT, Global Clinical Affairs, Cardiac Arrhythmias and Heart Failure, Abbott Medical Devices|Clay Cohorn, Program Director|+1 972 309 8087|clay.cohorn@abbott.com|
20503853|NCT00768560|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20550908|NCT02005445|VA Boston Healthcare System|Dr. Daniel Gottlieb|857-203-6375|daniel.gottlieb@va.gov|
20550909|NCT01314443|Ohio State University|Richard Bruno, PhD, RD|614-292-5522|bruno.27@osu.edu|
20550910|NCT01980914|Gerontology Research Unit|Boris Feldman|6048755115|boris.feldman@vch.ca|
20550911|NCT04545866|University of Alabama at Birmingham|Namasivayam Ambalavanan MD|2059344680|nambalav@uabmc.edu|
20550912|NCT05247866|Children's Hospital of Philadelphia|Jonathan Spergel|2155902549|spergel@chop.edu|
20550913|NCT04463719|University of Florida|Naykky Singh Ospina|(352) 273-8655|naykky.singhospina@medicine.ufl.edu|
20558415|NCT01807650|Amryt Pharma|Head of Clinical Development|+353 1 518 0200|medinfo@amrytpharma.com|
20558416|NCT02281526|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20558417|NCT01103960|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558418|NCT02294474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20558419|NCT00267696|The Ohio State University Comprehensive Cancer Center|Larry Copeland, MD|614-293-8697|Larry.Copeland@osumc.edu|
20558420|NCT00118898|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20558421|NCT05473000|The University of British Columbia|Dr. Michael Koehle|604-822-3838|michael.koehle@ubc.ca|
20558422|NCT01338012|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
20558423|NCT02714205|University of California, San Francisco|Mike Schembri, Data Systems Analyst|415-353-7161|michael.schembri@ucsf.edu|
20509745|NCT01266876|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
20509746|NCT01058395|Wayne State University|Dr. Jay Meythaler|(313) 375-7226|jmeythal@med.wayne.edu|
20509747|NCT04870099|Indiana University|Prof. Lorenzo Lorenzo-Luaces, Assistant Professor|8123456193|lolorenz@indiana.edu|
20509748|NCT05016037|Vanderbilt University Medical Center|Dr. Stephen Camarata|(615) 579-5608|stephen.camarata@vumc.org|
20509749|NCT03715205|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20509750|NCT00557362|University of California San Francisco Proctor Foundation|Tom M/ Lietman|4155022662|tom.lietman@ucsf.edu|
20509751|NCT02756845|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20509752|NCT03342404|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20509753|NCT01863901|Pacira Bioscience, Inc.|Medical Information|1-855-793-9729|MedInfo@Pacira.com|
20509754|NCT01332851|Family and Child Nursing, University of Washington|Dr. Monica Oxford|206-685-6107|mloxford@uw.edu|
20509755|NCT03299166|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20509756|NCT01425853|Bioiberica|Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
20509757|NCT00422903|GlaxoSmithKline|GSK Response Center|866-435-7343||
20509758|NCT00801138|Cleveland Clinic Foundation|Daniel I Sessler, MD|2164458396|sesslerd@ccf.org|
20509759|NCT01249157|Memorial Sloan Kettering|Dr. Maxine Jochelson|646-888-4507|JochelsM@mskcc.org|
20509760|NCT02996994|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
20509761|NCT00390429|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20509762|NCT02392468|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509763|NCT01039428|KDL|Study Director|818058844243|toiawase@advance-cro.co.jp|
20509764|NCT01313039|University of Miami Sylvester Comprehensive Cancer Center|Judith Hurley MD|305-243-6462|JHurley@med.miami.edu|
20509765|NCT03630016|Owlet Baby Care, Inc.|Madison Kenley, CCRP, BS|801-552-8383|mkenley@owletcare.com|
20509766|NCT01562678|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|617-667- 8630|cmantzor@bidmc.harvard.edu|
20509767|NCT01300767|Alcon Research|Director of Clinical Trials|1-800-241-7629||
20509768|NCT02858713|Department of Dermatology, Odense University Hospital|M.D. Mathias Tiedemann Svendsen|+45 61265827|m_tiedemann@hotmail.dk|
20509769|NCT00126425|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
20509770|NCT01388491|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20509771|NCT04035473|Athenex|Regional Project Manager|+886-277039399|lmeiying@athenex.com|
20509772|NCT00112840|University of Miami - Sylvester Comprehensive Cancer Center|Jaime Merchan, M.D.||jmerchan2@med.miami.edu|
20509773|NCT02875366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20509774|NCT00683774|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
20509775|NCT00514592|Umeå University|Dr Elias Johansson|+46907850000|elias.johansson@neuro.umu.se|
20509776|NCT02735044|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20509777|NCT01682759|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509778|NCT02308709|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20509779|NCT00397891|Wyeth|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509780|NCT00412113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20509781|NCT00796224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20509782|NCT04511338|Fresenius Medical Care North America|Senior Director of Statistics and Data Management|1-781-249-8216|chianghong.ho@fmc-na.com|
20509783|NCT03227224|Janssen Research & Development, LLC|SENIOR DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509784|NCT04195750|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20509785|NCT03782376|Janssen-Cilag Ltd.|Senior Director GI Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509786|NCT03219476|Medical College of Wisconsin|Lubna Chaudhary|414-805-4600|lchaudhary@mcw.edu|
20509787|NCT00360672|UT MD Anderson Cancer Center|Gautam Borthakur, M.D./Associate Professor|713-563-1586|eharriso@mdanderson.org|
20509788|NCT06535932|Philips|Sarah Bass|240-278-0838|sarah.bass@philips.com|
20509789|NCT02254304|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20509790|NCT01226472|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20509791|NCT01712776|Cleveland Clinic|Dr. Sharon E. Mace, Director of Research, ESI|(216) 445-4598|maces@ccf.org|
20509792|NCT02531633|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20509793|NCT02710422|University of Miami|Sanoj Punnen MD, MAS|305-243-6596|s.punnen@med.miami.edu|
20509794|NCT01030757|University of New Mexico|Ben Liem, MD|505-272-0086|bliem@salud.unm.edu|
20509795|NCT01952041|University of Washington School of Medicine|Dror Ben-Zeev, PhD|(206) 685-9655|dbenzeev@uw.edu|
20509796|NCT03650387|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
20509797|NCT01370499|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20509798|NCT00887822|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20528056|NCT00885378|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20509799|NCT03661983|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20509800|NCT02903966|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20509801|NCT01320033|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20528057|NCT04750278|Foresee Pharma|Chief Medical Officer|408-823-4807|yisheng.lee@foreseepharma.com|
20503854|NCT00117312|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20503855|NCT01128387|University of Wisconsin Carbone Cancer Center|Dr. Mark Ritter|608-263-8500|ritter@humonc.wisc.edu|
20503856|NCT01021111|Stanford University|Professor Thomas P. Andriacchi|6507238024|tandriac@stanford.edu|
20503857|NCT01535235|Medical College of Wisconsin|Dr. Leslie Cockerham|414-805-0738|lcockerham@mcw.edu|
20503858|NCT02696083|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
20503859|NCT00824421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503860|NCT02704104|Arch Therapeutics, Inc|Medical/Scientific Affairs|617 431-2313|jprats@archtherapeutics.com|
20503861|NCT05089708|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20503862|NCT02120417|Incyte Corporation|Study Director|855 463-3463||
20503863|NCT00927485|University of Puerto Rico Medical Sciences Campus|Dr. Marcia Cruz-Correa|787-758-2525|marcia.cruz1@upr.edu|1722
20503864|NCT00594399|Durham VA Medical Center (GRECC/HSRD)|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
20503865|NCT01440101|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20503866|NCT00659438|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20503867|NCT00046566|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|5049885165|jhe@tulane.edu|504
20536586|NCT02727816|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
20503868|NCT01491945|Endologix|Sripad Bellary, Director of Clinical Affairs|9257011628|sbellary@endologix.com|
20503869|NCT02700451|HospitalSS|Catherine Himo Gang|917-260-4603|gangh@HSS.EDU|
20503870|NCT01852084|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20503871|NCT01578902|Sunnybrook Research Institute|Dr Andrew Loblaw, Director GU Radiation Trials|4164804806|andrew.loblaw@sunnybrook.ca|
20503872|NCT00404092|University of Cologne|Oliver A. Cornely|+49 221 478 6494|Oliver.Cornely@zks-koeln.de|
20503873|NCT01511445|Amedica Corporation|Sonny Bal, MD|(573) 808-4512|SBal@amedica.com|
20503874|NCT02658461|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20503875|NCT02344576|University of Colorado School of Medicine|Dr. Larry Allen, Principal Investigator|303-724-4713|larry.allen@ucdenver.edu|
20503876|NCT01271686|University of California, San Diego|Dr. John Liu|858 534-7056|joliu@ucsd.edu|
20503877|NCT04233424|PolyPid|Clinical Development Manager|+972-74-7195700|olga.b@polypid.com|
20536587|NCT00255723|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
20536588|NCT02749201|maimonides medical center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
20536589|NCT03711370|California Polytechnic State University|Dr. Alison Ventura|(805) 756-5693|akventur@calpoly.edu|
20558424|NCT05879198|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
20558425|NCT03813147|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20503878|NCT04325503|Unversity of Michigan|Nicolaas Bohnen|734-998-8400|nbohnen@umich.edu|
20503879|NCT02337387|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20503880|NCT01856114|UT MD Anderson Cancer Center|Dr. David Hui, MD, Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
20503881|NCT02853760|University of Innsbruck, Department of Sport Science|Martin Niedermeier||martin.niedermeier@uibk.ac.at|
20503882|NCT01642212|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20503883|NCT00981526|UMass Medical School|Dr. Xiaoduo Fan|508-856-3881|xiaoduo.fan@umassmed.edu|
20503884|NCT01243268|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503885|NCT02272790|AstraZeneca|Pejvack Motlagh, MD|+44 (0) 7384 799 850|pejvack.motlagh@astrazeneca.com|
20503886|NCT00702143|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20503887|NCT02793544|National Marrow Donor Program/BeTheMatch|Steve Spellman|763-406-8334|sspellma@nmdp.org|
20503888|NCT04174599|Evivebiotech|Catrina Wang|021-61760866|catrina.wang@evivebiotech.com|
20503889|NCT00752986|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20503890|NCT02382133|Barnes-Jewish Hospital|Dr. Marilyn Schallom|314-286-0835|marilyn.schallom@bjc.org|
20503891|NCT00000479|Brigham and Women's Hospital|Julie E. Buring|617 732 4965|jburing@rics.bwh.harvard.edu|
20503892|NCT00045032|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20503893|NCT02582658|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20503894|NCT01841632|University Hospital Regensburg|Prof. Dr. Marc-H. Dahlke, Ph. D.|+49941944|marc.dahlke@ukr.de|6809
20503895|NCT04068103|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20503896|NCT03277196|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20503897|NCT02101437|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
20503898|NCT00745030|Northwestern University|Angelica Marconi|312-503-1999|a-marconi@northwestern.edu|
20503899|NCT00473694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503900|NCT03285529|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
20503901|NCT02468193|Novartis PharmaCeuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20503902|NCT00742781|Pennsylvania State University|Dr. Margherita Cantorna|814-863-2819|mxc69@psu.edu|
20503903|NCT04101890|Children's Research Institute|Elena Gibson|(202) 476-6877|egibson@cnmc.org|
20503904|NCT03109951|International St. Mary's Hospital, Catholic Kwandong University|Myong Ki Baeg|82-10-6391-9010|baegmk@gmail.com|
20503905|NCT04723537|RedHill Biopharma Ltd.|Gilead Raday, COO|+972-(0)3-541-3131|info@redhillbio.com|
20503906|NCT02513940|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@iu.edu|
20503907|NCT04645797|Apros Therapeutics|Tom Wu, PhD|+1-858-284-8839|tom_wu@aprostx.com|
20503908|NCT00089128|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20503909|NCT03424109|NYU Langone Health|Allison Cuthel|212-263-8631|Allison.Cuthel@nyulangone.org|
20503910|NCT00942409|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
20503911|NCT02015819|City of Hope Medical Center|Dr. Jana Portnow|6262189200|jportnow@coh.org|
20503912|NCT01464697|University of British Columbia|Dr. Jerilynn C. Prior, Professor|6048755927|jerilynn.prior@ubc.ca|
20503913|NCT01697215|Cleveland Clinic Foundation|Adriano Tonelli, MD|216-444-0812|tonella@ccf.org|
20503914|NCT02599402|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20503915|NCT03431012|KCL|Dr D D'Antoni||donatella.d'antoni@kcl.ac.uk|
20503916|NCT05340504|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
20503917|NCT03068715|Stanford University|Dr. Nolan Williams|(650)800-6920|nolanw@stanford.edu|
20503918|NCT03932240|Emory University|Laura Downey, MD|404-785-6670|laura.ansley.downey@emory.edu|
20503919|NCT02499952|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20503920|NCT02286102|Hospital for Special Surgery|Oheneba Boachie-Adjei, MD|212 606-1723|rosst@hss.edu|
20503921|NCT03830281|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20503922|NCT00410891|Stanford|Professor|6504984791|cta@stanford.edu|
20503923|NCT00201851|International Breast Cancer Research Foundation|Richard R. Love|608-698-7881|richardibcrf@gmail.com|
20503924|NCT03293680|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20503925|NCT00922935|Straumann|Kristina Espemar Holst, Senior Clinical Trial Manager|+41 61 965 11 11|info@straumann.com|
20503926|NCT02201940|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20503927|NCT00636818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20503928|NCT01119040|University Hospitals Case Medical Center|Jeffrey Marks, MD/Principal Investigator|216-983-4930|jeffrey.marks@UHhospitals.org|
20503929|NCT00074958|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20558426|NCT01693692|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20503930|NCT04898166|Jinnah postgraduate medical centre|Syeda Mahanum Ali|03033901112|mahanumsyed8@gmail.com|
20503931|NCT01894672|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman MD|646-888-4162|chapmanp@MSKCC.ORG|
20503932|NCT02690701|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|Novartis.email@novartis.com|
20503933|NCT02115308|Cardiovascular Imaging Technologies, LLC|Joseph Soltys, PhD|816-531-2842|jsoltys@cvit.com|103
20503934|NCT00749203|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-241-1563|adriana.feder@mssm.edu|
20503935|NCT02698189|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503936|NCT02319369|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20503937|NCT01564784|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503938|NCT01624142|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20503939|NCT01053429|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503940|NCT00947349|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503941|NCT03430310|The University of Alabama at Birmingham|Barbara Gower, PhD|205-934-4087|bgower@uab.edu|
20503942|NCT01446809|University of Washington|Dr Darin Davidson|206-543-3690|djdavi@uw.edu|
20503943|NCT01331161|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20503944|NCT03972488|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20503945|NCT02730546|Mayo Clinic|Harry H Yoon MD MHS|507-284-2511|yoon.harry@mayo.edu|
20503946|NCT04984889|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20503947|NCT02770807|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
20503948|NCT04907045|Kaiser Permanente Washington Health Research Institute|Joseph E Glass, PhD|206-287-4266|joseph.e.glass@kp.org|
20503949|NCT00222105|University of Kansas Medical Center|Cancer Center Clinical Trials Office|(913) 945-5059|SWILLIAM@kumc.edu|
20503950|NCT00374556|Johns Hopkins University School of Medicine|Michael Smith, PhD, Associate Professor of Psychiatry, Director of Behavioral Medicine|410-550-7000|msmith62@jhmi.edu|
20503951|NCT01416181|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20503952|NCT03874234|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20503953|NCT00430040|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
20503954|NCT01896232|Amgen Inc.|Study Director|866-572-6436||
20503955|NCT02983058|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-8436|marlene.carlson@nyspi.columbia.edu|
20503956|NCT00852644|Boston Medical Center|Minh Tam Truong|617-638-7070|minh-tam.truong@bmc.org|
20503957|NCT01583647|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503958|NCT03816995|The Cleveland Clinic|Rita Brienza|216-399-9186|brienzr@ccf.org|
20503959|NCT00541307|W. L. Gore & Associates, Inc.|Chad Badorek|928/437-8181|cbadorek@wlgore.com|
20503960|NCT01324830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20503961|NCT01485614|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20503962|NCT00733902|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503963|NCT02210780|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20503964|NCT03537664|University of Sao Paulo|Dr. Ericka Pinheiro|551126488293|erickapinheiro@usp.br|
20503965|NCT02872103|Generon|Jianmin Chen|7327100262|jianmin_chen@generonbiomed.com|
20503966|NCT03617926|Oystershell Laboratories|Frank Eertmans|+3293772485|fe@oystershell.be|
20503967|NCT01503021|Rockwell Medical, Inc|Senior Director, Clinical Research|248-960-9009|rd@rockwellmed.com|
20503968|NCT03941548|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20503969|NCT02081963|Department of Respiratory Medicine, Qilu Hospital of Shandong University|Dr.Yu Li|13791122770|qlliyu@163.com|
20503970|NCT01242111|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
20503971|NCT00870688|Desitin|Lohmueller|0049(0)40-59101|lohmueller@desitin.de|373
20503972|NCT00987415|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
20503973|NCT01929083|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@purdue.edu|
20503974|NCT02945657|Medimetriks Pharmaceuticals, Inc.|Director of Clinical Development|973-882-7512|clinicaltrials.gov_inquiries@medimetriks.com|524
20503975|NCT01591005|University Hospital Ostrava|Prof. David Skoloudik, MD, Ph.D.|+420597375613|skoloudik@hotmail.com|
20503976|NCT01075087|Northwestern University|Gildasio De Oliveira MD,MS|312-472-3573|g-jr@northwestern.edu|
20503977|NCT00087438|Radition Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
20503978|NCT01486264|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20503979|NCT00283387|Mayo Clinic|Dr. Dawn S. Milliner|507-284-7431|milliner.dawn@mayo.edu|
20503980|NCT03182738|Columbia University School of Nursing|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
20503981|NCT03584009|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20503982|NCT03102411|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
20503983|NCT01588821|Massachusetts General Hospital|Rebecca Suk Heist, MD|617-724-4000|rheist@partners.org|
20503984|NCT00509106|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
20503985|NCT03527043|Weill Cornell Medicine|Jonathan Gal|646-962-4811|jog4018@med.cornell.edu|
20550914|NCT00487747|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20550915|NCT00456547|Northwestern University Feinberg School of Medicine|Dr. Robert J McCarthy, Pharm D|312-926-9015|r-mccarthy@northwestern.edu|
20550916|NCT01359449|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20550917|NCT00330564|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
20550918|NCT02979522|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20550919|NCT01660698|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
20503986|NCT01697332|Brigham and Women's Hospital|Samuel Patz|6172780616|patz@bwh.harvard.edu|
20503987|NCT02039947|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
20503988|NCT01772134|GlaxoSmithKline|GSK Response Center|866-435-7343||
20550920|NCT00429104|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD.PhD./Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
20503989|NCT02500550|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
20503990|NCT03124069|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
20503991|NCT01309737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20503992|NCT03119649|Galapagos NV|Evelyn Fox|0032 15 34 29 00|evelyn.fox@glpg.com|
20503993|NCT00463437|GlaxoSmithKline|GSK Response Center|866-435-7343||
20503994|NCT01073943|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20503995|NCT05300087|Intech Biopharm Ltd.|Sabina Chien|+886-2-7721-8877|sabina.i198@intechbiopharm.com|631
20503996|NCT00761215|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
20503997|NCT05662332|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
20509802|NCT02045979|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509803|NCT00963469|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509804|NCT00585104|University of Utah Health Sciences Center|Andrew D. Michaels, MD|(801) 585-5971|Andrew.Michaels@hsc.utah.edu|
20509805|NCT00782756|Memorial Sloan Kettering Cancer Center|Dr. Philip Gutin|212-639-8556|gutinp@mskcc.org|
20509806|NCT03057106|Canadian Cancer Trials Group|Dr. Keyue Ding|1-613-533-6430|kding@ctg.queensu.ca|77705
20509807|NCT00354484|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20509808|NCT00378534|NIH NHLBI OCD DIR ORIC|Sara Hauffe, RN Protocol Liaison|301-827-2720|sara.hauffe@nih.gov|
20509809|NCT03261037|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20509810|NCT04423718|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20509811|NCT03381274|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20509812|NCT04284787|Yale School of Medicine|Amer Zeidan, MBBS Professor of Internal Medicine (Hematology)|(203) 200-4363|amer.zeidan@yale.edu|
20509813|NCT01874353|AstraZeneca|Global Clinical Program Lead|1-877-240-9479|information.center@astrazeneca.com|
20509814|NCT00911183|Institut Bergonié|Pr Pierre Soubeyran|33(0)556333333|p.soubeyran@bordeaux.unicancer.fr|
20509815|NCT04228276|Palo Alto VA|Dr. Jong Yoon|6504935000|jong.yoon@va.gov|
20509816|NCT03825536|University of California, San Francisco|Sulggi A. Lee|415-735-5127|sulggi.lee@ucsf.edu|
20509817|NCT06085443|YSLAB|Mélody DUTOT|33 (0)2.98.53.30.03|melody.dutot@yslab.fr|
20509818|NCT05298774|Yale University|Dr. Ira Leeds|(203)785-2616|ira.leeds@yale.edu|
20509819|NCT04992507|The Ohio State University Comprehensive Cancer Center|Dr. Aslam Ejaz|614-293-7171|aejaz@uic.edu|
20509820|NCT00081263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
20509821|NCT01852591|H. Lee Moffitt Cancer Center and Research Institute|Frederick Locke, M.D.|813-745-3509|frederick.locke@moffitt.org|
20509822|NCT01996865|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20509823|NCT04571684|University of Kansas Medical Center|Principal Investigator|913-945-7709|skessler2@kumc.edu|
20509824|NCT04732780|Imperial College London|Dr Vicky McKechnie|02083830689|vicky.mckechnie@nhs.net|
20509825|NCT01947894|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509826|NCT03796195|Northwestern University|David Walega, MD|3126952500|d-walega@northwestern.edu|
20509827|NCT00062647|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20509828|NCT02470429|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
20509829|NCT00804986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550921|NCT01907815|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD, Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20550922|NCT02151253|Duke University Health System|Andrew D. Krystal, MD, MS|919-971-4355|andrew.krystal@duke.edu|
20550923|NCT02485574|Chung-Ang University hospital|Kwang-Sup Song|+82-1037616503|ksong70@cau.ac.kr|
20528058|NCT01523834|Azienda Sanitaria Universitaria Integrata di Udine (A.S.U.I. Udine) - SOC Clinica Ematologica|Dr. Francesco Zaja, Co-Investigator of the Study|+39 0432559604|francesco.zaja@asuiud.sanita.fvg.it|
20528059|NCT03231397|Washington University School of Medicine|Dr. Sean J. English|(314) 362-5707|sjenglish@wustl.edu|
20528060|NCT04076319|USC Suzanne Dworak-Peck School of Social Work|Dr. Benjamin Henwood|+1 (213) 821-0496|bhenwood@usc.edu|
20528061|NCT03252145|University of California, San Francisco|Betty Smoot, DPTSc, PT|(707) 494-8262|Betty.Smoot@ucsf.edu|
20528062|NCT03504189|Nuvo Group|VP Clinical|+972-3-6242266|adar.shani@nuvocares.com|1630
20528063|NCT00950729|Centre hospitalier universitaire de Sherbrooke (CHUS)|François Cabana|1-819-346-1110|francois.cabana@usherbrooke.ca|14233
20528064|NCT01441245|Department of Internal Medicine, University of Siena, Le Scotte hospital, Siena, Italy|Alberto Palazzuoli MD, Cardiology Unit|+39577585363|palazzuoli2@unisi.it|
20528065|NCT02665741|University of California, Davis|Dr. Sooraj Tejaswi|916-734-7215|stejaswi@ucdavis.edu|
20528066|NCT01267929|Postgraduate Studied Program, faculty of medicine, Thammasat University|Miss Namfon Mahasup|+66 867733596|namfon_pt@yahoo.com|
20528067|NCT02626000|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20528068|NCT04727528|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20528069|NCT00576524|Children's Hospital of Philadelphia|Marsha Wallace|(215) 590-0119|wallacem@email.chop.edu|
20528070|NCT01662856|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
20528071|NCT01393522|Mercy Health Research|Timothy R. Smith, MD|314-251-8895|Timothy.Smith@mercy.net|
20528072|NCT01515566|University of Texas MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC / Asst. Professor, Palliative Care and Rehabilitation Medicine|713-792-6085|CR_Study_Registration@mdanderson.org|
20528073|NCT02085070|Yale Cancer Center|Director, Clinical Trials Office|12037372572|Joyce.Tull@yale.edu|
20528074|NCT01796301|Amgen Inc.|Study Director|866-572-6436||
20503998|NCT00667277|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|(212) 241-2297|ronald.hoffman@mssm.edu|
20503999|NCT03248128|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20504000|NCT01914679|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
20504001|NCT01696357|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
20504002|NCT01363050|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
20504003|NCT01126580|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20504004|NCT04109599|play2PREVENT Lab, Yale Center for Health and Learning Games, Department of Internal Medicine|Tyra Pendergrass Boomer, Deputy Director of Programs and Partnerships|+1 (203) 737-6101|tyra.pendergrass@yale.edu|
20504005|NCT01731002|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20504006|NCT00803114|University of Toronto|Dr. Alison Macarthur|416 586 4800|alison.macarthur@uhn.on.ca|6632
20504007|NCT00538681|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20504008|NCT03040154|Children's Hospital Los Angeles|Joyce R. Javier, MD, MPH, MS|(323)669-2113|jojavier@chla.usc.edu|
20504009|NCT02581995|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20504010|NCT01491958|The Ohio State University Comprehensive Cancer Center|Yvonne Efebera, M.D|614-293-3196|Yvonne.Efebera@osumc.edu|
20504011|NCT01385696|Almirall S.A.|Clinical Project Leader and Trial Manager|+34 93 291 3200||
20504012|NCT01695369|University of Houston, College of Optometry, TERTC|Jan Bergmanson, OD,PhD|713-743-1950|jbergmanson@uh.edu|
20504013|NCT03528681|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20504014|NCT01195025|University Hospital Linköping|Dr. Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
20504015|NCT01614457|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20504016|NCT03518840|Loyola University Chicago|Colleen Fitzgerald, M.D., M.S.|708-216-3380|CFITZGERALD@lumc.edu|
20504017|NCT00920309|Yale University School of Medicine|Dr. Neera Dahl|203-785-4184|neera.dahl@yale.edu|
20504018|NCT00327392|Eisai Inc|Eisai Medical Services|1-888-422-4743||
20504019|NCT03494647|Children's Hospital Colorado|Emily Sweeney, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20504020|NCT01531725|ZNA Middelheim Department Interventional Cardiology, Antwerpen, Belgium|Paul Vermeersch, MD, PhD|+32 3 280 3211|paul.vermeersch@zna.be|
20504021|NCT03723447|Cedars-Sinai|Dr Karen Zaghiyan|(310) 289-9224|kzaghiyan@yahoo.com|
20504022|NCT01854177|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
20504023|NCT00500071|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20504024|NCT01122927|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20504025|NCT02904226|Jounce Therapeutics, Inc.|Stew Kroll, Chief Development Officer|(650) 576-9679|skroll@jouncetx.com|
20504026|NCT00728416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20504027|NCT00389207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504028|NCT03348514|University of Kansas Medical Center|Dr. John A Taylor III|913-588-8170|Jtaylor27@kumc.edu|
20504029|NCT02371629|Novartis Pharmaceuticals|Study Director|862-778-8300||
20504030|NCT02700529|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
20528075|NCT00667563|AMC|Jeannette Y. Lee|5015266712|jylee@uams.edu|
20550924|NCT01214811|Molnlycke Health Care|Viktoria Ahlenius Körner|0046 31 7223000|viktoria.ahleniuskorner@molnlycke.com|
20550925|NCT00667368|University of Alabama at Birmingham|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
20550926|NCT00446290|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20550927|NCT00191789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20550928|NCT05582889|University of New Mexico|Dr. Cindy Blair|5059257907|CiBlair@salud.unm.edu|
20550929|NCT01782495|AbbVie|Global Medical Services|800-633-9110||
20550930|NCT01563003|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
20504031|NCT03502746|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
20504032|NCT05421754|Northwestern University|Shuai Xu|312-695-8106|stevexu@northwestern.edu|
20504033|NCT01051739|Iowa City Veterans Administration Medical Center|Michael Wall, M.D.|319-3380581|michael-wall@uiowa.edu|
20504034|NCT03192904|Ruijin Hospital Shanghai JiaoTong University School of Medicine|Prof. Hecheng Li, Chair of Thoracic Surgery|(86)13917113402|lihecheng2000@hotmail.com|
20504035|NCT03352245|Yale University|Dr. Brett Bade|203 785 6670|Brett.bade@yale.edu|
20504036|NCT01023789|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
20504037|NCT02533089|Li Ka Shing knowledge institute|Dr. L M Puchalski Ritchie|416 864 6060|lisa.puchalskiritchie@utoronto.ca|
20504038|NCT00095563|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
20504039|NCT03322358|University of Pennsylvania|Heather Schofield|617-233-4775|hschof@wharton.upenn.edu|
20504040|NCT02034123|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20504041|NCT00246259|Janssen Inc., Toronto, ON, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
20504042|NCT02240706|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504043|NCT03022461|Abbott|Poornima Sood|+17818528334|poornima.sood@abbott.com|
20504044|NCT01076179|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20504045|NCT03459040|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-6021|john.levine@mssm.edu|
20504046|NCT00986349|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
20504047|NCT02299934|University of Colorado, Denver|Dr. Samuel Chang|720-848-1875|SAMUEL.CHANG@UCDENVER.EDU|
20504048|NCT03815175|Abbott|Lijuan Jenn Wang|01-408-8453133|Lijuan.wang1@abbott.com|
20504049|NCT03577990|The University of North Carolina at Charlotte|Willie M. Abel, Associate Professor of Nursing|704-687-7949|wmabel@uncc.edu|
20504050|NCT00551707|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
20504051|NCT00488631|Janssen Research & Development|Senior Director|215-793-7540||
20504052|NCT01696461|National Marrow Donor Program/BeTheMatch|Dr. Steven Devine|7634068239|sdevine2@nmdp.org|
20504053|NCT05369806|University of Washington|Keshet Ronen|2065854363|keshet@uw.edu|
20504054|NCT00628355|Ribeirao Preto Medical School - University of Sao Paulo|Omero Benedicto Poli Neto|551636023183|polineto@fmrp.usp.br|
20504055|NCT00140855|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20504056|NCT01815957|UNewMexico|Bina Ahmed|505-272-7028|hkhawaja@salud.unm.edu|
20528076|NCT01041274|NYU Langone Medical Center|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
20504057|NCT03072602|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|12059754720|parora@uabmc.edu|
20504058|NCT03912584|Optos|Michael Sinai, PhD|+1 800 854 3039|MSinai@optos.com|1495
20504059|NCT01236391|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
20504060|NCT03542682|Yale School of Medicine|Laura Marie Nally, MD|(877) 925-3637|laura.nally@yale.edu|
20504061|NCT04321343|POXEL|Director, Medical Operations|+33 (0)4 37 37 20 10|carole.thang@poxelpharma.com|
20504062|NCT02871479|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@satalispharma.com|101
20504063|NCT01212445|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20504064|NCT00843986|Astellas Pharma Global Development|Medical Director||clinicaltrials@us.astellas.com|
20504065|NCT04865731|University of Texas Health Science Center at San Antonio|Dr. Shraddha Dalwadi|210-567-1203|dalwadi@uthscsa.edu|
20504066|NCT01075347|Natinal Taiwan University Hospital|We-Li Chen , MD|886-2-2356|chenweili@ntu.edu.tw|5206
20504067|NCT04909463|CommonSpiritHealth|Trenton Bradbury|7193730213|trenton_b1@yahoo.com|
20504068|NCT01672892|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20504069|NCT01419171|Peter Maurer, Director Clinical Trials|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
20504070|NCT01612793|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20528077|NCT02985021|VA Puget Sound HCS|Dr. Bruce Montgomery, PI|2062776878|rbmontgo@uw.edu|
20528078|NCT01951573|Alcon Research, Ltd.|Mary Fahmy, Head, Clinical Development, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20528079|NCT04399889|Duke University|Emily Poehlein, MB|919-668-8473|emily.poehlein@duke.edu|
20528080|NCT00707980|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20528081|NCT01537835|Denver Health and Hospital Authority|Marisha Burden, MD|303-602-5011|Marisha.Burden@dhha.org|
20528082|NCT01152996|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20528083|NCT02163681|University of Missouri|Talissa Altes, MD|573-882-1026|altest@health.missouri.edu|
20528084|NCT03077607|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528085|NCT00460239|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
20528086|NCT02455453|Washington University School of Medicine|Farrokh Dehdashti, M.D.|314-747-1604|dehdashtif@wustl.edu|
20558427|NCT02805595|Beth Israel Deaconess Medical Center|Martina Porter - Associate Directory of Dermatology Research|6176675834|mporter3@bidmc.harvard.edu|
20558428|NCT02906683|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3293-2455|toiawase@taiho.co.jp|
20528087|NCT03610334|Inflectis Bioscience|Dr Anne Visbecq (Chief Medical Officer)|0630632020|annevisbecq@inflectisbioscience.com|33
20528088|NCT00760487|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20558429|NCT04934137|University of Texas Medical Branch|Dr. Melissa Morrow|409-266-0344|memorrow@utmb.edu|
20504071|NCT00875420|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
20504072|NCT00886821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528089|NCT04957212|Cinnagen Co.|Dr.Nasim Anjidani|0989125477964|anjidani.n@orchidpharmed.com|
20504073|NCT00914628|AGC Biologics S.p.A|Anna Stornaiuolo|00390221277440|astornaiuolo@agcbio.com|
20504074|NCT03311126|University of Wisconsin Carbone Cancer Center|Julie Chang, MD|(608) 263-9823|jc2@medicine.wisc.edu|
20504075|NCT00942162|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504076|NCT02833311|Case Western Reserve University|Matthew Plow, Ph.D.|216-368-8969|map208@case.edu|
20504077|NCT01006356|Medical department / Korea|Medical Director|+82-2-2094-4518||
20504078|NCT01670201|Harborview Medical Center / Seattle, Washington|Dr Nicole Gibran|206-744-3140|nicoleg@uw.edu|
20504079|NCT01756157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20558430|NCT01167179|Radboud University Nijmegen Medical Center|Jacqueline de Leeuw MSc|+31243614925|j.deleeuw@kno.umcn.nl|
20558431|NCT00663117|Pennsylvania State University, College of Medicine Hershey, PA 17033|Jill P Smith, MD Professor of Medicine, Gastroenterology Division|717-531-3694|jsmith2@psu.edu|
20558432|NCT01158378|HyperBranch Medical Technology, Inc|Michael Carnahan, PhD|919-433-3329|michaelc@hyperbranch.com|
20558433|NCT02769065|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20504080|NCT01623466|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
20504081|NCT02799381|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20504082|NCT03368859|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20558434|NCT03017235|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DKO-Disclosure@ferring.com|
20504083|NCT02698410|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
20504084|NCT01713348|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
20504085|NCT02638012|St. Michael's Hospital|Dr. John Lee|416-864-5306|John.Lee@unityhealth.to|
20528090|NCT02813473|ECRI|Ron van Amsterdam|+31102062802|RvAmsterdam@cardialysis.nl|
20528091|NCT06363292|Laboratorios Sophia|Alejandra Sanchez Rios|+ 52 33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
20528092|NCT00519584|Cleveland Clinic|K. C. Cummings III, MD|216-444-1016|cummink2@ccf.org|
20558435|NCT02326844|National Cancer Institute|Dr. Jung-Min Lee|301-443-7735|leej6@mail.nih.gov|
20558436|NCT04602494|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|aeevins@mgh.harvard.edu|
20558437|NCT02593539|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20504086|NCT01498991|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
20504087|NCT00817414|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20504088|NCT00886938|Washington University|Dr. Jay F Piccirillo|(314) 362-8641|piccirilloj@ent.wustl.edu|
20504089|NCT01552876|Johnson & Johnson Vision Care|Katherine Osborn OD, MS FAAO|1 904 443-1032|kosborn@its.jnj.com|
20504090|NCT01012661|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
20504091|NCT03806452|THERAVIA|Clinical Operation Manager|+330149709583|laura.thomas-bourgneuf@theravia.com|
20504092|NCT03872180|Emory University Hospital/Winship Cancer Institute|Dr. Jonathon Cohen|4047781900|jonathon.cohen@emory.edu|
20504093|NCT00644592|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
20504094|NCT01157117|Ichan School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
20504095|NCT01931865|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
20504096|NCT00215930|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
20504097|NCT03215277|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20504098|NCT03596164|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20504099|NCT04112914|Seattle Children's Research Institute|Dr. Emily Kroshus|206-884-5326|Emily.Kroshus@seattlechildrens.org|
20504100|NCT01120626|Stanford University|Allan Reiss, MD|650-498-4538|reiss@stanford.edu|
20504101|NCT01244737|Children's Hospital of Philadelphia|Dr. Frederick Grant|267-600-1542|grantf@chop.edu|
20504102|NCT01667848|LudwigBoltzmannIOL|Dr. Bettina Klugsberger|+43 732 7806 2133|Bettina.Klugsberger@akh.linz.at|
20504103|NCT02955329|University of California, San Francisco|Dr. Gideon St. Helen|628-206-2687|gideon.sthelen@ucsf.edu|
20504104|NCT02835495|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolinn@wakehealth.edu|
20504105|NCT01225354|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
20504106|NCT00356915|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504107|NCT04871815|Emphycorp/Cellular Sciences, inc.|Dr. Alain Martin|9082371561|dr.martin@erols.com|
20504108|NCT05614011|QuantuMDx|Alice Toomey-Smith|4408708031234|alice.toomey-smith@quantumdx.com|
20504109|NCT01740362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504110|NCT02604264|Fresenius Medical Care North America|Jeffrey L. Hymes, MD|615-567-4821|Jeffrey.HymesMD@fmc-na.com|
20504111|NCT00424398|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
20504112|NCT01523821|Fred Hutchinson Cancer Research Center|H. Joachim Deeg, MD|206-667-5985|jdeeg@fredhutch.org|
20504113|NCT02335502|St. Jude Medical|Roni Diaz|+19723098601|RDiaz@sjm.com|
20504114|NCT01442181|UF Healthcare|Dr. Thomas Beaver|352-273-5503|thomas.beaver@surgery.ufl.edu|
20504115|NCT00709202|Nathan Kline Institute for Psychiatric Research|Dr. Robert C Principal Investigator. Smith,|845-398-6531|robert.smith@nki.rfmh.org|
20504116|NCT03133767|University of Iowa|Nicholas Mohr|319-384-8285|nicholas-mohr@uiowa.edu|
20504117|NCT03301857|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20504118|NCT03664726|University at Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
20504119|NCT00855439|University of Michigan|Rodica Pop-Busui, MD, PhD|734 647-9809|rpbusui@med.umich.edu|
20504120|NCT05502289|Johnson & Johnson Vision Care, Inc. (JJVC) 7500 Centurion|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
20504121|NCT04454411|University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
20550931|NCT01973166|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20504122|NCT00477087|Stanford University Medical Center|Sandy Srinivas, MD; Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
20504123|NCT01397851|independent|Richard Sedlmayr|6468412169|richard.sedlmayr@gmail.com|
20550932|NCT02999854|Kiadis Pharma Netherlands B.V|Klaudia Traudtner, MD. Head of Safety and Pharmacovigilance.|+31 (0)20 240 52 50|k.traudtner@kiadis.com|
20550933|NCT02848651|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550934|NCT04140292|Cleveland Clinic Foundation|Maytin, Edward, V|1-866-223-8100|taussigresearch@ccf.org|
20550935|NCT01013701|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20550936|NCT00667004|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20550937|NCT01267812|City of Hope|Dr. Matthew Mei|626-359-8111|mamei@coh.org|
20550938|NCT03241342|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
20550939|NCT00556712|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20550940|NCT00848367|Ottawa Hospital Research Institute|Dr. Giorgio Tasca|1-613-737-8085|gtasca@toh.on.ca|
20550941|NCT01059799|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20550942|NCT01537029|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
20550943|NCT00849810|University of Mississippi Medical Center|Professor of Medicine|601-984-5600|DMinor@umc.edu|
20550944|NCT01962207|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550945|NCT04049123|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@llilly.com|
20550946|NCT03653637|James J. Peters VA Medical Center|Dr. Marianne Goodman|6462457071|mggoodman2001@yahoo.com|
20550947|NCT04202354|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
20550948|NCT02960776|Columbia University Irving Medical Center|Marie-Pierre St-Onge|212-305-9379|ms2554@cumc.columbia.edu|
20550949|NCT02081690|Actelion Pharmaeuticals Ltd.|Clinical Trial Disclosure Manager||clinical-trials-disclosure@actelion.com|
20550950|NCT00360828|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
20550951|NCT01346839|Michael E. DeBakey VA Medical Center and Baylor College of Medicine|Dr. Hardeep Singh|713-794-8515|hardeeps@bcm.edu|
20550952|NCT00982488|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20504124|NCT02333227|Baylor College of Medicine, Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine|Dr. Kjersti Aagaard|7137988467|aagaardt@bcm.edu|
20504125|NCT00397150|Centre for International Health, University of Bergen, Norway|Prof Thorkild Tylleskar|+47 55588562|Thorkild.Tylleskar@cih.uib.no|
20504126|NCT04375878|First Wave BioPharma Inc.|Chief Medical Officer|(561) 589 7020|info@firstwavebio.com|
20504127|NCT01982630|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20504128|NCT00561353|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20558438|NCT00437125|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20558439|NCT02248961|R-Pharm|Boris Berezhanskiy, Medical Advisor|0074959567937|berezhanskiy@rpharm.ru|2468
20558440|NCT01288781|UWalesBangor|Mr Justin Stevan Lawley|00441248382810|pepa16@bangor.ac.uk|
20504129|NCT01273818|S.B.Ankara Diskapi Yildirim Beyazit Education and Teaching Hospital|Dr.Gaye Seker|+905323360618|gayeebru@superonline.com|
20504130|NCT03934684|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20504131|NCT00256295|University of California, Irvine|Nicole Macaranas|714-456-6550|nicole.macaranas@uci.edu|
20504132|NCT00765765|Cancer Institute of New Jersey|Dr. Vassiliki Karantza|732-235-8675|karantva@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20504133|NCT01097044|Clinuvel Pharmaceuticals Limited|Dr. Dennis Wright, Acting Chief Scientific Officer|646 527 7310|Dennis.Wright@clinuvel.com|
20504134|NCT01682044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20504135|NCT01903148|Hospital de Bellvitge|Dr. Alberto Martínez Castelao|610 459 262|albertomcastelao@gmail.com|
20504136|NCT02656472|Advocate Children's Hospital|Andrew VanBergen|7086848758|andrew.vanbergen@advocatehealth.com|
20504137|NCT05405166|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20504138|NCT01386385|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
20504139|NCT01167712|NRG Oncology|Linda Gedeon for Mark Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
20504140|NCT01084252|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20504141|NCT00853632|Edwards Lifesciences|Director of Clinical Affairs|949-250-2500|Aya_Westbrook@edwards.com|
20504142|NCT04364854|Medical University of South Carolina|Principal Investigator|843-876-8311|bonilha@musc.edu|
20504143|NCT04933812|Duke University|Dr. Sarahn Wheeler|919-668-5462|sarahn.wheeler@duke.edu|
20504144|NCT04493619|Opna Bio|Kerry Inokuchi|650-204-4065|info@opnabio.com|
20504145|NCT00468715|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org|
20504146|NCT04442581|University of Washington|Madeline Jacoby|2026068246|mjacoby@seattlecca.org|
20504147|NCT03063385|University of Pennsylvania School of Nursing|Dr. Antonia M. Villarruel|2158988283|amvillar@nursing.upenn.edu|
20504148|NCT02017444|University of Birmingham|Professor Alex Sinclair|+44 121 415 9125|a.b.sinclair@bham.ac.uk|
20504149|NCT01756976|Haemonetics|Clinical Project Manager|781-356-9595|michael.dioguardi@haemonetics.com|
20504150|NCT00918723|Fred Hutchinson Cancer Research Center|Dr. Mazyar Shadman|2066675467|mshadman@fredhutch.org|206
20504151|NCT02342171|Institute of Tropical Medicine|Prof. Dr. Johan van Griensven|+3232476426|jvangriensven@itg.be|
20504152|NCT02062177|Università Vita-Salute San Raffaele|Professor Testoni Pier Alberto|+390226432756|testoni.pieralberto@hsr.it|
20504153|NCT03716726|Boston Medical Center|Patricia Kavanagh, MD|617-414-3573|Patricia.Kavanagh@bmc.org|
20504154|NCT00469079|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
20504155|NCT02981472|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20504156|NCT02189382|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20504157|NCT03952130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20504158|NCT00621023|Duke University Medical Center|Dr. Carlos de Castro|919-684-8964|decas003@mc.duke.edu|
20504159|NCT01712360|Merz North America, Inc.|Ashlee Duncan|984-222-6040|Ashlee.Duncan@merz.com|
20504160|NCT04425850|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
20504161|NCT02907944|Yale School of Medicine|David Fiellin, MD|(203) 688-5555|david.fiellin@yale.edu|
20504162|NCT02559505|University Of Rochester|Dr. Jennifer Nayak|5852767404|Jennifer_Nayak@URMC.Rochester.edu|
20504163|NCT03523585|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
20504164|NCT00698516|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504165|NCT05882890|Rahbek FYS|Cathrine Rahbek|0045 30645390|cathrinerahbek@outlook.dk|
20504166|NCT01495988|The Emmes Corporation|Damon Collie|301-251-1161|dcollie@emmes.com|
20504167|NCT00753636|Northwestern University|Dr. Tanya Simuni, MD|312-503-2970|tsimuni@nmff.org|
20558441|NCT02531295|University of California, San Francisco|Sulggi Lee, MD PhD|415-735-5127|sulggi.lee@ucsf.edu|
20558442|NCT02835443|Enspire DBS Therapy, Inc.|Director of Clinical Trials|123-456-7890|info@enspiredbs.com|
20558443|NCT02791490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558444|NCT01189890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20504168|NCT04331899|Stanford University|Dr. Prasanna Jagannathan, MD|1-650-724-5343|prasj@stanford.edu|
20504169|NCT00101361|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|
20504170|NCT01062399|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20504171|NCT02424539|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20504172|NCT00719810|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
20504173|NCT03453060|Aronora, Inc.|Norah G. Verbout, Senior Scientist and Project Manager|503-964-0250|norah.verbout@aronorabio.com|
20504174|NCT04106492|Shasqi Inc|Jose M. Mejia Oneto, MD, PhD|415-800-1376|clinicalstudies@shasqi.com|
20504175|NCT00450463|National Cancer Institute|Dr. Ravi Madan|301-480-7168|ravi_madan@nih.gov|
20528093|NCT05259917|KalVista Pharmaceuticals Ltd.|Vice President Clinical|1 (857) 999-0075|clinical@kalvista.com|
20528094|NCT00592592|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
20528095|NCT03585712|HRA Pharma|Agnes Hemon|0140337092|a.hemon@hra-pharma.com|
20528096|NCT01090141|Unknown|Tawanda Gumbo||Unknown@utsouthwestern.edu|
20528097|NCT02886884|University of Miami|Dr. Joshua M. Hare, MD|305-243-5579|jhare@med.miami.edu|
20528098|NCT01096680|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20528099|NCT02697734|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20528100|NCT02324699|Icahn School of Medicine at Mount Sinai|Dr. Bruce Sands|212-241-8100|bruce.sands@mssm.edu|
20528101|NCT03970200|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20558445|NCT00871819|Boston Scientific|Nitzan Mekel-Bobrov, Ph.D.|(661) 949-4537|Nitzan.Mekel-Bobrov@bsci.com|
20558446|NCT05197257|University of Colorado|Dr. Bennett Chin|720-848-0000|Bennett.Chin@cuanschutz.edu|
20528102|NCT01607346|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528103|NCT01098162|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20528104|NCT01605825|Acorda Therapeutics, Inc.|Study Director|914-347-4300||
20528105|NCT00830518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20528106|NCT04333225|Baylor Scott & White Research Institute|Peter A. McCullough, MD, MPH|2148412000|peteramccullough@gmail.com|
20528107|NCT00494221|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20528108|NCT00583102|University of Iowa|Raymond Hohl, MD|319-356-8110|rhohl@pennstatehealth.psu.edu|
20528109|NCT01994902|Coloplast A/S|Medical Director|+45 49111395|dkbir@coloplast.com|
20528110|NCT00182000|Massachusetts General Hospital|Sabine Wilhelm, PhD|6177246146|swilhelm@partners.org|
20528111|NCT03951753|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20528112|NCT04633291|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
20528113|NCT01905592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20528114|NCT01483599|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20528115|NCT01142947|Center for Individualized and Genomic Medicine Research, Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|kwillia5@hfhs.org|
20528116|NCT03630705|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20528117|NCT01128400|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
20528118|NCT02362425|National Institute of Nursing|Katherine Meileur Chief, Neuromuscular Symptoms Unit|301-435-1503|meilleurk@mail.nih.gov|
20528119|NCT00596453|Johns Hopkins Medical Institutions|Misop Han, M.D.|410-502-7454|mhan1@jhmi.edu|
20528120|NCT03417752|VA Center of Excellence for Suicide Prevention|Elizabeth Karras, PhD|585-393-7285|elizabeth.karras-pilato@va.gov|
20528121|NCT02771860|University Gent|Prof. dr. Ruth Wittoek|+3293322522|anuschka.vandenbogaert@uzgent.be|
20528122|NCT00314808|Duke University|Deborah H. Allen, MSN, RN, CNS, FNP-BC, AOCNP|(919) 681-4719|allen079@mc.duke.edu|
20528123|NCT04304508|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20528124|NCT00699400|EMD Serono, Inc.|Mary C. Mahony, PhD, HCLD (AAB)|781.681.2438|mary.mahony@emdserono.com|
20528125|NCT02688764|Vifor Fresenius Medical Care Renal Pharma France|Milica Enoiu / Clinical Research Manager|+41588518264|milica.enoiu@viforpharma.com|
20558447|NCT02802319|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
20528126|NCT02113007|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
20528127|NCT01775787|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
20528128|NCT01299896|Vanderbilt University|Dr. Hilary A. Tindle|615-875-9726|hilary.tindle@vanderbilt.edu|
20558448|NCT04651114|University of Michigan|Dr. Claire Kalpakjian|734-763-0153|clairez@umich.edu|
20509830|NCT00959699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20509831|NCT03887286|University of Miami|Mary Sokoloski|305 585-6683|msokoloski@med.miami.edu|
20509832|NCT01885104|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509833|NCT01976624|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
20509834|NCT01895634|Johnson & Johnson K.K. Medical Company|Depertment Chief, Clinical Operation|+81-3-4411-6789|yikeda5@its.jnj.com|
20509835|NCT03325010|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20509836|NCT00926263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509837|NCT04350372|Abbott Structural Heart|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
20509838|NCT03398824|Boston Children's Hospital|Akiko Shimamura|617-919-6946|akiko.shimamura@childrens.harvard.edu|
20509839|NCT05307523|University of Washington|Reham A. Abuatiq, Research coordinator and a PhD candidate|6198309638|rabuat@uw.edu|
20509840|NCT04412668|aTyR Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
20509841|NCT00102804|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20509842|NCT02094664|UCLA Mattel Children's Hospital|Dr. Diana Chen|3108255930|dychen@mednet.ucla.edu|
20509843|NCT03864627|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20509844|NCT03595176|Shockwave Medical|Randee Randoll|408.577.7856|rrandoll@shockwavemedical.com|
20509845|NCT04673630|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20509846|NCT00864123|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
20509847|NCT03374891|"University of Colorado Denver | Anschutz"|Daniel Matlock, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20509848|NCT01201967|Massachusetts General Hospital|Jeff C. Huffman, MD|6177242910|jhuffman@partners.org|
20509849|NCT02058251|Medical University of South Carolina|Dr. Sudie Back|843-792-5915|backs@musc.edu|
20509850|NCT01190020|University of Iowa|Robert Summers, MD|319-356-2130|robert-summers@uiowa.edu|
20509851|NCT02116361|Allergan, Inc|Arlene Lum, PMP|714-246-5548|lum_arlene@allergan.com|
20509852|NCT02497287|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509853|NCT02659098|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509854|NCT04363944|University at Buffalo|Dr. Jeanne Langan|17168292905|jlangan@buffalo.edu|
20509855|NCT03517722|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH GI.|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509856|NCT02422186|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20509857|NCT03074318|Northwestern University|Seth Pollack, MD, Director of Sarcoma Program|312-503-5320|seth.pollack@northwestern.edu|
20509858|NCT01425307|The University of Texas School of Public Health|Barry Robert Davis|713-500-9515|barry.r.davis@uth.tmc.edu|
20509859|NCT00952419|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20509860|NCT03649815|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
20509861|NCT03573804|Dartmouth-Hitchcock|Timothy B Rooney, MD, PI|603-650-5000|timothy.b.rooney@hitchcock.org|
20509862|NCT02608099|Baim Institute for Clinical Research|Director of Trial Design and Development|617-307-5200|TrialDesignandDevelopmentStaff@baiminstitute.org|
20509863|NCT03770689|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20509864|NCT03040479|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20509865|NCT01736176|AbbVie|Global Medical Services|800-633-9110||
20509866|NCT00417248|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20509867|NCT05815758|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20509868|NCT00934791|Mayo Clinic|Dr. Patrick G. Dean|507-266-6953|dean.patrick2@mayo.edu|
20509869|NCT02353806|University of Texas Southwestern Medical Center|Jamie Morgan, MD|214-645-3838|jamie.morgan@utsouthwestern.edu|2147665011
20509870|NCT02425891|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20509871|NCT01654224|University of Pittsburgh|David Nace, MD, MPH|412 692-2366|naceda@upmc.edu|
20509872|NCT02145429|University of Pittsburgh|Charles F. Reynolds, MD|(412) 246-6414|reynoldscf@upmc.edu|
20509873|NCT03139435|Wake Forest Baptist Comprehensive Cancer Center|Roy Strowd|336-713-5440|rstrowd@wakehealth.edu|
20509874|NCT00608491|Duke University|Jenny Ibarra|9192363291|jenny.ibarra@duke.edu|
20509875|NCT00515099|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20509876|NCT00592072|Yale School of Medicine|Dr Robert Sherwin|203-785-6222|robert.sherwin@yale.edu|
20509877|NCT03369704|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20509878|NCT05333289|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20509879|NCT03148899|Medical Faculty Associates at The George Washington University|Dr. Vivek Jain|202-741-2676|vjain@mfa.gwu.edu|
20509880|NCT02010567|UNC Lineberger|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20509881|NCT00118040|University of Wisconsin|Howard H. Bailey, M.D.|608-263-8624|hhbailey@wisc.edu|
20509882|NCT02750501|Alcresta Therapeutics, Inc.|"Madhumalli (Molly) Sarkar, MD, PhD, Head of Clinical Development"|617 431 8866|msarkar@alcresta.com|
20509883|NCT03685643|University of Hong Kong|Dr Wong Chi Wai William|(852) 2518-5650|wongwcw@hku.hk|
20509884|NCT01738594|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@nm.org|
20509885|NCT03797144|Medtronic|Clinical Research Specialist|+39 3450225929|francesca.molineris@medtronic.com|
20509886|NCT00403390|Children's Hospital Boston|Jeremi Carswell, MD|617-355-7476|Jeremi.Carswell@childrens.harvard.edu|
20509887|NCT04430036|University of Texas Health Science Center at San Antonio|Robert Svatek, MD|210-567-5643|svatek@uthscsa.edu|
20509888|NCT01842334|Beth Israel Deaconess Medical Center|Dr. Kevin P Hill, Director of the Division of Addiction Psychiatry|617-667-1504|khill1@bidmc.harvard.edu|
20528129|NCT04474054|FARAPULSE|Christopher (Kit) Schneider|617-686-7661|christopher.schneider@bsci.com|
20528130|NCT05725824|University of Arizona|Dr. Bryan Wong|5206268549|bryanwong@arizona.edu|
20528131|NCT01502956|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20504176|NCT04893265|University of California San Francisco|Janice Tsoh, PhD, Professor/ Principal Investigator|4155028438|janice.tsoh@ucsf.edu|
20504177|NCT02523586|Oregon Health and Science University|Jeffrey Kirsch|503-494-9000|kirschje@ohsu.edu|
20504178|NCT00573131|Boston Scientific Corporation|Jessie Stockwell|1-612-618-1136|jessie.stockwell@bsci.com|
20504179|NCT03090191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504180|NCT01251575|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
20504181|NCT01845025|Novartis Pharmaceuticals|Study Director|862-778-8300||
20504182|NCT03102736|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-585-1640|james.murrough@mssm.edu|
20504183|NCT01973283|New York State Psychiatric Institute|Patrick J Brown|646-774-8666|patrick.brown@nyspi.columbia.edu|
20504184|NCT01126619|Abbott|Global Medical Services|800-633-9110||
20504185|NCT00947154|Stanford Medical Center, Department of Psychiatry|Matthew White, M.D., clinical assistant professor|650 725-5598|mpwhite@stanford.edu|
20504186|NCT01315574|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|
20504187|NCT00900796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504188|NCT03981029|Ottawa Hospital Research Institute|Alysha Harvey|613-737-8899|alyharvey@ohri.ca|73838
20504189|NCT01049776|Illinois CancerCare, P.C.|Sachdev Thomas, M.D.|309-243-3000|sthomas@illinoiscancercare.com|
20504190|NCT01602731|VA Loma Linda Healthcare System|Dr. Helme Silvet, cardiologist|9095836097|helme.silvet@va.gov|
20504191|NCT03014648|UPMC Hillman Cancer Center|Barbara M Stadterman, Regulatory Supervisor, Clinical Research Services|412-647-5554|stadtermanbm@upmc.edu|
20504192|NCT00749606|SUNY Upstate Medical University|Ruth S. Weinstock MD PhD|315-464-5740|weinstor@upstate.edu|
20504193|NCT01829048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504194|NCT01121406|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504195|NCT00504257|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, Principal Investigator|813-745-8478|robert.wenham@moffitt.org|
20504196|NCT01961531|BrUOG- Brown University Oncology Research Group|Jaroslaw Hepel, MD|401-863-3000|BrUOG@brown.edu|
20504197|NCT00716443|Galderma Laboratories, L.P.|Ron W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20504198|NCT02750410|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20504199|NCT02504541|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
20504200|NCT00759577|New York University|Dr. Victor Nitti|646 825 6300|Victor.Nitti@NYUMC.org|
20504201|NCT04249882|University of California Los Angeles|Dr. Lara Ray|310-206-6756|lararay@psych.ucla.edu|
20504202|NCT02176486|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20504203|NCT00651040|Rheumatology Institute Prague|Rheumatology Institute Prague|+420234075111|vencovsky@revma.cz|
20504204|NCT00472303|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20504205|NCT01043640|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
20504206|NCT02389881|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20504207|NCT00759603|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
20504208|NCT02580058|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504209|NCT00730236|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
20504210|NCT03486314|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20504211|NCT00613626|Hoosier Cancer Research Network|Georgia Gould|317-921-2050|ggould@hoosiercancer.org|
20504212|NCT05480514|Johnson & Johnson Vision Care, Inc. (JJVC)|Brian Pall|1-800-843-2020|bpall@its.jnj.com|
20504213|NCT00519532|UCB|UCB Clinical Trial Call Center|+18778229493||
20504214|NCT03232073|Actelion Pharmaceuticals Ltd|Associate Director Clinical Sciences Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20504215|NCT03395210|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
20504216|NCT00934895|Rutgers Cancer Institute of New Jersey|Deborah L Toppmeyer, M.D.|732-235-6789|toppmede@cinj.rutgers.edu|
20504217|NCT00597558|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director|919-843-9087|edwinkim@email.unc.edu|
20504218|NCT02579603|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504219|NCT04191668|Ectosense|Frederik Massie|+1 786 305 8547|frederik.massie@ectosense.com|
20504220|NCT03199911|University of California, San Francisco|Davin Ashraf MD|415-353-2800|davin.ashraf@ucsf.edu|
20504221|NCT01473004|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu|
20504222|NCT02939300|Massachusetts General Hospital|Priscilla Brastianos, MD|617-724-8770|pbrastianos@partners.org|
20528132|NCT01616758|Oncternal Therapeutics|Mary Bretimeyer|8582092082|mbreitmeyer@oncternal.com|208
20558449|NCT00077636|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20558450|NCT01966796|Far Eastern Memorial hospital|Dr. Ping-huai Wang|886-2-89667000|pinghuaiwang@gmail.com|2816
20558451|NCT01923896|Emory University|William G. Sharp Ph.D.|404-419-5162|wgsharp@emory.edu|
20558452|NCT00592319|Trustee of Boston Univ. Medical Campus|Dr. Zhi Wang|617-414-1590|zwang@bu.edu|
20558453|NCT02410967|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
20558454|NCT05082142|Northwestern University|Nicholas Dean (current fellow)|7806906285|nicholas.dean@northwestern.edu|
20558455|NCT00525135|University of California San Francisco|UCSF PRS Administrator|415-502-3212|Elaine.Cooperstein@ucsf.edu|
20558456|NCT04399551|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20558457|NCT04502056|JPAL North America|Tristan Loisel|6307476739|tloisel@povertyactionlab.org|
20504223|NCT05309668|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20504224|NCT03815292|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20504225|NCT01584024|University of Michigan|Dr. Mathilde Peters (PI)|734-925-2750|mcpete@umich.edu|
20509889|NCT00376675|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
20509890|NCT01833026|University of Illinois at Chicago|Min Joo|3129968039||
20509891|NCT00995215|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
20509892|NCT00942422|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
20509893|NCT01930487|Ocular Vascular Research Center, Indiana University School of Medicine|Brent Siesky, PhD, Assistant Director|317-278-0177|bsiesky@indiana.edu|
20509894|NCT01563406|Rush University Medical Center|Mary Hayden, MD|3129428727|mhayden@rush.edu|
20509895|NCT05559203|University of Stirling|Prof Anna C. Whittaker|0178646|a.c.whittaker@stir.ac.uk|7816
20509896|NCT01937624|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Kyle Cassas|864-454-7422|kcassas@ghs.org|
20509897|NCT00423592|Gilead Sciences, Inc.|Annemarie Vance|650-524-3829|Annemarie.Vance@gilead.com|
20509898|NCT03296280|South Texas Veterans Health Care System / UT Health San Antonio|Nilam Soni|210-949-9454|sonin@uthscsa.edu|
20509899|NCT00002981|Memorial Sloan Kettering Cancer Center|Dr. Steven Larson, MD|212-639-7373|LarsonS@MSKCC.ORG|
20509900|NCT02005510|University of Washington|Dr. Rachel Winer|2066165081|rlw@uw.edu|
20509901|NCT00255008|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20509902|NCT01300949|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
20509903|NCT01833806|Insightec|Nadir Alikacem, VP Global Regulated Clinical Affairs & CRO|(214) 630-2000|nadira@insightec.com|
20509904|NCT05083949|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509905|NCT00056550|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Development|508-370-5257|denise.tilton@gtc-bio.com|
20509906|NCT00322387|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20509907|NCT02092168|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20509908|NCT00195624|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
20558458|NCT02122341|USC Intitute of Urology|Dr. Matthew Dunn|323-865-3700|mdunn@med.usc.edu|
20504226|NCT00613314|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504227|NCT00702624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20504228|NCT01568944|Dental College of Georgia|chairman|706-7212442|chcutler@augusta.edu|
20504229|NCT04902885|Jiangsu Simcere Pharmaceutical Co., Ltd.|Study Director|86-025-85566666|simcere@simcere.com|
20504230|NCT02465034|Emory University|Dr. Michael Borich|404-712-0612|michael.borich@emory.edu|
20504231|NCT03033108|Kubota Vision Inc.|Clinical Trials Helpdesk|(206) 805-8310|clinicaltrials@kubotavision.com|
20504232|NCT01959204|PPSI|Study Director|8139279302|mgoodhead@pharmaprojectsolutions.com|
20504233|NCT02401256|Indiana University School of Medicine|Dr. Zeruesenay Desta|3172742823|zdesta@iu.edu|
20504234|NCT00893789|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20504235|NCT02024464|Alcon Research, LLC|Director, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20504236|NCT01479725|Beaumont Hospital, Royal Oak|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.edu|
20504237|NCT03818815|Novus Therapeutics|Clinical Director|949-679-1110|study006@novustherapeutics.com|
20504238|NCT04419506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504239|NCT04586712|University of Florida|Dr. Paul Borsa|352-294-1726|pborsa@ufl.edu|
20504240|NCT03767738|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20504241|NCT03047005|Yale University|Dr. Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
20504242|NCT03669133|Indiana University|Regina Weber|317-278-3584|reginaw@iu.edu|
20504243|NCT03293030|University of California San Francisco|Wilson Liao|415-476-8364|wilson.liao@ucsf.edu|
20504244|NCT02233842|National Cancer Institute (NCI)|Dr. Stephanie Land|240-276-6946|stephanie.land@nih.gov|
20504245|NCT02586805|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20504246|NCT01859403|VA San Diego Health Sciences|Amir Zarrinpar, MD, PhD, Assistant Professor of Gastroenterology|858-246-1665|azarrinpar@health.ucsd.edu|
20504247|NCT00811252|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20504248|NCT03185130|University Medical Center of Southern Nevada|Tony Zitek, MD|7023837885|zitek10@gmail.com|4
20504249|NCT01860170|Spectrum Health|A. Samer A;-Homsi|616-486-5933|a.samer.al-homsi@spectrumhealth.org|
20504250|NCT02317510|Lutfiye NBGH|Dr. Turgut Donmez|00905347400967|surgeont73@hotmail.com|
20504251|NCT02318602|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20558459|NCT01642602|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20558460|NCT01112514|Massachusetts General Hospital|Andrew T. Chan|617 726 3212|achan@partners.org|
20558461|NCT01118455|Cyberonics, Inc.|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
20558462|NCT01973491|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20558463|NCT02721641|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20558464|NCT01414413|Liverpool School of Tropical Medicine|Dr Peter MacPherson|0044151 705 3100|p.macpherson@liv.ac.uk|
20558465|NCT01987596|Barbara Ann Karmanos Cancer Institute|Dr. Maxim Yankelevich|313-745-5515|myankele@med.wayne.edu|
20558466|NCT01129336|Novartis Pharmaceuticals|Study Director|862-778-8300||
20558467|NCT00569803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20558468|NCT01993823|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+39933946470|ejimenezv@salvatbiotech.com|
20558469|NCT01355419|CHU St Pierre|Dr Marie Bruyneel|00325354219|Marie_BRUYNEEL@stpierre-bru.be|
20558470|NCT01622348|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20558471|NCT03765762|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20558472|NCT00791921|Professor, Department of Allergy and Rheumatology, Division of Internal Medicine, Graduate School of Medicine, University of Tokyo|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
20558473|NCT00389974|Princess Margaret Hospital, Toronto, Canada|Dr. Helen Mackay|(416) 946-2253|helen.mackay@uhn.ca|
20558474|NCT02392767|Dr. Loges + Co. GmbH|Dr. Birgit Goyvaerts|0049-4171-707182|goyvaerts@loges.de|
20558475|NCT04537897|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558476|NCT01034579|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20558477|NCT00178256|University of Rochester|Yuhchyau Chen MD, PhD|585-275-5575|yuhchyau_chen@urmc.rochester.edu|
20558478|NCT01763788|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20558479|NCT03321006|NYP Institute|Dr. Katharine Brewster|646 774 6380|Katharine.Brewster@nyspi.columbia.edu|
20558480|NCT03303469|The University of Alabama at Birmingham|Janis O'Malley|205-934-6504|jomalley@uabmc.edu|
20504252|NCT02095561|INSTITUTO NACIONAL DEL CÁNCER, ARGENTINA|Silvina Arrossi, Phd|541152390562|silviarrossi2020@gmail.com|
20504253|NCT01078753|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20504254|NCT00462423|Northern California Medical Center|Lynn E. Spitler, MD|415-435-9861|lynn@drspitler.com|
20504255|NCT00465569|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
20504256|NCT02362373|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
20504257|NCT01985321|Benu BioPharma, Inc.|Dr. Eric M. Morrel|5082085634|emorrel@benubio.com|
20504258|NCT00482001|Sunnybrook Health Sciences Centre|Dr. Mark Rapoport|416-480-4085|Mark.Rapoport@sunnybrook.ca|
20504259|NCT01015443|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20504260|NCT03652454|IzmirKCU|dr.dt.mücahid faik şahin|+902323254040|m.faiksahin@hotmail.com|
20504261|NCT00542828|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
20504262|NCT00095303|University of Miami Miller School of Medicine|Viviana E. Horigian, MD|305-243-4305|vhorigian@med.miami.edu|
20504263|NCT01773395|Dana-Farber Cancer Institute|Dr. Vincent Ho|617-632-5938|Vincent_Ho@dfci.harvard.edu|
20504264|NCT01364467|Virginia Commonwealth University|Kelley M. Dodson, MD, FACS|804-828-3965|kelley.dodson@vcuhealth.org|
20504265|NCT03228186|Rogel Cancer Center|Gregory Kalemkerian, MD|734-647-8921|kalemker@med.umich.edu|
20504266|NCT04312997|Pulmotect, Inc.|Dr. Brenton Scott, President & COO|713-579-9226|bscott@pulmotect.com|
20504267|NCT01634243|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20504268|NCT03953118|University of California San Francisco CA|Julie Schallhorn, MD|415-514-1922|julie.schallhorn@ucsf.edu|
20504269|NCT04283461|Kaiser Permanente Washington|Lisa Jackson, MD, MPH|206-442-5216|lisa.a.jackson@kp.org|
20504270|NCT05490771|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
20504271|NCT03842137|Butler Hospital|Ana M. Abrantes, Ph.D.|401-455-6440|aabrantes@carene.org|
20504272|NCT05139030|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20504273|NCT03655444|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
20504274|NCT01416129|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
20504275|NCT00816036|Department of Veterans Affairs|David Katz, MD, MSc|319-338-0581|david-katz@uiowa.edu|7598
20504276|NCT01299025|Region Örebro County|Dr Anette Forsberg|+46-19-6025788|anette.forsberg@regionorebrolan.se|
20504277|NCT00004980|Yale University School of Medicine|Ralph Hoffman|203-688-9734|ralph.hoffman@yale.edu|
20504278|NCT01624194|Stanford University|Antonio Y. Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
20504279|NCT03212261|Massachusetts General Hospital/Harvard Medical School|Dr. Giselle K. Perez|617-724-0765|gperez@mgh.harvard.edu|
20504280|NCT00820040|Medtronic|Heather McManus|2038213323|heather.mcmanus@medtronic.com|
20504281|NCT02256358|Haeundae Paik Hospital, Inje University|Kihwa Lee|82-51-797-0426|tedy333@paik.ac.kr|
20504282|NCT03195140|Tandem Diabetes Care, Inc|Jordan Pinsker, MD|858-366-6900|clinicalaffairs@tandemdiabetes.com|
20504283|NCT01259466|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
20504284|NCT02296840|Emory University|Roy Rajan, MD|404-778-2400|royrajan@yahoo.com|
20504285|NCT00729430|Brigham and Women's Hospital|Dr. Raymond Y. Kwong, Director of Cardiac Magnetic Resonance Imaging|857-307-1960|rykwong@partners.org|
20504286|NCT03429075|Imperial College London|Dr Robin Carhart-Harris|02075947992|r.carhart-harris@imperial.ac.uk|
20504287|NCT00814710|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504288|NCT03885284|Georgetown University|Benjamin Weinberg, MD|202-444-2223|baw12@gunet.georgetown.edu|
20504289|NCT04333966|University of North Texas Health Science Center|Dr. Dana Litt|817-735-5453|dana.litt@unthsc.edu|
20504290|NCT02932267|Galderma|Rajeev Chavda|0033|rajeev.chavda@galderma.com|492382928
20504291|NCT03476239|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20504292|NCT00630032|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
20504293|NCT05768789|University of Pittsburgh, UPMC|Harikesh Subramanian, MBBS, MS, D.ABA, ABPM-CI|412-647-9085|subramanianh4@upmc.edu|
20504294|NCT03746080|Stanford University|Lawrence Recht, MD|(650) 725-8630|lrecht@stanford.edu|
20504295|NCT05738486|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20504296|NCT00955110|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20504297|NCT02128490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20504298|NCT02243176|ASTRAZENECA INVESTMENT (CHINA) CO., LTD.|Xia, Zhang|+86 21 6030 2288|Xia.Zhang@astrazeneca.com|2035
20504299|NCT03113500|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
20550953|NCT04203238|Pennington Biomedical Research Center|Dr. Candida Rebello|2257633159|Candida.Rebello@pbrc.edu|
20504300|NCT06470087|Adichunchanagiri Institute of Medical Sciences, BG Nagara|Dr Naveen N|9980023372|drnaveenn@bgsaims.edu.in|+91
20504301|NCT02517515|AbbVie|Global Medical Services|800-633-9110||
20504302|NCT04745832|MEI Pharma|Richard Ghalie, MD CMO|858.898-0956|rghalie@meipharma.om|
20504303|NCT03638011|Maimonides Medical Center|Dr Dennis Feierman|718-283-6000|dfeierman@maimonidesmed.org|7703
20504304|NCT03440112|University of Michigan|Stiven Roytman|7349988424|stivenr@med.umich.edu|
20504305|NCT01009463|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504306|NCT02123329|Qatar University College of Pharmacy|Dr. Maguy El Hajj|0097444035577|maguyh@qu.edu.qa|
20504307|NCT04430348|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|info@nighthawkbio.com|
20504308|NCT03451825|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20504309|NCT02874794|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20504310|NCT03549520|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
20504311|NCT01021007|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20509909|NCT00707486|HemCon Medical Technologies|Staci McAdams|(503)245-0459|staci@hemcon.com|103
20558481|NCT00749125|University of Pennsylvania|Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
20558482|NCT03560258|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20558483|NCT01460160|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20558484|NCT03893825|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20558485|NCT01316341|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage@boehringer-ingelheim.com|
20558486|NCT02006121|Britannia Pharmaceuticals|Medical Director|+44 1189209500|reception@britannia-pharm.com|
20558487|NCT02354859|University of Washington|Christopher H. Goss, Professor of Medicine and Pediatrics|206-543-3166|goss@uw.edu|
20558488|NCT02357043|Remington-Davis Inc.|Dr. Ian Baird|6144872560|hbaird@remdavis.com|
20558489|NCT02979626|University of Colorado Denver|Dr. Suchitra Rao|7207771234|suchitra.rao@childrenscolorado.org|
20558490|NCT01336959|Mereo BioPharma|Dr. Ian Hodgson|+44 333 0237300|enquiries@mereobiopharma.com|
20558491|NCT01737996|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558492|NCT03000673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20558493|NCT01472562|Weill Cornell Medicine|Jia Ruan M.D, Ph.D|646.962.2064|amr2017@med.cornell.edu|
20558494|NCT01512745|Fudan University Shanghai Cancer Center, Shanghai; PLA Cancer Centre, The 81 Hospital of PLA, Nangjing|Co-Director of Clinical Trials|021-64433755|fudanlijin@163.com,qinsk@csco.org.cn|
20558495|NCT02357810|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
20558496|NCT03679767|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20558497|NCT05408468|University Hospitals Cleveland Medical Center|Dr. Grant Pignatiello|216-368-4480|gap54@case.edu|
20558498|NCT01960075|Medical University of South Carolina|Jordan Elm, PhD Biostatistician|843-876-1605|elmj@musc.edu|
20558499|NCT03396432|Children Hospital of Philadelphia|Dr. John Fiadjoe, PI|267-426-2961|fiadjoej@email.chop.edu|
20558500|NCT03221660|Ivoclar Vivadent AG|Dr. med. dent. Lukas Enggist, Dentist internal clinic (Principal Investigator)|+423 235 34 46|lukas.enggist@ivoclarvivadent.com|
20558501|NCT03104647|Shaare Zedek Medical Center|Dr. Yair Barzilay, PI|+972-2-6555166|barzilay@szmc.org.il|
20558502|NCT04235582|Aurora Health Care|Mindy Waite, Behavioral Health Research Scientist|414-773-4323|mindy.waite@aah.org|
20558503|NCT04591977|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|7175310003|jmoss1@pennstatehealth.psu.edu|323429
20558504|NCT02781506|UT Southwestern Medical Center|Dr. Raquibul Hannan|214-645-8525|Raquibul.Hannan@UTSouthwestern.edu|
20558505|NCT01340482|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20558506|NCT04424290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558507|NCT02936037|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33180401440|frederic.sedel@medday-pharma.com|
20558508|NCT03545113|Wake Forest University Health Sciences|Mariana Murea, MD|336-716-5777|mmurea@wakehealth.edu|
20558509|NCT00235443|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20558510|NCT02032173|Novartis Pharmaceuticals|Study Director|862-778-1873||
20558511|NCT01045122|University of Rochester Medical Center|Dr. Suzanne Karan|585-275-5161|Suzanne_Karan@urmc.rochester.edu|
20558512|NCT01017120|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558513|NCT00335725|IBSA instutut Biochimique SA|IBSA Clinical Research Manager|+41 58 360 1000|sd@ibsa.ch|
20558514|NCT01912222|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
20558515|NCT00603265|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20558516|NCT00010439|Medical University of South Carolina|Deborah A Bowlby, M.D., Assistant Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
20558517|NCT02961881|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20558518|NCT00854295|Zimmer Biomet|Erin Osborn|574-371-9884|erin.osborn@zimmerbiomet.com|
20558519|NCT00709592|Virginia Commonwealth University|Amir A Toor, MD|804-828-4360|atoor@mcvh-vcu.edu|
20558520|NCT03223272|UAB|Physician|4346545260|dacalhou@sentara.com|
20558521|NCT00451217|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558522|NCT03154359|Children's Mercy Hospital|James Steven Leeder, PharmD, PhD|816-731-7116|sleeder@cmh.edu|
20558523|NCT01582880|Massachusetts Eye and Ear Infirmary|Dr. Joseph Ciolino, MD|617-573-4437|joseph_ciolino@meei.harvard.edu|
20550954|NCT00001596|National Human Genome Research Institute|Dr. William A. Gahl|301-402-2739|gahlw@mail.nih.gov|
20558524|NCT04668989|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|jvega2@coopervision.com|
20558525|NCT00574990|Salt Lake City VA HSRD IDEAS 2.0 Center of Innovation|Dr. Charlene Weir|801-582-1565|charlene.weir@utah.edu|5114
20558526|NCT05033743|Indiana University School of Medicine|Chemen M. Neal, Associate Professor|3172789639|chmtate@iupui.edu|
20558527|NCT01592695|University of Iowa|Mark Vander Weg, PhD|319-338-0581|mark-vanderweg@uiowa.edu|7717
20558528|NCT00422799|Dana-Farber Cancer Institute|Irene M. Ghobrial|(617) 632-4218|Irene_Ghobrial@DFCI.HARVARD.EDU|
20550955|NCT01024296|Stanford University|Bilal M Shafi, MD|(215) 738-0400|bmshafi@stanford.edu|
20550956|NCT03867981|The Miriam Hospital|Principal Investigator|401-793-8966|junick@lifespan.org|
20550957|NCT01694641|Kaali Inst. IVF Center|Dr Peter Kovacs|36-1-202-2802|peterkovacs1970@hotmail.com|
20550958|NCT00289315|Pennington Biomedical Research Center|Lori Steib|(225) 252-5030|Lori.Steib@pbrc.edu|
20550959|NCT00264641|Hypoglycaemia Research Group|Prof. Birger Thorsteinsson|+4548294829|Birger.Thorsteinsson@regionh.dk|
20550960|NCT00180414|Boston Scientific|Jens Goetzke|+32 2 41|jens.goetzke@bsci.com|67011
20550961|NCT01909154|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
20550962|NCT00463346|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
20550963|NCT01572909|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20550964|NCT02703909|University of Missouri - Columbia|Terri G. Monk, MD, Principal Investigator|(573)-882-2568|monkt@health.missouri.edu|
20550965|NCT03641651|Zurich University of applied sciences|Prof. Dr. Markus Wirz|+41 58 934|markus.wirz@zhaw.ch|6321
20550966|NCT04779489|UT Southwestern Medical Center|Dr. Solomon Woldu|214-648-9558|solomon.woldu@utsouthwestern.edu|
20550967|NCT00951665|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20550968|NCT01199289|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20550969|NCT03879655|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
20550970|NCT02635828|The Ohio State Universtiy Wexner Medical Center|Director of Neuroanesthesia|6142933559|sergio.bergese@osumc.edu|
20550971|NCT02723084|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20550972|NCT02290509|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20550973|NCT00415909|University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor, Leukemia|713-794-5783|CR_Study_Registration@mdanderson.org|
20550974|NCT05024058|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20550975|NCT00139399|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
20550976|NCT00714389|University of Rochester|Gunhilde Buchsbaum, MD|585-273-3232|gunhilde_buchsbaum@urmc.rochester.edu|
20550977|NCT02734810|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
20528133|NCT03026283|Northwell Health|Pamela Noack|212 434 4926|pnoack@northwell.edu|
20528134|NCT01054222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504312|NCT04876391|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20504313|NCT04899271|Dompé Farmaceutici SpA|Clinical Development and Operations|+39 (0) 583831|clinical.trials@dompe.com|
20504314|NCT00813748|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20504315|NCT00892437|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20504316|NCT02286960|NYU Langone Health|Milan Amin|646-754-1206|Milan.Amin@nyulangone.org|
20504317|NCT01882725|Arizona Institute of Footcare Physicians|Kerry Zang, DPM|480-834-8804|kerryzang@aol.com|
20504318|NCT03427073|Almac Discovery|Professor Richard Kennedy, Medical Director|+44 28 3833 2200|richard.kennedy@almacgroup.com|
20504319|NCT01193335|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504320|NCT01733329|Hospital Universitario José Eleuterio González, Universidad Autónoma de Nuevo León|Dr. Flavio Hernández Castro|8112776459|flaviohernandezc@yahoo.com|
20504321|NCT02388776|Weill Cornell Medicine|Christine Lennon, M.D.|212-746-2621|chl9083@med.cornell.edu|
20504322|NCT03826914|University of Manitoba|Dr. Semone Myrie|(204) 474-7290|semone.myrie@umanitoba.ca|
20504323|NCT02379858|Medical College of Wisconsin|Matthew Goldblatt, MD|414-955-5751|mgoldbla@mcw.edu|
20504324|NCT04246047|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20504325|NCT02814721|Henry Ford Hospital|Dr. Lalathaksha Kumbar|3136271761|lkumbar1@hfhs.org|
20504326|NCT02502864|H. Lee Moffitt Cancer Center and Research Institute|Christine M. Walko, Pharm.D., BCOP|813-745-1519|christine.walko@moffitt.org|
20504327|NCT01175369|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
20504328|NCT00931164|University of Utah|Dr. Kathryn Swoboda|801-585-9717|taran@genetics.utah.edu|
20504329|NCT01472276|Queen's University, Belfast|Michelle McKinley, Professor|02890978936|m.mckinley@qub.ac.uk|
20504330|NCT01341912|Octapharma|VP of Clinical Research and Development|+41 554512141|sigurd.knaub@octapharma.com|
20504331|NCT03679494|Taipei MU|MS. Po-Yao Chiu|+886-2-27361661|m437106006@tmu.edu.tw|6311
20504332|NCT02527304|Montefiore Medical Center|Dr. Madhur Garg, Clinical Director, Department of Radiation Oncology|718-920-4361|mgarg@montefiore.org|
20504333|NCT01824602|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20504334|NCT00184054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
20504335|NCT00843180|UCSF|Dr. Wolf Mehling, MD|415-353 9506|mehlingw@ocim.ucsf.edu|
20504336|NCT02485717|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
20504337|NCT00104871|UT MD Anderson Cancer Center|Steven Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
20504338|NCT02192359|City of Hope Medical Center|Dr. Jana Portnow|626-546-8293|JPortnow@coh.org|
20504339|NCT05036785|Royal Devon and Exeter NHS Trust|Dr Ellen Richards|01392 411611|ellen.richards6@nhs.net|
20504340|NCT03721328|Nor Consult, LLC|Nor Consult|206-607-6861|regulatory@nor-consult.com|
20504341|NCT00457639|UT Southwestern Medical Center|Zahid Ahmad, M.D.|214-648-2377|zahid.ahmad@utsouthwestern.edu|
20504342|NCT00484354|Wake Forest School of Medicine|Michael Rocco, MD|3367164650|mrocco@wakehealth.edu|
20504343|NCT02117687|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20504344|NCT00002850|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20504345|NCT01450540|Philips|Senior Data Scientist|+14125423651||
20504346|NCT01477450|University of Cincinnati|Richard Branson||bransord@uc.edu|
20504347|NCT04002167|Stanford University|Hadi Hosseini|6507235798|hosseiny@stanford.edu|
20504348|NCT01586091|University of Charité Berlin; Dpt. of Dermatology and Allergy|Professor Marcus Maurer|+49 30 450 518 043|marcus.maurer@charite.de|
20504349|NCT00590161|Cleveland Clinic Lerner College of Medicine of Case Western Reserve University|Claudia O. Zein, MD, MSc|216-444-0421|zeinc@ccf.org|
20504350|NCT01687673|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|Katie.Kelley@ucsf.edu|
20504351|NCT02234622|Roudebush VA Medical Center|Louanne Davis Psy.D.|317-710-1338|louannedavis52@gmail.com|
20504352|NCT00618956|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|201-427-8218|robert.palmer@frx.com|
20504353|NCT03598777|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20504354|NCT02006576|University of Nebraska Medical Center|Amy Nelson|402-559-5536|amyjnelson@unmc.edu|
20504355|NCT00785577|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20504356|NCT01200433|Clevland Clinic Foundation|Ehab Farag, MD|216-444-9950|farage@ccf.org|
20504357|NCT02452359|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20504358|NCT01887210|Rhode Island Hospital|Dr. Larry Brown|401-793-8808|lkbrown@lifespan.org|
20504359|NCT00662155|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
20504360|NCT02515669|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20504361|NCT02985801|Mayo Clinic|Dr. Massimo Raimondo|904-953-6982|Raimondo.Massimo@mayo.edu|
20504362|NCT01909492|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
20504363|NCT01901328|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20504364|NCT01497171|Mayo Clinic|Dr. Emanuel C. Trabuco|507-284-7519|trabuco.emanuel@mayo.edu|
20504365|NCT02928289|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|877-266-1144|jdickerson@sightsciences.com|
20504366|NCT03439345|Nuffield Department of Population Health, University of Oxford|Associate Professor David Preiss|01865 743 743|lens@ndph.ox.ac.uk|
20528135|NCT00824655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504367|NCT05110300|Gaylord Specialty Healthcare|John Corbett|2032943224|jcorbett@gaylord.org|
20558529|NCT01965158|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
20558530|NCT04542226|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|Phone: +7(495) 730-75-45 ext.|DodonovNS@petrovax.ru|125
20558531|NCT01047475|Microbio / Sophie Chang|Director of Clinical Trials|886-2-2570-5596|sophie_chang@fountainmab.com|556
20558532|NCT00467142|Institut Bergonié|Pr Yves Becouran||y.becouarn@bordeaux.unicancer.fr|
20558533|NCT00919893|Clinic for urology and pediatric urology, JL-University, Giessen, Germany|Dr. F.M.E. Wagenlehner|0049 641 9944518|wagenlehner@AOL.com|
20558534|NCT00453479|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558535|NCT01580098|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
20558536|NCT01532817|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20558537|NCT03029780|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20558538|NCT00197028|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558539|NCT03308058|University of Nebraska Medical Center|Jane Meza|402-559-6825|jmeza@unmc.edu|
20558540|NCT03066622|Regions Hospital|Meghan O'Brien|651-254-5303|meghan.e.obrien@healthpartners.com|
20558541|NCT00641719|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20558542|NCT01622543|The Ottawa Hospital - Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
20558543|NCT04229030|Raziel Therapeutics|Racheli Gueta, Director of Clinical trials|97289126941|racheli@raziel-therapy.com|
20558544|NCT00535743|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558545|NCT03283696|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20558546|NCT00759772|Massachusetts General Hospital|Pouneh K. Fazeli, MD|617-726-3870|pkfazeli@partners.org|
20558547|NCT01568827|The Ohio State University|Dr. Joseph Kitzmiller|6142928438|joseph.kitzmiller@osumc.edu|
20558548|NCT01989598|Princess Margaret Cancer Centre|Dr. Suzanna Trudel|4169464501|Suzanne.Trudel@uhn.ca|4566
20550978|NCT00528398|City of Hope National Medical Center|Anthony Stein, M.D.|626-256-4673|AStein@coh.org|82405
20558549|NCT02761629|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20558550|NCT00562978|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|ANademanee@coh.org|82405
20558551|NCT00936221|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
20558552|NCT01348776|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
20558553|NCT02459080|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20558554|NCT04362137|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20558555|NCT00771875|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
20558556|NCT04112940|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|4165973422|tri-swallowinglab@uhn.ca|7802
20558557|NCT02130453|The University of Texas MD Anderson Cancer Center|Nicolas Palaskas, MD|(713) 745-1942|nlpalaskas@mdanderson.org|
20558558|NCT02204579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20558559|NCT00884754|London Health Sciences Centre|Philip Jones|519-685-8500|philip.jones@lhsc.on.ca|36306
20558560|NCT03176238|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20558561|NCT03556358|Tanvex|Study Director|19494838507|jennifer.lai@tanvex.com|
20558562|NCT00315588|University of Miami Miller School of Medicine Miami Fl|Dr. Rodolfo Alejandro|305 243 5324|ralejand@med.miami.edu|
20558563|NCT01065350|Mayo Clinic|Nathan J. Smischney, MD|507-255-6032|smischney.nathan@mayo.edu|
20558564|NCT03331185|University of Manitoba|Dr. Jonathan Bouwer|204 898 1132|jfbouwer@gmail.com|
20558565|NCT02875834|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20558566|NCT03697980|Medtronic Cardiac Rhythm and Heart Failure|CRM/MCS Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
20558567|NCT05200936|Mind Medicine Inc|Medical Affairs|1-332-245-4732|MedAffairs@mindmed.co|
20528136|NCT03782571|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|904 443-3402|TKarkkai@its.jnj.com|2126
20528137|NCT03091738|Virginia Commonwealth University|Jasmohan Bajaj, MD|804-828-4060|jasmohan.bajaj@vcuhealth.org|
20528138|NCT00199849|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20528139|NCT04656301|NY State Psychiatric Institute|Dr. Franklin Schneier|6467748041|franklin.schneier@nyspi.columbia.edu|
20528140|NCT01944644|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
20528141|NCT01826981|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20528142|NCT00168428|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20528143|NCT03457818|Columbia University|Dr. Mishaela Rubin|2019528237|mrr6@cumc.columbia.edu|
20528144|NCT03084302|University of Pittsburgh|Bethany Barone Gibbs, Associate Professor, University of Pittsburgh|412-383-4002|bbarone@pitt.edu|
20528145|NCT01704755|AbbVie (prior sponsor, Abbott)|Global Medical Information|800 633-9110||
20528146|NCT02028780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20528147|NCT00777335|University of California Los Angeles (UCLA) / Cancer International Research Group (CIRG) (Translational Research in Oncology TRIO) Inc.|Dr. Richard Finn|+ 1 310 586 2091|RFinn@mednet.ucla.edu|
20528148|NCT02187029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528149|NCT00264290|University of California, San Francisco|Peter W. Hunt, M.D.|415-476-4082|phunt@php.ucsf.edu|345
20528150|NCT00649792|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
20528151|NCT02782377|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
20528152|NCT01648920|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA. Director, Clinical Development and Medical Affairs|919-449-8873|nancy.herje@aerocrine.com|
20528153|NCT01188668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528154|NCT00303472|Amgen Inc.|Study Director|866-572-6436||
20528155|NCT03571607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528156|NCT04318132|Nidek.co., ltd.|Tadakazu Ichimura|+81-533-67-8904|tadakazu_ichimura@nidek.co.jp|
20528157|NCT02155322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20528158|NCT01124370|Respicardia|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
20528159|NCT00073008|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528160|NCT02036541|Allergan plc|Rupali Nangia|714-246-6020|rupali.nangia@allergan.com|
20528161|NCT01836185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20528162|NCT00808470|University of Texas at Dallas|Dr. Colleen Le Prell|214-905-3018|colleen.leprell@utdallas.edu|
20528163|NCT00523809|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
20528164|NCT02356107|University of Utah|Brent Kious, MD, PhD|(801) 581-4888|Brent.Kious@hsc.utah.edu|
20528165|NCT03337048|Coloplast A/S|Vice President, Medical Affairs|+45 49111111|clinical-studies@coloplast.com|
20528166|NCT01819844|Massachusetts General Hospital|Steven J. Russell|617-726-8722|sjrussell@partners.org|
20528167|NCT01454414|University of North Carolina at Chapel Hill|Dr. Meagan Vaughn|9196986208|meagan.vaughn@unc.edu|
20528168|NCT00586898|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|Scherh@mskcc.org|
20528169|NCT00636961|Novartis Pharmaceuticals|Study Director|862-778-8300||
20528170|NCT00868751|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
20528171|NCT00893971|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|605-305-2600|creisner@pearltherapeutics.com|
20528172|NCT03628716|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
20528173|NCT00856843|Braintree Laboratories, Inc.|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
20528174|NCT00262002|Novartis Vaccine and Diagnostics S.r.l|Posting Director||RegistryContactVaccineUS@novartis.com|
20528175|NCT01085084|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20558568|NCT00539279|VA San Diego Healthcare System|Steven R. Thorp, Ph.D., ABPP|(858) 552-8585|Steven.Thorp@va.gov|2468
20558569|NCT00405353|UCLA|Dr. Rhonda Voskuhl|(310) 206-4636|rvoskuhl@mednet.ucla.edu|
20558570|NCT01432535|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20558571|NCT00543400|Momenta Pharmaceuticals|Jim Roach, MD Chief Medical Officer|617-491-9700|jroach@momentpharma.com|
20558572|NCT03664739|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20558573|NCT00345384|Baylor Research Institute|President Baylor Research Institute|214-820-3296|researchclinicaltrials@baylorhealth.edu|
20558574|NCT00885352|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20504368|NCT03665155|Memorial Sloan Kettering Cancer Center|Jason Lewis, PhD|314-276-1830|lewisj2@mskcc.org|
20504369|NCT01826214|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
20558575|NCT00365378|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20504370|NCT06400238|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20504371|NCT02396147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20504372|NCT01981187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504373|NCT03187379|Cleveland Clinic Foundation|Dr. Matthew Kroh|12164457410|krohm@ccf.org|
20504374|NCT03839524|TRANSGENE|Director of Medical Affairs|+ 33 3 88 27 91 00|clinical.trials@transgene.fr|
20504375|NCT01142323|University of Miami|Dr. Cynthia Levy|305-243-2147|clevy@med.miami.edu|
20504376|NCT04329949|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20504377|NCT02037919|Family Planning Associates Medical Group , Ltd.|Allison A. Cowett, MD MPH|312-707-8988|aacowett@gmail.com|
20504378|NCT03851744|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
20504379|NCT02494141|"University of Colorado Denver | Anschutz"|Kristen Nowak, Ph.D.|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20504380|NCT00345605|Baylor College of Medicine|Dr. Sandesh Nagamani||nagamani@bcm.edu|
20504381|NCT01475955|DUSA Pharmaceuticals, Inc|Manager of Clinical Studies||houlihana@dusapharma.com|
20504382|NCT00917384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20504383|NCT01521845|Shaheed Beheshti Medical University|Dr.Jamshid Salamzadeh|00982188662334|j.salamzadeh@yahoo.com|
20504384|NCT01451515|St. Jude Children's Research Hospital|Hiroto Inaba, MD, PhD|(901) 595-3144|hiroto.inaba@stjude.org|
20504385|NCT03717922|UCLA Psychiatry & Biobehavioral Sciences|Dr. Taylor P. Kuhn, PhD|‭(310) 829-5968‬|tkuhn@mednet.ucla.edu|
20504386|NCT01458340|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20504387|NCT00427661|University of Pittsburgh-Department of Pediatrics|Nancy Harter-Administrative Director of Research|412-692-7487|harterne@upmc.edu|
20504388|NCT01702805|Emeritus Professor U Pennsylvania at CHOP and Emeritus Professor McMaster University, Dept Pediatrics|Haresh Kirpalani|267-844-3233|kirpalan@mcmaster.ca|
20504389|NCT01238120|University of Rochester Medical Center|Michelle C. Janelsins, PhD, MPH|(585) 276-4656|Michelle_Janelsins@urmc.rochester.edu|
20504390|NCT02888626|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20504391|NCT00736229|Saint Luke's Health System|Steven P. Marso, MD|816-932-5773|smarso@saint-lukes.org|
20504392|NCT00693706|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504393|NCT01576471|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
20504394|NCT04786210|NYU Langone Health|Nayoung Lee, MD|212-263-7019|nayoung.lee@nyulangone.org|
20504395|NCT04334148|Duke University|Dr. Susanna Naggie|919-684-2584|susanna.naggie@duke.edu|
20504396|NCT00498173|Lurie Center for Autism, Massachusetts General Hospital|Christopher John McDougle, M.D.|7818601721|cmcdougle@mgh.harvard.edu|
20504397|NCT00258154|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20504398|NCT02481505|Sintetica SA, via Penate 5 Mendrisio|Elisabetta Donati Clinical Project Leader|+41.91.640.42.50|edonati@sintetica.com|
20504399|NCT03772327|Weill Cornell Medicine|Dr. Grant Ellsworth|212-746-7204|gre9006@med.cornell.edu|
20504400|NCT04689828|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20504401|NCT06105138|Colorado State University|Dr. Hollis Karoly|970-491-3677|hollis.karoly@colostate.edu|
20504402|NCT04378426|Palo Alto VA|Carolyn Rodriguez, MD, PhD|650-493-5000|carolyn.rodriguez@va.gov|60067
20504403|NCT04322708|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20504404|NCT00213239|The Hospital for Sick Children, Department of Anesthesia and Pain Medicine|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
20504405|NCT00195351|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20504406|NCT02111369|Emory University|Dr. Michael Johns|323-865-9839||
20504407|NCT01233726|Intensive Care Unit, Hospital Clínico Universitario|Alfonso Mesejo|961 97 35 00|mesejo_alf@gva.es|
20504408|NCT03959189|Expansion Therapeutics, Inc.|Chief Medical Officer|858-764-4290|info@expansionrx.com|
20504409|NCT02493751|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504410|NCT01480180|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20504411|NCT02513446|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504412|NCT06081283|University of North Carollina at Chapel Hill|Meitra Kazemi|919-914-9579|meitra_kazemi@med.unc.edu|
20504413|NCT04323488|Stanford University|Jason Yeatman, PhD|(650) 321-7553|jyeatman@stanford.edu|
20504414|NCT00828451|Washington University|Aaron Hamvas, MD|314-454-6148|hamvas@kids.wustl.edu|
20504415|NCT02827877|City of Hope Medical Center|Dr. Joanne Mortimer|626-359-8111|jmortimer@coh.org|
20504416|NCT05175170|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Diane Chen|312-227-2939|DiChen@luriechildrens.org|
20504417|NCT01650805|ARIAD Pharmaceuticals, Inc.|Maureen Conlan, Senior Medical Director|1-617-621-2316|Maureen.Conlan@ariad.com|
20504418|NCT02625402|Massachusetts General Hospital|Karen Sepucha|6177243350|ksepucha@partners.org|
20504419|NCT04884243|Cloudbreak Therapeutics LLC|Dr. Rong Yang|9496798408|rong_yang@cloudbreaktherapeutics.com|
20504420|NCT00840463|UT Southwestern|Kelly Chin|214-645-1825|kelly.chin@utsouthwestern.edu|
20504421|NCT03414359|UAMS|Nadir El Sharawi|5016866114|nelsharawi@uams.edu|
20504422|NCT02043574|South Texas Veterans Health Care System|Monica Serra|210-617-5300|monica.serra@va.gov|15313
20504423|NCT00770861|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
20504424|NCT03750838|University of North Texas Health Science Center|Dr. Dana Litt|817-735-5453|dana.litt@unthsc.edu|
20504425|NCT02332915|University of Utah|Julie Wambaugh|8015846164|julie.wambaugh@health.utah.edu|
20504426|NCT02462889|Ophthalmic Consultants of Boston|Jeffrey S. Heier, MD|617-314-2694|jsheier@eyeboston.com|
20504427|NCT02258412|3M Health Care Business|Clinical Research Specialist|651-736-1578|mdavid@mmm.com|
20504428|NCT03497689|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20504429|NCT02032875|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20504430|NCT04060277|City of Hope Medical Center|Dr. Ryotaro Nakamura|6263598111|rnakamura@coh.org|
20504431|NCT01093612|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20504432|NCT04636177|Stanford University School of Medicine|Laura E Simons|(650) 736-0838|lesimons@stanford.edu|
20504433|NCT03191786|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20504434|NCT05847881|Back & Pain Center Clinical Research|Afton L. Hassett, PsyD|734-763-5226|afton@med.umich.edu|
20504435|NCT01382186|Center of Innovation on Disability and Rehabilitation Research|Dr. Jolie Haun|813-558-7622|jolie.haun@va.gov|
20504436|NCT04573777|UCaliforniaLA|David Liebeskind|‭(310) 963-5539‬|dliebeskind@mednet.ucla.edu|
20504437|NCT00678496|University of Sheffield|Daniel Hind, Assistant Director, Sheffield CTRU|+441142220707|d.hind@sheffield.ac.uk|
20504438|NCT02927223|Vanderbilt University Medical Center|Dr. Prince Kannankeril|615-322-7447|prince.kannankeril@vumc.org|
20504439|NCT01348919|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20504440|NCT01943539|Akili Interactive Labs|SVP of Medical Devices|617-456-0984|skellogg@akiliinteractive.com|
20504441|NCT01362322|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504442|NCT00728507|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
20504443|NCT04260607|Naval Medical Center Camp Lejeune|Naval Medical Center Camp Lejeune|317-691-1718|nathan.butler@usmc.mil|
20504444|NCT03715465|University of Michigan|Leslie Swanson|734-764-2242|lmswan@med.umich.edu|
20504445|NCT00430781|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504446|NCT05134974|Ocuphire|Drey Coleman, VP of Clinical Operations|813-404-1993|dcoleman@ocuphire.com|
20504447|NCT05408858|Massey University|Dr. Ilana Seager van Dyk|+64 4 979 3625|i.seagervandyk@massey.ac.nz|
20504448|NCT03618641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20504449|NCT02158533|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20504450|NCT00320671|Northwell|Delbert Robinson MD|718.470.8195|drobinson@nshs.edu|
20504451|NCT00384956|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20504452|NCT01532453|Galderma Spirig|Dr. Francine Santoro|+41 62 387 87 87|Francine.santoro@galderma.com|87 20
20504453|NCT03126227|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20504454|NCT03695276|UCSF|Rachel Willard-Grace|415-476-5248|Rachel.Willard@ucsf.edu|
20504455|NCT02417415|Vanderbilt University Medical Center|Italo Biaggioni|(615) 322-2318|italo.biaggioni@vumc.org|
20504456|NCT01575548|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20504457|NCT04281537|Amicus Therapeutics, Inc.|Patient Advocacy|001 6096622000|clinicaltrials@amicusrx.com|
20504458|NCT03230097|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504459|NCT05980416|Elevation Oncology|Medical Information|+1-716-371-1125|medinfo@elevationoncology.com|
20504460|NCT00609271|Tulane University|Dr. Lydia Bazzano|5049887323|lbazzano@tulane.edu|
20504461|NCT00635102|Yale University School of Medicine|Dr John Krystal|203-785-6396|john.krystal@yale.edu|
20504462|NCT01241539|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504463|NCT00440401|Medical Scientific Strategy|Medical Responsible|+45 4677 1111|clinicaltrials@nycomed.com|
20504464|NCT01925703|University of Maryland School of Pharmacy, Department of Pharmacy Practice and Science|Dr. Brent N. Reed||breed@rx.umaryland.edu|
20504465|NCT01937312|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20504466|NCT00058370|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
20504467|NCT00881205|Novartis Pharmaceuticals|Study Director|862-778-8300||
20504468|NCT02498652|Study Information Center AstraZeneca|Jesse Hall, MD|(877) 240-9479|information.center@astrazeneca.com|
20504469|NCT04207710|Henry Ford Health|Director of Research, Department of Anesthesiology|313-771-7128|knowak2@hfhs.org|
20504470|NCT06129487|University of Connecticut|Zexin Ma, Ph.D.|(860) 486-6871|zexin.ma@uconn.edu|
20504471|NCT00780403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20504472|NCT00847613|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504473|NCT01161225|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
20504474|NCT00587223|Organogenesis Inc.|Director of Clinical Operations||kgiovino@organo.com|
20504475|NCT04332419|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ram Gurajala, MD|1-866-223-8100|TaussigResearch@ccf.org|
20504476|NCT00519623|Altea Therapeutics|Pei-Ling Roerig, Sr. Manager Clinical Research, Altea Therapeutics|404-835-6415|proerig@alteatherapeutics.com|
20504477|NCT03819140|University of California, San Francisco|Heather Huddleston|(415) 353-7475|Heather.Huddleston@ucsf.edu|
20504478|NCT00658333|Novartis Pharmaceuticals|Study Director|862-778-8300||
20504479|NCT05755438|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20504480|NCT01885689|City of Hope|Dr. Monzi M.Al Malki, MD|626-359-8111|malmalki@coh.org|
20504481|NCT03914300|The Ohio State University Comprehensive Cancer Center|Dr. Bhavana Konda|614-293-9779|bhavana.konda@osumc.edu|
20504482|NCT02280811|National Cancer Institute|Dr. Christian Hinrichs|301-435-3027|hinrichs@nih.gov|
20504483|NCT06027593|Children's Hospital of Philadelphia|Kathleen Chiotos|267-426-7729|chiotosk@chop.edu|
20550979|NCT02801942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20509910|NCT03296072|GlaxoSmithKline|GSK Response Center|866-435-7343 Ext:|GSKClinicalSupportHD@gsk.com|
20558576|NCT03278886|Boston Medical Center|Dr. Jeffrey Samet|617-414-7444|jsamet@bu.edu|
20558577|NCT04161807|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical @Regulatory Affairs|0542220121|daganh@theranica.com|
20558578|NCT03354325|University of Utah|Eric Coon|801-662-3645|Eric.Coon@hsc.utah.edu|
20558579|NCT01421589|Massachusetts General Hospital|Hideo Makimura, MD, PhD|617-726-8277|hmakimura@partners.org|
20558580|NCT00251927|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20558581|NCT00658697|DFCI|Rana R. McKay, MD|6176323237|rana_yehia@dfci.harvard.edu|
20558582|NCT01170884|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20504484|NCT01548638|University of Pennsylvania Perelman School of Medicine|Dr. Rebecca Ashare|2157465789|rlashare@mail.med.upenn.edu|
20504485|NCT03476850|Medical University of South Carolina|Eric Bolin, MD|8437921869|bolin@musc.edu|
20504486|NCT02912364|Stanford University|Kimford Meador|650-725-6648|kmeador@stanford.edu|
20504487|NCT04037085|UPMC|Grace Lim, MD, MSc|412-641-1110|limkg2@upmc.edu|
20504488|NCT02049502|Emory University|Dr. Shaffer|404-778-5033|virginia.o.shaffer@emory.edu|
20504489|NCT03872427|The University of Texas MD Anderson Cancer Center|Dr. Funda Meric-Bernstam|(713) 794-1226|fmeric@mdanderson.org|
20504490|NCT00499915|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
20504491|NCT04090164|Mansoura University|Osama Hussein|00201099815110|osamahussein@mans.edu.eg|
20504492|NCT04067661|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
20504493|NCT07215806|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20504494|NCT05781542|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20504495|NCT04974307|National Institute of Child Health and Human Development (NICHD)|Dr. An Ngoc Dang Do|301-496-8849|an.dangdo@nih.gov|
20504496|NCT01332435|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504497|NCT03704051|California Polytechnic State University|Dr. Alison Ventura|(805) 756-5693|akventur@calpoly.edu|
20504498|NCT02495077|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20504499|NCT02742649|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20504500|NCT03348683|Icahn School of Medicine at Mount Sinai|Dr. Catherine A Bigelow|651-206-9069|cassie.bigelow@gmail.com|
20504501|NCT03167619|Duke Clinical Research Institute|Senior Biostatistician|919-668-8052|lilin.she@duke.edu|
20504502|NCT01092442|CryoLife, Inc.|Scott B. Capps, MS|800-438-8285|clinicaltrialregistration@cryolife.com|
20504503|NCT01335971|Johns Hopkins University School of Medicine|Alexis Rea|(443) 287-8496|area5@jhu.edu|
20504504|NCT03056287|Medical University of South Carolina|Chris Gregory|8437921078|gregoryc@musc.edu|
20504505|NCT05740813|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
20504506|NCT02439775|Medtronic|Elishea Argent, Sr. Clinical Research Specialist|(763)505-9584|elishea.n.argent@medtronic.com|
20504507|NCT04168203|BWH|Physician|6177326984|gpiazza@bwh.harvard.edu|
20504508|NCT01938625|Janssen Research & Development|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
20504509|NCT01660815|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20504510|NCT01748227|Richard L. Roudebush VAMC HSR&D|Dr. Marianne Matthias|317-988-4514|marianne.matthias@va.gov|
20504511|NCT01486238|Valley Retina Institute, PA|Victor Gonzalez, MD|956-631-8875|research@vritx.com|
20504512|NCT01415960|Grand Strand Urology Carolina Urology Reseearch Centre|Dr. Neal Shore MD|+1 843 839 1679|nshore@grandstrandurology.com|
20504513|NCT01330290|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
20504514|NCT01184989|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504515|NCT01570491|Cleveland Clinic|Daniel Sessler, MD|2164444900|sessled@ccf.org|
20504516|NCT05370157|University of Pittsburgh|Dr. Elizabeth McGuier|412-246-5895|millerea3@upmc.edu|
20504517|NCT01508676|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
20504518|NCT00609128|University of Wisconsin-Madison|Jim Stahl, PhD|608-263-6177|jlstahl@wisc.edu|
20504519|NCT03643692|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
20504520|NCT02495779|University of Pittsburgh, Graduate School of Public Health|James Egan|4126242255|jee48@pitt.edu|
20504521|NCT00754390|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
20504522|NCT00845429|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20504523|NCT00971321|GlaxoSmithKline|GSK Response Center|866-435-7343||
20509911|NCT02421146|Psychiatry Research, The Zucker Hillside Hospital|Andrea Joanlanne|7184708898|ajoanlanne@northwell.edu|
20509912|NCT01894776|Ottawa Hospital Research Institute|Dr. Bill Cameron|613-737-8899|bcameron@toh.ca|78923
20504524|NCT04222725|Tarsier Pharma|Zohar Milman|+972-50-8371319|Zohar Milman <zohar@Tarsierpharma.com>|
20504525|NCT03519178|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504526|NCT03256539|University of California, San Francisco|Dr. Yue Leng|415 502 2949|yue.leng@ucsf.edu|
20550980|NCT00127712|Purdue University|James E. Tisdale|317-613-2315|jtisdale@iupui.edu|306
20550981|NCT03055260|University of Minenesota|Russel Giveans|5042314007|russell.giveans@gmail.com|
20550982|NCT02507505|University of Pennsylvania Perelman School of Medicine|Mark D. Neuman, MD, MSc (Principal Investigator)|215-746-7468|mark.neuman@uphs.upenn.edu|
20550983|NCT02335489|St. Jude Medical|Roni Diaz|+1 972 309 8601|rdiaz@sjm.com|
20550984|NCT01207765|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
20550985|NCT01969240|Mayo Clinic|Dr. Erik Hess|507-284-7221|hess.erik@mayo.edu|
20550986|NCT02653391|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20550987|NCT02452346|Weill Cornell Medicine|Dr. Sangmin Lee, MD|646-962-2700|sal9053@med.cornell.edu|
20504527|NCT04045912|University of California, San Francisco|Dr. Jenny Liu|1-415-502-5200|Jenny.Liu2@ucsf.edu|
20504528|NCT00513344|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
20504529|NCT05917288|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20504530|NCT01591330|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20504531|NCT02782715|University of Wisconsin School of Medicine and Public Health|Michael Bassetti, MD, PhD|608-263-8500|bassetti@humonc.wisc.edu|
20504532|NCT04429932|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
20504533|NCT01294228|Alere San Diego|Director of Clinical Affairs|1-858-805-4808|william.arnold@alere.com|
20504534|NCT01919411|Massachusetts Eye & Ear Infirmary|Dr. Eric Holbrook|617-573-3209|Eric_Holbrook@meei.harvard.edu|
20504535|NCT00144300|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504536|NCT01031095|Bursa Postgraduate Hospital|Dr.Hasan ARI|00902243605050|hasanari03@yahoo.com|1739
20504537|NCT04125745|University of California San Francisco|Marc Simon, MD, Director of Pulmonary Vascular Disease and Pulmonary Hypertension Comprehensive Care|415-476-1325|Marc.Simon@ucsf.edu|
20504538|NCT00833859|H. Lee Moffitt Cancer Center and Research Institute|Gregory Springett, M.D., Ph.D., via Moffitt Cancer Center|813-745-6898|gregory.springett@moffitt.org|
20504539|NCT05493280|UT Southwestern|Lead Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20504540|NCT03294304|Masonic Cancer Center, University of Minnesota|Dr. Konety Badrinath|612-625-1655|brkonety@umn.edu|
20504541|NCT00957372|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
20504542|NCT04278573|Mayo Clinic|Dr. Stephen P. Merry|507-284-5180|merry.stephen@mayo.edu|
20504543|NCT01444391|Acclarent|Director Clinical|650-687-5888|lenglan1@its.jnj.com|
20504544|NCT01877655|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20504545|NCT02798523|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Luis Franco|+1 240 220 4366|luis.franco@nih.gov|
20504546|NCT00538733|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
20504547|NCT00095121|Gilead Sciences|John Flaherty, PharmD, Director, Clinical Research|650-522-5592|John.Flaherty@gilead.com|
20504548|NCT02677740|University of Minnesota|Silvia Mangia, Associate Professor|6126254920|mangia@umn.edu|
20504549|NCT04070378|The Feinstein Institutes for Medical Research|Marc L Gordon, MD|(516) 562-3492|mlgordon@northwell.edu|
20504550|NCT03567187|University of Kansas Medical Center|Neil Segal, MD|9135740961|segal-research@kumc.edu|
20504551|NCT01225068|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
20504552|NCT03596645|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20504553|NCT04358458|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
20504554|NCT06046560|Mass General Brigham|Alexander Blood, MD|617-732-7144|ablood3@mgb.org|
20504555|NCT02277444|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20504556|NCT05278104|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504557|NCT01843374|AstraZeneca|Paul Stockman, MD, PhD|+44 162-523-1815|Paul.Stockman@astrazeneca.com|
20504558|NCT01709799|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
20504559|NCT01123889|Loma Linda University Orthopaedic Surgery|Liz Clarke|909-558-5592|eaclarke@llu.edu|
20504560|NCT00812110|Akron Children's Hospital|P. Cooper White, M.D.|330-543-8530|CWhite@chmca.org|
20504561|NCT00443560|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
20504562|NCT02082184|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
20504563|NCT04352660|UCSD Shiley Eye Institute|Dr. Jiun Do|8585346290|jiundo@ucsd.edu|
20504564|NCT01197573|Cleveland Clinic|Bijan Eghtesad, MD|216 444-9898|eghtesb@ccf.org|
20504565|NCT01466751|Stanford University|Amit Etkin|650-725-5736|amitetkin@stanford.edu|
20504566|NCT02413255|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20504567|NCT02333331|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20504568|NCT02413398|Global Clinical Leader-Dapagliflozin AstraZeneca|Anna Maria Langkilde, MD PhD|Tel: + 46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20504569|NCT01494038|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20504570|NCT03847337|Vanderbilt University Medical Center|Zachary Warren|615-875-3085|zachary.e.warren@vumc.org|
20504571|NCT00537940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504572|NCT03215914|University of Pennsylvania|Cornelia V. Dalton Bakes|215-746-2085|corneliv@pennmedicine.upenn.edu|
20504573|NCT00623012|Yale University|Dr. Stuart Seropian|203-737-2477|Stuart.Seropian@yale.edu|
20504574|NCT03952546|Northwell Health System|Nancy Dengler, RN, MS Clinical Research Nurse|516-496-2637|ndengler@northwell.edu|
20504575|NCT00685178|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
20504576|NCT00249379|Virginia Commonwealth University|Michael Weaver, MD|804-828-1283|mweaver@mcvh-vcu.edu|
20504577|NCT00416351|Memorial Sloan Kettering Cancer Center|Dr. Steven Horowitz MD|646-608-2680|horwitzs@mskcc.org|
20504578|NCT00077623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20504579|NCT01334125|University of Massachusetts Medical School|Benjamin U. Nwosu, MD|5083347872|Benjamin.Nwosu@umassmemorial.org|
20509913|NCT02402881|The Johns Hopkins University|Elliott R Haut, MD PhD|410-502-3122|ehaut1@jhmi.edu|
20509914|NCT02614261|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20528176|NCT02070978|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20528177|NCT00376532|Thomas Jefferson University|David J. Whellan MD|215 955 2636|david.whellan@jefferson.edu|
20504580|NCT02412644|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
20504581|NCT02836886|Columbia University|Larisa Geskin, MD|2123055550|ljg2145@cumc.columbia.edu|
20550988|NCT00531050|Novartis Pharmaceuticals|Study Director|862-778-8300||
20550989|NCT01067456|MGH|Dr. Udo Hoffmann|617-726-1255|uhoffmann@partners.org|
20550990|NCT01411696|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20550991|NCT01034462|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20550992|NCT00227903|Yale University|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
20550993|NCT04273217|AbViro LLC|Urban Ramstedt|617-818-8112|urban.ramstedt@abviro.com|
20550994|NCT04309656|TB Alliance|Erica Egizi|917-696-4984|erica.egizi@tballiance.org|
20550995|NCT03720470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20550996|NCT02311933|Alliance for Clinical Trials in Oncology|Matthew P. Goetz, MD|: 507-284-2511|goetz.matthew@mayo.edu|
20550997|NCT05740644|Zynex Monitoring Solutions|Clinical Team|888-386-4185|clinical@zynexmonitoring.com|
20550998|NCT02056340|Beth Israel Deaconess Medical Center|Dr Maureeen Chase, Assistant professor of Emergency Medicine|6177542298|mchase1@bidmc.harvard.edu|
20550999|NCT03498300|Faculty of Medicine Siriraj Hospital, Mahidol University|Dr. Nalat Sompagdee|+6687-008-7100|pear_nalat@hotmail.com|
20551000|NCT01414855|Genentech, Inc.|Medical Communications|800-821-8590|genetech@druginfo.com|
20551001|NCT04851314|UC Irvine Health|Dr. Robert Ryan Field|7145065703|fieldr@uci.edu|
20551002|NCT00867009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20504582|NCT02138110|InVivo Therapeutics Corporation|Dr. Rich Toselli|(617) 863-5540|rtoselli@invivotherapeutics.com|
20504583|NCT00844298|Asan Medical Center, University of Ulsan College of Medicine|Dr. Dae-Young Kim|82230105930|dani@amc.seoul.kr|
20504584|NCT00882713|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20504585|NCT04901026|Faculty of Medicine, Prince of Songkla University|Dr Pittayapon Pitathawatchai|+6674451390|pittayapon.p@psu.ac.th|
20504586|NCT03180736|EMN|Sarah Lonergan, Trial lead|+44 7767565020|sarah.lonergan@emn.life|
20504587|NCT05299892|Hearts For Hearing|Sara Neumann, AuD|405-548-4300|sara.neumann@heartsforhearing.org|
20504588|NCT01389128|University of São Paulo|Dr. Silvana Maria Quintana|+55(16)36022813|quintana@fmrp.usp.br|
20504589|NCT01059812|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20504590|NCT01518530|Hillel Yaffe Medical Center|Dr. Yaron River|972-523-756-446|yaronr@hy.health.gov.il|
20504591|NCT00467844|GTx Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com|
20504592|NCT00149214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20504593|NCT00756002|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20504594|NCT01538615|University of Minnesota School of Nursing|Dr. Jayne A. Fulkerson|612-624-4823|fulke001@umn.edu|
20504595|NCT00290472|University of Chicago Comprehensive Cancer Center|Dr. Sonali M. Smith|7738342895|smsmith@medicine.bsd.uchicago.edu|
20504596|NCT00174941|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20504597|NCT00003820|Stanford University|Ranjana Advani, MD, Professor of Lymphoma|650-725-6456|radvani@stanford.edu|
20504598|NCT00981435|Stanford University|Clinical Research Coordinator|6507236995|mnunez1@stanford.edu|
20504599|NCT03968965|Hospital for Special Surgery|Celeste Abjornson|2127742126|AbjornsonC@HSS.edu|
20504600|NCT01120639|Stanford University|Dr. Scott Soltys (Associate Professor of Radiation Oncology)|650-724-1569|sgsoltys@stanford.edu|
20504601|NCT01844076|Fox Chase Cancer Center|Crystal Denlinger MD, FACP|215-214-1676|Crystal.Denlinger@fccc.edu|
20504602|NCT05483127|Alcon Research, LLC|Associate Director, CRD Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20504603|NCT00315302|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
20504604|NCT03794986|Yale University, School of Medicine|Dr. Joan Cook|203-856-2782|joan.cook@yale.edu|
20504605|NCT05309083|Washington University School of Medicine|Dr. Kerri Rawson|813-468-8900|rawson@wustl.edu|
20551003|NCT02289079|University of MInnesota|Dr. Jacob Hutchins|6126249990|hutc0079@umn.edu|
20504606|NCT01165229|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504607|NCT00474253|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20504608|NCT01720251|ANERGIS SA|Dr Gilles DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
20504609|NCT00550238|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20504610|NCT03133481|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
20504611|NCT02273115|University of Massachusetts - Baystate|Dr. Corina Schoen|4137543470|Corina.SchoenMD@baystatehealth.org|413
20504612|NCT03000452|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20504613|NCT02255838|University of Louisville|Rainer Lenhardt|5028523122|rainer.lenhardt@louisville.edu|
20504614|NCT05372315|Iworks Laser and Vision Center|Dr. Patrick L. Spencer|937-226-7870|iworkeye@gmail.com|
20504615|NCT00537745|PIRE|Patricia Hokanson|505-765-2325|info@bhrcs.org|
20551004|NCT03036072|Maine Medical Center|Alexa Craig, MD|207-396-6920|craiga@mmc.org|
20551005|NCT02671422|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551006|NCT04772755|Duke University|Emmanuel B Walter, MD, MPH|919-620-5346|chip.walter@duke.edu|
20551007|NCT00662363|Rehabilitation Institute of Chicago|Christina Marciniak|312-238-1000|cmarciniak@ric.org|
20551008|NCT05838742|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20551009|NCT05119569|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20551010|NCT03909178|Massachusetts General Hospital|Dr. Scott Martin|(617) 726-7500|sdmartin@partners.org|
20551011|NCT01754623|Florida Hospital Orlando (Formerly at Moffitt Cancer Center)|Ravi Shridhar, M.D., Ph.D.|407-303-5857|ravi.shridhar.md@flhosp.org|
20551012|NCT03700671|University of Central Lancashire|Stefan Birkett Lecturer in Exercise Science|01772 893325|sbirkett4@uclan.ac.uk|
20551013|NCT01083368|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
20551014|NCT03578367|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20551015|NCT00254540|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20551016|NCT01287897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551017|NCT02902965|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
20551018|NCT00293254|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20551019|NCT00503308|UCSF, San Francisco General Hospital|Deborah Cohan, MD|415 206 3658|cohand@obgyn.ucsf.edu|
20551020|NCT04481750|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
20551021|NCT01475331|Milton S. Hershey Medical Center|Dr. Matthew T. Moyer|717-531-3694|mmoyer@pennstatehealth.psu.edu|
20551022|NCT00462761|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20551023|NCT00723892|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800--672-6372|ClinicalTrialsDisclosure@merck.com|
20551024|NCT04532099|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20551025|NCT01194479|Department of Internal Medicine and Endocrinology, Yale University School of Medicine, New Haven, CT|Robert Sherwin, MD|(203) 785-3482|robert.sherwin@yale.edu|
20558583|NCT00452413|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20509915|NCT02460172|ZipLine Medical|Wendy Winters, Clinical Project Manager|408-506-1866|wwinters0@gmail.com|
20558584|NCT00773955|Washington University|Maria Q. Baggstrom, M.D.||Mbaggstr@im.wustl.edu|
20509916|NCT03512275|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20558585|NCT03119610|UT Health San Antonio|Sara Espinoza, MD|210-617-5197|espinozas2@uthscsa.edu|
20558586|NCT05150587|Alfasigma|Nicola Gargano - Senior Clinical Scientist|0039 (0)6 91395072|nicola.gargano@alfasigma.com|
20528178|NCT01133704|Dendreon Corporation|Kathleen Picha|206-265-4545|kpicha@dendreon.com|
20558587|NCT00332605|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
20558588|NCT00000143|Johns Hopkins School of Public Health|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
20558589|NCT02765490|Janssen Research & Development, LLC|Trial Physician, Medical Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20558590|NCT03237013|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
20558591|NCT04548531|Massachusetts General Hospital|Karen Sepucha|6177243350|ksepucha@mgh.harvard.edu|
20558592|NCT01466764|Stanford University|Gary Peltz|650-721-2487|gpeltz@stanford.edu|
20504616|NCT01512368|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Daniel Cuevas-Ramos|525554870900|shiverqks@hotmail.com|2407
20504617|NCT01823653|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
20504618|NCT01754688|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher, MD|612-624-4586|tslusher@umn.edu|
20504619|NCT01515072|Rutgers-New Jersey Medical School|Baburao Koneru, MD, MPH|(973) 972-9599|koneruba@njms.rutgers.edu|
20504620|NCT03700892|University of North Carolina at Chapel Hill, Center for Environmental Medicine Asthma and Lung Biology|Assistant Director of Clinical Research|919 966-5638|robinet@med.unc.edu|
20504621|NCT00849212|Eisai Call Center|Eisai Inc.|888-422-4743||
20504622|NCT04407507|Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V|Carmen de la Rocha|523320028697|carmen.delarocha@investigacionbiomedica.com.mx|306
20504623|NCT01499576|Konyang University Hospital|Dr. Kyung Ho SONG, Assistnat Professor of Konyang University||postit2@daum.net, postit@kyuh.ac.kr|
20504624|NCT02228499|The George Washington University|Dr. Seema Agrawal|202 699 1648|seema300@yahoo.com|
20504625|NCT00748657|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20504626|NCT01662999|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20504627|NCT02426086|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
20504628|NCT00524303|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504629|NCT03478683|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20504630|NCT01769404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20504631|NCT02293954|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20504632|NCT01330381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20504633|NCT05665335|Apyx Medical|Kari Larson, Sr. Director of Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
20504634|NCT01978912|Teijin America, Inc.|President|+1-212-308-8744|clinical-trials-safety@teijinpo.com|
20504635|NCT00401973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20504636|NCT01408537|Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Thailand|Dr. Pornthep Chanthavanich|6623549161|tmpct@mahidol.ac.th|
20504637|NCT01878006|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
20504638|NCT03019055|Froedtert Hospital and the Medical College of Wisconsin|Dr. Nirav Shah, MD|414-805-8900|cccto@mcw.edu|
20504639|NCT05099991|Stanford University|Research Team|(650) 497-5175|gynresearch@stanford.edu|
20504640|NCT04075604|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20504641|NCT02760602|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20504642|NCT00708877|University of Utah|Dr. Jason Schwarz|8015852708|jason.schwartz@hsc.utah.edu|
20504643|NCT03159754|University of Michigan|Steven Bruch, MD|7349368464|sbruch@umich.edu|
20504644|NCT04329923|UPenn|Amelia Anderson|215-509-5690|amelia.anderson@pennmedicine.upenn.edu|
20504645|NCT01272180|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20504646|NCT03334214|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20504647|NCT01260181|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20504648|NCT01330446|University of Texas M D Anderson Cancer Center|Dr. Gary B. Gunn|(713) 563-2562|gbgunn@mdanderson.org|
20504649|NCT01588197|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
20504650|NCT03351244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504651|NCT02951273|Rigshospitalet|Niels D. Olesen|004520262459|niels.damkjaer.olesen.01@regionh.dk|
20504652|NCT00121225|Princess Margaret Cancer Centre|Dr. David Hogg|416-946-4501|david.hogg@uhn.ca|4521
20504653|NCT00217438|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4933|wbensing@fhcrc.org|
20558593|NCT00258440|Oregon Health and Science Univeristy|Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
20558594|NCT00737061|Hologic, Inc.|Edward Evantash, MD, Medical Director, Vice President Medical Affairs|508-263-8475|edward.evantash@hologic.com|
20504654|NCT02437669|Columbia University College of Physicians and Surgeons|Daniel S. Tsze, MD, MPH|212-305-9825|dst2141@columbia.edu|
20558595|NCT03767634|Imperial College London|Dr Chris Gale|+44 (0)20 3315 3519|christopher.gale@imperial.ac.uk|
20558596|NCT01035333|Albany College of Pharmacy and Health Sciences|Dr Margaret Malone|518 694 7275|margaret.malone@acphs.edu|
20558597|NCT06173570|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20558598|NCT01844115|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20558599|NCT00366301|Brigham and Women's Hospital|Aruna Pradhan|617-732-8777|apradhan@partners.org|
20558600|NCT01372605|University of North Carolina-Chapel Hill|Dr. Brian Pence|9199667446|bpence@unc.edu|
20558601|NCT01108510|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20558602|NCT00210119|Institut Bergonie|Dr Gabriel Etienne||g.etienne@bordeaux.unicancer.fr|
20558603|NCT00951509|Human Engineering Research Labs|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
20558604|NCT01361620|George Washington University|Dr. Timothy McCaffrey|(202) 994-8919|mcc@email.gwu.edu|
20558605|NCT00706784|MGH|Alexandra B. Kimball, MD|617-726-5066|akimball@partners.org|
20558606|NCT01830881|Oregon Health and Science University|Lisa Bayer, MD|503-494-3666|whru@gmail.com|
20558607|NCT03125941|rigshospitalet|kristin steinthorsdottir, md|31666112|kjs@dadlnet.dk|
20558608|NCT00734214|McMaster University|Dr. Karen Choong|905-5212100|choongk@mcmaster.ca|75617
20558609|NCT00582491|Yale University School of Medicine|Peter Morgan, MD, PhD|203-974-7515|Peter.Morgan@yale.edu|
20558610|NCT01425632|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20558611|NCT00406419|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
20558612|NCT03487718|University of Kentucky|Ridge Preservation with Leukocyte Platelet Rich Fibrin: A Clinical, Radiographic, and Histomorphomet|8593236193|firasayafi@uky.edu|
20558613|NCT02340520|UConn Health|Nausherwan Burki, MD||nburki@uchc.edu|
20558614|NCT01121484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558615|NCT03915951|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558616|NCT00930943|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|781-588-5430|Spierings@MedVadis.com|
20558617|NCT03428126|MD Anderson Cancer Center|Dr. Michael Overman|(713) 792-2828|moverman@mdanderson.org|
20558618|NCT00447954|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20558619|NCT03916744|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20558620|NCT04524598|Limbix Health|Janel Shelton-DeMagnus, Research Operations Manager|8885462495|janel@limbix.com|709
20558621|NCT02066896|Federal University of Sao Paulo|Tania Sales de Alencar Fidelix|11991346992|fidelixtania@gmail.com|11
20558622|NCT00513786|The Ohio State University Comprehensive Cancer Center|Dr. David O'Malley|614-293-3873|David.O'Malley@osumc.edu|
20558623|NCT05067933|Vaxart|Melanie Drayton|650-392-3109|ClinicalTrials@Vaxart.com|
20558624|NCT03311230|University of Pennsylvania|Joseph Harrison|2157461249|joseph.harrison@uphs.upenn.edu|
20558625|NCT03342053|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20558626|NCT01302938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558627|NCT01586312|Instituto de Biología y Genética Molecular (IBGM)|Professor Javier Garcia-Sancho|34 983 423 084|jgsancho@ibgm.uva.es|
20558628|NCT02061696|Borgess Heart Institute|Frank Saltiel, MD|269-381-3963||
20558629|NCT02415998|University of Iowa|Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
20558630|NCT04921969|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20558631|NCT04287868|National Cancer Institute|Dr. Charalampos Floudas|240-858-3032|charalampos.floudas@nih.gov|
20558632|NCT01282476|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
20558633|NCT01542541|BIDMC|Dr Alan Moss|6176673197|amoss@bidmc.harvard.edu|
20558634|NCT00670462|University of Minnesota|Robert W. Jeffery PhD|612-626-8580|jeffe001@umn.edu|
20558635|NCT01811563|Duke University Medical Center|Samuel Wellman, MD|919-681-4055|samuel.wellman@duke.edu|
20558636|NCT01087723|The Medicines Company|Global Health Science Center|800-388-1183||
20558637|NCT00806624|Daiichi Sankyo.,LTD|Atsushi Nonogaki, Manager|81-80-3029-7553|nonogaki.atsushi.zz@daiichisankyo.co.jp|
20558638|NCT00636792|Millennium Pharmaceutical Inc|Carol Satler|(617) 551-3729||
20558639|NCT01235975|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558640|NCT01798186|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20558641|NCT00101660|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20558642|NCT00708305|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504655|NCT02088034|Northwestern University|Matthew J. O'Brien, MD|312-503-5046|matthew.obrien1@northwestern.edu|
20504656|NCT05780281|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
20504657|NCT00308620|University of Minnesota|David Boulware|6126269546|boulw001@umn.edu|
20504658|NCT00091793|Amgen Inc.|Study Director|866-572-6436||
20504659|NCT03002506|Texas Tech UHSC|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
20504660|NCT01025336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504661|NCT02102230|VA Palo Alto Health Care System|Kimberly Babson, PhD|831-325-1540|kimberly.babson@gmail.com|
20528179|NCT03372382|McGovern Medical School, University of Texas, Health Science Center at Houston|Dr Jenifer Dinis, MD|713 500 6421|jenifer.dinis@uth.tmc.edu|
20558643|NCT04711460|University of MN|Joan D. Lund|612-273-9115|Lund1687@umn.edu|
20558644|NCT00282815|University of Michigan|Devin Brown, MD|734-936-9075|devinb@umich.edu|
20558645|NCT00192023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20558646|NCT00114634|NICHD, NIH|Forbes D Porter|301-435-4432|fdporter@mail.nih.gov|
20558647|NCT02572817|National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
20558648|NCT02104830|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
20509917|NCT00113555|Uromedica|Timothy Plouffe|763-999-7048|tplouffe@uromedica-inc.com|
20528180|NCT01466075|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20551026|NCT02451839|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20551027|NCT02734238|Pennington Biomedical Research Center|Jennifer C. Rood|225-763-2524|jennifer.rood@pbrc.edu|
20551028|NCT01949051|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551029|NCT02935088|Abbott Vascular|Tarn Teraphongphom, Sr. Clinical Scientist|408-9310504|tarn.teraphongphom@abbott.com|
20551030|NCT01506479|University of Pittsburgh|Dr. Charity G. Moore|412-383-6630|cgp22@pitt.edu|
20551031|NCT01846507|Nationwide Children's Hospital|Sarah O'Brien, MD|614-722-3070|sarah.obrien@nationwidechildrens.org|
20551032|NCT01782859|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
20551033|NCT04994522|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20551034|NCT04900220|West Virginia University|Dr. Shafic Sraj - Associate Professor|304-293-3007|shafic.sraj@hsc.wvu.edu|
20551035|NCT04474704|The Ohio State University|Maged Costantine, MD|614-293-2222|Maged.Costantine@osumc.edu|
20551036|NCT00147199|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20551037|NCT03266094|Medtronic|Melody LaBeau, Director of Clinical Operations|763.526.2931|melody.a.labeau@medtronic.com|
20551038|NCT03128892|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
20551039|NCT01850524|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20551040|NCT00368355|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
20551041|NCT02727751|Ardelyx|Chief Development Officer|5107451752|drosenbaum@ardelyx.com|
20551042|NCT04061915|New York University|S. Raquel Ramos|212-992-5994|TheHOTIEStudy@gmail.com|
20551043|NCT03473808|Medical University of South Carolina|Amanda Vatinno|8437924840|vatinno@musc.edu|
20551044|NCT01706081|Memorial Sloan Kettering Cancer Center|Dr. Ting Bao MD|646-888-0865|baot@mskcc.org|
20551045|NCT03171415|Raziel Therapeutics|Racheli Gueta - Clinical Trials Manager|972-8-9126941|racheli@raziel-therapy.com|
20551046|NCT03057431|Inselspital, Bern University Hospital, Bern, Switzerland|Prof. Daniel Fuster|++41316323144|daniel.fuster@insel.ch|
20551047|NCT01085591|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
20551048|NCT03457129|University of Arizona, College of Medicine Phoenix|Stephanie Marsh, MPH, CCRC|602-255-7552|slmarsh@arizona.edu|
20551049|NCT03649750|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20551050|NCT00459667|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20551051|NCT00118365|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
20551052|NCT00396591|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
20551053|NCT00671502|Meda Pharma US|David Ginsberg, MD Sr Medical Director|732 564 2364|david.ginsberg@meda.us|
20551054|NCT01846611|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20551055|NCT00541034|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|1212-639-7053|brentjer@mskcc.org|
20551056|NCT01988857|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551057|NCT00847704|Oregon Health & Science University|Paul J. Cordo|503-418-2520|cordop@ohsu.edu|
20551058|NCT03061331|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20551059|NCT01905657|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20551060|NCT02123745|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
20551061|NCT04080297|Chief Exceutive Officer|Rob Crombie|+61 3 9657 0731|rcrombie@queoncology.com|
20551062|NCT02744391|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
20551063|NCT02607033|Baltimore VA Hosptial|Odessa Addison|4106057000|odessa.addison@va.gov|55393
20551064|NCT06092710|CAndreRenard|CEDRIC GARCION|+33661817274|cedric.garcion.osteo@gmail.com|
20551065|NCT02623439|University of California, San Diego|Michelle Padilla|(858) 822-5354|CancerCTO@health.ucsd.edu|
20551066|NCT01880840|Meda Pharmaceutical|Dr.Nancy Ruiz Chief Medical Officer|732 564 2200|nancy.ruiz@meda.us|2390
20551067|NCT04484142|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20551068|NCT05371509|Mayo Clinic|Umesh Goswami, M.B.B.S., M.D.|480-342-1137|goswami.umesh@mayo.edu|
20551069|NCT06253806|Washington University, Department of Otolaryngology - Head and Neck Surgery|Nyssa Farrell, MD|314-273-2490|nyssafarrell@wustl.edu|
20551070|NCT03851302|Bronx Veterans Medical Research Foundation|Principal Investigator|718-584-9000 x1742|NOAM.HAREL@VA.GOV|
20551071|NCT04434092|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20551072|NCT02879305|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20558649|NCT01614847|Northeastern State University Oklahoma College of Optometry|Thomas O. Salmon, OD, PhD, Professor|918-444-4011|salmonto@nsuok.edu|
20558650|NCT01165840|Texas Tech University HSC|Ronald Hall|214-358-9009|ronald.hall@ttuhsc.edu|
20558651|NCT00249496|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20558652|NCT02310126|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
20558653|NCT02441946|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20558654|NCT00439179|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
20558655|NCT04957732|University of Florida Shands Emergency Department|Richard Petrik, MD, Clinical Assistant Professor|352-265-5911||
20558656|NCT02378402|Department of Radiology, Chang Gung Memorial Hospital|Gigin Lin, MD, PhD|886-3-3281200|giginlin@cgmh.org.tw|2575
20504662|NCT00637728|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
20558657|NCT01232465|North Shore|Dennis Marchesi|516-562-1761|dmarches@nshs.edu|
20558658|NCT00758160|Janssen Pharmaceutical, Taiwan|Medical Affairs Director|+886-2-23762155||
20558659|NCT00545363|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20558660|NCT01258660|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20558661|NCT02136498|Group Health Research Institute|Principle Investigator|206-287-2737|mcclure.j@ghc.org|
20558662|NCT00350701|University at Buffalo|Dr. Paresh Dandona|7165351850|dandona@buffalo.edu|
20558663|NCT01840319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558664|NCT05064735|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20558665|NCT01396395|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20558666|NCT03691948|Medical University of South Carolina|Jenna L. McCauley, PhD, Assistant Professor of Psychiatry|8437923922|mccaule@musc.edu|
20558667|NCT01370005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558668|NCT02009696|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
20558669|NCT01018563|Eisai Medical Information|Eisai Medical Information|888 422 4743|esi_medinfo@eisai.com|
20558670|NCT02344537|New York State Psychiatric Institute|Brian Fallon, MD|6467748052|brian.fallon@nyspi.columbia.edu|
20558671|NCT00798486|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20558672|NCT00589550|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
20558673|NCT04844970|Lahey Hospital & Medical Center|Julia Roache, Manger, Research Programs|7817443055|julia.roache@lahey.org|
20558674|NCT00856661|H. Lundbeck A/S|study director||LundbeckClinicalTrials@Lundbeck.com|
20558675|NCT02120664|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20558676|NCT02460263|Outset Medical, Inc|Clinical Operations|(669) 231-8200|clinical@outsetmedical.com|
20558677|NCT02306122|Brown University|Joanne Michaud|401-863-9317|joanne_michaud@brown.edu|
20558678|NCT01351025|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
20504663|NCT01050062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504664|NCT00325572|Milton S. Hershey Medical Center|Jeanette C. Ramer MD|717 531-8414|jramer2@hmc.psu.edu|
20504665|NCT01873950|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
20504666|NCT03894540|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20504667|NCT03043365|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
20504668|NCT00593112|Massachusetts General Hospital|Paul Hammerness, M.D.|617-503-1040|phammerness@partners.org|
20558679|NCT00525603|The University of MD Anderson Cancer Center|William G. Wierda, MD/Associate Professor|713-745-0428|eharriso@mdanderson.org|
20558680|NCT02638623|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
20558681|NCT00180713|Imperial College London|Professor Martin R Wilkins|+44 (0)20 8383 2049|m.wilkins@imperial.ac.uk|
20558682|NCT00479089|The University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
20558683|NCT00735449|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20558684|NCT05295732|LEO Pharma A/S|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
20558685|NCT04152343|Dartmouth-Hitchcock Medical Center|Dr. Eric Hoffer, Director of Interventional Radiology|603 650 7417|hoffer@hitchcock.org|
20558686|NCT00550550|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20558687|NCT00118092|Karmanos Cancer Institute at Wayne State University|Elisabeth Iljas Heath, M.D.||heathe@karmanos.org|
20558688|NCT03519243|BIOCAD|Linkova Iuliia|+7 (495) 992 66 28|linkova@biocad.ru|930
20558689|NCT00591864|Mayo Clinic|Amy Lynn Conners MD|(507) 284-2511|MBI@mayo.edu|
20558690|NCT02459093|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
20558691|NCT01965938|Vanderbilt University School of Medicine|Dr. Bret Alvis, MD|615-343-6268|bret.d.alvis@vanderbilt.edu|
20558692|NCT02090634|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
20504669|NCT02723630|Eisai Inc.|Eisai Medical Services|1-888-247-2378|esi-medinfo@eisai.com|
20558693|NCT00977769|Oslo University Hospital|Professor Leiv Arne Rosseland|+4723070000|lrossela@ous-hf.no|
20558694|NCT02736968|University of California, San Diego|Sharon Reed, MD|858-822-2808|slreed@ucsd.edu|
20558695|NCT00171873|KKS Marburg|Carmen Schade-Brittinger|0049-6421-2866458|carmen.brittinger@kks.uni-marburg.de|
20558696|NCT02041923|University of Illinois at Chicago|Rosemary White-Traut|312-996-7935|rwt@uic.edu|
20558697|NCT04613882|Coopervision|Jose A. Vega, OD, MSc, FAAO|9256213761|javega@coopervision.com|
20558698|NCT00621296|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20558699|NCT00384059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558700|NCT01774071|Memorial Sloan Kettering Cancer Center|Dr. Steven Larson, MD|646-888-2212|LarsonS@MSKCC.ORG|
20558701|NCT00381641|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
20504670|NCT02532543|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidgetta_jenkins@unc.edu|
20504671|NCT00650585|PIRE|Heddy Clark|919-265-2643|hclark@pire.org|
20504672|NCT02640612|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504673|NCT03583424|The Ohio State University Comprehensive Cancer Center|Dr. Kami Maddocks|614-293-9165|Kami.Maddocks@osumc.edu|
20504674|NCT01144637|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20528181|NCT03479008|Unversity of Michigan|Dr. Benjamin Bassin|734 763-2134|bsbassin@med.umich.edu|
20528182|NCT02753816|Spectrum Health|Dr. Betsy Steensma|(616) 391-5701|elizabeth.steensma@spectrumhealth.org|
20528183|NCT02259400|"AOU G. Martino Universitary Hospital of Messina"|Dr. Vincenzo Salvo|+39 0902212132|salvovincenzo@virgilio.it|
20528184|NCT02384538|AbbVie|Global Medical Services|800-633-9110||
20528185|NCT02872909|University of Dundee|Professor Sally Ibbotson|01382 383499|s.h.ibbotson@dundee.ac.uk|
20528186|NCT02094326|Hospital Virgen de la Macarena|Dr. Federico Navarro Sarabia|+34 955 00 80 00|federico.navarro.sarabia@gmail.com|
20528187|NCT00809094|Stanford University|Dr. Carol Conrad|650-723-8325|cconrad@stanford.edu|
20528188|NCT01535443|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medial Director|+52 (33)30014200|lbaiza@sophia.com.mx|
20528189|NCT02620683|University of North Carolina Chapel Hill|Dr Raymond P. White Jr|919-537-3944|ray_white@unc.edu|
20528190|NCT00893074|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
20528191|NCT02260817|Decatur Memorial Hospital, Decatur, IL|Thomas H. Tarter, M.D., Ph.D - Director, Urologic Oncology, Cancer Care Specialists of Illinois|(217) 876-6600|ttarter@ccsci.net|
20528192|NCT03299101|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
20504675|NCT00906789|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
20504676|NCT02334267|Frenova Renal Research|Brigid Flanagan, MS, RN, CCRC|781-699-2970|Brigid.Flanagan@frenovarenalresearch.com|
20504677|NCT00923091|Daiichi Sankyo Europe, GmbH|Bettina Ammentorp|00498978080|bettina.ammentorp@daiichi-sankyo.eu|
20504678|NCT01889810|Queen's University, Belfast|Professor Michelle McKinley|02890978936|m.mckinley@qub.ac.uk|
20504679|NCT01645280|Janssen Pharmaceuticals|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
20504680|NCT01819922|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504681|NCT02460822|University of Michigan|Dr. Lawrence C. An|734-763-6099|lcan@med.umich.edu|
20504682|NCT04276558|Recordati Rare Diseases Sarl|Beatrice Martin, Clinical study Manager|+33 1 47 73 64 58|martin.be@recordati.com|
20504683|NCT01254344|Merck Sharp & Dohme (China) Ltd.|Naimi Missoum|+8621 2211 8546|naimi_missoum@merck.com|
20504684|NCT03322657|Cleveland Clinic Foundation|Dr. Ehab Farag|216 444-7550|FARAGE@ccf.org|
20504685|NCT04634162|Division of Cardiology University of Florida College of Medicine - Jacksonville|Francesco Franchi, MD|1-904-244-2060|francesco.franchi@jax.ufl.edu|
20504686|NCT03249350|Oregon Social Learning Center|Dr. Mike McCart|541-485-2711|MikeM@oslc.org|
20504687|NCT00624338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20504688|NCT01476787|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20504689|NCT04170621|FARAPULSE|Christopher (Kit) Schneider|6176867661|christopher.schneider@bsci.com|
20504690|NCT02986373|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20504691|NCT02514070|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
20504692|NCT00098059|Novartis Pharmaceuticals|Study Director|862-778-8300||
20504693|NCT01151137|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
20504694|NCT01933672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504695|NCT01684826|Philips|Frank Everaerts|+31630728782|frank.everaerts@philips.com|
20504696|NCT01274897|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20504697|NCT02768129|Butler Hospital|Benjamin Greenberg|(401) 455-6200|bgreenberg@butler.org|
20504698|NCT02680301|Seton Family of Hospitals/Ascension|Katherine Sebastian|801-598-2484|krsebastian@ascension.org|
20504699|NCT02378753|Centers for Disease Control and Prevention|Dr. Barbara Mahon|404-718-1157|bdm3@cdc.gov|
20504700|NCT00538642|University of Texas Health Science Center at San Antonio|Dr. Alexander Miller|210-567-5508|millera@uthscsa.edu|
20504701|NCT05635838|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20504702|NCT03590457|Rush University|Dr. Brady Scott|3129426389|jonathan_b_scott@rush.edu|
20504703|NCT03412630|ECOG-ACRIN Statistical Office|Study Statistician|4018639181|ecog-acrin@stat.brown.edu|
20504704|NCT02031146|University of Washington|Christina Marra, MD|206-744-3251|cmarra@uw.edu|
20504705|NCT05165394|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20504706|NCT04957498|Stanford University School of Medicine|Dr. James Lock|(650) 723-6643|jimlock@stanford.edu|
20504707|NCT00001259|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
20504708|NCT01582282|Procter and Gamble|John McRorie, PhD|513-622-1423|mcrorie.jw@pg.com|
20509918|NCT04474366|University of California, San Francisco|Esther Kim|415-353-9392|Esther.kim@ucsf.edu|
20509919|NCT00320190|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20509920|NCT03144089|University of Iowa Hospitals and Clinics|Ron Abrons, MD|(319) 353-8061|ron-abrons@uiowa.edu|
20509921|NCT03858686|Foresee Pharmaceuticals|Yisheng Lee, MD, Chief Medical Officer|4088234807|yisheng.lee@foreseepharma.com|
20509922|NCT04330989|University of North Carolina at Chapel Hill|Benjamin Chi|9194454147|bchi@med.unc.edu|
20509923|NCT02299206|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
20509924|NCT00691054|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
20509925|NCT02141854|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20528193|NCT04217317|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-5878|dfunes@wakehealth.edu|
20551073|NCT03204981|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
20504709|NCT00492622|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
20551074|NCT00623727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20551075|NCT03220217|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
20504710|NCT02629393|Origin Biosciences (affiliate of BridgeBio)|Business Development and Operations|650-391-9740|info@bridgebio.com|
20504711|NCT03937986|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
20504712|NCT00345371|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
20504713|NCT01853228|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20504714|NCT00435539|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
20504715|NCT02770287|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20504716|NCT02839746|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504717|NCT02089737|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
20504718|NCT00744055|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
20504719|NCT02767570|Stanford University|Julie Kolesar, PhD|614-561-1563|julie14@stanford.edu|
20504720|NCT04426630|Yale University School of Medicine|Dr. Jeremy Schwartz|2036801598|jeremy.schwartz@yale.edu|
20504721|NCT05523362|University Hospitals Cleveland Medical Center|Dr. Ian Neeland|(216)844-5965|Ian.Neeland@UHhospitals.org|
20504722|NCT00467649|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20504723|NCT03240081|OHSU|Dr. Martha Goetsch|503-494-3666|goetsch@ohsu.edu|
20504724|NCT04925570|Stanford Prevention Research Center, Department of Medicine, Stanford|Judith J. Prochaska, PhD, MPH|650-724-3608|jpro@stanford.edu|
20504725|NCT02111811|Crescenz VA Medical Center|David Oslin, MD|215-823-8594|dave.oslin@va.gov|
20504726|NCT00149825|Stanford University, School of Medicine|Rachel Manber, PhD|650-724-2377|Rmanber@stanford.edu|
20504727|NCT05593432|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20504728|NCT03529214|Ariadne Labs|Dr. Amber Weiseth|206-786-0282|aweiseth@ariadnelabs.org|
20504729|NCT05897853|Hospital of Ludwig Maximilians University, Munich|Prof. Dr. Michael Strupp|+49 894400|Michael.Strupp@med.uni-muenchen.de|76980
20504730|NCT03246074|SKCCC at Johns Hopkins|Stephanie Gaillard, MD PhD|410-955-3774|stephanie.gaillard@jhmi.edu|
20504731|NCT03291379|Biocompatibles UK Ltd|Sarah Cooper|07805354224|Sarah-Jane.Cooper@bsci.com|
20504732|NCT01039207|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
20551076|NCT00501293|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com|
20504733|NCT00938548|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
20504734|NCT01450137|Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland|Prof Peter M Villiger||peter.villiger@insel.ch|
20504735|NCT01926886|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20504736|NCT03368898|bakirkoy dr sadi konuk training and research hospital|İsmail Alay|+905462375638|dr_ismailalay@hotmail.com|
20504737|NCT04458857|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20504738|NCT04800315|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20504739|NCT01065428|Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine, China|Dr. Haibo Qiu; Dr. Christer Sinderby|008613951965301|haiboq2000@yahoo.com.cn|
20504740|NCT00753922|Ethicon Endo-Surgery|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
20504741|NCT00196937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20504742|NCT01322815|Ruesch Center at Georgetown Lombardi|John L Marshall|202.444.7064|marshalj@georgetown.edu|
20504743|NCT00968344|University of Texas Medical Branch|Douglas Paddon-Jones, Professor|409-772-3073|djpaddon@utmb.edu|
20504744|NCT05439928|Columbia University|Magdalena Bogun, MD|2128515494|mmb2263@cumc.columbia.edu|
20504745|NCT01526356|The University of Texas Health Science Center at Houston|Mary Kay Koenig, MD|713-500-7142|mary.k.koenig@uth.tmc.edu|
20504746|NCT03368404|Bausch + Lomb|Associate Director, Global Clinical Operations|+49 30 330 93|natasa.orlic-pleyer@bausch.com|318
20504747|NCT02983292|Senior Specialist-Clinical Study Management|Dr. Manvendra Saxena|+61 455 870 175|manvendra.saxena@smith-nephew.com|
20504748|NCT04725682|FDA/CDER/OGD|Wei-Jhe Sun, Ph.D.|301-796-6176|ORSHSR@fda.hhs.gov|
20504749|NCT00964795|Regeneron|Clinical Trials Administrator|9148475385|clinicaltrials@regeneron.com|
20504750|NCT03949673|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20504751|NCT01328873|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com|
20504752|NCT00153166|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
20504753|NCT00586690|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20504754|NCT01751646|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20504755|NCT02190591|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20504756|NCT00857246|Perlmutter Cancer Center|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
20504757|NCT00072189|California Cancer Consortium|DCC Project Administrator|: 626-256-4673|CCCP@coh.org|60094
20504758|NCT02973815|School of Nursing, University of Minnesota|Dr. Jayne A. Fulkerson|612-624-4823|fulke001@umn.edu|
20504759|NCT04542291|Washington University School of Medicine|Kian-Huat Lim, M.D.|314-362-6157|kian-huat.lim@wustl.edu|
20504760|NCT03661541|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
20504761|NCT04095416|Henry Ford Hospital|Raef Ali Fadel|3139321347|rfadel2@hfhs.org|
20504762|NCT01134510|Cedars-Sinai Medical Center|Stanely Jordan, MD|310-428-8186|stan.jordan@cshs.org|
20504763|NCT03037905|Cleveland Clinic|Christian N. Burchill, PhD, RN, CEN|216-445-9317|burchic@ccf.org|
20504764|NCT01607892|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20528194|NCT03836209|PrECOG|Li Chen, MS; Statistician|857-284-3670|Li Chen <lic@ds.dfci.harvard.edu>|
20551077|NCT00488345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504765|NCT03983941|Nationwide Children's Hospital|Julie Rice-Weimer, RN|614-355-3142|julie.rice-weimer@nationwidechildren.org|
20504766|NCT02273973|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20551078|NCT03626714|Auritec|Sarjan Shah|9092109715|sshah@auritecpharma.com|
20504767|NCT03022422|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20504768|NCT02403206|Alcon, A Novartis Division|Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20504769|NCT01676116|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20504770|NCT01287117|Genentech, Inc.|Medical Communications|800 821-8590||
20504771|NCT02042131|The University of Utah|Craig Bryan|801-587-7978|craig.bryan@utah.edu|
20504772|NCT02628223|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
20504773|NCT01821677|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|720-437-6500|clinicaltrials@ampiopharma.com|
20504774|NCT03461965|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Margaret Mann, MD|1-800-641-2422|CTUReferral@uhhospitals.org|
20504775|NCT02862912|Columbia University|Dr. Allison Lee|212-305-6494|al3196@cumc.columbia.edu|
20504776|NCT03572634|Sr. Director Drug Development/Clinical Operations|Susan Smith|210-414-7702|s.smith@toleropharma.com|
20504777|NCT00756977|Braintree Laboratories|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
20504778|NCT02606877|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504779|NCT00778999|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20504780|NCT02032524|Sanofi-Aventis Recherche & Developpement|Trial Transparency Team|800-633-1610|contact-us@sanofi.com|6#
20504781|NCT04513158|Norton Healthcare|Joseph M. Flynn, DO, MPH|502-272-5001|joseph.flynn@nortonhealthcare.org|
20504782|NCT03705494|The University of Hong Kong|Dr Kris LOK|39176690|krislok@hku.hk|
20504783|NCT02786537|UF Hepatology Research at CTRB|Lauren Morelli|352-273-9508|lauren.morelli@medicine.ufl.edu|
20504784|NCT03163342|Altimmune|Stephanie Holland, Clinical Project Manager|240|Sholland@altimmune.com|40
20504785|NCT02757547|Philips|Pat Olsen|(303) 475-3417|pat.olsen@philips.com|
20504786|NCT02162979|Loma Linda University|Tonya Hamilton, reszearch Compliance Auditor|909-558-4908|thamilton@llu.edu|
20504787|NCT01357239|Novartis Pharmaceuticals|Study Director|862-778-8300||
20504788|NCT01542372|Massachusetts|Dr. Devon Hinton|617-620-4522|DHINTON1@mgh.harvard.edu|
20504789|NCT01673061|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Medicine|2154562313|mohiuddk@einstein.edu|
20504790|NCT03455543|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
20504791|NCT00852930|Vanderbilt University School of Nursing|Sheila H, Ridner, PHD|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
20504792|NCT00779038|Janssen-Cilag Belgium|Study Responsible Physician|003214649584||
20504793|NCT05207436|VA San Diego Healthcare System|Leslie Morland|858-226-5765|leslie.morland@va.gov|
20504794|NCT02614794|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20504795|NCT04109443|Boston University School of Public Health|Kimberly M Nelson, PhD|617-358-1482|knel@bu.edu|
20504796|NCT03396471|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20504797|NCT02796144|University of North Carolina at Chapel Hill|Lars Fredrik Jarskog, MD|919-843-7683|lars_jarskog@med.unc.edu|
20504798|NCT01319929|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20504799|NCT03237845|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20504800|NCT01221233|University of Delaware, Department of Physical Therapy|Dr. Jaclyn Megan Sions, PhD, DPT, PT|302-831-7231|megsions@udel.edu|
20504801|NCT04355117|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20504802|NCT03291197|Physical Medicine and Rehabilitation Ottawa Resident|Dr. Marc Monsour|6137377350|mmonsour051@gmail.com|
20504803|NCT00234104|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
20504804|NCT04045613|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 76 302 53 10|manuel.haeckl@basilea.com|
20504805|NCT01243593|Sick Kids Hospital|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
20504806|NCT01633060|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20504807|NCT04460027|Stanford Prevention Research Center, Department of Medicine, Stanford University|Judith J. Prochaska, PhD|650-724-3608|jpro@stanford.edu|
20504808|NCT01057121|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
20504809|NCT01009294|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20504810|NCT01856673|CISALVA, Universidad del Valle|Maria Isabel Gutierrez|+57-2-5577206|maria.gutierrez@correounivalle.edu.co|103
20504811|NCT03114969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20504812|NCT02168946|Rempex Pharmaceuticals, A Wholly Owned Subsidiary of Melinta Therapeutics, Inc.|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
20504813|NCT02457897|NIDDK|Dr. Rebecca Brown|301-594-0609|Rebecca.Brown@NIH.gov|
20504814|NCT03134963|University of Leicester|Dr Lucy Beishon|0116252|lb330@le.ac.uk|3134
20504815|NCT01852344|University of Michigan|Dr. Chandra Sripada, MD PhD||csripada@umich.edu|
20504816|NCT01743027|Alcon Research, Ltd.|James Wheeler, Unit Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20504817|NCT00450866|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
20528195|NCT03739710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20551079|NCT02127567|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
20551080|NCT00903617|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551081|NCT01104636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551082|NCT00786487|University of Minnesota|Dr. Lisa Chow|612-625-8934|chow0007@umn.edu|
20558702|NCT01060020|Washington University School of Medicine|Brian R. Lindman, MD, Assistant Professor of Medicine|314-747-3617|brlindman@wustl.edu|
20558703|NCT01946243|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20558704|NCT01267825|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
20558705|NCT04249336|Dow University of Health Sciences|Syed Jaffar Abbas Zaidi|00923412481371|jaffar.zaidi@duhs.edu.pk|
20558706|NCT01242176|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558707|NCT00871351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20558708|NCT00398398|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20558709|NCT02291289|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20558710|NCT02949674|Instituto Mexicano del Seguro Social|Dr. Juan Lopez|+5257473500|juanlopez110@hotmail.com|25538
20558711|NCT00548041|Temple University Hospital|Dr. Ellen Tedaldi|215-707-2000|ellen.tedaldi@tuhs.temple.edu|
20558712|NCT01868035|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558713|NCT02550132|Université du Québec à Trois-Rivières|Dr Martin Descarreaux DC, PhD|18193765011|martin.descarreaux@uqtr.ca|3791
20558714|NCT01617083|University of South Florida Rothman Center|Study Coordinator|7277678393|ebrenna1@health.usf.edu|
20558715|NCT04995497|University of Iowa Healthcare|Archit Sharma, M.D.|(319) 384-7911|archit-sharma@uiowa.edu|
20558716|NCT00154063|Eisai Call Center|Eisai Inc.|888-422-4743||
20558717|NCT01804673|Clinic for Anaesthesiology, Intensive Care Unit and Pain Therapy at the Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Str. 33, 48149 Munster.|Head|+49 251 / 83 - 4 72 52||
20558718|NCT03483077|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558719|NCT01857934|St. Jude Children's Research Hospital|Sara M. Federico, MD|866-278-5833|referralinfo@stjude.org|
20558720|NCT01024959|Gen-Probe, Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
20504818|NCT00138151|Rutgers Cancer Institute of New Jersey|Lorna Rodriguez, MD, PhD|732-235-8675|rodriglo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20504819|NCT02624700|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|(804) 828-0450|AskMassey@vcu.edu|
20504820|NCT02675517|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504821|NCT01950078|Huazhong University of Science and Technology|Dr. Xianwei Zhang|027 83663173|znpin@sina.cn|
20504822|NCT05121103|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20504823|NCT02101008|Huntsman Cancer Institute|Kenneth Grossmann|801-587-4289|kenneth.grossmann@hci.utah.edu|
20504824|NCT02772783|Boston Children's Hospital|Belinda Lennerz|617 355 7476|belinda.lennerz@childrens.harvard.edu|
20504825|NCT02830165|University of California at Los Angeles, David Geffin School of Medicine, Radiation Oncology|Nicholas Nickols, MD|310 825-8278|nnickols@mednet.ucla.edu|50472
20504826|NCT03443024|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20504827|NCT00301067|Northwestern University|Clinical Trials Office|312-695-1301||
20504828|NCT01359982|EpicentRx, Inc|Study Director: Bryan Oronsky, Chief Medical Officer|8582291062|boronsky@epicentrx.com|
20504829|NCT02609399|Johns Hopkins University|Dr. Richard Rothman|410-735-6428|rrothma1@jhmi.edu|
20504830|NCT02453841|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
20504831|NCT01145391|University of Colorado Denver School of Medicine|Amy Huebschmann|303-724-2268|amy.huebschmann@ucdenver.edu|
20504832|NCT00970294|University of Kansas Medical Center|Patricia Kluding PT PhD|913-588-6918|pkluding@kumc.edu|
20504833|NCT04579393|The National Institutes of Health / The National Heart, Lung, and Blood Institute|Jeffrey Strich, MD|301.496.9320|jeffrey.strich@nih.gov|
20504834|NCT01333189|University of Colorado, Denver|Cory L Christiansen, PT, PhD|303-724-9101|cory.christiansen@ucdenver.edu|
20504835|NCT02312986|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
20504836|NCT01739595|Repros Therapeutics Inc|Jennifer Wike|2817193402|jwike@reprosrx.com|
20504837|NCT00393458|Novartis Pharmaceuticals|Study Director|862 778-8300||
20504838|NCT02509546|City of Hope Medical Center|Dr. Vinod Pullarkat, MD|626-359-8111|vpullarkat@coh.org|
20504839|NCT01282814|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20504840|NCT01524289|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20504841|NCT02104180|Mylan Medical SAS|Benoit LA ROCHE|+33 1 46 25 86 76|benoit.la-roche@mylan.com|
20504842|NCT01535937|NYSPI|Elias Dakwar, MD|646.774.8728|elias.dakwar@nyspi.columbia.edu|
20504843|NCT01326962|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20504844|NCT00793585|1st Affiliated Hospital, Sun Yat-Sen University|Xueqing Yu , M.D. & Ph.D.|8620-87766335|yuxq@mail.sysu.edu.cn|
20504845|NCT03425656|Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.|Dr. Reza Safaei, M.D|0098-9124548684|safaiino@sina.tums.ac.ir|
20504846|NCT00035815|Mayo Clinic|Eric J. Sorenson, MD|507 538-1037|sorenson.eric@mayo.edu|
20504847|NCT02209597|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20504848|NCT00003270|Roswell Park Comprehensive Cancer Center|Dr. Theresa Hahn|716-845-5819|theresa.hahn@roswellpark.org|
20504849|NCT01855789|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20504850|NCT01863758|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
20504851|NCT04952389|Mayo Clinic|Janalee K. Stokken, M.D.|507-284-1482|Stokken.Janalee@mayo.edu|
20504852|NCT01089725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504853|NCT01928030|Stanford University|Dr. Mark Pegram, Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
20504854|NCT02858193|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20504855|NCT01783522|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Beth Faiman|216-444-3705|faimanb@ccf.org|
20504856|NCT02420652|Rutgers Cancer Institute of New Jersey|Biren Saraiya, MD|732-235-3360|saraiybi@cinj.rutgers.edu|
20528196|NCT01753115|Emergent BioSolutions|Robert Hopkins, MD, MPH & TM, FACP, FIDSA, Medical Monitor|301-944-0136|HopkinsR@ebsi.com|
20558721|NCT00313911|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20558722|NCT03384953|Osher Center for Integrative Medicine|Dr. Lindsey C. McKernan|615-320-7770|lindsey.mckernan@vumc.org|
20558723|NCT01912781|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20558724|NCT02223065|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
20558725|NCT00684762|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20558726|NCT02524054|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|6176670572|rbanzett@bidmc.harvard.edu|
20558727|NCT02111213|Stanford University|Principal Investigator|6507232880|desparza@stanford.edu|
20558728|NCT02153359|Johns Hopkins University|Dr. Sonali Bose|410-550-2708|kladson1@jhmi.edu|
20558729|NCT04192630|Bausch + Lomb Incorporated|Anya Loncaric, Executive Director, Global Clinical Operations|(310) 770-7750|Anya.Loncaric@bauschcloud.com|
20558730|NCT01193582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558731|NCT01448421|keystoneheart|Karen Jaffe, VP RA./QA/CA|97246158005|karen.jaffe@keystoneheart.com|8005
20558732|NCT02289989|Rutgers Robert Wood Johnson Medical School|Amy Pappert, MD|732-235-7765|papperas@rwjms.rutgers.edu|
20558733|NCT01775930|UT MD Anderson Cancer Center|Dr. Eric Jonasch, MD / Professor, Genitourinary Medical Oncology|713- 563-7232|ejonasch@mdanderson.org|
20558734|NCT01208415|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
20558735|NCT01115491|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20558736|NCT03856996|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20558737|NCT03959592|Duke University|Alessandro Jammal, M.D., Ph.D.|919-684-0202|alessandro.jammal@duke.edu|
20558738|NCT01586338|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20558739|NCT02201446|Department of Burn Surgery, Changhai Hospital, The Second Military Medical University, Shanghai, People's Republic of China|Guo-sheng Wu|+86 18019359841|drwuguosheng@sina.cn|
20558740|NCT04071470|Vanderbilt University Medical Center|Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
20558741|NCT00786474|Duke University Medical Center|Thomas Ortel, MD, PhD, Principal Investigator|919-684-5350|thomas.ortel@duke.edu|3
20558742|NCT01868074|University of Iowa|Neil Segal, M.D., M.S.|3193560737|segal-research@uiowa.edu|
20558743|NCT03306043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20558744|NCT01544491|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20558745|NCT01799720|Universidad Miguel Hernández|Dr. Elena García García|965222025|egarcia@umh.es|2025
20558746|NCT01644396|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20558747|NCT01234649|Woman's Hospital|Dr Karen Elkind-Hirsch|225 231-5275|karen.elkind-hirsch@womans.org|2
20558748|NCT00896454|Amgen Inc.|Study Director|866-572-6436||
20558749|NCT00566943|Synovis Surgical Innovations|Lesa Hobright-Turner, Director Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
20558750|NCT00580229|University of South Florida|John D. Carter, M.D.|813-974-2681|jocarter@health.usf.edu|
20558751|NCT04131959|CytoSorbents|CytoSorbents|732-329-8885|info@cytosorbents.com|
20558752|NCT02838628|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20558753|NCT04719013|InMode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
20558754|NCT03904693|Actelion Pharmaceuticals Ltd.|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20558755|NCT04654468|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20558756|NCT06390826|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20558757|NCT01155661|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20558758|NCT05525286|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
20558759|NCT00960752|UT MD Anderson Cancer Center|Michael Davis, PHD., Chair, Melanoma Medical Oncology|713-792-3454|mdavies@mdanderson.org|
20504857|NCT00266110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20504858|NCT01266148|Novartis Pharmaceuticals|Study director|862-778-8300||
20504859|NCT01269125|Dept. of Ob/Gyn, Patra University School of Medicine, Greece|Apostolos Kaponis, M.D.|+30-2610999569|kaponisapostolos@hotmail.com|
20504860|NCT01300286|Duke University Medical Center|Dr. Ian Welsby|919-668-2699|ian.welsby@duke.edu|
20504861|NCT03635190|Cardio Flow, Inc.|Michael J Kallok, PhD|16512531754|mjkallok@cardioflow.net|
20504862|NCT00970203|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
20504863|NCT00417612|Yale University School of Medicine|Dr. Thomas O. Carpenter|203-785-6526|thomas.carpenter@yale.edu|
20504864|NCT03774745|University of California, Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
20504865|NCT01712438|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
20504866|NCT03216265|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20504867|NCT01306058|Principal Investigator|Dr. Tim Greten|301-451-4723|tim.greten@nih.hhs.gov|
20504868|NCT00849693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20504869|NCT00224107|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20504870|NCT01183858|Hoffmann-La Roche|Medical Communications|800-821-8590|genetech@druginfo.com|
20504871|NCT00098345|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20504872|NCT01048125|University of Missouri-Columbia|Dr. Anand Chockalingam|573/882-2296|chockalingama@health.missouri.edu|
20504873|NCT02046564|Otsuka Pharmaceutical Co. Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20504874|NCT01419249|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20504875|NCT01295905|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
20504876|NCT03707977|Harvard T.H. Chan School of Public Health|Molly Pretorius Holme|617-432-4377|mpretori@hsph.harvard.edu|
20558760|NCT05490329|Florida State University|Lisa Hightow-Weidman, MD, MPH|8506443296|lhightowweidman@fsu.edu|
20504877|NCT03842709|University of New Mexico-Dept of Neurosciences|ERIN MILLIGAN,|505-272-4411|EMilligan@salud.unm.edu|
20504878|NCT00641147|Johns Hopkins University|Study Coordinator|410-955-3817|lhylind1@jhmi.edu|
20504879|NCT00791128|GI Dynamics, Inc.|Project Manager, Clinical and Regulatory|781.357.3263|kwoessner@gidynamics.com|
20504880|NCT00984659|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504881|NCT00353977|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
20504882|NCT02424149|Hartford Hospital|Katie Propst, MD|860-972-4338|katie.propst@hhchealth.org|
20504883|NCT03063255|Department of Anesthesiology, NF/SG Veterans Health System|Dr. Jose R. Soberon, Jr.|352-413-2317|jsoberon@anest.ufl.edu|
20504884|NCT01505062|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20504885|NCT01745055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504886|NCT00328198|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
20504887|NCT00066781|Mayo Clinic|Matthew Goetz, M.D.|(507) 284-2511|goetz.matthew@mayo.edu|
20504888|NCT02048878|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
20504889|NCT01720667|University of California San Diego, School of Medicine|Dr. Richard Haas|(858) 822-6700|rhaas@ucsd.edu|
20504890|NCT03472534|Castle Creek Pharmaceuticals|Dr. Mary Spellman/Chief Medical Officer|862-286-0400|mspellman@castlecreekpharma.com|
20504891|NCT03756012|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
20504892|NCT01731691|Institute for Human Genetics and Biochemistry|Dr. Cynthia L. Bristow|631-444-6238|cynthia.bristow@stonybrook.edu|
20504893|NCT02984878|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
20504894|NCT03865407|Virginia Commonwealth University|Cristin Kaspar, MD|804-628-3866|cristin.kaspar@vcuhealth.org|
20504895|NCT02117050|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20504896|NCT02723162|Medical University of South Carolina|Dr. Kevin Gray|843-792-9162|graykm@musc.edu|
20504897|NCT00546819|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20504898|NCT00175006|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20504899|NCT02052960|Glycotope GmbH|Senior Director Clinical Department|0049309489|contact@glycotope.com|2600
20504900|NCT00807664|Coloplast|Dr Birte Petersen Jacobsen|004549110000|DKBIR@coloplast.com|1395
20504901|NCT03633331|City of Hope Comprehensive Cancer Center|Mina S. Sedrak MD, MS|626-218-4173|msedrak@coh.org|
20504902|NCT03233048|Mayo Clinic|Dr. Imad Absah|507-266-0114|absah.imad@mayo.edu|
20504903|NCT00491530|Abbott|Medical Information Specialist|800-633-9110||
20504904|NCT00883753|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20504905|NCT02859415|National Cancer Institute|Dr. David S. Schrump|240-858-7000|schrumpd@mail.nih.gov|
20504906|NCT00691574|Oregon Health & Science University|Alfred Lewy, MD, PhD|(503) 494-7746|lewy@ohsu.edu|
20504907|NCT01396525|AbbottVascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
20504908|NCT00949650|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504909|NCT02282332|MedStar Health Research Institute|Scientific Center Adminstrator|(301) 560-7300|Research@medstar.net|
20504910|NCT02278146|Skyline Urology|Fredrick Wolk, MD|+1 310.602.5005|fred.wolk@skyuro.com|
20504911|NCT02436239|Allergan|Armin Szegedi, MD, PhD, Vice President CNS Clinical Development|714-246-4500|IR-CTRegistration@allergan.com|
20504912|NCT03671369|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20504913|NCT02235285|The Department of Plastic Surgery, Winners Clinic|Dr. Cheol Hwan Kim|.+82.2.511.9446|winners511@naver.com|
20504914|NCT00069121|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20504915|NCT00942708|UT Southwestern|Kelly Chin|214-645-5989|kelly.chin@utsouthwestern.edu|
20504916|NCT03851510|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
20504917|NCT00953121|Preston Robert Tisch Brain Tumor Center at Duke University Medical Center|Dr. Annick Desjardins|919-684-1691|annick.desjardins@duke.edu|
20504918|NCT02704429|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20504919|NCT03557372|Dana Farber Cancer Institute|Dr. Shyam Tanguturi|617-632-0000|stanguturi@partners.org|
20504920|NCT00104104|Novatis Pharmaceuticals|Study Director|862-778-8300||
20504921|NCT02747628|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
20504922|NCT01894516|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
20504923|NCT05652660|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20504924|NCT02452970|EpicentRx, Inc.|Study Director: Bryan Oronsky, Chief Medical Officer|408-569-3202|boronsky@epicentrx.com|
20504925|NCT02340104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20504926|NCT01040832|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20504927|NCT01539837|Imperial College London|David Dexter|+44 (0)20 7594 6665|d.dexter@imperial.ac.uk|
20504928|NCT00950352|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
20504929|NCT01629667|MedImmune, LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20509926|NCT01868594|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20509927|NCT00356434|Johns Hopkins Univ|Abimbola Aina|410-955-8496|aaina1@jhmi.edu|
20509928|NCT00758576|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20509929|NCT01592773|Forest Research Institute|Joel Trugman, MD|201-427-8681|Joel.Trugman@frx.com|
20509930|NCT04418427|Adverum Biotechnologies|Study Medical Director|650-656-9323|clinicaltrials@adverum.com|
20509931|NCT01293123|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
20509932|NCT00121485|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|781 852 8334|psood@thoratec.com|
20509933|NCT04495673|University of Minnesota|Kelvin Lim|(612) 626-6772|kolim@umn.edu|
20509934|NCT02386605|Greater Los Angeles VA Healthcare System|Dr. Felice Reddy|3104783711|felice.reddy@gmail.com|
20509935|NCT03738878|Yale University|Nancy J. Brown|2037854672|nancy.j.brown@yale.edu|
20509936|NCT01888965|Georgetown Lombardi Comprehensive Cancer Center|John L Marshall|202 444 7064|marshalj@georgetown.edu|
20509937|NCT04076579|University of Michigan Rogel Cancer Center|Clinical Trials Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20509938|NCT03793010|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
20509939|NCT00186121|Stanford University Medical Center|Melinda Telli, MD|650-724-9533|mtelli@stanford.edu|
20551083|NCT02259582|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
20551084|NCT03518073|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20551085|NCT03045081|University of Washington|Dale J. Langford, PhD; Research Assistant Professor|2066160158|dalejwl@uw.edu|
20551086|NCT00475176|National Institute of Diabetes and Digestive and Kidney Diseases, National In|Jay H. Hoofnagle, M.D.|301-496-1333|hoofnaglej@mail.nih.gov|
20551087|NCT01853046|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20504930|NCT02648230|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
20558761|NCT03936777|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20558762|NCT02301156|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20558763|NCT04195880|Providence VAMC|Vincent Mor, Principal Investigator|4012737100|vincent_mor@brown.edu|6259
20558764|NCT01642082|NRG Oncology|Linda Gedeon, BA, CCRP Clinical Research Coordinator|716-845-1169|lgedeon@gogstats.org|
20558765|NCT01811940|NYSPI|Frances R. Levin, M.D.|646-774-6137|Frances.levin@nyspi.columbia.edu|
20558766|NCT03757234|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20558767|NCT01152294|Massachusetts General Hospital|Karen Sepucha, Ph.D.|617-724-3350|ksepucha@partners.org|
20558768|NCT00610701|University of Missouri|Brett D. Crist, MD|5738826562|cristb@health.missouri.edu|
20558769|NCT01744860|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20558770|NCT01283321|University of Maryland|Dr. Kenichi Tanaka|412-328-0205|ktanaka@anes.umm.edu|
20558771|NCT02274649|Shepherd Center|Michael Jones, PhD, Director Research|4043507595|mike_jones@shepherd.org|
20558772|NCT01928680|Chinese Academy of Medical Science|Dr. Qiao Li|86-18500027849|liqiaopumc@qq.com|
20558773|NCT02023879|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20558774|NCT03713021|Washington University School of Medicine|Ryan Jackson, M.D.|314-362-0365|jackson.ryan@wustl.edu|
20509940|NCT01569568|Children's National Medical Center|Dr. Andrea Gropman|202-476-2120|agropman@childrensnational.org|
20509941|NCT04124952|SightTrust Eye Institute|Andrew Shatz, MD|877.878.7890|ashatz@sighttrust.com|
20509942|NCT02306928|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45 7845 2845|krisoebr@rm.dk|
20509943|NCT03763942|Emory University|Dr. Jeb Jones|404-712-2275|jeb.jones@emory.edu|
20509944|NCT00166504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20509945|NCT02200510|CincinnatiChildrens|Lori Crosby|5136365380|lori.crosby@cchmc.org|
20509946|NCT02943577|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20509947|NCT01355224|Boston University School of Public Health|Dr. Catharine Wang|617-638-5187|clwang@bu.edu|
20509948|NCT00939055|EndoGastric Solutions|Senior Director Clinical Affairs|650-823-9093|gsahyun@endogastricsolutions.com|
20509949|NCT03502941|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
20509950|NCT00808028|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20509951|NCT04465240|University of Southern California|Daniel A. Hackman, Ph.D.|(213) 821-3112|dhackman@usc.edu|
20509952|NCT01222767|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
20509953|NCT00508001|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20509954|NCT04437511|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20509955|NCT05032755|Duke University Medical Center|Maggie Sweitzer|919-668-0094|maggie.sweitzer@duke.edu|
20558775|NCT00874432|University of Wisconsin - Madison|Dr. Arjang Djamali|(608) 262-9306|axd@medicine.wisc.edu|
20509956|NCT02498600|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|linda.gedeon@roswellpark.org|
20509957|NCT03093350|Baylor College of Medicine|Shaun Bulsara|713-798-8014|sbulsara@bcm.edu|
20509958|NCT05085275|USRC Kidney Research|Stephanie Brillhart, Senior Director Regulatory Compliance|303-881-9451|stephanie.brillhart@usrenalcare.com|
20509959|NCT01319045|UCLA|Jamil Aboulhosn|310-825-5950|jaboulhosn@mednet.ucla.edu|
20509960|NCT02912572|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
20509961|NCT01267955|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
20509962|NCT00729560|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
20509963|NCT03233308|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
20509964|NCT03662789|Oslo University Hospital|Dr. Lars Gullestad|0047 97644772|lars.gullestad@medisin.uio.no|
20509965|NCT03598140|UTexas Southwestern|Dr. Joshua Gaston|817-637-8043|drgaston@outlook.com|
20509966|NCT01023516|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20509967|NCT02432690|Sumitomo Pharma Oncology|Tegan Nguyen|617-674-8745|tegan.nguyen@oncology.sumitomo-pharma.com|
20509968|NCT02060903|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20509969|NCT05304611|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter Crompton|301-761-5042|pcrompton@niaid.nih.gov|
20509970|NCT03993119|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20509971|NCT02354690|National Center for Cancer Immune Therapy|Inge Marie Svane|0045386889339|inge.marie.svane@regionh.dk|
20509972|NCT00963820|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20509973|NCT05064007|Johns Hopkins University|Dr. Junxin Li|4105022608|junxin.li@jhu.edu|
20509974|NCT04556175|Northern Arizona University|Dr Julie Baldwin|928-523-6566|Julie.Baldwin@nau.edu|
20509975|NCT04430894|Dana-Farber Cancer Institute|Elizabeth K. O'Donnell, MD|617-632-3000|Elizabeth_ODonnell@DFCI.HARVARD.EDU|
20509976|NCT05549505|Arvinas Estrogen Receptor, Inc|Arvinas Estrogen Receptor, Inc.|475-345-3366|clinicaltrialsARV-471@arvinas.com|
20509977|NCT06408818|innovation Research and Training|Dr. Tracy Scull|9194937700|tscull@irtinc.us|
20509978|NCT00854061|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20509979|NCT02871791|Dana-Farber Cancer Institute|Sara Tolaney, MD MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
20509980|NCT02782364|University Hospital of South Manchester|Karen Telford|01612916654|karen.telford@uhsm.nhs.uk|
20509981|NCT04209634|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20509982|NCT01796106|DMG Dental Material Gesellschaft mbH|Manager Clinical Research|04084006|clinicalresearch@mtcompanies.com|232
20509983|NCT04107935|University of Pittsburgh|Dr. Linda Siminerio|412-559-0359|similx@upmc.edu|
20509984|NCT02268942|Medtronic Cardiac Rhythm and Heart Failure|Mary Jacoski|+15087390909|mary.v.jacoski@medtronic.com|
20509985|NCT02943668|Fred Hutch Cancer Research Center|Dr. Bart Scott|206.667.1990|bscott@fredhutch.org|
20509986|NCT05393570|UTSW - O'Donnell School of Public Health|Sarah E. Messiah|(972) 546-2919|Sarah.Messiah@UTSouthwestern.edu|
20509987|NCT06853210|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
20509988|NCT02369211|Brigham and Women's Hospital|James Webber|(617) 732-6877|jwebber1@partners.org|
20509989|NCT03128307|Zyppah|Jonathan Greenburg, DDS|(818) 414- 4817|jgreenburg@outlook.com|
20509990|NCT03399786|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20509991|NCT01855919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20509992|NCT03455530|University of Arizona|Dr. Paloma Beamer|520-626-0006|pbeamer@arizona.edu|
20509993|NCT01747447|Brigham and Women's Hospital|Meryl S LeBoff, M.D.|1-800-388-3963|vitalstudy@partners.org|
20558776|NCT05256381|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
20558777|NCT01076283|Brown University|Lorenzo Leggio, MD|401-863-1000|lorenzoleggio@gmail.com|
20558778|NCT02708433|University of North Carolina at Chapel Hill|Raymond P. White, Jr. DDS, PhD|919-537-3944|ray_white@unc.edu|
20509994|NCT01183728|Instituto de Biología y Genética Molecular (IBGM)|Dr. Javier García-Sancho|+34 98 318 48 27|jgsancho@ibgm.uva.es|
20509995|NCT01054339|Applied Genetic Technologies Corp.|Ellery D. Mangas|386-462-7106|emangas@agtc.com|
20509996|NCT00740116|Department of Obstetrics and Gynaecology, and Department of Clinical and Experimental Medicine, Linköpings universitet (LIU), Sweden|Professor Dr. Preben Kjölhede|+4638231188|preben.kjolhede@liu.se|
20509997|NCT03037489|Medivir AB|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
20509998|NCT02499172|Johns Hopkins Bloomberg School of Public Health|Dr. Mohammad Ali|410-502-3154|mali25@jhu.edu|
20509999|NCT01111331|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510000|NCT00724243|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20510001|NCT01842282|University of Michigan|Elif Oral|734-615-7271|eliforal@med.umich.edu|
20510002|NCT00908895|Département d'orthopédie, CHA-Pavillon Enfant-Jésus Québec|Dr Stéphane Pelet, MD, PhD|418-649-0252|stephane.pelet.ortho@gmail.com|3165
20510003|NCT00908050|Baylor College of Medicine/Houston Methodist|William Ondo, MD|713-363-8390|wondo@houstonmethodist.org|
20510004|NCT01997892|Amgen Inc.|Study Director|866-572-6436||
20558779|NCT00799643|Joslin Diabetes Center|Allison B.Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
20558780|NCT01518946|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@shire.com|
20558781|NCT03857841|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20558782|NCT04213989|Laser Lipo and Vein Center|Thomas Wright, MD|636-397-4012|info@laserlipoandveins.com|
20558783|NCT00440180|University of Utah|Marie Gibson|801-213-2845|marie.gibson@hsc.utah.edu|
20558784|NCT03918239|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@takeda.com|
20558785|NCT00963989|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
20558786|NCT01439087|Massachusetts General Hospital|Gary Tearney, MD, PhD|617-724-2979|GTEARNEY@PARTNERS.ORG|
20558787|NCT03390036|Anika|Carol Pekar, VP Clinical Affairs|781-457-9218|cpekar@anikatherapeutics.com|
20558788|NCT00358215|Amgen Inc.|Study Director|866-572-6436||
20558789|NCT00744237|Forest Laboratories, Inc|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
20558790|NCT01984424|Amgen Inc.|Study Director|866-572-6436||
20558791|NCT01089556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20558792|NCT01702428|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558793|NCT02091869|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-1538|perrytamarat@uams.edu|41538
20558794|NCT01533714|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20558795|NCT01560377|Novadaq Technologies, Inc.|Alicia Wilton|1.905.629.3822|awilton@novadaq.com|209
20558796|NCT04789577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20558797|NCT01275196|Novartis Pharmaceuticals|Study Director|862-778-8300||
20558798|NCT01027364|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
20558799|NCT00779584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558800|NCT01461993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558801|NCT02228525|Memorial Sloan Kettering Cancer Center|Dr. Eytan Stein, MD|646-608-3749|steine@mskcc.org|
20558802|NCT00680056|UNIFESP|Danilo Berton|55-11-55718384|dcberton@gmail.com|
20558803|NCT01304082|Massachusetts General Hospital|Brian Wainger|617-726-8810|bwainger@partners.org|
20558804|NCT02733042|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20558805|NCT03688711|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
20558806|NCT03056859|University of New Mexico Anesthesiology Department|Research Officer|505-272-2610|HSC-Anesthesiology@salud.unm.edu|
20558807|NCT01821898|Baylor College of Medicine/Texas Children's Hospital|Carla M. Davis, MD|832-824-1319|carlad@bcm.edu|
20558808|NCT04193293|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20558809|NCT02667444|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20558810|NCT05415124|NYU Langone Health|Melissa Debordeaux, MD|(212) 263-7300|Melissa.Debordeaux@nyulangone.org|
20558811|NCT04175912|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20558812|NCT01597388|AstraZeneca|Julie Charlton|+ 01625-582828|ClinicalTrialTransparancy@astrazeneca.com|
20558813|NCT04396535|Mayo Clinic|Dr. Konstantinos Leventakos|507-284-2511|leventakos.konstantinos@mayo.edu|
20558814|NCT01468532|Barbara Ann Karmanos Cancer Institute|Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
20558815|NCT03169881|University of Utah|Robin K Ohls, MD|801-581-7052|robin.ohls@hsc.utah.edu|
20558816|NCT03734991|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
20558817|NCT06536465|Recursion Pharmaceuticals, Inc.|Recursion Pharmaceuticals|385-374-1724|clinicaltrials@recursionpharma.com|
20558818|NCT03797326|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20558819|NCT03012061|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20558820|NCT01164228|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20558821|NCT04908449|Medical College of Wisconsin|Dr. Anne L. Castro|(414) 805-8700|anncastro@mcw.edu|
20558822|NCT02578914|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20558823|NCT00147225|University of Texas MD Anderson Cancer Center|Dr. Saroj Vadhan-Raj|713-792-7966|svadhanr@mdanderson.org|
20558824|NCT01032044|Mayo Clinic, Jacksonville, Florida, USA|Dr Michael B. Wallace|904 953-7630|wallace.michael@mayo.edu|
20558825|NCT01233609|Foundation Fighting Blindness Clinical Research Institute|Chief Drug Development Officer|410 423 0581|pzilliox@blindness.org|
20558826|NCT00735644|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20558827|NCT02961374|Cancer Prevention Network (CPN) - Mayo Clinic College of Medicine|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
20558828|NCT01861457|Medical University of South Carolina|Shaun A. Nguyen, MD, Associate Professor- Director of Clinical Research|8437921356|nguyensh@musc.edu|
20558829|NCT04536571|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20558830|NCT01567865|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20558831|NCT02780622|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20558832|NCT00309608|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558833|NCT00127413|VA Boston Healthcare System|John D. Otis|8573645740|john.otis@va.gov|
20558834|NCT01051063|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558835|NCT04885530|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20558836|NCT01091428|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20558837|NCT00214903|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|+49 (0) 30 945 101 20|dinger@zeg-berlin.de|
20558838|NCT02543723|East Carolina University|Essie Torres|252-328-1818|torrese@ecu.edu|
20558839|NCT00329719|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072842511|jaeckle.kurt@mayo.edu|
20558840|NCT01086605|Mayo Clinic|Alvaro Moreno-Asptia, M.D.|507/284-1159|morenoaspitia.alvaro@mayo.edu|
20558841|NCT01026909|Seattle Children's Hospital|Dr Klane White|206-987-5678|klane.white@seattlechildrens.org|
20558842|NCT01807221|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20504931|NCT02717546|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574.527.7934|ryan.boylan@zimmerbiomet.com|
20504932|NCT03849560|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|+7(495) 730-75-45|DodonovNS@petrovax.ru|125
20504933|NCT04382651|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20504934|NCT01507545|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20504935|NCT03739983|University of Wisconsin Carbone Cancer Center|Ryan Spencer, MD, MS|608-265-1700|rjspencer2@wisc.edu|
20504936|NCT00790296|University of Connecticut Health Center|Andrew Winokur MD PhD|860-679-6775|awinokur@uchc.edu|
20504937|NCT02612077|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20504938|NCT01753518|Mayo Clinic|Dr. Margaret Dow|507-266-8008|dow.margaret@mayo.edu|
20504939|NCT01971476|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20504940|NCT00940342|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
20504941|NCT02498821|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0835|Gina.Gilbert@crbard.com|
20504942|NCT04901507|Virginia Commonwealth University School of Dentistry|Dr. Caroline Carrico|804-828-8328|ckcarrico@vcu.edu|
20504943|NCT01716169|Stanford School of Medicine|Dr. Alfred Lane|650 721 7166|atlane@stanford.edu|
20504944|NCT00553787|Vivus, Inc|Wesley W Day PhD|650-934-5200|day@vivus.com|
20504945|NCT01088412|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20504946|NCT00793104|RI Biologics|Robin Waite , Clinical Projects Director|386-418-8888|rwaite@rtix.com|
20504947|NCT00466752|University of Washington / Seattle Cancer Care Alliance|Evan Yu|206-288-1152|evanyu@u.washington.edu|
20558843|NCT06017999|Xgene Pharmaceutical|Director of Clinical Trials|+886-2-2528-0580|emily.chen@xgenepharm.com|
20504948|NCT00754767|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
20504949|NCT03494725|DuPont Nutrition and Biosciences|Elaine Patterson, Ph. D.|+358-40-4827-626|elaine.patterson@dupont.com|
20504950|NCT02619253|IndianaU|Dr. Nabil Adra|317-278-7728|nadra@iu.edu|
20504951|NCT00514449|Western Psychiatric Institute and Clinic|Dr. Konasale Prasad|412-586-9014|prasadkm@upmc.edu|
20504952|NCT04083144|Centre for Addiction and Mental Health|Dr. Bernard Le Foll|4165358501|bernard.lefoll@camh.ca|33111
20504953|NCT01363843|BrUOG|William Sikov, MD and Kimberly Perez, MD|4018633000|kayla_rosati@brown.edu|
20504954|NCT02694029|UT Southwestern Medical Center|Asal Rahimi, MD|214/645-8556|Asal.Rahimi@UTSouthwestern.edu|
20504955|NCT01417286|Cancer Institute of New Jersey Rutgers|Dr. Haffty|732-235-8675|hafftybg@cinj.rutgers.edu|
20510005|NCT00364611|Sanofi-aventis|Trial Transparency Team||Contact-us@sanofi.com|
20558844|NCT03076359|Vanderbilt University|Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
20504956|NCT00995371|Coastal Orthopedics & Sports Medicine|Lois A. Davis|941-782-1353|ldavis@coastalorthopedics.com|
20504957|NCT00306891|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20504958|NCT00673673|Yale University|Dr. Jill Lacy|203-737-1600|jill.lacy@yale.edu|
20558845|NCT02040792|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20504959|NCT01811030|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20504960|NCT01462292|GlaxoSmithKline|GSK Response Center|866-435-7343||
20504961|NCT02333045|Emory University|Anandi Sheth, MD|404-616-6240|ansheth@emory.edu|
20504962|NCT00206518|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
20504963|NCT02335450|Oakland University|Beth Black|248-364-8694|bblack@oakland.edu|
20504964|NCT02613572|Scheie Eye Institute; Perelman School of Medicine; University of Pennsylvania|Benjamin J. Kim, MD|215-662-8675|benjamin.kim@uphs.upenn.edu|
20504965|NCT02342561|The Orthopaedic Research Unit, Department of Orthopaedic Surgery and Trauma, Odense University Hospital, Denmark|Nikolaj Milandt, Undergraduate researcher|26616611|nikolaj.rongsted.milandt@rsyd.dk|0045
20504966|NCT04538950|Mayo Clinic|John P. Bois, M.D.|507 284-4072|Bois.John@mayo.edu|
20504967|NCT00231478|Hoffman-LaRoche|Medical Communications|800-821-8590||
20504968|NCT00853905|Wills Eye Hospital Glaucoma Research Center|Marlene Moster MD|215-825-4713|jmolineaux@willseye.org|
20504969|NCT01748695|Brigham and Women's Hospital|Dr. Christine N. Sang, Director of Translational Pain Research|617-525-7246|csang@partners.org|
20504970|NCT05610969|University of Pennsylvania|Veena Graff MD, MS|(215) 662-8244|veena.graff@pennmedicine.upenn.edu|
20504971|NCT00847561|The Johns Hopkins University School of Medicine|Dr. Golda Ginsburg|410-955-1544|gginsbu@jhmi.edu|
20504972|NCT02234011|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
20504973|NCT02053246|University of Florida|Dr. Julio Duarte|352-273-8132|juliod@cop.ufl.edu|
20504974|NCT01399827|Massachusetts General Hospital|Craig Surman, MD|617-726-8392|csurman@partners.org|
20504975|NCT02369510|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@MountSinai.org|
20504976|NCT02029430|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20504977|NCT03465735|Mayo Clinic|Waldemar E. Wysokinski, M.D., Ph.D.|507-266-6717|Wysokinski.Waldemar@mayo.edu|
20504978|NCT04661813|University of Washington|Dr. Chris Longenecker|2066161159|ctlongen@uw.edu|
20504979|NCT04285723|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20504980|NCT03067311|University of North Carolina at Chapel Hill|David Penn, PhD|(919) 843-7514|dpenn@email.unc.edu|
20504981|NCT02903511|"University of Colorado Denver | Anschutz"|Godela Brosnahan, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20504982|NCT00907738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20504983|NCT05363293|Alzamend Inc.|Eve Del Rio, MD, PhD|9736993847|Eve@RioPharma.com|
20504984|NCT06384989|The Ohio State University|Julie Mansfield|614-366-2101|julie.mansfield@osumc.edu|
20504985|NCT02605863|University of Rochester|Edward Messing, ND|585-275-0998|edward_messing@urmc.rochester.edu|
20504986|NCT00112151|Univeristy of Colorado at Denver|Dr. Robert S. Schwartz, Head, Division of Geriatric Medicine|303-724-1919|robert.schwartz@ucdenver.edu|
20504987|NCT01777438|UZ Leuven|Dr Hellings|+32 16 332338|peter.hellings@uzleuven.be|
20504988|NCT00375934|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
20504989|NCT01792986|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
20504990|NCT03191396|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20504991|NCT01438710|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
20504992|NCT05094154|Vanderbilt University Medical Center|Edward T Qian, MD|615-322-2386|edward.t.qian@vumc.org|
20504993|NCT00945750|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20504994|NCT00893113|Chesapeake Urology Research Associates|Ronald Tutrone, MD|443.471.5742|hthomas@cua.md|
20504995|NCT02100657|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
20504996|NCT02133235|NTUH|YJ Cheng|886-2-23123456|chengyj@ntu.edu.tw|62158
20504997|NCT02531035|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20504998|NCT03726671|University of North Carolina at Chapel Hill|Julie M. Stegall, MSW|704-250-5048|julie_stegall@unc.edu|
20504999|NCT01383200|Bascom Palmer Eye Institute|Dr. Sonia Yoo|305-243-2020|syoo@med.miami.edu|
20505000|NCT03270085|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
20505001|NCT04510922|University of Cincinnati|Alberto Espay, MD, MSc|5135584050|espayaj@ucmail.uc.edu|
20505002|NCT03692910|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20505003|NCT01322607|Baltimore VA Medical Center (VAHMCS)|Research Specilist|410-605-7156|alyssa.stookey@va.gov|
20505004|NCT00151411|Penn State Hershey|Sandy Eyer|717-531-1540|seyer@hmc.psu.edu|
20505005|NCT01283581|Melinta Therapeutics|Dr. Sue Cammarata|312-724-9401|scammarata@melinta.com|
20505006|NCT00486226|Codman&Shurtleff|Arnaud Nicolas|+33 0 155 004 543|anicolas@its.jnj.com|
20505007|NCT01259492|Novartis Pharmaceuticals|Study Director|8627788300||
20505008|NCT00117962|Washington University School of Medicine|Dr. Ramaswamy Govindan||rgovinda@dom.wustl.edu|
20505009|NCT03846947|UNC Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20505010|NCT02392208|University of Michigan|Dr. Bruce A. Mueller|734-763-6629|muellerb@med.umich.edu|
20505011|NCT02657252|UPECLIN|Dr. Matheus Bertanha|+551438116305|matheus.fameca@ig.com.br|
20505012|NCT02889510|Dynamic Science S.L|Anna Royo|+34680603119|a.royo@dynasolutions.com|
20505013|NCT00634543|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
20505014|NCT00474630|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
20505015|NCT03515538|EpicentRx, Inc|Bryan Oronsky|858-229-1062|mstirn@epicentrx.com|
20505016|NCT04243369|Philips|T.J. Battisti|(425) 205-3515|t.j.battisti@philips.com|
20505017|NCT03323307|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
20505018|NCT01954628|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 (604) 629-9223|clinical@aqxpharma.com|
20505019|NCT02740153|Children's National Medical Center|Dr. Nicholas Ah Mew|202-476-5863|nahmew@childrensnational.org|
20505020|NCT00052429|Memorial Sloan Kettering Cancer Center|Dr. Suzanne Wolden|212-639-5148|woldens@mskcc.org|
20505021|NCT01736683|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505022|NCT04021472|VA Bedford Healthcare System|Timothy P. Hogan|781-687-3181|timothy.hogan@va.gov|
20505023|NCT03069690|University of Pittsburgh Medical Center|Dr. Michele Levine|(412) 647-0703|levinem@upmc.edu|
20505024|NCT02564120|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
20505025|NCT00631319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20505026|NCT00891657|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
20505027|NCT00577590|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20505028|NCT00670111|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
20505029|NCT00844883|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20505030|NCT02623361|UCSF|Matthias Behrends, PI|415 476 3761|matthias.behrends@ucsf.edu|
20505031|NCT00318708|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
20505032|NCT01857986|Hospitech Respiration|Clinical Trials Manager|+972-3-9191648|adir@hospitech.co.il|5
20505033|NCT00537823|Washington University School of Medicine|David Linehan, M.D.||David_Linehan@URMC.Rochester.edu|
20505034|NCT02873221|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20505035|NCT03811951|University of Illinois at Chicago - College of Pharmacy|Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
20505036|NCT00909090|University of Georgia|Dr. Billy Hammond, Principal Investigator|(706) 54204812|bhammond@uga.edu|
20505037|NCT02004990|University of Minnesota|Robert S. Jones DDS PhD|612-626-2900|rsjones@umn.edu|
20505038|NCT01749735|Spaulding Rehabilitation Hospital|Dr. Paolo Bonato|617-952-6319|pbonato@partners.org|
20505039|NCT02926573|Washington University School of Medicine|Melanie Townsend, M.D.|314-362-4470|townsendm@wustl.edu|
20505040|NCT03099369|University of North Carolina at Chapel Hill|David Lee, MD|347-882-8010|dave.lee0530@gmail.com|
20505041|NCT00611455|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505042|NCT04601272|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.harvard.edu|
20505043|NCT01678846|London School of Hygiene and Tropical Medicine|Dr Karen Devries|0207958 8164|Karen.Devries@lshtm.ac.uk|8164
20505044|NCT00414440|Novartis|Study Director|+1 (862) 778-8300||
20505045|NCT02732912|Oxford Brookes University|Dr Derick Wade|+447818452133|derick.wade@ntlworld.com|
20505046|NCT01873742|Modum Bad Research Institute|Dr. Terje Tilden|+4732749869|tilden@modum-bad.no|
20505047|NCT01832961|Imperial College|Ada Clarice Gastaldi|55 020 7351 8051|ada@fmrp.usp.br|
20551088|NCT01711177|Université de Montreal|Pierre Forcier|514-343-7468|pierre.forcier@umontreal.ca|
20505048|NCT01707147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505049|NCT04435769|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505050|NCT02489630|Virginia Tech SOM / Carilion Clinic (prior)|Dr Karen J Bowers, co-PI|678-591-7280|bowerskj@gmail.com|
20505051|NCT01056523|Jewish General Hospital|Dr. Assouline|514-340-8222|sarit.assouline@mcgill.ca|8434
20505052|NCT03429556|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20505053|NCT01596595|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
20505054|NCT02262130|CHU de Reims|Pr Manuelle Viguier|00333 26 78 43 43|mviguier@chu-reims.fr|
20505055|NCT04441931|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20505056|NCT02050048|NorthShore Univeristy HealthSystem|Dr. Russell Brown|847-657-1900|rbrown@northshore.org|
20505057|NCT02088216|Qilu Hospital of Shandong University|Yu Li|13791122770|qlliyu@163.com|
20505058|NCT03118843|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20505059|NCT01589094|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@mskcc.org|
20505060|NCT04224987|UCSF Proctor foundation|Dr Thomas Lietman|4154761442|tom.lietman@ucsf.edu|
20510006|NCT01562379|Johns Hopkins Bloomberg School of Public Health|Parul Christian|1-410-955-1188|pchrist1@jhu.edu|
20510007|NCT03350724|The University of Texas Health Science Center at Houston|Jennifer James, DMD, MS|713-486-4383|Jennifer.D.James@uth.tmc.edu|
20510008|NCT02134912|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
20510009|NCT01935622|Virginia Commonwealth University|Antonio Abbate|8048280513|aabbate@vcu.edu|
20510010|NCT04097925|Hospital de Bellvitge|Clinical Project Manager|+34675335888|anavarroa@bellvitgehospital.cat|
20510011|NCT02636049|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
20510012|NCT04806165|Washington University in St. Louis School of Medicine|Ellen E. Fitzsimmons-Craft|314-286-2074|fitzsimmonse@wustl.edu|
20510013|NCT03702439|Imperial Prostate|David Eldred-Evans|020 7594 7773|d.eldred-evans@imperial.ac.uk|
20510014|NCT00416572|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|scheier@cmu.edu|
20510015|NCT00584987|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
20510016|NCT02481986|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
20510017|NCT01944462|Thomas Jefferson University|Laura T. Pizzi, PharmD, MPH; Principal Investigator|215-955-1159|laura.pizzi@rutgers.edu|
20510018|NCT03225833|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
20551089|NCT01463878|Eastern Virginia Medical School|Dr Paul Marik|757-446-8910|marikpe@evms.edu|
20551090|NCT03804879|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20551091|NCT02436889|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
20510019|NCT00723489|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20558846|NCT01757665|Edwards Lifesciences, LLC|Aya Westbrook, PhD, Director of Clinical Program Management|949-250-2500|aya_westbrook@edwards.com|4035
20558847|NCT00594906|University of Rochester|Dr. J. Edward Puzas|(585) 275-3664|edward_puzas@urmc.rochester.edu|
20505061|NCT03165981|Duke University|Dr. Emmanuel B. Walter|919-620-5346|chip.walter@duke.edu|
20505062|NCT05243550|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
20505063|NCT01486316|Medtronic, Inc|Rachael Rose, Clinical Research Specialist|763-526-2332|rachael.k.rose@medtronic.com|
20505064|NCT03990766|Washington University School of Medicine|Dr. Jake Lee|3143937248|jakejlee@wustl.edu|
20505065|NCT00403117|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
20505066|NCT01543490|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
20505067|NCT04192448|Eastern Michigan University|Elizabeth Neilson|734-487-4988|eneilso1@emich.edu|
20505068|NCT04168645|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org|
20505069|NCT02400346|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
20505070|NCT02114203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505071|NCT01518699|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20505072|NCT02110108|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20505073|NCT01981122|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
20505074|NCT02123017|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20505075|NCT02773758|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505076|NCT00500149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20505077|NCT01592851|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505078|NCT00521339|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20505079|NCT00089843|Massachusetts General Hospital|Anne Klibanski, M.D.|617-726-3870|aklibanski@partners.org|
20505080|NCT01819935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505081|NCT01157169|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20505082|NCT00663858|Aeterna Zentaris|Herbert Sindermann|+49 69 42602 3429|HSindermann@aezsinc.com|
20505083|NCT03060577|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20505084|NCT02435173|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20505085|NCT02940886|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
20505086|NCT03454048|Radboud university medical center|Prof. dr. Teun Bousema|+3124 3614306|teun.bousema@radboudumc.nl|
20505087|NCT03152136|Cala Health|Paula Chidester|650-273-7436|paula@calahealth.com|
20505088|NCT02584634|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505089|NCT02225223|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
20505090|NCT00352781|Centre for Addiction and Mental Health|Co-Investigator|416-535-8501|laurie_zawertailo@camh.net|7422
20505091|NCT01650779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20505092|NCT03567291|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20505093|NCT03666143|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20505094|NCT01103349|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505095|NCT00073333|University of Central Florida|Deborah C. Beidel, Ph.D.|407-823-3254|deborah.beidel@ucf.edu|
20505096|NCT01148056|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
20505097|NCT00958568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505098|NCT00915005|UT MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
20505099|NCT00471380|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20505100|NCT04978376|University of Illinois Chicago|Kelsey Gabel|312-413-8911|kdipma2@uic.edu|
20505101|NCT00283712|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20505102|NCT03735095|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20505103|NCT03952650|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Dave Cook|240.627.3066|david.cook@nih.gov|
20505104|NCT04084392|Vanderbilt University Medical Center|Dr. Dave Marcovitz|615-936-3555|david.marcovitz@vumc.org|
20505105|NCT03988751|Wake Forest University School of Medicine|Dr. Clancy Clark|335-480-8064|cjclark@wakehealth.edu|
20505106|NCT01938170|UNC Chapel HIll|Ravi Jhaveri MD|919-962-5136|ravi.jhaveri@unc.edu|
20505107|NCT01625169|USC|LaShonda Spencer|323 226-6437|lspencer@usc.edu|
20505108|NCT02441803|University of Texas MD Anderson Cancer Center|Dr. Richard Champlin, MD/Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
20505109|NCT03065530|The First Affiliated Hospital of Nanjing Medical University|Dr. Shijiang Liu, Dr. Mei Gao|+862568303569|liushijiang1983@hotmail.com|
20505110|NCT01325493|Children's National Health System|Julia Finkel|2024764867|JFINKEL@childrensnational.org|
20505111|NCT02240628|The University of Texas Health Science Center at Houston|Dr. Samia Khalil|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
20505112|NCT02285010|Mahidol University|Dr.Taniga Kiatchai|+66-2-419-7990|taniga@gmail.com|
20505113|NCT02708212|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|
20505114|NCT05341466|University of Colorado, Boulder|Andrew Q. Tan|303-735-0259|andrew.tan@colorado.edu|
20505115|NCT01457339|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20505116|NCT02730247|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20505117|NCT00394914|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20558848|NCT02564055|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505118|NCT02092415|Oregon Health & Science University|Jonathan Lindner MD|503 595-8750|lindnerj@ohsu.edu|
20505119|NCT00312377|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20505120|NCT04940598|UAB|Gordon Fisher|2059964114|grdnfs@uab.edu|
20505121|NCT00044044|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20505122|NCT05258058|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
20505123|NCT04286867|Kent State University|William Lechner|8144501093|wlechner@kent.edu|
20505124|NCT02179398|Geneva University Hospital|Dr. Laurence Lacroix|+41223725082|laurence.lacroix@hcuge.ch|
20505125|NCT00603044|The University of Chicago Medicine|Fuad Baroody, MD|(773) 702-4790|fbaroody@surgery.bsd.uchicago.edu|
20505126|NCT03896425|University of Minnesota|Rebecca Kazinka|612-626-6772|kazin003@umn.edu|
20505127|NCT00408681|Fred Hutchinson Cancer Research Center|Paul J. Martin, M.D.|206-667-4798|pmartin@fredhutch.org|
20505128|NCT03004846|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20505129|NCT01050660|Yale University|Dr. Orly Levit|203-688-2320|orly.levit@yale.edu|
20505130|NCT00649961|Imperial College London|Dr Nazakat Merchant|00447825881907|nazakat.merchant@kcl.ac.uk|
20505131|NCT02519231|University of Washington|Dr. Emily Godfrey|206.685.4895|godfreye@uw.edu|
20505132|NCT00447421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505133|NCT01787591|The Ohio State University|Richard S. Bruno, PhD, RD|614-292-1698|bruno.27@osu.edu|
20505134|NCT02725177|Cleveland Clinic Foundation|Daniel Culver, DO|216-444-6508|culverd@ccf.org|
20505135|NCT02707757|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
20505136|NCT00815308|Shandong Cancer Hospital and Institute|Jinming Yu|86-531-87984729|jn7984729@public.jn.sd.cn|
20505137|NCT00377299|UT Southwestern Medical Center at Dallas|Dr. E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
20505138|NCT04799782|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
20505139|NCT00969618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505140|NCT05287893|Medicines for Malaria Venture|Joerg Moehrle|+41 22 555 03 00|info@mmv.org|
20505141|NCT01277289|Erydel|Angelo Andriulli, MD|+39 882 410784|aandriulli@operapadrepio.it|
20505142|NCT00092547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505143|NCT00084682|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
20505144|NCT01166659|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20505145|NCT02988986|Houston Methodist Hospital|Dr. Jenny Chang, Director of Houston Methodist Cancer Center|713-441-0681|jcchang@houstonmethodist.org|
20505146|NCT02901262|UNIMIB, ASST-MONZA San Gerardo Hospital|Prof. Giuseppe Citerio|0039 039 233 4316|giuseppe.citerio@unimib.it|
20505147|NCT03088605|Topivert Pharma Ltd|Director of Clinical Trials|+44 203 763 9469|info@topivert.com|
20505148|NCT02397655|Xuanwu hospital, Capital medical university|Dr. Yang Hua|86-10-83198923|dryanghua99@163.com|
20505149|NCT03321617|New York State Psychiatric Institute|Ragy Girgis, MD|646-774-5553|ragy.girgis@nyspi.columbia.edu|
20505150|NCT00915967|Oregon Health & Science University|Director of Clinical Trials|503-494-4314|nsgclinicalresearch@ohsu.edu|
20505151|NCT02747043|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20505152|NCT03136705|Northwestern University Feinberg School of Medicine|Doctor|312-503-6921|tamara.isakova@northwestern.edu|
20505153|NCT01958606|University of Cincinnati|Pierce Boyne|513-558-7499|Pierce.Boyne@uc.edu|
20505154|NCT01215318|University Hospital of Zurich|Irene A Burger|+41 44 255 11 11|irene.burger@usz.ch|
20505155|NCT04655586|Arca biopharma Inc.|Dr. Michael Bristow|720-940-2100|Michael.Bristow@arcabio.com|
20505156|NCT02345369|Bassett Medical Center|clinical research nurse supervisor|6075476965|jennifer.victory@bassett.org|
20505157|NCT03897712|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bauschhealth.com|
20505158|NCT00553059|University of Texas (UT) MD Anderson Cancer Center|Michael J. Fisch, MD/Department of General Oncology|713-563-9905|mfisch@mdanderson.org|
20505159|NCT01966731|Cincinnati Children's Hospital Medical Center|Russell Ware, MD, PhD|(513) 803-1108|russell.ware@cchmc.org|
20505160|NCT01380093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505161|NCT04734873|Corvus Pharmaceuticals|Study Director|650-900-4520|clinicaltrials@corvuspharma.com|
20505162|NCT00592683|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
20505163|NCT00201201|University of Connecticut|Patricia J. Neafsey, PhD|860-486-0779|pjneafsey@actualmeds.com|
20505164|NCT00621933|Allergan, Inc|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20505165|NCT04901897|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20505166|NCT00545818|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20505167|NCT00609609|The University of Texas (UT) MD Anderson Cancer Center|Dr. Amin Majid Alousi, Associate Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
20505168|NCT02677701|Seattle Children's Hospital|Arthur Baines|2068841431|arthur.baines@seattlechildrens.org|
20505169|NCT04530825|Washington University School of Medicine|Maura Kepper, Ph.D.|314-935-0142|kepperm@wustl.edu|
20505170|NCT03870022|Pivot Health Technologies Inc.|VP of Clinical and Medical Affairs|415-757-7696|marler@pivot.co|
20505171|NCT04101422|Moffitt Cancer Center|Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
20505172|NCT00552305|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20505173|NCT01241513|USARIEM|Charles S Fulco, PI|508 233-4893|charles.fulco@us.army.mil|
20505174|NCT01174784|Avinger Inc.|Thomas Lawson, PhD|650.241.7900|tlawson@avinger.com|
20505175|NCT01671488|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
20558849|NCT01375959|Albert Einstein College of Medicine|Dr. Jill Crandall|718-430-3765|jill.crandall@einstein.yu.edu|
20558850|NCT01576055|W.L. Gore & Associates|Thomas Sabin|928-864-3153|tsabin@wlgore.com|
20558851|NCT01930435|UCSF|Dr. Sue Yom|415-353-7175|yoms@radonc.ucsf.edu|
20558852|NCT00832338|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
20558853|NCT04241575|The Chinese University of Hong Kong|Dr Vincent Wong|+85235054205|wongv@cuhk.edu.hk|
20558854|NCT02226172|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558855|NCT00479037|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
20558856|NCT02500979|AstraZeneca|Dr. Peter Ohman|+1 (301) 398-0120|Peter.Ohman@astrazeneca.com|
20558857|NCT01613027|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20558858|NCT00299195|Memorial Sloan Kettering Cancer Center|Dr. Jay Boyle, MD|212-639-2906|boylej@mskcc.org|
20558859|NCT04267614|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558860|NCT02707523|UAB|Dr. Michele Kong, PI|205-6389387|mkong@peds.uab.edu|
20558861|NCT02590068|The Rockefeller University|Dr. Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
20505176|NCT03503773|Ablative Solutions Inc|Kate Rumrill, CEO|1 650-688-9743|krumrill@ablativesolutions.com|
20505177|NCT00607828|University of Nebraska Medical Center|Chi Lin|402-552-3844|clin@unmc.edu|
20505178|NCT00425438|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20505179|NCT02134314|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|310-248-8186|noriko.ammerman@cshs.org|
20505180|NCT02902809|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
20505181|NCT00532259|CureTech Ltd.|Director Clinical Resaerch|+972-8-9324000|talh@curetechbio.com|
20505182|NCT03511638|Bausch & Lomb|Study Director|510-259-5284|aloncaric@bauschhealth.com|
20505183|NCT01208181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505184|NCT00943878|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
20505185|NCT01478347|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20505186|NCT01645930|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20505187|NCT01164501|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505188|NCT03489291|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
20505189|NCT01096667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505190|NCT01765712|Nicholas Institute of Sports Medicine and Athletic Trauma|Malachy McHugh Director of Research|2124342714|mchugh@nismat.org|
20505191|NCT01845077|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505192|NCT01004107|Merz North America|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
20505193|NCT00465738|Merz Pharmaceuticals GmbH|Claus Goebel, MD|+49-69-1503-6461|claus.goebel@merz.de|
20505194|NCT01435512|BVARI|Dr. Casey Taft|857-364-6261|casey.taft@va.gov|
20505195|NCT02989727|Univeristy of Saskatchewan|Dr. Evyn Peters|13062904493|evyn.peters@usask.ca|
20505196|NCT01507246|Atlanta Colon and Rectal Surgery|Stephen Cohen, MD|770-997-1975|klong@atlantacolon.com|
20505197|NCT04902950|Reading Hospital|Amir Behnam, MD|610-988-9127|amir.behnam@towerhealth.org|
20505198|NCT02975349|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20505199|NCT03551522|CymaBay Therapeutics, Inc.|Barry Crittenden, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
20505200|NCT05136885|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257|healeyalsplatform@mgh.harvard.edu|(HALT ALS)
20505201|NCT02653092|University of Colorado School of Medicine|Dr. Nanette Santoro|303-724-2041|Nanette.Santoro@uanschutz.edu|
20505202|NCT01318902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20505203|NCT02699515|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|+49
20505204|NCT01240811|University of Pittsburgh|Sharon Achilles, MD, PhD|412-641-1403|achisx@upmc.edu|
20505205|NCT02898207|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
20505206|NCT03026504|Mayo Clinic|Matthew Koster, M.D.|507-284-5800|koster.matthew@mayo.edu|
20505207|NCT01976819|University Medical Center Groningen and University of Groningen|Prof. Dr. Bernard F.A.M. van der Laan, PhD, MD|0031 (50) 361 27 00|b.f.a.m.van.der.laan@umcg.nl|
20551092|NCT05584176|MP Biomedicals|Dana Hummel|8008540530|Dana.Hummel@mpbio.com|7019
20551093|NCT00100815|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20551094|NCT01710033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551095|NCT01244906|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
20551096|NCT02746874|Northwestern University|David Walega, MD|312-695-0061|d-walega@northwestern.edu|
20551097|NCT04483011|Bioenergy Life Science, Inc.|Alex Xue, Chief Technology Officer|763-746-0032|alex.xue@bioenergyls.com|3924
20551098|NCT00276159|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
20551099|NCT04356690|Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center|John Mark Sloan, MD|617-638-7002|mark.sloan@bmc.org|
20551100|NCT02426892|UT MD Anderson Cancer Center|Dr. Renata Ferrarotto,MD, Associate Professor, Thoracic-Head & Neck Med Onc|(713) 745-6774|rferrarotto@mdanderson.org|
20551101|NCT03178773|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
20551102|NCT03402386|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
20505208|NCT03825042|A.Menarini Industrie Farmaceutiche Riunite Srl|Director of Clinical Operations|0039 055 5680459|pfabrizzi@menarini.it|
20505209|NCT01997567|Rush University Medical Center Department of Anesthesiology|Sandeep Amin, M.D|312-942-6449|Sandeep_Amin@rush.edu|
20505210|NCT02316470|Valneva Austria GmbH|Manager Clinical Research|+43120620|info@valneva.com|0
20505211|NCT01856491|Boston Scientific|Anneleen Viville|0032479983495|anneleen.viville@bsci.com|
20505212|NCT01289392|Associação Fundo de Incentivo à Pesquisa|Dr Teresa Cristina Barros Schutz|55-21-99868033|schutzferraz@gmail.com|
20505213|NCT00733512|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20505214|NCT05085392|Montana State University|Dr. Lauren Davis|8287736328|laure.davis6@montana.edu|
20505215|NCT01158534|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
20505216|NCT01988012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20505217|NCT01058369|Universitätsklinikum Erlangen, Medizinische Klinik 5|Prof. Dr. med. Stefan Krause||stefan.krause@uk-erlangen.de|
20505218|NCT04003155|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20510020|NCT02274311|Hospital das Clinicas da Faculdade de Medicina da USP|Dr. Felipe Henning Gaia Duarte|+5511987550990|drfelipegaia@outlook.com|
20558862|NCT03632434|University of East London|Professor Cynthia Fu|07563 240193|c.fu@uel.ac.uk|
20558863|NCT01182727|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
20558864|NCT04297241|Cincinnati Children's Hospital|Mary Banks|513-636-2147|mary.banks@cchmc.org|
20558865|NCT00886262|Medical University of South Carolina|Dr. Scott Reeves|843-792-5699|reevess@musc.edu|
20558866|NCT04038346|University of Pittsburgh Children's Hospital of Pittsburgh|Desiree Neville|412-692-7692|desiree.neville@chp.edu|
20558867|NCT01844193|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
20558868|NCT01088529|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20558869|NCT05832437|Columbia University School of Nursing|Maureen George|212-305-1175|mg3656@cumc.columbia.edu|
20558870|NCT05376371|University or Wisconsin-Madison|Ryan Westergaard|6082657927|rpw@medicine.wisc.edu|
20558871|NCT04159415|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20558872|NCT05407311|Clarity Pharmaceuticals|Dr. Othon Gervasio, Chief Medical Officer|+61 (0)2 9209 4037|info@claritypharmaceuticals.com|
20558873|NCT02400437|Dana-Farber Cancer Institute|Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
20558874|NCT00337662|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20505219|NCT00502905|UT MD Anderson Cancer Center|Gabriela Rondon, MD / Assistant Professor|713 745-2294|celsaenz@mdanderson.org|
20528197|NCT03642067|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20528198|NCT03124160|FHI 360|David Hubacher|+1-919-321-3459|dhubacher@fhi360.org|
20528199|NCT04313400|Amarex Clinical Research, LLC|Dr. Ahmad Bayat, Sr Director II, Regulatory Affairs|301-956-2523|ahmadb@amarexcro.com|
20528200|NCT01263717|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
20528201|NCT01461473|Stanford University|Clete A. Kushida, M.D., Ph.D.|650-721-7560|clete@stanford.edu|
20528202|NCT01784926|Oslo University Hospital|Dr. Olav Kristianslund|+4723015168|olav.kristianslund@medisin.uio.no|
20528203|NCT00329745|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528204|NCT01534416|Icahn School of Medicine at Mount Sinai|Dr. Rachel L. Barr Grzesh|212-241-2995|rachel.barr@mssm.edu|
20528205|NCT03224624|VA San Diego Healthcare System|Dena Rifkin|8585528585|dena.rifkin@va.gov|2784
20528206|NCT01884545|NYU Rory Meyers College of Nursing|Allison A. Vorderstrasse, DNSc, APRN, FAAN|212-998-5786|allisonvorderstrasse@nyu.edu|
20528207|NCT01424241|Columbia University Medical Center|Pamela Freda, MD|212-305-2254|puf1@columbia.edu|
20528208|NCT05537428|Yale University|Philip Corlett|2039747866|philip.corlett@yale.edu|
20528209|NCT02937636|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20528210|NCT00770913|Eisai Co.,Ltd. Eisai Product Creation Systems|Tomoki Kubota, Study Director|+81-3-3817-3908|t2-kubota@hhc.eisai.co.jp|
20528211|NCT00596102|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 20620|info@valneva.com|0
20528212|NCT00359294|PharmaMar USA Inc|Responsible medical officer|1 212 201 6770|ccoronado@pharmamar.com|
20528213|NCT00583011|University of Oklahoma Health Science Center|Andrew Elimian, MD|9142317323|aelimian@aol.com|
20528214|NCT03360214|Columbia University|Sherene Ishtihar|212-342-3681|si2271@cumc.columbia.edu|
20528215|NCT04208412|KalVista Pharmaceuticals Ltd.|Vice President Clinical|1 (857) 999-0075|clinical@kalvista.com|
20528216|NCT02946021|Tactile Medical|Jill Christensen|(612) 355-5123|jchristensen@tactilemedical.com|
20528217|NCT02347072|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-350-2600|creisner@pearltherapeutics.com|
20505220|NCT02778880|Cincinnati Children's Hospital Medical Center|Theresa Frey, MD|513-636-7966|theresa.frey@cchmc.org|
20505221|NCT01666444|Vice President, Clinical Affairs|Kristi Manjarrez|206-689-2256|kmanjarrez@ventirx.com|
20505222|NCT00935857|Northwestern University|Rajesh N. Keswani|312-695-5620|raj-keswani@northwestern.edu|
20505223|NCT00950690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20505224|NCT01713036|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20505225|NCT00592358|Massachusetts General Hospital|Janet Wozniak, MD|(617)503-1038|jwozniak@partners.org|
20505226|NCT04011436|Universidad Nacional de Colombia|Pt. Luisa Prieto|+57 3202082723|lfprietog@unal.edu.co|
20528218|NCT01608672|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20528219|NCT02259699|University of California, Irvine|Dr. Lari Wenzel|949-824-3926|lwenzel@uci.edu|
20528220|NCT00777062|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
20551103|NCT01896531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20551104|NCT00268996|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551105|NCT02956486|Eisai Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20505227|NCT04760314|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20505228|NCT01013883|Darlington Memorial Hospital|Dr Rajender singh|01325380100|drrsdogra@yahoo.com|3444
20505229|NCT01371838|AstraZeneca Pharmaceuticals|Melnick, David A / Exec Dir Med Science|+1 302 886 5627|David.Melnick@astrazeneca.com|
20505230|NCT04315363|Northeastern University|Meishan Ai|858-265-7288|ai.me@northeastern.edu|
20505231|NCT01509586|Medical University of South Carolina|Dr. Matthew J. Carpenter|843-876-2436|carpente@musc.edu|
20505232|NCT04013737|Health Protection Research Unit in HCAI and AMR, Imperial College London|Head of Operations|020 3313 2732|head.ops@imperial.ac.uk|
20505233|NCT00641043|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505234|NCT01096771|Indiana University School of Medicine|Dr. William Carlos|3178807819|wcarlos@iu.edu|
20505235|NCT00907478|Amgen Inc.|Study Director|866-572-6436||
20505236|NCT01936649|GE Healthcare|Dr. Jose Zubeldia|011-44-1494-543137|jose.zubeldia@ge.com|
20505237|NCT01591018|University Hospital Ostrava|David Skoloudik|00420597375630|skoloudik@hotmail.com|
20505238|NCT02546856|Servicio de Cardiologıa, Hospital Universitario Galdakao-Usansolo, OSI Barrualde-Galdakao-Osakidetza, Servicio Vasco de Salud, Galdakao, Bizkaia, Spain .BIOCRUCES, Instituto de Investigacion Sanitaria, Bizkaia, Spain|Juana Oyanguren, Nursing graduate, Master in Heart Failure, CV Pathology and Thrombosis Specialist|34 656780945|juanaoy@hotmail.com|
20505239|NCT03132246|University of Maryland School of Medicine|Dr. Aaron Johnson|410-328-1868|ajohnson1@som.umaryland.edu|
20505240|NCT03268746|Alcon Research|Clinical/Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20505241|NCT00589472|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin|646-422-4470|slovins@mskcc.org|
20505242|NCT00117338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505243|NCT00546351|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
20505244|NCT01342640|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20505245|NCT02616029|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20505246|NCT02267577|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
20505247|NCT00824538|University of California San Francisco|Hope S Rugo|877-827-3222|clinicaltrials@ucsf.edu|
20505248|NCT00479466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505249|NCT02383719|Convergent Engineering|Study Coordinator|3523784899|carl@conveng.com|113
20505250|NCT02927171|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
20505251|NCT01065480|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|nunesed@nyspi.columbia.edu|
20505252|NCT00850499|Johnson & Johnson Pharmaceutical Research & Development|Andrew Cakana, MD, FRC Path||[ACAKANA@ITS.JNJ.COM|
20505253|NCT00718861|Novartis Pharmaceuticals|Study Director|8627788300||
20505254|NCT01703819|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
20505255|NCT01302041|Astellas Pharma Global Devlopment, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
20505256|NCT00858702|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20505257|NCT01834144|University of Manitoba|Dr. Jonathan McGavock|204-480-1359|jmcgavock@chrim.ca|
20505258|NCT01849250|The University of Texas MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention|713-792-7734|PHBrown@mdanderson.org|
20505259|NCT00367640|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20505260|NCT02631135|UludagU|Hale Aksu Erdost,MD,spesialist|+905323615722|haleaksu78@yahoo.com|
20505261|NCT04504032|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20505262|NCT00771030|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20505263|NCT01839188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505264|NCT04983901|The University of M.D. Anderson Cancer Center|Dr. Issam I Raad|713-792-6237|iraad@mdanderson.org|
20505265|NCT02805907|MurciaSalud|Dr. Rubén Andújar-Espinosa|0034669500052|rubemed@hotmail.com|
20505266|NCT02046135|Cohen Children's Medical Center|Dr. James Schneider|7184703330|jschneide2@northwell.edu|
20505267|NCT01933984|Division of Critical Care Medicine, Department of Medicine, Changhua Christian Hospital|Dr. Shin-Hwar Wu|886-4-7238595|126366@cch.org.tw|3971
20505268|NCT02544984|The University of Texas Health Science Center at Houston|Ricardo A. Mosquera, MD|(713) 500-5650|Ricardo.A.Mosquera@uth.tmc.edu|
20505269|NCT02416908|Washington University School of Medicine|Geoffrey Uy, M.D.|314-747-8439|guy@wustl.edu|
20505270|NCT03100435|Tufts University|Robert Gyurko|6176366531|robert.gyurko@tufts.edu|
20505271|NCT03792750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20505272|NCT01651052|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
20505273|NCT04983940|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Dr. Ranjth Ramasamy|305-243-6596|Ramasamy@miami.edu|
20505274|NCT04156646|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20505275|NCT04337138|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505276|NCT00392444|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@toh.on.ca|70175
20505277|NCT00387660|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20505278|NCT01183546|Human Engineering Research Laboratories|Dr. Alicia Koontz|412-822-3700|alicia.koontz@va.gov|
20505279|NCT00138125|University of California at Los Angeles|Richard J. Pietras, M.D. Ph.D|310 825 9769|rpietras@ucla.edu|
20505280|NCT00638846|Vistakon|Kurt Moody OD|904-443-3088||
20505281|NCT00734929|Duke University Medical Center|Dr. Ashraf Habib|9196686265|habib001@mc.duke.edu|
20510021|NCT03657576|The University of Alabama at Birmingham|James Markert, MD|2059347171|jmarkert@uabmc.edu|
20558875|NCT02088632|Jefferson Headache Center|Clinical research manager|2159552680|mary.hopkins@jefferson.edu|
20558876|NCT01263106|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505282|NCT02351037|Pharmacyclics|Priyanka Mandava, Director of Clinical Operations|408-215-3776|psingh@pcyc.com|
20505283|NCT03176966|Vanderbilt University Medical Center|Michael McGill|615-322-4643|michael.g.mcgill@vumc.org|
20505284|NCT01520922|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20505285|NCT01903434|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505286|NCT01202110|Cedars-Sinai|Leah Silbert|310 423-3783|Leah.Silbert@cshs.org|
20505287|NCT02269319|MicuRx Pharmaceuticals Inc.|John M. Sall, Global Head of Regulatory|919-670-7803|jsall@micurx.com|
20505288|NCT03314519|Mahidol University|Kasana Raksamanee|66967841010|kasana@gmail.com|
20505289|NCT01912872|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20505290|NCT03042611|Elevar Therapeutics, Inc|Elevar Clinical Trials|(801) 303-7440|info-clinicalstudy@elevartherapeutics.com|
20505291|NCT02024711|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20505292|NCT02344628|London School of Hygiene and Tropical Medicine|Dr Michael Marks|+447984643424|michael.marks@lshtm.ac.uk|
20505293|NCT06001372|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20505294|NCT02241512|UT Southwestern|Dr. David Troendle|214456-8000|david.troendle@utsouthwestern.edu|
20505295|NCT04275310|Virginia Commonwealth University|Eric Benotsch|804-828-0133|ebenotsch@vcu.edu|
20505296|NCT04410783|Washington Univeristy|Brian M Fuller|3147475368|fullerb@wustl.edu|
20505297|NCT02345161|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505298|NCT02284399|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
20505299|NCT04635735|Memorial Sloan Kettering Cancer Center|Dr. Gunjan Shah, MD|646-608-3734|shahg@mskcc.org|
20505300|NCT03904446|University of Iowa|Cynthia A. Wong, MD|13193563868|cynthia-wong@uiowa.edu|
20505301|NCT02238028|Fudan University|Dr. Haidong Kan|+86-021-54237908|kanh@fudan.edu.cn|
20505302|NCT03090620|UColorado|Dr. George Sam Wang|303-724-9967|george.wang@childrenscolorado.org|
20505303|NCT03554005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505304|NCT02834052|AUGUSTA UNIVERSITY MEDICAL CENTER|Dr Asha Nayak|7067216748|anayak@augusta.edu|
20505305|NCT00631488|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505306|NCT00103194|"ECOG Statistical Office"|"Study Statistician"|617-632-3012||
20505307|NCT03648476|Indiana University|Dawn Neumann|3173292188|dmneuman@iupui.edu|
20505308|NCT02855411|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20505309|NCT02639182|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20505310|NCT00907881|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505311|NCT01391312|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20505312|NCT03864237|Brown University School of Public Health|Kate B. Carey|4018636558|kate_carey@brown.edu|
20510022|NCT05492877|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20510023|NCT01426009|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20510024|NCT02283333|Ralph H. Johnson VA Medical Center|Dr. Ron Acierno, PI|843-364-1667|ron.acierno@va.gov|
20510025|NCT01856855|University of Alabama at Birmingham (UAB)|John Fiveash, MD|(205) 975-0224|jfiveash@uabmc.edu|
20510026|NCT04099836|Duke University Medical Center|Dr. Thomas Stinchcombe|919-681-9509|Thomas.stinchcombe@duke.edu|
20510027|NCT01550315|Vanderbilt Universtiy|Alfredo Gamboa|6158751003|alfredo.gamboa@vumc.org|
20510028|NCT00397631|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510029|NCT02661256|NYU-Winthrop Hospital|Nazeeh Hanna, MD|6314211424|nazeehhanna@gmail.com|
20510030|NCT01878175|Durham VA Medical Center|Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
20510031|NCT03531918|Fred Hutchinson Cancer Center|Roland Walter, Member of Clinical Research Division|206-667-3599|rwalter@fredhutch.org|
20510032|NCT02711553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20528221|NCT01134393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20558877|NCT00882921|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20505313|NCT01097616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505314|NCT01848821|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|617-724-8604|dyeh2@partners.org|
20558878|NCT00715741|University of Utah|Harriet Hopf, MD|801-205-1013|Harriet.Hopf@hsc.utah.edu|
20505315|NCT00130208|Keryx Biopharmaceuticals|Medical Information|1-844-44-KERYX|medicalinfo@keryx.com|
20505316|NCT00591227|Rush University Medical Center|David Baldwin MD|312-942-6163|david_baldwin@rush.edu|
20558879|NCT01356667|UCLA, Integrated Substance Abuse Programs|Dr. Daniel Dickerson|562-277-0310|daniel.dickerson@ucla.edu|
20558880|NCT05027074|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20558881|NCT04150029|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
20558882|NCT02322814|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20558883|NCT04635059|Medical College of Wisconsin|Deepak Kilari, MD|414-805-4600|dkilari@mcw.edu|
20558884|NCT04386746|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Max Kates, MD|4105028130|mkates@jhmi.edu|
20558885|NCT03864926|University of Wisconsin Hospital and Clinics|Sandesh Parajuli, MD, MBBS|(608) 265-0152|sparajuli@medicine.wisc.edu|
20558886|NCT00445601|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|206-667-2933|ctangen@fredhutch.org|
20558887|NCT00373295|New York State Psychiatric Institute|Dr. Margaret Haney|646-774-6129|reslabsurc@gmail.com|
20558888|NCT01649596|Genesys Regional Medical Center|Surgeon|810-606-6500|twasfie@gmail.com|
20558889|NCT02165904|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
20558890|NCT00956540|Hospital Virgen de la Salud|Dr. Gonzalo Hernández|0034629625428|ghernandezm@telefonica.net|
20558891|NCT02771210|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20558892|NCT04012814|Venus Concept|Director of Clinical Affairs|1-888-907-0115|mgronski@venusconcept.com|
20558893|NCT04397523|Institute for Transfusion Medicine of RNM|Assoc. Prof. Dr. Rada M. Grubovic Rastvorceva, MD MSci PhD, CMO|+38923226923|drgrubovic@gmail.com|
20558894|NCT02694640|University of South Carolina|Dr. Bernardine Pinto|8037779272|pintob@mailbox.sc.edu|
20558895|NCT01394250|The Chidren's Hospital of Philadelphia|Deb Potts|215-590-7098|pottsd@email.chop.edu|
20558896|NCT00601718|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
20558897|NCT01865617|Fred Hutchinson Cancer Research Center|Dr. Jordan Gauthier|206-667-2713|jgauthier@fredhutch.org|
20558898|NCT00502996|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20558899|NCT00267111|Mount Sinai Hospital|Dr. Vibhuti Shah|416-586-4816|vshah@mtsinai.on.ca|
20558900|NCT02132533|UT Southwestern Medical Center|Chet Edward Wells, MD|214-648-2316|dawn.wilson@utsouthwestern.edu|
20558901|NCT02354963|IIS La Fe|Dr Cesar Diaz-Garcia|961 24 67 00|cesar.diaz@ivirma.com|
20558902|NCT01463293|Fonterra Research Centre|Dr James Dekker|+64 6 350 6323|james.dekker@fonterra.com|
20558903|NCT01290536|University of California San Francisco|Nicholas Fidelman, MD|1-415-353-1300|Nicholas.Fidelman@ucsf.edu|
20558904|NCT00988351|Malcom Randall VA|Dr. Richard B. Berry|3522621575|Richard.Berry@medicine.ufl.edu|
20558905|NCT00183456|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
20558906|NCT01896115|Boston Scientific|Stephen Carcieri, PhD|661-949-4756|Stephen.Carcieri@bsci.com|
20558907|NCT02649322|Orlando Health|Daryl C. Osbahr, MD|321.843.4800|Daryl.Osbahr@orlandohealth.com|
20558908|NCT01551303|Massachusetts General Hospital|Dr. Elizabeth Hoge|617-724-0859|ehoge@partners.org|
20558909|NCT04642469|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20558910|NCT00787722|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20558911|NCT02303626|BioCryst Pharmaceuticals, Inc|VP Clinical Development|(+1) 919 859 1302|clinicaltrials@biocryst.com|
20558912|NCT01265823|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20558913|NCT03662360|Clinica Luganese Moncucco|Dr. Med. Pio Fontana|0041919608712|pioeugenio.fontana@moncucco.ch|
20558914|NCT02302066|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20558915|NCT03777865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558916|NCT01722318|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
20558917|NCT04694482|ASST Monza|Dr. Alice Caldiroli|+3495009941|a.caldiroli@asst-monza.it|
20510033|NCT00778310|University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
20510034|NCT00572728|ACRIN|Ben Herman|401.863.9188|bherman@stat.brown.edu|
20510035|NCT01529450|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
20510036|NCT03457636|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
20510037|NCT02724111|Korea University Guro Hospital|Dr Byung Gun Lim|82-2-2626-1437|bglim9205@korea.ac.kr|
20510038|NCT00533351|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20510039|NCT01828567|Durham VA Center of Innovation in Primary Care|Eugene Z Oddone, MD, MPSc|919-286-0411|eugene.oddone@va.gov|
20510040|NCT02332876|University of San Diego, California|Dr. Sheri Hartman|8585349235|sjhartman@ucsd.edu|
20510041|NCT02415595|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20510042|NCT01637090|Boston Medical Center|Adam Lerner, MD|617-638-8265|adam.lerner@bmc.org|
20510043|NCT04063865|Indiana University|Chandrashekhar Kubal|317-312-2601|sakubal@iupui.edu|
20510044|NCT01700140|SymBio Pharmaceuticals|Nobuyuki Koseki|+81-3-5472-1127||
20510045|NCT01060124|Medical affairs, Janssen Korea, Ltd.|CRA|82220944835||
20510046|NCT01708915|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510047|NCT01045551|Columbia University Medical Center|Julian Mackay-Wiggan, MD, MS|212-305-6953|jc299@cumc.columbia.edu|
20558918|NCT05259774|Relife Srl|Lia Fabbri|05556809528|lfabbri@relifecompany.it|
20558919|NCT00461292|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20558920|NCT02180438|University of Washington|Dr. Geoffrey S Gottlieb. MD PhD (PI)|1-206-616-2631|gottlieb@uw.edu|
20558921|NCT02058290|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
20510048|NCT03231228|B. Braun Medical Inc.|Diana Valencia MD|610-596-2875|diana.valencia@bbraunusa.com|
20510049|NCT01222416|Vanderbilt-Ingram Cancer Center|A Bapsi Chakravarthy, MD Program Director, Radiation Oncology|615-322-2555|babsi.chak@vanderbilt.edu|
20558922|NCT01238549|VAORD|Dr. Ann Spungen|718-584-9000|ann.spungen@va.gov|5814
20558923|NCT00785707|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
20558924|NCT03295266|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558925|NCT00105586|Washington University in St. Louis|Eric Lenze|314-362-1671|lenzee@wustl.edu|
20558926|NCT02262260|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20558927|NCT01794117|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Edward W. Cowen|301-827-2328|cowene@mail.nih.gov|
20558928|NCT00405704|UNC Chapel Hill|Dr. Myra Carpenter, Senior Investigator|919-962-3245|myra_carpenter@unc.edu|
20558929|NCT02696902|MedImmune, LLC|Mark Esser|+1 301 3986849|information.center@astrazeneca.com|
20558930|NCT01741454|University of Wisconsin School of Medicine & Public Health|Shuang Li (Linda)|608.263.8336|lis@urology.wisc.edu|
20558931|NCT03599986|DataClin|Medical Writer|(+2) 01001566602|mariam.abdalla@dataclin.com|
20558932|NCT02401308|St. Joseph's Hospital and Medical Center|Lisa Arnold - Operations Manager Neurosurgery Clinical Research|602-406-9593|lisa.arnold@dignityhealth.org|
20510050|NCT01744340|BrUOG-Brown University Oncology Research Group|Howard Safran, MD|4018633000|kristen_mitchell@brown.edu|
20558933|NCT02998021|University of Pittsburgh|Alicia Koontz, PhD|4128223700|akoontz@pitt.edu|
20558934|NCT06385483|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20558935|NCT05569954|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20558936|NCT04858295|University of Pennsylvania|Dr. Sarah Schrauben|267-324-7588|sarahsch@upenn.edu|
20558937|NCT00654940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20558938|NCT00802737|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558939|NCT03677128|Duke University|Kristin Schroeder, MD MPH|919-668-6288|kristin.schroeder@duke.edu|
20558940|NCT04435795|Research Institute of the McGill University Health Center|Dr Nicole EZER|514-934-1934|nicole.ezer@mcgill.ca|76192
20558941|NCT00619476|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20558942|NCT01625910|University of Minnesota, Department of Family Medicine and Community Health|Steven D. Stovitz, MD, MS|612-310-2344|sstovitz@umphysicians.umn.edu|
20558943|NCT02391038|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20558944|NCT02959138|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20510051|NCT00518336|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510052|NCT04337203|Wake Forest Baptist Comprehensive Cancer Center|Carol Kittel|336-399-3832|c.kittel@wakehealth.edu|
20510053|NCT00703729|CU Sports Medicine|Dr. Eric McCarty|303-441-2118|cyndi.long@ucdenver.edu|
20510054|NCT03053180|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20510055|NCT01928186|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20510056|NCT00511706|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20510057|NCT02972658|AstraZeneca|AstraZeneca Information Center|877-240-9479|information.center@astrazeneca.com|
20510058|NCT03958149|Imperial College Healthcare NHS Trust|Key investigator|02033121077|annabellelee@nhs.net|
20510059|NCT00461851|Yale University Yale Cancer Center|Dr Michael Hurwitz|2037371600|Hari.deshpande@yale.edu|
20510060|NCT00621764|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20510061|NCT01493024|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20510062|NCT03031327|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20510063|NCT02059174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510064|NCT04397757|University of Pennsylvania|Regulatory Lead|512-662-4484|psom-ind-ide@pobox.upenn.edu|
20510065|NCT02306148|University of Sao Paulo - School of Medicine|Dr Isabel Sacco|0055 11 996431511|icnsacco@usp.br|
20510066|NCT01901809|Johns Hopkins University School of Medicine|Kavita Sharma, MD|410-955-7670|ksharma8@jhmi.edu|
20510067|NCT02776904|University of Arkansas for Medical Sciences|Dr. Charlotte Yates|501-450-5542|cyates@uca.edu|
20510068|NCT04167514|CSL Behring|Clinical Study Disclosure Manager|1- 610-878-4697|clinicaltrials@cslbehring.com|
20510069|NCT00290355|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510070|NCT03345849|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20510071|NCT00033514|Medical University of South Carolina|Carolyn Britten|843-792-4271|britten@musc.edu|
20510072|NCT03595982|Icahn School of Medicine at Mount Sinai|Dr. Melissa Chu Lam|520-360-8807|melissachu.md@gmail.com|
20510073|NCT01228084|Oregon Health & Science University, Knight Cancer Institute|Joshi Alumkal, MD|503-494-1091||
20510074|NCT03577028|Harpoon Therapeutics|Medical Director|1-650-452-728|HPN4241001@harpoontx.com|
20510075|NCT01599585|National Center for Telehealth and Technology|Larry D. Pruitt, PhD|253-968-2946|larry.d.pruitt21.civ@mail.mil|
20510076|NCT04564027|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|Information.center@astrazeneca.com|
20510077|NCT00777036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20510078|NCT04632589|University of Iowa|Anna Stanhewicz, PhD|3194671732|anna-stanhewicz@uiowa.edu|
20510079|NCT05827978|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20510080|NCT05564039|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
20510081|NCT04566445|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20510082|NCT04785144|Kaiser Permanente Washington|Lisa Jackson|206-442-5216|lisa.a.jackson@kp.org|
20510083|NCT04453722|Cleveland Clinic|Daniel I. Sessler, Professor & Chair|216-445-6500|DS@CCF.org|
20510084|NCT00610714|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20510085|NCT00829010|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558945|NCT02873286|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20558946|NCT01327547|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20558947|NCT02240589|Indiana University School of Medicine|Flora Hammond, MD|317-329-2106|flora.hammond@rhin.com|
20558948|NCT01681368|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
20558949|NCT02354924|Mackay Memorial Hospital_Taipei|Dr. Huey-Chuan Cheng|886-2-25433535|hccheng@ms2.mmh.org.tw|
20558950|NCT00900627|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
20558951|NCT02821832|National Institute of Allergy and Infectious Diseases|Dr. Clif E. Barry 3rd|301-693-4665|cbarry@niaid.nih.gov|
20558952|NCT03685708|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
20558953|NCT02682498|UC Irvine Health|Joseph Rinehart|714-456-5059|jrinehar@uci.edu|
20558954|NCT01311362|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4966215639197|gerd.mikus@med.uni-heidelberg.de|
20510086|NCT00369564|Nemours Children's Clinic|Scott Bradfield, MD|904-697-3793|sbradfie@nemours.org|
20510087|NCT00137267|Bedford VA Medical Center|Dr. David Smelson|781-687-2845|david.smelson@va.gov|
20510088|NCT00638989|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
20510089|NCT03288311|Vanderbilt University Medical Center|Jonathan Casey, Assistant Professor of Medicine|6158754681|Jonathan.d.Casey@vumc.org|
20510090|NCT00853112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510091|NCT01553591|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20510092|NCT02599441|University at Buffalo|Research coordinator|7162043209|mk67@buffalo.edu|
20510093|NCT00513370|Abbott|Medical Information Specialist|1-800-633-9110||
20510094|NCT00809055|Brigham and Women's Hospital|Dr. Terrie Inder|617-525-6650|tinder@partners.org|
20510095|NCT01818765|Oxford university hospitals NHS Foundation Trust|Dr James Gamble|+441865221012|drjgamble1@jhpg.net|
20510096|NCT01228149|Dept. of Ophthalmology, University Medical Center Mainz|Dr. Dr. Katrin Lorenz|00496131174069|lorenz@augen.klinik.uni-mainz.de|
20510097|NCT02417129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510098|NCT02005211|AstraZeneca|Vice President, Neuroscience iMed||ClinicalTrialTransparency@astrazeneca.com|
20510099|NCT01917136|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
20510100|NCT04589832|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
20510101|NCT02202161|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510102|NCT00952133|NYU Langone Medical Center|Jeanna Blitz, MD|212-263|jeanna.viola@nyumc.org|0667
20510103|NCT01603628|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20510104|NCT01969565|Emory University|Jonathan Kaufman, MD|404-778-1900|jlkaufm@emory.edu|
20510105|NCT00832091|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-208-9191|nturjman@regenerx.com|108
20510106|NCT03667573|Malcom Randall VA Medical Center|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
20510107|NCT00952588|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20510108|NCT01108068|University of Maryland School of Medicine|Elizabeth Streeten, MD|410-328-3335|estreete@som.umaryland.edu|
20510109|NCT00836953|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20510110|NCT01021553|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510111|NCT01950364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20510112|NCT00935701|Kennedy Krieger Institute|Lana Warren|4439239312|WarrenL@kennedykrieger.org|
20510113|NCT02201251|Janssen Research & Development, LLC|Director - Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20510114|NCT05259800|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20510115|NCT04048876|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20510116|NCT04055844|University of Minnesota, Masonic Cancer Center|Mark Juckett , MD|612-676-4200|juck0001@umn.edu|
20510117|NCT04716010|University of North Carolina at Chapel Hill|Lindsey Smith Taillie, PhD|(919) 445-8313|taillie@unc.edu|
20510118|NCT00679380|Santarus, Inc.|Michael Huang, M.D., Senior Medical Director|858-314-5700|contact@santarus.com|
20510119|NCT02996500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510120|NCT01099761|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510121|NCT01347840|Ethicon Endo-Surgery, Inc.|Amy Mahanes|513-337-8366|amahanes@its.jnj.com|
20510122|NCT00928304|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
20558955|NCT02222896|Microbac|Dr. Bashir|703-925-9366|muhammad.bashir@microbac.com|
20558956|NCT00654329|Children's National Medical Center|Julia C. Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
20558957|NCT01744496|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20558958|NCT01729728|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20558959|NCT03772314|Emory University|Dr. Lynn Marie Trotti|404-712-7240|lbecke2@emory.edu|
20558960|NCT00672958|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20558961|NCT02796963|UNC Project-China|Dr. Weiming Tang|+86-21-83755824|weimingtangscience@gmail.com|
20558962|NCT00119262|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20558963|NCT00110513|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Affairs|508-370-5257|denise.tilton@gtc-bio.com|
20510123|NCT03580525|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
20510124|NCT01183481|Sunnybrook Health Sciences Centre|Dr. Edward Chow|416-480-4998|edward.chow@sunnybrook.ca|
20510125|NCT01359111|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
20558964|NCT01927718|UT MD Anderson Cancer Center|Qaiser Bashir, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|QBashir@mdanderson.org|
20558965|NCT00240526|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558966|NCT01009047|Janssen Research & Development, LLC|Senior Director, Clinical Leader|+1-609-730-2436||
20558967|NCT01716208|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20558968|NCT02029040|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|Mohamed.Badawy@UTsouthwestern.edu|
20558969|NCT01017653|Preston Robert Tisch Brain Tumor Center|Annick Desjardins||annick.desjardins@dm.duke.edu|
20558970|NCT01630590|UT MD Anderson Cancer Center|Dr. Paul Corn, Chair Ad Interim, Genitourinary Medical Oncology|(713) 563-7208|pcorn@mdanderson.org|
20558971|NCT01752413|Memorial Blood Centers|Jed B Gorlin MD, MBA|651-332-7284|Jed.Gorlin@innovativeblood.org|
20558972|NCT02366936|Duke University Health System|Dr. William Malcolm|919-681-4913|william.malcolm@duke.edu|
20558973|NCT01751113|GlaxoSmithKline|GSK Response Center|866-435-7343||
20558974|NCT02878213|EPD Solutions|Chen Sagy Bross|+972-50-5560073|chensb@epd-medical.com|
20558975|NCT00656916|UT MD Anderson Cancer Center|Lara Bashoura, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20558976|NCT02512510|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20558977|NCT02141659|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20558978|NCT04110366|Imperial College London|Dr Ryan Thwaites|(0044) 0203 3125730|r.thwaites@imperial.ac.uk|
20510126|NCT04223778|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20510127|NCT04540627|mAbxience Research SL|Director of Clinical Trials|+34917711500|susana.millan@mabxience.com|
20510128|NCT01465958|Grifols Therapeutics Inc|Henry Li, PhD|800-20-2807|henry.li@grifols.com|
20510129|NCT03109418|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
20510130|NCT02043704|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
20510131|NCT02785588|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
20510132|NCT06115681|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510133|NCT00211536|Sr. Clinical Research Manager|John Shin|818-576-4019|john.shin@medtronic.com|
20510134|NCT00669240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510135|NCT02583399|Cumberland Pharmaceuticals Inc.|Sr. Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
20510136|NCT00686699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510137|NCT03276494|Ohio State University|Thomas Lawson|614-366-7312|thomas.lawson@osumc.edu|
20510138|NCT04610827|Mayo Clinic|Julie M. Baughn, M.D.|507-293-1031|Baughn.Julie@mayo.edu|
20510139|NCT01693562|MedImmune, LLC|Ashok Gupta|+13013981287|information.center@astrazeneca.com|
20510140|NCT02759939|Dartmouth College|Rachel Thompson|6036530860|rachel.thompson@dartmouth.edu|
20510141|NCT00087594|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20510142|NCT00768040|Novartis Pharmaceuticals|Study Director|862-778-8300||
20510143|NCT00551200|Hyperion Therapeutics|Sr. Vice President and Chief Medical Officer, Bruce F. Scharschmidt|(650) 745-7851|bruce.scharschmidt@hyperiontx.com|
20510144|NCT03347279|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
20510145|NCT01646151|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20510146|NCT02094612|Kaiser Permanente Division of Research|Monique Does, Project manager|510-891-3612|monique.does@kp.org|
20510147|NCT01542632|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20510148|NCT03991936|Weill Cornell Medicine|Dr. Shari Lipner|6469623376|shl9032@med.cornell.edu|
20510149|NCT02773849|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
20510150|NCT05306964|University of Pittsburgh|Raghavan Murugan, MD, MS, FRCP, Principal Investigator|412-647-8499|muruganr@ccm.upmc.edu|
20510151|NCT01263470|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20510152|NCT01327573|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
20510153|NCT01108263|Georgetown University|Dr. John Steinberg, Principal Investigator|202-444-0793|zr40@georgetown.edu|
20510154|NCT00712712|Institute Bergonie|Dr. Jean Palussière|05 56 33 37 50|j.palussiere@bordeaux.unicancer.fr|
20510155|NCT01685372|University of Colorado School of Medicine|Donna Curtis, MD, MPH|720-777-6981|donna.curtis@childrenscolorado.org|
20510156|NCT02055872|McMaster University|Simon Oczkowski|905 521 2100|oczkowsj@mcmaster.ca|42442
20510157|NCT01029691|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
20510158|NCT05245071|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20510159|NCT01602822|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org|
20510160|NCT02329860|clinical operation|Zexiang.huang/ project manager|13811725417|zexiang.huang@hengrui.com|
20510161|NCT02477800|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20510162|NCT00129376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20510163|NCT03369340|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20510164|NCT02061540|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
20510165|NCT01076270|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4730|wbensing@fredhutch.org|
20510166|NCT01948518|Cleveland Clinic|Umur Hatipoğlu, MD|216-636-5344|HATIPOU@ccf.org|
20536590|NCT04188834|Georgia Institute of Technology Atlanta|Dr. Annabelle Singer|404.385.4936|annabelle.singer@bme.gatech.edu|
20558979|NCT02471404|AstraZeneca|Eva Johnsson, MD, PhD|+46 (0)31776 24 84|ClinicalTrialTransparency@astrazeneca.com|
20510167|NCT04005755|AFT Pharmaceuticals|Jennifer Zhang -Project Leader|+ 64 9 488 0232|jenniferz@aftpharm.com|710
20510168|NCT02289833|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20510169|NCT04509024|Carnegie Mellon University|Dr. Seth Wiener, Associate Professor|412-268-5669|sethw1@cmu.edu|
20510170|NCT02561273|University of Nebraska Medical Center|Matthew Lunning|402-559-7164|mlunning@unmc.edu|
20510171|NCT02723019|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
20510172|NCT03597789|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-5082|djjones@email.unc.edu|
20510173|NCT00958191|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
20510174|NCT00611767|Yale University School of Medicine|Dr. Ismene L. Petrakis, Professor of Psychiatry|203-932-5711|Ismene.petrakis@yale.edu|2244
20510175|NCT01642004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20510176|NCT02718625|Smith & Nephew, Inc.|Natasha Schappell, Clinical Study Manager|817-302-3949|Natasha.Schappell@smith-nephew.com|
20510177|NCT00598806|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20510178|NCT00811395|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
20510179|NCT00170846|Novartis Pharmaceuticals|Study director|862-778-8300||
20510180|NCT00528840|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20510181|NCT04995666|Phonak Audiology Research Center|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20510182|NCT04554394|Pulse Biosciences, Inc.|William A. Knape|(919) 757-2033|bill.knape@pulsebiosciences.com|
20510183|NCT01766401|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20510184|NCT01523613|University of Michigan|Dr. Mathilde Peters||mcpete@umich.edu|
20510185|NCT00808132|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510186|NCT02795182|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20510187|NCT02520141|M D Anderson Cancer Center|Milind Javle|(713) 792-5434|mjavle@mdanderson.org|
20510188|NCT01628718|Massachusetts Veterans Epidemiological Research and Information Center|Brett T. Litz, PhD|617-584-9314|litzb@bu.edu|
20528222|NCT03658642|Yale School of Medicine|Ted Melnick, MD, MHS Associate Professor of Emergency Medicine and of Biostatistics (Health Informat|(203) 785-5174|edward.melnick@yale.edu|
20528223|NCT00098670|The Ohio State University|Dr. Thomas Lin||thomas.lin@osumc.edu|
20528224|NCT01808222|Emory University|David Schuster MD|404-712-4859|dschust@emory.edu|
20528225|NCT03762681|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20528226|NCT03290391|Boston Medical Center and BU Chobanian & Avedisian School of Medicine|Jeffrey Samet, MD MA MPH|(617) 414-7288|jsamet@bu.edu|
20528227|NCT02548949|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528228|NCT01396551|Varian Medical Systems|Julie Allen|206-330-2605|julie.allen@varian.com|
20528229|NCT00524680|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20528230|NCT01146561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528231|NCT02801370|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20528232|NCT03078127|University of North Carolina at Chapel Hill|Scott Donaldson, MD|984-974-9198|scott_donaldson@med.unc.edu|
20528233|NCT00829829|Regeneron Pharmaceuticals, Inc. Phone:|Clinical Trial Management||clinicaltrials@regeneron.com|
20528234|NCT02984267|Arizona Anesthesia Consultants|Dr. Thomas Vernon|480-570-7082|tvernon@azanesthesia.net|
20528235|NCT01249833|Trial Management Group Inc.|Joanne Morris, Clinical Research Quality Manager|4169297717|joanne@tmginvestigators.com|
20528236|NCT03796676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528237|NCT00535392|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20528238|NCT01900899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528239|NCT02828137|Inha University Hospital|Dr. Sung Woo Kwon|821031133363|kwonswdr@gmail.com|
20528240|NCT02772809|University of Pennsylvania|Michelle J Johnson|215 893-2665|johnmic@pennmedicine.upenn.edu|
20528241|NCT02860507|Merck Pharmaceuticals|Chadwick Neal / Medical Affairs Director|2056010605|chadwick.neal@merck.com|
20528242|NCT00723697|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
20528243|NCT00534105|Baystate Medical Center|Glenn Markenson MD|413-794-8073|glenn.markenson@bhs.org|
20528244|NCT03402230|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
20528245|NCT00978341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20528246|NCT03035916|China-Japan Unit Hospital of Jilin University|Dr. Guoqing Zhao|0435-84995117|zhaogq65@126.com|
20528247|NCT03885999|The Chinese University of Hong Kong, Department of Surgery, Prince of Wales Hospital|Dr. Kaori Futaba|0085264630121|kfutaba@surgery.cuhk.edu.hk|
20528248|NCT02452554|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20528249|NCT02749799|Dr. Reddys Laboratories Inc|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20528250|NCT00520767|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
20528251|NCT00401193|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20528252|NCT02526160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20528253|NCT00398216|Daiichi Sankyo, Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
20528254|NCT00570960|University of Virginia|Patrick G. Northup, M.D.|434-924-0000|northup@virginia.edu|
20528255|NCT01962948|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
20528256|NCT02207400|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528257|NCT03396822|University of Maryland School of Medicine|Daniel Harrison|410-328-5605|dharrison@som.umaryland.edu|
20510189|NCT00945594|University of Oklahoma Health Sciences Center|Lieschen Quiroz, MD|405-271-8787|lieschen-quiroz@ouhsc.edu|
20510190|NCT03258762|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20510191|NCT00060333|Mayo Clinic|Barbara A. Pockaj, MD|507/284-3559|pockaj.barbara@mayo.edu|
20510192|NCT05954065|Erchonia|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
20510193|NCT05325333|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
20510194|NCT03893630|University of Kentucky|Dr. John M. O'Brien|8592575158|john.obrien2@uky.edu|
20510195|NCT04334876|Indiana University|Courtney Rowan|317-944-7065|coujohns@iu.edu|
20510196|NCT02530281|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
20510197|NCT03557801|Vanderbilt University Medical Center|Dr. Lucy Spalluto|615 343 1187|lucy.b.spalluto@vumc.org|
20510198|NCT03558503|UroGen Pharma|Elyse Seltzer, MD|1-646-492-8518|elyse.seltzer@urogen.com|
20510199|NCT02646891|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20510200|NCT01866839|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
20558980|NCT01927731|The University of Texas MD Anderson Cancer Center|Uday Popat, M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
20510201|NCT02591511|Taipei medical university|Dr. Chia-Yun Lin|+886919986391|windoct@hotmail.com|
20510202|NCT01104922|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor; ClinicalTrials.gov Admin|412-647-5554|stadtermanbm@upmc.edu|
20510203|NCT03501979|University of Alabama at Birmingham|Dr. Erica Stringer-Reasor|205-975-2914|esreasor@uabmc.edu|
20510204|NCT00779116|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20510205|NCT00706264|Hospital Vall d'Hebron|Maria M Goya|934893085|maria.goya@vhir.org|4652
20510206|NCT02079311|Universitätsklinikum Gießen und Marburg GmbH|Prof Alexander Torossian|(+49) 06421 - 286 9864|alexander.torossian@med.uni-marburg.de|
20510207|NCT01714336|Mayo Clinic|Dr. Mark Pagnano|507-284-2511|pagnano.mark@mayo.edu|
20510208|NCT01756833|University of Maryland School of Medicine|Michael L. Terrin, MDCM, MPH, Contact Principal Investigator|410-706-6139|mterrin@som.umaryland.edu|
20510209|NCT00886587|Johnson & Johnson Consumer Inc|Amisha Parikh-Das, PhD/Study Director|973 385-2863 USA EST|AParikh1@its.jnj.com|
20510210|NCT00398086|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20510211|NCT00696774|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20510212|NCT04084210|University of Wisconsin- Madison|Megan Piper, PhD, Director of Research Professor|608-265-5472|mep@ctri.wisc.edu|
20510213|NCT00890201|Hospital de La Serena|Marcelo A. Beltran, M.D. - Department of Surgery - Hospital de La Sererna|56 51 485923|beltran_01@yahoo.com|
20510214|NCT00033293|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20510215|NCT02087241|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
20510216|NCT01955005|Iowa City VA Health Care System|Carolyn L Turvey|319 338 0581|Carolyn.Turvey@VA.Gov|7714
20510217|NCT02877134|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH GI|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20510218|NCT01197794|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
20510219|NCT01055457|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D.- PRINCIPAL RESEARCH OPTOMETRIST, Clin Ops|904-443-3500|KCANAVA2@its.jnj.com|
20510220|NCT02187224|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
20510221|NCT00835276|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20510222|NCT04922710|AdventHealth Research Institute|Kirk Erickson, Director of Translational Neuroscience|412-576-3724|kirk.erickson@adventhealth.com|
20510223|NCT02031627|Tactile Medical|Susy Peters, Clinical Trial Manager|612-540-7175|speters@tactilemedical.com|
20510224|NCT01010776|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
20558981|NCT01812005|The Ohio State University James Comprehensive Cancer Center|Kristie Blum, MD|614-293-7807|Kristie.Blum@osumc.edu|
20558982|NCT00305864|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20558983|NCT01450787|Coa Research Foundation|Kenneth A Beckman, MD|614-506-4720|kenbeckman22@aol.com|
20558984|NCT02836613|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20558985|NCT01464255|Clinical Research Center, University of California, Berkeley, School of Optometry|Thao N Yeh, O.D.|(510) 642-9649|thaoyeh@berkeley.edu|
20558986|NCT03881059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20558987|NCT02065570|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20558988|NCT03299062|University of Arkansas for Medical Sciences|Rohit Dhall, MD|6025033193|rdhall@uams.edu|
20558989|NCT04267575|Jerome Canady Research Institute for Advanced Biological and Technological Sciences|Jerome Canady, M.D.|301-270-0147|drjcanady@gwu.edu|
20558990|NCT00785538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20558991|NCT03382600|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20558992|NCT02874066|National Taiwan University Hospital|Chen-Hua Liu|+886-972651880|jacque_liu@mail2000.com.tw|
20558993|NCT03141528|Inselspital|Dr. Tina Pedersen|+4522125797|tinaheidipedersen@yahoo.dk|
20558994|NCT02917577|UCalgary|Heinrike Schmeling|4039553194|schmelingresearch@albertahealthservices.ca|
20558995|NCT02066532|Columbia University Irving Medical Center|Dawn Hershman, MD|212-305-5098|dlh23@cumc.columbia.edu|
20558996|NCT05033080|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20558997|NCT04485546|Dompé Farmaceutici S.p.A|Sarah Wilting, OD MS|833-366-7387|usmedinfo@dompe.com|
20510225|NCT01229410|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20558998|NCT03560245|Neurotropebioscience, Inc|Alan J. Tuchman, MD, Acting Chief Medical Officer|973-242-0005|atuchman@neurotrope.com|
20558999|NCT01381952|Karolinska University Hospital|Dr. Söderman|+46851774037|michael.soderman@karolinska.se|
20559000|NCT01378520|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
20559001|NCT00547105|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
20559002|NCT00459303|National Taiwan University Hospital|Fung-Rong Hu|+886223123456|fungronghu@ntuh.gov.tw|2131
20559003|NCT00675415|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
20559004|NCT01719900|University of Calgary|Dr. Raylene Reimer|14032208218|reimer@ucalgary.ca|
20559005|NCT05819619|Hackensack Meridian Health|Melissa M. Figueroa, MD, MPH, FACOG|551-996-8400|melissa.figueroa@hmhn.org|
20559006|NCT01040780|Cancer Hospital, Chinese Academy of Medical Sciences|Yan Sun, M.D.|0086-010-87788519|zhangheping@csco.org.cn|
20559007|NCT03681639|Zimmer Biomet|Esther Foo|+41792894930|esther.foo@zimmerbiomet.com|
20559008|NCT00581113|Virginia Commonwealth University|Martha D. Wellons|804-628-1939|mwellons@vcu.edu|
20559009|NCT01818141|Hartford Hospital|Dr. David P. Nicolau, PharmD, FCCP, FIDSA|860-972-3941|david.nicolau@hhchealth.org|
20505317|NCT01733069|Gen-Probe Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
20505318|NCT01372878|Given Imaging|"Ravit Peled | Biostatistics and Data Management Manager"|+972 (4) 909-7894|ravit.peled@givenimaging.com|7894
20505319|NCT02296346|Huntsman Cancer Institute, University of Utah|Dr. Daniel Couriel|801-213-3082|dan.couriel@hci.utah.edu|
20505320|NCT02739698|University Hospital Reina Sofia, Cordoba, Spain|Angela Casado-Adam, MD|0034957010439|angeti@hotmail.com|
20505321|NCT03626415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505322|NCT01834326|University of Michigan|Stephen E. Feinberg|734 763 5963|sefein@med.umich.edu|
20505323|NCT01530399|TMC|Peter Villiger|+19732906340|peter.villiger@themedco.com|
20505324|NCT02064439|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20505325|NCT03350750|Johns Hopkins|Jessica Wollett|6673068141|jwollet1@jh.edu|
20505326|NCT02433288|AstraZeneca|Traxler, Barry M|+1 301 398 0657|barry.traxler@astrazeneca.com|
20505327|NCT00205504|Virginia Commonwealth University|Kai Cheang, Principal Investigator|804-828-9698|kicheang@vcu.edu|
20505328|NCT02234583|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
20505329|NCT02367170|University of Florida|PhD in exercise physiology|352 2736105|UFCT-gov@ufl.edu|
20505330|NCT02688842|Shanghai Microport Medical (Company) Co.,Ltd.|Haotian Zhang|+86-21-38954600|zhanght@microport.com|8552
20505331|NCT00062738|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
20505332|NCT01842464|Western Galilee MC|Menahem Neuman|+972546444033|mneuman@netvision.net.il|
20505333|NCT00114114|Massachusetts General Hospital|Dr. Ben Leder|617-726-6723|bzleder@partners.org|
20505334|NCT01985685|Beth Israel Deaconess Medical Center|Dr. Katherine Berg|617-667-5864||
20505335|NCT01214434|Promius Pharma, LLC|Medical Information Center|888 966-8766|product-complaints@promiuspharma.com|
20505336|NCT02075255|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
20505337|NCT01188798|St. Jude Children's Research Hospital|Asha Pillai, MD|1-866-278-5833|info@stjude.org|
20505338|NCT01748760|Brown University|Shirley Yen, Ph.D.|401-444-1915|Shirley_Yen_PhD@Brown.edu|
20505339|NCT00872898|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
20505340|NCT00863928|Virginia Mason Medical Center|Kathryn Dahl, RN|206-341-0578|kathryn.dahl@vmmc.org|
20505341|NCT01269034|Albert Einstein College of Medicine|Roger Hicks, Administrative Director for Research - Department of Pediatrics|718-920-7386|roger.hicks@einsteinmed.org|
20505342|NCT01001494|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20505343|NCT02795156|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20505344|NCT03320512|University of North Carolina at Chapel Hill|Lisa Hightow-Weidman|919-843-0033|lisa_hightow@med.unc.edu|
20505345|NCT02428140|University of Alberta|Dr. Brian Buck|78024819227|bbuck@Ualberta.ca|
20505346|NCT03534271|Rush University|Dr. Jonathan Brady Scott|3129426389|jonathan_b_scott@rush.edu|
20505347|NCT02961764|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20505348|NCT04331730|Alkahest, Inc.|Head of Communications|(650) 801-0474|trials@alkahest.com|
20505349|NCT01469052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505350|NCT00633139|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20505351|NCT02160977|Peking University Third Hospital|Dr. Jia-Kuo Yu|86-10-82267392|yujiakuo@126.com|
20505352|NCT02211495|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20505353|NCT04773041|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6363|bhavani.x.kashyap@healthpartners.com|
20505354|NCT04963179|Womed|Director of Clinical Affairs|0785225561|pauline@womedtech.com|+33
20505355|NCT05270694|MaineHealth Institute for Research|Dr. Kathleen Fairfield|207-661-7614|kathleen.fairfield@mainehealth.org|
20505356|NCT01842061|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
20505357|NCT00128206|University of California, San Francisco|Mary White|415-476-5213|mary.white@nursing.ucsf.edu|
20505358|NCT04220489|UPMC|Jacques E. Chelly, MD, PhD, MBA|412-623-6904|chelje@anes.upmc.edu|
20505359|NCT03032068|Cleveland Clinic|Jayson Zadzilka|216-445-8023|zadzilj@ccf.org|
20505360|NCT05047640|University of Miami|Giselle Guerra|3053555803|gguerra@med.miami.edu|
20505361|NCT03132805|Johns Hopkins University|Nicholas S. Ialongo, Principal Investigator|410-493-1252|nialong1@jhu.edu|
20505362|NCT03009539|University of Miami|Guillermo Prado|305-284-2002|gprado@miami.edu|
20505363|NCT03151148|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20505364|NCT00710034|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
20505365|NCT00494871|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20559010|NCT01222832|SEMC|Peter catalano|617-789-5004|peter.catalano@steward.org|
20510226|NCT01736930|Jaeb Center for Health Resesarch|Roy W. Beck, MD, PhD|813-975-8690|jdrfapp2@jaeb.org|
20510227|NCT00678249|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|john.reviere@crbard.com|
20510228|NCT00721357|Ralph H Johnson VAMC|Chris Gregory|(843)792-1078|Christopher.Gregory@va.gov|
20510229|NCT01846208|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
20510230|NCT01268514|Medtronic|Andrea DiScipio, Clinical Research Associate|781-491-5350|andrea.l.discipio@medtronic.com|
20510231|NCT01424306|Fred Hutchinson Cancer Research Center|Mario Kratz|206-667-7362|mkratz@fredhutch.org|
20510232|NCT00369928|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
20510233|NCT01875874|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
20510234|NCT00407420|University of Bristol|Julian Hamilton-Shield|00441173420183|j.p.h.shield@bristol.ac.uk|
20510235|NCT00374127|New York State Psychiatric Institute at Columbia University Medical Center|Dr. Meg Haney, Professor of Neurobiology|6467746153|meg.haney@nyspi.columbia.edu|
20510236|NCT03344562|University of Texas Southwestern Medical Center|Dr. Amy Mathews - ASSISTANT PROFESSOR|214/645-1719|Amy.Mathews@UTSouthwestern.edu|
20510237|NCT02736474|Shanghai Mental Health Center|Chief Physician Dr Du. Jiang Du|86-21-64387250|dujiangdou@163.com|
20510238|NCT02382276|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20510239|NCT00928499|University of California, Irvine|Karen Noblett, MD|714-456-8564|knoblett@uci.edu|
20510240|NCT02313506|Arthritis Research Canada|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
20510241|NCT00703781|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
20510242|NCT02168816|Loyola University Medical Center|Michael Pinzur, M.D.|708-216-4993|mpinzu1@lumc.edu|
20510243|NCT03714256|Permobil|Vice President of Research and Innovation|+46703836763|karin.leire@permobil.com|
20510244|NCT01066546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510245|NCT03860181|Medical University of South Carolina|Josef Eichinger, MD|843-876-0111|eichinge@musc.edu|
20510246|NCT05439876|School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan|Shao-Yu Tsai|(02)23123456#288904|stsai@ntu.edu.tw|
20510247|NCT02545049|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20510248|NCT01586962|Novartis|Clinical Project Leader|+41223633111||
20510249|NCT03300557|University of Minnesota/Masonic Cancer Center|Britt Erickson|612-626-6283|bkeric@umn.edu|
20510250|NCT04960397|University of Maryland|Dr. James D. Campbell|410-706-5328|jcampbel@som.umaryland.edu|
20510251|NCT01394211|University of Arizona Cancer Center|Program Coordinator|5206260301|aselegue@email.arizona.edu|
20510252|NCT04191096|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510253|NCT00387829|Intergra LifeSciences|Director of Medical Affairs|609-275-0500|clinicalaffairs-neuro@integralife.com|
20510254|NCT01004861|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20510255|NCT00003389|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
20510256|NCT02554721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20510257|NCT01662752|St Mark's Hospital|Professor Robin Kennedy|+44(0)2082354046|robin.kennedy@nhs.net|
20510258|NCT04657003|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20528258|NCT04560868|Kaiser Permanente Washington Health Research Institute|Director, Investigative Science|206-287-2737|jennifer.b.mcclure@kp.org|
20528259|NCT01763827|Amgen Inc.|Study Director|866-572-6436||
20528260|NCT03746405|Duke University|Dr Lysianne Beynel|919-681-1157|lysianne.beynel@duke.edu|
20559011|NCT01554982|Keryx|Lisa Loram|919-434-6195|lisa.loram@keryx.com|
20559012|NCT00678444|UPittsburgh|Dr. Jerry Lowder|314-747-1402|lowderj@wudosis.wustl.edu|
20505366|NCT03918642|VA Greater Los Angeles Healthcare System|Brandon C. Yarns|310-478-3711|brandon.yarns@va.gov|
20505367|NCT03238248|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20505368|NCT00972244|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20505369|NCT00090285|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505370|NCT04146272|Bernafon AG|Barbara Simon|+41 31 998 15 15|bsim@bernafon.com|1664
20505371|NCT04498910|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20505372|NCT03881163|Zambon S.p.A|Valentina Vaja|+390266524497|Valentina.Vaja@ZambonGroup.com|
20505373|NCT02345434|Columbia University|Adam Sacarny|212 305 7084|ajs2102@columbia.edu|
20505374|NCT01022853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505375|NCT00532883|NHLBI|Harvey Luksenburg|301-435-0050|luksenburgh@mail.nih.gov|
20505376|NCT01327339|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505377|NCT01172288|Yale University- School of Medicine|Associate Professor|(203)737-4809|michael.bloch@yale.edu|
20505378|NCT02795767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20505379|NCT03964415|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20505380|NCT01302769|99MDG Regional Clinical Investigation Program|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20505381|NCT01016483|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
20505382|NCT01097330|Population Health Research Institute|Dr. Carlos Morillo|905-527-4322|Carlos.Morillo@phri.ca|40311
20505383|NCT05848245|King Abdulaziz University|Dr. Zuhair Natto|9666943899|znatto@kau.edu.sa|
20528261|NCT00412932|Daiichi Sankyo|John Raia|973-630-2683|jraia@dsus.com|
20528262|NCT00112918|Hoffman-LaRoche|Medical Communications|800-821-8590||
20505384|NCT00477451|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20559013|NCT02169830|Saint Louis University|Dr. Anthony A Mikulec|314-977-8884|anthony.mikulec@health.slu.edu|
20528263|NCT02372383|UColorado|Dr. Stacey Martiniano|7207776181|stacey.martiniano@childrenscolorado.org|
20528264|NCT05886907|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20528265|NCT01763203|Icahn School of Medicine at Mount Sinai|Dr. Barbara Vickrey; Chair of Neurology|2122415698|barbara.vickrey@mssm.edu|
20528266|NCT02187861|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20528267|NCT02756819|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20528268|NCT01491841|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20528269|NCT00741598|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
20528270|NCT04105842|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20528271|NCT02087670|Universidad de Antioquia|Jesus Alberto Plata Contreras|5742196478|rehabilitacionsalud@siu.udea.edu.co|
20528272|NCT03076996|FHI 360|Dr. Lisa Dulli|919-544-7040|ldulli@fhi360.org|11396
20528273|NCT01027468|Medical University of Vienna|Assoc.Prof.PD.Dr.Stefan Sacu|+43404001|stefan.sacu@meduniwien.ac.at|7937
20528274|NCT00988000|Imperial College|Professor Martyn Partridge|+44 (0)20 7594 7959|m.partridge@imperial.ac.uk|
20528275|NCT02144077|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32 66|ameluz@biofrontera.com|
20528276|NCT01462305|Philips|Sr. Clinical Development Scientisit|+41 79 460 0622|fatima.sertkuniyoshi@philips.com|
20528277|NCT00368459|Stanford University|Victor Henderson|650-723-5456|vhenderson@stanford.edu|
20559014|NCT03204695|Coherex Medical, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20510259|NCT05158244|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510260|NCT02185040|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|866-260-1599|ClinicalTrialDisclosure@Celgene.com|
20510261|NCT01792024|University of Chicago|Dr. Aytekin Oto|773-834-7424|aoto@radiology.bsd.uchicago.edu|
20510262|NCT00718887|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20510263|NCT00775138|Insmed|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
20510264|NCT00141297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510265|NCT00848172|NINDS|Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
20510266|NCT00103207|ECOG Statistical Office|Study Statistician|617-632-3012||
20510267|NCT03442595|MedStar Health|Dr Michelle F Magee, Director MedStar Diabetes Institute|202-877-2383|michelle.f.magee@medstar.net|
20510268|NCT01562327|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20510269|NCT02447952|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20559015|NCT04834362|National Institute of Neurosciences and Hospital, Dhaka|Dr. Mashfiqul Hasan|+8801816268746|mashfiqul.hasan@nins.gov.bd|
20559016|NCT02555371|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20559017|NCT03095599|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
20559018|NCT00299689|James Graham Brown Cancer Center, University of Louisville|Dr. Jason Chesney|502/852-3679|jaches03@exchange.louisville.edu|
20559019|NCT00968838|The University of Texas M D Anderson Cancer Center|Dr. Emil J. Freireich MD/Professor|713-792-2660|eharriso@mdanderson.org|
20559020|NCT00742885|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559021|NCT04781647|Assembly BioSciences Inc.|Director of Clinical Operations|415-366-5172|psalstrand@assemblybio.com|
20559022|NCT01755689|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559023|NCT02930122|University of Kentucky|Dr. Cale Jacobs|859-218-3065|cale.jacobs@uky.edu|
20559024|NCT03943589|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
20559025|NCT04329104|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter Crompton|301-761-5042|pcrompton@niaid.nih.gov|
20559026|NCT00830947|OrthoAccel Technologies, Inc.|Zaffer Syed, Director of Clinical & Regulatory Affairs|(832) 803-0339|zsyed@orthoaccel.com|
20559027|NCT04176133|Mayo Clinic|Robert J. Pignolo, MD, PhD|507-255-8716|Pignolo.Robert@mayo.edu|
20559028|NCT01238575|Emory University|Lawrence Scahill, MSN, PhD||lawrence.scahill@emory.edu|
20559029|NCT00883103|Baystate Medical Center|Oz Harmanli, MD|4137945608|oz.harmanli@baystatehealth.org|
20559030|NCT02001974|Dompé Farmaceutici|Pieradelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
20559031|NCT00993317|Korea Otsuka Pharmaceutical|Eun Young Cho, Clinical Trial Manager|+82-2-3287-9233|hyerim@otsuka.co.kr|
20559032|NCT01380990|UCL Institute of Child Health|Dr Claire Booth|+44207 905 2198|C.Booth@ucl.ac.uk|
20559033|NCT04422639|University of Arkansas for Medical Sciences|Assistant Director of Cancer Clinical Trials|501-686-8274|bscanlan@uams.edu|
20559034|NCT01964521|The Norfolk & Norwich University Hospitals NHS Foundation Trust|Dr Ketan Dhatariya|+44 1603 286286|ketan.dhatariya@nnuh.nhs.uk|
20559035|NCT02374593|Riley Hospital for Children|Dr. Erica Eugster|317 944-3889|eeugster@iu.edu|
20559036|NCT00579982|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559037|NCT02593032|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@pennmedicine.upenn.edu|
20559038|NCT02038764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559039|NCT03853317|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20559040|NCT01306175|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559041|NCT04844918|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20559042|NCT01990820|NorthShore University HealthSystem|Dr. Mark Gerber|847-504-3300|mgerber@northshore.org|
20510270|NCT03442933|Universidad Europea de Madrid|Gerson Garrosa Martín|+34 663 294 774|g.garrosa@gmail.com|0034
20559043|NCT01558674|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559044|NCT00981825|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20510271|NCT02181504|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20559045|NCT02743793|DAIT/NIAID|Director, Clinical Research Operations Program|13015947669|DAITClinicalTrialsGov@niaid.nih.gov|
20559046|NCT03285113|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
20559047|NCT02965144|Rigshospitalet|Karin Piil|0045612078067|Karin.Piil@regionh.dk|
20559048|NCT00849680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
20559049|NCT02207374|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20559050|NCT00322374|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20559051|NCT03897205|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
20559052|NCT04276090|University of Kentucky|Dr. Michael Cavnar|859-323-8920|michael.cavnar@uky.edu|
20559053|NCT03912220|Johns Hopkins University|Dr. Ahmet Hoke|410-955-2227|ahoke1@jh.edu|
20559054|NCT02913521|Egeen|Kalev Kask|16504690600|kalev.kask@egeeninc.com|
20559055|NCT01850082|VA Boston Healthcare System|Marco Zenati, M.D.|857-203-6815|Marco.Zenati@va.gov|
20559056|NCT01680458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559057|NCT02138747|Astellas Pharma US, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
20559058|NCT00183443|Stanford University|Dr. Patricia Suppes|6504935000|tsuppes@Stanford.edu|62567
20559059|NCT00220961|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu|
20559060|NCT03406702|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20559061|NCT00601003|Beat Childhood Cancer|Giselle Sholler, MD|704-381-9900|Giselle.Saulniersholler@atriumhealth.org|
20559062|NCT03729024|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
20559063|NCT04394247|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559064|NCT02768558|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
20559065|NCT04318093|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20559066|NCT02559609|UConn Health|Sheia Alessi|860-679-1849|salessi@uchc.edu|
20559067|NCT00514046|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
20559068|NCT00655551|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
20559069|NCT01734434|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20559070|NCT02956434|VA Boston Healthcare System|Dr. Johanna Thompson-Hollands|857-364-2311|johanna.thompson-hollands@va.gov|
20559071|NCT02049710|Carnegie Mellon University, Social and Decision Sciences|Mandy Lanyon, Research Associate II|4122683249|mandy@cmu.edu|
20510272|NCT00887913|Syneron Medical Ltd|Hanit Brenner-Lavie|972-73-244-2200|hanitb@syneron.com|581
20559072|NCT03391960|3M|Helen Han|651-737-9234|mhan3@mmm.com|
20559073|NCT06211296|Pi-Cardia|Hadas Givon, VP CA/RA|+972-8-9484800|hadas@pi-cardia.net|
20559074|NCT04448236|Haven of Hope hospital, Hospital Authority|Dr. Lau Chung Wai|27038888|lcw431@ha.org.hk|
20559075|NCT02609659|AbbVie|Global Medical Services|800-633-9110||
20559076|NCT01432015|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
20559077|NCT01155388|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20559078|NCT01004250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20559079|NCT03884231|Abbott|Tucker Tomlinson|+1/ 972 526 9646|tucker.tomlinson@abbott.com|
20559080|NCT01853254|Hoffmann-La Roche|Medical Communications|800 821-8590||
20559081|NCT02462083|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
20559082|NCT01642186|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa, MD|646-824-6566|abou-alg@mskcc.org|
20559083|NCT03888885|The Chinese University of Hong Kong|Dr. Sum Kim Wai Raymond|+852 39436091|kwsum@cuhk.edu.hk|
20559084|NCT00962585|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
20559085|NCT02254421|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20559086|NCT00867490|Novartis Pharmaceuticals|Study Director|862 778-8300||
20559087|NCT00358150|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20559088|NCT00179010|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
20559089|NCT03748979|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20559090|NCT02766673|Children's Hospital of Philadelphia|Natalie Napolitano, MPH, RRT-NPS, FAARC|215-590-1708|napolitanon@email.chop.edu|
20559091|NCT04747275|Children's Mercy|Max Feldt|816-960-8892|mmfeldt@cmh.edu|
20559092|NCT02360774|Beth Israel Deaconess Medical Center|Jody Dushay|6176671996|jdushay@bidmc.harvard.edu|
20559093|NCT00531011|Abbott Vascular, Italy|Maria Jose' M. Lopera|+39-02-516251|mariajose.lopera@av.abbott.com|
20559094|NCT03268590|Case Western Reserve University|Michael John Decker, PhD|216-368-2467|mjd6@case.edu|
20559095|NCT05719285|Cleveland Clinic Foundation|Dr. Lauren Gleich|701-330-1669|LAURENGLEICHDO@GMAIL.COM|
20559096|NCT02173535|Johnson & Johnson Vision Care Inc.|Charis Lau, Pharm.D., O.D., FAAO|(904) 443-1293|MLau87@ITS.JNJ.com|
20559097|NCT02823964|Anthera Pharmaceuticals|Nicole Ramza|510-856-5600|info@anthera.com|
20510273|NCT01671605|Vanderbilt University Medical Center|Valentina Kon|6153224883|valentina.kon@vanderbilt.edu|
20528278|NCT01457417|Healthcare Pharmaceuticals, Inc|Cynthia Sirard, MD|617-714-0357|CSirard@hcven.com|
20559098|NCT04204772|University of Minnesota, Department of Medicine|Armin Rashidi, MD, PhD|612-624-0123|arashidi@umn.edu|
20559099|NCT03875495|Genenta Science|Chief Medical Officer|+39 02 2643 3982|info-trial@genenta.com|
20510274|NCT01200758|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20510275|NCT01371721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559100|NCT04800757|The University of Texas Health Science Center at Houston|Maria Eugenia Fernandez-Esquer|(713) 500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
20559101|NCT00227760|Princess Margaret Cancer Centre - University Health Network|Dr. Srikala Sridhar|416-946-2249|srikala.sridhar@uhn.ca|
20559102|NCT05462652|Big Health, Inc.|Jessica Lake|(510) 244-3753‬|research@bighealth.com|
20559103|NCT03410914|Sunnybrook Health Sciences Centre|Dr. Paul Karanicolas|4164806100|paul.karanicolas@sunnybrook.ca|4774
20559104|NCT00855868|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20559105|NCT00859508|Synthes USA HQ, Inc.|Heidi Hausner, Clinical Research Manager|610-719-5707|hausner.heidi@synthes.com|
20559106|NCT00600743|St. Luke's/Roosevelt Hospital|Harry R. Kissileff|212-523-4200|hrk2@columbia.edu|
20559107|NCT03537261|Massachusetts General Hospital Lurie Center|Lisa Nowinski, PhD|781-860-1700|lnowinski@mgh.harvard.edu|
20510276|NCT00545584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510277|NCT01795716|Shanghai Jiaotong University School of Medicine Ruijin Hospital|Dr. Zhou Li|13816510379|lizhou999_999@yahoo.com|
20510278|NCT03341728|University of North Caroilina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
20510279|NCT00461552|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
20510280|NCT01289028|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20510281|NCT00384449|Oregon Health & Science University|Dr. Christina J. Flaxel|(503) 418-3352|flaxelc@ohsu.edu|
20510282|NCT00998985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510283|NCT01100762|University of Maryland, Baltimore|Gad Alon, PhD, PT|410-706-7733|galon@som.umaryland.edu|
20510284|NCT02152540|DVBIC, VA Palo Alto/Stanford School of Medicine|Dr. Maheen M. Adamson|6502136307|madamson@stanford.edu|
20510285|NCT01012037|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510286|NCT06022224|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20510287|NCT00415623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20510288|NCT01855867|The Fenway Institute|Dr. Kenneth Mayer, Medical Research Director|6179276374|kmayer@fenwayhealth.org|
20510289|NCT03116841|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20510290|NCT03267576|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20510291|NCT01369069|University of Virginia|Karen C. Johnston, MD|434 924-5323|kj4v@virginia.edu|
20510292|NCT02573012|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20510293|NCT00882362|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20510294|NCT01432938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20510295|NCT02096471|The Univ of Alabama at Birmingham|Gary Cutter, PhD|205.975-5048|cutterg@uab.edu|
20510296|NCT01401101|RAND Corporation|Lisa S. Meredith, PhD|310.393.0411|seidel@rand.org|7365
20510297|NCT01635244|University of Michigan|David Bach, MD|734-615-4907|dbach@med.umich.edu|
20510298|NCT01555541|University of California, San Francisco|Charalambos Andreadis, MD, MSCE, Associate Professor of Clinical Medicine|877-827-3222|cancertrials@ucsf.edu|
20510299|NCT02463331|Clinic Hospital of University of Sao Paulo|Lydia Teófilo de Moraes Falcão|55-81-996486935|lydiatmf@yahoo.com.br|81
20510300|NCT04396106|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
20510301|NCT01579162|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
20510302|NCT02746991|EyePoint Pharmaceutical|Flavio Leonin Jr., MD|617-972-6024|fleonin@eyepointpharma.com|
20510303|NCT03049852|Cloudbreak Therapeutics, LLC|Dr, Jinsong Ni|9496789752|Ni-Jinsong@cloudbreaktherapeutics.com|
20510304|NCT02709889|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20510305|NCT01436357|University of New Mexico and Johns Hopkins University|Kimberly Page, Ph.D., M.P.H. and Andrea Cox, M.D., Ph.D.|505-272-2520, 410-502-2715|pagek@salud.unm.edu, acox@jhmi.edu|
20510306|NCT00656799|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20510307|NCT05281094|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
20510308|NCT02020304|Wake Forest School of Medicine|Vernon H Ross MD|336-718-8278|vhross@wakehealth.edu|
20510309|NCT02469597|Northwell Health- Cohen Children's Medical Center|Dr. Kristy Williamson|718-470-7640|kwilliam12@nshs.edu|
20510310|NCT03285061|Brigham & Women's Hospital|Dr. Christopher Chiodo|617-983-7363|cchiodo@bwh.harvard.edu|
20510311|NCT02683668|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
20510312|NCT02390167|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20510313|NCT02308839|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
20510314|NCT01265719|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510315|NCT04144140|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20510316|NCT00027027|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20510317|NCT00290329|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510318|NCT02442765|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20510319|NCT01749930|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
20510320|NCT04735432|argenx BV|Regulatory Manager|+32 9 310 34 00|regulatory@argenx.com|
20559108|NCT01177813|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510321|NCT00935766|Denver Health Medical Center|Carlin Long, MD|303-602-3899|carlin.long@dhha.org|
20510322|NCT01823991|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nagi Kumar|813-745-6885|nagi.kumar@moffitt.org|
20510323|NCT01066819|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20510324|NCT02408016|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
20510325|NCT00805194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510326|NCT03502265|University of Southern California|Beth Smith|323-361-4670|beth.smith@usc.edu|
20510327|NCT02184520|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
20510328|NCT02385292|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20528279|NCT00715299|VAHSRD and Medical University of South Carolina|Steve Kautz, PhD, Principal Investigator|843-792-3867|kautz@musc.edu|
20528280|NCT02020889|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528281|NCT01540981|UNMC|Joyce Black|(402) 559-6573|jblack@unmc.edu|
20528282|NCT00232557|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20528283|NCT02826161|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
20528284|NCT04435808|The University of New Mexico School of Medicine|Walter Dehority|5052725535|wdehority@salud.unm.edu|
20528285|NCT05347966|UBC|Dr. Haakon Nygaard|604-827-0600|haakon.nygaard@ubc.ca|
20528286|NCT02768792|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20528287|NCT02087943|CelgeneCorp|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|amcclain@celgene.com|
20528288|NCT02716506|Kanta-Häme Central Hospital|Dr Nina Mattsson|+358407338307|nina.mattsson@fimnet.fi|
20528289|NCT01690299|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
20528290|NCT05753735|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Nikola Anusic, Protocol Study Coordinator|216-421-5986|a.nikolau@icloud.com|
20528291|NCT01563913|VA Portland Health Care System|Kathryn Chung, MD|5037211091|Kathryn.Chung@va.gov|
20528292|NCT02091414|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20528293|NCT00551174|Hoffmann-La Roche|Medical Communications|800-821-8590||
20528294|NCT03146741|University of Pennsylvania|Dr. Peter Reese|215-900-3782|peter.reese@uphs.upenn.edu|
20528295|NCT02589847|Rebiotix, Inc.|Clinical Development|651-705-8778|US8-StudyInfo@ferring.com|
20528296|NCT00551525|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20528297|NCT04676724|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20528298|NCT00287729|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
20528299|NCT02488018|Addis Ababa University [Office telephone +251011-655-1927]|Abera Belay (PhD Candidate)|Mobile +251911840655|ab.berabelay@gmail.com|
20528300|NCT01348100|Novartis Pharmaceuticals|Study Director|862 778-8300||
20528301|NCT01129804|UConn Health|Mark D. Litt, PhD; Principal Investigator|860-679-4680|litt@uchc.edu|
20528302|NCT03882957|Geisel School of Medicine (Dartmouth College)|Diane Gilbert-Diamond|603-646-5403|diane.gilbert-diamond@dartmouth.edu|
20528303|NCT04399538|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528304|NCT01926197|Stanford Medicine at Stanford University|Samantha Wong|650-498-8495|swong8@stanford.edu|
20528305|NCT00492232|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20528306|NCT00410059|UT MD Anderson Cancer Center|Vice President Clinical Research/Clinical Research Operations|713-792-7734|CR_Study_Registration@mdanderson.org|
20528307|NCT02756364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20528308|NCT02223364|Mayo Clinic|Dr. Sandra L. Kopp|507-284-6637|Kopp.Sandra@mayo.edu|
20528309|NCT01416155|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20528310|NCT02685072|Yale School of Public Health|Kimberly Yonkers, MD|(203) 764-6621|kimberly.yonkers@yale.edu|
20528311|NCT01342172|Icahn School of Medicine at Mount Sinai|Dr. Matthew Galsky|212-241-8816|matthew.galsky@mssme.edu|
20528312|NCT03597139|Aurinia Pharmaceuticals|Mary Palmen|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20528313|NCT00477204|University of Colorado Denver|David Maahs, MD, PhD|303-724-2323|david.maahs@ucdenver.edu|
20528314|NCT04811664|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20528315|NCT00382109|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20528316|NCT02717442|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
20528317|NCT05052697|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528318|NCT02724410|Atrium Health|Dr. B. Todd Heniford|704-355-3168|Todd.Heniford@atriumhealth.org|
20528319|NCT01289574|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
20528320|NCT01402986|MedImmune, LLC|Meena Jain, MB BChir, Director, Clinical Development,|301-398-0000|JainM@medimmune.com|
20528321|NCT02634983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20528322|NCT02226120|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20528323|NCT00076258|UT Southwestern Medical Center|Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
20528324|NCT03634813|Yale School of Medicine|Robert B. Schonberger, Director of Clinical Scientist Track Program|203-785-3941|robert.schonberger@yale.edu|
20528325|NCT02669043|Massachusetts General Hospital|Dr.Cristina Cusin|617-726-6421|ccusin@partners.org|
20528326|NCT03884270|Loyola University Chicago|Dr. Sarah Kinsinger|708-216-0464|sarah.kinsinger@lumc.edu|
20528327|NCT00661453|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
20528328|NCT02919007|Home Skinovations|Dr Liora Levi|+97249097470|LioraL@silkn.com|
20528329|NCT00467558|University of Minnesota|Jon E. Grant, MD|612-273-9736|grant045@umn.edu|
20510329|NCT03818399|Virginia Commonwealth University|Roy Sabo, PhD|804-828-3047|roy.sabo@vcuhealth.org|
20559109|NCT02368002|University of Minnesota|Nancy Sherwood|612-625-4567|sherw005@umn.edu|
20528330|NCT04679948|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20528331|NCT02636439|Wake Forest School of Medicine|Dalane W. Kitzman, MD|336-716-3274|dkitzman@wakehealth.edu|
20528332|NCT02494401|University of New Mexico|Janet Poole|(505) 272-1753|JPoole@salud.unm.edu|
20528333|NCT05188729|Verrica Pharmaceuticals|Susan Cutler, VP Medical Affairs|484-773-089|scutler@verrica.com|
20528334|NCT03646487|University of Illinois Chicago|Mary Dawn Koenig, PhD, RN, FACNM|312-996-7982|marydh@uic.edu|
20528335|NCT01732445|Mayo Clinic|Ruben A. Mesa, M.D.|480/301-8335|mesa.ruben@mayo.edu|
20528336|NCT02849704|Children's Hospital of Philadelphia|Virginia Stallings, MD|267.425.1633|stallingsv@email.chop.edu|
20528337|NCT05346237|University hospital Osijek|Željka Laksar Klarić|+38598666494|zeljka.l.klaric@gmail.com|
20528338|NCT03638466|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
20528339|NCT03251482|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20528340|NCT04508647|University of Colorado Hospital|Manali Kamdar, MD|720-848-6400|manali.kamdar@cuanschutz.edu|
20528341|NCT02447328|AstraZeneca Korea|Karin Otter, MD, PhD|+82 2 2188 0968|Karin.Otter@astrazeneca.com|
20559110|NCT04011384|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
20510330|NCT00535236|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510331|NCT04880642|Vicore Pharma|CEO Carl-Johan Dalsgaard|+46 (0) 317880560|info@vicorepharma.com|
20528342|NCT00707967|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528343|NCT02155309|Henry Jackson Military Foundation for Naval Medical Research Unit - Dayton|Daniel Geyer, MPH|(937) 938-3922|daniel.geyer.1.ctr@us.af.mil|
20528344|NCT00802672|Perrigo Company|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
20528345|NCT00006244|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20528346|NCT01220726|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
20528347|NCT02579382|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20528348|NCT04336475|Cukurova University|Dr Nihan Cuzdan, MD, principal investigator|05052706846|nihancuzdan@hotmail.com|
20528349|NCT01952418|Massachusetts General Hospital|Norman Nishioka, MD|6177264422|NNISHIOKA@PARTNERS.ORG|
20528350|NCT03304106|Cochlear Limited|Laura Chenier, Clinical Project Manager|422-325-4171|lchenier@cochlear.com|
20528351|NCT01990573|Washington University School of Medicine|Dr. Anshuman Sharma|314-457-3147|sharma.a@wustl.edu|
20510332|NCT02390323|Hospital for Special Surgery|Semih Gungor|212-606-1206|gungors@hss.edu|
20510333|NCT01671176|Oticon Medical LLC|Ravi Sockalingam|9082023524|rsoc@oticomedical.com|
20510334|NCT02987205|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
20510335|NCT02275052|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510336|NCT00561795|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510337|NCT02807376|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20510338|NCT01947127|Faculty of Medicine, Chulalongkorn University|Khrongwong Musikatavorn, M.D.|+6622564553|kmusikatavorn@yahoo.com|
20510339|NCT04652102|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
20510340|NCT03062605|UCLA|Dr. Vladimir W. Spolsky|310-794-0700|vspolsky@dentistry.ucla.edu|
20510341|NCT02405091|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20510342|NCT01009333|Medtronic Neuromodulation|Maureen McGuire, Sr. Program Manager|763-526-8425|maureen.mcguire@medtronic.com|
20510343|NCT02139176|UNC Chapel Hill/UNC Project Lilongwe|Nora Rosenberg, PhD|+265 (0)99 109 0676|Nora_Rosenberg@unc.edu|
20510344|NCT01056601|Masonic Cancer Center, University of Minnesota|Arkaduisz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
20510345|NCT02246309|Center for Human Reproduction|Dr. David Barad, Director of Clinical Research|2129944400|dbarad@theCHR.com|212
20510346|NCT00247962|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20510347|NCT02815982|University of South Florida|Dr. Marilyn Stern|8139740966|mstern1@usf.edu|
20510348|NCT01469637|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20510349|NCT00598585|Charles R. Drew University|Theodore C. Friedman MD PhD|3106685197|theodorefriedman@cdrewu.edu|
20510350|NCT03514394|University of Washington|Morgan Johnson|17154161493|mjohn23@uw.edu|
20510351|NCT02237898|Yale School of Medicine|Dr. Megan Smith|(203) 764-8655|megan.smith@yale.edu|
20510352|NCT00542425|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
20510353|NCT00193128|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20510354|NCT01601873|The University of Texas Health Science Center at Houston|Kristofer Charlton-Ouw, MD|(713) 486-5117|Kristofer.CharltonOuw@uth.tmc.edu|
20510355|NCT01809327|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20510356|NCT03196973|Laboratorios Salvat, S.A.|Medical Director|933946400|ejimenez@svt.com|
20510357|NCT02176005|Da Volterra|Dr. Annie Ducher, Chief Medical Officer|+33 1 58 39 32 20|annie.ducher@davolterra.com|
20510358|NCT02802735|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20528352|NCT02511132|Gradalis, Inc.|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
20528353|NCT03188523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20528354|NCT01983826|University of Iowa|Dr. Darren P. Casey||darren-casey@uiowa.edu|
20528355|NCT01649362|Centre Hospitalier de Luxembourg|Dr Manon Bache|+352 4411 3157|manon.bache@hotmail.com|
20528356|NCT02906579|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
20510359|NCT01024946|Memorial Sloan Kettering Cancer Center|Dr. Lee Krug|646-888-4201|krugl@mskcc.org|
20559111|NCT03192215|Columbia University|Mitchell S.V. Elkind, MD, MS, FAHA/ Randolph S. Marshall, MD, MS (trial investigators)|212-305-1710/ 212-305-8389|mse13@cumc.columbia.edu, rsm2@cumc.columbia.edu|
20510360|NCT03147495|PLA Institute of Orthopaedics, Xijing Hospital, Fourth Military Medical University, No.17, Changle West Road, Xincheng District, Xi'an, Shanxi Province, China|Dr. Cheng Huang|0086-57427754027|jfj113hc@163.com, jfj906hc@163.com|
20510361|NCT02483611|University of Sao Paulo|Dra Waynice Neiva de Paula Garcia|551636021000|waynicegarcia@gmail.com|2211
20510362|NCT02608892|Children's Hospital of Eastern Ontario|Dr Denise Harrison|613-737-7600|dharrison@cheo.on.ca|4140
20510363|NCT02590406|Institut universitaire Cardiologie et Pneumologie de Québec|Dr Jean S Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
20510364|NCT04840849|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20510365|NCT00957723|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
20510366|NCT00877890|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20510367|NCT00984009|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20510368|NCT02871570|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510369|NCT03516227|National Defense Medical Center, Taiwan|Dr. Yu-Ju Chen|886-287923100|judychen37@gmail.com|18762
20510370|NCT02036476|Dana-Farber Cancer Institute|Dr. Robert Haddad|617.632.3090|ROBERT_HADDAD@DFCI.HARVARD.EDU|
20510371|NCT00537810|Yale University School of Medicine|Dr. Carlos Grilo|2037852792|carlos.grilo@yale.edu|
20510372|NCT03452397|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20510373|NCT00125268|Mayo Clinic|Dr. Matthew A. Butters|480-301-7745|butters.matthew@mayo.edu|
20510374|NCT00925522|St. Jude Medical|Nancy Ouch, Project Manager|949.769.5041|nouch@sjm.com|
20510375|NCT02253173|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|sebastian.mirkin@therapeuticsmd.com|1952
20510376|NCT00671515|University Hospitals Cleveland Medical Center|Dr. Joseph Calabrese|216-844-2865|Joseph.Calabrese@UHhospitals.org|
20510377|NCT02985684|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
20510378|NCT00631969|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20510379|NCT00846027|Hoffmann-La Roche|Medical Communications|800 821-8590||
20510380|NCT02009501|Mount Sinai St. Luke's|Dr. John C. Lantis II||JLantis@chpnet.org|
20510381|NCT00041119|Dana-Farber Cancer Institute|Lawrence N. Shulman, M.D.|(617)-632-2277|Lawrence_Shulman@dfci.harvard.edu|
20510382|NCT03228836|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
20510383|NCT00948389|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
20510384|NCT01619176|CNR IAC|DR. Christine Nardini|+393386947833|christine.nardini.rsrc@gmail.com|
20510385|NCT01722552|Boston University School of Public Health|Dr Lora Sabin|617-414-1272|lsabin@bu.edu|617
20510386|NCT00568399|Washington University School of Medicine|James Delmez, MD|314 362 7207|jdelmez@dom.wustl.edu|
20510387|NCT02967562|King's College London|Professor Anne Greenough|02032999000|anne.greenough@kcl.ac.uk|
20510388|NCT03574987|University of Bath|Professor Javier Gonzalez|0122538|j.t.gonzalez@bath.ac.uk|5518
20510389|NCT04586127|Wake Forest University School of Medicine|Dr. Emily Haines|(336) 716-5170|ehaines@wakehealth.edu|
20510390|NCT02381795|Clinvest Research|Clinical Data Manager|417-883-7889|jsly@clinvest.com|
20510391|NCT00932399|Seattle Epidemiologic Research and Information Center|Alyson Littman|206-277-4182|alyson.littman@va.gov|
20510392|NCT02176226|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
20510393|NCT01173874|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|646-774-8436|mcarlson@nyspi.columbia.edu|
20510394|NCT03894501|Rutgers Robert Wood Johnson Medical School|Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
20510395|NCT01488994|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20510396|NCT01072500|Wake Forest School of Medicine|Michael Miller|336-716-6837|mmiller@wakehealth.edu|
20510397|NCT02908841|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
20510398|NCT01611558|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20510399|NCT02465957|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20510400|NCT01520727|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20510401|NCT03798366|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20510402|NCT01245972|ucsdmed|S. Brian Jiang|8586571663|s2jiang@ucsd.edu|
20510403|NCT00366106|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20510404|NCT01412333|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20510405|NCT04005885|CooperVision. Inc|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
20510406|NCT02089191|Alcon Research, Ltd.|Global Medical Affairs Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20510407|NCT00750867|University of Massachusetts Medical School|Dr.Peter Novak|508-334-4973|novakp@ummhc.org|
20510408|NCT00474539|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20510409|NCT03018340|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20510410|NCT01836549|University of Tennessee Health Science Center|Dr. Mehmet Kocak|9014482937|mkocak1@uthsc.edu|901
20510411|NCT00676806|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
20510412|NCT02192190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20510413|NCT00266799|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20559112|NCT02731313|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20559113|NCT04716881|Go Medical Industries, Pty Ltd|Director of Operations|61(8) 9388 1700|ctc@gomedical.com.au|
20510414|NCT02607865|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20559114|NCT00363896|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20559115|NCT00924469|Janssen Research & Development, LLC 10990 Wilshire Blvd, Suite 1200 Los Angeles, CA 90024|Senior Director, Clinical Research|(310) 914-2917||
20559116|NCT01598428|Shandong University|Dr.Yang Gao|0086-543-89268587|pinkapples@126.com|
20559117|NCT04147260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559118|NCT00630058|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20559119|NCT01651936|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
20559120|NCT02162992|H. Germans Trias i Pujol|Dr. Roger Villuendas|+34 4978398|rogervilluendas@hotmail.com|
20559121|NCT01555021|Massachusetts General Hospital, Boston, MA|John D. Matthews, M.D., M.Sc.|617-643-9095|jmatthews@partners.org|
20559122|NCT02204293|Helios Fachklinik Vogelsang-Gommern GmbH, Germany|Prof. Dr Eugen Feist|+49 30 450 513 192|eugen.feist@charite.de|
20559123|NCT02697006|Fresenius MCD|Dr. Anja Derlet-Savoia|+49 6172 608 2801|Anja.Derlet@fmc-ag.com|
20559124|NCT00614198|Center for Autisme|Lennart Pedersen|44982355|lpe@centerforautisme.dk|
20559125|NCT03051659|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
20559126|NCT01266993|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20559127|NCT01000376|Eisai|Dr. Peter Tarassoff|888-422-4743||
20559128|NCT02372058|Albert Einstein Medical Center located in Philadelphia, Pennsylvania, USA|Dr. David L. Schutzman|215-456-6698|schutzmand@einstein.edu|
20559129|NCT01994720|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00||
20559130|NCT02216422|AbbVie|Global Medical Services|800-633-9110||
20559131|NCT00967018|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20559132|NCT04793464|University of Oregon|Dr. Leslie Leve|541-346-9528|leve@uoregon.edu|
20559133|NCT00401102|Iona College|Dr. Colleen Jacobsonn|646-207-3563|cjacobson@iona.edu|
20559134|NCT00762021|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20559135|NCT00845871|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20559136|NCT03380780|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20510415|NCT03227692|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
20510416|NCT01657253|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Director of Clinical Trials|52+ 33 30014200|leopoldo.baiza@sophia.com.mx|
20510417|NCT01970540|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
20510418|NCT00242710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510419|NCT00579527|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
20510420|NCT00381706|Dana Farber Cancer Institute|Peter Enzinger, M.D.||peter_enzinger@dfci.harvard.edu|
20510421|NCT00203294|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@Jefferson.edu|
20510422|NCT02364999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510423|NCT02541994|Ochsner Health Services|Dr. Andrew Lawton|504-842-3995|andrew.lawton@ochsner.org|
20510424|NCT03427528|Northwestern University, CCH|Dr. Darius Tandon|+1 312 503 3398|dtandon@northwestern.edu|
20510425|NCT00550615|University of Nebraska Medical Center|Julie M Vose|402-559-348|jmvose@unmc.edu|
20510426|NCT04180475|University of Virginia|John Stankovic|434-982-2275|jas9f@virginia.edu|
20510427|NCT01948791|Novartis Pharmaceuticals|Study Director|862-778-8300||
20510428|NCT02555722|CooperVision Inc.|Senior Manager, Clinical Research|925-730-6754|PChamberlain@coopervision.com|
20510429|NCT00702949|Mayo Clinic|Charles Loprinzi, M.D.|507/284-1623|cloprinzi@mayo.edu|
20510430|NCT00135694|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20510431|NCT02584660|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20510432|NCT00523744|Novartis Pharmaceuticals|Study Director|862-778-8300||
20510433|NCT04623255|University College London|Prof Marie Scully|+ 44 (0)20 3447 9884|m.scully@ucl.ac.uk|
20510434|NCT02120469|City of Hope|Dr. Yuan Yuan|626-359-8111|yuyuan@coh.org|
20510435|NCT01040728|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510436|NCT01003067|Hirslanden Bern|Prof. Christoph A. Maurer|+41 31 335 33 33|christoph.maurer@hin.ch|
20510437|NCT02583711|Imperial College London|Ms Aliza Abeles|07834987667|aliza.abeles@gmail.com|
20510438|NCT02282930|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
20510439|NCT00281528|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20510440|NCT01981096|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|susmita.kashikar-zuck@cchmc.org|
20510441|NCT01225211|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20510442|NCT01987609|UCSD Medicine|Director of Clinical Trials Unit|858-657-8322|dermstudies@Ucsd.edu|
20510443|NCT01431794|Johns Hopkins University School of Medicine|Dr. Ana De Jesus-Acosta|443-287-0411|adejesu1@jhmi.edu|
20510444|NCT02610231|Kyowa Kirin|Development Devision - Project Management Department|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20510445|NCT01901679|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
20510446|NCT01279954|Oregon Health & Science University|Eric Suler, MD|503-494-5023|suhlere@ohsu.edu|
20559137|NCT01374802|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559138|NCT01291225|Center for Injury Research and Policy|Dr. Gary Smith|614-355-5850|Gary.Smith@Nationwidechildrens.org|
20559139|NCT00591123|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Zev Wainberg, MD|310-829-5471|zwainberg@mednet.ucla.edu|
20536591|NCT00553436|Ethicon Endo-Surgery, Inc|Amy Mahanes, Clinical Research Associate II|513-337-8366|amahanes@its.jnj.com|
20559140|NCT02855164|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20510447|NCT01134328|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20510448|NCT01711359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20510449|NCT01066637|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20510450|NCT02698176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510451|NCT00805142|Janssen R&D, 1125 Trenton-Harbourton Road, Titusville, PA 18902, USA|Senior Director, Clinical Leader|609-730-6777||
20510452|NCT00424463|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20510453|NCT02449915|TriHealth Inc.|Jennifer Yeung, DO|513-463-4300|Jennifer_Yeung@trihealth.com|
20510454|NCT01497665|Angiochem Inc.|Betty Lawrence, Vice President, Development|514-788-7800|blawrence@angiochem.com|205
20510455|NCT01021293|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510456|NCT02049385|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
20510457|NCT04607291|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
20510458|NCT05466240|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
20510459|NCT02679222|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20510460|NCT00945945|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20510461|NCT00626327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20510462|NCT01672827|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|paulsherwin@ge.com|
20510463|NCT00286156|Cleveland Clinic|Dr William Braun Consultant Staff Nephrology, Cleveland Clinic|216/444/6995|braunw@ccf.org|
20510464|NCT01800162|University of Pennsylvania|Dr. Kurt Barnhart|215-662-2974|KBarnhart@uphs.upenn.edu|
20510465|NCT04050540|University of Washington, Department of Global Health|Jenell Stewart|206 520 3866|jenells@uw.edu|
20510466|NCT01060150|Medical Affairs / Janssen-Cil Korea|Clinical Research Director|82-2-2094-4518||
20510467|NCT02516306|Encore Vision, Inc|Jerry M. Stein, Ph.D.|817-292-6963|summercreekc@gmail.com|
20510468|NCT02736149|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-272-6138|info@eigerbio.com|
20510469|NCT03727802|Toray Industries, Inc|Clinical Trials Information Desk|+81-3-3245-8576|clinical-trials.toray.mb@mail.toray|
20510470|NCT00256204|Teva Branded Pharmaceutical Products R&D|Dennis Ahern, MS, Director|215-293-6339|dennis.ahern@tevausa.com|
20510471|NCT01566981|Department of family medicine, Medical Faculty in Ljubljana|Dr. Rade Iljaž|'386 31 300- 381|radeiljaz@gmail.com|
20510472|NCT02177942|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510473|NCT01351415|Hoffmann-La Roche|Medical Communications|888-6821-8590|genentech@druginfo.com|
20510474|NCT01234337|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20510475|NCT01309646|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510476|NCT01365195|Cedars Sinai Medical Center|Research project Advisor|310-423-1682|Ofelia.Elvir-Lazo@cshs.org|
20510477|NCT00824746|Chonnam National University Hwasun Hospital|Young-Chul Kim, MD, PhD|82-61-379-7614|kyc0923@jnu.ac.kr|
20510478|NCT03525613|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20510479|NCT03480360|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|(603) 650-4628|Kenneth.R.Meehan@hitchcock.org|
20510480|NCT02365961|Hawkins Foundation|Hawkins Foundation Research Coordinator|864 454 7458|info@hawkinsfoundation.com|
20510481|NCT00374452|VA Palo Alto Health Care System|Mary K. Goldstein, MD|650-493-5000|mary.goldstein@va.gov|1,1,62105
20510482|NCT00389805|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20510483|NCT01315873|New York University School of Medicine|Michael Grossbard, MD|646 501 9305|Michael.Grossbard@nyumc.org|
20510484|NCT01756391|Boston Children's Hospital|Wanda Phipatanakul|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
20510485|NCT03117309|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20510486|NCT02076243|Icahn School of Medicine at Mount Sinai|Dr. Philip Friedlander|212-824-8584|philip.friedlander@mssm.edu|
20510487|NCT00590031|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, Attending|+1646-888-4183|ilsond@mskcc.org|
20510488|NCT01610414|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510489|NCT01402375|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-6626|achang3@yahoo.com|
20510490|NCT03726749|MGH|Dr Sebastian Unizony|617-726-7938|sunizony@mgh.harvard.edu|
20510491|NCT00472043|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20510492|NCT04957745|Schepens Eye Research Institute of Massachusetts Eye and Ear|Dr. Jaehyun Jung|6179122525|jaehyun_jung@meei.harvard.edu|
20510493|NCT00826540|Mayo Clinic|Dr. Axel Grothey, M.D.|(507) 284-4430|grothey.axel@mayo.edu|
20510494|NCT01166386|Carolinas Healthcare System, Carolinas Medical Center|Dr. Janet Niemeier|704 355 2046|janet.niemeier@carolinashealthcare.org|
20510495|NCT01564485|University of California, Irvine|Ashwini Erande, Clinical Coordinator|714 456 7025|aerande@uci.edu|
20510496|NCT00852761|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510497|NCT03922711|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
20510498|NCT02390362|The Research Institute at Nationwide Children's Hospital|William E. Smoyer, MD.|6147222683|william.smoyer@nationwidechildrens.org|
20528357|NCT02030119|Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
20528358|NCT00759655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528359|NCT01999985|H. Lee Moffitt Cancer Center and Research Institute|Thoracic CRO, attn: Dr. Ben Creelan|813-745-3050|ben.creelan@moffitt.org; thoraciccro@moffitt.org|
20559141|NCT00876460|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559142|NCT02468934|SPR Therapeautics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
20559143|NCT00383240|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20559144|NCT02133924|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-3429|john.levine@mssm.edu|
20559145|NCT00003458|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20559146|NCT02044458|Aurora Health Care, Inc.|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aurora.org|
20559147|NCT01919996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559148|NCT02924389|Emory University|Cecile Lahiri, MD|404-616-6306|cdelill@emory.edu|
20559149|NCT02802020|Boston Scientific Corporation|Brian Vatcher|+1-508-683-5274|brian.vatcher@bsci.com|
20559150|NCT01474512|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20559151|NCT01938664|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
20559152|NCT02516579|Addmedica|Medical director|+33172690186|corinne.duguet@addmedica.com|
20559153|NCT01154036|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559154|NCT04076020|University of Pittsburgh|Dr. Jared Magnani|(412)383-0611|magnanij@pitt.edu|
20559155|NCT05022602|Seno Medical, Inc.|Shaan Schaeffer|6106983259|sschaeffer@senomedical.com|
20510499|NCT04009824|University of Maryland School of Medicine - Center for Vaccine Development|Dr. Matthew Laurens|410-706-5328|mlaurens@som.umaryland.edu|
20510500|NCT03032523|Yale University|Laura Nally, MD, Instructor in Pediatrici Endocrinology|9728324734|laura.nally@yale.edu|
20510501|NCT05375838|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20510502|NCT02178592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20510503|NCT05592145|Atrium Health Wake Forest Baptist|Renea Jennings RN,BSN,CCRP|336-716-4417|rjenning@wakehealth.edu|
20510504|NCT02975206|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
20510505|NCT00807989|Yonsei University Severance Hospital|Dr. Yoon||BILEE@yuhs.ac|
20510506|NCT01893879|Stanford University|Leslie Roche, RN|650-723-1396|lesroche@stanford.edu|
20510507|NCT01984294|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20510508|NCT03675685|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
20510509|NCT00392210|University of Rochester|Michael K. Flynn, MD|585-273-3232||
20510510|NCT02067104|University of Arizona|Amy Selegue|520-626-0301|aselegue@email.arizona.edu|
20510511|NCT02140762|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20510512|NCT02067806|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
20510513|NCT01277666|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510514|NCT01385098|Houston Methodist Hosptial|Sherman Vadim|713-441-5514|vsherman@tmhs.org|
20510515|NCT00554840|Maryland Psychiatric Research Center|Elaine Weiner, M.D.|410-402-7694|eweiner@mprc.umaryland.edu|
20510516|NCT03474172|Guangdong Provincial Hospital of Chinese Medicine|Director of department of Clinical Epidemiology|+862081887233|darongwu@163.com|35842
20510517|NCT02561572|Sheffield Teaching Hospitals NHS Foundation Trust|Dr Matthew Wiles|00441142712381|matthew.wiles@sth.nhs.uk|
20510518|NCT00795717|Tufts University School of Medicine|Christine A. Wanke, MD|617-636-3811|christine.wanke@tufts.edu|
20510519|NCT00410514|Astellas Pharma Global Development, Inc. (APGD)|Associate Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
20510520|NCT00211692|VA San Diego Healthcare System|Samuel B. Ho, MD, Chief GI Section|858-552-8585|samuel.ho2@va.gov|2631
20510521|NCT02691468|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
20510522|NCT01021423|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20510523|NCT00394654|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
20510524|NCT00122317|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
20510525|NCT02886338|TMU|Fat-Moon, Suk|29307930|fmsuk@tmu.edu.tw|7923
20510526|NCT03756285|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20510527|NCT00807456|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
20510528|NCT06334055|Masimo Corporation|Ahmed Alghazi, M.B.Ch.B|949-297-7000|studies@masimo.com|
20510529|NCT00498706|Northwestern University|Dr. David C. Mohr|312-503-1403|d-mohr@northwestern.edu|
20510530|NCT04728815|Duke University|Scott Compton, Ph.D.|919-668-0063|compt004@duke.edu|
20510531|NCT00957034|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20510532|NCT02399345|AbbVie|Global Medical Information|800-633-9110||
20510533|NCT01041027|Montefiore Medical Center|Dr. Dennis Yi-Shin Kuo|718-405-8086|dykuo@montefiore.org|
20510534|NCT02493712|Holy Stone Healthcare Co., Ltd|YUCHIH, Chen|886287975966|ivychen@hshc.com.tw|272
20510535|NCT02132169|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20510536|NCT00959192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510537|NCT00532441|Hoosier Cancer Research Network, Inc.|Dr. EG Chiorean, MS|317-921-2050|jsmith@hoosiercancer.org|
20510538|NCT01967134|IAVI|Dr. Dereck Tait|27214424991|dtait@iavi.org|
20510539|NCT00443534|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510540|NCT00305773|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Steven Gore, MD||gorest@jhmi.edu|
20510541|NCT00303329|Novartis Pharmaceuticals|Study Director|862-778-8300||
20510542|NCT00413231|Medtronic Vascular, Inc.|PJ Belmont, Clinical Research Specialist|707-480-3025|PJ.Belmont@Medtronic.com|
20510543|NCT03474380|HSRD ADAPT|Courtney Van Houtven|919-286-6936|courtney.vanhoutven@va.gov|
20510544|NCT00303719|Masonic Cancer Center, University of Minnesota|Erica Warlick, MD|612-625-8942|ewarlick@umn.edu|
20510545|NCT01641952|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20510546|NCT04495166|Medical School of the University of Sao Paulo|Daniel Fatori|5511 96162-6183|daniel.fatori@gmail.com|
20510547|NCT02176031|Dana-Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|CSCUTLER@PARTNERS.ORG|
20510548|NCT02516605|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20510549|NCT00816062|Medtronic|Rianna Rapson|7635262170|rianna.k.rapson@medtronic.com|
20510550|NCT04235959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20510551|NCT03055806|Ixchelsis Limited|Chief Medical Officer|44 (0) 1227-832760|ian.osterloh@ixchelsis.com|
20510552|NCT04601194|Indiana University|Michelle Salyers|317-274-2904|mpsalyer@iu.edu|
20510553|NCT01694667|University of California, San Francisco|Stephen Bent|415-221-4810|Stephen.Bent@ucsf.edu|3457
20510554|NCT04905563|Le Bonheur Children's Hospital|Lindsey Locke, MSN|(901) 287-8931|lindsey.locke@lebonheur.org|
20510555|NCT01797302|University of Pittsburgh School of Medicine|Kumaravel Rajakumar|412-692-5822|kumaravel.rajakumar@chp.edu|
20510556|NCT00348686|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20510557|NCT02911324|Columbia University/New York State Psychiatric Institute|Reilly Kayser, MD|646-774-8118|reilly.kayser@nyspi.columbia.edu|
20510558|NCT01258738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510559|NCT02418000|Spirita Oncology, LLC|Chief Development Officer|+1 (713) 898-8965|linda.paradiso@spiritaoncology.com|
20510560|NCT00689611|Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital/McGill University|Dr. Mark J. Eisenberg|514.340.8222|mark.eisenberg@mcgill.ca|3564
20510561|NCT00724594|Medical University of South Carolina|Dr. Dorothea Jenkins|843-792-4341|jenkd@musc.edu|
20510562|NCT00405756|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20510563|NCT02404792|University of Colorado|Kristine Erlandson (PI)|303-724-4941|kristine.erlandson@ucdenver.edu|
20510564|NCT02870348|Instituto Grifols SA|Sandra Camprubi|+34935710049|sandra.camprubi@grifols.com|
20510565|NCT01051856|Mayo Clinic|Florencia G. Que, MD|507-284-6178|que.florencia@mayo.edu|
20510566|NCT00672139|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
20510567|NCT01117428|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
20510568|NCT02519777|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20510569|NCT02195531|Philips Research|Senior Scientist|+31628041122|Joyca.lacroix@philips.com|
20510570|NCT00602043|University of Pennsylvania|Dr. David Mankoff|(2015) 615-3687|david.mankoff@uphs.upenn.edu|
20510571|NCT01038635|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20510572|NCT01227252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20510573|NCT04912297|Finnish Institute for Health and Welfare|Dr. Merit Melin, Research manager||merit.melin@thl.fi|
20510574|NCT04542525|Alcon Research, LLC|Director of Clinical Projects, Surgical|+1-817-909-6199|jessie.hull@alcon.com|
20510575|NCT01034709|QIAGEN|Kevin Modarress, PhD Senior Manager Regulatory Affairs Operations NA, Regulatory Affairs|301-944-7103|kevin.modarress@qiagen.com|
20510576|NCT01284127|Johns Hopkins University|Michael Levy|443-287-4612|mlevy@jhmi.edu|
20510577|NCT01683058|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20510578|NCT01057394|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
20510579|NCT01195636|Xenon Pharmaceuticals Inc.|Dr. Paul Goldberg, VP Clinical Development|604-484-3300|pgoldberg@xenon-pharma.com|
20510580|NCT00660816|CCCC|Dr. Afshin Dowlati|216-844-1228|afshin.dowlati@uhhospitals.org|
20510581|NCT00641745|Sunovion|Josephine Cucchiaro, PhD; Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20510582|NCT01646346|Yale University|Dr. Suzanne Evans, MD, MPH|(203) 785-5175|suzanne.evans@yale.edu|
20510583|NCT02130635|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510584|NCT01142791|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
20510585|NCT04111185|Duke University|Marat Fudim, MD, MHS|919-684-1284|marat.fudim@duke.edu|
20510586|NCT04733664|Richard L. Roudebush VA Medical Center|Dr. Arjun D. Sinha|---|adsinha@iu.edu|
20510587|NCT00866606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510588|NCT00806494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510589|NCT01899729|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20510590|NCT01454531|ALK-ABELLÓ|ALICIA MARIN|+34 913276127|amaes@alk.net|
20510591|NCT01512849|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20510592|NCT04227119|Emory University|Anand Shah, MD|404-712-4063|anand.d.shah@emory.edu|
20510593|NCT03458234|University of Alabama at Birmingham (UAB)|Andrew McDonald, MD; Principal Investigator|(205) 934-5670|ammcdonald@uabmc.edu|
20510594|NCT01801189|Legacy Weight and Diabetes Institute|Dr. Valerie Halpin|503-413-7557|vhalpin@lhs.org|
20510595|NCT07072962|Baylor College of Medicine|Bijan Najafi|424-467-7127|najafi.bijan@gmail.com|
20510596|NCT05315297|Stanford University School of Medicine|Dr. Raymond Chou, MD|650-723-5256|raymond.chou@stanford.edu|
20510597|NCT01084096|NICHDGlobal|Dr. Elizabeth McClure, Data Coordinating Center PI|919-316-3773|mcclure@rti.org|
20510598|NCT00027846|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20528360|NCT01400906|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510599|NCT02033369|NYSPI|Franklin Schneier, MD|646-774-8041|fschneier@nyspi.columbia.edu|
20510600|NCT01503229|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20510601|NCT01354964|Albert Einstein College of Medicine|Dr. Meredith Hawkins|7184302903|meredith.hawkins@einsteinmed.org|2903
20510602|NCT00711009|Abbott|Global Medical Services|800-633-9110||
20510603|NCT01062230|Huntsman Cancer Institute at the University of Utah Medical Center|Maurizio Zangari, MD Principal Investigator|801-585-3229||
20510604|NCT04335929|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
20510605|NCT03999203|Queen's University Belfast|Professor Liam Heaney|02890976376|l.heaney@qub.ac.uk|
20510606|NCT01319539|Columbia University Medical Center|Kevin Kalinsky, MD|212-305-1945|kk2693@cumc.columbia.edu|
20510607|NCT02534324|Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+66818390511|Khrongwong.m@chulahospital.org|
20510608|NCT01138995|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
20510609|NCT05604781|Center For Sight|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
20510610|NCT01459016|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20510611|NCT04259749|RAND|William G. Shadel|412-683-2300|shadel@rand.org|4489
20510612|NCT00303602|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20510613|NCT02885506|Medicines for Malaria Venture|Dr Cristina Donini|0041 22 555 0312|doninic@mmv.org|
20510614|NCT02889861|Immunocore, LLC|Chris Holland, Executive Director Head of Biometrics|1-267-589-9204|chris.holland2@immunocore.com|
20510615|NCT00620126|University of Maryland. Baltimore|PI|410-706-3387|rcross@medicine.umaryland.edu|
20510616|NCT00784225|SWOG Statistical Center|SELECT/S0000B Statistician|2066674623|adarke@fredhutch.org|
20510617|NCT02551874|AstraZeneca|Global Clinical Lead|+46 (0)31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20510618|NCT00313716|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
20510619|NCT02491463|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510620|NCT01491802|Queen's University|Kathy Webb|613-549-6666|kw2@queensu.ca|4950
20510621|NCT03993314|University of Alabama at Birmingham|Dr. Mark Powell|205-934-6007|mfpowell@uabmc.edu|
20510622|NCT01864746|German Breast Group (GBG) Forschungs GmbH|Prof. Dr. Sibylle Loibl|+49 6102 7480|penelope@gbg.de|0
20510623|NCT00663208|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20510624|NCT01005966|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510625|NCT03500302|Johns Hopkins University|Allison Hays|443-287-6827|ahays2@jhmi.edu|
20510626|NCT01451203|Astellas Pharma Inc|Vice President, Japan/Asia Clinical Development||Astellas.resultsdisclosure@astellas.com|
20510627|NCT00039377|Roswell Park Cancer Institute|Meir Wetzler, M.D.||meir.wetzler@roswellpark.org|
20510628|NCT02873598|University of Colorado Cancer Center|Dr. Sana Karam|7208480141|sana.karam@cuanschutz.edu|
20510629|NCT04067310|Instituto Nacional do Câncer|Director of Clinical Trials|+552132076549|cecilia.silva@inca.gov.br|
20510630|NCT01249404|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
20510631|NCT03890731|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20510632|NCT02528643|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
20510633|NCT02058940|The University of North Carolina at Chapel Hill|Nicole R. Pinelli|919-962-1641|nickipinelli@unc.edu|
20510634|NCT02377674|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
20510635|NCT03308799|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
20510636|NCT02146274|Duke University School of Medicine|Vice Dean of Clinical Research|919-684-4979|awindham@duke.edu|
20510637|NCT03521089|Mayo Clinic|Dr. Yonas Geda|480-301-6934|geda.yonas@mayo.edu|
20510638|NCT01494753|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
20510639|NCT02039687|Araim Pharmaceuticals, Inc.|Chief Medical Officer|914-762-7586|info@araimpharma.com|
20510640|NCT00053482|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
20510641|NCT01349491|University of Oklahoma Health Sciences Center|Stavros Stavrakis|405-271-9696|stavros-stavrakis@ouhsc.edu|37539
20510642|NCT01432236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510643|NCT05064449|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20510644|NCT04492514|University of Cincinnati|Clinical Research Director|513-584-0156|mcmahasn@ucmail.uc.edu|
20510645|NCT01640353|SI-BONE, Inc.|Daniel Cher, MD, Vice President of Clinical Affairs|650-269-5763|dcher@si-bone.com|
20510646|NCT01524900|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510647|NCT03758612|TB Alliance|Majda Benhayoun|347-601-8225|majda.benhayoun@tballiance.org|
20510648|NCT00570089|Cedars-Sinai Medical Center|C. Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
20510649|NCT04450394|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20510650|NCT00001151|NIH|Stephen J. Marx, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|3014965051|marxs@mail.nih.gov|
20510651|NCT03891199|West Virginia University|Brock A. Lindsey, MD|304-293-1317|blindsey@hsc.wvu.edu|
20510652|NCT01192139|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20510653|NCT03812224|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20510654|NCT01273207|National Heart Lung and Blood Institute|Dr Richard Childs|+301-451-7128|childsr@nhlbi.nih.gov|
20510655|NCT04853368|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20510656|NCT00612573|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20510657|NCT02990325|Abivax|Sophie Biguenet|+33 (0) 1 53 83 08 41|sophie.biguenet@abivax.com|
20528361|NCT03130959|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20510658|NCT05386368|Atrium Health Wake Forest Baptist|Joseph Molnar MD|336-716-4171|jmolnar@wakehealth.edu|
20528362|NCT04446429|Applied Biology|Director of Clinical Trials|+1-949-387-4526|monican@appliedbiology.com|
20559156|NCT03230864|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20510659|NCT01822886|"Policlinico S.Orsola-Malpighi - Institute of Hematology L. e A. Seràgnoli, University of Bologna, Via Massarenti, 9-40138 Bologna, Italy"|Zinzani Pier Luigi/Argnani Lisa|+39 0516364042|pierluigi.zinzani@unibo.it/lisa.argnani@unibo.it|
20510660|NCT03633461|Oyster Point Pharma, Inc.|Jeffery Nau|609-382-9035|jnau@oysterpointrx.com|
20510661|NCT01880320|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
20510662|NCT02643420|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
20510663|NCT02127970|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20510664|NCT01710709|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
20510665|NCT04446039|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20510666|NCT00542321|University of Texas Health Science Center at Houston|Sandra K. Hanneman, PhD, RN, FAAN|713-500-2030|Sandra.K.Hanneman@uth.tmc.edu|
20510667|NCT01639599|Seoul St.Mary's Hospital,|Young Eun Moon|822-2258-6163|0910momo@naver.com|
20510668|NCT04138758|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510669|NCT00923481|National Cancer Institute, National Institutes of Health|Dr. Shivaani Kummar|301-435-5402|kummars@mail.nih.gov|
20510670|NCT02988115|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20510671|NCT01731951|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
20510672|NCT00253747|University of CIncinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
20510673|NCT00104299|DAIT/NIAID|Associate Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20510674|NCT02452034|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510675|NCT01716585|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20510676|NCT00431132|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20510677|NCT05102734|Perelman School of Medicine at the University of Pennsylvania|Dr. John C. Greenwood|18568167172|john.greenwood@pennmedicine.upenn.edu|
20528363|NCT05205005|Harry S. Truman Memorial Veterans' Hospital|Harry S. Truman Memorial Veterans' Hospital Research Service|573- 814-6000|Camila.Manrique-Acevedo@va.gov|56550
20510678|NCT03288987|Aryogen|Dr. Nasim Anjidani (Director of Medical- Clinical Trials)|009809125477964|anjidani.n@orchidpharmed.com|
20510679|NCT00275834|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
20510680|NCT01143116|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
20510681|NCT02630459|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20510682|NCT00125138|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20510683|NCT00750360|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510684|NCT03479203|University of Pennsylvania|Felix W.Wehrli, PhD|215-662-7951|felix.wehrli@pennmedicine.upenn.edu|
20510685|NCT01603615|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20510686|NCT03419741|Medical University of SouthCarolina|Dr. Xingbao Li|843 7925729|lixi@musc.edu|
20510687|NCT04354870|NYU Langone Health - Bellevue Hospital|H. Michael Belmont, MD|646-501-7400|Michael.Belmont@nyulangone.org|
20510688|NCT03384316|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|straussjy@nci.nih.gov|
20510689|NCT00836342|Clinical Unit for Research Trials in Skin, Massachusetts General Hospital|Kristen Corey|617-726-1302|kcorey1@partners.org|
20510690|NCT01539720|Planned Parenthood of the St. Louis Region and Southwest Missouri|Director of Research|314-531-7526|research@ppslr.org|384
20510691|NCT00298766|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
20510692|NCT03927703|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20510693|NCT02600715|University of Kansas School of Medicine-Wichita|Jennifer Duong, MPH, Research Associate|316-962-3126|jduong@kumc.edu|
20510694|NCT02500901|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
20510695|NCT00656136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510696|NCT00821886|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20510697|NCT03938857|Duke University|Mara L. Becker, MD, MSCE|919-613-1942|mara.becker@duke.edu|
20510698|NCT01398176|UFlorida|Dr. Susan S. Percival|352-392-1991|percival@ufl.edu|201
20510699|NCT01871870|Legacy Health System|Dr. Ken Ward|971-570-2632|kenward503@msn.com|
20559157|NCT00432679|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559158|NCT02056119|Rush University Medical Center|David Vines, PhD, RRT|3129424408|david_vines@rush.edu|
20559159|NCT03220737|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
20559160|NCT01316692|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-875-8359|jeff.sosman@vanderbilt.edu|
20559161|NCT00178620|The University of Texas Health Science Center at Houston|Dr. Richard W. Smalling|713-500-6559|richard.w.smalling@uth.tmc.edu|
20559162|NCT01686932|Novartis|Study Director|862-778-8300||
20559163|NCT03121534|The University of Texas MD Anderson Cancer Center|Philip Thompson MD.|713-745-5732|PAThompson2@mdanderson.org|
20559164|NCT01284140|University of Iowa|Brian K. Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
20559165|NCT03044353|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20559166|NCT01079143|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20559167|NCT02708238|"Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II"|Annamaria Staiano|00390817462679|staiano@unina.it|
20559168|NCT01313923|UC Irvine Dermatology Research Center|Sergei A. Grando, MD, PhD, DSc|9498242713|sgrando@uci.edu|
20559169|NCT01388530|David Geffen School of Medicine at UCLA|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
20510700|NCT00490815|Alimera Sciences, Inc|Kathleen Billman, Senior Director of Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
20510701|NCT01508221|University of Cincinnati|Alison Kastl|513-584-0436|Kastla@ucmail.uc.edu|
20510702|NCT01904760|Department of Anesthesiology, Peking University School and Hospital of Stomatology, Beijing, China|Xudong Yang|8610-82195287|kqyangxudong@163.com|
20528364|NCT00694356|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20528365|NCT01247675|Ascendis Pharma A/S|Michael Beckert, MD|(+49) 172-155-2596|mb@ascendispharma.com|
20528366|NCT03042910|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528367|NCT03083808|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
20528368|NCT02933528|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20528369|NCT02700425|The University of Chicago|Dr. Gaurav A. Upadhyay, MD|773-702-5988|gupadhyay@medicine.bsd.uchicago.edu|
20528370|NCT01301079|Federal University of Sao Paulo|Plínio da Cunha Leal|55-98-8852-2021|pliniocunhaleal@hotmail.com|
20528371|NCT00313586|ECOG Statistical Office|Study Statistician|617-632-3012||
20528372|NCT01639703|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
20559170|NCT05284019|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20528373|NCT00479115|Cincinnati Children's Hospital Medical Center|Stella Davies, MBBS, PhD, MRCP|513-636-1371|Stella.Davies@cchmc.org|
20528374|NCT04472494|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20528375|NCT03519919|CooperVision.Inc|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20528376|NCT00943592|University of Chicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
20528377|NCT01909973|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
20528378|NCT00169104|Dartmouth-Hitchcock Medical Center / Norris Cotton Cancer Center|Gary N. Schwartz MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
20528379|NCT03476642|Penn State MS Hershey College of Medicine-PennState Health|Dr. Sanjib Adhikary|717-531-6140|sadhikary@pennstatehealth.psu.edu|
20528380|NCT02438280|University of Washington|Dr. Greg Huang, Professor and Chair of Orthodontics|(206) 616-6996|ghuang@uw.edu|
20528381|NCT02457195|The Pennsylvania State University College of Medicine|Dr. Piotr Janicki|7175315680|pjanicki@pennstatehealth.psu.edu|
20528382|NCT04819438|Zambon S.p.A.|Dr. Mathias Knecht, Chief Medical Officer|+41.91.960.4187|mathias.knecht@zambongroup.com|
20528383|NCT05359952|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
20528384|NCT05980013|Zynex Monitoring Solutions|ZMS Clinical|888-386-4185|clinical@zynex.com|
20528385|NCT01882803|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20528386|NCT00657657|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528387|NCT01515696|Medical University of Vienna|Nadja Haiden M.D.|+431404003232|nadja.haiden@meduniwien.ac.at|
20528388|NCT02521792|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20528389|NCT00398047|Wake Forest University Health Sciences|Ralph D'Agostino Jr., Ph.D.|113-716-3483|rdagosti@wfubmc.edu|
20528390|NCT00237692|Center for Primary Care, HSRD COIN|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
20528391|NCT00902746|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
20528392|NCT05050448|Medical Pain Consultants|Dr. Ralph Ortiz|607-844-9979|rodoc@cnymail.com|
20528393|NCT05391555|University of California San Francisco|Rachel Eshima McKay|415-476-9035|rachel.eshima@ucsf.edu|
20528394|NCT00351936|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
20528395|NCT02081001|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP for Drug Development|512-498-2675|mcummins@xerispharma.com|
20528396|NCT04274075|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20528397|NCT00123682|VA New York Harbor Healthcare System|Dr. Scott Sherman, PI|212-686-7500|scott.sherman@va.gov|7386
20528398|NCT00090870|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20528399|NCT01151345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528400|NCT02588092|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20528401|NCT01030718|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20528402|NCT03853291|Weill Cornell Medicine|Dr. Catherine Riffin, Assistant Professor of Psychology in Medicine|646.962.7160|acr2213@med.cornell.edu|
20528403|NCT02974803|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
20528404|NCT01904032|Loyola University Chicago|Sue Penckofer, Ph.D., F.A.A.N.|773-508-8949|spencko@luc.edu|
20528405|NCT02432209|Yale School of Public Health|Fangbai Sun|2037855185|fangbai.sun@yale.edu|
20528406|NCT02611765|Baylor College of Medicine|Jose Serpa-Alvarez|713 798-7910|jaserpaa@bcm.edu|
20528407|NCT03148067|University of Sao Paulo|Physician|551126616900|priscila.rosalba@hc.fm.usp.br|
20528408|NCT01961167|W. L. Gore & Associates|Melissa Zambeck|928-856-4900|mzambeck@wlgore.com|
20528409|NCT02934555|Beth Israel Deaconess Medical Center|Dr. Michael Donnino|6177542882|mdonnino@bidmc.harvard.edu|
20528410|NCT04485637|University of Southern California|Wandi Bruine de Bruin|4126385875|wandibdb@usc.edu|
20528411|NCT02774005|Santhera Pharmaceuticals (Switzerland) Ltd|Head of Regulatory Affairs EU|+41 6190689|julien.gaudias@santhera.com|50
20528412|NCT01451554|Mayo Clinic|Jon O. Ebbert, MD|507-255-3965|ebbert.jon@mayo.edu|
20559171|NCT02420327|University of Maryland School of Medicine|Dr. Britta Hahn|410-402-6112|bhahn@som.umaryland.edu|
20559172|NCT01990300|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20528413|NCT03178851|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20510703|NCT00783263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510704|NCT00106626|Merck & Co., Inc.|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20510705|NCT00721136|Johns Hopkins Medical Institutions|Charles Henrikson, MD|503 494 7400|chenriks@jhmi.edu|
20510706|NCT01747928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510707|NCT04335552|Duke University|Jason Stout, MD, MHS|919-668-0826|jason.stout@dm.duke.edu|
20510708|NCT00611351|University of Nebraska Medical Center|Lori Maness-Harris|402-559-3848|lmaness@unmc.edu|
20510709|NCT03018028|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20510710|NCT00107536|The Ohio State University Comprehensive Cancer Center|Tanio Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
20510711|NCT02532998|AstraZeneca AB|AZD9977 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20510712|NCT02065479|University of Florida|Dr. Dominick Angiolillo|904-244-3378|dominic.angiolillo@jax.ufl.edu|
20510713|NCT03243981|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
20510714|NCT01483378|NYU Langone Medical Center|Dr. Elisabeth J. Cohen|212-263-3262|elisabeth.cohen@nyumc.org|
20510715|NCT01077310|Yale School of Medicine|Principle Investigator|203-737-2883|sandra.springer@yale.edu|
20510716|NCT01878786|MedStar Georgetown Transplant Institute|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
20510717|NCT04062240|Mayo Clinic|Dr. Matthew Ritter|507-255-5123|Ritter.Matthew@mayo.edu|
20510718|NCT01957111|University of Pennsylvania|Philip Gehrman|215-746-3578|gehrman@exchange.upenn.edu|
20510719|NCT03961529|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20510720|NCT03644173|Hackensack meridian Health|Manager, Investigator Initiated Research Program|5519961244|Elli.GournaPaleoudis@hmhn.org|
20510721|NCT00362440|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
20510722|NCT02625610|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20510723|NCT03500419|Mayo Clinic|Matthew (Matt) J. Ziegelmann, M.D.|507-266-3982|Ziegelmann.Matthew@mayo.edu|
20510724|NCT01783223|Hennepin Healthcare Department of Emergency Medicine|Director of Research|6128733000|james.miner@hmced.org|
20510725|NCT01396486|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
20510726|NCT00082628|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20510727|NCT03459794|University of Georgia|Dr Adrian Wolstenholme|706 542 2404|adrianw@uga.edu|
20510728|NCT01612494|Washington University School of Medicine|Dr. Angela Lumba-Brown|314-362-4325|lumba_a@kids.wustl.edu|
20510729|NCT03986671|Powell Mansfield Inc.|Chris Studer|6198101000|cstuder@powellmansfield.com|
20510730|NCT02074436|Emory University|Dr. Ana Antun|404-778-1900|ana.antun@emoryhealthcare.org|
20510731|NCT02169466|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
20510732|NCT03490734|University of North Carolina at Chapel Hill|Kyle Burger, PhD, RD, MPH|9198439933|kyle_burger@unc.edu|
20510733|NCT01694966|Cosmo Technologies Ltd|R&D Manager|111111111|rjones@cosmopharma.com|11111
20510734|NCT00994890|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510735|NCT00792922|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
20510736|NCT02350660|University of Virginia|Department of Medicine and Pediatrics|434.924.0000|spc7w@virginia.edu|
20510737|NCT03323385|Baudax Bio Inc.|Development|484-395-2440|info@baudaxbio.com|
20510738|NCT00699582|Eisai Call Center|Eisai Inc.|888-422-4743||
20510739|NCT04422951|Stanford University|Thomas N. Robinson, MD, MPH|(650) 723-5331|tom.robinson@stanford.edu|
20510740|NCT01849289|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20510741|NCT00352027|St. Jude Children's Research Hospital|Jamie Flerlage, MD|901-595-0392|jamie.flerlage@stjude.org|
20510742|NCT04491591|Washington University School of Medicine|Mary Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
20510743|NCT02505269|Massachusetts General Hospital|Dr. Jeremy Abramson|617-724-4000|JABRAMSON@mgh.harvard.edu|
20510744|NCT03099304|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
20510745|NCT02692560|Kaiser Permanente Washington Health Research Institute|Dori Rosenberg, PhD, MPH|206-287-2532|rosenberg.d@ghc.org|
20510746|NCT01529827|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20510747|NCT03810053|University of Arkansas for Medical Sciences|Matthew Henry|5016868274|mhenry3@uams.edu|
20510748|NCT00715949|The Children's Hospital of Philadelphia|Michael L. Nance|215-590-5932|nance@email.chop.edu|
20510749|NCT00420212|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20510750|NCT01326910|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist Clinical Quality Systems and Process|928-277-0715|jhauze@its.jnj.com|
20510751|NCT03701061|Emory University|Nadine Rouphael|404-712-1435|nroupha@emory.edu|
20510752|NCT02109939|Assurex Health|Lindsey Burns|5137015068|lindsey.burns@myriad.com|
20510753|NCT01058356|Pharmbio Korea Co., Ltd.|Korea Association for the Study of Intestinal Disease (KASID)|82-2-587-2551|pharmbio@hotmail.com|
20510754|NCT02993783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20510755|NCT02582151|Lawson Health Research|Blayne Welk|5196466000|lawson@lawsonresearch.ca|
20510756|NCT01309581|Mount Sinai School of Medicine|James Murrough|212 241 7574|James.Murrough@mssm.edu|
20510757|NCT01914510|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
20510758|NCT03922945|VIVUS|Sr. Director, Clinical Research|650-934-5200|clinical@vivus.com|
20510759|NCT01347931|Clinical Reseach Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
20510760|NCT03287960|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20510761|NCT01667731|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20559173|NCT01231503|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559174|NCT01225835|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20559175|NCT03119571|University of Minnesota|Demetri Yannopoulos, MD|6126261382|yanno001@umn.edu|
20559176|NCT01146574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20559177|NCT02589392|Galderma|Stéphanie Leclerc|+33492386706|stephanie.leclerc@galderma.com|
20559178|NCT02293837|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20559179|NCT04779242|Paratek Pharmaceuticals Inc|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20559180|NCT01757067|University of Maryland Medical Center|Dr. Timm-Michael Dickfeld|410-328-7801|Tdickfel@som.umaryland.edu|
20559181|NCT01076088|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559182|NCT02643979|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|daniel.katz@mountsinai.org|
20559183|NCT03053492|Medical University of South Carolina|Michelle Woodbury|843-792-1671|woodbuml@musc.edu|
20559184|NCT02087150|Acclarent|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
20559185|NCT02571439|Maimonides Medical Center|Dr Kalpana Tyagaraj|7182836000|KTyagaraj@maimonidesmed.org|
20559186|NCT00683449|MediciNova, Inc.|Kazuko Matsuda, MD PhD MPH, Vice President, Clinical Development|858-373-1500|matsuda@medicinova.com|132
20559187|NCT00925782|University of Kansas Medical Center|Omar Aljitawi, M.D., Assistant Professor of Medicine|913-588-6029|oaljitawi@kumc.edu|
20559188|NCT01448044|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20559189|NCT00780442|Medical University of South Carolina|Dr. Kimber L. Price|843-792-4847|pricekl@musc.edu|
20559190|NCT01272882|ChristianaCHS|Gerard Fulda|302-733-4260|gfulda@christianacare.org|
20559191|NCT00507026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559192|NCT00681187|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20559193|NCT04230980|Weill Cornell Medical College|Grace Tan, Clinical Research Coordinator|212-746-3208|grt2008@med.cornell.edu|
20559194|NCT01600950|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20510762|NCT00561912|UT MD Anderson Cancer Center|Ana M. Aparicio, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20510763|NCT01345162|IRCCS Policlinico S Matteo|Dr Massimo Allegri|00390382502627|massimo.allegri@unipv.it|
20510764|NCT02049476|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Jennifer E. Thorne, MD, PhD; Professor of Ophthalmology & Epidemiology,Director of Ocular Immunology|410-955-2966|jthorne@jhmi.edu|
20510765|NCT00519090|Novartis Pharmaceuticals|Study Director|862-778-8300||
20510766|NCT01977651|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20510767|NCT02906644|Duke University|Clinical Research Coordinator|(919) 668-5055|al.salley@duke.edu|
20510768|NCT00667381|University of California, Irvine|Arnold Seto|714-456-6699|aseto@uci.edu|
20510769|NCT04646668|University of Kansas Medical Center|Leah Lambart Graduate Research Assistant|9139457862|llambart@kumc.edu|
20510770|NCT03672006|Medical College of Wisconsin|Dr. Shelia Hanson|414-266-3728|shanson@mcw.edu|
20510771|NCT00777790|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20510772|NCT02074059|Windtree Therapeutics, Inc.|Executive Director, Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|9477
20510773|NCT04383665|Keck School of Medicine of University of Southern California|Dr Darrin Lee|(323) 442-5720|darrinjl@usc.edu|
20510774|NCT01973205|Novartis|Clinical Project Leader|9735038000||
20510775|NCT04056325|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
20510776|NCT03128372|Medtronic|Julia Katilius|1 303-305-2278|julia.z.katilius@medtronic.com|
20510777|NCT04249076|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
20510778|NCT00732199|John D. Dingell VA Medical Center|Susmita Chowdhuri|313 576 1000|susmita.chowdhuri@va.gov|3685
20510779|NCT00265382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20510780|NCT02242305|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510781|NCT03547960|Imperial College London|Gary Frost|2075940959|g.frost@imperial.ac.uk|
20510782|NCT02543801|Kootenai Health|Director of Research Programs|2086254223|salbritton@kh.org|
20510783|NCT01756846|University Medical Center Utrectht|Dr. Judith Poldervaart|008875 55105|j.poldervaart@umcutrecht.nl|
20510784|NCT01521260|University Medical Center Groningen - Center for dentistry and oral hygiene|Y.C.M. de Waal|+31 50-3639051|y.c.m.de.waal@umcg.nl|
20510785|NCT03481634|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20510786|NCT02358876|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
20510787|NCT01455064|Abbott Diabetes Care|Shridhara A. Karinka, Ph.D., Director of Clinical Affairs|510-749-6393|SHRIDHARA.ALVA@ABBOTT.COM|
20510788|NCT00412425|UT MD Anderson Cancer Center|Agop Bedikian, MD Professor||asreckew@mdanderson.org|
20510789|NCT02274766|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
20510790|NCT02607735|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20510791|NCT00869375|OUHSC|J. Emilio Exaire MD|405 271 4742|jose-exaire@ouhsc.edu|44744
20510792|NCT02599324|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20528414|NCT02576977|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510793|NCT00606021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20559195|NCT00658736|Cleveland Clinic|Dr. Tyler Stevens|216 445-1996|stevent@ccf.org|
20510794|NCT03480841|University of North Carolina at Chapel Hill|Dr. Linda Beeber|(919) 966-8148|beeber@email.unc.edu|
20559196|NCT02788006|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20559197|NCT00318149|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559198|NCT02269943|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20559199|NCT03541642|Temple University|Dr. Sarah Bass|215-204-5110|sbass@temple.edu|
20559200|NCT03523871|NYU Langone Health|Luis Angel, MD|646-501-0119|Luis.Angel@nyulangone.org|
20559201|NCT01952301|Perio Health Professionals, PLLC|Dr. Michael K. McGuire|713-783-5442|mkmperio@swbell.net|
20559202|NCT00219141|Novartis Pharmaceuticals|Study Director|862 778-8300||
20559203|NCT00972179|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20559204|NCT03055832|TearFilm Innovations, Inc.|Rob Thornhill|844-458-9776|rthornhill@tearfilm.com|
20559205|NCT03619174|Viveve|Vice President, Clinical & Medical Affairs|720-696-8173|clinicalaffairs@viveve.com|
20528415|NCT02957357|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
20528416|NCT03117634|Singapore National Eye Center|Gemmy Cheung, Principal Investigator|+65 6322 8335|gemmy.cheung.c.m@singhealth.com.sg|
20559206|NCT00792428|Beth Israel Deaconess Medical Center|Gottfried Schlaug, MD, PhD|617-632-8917|gschlaug@bidmc.harvard.edu|
20559207|NCT04285229|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20559208|NCT01012973|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20559209|NCT02061761|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20559210|NCT02341144|Johns Hopkins All Children's Hospital|Nicole Chandler|7277674170|nicole.chandler@jhmi.edu|727
20559211|NCT03216902|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
20559212|NCT00903786|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
20559213|NCT02452866|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
20559214|NCT01414426|UChicago|Dr. Alexander Pearson|855-702-8222|apearson5@medicine.bsd.uchicago.edu|
20559215|NCT01857622|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
20559216|NCT02076074|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8610|izoberi@wustl.edu|
20559217|NCT01267253|NRG Oncology|Linda Gedeon for Wei Deng,PhD|716-845-1169|lgedeon@gogstats.org|
20559218|NCT00064025|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@norgoncology.org|
20559219|NCT01370603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559220|NCT01234766|Dartmouth-Hitchcock Medical Center|Frederick Lansigan, MD|603-650-4628|Frederick.Lansigan@hitchcock.org|
20559221|NCT00518713|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20559222|NCT01515345|Kaiser Franz Josef Hospital|Univ.Prof. Dr Günter Christ|+43160191|guenter.christ@wienkav.at|2508
20559223|NCT00547911|National Institutes of Health|Dr. David Goldstein|301-496-1115|goldsteind@ninds.nih.gov|
20559224|NCT02413190|Kennedy Krieger Institute|Dr. Kathryn Wagner|443-923-9525|wagnerk@kennedykrieger.org|
20559225|NCT01644474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20559226|NCT00050089|VAMC Bronx|Dr. Sheldon Brown|(718) 584-9000|sheldon.brown@va.gov|6666
20559227|NCT01097460|Merrimack Pharmaceuticals|Dr. Victor Moyo|1-617-441-1094|vmoyo@merrimackpharma.com|
20559228|NCT01163747|Hoffman-LaRoche|Medical Communications|800-821-8590||
20559229|NCT01404611|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
20559230|NCT01216293|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20559231|NCT04714216|Emory University|Dr. Francisco J. Pasquel|404-778-1695|fpasque@emory.edu|
20559232|NCT01868789|Orthopedic Foot and Ankle Center|Dr. Gregory Berlet|6148958747|ofacresearch@orthofootankle.com|
20559233|NCT01682538|Swedish Orphan Biovitrum|Medical Director|+4686972000|erik.brouwer@sobi.com|
20559234|NCT01349829|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20559235|NCT00513019|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
20559236|NCT00777803|Merz Pharmaceuticals GmbH|Matthias Zerm|+49 69 1503|matthias.zerm@merz.de|865
20559237|NCT00528190|Ottawa Hospital Research Institute|Shawn Aaron|613-737-8259|saaron@ohri.ca|
20559238|NCT01995357|Coloplast A/S|MD, Medical Director|+45 4911 1395|dkbir@coloplast.com|
20559239|NCT00377741|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20559240|NCT01852162|University of Florida|Dominick Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
20559241|NCT01500226|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781-257-2536|mhuber@tesarobio.com|
20559242|NCT02955277|Assuta Hospital Systems|Dr. Zvi Buckman|+97237462520|Bukman_tz@mac.org.il|
20559243|NCT04212169|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20559244|NCT00225420|Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20559245|NCT00504348|Tokyo Medical and Dental University|Kazuki Takada, M.D.|81-3-3813-6111|takada.rheu@tmd.ac.jp|
20559246|NCT02819479|Norton Neuroscience Institute|Shervin R. Dashti, MD, PhD, Principal Investigator|502-394-6390|shervin.dashti@nortonhealthcare.org|
20559247|NCT01118962|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20559248|NCT03985098|University of Houston|Susan Abughosh|832-842-8395|smabughosh@uh.edu|
20559249|NCT01861301|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
20559250|NCT00593554|IndianaU|Dr. Sherif Farag|317-278-0460|ssfarag@iu.edu|
20559251|NCT03685747|Thomas Jefferson University|Walter Kraft|2159559077|walter.kraft@jefferson.edu|
20559252|NCT00795132|University of Utah|Dr. Michael Pulsipher|801-588-2680|michael.pulsipher@hsc.utah.edu|
20559253|NCT02561455|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20510795|NCT01362049|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|(802) 847-7633|Sharon.Henry@uvm.edu|
20510796|NCT03198884|SIHF Healthcare|John Verna|618-337-8153|jverna@sihf.org|
20510797|NCT01202643|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
20510798|NCT02417935|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20510799|NCT00852124|UMARYLAND|Alessio Fasano|617-726-1450|afasano@partners.org|
20510800|NCT01228435|Massachusetts General Hospital|Lecia Sequist|617-726-7812|lvsequist@partners.org|
20510801|NCT02850276|Icahn School of Medicine at Mount Sinai|Dr. Jessica Robinson-Papp|212-241-8390|jessica.robinson-papp@mssm.edu|
20510802|NCT04815291|Merit Medical Systems Inc.|Casey Holland|6178420251|casey.holland@merit.com|
20510803|NCT02183792|University of Southern California School of Pharmacy|Tien Ng, Pharm.D.|3234421840|tienng@usc.edu|
20510804|NCT02910492|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20510805|NCT02994043|University of Colorado Denver|Jamie Laurin|303-724-3183|JAIME.LAURIN@CUANSCHUTZ.EDU|
20510806|NCT00095836|Massachusetts General Hospital|John Clark, MD|617-724-4000|jrclark@partners.org|
20510807|NCT00989664|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510808|NCT01158885|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20510809|NCT00962780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510810|NCT01813149|Cleveland Clinic Foundation|Michael Stanton Hicks, MD|216-445-3497|stantom@ccf.org|
20510811|NCT02363322|NIAID/LIR|Dr. Richard T. Davey, Jr.|301-496-8029|rdavey@niaid.nih.gov|
20510812|NCT02269709|University of Michigan|Frank W. DiPaola, MD|734-763-9650|dipaolaf@med.umich.edu|
20510813|NCT04098172|First Affiliated Hospital of Xi 'an Jiaotong University|Dr. Ning Guo|13991229101|drnguo@gmail.com|+86
20510814|NCT02504424|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|
20510815|NCT00426842|James J Peters VAMC|Dr. Jill M. Wecht|718-584-9000|jm.wecht@va.gov|3122
20510816|NCT00090844|Division of Hematology & Oncology, University of California, San Francisco|Pamela Munster, MD|415-476-1000|Pmunster@medicine.ucsf.edu|
20510817|NCT00982111|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20510818|NCT01070381|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20510819|NCT01230827|Johnson & Johnson Pharmaceutical Research & Development|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20510820|NCT01032265|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@jll.se|
20510821|NCT01854918|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20510822|NCT00673075|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
20510823|NCT02918006|Vaxart, Inc.|Sean Tucker, PhD, Chief Scientific Officer|650-550-3502|stucker@vaxart.com|
20510824|NCT02936206|Icahn School of Medicine at Mount Sinai|Dr. Amy Tiersten|212-241-3300|amy.tiersten@mssm.edu|
20510825|NCT02510885|Duke Eye Center|Dr. Priyatham Mettu|919-684-9010|priyatham.mettu@duke.edu|
20510826|NCT03373006|HALO Diagnostics|Chief Research Officer|760-766-2047|bernadette@halodx.com|
20510827|NCT00453349|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20510828|NCT00381810|Genentech, Inc.|Medical Communications Specialist|800 821-8590|genentech@druginfo.com|
20510829|NCT00367380|Malaria Vaccine and Drug Development|Sócrates Herrera MD, principal investigator|(572) 5216232 - 5574929|sherrera@inmuno.org|
20510830|NCT01513460|Novartis Pharmaceuticals|Study Director|862-778-8300||
20510831|NCT00489216|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20510832|NCT00149227|Department of Cardiology, Kyoto Prefectural University of Medicine|Prof. Hiroaki Matsubara|+81-75-251-5511|matsubah@koto.kpu-m.ac.jp|
20510833|NCT02312934|Vanderbilt University Medical Center|Dr. Paul A. Newhouse|(615) 327-7009|paul.newhouse@vumc.org|
20510834|NCT03395704|La Jolla Pharmaceutical Company|Stew Kroll, MA|650-576-9679|skroll@ljpc.com|
20510835|NCT02475564|Hospital de Clínicas de Porto Alegre, RS|Dr. Ricardo Francalacci Savaris|+55 51 33598653|rsavaris@hcpa.edu.br|
20510836|NCT03414372|University of North Carolina at Chapel Hill|Bryce Stamp, MPH|919-966-7430|bstamp@ad.unc.edu|
20510837|NCT00772031|The EMMES Corporation|Anne S Lindblad, PhD|301 251 1161|alindblad@emmes.com|105
20510838|NCT03428230|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
20510839|NCT02194699|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
20510840|NCT02719028|Golden Biotechnology Corp|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
20510841|NCT01191190|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
20510842|NCT01753765|Pacira Bioscience, Inc.|Medical Information|1-855-793-9729|MedInfo@Pacira.com|
20510843|NCT00577382|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
20510844|NCT03007472|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
20510845|NCT00649220|Merz Pharmaceuticals GmbH|Manager Public Disclosure|+49 69 1503 865|matthias.zerm@merz.de|
20510846|NCT00525499|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
20510847|NCT01111058|University of Chicago|Everett Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
20510848|NCT02790476|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
20528417|NCT01073163|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20528418|NCT00703677|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
20528419|NCT03859648|MED-EL Corporation|MED-EL Corporation|919-314-1437|research.us@medel.com|
20510849|NCT03287089|Atrium Health|Dina Bastawros, MD|336-718-1970|dina.bastawros@gmail.com|
20510850|NCT01729559|Scripps Mercy Hospital|Steven R. Shackford, MD|619-299-2600|shackford.steven@scrippshealth.org|
20559254|NCT04764929|Columbia University|Patrick Wilson, MD|212-305-8458|ptw2107@cumc.columbia.edu|
20559255|NCT02137538|Stanford University|E Kirk Neely|650-723-5791|neely@stanford.edu|
20559256|NCT02338713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20559257|NCT00262743|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
20559258|NCT05258747|Sandoz|Sandoz Disclosure Office|+49 8024 / 908 0|sandoz.disclosure@sandoz.com|
20559259|NCT05584657|Iterum Therapeutics|Senior Vice President and Head of Clinical Development|8606614035|saronin@iterumtx.com|
20559260|NCT05454449|National Yang-Ming Chiao-Tung University|Yi-Fen Shih, Ph.D Department of Physical Therapy and Assistive Technology|+886-2-28267340|yfshih@nycu.edu.tw|
20559261|NCT02701582|NYU School of Medicine|Marc Bloom, MD, PHD|305 689-2388|mbloom@miami.edu|
20559262|NCT03092960|Stanford University|Lisa Goldman Rosas|(650) 721-8415|lgrosas@stanford.edu|
20559263|NCT01033773|MedStar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
20559264|NCT01406860|University of Iowa Hospitals and Clinics|Brett Faine|3193108067|brett-faine@uiowa.edu|
20559265|NCT01950273|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559266|NCT01254565|Amgen, Inc|Study Director|866-572-6436||
20559267|NCT00472186|Dupage Chidlren's ENT & Allergy|Manali Amin, MD|630-785-0367|manali.amin@gmail.com|
20559268|NCT02367014|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
20559269|NCT02726399|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
20559270|NCT02722941|Moffitt Cancer Center|Taiga Nishihori, MD|813-745-8156|Taiga.Nishihori@moffitt.org|
20559271|NCT04006366|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
20559272|NCT04430335|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-9055|megreen@wakehealth.edu|
20559273|NCT03123263|TTUHSC-El Paso|Sumit Gaur|9152155200|sumit.gaur@ttuhsc.edu|
20559274|NCT01080196|University of Utah|Dr Paul LaStayo|8019719298|paul.lastayo@health.utah.edu|
20510851|NCT01028131|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
20510852|NCT00608426|Center for Chronic Disease Outcomes Research|Steven Fu, Director|612-467-1979|steven.fu@va.gov|
20510853|NCT00761891|Department of Pharmacology, School of Medicine, Vanderbilt University|Olivier Boutaud, PhD|615-343-7398|olivier.boutaud@vanderbilt.edu|
20510854|NCT01453439|Massachusetts General Hospital|Dr. Sabine Wilhelm, Ph.D.|+1(617)724-6146|swilhelm@mgh.harvard.edu|
20510855|NCT01014442|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20510856|NCT03520842|Stanford University|Heather Wakelee|(650) 498-6000|ccto-website@stanford.edu|
20510857|NCT02512094|Faculty of Medicine Siriraj Hospital, Mahidol University|Panai Laohaprasitiporn||panailao@gmail.com|
20510858|NCT02764229|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
20510859|NCT00804596|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20510860|NCT02135848|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510861|NCT00147082|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
20510862|NCT02030067|Processa Pharmaceuticals|Director Drug Development and Regulatory Affairs|443-631-6614|pfranks@processapharmaceuticals.com|
20510863|NCT04269629|Department of Dermatology and Venerology|Assoz.-Prof. Dr. Gunter Sturm|+4331638580318|gunter.sturm@medunigraz.at|
20510864|NCT04118127|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20510865|NCT03845504|Stanford University|Director, Research Development, Integrity and Strategy|(650) 736-4559|aimnoe@stanford.edu|
20510866|NCT01646255|UCB|Study Director|+1877 822||9493
20510867|NCT01376908|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
20510868|NCT01072656|Cleveland Clinic|Dr Andre Machado|216-444-4270|machada@ccf.org|
20510869|NCT02430389|Northwester University|Laura B. Hemmer, M.D.|312-695-0061|l-hemmer@northwestern.edu|
20510870|NCT01681836|University of Pittsburgh|Dr. Kara Hughan|412-692-5170|kara.hughan@chp.edu|
20510871|NCT00742391|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
20510872|NCT02394028|Hoffmann La-Roche|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy|800 821-8590|genentech@druginfo.com|
20510873|NCT00205374|University of Wisconsin-Madison|J. Scott McMurray, MD|608-262-7181|mcmurray@surgery.wisc.edu|
20510874|NCT02142712|University of New Mexico - Neurology Department|Dr. Vishnumurthy Shushrutha Hedna|505-272-3342|Drshushrutha@gmail.com|
20510875|NCT02239562|University of Miami|Christopher O'Brien|305-243-2329|CObrien@med.miami.edu|
20510876|NCT01205646|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
20510877|NCT01241318|"Ariadne Labs|BWH & HSPH"|Katherine Semrau (Epidemiologist, co-PI)|6177805311|ksemrau@ariadnelabs.org|
20510878|NCT02355665|JNJWorldwide|Andrew Myers, MD, Director, Clinical Research|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
20510879|NCT04129242|The Medical University of SC|Dr. Bashar Badran|843-792-6076|badran@musc.edu|
20510880|NCT03194256|Brown University|Suzanne Colby|4028636621|suzanne_colby@brown.edu|
20510881|NCT02853318|Roswell Park Comprehensive Cancer Institute|Katy Wang, Statistician, M.A.|7168451300|katy.wang@roswellpark.org|6269
20510882|NCT00780676|University of Texas (UT) MD Anderson Cancer Center|Stacy Moulder, MD/Associate Professor, Breast Medical Oncology|713-792-2360|CR_Study_Registration@mdanderson.org|
20510883|NCT02646332|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|williamhsup@yahoo.com.tw|78233
20510884|NCT01882439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
20510885|NCT00527722|UT MD Anderson Cancer Center|Sanjay Gupta, MD|713-563-7341|srao@mdanderson.org|
20510886|NCT02909504|University Hospitals Cleveland Medical Center|Dr. Keming Gao, MD, PhD|2168442865|keming.gao@UHhospitals.org|
20559275|NCT03988374|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|6098061200|annhita.ghassemi@churchdwight.com|
20510887|NCT02055976|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510888|NCT00751335|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAP.trial@fphcare.co.nz|7044
20510889|NCT03769753|Memorial Sloan Kettering Cancer Center|T. Peter Kingham, MD|212-639-5260|kinghamp@mskcc.org|
20510890|NCT00684073|Schering-Plough|Head, Clinical Trials Registry and Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20510891|NCT01869686|Amgen Inc.|Study Director|866-572-6436||
20510892|NCT01657903|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510893|NCT00620815|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20510894|NCT00983827|University of Utah|Dr. Steven Edgley|801-581-4695|carma.hyde@hsc.utah.edu|
20510895|NCT00574340|University of Maryland, Baltimore|Dr. Stephen N. Davis|410-328-2488|sdavis@medicine.umaryland.edu|
20510896|NCT02146352|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
20510897|NCT00396266|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20510898|NCT02828982|University of Michigan|Dr. Deanna Gates|(734) 647-2698|gatesd@umich.edu|
20510899|NCT01156012|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
20510900|NCT02705755|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20510901|NCT04308668|University of Minnesota|David Boulware, MD, MPH|6125552020|covid19@umn.edu|
20510902|NCT01020812|Stanford University|Daniel T Chang|650-723-6171|dtchang@stanford.edu|
20510903|NCT02927990|Philips Medical Systems B.V.|Pim van Lochem|+31 (0)634322891|pim.vanlochem@philips.com|
20510904|NCT00960323|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20510905|NCT01522963|University of Minnesota|Michael Kotlyar|6126251160|kotly001@umn.edu|
20510906|NCT02996981|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
20510907|NCT03258710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20510908|NCT03451630|UPMC Center for High-Value Health Care|Kelly Williams, PhD, MPH|412-454-1198|williamsk17@upmc.edu|
20510909|NCT02041533|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20510910|NCT00545740|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20510911|NCT02117024|Clinical Development|Lori McDermott|919-794-8950|lmcdermott@heatbio.com|
20510912|NCT03138798|Icahn School of Medicine at Mount Sinai|Dr. Eric Bergh|908-625-8148|eric.bergh@mssm.edu|
20510913|NCT00565721|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
20510914|NCT02813681|University of Texas Medical Branch|Denise Wilkes|409-772-1221|dwilkes@utmb.edu|
20510915|NCT00529152|ApoPharma|Dian Shaw, Manager Clinical Research|416-401-7283|dshaw@apotex.com|
20510916|NCT02500706|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20510917|NCT01497899|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20510918|NCT02026193|Rambam health Care campus|Dr Shahar Kol , Director IVF Unit|97247773232|skol@rambam.health.gov.il|
20510919|NCT02347124|Kaiser Permanente Washington Health Research Institute|Dr. Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
20510920|NCT02499380|PneumRx|Jörg Rennecke|+49 211 5422750|medical.services@btgplc.com|
20510921|NCT01874288|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
20510922|NCT04212221|Zai Lab (Shanghai) Co.,Ltd.|Medical Director|+86 4008201022|medinfo@zailaboratory.com|
20510923|NCT03123549|NuVasive, Inc.|Jessica Fulwider|7037721455|jfulwider@nuvasive.com|
20510924|NCT03681808|Bausch & Lomb|Study Director|585-338-6399|Robert.Steffen@bausch.com|
20510925|NCT05223478|Ocuphire|Drey Coleman VP of Clinical Operations|8134041993|dcoleman@ocuphire.com|
20510926|NCT03370133|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20510927|NCT00636506|American Medical Systems|Men's Health Clinical Affairs|952-930-6328|Karen.Seybold@ammd.com|
20510928|NCT01624974|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510929|NCT03607994|Wake Forest Baptist Health|Catherine Tegeler - Project Manager|336-716-9341|categele@wakehealth.edu|
20510930|NCT01408862|Institute of Medical Research (UBA-CONICET)|Dr. Carlos Jose Pirola|541145148701|cpirola@ciudad.com.ar|167
20510931|NCT00498927|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212 639 7523|omuroa@mskcc.org|
20510932|NCT03125902|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20510933|NCT01775995|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
20510934|NCT01997333|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
20510935|NCT04411472|AM-Pharma|AM-Pharma Office|+31 (0)30 22 89 222|office@am-pharma.com|
20510936|NCT05060003|Washington University School of Medicine|George Ansstas, M.D.|314-362-5677|gansstas@wustl.edu|
20510937|NCT01558791|National Center for PTSD|Dr. Jessica Hamblen, PI|802-296-5132|Jessica.Hamblen@va.gov|5389
20510938|NCT01747655|AbbVie|Global Medical Information|1-800-633-9110||
20510939|NCT02275559|UMass Chan Medical School|Dr James Carmody|5088561205|james.carmody@umassmed.edu|
20510940|NCT02699632|Pennington Biomedical Research Center|Leanne Redman, Principal Investigator|2257630947|Leanne.Redman@pbrc.edu|
20510941|NCT01259388|Birmingham VA Medical Center|Dr. John Rinker|205-934-2402|John.Rinker@va.gov|
20510942|NCT03512028|Washington University School of Medicine|Catherine Lang|314-286-1945|langc@wustl.edu|
20510943|NCT03529162|Saint Louis University|Sarah Dawson, Research Nurse|314-977-4106|sarah.dawson@health.slu.edu|
20551106|NCT01905384|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
20510944|NCT05414422|Perception Neuroscience|Clinical Trials Group|+49 (0) 89 2153 9035|clinicaltrials@perceptionneuroscience.com|
20510945|NCT02728804|SWOG Statistics and Data Management Center|Cancer Care Delivery Committee Statistician|2066674623|adarke@fredhutch.org|
20510946|NCT01888367|Promius Pharma, LLC, Dr. Reddy's Laboratories|VP, Drug Development|609-375-9855|kallenby@drreddys.com|
20510947|NCT00591786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20510948|NCT01920061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510949|NCT00198042|Hospital for Special Surgery|Scott Rodeo, MD|212-606-1000|rodeos@hss.edu|
20510950|NCT03969589|VISN 5 MIRECC|Amy Drapalski|443-421-6273|amy.drapalski@va.gov|
20510951|NCT00517634|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510952|NCT03091920|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
20510953|NCT03143855|Virginia Commonwealth University|Dr. F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
20510954|NCT00422942|Hoffmann-LaRoche|Medical Communications Organization|800-821-8590|genentech@druginfo.com|
20510955|NCT02978339|Mayo Clinic|John E. Eaton, M.D.|507-284-3917|Eaton.John@mayo.edu|
20510956|NCT00701064|VA|Shawn Youngstedt|803-767-3208|shawn.youngstedt@asu.edu|
20510957|NCT02098733|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20510958|NCT00695318|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
20510959|NCT01665040|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|rjain@bsci.com|
20510960|NCT00939094|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20510961|NCT05453006|University of Minnesota|Christina Bliss Barsness|612-625-7179|blis0015@umn.edu|
20510962|NCT01906489|Akebia Therapeutics|Akebia Therapeutics|617-844-6128|trials@akebia.com|
20510963|NCT00195702|Abbott|Global Medical Services|800-633-9110||
20510964|NCT03721549|WCCT Global|Erin Flynn, Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
20510965|NCT00508469|Alcon France|Severine Durier, PharmD|+33 1 47 10 48 43||
20528420|NCT02315664|Arthritis Research Canada|Dr. Linda Li, Professor, University of British Columbia|604-207-4020|lli@arthritisresearch.ca|
20528421|NCT01677182|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20559276|NCT03249376|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20559277|NCT01335308|University of Michigan|Ken Resnicow|734 647 0212|kresnic@umich.edu|
20559278|NCT00627042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20559279|NCT02774343|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|713-486-2867|Joy.M.Schmitz@uth.tmc.edu|
20559280|NCT02264574|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
20559281|NCT02900781|Texas Tech University Health Sciences Center|Nancy Swinford CCRC|8067432569|nancy.swinford@ttuhsc.edu|
20559282|NCT04254679|McGill University|Dr. Julio F. Fiore Jr|514 934-1934|julio.fiorejunior@mcgill.ca|35655
20559283|NCT03954158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20510966|NCT01078389|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20510967|NCT04823494|GN|Todd Fortune|763-772-5566|tfortune@gnresound.com|
20559284|NCT02206152|University of Minenesota|Elizabeth Seaquist, MD|612-624-9176|chape044@umn.edu|
20528422|NCT02501161|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20559285|NCT00478608|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20559286|NCT02080520|Atherosclerosis Research Unit, University of Southern California|Howard N. Hodis, M.D.|323-442-1478|athero@usc.edu|
20559287|NCT00390455|Dana-Farber Cancer Institue|Harold Burstein, M.D.||hburstein@partners.org|
20559288|NCT05641077|Cleveland Clinic|Lannah Lua-Mailland|216-314-2163|lual@ccf.org|
20559289|NCT00794820|University of Texas (UT) MD Anderson Cancer Center|Susan O'Brien, MD/ Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20559290|NCT04496414|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|
20559291|NCT02406261|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
20559292|NCT03039543|Seoul National University Bundang Hospital|Dr. Junghee Ryu, Associate Professor|82-31-787-7497|jinaryu74@gmail.com|
20559293|NCT01591460|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20559294|NCT03679013|Inova Fairfax Hospital|Ramesh Singh, MD|(703)776-8025|ramesh.singh@inova.org|
20559295|NCT01930643|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|+886-975837711|jeff01@mmh.org.tw|
20559296|NCT01861756|Aristotle University Thessaloniki|Dr. Apostolos Tsapas||atsapas@auth.gr|
20559297|NCT00610675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559298|NCT01458249|Eisai Co., Ltd.|Sun Asami|+81-3-3817-5252||5252
20559299|NCT01824082|University of California San Diego|Brian M. Ilfeld|858-822-0776|bilfled@health.ucsd.edu|
20559300|NCT00176865|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
20559301|NCT00684983|Mayo Clinic|Paul Haluska Jr MD PhD|507-284-1159|haluska.paul@mayo.edu|
20559302|NCT02379117|UNottingham|Dr Gordon Moran|44 [0]115 9249924|Gordon.Moran@nottingham.ac.uk|70608
20559303|NCT02501135|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
20559304|NCT02176928|University of Miami|Shirin Shafazand, MD, MS|305-243-7888|sshafazand@med.miami.edu|
20559305|NCT00360555|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
20559306|NCT01603940|Hospital Universitario Pedro Ernesto (UERJ)|Ronaldo Altenburg Gismondi, MD, PhD|+5521996092383|ronaldogismondi@gmail.com|
20559307|NCT02018861|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20559308|NCT02748564|Cancer Institute of New Jersey|Adam Berger, MD|215-235-8079|ab2047@cinj.rutgers.edu|
20559309|NCT00163215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559310|NCT00739583|Johns Hopkins University|Simon C Mears|410-550-0101|smears1@jhmi.edu|
20559311|NCT01668147|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20559312|NCT01809210|AstraZeneca|Dr Gabriella Mariani , MD|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
20559313|NCT02662244|UCSD|Dr. Arisa Ortiz|858-657-1697|dermstudies@ucsd.edu|
20559314|NCT00315627|University of Miami Miller School of Medicine|Dr. Rodolfo Alejandro|305 243-5324|ralejand@med.miami.edu|
20559315|NCT01115998|University of Oklahoma Health Sciences Cetner|Director of Sponsored Programs|405-271--2090|mary-cotter@ouhsc.edu|
20559316|NCT00224133|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20559317|NCT00827944|Derriford Hospital, Department of Surgery|Pr. Andrew KINGSNORTH|+44 175 276 3017|Andrew.Kingsnorth@phnt.swest.nhs.uk|
20559318|NCT00709891|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20559319|NCT03699124|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
20559320|NCT02968940|NYU Langone Health - Perlmutter Cancer Center|Sylvia Kurz, MD, PhD|212-731-6267|Sylvia.Kurz@nyulangone.org|
20559321|NCT00506285|Psychiatry Research Clinic|Barrie K. Marchant|801 585-6663|barriemarchant@aol.com|
20559322|NCT01305356|Wright Medical|Justin Moss|615-236-4984|Justin.Moss@wright.com|
20559323|NCT00551213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559324|NCT01890967|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20559325|NCT03905811|University of Iowa|Jordan Schultz|3193849388|jordan-schultz@uiowa.edu|
20559326|NCT01383993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559327|NCT04975789|University of Wisconsin - Madison, School of Nursing|Maichou Lor, PhD, RN|608-265-4248|mlor2@wisc.edu|
20559328|NCT01489020|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
20559329|NCT03796689|University of California, San Fransico|Dr. Mark Pletcher, Professor|415-514-8008|mark.pletcher@ucsf.edu|
20559330|NCT03294213|Ambu A/S|Anna Lundgaard|+4529643748|aclu@ambu.com|
20559331|NCT02451930|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20559332|NCT00415493|ASTHMA Inc.|Principal Investigator|(510) 620-5714|dennis.shusterman@cdph.ca.gov|
20559333|NCT02485353|IndianaU|Hamid Sayar, MD|317-948-7576|ssayar@iu.edu|
20559334|NCT04758403|BIDMC|Adnan Majid|617-632-8386|tsipresearchstaff@bidmc.harvard.edu|
20559335|NCT04411940|Cycle Pharmaceuticals|Head of Global Regulatory Affairs & Clinical Development|+441223803635|claudia.percivalle@cyclepharma.com|
20559336|NCT03354637|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
20559337|NCT02774265|University of Maryland Medical Center|Dr. Bryce Haac|410-328-3495|bhaac@som.umaryland.edu|
20559338|NCT02086552|Mayo Clinic|Francis K Buadi, MD|507/284-2511|Kumar.Shaji@mayo.edu|
20559339|NCT00634322|BTG International (Protherics)|VP Clinical Development, BTG International|610-943-3632|janet.rush@btgplc.com|
20559340|NCT04102540|University of Colorado College of Nursing|Dr. Samantha Stonbraker|3037248281|Samantha.Stonbraker@CUAnschutz.edu|
20559341|NCT00906503|Barbara Ann Karmanos Cancer Institute|Barbara Ann Karmanos Cancer Institute|313-576-9370|davisv@karmanos.org|
20559342|NCT02339389|Brigham and Women's Hospital|Bhavani Kodali|6175258449|bkodali@partners.org|
20559343|NCT01567163|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20559344|NCT03405662|University of California, San Francisco & San Francisco VA Health Care System|Dr. Linda Chao|415-221-4810|linda.chao@ucsf.edu|24386
20559345|NCT00280293|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
20559346|NCT00581256|University of Michigan Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
20559347|NCT01348854|Abbott Medical Optics|Carrie Garufis|714-247-8200|carrie.garufis@amo.abbott.com|
20559348|NCT01720797|University of Florida|Calogero Dolce, DDS, PhD|352-273-5700|cdolce@dental.ufl.edu|
20559349|NCT04524104|Univeristy of Illinois, Chicago|Nan Lv, PhD, Research Scientist|312-802-1072|lvn2017@uic.edu|
20559350|NCT00983619|MedImmune, LLC|Shahram Rahimian|800-236-9933|information.center@astrazeneca.com|
20559351|NCT00724061|Northwestern University|Dr. Timothy Kuzel|312-695-6180|cancertrials@northwestern.edu|
20559352|NCT04827134|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20559353|NCT01048606|Université de Sherbrooke|Pr Isabelle Dionne, Ph.D., vice-dean to research and graduate studies|1-819-821-8000|isabelle.dionne@usherbrooke.ca|63327
20559354|NCT02443103|IndianaU|Dr. Kathy Miller|317-948-3855|kathmill@iu.edu|
20559355|NCT03358329|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
20559356|NCT02982720|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
20559357|NCT01448525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20559358|NCT03875911|UCLA Jules Stein Eye Institute|Dr. Joseph Caprioli|310-825-6323|caprioli@jsei.ucla.edu|
20559359|NCT02144519|University of South Carolina|Michael W Beets|8037773003|beets@mailbox.sc.edu|
20559360|NCT02343575|Stanford University|Yelizaveta Sher, MD|650-736-0459|ysher@stanford.edu|
20559361|NCT03824938|Columbia University Irving Medical Center|Victoria M. Leavitt, MD|212-342-1351|vl3227@cumc.columbia.edu|
20559362|NCT00287469|Armed Forces Research Institute of Medical Services|Mrigendra P. Shrestha MD|662-644-4888|shrestham@afrims.org|
20559363|NCT05515679|Hopeful Aging|Michael Skrajner|4404777881|info@hopefulaging.com|
20559364|NCT00393094|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
20559365|NCT02019602|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20559366|NCT03228017|NYU Langone|Dr. Michael Garshick|212-263-0855|michael.garshick@nyulangone.org|
20559367|NCT01872949|CHF Solutions, Inc.|Audrey Singh|952-345-4217|audrey.singh@chf-solutions.com|
20559368|NCT02969031|Dana-Farber Cancer Institute|Julie Goldman|617-632-5563|Julie_Goldman@dfci.harvard.edu|
20559369|NCT01556763|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
20559370|NCT02258464|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20559371|NCT04170296|Endo Pharmaceuticals|David Hernandez, MD|800-462-3636|clinicaltrials@endo.com|
20559372|NCT00932646|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559373|NCT00653263|UArkansas|Michael J Mancino|501-526-8442|mjmancino@uams.edu|
20559374|NCT00776100|Mayo Clinic|Steven E. Schild, M.D.|507-538-1760|sschild@mayo.edu|
20559375|NCT03687450|Brigham and Women's Hospital|Julia Loewenthal, MD|6177325500|jloewenthal@bwh.harvard.edu|
20559376|NCT03567993|UMass Chan Medical School|Dr. Rajani Sadasivam|508-456-8923|rajani.sadasivam@umassmed.edu|
20559377|NCT02285595|Sonendo, Inc.|Director of Clinical Research|9496678036|clinical@sonendo.com|
20559378|NCT01960790|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20559379|NCT04129580|Penn State Milton S. Hershey Medical Center|Dr Sarah Kawasaki|7175311000|skawasaki@pennstatehealth.psu.edu|
20559380|NCT02435511|University of Chicago|Dr. Stacy Lindau|7738348986|slindau@bsd.uchicago.edu|
20559381|NCT02711995|Weill Cornell Medicine|Katerina Andreadis|646-962-9883|kaa2055@med.cornell.edu|
20559382|NCT00322868|Case Western Reserve University|Michael W Konstan, MD|2168443267|michael.konstan@case.edu|
20559383|NCT03615482|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559384|NCT04006795|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20559385|NCT03248570|University of California, San Francisco|Dr. David Oh, MD|(415) 476-1000|David.Oh@ucsf.edu|
20559386|NCT04404257|William Beaumont Hospitals|Dr. Simon Dixon, MD|248-898-4198|simon.dixon@beaumont.edu|
20559387|NCT03114995|Cardiovascular Center, Seoul National University Bundang Hospital|Dr. Tae-Jin Youn|+82-31-787-7031|ytjmd@snubh.org|
20559388|NCT04223154|Wake Forest University School of medicine|Colleen A. Hanlon, Ph.D.|336-716-5465|chanlon@wakehealth.edu|
20528423|NCT03159299|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
20505385|NCT00940927|Nemours Children's Clinic|Kathryn Blake, Pharm.D.|904 858 3806|kblake@nemours.org|
20505386|NCT03245814|The University of Arizona|Dr. Maggie O'Haire|520-621-6767|maggieohaire@arizona.edu|
20505387|NCT00946270|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD./Professor|713-745-3429|sverstov@mdanderson.org|
20505388|NCT02263365|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
20505389|NCT00510692|S.L.A. Pharma (UK) Ltd|Dr Chris Jordan|+44 (0)1923 681001|cjordan@slapharma.com|
20505390|NCT00945191|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20505391|NCT00784784|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
20505392|NCT01004146|University of Texas at Houston Medical School / Dept. of Anesthesiology|Dr. Davide Cattano|713-500-6235|davide.cattano@uth.tmc.edu|
20528424|NCT00667992|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20528425|NCT00762762|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
20528426|NCT02489448|Yale School of Medicine|Lajos Pusztai, MD, DPhil Professor of Medicine (Medical Oncology)|(203) 737-8309|lajos.pusztai@yale.edu|
20528427|NCT02096276|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20528428|NCT03331263|Medline Industries, Inc.|Senior Regulatory Affairs Specialist|8476433515|aminarcik@medline.com|
20528429|NCT01703169|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
20528430|NCT02014519|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528431|NCT00315614|University of Miami|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
20528432|NCT02630563|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
20528433|NCT00929994|Toronto Rehab|Dr.|4169781739|dina.brooks@utoronto.ca|
20528434|NCT00621257|children's Hospital Boston|Helen Pappa, MD, MPH, Principal Investigator|617-355-6058|helen.pappa@childrens.harvard.edu|
20528435|NCT01255904|Baylor College of Medicine|Jason Reynolds|(210) 704-2680|jmreynol@bcm.edu|
20528436|NCT03258645|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20528437|NCT02061813|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20528438|NCT01705080|Abbott|Steven Madej|651-756-2230|smadej@sjm.com|
20528439|NCT00828061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20528440|NCT02075008|Novartis Pharmaceuticals|Study Director|862-778-8300||
20528441|NCT00572455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528442|NCT00909220|Northwestern University|Jackie Gollan, Ph.D. Associate Professor of Psychiatry and Behavioral Sciences|312-695-6121|j-gollan@northwestern.edu|
20528443|NCT02821416|AstraZeneca|Maria Jison|001-202-577-6213|Maria.Jison@astrazeneca.com|
20528444|NCT01449864|University of Pennsylvania|John Plastaras, MD, PhD|267-972-3539|plastaras@uphs.upenn.edu|
20528445|NCT02256917|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
20528446|NCT02082769|Department of Endocrinology, Xijing Hospital, Fourth Military Medical University|Qiuhe Ji|+86-29-84775213|qiuheji@hotmail.com|
20528447|NCT01308463|Zimmer Biomet|Kelly Francher|574-371-9783|kelly.francher@zimmerbiomet.com|
20559389|NCT02466126|Department of Veterans Affairs, Micheal E. DeBakey VAMC|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
20559390|NCT00590980|University of Illinois at Chicago|Sepideh Amin-Hanjani, MD|312-996-4842|hanjani@uic.edu|
20559391|NCT02718417|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559392|NCT01023308|Novartis Pharmaceuticals|Study Director|862-778-8300||
20559393|NCT01646320|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
20559394|NCT02892409|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20559395|NCT01300559|Duke University Medical Center|Steven E. Hill, M.D.|681-6614|hill0012@mc.duke.edu|
20559396|NCT01440049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559397|NCT02268552|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20559398|NCT00447330|Duke University Medical Center|Brant Hamel|919-668-1861|brant.hamel@duke.edu|
20559399|NCT02971891|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20559400|NCT02748512|Axiom|Kelley Collins-Winters, RTR, BS, MBA|469-667-6655|kelleyc@axiom.cc|
20559401|NCT00997243|Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center|Alison Walker, MD|614-293-3196|Alison.Walker@osumc.edu|
20559402|NCT01754779|UT Southwestern Medical Center|Dr. Naim Maalouf|214/648-2954|naim.maalouf@utsouthwestern.edu|
20559403|NCT03415022|New York State Psychiatric Institue|Dr. Franklin Schneier|646-774-8041|Franklin.Schneier@nyspi.columbia.edu|
20559404|NCT04963764|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Todd Florin|312-227-6080|edpneumoniaresearch@luriechildrens.org|
20559405|NCT03226457|University of Dundee|Dr Natalie Mordi (Principle Investigator)|+ 44 (0) 1382 383 667|n.a.mordi@dundee.ac.uk|
20559406|NCT03583541|Washington University in St. Louis|Fred Ssewamala|3149358521|fms1@wustl.edu|
20559407|NCT00884286|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
20559408|NCT01196104|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20559409|NCT00409240|Providence VAMC|Wen-Chih Wu, MD|401-273-7100|wen-chih.wu@va.gov|6237
20559410|NCT04655313|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20559411|NCT03781960|University of Pennsylvania Hospital|Thomas Karasic, MD|215-614-1858|thomas.karasic@pennmedicine.upenn.edu|
20505393|NCT02099799|VA Boston Healthcare System|Marilyn Moy, MD, MSc|857-203-6622|marilyn.moy@va.gov|
20528448|NCT01042392|Novartis Pharmaceuticals|Study Director|862-778-8300||
20528449|NCT03117361|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
20510968|NCT03691831|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
20510969|NCT02198040|Universidad de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
20510970|NCT04524663|Stanford University|Dr. Julie Parsonnet, MD|(650) 725-4561|parsonnt@stanford.edu|
20510971|NCT03359811|UT MD Anderson Cancer Center|Dr. Juan Cata, MD, Associate Professor, Anesthesiology & PeriOper Med|(713) 792-7452|jcata@mdanderson.org|
20510972|NCT01080794|Beth Israel Deaconess Medical Center|Dr. Alvaro Pascual-Leone|(617) 667-0203|apleone@bidmc.harvard.edu|
20510973|NCT01189201|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20510974|NCT01682876|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
20510975|NCT00578331|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20510976|NCT03852901|National Institute on Aging|Josephine M. Egan, MD, Clinical Director|410-558-8414|eganj@mail.nih.gov|
20510977|NCT00911508|Mayo Clinic|Dr. Douglas L. Packer|507-255-6263|CABANA@mayo.edu|
20510978|NCT03374982|University of Nebraska Medical Center|Zachary Houser|402-980-9633|zach.houser@unmc.edu|
20510979|NCT00240331|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20510980|NCT01409382|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|55-21-999737500|sclapauch@gmail.com|
20510981|NCT01233076|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
20510982|NCT01266967|GlaxoSmithKline|GSK Response Center|866-435-7343||
20510983|NCT04563845|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20510984|NCT01519700|Sandoz|Dr. Roumen Nakov, Global Programme Medical Director|+49 8024 4764704|roumen.nakov@sandoz.com|
20510985|NCT00103376|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20510986|NCT03824704|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20510987|NCT01091116|Menarini-Ricerche|Clinical Research Director|+39-055-56809990||
20510988|NCT01160458|National Cancer Institute, National Institutes of Health|Dr. Raffit Hassan, M.D.|301-451-8742|hassanr@mail.nih.gov|
20510989|NCT00182793|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
20510990|NCT02155660|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
20510991|NCT03730987|University of Miami|Dr. Victoria Behar-Zusman|305-2849139|vbehar-zusman@miami.edu|
20510992|NCT02505945|Torax Medical|Adam Ahlstrom|651-361-8900|aahlstro@its.jnj.com|
20510993|NCT00386152|Centocor Ortho Biotech Services, LLC|Nephrology Therapeutic Area, Medical Lead|215-325-4176||
20510994|NCT02083406|Medicines for Malaria Venture (MMV)|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
20510995|NCT02577107|Novartis Pharmaceuticals|Study Director|862-778-8300||
20510996|NCT00218439|University of Minnesota College of Pharmacy|Dr. Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20510997|NCT02615158|University of Maryland School of Medicine|Dr. Maureen Black|410-706-2136|mblack@som.umaryland.edu|
20510998|NCT03558230|Medical University of South Carolina|Dr. Na Jin Seo|843-792-0084|seon@musc.edu|
20510999|NCT00883896|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511000|NCT00991458|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20511001|NCT03306589|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
20511002|NCT01856920|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Office|855-797-9277|Bobby.Reddy@immunitybio.com|
20511003|NCT00731094|VA Pittsburgh Healthcare System|Kelly Hyman Burkitt, PhD|412-360-2202|Kelly.Burkitt@va.gov|
20511004|NCT03380091|University of California, San Francisco|Heather Huddleston|(415) 353-3040|Heather.Huddleston@ucsf.edu|
20511005|NCT02515890|University of Pittsburgh|Keith M. Vogt, MD., PhD.|412-999-8570|vogtkm@upmc.edu|
20511006|NCT01980056|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
20511007|NCT03802331|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511008|NCT01196793|Imperial College London NHS Trust|Dr Hermione Lyall|02033126965|hermione.lyall@nhs.net|
20511009|NCT00368069|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20511010|NCT03010358|OHSU Knight Cancer Institute|Bria Thurlow|503-494-4292|thurlow@ohsu.edu|
20511011|NCT00014560|Dartmouth Hitchcock|Dr. Pamela Ely|603-653-9071||
20511012|NCT02195895|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
20511013|NCT02675933|Dell Children's Medical Center of Central Texas|Dr. Catherine Yee|5123240000|ceyee@ascension.org|86878
20511014|NCT00958282|University of Minnesota|Dr. Marc Mooney|6129916875|moon0078@umn.edu|
20511015|NCT00859495|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
20511016|NCT00579059|Biomet, LLC|Megan Lawson, Clinical Research Specialist|1-800-348-9500|megan.lawson@biomet.com|1183
20511017|NCT00779506|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20511018|NCT01218477|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20511019|NCT03970330|MSHersheyMC|Dr. Kristin Riley|717-531-6447|kriley1@pennstatehealth.psu.edu|
20511020|NCT00787527|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD/ Associate Professor|713-792-2860|yoki@mdanderson.org|
20511021|NCT03137433|University of Minnesota|Aaron Kelly, PhD|612-626-3492|kelly105@umn.edu|
20511022|NCT00083616|Amgen Inc.|Study Director|866-572-6436||
20511023|NCT03485976|Oregon Health & Science University, Department of Dermatology|Teri Greiling, MD, PhD|503-494-8452|PRPStudy@ohsu.edu|
20511024|NCT01199952|University of California, San Francisco|Director for Research Operations|415-206-2476|abby.sokoloff@ucsf.edu|
20511025|NCT01474993|UMass Medical School|Andrew Zimmerman, M.D.|508-856-3279|Andrew.Zimmerman@umassmemorial.org|
20511026|NCT03570476|University of Washington|Dr. Bruce Montgomery, PI|206-598-0860|rbmontgo@uw.edu|
20511027|NCT03742271|Johnson & Johnson Vision Care Inc.|John Buch OD F.A.A.O- Sr. Principal Research Optometrist|+1 904 443-1707|JBUCH@its.jnj.com|
20511028|NCT00890396|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
20559412|NCT01094171|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505394|NCT03290300|Aerin Medical, Inc.|Scott Wolf, M.D.; Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
20505395|NCT02124798|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505396|NCT01797432|University of Minnesota|Maria Hordinsky, MD|612-625-6118|hordi001@umn.edu|
20505397|NCT02792777|Thomas Jefferson|Kristin L Rising, MD MS|215-503-5507|kristin.rising@jefferson.edu|
20505398|NCT03863496|Ilizarov centre|Sergey Raybukh|+79226716007|rso_@mail.ru|
20505399|NCT00487279|St. Jude Medical CRMD|Heidi Hinrichs/Sr. Director, Clinical Operations|(818) 493-3297|hhinrichs@sjm.com|
20505400|NCT02746679|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
20505401|NCT01221298|AbbVie|Global Medical Services|800-633-9110||
20505402|NCT04036136|University of North Carollina at Chapel Hill|Gabriel Dichter, PhD|919-364-4275|dichter@med.unc.edu|
20505403|NCT04076072|Vanderbilt University Medical Center|Marybeth Carter|615-936-1639|Marybeth.l.carter@vumc.org|
20505404|NCT00469014|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Professor, Chair, Stem Cell Transplantation|713-792-3618|CR_Study_Registration@mdanderson.org|
20505405|NCT00515463|Amgen Inc.|Study Director|866-572-6436||
20505406|NCT00916721|Massachusetts General Hospital|A. Eden Evins, MD, MPH, Director Center for Addiction Medicine|617-643-4679|a_eden_evins@hms.harvard.edu|
20505407|NCT01797029|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
20505408|NCT02101411|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
20505409|NCT02644525|Laboratory of Parasitic Diseases, NIAID/NIH|Elise O'Connell, MD, Principal Investigator|301-661-0172|oconnellem@mail.nih.gov|
20505410|NCT03028025|VALBHS|Dr. Arnold Seto|562-826-8000|arnold.seto@va.gov|
20505411|NCT02399475|University of Pennsylvania|Dr. Anne Cappola|2155375359|acappola@pennmedicine.upenn.edu|
20505412|NCT01810991|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20505413|NCT03340805|The Children's Hospital of Philadelphia|Dr. Scott L. Weiss, study co-PI|215-590-5505|WeissS@email.chop.edu|
20505414|NCT00404768|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505415|NCT03575468|Consumer Wellness Solutions|Dr. Katrina Vickerman|469-608-4208|katrina.vickerman@optum.com|
20505416|NCT01118143|University of Tromsø|Professor Jan Bergdahl|+4777649122|jan.bergdahl@uit.no|
20505417|NCT02112448|Advocate Children's Hospital|Jamie Penk|7086845580|jamie.penk@advocatehealth.com|
20505418|NCT02026908|Northwestern University/Northwestern Memorial Hospital|Samdeep Mouli MD|312-926-5200|s-mouli@northwestern.edu|
20505419|NCT03729869|Medical University of South Carolina|Lisa Nunn, Program Manager|843-792-0476|jenkinli@musc.edu|
20505420|NCT01597622|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20505421|NCT04543955|University of Kentucky|Dr. Lowell Anthony|859-323-8043|lowell.anthony@uky.edu|
20511029|NCT00440232|Jefferson Headache Center/Thomas Jefferson University|Stephen D. Silberstein, M.D.|215-955-2243|stephen.silberstein@jefferson.edu|
20511030|NCT00362297|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
20511031|NCT03417999|Children's Hospital of Philadelphia|Dr. Kelly Grogan|410-279-6994|grogank@chop.edu|
20511032|NCT02185729|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20511033|NCT02514889|UCLA Fielding School of Public Health, 650 Charles Young Drive, Los Angeles, CA 90095|William J. McCarthy, Ph.D., Professor|310-794-7587|wmccarth@ucla.edu|
20511034|NCT05111548|University of Michigan|Dr. Cynthia Burton|734-615-9821|czburton@med.umich.edu|
20511035|NCT01846039|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20511036|NCT03330275|Johnson & Johnson Vision Care, Inc.|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
20511037|NCT01855607|Columbia University Irving Medical Center|Dawn L. Hershman, MD, MS, FASCO|212 305-1945|dlh23@columbia.edu|
20511038|NCT01101321|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20511039|NCT02406586|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20511040|NCT02839330|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20511041|NCT03339999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20511042|NCT03028324|University of Miami|Joyce Rios Gomes-Osman|305-284-2632|j.gomes@miami.edu|
20511043|NCT01182480|Denver Health and Hospital Authority|Andrew W. Steele, MD, MPH, MSc|303-602-9773|andy.steele@dhha.org|
20511044|NCT00661362|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20511045|NCT00535262|Depression Evaluation Service, New York State Psychiatric Institute|Deborah A. Deliyannides, M.D. Research Psychiatrist|(212) 543-5734|deliiyan@nyspi.columbia.edu|
20511046|NCT01707667|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20511047|NCT01654666|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D|8683198127|jixunming@vip.163.com|
20511048|NCT04805892|Quality Research and Invention LLC|Zanetta Malanowska-Stega|6464001204|jstega@optonline.net|
20511049|NCT03432819|RAND Corporation|Laura Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
20511050|NCT04382066|PharmaMar, S.A.|Clinical Development Virology Business Unit PharmaMar|+34 91 846 60 00|clinicaltrials@pharmamar.com|
20511051|NCT01430559|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511052|NCT01220024|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20511053|NCT02467504|Peking university People's Hospital|Prof. Zhanguo Li|+86-13810001444|13810001444@163.com|
20511054|NCT00174460|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511055|NCT04225026|Galera Therapeutics|Judy Schnyder, Sr. Vice President, Clinical Operations|484-870-9625|jschnyder@galeratx.com|
20511056|NCT04462731|University of Pennsylvania|Ya-Hsin Yu|215-898-4927|yayu@upenn.edu|
20511057|NCT00672490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20511058|NCT03698370|Stanford University|Dr. Andrei Iagaru, MD|650-728-4711|aiagaru@stanford.edu|
20511059|NCT03982069|University of Pittsburgh|Dr. Katherine Williams|412-383-1979|kvw3@pitt.edu|
20511060|NCT01303159|Weill Cornell Medical College|Michel Kahaleh|646-962-4797|mik9071@med.cornell.edu|
20511061|NCT00914940|Fred Hutchinson Cancer Research Center|Marie Bleakley, MD|206-667-6572|mbleakle@fredhutch.org|
20511062|NCT00733096|Johns Hopkins School of Medicine|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
20511063|NCT02735382|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Mark Zehner, MS|6082627568|mark.zehner@ctri.wisc.edu|
20511064|NCT00760994|VA Puget Sound Health Care System|Tracy Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
20511065|NCT01853397|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
20511066|NCT02132312|Omeros Corporation|Omeros Clinical Trial Information|ctinfo@omeros.com|ctinfo@omeros.com|
20511067|NCT01632345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511068|NCT00089505|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20511069|NCT01724021|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20511070|NCT02543918|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
20511071|NCT03503617|Flint Rehabilitation Devices|Daniel Zondervan|9493137322|dzondervan@flintrehab.com|
20511072|NCT01005875|University of Alabama at Birmingham|Dr. Kimberly Keene|2-5-934-5670|kkeene@uab.edu|
20511073|NCT00078715|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos A. Zarate, Jr.|301-451-0861|zaratec@mail.nih.gov|
20511074|NCT00606931|Naviscan Inc|Judith E Kalinyak, MD, PhD, Medical Director|858-587-3641|jkalinyak@naviscan.com|108
20511075|NCT04241627|University of Southern California Keck School of Medicine Department of Pediatrics|Caitlin Sayegh|13233617748|cssayegh@chla.usc.edu|
20511076|NCT00266695|Chromaderm|info@chroma-derm.com|info@chroma-derm.com||
20511077|NCT02380703|Baylor College of Medicine|Mark Kunik, MD, MPH, Primary Investigator|713-794-8639|mkunik@bcm.edu|
20511078|NCT04490499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511079|NCT00245635|Montefiore Medical Center, Albert Einstein College of Medicine|Eric Hollander, MD|7189204287|eholland@montefiore.org|
20511080|NCT01843933|Yale University|Melissa Langhan|2037377413|melissa.langhan@yale.edu|
20511081|NCT01373294|H. Lee Moffitt Cancer Center and Research Institute|Dr. Mayer Fishman|813-745-8311|mayer.fishman@moffitt.org|
20511082|NCT02694562|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
20511083|NCT00807768|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
20511084|NCT01522391|Pergamum AB|Margit Mahlapuu PhD, Assoc. Prof. in Molecular Medicine|+46 70 631 01 09|margit.mahlapuu@pergamum.com|
20511085|NCT00758420|BTG International Inc.|David Wright MBBS|610-943-3538|david.wright@btgplc.com|
20511086|NCT01835964|University of Virginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20511087|NCT00877929|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511088|NCT00554229|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20511089|NCT01140646|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
20559413|NCT00594932|Oklahoma Medical Research Foundation|Joan T Merrill M.D.|405 271 7805|joan-merrill@omrf.org|
20511090|NCT03006276|BioDelivery Sciences|Todd Kunkel, PharmD Director, Scientific Communications|913-940-1789|tkunkel@bdsi.com|
20559414|NCT01536145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511091|NCT04126187|Gainesville Eye Associates|Clayton Blehm, MD|17705324444|claytonblehm@gmail.com|
20511092|NCT03245372|Hospital Universitario Virgen del Rocío, Servicio Andaluz de Salud|Dr. Alejandro Domínguez-Blanco|0034660762856|aledguez@gmail.com|
20511093|NCT02155725|LFB Biomédicaments|Medical Director France|33 169827229|zitounis@lfb.fr|
20511094|NCT00784836|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
20511095|NCT02720627|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20511096|NCT03815006|Manchester University NHS Foundation Trust|Dr Lala Leelarathna|01612766706|lalantha.leelarathna@manchester.ac.uk|
20511097|NCT02612194|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20511098|NCT02539160|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
20511099|NCT01681004|SI-BONE, Inc.|Daniel Cher, Vice President of Clinical Affairs|408-207-0700|dcher@si-bone.com|
20511100|NCT00372905|Northwestern University|Jane Winter, MD|312 695 4033|Jwinter@nm.org|
20511101|NCT01148836|Cleveland Clinic|Jacqueline Sharp, CNP|216-636-0000|pylej@ccf.org|
20511102|NCT00434876|Philadelphia VAMC|Subhajit Chakravorty|215-823-5800|Subhajit.Chakravorty@va.gov|3405
20511103|NCT01922336|Samsung Bioepis Co., Ltd.|Director of Clinical Trials|+82 31 8061 4534|sbregistry@samsung.com|
20511104|NCT03539900|Yale University|Dr Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
20511105|NCT03726320|NYU Langone Health|Danil Makarov|212-263-4961|Danil.Makarov@nyulangone.org|
20511106|NCT02679560|UC Davis|Dr. Ian Brown|(916)734-1279|iebrown@ucdavis.edu|
20511107|NCT01684930|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
20559415|NCT02444234|University of Southern California|Paul M Beringer, Pharm.D.|323-442-1402|beringer@usc.edu|
20559416|NCT01183650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20511108|NCT00337935|Centocor Ortho-Biotech LLC.|Vice President, Medical Affairs|800.457.6399||
20511109|NCT01884675|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511110|NCT02361307|Mahidol University|Piyapat Dajpratham|6624197508|piyapat.daj@mahidol.ac.th|
20511111|NCT00329433|Washington University School of Medicine|Michael S. Avidan, MBBCh|314-747-4155|avidanm@wustl.edu|
20511112|NCT01336647|Hatchtech Pty Ltd|Clinical Manager|+61 3 9092 0490|tahveninen@hatchtech.com.au|
20559417|NCT00088205|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20559418|NCT05199233|Mayo Clinic Rochester|Dr. Ivana T. Croghan|507 284-2511|gimresearchstudies@mayo.edu|
20559419|NCT00736073|DUMC|Dr. Martin Poleski|9196841817|martin.poleski@dm.duke.edu|
20505422|NCT03823937|Sultan.abdulhamid|Tugbaozsoy|+905074583382|tugbaozsoyy@gmail.com|
20505423|NCT01228071|Endo Pharmaceutical, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20505424|NCT03463265|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
20505425|NCT05057988|Stanford University|Dr. Dokyoung Sophia You|650-724-9320|dsyou@stanford.edu|
20505426|NCT02385123|Emory University|Rafi Ahmed, PhD|404-727-3571|rahmed@emory.edu|
20505427|NCT02057237|Princess Margaret Cancer Centre|Dr. Anthony Joshua|416-946-4501|anthony.joshua@uhn.ca|2520
20505428|NCT04230486|Wake Forest School of Medicine|Huai Jiang, PhD|336-695-6460|jianghuai.ws@gmail.com|
20505429|NCT03215264|University of Pennsylvania/ Abramson Cancer Center|Thomas Karasic, MD|2156141858|thomas.karasic@pennmedicine.upenn.edu|
20505430|NCT01397071|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
20505431|NCT02145156|University of Colorado Denver|Julie A. Maertens|303-724-7319|julie.maertens@ucdenver.edu|
20505432|NCT02615535|Spaulding Rehabilitation Hospital|Dr. Ginger Polich|617 952 5000|ginger.polich@mgh.harvard.edu|
20505433|NCT01740440|BioMedical Research Ltd|Gary Rainsford|0035391774361|grainsford@bmr.ie|
20505434|NCT02417233|University of California San Francisco|Dr. Sheri Lippman|415-476-6319|sheri.lippman@ucsf.edu|
20505435|NCT02409784|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20505436|NCT01063751|Stryker - Joint Replacement|Filesha Haniff / Clinical Study Manager|1 470.528.9214|filesha.haniff@stryker.com|
20505437|NCT00614666|University of Arizona|Dr. John Galgiani|(520) 626-4968|spherule@email.arizona.edu|
20505438|NCT01600131|Veterans Health Administration|Constance Uphold|352-548-6000|connie.uphold@va.gov|106893
20505439|NCT01264965|University of Chicago|Theodore Karrison|773-702-9326|karr@health.bsd.uchicago.edu|
20505440|NCT02519244|The University of Texas Health Science Center at Houston|Shuo-Hsiu Chang, PT, PhD|713-799-7016|shuo-hsiu.chang@uth.tmc.edu|
20505441|NCT02221739|Weill Cornell Medical College|Silvia Formenti, M.D.|646-962-4065|formenti@med.cornell.edu|
20505442|NCT02487745|Johns Hopkins University School of Medicine|Kenneth Silverman|4105502694|ksilverm@jhmi.edu|
20511113|NCT01004822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511114|NCT01858701|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20511115|NCT00187655|UCSF|Richard Castro, MD|4155144363|Rich.Castro@ucsf.edu|
20528450|NCT00587795|Mayo Clinic|Dr. David Dennison|507-284-7405|Dennison.David@mayo.edu|
20559420|NCT02563834|Indiana University|Dr. Kieren J Mather|317-278-7826|kmather@iu.edu|
20511116|NCT00953849|Ralph H. Johnson VA Medical Center, Charleston, SC|M. Rita I. Young, Ph.D.|843-792-9953|rita.young@va.gov|
20511117|NCT01115166|Department of Anaestesilogy and Intensive Care|Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
20511118|NCT01801475|Stanford University|Dr. David R Drover|6507250364|ddrover@stanford.edu|
20511119|NCT01786707|University of Miami School of Medicine|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
20511120|NCT00421928|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20511121|NCT00444028|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20511122|NCT02138227|Temple University|Dr. Laura Siminoff|(215) 204-8726|lasiminoff@temple.edu|
20511123|NCT00346476|Desmond Tutu HIV Centre|Prof LG Bekker|+27216506966|Linda-Gail.Bekker@hiv-research.org.za|
20511124|NCT01881867|Cancer Immunotherapy Trials Network|CITN Director|206-667-4141|mcheever@fredhutch.org|
20511125|NCT04156802|Wake Forest University School of Medicine|Merideth Addicott, PhD|336-716-7792|maddicot@wakehealth.edu|
20511126|NCT04120116|Frequency Therapeutics|Director of Clinical Trials|781-315-4600|clinicaltrialsinformation@frequencytx.com|
20511127|NCT00965458|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20511128|NCT02223637|GlaxoSmithKline|GSK Response Center|866-435-7343|geetha.x.kamath@gsk.com|
20511129|NCT00692198|Johns Hopkins Bloomberg School of Public Health|James Tonascia, PhD|410-955-8175|jtonasc1@jhu.edu|
20559421|NCT00688259|VA Greater Los Angeles Healthcare System at West Los Angeles|Shirley M. Glynn, Ph.D.|3102683939|shirley.glynn@va.gov|
20559422|NCT03657264|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
20511130|NCT00594958|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
20511131|NCT03233009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20511132|NCT02181634|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|pcata@jimmy.harvard.edu|
20511133|NCT00134563|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
20511134|NCT03382639|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20511135|NCT00987558|Bial - Portela & Cª, S.A.|Head of Clinical Research||jose.rocha@bial.com|
20511136|NCT01072175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20511137|NCT00682539|Department of Ophthalmology, Medical University Vienna|Dr. Katharina Kriechbaum|00431 40400 79480|katharina.kriechbaum@meduniwien.ac.at|
20511138|NCT02257970|Stanford University, School of Medicine|Dr. Stanley Rockson|650-725-7571|rockson@stanford.edu|
20511139|NCT02477215|Medical College of Wisconsin|Parameswaran Hari|414-805-4600|phari@mcw.edu|
20511140|NCT00285857|Stanford University|James M. Ford|(650) 498-6689|jmf@stanford.edu|
20511141|NCT02546193|Mayo Clinic|VanessaTorbenson, M.D.|507-266-9873|torbenson.vanessa@mayo.edu|
20511142|NCT02545270|Department of Anesthesiology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev Denmark|MD. G. G. Nervil||gustavnervil@gmail.com|
20511143|NCT02206776|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|650-723-4095|ocdresearch@stanford.edu|
20511144|NCT04738123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20511145|NCT04051320|University of North Carolina at Chapel Hill|Crystal Schiller, PhD|919-966-5243|crystal_schiller@med.unc.edu|
20511146|NCT00486720|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20511147|NCT00286234|Sanford School of Medicine, University of South Dakota|Dr. William Harris|16052716917|bill@omegaquant.com|2
20511148|NCT01205399|C. R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
20511149|NCT00302731|University of Kansas Medical Center|Jeanne A Drisko, MD, CNS, FACN|913-588-6208|jdrisko@kumc.edu|
20511150|NCT01000311|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20511151|NCT02780869|Biom'up|Rachel Hoffman, Vice President Clinical Operations North America|404-702-9253|r.hoffman@biomup.com|
20511152|NCT01610752|Pennington Biomedical Research Center|Dr. Leanne M. Redman|2257630947|leanne.redman@pbrc.edu|
20511153|NCT00283062|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20511154|NCT01468844|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
20511155|NCT04745065|Pro-Change Behavior Systems, Inc.|Kerry E. Evers|401-360-2980|kevers@prochange.com|
20511156|NCT01535638|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511157|NCT00819052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511158|NCT03524664|Mt. Hope Family Center, University of Rochester|Dr. Christie Petrenko|(585) 275-2991|christie_petrenko@urmc.rochester.edu|241
20511159|NCT01482598|Abbott|Alessandra Denaro, Sr. Director Clinical Site Management||alessandra.denaro@abbott.com|
20511160|NCT00423267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20511161|NCT03702166|UT Health San Antonio|John Moring, PhD|(210) 562-6716|moringj@uthscsa.edu|
20511162|NCT00827112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511163|NCT01333865|Massachusetts General Hospital|Gagan Joshi, MD|617-724-2344|joshi.gagan@mgh.harvard.edu|
20511164|NCT00515021|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
20511165|NCT02218424|Ann & Robert H. Lurie Children's Hospital of Chicago|Hubert Benzon, MD; Primary Investigator|312-227-5122|hbenzon@luriechildrens.org|
20511166|NCT02613910|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559423|NCT05126459|Loma Linda University Health|Dr. Jung-Wei Chen|909 558 1000|JWChen@llu.edu|
20559424|NCT00065468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559425|NCT01058863|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20511167|NCT00490477|University of Turin, Italy|V. M. Ranieri, MD|00390116334001|marco.ranieri@unito.it|
20511168|NCT02028182|Allerderm(dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smarthealth.com|
20511169|NCT01519648|National Hematological Society|Professor Galina A Klyasova|+7(495)6125181|klyasova.g@blood.ru|
20511170|NCT01277757|University of Texas (UT) MD Anderson Cancer Center|Funda Meric-Bernstam, MD/Chair, Investigational Cancer Therapeutics|713-563-4347|fmeric@mdanderson.org|
20511171|NCT03808298|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20511172|NCT02022566|Lunds university|Physical therapist Therese Jönsson|0046703360721|therese.jonsson@med.lu.se|
20511173|NCT02946515|University of Minnesota - Division of Epidemiology and Community Health|Dr. Nancy E. Sherwood, Associate Professor|612-625-4567|sherw005@umn.edu|
20511174|NCT02818582|National Institute of Allergy and Infectious Diseases|Higgs, Elizabeth|+1 301 768 3947|ehiggs@niaid.nih.gov|
20511175|NCT02196025|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
20511176|NCT00564876|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
20511177|NCT03039686|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20511178|NCT02528331|Duke University|Richard Weiner, MD, PhD|919-681-8742|weine002@duke.edu|
20511179|NCT02392078|Monteris Medical|Christa Seligman|(952) 463-7747|cseligman@monteris.com|
20511180|NCT02079077|University of Manitoba|Keith Fowke|204-789-3296|keith.fowke@umanitoba.ca|
20511181|NCT02843282|University of Texas at Dallas, Center for BrainHealth|Erin Venza, Research Clinician|972-883-3208|erin.venza@utdallas.edu|
20511182|NCT05981443|University of Kentucky|Dr. Cody Blanchard|859-323-5867|cody.blanchard@uky.edu|
20511183|NCT00224952|The Children's Mercy Hospital|J. Steven Leeder Pharm D, PhD|816-234-3059|sleeder@cmh.edu|
20511184|NCT02087085|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20511185|NCT00635804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511186|NCT02680158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20511187|NCT03734601|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
20511188|NCT01425268|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|9003
20511189|NCT00719706|McLean Hospital|Dr. Brian Brennan|617-855-2911|bbrennan@partners.org|
20511190|NCT02681094|AstraZeneca|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20511191|NCT00508872|UT MD Anderson Cancer Center|Eddie Abdalla, MD/Assistant Professor|713-792-6940||
20511192|NCT03927209|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511193|NCT02210559|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-069Study@fibrogen.com|
20511194|NCT00310440|Nor Consult, LLC|Lead Clinical Research Associate|2066076861|p15@nor-consult.com|
20511195|NCT00792467|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
20511196|NCT01256424|Photocure|Vice President Research and Development|+47 22062210|ifh@photocure.no|
20511197|NCT01287403|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, MD, PhD|+41217858054|maurice.beaumont@rdls.nestle.com|
20511198|NCT00148109|University of Michigan Comprehensive Cancer Center|Dr. Rashmi Chugh|(734) 936-5710|rashmim@umich.edu|
20511199|NCT01098266|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
20511200|NCT04871451|AEON Biopharma, Inc.|Dana Testa, PharmD|949-354-6499|dt@aeonbiopharma.com|
20511201|NCT00438815|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20511202|NCT01733758|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511203|NCT02547064|Keimyung university|Hyun-Chang Kim|+821028862876|onidori1979@gmail.com|
20511204|NCT02357394|University of Kansas Health System, Dept of OBGYN|Dr. Gene Lee|9135886201|glee@kumc.edu|
20511205|NCT04594213|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20511206|NCT03814499|Fondazione Telethon|Head of Clinical Development and Operations|+3902202217224|szancan@telethon.it|
20511207|NCT03764813|Fondazione Policlinico Gemelli IRCCS|luciana teofilili medical director of the UNICATT cord blood bank|39 06 30154180|luciana.teofili@unicatt.it|
20511208|NCT00408408|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
20511209|NCT02898662|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20511210|NCT00917553|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
20511211|NCT01616173|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale MD|312-695-3045|ryrahangdale@hotmail.com|
20511212|NCT01905241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
20511213|NCT03172026|University of California Los Angeles|Dr. Bruce H. Dobkin|310-206-6500|BDobkin@mednet.ucla.edu|
20511214|NCT04680273|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20511215|NCT04168775|University of North Carolina at Chapel Hill|Michael B. Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
20511216|NCT01177943|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20511217|NCT02109731|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
20511218|NCT00779142|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skurup@wakehealth.edu|
20511219|NCT04652245|Meda Pharma GmbH & Co. KG (A Viatris Company)|Christine Kolb|+496172888|christine.kolb@viatris.com|2511
20511220|NCT00967473|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
20511221|NCT02816255|Weill Cornell Medicine|Matthew R. Ebben, Ph.D.|646-962-9313|mae2001@med.cornell.edu|
20511222|NCT00026559|National Institute of Mental Health|Pao, Maryland|+1 301 435 5770|paom@mail.nih.gov|
20528451|NCT00540644|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
20511223|NCT04047472|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20528452|NCT01869777|Wake Forest University Health Sciences|Principal investigator|336-716-5440|tpardee@wakehealth.edu|
20559426|NCT03653416|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
20559427|NCT00549822|Massachusetts General Hospital|Dr. Paul Goss|617-724-3118|pgoss@mgh.harvard.edu|
20559428|NCT00570258|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
20559429|NCT02682563|AmsterdamUMC|Erik van Bommel|+31 20 444 2264|e.vanbommel@amsterdamumc.nl|
20559430|NCT03050398|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20559431|NCT01083160|Abbott|Global Medical Services|1-800-633-9110||
20559432|NCT01951092|Alpert Medical School of Brown University/The Miriam Hospital|Aadia Rana, MD|401-793-4680|arana@lifespan.org|
20559433|NCT00918749|Warner Chilcott|Grexan Wulff, Manager, Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20559434|NCT01708187|Orthopedic Foot and Ankle Center|Gregory Berlet, MD|614-895-8747|ofacresearch@orthofootankle.com|
20559435|NCT03018106|Emory University|Gina Northington, MD|(404) 778-5770|gina.northington@emory.edu|
20559436|NCT00136916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20559437|NCT01991197|Clinical Research Centre, St Vincent's University Hospital, Dublin, Ireland|Dr Maeve Lynch||maeve.lynch2@hse.ie|
20559438|NCT00195715|Abbott|Global Medical Services|1-800-633-9110||
20559439|NCT03844321|Massachusetts General Hospital|Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
20559440|NCT03421496|Radius Health|Bruce Mitlak, MD; Head of Discovery Science and Chief Medical Officer|617-444-1943|bmitlak@radiuspharm.com|
20559441|NCT05822921|Virginia Tech|Dr. Angela Scarpa|540-231-2615|ascarpa@vt.edu|
20559442|NCT00544544|McLean Hospital|Brian P. Brennan, M.D.|617-855-2911|bbrennan@partners.org|
20559443|NCT03277378|Abbott|Robyn Capobianco, PhD|+1 512 286 4274|robyn.capobianco@abbott.com|
20528453|NCT02072941|University of California San Francisco|Dr. Rebecca Sudore|(415) 221-4810|rebecca.sudore@ucsf.edu|23475
20559444|NCT02397265|Imperial College London|Nick Oliver|020 7594 2460|nick.oliver@imperial.ac.uk|
20559445|NCT02036515|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559446|NCT01823614|Central Research Institute for Epidemiology|Dmitry Kireev|+74959749646|dmitry.kireev@pcr.ru|2227
20559447|NCT01671748|Cardiff and Vale University Health Board|Dr Judith White|02920744771|judith.white3@wales.nhs.uk|
20559448|NCT02601937|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
20528454|NCT02982863|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559449|NCT04145349|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20528455|NCT03549598|Mayo Clinic|John P. Bois, M.D.|507-284-3545|Bois.John@mayo.edu|
20528456|NCT04167189|PhenoSolve|Lynn Feldman|617-879-1670|lynn@phenosolve.com|
20528457|NCT02869893|Cincinnati Children's Hospital Medical Center|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
20528458|NCT03066778|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20528459|NCT02681458|Islamic Azad University of Mashhad|Dr. Hassan Yazdanfar|00985136631004|hasanyazdanfar@yahoo.com|
20528460|NCT03021317|University of Chicago|Sr. Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
20528461|NCT01765569|Organization: Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20528462|NCT00423813|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
20528463|NCT01386944|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
20528464|NCT03883477|Cedars-Sinai Medical Center, Department of Orthopedic Surgery|Clinical Trial RN|3104235900|rodriquezsv@csmns.org|
20559450|NCT06437626|Pharmasoft|Meshcherskiy Y.E., Medical director|+ 7 (495) 626-47-55|pharmasoft@pharmasoft.ru|140
20559451|NCT03367962|Stanford University|Dr. Robert Negrin|6507230822|negrs@stanford.edu|
20505443|NCT00406315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20505444|NCT02844582|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20505445|NCT03799718|Brainstorm Cell therapeutics|Chief Medical Officer|201-488-0460|Clinical.Trial@brainstorm-cell.com|
20505446|NCT00321984|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20505447|NCT01469013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505448|NCT00076219|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Paul M. Palevsky MD|410-360-3932|paul.palevsky@va.gov|
20505449|NCT05232097|Helsinki University Hospital|Dr. Jari Punkkinen|+358 50 427 9864|jari.punkkinen@hus.fi|
20505450|NCT00871858|Institut Bergonié, Medical Oncology department|Dr. Nathalie Quenel-Tueux|05.56.33.33.33|N.Quenel-Tueux@bordeaux.unicancer.fr|
20505451|NCT02553915|Massachusetts General Hospital|Dr David Mischoulon, Director, Depression Clinical and Research Program, MGH|617-724-5198|dmischoulon@mgh.harvard.edu|
20505452|NCT00700752|Vistakon|Kurt Moody OD|904-443-3088||
20505453|NCT03303339|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
20505454|NCT01426386|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20505455|NCT01858428|Spectranetics|Julie Wolfram Smith|763-955-1072|julie.wolframsmith@spnc.com|
20505456|NCT01206595|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20505457|NCT02116972|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20505458|NCT01879618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505459|NCT01137435|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20505460|NCT03531957|Asana BioSciencxes, LLC|Pablo Jimenez|9086980782|pablo.jimenez@asanabio.com|
20505461|NCT02679066|Johns Hopkins Bayview|Erik Hasenboehler MD|4105504190|ehasenb1@jhmi.edu|
20505462|NCT01416610|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20559452|NCT03595683|University of Chicago|Dr. Randy Sweis|773-834-3094|rsweis@uchicago.edu|
20511224|NCT01016912|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
20511225|NCT00496782|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20511226|NCT01288911|Astellas Pharma Global Development, Inc. (APGD)|Executive Medical Director||Astellas.resultsdisclosure@astellas.com|
20511227|NCT02431559|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20511228|NCT02452892|Tal Medical|Dr. Atul Pande, MD, Chief Medical Officer||apande@talmedical.com|
20511229|NCT03820388|University of California Davis|Dr. Hong Liu|916-734-5031|hualiu@ucdavis.edu|
20511230|NCT00955682|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511231|NCT00469391|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
20511232|NCT01680835|Medtronic|Jennifer Seamans, M.S., Clinical Research Program Manager|763-398-7455|jennifer.l.seamans@medtronic.com|
20511233|NCT01294319|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Dr. Lynnette Nieman|301-496-4000|niemanl@mail.nih.gov|
20511234|NCT03279731|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
20511235|NCT01135368|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20511236|NCT00252499|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kristina.utzschneider@va.gov|
20511237|NCT01365468|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20511238|NCT01861587|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
20559453|NCT04569058|Massachusetts General Hospital|T. Atilla Ceranoglu, MD|617-726-1291|aceranoglu@mgh.harvard.edu|
20559454|NCT05675709|Oregon Health & Science University|Susan Flocke|503 494 4404|fmresrch@ohsu.edu|
20559455|NCT02307916|Massachusetts Eye and Ear|Dr. Brad Welling|617-573-4075|brad_welling@meei.harvard.edu|
20559456|NCT05876351|European Clinical Trial Information|Alexion Pharmaceuticals Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20559457|NCT04168385|Mirum Pharmaceuticals, Inc.|Mirum Clinical Trials|16506674085|medinfo@mirumpharma.com|
20511239|NCT01002573|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
20511240|NCT00617994|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
20511241|NCT00690612|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20511242|NCT02926833|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
20511243|NCT05040295|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511244|NCT01559649|Michael E. DeBakey VA Medical Center|Stephanie Daniels|713-743-2570|skdaniels@uh.edu|
20511245|NCT00346775|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511246|NCT01054209|Brighton and Sussex University Hospitals Trust|Dr Mark Harper|01273696955|mark.harper@bsuh.nhs.uk|4307
20511247|NCT01096017|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20559458|NCT03207711|University of California, San Francisco|Frederick Hecht, MD|(415) 353-9743|rick.hecht@ucsf.edu|
20511248|NCT02600559|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20511249|NCT00953576|Beth Israel Deaconess Medical Center|Glenn Bubley, MD||gbubley@bidmc.harvard.edu|
20511250|NCT02965027|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
20511251|NCT00665366|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20511252|NCT02582216|Hôpital Erasme|Dominique Mouraux|+32/2.555.38.48|dmouraux@ulb.ac.be|
20511253|NCT01545375|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511254|NCT04177862|University of Minnesota|Dr. Jonah Pearson|218-280-8348|pears731@umn.edu|1
20511255|NCT05637515|Biocon Biologics Limited|Sarika S Deodhar|0802808|Sarika.Deodhar@biocon.com|5302
20511256|NCT04516291|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511257|NCT02158949|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
20511258|NCT04250558|Dartmouth Hitchcock Medical Center|Dr. Ida Leah Gitajn|(603) 650-5133|ida.leah.gitajn@hitchcock.org|
20511259|NCT04812678|FasciaFrance|Dr Bertrand|+33682308609|isa.bertrand.cerap@gmail.com|
20511260|NCT01793610|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20511261|NCT01513538|Medtronic|Céline This|33 6 89 71 90 67|celine.this@medtronic.com|
20511262|NCT01827462|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20511263|NCT02452320|Weill Cornell Medicine|Farrell Cooke, Senior Research Assistant|212-746-2774|fac2010@med.cornell.edu|
20511264|NCT03737812|AbbVie|Global Medical Services|800-699-9110|abbvieclinicaltrials@abbvie.com|
20511265|NCT02624713|Tel-Hai College|Prof. Moria Golan|972547240330|moria.golan@mail.huji.ac.il|
20511266|NCT01161173|Hoffman-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20511267|NCT02557308|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
20559459|NCT05108649|University of Pennsylvania|Valentina Goren, MRA Project Manager|215-746-3602|vsoup@pennmedicine.upenn.edu|
20559460|NCT03553940|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
20559461|NCT01010217|UT MD Anderson Cancer Center|Dr. Stefan O Ciurea, Associate Profeddor of Stem Cell Transplantation|713-745-0146|sciurea@mdanderson.org|
20559462|NCT04242875|Carolina Eyecare Physicians|Director of Research|8438813937|hsandoval@cepmd.com|
20559463|NCT02501759|OHSU Knight Cancer Institute|Fegus Coakley|503-494-2333|coakleyf@ohsu.edu|
20559464|NCT02213055|The Deirdre Imus Environmental Health Center at HackensackUMC|Project Manager, Environmental Research|551-996-8071|dimuscenter@hackensackumc.org|
20511268|NCT03911401|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20511269|NCT01811004|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20511270|NCT06104423|A.MENARINI I.F.R SrL|Simone Baldini Global Clinical Operations Manager|055 56801|sbaldini@menarini.it|
20559465|NCT00231894|Nathan Kline Institute ofr Psychiatric research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
20559466|NCT03190083|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nidhi Sharma|+1 216-444-9014|sharman2@ccf.org|
20559467|NCT02025205|Pulmonx|Narinder Shargill, Vice President, Global Medical and Clinical Affairs|650-216-0108|nshargill@pulmonx.com|
20559468|NCT04675242|Nicox Ophthalmics, Inc.|Doug Hubatsch|832-360-3022|hubatsch@nicox.com|
20559469|NCT03260504|University of Washington|Scott Tykodi, MD, PhD|206-606-7763|stykodi@fredhutch.org|
20559470|NCT00846742|St. Jude Children's Research Hospital|Matt Ehrhardt, MD, MS|(901) 595-5913|matt.ehrhardt@stjude.org|
20559471|NCT03542175|Memorial Sloan Kettering Cancer Center|Dr. Atif Khan, MD|848-225-6334|khana7@mskcc.org|
20559472|NCT05868954|Wake Forest University Health Sciences|Julio Mateus Nino, MD, PhD|704-355-8248|julio.mateusnino@advocatehealth.org|
20559473|NCT03051997|Medcial University of South Carolina|Professor|843-876-1840|cunninpb@musc.edu|
20559474|NCT01435798|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
20559475|NCT01586000|Premier Research|Kimberly Myer, Sr. Program Director, NIH|984-238-1297|Kimberly.Myer@premier-research.com|
20559476|NCT01570868|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20559477|NCT04936308|Janssen Research & Development, LLC|Senior Medical Leader PEDIATRICS IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20559478|NCT02611830|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20559479|NCT02275533|University of Chicago|Theodore Karrison|708-925-6771|tkarrison@health.bsd.uchicago.edu|
20559480|NCT03370276|Moffitt Cancer Center|Christine Chung, MD|813-745-5061|Christine.Chung@moffitt.org|
20559481|NCT03500172|Johns Hopkins Bloomberg School of Public Health|Dr. Stefan Baral|4105028975|sbaral@jhu.edu|
20559482|NCT05480722|University of Delaware|William B Farquhar|302-831-6168|wbf@udel.edu|
20559483|NCT04759885|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
20559484|NCT05294419|Genomics Ltd|Seamus Harrison|+44 1865 981600|seamus.harrison@genomics.com|
20559485|NCT04684914|Altimmune|Randy Brown|3179003335|rbrown@altimmune.com|
20559486|NCT02218203|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
20559487|NCT04471792|Kansas State University|Dr. Judy Delp|3522269535|mullerdelp@vet.k-state.edu|
20559488|NCT03997851|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
20559489|NCT07083843|OmanMOH|Amal Salim AlSahi|96103040|amalalsahi@gmail.com|968
20559490|NCT04007796|San Francisco VA Health Care System|Dr. Liz Goldstein|415-694-3443|lizabeth.goldstein2@va.gov|
20559491|NCT04988477|Hennepin Healthcare Research Institute|Dr. Sandra Japuntich|6128736856|sandra.japuntich@hcmed.org|
20559492|NCT05089656|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20559493|NCT04191135|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559494|NCT05161689|Mahidol University Faculty of Social Sciences and Humanities|Chair of the Institutional Review Board|+662-441-9180|mussirb310@gmail.com|
20559495|NCT03038672|Mayo Clinic|Stephen Ansell|(507)284-5096|ansell.stephen@mayo.edu|
20559496|NCT04423393|Vir Biotechnology, Inc.|Study Inquiry|(415) 906-4324|clinicaltrials@vir.bio|
20511271|NCT02918968|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20511272|NCT05602818|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20511273|NCT00727246|University of Pittsburgh|Patricia M Arenth PhD|412-648-6666|arenpm@upmc.edu|
20511274|NCT00538434|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
20511275|NCT00351611|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511276|NCT01589185|Aridis Pharmaceuticals, Inc.|Lynne Deans, M.T.|408-385-1742|deansl@aridispharma.com|
20511277|NCT02046993|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
20528465|NCT01658904|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
20528466|NCT00531947|Mylan Specialty L.P.|Kim Portland, Ph.D.|908.542.2636|kimberly.portland@mylan.com|
20559497|NCT05220501|Sunnybrook Health Sciences Centre|Dr. Laurence Klotz|+1. 416 480 4673|Laurence.Klotz@sunnybrook.ca|
20559498|NCT02692235|AWFiS|Robert Olek|+48 58 5547392|robol@awf.gda.pl|
20559499|NCT05160025|Rutgers University|Dr. John Palmieri, Study Coordinator|9733562378|john.palmieri@rutgers.edu|
20559500|NCT01929993|Fundação Oswaldo Cruz|Dr Fábio Russomano|55 21 25541815|fabiorussomano@gmail.com|
20559501|NCT00107380|SWOG Statistical Center|Study Statistician|206-667-4623||
20559502|NCT03673098|Massachusetts General Hospital|Dr. Christina Psaros|617-726-7458|cpsaros@mgh.harvard.edu|
20559503|NCT01268059|MedImmune, LLC|Mohammed Dar, MD, Vice President & Head, Clinical Development, Oncology|+1 301-398-0000|information.center@astrazeneca.com|
20559504|NCT03660943|Centrexion Therapeutics, Inc.|Director of Clinical Operations|617-837-6911|info@centrexion.com|
20559505|NCT03850444|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559506|NCT01330043|Stanford University|Dr. Sean P. David|401-265-2275|spdavid@stanford.edu|
20559507|NCT00839917|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559508|NCT02472314|Wayne State University School of Medicine and Cleveland Clinic Florida|Vani J. Sabesan, MD|131375138489|sabes001@gmail.com|
20559509|NCT05794997|Brigham and Women's Hospital|Rishi J Desai, PhD|6172780932|rdesai@bwh.harvard.edu|
20559510|NCT01969162|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20559511|NCT02096081|Merz North America, Inc.|Michelle Widmann|919-582-8238|Michelle.Widmann@merz.com|
20511278|NCT00886626|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20559512|NCT00109928|SWOG Statistical Center|Study Statistician|206-667-4623||
20559513|NCT01041508|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20559514|NCT04463615|City of Hope Medical Center|Dr. Christiane Querfeld|6263598111|cquerfeld@coh.org|
20559515|NCT02491892|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20559516|NCT01734850|CSL Behring|Trial Registration Coordinator|484-878-4000|clinicaltrials@cslbehring.com|
20559517|NCT01405794|University of Utah|Dr. Mark Munger|801-581-6165|mmunger@hsc.utah.edu|
20559518|NCT00661258|Boston University Center for Global Health and Development|Dr. Lora Sabin|617-414-1272|lsabin@bu.edu|
20559519|NCT04496167|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
20559520|NCT03088137|IVFarma LLC|Mikhail Polzikov (PhD)|+74996455342|mikhail.polzikov@ivfarma.ru|1
20559521|NCT00598481|Fondazione Telethon|Fondazione Telethon||cvezzali@telethon.it|
20559522|NCT04612049|University of Montreal|Dr Danielle Levac|5148639108|danielle.levac@umontreal.ca|
20559523|NCT01712789|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20559524|NCT02408549|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20559525|NCT01833117|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20559526|NCT01024751|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.reindel@bausch.com|
20559527|NCT02448719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20559528|NCT01232556|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559529|NCT00955903|Wake Forest School of Medicine|Jamy Ard, MD|3367169837|jard@wakehealth.edu|
20559530|NCT03020095|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
20559531|NCT04033991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559532|NCT01603121|Eastern Virginia Medical School|Dr. David Lieb, Principal Investigator|7574465910|liebdc@evms.edu|
20559533|NCT00577720|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20559534|NCT02410161|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20559535|NCT01628510|Washington University|Roberta Pineda|314-286-1304|pineda_r@kids.wustl.edu|
20559536|NCT04707391|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20559537|NCT04374565|University of Virginia|Dr. Jeffrey Sturek|434-284-1776|JMS3HK@hscmail.mcc.virginia.edu|
20559538|NCT03246672|William S Middleton Memorial Veterans Hospital|Dr. Corrine Voils|608-262-9636|corrine.voils@va.gov|
20559539|NCT01932996|University of Minnesota|Rebekah Pratt|612-625-1196|rjpratt@umn.edu|
20559540|NCT02923895|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20559541|NCT03983993|Emory University|Olatunji Alese|404-778-6639|olatunji.alese@emory.edu|
20559542|NCT02500316|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20559543|NCT01406717|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
20559544|NCT02040090|Kamada|Eran Schenker, VP Medical Director|+972-8-9406472|Erans@kamada.com|
20559545|NCT03257995|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20559546|NCT02554435|California State Polytechnic University, Pomona|Dr. Zakkoyya Lewis|5628819950|drkoyyalewis@gmail.com|
20559547|NCT01614574|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20559548|NCT02875561|University of Colorado|Dr. Saketh Guntupalli|303-724-2024|saketh.guntupalli@cuanschutz.edu|
20559549|NCT01168674|Tufts Medical Center|Dr. Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
20559550|NCT02584855|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20559551|NCT02337478|Wake Forest University Health Sciences|Timothy Pardee, MD, Ph.D.|336-716-5440|tpardee@wakehealth.edu|
20559552|NCT00895843|University of Manchester|Mr Sin L Yong|01612756806|sin.l.yong@manchester.ac.uk|
20559553|NCT03171168|Montefiore Medical Center|Matthew Bartels|(914) 597-2332|MBARTELS@montefiore.org|
20559554|NCT03786094|Spexis AG|Christian Zwingelstein|+41 61 567 16 00|info@spexisbio.com|
20559555|NCT02906202|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
20559556|NCT03698864|Processa Pharmaceuticals|Mary G. Nyberg, VP Clinical Operations|443-776-3133|mnyberg@processapharmaceuticals.com|
20559557|NCT04131907|Laborie Medical Technologies|Jill Moland|800-522-6743|jmoland@laborie.com|
20559558|NCT00859131|Medical University of South Carolina|Kenneth Chavin, MD, PhD|843-792-3368|chavinkd@musc.edu|
20559559|NCT03428815|University of Pittsburgh|Dr. Goeran Fiedler|14126246475|gfiedler@pitt.edu|
20559560|NCT02404493|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
20559561|NCT01700348|Philips Oral Healthcare, Inc|Marcia Delaurenti, Clinical Project Manager|425-908-1212|marcia.delaurenti@philips.com|
20559562|NCT03958630|National Institute of Mental Health|Innis, Robert|+1 301 594 1368|robert.innis@nih.gov|
20559563|NCT03796013|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20559564|NCT01736358|Montefiore Medical Center|Dr.David Hoenig||dhoenig@montefiore.org|
20559565|NCT04157686|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
20559566|NCT01021878|Pontifícia Universidade Católica do Paraná|Dr. Roberto Pecoits-Filho and Dr. Thyago P. Moraes|554132713150|r.pecoits@pucpr.br|
20559567|NCT01155726|Alcon Research|Director of Clinical Trials|1-800-241-7629||
20511279|NCT05375942|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511280|NCT00598442|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20511281|NCT00457951|Chimerix|Zahra Masoud|763-300-0559|zmasoud@chimerix.com|
20511282|NCT03781167|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20511283|NCT00462501|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
20511284|NCT03740152|Massachusetts General Hospital|Dr. Paolo Cassano, M.D.|617-643-9622|pcassano@mgh.harvard.edu|
20511285|NCT00504595|Novartis Pharmaceuticals|Study Director|862-778-8300||
20511286|NCT05489146|University of Pittsburgh|Amit Sethi, Associate Professor, Department of Occupational Therapy,|4123836619|asethi@pitt.edu|
20511287|NCT05047601|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511288|NCT04834375|Northwell Health|Dr. Stella Hahn|516-465-5400|sthahn@northwell.edu|
20511289|NCT03026556|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511290|NCT02208466|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
20511291|NCT03088345|Medical College of Wisconsin/Children's Hospital of Wisconsin|Dr. Amee Bigelow|5136364200|amee.bigelow@cchmc.org|
20511292|NCT01521494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20511293|NCT00689728|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20511294|NCT00689299|Greer Laboratories, Inc. for Antigen Laboratories, Inc.|Mark Hites|828-759-7548|mhites@greerlabs.com|
20511295|NCT01190839|Janssen Pharmaceuticals|Strategic Lead Gastroenterology||ClinicalTrialDisclosure@its.jnj.com|
20511296|NCT02058966|Veterans Affairs Portland Healthcare System|Dr. William Hoffman|503-220-8262|hoffmanw@ohsu.edu|56491
20511297|NCT00765726|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511298|NCT01265511|Scynexis|Katyna Borroto-Esoda|9192374431|katyna.borroto-esoda@scynexis.com|
20511299|NCT02993731|Sumitomo Dainippon Pharma Oncology|Cindy Oh|617-674-8628|coh@bostonbiomedical.com|
20511300|NCT01362062|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20511301|NCT00758394|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20511302|NCT03461705|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
20511303|NCT01197495|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20511304|NCT00508820|Amgen Inc.|Study Director|866-572-6436||
20511305|NCT02549040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511306|NCT01945866|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
20511307|NCT01674010|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
20511308|NCT03159455|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511309|NCT02713490|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20511310|NCT03427931|University of Virginia|Sue Brown, MD|4349820602|sab2f@virginia.edu|
20511311|NCT00960869|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
20511312|NCT01714726|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20511313|NCT03044691|Unversity of Florida|Assistant Professor|(352) 294-4997|rsalloum@ufl.edu|
20511314|NCT01789476|Cara Therapeutics, Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|(203) 567-1502|fmenzaghi@caratherapeutics.com|
20559568|NCT05305040|AlloVir, Inc.|Kevin Anderson|617-433-2605|kanderson@allovir.com|
20511315|NCT00501969|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20511316|NCT02558634|Vancouver Coastal Health Research Association|Amanda Chisholm, Manager, Internal Awards|6048754111|amanda.chisholm@vch.ca|21696
20511317|NCT03814824|Northwell Health|Dr. Arvind Trindade|516-387-3990|atrindade@northwell.edu|
20511318|NCT00835861|Maternal-Fetal Medicine and Obstetrics at UT Southwestern|M. Ashley Hickman Zink|469-303-3591|m.ashley.hickman@gmail.com|
20511319|NCT00151775|Daiichi Sankyo|Howard Kessler, Senior Director Regulatory Operations|732-590-5032|hmkessler@dsi.com|
20511320|NCT01238861|MedImmune, LLC|Rene van der Merwe, MBChB, MFPM, Medical Officer|301-398-0000|vandermerwer@medimmune.com|
20511321|NCT02145949|University of Oregon|Dr. Hans Dreyer|541-346-3902|hcdreyer@uoregon.edu|
20511322|NCT00761761|Univeristy Of Pittsburgh Medical Center|K.N. Roy Chengappa, MD|412-246-5006|chengappakn@upmc.edu|
20511323|NCT00460421|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
20511324|NCT01097057|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20511325|NCT01270139|Ural Institute of Cardiology|Dr. Alexander Kharlamov|0031627849118|drskharlamov@gmail.com|
20511326|NCT01512758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20511327|NCT03198559|University of Melbourne|Professor Sharon Lewin|+61 (0)3 8344 3309|sharon.lewin@unimelb.edu.au|
20511328|NCT02702115|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
20511329|NCT06304064|Capricor Inc.|Study Director|858-727-1755|mawadalla@capricor.com|
20511330|NCT04337827|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Dr. Deepa Jagadeesh|1-866-223-8100|TaussigResearch@ccf.org|
20511331|NCT01636102|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20511332|NCT05600101|Dana-Farber Cancer Institute|Dr. Gregory Abel|(877) 442-3324|Gregory_Abel@dfci.harvard.edu|
20559569|NCT02054247|Eskisehir Osmangazi University|Dr. Onur Armagan|00902222392979|dronurarmagan@hotmail.com|
20511333|NCT03947333|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
20511334|NCT00267202|Novartis Pharmaceuticals|Clinical Director|862-778-1768|maria.figliomeni@novartis.com|
20559570|NCT01195675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559571|NCT02424344|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20559572|NCT01174550|Duke University Medical Center|Dr. Pamela Douglas|919-668-8700|pamela.douglas@duke.edu|
20559573|NCT01536262|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559574|NCT00412516|PATH|Anthony A Marfin, Director Japanese Encephalitis Vaccine Introduction and Sustainability Project|2062853500|aamarfin@path.org|
20559575|NCT05257837|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
20559576|NCT03639675|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20559577|NCT02459587|Veterans Health Administration|Dr. Mark Ilgen|7349366266|mark.ilgen@va.gov|
20559578|NCT04731714|Washington University School of Medicine|Kevin J. Black, M.D.|314-362-5041|kevin@wustl.edu|
20559579|NCT05343455|Journey Medical Corporation|Dr. Srinivas Sidgiddi|9084585362|ssidgiddi@jmcderm.com|
20559580|NCT03468426|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559581|NCT02139982|The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University|Dr. Ting Li|008613587876896|liting1021@aliyun.com|
20559582|NCT04466618|Mayo Clinic|Dr Adrian Vella|5072843754|vella.adrian@mayo.edu|
20559583|NCT04004208|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20559584|NCT00839982|FCHRC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@seattlecca.org|
20559585|NCT01364727|Stanford University Medical Center|Heather A Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
20559586|NCT00939796|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20559587|NCT01676220|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
20559588|NCT02411591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20559589|NCT04227340|St. Jude Children's Research Hospital|Belinda Mandrell, PhD, RN|(901) 595-4209|belinda.mandrell@stjude.org|
20559590|NCT00445263|SAMU 93|Pr Frédéric Lapostolle|0033148964454|frederic.lapostolle@avc.aphp.fr|
20559591|NCT00750893|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20559592|NCT00788255|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
20559593|NCT01152554|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20559594|NCT02117544|Alcon Research, Ltd|Clinical Project Lead, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20559595|NCT03486899|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20559596|NCT01439711|Duke University Medical Center|E. Shelley Hwang MD MPH|919-684-6849|shelley.hwang@duke.edu|
20559597|NCT02397460|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559598|NCT01767129|Avanir Pharmaceuticals|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
20559599|NCT01146808|Columbia University Medical Center|Robert S. Brown Jr., MD, MPH|(212) 305-3839|tt2103@columbia.edu|
20559600|NCT02225275|The University of Texas MD Anderson Cancer Center|Dr. Alessandra Ferrajoli MD/ Professor|173-792-2063|aferrajo@mdanderson.org|
20559601|NCT00597870|Lundquist Institute of BioMedical Studies|Rodney A. White, MD|3109635230|rawhite@ucla.edu|
20559602|NCT01473420|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559603|NCT00738530|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20559604|NCT01656759|Rush University|Sean Kearns|708-236-2664|sean_m_kearns@rush.edu|
20559605|NCT02329600|Faculty of Oral and Dental Medicine Cairo University|Dr. Noha Ayman Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
20559606|NCT04374500|Umeå University, Umeå, Sweden|Stefan Söderberg|+46 70 319 38 03|stefan.soderberg@umu.se|
20559607|NCT04963062|University of Wisconsin School of Medicine and Public Health|Shuang Li|608.263.8336|lis@urology.wisc.edu|
20559608|NCT01607411|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559609|NCT03262701|Loma Linda University School of Dentistry|Yoon Jeong Kim|(909) 558-4610|yjkim02d2@llu.edu|
20559610|NCT04387162|Atlanta VA Medical Center|Amy Rodriguez|404-321-6111|amy.rodriguez@va.gov|
20559611|NCT03749460|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
20559612|NCT01513967|Regenera Pharma Ltd|Dr Konstatin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
20559613|NCT01987830|Massachusetts General Hospital|Dr. Elizabeth Gerstner|(617) 726-2000|EGERSTNER@mgh.harvard.edu|
20559614|NCT03990363|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20559615|NCT01349660|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
20559616|NCT01706965|New York State Psychiatric Insititute|Marlene Carlson|646-774-8436|marlene.carlson@nyspi.columbia.edu|
20559617|NCT01563978|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44-1625-512415|dave.goldstraw@astrazeneca.com|
20559618|NCT05764239|Synlogic|Clinical Operations|(617) 401-9975|info@synlogictx.com|
20559619|NCT00057811|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20559620|NCT00556374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20559621|NCT00847301|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559622|NCT00996580|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20559623|NCT05708846|vitalera (FollowHealth SL)|Data Scientist of vitalera|+34644499760|dheart@humanitcare.com|
20559624|NCT03621982|ADC Therapeutics|Yvan LeBruchec|+41799110551|Yvan.LeBruchec@adctherapeutics.com|
20559625|NCT00238420|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20511335|NCT00399542|Sucampo Pharmaceuticals, Inc.|Raymond Panas, PhD|301-961-3400|info@sucampo.com|
20559626|NCT00442286|CVRx|Vice President of Clinical Research|763-416-2876|lgalle@cvrx.com|
20511336|NCT00612456|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511337|NCT00808665|Vanderbilt University Medical Center|James Blair DO|615-343-6082|james.l.blair@vanderbilt.edu|
20511338|NCT00334893|Memorial Sloan-Kettering Cancer Center|Dr. Martee L. Hensley|646-888-4222|hensleym@mskcc.org|
20511339|NCT01552408|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
20511340|NCT03223649|National Institutes of Health|Jack A. Yanovski, MD, PhD|3014960858|jy15i@nih.gov|
20511341|NCT02347345|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
20511342|NCT03523390|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20511343|NCT02260791|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|+44 1896 668 173|Clinical-Trials@fk-b.com|
20511344|NCT02924129|Saluda Medical|Angela Leitner|651-208-4223|angela.leitner@saludamedical.com|
20511345|NCT00596622|Indiana University School of Medicine|Amit Anand|3172747422|aanand@iupui.edu|
20511346|NCT02172820|The University of Vermont|Diann Gaalema, Ph.D., PI|802-656-9874|Diann.Gaalema@med.uvm.edu|
20511347|NCT01348828|Endologix|Sripad Bellary, Director Clinical Affairs|9257011628|sbellary@endologix.com|
20511348|NCT04246996|Dell Medical School at The University of Texas at Austin|Mary Rieger, MD, MAS|512-324-7036|mary.rieger@austin.utexas.edu|
20511349|NCT00545974|UCSF Memory and Aging Center|Dr. Adam L. Boxer|4154760668|aboxer@memory.ucsf.edu|
20511350|NCT02442284|AbbVie|Global Medical Services|800-633-9110||
20511351|NCT02815670|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511352|NCT03137173|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
20511353|NCT00842829|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20511354|NCT04047342|Geisinger Clinic|Amir Goren|5702144395|agoren@geisinger.edu|
20511355|NCT00280059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511356|NCT00495794|VA Center for Clinical Management Research; University of Michigan|Dr. Michele Heisler|734-845-3504|mheisler@umich.edu|
20511357|NCT02127931|CogCubed|Monika Roots, MD|6122509737|monika.d.heller@gmail.com|
20511358|NCT01130831|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20511359|NCT00951912|the First Affiliated Hospital of Sun Yat-sen University|Dr. Yan-bin Ye|8620-87755766|yanbinye72@163.com|8179
20511360|NCT01212627|Brown University Oncology Research Group (BrUOG)|Angela Taber, MD|4018633000|kayla_rosati@brown.edu|
20511361|NCT02173158|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
20511362|NCT01377194|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20511363|NCT01728454|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20511364|NCT00387621|Mayo Clinic|Dr Horng Chen|507-284-4343|chen.horng@mayo.edu|
20511365|NCT02980211|University of Iowa College of Dentistry|Dr. Gustavo Avila-Ortiz, Professor and Chair, Department of Periodontics|3193357241|gustavo-avila@uiowa.edu|
20511366|NCT01832753|The Children's Hospital of Philadelphia|Andrea Kelly, MD MSCE|215-590-3174|kellya@email.chop.edu|43174
20511367|NCT03077646|Children's Hospital at Montefiore|Alyssa Silver, MD|718-741-2304|alysilve@montefiore.org|
20511368|NCT00323479|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20511369|NCT03014700|Stanford university School of Medicine|Glyn David Williams|650-723-5728|jumbo@stanford.edu|
20511370|NCT01272245|UT MD Anderson Cancer Center|Kantarjian,Hagop M|713-792-7026|CR_Study_Registration@mdanderson.org|
20511371|NCT04927858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0217|clinicaltriage.rdg@boehringer-ingelheim.com|
20511372|NCT02545504|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20511373|NCT00950755|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511374|NCT01716221|University of Colorado|Dr. Olga Klepitskaya|303-724-8984|olga.klepitskaya@ucdenver.edu|
20511375|NCT01018680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20511376|NCT02930889|University of Minnesota|Jafar Golzarian, MD|612-626-5566|jafar@umn.edu|
20511377|NCT04398030|Capillary BioMedical, Inc.|Alayne Lehman Director of Clinical Affairs|949-317-1711|alayne.lehman@capillarybio.com|
20511378|NCT01206296|MedStar Health Research Institute|Director of Clinical Trials|301-560-7300|Research@MedStar.Net|
20511379|NCT01520038|University of Pennsylvania|John Christodouleas, MD|215-662-6568|christojo@uphs.upenn.edu|
20511380|NCT05056311|Indiana University|Elaine Cuevas|317-278-7495|elinder@iu.edu|
20511381|NCT02641691|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
20511382|NCT03503565|KYUNG HEE UNIVERSITY HOSPITAL AT GANGDONG|Dr Hyungseok Seo|+821029306885|seohyungseok@gmail.com|
20511383|NCT03799198|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20511384|NCT00548340|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
20511385|NCT01710007|Orient Europharma Co., Ltd.|Vivian Lu|+886-2-2755-4881|Vivian.Lu@oppharma.com|2958
20511386|NCT01153971|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20511387|NCT03410693|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20511388|NCT03628781|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|15136368296|jeff.epstein@cchmc.org|
20511389|NCT00994123|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20511390|NCT03778021|University of Washington, Department of Epidemiology|Shirley A.A. Beresford, Principal Investigator|206 543 9512|beresfrd@uw.edu|
20511391|NCT02687815|University of Pittsburgh|Dr. Juan Celedón|(412) 692-8429|juan.celedon@chp.edu|
20559627|NCT00641186|Baylor College of Medicine|Christine Hunter|713-798-3951|chunter@bcm.edu|
20511392|NCT01778296|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
20559628|NCT02922985|University of Texas Medical Branch|Emily Hadley|4022028626|ehadley15@gmail.com|
20559629|NCT05221749|Alexandria University|Nour Ammar|4868066|nour.ammar@alexu.edu.eg|201
20559630|NCT02218489|Kala Pharmaceuticals, Inc|VP, Clinical Development|781-996-5252|Results003@kalarx.com|
20559631|NCT04140890|Wayne State University|Dr. Yi-Ling Hu|3142039991|ha1124@wayne.edu|
20559632|NCT01053637|BAYLOR COLLEGE OF MEDICINE|Corrie E. Chumpitazi|832 824-1353|corriec@bcm.edu|
20559633|NCT02102464|TearScience, Inc.|VP Clinical and Regulatory Affairs|919-467-4007|regulatory@tearscience.com|
20559634|NCT02388074|bioAffinity Technologies Inc.|Bijal Karia, PhD Director of Research|2107485287|bk@bioaffinitytech.com|
20559635|NCT00915902|Nemours Alfred I. duPont Hospital for Children|Research Coordinator|302-651-6686|cprosper@nemours.org|
20559636|NCT01778062|Novartis Pharmaceuticals|Study Director|862-778-8300||
20559637|NCT00950937|Hospital de Clínicas de Porto Alegre|Pedro Dall'Ago|555133038751|pdallago@pq.cnpq.br|
20559638|NCT01824472|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
20559639|NCT04039503|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20559640|NCT01815736|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20559641|NCT02413684|Duke Asthma, Airway and Allergy Center|Njira Lugogo|919-613-5707|njira.lugogo@duke.edu|
20559642|NCT04436796|Sansum Diabetes Research Institute|Jordan Pinsker|805-682-7640|jpinsker@sansum.org|
20559643|NCT03387514|UW School of Medicine and Public Health|Steve Cho, MD|608-263-5585|cho85@wisc.edu|
20559644|NCT04701593|Virginia Tech|Dr Vishak John|(540) 855-5100|vishakjohn@vt.edu|
20559645|NCT00462644|Wake Forest University, Department of Surgery|Amy N. Hildreth, MD||ahildret@gmail.com|
20559646|NCT03040687|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
20559647|NCT03317379|New York State Psychiatric Institute|Lisa Ranzenhofer, PhD|240 671 9040|lr2840@cumc.columbia.edu|
20559648|NCT02846558|Johns Hopkins Department of Neurology|Dr. Ellen Mowry, M.D., M.C.R.|410-502-0675|emowry1@jhmi.edu|
20559649|NCT04445155|University of South Florida|Dr. Ukamaka Oruche|813-396-2524|orucheu@usf.edu|
20559650|NCT01875861|Central Arkansas Veterans Healthcare System|Dr. Richard Owen|(501) 257-1710|Richard.Owen2@va.gov|
20559651|NCT03363659|Advocate Aurora Health|Manager of Oncology research|414 778 4345|karen.cheek@aah.org|
20559652|NCT03872388|MD Anderson Cancer Center|Carlos Barcenas, MD|(713) 794-5098|chbarcenas@mdanderson.org|
20559653|NCT05516342|Hopeful Aging|Michael Skrajner|4404777881|mike@hopefulaging.com|
20559654|NCT01866475|Teleflex|Tatiana Puga|2104451794|tatiana.puga@teleflex.com|
20559655|NCT01781611|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405-822-2336|joan-merrill@omrf.org|
20559656|NCT05818540|Bleep, LLC|Stuart Heathington|919-619-7170|stuart@bleepsleep.com|
20559657|NCT01477749|Dendreon Pharmaceuticals, Inc.|Lynn Ngo|206-274-6763|lngo@dendreon.com|
20559658|NCT02308501|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
20559659|NCT04172987|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20559660|NCT02186938|MUSC|Dr Hand|843-792-5442|handw@musc.edu|
20559661|NCT03862482|Université de Montréal|Dr. Aldo Joseph Camarda|514-343-7124|aj.camarda@umontreal.ca|
20559662|NCT04179461|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
20559663|NCT03100838|USFDA|Dr. Minori Kinjo|240-40269118|minori.kinjo@fda.hhs.gov|
20559664|NCT00184028|USC/Norris Comrpehensive Cancer Center|Barbara Gitlitz, MD|323-865-3906|Gitlitz@usc.edu|
20559665|NCT01347645|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20559666|NCT01141660|Eastern Virginia Medical School|Cristina Baldassari|7576689853|baldassc@yahoo.com|
20559667|NCT01438229|St. Jude Medical|Steven Madej|651-756-2230|smadej@sjm.com|
20559668|NCT00209027|Emory University|Erica Duncan|404-321-6111|erica.duncan@va.gov|7532
20528467|NCT01183416|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
20559669|NCT03785340|Ocugen|Vijay Tammara, VP, Strategic regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
20559670|NCT01848834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559671|NCT01342029|Cedars-Sinai Medical Center|C.Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
20559672|NCT00813111|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20559673|NCT04648891|Mayo Clinic|David G. Lott, M.D.|480-342-2983|Lott.David@mayo.edu|
20559674|NCT03259373|Harvard Pilgrim Health Care|Richard Platt, MD|(617) 867-4912|Richard_Platt@harvardpilgrim.org|
20559675|NCT05087095|Virginia Commonwealth University|Ashlee Loughan, PhD, LCP|804-828-9815|ashlee.loughan@vcuhealth.org|
20559676|NCT01923428|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
20559677|NCT00850720|Children's Healthcare of Atlanta|Kiran Hebbar, MBBS|404-785-1600|kiran.hebbar@choa.org|
20559678|NCT00885495|University of Cincinnati College of Medicine|Dr. Carl J. Fichtenbaum|513-584-6361|carl.fichtenbaum@uc.edu|
20559679|NCT02107443|University of Rochester, Medical Center|Dr. Supriya Mohile, Professor of Medicine|585-275-0394|URCC_COACH@URMC.Rochester.edu|
20559680|NCT01400893|CytoPherx, Inc|H. David Humes|734-997-7055|dhumes@cytopherx.com|302
20559681|NCT00946647|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20559682|NCT00519636|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559683|NCT01368211|Transfusion Service Rigshospitalet - Dept of Immunology, Copenhagen Denmark|Dr. Pär Johansson|+45 35452030|per.johansson@rh.regionh.dk|
20559684|NCT03057834|Wake Forest University School of Medicine|Candace Parker-Autry, MD|336-716-3779|candace.parkerautry@wfusm.edu|
20559685|NCT00670982|Dana-Farber Cancer Institute|Harold J. Burstein, MD|617-632-2335|hal_burstein@dfci.harvard.edu|
20559686|NCT02683993|Boston Scientific|Teri Bird|6123221189|teri.bird@bsci.com|
20559687|NCT01500746|Northwestern University|Dr. Elliot Hirsch|312-695-6022|elliot-hirsch@md.northwestern.edu|
20559688|NCT02406209|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20559689|NCT02334527|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20559690|NCT01591161|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20559691|NCT04630756|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20559692|NCT04178551|VA Connecticut Healthcare System|William C. Becker, MD|203-932-5711|william.becker4@va.gov|2427
20559693|NCT05593211|Anthem Biotechnologies|Jeremy D. Ollerenshaw, Ph.D.|770.337.2390|ollerenj@anthembiotech.com|
20559694|NCT04343222|University of Wisconsin - Madison|Maxwell Wingelaar|231-233-6051|mwingelaar@uwhealth.org|
20559695|NCT03077620|Washington University in St Louis School of Medicine|Dr. Brendan Lucey|314-747-3805|luceyb@wustl.edu|
20528468|NCT00305565|Cyberonics Inc.|Mark Bunker Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
20559696|NCT03225846|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
20559697|NCT04248465|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20559698|NCT01254890|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
20559699|NCT00118144|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20559700|NCT04069221|Medicines for Malaria Venture|Dr Myriam El Gaaloul, PharmD|+41 22 555 0377|elgaaloulm@mmv.org|
20559701|NCT01159535|University of Washington|Dr. Sarah Bowen|(206) 543-3452|swbowen@uw.edu|
20559702|NCT00245011|Sidney Kimmel Comprehensive Cancer Center|David M. Loeb, M.D., Ph.D., Director, Musculoskeletal Tumor Program|410.502.7247|loebda@jhmi.edu|
20559703|NCT00550173|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20559704|NCT01728805|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
20559705|NCT02018315|University of Texas Southwestern Medical Center|Juan Pascual, M.D., Ph.D.|214-648-3550|juan.pascual@utsouthwestern.edu|
20559706|NCT00107744|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|504-988-5165|jhe@tulane.edu|
20559707|NCT00810641|KONOS|Treatment of apogeotropic HC BPPV|82 10 5538 6565|ohsun@jbnu.ac.kr|
20559708|NCT01556243|Mayo Clinic|Judy Boughey|507-266-9997|Boughey.Judy@mayo.edu|
20559709|NCT01388543|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
20559710|NCT03703206|University of Pennsylvania|Nabil Elkassbany, MD|2158236700|nabil.elkassabany@uphs.upenn.edu|
20559711|NCT02325713|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20559712|NCT02359019|Barbara Ann Karmanos Cancer Institute|Dr. Ammar Sukari|313-576-8778|sukaria@karamanos.org|
20559713|NCT01213173|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
20559714|NCT02253316|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8323|rvij@wustl.edu|
20559715|NCT02353832|University of Texas Southwestern|Michael Folkert, M.D., Ph.D.|214-645-8525|Michael.Folkert@utsouthwestern.edu|
20559716|NCT00904150|Centre for Neuroscience and Trauma, Queen Mary, University of London|Professor Anne MacGregor|+44 7774 868628|e.macgregor@qmul.ac.uk|
20505463|NCT00492921|JHU SKCCC|Dr. Javier Bolanos Meade|410-614-6398|Fbolano2@jhmi.edu|
20505464|NCT01696877|Johns Hopkins University|Emmanuel S. Antonarakis, M.D., principal investigator|443-287-0553|eantona1@jhmi.edu|
20505465|NCT01566838|Cardiac, Vascular, and Thoracic Surgery Associates|Sandeep Khandhar, MD|703-280-5858|SKhandhar@CVTSA.com|
20505466|NCT00864227|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20505467|NCT03461289|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
20505468|NCT03241173|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20505469|NCT00492401|The Ohio State University Comprehensive Cancer Center|William Blum, MD|614-293-9273|William.Blum@osumc.edu|
20505470|NCT02698423|Geneva University Hospitals|Dr Manuela Viviano|07955 32 272|manuela.viviano@hcuge.ch|
20505471|NCT01319760|Columbia Presbytarian Hospital, NY|Dr. Ajay Kirtane|212-305-7060|akirtane@columbia.edu|
20505472|NCT00081289|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20505473|NCT01553539|Wake Forest University Health Sciences|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
20505474|NCT00530712|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20505475|NCT02749370|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20505476|NCT01519427|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
20505477|NCT03894904|The University of Texas Health Science Center at Houston|Nischal K. Gautam, MD|(713) 500-6200|Nischal.K.Gautam@uth.tmc.edu|
20505478|NCT03020524|University of Pennsylvania|Regulatory Lead|215.662.4484|psom-ind-ide@pobox.upenn.edu|
20505479|NCT04064684|The University of Texas Health Science Center at Houston|Alvaro Jose Coronado Munoz, MD|713-500-5553|Alvaro.J.CoronadoMunoz@uth.tmc.edu|
20505480|NCT00651118|Meda Pharmaceutical|David Ginsberg,..|732 564 2364|david.ginsberg@meda.us|
20505481|NCT00121810|Hoffmann-La Roche|Medical Communications|800-821-8590||
20505482|NCT02190435|William Beaumont Hospital|Denise Koueiter, MS|248-551-5166|denise.koueiter@beaumont.org|
20505483|NCT02260193|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|+1 617-844-6128|trials@akebia.com|
20505484|NCT00935220|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505485|NCT01377467|University Hospital Zürich|Prof. Rudolf P. Wüthrich|+41 44 255 33 84|rudolf.wuethrich@usz.ch|
20505486|NCT01415440|NYSPI|Jonathan Posner, MD|6467745735|jonathan.posner@nyspi.columbia.edu|
20505487|NCT00336492|Johnson & Johnson Pharmaceutical Research and Development|Senior Director, Clinical Research|610-240-8092||
20505488|NCT01781026|Yale University|Harriet Kluger||Harriet.Kluger@yale.edu|
20559717|NCT05567952|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559718|NCT02385721|Boryung Pharmaceutical Co., Ltd|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
20559719|NCT03280563|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20559720|NCT04096365|AtaCor Medical, Inc.|Alan Marcovecchio, Vice President, Clinical Affairs|949 391 2252|alan@atacor.com|
20559721|NCT00920374|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559722|NCT05373901|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20559723|NCT02065245|University of Miami, Miller School of Medicine - Interdisciplinary Stem Cell Institute (ISCI)|Joshua M Hare, MD|305-243-5579|JHare@med.miami.edu|
20559724|NCT01518257|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20559725|NCT02107274|Ministry of Health of Malaysia|Dr. Albert Iruthiaraj L. Anthony|+60174633410|albert5409@yahoo.com|
20559726|NCT03531905|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20559727|NCT01036087|UT MD Anderson Cancer Center|Dr. Naoto Ueno, Professor, Breast Medical Oncology|(713) 792-8754|nueno@mdanderson.org|
20559728|NCT03961256|Mayo Clinic|Mark D. Stegall, M.D.|507-266-2812|Stegall.Mark@mayo.edu|
20511393|NCT04602078|Spanish Oncology GenitoUrinary Group (SOGUG)|A responsible person designated by the Sponsor|0034934344412|investigacion@mfar.net|
20511394|NCT03757585|Massachusetts General Hospital|Janet Wozniak|6176436617|jwozniak@partners.org|
20511395|NCT03472586|Thomas Jefferson University|Marlana Orloff, MD|215-955-9974|marlana.orloff@jefferson.edu|
20511396|NCT02706327|Eastern Mediterranean University|Yasin YURT|+905338724271|fzt.yasinyurt@gmail.com|
20511397|NCT04542304|Stanford University|Tammy Lisa Sirich, MD|650-849-1907|tsirich@stanford.edu|
20511398|NCT04963231|Rhythm Clinical Trials|Rhythm Pharmaceuticals, Inc.|857-264-4280|clinicaltrials@rhythmtx.com|
20511399|NCT02928900|University of Washington|Pamela Kohler|206.221.5746|pkohler2@uw.edu|
20511400|NCT03868410|Cleveland Clinic|Dr. Ela Plow|216-445-6728|plowe2@ccf.org|
20511401|NCT01059175|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
20511402|NCT02957149|Mayo Clinic|Matthew Gettman, MD|507-284-3249|Gettman.Matthew@mayo.edu|
20511403|NCT06045026|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20511404|NCT04550234|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20511405|NCT01407068|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20511406|NCT03693846|University of Pennsylvania|Thomas Karasic, MD|215-614-1858|thomas.karasic@pennmedicine.upenn.edu|
20511407|NCT01100931|National Cancer Institute, National Institutes of Health|Dr. Giuseppe Giaccone|301-496-4916|giacconeg@mail.nih.gov|
20511408|NCT01474291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20511409|NCT03471507|Duke University Medical Center|Lance Roy, M.D.|919-684-8111|lance.roy@duke.edu|
20511410|NCT02213666|Beth Israel Deaconess Medical Center|Elad Anter, MD|617-632-9209|eanter@bidmc.harvard.edu|
20511411|NCT01319422|Yale University|Madhav Dhodapkar, M.D.|203-785-4144|madhav.dhodapkar@yale.edu|
20511412|NCT01399619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511413|NCT00750061|China Spinal Cord Injury Network|Dr. Wendy Cheng|+852 28660829|wendycheng@chinasci.net|
20511414|NCT03661346|University of Texas Medical Branch - Galveston|Dr. Mohamad Chaaban|281-338-0829|mrchaaba@UTMB.EDU|
20511415|NCT03417245|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20511416|NCT04491955|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20559729|NCT02708641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
20511417|NCT02708524|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D. PRINCIPAL RESEARCH OPTOMETRIST|904-443-1474|KCANAVA2@its.jnj.com|
20511418|NCT04620356|kimberlyClark|Clinical Science Manager|+55 11 45034500|debora.rodrigues@kcc.com|
20511419|NCT00822185|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20511420|NCT00638820|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
20511421|NCT04435431|Integrative Research Laboratories Sweden AB|Joakim Tedroff, Chief Medical Officer|+46707601691|joakim.tedroff@irlab.se|
20511422|NCT00679354|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20511423|NCT02951143|University of Kentucky|Mikhail Koffarnus|8593236402|koffarnus@uky.edu|
20511424|NCT01590628|Gamida Cell|Kelly Myers, CRA|026595631|kelly@gamida-cell.com|
20511425|NCT00229931|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6307|sonny-icks@dmei.org|
20511426|NCT00475657|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20511427|NCT02992743|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20511428|NCT00761735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511429|NCT00398476|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511430|NCT00998166|Columbia University|Mark Stoopler, MD|212-305-8230|mbs5@cumc.columbia.edu|
20511431|NCT00450814|Mayo Clinic|Angela Dispenzieri, M.D., Morie A. Gertz, M.D.|(507) 284-2511|Dispenzieri.Angela@mayo.edu, Gertz.Morie@mayo.edu|
20511432|NCT03724552|Massachusetts General Hospital|T. Atilla Ceranoglu, MD|617-726-1291|aceranoglu@mgh.harvard.edu|
20511433|NCT01757821|University of Minnesota|James Carey|612-626-2746|carey007@umn.edu|
20511434|NCT03831282|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
20559730|NCT03251144|University of California Los Angeles|Theodoros Kelesidis|3108257875|tkelesidis@mednet.ucla.edu|
20559731|NCT03158948|INOTREM SA|Executive VP Research and Medical Sciences|30 62 86 51|jjg@inotrem.com|+33 (0)6
20511435|NCT01258803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20511436|NCT00920582|Provention Bio, Inc.|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
20511437|NCT05227404|University of Minnesota|Eileen Denning|612-626-8049|edenning@umn.edu|
20511438|NCT03360695|Massachusetts General Hospital|Kelly Irwin, MD, MPH|617-643-4453|kirwin1@partners.org|
20511439|NCT02787655|Atl VA|Joe Nocera|404 321 6111|joe.nocera2@va.gov|206354
20559732|NCT04730947|Mayo Clinic|Dr. Barry A. Borlaug|507-293-2762|borlaug.barry@mayo.edu|
20559733|NCT01033643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559734|NCT01625338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20559735|NCT03861728|University of Miami|Wendy Lee|305-326-6434|wlee@miami.edu|
20559736|NCT00354029|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
20559737|NCT01021332|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||astellas.resultsdisclosure@astellas.com|
20559738|NCT00787943|Northwestern University|Amy Paller, MD|312-695-3721|apaller@northwestern.edu|
20559739|NCT02033993|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
20559740|NCT04990687|UAB|Samantha White|205-934-1989|swwhite@uabmc.edu|
20559741|NCT00765661|Veloxis|Christina Sylvest, Sr VP Global Clinical Development & Operations|45 20553877|csy@veloxis.com|
20559742|NCT01600703|University Health Network|Dr. Gary Lewis|416-340-4270|gary.lewis@uhn.ca|
20559743|NCT02633891|BVAMC|Dr. Lindsay Zilliox|410-328-3100|lzilliox@som.umaryland.edu|
20559744|NCT00108524|Durham VAMC|William S Yancy, Jr. MD, MHSc|919-286-0411|william.yancy2@va.gov|7770
20559745|NCT01349907|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559746|NCT00344370|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
20559747|NCT01310868|University College London|GALA-5 Trial Coorinator|0207 679 9898|ctc.sponsor@ucl.ac.uk|
20559748|NCT00305682|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
20559749|NCT01628874|Children's Hospital Colorado|Dr. Ryan Caltagirone|303-521-8563|ryan.caltagirone@childrenscolorado.org|
20559750|NCT00873093|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20559751|NCT01008722|University of California, San Diego|Dr. Sanjiv Narayan (Professor of Medicine, Principal Investigator)|(650) 498-8161|sanjiv1@stanford.edu|
20559752|NCT00146640|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20559753|NCT02059161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559754|NCT02511561|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20511440|NCT02071823|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20559755|NCT01723826|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20559756|NCT02013687|Fraunhofer USA Center for Molecular Biotechnology|Dr. Jessica Chichester, Senior Scientist Immunology|302-369-3635|jessica.chichester@fhcmb.org|
20559757|NCT01782326|Novartis Pharmaceuticals|Study Director|862-778-8300||
20559758|NCT05049616|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD|(713) 500-6421|michal.f.bartal@uth.tmc.edu|
20559759|NCT04894903|Vanderbilt University Medical Center|William Martinez, MD, MS|615-936-1010|william.martinez@vumc.org|
20559760|NCT01112696|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
20559761|NCT01822353|Helsinki University Hospital, Helsinki, Finland|Paula Kauppi, Chief Specialist|+358504286802|paula.kauppi@hus.fi|
20559762|NCT02550873|Promedior Inc.|Renu Gupta, MD, Chief Medical Officer|856-722-9824|rgupta@promedior.com|
20559763|NCT04320615|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20559764|NCT04504916|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559765|NCT00003509|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20559766|NCT00075803|NHLBI|Nancy DiFronzo, PhD|301-435-0065|difronozon@nhlbi.nih.gov|
20559767|NCT02684903|University of Oregon|Dr. Elizabeth Skowron|541-346-9329|eskowron@uoregon.edu|
20559768|NCT04213846|University of Washington|Christine Lee, Ph.D.|206-543-6574|leecm@uw.edu|
20559769|NCT03374072|Boston University|Dr. Gael Orsmond|(617)353-2703|gorsmond@bu.edu|
20559770|NCT01672983|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20559771|NCT00802841|Novartis|Study Director|862-778-1873||
20559772|NCT02174198|Columbia University|Nurit Bittner, DDS, MS, Dip.ABP|212-342-2763|nb2203@cumc.columbia.edu|
20559773|NCT00432159|Depuy Synthes|Lynn Wilson|508-880-8109|lwilso45@its.jnj.com|
20559774|NCT02823990|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20559775|NCT01939158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559776|NCT05310084|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559777|NCT02123966|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
20559778|NCT01460381|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20559779|NCT01097655|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20559780|NCT03303105|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20559781|NCT01824446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20559782|NCT03527277|University of California, Davis|Kimber Stanhope|5302190914|klstanhope@ucdavis.edu|
20559783|NCT01333943|Hospital for Special Surgery|David H. Kim, MD|(212) 606-1206|KimD@HSS.EDU|
20511441|NCT00556140|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
20559784|NCT02091063|Columbia University|Jennifer Amengual, MD|212-305-0591|jea2149@cumc.columbia.edu|
20559785|NCT02652130|Mesoblast, Inc.|Christopher James, VP, Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
20559786|NCT02028884|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20559787|NCT02403674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20559788|NCT00826280|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
20559789|NCT03487666|Georgetown University|Candace Mainor, MD|202-444-2223|Candace.Mainor@gunet.georgetown.edu|
20559790|NCT05559047|Bleep, LLC|Stuart Heatherington|919-619-7170|stuart@bleepsleep.com|
20559791|NCT03930186|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20559792|NCT04569240|Cleveland Clinc|Andrea Parianos|216-445-8354|debsa@ccf.org|
20559793|NCT05205941|MMV|Benoit Bestgen|+41797651868|bestgenb@mmv.org|
20559794|NCT02800928|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
20559795|NCT01853163|Navitas Life Sciences GmbH|Managing Director|+49 (0) 69-66 80 30-0|marty.boom@navitaslifesciences.com|
20559796|NCT05968482|Amzell BV|Chief Executive Officer|+31235560460|amzell-disclosure@amzell.com|
20559797|NCT02559817|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20559798|NCT03389893|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
20559799|NCT04305236|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20559800|NCT01925170|Mayo Clinic|Dr. Deborah Rhodes|507-284-7971|rhodes.deborah@mayo.edu|
20559801|NCT02034435|Vanderbilt University Medical Center|Dr. James M. Luther, MD|(615) 936-3420|james.luther@vumc.org|
20559802|NCT02874846|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20559803|NCT00801242|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20559804|NCT02554513|VASLCHCS|Dr. Shannon Mauszycki|801-582-1565|shannon.mauszycki@utah.edu|
20559805|NCT00388362|Stanford University|Laura Johnston, MD|650-723-0822|janices1@stanford.edu|
20559806|NCT02760862|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
20559807|NCT00429702|SunCoast CCOP Research Base|SunCoast CCOP Research Base Lead Biostatistician|18009091242|ccop@epi.usf.edu|
20559808|NCT02335268|GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH|Dr. Carsta Köhler|+49 351 25933|info@gmiho.de|100
20559809|NCT02859597|Montefiore Medical Center|Dr.Jay Berger|7189204316|jberger@montefiore.org|
20559810|NCT02916862|Florida International University|Cristina Palacios|3053483235|crpalaci@fiu.edu|
20559811|NCT03160079|University of California, San Diego, Moores Cancer Center|Dr. James Mangan|858-822-6600|jmangan@health.ucsd.edu|
20559812|NCT01107730|Attikon Hospital|Ioannis K. Toumpoulis|00306977243942|toumpoul@otenet.gr|
20559813|NCT05893797|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20559814|NCT04770220|Alzheon|Aidan Power|(508) 861-7709|aidan.power@alzheon.com|
20559815|NCT04955626|BioNTech clinical trials patient information|BioNTech SE|+49 6131 90840|patients@biontech.de|
20559816|NCT03873246|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20559817|NCT01857323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20559818|NCT04209790|Geisinger|Regulatory Project Manager|570-214-2462|khassanzadeh@geisinger.edu|
20559819|NCT01638468|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
20559820|NCT04060680|Medtronic|Drew Turk, Clinical Research Specialist|7633580375|drew.turk@medtronic.com|
20559821|NCT05617040|Barinthus Biotherapeutics|Chief Medical Officer|+44 1865 818808|enquiries@barinthusbio.com|
20559822|NCT02711826|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20559823|NCT01133860|IRCCS Policlinico San Matteo Foundation|Prof. Carlo Balduini|0039.0382.502580|c.balduini@smatteo.pv.it|
20559824|NCT00729690|Rush University|Asokumar Buvanendran|(312) 942-3685|asokumar@aol.com|
20559825|NCT02169219|Massachusetts General Hospital, Division of Rheumatology|Dr. John Stone|617-643-2140|adfernandes@mgh.harvard.edu|
20559826|NCT02886936|University of Pennsylvania|Jessica Kenia, Research Coordinator|215-893-2678|jessica.kenia@pennmedicine.upenn.edu|
20559827|NCT04562779|Denver Health & Hospital Authority|Dr. Dale Terasaki|303-602-6922|dale.terasaki@dhha.org|
20559828|NCT02320721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20559829|NCT03173248|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33155726000|scientificinformation@servier.com|
20559830|NCT01544582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511442|NCT05146999|Galderma Research & Development, LLC|Felipe Weinberg, MD, MPH|817-961-5000|aestheticclinicaltrials@galderma.com|
20511443|NCT03319160|Zoll|Mike Osz|412-968-3333|mosz@zoll.com|
20511444|NCT03604159|NYU Langone|Dr. Joshua Lee|646-501-3552|Joshua.Lee@nyulangone.org|
20511445|NCT00851721|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20511446|NCT00665002|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey E. Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
20511447|NCT04533204|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|734-763-9259|bhampste@med.umich.edu|
20511448|NCT00383292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20511449|NCT00697255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511450|NCT01005355|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20511451|NCT03570658|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20511452|NCT01333501|Novartis Pharmaceuticals|Study Director|862-778-8300||
20559831|NCT02419755|St. Jude Children's Research Hospital|Tanja A. Gruber, MD, PhD|901-595-2252|tanja.gruber@stjude.org|
20559832|NCT00852137|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
20511453|NCT01353976|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
20511454|NCT02354599|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20511455|NCT04806334|Cedars-Sinai Medical Center|Charles J Rosser, MD|310-423-3723|Charles.rosser@cshs.org|
20511456|NCT00660829|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
20511457|NCT03590613|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20511458|NCT00967343|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@Kiadis.com|
20511459|NCT02195349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20511460|NCT00957827|University of Pennsylvania|Eric Granquist|215 880-7568|eric.granquist@uphs.upenn.edu|
20511461|NCT02501642|James A. Haley VA|Tracy Kretzmer, Ph.D.|813-972-2000|tracy.kretzmer@va.gov|5729
20511462|NCT00934661|Anesthesiology|Dr. Pamela Nagle Assistant Professor|336-716-7180||
20511463|NCT03724305|Henry Ford Health|Chaewon Sagong|2483442409|csagong1@hfhs.org|
20511464|NCT05959564|University of Maryland, College Park|Xiaoli Nan|301-405-0640|nan@umd.edu|
20511465|NCT01358266|Santen Inc.|Clinical Operations|+1-415-268-9100|clinicaltrials@santen.com|
20511466|NCT01846442|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
20511467|NCT01685320|Campus Bio-medico University|Prof. Massimiliano Carassiti|+39-06-225411952|m.carassiti@unicampus.it|
20511468|NCT02477319|Seattle Children's Hospital|Umer Khan (Principal Biostatistician)|206-884-7516|umer.khan@seattlechildrens.org|
20511469|NCT00679042|CellTrans Inc.|Jennifer Cook|312-413-7727|jenny@celltransinc.com|
20511470|NCT00379639|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20511471|NCT03053102|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20511472|NCT01798056|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511473|NCT01269346|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20511474|NCT00247416|University of Kentucky Markey Cancer Center|Suzane Arnold, MD|859 323 8043|smarno0@uky.edu|
20511475|NCT00474994|Memorial Sloan Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|KeohanM@mskcc.org|
20511476|NCT02660489|Imperial College London|Professor Sebastian Johnston|+44 (0)20 7594 3764|s.johnston@imperial.ac.uk|
20511477|NCT01700907|Sapporo Medical University School of Medicine|Michiaki Yamakage|+81116112111|yamakage@sapmed.ac.jp|3568
20511478|NCT05064436|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20511479|NCT01342445|University of Rhode Island|Dr. Lisa Weyandt|(401)874-2087|lisaweyandt@uri.edu|
20511480|NCT02652793|Hospital Clinic of Barcelona|Dr. José Luis Blanco|+34 932275400|jlblanco@clinic.cat|
20511481|NCT00070070|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20511482|NCT05450198|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@msd.com|
20511483|NCT04511533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511484|NCT01224171|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20511485|NCT01928758|Penn State College of Medicine|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
20511486|NCT02718131|University of Alabama at Birmingham|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
20511487|NCT04140942|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
20511488|NCT01911546|Former: Cedars-Sinai Medical Center, Comprehensive Transplant Center|Dr. Joseph Kahwaji, MD, MPH|310-423-2641|joseph.m.kahwaji@kp.org|
20511489|NCT02103608|Tennesse clinical research center|Dr. Michael Gold|615-383-2400|drgold@goldskincare.com|
20511490|NCT01388946|Aretaieo Hospital University of Athens|Argyro Fassoulaki|+30 6936701333|fassoula@aretaieio.uoa.gr|
20511491|NCT00892710|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20511492|NCT00381680|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20511493|NCT03290131|RVL Pharmaceuticals, Inc.|Vice President, Regulatory Affairs and Quality|908-809-1300|Regulatory@RVLpharma.com|
20511494|NCT00731640|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20511495|NCT00361504|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20511496|NCT04899362|the First Hospital of Jilin University|Dr Yi Yang|0431|doctoryangyi@163.com|88782378
20511497|NCT03045926|Ipsen Pharma SAS|Medical Director|+33 (0)158335000|clinical.trials@ipsen.com|
20511498|NCT04548349|Beth Israel Deaconess Medical Center|Jean S. McGee, MD, PhD|(617) 667-5834|jmcgee2@bidmc.harvard.edu|
20511499|NCT03554798|FIDEC Corporation|Ricardo Rüttimann, PhD|+5491161188536|rruttimann@fidec-online.org|
20511500|NCT01982539|Depomed|Clinical Operations||clinicaltrials@depomed.com|
20511501|NCT01374516|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20511502|NCT00401414|Brigham and Women's Hospital|Mark A. Creager|617-732-5267|mcreager@partners.org|
20511503|NCT03866811|Columbia University|Dr. Lauren Chernick|2123056628|lc2243@columbia.edu|
20511504|NCT02078557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511505|NCT01012765|Novartis Pharmaceuticals|Study Director|862-778-8300||
20511506|NCT01326312|Oncternal|Mary Breitmeyer|858-434-1113|mbreitmeyer@oncternal.com|
20511507|NCT00635362|University of Chicago|Amy Whitaker, MD|773-834-4129|awhitaker@babies.bsd.uchicago.edu|
20511508|NCT02223520|Johns Hopkins Medical Institutions|Aaron M. Milstone, M.D., M.H.S.|410-614-3917|amilsto1@jhmi.edu|
20511509|NCT02185131|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
20511510|NCT00499694|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
20511511|NCT01830621|The Ottawa Hospital Regional Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
20511512|NCT03556202|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20511513|NCT03301272|University of North Carolina at Chapel Hill|Daniel Roque, MD|919-966-8178|droque@neurology.unc.edu|
20511514|NCT04034225|Sensei Bio|Alice Drumheller|2404548027|adrumheller@senseibio.com|
20511515|NCT01591044|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20559833|NCT03824535|Stanford University|Dr. Carina Mari Aparici|650-497 9280|drmari@stanford.edu|
20559834|NCT02841267|Hugo W. Moser Research Institute at Kennedy Krieger Inc.|Dr. Kathryn R. Wagner|443-923-9525|wagnerk@kennedykrieger.org|
20559835|NCT06403605|ETS Wound Care, LLC|Donald Buck, MD|410-490-5998|dbuck@etswoundcare.com|
20559836|NCT02699190|The Children's Hospital of Philadelphia|Dr. Adeline Vanderver|215-590-1719|vandervera@chop.edu|
20559837|NCT05194735|Alaunos Therapeutics, Inc.|Jaymes Holland|6502732627|jholland@alaunos.com|
20559838|NCT00731042|3M Company|Chou Eyberg|651-737-0934|cieyberg1@mmm.com|
20559839|NCT05737550|Kontigo Care AB|Markku Hämälainen, CSO|+46 (0)76 947 3132|markku.hamalainen@kontigocare.com|
20559840|NCT02600429|clinical operation|Director of clinical operation||swkang@regentreellc.com|
20559841|NCT01414036|Boston Medical Center|Karen E. Lasser|617-414-6688|karen.lasser@bmc.org|
20559842|NCT02491411|SKCCC at JHU|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
20511516|NCT01230021|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20511517|NCT00736840|Exalenz Bioscience|Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|513
20511518|NCT01411917|University of Wisconsin School of Medicine, Department of Anesthesiology|Kristopher Schroeder|608-232-1542|kmschro1@wisc.edu|
20511519|NCT02791906|University of Pennsylvania|Associate Professor|2152007779|julio.chirinos@uphs.upenn.edu|
20511520|NCT01815099|Hartford Hospital|Gretchen Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
20511521|NCT01475214|Jean Mayer Human Nutrition Research Center on Aging at Tufts University|Dr. Bess Dawson-Hughes|617-556-3066|bess.dawson-hughes@tufts.edu|
20511522|NCT00643851|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20511523|NCT03289676|UNIVERSITY OF MASSACHUSETTS BOSTON|Dr. Sun Kim|6172875372|sun.kim@umb.edu|6172875372
20511524|NCT00954356|Xenon Pharmaceuticals Inc.|Vice President Clinical|6044843300|pgoldberg@xenon-pharma.com|
20511525|NCT01811693|Keck School of Medicine of USC|Nerses Sanossian, MD|323-442-7793|nsanossi@usc.edu|
20511526|NCT04369742|NYU Langone Health|Mark Mulligan, MD|(212) 263-5182|Mark.mulligan@nyulangone.org|
20511527|NCT02451137|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20511528|NCT03747497|MicuRx Pharmaceuticals, Inc.|Study Director|510-782-2022|info@micrux.com|
20511529|NCT03044730|Northwestern University, Feinberg School of Medicine|William John Gradishar, MD, FACP, FASCO|(312) 695-4541|w-gradishar@northwestern.edu|
20511530|NCT00990782|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
20511531|NCT02777554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20511532|NCT01008059|Washington University|Evan D. Kharasch, MD PhD|314-362-8796|kharasch@wustl.edu|
20511533|NCT00278473|Icahn School of Medicine at Mount Sinai|Dr. Mary V. Solanto|212-241-5420|Mary.Solanto@mssm.edu|
20511534|NCT04854421|Pennington Biomedical Research Center|Dr. Steven Heymsfield|(225) 763-2541|steven.heymsfield@pbrc.edu|
20511535|NCT00721513|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
20511536|NCT02322866|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20511537|NCT00718809|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
20511538|NCT00798161|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511539|NCT03735680|OncoNano Medicine, Inc.|Vice President, Clinical Operations|682-285-1411|clinicaltrials@onconanomed.com|
20511540|NCT01905631|Center for Clinical and Cosmetic Research|Dr. Mark Nestor|3059336716|nestormd@admcorp.com|
20511541|NCT03930524|University of Michigan|Dr. Megan Patrick|734-763-5043|meganpat@umich.edu|
20511542|NCT03078504|Saint Louis University|Dr.Zafar Jamkhana|314-577-8856|zafar.jamkhana@health.slu.edu|
20511543|NCT01141569|BC Cancer Agency Vancouver Cancer Centre|Dr. Christian Kollmannsberger|604-877-6000|ckollmannsberger@bccancer.bc.ca|
20511544|NCT01711736|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511545|NCT00465101|American Medical Systems|Mara M. LaRock, Senior Manager, Clinical Franchise Lead|952-930-6000|mara.larock@bsci.com|
20511546|NCT03648073|University of Alabama at Birmingham|Samuel Galgano, Principal Investigator|2059341449|samuelgalgano@uabmc.edu|
20511547|NCT00683852|Massachusetts General Hospital, CTNI|Martina Flynn, Director, Clinical Trial Operations|617-643-6028|mflynn2@partners.org|
20511548|NCT04145531|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20511549|NCT00933543|Photocure|Project director Per Fuglerud|+47 22 06 16 54|pf@photocure.no|
20511550|NCT04988035|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20511551|NCT03602976|University of Pennsylvania|Dr. Ethan Weinberg|215-349-8222|ethan.weinberg@pennmedicine.upenn.edu|
20511552|NCT04837807|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
20511553|NCT04629534|Medical University of South Carolina|Carol Wagner|843-792-5179|wagnercl@musc.edu|
20511554|NCT00308555|UCSF/San Francisco General Hospital|Dr. Donald I. Abrams|415-476-4082|dabrams@hemeonc.ucsf.edu|444
20511555|NCT03732534|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20511556|NCT02190604|Novartis|Study Director|862-778-8300||
20511557|NCT02797951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20511558|NCT00814502|Massachusetts General Hospital|Kaloyan Tanev, M.D.|617-726-7511|ktanev@partners.org|
20511559|NCT03709342|CalciMedica|Sudarshan Hebbar, MD|816-838-7105|sudarshan@calcimedica.com|
20528469|NCT02446847|The Rockefeller University|Dr. Marina Caskey, Associate Professor of Clinical Investigation|212-327-7396|mcaskey@rockefeller.edu|
20528470|NCT02984644|University of Texas Health Science Center at San Antonio|Dr. Eugenio Cersosimo|210-358-7200|cersosimo@uthscsa.edu|
20528471|NCT04074330|Takeda|Medical Director|1-877-825-3327|TrialDisclosures@takeda.com|
20559843|NCT00924664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528472|NCT00502853|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20559844|NCT01598987|Novartis Pharmaceuticals|Study Director|862-778-8300||
20511560|NCT03735849|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20511561|NCT05113277|Florida State University|Danielle M. Morabito|850) 645-1766|morabito@psy.fsu.edu|
20511562|NCT04585906|Johns Hopkins Center for Indigenous Health|Emily E. Haroz, PhD, Co-Director of Research|410-960-9503|eharoz1@jhu.edu|
20511563|NCT04626947|University of Pittsburgh|David G. Binion|412-647-4194|binion@pitt.edu|
20511564|NCT01766466|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888.779.MDCO|jayne.prats@themedco.com|1510
20511565|NCT01533974|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.|206-667-5074|jbricker@fredhutch.org|
20511566|NCT00370994|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti|270-554-8373|drlm@thepainmd.com|101
20511567|NCT03907072|WAVE Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
20511568|NCT00591305|Boston Medical Center|Zhi Wang, MD|617-414-1590|zwang@bu.edu|
20511569|NCT02463097|Medtronic Minimed|Thomas Thoub|8185763142|thomas.troub@medtronic.com|
20511570|NCT03326323|Inova Heart and Vascular Institute|Eric L. Sarin MD|703-776-4138|eric.sarin@inova.org|
20511571|NCT03260699|Department of Orthopaedic Surgery, Cleveland Clinic|Alison Klika, Research Manager|216 444-4954|klikaa@ccf.org|
20511572|NCT04278846|Cleveland Clinic|Raymond Isakov, MD|216 445-3765|ISAKOVR@ccf.org|
20511573|NCT02243306|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20511574|NCT02221882|Eli Lilly and Company|Chief Medical Officer|800+545-5979|ClinicalTrials.gov@lilly.com|
20511575|NCT00796367|Vivus, Inc|Wesley W Day, PhD|650.934.5200|day@vivus.com|
20511576|NCT02394457|Naval Medical Center San Diego|Steven Hanling, MD|619-532-8954|steven.r.hanling@mail.mil|
20511577|NCT01598831|Asahi Kasei Pharma America Corp.|Director of Clinical Operations|(781) 419-1919|pallton@akpamerica.com|
20511578|NCT02384096|Boston Scientific Neuromodulation|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
20511579|NCT02903121|Oregon Health and Science University|Alison Edelman, MD, MPH|5034943666|edelmana@ohsu.edu|
20511580|NCT02370173|University of Arizona|"Dr. William D. Scott Killgore"|(520) 621-0605|killgore@arizona.edu|
20511581|NCT01315158|Washington University School of Medicine|Faris Murad, M.D.||fmurad@northshore.org|
20511582|NCT02249377|New York Langone Health|Eric Strauss, MD|646 501 7223|Eric.Strauss@nyumc.org|
20511583|NCT00307736|Massachusetts General Hospital|Lawrence Blaszkowsky|6177244637|lblaszkowsky@partners.org|
20511584|NCT01365182|Case Western Reserve University|Amy Zhang PhD|2163680968|amy.zhang@case.edu|
20511585|NCT02939326|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
20511586|NCT01668017|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20511587|NCT01087944|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20511588|NCT00553319|Columbia University|Frances R. Levin, M.D.|646-774-6137|frl2@columbia.edu|
20511589|NCT01979003|University of Arkansas for Medical Sciences|Alexander Burnett|5016868274|aburnett@uams.edu|
20511590|NCT00976521|Atrium Medical Corporation|Leah Hollins, Director of Clinical Affairs|603-880-1433|lhollins@atriummed.com|5365
20511591|NCT01731600|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20511592|NCT03575975|Georgia Institute of Technology|Dr. Young-Hui Chang|404-894-9993|yh.chang@ap.gatech.edu|
20511593|NCT02984228|Hospital for Special Surgery|Jennifer Cheng|6467146870|chengj@hss.edu|
20511594|NCT00465894|University of Alabama at Birmingham|Dr. Holly E. Richter|205-934-1704|hrichter@uabmc.edu|
20511595|NCT01636076|Novartis Pharmaceuticals|Study Director|862-778-8300||
20511596|NCT01159665|ThromboGenics|Dr. Petra Kozma-Wiebe|+32 16751310|Petra.kozma@thrombogenics.com|
20511597|NCT01526343|Washington University School of Medicine|Jennifer Bell, Manager of Clinical Trials|314-747-6969|jennifer.bell@wustl.edu|
20511598|NCT00544674|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
20511599|NCT00129220|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20511600|NCT00540228|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511601|NCT01883362|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20511602|NCT03740724|Castle Creek Biosciences|Castle Creek Biosciences Clinical Trial Director|484-713-6000|clinicalresearch@castlecreekbio.com|
20511603|NCT01230489|University of Missouri-Columbia|Harold Moore|5738824433|mooreh@health.missouri.edu|
20511604|NCT01977573|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511605|NCT01441882|Oregon Health & Science University|Stephen Spurgeon|503-494-4606|spurgeos@ohsu.edu|
20511606|NCT01302366|Perlmutter Cancer Center at NYU Langone|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
20511607|NCT02010359|Children's Hospital of Philadelphia|Dr. Rachana Shah|215-590-3390|shahr@email.chop.edu|
20511608|NCT00847002|Tactile Systems Technology, Inc|Sunday Hoy, Director of Clinical Research|612.355.5100||
20511609|NCT00198107|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
20511610|NCT02163759|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20511611|NCT03996694|BioDelivery Sciences|Todd Kunkel, PharmD Director, Scientific Communications|913-940-1789|tkunkel@bdsi.com|
20559845|NCT02941146|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20559846|NCT01616563|Metabolic Syndrome Canada|Rupinder Dhaliwal|613 484 3830|rupinder.dhaliwal@metsc.ca|
20559847|NCT00072475|University of Minnesota|Pankaj Gupta, M.D.||gupta013@umn.edu|
20559848|NCT02331940|University of Crete|Director of Clinical Trials|2810394824|izolthi@gmail.com|0030
20559849|NCT01450943|VA Northern California Health Care System|Sara Dahle, D.P.M., M.P.H.|916-843-7151|Sara.dahle@va.gov|
20511612|NCT02748096|University of Oxford|Professor Anrew Price|+44 1865 223421|andrew.price@ndorms.ox.ac.uk|
20511613|NCT01756586|University of Chicago|TARIQ MALIK|773-834 3643|tmalik@dacc.uchicago.edu|
20559850|NCT05153174|University of Rochester Medical Center|Dr Thu H. Le, MD, FAHA - Chief of Nephrology|585-273-4259|thu_le@urmc.rochester.edu|
20559851|NCT02023944|Bedford Veterans Hospital|Maureen K. O'Connor|781-687-2830|maureen.oconnor@va.gov|
20559852|NCT04822298|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20559853|NCT04351750|National Cheng Kung University|Dr. Kuan-Yin Lin|+88662353535|10802003@gs.ncku.edu.tw|5931
20559854|NCT01421771|University of New Mexico Health Sciences Center|Samiha Mateen|505-272-6057|smateen@salud.unm.edu|
20559855|NCT03201757|Alkermes|Global Clinical Services|888-253-8008|clinicaltrials@alkermes.com|
20559856|NCT02521259|Seoul National University Bundang Hospital|Dr. YEA JI LEE|+821086307701|ladydaisy82@naver.com|
20559857|NCT00412867|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20559858|NCT02886728|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20559859|NCT02029703|Cleveland Clinic|M. Elaine Husni, MD, MPH|216-445-1853|HUSNIE@CCF.ORG|
20559860|NCT02988375|Henry Ford Health|Dr. Christopher Drake|(248) 344-6672|cdrake1@hfhs.org|
20559861|NCT00180687|Imperial College London|Dr. Nawar Alkhamesi|442033121110|n.alkhamesi@imperial.ac.uk|
20559862|NCT04990440|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20528473|NCT03124537|Brandeis University|Alycia Bisson|781 736 3284|lifespanlab@brandeis.edu|
20528474|NCT03681184|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20511614|NCT00451191|George Washington University Biostatistics Center|Kathryn Hirst, PhD, Research Professor, PI of coordinating center|301-881-9260|khirst@bsc.gwu.edu|8025
20511615|NCT01013207|ResMed Ltd|Alison Wimms|+61 8884 2583|alison.wimms@resmed.com.au|
20511616|NCT04070157|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
20511617|NCT01541644|University of Maryland Baltimore Greenebaum Cancer Center|Emily Parks|410-328-7340|eparks@umm.edu|
20511618|NCT01966458|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
20511619|NCT01458535|AbbVie|Global Medical Services|800-633-9110||
20511620|NCT00940446|OrthoIndy|Dr David A Fisher|(317) 802-2000|dafisher@orthoindy.com|
20511621|NCT01711424|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20511622|NCT00463385|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20511623|NCT00344968|Alimera Sciences, Inc.|Kathleen Billman, Senior Director of Scientific Affairs|678-572-1302|kathleen.billman@alimerasciences.com|
20511624|NCT00503035|UT MD Anderson Cancer Center|Dr. Imad Shureiqi, MD|713-745-4929|ishureiqi@mdanderson.org|
20511625|NCT04001790|Virginia Commonwealth University|Carol Schall|8048286979|cmschall@vcu.edu|
20511626|NCT03342911|Thomas Jefferson University|Jennifer Johnson|215-955-8874|jxj021@jefferson.edu|
20511627|NCT05028816|UT Southwestern Department of Plastic Surgery Research|Jennifer Barillas, Research Coordinator|214-645-8907|jennifer.bqarillas@utsouthwestern.edu|
20511628|NCT04552769|Stanford University|Saad A. Khan, MD|650-498-6000|saad.a.khan@stanford.edu|
20511629|NCT04579666|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20511630|NCT04576702|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20511631|NCT03099096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20511632|NCT02985996|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
20511633|NCT00401726|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20511634|NCT02067728|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-655-3613|alc@uicomp.uic.edu|
20511635|NCT01015170|Centre for Addiction and Mental Health|Dr. Peter Selby; Dr. Laurie Zawertailo Principal Investigator|416-535-8501|laurie.zawertailo@camh.ca|77422
20511636|NCT00694070|Ascensia Diabetes Care|Clinical Research Scientist|574-257-3063||
20511637|NCT03532048|Baylor College of Medicine|Teresia O'Connor|7137986782|teresiao@bcm.edu|
20511638|NCT01901393|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20511639|NCT02694393|University of Pittsburgh|Dr. Joseph Pilewski|(412) 692-2210‬|pilewskijm@upmc.edu|
20511640|NCT01225029|Icahn School of Medicine at Mount Sinai|Dr. Annemarie Stroustrup|212-241-6186|annemarie.stroustrup@mssm.edu|
20511641|NCT04113746|Icahn School of Medicine at Mount Sinai|Juan P. Wisnivesky, MD, DrPH|212-824-7567|juan.wisnivesky@mountsinai.org|
20511642|NCT03125382|IMP|Drª. Milene Fernandes|00351965751328|milenefernandes@hotmail.com|
20511643|NCT06016556|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511644|NCT00629343|Columbia University|Robert Taub, MD, PhD|(212) 305-4076|rnt1@columbia.edu|
20511645|NCT04246593|State University of New York at Buffalo|Dr. Lucia Leone|(716) 829-6040|lucialeo@buffalo.edu|
20511646|NCT00429026|U.T. M.D. Anderson Cancer Center|Naoto Ueno, MD, PhD / Associate Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
20511647|NCT00620191|Columbia University Medical Center|Jose Luchsinger|212-3054730|jal94@cumc.columbia.edu|
20511648|NCT00903357|Department of Pediatrics, Soonchunhyang University Hospital|Bok Yang Pyun, M.D.|+82-2-709-9339|bypyun@hanmail.net|
20511649|NCT04930562|BioNova Pharmaceutical Limited Company|Medical Director|+86(21)50901280|yu.wang@bionovapharma.com|
20511650|NCT00889928|Ethicon Endo Surgery, Inc|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
20511651|NCT00678652|Clinical Trials Center, WRAIR|Paul B. Keiser, M.D.||noinformation@available.com|
20511652|NCT00674440|Children's Hospital of Philadelphia/Perelman School of Medicine, University of Pennsylvania|Lisa J. States, MD|267-425-7146|states@chop.edu|
20511653|NCT01990339|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20511654|NCT00928642|Madigan Army Medical Center|COL David E. McCune, MD, MC|253-968-1155|david.e.mccune.mil@mail.mil|
20511655|NCT04604015|NovaSignal|Manja Lenkin|8776387251|manja.lenkin@novasignal.com|
20511656|NCT02205177|Mayo Clinic|Stephen P Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
20511657|NCT02129192|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511658|NCT01143818|Abbott|Global Medical Services|800-633-9110||
20511659|NCT02576652|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20511660|NCT01756209|Pugliese Hospital of Catanzaro|Dr Francesco Peltrone, Responsible of clinical trial|+.39 0961 7123222|gallelli@unicz.it|
20511661|NCT02811640|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@toh.ca|81620
20511662|NCT02229513|Baylor University Medical Center|Dr. Janice Mitchell, PI|713-705-6240|janicemitchellmd@gmail.com|
20511663|NCT01633398|National University Health System, Singapore|Carolyn Lam|(65)67048965|carolyn.lam@duke-nus.edu.sg|
20511664|NCT04557189|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20511665|NCT01349816|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20511666|NCT01383317|Wake Forest University Health Sciences|Dr. Scott Miller|3367167437|scmiller@wakehealth.edu|
20511667|NCT01766024|BIOCAD|Director of Clinical Trials|7 (812) 380 49 33|biryulin@biocad.ru|925
20511668|NCT02569996|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
20511669|NCT01207427|Cubist Pharmaceuticals|Vice President Clinical Research|(781) 860-8660||
20511670|NCT02513732|Abbott|Hajime Kusano, Senior Adviser Clinical|+1 4088451626|hajime.kusano@abbott.com|
20511671|NCT00467051|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20559863|NCT03712098|SUNY Buffalo|Rebecca Ashare|7168296273|rlashare@buffalo.edu|
20559864|NCT02537444|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20559865|NCT01330355|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
20559866|NCT04830514|University of Arkansas for Medical Sciences|David D. Church, Ph.D., Assistant Professor|5015265709|dchurch@uams.edu|
20559867|NCT01275053|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
20559868|NCT01066156|Cambridge Health Alliance|Igor Elman|(617) 665-1000|ielman@challiance.org|
20559869|NCT01700673|Johns Hopkins University School of Medicine, Division of Hematologic Malignancies|Jonathan Webster, MD|4106149106|jwebst17@jhmi.edu|
20559870|NCT01052662|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
20511672|NCT02279082|Dr. Reddy's Laboratories|Clinical Operations Director|609-282-1476|kgulbronson@promiuspharma.com|
20511673|NCT02848781|College of Medicine - Phoenix|Rodrick Tung, MD|602-521-3090|rodricktung@arizona.edu|
20511674|NCT01171794|Stanford University School of Medicine|Grant S Lipman ( PI)|4152909286|lipmangrant@gmail.com|
20559871|NCT00401817|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
20511675|NCT01972282|St. Antonius Ziekenhuis, Nieuwegein, Netherlands|Dr. Lucas V.A. Boersma||l.boersma@antoniusziekenhuis.nl|
20511676|NCT00846573|UMass Medical School|Dr. Mitchell Albert|(617) 875-2141|albertmi@tbh.net|
20559872|NCT02071095|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
20559873|NCT03023332|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
20559874|NCT01852955|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
20559875|NCT01627340|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559876|NCT01272011|Malcom Randall VAMC|Dr. Nicole Tester|352-376-1611|ntester@phhp.ufl.edu|7507
20559877|NCT06096181|Cedars-Sinai Medical Center|Glenn Tan, MD|310-423-5841|Glenn.Tan@cshs.org|
20559878|NCT02240680|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20559879|NCT01657032|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Pieścik-Lech|+48-22-45-23-309|hania@ipgate.pl|
20505489|NCT02517047|Boston Children's Hospital|Dr. Wanda Phipatanakul|6173556117|wanda.phipatanakul@childrens.harvard.edu|
20511677|NCT05732610|Medical Group Care|Tomaz Lovse|239 631 1907|tomaz.lovse@mgc.us|
20511678|NCT00656669|IndianaU|Dr. Kathy Miller|317-944-0920||
20511679|NCT04717323|Altec Inc.|Dr. Paola Contessa|5085458236|pcontessa@altecresearch.com|
20511680|NCT01553708|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Associate Prof. Pornanong Aramwit, Pharm.D., Ph.D.|+66-02-218-8409|paramwit@gmail.com|
20511681|NCT03575806|Tsinghua University|Statistician of Clinical Trials||majunfan2@sina.com|
20511682|NCT00219349|New York State Psychiatric Institute|Franklin Schneier MD|2125435368|fschneier@nyspi.columbia.edu|
20511683|NCT03377803|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
20511684|NCT05461742|Brown University|Dr. Tayla von Ash|401-863-6192|tayla_ash@brown.edu|
20511685|NCT00270205|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20528475|NCT03338244|UC San Francisco - Proctor Foundation|Thomas Lietman|(415) 476-1442|tom.lietman@ucsf.edu|
20528476|NCT03162328|Philips|Gary Garcia|6085129475|gary.garcia@philips.com|
20528477|NCT03301831|Case Western Reserve University|Valerie Boebel Toly, PhD, RN, CPNP|(216) 368-3082|vab@case.edu|
20505490|NCT03103750|Yale School of Medicine|Marc Potenza, PhD, MD|(203) 974-7356|marc.potenza@yale.edu|
20505491|NCT01663740|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20505492|NCT01522651|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20505493|NCT02658656|James J Peters VA Medical Center|Dr. Ann Spungen, Study Chairperson|7185849000|ann.spungen@va.gov|5814
20505494|NCT03624101|University of Alabama at Birmingham Child Health Research Unit|Heather Hathorne|2055032829|hyhathorne@uabmc.edu|
20505495|NCT04267562|MicroCube, LLC|Dinesh Mody|(510) 651-5000|m@minitouch.us|
20505496|NCT00912158|Chest Department, Faculty of Medicine, Assiut University- EGYPT|Dr. Maha K Ghanem, MD, FCCP|+ 2 0127694434|mahaghanem@hotmail.com|
20505497|NCT02338076|Rockefeller University|Dr. Emma Guttman|212-327-8333|skhattri@rockefeller.edu|
20505498|NCT03459131|Alcon, A Novartis Division|Sr Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20505499|NCT00408421|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20505500|NCT02772965|University of North Carolina at Chapel Hill|Michael Kappelman, MD, MPH|919-966-1343|michael_kappelman@med.unc.edu|
20505501|NCT03478878|National Institutes of Health|Emily Chew, MD, Principal Investigator, NEI|3014966583|emily.chew@nih.gov|
20505502|NCT03046472|Maccabi Health services and Wingate college|Neta Vitman|0508955529|vitmanan@gmail.com|
20505503|NCT01614769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505504|NCT02115815|MedImmune, LLC|Judith Falloon, MD|301-398-5000|falloonj@medimmune.com|
20505505|NCT01989546|National Cancer Institute|Dr. Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
20505506|NCT03960138|University of Missouri|Dr. Brett Froeliger|5738824785|froeligerb@health.missouri.edu|
20505507|NCT04688346|University of Washington|Dr. Travis Nelson|206-290-2899|tmnelson@uw.edu|
20505508|NCT04439838|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505509|NCT01741272|Alberta Health Services|Dr. Robert Balyk|7804395858|rbalyk6@aol.com|
20505510|NCT01958671|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505511|NCT02778867|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
20505512|NCT01290484|Stanford University|Dr. Alfred Lane|650-721-7170|alfred.lane@stanford.edu|
20511686|NCT03446846|Minerva Neurosciences, Inc.|Head of Research & Development|617.600.7375|jsaoud@minervaneurosciences.com|
20511687|NCT00066573|NCIC Clinical Trials Group|Dr. Wendy Parulekar|1-613-533-6430|wparulekar@ctg.queensu.ca|
20511688|NCT00869362|Massachusetts General Hospital Diabetes Center|Deborah J. Wexler MD|617-726-8722|dwexler@partners.org|
20511689|NCT02147132|UC COM Psychiatry Dept. -- Addiction Sciences Division|Jeff Theobald|5135858281|theobajy@ucmail.uc.edu|
20511690|NCT00808769|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
20511691|NCT02842736|Channel Medsystems|Clinical and Regulatory Affairs|510-338-9301|clinreg@channelmedsystems.com|
20511692|NCT00453336|University of Miami Sylvester Comprehensive Cancer Center|Francisco Civantos MD|305-243-5276|fcivanto@med.miami.edu|
20528478|NCT00913770|Yale University|Gail D'Onofrio, MD, MS|203-785-4404|gail.donofrio@yale.edu|
20528479|NCT02348008|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20528480|NCT03852498|bluebird bio, Inc|Study Medical Director|+1-833-999-6378|clinicaltrials@bluebirdbio.com|
20528481|NCT01446250|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20528482|NCT03268005|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20528483|NCT00980655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559880|NCT03633903|Laureate Institute for Brain Research|Namik Kirlic, PhD|918-502-5747|nkirlic@laureateinstitute.org|
20559881|NCT01657682|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20559882|NCT00525057|UT MD Anderson Cancer Center|Patrick Lin, MD/Professor, Orthopaedic Oncology|(713) 745-0088|plin@mdanderson.org|
20559883|NCT02150044|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20559884|NCT01719861|Stanford University Medical Center|Joel Neal, MD, PhD; Assistant Professor of Medicine|650-725-3081|jwneal@stanford.edu|
20559885|NCT04183192|U.S. Food and Drug Administration|David Strauss, MD, PhD|3017966323|David.Strauss@fda.hhs.gov|
20559886|NCT00628628|The University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
20559887|NCT02839681|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
20559888|NCT01653847|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
20559889|NCT02165124|Johns Hopkins Univesity|Dr. Clifford Weiss|4106141046|cweiss@jhmi.edu|
20528484|NCT03939533|CRMG|Patrick Murphy|413-821-0022|p.murphy@crmg-usa.com|
20528485|NCT00357890|Nemours Children's Health|Larry A Fox, MD|9046973600|larry.fox@nemours.org|
20528486|NCT00248833|WRAIR|Paul B. Keiser|866-856-3259|clinical1@na.amedd.army.mil|
20528487|NCT02427802|Innocoll|Lesley Russell, MBChB, MRCP, Chief Medical Officer|484-406-5206|lrussell@innocoll.com|
20528488|NCT02672176|University of California, Davis|Heather M. Young, Principal Investigator|916-734-4745|hmyoung@ucdavis.edu|
20528489|NCT02823470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20528490|NCT02748057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20528491|NCT03834025|University of North Carolina at Chapel Hill|Marisa Domino, PhD|919-966-3891|domino@unc.edu|
20528492|NCT04541329|University of California, San Francisco|Raymond Cho, MD, PhD|415 353 7800|rashes@ucsf.edu|
20528493|NCT02793947|University of Iowa Hospitals and Clinics|Dr. Michael Willey|319-384-8452|michael-willey@uiowa.edu|
20528494|NCT02179047|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
20528495|NCT02213380|The second affiliated hospital and Yuying children's hospital of Wenzhou medical university|Ting Li|008613587876896|liting1021@aliyun.com|
20528496|NCT02090777|Duke Eye Center|Jullia Rosdahl MD PhD|919-684-8850|jullia.rosdahl@duke.edu|
20528497|NCT03063619|M D Anderson Cancer Center|Dr. Banu Arun|(713) 792-2817|barun@mdanderson.org|
20528498|NCT01563198|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant)|617 734 9087|drevlang@gmail.com|
20528499|NCT01490840|Novartis|Study Director|862-778-8300||
20528500|NCT03639857|University of Central Florida College of Medicine|Dr. David Weinstein|407-266-4900|david.weinstein@ucf.edu|
20528501|NCT01025284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20528502|NCT01465230|Yale University|Dr. Terri Parker|203-737-5312|terri.parker@yale.edu|
20528503|NCT00905567|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20528504|NCT02542397|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
20528505|NCT00389467|Georgetown University|Chelsea S. Kidwell, MD|202-687-7302|ck256@georgetown.edu|
20528506|NCT02362191|University of North Carolina at Chapel Hill|David Rubinow, MD|919-445-0220|drubinow@med.unc.edu|
20528507|NCT01738919|Aarhus University Hospital|Janni Kjaergaard Thillemann|+45 28137303|teamjanni@gmail.com|
20528508|NCT01473940|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
20528509|NCT00547248|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528510|NCT00534248|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
20528511|NCT02020369|LFB USA Inc.|Jeffry Lawrence, MD, Vice President, Clinical Development|+1.508.370.5113|jeffry.lawrence@lfb-usa.com|
20528512|NCT02532257|The University of Texas MD Anderson Cancer Center|Loretta Nastoupil, MD|(713) 792-2860|lnastoupil@mdanderson.org|
20528513|NCT02849171|Memorial Sloan Kettering Cancer Center|Ronald Blasberg, MD|646-888-2211|blasberr@mskcc.org|
20528514|NCT02090283|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
20559890|NCT00768599|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
20528515|NCT03132415|University of Pennsylvania|Jose Bauermeiser|215-898-9993|bjose@upenn.edu|
20528516|NCT00459810|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|(503) 494-2897|eilersk@ohsu.edu|
20528517|NCT02224612|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
20559891|NCT01845636|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
20559892|NCT02015195|Division of Emergency Medicine, Department of Surgery, Stanford University School of Medicine|Paul Auerbach, MD|650.725.9445|auerbach@stanford.edu|
20559893|NCT01318811|Vanderbilt_Univeristy MC|Dr. Thomas Golper|615-322-5914|thomas.golper@vumc.org|
20559894|NCT00131911|Mayo Clinic Cancer Center|Timothy J. Hobday M.D.||Hobday.timothy@mayo.edu|
20559895|NCT02402764|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hyo Sook Han|813-745-8960|hyo.han@moffitt.org|
20559896|NCT05768945|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20559897|NCT01670500|DFCI|Project Manager|617-632-2257|CTOPM@dfci.harvard.edu|
20559898|NCT03658811|Toyos Clinic|Dillon O'Brien|6153274015|dobrien@toyosclinic.com|6
20559899|NCT04951479|UPMC|Anish Ghodadra, MD|4126470104|ghodadraa@upmc.edu|
20559900|NCT02507219|Laureate Institute for Brain Research|Dr. Martin Paulus|918-502-5120|mpaulus@laureateinstitute.org|
20559901|NCT05397470|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
20559902|NCT00394095|University of Cincinnati|Melissa DelBello, MD|513-558-4489|melissa.delbello@uc.edu|
20559903|NCT01256476|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
20559904|NCT02401529|King Fahd General Hospital|Dr Faris Ahmed Bahammam|00966554699544|dr_farisbahammam@yahoo.com|
20559905|NCT04034238|National cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
20559906|NCT02651103|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
20559907|NCT01106287|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559908|NCT01789203|Methodist Hospital|Samir Patel|267-808-0577|spatel2@houstonmethodist.org|
20559909|NCT00951561|Another Way Products|Charles Tepper|917-538-6894|charles_tepper@yahoo.com|
20559910|NCT05176353|University of Michigan|Owen Albin, MD|734.232.1871|oalbin@med.umich.edu|
20559911|NCT01254305|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20559912|NCT00765362|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|1323
20559913|NCT04365413|University of Oklahoma Health Sciences Center, Stephenson Cancer Center|Lacey McNally|405-325-0789|lacey-mcnally@ouhsc.edu|
20559914|NCT02037061|Cleveland Clinic|Dr. Cecile Unger|216-444-0542|ungerc@ccf.org|
20559915|NCT03019458|Sunshine Care Foundation|Dr. Patrick Acuna|+63 947 959-1851|patrick_acuna@hotmail.com|
20559916|NCT00557505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559917|NCT00031447|Collaborative Antiviral Study Group|Penelope M Jester|205-934-2424|pjester@peds.uab.edu|
20559918|NCT01636362|Molnlycke Health Care AB|Joan Wilson|706 504 8997|joan.wilson@molnlycke.com|
20559919|NCT00519779|The Ohio State University|Dr. Janice Kiecolt-Glaser|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
20559920|NCT03330119|Main Line Health System|Dr. Norman Brest|484-476-2325|brestn@mlhs.org|
20559921|NCT01561079|Johns Hopkins University School of Medicine|Dr. Lauren M Jansson|410-550-5438|ljansson@jhmi.edu|
20559922|NCT02062905|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
20559923|NCT00664521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20559924|NCT01323660|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559925|NCT00751790|Debiopharm S.A.|Eija Lundström|+41 21 3210111|elundstrom@debiopharm.com|
20559926|NCT01276535|Westlake Dermatology|Gregory A. Nikolaidis, MD|512-328-3376|karen@westlakedermatology.com|
20559927|NCT02949518|Hospital for Special Surgery|Dr. Ellen Soffin|212-606-1206|soffine@hss.edu|
20559928|NCT01106976|VAAAHS|Nicolaas Bohnen|7349988400|Nicolaas.Bohnen@va.gov|
20559929|NCT03560141|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20559930|NCT05677867|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559931|NCT05570747|Bleep, LLC|Stuart Heatherington, Founder and Executive Chairman of Bleep|(919) 619-7170|stuart@bleepsleep.com|
20559932|NCT01521949|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
20559933|NCT02783482|Green Cross Corporation|Clinical Project Manager|82 31 260 9472|sungsil.lee@gccorp.com|
20559934|NCT01341080|Rush University Medical Center|Deborah A Hall MD PhD|312-563-2900|Deborah_A_Hall@rush.edu|
20559935|NCT03836664|University of Kansas Medical Center|Dr Dipika Aggarwal, Clinical Assistant Professor|9139459926|daggarwal@kumc.edu|
20559936|NCT03566680|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
20559937|NCT02724020|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20551107|NCT03325075|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20551108|NCT04210310|NYU Langone Health - Preston Robert Tisch Center for Men's Health|Lawrence Newman, MD|646-754-2000|Lawrence.Newman@nyulangone.org|
20551109|NCT00862745|University of California, San Francisco|Dr. Jeanette Brown|415-353-9751|brownj@obgyn.ucsf.edu|
20551110|NCT00697203|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20551111|NCT02617511|University of Manitoba|Dr. Stephen Cornish|204-474-9981|Stephen.Cornish@umanitoba.ca|
20551112|NCT00255047|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20551113|NCT00811473|AstraZeneca|Gerard Lynch||aztrail_results_posting@astrazeneca.com|
20551114|NCT04127331|Nationwide Children's Hospital|Dr. Alok Moharir|614-722-4200|alok.moharir@nationwidechildrens.org|
20551115|NCT02704975|United States Army|Rob Halle|910-689-8887|robhalle@gmail.com|
20551116|NCT01585194|MD Anderson Cancer Center|Dr. Sapna P. Patel/Associate Professor, Melanoma Medical Oncology|713-792-2921|sppatel@mdanderson.org|
20551117|NCT00732615|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20559938|NCT00425503|Baylor College of Medicine|Dr. Teresa Hayes - Associate Professor|713-794-7368|thayes@bcm.edu|
20559939|NCT02179918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559940|NCT00276250|Emory University|Nicole Turgeon, MD|404-727-3257|nturgeo@emory.edu|
20559941|NCT03189134|Boston Children's Hospital|Aditya K. Kaza, MD|617-355-7932|aditya.kaza@cardio.chboston.org|
20559942|NCT02118714|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20559943|NCT02954575|Octapharma AG|Cristina Solomon|+41 (0)55 451 21 89|Cristina.Solomon@octapharma.com|
20559944|NCT00229619|NIH National Heart, Lung and Blood Institute|Adrian Wiestner MD, NHLBI|301-594-6855|wiestnera@nhlbi.nih.gov|
20559945|NCT00570661|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
20559946|NCT01734382|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20559947|NCT03890120|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20559948|NCT04537949|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20559949|NCT04081298|Fred Hutchinson Cancer Center|Heather Greenlee|206-667-4502|hgreenlee@fredhutch.org|
20559950|NCT00479674|Duke University Medical Center|Dr. Kimberly Blackwell|919-668-1748|black034@duke.edu|
20559951|NCT01054911|University of Alabama in Birmingham, Comprehensive Cancer Center|Dr. James Posey, MD|205-934-0916|jposey@uabmc.edu|
20559952|NCT00905060|University of California, Davis|Dr. Orin Bloch, MD||obloch@ucdavis.edu|
20559953|NCT03293485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20559954|NCT00087490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20559955|NCT00761774|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20559956|NCT01077024|University of Cincinnati Addiction Sciences Division|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
20559957|NCT00755755|PregLem S.A.|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
20559958|NCT02300311|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20559959|NCT02687919|University of Iowa|Amanda Irish||amanda.k.irish@gmail.com|
20559960|NCT00419003|Baylor College of Medicine|Dr. Sanjay Mathew|7137985439|sjmathew@bcm.edu|
20559961|NCT00772928|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20559962|NCT01653743|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20559963|NCT03748771|University of California San Diego|Dr. Rakesh Bhattacharjee|858-966-5846|rlbhattacharjee@ucsd.edu|
20511693|NCT01002118|University of Iowa|Jennifer Robinson|319-384-1563|jennifer-g-robinson@uiowa.edu|
20511694|NCT02646566|Acacia Pharma|Dr Gabriel Fox|01223875919764|GabrielFox@acaciapharma.com|
20559964|NCT02444143|University of Illinois at Chicago|Dr. Patricia West-Thielke|312-996-5695|pwest@uic.edu|
20559965|NCT00483262|Dana-Farber Cancer Institute|Irene Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
20559966|NCT00832260|Hospital Universitari i politecnic La Fe|Dr. José Olagüe|+34 961 24 40 00|jolague@terra.com|
20559967|NCT04992442|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20559968|NCT02303574|AstraZeneca|Bengt Larsson|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20559969|NCT01359410|Washington University School of Medicine|William Hawkins, M.D.|314-362-7046|hawkinsw@wustl.edu|
20559970|NCT05590910|UT Health San Antonio-Faculty; Texas Woman's University-Student|Jorgie Ann Contreras|2107235319|contrerasj6@uthscsa.edu|
20559971|NCT00994279|Wake Forest NCI NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20559972|NCT01606189|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20559973|NCT01354938|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954||
20559974|NCT01167023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20559975|NCT00410384|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559976|NCT02206685|Baylor College of Medicine|Kim P. Nguyen, MD, Principal Investigator|832-824-5907|kpnguyen@texaschildrens.org|
20559977|NCT01345292|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20559978|NCT01385280|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
20559979|NCT01893320|The University of Texas MD Anderson Cancer Center|Naval Daver MD, Associate Professor|713-794-4392|NDaver@mdanderson.org|
20559980|NCT00465361|Children's Mercy Hospitals and Clinics|Sarah S. Nyp|816-234-3000|ssnyp@cmh.edu|
20559981|NCT05406791|University of Illinois at Chicago|Colleen Stiles-Shields, PhD|312-413-1128|ecss@uic.edu|
20559982|NCT00515086|Novartis Pharmaceuticals|Study Director|862-778-8300||
20559983|NCT02373813|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20559984|NCT02967016|Rutgers SUNJ|Dr. Antonio Gonzalez|4133869415|ajantoni@gmail.com|
20559985|NCT01447914|University of Texas (UT) MD Anderson Cancer Center|Robert Orlowski, MD, PhD / Professor, Department of Lymphoma/Myeloma|713-792-2860|ROrlowski@mdanderson.org|
20559986|NCT05967442|Advocate Christ Medical Center|Marc McDowell|708684800|marc.mcdowell@aah.org|
20559987|NCT01511536|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20559988|NCT02357758|London Health Sciences Centre|Dr. Sumit Dave|519.685.8439|Sumit.Dave@lhsc.on.ca|
20559989|NCT02297503|Galderma|Maria Norberg|+46184891267|maria.norberg@galderma.com|
20511695|NCT02806700|Center for Digital Health|Director of Research|2674280125|digitalhealth@uphs.upenn.edu|
20511696|NCT00830310|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
20511697|NCT01050998|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
20559990|NCT02021461|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
20559991|NCT02703532|Emory University|Sarah Blanton, PT, DPT, NCS, FNAP|404-712-2222|sblanto@emory.edu|
20559992|NCT01161160|GlaxoSmithKline|GSK Response Center|866-435-7343||
20559993|NCT03738241|Baylor College of Medicine|Hana El Sahly, MD, FIDSA|713-798-2058|hana.elsahly@bcm.edu|
20559994|NCT01244763|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
20559995|NCT04170023|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20559996|NCT04003974|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
20559997|NCT02400307|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20559998|NCT03248440|Senju USA, Inc.|Takahiro Ogawa, PhD|+1 818 719 7190|ogawataka@senju-usa.com|
20559999|NCT02015663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20560000|NCT02987829|Tracon Pharmaceuticals Inc.|Charles Theuer, MD PhD|8585500780|ctheuer@traconpharma.com|
20560001|NCT01911221|Novartis Vaccines and Diagnostics|Posting Director||RegistryCpontactVaccinesUS@novartis.com|
20560002|NCT02531438|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
20560003|NCT04653051|Zimmer Biomet|Georgia Tsapara|+41 79 94 54936|georgia.tsapara@zimmerbiomet.com|
20560004|NCT01813422|Amgen Inc.|Study Director|866-572-6436||
20560005|NCT00811187|Montefiore Medical Center|Research Program Administrator|718-405-8526|fheitor@montefiore.org|
20560006|NCT00329303|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20560007|NCT03704298|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20560008|NCT00558753|Rush University Medical Center|Asokumar Buvanendran, M.D.|(312) 942-3685|asokumar@aol.com|
20560009|NCT00487721|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848 0655|Thomas.Flaig@ucdenver.edu|
20560010|NCT00310362|MInneapolis VA Health Care System|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu|
20560011|NCT03453385|Medical University of South Carolina (MUSC)|Dr. Matthew Carpenter|843-876-2436|carpente@musc.edu|
20505513|NCT00960440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560012|NCT00577629|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
20560013|NCT04159896|Karmanos Cancer Institute|Dr. Elisabeth Heath|313.576.8734|heathe@karmanos.org|
20560014|NCT01449721|Christiana Care Health System|Ryan Arnold, MD, Director of Research, Emergency Medicine|302-733-5108|ryarnold@christianacare.org|
20560015|NCT03864133|Wake Forest University Health Sciences|Keith Walter, MD|336-716-3937|kwalter@wakehealth.edu|
20560016|NCT02668432|University of Texas Health San Antonio|Bethany Kalich, PharmD|210-883-1177|kalich@uiwtx.edu|
20560017|NCT01577732|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560018|NCT03706690|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20560019|NCT03803774|National Cancer Institute|Dr. Vassiliki Saloura|240-760-6352|vassiliki.saloura@nih.gov|
20560020|NCT04019561|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20560021|NCT05781490|Lument AB|Dr Jan Marsal|+46709822008|jan.marsal@med.lu.se|
20560022|NCT02044419|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
20560023|NCT03212365|University of Utah|Christopher Pannucci, MD|801 581 2121|christopher.pannucci@hsc.utah.edu|
20560024|NCT03713645|Temple University Hospital, Inc.|Adam Diamond, PharmD, BCPS, FAST|215-280-8041|adam.diamond@tuhs.temple.edu|
20560025|NCT01342887|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS||rwalter@fredhutch.org|
20560026|NCT01031043|Georgia Regents University|Gregory N. Postma MD|706-721-6100|gpostmat@gru.edu|
20560027|NCT04880161|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
20560028|NCT01354106|cyberDERM|Dr. Gary Grove|610-325-0112|GGrove@cyberderm-inc.com|
20560029|NCT00231179|Children's Hospital of Philadelphia|Jerilynn Radcliffe, PhD|215-590-7446|Radcliffe@email.chop.edu|
20560030|NCT02068729|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
20560031|NCT01764386|Orexigen Therapeutics, Inc.|Executive Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
20560032|NCT02788656|Brigham and Women's Hospital|Akshay Desai|617-732-7046|adesai@bwh.harvard.edu|
20560033|NCT03169361|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20560034|NCT02263885|InSightec|Nadir Alikacem, PhD|214-630-2000|nadira@insightec.com|
20560035|NCT02271594|BD|Dr. Ken Strauss|32475380454|kenneth.strauss@bd.com|
20560036|NCT04446975|UNMC|Dr. Karsten Bartels|(402) 559-4081|anesthesiology.research@unmc.edu|
20560037|NCT00495469|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560038|NCT01819415|Maisonneuve-Rosemont Hospital|Dr. Flavio Rezende|514-867-2990|frezendef@hotmail.com|
20560039|NCT04454567|Assembly Biosciences|Executive Director of Clinical Operations|833-509-4583|Clinicaltrials@assemblybio.com|
20560040|NCT03815916|Clene Nanomedicine|Jeremy Evan, PA-C|5419086335|jeremy@clene.com|
20505514|NCT01070303|Abbott|Global Medical Services|800-633-9110||
20505515|NCT03121352|University Hospitals|Joseph Baar|216-844-8683|joseph.baar@uhhospitals.org|
20505516|NCT01505491|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505517|NCT02191917|BioMarin Pharmacuetical Inc.|Trial Specialist|1-800-983-4587|medinfo@bmrn.com|
20505518|NCT00859898|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
20505519|NCT03408873|Case Western Reserve University and University Hospitals Cleveland Medical Center|Joy Yala, MPH|216-368-0783|jxy790@case.edu|
20505520|NCT01312428|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
20505521|NCT04860713|Maimonides Medical Center|Research Administration Director|718-283-6896|alikourezos@maimonidesmed.org|
20505522|NCT01797783|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-888-451-3937|alcon.medinfo@alcon.com|
20505523|NCT02786355|UBC Department of Anesthesia - BC Women's Hospital|James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
20505524|NCT04412954|Ohio State Univeristy|Sandy Solove|6142478366|solove.3@osu.edu|
20528518|NCT00697593|Merck Serono S.A., a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20560041|NCT03748264|Philips|Jeff Jasko|4125423651|Jeff.Jasko@philips.com|
20560042|NCT01123161|Cedars-Sinai Medical Center|Dr. Patrick Lyden|310-423-5166|lydenp@cshs.org|
20560043|NCT02459964|UT MD Anderson Cancer Center|Sai-Ching J. Yeung, MD, Professor, Emergency Medicine|(713) 745-9911|syeung@mdanderson.org|
20560044|NCT00550732|Merck Sharp & Dohme Corp.|Senior Vice President, Globalo Clinical Development||ClinicalTrialsDisclosure@merck.com|
20560045|NCT02435901|Northwell Health System Cohen Children's Medical Center of NY|Indira Sahdev, MD|7184703460|isahdev@northwell.edu|
20560046|NCT00926393|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20560047|NCT03311854|Sobi AG|Veronica Asnaghi, MD|+41 61 201 13 20|veronica.asnaghi@sobi.com|
20560048|NCT01207934|Washington University School of Medicine|Samuel Klein, MD|3143628708|sklein@wustl.edu|
20560049|NCT02307123|Tampere University Hospital|Toni Pakkanen, MD|358408227209|toni.pakkanen@icloud.com|
20560050|NCT00106431|Celgene Corporation|Elizabeth Faust, PhD, Vice President, Clinical Research Services|617/583-1300|EFaust@Celgene.com|
20511698|NCT00265109|Weill Cornell Medicine|Katharine A. Phillips MD|646-962-2820|kap9161@med.cornell.edu|
20560051|NCT03302910|Indiana University School of Medicine|Peter S. Pang|317-880-3900|ppang@iu.edu|
20560052|NCT00707863|Indiana Uiniveristy|Amit Anand MD|3172747422|aanand@iupui.edu|
20560053|NCT02223689|Medline Industries, Inc.|Lori Rotolo|8476434640|lrotolo@medline.com|
20560054|NCT00051311|National Cancer Institute|Dr. Ronald Gress|240-760-6167|Ronald_Gress@nih.gov|
20560055|NCT00953160|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
20560056|NCT01427907|Fresenius Medical Care, North America|Mayuri Thakuria MD (MBBS), MPH|781-699-4645|mayuri.thakuria@fmc-na.com|
20560057|NCT01328587|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
20560058|NCT03413605|Center for Asian Health, Lewis Katz School of Medicine, TempleUniversity|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
20560059|NCT00674492|Center for Healthcare Organization and Implementation Research|Jack A. Clark, PhD|781.687.2937|Jack.Clark@va.gov|
20560060|NCT00335153|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20560061|NCT04038099|UT Southwestern Medical Center|Christina Hicks, MS, APRN, WHNP-BC, FAUNA|2146453848|christy.hicks@utsouthwestern.edu|
20560062|NCT03688542|Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
20560063|NCT01113463|University of Texas MD Anderson Cancer Center|Charles A. Conrad, MD / Professor, Neuro Oncology|713-792-2883|CR_Study_Registration@mdanderson.org|
20560064|NCT02724787|James A. Haley Veterans' Hospital|Dr. Shannon Miles|813-972-2000|shannon.miles@va.gov|6728
20560065|NCT02478359|Kaiser Permanente|Huong Q2 Nguyen, Research Scientist|626-564-3935|huong.q2.nguyen@kp.org|
20560066|NCT01818700|Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University school of medicine, Seoul Korea|Dr. Whan Eoh|82-2-3410-3491|w.eoh@samsung.com|
20560067|NCT01417000|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
20560068|NCT00562965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560069|NCT00958009|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
20560070|NCT02284464|Hospital Regional Universitario de Málaga|Dr. Domingo Hernandez|951291174|domingohernandez@gmail.com|
20560071|NCT03379233|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20560072|NCT00965484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560073|NCT00848211|Thymon LLC|Gideon Goldstein, MD, PhD|(973) 467-9558|gidgold@gmail.com|
20560074|NCT01124617|Neuroscience department, clinical science department, R&D in Janssen Japan, Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
20560075|NCT00945477|Illinois CancerCare, P.C.|James Knost, M.D.|309-243-3000|jknost@illinoiscancercare.com|
20560076|NCT02825043|University of Oklahoma Health Sciences Center Dept. of Medicine|Clinical Trials Manager|(405)271-6651|research@ouhsc.edu|
20560077|NCT00083174|Canadian Cancer Trials Group|Senior Biostatistician|613-533-6430|dtu@ctg.queensu.ca|
20560078|NCT03582137|University of Colorado|Maureen Leehey, MD|3037248288|maureen.leehey@cuanschutz.edu|
20560079|NCT04582045|HealthPartners Institute|Linda M. Loes|952-967-7862|linda.m.loes@healthpartners.com|
20560080|NCT00859014|University of Texas Health Science Center|Dr. Sean I. Savitz, Professor and Director of Stroke|713.500.7083|sean.i.savitz@uth.tmc.edu|
20560081|NCT00162942|Otsuka America Pharmaceutical, Inc|Tao Wang|240-683-3213|tao.wang@otsuka-us.com|
20560082|NCT01253200|Boston Scientific|Timothy Meyer; Director of Clinical Trials|651 581 3425|Timothy.meyer@bsci.com|
20560083|NCT02049437|University Hospitals Cleveland Medical Center|Marijke Frederix, PhD|(216) 844-0383|marijke.frederix@UHhospitals.org|
20560084|NCT00783718|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20560085|NCT02706626|Criterium, Inc.|Tom Stinchcombe|9196819509|Thomas.stinchcombe@duke.edu|
20560086|NCT01055782|Specialist Doctors Rolighedsvej|Lene Hendel MD|+4545819090|lene@hendel.dk|
20560087|NCT01163149|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
20560088|NCT01027871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20560089|NCT03782727|Cardiff and Vale University Health Board|Dr Rachel Abbott|02920743181|rachel.abbott@wales.nhs.uk|
20560090|NCT02405390|Nicklaus Children's Hospital|Jose M. Vargas Loayza, M.D.|786-624-3588|jose.vargas-loayza@mch.com|
20560091|NCT04887285|Northwestern University|Steven P. Cohen|312-695-2500|steven.cohen@northwestern.edu|
20560092|NCT04640571|University of Maryland, Baltimore|James Polli|410-465-3466|jpolli@rx.umaryland.edu|
20560093|NCT04515797|Massachusetts General Hospital|Dr. Raymond Chung|6177247562|Chung.Raymond@mgh.harvard.edu|
20560094|NCT02774213|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
20560095|NCT04883346|Section on Growth and Obesity, NICHD, NIH|Jack A. Yanovski, MD, PhD|301-496-0858|yanovskj@mail.nih.gov|
20560096|NCT04736056|Duke University|Hannah Fisher, PhD|919-416-3471|hannah.fisher@duke.edu|
20511699|NCT02967393|Vanderbilt University Medical Center|Kathryn M. Edwards MD|615-322-8792|kathryn.edwards@vanderbilt.edu|
20560097|NCT04529538|PATH|Chris Gast, Ph.D.|206-285-3500|cgast@path.org|
20528519|NCT03498313|University of Illinois at Chicago|Dr. Tory Eisenlohr-Moul, Assistant Professor of Psychiatry|859-317-0503|temo@uic.edu|
20528520|NCT04026750|High Point Clinical Trials Center|Melanie Fein, MD|1-336-841-0700|mfein@highpointctc.com|2530
20528521|NCT02964338|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20560098|NCT02223182|DBV Technologies|Pharis Mohideen, MD Chief Medical Officer|908-679-5200|clinicaltrials@dbv-technologies.com|
20505525|NCT00748826|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20505526|NCT02214186|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|M.D. Wallace Andrino da Silva|+551126616787|wallaceandrino@yahoo.com.br|
20505527|NCT01525849|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|
20505528|NCT00793819|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
20505529|NCT02560701|Harvard Pilgrim Health Care Institute|Dr. J. Frank Wharam|(617) 867-4948|jwharam@post.harvard.edu|
20505530|NCT05748925|mansoura urology and nephrology center|Nourelsabah Mohamed Elbialy , consaltant nephrology|01065619243|nourelsabah@mans.edu.eg|
20505531|NCT01776268|Vanderbilt University Medical Center|James Wynn MD||james.wynn@peds.ufl.edu|
20505532|NCT01847547|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505533|NCT04392011|Washington State University|Dr. Mary Paine|509-358-7759|mary.paine@wsu.edu|
20505534|NCT00611130|Catalyst Pharmaceutical Partners, Inc.|M Douglas Winship|305-529-2522|dwinship@catalystpharma.com|12
20505535|NCT01765647|University of Alberta|Dory Sample|780-248-5599|dory.sample@ahs.ca|
20505536|NCT03662334|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
20505537|NCT00691197|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20505538|NCT00298610|Walter Reed Army Institute of Research|Shon A. Remich, MD|254-733-628-670|sremich@hotmail.com|
20505539|NCT01734993|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20505540|NCT03694522|Amgen|Study Director|866-572-6436|medinfo@amgen.com|
20505541|NCT02760407|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
20505542|NCT02522377|CLEVELAND CLINIC FOUNDATION|MURAT ALTINAY, MD|2164453359|altinam@ccf.org|
20505543|NCT01158950|University of California, San Francisco|Dr. Jennifer Mitchell|510-985-3522|jennifer.mitchell@ucsf.edu|
20505544|NCT02137772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505545|NCT01844700|Zucker Hillside Hospital, Division of Psychiatry Research|Anil Malhotra, MD|718-470-8281|amalhotra@nshs.edu|
20505546|NCT03809546|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20505547|NCT00501852|Novartis Pharmaceuticals|Study Director|862-778-8300||
20505548|NCT01171521|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
20505549|NCT01927562|Fractyl|Sarah Hackett|617-596-9522|shackett@fractyl.com|
20505550|NCT00652093|Translational Pain Research, University of Rochester Medical Center|Dr. John D. Markman, MD|585-276-3616|john_markman@urmc.rochester.edu|
20505551|NCT02213757|MHRI|Dr. Richter|2028776526|Lee.Ann.Richter@medstar.net|
20505552|NCT01422304|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505553|NCT02722577|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China|Guodong Niu|+86(10)88398866|guodongniu@fuwai.com|
20505554|NCT03418662|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
20505555|NCT00866294|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505556|NCT02508701|Purdue University|Stewart Chang Alexander|765-427-9860|alexan90@purdue.edu|
20505557|NCT02167204|University of Washington|Hannah Linden|206-606-2053|hmlinden@uw.edu|
20505558|NCT01863563|Children's Hospital of the Kings Daughters|Craig Derkay, MD|757.668. 9327|Craig.Derkay@chkd.org|
20505559|NCT00734409|Duke University Health System|DaiWai M Olson, PhD RN|(919) 668-3751|Olson006@mc.duke.edu|
20505560|NCT03415464|FACULTY OF SPORT|Vedran Hadzic|+38615207700|vedran.hadzic@fsp.uni-lj.si|728
20505561|NCT02273323|Unilever R&D Vlaardingen|Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
20505562|NCT03117049|Ono Pharmaceutical Co. Ltd|Medical Information Center|---|clinical_trial@ono.co.jp|
20505563|NCT00839098|Human Engineering Reserach Laboratories|Clinical Coordinator|412-822-3700|annmarie.kelleher@va.gov|
20505564|NCT00798967|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20505565|NCT01354691|Bar Ilan University|Jonathan Rabinowitz, PhD||jonathan.rabinowitz@biu.ac.il|
20505566|NCT03090737|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20505567|NCT03141307|University of Utah|Dr. Bob Wong|801-587-9666|bob.wong@nurs.utah.edu|
20505568|NCT00227877|Boston Children's Hospital - Center for Adolescent Substance Use and Addiction Research|Sion Kim Harris, PhD|857-218-4304|sion.harris@childrens.harvard.edu|
20505569|NCT01452425|UCLouvain|Pr Patrice Forget|3227641821|forgetpatrice@yahoo.fr|
20505570|NCT03458000|George Washington University|Dr. Andrew Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
20505571|NCT00328263|Bio-K+ International Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
20505572|NCT02522481|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
20505573|NCT03123939|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20505574|NCT01115569|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
20505575|NCT01254604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505576|NCT03504774|Stanford University School of Medicine|Sayantani B. Sindher, MD|650-521-7237|tina.sindher@stanford.edu|
20505577|NCT01781429|BioMed Valley Discoveries|Brent Kreider, PhD|816-960-4644|bkreider@biomed-valley.com|
20511700|NCT00895817|Walter Reed Army Medical Center|Dr. Fouad J Moawad|(301) 295-4600|fouad.moawad@us.army.mil|
20511701|NCT00234533|Ipsen|Medical Director, Pediatric Endocrinology||clinical.trials@ipsen.com|
20511702|NCT02967055|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
20511703|NCT04717466|University of Miami|Dr. Hideki Mochizuki|305-234-4472|hxm414@med.miami.edu|
20511704|NCT05705544|Vanderbilt University Medical Center|Dr. Fabian Maldonado|(615) 322-5000|fabien.maldonado@vumc.org|
20511705|NCT03550989|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20511706|NCT05437211|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20511707|NCT00740129|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20511708|NCT04081727|ZSX Medical, LLC|Director of Clinical Affairs|617-631-8865|info@zsxmedical.com|
20511709|NCT05664672|Altria|Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
20511710|NCT00617942|Brown University Oncology Research Group (BrUOG)|William Sikov, MD|4018633000|BrUOG@brown.edu|
20511711|NCT04095039|Duke University School of Medicine|Hrishikesh Chakraborty, DrPH|919-668-1238|hrishikesh.chakraborty@duke.edu|
20511712|NCT04768881|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20511713|NCT04236986|Yale University|Dr. Kelly Cosgrove Principal Investigator|2037376969|kelly.cosgrove@yale.edu|
20511714|NCT01326481|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
20511715|NCT01475513|Virginia Commonwealth University|Kai Cheang|8049863269|kicheang@vcu.edu|
20511716|NCT03164629|University of Miami|Shivank Bhatia, MD|305-585-7500|SBhatia1@miami.edu|
20511717|NCT00735839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511718|NCT04553497|Ege University Faculty of Medicine, Physical Medicine and Rehabilitation|Dr. Emine Duran|+905372103145|docemineduran@gmail.com|
20511719|NCT01038609|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20511720|NCT03241485|University of Chicago Medicine|Richa Dhawan|773-702-1000|rdhawan@dacc.uchicago.edu|
20511721|NCT01728194|Well Cornell Medicine|Faith M. Gunning, PhD, Vice Chair for Research, Dept of Psychiatry|212-746-5832|fgd2002@med.cornell.edu|
20511722|NCT02309372|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
20511723|NCT02054572|Amgen Inc.|Study Director|866-572-6436||
20511724|NCT00242658|Penn State Milton S. Hershey Medical Center|Chris Sciamanna, MD, MPH|717-531-8161|cns10@psu.edu|
20511725|NCT01314261|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20511726|NCT01466972|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
20511727|NCT01231620|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551118|NCT01333059|Cook Children's Medical Center|Javier Gelvez, MD||Javier.Gelvez@cookchildrens.org|
20511728|NCT04524507|University of North Carolina at Chapel Hill|Luther Bartelt, MD|919-966-2537|barteltl@ad.unc.edu|
20511729|NCT01066624|South Texas Veterans Health Care System|Juan J Toro|210-617-5300|juan.toro2@va.gov|16777
20511730|NCT01594424|Cedars-Sinai Medical Center, Comprehensive Transplant Center|Jua Choi, PharmD|310-248-8186|jua.choi@cshs.org|
20511731|NCT03216499|Adult Brain Tumor Consortium (ABTC)|Roy Strowd, MD|410-955-8837|jfisher@jhmi.edu|
20511732|NCT02486263|Nationwide Children's Hospital|Dr. Sudarshan Jadcherla|614-355-6643|sudarshan.jadcherla@nationwidechildrens.org|
20511733|NCT00508118|Duke University Medical Center|Andrew Shaw MD|919 286 6938|andrew.shaw@duke.edu|
20511734|NCT02441517|Astellas Pharma Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
20511735|NCT01393444|University of Pittsburgh|Jennifer Collinger|412-383-1274|collingr@pitt.edu|
20511736|NCT02730234|Midwest Cardiovascular Research Foundation|Nicolas W Shammas|5633242828|shammasg@mcrfmd.com|102
20511737|NCT02911285|Medical University of South Carolina|Stacey Sellers, Program Manager|843-792-5807|sellersst@musc.edu|
20511738|NCT03418727|Ocugen|Vijay Tammara, VP, Strategic Regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
20511739|NCT01740297|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20511740|NCT00761462|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20511741|NCT02047929|Carolinas HealthCare System|Dr. Thomas Ludden|704-608-2390|tom.ludden@carolinashealthcare.org|
20511742|NCT02985541|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20511743|NCT02383966|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20511744|NCT02883400|Atrium Health|Dr. Mark Russo,|704-355-6649|mark.russo@atriumhealth.org|
20511745|NCT00333437|University of California San Francisco|Jeffrey A. Golden, MD|415-353-2935|Jeff.Golden@ucsf.edu|
20511746|NCT02032433|NYU School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyumc.org|
20511747|NCT02696980|University of Vermont|Anne Dixon, MD|802 847 2700|anne.dixon@uvm.edu|
20511748|NCT03022526|University of Pittsburgh|Dr. Grace Lim|412-641-2179|limkg2@upmc.edu|
20511749|NCT01479777|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Dr. Cristina Sadowsky|443-923-9210|sadowsky@kennedykrieger.org|
20511750|NCT00887562|Columbia University|Michio Hirano, MD|12123051048|mh29@cumc.columbia.edu|
20511751|NCT01241591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511752|NCT01945034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551119|NCT04446377|AI Therapeutics|Peter R. Young/Chief Scientific Officer|203-458-7100|pyoung@ai-thera.com|
20511753|NCT00478218|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20551120|NCT01733407|Massachusetts General Hospital|Dr. Florian Eichler|617-643-3799|Feichler@partners.org|
20551121|NCT04152603|Seattle Children's Research Institute|Professor Stephanie Kraft|20688471022068841191|stephanie.kraft@seattlechildrens.org|
20511754|NCT02389621|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20511755|NCT04158466|Bausch Health|Study Director|(585) 338-6399|robert.steffen@bausch.com|
20511756|NCT03323034|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20511757|NCT00661037|Ospedali del Tigullio, Lavagna, Italy|Dr Michele Brignole|0185 329567329|aritmo@asl4.liguria.it|0039
20511758|NCT02191033|Yale University|Deepa Camenga, MD|203-737-8310|deepa.camenga@yale.edu|
20511759|NCT02815540|Gillette Children's Specialty Healthcare|Director of Research|651-229-1745|Research@gillettechildrens.com|
20511760|NCT02222246|Duke University|Dr. Paula Tanabe|919-613-6038|paula.tanabe@duke.edu|
20511761|NCT02064231|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
20511762|NCT01255865|3M|Terri White|651-733-0228|twhite3@mmm.com|
20511763|NCT04887922|Washington University School of Medicine|Chet Hammill, M.D., MCR|314-273-1809|hamillc@wustl.edu|
20511764|NCT00953017|Fort Belvoir Community Hospital|Dr. Michael Hjelkrem|531-231-2015|mhjelkrem@yahoo.com|
20511765|NCT01300741|Alcon Research|Director of Clinical Trials|1-800-241-7629||
20511766|NCT01055184|University of Rochester|Dr. John J. Treanor|585-275-5871|john_treanor@urmc.rochester.edu|
20511767|NCT01548573|University of Iowa|Guido Tricot, MD, PhD|319-356-3425|guido-tricot@uiowa.edu|
20511768|NCT03541356|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
20511769|NCT00290511|UT MD Anderson Cancer Center|Dr. Felipe Samaniego, MD-Professor, Lymphoma-Myeloma|(713) 745-6824|fsamaniego@mdanderson.org|
20511770|NCT00558831|Northwestern University|Amy Paller, MD|312-695-6829|apaller@nmff.org|
20511771|NCT00447265|DAIT/NIAID|Associate Director for Clinical Research|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20511772|NCT03557775|Medical University of South Carolina|Dr. Heather Shaw Bonilha|843-792-2527|bonilhah@musc.edu|
20511773|NCT03948646|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20511774|NCT02626910|University of Pennsylvania|Dr. Hillary R. Bogner|215-746-4181|Hillary.Bogner@uphs.upenn.edu|
20511775|NCT00276458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511776|NCT01428882|Hospital San Pedro de Alcantara, Caceres|Dr. Javier Molina-Infante|0034927621543|xavi_molina@hotmail.com|
20511777|NCT01678586|Massachusetts General Hospital|Dr. Lucy Chen|617-724-6102|mghpainresearch@partners.org|
20511778|NCT03455556|Mayo Clinic|Alex A Adjei, MD, PhD|(507) 284-2511|Adjei.Alex@mayo.edu|
20511779|NCT02058849|University of Kentucky|Dr. Travis Thomas, Associate Professor|859-218-0863|dth225@uky.edu|
20511780|NCT01049360|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
20511781|NCT01694849|GENFIT|Carol Addy, MD MMSc|+01 6179536469||
20511782|NCT02304484|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20511783|NCT04338685|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20511784|NCT00570492|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511785|NCT00976989|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20511786|NCT00908375|Northwestern University|K Malik|3129262280|kmalikmd@yahoo.com|
20511787|NCT04419558|FibroGen, Inc.|Clinical Trial Information Desk|(415) 978-1427|zephyrus@fibrogen.com|
20511788|NCT02279888|Vanderbilt University Medical Center|Dr. Lynne Stevenson|6159368187|lynne.w.stevenson@vanderbilt.edu|
20511789|NCT05240313|Boston College|Christopher Salas-Wright|617-552-1295|christopher.salas-wright@bc.edu|
20511790|NCT00752206|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
20511791|NCT01539512|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20511792|NCT01484691|University of California, San Francisco|PI: Prescott G. Woodruff, MD, MPH|415-514-2061|prescott.woodruff@ucsf.edu|
20511793|NCT04668157|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20511794|NCT03958045|University of Kentucky|Dr. Zhonglin Hao|859-218-6704|zhonglin.hao@uky.edu|
20511795|NCT03449342|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20511796|NCT02283411|Abbott Diabetes Care|Shridhara A Karinka, PhD|510-749-6393|shridhara.alva@abbott.com|
20511797|NCT03158532|ISCS|Roberto Léo da Silva|55 48 999099790|robertoleo@hotmail.com|
20511798|NCT03282123|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20511799|NCT03457701|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20511800|NCT03329404|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
20511801|NCT01211405|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20511802|NCT01463631|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20511803|NCT01078974|Dana-Farber Cancer Institute|Steven P. Treon|617-632-2681|steven_treon@dfci.harvard.edu|
20511804|NCT03039699|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20511805|NCT01397409|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20511806|NCT00422227|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20511807|NCT01941472|Peking Union Medical College Hospital|Bin Du|8610-69155036|dubin98@gmail.com|
20511808|NCT00686894|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20511809|NCT01791543|Vanderbilt University Medical Center|William G Stevenson, MD|1-615-322-2318|william.g.stevenson@vumc.org|
20511810|NCT00963040|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|781-588-5430|Spierings@MedVadis.com|
20511811|NCT01790633|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
20511812|NCT02544607|Massachusetts General Hospital|Dr. Cristina Cusin|617-726-6421|ccusin@mgh.harvard.edu|
20511813|NCT00726882|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20551122|NCT02455531|Carelon Research|Dr. Felicia Trachtenberg|Felicia.Trachtenberg@carelon.c|Felicia.Trachtenberg@carelon.com|
20511814|NCT00594568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20511815|NCT01198327|Wilmer Eye Institute|Peter Campocahiro|410-955-5106|pcampo@jhmi.edu|
20511816|NCT02526017|Five Prime Therapeutics|Helen Collins, Chief Medical Officer|650-745-9633|helen.collins@fiveprime.com|
20511817|NCT00921934|Department for Complementary and Alternative Medicine|Dr. med. Martin Schencking|+0049-2602-684-614||
20511818|NCT01600755|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
20511819|NCT00238108|Brigham and Women's Hospital|Dr. Frank Scheer|617-732-7014|fscheer@rics.bwh.harvard.edu|
20511820|NCT01249625|University of Texas Southwestern|Dr. Trish Perl|214-648-9022|Trish.Perl@UTSouthwestern.edu|
20511821|NCT02204449|UHN Toronto|Dr. Sherry Grace|416.736.2100|sgrace@yorku.ca|22364
20511822|NCT04645342|UCSF|Dr. Thomas Dewland|415-476-5706|thomas.dewland@ucsf.edu|
20511823|NCT04311411|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20511824|NCT03533829|Duke Vaccine and Trials Unit|Kristen Gunnell|9196848891|kristen.gunnell@duke.edu|
20511825|NCT01976663|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20511826|NCT05888740|Vibrato Medical|Vice President of Clinical Affairs|2139215088|bisrat@vibratomedical.com|
20511827|NCT01982942|Medicinova Inc|Director, Medical Writing|8582468680|makhay@medicinova.com|
20511828|NCT04384120|Henry Ford Health|Dr. Joseph Tramer|2165362904|jtramer1@hfhs.org|
20511829|NCT01151085|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511830|NCT04969653|Momentum Data Ltd|Dr Andrew McGovern|07531221970|andy.mcgovern@momentumdata.co.uk|
20511831|NCT03413618|Pirogov Russian National Research Medical University|Dr. Kirill Lobastov|+7-985-211-63-31|lobastov_kv@hotmail.com|
20511832|NCT04446182|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov/CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
20511833|NCT00003526|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20560099|NCT03552978|San Francisco Veterans Affairs Medical Center|Ellen Herbst, MD|415-221-4810|Ellen.Herbst@va.gov|24926
20560100|NCT03888365|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
20560101|NCT00114959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20560102|NCT00333138|Novartis pharmaceuticals|Study director|862-778-8300||
20560103|NCT00663962|Queen's University|Pregabalin and Post-thoracotomy pain|(613) 548-7827|zamoraj@kgh.kari.net|
20560104|NCT01974687|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560105|NCT01515319|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
20560106|NCT02624778|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20560107|NCT04672460|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquires@pfizer.com|
20560108|NCT03575962|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20560109|NCT04940390|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
20560110|NCT02949271|Duke University|Ashraf Habib, M.D.|919-681-4544|ashraf.habib@duke.edu|
20560111|NCT05336123|Brown University|Dr. Lauren Weinstock|401-455-6304|Lauren_Weinstock@brown.edu|
20560112|NCT02092987|Columbia University Medical Center|Jose Luchsinger|212-305-4730|jal94@cumc.columbia.edu|
20560113|NCT03929302|UT Southwestern Medical center|Namrata Das|2146082836|Namrata.Das@utsouthwestern.edu|
20560114|NCT00715390|The Children's Hospital of Philadelphia|Ronald Litman, DO|215-590-5091|litmanr@email.chop.edu|
20560115|NCT03835546|Fundació Lluita contra la SIDA|Jose A. Muñoz-Moreno|+34 93 497 84 14|jmunoz@flsida.org|
20560116|NCT03239210|NYU Langone Health|Nicolette Recchia|845-398-6563|nicolette.recchia@nyulangone.org|
20560117|NCT02664220|McGovern Medical School, University of Texas Health Sciences Center at Houston|Dr. Kuojen Tsao|713-500-7300|Kuojen.Tsao@uth.tmc.edu|
20560118|NCT01575860|Abramson Cancer Center of the University of Pennsylvania|Jakub Svoboda, MD. Study Principal Investigator|855-216-0098|PennCancerTrials@emergingmed.com|
20560119|NCT01403987|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|617-6386563|brian.jacobson@bmc.org|
20560120|NCT00305760|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
20560121|NCT00180674|Imperial College London|Prof Mark Thursz|+44 (0)20 3312 1903|m.thursz@imperial.ac.uk|
20560122|NCT00278564|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
20560123|NCT01094743|Johnson & Johnson Vision Care|Huan Sheng, MD, PhD|1-904-443-3440|HSheng2@its.jnj.com|
20560124|NCT02851511|University of Florida|Adam Woods, Ph.D.|352-294-5842|ajwoods@phhp.ufl.edu|
20511834|NCT04196023|Vanderbilt University Medical Center|Dr. Qi Dai|(615)936-0707|qi.dai@vanderbilt.edu|
20511835|NCT00489411|University of Michigan School of Nursing|Ellen Lavoie Smith, PhD, APRN, AOCN, FAAN|734-936-1267|Ellenls@med.umich.edu|
20511836|NCT04389294|Hospital for Special Surgery|Dr. Ellen M. Soffin|(212) 606-1206|SoffinE@HSS.edu|
20511837|NCT01748162|University of Michigan|Dr. David J. Brown||davidjb@med.umich.edu|
20511838|NCT03219372|Cedars Sinai Medical Center|Shehnaz K. Hussain, PhD, ScM|310-429-9859|Shehnaz.Hussain@cshs.org|
20511839|NCT03841331|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
20560125|NCT02321540|UT MD Anderson Cancer Center|Dr. John V. Heymach, Chair, Thoracic-Head & Neck Med Onc|(713) 792-6363|jheymach@mdanderson.org|
20560126|NCT03606460|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20560127|NCT04878172|Cynosure|Jamie Trimper|9788776342|jamie.trimper@cynosure.com|
20560128|NCT02256969|Massachusetts Eye and Ear Infirmary|Assistant Professor of Ophthalmology|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|6060
20511840|NCT00779857|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
20511841|NCT04640168|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20511842|NCT02866721|University Hospitals, Rainbow Babies and Children's Hospital|Erica Roesch, MD|(216) 844-3267|Erica.Roesch@UHHospitals.org|
20560129|NCT01902901|Kaiser Permanente Center for Health Research|Katrina Goddard|503-335-6353|katrina.ab.goddard@kpchr.org|
20511843|NCT00442572|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20511844|NCT01023815|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20511845|NCT01383759|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
20511846|NCT02556112|711 Human Performance Wing, U.S. Air Force|Col Nicole Armitage|937-255-3784|nicole.armitage@us.af.mil|
20511847|NCT01683565|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
20511848|NCT04479358|University of Chicago|Pankti Reid, MD|7737021220|pankti.reid@bsd.uchicago.edu|
20511849|NCT06241768|Wake Forest University School of Medicine|Dr. Anna Snavely|336-716-2011|asnavely@wakehealth.edu|
20511850|NCT04957979|HealthPartners Institute|Steven P. Dehmer, PhD|952-967-5216|steven.p.dehmer@healthpartners.com|
20511851|NCT02566304|Thomas Jefferson University|Usama Gergis, MD|215-955-8874|usama.gergis@jefferson.edu|
20511852|NCT04410991|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20511853|NCT00764465|GSIDA|David Condoluci|856-566-3190|dcondoluci@gsida.org|
20511854|NCT01195662|ClinicalTrialTransparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
20511855|NCT04828993|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511856|NCT01250418|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
20511857|NCT00104858|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
20511858|NCT06288607|The First Affiliated Hospital with Nanjing Medical University|Dr. Yang Xu|+8613851856794|yangxu@njmu.edu.cn|
20511859|NCT05966129|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
20511860|NCT01298323|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20511861|NCT01761565|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20511862|NCT05182840|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511863|NCT02161380|Bascom Palmer Eye Institute.|Dr. Byron Lam.|305 326 6021|blam@med.miami.edu|
20511864|NCT00863265|Washington University School of Medicine|Richard E. Ostlund MD|314-362-3516|rostlund@wustl.edu|
20511865|NCT00938457|Mayo Clinic|Dr. Robert C. Miller|507-284-2669|miller.robert@mayo.edu|
20511866|NCT03679117|Lifespan Hospital|Margaret Bublitz|401-323-3356|mbublitz@lifespan.org|
20511867|NCT05510297|University of Southern California|Dr. Stacey Schepens Niemiec|323-442-2069|schepens@usc.edu|
20511868|NCT01738672|University of Pittsburgh|Ya'aqov Abrams, MD||abramsym@upmc.edu|
20511869|NCT04794491|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@jazzpharma.com|
20511870|NCT00948896|University of California, San Francisco|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
20511871|NCT00945815|SWOG Statistical Center|SWOG Leukemia Statistician|206-667-4408||
20511872|NCT02023515|UKentucky|Kelly Webber, PhD, RD, LD|859-257-4351|kelly.webber@uky.edu|859
20511873|NCT01590810|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511874|NCT02400281|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20511875|NCT00412360|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20528522|NCT04812184|Indiana University School of Medicine|Nicholas Pettit|18653688599|nrpettit@iu.edu|
20528523|NCT02239640|Medtronic|Oscar Bolanos|949-527-0822|Oscar.bolanos@medtronic.com|
20528524|NCT05076604|Washington University School of Medicine|Matthew Schill|3147470707|schillm@wustl.edu|
20528525|NCT00184002|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
20528526|NCT00320242|Beth Israel Deaconess Medical Center and Harvard Medical School|Dr. David K. Simon, Associate Professor of Neurology|617-735-3251|dsimon1@bidmc.harvard.edu|
20528527|NCT01724177|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20528528|NCT00206427|Baylor Breast Cancer|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.tmc.edu|
20528529|NCT00581061|University of California, Irvine|Doug Skarecky|714-456-6744|dwskarec@uci.edu|
20528530|NCT00281697|Genentech, Inc.|Medical Communications|800 821-8590||
20528531|NCT04892446|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20528532|NCT03193047|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20528533|NCT02328937|Johnson & Johnson Vision Care Inc.|Tawnya Wilson - PRINCIPAL RESEARCH OPTOMETRIST|+1 904 443-1834|TWilson@ITS.JNJ.com|
20528534|NCT00705341|Johns Hopkins University|Anne Capser|410-955-8183|ashankli@jhsph.edu|
20528535|NCT02237989|Eskisehir Osmangazi University|Dr. Fulya Bakılan|+905057737335|fulyabakilan@gmail.com|
20528536|NCT03665077|George Washington Cancer Center|Dr. Pavani Chalasani|(202)-741-2277|pavani.chalasani@email.gwu.edu|
20528537|NCT00435461|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528538|NCT01472822|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jeong-Hwan Seo, MD|82-63-276-8284|vivaseo@jbnu.ac.kr|
20528539|NCT00205660|Washington University|Michael Yingling|5735791412|yinglinm@wustl.edu|
20528540|NCT01768559|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20528541|NCT02959918|Selecta Biosciences, Inc.|Dr. Peter Traber|713-540-9776|ptraber@selectabiosciences.com|
20528542|NCT00837967|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20511876|NCT01396434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528543|NCT02504320|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20528544|NCT01210222|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
20528545|NCT01737879|Amgen Inc.|Study Director|866-572-6436||
20528546|NCT00685360|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20560130|NCT00372567|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528547|NCT02497404|Weill Cornell Medical College|Sebastian Mayer, MD|646-962-7950|sam2033@med.cornell.edu|
20528548|NCT01504672|Umeå University|Dr. Maria Gustafsson|0046703978717|maria.gustafsson@umu.se|
20528549|NCT01309451|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
20528550|NCT00547157|Amgen Inc.|Study Director|866-572-6436||
20528551|NCT04186221|TransMedics, Inc.|Laura Damme, VP Clinical Affairs|978-552-0900|ldamme@transmedics.com|
20505578|NCT00719576|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
20528552|NCT01654263|Group Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|Jackson.L@ghc.org|
20528553|NCT02383355|Radboudumc|Wouter van der Heijden|0031 24 3616980|wouter.vanderheijden@radboudumc.nl|
20528554|NCT02787083|Philadelphia Urosurgical Associates, PC|Kristene E Whitmore MD|215-704-1457|bladder1@aol.com|
20528555|NCT01588405|United Therapeutics|Nicole Leedom|919-425-5870|nleedom@unither.com|
20528556|NCT00845676|San Francisco General Hospital/UCSF|Brad Hare, MD|415-476-4082|chare@php.ucsf.edu|556
20528557|NCT00681265|Eyeon Therapeutics, Inc.|David M. Kleinman||dave@eyeontherapeutics.com|
20560131|NCT01079598|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
20560132|NCT02347943|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
20560133|NCT01873287|Children's Hospital of Eastern Ontario|Dr. Roger Zemek|613-737-7600|rzemek@cheo.on.ca|
20560134|NCT00303303|Carolinas Medical Center|William Kerns II MD Program Directorm Medical Toxicology|704-355-5297|rkerns@carolinas.org|
20528558|NCT03275389|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20528559|NCT03565874|Department of Child and Adolescent Psychiatry, University Hospital of Lausanne|Dr. Sébastien Urben|+41 21 314 7492|sebastien.urben@chuv.ch|
20528560|NCT04441788|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
20528561|NCT00753298|Astra Tech AB|Head of Therapeutic Area Health Care|+46317763000||
20528562|NCT01196377|Vanderbilt University School of Medicine|Dr. Donald H Arnold|6155790516|don.arnold@vanderbilt.edu|
20528563|NCT00995722|University Of Miami|Dr. Benatar|305-243-6480|MBenatar@med.miami.edu|
20528564|NCT01310127|Discover Vision Centers|Melissa Toyos, MD|816-478-1230|mtoyos@discovervision.com|
20528565|NCT00947310|University of Rochester, Heart Research Follow-up Program|Dr. Arthur J. Moss|585-275-5391|arthur.moss@heart.rochester.edu|
20528566|NCT04727736|UPMC Hillman Cancer Center|Barbara M Stadterman, Clinical Research Manager - Regulatory|412-647-5554|stadtermanbm@upmc.edu|
20528567|NCT01867515|VA Portland HCS, RR&D National Center for Auditory Rehabilitative Research|Michelle R. Molis, PhD|503-220-8262|michelle.molis@va.gov|55574
20528568|NCT02171429|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20528569|NCT00558012|University of Pittsburgh|Dr. Susan Greenspan|412-692-2477|greenspn@pitt.edu|
20528570|NCT00305227|University of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
20528571|NCT00856791|Onconova Therapeutics, Inc.|Francois E. Wilhelm, MD, PhD|609 281-7086|fwilhelm@onconova.us|
20528572|NCT04846270|Essity Hygiene and Health AB|Fredrik Agholme|+4670323634|fredrik.agholme@essity.com|
20528573|NCT00700375|Osaka General Medical Center|Prevention on Conrast-Induced Nephropathy With Bolus Injection of Sodium Bicarbonate|81-6-6692-1201|u_hiromichi@yahoo.co.jp|
20528574|NCT03492437|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20528575|NCT05133323|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20528576|NCT00632125|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
20528577|NCT02697214|The Cleveland Clinic|Marc Gillinov, MD|216 445-8841|GILLINOM@ccf.org|
20528578|NCT02459197|Tools4Patient|Chief Scientific Officer|+32 71 91|alvaro.pereira@tools4patient.com|94 00
20528579|NCT00577772|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|dibaise.john@mayo.edu|
20528580|NCT04152083|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20528581|NCT03280056|Brainstorm Cell Therapeutics|Chief Medical Officer|+1-201-488-0460|ClinicalTrial@brainstorm-cell.com|
20528582|NCT04254081|University of California, San Diego|UCSD Family Planning Research|(858) 329-4464|familyplanningresearch@health.ucsd.edu|
20528583|NCT00878800|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
20528584|NCT01135524|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20505579|NCT06094296|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20505580|NCT03332667|New Advances in Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
20505581|NCT01035606|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@ucsf.edu|
20505582|NCT01849848|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
20505583|NCT01809262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505584|NCT02404155|Maryland Psychiatric Research Center|Dr. Deanna L. Kelly, Pharm.D., BCPP|410-402-6860|dlkelly@som.umaryland.edu|
20505585|NCT02202031|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
20505586|NCT02184143|Vanderbilt University Medical Center|Kristin Archer|(615) 322-2732|kristin.archer@Vanderbilt.Edu|
20505587|NCT01596842|Dong-A University|Professor|82-51-240-2811|anws@dau.ac.kr|
20505588|NCT00431847|Philadelphia Veterans Affairs Medical Center|Rollin M Gallagher, MD, MPH|(215) 823-5800|Rollin.Gallagher@va.gov|4907
20505589|NCT00339183|Amgen Inc.|Study Director|866-572-6436||
20505590|NCT00446446|Amgen Inc.|Study Director|866-572-6436||
20505591|NCT02142894|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
20505592|NCT01564654|ConforMIS|Marc Quartulli, VP Clinical Affairs|781-345-9191|marc.quartulli@conformis.com|
20505593|NCT00717418|Allergan, Inc.|Vice President, GHOSR|714-246-4500|clinicaltrials@allergan.com|
20505594|NCT01024465|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
20511877|NCT04678557|Vertex|Medical Information|617-341-6777|medicalinfo@vrtx.com|
20511878|NCT02260804|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
20511879|NCT06212310|UT Southwestern Medical Center|Sayoni Lahiri|214-645-2563|sayoni.lahiri@utsouthwestern.edu|
20511880|NCT00509223|Baker IDI Heart and Diabetes Institute|Jonathan Shaw, MD, FRACP, FRCP|+61 (0) 3 8532 1821|jonathan.shaw@bakeridi.edu.au|
20511881|NCT03965754|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20511882|NCT02335229|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
20511883|NCT00437294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20511884|NCT02464176|Wake Forest Baptist Medical Center|Dr. James D. Turner|3367164998|jturner@wakehealth.edu|
20511885|NCT00449761|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20511886|NCT01339273|Oxford University Hospitals NHS Trust|Dr Nicholas Crabtree|01865 221590|nicholas.crabtree@ouh.nhs.uk|
20511887|NCT01422876|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511888|NCT00536991|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20511889|NCT00054639|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
20511890|NCT03464110|Duke University|Dr. Kathryn Pollak|919-681-4757|kathryn.pollak@duke.edu|
20511891|NCT01366846|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20511892|NCT03724422|University of Louisville|Salwa Rashid|5028526964|salwa.rashid@louisville.edu|
20511893|NCT02856282|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20511894|NCT02406937|Sprim (Shanghai) Consulting Co., Ltd.|Dr. Charlie Zhang|+86 (21) 51097272|charlie.zhang@sprim.cn|
20511895|NCT05299359|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20511896|NCT04961645|Emory University|Daniel Dilks, PhD|404-727-2980|dilks@emory.edu|
20511897|NCT03988049|University of Utah Dermatology|Dr. David Smart, Assistant Professor, Dermatology|8015816465|david.smart@hsc.utah.edu|
20511898|NCT04780776|Boston University School of Medicine|Dr. Michael F. Holick|(617) 358-6139|mfholick@bu.edu|
20511899|NCT03113760|AB2 Bio Ltd.|Eduardo Schiffrin|+41 21 694 00 40|eduardo.schiffrin@ab2bio.com|
20511900|NCT00423137|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511901|NCT01243762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20511902|NCT02059265|NRG Oncology|Christopher Purdy on behalf of Austin Miller|(716)845-1300|purdyc@nrgoncology.org|2296
20511903|NCT01499498|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
20511904|NCT03303144|Rockwell Medical|Dr Ray Pratt|248 960-9009|rpratt@rockwellmed.com|405
20511905|NCT01797458|Preventive and Paediatric Dentistry Department of Greifswald University, Germany|Prof. Dr. Christian Splieth|+ 49 3834 867101|splieth@uni-greifswald.de|
20511906|NCT03605758|Albert Einstein College of Medicine|Dr. Christina Coyle|718-430-3525|christina.coyle@einsteinmed.edu|
20511907|NCT04804579|Boston University School of Public Health|Theresa W. Kim MD|(617) 414-6932|therkim@bu.edu|
20511908|NCT04753606|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20511909|NCT04436497|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
20511910|NCT05059366|University of Miami|Alecia Sabartinelli Stein, MD|305 585 8380|asabartinelli@med.miami.edu|
20511911|NCT04366258|NYU Langone Health|Dan Iosifescu, MD|646-754-5156|Dan.Iosifescu@nyulangone.org|
20511912|NCT01725217|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20511913|NCT03546270|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20511914|NCT00750373|Asan Medical Center|Dr. Duk-Hyun Kang|82-2-3010-3149|dhkang@amc.seoul.kr|
20511915|NCT02940392|Boston Scientific|Director, Clinical Operations|9529306000|teresa.takle-flach@bsci.com|
20511916|NCT01042288|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20511917|NCT03205046|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
20511918|NCT00634933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511919|NCT02276274|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20511920|NCT02219477|AbbVie|Global Medical Services|800-633-9110||
20511921|NCT03522506|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20511922|NCT05643573|Bayer AG|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20511923|NCT02478281|American Regent Inc.|Hal Rathfon, RPh|631-772-3555|HRathfon@americanregent.com|
20511924|NCT04409262|Hoffmann - La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20511925|NCT03205605|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20511926|NCT02396849|Indiana University|Christina Tiller|317-044-4522|ctiller@iu.edu|
20511927|NCT03572153|Baylor University|Gary Elkins, PhD|254-296-0824|gary_elkins@baylor.edu|
20511928|NCT03328325|University of Rochester|Angela Branche, MD, Site Principal Investigator|585-275-5871|angela_branche@urmc.rochester.edu|
20511929|NCT03677440|Kessler Foundation|Brian Sandroff, PhD|973-965-6649|bsandroff@kesslerfoundation.org|
20511930|NCT00931515|Pioneer Surgical Technology|Director of Regulatory and Clinical Affairs|906-225-5602|emilydowns@pioneersurgical.com|
20511931|NCT03655951|innovation Research & Training|Dr. Tracy Scull|919-493--7700|tscull@irtinc.us|118
20511932|NCT00113321|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, M.D., Professor|713/792-7026|eharriso@mdanderson.org|
20511933|NCT01375491|University of California, San Diego|Dr. Karen Louise Herbst|858-552-8585|kaherbst@gmail.com|7384
20511934|NCT03145207|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20560135|NCT00691028|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20560136|NCT00402883|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20560137|NCT01528124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20560138|NCT00058058|American College of Radiology Imaging Network|Senior Director of Protocol Management||Donna Hartfeil <dhartfeil@acr.org>|
20560139|NCT03085017|Loma Linda University Health Care|David G. Rabkin, MD FACS|909-558-4354|drabkin@llu.edu|
20560140|NCT00451698|Medical College of Wisconsin|Dr. Steven Zangwill|414-266-2380|szangwill@chw.org|
20560141|NCT03825393|Tokat State Hospital|Dr.Sevil Okan|5308211797|doctorsevil@yahoo.com|
20560142|NCT01169519|Duke University Medical Center|Dr. Kevin Hill|919-668-8305|kevin.hill@duke.edu|
20560143|NCT00582790|University of Wisconsin Carbone Cancer Center|Study coordinator|(608) 263-7107|uwcccgu@medicine.wisc.edu|
20560144|NCT04337489|Imperial College London|Fahad Iqbal|020 3312 6666|f.iqbal@imperial.ac.uk|
20560145|NCT00372528|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560146|NCT02412761|The University of Texas Health Science Center at Houston|Joyce P. Samuel, MD, MS|(713) 500-5670|Joyce.P.Samuel@uth.tmc.edu|
20560147|NCT04796935|Elevate Clinical Consulting|Keri Urwin|919-247-8845|kurwin@elevateclinicalconsulting.com|
20560148|NCT01192295|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20560149|NCT00630539|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20560150|NCT01253980|Poisons Information Centre, Red Cross War Memorial Children's Hospital and University of Cape Town|Dr Kate Balme|+27 21 658 5308|kate.balme@uct.ac.za|
20560151|NCT00696293|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
20560152|NCT01700530|University of Missouri|John P. Thyfault, PhD|573-874-9728|thyfaultj@missouri.edu|
20560153|NCT02953548|GW Research Ltd|Medical Enquires|+44 01223 238170; 1877886281|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20560154|NCT01023178|Stanford University|Sejal Shah MD|6507235791|sshah2@stanford.edu|
20560155|NCT04833855|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20560156|NCT02806336|Baltimore VA Geriatric Research Education and Clinical Center|Dr. Leslie Katzel|4106057248|leslie.katzel@va.gov|
20560157|NCT01688102|The Rockefeller University|Dr. Manish Ponda|212-327-7631|mponda@rockefeller.edu|
20560158|NCT00610883|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
20560159|NCT02338609|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|novartis.email@novartis.com|
20560160|NCT05705167|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
20560161|NCT03437668|UCaliforniaLA|Stephen R Marder|3102670221|smarder@mednet.ucla.edu|
20560162|NCT02099539|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20560163|NCT05812794|The University of Texas Health Science Center at Houston|Stuart Mason Fraser, MD|713-500-7142|Stuart.M.Fraser@uth.tmc.edu|
20560164|NCT03473756|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20560165|NCT03714022|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20560166|NCT02148718|AbbVie|Global Medical Services|800-633-9110||
20560167|NCT02538679|Cedars Sinai Medical center|Dr. Karen Zaghiyan|310-289-9224|karen.zaghiyan@cshs.org|
20560168|NCT01007552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|groman@appliedstats.com|847
20560169|NCT04482855|University of Pennsylvania School of Nursing|Dr. Jie Deng|2155734729|jiedeng@nursing.upenn.edu|
20560170|NCT04438785|Grupo Hospitalario Quironsalud|Francisco Jesus Gonzalez|0034645014593|fgonzasan@gmail.com|
20560171|NCT02027935|University of Texas MD Anderson Cancer Center|Dr. Adi Diab|(713) 745-7336|adiab@mdanderson.org|
20560172|NCT04873817|Abbott|Devyani Nanduri, Sr. Director, Clinical and Regulatory Affairs|+16698329450|Devyani.Nanduri@abbott.com|
20560173|NCT00216320|Innovative Neurotronics|Director of Clinical Research|512-721-1922|hrogers@ininc.us|
20560174|NCT00924560|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20560175|NCT00593320|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8502|jbradley@radonc.wustl.edu|
20560176|NCT00604786|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
20560177|NCT03323151|ECOG-ACRIN Statistical Center|Opeyemi Jegede, Statistician|617-582-7613|ojegede@ds.dfci.harvard.edu|
20560178|NCT00665561|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560179|NCT02337361|Public Health Institute/Alcohol Research Group|Madhabika B. Nayak|510-898-5849|mnayak@arg.org|
20560180|NCT01641861|Khon Kaen University|Dr. Kemporn Kitsahawong|66-910-566-996|kkempo@kku.ac.th|
20560181|NCT00814489|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560182|NCT01449929|GlaxoSmithKline|GSK Response Center|866-435-7343||
20511935|NCT05436067|CFD Research Corporation|Dr. Paulien Roos|256 715 6817|paulien.roos@cfd-research.com|
20511936|NCT05689554|University of Washington|Dr. Elizabeth Phelan|(206) 744-9112|phelane@uw.edu|
20511937|NCT00157157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20511938|NCT01678794|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
20511939|NCT00121251|Weill Cornell Medical College|Cooperative Group Program Manager|646-962-9377|has7003@med.cornell.edu|
20511940|NCT05981508|Morehouse School of Medicine|Candice L. Alick, PhD|404-752-1009|calick@msm.edu|
20560183|NCT05927480|HealthPartners Institute|Sandy Vang, Director of Research Administration at Regions Hospital|1-651-254-6961|sandy.x.vang@healthpartners.com|
20560184|NCT01955382|NIAID/NIH|Dr. Rick M. Fairhurst, Principal Investigator|301-761-5077|rfairhurst@niaid.nih.gov|
20560185|NCT04610684|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
20560186|NCT02395185|Shriners Hospital for Children|Rebecca Davis|859-268-5705|rfdavis@shrinenet.org|
20560187|NCT02153788|Duke University Medical Center|Andrew Krystal, MD|919-681-8742|andrew.krystal@duke.edu|
20560188|NCT01876043|Institut Bergonié|Dr Antoine ITALIANO|+33556333333|a.italiano@bordeaux.unicancer.fr|
20560189|NCT01032850|University of New Mexico Cancer Center|Dr. Yehuda Patt, MD|505-925-0405|yzpatt@salud.unm.edu|
20560190|NCT00079937|Novartis Pharmaceuticals|Study Director|862-778-8300||
20560191|NCT01207908|Cincinnati Children's Hospital Medical Center|Dr. Meilan Rutter|513-636-4744|meilan.rutter@cchmc.org|
20560192|NCT05458102|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20560193|NCT00852475|Baltimore VAMC and University of Maryland Medical Center|Michael Miller, MD|4103286299|mmiller@medicine.umaryland.edu|
20560194|NCT00498186|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20560195|NCT00367237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20560196|NCT01175707|Cubist Pharmaceuticals|Vice President, Clinical Research|781-860-8318||
20560197|NCT00112723|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
20560198|NCT00350532|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4498|jimeisenach@gmail.com|
20560199|NCT04170764|TriHealth|Dr. Emily Aldrich|513-463-4300|Emily_Aldrich@trihealth.com|
20505595|NCT00733356|University of California Irvine Child Development Center|Kinberley Lakes|949-824-3009|klakes@uci.edu|
20560200|NCT01598025|Memorial Sloan Kettering Cancer Center|Dr. Richard O'Reilly, MD|646-888-2157|oreillyr@mskcc.org|
20560201|NCT04531540|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20560202|NCT00003377|Gynecologic Oncology Group Statistical & Data Center|Melissa Leventhal|(716)845-5702|mleventhal@gogstats.org|
20560203|NCT00427973|Massachusetts General Hospital Cancer Center|Andrew X. Zhu, MD|617-643-3415|azhu@partners.org|
20560204|NCT02584790|Pamela Youde Nethersole Eastern Hospital|Dr Wong Kai Chuen|(852) 64600771|wkc568@ha.org.hk|
20560205|NCT05142228|University of Maryland, School of Dentistry|Dr. Marcela Romero Reyes|4107067168|mromero@umaryland.edu|
20560206|NCT04541186|89bio, Inc.|Entrigue Study Team|1-415-432-9270|Ct.gov_SHTG@89bio.com|
20560207|NCT00578227|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560208|NCT00980278|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
20560209|NCT03610633|Medical University of South Carolina|Laura Lohnes|843-792-7709|lohnes@musc.edu|
20505596|NCT02836990|University at Buffalo, SUNY|Dr Linda Harris|7168594207|lmharris@buffalo.edu|
20505597|NCT03078608|Kaiser Permanente Northern California|Elaine Kurtovich|510-891-3118|elaine.m.kurtovich@kp.org|
20505598|NCT01455428|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505599|NCT01747330|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20505600|NCT02535949|Washington University School of Medicine|Dr. Philip Spinella|314-286-0858|pspinella@wustl.edu|
20505601|NCT00789477|Regeneron|Clinical Trial Management|9148475385|clinicaltrials@regeneron.com|
20505602|NCT00455858|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20505603|NCT02092389|AbbVie|Global Medical Information|1-800-633-9110||
20505604|NCT00787332|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
20505605|NCT02273310|The Children's Hospital of Philadelphia/Perleman School of Medicine of The University of Pennsylvania|Lamia Barakat, Ph.D.|267-426-8135|barakat@email.chop.edu|
20505606|NCT03958201|University of Washington|Research Coordinator|206-744-4634|ajames1@uw.edu|
20505607|NCT00751881|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20505608|NCT00564629|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
20505609|NCT02119104|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505610|NCT01632878|Mylan|Patrick Aubonnet / Medical Director||patrick.aubonnet@mylan.com|
20505611|NCT02307526|James J. Peters VA Medical Center|Jill M. Wecht|7185849000|jm.wecht@va.gov|3122
20505612|NCT02222129|USAF|Richard Knight, MD|+44 1638 528186|richard_b_knight@yahoo.com|
20505613|NCT01651260|Hollister Incorporated|Malford Cullum|847-918-3975|malford.cullum@Hollister.com|
20505614|NCT01558089|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505615|NCT02144220|University of Rochester|Ray Dorsey, MD|585-275-0663|ray.dorsey@chet.rochester.edu|
20505616|NCT03419533|The University of Adelaide|Prof. Helen Marshall|8161 8115|helen.marshall@adelaide.edu.au|
20505617|NCT01952015|Novartis Pharmaceuticals|Study Director|862-778-8300||
20505618|NCT02239094|Depression Evaluation Service (New York State Psychiatric Institute)|David J. Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
20505619|NCT03648996|University of Missouri, School of Medicine|Dr. Camila Manrique, MD|(573) 882-2554|manriquec@umsystem.edu|
20505620|NCT00317941|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20505621|NCT03242759|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505622|NCT00064662|New England Research Institutes|Anne M. Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
20505623|NCT02186795|MUSC|Sylvia Wilson, MD|843-732-2322|wilsosh@musc.edu|
20505624|NCT03008590|VA Boston Healthcare System|Dr Paul Monach, Chief, Rheumatology Section|857-364-5552|Paul.Monach@va.gov|
20505625|NCT03519308|Abramson Cancer Center, University of Pennsylvania|Liudmila Mazaleuskaya/Pancreas Research Program Manager|2674559141|mazali@pennmedicine.upenn.edu|
20505626|NCT00365976|Duke University|Jenny Bridgers, CRC|919-684-0752|jenny.bridgers@duke.edu|
20505627|NCT02986958|Johns Hopkins Bloomberg School of Public Health|Research Program Manager|410-614-7910|dechava1@jhu.edu|
20505628|NCT01963117|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
20505629|NCT01780389|Duke University Medical Center|David Marks, MD|619 668-2859|d.marks@duke.edu|
20505630|NCT01095250|Novartis Pharmaceuticals|Study Director|862-778-8300||
20505631|NCT01000064|Vanderbilt University Medical Center|Dr. Michael G. Tramontana|615-327-7144|Michael.Tramontana@Vanderbilt.Edu|
20505632|NCT02518620|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
20511941|NCT02263118|Ecole Polytechnique|Dr. Jose Tomas Prieto|+50252800643|jose-tomas.prieto@polytechnique.edu|
20511942|NCT00470301|Montefiore Medical Center|NYCC Coordinating Center|718-405-8404|jsparano@montefiore.org|
20511943|NCT02277665|Dartmouth-Hitchcock|Dr. Alan J. Budney|603-646-7088|alan.j.budney@dartmouth.edu|
20511944|NCT05292248|Case Western Reserve University|Kylie Meyer, Principal Investigator|216-368-1928|knm77@case.edu|
20511945|NCT01473602|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20511946|NCT00560573|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20511947|NCT01363999|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20511948|NCT02506101|Johns Hopkins Medicine|Dr. Ginette Okoye|410-502-7546|CTReP@jhmi.edu|
20511949|NCT01308476|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20511950|NCT02696382|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
20511951|NCT03986216|Northwestern University|Dr. Jun Yao|3129089060|j-yao4@northwestern.edu|
20511952|NCT03246152|Cairo University|Dr. Ayman Elnahry|00201224927604|ayman_elnahri@hotmail.com|
20511953|NCT03478982|Cares|UCB|+1 844 599|UCBCares@ucb.com|2273
20511954|NCT01005810|Medical University of South Carolina|Dr. Kevin M. Gray, Associate Professor|843-792-6330|graykm@musc.edu|
20511955|NCT04359758|Georgetown Lombardi Comprehensive Cancer center|Marc D. Schwartz, PhD|2026870185|schwartm@georgetown.edu|
20511956|NCT03358407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20511957|NCT00483574|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20511958|NCT03864406|Clinical Center|Hadigan, Colleen|+1 301 594 5754|hadiganc@niaid.nih.gov|
20511959|NCT01012609|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
20511960|NCT01828164|SmileSonica Inc.|John Simon, Regulatory Affairs Manager|780-975-0095|john@johnsimon.ca|
20511961|NCT04983589|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20511962|NCT00924820|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Professor, Neuro-Oncology|(713) 745-3072|jdegroot@mdanderson.org|
20511963|NCT00585468|University of Utah|Fuad Shihab, MD|801-585-3823|fuad.shihab@hsc.utah.edu|
20511964|NCT04259905|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
20511965|NCT01279265|University of Texas Health Science Center at Houston|Dr. J. Marc Rhoads, Director, Pediatric Gastroenterology|713-500-7642|j.marc.rhoads@uth.tmc.edu|
20511966|NCT00978120|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20511967|NCT03253809|Cleveland Clinic|Dr. Mark Neibauer|216-444-3160|niebaum@ccf.org|
20511968|NCT03992456|Duke Cancer Institute|John Strickler, MD|(507) 284-2511|john.strickler@duke.edu|
20511969|NCT03176953|National Center for PTSD|Sonya Norman, PhD|858-518-8266|sonya.norman@va.gov|
20511970|NCT00762073|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20511971|NCT01068418|Brigham and Women's Hospital, Harvard Medical School|Jonathan S. Williams|6177325666|jwilliams5@partners.org|
20560210|NCT01051778|Cairo university|Usama .M .Fouda|+20123595106|umfrfouda@yahoo.com|
20560211|NCT03419780|University of Pennsylvania|Dr Rebecca Hamm|215-662-6913|rebecca.feldmanhamm@pennmedicine.upenn.edu|
20505633|NCT00978445|Cleveland Clinic Foundation|Dr. Heather Gornik|216-445-3689|gornikh@ccf.org|
20505634|NCT00410280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505635|NCT03625986|Penn State College of Medicine|Dr. Jonathan Foulds|(717) 531-3504|jfoulds@pennstatehealth.psu.edu|
20505636|NCT01850563|Dartmouth-Hitchcock Medical Center|Alan Hartford, MD, PhD, FACR, Professor of Medicine (RadOnc) Director, Radiation Oncology|603-650-6600|Alan.C.Hartford@Hitchcock.org|
20505637|NCT04359823|MUSC|Gabriella Santa Lucia|724-413-8833|santaluc@musc.edu|
20505638|NCT02078713|University of California, San Francisco|Dr. Christine Dehlendorf, Principal Investigator|415-206-8712|christine.dehlendorf.@ucsf.edu|
20505639|NCT02096861|Celltrion, Inc.|BoYoung Choi / Clinical Operation Team Leader|+82-32-850-6594|BoYoung.Choi@celltrion.com|
20505640|NCT03123354|Masimo Corporation|Vikram Ramakanth|1 (949) 297-7416|clinicalresearchdept@masimo.com|
20505641|NCT03074162|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505642|NCT00589888|Emory Univ SOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
20505643|NCT02948777|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-47171990|marja-riitta.taskinen@helsinki.fi|
20505644|NCT03242928|Novartis Pharma AG|Clinical Disclosure Office|613241111|Novartis.email@Novartis.com|
20505645|NCT03333057|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
20505646|NCT00625365|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
20505647|NCT03650452|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20505648|NCT02969317|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505649|NCT06648161|Kocaeli University|Dr. Resmiye Özdilek|+90 262 303 47 38|resmiyeozdilek@gmail.com|
20505650|NCT05730829|McMaster University|Dr Lisa Carlesso|2896805640|carlesl@mcmaster.ca|
20505651|NCT02880319|DFCI/BWH|Dr. Tracy Balboni|6177327948|tbalboni@bwh.harvard.edu|
20505652|NCT05014776|SKCCC Johns Hopkins Medical Institution|Katherine Bever, MD|443-287-0966|kbever1@jhmi.edu|
20505653|NCT01703286|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505654|NCT02421120|Hartford Hospital|Dr. Joseph L. Kuti, PharmD|860-972-3612|joseph.kuti@hhchealth.org|
20505655|NCT00931892|Beth Israel Deaconess Medical Center|Dr. Ciaran Kelly|617-667-1272|ckelly2@bidmc.harvard.edu|
20505656|NCT01876732|Staten Island University Hospital|Suzanne El-Sayegh|718-226-6158|uviola@siuh.edu|
20505657|NCT00964548|UMASS Medical School|Susanne Muehlschlegel, MD, MPH, Principal Investigator|508-856-4667|susanne.muehlschlegel@umassmemorial.org|
20560212|NCT01605136|Clinuvel Inc.|Dr. Dennis Wright|646 527 7310|Dennis.Wright@clinuvel.com|170
20511972|NCT03155269|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20511973|NCT00910000|Dana-Farber Cancer Institute|Ursula Matulonis, MD|617-632-2334|umatulonis@partners.org|
20511974|NCT04637815|RAND|David P. Kennedy|3104673904|davidk@rand.org|6133
20511975|NCT01977625|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
20511976|NCT02594384|OrphAI Therapeutics|Esther Nkrumah|267 512-1750|enkrumah@orphai-therapeutics.com|
20511977|NCT02427568|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20511978|NCT01717521|UWMC|Dr. Laurent Bollag|2063277328|bollag@uw.edu|
20511979|NCT03919669|University of WI Alzheimer's Disease Research Center|Dr. Sterling Johnson|608-262-9549|scj@medicine.wisc.edu|
20511980|NCT02319642|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20511981|NCT01265875|Dartmouth-Hitchcock Medical Center|Timothy Gardner, MD|603-650-6472|timothy.b.gardner@hitchcock.org|
20511982|NCT04409509|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20511983|NCT01958593|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20511984|NCT02331680|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
20511985|NCT05147311|Brigham and Women's Hospital|Dr. Hermioni Amonoo, Director of Well-Being and Cancer Research Program|‭(617) 525-7472‬|hermioni_amonoo@dfci.harvard.edu|
20511986|NCT02504099|AbbVie|Global Medical Services|800-633-9110||
20511987|NCT00145795|The University of Chicago Department of Health Studies, Section of Infectious Diseases and Global Health|Dr. David Pitrak|(773) 702-2710|dpitrak@medicine.bsd.uchicago.edu|
20511988|NCT04505592|Icahn School of Medicine at Mount Sinai|Dr. Hooman Poor|(212) 241-5656|hooman.poor@mountsinai.org|
20511989|NCT02648646|University of North Carolina|Yvonne Golightly PT, PhD, Assistant Professor of Epidemiology|919-966-0566|golight@email.unc.edu|
20511990|NCT03480243|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20511991|NCT00761085|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20511992|NCT01522755|Medtronic|Foudali Latifa|+33 631992144|latifa.foudali@medtronic.com|
20511993|NCT03414658|Dana-Farber Cancer Institute|Adrienne G. Waks, MD|617-632-3800|Adrienne_Waks@dfci.harvard.edu|
20511994|NCT02388906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20511995|NCT05934591|University of Illinois Urbana Champaign|Dr. Liliane Windsor|2173001782|lwindsor@illinois.edu|
20511996|NCT05770401|University of Montana|Jane Reynolds Salois|406-243-2138|jane.salois@umontana.edu|
20511997|NCT00402298|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20511998|NCT04784455|Akari Therapeutics|Chief Scientific Officer|+44 208 004 0261|miles.nunn@akaritx.com|
20511999|NCT00147290|Medtronic|Elisabetta Santi|003906328141|elisabetta.santi@medtronic.com|
20512000|NCT04298229|Vanderbilt University Medical Center|Zachary Cox|615-966-7107|zachary.l.cox@vumc.org|
20512001|NCT00071006|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512002|NCT03142919|LIBR|Jonathan Savitz|9185025104|jsavitz@laureateinstitute.org|
20512003|NCT05261126|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512004|NCT05939388|Wake Forest University Health Sciences|Michelle Olshan-Perlmutter|704-358-2800|michell.olshanperlmutter@atriumhealth.org|
20512005|NCT03901274|University of South Carolina|Dr. Mark Weist|803-777-8438|weist@mailbox.sc.edu|
20512006|NCT05570604|Ohio State University|Dr. Diane Von Ah|614-688-0722|vonah.1@osu.edu|
20512007|NCT05074303|University of Florida|Dr. Wendy Dahl|3522943707|wdahl@ufl.edu|
20512008|NCT04527380|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20512009|NCT03671746|Massachusetts General Hospital|Dr. Arun Aneja, MD, PhD|617-726-6546|aaneja@mgh.harvard.edu|
20512010|NCT03810417|University of Maryland|Stephen Gottlieb, MD|410-328-7877|sgottlie@som.umaryland.edu|
20512011|NCT03668379|University of California, San Francisco|John Sauceda, PhD, Associate Professor|415-502-1000|john.sauceda@ucsf.edu|17172
20512012|NCT00953173|Apollo Endosurgery Inc|Director of Clinical Affairs|512-279-5157|jose.naveira@apolloendo.com|
20512013|NCT00938366|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20512014|NCT01085331|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20512015|NCT00056472|Weill Cornell Medical College|Barnett S. Meyers, MD|914-997-5721|bmeyers@med.cornell.edu|
20512016|NCT01869959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512017|NCT01965600|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512018|NCT00563706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512019|NCT04074109|VA Palo Alto Health Care System|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
20512020|NCT03280628|Vanderbilt University Medical Center|Dr. Holly Hanson|615-936-7317|holly.r.hanson@vumc.org|
20512021|NCT03315780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20512022|NCT01001195|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20512023|NCT03839693|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
20512024|NCT04524351|Annovis Bio|Maria Maccecchini, PhD, CEO|(610) 727-3710|maccecchini@annovisbio.com|
20512025|NCT00700115|Emory University School of Medicine|Dr. Igho Ofotokun|404-616-0659|iofotok@emory.edu|
20512026|NCT02983305|University of Michigan|Sara|734-936-7567|weisssar@umich.edu|
20512027|NCT00822237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512028|NCT00347776|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
20512029|NCT01969201|IBSA Insitut Biochimique|Project Leader|+41 58 360 10 00|rd@ibsa.ch|
20512030|NCT02192307|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20512031|NCT04621227|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512032|NCT00938392|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512033|NCT02916056|vTv Therapeutics|Ann Gooch PhD, VP Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
20512034|NCT00124709|Novartis Pharmaceuticals|Study Director|862-778-8300||
20560213|NCT01072929|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20560214|NCT02929108|Washington University School of Medicine|Debra Oliver, Ph.D.|314-747-5361|oliverd@wustl.edu|
20560215|NCT01008748|UT MD Anderson Cancer Center - Clinical Research Operations|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
20560216|NCT00052962|National Cancer Institute, National Institutes of Health|Marybeth Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
20560217|NCT04654351|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20560218|NCT01414166|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560219|NCT03682536|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20560220|NCT04824131|HPTN Statistical & Data Management Center|HPTN Statistical Manager|1206-667-4004|HPTN-Data-Access@scharp.org|
20560221|NCT05489224|CELLTRION, Inc.|Head of Clinical Planning Department 3|+82-32-850-4167|jeehye.suh@celltrion.com|
20560222|NCT04794062|Good Samaritan Hospital, TriHealth|Leonid Khokhlov, MD|5138858974|leonkhokhlov@gmail.com|
20560223|NCT03686384|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
20560224|NCT03643965|Calliditas Therapeutics|Clinical Program Leader|0737456451|kristin.onnestam@calliditas.com|
20560225|NCT06268301|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20560226|NCT02820051|UANL|Dr. Julio E. González-Aguirre|82204444|jeglza111@gmail.com|229
20560227|NCT04536025|University of Colorado|Dr. Chelsey Anderson|12069926861|chelsey.anderson@cuanschutz.edu|
20560228|NCT03008122|Saint Louis University|Sarah George, MD|314-977-9035|sarah.george@health.slu.edu|
20560229|NCT01222247|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
20560230|NCT02084082|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20560231|NCT00832780|University of New Mexico Comprehensive Cancer Center|Ben Liem, MD|505-272-0086|BLiem@salud.unm.edu|
20560232|NCT02655653|Montefiore Medical Centr|Dr. Jonathan Leff|7189205409|jleff@montefiore.org|
20560233|NCT03298113|3M Healthcare Business Group|Nancy Klinger, Clinical Manager|651 736|nmklinger@mmm.com|5825
20560234|NCT05121675|Perelman School of Medicine|Dr. Heather Nuske|2153495537|Heather.Nuske@Pennmedicine.upenn.edu|
20560235|NCT03289455|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
20560236|NCT00333788|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
20560237|NCT03298815|University of Utah|Catherine Lee, MD|206-667-4922|Catherine.Lee@hci.utah.edu|
20560238|NCT00935792|Mayo Clinic|Timothy Call, M.D.|5076682050|Call.Timothy@mayo.edu|
20560239|NCT02322775|AstraZeneca Research and Development|Mitchell Goldman, Global Clinical Leader Benralizumab|301 398 0323|Mitchell.Goldman@astrazeneca.com|+1
20560240|NCT02956967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560241|NCT02451423|University of California, San Francsico|Dr. Lawrence Fong, MD|(415) 514-3160|lawrence.fong@ucsf.edu|
20560242|NCT01939938|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
20560243|NCT00764868|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20560244|NCT00308061|University of Bamako Faculty of Medicine, Mali|Mahamadou A. Thera, MD MPH|223-222-1809|mthera@mrtcbko.org|
20560245|NCT01521143|Prima BioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
20512035|NCT00122954|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
20512036|NCT01728376|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512037|NCT00626574|University of South Florida|Enrico M Camporesi MD|813-844-7170|ecampore@health.usf.edu|
20512038|NCT01683331|University of Michigan|Akinlolu Ojo|734 936-4890|aojo@umich.edu|
20512039|NCT03891602|Hackensack Meridian Health|Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN|2018803443|lisa.carterbawa@hmh-cdi.org|
20512040|NCT03491800|University of North Carolina at Chapel Hill|Crystal Wiley Cené, MD, MPH, FAHA|919-445-6783|crystal_cene@med.unc.edu|
20512041|NCT02303977|Abramson Cancer Center, Penn Presbyterian Medical Center|Dr. Christine Ciunci|215-662-9801|christine.ciunci@pennmedicine.upenn.edu|
20512042|NCT04341727|Washington University School of Medicine|Jane O'Halloran|314 454 0058|janeohalloran@wustl.edu|
20512043|NCT05604521|Sanaria Inc.|Chief Medical Officer|301-770-3222|sanaria@sanaria.com|
20512044|NCT00057330|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512045|NCT01491737|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20512046|NCT02354352|Ohio State University|Dr. Subha Raman|614-293-8963|raman.1@osu.edu|
20512047|NCT03110107|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20512048|NCT00812968|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20512049|NCT00494234|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20512050|NCT00556907|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
20512051|NCT00505765|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
20512052|NCT02743117|MedImmune, LLC|Raburn Mallory, MD|301-398-000|information.center@astrazeneca.com|
20512053|NCT01207219|The Department of Psychiatry,HKU|Dr.Lin Jingxia|+85222553064|jingxia.lin@gmail.com|
20512054|NCT01453296|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512055|NCT00620776|University of Pennsylvania|Dr. Paul Crits-Christoph|(215) 662-7993|crits@mail.med.upenn.edu|
20512056|NCT00766727|Neodyne|VP, R&D/OPS|5104564128|jzepeda@neodynebio.com|128
20512057|NCT00615927|Duke University Medical Center|Annick Desjardins, MD, FRCPC|919-668-|annick.desjardins@dm.duke.edu|
20512058|NCT00183170|Boston University School of Public Health|Dr. Jonathan Howland, Professor||jhowl@bu.edu|
20512059|NCT00761969|Department of Vascular Diseases, University of Ljubljana Med Ctr|Ales Blinc, MD, DSc|+386 1 522 80 32|ales.blinc@kclj.si|
20512060|NCT03056456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20512061|NCT00483119|NYU School of Medicine|Elise Kelman, Associate Director of Research Administration|2122639073|elise.kelman@nyumc.org|
20512062|NCT04668066|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512063|NCT02369874|AstraZeneca|Nassim Morsli|+44 7384 520046|nassim.morsli@astrazeneca.com|
20512064|NCT00596466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560246|NCT00783692|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20560247|NCT03750656|University of Kansas Medical Center|Dr. David Duchene|(913) 588-8721|dduchene@kumc.edu|
20560248|NCT03005288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20512065|NCT01891669|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512066|NCT01015118|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20512067|NCT04365387|Galderma Research & Development, LLC|Sponsor|817 961 5000|aestheticclinicaltrials@galderma.com|
20512068|NCT00480077|Medtronic Bakken Research Center|Director CRDM|31-43-3566813||
20512069|NCT00262119|Medtronic|Senior Clinical Research Manager|0039-0632814225|andrea.grammatico@medtronic.com|
20512070|NCT00859313|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
20512071|NCT01215968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512072|NCT02500732|University of Calgary|Dr. Satish R Raj|403-210-6152|satish.raj@ucalgary.ca|
20512073|NCT01958619|Medicines for Malaria Venture (MMV)|Dr Thomas Rueckle PhD|+41 22 799 4567|ruecklet@mmv.org|
20512074|NCT01710839|Retina Consultants of Houston|Charles C Wykoff, PhD, MD|713-524-3434|ccwmd@houstonretina.com|
20512075|NCT03759340|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
20512076|NCT01054443|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20512077|NCT00409565|University of Pittsburgh Cancer Institute|Michael Gibson, MD|412-692-2600|gibsonmk@upmc.edu|
20512078|NCT00985114|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
20512079|NCT02950831|St. Jude Medical|Filippo Agnesi|14694184987|filippo.agnesi@abbott.com|
20512080|NCT01119118|University of Wisconsin Carbone Cancer Center|Dr. Glenn Liu|608-265-8689|gxl@medicine.wisc.edu|
20512081|NCT04487886|Emory University|Edmund Waller, MD, PhD|404-727-4995|ewaller@emory.edu|
20512082|NCT01676818|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
20512083|NCT03548454|Stanford University|Dr. Vafi Salmasi|650-725-0246|vsalmasi@stanford.edu|
20512084|NCT01600677|UPittsburgh|Steven M. Handler, MD, PhD|412-864-1878|handler@pitt.edu|
20512085|NCT02899884|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20512086|NCT02207413|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512087|NCT04075656|Emory University|Chia-shi Wang, MD, MS|404-727-5728|chia-shi.wang@emory.edu|
20560249|NCT03050294|Wake Forest Baptist Health|Steven R. Feldman|336-716-7740|sfeldman@wakehealth.edu|
20560250|NCT00819234|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20512088|NCT01140815|AORI|Knee Research Director|7036194423|nancylparks@gmail.com|
20512089|NCT01361308|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
20512090|NCT02503215|Nephrology Division, University of São Paulo|Dr Bruno Caldin da Silva|5511997620521|brunocaldin@hotmail.com|
20512091|NCT00706901|Charleston VAMC|Elizabeth Santa Ana, Ph.D.|(843) 789-7168|elizabeth.santaana2@va.gov|
20512092|NCT03433482|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20512093|NCT01646268|UCB Clinical Trial Call Center|Study Director|+1 844-599-2279||
20512094|NCT00906776|Rotschild hospital|Prof Philippe Bouchard|+33614656947|phbouch@noos.fr|
20512095|NCT00461591|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20512096|NCT01519635|Service of Nephrology, Centre Hospitalier Universitaire Vaudois, Lausanne|Prof Michel Burnier|+41 21 314 11 54|michel.burnier@chuv.ch|
20512097|NCT04478994|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
20512098|NCT00518531|Amgen Inc.|Study Director|866-572-6436||
20512099|NCT00457249|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20512100|NCT03681769|Medical University of South Carolina|Dr. Jeff Borckardt|843-792-3295|borckard@musc.edu|
20512101|NCT04888377|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
20512102|NCT00526162|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com|
20512103|NCT05279807|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
20512104|NCT01169259|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|VITAL Study Director|1-800-388-3963|vitalstudy@partners.org|
20512105|NCT04242446|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20512106|NCT03587116|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
20512107|NCT04293341|Department of Veterans Affairs|Daniel Gros, PhD|843-789-7311|daniel.gros@va.gov|
20512108|NCT06390085|University of Virginia, Systems and Information Engineering|Gregory Gerling|4349240533|gg7h@virginia.edu|
20512109|NCT05993299|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20512110|NCT05644756|Brown University|Dr. Ruben Martinez|4014441915|ruben_martinez@brown.edu|
20512111|NCT04058990|Boston Scientific Japan K.K.|Sachiyo Sato/Clinical Project Manager|+81-3-6853-7500|Sachiyo.Sato@bsci.com|
20512112|NCT03985982|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
20512113|NCT03093480|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
20512114|NCT03526549|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
20512115|NCT05981365|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512116|NCT02989623|Thomas Jefferson University|Mathew Thakur|215-503-7874|Mathew.Thakur@Jefferson.edu|
20512117|NCT05471921|Columbia University|Jeremy Kane|212-305-2862|jk4397@cumc.columbia.edu|
20512118|NCT03927989|Medical University of South Carolina|Dr. Alana Rojewski (PI)|843-876-1593|rojewski@musc.edu|
20512119|NCT02593175|MD Anderson Cancer Center|Clinton Yam|832-589-8343|cyam@mdanderson.org|
20512120|NCT04199312|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20512121|NCT00478933|Medtronic BRC|Margriet Kruijshoop, Clinical Research Manager|+31623910708|margriet.kruijshoop@medtronic.com|
20512122|NCT05984784|Inmagene LLC|Clinical Trials Lead|(858) 345-6927|ClinicalTrials@imagenebio.com|
20512123|NCT02203305|University of North Carolina at Chapel Hill|Dr. Margaret Dillon|9199665251|mdillon@med.unc.edu|
20512124|NCT01298362|Hellenic Society of Breast Surgeons|Christos J Markopoulos, MD, MPhil Professor of Surgery-Athens University Medical School|+30 210 6862527|cmarkop@hol.gr|
20512125|NCT00302068|DukeUMC|Dr. James Blumenthal|919-684-3969|blume003@mc.duke.edu|
20512126|NCT02980666|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20512127|NCT01335620|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
20512128|NCT02951182|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20512129|NCT00455923|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512130|NCT02686749|Cleveland Clinic|Oussama Wazni, MD|216-444-2131|waznio@ccf.org|
20512131|NCT04762771|baptist health south florida|Raul Herrera, MD (Director Miami Cardiac & Vascular Institute)|786-596-7609|RaulH@BaptistHealth.net|
20512132|NCT03107442|FIBAO|Dr José Antonio Vargas-Hitos|625943933|joseantoniovh@hotmail.com|+34
20512133|NCT00145119|Medtronic Bakken Research Center|Director CRDM|+31 43 3566||566
20512134|NCT02951130|UC Davis School of Medicine|Satyan Lakshminrusimha|916 734 5178|slakshmi@health.ucdavis.edu|
20512135|NCT03795233|Boston Medical Center|Tamar Barlam, MD MSC|617 414 5190|tamar.barlam@bmc.org|
20512136|NCT02756182|Laborie|Clinical Research Manager|9056121170|sgallone@laborie.com|1755
20512137|NCT05267652|Vanderbilt University Medical Center|Jonathan D Casey, MD, MSc|615-875-4681|Jonathan.d.Casey@vumc.org|
20512138|NCT02711306|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
20512139|NCT01255449|IRCCS Azienda Ospedaliera Universitaria San Martino IST - Genova, Italy|Dr. Giovanni Barisione|+39010555|giovanni.barisione@hsanmartino.it|3367
20512140|NCT01979029|First Hospital of Jilin University|Jian Suo|0431-88785605|suojian42@hotmail.com|
20512141|NCT06768658|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20512142|NCT01100073|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20512143|NCT00299546|Centocor Research & Development, Inc.|Associate Director Clinical Research|1-800-457-6399||
20512144|NCT03099265|Yale School of Medicine|Kimberly L. Johung, MD, PhD Associate Professor of Therapeutic Radiology|(203) 200-2008|kimberly.johung@yale.edu|
20512145|NCT01605539|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212-824-9314|yasmin.hurd@mssm.edu|
20512146|NCT00968539|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512147|NCT00326118|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512148|NCT01741259|OB Anesthesia Associates|Christy Morgan, MD|314-469-6800|christylmorganmd@gmail.com|
20560251|NCT04011033|BeijingYouan Hospital|Lu Jun|+86-010-83997153|lujun98@ccmu.edu.cn|
20560252|NCT00209274|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-421-6994|chithra.sangli@av.abbott.com|
20560253|NCT01394991|Johnson and Johnson PRD|Clinical Development Team Lead|1 908 218 6097||
20560254|NCT03073005|Northwestern University|Dr. Jeffrey H Barsuk|312-926-5924|jbarsuk@nm.org|
20560255|NCT01734811|Inmunotek|Medical Director|916 510 010|mcasanovas@inmunotek.com|
20560256|NCT02427646|LHSC|Dr. Mandar Jog|519-685-8500|mandar.jog@lhsc.on.ca|76708
20560257|NCT03824236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20560258|NCT01290094|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20512149|NCT01256086|University of Florida, Department of Pharmacotherapy and Tanslational Research, 100486 Gainesville, FL 32610|Prof. Dr. Leslie Hendeles|+1 352 279|hendeles@cop.ufl.edu|6027
20560259|NCT01786343|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
20512150|NCT03305159|Northwestern University Feinberg School of Medicine|Supriya Rastogi|supriya.rastogi@northwestern.e|supriya.rastogi@northwestern.edu|
20560260|NCT01101542|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560261|NCT00701311|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
20560262|NCT01712685|National Cancer Institute|Dr. Adam Metwalli|301-435-6237|metwallia@mail.nih.gov|
20512151|NCT02094573|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20512152|NCT00643006|Gothenburg University|Dr. K Mannerkorpi|046-31-24220|kaisa.mannerkorpi@rheuma.gu.se|
20560263|NCT01871285|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20560264|NCT03015740|M D Anderson Cancer Center|Dr. Pavlos Msaouel|713-563-4585|PMsaouel@mdanderson.org|
20560265|NCT04207255|Medical University of South Carolina|Alan Brisendine|(843) 792-9007|brisend@musc.edu|
20560266|NCT03253653|San Diego State University Research Foundation|Dr. Nada Kassem|619-370-7488|Nkassem@sdsu.edu|
20560267|NCT01489176|University of Nebraska Medical Center|Thomas R Porter|402-559-5156|trporter@unmc.edu|
20560268|NCT05541497|Yale School of Medicine|Lisa Fucito, PhD: Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry|(203) 688-1878|lisa.fucito@yale.edu|
20560269|NCT04091672|AVITA Medical|SVP Global Clinical Research|1-833-462-8482|ekirshner@avitamedical.com|
20560270|NCT05296629|Journey Medical Corporation|Dr. Srinivas Sidgiddi|9084585362|ssidgiddi@jmcderm.com|
20560271|NCT01796665|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20560272|NCT02268396|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20560273|NCT01565538|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|020-87343439|wsysums@163.net|
20560274|NCT01304706|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
20560275|NCT00359619|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560276|NCT02655692|Yale University|John Krystal|203.785.6396|john.krystal@yale.edu|
20560277|NCT00716079|The George Institute for Global Health|Professor Craig Anderson|+612 9993 4521|canderson@georgeinstitute.org.au|
20560278|NCT04978363|University of Iowa|Molly Pacha|319-290-7596|molly-pacha@uiowa.edu|
20560279|NCT01251614|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20560280|NCT00049517|ECOG Statistical Office|Statistician|617-632-3012||
20560281|NCT01419717|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20512153|NCT03772574|BC Women's Hospital|Dr. Anthony Chau|604-875-2158|anton.chau@ubc.ca|
20512154|NCT00617175|MEDTRONIC Clinical Research Institute|Laura Manotta|+39022413.1|laura.manotta@medtronic.com|
20512155|NCT03586427|Gate Neurosciences, Inc|Chief Medical Officer|2032473895|ron.burch@gateneuro.com|
20512156|NCT02384200|UCSD Medical Center|Paul Zupkas, Ph.D.|6195432628|pzupkas@ucsd.edu|
20512157|NCT03193996|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
20512158|NCT05125224|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20512159|NCT00593385|Getinge|Elizabeth Bulger, Director of Clinical Affairs|1-603-864-5368|elizabeth.bulger@getinge.com|
20512160|NCT01471197|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20512161|NCT02352831|Washington University School of Medicine|Andrea Wang-Gillam, M.D., Ph.D.|314-362-5740|awang-gillam@wustl.edu|
20512162|NCT00924313|National Cancer Institute, National Institutes of Health|Dr. Peter L. Choyke|301-402-8409|pchoyke@mail.nih.gov|
20512163|NCT01283009|Memphis VA Medical Center|Dr. Gianfranco U. Meduri|(901) 577-7520|Gianfranco.Meduri@va.gov|
20512164|NCT05102162|University of Florida College of Pharmacy|Nicole Maranchick|352-273-6803|n.maranchick@cop.ufl.edu|
20512165|NCT01353586|Biosense Webster, Inc|Kendra McInnis, Manager, Clinical Operations|909-839-7284|kmcinnis@its.jnj.com|
20512166|NCT05027958|Division of Intramural Research, NHLBI|Kevin P. Fennelly, M.D., MPH, ATSF|301-385-0807|kevin.fennelly@nih.gov|
20512167|NCT00595946|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20512168|NCT04369885|University of North Carolina at Chapel Hill|Michael B Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
20512169|NCT03715335|Cincinnati Children's Hospital Medical Center|Dr. Jennifer Reed|(513) 636-7966|jennifer.reed@cchmc.org|
20512170|NCT02234427|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
20512171|NCT02242942|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20560282|NCT02857283|UNC Center for Environmental Medicine, Asthma and Lung Biology|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
20560283|NCT00093795|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
20512172|NCT04882085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560284|NCT00940017|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20560285|NCT00613301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20560286|NCT00961805|Federal University of Sao Paulo|Andreia S Baptista, PT|551155764239|deiasalvador1@yahoo.com.br|
20560287|NCT01684046|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20560288|NCT05080192|University of Pennsylvania|Seavmeiyin Kun|215-917-0115|seavmeiyin.kun@pennmedicine.upenn.edu|
20560289|NCT04094064|University of Virginia Center for Diabetes Technology|Dr. Meaghan Stumpf|(434) 982-4351|MMS5CF@hscmail.mcc.virginia.edu|
20560290|NCT03614130|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20560291|NCT03371108|Gan & Lee Pharmaceuticals USA Corp.|Jia Lu, MD, PhD Executive Director of US Clinical Sciences|+1 888-288-5395|Jia.Lu@ganlee.us|
20560292|NCT05805059|Coopervision|Jose A. Vega,OD,MSc,FAAO, PhD|925-621-3761|jvega2@coopervision.com|
20560293|NCT04188288|Yale University|Kathleen Garrison, PhD|203-737-6232|kathleen.garrison@yale.edu|
20560294|NCT02790606|C.R. Bard|Talar Saber, Clinical Project Manager|480-379-2839|talar.saber@crbard.com|
20560295|NCT02735915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20560296|NCT05328973|M.D. Anderson Cancer Center|Neil Bailard, MD|713-597-1687|nbailard@mdanderson.org|
20560297|NCT02596906|Center for BrainHealth, The university of Texas at Dallas|Dr. Namrata Das|9728833266|Namrata.Das@utdallas.edu|
20560298|NCT03570255|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
20560299|NCT00790062|University of Alabama at Birmingham|Alan T. N. Tita, MD|(205) 934-9616|atit@uab.edu|
20560300|NCT02680756|Shield Therapeutics|Jackie Mitchell MA DPhil|0044 752 565 6885|jmitchell@shieldtx.com|
20560301|NCT00480441|Treatment Research Center|Dr. Marina Goldman, Principle Study Investigator|215 222 3200|marinag@mail.med.upenn.edu|104
20560302|NCT02374957|Wake Forest University Health Sciences|Dr. Matthew Edwards|336-716-9343|medwards@wakehealth.edu|
20560303|NCT03681691|Wake Forest University Health Science|Christina Hugenschmidt, PhD|336.713.4190|chugensc@wakehealth.edu|
20560304|NCT00748969|LA Biomed at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1972|lpolgreen@labiomed.org|
20560305|NCT02334306|MedImmune, LLC|Gabor Illei|+1 240 558 0038 118|information.center@astrazenea.com|
20560306|NCT01687270|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20560307|NCT00465985|Novartis Pharmaceuticals|Study Director|862-778-8300||
20560308|NCT03532178|UCaliforniaSF|Dr. Chanhung Lee|4154762131|chanhung.lee@ucsf.edu|
20560309|NCT03302156|UW School of Medicine and Public Health|Elizabeth Sadowski, MD|608-263-9028|esadowski@uwhealth.org|
20560310|NCT02390557|Massachusetts General Hospital, Mongan Institute for Health Policy|Lisa I. Iezzoni, MD, MSc|6176430657|liezzoni@mgh.harvard.edu|
20512173|NCT05014672|Calliditas Therapeutics AB|Head of Clinical Operations|+4684113005|info@calliditas.com|
20512174|NCT04336189|UCSF|Grant Dorsey|415-310-0525|grant.dorsey@ucsf.edu|
20512175|NCT04455620|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20512176|NCT04881149|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20512177|NCT05681715|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20560311|NCT01608971|Heart and Diabetes Center NRW|Andreas Koster|0043 5731 3284|akoster@hdz-nrw.de|
20512178|NCT05116241|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
20512179|NCT02265874|The Ohio State University Wexner Medical Center|Dr. Elliott Crouser|16142934925|elliott.crouser@osumc.edu|
20512180|NCT02268214|AstraZenenca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20512181|NCT00457795|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20512182|NCT04563039|Avvio Medical, Inc.|VP of RA / QA / CA|4158872037|clinicalaffairs@avviomed.com|
20512183|NCT04584294|VA Puget Sound Health Care System|Lisa Callegari (Principal Investigator)|206-277-3129|Lisa.Callegari@va.gov|
20512184|NCT03447015|Mutah University|Dr Reham Khresheh|0791425992|rehamkh@mutah.edu.jo|
20512185|NCT04242498|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20512186|NCT01003691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512187|NCT01652040|Hunter Holmes McGuire VA Medical Center|Ashraf S. Gorgey|8046755000|ashraf.gorgey@va.gov|3386
20512188|NCT03225313|Theodor Bilharz Research Institute|Dr Muhammed Hussein|00201001434459|muhamed.hussein@gmail.com|
20512189|NCT03832907|Emory University|Dr. Umpierrez|404-778-1665|geumpie@emory.edu|
20512190|NCT00308230|Emory University|Wendy Book|404-778-5545|wbook@emory.edu|
20512191|NCT00828009|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20512192|NCT07002632|University of Health Sciences, Gaziosmanpasa Training and Research Hospital|Ethem ilhan, MD|+90 505 591 86 50|ethem.ilhan@sbu.edu.tr|
20512193|NCT05405218|Sonex Health, Inc.|Amy Stegner, Vice President Clinical Affairs|(888) 518-8780|astegner@sonexhealth.com|
20512194|NCT02996266|Becton, Dickinson and Company|Director, Global Clinical Affairs - Urology and Critical Care|9733077325|kirsten.hammitt@bd.com|
20512195|NCT04938687|Spaulding Rehabilitation Hospital|Qing Mei Wang, MD, PhD|(617) 952-5299|wang.qingmei@mgh.harvard.edu|
20512196|NCT02284880|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20512197|NCT00887965|Amgen Inc.|Study Director|866-572-6436||
20512198|NCT01656850|Taipei Medical University|Liu, Jen-Fang|+886-3-2118999|liujenfa@mail.cgust.edu.tw|5487
20512199|NCT00396318|Genentech, Inc.|Medical Communications|800-821-8590||
20512200|NCT00602927|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
20512201|NCT00296192|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20512202|NCT03504839|The Ohio State University Medical Center|Clinical Research Coordinator - Adrianne Miller|614-688-8252|adrianne.miller3@osumc.edu|
20512203|NCT02074982|Novartis Pharmaceuticals|Study Director|862-778-8300||
20512204|NCT03065517|Evidence-Based Practice Institute, Inc.|Angela Kelley Brimer|253-279-8659|research@jasprhealth.com|
20560312|NCT03278028|Aclaris Therapeutics|Executive Director, Clinical Operations|+1(484) 329-2144|jschnyder@aclaristx.com|
20512205|NCT02525627|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Doug McGurty|+44 (0) 1635 500690|doug.mcgurty@stryker.com|
20512206|NCT02875340|ValiSeek Limited|Suzanne Dilly|+442030084416|suzanne.dilly@valirx.com|
20512207|NCT01160770|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20512208|NCT01064830|University of North carolina-Chapel Hill|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
20512209|NCT01432600|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
20512210|NCT00514709|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20512211|NCT02411110|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20512212|NCT02530320|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
20512213|NCT00005803|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
20512214|NCT01354015|Tulane University|Dr Vivian Fonseca|5049884026|vfonseca@tulane.edu|
20512215|NCT02871921|MGH|Dr. Hiroko Dodge, Director of Research Analytics|724-494-3605|hdodge@mgh.harvard.edu|
20512216|NCT00320801|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
20512217|NCT01293682|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
20512218|NCT00491322|Massachusetts General Hospital|Dr. Sherri-Ann M. Burnett-Bowie|6177245594|sburnett-bowie@mgh.harvard.edu|
20512219|NCT02277548|University of Pennsylvania|Dr. Erin McMenamin|251-662-2428|Erin.McMenamin@pennmedicine.upenn.edu|
20512220|NCT00807040|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
20512221|NCT00544713|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20512222|NCT02511587|Medical University of Vienna|Univ.-Prof. Dr. Ursula Wiedermann|0043 1 40160 38291|ursula.wiedermann@meduniwien.ac.at|
20512223|NCT00890409|Children's Hospital, Fudan University|Prof. Xiaomei Shao|86-21-64931913|zhou_wenhao@yahoo.com.cn|
20512224|NCT02353572|University of Colorado|Choon-kee Lee, MD|7208489252||
20512225|NCT03099655|Medtronic|Erika Pouliot|+17635261270|erika.pouliot@medtronic.com|
20512226|NCT01870921|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20512227|NCT02060188|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20512228|NCT00510497|University of Pittsburgh|Sharon A. Riddler, MD, MPH|412-383-1675|riddler@pitt.edu|
20512229|NCT05445466|BIDMC|Dr. Paulo Lizano|201-776-6708|lizanopl@gmail.com|
20512230|NCT01714921|Medtronic GmbH|ProSA clinical research contact|004921598149|rs.dusclinicalcooperation@medtronic.com|0
20512231|NCT05455684|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20512232|NCT05204563|Evopoint Biosciences USA, Inc.|Evopoint Biosciences|646-750-2661|info@evopointbio.com|
20512233|NCT04411641|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20512234|NCT04678440|University of California Davis|Simon Cherry|(530) 754-9419|srcherry@ucdavis.edu|
20512235|NCT05487625|Fralin Biomedical Research Institute at VTC|Roberta Freitas Lemos|540 526 2106|rflemos@vtc.vt.edu|
20512236|NCT01795534|Bangor University|Dr Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
20512237|NCT04342390|Arkansas Children's Research Insitute|Emir Tas|4126928688|tase2@upmc.edu|
20512238|NCT04813484|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
20512239|NCT03884556|Trishula Therapeutics|Trishula Info|(650) 509-5732|info@trishulatx.com|
20512240|NCT00352794|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD., Professor|713-745-3429|sverstov@mdanderson.org|
20512241|NCT02008396|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20512242|NCT01233284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20512243|NCT02630992|University of Pittsburgh|Nader Shaikh|412-692-8111|nader.shaikh@chp.edu|
20512244|NCT05403502|Tandem Diabetes Care|Sr. Supervisor of Clinical Operations|+18583666900|clinicalaffairs@tandemdiabetes.com|
20512245|NCT01058707|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
20512246|NCT00167414|University of Rochester|Hong Zhang|585-341-6750|hong_zhang@urmc.rochester.edu|
20512247|NCT03722459|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20512248|NCT03826771|Medical University of South Carolina|Chris Gregory|843-792-1078|gregoryc@musc.edu|
20512249|NCT04814654|Montefiore Medical Center|Dr. Viraj Patel|718-920-5256|vpatel@montefiore.org|
20512250|NCT01875731|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43632100|torresfernandoadrian@gmail.com|1014
20512251|NCT03417102|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20512252|NCT03188991|US Biotest, Inc.|Gere S. diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
20512253|NCT03309072|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
20512254|NCT00795210|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
20512255|NCT03255226|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
20512256|NCT00685763|University of Florida Proton Therapy Institute|Charles Nichols, M.D.|904-588-1800|rnichols@floridaproton.org|
20512257|NCT00242567|Novartis Pharmaceuticals|Study Director|862-778-8300||
20512258|NCT01817764|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512259|NCT01510704|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
20512260|NCT02525575|Department of Veteran Affairs|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
20512261|NCT01301625|Abbott Vascular|Jeffrey T. Ellis|(408) 845-8184|jeffrey.ellis@av.abbott.com|
20512262|NCT00337727|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20512263|NCT00517868|Vaneltix Pharma, Inc.|CEO|732-354-3217|info@vaneltix.com|
20512264|NCT06067191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512265|NCT00323362|Rutgers Cancer Institute of New Jersey|Dr. Joseph Aisner, MD|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20512266|NCT00625846|Mayo Clinic|Keith C. Bible, M.D., Ph.D.|507-284-2511|bible.keith@mayo.edu|
20512267|NCT03733418|Vanderbilt University Medical Center|Dr. Jin Han|16159360253|jin.h.han@vumc.org|
20512268|NCT00661960|UCaliforniaDavis|David Asmuth/Principal Investigator|9167348695|david.asmuth@ucdmc.ucdavis.edu|
20512269|NCT01833897|New York State Psychiatric Institute|Joshua Kantrowitz|646-774-6738|jkantrowitz@nki.rfmh.org|
20512270|NCT00669110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512271|NCT01244516|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
20512272|NCT00941681|Cytokinetics, Inc.|Project Manager|650-624-2918||
20512273|NCT02335411|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512274|NCT03091478|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Rachel Levy, MS, CCRP|410-502-8738|rlevy16@jhmi.edu|
20512275|NCT03075826|Weill Cornell Medical College|Dr.Pinkal Desai|646-962-2700|pid4006@med.cornell.edu|
20512276|NCT04190056|University of California, San Francisco|Dr. Pamela Munster, MD|(415) 502-3598|pamela.munster@ucsf.edu|
20512277|NCT04456998|GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB002, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
20512278|NCT03707145|Aberystwyth University|Dr Marco Arkesteijn|+44(0)1970628559|maa36@aber.ac.uk|
20512279|NCT04221477|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20512280|NCT02316002|University of Pennsylvania (Abramson Cancer Center)|Dr. Joshua Bauml|215-662-4000|melissa.volpe@pennmedicine.upenn.edu|
20512281|NCT05012943|Vinmec Healthcare System|Nguyen Xuan Hung|+84-865438388|v.hungnx1@vinmec.com|
20512282|NCT04228107|University of Colorado|Heather De Keyser MD MSCS|720-777-4108|heather.dekeyser@childrenscolorado.org|
20512283|NCT00400985|Medtronic BRC, The Netherlands, Maastricht|Director CRDM|+31 43 3566||566
20512284|NCT00965562|Donaghue Medical Research Foundation|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
20512285|NCT03792633|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20512286|NCT05382637|Children's National Hospital|Andrew Dauber, MD|202-476-2121|adauber@childrensnational.org|
20512287|NCT05048875|Johns Hopkins School of Public Health Center for Immunization Research|Dr Anna Durbin|410-955-1622|adurbin1@jhu.edu|
20512288|NCT04755283|Anthos Therapeutics, a Novartis company|Study Director|+1-888-669-6682|Novartis.email@Novartis.com|
20512289|NCT03222570|University of Minnesota|Meredith Gunlicks-Stoessel|612-624-9249|mgunlick@umn.edu|
20512290|NCT03741335|Oregon Health & Science University|Dr. Kerri Winters-Stone|503-494-0813|wintersk@ohsu.edu|
20512291|NCT04049474|NYU Langone Health|Lira Gutierrez|212-263-6181|Lira.Gutierrez@nyulangone.org|
20512292|NCT02970877|University Health Network|Scientific Associate|416-340-5159|kschweng@uhnresearch.ca|
20512293|NCT04103645|Weill Cornell Medicine|Joseph Scandura, MD|(212) 746-2072|jms2003@med.cornell.edu|
20512294|NCT04410978|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20512295|NCT00318357|The University of Hull; Department of Cardiology; United Kingdom|John Cleland, Professor|Telephone: 0044 1482 624084||
20512296|NCT02684162|The University of Texas MD Anderson Cancer Center|Betul Oran, MD / Stem Cell Transplantation|713-745-2820|BOran@mdanderson.org|
20512297|NCT05153629|Stanford University|Simon Conti, MD|650-723-3391|sconti@stanford.edu|
20512298|NCT05125237|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20512299|NCT04560088|University of Rochester Medical Center|Autumn Gallegos, PhD|5852752824|autumn_gallegos@urmc.rochester.edu|
20512300|NCT04089566|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20512301|NCT01083121|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20512302|NCT02665273|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
20512303|NCT03378921|Department of Gastrointestinal surgery, Helsinki University Hospital|Dr. Essi Karjalainen|+358504621853|essi.karjalainen@hus.fi|
20512304|NCT00594009|University of Texas Medical Branch|Victor Cardenas, MD|(409) 772-2436|vcardena@utmb.edu|
20512305|NCT03743571|University of Nevada Reno|Cynthia Lancaster|(775) 682-8144|cynthialancaster@unr.edu|
20512306|NCT04115488|Polpharma Biologics S.A.|Director Clinical Research and Development|+48 607 697 896|clinicaltrials@polpharmabiologics.com|
20512307|NCT00885677|Medtronic EMEA RCC|Valentina Amori|3425417863|valentina.amori@medtronic.com|
20512308|NCT02159872|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Professor|713-792-4764|ejabbour@mdaderson.org|
20512309|NCT00516217|University of Chicago|Sonali Smith, M.D.||smsmith@medicine.bsd.uchicago.edu|
20512310|NCT00795886|Primary Children's Medical Center|Michael Pulsipher, MD|801-662-4732|Michael.Pulsipher@hsc.utah.edu|
20512311|NCT00710840|University of Colorado Denver, Anschutz Medical Center|Dr. Jennifer Stevens-Lapsley|303-724-9170|Jennifer.Stevens-Lapsley@ucdenver.edu|
20512312|NCT00157820|Hospital General Universitario de Valencia, Spain|Dr.A.Quesada||aquesadad@secardiologia.es|
20512313|NCT02674568|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20512314|NCT01939834|University of Virginia|Sue Brown|434-924-1825|sab2f@virginia.edu|
20512315|NCT01118949|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20512316|NCT02850159|Samsung Medical Center|Dr. Won Hyuk Chang|82234102818|wh.chang@samsung.com|
20512317|NCT02060526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20512318|NCT03572049|University of Alabama at Birmingham|Dr. Peter G. Pappas|2059347292|ppappas@uabmc.edu|
20512319|NCT01441401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512320|NCT03457727|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20512321|NCT00464308|Janssen-Cilag Pty Ltd|Executive Director, Medical & Scientific Affairs|+61 2 9815 3219|mhandel@its.jnj.com|
20512322|NCT01721200|Yale University|Liana Fraenkel, MD, MPH, Department of Medicine||liana.fraenkel@yale.edu|
20512323|NCT00630994|Mayo Clinic|Dr. Ruben A. Mesa|507-284-2511|mesa.ruben@mayo.edu|
20512324|NCT03533608|Center for Clinical Managment Research|Dr. Rebecca Sripada|734-222-7432|rebecca.sripada@va.gov|
20512325|NCT03286426|Duke Eye Center|Dr. Grace Prakalapakorn|+1 919 684 7679|grace.prakalapakorn@duke.edu|
20512326|NCT05553600|Kimberly-Clark Corporation|Jin Zhang|770-587-8000|jin.zhang@kcc.com|
20512327|NCT04930536|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20512328|NCT04292171|University of Nevada Las Vegas School of Medicine|Adam V. Levy MD|702-671-2300|adam.levy@unlv.edu|
20512329|NCT00556972|Coloplast A/S|Thais Benjamin N. Christensen, Senior Clinical Project Manager|+4549112668|dkthc@coloplast.com|
20512330|NCT02116309|Johns Hopkins University|Dr. Vikesh Singh|4106146708|vakshin1@jhmi.edu|
20512331|NCT00471237|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512332|NCT00848965|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512333|NCT03710824|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20512334|NCT02329834|scPharmaceuticals|Sr. Vice President of Clinical Development and Medical Affairs||jmohr@scpharma.com|
20512335|NCT00659945|University of Pittsburgh|Manuel C. Vallejo, MD|412-641-4260|vallejomc@anes.upmc.edu|
20512336|NCT01605370|Mayo Clinic|Marek Belohlavek, M.D., Ph.D.|408-301-6694|belohlavek.marek@mayo.edu|
20512337|NCT01976104|Eisai Call Center|Eisai Inc.|888-422-4743|esi_medinfo@eisai.com|
20512338|NCT01993238|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
20512339|NCT01509638|Cleveland Clinic Florida|Marylise Boutrous, MD|954-659-5000|canedoj@ccf.org|
20512340|NCT03862469|University of Illinois at Chicago|Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
20512341|NCT02181673|Janssen Research & Development, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20512342|NCT00326625|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20512343|NCT03046966|University of Arkansas for Medical Sciences|Jennifer Rumpel, MD|501-364-2980|Jarumpel@uams.edu|
20512344|NCT04764669|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20512345|NCT01783860|Rasoule-Akram Hospital|Dr. Mohsen Bahmani-Kashkouli|00982166558811|bahmanik@eyeplasticsurgeries.com|
20512346|NCT03992261|Mayne Pharma|Lee Ann McDowell, PharmD - Director of Medical Affairs|4124776681|leeann.mcdowell@maynepharma.com|
20512347|NCT00258310|Barbara Ann Karmanos Institute|George Yoo, M.D.|(313) 576-9782|yoog@karmanos.org|
20512348|NCT00256217|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20512349|NCT00759668|Alcon Italia SpA|Marcello Fornoni|39.02.81.303.226|marcello.fornoni@alconlabs.com|
20512350|NCT00552812|Johns Hopkins School of Medicine|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
20512351|NCT00806416|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20512352|NCT02989922|Jiangsu HengRui Pharmaceuticals Co., Ltd|Linna Wang|+862161053363|linna.wang@hengrui.com|
20512353|NCT04035694|innovation Research & Training|Dr. Tracy Scull|(919) 493-7700|tscull@irtinc.us|
20512354|NCT02024386|Duke University School of Medicine|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
20512355|NCT03664024|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512356|NCT01157065|Alcon Research, Ltd.|Mehdi Hosseini, Clinical Trial Manager|1-888-451-3937|alcon.medinfo@alcon.com|
20512357|NCT00318409|San Francisco Department of Public Health|Moupali Das, MD, MPH|415-437-6204|moupali.das@sfdph.org|
20512358|NCT05275673|Faeth Therapeutics, Inc|Medical Monitor|7084069282|clinicaltrials@Faeththerapeutics.com|
20512359|NCT02325739|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20512360|NCT03426995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20512361|NCT00227591|ECOG Statistical Office|Study Statistician|617-632-3012||
20512362|NCT02181075|Oncology Clinical Trials Group|Sarah Pearson, Trial Management Director|01865 227160|sarah.pearson@oncology.ox.ac.uk|
20512363|NCT04150107|Oramed, Ltd.|Miriam Kidron, PhD|+972-2-566-0001|miriam@oramed.com|
20512364|NCT00650806|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
20512365|NCT02080273|Colgate Palmolive Company|Maria Ryan|732-878-7766|maria_ryan@colpal.com|
20512366|NCT01465048|University of Oxford|Dr Susanne Sheehy||susanne.sheehy@balliol.ox.ac.uk|
20512367|NCT00605839|Indiana University School of Medicine|Aaron E. Carroll|3172780552|aaecarro@iupui.edu|
20512368|NCT03917654|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
20512369|NCT01883141|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
20512370|NCT00673712|Halyard Health|Sr. Director Clinical Research|5132538033|alan.dine@hyh.com|
20512371|NCT01489865|Lombardi Comprehensive Cancer Center|Benjamin Weinberg, MD|202-444-2223|baw12@gunet.georgetown.edu|
20512372|NCT00972309|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20512373|NCT01593761|CrystalGenomics, Inc.|Seonggu Ro, Ph.D, Chief Technology Officer|82 31 628 2783|sgro@cgxinc.com|
20512374|NCT05554471|Cordis|Jenny Jimenez|+1 646 483-6846|jenny.jimenez@cordis.com|
20512375|NCT04479241|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
20512376|NCT02576951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20512377|NCT03285581|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20512378|NCT02218619|Columbia University Irving Medical Center|Robin Goland, MD|212-851-5494|rsg2@cumc.columbia.edu|
20512379|NCT00223990|Kenya Medical Research Institute|Bernhards R. Ogutu, PhD|254-57-22942|bogutu@kisian.mimcom.net|
20512380|NCT01419028|Alexion International Sarl|Alexion Pharmaceuticals||clinicaltrials@alxn.com|
20512381|NCT04020822|Medtronic Diabetes|Kusal Ahangama, Clinical Study Manager|+18185765023|kusal.c.ahangama@medtronic.com|
20512382|NCT01319994|Queen Mary University of London|Prof M Korbonits|+442078826197|m.korbonits@qmul.ac.uk|
20512383|NCT01340794|Mayo Clinic Cancer Center|Keith Bible, M.D., Ph.D.||bible.keith@mayo.edu|
20512384|NCT00741026|American Medical Association|Vance L. Albaugh, Principle Investigator|(800) 243-1455|vance.l.albaugh@vanderbilt.edu|
20512385|NCT01568255|Cedars Sinai|Margo Minissian, PhD|310-423-5195|Margo.Minissian@cshs.org|
20512386|NCT01808508|Children's Hospital of Philadelphia|Carole L. Marcus, MBBCh|267-426-5842|marcus@email.chop.edu|
20512387|NCT02712359|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20512388|NCT03387423|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512389|NCT03862807|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20512390|NCT00798707|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512391|NCT04476654|Virginia Commonwealth University|Dr. Vanessa Sheppard|804-828-8892|vlbsheppard@vcu.edu|
20512392|NCT01473589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512393|NCT00929201|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512394|NCT00566969|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
20512395|NCT01513759|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
20512396|NCT03606109|NYU Langone Health|Michael J. Alaia, MD|646-501-7223|Michael.Alaia@nyulangone.org|
20512397|NCT02305329|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20512398|NCT01107834|Washington University|William T. Cade|314-286-1432|tcade@wustl.edu|
20512399|NCT03722849|The University of Melbourne|Dr Stuart Mazzone|+61383446457|stuart.mazzone@unimelb.edu.au|
20512400|NCT03514121|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20512401|NCT01900392|UPENN|Catherine Reale|2157464009|catherine.reale@uphs.upenn.edu|
20512402|NCT04633434|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
20512403|NCT03354143|IEEM|Dr. Rong Zhang|214-345-4245|rongzhang@texashealth.org|
20512404|NCT00297882|University of Yaounde 1, Cameroon|Professor Wilfred Mbacham|+237 677579180|wfmbacham@yahoo.com|
20512405|NCT04242264|Cincinnati Children's Hospital Medical Center|Robert W Frenck, Jr, M.D.|513-636-4463|Robert.Frenck@cchmc.org|
20512406|NCT00544778|City of Hope National Medical Center|Paul Frankel, Ph. D.|(626)359-8111|pfrankel@coh.org|65265
20512407|NCT00348348|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
20512408|NCT00578448|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20512409|NCT01317199|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Channing Paller|410-955-8239|cpaller1@jhmi.edu|
20512410|NCT01353209|University of Cincinnati|Susan McMahan, Clinical Research Manager|513-558-4831|Susan.mcmahan@uc.edu|
20551123|NCT00530764|GW Pharma Ltd.|Matthew Hersch, Senior Clinical Project Manager|+44 1353 616600|mhersch@gwpham.com|
20512411|NCT03112720|RWJMS/Rutgers Health|william grubb md|732 235 7827|grubbwr@rwjms.rutgers.edu|
20512412|NCT02920866|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
20512413|NCT01312948|ResMed Ltd|Alison Wimms|+6188842583|alison.wimms@resmed.com.au|
20512414|NCT02686437|Sport and Spine Rehab Clinical Research Foundation|Jena Etnoyer-Slaski|301-251-2777|jslaski@ssrehab.com|838
20512415|NCT03237325|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
20512416|NCT02684370|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20512417|NCT00552422|Columbia University|David Lederer|212-342-4167|tjb2134@cumc.columbia.edu|
20512418|NCT00627094|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
20512419|NCT00561600|DePuy Orthopaedics|Dave Whalen Clinical Portfolio Leader|574-372-7028|dwhalen@its.jnj.com|
20512420|NCT00944528|Assistant Research Practice Manager|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
20512421|NCT01165424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20512422|NCT04139642|The Ohio State University|Dr. Ajit Chaudhari|+1-614-292-0558|chaudhari.2@osu.edu|
20512423|NCT01040624|University of Florida Health Proton Therapy Institute|Nancy P. Mendenhall, MD|904-588-1000|rtoton@floridaproton.org|
20512424|NCT00433771|Boston Scientific Corporation|Jeremy Bolt|508-683-4006|boltj@bsci.com|
20512425|NCT03733301|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20512426|NCT00380861|DePuy Orthopaedics|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
20512427|NCT01965431|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20512428|NCT04635631|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512429|NCT00577031|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20512430|NCT00943826|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20512431|NCT04342130|University of Rochester|Paul Geha|203-752-8256|paul_geha@urmc.rochester.edu|
20512432|NCT00557830|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20512433|NCT00127192|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20512434|NCT01856257|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20512435|NCT04935931|Children's Mercy Kansas City|Dr. Stephani Stancil|816-234-3000|slstancil@cmh.edu|
20551124|NCT01414075|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
20551125|NCT01590238|New York Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
20551126|NCT01187043|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
20551127|NCT04903626|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20512436|NCT00077766|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20551128|NCT00573534|Columbia University/New York State Psychiatric Instittue|Stephen J. Donovan MD|646 774 8078|sd45@columbia.edu|
20512437|NCT01886105|Johns Hopkins University|Dr. Brian H. Ladle|443-287-3534|bladle@jhmi.edu|
20512438|NCT00357734|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20512439|NCT00389168|Karolinska Institutet, Stockholm, Sweden|Thomas Kahan, MD|+46 8 123 568 61|thomas.kahan@ds.se|
20528585|NCT03318003|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
20528586|NCT01247350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512440|NCT02057549|The University of Texas Houston Health Science Center|Dr. Carlos J. Roldan MD|713-792 6070|croldan@mdanderson.org|
20512441|NCT01360021|Astrazeneca|Goran Eckerwall, MD||aztrial_results_posting@astrazeneca.com|
20512442|NCT03843775|Memorial Sloan Kettering Cancer Center|Dr. Rona Yaeger MD|646-888-5109|yaegerr@mskcc.org|
20512443|NCT00003726|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
20512444|NCT02212834|Group Health Research Institute|Karen J. Wernli, PhD|206-287-2934|wernli.k@ghc.org|
20512445|NCT00530621|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512446|NCT02596009|Novartis Pharmaceuticals|Study Director|862-778-8300||
20512447|NCT05444114|University of Colorado Colorado Springs|Lori James|7192554172|ljames@uccs.edu|
20512448|NCT02255422|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20512449|NCT02062385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512450|NCT03222856|MedSIR|Scientific Director|+34 611261467|alicia.garcia@medsir.org|
20512451|NCT01035229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20512452|NCT01628159|BD|Director of Clinical Affairs|763-445-2385|anna.lovas@bd.com|
20512453|NCT02513095|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201 326 5300|medinfo@eagleus.com|
20512454|NCT02384239|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
20512455|NCT01299272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512456|NCT03926728|Statens Serum Institut|Per Skallerup|+4532688554|PRSK@SSI.dk|
20512457|NCT03669640|F. Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20512458|NCT03993288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20512459|NCT00366678|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20512460|NCT01387672|Womens' College Hospital|Dr. Sophie Jamal|416-351-3732|sophie.jamal@wchospital.ca|2873
20512461|NCT03286400|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
20512462|NCT01150409|The Cleveland Clinic Foundation|Jorge Guzman MD|216-445-5765|guzmanj@ccf.org|
20512463|NCT00315328|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
20512464|NCT00826176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20512465|NCT00740480|ENTrigue Surgical, Inc.|Gabriele Niederauer, PhD|210-298-6398|gabi.niederauer@entriguesurgical.com|6336
20512466|NCT00448630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20512467|NCT04662086|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
20512468|NCT03079869|Kaiser Permanente|KPSC PRS Administrator|626-720-7463|RE-CTCAT@kp.org|
20512469|NCT00665704|VA Center for Clinical Management Research Health Services Research & Development, VA Ann Arbor Healthcare System, Ann Arbor, MI.|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
20512470|NCT04253756|University of Texas Southwestern Medical Center|Sonja Stutzman, Research Programs Manager|214-648-6719|sonja.stutzman@utsouthwestern.edu|
20512471|NCT00540007|Washington University School of Medicine|Todd Fehniger, M.D., Ph.D.|314-747-1385|tfehnige@wustl.edu|
20512472|NCT00568776|Transition Therapeutics Ireland Limited|Aleksandra pastrak, MD, PhD, Vice President, Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
20512473|NCT01005680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512474|NCT01456000|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
20512475|NCT04305184|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
20512476|NCT03731325|Washington University in St. Louis|Tina Day|314-286-0079|dayt@wustl.edu|
20512477|NCT04928794|Anesthesiology Department, University of New Mexico|Anesthesiology Research Director|505-272-2610|HSC-Anesthesiology@salud.unm.edu|
20512478|NCT03506646|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20512479|NCT04484805|Liberating Technologies, Inc.|Dr. Todd Farrell|774-233-0873|todd.farrell@liberatingtech.com|
20512480|NCT02118896|Astellas Pharma Europe Limited|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
20512481|NCT03292731|University of Pittsburgh|steve caritis|412 641 5256|scaritis@mail.magee.edu|
20512482|NCT04221373|Icahn School of Medicine at Mount Sinai|Dr. Chung-Ying Tsai|(212) 241-7073|chung-ying.tsai@mountsinai.org|
20512483|NCT00212446|New York Downtown Hospital (hospital bankrupt/closed)|Dr. Jeffrey Karsdon||JK_MD@yahoo.com|
20512484|NCT02203604|Dana Farber Cancer Institute|Ann Silk, MD|617-632-6571|Ann_Silk@dfci.harvard.edu|
20512485|NCT00186875|St. Jude Children's Research Hospital|Sima Jeha, MD|866-278-5833|info@stjude.org|
20512486|NCT00029107|NIAID/NIH|Michael C Sneller, MD|301-496-0491|msneller@niaid.nih.gov|
20512487|NCT00138658|OncoGenex Pharmaceuticals|Dr. Patricia Stewart, Vice President Medical Affairs|425-686-1500|psstewartmd@oncogenex.com|
20512488|NCT03952377|SpineThera|Jeff Missling, CEO|+1(612)-508-4795|jmissling@spinethera.com|
20512489|NCT00131573|Boston Scientific|Director of Clinical Operations|866-360-4747|valerie.lucero-cimmarusti@bsci.com|
20512490|NCT02050373|UFGoias|Daniella Salvador|556235583272|danirnsalvador@gmail.com|
20512491|NCT01067339|Mayo Clinic|Amir Lerman, MD|507-284-6429|lerman.amir@mayo.edu|
20528587|NCT02762071|Johns Hopkins University|Uma Srikumaran|443-546-1550|us@jhmi.edu|
20512492|NCT01179191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528588|NCT01101750|MedStar Health Research Institute|Veronica Gomez-Lobo, MD|202-877-4099|veronica.gomez-lobo@medstar.net|
20512493|NCT00572910|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512494|NCT01260194|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20512495|NCT01803464|University of Delaware|Dr. Christopher Modlesky|302-831-4185|modlesky@udel.edu|
20512496|NCT02424851|Oxford University Hospitals NHS Foundation Trust|Richard Brouwer|441865226950|richard.brouwer@ouh.nhs.uk|
20512497|NCT02860039|Vanderbilt-Ingram Cancer Center|Natasha Halasa, MD, MPH|800-811-8480|natasha.halasa@vumc.org|
20512498|NCT01139801|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
20512499|NCT01596088|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
20512500|NCT01102972|ViiV Healthcare|GSK Response Center|866-435-7343||
20512501|NCT02222168|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20512502|NCT01281475|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
20512503|NCT04611152|Kodiak Sciences Inc|Pablo Velazquez-Martin|6502810850|clinops@kodiak.com|
20512504|NCT00602667|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|amar.gajjar@stjude.org|
20512505|NCT02339246|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
20512506|NCT03628872|Columbia University College of Dental Medicine|Dr. Philip Y Kang|212-342-5244|pyk2104@cumc.columbia.edu|
20512507|NCT03179462|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
20512508|NCT00790270|Stony Brook U|Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
20512509|NCT04636437|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20512510|NCT00816166|Codman Neuro|Jonathan Megerian, MD PhD|508-880-8274|jmegeri1@its.jnj.com|
20512511|NCT01071278|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512512|NCT02851069|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20512513|NCT00352664|UT MD Anderson Cancer Center|Eduardo Bruera, MD / Professor|713-792-6084||
20512514|NCT02146365|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20512515|NCT06212544|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
20512516|NCT01525407|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|2066672827|mmielcar@fredhutch.org|
20512517|NCT01721369|Hospital Vall hebron|Dr. Angel Moya||amoyamitjans@gmail.com|
20512518|NCT03505606|Anglia Ruskin University|Mrs Louisa Haine - Lecturer in Vision Sciences|01223695445|louisa.haine@aru.ac.uk|
20512519|NCT02087865|Cleveland Clinic|Dr. Stephen M. Rao|216 312-4168|raos2@ccf.org|
20512520|NCT03781817|University of Alabama at Birmingham, Department of Pediatrics|James Statler, MD|(205) 638-6048|jstatler@uabmc.edu|
20512521|NCT01017731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512522|NCT00511329|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
20512523|NCT00648739|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20512524|NCT00698009|UT MD Anderson Cancer Center|Eugenie S Kleinerman,MD/Professor, Pediatrics - Research|(713) 497-6226|ekleiner@mdanderson.org|
20512525|NCT00564486|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20512526|NCT02195921|Tianjin University of Traditional Chinese Medicine|Acupuncture for Chemotherapy-Induced Nausea and Vomiting: A Randomized Clinical Trial|+86 13920921016|guoyi_168@163.com|
20512527|NCT04362761|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20512528|NCT00896038|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|3014516960|melanies@mail.nih.gov|
20512529|NCT02729545|Beijing Hospital of Integrated Traditional Chinese and Western Medicine|Dr. Yu Cao|086|howgreenbreeze@126.com|88223667
20512530|NCT00915473|Mayo Clinic|Dr. David Dodick|480-301-5797|dodick.david@mayo.edu|
20512531|NCT01389024|The Johns Hopkins University School of Medicine|Dr. James Casella|410-955-6132|jcasella@jhmi.edu|
20512532|NCT00534209|UM/Sylvester Comprehensive Cancer Center|Luis Raez MD|305-243-4909|lraez@med.miami.edu|
20512533|NCT00704717|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20512534|NCT01245595|Stanford University Medical Center|Dr. David M. Axelrod|650-723-7913|daxelrod@stanford.edu|
20512535|NCT00529802|The University of Chicago|Walter Stadler, MD|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
20512536|NCT00367679|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512537|NCT00197184|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512538|NCT01687400|Washington University School of Medicine|John Welch, M.D., Ph.D.|314-362-2626|jwelch@wustl.edu|
20512539|NCT01325701|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
20512540|NCT00388674|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20512541|NCT03576131|Genmab|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
20512542|NCT01339858|Indiana University Psychotic Disorders Program|Alan Breier|317-880-8495|abreier@iupui.edu|
20512543|NCT00996632|University of Trieste|Prof. Nicolò de Manzini|+390403994152|nicolo.demanzini@aots.sanita.fvg.it|
20512544|NCT01372254|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
20512545|NCT02912507|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20512546|NCT03910439|National Cancer Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
20512547|NCT00539006|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512548|NCT04776135|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20512549|NCT00769132|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512550|NCT02230332|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
20512551|NCT02586909|Axovant Gene Therapies|Yi Mo, PhD|1-929-227-3828|yi.mo@axovant.com|
20560313|NCT03635112|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20560314|NCT01950260|Mayo Clinic|Dr. Marius N. Stan|507-284-2463|stan.marius@mayo.edu|
20560315|NCT01882062|Inserm U1127|Dr Fanny MOCHEL|+33 (0)1 5727 46 78|fanny.mochel@upmc.fr|
20560316|NCT03283553|Johns Hopkins University|Research Program Manager|410-614-7910|dechava1@jhu.edu|
20560317|NCT03686683|Dendreon Corporation|Director, Clinical Operations|206-455-2476|clinical@dendreon.com|
20560318|NCT03255941|FHI 360|Mario Chen|919 544 7040|mchen@fhi360.org|11399
20560319|NCT00372060|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20505658|NCT02207530|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
20505659|NCT00305006|Teachers College, Columbia University|Dr. Andrew Gordon|212-678-3326|ag275@columbia.edu|
20505660|NCT00986258|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
20505661|NCT04964063|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
20505662|NCT01084499|Asan Medical Center|Principal Investigator||mdlhs@amc.seoul.kr|
20505663|NCT01120093|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20505664|NCT03649321|UT Southwestern Medical Center|Dr. Syed Kazmi|214-648-4180|syed.kazmi@utsouthwestern.edu|
20505665|NCT04929262|Temple University|Margaret Crane|‭(215) 204-7165‬|margaret.crane@temple.edu|
20505666|NCT01387295|Herlev University Hospital|Dr Dorte Nielsen|+45 38682344|dorte.nielsen.01@regionh.dk|
20505667|NCT00816907|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
20505668|NCT01488318|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|414-647-5554|stadtermanbm@upmc.edu|
20505669|NCT00723840|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20505670|NCT03036592|University of Murcia|Prof. Marta Garaulet Aza|868884030|garaulet@um.es|
20505671|NCT05100199|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
20505672|NCT02853331|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505673|NCT03425799|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
20505674|NCT02062151|USF Pediatrics|Laura Weathers|813/844-3046|lweathers@health.usf.edu|
20505675|NCT04004507|Ophthalmic Consultants Of Long Island|Dr. Marguerite McDonald|7342501718|margueritemcdmd@aol.com|
20505676|NCT00257192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20505677|NCT02289755|Allena Pharmaceuticals|VP of Clinical Development|617-467-4577|akausz@allenapharma.com|314
20505678|NCT00751101|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
20505679|NCT02086565|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
20505680|NCT00739297|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505681|NCT01400971|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20505682|NCT01242020|Associate Dean for Clinical and Translational Research, College of Physicians and Surgeons|Muredach P. Reilly, MBBCh, MSCE|212-305-9453|mpr2144@cumc.columbia.edu|
20505683|NCT01595646|Wake Forest School of Medicine|Suzanne Craft, PhD|3366-713-8830|suzcraft@wakehealth.edu|
20505684|NCT00693719|University of Arizona Cancer Center|Dr. Robert Livingston|520/626-4175|rlivingston@azcc.arizona.edu|
20505685|NCT02946229|GE Healthcare|Sean Lucas - Research Manager|1-248-533-5575|sean.lucas@ge.com|
20505686|NCT00642616|Sanofi|Trial Transparency Team||ContactUS@sanofi.com|
20505687|NCT01161524|Eisai Inc.|Eisai Call Center|888-422-4743||
20505688|NCT00339079|Brigham and Women's Hospital|Arthur J. Barsky, MD|617-732-5236|abarsky@partners.org|
20505689|NCT00399802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505690|NCT00542815|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20505691|NCT04946344|Wake Forest University|Dr. Stephen Messier|336-758-3969|messier@wfu.edu|
20505692|NCT01041573|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
20505693|NCT04172831|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
20505694|NCT02955186|Yale School of Medicine|Dana Cavallo, Project Coordinator|203-610-9788|dana.cavallo@yale.edu|
20505695|NCT01088815|Johns Hopkins SKCCC|Dr. Ana De Jesus Acosta|443-287-0411|adejesu1@jhmi.edu|7-0411
20505696|NCT02234115|Foresee Pharmaceuticals co., Ltd.|Dr. John Mao||john.mao@foreseepharma.com|
20505697|NCT01618656|Yale University School of Medicine|Deepak Cyril D'Souza, MD|203-932-5711|deepak.dsouza@yale.edu|2594
20505698|NCT01276847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505699|NCT01899144|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20505700|NCT04770155|University of Mississippi Medical Center|Director of Clinical Trials|601-815-5000|clinicaltrials@umc.edu|
20505701|NCT02021812|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
20505702|NCT03634072|Children's Hospital of Philadelphia|Dr Mark Fogel|215-590-7566|fogel@chop.edu|
20505703|NCT01765764|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20505704|NCT00929578|Tufts Medical Center|Alice Gottlieb, MD PhD|617-636-7462|agottlieb@tuftsmedicalcenter.org|
20505705|NCT01597193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505706|NCT03595215|TheraNova|Clinical Research Associate|415-926-8616|akrajcevska@theranova.com|
20505707|NCT03184701|Albert Einstein Healthcare Netwrok|Manisha Verma|2154561026|vermam@einstein.edu|
20505708|NCT04073823|Tactile Medical|Michelle Wetherby|612.230.4576|mwetherby@tactilemedical.com|
20505709|NCT03844633|Ohio State University|Maria Gallo|6146882145|gallo.86@osu.edu|
20560320|NCT02865434|Navidea Biopharmaceuticals|Bonnie Abbruzzzese|6147937500|babbruzzese@navidea.com|
20560321|NCT01579578|AstraZeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
20560322|NCT03432533|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20560323|NCT01648283|Washington University School of Medicine|Evan D. Kharasch, MD, PhD|314-362-8796|kharasch@wustl.edu|
20560324|NCT00372970|Temple University|Frank Friedenberg|215-707-9900|frank.friedenberg@temple.edu|
20505710|NCT01593748|MUSC|Cameron Coggins|843-792-4743|cogginca@musc.edu|
20505711|NCT03569111|Medtronic|Julie Krzykowski|763-202-3325|Julie.Krzykowski@Medtronic.com|
20505712|NCT03596177|MedImmune, LLC|Victoria Parker|+44 747 1357172|information.center@astrazeneca.com|
20505713|NCT01301742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505714|NCT04083222|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
20505715|NCT01937130|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20505716|NCT04191967|Univerisity of North Carolina (UNC)|Dr. Chemtai Mungo, MD, MPH|(984) 974-1000|cmungo@email.unc.edu|
20505717|NCT01431144|University of Louisville|Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
20505718|NCT02322892|Beth Israel Deaconess Medical Center|Dr. Lars W. Andersen|6173886343|larswiuffandersen@gmail.com|
20505719|NCT02125331|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
20505720|NCT01432262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505721|NCT00165646|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
20505722|NCT01104558|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20505723|NCT00696657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20505724|NCT05131880|Universidad Europea de Madrid|Alberto Bermejo Franco|+34912115535|alberto.bermejo@universidadeuropea.es|
20505725|NCT02601001|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20505726|NCT01790438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505727|NCT00962065|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH|281-863-3000||
20505728|NCT01847638|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
20505729|NCT00950612|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505730|NCT02433210|University of Missouri, Department of Medicine, Division of Nephrology|Dr. Madhukar Misra, MD|573 882-7993|misram@health.missouri.edu|
20505731|NCT02819310|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
20505732|NCT02046265|University of Pennsylvania School of Nursing|Dr. Anne Teitelman|215-898-1910|teitelm@nursing.upenn.edu|
20505733|NCT01793051|UT MD Anderson Cancer Center|Dr. Robert Orlowski, Professor, Lymphoma-Myeloma|(713) 794-3234|rorlowski@mdanderson.org|
20505734|NCT00059215|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505735|NCT01419275|Stanford University|Dr. Greg Zaharchuk|650-736-6172|susanmir@stanford.edu|
20505736|NCT04985799|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH, Professor of OBGYN|919-966-0014|jennifer_wu@med.unc.edu|
20505737|NCT02073435|Northwestern University|Donna Woods, MD|312-503-5550|woods@northwestern.edu|
20505738|NCT04494633|Clinical Tools, Inc.|Mary Metcalf, PhD, MPH|(919) 960-8118|metcalf@clinicaltools.com|
20505739|NCT04907539|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
20505740|NCT02369835|Stanford University|Beth Beadle|650-723-6194|bbeadle@stanford.edu|
20505741|NCT02311478|University of Utah|Dr. Dave Turok|8015818160|david.turok@hsc.utah.edu|
20505742|NCT03276936|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20505743|NCT03041116|Retrophin, Inc.|Clinical Trial Information Desk|+1-877-659-5518|medinfo@retrophin.com|
20505744|NCT00943319|UChicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
20505745|NCT02043301|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505746|NCT02653976|Solasia Pharma K.K.|Clinical Development Department|+81358438045|clinicaldev@solasia.co.jp|
20505747|NCT02023164|TerSera Therapeutics LLC|Executive Director, Clinical Development|888 600 8116|jnorth@tersera.com|
20505748|NCT02436577|AstraZeneca AB|Brilinta Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20505749|NCT03703375|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
20505750|NCT01675011|Boston Scientific|Anastasia Becker - Director of Clinical Trials|763-494-2170|Ana.Becker@bsci.com|
20505751|NCT00615290|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505752|NCT02849990|University of Washington|Dr. Michael Schweizer|2066066252|schweize@uw.edu|
20505753|NCT02531373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505754|NCT04179968|UT Southwestern Medical Center|Kelli Key, Ph.D.|214-648-8152|Kelli.Key@UTSouthwestern.edu|
20505755|NCT01996319|Novartis Pharmaceuticals|Study Director|862-778-8300||
20505756|NCT00637273|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20505757|NCT04465370|Edwards Lifesciences|Cristina Johnson|888.713.1564|CC_Clinical_Affairs@edwards.com|
20505758|NCT01702363|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505759|NCT00002663|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
20505760|NCT01351766|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
20505761|NCT01016106|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
20505762|NCT00525148|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505763|NCT03015610|Duke University|Jason Lang, MD|919-684-3364|jason.lang@duke.edu|
20505764|NCT01603641|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20512552|NCT00877799|Cara Therapeutics Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
20512553|NCT04054011|UCSD Dermatology|Joyce Yuan, MD|(858) 657-8322|joyce.yuan2@ucsf.edu|
20512554|NCT00592007|UC San Diego, Moores Cancer Center|Lyudmila Bazhenova, MD|858 822 6189|lbazhenova@ucsd.edu|
20512555|NCT00595127|Memorial Sloan Kettering Cancer Center|Farid Boulad, MD, Attending|+1212-639-2429|bouladf@mskcc.org|
20512556|NCT00538473|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512557|NCT01569074|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20512558|NCT01410565|Spectrum Pharmaceutical Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
20512559|NCT02466776|Kaiser Permanente|Dr. Mary Zaki|503-332-2390|mary.nasry@gmail.com|
20512560|NCT00203892|University of Chicago|Dr. Hedy Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
20512561|NCT02709759|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
20512562|NCT01036594|University of California, San Francisco|Dr. Terence Friedlander, MD|(415) 514-6380|Terence.Friedlander@ucsf.edu|
20512563|NCT03466060|Johnson & Johnson Vision Care Inc.|Meredith Bishop, OD, MS, FAAO- Senior Principal Research Optometrist|904-443-1396|MBishop4@its.jnj.com|
20512564|NCT03387267|Nestlé Health Science|Kemuel Reyes|(908) 333-9379|Kemuel.Reyes@us.nestle.com|
20512565|NCT00244881|Dana-Farber Cancer Institute|Dr Harold Burstein|617-632-3800|hburstein@partners.org|
20512566|NCT03345485|Mundipharma Research Limited|Mónica Araujo - Senior Programmer, Data Management|+447922223436|monica.araujo@mundipharma-rd.eu|
20512567|NCT01610284|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20512568|NCT00442338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512569|NCT01125358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512570|NCT01060007|Washington University School of Medicine|Parag Parikh, M.D.|314-362-9703|pparikh@radonc.wustl.edu|
20512571|NCT05168657|University of Colorado|Dr. Sean Oser|3037245828|sean.oser@cuanschutz.edu|
20512572|NCT03003793|Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen|Lise Gether, MD||lise.gether.01@regionh.dk|
20512573|NCT02379442|NHLBI, NIH|Sawa Ito, MD|301-326-5233|itos3@upmc.edu|
20512574|NCT00937859|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20512575|NCT01153685|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560325|NCT02359058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512576|NCT03539952|Orphalan SA|Frank Verheggen - Head Clinical Operations|+31625241264|frank.verheggen@orphalan.com|
20512577|NCT02184988|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
20512578|NCT03075215|Boston Scientific|Clinical Trial Manager|1-800-227-3422|Sara.Veraghtert@bsci.com|
20512579|NCT01821391|Galderma R&D SNC|CTA Coordinator|+33 493 95 70 85|cta.coordinator@galderma.com|
20560326|NCT00916006|LEO Pharma|Dr. Torsten Skov|+4520736294|tosdk@leo-pharma.com|
20512580|NCT01843660|Janssen China, Beijing|Therapeutic Area Physician|+86-10-58218709||
20512581|NCT01977482|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512582|NCT00209560|Eisai Inc|Eisai Medical Services|1-888-422-4743||
20512583|NCT02500147|Columbia University|Aviva B Sopher, MD, MS|212-305-9362|ahs32@cumc.columbia.edu|
20512584|NCT05460832|Modern Biosciences|Chief Scientific Officer|+44 (0) 207 444 0066|IST-06@istesso.co.uk|
20512585|NCT01608321|VA Palo Alto Health Care System|Director, WRIISC|650-493-5000|wes.ashford@va.gov|
20512586|NCT00540982|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20512587|NCT01392469|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20512588|NCT01736527|Bausch & Lomb Incorporated|Raphaële Siou-Mermet, MD, MS|+33160871491|raphaele.siou-mermet@bausch.com|
20512589|NCT02238639|Hospital Ramon y Cajal|David Jimenez|+34913368133|djimenez.hrc@gmail.com|
20512590|NCT01771627|MUSC|Dr. Ben Toll|843-792-9162|toll@musc.edu|
20512591|NCT03486327|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
20512592|NCT03126682|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
20512593|NCT02056431|Kaiser Permanente Division of Research|Dr. Alyce S. Adams|510-891-5921|Alyce.S.Adams@kp.org|
20512594|NCT03443973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20512595|NCT01956123|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20512596|NCT00467038|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|marianne.goodman@va.gov|5188
20512597|NCT00398632|Stanford University Medical Center, Department of Psychiatry|Lorrin Koran, M.D., Professor of Psychiatry, Emeritus|650 498 5035|lkoran@stanford.edu|
20512598|NCT00267020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512599|NCT00640614|Allerderm|Kim Sullivan|602-225-0595||
20512600|NCT01476345|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512601|NCT02209454|Menarini Ricerche S.p.A.|Corporate Director of Clinical Research|0555680|acapriati@menarini-ricerche.it|9990
20512602|NCT02545868|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20512603|NCT01777191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20560327|NCT03669042|Artivion, Inc.|Karen Sylvester|7704193355|karen.sylvester@artivion.com|
20560328|NCT05302791|University of Montana|Dustin Slivka|406-243-2389|dustin.slivka@umontana.edu|
20560329|NCT04447820|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20560330|NCT02487446|Novartis Pharmaceuticals|Study Director|862-778-1873||
20512604|NCT01932801|University of Washington / Washington State University|Dr. Susan Collins|12068327885|susan.collins@wsu.edu|
20512605|NCT04465916|ENYO Pharma SA|Pietro Scalfaro|+33437700219|ps@enyopharma.com|
20512606|NCT01856686|Spanish Foundation for Neurometrics Development|Dr. Moises Aguilar Domingo|+441615312645|moises@bigdata4brain.co.uk|
20512607|NCT00468312|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20560331|NCT00741273|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
20560332|NCT01823341|Jaeb Center for Health Research|Judy Sibayan, MPH, CCRP|813-975-8690|jsibayan@jaeb.org|
20560333|NCT00689104|Astellas Pharma Europe B.V.|Director Medical Science||ClinicalTrials.Disclosure@us.astellas.com|
20512608|NCT00997672|University Federico II, Naples, Italy|Dr. Francesco Saccà|3470734774|francesco.sacca@unina.it|+39
20512609|NCT00869141|Stein Eye Institute|Dr. Simon K. Law|(310)794-1477|law@jsei.ucla.edu|
20512610|NCT00254488|Weill Cornell Medical College|Robert C. Young, MD, Professor of Psychiatry|914-997-5886|ryoung@med.cornell.edu|
20512611|NCT01053078|University of Minnesota|Elizabeth Seaquist|612 624 9176|seaqu001@umn.edu|
20512612|NCT01092676|LHSC Lawson HRI|Rodrick Lim|5198525496|rod.lim@lhsc.on.ca|
20512613|NCT02886494|Charsire Biotechnology Corp.|R&D associate|+886-6-702-0817|cs42@charsire.com|
20512614|NCT00916617|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512615|NCT02249065|Galderma Laboratories L.P.|Dr. Jean Philippe York|817-961-5468|jp.york@galderma.com|
20512616|NCT00566631|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
20512617|NCT02723786|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20512618|NCT01143610|School of Dentistry at Bauru - USP|Adriana Campos Passanezi Sant'Ana|00 55 14 3235-8278|acpsantana@usp.br|
20512619|NCT03170271|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20512620|NCT00535873|The University of Texas M D Anderson Cancer Center|Alessandra Ferrajoli, MD/Associate Professor|713-792-2063|eharriso@mdanderson.org|
20512621|NCT02701049|Brigham and Women's Hospital|Dr. Adil H. Haider|617-525-9280|ahhaider@bwh.harvard.edu|
20512622|NCT01984229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20512623|NCT01418365|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20512624|NCT03226366|Intermountain Healthcare|Director, Office of Research|(801) 408-1991|officeofresearch@imail.org|
20512625|NCT03319368|University of Maryland School of Medicine|Alison Lydecker, MPH|410-706-0065|alydecke@som.umaryland.edu|
20512626|NCT01267227|University of Mississippi|Dr. Daniel Riche|601-984-2640|driche@umc.edu|
20512627|NCT00824993|UT MD Anderson Cancer Center|Lu,Huifang,M.D. PH.D. / General Internal Medicine|713-563-4462|HLU@MDANDERSON.ORG|
20560334|NCT01155999|Laboratoires Thea|Pascale Pouliquen (Medical director)|0473963614|p.pouliquen@laboratoires-thea.fr|
20505765|NCT00570739|Daiichi Sankyo, Inc.|John Raia, Senior Director Professional Affairs|(973) 944-2683|jraia@dsi.com|
20505766|NCT00325442|United Therapeutics Corporation|Kevin Laliberte, PharmD; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
20505767|NCT01729598|University of Kentucky|Dr. Gregory A. Jicha|859-323-5550|gregory.jicha@uky.edu|
20505768|NCT01905397|Duke University Medical Center|Dan Blazer III, MD|919-668-1861|trey.blazer@duke.edu|
20505769|NCT01921270|Emory University|Dr. Stewart Factor|404-728-4952|sfactor@emory.edu|
20505770|NCT00844428|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alxn.com|
20505771|NCT02680847|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505772|NCT02138578|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-4300|sprattda@med.umich.edu|
20505773|NCT01096550|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
20505774|NCT01713400|H. Lee Moffitt Cancer Center and Research Institute|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
20505775|NCT01345786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20505776|NCT04436510|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
20505777|NCT01519570|The Ohio State University College of Pharmacy|Stuart Beatty|6146888466|beatty.52@osu.edu|
20505778|NCT02389946|BIOTRONIK, Inc|Amy Culley, Director of Vascular Intervention Clinical Studies|503-451-8034|amy.culley@biotronik.com|
20505779|NCT01605396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505780|NCT04598165|Women and Infants Hospital of Rhode Island|Jennifer Unger, MD, MPH. Associate Professor, Department of Obstetrics and Gynecology|(401) 274-1122|jennifer_unger@brown.edu|48554
20505781|NCT03677089|Massachusetts General Hospital - Clinical Coordinating Center|Dr. Karen Kuhlthau|617-724-2842|KKUHLTHAU@PARTNERS.ORG|
20505782|NCT01323673|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505783|NCT04400318|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20505784|NCT01641835|Heidelberg Engineering GmbH|Gerhard Zinser, PhD|+4962216463|Contact@HeidelbergEngineering.com|0
20505785|NCT03805932|National Cancer Institute|Dr. Robert J. Kreitman|301-480-6187|kreitmar@mail.nih.gov|
20505786|NCT05141435|Children's Hospital of Chongqing Medical University|Prof. Shi Yuan|+86 15084335697|shiyuan@hospital.cqmu.edu.cn|
20505787|NCT00953043|Mayo Clinic|Dr. Michael Camilleri, Professor of Medicine and Physiology, Gastroenterology|507-266-2305|camilleri.michael@mayo.edu|
20505788|NCT03059810|Johnson & Johnson Vision|Thomas Karkkainen- SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
20505789|NCT00747617|UCSD School of Medicine|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
20505790|NCT03509207|Medical University of Graz|Prof. Edgar Petru|0043 31638581082|edgar.petru@medunigraz.at|
20505791|NCT04657016|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20505792|NCT05291598|University of Miami Department of Orthopedics|Dr. Victor Hernandez|(305) 689-5195|vhh1@miami.edu|
20505793|NCT00738543|University of Guanajuato|Alejandro Macias|52 477 7145859|aaeemmhh@yahoo.com|400
20505794|NCT03609658|Wake Forest School of Medicine|Jennifer Gabbard, M.D.|336-716-8028|jgabbard@wakehealth.edu|
20505795|NCT00523341|Amgen Inc.|Study Director|866-572-6436||
20505796|NCT01356602|Novartis Pharmaceuticals|Study Director|862-778-8300||
20512628|NCT00518011|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20560335|NCT01114620|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512629|NCT03409328|Rosalind Franklin University|Dr. Brian Feinstein|847-578-8736|brian.feinstein@rosalindfranklin.edu|
20512630|NCT02998645|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20512631|NCT03701516|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Director|1-904-629-2289|BPALL@its.jnj.com|
20512632|NCT03930615|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512633|NCT02139969|Boston Scientific Corporation|Laura Olson, Clinical Project Manager|9529306428|laura.olson2@bsci.com|
20560336|NCT03658629|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20560337|NCT01125774|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560338|NCT02698436|JNJWorldwide|Lisa Fitzgerald|+1 908-904-6235|lfitzge6@its.jnj.com|
20560339|NCT00097370|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560340|NCT02081365|Maurice H. Kornberg School of Dentistry, Temple University|Marisol Tellez M. BDS, MPH, Ph.D|215-707-1773|marisol@temple.edu|
20560341|NCT03230006|Center for Anxiety and Related Disorders, Boston University|Dr. Todd Farchione|6173539610|tfarchio@bu.edu|
20560342|NCT00901485|Royal Brompton Hospital|Miss Julia Kelly|+44 2073528121|j.kelly@rbht.nhs.uk|4183
20560343|NCT01919619|M D Anderson Cancer Center|Issa Khouri, MD / Stem Cell Transplantation Department|713-792-8750|ikhouri@mdanderson.org|
20560344|NCT00929305|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20560345|NCT05642000|University of California San Diego|Rebecca Fielding-Miller|8583810603|rfieldingmiller@health.ucsd.edu|
20560346|NCT00172185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20560347|NCT04669249|PRO Health Group|Dr. Steven Proctor|305-814-7762|sproctor@prohealthgroup.net|
20560348|NCT00723294|Weill Cornell Medicine|Rache M. Simmons, MD|(212) 821-0870|rms2002@med.cornell.edu|
20560349|NCT01257503|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
20560350|NCT01211665|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20560351|NCT01456780|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
20560352|NCT01501929|University of Texas Southwestern|Wanpen Vongpatanasin|2146482103|Wanpen.Vongpatanasin@UTSouthwestern.edu|
20560353|NCT02359838|Dana-Farber Cancer Institute|Gregory A. Abel|617-632-2304|gregory_abel@dfci.harvard.edu|
20560354|NCT04760444|University of Michigan School of Social Work|Dr. Jaclynn Hawkins|(734) 647-4072|jachawk@umich.edu|
20560355|NCT02333630|Nationwide Children's Hospital|David Stukus, MD|614 722-4808|david.stukus@nationwidechildrens.org|
20560356|NCT05349864|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560357|NCT00984282|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20560358|NCT02223793|University of Oslo|Karianne Svendsen|+4795026445|karianne.svendsen@medisin.uio.no|
20560359|NCT00315055|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20560360|NCT02359435|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20560361|NCT02912195|Alameda Health System|Andrew Herring|510 437-8356|aherring@alamedahealthsystem.org|
20560362|NCT01515956|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
20560363|NCT01711918|University of Iowa|Dr. Ron Schey|3193849756|ron-schey@uiowa.edu|
20560364|NCT00507208|University of Alabama at Birmingham|William Carroll, MD|205-934-9713|wcarroll@uabmc.edu|
20560365|NCT00463151|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20560366|NCT05349084|Washington University School of Medicine|Dr. Pamela K. Woodard|314-362-7100|woodardp@wustl.edu|
20560367|NCT00972543|Merck Serono S.A., a division of Merck KGaA|Medical Responsible|+49-6151-75-5200|service@merckgroup.com|
20560368|NCT00293462|University of California, San Francisco|Marylin J. Dodd, RN, PhD, FAAN|415-476-2191|Marylin.dodd@ucsf.edu|
20560369|NCT00688688|Astellas Pharma Global Development, Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
20560370|NCT04296942|National Cancer Institute|Dr. Fatima H. Karzai|301-480-7174|fatima.karzai@nih.gov|
20560371|NCT01770860|Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.|Associate Director, Clinical Research|973-385-7984||
20560372|NCT01528709|Lynn Heart and Vascular Institute, Boca Raton Regional Hospital|Dr. Alexander Kulik|5619556300|alex_kulik@yahoo.com|
20560373|NCT01034111|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560374|NCT01237678|ImmunoGen Inc.|Dr. Richard Bates, Sr. Manager, Publications|781 895 0196|Richard.Bates@immunogen.com|
20560375|NCT02726178|Sainte Justine university hospital center|Dr. Anne Monique Nuyt|514 3454931|anne-monique.nuyt@recherche-ste-justine.qc.ca|3971
20560376|NCT05124899|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20560377|NCT02341534|BIOTRONIK SE & Co. KG|Sascha Mrosk, Senior Clinical Project Manager|15168901308|sascha.mrosk@biotronik.com|0049
20560378|NCT00438971|Rush University|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
20560379|NCT00714233|University of Rochester|Kathleen M Hoeger MD MPH|5852757891|Kathy_hoeger@urmc.rochester.edu|
20560380|NCT04880070|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20560381|NCT00530777|University of Washington|Dr. Carey Farquhar|206-543-4278|cfarq@uw.edu|
20560382|NCT03163992|Samsung Medical Center|Jeeyun Lee|8223410-1779|jyunlee@skku.edu|
20560383|NCT01582243|Novartis Pharmaceuticals|Study Director|862-778-8300||
20560384|NCT03382821|University of Utah, Department of Physical Medicine and Rehabilitation|Dr. Zachary McCormick|801-587-5432|PMR.Research@hsc.utah.edu|
20528589|NCT02693262|University of California, San Diego|Jonathan Hsu, MD, MAS|858-246-2972|jonathan.hsu@ucsd.edu|
20528590|NCT01029262|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1588|clinicaltrialdisclosure@celgene.com|
20528591|NCT01753713|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-844-5060|ahluwam@ccf.org|
20512634|NCT03644927|Veterans Administration Boston Healthcare System and BU School of Medicine|Erica R Scioli, PhD|857 364 6293|ericarose.scioli@va.gov|
20512635|NCT00956813|Mayo Clinic|Debra L. Barton, RN, PhD, AOCN||barton.debra@mayo.edu|
20512636|NCT02864953|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20512637|NCT00981019|Max Planck Institute for Human Development, Harding Center for Risk Literacy|Dr. Odette Wegwarth|+49-30-82406|wegwarth@mpib-berlin.mpg.de|695
20512638|NCT00358670|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20512639|NCT05083559|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
20512640|NCT03752866|Abbott|Vinny Podichetty, Sr. Director, Global Clinical Affairs|+1 408-845-1639|vinny.podichetty@abbott.com|
20512641|NCT00905437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512642|NCT05794126|CooperVision Inc.|José A. Vega OD, PhD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
20512643|NCT03252015|Eli Lilly and Company|Cheif Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20512644|NCT03128931|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
20512645|NCT04993339|University of Miami|Dr. Francesco Travascio|3052842371|f.travascio@miami.edu|
20512646|NCT00903409|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512647|NCT00797316|Novartis Pharmaceuticals|Study Director|862-778-8300||
20512648|NCT01497860|Children's National Medical Center|Associate Professor|2024765046|ehwang@childrensnational.org|
20512649|NCT01852669|Monash University|Dr Shaun Lee|55145890|shaun.lee@monash.edu|
20512650|NCT01121224|VA North Texas Health Care System|Dr. Subhash Banerjee|(214) 857-1608|Subhash.Banerjee@va.gov|
20512651|NCT03712462|Drexel University|Dr. Adrienne Juarascio|215-553-7154|adrienne.s.juarascio@drexel.edu|
20512652|NCT00379821|Malaria Section, Center for Vaccine Development, University of Maryland School of Medicine|Christopher Plowe, MD, MPH|410-706-2491|cplowe@medicine.umaryland.edu|
20512653|NCT01126359|Department of Orthopaedics|Dr. Erik Kubiak|801-587-5404|Erik.Kubiak@hsc.utah.edu|
20512654|NCT02332655|Kennedy Krieger Institute|Dr. Anne Comi|4439239172|comi@kennedykrieger.org|3-9172
20528592|NCT02620787|Center for Anti Infective Research and Development|Dr. David P. Nicolau|(860) 972-3941|david.nicolau@hhchealth.org|
20528593|NCT01896193|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20528594|NCT00807612|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20528595|NCT05612217|Servier|olga linnik|8-495-93707-00|olga.linnik@servier.com|
20528596|NCT04607135|Duke University|Kathy Nightingale, Ph.D.|919-660-5175|kathy.nightingale@duke.edu|
20528597|NCT03465709|Apellis Pharmaceuticals. Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20528598|NCT01408901|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
20528599|NCT04978337|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20528600|NCT00074815|Duke University School of Medicine|Jeffrey Sapyta, PhD|919-668-0069|jeffrey.sapyta@duke.edu|
20528601|NCT01436227|M.D. Anderson Cancer Center|Eric Jonasch, MD|713-792-2830|ejonasch@mdanderson.org|
20528602|NCT05593770|Research Organization (KC) Ltd|Clinical Project Manager|+44 (0) 7494 795 982|nectar@rokcservices.com|
20528603|NCT04865419|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20528604|NCT05446142|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528605|NCT00889915|Duke Clinical Research Institute - Duke University School of Medicine|John S. March, MD, MPH|919-668-7818|john.march@duke.edu|
20528606|NCT02098395|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20528607|NCT01310582|Clinical Research Group|Kirtanaa Voralu, Associate Director Research Management|215-255-7878|kirtanaa.voralu@drexelmed.edu|7878
20528608|NCT01509612|Medical University of Vienna|Michael Frass, MD|+436645453040|office@ordination-frass.at|
20528609|NCT02536105|Massachusetts General Hospital|Dr. Thomas Spencer|617-724-5600|spencer@helix.mgh.harvard.edu|
20528610|NCT04585243|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|717-531-0003|jmoss1@pennstatehealth.psu.edu|323429
20528611|NCT02733341|The Royal Wolverhampton NHS Trust|Professor James Cotton|01902307999|jamescotton@nhs.net|
20528612|NCT00282152|Vanderbilt University Medical Center|David Charles, MD||david.charles@Vanderbilt.Edu|
20528613|NCT00585325|University of Wisconsin-Madison|Cindy Schmitz, RN, MS, NP|608-262-2664|CSchmitz@uwhealth.org|
20528614|NCT03092791|Takeda|Senior Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20528615|NCT02182830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20528616|NCT01990768|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
20528617|NCT00154375|Novartis Pharmaceuticals|Study Director|862-778-8300||
20528618|NCT01181947|St. Antonius Ziekenhuis|Dr. Robin Heijmen|0031306092047|r.heijmen@antoniusziekenhuis.nl|
20528619|NCT04162795|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20528620|NCT01440634|UT Southwestern Medical Center|Dr. Carlos H Timaran|2146450533|timaran1@msn.com|
20528621|NCT02029274|Novartis Pharmaceuticals|Study Director|862-778-8300||
20528622|NCT01790516|Inova Health Care System|Dr John Deeken, PI|703 776 8161|john.deeken@inova.org|
20528623|NCT03749109|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20528624|NCT03034135|Cantex Pharmaceuticals|Stephen Marcus MD|9543153660|smarcus@cantex.com|
20528625|NCT02014051|SymBio Pharmaceuticals|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
20528626|NCT01972464|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu|
20528627|NCT03031340|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
20528628|NCT04530838|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528629|NCT00803712|Amgen Inc.|Study Director|866-572-6436||
20505797|NCT01605071|University of Colorado Denver, Anschutz Medical Campus|Kimberly Cox-York||KIMBERLY.COX-YORK@CUANSCHUTZ.EDU|
20505798|NCT01931462|University of Wisconsin|Director of Clinical Research, Department of Surgery|608-262-0540|clinicalresearch@surgery.wisc.edu|
20505799|NCT00051558|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20512655|NCT02682069|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
20512656|NCT02786810|University of Tennessee Health Science Center|Dr. David Hains|9012874876|dhains@uthsc.edu|
20551129|NCT03035409|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20505800|NCT00510224|UCSF|Charles J. Ryan, MD|415-353-9279|ryanc@medicine.ucsf.edu|
20505801|NCT04067765|University of Kansas|Dr. Michael Amlung|785-864-0334|mamlung@ku.edu|
20505802|NCT01881620|Institut Bergonié, Medical Imaging Department|Dr. Anne-Laure Cazeaux, Nuclear physician|05.56.33.78.60|A.cazeaux@bordeaux.unicancer.fr|
20505803|NCT04936724|University of Pennsylvania|Andrew Strasser Ph.D.|215-746-5788|strasse3@pennmedicine.upenn.edu|
20505804|NCT01808118|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20505805|NCT00414310|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair, Leukemia Department|713-792-7026|hkantarjian@mdanderson.org|
20505806|NCT03902366|VA Portland Health Care System|Jennifer Loftis, PhD|503-220-8262|jennifer.loftis@va.gov|57155
20505807|NCT03070730|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|617-632-8454|rfreeman@bidmc.harvard.edu|
20505808|NCT01701583|University of Colorado|Jenny Stitt|303-724-7205|jenny.stitt@ucdenver.edu|
20505809|NCT01441440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inuiries@pfizer.com|
20505810|NCT01993329|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505811|NCT05070429|University of North Carolina, Chapel Hill|Lisa Gravens-Mueller, Biostatistician/Supervisor|919-962-3098|lgravens@email.unc.edu|
20505812|NCT03097328|Dana Farber Cancer Institute|Bradley McGregor, MD|617-632-6328|Bradley_McGregor@DFCI.harvard.edu|
20505813|NCT01798134|Boston Scientific Corporation|Senior Clinical Program Manager|763-494-2172|hansenj2@bsci.com|
20505814|NCT00366548|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20505815|NCT01252134|Alcon Research, Ltd.|Director of Medical Affairs|888.451.3937|medinfo@alconlabs.com|
20505816|NCT02678741|LumaBridge|Timothy Vreeland, MD|6363465458|tvreeland@lumabridge.com|
20505817|NCT01795898|Janssen Philippines|Medical Affairs Manager|+632-8247901||
20505818|NCT04510194|University of Minnesota|Carolyn Bramante|612-624-0468|jcharles@umn.edu|
20505819|NCT02983981|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
20505820|NCT01984346|AtriCure|Medical Director of Clinical Education|513-560-5974|SGaynor@atricure.com|
20505821|NCT01523808|Erytech Pharmaceuticals|Director of Clinical Trials|+33 4 78 74 44 38|contact@erytech.com|
20505822|NCT00372190|Radboud University Medical Center|Dr. M.I.J.Withagen|+31 6 51262468|M.I.J.Withagen@umcutrecht.nl|
20505823|NCT01623531|Department of Anesthesia, Dalhousie University, Halifax, Canada|Dr. Myron Kwapisz|+1 902 473 4326|myron.kwapisz@nshealth.ca|
20505824|NCT00623467|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20505825|NCT02597673|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
20505826|NCT01134887|Veterans Administration Health Services Research and Development|Richard M. Frankel Ph.D.|317-988-4000|Richard.Frankel@VA.Gov|
20505827|NCT02834403|Houston Methodist Cancer Center|Polly Niravath, MD|713-441-0629|ccresearch@houstonmethodist.org|
20505828|NCT02341014|Memorial Sloan Kettering Cancer Center|Dr. Steve Horwitz, MD|646-608-2680|horwitzs@MSKCC.ORG|
20505829|NCT04705597|BioAge Labs, Inc.|Patrick Martin, M.D.|215-260-5134|patrick@bioagelabs.com|
20505830|NCT03691623|Enanta Pharmaceuticals, Inc.|Guy De La Rosa, MD, Senior Medical Director, Infectious Diseases|+1 857 760 0548|gdelarosa@enanta.com|
20505831|NCT02816710|Department of Ophthalmology, Ruijin Hospital Affiliated Shanghai Jiaotong University School of Medicine, 197 Ruijin Er Road, 200025, Shanghai, China.|Dr. Xi Shen|021-64370025|carl_shen2005@126.com|
20505832|NCT00390780|Bioalliance Pharma|Dr Pierre Attali|+33 (0)1 45 58 76 00|pierre.attali@bioalliancepharma.com|
20505833|NCT00273858|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505834|NCT02045277|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20505835|NCT02232516|Northwestern University, Feinberg School of Medicine|Dr. Jonathan Moreira|312-695-6180|jonathan.moreira@northwestern.edu|
20505836|NCT02440178|seoul national university|Pf. Youngil Koh|82-2-2072-7217|go01@snu.ac.kr|
20512657|NCT01819467|NHRMC|Dr. Henry Easley|910. 667-9238|sandy.easley@seahec.net|
20512658|NCT03256526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512659|NCT01607398|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512660|NCT00602979|Weill Cornell Medicine|Michele Steinkamp|212-746-2953|mls9004@med.cornell.edu|
20512661|NCT01426828|University of Pennsylvania|CCI @ University of Pennsylvania|(215)662-4000||
20512662|NCT01461369|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
20512663|NCT01247974|CorMatrix Cardiovascular|Director, Clinical Development|240-247-1170|clinical@aziyo.com|
20512664|NCT00734617|Duke Center for Nicotine & Smoking Cessation Research|Jed E. Rose, Ph.D.|919 668-5093|rose0003@mc.duke.edu|
20512665|NCT01598740|Sorbent Therapeutics, Inc.|Howard Dittrich, MD|858-405-1429|hdittrich@sorbent.com|
20512666|NCT03029104|CXL Ophthalmics, LLC|Chief Clinical Development Officer|339-234-6020|info@cxlophthalmics.com|
20551130|NCT02642952|Ramón y Cajal University Hospital|Dr. Andrés Reyes Valdivia|0034 629586239|cauzaza@hotmail.com|
20551131|NCT00923598|University of California San Diego|Dr. Brian Ilfeld, Professor of Anesthesiology, In Residence|(858) 444-5949|bilfeld@ucsd.edu|
20551132|NCT00927784|Mount Sinai School of Medicine|Deborah Ascheim, MD, Principal Investigator, Data Coordinating Center|212-659-9567|deborah.ascheim@mssm.edu|
20551133|NCT02457910|Vanderbilt University Medical Center|Vandana Abramson, MD|(615)936-8422|vandana.abramson@vumc.org|
20560385|NCT01805323|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20560386|NCT00797225|AbbVie|Global Medical Services|800-633-9110||
20560387|NCT02408965|UCSF|Jennifer Kerns|4152068715|Jennifer.kerns@ucsf.edu|
20560388|NCT02096003|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
20560389|NCT01511250|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20560390|NCT01763047|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD., M.S., F.A.A.O- Senior Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
20560391|NCT01112735|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|734-646-8214|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20560392|NCT02148809|HospitalSS|Dr. Friedrich Boettner|2127742127|boettnerf@HSS.edu|
20560393|NCT02783950|University of Michigan|Todd Morgan, MD|734-647-8902|tomorgan@med.umich.edu|
20560394|NCT01767909|Wake Forest School of Medicine|Suzanne Craft, PhD, Project Director for Clinical Trial|(336) 713-8830|suzcraft@wakehealth.edu|
20560395|NCT04348370|Texas A&M University College of Medicine|Jeffrey D. Cirillo|979-436-0343|jdcirillo@tamu.edu|
20512667|NCT01177735|University of Arkansas for Medical Sciences|Saad Usmani, MD|501-526-6876||
20512668|NCT00623441|Medtronic Bakken Research Center|Sofia Pateraki, MSc - Sr. Clinical Research Specialist|+31 43 3566785|sofia.pateraki@medtronic.com|
20512669|NCT00499252|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20512670|NCT01341067|Rocky Mountain Diabetes and Osteoporosis Center|Mark Sulik, PharmD CCRP|208-528-9642|mark@idahomed.com|
20512671|NCT01940276|Duke University|Daniel George, MD|919-668-4615|daniel.george@duke.edu|
20512672|NCT02822612|Moorfields Eye Hospital NHS Foundation Trust|Pearse Keane|02072533411|pearse.keane@moorfields.nhs.uk|
20512673|NCT00124579|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
20512674|NCT00703261|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20512675|NCT00722007|Corin USA Limited|Lucinda Gerber|(772) 321 2478|lucinda.gerber@coringroup.com|
20512676|NCT01700335|SymBio Pharmaceuticals|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
20512677|NCT01612780|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20512678|NCT00556166|Columbia University|Dennis Fowler|212-305-9914|dlf91@columbia.edu|
20512679|NCT05005130|University of North Carolina at Chapel Hill|Michael Herce, MD, MPH, MSc|919-966-2537|michael_herce@med.unc.edu|
20512680|NCT03020966|Hospital for Special Surgery|Dr. Jacques Yadeau|(212) 774-2224|Yadeauj@hss.edu|
20512681|NCT02964910|Shandong Center for Disease Control and Prevention, Jinan, China|Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention|0531-82679606|aqxuepi@163.com|
20512682|NCT00157573|MGH DF/HCC|Richard T Penson MD MCCP|617-726-8566|rpenson@partners.org|
20512683|NCT02115373|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20512684|NCT01638416|Australian and New Zealand Intensive Care Research Centre|Dr. Cooper|+61 3 9903 0071|anzicrc@monash.edu|30071
20512685|NCT00962013|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
20512686|NCT00424632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20512687|NCT02628418|Fondazione Salvatore Maugeri|Dr. Palmira Bernocchi|00390308253|palmira.bernocchi@fsm.it|260
20512688|NCT01527942|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Ioannis Raftopoulos, MD||IRaftopo@stfranciscare.org|
20512689|NCT04007406|DAMIAN Pharma AG|Teresa Gerlock/Chief Operations Officer|+41 79 230 8591|teresa.gerlock@damianpharma.com|
20512690|NCT03159611|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20512691|NCT00116207|University of Michigan|Eva L. Feldman, Professor of Internal Medicine|7347637274|efeldman@med.umich.edu|
20512692|NCT02072174|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20512693|NCT05674721|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20512694|NCT02067585|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
20512695|NCT04466956|Barts Health NHS Trust|Dr Anna McDougall|02078827272|anna.mcdougall@nhs.net|
20512696|NCT00633009|Nielsen BioSciences, Inc.|Stewart Nielsen|858.571.2726|stewart@nielsenbio.com|
20512697|NCT00203931|University of Chicago|Kristen Wroblewski|773-702-7173|kwroblewski@health.bsd.uchicago.edu|
20512698|NCT03506425|Duke University|Richard Bedlack, M.D., Ph.D.|919-668-2839|richard.bedlack@duke.edu|
20512699|NCT01771172|Medtronic, Inc.|Medtronic CRDM Clinical Trial Manager|763-505-6000|medtronicCRMtrials@medtronic.com|
20551134|NCT00467259|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20551135|NCT06079320|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551136|NCT01405742|University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
20551137|NCT02196558|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
20551138|NCT03428360|Aquestive Therapeutics|Clinical Project Manager|9089411896|cbuan@aquestive.com|
20551139|NCT02028065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20551140|NCT00830596|Palmer College of Chiropractic|Christine Goertz, DC, PhD, Principal Investigator|(563) 884-5150|christine.goertz@palmer.edu|
20551141|NCT02107482|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
20551142|NCT00576927|Emory University Division of General Medicine and Geriatrics|Dr. Patricia Griffiths|404-321-6111|pcgriff@emory.edu|7138
20551143|NCT04570150|UCSD|Dr. Rodney Gabriel|6194710670|ragabriel@health.ucsd.edu|
20551144|NCT04899921|Dana-Farber Cancer Institute|Senior Physician|6176326836|ann_silk@dfci.harvard.edu|
20551145|NCT01457521|Gynuity Health Projects|Elizabeth Raymond|2124481230|eraymond@gynuity.org|
20560396|NCT03663712|Duke University|Dan G. Blazer III, MD|919-668-1861|trey.blazer@duke.edu|
20512700|NCT00118209|Washington University School of Medicine|Nancy Bartlett, M.D.|314-362-5654|nbartlet@wustl.edu|
20512701|NCT00440193|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20512702|NCT00834366|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20512703|NCT02587117|B.P. Koirala Institute of Health Sciences|Dr. Ramayan Prasad Kushwaha|977-9842207716|visitramayan007@yahoo.com|
20512704|NCT03014570|University of Maryland School of Nursing|Barbara Resnick PhD, CRNP Professor and PI among MPIs of the trial|410 706 5178|resnick@umaryland.edu|
20512705|NCT00090259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20512706|NCT03506724|Icahn School of Medicine at Mount Sinai|Dr. Dyese Taylor|973-926-5508|Dyesetaylor@gmail.com|
20512707|NCT00345969|Washington University School of Medicine|Ellen F. Binder, MD|314-286-2707|ebinder@wustl.edu|
20512708|NCT02380248|Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA-GDD|1-888-451-3937|alcon.medinfo@alcon.com|
20512709|NCT04736316|University of Washington|Dr. Kelli O'Laughlin|206-744-2559|kolaugh@uw.edu|
20512710|NCT01275170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512711|NCT00865306|Massachusetts General Hospital|Dina R. Hirshfeld-Becker, PhD|617-503-1408|dhirshfeld@partners.org|
20512712|NCT02656875|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20512713|NCT02704130|Atrium Health|Blair Stephenson, Research Business Manager|704-446-4845|blair.stephenson@atriumhealth.org|
20512714|NCT02184169|Boston Childrens Hospital|John Kheir|6173556000|john.kheir@childrens.harvard.edu|
20512715|NCT04686500|University of Texas Southwestern Medical Center|Dr. David Parsons|214/645-8525|david.parsons@utsouthwestern.edu|
20512716|NCT04176354|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512717|NCT01306968|Uniformed Services University of Health Sciences|Dr. R. Scott Miller, M.D.|301-816-8424|robert.s.miller@us.army.mil|
20512718|NCT01381068|UCSD|Neil Finer||nfiner@ucsd.edu|
20512719|NCT02262507|Cincinnati Childrens Hospital Sports Medicine|Dr. Gregory Myer|513-636-0249|greg.myer@cchmc.org|
20512720|NCT05376293|The Miriam Hospital|Dr. Jessica Unick|401-793-7966|junick@brownhealth.org|
20512721|NCT00690573|Abbott|Global Medical Services|800-633-9110||
20512722|NCT00939367|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
20512723|NCT00902486|Incyte Corporation|Study Director|855 463-3463||
20512724|NCT01298661|Universidade Federal de São Carlos|Juliano Ferreira Arcuri|+55 (16) 33518343|julianoarcuri@gmail.com|
20512725|NCT01563029|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512726|NCT01569594|Aziyo Biolgics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
20528630|NCT02588586|The Rockefeller University|Dr. Marina Caskey, Professor of Clinical Investigation|2123277396|mcaskey@rockefeller.edu|
20512727|NCT03069365|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20512728|NCT02861534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512729|NCT02780115|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20512730|NCT00194116|Univeristy Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|Keming.Gao@uhhospitals.org|
20512731|NCT01327989|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949-837-3700|manish.gupta@medtronic.com|
20512732|NCT02086968|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
20512733|NCT01211873|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
20512734|NCT03387735|UW Madison|CHESS Statistician|6084772614|ocody@wisc.edu|
20512735|NCT00537056|David Geffen School of Medicine at UCLA|Andrew Quon, M.D. Professor Division of Nuclear Medicine|310-983-1419|aquon@mednet.ucla.edu|
20512736|NCT01257737|Horizon Therapeutics, LLC|Colleen Canavan, Director|1-224-383-3000|clinicaltrials@horizonpharma.com|
20512737|NCT02985515|Washington University in St. Louis|Pawina JIramongkolchai, MD|314-393-2455|pawina@wustl.edu|
20512738|NCT03359473|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20512739|NCT05302414|National Yang Ming Chiao Tung University, Department of Nursing|Hui-Wen Chen Phd candidate|+886939947807|m513102001@gmail.com|
20512740|NCT00742859|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20512741|NCT06251154|CooperVision, Inc.|José A. Vega OD, MSc, PhD, FAAO|+19256213761|jvega2@coopervision.com|
20512742|NCT00792142|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20512743|NCT00445458|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20512744|NCT01071083|Biogen Idec Inc|Biogen Idec Medical Director|1-617-679-2000|neurologyclinicaltrials@biogenidec.com|
20512745|NCT04732728|Boston Scientific|Thomas Stoltz, Clinical Trial Manager|1-800-CARDIAC|thomas.stoltz@bsci.com|
20512746|NCT01523301|UCB|Study Director|+1877 822 9493||
20512747|NCT00728988|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512748|NCT01895088|AcuFocus, Inc.|Eugenia Thomas, Director Clinical Trials|9495859511|nthomas@acufocus.com|
20512749|NCT00091507|Tufts Medical Center|Co-Principal Investigator|617-636-8788|jbeshansky@tuftsmedicalcenter.org|
20512750|NCT05013749|Fundación Valle del Lili|Albaro José Nieto Calvache|(+57) 6023319090|albaro.nieto@fvl.org.co|3056 - 305
20512751|NCT00246441|MUSC|Dr. Sarah Book|8437925200|booksw@musc.edu|
20512752|NCT02017535|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
20512753|NCT02426125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20512754|NCT00938015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512755|NCT02341482|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20528631|NCT02861664|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20528632|NCT00905632|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20512756|NCT03186794|Clinical Center|Leighton Chan|+1 301 496 4733|chanle@cc.nih.gov|
20560397|NCT04956692|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20560398|NCT03541603|Tenax Therapeutics, Inc.|Stuart Rich, MD; Chief Medical Officer|919 855 2100|s.rich@tenaxthera.com|
20560399|NCT02234310|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
20560400|NCT01822821|Cleveland Clinic|Nicole Zimmerman|216-636-9449|zimmern2@ccf.org|
20560401|NCT03251378|HUTCHMED International|William Schelman, MD, PhD|973-306-4490|albertof@hutch-med.com|+1
20512757|NCT01166126|H. Lee Moffitt Cancer Center and Research Institute|Ragini Kudchadkar, M.D.|813-745-8581|ragini.kudchadkar@moffitt.org|
20560402|NCT04996069|Tufts University School of Dental Medicine|Mabi Singh|6176363931|mabi_l.singh@tufts.edu|
20560403|NCT00615433|Sunovion Pharmacetuicals Inc.|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20560404|NCT04739423|CuraSen Therapeutics, Inc|Clinical Trial Information Desk|+1 650 475 2842|clinicaltrials@curasen.com|
20560405|NCT05174065|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20560406|NCT03507309|Imperial College Healthcare NHS Trust|Dr Amit Kaura|020 3312 6666|amit.kaura@nhs.net|
20560407|NCT01737268|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration|+81-3-3244-0512|Astellas.resultsdisclosure@astellas.com|
20560408|NCT01925781|Creighton University|Director of Clinical Trials|402-280-4961|sandrabyers@creighton.edu|
20560409|NCT02753530|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
20560410|NCT02696226|Cleveland Clinic|Dr. Douglas Johnston|216-444-5613|JOHNSTD3@ccf.org|
20560411|NCT01221181|Columbia University Medical Center|Andrew Bomback, MD, MPH|212-305-0320|asb68@cumc.columbia.edu|
20560412|NCT03369951|Northwestern University of Feinberg School of Medicine|Richard G. Wunderink, MD|312-695-1878|r-wunderink@northwestern.edu|
20560413|NCT00429793|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20560414|NCT02230579|Medicines for Malaria Venture|Dr Cristina Donini - Associate Director|00 41 22 555 03 12|doninic@mmv.org|
20560415|NCT00062868|Baylor College of Medicine|Dr. Helen E. Heslop|832-824-4662|hheslop@bcm.edu|
20560416|NCT01324882|UConn Health Center|Joseph Anderson|8022959362|joseph.anderson@dartmouth.edu|6003
20560417|NCT04949399|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20560418|NCT00670540|University Hospital Grenoble|Jean-Luc Bosson|33 4 76 76 50 40|jean-luc.bosson@imag.fr|
20560419|NCT01866917|Montefiore Medical Center|Ja Hyun Shin|718-920-5157|JASHIN@montefiore.org|
20560420|NCT03896230|Hackensack Meridian Health|Gabrielle L. Procopio, Pharm.D., BCPS|551-996-4368|Gabrielle.Procopio@hmhn.org|
20512758|NCT00478673|Boston Scientific Corporation|Jim Taufen, Regulatory Affairs Manager|763-255-0683|taufenj@bsci.com|
20512759|NCT04797637|Vanderbilt University Medical Center|Lisa C. Zukerwise, MD|9144203838|lisa.zuckerwise@vumc.org|
20512760|NCT00960687|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20512761|NCT02362646|Icahn School of Medicine at Mount Sinai|Annetine Gelijns, PhD|212-659-9567|annetine.gelijns@mssm.edu|
20512762|NCT03907540|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
20512763|NCT01216319|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
20512764|NCT02357173|Medical University of South Carolina|Dr. Matthew Carpenter|843-876-2436|carpente@musc.edu|
20512765|NCT02666768|The Lundquist Institute at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1961|lpolgreen@lundquist.org|
20512766|NCT01023022|Institute of Cardiology|Prof. Hanna Szwed|48 22 343 46 00|hszwed@ikard.pl|
20512767|NCT03728257|University of Pittsburgh|Annette DeVito Dabbs|4126245314|ajdst42@pitt.edu|
20512768|NCT03428217|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
20512769|NCT03889197|Department of Biostatistics and Health Data Science, Indiana University School of Medicine|Kelly Mosesso, MA; Biostatistician II|317-278-5439|kmosesso@iu.edu|
20560421|NCT02613897|University of Texas Health San Antonio|Yuejuan Qin|210-617-5300|qiny@uthscsa.edu|
20512770|NCT05246111|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20512771|NCT01329562|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-890-7888|jtarrasch@clinvest.com|
20512772|NCT03151226|Wake Forest School of Medicine|Dr. Peter H. Pan|336-718-8278|ppan@wakehealth.edu|
20512773|NCT00061568|National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|John Tisdale, M.D.|301.402.6497|johntis@nhlbi.nih.gov|
20512774|NCT01516684|Wake Forest University Health Sciences|Thomas McLean|336-716-5440|tmclean@wakehealth.edu|
20512775|NCT00402779|UT MD Anderson Cancer Center|Dr. John V. Heymach, PHD/Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
20512776|NCT03239340|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20512777|NCT04933708|Hospital of the University of Pennsylvania|Fei Cai|215-313-0656|feicai90@gmail.com|
20512778|NCT01205568|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@childrens.harvard.edu|
20512779|NCT00777920|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20512780|NCT02392377|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr Jennifer Eads|(216) 844-6031|jennifer.eads@uhhospitals.org|
20512781|NCT00526227|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com|
20512782|NCT05378269|Dare Bioscience, Inc.|Jessica Hatheway, VP Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
20512783|NCT00684645|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512784|NCT01186744|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512785|NCT02547779|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
20512786|NCT02325401|University of Cincinnati|Trisha Wise-Draper M.D., Ph.D., Associate Professor of Medicine, Medical Director of the UC Cancer C|(513) 558-2826|wiseth@ucmail.uc.edu|
20512787|NCT00830388|University of Alabama at Birmingham|Wendy Cantrell|205-502-9960|wcantrell@uabmc.edu|
20560422|NCT01140347|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20560423|NCT00569946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560424|NCT00587288|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20560425|NCT00797862|Novartis Pharmaceuticals|Study Director|862- 778- 8300||
20505837|NCT01070550|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20505838|NCT01532700|University Health Network|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
20505839|NCT01585961|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
20505840|NCT05058664|University of Michigan|Ewa Czyz|734 764-9466|ewac@med.umich.edu|
20505841|NCT01258348|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505842|NCT03480282|Beth Israel Deaconess Medical Center|Mara Schonberg|16177541414|mschonbe@bidmc.harvard.edu|
20505843|NCT01163162|Indiana University|Dr. Rajiv Agarwal|317 988 2241|ragarwal@iu.edu|
20505844|NCT03685019|University of Oxford|Thomas Hamilton|01865 227374|thomas.hamilton@ndorms.ox.ac.uk|
20505845|NCT00109733|EMD Serono|Sanja Dragnic/Medical Responsible|+7816814017|sanja.dragnic@emdserono.com|
20505846|NCT04126603|George Washington University|Sabyasachi Sen|202-994-8560|ssen1@gwu.edu|
20505847|NCT02606045|University of Pittsburgh|Margaret V. Ragni, MD, PHD|412-209-7480|ragni@pitt.edu|
20505848|NCT03952468|VA Providence Health Care system|Dr. Jennifer Primack|(401) 273-7100|Jennifer.Primack@va.gov|16295
20505849|NCT02758717|Lombardi Comprehensive Cancer Center|Bruce D. Cheson, M.D.|507-266-0800|bdc4@georgetown.edu|
20505850|NCT01671085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505851|NCT00365716|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505852|NCT02759146|Michigan State University|Dr. Gwen Wyatt|517-353-6672|gwyatt@msu.edu|
20505853|NCT00506077|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505854|NCT04332640|Johnson & Johnson Surgical Vision|Head of Clinical Science|7142478200|LVarga17@ITS.JNJ.com|
20505855|NCT00316303|Dartmouth-Hitchcock|Stanley Rosenberg, Ph.D.|603-653-0740|Stanley.d.rosenberg@dartmouth.edu|
20505856|NCT00385268|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
20505857|NCT02375698|UCT|Dr. Rodney Dawson|27214066850|rodney.dawson@uct.ac.za|
20505858|NCT00772967|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20505859|NCT02229864|Abbott Vascular|Latania Chura|503-935-3002|latania.chura@abbott.com|
20505860|NCT00872833|New England Research Institutes, Inc.|Eric Gerstenberger|6179237747|egerstenberger@neriscience.com|
20505861|NCT00509873|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20505862|NCT02345642|Hospital for Special Surgery|Dr. Geoffrey Westrich|212-606-1510|ortizp@hss.edu|
20505863|NCT02588248|UHClevelandMC|L-Menthol Injection as a Novel Technique during Colonoscopy: The MINT-C study|216-844-1000|Richard.wong@UHhospitals.org|6172
20505864|NCT04229446|OsloUH|Primary Investigator Dr. Tone Rustøen|+47 22859229|tone.rustoen@medisin.uio.no|
20505865|NCT00705224|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20505866|NCT02566525|University of Kentucky College of Medicine|Dr. Joseph Zwischenberger, MD|859-323-6013|jzwis2@uky.edu|
20505867|NCT00337467|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20505868|NCT03141086|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20505869|NCT01745627|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20505870|NCT04430582|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6173091966|MaryElizabeth.Patti@Joslin.Harvard.edu|
20505871|NCT03607682|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
20505872|NCT01109004|The Emmes Corporation|Adam Mendizabal, PhD||amendizabal@emmes.com|
20505873|NCT02410902|Curemark|William E. Gannon, Jr MD, Medical Director|914-824-9716|william.gannon@curemark.com|
20505874|NCT01043185|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20512788|NCT03284424|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512789|NCT01838863|Denver Health Medical Center|Dr. Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
20505875|NCT00137436|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20505876|NCT00701727|Radiant Research|Michael H Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|
20505877|NCT00912015|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20512790|NCT03349437|Philips|Biostatistician|412-542-3651|jeff.jasko@philips.com|
20512791|NCT03976076|Bio-Pharm Solutions Co., Ltd.|Bio-Pharm Solutions Medical Information|NA|conference.clinical@b-psol.com|
20512792|NCT00765999|Allergan, Inc.|Vice President, Clinical Development, Gastrointestinal|1-862-261-7000|IR-CTRegistration@allergan.com|
20512793|NCT02367729|Medical College of Wisconsin|Dr. Katja Kovacic|4142663915|kkovacic@mcw.edu|
20512794|NCT03692078|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
20512795|NCT05041803|Sun Pharmaceutical Industries Limited|Head, Regulatory Affairs|9122 66455645|Clinical.Trial@sunpharma.com|
20512796|NCT05723835|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20512797|NCT05226286|Medtronic|Mylene Champs|7635261627|mylene.champs@medtronic.com|
20512798|NCT00457418|Merck Sharp & Dohme Corp.|Senior Vice President,Global CLinical Development||ClinicalTrialsDisclosure@merck.com|
20512799|NCT02446496|GlaxoSmithKline|GSK Response Center|866-435-7343||
20512800|NCT04854707|IVFarma LLC|General Manager|+74996455342|info@ivfarma.ru|
20512801|NCT02953418|Medtronic MITG-RGI|Director of Clinical Affairs|303-882-6759|Tumordirectedtherapiesclinical@Medtronic.com|
20512802|NCT00956709|CHU de Nantes|Dr Pham Dang|33 2 53 48 24 15|charles.phamdang@chu-nantes.fr|
20512803|NCT01346501|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20512804|NCT04101721|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20512805|NCT00486642|Bristish Columbia Cancer Agency|Dr. Kim N. Chi|604-877-6000|kchi@bccancer.bc.ca|2746
20512806|NCT02564952|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20512807|NCT00756652|Mentor Worldwide, LLC|Sponsor|949-453-6408|mgpas@its.jnj.com|
20512808|NCT03706209|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|
20512809|NCT03491228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512810|NCT00686231|UCSF|Andrew Boyle|415-514-0827|aboyle@medicine.ucsf.edu|
20512811|NCT01215955|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20512812|NCT00038467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512813|NCT03972709|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20512814|NCT01339000|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
20512815|NCT01393626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512816|NCT02858076|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
20512817|NCT01141049|NYSPI|john mariani md|646-774-6140|john.mariani@nyspi.columbia.edu|
20512818|NCT04193033|Michael E DeBakey VAMC|Dr. Natalie Hundt|713-440-4450|Natalie.Hundt@va.gov|
20505878|NCT05137041|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20505879|NCT02090114|Johns Hopkins University School of Medicine|Samuel Denmeade, M.D.|410-502-8341|denmesa@jhmi.edu|
20505880|NCT00392171|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20505881|NCT03499808|SWOG Statistics and Data Management Center|Adam Rosenthal|206-652-9711|adamr@crab.org|
20505882|NCT03470922|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20505883|NCT02856581|Mayo Clinic|Dr. Ivana T. Croghan|507-284-7313|croghan.ivana@mayo.edu|
20505884|NCT02163993|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505885|NCT01345123|Health Dialog|David R Veroff, MPP, SVP Analytic Development|617-406-5219|dveroff@healthdialog.com|
20505886|NCT00883558|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
20505887|NCT01815333|UT MD Anderson Cancer Center|Haesun Choi, MD/ Professor, Abdominal Imaging Department|713-745-4693|hchoi@mdanderson.org|
20505888|NCT00536731|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20505889|NCT00771407|LifeCell Corporation|Chief Medical Officer|908-947-1104|mfranz@lifecell.com|
20505890|NCT04184622|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20505891|NCT02795988|Imugene|Study Director|+61 2 9423 0881|info@imugene.com|
20551146|NCT01322360|Roxane Laboratories, Inc|Anton (Tony) Amann, PhD, Executive Director, Drug Regulatory and Medical Affairs|614-272-4785|Tony.Amann@boehringer-ingelheim.com|
20551147|NCT04059094|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551148|NCT01339429|Brigham and Women's Hospital|Dr. Gita Mody|617-921-8221|gmody@partners.org|
20551149|NCT02994979|The New Jewish Home|Dr. Kenneth Boockvar|212-870-5062|kenneth.boockvar@mssm.edu|
20551150|NCT00680043|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20551151|NCT02111850|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
20551152|NCT01980875|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20505892|NCT02985450|Carla Coffin|Dr.|403-220-7808|cscoffin@ucalgary.ca|
20512819|NCT03265483|Vanderbilt University Medical Center|Martha J. Shrubsole|(615)936-0812|martha.shrubsole@Vanderbilt.Edu|
20560426|NCT01743729|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20560427|NCT05074498|Truebinding, Inc|Dongxu Sun|650-847-1117|info@truebinding.com|
20560428|NCT01240356|The University of Texas Health Science Center at Houston|James C. Grotta, MD|+1 (713) 500-7088|james.c.grotta@uth.tmc.edu|
20560429|NCT01306331|Evofem|Clinical Operations|858-550-1900|clinicaloperations@evofem.com|
20560430|NCT04048135|89bio, Inc.|Clinical Director|1-858-261-8838|bio89-100-002@89bio.com|
20560431|NCT00887640|Duke University Medical Center|Dr. Andrew Armstrong|919-668-8108|andrew.armstrong@dm.duke.edu|
20528633|NCT01520207|Brigham and Women's Hosptial|Dr. Finnian Mc Causland|6177326432|fmccausland@partners.org|
20560432|NCT03127358|Albert Einstein College of Medicine|Julia Arnsten, MD|718-920-6641|jarnsten@montefiore.org|
20560433|NCT00409708|Novartis Pharmaceuticals|Study Director|862 778-8300||
20560434|NCT00946114|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560435|NCT02213900|Indiana University|Babar Khan, MD|317-274-9132|bakhan@iu.edu|
20560436|NCT02685293|Pearl Therapeutics Inc.|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20560437|NCT00088465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20560438|NCT00448864|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20560439|NCT01390857|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560440|NCT02757885|Emory University|Professor of Pediatrics, Dr. Suhag H. Parikh|4047853240|suhag.parikh@emory.edu|
20560441|NCT02485964|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
20560442|NCT01474538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20560443|NCT02688621|University of Vermont|Doris Ogden|802-656-1960|doris.ogden@uvm.edu|
20560444|NCT04565249|Pliant Therapeutics, Inc.|Éric Lefebvre, M.D., Chief Medical Officer|1-650-481-6779|ELefebvre@pliantrx.com|
20560445|NCT00496379|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-2335|nlin@partners.org|
20560446|NCT00623506|Durham VA Medical Center|Christine E. Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
20560447|NCT01289119|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20560448|NCT01704846|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20560449|NCT00530335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20560450|NCT01244984|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560451|NCT01492309|UPenn|Deborah Kim, MD|6107261020|drkim@upenn.edu|
20560452|NCT01360840|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20560453|NCT02002819|UCLA Mary S. Easton Center for Alzheimer's Disease Research|Dr. Keith Vossel|310-794-3665,|neuroeaston@mednet.ucla.edu|
20560454|NCT01004263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560455|NCT04034121|Elixir Medical|Candace Elek, Executive Vice President, Clinical Research|408-636-2020|celek@elixirmedical.com|
20560456|NCT01982760|Case School of Medicine|Dr. Bahman Guyuron|440-461-7999|bguyuron@guyuron.com|
20560457|NCT00821236|Durrie Vision|Brigette Ellis|913-491-3330|bellis@durrievision.com|7255
20560458|NCT03587194|Psoriasis Treatment Center of Central New Jersey|Ashley Reed|6094434500|ashley.reed@schweigerderm.com|
20560459|NCT01104103|The University of Texas Health Science Center at Houston|Dr. Richard Bradley|713-500-7878|Richard.N.Bradley@uth.tmc.edu|
20560460|NCT00282438|Northwestern University|Dr Richard Burt, Chief, Division of Immunotherapy, Department of Medicine|312-695-4960|rburt@northwestern.edu|
20560461|NCT02397889|Icahn School of Medicine at Mount Sinai|Adriana Feder|212-659-9279|adriana.feder@mssm.edu|
20560462|NCT01125202|New York University School of Medicine|Mary Ann Sevick, ScD|6465012621|mary.sevick@nyumc.org|646
20560463|NCT04500821|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
20560464|NCT01363479|Helsinn Healthcare SA|Marco Palmas MD, Head of Clinical Development|+41919852121|marco.palmas@helsinn.com|
20560465|NCT03178201|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
20560466|NCT02282527|Grifols Therapeutics Inc.|Henry Li|1-919-316-6042|henry.li@grifols.com|
20560467|NCT01872611|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
20560468|NCT03537651|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20560469|NCT03057132|Cancer Treatment Centers of America|Joseph Rudolph, BSN, RN, CWOCN, DWC|(215) 537-4678|Joe.Rudolph@ctca-hope.com|
20560470|NCT04436029|Cartesian Therapeutics|Chief Medical Officer|(301) 348-8698|trials@cartesiantx.com|
20560471|NCT02696785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20560472|NCT03486197|University of Washington/Fred Hutch Cancer Center Proton Therapy|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
20560473|NCT01016353|KCI|Senior Director, Global Clinical Development|(210) 255-5595|jane.hart@kci1.com|
20560474|NCT04863898|RTI International|Laura Nyblade, Fellow|202-728-1961|lnyblade@rti.org|
20560475|NCT02431533|Pharmabiotix, Inc|Mark Cobb|214-327-4712|cobbcoinc@aol.com|
20560476|NCT02303743|Hospital Germans Trias i Pujol|Dr. Vicente Lorenzo-Zúñiga García|+34-934978866|vlorenzo.germanstrias@gencat.cat|8443
20560477|NCT01258387|Acorda Therapeutics, Inc.|Anthony Caggiano, MD, PhD|914-347-4300|tcaggiano@acorda.com|5150
20560478|NCT05051540|University of Miami|Hadar Lev-Tov, MD|305-243-1953|hlevtov@med.miami.edu|
20560479|NCT05780047|Million Marker Wellness, Inc.|Carol Kwiatkowski, VP of Research|510-305-5690|carol@millionmarker.com|
20528634|NCT02465437|Corbus Pharmaceuticals, Inc.|John Skutnik, MS|781-562-9853|jskutnik@corbuspharma.com|
20528635|NCT01059773|Janssen-Cilag France|EMEA THERAPEUTIC AREA LEADER|+33 6 15167408||
20528636|NCT02258217|OhioHealth Research Institute|Anand Gupta|614-788-3868|anand.gupta@ohiohealth.com|
20560480|NCT03194776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20560481|NCT02963597|Albert Einstein Healthcare Network|Dr Sunil Sharma|2154566950|sharmasu@einstein.edu|
20560482|NCT01110174|PI has left the institution, all efforts to locate PI have been exhausted.|PI has left the institution, all efforts to locate PI have been exhausted.||steve.martinez@ucdmc.ucdavis.edu|
20560483|NCT04816526|Cartesian Therapeutics|Dr. Milos Miljkovic, Chief Medical Officer|4436335855|milos@cartesiantx.com|
20560484|NCT01190176|GlaxoSmithKline|GSK Response Center|866-435-7343|pr266560@gsk.com|
20560485|NCT02909101|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
20560486|NCT02189863|Alcon Research, Ltd.|Global Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20560487|NCT03697460|Mayo Clinic|Aaron R. Mangold, M.D.|480-301-6479|Mangold.Aaron@mayo.edu|
20560488|NCT00365417|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
20560489|NCT02141581|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20512820|NCT03597620|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
20512821|NCT00664066|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20512822|NCT03509766|Johns Hopkins School of Medicine|Jody Tversky|410-550-5949|jodytversky@jhmi.edu|
20512823|NCT02575807|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
20512824|NCT02180659|Titan Pharmaceuticals|Kate Beebe DeVarney|650-244-4990|kdevarney@titanpharm.com|
20512825|NCT03000075|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20512826|NCT00111007|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20512827|NCT01495793|UCB Pharma|UCB Clinical Trial Call Center|+1877-822||9493
20512828|NCT01955473|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20512829|NCT01154673|University of Toronto|Mario Ostrowski, Principal Investigator, Professor of Medicine|416-946-5805|mario.ostrowski@gmail.com|
20512830|NCT04828551|Massachusetts General Hospital|Anthony Samir|6178523241|asamir@mgh.harvard.edu|
20512831|NCT03083639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20512832|NCT01923961|eXcorLab GmbH|'Dr. Horst-Dieter Lemke|+49-6022-812647|horstdieter.lemke@excorlab.de|
20512833|NCT04141670|ARMGO Pharma, Inc|Eugene Marcantonio MD PhD|2014633634|gmarcantonio@armgo.com|
20512834|NCT00929864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20512835|NCT03791619|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@its.jnj.com|
20512836|NCT03940742|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20512837|NCT00621309|University of Washington|Dr. David L. Eaton|206-543-7468|deaton@uw.edu|
20512838|NCT01187511|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
20512839|NCT02925650|Alzheimer's Disease Cooperative Study|Howard Feldman MDCM, FRCP(C)|858-246-1347|hhfeldman@health.ucsd.edu|
20512840|NCT02424357|University of Miami|Hilda Capo|305-326-6555|hcapo@med.miami.edu|
20512841|NCT04616768|University of Pennsylvania|Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
20560490|NCT01959880|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20512842|NCT02061293|NYU Langone Health|Samantha Podrebarac, MSc|212-263-0912|Samantha.Podrebarac@nyulangone.org|
20512843|NCT00483717|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|601-650-4200|dbregman@lpicrd.com|828
20512844|NCT00604175|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)-628-3313|ACTGCT.Gov@s-3.com|
20512845|NCT03353415|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6713092635|MaryElizabeth.Patti@Joslin.Harvard.edu|
20512846|NCT00975000|Amgen Inc.|Study Director|866-572-6436||
20512847|NCT00359073|University of Wisconsin Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
20512848|NCT01371006|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20512849|NCT00891527|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@cardio.chboston.org|
20512850|NCT03291847|Johns Hopkins University School of Medicine|Lauren Jansson|4105504114|ljansson@jhmi.edu|
20512851|NCT03515837|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20512852|NCT01964898|The Miriam Hospital|Andrew Busch PhD|4017938189|andrew_busch@brown.edu|
20512853|NCT03151967|University of Washington|Ann Stapleton, MD|2066609981|stapl@uw.edu|
20512854|NCT02957682|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20512855|NCT03612713|Yale University School of Medicine|Data Manager|203-737-5430|Theresa.Babuscio@yale.edu|
20512856|NCT00149669|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20512857|NCT02458365|Pro-Change Behavior Systems, Inc.|Deborah Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
20512858|NCT02953262|Center for Healthcare Organization and Implementation Research (CHOIR) United States Department of Veterans Affairs VA Bedford Healthcare System|Stephanie Shimada, PhD|781-687-2208|Stephanie.Shimada@va.gov|
20512859|NCT00934622|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20512860|NCT02406742|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20512861|NCT00438932|University of Miami Miller School of Medicine|Tamara Isakova, MD, MMSc|305-243-4374|tisakova@med.miami.edu|
20512862|NCT00759174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528637|NCT03904420|Cochlear Limited|Laura Chenier|+14423254171|lchenier@cochlear.com|
20560491|NCT01677936|Louisville Metabolic and Atherosclerosis Research Center|Kathy Schmitz RN|502.515.5672|kschmitz@lmarc.com|
20528638|NCT00614874|Creighton University School of Medicine|Dr. Tammy Wichman|402-449-4486|wichman@creighton.edu|
20512863|NCT01890109|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20512864|NCT01643928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560492|NCT03837028|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
20560493|NCT00157014|Astellas Pharma Canada, Inc|Associate Director, Scientific Affairs||clinicaltrials@us.astellas.com|
20560494|NCT01362491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512865|NCT03336645|Shire|Study Physician|1 866-842-5335|ClinicalTransparency@takeda.com|
20512866|NCT01316523|University of California, Davis|Leslie Garcia|916-734-0156|lesgarcia@ucdavis.edu|
20512867|NCT03395197|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512868|NCT00602641|ECOG Statistical Office|Study Statistician|617-632-3012||
20512869|NCT06134128|VA Portland Healthcare System|Kate Shirley, PhD|503-220-8262|kate.shirley@va.gov|52470
20512870|NCT02148835|Preventive Cardiology, University of Munich|Prof. Dr. C. von Schacky|+49 89 44005 2165|clemens.vonschacky@med.uni-muenchen.de|
20512871|NCT01988337|DMG Dental Material Gesellschaft mbH|Manager Clinical Research|04084006|clinicalresearch@mtcompanies.com|232
20512872|NCT04701658|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20512873|NCT01785472|Novartis|Study Director|862-778-8300||
20512874|NCT01294709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512875|NCT03099161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512876|NCT00110084|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
20512877|NCT01793285|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512878|NCT05511428|Thomas Jefferson University|Adam Binder, MD|215-955-8874|Adam.binder@jefferson.edu|
20512879|NCT00943384|DePuy Synthes Clinical Affairs|Allyson Morris, PhD, CCRP, Staff Clinical Research Scientist|610-719-5298|morris.allyson@synthes.com|
20512880|NCT04088734|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20512881|NCT00096200|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Steven Waggoner, MD|216-844-5011|steven.waggoner@uhhospitals.org|
20512882|NCT03611751|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20512883|NCT05004181|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20512884|NCT01526629|Medtronic|Latifa Foudali|0155381700|latifa.foudali@medtronic.com|
20512885|NCT03868059|Lipocine|Shadi Mehraban|801-994-7383|sm@lipocine.com|2191
20512886|NCT04066894|M D Anderson Cancer Center|Dr. Craig Messick|(713) 745-1544|cmessick@mdanderson.org|
20512887|NCT04278872|Sojournix, Inc.|Head of Regulatory Affairs|6174758469|clinicaltrials@sojournixpharma.com|
20512888|NCT02689973|SWPS University of Social Sciences and Humanities|Dr Aleksandra Luszczynska, Principal Investigator|+4877507260|aluszczynska@swps.edu.pl|
20512889|NCT01283282|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
20512890|NCT00096031|SWOG Statistical Center|Study Statistician|206-667-4623||
20512891|NCT00083226|ECOG Statistical Office|Study Statistician|617-632-3012||
20512892|NCT00909857|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20512893|NCT03878108|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
20512894|NCT04800510|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
20512895|NCT01682681|Janssen Korea, Location: 25F, LS , Yongsan Tower, 191, Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Associate, Medical affairs|82-2-2094-4837||
20512896|NCT03515681|Columbia University|Steven J. Shea, MD|212-305-6355|ss35@cumc.columbia.edu|
20512897|NCT02044094|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20512898|NCT03205163|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
20512899|NCT00005879|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
20512900|NCT01238172|Moores Cancer Center|J. Kellogg Parsons, M.D., MHS|858-822-7874|jkparsons@ucsd.edu|
20512901|NCT05022121|University of Minnesota|Brent Leininger|6126266477|lein0122@umn.edu|
20512902|NCT04502862|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20512903|NCT00584831|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
20512904|NCT01393717|City of Hope National Medical Center|Dr. Robert Chen|626-256-4673|RChen@coh.org|82405
20512905|NCT00391092|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20512906|NCT00858234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512907|NCT03569020|Beth Israel Deaconess Medical Center|Dr. Stephen Juraschek|617-754-1416|sjurasch@bidmc.harvard.edu|
20512908|NCT02428231|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20512909|NCT01652573|Yale School of Medicine|Dr. Karl Insogna|203-737-2871|karl.insogna@yale.edu|
20512910|NCT01453101|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20512911|NCT02706041|The University of Texas Health Science Center at Houston|John A. Harvin, MD, FACS, Associate Professor|(713) 500-7244|John.Harvin@uth.tmc.edu|
20512912|NCT01052038|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
20512913|NCT03901352|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20512914|NCT05150340|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20512915|NCT01615822|Medicines for Malaria Venture|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
20512916|NCT03981614|University of Texas; MD Anderson Cancer Center|Scott Kopetz, M.D.|(507) 266-0800|SKopetz@mdanderson.org|
20512917|NCT03901339|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20512918|NCT02742818|Hospital Israelita Albert Einstein|Dr. Nelson Wolosker|+55 11 2151-5423|nwolosker@yahoo.com.br|
20512919|NCT02643394|UT Southwestern Medical Center|David McDonagh, MD|214-648-8083|david.mcdonagh@utsouthwestern.edu|
20560495|NCT02933320|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20560496|NCT01996644|Washington University|Cheri Levinson|5023456483|cherialevinson@wustl.edu|
20560497|NCT02950545|University of Virginia|Principal Investigator|434-924-8021|djc4f@virginia.edu|
20560498|NCT03398356|Wroclaw Medical University|Dr Edyta Sutkowska|+48/503077016|edytasutkowska@yahoo.com|
20560499|NCT02775617|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
20560500|NCT00875641|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560501|NCT01454362|Queen Mary University of London|Dr Hayden McRobbie|0207 882 7260|researchamendments@bartsandthelondon.nhs.uk|
20560502|NCT02419521|Medtronic Coronary Structual Heart|Beth Moe, Clinical Study Manager||beth.moe@medtronic.com|
20560503|NCT01928940|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560504|NCT02954055|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki, PhD|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
20560505|NCT00587132|Mayo Clinic|Dr. Naoki Takahashi|507-284-7249|takahashi.naoki@mayo.edu|
20560506|NCT01352507|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20560507|NCT01119703|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560508|NCT04668144|University of Florida College of Medicine Jacksonville|Francesco Franchi, MD|904244206|francesco.franchi@jax.ufl.edu|
20560509|NCT03999944|FRESCA Medical|Vice President, RA/CA/QA|949-542-3535|mlmooney@frescamed.com|
20512920|NCT03354169|University of Pennsylvania|Kelly C. Allison, PhD|215-898-2823|kca@pennmedicine.upenn.edu|
20512921|NCT00835068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20512922|NCT02843308|Stanford University School of Medicine|Carolyn Rodriguez, MD, PhD|650-723-4095|ocdresearch@stanford.edu|
20512923|NCT04971226|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20512924|NCT04439149|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20512925|NCT03974516|i Cure Biotech Co., Ltd.|David Liu|+886-955-104-105|white06041983a@gmail.com|
20512926|NCT05264506|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20512927|NCT05990075|James A. Haley Veterans' Hospital|Vanessa Panaite, PhD|813-768-2193|vanessa.panaite2@va.gov|
20512928|NCT02494544|restor3d|Tara Mann - Director of Clinical Affairs|(984) 888-0593|clinicalresearch@restor3d.com|
20512929|NCT02032823|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20512930|NCT05919823|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20512931|NCT04521608|Mayo Clinic|Roberto Benzo, M.D.|480-301-8244|benzo.roberto@mayo.edu|
20512932|NCT02588651|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Study Principal Investigator|1-866-223-8100|TaussigResearch@ccf.org|
20512933|NCT05256992|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20512934|NCT04083378|The University of Texas MD Anderson Cancer Center|Dr. Bruno Odisio|(713) 563-1066|bcodisio@mdanderson.org|
20512935|NCT04803214|Mainstay Medical|Jennifer Tinsley, Director of Clinical Affairs|(877) 702-8488|info@mainstaymedical.com|
20512936|NCT00644228|SWOG Statistical Center|Study Statistician|206-667-4623||
20512937|NCT06078124|Washington University in St. Louis|Dr. Lindsay Stark|314-935-4747|lindsay.stark@wustl.edu|
20512938|NCT05824273|Hackensack Meridian Health - Center for Discovery and Innovation|Ana Vielma|2018803100|ana.vielma@hmh-cdi.org|
20512939|NCT02736695|Mayo Clinic|Keith Josephs, M.D.|507-266-4106|josephs.keith@mayo.edu|
20512940|NCT00285012|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20512941|NCT02843529|Altoida Inc.|Ioannis Tarnanas|+18325975076|Ioannis@altoida.com|
20512942|NCT05298345|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20512943|NCT04050293|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
20512944|NCT05711524|Weill Cornell Medicine|Dr. Melissa Cushing|212-746-3527|mec2013@med.cornell.edu|
20512945|NCT05631093|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
20512946|NCT00417859|University Hospital of Lausanne|Prof Brigitte Jolles|0213149629|brigitte.jolles@chuv.ch|
20512947|NCT04223193|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20512948|NCT00597883|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
20512949|NCT03193190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20512950|NCT03532295|Washington University School of Medicine|Dr. Milan Chheda|314-747-7222|mchheda@wustl.edu|
20512951|NCT06474715|Columbia University Irving Medical Center|Lauren Houghton, PhD Msc|212-342-0246|lh2746@cumc.columbia.edu|
20512952|NCT03732677|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20512953|NCT06232408|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
20512954|NCT02949219|Mayo Clinic|Robert R. McWilliams, M.D.|507-266-9161|mcwilliams.robert@mayo.edu|
20512955|NCT05734014|Montana State University|Vanessa Simonds|4069947396|vanessa.simonds@montana.edu|
20512956|NCT04024254|Rush University Medical Center|Dr Lydia Usha|312-942-5904|Lydia_Usha@rush.edu|
20512957|NCT07046403|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
20512958|NCT03229941|New York Veterans Affairs Healthcare System, Brooklyn|Panagiotis Kougias|718-836-6600|panagiotis.kougias@va.gov|
20512959|NCT05257109|Yale University|Dr. Danielle Davis|2039747607|danielle.davis@yale.edu|
20560510|NCT00884611|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
20560511|NCT02095158|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20560512|NCT01366196|Hss|Dr. Michael Urban|(212) 606-1000|UrbanM@hss.edu|
20512960|NCT02038959|University of Rochester|Ray Dorsey, MD|585-276-6824|ray.dorsey@chet.rochester.edu|
20512961|NCT03233737|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
20512962|NCT00819091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20512963|NCT01320826|University of Alberta|Dr. Michael Kolber|(780) 616-8411|mkolber@ualberta.ca|
20512964|NCT03911960|Hennepin Healthcare|Sandra Japuntich|6128736856|sandra.japuntich@hcmed.org|
20512965|NCT03610646|Viatris|Dr. Prasanna Ganapathi, Head of Global Clinical Strategy and Innovation|+91 80 6672800|prasanna.ganapathi@viatris.com|
20512966|NCT00424515|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
20512967|NCT00080288|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20512968|NCT02576054|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20512969|NCT00791154|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20512970|NCT03638102|University of Illinois Chicago|Sirimon Reutrakul|3124135357|sreutrak@uic.edu|
20512971|NCT01208922|Dr. Falk Pharma GmbH|Department of Clinical Research|0049 7611514|zentrale@drfalkpharma.de|0
20512972|NCT03403712|Helsinn SA|Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
20512973|NCT01787188|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
20512974|NCT05349188|Northwell Health|Dr. Mark Butler, PhD|908-414-0238|markbutler@northwell.edu|
20512975|NCT03829462|Institut régional du Cancer de Montpellier|Dr Emmanuelle Samalin|467613136|emmanuelle.samalin@icm.unicancer.fr|+33
20512976|NCT06065176|University of Utah|Sarang Yoon, PI|801-203-0320|sarang.yoon@hsc.utah.edu|
20512977|NCT03801369|Oregon Health & Science University - Knight Cancer Institute|Gordon Mills, MD, PhD|503-346-4660|millsg@ohsu.edu|
20512978|NCT04644237|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20512979|NCT03131817|University of California, San Francisco|Dr. Simon Little|4152995650|simon.little@ucsf.edu|
20512980|NCT04824560|University of New Mexico College of Pharmacy|Alexandra Herman|505-272-7630|asible@salud.unm.edu|
20512981|NCT03494816|University of Cambridge|Prof Grant Stewart|01223 256211|gds35@cam.ac.uk|
20512982|NCT05573113|Children's Mercy Kansas City|Sherwin Chan|816-234-3273|sschan@cmh.edu|
20512983|NCT05838755|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20512984|NCT04439110|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20512985|NCT00131937|ECOG Statistical Office|Study Statistician|617-632-3012||
20512986|NCT05073692|Kaiser Permanente Division of Research|Romain Neugebauer|510-891-3234|Romain.S.Neugebauer@kp.org|
20512987|NCT06873867|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
20512988|NCT04647253|Boston Scientific|Patricia O'Mara|518-744-0046|patricia.omara@bsci.com|
20512989|NCT01209234|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
20512990|NCT02706353|M.D. Anderson Cancer Center|Adi Diab, MD|713-792-2921|MDADiab@mdanderson.org|
20512991|NCT03560466|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20512992|NCT04071366|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20512993|NCT02239692|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20512994|NCT01678924|Allergan plc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20512995|NCT01629134|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
20512996|NCT03232749|University of Florida|MaryBeth Horodyski, Ed.D., ATC, LAT, FNATA|352-273-7074|horodmb@ortho.ufl.edu|
20512997|NCT02277639|Children's Hospital of Philadelphia|Nancy Bunin, MD|215-590-2255|buninn@email.chop.edu|
20512998|NCT02156466|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20512999|NCT01784419|University of California, San Francisco|Dennis W. Nielson, MD, PhD||Dennis.Nielson@ucsf.edu|
20513000|NCT02253654|Amgen Inc.|Study Director|866-572-6436||
20513001|NCT00069160|National Cancer Institute, National Institutes of Health|Susan E. Bates, M.D.|301-402-1357|BatesS@mail.nih.gov|
20513002|NCT03044431|Lung Institute|Melissa Rubio, PhD, APRN|214-504-2117|pidallas@lunginstitute.com|
20513003|NCT03456726|Eisai Co., Ltd|Eisai Inquiry Service|None|eisai-chiken_hotline@hhc.eisai.co.jp|
20513004|NCT01614925|Straumann|Michel Mallaun||michel.mallaun@straumann.com|
20513005|NCT04470622|Heron Therapeutics, Inc.|Sophie Visonneau|858-251-7232|svisonneau@herontx.com|
20513006|NCT04313023|Pulmotect, Inc.|Dr. Brenton Scott, President & COO|713-579-9226|bscott@pulmotect.com|
20513007|NCT00399490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513008|NCT03978117|Masonic Cancer Center|Dorothy Hatsukami, PhD|(612) 626-2121|hatsu001@umn.edu|
20513009|NCT00414011|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
20513010|NCT02307188|Columbia University Medical Center|Abgelo Biviano|212-305-7646|ab542@columbia.edu|
20513011|NCT00817778|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20513012|NCT03343054|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513013|NCT01818414|University of Minnesota|Christy Boraas, MD, MPH|612-273-7111|bora0021@umn.edu|
20513014|NCT01286207|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20513015|NCT00981409|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513016|NCT00450177|Weill Cornell Medical College|Philip S. Barie, MD|646-962-2580|pbarie@med.cornell.edu|
20560513|NCT01941316|Cancer Research and Biostatistics|Director of Quality and Regulatory Compliance|206-839-1782|lisau@crab.org|
20513017|NCT02923115|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20560514|NCT02775435|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20513018|NCT00774202|Weill Cornell Medical College|James B. Bussel, M.D. Professor of Pediatrics|212-746-3474|jbussel@med.cornell.edu|
20528639|NCT01001910|Montefiore Medical Center|Clinical Supervisor|718-405-8395|bkhaksari@montefiore.org|
20560515|NCT00941031|Novartis Pharmaceuticals|Study Director|862-778-8300||
20560516|NCT00100659|Johns Hopkins University School of Medicine|Kathleen B. Schwarz, M.D.|410-955-8769|kschwarz@jhmi.edu|
20560517|NCT04555044|Organization: Baxter Healthcare|Name/Official Title: Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20560518|NCT01835899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20560519|NCT01859195|The Miriam Hospital|Principal Investigator|401-793-4775 or 401-793-8180|scu-uvin@lifespan.org; kate.guthrie@lifespan.org|
20560520|NCT03569813|Emory University|Aaron Siegler, PhD|404-712-9733|asiegle@emory.edu|
20560521|NCT03163511|Vertex Pharmaceuticals, Inc|Gautham Marigowda|617-961-0568|gautham_marigowda@vrtx.com|
20560522|NCT04001114|University of Maryland|Britta Hahn, Ph.D.|410-402-6112|bhahn@som.umaryland.edu|
20560523|NCT00614744|Brown University, Women & Infants Hospital of Rhode Island|Abbot Laptook|401-274-1122|alaptook@wihri.org|47421
20560524|NCT03285711|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20560525|NCT00235495|University of Miami|Dr. Myron D. Ginsberg|305-243-6103|MGinsberg@med.miami.edu|
20560526|NCT00490555|University of Washington|Dr. Stephanie Page|2066160483|page@u.washington.edu|
20560527|NCT02320253|MGH Diabetes Center|Dr. Deborah J. Wexler|617-726-8767|dwexler@mgh.harvard.edu|
20560528|NCT00603538|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505893|NCT00069576|GWU Biostatistics Center|Rebecca Clifton, Ph.D.|(301) 881-9260|rclifton@bsc.gwu.edu|
20505894|NCT04060667|Massachusetts General Hospital|Adeline Boatin|617 724 61320|adeline_boatin@mgh.harvard.edu|
20505895|NCT00148733|University of Bergen|Tor A Strand|90971086|tor.strand@cih.uib.no|
20505896|NCT00114972|Boston Scientific|Nic Van Dyck / Senior Program Manager|+ 31 43 356 8328|vandyckn@bsci.com|
20505897|NCT00358917|Abbott|Medical Information Specialist|800-633-9110||
20505898|NCT00759473|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
20505899|NCT02005601|Hospital for Special Surgery|Dr. Jacques Yadeau|212-606-1206|yadeauj@hss.edu|
20505900|NCT02890329|Dana Farber Cancer Institute|Dr. Jacqueline Garcia|617-632-1906|Jacqueline_Garcia@dfci.harvard.edu|
20505901|NCT02401555|Bio-Rad Laboratories|David Bhend|425 498 1758|david_bhend@bio-rad.com|
20505902|NCT01732263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20505903|NCT00231062|Acclarent|Laura England, Manager-Clinical Affairs|650-687-4466|lenglan1@its.jnj.com|
20505904|NCT00668525|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Carl Gommoll, MS|201-427-8000|carl.gommoll@frx.com|
20505905|NCT00590681|University of Chicago|Amanda Spratt|773-834-4031|aspratt@bsd.uchicago.edu|
20505906|NCT01259297|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20505907|NCT02991820|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
20505908|NCT00443430|University of Washington and Seattle Children's Hospital|Carol Wallace, MD Principal Investigator|206-987-2057|cwallace@u.washington.edu|
20505909|NCT00592501|Massachusetts General Hospital|Annie W. Chan, MD|617-726-5184|AWCHAN@PARTNERS.ORG|
20505910|NCT00053846|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20505911|NCT00279500|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director, Clinical and Scientific Research|8188335089|jdorn@secondsight.com|
20505912|NCT03880227|The University of Texas at Dallas|Hans Klein|8304562444|hans.klein@utdallas.edu|
20505913|NCT00504166|University of California San Francisco|Dr. Thomas M. Link|415-353-2450|Thomas.Link@ucsf.edu|
20505914|NCT00170157|Mayo Clinic|Eugene D. Kwon||kwon.eugene@mayo.edu|
20505915|NCT02650284|Stryker|Alissa Connelly|+61294671000|alissa.connelly@stryker.com|1075
20505916|NCT01417780|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
20505917|NCT00554294|Research Institute of Child Nutrition, Dortmund|Dr. Mathilde Kersting|0049 231 79221013|kersting@fke-do.de|
20505918|NCT01929044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505919|NCT05022004|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
20505920|NCT01461863|Dartmouth-Hitchcock|Dr. Charles Fordham von Reyn|6036505000|fvr@dartmouth.edu|8840
20505921|NCT01555463|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20505922|NCT02084134|Washington University School of Medicine|Dr. Julie Silverstein|314-747-7006|jsilverstein@wustl.edu|
20505923|NCT04333433|Santen, Inc.|Edith van Dijkman|+31683667357|edith.vandijkman@santen.com|
20505924|NCT02807454|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20505925|NCT05468086|Cedars-Sinai Medical Center|Omer Liran, MD, MSHS|31042333754|omer.liran@cshs.org|
20505926|NCT01165203|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505927|NCT01070784|AstraZeneca|Goran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
20505928|NCT00797459|Medicis|Ron Staugaard|480-291-5652|rstaugaard@medicis.com|
20505929|NCT02815397|Northwestern University|Dr. R Karmali|312-695-6832|reem.karmali@northwestern.edu|
20505930|NCT00085540|Adult Brain Tumor Consortium (ABTC)|Howard Fine, MD|410-955-8837|jfisher@jhmi.edu|
20505931|NCT01518192|Department of Infectious Diseases, University Medical Center Ljubljana|Franc Strle|+386 1 522 2610|franc.strle@kclj.si|
20505932|NCT00783705|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
20505933|NCT00426751|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505934|NCT01618955|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President-Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
20513019|NCT03869684|Senju Pharmaceutical Co. Ltd.|Director, Clinical Development|+81 078 777 1018|senju-clinicaltrials@senju.co.jp|
20513020|NCT04056299|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20513021|NCT03895307|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
20513022|NCT01227954|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20513023|NCT00720473|McLean Hospital|Dr. Brent Forester|(617) 855-3622|bforester@partners.org|
20513024|NCT02846740|University of Maryland Baltimore|Nithin krishna|4103286661|nkrishna@som.umaryland.edu|
20513025|NCT00078312|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20513026|NCT01296152|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20513027|NCT04840901|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20513028|NCT01268683|Biogen|Medical Director|866-633-4636|clinicaltrials@biogen.com|
20513029|NCT04256759|Mayo Clinic|Jason Sluzevich, M.D.|904-953-6192|sluzevich.jason@mayo.edu|
20513030|NCT04661540|CalciMedica|Sudarshan Hebbar, MD (Chief Medical Officer)|(816) 838-7105|sudarshan@calcimedica.com|
20513031|NCT04075292|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20528640|NCT01549340|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20528641|NCT03173456|Department of Emergency Medicine Albert Einstein Coll of Med|Dr. Polly Bijur|914-661-4707|polly.bijur@einsteinmed.org|
20528642|NCT01733121|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20528643|NCT03061188|Northwestern University, Feinberg School of Medicine|Young Kwang Chae, MD, MPH, MBA|312-926-4248|YCHAE@nm.org|
20528644|NCT00613379|Cytodyn, Inc.|Dr. Nader Pourhassan|360-980-8524|npourhassan@cytodyn.com|
20528645|NCT02609984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20528646|NCT02404610|Hennepin Healthcare|Audrey Hendrickson|6128739528|audrey.hendrickson@hcmed.org|
20528647|NCT02306850|Saint Louis University|John Richart, MD|314-577-8854|john.richart@health.slu.edu|
20528648|NCT02420262|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20528649|NCT00941304|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20528650|NCT03293394|Spedali Civili di Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
20528651|NCT00086450|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster, M.D., Ph.D.|212-860-1056|valentin.fuster@mssm.edu|
20528652|NCT00784719|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528653|NCT03774888|University of Alabama at Birmingham|Hussein Basma, DDS, MS|2059344506|basma86@uab.edu|
20528654|NCT04633226|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20528655|NCT06329687|Oyster Point Pharma Inc|Marian Macsai, MD|3122592477|marian.macsai@viatris.com|
20528656|NCT04156906|The Children's Hospital of Philadelphia|Stella Chou, MD|215-590-0947|chous@chop.edu|
20528657|NCT05415462|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20528658|NCT01408719|Agriculture and Agri-food Canada|Dr. Nancy Ames|204-474-7187|nancy.ames@agr.gc.ca|
20528659|NCT00290654|Masonic Cancer Center, University of Minnesota|Todd Tuttle, M.D.|612-625-2991|tuttl005@umn.edu|
20528660|NCT00544908|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
20528661|NCT02651337|Alcyone LifeSciences|Director of Clinical Operations|9787091946|jmcguire@alcyonels.com|
20528662|NCT02137226|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20528663|NCT02998996|Eurocine Vaccines AB|Anna-Karin Maltais|+46 76 233 81 62|annakarin.maltais@eurocine-vaccines.com|
20528664|NCT00882661|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
20528665|NCT04270695|China Medical University|Ms Weng|0975127007|chuyu0608@gmail.com|
20528666|NCT00003896|SWOG Statistical Center|Gynecologic Committee Statistician|206-667-4623||
20528667|NCT01398358|University of Michigan|Julie Lumeng, MD|jlumeng@umich.edu|jlumeng@umich.edu|
20528668|NCT02373137|Kaiser Permanente / University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|650-299-2111|Jennifer.Rose-Nussbaumer@kp.org|
20528669|NCT02022735|University of Miami|Corneliu Luca, MD, PhD|305-243-6732|cluca@med.miami.edu|
20528670|NCT00985686|Canadian Institute of Natural and Integrative Medicine|Dr. John Toews|4032200022|j.toews@cinim.org|111
20528671|NCT03134911|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20528672|NCT01087203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528673|NCT00537290|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
20528674|NCT02559570|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20528675|NCT04388176|Vicore Pharma AB|Carl-Johan Dalsgaard|+46 70 975 98 63|carl-johan.dalsgaard@vicorepharma.com|
20528676|NCT02364076|Georgetown University Medical Center -Lomabardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
20528677|NCT02497937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20528678|NCT00360009|University of Florida Department of Neurology|Michael Okun, M.D.|352-273-5550|okun@neurology.ufl.edu|
20528679|NCT01616160|Massachusetts General Hospital|Daniel L. Hamilos, M.D.|617-726-5090|dhamilos@partners.org|
20528680|NCT01903993|Hoffmann-La Roche|Medical Communications|800 821|genentech@druginfo.com|8590
20551153|NCT00513474|Massachusetts General Hospital|Bimalangshu R. Dey, MD, PhD||bdey@mgh.harvard.edu|
20551154|NCT00195676|Abbott|Global Medical Services|800-633-9110||
20551155|NCT01189812|Columbia Northwest Pharmaceuticals|Director of Clinical Operations|425.453.0404|jhobus@nwcrc.net|
20551156|NCT02059057|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|kristi.winterfeldt@bsci.com|
20513032|NCT01826201|Moleculin, LLC|Chief Medical Officer|713-953-7676|Carena@moleculin.com|232
20560529|NCT05750745|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20560530|NCT05064761|Galderma Research and Development, LLC (GLLC)|Clinical Project Manager|+1 817-961-5000|aestheticclinicaltrials@galderma.com|
20560531|NCT04794179|University of Utah Healthcare|Richard Gurgel MD, PI|801-585-1626|Richard.Gurgel@hsc.utah.edu|
20560532|NCT03109015|Duke University|Michael Harrison, MD|919-668-8108|michael.harrison@duke.edu|
20560533|NCT01096056|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560534|NCT03568162|Ichnos Sciences SA|Ichnos Sciences Clinical Trials Administrator|315-583-1249|clinicaltrials@ichnossciences.com|
20560535|NCT00768066|The EMMES Corporation|Adam Mendizabal, Biostatistician|301-251-1161|amendizabal@emmes.com|221
20560536|NCT04831775|The University of Texas at Austin|Dr. Heather Cuevas|5124226059|hcuevas@mail.nur.utexas.edu|
20513033|NCT00857493|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20513034|NCT05292053|Baylor Scott & White Research Institute|Clinical Research Manager|214-820-1771|Felicia.Padilla@BSWHealth.org|
20513035|NCT00103259|Eastern Cooperative Oncology Group (ECOG) Statistical Office|ECOG Statistician|617-632-3012||
20513036|NCT01572428|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
20513037|NCT03224234|Emory University|Dr. Umpierrez|404-251-8957|geumpie@emory.edu|
20513038|NCT02610842|Unicamp - University of Campinas|Dr. Eduardo de Paiva Magalhaes|+55 (19) 35217113|dreduardomagalhaes@gmail.com|
20513039|NCT02360059|The University of Texas (UT) MD Anderson Cancer Center|Dr. David L. Ramirez, Assistant Professor, Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20513040|NCT00481871|Allos Therapeutics, Inc.|Michael Saunders, MD|303-426-6262|msaunders@allos.com|
20513041|NCT03332212|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513042|NCT00609115|AMES Technology, Inc.|Dr. Paul Cordo|503 970 6129|pcordo@amesdevices.com|
20513043|NCT03690375|Siperstein Dermatology Group|founder/physician|5613647774|info@sipderm.com|
20513044|NCT03985293|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513045|NCT03107715|University Hospitals Rainbow Babies and Children's Hospital|Lydia Furman MD, PI|216-844=8260|lydia.furman@uhhospitals.org|
20513046|NCT01907516|John A Burns School of Medicine / University of Hawaii Dept of Obstetrics and Gynecology|Marguerite Lisa Bartholomew MD|808-983-6761|mbarthol@hawaii.edu|
20513047|NCT02181127|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
20513048|NCT01211613|University of Pittsburgh, Department of Physical Therapy'|Michael J Schneider, DC, PhD|412-383-6640|mjs5@pitt.edu|
20513049|NCT01020773|Beijing Shijitan Hospital|Department of Respiratory Medicine|86-010-63926385|mayingmin@hotmail.com|
20513050|NCT03853213|Columbia University Irving Medical Center|Dr. Jeffrey Birk|212-342-5503|jlb2287@cumc.columbia.edu|
20513051|NCT03302299|University of California San Francisco|Dr. Judy Hahn|415-476-5815|judy.hahn@ucsf.edu|
20513052|NCT01458132|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513053|NCT00350337|United States Army Medical Materiel Development Activity|Division of Regulated Activities and Compliance Director|301-619-0317|USAMRMCREGULATORYAFFAIRS@amedd.army.mil|
20513054|NCT01788163|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|Haiyi.Jiang@astrazeneca.com|
20513055|NCT00545441|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
20513056|NCT00265239|Kumamoto University|Dr. Kenichi Tsujita|+81-96-373-5175|tsujita@kumamoto-u.ac.jp|
20513057|NCT02803138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20560537|NCT00337818|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513058|NCT04318535|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20513059|NCT01733186|MEDIPOST Co., Ltd.|Director of Product Development Department|+82-2-3465-6740|meehyunj@medi-post.co.kr|
20513060|NCT00021229|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
20513061|NCT01901146|Amgen Inc.|Study Director|866-572-6436||
20513062|NCT02007369|School of Public Health, The University of Hong Kong|Dr. Cheung, Yee Tak Derek|+852 39176652|derekcheung@hku.hk|
20513063|NCT00297492|University of Vermont|Dr. John Hughes|802-656-9610|John.Hughes@uvm.edu|
20513064|NCT02675426|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20513065|NCT03724968|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
20513066|NCT01858558|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Philip Imus, MD|410-955-8873|pimus1@jhmi.edu|
20513067|NCT02237118|Clinique Mutualiste du Medoc|Dr Anne Solanilla|+33 5 56 73 11 43|annasolanilla@yahoo.fr|
20513068|NCT02316678|University of Pennsylvania|James Lewis|215-573-5137|lewisjd@upenn.edu|
20513069|NCT00569231|University of Arkansas for Medical Sciences|Mayumi Nakagawa, MD, PhD|(501) 686-8635|mnakagawa@uams.edu|
20513070|NCT02328547|Montefiore Medical Center|Dr. Olga C. Aroniadis, PI|718-920-4846|oaroniad@montefiore.org|
20513071|NCT00044005|Sunovion|Josephine Cucchiaro, PhD|201-592-2050|josepine.cucchiaro@sunovion.com|
20513072|NCT01190098|Cleveland Clinic|Nancy Foldvary-Schaefer, DO, MS|216-445-2990|foldvan@ccf.org|
20513073|NCT00344305|MedImmune, LLC|Raburn Mallory MD/ Sr Dir Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
20513074|NCT01999231|Shanghai Public Health Clinical Center|Shuihua Lu|(+86)18930811818|tubercle@gmail.com|
20513075|NCT00176501|Rutgers Cancer Institute of New Jersey|Dr. Roger Strair, MD, PhD|732-235-8675|strairrk@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20513076|NCT01586624|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20513077|NCT00545181|Indiana University School of Medicine|David Haas, MD MS|3176307837|dahaas@iupui.edu|
20513078|NCT00953927|Aeras|Bernard Landry|301-547-2919|blandry@aeras.org|
20528681|NCT03620383|Oregon Health & Science University|Ramsey Al-Hakim, MD|503-494-7660|alhakim@ohsu.edu|
20560538|NCT00336232|Tufts University|Sarah Booth, PhD|617-556-3231|sarah.booth@tufts.edu|
20560539|NCT04783415|City of Hope Medical Center|Dr. Alexey Danilov|626-359-8111|adanilov@coh.org|
20560540|NCT03115346|VA Hospital|Dr. Mark Eid|502-295-8961|mark.a.eid01@gmail.com|
20560541|NCT03590743|Mayo Clinic|Robert D. McBane, II M.D.|507-266-3964|mcbane.robert@mayo.edu|
20560542|NCT02266329|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
20560543|NCT02178436|Karmanos Cancer Institute|Mohammed Najeeb Al Hallak M.D.|313-576-8718|alhallakm@karmanos.org|
20560544|NCT00725010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20560545|NCT03499600|George Mason University|Dr. Amanda Sanchez|703-993-1354|asanch49@gmu.edu|
20560546|NCT02414828|Aeras|Ann Ginsberg, Chief Medical Officer|301-547-2912|aginsberg@aeras.org|
20513079|NCT01396161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513080|NCT04604496|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513081|NCT02962739|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
20513082|NCT00822679|University of Arizona|Sairam Parthasarathy|5206266109|sparthasarathy@deptofmed.arizona.edu|
20513083|NCT00306852|University of Miami|Dr. Steven Gedde|305-326-6435|sgedde@med.miami.edu|
20513084|NCT03578276|Carolina Eyecare Physicians, LLC|Director of Research|8438813937|hps@cepmd.com|
20513085|NCT04221087|University of PIttsburgh|Dr. Allison Williams|4126925135|williamsae2@upmc.edu|
20513086|NCT02360397|Brigham and Women's Cardiovascular Associates at Kent Hospital|Chester M. Hedgepeth, MD, PhD|(401) 737-7010|chedgepeth@kentri.org|32880
20513087|NCT01537549|Weill Cornell Medicine|Dr. Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
20513088|NCT00883740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513089|NCT02556931|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Amy Dezern|410-502-7208|adezern1@jhmi.edu|
20513090|NCT03361917|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
20513091|NCT02039817|Conatus Pharmaceuticals|Jean L. Chan, MD|858 376 2632|jchan@conatuspharma.com|
20513092|NCT01875991|Amgen Inc.|Study Director|866-572-6436||
20513093|NCT02125734|Novartis Pharmaceuticals|Study Director|862-778-8300||
20513094|NCT01308762|Immodulon Therapeutics, The London Clinic Cancer Centre, London W1G 6JA,|Clinical Trials Co-ordinator|+44 (0)203 219 3568/3572|Ilda@immodulon.com|
20513095|NCT02617446|Windtree Therapeutics, Inc.|Phillip D. Simmons, Executive Director of Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|
20513096|NCT03030638|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513097|NCT01556490|Boston Scientific|Clinical Research Manager|16138011844|chantal.laframboise@bsci.com|
20513098|NCT02058368|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20513099|NCT01652872|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20513100|NCT02587325|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
20513101|NCT00390572|VA HSRD|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
20513102|NCT04236635|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
20513103|NCT02913261|Novartis Pharmaceuticals|Study Directr|862-778-8300|novartis.email@novartis.com|
20513104|NCT01445873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513105|NCT03078192|Duke University Medical Center|Bastiaan Driehuys|919-684-7786|bastiaan.driehuys@duke.edu|
20513106|NCT03703297|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20513107|NCT01336608|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513108|NCT00821041|University of Manitoba|Study Coordinator|204-787-5098|NVincent@exchange.hsc.mb.ca|
20513109|NCT00786019|University of Colorado|Judith Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
20513110|NCT02437890|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
20513111|NCT04723173|Sonova AG|Bernhard Buschle|+41 58 928 44 21|bernhard.buschle@sonova.com|
20513112|NCT02996448|NIAID, NIH|Alexandra Freeman|301-594-9045|freemaal@mail.nih.gov|
20513113|NCT01284244|Mount Sinai Hospital|Dr. Danny Lovatsis|416-586-4566|danny.lovatsis@sinaihealthsystem.ca|
20513114|NCT03583931|Denver Health and Hospital Authority|Dr Fredric Pieracci|303-602-1863|Fredric.Pieracci@dhha.org|
20513115|NCT00902265|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20513116|NCT02866695|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
20513117|NCT05016765|Washington University School of Medicine|Kevin J. Black, M.D.|1-314-362-5041|kevin@wustl.edu|
20513118|NCT01988493|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20513119|NCT00535301|SCPMG/Kaiser Permanente|John N. Nguyen, MD|562-657-2642|john.n.nguyen@kp.org|
20513120|NCT01447628|Imperial College London|Professor Martin Wilkins|0203 313 8078|jacob.bonner@nhs.net|38078
20513121|NCT00185731|Stanford University School of Medicine|Alice Fan, MD|650-725-6454|afan@stanford.edu|
20513122|NCT03087773|Medical University of Graz|Univ.-Prof. PD Harald Sourij, MD, MBA|+43 316 385 81310|ha.sourij@medunigraz.at|
20513123|NCT00396981|University of California, UCSF Medical Center|S. Claiboren Johnston, MD, PhD|415-502-7487|Clay.Johnston@ucsfmedctr.org|
20513124|NCT02494583|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560547|NCT02376933|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
20560548|NCT01796977|Halyard Health, Inc.|Director of Clinical Affairs|470-448-5352|david.curd@hyh.com|
20560549|NCT01779375|George Washington University Biostatistics Center|Sharon Edelstein|3018819260|sharone@bsc.gwu.edu|
20513125|NCT05144477|Columbia University Irving Medical Center|Dr. Talea Cornelius|(212) 342-5503|tmc2184@cumc.columbia.edu|
20513126|NCT00639158|Abbott|Global Medical Services|800-633-9110||
20513127|NCT02703779|University of Kansas Cancer Center|Dr. Sid Ganguly|913-588-6030|sganguly@kumc.edu|
20560550|NCT00389519|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
20505935|NCT01200511|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20513128|NCT00627458|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513129|NCT03891875|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20513130|NCT00854607|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20513131|NCT02192541|National Cancer Institute|Alice P. Chen, M.D.|(240) 781-3320|chenali@mail.nih.gov|
20513132|NCT02009982|Emory University|Dr. David De Lurgio|404-251-1481|ddelurg@emory.edu|
20513133|NCT00965263|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|6467746153|meg.haney@nyspi.columbia.edu|
20513134|NCT02756078|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan - PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
20528682|NCT00184093|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
20551157|NCT02200445|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
20551158|NCT03334903|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177325500|wfitz@bwh.harvard.edu|
20505936|NCT03288779|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
20505937|NCT03403491|patientMpower Ltd|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
20505938|NCT01355068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505939|NCT00540722|Adult Brain Tumor Consortium (ABTC)|John Fiveash, MD|410-955-8837|jfisher@jhmi.edu|
20505940|NCT01770353|Ipsen Bioscience, Inc|Medical Director|See email|clinical.trials@ipsen.com|
20505941|NCT00376688|The University of Chicago Comprehensive Cancer Center|Dr. Gini F. Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
20505942|NCT03022032|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-632-2334|alexi_wright@dfci.harvard.edu|
20505943|NCT00620321|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20505944|NCT01113398|Duke University Medical Center|Katherine B. Peters, MD, PhD|919-684-6173|katy.peters@duke.edu|
20505945|NCT02279524|Galmed Research and Development, Ltd.|Medical Director|+972.3.693.8448|clinicaltrial@galmedpharma.com|
20505946|NCT01746732|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20505947|NCT02817555|Eastern Health|Andrea Woodland|7097778146|andrea.woodland@easternhealth.ca|
20505948|NCT01755195|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
20505949|NCT02340819|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20505950|NCT03463941|Duke School of Nursing|Cherie Conley|2166597128|cherie.conley@duke.edu|
20505951|NCT02273050|AstraZeneca|Eva Johnsson, MD, PhD|46 31 7762484|Eva.Johnsson@astrazeneca.com|
20505952|NCT00750555|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
20505953|NCT03539458|Abbott Vascular Structural Heart|Reshma Rao, Principal Study Clinical Research Associate|651-756-2542|reshma.rao@abbott.com|
20505954|NCT05936385|Nemours Children's Health|Thao-Ly Phan, Associate Professor of Pediatrics|302-331-7342|tphan@nemours.org|
20505955|NCT02042404|EarLens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650 366 9000|slevy@earlenscorp.com|
20505956|NCT03100942|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20505957|NCT00718419|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20505958|NCT01675531|Seoul ST.Mary's Hospital|Jin-Hyong Kang|82-2-2258-6043|jinkang@catholic.ac.kr|
20505959|NCT01617681|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20505960|NCT01883440|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
20505961|NCT02528500|W. L. Gore & Associates|Rimma Zakharyan|928 310 6961|rzakhary@wlgore.com|
20505962|NCT01405313|ResMed|Director Medical Affairs|+6128841000|adamb@resmed.com.au|
20505963|NCT02280291|NYU Langone Health|Nirmal Tejwani|212 598 6599|Nirmal.Tejwani@nyulangone.org|
20505964|NCT05175261|Prolocor, Inc|David J Schneider, MD|8023730071|david.schneider@prolocor.com|
20505965|NCT02918266|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20505966|NCT01293032|Virginia Commonwealth University/Massey Cancer Center|Harry D Bear, MD, PhD|804-828-9325|harry.bear@vcuhealth.org|
20505967|NCT02243527|University of British Columbia|Dr. Jordan A. Guenette|604.682.2344|Jordan.guenette@hli.ubc.ca|62129
20505968|NCT01106534|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20505969|NCT02262039|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
20505970|NCT04174638|Akdeniz University|Dr Sefika Tugba Yangoz|+905058039716|tugbayangoz@gmail.com|
20505971|NCT01831934|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20505972|NCT02641236|Dana-Farber Cancer Institute|Dr. Leslie Lehmann|617-632-4882|Leslie_Lehmann@DFCI.HARVARD.EDU|
20505973|NCT00905307|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3924||
20505974|NCT05590793|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20505975|NCT04488822|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
20551159|NCT00587561|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|2039325711|joanna.fiszdon@va.gov|2231
20551160|NCT00959842|Professor|Dr. Greg Shearer|814-867-3040|gcs13@psu.edu|
20551161|NCT01662908|Daiichi Sankyo, Inc.|Senior Director, CVM TA Development|732-590-5000||
20551162|NCT04244786|New York State Psychiatric Institute|Jeffrey Miller|646-774-7613|jeffrey.miller@nyspi.columbia.edu|
20551163|NCT03274687|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20551164|NCT00613938|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
20551165|NCT02636868|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|215-488-9477|psimmons@windtreetx.com|
20505976|NCT03838367|CytoDyn|Joseph Meidling - Vice President, Clinical Operations|3609808524|jmeidling@cytodyn.com|
20551166|NCT03025542|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20560551|NCT03425539|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
20513135|NCT02268045|mAbxience|Susana Millan|+34917711500|Susana.Millan@mabxience.com|9284
20513136|NCT01158976|University of Chicago|Kathry Keenan|773-702-4449|kekeenan@uchicago.edu|
20513137|NCT03151707|McLean Hospital|Dost Ongur|6178553922|dongur@partners.org|
20513138|NCT00514501|Progenics Pharmaceuticals, Inc.|Senior Director of Clinical Communications|914 784-1825|vdipippo@progenics.com|
20513139|NCT00646282|Emory University|Dr. Antonio Guasch|404-727-2522|aguasch@emory.edu|
20513140|NCT00530088|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20513141|NCT02328404|Hayat Pharmaceutical industries|DR. ALA' ABU RUQA'A|00962 6 4162607|tbd@hayatpharma.com|225
20513142|NCT00397904|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
20513143|NCT04348292|Emory University|Jennifer Carlisle, MD|404-778-2304|jennifer.w.carlisle@emory.edu|
20513144|NCT02181842|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20513145|NCT00758706|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20513146|NCT03474640|TopAlliance BioSciences|Dr. Kevin Li|301-640-5166|kevin_li@topalliancebio.com|
20513147|NCT04166851|Rutgers School of Public Health|Cui Yang|1-732-235-9754|cui.yang@rutgers.edu|
20513148|NCT00367601|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20513149|NCT01236053|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513150|NCT02304302|Case Western Reserve University|Melissa Stasko, JD, MA|216-844-7281|Melissa.Stasko@case.edu|
20513151|NCT00391118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20513152|NCT02719639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513153|NCT01892020|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20513154|NCT02251431|Baylor Scott & White Research Institute|Biostatistician|8033190755|gelareh.rahimighazikalayeh@bswhealth.org|
20513155|NCT02493088|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Jérôme SAINT-MARTIN, study director|+33 5 46 45 66 03|jerome.saint-martin@ch-larochelle.fr|
20513156|NCT00094900|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Raphaela Goldbach-Mansky, MD|13014356243|goldbacr@mail.nih.gov|
20513157|NCT03739684|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
20513158|NCT03252756|NYU Langone Health|Michael Bogenschutz, PhD|646-501-4026|Michael.Bogenschutz@nyulangone.org|
20513159|NCT03594175|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20513160|NCT01915498|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20513161|NCT01500434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
20513162|NCT02953873|Medical University of South Carolina|Caitlin Schaffner|843-792-7558|schaffne@musc.edu|
20513163|NCT00700310|Eisai Call Center|Eisai Inc.|888-422-4743||
20513164|NCT01143272|Johns Hopkins Bloomberg School of Public Health|Stephan Ehrhardt|410-502-3872|sehrhard@jhsph.edu|
20513165|NCT00303316|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20513166|NCT01726335|Janssen-Cilag Ltd.|Medical Group Manager|+55 11 30302738||
20513167|NCT01375569|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@mail.nih.gov|
20513168|NCT01614613|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
20513169|NCT01557452|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
20513170|NCT01543607|Mass. General Hospital|William R. Brugge|617-724-0578|wbrugge@partners.org|
20513171|NCT02625207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513172|NCT01528878|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20513173|NCT01160198|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513174|NCT01318733|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20513175|NCT00448682|University of Miami Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-6608|bardalan@med.miami.edu|
20513176|NCT01796860|University of Texas Southwestern Medical Center|Karen J McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
20513177|NCT01408576|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20513178|NCT00802529|Imperial College London|Professor Adolfo Bronstein (Clinical professor and Head of neuro-otology group)|(0)20 3313 5525|a.bronstein@imperial.ac.uk|+44
20513179|NCT03565666|Mass. General Hospital|Dr. Steven J. Russell|617-726-8722|sjrussell@mgh.harvard.edu|
20513180|NCT02703454|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
20513181|NCT02284373|New York University Langone Medical Center|Todd Berland, MD|212 263 5060|todd.berland@nyumc.org|
20513182|NCT02016755|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
20513183|NCT02533505|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20513184|NCT01289431|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20513185|NCT01230502|University of Wisconsin|Professor William Burlingham, PhD|(608) 263-0119|BURLINGHAM@SURGERY.WISC.EDU|
20513186|NCT03870737|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
20560552|NCT01080131|Novartis Pharmaceuticals|Study Director|862 778-8300||
20513187|NCT00390949|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
20560553|NCT05579886|CooperVision Inc.|José A. Vega OD, MSc, FAAO, PhD|19256213761|javega@coopervision.com|
20560554|NCT00299702|Ortho-McNeil, Inc. N America Pharm CNS/IM|Therapeutic Area Lead|609-730-3693||
20513188|NCT03061279|Stanford University|Derek Amanatullah, MD, PhD|650-723-2257|dfa@stanford.edu|
20513189|NCT02320838|Universidad de Castilla-La Mancha|Dr. Juan Avendaño Coy|+34 925268800|juan.avendano@uclm.es|5014
20513190|NCT03964220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513191|NCT01307631|Dana-Farber Cancer Institute|Jennifer Curtis, MS|617-582-7183|jennifer_curtis@dfci.harvard.edu|
20513192|NCT01093482|VENTILA group|Andres Esteban|34916834982|aesteban@ucigetafe.com|
20513193|NCT02748616|NYU Langone Health|Norman Javitt, MD|212-263-6588|Norman.Javitt@nyulangone.org|
20513194|NCT01117090|Medtronic Restorative Therapies Group - Targeted Drug Delivery|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
20513195|NCT02216214|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20513196|NCT05354206|Washington University in St. Louis|Dr. Ismael Seáñez|3149357665|ismaelseanez@wustl.edu|
20513197|NCT01414062|Columbia University Irving Medical Center|Dawn Hershman, MD, MS|212-342-4580|dlh23@cumc.columbia.edu|
20513198|NCT04285983|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20513199|NCT04936334|Indiana University, Department of Urology|Jennifer Lehman, RN, Senior Research Leader|317-948-9575|jgeck@iu.edu|
20513200|NCT02209272|Mayo Clinic|Dr. Jacob L. Sellon|507-284-2608|sellon.jacob@mayo.edu|
20513201|NCT00663039|MPRC|Elliot Hong|410-402-6828|ehong@mprc.umaryland.edu|
20513202|NCT03747939|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20513203|NCT00597727|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20513204|NCT04529096|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20513205|NCT01289990|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdf@boehringer-ingelheim.com|
20513206|NCT03454672|Novoxel Ltd|Ifat Klein|+972-52-6009860|ifat@novoxel.com|
20513207|NCT01488071|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
20513208|NCT02139306|PTC Therapeutics, Inc|Joseph McIntosh|908 912-9138|jmcintosh@ptcbio.com|
20513209|NCT04449354|HidraMed Solutions Ltd|Suzanne Moloney|+353873220509|suzanne@hidramedsolutions.com|
20513210|NCT05899218|University of Pennsylvania|Dr. Jennifer Tran|2158983616|jtgtran@nursing.upenn.edu|
20513211|NCT01220128|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513212|NCT00919932|University of Pittsburgh|Dr Han Liang|412-624-4141|liangh2@upmc.edu|
20513213|NCT02873195|Duke University Medical Center|Niharika Bansal Mettu, M.D.|919-681-2954|niharika.mettu@duke.edu|
20513214|NCT02508649|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20513215|NCT02360124|University of Hong Kong|Prof. E.C.M. Lo|852-2859 0292|edward-lo@hku.hk|
20513216|NCT01115699|Mayo Clinic|Michelle Skime, Supervisor - Senior Clinical Research Coordinator|507-255-0501|skime.michelle@mayo.edu|
20513217|NCT02149199|AstraZeneca AB|Stefan Ivanov|000000000000|information.center@astrazeneca.com|
20513218|NCT01806259|UoA|Prof Patrice Forget|497 12 28 36|forgetpatrice@yahoo.fr|
20513219|NCT00752895|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20513220|NCT00633217|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513221|NCT00314262|Emory University School of Medicine|Dong Shin, MD|404-778-2980|dmshin@emory.edu|
20513222|NCT04881448|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513223|NCT01966107|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20513224|NCT00532779|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
20513225|NCT02662556|AcelRx Pharmaceuticals, Inc.|Pamela P. Palmer, MD, PhD, Chief Medical Officer|650-216-3504|ppalmer@acelrx.com|
20513226|NCT00788008|Duke University Medical Center|Deborah Attix, PhD|919-668-2846|deborah.koltai@dm.duke.edu|
20513227|NCT02424799|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20513228|NCT02175472|PhotoPharmics, Inc.|Dan Adams|801-770-6960|dan.adams@photopharmics.com|
20513229|NCT00828516|Lynda Jackson Macmillan Centre|Dr Beverley de Valois|+44(0)1923-844456|beverley.devalois@nhs.net|
20513230|NCT00689273|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513231|NCT05406596|Seigla Medical|John Schultz|7632133026|jschultz223@gmail.com|
20513232|NCT00834288|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20513233|NCT00572468|Portland VA Health Care System|Wesley Stoller|503-220-8262|wesley.stoller@va.gov|54931
20513234|NCT04876482|Department of Physical Therapy, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan|Yi-Ju, Lai|+886963123117|jasmine19900728@gmail.com|
20513235|NCT03877484|Smith and Nephew|Clinical Study Manager|1482673917|rebecca.mcdonald@smith-nephew.com|+44
20513236|NCT02082262|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20513237|NCT01074307|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20513238|NCT02162511|Stanford University|Erica Goodwin|253-508-3556|egood55@stanford.edu|
20513239|NCT02413879|Prescient Surgical|Director of Clinical|6504895025|lclaude@prescientsurgical.com|
20513240|NCT02476851|Haemonetics Corporation|Jan Hartmann, MD|(781) 348 7396|Jan.Hartmann@haemonetics.com|
20513241|NCT01399125|Novartis Pharmaceuticals|Study Director|8627788300||
20513242|NCT00337129|SWOG Statistical Center|Head and Neck Committtee Statistician|(206)-667-4623||
20513243|NCT00647426|Abramson Cancer Center|Tracey Evans MD|215 614 0861|Christine.Bonney@UPHS.upenn.edu|
20513244|NCT00804349|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
20513245|NCT00563524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513246|NCT03608696|Thomas Jefferson University|Walter Kraft|2159559077|walter.kraft@jefferson.edu|
20513247|NCT03712137|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20513248|NCT02626182|National Jewish Health|Jennifer Taylor-Cousar, MD, MSCS, ATSF|3032702764|Taylor-CousarJ@NJHealth.org|
20513249|NCT02267850|Biolux Research Ltd|Clinical Studies Manager|1-604-669-0674|d.skrenes@bioluxresearch.com|
20513250|NCT01084603|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20513251|NCT02483481|Children's Mercy Kansas City|Dr. Sherwin Chan|816-234-3273|sschan@cmh.edu|
20513252|NCT02580318|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
20513253|NCT03379246|TriHealth Inc.|Dr. Catrina Crisp|513-463-4300|Catrina_Crisp@trihealth.com|
20513254|NCT03836729|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
20513255|NCT00948025|AxoGen, Inc|Vice President, Clinical and Translational Sciences|3864626829|edevinney@axogeninc.com|
20513256|NCT01508325|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20513257|NCT01392170|University of Texas (UT) MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Professor, Leukemia|713-745-4009|CR_Study_Registration@mdanderson.org|
20513258|NCT02613416|Stony Brook University|Caterina Vacchi-Suzzi|631-444-8074|caterina.vacchi-suzzi@stonybrookmedicine.edu|
20513259|NCT01542684|The University of Texas MD Anderson Cancer Center|Zeev Estrov, MD/Professor|713-794-1675|eharriso@mdanderson.org|
20513260|NCT02535247|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
20513261|NCT00323635|Brigham and Women's Hospital|Quentin Regestein|617-732-4497|qregestein@partners.org|
20513262|NCT03543046|Orlando Health|Corporate Director of Compliance and Regulations|3218413687|Tara.Roberts@orlandohealth.com|
20513263|NCT01398982|UHN|Kate Butler|416-340-4800|kbutler@uhnresearch.ca|2343
20513264|NCT03174925|Stanford University Medical Center|Aya Kamaya, Professor of Radiology|650-725-1812|kamaya@stanford.edu|
20513265|NCT01791127|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
20513266|NCT00520494|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20513267|NCT04247594|Global Blood Therapeutics, Inc.|Eleanor Lisbon|+1 913 449 4319|elisbon@gbt.com|
20513268|NCT02229487|Ramathibodii Hospital, Mahidol University|Sirimon Reutrakul|66922011647|sreutrakul@yahoo.com|708
20513269|NCT02018042|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
20513270|NCT02353299|Sleep Disorders and Research Center Henry Ford Hospital|Christopher L Drake|248-344-6672|cdrake1@hfhs.org|
20513271|NCT00589693|Janssen R&D US|Sr Director Clinical Development|1 510 248-2310||
20513272|NCT03231709|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20513273|NCT02609178|Stomatological Hospital of FMMU|Pingting Lin, PhD|+86 15249049902|biu79@hotmail.com|
20513274|NCT01128153|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
20513275|NCT02419469|UT MD Anderson Cancer Center|Rytting,Michael E.,M.D. / PEDIATRICS|713-792-7734|CR_Study_Registration@mdanderson.org|
20513276|NCT01682512|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513277|NCT00713830|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20513278|NCT00422058|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20513279|NCT02787785|Boston Scientific|Clinical Trial Manager or Director of Clinical Trials (Cardiology Rhythm Management)|1-800-227-3422|jill.leigh@bsci.com|
20513280|NCT02030834|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20513281|NCT04671329|Hologic, Inc.|Muhammad Waqas, Director of Global Clinical Affairs|(508) 826-7183|ClinicalResearch@Hologic.com|
20513282|NCT03111407|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
20513283|NCT03778190|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
20513284|NCT01766310|Queen Sirikit National Institute of Child Health|Dr. Orawan Iamopas|66-2-354-8415|orawaneamopas@yahoo.com|3327
20513285|NCT01591499|CooperVision|Caroline Bonneville and Sandrine Cheneau, Study Managers|+33609202762|caroline.bonneville@coopervision-fr.com|
20513286|NCT00902278|University of Massachusetts Medical School|Mary Co|5088562927|mary.co@umassmed.edu|
20513287|NCT02618772|MUHC|Dr. Jennifer Turnbull|514-412-4400|jennifer.turnbull@mcgill.ca|23039
20513288|NCT00446134|Valeant Pharmaceuticals International, Inc.|Senior Director Clinical Development|908-927-1782|ralph.doyle@valeant.com|
20513289|NCT01311505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513290|NCT02737072|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20513291|NCT00567996|Novartis Pharmaceuticals|Study Director|862-778-8300||
20513292|NCT02956005|MedStar Georgetown Transplant Institute|Alexander Gilbert|202-444-0621|Alexander.J.Gilbert@gunet.georgetown.edu|
20513293|NCT02762877|Genomic Health, Inc.|Director of Clinical Trials|1.650.569.2042|kgran@genomichealth.com|
20513294|NCT02524665|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513295|NCT04179474|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20513296|NCT02602080|Hospital for Special Surgery|George Birch|212-774-7377|birchg@hss.edu|
20513297|NCT01407107|University of Texas Southwestern Medical Center|Dr. Jonathan Dowell|214-648-7097|jonathan.dowell@utsouthwestern.edu|
20513298|NCT03934437|Johns Hopkins University|Larry Chang|4109551725|lchang8@jh.edu|
20513299|NCT02574260|Amgen, Inc.|Study Director|866-572-6436||
20528683|NCT05095311|Indiana University|Curtis Goss, Student Investigator|8178080085|csgoss13@gmail.com|
20551167|NCT03745937|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
20551168|NCT02659709|Wills Eye Hospital, Glaucoma Service|Dr. Jonathan S. Myers|215-928-3197|jmyers@willseye.org|
20551169|NCT00312494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20551170|NCT00429507|University of Texas (UT) MD Anderson Cancer Center|Nato Ueno, MD, PhD/Professor, Breast Medical Oncology||CR_Study_Registration@mdanderson.org|
20513300|NCT01066039|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20513301|NCT00057785|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20513302|NCT01083901|University of Colorado Denver|Catherine M. Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
20513303|NCT01197456|UC San Diego|Irene Su, MD MSCE|858-822-5986|hisu@ucsd.edu|
20513304|NCT03022799|Kainos Medicine, Inc|Dr. JaeMoon Lee|+1 408 202 4017|jlee@kainosmedicine.com|
20513305|NCT02642991|CooperVision, Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
20513306|NCT00683046|University of Chicago Medicine|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
20513307|NCT00883129|David Geffen School of Medicine at UCLA|Donald P. Tashkin, M.D.|310-825-5316|dtashkin@mednet.ucla.edu|
20513308|NCT03273257|Papworth Hospital NHS Foundation Trust|David Jenkins, MD; Principal Investigator and ICA Board member|+44 1223 638000|david.jenkins1@nhs.net|
20513309|NCT00407966|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
20513310|NCT01185639|Wake Forest University Health Sciences|Dr. William Blackstock|336-713-6501|ablackst@wakehealth.edu|
20513311|NCT02200614|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20513312|NCT01898884|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20513313|NCT00434148|Novartis Pharmaceuticals|Study Director|862-778-8300||
20513314|NCT01556165|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
20513315|NCT03980561|MUSC|Amanda Wagner|8437920484|wagne@musc.edu|
20513316|NCT02531698|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513317|NCT02049931|Seoul National University|Professor Jin S. Yeom|82-31-787-7195|highcervical@gmail.com|
20513318|NCT01456494|University of Chicago|Mary Akel|773-834-4489|makel@medicine.bsd.uchicago.edu|
20513319|NCT02395536|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
20513320|NCT00701558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20513321|NCT01640964|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20513322|NCT02787746|Department of Neurology, Xuan Wu Hospital of Capital Medical University; Freindship Hospital of Capital Medical University|Jianping Jia|+86 10 83188730|jjp@ccmu.edu.cn|
20513323|NCT04633187|Enanta Pharmaceuticals|Study Director|617-607-0800|enquiries@enanta.com|
20513324|NCT04822701|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513325|NCT02771340|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
20513326|NCT04148508|University of Exeter|Professor Ed Watkins|01392 724692|e.r.watkins@exeter.ac.uk|
20513327|NCT01142466|Merck Serono GmbH, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
20513328|NCT04084028|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
20513329|NCT01422720|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
20513330|NCT00606801|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20513331|NCT03067506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20513332|NCT02499406|VACHS|Investigator|203 932 5711|suzanne.decker@va.gov|
20513333|NCT01485588|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
20551171|NCT04538066|Synaptogenix, Inc.|Chief Medical Officer|973 242-0005|atuchman@synaptogen.com|
20513334|NCT00552617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20513335|NCT04651218|University of Kentucky|Dr. Kyle Flack|5182574351|kyle.flack@uky.edu|
20513336|NCT03940326|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
20513337|NCT01467570|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Piescik-Lech|+48-22-45-23-309|hania@ipgate.pl|
20513338|NCT03005379|VA Cooperative Studies Program|Yuan Huang, Ph.D., Biostatistician|2039325711|yuanhuang1@va.gov|
20513339|NCT02869295|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
20513340|NCT01331083|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
20513341|NCT02239601|CancerCare Manitoba|Marshall Pitz|2044751431|Mpitz@cc.umanitoba.ca|
20513342|NCT00566618|UT MD Anderson Cancer Center|Debu Tripathy, Chair, Breast Medical Oncology|(713) 792-2817|dtripathy@mdanderson.org|
20513343|NCT00690924|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20513344|NCT00068406|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
20513345|NCT01954082|University of Rochester|Dale Phelps|(585) 275-2972|dale_phelps@urmc.rochester.edu|
20513346|NCT01377233|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
20513347|NCT01785875|Amgen Inc.|Study Director|866-572-6436||
20513348|NCT03112993|University of Missouri|Dr. Boris Mraovic, MD, Professor of Clinical Anesthesiology|573-882-2568|mraovicb@health.missouri.edu|
20513349|NCT03137082|Stony Brook University|Dr Helen C Fox|631 632 0057|helen.fox@stonybrookmedicine.edu|
20513350|NCT00417027|Northwestern University Feinberg School of Medicine|Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
20513351|NCT00707174|University of Utah|Glen Bowen, MD|801-581-0255|glen.bown@hci.utah.edu|
20513352|NCT00544557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513353|NCT00939705|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
20513354|NCT00716586|University of Illinois at Chicago|Emeritus Professor of Ophthalmology|312 997-3646|gerafish@uic.edu|
20513355|NCT04057118|Oscotec Inc.|Sungsil Lee/Team Leader of Clinical Development|+82316287624|sslee@oscotec.com|
20513356|NCT01676311|Spaulding Rehabilitation Hospital|Ross Zafonte, DO|617-952-5227|rzafonte@mgh.harvard.edu|
20513357|NCT03250507|Henry Ford Hospital|Christina Fidkowski, MD|313-916-7648|cfidkow1@hfhs.org|
20513358|NCT01850108|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20560555|NCT01560949|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|(713) 792-2828|gvaradha@mdanderson.org|
20560556|NCT00751036|Novartis Pharmaceuticals|Study Director|862-778-8300||
20560557|NCT04580407|Director|Study|+1-877-825-3327|TrialDisclosures@takeda.com|
20560558|NCT03921528|Scholar Rock|Clinical Trials Coordinator|833-724-7625|clinicaltrials@scholarrock.com|
20560559|NCT01245413|Lægehuset, Skodsborg Strandvej 125A, 2942 Skodsborg, Denmark|Dr. Claus Hyldahl|4545801331|hyldahl@info.dk|
20560560|NCT02530151|Northwestern University|Michael Terry, MD|312-472-6488|mterry@nm.org|
20560561|NCT01374490|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20560562|NCT04155424|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20560563|NCT03379740|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20560564|NCT04867902|Massachusetts General Hospital|Dr. Emily Feig|617-724-9140|efeig@mgh.harvard.edu|
20560565|NCT02501629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20560566|NCT02004613|Cleveland Clinic Foundation|Dr. Alparslan Turan|216-445-9857|turana@ccf.org|
20560567|NCT03120676|Memorial Sloan Kettering Cancer Center|Dr. Anas Younes, MD|212-639-5059|younesa@mskcc.org|
20560568|NCT00886613|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560569|NCT03647475|Medtronic Coronary/Renal Denervation (C/RDN)|Cecile Mahoney, Sr. Clinical Research Specialist|763-505-1057|cecile.c.mahoney@medtronic.com|
20560570|NCT04577183|RedDress Medical|Clinical Trial Manager|1-800-674-9615|alon@reddress.co.il|
20560571|NCT01721564|Royal Prince Alfred Hospital, Sydney, Australia|Prof David Celermajer|+61 2 9515 6519|david.celermajer@email.cs.nsw.gov.au|
20560572|NCT02321748|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20560573|NCT02072226|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20560574|NCT00360126|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560575|NCT03255018|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
20560576|NCT00810303|Department of Clinical Pharmacology|Danilo Wegner|+4903834865640|dwegner@uni-greifswald.de|
20560577|NCT01720043|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
20560578|NCT01688973|City of Hope National Medical Center|Przemyslaw W. Twardowski, MD|626-256-4673|ptwardowski@coh.org|68218
20560579|NCT02022462|University of Southern California|Dr. John Brekke|213-740-0297|brekke@usc.edu|
20560580|NCT01124162|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20560581|NCT01702896|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
20560582|NCT04371536|Baylor College of Medicine|Dr. Jacquelyn Powers|832-824-7330|jmpowers@txch.org|
20560583|NCT03557385|Duke Clinical Research Institute|Marjan Cobbaert|9196995638|mr157@duke.edu|
20560584|NCT02712099|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20560585|NCT00908947|BD/Bard|Talar Saber, Senior Project Manager, Clinical Affairs|1.480.379.2839|Talar.Saber@crbard.com|
20560586|NCT03613129|Bateman Horne Center|Lucinda Bateman, MD|(801) 359-7400|LBateman@batemanhornecenter.org|
20560587|NCT00938340|Penn State University|Penny Kris-Etherton||pmk3@psu.edu|
20560588|NCT02796092|GITMI (University of Zaragoza)|Prof. Alicia Laborda|0034 976 76 15 49|alaborda@unizar.es|
20560589|NCT02534896|SPARC|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
20560590|NCT00711646|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20560591|NCT04381494|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20560592|NCT03441360|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20560593|NCT00269399|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
20560594|NCT03396835|Masimo Corporation|Tala Harake|949-297-7137|studies@masimo.com|
20560595|NCT03439124|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
20560596|NCT01451814|Brown University School of Public Health|Dr. Christopher Kahler|401 863-6651|Christopher_Kahler@brown.edu|
20560597|NCT02467491|University of Florida|Dr. Vincenzo Valiani|352-2835906|vincio86@gmail.com; v.valiani@ufl.edu|
20560598|NCT04353037|UnitedHealth Group R&D / Optum Labs|Mike Lahm, Director Data Science|302-379-0209|MichaelLahm@uhg.com|
20560599|NCT03710564|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20560600|NCT02749045|University of Pittsburgh Medical Center|Prem Soman, MD, PhD|412 647 3435|somanp@upmc.edu|
20560601|NCT02993471|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20560602|NCT02446223|Cosmetic Laser Dermatology/West Dermatology Research|Clinical Research Coordinator|858 657 1004|IGuiha@CLderm.com|
20560603|NCT00920686|NeurAxon, Inc|Thomas Lategan, PhD|417 673 6697|tlategan@neuraxon.com|
20560604|NCT03006341|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20560605|NCT02243007|Massachusetts General Hospital|David P. Ryan, MD|6177240245|dpryan@mgh.harvard.edu|
20513359|NCT03127943|UNC Department of Oral and Maxillofacial Surgery|Raymond P. White Jr DDS, PhD|919-537-3944|ray_white@unc.edu|
20513360|NCT01029769|Technische Universitaet Muenchen, Germany|Prof. Dr. Dr. Stefan Leucht|+498941404200|stefan.leucht@tum.de|
20513361|NCT03273712|University of Iowa|M. Sue O'Dorisio, MD, PhD|(319) 335-7234|sue-odorisio@uiowa.edu|
20513362|NCT04333199|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20513363|NCT01468974|Abbott Vascular|Nadia bouhdi||nadia.bouhdi@av.abbott.com|
20560606|NCT03101592|David Geffen School of Medicine at UCLA|Dr. Risa Hoffman, MD, MPH; Director of GHP; Associate Professor of Clinical Medicine|310 825-7225|rhoffman@mednet.ucla.edu|
20560607|NCT01522339|Cincinnati Children's Hospital Medical Center|Jean Tkach|513-636-7166|jean.tkach@cchmc.org|
20513364|NCT00666718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20528684|NCT03790865|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
20528685|NCT00972283|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20528686|NCT02308371|University of North Carolina|Dr. Melissa Hines|901-652-6138|mhinesthomas@gmail.com|
20528687|NCT04229771|William Beaumont Hospital|Dr. Dianne Schlachter, Staff Physician|248-551-2020|dianne.schlachter@beaumont.org|
20528688|NCT02903420|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
20528689|NCT04672044|Birmingham VA Medical Center|Research Integrity Officer|2059338101|latanya.higginbottom@va.gov|337436
20528690|NCT00334295|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20528691|NCT00792116|Baylor|Craig Johnston|713-798-2068|caj@bcm.edu|
20528692|NCT02453256|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20528693|NCT01216332|Vanderbilt|Dr. Natasha Halasa|6153223346|natasha.halasa@vanderbilt.edu|
20528694|NCT03479944|Alcon Japan Ltd.|Group Manager, Surgical, Alcon Japan|03-6899-5061|alcon.medinfo@alcon.com|
20528695|NCT01066871|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20528696|NCT00729300|Baylor College of Medicine|Christopher Verrico|713-791-1313|verrico@bcm.edu|26020
20528697|NCT01124292|Georgia Institute of Technology|Dr. Maysam Ghovanloo|404-385-7048|mgh@gatech.edu|
20528698|NCT01680653|Stanford University|Dr. Bruce Buckingham|650-725-6549|bbendo@stanford.edu|
20528699|NCT03373461|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20528700|NCT01243177|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20528701|NCT03020550|University of California, Davis|Michelle Dossett, MD, PhD|916-734-5367|mdossett@ucdavis.edu|
20528702|NCT01431313|University of Pittsburgh|Marc A. Simon, MD|4128023131|SIMONMA@UPMC.EDU|
20528703|NCT02484092|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528704|NCT05554640|Johnson & Johnson Vision Care (JJVC)|John R. Buch, O.D., M.S.|1-800-843-2020|jbuch@its.jnj.com|
20528705|NCT03335813|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. John Greskovich|1-866-223-8100|taussigresearch@ccf.org|
20528706|NCT01639144|Center for Research & Grants, Baptist Health South Florida|Gary M. Kiebzak, Ph.D., Co-investigator and Clinical Research Administrator|786-268-6224|garyk@baptisthealth.net|
20528707|NCT00652145|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
20528708|NCT00472732|Children's Research Institute|Andrea Gropman, M.D.|202-476-2120|agropman@childrensnational.org|
20528709|NCT03872843|Wake Forest|Dr. Jorge Gutierrez|336-716-2011|jgutierrez@wakehealth.edu|
20513365|NCT00963599|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20513366|NCT03959137|MSD Belgium|Stephanie Coulon|0032 485 461 467|stephanie.coulon@merck.com|
20513367|NCT00998582|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
20513368|NCT01032330|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20513369|NCT00190684|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20513370|NCT03496207|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20513371|NCT03304210|Ghent University|Prof|+32(0)93326251|wim.ceelen@ugent.be|
20513372|NCT00810615|San Antonio Military Medical Center, Wilford Hall Ambulatory Surgical Center|Dr. George Wolf, Associate Investigator|210-292-3483|earl.wolf.ctr@us.af.mil|
20513373|NCT02567266|University of Miami|Dr. Amanda Jensen-Doss|+1 (305)284-8332|ajensendoss@miami.edu|
20513374|NCT00837031|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20513375|NCT02020785|Geisinger|Alex Chang, MD|570-271-8026|achang@geisinger.edu|
20513376|NCT05149989|Liverpool University Hospitals NHS Foundation Trust|Dr Tristan Payne|+44(0)1517064553|tristan.payne@liverpoolft.nhs.uk|
20513377|NCT00995488|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain|734-647-8903|mahahuss@umich.edu|
20513378|NCT04529499|Dr Reddy's Laboratories Ltd.|Dr. Srinivas Shenoy B.,|49002900|srinivassshenoyb@drreddys.com|
20513379|NCT00683904|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20513380|NCT04628221|MCRA, LLC|Nicole Harris|202-552-5800|nharris@mcra.com|5823
20513381|NCT02441179|Teleton Institute|Dr. Angela Navarrete-Opazo|+56 0226772075|angelaandrean@gmail.com|
20513382|NCT01494649|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513383|NCT03091400|Icahn School of Medicine at Mount Sinai|James F Sumowski, PhD|212-241-6854|james.sumowski@mssm.edu|
20513384|NCT01656967|The University of Texas Health Science Center at Houston|Dr. Carin A. Hagberg|(713) 500-6240|Carin.A.Hagberg@uth.tmc.edu|
20513385|NCT00975884|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513386|NCT00051636|Novartis|Study Director|862-778-8300||
20513387|NCT02340078|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
20513388|NCT01831596|KCI|VP, Global Clinical Development|210-255-5595|jkhart@mmm.com|
20513389|NCT03958071|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513390|NCT02414854|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20513391|NCT01355523|Herlev Hospital, Department of Surgery|MD Melissa Voigt Hansen|+45 20661119|melissa.voigt.hansen@regionh.dk|
20513392|NCT02766088|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
20513393|NCT01222715|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20513394|NCT04440163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513395|NCT02577900|Queen Elizabeth Hospital|Dr. Tsang Ka-Kit|+852-35062610|kktsang3@netvigator.com|
20528710|NCT01761643|UC San Diego|Mike Duszynski|6195438080|mduszynski@health.ucsd.edu|
20528711|NCT00856999|Oregon Health & Sciences University|Roger Dailey, MD, FACS|503-494-3020|daileyr@ohsu.edu|
20528712|NCT02609386|Eterna Therapeutics|VP of Quality|212-582-1199|info@eternatx.com|
20513396|NCT03851107|McGill University|Dr. Dana Anaby|15143984400|dana.anaby@mcgill.ca|00394
20560608|NCT00647348|University of London|Professor Jeremy Chataway, Chief Investigator|07974752295|j.chataway@ucl.ac.uk|
20560609|NCT00619151|Sorin Group USA, Inc.|Barbara Mathews Director Clinical and Medical Affairs|512-435-3602|Barbara.mathews@sorin.com|
20560610|NCT03404609|Stanford University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
20560611|NCT01675830|Boston Children's Hospital|Karen Sakakeeny|617-355-6369|Karen.Sakakeeny@childrens.harvard.edu|
20560612|NCT00631917|Novartis Pharmaceuticals|Study Director|862-778-8300||
20513397|NCT01440595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20513398|NCT01347879|Virginia Clinical Research, Inc.|Dr David Pariser|757-625-0151|dpariser@pariserderm.com|
20513399|NCT00068770|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
20513400|NCT01754480|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
20513401|NCT01466673|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
20513402|NCT02725671|Johns Hopkins University|Dr. Armin Zadeh|4105020549|arminzadeh@jhu.edu|
20513403|NCT02981602|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20513404|NCT04000373|Cleveland Clinic Neurological Institute Mellen Center|Research Nurse Coordinator|216-445-5877|stoughd@ccf.org|
20513405|NCT02492295|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|215-456-2313|MOHIUDDK@EISNTEIN.EDU|
20513406|NCT02983227|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20513407|NCT01706770|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|(978) 658-6888||151
20513408|NCT00068445|Mayo Clinic|Charles L. Loprinzi, M.D.|507-284-3731|cloprinzi@mayo.edu|
20513409|NCT01155284|Sanford Research|Kurt J. Griffin, PhD, MD, Director of Clinical Trials|6053126000|kurt.griffin@sanfordhealth.org|
20513410|NCT01896700|Portland VA Health Care System|Andrea Hildebrand|503-220-8262|hildeand@ohsu.edu|52016
20513411|NCT00123487|Bristol-Myers Squibb|: Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20513412|NCT00423488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20513413|NCT00886782|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20513414|NCT01255722|Section Head Interventional and Cardiac Radiology - Kantonsspital Lucerne, Spitalstrasse, 6006 Lucerne, Switzerland|Prof. Dr. med. Martin HOFFMANN|+41 41 205 4660|martin.hoffmann@luks.ch|
20513415|NCT02643966|University of Pittsburgh|Dr. Wendie A. Berg|412-641-1635|bergwa@upmc.edu|
20513416|NCT02245360|Abbott|Dmitri Kazei MD, PhD|+31 294477008|dmitri.kazei@abbott.com|
20513417|NCT03835975|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513418|NCT01362959|Department of Intensive care, Deventer Hospital|Dr. Huub van den Oever|+31 570 535346|h.vandenoever@dz.nl|
20513419|NCT03070431|Department of Radiation Oncology, University of Lübeck, Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|rades.dirk@gmx.net|45400
20513420|NCT00701935|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20513421|NCT01542736|University of Colorado Denver|Jennifer Raybin, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20513422|NCT01783483|Zimmer Biomet|Brian M Hatcher, PhD|904-741-4400|brian.hatcher@zimmerbiomet.com|
20513423|NCT00947518|Department of Pediatrics, All India Institute of Medical Sciences, New Delhi|Mari Jeeva Sankar|+91-11-26594372|jeevasankar@gmail.com|
20513424|NCT00717873|Barnes Jewish Hospital|Darnetta Clinkscale|(314) 362-1276|MDB3455@bjc.org|
20513425|NCT00370396|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513426|NCT02065791|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20513427|NCT02282111|The Johns Hopkins Hospital|Dr. Mouen A. Khashab|410-502-0064|mkhasha1@jhmi.edu|
20513428|NCT02702271|Boston Scientific|Director of Clinical Trials|1-800-CARDIAC|peter.maurer@bsci.com|
20513429|NCT03467971|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20513430|NCT01174368|The Rogosin Institute|Angelica Nazarian|212-746-1551||
20513431|NCT00479765|Boston Scientific Corporation|Jessie Stockwell|16126181136|jessie.stockwell@bsci.com|
20513432|NCT02580201|FIDEC Corporation|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
20513433|NCT00363129|Mayo Clinic|Lisa Kottschade, RN, MSN, CNP|507-284-2511|kottschade.lisa@mayo.edu|
20513434|NCT03707522|University of Nevada, Reno|Martha Zimmermann|7756368067|mzimmermann@nevada.unr.edu|
20513435|NCT05166512|Johns Hopkins Bloomberg School of Public Health|Dr. Julia Wolfson|410-614-4907|jwolfso7@jhu.edu|
20513436|NCT00420849|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20513437|NCT00383019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513438|NCT05789420|Philip Morris Products S.A.|Xavier Jaumont, Global Head of Clinical Development and Operations|+41582421111|ClinicalTrials.PMI@pmi.com|
20513439|NCT02278952|University of California, San Francisco|Dr. John Greenland|415-476-0789|john.greenland@ucsf.edu|
20513440|NCT00659581|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513441|NCT00725725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Develpment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20513442|NCT01337609|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|mfava@partners.org|
20513443|NCT01619085|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513444|NCT05473247|Berry College|Kameron Suire|3373968980|ksuire@berry.edu|
20513445|NCT02392559|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20528713|NCT00103662|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20528714|NCT01354197|Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand|Kaweesak Chittawatanarat|053-935533|kchittaw@gmail.com|
20528715|NCT00105989|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20528716|NCT00610168|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513446|NCT01345058|Brigham and Women's Hospital|Jong Woo Lee, MD, PhD||JLEE38@BWH.HARVARD.EDU|
20513447|NCT02820324|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20513448|NCT00000135|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
20513449|NCT03162354|Penn State College of Medicine, Penn State Health Children's Hospital|Kent P. Hymel, MD; Professor of Pediatrics; Study PI|7036748989|kphymel@gmail.com|
20513450|NCT00944125|Aurora Health Care|Imran K. Niazi, MD|414-645-6070|imran.niazi@aurora.org|
20513451|NCT03125629|Stanford University|Andrei Iagaru|650-725-4711|aiagaru@stanford.edu|
20513452|NCT00743119|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|zc2160@cumc.columbia.edu|
20513453|NCT02989610|Abbott|Tucker Tomlinson, Scientist, Clinical Research|+19725269646|Tucker.Tomlinson@Abbott.com|
20513454|NCT04508621|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|Greg.Sullivan@TonixPharma.com|
20513455|NCT04499391|Penn State College of Medicine|Dr. Jennifer Kraschnewski|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
20513456|NCT00833976|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
20513457|NCT04575038|Clear Creek Bio, Inc.|Barbara Powers, Vice President Clinical Operations|16177652252|clinical@clearcreekbio.com|
20513458|NCT00201734|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
20513459|NCT02464059|University of North Carolina at Chapel Hill|Michael Bradley Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
20513460|NCT00634582|Comprehensive Cancer Center of Wake Forest Univeresity|Gary Schwartz, PhD|336-716-7446|gschwart@wakehealth.edu|
20513461|NCT03591107|RAND|Lisa Meredith, Senior Behavioral Scientist|310.393.0411|seidel@rand.org|7365
20513462|NCT01902134|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
20513463|NCT00305110|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
20513464|NCT03141931|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
20513465|NCT01272193|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20513466|NCT02685956|Global BioClinical|Jennifer Maas|206-240-8632|jen.maas@globalbioclinical.com|
20513467|NCT02661282|UT MD Anderson Cancer Center|Shiao-Pei Weathers, MD, Associate Professor, Neuro-Oncology|(713) 792-3906|sweathers@mdanderson.org|
20513468|NCT01363401|Hanyang University Seoul Hospital|Seung-Hyun Kim, M.D., Ph.D.|+82-2-2290-8114|kimsh1@hanyang.ac.kr|
20513469|NCT00350519|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Vice President Medical Affairs COBS|215-325-4464||
20513470|NCT00823459|University of California, San Francisco|Susan Chang, MD|(415) 353-2966|jessica.carlson@ucsf.edu|
20513471|NCT00736099|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513472|NCT05105477|Edwards Lifesciences|Cristina Johnson|888.713.1564|CC_Clinical_Affairs@edwards.com|
20513473|NCT01637961|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20513474|NCT03101293|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20513475|NCT02833857|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20513476|NCT01207401|University of California, San Diego|Dr. Sheila Krishnan Mody|(619)543-6777|smody@ucsd.edu|
20513477|NCT01498419|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
20513478|NCT03555890|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20513479|NCT03372369|University of North Carolina at Chapel Hill|Seri Link Anderson, PhD|919-619-0433|seri.link.a@gmail.com|
20513480|NCT04682639|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513481|NCT01383954|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
20513482|NCT00763269|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
20513483|NCT04388527|University of Pennsylvania|Regulatory Lead|512-662-4484|psom-ind-ide@pobox.upenn.edu|
20513484|NCT03471182|Yale University School of Medicine|Patrick Worhunsky|203-737-2668|patrick.worhunsky@yale.edu|
20513485|NCT01305265|Dept. of Anesthesia & Perioperative Care, UCSF San Francisco|Kolodzie, Kerstin M.D, PhD, Principal Investigator|4158853647|kolodziek@anesthesia.ucsf.edu|
20513486|NCT03451331|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20513487|NCT00289731|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513488|NCT01017029|Pharmaceuticals|Novartis|+1(862)778-8300||
20513489|NCT06118359|University of Wisconsin|Angela Ingraham|513-833-5205|aingraham.md.ms@gmail.com|
20551172|NCT03316131|AstraZeneca RD, Gothenburg|Fredrik Erlandsson|1-877-240-9479|information.center@astrazeneca.com|
20551173|NCT00478569|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20551174|NCT00708162|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20551175|NCT02169739|University of California Los Angeles|Latisha Sharma, MD|310-794-6379|lali@mednet.ucla.edu|
20551176|NCT02880189|Mayo Clinic|Dr. Barham K. Abu Dayyeh|507-284-1825|AbuDayyeh.Barham@mayo.edu|
20551177|NCT04396990|Vance Thompson Vision|Keeley Boever|6053613937|keeley.boever@vancethompsonvision.com|
20551178|NCT00826020|University of Nebraska Medical Center|David Mercer|402-559-6955|dmercer@unmc.edu|
20551179|NCT02338960|AMAG Pharmaceuticals|Medical Information|1-877-411-2510||
20551180|NCT01525550|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551181|NCT02877082|Emory University/Winship Cancer Institute|Zaid Al-Kadhimi, MD|404-778-1900|zalkadh@emory.edu|
20551182|NCT03480750|National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University|Dr. Yu-Fang Huang|886 6 2353535|yufangh@mail.ncku.edu.tw|5221
20551183|NCT02493608|Texas Tech Health Sciences Center|Chadley Copeland|8067434752|chadley.copeland@ttuhsc.edu|
20560613|NCT02403323|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20513490|NCT00618774|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513491|NCT02770716|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
20513492|NCT01725113|NYU Langone Health|Candace Grant|5166632171|Candace.Grant@nyulangone.org|
20513493|NCT00446264|University of Lille|Violeta Raverdy|00 33 3 20 62 34 30|vraverdi@univ-lille2.fr|
20513494|NCT02753400|Kubota Vision Inc.|Clinical Trials Helpdesk|2068058310|clinicaltrials@kubotavision.com|
20513495|NCT03989115|Revolution Medicines|Vice-President Clinical Operations|650-779-2300|RMC-4630-02@revmed.com|
20528717|NCT01588158|Massachusetts General Hospital|Neal Chen, MD||nchen1@partners.org|
20528718|NCT02820870|VA Center for Clinical Management Research|Jeremy Sussman, MD, MS - Principal Investigator|(734) 845-5200|jeremysu@med.umich.edu|
20528719|NCT01369745|Zalicus|Margaret Lee,PhD|617-301-7142|mlee@zalicus.com|
20505977|NCT03406104|Gensight Biologics|Magali TAIEL Chief Medical Officer|0762891252|mtaiel@gensight-biologics.com|
20560614|NCT03582956|Yale University|Michelle Van Name|2037855831|michelle.vanname@yale.edu|
20505978|NCT03277729|Fred Hutchinson Cancer Center|Mazyar Shadman|206-667-4216|mshadman@fredhutch.org|
20505979|NCT04111276|University of Tennessee|Dr. Michael LaCour|865-974-7684|mlacour@utk.edu|
20505980|NCT01035255|Novartis Pharmaceuticals|Study Director|862-778-8300||
20505981|NCT00803244|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20505982|NCT00616239|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
20505983|NCT02873715|University at Buffalo|Leonard H. Epstein, PhD, SUNY Distinguished Professor|716-829-3400|lhenet@buffalo.edu|
20505984|NCT01254396|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20505985|NCT00933335|GlaxoSmithKline|GSK Response Center|866-435-7343||
20505986|NCT04590937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505987|NCT02026271|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
20505988|NCT02275026|Icahn School of Medicine at Mount Sinai|Dr. Joshua Mincer|(917) 922-9475|joshua.mincer@mountsinai.org|
20505989|NCT01585129|WashingtonU|Dr. Anthony Shanks|3179448182|ashanks@iupui.edu|
20505990|NCT00374907|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20505991|NCT01108809|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20505992|NCT03395340|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Edward W. Cowen|301-827-2328|cowene@mail.nih.gov|
20505993|NCT01293396|Medical University of Graz|Dr. Norbert Tripolt|0316385|norbert.tripolt@medunigraz.at|78038
20505994|NCT02213198|UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
20505995|NCT00001262|National Institute of Child Health and Human Development|Kaler, Stephen G|+1 301 451 6034|kalers@mail.nih.gov|
20505996|NCT00878072|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20505997|NCT01704781|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
20505998|NCT01280123|Northwestern University|Tanya Simuni, MD||TSimuni@nm.org|
20505999|NCT02504892|National Cancer Institute|Dr. Ramaprasad Srinivasan|301-451-2298|srinivasanr@mail.nih.gov|
20506000|NCT00524745|PATH|Kathleen Neuzil, Principal Investigator|206-285-3500|kneuzil@path.org|4864
20506001|NCT00576693|Medical University of South Carolina|Marc I. Chimowitz, MBChB|843-792-3020|mchimow@musc.edu|
20506002|NCT00540449|Janssen Infectious Diseases BVBA|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
20506003|NCT03643432|Oxford University Hospitals NHS FT|Jon Room|01865737526|jonathan.room@ouh.nhs.uk|
20506004|NCT03283163|VA Boston Healthcare System|Erica R. Checko (Scioli), PhD|857-364-5696|ericarose.scioli@va.gov|
20506005|NCT04238663|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
20506006|NCT03017924|Cincinnati Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
20506007|NCT05128162|University of Michigan|Kevin Boehnke, PhD|734-998-6939|kboehnke@med.umich.edu|
20506008|NCT00370149|Riley Hospital for Children|Elaine G Cox, MD|317-944-7260|elmcox@iu.edu|
20506009|NCT01429792|Hoffman-La Roche|Medical Communications|8008218590|genentech@druginfo.com|
20506010|NCT00726323|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506011|NCT02599766|Swiss TPH|Dr. Karin Hediger|0041795197885|karin.hediger@unibas.ch|
20506012|NCT00669539|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
20506013|NCT00376597|The Ohio State University Comprehensive Cancer Center|Electra D. Paskett, PhD|614-293-3917|electra.paskett@osumc.edu|
20506014|NCT05374408|UNMC|Margaret Emerson|4025596625|margaret.emerson@unmc.edu|
20506015|NCT05100316|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20506016|NCT00879814|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506017|NCT00630812|Pharmaxis|Brett Charlton|02 94547210|Brett.Charlton@pharmaxis.com.au|
20506018|NCT00972478|SWOG|Study Statistician|206-667-4623||
20506019|NCT02561000|Tufts Medical Center|Athan Kuliopulos, MD, PhD|617-636-8482|athan.kuliopulos@tufts.edu|
20506020|NCT01234402|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20506021|NCT03993691|University of North Carolina at Chapel Hill|Director, Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20506022|NCT05761444|Organon Korea Co. Ltd|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20506023|NCT00752609|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20528720|NCT02754518|University of Chicago|Sara Kalantari, MD|773-834-6853|skalantari@medicine.bsd.uchicago.edu|
20506024|NCT05114590|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20506025|NCT01757704|Lunds University|Dr. Bansi Koul|+4646171649|bansi.koul@skane.se|
20506026|NCT00938327|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513496|NCT02135874|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Proffessor|713-792-4764|eajabbour@mdanderson.org|
20513497|NCT01415921|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
20513498|NCT02660385|University of Connecticut/formerly Yale University|Meghan O'Connell, Program Manager|860-634-4152|meghan.oconnell@uconn.edu|
20513499|NCT01830920|Thrasos Therapeutics, Inc.|Jerome Rossert, MD, PhD, Chief Scientific Officer||Jerome.Rossert@thrasos.com|
20513500|NCT01313728|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
20528721|NCT00613821|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
20528722|NCT02051790|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20528723|NCT01266824|Children's Hospital of Philadelphia|Dr. Amy Cohen|215-590-1000|cohenam@email.chop.edu|
20528724|NCT02302846|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
20528725|NCT00411450|Amgen Inc.|Study Director|866-572-6436||
20528726|NCT00397189|Neurim Pharmaceuticals|VP clinical and regulatory affairs|+972-3-6499340|Talin@neurim.com|
20528727|NCT00235573|University of Florida|Gail Kauwell|352-392-1991|gkauwell@ufl.edu|227
20528728|NCT00141518|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20528729|NCT01806168|Vancouver Coastal Health / Vancouver General Hospital|Kawai Leong, MD, MSc, FRCPC|604-875-8289|kawai.leong@vch.ca|
20528730|NCT03410992|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20528731|NCT01468454|Children's Hospital of Philadelphia - Department of Radiology|Lisa J. States, MD|267-245-7146|states@chop.edu|
20528732|NCT01100723|University of Colorado|Dr. David M. Spiegel|303-724-7797|david.spiegel@ucdenver.edu|
20528733|NCT02104427|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7072|lwchang@taigenbiotech.com|1227
20528734|NCT01462630|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
20528735|NCT01464190|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
20528736|NCT02134795|Scion NeuroStim|Dr. Robert Black|(919) 260-5528|rblack@scionneurostim.com|
20528737|NCT00844090|Omaha VA Medical Center|Cyrus Desouza MD|402-995-5506|cyrus.desouza@va.gov|
20528738|NCT01048541|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
20528739|NCT03060291|University of Oregon Prevention Science Institute|Dr. Allison Caruthers|503-412-3770|ascaru@uoregon.edu|
20528740|NCT00718094|University Louisville|Gerald Dryden, MD|502-852-0156|gwdryd01@louisville.edu|
20528741|NCT00618826|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
20528742|NCT05171270|University of Oxford|Professor Laura Coates|07870257823|laura.coates@ndorms.ox.ac.uk|
20528743|NCT01509664|New York Obesity Nutrition Research Center|Dr Allan Geliebter|212-523-4184|ag58@columbia.edu|
20528744|NCT02105285|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
20528745|NCT02585713|Mayo Clinic|Robert D. McBane, M.D.|507/284-4565|Mcbane.robert@mayo.edu|
20528746|NCT01150903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528747|NCT04736069|Ufuk University|Nihan Cüzdan|5052706846|nihancuzdan@hotmail.com|
20528748|NCT00573872|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
20528749|NCT04060797|Zhongda Hospital Affiliated to Southeast University|Dr. Gaojun Teng|13805175100|gjteng@vip.sina.com|
20528750|NCT01861002|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Roy Leong, BA, CCRP|323-361-5132|rleong@chla.usc.edu|
20528751|NCT00110357|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20528752|NCT01064362|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528753|NCT00656175|UCLA CARE Center|Dr. Jordan Lake|310-557-9679|jlake@mednet.ucla.edu|
20528754|NCT01540513|University of Wisconsin Carbone Cancer Center|Dr. Lance Hall|608-263-5585|lhall@uwhealth.org|
20528755|NCT02273362|Mayo Clinic|Kenneth K. Tanabe, M.D.|507-284-2511|ktanabe@partners.org|
20528756|NCT03283930|National Institute of Mental Health (NIMH)|Dr. Daniel Pine|+1 301 594 1318|daniel.pine@nih.gov|
20528757|NCT00805129|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin, MD|646-888-4700|bajorind@mskcc.org|
20528758|NCT02588664|Wake Forest University Health Sciences|Dr. Pamela W. Duncan|(336) 716-5068|pduncan@wakehealth.edu|
20528759|NCT00396383|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20528760|NCT01839916|University of Chicago|Dr. Hongtao Liu|773-834-1736|hliu2@medicine.bsd.uchicago.edu|
20528761|NCT00534638|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528762|NCT03866278|Massachusetts General Hospital|Principal investigator|6176709739|patrick.purdon@MGH.HARVARD.EDU|
20528763|NCT00227019|Stanford University|Heather Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
20528764|NCT02500719|University of Arkansas for Medical Sciences|Dr. Keith A. Bush|501.526.8347|kabush@uams.edu|
20528765|NCT00990509|University of Arizona|Chelsea Kidwell, MD|(520) 626-7159|ckidwell@neurology.arizona.edu|
20528766|NCT02710084|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|212-659-9134|alexander.kolevzon@mssm.edu|
20528767|NCT00181883|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
20528768|NCT05305989|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20528769|NCT03538691|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20528770|NCT01909141|Cairo University|Dr. Ghada Abdel Fattah|00201006513305|ghadaabdelfatah2007@yahoo.com|
20528771|NCT03715452|Osprey Medical, Inc.|Vice President of Clinical Affairs|952.955.8236|kknish@ospreymed.com|
20513501|NCT01080209|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20528772|NCT00481767|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528773|NCT01366638|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
20528774|NCT00636636|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
20560615|NCT00197236|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560616|NCT03885596|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
20560617|NCT00746330|Novartis Pharmaceuticals|Study Director|862-778-8300||
20560618|NCT01076335|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20560619|NCT03360422|Northeastern University|Robert Leeman|6173736501|r.leeman@northeastern.edu|
20560620|NCT02616263|Washington University in St. Louis, School of Medicine, Program in Physical Therapy|Dr. Mary Hastings, Professor|3142107108|hastingsmk@wustl.edu|
20560621|NCT04807517|Massachusetts General Hospital Lurie Center for Autism|Lurie Center Research Manager|781-860-1711|luriecenterresearch@mgh.org|
20560622|NCT02939183|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20560623|NCT05015478|Icahn School Of Medicine at Mount Sinai|Mariana Figueiro PhD|212-241-6500|Mariana.Figueiro@mountsinai.org|
20560624|NCT04319094|Mass General Hospital|Dr. Jin hui Joo|410-724-5317|jhjoo@mgh.harvard.edu|
20513502|NCT00572156|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20560625|NCT04081545|Virginia Mason Medical Center|Christine Oryhan|206-223-6980|christine.oryhan@virginiamason.org|
20560626|NCT04639947|Duke Eye Center|Dr. Sanjay Asrani|+1 919 684 8656|sanjay.asrani@duke.edu|
20560627|NCT00654238|Abramson Cancer Center at the University of Pennsylvania|Dr. Marcia Brose|215-746-6344|brosem@mail.med.upenn.edu|
20560628|NCT00877851|Queen's University, Belfast|Prof Michelle McKinley|+44(0)2890632685|m.mckinley@qub.ac.uk|
20560629|NCT03424239|Massachusetts General Hospital|Dr. Elaine Yu|617-643-6353|ewyu@mgh.harvard.edu|
20560630|NCT00770211|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
20560631|NCT00318656|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560632|NCT01446003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560633|NCT02982928|Nationwide Children's Hospital|Ahsan Syed, MD|614-722-4200|Ahsan.Syed@nationwidechildrens.org|
20560634|NCT03905135|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
20560635|NCT01740557|M D Anderson Cancer Center|Dr. Rodabe Amaria M.D.|(713) 792-2921|rnamaria@mdanderson.org|
20560636|NCT02806895|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20513503|NCT00720304|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Min Yao, MD|1-800-641-2422|CTUReferral@UHhospitals.org|
20513504|NCT01087801|ChiRhoClin, Inc.|Edward Purich, Ph.D.|301-476-8388|mdoerr@chirhoclin.com|
20513505|NCT04330482|Rhode Island Hospital|Geoffrey Tremont|401-444-4500|gtremont@lifespan.org|
20513506|NCT00996918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513507|NCT01382901|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|601-650-4200|mfalone@luitpold.com|
20513508|NCT01333475|National Cancer Institute|Dr. Shivaani Kummar|301-435-0517|kummars@mail.nih.gov|
20513509|NCT04440007|Sorrento Therapeutics, Inc.|Mike Royal, MD|858-203-4100|mroyal@sorrentotherapeutics.com|4146
20513510|NCT03118765|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20513511|NCT03674827|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513512|NCT03398928|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
20513513|NCT00294632|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Wang, Professor, Lymphoma/Myeloma|713-792-2860|miwang@mdanderson.org|
20513514|NCT04816877|Beth Israel Deaconess Medical Center|Dr. Sunil Sheth|6176675576|ssheth@bidmc.harvard.edu|
20513515|NCT01532349|Johns Hopkins University|Dr. Meredith Atkinson|410-955-2467|matkins3@jhmi.edu|
20513516|NCT00759759|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
20513517|NCT02432456|Medical College of Wisconsin|Thomas Carver|414-955-1733|tcarver@mcw.edu|
20513518|NCT00864084|The University of Manitoba|Ms Elizabeth Harvey|204-977-5656|harveye@cc.umanitoba.ca|
20513519|NCT01861717|JOHN WAYNE CANCER INSTITUTE|Dr. Daniel Kelly|310-582-7450|Daniel.Kelly2@providence.org|
20513520|NCT02450760|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.edu|
20513521|NCT00681824|Baxter Healthcare Corporation|Guenter Zuelow, Associate Medical Director||guenter_zuelow@baxter.com|
20513522|NCT03724916|Takeda|Contact|+1-877-825-3327|medinfoUS@takeda.com|
20513523|NCT00683332|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513524|NCT00176852|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
20513525|NCT02542150|"University of Colorado Denver | Anschutz"|Jody Tanabe, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20513526|NCT00670267|Baylor College of Medicine|N.A. Hanania, M.D.||hanania@bcm.edu|
20513527|NCT03512067|Brigham and Women's Hospital|Dr. Gyorgy Frendl|617-732-5910|gfrendl@bwh.harvard.edu|
20513528|NCT00406107|Palmetto Retina Center|John A. Wells, III, M.D.|803-931-0077|jackwells@palmettoretina.com|
20513529|NCT02773446|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
20513530|NCT04023994|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20513531|NCT01613131|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
20513532|NCT02454972|Pharma Mar S.A.|Clinical Development, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
20513533|NCT00780715|University of Dundee|Professor Ewan Pearson|+44 (0) 1382 383387|e.z.pearson@dundee.ac.uk|
20513534|NCT01020305|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
20513535|NCT00467818|UMDNJ|Sherie Novotny MD|(732) 235-4119|novotnsl@rutgers.edu|
20513536|NCT01402115|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Dal-Sik Kim, MD|82-63-276-8284|dskim@chonbuk.ac.kr|
20513537|NCT03202628|Mayo Clinic|Dr. Prashant Kapoor|507-284-2511|Kapoor.Prashant@mayo.edu|
20560637|NCT02042443|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408||
20513538|NCT01070966|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20513539|NCT00736333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development||ClinicalTrialsDisclosure@merck.com|
20513540|NCT04822467|Cleveland Clinic Foundation|Dr. Donald Kirby, MD|216-444-0446|kirbyd@ccf.org|
20513541|NCT01878500|Johns Hopkins University|Dr. John P Gearhart|410-955-5358|jgearha2@jhmi.edu|
20513542|NCT02117479|Incyte Corporation|Study Director|855 463-3463||
20513543|NCT02261974|Viveve, Inc.|Debbie Wilkerson, PhD, Vice President, Clinical and Medical Affairs|610-209-9980|dwilkerson@viveve.com|
20513544|NCT03216954|University of Kentucky|William W. Stoops, PhD|859-257-5388|william.stoops@uky.edu|
20513545|NCT00323271|VA Connecticut Healthcare System|Robert Kerns, PhD|203-932-5711|robert.kerns@va.gov|3841
20513546|NCT02572427|University of Arkansas for Medical Sciences|Dr Richard Whit Hall|501-680-7894|HallRichardW@uams.edu|
20513547|NCT04736576|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513548|NCT00123110|University of Pennsylvania, School of Medicine|Anne R. Cappola, M.D., ScM|(215) 573-5359|ACappola@mail.med.upenn.edu|
20513549|NCT02135094|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
20513550|NCT00657917|Uniformed Services University of the Heralth Sciences|COL Naomi Aronson MC|301-295-3621|naronson@usuhs.mil|
20513551|NCT02525562|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
20513552|NCT02354976|AstraZeneca|Torbjörn Lundström|46 317064100|Torbjorn.lundstrom@astrazeneca.com|
20513553|NCT00802633|Vanderbilt University|Sam Chang|615-322-2101|sam.chang@Vanderbilt.Edu|
20513554|NCT02164539|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513555|NCT01493531|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
20513556|NCT01946282|University of Texas Southwestern Medical Center, Moncrief Cancer Institute|Dr. Keith Argenbright, Director, Moncrief Cancer Institute|817-288-0070|keith.argenbright@utsouthwestern.edu|
20513557|NCT03031431|Boston Children's Hospital|Dr. Anne Hansen|(617)-355-6027|Anne.Hansen@childrens.harvard.edu|
20513558|NCT01612702|Joint Reconstruction Center, Seoul National University Bundang Hospital|Dr. TK Kim|82-31-787-7196|osktk@snubh.org|7200
20513559|NCT00527397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20513560|NCT03012815|Mayo Clinic|Ruth Bates|507-255-8716|Bates.Ruth@mayo.edu|
20513561|NCT01462695|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20513562|NCT02400905|Veryan Medical|Nick Yeo|+44 1403 258984|nick.yeo@veryanmed.com|
20513563|NCT00879970|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513564|NCT01431755|Q-Med AB|Head of Medical Affairs|+46 (0) 18 474 90 00|reception.SEUPP@galderma.com|
20513565|NCT05552430|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Dr. Ryan Mace|617-724-7030|rmace@mgh.harvard.edu|
20513566|NCT00061945|University of Chicago Medical Center|Wendy Stock, M.D.||wstock@medicin.bsd.uchicago.edu|
20513567|NCT01039584|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20513568|NCT02740660|Pennington Biomedical Research Center|Dr. Daniel Hsia|225-763-3000|clinicaltrials@pbrc.edu|
20513569|NCT03672396|University of North Carolina at Chapel Hill|Erik Hanson, PhD|19199620816|edhanson@email.unc.edu|
20513570|NCT01890694|NYU Langone Medical Center|Office of Clinical Trials|646-754-7431|clinicaltrials@nyumc.org|
20513571|NCT00558519|University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
20513572|NCT03001011|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20513573|NCT04355767|Stanford University|Kevin Schulman, MD|(650) 724-0543|kevin.schulman@stanford.edu|
20513574|NCT01999322|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20513575|NCT02033382|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
20513576|NCT03338673|University of Michigan|Dr. Cynthia Burton|7347639259|czburton@umich.edu|
20513577|NCT01005407|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
20513578|NCT00301873|Duke Comprehensive Cancer Center|Mary Lou Affronti, RN, MSN, ANP, MHSc Senior Investigator|919-684-6239|mary.affronti@duke.edu|
20513579|NCT02936479|NYU Langone Health- Transplant Institute|Cecilia Deterville, MS, CCRC|212.263.3620|Cecilia.Deterville@nyulangone.org|
20513580|NCT03574818|Montefiore Medical Center|Balazs Halmos|7184058404|bahalmos@montefiore.org|
20513581|NCT00393978|University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience|Melissa P. DelBello, MD|513-558-2989|Melissa.DelBello@uc.edu|
20513582|NCT04583592|Sagent Pharmaceuticals, Inc.|Cynthia Tinkoff, Pharm.D. Manager, Medical Affairs|847-908-6913|ctinkoff@sagentpharma.com|
20513583|NCT04523831|Dhaka Medical College|Dr. Reaz Mahmud, Principal investigator|01912270803|reazdmc22@yahoo.com|+88
20513584|NCT04556838|VivaVision Biotech, Inc.|Joanne Li, M.D.|86-02158598290|joanne.li@vivavisionbio.com|
20513585|NCT00995930|Novartis Pharmaceuticals|Study Director|862-778-8300||
20513586|NCT02517099|Imperial College London|Professor Sejal Saglani|02075943167|s.saglani@imperial.ac.uk|
20513587|NCT01031134|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
20513588|NCT05788237|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513589|NCT01998035|Columbia University Irving Medical Center|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
20513590|NCT04071392|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
20513591|NCT01246973|University of Rochester|Julie Ryan|585-276-3862|julie_ryan@urmc.rochester.edu|
20513592|NCT00918229|BioProtect|Shaul Shohat|+972545423774|Shaul@bioprotect.com|
20513593|NCT03053622|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20513594|NCT02598622|Indiana University|Dr. Chie Schin-Shih|317-944-8784|shih2@iu.edu|
20513595|NCT00581386|UTHSC- Houston Medical School|Dr. Carin A. Hagberg|713.500.6222|maddukuri.vineela@uth.tmc.edu|
20513596|NCT01416142|Bausch & Lomb Incorporated|Dr. William Reindel|(585) 338-8129|william.reindel@bausch.com|
20513597|NCT00678379|Charlotte Eye Ear Nose and Throat|Jonathan Moss MD|704-295-3000|jmoss@ceenta.com|
20513598|NCT04335110|Oregon Health & Science University|Dr. Allison Lindauer|15034946976|lindauer@ohsu.edu|
20513599|NCT03254719|Palmer Center for Chiropractic Research|Dr. Anna Walden-Cobb|563-949-0676|anna.waldencobb@palmer.edu|
20513600|NCT04006847|Penn State Health|Seema Naik, MD|7175318678|snaik@pennstatehealth.psu.edu|
20513601|NCT02292433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513602|NCT02177773|Unviersity of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|22648
20513603|NCT03333382|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
20513604|NCT02513459|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20513605|NCT02314520|Penn State Health Milton S. Hershey Medical Center Dept of Neurosurgery|Dr. J. Christopher Zacko|717-531-1279|jzacko@pennstatehealth.psu.edu|
20513606|NCT01430182|Baylor College of Medicine|Neil Bailard|713-798-7356|bailard@bcm.edu|
20560638|NCT02735187|Philips Light & Health|Dr. Joerg Liebmann|+ 49-(0)1733715907|joerg.liebmann@philips.com|
20560639|NCT01007149|Novartis Pharmaceuticals|Study Director|862-778-8300||
20513607|NCT00830063|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513608|NCT00787566|Aviana Consulting, LLC|Vanaja V. Ragavan, M.D.|610-795-7403|vvragavan@comcast.net|
20513609|NCT00661674|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
20513610|NCT01551550|TissueTech|Medical Affairs|(888) 296-8858|info@tissuetech.com|
20513611|NCT00660790|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
20513612|NCT03094806|New York Methodist Hospital|Jeremy A Weingarten, MD|718-780-5835|jaw9031@nyp.org|
20513613|NCT04214951|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
20513614|NCT00686374|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20513615|NCT03903640|Washington University School of Medicine|Dr. George Ansstas|314-508-4426|gansstas@wustl.edu|
20513616|NCT01808209|Opthalmic Research Group, Aston University, Birmingham, UK|Jonathan Walker||JWalker@coopervision.co.uk|
20513617|NCT05795062|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513618|NCT03007537|Nanjing First Hospital, Nanjing Medical University|Dr. Xiaobin Ji|13705174622|xbji007@126.com|
20513619|NCT00459381|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
20513620|NCT02629133|Womene and Infants Hospital|Caron Zlotnick|401-474-3332|czlotnick@butler.org|
20513621|NCT05180630|Sonova USCS|Director of Clinical Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20513622|NCT02011516|University of Pennsylvania|Teresa R. Franklin, Ph.D., Research Associate Professor of Neuroscience in Psychiatry|215-222-3200|teresafr@mail.med.upenn.edu|119
20513623|NCT00709735|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
20513624|NCT00386100|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513625|NCT01632683|Oregon Health & Science University|Michael Aziz, MD|503-494-5581|azizm@ohsu.edu|
20513626|NCT02523274|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
20513627|NCT01032759|Duke University Medical Center|Dr. Ashraf Habib|9196686266|habib001@dm.duke.edu|
20513628|NCT02328807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Julio M. Pow-Sang|813-745-2226|julio.powsang@moffitt.org|
20513629|NCT00117585|Portland VA Medical Center|Dr. David Hickam|(503) 721-7817|david.hickam@va.gov|
20513630|NCT00849524|University of California, San Diego|Januario Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
20513631|NCT00919802|UAB|Timothy Ness|205-975-9643|tness@uabmc.edu|
20513632|NCT02128867|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
20513633|NCT01027884|University Hospital Leuven-Children Hospital|Dr Gunnar Buyse|+32 016343845|gunnar.buyse@uzleuven.be|
20513634|NCT01147016|Barbara Ann Karmanos Cancer Institute|Dr. Amy Weise|248-344-6688|aweise3@hfhs.org|
20513635|NCT03670537|Auerbach Hematology and Oncology|Michael Auerbach|4107804050|mauerbachmd@abhemonc.com|
20513636|NCT02624518|Stanford Medicine at Stanford University|David G Marcellus|650-723-4547|dmarcel2@stanford.edu|
20513637|NCT02729194|University of Michigan Rogel Cancer Center|Dr. Ajjai Alva, M.D.|734-936-0091|ajjai@umich.edu|
20513638|NCT01256398|University of California San Diego Moores Cancer Center|Matthew Wieduwilt, MD, PhD|858-822-6848|mwieduwilt@ucsd.edu|
20513639|NCT04380701|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20513640|NCT01777425|UZ Leuven|Prof. Dr. P. Hellings|+3216332340|peter.hellings@uzleuven.be|
20513641|NCT01021137|James H. Quillen VA Medical Center|Director of Vestibular Laboratory|423-926-1171|faith.akin@va.gov|7376
20513642|NCT02122471|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
20513643|NCT00204932|U Wisconsin-Madison|Dale Schoeller Principal Investigator|608-262-1082|dschoell@nutrisci.wisc.edu|
20513644|NCT03593772|James A. Haley Veteran Hospital Research Service|Dr. Jolie Haun|904-377-6796|Jolie.Haun@va.gov|
20513645|NCT03125915|Hunter College, CUNY|Tyrel Starks, Associate Professor|212-206-7919|tstarks@hunter.cuny.edu|934
20513646|NCT02731833|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513647|NCT04542330|University of Southern Denmark|Professor Christine Stabell Benn|+45 25883964|cbenn@health.sdu.dk|
20513648|NCT02176642|Duke University|Nazema Siddiqui MD||nazema.siddiqui@duke.edu|
20513649|NCT00727298|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
20513650|NCT00295620|ABCSG|Trial Office Director|+43 1 4089230|info@abcsg.at|
20513651|NCT01309828|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20513652|NCT00217971|Columbia University|Frances R. Levin, M.D.|(212) 543-5896|frl2@columbia.edu|
20560640|NCT01913340|University of California San Francisco|Yvonne Wu, MD MPH||wuy@ucsf.edu|
20506027|NCT01425190|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506028|NCT00584220|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
20506029|NCT00195260|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506030|NCT02749721|Rush University Medical Center|Dr. John Zajecka|312-942-5592|John_Zajecka@rush.edu|
20506031|NCT01379534|Novartis|Study Director|862-778-8300||
20506032|NCT02691247|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
20506033|NCT02552355|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
20506034|NCT01519245|University of Saskatchewan|Dr. Kelsey Brose, Primary Investigator|306-655-1483|kelsey.brose@saskcancer.ca|
20506035|NCT01556633|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20506036|NCT03321929|Lumicell|Jorge Ferrer, PhD|617-571-0592|jmferrer@lumicell.com|
20506037|NCT01253460|The University of Texas MD Anderson Cancer Center|William G Wierda, MD/Professor|713-745-0428|wwierda@mdanderson.org|
20506038|NCT01052012|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20506039|NCT00878228|Hospital for Special Surgery|Dr. David Kim|212-606-1206|KimD@hss.edu|
20506040|NCT02582749|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
20506041|NCT01413178|U.T. MD Anderson Cancer Center|Dr. Muzaffar H. Qazilbash / Stem Cell Transplantation and Cellular Therapy|713-745-3219|mqazilba@mdanderson.org|
20506042|NCT00872170|New England Research Institutes|Nancy Gee|617-972-3295|ngee@neriscience.com|
20506043|NCT00804193|Perrigo|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
20506044|NCT04415489|University of North Carolina at Chapel Hill|Sarah Moustafa, MD|919-908-0000|sarah_moustafa@med.unc.edu|
20506045|NCT00237796|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
20506046|NCT01193348|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|clinicaltrials@alxn.com|clinicaltrials@alxn.com|
20506047|NCT00968253|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20506048|NCT01721408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506049|NCT04160468|ContraFect|Medical Director|914-207-2300|clinicalstudies@contrafect.com|
20506050|NCT01187901|University of Utah|N. Jewel Samadder|801-213-4211|jewel.samadder@hsc.utah.edu|
20506051|NCT03987620|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
20506052|NCT02149836|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
20506053|NCT03860844|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20506054|NCT01128972|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506055|NCT04624932|University of British Columbia|Dr. Mariana Brussoni|604-875-3712|mbrussoni@bcchr.ubc.ca|
20506056|NCT01678807|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20506057|NCT02574312|DePuy Ortho Joint US|Kirstin Cosgrove|800-827-7003|kcosgro1@its.jnj.com|
20506058|NCT01027910|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
20506059|NCT05306873|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20506060|NCT06787781|university of messina|Dr Fiammetta Iannuzzo|327 628 4688|fiannuzzo@unime.it|
20506061|NCT04920084|Memorial Sloan Kettering Cancer Center|Dr. Urvi Shah, MD, MS|646-608-3713|shahu@mskcc.org|
20506062|NCT00074412|Statistical Center for HIV/AIDS Research and Prevention|Statistical Research Associate|2066677524|cherron@fhcrc.org|
20506063|NCT03300752|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
20506064|NCT05113953|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20506065|NCT02626819|Manhattan Campus of the VA NY Harbor Healthcare System|Melanie Jay, MD MS|212-686-7500|melanie.jay@va.gov|5097
20506066|NCT02361762|Boston Children's Hospital|Dr. Susan Faja|617-919-4108|susan.faja@childrens.harvard.edu|
20506067|NCT03488472|University of Alabama at Birmingham (UAB)|Drexell Hunter Boggs, MD; Principal Investigator|(205) 934-3411|dboggs@uabmc.edu|
20506068|NCT00028002|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
20506069|NCT02491437|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
20506070|NCT00502307|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
20506071|NCT02094872|Yale University|Manuel Avedissian, M.D.|203-737-3669|manuel.avedissian@yale.edu|
20506072|NCT00539253|Johns Hopkins Hospital|Ihab R. Kamel, M.D. PhD|410-955-4567|ikamel@jhmi.edu|
20506073|NCT04467164|Massachusetts General Hospital, Harvard Medical School|Jill M. Goldstein|617-724-3776|jill_goldstein@hms.harvard.edu|
20506074|NCT02750813|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20506075|NCT01998581|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20506076|NCT00255684|Wake Forest|Gordon L. Phillips|604.875.4111|gophilli@wakehealth.edu|67806
20506077|NCT02273752|Emory University|R. Donald Harvey, PharmD|404-778-1900|donald.harvey@emory.edu|
20506078|NCT00903032|VA ECHCS|P. Michael Ho|720-857-5115|Michael.Ho@va.gov|
20506079|NCT01380106|Boston VA Research Institute, Inc.|Nikhil C. Munshi, M.D.|6176325607|nikhil.munshi@dfci.harvard.edu|
20506080|NCT01763905|Amgen Inc.|Study Director|866-572-6436||
20506081|NCT04346628|Stanford University|Yvonne A. Maldonado, MD|(650) 723-5682|bonniem@stanford.edu|
20506082|NCT02251704|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20506083|NCT00681538|GW Pharma Ltd|Richard Potts, Clinical Operations Director|+44 1353 616600|rp@gwpham.com|
20506084|NCT04889144|Fred Hutchinson Cancer Center|Megan Shen, Associate Professor|206-667-4172|mshen2@fredhutch.org|
20506085|NCT03430245|Candela Corporation|Director of Clinical Marketing|+1 949.246.7983|doranr@candelamedical.com|
20513653|NCT02556632|University of Rochester|Julie Ryan Wolf, PhD, MPH; Associate Professor of Dermatology and Radiation Oncology|585-276-3862|julie_ryan@urmc.rochester.edu|
20513654|NCT00808015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513655|NCT01397656|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
20513656|NCT06610279|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20513657|NCT00084617|National Cancer Institute|Joanna Brell MD|240-276-7050|brelljm@mail.nih.gov|
20513658|NCT01625286|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20513659|NCT00928135|University of Iowa|Lakshmi Durairaj|3193537968|lakshmi-durairaj@uiowa.edu|
20513660|NCT01222871|SEMC|Dr. Peter catalano|1-617-789-5004|peter.catalano@steward.org|
20513661|NCT00304954|NEI|Dr. Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
20513662|NCT01440647|Women & Infants Hospital of Rhode Island|Abbot R. Laptook, MD, Professor of Pediatrics The Warren Alpert Medical School of Brown University M|401-274-1122|ALaptook@WIHRI.org|7404
20513663|NCT04036227|Gesynta Pharma AB|Charlotte Edenius|+46733864246|ctg@gesynta.se|
20513664|NCT01735877|Christian Medical College & Hospital|Dr Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
20513665|NCT03182920|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20513666|NCT01326702|Memorial Sloan Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
20513667|NCT02082912|Emory University|Dr. Andrew John Butler|404-413-1415|ajbutle@emory.edu|
20513668|NCT02580188|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
20513669|NCT02412956|The George Washington University|Dr. Lorien Abroms||lorien@gwu.edu|
20513670|NCT01835132|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
20513671|NCT03154333|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
20513672|NCT00361257|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20513673|NCT05319977|RTI International|Yukiko Washio|9194852794|ywashio@rti.org|
20513674|NCT00782275|Beth Israel Deaconess Medical Center|David F. McDermott MD PhD|617-632-9262|dmcdermo@bidmc.harvard.edu|
20513675|NCT00331773|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20513676|NCT00747747|Galsor s.r.l.|Dr. Sandro Soriano/Director of Clinical Trials|0039 0827 601723|sandro.soriano@galsor.it|
20513677|NCT00272337|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
20513678|NCT02184494|Florida State University|Michael J. Ormsbee|6103313126|mormsbee@fsu.edu|
20513679|NCT01872689|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20513680|NCT02143947|Quinnipiac University|Juan C Garbalosa, PT, PhD, Director Motion Analysis Laboratory|203 582 8552|juan.garbalosa@quinnipiac.edu|
20513681|NCT04980521|University of North Dakota|Dr. Gary Schwartz|701-777-6598|gary.schwartz@und.edu|
20513682|NCT01244815|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20513683|NCT01173159|Cincinnati Children's Hospital Medical Center|Crystal Slaughter, BA, CCRC|513-636-0137|crystal.slaughter@cchmc.org|
20513684|NCT00697112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513685|NCT02786498|University of Maryland Baltimore, School of Medicine, Department of Orthopaedics|Dr Gerard Slobogean|410-28-6280|gslobogean@som.umaryland.edu|
20513686|NCT01427920|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20513687|NCT04228302|EicOsis|Dr. William Schmidt|650-438-3018|wkschmidt@eicosis.com|
20513688|NCT00054275|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Paula Silverman, MD|216-844-3951|paula.silverman@uhhospitals.org|
20513689|NCT03402126|Medtronic Inc|Joy Aso, Clinical Research Specialist|4015454454|joy.a.aso@medtronic.com|
20513690|NCT02444182|Kuwait University - Faculty of Dentistry|Dr. Abrar Alanzi|24636812|aalanzi@hsc.edu.kw|
20513691|NCT01412710|Florida International University|Fatma G. Huffman|305-348-3877|huffmanf@fiu.edu|
20513692|NCT01959230|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
20513693|NCT01453374|Alkermes|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
20513694|NCT01223196|UT Health Science Center San Antonio|Franco Folli, MD PhD/Professor|210-567-4826|FOLLI@uthscsa.edu|
20513695|NCT01238822|Cincinnati Children's Hospital Medical Center|Jeff Epstein||jeff.epstein@cchmc.org|
20513696|NCT02487979|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20513697|NCT00447694|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20513698|NCT01965535|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20513699|NCT01169987|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20513700|NCT00829439|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
20513701|NCT01602198|Cleveland Clinic|Stephen Rao|216-444-1025|raos2@ccf.org|
20513702|NCT01825876|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20513703|NCT03636542|University of Minnesota|Jason Habeck|612-625-7675|habe0073@umn.edu|
20513704|NCT05149287|University of Kentucky|Austin Stone|(859) 323-5533|austin.stone@uky.edu|
20513705|NCT02059187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20513706|NCT03751020|Yale University School of Public Health (Social and Behavioral Sciences)|Dr. John Pachankis|(203) 785-3710|john.pachankis@yale.edu|
20513707|NCT01889862|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
20513708|NCT00528879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20513709|NCT00078819|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20513710|NCT04133519|metaMe Health|Dr. David Recker, Chief Medical Officer|1-888-463-8262|info@metamehealth.com|
20513711|NCT02217345|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@mgh.harvard.edu|
20560641|NCT02784704|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
20560642|NCT05010304|University of Texas Southwestern|Dr Timothy Chow|2144569093|timothy.chow@utsouthwestern.edu|
20560643|NCT01516892|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20560644|NCT05355116|University of Winchester|Dr James Belsey|(+44) 07799040556|KneeResearch@pm.me|
20560645|NCT00868231|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20560646|NCT01260662|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
20560647|NCT03049111|University of North Carolina at Chapel Hill|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
20560648|NCT00672256|Duke University Medical Center|Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
20560649|NCT01801930|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20506086|NCT05628181|University of Michigan|Donovan Maust|734-845-3649|maustd@med.umich.edu|
20506087|NCT00610727|Alexza Pharmaceuticals, Inc.|Dave Hasegawa, VP, Device Development|650.947.7031|dhasegawa@alexza.com|
20513712|NCT00971204|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
20513713|NCT04130919|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20513714|NCT00845026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20513715|NCT01203774|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20513716|NCT02565485|University Hospitals Cleveland Medical Center|Justin R. Lappen MD|216-844-3787|Justin.Lappen@UHhospitals.org|
20513717|NCT01749033|Northwerstern University|Ling Hu M.D.|312-695-3428|l-hu2@northwestern.edu|
20513718|NCT04974645|Stanford Prevention Research Center, Department of Medicine, Stanford|Judith J. Prochaska, PhD, MPH|650-724-3608|jpro@stanford.edu|
20513719|NCT01364298|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20513720|NCT01166997|EKOS Corporation|Lynn Allen|4254153100|Lynn.Allen@ekoscorp.com|
20513721|NCT03550794|Montefiore Medical Center|Dr. Ari Moskowitz|7189202956|amoskowitz@montefiore.org|
20513722|NCT01864525|Syracuse University|Dr. Soren Lowell|315-443-9648|slowell@syr.edu|
20513723|NCT01890785|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20513724|NCT03296553|Instituto Nacional de Cancerología|Dr. Patricia Volkow|01 55 5628 0400|pvolkowf@gmail.com|12120
20513725|NCT00065065|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
20513726|NCT04363736|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20513727|NCT01050673|Northwestern Medical Faculty Foundation|Dr Robert D Galiano, Assistant Professor of Surgery|312-695-6022|rgaliano@nmh.org|
20513728|NCT01458119|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20513729|NCT03033069|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20513730|NCT01189071|University of Missouri-Columbia|Dr. Mark Wakefield|573-882-0496|wakefieldmr@health.nissouri.edu|
20513731|NCT00789828|Novartis Pharmaceuticals|Study Director|862-778-8300||
20513732|NCT02623426|Johns Hopkins Bloomberg School of Public Health|Douglas A Jabs, MD, MBA|410 -955-1254|djabs1@jhmi.edu|
20513733|NCT02094937|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513734|NCT00555399|University of Texas M D Anderson Cancer Center|Dr. Vinay K. Puduvalli|(713) 745-2343|vpuduval@mdanderson.org|
20513735|NCT05458895|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20513736|NCT04639310|Xenon Pharmaceuticals Inc|Dr. Noam Butterfield|604 484 3300|nbutterfield@xenon-pharma.com|
20513737|NCT02322242|Sunnybrook Health Sciences Centre|Dr. Stephen Choi|4164804864|stephen.choi@sunnybrook.ca|
20513738|NCT01835470|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20513739|NCT01011907|UCSF: EGCRC|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
20513740|NCT00524576|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513741|NCT00207714|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
20513742|NCT03627195|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20513743|NCT00328042|VA San Diego|Dr. Erik Groessl|858-552-8585|erik.groessl@va.gov|
20513744|NCT02290028|BIOTRONIK, Inc.|Senior Manager, Scientific Affairs|1-800-547-0394|crystal.miller@biotronik.com|
20513745|NCT03862625|Istanbul University|Dr. Merve Damla Korkmaz|+905556297264|mervedml@gmail.com|
20513746|NCT03615079|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.Edu|
20506088|NCT04742907|Tsumura USA, Inc.|Yu Tanaka, Ph.D., MBA|609-799-2083|Tanaka_yuu@mail.tsumura.co.jp|
20506089|NCT01428063|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20506090|NCT03508622|Children's Hospital Los Angeles|Brenda Manzanarez|323/361-8245|bmanzanarez@chla.usc.edu|
20506091|NCT01005719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20506092|NCT02499146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506093|NCT03161678|University of Maryland, School of Medicine|Joshua P. Lewis, PhD|410-706-5087|jlewis2@som.umaryland.edu|
20506094|NCT03347617|Oregon Health and Science University|Amy Huddleston|5034942910|huddlesa@ohsu.edu|
20506095|NCT05309369|Medical University of South Carolina|Professor|843 367 4260|mintzerj@musc.edu|
20506096|NCT03007953|Department of Veterans Affairs|Dr. Lynn F. Reinke|206-277-4186|Lynn.Reinke1@va.gov|
20506097|NCT00923910|National Cancer Institute|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
20513747|NCT02614703|Dostor's Hospital at Renaissance|Dr Ingrid M Chacon|(956) 362-3636|I.chacon@dhr-rgv.com|
20506098|NCT00829166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20513748|NCT02402933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20560650|NCT03106025|Loma Linda University Medical Center|Dr. Stephanie Tseeng|9095584000|ttseeng@llu.edu|
20560651|NCT01335789|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5216|mcraeal@musc.edu|
20560652|NCT03783533|University of Washington|Dr. Jessica Jenness|206-616-7967|jennessj@uw.edu|
20560653|NCT01268891|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20513749|NCT01110499|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20513750|NCT00856778|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
20513751|NCT01681771|Linköping University, Department of social and welfare studies. Linköping University|Prof. RN Peter Johansson|+4613313685|peter.b.johansson@liu.se|
20513752|NCT00265083|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
20513753|NCT03208933|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20513754|NCT01265966|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
20513755|NCT02096029|Medical University of South Carolina|Amy Boatright, Program Coordinator|843-876-2440|boatrigh@musc.edu|
20513756|NCT04242186|Hebrew SeniorLife|Sarah Berry, MD, MPH|617-971-5355|sarahberry@hsl.harvard.edu|
20513757|NCT00550420|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513758|NCT04378010|Enanta Pharmaceuticals, Inc|Alaa Ahmad|1-617-607-0800|aahmad@enanta.com|
20513759|NCT01792284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20513760|NCT02019979|Icahn School of Medicine at Mount Sinai|Dr. Anish Parikh|(212) 241-4705|anish.parikh@mountsinai.org|
20513761|NCT00353938|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
20513762|NCT02732587|Yale University Dept of Psychiatry|Dr Suchitra Krishnan-Sarin|203-974-7595|suchitra.krishnan-sarin@yale.edu|
20513763|NCT00379587|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH|617-632-5946|corey_cutler@dfci.harvard.edu|
20513764|NCT03237611|Albert Einstein College of Medicine|Dr. Richard Gralla|718-918-6235|richard.gralla@nbhn.net|
20513765|NCT01928446|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
20513766|NCT00628394|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
20513767|NCT06156969|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|PBONATO@mgh.harvard.edu|
20513768|NCT00923195|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20513769|NCT00525031|UT MD Anderson Cancer Center|Wen-Jen Hwu, MD/Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20513770|NCT02873481|Virginia Commonwealth University School of Nursing|Dr. Patricia Kinser, Assistant Professor|804-828-9140|kinserpa@vcu.edu|
20513771|NCT02370784|University of Pittsburgh School of Medicine|Robyn T. Domsic, MD MPH|412-383-8000|rtd4@pitt.edu|
20513772|NCT02140164|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
20513773|NCT00478361|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Nizar M Tannir, MDChair Ad Interim, Genitourinary Medical Oncology|713-563-7265|ntannir@mdanderson.org|
20513774|NCT01814761|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20513775|NCT02962882|Molnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
20513776|NCT01725984|Ludwig Maximilian Universität|Dr. Ricarda Bauer|+49 89 7095|Ricarda.Bauer@med.uni-muenchen.de|
20513777|NCT00325403|United Therapeutics Corporation|Kevin Laliberte; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
20513778|NCT03763331|Purdue University|Dr. Bruno Roseguini|7654906284|brosegui@purdue.edu|
20513779|NCT01155063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513780|NCT04741503|Washington University School of Medicine|Ashley J. Housten, OTD, MSCI|314-454-7958|ahousten@wustl.edu|
20513781|NCT01663714|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513782|NCT00597584|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20513783|NCT02797964|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20513784|NCT01456052|Lexicon Pharmaceuticals, Inc.|Manager of Regulatory Affairs|281-863-3260|plogan@lexpharma.com|
20513785|NCT02424565|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513786|NCT01677910|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
20513787|NCT03650400|Novartis Pharmaceuticals|Study Director|882 778 8300|Novartis.email@Novartis.com|
20513788|NCT01703741|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20513789|NCT00374543|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
20513790|NCT03066440|UBMD Pediatrics|Dr. Amanda B. Hassinger, Medical Director of the UBMD Pediatrics Sleep Center|716-323-0158|albrooks@buffalo.edu|
20513791|NCT03723590|Medline Industries|Julie Miller|630-418-6891|jamiller@medline.com|
20513792|NCT04991311|Zealand Pharma A/S|Head of clinical operations|+45 8877 3600|info@zealandpharma.com|
20513793|NCT01990898|Cleveland Clinic|Dr. Daniel Shoskes||dshoskes@gmail.com|
20513794|NCT00755937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20513795|NCT01106352|Bayer|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
20513796|NCT03876873|University of Missouri-Columbia|Boris Mraovic|5738822568|mraovicb@health.missouri.edu|
20513797|NCT03547531|Prince of Songkla University|istiyanti Hapsari|+66980493996|istiyantihapsari@gmail.com|
20513798|NCT03944707|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20513799|NCT02649608|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
20513800|NCT00183469|University of Texas Health Science Center San Antonio|Charles L. Bowden, M.D. Clinical Professor|210 567 5405|bowdenc@uthscsa.edu|
20560654|NCT00991276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506099|NCT01635933|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
20513801|NCT02348619|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20513802|NCT02577042|Fundació Lluita contra la SIDA|Director of Clinical Trials|+34 93 497 84 14|enegredo@flsida.org|
20513803|NCT00751998|Boston Scientific Corporation|Joyce Peetermans, PhD, Director Endoscopy Clinical|508-683-4211|peetermj@bsci.com|
20513804|NCT04126733|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20513805|NCT02598193|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20513806|NCT02555618|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20513807|NCT02964897|Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System|Keith McInnes, Principal Investigator|617-504-1630|donald.mcinnes@va.gov|
20513808|NCT02238977|University of Arkansas for Medical Sciences|Pedro Delgado, M.D.|501-526-8100|pldelgado@uams.edu|
20513809|NCT01428024|Q-Med AB|Head of Medical Affairs|+ 46 (0) 18 4749000|reception.SEUPP@galderma.com|
20513810|NCT01280981|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20513811|NCT00524394|University of Texas Health Science Center|James Murphy, PhD|713-500-5714|james.r.murphy@uth.tmc.edu|
20513812|NCT01254045|Stanford University School of Medicine|Scott S. Hall, PhD|650-498-4799|hallss@stanford.edu|
20513813|NCT00520351|Centre for Contact Lens Research|Craig A Woods, Research Manager|519-888-4567|cawoods@sciborg.uwaterloo.ca|36547
20513814|NCT06079853|Columbia University School of Nursing|Allison A. Norful|2123057157|aan2139@cumc.columbia.edu|
20513815|NCT03797222|Children's Hospital of Philadelphia|Lauren Mitteer|215-590-3174|mitteerl@chop.edu|
20513816|NCT03567239|Madonna Rehabilitation Hospital|Chase Pfeifer, Ph.D.|402-413-4504|cpfeifer@madonna.org|
20513817|NCT00614458|UNC Chapel Hill|Professor of Medicine, Director Translational Research IGHID|919 966 6388|dmargo@med.unc.edu|
20506100|NCT04525222|Fred Hutchinson Cancer Center|Jaimee Heffner, Ph.D., Associate Professor|206.667.7314|jheffner@fredhutch.org|
20506101|NCT01544595|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20506102|NCT04072237|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
20506103|NCT04985773|Infraredx, A Nipro Company|Priti Shah|781-345-9646|pshah@infraredx.com|646
20506104|NCT02379923|Asahi Intecc USA, Inc.|Robert Ricker|408.429.3749|robertr@asahi-intecc.com|
20506105|NCT03382899|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|www.ClinicalTrials.gov@lilly.com|
20506106|NCT03638947|UIOWA|Randy W. Loftus|6033066475|randy-loftus@uiowa.edu|
20506107|NCT01402284|National Cancer Institute|Dr. Dickran Kazandijian|301-480-8870|kazandijiandg@mail.nih.gov|
20506108|NCT02928406|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20506109|NCT03302416|Univesity of Pittsburgh|Rajesh Narendran|412-647-5176|narendranr@upmc.edu|
20506110|NCT01745393|Temple University|Bradley Collins|215-204-2849|collinsb@temple.edu|
20506111|NCT01613014|NIAAA|Megan Ryan, Clinical Program Director|3014434225|mryan1@mail.nih.gov|
20506112|NCT05319535|Durham VA Medical Center|Courtney H Van Houtven, PhD|919-286-6936|courtney.vanhoutven@va.gov|
20506113|NCT01064648|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
20506114|NCT05513391|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20506115|NCT02429427|Imperial College London|Prof Charles Coombes|+44 20 7594 2135|c.coombes@imperial.ac.uk|
20506116|NCT00719732|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20506117|NCT04038255|University of Miami|Dr. Taghrid Asfar|+1 (901)-371-7229|tasfar@miami.edu|
20506118|NCT05183867|Center for Healthy Minds|Simon Goldberg|(608) 265-8986|sbgoldberg@wisc.edu|
20506119|NCT04491877|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20506120|NCT03538652|National Institute on Drug Abuse (NIDA)|Dr. David Epstein|667-312-5092|david.epstein@nih.gov|
20506121|NCT06018350|Duke University|Kai Sun, M.D.|919-681-7417|kai.sun@duke.edu|
20506122|NCT01915108|assistant professor|Dr. Sangjin Park|82-53-620-3366|apsj0718@naver.com|
20506123|NCT00458406|CTRC, Children's Hospital of Philadelphia|Paul R. Gallagher, MA|215-590-2739|gallagherp@email.chop.edu|
20506124|NCT01597557|University at Buffalo|Dr. Anne Curtis|716-859-4828|abcurtis@buffalo.edu|
20506125|NCT03161938|Rigshospitalet|Kristin steinthorsdottir|31666112|kjs@dadlnet.dk|
20506126|NCT04149899|Bausch & Lomb Incorporated|Clinical Development|949-416-1194|kevin.kerr@bausch.com|
20506127|NCT02078882|University of California Davis|Christopher L Bowlus|9167348696|clbowlus@ucdavis.edu|
20506128|NCT03165721|National Cancer Institute|Dr. John Glod|240-760-6194|john.glod@nih.gov|
20506129|NCT01863849|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
20506130|NCT01457118|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
20506131|NCT02324842|University of Texas Health San Antonio|Eugenio Cersosimo, MD|210-358-7220|cersosimo@uthscsa.edu|
20506132|NCT03540134|University of Virginia|Dr. Jeff Elias|(434) 924-0451|FUSbrain@virginia.edu|
20506133|NCT04341675|University of Cincinnati|Nishant Gupta, MD|513-558-4861|Nishant.Gupta@uc.edu|
20506134|NCT02750800|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20506135|NCT03226223|New York State Psychiatric Institute|Dr. Jermaine Jones|6467746113|jermaine.jones@nyspi.columbia.edu|
20506136|NCT03456713|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20513818|NCT02769000|Virginia Commonwealth University|Timothy Harris, MD|804-828-7232|timothy.harris@vcuhealth.org|
20528775|NCT01237327|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506137|NCT03848221|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
20506138|NCT01263691|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
20506139|NCT02012608|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
20560655|NCT03615001|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
20560656|NCT05457842|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
20560657|NCT03441984|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20560658|NCT02280655|Emory University|Dr. John D. Roback|404-712-1774|jroback@emory.edu|
20560659|NCT04088188|MD Anderson|Shubham Pant|832-803-5306|spant@mdanderson.org|
20560660|NCT03124108|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
20560661|NCT02266810|Intersect ENT|James Stambaugh (VP, Clinical Affairs)|650-641-2103|jstambaugh@intersectent.com|
20513819|NCT04288115|Central Arkansas Veterans Healthcare System|Spyridoula Maraka, MD, MS|(501) 257-5848|Spyridoula.Maraka@va.gov|
20513820|NCT00729365|Northwestern University Feinberg School of Medicine|Mark E. Molitch|312 503-4130|molitch@northwestern.edu|
20513821|NCT02720224|Estetra SPRL|Marie Mawet||mmawet@mithra.com|
20513822|NCT00751972|HeartWare Inc|Director Clinical Project Management|508 739-0867|sbell@heartwareinc.com|
20513823|NCT02766400|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
20513824|NCT01133392|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20513825|NCT03185949|Endobar Solutions LLC|Director, Clinical Affairs|8456800424|nodar@endobarsolutions.com|
20513826|NCT02926053|National Center of Cancer Immune Therapy, Department of Oncology|Troels Holz Borch, MD, PhD, principal investigator|004524460492|troels.holz.borch@regionh.dk|
20513827|NCT00500656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20513828|NCT03751124|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
20513829|NCT04777591|University of Virginia|John T Stranix, MD|434-924-5078|jts3v@uvahealth.org|
20513830|NCT01407575|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
20513831|NCT00894465|Washington University School of Medicine|Dr. Paul Austin|(314) 454-6034|austinp@wustl.edu|
20513832|NCT01406873|University of Rochester|Charles Thornton, MD|585-275-2542|Charles_Thornton@urmc.rochester.edu|
20513833|NCT00854620|Stanford University, Stanford Cancer Center|Sandy Srinivas, MD|650-725-2078|sandysri@stanford.edu|
20513834|NCT01577966|UAB|Burt Nabors, MD|205-934-2424|bnabors@uabmc.edu|
20513835|NCT02609737|Memorial Sloan Kettering Cancer Center|Dr. Lisa Bodie, MD, PhD|212-639-6650|bodeil@mskcc.org|
20560662|NCT00578617|Mayo Clinic|Kristi Monahan|507-255-6676|CABANA@mayo.edu|
20513836|NCT04636398|University of California San Francisco|Alison El Ayadi|415-659-8367|alison.elayadi@ucsf.edu|
20513837|NCT01169649|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes|646-888-4185|reidyd@mskcc.org|
20513838|NCT00534092|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20528776|NCT00524173|NIDDK|Marc Ghany, MD|301-402-5115|marcg@intra.niddk.nih.gov|
20506140|NCT01202227|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506141|NCT00643487|Upstate Medical University|Thomas V. Smallman|315-464-8618|smallmat@me.com|
20506142|NCT01894477|Fred Hutchinson Cancer Research Center|Eileen J Sickle|206-271-7066|esickle@fredhutch.org|
20506143|NCT01706549|Tampere University Hospital|MD Satu Pokkinen|+3583311611|Satu.pokkinen@pshp.fi|
20506144|NCT02424955|Stanford University|Lucas Kas Vitzthum|(650) 498-6000|ccto-website@stanford.edu|
20506145|NCT02534805|Virginia Commonwealth University|Dr. Jasmohan Bajaj|(804) 828-4060|jasmohan.bajaj@vcuhealth.org|
20506146|NCT00850759|UAB|David Schwebel|205-934-8745|schwebel@uab.edu|
20506147|NCT03196505|University of California-San Francisco Fresno|Dr. Pearl Ma|5592614500|pma@fresno.ucsf.edu|
20506148|NCT01753076|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506149|NCT02575079|Emory University|Elizabeth Stenger|404-785-1272|elizabeth.o'brien.stenger@emory.edu|
20506150|NCT02389816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20506151|NCT00300469|Abbott|Medical Information Specialist|800-633-9110||
20506152|NCT01259856|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|212-241-2296|ronald.hoffman@mssm.edu|
20506153|NCT00788775|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
20506154|NCT00578864|BAYLOR|Peter Zage, MD|832-824-4615|pezage@txch.org|
20506155|NCT03796091|Green Counseling Services PLLC|Dr. Melinda Green|5154508913|drgreen@greencounselingservice.com|
20506156|NCT01217190|Par Pharmaceutical|Medical Affairs|1-800-828-9393|DrugInfo@strativapharma.com|
20506157|NCT01594476|Oregon Health & Science University|Dr. Maureen Baldwin, MD MPH|(503) 494-9762|schaum@ohsu.edu|
20506158|NCT01087528|Givenimaging|Hilla Debby/Director of clinical affairs|972490977740|hila.debby@givenimaging.com|77740
20506159|NCT00436969|DePuy Mitek|Aileen Michael|508.828.3337|amichae2@its.jnj.com|
20506160|NCT03116399|Weill Medical College of Cornell University|Sara J. Czaja, PhD|646-962-7141|sjc7004@med.cornell.edu|
20506161|NCT01226420|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
20506162|NCT00418262|University of Oklahoma Health Sciences Center|Mark Wolraich, M.D.|(405) 271-5700|mark-wolraich@ouhsc.edu|45123
20506163|NCT00601523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20506164|NCT04072146|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20506165|NCT01617434|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20506166|NCT01987986|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
20506167|NCT00540436|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513839|NCT02919475|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
20513840|NCT02323295|Massachusetts General Hospital|Dr. Joseph Schwab|617-643-0547|JHSCHWAB@PARTNERS.ORG|
20506168|NCT00905021|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
20513841|NCT00775983|UCSF|Abby Sokoloff|4155140440|sokoloffa@obgyn.ucsf.edu|
20560663|NCT01219855|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
20528777|NCT04233671|The University of Alabama|Dr. Mercy Mumba|205-348-6317|mnmumba@ua.edu|
20528778|NCT02557516|Innate Pharma|Dr. Agnes BOYER-CHAMMARD, Medical Director|+33430303030|Agnes.BOYER-CHAMMARD@innate-pharma.fr|
20528779|NCT00669318|Mayo Clinic Cancer Center|Timothy G. Call MD||call.timothy@mayo.edu|
20506169|NCT00786838|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Senior Medical Director|1 908 704-5779||
20528780|NCT00983645|Loma Linda University Medical Center Transplantation Institute|Dr. Pedro Baron|909-558-3636|pbaron@llu.edu|36792
20528781|NCT03397121|The Medicines Company|Vice President - Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
20528782|NCT00327340|OncoGenex Pharmaceuticals|Monica S. Krieger, PhD|425-686-1558|mkrieger@oncogenex.com|
20528783|NCT04085601|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20528784|NCT02418234|Hangzhou first people's hospital|Prof. Shenglin Ma|086057156007664|mashenglin@medmail.com.cn|
20528785|NCT00003483|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20528786|NCT01716663|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
20528787|NCT03407417|University of Florida|Dr. Benjamin Lok|352-214-9829|lok@ufl.edu|
20528788|NCT01460732|Hypertension Center, Third University Department of Medicine|George S. Stergiou|0030 210 7763117|gstergi@med.uoa.gr|
20528789|NCT01300247|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20528790|NCT00922116|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20528791|NCT06060496|University of Kentucky|Gopalkumar Rakesh, MD|8592579402|gopalkumar.rakesh@uky.edu|
20528792|NCT02028507|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20506170|NCT04937816|Boehringer Ingelheim, Call Center|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20506171|NCT00390364|Sidney Kimmel Comprehensive Cancer Center at JHMI|Manuel Hidalgo, MD (no longer works at Hopkins)|410-502-5328|tbrown55@jhmi.edu|
20506172|NCT02488759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20506173|NCT05281523|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20506174|NCT05513053|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20506175|NCT00924352|Vector Oncology (formerly Accelerated Community Oncology Research Network, Inc.)|Vice President of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
20506176|NCT00418834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20506177|NCT01953328|Amgen Inc.|Study Director|866-572-6436||
20506178|NCT02775760|Boston University Chobanian & Avedisian School of Medicine|Karin Schon, Ph.D.|(617) 358-2118|kschon@bu.edu|
20506179|NCT01760941|Virginia Commonwealth University/Massey Cancer Center|Drew Moghanaki, MD, MPH|804-765-5850|Drew.moghanaki@vcuhealth.org|
20506180|NCT00492856|SWOG Statistical Center|SWOG Leukemia Committee Statistician|206-667-4408||
20506181|NCT00751530|Community Research Initiative|Project Manager|617 502 1700|pmacht@crine.org|
20506182|NCT02245568|TauRx Therapeutics Ltd|Dr. Diane Downie|+44 1224440905|info@taurx.com|
20506183|NCT02044159|Children's Hospital of Eastern Ontario|Katie O'Hearn, Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
20506184|NCT01111539|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20506185|NCT03628417|Szeged University|Principal Investigator, Assistant Professor|+36-62-545-259|kis.erika.gabriella@med.u-szeged.hu|
20506186|NCT02713230|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-397-2467|MedInfo@pacira.com|
20506187|NCT05619172|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
20506188|NCT00812916|Biosense Webster, EMEA|Nathalie Macours|+32 2 7463076|MNathalie@its.jnj.com|
20506189|NCT00769704|Amgen, Inc.|Study Director|866-572-6436||
20506190|NCT00450372|UM/Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4909|lfeun@med.miami.edu|
20506191|NCT05131451|Johns Hopkins University|Dr. Risa Wolf|4109556463|rwolf@jhu.edu|
20506192|NCT00335504|Mayo Clinic|Dr. Paul Limburg|507-266-9093|limburg.paul@mayo.edu|
20506193|NCT01487668|Department of Veterans Affairs, VA Ann Arbor Healthcare System|Amy M. Kilbourne, PhD, MPH|734-845-3452|amy.kilbourne@va.gov|
20506194|NCT01856595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506195|NCT01835496|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
20506196|NCT04426825|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20506197|NCT03000309|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
20506198|NCT02145299|Yale School of Medicine|Dr. Alexandra Lansky|203-737-2142|alexandra.lansky@yale.edu|
20506199|NCT06150573|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20506200|NCT01071044|Rochester Center for Behavioral Medicine|Joel L. Young, MD|248-608-8800|jyoung@rcbm.net|261
20506201|NCT02284906|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20506202|NCT03909763|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
20506203|NCT00818324|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20506204|NCT01727713|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20506205|NCT01212172|UC Irvine Dermatology Research Center|Christopher B. Zachary|949 824 7103|czachary@uci.edu|
20506206|NCT01253044|VA San Diego Healthcare System and UCSD|Dr. Ariel Lang|858-246-0631|ajlang@ucsd.edu|
20506207|NCT03885726|Vapotherm, Inc.|George C. Dungan, II|(267)347-3305|gdungan@vtherm.com|
20506208|NCT03450369|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
20506209|NCT02868216|Cardiologia (Institute of Cardiology of Rio Grande do Sul/University Foundation of Cardiology|Dra Marcia Moura Schmidt|5551 32333600|mmoura22@terra.com.br|3765
20506210|NCT00987623|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20513842|NCT01059071|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
20513843|NCT00936884|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
20513844|NCT00674219|UCLA Department of Psychiatry|Alexander Bystritsky MD PhD|(310) 206-5133|abystritsky@mednet.ucla.edu|
20513845|NCT02280421|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20513846|NCT02410837|Medtronic|Jennifer Wolvers|763-258-9405|Jennifer.Wolvers@Medtronic.com|
20513847|NCT00837577|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20513848|NCT00033631|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20513849|NCT00711867|Mayo Clinic|Terrence L Trentman MD|480-301-8000|trentman.terrence@mayo.edu|
20513850|NCT01159769|Alcon Research, Ltd.|Director of Medical Affairs|800-862-5266|medinfo@alconlabs.com|
20513851|NCT02372682|Saint Louis University|Anna Hardy, Research Nurse Coordinator|314-268-5785|anna.hardy@health.slu.edu|
20513852|NCT01325532|Massachusetts General Hospital, Dept of Psychiatry|Dr David Mischoulon|617-724-5198|dmischoulon@partners.org|
20513853|NCT00272961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513854|NCT03216200|DeviceFarm|VP Operations|510-295-5293|timgrammer@devicefarmtech.com|
20513855|NCT01507831|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20513856|NCT03196791|Korea university Anam Hospital|Dr. Shin Hoo Park|+82-10-6735-1824|bulsajo333@hanmail.net|
20513857|NCT03411642|University Medical Center Hamburg-Eppendorf|Prof. Dr. Götz Thomalla|+4940501377410|thomalla@uke.de|
20513858|NCT00904189|University of Rochester Medical Center|Steven Swarts|5852755623|christine_huggins@urmc.rochester.edu|
20513859|NCT03056001|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20513860|NCT01721967|Duke University Health System|Andrew Wang, MD|919-681-6197|a.wang@duke.edu|
20513861|NCT02295280|Saint Louis University|Dorothea Mostello, MD, Maternal Fetal Medicine Faculty|314-977-2090|mostello@slu.edu|
20513862|NCT02875067|NYU Langone Health|Catherine Diefenbach, MD|212-731-5670|Catherine.Diefenbach@nyulangone.org|
20513863|NCT01241565|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
20513864|NCT02713243|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20513865|NCT03056352|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
20513866|NCT02971605|Johns Hopkins University School of Medicine|Frederick Barrett, Ph.D., Principal Investigator|4105509777|fbarret2@jhmi.edu|
20528793|NCT02258659|University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
20528794|NCT03990051|Glia, LLC|Wei-wei Chang, PhD; President|(617) 794-8922|chang@gliacell.com|
20528795|NCT00272844|Boston Children's Hospital|Dr. Mira Irons|617-355-2449|mira.irons@childrens.harvard.edu|
20528796|NCT03743025|Emory University|Dr. Francisco J. Pasquel|404-778-1695|fpasque@emory.edu|
20528797|NCT01960465|Jesse Brown VAMC|Dr. Bharati Prasad|312-569-6343|bharati.prasad@va.gov|
20528798|NCT00791700|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528799|NCT03672344|BioStream Technologies, LLC|Michael Farber|856-222-1122|farberm@biostreamtech.com|
20528800|NCT00996034|Yale University|Irina Esterlis, Ph.D.|203-932-5711|irina.esterlis@yale.edu|3109
20528801|NCT01720524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506211|NCT00962000|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20506212|NCT01125176|Weill Cornell Medical College|Richard Furman, MD|646-962-2064|rrfurman@med.cornell.edu|
20506213|NCT00850460|The Rockefeller University Center for Clinical and Translational|Principal Investigator|212 327-8408|trinnamaningatmd@yahoo.com|
20506214|NCT02773914|Göteborg University|Isabelle Andersson Hammar|+4631 786 5719|isabelle.a-h@neuro.gu.se|
20506215|NCT00988559|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
20506216|NCT02224846|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20506217|NCT05372575|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20506218|NCT03196297|Novo Nordisk A/S|Clinical Transparency and Medical Writing (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20506219|NCT02538666|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20506220|NCT03510663|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20506221|NCT03208192|Moscow Clinical Scientific Center|Mikhail Efanov, MD, PhD,|+79161058830|m.efanov@mknc.ru|
20506222|NCT00843622|Fagerström Consulting AB|Dr Karl Fagerström||karl.fagerstrom@swipnet.se|
20506223|NCT02615717|University of Nebraska, Lincoln|Christina Hein, M.A.|7036184722|chein9@gmail.com|
20506224|NCT04942483|Imperial College London|Professor Andrew Bush|020 7352 8121|a.bush@imperial.ac.uk|2255
20506225|NCT01943864|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506226|NCT00320385|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506227|NCT04370028|OOO NPF Materia Medica Holding|Mikhail Putilovskiy, MD, PhD|+74952761575|PutilovskiyMA@materiamedica.ru|302
20506228|NCT02492750|Mayo Clinic|John A Lust MD PhD|507/284-2511|lustj@mayo.edu|
20506229|NCT02965534|University of Applied Sciences Jena|Philipp Hessler|+4916097089677|philipp@hessler.de|
20506230|NCT03230175|TissueTech, Inc.|Nick McCoy, Vice President Clinical Operations|7867340023|nmccoy@tissuetechinc.com|
20506231|NCT02200458|Christie Medical Holdings, Inc.|Clinical Affairs Manager|901-721-0330|christiemedinfo@christiedigital.com|
20506232|NCT00748540|MED-EL Corporation|Allison Racey, AuD|888-633-3524|allison.racey@medel.com|
20506233|NCT04743635|Revelle Aesthetics, Inc.|Rachel Walsh, Senior Manager of Clinical Affairs|6509634498|rwalsh@revelleax.com|
20506234|NCT01954121|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20528802|NCT02493452|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
20506235|NCT01043523|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20513867|NCT00597207|ZOLL Medical Corporation|Sr. Director of Clinical Research|978-421-9655|uherken@zoll.com|
20513868|NCT02522949|Enzymatica AB|Enzymatica AB|+46 46 286 31 00|info@enzymatica.com|
20513869|NCT03439293|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20513870|NCT00493181|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
20513871|NCT00660049|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
20513872|NCT03077828|Northwestern University|Dr. Jane N. Winter, M.D.|3126954538|j-winter@northwestern.edu|
20513873|NCT03536819|Inmode Ltd|Maria Shusterman, Clinical Director|9057070975|maria.shusterman@inmodemd.com|
20513874|NCT00869089|University Hospitals Case Medical Center|Neil J. Korman, MD Principal Investigator|216-844-7164|neil.korman@UHHospitals.org|
20513875|NCT00676026|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
20513876|NCT05037409|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20513877|NCT03499249|Baylor College of Medicine and Texas Children's Hospital|Sanjiv Harpavat|832-824-2099|harpavat@bcm.edu|2144
20513878|NCT04499235|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20513879|NCT01374906|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20513880|NCT02795780|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20513881|NCT02475980|University of New Mexico Health Sciences Center|Nancy Sokkary, MD|email|HSC-FamilyPlanningResearch@salud.unm.edu|
20513882|NCT01880541|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
20513883|NCT00435825|Hoffman-LaRoche|Medical Communications|800-821-8590||
20513884|NCT00430638|Daiichi Sankyo|Global Clinical Leader|1-908-992-6400||
20513885|NCT02367781|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20513886|NCT01529749|Hospital Clínic|FELIPE GARCIA ALCAIDE|34619175783|FGARCIA@clinic.cat|
20513887|NCT00378482|AstraZeneca Clinical Study Information Center|Global Clinical Lead|8772409479|information.center@astrazeneca.com|
20513888|NCT05166421|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|Information.center@astrazeneca.com|
20513889|NCT01246986|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20513890|NCT01335399|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20513891|NCT03990389|The University of Chicago|Dr. David Beiser|773-702-0307|dbeiser@medicine.bsd.uchicago.edu|
20513892|NCT01883999|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
20513893|NCT03770000|Rhizen Pharmaceuticals AG|Dr. Ajit Nair|+41 32 580 0113|an@rhizen.com|
20513894|NCT02595528|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20513895|NCT03202511|Division of Clinical Pharmacology, School of Medicine, Indiana University|Dr. Zeruesenay Desta|317-274-2823|zdesta@iu.edu|
20513896|NCT00686790|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
20513897|NCT00096382|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20513898|NCT00382291|University of Florida|Dr. Regina Bussing|(352) 273-7550|rbussing@ufl.edu|
20513899|NCT01270841|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
20513900|NCT01375010|Columbia University|Elizabeth Shane, MD|212-305-6289|es54@cumc.columbia.edu|
20513901|NCT02266706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20513902|NCT01977352|Icahn School of Medicine at Mount Sinai|Dr. Ali Shariat||alishariatmd@gmail.com|
20513903|NCT00409188|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20513904|NCT02879747|Queen Silvia Children´s Hospital and University of Gothenburg|Dr Jovanna Dahlgren, PI and director of Department of Pediatrics|+46702750233|jovanna.dahlgren@gu.se|
20513905|NCT00275028|Dana-Farber Cancer Institute|Kimberley MacNeill|617-632-2621|kmacneill@partners.org|
20513906|NCT01847313|University College Dublin|Prof Carel le Roux|+353 1 716 6831|carel.leroux@ucd.ie|
20513907|NCT00598559|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20513908|NCT00515073|University of Texas MD Anderson Cancer Center|Anuja Jhingran, MD / Professor, Radiation Oncology Department|713-563-6900|CR_Study_Registration@mdanderson.org|
20513909|NCT02764489|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20513910|NCT00881959|Zimmer Dental|Hai Bo Wen|760 929 4312|haibo.wen@zimmer.com|
20513911|NCT02791659|Gastroenterology endoscopy center|Phonthep Angsuwatcharakon, MD|6622564265|borndeb@yahoo.com|
20513912|NCT03840811|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|(919) 843-6893|mmhobbs@med.unc.edu|
20513913|NCT01904383|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513914|NCT01625845|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
20513915|NCT02853929|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20513916|NCT01294592|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513917|NCT02762565|University of Pennsylvnia|Robyn Broach|215-662-7300|robyn.broach@uphs.upenn.edu|
20513918|NCT01113710|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20513919|NCT03103581|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
20513920|NCT00623623|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20513921|NCT02186808|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
20513922|NCT00693784|Spinal Restoration, Inc.|Jeff F. Doerzbacher|512 225-0405|jeffdoerzbacher@spinalrestoration.com|
20513923|NCT02265952|Regeneron Pharmaceuticals, Inc.|Clinical Trial Information|844-734-6643|clinicaltrials@regeneron.com|
20513924|NCT01072032|Baltimore Veterans Affairs|Dr. Ron Goodman|410-605-7000|ronald.goodman@va.gov|
20560664|NCT01670019|Duke University|John Beyer, M.D.|919-668-0209|john.beyer@dm.duke.edu|
20560665|NCT00883350|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
20560666|NCT05487703|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560667|NCT01129778|Stanford University|W. Ray Kim, MD, Chief of Gastroenterology and Hepatology|650-725-6511|wrkim@stanford.edu|
20560668|NCT04939428|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20560669|NCT05096117|National Institute on Alcohol Abuse and Alcoholism|Dr. Daniel Falk|3014430788|falkde@mail.nih.gov|
20560670|NCT03781804|OptiNose|John Messina, PharmD, SVP of Clinical Research & Medical Affairs|267-521-0565|John.Messina@optinose.com|
20560671|NCT03717194|Seoul National University Bundang Hospital|Soo Lim|+82-31-787-7035|limsoo@snu.ac.kr|
20560672|NCT03184428|Eyestylianides ophthalmology center|Christoforos Stylianides|0035725320244|Info@eyestylianides.com|
20560673|NCT00561574|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560674|NCT00445692|Fred Hutch Cancer Research Center|Leona A. Holmberg, MD, PhD|206-667-6447|lholmber@fredhutch.org|
20560675|NCT03860077|Brown University|Dr. Rachel Cassidy|4018636621|rachel_cassidy@brown.edu|
20560676|NCT02147990|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20560677|NCT00630864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560678|NCT00430677|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20513925|NCT02062606|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
20560679|NCT02639429|The University of Texas Health Science Center at Houston|Mesk Alrais, MD|(713) 566-5735|Mesk.A.Alrais@uth.tmc.edu|
20560680|NCT02040844|Circassia Ltd|VP Clinical Operations|+44 1865 405560|info@circassia.com|
20560681|NCT00946192|Massachusetts General Hospital and Harvard Medical School|Madhu Misra, MD; Chief, Pediatric Endocrine|6177245602|mmisra@mgh.harvard.edu|
20560682|NCT02014558|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20560683|NCT03181724|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
20560684|NCT03032159|Seattle Children's|Tumaini R. Coker, MD, MBA|206-884-0559|Tumaini.Coker@seattlechildrens.org|
20560685|NCT05460663|University of New Mexico, College of Nursing|Stephen H. A. Hernandez, PhD, RN, FAAN|505-272-0756|shhernandez@salud.unm.edu|
20560686|NCT00681811|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20560687|NCT02068885|Boston Children's Hospital|Cara Ebbeling, PhD, Co-Director, New Balance Foundation Obesity Prevention Center|617-919-3457|Cara.Ebbeling@childrens.harvard.edu|
20560688|NCT00828919|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560689|NCT01562743|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-6361-7366||
20560690|NCT05567159|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20560691|NCT03719677|Wayne State University|Heather Fritz|313-664-2627|Heather.fritz@wayne.edu|
20560692|NCT03059992|SCYNEXIS, Inc.|Dr. David Angulo, SCYNEXIS CEO|201-884-5471|david.angulo@scynexis.com|
20560693|NCT04159506|VA Connecticut Healthcare System|Steve Martino, Ph.D.|203-932-5718|Steve.Martino@va.gov|7418
20560694|NCT02449044|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20513926|NCT00326885|Fresenius Biotech|Manager, Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
20513927|NCT01042977|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20513928|NCT02499354|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com|
20513929|NCT04303845|Mayo Clinic|Rashmi B. Halker Singh, M.D.|480-301-8100|Halker.Rashmi@mayo.edu|
20513930|NCT04356573|UAMS|Robert Wolfe|501-526-5708|rrwolfe2@uams.edu|
20513931|NCT01577537|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
20513932|NCT01460927|El.En. Electronic Engineering S.p.A.|Alessandro Bizzarri|+39 055 8826807|a.bizzarri@elen.it|
20513933|NCT01170364|NYPInstitute|Dr. Laurel Mayer|646-774-8067|lsm16@columbia.edu|
20513934|NCT04132232|UAB|Christina Blanchard|205-934-7982|ctblanchard@uabmc.edu|
20513935|NCT01717456|University of North Carolina at Chapel Hill|William E. Whitehead, PhD, Professor of Medicine|(919) 843-6961|William_Whitehead@med.unc.edu|
20513936|NCT00986154|Daiichi Sankyo, Inc.|Lee Schwocho, Sr. Director|732-590-5000|lschwocho@dsi.com|
20513937|NCT03726437|GEORGIA STATE UNIVERSITY|Dr. Laura Salazar|4044131396|lsalazar1@gsu.edu|
20513938|NCT00580333|Massachusetts General Hospital|Dr. Steven Isakoff|617 726 6500|sisakoff@partners.org|
20513939|NCT00267007|Centocor Ortho Biotech Services, LLC (COBS)|Vice President|215 325 4464||
20513940|NCT01917188|Intermountain Heart Institute|Patti Spencer|8015074700|patti.spencer@imail.org|
20513941|NCT02400073|ResMed|Senior Manager, Medical Affairs|+61 8884 1123|alison.wimms@resmed.com|
20513942|NCT01252238|Brigham and Women's Hospital|Dr. Jonathan Williams|617-278-0882|jwilliams5@partners.org|
20513943|NCT00068237|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20513944|NCT01190202|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20513945|NCT03029000|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20513946|NCT00827073|Robert Cizik Eye Clinic|Joseph Selem, MD|713-559-5263|laurabaker@cizikeye.org|
20513947|NCT01364259|Stanford University Cancer Center|Dr. Scott G. Soltys, Assistant Professor|650.724.1569|sgsoltys@stanford.edu|
20513948|NCT00990093|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
20560695|NCT05968079|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20513949|NCT01164137|Westview Physician Collaborative|Allan Bailey, M.D.; Study Principal Investigator|(780)-975-1131|baileymd@telusplanet.net|
20513950|NCT01203319|Jiangsu Provincial Center for Disease Control and Prevention|Fengcai Zhu|#86-25-83759418|jszfc@vip.sina.com|
20528803|NCT00527826|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560696|NCT02501811|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
20560697|NCT00662909|Astellas Pharma Global Development, Inc.|Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
20560698|NCT02738840|Abbott|Robyn A Capobianco|+1 512 934 3941|robyn.capobianco@abbott.com|
20560699|NCT01801449|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Montealegre, Gina|+1 301 761 7747|montealegrega@mail.nih.gov|
20560700|NCT02162446|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20560701|NCT01311648|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20560702|NCT01645111|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
20513951|NCT04147611|University of Miami|Dr. Hillary Snapp|305-243-4611|hsnapp@med.miami.edu|
20560703|NCT03618095|Boston Scientific|Amy Maurer|800-876-9960|amy.maurer@bsci.com|
20513952|NCT05003167|Purdue University|Jessica Huber, Professor and PI|765-494-3796|jhuber@purdue.edu|
20560704|NCT01171924|Curis, Inc.|Associate Director of Regulatory Affairs|(617) 503-6548|lsaunders@curis.com|
20560705|NCT05526911|TB Alliance|Antonio Lombardi|917.601.0024|antonio.lombardi-consultant@tballiance.org|
20513953|NCT01010230|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-278-5833|kiri.ness@stjude.org|
20513954|NCT01585831|University of Colorado Denver|Nicole Tartaglia, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20560706|NCT05025449|Emory University|Laura Oh, MD|404-778-1709|laura.oh@emory.edu|
20560707|NCT00256308|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
20513955|NCT01123980|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20560708|NCT01537133|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
20560709|NCT02165605|UT Southwestern Medical Center|Sarmistha Sen|214-645-1477|Sarmistha.Sen@UTSouthwestern.edu|
20560710|NCT00762463|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560711|NCT00531479|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560712|NCT03766438|Mayo Clnic|Mark Wieland, MD, MPH|507-284-1195|wieland.mark@mayo.edu|
20513956|NCT01225991|University of California, Los Angeles|Dr. Helen Lavretsky,|310-794-4619|hlavretsky@mednet.ucla.edu|
20513957|NCT04444752|Head of Clinical Operations US|Malinda Longphre|+15105203361|Mlongphre@connectpharm.com|
20513958|NCT01963676|UNC Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
20513959|NCT02496221|GlaxoSmithKline|GSK Response Center|866-435-7343||
20513960|NCT01447329|Mike O'Callaghan Military Medical Center, Clinical Investigation Program|Amanda Crawford|(702) 653-3583|amanda.j.crawford.ctr@health.mil|
20513961|NCT01120600|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20513962|NCT02464878|Massachusetts General Hospital|James Markmann|617-643-4533|jmarkmann@mgh.harvard.edu|
20513963|NCT00833547|Massachusetts General Hospital|Dr. Dara Manoach|617-726-6148|dara@nmr.mgh.harvard.edu|
20513964|NCT00142454|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20513965|NCT00566098|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
20513966|NCT02460874|UAB|Dr. Hunter Boggs|205-934-5670|dboggs@uabmc.edu|
20513967|NCT01690520|Deverra Therapeutics|Chief Scientific Officer|206-519-5304|cdelaney@deverratx.com|
20513968|NCT02236754|Columbia University|Dr. Paul Harris|212-305-7363|peh1@cumc.columbia.edu|
20513969|NCT04364165|Desmond Tutu Health Foundation (DTHF)|Philip Smith|+27 21 650 1895|philip.smith@hiv-research.org.za|
20513970|NCT01014390|Hôpital Erasme|Jacques Devière, MD, PhD|(32) 0-2-555-4697.|Jacques.Deviere@erasme.ulb.ac.be|
20513971|NCT04313283|University of Maryland Baltimore|Sarah Dababnah|14107068076|sdababnah@ssw.umaryland.edu|
20513972|NCT00892697|University at Buffalo|Andrew Talal, MD|716-888-4737|ahtalal@buffalo.edu|
20513973|NCT00368537|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20513974|NCT04248855|Kanyos Bio (A wholly owned subsidiary of Anokion SA)|Medical Director|+1 857-320-6607|clinicaltrials@anokion.com|
20513975|NCT05483920|Black Hills State University|Dr. Ashley Pfeiffer|(605) 381-5370|ashley.pfeiffer@bhsu.edu|
20513976|NCT01368276|Amgen, Inc.|Study Director|866-572-6436||
20513977|NCT02041494|University of California, San Francisco|Dr. Hobart W. Harris, Chief of General Surgery|(415) 514-3891|hobart.harris@ucsf.edu|
20513978|NCT03341273|Duke University|Ephraim L. Tsalik, MD, MHS, PhD|919-684-3114|e.t@duke.edu|
20513979|NCT02784925|WanFangH|Ming-Shun Wu|88629307930|mswu@tmu.edu.tw|7923
20513980|NCT00685919|Vanderbilt University Medical Center|Alfredo Gamboa, MD|615-875-1003|alfredo.gamboa@vumc.org|
20513981|NCT01674478|Wake Forest University Health Sciences|Dr. Qing Yang||qyang@wakehealth.edu|
20513982|NCT02281409|Memorial Sloan Kettering Cancer Center|Dr. Jedd Wolchok, MD, PhD|646-888-2315|wolchokj@mskcc.org|
20513983|NCT05784571|Pennington Biomedical Research Center, Baton Rouge, LA|Candida Rebello|2257633159|Candida.Rebello@pbrc.edu|
20560713|NCT02466516|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20513984|NCT02732561|Wake Forest Health Sciences|James Kimball, MD|1 (336) 716-9702|jkimball@wakehealth.edu|
20513985|NCT01886300|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20513986|NCT01156571|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
20513987|NCT01797120|PrECOG, LLC|Carolyn Andrews|267-207-4070|candrews@precogllc.org|
20513988|NCT00295854|Medicinova Inc|Richard E. Gammans PhD Chief Developing Officer|848-373-1500|gammans@medicinova.com|
20560714|NCT04358549|FUJIFILM Pharmaceuticals U.S.A., Inc.|Clinical Research Manager|No phone at site|fphucontact@fujifilm.com|
20513989|NCT00672620|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20513990|NCT02736227|Northwestern University|Josh Levitsky|312-695-4413|j-levitsky@northwestern.edu|
20513991|NCT03947788|NorthShore University HealthSystem|Emily White VanGompel|224-364-7300|ewhitevangompel@northshore.org|
20513992|NCT02199652|Medical College of Georgia; Augusta University|William Vaughn McCall|7067216719|WMCCALL@augusta.edu|
20513993|NCT02951884|Loyola University Medical Center|William Lack, M.D.|708-216-1175|wlack@luc.edu|
20513994|NCT02114931|Amgen Inc.|Study Director|866-572-6436||
20513995|NCT03870997|Evidation Health|Executive Director, Digital Health Outcomes|650-389-9550|results@evidation.com|
20513996|NCT03818919|Henry Ford Health System|Dr. Toufic Jildeh|(517)2308511|touficjildeh@gmail.com|
20560715|NCT03712930|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20513997|NCT01205529|Vanderbilt University Medical Center|Dan Roden|6153220067|dan.roden@Vanderbilt.Edu|
20513998|NCT00667719|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20513999|NCT03840135|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|+7(495) 730-75-45|DodonovNS@petrovax.ru|125
20514000|NCT01827371|Group Health Research Institute|Lisa Jackson, M.D., M.P.H.|206-442-5216|Jackson.L@ghc.org|
20514001|NCT02662608|The University of Texas (UT) MD Anderson Cancer Center|Dr. Renata Ferrarotto, Asst Professor/Thoracic/Head & Neck Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20514002|NCT00950599|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20514003|NCT03803085|Brandeis University|Yujun Liu|781-736-3300|lyujun@brandeis.edu|
20514004|NCT01361607|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
20514005|NCT00373685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514006|NCT02570165|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514007|NCT01455545|SESCAM - HOSPITAL UNIVERSITARIO DE GUADALAJARA|Dr. Carlos Almonacid|+34 655 53 44 75|caralmsan@gmail.com|
20514008|NCT05266456|Vaxcyte|Vice President of Clinical Development|(650) 585-0029|clinicaltrialsgov@vaxcyte.com|
20514009|NCT01610167|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|(260) 755-1099||
20514010|NCT04726514|Berendo Scientific, LLC|Eric Kezirian|4152358706|eric.kezirian@gmail.com|
20514011|NCT03276962|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20514012|NCT00411762|Yale University|Howard Hochster||Howard.Hochster@yale.edu|
20514013|NCT01238211|The Ohio State University|Guido Marcucci, M.D.||Guido.Marcucci@osumc.edu|
20514014|NCT04428502|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514015|NCT01358708|Aptalis Pharma US, Inc.|Robert Winkler MD, VP, Clinical Development and Operations|(908) 429-4479|rwinkler@aptalispharma.com|4175
20514016|NCT02995694|Alvogen Pine Brook|Meena Venugopal|973-532-7824|meena.venugopal@alvogen.com|
20514017|NCT03712228|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20514018|NCT01964105|WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, SAINT LOUIS|TERENCE MICHAEL MYCKATYN, PI, PROFESSOR, PLASTIC SURGERY|314-362-4263|myckatyn@wustl.edu|
20514019|NCT01430104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20514020|NCT05288673|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|8557522356|clinicaltrials@alexion.com|
20514021|NCT04080882|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
20514022|NCT04553484|Semler Scientific|Gena Parker|669-230-2729|gparker@semlerscientific.com|
20514023|NCT01565382|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20514024|NCT00281827|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
20514025|NCT00579254|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20514026|NCT02557672|Mayo Clinic|Gregory A. Nuttall, M.D.|(507) 255-3298|gnuttall@mayo.edu|
20514027|NCT00343642|Rush University Medical Center|Ece A Mutlu, Principal Investigator|312 942 5861|Ece_Mutlu@rush.edu|
20514028|NCT02462382|Orlando Orthopaedic Center|Randy Schwartzberg, MD|407-254-2500|orlandosportsdoc@yahoo.com|
20514029|NCT00766506|Janssen-Cilag Ltd. 50-100 Holmers Farm Way, High Wycombe , BUCKS, UK, HP12 4EG|Study Responsible Physician|+44 (0) 1494 567 444||
20514030|NCT00860574|Fred Hutch/University of Washington Cancer Consortium|Joachim Deeg|206.667.5985|jdeeg@fredhutch.org|
20514031|NCT02006407|University of Michigan Comprehensive Cancer Center|Dr. Carl Johannes Koschmann, M.D.|734-647-2893|ckoschma@umich.edu|
20514032|NCT03262233|UW-Madison|John Curtin|608-262-0387|jjcurtin@wisc.edu|
20514033|NCT03877237|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
20514034|NCT03372083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20514035|NCT02544633|Mirati Therapeutics, Inc.|Vanessa Tassell, Vice President, Clinical Science|858-332-3438|tassellv@mirati.com|
20514036|NCT02092961|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20514037|NCT02270983|Forest Research Institute, Inc., an affiliate of Allergan|Therapeutic Area Head|862-261-7000|IR-CTRegistration@allergan.com|
20514038|NCT00124176|Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
20514039|NCT01623830|Emory University|Barbara Rothbaum|404-712-8866|brothba@emory.edu|
20514040|NCT00928252|The Queen's Medical Center|Sandi Kwee, MD, PhD|8086915466|skwee@queens.org|
20514041|NCT01605461|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514042|NCT02024698|CooperVision, Inc.|Manager Global Medical/Scientific Affairs|925-621-3761|javega@coopervision.com|
20514043|NCT03549130|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20528804|NCT00158262|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
20560716|NCT02909439|Stony Brook Medicine|Ramon Abola, Clinical Associate Professor|631-444-2975|ramon.abola@stonybrookmedicine.edu|
20560717|NCT00785772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560718|NCT01168401|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
20514044|NCT01078623|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20514045|NCT00463866|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20514046|NCT00950183|OrthoCarolina|Dr. Robert B. Anderonson|704-323-2000|robert.anderson@orthocarolina.com|
20514047|NCT02883673|Alydia Health|Kathryn Wine, VP Clinical Operations|415-990-4104|kathryn@alydiahealth.com|
20514048|NCT02144259|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|courtney.schreiber@uphs.upenn.edu|
20514049|NCT03568500|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20514050|NCT00943800|University of Chicago|Hongtao Liu|773-834-8980|hliu2@medicine.bsd.uchicago.edu|
20514051|NCT01768000|Centre for Addiction and Mental Health|Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
20514052|NCT02655354|University of Washington School of Medicine|Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
20514053|NCT00950833|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514054|NCT04895618|Regulatory Insight, Inc.|Elvira Cawthon|Results Point of Contact Name|elvira@reginsight.com|
20514055|NCT03522584|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
20514056|NCT01095757|Winship Cancer Institute Emory University|Dr. Edmund Waller|404-727-4995|ewaller@emory.edu|
20514057|NCT01578707|Pharmacyclics, LLC|Anita Szoke|(669) 215-7235|aszoke@pcyc.com|
20514058|NCT04120194|Novavax Inc|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20514059|NCT01202994|University of Utah|Dr. Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|801
20514060|NCT02528318|Windtree Therapeutics, Inc.|Robert Segal, MD, FACP|215-488-9300|rsegal@windtreetx.com|9450
20560719|NCT00248612|Center for Anxiety and Related Disorders at Boston University|Todd J. Farchione, PhD|617 353 9610|tfarchio@bu.edu|
20514061|NCT02622074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514062|NCT01859325|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
20514063|NCT01684722|University of Washington|Ian de Boer, MD, MS|2066165403|deboer@u.washington.edu|
20514064|NCT00219557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514065|NCT01042496|Mayo Clinic|Dr. Mark A. Frye|507-284-6213|MFrye@mayo.edu|
20514066|NCT02273206|Clinical Directors Network|Andrea Cassells, MPH|212-382-0699|acass@cdnetwork.org|227
20514067|NCT03082391|Cleveland Clinic Foundation|Dr. Michael Rosen|2164453441|rosenm@ccf.org|
20514068|NCT03063632|Cancer Immunotherapy Trials Network|Anna Wright|206-667-2541|akwright@fredhutch.org|
20514069|NCT00927888|Stanford University|David Drover, MD|6507250364|ddrover@stanford.edu|
20514070|NCT02741271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514071|NCT03652961|NYU Langone Health|Gregg J. Silverman, MD MACR|212 263 9440|Gregg.Silverman@nyulangone.org|
20514072|NCT00410410|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20514073|NCT01783496|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
20514074|NCT00106028|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20514075|NCT02296606|The University of Texas Southwestern Medical Center|DaiWai Olson|214-648-8946|Daiwai.Olson@UTSouthwestern.edu|
20514076|NCT00947011|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20514077|NCT00833781|Mass General Hospital|Dr. Rajesh Gandhi|617-724-9690|rgandhi@partners.org|
20514078|NCT00449930|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20514079|NCT02746705|NYU Langone Health|Leigh Charvet|929 455 5125|leigh.charvet@nyulangone.org|
20514080|NCT03124381|Johnson & Johnson Consumer Inc.|Ali Fassih, Ph.D.|908-904-3259|Afassih@its.jnj.com|
20514081|NCT01365845|University of Florida Proton Therapy Institute|Dr. Julie Bradley|904-588-1800|jbradley@floridaproton.org|
20514082|NCT01190306|Topcon Medical Systems|Robert Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
20514083|NCT05017493|Hiwa Hospital - KRG|Dr. Dara Omer|+9647701586707|mailto:danaomar1979@gmail.com|
20514084|NCT03940586|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514085|NCT00738920|University at Buffalo, SUNY|Dr. Jeffrey Lackner|716-898-5671|lackner@buffalo.edu|
20514086|NCT03821324|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20514087|NCT00530439|Odense University Hospital|Dr. Christina Vinter|+45 21782118|c.vinter@dadlnet.dk|
20514088|NCT00951899|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
20514089|NCT04929522|AinShams University|Director of Clinical Trials in Endodontics|+2022639083|endohashem@gmail.com|
20514090|NCT04385199|Henry Ford Health System|Dr Geneva Tatem|313-916-2431|gtatem1@hfhs.org|
20514091|NCT03705169|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20514092|NCT00185211|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20514093|NCT01759537|NYU College of Dentistry|Ismael Khouly|212-998-9800|iek3@nyu.edu|
20514094|NCT01893983|San Francisco VA Healthcare System|Dr. Karen Seal|415-2214810|karen.seal@va.gov|24852
20514095|NCT01165242|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514096|NCT01725815|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
20514097|NCT04126057|SightGlass Vision, Inc.|Joe Rappon, OD, MS, FAAC|678-642-9117|joe@sightglassvision.com|
20514098|NCT01859390|University of Colorado School of Medicine|Dr. Scott Sagel, Professor of Pediatrics|720-777-2522|scott.sagel@ucdenver.edu|
20514099|NCT01567371|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
20560720|NCT03079375|OdenseUH|Lene V. Ravn-Nielsen clinical pharmacist|+4523467925|lene.ravn-nielsen@rsyd.dk|
20514100|NCT01706198|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514101|NCT01084005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514102|NCT02415166|LaurateInstitute|Jonathan Savitz|918 502 5104|jsavitz@laureateinstitute.org|
20514103|NCT00606684|GlaxoSmithKline|GSK Response Center|866-435-7343||
20506236|NCT02796924|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
20506237|NCT01465178|University of Wisconsin|Neil Binkley|608-265-6410|nbinkley@wisc.edu|
20506238|NCT01568905|University of Minnesota Tobacco Research Programs|Dorohty Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
20514104|NCT00472446|Cantonal Hospital St. Gallen|Thomas Steffen, MD|0041 71 494 1111|thomas.steffen@kssg.ch|
20514105|NCT00671671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514106|NCT00772577|Novartis Pharmaceuticals|Study Director|862-778-8300||
20514107|NCT03211156|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|schwebke@uab.edu|
20514108|NCT00208949|Emory University|Dr. Sagar Lonial|404-778-1900|SLONI01@emory.edu|
20514109|NCT02145403|University of Michigan Rogel Cancer Center|Attaphol Pawarode, M.D.|734-936-8785|pawarode@med.umich.edu|
20514110|NCT00553540|Cleveland Clinic Florida|Dr. David Westerdahl|954-659-5422|westerd@ccf.org|5422
20514111|NCT03565211|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20514112|NCT00323609|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
20514113|NCT03124797|Masimo|Tala Harake||studies@masimo.com|
20514114|NCT00676585|Beth Israel Deaconess Medical Center|Dr. Michael Donnino||mdonnino@bidmc.harvard.edu|
20514115|NCT01023269|Medtronic International Trading Sarl|Alexandra Delacour, Clinical Research Manager|0041218027622|alexandra.delacour@medtronic.com|
20514116|NCT01953783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20514117|NCT01789281|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20514118|NCT00814658|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
20514119|NCT05267574|Reneo Pharmaceuticals, Inc.|Alex Dorenbaum, MD, Chief Medical Officer|(415) 328-9115|adorenbaum@reneopharma.com|
20514120|NCT01141283|Purdue Pharma LP|Clinical Leader, Medical Director|800-733-1333||
20514121|NCT06371079|Basrah Medical College|Loay Abdulmutalib Almusawi|009647705559205|loay.almusawi@uobasrah.edu.iq|
20514122|NCT00575328|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
20514123|NCT04322968|VA Ann Arbor Healthcare System|Dr. Alisher Dadabayev, Pain POC|734-222-7639|Alisher.Dadabayev@VA.GOV|
20514124|NCT00124449|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20514125|NCT01504867|Mayo Clinic|Dr. Daryl J. Kor|507-284-7678|Kor.Daryl@mayo.edu|
20514126|NCT00571922|NYU Langone Medical Center|The Office of Clinical Trials|212.263.4210|clinicaltrials@nyumc.org|
20514127|NCT01785186|Tropical Institute of the Ludwig-Maximilians University in Munich, Germany|Dr. Norbert Heinrich|0049 89 2180 17605|heinrich@lrz.uni-muenchen.de|
20514128|NCT04525157|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
20514129|NCT03210259|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514130|NCT02533999|Nemours Children's Specialty Care|Kathryn Blake, PharmD|904-697-3806|kathryn.blake@nemours.org|
20514131|NCT02163811|VA Puget Sound Health Care System|Dr. Aaron Turner|(206) 277-6134|Aaron.Turner@va.gov|
20514132|NCT01154153|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
20514133|NCT02473510|MedImmune, LLC|Ashwin Swami, MD|+1 301 398 5000|information.center@astrazeneca.com|
20514134|NCT01392859|Children's Mercy Hospital|Dr. Bridgette Jones|816-302-3811|bljones@cmh.edu|
20514135|NCT00389649|Universitry of Maryland|Stephen Gottlieb, MD|4103288788|sgottlie@medicine.umaryland.edu|
20514136|NCT00964223|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514137|NCT02006147|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
20514138|NCT03404206|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20514139|NCT05478603|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514140|NCT00345683|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514141|NCT00492089|The University of Texas MD Anderson Cancer Center|Monica Loghin, MD / Assistant Professor|K Hunter, RN 713-745-5769|CR_Study_Registration@mdanderson.org|
20514142|NCT03634488|Vanderbilt UniversityVanderbilt-Meharry Center of Excellence in Sickle Cell Disease|Leshana Saint Jean|6158751992|leshana.saint.jean@vumc.org|
20551184|NCT03060447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20551185|NCT02232425|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
20514143|NCT03182686|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20514144|NCT00863369|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20514145|NCT01154127|Novartis Pharmaceuticals|Study Director|862-778-8300||
20514146|NCT01697449|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20514147|NCT01169844|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
20514148|NCT03654209|Indiana University|Clinical Research Coordinator|317-948-0724|rlahr@iu.edu|
20514149|NCT01337050|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514150|NCT00003102|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20514151|NCT04643782|Northwestern University|Phyllis Zee, MD|312-503-5944|SleepSensors@northwestern.edu|
20514152|NCT01989195|Stanford University|Phillip C. Yang, MD|650-498-8008|phillip@stanford.edu|
20514153|NCT00096486|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
20514154|NCT01559818|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0)20 3137 6346|info@immodulon.com|
20514155|NCT04071626|University Hospitals Cleveland Medical Center|Dr. Trevor Jenkins|(216)844-1229|Trevor.Jenkins@UHhospitals.org|
20514156|NCT00529568|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551186|NCT00498602|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551187|NCT01113801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20514157|NCT04049552|UT Health San Antonio|Dean L Kellogg Jr.|210-617-5311|kelloggd@uthscsa.edu|
20514158|NCT01201356|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20514159|NCT00931385|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514160|NCT03360656|CoolTech|Director of Clinical Operations|2036856352|channan@cooltechcorp.com|
20514161|NCT00811070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514162|NCT05113901|Rush University Medical Center|Methylprednisolone Taper to Treat Delayed Post-Operative Recovery After Total Knee Arthroplasty: a D|3124322468|anne.debenedetti@rushortho.com|
20514163|NCT04582409|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20514164|NCT00665626|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20514165|NCT00585039|Phoenix Children's Hospital|Dr Blake Bulloch|602-546-1950|bbulloch@phoenixchildrens.com|
20514166|NCT01799213|Veterans Health Administration, West Haven, CT|Lisa G. Suter, MD|2039325711|lisa.suter@va.gov; lisa.suter@yale.edu|
20514167|NCT01629693|Alcon Research, Ltd.|Jessie Lemp, GMA Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20514168|NCT03927781|University of Missouri|Dr Katie Murray|573-884-8768|murraykat@health.missouri.edu|
20514169|NCT04079842|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
20514170|NCT01025193|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
20514171|NCT02904200|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
20514172|NCT01901211|Holland Bloorview Kids Rehabilitation Hospital|Darcy Fehlings, MD, MSc, FRCP(C)|416-425-6220|dfehlings@hollandbloorview.ca|3586
20514173|NCT02133352|Boston University|Kimberly Finch|617-638-4475|kimtobin@bu.edu|
20514174|NCT00677924|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20514175|NCT02257632|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20514176|NCT02468557|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20514177|NCT01312779|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
20514178|NCT01621490|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20514179|NCT00506753|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
20514180|NCT00125359|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
20514181|NCT01809054|Sinai Center for Thrombosis Research|Kevin Bliden|4106014795|kbliden@lifebridgehealth.org|
20514182|NCT01764854|Ardelyx, Inc.|Chief Development Officer|617 513-4929|drosenbaum@ardelyx.com|
20514183|NCT01759381|Duke|Carlos A. Bagley|919-943-1564|carlos.bagley@gmail.com|
20514184|NCT03263195|Department of Pediatrics Ribeirão Preto Medical School|Dr. Marisa Mussi-Pinhata|55-16-3602-2807|mmmpinha@fmrp.usp.br|
20514185|NCT03377556|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20514186|NCT00910858|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20528805|NCT03628378|Columbia University Irving Medical Center|Jeffrey A. Geller, MD|212-305-1120|jg2520@cumc.columbia.edu|
20528806|NCT01421641|Oregon Health & Science University|Paula Bednarek|(503) 418-4500|bednarek@ohsu.edu|
20528807|NCT00883415|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
20528808|NCT02420119|HaEmek Medical Center|Dr.Frieda Wolf|97246495476|friedawolf@hotmail.com|
20528809|NCT02364388|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
20528810|NCT02256839|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
20528811|NCT01843803|Department of Veterans Affairs|Frances M Weaver|708-202-5866|frances.weaver@va.gov|
20528812|NCT01850394|Faculty of Medicine, Ramathibodi Hospital, Mahidol University|Dr. Paphon Sa-ngasoongsong|66-2-2011589|chan3s@hotmail.com|
20528813|NCT00436826|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20528814|NCT03509181|McLean Hospital|Courtney Beard|617-855-3557|cbeard@mclean.harvard.edu|
20528815|NCT04550364|Universoty of Oslo|Psychologist and PhD Bente Sommerfeldt|004793221280|bsommerfeldt@gmail.com|
20528816|NCT05285787|Epizon Pharma|John Rudy|2127551000|jrudey@epizonpharma.com|
20528817|NCT04004260|Lamar University|Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 821 9443|vmanchaiah@lamar.edu|
20528818|NCT03382418|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20528819|NCT02360280|Minneapolis VA Medical Center|Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
20528820|NCT03138577|Weill Cornell Medical College|Dr. Tiffany Tedore|212-746-2725|tft9001@med.cornell.edu|
20528821|NCT05464420|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20528822|NCT01383018|Boston Scientific|Amanda Vail, Clinical Project Manager|612-749-5366|amanda.vail@bsci.com|
20528823|NCT02472886|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20528824|NCT01051817|Novartis Pharmaceuticals|Study Director|862-778-8300||
20528825|NCT00438204|Barbara Ann Karmanos Cancer Institute|Antionette J. Wozniak, M.D., F.A.C.P.|(313)576-8752|wozniakt@karmanos.org|
20528826|NCT00320788|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator||clinicaltrials@regeneron.com|
20528827|NCT04346199|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20528828|NCT00627926|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
20528829|NCT03414229|Memorial Sloan Kettering Cancer Center|Dr. Sanda D'Angelo, MD|646-888-4159|dangelos@mskcc.org|
20528830|NCT03576924|University of British Columbia|Dr. Mary Jung|1-250-807-9670|mary.jung@ubc.ca|
20528831|NCT04533438|Aerin Medical|Sr. Manager of Clinical Operations|312-888-0441|tdang@aerinmedical.com|
20536592|NCT01955369|Klinikum der Stadt Ludwigshafen|Dr. Joachim Wolf|0049-621|joachim.wolf@diakonissen.de|4200
20514187|NCT00827827|Baltimore VAMC|Frederick M. Ivey|410-375-8419|fivey@grecc.umaryland.edu|
20514188|NCT04169282|Duke University|Loretta Que, MD|919-681-8551|loretta.que@duke.edu|
20514189|NCT00698022|Corcept_Therapeutics|Robert Roe, MD|650-688-8812|rroe@corcept.com|
20514190|NCT00621686|Mayo Clinic|Evanthia Galanis, M.D.|507/284-3559|Galanis.evanthia@mayo.edu|
20514191|NCT00447603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514192|NCT01275313|University of Pittsburgh|David Brienza, Professor|412-624-6383|DBRIENZA@pitt.edu|
20514193|NCT00631670|University of Florida, Dept. of Radiation Oncology|Bridget Fitzgerald, Clinical trials coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
20514194|NCT00322309|BUPA CSU, Boston University School of Medicine|Maryam Afshar, MD|617-414-1990|maryam.afshar@bmc.org|
20514195|NCT03818737|Emory University|Kenneth Mautner, MD|404-778-7142|kmautne@emory.edu|
20514196|NCT01907737|HCFMUSP/FFM|Adriana Conforto|551126617955|adriana.conforto@gmail.com|
20514197|NCT03135379|Brooke Army Medical Center|Benjamin M. Krainin|210-916-0808|Benjamin.M.Krainin.mil@mail.mil|
20514198|NCT00330421|Dana-Farber Cancer Institute|Jeffrey A. Morgan, M.D.|617-632-5204|jamorgan@partners.org|
20514199|NCT01630200|Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology|Dr. Matthias Urban|+43(0)6508125980|matthias.urban1@gmx.net|
20514200|NCT02008721|Department of Neurology, Ludwig-Maximilians-University Munich, Munich, Germany|Prof. Dr. Johannes Levin||johannes.levin@med.uni-munechen.de|
20514201|NCT04634110|University of Colorado Hospital|Dr. Chad Rusthoven|720-516-0150|chad.rusthoven@cuanschutz.edu|
20560721|NCT01107626|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20514202|NCT01567306|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
20514203|NCT01684566|Camurus AB|Håkan Olsson DDS, PhD|+46 46 2863852|Hakan.Olsson@camurus.com|
20514204|NCT00815490|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
20514205|NCT02203565|Stanford University School of Medicine|Dr. Kathleen Horst|6507256009|kateh@stanford.edu|
20514206|NCT04272775|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20560722|NCT04310579|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
20560723|NCT03467724|Venus Concept|Director of Clinical Affairs|1-888-907-0115|mgronski@venusconcept.com|
20560724|NCT02236559|McGovern Medical School at The University of Texas Health Science Center at Houston|Dr. Pratik Doshi, MD||pratik.b.doshi@uth.tmc.edu|
20514207|NCT00738673|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20514208|NCT01967888|Dompé|Mauro P. Ferrari, Pharm D|+3902583831|info@dompe.com|
20514209|NCT00267293|Penn State Children's Hospital|Ian M Paul, MD, MSc|717-531-5656|ipaul@hmc.psu.edu|
20514210|NCT03596918|AMC Statistical and Data Analysis Center|Dr. Jeannette Y. Lee|(501) 526-6712|jylee@uams.edu|
20514211|NCT02436135|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20514212|NCT02063698|Mayo Clinic|Aminah Jatoi, MD|(507) 284-7202|Jatoi.Aminah@mayo.edu|
20514213|NCT00297479|UT MD Anderson Cancer Center|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
20514214|NCT01664494|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20514215|NCT03263819|Vanderbilt University Medical Center|Dr.Cyndya A. Shibao|6159364584|cyndya.shibao@vumc.org|
20514216|NCT00125931|McLean Hospital|Beth Murphy, MD PhD|617-855-2297|BMurphy5@partners.org|
20514217|NCT01427803|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
20514218|NCT01612156|University of Southern California|Begum Ozel, MD|323-441-9589|ozel@usc.edu|
20514219|NCT00686920|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20514220|NCT05085613|Johns Hopkins Bloomberg School of Public Health|Caitlin Weiger|301-712-8357|cweiger2@jhmi.edu|
20514221|NCT00198081|Indiana University|Christian M. Schmidt, MD|317-278-8349|maxschmi@iupui.edu|
20514222|NCT02974114|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20514223|NCT03654898|Baylor College of Medicine Childrens Foundation Malawi|Maria Kim|+26599869090|mkim@tingathe.org|
20514224|NCT01138150|The Johns Hopkins University School of Medicine|Dr. Lee Peterlin|410-550-5452|lpeterlin@jhmi.edu|
20514225|NCT00545233|Hoffman-LaRoche|Medical Communications|800-821-8590||
20514226|NCT00973856|Cleveland Clinic Akron General|Eliot Mostow, MD||emostow@akronderm.com|
20514227|NCT02124746|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20514228|NCT00397839|Hoffmann-La Roche|Medical Communications|800-821-8590||
20514229|NCT02005354|Plymouth Hospitals NHS Trust|Dr David Tucker|01752 432595|david.tucker1@nhs.net|
20514230|NCT03811249|Refocus Group, Inc.|Linda Stewart, Director of Regulatory and Quality|214-368-0200|lstewart@refocus-group.com|431
20514231|NCT01712230|University of Colorado Anschutz Medical Campus|Wendy Kohrt, PhD|303-724-1913|Wendy.Kohrt@CUAnschutz.edu|
20514232|NCT01741480|WashingtonU|Dr. Marin Kollef|314-454-8764|mkollef@dom.wustl.edu|
20514233|NCT00362401|Aarhus University Hospital, Skejby|Dr. Thais A. Pedersen, primary investigator|+45 8949 5484|thais.a.pedersen@ki.au.dk|
20514234|NCT01783730|AbbVie|Global Medical Services|800-633-9110||
20514235|NCT02151461|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
20514236|NCT04304950|Rush University Medical Center|Dr. Garth R. Swanson|312-563-3871|Garth_Swanson@rush.edu|33871
20514237|NCT00408876|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20514238|NCT00990561|UCSF|John Koo, Principle Investigator|415-476-4701|john.koo@ucsfmedctr.org|
20514239|NCT01488019|Mylan UK|Dik Ng, PhD, Director Clinical Science|+44 1304626895|dik.ng@mylan.co.uk|
20514240|NCT01512979|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514241|NCT02033876|Mayo Clinic|Dr. Michael Camilleri|507-284-2687|camilleri.michael@mayo.edu|
20514242|NCT01606137|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20560725|NCT02049866|Columbia University|Mariana Bucovsky|212-305-7225|mb3523@cumc.columbia.edu|
20560726|NCT03533036|UCLA|Dr. Aparna Sridhar, Associate Clinical Professor|3107947274|asridhar@mednet.ucla.edu|
20514243|NCT00066807|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
20514244|NCT00420290|Vanderbilt University|Adriana Hung, MD||adriana.hung@vanderbilt.edu|
20514245|NCT05028751|Kronos Bio, Inc.|VP, Corporate Affairs|+16507815200|media@kronosbio.com|
20514246|NCT02248285|BioFire Diagnostics|Director of Clinical Affairs|8017366354|kevin.bourzac@biofiredx.com|
20514247|NCT04967313|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
20514248|NCT03167099|West Virginia University|Dr. David Hubbard|304-293-3900|dhubbard@hsc.wvu.edu|
20514249|NCT03322462|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20514250|NCT01393990|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20514251|NCT00740727|Massachusetts General Hospital|Stephen H. Thomas MD MPH|6177267622|stephen-thomas@ouhsc.edu|
20514252|NCT05321810|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514253|NCT02720952|Diurnal Limited|Dr John Porter||info@diurnal.co.uk|
20514254|NCT00720798|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20514255|NCT00433381|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20514256|NCT02806232|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20514257|NCT00803959|New England Research Institutes|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
20514258|NCT00434161|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|clinical@sobi.com|
20514259|NCT03342898|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20514260|NCT01387282|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
20514261|NCT02661126|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514262|NCT03997448|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
20514263|NCT02451670|HealthPartnersInstitute|Rebecca Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
20514264|NCT00461500|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514265|NCT01151813|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
20514266|NCT00521456|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20514267|NCT01513551|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514268|NCT02057952|Regenstried Institute|Daniel O. Clark, PhD|317-274-9292|daniclar@iu.edu|
20514269|NCT01267266|University of Chicago|Walter M. Stadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
20514270|NCT01335477|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514271|NCT00549198|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514272|NCT01473758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20514273|NCT02480010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20514274|NCT04229303|Zambon SpA|Arnd Mueller, MD|+39 02 665241|clinicaltrials@zambongroup.com|
20514275|NCT01165684|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20514276|NCT04549259|Center for AIDS Intervention Research, Medical College of Wisconsin|Dr. Jennifer Walsh and Dr. Andrew Petroll|414-955-7710|jwalsh@mcw.edu|
20514277|NCT00901628|Joint Reconstruction Center, Seoul National University Bundang Hospital|Tae Kyun Kim|82-31-787-7196|osktk@snubh.org|
20514278|NCT02203747|Abbott Medical Optics|Carrie Garufis|714-566-3728|carrie.garufis@abbott.com|
20514279|NCT00608205|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
20514280|NCT01003886|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514281|NCT02462421|University of Maryland School of Medicine|Dr. Simeon Taylor (Professor of Medicine)|410-706-6439|staylor2@som.umaryland.edu|
20514282|NCT00992264|Group Health Research Institute|Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
20514283|NCT00909727|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
20514284|NCT01136226|Chesapeake Urology Research Associates|Heather Thomas, Administrator|443.471.5742|hthomas@cua.md|
20514285|NCT01339910|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20514286|NCT00287287|University of Kentucky|Kenneth Ain|8593236652|kenneth.ain@uky.edu|
20514287|NCT02965820|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
20514288|NCT00829413|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
20514289|NCT00891774|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20514290|NCT00004143|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
20514291|NCT03175120|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20514292|NCT03882047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514293|NCT00723554|Actelion Pharmaceuticals, US, Inc.|Wade Benton, PharmD/ Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
20560727|NCT04969822|Vitrolife A/S|Mr. Jørgen Berntsen|+4551542005|jberntsen@vitrolife.com|
20514294|NCT02578732|Brown University Oncology Research Group|Howard Safran, MD|401-863-300|BrUOG@BROWN.EDU|
20514295|NCT01614509|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
20514296|NCT01894984|XIAN-JANSSEN PHARMACEUTICAL|Medical affairs director|86-10-58218307||
20560728|NCT00763282|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
20560729|NCT02060279|Nemours Children's Specialty Care|Dr. Amanda Lochrie|904-697-3698|alochrie@nemours.org|
20560730|NCT01970943|Massachusetts General Hospital|Dr David Borsook, study PI|6172817135|david.borsook@childrens.harvard.edu|
20560731|NCT02219490|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20560732|NCT00335556|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20514297|NCT00827359|Beth Israel Deaconess Medical Center|Rupal Bhatt|6177352060|rbhatt@bidmc.harvard.edu|
20514298|NCT00475852|Johnson & Johnson Pharmaceutical Research & Development, LLC|Vice President, Franchise Development|610-651-6628||
20514299|NCT01809314|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20514300|NCT00863057|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20514301|NCT02345486|Vanderbilt University Medical Center|Dr. Matthew Semler|615-322-3412|matthew.w.semler@vumc.org|
20514302|NCT03412019|Tufts Medical Center|Dan Drzymalski, MD|617 636 4526|ddrzymalski@tuftsmedicalcenter.org|
20514303|NCT03563027|Crescenz Veterans Affairs Medical Center|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
20514304|NCT01698320|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20514305|NCT00386724|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20514306|NCT01215123|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20514307|NCT02752256|University of Iowa Hospitals and Clinics|Brett Faine|319-384-6800|brett-faine@uiowa.edu|
20514308|NCT01172353|Hospital Sao Lucas|Vitor Osório Gomes, MD, PhD|55 51 33203494|pesquisa@cardiarte.com.br|
20514309|NCT02040766|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20514310|NCT01068873|Lewis Katz School of Medicine at Temple University|Lisa Landsberg|12157077303|lisa.landsberg@temple.edu|
20514311|NCT00479401|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514312|NCT02777931|Aevi Genomic Medicine|Garry A Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
20514313|NCT01208402|Duke University Medical Center - Department of Anesthesiology|William White / Statistician|919-684-4081|white013@mc.duke.edu|
20514314|NCT01571635|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20514315|NCT02868281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20514316|NCT01722266|University at Buffalo|Nitesh D Kuhadiya,MD,MPH ;Co-Investigator;Assistant Professor of Medicine, Section of Endocrinology|716-626-7998|niteshku@buffalo.edu|
20514317|NCT00706706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514318|NCT02191579|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20514319|NCT00769015|Thomas Jefferson University|Robin Casten|215-503-1250|Robin.Casten@jefferson.edu|
20514320|NCT02060461|Cleveland Clinic|William J Dupps, Jr, MD, PhD|216-444-8396||
20514321|NCT01976390|Division of Transplant Surgery OSUMC|Director of Research Operations|614-293-8021|brenda.cuson@osumc.edu|
20514322|NCT00331630|Northwestern University|Virginia Kaklamani|312-695-1301||
20514323|NCT01133821|University of Pittsburgh School of Medicine|Holly A. Swartz M.D.|412-246-5588|swartzha@upmc.edu|
20514324|NCT02917447|VA Puget Sound Health Care System|Keren Lehavot, PhD|206-277-1511|keren.lehavot@va.gov|
20514325|NCT03081767|Stanford University|Andrei Iagaru|6507254711|aiagaru@stanford.edu|
20514326|NCT05569148|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20514327|NCT02149303|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20514328|NCT02275923|Medtronic|Jennifer Seamans, Principal Clinical Research Specialist|7635262835|jennifer.l.seamans@medtronic.com|
20514329|NCT02038634|Medical College of Wisconsin|Karen Gonzalez|414-955-3221|kgonzalez@mcw.edu|
20514330|NCT03220230|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514331|NCT02763579|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20514332|NCT02967133|Duke University Medical Center|Neal Ready MD PhD|(919) 681-6932|neal.ready@duke.edu|
20514333|NCT01464359|University of Minnesota, Pediatrics Blood and Marrow Transplant|Michael R Verneris|612-626-2961|verneris@umn.edu|
20514334|NCT02668783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514335|NCT00112489|NRG Oncology - Buffalo Office|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
20514336|NCT02117193|Federal University of Rio Grande do Sul|Dr Marco Aurélio Vaz|555133085860|marcovaz@esef.ufrgs.br|
20514337|NCT04467697|Marius Pharmaceuticals, LLC|Nita Nimmons|919-374-1913|Nita@mariuspharma.com|
20514338|NCT05751629|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20514339|NCT01909466|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20514340|NCT02231710|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384-1100|clinicaltrials@bellicum.com|
20514341|NCT03051256|Relmada Therapeutics|Chief Medical Officer|646-876-3459|info@relmada.com|
20514342|NCT00673361|Duke University Medical Center|Michael A Morse, M.D.|919-681-3480|morse004@mc.duke.edu|
20514343|NCT00124020|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20514344|NCT00268346|Cleveland Clinic Taussig Cancer Institute|David Adelstein MD|216-444-9310|adelstd@ccf.org|
20514345|NCT01799590|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
20514346|NCT00981253|Duke Health|Dr. James A. Blumenthal|919-684-3828|james.blumenthal@duke.edu|
20514347|NCT00294723|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20514348|NCT01127581|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20514349|NCT00730522|Catalyst Pharmaceuticals|Chief Scientific Officer|305-420-3200|gingenito@catalystpharma.com|
20514350|NCT03038113|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20514351|NCT02004704|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20514352|NCT01755858|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20514353|NCT03421652|Karmanos Cancer Institute|Nitin Vaishampayan, MD|313-576-9624|nvaisham@med.wayne.edu|
20514354|NCT03979677|Vanderbilt University Medical Center|Richard A. Roberts, Ph.D.|6153227384|richard.a.roberts@vanderbilt.edu|
20514355|NCT02539563|Wake Forest School of Medicine|Lynnette Harris, BSN|336-716-6049|lcharris@wakehealth.edu|
20514356|NCT01580020|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20514357|NCT01724359|Jan-Cil Mexico|GERENTE MEDICO REGIONAL|52 55 5237 3410||
20514358|NCT02077192|Rigel Pharmaceuticals, Inc.|Director of Clinical Operations|(650) 624-1100|clinicaltrials@rigel.com|
20514359|NCT01335464|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514360|NCT00591253|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20514361|NCT01841359|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6173092635|MaryElizabeth.Patti@joslin.harvard.edu|
20514362|NCT00871169|University of New Mexico Comprehensive Cancer Center|Fa-chyi Lee, MD|505-925-0405|flee@salud.unm.edu|
20514363|NCT02168270|University of Nebraska Medical Center|Dr. Nicole Shonka|402-559-5166|nshonka@unmc.edu|
20514364|NCT02611206|University of Minnesota|Kathryn Cullen|612-625-3403|rega0026@umn.edu|
20514365|NCT03493698|Spring Bank Pharmaceuticals, Inc.|Don Mitchell, Vice President, Operations & Corporate Development|(508) 689-9737|dmitchell@springbankpharm.com|
20514366|NCT03361956|Janssen Sciences Ireland UC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20514367|NCT03198988|ART MEDICAL|Mrs Shirly Steinlauf|972-54-5804242|shirly@artmedical.com|
20514368|NCT00235833|Abbott|Medical Information Specialist|800-633-9110||
20514369|NCT00291330|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514370|NCT01829295|F.I. Proctor Foundation, UCSF|Dr. Nisha Acharya|4154768131|Nisha.Acharya@ucsf.edu|
20514371|NCT00757666|Boston Scientific|Director of Clinical Affairs|651-582-2277|cshd@bsci.com|
20514372|NCT02629965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514373|NCT03443869|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514374|NCT02390219|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20514375|NCT00299728|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20514376|NCT02230085|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
20514377|NCT00580983|University of Michigan Comprehensive Cancer Center|Dr. Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
20514378|NCT01360632|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20514379|NCT01298596|University of Washington|Dr. Michael H. Chung|‭(206) 302-8361‬|mhchung@uw.edu|
20514380|NCT04128696|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20514381|NCT02046369|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20514382|NCT01191255|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
20514383|NCT02196506|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20514384|NCT03387059|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20514385|NCT03501550|Cocrystal Pharma Inc|Luz Pascual|9083611678|lpascual@cocrystalpharma.com|
20514386|NCT01743677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514387|NCT03092089|University of Alberta Hospital|Dr Kevin Bainey|780-407-2176|Kevin.Bainey@albertahealthservices.ca|
20514388|NCT04578548|Galapagos NV|Galapagos Medical Information|+3215342900|medicalinfo@glpg.com|
20551188|NCT02436356|Vanderbilt University Medical Center|Jeffry S. Nyman, Ph.D.|615-936-6296|jeffry.s.nyman@vumc.org|
20551189|NCT04577118|iotaMotion, Inc|Laura Chenier|442-325-4171|lchenier@iotamotion.com|
20551190|NCT00810407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551191|NCT03287804|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
20551192|NCT03742154|MUSC|Lisa Coles Program Coordinator|843-876-2291|colesl@musc.edu|
20551193|NCT04008030|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20551194|NCT00003644|NRG Oncology|Linda Gedeon, Christopher Purdy on behalf of Mark Brady, PhD|(716) 845-1169|lgedeon@gogstats.org|
20551195|NCT04249310|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551196|NCT01454947|University of Southern California|Jason N. Doctor|213.821.8142|jdoctor@usc.edu|
20551197|NCT03108027|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
20551198|NCT02574247|University of Illinois at Urbana-Champaign|Dr. Ian Mertes|217-300-4756|imertes@illinois.edu|
20551199|NCT01382446|SJHMC|Tracy L. Thomas MSN RN CCRN ACNS-BC|602-406-2567|Tracy.Thomas007@dignityhealth.org|
20551200|NCT02536196|Keystone Heart|Pauliina Margolis - CMO|813.530.8200|pauliina.margolis@keystoneheart.com|
20551201|NCT04458909|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20560733|NCT02365298|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan|904-443-3449|CColesb@ITS.JNJ.com|
20514389|NCT00395083|VA Boston Healthcare System - MAVERIC|Dr. Sarah Leatherman|857-364-4220|sarah.leatherman@va.gov|
20514390|NCT00972153|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
20514391|NCT01077713|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20514392|NCT02482805|University of Texas at Austin|Michelle Davis|214-470-1371|michelledavis@utexas.edu|
20514393|NCT01806597|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20514394|NCT01034137|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20514395|NCT03572933|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20514396|NCT01828255|The New York Eye and Ear Infirmary|Dr Gustavo De Moraes|+1 212 477 7540|demoraesmd@gmail.com|
20514397|NCT00439608|BrUOG|Howard Safran, MD|401-863-3000|Hsafran@lifespan.org|
20514398|NCT02049359|Campbell University|Jennifer Smith|2522439800|jsmith@cfhcnc.org|224
20514399|NCT01405950|Acorda Therapeutics, Inc.|Herbert Henney, PharmD|914-347-4300|hhenney@acorda.com|5138
20514400|NCT01381900|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20514401|NCT01772368|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
20514402|NCT02449291|Acacia Pharma Ltd|Gabriel Fox|01-223919764|gabrielfox@acaciapharma.com|
20514403|NCT02363010|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
20514404|NCT03347695|Fujian Medical University Union Hospital|Dr. Liangwan Chen|861335825333|chenliangwan@tom.com|
20514405|NCT02884206|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20514406|NCT02491788|Stanford University|Dr. Jamie Zeitzer|16504935000|jzeitzer@stanford.edu|
20514407|NCT03341507|Iuliu Hatieganu University of Medicine and Pharmacy- Cluj Napoca Romania|Dr Ioan Florin Marchis|+40757065205|marchis.ioan@umfcluj.ro|0757065205
20514408|NCT00514137|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
20514409|NCT02927847|Duke University|Maggie M Sweitzer, PhD|919-668-0094|maggie.sweitzer@duke.edu|
20514410|NCT02619799|Rangaraya medical college|Dr.Paleti Sophia|9948599758 ,08842343023|dr.sophia29@gmail.com|
20514411|NCT01142297|University of Texas Health Science Center at San Antonio|Thomas W. Oates|210-567-3590|oates@uthscsa.edu|
20514412|NCT03255031|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Gene-Jack Wang|301-496-5012|gene-jack.wang@nih.gov|
20514413|NCT01092702|Mayo Clinic|J Taylor Hays. MD|507-266-1944|nicotineresearch@mayo.edu|
20514414|NCT01107535|Abbott|Global Medical Services|1-800-633-9110||
20514415|NCT01155583|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Jason Valent|+1 216-445-7238|VALENTJ3@ccf.org|
20514416|NCT00621179|Colorado Center for Reproductive Medicine|Eric Surrey|303-788-8300|esurrey@colocrm.com|
20514417|NCT00585351|University of Iowa|Enrique Leira, MD, MS|319-356-8755|enrique-leira@uiowa.edu|
20514418|NCT01001169|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514419|NCT01608295|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
20514420|NCT02536378|Silk Road Medical, Inc.|Ric Ruedy, Executive VP, Clinical, Regulatory and Quality Affairs|408-585-2112|ric@silkroadmed.com|
20514421|NCT00602030|Syndax Pharmaceuticals, Inc.|Michael Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
20514422|NCT01271933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514423|NCT01620983|Virginia Commonwealth University|Dr. Daniel L. Riddle|804-828-0234|dlriddle@vcu.edu|
20514424|NCT03944486|Imperial College London|Research Integrity Officer|+44 (0)20 7594 1872|e.magnusson@imperial.ac.uk|
20514425|NCT00798889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514426|NCT05085964|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
20514427|NCT01534975|Los Angeles Biomedical Research Institute|Matthew Budoff|3102224107|mbudoff@labiomed.org|310
20514428|NCT00707915|Minami-hanno Hospital|Director of clinical trials|81.42.972.7111|haloperidol1mg@hotmail.com|
20514429|NCT00252187|Mayo Clinic|Dr. Horng H. Chen|507-778-2354|chen.horng@mayo.edu|
20514430|NCT03764059|Peking University Hospital of Stomatology|Xiaoyan Wang|010-82195525|wangxiaoyanpx@163.com|
20514431|NCT01102777|VA Ann Arbor Center for Clinical Management Research|Fatima Makki|+1 (734) 845-3623|Fatima.Makki@va.gov|
20514432|NCT01875445|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu|
20514433|NCT01943461|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20514434|NCT00593333|Department of Surgery/Division of Orthopaedics|Taylor Vlack, Research Nurse Coordinator|205-996-6781|tmwebb@uabmc.edu|
20514435|NCT02175966|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20514436|NCT01752920|Basilea Pharmaceutica International Ltd.|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
20514437|NCT01738581|University of Minnesota|Dr. Teresa Kimberley|612-626-4096|tjk@umn.edu|
20514438|NCT01665053|Boston Scientific|Patricia O'Mara, Clinical Trial Manager|518-792-5673|patricia.o'mara@bsci.com|
20514439|NCT01033383|Yale University|Dr. Manisha Juthani-Mehta|(203)785-7571|manisha.juthani@yale.edu|
20514440|NCT00210626|Centocor Ortho Biotech Services, LLC (COBS)|Vice President Medical Affairs|215-325-4464||
20514441|NCT00771901|Washington University School of Medicine in Saint Louis, Missouri|Samuel Klein, M.D.|314-362-8708|sklein@wustl.edu|
20514442|NCT02862535|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20514443|NCT02280356|Memorial Sloan Kettering Cancer Center|Dr. Marisa Kollmeier, MD|212-639-3952|KollmeiM@mskcc.org|
20514444|NCT01086215|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
20514445|NCT01965652|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
20514446|NCT02524106|University of California San Francisco|Priscilla Hsue, PI|415-206-8257|priscilla.hsue@ucsf.edu|
20514447|NCT01121900|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20514448|NCT03469271|Mayo Clinic|Aminah Jatoi, M.D.|507-266-0984|huyber.christine@mayo.edu|
20514449|NCT01328054|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514450|NCT04147715|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20514451|NCT00616928|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514452|NCT02173301|Dr Reddy's Laboratories Ltd.|Dr. Srinivas Shenoy B.,|49002900|srinivassshenoyb@drreddys.com|
20514453|NCT03740100|MD Anderson Cancer Center|Dr. Faye Johnson|7137922121|fmjohns@mdanderson.org|
20514454|NCT03120520|Bausch Health Americas, Inc|Clinical Operations Director|908-927-0873|lindsey.mathew@bauschhealth.com|
20514455|NCT02340156|SynerGene Therapeutics, Inc.|Senior Consultant|301-706-1509|clinicaltrial@synergeneus.com|
20514456|NCT01710306|Department of Veteran's Affairs- Office of Research and Development|Anne G. Sadler, Ph.D., R.N.|319-338-0581|anne.sadler@va.gov|7992
20514457|NCT02123459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20514458|NCT00528437|NYU Langone|Dr. Sharon Gardner|212-263-9913|Sharon.Gardner@nyulangone.org|
20514459|NCT00634283|Laboratory of Brain, Behavior, and Pharmacology at UCLA|Director of the Laboratory of Brain|310-825-0207|info@brain.ucla.edu|
20514460|NCT01386879|University of Missouri Columbia|Boris Mraovic|573-882-2568|mraovicb@health.missouri.edu|
20514461|NCT01715415|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20514462|NCT04136626|Massachusetts General Hospital|Dr. Sabine Wilhelm, Chief of Psychology|617-724-6146|swilhelm@mgh.harvard.edu|
20514463|NCT00628745|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514464|NCT04160078|Emory University|Dayna Johnson, PhD, MPH, MSW, MS|404-727-8708|dayna.johnson@emory.edu|
20514465|NCT03974152|Eastern Virginia Medical School|Dr. Paul Harrell|757-446-6047|harrelpt@evms.edu|
20514466|NCT00936377|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
20514467|NCT03877055|Memorial Sloan Kettering Cancer Center|Dr. Gilles Salles, MD, PhD|646-608-4153|SallesG@mskcc.org|
20514468|NCT00387712|Baltimore VAMC|Charlene Hafer-Macko|410-605-7000|charlene.hafer-macko@va.gov|5451
20514469|NCT02030574|Brown Oncology Research Groupl|Kristen M. Mitchell|4018633000|kristen_mitchell@brown.edu|
20514470|NCT01411267|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20514471|NCT00996866|Winthrop-University Hospital|John Aloia, MD|516-663-2442|jaloia@winthrop.org|
20514472|NCT00671879|Meda Pharma US|David Ginsberg, DO Sr Dir Medical Scientific Affairs|732 564 2347|david.ginsberg@meda.us|
20514473|NCT04633837|American Health Network|Brian Badman|317-208-3866|bbadman@gmail.com|
20514474|NCT02891200|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
20514475|NCT03907280|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514476|NCT03843957|Wake Forest University School of Medicine|Dr. David P. Miller, Jr|336-713-5218|dmiller@wakehealth.edu|
20514477|NCT04480463|SamChunDang Pharm. Co. Ltd.|Byung Jhip Ha, Director of Bio Research Center|+82-31-869-7327|scd411clinical@scd.co.kr|
20514478|NCT01399723|KEMRI-Wellcome Trust Research Prorgamme|Dr. Ambrose Agweyu|254202715160|aagweyu@kemri-wellcome.org|
20514479|NCT00810732|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514480|NCT03534986|International Biophysics Corporation|VP of Engineering and Quality|512-814-0046|quailty@biophysicscorp.com|
20514481|NCT00752791|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20514482|NCT04535609|Reneo Pharmaceuticals, Inc.|Alex Dorenbaum, MD, Chief Medical Officer|(415) 328-9115|adorenbaum@reneopharma.com|
20514483|NCT01769378|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20514484|NCT00678392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514485|NCT01958281|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20514486|NCT05117099|University of Oregon Prevention Science Institute|Dr. Allison Caruthers|503-412-3770|ascaru@uoregon.edu|
20514487|NCT02784106|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20514488|NCT00718159|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20514489|NCT00417274|Clevland BioLabs|Michael Kurman, MD|716-849-6810|mkurman@cbiolabs.com|
20514490|NCT00175019|Takeda Global Research & Development Center, Inc.|Senior Vice President, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20514491|NCT01405820|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20514492|NCT01665170|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiß|0641-7960|klinischeforschung@pascoe.de|
20514493|NCT03151499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514494|NCT00415532|Amgen Inc.|Study Director|866-572-6436||
20514495|NCT01952574|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20514496|NCT01189240|Adult Brain Tumor Consortium (ABTC)|Dr. Edward Pan||Edward.Pan@UTSouthwestern.edu|
20514497|NCT00770991|Cleveland Clinic|Dr. Carol Burke|216 444-6864|burkec1@ccf.org|
20514498|NCT02159859|Beaumont Health|Lama Hsaiky, Pharm.D. (Primary investigator)|313-593-7264|lama.hsaiky@beaumont.org|
20514499|NCT02087046|Abbott|Clinical Research Scientist|972-309-8000|mike.frassica@abbott.com|
20514500|NCT02444533|Mayo Clinic|Dr. Daniel Price|507-293-4395|Price.Daniel@mayo.edu|
20514501|NCT03567057|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
20514502|NCT00490061|Stanford University|Quynh Le|650-498-5032|qle@stanford.edu|6506370734
20514503|NCT00886483|The Ohio State University|L. Eugene Arnold, M.D. M.Ed.|614-685-6708|L.Arnold@osumc.edu|
20514504|NCT01945138|University of Minnesota|Dr. Melena Bellin|612-624-5409|bell0130@umn.edu|
20514505|NCT00947856|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20514506|NCT03929224|Michigan Ear Institute|Seilish Babu, MD|(248) 865-4444|sbabu04@gmail.com|
20514507|NCT03760510|Vanderbilt University Medical Center|Janna Landsperger|6153223412|janna.landsperger@vumc.org|
20514508|NCT00871728|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
20514509|NCT02418910|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
20514510|NCT01288833|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
20514511|NCT00686803|Palatin Technologies, Inc.|Robert Jordan, Executive Director of Clinical Operations|609.495.2200|rjordan@palatin.com|
20514512|NCT02472977|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Clinical.Trials@bms.com|Clinical.Trials@bms.com|
20514513|NCT00140556|Duke University Medical Center, Dept Radiation Oncology|David Brizel, MD|919 668-5637|david.brizel@duke.edu|
20514514|NCT03867383|Stanford University|Dr. Jessica Ansari|760-845-0328|jansari@stanford.edu|
20514515|NCT00566709|"University Hospital Virgen del Rocío"|Santiago R Leal-Noval, MD, PhD|0034954012528|srlealnoval@gmail.com|
20514516|NCT03331965|Duke University Medical Center|Dr. James Ronald|919.684.7299|james.ronald@duke.edu|
20514517|NCT02668302|Collin County ENT|Keith E Matheny, MD (Principal Investigator)|(972) 596-4005|kmatheny618@gmail.com|
20514518|NCT03775681|UT MD Anderson Cancer Center|Katherine Hagan, Associate Professor, Anesthesiology & PeriOper Med|(713) 794-5945|khagan@mdanderson.org|
20514519|NCT00895583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514520|NCT03558997|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20514521|NCT01149616|Beth Israel Deaconess Medical Center|Dr Lauren Fisher|6176671853|lauren_fisher@dmgaz.org|
20514522|NCT03529955|Tulane University|Carole Bitar, MD, FAAD|202-642-8122|cbitar@tulane.edu|
20514523|NCT01986790|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
20514524|NCT01491490|GW Research Ltd.|Mr Colin Stott|+44 (0)1980 557000|cgs@gwpharm.com|
20514525|NCT03016078|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
20514526|NCT02457728|St John of God Hospital Vienna|Bernhard Dauser, MD, PhD|+4321121|b.dauser@hotmail.com|5098
20514527|NCT02378506|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514528|NCT00254397|University of Texas MD Anderson Cancer Center|Patrick Hwu, MD / Professor, Melanoma Medical Oncology|713-792-2921|phwu@mdanderson.org|
20514529|NCT01070394|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
20514530|NCT03586830|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20514531|NCT04192799|The Dartmouth Institute for Health Policy & Clinical Practice|Stephanie Acquilano, Research Project Director|603-646-5937|stephanie.acquilano@dartmouth.edu|
20514532|NCT00458302|Jan-Cilag Germany|EMEA Medical Affairs Director Virology|+49 7624 907580||
20514533|NCT01144663|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20514534|NCT03015142|Philips|Rami Nachabe|+1-513-926-1486|rami.nachabe@philips.com|
20514535|NCT01466686|Sidney Kimmel Comprehensive Cancer Center @ Johns Hopkins Medicine|Kristin Redmond, MD|4109556980|kjanson3@jhmi.edu|
20514536|NCT01467063|Nemours Children's Health System|Dominique Darmaun|904-697-3674|Ddarmaun@nemours.org|
20514537|NCT02802514|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20514538|NCT01045499|Columbia University|Jeffrey Zitsman, MD|212-305-8862|jlz2@cumc.columbia.edu|
20514539|NCT03273387|Department of Cardiology and Vascular Medicine, Universitas Indonesia|dr. Bambang WIdyantoro, FIHA, PhD|+628128164299|bambang_ui@yahoo.com|
20514540|NCT00658320|Novartis Pharmaceuticals|Study Director|862-778-8300||
20514541|NCT00746668|Jesse Brown VAMC|Dr. Janet P. Szlyk, PhD|312-997-3644|Janet.Szlyk@va.gov|
20514542|NCT00557882|MedStar Washington Hospital Center|Andrew Sokol, MD|2028776526|andrew.i.sokol@medstar.net|
20514543|NCT01007916|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20514544|NCT02040428|Ethicon, Inc.|Richard Kocharian, MD, PhD|1 (908) 218-2013|rkochar1@ITS.JNJ.com|
20514545|NCT02058628|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514546|NCT02961920|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82324603624|jjchoi2@gilhospital.com|
20514547|NCT01172600|Cleveland Clinic|Alparslan Turan, MD|216-445-9857|turana@ccf.org|
20528832|NCT00271219|Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Johns Hopkins University School of Medicine|Dr. Hendree Jones|919-485-2664|hjones18@jhmi.edu|
20514548|NCT01927757|Amgen Inc.|Study Director|866-572-6436||
20514549|NCT00444795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
20514550|NCT00988169|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
20514551|NCT04690413|NOWDiagnostics|Beth Cobb|479-966-4531|beth.cobb@nowdx.com|
20514552|NCT02322879|BIDMC|Michael Ganetsky, MD|617-754-2323|mganetsk@bidmc.harvard.edu|
20551202|NCT02493621|MUSC|Sylvia Wilson|8437922322|wilsosh@musc.edu|
20514553|NCT00130520|Arizona Cancer Center, University of Arizona|Setsuko K. Chambers, M.D.|520-626-0950|schambers@azcc.arizona.edu|
20514554|NCT01464827|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20514555|NCT03487796|Rhode Island Hospital|Larry K. Brown, MD|(401) 793-8808|lkbrown@lifespan.org|
20514556|NCT00613574|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514557|NCT00176904|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
20514558|NCT04604184|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514559|NCT00582036|University of Oklahoma Health Sciences Center|George Selby, MD|405-271-4022|george-selby@ouhsc.edu|
20514560|NCT02711956|Zenith Epigenetics Ltd|Zenith Study Team|(415) 470-5600|ZEN003694-002@zenithepigenetics.com|
20514561|NCT05487456|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20514562|NCT01924871|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
20514563|NCT01625377|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20514564|NCT03513497|University of North Carolina at Chapel Hill|Julie Marchesan, DDS, PhD|919-537-3853|julie_marchesan@unc.edu|
20514565|NCT02043366|Tianjin Medical University General Hospital|Dr. Guolin Wang|+8615822855556|wangguolinghad@hotmail.com|
20514566|NCT01412541|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
20514567|NCT03294538|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20514568|NCT03295643|Pivot Health Technologies Inc.|Senior Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
20514569|NCT01489956|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20514570|NCT00422656|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
20514571|NCT01090765|National Cancer Institute|Dr. William Dahut|301-496-4251|dahutw@mail.nih.gov|
20514572|NCT01977092|Public Health Institute|Elizabeth Mahoney|(818)310-2684|lmahoney@bhrsca.org|
20514573|NCT01462565|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514574|NCT00782509|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514575|NCT00928083|Medicines for Malaria Venture|Dr. Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
20514576|NCT03222141|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
20514577|NCT00441584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20514578|NCT01584609|Penumbra, Inc.|Michaella Corso|(510) 748-3200|mcorso@penumbrainc.com|
20514579|NCT01418352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20514580|NCT00619619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514581|NCT01224210|Tufts Medical Center|Ioana Preston MD|617-636-7609|ipreston@tuftsmedicalcenter.org|
20514582|NCT01401478|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20514583|NCT01814137|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20514584|NCT01798485|Synta Pharmaceuticals|President, Chief Executive Officer|781-541-7261||
20514585|NCT03687125|Mundipharma Research Limited|Terry Nichols|(0044)1223424444|terry.nichols@mundipharma-rd.eu|
20514586|NCT01992107|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20514587|NCT02022007|Woman''s Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
20514588|NCT01214603|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20514589|NCT01507896|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20514590|NCT01413399|Mecklenburg EMS Agency|Jonathan R Studnek PhD|7049436046|jonst@medic911.com|
20514591|NCT01982383|Medical Faculty Associates|Nicole Swanson|202-741-2437|nswanson@mfa.gwu.edu|
20514592|NCT02746263|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20514593|NCT01523964|DART Therapeutics|Chief Operating Officer|415-341-5783|egoldstein@dartrx.com|
20514594|NCT03156270|Dept. of Otolaryngology-Head and Neck Surgery, The Ohio State University|Kai Zhao, PhD.|614-293-3857|zhao.1949@osu.edu|
20514595|NCT00446654|Progen Pharmacauticals Ltd|Director of Clinical Trials|+61 7 32739133||
20514596|NCT02087059|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20514597|NCT01261325|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
20514598|NCT01878656|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
20514599|NCT00947765|Dr. Chetan Muralidhara Rao Dojode. Resident in Orthopaedics and Traumatology.|Dr. Chetan Muralidhara Rao Dojode, MBBS,MS(Ortho)|91 9844592532|docchetanmd@yahoo.co.in|
20514600|NCT01033864|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20551203|NCT00632411|University of Tennessee Health Science Center|Dr. Robert Klesges|901-448-3174|lcolvin1@uthsc.edu|
20551204|NCT00770289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551205|NCT02733991|Medtronic Diabetes EMEA|Ohad Cohen M.D., Medical Affairs Director|+972 54 321 1108|ohad.cohen@medtronic.com|
20551206|NCT00765375|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
20551207|NCT02545101|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
20560734|NCT02347917|Sumitomo Dainippon Pharmaceutical|Clinical Research (Oncology)|e-mail only|cc@ds-pharma.co.jp|
20528833|NCT00099632|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20560735|NCT03736785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20560736|NCT02974010|NeuroRx|Martin Brecher|+1 484 254 6134|mbrecher@neurorxpharma.com|
20560737|NCT00728845|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20560738|NCT00320489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20528834|NCT02600611|Motif BioSciences|David Huang|936-577-5770|david.huang@motifbio.com|
20528835|NCT00571662|University of Nebraska Medical Center|R Gregory Bociek|402-559-5388|rgbociek@unmc.edu|
20528836|NCT03167255|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
20528837|NCT01429298|Department of Emergency Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
20528838|NCT03471832|CooperVision|Jose A.Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20528839|NCT02385110|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Professor|713-794-4392|NDaver@mdanderson.org|
20528840|NCT01888952|CTRC@UTHSCSA|Anand Karnad, MD|210-450-1000|karnad@uthscsa.edu|
20528841|NCT03300180|Indiana University School of Medicine; Indiana University Center for Aging Research; Regenstrief Institute, Inc.|Nicole R. Fowler, PhD, MHSA; Associate Professor of Medicine|317-274-9021|fowlern@iu.edu|
20528842|NCT00461097|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
20528843|NCT01554163|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20528844|NCT01941537|Rockefeller University|James Krueger|2123277730|kruegej@rockefeller.edu|
20528845|NCT00857961|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20528846|NCT05259163|Evolution Optiks|Raul Mihali|2039815480|raul.mihali@evolutionoptiks.com|
20528847|NCT05251233|Washington University School of Medicine|Natasha Leigh-Matijakovich, M.D.|314-362-7147|leigh@wustl.edu|
20528848|NCT01239394|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
20528849|NCT02603211|Temple University|Chang-hee Won|2152046158|cwon@temple.edu|
20528850|NCT00524771|Center for Epidemiology and Health Research, Germany|Dr. Juergen Dinger|0049 (0)30 945 101 20|dinger@zeg-berlin.de|
20528851|NCT00377637|Hoffman-LaRoche|Medical Communications|800-821-8590||
20528852|NCT01965002|Stanford Univeristy Medical Center|Pejman Ghanouni, MD, PhD|650-498-4485|ghanouni@stanford.edu|
20528853|NCT00493012|Heart and Diabetes Center North Rhine-Westfalia|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
20528854|NCT04147247|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20528855|NCT02915159|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20528856|NCT04534517|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20528857|NCT02121795|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230|ClinicalTrialDisclosures@gilead.com|
20528858|NCT00823264|Emory University|Dr. Brent Morgan|404-616-4403|bmorg02@emory.edu|
20528859|NCT03180957|University of Oxford|Professor Jagdeep Nanchahal|+44(001865 612633|jagdeep.nanchahal@kennedy.ox.ac.uk|
20528860|NCT03557918|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20528861|NCT04575090|UTSouthwestern Medical Center|Zahid Ahmand, MD|214-648-2377|zahid.ahmad@utsouthwestern.edu|
20560739|NCT00996372|Sprout Pharmaceuticals|VP, Clinical Development|9198820850|clinicaltrials@sproutpharma.com|
20528862|NCT03373760|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20560740|NCT05650333|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Centre|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560741|NCT03058783|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20560742|NCT03852433|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20560743|NCT02524288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560744|NCT00517933|Duke Clinical Research Institute|Kevin J Anstrom, PhD|919-668-8902|kevin.anstrom@duke.edu|
20560745|NCT05096884|Hackensack Meridian Health|Jana Tancredi|5519962353|Jana.Tancredi@hmhn.org|
20560746|NCT04927975|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20560747|NCT04678830|CytoDyn Inc.|Bernie Cunningham, PhD|(360) 980-8524|bcunningham@cytodyn.com|
20560748|NCT05550337|Teva Pharmaceuticals, Inc.|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
20560749|NCT01836458|Novartis Pharmaceuticals|Study Director|862-778-8300||
20560750|NCT00112112|MedImmune, LLC|Raburn Mallory|301-398-0000|malloryr@medimmune.com|
20560751|NCT02931396|University of Pittsburgh|Alicia Koontz|4128223700|akoontz@pitt.edu|
20560752|NCT00147043|Imperial College London|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
20560753|NCT04057196|Duke University|Katherine Ramos, Ph.D.|919-416-3434|Katherine.Ramos@duke.edu|
20560754|NCT01118377|Hoffmann-La Roche|Medical Communications|800 821-8590||
20560755|NCT02085356|University of Miami Miller School of Medicine|Violeta Rodriguez|3052432188|vjrodriguez@med.miami.edu|
20560756|NCT00739102|Cordis Corporation, a Johnson & Johnson company|Patricia Schleckser, Director Medical Affairs|908-541-4564|pschleck@its.jnj.com|
20560757|NCT01062126|Abbott (Previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim1@abbott.com|
20560758|NCT00646451|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
20560759|NCT03784963|The University of Chicago|Dr. Ann Nguyen, MD|773-702-9396|anguyen3@medicine.bsd.uchicago.edu|
20560760|NCT00349908|Codman & Shurtleff|J. Thomas Megerian, MD|508.828.8274|jmegerian1@its.jnj.com|
20560761|NCT00109967|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.||ansell.stephen@mayo.edu|
20514601|NCT02400710|Center for Integrated Healthcare, Syracuse Veterans Affairs Medical Center|Kyle Possemato, Ph.D.|315-425-4400|kyle.possmato@va.gov|53551
20514602|NCT03187080|University of Wisconsin School of Medicine and Public Health|Venkat Rao, MD, MBA|(608) 263-1223|rao@surgery.wisc.edu|
20514603|NCT02330081|Terumo BCT|Beth Crump|+1 303 231-4606|beth.crump@terumobct.com|
20514604|NCT00722111|VAHSRD|Dr. JoAnne Robbins|608-256-1901|bert.landreth@va.gov|11697
20514605|NCT02707432|University of North Carolina at Chapel Hill|Stephanie Hoover, PhD|919-966-1649|stephanie_hoover@med.unc.edu|
20560762|NCT02702921|Ethicon Endo Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
20560763|NCT01760291|Boston Scientific|Director of Clinical Trials|18002273422|peter.maurer@bsci.com|
20560764|NCT02052648|Lumos Pharma Corporation|Lumos Pharma, Inc.|515-598-2921|clinical.trials@lumos-pharma.com|
20560765|NCT01325870|Advanced Circulatory|Clinical Research Associate|651-403-5606|nburkhart@advancedcirculatory.com|
20560766|NCT01117480|AbbVie|Global Medical Information|800-633-9110||
20560767|NCT02955069|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20560768|NCT03721016|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
20560769|NCT03700658|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20560770|NCT04148937|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20560771|NCT02488317|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
20560772|NCT01149681|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
20560773|NCT02232178|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20560774|NCT00817635|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20560775|NCT00918957|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20560776|NCT03107611|Mylan Pharmaceuticals Pvt Ltd|Prasanna C Ganapathi, Clinical Sciences Program Lead|+91 9148448200|PrasannaC.Ganapathi@mylan.in|
20560777|NCT02753413|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560778|NCT01720446|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20560779|NCT01020838|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
20514606|NCT01957657|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514607|NCT01688037|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20514608|NCT02100956|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
20514609|NCT03035227|Kansas City Heart Rhythm Institute|Dr. Dhanunjaya Lakkireddy|913-449-1297|dhanunjaya.lakkireddy@hcahealthcare.com|
20514610|NCT01983020|Beth Israel Medical Center|Ronald Kaplan, MD||rkaplan@chpnet.org|
20514611|NCT04345471|Mochida Pharmaceutical Company, Ltd.|Director of Clinical Research Department|+81332256331|clinical.trials.contact@mochida.co.jp|
20514612|NCT01098240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514613|NCT03280537|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20514614|NCT01588106|GWT-TUD GmbH|Dr. Carsta Köhler|+49 (0) 351 25933 100|contact@gwtonline.de|
20514615|NCT01015612|Medtronic|Dr Deama Amr (PhD)|+61 2 9857 9157|deama.amr@medtronic.com|
20514616|NCT01016652|Johnson & Johnson Vision Care|Thomas R. Karkkainen OD, MS, FAAO Senior Principal Research Optometrist|(904)443-3402|TKarkkai@its.jnj.com|
20514617|NCT02034799|Ethicon, Inc|Senior Director of Ethicon Clinical R&D|(908) 218-2492|jbatill2@its.jnj.com|
20560780|NCT01167426|Teva Pharmaceuticals Medical Affairs|Thomas Smith, MD|816-508-5128|tom.smith@tevapharm.com|
20560781|NCT01524536|National Institute of Allergy and Infectious Diseases|Paneez Khoury|+1 301 402 3773|khouryp@niaid.nih.gov|
20514618|NCT01956279|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
20514619|NCT02265848|Center for Clinical Research / Carolinas Pain Institute|Dr. James North MD|3367656181|jhong@ccrpain.com|
20514620|NCT02322528|University of Rochester|Dr. James V. Aquavella|585-276-7439|rick_barrett@urmc.rochester.edu|
20514621|NCT01717898|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
20514622|NCT02224456|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20514623|NCT01241461|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20514624|NCT02497391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20514625|NCT01664052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20514626|NCT03740698|Imperial College London|Prof Nick Oliver|+44 (0)20 7594 1796|nick.oliver@imperial.ac.uk|
20514627|NCT00401882|Beaumont|David Haines, MD|248-898-4198|david.haines@beaumont.edu|
20514628|NCT02625766|University of Maryland Medical Center|Research Administrator|4103289579|NO'Hara@som.umaryland.edu|
20514629|NCT00633152|Cerexa, Inc.|Vice President, Clinical Sciences|510-285-9200|clinicaltrials@cerexa.com|
20514630|NCT05216978|Brigham and Women's Hospital|Dr. Hermioni Amonoo, Director of Well-Being and Cancer Research Program|‭617-525-7472‬|hermioni_amonoo@dfci.harvard.edu|
20514631|NCT02429869|University of California, San Francisco|Rodney Rogers|415-514-6454|Rodney.Rogers@ucsf.edu|
20514632|NCT03467412|Follicum AB|CEO Jan Alenfall|+46 (0)70 931 51 15|jan.alenfall@follicum.com|
20514633|NCT00789802|Washington University|Dr. Tessa Madden|3147471331|maddent@wustl.edu|
20528863|NCT01093586|Case Comprehensive Cancer Center|Brenda Cooper MD|216-844-3213|brenda.cooper@uhhospitals.org|
20514634|NCT01975090|Novate Medical|Gordon Crowley|+353 91 750 030|gordon.crowley@novate.ie|
20514635|NCT02410252|Partners Connected Health Innovations|Amanda Centi|6177242158|acenti@partners.org|
20514636|NCT03043274|University of Kentucky|Dr. Khaled M. Ziada|8593236036|khaled.ziada@uky.edu|
20514637|NCT03433001|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20514638|NCT00958581|NYU hospital for Joint Diseases|Dr. Thomas Errico (Chief of Spine), Dr. Kushagra Verma (Co-investigator)|212-598-6076|thomas.errico@nyumc.org; vermak01@gmail.com|
20514639|NCT00006170|University of Pittsburgh|Dr. Michele Levine|412-647-0703|levinem@upmc.edu|
20514640|NCT01162499|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
20514641|NCT01452529|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20514642|NCT01038557|Oregon Health & Science University|Dr. Martin A. Schreiber|503-494-8324|schreibm@ohsu.edu|
20560782|NCT04176458|Northwestern University|Daniel Ganger, MD|3126954496|daniel.ganger@nm.org|
20560783|NCT02131324|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
20560784|NCT00891618|University of Texas MD Anderson Cancer|Michael Wang, MD / Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
20560785|NCT04582877|Zurich Medical|Charles Chan|(612) 889-9412|cchan@zurichmed.com|
20560786|NCT00003656|Weill Cornell Medical College|Sharon Singh|(646) 962-9340|shs4011@med.cornell.edu|
20560787|NCT00742274|W.L. Gore and Associates|Jennifer Gorman|928-864-3381|jgorman@wlgore.com|
20560788|NCT00073957|Beth Israel Deaconess Medical Center|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
20560789|NCT04523181|Golden Biotechnology Corporation|Dr. Howard Cheng|+886228086006|howard@goldenbiotech.com|826
20560790|NCT01481935|University of Maryland School of Medicine|Anthony D. Harris, MD MPH|410-706-0064|aharris@epi.umaryland.edu|
20560791|NCT01560143|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
20560792|NCT01639443|West Los Angeles VA / Cedars-Sinai Medical Center|Jennifer Talley Soares|(310) 478-3711|jennifer.soares@va.gov|83240
20560793|NCT01248221|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
20560794|NCT04305912|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
20560795|NCT00928200|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20560796|NCT01268566|MedImmune, LLC, an affiliate of AstraZeneca|A Phase 2 Study of MEDI-575 in Adult Subjects with Recurrent Glioblastoma Multiforme|1-877-240-9479|information.center@astrazeneca.com|
20560797|NCT00601965|Veterans Medical Research Foundation|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
20560798|NCT01649427|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
20560799|NCT02138916|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
20560800|NCT01348087|Novartis Pharmaceuticals|Study Director|862-778-8300||
20514643|NCT04527471|Verona Pharma|Margot MacDonald-berko|833-417-0262|margot.macdonald-berko@veronapharma.com|
20560801|NCT00555581|Hospital for Special Surgery|Robert F. Spiera|212-774-2048|spierar@hss.edu|
20560802|NCT05822440|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20560803|NCT00117988|UT MD Anderson Cancer Center|Dr. Anas Younes, MD / Professor||etubbs@mdanderson.org|
20528864|NCT00613366|Oregon Health & Science University|Dr. Alison Edelman|503.494.5949|edelmana@ohsu.edu|
20560804|NCT02387749|Cairo university, faculty of medicine|Dina Mohammed Riad Ebrahim Abdelmagid|+201112052600|drdina_m@hotmail.com|
20560805|NCT02809911|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
20560806|NCT01113515|NovaLead Pharma Pvt. Ltd.|Supreet Deshpande|+91-866-965-6660|supreet@novaleadpharma.com|12
20514644|NCT01492582|University of Alabama at Birmingham|Dr. Wendy Landier, Deputy Director, Institute for Cancer Outcomes and Survivorship|(205) 638-2120|wlandier@peds.uab.edu|
20528865|NCT01968811|Sahlgrenska university Hospital|Dr Marcus Langenskiöld|+46 709 433160|marcus.langenskiold@vgregion.se|
20528866|NCT03868839|University of Massachusetts Medical School|Xiaoduo Fan|5088563881|xiaoduo.fan@umassmed.edu|
20514645|NCT01628120|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560807|NCT02482233|Royal Columbian Hospital / University of British Columbia|Dr. Susan Ming Lee|604-520-4253|susanlee.anesthesia@gmail.com|
20560808|NCT04888585|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20560809|NCT03822351|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20514646|NCT01165996|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|216-444-8170|saunthy@ccf.org|
20560810|NCT02237079|Tulane University|Dr. Franck Mauvais-Jarvis|504-988-5990|fmauvais@tulane.edu|
20560811|NCT02929069|Yale University|John Pachankis, PhD|(203) 785-3710|john.pachankis@yale.edu|
20560812|NCT02708862|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
20560813|NCT06044948|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|8884513937|alcon.medinfo@alcon.com|
20560814|NCT03788291|University of Rochester|Paul Barr, MD|585-273-3258|paul_barr@urmc.rochester.edu|
20560815|NCT02081391|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|Clinical-Trials@grunenthal.com|3223
20560816|NCT01458275|Sunovion|Respiratory Medical Director|1-866-503-6351||
20560817|NCT00813488|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
20560818|NCT01559090|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20560819|NCT03677375|Masimo|Tala Harake|9492977000|studies@masimo.com|
20560820|NCT00126113|National Center for Rehabilitative Auditory Research|Gabrielle Saunder Ph.D.|503-220-8262|gabrielle.saunders@va.gov|56210
20560821|NCT03971357|Price Vision Group|Marianne Price|317-814-2990|mprice@cornea.org|
20560822|NCT01143077|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
20560823|NCT01555762|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20560824|NCT01333514|Rush University Medical Center|Chung-Kay Koh|8475305230|chungkay@gmail.com|
20560825|NCT00819910|Brooke Army Medical Center|Ahmad Slim, MD|2109164717|ahmad.slim@us.army.mil|
20560826|NCT00836810|University of Bristol|Professor John Kirwan|+44 117 342 2904|John.Kirwan@Bristol.ac.uk|
20560827|NCT01912495|Erasmus MC|B.J.A.Rijnders|0031107034529|b.rijnders@erasmusmc.nl|
20560828|NCT00871429|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
20560829|NCT03102242|Mayo Clinic|Helen J. Ross, MD|4803018000|Ross.Helen@mayo.edu|
20560830|NCT05273801|Shirley Ryan AbilityLab|Dr. Miriam Rafferty|3122387233|mrafferty@sralab.org|
20560831|NCT04257058|Emory University|Dr. Jordan Marchak|404-727-2293|jgillel@emory.edu|
20560832|NCT03227757|Abbott|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
20560833|NCT03297112|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
20560834|NCT01144468|University Health Network|Dr. Angela Cheung|416-340-4841|jscher@uhnresearch.ca|
20560835|NCT02960659|NIDDK|Dr. Stephanie Chung|301-402-2122|stephanie.chung@nih.gov|
20560836|NCT04476472|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20560837|NCT00821184|Lahey Clinic|John T. Stoffel, MD|781-744-5481|John.T.Stoffel@lahey.org|
20560838|NCT04199728|Penn State College of Medicine|Dr. Scott Bunce|215-510-8295|sbunce@pennstatehealth.psu.edu|
20560839|NCT03068468|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20560840|NCT02555449|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20560841|NCT03895034|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
20560842|NCT01510912|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
20560843|NCT03181958|Children's Hospital of Chongqing Medical University|Dr.Yuan Shi|+86 23 68757731|shiyuan@hospital.cqmu.edu.cn|
20560844|NCT00959920|Loyola University Medical Center|Dr. Sarita Massey|708-354-9250|smassey@lumc.edu|
20560845|NCT02786771|Partners Connected Health Innovation|Odeta Dyrmishi - Acting Project Manager|6177243605|odyrmishi@partners.org|
20560846|NCT01063036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20560847|NCT01977612|Washington University School of Medicine|Lindsay Kuroki, M.D.|314-362-2368|kurokil@wustl.edu|
20514647|NCT00017563|OHSU Knight Cancer Institute|Tomasz Beer, M.D.|503-494-1080|beert@ohsu.edu|
20514648|NCT04081337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20514649|NCT02637076|CAMH|Dr. Stephen Kish|416-535-8501|stephen.kish@utoronto.ca|36256
20514650|NCT02642627|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
20514651|NCT02295774|Humanitas Research Hospital & Humanitas University|Alessandro Repici MD|00390282247493|alessandro.repici@hunimed.eu|
20514652|NCT01633827|Brigham and Women's Hospital|David Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
20514653|NCT05425966|University of California San Francisco|Lauren Haack, PhD|415-502-8060|lauren.haack@ucsf.edu|
20514654|NCT03267030|NOPHO|Dr Birgitte Klug Albertsen|+45 20224643|biralber@rm.dk|
20514655|NCT01851590|Department of Cardiac Surgery, Heart and Lung Centre, Helsinki University Hospital, Finland|Janne Jokinen, MD, PhD, Consultant Cardiothoracic Surgeon|50 554 8103|janne.jokinen@helsinki.fi|+358
20514656|NCT00696709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514657|NCT00310856|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20560848|NCT02715258|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20560849|NCT04208243|Children's Hospital Colorado|Dr. Jennifer Raybin|720-777-3407|jennifer.raybin@childrenscolorado.org|
20560850|NCT00943605|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20560851|NCT00913913|Dartmouth-Hitchcock Medical Center|Dr. Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
20560852|NCT01956669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20560853|NCT01908634|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
20560854|NCT01771666|Stanford University|Dr. Irene Wapnir|650-724-1953|Wapnir@stanford.edu|
20560855|NCT00464672|Novartis Vaccines and Diagnostics|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com|
20514658|NCT00443352|Thomas Jefferson University|William B Young, MD|215-955-2243|william.b.young@jefferson.edu|
20560856|NCT00601640|University of Arizona/Arizona Cancer Center|Joanne Jeter, MD|520.626.9295|jjeter@azcc.arizona.edu|
20514659|NCT02462070|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20514660|NCT00321711|Amgen Inc.|Study Director|866-572-6436||
20514661|NCT01186978|Duke University Health System|Assistant Research Practice Manager (ARPM) for Clinical Trials|919-668-5211|Jennifer.Mewshaw@duke.edu|
20514662|NCT01227668|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20514663|NCT01306253|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20514664|NCT00543439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514665|NCT01709383|Georgetown University|Elizabeth H. Lacey, PhD, Study Coordinator|202-877-1124|ehl4@georgetown.edu|202
20514666|NCT00583596|St. Jude Medical Formally AGA Medical Corporation|Jeffrey Mifek|6517565586|jmifek@sjm.com|
20514667|NCT01855126|Rensselaer Polytechnic Institute|Mariana Figueiro|(518)687-7142|figuem@rpi.edu|
20514668|NCT00656019|StanfordU|Dr. Melinda Telli|650-724-9533|steinhau@stanford.edu|
20514669|NCT02407756|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20514670|NCT01166971|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20514671|NCT04326842|The First Affiliated Hospital of Harbin Medical University|Dr. Hong Zhang|+86 0451-85553952|2315186458@qq.com|
20514672|NCT00961051|Abbott Medical Optics|Eugenia Thomas, O.D.|714-247-8723|eugenia.thomas@amo.abbott.com|
20514673|NCT01357356|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20514674|NCT03944785|Supernus Pharmacueticals|Gianpiera Ceresoli-Borroni|301-838-2521|gceresoliborroni@supernus.com|
20514675|NCT04535583|Geisel School of Medicine at Dartmouth|Dr. Lisa A. Marsch|603-646-7092|lisa.a.marsch@dartmouth.edu|
20514676|NCT01078090|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20514677|NCT00924066|National Cancer Institute|Antonio Fojo, M.D.|301-496-2631|fojot@mail.nih.gov|
20514678|NCT01748890|Massachusetts General Hospital|Anthony E. Samir|6178523241|asamir@partners.org|
20514679|NCT02669264|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20514680|NCT00526890|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20514681|NCT02220907|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20514682|NCT02995837|University of Miami|Ignacio Tapia, MD|3052439885|itapia@miami.edu|
20514683|NCT01859702|Alcon Research, Ltd.|Abayomi Ogundele, Global Medical Affairs Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20514684|NCT03369756|B. Braun Medical Inc.|Dr. Diana Valencia|610-596-2875|diana.valencia@bbraunusa.com|
20514685|NCT04014959|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
20514686|NCT05286528|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514687|NCT02004847|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
20514688|NCT03827213|Montefiore Medical Center|Elilary Medilla Medrano|(718) 920-4316|emontill@montefiore.org|
20514689|NCT03381248|Avanos Medical|David Curd|470-448-5178|david.curd@avanos.com|
20514690|NCT05188521|Mayo Clinic|Dr. Aaron R. Mangold, Principal Investigator|480-301-9196|mangold.aaron@mayo.edu|
20514691|NCT01341639|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514692|NCT04582266|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20514693|NCT00202449|VA PSHCS|Murray Raskind, MD|206-764-2702|Murray.Raskind@va.gov|
20514694|NCT01379781|Columbia University Medical Center|Catherine Monk, Ph.D., Assoc Professor|(646) 774-8941|cem31@columbia.edu|
20514695|NCT02247479|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
20514696|NCT01132118|Brigham and Women's Hospital|Dr. Daniel H. Solomon|617-525-8127|dsolomon@partners.org|
20514697|NCT04942379|UMass Chan Medical School|Dr. Michelle Trivedi|7744418086|Michelle.Trivedi3@umassmed.edu|
20514698|NCT03287050|University of Michigan|Zachery Reichert|764-3066|zreiche@med.umich.edu|
20514699|NCT03889756|Yale University|Dr. Michael Bloch|203 7374809|michael.bloch@yale.edu|
20514700|NCT01717014|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
20514701|NCT00820235|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20514702|NCT01299038|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
20514703|NCT00322556|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20514704|NCT00832078|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
20514705|NCT03551730|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20514706|NCT00955032|Center for Neurological Restoration Cleveland Clinic|Dr. Hubert Fernandez|(216) 445-1108|fernandez@neurology.ufl.edu|
20560857|NCT01710514|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20514707|NCT05432271|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
20514708|NCT03158298|Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany|Dr. Benjamin Schleenvoigt|+49 3641 9 32 46|benjamin.schleenvoigt@med.uni-jena.de|70
20560858|NCT01078233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560859|NCT04490148|Penn State College of Medicine|Dr. Andrew Geronimo|717 531 0003|ageronimo@pennstatehealth.psu.edu|282576
20514709|NCT01259427|VISN 5 MIRECC|Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
20514710|NCT03020472|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20528867|NCT01936363|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20528868|NCT02372344|AstraZeneca Pharmaceuticals|Stefan C Carlsson, MD, PhD, Global Clinical Lead|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20528869|NCT00872521|Jan-Cil Australia|Regional Medical Affairs Director Asia Pacific|61 427564369||
20528870|NCT05225558|LigaChem Biosciences, Inc.|Seonghye Cheon|+82)2-6952-0689|scheon@ligachembio.com|
20528871|NCT03006562|Johns Hopkins Brady Urological Institute|Dr. Mohamad Allaf|410-955-6100|mallaf@jhmi.edu|
20528872|NCT02644278|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20528873|NCT01089127|Novartis Pharmaceuticals|Study Director|862 778-8300||
20528874|NCT03200548|University of Michigan|Suzanna Zick|734-998-9553|szick@med.umich.edu|
20528875|NCT00572260|Duke University Health System|Yong Choi, Clinical Research Coordinator|919-684-7584|yong.choi@duke.edu|
20528876|NCT00875563|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
20528877|NCT00059228|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
20528878|NCT02427841|OHSUKCI|Dr. Gina Vaccaro|503-216-6300|vaccarog@ohsu.edu|
20528879|NCT00511810|University of Cincinnati|Robert McNamara, PhD|513-558-5601|robert.mcnamara@uc.edu|
20528880|NCT02896569|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20528881|NCT00313846|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20528882|NCT00970489|Harvard School of Public Health|Namasha Schelling|617-432-1734|nschelling@hsph.harvard.edu|
20528883|NCT02592447|H Lee Moffitt Cancer Center and Research Institute|Heather Jim, PhD|813-745-6369|Heather.Jim@moffitt.org|
20528884|NCT03428100|Eli Lilly and Company|Chief Medical Officer|800-459-5979|ClinicalTrials.gov@lilly.com|
20528885|NCT03861780|Bioscience Laboratories|Principal Investigator II/Training Coordinator|(406) 587-5735|cduley@biosciencelabs.com|110
20528886|NCT03929263|Oklahoma State University|Kara Kerr|9186971478|kara.kerr@okstate.edu|
20528887|NCT01096160|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20528888|NCT00627497|Medtrionic spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20528889|NCT02855567|Icahn School of Medicine at Mount Sinai|Dr. Charles Ascher-Walsh|212-241-2827|Charles.ascher-walsh@mssm.edu|
20528890|NCT01556932|Virginia Commonwealth University/ Hospice & Pallative Medicine|Devon S. Flecher, MD|804-828-9723|dsfletcher@mcvh-vcu.edu|
20528891|NCT03231306|UAB|Coretta Thomas, Scientist & Data Manager for NF Consortium|2059758629|coretta@uab.edu|
20528892|NCT01808261|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528893|NCT02264210|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|86-20-87343439|wangsy@sysucc.org.cn|
20528894|NCT03956030|Penn State Health, Milton S. Hershey Medical Center|Dr. Christina DeAngelis|717-531-5994|cdeangelis2@pennstatehealth.psu.edu|3763
20528895|NCT04501952|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20528896|NCT02080364|vTv Therapeutics LLC|Ann Gooch PhD,RAC,CCRP; Vice President Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
20528897|NCT00991289|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20528898|NCT01456143|Mt Sinai|Brett Miles||Brett.Miles@mountsinai.org|
20528899|NCT05568797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20528900|NCT02797678|Philips Respironics|Senior Data Manager|7243877949|Jeff.Jasko@philips.com|
20528901|NCT03131687|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20528902|NCT02401035|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20528903|NCT00869128|Shoham Geriatric Medical Center, Pardes Hana, Israel|D. Garfinkel , MD|Tel: 972-4-6375667|dorong@shoham.health.gov.il|
20528904|NCT05137002|CinCor Pharma|Yuan-Di Halvorsen|617-675-8126|yhalvorsen@cincor.com|
20528905|NCT01670045|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20528906|NCT00768287|Medexus Pharma, Inc.|Clinical Trial Manager|1-312-548-3125|julissa.leon@medexus.com|
20528907|NCT03046953|CRCTU Birmingham|C Morland Cinical Trial Coordinator|+44 121 371 7862|avail-t@trials.bham.ac.uk|
20528908|NCT03828214|College of St. Scholastica|Dr. Alexandra Borstad|614-395-1708|aborstad@css.edu|
20528909|NCT04283253|UNIVERSITY OF PITTSBURGH|George Wittenberg|4126484178|GEOWITT@PITT.EDU|
20528910|NCT00420628|Bausch & Lomb|Timothy Comstock OD|(585) 338-6631|tcomstock@bausch.com|
20528911|NCT02716584|VA Greater Los Angeles Healthcare System|Dr. Robert Kern|310-478-3711|Robert.Kern2@va.gov|49229
20528912|NCT01830933|University of California, San Francisco|Celia P. Kaplan, Professor|415-502-5601|celia.kaplan@ucsf.edu|
20528913|NCT01868165|Imperial College London|Dr Ruth Peters|07950289662|r.peters@imperial.ac.uk|
20528914|NCT00103285|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20528915|NCT00452439|University of Texas (UT) MD Anderson Cancer Center|Maria Cabanillas, Associate Professor, Endocrine Neoplasia and HD|(713) 563-0764|mcabani@mdanderson.org|
20528916|NCT01381926|UAB|Dr. Amy Warriner|205-996-4004|awarriner@uabmc.edu|
20528917|NCT02271217|Acorda Therapeutics|Holly Roberts, Executive Medical Director|914-326-5000|hroberts@acorda.com|
20528918|NCT03974802|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20528919|NCT02624947|Novavax Inc|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20528920|NCT01550510|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
20528921|NCT03107182|University of Chicago|Ari Rosenberg|773-702-8222|arirosenberg@bsd.uchicago.edu|
20528922|NCT05787860|Icahn School of Medicine at Mount Sinai|Giselle Singer|212-241-3288|giselle.singer@mssm.edu|
20528923|NCT06785090|College of Medicine, University of Baghdad|Enas Sabeeh|09647704294077|inas.abd2206m@comed.uobaghdad.edu.iq|
20528924|NCT01065558|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
20560860|NCT00683410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560861|NCT03586167|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20560862|NCT00591838|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4633|clifford.robinson@wustl.edu|
20560863|NCT03761784|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
20560864|NCT02001714|Beaumont Health|Ananias C. Diokno, MD||ananias.diokno@beaumont.edu|
20560865|NCT04163458|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20560866|NCT00295867|UCSF Helen Diller Family Comprehensive Cancer Center|Hope S. Rugo|415-353-7618|hrugo@medicine.ucsf.edu|
20560867|NCT01981850|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20560868|NCT01467700|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20560869|NCT01078246|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20560870|NCT00121199|SWOG Statistical Center|Study Statistician|206-667-4623||
20560871|NCT03168438|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20560872|NCT01103973|Boston IVF|Alice D. Domar, PhD|781-434-6500|domar@domarcenter.com|
20560873|NCT04109118|Boston Medical Center and BU School of Medicine|Tae Woo Park, MD|617-414-1906|taewoo.park@bmc.org|
20514711|NCT00096265|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
20560874|NCT01830842|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|MAddicott@uams.edu|501
20560875|NCT03235349|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20560876|NCT03394027|National Cancer Institute|Dr. Stanley Lipkowitz|240-760-6129|lipkowis@navmed.nci.nih.gov|
20560877|NCT04432974|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia|Dr. Massimiliano Paltenghi|(+39) 3487046844|massimiliano.paltenghi@spedalicivili.brescia.it|
20560878|NCT05191797|University of Washington|Rafael Santana-Davila|2066062190|rafaelsd@uw.edu|
20560879|NCT05887323|Abbott|Director of Clinical Research|9725269673|kwangdeok.lee@abbott.com|
20560880|NCT01018511|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
20560881|NCT00658411|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
20560882|NCT02926937|Lexicon Pharmaceuticals, Inc,|Medical Affairs|338-6064|medical-information@lexpharma.com|(510)
20560883|NCT04985383|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
20560884|NCT01729871|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20560885|NCT01137292|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560886|NCT01772719|University of Louisville, James Graham Brown Cancer Center|James Graham Brown Cancer Center, Clinical Trials|502-562-3429|ctobcc@louisville.edu|
20560887|NCT03663101|Ipsen Innovation SAS|Medical Director|see email|clinical.trials@ipsen.com|
20560888|NCT00477412|UT MD Anderson Cancer Center|Michael Wang, Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
20560889|NCT05365633|University of Oklahoma|Dr. Julia McQuoid|405-271-8001|julia-mcquoid@ouhsc.edu|1
20560890|NCT00661778|Hoffmann-La Roche|Medical Communications|800 821-8590||
20560891|NCT02695290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20560892|NCT02891629|EyeFree Assisting Communication|Or Retzkin, CEO|+972526490093|or@eyecontrol.co.il|
20560893|NCT02734056|Brigham|Bhavani Kodali|6175258449|kodali@zeus.bwh.harvard.edu|
20560894|NCT01249092|Cleveland Clinic|Claudia O. Zein, MD|216-444-0421|zeinc@ccf.org|
20560895|NCT00802919|Nathan Kline Institute for Psychiatric Research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
20514712|NCT01506323|VA San Diego Healthcare System|Dr. Jill E. Bormann|858-552-8585|jill.bormann@va.gov|x2378
20514713|NCT02232074|Boston Medical Center|Tracy Battaglia|617.638.8036|tracy.battaglia@bmc.org|
20560896|NCT00151996|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20560897|NCT02657629|HackensackUMC|Nicole Spillane MD|917-446-6656|nspillane@hackensackumc.org|
20560898|NCT04866407|Rutgers RWJMS|Dr Sydney Asselstine|6469403587|sydneyasselstine@gmail.com|
20560899|NCT02001623|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
20560900|NCT03669354|Southern California University Of Health Sciences|Anupama Kizhakkeveettil|(562) 475-5158|anu@scuhs.edu|
20560901|NCT02175212|Hospital Universitario de la Princesa; Health Research Institute IIS from Hospital Universitario de la Princesa|Dr. Almudena Zapatero|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
20560902|NCT01570751|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20560903|NCT01072357|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
20560904|NCT01876511|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20560905|NCT00315120|University of North Texas Health Science Center-The Osteopathic Research Center|John C. Licciardone, DO, MS, MBA|817-735-2028|john.licciardone@unthsc.edu|
20560906|NCT05419557|Inova Health System|Dr. Elyssa Wood|5714728649|elyssa.wood@inova.org|
20560907|NCT00016913|Department of Medicine, Memorial Sloan-Kettering Cancer Center|Wm. Kevin Kelly, DO||kellyw@mskcc.org|
20560908|NCT01196988|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560909|NCT00601848|University of Pennsylvania|Keith A Cengel, MD, PhD|(215) 615-5312|cengel@pennmedicine.upenn.edu|
20560910|NCT04012853|WJB Dorn VA Medical Center|Dr. X. Michelle Androulakis Chief of Neurology|803-776-4000|xiao.androulakis@va.gov|4077
20560911|NCT04304534|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20560912|NCT01695317|St. olavs Hospital|Dr. knut Hagen|95401579|knut.hagen@stolav.no|
20514714|NCT00704418|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
20560913|NCT03055767|"University of California, Irvine | Dept. of Anesthesiology & Perioperative Care"|Shalini Shah, MD|(949) 824-7246|ssshah1@hs.uci.edu|
20560914|NCT02228408|New York University Medical Center|David Charytan|(646) 501-9086|david.charytan@nyulangone.org|
20560915|NCT02759731|National Cancer Institute|Dr. Steven Pavletic|240-760-6174|pavletis@mail.nih.gov|
20560916|NCT00618540|University of Minnesota, Pediatric BMT|Dr. Angela Smith, MD|612-626-2778|smith719@umn.edu|
20560917|NCT01466881|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|hongli@fredhutch.org|
20560918|NCT00606580|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
20560919|NCT01101165|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
20560920|NCT04580303|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
20560921|NCT01833065|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20560922|NCT01444287|Vistakon|Noel Brennan|1 904 4433494|nbrenna2@its.jnj.com|
20560923|NCT00434278|Genentech, Inc.|Medical Communications|800-821-8590||
20560924|NCT02299635|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560925|NCT00828672|UZ Leuven|Prof. Dr. Eric Van Cutsem|+32 16 34 42 18|Eric.VanCutsem@uzleuven.be|
20560926|NCT02427737|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant sponsoring site-PIs); CEO|617 734 9087|drevlang@ComfortTalk.com|
20560927|NCT01134575|The University of Texas MD Anderson Cancer Center|Hagop M. Kantarnian, MD/Chair|713-792-7026|hkantarjian@mdanderson.org|
20560928|NCT02047461|Origin Biosciences (affiliate of BridgeBio)|Business Development and Operations|650-391-9740|info@bridgebio.com|
20560929|NCT00015457|National Institutes of Health|Barbara I Karp, MD|301-496-0150|karpb@ninds.nih.gov|
20560930|NCT04974489|University of North Carolina, Chapel Hill|M. Justin Byron, PhD|(919)966-3292|jbyron@unc.edu|
20560931|NCT01456936|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560932|NCT03095508|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
20560933|NCT02317705|On Target Laboratories|Tommy Lee, MSHS, Vice President, Clinical Operations|765-588-4547|Tlee@ontargetlabs.com|
20560934|NCT01674569|Tyrogenex, Inc|Sr Vice President, Development|240-403-7153|Dan@tyrogenex.com|
20560935|NCT01599325|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20560936|NCT01878890|Institut Bergonié|Dr Guilhem Roubaud|33 5 56 33 33 33|g.roubaud@bordeaux.unicancer.fr|
20560937|NCT00578214|Mayo Clinic|Dr. Clark C. Otley|507-284-3579|otley.clark@mayo.edu|
20560938|NCT05674370|Mayo Clinic|Dr. Matthew Binicker|507-284-3697|binnicker.matthew@mayo.edu|
20560939|NCT02701361|Duke University Health System|Christopher Cox|9196817232|christopher.cox@duke.edu|
20560940|NCT02410291|Sunnybrook Health Sciences Centre|Krista Dawdy, Clinical Educator|416 480 6104|krista.dawdy@sunnybrook.ca|
20560941|NCT00097253|The Ohio State University, Department of Psychiatry|Janice K. Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
20514715|NCT01579474|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20560942|NCT02430532|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20560943|NCT03256344|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20560944|NCT01879371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20560945|NCT02606734|Osprey Medical|Michele Shepard|952-955-5236|mshepard@ospreymed.com|
20560946|NCT00580801|Janssen Research & Development, LLC, Titusville, NJ|Clinical Leader|609-730-3174||
20560947|NCT02595398|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20560948|NCT00502593|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560949|NCT02121418|University of Washington|Dr. Pamela Becker|206-606-7273|pbecker@u.washington.edu|
20560950|NCT00880906|Vanderbilt University|Michael Vaezi, MD, PhD|615-322-3739|michael.vaezi@vanderbilt.edu|
20560951|NCT01534910|Los Angeles Biomedical Research Institute|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
20560952|NCT00544440|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024|Senior Director|310-943-8040||2917
20560953|NCT03601507|University of Arizona Cancer Center|Ricklie Julian, MD|520-694-2873|rickliej@arizona.edu|
20560954|NCT01664104|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20560955|NCT03061513|Weill Cornell Medical College|Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
20560956|NCT01460342|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20560957|NCT02107014|University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu|
20560958|NCT00586339|GlaxoSmithKline|GSK Response Center|866-435-7343||
20560959|NCT03523962|University of Maryland, Baltimore|Research Administrator|410-706-6823|ahowe@som.umaryland.edu|
20514716|NCT01075763|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20514717|NCT00586521|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20514718|NCT00747552|University of Utah|Donald Null M.D.|801.588-3865|donald.null@imail.org|
20514719|NCT03083483|Duke University|Hannah Palmer|919-613-7665|hlp14@duke.edu|
20514720|NCT00580853|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
20514721|NCT03581474|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
20514722|NCT01626820|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514723|NCT04579926|Klein Buendel, Inc.|Julia Berteletti|3035654321|jberteletti@kleinbuendel.com|
20514724|NCT02588573|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
20560960|NCT03727854|Seoul National University Hospital|Professor|82-2-2072-2217|ymchomd@snu.ac.kr|
20560961|NCT01081145|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20560962|NCT04210024|University of Kentucky|Dr. Brittany Smalls|859-323-4916|brittany.smalls@uky.edu|
20514725|NCT01751412|Massachusetts General Hospital|Thomas F. DeLaney, MD|617-726-6876|TDELANEY@mgh.harvard.edu|
20560963|NCT01311713|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20560964|NCT04549051|Albert Einstein College of Medicine|Sayed Wahezi, M.D.|718-920-7246|swahezi@montefiore.org|
20560965|NCT00731211|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20514726|NCT01711021|Noven Pharmaceuticals, Inc.|Study Director|(305) 253-5099|ClinicalTrials@noven.com|
20514727|NCT01673009|Indiana University|Kent Robertson MD PhD|317-944-8784|krobert@iu.edu|
20514728|NCT01844583|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20514729|NCT00449072|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
20514730|NCT02623959|UT MD Anderson Cancer Center|Ost,David,M.D. / DOST@MDANDERSON.ORG|713-745-8775|DOst@mdanderson.org|
20514731|NCT01787825|CapsoVision, Inc.|Director of Clinical Affairs|408-624-1488|andra.thomas@capsovision.com|117
20514732|NCT03352427|University of Michigan|Carl Koschmann, MD|734-615-2736|ckoschma@umich.edu|
20514733|NCT04394754|Yale University|Francis Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
20514734|NCT00989261|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
20514735|NCT03291509|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
20514736|NCT00617461|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20514737|NCT01821625|UT Southwestern Medical Center at Dallas|William M Lee, MD|214 645 6111|william.lee@utsouthwestern.edu|
20514738|NCT02950753|UMCSouthernNevada|Dr. Tony Zitek|702-383-7885|zitek10@gmail.com|3
20514739|NCT03503474|University of Leeds|Professor Mark Wilcox|+441133926818|mark.wilcox@nhs.net|
20514740|NCT03559010|HRA Pharma|Christine VENARD|33 1 84 13 92 44|c.venard@hra-pharma.com|
20514741|NCT00457665|UTSouthwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
20514742|NCT00565370|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20514743|NCT02535000|Serviço de Anestesiologia de Joinville|Antonio Bedin|+554734331666|abjoimailbox-ct@yahoo.com|
20514744|NCT01847196|BiO2 Medical|Margaret Tumas, VP of Clinical Affairs|720-635-3232|mtumas@bio2medical.com|
20514745|NCT00168337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20514746|NCT01620489|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20514747|NCT03979209|Rush UMC|Bobby Tajudeen, MD|312-942-6100|Bobby_Tajudeen@rush.edu|
20514748|NCT04749524|Intelligent Hearing Systems Corp|Dr. Rafael E. Delgado|305-668-6102|redelgado@ihsys.com|
20514749|NCT03264066|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20514750|NCT01484028|Vistakon, Johnson and Johnson Vision Care|Dr. Michael Mayers, O.D., FAAO, Senior Research Optometrist|1 904 443 3252|mmayers@its.jnj.com|
20514751|NCT02922959|University of Cincinnati Addiction Sciences Division|Theresa Winhusen|5135858292|winhust@ucmail.uc.edu|
20514752|NCT03872700|Montefiore Medical Center|Dr. Benjamin W Friedman|718-920-6626|befriedm@montefiore.org|
20514753|NCT00492206|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|412-648-6507|tarhiniaa@upmc.edu|
20514754|NCT01193517|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-792-2828|moverman@mdanderson.org|
20514755|NCT01360450|Johns Hopkins Medical Institution|Estelle B Gauda|4106140151|egauda1@jhmi.edu|
20514756|NCT02115256|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
20514757|NCT00146770|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20514758|NCT01185288|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20514759|NCT01505465|HSS|Dr. Memtsoudis|(212) 606-1000|MemtsoudisS@hss.edu|
20514760|NCT01626859|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20514761|NCT02427607|Eisai Co., Ltd.|Hidetaka Hiramatsu|+81-3-3817-5245|esi_medinfo@eisai.com|
20514762|NCT02277769|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20514763|NCT02826603|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20514764|NCT00905489|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514765|NCT03621085|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
20514766|NCT01626885|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20514767|NCT00974142|University of Pittsburgh Medical Center|Michael Donahoe MD|412-648-9636|donahoem@upmc.edu|
20514768|NCT00982410|Ann Arbor Veteran Affairs|Dr. Mark Ilgen|(734) 845-3646|Mark.Ilgen@va.gov|
20514769|NCT01557595|UAB|Dr. Rachel Fargason|205-934-5151|rfargason@uab.edu|
20514770|NCT00759148|Alcon Research, Ltd.|Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20514771|NCT01073020|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 1966|mary.elizabeth.patti@joslin.harvard.edu|
20514772|NCT01644890|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
20514773|NCT04642950|Nobel Pharma Co. Ltd.|Information Desk|+81-3-6670-3800|taniguchi.masaki@nobelpharma.co.jp|
20514774|NCT02452060|NYU Langone Medical Center|Jing Wang|212-460-0176|jing.wang@nyulangone.org|
20514775|NCT03031899|The Oxford Dental college|Dr. Anisha Yaji|9480718531|dr.anishayaji@gmail.com|
20514776|NCT01060670|Integra LifeSciences, Inc.|Katie Bush, PhD- Manager, Global Medical Affairs- Tissue Technology|617-268-1616|katie.bush@integralife.com|267
20514777|NCT00094302|New England Research Institutes|Brian Harty|617-972-3224|bharty@neriscience.com|
20514778|NCT04089982|Duke University|James M. Davis, MD|919-668-5055|james.m.davis@duke.edu|
20514779|NCT01535326|Dalin Tzu Chi Hospital|Dr. Yu-Hsi Hsieh|88652648000|hsieh.yuhsi@msa.hinet.net|5241
20528925|NCT03654729|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46732344698|kristina.sjoblom@egetis.com|
20528926|NCT01449734|CSCC Germany, Jena University Hospital|Christiane Hartog, MD|+49 3641 9323171|christiane.hartog@med.uni-jena.de|
20528927|NCT02675764|Medical University of South Carolina|Dr. Na Jin Seo|8437920084|seon@musc.edu|
20528928|NCT00335517|University of Rochester|Glenn Rectine, MD|585-275-8780|glenn_rectine@urmc.rochester.edu|
20528929|NCT00052078|Johns Hopkins University|John Walkup|212-746-1891|jtw9001@med.cornell.edu|
20528930|NCT04780815|ImperialBrands PLC|Simon McDermott|+44 (0)117 332 0225|simon.mcdermott@uk.imptob.com|
20528931|NCT02245815|Instituto Mexicano del Seguro Social|Dra. Guadalupe Gómez Rodríguez|477 75 23 166|lupitaneonato@gmail.com|
20528932|NCT01919164|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20528933|NCT01398852|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
20528934|NCT00588146|Mayo Clinic|Karen L. Swanson, D.O.|507-255-3214|swanson.karen@mayo.edu|
20528935|NCT02100839|Linear Clinical Research Ltd|Dr. Janakan Krihnarajah, MBBS (Hons), FRACP|800 393 8820|JKrishnarajah@linear.org.au|
20528936|NCT03442725|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
20528937|NCT01543568|Retina Consultants of Houston|David Brown, MD|713-524-3434|dmbmd@houstonretina.com|
20528938|NCT03440619|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20528939|NCT00463801|Novartis Pharmaceuticals|Study Director|862-778-8300||
20528940|NCT03272347|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20528941|NCT00940888|Saint Jude Medical|Grant Kim, Director Clinical Studies|818-493-3147|gkim@sjm.com|
20528942|NCT00578279|Indiana University Medical Center|Julia K. LeBlanc, MD|(317) 948-8125|juleblan@iupui.edu|
20528943|NCT00678015|University of California, San Francisco|Dr. Terence Friedlander|415-353-7171|terence.friedlander@ucsf.edu|
20528944|NCT01971567|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
20528945|NCT00391872|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20528946|NCT01409915|"University of Colorado Denver | Anschutz Medical Campus"|John O'Shaughnessy, MS, Clinical Research Services Principal Professional|3037247924|john.oshaughnessy@cuanschutz.edu|
20528947|NCT00511173|Creighton University|Christopher Destache|402-280-4744|destache@creighton.edu|
20514780|NCT03705351|Providence Health & Services|Chiayi Chen / Director of PBSI and WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
20514781|NCT00494975|Dermatology|Ko Mei-Ju|886-223123456|kmjmay@gmail.com|2141
20514782|NCT00929500|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
20514783|NCT02710071|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
20514784|NCT03734237|USUHS|Timothy Burgess, MD, MPH|(301) 295-9792|timothy.burgess@usuhs.edu|
20514785|NCT01236170|VA Pittsburgh Healthcare System|Dr. Larissa Myaskovsky|4123602241|Larissa.Myaskovsky@va.gov|
20514786|NCT02833415|University of Texas Southwestern Medical Center|Ian J. Neeland MD|214-645-1267|ian.neeland@utsouthwestern.edu|
20514787|NCT01238848|Hospital General de Niños Pedro de Elizalde|Maria I. Espelt, MD|541146136968|cespelt@fibertel.com.ar|
20514788|NCT00576901|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20514789|NCT02398188|Neothetics, Inc.|Neothetics Clinical|858-550-1900||
20514790|NCT01259869|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
20514791|NCT06076681|TenNor Therapeutics (Suzhou) Limited.|TenNor Medical Information|0512-86861979|info@tennorx.com|
20514792|NCT03209570|Insight Therapeutics, LLC|H. Edward Davidson, PharmD, MPH|7576246040|EDavidson@inther.com|
20514793|NCT00118053|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20514794|NCT00220701|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
20514795|NCT01176448|University of Virginia Dept of Otolaryngology Head and Neck Surgery|J. Jared Christophel MD|434-243-9391|jjchristop@gmail.com|
20514796|NCT00755326|University of Maryland Center for Integrative Medicine|Brian M. Berman|410706-6181|bberman@som.umaryland.edu|
20514797|NCT02140957|St. Michael's Hospital|Dr. Jonathon Maguire|(416) 919-3462|jonathon.maguire@utoronto.ca|
20514798|NCT02971956|Dana-Farber Cancer Institute|Peter C. Enzinger MD|(877) 442-3324|Peter_Enzinger@dfci.harvard.edu|
20514799|NCT03256968|Universtiy of Alabama at Birmingham|Steven Rowe|205-975-9776|srowe@uabmc.edi|
20514800|NCT01617577|University of South Florida|Professor Juan Sanchez-Ramos|813-974-5841|jsramos@health.usf.edu|
20514801|NCT00368966|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20514802|NCT01689974|New York University School of Medicine|Sylvia Formenti, MD|646.962.4073|formenti@med.cornell.edu|
20514803|NCT03119064|Brown University Oncology Research Group|Heinrich Elinzano, MD|401-863-3000|BrUOG@BROWN.EDU|
20514804|NCT01333033|Alliance for Clinical Trials in Oncology|Karyn Goodman, M.D.|(212) 639-3983|goodmank@mskcc.org|
20514805|NCT00804609|Stanford University|Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
20514806|NCT01388647|Vector Oncology|Vice President of Scientific Affairs|901-435-5550|mwalker@vectoroncology.com|1759
20514807|NCT01544166|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20514808|NCT01006707|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
20514809|NCT03361423|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|+972723909755|daganh@theranica.com|
20514810|NCT00818623|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20514811|NCT00358826|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
20528948|NCT04826484|Johns Hopkins University School of Medicine|Andrew T. Gabrielson, MD|410-955-5000|atg@jhmi.edu|
20560966|NCT02703714|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|katie.kelley@ucsf.edu|
20514812|NCT01110681|Q-Med AB|Head of Medical Affairs|+ 46 (0)18 4749000|reception.SEUPP@galderma.com|
20514813|NCT02015793|AbbVie|Global Medical Services|800-633-9110||
20560967|NCT01331824|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|212-241-6756|matthew.galsky@mssm.edu|
20560968|NCT01606124|Mayo Clinic|Frank A. Sinicrope, M.D.|507-284-2511|sinicrope.frank@mayo.edu|
20560969|NCT01091454|Mayo Clinic|Alvaro Moreno-Aspitia MD|507-284-1159|morenoaspitia.alvaro@mayo.edu|
20560970|NCT02030028|University of Pittsburgh|Dr. Dana Ascherman (Principal Investigator)|14123838123|DAscher@pitt.edu|
20560971|NCT01144949|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
20560972|NCT02008292|Yale University|Dr. Kelly Cosgrove|203-737-6969|kelly.cosgrove@yale.edu|
20560973|NCT00427557|MD Anderson Cancer Center|Dr. Partow Kebriaei|713-563-5174|celsaenz@mdanderson.org|
20560974|NCT04460898|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560975|NCT03223883|University of Iowa Carver College of Medicine|Dr. Diana Jalal|319-356-3500|diana-jalal@uiowa.edu|
20560976|NCT05298111|Universiti Sultan Zainal Abidin|Ms Ong Ying Qian|+60142186195|oyq0109@gmail.com|
20560977|NCT02380742|Loyola University|Brendan Martin, Biostatistician|708-216-8051|bmartin5@luc.edu|
20560978|NCT03518112|The University of Texas MD Anderson Cancer Center|Dr. Elias Joseph Jabbour MD/Professor|713-792-4764|ejabbour@mdanderson.org|
20560979|NCT02220478|Zimmer Biomet|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
20560980|NCT02628093|Weill Cornell Medicine|Koianka Trencheva|646-9622342|kivanova@med.cornell.edu|
20560981|NCT02814643|AstraZeneca|Mitchell Goldman MD, PhD|+1 610 457 5585|Mitchell.Goldman@astrazeneca.com|
20560982|NCT02263508|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20560983|NCT01280591|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20560984|NCT03357341|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20560985|NCT00930813|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
20560986|NCT05790408|Northwestern University|Angelo P. Tanna|3129088152|atanna@northwestern.edu|
20560987|NCT01048788|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20560988|NCT01131494|University Federal of Bahia|Natalie Argolo Ponte|55 31 3274 5579|natyargolo@hotmail.com|
20560989|NCT02145182|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
20560990|NCT00588666|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
20560991|NCT01233050|Penn Medicine|Dr. Najjia Mahmoud, MD, Cheif of Colorectal Surgery|(215) 662-2078|najjia.mahmoud@uphs.upenn.edu|
20560992|NCT03999554|FluGen|Pamuk Bilsel, CSO|6084426562|pbilsel@flugen.com|
20514814|NCT04317781|The University of Texas MD Anderson Cancer Center|Qaiser Bashir, M.D. / Stem Cell Transplantation and Cellular Therapy Department|713-794-4422|qbashir@mdanderson.org|
20514815|NCT02531022|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
20514816|NCT04756141|Mayo Clinic|Adrian G. Dumitrascu, M.D.|904-956-0081|Dumitrascu.Adrian@mayo.edu|
20514817|NCT04177810|SKCCC Johns Hopkins Medical Institution|Dung Le, MD|443-287-0002|Dle@jhmi.edu|
20514818|NCT02843074|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20514819|NCT03521999|Ralph H. Johnson VA Medical Center|Research Coordinator|843-301-9917|sarah.szafranski@va.gov|
20514820|NCT01564758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514821|NCT01211769|UNIFESP|José Carlos Fernandes Galduróz|55 11 21490168|galduroz@psicobio.epm.br|
20514822|NCT01214330|Mike O'Callaghan Military Medical Center|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
20514823|NCT00947427|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
20514824|NCT01533428|Astellas Pharma Global Development|Medical Science Director, Global Medical Science|+31(0)715454002|Astellas.resultsdisclosure@astellas.com|
20514825|NCT02473991|ain shams university maternity hospital|prof Dr khaled ebrahim abdalla|00201023220701|drkhaled_abdallah@med.asu.edu.eg|
20514826|NCT00859469|Columbia University|Joshua Leinwand|212-305-4076|jcl2125@columbia.edu|
20514827|NCT03896490|Queen's University Belfast|Dr Oliver Perra|+44289097|o.perra@qub.ac.uk|2313
20514828|NCT01879800|Baylor College of Medicine|Dr. Lilian Dindo|713-791-1414|lilian.dindo@bcm.edu|10296
20528949|NCT02250300|Froedtert and the Medical college of Wisconsin|Mehdi Hamadani, MD|414-805-4600|mhamadani@mcw.edu|
20560993|NCT00703911|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20560994|NCT02082158|National Center for Occupational Health and Infection Control|Aaron Eagan|352-376-1611|aaron.eagan@va.gov|4973
20560995|NCT00957229|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
20560996|NCT00927823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20560997|NCT00543725|Janssen Infectious Diseases BVBA|Medical Leader|32 14 641418||
20560998|NCT00906698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20560999|NCT01250002|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
20561000|NCT02430181|Eiger BioPharmaceuticals, Inc|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
20561001|NCT03879642|Nemours Children's Health-Jacksonville|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
20561002|NCT04054661|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
20561003|NCT02020018|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7066|schaff.hartzell@mayo.edu|
20561004|NCT03404843|Colorado State University|Frank Dinenno|970-491-3203|frank.dinenno@colostate.edu|
20561005|NCT00567164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20561006|NCT04044664|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
20561007|NCT02005666|Cadila Healthcare Limited|Mr Anuj K Saini|02717623666|Anuj.Saini@zyduscadila.com|314
20561008|NCT00001575|National Cancer Institute|Thomas Waldmann M.D.|301-496-6653|waldmann@nih.hhs.gov|
20561009|NCT00478556|UAB Hospital Radiology|Lisa Nelson|205-934-4015|lnelson@uabmc.edu|
20561010|NCT00831792|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-7734|PCORN@MDANDERSON.ORG|
20561011|NCT01982643|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
20561012|NCT01744691|Pharmacyclics, Inc.|Dr. Alvina Chu|855-427-8846|medinfo@pcyc.com|
20561013|NCT02086708|Massachusetts General Hospital|Dr. Uzma Shah|617-726-1450|USHAH@mgh.harvard.edu|
20561014|NCT04588480|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20561015|NCT01242085|VA Palo Alto HCS|Steven T Woolson, MD|650-493-5000|steven.woolson@va.gov|66101
20561016|NCT01178762|National Taiwan University Hospital|Yan-Ming Chen / Yu-Chih Hou|886-2-2312-3456|louice1070@gmail.com|62131
20561017|NCT02377362|GLWL Research Inc|Study Director||choruspharma@lists.lilly.com|
20514829|NCT03083132|University of Arkansas for Medical Sciences|Dr. Tuhin Virmani|501-686-7235|tvirmani@uams.edu|
20514830|NCT03118739|AstraZeneca R&D|Fredrik Erlandsson, Global Clinical Lead|+46317762365|Fredrik.Erlandsson@astrazeneca.com|
20514831|NCT00669955|Axcan Pharma Inc.|Monique Giguere, PhD, Programs Director,|1-800-565-3255||2078
20514832|NCT00717977|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|rbeck@jaeb.org|
20514833|NCT01893138|Cook MyoSite, Inc.|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
20514834|NCT00824460|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
20514835|NCT01326026|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20514836|NCT01170260|University of New Mexico Health Sciences|Hadya Khawaja|505-272-7028|hkhawaja@salud.unm.edu|
20514837|NCT04317053|NYU Langone Health|Kelly Doran, MD, MHS|212-263-5850|Kelly.Doran@nyulangone.org|
20514838|NCT04274192|University of Arkansas for Medical Sciences|Dr. Sherry Courtney|501-364-1028|SECourtney@uams.edu|
20514839|NCT00289458|University of Saskatchewan|Dr. Cathy M. Arnold|306 966 6588|cathy.arnold@usask.ca|
20514840|NCT03507439|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20514841|NCT00874757|University of Nebraska Medical Center|Timothy R McGuire|402-651-2496|trmcguir@unmc.edu|
20514842|NCT00313703|Montefiore Medical Center|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20514843|NCT02180061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514844|NCT02557945|New York State Psychiatric Institute|Scott Small, MD|212-305-1269|sas68@cumc.columbia.edu|
20514845|NCT00056160|Celgene Corporation|Robert Knight, M.D.|908-673-9749|rknight@celgene.com|
20514846|NCT01551095|Johns Hopkins University|Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
20514847|NCT01469364|Duke University|Dr. Scott Palmer|919-684-0245|palme002@mc.duke.edu|
20514848|NCT02742090|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20514849|NCT01590433|Beth Israel Deaconess Medical Center|Jody Dushay|617-667-9344|jdushay@bidmc.harvard.edu|
20514850|NCT00555009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20514851|NCT01767597|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
20514852|NCT03355742|Clinical Affairs, Abbott Vascular|Siok Hwee Tan, PhD, Principal Clinical Research Scientist|+1 408-845-3581|siokhwee.tan@abbott.com|
20514853|NCT00836927|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514854|NCT02243020|MicroTransponder Inc.|VP Clinical Affairs|5123714160|brent@microtransponder.com|
20514855|NCT04064229|ivWatch, LLC|Jason Naramore|1-855-489-2824|jason.naramore@ivwatch.com|7019
20514856|NCT02518230|Children's Mercy Hospital|Winston Manimtim|816-234-3000|wmmanimtim@cmh.edu|
20514857|NCT00614055|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20514858|NCT02958956|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20514859|NCT04820842|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20514860|NCT01296932|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514861|NCT00093964|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20514862|NCT01095003|Institut de Recherche Pierre Fabre|Karim Keddad|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
20561018|NCT02718118|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
20561019|NCT01190150|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20561020|NCT04469218|Lineus Medical|CEO|844-546-3728|vance@lineusmed.com|
20561021|NCT02750709|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
20561022|NCT00404079|Oslo University Hospital Ullevaal|Project Manager: Philip Wilkens|004723016140|philip.wilkens@medisin.uio.no|
20561023|NCT01859312|National Institute of Child Health and Human Development (NICHD)|Deborah P. Merke, MD, MS|301-496-0718|DMerke@cc.nih.gov|
20561024|NCT00853827|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20561025|NCT01506362|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
20561026|NCT00290732|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
20561027|NCT00843193|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561028|NCT02057718|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20561029|NCT01320072|Montefiore Medical Center|Dr. Elina Jerschow, attending physician|9173625291|ejerscho@montefiore.org|
20561030|NCT02512042|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
20561031|NCT00952718|ChangGungMH|Dr. Liaw MY|+8867317123|myliaw1@yahoo.com.tw|8199
20561032|NCT03563053|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
20561033|NCT00124982|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20514863|NCT02637557|Ironwood Pharmaceuticals, Inc.|IW-3718-202 Study Chair|1 (617) 621-7722|Info@ironwoodpharma.com|
20514864|NCT03617692|University of Colorado Boulder|Angela Bryan, PhD|3034929549|Angela.Bryan@Colorado.EDU|
20514865|NCT02442856|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
20514866|NCT02207621|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20514867|NCT00958256|University of Texas (UT) MD Anderson Cancer Center|Jorge Romaguera, MD/Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
20514868|NCT01769209|Stanford University Medical Center|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
20514869|NCT00049036|AIDS Malignancy Consortium|Jeannette Lee|501-526-6712|jylee@uams.edu|
20514870|NCT03036579|University of Michigan|Dennis J. Fasbinder, DDS|7346474450|djfas@umich.edu|
20514871|NCT02848599|University Hospital Osijek, Croatia|Dr. Gordana Kristek|+385915115746|gordanaldrmed@yahoo.com|
20514872|NCT02363907|Dexcom|Eileen Casal, RN, MSN|8588759774|ecasal@dexcom.com|
20514873|NCT00634907|University of Utah|Dr. Gwen McMillin/Principal Investigator|801-583-2787|gwen.mcmillin@aruplab.com|2671
20514874|NCT04041570|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20514875|NCT01338636|Brigham and Women's Hospital Heart and Vascular Center|Aaron B. Waxman|617-525-9733|abwaxman@partners.org|
20514876|NCT02385526|Cyberonics, Inc.|Peter Sears, Clinical Project Manager|(281) 228-7597|peter.sears@cyberonics.com|
20514877|NCT02498522|AinShamsU|Dr. Ahmed kotb|1008681999|ahmedmkotp@hotmail.com|+20
20514878|NCT03532009|Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20514879|NCT01602614|University of Alabama at Birmingham|David Kimberlin, MD|205 934-2424|Dkimberlin@peds.uab.edu|
20514880|NCT02866175|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20514881|NCT01694485|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20514882|NCT02907203|W. L. Gore and Associates|Rizwan Afzal|6236404888|rafzal@wlgore.com|
20514883|NCT03463525|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
20514884|NCT00681863|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514885|NCT03588390|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514886|NCT00384033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514887|NCT00952484|Alexion Pharma GmbH|Alexion Pharma GmbH|(617) 494-1393|ClinicalTrials@alxn.com|
20514888|NCT02422290|New York State Psychiatric Institute|Pablo H. Goldberg, MD|646-774-6318|Pablo.Goldberg@nyspi.columbia.edu|
20514889|NCT02750306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514890|NCT00760383|Human Physiology, University of Oregon|Hans C. Dreyer, PT, PhD|541-346-5775|hcdreyer@uoregon.edu|
20514891|NCT00192296|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
20514892|NCT02659202|Mayo Clinic|Dr. Bruce Johnson|507-284-4375|johnson.bruce@mayo.edu|
20514893|NCT01842958|Straumann USA, LLC|Kelly Jork|978-747-2533|kelly.jork@straumann.com|
20514894|NCT01829477|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20514895|NCT00897897|Philips Healthcare|Director, Clinical and Regulatory Affairs|425-487-7665|sarah.baxter@philips.com|
20514896|NCT01336894|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
20514897|NCT00868309|Instituto Bioclon S.A. de C.V.|Walter Garcia|+52 (55)54883700|wgarcia@silanes.com.mx|3785
20514898|NCT00299156|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD /Professor|713-792-7026|eharrison@mdanderson.org|
20514899|NCT01725451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20514900|NCT00455663|UTHSCSA|Dawn I. Velligan|210-567-5508|velligand@uthscsa.edu|
20514901|NCT01684410|Grifols Therapeutics Inc.|Henry Li, PhD|919-316-6042|henry.li@grifols.com|
20514902|NCT00903383|Lexicon Pharmaceuticals, Inc.|Joel Freiman, MD, MPH|281-863-3070||
20514903|NCT01195922|University of California San Diego|D. J. Silvio Gutkind|(858) 534 5980|sgutkind@ucsd.edu|
20514904|NCT01934296|University of California San Francisco|Dr. Sarah Wang, Director of Clinical Research|416-353-7885|Sarah.Wang@ucsf.edu|
20514905|NCT00482547|C. R. Bard|Vanessa Dell Clinical Research Scientist|908-277-8094|vanessa.dell@crbard.com|
20514906|NCT00320593|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
20561034|NCT03645031|University of Florida|Dr. Barbara K. Smith|352-294-5315|bksmith@ufl.edu|
20561035|NCT00482729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20561036|NCT02234128|Lung Bioengineering Inc.|Michael Roberts, Director Regulatory Affairs|2406502261|mroberts@lungbioengineering.com|
20561037|NCT03179787|Otsuka Pharmaceutical Co., Ltd.|Section Chief of Pharmacovigilance|+81-3-6717-1400|Sugimoto.Yuna@otsuka.jp|
20561038|NCT01729819|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20561039|NCT00377455|Georgetown University|Dr. Virginia Steen|202-444-6200|steenv@georgetown.edu|
20561040|NCT03284411|Medtronic|SCS Dosing Clinical Research Study Team|800-633-8766|rs.scsdosing@medtronic.com|
20561041|NCT01259102|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
20561042|NCT00686517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20561043|NCT02162667|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
20561044|NCT01803646|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
20561045|NCT01541358|David Geffen School of Medicine at UCLA|Andrew Quon, MD|310-983-1419|AQuon@mednet.ucla.edu|
20561046|NCT01693614|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20561047|NCT02156687|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
20561048|NCT03768856|Cleveland Clinic, Case Comprehensive Cancer Center|Dr Shlomo Koyfman|1-800-223-2273|TaussigResearch@ccf.org|
20561049|NCT00420316|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561050|NCT02281318|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561051|NCT01281813|Janssen Research & Development, LLC|Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20561052|NCT05257798|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561053|NCT00812877|Oregon Health & Science University|Dr. Thomas J. Hilton|503.494.8672|hiltont@ohsu.edu|
20561054|NCT01064817|Promedior, Inc.|Elizabeth G. Trehu, MD|781-538-4203|btrehu@promedior.com|
20561055|NCT02274493|UT MD Anderson Cancer Center|Dr. Jesse C Selber / Professor, Plastic Surgery|713-794-1297|jcselber@mdanderson.org|
20561056|NCT00558363|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561057|NCT03102710|Massachusetts General Hospital, Harvard Medical School|Jian Kong, Principal Investigator|617-726-7893|jkong2@mgh.harvard.edu|
20514907|NCT00283686|Emory University|Dr. Arlene Chapman|(404) 712-1993|abchapm@emory.edu|
20514908|NCT01076166|Abbott|Global Medical Services|1-800-633-9110||
20514909|NCT02755545|Galderma|Director, Medical Affairs and Clinical Development|8179615325|matthew.meckfessel@galderma.com|
20514910|NCT01716754|Novartis Pharmaceuticals|Study Director|862-778-8300||
20514911|NCT00481247|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20514912|NCT04371419|Massachusetts Institute of Technology|Pierre-Luc Vautrey|(617) 258-7013|vautrey@mit.edu|
20514913|NCT02931565|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
20514914|NCT00638157|Cubist Pharmaceuticals|Ed Campanaro / Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
20514915|NCT02110706|Yale School of Medicine|Dr. Richard Nowak, MD,MS|203-785-4085|richard.nowak@yale.edu|
20514916|NCT04992052|Northwell Health System|Nancy Dengler, Clinical Research Nurse|516-496-2637|ndengler@northwell.edu|
20514917|NCT02970669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20514918|NCT00876733|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514919|NCT01714505|University of Virginia|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu|
20514920|NCT02611752|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
20514921|NCT01569828|Novartis Pharmaceuticals|Study Director|862-778-8300||
20514922|NCT00686036|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20514923|NCT01297257|Clinical Research Director|Frank van Leeuwen, M.D.|+31433566622|frank.van.leeuwen@medtronic.com|
20551208|NCT00422591|UT MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD|713-792-7734|CR_Study_Registration@mdanderson.org|
20514924|NCT01960816|Aerin Medical, Inc.|Scott Wolf, M.D., President and Chief Medical Officer|650-434-3247|scott@aerinmedical.com|
20514925|NCT02099266|University of Kansas Cancer Center|Dr. Omar Aljitawi|(913) 588-6030|SWILLIAM@kumc.edu|
20514926|NCT03065283|Department of Physical Therapy|Prof. Dr. Pedro Lima|558533668091|pedrolima@ufc.br|
20514927|NCT05780541|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
20514928|NCT03329027|Vibrantgastro|Clinical trials manager|046663322|service@vibrantgastro.com|
20514929|NCT04849988|AEON Biopharma, Inc.|Dana Testa, PharmD|949-354-6499|dt@aeonbiopharma.com|
20514930|NCT03185065|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
20551209|NCT00913003|Northwestern University|Paul Fitzgerald|312-695- 1064|p-fitzgerald2@northwestern.edu|
20551210|NCT02659631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551211|NCT02377466|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20551212|NCT00495170|UT MD Anderson Cancer Center|Dr. Joe Chang / Professor, Radiation Oncology Department|713-563-2337|jychang@mdanderson.org|
20551213|NCT04191499|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20551214|NCT00680745|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20551215|NCT01928329|C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology)|Kevan Herold, MD|(203) 785-6507|kevan.herold@yale.edu|
20551216|NCT00330616|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551217|NCT02403154|Indiana University|Krista Brown, Clinical Research Coordinator|317-963-1944|brownkm@indiana.edu|
20551218|NCT01119131|VA Portland Health Care System|Amie Hiller, MD|503.721.1091|peterami@ohsu.edu|
20551219|NCT00993291|Vanderbilt University|Fenna Phibbs M.D.|615-936-2025|fenna.phibbs@vanderbilt.edu|
20551220|NCT00003492|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20551221|NCT03566823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20561058|NCT01368406|Programa de Esquizofrenia PROESQ UNIFESP|Cecilia Attux|551155733599|cattux@gmail.com|
20561059|NCT03131206|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
20561060|NCT01313182|New York University School of Medicine|Dr. Michael Phillips|212 263 4316|michael.phillips@nyumc.org|
20561061|NCT00130780|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris, Attending|+1646-888-4205|krism@mskcc.org|
20561062|NCT02846415|School of Nursing, The Hong Kong Polytechnic University|Dr Daphne Cheung|+852 27664534|cheungdaphne@polyu.edu.hk|
20561063|NCT00667693|Cleveland Clinic Foundation|Daniel I Sessler, MD|216-445-8396|sesslerd@ccf.org|
20561064|NCT02322216|Alcon, a Novartis Company|Clinical Project Lead, GCRA-Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20561065|NCT01651949|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561066|NCT00678795|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20561067|NCT01636206|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20561068|NCT00542386|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20561069|NCT00434018|VACO|Dr. Shirley Groer|202-553-9899|Shirley.Groer@va.gov|
20561070|NCT00608907|Johnson & Johnson Pharmaceutical Research & Development|Helgi van de Velde, MD, PhD||HVDVELDE@ITS.JNJ.COM|
20561071|NCT01689519|Hoffmann-La Roche|Medical Communications|800 821-8590||
20561072|NCT01787240|MGH|Dr. Cristina Cusin|617 726 6421|ccusin@partners.org|
20561073|NCT01161563|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
20561074|NCT03237936|Santen Inc|R&D Quality Manager|4152689199|evelyn.chikere@santen.com|
20561075|NCT02982213|Northwestern University|Feyce Peralta, MD|312-472-3585|feyce.peralta@northwestern.edu|
20561076|NCT01549652|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
20561077|NCT00559949|UNC Lineberger Comprehensive Cancer Center|Dr. David Neil Hayes|919-966-3786|hayes@med.unc.edu|
20561078|NCT01669148|Massachusetts General Hospital|Thomas J. Brady, MD|6177268294|tbrady@mgh.harvard.edu|
20561079|NCT03068611|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
20561080|NCT03861169|Sight Sciences|Tommie Rodriguez, Senior Clinical Research Manager|818-687-3310|trodriguez@sightsciences.com|
20561081|NCT01335932|FHCRC|Dr.Michael Boeckh|206 667-6706|mboeckh@fredhutch.org|
20561082|NCT01992354|GE Healthcare|John Strohmeyer|+1 609 865 7423|john.strohmeyer@ge.com|
20561083|NCT01559506|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
20561084|NCT00835380|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561085|NCT03247543|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
20561086|NCT01097343|St. Vincent Medical Group|Dr. Joseph S. Rossi|765 482 0656|jrossi@thecaregroup.com|
20561087|NCT00964119|University of Wisconsin - Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
20561088|NCT02059980|University of Wisconsin-Milwaukee|Dr. Han Joo Lee|414-229-5858|leehj@uwm.edu|
20561089|NCT01104415|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
20561090|NCT00917865|Emory University|David Schuster, MD|404-712-4859|dschust@emory.edu|
20561091|NCT01582945|Massachusetts General Hospital|Dr. Cristina Cusin|6177266421|ccusin@mgh.harvard.edu|
20561092|NCT01726023|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.Wilson2@astrazeneca.com|
20561093|NCT04858425|First Wave BioPharma|VP, Regulatory, QA & Compliance|19194491484|AChandler@FirstWaveBio.com|
20561094|NCT05457491|Mayo Clinic|Saranya P. Wyles, M.D., Ph.D.|507-284-5475|Wyles.Saranya@mayo.edu|
20561095|NCT02824432|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20561096|NCT05365386|Novoxel Ltd|Dr. Ifat Klein|+972.52-6009860|ifat@novoxel.com|
20561097|NCT05196737|Medical University of South Carolina|Gretchen Seif, PT, DPT, MHS, OCS, FAAOMPT|(843) 792-9345|seif@musc.edu|
20561098|NCT05824351|Duke University|Amy Barto, MD|919-684-1817|amy.barto@duke.edu|
20561099|NCT00828945|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561100|NCT04164563|Brigham and Women's Hospital|Dr. Jeremy T. Smith|6177325322|jsmith42@bwh.harvard.edu|
20561101|NCT02698241|Medtronic CRHF Clinical Research|Joe Hobbs Clinical Research Specialist|800-633-8766|joe.hobbs@medtronic.com|
20561102|NCT03722446|University of Michigan - Department of Anesthesiology|Dr. Carlo Pancaro|617-435-5403|cpancaro@med.umich.edu|
20561103|NCT00635817|Abbott|Global Medical Services|800-633-9110||
20514931|NCT01691508|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514932|NCT03731182|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20514933|NCT02006706|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20514934|NCT04161144|Medical University of South Carolina|Dr. Michael Saladin|8437925306|saladinm@musc.edu|
20514935|NCT05431153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514936|NCT04828161|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20514937|NCT02352337|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20514938|NCT02458638|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20514939|NCT01908127|Tehran University of Medical Sciences|Dr. Mehrsa Paryab|00989121091675|drmparyab@yahoo.com|
20514940|NCT03495648|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
20514941|NCT02324972|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 604-629-9223|clinical@aqxpharma.com|
20561104|NCT04969991|Ophirex, Inc.|Tim Platts-Mills, Chief Medical Officer|5592406073|tim@ophirex.com|
20561105|NCT01210820|AMO Development, LLC|Carrie Garufis|714-566-3728|carrie.garufis@amo.abbott.com|
20561106|NCT01875250|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|m480i@nih.gov|
20561107|NCT02749968|University of Cincinnati|Michael Goodman|5135585661|michael.goodman@uc.edu|
20561108|NCT00538213|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561109|NCT03140176|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561110|NCT03196167|Yale University|Amit Bardia|2038436469|amit.bardia@yale.edu|
20561111|NCT04622527|Mayo Clinic|Dr. Ivana Croghan|507-284-2511|gimresearchstudies@mayo.edu|
20561112|NCT01090024|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561113|NCT00149630|Baylor College of Medicine|Thomas R. Kosten, M.D.|(713) 794-7032|kosten@bcm.edu|
20561114|NCT03667547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561115|NCT00567879|Novartis|Study Director|862-778-8300||
20561116|NCT03720990|University of Nebraska Medical Center|William Rizzo|402-559-2560|wrizzo@unmc.edu|
20561117|NCT00580073|University of Wisconsin-Madison|CRA|608-265-4347|smccarthy@medicine.wisc.edu|
20561118|NCT01546155|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
20561119|NCT02930343|JIPMER|Dr Pooja Belani|8940482248|drpoojabelani@gmail.com|
20561120|NCT01549314|Massachusetts General Hospital Endocrine Unit|Dr. Melissa Putman|857-218-5017|msputman@partners.org|
20561121|NCT02899000|Galderma Laboratories, LP|Dr. Jean Philippe York, Medical Affairs Manager|1-817-961-5468|jp.york@galderma.com|
20561122|NCT00486759|Hoffmann-La Roche|Medical Communications|800 821-8590||
20561123|NCT01025843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561124|NCT00516503|Mayo Clinic|Debra Barton, R.N., Ph.D.||Barton.debra@mayo.edu|
20561125|NCT01649791|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20561126|NCT02987543|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20561127|NCT03224299|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
20561128|NCT03646669|Icahn School of Medicine at Mount Sinai|Maria Peralta|212-274-7571|Maria.peralta@mountsinai.org|
20561129|NCT00309452|Yale University|Vinod H. Srihari|2039747816|vinod.srihari@yale.edu|
20561130|NCT00771667|Janssen Research and Development, US|Director, Clinical Research|610-651-6554||
20561131|NCT01897233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20561132|NCT02076919|Alcon Research, Ltd.|Principal Clinical Scientist, CA CSI ID|1-888-451-3937|alcon.medinfo@alcon.com|
20561133|NCT02504619|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
20561134|NCT03265210|Weill Cornell Medicine|Dimitris Kiosses, PhD|914-997-4381|dkiosses@med.cornell.edu|
20561135|NCT01883492|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
20561136|NCT00796068|Fred Hutchinson Cancer Center|Dr. Filippo Milano|206-667-5925|fmilano@fredhutch.org|
20514942|NCT02236338|Virginia Commonwealth University|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
20514943|NCT01082952|King Saud University|Dr. Rabih Halwani|00966551307134|rhalwani@ksu.edu.sa|
20514944|NCT00135707|Dept of Obstetrics and Gynecology, University of Pittsburgh|Dr. James Roberts|412-641-1427|RSIJMR@mwri.magee.edu|
20514945|NCT01681030|Ethicon, Inc|Richard Kocharian, MD, PhD|+1-908-218-2013|rkochar1@its.jnj.com|
20514946|NCT02524379|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
20514947|NCT01829464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20514948|NCT03996603|University of Alabama at Birmingham|Kyle Norris, MD Principal Investigator|(205) 934-1704|kyleparkernorris@gmail.com|
20514949|NCT02743702|University of Seville|Dr. Jose J. Jimenez-Rejano|+34667309369|jjjimenez@us.es|
20514950|NCT02207309|Ludwigs-Maximilians-Universtity of Munich|Lars Lindner|0049894400|Lars.Lindner@med.uni-muenchen.de|74768
20514951|NCT03465891|Memorial Sloan Kettering Cancer Center|Dr. Lia Palomba|646-608-3711|palombam@mskcc.org|
20514952|NCT00710203|UC Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
20514953|NCT02737306|CytoDyn|Joseph Meidling Executive Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
20514954|NCT05034731|Advanced Bionics|Ankur Kaushal, VP of Global Regulatory Affairs|6613621400|clinicalresearch@advancedbionics.com|
20514955|NCT03937466|Wake Forest University School of Medicine|Nancy Avis, PhD|336-716-6974|navis@wakehealth.edu|
20514956|NCT00622908|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
20514957|NCT03213210|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
20514958|NCT00963157|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
20514959|NCT00684671|GlaxoSmithKline|GSK Response Center|866-435-7343||
20514960|NCT04571242|SGX Medical|VP of Clinical Affairs|818-527-2710|clinical@sgxmedical.com|
20514961|NCT02649231|University of Exeter|Professor Celia Morgan|01392 724649|Celia.Morgan@exeter.ac.uk|
20514962|NCT00437281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514963|NCT02354378|Boston Children's Hospital|Keira Mason, MD|6173552339|keira.mason@childrens.harvard.edu|
20514964|NCT05105711|University of North Carolina at Chapel Hill|Melissa Gilkey, PhD|919-966-8650|gilkey@email.unc.edu|
20514965|NCT03402893|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
20514966|NCT04738279|NorthShore University HealthSystem|Nirav Shah, MD, MPH|(847) 570-1236|nshah2@northshore.org|
20514967|NCT01411995|Washington University School of Medicine|Dr Colleen McNicholas|314-747-1331|mcnicholasc@wudosis.wustl.edu|
20514968|NCT00891878|Mayo Clinic|Aminah Jatoi, M.D|(507) 284-5352|jatoi.aminah@mayo.edu|
20514969|NCT01636297|Cleveland Clinic|Dr. Jay Alberts|216-445-3222|albertj@ccf.org|
20514970|NCT02292238|Weill Cornell Med/ Burke Neurological Institute|Gary E Gibson, Professor of Neuroscience|9145972291|ggibson@med.cornell.edu|
20561137|NCT00286741|Durham VA Medical Center|David Edelman|919-286-6936|dedelman@duke.edu|
20561138|NCT03383887|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
20561139|NCT00300456|Abbott|Medical Information Specialist|800-633-9110||
20561140|NCT03608670|Medtronic Cardiac Rhythm Management|CRM Clinical Research|+1 800 328 2518|rs.medtronicCRMtrials@medtronic.com|
20561141|NCT01806714|University of Rochester|Dr. Cynthia Rand|585 275-9316|cynthia_rand@urmc.rochester.edu|
20561142|NCT02155829|USUHS|Dr. David M. Benedek|(301) 295-3294|david.benedek@usuhs.edu|
20561143|NCT01919697|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
20561144|NCT04107805|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561145|NCT01253226|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561146|NCT03098966|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20561147|NCT00816829|Solvay Pharmaceuticals|Sven Voet, Global Communication|+32 (0) 2 509 69 77|sven.voet@solvay.com|
20561148|NCT03643211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561149|NCT04536077|Washington University School of Medicine|Roheena Z. Panni, M.D.|314-362-7046|roheenazpanni@wustl.edu|
20561150|NCT04798521|Oregon Health & Science University|Dr. P. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
20561151|NCT02443792|U of Cape Town|Dr. Justin Shenje|0027788938497|justintshenje@gmail.com|
20561152|NCT02908620|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
20561153|NCT04548622|Yale University Department of Psychiatry|Dr. Philip R. Corlett PhD|(203) 974-7866|philip.corlett@yale.edu|
20561154|NCT01155869|Providence VA Medical Center|Peter Friedmann|401-273-7100|peter.friedmann@va.gov|6240
20561155|NCT01843465|Clinique Pasteur, Toulouse, France|Dr Serge Boveda|(33) 5 62 21 16 45|sboveda@clinique-pasteur.com|8819
20561156|NCT00967369|UT MD Anderson Cancer Center|Dr. Michelle A Fanale / Associate Professor, Lymphoma/Myeloma|713-792-2860|MFANALE@MDANDERSON.ORG|
20561157|NCT00881335|Shanghai Tenth People's Hospital, Tongji University|Zhang Xiangyu|86-21-66307174|xiangyu62@126.com|
20561158|NCT01615809|Fundaciò per la Recerca i la Docencia sant Joan de Deu|Rosa Maria morales Palau|936009751|rmorales@fsjd.org|
20561159|NCT00554801|Portland VA Medical Center|Marjorie R. Leek|503-220-8262|Marjorie.Leek@va.gov|54525
20561160|NCT00331162|Wake Forest University Health Sciences|Dr. Alan Farney|336-716-6510|afarney@wakehealth.edu|
20561161|NCT02908464|Beth Israel Deaconess Medical Center|Brian O'Gara, MD, MPH|617-754-3189|bpogara@bidmc.harvard.edu|
20561162|NCT02163915|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20561163|NCT00603447|Amgen, Inc.|Study Director|866-572-6436||
20561164|NCT00470626|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
20561165|NCT00777556|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20561166|NCT02689349|Envoy Medical Corp.|Elizabeth Anderson, Ph.D.|(1) 651-788-3017|landerson@envoymedical.com|
20561167|NCT01185522|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20561168|NCT02962674|seleon gmbh|Annegret Genger|+49 175 934 91 83|Annegret.Genger@seleon.de|
20561169|NCT00669461|University of Arkansas for Medical Sciences|Muhannad Heif, MD|5016500215|mmheif@gmail.com|
20514971|NCT00494806|MD Anderson Cancer Center|Robert L. Massey, PhD, RN|713-792-3704|rlmassey@mdanderson.org|
20514972|NCT01754259|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6291|mdicarli@partners.org|
20514973|NCT03520283|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
20514974|NCT01103505|Notal Vision|Grace Chang, MD, PhD|571-719-6416|Grace.Chang@NotalVision.com|
20514975|NCT02041702|Abbott (formerly St. Jude Medical)|Clinical Project Leader Asia|0085229967605|lyim@sjm.com|
20514976|NCT00203307|Thomas Jefferson University/ Jefferson Headache Center|Stephen D. Silberstein, M.D.- Principal Investigator|215-955-2243|stephen.silberstein@jefferson.edu|
20514977|NCT02387814|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20514978|NCT01364870|University of Iowa College of Nursing|Barbara Rakel, PhD, RN, FAAN|319-335-7036|barbara-rakel@uiowa.edu|
20514979|NCT01618305|Westat|Lauren Laimon, Project Manager|240-453-2987|laurenlaimon@westat.com|
20514980|NCT01841606|UBC Department of Anesthesia - BC Women's Hospital|Mr. James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
20514981|NCT02286518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20514982|NCT01309919|Baystate Medical Center|Dr. Katharine White|413-794-5256|katharine.white@bhs.org|
20514983|NCT02102490|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20514984|NCT00095199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20514985|NCT02525029|University of Minnesota, Masonic Cancer Center|Dr. Shernan Holtan, MD|(612) 626-5654|sgholtan@umn.edu|
20514986|NCT02938494|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20514987|NCT01736553|The Ohio State Unviersity Wexner Medical Center|Dr. Stephen Kolb|614-366-9050|stephen.kolb@osumc.edu|
20514988|NCT01896297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20514989|NCT00003782|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
20514990|NCT01890707|Northwestern University|Shireen Ahmad MD|312-472-3585|sahmad@northwestern.edu|
20514991|NCT02743442|Fondation Ophtalmologique A. de Rothschild|Dr Amélie Yavchitz (deputy head of the clinical research unit)|+33148036454|ayavchitz@for.paris|
20514992|NCT00385541|Columbia University|Dr. Pamela Flood|201-370-3933|pflood@stanford.edu|
20528950|NCT05122624|Johns Hopkins Bloomberg School of Public Health|Dr. Yeonsoo Baik|410-955-2378|ybaik3@jh.edu|
20561170|NCT00364286|The University of Texas MD Anderson Cancer Center|Susan O'Brien, MD/ Professor|713-792-7543|eharriso@mdanderson.org|
20561171|NCT03686813|Duke University|Richard Moon, M.D.|919-684-8762|richard.moon@duke.edu|
20561172|NCT01227278|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
20528951|NCT00215644|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20514993|NCT00929708|AstraZeneca|Carin Jorup, MSD||clinicaltrialtransparency@astrazeneca.com|
20561173|NCT04020718|Massachusetts General Hospital|Dr. Gina Kruse|6177243157|gkruse@mgh.harvard.edu|
20561174|NCT00332644|University of Wisconsin|Piper, Megan E|608-265-5472|mep@ctri.medicine.wisc.edu|
20561175|NCT03546907|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20561176|NCT00565110|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
20561177|NCT00975806|Celgene Corporation|Anne McClain,Senior Manager|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
20561178|NCT00246012|Centocor, Inc.|Senior Director|908-927-2116||
20561179|NCT04889664|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-585-4661|adriana.feder@mssm.edu|
20561180|NCT04181632|Nemours Children's Health System (North Florida/JAX)|Jennifer Pfieffer|904 383 0414|jennifer.pfieffer@nemours.org|
20561181|NCT03636451|University of California, San Diego|Sheila Mody|8583294464|smody@health.ucsd.edu|
20561182|NCT02469064|Universidad del Valle|Dr Lina Marcela Sandoval Moreno|316 478 0808|linamarce48@gmail.com|
20561183|NCT00422201|HRA Pharma|Head of Clinical Research|0033140331130|s.durand@hra-pharma.com|
20561184|NCT03408860|University of Kentucky|Shannon Sauer-Zavala|858-218-4082|ssz@uky.edu|
20561185|NCT01120275|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
20561186|NCT01191086|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|bob.anders@upsher-smith.com|
20561187|NCT00771849|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20561188|NCT02087306|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20561189|NCT02736799|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
20561190|NCT01833832|National Cancer Institute|Dr. Jeremy Davis|240-760-6229|jeremy.davis@nih.gov|
20561191|NCT01156116|University of Chicago|Esra Tasali|773-702-1497|etasali@medicine.bsd.uchicago.edu|
20561192|NCT00197015|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561193|NCT00614406|Oregon Health and Sciences University|Allison Edelman, MD, MPH|503-494-5949|edelmana@ohsu.edu|
20561194|NCT04511650|EyePoint Pharmaceuticals, Inc.|Dario Paggiarino, MD|8589670016|dpaggiarino@eyepointpharma.com|
20561195|NCT04059237|Stanford University|Catherine Benedict, PhD|650-498-9111|cbenedict@stanford.edu|
20514994|NCT02154529|Kadmon Corporation|Associate Vice President, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
20514995|NCT02761980|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20514996|NCT02780661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20514997|NCT01806688|Agriculture and Agri-Food Canada|Dr. Heather Blewett|204 237-2954|hblewett@sbrc.ca|
20514998|NCT01104207|VA Portland Medical Center|Robert L. Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
20514999|NCT01907087|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
20515000|NCT03312530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20515001|NCT02708290|ImagiRation LLC|Dr. Andrey Vyshedskiy, Founder|6174338577|vysha@bu.edu|
20515002|NCT03229252|Spyryx Biosciences|Dr. Rob Tarran|919-966-7052|rtarran@spyryxbio.com|
20515003|NCT02192905|University of Massachusetts Medical School|Sherry Pagoto, Professor|508-856-5159|study@umassmed.edu|
20551222|NCT03847233|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
20551223|NCT01188694|University of Washington|Lori Zoellner|206 685-3617|zoellner@u.washington.edu|
20551224|NCT01706003|UT Southwestern Medical Center|Deborah I. Friedman, MD, MPH, Professor of Neurology and Neurotherapeutics and Ophthalmology|2146483517|Deborah.Friedman@utsouthwestern.edu|
20551225|NCT03182829|DOASENSE GmbH|Harenberg, Job Prof Dr.|+496221825|j.harenberg@doasense.de|9785
20551226|NCT05608005|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20551227|NCT02366845|University of Colorado|Dr. Marc Moss|303-724-6080|marc.moss@cuanschutz.edu|
20551228|NCT05022784|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551229|NCT03020407|Department of Emergency Medicine, Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+6626494000|kmusikatavorn@yahoo.com|83058
20551230|NCT01585428|National Cancer Institute|D. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20551231|NCT00911495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551232|NCT02699554|University of Washington|Katherine Steele|206-685-2390|kmsteele@uw.edu|
20551233|NCT00788151|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
20551234|NCT01985581|Center for Pediatric Excellence|Dr. Judy van Stralen|613-726-7355|judyvanstralen@bellnet.ca|
20551235|NCT00065507|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20551236|NCT03635957|Horizon Therapeutics Ireland DAC|Paul Peloso, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
20551237|NCT00350636|Watson Laboratories, Inc|Gary Hoel, PhD, Executive Director|801-808-8866|gary.hoel@watson.com|
20551238|NCT01214161|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
20551239|NCT01647282|UNMC College of Dentistry|Dr. Amy C. Killeen|402-202-7848|akilleen@unmc.edu|
20551240|NCT01042236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551241|NCT02261714|Targovax ASA|Chief Medical Officer|004721398810|contact@targovax.com|
20551242|NCT02522286|Palo Alto Medical Foundation Research Institute|Dr. Ming Tai-Seale|650-853-4779|Tai-SealeM@pamfri.org|
20551243|NCT03889158|University of Illinois at Chicago|Dr. Elizabeth Lefferts|312-996-9607|eschro7@uic.edu|
20551244|NCT02411292|Division of Plastic Surgery, University of Utah|Dr. Christopher J. Pannucci, M.D., M.S.|801-581-7719|christopher.pannucci@hsc.utah.edu|
20551245|NCT00453921|Dartmouth Hitchcock Medical Center|Dr. Laura Flashman|6036505824|Laura.A.Flashman@hitchcock.org|
20551246|NCT00303498|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551247|NCT00174915|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20561196|NCT00906035|Upenn|Emile Mohler, MD|215-573-6606|Emile.Mohler@uphs.upenn.edu|
20561197|NCT02050308|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
20561198|NCT03058991|Boston University Charles River Campus|Dr. Michael Otto|617-353-9610|mwotto@bu.edu|
20561199|NCT01972152|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Drug Development|512-498-2675|mcummins@xerispharma.com|
20561200|NCT01186848|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20561201|NCT02596035|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
20561202|NCT00509769|Genentech, Inc.|Medical Communications|800 821-8590||
20561203|NCT03320096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20561204|NCT01194258|Halozyme Therapeutics|Vice President, Endocrinology Clinical Development|858-794-8889||
20561205|NCT02526680|Wills Eye Hospital Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
20561206|NCT02873754|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
20561207|NCT03495713|Abramson Cancer Center at Penn Medicine|John P. Plastaras, MD, PhD|855-216-0098|PennCancerTrials@emergingmed.com|
20561208|NCT02979899|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
20561209|NCT01321606|William S. Middleton Memorial Veterans Affairs Medical Center|Dr. Nasia Sardar|608-256-1901|nasia.safdar@va.gov|17800
20561210|NCT03593070|Rush University College of Nursing|Dr. Olimpia Paun|3129426996|olimpia_paun@rush.edu|
20561211|NCT04979988|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561212|NCT00414206|CoMentis, Inc.|Carl Grove|650-869-7600|cgrove@comentis.com|
20561213|NCT03612804|VA Puget Sound Health Care System|Steven B Zeliadt|206-277-4175|Steven.Zeliadt@va.gov|
20561214|NCT04550039|Shirley Ryan AbilityLab|Katherine Enzler, Physical Therapist|312-238-2941|kenzler@sralab.org|
20561215|NCT00462943|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20561216|NCT03328949|Shockwave Medical, Inc.|Beaux Alexander, Vice President of Clinical Affairs|510-279-4262 ext. 145|balexander@shockwavemedical.com|
20561217|NCT01697319|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
20561218|NCT01421654|ResMed|Amy Blase/Clinical Research Manager|858-836-6715|amy.blase@resmed.com|
20561219|NCT04222959|San Diego State University Research Foundation|Elizabeth Reed|508-212-1517|ereed@sdsu.edu|
20561220|NCT00392678|Joslin Diabetes Center|Allison B. Goldfine, MD co-investigator|617-309-2643|allison.goldfine@joslin.harvard.edu|
20561221|NCT01543685|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
20561222|NCT01838551|Strongbridge Biopharma|Chief Medical Officer|14845890392|f.cohen@strongbridgebio.com|
20561223|NCT00906282|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
20561224|NCT01391013|Jan-Cil Italy|Therapeutic Area Medical Manager|39 02 2510589||
20561225|NCT02685033|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20561226|NCT00708097|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561227|NCT00628862|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20561228|NCT03720210|Mayo Clinic|Marius N. Stan, M.D.|507-266-3769|Stan.Marius@mayo.edu|
20561229|NCT02614560|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20561230|NCT04033432|Northwestern University|Maha Hussain, MD|312-908-5487|mhussain@northwestern.edu|
20561231|NCT01551056|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20561232|NCT03110458|Sensorion|Director of Regulatory Affairs|+33 4 67 20 77 30|contact@sensorion-pharma.com|
20561233|NCT00738699|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20561234|NCT00549848|St. Jude Children's Research Hospital|Sima Jeha, MD|(901) 595-3901|sima.jeha@stjude.org|
20561235|NCT01213706|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
20561236|NCT00868192|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
20561237|NCT02174562|Thomas Jefferson University|Barry Rovner, MD|215-503-1243|Barry.Rovner@Jefferson.edu|
20515004|NCT04583579|Lexitas Pharma Services|Dr. Andrew Pucker|9205792900|andrewpucker@hotmail.com|
20515005|NCT00974493|Oxford University Hospitals NHS Trust|Matthew Scarborough|07872436461|matthew.scarborough@ouh.nhs.uk|
20515006|NCT02261428|"Attikon General University Hospital of Athens"|Mr. Konstantinos Grigoriadis ICU Physical Therapist|00302105832489|grigoriakost@gmail.com|
20515007|NCT04488575|Evelo Biosciences Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
20515008|NCT02401542|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
20515009|NCT02337933|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20515010|NCT03093454|Duke Health|Scott Hollenbeck, MD|919-681-5079|scott.hollenbeck@duke.edu|
20515011|NCT00100165|University of Colorado, Denver|Dr. Robert Freedman|303 724-4940|robert.freedman@ucdenver.edu|
20515012|NCT02850068|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20515013|NCT00761592|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
20515014|NCT00795665|University of California Davis|Analyst|916-734-8053|nlogihara@ucdavis.eduu|
20515015|NCT01612000|Protein Sciences Corproation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20515016|NCT02173704|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515017|NCT03106870|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20515018|NCT02627742|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20515019|NCT01645306|advanceCOR GmbH|Prof. Dr. Götz Münch, CRP & CEO|+4989200020410|muench@advancecor.com|
20561238|NCT05193318|Metrohealth Hospital System (formerly employee of Medical University of South Carolina)|Eric Dobson, MD (principal nvestigator)|513-504-2091|edobson@metrohealth.org|
20561239|NCT03201809|UC Davis|Dr. Granger Wong, Chief and Professor of Plastic Surgery|(916) 734-7289|gwong@ucdavis.edu|
20561240|NCT05097573|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20561241|NCT00742573|New York State Psychiatric Institute|Mark Olfson, MD, MPH|646-774-6413|mark.olfson@nyspi.columbia.edu|
20561242|NCT00657280|Stanford Hospital and clinics|Dr. Michael Fowler Director of the Heart Failure|650-721-5540|mfowler@stanford.edu|
20561243|NCT02046616|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561244|NCT04420195|NYU Langone Health|Tyler C Lewis|646-501-4222|Tyler.lewis@nyulangone.org|
20561245|NCT00130637|National Eye Institute, NIH|H. Nida Sen, MD, MHS|301-435-5139|senh@nei.nih.gov|
20561246|NCT00942149|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
20561247|NCT01591616|Virginia Commonwealth University, School of Dentistry|Tegwyn H. Brickhouse, DDS, PhD|(804) 827-2699|thbrickhouse@vcu.edu|
20561248|NCT01959412|Novartis Pharmaceuticals|Study Director|862-778-8300||
20561249|NCT00158054|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
20561250|NCT00414648|Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati|Francis X. McCormack, MD|513-558-4831|mccormfx@ucmail.uc.edu|
20561251|NCT01490580|NICU, CHI Créteil|Dr Xavier Durrmeyer|+33145175433|xavier.durrmeyer@chicreteil.fr|
20561252|NCT00383188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561253|NCT00410124|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
20561254|NCT01147380|University of Miami|Dr. Seigo Nishida|305-355-5760|snishida@med.miami.edu|
20561255|NCT00117663|Group Health Research Institute|Diana Buist PhD, Principal Investigator|206-287-2931|buist.d@ghc.org|
20561256|NCT00988637|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Dierctor|817-961-5358|ron.gottschalk@galderma.com|
20561257|NCT03098030|United Therapeutics Corporation|Program Manager, Oncology|919-485-8350|kmaher@unither.com|
20561258|NCT03310983|University of Kansas Medical Center|Dr. Holly Hull|9135881000|hhull@kumc.edu|
20561259|NCT03368001|Vanderbilt University Medical Center|Blythe Corbett, Ph.D.|615-936-0280|blythe.corbett@vumc.org|
20561260|NCT01656304|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
20561261|NCT04391309|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20561262|NCT05826431|UW Medicine Multiple Sclerosis Center|Dr. Kevin Alschuler, Director of Rehabilitation Research|206-668-8413|kalschul@uw.edu|
20561263|NCT03028363|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20561264|NCT00782639|Bracco Diagnostics, Inc|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
20515020|NCT03445195|Entasis Therapeutics|Chief Medical Officer|781-810-8940|Enquiries@entasistx.com|
20515021|NCT02584140|UCSD Medical Center, Antiviral Research Center|Jill Blumenthal, MD|(619) 471-3913|jblumenthal@health.ucsd.edu|
20515022|NCT01180244|Department of Mechanical Engineering, Kettering University|Dr. Jeffrey B. Hargrove||jhargrov@kettering.edu|
20528952|NCT01476267|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20515023|NCT00906425|Institut Straumann|Michael Hotze, PhD|+4161965|michael.hotze@straumann.com|1235
20528953|NCT03512353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20528954|NCT03939923|West Virginia University|Director of Research in Department of Anesthesiology|304-598-4122|david.scalzo@hsc.wvu.edu|
20528955|NCT01666912|UNC_ChapelHill|Amy G. Bryant, Assistant Professor|919-843-5633|amy_bryant@med.unc.edu|
20528956|NCT00308516|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20528957|NCT03782987|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515024|NCT00620763|United States Department of Agriculture Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
20515025|NCT01595009|Novartis Pharmaceuticals|Study Director|862-778-1873||
20515026|NCT00506909|UCSD|David Feifel||dfeifel@kadimanp.com|
20515027|NCT04956666|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
20515028|NCT00729859|University of Washington|Stephanie T. Page, MD, PhD|206-616-0483|page@u.washington.edu|
20515029|NCT03172780|Mylan Pharmaceuticals Pvt Ltd.|Dr. Prasanna C Ganapathi, Associate Vice President, Global Clinical Sciences|08066728952|PrasannaC.Ganapathi@mylan.in|28952
20515030|NCT03758365|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
20515031|NCT01111110|University of Florida|Dr.Sreekala Prabhakaran. Clinical Assistant Professor Pediatrics|352-273-8381|sprabhakaran@peds.ufl.edu|
20515032|NCT02623829|Icahn School of Medicine at Mount Sinai|Dr. Daniel Bernstein|212-731-3311|daniel.bernstein@mountsinai.org|
20515033|NCT00662025|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515034|NCT01700621|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20528958|NCT02581488|Smith and Nephew|SR. Clinical Study Manager, US Global Clinical Operations|+1 817-302-3959|Darrell.Lange@smith-nephew.com|
20528959|NCT01223404|University of Maryland School of Medicine|Dr. Britta Hahn|4104026112|bhahn@mprc.umaryland.edu|
20528960|NCT00707057|SCOLR Pharma Inc|Stephen Turner, VP and Chief Technical Officer|425-368-1050|sturner@scolr.com|1001
20528961|NCT02492165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20528962|NCT02749227|Columbia University|Pamela U. Freda, MD|212-305-2254|puf1@cumc.columbia.edu|
20528963|NCT03782181|University of Balearic Islands|José Mingorance|+34677602465|josea.mingorance@uib.es|
20528964|NCT01587105|Seattle Children's Hospital|Rita Mangione-Smith, MD, MPH|2068848242|Rita.Mangione-Smith@seattlechildrens.org|
20561265|NCT00768651|Faculty of Medicine and Dentistry, University of Alberta|Peter Senior, MD, PhD - Professor of Medicine, Medical Director-Clinical Islet Transplant Program,|780-407-1480|peters@islet.ca|
20515035|NCT02869646|Tibor Rubin VA Medical Center|Michael Hollifield, M.D.|562 826-8000|michael.hollifield@va.gov|4324
20515036|NCT02035137|New Advances in Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
20515037|NCT01288859|University of Naples|Prof. Vincenzo Fogliano|+39 0812539356|fogliano@unina.it|
20515038|NCT03349333|Mundipharma(China) Co.,Ltd|clinical study manager|8610-65636856|guodong.lu@mundipharma.com.cn|
20515039|NCT02985151|Dermatology SLUCare Physician Group|Research Manager/Coordinator|314 977-1794|rhonda.lebbing@health.slu.edu|
20515040|NCT00290745|Duke University and Duke Cancer Institute|Dr. E. Shelly Hwang, MD, MPH|(919) 684-6849|shelley.hwang@duke.edu|
20515041|NCT00783796|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20515042|NCT02300025|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
20515043|NCT00626925|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
20515044|NCT00780026|University of Michigan|Subramanian Sathishkumar||ssatish@med.umich.edu|
20515045|NCT02959775|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
20515046|NCT01215942|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20515047|NCT03305055|Johns Hopkins University|James A. Fauerbach|410-550-0890|jfauerb1@jhmi.edu|
20515048|NCT00113490|MedImmune|M. Pamela Griffin, MD/ Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
20515049|NCT01816477|Mayo Clinic|Dr. Dawn E. Jaroszewski|480-301-7865|Jaroszewski.Dawn@mayo.edu|
20515050|NCT00819247|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20515051|NCT02162758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20515052|NCT04471935|Flint Rehabilitation Devices|Ian Russell|3392232676|irussell@flintrehab.com|
20515053|NCT05343156|Oculis SA|Bastian Dehmel, Chief Development Officer|0041 21 711 39 70|bastian.dehmel@culis.com|
20515054|NCT02540356|Baxalta, now part of Shire|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
20515055|NCT01166568|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
20515056|NCT03335371|vTv Therapeutics LLC|Study Director|336-841-0300|clinicaltrials@vtvtherapeutics.com|
20515057|NCT01832090|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
20515058|NCT00249821|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20515059|NCT01348542|Penn State University College of Medicine|Alexandros Vgontzas|717 531-7278|vgontzas@pennstatehealth.psu.edu|
20515060|NCT00467584|Mayo Clinic|Dr. Dean M. Wingerchuk|480-301-6328|wingerchuk.dean@mayo.edu|
20515061|NCT00926289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515062|NCT00319956|University of Kentucky Medical Center|Dr. Hubert O. Ballard|859-323-1496|hoball2@uky.edu|
20515063|NCT00753714|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20515064|NCT01202747|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
20515065|NCT01446913|Yale University School of medicine|Henry Klar Yaggi, MD (PI)|203-785-4163|henry.yaggi@yale.edu|
20515066|NCT04000009|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
20515067|NCT02626949|Icahn School of Medicine at Mount Sinai|Jeffrey Weiss, PhD, MS|212-824-7575|Jeffrey.Weiss@mountsinai.org|
20515068|NCT01965561|USAISR|John Kragh, MD|210.539.2210|john.f.kragh.civ@mail.mil|
20515069|NCT00717756|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
20515070|NCT00673790|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20515071|NCT01483872|UCSD|Saima Aslam|858 657 7463|saslam@ucsd.edu|
20515072|NCT01873859|Cardiovascular research center, Shahid Beheshti University of Medical Sciences|Dr. Saeed Alipour Parsa, director of clinical trial|+9821 2208 3106|s_alipour@sbmu.ac.ir|
20515073|NCT03977584|Hoffmann-La Roche|BN40199|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
20515074|NCT01042366|University of Pittsburgh|John Kirkwood, MD|(412) 623-7707|KirkwoodJM@upmc.edu|
20515075|NCT05328375|Columbia University Irving Medical Center|Dr. Andrea T. Duran, Assistant Professor of Medical Sciences|212.342.4491|atd2127@cumc.columbia.edu|
20515076|NCT04849845|MannKind Corporation|Johanna Ulloa|818-661-5000|contact@mannkindcorp.com|
20515077|NCT02929979|VA Palo Alto Healthcare System|Adrienne Heinz|9196306847|adrienneheinz@gmail.com|
20515078|NCT00101582|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
20515079|NCT01919190|Pacira Pharmaceuticals, Inc.|Paci|1-855-793-9727|MedInfo@pacira.com|
20515080|NCT02146430|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|+1 (908) 992-6400|CTRinfo@DSI.com|
20515081|NCT01893905|Complejo Hospitalario de La Coruña (CHUAC)|Dr Francisco Blanco, study coordinator|981 17 80 00|fblagar@sergas.es|
20515082|NCT01768858|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20515083|NCT01581970|Masonic Cancer Center, University of Minnesota|Dr. Gautam Jha|612-624-5373|jhaxx014@umn.edu|
20515084|NCT03093324|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20515085|NCT01797471|University of Miami|Jean L. Wright MD|305-243-5965|jwright3@med.miami.edu|
20515086|NCT01693484|LSU Health Science Center Shreveport|Dr Todd Jaeblon|318 675 6180|tjaebl@lsuhsc.edu|419
20515087|NCT00132002|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20515088|NCT01568008|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20515089|NCT03467477|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20515090|NCT03493126|The Ohio State University|Dr. Andrew Hundley|614-293-4647|andrew.hundley@osumc.edu|
20515091|NCT00421174|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
20515092|NCT00992407|R&D Clinical Research, Seoul KOREA|Clinical Research Director|+82 2 2094 -4518||
20515093|NCT04700449|Suzhou Connect Biopharmaceuticals, Ltd|John Guo, Director of Clinical Operation|051253577866|jwguo@connectpharm.com|
20515094|NCT03738332|University of Pennsylvania|Dr. Jie Deng|215-573-2393|jiedeng@nursing.upenn.edu|
20515095|NCT02336737|Endomag|Clinical Develoment Director|+44 7851 247439|mwomack@endomag.com|
20515096|NCT02396381|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20515097|NCT03197064|Stanford University|Dr. Mark Burbridge|(650) 353-8484|markburb@stanford.edu|
20515098|NCT00356200|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
20515099|NCT00635778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515100|NCT00812253|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
20515101|NCT01884025|Central Arkansas Veterans Healthcare System|Dr. Kristen Viverito|501-257-1699|KRISTEN.VIVERITO@VA.GOV|
20515102|NCT02909140|Wilmer Eye Institute|Dr. Fasika Woreta|(410) 955-5650|fworeta1@jhmi.edu|
20515103|NCT02059993|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Zhihong Liu|+86-01088398196|zhihongliufuwai@163.com|
20515104|NCT02655237|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20515105|NCT03679741|Johnson & Johnson Vision Care|John Buch, O.D., M.S. Sr. Prinicpal Research Optometrist|904 443-1707|JBUCH@its.jnj.com|
20515106|NCT05380635|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
20515107|NCT02456532|Henry Ford Health System|Timothy Roehrs|13138026681|troehrs1@hfhs.org|
20515108|NCT01000337|Aretaieio Hospital, University of Athens|Argyro Fassoulaki|+30210 7286334|fassoula@aretaieio.uoa.gr|
20515109|NCT02750761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515110|NCT02227862|Mylan Inc.|David Gillogly, Head of Global Clinical Operations|+1 (724) 4856581|david.gillogly@mylan.com|
20515111|NCT00419926|Novartis Pharmaceuticals|Study Director|862-778-8300||
20515112|NCT02511236|University of Miami Miller School of Medicine|David J. Lee|305-243-9680|dlee@med.miami.edu|
20515113|NCT00266409|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20515114|NCT02116803|Novartis Pharmaceuticals|Study Director|862-778-8300||
20515115|NCT03309449|SUNY Upstate Medical University|William Eggleston|315-464-8906|egglestw@upstate.edu|
20515116|NCT04128007|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20515117|NCT05476679|Raziel Therapeutics|Racheli Gueta, Director of Clinical Trials|972-8-9126941|racheli@raziel-therapy.com|
20515118|NCT00601354|Stanford University|Dr. Debra L Safer|650-723-7928|dlsafer@stanford.edu|
20515119|NCT04616417|University of Illinois at Chiago|Principal Investigor|312-355-3245|Sana.Salih@bsd.uchicago.edu|
20515120|NCT00278512|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
20515121|NCT01620177|National Advanced Driving Simulator|Dr. Timothy L. Brown, Co-PI|319-335-4785|timothy-l-brown@uiowa.edu|
20515122|NCT04041609|Lyra Therapeutics|Lyra Clinical|617-393-4600|lyraclinical@lyratx.com|
20515123|NCT01789320|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20515124|NCT00679783|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20515125|NCT00310427|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
20515126|NCT00756964|University of Florida|A. Ahsan Ejaz, M.D.|3522735328|ejazaa@medicine.ufl.edu|
20515127|NCT00814320|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20515128|NCT00491504|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20515129|NCT00619385|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
20515130|NCT03730103|The Cleveland Clinic|Lynn Borzi, Research Administrator|216-445-3158|borzil@ccf.org|
20515131|NCT02789111|University of Virginia Department of Aneshtesiology|Bhiken Naik MD|434-924-2283|BIN4N@hscmail.mcc.virginia.edu|
20515132|NCT01488578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515133|NCT02308111|Intercept Pharmaceuticals, Inc.|Medical Information|+1 884-782-4278|medinfo@interceptpharma.com|
20515134|NCT03271528|Boston Medical Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
20515135|NCT00306384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20515136|NCT00929357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515137|NCT00745251|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
20515138|NCT02928848|University of Pennsylvania|Dr. H. Branch Coslett|2156623606|hbc@pennmedicine.upenn.edu|
20515139|NCT02666430|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
20515140|NCT03828461|Stanford University|Carolyn Rodriguez, MD, PhD|650-723-4095|cr2163@stanford.edu|
20515141|NCT04523142|Novaliq GmbH|Sonja Krösser|+49 6221 50259|info@novaliq.com|0
20515142|NCT01463683|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515143|NCT03111147|William Beaumont Hospitals|Pamela Sloan, Clinical Research Manager|248-551-6059|pamela.sloan@corewellhealth.org|
20515144|NCT01565083|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20515145|NCT01118728|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20515146|NCT04555525|Skin Sciences, PLLC|Senen Pena|502-451-9000|spdermresearch@yahoo.com|
20515147|NCT01323998|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515148|NCT02178709|IndianaU|Dr. Amikar Sehdev|(317) 274-0339|asehdev@iupui.edu|
20515149|NCT02946385|GlaxoSmithKline|GSK Response Center|866-435-7343|anand.n.harpalani@gsk.com|
20515150|NCT01526538|Johns Hopkins University|Matthew Johnson Ph.D.|4105500056|mwj@jhu.edu|
20515151|NCT01691859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20515152|NCT00976664|National University of Health Sciences|Dr. Jerrilyn Cambron|630-889-6536|jcambron@nuhs.edu|
20515153|NCT02688400|Arthrolab inc.|Dr.Jean-Pierre Pelletier|+1 (514) 992-4939|dr@jppelletier.ca|
20515154|NCT02767388|University of Nebraska Medical Center|David Anderson|402-559-6870|david.anderson@unmc.edu|
20515155|NCT03519256|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20515156|NCT00275002|Pediatric Brain Tumor Consortium|Dana Wallace|901-595-2617|dana.wallace@stjude.org|
20515157|NCT05456529|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20515158|NCT02374918|University of Arizona|"Dr. William Scott Killgore"|(520) 621-0605|killgore@psychiatry.arizona.edu|
20515159|NCT01506947|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20515160|NCT03104205|Dartmouth-Hitchcock|John A. Batsis|6036505000|john.a.batsis@hitchcock.org|
20515161|NCT02752776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20515162|NCT02492958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515163|NCT00108732|ECOG Statistical Office|Study Statistician|617-632-3012||
20515164|NCT00670956|University of California San Francisco|Hanmin Lee, MD|415-476-4086|hanmin.lee@ucsf.edu|
20515165|NCT01946165|UT MD Anderson Cancer Center|Christopher J. Logothetis M.D. / Genitourinary Medical Oncology|713-792-2830|clogothe@mdanderson.org|
20515166|NCT01060592|Crospon|John O'Dea PhD|+353-91-519880|jodea@crospon.com|
20515167|NCT01766921|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20515168|NCT01901055|University of Pittsburgh|Eileen R. Chasens, PhD, Professor of Nursing|412-624-9380|chasense@pitt.edu|
20515169|NCT00708422|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
20515170|NCT01654107|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|7322354341|marc.steinberg@rutgers.edu|
20515171|NCT00337571|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20515172|NCT02356471|Wake Forest University Health Sciences|Dr. Clancy Clark|336-716-7207|cjclark@wakehealth.edu|
20515173|NCT01491620|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20515174|NCT00638365|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
20515175|NCT01569451|University of Colorado|Stefan Sillau|303-724-8657|stefan.sillau@ucdenver.edu|
20515176|NCT00635154|Mayo Clinic|Dr. John Lust||lust.john@mayo.edu|
20515177|NCT01399736|Maasstad Hospital|Dr.Pieter Smits|+31102913322|SmitsP@maasstadziekenhuis.nl|
20515178|NCT02795104|The Ohio State University Comprehensive Cancer Center|Ryan Baltic|614-293-4121|ryan.baltic@osumc.edu|
20515179|NCT00948675|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20515180|NCT02296775|Dr. Reddy's Laboratories Ltd, Biologics Survey No. 47, Bachupally Village, Bachupally Mandal, Medchal Malkajgiri District Telangana, India - 500 090|Dr. Ankit Ranpura, MD (Associate Director- Clinical Development)|040 4464 4000|ankitr@drreddys.com|
20515181|NCT01654380|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20515182|NCT01575522|Dana-Farber Cancer Institute|Sara M. Tolaney, MD, MPH|617.632.5743|Sara_Tolaney@dfci.harvard.edu|
20515183|NCT02582970|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20515184|NCT03552757|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20515185|NCT04652453|Department of Internal Medicine: Yale School of Medicine|Lauren Ferrante, MD, MHS|(203) 785-3207|lauren.ferrante@yale.edu|
20515186|NCT04543136|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
20515187|NCT02192099|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20515188|NCT00386009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20515189|NCT00711464|University of California, Los Angeles|Michael Minzenberg, MD|(310) 825-7642|MMinzenberg@mednet.ucla.edu|
20515190|NCT00585780|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
20515191|NCT02026453|Cedars-Sinai Medical Center|Dr. Joshua M. Pevnick|310-423-6976|Joshua.Pevnick@cshs.org|
20515192|NCT02597543|UCSD|Paul Kim, MD|3104907217|pjk017@ucsd.edu|
20515193|NCT01862328|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20515194|NCT02482571|University of Minnesota|Silvia Mangia, PhD|6126254920|mangia@umn.edu|
20515195|NCT00440596|Kent State University|Joel Hughes|330-672-7721|jhughes1@kent.edu|
20515196|NCT03922477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20515197|NCT01498484|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
20515198|NCT04104646|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20515199|NCT01199601|Columbia University|Dr. Catherine Todd|212-305-4805|cst2121@columbia.edu|
20515200|NCT02607800|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20515201|NCT01656889|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20515202|NCT03387098|Immunitybio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20515203|NCT02486796|Midwestern Regional Medical Center, Inc.|Director of ClinicalResearch|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
20515204|NCT02974153|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20515205|NCT02521948|Essential Medical, Inc|Director of Operations|610-557-1009|todd@essmedclosure.com|
20515206|NCT00423800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20515207|NCT01576588|Vilnius University Hospital Santaros Klinikos|Regina Pileckyte, investigator|+370 5 2501384|regina.pileckyte@santa.lt|
20515208|NCT02114307|Imperial College London|Dr Tristan Lane|02033117317|tristan.lane@imperial.ac.uk|
20515209|NCT03387033|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
20515210|NCT00601484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515211|NCT03504852|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20515212|NCT03850509|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20515213|NCT00969332|UCLA|Dr. Kara L. Calkins|310-825-9330|KCalkins@mednet.ucla.edu|
20515214|NCT00576199|Hoffmann-La Roche|Medical Communications|800 821-8590||
20515215|NCT03131999|Medical University of South Carolina|Charlton Strange, MD|843-792-3174|strangec@musc.edu|
20515216|NCT03495869|Virginia Commonwealth University|Lori Keyser-Marcus, PhD|(804) 828-4164|lori.keysermarcus@vcuhealth.org|
20515217|NCT03482713|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-80-672-6372|ClinicalTrialsDisclosure@merck.com|
20515218|NCT04634409|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20515219|NCT05856123|Mayo Clinic|Deanna Covelli|480-342-5284|covelli.deanna@mayo.edu|
20515220|NCT05514119|Mayo Clinic|Channa Jayasekera, M.D.|480-342-1095|jayasekera.channa@mayo.edu|
20515221|NCT00278200|Johns Hopkins University|Richard Ambinder, MD, PhD|4109558839|rambind1@jhmi.edu|
20515222|NCT01521559|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
20515223|NCT02228382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515224|NCT02337465|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ping Xia|1-866-223-8100|TaussigResearch@ccf.org|
20515225|NCT02918162|Columbia University|Gulam Manji, MD, PhD|212-305-7115|gam2140@cumc.columbia.edu|
20515226|NCT00395226|Essentia Institute of Rural Health|Brian Johnson|218-786-8856|bjohnson3@eirh.org|
20515227|NCT01747850|CAMH|Dr. Jose Trigo|416.535.8501|jose.trigo@camh.ca|30021
20515228|NCT00576381|The Children's Hospital of Philadelphia|Dr Athena Zuppa|267-426-5753|zuppa@email.chop.edu|
20515229|NCT01031537|Division of Occupational Health and Safety, NIH|Dr. James M. Schmitt|301-496-4411|james_schmitt@nih.gov|
20515230|NCT03238677|Syracuse University|Jonathan Preston|3154433143|jopresto@syr.edu|
20515231|NCT00231868|Montefiore Medical Center|Dr. Dennis Yi-Shin Kuo|718-405-8082|DYKUO@montefiore.org|
20515232|NCT03256799|UAB|Steven M. Rowe|205-975-9776|smrowe@uab.edu|
20515233|NCT02226796|University of Minnesota Duluth|Sharyl Samargia-Grivette|218-726-8347|samargia@d.umn.edu|
20515234|NCT03522948|Boston University|Tibor Palfai|617-353-9345|palfai@bu.edu|
20515235|NCT01802879|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20515236|NCT01948505|Pacific Neuroscience Institute|Dr. Walavan Sivakumar|424-212-5361|walavan.sivakumar@gmail.com|
20515237|NCT00712010|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont|+41217858054|maurice.beaumont@rdls.nestle.com|
20515238|NCT02187042|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515239|NCT01807871|University of Vermont|Dr. John Hughes|802-656-1640|John.Hughes@med.uvm.edu|
20515240|NCT01659567|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20515241|NCT03019965|CISMexico|Dr. Yazmín Fuentes|55276900|yazmin_fuentes@hotmail.com|22462
20515242|NCT02983448|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|405-271-4742|stavros-stavrakis@ouhsc.edu|37507
20515243|NCT01179919|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
20515244|NCT01650324|Taipei Medical University - Wanfang Hospital|Dr. Yi-Jen Chen|886-2-2930-7930|yjchen@tmu.edu.tw|2543
20515245|NCT04582396|Columbia University|Dr. Sachin Agarwal|2123421335|sa2512@cumc.columbia.edu|
20515246|NCT01586741|Karolinska University Hospital|D. Peter Emanuelsson|+46851770000|peter.emanuelsson@sll.se|
20515247|NCT01915732|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515248|NCT01325207|Northwestern University|Jeffrey Raizer, MD||Jeffrey.Raizer@nm.org|
20515249|NCT00698685|University of Arizona, Arizona Cancer Center|Andrew M. Yeager, MD|520-626-0662|ayeager@azcc.arizona.edu|
20515250|NCT01254409|Promedior, Inc.|Dr. Bernt van den Blink|781-538-4203|bvandenblink@promedior.com|
20515251|NCT01974895|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515252|NCT01513148|Shenandoah University|Dr. Todd Telemeco|540-545-7398|ttelemec@su.edu|
20515253|NCT03500484|Yale University / Yale School of Medicine|Ania Jastreboff, MD, PhD|203 737 1932|ania.jastreboff@yale.edu|
20515254|NCT00449150|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
20528965|NCT01957579|MedImmune, LLC|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
20528966|NCT01000974|GlaxoSmithKline|GSK Response Center|866-435-7343||
20528967|NCT02726789|Replicor Inc.|Chief Scientific Officer|514 733 1998|availlant@replicor.com|
20528968|NCT01307891|University of Alabama at Birmingham|Andres Forero, M.D.|205-934-7167|aforero@uab.edu|
20528969|NCT03365934|JNJWorldwide|Amisha Parikh-Das|973-255-8701|aparikh1@its.jnj.com|
20528970|NCT02750332|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
20528971|NCT02937740|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
20528972|NCT04194489|Mt. Hope Family Center, University of Rochester|Dr. Christie Petrenko|(585) 275-2991|christie.petrenko@rochester.edu|241
20528973|NCT01000987|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
20528974|NCT01851655|University of Florida|Dr. Terese Chmielewski|352-273-6104|tchm@ufl.edu|
20528975|NCT02485483|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20528976|NCT04611542|Oregon Research Behavioral Intervention Strategies, Inc. dba Behavioral Influents Innovations|Dr. Jeremy Jones|541-484-2123|jeremy.jones@influentsin.com|
20528977|NCT02291029|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20528978|NCT00522548|University of Pennsylvania|Roy Bloom, MD|215-662-4643|roy.bloom@uphs.upenn.edu|
20528979|NCT04155463|Boise State University|Dr. Cynthia Curl|208-426-3924|cynthiacurl@boisestate.edu|
20528980|NCT00113295|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
20528981|NCT01714544|Promius Pharma|Director Clinical Operations|609-282-1404|jfraser@drreddys.com|
20528982|NCT02143024|UC Davis Department of Psychiatry and Behavioral Sciences|Ladson Hinton, MD|(916) 734-3485|lwhinton@ucdavis.edu|
20528983|NCT06597084|BIAL - Portela & Ca, SA|Responsible of Clinical Operations|+351229866100|clinical.trials@bial.com|
20528984|NCT05219968|Lyra Therapeutics|Senior Vice President, Clinical Affairs|617-393-4600|lyraclinical@lyratx.com|
20528985|NCT04587336|Health Systems Research Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Allison Lewinski, PhD, MPH, RN, FAAN|919-286-0411|Allison.Lewinski@va.gov|174048
20528986|NCT00913081|University of Pennsylvania|Richard L. Dunbar, MD, PI|609 413-1067|richard.dunbar@uphs.upenn.edu|
20528987|NCT03569098|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
20528988|NCT00758498|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
20528989|NCT01516736|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
20528990|NCT04403113|Marmara University|Assoc. Prof Gonul Acar|5323778878|gonulacar34@gmail.com|+90
20528991|NCT02781818|UNC Dermatology|Dr. Christopher Sayed|984-974-3900|christopher_sayed@email.unc.edu|
20528992|NCT01877668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
20528993|NCT01302418|QIAGEN|Tony Lam|301-944-7090|tony.lam@qiagen.com|
20528994|NCT01697800|Johns Hopkins Medicine|Zubair Khan|410-955-3157|zkhan@jhmi.edu|
20528995|NCT00954122|AstraZeneca|Gerard Lynch|4415 09645895|clinicaltrialtransparency@astrazeneca.com|
20528996|NCT00666211|Vanderbilt-Ingram Cancer Center|Nancy Wells, Director of Nursing Research Patient Care Svcs|615-322-6184|nancy.wells@vanderbilt.edu|
20528997|NCT02881658|The University of Hong Kong|Dr Cheung Ching Lung|(852)28315085|lung1212@hku.hk|
20528998|NCT02999789|University of California, San Francisco|Eddie Cruz-Romero, MD, MPH|(628) 206-2837|Edward.Cruz@ucsf.edu|
20528999|NCT01065571|University of Illinois at Chicago|Joanne Tobacman, MD|312-569-7826|jkt@uic.edu|
20515255|NCT06331156|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20515256|NCT00546390|University of Alb erta|Dr B Finegan|7809701302|bfinegan@ualberta.ca|780
20515257|NCT00855842|Boston University|Lynn Borgatta, MD|617-414-3440|lynn.borgatta@bmc.org|
20515258|NCT02978326|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20515259|NCT02024087|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515260|NCT02129348|New York State Psychiatric Institute|Davangere Devanand, MD|646.774.8656|dpd3@cumc.columbia.edu|
20515261|NCT02327195|The Ohio State University Wexner Medical Center|Nicoleta Stoicea|614-293-3559|nicoleta.stoicea@osumc.edu|
20515262|NCT02019940|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
20515263|NCT01598701|University of Texas Health Science Center at Houston|Carlos Artime, MD|713-500-6200|Carlos.Artime@uth.tmc.edu|
20515264|NCT01709032|Children's Hospital of Philadelphia|Janet Kwiatkowski, MD|215-590-3437|kwiatkowski@email.chop.edu|
20515265|NCT01265784|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
20515266|NCT01937364|Essentia Health|Jeffrey E. Lyon, M.D.|218-786-2802|jeffrey.lyon@essentiahealth.org|
20515267|NCT04799158|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT|medicalinformation@phathompharma.com|7426
20515268|NCT00936975|ECOG-ACRIN Cancer Research Group|Results Reporting Statistician|401-863-9188|bherman@stat.brown.edu|
20515269|NCT01592799|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515270|NCT02255513|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
20515271|NCT01055223|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515272|NCT02568384|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20515273|NCT01485536|The University of Texas (UT) MD Anderson Cancer Center|Yasuhiro Oki, Associate Professor, Lymphoma/Myeloma|713-792-7734|CR_Study_Registration@mdanderson.org|
20529000|NCT04878055|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20529001|NCT02907463|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
20529002|NCT01447407|NovaDigm Therapeutics, Inc.|John P. Hennessey, Jr.|12676405189|john_hennessey@novadigm.net|
20515274|NCT00329602|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561266|NCT02104765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20515275|NCT00510510|Novartis Pharmaceuticals|Study Director|862-778-8300||
20515276|NCT01066052|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20515277|NCT01497938|Medtronic|Thomas Troub|(818) 576-3142|thomas.troub@medtronic.com|
20515278|NCT00365352|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20515279|NCT00097695|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20515280|NCT00905125|Medicine and Molecular Virology & Microbiology, Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
20515281|NCT02109133|Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine,Severance Hospital, Yonsei University Health System|Dr. Sun-Jun, Bae|+82-02-2228-4438|SJBAI1@yuhs.ac|
20515282|NCT03363581|Imperial College London|Prof Carel le Roux|07970719453|carel.leroux@nhs.net|
20515283|NCT05200858|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20515284|NCT02448771|Dana-Farber Cancer Institute|Rinath Jeselsohn|617.632.6887|rinath_jeselsohn@dfci.harvard.edu|
20515285|NCT03457909|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
20515286|NCT02683187|Duke University Medical Center|Dr. David D'Alessio|919-684-5778|david.d'alessio@duke.edu|
20515287|NCT06611410|CooperVision|Lee Hall|+19256604365|LHall@coopervision.com|
20515288|NCT01052116|ALA - ACRC|Robert A. Wise|(410) 550-0545|rwise@jhmi.edu|
20515289|NCT00590395|Cedars Sinai Medical Center|Alan Waxman, M.D.|310-423-8000|Alan.Waxman@cshs.org|
20515290|NCT00862979|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20515291|NCT01027143|Duke University Medical Center|Jason Lang, MD|919-684-9590|jason.lang@duke.edu|
20515292|NCT01290263|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
20515293|NCT02624843|South Florida Family Health & Research|Elisabeth Rivera|3053870051|elisabeth@sffhrc.com|
20515294|NCT02518113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20515295|NCT00287118|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20515296|NCT02324465|Vanderbilt University Medical Center|Doug Hester|6153439419|doug.hester@vanderbilt.edu|
20515297|NCT01631864|Novartis Pharmaceuticals|Study Director|862-778-8300||
20515298|NCT02132247|IBSA Pharma Inc.|Christopher Jones, Ph.D.|(202) 753-6475|chris.jones@ibsapharma.com|7005
20515299|NCT04908748|Teikoku Seiyaku Co.,Ltd.|Hirofumi Fujiwara|+81362649123|hirofumi-fujiwara@teiyaku.co.jp|
20515300|NCT02433665|Duke University Medical Center|Dr. Daniele Marin|919.684.7709|daniele.marin@duke.edu|
20515301|NCT00757601|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515302|NCT01860976|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20515303|NCT02892500|Sanford Health|Christie Ellison|605-312-6030|christie.ellison@sanfordhealth.org|
20515304|NCT02153398|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
20515305|NCT02204371|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515306|NCT00571428|Sunovion|Brovana Medical Director|1-866-503-6351||
20515307|NCT02246478|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
20515308|NCT00998023|University of Florida|J Mocco, M.D.|352-273-9000|jmocco@neurosurgery.ufl.edu|
20515309|NCT02901899|Northwestern University|Daniela Matei, MD|312.472.4684|daniela.matei@northwestern.edu|
20515310|NCT02566135|Medical College, Baroda.|Dr Aditi Amrutlal Dhimar|09825334605|dhimaraditi@yahoo.in|
20515311|NCT00865709|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20515312|NCT00429923|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325|jbrace@siriontherapeutics.com|343
20515313|NCT03276975|Duke University Medical Center|Timothy J. Amrhein, MD|9196841909|timothy.amrhein@duke.edu|
20515314|NCT00662129|Mayo Clinic|Donald W. Northfelt, MD, FACP|507/284-1159|northfelt.donald@mayo.edu|
20515315|NCT03978403|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
20515316|NCT02153736|Virginia Commonwealth University|Stacey Dusing, PT, PhD, PCS, Director Motor Development Lab|804-628-3632|scdusing@vcu.edu|
20515317|NCT00767507|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
20515318|NCT00966953|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20515319|NCT00796510|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515320|NCT01734772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515321|NCT05030753|Univeristy of Virginia|Jamie Zoellner|434-962-4488|jz9q@virginia.edu|
20515322|NCT03580343|Washington University in St. Louis|Lynn Hassman, Assistant Professor and Study PI|3142730341|lhassman@wustl.edu|
20515323|NCT02099461|Amgen Inc.|Study Director|866-572-6436||
20515324|NCT03277183|NFSGVA|Dr. Mark Segal|3523761611|mark.segal@va.gov|104496
20515325|NCT00809809|Integrative Medicine Institute|David Riley, MD|505 690-0688|dsriley@integrativemed.org|
20515326|NCT00720122|Massachusetts General Hospital|Madhusmita Misra, M.D., Associate Professor in Pediatrics, Assistant Pediatrician|617-724-5602|mmisra@partners.org|
20515327|NCT03072459|Smith & Nephew, Inc.|Salima Reddy|817-916-2233|salima.reddy@smith-nephew.com|
20515328|NCT02275364|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515329|NCT03177603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20515330|NCT03595657|CStone Pharmaceuticals|Zhang Wenyun|+86 021-60333416|CstoneRA@cstonepharma.com|
20515331|NCT01200394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515332|NCT04107493|ResMed|maureen crocker|+1 8588366653|maureen.crocker@resmed.com|
20515333|NCT00630565|University of Minnesota, Masonic Cancer Center|Dr. Daniel Weisdorf, MD|+1 612-624-3101|weisd001@umn.edu|
20515334|NCT00663871|University of Pittsburgh, Heart and Vascular Institute|Matthew F. Muldoon, MD, MPH|412-624-8798|mfm10@pitt.edu|
20529003|NCT00580957|Vanderbilt University|Italo Biaggioni, M.D. Professor of Medicine|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
20529004|NCT01719380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529005|NCT00433550|Mayo Clinic|Robert R. McWilliams, M.D.||mcwilliams.robert@mayo.edu|
20529006|NCT02532374|Philip Morris Products S.A.|Loyse Felber Medlin|+41 (58) 242 2686|Loyse.FelberMedlin@pmi.com|
20529007|NCT02862080|The University of Texas Health Science Center at Houston|Marcie Kern, PT, MSPT|713-799-6995|neurorecoveryresearch@memorialhermann.org|
20529008|NCT01765296|CrystalGenomics, Inc.|Chief Medical Officer|+82-31-628-2871|sang-yoon.lee@cgxinc.com|
20529009|NCT03257436|BostonScientific|Sharda Mehta|6785967330|sharda.mehta@bsci.com|
20529010|NCT01619852|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
20529011|NCT02659943|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@nih.gov|
20529012|NCT05438277|Campbell Foundation|Research Manager|9017595413|mknack@campbell-foundation.org|
20529013|NCT01305811|New England School of Acupuncture|Lisa Conboy|6175581788|lconboy@nesa.edu|145
20529014|NCT01723072|Novartis Pharmaceuticals|Study Director|1-888-669-6682||
20529015|NCT01841970|Medtronic Surgical Innovations|Study Director, Clinical Research|508-452-4028||
20529016|NCT03478371|Procter & Gamble Co|Jan Streicher-Scott, PhD, RPh|513-634-5584|streicherscott.jl@pg.com|
20529017|NCT01411852|Resuscitation Outcomes Consortium|Susanne May, PhD, Principal Investigator|206-685-1302|sjmay@uw.edu|
20529018|NCT01715948|Capital Health|Dr. Manohar Bance|902-473-5975|m.bance@dal.ca|
20529019|NCT04693078|Shaare Zedek Medical Center|Dr. Dan Meir Livovsky|+34603833576|danlivo@yahoo.com|
20529020|NCT01118663|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20515335|NCT02729896|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20529021|NCT04039204|Wake Forest University School of Medicine|Bruce Lessey, Ph.D., M.D.|336-713-0380|blessey@wakehealth.edu|
20529022|NCT01189461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529023|NCT02149264|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20529024|NCT02487797|Northwestern University, Yale University|Dr. Moeun Son|475-414-5328|moeun.son@yale.edu|
20529025|NCT02824627|University of Nebraska Medical Center|Soonjo Hwang|402-552-6351|soonjo.hwang@unmc.edu|
20529026|NCT01938846|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20529027|NCT01242241|Baylor College of Medicine|Dr. Olutoyin A. Olutoye|832-824-5800|oao@bcm.edu|
20529028|NCT02499120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529029|NCT01689441|Brigham and Women's Hospital|David Leaf, MD, MMSc|617-732-5500|deleaf@partners.org|
20529030|NCT02477358|University of Nebraska Medical Center|Elisabeth Easley|530-524-6020|eleasley@gmail.com|
20529031|NCT02282163|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound Programs|1-609-514-2506|Melda.Dolan@diag.bracco.com|
20529032|NCT00964028|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529033|NCT03472521|Stanford University|Dr. Pamela Flood, MD, MA|201-370-3933|pflood@stanford.edu|
20515336|NCT01835145|Alliance for Clinical Trials in Oncology|Jason J. Luke, M.D.||jluke@medicine.bsd.uchicago.edu|
20515337|NCT00582309|UNM|Gary Iwamoto|505-272-4751|giwamoto@salud.unm.edu|
20515338|NCT03123822|UAB|Katherine Weise|2059752020|kweise@uab.edu|
20515339|NCT04094870|University of North Carolina at Chapel Hill|Elizabeth Stringer, MD, MSc|919-966-1601|elizabeth_stringer@med.unc.edu|
20515340|NCT03384745|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
20515341|NCT00918671|NTNU|Professor Knut Hagen|+4772575080|knut.hagen@ntnu.no|
20515342|NCT00669578|Mayo Clinic|Ayalew Tefferi, M.D.||tefferi.ayalew@mayo.edu|
20515343|NCT02708277|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
20515344|NCT01058421|University of Colorado|Dr. Marc Moss|303-724-6079|marc.moss@ucdenver.edu|
20515345|NCT01924390|UTHSCSA Periodontics|Brian L. Mealey|210-567-3589|mealey@uthscsa.edu|
20515346|NCT02984683|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|option 6
20515347|NCT01592370|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20515348|NCT01050231|University of California Irvine|Dr David Reinkensmeyer|(949) 824-5218|dreinken@uci.edu|
20515349|NCT00455533|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20515350|NCT02785172|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20515351|NCT02415959|Abbott|Suntje Sander-Struckmeier|+49 (0) 511 6750 3254|suntje.sander@abbott.com|
20515352|NCT01048333|Astra Zeneca|Gerard Lynch|+44 1509 645895|ClinicalTrialTransparency@astrazeneca.com|
20515353|NCT01396044|Northwestern University|Dr. Curtis Weiss|(312) 695-6439|curtisweiss@northwestern.edu|
20515354|NCT02739542|UT Southwestern Medical Center|Darin T. Okuda, M.D.|214-645-8800|darin.okuda@utsouthwestern.edu|
20515355|NCT03008460|Ipsen|Ipsen Medical Director|use email|clinical.trials@ipsen.com|
20515356|NCT00955747|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
20515357|NCT02260492|Oriel Therapeutics, a Novartis Company|Malinda Longphre PhD, Director Clinical Reserach|9193131290|mlongphre@orieltherapeutics.com|114
20529034|NCT01603407|University of Rochester|Robert Griggs|585-275-6072|robert_griggs@urmc.rochester.edu|
20529035|NCT03705286|Duke University|Miriam Treggiari|919-681-9933|miriam.treggiari@duke.edu|
20529036|NCT01074177|Massachusetts General Hospital|Lecia Van Damn Sequist|617-724-4000|lvsequist@partners.org|
20529037|NCT01514383|Medline Industries, Inc|Ed Drower, Clinical Project Director|847-643-3874|edrower@medline.com|
20529038|NCT02106351|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20515358|NCT00996736|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
20515359|NCT01693783|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-4501|Amit.Oza@uhn.ca|3911
20551248|NCT02132767|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
20515360|NCT02346201|Johns Hopkins School of Public Health|Jennifer Jones, Research Coordinator|44377086812|jejones@jhu.edu|
20515361|NCT03708211|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20515362|NCT00462982|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
20515363|NCT00409578|Novartis Pharmaceuticals|Study Director|862 778-8300||
20515364|NCT00770315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20515365|NCT04256421|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20515366|NCT02785913|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20515367|NCT02841709|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
20515368|NCT01929109|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20515369|NCT01402908|Medigen Biotechnology Corp.|Clinical Research Manager|886-2-77361234|Doyce.Chen@medigen.com.tw|
20515370|NCT01739790|Minneapolis VA Healthcare System|Dennis E. Niewoehner, MD|612-467-4412|niewo001@umn.edu|
20515371|NCT02581345|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
20515372|NCT02122796|Allina Health|Director of Integrative Health Reseach Center|612-262-2354|jeffery.dusek@allina.com|
20515373|NCT00234078|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20515374|NCT03471078|Dova|VP of Global Drug Development|9193387864|clinical@dova.com|
20515375|NCT01544361|MedImmune, LLC.|Joseph M. Parker, Director, Clinical Development|301-398-0000|parkerj@medimmune.com|
20515376|NCT05568225|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20515377|NCT02405325|UCSD|Loki Natarajan|8588224763|lnatarajan@ucsd.edu|
20515378|NCT03068273|Scripps Health|Athena Philis-Tsimikas|858-678-7077|philis-tsimikas.athena@scrippshealth.org|
20515379|NCT03901573|NeoImmuneTech,INC|Alex Oh|301-337-2283|aho@neoimmunetech.com|
20515380|NCT02675543|University of Brescia|Francesco Semeraro|+30 030 3995308|francesco.semeraro@unibs.it|
20515381|NCT02309099|University of North Carolina at Chapel Hill|Dr. Meredith Rooth|919-966-5251|meredith_rooth@med.unc.edu|
20515382|NCT03012477|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
20515383|NCT02819362|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20515384|NCT05301751|Allgenesis Biotherapeutics Inc.|Tan Nguyen, Vice President of R&D|+886-2-87871232|tan.nguyen@allgenesis.com|105
20515385|NCT00797108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515386|NCT01141725|FHCRC/UWMC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@uw.edu|
20515387|NCT02362594|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515388|NCT03803943|Northwestern University|Megan Roberts|(847) 491-3066|megan.y.roberts@northwestern.edu|
20515389|NCT01574248|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
20515390|NCT02922868|Wake Forest|Dr Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
20515391|NCT01781286|University of Missouri|Dr. Heather Leidy|(573) 882-4288|leidyh@health.missouri.edu|
20515392|NCT00995410|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
20515393|NCT03594123|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20515394|NCT03365375|Indiana University|Paul Musey|317-880-3900|pmusey@iu.edu|
20515395|NCT02483975|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515396|NCT00818883|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20515397|NCT02166697|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20515398|NCT00939653|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20515399|NCT01556009|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
20515400|NCT01505530|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20515401|NCT03879239|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
20515402|NCT03179345|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
20515403|NCT02585700|Clinical Center of Serbia-Clinic for Infectious and Tropical Diseases|Dr. Goran Stevanovic|+381 64 1703059|goran_ste@yahoo.com|
20515404|NCT01618266|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20515405|NCT01966042|Federal University of Sao Paulo (UNIFESP)|Dr. Nelson Americo Hossne Junior|+55 11 5571-2719|nelson.hossne@gmail.com|
20515406|NCT00625807|Massachusetts General Hospital|Sara Lazar|617-724-2256|slazar@mgh.harvard.edu|
20515407|NCT03267264|Becton Dickinson|Michael Gibney|201-847-6170|michael_gibney@bd.com|
20515408|NCT02224391|UT MD Anderson Cancer Center|Dr. Jason Robinson, PHD- Associate Professor, Behavioral Science|(713) 792-0919|jdrobinson@mdanderson.org|
20515409|NCT00084084|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20515410|NCT00454636|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20515411|NCT01400113|St. Joseph's Hospital Health Center|Michael Pratts, MD|315-726-8610|michael.pratts@sjhsyr.org|
20515412|NCT02114697|Emory University|John Oshinski PhD|404-727-5894|jnoshin@emory.edu|
20515413|NCT01984242|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20515414|NCT02334059|Penn State Health Anesthesiology and Perioperative Medicine|Sanjib D Adhikary|717-531-6597|sadhikary1@pennstatehealth.psu.edu|
20515415|NCT03644095|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20529039|NCT01401543|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561267|NCT04771273|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561268|NCT01624168|Appalachian State University|Dr. Karen Caldwell, Professor|828-262-6045|caldwellkaren@appstate.edu|
20515416|NCT04333095|Baylor Scott & White Research Institute|Sarah Hale, Project Manager|469-814-4845|Sarah.Hale@BSWHealth.org|
20515417|NCT00984295|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515418|NCT03740165|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20515419|NCT03049618|University of Southern California|Victoria Soto|323-865-3441|victoria.soto@med.usc.edu|
20515420|NCT04582539|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20515421|NCT06052566|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20515422|NCT01004770|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|rubin.sheng@ge.com|
20515423|NCT00788957|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20515424|NCT03845933|Evergreen General Hospital|Dr Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
20515425|NCT02579096|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
20515426|NCT02097121|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20515427|NCT00319449|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20515428|NCT02739984|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20515429|NCT00979628|EUSOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
20515430|NCT00911859|Janssen R&D BE|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20515431|NCT02042911|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
20515432|NCT00767325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20515433|NCT03538756|RxFunction, Inc.|Lars Oddsson, PhD|612-358-2140|loddsson@rxfunction.com|
20515434|NCT00752856|UCSD|Sheldon Morris|8583364088|shmorris@ucsd.edu|
20515435|NCT02688608|Stanford Medicine at Stanford University|Saad A Khan, MD|650-507-5624|Saad.A.Khan@stanford.edu|
20515436|NCT00764309|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20515437|NCT03968224|UIM Enfermedades Endocrinas. Hospital de Especialidades Centro Médico Nacional Siglo XXI|Aldo Ferreira Hermosillo|+(52)15556276900|aferreira@endocrinologia.org.mx|21913
20515438|NCT02207231|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20515439|NCT02258256|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
20515440|NCT04637997|University Hospital Erlangen, Vascular Surgery|Dr. med. Antje Mükke|+4991318532968|antje.muekke@uk-erlangen.de|
20515441|NCT00502775|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515442|NCT01315145|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
20515443|NCT03392974|BioMarin Pharmaceutical Inc.|Medical Manager, Clinical Science|415-996-2917|divya.reddy@bmrn.com|
20515444|NCT00655642|Vanderbilt University|Dr. Tyler Barrett|6159360253|tyler.barrett@vanderbilt.edu|
20515445|NCT02016300|Stanford University|Jason Dragoo, MD|650-721-3430|jdragoo@stanford.edu|
20515446|NCT06165744|Alcon Research, LLC|Sr. Principal Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20515447|NCT01545076|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20515448|NCT01546987|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20515449|NCT02134756|University of South Florida|Marcus Kilpatrick|(813) 362-6696|mkilpatrick@usf.edu|
20515450|NCT00583700|West Virginia University|Geraldine Jacobson, MD, MBA, MPH, FACR|(304) 293-7227|GMJACOBSON@hsc.wvu.edu|
20515451|NCT05381948|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
20515452|NCT04471207|Medical University of South Carolina|Stacey Sellers|843-792-5807|sellersst@musc.edu|
20515453|NCT06046482|The University of Texas MD Anderson Cancer Center|Renata Ferrarotto, MD|(713) 745-6774|rferrarotto@mdanderson.org|
20529040|NCT00069823|Johns Hopkins University|Ellen Brown|443-287-3170|ala-acrc@jhsph.edu|
20515454|NCT00928954|Case Western Reserve University|R. John Leigh, M.D.|216-844-3190|rjl4@case.edu|
20515455|NCT00724568|University of Michigan Comprehensive Cancer Center|Dr. Moshe Talpaz|734-764-8195|mtalpaz@umich.edu|
20529041|NCT02541409|Johns Hopkins University Bloomberg School of Public Health|Dr. Shruti Mehta|443-287-3837|smehta@jhu.edu|
20515456|NCT00561730|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20515457|NCT02841774|Northwestern University|Dr. Matthew Feinstein|3126643278|matthewjfeinstein@northwestern.edu|
20515458|NCT00520741|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20515459|NCT04373434|Emory University|Michelle C. Kegler, MPH, DrPH|404-712-9957|mkegler@emory.edu|
20515460|NCT03702621|Indiana University|Dr. Yar Luan Yeap|317-274-0275|yyeap@iupui.edu|
20515461|NCT00527423|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
20515462|NCT00650936|Abbott|Maren Wagner, Clinical Program Director|7517565585|maren.wagner@abbott.com|
20515463|NCT00067236|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
20515464|NCT03194464|VA Northern California Health Care System|Dr. Carolynn Patten (Principal Investigator)|916.724.5029|carolynn.patten@va.gov|
20515465|NCT01385033|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561269|NCT02357784|Northwestern University|Dr. Margaret Mueller|13124723874|mgmueller@nm.org|
20515466|NCT02446132|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|clinicaltransparency@otsuka-us.com|
20515467|NCT05526248|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20529042|NCT03560869|University of Delaware|William B. Farquhar|302-831-6178|wbf@udel.edu|
20561270|NCT00995709|Novartis Pharmaceuticals|Study Director|862-778-8300||
20561271|NCT01944319|Peking University Third Hospital|Dr. Qingtao ZHOU|86-10-82265562|zhouqingtaobysy@sina.com|
20561272|NCT04026620|University of North Carolina at Chapel Hill|Julie Hasken, PhD|704-250-5000|julie_hasken@unc.edu|
20561273|NCT00604721|UNC Lineberger Comprehensive Cancer Center|Bert. H. O'Neil, Associate Professor, Clinical Research|919-966-4431|bert_oneil@med.unc.edu|
20561274|NCT04776213|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20561275|NCT03392532|Alcon, A Novartis Division|CDMA Project Lead, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20561276|NCT00556543|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
20561277|NCT03772964|University of Pittsburgh|Dr. Brian Zuckerbraun|(412) 647-3065|zuckerbraunbs@upmc.edu|
20561278|NCT01286402|University of Texas Health Science Center at Houston|Angela Stotts, PhD, PI|713-500-7590|Angela.L.Stotts@uth.tmc.edu|
20561279|NCT02987335|Albert Einstein College of Medicine|Dr Meredith Hawkins|718.430.3186|meredith.hawkins@einsteinmed.org|
20561280|NCT01981356|Center for Innovation to Implementation, VA Palo Alto HCS|Matthew Boden, Ph.d.|650-493-5000|Matthew.Boden@va.gov|27529
20561281|NCT01670110|Mayo Clinic|Marie C. Hogan, M.D., Ph.D.|507-284-3479|Hogan.Marie@mayo.edu|
20561282|NCT01751724|University of Miami|Eduardo Bancalari M.D., Director Division of Neonatology|3055856408|ebancalari@miami.edu|
20561283|NCT03395353|Shionogi|Corporate Communications Department|+81-6-6209-7885|shionogiclintrials-admin@shionogi.co.jp|
20561284|NCT03981549|The Emmes Company, LLC|Principal Investigator of the TRUST Data Coordinating Center|301-251-1161|trust@emmes.com|
20561285|NCT05012644|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561286|NCT01278862|3M HCBG Clinical Operations|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
20561287|NCT00798265|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20561288|NCT04341298|Avulux|Dr. Charles Posternack, President|833-288-5890|cposternack@avulux.com|
20561289|NCT03425643|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20561290|NCT03141788|3M|Elaine Egging|651-737-0263|eegging@mmm.com|
20561291|NCT04133363|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS, MS, Interim Dean, Principal Investigator|205-9344506|ngeurs@uab.edu|
20561292|NCT01838200|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20561293|NCT04415333|North Carolina A&T State University|Marc Cook, PhD|336-285-3547|mdcook@ncat.edu|
20561294|NCT03354390|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator|301-451-7128|childsr@nhlbi.nih.gov|
20561295|NCT03523702|Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
20561296|NCT00589667|Memorial Sloan-Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
20561297|NCT02804594|University of California San Francisco|Emmanuelle Waubant, MD|415 514 2468|Emmanuelle.Waubant@ucsf.edu|
20561298|NCT03538041|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20561299|NCT00726596|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu|
20561300|NCT02743078|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
20561301|NCT02126878|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20561302|NCT02425449|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
20561303|NCT00531518|Maine Medical Center Research Institute|William R McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
20561304|NCT02034916|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561305|NCT04008836|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
20561306|NCT03336450|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20561307|NCT00798096|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20561308|NCT03670602|University at Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
20561309|NCT03557333|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
20561310|NCT00864682|Virginia Mason Medical Center|Joseph M. Neal, MD|206-223-6980|anejmn@vmmc.org|
20561311|NCT00957658|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
20561312|NCT01585038|Indiana University School of Medicine|Samir K Gupta, Md, MS|317-274-7926|sgupta1@iu.edu|
20561313|NCT00588965|MetroHealth Medical Center|Dr. Elizabeth Kaufman|216-778-2349|ekaufman@metrohealth.org|
20561314|NCT01234532|University of Maryland, Baltimore|Katherine Tkaczuk, M.D.|410-328-2565|ktkaczuk@umm.edu|
20561315|NCT03748433|Imperial College London|Professor Nick Oliver|+44 (0)20 7594 1796|nick.oliver@imperial.ac.uk|
20561316|NCT02957539|VA Puget Sound Health Care System|Paul Hebert|2062774165|paul.hebert2@va.gov|
20561317|NCT01183533|University of Texas Health Science Center at Houston|Sean I. Savitz, MD|713-500-7083|sean.i.savitz@uth.tmc.edu|
20561318|NCT00217672|University of California, Los Angeles|Sara Hurvitz, M.D.|310-829-5471|shurvitz@mednet.ucla.edu|
20561319|NCT00208507|DePuy Orthopaedics, Inc|Dave Whalen|574-372-7028|DWhalen@its.jnj.com|
20561320|NCT03038399|ReveraGen BioPharma Inc.|Dr. Eric Hoffman|301-762-7980|ericphoffman@gmail.com|
20561321|NCT04567888|Twill|Eliane M. Boucher, PhD (Sr Director of Research Strategy)|(800) 264-6428|eliane@twill.health|
20561322|NCT00619645|University of California Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
20561323|NCT04173572|University of North Carolina at Chapel Hill|Tonya Elliott|919-966-3915|tonya_elliott@med.unc.edu|
20561324|NCT02026258|UConn Health|Flavio Uribe|8606793656|furibe@uchc.edu|
20561325|NCT04615299|John Dingell VA Medical Center|Dr Padmavathi Patel|313-576 2731|Padmavathi.Patel@va.gov|
20561326|NCT00878722|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
20561327|NCT04286529|Mayo Clinic|Rajiv Kumar, MD|507-284-0020|rkumar@mayo.edu|
20561328|NCT02341625|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20561329|NCT05325853|American Genomics, LLC|Dr. Martin Uram|973-885-3447|aschupp@cmcturnkey.com|
20561330|NCT01839877|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20561331|NCT01544062|University of Washington|Srdjan Jelacic, MD|(206) 598-3777|sjelacic@uw.edu|
20561332|NCT00597519|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
20561333|NCT05484726|Fatima Memorial Hospital Shadman Lahore|Assistant Professor Dr Rafia Gul|00923064620027|docrafiagul@gmail.com|
20561334|NCT02781584|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20561335|NCT03396913|Lumenis|Yair Manor, Clinical Director|+972-52-3763416|yair.manor@lumenis.com|
20561336|NCT01093534|Astellas Pharma Europe Ltd.|Director Medical Affairs - Urology||clinicaltrials@us.astellas.com|
20561337|NCT04436120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561338|NCT00281918|Hoffmann-LaRoche|Medical Communications|800-821-8590||
20561339|NCT02124460|Massachusetts General Hospital|Dr. Elsie Taveras|617-726-8555|elsie.taveras@mgh.harard.edu|
20561340|NCT01199237|University of California, San Francisco|Rachel Eshima McKay|415-502-1715|eshimar@anesthesia.ucsf.edu|
20561341|NCT03008915|Columbia University|Dr. Carrie Pistenmaa|212-342-4162|"cp2346@atcumc.columbia.edu"|
20561342|NCT00712166|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
20515468|NCT03444038|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20529043|NCT01801111|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20515469|NCT02354586|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20515470|NCT02606500|University medical centre Ljubljana|Professor Eda Vrtacnik Bokal|+38615226060|eda.bokal@guest.arnes.si|
20515471|NCT03104322|patientMpower|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
20515472|NCT00721409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515473|NCT02402166|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20515474|NCT01134081|University of Michigan|Dr. William Giannobile|734 763 2105|wgiannob@umich.edu|
20515475|NCT00810368|Georgetown University Medical Center|Dr. James N Baraniuk|202-687-8231|baraniuklab@gmail.com|
20515476|NCT00623103|Novartis Pharmaceuticals|Study Director|862-778-8300||
20515477|NCT01400425|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20515478|NCT03239522|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20515479|NCT03272139|Department of Anesthesiology, Critical Care & Pain Management|Dr. David Kim|212-606-1206|kimd@hss.edu|
20515480|NCT01024738|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20515481|NCT03209882|University of Texas at Arlington|Fenghua Tian|8178075271|fenghua.tian@gmail.com|
20515482|NCT03622658|Kinevant Sciences Inc. on behalf of Kinevant Science GmbH|Dr. Simon Lowry, Chief Medical Officer|646-495-5368|simon.lowry@roivant.com|
20515483|NCT02720510|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20515484|NCT01153984|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20515485|NCT00973700|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
20515486|NCT04763876|William Beaumont Army Medical Center Department of Emergency Medicine|Nathaniel James Turner|915-742-6228|nathaniel.j.turner3.mil@mail.mil|
20515487|NCT03499964|Urotronic, Inc|Vice President of Clinical Affairs|763-285-7489|info@urotronic.com|
20515488|NCT03718455|Mayo Clinic|Genevieve A. Woodard, M.D., Ph.D.|507-538-3945|Woodard.Genevieve@mayo.edu|
20515489|NCT01105650|Masonic Cancer Center, University of Minnesota|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu|
20515490|NCT01047345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515491|NCT00806156|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
20515492|NCT00282256|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
20515493|NCT01095510|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20515494|NCT02106065|VA Palo Alto Health Care System|Dr. Kaci Fairchild|6504935000|jenniferkaci.fairchild@va.gov|63432
20515495|NCT01890915|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
20515496|NCT00424489|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
20515497|NCT03312257|Ohio State University|Jeffrey Walline|614-247-6840|walline.1@osu.edu|
20551249|NCT00778700|Incyte Organization|Study Director|1-855-463-3463|medinfo@incyte.com|
20551250|NCT03227029|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20551251|NCT04984993|Futura Medical Development Ltd.|Andrew Graham, Senior Clinical Project Manager|+44 1483 685682|Andy.Graham@futuramedical.com|
20551252|NCT03318315|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-5328|kneuzil@som.umaryland.edu|
20551253|NCT02140788|Duke University Health System|Joseph P. McEvoy|919-819-9295|JMCEVOY@gru.edu|
20551254|NCT02611778|bioeq GmbH|Head of Clinical Development|+498024463330|columbus@bioeq.com|
20551255|NCT02968563|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20551256|NCT03035708|National Institute on Alcohol Abuse and Alcoholism|Health Scientist Administrator|301-443-0788|falkde@mail.nih.gov|
20551257|NCT01496313|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20551258|NCT03254927|Celldex Therapeutics|Chief Medical Officer|844-723-9363|info@celldex.com|
20551259|NCT01341964|Population Health Reseach Institute, Hamilton, ON, Canada|Lynda Hill|905-297-3479|Lynda.Hill@phri.ca|40323
20551260|NCT00909389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20551261|NCT01528254|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20561343|NCT04173962|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-585-4640|james.murrough@mssm.edu|
20561344|NCT02289560|Insightec|Nadir Alikacem, SVP Global Regulated Clinical Affairs|214-630-9900|nadira@insightec.com|
20561345|NCT02540213|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561346|NCT01673113|Massachusetts General Hospital|Dr. Lilit Garibyan|617-726-6168|lgaribyan@partners.org|
20561347|NCT01769391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561348|NCT03386929|Worldwide Innovative Network (WIN) Association|Fanny Wunder, Project Manager|0033604090029|fanny.wunder@winconsortium.org|
20561349|NCT02837237|KBP Biosciences Co., Ltd.|Vincent J. Benn|2677996545|vince.benn@kbpbiosciences.com|
20561350|NCT00038103|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20561351|NCT01144182|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
20561352|NCT02317016|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20561353|NCT02555631|Albert Einstein College of Medicine|Dr. Elizabeth Walker|718-430-3242|elizabeth.walker@einstein.yu.edu|
20561354|NCT02013037|Cedars Sinai Smidt Heart Institute|Dr. Jignesh Patel|310-248-8300|jignesh.patel@cshs.org|
20515498|NCT00982553|Imperial College|Dr Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
20561355|NCT02465359|University of South Florida|Tuan H. Vu, MD|813-974-9413|tvu6@usf.edu|
20561356|NCT02952261|Shanghai Pulmonary Hospital affiliated to Tongji university|Dr. Chang Chen|+86 13816869003|chenthoracic@163.com|
20561357|NCT05052983|Galderma Research & Development|Sponsor|(817) 961-5000|clinical.studies@galderma.com|
20561358|NCT01942707|Universidade Federal de São Paulo|Dr. Heraldo Carlos Borges Inforzato|55-13-997112644|heraldo@litoral.com.br|
20561359|NCT02812966|Advocate Aurora Research Institute|Director, Clinical Trials Research Cardiovascular and Multiple Specialties|708-860-7792|laura.wrona@aah.org|
20561360|NCT01066923|University of Pittsburgh|Clifton Callaway|412-647-3078|callawaycw@upmc.edu|
20561361|NCT00954707|Cordis Corporation, a Johnson & Johnson company|Amy Orlick, Associate Director|908-541-4347|aorlick@its.jnj.com|
20561362|NCT01070888|Boston Children's Hospital|Wanda Phipatanakul|857-218-5336|wanda.phipatanakul@childrens.harvard.edu|
20561363|NCT02195713|Theranova, LLC|Devyani Nanduri|415-926-8616|dnanduri@theranova.com|
20561364|NCT02631148|Brigham and Women's Hosptial|Dr. Ciaran McMullan|617 732 5500|mcmullcj@gmail.com|
20561365|NCT00357396|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
20561366|NCT04002973|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
20561367|NCT00487578|Clinvest|M.E. Beach|(417) 841-3618|mbeach@clinvest.com|
20561368|NCT02378714|Northwestern University|Dr. Brian Hitsman|312-504-5834|b-hitsman@northwestern.edu|
20561369|NCT02525796|Brigham and Women's Hospital|Anand Vaidya|16177325666|anandvaidya@bwh.harvard.edu|
20561370|NCT00726999|Medical College of Wisconsin|Lynn Rusy, MD|414-266-2555|lrusy@chw.org|
20561371|NCT00955825|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20561372|NCT02488980|Penn State Hershey Infectious Diseases|Jose Stoute, MD|800-243-1455|noemail@no.com|
20561373|NCT02729701|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-205-6382|bkimler@kumc.edu|
20561374|NCT02385669|University of Virginia|Craig L. Slingluff, Jr. MD|434-924-9311|cls8h@virginia.edu|
20561375|NCT02810080|ZOLL|Nathan Burkhart|763.367.0462|nburkhart@zoll.com|
20561376|NCT03597100|Cala Health|Sr. Director of Clinical Operations|6506515296|vivien@calahealth.com|
20561377|NCT02620761|Medical College of Wisconsin|Jeffrey Segar|14143377702|jsegar@mcw.edu|
20515499|NCT00235456|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20515500|NCT00536575|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20515501|NCT01089647|University of Cincinnati|Dr. Ann Romaker|513-475-7500|romakean@ucmail.uc.edu|
20515502|NCT00198029|Hospital for Special Surgery|Dr. Lisa Mandl|212-774-2555|MandlL@hss.edu|
20515503|NCT01085344|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
20515504|NCT01626079|Abbott|Sripad Bellary|4088458114|sripad.bellary@abbott.com|
20515505|NCT01457053|University of Cincinnati Medical Center|Dr. Myron C. Gerson/Professor of Medicine|5135583074|myron.gerson@uc.edu|
20515506|NCT04894994|RAPT Therapeutics|William Ho|650-489-9037|bill.ho@RAPT.com|
20515507|NCT02430870|Takeda|Medical Director Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20515508|NCT02780687|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515509|NCT03982433|Boston University|Tibor Palfai, PhD|6173539345|palfai@bu.edu|
20515510|NCT04257929|Harmony Biosciences|Sharon Wolfe-Schwartz, Executive Director, Medical and RegulatoryWriting|267-965-0270|swolfe-schwartz@harmonybiosciences.com|
20515511|NCT05665595|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20515512|NCT05771428|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20515513|NCT04025229|UNC Lineberger Comprehensive Cancer Center|Luz Andrea Cuaboy|1-919-843-1177|luz_cuaboy@med.unc.edu|
20515514|NCT03815942|University of Oxford|Dr Mark Tuthil|01865 227042|mark.tuthill@oncology.ox.ac.uk|
20515515|NCT03717064|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20515516|NCT01298570|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20515517|NCT00076102|National Cancer Institute (NCI), National Institutes of Health (NIH)|Brigitte C. Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
20515518|NCT03165058|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
20515519|NCT01076972|Abbott|Global Medical Services|800-633-9110||
20515520|NCT03252964|Savvysherpa, Inc.|Jared Jones, PhD|7635493540|JaredJones@savvysherpa.com|8116
20515521|NCT04815863|Renji Hospital, Shanghai Jiaotong University School of Medicine|Dr. Meng Jiang|+86 13788912766|jiangmeng0919@163.com|
20561378|NCT00816751|UC San Diego Health|Jessica M. Kingston, MD|858-249-1204|jkingston@ucsd.edu|
20561379|NCT05174013|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20561380|NCT03036735|Steward Health Care|Dr Peter Catalano|617-789-5004|peter.catalano@steward.org|5004
20561381|NCT00344019|BIDMC|Director of Clinical Trials|6176678800|dcutlip@bidmc.harvard.edu|
20515522|NCT02270736|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20515523|NCT00262600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515524|NCT02710123|SUNY Buffalo|John Leddy MD|7162043200|leddy@buffalo.edu|
20515525|NCT06132919|MC2 Therapeutics|Chief Medical Officer|+45 2018 1111|info@mc2therapeutics.com|
20515526|NCT01957488|Coloplast|Medical Director|+45 4911 1395|dkbir@coloplast.com|
20561382|NCT02503202|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561383|NCT00139737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561384|NCT02925195|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
20515527|NCT01424722|Abbott Medical Devices|Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
20515528|NCT01025037|Tornier, Inc.|Manager of Clinical Operations|952-426-7674|serickson@tornier.com|
20515529|NCT01346852|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515530|NCT02674334|West Virginia University Department of Orthopaedics|Dr. George K Bal|304-293-1310|gbal@hsc.wvu.edu|
20515531|NCT00600925|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20515532|NCT04558554|Fred Hutchinson Cancer Center|Katrina Ortblad|206.667.7267|kortblad@fredhutch.org|
20515533|NCT02660242|Jaeb Center for Health Research|Stephanie DuBose|813.975.8690|sdubose@jaeb.org|
20515534|NCT00770510|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
20515535|NCT04087395|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
20515536|NCT02348385|Yale|Kelly Cosgrove|203-737-6969|kelly.cosgrove@yale.edu|
20515537|NCT02796664|Asan Medical Center|Dr. Dae Chul Suh|+82-2-3010-4366|dcsuh@amc.seoul.kr|
20515538|NCT01189123|Vanderbilt University Medical Center|Dr. Keipp Talbot|6153222035|keipp.talbot@vanderbilt.edu|
20515539|NCT02115646|MGH Wellman Center|Kachiu Lee, MD|4018303128|klee52@partners.org|
20515540|NCT00995553|Minneapolis VA Health Care System|Dr. Tasha Nienow|612-467-1004|Tasha.Nienow@va.gov|
20515541|NCT01531205|H. Lee Moffitt Cancer Center and Research Institute|Julio Pow-Sang, M.D.|813-745-2226|julio.powsang@moffitt.org|
20515542|NCT00927810|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20515543|NCT00006156|National Institute of Child Health and Human Development|Nelson, Lawrence Merle|+1 301 402 6608|nelsonl@mail.nih.gov|
20515544|NCT02465567|Pearl Therapeutics Inc|Pearl Therapeutics Inc|1-877-240-9479|information.center@astrazeneca.com|
20515545|NCT02001558|University of Alabama at Birmingham|Yuying Chen, MD, PhD|205-934-3329|yuyingchen@uabmc.edu|
20515546|NCT04117607|ICON CRU|Dr. Dennis Ruff, Senior Medical Director|210-283-4572|Dennis.Ruff@iconplc.com|
20515547|NCT01807637|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|15015267773|msmennemeier@uams.edu|
20515548|NCT00950807|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515549|NCT00337077|ECOG Statistical Office|Study Statistician|617-632-3012||
20515550|NCT06179108|LB Pharmaceuticals Inc|Leslie Callahan, Head, Clinical Operations|9086556884|leslie@lbpharma.us|
20515551|NCT00814463|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
20515552|NCT01370408|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
20515553|NCT02665143|Yale School of Medicine|Thomas Prebet, MD, PhD|(203) 200-4363|thomas.prebet@yale.edu|
20515554|NCT05723822|RxFunction|Clinical Research Specialist|612-358-2141|Yvonne.Rumsey@rxfunction.com|
20515555|NCT05014412|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515556|NCT02353169|British Columbia Children's Hospital Research Institute|Simon D. Whyte|604-875-2711|swhyte@cw.bc.ca|
20515557|NCT01041781|Fox Chase Cancer Center|Martin J. Edelman, M.D.|(215) 728-4790|martin.edelman@fccc.edu|
20515558|NCT05049460|University of Kentucky, Lexington|Gopalkumar Rakesh MD|859-257-9402|gopalkumar.rakesh@uky.edu|
20515559|NCT02532010|Weill Cornell Medicine|Dr. Sangmin Lee|646-962-2700|sal9053@med.cornell.edu|
20515560|NCT05065502|VA Ann Arbor Health Care System|Jeremy Sussman, MD, MS, Corresponding Principal Investigator|N/A|Jeremy.Sussman@va.gov|
20515561|NCT04552704|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20515562|NCT00696449|Wake Forest University Health Sciences|Steven Feldman|3367167740|sfeldman@wakehealth.edu|
20515563|NCT00918567|SUNY Buffalo|James Waxmonsky M.D.|305 348 3258|jwaxmons@fiu.edu|
20515564|NCT03066999|PUR Clinic|Dr Sijo Parekattil|3525368761|sijo@orlandohealth.com|
20515565|NCT00661999|Mayo Clinic Rochester|Dr. Charles L. Loprinzi|507-284-8666|cloprinzi@mayo.edu|
20515566|NCT04068142|UAMS|Dr Michael Wilson|501-686-7000|MPWilson@uams.edu|
20515567|NCT01790568|University of Michigan Comprehensive Cancer Center|Dr. Pavan Reddy, M.D.|734-936-8785|reddypr@umich.edu|
20515568|NCT01361126|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20515569|NCT02994056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20561385|NCT05252871|Western University of Health Sciences|Frank Spors|9097063883|fspors@westernu.edu|
20515570|NCT02969499|University of British Columbia|Dr. Simon Woo|604-520-4662|simon.woo@fraserhealth.ca|
20561386|NCT01245439|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20561387|NCT02178540|Novartis Pharmaceuticals|Study Director|862-778-8300||
20515571|NCT02742181|University Hospitals Cleveland Medical Center|Sharon Stein|(216)844-2873|Sharon.Stein@UHhospitals.org|
20515572|NCT01346410|Mercy|Dr Kathy Baglan|3144345886|kathy.baglan@mercy.net|
20561388|NCT03673943|RadioMedix Inc|Ebrahim Delpassand|7134999733|edelpassand@radiomedix.com|
20561389|NCT03525119|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20561390|NCT03781336|National Institutes of Health|Psychologist|3014027360|amelir@mail.nih.gov|
20561391|NCT01852019|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888-779-MDCO|jayne.prats@themedco.com|1510
20561392|NCT00932022|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20561393|NCT03888755|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20561394|NCT00982033|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
20561395|NCT04379713|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561396|NCT01872819|University of Washington|Dr. Pamela Becker|206-288-7273|pbecker@u.washington.edu|
20515573|NCT02576990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515574|NCT05905783|Acelyrin Inc.|Clinical Trials Information Desk|(650) 231 6625|info@alumis.com|
20515575|NCT01575054|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20515576|NCT01179490|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
20515577|NCT01508936|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20515578|NCT00679367|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
20529044|NCT01210482|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515579|NCT03365947|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400|info@arrowheadpharma.com|
20515580|NCT02518685|BAROnova, Inc|Lian Cunningham, MD, PhD|650.638.9796|lcunningham@baronova.com|22
20515581|NCT00336024|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
20515582|NCT03946449|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
20515583|NCT03533946|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov and CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
20515584|NCT05067504|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20515585|NCT02303548|Asan Medical Center|Director of Clinical Trials|8230103350|wonpia73@naver.com|
20515586|NCT04720664|Georgetown University|Nadia Ashai, MD|202-444-2223|nadia.ashai@medstar.net|
20515587|NCT02322047|Veterans Affairs Puget Sound Health Care System|Tracy Simpson, PhD|206-277-3337|tracy.simpson@va.gov|
20515588|NCT03311646|Medical University of South Carolina|Dr. Tracy Smith|843-792-5164|smithtra@musc.edu|
20515589|NCT03103100|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
20515590|NCT00531206|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515591|NCT02906709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529045|NCT01223937|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20529046|NCT03284853|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. Vice President, Clinical Development & Medical Affairs.|+1 908 947 3551|msenchyna@aeriepharma.com|
20529047|NCT05176717|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
20529048|NCT00765817|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20529049|NCT00765947|Novartis Pharmaceuticals|Study Director|862-778-8300||
20529050|NCT02308228|University of Kentucky|Douglas Long|859-323-5438|DELONG2@UKY.EDU|
20529051|NCT01043133|USUHS|Ronald W. Gimbel|301-295-3077|rgimbel@usuhs.mil|
20529052|NCT03999749|NYU Langone Health|Janice Mehnert, M.D.|212-731-5431|janice.mehnert@nyulangone.org|
20529053|NCT00255164|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20529054|NCT03677869|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
20529055|NCT02735473|University of Minnesota|Jeffrey R Wozniak|612-273-9741|jwozniak@umn.edu|
20529056|NCT04776928|University of Michigan|Jennifer Waljee|(734) 936-8925|filip@med.umich.edu|
20529057|NCT01845597|Rebound Research and Education Foundation.|Pamela Fairchild|3604498728|pfairchild@reboundmd.com|
20529058|NCT01781208|Cincinnati Children's Hospital Medical Center, Department of Radiology|Jonathan Dillman, MD|513 803-7114|jonathan.dillman@cchmc.org|
20529059|NCT03506438|Duke|Christopher Cox|9196817232|christopher.cox@duke.edu|
20529060|NCT01128296|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
20529061|NCT01914393|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20529062|NCT02806713|University of Massachusetts UMass Memorial|Michael K Flynn|(508) 856-5152|michael.flynn@umassmemorial.org|
20529063|NCT02824224|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20529064|NCT00552695|Stony Brook U|Adam Singer|631-444-7857|adam.singer@stonybrook.edu|
20529065|NCT00368108|Eisai Call Center|Eisai Inc.|888-422-4743||
20529066|NCT02363387|Johns Hopkins University School of Medicine|Kenneth Silverman|443-617-6051|ksilverm@jhmi.edu|
20529067|NCT02299388|Tulane University|Dr. Tina Thethi|504-988-5044|tthethi@tulane.edu|
20529068|NCT04391179|University of Michigan|Jason Knight, MD, PhD|734-763-3031|jsknight@med.umich.edu|
20529069|NCT03334188|"University of Colorado | School of Medicine | ACCORDS"|Dr. Larry Allen, Professor of Medicine|303-724-4713|larry.allen@cuanschutz.edu|
20561397|NCT00001304|National Institute of Child Health and Human Development|WINER, Karen|+1 301 435 6877|winerk@mail.nih.gov|
20561398|NCT02148133|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20515592|NCT05227820|The Regenesis Project|Chief Research Coordinator|(989) 245-9205|jharoon@theneuroassociates.com|
20529070|NCT04218279|University of Pittsburgh|P. Daniel Patterson|412-864-3830|pdp3@pitt.edu|
20529071|NCT00003537|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20561399|NCT03808883|Case Western Reserve University|Sarah Fulton, MA, RA, Begun Center, Jack, Joseph and Morton Mandel School of Applied Social Science|216-368-0429|sarah.fulton@case.edu|
20515593|NCT00977106|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20515594|NCT02419313|Yale-Department of Neurology|Bahman Jabbari M.D , Professor Emeritus- Neurology|914-482-8542|bahman.jabbari@yale.edu|
20515595|NCT00825227|Cephalon, Inc.|Vice President, Clinical Research|1-800-896-5855||
20515596|NCT00376948|Barbara Ann Karmanos Cancer Institute|Almhanna Khaldoun, M.D.|313-576-8746|almhanna@karmanos.org|
20515597|NCT00442936|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515598|NCT01449266|Guerbet|Dr. Pierre Desché, MD - VP Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20515599|NCT00524459|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20515600|NCT02428699|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20515601|NCT02433678|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
20515602|NCT04424407|Stanford University|Andrea Goldstein-Piekarski, PhD|650-721-4780|agoldpie@stanford.edu|
20515603|NCT02684578|University of California, San Francisco|Dr. Jay Stewart|628-206-3123|jay.stewart@ucsf.edu|
20515604|NCT02460159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515605|NCT01193608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515606|NCT01933295|Henry Ford Health|Christopher Drake|(248) 344-6672|cdrake1@hfhs.org|
20515607|NCT04026126|University of Kansas Medical Center|Paige Geiger, PhD|913-588-7408|pgeiger@kumc.edu|
20515608|NCT01434121|Virginia Commonweath University|Alpha A. Fowler, III, MD|804-628-5710|afowler@mcvh-vcu.edu|
20515609|NCT01492400|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20515610|NCT00659607|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515611|NCT02349893|Olympus Europa SE & Co. KG|Dr Samuel Faran|0049 1607168798|samuel.faran@olympus.com|
20515612|NCT02899338|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515613|NCT00486837|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20515614|NCT05694013|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20515615|NCT04817891|University of Michigan|Dr. Benjamin Hampstead|734-936-6185|bhampste@med.umich.edu|
20515616|NCT04981912|UCSD|Michael Choi|8585341765|mychoi@ucsd.edu|
20515617|NCT04534283|IndianaU|Dr. Anita Turk|(317) 274-0335|aaturk@iu.edu|
20515618|NCT05630547|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
20515619|NCT00977470|Mass General Hospital Cancer Center|Maria Kempner|508-533-4132|mkempner@partners.org|
20515620|NCT03257462|Spruce Biosciences, Inc.|Spruce Clinical Trials|415-655-4169|clinicaltrials@sprucebio.com|
20515621|NCT00368277|Novaris Phamaceuticals|Study Director|862-778-8300||
20515622|NCT02364557|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20515623|NCT03978624|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
20515624|NCT04347239|CytoDyn Inc.|Bernie Cunningham, PhD, MRPharmS; VP Operations|5164060197|bcunningham@cytodyn.com|
20561400|NCT02613364|University of Rochester Medical Center|Dr. Karen Mustian, Study PI|585-275-0557|karen_mustian@urmc.rochester.edu|
20561401|NCT01909336|HIMFG|Claudia Montserrat Flores Robles|(52) 5566756686|montseflores@hotmail.com|
20561402|NCT01235949|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561403|NCT00754936|Weill Cornell Medicine|George S Alexopoulos|914-997-5767|gsalexop@med.cornell.edu|
20561404|NCT01114945|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
20561405|NCT00371566|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561406|NCT00972504|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561407|NCT04246762|R-Pharm|Marina Beloukhova, Scientific advisor|0074959567937|beloukhova@rpharm.ru|2129
20561408|NCT02878330|MedImmune, LLC|M. Pamela Griffin|+1 301-398-4059|information.center@astrazeneca.com|
20561409|NCT02476890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561410|NCT00082810|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
20561411|NCT02914522|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20561412|NCT00177216|University of Pittsburgh|Jean Miewald|412-246-6406|miewaldjm@upmc.edu|
20561413|NCT00811057|University of Mississippi Medical Center|Dr. Rick Martin|601-815-7035|rmartin@umc.edu|
20561414|NCT01773122|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20561415|NCT01264718|Medica Research Institute|Dr. Glenn Flores, Distinguished Chair of Health Policy Research|952-992-3367|Glenn.Flores@medica.com|
20561416|NCT01975467|Sonoma Orthopedics|Rick Epstein|8479872516|repstein@sonomaorthopedics.com|
20561417|NCT03545984|Cleveland Clinic|Dr. Maged Argalious|+12164452064|ARGALIM@ccf.org|
20561418|NCT01768676|Vivus|Wesley D Day, PhD|650-934-5200||
20561419|NCT03906968|MUSC|Dr. Zachary M. Soler|(843) 792-3531|solerz@musc.edu|
20561420|NCT03121950|The Ohio State University|Deb Kegelmeyer|614-293-0214|kegelmeyer.1@osu.edu|
20561421|NCT03693742|BC Cancer - Vancouver|Study Manager|(604) 877-6000,|hsaprunoff@bccancer.bc.ca|
20561422|NCT02023125|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561423|NCT03183518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20515625|NCT03076255|Thomas Jefferson University|Voichita Bar-Ad, MD|215-955-6702|Voichita.BarAd@jefferson.edu|
20515626|NCT05097989|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
20561424|NCT04248829|Yuhan Corporation|Dongmin Kim|+82-2-828-0523|clinicaltrials@yuhan.co.kr|
20561425|NCT02132702|Clinic for Spinal Cord Injuries, Rigshospitalet, University of Copenhagen|Carsten Bach Baunsgaard|1111111111|carsten.bach.baunsgaard@regionh.dk|
20561426|NCT02251613|Alcon Japan, Ltd.|Hironari Sakaguchi, Phase IV Clinical & Regulatory Affairs, Japan|+81 3 6899 5054|Hironari.Sakaguchi@alcon.com|
20561427|NCT01867580|KCI, an Acelity Company|Anthony Tate, RN, BSN|210-515-4060|anthony.tate@kci1.com|
20561428|NCT01304147|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-7574|james.murrough@mssm.edu|
20561429|NCT01244828|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561430|NCT05208359|Loyola University Chicago|Sungha Kang|7735082712|skang@luc.edu|
20561431|NCT04411082|Imara, Inc.|Rahul Ballal|617-206-2020|rballal@imaratx.com|
20561432|NCT02787694|University of Alabama at Birmingham|David A. Brown, PT, PhD|205-975-2788|dbrownpt@uab.edu|
20561433|NCT01198275|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr. Savina Nodari|00390303996|nodari@med.unibs.it|587
20561434|NCT00150176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20561435|NCT00393848|UAMS|Arny Ferrando|501-526-5711|aferrando@uams.edu|
20561436|NCT02192606|Brigham and Women's Hospital|Jon I. Einarsson|617-732-5500|jeinarsson@partners.org|
20561437|NCT02550197|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20561438|NCT04763044|Procter & Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20561439|NCT01616654|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20561440|NCT00610688|Cincinnati Children's Hospital Medical Center|Dr. Adekunle Dawodu|513-636-1966|Adekunle.Dawodu@cchmc.org|
20561441|NCT01772420|Albert Einstein College of Medicine|Dr. Amit K. Verma|718-430-8761|amit.verma@einsteinmed.edu|
20561442|NCT00753012|Massachusetts General Hospital|Dr. Paul Hammerness|(503)617-1040|phammerness@partners.org|
20561443|NCT01027286|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
20561444|NCT00094809|Amgen Inc.|Study Director|866-572-6436||
20561445|NCT02699970|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
20561446|NCT05372094|Sonova US|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20515627|NCT01822548|Azienda ospedaliero-universitaria di Parma|Prof.ssa Ivana Zavaroni|+390521033306|ivana.zavaroni@unipr.it|
20515628|NCT05275998|TaiMed Biologics|Dr. Kuei-Ling Kuo|+886-2-26580058|kkuo@taimedbio.com|118
20515629|NCT03641742|Columbia University Irving Medical Center|Dr. Christine Kim Garcia|2123058203|ckg2116@cumc.columbia.edu|
20515630|NCT01867242|University of Minnesota|Dorothy Hatsukami, PhD|612-626-2121|hatsu001@umn.edu|
20515631|NCT01600495|University of São Paulo.|Prof. Alessandra Cristina Marcolin|Tel.: (16) 36022587|dralemar@uol.com.br|55 +
20515632|NCT01139164|Medical University of South Carolina|Dr. Robert K Stuart|843-792-4271|stuartrk@musc.edu|
20515633|NCT02719522|Medtronic Neurovascular|Claudia Campo|0039 0224137325|claudia.campo@medtronic.com|
20515634|NCT03184441|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
20515635|NCT00264810|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
20515636|NCT00205049|University of Wisconsin|Research Program Manager - Kelly Richie|608-262-5404|kr2@medicine.wisc.edu|
20515637|NCT04803357|university of Washington Diabetes Institute|Dr, Nicole Ehrhardt|2404479566|nehrhard@uw.edu|
20515638|NCT05932654|Biosion, Inc.|Kathy Zhang|+86 18801904945|kathy.zhang@biosion.com|
20515639|NCT02879643|Therapeutic Advances in Childhood Leukemia and Lymphoma|Ellynore Florendo, CCRP|323-361-3022|eflorendo@chla.usc.edu|
20515640|NCT00182091|Massachusetts General Hospital|Dr. Anne Klibanski|617-726-3870||
20515641|NCT02199509|National Institutes of Health|Dr. Mark Hallett||hallettm@ninds.nih.gov|
20515642|NCT00483496|Orfagen|Clinical project manager|0033534506462|caroline.miklaszewski@orfagen.com|
20515643|NCT01658943|SWOG Statistical Center|SWOG Statistician|206-667-4408||
20515644|NCT02625545|NeoTract/Teleflex|Emily Hergenreter, Sr. Director of Clinical Affairs|650-793-5570|Emily.Hergenreter@Teleflex.com|
20515645|NCT00936390|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20515646|NCT02093689|Omeros Corporation|Medical Monitor|206-676-5000|info@omeros.com|
20515647|NCT01880099|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20515648|NCT00634179|Emory University|Christopher R. Flowers, MD, MS|404-778-3935|crflowe@emory.edu|
20515649|NCT00539539|Resusciatation Outcomes Consortium, University of Washington|Susanne May, Ph.D.|206-685-1302|sjmay@uw.edu|
20515650|NCT04947579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20515651|NCT04272801|University of Virginia|Dr. Shayna Showalter|434-956-8032|snl2t@uvahealth.org|
20515652|NCT00475020|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-745-3055|UPOPAT@MDANDERSON.ORG|
20515653|NCT03481309|University of North Carolina at Chapel Hill|Dr. Sangtae Ahn|9195233127|sangtae_ahn@med.unc.edu|
20515654|NCT02130466|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515655|NCT04529109|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
20515656|NCT04603937|Kodiak Sciences Inc|Pablo Velazquez-Martin|1 (650) 281-0850|ClinOps@kodiak.com|
20515657|NCT01922349|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515658|NCT01611090|Janssen Research & Development, LLC|Medical Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20515659|NCT05109234|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20515660|NCT00993616|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20515661|NCT04533646|University of Pittsburgh Medical Center|Associate Professor of Medicine|4125869700|ullalj@upmc.edu|
20515662|NCT02585258|Amsterdam UMC, Vrije Universiteit|Prof Maarten Boers|+3120-4444474|eb@amsterdamumc.nl|
20561447|NCT02242773|University of Miami|Sanoj Punnen, MD|+1 (305) 2436596|s.punnen@med.miami.edu|
20515663|NCT05125952|Duke University School of Medicine|Elias Pratt|919-684-8111|elias.pratt@duke.edu|
20515664|NCT02051309|Yale School of Medicine|Sherry McKee PhD|2037373529|sherry.mckee@yale.edu|
20515665|NCT03724149|Perelman School of Medicine|Dr. Peter Reese|215-900-3782|amussell@upenn.edu|
20515666|NCT01669538|University of Pennsylvania|Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
20515667|NCT03581448|Florida Atlantic University|Dr. Erik Engeberg|5612970530|eengeberg@fau.edu|
20515668|NCT02180711|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20515669|NCT01619800|Icahn School of Medicine at Mount Sinai|Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20515670|NCT02848326|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20515671|NCT00927992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515672|NCT00414466|Medtronic Neuromodulation|Robert Spencer, Clinical Research Manager|(763) 514-0253|robert.j.spencer@medtronic.com|
20515673|NCT00458848|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
20515674|NCT02684344|University of Rochester|Edward Messing|585 - 275 - 0998|edward_messing@urmc.rochester.edu|
20515675|NCT01701024|Exec Dir Clinical Dir|Johnson Varughese|908-927-1162|johnson.varughese@valeant.com|
20515676|NCT02086188|EvergreenHealth|Theodore Brown, MD|4258995350|TRBrown@evergreenhealthcare.org|
20515677|NCT01494506|Merrimack Pharmaceuticals, Inc.|Dr. Eliel Bayever|6174411000|EBayever@merrimack.com|7676
20515678|NCT05216081|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
20515679|NCT00863746|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20515680|NCT02395822|University of Minnesota Masonic Cancer Center|Yumna Akhtar - Ct.gov Manager|612-624-6313|akhta012@umn.edu|
20515681|NCT02127281|Cleveland Clinic|Alison K. Klika, MS, Research Manager, Department of Orthopaedic Surgery|(216) 444-4954|klikaa@ccf.org|
20515682|NCT00153803|Dartmouth-Hitchcock Medical Center|Clinical Research Office||Cancer.Research.Nurse@Dartmouth.edu|
20515683|NCT03292653|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20515684|NCT05037097|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
20515685|NCT01059500|indiana university school of medicine|jeffrey kline|317 880 3869|jefkline@iu.edu|
20515686|NCT05343715|Biosidus S.A.U.|Director of Clinical Trials|+541149098044|v.berstein@biosidus.com.ar|
20515687|NCT00376220|Johns Hopkins University School of Medicine|Jennifer L. Payne M.D.|410-502-0050|jpayne5@jhmi.edu|
20515688|NCT00920140|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515689|NCT01124149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20515690|NCT02773836|European Network for Smoking and Tobacco Prevention|Dr Constantine Vardavas|+306937281680|vardavas@tobcontrol.eu|
20515691|NCT00436007|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515692|NCT01439165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20515693|NCT03331042|Sequential Medicine Ltd|Thomas Dahl|617-818-2735|tadahl@outlook.com|
20515694|NCT00683020|University of California, San Francisco|Dean Schillinger, MD/Study Principal Investigator|415-206-8940|dschillinger@medsfgh.ucsf.edu|
20515695|NCT03204526|UC Davis Health|Kiarash Shahlaie, MD, PhD, FAANS, Bronte Professor of Neurological Surgery|916-734-6342|krshahlaie@ucdavis.edu|
20515696|NCT00688064|Galderma|Jean-Charles Dhuin, Clinical Project Manager|+33 4 92 95 29 21|jean-charles.dhuin@galderma.com|
20515697|NCT05518487|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20515698|NCT02003053|University of Kentucky|Dr. Peter Morris|8593235045|peter.morris@uky.edu|
20515699|NCT01362998|University Hospitals of Cleveland|Evan Goodman, principal investigator|2168445300|evan.goodman@uhhospitals.org|
20515700|NCT02194998|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20515701|NCT01458405|Capricor, Inc.|Vice President of Clinical Research and Development Operations|858-727-1755|clinicaltrialsgov@capricor.com|
20515702|NCT02497781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515703|NCT02236130|University of Mississippi Medical Center|Madhankumar Sathyamoorthy|6018157066|msathyamoorthy@umc.edu|
20515704|NCT00525590|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20515705|NCT04276883|Bioxcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
20515706|NCT00320112|VA HSRD|Fatima Makki|734 845 3623|Fatima.Makki@va.gov|
20515707|NCT02073643|Rush University Medical Center|Brad Appelhans, PhD|312-942-3477|brad_appelhans@rush.edu|
20515708|NCT00979732|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
20515709|NCT03696225|VA Portland Health Care System|Dr. Maya E. O'Neil, Principal Investigator|503-220-8262|Maya.Oneil@va.gov|54522
20515710|NCT03356821|UMC Utrecht, The Netherlands|Prof. M.J.N.L. Benders, MD, PhD, neonatologist|+31 88 755 5555|m.benders@umcutrecht.nl|
20515711|NCT01334827|The Miriam Hospital|Dr Kate Guthrie, Co-Investigator, Project MIST Lead Investigator|401-793-8180|kate.guthrie@lifespan.org|
20515712|NCT02468778|Abbott Vascular|Sandeep Pingle, Principal Clinical Scientist|408-845-2111|Sandeep.pingle1@abbott.com|
20515713|NCT00414765|Novartis Pharmaceuticals|Study Director|18627788300|Novartis.email@novartis.com|
20515714|NCT04354012|Wake Forest|Research Administrative Coordinator|336-716-2903|irichard@wakehealth.edu|
20515715|NCT05295953|University of Kentucky, Lexington|Gopalkumar Rakesh MD|859-257-9402|gopalkumar.rakesh@uky.edu|
20515716|NCT04559854|Oregon State University|Jessica Gorman|541-737-2323|Jessica.Gorman@oregonstate.edu|
20515717|NCT01199861|Novartis Pharmaceuticals|Study Director|862-778-8300||
20515718|NCT00661505|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20515719|NCT00796822|Indiana University School of Medicine|Dr. Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
20529072|NCT00716807|UCSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
20515720|NCT00143819|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
20561448|NCT04842604|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20561449|NCT01377623|UMDNJ-New Jersey Medical School|Alex Bekker|973-972-5007|alex.bekker@nyumc.org|
20561450|NCT04897737|UCLA|Dr. Dvora Joseph Davey, PI|310-701-1526|dvoradavey@ucla.edu|
20561451|NCT00478335|University of Colorado Denver|Melissa Cadnapaphornchai, MD|720776263|melissa.cadnapaphornchai@ucdenver.edu|
20515721|NCT02698800|Columbia University Medical Center|Dr. Ari Shechter, Principal Investigator|212-342-4487|as4874@cumc.columbia.edu|
20515722|NCT03587207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20515723|NCT03283709|University of Kentucky|Hiroko Nagaoka|859-257-2101|h.nagaoka@uky.edu|
20515724|NCT00117949|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20515725|NCT00615784|abramsoncc, University of Pennsylvania|Harjeet Sembhi, research program director|215-220-9688|harjeet.sembhi@pennmedicine.upenn.edu|
20515726|NCT03676803|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD|310-206-1987|zli@medent.ucla.edu|
20515727|NCT00406848|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20515728|NCT01355081|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20515729|NCT02456909|Medical College of Wisconsin|Keri R. Hainsworth, PhD|414-266-6306|khainswo@mcw.edu|
20515730|NCT01566409|Pediatric Department, Hospital Lillebaelt, Kolding|Dr. Line Modin|0045 61386349|line.modin@rsyd.dk|
20515731|NCT03309956|Columbia University|Leonardo Liberman, MD|212-305-8509|ll202@cumc.columbia.edu|
20515732|NCT02768298|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@@novartis.com|
20515733|NCT00922779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20515734|NCT01210001|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515735|NCT00788125|City of Hope National Medical Center|Dr. Judith Sato|626-218-5430|jsato@coh.org|
20515736|NCT03900624|Johns Hopkins All Children's Hospital|Dr. Anthony Sochet|7277672912|Anthony.Sochet@jhmi.edu|
20515737|NCT00872079|University of Louisville|Michael Brier|502-852-0246|mbrier@louisville.edu|
20515738|NCT00444145|Vanderbilt University|Dr. Michael Vaezi|615-322-3739|tina.higginbotham@vanderbilt.edu|
20515739|NCT01374919|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com|
20515740|NCT03805438|Duke University|Riley Landreth, DO|919-684-8111|riley.landreth@duke.edu|
20515741|NCT00366899|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20551262|NCT01608659|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20551263|NCT00737282|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20551264|NCT02763189|Wake Forest School of Medicine|Dr. Michael A. Olympio|3369182132|molympio@wakehealth.edu|
20551265|NCT02049957|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20551266|NCT03557151|Nemours Children's Hospital, Delaware|Melissa A. Alderfer, Ph.D., Center Director & Principal Research Scientist|302-651-6522|melissa.alderfer@nemours.org|
20551267|NCT02810392|Wake Forest School of Medicine|Cheryl Bushnell, MD|336-713-2983|cbushnel@wakehealth.edu|
20551268|NCT00840294|University of Chicago|Scott Eggener|(773) 702-5195|seggener@surgery.bsd.uchicago.edu|
20551269|NCT03383198|Prisma Health|Dr. William R. Hand|864.522.3707|William.Hand@prismahealth.org|
20551270|NCT05392998|Clínica Rementería|Dr. Inés Contreras|34913083838|contreras@clinicarementeria.es|
20551271|NCT01516346|University of Pennsylvania|Julio Chirinos, MD, PhD|215-573-6606|julio.chirinos@pennmedicine.upenn.edu|
20551272|NCT00828347|Department of Nephrology, Kumamoto University Graduate School of Medical Sciences|A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism|+81-96-373-5164|m-adachi@gpo.kumamoto-u.ac.jp|
20551273|NCT02947997|Massachusetts General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
20551274|NCT04868890|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
20551275|NCT02418026|Groupe Hospitalier de la Rochelle Ré Aunis|Mrs Sandrine Delavaux|+33 5 46 45 50 50|saniade@msn.com|
20551276|NCT02669433|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
20551277|NCT00379574|Asan Medical Center, Ulsan University College of Medicine|Dr. Cheolwon Suh|+82-2-3010-3209|csuh@amc.seoul.kr|
20551278|NCT03626623|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
20551279|NCT01190878|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
20551280|NCT02157298|AstraZeneca K.K.|Yuji Ageishi|+81-3-6268-2740|Yuji.Ageishi@astrazeneca.com|
20551281|NCT00989014|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20551282|NCT00883116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20551283|NCT03715764|Region Västra Götaland, Närhälsan|PhD-student, Chan-Mei Ho-Henriksson|+46709892821|chan-mei.ho@vgregion.se|
20551284|NCT03445650|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20561452|NCT01191788|RAND Corporation|Katherine Watkins|(310) 393-0411|kwatkins@rand.org|6509
20515742|NCT00419770|Los Angeles Biomedical Research Institute|Brad Spellberg|310-781-3680|bspellberg@dhs.lacounty.gov|
20515743|NCT01781637|Boston Children's Hospital|Lynda Schneider|617-355-6180|lynda.schneider@childrens.harvard.edu|
20515744|NCT02637232|Galderma|Stéphanie Leclerc|+33492386706|stephanie.leclerc@galderma.com|
20515745|NCT02999178|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515746|NCT00090857|Dana-Farber Cancer Institute|Judy E. Garber, MD, MPH|617.632.2282|Judy_Garber@dfci.harvard.edu|
20515747|NCT05097326|Stanford University|Principal Investigator|(650) 497-5175|gynresearch@stanford.edu|
20515748|NCT01483352|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20515749|NCT03480425|University of Saskatchewan|Dr. William P. McKay|306 250 5344|bill.mckay@usask.ca|
20515750|NCT01244126|Baylor College of Medicine, Department of Anesthesiology|Dr. Helena Karlberg Hippard|832-824-5800|hxkarlbe@texaschildrens.org; karlberg@bcm.edu|
20515751|NCT05920161|Yale School of Medicine|Elizabeth Goldfarb, PhD|203-737-6365|elizabeth.goldfarb@yale.edu|
20515752|NCT01451762|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
20515753|NCT03469297|MicroOptx|VP of Clinical|888-591-2784|info@microoptx.com|
20515754|NCT01771965|MUSC|Tracy Stecker, PhD|843.792.7287|stecker@musc.edu|
20515755|NCT02696070|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
20515756|NCT02424188|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20515757|NCT00630305|Johnson & Johnson Vision Care, Inc.|Kurt Moody, OD|1-904-443-3088|kmoody1@its.jnj.com|
20515758|NCT01085045|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20515759|NCT02753842|Emory University|Aaron Siegler|404-712-9733|asiegle@emory.edu|
20515760|NCT02248597|Wake Forest Baptist Comprehensive Cancer Center|Study Nurse|336-716-4761|krike@wakehealth.edu|
20515761|NCT03601637|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20515762|NCT00038675|University of Texas (UT) MD Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
20515763|NCT04510857|Barron Associates, Inc.|Richard Adams|4348253435|adams@bainet.com|
20515764|NCT04347291|Vanderbilt University Medical Center|Dr. Lindsay Mayberry|615-875-5821|lindsay.mayberry@vumc.org|
20515765|NCT02564263|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515766|NCT01644500|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20515767|NCT01347788|Massachusetts General Hospital|Matthew R Smith, MDPhD|617-763-3748|smith.matthew@mgh.harvard.edu|
20515768|NCT02774798|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
20515769|NCT00322491|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
20515770|NCT00720096|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, M.D., via Moffitt Cancer Center|813-745-4933|robert.wenham@moffitt.org|
20515771|NCT04557124|VA Connecticut Healthcare System|Joanna Fiszdon, Principal Investigator|203-932-5711|Joanna.fiszdon@va.gov|
20515772|NCT00001849|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
20515773|NCT01626664|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
20515774|NCT01346085|Ospedale San Raffaele|Dr Lorenzo Piemonti|+390226432706|piemonti.lorenzo@hsr.it|
20515775|NCT03127137|Northwestern University|Paul C. Fitzgerald RN, BSN, MS|312-695-1064|p-fitzgerald2@northwestern.edu|
20515776|NCT02747615|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
20515777|NCT02319148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515778|NCT00264797|Univ of Colorado Denver; Univ of Cincinnati|Dr. Paula Riggs; Dr. Theresa Winhusen|303-724-2235; 513-487-7800|paula.riggs@ucdenver.edu; winhusen@carc.uc.edu|
20515779|NCT00048048|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20515780|NCT03992196|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20515781|NCT01880073|Center for Reproductive Medicine|Dr. Steven Spandorfer|646-962-3638|sdspando@med.cornell.edu|
20515782|NCT00733330|DePuy International|Kimberly Dwyer||kdwyer2@its.jnj.com|
20515783|NCT02388763|Alcon, A Novartis Division|GMA Franchise Head - Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20515784|NCT01604850|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20515785|NCT01703832|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
20515786|NCT00243932|Columbia University|Hiroshi Mitsumoto, MD|2123052940|hm264@cumc.columbia.edu|
20515787|NCT00543309|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, M.D., M.P.H.|312 227 1551|jmcostello@luriechildrens.org|
20515788|NCT01931033|Massachusetts General Hospital|Gagan Joshi, MD|617-726-1541|gjoshi@mgh.harvard.edu|
20515789|NCT01249664|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20515790|NCT01632709|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
20515791|NCT01767064|USCalifornia|Jason Doctor|213.821.8142|jdoctor@usc.edu|
20515792|NCT01307098|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20515793|NCT03977051|Imperial College London|Dawn Goodall|+44 (0) 203 313 4268|dawn.goodall1@nhs.net|
20515794|NCT01345019|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20515795|NCT03830164|UT MD Anderson Cancer Center|Dr. Chad Tang, Associate Professor, Radiation Oncology Department|(713) 745-7179|ctang1@mdanderson.org|
20515796|NCT00860405|Fresenius Kabi Aktiengesellschaft, Else-Kröner-Str. 1, 61352 Bad Homburg, Germany|Professor Dr. Martin Westphal, Chief Medical Officer|+49 6172 686 7280|martin.westphal@fresenius-kabi.com|
20515797|NCT04457310|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu|
20515798|NCT01074554|Vanderbilt University School of Medicine|Dr. Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
20561453|NCT03939819|Emory University|Dr. Elizabeth Hechenbleikner|404-778-3712|elizabeth.hechenbleikner@emory.edu|
20561454|NCT02903836|Wockhardt|Dr Manishkumar D Shah|02226534444|manish.shah@wockhardt.com|6893
20561455|NCT01183780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561456|NCT04089488|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
20561457|NCT04628572|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561458|NCT02470949|University of Florida|Michelle Cardel, PhD, RD|(352) 273-9703|mcardel@ufl.edu|
20561459|NCT00855465|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20561460|NCT01595854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561461|NCT04365400|Afimmune|Study Director|+3532946380|info@afimmune.com|
20561462|NCT00079183|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
20561463|NCT00770965|Novartis|Study Director|862-778-8300||
20561464|NCT02371746|Envisia Therapeutics, Inc.|Kristin Blackwell, Consultant, Regulatory Affairs & Quality Assurance|919-219-6448|kristin.blackwell@envtx.com|
20561465|NCT00436644|Mayo Clinic|Dr. Paul Haluska|507-266-2123|haluska.paul@mayo.edu|
20561466|NCT04364269|Vifor Pharma, Inc.|CSL Vifor|+41 588 518 000|VIT2763-THAL-201.study@viforpharma.com|
20561467|NCT01157182|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20561468|NCT02534350|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20561469|NCT04673851|University of North Carolina at Chapel Hill|Bryan Stiles, MA|919-590-5811|stilesb@unc.edu|
20561470|NCT00319436|Yale University School of Medicine, Department of Psychiatry and Yale Child Study Center|Nancy Suchman, Ph.D., Associate Professor|203-937-3486|nancy.suchman@yale.edu|7430
20561471|NCT00790790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561472|NCT03399370|The Medicines Company|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
20561473|NCT01161498|Amgen, Inc.|Study Director|866-572-6436||
20561474|NCT02807493|University of Minnesota|James Gambucci|612-625-7448|gambu001@umn.edu|
20561475|NCT01493778|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20561476|NCT01227707|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561477|NCT01224678|University of Vermont|Marie E. Wood, M.D|802-656-5452|marie.wood@uvm.edu|
20561478|NCT05819190|Pharmndev Experts|Dr Bernard Gout Organization|+41798659000|Email:bgout@pharmndev.ch|
20561479|NCT04495634|University of North Carolina at Chapel Hill|Doreen Steed, R.T. (R)(M)|919-966-0188|doreen_steed@med.unc.edu|
20561480|NCT03105128|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20561481|NCT03468920|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20561482|NCT00823979|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561483|NCT03523091|William Beaumont Hospital|Jennifer Giordano|248-551-3517|jennifer.giordano@beaumont.org|
20561484|NCT00741988|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20561485|NCT02885311|Northwell Health|Dr. Jonathan Morgenstern|(516) 837-1694|jmorgenste@northwell.edu|
20561486|NCT01001078|Maisonneuve-Rosemont Hospital|Nikola Joly, M.D.|+1 514 252 3426|nikola.joly@umontreal.ca|
20561487|NCT02685488|University of Arizona|Dr. John J.B. Allen|(520) 621-7448|john.jb.allen@arizona.edu|
20561488|NCT05019729|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20561489|NCT04318444|Columbia University|Jon T. Giles, MD|212-305-6327|jtg2122@cumc.columbia.edu|
20561490|NCT03254394|Washington University in St Louis|Simon Haroutounian, PhD. Associate Professor|3132861715|sharout@wustl.edu|
20561491|NCT00536380|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20561492|NCT00387465|SKCCC|John Wrangle, MD|843-792-7789|wrangle@musc.edu|
20561493|NCT03418324|Cedars-Sinai Medical Center|Edwin Posadas, MD|310-423-7600|Edwin.Posadas@cshs.org|
20561494|NCT00907218|MassGH|Dr. Timothy Wilens|617-724-5226|twilens@partners.org|
20561495|NCT04520165|CHU-Uliege|Dr Florence Schleich|003243667881|fschleich@chuliege.be|
20561496|NCT05233085|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20515799|NCT00497796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20561497|NCT05147233|OCULIS Operations SàrI|Sharon Klier, M.D., M.S., M.P.H, Chief Development Officer|+41 21 711 3970|info@oculis.com|
20561498|NCT04670822|State University of New York at Buffalo|Dr. Xiaozhong Wen|7168296811|xiaozhon@buffalo.edu|
20561499|NCT04517864|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561500|NCT01049503|Bauru Dental School/University of São Paulo|Dr. Marília Buzalaf|+55 14 32358346|mbuzalaf@fob.usp.br|
20515800|NCT02120443|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
20515801|NCT01004172|Dana-Farber Cancer Institure|Nancy Lin, MD|617.632.2335|nlin@partners.org|
20515802|NCT02445456|Oxford University Hospitals NHS Foundation Trust|Miss Helen Jones|01865 235657|helen.jones3@ouh.nhs.uk|
20515803|NCT02352298|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303-724-6761|satish.garg@ucdenver.edu|
20515804|NCT02446626|National Institute of Allergy and Infectious Diseases|Marques, Adriana|+1 301 435 7668|amarques@niaid.nih.gov|
20515805|NCT04526210|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20515806|NCT02924038|University of California, San Francisco|Dr. Nicholas Butowski, MD|415-353-7500|Nicholas.Butowski@ucsf.edu|
20515807|NCT01269801|AboutSkin|Joel L. Cohen, MD|303-756-7546|research@aboutskinderm.com|
20561501|NCT03169244|University of North Carolina at Chapel Hill|James C. Garbutt, MD|919-445-0205|jc_garbutt@med.unc.edu|
20561502|NCT02986178|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
20561503|NCT02577523|NeuroDerm Ltd.|Laurence Salin, MD, Senior Medical Director||laurence@neuroderm.com|
20561504|NCT01199783|Herz- und Diabeteszentrum NRW|PD Dr. Bernd Stratmann|+495731973768|bstratmann@hdz-nrw.de|
20561505|NCT00391846|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20561506|NCT03624413|Emory University|Brian C. Zanoni, MD|404-727-0284|brian.christopher.zanoni@emory.edu|
20561507|NCT02477670|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|SDube@avanir.com|
20561508|NCT00970307|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561509|NCT01458210|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561510|NCT02224924|Memorial Sloan Kettering Cancer Center|Dr. Amgad Moussa MD|212-639-3690|moussaa@mskcc.org|
20561511|NCT01169311|Covidien|Tam LaFleur|203-821-4744|tam.lafleur@covidien.com|
20561512|NCT00545844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20561513|NCT01329328|University of Verona|Prof. Carlo Zancanaro|+390458027155|carlo.zancanaro@univr.it|
20561514|NCT01596751|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
20561515|NCT02506257|AMC Amsterdam|Dr. IJE van Der Muelen|020 - 566 9111|TtT@amc.uva.nl|
20561516|NCT00964366|GlaxoSmithKline|GSK Response Center|888-435-7343||
20561517|NCT01370694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561518|NCT02393716|Medtronic|Kristel Wittebols Sr. Clinical Research Director|31 (0)43-3566566|kristel.wittebols@medtronic.com|
20561519|NCT03760419|Vanderbilt University Medical Center|Derek J. Williams, MD, MPH|615-322-2744|derek.williams@vumc.org|
20561520|NCT01924767|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561521|NCT01193153|Janssen Scientific Affairs, LLC, Titusville, NJ|Director of Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20561522|NCT01648140|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561523|NCT01678196|Minneapolis VA Healthcare Service Center|Christopher Erbes, PhD|612-725-2000|christopher.erbes@va.gov|2125
20561524|NCT01563354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20561525|NCT01565928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561526|NCT01119950|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
20561527|NCT05334758|BioTeke USA|Chang Turkmani|202-679-2112|chang@themegaco.com|
20561528|NCT01740817|University of Texas Health Science Center at San Antonio|Dr. Nicolas Musi|200-562-6152|musi@uthscsa.edu|
20561529|NCT01986686|Stony Brook Medicine|Roberto Bergamaschi, MD, PhD|631-638-2215|roberto.bergamaschi@stonybrookmedicine.edu|
20561530|NCT01988233|University of Illinois Chicago|Dr. David X. Marquez|3129961209|marquezd@uic.edu|
20515808|NCT02473640|Synthetic Biologics Inc.|Michael Kaleko, M.D.|(240) 238-3862|mkaleko@syntheticbiologics.com|
20515809|NCT02472522|Tata Main Hospital, Jamshedpur, India|Specialist, Anaesthesia & Critical Care|91-9431166582|debsanjay@gmail.com|
20515810|NCT02777528|WL Gore|Meier Hsu|928-864-3338|mhsu@wlgore.com|
20515811|NCT00890981|Amgen Inc.|Study Director|866-572-6436||
20515812|NCT00453362|Hoffman-LaRoche|Medical Communications|800-821-8590||
20515813|NCT04885296|Johnson & Johnson Vision Care, Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-608-7238|jbuch@its.jnj.com|
20515814|NCT03718234|University of Minnesota|Kyriakie Sarafoglou|6126245965|saraf010@umn.edu|
20515815|NCT00433147|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@Alexion.com|
20515816|NCT01882647|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|585-571-1800|clinicalreseach@therapeuticsinc.com|
20515817|NCT02937701|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20515818|NCT02683083|Camel-IDS|Tony Lahoutte|0032 24799360|tony.lahoutte@camel-ids.com|
20515819|NCT00416520|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20515820|NCT02735174|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
20515821|NCT00290147|Naval Medical Research Center, Viral Diseases Department|Charmagne Beckett, LCDR, MC, USNR|301-295-6400|charmagne.beckett@med.navy.mil|
20515822|NCT00755196|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515823|NCT04084483|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20515824|NCT03831451|University of Michigan|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
20515825|NCT02636907|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515826|NCT00762086|A. Stein Regulatory Affairs Consulting|Shmulik Adler|972-9-767-0002|shmulik@asteinrac.com|
20515827|NCT04538170|Department of Anaesthesiology and Intensive Care Medicine, Eberhard-Karls-University,Tuebingen, Germany|Dr. Barbara Schlisio|+4970712985535|barbara.schlisio@med.uni-tuebingen.de|
20515828|NCT01076452|Hines Veterans Affairs Hospital Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D|708-202-8387|frances.weaver@va.gov|25866
20515829|NCT01652001|University of Granada|Dr. Gómez-Moreno|+34000000000|ggomez@ugr.es|
20515830|NCT01682083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20515831|NCT00864097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515832|NCT05194839|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
20515833|NCT01661114|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
20561531|NCT03264248|University of Pittsburgh|Dr. Jonathan Pearlman|412-822-3685|jlp46@pitt.edu|
20515834|NCT03629925|Innovent Biologics (Suzhou) Co., Ltd|YiBo|+86 13382419112|jessica.yi@innoventbio.com|
20561532|NCT00470106|VA Greater Los Angeles|Michael F. Green, PhD|(310)2693376|michael.green6@va.gov|
20561533|NCT01256034|Chiba University Graduate School of Medicine|Dr. Katsunori Furukawa|+81-43-226-2269|k-furukawa@umin.ac.jp|
20561534|NCT01713530|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20561535|NCT03743246|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20561536|NCT00373269|Temple University|Dr. Nina T. Gentile|215-707-8402|ngentile@temple.edu|
20515835|NCT01225146|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
20515836|NCT01014728|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
20515837|NCT01050647|Stanford University|Dr. Anna Girsen|6507255720|agirsen@stanford.edu|
20515838|NCT03661528|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20515839|NCT02732210|Amgen Inc.|Study Director|866-572-6436||
20515840|NCT05233163|Columbia University Irving Medical Center|Ani Nalbandian, MD|646-906-2255|an2558@cumc.columbia.edu|
20515841|NCT02649387|Mayo Clinic|Asher Alban Chanan Khan|904-953-0450|Chanan-Khan.Asher@mayo.edu|
20515842|NCT02724800|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD|412-360-2806|Adam.Bramoweth@va.gov|
20515843|NCT02412228|Brown University Oncology Research Group|John Reagan, MD|401-863-3000|BrUOG@Brown.edu|
20515844|NCT00365261|University of California, San Diego|Joel Dimsdale, M.D., Principal Investigator|619 543-5592|jdimsdale@ucsd.edu|
20515845|NCT03561883|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
20515846|NCT05956665|Vanderbilt University School of Nursing|Jennifer Kim, DNP, GNP-BC|615-936-0739|jennifer.kim@vanderbilt.edu|
20515847|NCT02096718|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515848|NCT02385097|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
20515849|NCT03441581|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20561537|NCT01184508|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20515850|NCT01939197|AbbVie|Global Medical Services|800-633-9110||
20515851|NCT02545998|Oxshott Medical Practice|Dr Sarah Glynne|01372 844000|sarah.glynne@nhs.net|
20515852|NCT03118466|Massachusetts General Hospital|Andrew Brunner MD|6177241124|abrunner@mgh.harvard.edu|
20515853|NCT01430741|Bedford VA|Dr. David Smelson, Professor|781-570-1903|david.smelson@va.gov|
20515854|NCT05215951|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20515855|NCT02070237|Memorial Care|Dr. Jennifer McNulty|562-933-2730|jjmcnulty@sbcglobal.net|
20515856|NCT01641445|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
20515857|NCT04028843|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|Leanne.Redman@pbrc.edu|
20515858|NCT03298451|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1 8772409479|information.center@astrazeneca.com|
20515859|NCT01347710|Lantheus Medical Imaging|CMO|978-671-8544|c.orlandi@lantheus.com|
20515860|NCT03339349|University of Utah|Daniel Jones|801-581-2121|daniel.jones2@gmail.com|
20515861|NCT04591626|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20515862|NCT01968382|Virginia Commonwealth University|Stephanie Taylor MSN, RN|804-828-9311|stephanie.taylor@vcuhealth.org|
20515863|NCT01434342|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20515864|NCT00950872|Covidien|Noreen Fahey, Director, Clinical Program Management|203-821-4716|noreen.fahey@covidien.com|
20515865|NCT00878995|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
20515866|NCT01661270|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20515867|NCT02480764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20515868|NCT02457832|Associate Professor of Medicine Emory University School of Medicine, Department of Medicine, Division of Geriatrics and Gerontology; Research Health Scientist Atlanta VA Health Care System, Center for Visual and Neurocognitive Rehabilitation|Madeleine E. Hackney, Ph.D.|404-315-4100|mehackn@emory.edu, madeleine.hackney@va.gov|373141
20515869|NCT01333527|Research Associate|Anelise Silveira|780-492-2398|anelise.silveira@ahs.ca|
20515870|NCT01868009|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515871|NCT02467621|Copenhagen University Hospital Rigshospitalet, Dept. of Intensive Care 4131|Dr. Morten Hylander Møller|22555343|mortenhylander@gmail.com|+45
20515872|NCT04183231|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-2516831|drmilgrom@silverarrest.com|
20515873|NCT00860028|Yale School of Medicine|Dr. Stephanie O'Malley|203-974-7590|stephanie.omalley@yale.edu|
20515874|NCT03218592|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|9199969998|akashuba@unc.edu|
20515875|NCT02514174|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515876|NCT01108094|Stanford University Medical Center|Jean Tang MD PhD, Associate Professor of Dermatology|650-723-6316|tangy@stanford.edu|
20515877|NCT01137539|Michigan Institute of Women's Health|Salil Khandwala/Medical Director|313-982-0200||
20515878|NCT03290326|BIDMC|Principal Investigator - Emiliano Santarnecchi|617-667-0326|esantarn@bidmc.harvard.edu|
20515879|NCT05086835|McLean Hospital|Dr. Roger Weiss|617-855-2242|rweiss@mclean.harvard.edu|
20515880|NCT00248638|Emory University|Thomas R. Ziegler M.D.|4047277354|Tzieg01@emory.edu|
20515881|NCT02918877|Beth Israel Deaconess Medical Center|Dr. Brian P. O'Gara|617-549-2974|bpogara@bidmc.harvard.edu|
20515882|NCT05818137|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20515883|NCT01699607|Yale|Dr. Kelly Cosgrove, Ph.D.|203-737-6969|kelly.cosgrove@yale.edu|
20515884|NCT05346055|Weill Cornell Medical College|Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
20515885|NCT00728949|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20515886|NCT01996033|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
20515887|NCT02252562|Dartmouth-Hitchcock Medical Center|Matthew D. Koff, MD Staff Physician, Anesthesiology|(603) 650-5922|Matthew.D.Koff@hitchcock.org|
20561538|NCT01269736|Yale University|Professor Marjorie Funk, PhD, RN|(203) 737-2346|marjorie.funk@yale.edu|
20561539|NCT02861937|Krishnadevaraya college of dental sciences|Dr. Rudrakshi C|080-28467083|drrudrakshi@rediffmail.com|
20561540|NCT00756730|Community Research initiavte|Dr. Daniel Skiest|413 794 5376|Daniel.Skiest@baystatehealth.org|
20561541|NCT00166166|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
20561542|NCT00639002|Incyte Corporation|Study Director|855 463-3463||
20561543|NCT02509585|Cardinal Health|LaTosha Eligon|913-661-3896|latosha.eligon@cardinalhealth.com|
20561544|NCT00739765|New York State Psychiatric Institute|John C. Markowitz, M.D.|646 774-8098|jcm42@cumc.columbia.edu|
20561545|NCT01323777|Alcon Japan, Ltd.|Group Manager, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20561546|NCT04210180|Rose Research Center|Jed E. Rose, Ph.D.|9193282345|jed.rose@roseresearchcenter.com|
20515888|NCT04818242|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
20515889|NCT01087970|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20515890|NCT02143102|Elucid Bioimaging|Andrew J. Buckler|978-468-0508|andrew.buckler@elucidbio.com|
20515891|NCT03027661|University of Tennessee Health and Science Center|Elaine Todd, Director of Sponsored Programs - Contracts and research agreements|9014483303|ElaineTodd@uthsc.edu|
20515892|NCT00708019|University of California, San Francisco|Christine Miaskowski|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
20515893|NCT00369590|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
20515894|NCT04099888|PCI Biotech AS|Chief Executive Officer|(+47) 67 11 54 00|post@pcibiotech.no|
20515895|NCT00023309|National Institute of Diabetes and Digestive and Kidney Diseases, NIH|Marc G. Ghany, M.D|3014961721|marcg@mail.nih.gov|
20515896|NCT00208026|The Children's Hospital of Philadelphia|Albert C. Yan, M.D.|(215) 590-2158|Yana@email.chop.edu|
20515897|NCT00891293|GlaxoSmithKline|GSK Response Center|866-435-7343||
20515898|NCT01448057|Novartis consumer Health a GSK Consumer Healtcare company|Director Clinical research Respiratory|(1) 5512065988|anna.x.grinienko@gsk.com|
20515899|NCT03124966|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20515900|NCT03883906|Cincinnati Children's Hospital Medical Center|Michael Grimley, MD|513-803-3218|Michael.Grimley@cchmc.org|
20515901|NCT00874237|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
20515902|NCT00924326|National Cancer Institute|Steven Rosenberg, M.D., Ph.D.|240-858.3080|sar@nih.gov|
20515903|NCT00147030|National Perinatal Epidemiology Unit, University of Oxford|Director of NPEU Clinical Trials Unit|01865 289700|ctu@npeu.ox.ac.uk|89728
20515904|NCT00262964|Washington University School of Medicine|Elisa Fabbrini, MD|314-362-8156|efabbrini@dom.wustl.edu|
20515905|NCT03912337|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20515906|NCT02458469|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
20515907|NCT01496183|The State University of New York at Buffalo|Dr. Elsa Daurignac, Research Assistant Professor|716-898-4540|ecd3@buffalo.edu|
20515908|NCT03130699|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
20515909|NCT03325426|UCSF|Elaine Ku|415-502-7760|elaine.ku@ucsf.edu|
20515910|NCT02370407|Johns Hopkins University|Dr. Lauren Thomaier|410-955-6710|lthomai1@jhmi.edu|
20515911|NCT03682900|Oregon Research Behavioral Intervention Strategies, Inc.|Judy A. Andrews, Senior Scientist|541-484-2123|Judy.Andrews@Influentsin.com|
20515912|NCT06354270|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20515913|NCT00680121|University of Kansas Medical Center|Ann Manzardo, PhD|(913) 588-6473|amanzardo@kumc.edu|
20515914|NCT02809183|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
20515915|NCT02942966|Philips Image Guided Therapy|Nicolas Aguirre|(612) 297-6655|nicolas.aguirre@philips.com|
20515916|NCT02933866|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20515917|NCT02603952|MedImmune, LLC|Raburn Mallory|301-398-4095|information.center@astrazeneca.com|
20515918|NCT02789033|Universidad de Guadalajara|PhD. Leonel García Benavides|+52 (33) 20 00 23 00|drleonelgb@hotmail.com|64096
20515919|NCT00301756|Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
20515920|NCT04567342|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20515921|NCT00958243|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20515922|NCT04646109|Afyonkarahisar Health Sciences University|Prof. Dr. Nurullah Okumuş|+90 532 4372406|drnuri@hotmail.com|
20515923|NCT06176768|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20515924|NCT01226797|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515925|NCT03571048|University of Colorado School of Medicine|Elizabeth Thomas, MD|303-724-9083|elizabeth.thomas@cuanschutz.edu|
20515926|NCT00577460|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515927|NCT00534703|Imperial College London|Dr Alexander Lyon|+442075943409|a.lyon@imperial.ac.uk|
20515928|NCT00582400|University of Texas Medical Branch at Galveston|Dr. Avi B. Markowitz|4097721164|abmarkow@utmb.edu|
20515929|NCT01936948|White River Junction VA Medical Center|Heiko Pohl|802-295-9363|heiko.pohl@va.gov|5591
20515930|NCT02365207|University of Texas Health San Antonio|Robert Svatek|210-567-5676|svatek@uthscsa.edu|
20515931|NCT03006978|Sight Sciences|Jaime Dickerson|(877) 266-1144|jdickerson@sightsciences.com|
20515932|NCT01318499|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
20515933|NCT01395030|The Queen's Medical Center|Program Director for PET Research|808-691-5466|skwee@queens.org|
20515934|NCT01988922|Washington University in St. Louis School of Medicine|Dr. Lesley K Rao|3143690683|raol@wustl.edu|
20515935|NCT01974141|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20561547|NCT05190419|UNION therapeutics A/S|UNION therapeutics A/S|+4561777435|clinicaltrials@uniontherapeutics.com|
20561548|NCT03210402|Medtronic Inc|Mike Bennett, Clinical Study Manger|262-362-1956|mike.s.bennett@medtronic.com|
20561549|NCT04470193|University of Utah|Flory Nkoy, MD, MS, MPH|801-662-3660|flory.nkoy@hsc.utah.edu|
20561550|NCT04663802|University of Pennsylvania|Dr. Meeta Prasad Kerlin (PI)|215-746-0446|prasadm@pennmedicine.upenn.edu|
20561551|NCT02517307|Oregon Health & Science University|Melanie Gillingham, PhD|503-494-1682|gillingm@ohsu.edu|
20561552|NCT03863834|Inmode Ltd|Maria Shusterman, Clinical Director|9057070975|maria.shusterman@inmodemd.com|
20561553|NCT02770248|Alcon, A Novartis Division|Field Medical, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
20561554|NCT01597128|University of Kentucky Medical Center|J. Scott Roth, M.D.|859-323-6346|arockich@uky.edu|246
20515936|NCT01607645|FHCRC|Derek L. Stirewalt|2066675386|dstirewa@fhcrc.org|
20515937|NCT04977336|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20515938|NCT04538040|Gilead Sciences|Lisa Sterman, MD, MPH|415-407-8434|Lisa.Sterman@Gilead.com|
20515939|NCT02494713|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
20515940|NCT01606306|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
20515941|NCT01759290|Abbott Vascular|Kunal Sampat|408-845-0746|kunal.sampat@av.abbott.com|
20515942|NCT03629249|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20515943|NCT00352690|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovinda@dom.wustl.edu|
20515944|NCT01475474|Renew Medical, Inc.|Victoria Mackinnon, Vice President, Regulatory, Clinical & Quality|1-888-987-2929|victoria@renew-medical.com|
20515945|NCT06096168|SERF|Sponsor|0472056010|clinical@serf.fr|
20515946|NCT02914795|Medical University of Grazt|Assoc. Prof. Dr. Dirk von Lewinski|+43 316 385|dirk.von-lewinski@medunigraz.at|80684
20515947|NCT03086356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515948|NCT01264952|Institute of Oncology Ljubljana|Gregor Sersa, PhD|+386 1 5879 434|gsersa@onko-i.si|
20515949|NCT01471522|NYU Langone Health|Anna Naumova|212.263.6927|Anna.Naumova@nyulangone.org|
20515950|NCT01691248|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515951|NCT02863575|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20515952|NCT03348423|Baudax Bio, Inc.|Development|484-395-2440|info@baudaxbio.com|
20515953|NCT04349917|University of North Carolina at Chapel Hill|Jessica R. Cohen, PhD|(919) 843-3753|jrcohen@unc.edu|
20515954|NCT02087514|Columbia University Medical Center|Dr. Eldad Hod|(212) 342-5648|eh2217@cumc.columbia.edu|
20515955|NCT00633399|Massachusetts General Hospital CNTI|George I Papakostas, M.D. - Scientific Director|6177266697|gpapakostas@partners.org|
20515956|NCT01759277|University of California San Diego|Brian Ilfeld|858-822-2171|bilfeld@ucsd.edu|
20515957|NCT05628675|King's College London/South London and Maudsley NHS|Dr Rebecca Cockburn|02032288800|rebecca.cockburn@kcl.ac.uk|
20515958|NCT00726739|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
20515959|NCT00088829|Georgetown University Medical Center|Claudine Isaacs, MD|202-444-3677|isaacsc@georgetown.edu|
20515960|NCT01367275|University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
20515961|NCT01648166|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
20515962|NCT00883090|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20515963|NCT02532764|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
20515964|NCT01475838|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20515965|NCT01717976|Durham VA HSR&D|Susan N. Hastings|919-286-0411|susan.hastings@va.gov|4033
20515966|NCT01365650|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
20515967|NCT00771537|Indiana University|Gregory D Zimet|317-274-8812|gzimet@iupui.edu|
20515968|NCT02148302|SerenaGroup|Thomas E. Serena, MD|617-945-5225|serena@serenagroups.com|
20515969|NCT02932878|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20515970|NCT00262223|The City College of New York|Denise A. Hien, Ph.D.|(212) 650-5666|dhien@ccny.cuny.edu|
20515971|NCT00437658|AbbVie|Global Medical Services|800-633-9110||
20515972|NCT03952143|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20515973|NCT02152566|Fisher & Paykel Healthcare|Dr Rachel Vicars|09 574 0123|rachel.vicars@fphcare.co.nz|7759
20515974|NCT01866319|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515975|NCT02731157|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
20515976|NCT01351506|Chiang Mai University|Dr.Kaweesak Chittawatanarat|+66815951259|kchittaw@gmail.com|
20515977|NCT00623779|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
20515978|NCT01856309|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Associate Director, Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20515979|NCT00220337|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20515980|NCT00832377|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20515981|NCT01273181|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20551285|NCT01361464|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
20551286|NCT03021265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551287|NCT00818662|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20551288|NCT01722071|University of Michigan|Tiffany Love, PhD|734-219-3674|tiflove@umich.edu|
20551289|NCT01106898|University of Nebraska Medical Center|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
20551290|NCT01338493|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
20515982|NCT00944697|Mundipharma Research GmbH|Director of Medical Operations|44 01223424900|info@contact-clinical-trials.com|
20515983|NCT03249584|MedtronicNeuro|Eric Grovender|763-514-4000|eric.a.grovender@medtronic.com|
20551291|NCT01698801|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20515984|NCT01876706|NeoTract|Monica Ransom Director of Clinical Operations|4159648770|Monica.Ransom@Teleflex.com|
20515985|NCT00604500|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsresultsdisclosure@merck.com|
20515986|NCT02597998|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515987|NCT02191891|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20515988|NCT02339233|University of Lousiville|Dr. Susan Harkema|502-581-8675|susan.harkema@louisville.edu|
20515989|NCT00765648|Cleveland Clinic|Frank Peacock MD|(216) 445-4557|peacocw@ccf.org|
20515990|NCT01062256|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
20515991|NCT03049488|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
20515992|NCT02921737|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20515993|NCT03472365|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Medical Director: Linna Wang|+86-13581990612|linna.wang@hengrui.com|
20515994|NCT01929642|Boling Center for Developmental Disabilities|Dr. Tanjala Gipson|901-448-6512|sbarden@uthsc.edu|
20515995|NCT00537030|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20515996|NCT02828917|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
20515997|NCT00669864|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20515998|NCT00162123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20515999|NCT02016170|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
20516000|NCT02327130|Isomark, LLC|Dr. Daniel Butz, Chief Scientific Officer|(608) 561-1895|daniel.butz@isomark.com|
20516001|NCT00493831|University of Nebraska Medical Center|Stephen Rennard|402-559-7313|srennard@unmc.edu|
20516002|NCT02672553|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
20516003|NCT00408902|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
20516004|NCT00970281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20516005|NCT00159965|Rhode Island Hospital|W. Curt LaFrance, Jr., MD, MPH|401-444-3534|William_LaFrance_Jr@Brown.edu|
20516006|NCT02003183|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Gary Small|3108250291|gsmall@mednet.ucla.edu|
20516007|NCT03104738|The Ohio State University|Ana Mavarez-Martinez, PostDoctoral Reseacher|614-293-3559|ana.mavarezmartinez@osumc.edu|
20516008|NCT00841100|University of Miami|Judy Schaechter|305-243-3993|JSchaech@med.miami.edu|
20516009|NCT03338972|Fred Hutchinson Cancer Center|Dr. Damian Green|2066675398|dgreen@fredhutch.org|
20516010|NCT02589171|The University of Texas Health Science Center at Houston|Associate Professor|(713) 500-7277|Shinil.K.Shah@uth.tmc.edu|
20516011|NCT00448175|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
20516012|NCT03633721|Albert Einstein College of Medicine|Dr. Anjali Sharma|7185152593|anjali.sharma@einsteinmed.edu|
20516013|NCT03054103|Wake Forest University Health Sciences|Dr. Timothy Harwood|3367164498|tharwood@wakehealth.edu|
20516014|NCT02343120|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20516015|NCT05277389|Arizona State University|Claire Honeycutt, Associate Professor|4809658453|claire.honeycutt@asu.edu|
20516016|NCT03069937|Medical University of South Carolina|Principal Investigator|843-792-4271|gourdith@musc.edu|
20516017|NCT01046253|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516018|NCT02339909|Imperial College London|Colin Bicknell|02078866666|colin.bicknell@imperial.ac.uk|6072
20516019|NCT00981305|SeoulNUH|Myung Jae Jeon|82-2-2072-1916|jeonmj@snu.ac.kr|
20516020|NCT02519322|M D Anderson Cancer Center|Dr. Rodabe Amaria|(713) 792-2921|rnamaria@mdanderson.org|
20516021|NCT01766778|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20516022|NCT01054599|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
20516023|NCT00743197|Northwestern University|Dr. Martha Gulati, Principal Investigator|312-695-4965|mgulati@nmh.org|
20516024|NCT01104662|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
20516025|NCT00479258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20516026|NCT00373217|University of Virginia|Craig Slingluff MD, Professor of Surgery|4349249311|cls8h@virginia.edu|
20516027|NCT00934934|CERU Queens University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
20516028|NCT04188106|Rose Research Center|Perry Willette, MD|919.908.0945|perry.willette@roseresearchcenter.com|
20551292|NCT00775645|SWOG Statistical Center|Study Statistician|206-667-4623||
20551293|NCT02625259|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20551294|NCT03195088|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551295|NCT02998840|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20551296|NCT00665847|Tibotec Pharmaceuticals, Ireland|Senior Director|32 14 641 265|gdsmedt1@its.jnj.com|
20551297|NCT01686633|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551298|NCT02530554|Evic Romania|Dr. R Olsavszky|40 21 335 70 91|evicromania@evic.ro|
20551299|NCT02192814|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
20551300|NCT00511667|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561555|NCT03538054|The University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu|
20561556|NCT00667745|Bipolar Clinic and Research Program at|Dr. Andrew Nierenberg, Director of the Bipolar Trials Network|617-724-0837|ANIERENBERG@PARTNERS.ORG|
20561557|NCT02351180|Washington University in St. Louis|Ramsey Hachem, MD|3144548766|rhachem@wustl.edu|
20516029|NCT01507051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20529073|NCT03442088|University Hospitals Cleveland Medical Center|Dr. Neil Korman, Director Clinical Trials Unit|216-844-8200|Neil.Korman@UHhospitals.org|
20529074|NCT01001520|University of Pennsylvania|Caryn Lerman, PhD|215-746-7141|clerman@mail.med.upenn.edu|
20529075|NCT00357877|Kaiser Permanente Data Coordinating Center|Dr. William Vollmer|503-335-6755|william.vollmer@kpchr.org|
20529076|NCT02541422|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
20529077|NCT01051557|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|kaleyt@mskcc.org|
20529078|NCT04668209|University of Arizona|Jessica Winters|520-780-1882|jwinters1@arizona.edu|
20529079|NCT02958787|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, MD|734-232-5244|sprattda@umich.edu|
20561558|NCT00208767|Emory University School of Medicine|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
20561559|NCT02930590|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
20561560|NCT00605033|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20561561|NCT02666742|Kansas City Heart Rhythm Institute|Donita Atkins|913-253-3064|Donita.Atkins@hcahealthcare.com|
20561562|NCT04181307|NYU Langone Health|Andrea B. Troxel, ScD|646-501-3654|andrea.troxel@nyulangone.org|
20561563|NCT02299336|Retina Consultants of Houston|Dr. Charles C. Wykoff|7135243434|ccwmd@houstonretina.com|
20561564|NCT01910636|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20561565|NCT01359371|VA Center for Clinical Management Research Health Services|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
20561566|NCT01212757|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20561567|NCT00573833|Memorial Sloan Kettering Cancer Center|Dr. Josh Yoshiya Yamada, Assistant Attending|+1212-639-2950|yamadaj@mskcc.org|
20561568|NCT04493242|Direct Biologics, LLC|Dr. Amy Lightner|512-354-7124|alightner@directbiologics.com|
20561569|NCT00849147|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20561570|NCT04722003|Emory University Vaccine and Treatment Evaluation Unit (VTEU)|Varun K. Phadke, MD|404-712-9046|varun.phadke@emory.edu|
20561571|NCT00028769|SWOG Statistical Center|Study Statistician|206-667-4623||
20561572|NCT01499134|Thomas Jefferson University|Danielle Duffy MD|215 955 5050|Danielle.Duffy@jefferson.edu|
20561573|NCT01012388|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
20561574|NCT04035668|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20561575|NCT02937831|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20561576|NCT02630719|Truman Medical Center|Sean Gratton MD|816-404-5275|sean.gratton@tmemed.org|
20561577|NCT03426228|Fakih IVF|Dr. Ayla Coussa|+971501403866|A.coussa@warwick.ac.uk|
20561578|NCT02027558|VA Greater Los Angeles Healthcare System|Cathy Alessi, MD|818-891-7711|Cathy.Alessi@va.gov|39311
20561579|NCT00831272|University of Pennsylvania|David Oslin|215 823 5894|oslin@upenn.edu|
20561580|NCT00114244|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20561581|NCT02694978|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20561582|NCT03848910|Hearing CRC Melbourne|Professor Robert Cowan|+61 3 9035 5347|r.cowan@unimelb.edu.au|
20516030|NCT01519661|Novartis Pharmaceuticals|Study Director|862-778-8300||
20516031|NCT00420303|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20516032|NCT02311361|National Cancer Institute|Dr. Tim Greten|240-760-6114|tim.greten@nih.gov|
20516033|NCT01978743|Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
20516034|NCT00745420|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20516035|NCT01941095|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20516036|NCT04486066|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|tracy.simpson@va.gov|
20516037|NCT01532141|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20516038|NCT00594685|New England Research Institutes|Susan Assmann|617-923-7747|sassmann@neriscience.com|548
20516039|NCT04455633|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
20516040|NCT03527745|Swiss Tropical and Public Health Institute|Jennifer Keiser, PhD|+41 (61) 284 8218|jennifer.keiser@swisstph.ch|
20516041|NCT03344510|Perelman School of Medicine at the University of Pennsylvania|Dr. Joseph Sobanko|215.360.0909|joseph.sobanko@uphs.upenn.edu|
20516042|NCT02215161|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
20516043|NCT03765502|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20516044|NCT00048568|Bristol Myers-Squibb|BMS Study Director||clinical.trials@bms.com|
20516045|NCT03831048|TransMedics, Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
20516046|NCT01027780|University of Rochester|Dr. Jan Moynihan|585-275-4648|jan_moynihan@urmc.rochester.edu|
20516047|NCT01315249|Novartis|Study Director|41 61 324 1111||
20516048|NCT03227445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20516049|NCT02831569|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20516050|NCT03164772|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20516051|NCT01029353|Vanderbilt University Medical Center|Martin L Blakely, MD|615-936-7211|martin.blakely@vumc.org|
20561583|NCT01376089|GE Healthcare|Lauren Lim, PharmD|1-626-356-1937|lauren.lim@ge.com|
20516052|NCT00954915|MacroGenics, Inc.|Teplizumab Program Manager||info@macrogenics.com|
20561584|NCT03854253|Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia|Dr. Stanislav Sapozhnikov|+79091919191|stas_ss@bk.ru|
20561585|NCT00419094|UCB, Inc.|Study Director|+1 877 822 9493||
20561586|NCT01811706|University of Florida|Dr. Guangbin Xia, Assistant Professor|352-273-5550|guangbin.xia@neurology.ufl.edu|
20516053|NCT03002597|Children's Hospital of Pittsburgh UPMC|Dr. Kanwal Nischal|4126928940|nischalkk@upmc.edu|
20516054|NCT00849901|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20516055|NCT03828734|University of North Carolina at Chapel Hill|Justin Riddle, PhD|919-966-4755|justin_riddle@med.unc.edu|
20516056|NCT03433430|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20516057|NCT05214560|Becton, Dickinson and Company|Clinical Project Manager|00393452237718|gloria.viti@bd.com|
20516058|NCT01765530|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-724-4490|rkacmarek@partners.org|
20516059|NCT02134522|Yale University|Nicola Santoro|2037376356|nicola.santoro@yale.edu|
20516060|NCT01030965|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516061|NCT02097290|Boston Scientific|Gregory Voss|6515813068|Gregory.Voss@bsci.com|
20516062|NCT02534493|Pressure Profile Systems|Jae Son|3106418100|jaeson@pressureprofile.com|
20516063|NCT01993875|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20516064|NCT03144687|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20516065|NCT01478620|"Kiev regional City Hospital"|Ivanov, Dmitry|+38 (039) 247 12 36|ivanovdd@i.kiev.ua|
20516066|NCT02098993|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
20516067|NCT00672854|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20516068|NCT02380183|Montefiore Medical Center|Dr. Amaresh Vydynathan|718-920-4316|avydynathan@montefiore.org|
20516069|NCT02888171|University of Alabama at Birmingham|Orlando M. Gutierrez, MD|205-996-2736|ogutierrez@uabmc.edu|
20516070|NCT01411332|University of Miami|Alan Pollack MD, PhD|305-243-4916|apollack@med.miami.edu|
20516071|NCT02170688|Duke University Medical Center|Lisa Ho, MD|919-684-7890|lisa.ho@duke.edu|
20516072|NCT01894178|Baylor College of Medicine|Dr. Lee Chang|713-873-4321|lcchang@bcm.edu|
20516073|NCT02079532|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20516074|NCT01402947|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20516075|NCT00591630|University of Texas MD Anderson Cancer Center|Issa F. Khouri, MD / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
20516076|NCT02218164|H. Lee Moffitt Cancer Center and Research Institute|Dr. Christine Chung|813-745-5061|christine.chung@moffitt.org|
20516077|NCT02419690|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
20516078|NCT02405195|Västra Götalandsregionen|Lukas Lannemyr|46313428860|lukas.lannemyr@vgregion.se|
20516079|NCT01432171|Dana-Farber Cancer Institute|Dr. Andrew Norden, M.D., M.P.H. - Lead Principal Investigator|617-632-2166|anorden@partners.org|
20516080|NCT01706926|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
20516081|NCT00993187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372||
20516082|NCT01387737|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20516083|NCT00441467|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
20516084|NCT02289963|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20516085|NCT03514420|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20516086|NCT01042522|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20516087|NCT00318812|Ottawa Hospital Research Institute|Dr Deborah Zimmerman, principal investigator|613-738-8400|dzimmerman@toh.on.ca|82534
20516088|NCT01746017|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20516089|NCT03422653|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20516090|NCT01675622|Mundipharma (China) phamaceutical CO. LTD|Director of R&D|0086-10-65636800||
20516091|NCT01101022|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20516092|NCT03075761|The University of Texas Southwestern Medical Center|Ayesha Zia, MD|214-456-7000|Ayesha.Zia@UTSouthwestern.edu|
20516093|NCT01139047|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20516094|NCT00485472|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20516095|NCT01492361|Amarin Pharma, Inc.|Dr. Alexander Giaquinto, Executive Director, Regulatory Affairs|908-326-1324|alex.giaquinto@amarincorp.com|
20516096|NCT04083859|Wake Forest University School of Medicine|Dr. David P. Miller, Jr|336-713-5218|dmiller@wakehealth.edu|
20516097|NCT00560235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516098|NCT01595503|University of Michigan|stephan taylor|7349364955|sftaylor@umich.edu|
20516099|NCT04015232|Lambda Therapeutic Research Ltd.|Dr. Adarsh Kumar Garg, M.B.B.S. Principal Investigator|+91-79-40202020|adarshgarg@lambda-cro.com|
20516100|NCT03538587|National Cancer Institute|Staci M. Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
20516101|NCT00365300|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20561587|NCT00701896|Ohio State University|Dr. Philip Diaz|6142934925|diaz.3@osu.edu|
20561588|NCT03020745|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20561589|NCT00743444|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20561590|NCT02452918|Melinta Therapeutics|Study Director|1-844-633-6568|medinfo@melinta.com|
20561591|NCT00807144|Imperial College Healthcare NHS Trust|Adam McLean|+44 020 8383 5164|adammclean@nhs.net|
20516102|NCT01991470|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20529080|NCT03570047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516103|NCT02896361|Abbott Neuromodulation|Filippo Agnesi, PhD|972-526-4860|filippo.agnesi@abbott.com|
20561592|NCT02680457|Instituto de Terapéutica Experimental y Clínica, Universidad de Guadalajara|Dr. Manuel González Ortiz|+52 3310585200|uiec@prodigy.net.mx|34212
20561593|NCT00989937|UCSD|David Feifel||dfeifel@kadimanp.com|
20561594|NCT02567656|Rhizen Pharmaceuticals S.A.|Prajak Barde MD|+41 32 580 0113|pjb@rhizen.com|
20561595|NCT00203216|Thomas Jefferson University/Jefferson Headache Center|Dr. William Young, Principal Investigator|215-955-2243|William.B.Young@Jefferson.Edu|
20561596|NCT03287622|University of Michigan|Dr. Terri Voepel-Lewis|734-646-6803|terriv@umich.edu|
20561597|NCT05882812|Medical Pain Consultants|Dr. Ralph Ortiz|607-844-9979|rodoc@cnymail.com|
20561598|NCT02057692|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
20561599|NCT03923491|Brown University School of Public Health|Dr. Alison Tovar|401-863-7327|alison_tovar@brown.edu|
20561600|NCT01192542|Johnson and Johnson Vision Care|Brian Pall, O.D., M.S. F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
20561601|NCT00355914|Pain Management Center of Paducah, Paducah, KY|Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|100
20561602|NCT02633358|China Medical University Hospital, Taichung, Taiwan|Dr. Da-Long Chen, director of cardiac intensive care unit|0952122027|my686chen@gmail.com|
20561603|NCT03823300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561604|NCT02513238|Rigshospitalet|Principal Investigator, Mesrix|26276374|c.gronhoj@gmail.com|
20561605|NCT03622580|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561606|NCT00354640|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
20561607|NCT01930045|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561608|NCT00241644|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561609|NCT00943735|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561610|NCT00486330|Yale University AIDS Program|R. Douglas Bruce|2037374040|robert.bruce@yale.edu|
20561611|NCT03804918|Imperial College London|Dr Gehan Soosaipillai|+44 20 3312 6666|gsoosaip@ic.ac.uk|7651
20561612|NCT01087762|Cares|UCB|+1887822||9493
20561613|NCT00813904|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
20561614|NCT01405924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561615|NCT02507336|University of Miami|Izidore Lossos MD|+1 (305) 2434785|ilossos@med.miami.edu|
20561616|NCT05340244|GE Healthcare|Tracy Grzendzielewski|414-218-6167|tracy.grzendzielewski@ge.com|
20561617|NCT03621761|University of Michigan|Tiffany Braley|734-232-1147|tbraley@med.umich.edu|
20561618|NCT01050569|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
20516104|NCT01453075|VA ORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|1251
20561619|NCT03951649|UAB|Rachel Sinkey|(205) 934-5611|rsinkey@uabmc.edu|
20561620|NCT00758602|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561621|NCT05046132|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20561622|NCT03987451|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20561623|NCT02441036|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20561624|NCT01122901|Adult Brain Tumor Consortium|David Peereboom, MD|410-955-8837|jfisher@jhmi.edu|
20561625|NCT00612586|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561626|NCT00395018|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20561627|NCT00530842|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561628|NCT00128193|Colorado State University, Department of Microbiology, Immunology and Pathology|Patrick J. Brennan, Ph.D.|970-491-6700|patrick.brennan@colostate.edu|
20561629|NCT00761930|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
20561630|NCT03257813|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|3001 4200|ricardo.llamas@sophia.com.mx|1059
20561631|NCT03478696|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20561632|NCT03615924|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20561633|NCT00716144|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561634|NCT00880048|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561635|NCT01069341|The University of Medicine and Dentistry of New Jersey|Dr. Neelakshi Bhagat|973-972-2032|bhagatne@umdnj.edu|
20561636|NCT00290706|Northwestern University|Leo Gordon|312-695-4520|l-gordon@northwestern.edu|
20561637|NCT04066738|Oxford University Hospitals NHS Foundation Trust|Prof. Tim Betts|01865 220256|ep.doctors@ouh.nhs.uk|
20561638|NCT01196429|NRG Oncology Statistics and Data Management Center - Buffalo|Linda Gedeon for William Brady PhD|716-845-5702|lgedeon@nrgoncology.org|
20561639|NCT03768206|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
20561640|NCT05328297|Janssen Research & Development|Senior Director Clinical Sciences Neuroscience|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20561641|NCT04513522|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20561642|NCT04541303|Univ of Mo|Brianna Castillo MD|813-765-1619|briannacastillo.md@gmail.com|
20561643|NCT03351075|KU Leuven|Prof. An De Groef|+32 16 342 171|an.degroef@kuleuven.be|
20516105|NCT00637299|Fondazione Salvatore Maugeri|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
20516106|NCT00959660|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
20516107|NCT00496964|Virginia Commonwealth University|Dr. Sheryl Finucane|804-628-3639|sfinucan@vcu.edu|
20516108|NCT02942264|National Cancer Institute|Dr. Jing Wu|240-760-6036|jing.wu3@nih.gov|
20516109|NCT01328093|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561644|NCT01613118|Travere Therapeutics, Inc.|Jula Inrig, MD|1-445-529-6312|Jula.Inrig@travere.com|
20561645|NCT01072006|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
20561646|NCT05219253|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20561647|NCT03086369|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20561648|NCT03175172|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
20561649|NCT02974634|University of Pennsylvania|Dr. Robert Krouse|215-615-4573|robert.krouse@pennmedicine.upenn.edu|
20561650|NCT00550394|University of Cincinnati|Melissa DelBello, MD, MS|513-558-2989|delbelmp@uc.edu|
20561651|NCT04668339|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
20561652|NCT00178399|University of Rochester|Michael Milano|585-273-4096|michael_milano@urmc.rochester.edu|
20561653|NCT04860258|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
20561654|NCT01124188|UPMC Late Life Depression|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
20561655|NCT01645098|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
20561656|NCT01324453|Minneapolis Heart Institute Foundation|Jane Fox|6128636289|jane.fox@allina.com|
20561657|NCT00708032|Johnson & Johnson Vision Care, Inc.|Kathy Osborn, OD|+1 904 443-1032|clinicalstudies@its.jnj.com|
20561658|NCT02711839|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
20561659|NCT03290248|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20561660|NCT00004124|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|(206) 667-4623|ctangen@fredhutch.org|
20561661|NCT01815008|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
20561662|NCT02107339|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
20561663|NCT02200523|Cleveland Medical Devices|Sarah Weimer|216-791-6720|sweimer@clevemed.com|
20561664|NCT03245580|Parkview Mirro Research Center|Christina Zelt RN|2602664153|christina.zelt@parkview.com|
20561665|NCT01613716|Cleveland Clinic Foundation|Sunil K. Srivastava, MD|216-636-2286|srivass2@ccf.org|
20561666|NCT03557008|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20561667|NCT00590707|Johns Hopkins|frederick Sieber|410-550-0942|fsieber1@jhmi.edu|
20561668|NCT03959241|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20561669|NCT02311972|Duke University|Dr. Robin B. Dail|919-684-3786|robin.dail@duke.edu|
20561670|NCT03192046|UtexasSouthwestern|Staci Shearin|214-648-6564|staci.shearin@utsouthwestern.edu|
20561671|NCT03557658|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20561672|NCT01194154|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561673|NCT01505881|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561674|NCT00842257|Massachusetts General Hospital|Dr. David Patrick Ryan, Chief, Hem/Onc|617-974-4545|DPRYAN@mgh.harvard.edu|
20561675|NCT01147341|michael schiff|Michael schiff|303 773 8429|michael.schiff@me.com|
20561676|NCT01901276|Columbia University Medical Center|Daniel Freedberg, MD, MS|212-305-1021|def2004@cumc.columbia.edu|
20561677|NCT01596504|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20561678|NCT02314117|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20561679|NCT04439799|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|305-243-6596|Ramasamy@miami.edu|
20561680|NCT05565391|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561681|NCT04296227|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
20561682|NCT02716324|The Children's Hospital of Philadelphia|James Guevara, MD MPH|2155901130|guevara@email.chop.edu|
20561683|NCT00888979|UConn Health|Cheryl Oncken|860-679-3425|oncken@uchc.edu|
20561684|NCT00949975|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20516110|NCT04421508|Bellerophon Therapeutics|Bobae Kim|(917) 675-2254|bobae.kim@bellerophon.com|
20561685|NCT04347954|Stanford University|Jayakar Nayak, MD, PhD|(650) 723-5281|jnayak@stanford.edu|
20561686|NCT00909363|Weill Cornell Medicine|Dr james B Bussel|917-291-5091|jbussel@med.cornell.edu|
20561687|NCT03280836|Penn State University|Dr. Kathleen Sturgeon|7175314530|kms99@psu.edu|284676
20561688|NCT01891968|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD|713-745-3428|CR_Study_Registration@mdanderson.org|
20561689|NCT04141917|University of Washington|Dr. Helen Chu|206-685-8702|helenchu@uw.edu|
20561690|NCT02954848|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20561691|NCT02326649|UCSD|Christopher Davis|8589665855|cdavis@rchsd.org|5668
20516111|NCT03980483|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20516112|NCT02576249|Mayo Clinic|Dr. Jacob Sellon|507-255-1141|sellon.jacob@mayo.edu|
20561692|NCT02950558|University of Cincinnati|Jun-Ming Zhang, MD, MSc|5135582427|jun-ming.zhang@uc.edu|
20561693|NCT03253913|University of Cincinnati|Nishant Gupta, MD|5135584831|nishant.gupta@uc.edu|
20516113|NCT00784849|LSU Dept of Surgery|Dr. Eugene Woltering|504 464-8500|ewolte@lsuhsc.edu|
20516114|NCT04622709|University of North Carolina, Chapel Hill|Jennifer E. Flythe, MD, MPH|(919) 445-2656|jflythe@med.unc.edu|
20516115|NCT00760266|Novartis Pharmaceuticals|Study Director|862-778-8300||
20516116|NCT05150964|Sonova USCS|Director of Clinical Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20516117|NCT01239121|James J. Peters VA Medical Center|Kenneth Boockvar|718-584-9000|kenneth.boockvar@va.gov|3807
20516118|NCT03657160|Takeda|Study Director|+1-877-825-3327|medinfoUS@takeda.com|
20516119|NCT00488865|Rex Medical|James Bressler|610-940-0665|ebressler@rexmedical.com|
20516120|NCT00686959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20516121|NCT02178722|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20561694|NCT02808338|Philips|Clinical Operations Manager|14125423669|jeremy.powers@philips.com|
20561695|NCT02194933|Otsuka Data Transparency Organization|Global Clinical Development||DT-inquiry@otsuka.jp|
20561696|NCT02053363|Rady Children's Hospital|Michael P Kelly|858-576-1700|mkelly5@rchsd.org|223750
20516122|NCT00440557|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Sr Director of Clinical Research|908-927-2116||
20561697|NCT02000817|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20561698|NCT04349150|Massachusetts General Hospital|Daniel C. Chung, MD|6177263544|chung.daniel@mgh.harvard.edu|
20561699|NCT03383146|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20561700|NCT05382104|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20561701|NCT03506880|The Pennsylvania State University|Dr. Rob Turrisi|814-865-7808|rturrisi@psu.edu|
20561702|NCT02336438|Bassett Healthcare Network|Dr. Amy Freeth|607-547-3273|amy.freeth@bassett.org|
20561703|NCT01317420|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561704|NCT05686421|Wills Eye Hospital|Joel Schuman, MD FACS|215-928-3197|JSchuman@willseye.org|
20561705|NCT00857649|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20561706|NCT02533167|Wake Forest Health Sciences|Ashley Tonidandel, MD|336-718-8278|atonidan@wakehealth.edu|
20561707|NCT00367055|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561708|NCT00145041|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
20561709|NCT00299741|Massachusetts General Hospital|Dr. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
20561710|NCT01123083|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561711|NCT00961636|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561712|NCT04884737|UCLA School of Nursing|Barbara Bates-Jensen, PhD, RN, FAAN|626-437-8543|batesjen@sonnet.ucla.edu|
20561713|NCT00939991|Duke University Medical Center|Katherine Peters, MD, PhD|919-684-3914|katherine.peters@dm.duke.edu|
20561714|NCT02486588|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
20561715|NCT02754479|DuPage Medical Group|Kelly Stankiewicz, MD FAAD|(630) 547-5040|kjstanki@gmail.com|
20561716|NCT02106442|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20561717|NCT01303835|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
20516123|NCT01572948|University of Alabama at Birmingham, Division of Pulmonary, Allergy, and Critical Care Medicine|J. Michael Wells, M.D.|205-934-6047|jmwells@uab.edu|
20516124|NCT01973348|Indiana University|Dr. Daniel Neely, PI|3172741214|deneely@iupui.edu|
20516125|NCT01270919|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
20516126|NCT01126736|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20516127|NCT00784823|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|Joshua.Zenreich@hmhn.org|
20516128|NCT01720264|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
20516129|NCT02870920|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
20516130|NCT01479439|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
20516131|NCT02079766|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20516132|NCT03117569|Viral Hepatitis Clinical Research Program Kirby Institute|Clinical Trials Manager|+61 9385 0900|pmarks@kirby.unsw.edu.au|
20551301|NCT03605303|Johnson & Johnson Vision Care Inc.|Brian Pall OD, MS, FAAO - Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
20516133|NCT01853553|University of Colorado|Dr. Michel Chonchol|303-724-7796|Michel.Chonchol@ucdenver.edu|
20516134|NCT03018249|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|linda.gedeon@roswellpark.org|
20516135|NCT03883607|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
20516136|NCT00824265|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20516137|NCT01248247|UT MD Anderson Cancer Center|Dr. Marcelo Vailati Negrao, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 614-4938|mvnegrao@mdanderson.org|
20516138|NCT00911898|South Texas Accelerated Research Therapeutics|Dr. Muralibhar Beeram|210-593-5921|murali.beeram@stoh.com|
20551302|NCT01472081|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20551303|NCT04702997|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20551304|NCT01386554|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20551305|NCT02759471|CooperVision|Senior Manager Global Medical Scientific Affairs|1-925-621-3761|javega@coopervision.com|
20551306|NCT02554812|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551307|NCT01103284|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
20551308|NCT00936910|Children's Hospital of Pittburgh|Dr. William McGhee, Clinical Pharmacy Specialist, Transplant|412-692-5733|william.mcghee@chp.edu|
20551309|NCT02057198|Duke University Medical Center|Daniel Sexton, M.D.|919-684-4596|sexto002@mc.duke.edu|
20551310|NCT00503009|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551311|NCT03878745|Becton Dickinson|Michael Gibney|201-847-6170|Michael.gibney@bd.com|
20551312|NCT02355691|UNC Orthopaedics|Scott Eskildsen, MD|(919) 966-9166|seskilds@unch.unc.edu|
20551313|NCT03540147|University of Texas at Austin|Hirofumi Tanaka|5122324801|htanaka@austin.utexas.edu|
20551314|NCT01349803|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20551315|NCT03232281|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
20551316|NCT01403246|GIMEMA|Alfonso Piciocchi|+393203671224|a.piciocchi@gimema.it|
20551317|NCT02345811|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20551318|NCT03040466|UCSF|Dr. Thomas Chi|415-476-1611|tom.chi@ucsf.edu;manint.usawachintachit@ucsf.edu|
20561718|NCT02355158|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
20561719|NCT03284957|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20561720|NCT02945332|Texas Tech University|Dr. Nikhil Dhurandhar|806 834-6446|nikhil.dhurandhar@ttu.edu|
20561721|NCT03544515|Columbia University College of Dental Medicine|Philip Y. Kang, DDS|212-342-5244|pyk2104@cumc.columbia.edu|
20561722|NCT02496702|Technical University of Denmark, Center for Playware|Jari Due Jessen|+45 45 25 39 29|jdje@elektro.dtu.dk|
20561723|NCT01400776|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20561724|NCT01904071|Maimonides Medical Center|Dr. Eitan Dickman, Director of EM Ultrasound|718-283-6057|edickman@maimonidesmed.org|
20561725|NCT02694835|Alcon, A Novartis Division|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20561726|NCT02064959|The University of Texas Health Science Center at Houston|Georgene W. Hergenroeder, Ph.D., Associate Professor|713-500-6230|lisa.h.schmitt@uth.tmc.edu|
20561727|NCT00941655|National Cancer Institute, National Institutes of Health|Dr. Udo Rudloff|301-496-3098|Udo.Rudloff@nih.gov|
20561728|NCT00446550|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
20561729|NCT01759264|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20561730|NCT02698891|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-3800|nlin@partners.org|
20561731|NCT00711958|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
20561732|NCT02383472|Boston Children's Hospital|Dr. William Meehan|781-216-1328|William.Meehan@childrens.harvard.edu|
20561733|NCT02013830|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561734|NCT01111526|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lia Perez|813-745-3665|lia.perez@moffitt.org|
20561735|NCT04424641|Genmab|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
20561736|NCT00597038|UCSF Helen Diller Family Comprehensive Cancer Center|Adil Daud, Director, Melanoma Clinical Research|415-353-7392|adaud@medicine.ucsf.edu|
20561737|NCT04238429|Sun Yat-sen University|Dr. Hongchun Liu|86-13826189071|hongchun_liu@vip.sina.com|
20561738|NCT01171625|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
20561739|NCT03262935|Byondis B.V.|Clinical Development|0031246795101|clinicaltrials@byondis.com|
20561740|NCT00186186|Stanford University|Dr. Terence Ketter, Chief Bipolar Disorder Clinic|650-723-2515|tketter@stanford.edu|
20561741|NCT03387319|Emory University|Kimberly R Jacob Arriola, PhD, MPH|404-727-2600|kjacoba@emory.edu|
20561742|NCT00762606|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20516139|NCT01900730|UT MD Anderson Cancer Center|Dr. Wendy Woodward, PHD/ Professor, Radiation Oncology Department|713-563-8481|wwoodward@mdanderson.org|
20516140|NCT02109042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20516141|NCT01163760|Vistakon|Kurt Moody OD, FAAO|904-443-3088||
20516142|NCT00324168|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
20516143|NCT00274937|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20516144|NCT02189941|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
20516145|NCT03478397|CEDES|Dr. Silvina Arrossi|541148651007|silviarrossi2020@gmail.com|
20516146|NCT00705003|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
20516147|NCT00643578|University of Florida Asthma Research Lab|Dr. Leslie Hendeles|352-273-6027|hendeles@cop.ufl.edu|
20516148|NCT02017964|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20516149|NCT02005536|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20516150|NCT01434693|Coronado Biosciences|Vice President Clinical Operations|781.652.4516|nsilver@coronadobio.com|
20516151|NCT04006171|Near East University|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
20516152|NCT00912288|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516153|NCT02506309|Brno University Hospital|dr. Martin Huser|+420532233843|huser.martin@fnbrno.cz|
20516154|NCT01440283|St. Jude Children's Research Hospital|Chia-ho Hua, PhD|901-595-3610|chia-ho.hua@stjude.org|
20516155|NCT01449630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20516156|NCT03138330|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
20516157|NCT02016612|Bengtson Center|Dr Bradley Bengtson|616 588 8880|drb@bengtsoncenter.com|
20516158|NCT02087904|AbbVie|Global Medical Services|AbbVie|abbvieclinicaltrials@abbvie.com|
20516159|NCT01735630|Transition Therapeutics Ireland Limited|Aleksandra Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
20516160|NCT01327963|EndoGastric Solutions|Adrian Lobontiu, Chief Medical Officer|1 650-474-9259|alobontiu@endogastricsolutions.com|
20516161|NCT03099538|Mayo Clinic|Aaron R. Mangold, MD|480-301-4256|mangold.aaron@mayo.edu|
20516162|NCT01196052|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20561743|NCT05641311|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20561744|NCT01568918|Mayo Clinic|Michelle Clarke, M.D.|(507) 284-5317|Clarke.Michelle@mayo.edu|
20561745|NCT04301986|UNC Center for Esophageal Diseases & Swallowing|Ariel E. Watts, Assistant Director of Clinical Trial Operations|919-962-7316|ariel_watts@med.unc.edu|
20516163|NCT01390233|University of Arizona (Investigator has changed institutions - study completed at University of South Carolina)|Meg Hill, MBBS|520 626 6174|meghanhill@obgyn.arizona.edu|
20516164|NCT03959683|INDIANA UNI SCHOOL OF MEDICINE|Erica Sahm|317-274-3560|esahm@iuhealth.org|
20516165|NCT02495467|Richmond Pharmacology Limited|Dr Jorg Taubel|020 8664 5200|j.taubel@richmondpharmacology.com|
20516166|NCT03287310|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
20516167|NCT04625114|University Hospital Ghent|Dr Marie-Angélique De Scheerder|+32 9 33 21349|marie-angelique.descheerder@uzgent.be|
20516168|NCT01629381|University of Padua|Dr. Giuseppe Camporese|049 8212882|giuseppe.camporese@aopd.veneto.it|+39
20516169|NCT02158494|University of Wisconsin - Madison|Mitchell Tyler|608-262-5112|metyler1@wisc.edu|
20516170|NCT00906347|University of Texas Southwestern Medical Center|Dr. April Bleich|214-648-2316|april.bleich@gmail.com|
20516171|NCT00802100|Columbia University|Scott Stroup|(212) 543-5676|stroups@nyspi.columbia.edu|
20516172|NCT04448886|DFCI|Se Eun Kim|9196228080|seeunk@ds.dfci.harvard.edu|
20516173|NCT02688556|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|clinical.trials@sparcmail.com|
20516174|NCT02849652|University of Pennsylvania|Dr. Robert Schnoll|2157467143|schnoll@pennmedicine.upenn.edu|
20516175|NCT00472290|Amgen Inc.|Study Director|866-572-6436||
20516176|NCT00777829|UCSD|Dr. Sara C. Mednick|8586423192|mednicks@uci.edu|
20516177|NCT03205553|University of Arkansas for Medical Sciences|Dr. Patrick Bonasso|(501) 364-2943|PCBonasso@uams.edu|
20516178|NCT04826809|Mayo Clinic|Dr. Janielle R. Nordell|507-594-4700|Nordell.Janielle@mayo.edu|
20516179|NCT02359305|Nationwide Children's Hospital - Dept. of Anesthesiology & Pain Medicine|Dr. Arlyne Thung|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
20516180|NCT02461771|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20516181|NCT00854308|Hoffman-LaRoche|Medical Communications|800-821-8590||
20516182|NCT01390844|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20516183|NCT00745095|JJPVAMC National Center of Excellence for the Medical Consequeunces of Spinal Cord Injury|Dr. Mark A. Korsten, Chief of Gastroenterology|718-584-9000|mark.korsten@va.gov|6753
20516184|NCT00076050|University of Miami|Silvina Levis MD|305-575-3388|slevis@med.miami.edu|
20516185|NCT04448678|University of Utah|Anne Kirchhoff|801-587-4084|Anne.Kirchhoff@hci.utah.edu|
20516186|NCT00113425|University of Michigan Dept of Dermatology|Dr. Jeffrey Orringer|734-936-4075|jorringe@umich.edu|
20516187|NCT01106326|University of Rochester|Maria Fagnano|5852758220|maria_fagnano@urmc.rochester.edu|
20516188|NCT01353495|Wright Medical Technology, Inc.|Jonette Hodge, MSN, RN, CCRP, Director, Medical Affairs|8002387188|jonette.hodge@wmt.com|4747
20516189|NCT01313416|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
20516190|NCT00304083|SARC|Research Project Manager|734-930-7600|sarc@sarctrials.org|
20516191|NCT01044732|Avantis Medical Systems|Jack Higgins, MD - Chief Medical Officer|6508239216|jhiggins@avantismedical.com|
20516192|NCT02304432|McLean Hospital|Dr. Deborah Levy|617-855-2854|dlevy@mclean.harvard.edu|
20516193|NCT03991494|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20516194|NCT00098371|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-9869|John.Byrd@osumc.edu|
20516195|NCT00860314|University Hospital Hamburg-Eppendorf, Heart Center|Tim Risius, MD|+49-40-42803|risius@uke.uni-hamburg.de|4142
20516196|NCT01523899|University of California-Davis|Larissa May, MD|9167345000|lsmay@ucdavis.edu|
20516197|NCT00683293|Kantonsspital Aarau|Dimtri SARLOS|00418384141|la.kots@ksa.ch|
20516198|NCT02126306|HMO|Dr Gadi Lalazar|97226777337|lalazar@hadassah.org.il|
20516199|NCT02920996|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|(617) 632-3468|mark_awad@dfci.harvard.edu|
20516200|NCT02507375|Hoffmann-La Roche|Medical Communications|800-821-8590||
20516201|NCT02158936|Novartis Pharma AG|Study Director|862-778-8300||
20516202|NCT00522457|Fresenius Biotech North America|Manager of Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
20516203|NCT00633256|Yale University|James Poling, Ph.D.|203-937-4830|james.poling@yale.edu|
20516204|NCT02817841|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
20516205|NCT00705536|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
20516206|NCT00549718|Sunovion Pharmaceuticals Inc.|Josephine Cucchiaro|201-592-2050|josephine.cucchiaro@sunovion.com|
20516207|NCT00397488|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
20516208|NCT04742283|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20516209|NCT01458561|CryoLife, Inc.|Scott B. Capps, Vice President, Clinical Research|770-419-3355|capps.scott@cryolife.com|
20516210|NCT04032977|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|clinicaltrials@prolleniumus.com|
20516211|NCT02158572|Agile Therapeutics|Michelle Previtera, Associate Director of Clinical Development|609-683-1880|mprevitera@agiletherapeutics.com|
20516212|NCT02880761|Continuous Quality Improvement Experts Congress of Changping District|Director of Continuous Quality Improvement Experts Congress of Changping District|+861069006549|zhangdongliang@pkuih.edu.cn|1069006789
20516213|NCT03597256|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20516214|NCT02106156|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20516215|NCT01907334|University of Florida|Leslie Hendeles, PharmD|352-273-6027|hendeles@cop.ufl.edu|
20561746|NCT01989910|Taipei Veterans General Hospital|Dr. WEN-WEI KU|+886228751997|stephaneku@gmail.com|
20516216|NCT00722124|Mayo Clinic|Amit Sood, MD|507-266-1944|nicotineresearch@mayo.edu|
20516217|NCT00581139|University of California, Irvine|Dr. Zeev Kain|714-480-0039|zkain@uci.edu|
20561747|NCT00922207|HoffmannLa Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561748|NCT01802632|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
20561749|NCT03299816|Johns Hopkins University School of Medicine|Deidra C. Crews, MD, ScM|410-502-0518|dcrews1@jhmi.edu|
20561750|NCT01733238|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20561751|NCT02311907|Mayo Clinic|Charles L. Loprinzi M.D.|507/284-1623|cloprinzi@mayo.edu|
20561752|NCT00367991|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
20516218|NCT02606708|New York University School of Medicine|Carmen Perez, MD|212 731 5003|carmen.perez@nyumc.org|
20561753|NCT03515304|Johns Hopkins University - Baltimore, MD|Dr. Thorsten Leucker|4105020469|tleucke1@jhmi.edu|
20516219|NCT00840632|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516220|NCT01725529|Janssen R&D US|ASSOCIATE DIRECTOR, MEDICAL DEPARTMENT||ClinicalTrialDisclosure@its.jnj.com|
20516221|NCT01104025|Cincinnati Children's Hospital Medical Center|Michael Jordan, MD|513-803-9063|Michael.Jordan@cchmc.org|
20516222|NCT04927013|Emory University|Yue Guan, PhD|404-712-1671|yue.guan@emory.edu|
20516223|NCT02031978|USDA Food and Nutrition Service|Courtney Paolicelli|7036054370|Courtney.Paolicelli2@usda.gov|
20516224|NCT00051025|Eisai Call Center|Eisai Inc|888-422-4743||
20516225|NCT01179048|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20516226|NCT03203447|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20529081|NCT01351090|Luitpold Pharmaceuticals, Inc.|David Bregamn, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
20561754|NCT03368937|University of Virginia|Sue Brown|434-982-0206|sab2f@virginia.edu|
20561755|NCT01271452|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20561756|NCT03586544|The Ohio State University|Dharini Bhammar|614-866-9467|dharini.bhammar@osumc.edu|
20561757|NCT01832506|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20561758|NCT00539292|The Hospital for Sick Children|Dr Jacob C Langer|416-813-7340|jacob.langer@sickkids.ca|
20561759|NCT02165761|W.L. Gore and Associates, Inc.|Suzy Palmer, CCRP|928-864-3670|supalmer@wlgore.com|
20561760|NCT00176839|University of Minnesota Masonic Cancer Center|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
20561761|NCT02020616|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561762|NCT02885350|Helsinki University Central hospital/Women's hospital/anaesthesia|Dr Antti Vaananen|358504271850|antti.vaananen@hus.fi|
20561763|NCT00324038|Napp Pharmaceutical Ltd|Dr Paul Schofield, Medical Director|01223424444|info@contact-clinical-trials.com|
20561764|NCT03070483|Loyola University Chicago|Dr. Holly Kramer|7083279039|hkramer@lumc.edu|
20561765|NCT02031471|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20561766|NCT01215695|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
20561767|NCT01378065|Coloplast Corp|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
20561768|NCT00361283|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
20561769|NCT01837641|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20561770|NCT01579916|MedImmune, LLC|Raburn Mallory, MD/Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
20561771|NCT03264456|University of Alabama at Birmingham|Samuel Galgano|2059341388|samuelgalgano@uabmc.edu|
20561772|NCT03360396|Boston Scientific Corporation|Jessica Stockwell|612-618-1136|Jessie.Stockwell@bsci.com|
20561773|NCT00688519|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561774|NCT00329732|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@jefferson.edu|
20561775|NCT02551055|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20561776|NCT00430300|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561777|NCT02205307|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
20561778|NCT01063517|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
20561779|NCT02041104|Mlinotest d. d.|Ana Velikonja|0038651321785|anaa.velikonja@gmail.com|
20561780|NCT04001829|ECOG-ACRIN Biostatistics Center|Study statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20561781|NCT05011396|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
20561782|NCT03253848|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20561783|NCT01393119|Oncternal Therapeutics|Mary Breitmeyer|8582092082|mbreitmeyer@oncternal.com|208
20561784|NCT01266265|United Therapeutics Corporation|Nicole Leedom|919-425-5870|nleedom@unither.com|
20561785|NCT01580293|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20561786|NCT05674136|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20561787|NCT02983617|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20561788|NCT02860286|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
20561789|NCT04218110|Eurofins EVIC|Commercial Manager|+40 213357090|luciachirita@eurofins.com|
20561790|NCT00516386|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
20561791|NCT00002842|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|
20561792|NCT02015546|Duke University Medical Center|Dr. Ashwin Patkar|919-681-0613|ashwin.patkar@duke.edu|
20516227|NCT01203878|Tennessee Clinical Research Center|Medical Director|615-383-2400|jbiron@tnclinicalresearch.com|
20516228|NCT00445003|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|aglassman@jaeb.org|
20561793|NCT05855655|Brown University|Shufang Sun|401-863-5735|shufang_sun@brown.edu|
20561794|NCT04580160|Vesper Medical|Joseph C. Griffin, III|4848926340|Jgriffin@vespermedical.com|
20561795|NCT02296424|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
20561796|NCT01337635|Medical College of Wisconsin|Yvonne Chiu, MD|414-955-2818|ychiu@mcw.edu|
20561797|NCT01113931|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20561798|NCT03176654|Loma Linda University Health|Everett Lohman, PhD. Professor||elohman@llu.edu|83171
20561799|NCT01290224|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu|
20561800|NCT03684265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561801|NCT02570295|Swiss Federal Institute of Sport Magglingen SFISM|Dr. Thomas Wyss|+41 58 467 64 16|thomas.wyss@baspo.admin.ch|
20561802|NCT02969863|MGH|Courtney Balliro, BS RN CDE|617-726-1242|cballiro@partners.org|
20561803|NCT02705586|VA Portland Health Care System|Dr. Amie Hiller|503 721 1091|peterami@ohsu.edu|
20561804|NCT03608839|State University of Campinas (UNICAMP)|Dr Rodrigo Pessoa Cavalcanti Lira|551935217396|alayf@hotmail.com|7396
20561805|NCT02045836|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561806|NCT01794936|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20561807|NCT03920215|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20561808|NCT05575375|The Miriam Hospital|Emily Gathright|4017938271|emily.gathright@brownhealth.org|
20561809|NCT03320434|Ora, Inc|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
20561810|NCT03024606|Saint Louis University|Research Nurse|314-977-2090|jathompson@slu.edu|
20561811|NCT01576523|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20561812|NCT02547922|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20561813|NCT01867632|MUHC|Dr. Mirko Gilardino|514.934.1934|Mirko.Gilardino@muhc.mcgill.ca|
20561814|NCT01996917|Columbia University|Christine Rohde, MD|212-342-3707|chr2111@cumc.columbia.edu|
20561815|NCT00739141|Memorial Sloan Kettering Cancer Center|Juliet Barker, MBBS|646-608-3756|barkerj@mskcc.org|
20561816|NCT00102063|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
20561817|NCT02498769|Duke University Health System|Dr. Joseph P Mathew Professor of Anesthesiology and Chairman Department of Anesthesiology|919-681-6646|joseph.mathew@duke.edu|
20561818|NCT04707313|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20561819|NCT02739035|Mayo Clinic|Gabriel Schouten - Clinical Research Coordinator|5072665895|schouten.gabriel@mayo.edu|
20561820|NCT01591733|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
20516229|NCT00528606|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20516230|NCT02475954|Rutgers - Robert Wood Johnson Medical School|Roseanne D. Dobkin|732-235-4051|dobkinro@rutgers.edu|
20516231|NCT00874887|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20516232|NCT03503578|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
20516233|NCT03656783|Brigham and Women's Hospital|Marcelo Di Carli, MD|6177326290|mdicarli@bwh.harvard.edu|
20516234|NCT01918397|Boston University School of Public Health|Charles R Horsburgh, MD|617-414-1282|rhorsbu@bu.edu|
20516235|NCT00880568|Merck Sharp & Dohme|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20516236|NCT00620022|Novartis Pharmaceuticals|Study Director|862 778-8300||
20561821|NCT00940992|Solgel|Ofra Levy-Hacham, Ph.D, VP of Quality Assurance|972-8-9313433|ofra.levy-hacham@sol-gel.com|3802
20561822|NCT05019144|Medical University of South Carolina|Dr. Aaron P. Lesher|843-408-6782|leshera@musc.edu|
20561823|NCT04221438|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20561824|NCT05673720|Florida State University|Geraldine Martorella, Hyochol Ahn|850-645-9758|gmartorella@fsu.edu|
20561825|NCT00588770|ECOG-ACRIN Cancer Reserch Group Statistical Office|Study statistician|6176323012|eatrials@jimmy.harvard.edu|
20561826|NCT02950896|Washington University School of Medicine|Heather McKenzie|3142862628|heather.mckenzie@wustl.edu|
20561827|NCT00839540|Michigan State University|Dr. Gary E.Stein, Pharm.D.|517-353-5126|steing@msu.edu|
20561828|NCT00617201|University of Kentucky|Dr. Sharon Walsh|859-257-2684|sharon.walsh@uky.edu|
20561829|NCT00546871|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20561830|NCT01713946|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20561831|NCT04036058|Wm. S. Middleton Memorial VA Hospital|Linda McKinley|608-256-1901|linda.mckinley2@va.gov|
20561832|NCT02878850|Duke University|Miriam Treggiari|9196819933|miriam.treggiari@duke.edu|
20561833|NCT01286272|Alliance for Clinical Trials in Oncology|Kristie A. Blum, MD|614-293-8858|kristie.blum@osumc.edu|
20561834|NCT06331403|Massachusetts General Hospital|Lucy Finkelstein-Fox, PhD|617-726-6300|lfinkelsteinfox@mgh.harvard.edu|
20561835|NCT03622593|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561836|NCT02284555|Destiny Pharma|Director of Projects|+44 (0)1273 704440|medinfo@destinypharma.com|
20561837|NCT00534937|Allegheny General Hospital|Dr. Satish Muluk|(412) 359-3714|muluk@usa.net|
20561838|NCT02568644|Universidade Federal de Minas Gerias|Dr. Antonio Lucio Teixeira||altexr@gmail.com|
20561839|NCT03593876|University of Pittsburgh|Dr. Elizabeth Skidmore|(412) 383-6617|skidmore@pitt.edu|
20561840|NCT00432458|Mayo Clinic|Dr. Thomas Witzig||witzig@mayo.edu|
20561841|NCT00854906|University of Arkansas for Medical Sciences|Richard Harper|501 526-6000|harperricharda@uams.edu|2616
20516237|NCT01423760|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20516238|NCT01617668|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20561842|NCT00071799|Celgene Corporation|CL Beach||CLBeach@celgene.com|
20516239|NCT00925769|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561843|NCT04147897|University of Washington|Dror Ben-Zeev, Professor|206-685-9655|dbenzeev@uw.edu|
20561844|NCT04527549|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20561845|NCT00814346|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20561846|NCT03941912|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
20561847|NCT05136443|Cornea Research Foundation of America|Marianne Price|317-814-2990|mprice@cornea.org|
20561848|NCT01241435|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561849|NCT00326924|Ottawa Hospital Research Institute|Dean Fergusson, Senior Scientist|613-737-8480|dafergusson@ohri.ca|
20561850|NCT02221219|University of Kentucky|Research Protocol Manager/Clinical/UKHC|(859) 257-1000|hong.huang@uky.edu|
20561851|NCT03718767|National Cancer Institute|Dr. Jing Wu|240-760-6036|jing.wu3@nih.gov|
20561852|NCT05694065|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr. Fenghua Ding|+00 86 21 64370045|ruijindfh@126.com|
20561853|NCT00346333|Harvard Medical School|Eliot L. Berson, M.D.|617-573-3600|marilyn_sullivan@meei.harvard.edu|
20561854|NCT00596167|Indiana University School of Medicine|Brian Decker MD, PharmD|317-278-2868|bsdecker@iupui.edu|
20561855|NCT03460756|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20561856|NCT04333758|Tan Tock Seng Hospital Pte Ltd|Ms Lim Chien Joo|9035249|Chien_Joo_LIM@ttsh.com.sg|
20561857|NCT03193619|Becton, Dickinson, and Company|Anna Lovas|952-239-0548|anna.lovas@bd.com|
20561858|NCT03963583|Johns Hopkins University School of Nursing|Martha Abshire Saylor|4433406201|mabshir1@jhu.edu|
20561859|NCT02203630|Vanderbilt University Medical Center|Raj Keriwala|615-322-3412||
20561860|NCT03946670|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20561861|NCT00717626|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
20516240|NCT01171690|Mayo Clinic|Marius Stan, MD|507-284-2463|stan.marius@mayo.edu|
20516241|NCT01038856|University of Oklahoma|Research Regulatory Specialist III|405-271-8777|sharon-ross@ouhsc.edu|48394
20516242|NCT00193037|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
20516243|NCT02300103|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20516244|NCT04091971|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jeffrey.miller@nyspi.columbia.edu|
20516245|NCT03340727|RTI International|Abhik Das|301-770-8214|adas@rti.org|
20516246|NCT00877032|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516247|NCT00669942|Novartis|Study Director|862-778-8300||
20516248|NCT03752528|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
20516249|NCT04056182|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frances.levin@nyspi.columbia.edu|
20516250|NCT00282048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516251|NCT02107092|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20516252|NCT02703948|Galderma R&D, LLC|US A&C Clinical Operations|8179615111|courtney.maguire@galderma.com|
20516253|NCT00259012|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20516254|NCT04005859|Atrium Health|Dr. Kevin Kasten|704-355-1813|kevin.kasten@atriumhealth.org|
20516255|NCT00581971|UAB Hospital|Dr. Sharon Spencer Professor of Radiation Oncology|205-934-2762|sspencer@uabmc.edu|
20516256|NCT01789905|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516257|NCT04213326|Exact Sciences|Adriann Kern|4843563027|akern@exactsciences.com|
20516258|NCT02549092|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20516259|NCT01954264|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516260|NCT03002077|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20516261|NCT03611608|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20516262|NCT03048500|Northwestern University|Young Chae, MD|312-695-1301|young.chae@northwestern.edu|
20516263|NCT02980978|Minneapolis Heart Institute Foundation|Population Health Program Manager|612-863-4222|gbenson@mhif.org|
20516264|NCT01941030|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
20516265|NCT00585689|University of Michigan Comprehensive Cancer Center|Dr. David Smith, M.D.|734-936-6884|dcsmith@umich.edu|
20516266|NCT04166032|Cleveland Clinic|Kimberly Jenkins, Research Administrator|216-445-4791|jenkink@ccf.org|
20516267|NCT01884740|Weill Cornell Medicine|Jeffery Greenfield, MD PhD|212-746-2363|jpgreenf@med.cornell.edu|
20516268|NCT02781727|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
20516269|NCT01378975|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20516270|NCT01023074|Portland VA Medical Center|Robert Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
20516271|NCT00694551|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-4398|mayer.fishman@moffitt.org|
20516272|NCT03154658|University of Texas Southwestern|Anthony Machi M.D.|2146486400|anthony.machi@utsouthwestern.edu|
20516273|NCT02424097|UCSF - School of Dentistry|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
20516274|NCT01215981|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
20516275|NCT02943447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20516276|NCT05017480|Suzhou Connect Biopharmaceuticals, Ltd|John Guo, Director of Clinical Operation|051253577866|jwguo@connectpharm.com|
20516277|NCT00963482|Divsion Substance Use Disorder, Psychiatric Hospital of the Univeristy of Basel|M. Sc. S. Müller (Site-investigator) Prof. G. A. Wiesbeck (PI)|+41 61 325 53 33|sandra.mueller@upkbs.ch|
20516278|NCT01794039|Mayo Clinic|Shaji K. Kumar, M.D.|(507) 284-2017|kumar.shaji@mayo.edu|
20516279|NCT01136382|AstraZeneca|Geoff Gilmartin||ClinicalTrialTransparency@astrazeneca.com|
20516280|NCT02562378|Medica Scientia Innovation Research (MEDSIR)|Scientific director|+34 93 221 41 35|trialsregister.medsir@medsir.org|
20516281|NCT04503603|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20561862|NCT02806869|University of Michigan|Dr. Duxin Sun|734-615-8740|duxins@med.umich.edu|
20561863|NCT04001517|EIP Pharma|Dr. John Alam|6176698426|johnjalam@gmail.com|
20561864|NCT00057837|ECOG Statistical Office|Study Statistician|617-632-3012||
20561865|NCT02425111|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20561866|NCT00585533|Huntsman Cancer Institute/University of Utah|Wallace Akerley, MD|801-585-5986|wallace.akerley@hci.utah.edu|
20561867|NCT02798835|Department of Anesthesia and Perioperative Care, Vancouver General Hospital, Vancouver, BC, Canada.|Dr. Steven Lee|6048754111|steven.lee2@vch.ca|61534
20561868|NCT03482011|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20561869|NCT00468052|UMDNJ|Anuradha Patel, MD|973 972-5254|patelan@umdnj.edu|
20561870|NCT02709655|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20561871|NCT03687892|Stanford University|Principal Investigator|650-736-2233|nbassano@stanford.edu|
20561872|NCT02459899|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20561873|NCT01118338|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20561874|NCT00833365|University of Utah|Dr. Gary Chan|801-587-7508|gary.chan@hsc.utah.edu|
20561875|NCT03165175|Naval Health Research Center|Suzanne Hurtado|619-553-7806|suzanne.l.hurtado.civ@mail.mil|
20561876|NCT06315907|Pennington Biomedical Research Center|Professor|+1 (225) 763-2585|corby.martin@pbrc.edu|
20561877|NCT00630786|Amgen Inc.|Study Director|866-572-6436||
20561878|NCT00147277|Medtronic Italia S.p.A.|Laura Manotta|003902241371|laura.manotta@medtronic.com|
20561879|NCT01585558|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20561880|NCT00762619|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
20561881|NCT01350804|Novartis|Study Director|862-778-8300||
20561882|NCT03516942|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20561883|NCT03215927|University of Pittsburgh|Rohit Aggarwal|4123838123|aggarwalr@upmc.edu|
20516282|NCT02653664|University of Washington|Dr. Mark Jensen|206-543-3185|mjensen@uw.edu|
20561884|NCT03779048|University of Pennsylvania|Dr. Jena Tronieri|2157465045|jena.tronieri@pennmedicine.upenn.edu|
20561885|NCT01134562|Amgen, Inc|Study Director|866-572-6436||
20561886|NCT00768664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561887|NCT02544152|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20561888|NCT00423098|Novartis Pharmaceuticals|Study Director|862-778-8300||
20561889|NCT02320123|UT Southwestern Medical Center|Dr. Ramona Rhodes|214-648-9012|ramona.rhodes@utsouthwestern.edu|
20561890|NCT04480827|Galmed Pharmaceuticals|Dr. Yossi Gilgun-Sherki|972.3.693.8448|yossigs@galmedpharma.com|
20561891|NCT00465816|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561892|NCT02207972|Mount Sinai West|Dr Barbara Orlando MD and PI|2125236915|barbara.orlando@mountsinai.org|
20561893|NCT01426269|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
20561894|NCT03675581|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561895|NCT00799396|University of Maryland School of Medicine|Alan R Shuldiner, MD|410-706-1623|ashuldin@medicine.umaryland.edu|
20561896|NCT01867216|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561897|NCT00773370|VA Medical Center, Baltimore Maryland|Mary Stuart, ScD, VA Research Investigator|410-455-2084|stuart@umbc.edu|
20561898|NCT01112670|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
20561899|NCT01765543|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20561900|NCT03454529|Karmanos Cancer Institute|Michael Simon,MD|313. 576-8727|simonm@karmanos.org|
20561901|NCT04956575|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20561902|NCT00114101|Roswell Park Cancer Institute|Philip McCarthy, MD||philip.mccarthy@roswellpark.org|
20561903|NCT00507689|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20561904|NCT00831415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20561905|NCT01188499|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|Jeffrey.Skolnik@tetralogicpharma.com|141
20561906|NCT00424762|University of Texas Southwestern Medical Center at Dallas|Dr. Darren K. McGuire|214 645 7520|darren.mcguire@utsouthwestern.edu|
20561907|NCT01145885|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561908|NCT05299606|ETHICON|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
20561909|NCT00723450|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561910|NCT00189202|University of Michigan|Dr. Akinlolu Ojo, Professor of Medicine|734 9364890|aojo@umich.edu|
20561911|NCT01135511|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516283|NCT02091882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20516284|NCT00556049|MGH Cancer Center|Dr. M. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
20516285|NCT00727571|Amgen Inc.|Study Director|866-572-6436||
20516286|NCT03247556|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
20516287|NCT00358449|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516288|NCT01804270|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
20516289|NCT02006160|UBMD Neurology|Dr. Ralph Benedict|7163230556|benedict@buffalo.edu|
20561912|NCT02880241|Medicines for Malaria Venture (MMV)|Dr Stephan Duparc, Chief Medical Officer|+41 22 555 0351|duparcs@mmv.org|
20561913|NCT02537522|Johnson & Johnson Vision Care Inc.|Andrea Le, OD -Manager Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
20561914|NCT00971789|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
20561915|NCT02570711|Acerta Pharma, LLC|Priti Patel, MD, Vice President - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20561916|NCT02248480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561917|NCT01595321|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|Laherda@jhmi.edu|
20561918|NCT04795752|Sight Sciences, Inc|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
20561919|NCT00792948|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|(206) 667-4623||
20561920|NCT06129045|Black Hills State University|Ashley Pfeiffer|6053815370|ashley.pfeiffer@bhsu.edu|
20561921|NCT00800605|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
20561922|NCT01582269|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20561923|NCT06218251|ABBVIE CALL CENTER|AbbVie|844-663-3742|abbvieclinicaltrials@abbvie.com|
20561924|NCT05076266|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20516290|NCT01469767|Wake Forest University Health Sciences|Steve Feldman MD|336-716=3775|sfeldman@wakehealth.edu|
20516291|NCT01541891|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medical Director|+52 (33)30014200|leopoldo.baiza@sophia.com.mx|
20516292|NCT02188303|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20516293|NCT02589808|Imperial College|Petros Nihoyannopoulos|020 3311 3311|p.nihoyannopoulos@imperial.ac.uk|
20516294|NCT04206332|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20516295|NCT02334722|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
20516296|NCT01644058|Université de Montréal|Elham Emami, DDS, MSc, PhD|514-343-6111|elham.emami@umontreal.ca|6053
20516297|NCT05612724|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|732 824 7241|subramga@sdm.rutgers.edu|
20516298|NCT03112863|UC Davis Dermatology|Iryna Rybak|916-551-2636|irybak@ucdavis.edu|
20516299|NCT01969747|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20516300|NCT04000815|Dr.Ali Cenk Ozay|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
20516301|NCT00239577|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516302|NCT02631772|Medical University of South Carolina|Dr. Derek Dubay|843-792-3368|dubay@musc.edu|
20516303|NCT02422264|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20516304|NCT03988803|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20516305|NCT00603187|University of Washington|Dr. John K. Amory|206.616.1727|jamory@u.washington.edu|
20516306|NCT03021018|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20516307|NCT00840099|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516308|NCT00856388|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20516309|NCT00150462|Amgen, Inc.|Study Director|866-572-6436||
20516310|NCT01212874|Loma Linda University Anesthesiology|Patricia Moore|1-909-558-4475|pamoore@llu.edu|
20516311|NCT00569374|University of Arkansas for Medical Sciences Center for Addiction Research|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
20516312|NCT01666730|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. David Bajor|1-800-641-2422|CTUReferral@UHhospitals.org|
20561925|NCT00997386|University of Arizona Cancer Center|Program Coordinator|52-626-0301|aselegue@email.arizona.edu|
20516313|NCT04638153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516314|NCT02829268|Washington University School of Medicine, Department of Medicine, Division of Endocrinology|Fumihiko Urano, MD, PhD|314-362-8683|urano@wustl.edu|
20516315|NCT03021538|Cleveland Clinic|Michael Tong, M. D.|216-445-0807|tongz@ccf.org|
20516316|NCT03553823|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20516317|NCT03603314|Sensorion|Director of Regulatory Affairs|+33467207720|contact@sensorion-pharma.com|
20516318|NCT01389102|KV Pharmaceutical Company|Jim Joffrion|314-645-6600|jjoffrion@kvph.com|3410
20516319|NCT03450070|Johnson & Johnson Consumer Inc.|Heather Smith|908-874-1235|HSmith21@its.jnj.com|
20516320|NCT00050778|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20516321|NCT02015390|Texas Medical Branch, University of, Galveston|Study PI|409-747-5760|zgugala@utmb.edu|
20516322|NCT01878825|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516323|NCT01361048|UAB|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
20516324|NCT01661686|Erasmus University Medical Center|Dr. V.M.C.W. Spaander|0031 10 703 5643|v.spaander@erasmusmc.nl|
20516325|NCT04753710|Sintetica SA|Roberta Bianchi|0041 91 640 42 50|rbianchi@sintetica.com|
20516326|NCT04869787|Cincinnati Children's Hospital Medical Center|Dr. Stuart L.Goldstein|513-636-4837|stuart.goldstein@cchmc.org|
20516327|NCT00813293|Beth Israel Deasoness Medical Center|Andrea Bullock MD, MPH||abullock@bidmc.harvard.edu|
20516328|NCT00533273|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20516329|NCT02794974|HELIOS Medical Center Schwerin, Germany|Ronald Seidel|+49 385 5204251|ronald.seidel@helios-kliniken.de|
20561926|NCT02582593|University of Florida|Dawn Bowers, Ph.D.|(352) 273-6617|dawnbowers@phhp.ufl.edu|
20516330|NCT05194722|Washington University School of Medicine|Abby Cheng, MD, PI|314-747-2823|chengal@wustl.edu|
20516331|NCT01873586|SeaSpine|Director Clinical Affairs||tish.mikoczi@seaspine.com|
20516332|NCT00454909|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516333|NCT00870870|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20516334|NCT00487669|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
20561927|NCT03785782|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20516335|NCT03005522|Banner University Medical Center|Dr Noah Tolby|520-694-8888|ntolby@aemrc.arizona.edu|
20516336|NCT01918800|Portland VA Medical Center|Cinda Hugos|503-220-8262|hugosc@ohsu.edu|52338
20561928|NCT00818454|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20561929|NCT03573518|Botanix Pharmaceuticals|Head of Development|+1 445 300 3403|trials@botanixpharma.com|
20561930|NCT01307267|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561931|NCT01924975|University of Iowa Hopspital & Clinics|Satoshi Hanada/Clinical Assistant Professor|3193561219|satoshi-hanada@uiowa.edu|
20516337|NCT03639311|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20561932|NCT04483856|Relife Srl|Clinical Trials Coordinator|05556809528|lfabbri@relifecompany.it|
20516338|NCT00822926|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
20516339|NCT04881968|The Dartmouth Institute|Dr. Amber Barnato|603-646-5237|amber.barnato@dartmouth.edu|
20516340|NCT03125200|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20516341|NCT01312922|ANeuroTech|Dr. E. Buntinx, MD|+32 (0) 473 861 079|erik.buntinx@aneurotech.com|
20516342|NCT00515203|Amgen Inc.|Study Director|866-572-6436||
20516343|NCT01937390|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20516344|NCT01874951|Depression Clinical and Research Program, Massachusetts General Hospital|David Mischoulon, MD, PhD, Director of Research|617-724-5198|dmischoulon@partners.org|
20516345|NCT03544138|Preceptis Medical|Steve Anderson|612-327-4795|steve@preceptismedical.com|
20516346|NCT04190693|Imcyse SA|Jean Van Rampelbergh|+3243251100|j.vanrampelbergh@imcyse.com|
20516347|NCT04657770|UCLA|Steve Cramer|424-522-7273|SCCramer@mednet.ucla.edu|
20516348|NCT00746798|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20516349|NCT00878878|GE Healthcare|Ruben Sheng, M.D.|1-609-514-6899|Rubin.Sheng@ge.com|
20516350|NCT00633594|Sarah Cannon Research Institute|Ian Flinn, MD|1-877-691-7274|asksarah@scresearch.net|
20516351|NCT02028715|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
20516352|NCT01287013|National Institutes of Health|Bradford Wood, MD|(301) 496-7739|bwood@nih.gov|
20516353|NCT01471093|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20516354|NCT03334825|New York City Department of Health and Mental Hygiene|Dr. Ellen Wiewel|347-396-7653|ewiewel@health.nyc.gov|
20516355|NCT01710657|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20516356|NCT00978822|Albany Medical Center|Panayiotis Varelas|2488739855|varelap@amc.edu|
20516357|NCT04407806|William Beaumont Hospital|Dr. Graham Krasan, Pediatric Infectious Disease Specialist|248-551-0046|graham.krasan@beaumont.org|
20516358|NCT02058498|Mayo Clinic Jacksonville|Jennifer Serotta, DNP, ARNP|904-956-3200|serotta.jennifer@mayo.edu|
20516359|NCT05327491|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20516360|NCT02163837|Chu St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@stpierre-bru.be|
20516361|NCT02379247|University of Kansas Medical Center|Dr. Priyanka Sharma|9135886079|psharma2@kumc.edu|
20516362|NCT01035060|University of Florida|Dr. Thomas Buford|352-273-5918|tbuford@ufl.edu|
20516363|NCT02770625|ISU ABXIS Co., Ltd.|Taekseung Kim|+82.31.696.4715|kimts@isu.co.kr|
20561933|NCT01786564|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
20561934|NCT00494442|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20561935|NCT01241292|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20561936|NCT03034915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20561937|NCT02138006|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
20561938|NCT03861767|UPMC|Matthew D. Neal, MD FACS|412-647-1158|nealm2@upmc.edu|
20561939|NCT03184558|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|trialsites@bergenbio.com|
20561940|NCT01254019|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516364|NCT01382719|Palatin Technologies, Inc.|Jeffrey Edelson, MD, FRCPC|(609) 495-2200|jedelson@palatin.com|
20516365|NCT01346397|Boris Petrovsky research cener od surgery|Dr Michael Kaabak|+74992481344|kaabak@hotmail.com|
20516366|NCT00064753|University of North Carolina at Chapel Hill|Dr. Myra Carpenter|9199429408|myra_carpenter@unc.edu|
20516367|NCT02193880|University of Alabama at Birmingham|Tiffany D Hill|205-996-8023|tiffanydhill@uabmc.edu|
20516368|NCT02202850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20516369|NCT00615069|W.L. Gore and Associates|Jennifer Gorman|928 864 3381|jgorman@wlgore.com|
20516370|NCT02996682|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20516371|NCT01981720|Protalix Ltd.|Sari Alon MSc|+972-4-9028100|sari@protalix.com|215
20516372|NCT03522675|NeXtGen Biologics, Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
20516373|NCT00707161|Huntsman Cancer Institute|Dennis Shrieve, MD|801-581-8793|dennis.shrieve@hci.utah.edu|
20516374|NCT02674477|Johns Hopkins University|Dr. Alexis Hammond|410-550-0045|ahammon9@jhmi.edu|
20516375|NCT02511782|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
20516376|NCT00834756|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516377|NCT01173692|UT MD Anderson Cancer Center|Brandon Gunn, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2562|gbgunn@mdanderson.org|
20516378|NCT01472341|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20516379|NCT00579670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561941|NCT03061474|University of California, Irvine|Dr. Joshua Grill|(949) 824-5905|jgrill@uci.edu|
20561942|NCT01391130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20561943|NCT04303156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20561944|NCT05001945|Mineralys Therapeutics|David Rodman, MD Chief Medical Officer|1-888-378-6240|drodman@mineralystx.com|
20561945|NCT00545077|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20561946|NCT01179334|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20561947|NCT04177394|Abbott|Melody Dong|4086434617|melody.dong@abbott.com|
20561948|NCT00843882|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20561949|NCT00256243|Chao Family Comprehensive Cancer Center|Dr. Rita Mehta|(714) 456-5153|rsmehta@uci.edu|
20561950|NCT05797155|Oregon Research Behavioral Intervention Strategies Inc.|Dr. Dana Smith|541-484-2123|danas@ori.org|
20561951|NCT00026312|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20561952|NCT02445391|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
20561953|NCT02322840|Medtronic|Yetunde Ishola (Clinical Study Manager)|734-221-8182|yetunde.a.ishola@medtronic.com|
20561954|NCT05672030|Brigham and Women's Hospital, Allergy and Clinical Immunology|Tanya M. Laidlaw, MD, Associate Professor of Medicine|6177329850|tlaidlaw@partners.org|
20561955|NCT05793112|Massachusetts General Hospital|Dr. Qian Yuan|6172435466|QYUAN@mgh.harvard.edu|
20561956|NCT02098343|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20561957|NCT05515562|Wake Forest University Health Sciences|John Williamson, PharmD|336.713.3431|johnwill@wakehealth.edu|
20561958|NCT05314634|National Taiwan Normal University|Ruei-Hong Li|+886988163220|rueihongli@gmail.com|
20561959|NCT03889925|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
20561960|NCT03762668|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20516380|NCT04365153|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
20516381|NCT00296647|UW-Center for Tobacco Research and Intervention|Stevens Smith, PhD|608-262-7563|sss@ctri.medicine.wisc.edu|
20516382|NCT00986245|Seoul National University Hospital|BS Jeon|82-2-2072-2876|brain@snu.ac.kr|
20516383|NCT01157091|City of Hope|Dr. Sumanta Pal|626-359-8111|SPal@coh.org|
20516384|NCT05093205|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516385|NCT02567968|University of Chicago|Aaron Fox, PhD|7737020021|aaronfox@uchicago.edu|
20516386|NCT00360360|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-MY-1-SCRI|asksarah@scresearch.net|
20516387|NCT02597101|Allegheny Health Network|Dr. Nick Giannoukakis|412-359-6394|nick.giannoukakis@ahn.org|
20516388|NCT03693430|Novo Nordisk A/S|Clinical Reporting Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20516389|NCT00985257|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20516390|NCT02930005|The University of Texas Health Science Center at Houston|Dr. Olaoluwa O. Okusaga|(713) 741-3952|Olaoluwa.O.Okusaga@uth.tmc.edu|
20516391|NCT02373098|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email.@novartis.com|
20516392|NCT02265783|Medtronic|Michael Luna-Victoria|3033052463|michael.luna-victoria@medtronic.com|
20516393|NCT01658228|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
20516394|NCT03252353|Chiasma|Asi Haviv, VP Clinical development|972-8-939-3888|Asi@chiasmapharma.com|
20516395|NCT05067647|Ethicon Endo-Surgery, Inc.|MEDICAL DIRECTOR LCM Compliance|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20529082|NCT00028262|National Institute of Child Health and Human Development|Dr. Anil Mukherjee|+1 301 496 7213|mukherja@exchange.nih.gov|
20529083|NCT00130689|Dana-Farber Cancer Institute|Jennifer Ang Chan, MD, MPH|617-632-6315|jennifer_chan@dfci.harvard.edu|
20529084|NCT00268983|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529085|NCT01348139|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20529086|NCT01015326|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
20529087|NCT02762084|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|Info@Pellepharm.com|
20529088|NCT02254772|Stanford Univeristy Medical Center|Ronald Levy, MD, Professor of Medicine|650-725-6452|levy@stanford.edu|
20529089|NCT00716456|Memorial Sloan Kettering Cancer Center|Dr. Gregory J. Riely|646-888-4199|rielyg@mskcc.org|
20529090|NCT00447772|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
20529091|NCT04556760|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
20529092|NCT05926648|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20529093|NCT01805895|Augusta University|Dr Jeffrey Switzer|7067211691|jswitzer@augusta.edu|
20529094|NCT02849743|The Children's Hospital of Philadelphia|Dr. Shana McCormack|(215) 590-3174|mccormacks1@chop.edu|
20529095|NCT03677635|King's College London|Dr Clementine Edwards|07557866053|clementine.edwards@kcl.ac.uk|
20529096|NCT03064113|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20529097|NCT02050334|Chemigen|Consultant|317 293-0852|farlowds@yahoo.com|
20529098|NCT03874013|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20529099|NCT00121719|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20529100|NCT01129245|Oregon Health and Science University|Alison Edelman|503-494-5949|edelmana@ohsu.edu|
20529101|NCT01472445|Stanford University|Melinda Telli, Associate Professor of Medicine (Oncology)|650-724-9533|mtelli@stanford.edu|
20529102|NCT01026948|University of Liverpool|Professor Zarko Alfirevic|00 44(1)51 702|zarko@liverpool.ac.uk|4100
20529103|NCT01705977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20529104|NCT01951118|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
20561961|NCT01402531|UCSD|Department of Surgery|(858) 657-5291||
20561962|NCT06258785|Endeavor Health|Dr. Claudia Paya Ten|847-570-4729|claudia.payaten@endeavorhealth.org|
20561963|NCT05764161|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20561964|NCT02613871|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20561965|NCT00604019|RUSH University Medical Center|Gourang Patel, PharmD|312-942-4258|gourang_p_patel@rush.edu|
20516396|NCT01709474|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20516397|NCT01874756|Indiana University|Dr. Alan Breier|3178808495|abreier@iupui.edu|
20516398|NCT00855738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516399|NCT03151057|Northwell Health Cancer Institute|Dr. Douglas Gladstone|(516) 734-8900|msteve35@jhmi.edu|
20516400|NCT00323193|VA VISN 5 Mental Illness Research, Education and Clinical Center|Richard W. Goldberg, Ph.D.|410-637-1851|richard.goldberg@va.gov|
20516401|NCT03929393|University of Minnesota|Brent Leininger|(612) 626-6477|lein0122@umn.edu|
20516402|NCT01320696|Resilience Inc.|Wael El-Amin, M.D.|(240)885-1221|Wael.el-amin@resilience.com|
20516403|NCT01314742|Vanderbilt University Sch of Medicine|Dr. Beatrice Stefanescu|6159365933|beatrice.stefanescu@Vanderbilt.edu|
20516404|NCT02268500|University of Minnesota|Orly Vardeny, Associate Professor of Medicine|612.467.4586|ovardeny@umn.edu|
20516405|NCT00119379|University Hospitals Case Medical Center|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
20516406|NCT03929367|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
20516407|NCT01706536|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20516408|NCT03262012|AstraZeneca|Paul M. Dorinsky, MD|1-877-240-9479|information.center@astrazeneca.com|
20516409|NCT00154102|Merck Serono|Monika Foerster/Clinical Trial Leader|+496151729517|monika.foerster@merck.de|
20516410|NCT03325114|University of Rochester|Carrie Dykes|15852750736|carrie_dykes@urmc.rochester.edu|
20516411|NCT01721681|Bio Products Laboratory Ltd|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
20516412|NCT02055963|UT MD Anderson Cancer Center|Dr. Juan P. Cata, MD-Associate Professor, Anesthesiology & PeriOper Med|(713) 792-7452|jcata@mdanderson.org|
20516413|NCT04915755|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20516414|NCT03655106|William Beaumont Hospitals|Amit Bahl, MD|2488982245|amit.bahl@beaumont.edu|
20516415|NCT01191320|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
20529105|NCT02989402|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20529106|NCT02288819|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge|0473924199|frederik.verbrugge@zol.be|+32
20516416|NCT02962934|University of Queensland Center for Clinical Research|Professor Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
20516417|NCT05087524|University of Wisconsin - Madison|Dr. Ellen Wald|(608) 263-8558|erwald@pediatrics.wisc.edu|
20561966|NCT01831791|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561967|NCT00494780|GlaxoSmithKline|GSK Response Center|866-435-7343||
20561968|NCT01190007|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516418|NCT00546897|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20516419|NCT01297348|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20516420|NCT02495857|Teva Pharmaceuticals Inc. USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
20516421|NCT01367457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|001
20516422|NCT03447262|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20516423|NCT01032083|Imperial College London|Professor Thomas Barnes||t.r.barnes@imperial.ac.uk|
20516424|NCT01173211|Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
20516425|NCT05038293|University of Washington Department of Periodontics|Dr. Diane Daubert|206-685-3766|ddaubert@uw.edu|
20516426|NCT01838941|McGill University Health Centre|Dr. Nancy Braverman, Associate Professor, Human Genetics and Pediatrics|(514) 934-1934|nancy.braverman@mcgill.ca|23404
20516427|NCT02822235|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20516428|NCT02910037|The University of California, San Francisco|Dr. Charles Chiu|(415) 514-8219|charles.chiu@ucsf.edu|
20516429|NCT00999037|University of California at Los Angeles|Katherine Wesseling-Perry|310-206-6987|kwesseling@mednet.ucla.edu|
20516430|NCT00436553|Novartis Pharmaceuticals|Study Director|862 778-8300||
20516431|NCT02457520|SPIL|Clinical Trials|912266455645|Clinical.Trials@sparcmail.com|
20516432|NCT01772537|The Johns Hopkins University|Dr. Charles Brown|410-955-0994|cbrown@jhmi.edu|
20516433|NCT00450190|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20516434|NCT01536574|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516435|NCT01376167|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516436|NCT00656305|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
20516437|NCT02193165|Colgate Palmolive|William Devizio|732-878-7901|william_devizio@colpal.com|
20516438|NCT04239872|University of Michigan School of Dentistry|Dr. Livia Tenuta|734-763-3703|litenuta@umich.edu|
20516439|NCT03541941|Cleveland Clinic Foundation|Dr. Michael Rosen|216-445-3441|rosenm@ccf.org|
20516440|NCT00112463|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
20516441|NCT01214850|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20516442|NCT00565448|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20516443|NCT01863745|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20516444|NCT00193609|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20516445|NCT00735904|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516446|NCT03865654|Dana-Farber Cancer Institute|Rachel Freedman, M.D., M.P.H.|617-632-3800|rafreedman@partners.org|
20516447|NCT02543554|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wustl.edu|
20516448|NCT00610363|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20516449|NCT03204539|UC Davis|Dr. Jonathan Ducore|916-734-3461|jmducore@ucdavis.edu|
20516450|NCT01171963|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516451|NCT03221374|Carnegie Mellon University|Dr. Bin He|412-268-9857|bhe1@andrew.cmu.edu|
20516452|NCT00818337|Creighton University|Kathleen Packard, PharmD|402-280-2668|kpackard@creighton.edu|
20516453|NCT02519491|University of Ottawa Heart Institute|Dr. Benjamin Hibbert, Cardiologist|613-696-7000|bhibbert@ottawaheart.ca|
20516454|NCT03361228|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20516455|NCT00302952|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20516456|NCT03660839|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20516457|NCT00401778|Emory University|Suresh S. Ramalingam, MD|404-778-5378|ssramal@emory.edu|
20516458|NCT02979353|Vanderbilt University Medical Center|Sandra F Simmons, PhD, Principle Investigator|615-343-6729|sandra.simmons@vumc.org|
20516459|NCT00720330|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20516460|NCT01722877|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633200263|shammas@mchsi.com|
20516461|NCT03897088|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
20516462|NCT03097783|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20516463|NCT00699491|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@im.wustl.edu|
20516464|NCT04320849|Duke University Medical Center|Dr. Jonathan Piccini|919-668-8049|jonathan.piccini@duke.edu|
20516465|NCT02287675|Kettering Health Network|Dr. Arash Kardan|937-395-8611|arash.kardan@ketteringhealth.org|
20516466|NCT00319735|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20516467|NCT02227121|Medtronic Cardiac Rhythm and Heart Failure|Griet Wouters|800-328-2518|MedtronicCRMtrials@medtronic.com|
20516468|NCT03486990|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20516469|NCT01569152|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
20516470|NCT03187002|Stanford University|Research Manager|6507211567|fpresearch@stanford.edu|
20516471|NCT01469546|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
20516472|NCT01096290|University of South Alabama|Jack DiPalma, MD|251-660-5555|jdipalma@health.southalabama.edu|
20529107|NCT02039778|Mount Sinai Beth Israel|Dr. Rahul Parikh|732-253-3939|parikhrr@cinj.rutgers.edu|
20516473|NCT00385684|Tuscaloosa VA Medical Center|Andrea L. Snow|205-554-2000|lynn.snow@va.gov|2260
20561969|NCT04589689|Stanford University|Jessie Wong, PhD|6507361517|wongjj@stanford.edu|
20561970|NCT03109795|University of Iowa|Professor|319-335-9487|gary-pierce@uiowa.edu|
20561971|NCT00845832|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20561972|NCT01665092|Univeristy of Mississippi Medical Center|Alan Jones|601-384-5586|aejones@umc.edu|
20561973|NCT03260140|VA Puget Sound Health Care Sysem|Margaret P. Collins|206.764.2085|margaret.collins@va.gov|
20561974|NCT00463788|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20561975|NCT00360698|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
20561976|NCT01755949|Mayo Clinic|Joseph L. Blackshear, Principal Investigator|904-953-7279|blackshear.joseph@mayo.edu|
20561977|NCT00831675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20561978|NCT04598321|Brown University Oncology Research Group (BrUOG)|Assistant Director|401-863-3000|BrUOG@brown.edu|
20561979|NCT01692938|Stanley M. Truhlsen Eye Institute|Quan Nguyen, MD Director of the Stanley M. Truhlsen Eye Institute|402-559-4276|quan.nguyen@unmc.edu|
20561980|NCT02423291|"Institute of Hematology L. e A. Seràgnoli, AOU Policlinico S.Orsola-Malpighi Via Massarenti, 9 - 40138 Bologna Italy"|MD Vittorio Stefoni|+39 0512143680|vittorio.stefoni2@unibo.it|
20561981|NCT01647438|Northwestern University|Dr. Namratha Kandula, Principal Investigator|312-503-6470|nkandula@nm.org|
20561982|NCT05283395|Alcon Research, LLC|Scientific Advisor, Clinical R&D|1-888-451-3937|alcon.medinfo@alcon.com|
20561983|NCT01063972|University of Kansas Medical Center|Sharon Fitzgerald, MPH|913-588-3488|sfitzgerald@kumc.edu|
20561984|NCT00634621|GE Healthcare|Emilio Moreno Carretero, M.D.|011-34-9166-30970|Emilio.Morenocarretero@ge.com|
20561985|NCT00712335|Inje University|Dr. Chang-Keun Kim|82-2-950-8832|kimck@paik.ac.kr|
20561986|NCT03401112|Imara Inc.|Imara Clinical Operations|617-206-2020|info@imaratx.com|
20561987|NCT01264679|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20561988|NCT03475316|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
20561989|NCT00424645|UT MD Anderson Cancer Center|Saroj Vadhan, MD||CR_Study_Registration@mdanderson.org|
20561990|NCT01595061|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
20561991|NCT03189589|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20561992|NCT03194958|Washington University in St. Louis|Matthew Kreuter|314-935-3701|mkreuter@wustl.edu|
20561993|NCT00317226|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
20561994|NCT00959946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20561995|NCT00356265|University of Michigan|Crystal Gadegbeku||crystal.Gadebeku@tuhs.temple.edu|
20561996|NCT02971488|Hospital Universitario Infanta Leonor|Pablo Ryan|0034616832148|pablo.ryan@salud.madrid.org|
20561997|NCT02348658|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20561998|NCT01152190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20561999|NCT00258895|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20562000|NCT01335542|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
20562001|NCT00547118|Maryland Psychiatric Research Center|Dr. Robert W. Buchanan|410-402-7876|rwbuchanan@mprc.umaryland.edu|
20562002|NCT00834834|NYSPI|Barbara Stanley, Ph.D.|6467747582|stanley@nyspi.columbia.edu|
20562003|NCT00373529|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20562004|NCT00748410|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562005|NCT04970342|National Advanced Driving Simulator, University of Iowa|Timothy Brown, Ph.D.|3193354785|timothy-l-brown@uiowa.edu|
20562006|NCT01625013|University of California, San Francisco|Anthony Luke, MD|4155146120|Anthony.Luke@ucsf.edu|
20562007|NCT02601170|Tri-service general hospital|Dr. Tsung-Ying Li|886-2-87927166|doc31141@gmail.com|
20562008|NCT02763124|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
20562009|NCT00385801|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
20562010|NCT02247063|University of Michigan|Thiago Nascimento|734-615-9390|Nasci@umich.edu|
20562011|NCT01190566|Seoul National University Hospital|Woo Kyung Moon|82-2-2072-2584|moonwk@snu.ac.kr|
20562012|NCT01123928|Zhongshan Ophthalmic Center|Dr. Nathan Congdon|13925056342|ncongdon1@gmail.com|
20562013|NCT04178941|Children's Hospital of Philadelphia|Chris Bonafide, MD, MSCE|267-426-2901|bonafide@chop.edu|
20562014|NCT01810263|Seoul National University Bundang Hospital|Nam-Jong Paik|82-031-787-7731|njpaik@snu.ac.kr|
20562015|NCT01390402|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
20562016|NCT03995069|Ralph H. Johnson VA Health Care System|Principal Investigator|8434671373|NaJin.Seo@va.gov|
20562017|NCT03602911|West Virginia University|Rusha Patel, MD|4052717559|Rusha-Patel@ouhsc.edu|
20562018|NCT01170026|Department of Psychiatry and Human Behavior, The Alpert Medical School of Brown University|Dr. Anthony Spirito|401-369-2435|anthony_spirito@brown.edu|
20516474|NCT02801877|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
20516475|NCT00463606|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20562019|NCT05777785|VIZO Specs|Yael Richter, PhD|972-54-7384809|yaelr@vizo-o.com|
20562020|NCT02188420|University of Minnesota|Kate Frost|612-626-0637||
20562021|NCT05644444|Reckitt Benckiser Health Limited|Clinical Study Manager|+44 (0)1482 326151|ClinicalRequests@reckitt.com|
20562022|NCT04817670|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
20562023|NCT03215095|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
20562024|NCT00304031|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20516476|NCT02228174|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
20516477|NCT01223365|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20562025|NCT04951310|University of Pennsylvania|Dr. Katherine Milkman|215-573-9646|bcfg@wharton.upenn.edu|
20562026|NCT01188655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562027|NCT00493649|US Oncology Research, McKesson Specialty Health|Dr. Stephen E Jones|832-381-7580|steve.jones@usoncology.com|
20562028|NCT02639286|NIDDK|Dr. Rebecca Brown|301-594-0609|rebecca.brown@nih.gov|
20562029|NCT00925899|Bispebjerg Hospital|Lise Pedersen|004535312305|lise.pedersen.01@regionh.dk|
20562030|NCT00683696|Biotronik, Inc.|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
20562031|NCT00089544|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20562032|NCT00227994|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
20562033|NCT02396316|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20516478|NCT02682602|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
20516479|NCT02140060|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20529108|NCT01715233|Baylor University Medical Center Dallas Texas|Ronan J. Kelly MD MBA|214-820-2828|Ronan.Kelly@bswhealth.org|
20529109|NCT03505372|Beth Israel Deaconess Medical Center|Dr Jordana Phillips|617 667 1630|jphilli2@bidmc.harvard.edu|
20529110|NCT03065647|University of Michigan|Robert Neumar|734-936-0253|neumar@umich.edu|
20529111|NCT01678664|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20529112|NCT00826150|BioCancell Ltd.|VP Clinical|+97225486553|monique.ben-am@biocancell.com|
20529113|NCT02981914|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|karrisont@nrgoncology.org|
20529114|NCT01852513|The University of Chicago|Dr. Jayant Pinto, PI|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
20529115|NCT03801642|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu|
20529116|NCT01462110|Johnson & Johnson Consumer Inc.|Michael Lynch|908-433-6423|mlynch23@ITS.JNJ.com|
20529117|NCT00753675|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20529118|NCT04457362|NYU Langone Health|Nader Paksima|2122632193|Nader.Paksima@nyulangone.org|
20529119|NCT05279131|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20529120|NCT00594230|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
20529121|NCT00333710|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4707|amy.silberbogen@va.gov|
20529122|NCT00401518|Globus Medical|Director of Clinical Affairs|610-930-1800|jmyer@globusmedical.com|
20529123|NCT01877161|Seoul National University Bundang Hospital|Nam-Jong Paik|031-787-7731|njpaik@snu.ac.kr|7731
20529124|NCT00672633|Boston Children's Hospital|Dr. Stavroula Osganian, Principal Investigator|8572184728|stavroula.osganian@childrens.harvard.edu|
20529125|NCT00929344|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
20529126|NCT01545141|Roswell Park Cancer Institute|Kris Attwood|716-845-2300|Kristopher.attwood@roswellpark.org|
20529127|NCT01575756|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
20529128|NCT02317991|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20529129|NCT02019550|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20529130|NCT01289548|Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology|Hua zheng|00862783663173|huaz1980@hotmail.com|
20529131|NCT02359110|Penn State Milton S. Hershey Medical Center|Timothy Deimling, M.D.|717-531-3503|tdeimling@pennstatehealth.psu.edu|
20529132|NCT04754646|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
20529133|NCT04771013|GIMUNICAH|Héctor M. Ramos-Zaldívar|+56934988958|hramos@unicah.edu|
20529134|NCT00823134|ResMed Germany Inc|Oliver Munt|0899901|oliver.munt@resmed.de|00
20529135|NCT03045653|Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative innovation center for Cancer Medicine|Zhongyu Yuan|+8613798027658|yuanzhy@sysucc.org.cn|
20529136|NCT00193414|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20529137|NCT00379834|West Virginia University|Dr. Tony Realini|3045986926|realinia@wvuhealthcare.com|
20529138|NCT01519817|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
20529139|NCT02922153|AtriCure|Nfii Ndikitum|513-644-8192|nndikintum@atricure.com|
20529140|NCT00956839|Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow|Professor Eesh Bhatia|00915222494382|ebhatia@sgpgi.ac.in|
20529141|NCT03979066|Columbia University|Gulam Manji, MD, PhD|212-305-0592|gam2140@columbia.edu|
20529142|NCT00994110|Memorial Sloan Kettering Cancer Center|Dr. Peter Allen|212-639-5132|allenp@mskcc.org|
20529143|NCT01111565|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20529144|NCT02683239|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20529145|NCT03846544|Brussels IVF|Dr Liese Boudry|024779857|liese.boudry@uzbrussel.be|
20529146|NCT04131712|University of Kentucky|Douglas Long|859-323-5438|delong2@uky.edu|
20529147|NCT00815997|NPO International TRI Network|Sigeru Saito, MD, Principal Investigator|+81-467-461717|saito@shonankamakura.or.jp|10490
20529148|NCT04613739|Harvard Pilgrim Health Care Institute|Dr. Alison Galbraith|617-867-4893|alison_galbraith@harvardpilgrim.org|
20529149|NCT00766597|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20529150|NCT00943397|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20529151|NCT01254656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562034|NCT01823536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20529152|NCT01178125|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20562035|NCT05636332|Philips|Tiffani Bowers|724-989-3072|tiffani.bowers@philips.com|
20562036|NCT03648762|VA Pittsburgh Healthcare System|Daniel E. Forman, MD|(412) 360-2917|Daniel.Forman@va.gov|
20562037|NCT02135679|University of Pennsylvania|Ching Lai|267-250-9244|ching.lai@pennmedicine.upenn.edu|
20562038|NCT04112069|Mass. General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
20562039|NCT01662336|AbbVie (prior Sponsor Abbott)|Global Medical Services|800-633-9110||
20562040|NCT02189252|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
20562041|NCT00566735|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
20562042|NCT04603924|Robert Homolka|Sr. Vice President Clinical Operations|8572991035|bob.homolka@neurobopharma.com|
20562043|NCT01175317|Maastricht University Medical Center|Kostan Reisinger|0031433881494|k.reisinger@maastrichtuniversity.nl|
20562044|NCT02164240|DFCI|Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
20562045|NCT00686855|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
20562046|NCT01731041|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
20562047|NCT02731755|University of Reading|Prof Jeremy Spencer|+44(0) 1183788724|j.p.e.spencer@reading.ac.uk|
20562048|NCT01460446|Hoffmann-La Roche|Medical Communications|800 821-8590||
20562049|NCT02139046|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20516480|NCT06358820|Gaozhou People's Hospital|Shanshan Deng|13927596600|276531255@qq.com|
20562050|NCT00779870|Imperial College London|Prof Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20562051|NCT01582100|Northwestern University|Christine Ebert Nelson|3126954513|c-ebert@northwestern.edu|
20562052|NCT01040689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20562053|NCT05876949|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
20562054|NCT02334436|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
20562055|NCT03145480|Northwell Health|Jacqueline Barrientos, MD|516-470-4050|jbarrientos@northwell.edu|
20562056|NCT03593213|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20562057|NCT00668863|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562058|NCT04153435|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
20562059|NCT00869323|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
20562060|NCT01068743|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20562061|NCT00638963|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20516481|NCT04408586|Mayo Clinic|Andres J. Acosta, M.D., Ph.D.|507-266-6931|Acosta.Andres@mayo.edu|
20516482|NCT01811953|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20516483|NCT02110277|UConn Health|Dr.Molly Brewer|860-679-2100||
20516484|NCT00070291|ECOG Statistical Office|Study Statistician|617-632-3012||
20516485|NCT00520130|National Cancer Institute|Dr. Steven Z. Pavletic|301- 402-4899|sp326h@nih.gov|
20516486|NCT02533258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516487|NCT03497897|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@novartis.com|
20516488|NCT00723528|Janssen Research & Development, LLC|Senior Director, Clinical Development|793-7633||215
20516489|NCT02627924|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20516490|NCT01993030|The Second Xiangya Hospital of Central South University|Dr. Li Qian|+86-13958104032|649418291@qq.com|
20516491|NCT03921294|Indiana Hemophilia & Thrombosis Center|Kat Molitor|3178710011|kmolitor@ihtc.org|
20516492|NCT01033565|University of Nebraska|Howard Needelman MD|402-559-4097|hneedelm@unmc.edu|
20516493|NCT01591785|Icahn School of Medicine at Mount Sinai|Gary Goldenberg, MD|212-241-6500|garygoldenbergmd@gmail.com|
20516494|NCT00667862|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20516495|NCT01049334|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
20562062|NCT00846066|Childrens Mercy Hospital|Nasreen Talib MD, MPH.|816-234-3242|ntalib@cmh.edu|
20516496|NCT03979079|Institut Bergonié|Dr Carine Bellera|33 0 5 56 33 04 95|c.bellera@bordeaux.unicancer.fr|
20516497|NCT01819597|Cedars-Sinai Medical Center|Nestor Gonzalez, MD. Professor of Neurosurgery|310 423 0783|nestor.gonzalez@cshs.org|
20516498|NCT00987948|Hawaii Center for AIDS, University of Hawaii|Dr. Cecilia M Shikuma|8086921328|shikuma@hawaii.edu|
20516499|NCT04123548|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20516500|NCT01171989|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516501|NCT02339558|Prince of Wales Hospital|Brigette B.Y. Ma|(852) 26321042|brigette@clo.cuhk.edu.hk|
20516502|NCT00645762|Entellus Medical|Entellus Medical|763-463-1599||
20516503|NCT01247701|Baylor College of Medicine/Texas Children's Hospital|Caridad A. Martinez|832-824-4692|camartin@texaschildrens.org|4670
20516504|NCT04166630|Emory University|Randi Smith|404-251-8914|randi.smith@emory.edu|
20516505|NCT01034358|Mayo Clinic|Jeanne Tung, MD|507-266-0114|tung.jeanne@mayo.edu|
20529153|NCT02948829|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20562063|NCT00588809|The University of Chicago Medicine|Olatoyosi Odenike, MD|(773) 702-6149|todenike@medicine.bsd.uchicago.edu|
20562064|NCT01667796|Johns Hopkins|Ellen Mowry|4106141522|vitamindtrialms@jhmi.edu|
20562065|NCT01836133|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20562066|NCT02755116|Icahn School of Medicine at Mount Sinai|Dr. Jaime B. Hyman|212-241-7473|Jaime.hyman@mountsinai.org|
20516506|NCT02968992|Johns Hopkins University|Jeremy D. Waltson, MD|410-550-1003|jwalston@jhmi.edu|
20516507|NCT01534663|University Hospital Jena|Christian Schulze, MD, PhD|03641-9 32 41 04|christian.schulze@med.uni-jena.de|
20516508|NCT00627016|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20562067|NCT02200770|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20562068|NCT04925765|University of Pittsburgh Medical Center|Dr. Katherine Grace Lim|4126411777|limkg2@upmc.edu|
20562069|NCT01124734|Penn State Cancer Institute|Joseph Drabick, MD|717 531 5059|jdrabick@pennstatehealth.psu.edu|
20562070|NCT01214824|Abbott Diabetes Care|Director Global Clinical and EMEA Regulatory Affairs|01993863164|joe.bugler@abbott.com|
20562071|NCT01510717|Alcon Research, Ltd.|Magda Michna, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20562072|NCT02476409|University of North Carolina at Chapel Hill|Amanda Lee|919-843-9936|akg72@med.unc.edu|
20562073|NCT02555215|Biogen|Medical Director, Overall Study Officials|866-633-4636|clinicaltrials@biogen.com|
20562074|NCT00529789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20562075|NCT01202955|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
20562076|NCT03293498|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20562077|NCT01278394|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
20562078|NCT00818805|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20562079|NCT02115139|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
20562080|NCT00468910|Northwestern University|Dr. Seema Khan|312-503- 4236|skhan@nm.org|
20562081|NCT01909778|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20562082|NCT01121549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562083|NCT04789408|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20562084|NCT05841680|Florida International University|Jeremy Pettit|3053481671|jpettit@fiu.edu|
20562085|NCT01391832|University of Texas at Dallas|Dr. John Hart, Jr.|972-883-4853|jill.ritter@utdallas.edu|
20562086|NCT01154985|Mochida Pharmaceutical Company Ltd.|Hironori Sato, Director|+81-3-3225-6331|hnsato@mochida.co.jp|
20562087|NCT00589277|Yale University School of Medicine|Benjamin Toll, Ph.D. Associate Professor of Psychiatry|(203) 974 5767|benjamin.toll@yale.edu|
20562088|NCT03345901|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
20562089|NCT00722046|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562090|NCT00925587|Amgen Inc.|Study Director|866-572-6436||
20562091|NCT00490802|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
20562092|NCT00085436|Dartmouth-Hitchcock Medical Center|Dr. Marc S. Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
20562093|NCT01668940|The Hospital for Sick Children|Dr Shinya Ito, Principal Investigator|4168135776|shinya.ito@sickkids.ca|205776
20562094|NCT00516321|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562095|NCT01292252|University of California, San Francisco|Shane Burch, MD|415-353-4487|Shane.Burch@ucsf.edu|
20562096|NCT00373386|Research Institute at Nationwide Children's hospital|Robert P. Hoffman MD|614-722-4425|robert.hoffman@nationwidechildrens.org|
20562097|NCT01556724|University of Pittsburgh|Susan Sandusky|412-383-1036|sis127@pitt.edu|
20562098|NCT00714714|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director Clinical Operations|949-973-1153|David.Linberry@valeant.com|
20562099|NCT01925469|University of Pennsylvania|Dr. Emelia Bachman|443-955-9195|emeliacleo@gmail.com|
20562100|NCT01185561|Loyola University|Sue Penckofer, Ph.D.|708-216-9303|spencko@luc.edu|
20562101|NCT01078116|Abbott|Global Medical Services|1-800-633-9110||
20562102|NCT01296815|Centro de Investigación en. Enfermedades Infecciosas|Gustavo Reyes-Teran|52 55 56667985|gustavo.reyesteran@gmail.com|
20562103|NCT02369484|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
20562104|NCT02178241|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20562105|NCT02252042|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20516509|NCT02535611|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
20516510|NCT04088760|Cincinnati Children's Hospital Medical Center|Rebecca Marsh, MD|(513) 803-1139|Rebecca.Marsh@cchmc.org|
20516511|NCT00377260|Children's Hospital of Pittsburgh of UPMC|Efficacy of Antimicrobials in Young children with Acute Otitis Media|412-692-5249|Hoberman@chp.edu|
20516512|NCT00829530|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516513|NCT01391793|UPMC Children's Hospital of Pittsburgh|Nader Shaikh, MD, MPH|412-692-8111|nader.shaikh@chp.edu|
20516514|NCT01015625|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
20562106|NCT00979992|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Administration and Operations|716-845-5702|kurasa@nrgoncology.org|
20562107|NCT04532528|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20562108|NCT02658240|UT Southwestern Medical Center|Irina Gasanova|4694191997|Irina.Gasanova@UTSouthwestern.edu|
20562109|NCT03691428|Yale|Dr. Joan Monin|203785-2895|joan.monin@yale.edu|
20562110|NCT01460290|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
20562111|NCT02527148|Stryker South Pacific|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
20562112|NCT01140048|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562113|NCT00908830|University of Michigan Health System|Linda Stuckey, Pharm.D|734-936-8129|lindastu@med.umich.edu|
20562114|NCT02448446|South Coast Retina Center|Dr. Julie Gasperini|5629847024|jgasperini@gmail.com|
20562115|NCT01254188|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20516515|NCT05439252|University of Bath|Dr Oliver Perkin|01225384356|o.j.perkin@bath.ac.uk|
20562116|NCT04283552|Washington University School of Medicine|Richard L. Wahl, M.D.|314-362-7100|rwahl@wustl.edu|
20562117|NCT02957136|Duke University Health System|Christopher Polage|919-668-5008|christopher.polage@duke.edu|
20562118|NCT04975308|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20562119|NCT00442117|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclcosure@merck.com|
20562120|NCT01568073|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20562121|NCT00841035|University of Alabama at Birmingham|Research Nurse Supervisor of Clinical trials|(205)975-0450|jhrichardson@uabmc.edu|
20562122|NCT00891176|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562123|NCT00433199|Abbott|Global Medical Services|800-633-91110||
20562124|NCT00357097|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562125|NCT00658996|Bausch & Lomb Incorporated|Gerard Cairns, PhD, MCOptom|(585) 338-5170|gerard.cairns@bausch.com|
20562126|NCT02994654|AVITA Medical|VP Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
20562127|NCT00605904|NIAAA, NIH|Markus Heilig|301.435.9386|mheilig@mail.nih.gov|
20562128|NCT03505099|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
20562129|NCT03603717|Department of Veterans Affairs, Center of Excellence for Suicide Prevention|Wilfred Pigeon, PhD|(585) 393-7918|wilfred.pigeon2@va.gov|
20562130|NCT00732381|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20562131|NCT00457691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562132|NCT03619226|Coloplast A/S|Julie Schnipper, Medical Writer|49111257|dkjuls@coloplast.com|
20562133|NCT04584099|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20562134|NCT04786457|University of Maryland, Baltimore, Center for Vaccine Development and Global Health|Kirsten E. Lyke, MD|410-706-5328|klyke@som.umaryland.edu|
20562135|NCT03073941|Zimmer Biomet|Chiara Griffoni, Clinical Project Senior Lead|+41 79 560 16 28|chiara.griffoni@zimmerbiomet.com|
20562136|NCT01149369|Johns Hopkins Data Coordinating Center|Katherine Yates|443-287-0082|kyates1@jhu.edu|
20562137|NCT02616900|eSight Corporation|Rob Hilkes|613 276-4145|rhilkes@eSightcorp.com|
20562138|NCT02242487|Acorda Therapeutics|Dr. Charles Oh, Senior Vice President - Clinical Development|914-326-5455|coh@acorda.com|
20562139|NCT03644849|Saint Louis University|Dr. Ramona Behshad|314-977-9721|ramona.behshad@health.slu.edu|
20562140|NCT00508924|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20562141|NCT02755805|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
20562142|NCT02593149|Pursuit Vascular, Inc.|Laurie Lynch, PhD|6124249006|llynch@pursuitvascular.com|
20562143|NCT01636687|Novartis Pharmaceuticals|Study Director|+1-862-778-8300|Novartis.email@novartis.com|
20516516|NCT05600322|Photocure ASA|Clinical Director|+4722062210|research@photocure.com|
20516517|NCT04466111|SGX Medical|VP of Clinical|818-527-2710|clinical@sgxmedical.com|
20516518|NCT00105196|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20516519|NCT00893464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20516520|NCT00286754|Department of Veterans Affairs|Sundar Natarajan, MD, Staff Physician|212-686-7500|Sundar.Natarajan@va.gov|3287
20516521|NCT00910663|TEVA Pharmaceuticals USA|Associate DIrector, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516522|NCT02024646|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
20516523|NCT01844375|Faculty of Medicine siriraj Hospital|Dr.Mingkwan Wongyingsinn|6624197995|mingkwan.won@mahidol.ac.th|
20516524|NCT03627091|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20516525|NCT01498120|UCB BIOSCIENCES GmbH|Clinical Trial Registries and Results Disclosure|40789+49 2173 48|clinicaltrials@ucb.com|15 15
20516526|NCT03115177|Rush University Medical Center|Dr. Allison Rao|608-445-0545|allison.rao@gmail.com|
20516527|NCT00678639|Wake Forest University Baptist Medical Center|Chadwick Miller, MD|336-716-1740|cmiller@wfubmc.edu|
20516528|NCT02642835|Medway NHS Foundation Trust|Professor Jonaathan Duckett -Consultant Urogynaecologist|01634|jraduckett@hotmail.com|835154
20516529|NCT03506386|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20516530|NCT01546545|Pennington Biomedical Research Center|Jeffrey Gimble, MD, PhD|225-763-3000|doctors@pbrc.edu|
20516531|NCT04060147|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20516532|NCT00336479|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
20516533|NCT00550537|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn, Principal Investigator||leora.horn@vanderbilt.edu|
20516534|NCT02008565|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20516535|NCT00268905|Eisai|Prash Krishna, Study Director|888-422-4743||
20516536|NCT00617305|Gilead Sciences|Ellen Shen, PhD, Senior Manager, Regulatory Affairs|+1 (650) 522-5278|Ellen.Shen@gilead.com|
20516537|NCT02193178|CooperVision, Inc.|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
20516538|NCT03435081|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20516539|NCT00420238|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20516540|NCT00048581|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20516541|NCT01406795|Stanford University|Rusty Hofmann|6507366096|lhofmann@stanfordhealthcare.org|
20516542|NCT03966365|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20516543|NCT04753437|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20516544|NCT03567174|Johns Hopkins University|Gregory M. Lucas|410 614 0560|glucas@jhmi.edu|
20516545|NCT02865122|Elgan Pharma Ltd.|Miki Olshansky, Chief Executive Officer|972-4-6098600|Miki@elganpharma.com|
20516546|NCT06090461|Currax Pharmaceuticals LLC|SVP, Chief Medical Officer|708.834.8254|mkyle@curraxpharma.com|
20516547|NCT04298918|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20516548|NCT05376319|Mayo Clinic|Ulrich Specks, M.D.|507-284-2494|specks.ulrich@mayo.edu|
20562144|NCT02771899|Columbia University Medical Center|Dr. Lawrence Lenke|2129324410|ll2989@columbia.edu|
20562145|NCT00980330|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20562146|NCT01039688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562147|NCT00475319|Dermatologicals & Ophthalmologicals, Otsuka Pharmaceutical Co., Ltd.|Eiji Murakami|+81-6-6231-6067||
20562148|NCT03520413|Durham Veterans Affairs Medical Center|Matthew Crowley, MD|919-286-0411|matthew.crowley@va.gov|
20562149|NCT00346151|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20562150|NCT03698708|Nemours Children's Health|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
20562151|NCT04054635|University of Manitoba|Dr. Robert J. Schroth|204-977-7764|robert.schroth@umanitoba.ca|
20562152|NCT03737240|University of Miami Miller School of Medicine|Dr. Rodolfo Galindo|305-243-7707|Rodolfo.galindo@miami.edu|
20562153|NCT00891930|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|866-572-6436|Bobby.Reddy@Immunitybio.com|
20562154|NCT03040661|Inova Heart and Vascular Institute|Vineet Kumar|(703) 289-9400|vineet.kumar@inova.org|
20562155|NCT02384070|Odessa Heart Institute / Permian Research Foundation|Fernando Boccalandro MD FACC FSCAI|432-3373117|Fboccalandro@echd.org|
20562156|NCT02202499|H. Lee Moffitt Cancer Center and Research Institute|Dr. Thomas Brandon|813-745-1750|thomas.brandon@moffitt.org|
20562157|NCT01852071|Orchard Therapeutics (Europe) Ltd|Orchard Medical Information|+44 (0) 203 808 8286|medinfo@orchard-tx.com|
20562158|NCT01240330|Venous Health Systems, Inc.|Director of Quality Assurance & Operations|(650)646-3327|rlaguna@venoushealth.com|104
20562159|NCT00535145|Ortho-McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
20562160|NCT00376363|University of North Carolina|Donald Budenz|919-843-0297|donald_budenz@med.unc.edu|
20562161|NCT01059877|QuietMind Foundation|Marvin Berman, PhD|610.940.0488|marvinberman@quietmindfdn.org|
20562162|NCT00640250|Institute of Clinical Research, Department of Dermoto Venerology and Allergy Center|Evy Paulsen, MD|+45 65 41 27 08||
20562163|NCT00439569|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
20562164|NCT02214160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20562165|NCT02423798|Medtronic Minimed|Odile O'Sullivan, Clinical Trial Manager|8184763319|odile.osullivan@medtronic.com|
20562166|NCT01224015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20562167|NCT00275392|James H. Quillen VAMC|Courtney D. Hall, PhD|423-926-1171|courtney.hall@va.gov|7518
20562168|NCT04221828|US Biotest, Inc.|Gere S. diZerega, MD|18055951300|gere.dizerega@usbiotest.com|
20562169|NCT01430611|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20562170|NCT02204982|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20562171|NCT00886145|James J. Peters VA Medical Center|William A. Bauman|718-584-9000|william.bauman@va.gov|5428
20562172|NCT00857545|NRG Oncology|Linda Gedeon for Wei Deng PhD|716-845-1169|lgedeon@gogstats.org|
20562173|NCT00457743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20562174|NCT01837966|NYU School of Medicine|Associate Professor ; Res Program Dir/Medical Dir Day Surgery; Vice Chair for Education|212.263.5072|michael.wajda@nyumc.org|
20562175|NCT00237770|James J Peters VA Medical Center|Dr. Jill M. Wecht, principal Investigator|718 584-9000|jm.wecht@va.gov|3122
20562176|NCT00392054|Population Health Research Institute|Carlos A. Morillo, MD, FRCPC, FACC, FHRS, FESC, FHRS|905-527-4322|Carlos.Morillo@phri.ca|40311
20562177|NCT00159783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20516549|NCT01124175|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516550|NCT00942968|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516551|NCT00428298|Johns Hopkins UNiversity School of Medicine|Jennifer L. Payne MD|410-502-0050|jpayne5@jhmi.edu|
20516552|NCT01340495|Massachusetts General Hospital|Shannon MacDonald, MD|617-643-7250|SMACDONALD@mgh.harvard.edu|
20516553|NCT02262377|Boston Medical Center|Paula Gardiner|414-6267|Paula.GardinerMD@gmail.com|617
20516554|NCT01045096|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20516555|NCT00156247|UMDNJ-Robert Wood Johnson Medical School|Melissa Magliocco, MD|(732) 235-5735|maglioma@umdnj.edu|
20516556|NCT01511939|Arthritis Treatment Center|Manager, Clinical Research Department|301-624-1168|tgillis@arthritistreatmentcenter.com|
20516557|NCT03649841|University of Washington|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
20516558|NCT03618147|Kuwait Society of Allergy & Clinical Immunology|Kuwait Society of Allergy & Clinical Immunology|0096524636478|walherz@hsc.edu.kw|
20516559|NCT01529060|Baylor|Alyssa Tran, BS|832-822-4264|alyssat@bcm.edu|
20516560|NCT02440308|Stanford Healthcare|Dr. Andrei Iagaru, Chief of the Division of Nuclear Medicine and Molecular Imaging|650-725-4711|aiagaru@stanford.edu|
20516561|NCT02883452|Celltrion, Inc.|SungHyun Kim|+82 32 850 5778|sunghyun.kim@celltrion.com|
20516562|NCT04257474|Moffitt Cancer Center|Susan T. Vadaparampil, PhD, MPH|813-745-1997|Susan.Vadaparampil@moffitt.org|
20516563|NCT00517530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20516564|NCT00667095|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|peterou.steven@mayo.edu|
20516565|NCT01520909|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516566|NCT00374335|Children's Mercy Hospitals and Clinics|Dr. Kimberly Horii|816-234-3924|kahorii@cmh.edu|
20516567|NCT01882257|University of Michigan Health System|Robert G. Sitrin, M.D.|(734) 936-5201|rsitrin@umich.edu|
20516568|NCT00830206|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516569|NCT01900691|Cook Research Incorporated|Alan Saunders, MDR, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
20516570|NCT02393417|Nielsen BioSciences Inc.|David Burney, PhD, MBA|858-571-2726|david@nielsenbio.com|
20516571|NCT02736721|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20562178|NCT02928224|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562179|NCT02538107|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20562180|NCT01236560|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20562181|NCT00919763|Galderma|Clinical Operations|8179615000|Clinical.Studies@galderma.com|1
20551319|NCT05584644|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562182|NCT00664430|Abbott|Global Medical Services|800-633-9110||
20562183|NCT02471755|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Dr.Xiaoxu Liu|+86 10 8800 1124|liuxiaoxu_lxx@163.com|
20562184|NCT04740164|The University of Texas MD Anderson Cancer Center|Dr. Katherine Hagan|(713) 794-5945|khagan@mdanderson.org|
20562185|NCT05216510|Tonix Pharmaceuticals|Herb Harris, MD, PhD|(862) 904-0355|herb.harris@tonixpharma.com|
20562186|NCT05323734|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20562187|NCT05061693|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20562188|NCT04009577|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20562189|NCT01600729|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20562190|NCT04923724|Washington University School of Medicine|Venessa Riegler|314-362-1721|rieglerv@wustl.edu|
20516572|NCT01643707|Medtronic|Sr Clinical Research Program Manager|+1 (651) 308 3608|jennifer.tinsley@medtronic.com|
20516573|NCT04112823|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20516574|NCT00625443|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20516575|NCT03136380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20516576|NCT02728102|The Emmes Company|Adam Mendizabal, PhD|301-284-1798|amendizabal@emmes.com|
20516577|NCT00830232|Dallas VA Medical Center|Dr. Carlos H Timaran|2148570336|carlos.timaran@va.gov|
20516578|NCT03834870|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
20516579|NCT02419937|United States Air Force|Dr. Matthew B. Carroll|228-376-3829|mcar100210@yahoo.com|
20516580|NCT00553280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516581|NCT01182415|Massachusetts General Hospital|Dr. Yi-Bin Chen|617-726-0187|YCHEN6@PARTNERS.ORG|
20516582|NCT01544127|Canandaigu VA Medical Center|Dr. Peter Britton|585-393-7926|peter.britton@va.gov|
20516583|NCT01437501|Johns Hopkins Bloomberg School of Public Health|Thomas W. Kensler, PhD|410-955-1292|tkensler@jhsph.edu|
20516584|NCT01256684|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
20516585|NCT02914600|Galapagos NV|Galapagos Medical Information|+3215342900|medicalinfo@glpg.com|
20516586|NCT05452798|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20516587|NCT01185548|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20551320|NCT03683758|Mountain Health and Performance|Dr. Matthew Wentzell|6043566986|drwentzell@mountainhp.ca|
20551321|NCT01172847|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20551322|NCT01163279|Baycrest Health Sciences|Dr. Deirdre Dawson|416-785-2500|ddawson@research.baycrest.org|2136
20551323|NCT00119392|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
20551324|NCT00665353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20551325|NCT00594997|Brigham and Women's Hospital|Nancy Shadick|617-732-5266|nshadick@partners.org|
20551326|NCT00583804|MetroHealth Medical Center|Principal Investigator|2169573683|ue.fes.clinicaltrials@gmail.com|
20551327|NCT00705081|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20551328|NCT01290640|The University of Tennessee|Dr. Richard Komistek, Professor|865-974-4159|rkomiste@utk.edu|
20551329|NCT01601626|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20551330|NCT01623323|OptiNose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
20551331|NCT03045887|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20551332|NCT02632552|U.S. Department of Veterans Affairs, Center for Healthcare Organization and Implementation Research (CHOIR)|Timothy P. Hogan, PhD,|508-244-2303|Timothy.Hogan@VA.gov|
20551333|NCT02074631|University of Minnesota, Masonic Cancer Center|Dr. Kyriakie Sarafoglou|(612) 624-5965|saraf010@umn.edu|
20551334|NCT04155632|Medical University of South Carolina|Dr. Xiaolong Peng|8437928642|pengxi@musc.edu|
20551335|NCT00546637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20551336|NCT03274440|Columbia University/New York State Psychiatric Institute|Dr. Reilly Kayser|6467748118|reilly.kayser@nyspi.columbia.edu|
20551337|NCT01291173|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20551338|NCT00390858|Novartis Pharmaceuticals|Study Director|862-778-8300||
20551339|NCT01230801|BioMarin Pharmaceutical Inc.|Manager, Clinical Operations|415-455-7448|Slava.Titov@bmrn.com|
20551340|NCT00450450|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20551341|NCT02402309|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20551342|NCT02024867|University at Buffalo|Dr. Lucy Holmes|716-878-7277|LHolmes@upa.chob.edu|
20551343|NCT02865187|Wright State University|Steven R Lindheim|858-740-1083|doclalalindheim@gmail.com|
20551344|NCT04267133|University of Rochester|Jean-Philippe Couderc, PhD|585-275-1096|heartjpc@heart.rochester.edu|
20551345|NCT01110707|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20551346|NCT01930747|az sint jan brugge|jan mulier|0032486729203|jan.mulier@azsintjan.be|
20562191|NCT00958633|University Of British Columbia|Dr. Lakshmi Yatham|604-822-7310|yatham@mail.ubc.ca|
20516588|NCT00425672|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
20516589|NCT00234286|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
20516590|NCT02605395|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516591|NCT01422538|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20516592|NCT00184600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20516593|NCT02763865|Medical University of South Carolina|Gonzalo REvuelta|843-792-7262|revuelta@musc.edu|
20516594|NCT00696020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20516595|NCT00624065|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516596|NCT01387022|CAPRISA|Head of Statistics and Data Management|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
20516597|NCT03257722|Augusta University|Asha Nayak, MD|706-721-2505|anayak@augusta.edu|
20516598|NCT01972204|Mirai Iryo Research Center|Tomoko Machida (Director)|81-3-3263-4801|machida@mirai-iryo.com|
20516599|NCT02076022|University of Pittsburgh Plastic Surgery|Patsy Simon|412-648-9207|simopa@upmc.edu|
20516600|NCT00524264|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20516601|NCT00819507|Oregon Health & Science University|Eric Simpson|503-494-2121|simpsone@ohsu.edu|
20516602|NCT01536405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20516603|NCT02661295|NYU Langone Health|Candace Grant, MD|516-663-0333|candace.grant@nyulangone.org|9054
20516604|NCT02336165|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20516605|NCT00267644|Maimonides Medical Center|Dr. Eitan Dickman, MD; Principal Investigator|718-283-6057|edickman@maimonidesmed.org|
20516606|NCT02726581|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20516607|NCT02865850|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
20516608|NCT00176306|University of Kentucky|Aaron Cook|8593239258|amcook0@email.uky.edu|
20516609|NCT00772941|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516610|NCT02255097|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20516611|NCT02514122|University of Saskatchewan|Dr. William P. McKay|1 306 655 1202|bill.mckay@usask.ca|
20516612|NCT01010542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516613|NCT01118312|Johns Hopkins University|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
20516614|NCT02082392|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
20516615|NCT04510285|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,MD|646-888-4186|janjigiy@mskcc.org|
20516616|NCT03555305|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20516617|NCT00925054|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
20516618|NCT03135834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516619|NCT02100228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516620|NCT00214422|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphausen@nih.gov|
20516621|NCT01073657|Veterans Health Adminstration|Marsha Langer Ellison, Ph.D.|781 687 3401|Marsha.Ellison@va.gov|
20516622|NCT02421952|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
20516623|NCT00854100|Allergan, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20516624|NCT02744352|University of Pennsylvania|Anmol Madaan, Clinical Research Coordinator|2156623778|Anmol.Madaan@Pennmedicine.Upenn.edu|
20516625|NCT02216071|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
20516626|NCT01066143|McLean|Igor Elman, PI|(800) 333-0338|ielman@partners.org|
20516627|NCT01294787|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
20516628|NCT01948258|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
20516629|NCT00834535|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516630|NCT03547622|Yale University|Theresa Babuscio Data Manager|203 737 5430|theresa.babuscio@yale.edu|
20516631|NCT00210223|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20516632|NCT03785548|TriHealth Inc.|Tiffanie Tam, Md|513-463-4300|Tiffanie_Tam@trihealth.com|
20516633|NCT00396279|Amgen Inc.|Study Director|866-572-6436||
20516634|NCT01199848|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
20516635|NCT01375660|Jesse Brown VA Medical Center|Dr. Barengolts, Attending Endocrinologist, Chief, Section of Endocrinology|312-569-7651|Elena.Barengolts@va.gov|
20551347|NCT03179995|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
20551348|NCT00003901|Memorial Sloan Kettering Cancer Center|Valerie Rusch, MD|212-639-5873|ruschv@mskcc.org|
20551349|NCT05319795|University Health Network|Professor Catriona Steele|4165973422|catriona.steele@uhn.ca|7802
20551350|NCT02268864|Janssen Research and Developement, Belgium|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
20551351|NCT02049307|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
20551352|NCT02612428|Vital Therapies, Inc.|Robert Ashley, Chief Technical Officer|001 858-673-6840|rashley@vitaltherapies.com|
20551353|NCT03611790|BioMDg, CRO for VITAL Study|Sigi Caron, President and CEO at BioMDg|(831) 346-6970|sigi@biomdg.com|
20551354|NCT02141997|AbbVie|Global Medical Information|1-800-633-9110||
20551355|NCT03063476|Vanderbilt University Medical Center|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vanderbilt.edu|
20551356|NCT05167734|Mayo Clinic|Matthew Warner, M.D.|507-422-1714|Warner.Matthew@mayo.edu|
20551357|NCT01510379|The Ohio State University|Kyle A. Perry, MD|614-293-5815|kyle.perry@osumc.edu|
20551358|NCT00451321|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562192|NCT01071993|University of Oklahoma|Mazen Abu-Fadel, MD|405-271-4742|mazen-abufadel@ouhsc.edu|
20562193|NCT00305695|NRG Oncology|Linda Gedeon on behalf of James Kauderer, MA, BS|716-845-1169|linda.gedeon@roswellpark.org|
20516636|NCT01832259|Huntsman Cancer Institute / University of Utah|Josiah Lyn Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
20516637|NCT00487565|DePuy Orthopaedics, Inc.|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
20516638|NCT00654030|University of Kentucky|Dr. Edward Hirschowitz|859-323-5045|eahirs2@uky.edu|
20516639|NCT00905346|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516640|NCT01435265|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-7740|sfeldman@wakehealth.edu|
20516641|NCT03351335|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20516642|NCT04605094|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20516643|NCT02724462|Fred Hutchinson Cancer Research Center|Dr. Jonathan Bricker|206-667-5077|jbricker@fredhutch.org|
20516644|NCT00979303|Children's Hospital Boston|Christina Miyake|832-826-5650|cymiyake@bcm.edu|
20516645|NCT00469417|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20516646|NCT02059070|Wayne State University, School of Medicine|Pranav Patel|313-745-7233|gmckelve@dmc.org|
20516647|NCT01954394|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20516648|NCT00909610|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516649|NCT03585790|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
20516650|NCT04089735|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
20516651|NCT02337218|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20516652|NCT02071108|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
20516653|NCT01026623|Memorial Sloan Kettering Cancer Center|Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
20516654|NCT02128997|UPENN|Valerie Riis|2154989099|valerie.armendariz@uphs.upenn.edu|215
20516655|NCT03342157|Advocate Aurora Health|Dr. Bradley Gose|414-385-2590|bradley.gose@aah.org|
20516656|NCT02196766|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
20516657|NCT00418184|Enzymotec Ltd|Yael Richter Ph.D|+972 74 7177 177|Yaelr@enzymotec.com|144
20516658|NCT00840866|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516659|NCT01036009|Benioff Children's Hospital at UCSF|Biljana Horn|415 476 2188|hornb@peds.ucsf.edu|
20516660|NCT03107091|BioVie|Penelope Markham|17035989972|pmarkham@biovieinc.com|
20516661|NCT02332863|University of Colorado - Anschutz Medical Campus|Dr. Sachin Wani|720-848-2786|sachin.wani@cuanschutz.edu|
20516662|NCT03049215|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
20516663|NCT03025880|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20516664|NCT01275586|Indiana University|Dr. Melissa Markel|317-944-4969|memarkel@iu.edu|
20516665|NCT00672178|Duke University Medical Center|John Kirkpatrick, MD, PhD|919 668-7342|kirkp001@mc.duke.edu|
20516666|NCT02924883|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20516667|NCT04121364|RevBio|Dr. Alan Pollack|9145226972|apollack@revbio.com|
20516668|NCT02377947|Abbott|Dr. Shubhangi Desai|+91 22 7175 7408|shubhangi.desai@abbott.com|
20516669|NCT02587962|Medivir AB|Chief Medical Officer|+46854683100|info@medivir.com|
20516670|NCT00312663|WRAIR|James Cummings, MD|301-319-9312|james.cummings@us.army.mil|
20516671|NCT01054586|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516672|NCT02098876|Northeast Georgia Health System|Habib Samady|770-297-3549|Habib.Samady@nghs.com|
20516673|NCT01263704|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20516674|NCT01061866|National Institute of Neurology and Neurosurgery of Mexico|Julio Sotelo|5255-5652-8285|jsotelo@unam.mx|
20516675|NCT00102440|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20516676|NCT01314417|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
20516677|NCT04786184|Columbia University|Annamaria Norweg, PhD|212-305-1651|amn2212@cumc.columbia.edu|
20516678|NCT02834663|Wonkwang University Hospital|Dr. Seung Joon Lee|010-5004-8165|eunilsa@hanmail.net|
20516679|NCT03965091|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20516680|NCT02420210|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20516681|NCT01534520|UPittsburgh|Dionne Best|412-641-5496|dbest@upmc.edu|
20516682|NCT02729714|EvergreenHealth Medical Center|Dr. Daniel Burdick|4258993108|djburdick@evergreenhealthcare.org|
20516683|NCT00857623|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20516684|NCT04185909|Apyx Medical|Kari Larson, MBA, Sr. Director, Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
20516685|NCT02601560|MedImmune, LLC|Richard George, MD, Director, Clinical Development|+1-301-398-5681|information.center@astrazeneca.com|
20516686|NCT01417078|Acorda Therapeutics, Inc.|Executive Medical Director - Clinical Development & Medical Affairs|914-347-4300|dsquillacote@acorda.com|5367
20516687|NCT00626548|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20516688|NCT01234103|University of California, San Francisco|Cherrie B. Boyer, PhD|4154762184|Cherrie.Boyer@ucsf.edu|
20516689|NCT00580138|University of Arkansas for Medical Sciences Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
20516690|NCT01059903|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20516691|NCT02563808|University of Pennsylvania Hospital|Lee Fleisher|2156623738|lee.fleisher@uphs.upenn.edu|
20516692|NCT00385593|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20516693|NCT04384978|DreamFace Technologies, LLC|President and CEO|7202015694|mmahoor@dreamfacetech.com|
20562194|NCT01499654|Northwestern University|Edwin Wu, MD|847-535-7270|ed-wu@northwestern.edu|
20562195|NCT01649180|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
20562196|NCT00794118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562197|NCT04305405|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20562198|NCT03072953|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20516694|NCT03586726|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20562199|NCT00206375|Texas Children's Hospital, Baylor College of Medicine|Dr. MJ Redondo (designated by the institution to enter results)|832-822-1019|redondo@bcm.edu|
20562200|NCT01353963|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562201|NCT01420549|Aché Laboratórios Farmacêuticos S. A.|Antonio Carlos Amedeo Vattimo|+55 11 26088111|antonio.vattimo@ache.com.br|
20562202|NCT04250883|Radboud umc|Dr. Michiel Warle|024-3613808|michielwarle@radboudumc.nl|
20562203|NCT02763319|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20562204|NCT04926181|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 476-1000|Rahul.Aggarwal@ucsf.edu|
20562205|NCT02499159|Inova Health System|Devon Collins|703-776-4096|Devon.Collins@inova.org|
20562206|NCT00083551|UAMS Myeloma Institute|Bart Barlogie|501-526-6990|barlogiebart@uams.edu|2420
20562207|NCT00687856|University of Pittsburgh|John Gorcsan MD|4126476570|gorcsanj@upmc.edu|
20562208|NCT02564744|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20562209|NCT04040296|Yale University|Abinet Aklilu|203-737-1787|abinet.aklilu@yale.edu|
20562210|NCT01956032|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20562211|NCT01571557|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20562212|NCT01177670|Hologic, Inc.|Edward Evantash, MD|508-263-8475|edward.evantash@hologic.com|
20562213|NCT00749749|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|Innocoll|484-406-5211|ctucker@innocoll.com|
20562214|NCT02663297|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
20562215|NCT03835819|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
20562216|NCT01269749|University of Florida|Dr Scott Rivkees|352-273-9001|srivkees@ufl.edu|
20562217|NCT02918279|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20562218|NCT00309907|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20562219|NCT00869258|Columbia University|Robert Fine, MD|212-305-1168|rlf20@columbia.edu|
20562220|NCT00636207|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562221|NCT02888080|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20562222|NCT01641198|Université de Montréal|Dr. Aldo-Joseph Camarda|(514) 343-7124|aj.camarda@umontreal.ca|
20562223|NCT00568854|Los Angeles County Department of Public Health|Dr. Alicia Chang|213-745-0846|alchang@ph.lacounty.gov|
20562224|NCT00666276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562225|NCT02594735|GWU Myositis Center|Dr. Rodolfo Curiel|202-741-2488|rcuriel@gwu.edu|
20562226|NCT01296191|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
20516695|NCT03458871|The University of Texas Health Science Center at Houston|Dr. Argyrios Stampas|713-797-5938|argyrios.stampas@uth.tmc.edu|
20516696|NCT02612337|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
20516697|NCT00322465|University of Alabama at Birmingham|Jane R. Schwebke, MD|(205) 975-5665|schwebke@uab.edu|
20516698|NCT00183794|USC/Norris Cancer Comprehensive Cancer Center|Agustin Garcia, MD|323-865-3900|aagarcia@usc.edu|
20516699|NCT00389064|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20516700|NCT02963259|Abbott|Erika Ross|+19725268207|Erika.ross@abbott.com|
20516701|NCT05665426|Zhejiang Chhinese Medicial University|Siyi Zheng|+86159 9008 8547|zsy980714@gmail.com|
20516702|NCT03857919|Sight Sciences|Tommie Rodriguez, Senior Clinical Research Manager|18186873310|trodriguez@sightsciences.com|
20516703|NCT05369208|Sobi Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
20516704|NCT04934722|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20516705|NCT00371839|Portland VAMC|Dr. Marjorie R. Leek|(909)825-7084|Marjorie.Leek@va.gov|7293
20516706|NCT01149473|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516707|NCT00773422|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
20516708|NCT00834249|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516709|NCT00851877|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
20516710|NCT00620074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20516711|NCT00829673|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516712|NCT00096447|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20516713|NCT00573066|Children's Hospital of Philadelphia|Athena Zuppa|267-426-7359|zuppa@email.chop.edu|
20516714|NCT02473718|University of Texas Southwestern Medical Center|Catherine Chen|214-648-9095|catherine.chen@utsouthwestern.edu|
20516715|NCT02246166|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516716|NCT00834743|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20562227|NCT04567407|Boston Children's Hospital|Roland Brusseau MD|857-218-4814|roland.brusseau@childrens.harvard.edu|
20516717|NCT00086996|SWOG Statistical Center|Study Statistician|206-667-4623||
20562228|NCT03844269|Akili Interactive Labs, Inc.|Minny Suh|857-254-4444|minny@akiliinteractive.com|
20562229|NCT00665444|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
20516718|NCT02770820|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
20516719|NCT02331394|Jewish General Hospita;|Goulnar Kasymjanova|514-340-8222|gkasymja@jgh.mcgill.ca|24312
20516720|NCT01371786|Sunovion|Respiratory Medical Director|1-866-503-6351||
20516721|NCT01313273|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20516722|NCT00552669|Centro de Estudios en Cardiologia Intervencionista|Alfredo Rodriguez, MD, PHD|541149648721|rodrigueza@sanatorio-otamendi.com.ar|
20516723|NCT03687736|Q-Med AB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
20516724|NCT02841033|Boston Medical Center|Vaishali Sanchorawala, MD|617-638-8213|vaishali.sanchorawala@bmc.org|
20516725|NCT04459585|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20516726|NCT03195491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20516727|NCT01270503|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20516728|NCT02459951|Albert Einstein Healthcare Network|Nathaniel Mayer MD|215 663 6681|nmayer@einstein.edu|
20516729|NCT00724477|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20516730|NCT00252720|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
20516731|NCT01792635|Pfizer, Inc.|Pfizer ClnicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562230|NCT00101010|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Alma Rodriguez, MD, Lymphoma||CR_Study_Registration@mdanderson.org|
20562231|NCT01075217|Bracco Diagnostics Inc|Usha Halemane|609.514.2578|Usha.Halemane@diag.bracco.com|
20562232|NCT03897348|University of California, San Francisco/San Francisco VA Health Care System|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
20562233|NCT01369498|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20562234|NCT01394510|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kutzschn@uw.edu|6-3568
20562235|NCT02539108|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20516732|NCT01745120|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
20516733|NCT02819323|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20516734|NCT02017223|University of Southern California|Donna Spruijt-Metz, MFA PhD|310-577-6248|dmetz@usc.edu|
20516735|NCT01401647|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
20516736|NCT01675765|Aduro Biotech, Inc.|Corporate Communications|510-848-4400|press@aduro.com|
20516737|NCT02512393|The University of Texas Health Science Center at Houston|Hyochol Ahn, PhD, ARNP|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
20516738|NCT01185821|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20516739|NCT01837654|Assaf Harofhe MC|Dr. Kobi Stav|972-8-9779409|stavkobi@yahoo.com.au|
20516740|NCT04107675|Zambon SpA|Ferdinando Ceravolo, MD|02 665241|ferdinando.ceravolo@zambongroup.com|
20516741|NCT00846495|Clinvest|Rebecca Browning|417-841-3664|rbrowning@clinvest.com|
20516742|NCT01265056|The University of Iowa|Jennifer Lassner|319-335-2123|jennifer-lassner@uiowa.edu|
20516743|NCT01416584|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20516744|NCT01624363|Indiana Universtiy Schol of Medicine|John DeWitt, MD, Director, Endoscopic Ultrasound|317-944-1113|jodewitt@iu.edu|
20516745|NCT01650350|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-3000|Kayla_rosati@brown.edu|
20516746|NCT00537979|Abbott|Global Medical Services|800-633-9110||
20516747|NCT02431494|Nova Southeastern University|Sue Breno|9542621447|sb1382@nova.edu|
20516748|NCT03459807|University of California, San Francisco|Dr. Chi-yuan Hsu|415-476-2172|chi-yuan.hsu@ucsf.edu|
20516749|NCT02392000|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley|781-687-2273|karen.quigley@va.gov|
20516750|NCT01985308|Wave Neuroscience, Inc.|Mazaya Soundra, Clinical Trials Manager|9492292869|mazaya@waveneuro.com|
20516751|NCT03286465|The University of Texas Health Science Center at Houston|Javier Barreda Garcia, MD|713-500-6838|Javier.BarredaGarcia@uth.tmc.edu|
20516752|NCT00965185|Massachusetts General Hospital|Dr. Steven K Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu|
20516753|NCT03197883|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20516754|NCT04841317|Stanford University|Paul J. Wang, MD|(650) 723-7111|Paul.J.Wang@stanford.edu|
20516755|NCT00858845|University of California, Los Angeles (UCLA)|Dr. Holly R. Middlekauff|310-206-6672|hmiddlekauff@mednet.ucla.edu|
20516756|NCT04916548|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
20516757|NCT01964092|University of Oslo|Silje Endresen Reme|22845236|s.e.reme@psykologi.uio.no|+47
20516758|NCT00762307|Zeltiq Aesthetics|Kerrie Jiang, Director of Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20516759|NCT00091260|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
20516760|NCT03243630|Yale University|Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
20516761|NCT00939003|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20516762|NCT02131129|IndianaU|Dr. Michael Francis|317-880-8495|mmfranci@iupui.edu|
20516763|NCT03707912|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20562236|NCT04018924|Emoled|Duccio Rossi Degl'Innocenti|+39 0550751981|d.rossi@emoled.com|
20562237|NCT01968226|Cleveland Clinic|Dr. Balaji Tamarappoo|216-444-6765|tamarab@ccf.org|
20516764|NCT02934347|Glan Clwyd Hospital, Betsi Cadwaladr University Health Board|Dr Raj Reddy|01745 583910|Rajashekhar.Reddy@wales.nhs.uk|
20516765|NCT00486863|Warren Alpert Medical School of Brown University, Lifespan Center for International Health Research|Jennifer Friedman, M.D., Ph.D|(401) 444-7449|jennifer_friedman@brown.edu|
20562238|NCT00566527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562239|NCT01943916|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
20562240|NCT01576484|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20562241|NCT00581854|University of Wisconsin|Brad S Kahl, MD|608-263-1836|bsk@medicine.wisc.edu|
20562242|NCT05444244|University of Wisconsin School of Medicine and Public Health|Andrea Gilmore-Bykovskyi|6082623057|algilmore@wisc.edu|
20562243|NCT03823911|Institute of Human Virology, University of Maryland School of Medicine|Dr. Poonam Mathur|410-706-4745|pmathur@ihv.umaryland.edu|
20562244|NCT03302741|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
20562245|NCT01243619|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon MD, PhD|617-732-8564|hmamon@lroc.harvard.edu|
20562246|NCT00233519|University of Rochester Medical Center|Richard T. Moxley, III MD|585-275-5006|RichardT_Moxley@urmc.rochester.edu|
20562247|NCT00094575|VAMC Minneapolis, MN|Dr. Frank A. Lederle|612-725-2158|Frank.Lederle@va.gov|
20562248|NCT05714696|Florida State University College of Medicine|Dr. Mary Gerend|8506451541|mary.gerend@med.fsu.edu|
20562249|NCT00837616|Nemours Children's Clinic|Dr. Nelly Mauras|(904) 697-3674|nmauras@nemours.org|
20562250|NCT04090190|Mass General Brigham|Vatche Minassian, MD, MPH|(617) 732-4838|vminassian@bwh.harvard.edu|
20562251|NCT02674750|Curis, Inc.|Reinhard von Roemeling, M.D., Senior Vice President, Clinical Development|617-503-6500|rvonroemeling@curis.com|
20562252|NCT00940537|Washington University School of Medicine|Gary Skolnick|314-362-5292|gskolnic@wustl.edu|
20562253|NCT01685606|Brown University Oncology Research Group (BrUOG)|Dr. Peter Quesenberry|4018633000|kayla_rosati@brown.edu|
20562254|NCT01787760|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
20562255|NCT03512756|Tyme, Inc.|Study Director|617-674-9069|Maria.Loushin@TymeInc.com|
20562256|NCT01597258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562257|NCT00933400|American College of Radiology|Communications Director|215-574-3150|nfredericks@acr.org|
20562258|NCT01764464|University of Rochester|John Markman|585-276-3616|john_markman@urmc.rochester.edu|
20562259|NCT02079844|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20562260|NCT01401023|Michigan State University|Dr. Gary Stein, Pharm D|517-353-5126|steing@msu.edu|
20562261|NCT00981630|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20562262|NCT04120454|The Ohio State University Comprehensive Cancer Center|Dr. Asrar Alahmadi|614-293-6786|Asrar.Alahmadi@osumc.edu|
20562263|NCT03439891|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|katie.kelley@ucsf.edu|
20562264|NCT02576574|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20562265|NCT05470868|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
20562266|NCT03936660|Duke Clinical Research Institute|Chris Granger, MD|9196688700|christopher.granger@duke.edu|
20562267|NCT00233090|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
20562268|NCT00840177|SWOG Statistical Center|S0919 Statistician|2066674623|amoseley@fredhutch.org|
20562269|NCT02407249|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
20562270|NCT01622868|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20562271|NCT00402896|The University of Texas (UT) MD Anderson Cancer Center|Carlos A. Jimenez, MD/Professor, Pulmonary Medicine||CR_Study_Registration@mdanderson.org|
20562272|NCT01318382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20562273|NCT01599104|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
20562274|NCT00019747|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20562275|NCT00687167|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20562276|NCT02271854|Novartis Consumer Health a GSK Consumer Healthcare company|Director Clinical Research pain category|+413635528||
20562277|NCT01308567|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20516766|NCT03797872|University of Oxford|Professor Laura Coates|+447870257823|laura.coates@ndorms.ox.ac.uk|
20562278|NCT00542789|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20562279|NCT01571596|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20562280|NCT03344536|Memorial Sloan Kettering Cancer Center|Dr. Komal Jhaveri MD|646-888-5145|jhaverik@mskcc.org|
20562281|NCT04676334|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
20562282|NCT03795194|Phoenix Children's|Research Coordinator|6029331858|zhunteman@phoenixchildrens.com|
20562283|NCT01647581|VA|Linda Feagins|214-587-1603|linda.feagins@austin.utexas.edu|
20562284|NCT01105117|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
20562285|NCT00585052|University of Iowa|Raymond Hohl, MD|319-335-6564|rhohl@pennstatehealth.psu.edu|
20562286|NCT00774397|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20516767|NCT00355797|BIOTRONIK, Inc.|CLEAR Study CSE|503-451-8051||
20516768|NCT01466166|Horizon Pharma Rheumatology LLC|Jeffery Nieves, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
20516769|NCT00328926|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20516770|NCT02269657|Children's Hospital of Philadelphia|Saba Pasha, PhD|215-590-1815|pashas@email.chop.edu|
20516771|NCT03612960|Pennsylvania State University|Dr. Andrea Hobkirk|7175310003|ahobkirk@pennstatehealth.psu.edu|286415
20562287|NCT00077675|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20516772|NCT00272779|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
20562288|NCT04425863|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
20562289|NCT02601820|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-260-4062|donna_evon@med.unc.edu|
20562290|NCT01599793|University of Chicago|Russell Szmulewitz, MD|773-702-7609|rszmulew@medicine.bsd.uchicago.edu|
20562291|NCT02966275|MGH|Courtney Balliro BS, RN, CDE|617-726-1242|cballiro@partners.org|
20562292|NCT03122236|University of Florida|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
20562293|NCT00829036|Atlanta VA Rehab R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
20562294|NCT04530149|Maimonides Medical Center|Research Administration Director|7182836896|alikourezos@maimo.org|
20562295|NCT00277355|Massachusetts General Hospital|Merit Cudkowicz, MD, MSc|617-726-1873|mcudkowicz@partners.org|
20562296|NCT00538759|Minneapolis Heart Institute Foundation|Lisa Tindell, Director of Clinical Operations|6128633816|Lisa.Tindell@allina.com|
20562297|NCT01514149|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
20562298|NCT00808405|University of Washington|Connie Celum, MD, MPH|206-520-3824|ccelum@uw.edu|
20562299|NCT02675244|Icahn School of Medicine at Mount Sinai|Annetine Gelijns|212-659-9567|annetine.gelijns@mountsinai.org|
20562300|NCT00391898|Novartis Pharmaceuticals|Study Director|862 778-8300||
20562301|NCT01396837|RedDress|Saron Sirota, Clinical Team Leader|+972-54-5800765|sharon@reddress.co.il|
20562302|NCT01316263|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20562303|NCT03873337|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
20562304|NCT01574807|Division of Endodontics|Dr. John Nusstein|614-292-3596|nusstein.1@osu.ed|
20562305|NCT02512965|Canadian Cancer Trials Group|Dr. Keyue Ding|16135336430|kding@ctg.queensu.ca|77705
20562306|NCT00835770|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20562307|NCT01185782|Merck Serono Co., Ltd., Japan, an affiliate of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20562308|NCT02507752|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20562309|NCT01444417|Amgen Inc.|Study Director|866-572-6436||
20562310|NCT03994705|Cartesian Therapeutics|Dr. Vera Sarkodie Medical Director,|617-231-8085|vera.sarkodie@cartesiantx.com|
20562311|NCT01576952|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
20562312|NCT00028093|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Combination of Pegylated Interferon and Ribavirin as Therapy for Patients With Chronic Hepatitis C W|3014961333|hoofnaglej@extra.niddk.nih.gov|
20562313|NCT00042224|Northshore LIJ Health System|Georgios Petrides, M.D.|718-470-8569|GPetride@NSHS.EDU|
20562314|NCT00736853|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K.|Medical Director|+81-3-4411-5509||
20516773|NCT02440711|University of Washington|Dr. Brian Hafner|206-685-0214|bhafner@uw.edu|
20516774|NCT03199872|RhoVac ApS|Steven Glazer, MD|+4525674434|sgl@rhovac.com|
20516775|NCT01631331|Stanford University|Dr. Gina Kwon|650-724-3859|gkwon@stanford.edu|
20516776|NCT03450057|General Hospital of Athens 'Alexandra', Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine|Prof. Evangelos Terpos|+302102162540|eterpos@med.uoa.gr|
20516777|NCT05755282|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
20516778|NCT04089917|Department of Interventional Neuroradiology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain|Mariano Espinosa de Rueda|+34 968 36 96 42|mm.espinosa@gmail.com|
20516779|NCT00829790|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516780|NCT03214952|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20516781|NCT03769896|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
20516782|NCT01015703|BTG International Inc.|SVP Clinical Development|610-278-1660|angela.ogden@btgplc.com|
20516783|NCT01083693|Abbott|Global Medical Services|1-800-633-9110||
20516784|NCT01693523|UT MD Anderson Cancer Center|Dr. David Fogelman/ Associate Professor, GI Medical Oncology|832-710-7754|dfogelman@mdanderson.org|
20516785|NCT00834418|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516786|NCT00085293|University of Texas MD Anderson Cancer Center|Steven I. Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
20516787|NCT04567186|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO, Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20516788|NCT00004562|New York University School of Medicine|Judith S. Hochman, M.D.|212-263-6927|judith.hochman@nyumc.org|
20516789|NCT04860804|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
20516790|NCT00376623|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20516791|NCT00301366|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20516792|NCT04247282|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20516793|NCT00904345|University of Michigan Rogel Cancer Center|Shruti Jolly, M.D.|734-936-4302|shrutij@med.umich.edu|
20516794|NCT00783367|University of Pennsylvania, Clinical Research Unit, Lymphoma Group|Ellen Napier, CRNP|215.279.1972|Ellen.Napier@pennmedicine.upenn.edu|
20516795|NCT01602419|Octapharma AG|Sigurd Knaub/SVP CR&D Haematology|+41 55 4512141|Sigurd.Knaub@octapharma.com|
20516796|NCT02294253|NYS Psychiatric Institute|Adam Bisaga MD|646-774-6155|adam.bisaga@nyspi.columbia.edu|
20516797|NCT04920929|Access Vascular Inc.|Brian Hanley|1-781-538-6594|bhanley@accessvascularinc.com|101
20516798|NCT03956862|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB001, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
20516799|NCT02714062|VIVUS|Sr. Director, Clinical Research|650-934-5200||
20516800|NCT02294604|Shuang Ho Hospital, Taipei Medical University|Dr. Ka-Wai Tam|886-2-22490088|kelvintam@h.tmu.edu.tw|8860
20516801|NCT01780870|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
20562315|NCT03473340|University of Michigan|VIbha Lama|734-936-5010|vlama@med.umich.edu|
20562316|NCT04623008|Ohio State University College of Nursing|Mei-Wei Chang, PhD|614-247-7211|chang.1572@osu.edu|
20562317|NCT03568422|Canadian Cancer Trials Group|Pierre-Olivier Gaudreau|6135336430|p-ogaudreau@ctg.queensu.ca|
20562318|NCT03803605|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-2537|cynthia_gay@med.unc.edu|
20562319|NCT01875848|VACT West Haven HealthCare System|William, Becker M.D|203-932-5711|william.becker4@va.gov|2247
20562320|NCT01437605|Moffitt Cancer Center|Dr. Nikhil Khushalani|813-745-3437|Nikhil.Khushalani@Moffitt.org|
20562321|NCT00434304|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562322|NCT05262738|University of Texas at Austin, Dell Medical School|Alexander Saucedo, MD|210-845-7571|alexander.saucedo@ascension.org|
20562323|NCT00687713|National Institute on Drug Abuse|Ann Anderson, MD|301-827-5916|aanderso@nida.nih.gov|
20562324|NCT02374463|Baltimore VA Medical Center|Leslie Katzel, MD, PhD|410-605-7248|leslie.katzel@va.gov|
20562325|NCT03538717|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562326|NCT01424397|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562327|NCT02767765|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20562328|NCT01318967|Wake Forest School of Medicine|Michael Rocco, MD|336-716-4650|mrocco@wfubmc.edu|
20562329|NCT01951170|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20562330|NCT01305252|Stanford University School of Medicine|Roham Zamanian, MD, FCCP|650- 725-5495|zamanian@stanford.edu|
20562331|NCT00804648|Vistakon|Arthur Shedden MD|904-443-1557||
20562332|NCT03631433|OSU|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
20562333|NCT04723394|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20562334|NCT00446459|University of Washington|Dr. Connie L. Davis|206-598-7162|cdavis@u.washington.edu|
20562335|NCT01965665|Duke University Medical Center|Michael Kerzner, DMP|919-613-4449|michael.kerzner@duke.edu|
20562336|NCT00253890|Butler Hospital|Dr. Michael D. Stein, MD|401-455-6646|mstein@butler.org|
20562337|NCT00858117|Northwestern University|Olga Frankfurt, MD|312 695 6180|o-frankfurt@northwestern.edu|
20562338|NCT00371787|Centre for Contact Lens Research|Dr. Craig Woods|1-519-888-4567|cawoods@uwaterloo.ca|36547
20562339|NCT02355275|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@gmail.com|838
20562340|NCT02115828|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
20562341|NCT01972724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20562342|NCT02765100|Weill Cornell Medicine|James H Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
20562343|NCT04977700|Klein Buendel, Inc.|Julia Berteletti|303-565-4321|jberteletti@kleinbuendel.com|
20562344|NCT01900249|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20562345|NCT02652442|James H Quillen VAMC|Research Health Science Specialist|(423) 926-1171|courtney.hall@va.gov|7518
20562346|NCT00244855|Fred Hutchinson Cancer Research Center|Dr. David Maloney|206-667-5616|dmaloney@fredhutch.org|
20562347|NCT02529995|AstraZeneca|Global Clinical Lead, Yuri Rukazenkov|+44 1625 231825|Yuri.Rukazenkov@astrazeneca.com|
20562348|NCT01883908|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
20562349|NCT01911169|Medical University of South Carolina|Dr. James Oates|843-789-6797|oatesjc@musc.edu|
20562350|NCT00364013|Amgen Inc.|Study Director|866-572-6436||
20562351|NCT00293293|Moffitt Cancer Center|Patricia L. Judson, M.D.|813-745-1600|Patricia.Judson@moffitt.org|
20516802|NCT03861845|Florida International University|Dr. Jaclyn Schwartz|305-348-3106|jschwart@fiu.edu|
20562352|NCT01149512|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
20562353|NCT00149838|MUSC|Mark S. George, MD, Professor|8438700368|georgem@musc.edu|
20562354|NCT03740009|UNC School of Medicine|Crystal Schiller, PhD|919-966-4810|crystal_schiller@med.unc.edu|
20562355|NCT01061151|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20562356|NCT00523237|Stanford University|Philip Grant, MD|650-723-2804|pmgrant@stanford.edu|
20516803|NCT01513174|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
20516804|NCT00850174|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516805|NCT02413320|University of Kansas Medical Center|Dr. Priyanka Sharma|913-588-6029|psharma2@kumc.edu|
20516806|NCT01363765|InCo-TB project, Gama Filho University|Anete Trajman|5521-82189194|atrajman@gmail.com|
20516807|NCT01900626|University of Wisconsin School of Medicine and Public Health|Benjamin J. Walker, MD|608/262-8858|bjwalker2@wisc.edu|
20516808|NCT02251886|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
20516809|NCT02682784|Medical University of South Carolina|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
20516810|NCT01702987|Beth Israel Deaconess Medical Center|Jim Wu|617-754-2390|jswu@bidmc.harvard.edu|
20516811|NCT00752973|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 345 9001|natalie.yantovskiy@taro.com|
20516812|NCT05428020|Rush University Medical Center|Anne DeBenedetti, Director of Research, Adult Reconstruction|3124322468|anne.debenedetti@rushortho.com|
20516813|NCT03502148|Privo Technologies|Dr. Manijeh Goldberg|9785872322|mgoldberg@privotechnologies.com|
20516814|NCT00365846|Emory University|Stuart Knechtle, MD|404-727-8465|stuart.knechtle@emoryhealthcare.org|
20516815|NCT01010932|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20516816|NCT02057458|Augusta University|Ryan Harris, PhD|7067215998|ryharris@augusta.edu|
20516817|NCT04263649|Becton, Dickinson and Company|Clinical Project Manager|00393452237718|gloria.viti@bd.com|
20562357|NCT01236001|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20562358|NCT01691690|Nationwide Children's Hospital|Dr. Arlyne Thung|(614) 722-4200|Arlyne.Thung@NationwideChildrens.org|
20562359|NCT04530747|Pennington Biomedical Research Center|Prachi Singh|12257633151|prachi.singh@pbrc.edu|
20562360|NCT03292913|RTI International Institute|Megan Lewis|206-268-3613|melewis@rti.org|
20562361|NCT03950622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562362|NCT04056624|East Carolina University, Department of Public Health|Stephanie Jilcott Pitts|252-744-5572|jilcotts@ecu.edu|
20562363|NCT00548418|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
20562364|NCT03977935|Changhai Hospital|Investigator of Clinical Trials|15021569528|1372971347@qq.com|
20562365|NCT01047241|Copenhagen University Hospital, Rigshospitalet|Sponsor's contact person Bettina Nygaard Nielsen|+45 35459546|bettina.nygaard.nielsen@regionh.dk|
20562366|NCT02092116|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
20562367|NCT03531840|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
20562368|NCT00770757|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@dom.wustl.edu|
20562369|NCT02267824|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
20562370|NCT00939510|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
20562371|NCT02933944|Targovax|Chief Medical Officer|+ 47 21398810|contact@targovax.com|
20562372|NCT02261467|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
20562373|NCT01199705|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20562374|NCT01415349|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20562375|NCT01041417|Emory University School of Medicine|Dr. Arshed Quyyumi|4047273655|aquyyum@emory.edu|
20562376|NCT02918071|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
20562377|NCT01616459|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562378|NCT03394885|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|angeles.secord@duke.edu|
20562379|NCT02515305|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20562380|NCT00203411|Translational Research in Oncology|Dr. Arash Naeim|310 267-6810|anaeim@mednet.ucla.edu|
20562381|NCT04980755|University of Plymouth|Dr Joseph Lanario|01752 764403|joseph.lanario@plymouth.ac.uk|
20562382|NCT01212991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562383|NCT03949335|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|ethoma39@its.jnj.com|
20562384|NCT01351272|Universitätsklinikum Würzburg|Prof. Dr. M. Herrmann|093120176650|Herrmann_m@ukw.de|
20562385|NCT01926977|Sierra Eye Associates|Arshad Khanani M.D., Vitreo-Retinal Diseases and Surgery|775-329-0286|arshad.khanani@gmail.com|
20562386|NCT02531113|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
20562387|NCT00632424|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
20562388|NCT00801983|University of Pittsburgh|Dr. Nancy Baker|412 383-6607|nab36@pitt.edu|
20562389|NCT02270645|University of Miami|Keyvan Nouri|3052433380|knouri@med.miami.edu|
20562390|NCT03149991|Massachusetts General Hospital|Dr. Rebecca Hock|617-872-3711|rhock@mgh.harvard.edu|
20562391|NCT02631603|LMU/ Haunersches Kinderspital|Prof. Dr. med. Matthias Griese|+498944000|matthias.griese@med.uni-muenchen.de|57870
20562392|NCT03122886|Mayo Clinic|Aminah Jatoi, MD|507/284-2511|Jatoi.Aminah@mayo.edu|
20562393|NCT03312907|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20562394|NCT03314753|Medtronic|Study Project Manager (CSM)|00491742122|petra.kremer@medtronic.com|081
20562395|NCT04688450|Massachusetts General Hospital|Dr. Andrew Tomas Reisner|617-726-2241|areisner@mgh.harvard.edu|
20562396|NCT02544074|The Ohio State University|Douglas Scharre, MD|614-293-4969|Doug.Scharre@osumc.edu|
20562397|NCT04498052|University of Utah|Kensaku Kawamoto, MD, PhD, MHS / Associate Chief Medical Information Officer|801-581-4080|kensaku.kawamoto@utah.edu|
20562398|NCT03189524|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20562399|NCT04879524|Queen Mary University of London|P Chaichanavichkij|020 7882 8752|p.chaichanavichkij@qmul.ac.uk|
20562400|NCT01780298|Philip Morris Products S.A.|Julia HOENG, PhD|+41 (58) 242 2214|clinicaltrials.pmi@pmi.com|
20562401|NCT03718065|Medical University of South Carolina|Dr. Constance Guille|843-792-6489|guille@musc.edu|
20562402|NCT05286385|Cochlear Ltd.|PRS Specialist, Clinical Affairs|+61294286555|cltd-prs-admin@cochlear.com|
20562403|NCT04252586|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20562404|NCT00232180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562405|NCT02748317|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
20562406|NCT00414544|Cosmeta, A Gel-Del Technolgies Company|Dr. David B. Masters|651 209-0707|dmasters@gel-del.com|
20562407|NCT04259450|Affimed GmbH|Clinical Operations|+49 62216530770|trials@affimed.com|
20562408|NCT03452189|NYU Langone Health|Dr. Jerome Lowenstein|+1 212 263 5635|Jerome.Lowenstein@nyulangone.org|
20562409|NCT03390296|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Associate Professor|713-794-4392|NDaver@mdanderson.org|
20562410|NCT02724592|University of Greifswald|Dr. Mohammad Alkilzy|0049-17623399340|alkilzym@uni-greifswald.de|
20562411|NCT01714492|The University of Tennessee|Richard Komistek, Ph. D.|8659744159|rkomiste@utk.edu|
20516818|NCT01783561|Neonatal Research Institute, Sharp Mary Birch Hospital for Women and Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com|
20516819|NCT04503174|Tandem Diabetes Care|Clinical Affairs|877-801-6901|clinicalaffairs@tandemdiabetes.com|
20516820|NCT00221299|Unversity of California Davis|Nancy E. Lane MD, Director, Center for Musculoskeletal Health|916 734-0753|nancy.lane@ucdmc.ucdavis.edu|
20516821|NCT03999684|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
20516822|NCT00836056|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20562412|NCT02584829|Fred Hutchinson Cancer Research Center|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
20562413|NCT01950780|Columbia University Dept of Dermatology|Director of Clinical Research Dermatology|2123056953|jc299@cumc.columbia.edu|
20562414|NCT00639860|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
20562415|NCT01065506|The University of Texas at Austin|Jasper Smits|512-475-8095|smits@utexas.edu|
20516823|NCT02711852|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20562416|NCT01035658|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20562417|NCT02988817|Genmab A/S|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
20562418|NCT03926039|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
20562419|NCT05082935|University of Oregon|Dr. Leslie Leve|541-346-9528|leve@uoregon.edu|
20529154|NCT01004978|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20562420|NCT02122445|Sport and Spine Rehab Clincal Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
20562421|NCT02869334|Nathan Kline Institute|Dr. Daniel Javitt|8453986534|javitt@nki.rfmh.org|
20562422|NCT02379819|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20562423|NCT01839331|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|720-437-6500|clinicaltrials@ampiopharma.com|
20562424|NCT03752151|Medtronic, Plc|Dana Wigert, Sr Prin Clinical Research Specialist|+17635262802|dana.wigert@medtronic.com|
20562425|NCT03029598|University of Washington - Cancer Vaccine Institute|Director of Clinical Operations|2062459258|childj@uw.edu|
20562426|NCT03074331|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20562427|NCT03451721|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
20562428|NCT00350792|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20562429|NCT01546753|University of Arkansas for Medical Sciences|Dr. Stacie Jones|(501) 364-1060|JonesStacieM@uams.edu|
20562430|NCT00960141|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20562431|NCT04086966|University of Alabama at Birmingham|April Riddle|(205)934-6504|ariddle@uabmc.edu|
20562432|NCT03036813|Global Blood Therapeutics|Margaret Tonda, PharmD, Sr. Director, Clinical Science|(650) 741-7761|mtonda@gbt.com|
20562433|NCT04470375|University of South Dakota|Dr. Kory Zimney|16056586373|kory.zimney@usd.edu|
20562434|NCT04762875|Ensoma|Elizabeth Hook|617-766-3917|ehook@ensoma.com|
20562435|NCT05946551|Emory University|Tiffany Walker, MD Assistant Professor|404-778-1621|tiffany.austin.walker@emory.edu|
20562436|NCT01390818|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
20562437|NCT01943799|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20562438|NCT04594759|Medical University of South Carolina|Dr. Samantha Karlin|(843)- 714-0146|karlin@musc.edu|
20516824|NCT00576056|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
20516825|NCT00998374|Lenox Hill Hospital|Dr. Mitchell Roslin|212-434-3285|MRoslin@NSHS.edu|
20516826|NCT03420300|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-223123456|jacque_liu@mail2000.com.tw|63572
20516827|NCT01790581|UNC Charlotte|Erik Wikstrom|704-778-5784|ewikstrom@uncc.edu|
20516828|NCT00584922|University of Oklahoma Health Science Center|Sunny Po, MD, PhD|405-271-9696|Sunny-Po@ouhsc.edu|
20516829|NCT02779543|Weill Cornell Medical College|Dr. Ana Krieger|6469629316|ack2003@med.cornell.edu|
20516830|NCT02372630|State University of NY at Buffalo|Paresh Dandona, B.Sc., M.B. B.S., D.Phil., F.R.C.P|71653518520|dandona@buffalo.edu|
20516831|NCT05275205|Unity Biotechnology, Inc.|Study Director|650-513-0096|UBX1325_medicalmonitor@unitybiotechnology.com|
20516832|NCT02629094|National Institute of Allergy and Infectious Diseases|Hadigan, Colleen|+1 301 594 5754|hadiganc@mail.nih.gov|
20516833|NCT03041025|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20516834|NCT03962348|Columbia University Irving Medical Center|Dr. Michael Compton|646-774-8476|mtc2176@cumc.columbia.edu|
20516835|NCT02648880|University of Colorado|Ryan Marker|3037240819|ryan.marker@cuanschutz.edu|
20516836|NCT03880266|Dermira, Inc|Jordan Adajar|650-421-2919|jordan.adajar@dermira.com|
20516837|NCT02350647|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
20516838|NCT00831428|University of Dundee|Dr Karine Clearie|01382 496440|k.clearie@dundee.ac.uk|
20516839|NCT01577381|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516840|NCT01313780|Seoul Asan Hospital|Taewon Kim|82-2-3010-3910|twkimmd@amc.seoul.kr|
20516841|NCT00467896|Actelion Pharmaceuticals, US, Inc.|Wade Benton, Pharm D / Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
20516842|NCT03772522|MAP Centre for Urban Health Solutions, Unity Health Toronto|Dr. Naomi Thulien|647-460-0781|ThulienN@mcmaster.ca|
20516843|NCT03818581|Massachusetts General Hospital|Dr. John Winkelman|617-643-9101|jwwinkelman@mgh.harvard.edu|
20516844|NCT01686451|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou, 325000, China|Dr. JiFei Tang|+8615968766021|jiftang@126.com|
20516845|NCT02096211|Johnson & Johnson MedTech|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
20516846|NCT01281501|Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital.|Khrongwong Musikatavorn, MD|+662-256-4000|kmusikatavorn@yahoo.com|4553-5
20516847|NCT00561834|Rocky Mountain Lions Eye Institute, Dept. of Ophthalmology|Dr. Naresh Mandava, M.D.|720-848-2500|Naresh.mandava@ucdenver.edu|
20529155|NCT00369915|NIMH/NIH|Maura Furey, PhD|301-594-7773|mfurey@mail.nih.gov|
20529156|NCT00814138|University of Kansas Medical Center|Richard J. Barohn, MD/ Chairman of Neurology|913-588-6094|rbarohn@kumc.edu|
20529157|NCT02381678|Guangdong General Hospital|Dr. Huiming Guo (Chief in Cardiac Surgical Department)|86-13609089789|guohuiming@vip.tom.com|
20516848|NCT02996591|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
20516849|NCT01439880|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20562439|NCT01691326|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20562440|NCT01832480|Tulane University School of Public Health and Tropical Medicine|Patricia Kissinger, Ph.D.|504-988-7320|kissing@tulane.edu|
20562441|NCT03639558|University of Nottingham/Psychiatric Hospital of the Cross|Dr. Joseph Dib|07748668553|joseph.elie.dib@gmail.com|
20562442|NCT03144674|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20562443|NCT02414204|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Timmy Lee|205-934-3589|txlee@uab.edu|
20562444|NCT01395758|ArQule, Inc.|Brian Schwartz, MD Chief Medical Officer|781-994-0300|ClinicalTrials@arqule.com|
20562445|NCT01514734|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20562446|NCT00696618|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)641-8762|ejfuchs@jhmi.edu|
20562447|NCT03942042|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20562448|NCT05135000|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20562449|NCT02788773|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
20562450|NCT04411056|The Guthrie Clinic|Praneet Madabhushi MD|5708874882|praneeth.madabhushi@guthrie.org|
20562451|NCT03702842|University of Florida|Emily J Fox, Research Associate Professor|352-273-6085|ejfox@phhp.ufl.edu|
20562452|NCT03632941|Duke University|Michael Morse, M.D.|919-681-3480|michael.morse@duke.edu|
20562453|NCT02460900|NIH|National Heart, Lung and Blood Institute--Josh Fessel|3018275514|josh.fessel@nih.gov|
20562454|NCT05985044|Johns Hopkins University School of Nursing|Dr.Binu Koirala|707-225-2166|bkoiral1@jhu.edu|
20562455|NCT04888637|University of Arkansas for Medical Sciences (UAMS)|University of Arkansas for Medical Sciences (UAMS)|501-526-6876|ORRAClinicalTrials-govadmin@uams.edu|
20562456|NCT04520061|Mass General Hospital|Lisa Morse|617-724-2000|lgmorse@partners.org|
20562457|NCT04163328|UAB|Dr. Kelly K. Nichols|205-975-9935|nicholsk@uab.edu|
20562458|NCT02279095|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20562459|NCT05938413|Columbia University|Rebecca Schnall, PhD, MPH, RN|212-342-6886|rb897@cumc.columbia.edu|
20562460|NCT04922021|LEO Pharma A/S|Disclosure Specialist|+4544945888|disclosure@leo-pharma.com|
20562461|NCT01285999|Cardiovascular Institute and Fu Wai Hospital|Dr. Runlin Gao|+861068314466|gaorunlin@citmd.com|
20562462|NCT04300647|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20562463|NCT05055778|University of Virginia|Kara P. Wiseman, MPH, PhD|434-243-8126|kara.wiseman@virginia.edu|
20562464|NCT04714320|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20562465|NCT03190174|Sarcoma Oncology Research Center|Erlinda M. Gordon, MD/Principal Investigator|310-552-9999|egordon@sarcomaoncology.com|
20562466|NCT04755660|National Taipei University of Nursing and Health Sciences|Dr. Tingru Lin|886-2-28227101|tingru@ntunhs.edu.tw|3150
20562467|NCT02879162|Canadian Cancer Trials Group|Dr. Janet Dancey|6135336000|jdancey@ctg.queensu.ca|75606
20562468|NCT02824029|Karmanos Cancer Institute|Dr. Dipenkumar Modi, MD|313-576-8782|modid@karmanos.org|
20562469|NCT03873779|Zeltiq|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20562470|NCT02581215|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20562471|NCT05930782|MMV Medicines for Malaria Venture|Dr Anne Claire Marrast|+41 22 555 03 00|marrasta@mmv.org|
20562472|NCT04270526|Mount Auburn Hospital|William Winkelman|617-354-5452|william.winkelman@mah.harvard.edu|
20562473|NCT02566902|University of California - San Diego|Mike Gardiner, MD|8589668036|magardiner@ucsd.edu|
20516850|NCT02956460|CooperVision|Jose Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com|
20516851|NCT02378935|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20516852|NCT01980771|State University of New York, Downstate Medical Center|Tracey Wilson, Principal Investigator|718 270 2105|Tracey.Wilson@downstate.edu|
20516853|NCT01163461|VAMC Puget Sound|Dr. Diane Kendall (PI)|206-762-1010|diane.kendall@va.gov|
20516854|NCT04129346|Northwestern University Feinberg School of Medicine|Siobhan Phillips|312-503-4235|smphillips@northwestern.edu|
20516855|NCT03935880|University of Wisconsin - Madison|Andrew Brooks|248-953-9777|abrooks2@uwhealth.org|
20516856|NCT02476994|Baxter Healthcare|Clinical Trials Disclosure Group||joe_archer@baxter.com|
20516857|NCT02563561|Spectrum Pharmaceuticals, Inc. Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
20516858|NCT03154047|Prothena Biosciences|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
20516859|NCT00365365|Sanofi|Trial Transparency Team||Contact_Us@sanofi.com|
20516860|NCT01796171|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
20516861|NCT00418561|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20516862|NCT02322593|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
20516863|NCT00200785|Silliker, Inc./Plant Bioactives Research Institute, Inc.|Larry D. Lawson|801-226-3041|larry.lawson@silliker.com|
20516864|NCT04274686|University of New Mexico|Dr. Neal Gerstein|505-272-2610|ngerstein@salud.unm.edu|
20516865|NCT02566239|Oregon Health & Science University|Dr. Jeffrey Kaye|503 494 6695|kaye@ohsu.edu|
20516866|NCT03496623|United Therapeutics|United Therapeutics Global Medical Information|240-821-1881|304perfectstudy@lungbiotechnology.com|
20516867|NCT02543203|The Ohio State University Nisonger Center|Dr. Jill Ann Hollway|614-688-3848|Jill.Hollway@osumc.edu|
20516868|NCT03020615|St. Jude Children's Research Hospital|Jeremie Estepp, MD|(901) 595-5703|jeremie.estepp@stjude.org|
20516869|NCT00089661|Amgen Inc.|Study Director|866-572-6436||
20516870|NCT02062580|University of Cape Town and University of Washington|Heather Jaspan|+2721 4066823|hbjaspan@gmail.com|
20516871|NCT02077465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20516872|NCT05704426|Hackensack Meridian Health|Sameer Jamal, MD|15519962997|Sameer.Jamal@hmhn.org|
20516873|NCT02481830|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1(800) 332-2056|Clinical.Trials@bms.com|
20516874|NCT04627038|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20516875|NCT00794963|North Shore Long Island Jewish Health System, Zucker Hillside Hospita, Glen Oaks, NY|Peter Manu, MD|718 470-8290 pmanu@nshs.edu||
20562474|NCT01108003|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20562475|NCT04425629|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20562476|NCT03113617|Stanford Medicine at Stanford University|David G Marcellus|650-723-4547|dmarcel2@stanford.edu|
20562477|NCT01406223|Duke University Medical Center|Principal Investigator|919-668-3987|francis.mcclernon@duke.edu|
20516876|NCT01827163|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
20516877|NCT03375463|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20516878|NCT01037114|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516879|NCT03075553|Mayo Clinic|Stephen M Ansell MD PhD|507/284-2511|ansell.stephen@mayo.edu|
20516880|NCT03620747|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20516881|NCT01808794|Tufts University|Associate Vice Provost for Research Administration & Development|617-627-7000|tss@tufts.edu|
20516882|NCT04314362|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
20516883|NCT02129426|University of Louisville|John W. Berkenbosch|502-852-3720|john.berkenbosch@louisville.edu|
20516884|NCT01860521|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|Dr. Umberto Leone Roberti Maggiore|00393289461340|ulrm@libero.it|
20516885|NCT00904423|Stanford Cancer Institute, Stanford University|Mark D Pegram, MD|650-723-5801|mpegram@stanford.edu|
20516886|NCT03025945|Arizona Eye Consultants|Sean McCafferty, MD|520-327-3487|sjmccafferty66@hotmail.com|
20516887|NCT00635492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20516888|NCT03617523|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
20516889|NCT00467363|NICHD|Dr Enrique Schisterman|(301) 435-6893|schistee@mail.nih.gov|
20516890|NCT00982397|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
20516891|NCT00578552|Mayo Clinic|Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
20516892|NCT05169710|Sumitomo Pharma America Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@suniovion.com|
20516893|NCT04400890|formerly of Mount Carmel Health Systems|Marvin McCreary, MD|614-526-8492|Marvin.McCreary+RCT@gmail.com|
20516894|NCT05615935|National Taiwan University|Dr. Piao-Yi Chiou|02-2312-3456|piaoyi@ntu.edu.tw|288427
20516895|NCT00693628|Department of Orthopedic Surgery & Rehabilitation, Orthotics and Prosthetics Division|Jonathan Day||jonathan-day@ouhsc.edu|
20516896|NCT01079988|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20516897|NCT02158663|James A. Haley VA Hospital|F. Andrew Kozel|(813) 972-2000|FRANK.KOZEL@VA.GOV|
20516898|NCT04544787|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
20516899|NCT03273153|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20516900|NCT02512900|MedImmune, LLC|Rene van der Merwe, Senior Director, Clinical Development, Respiratory, and Inflammation|301-398-0000||
20516901|NCT00838539|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20516902|NCT01908205|Holland Bloorview Kids Rehabilitation Hospital|Lisa Genore|416-425-6220|lgenore@hollandbloorview.ca|6443
20516903|NCT00408070|UCHC|Paige Dunion|860-679-6571|pdunion@uchc.edu|
20516904|NCT03500692|Abbott|Sripad Bellary|6503531726|sripad.bellary@abbott.com|
20516905|NCT04149964|William Beaumont Hospitals|Mitchell Shecter, DO|2487629363|mitchell.shecter@corewellhealth.org|
20516906|NCT01379664|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
20516907|NCT01697696|Novartis Pharmaceuticals|Study Director|862-778-8300||
20516908|NCT01424644|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20516909|NCT03616106|University of Colorado College of Nursing|Samantha Stonbraker, Assistant Professor|720-880-8194|Samantha.Stonbraker@Cuanschutz.edu|
20516910|NCT01880593|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
20516911|NCT02272777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20516912|NCT04732195|Emory University|Dr. Lokesh Guglani|404-712-2324|lokesh.guglani@emory.edu|
20516913|NCT02298322|Zeltiq Aesthetics, Inc. an Allergan Affiliate|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20516914|NCT00440297|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20516915|NCT02445339|NYU Langone Health|Ryan P. McCormack, MD|212-562-6561|Ryan.McCormack@nyulangone.org|
20516916|NCT03206177|University of Oklahoma Health Sciences Center, Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
20516917|NCT02024932|Novartis Pharmaceuticals|Study Director|862-778-1873||
20516918|NCT00727961|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20516919|NCT02186821|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
20516920|NCT05472038|BioNTech clinical trials patient information|BioNTech SE|6131 90840|patients@biontech.de|
20516921|NCT00539071|Northwestern University|Dr. Herbert Meltzer|(312) 503-0309|h-meltzer@northwestern.edu|
20516922|NCT03235739|Cleveland Clinic|Alparslan Turan, MD|216-4459857|turana@ccf.org|
20516923|NCT02847650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516924|NCT00218257|University of Minnesota|Dr. Sheila Specker|612-273-9806|speck001@umn.edu|
20516925|NCT02517294|Nemours|Dr Katrin Post-Martens|904-330-9942|Katrin.Post-Martens@nemours.org|
20529158|NCT01050946|Medical College of Wisconsin|Jeanne Palmer,MD|414-805-6800|jpalmer@mcw.edu|
20529159|NCT00583908|Vistakon|Kurt Moody, OD FAAO|904-443-3088|kmoody1@its.jnj.com|
20562478|NCT01937507|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
20529160|NCT01749410|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20529161|NCT00270296|Harvard TH Chan School of Public Health|Dr. Roger Shapiro|617-432-2334|rshapiro@hsph.harvard.edu|
20529162|NCT01265394|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
20529163|NCT01116037|Medtronic|Ryan Palmer|+17635149732|ryan.j.palmer@medtronic.com|
20529164|NCT00848757|Yale University School of Medicine|Michelle Van Name|203-785-5831|michelle.vanname@yale.edu|
20529165|NCT01064414|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20529166|NCT00249873|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
20529167|NCT00412841|NYULMC|Dr. H. Michael Belmont|212-598-6518|michael.belmont@nyumc.org|
20529168|NCT04553666|University of Rochester Medical Center|Dr. Nikesha Gilmore, Assistant Professor|1-585-275-1275|nikesha_gilmore@urmc.rochester.edu|
20529169|NCT01781962|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20529170|NCT01167569|Rutgers RWJMS|Alan Spotnitz, MD|732-235-9806|spotnitz@rwjms.rutgers.edu|
20529171|NCT05417412|San Diego State University|Dr. V. Robin Weersing|619-594-8892|robin.weersing@sdsu.edu|
20529172|NCT01576575|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20529173|NCT00954681|NYSPI/Columbia University|John J. Mariani|6467746140|john.mariani@nyspi.columbia.edu|646
20529174|NCT03075267|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
20529175|NCT02168491|Medical University Vienna, Austria|Prof. Dr. Michael Krebs|+ 43 1 40400|michael.krebs@meduniwien.ac.at|43120
20529176|NCT00809445|Columbia University, Mailman School of Public Health|Dr. Lisa Metsch|212-305-3577|lm2892@columbia.edu|
20529177|NCT03335800|Associate Professor of Medicine, Stanford University|Minang (Mintu) Turakhia, Associate Professor of Medicine, Stanford University|(650) 493-5000|mintu@stanford.edu|
20529178|NCT01566604|Novartis|Study Director|862-778-8300||
20529179|NCT01204203|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
20529180|NCT01610037|Novartis Pharmaceuticals|Study Director|862-778-8300||
20529181|NCT01668836|Heart Institute (InCor), University of São Paulo Medical School|Antonio de Padua Mansur - Associate Professor|55-11-26615387|apmansur@usp.br; apmansur@yahoo.com|
20529182|NCT00972959|"Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital of Athens,"|Prof. M. A. Dimopoulos|0030 210 3381511|mdimop@med.uoa.gr|
20529183|NCT02895035|Penn State Hershey Eye Center|Seth Pantanelli|717-531-5690|spantanelli@pennstatehealth.psu.edu|
20529184|NCT00661089|The Rehabilitation Institute of Chicago|Dr. Christina Marciniak|312-238-1000|cmarciniak@ric.org|
20529185|NCT00274742|Amgen Inc.|Study Director|866-572-6436||
20529186|NCT02697071|Lewis Gale Medical Center|Corey Heitz, MD|5406322364|coreyheitzmd@gmail.com|
20529187|NCT02256696|Vanderbilt University|Dr. Kelly Dooley|(615) 322-8972|kelly.e.dooley@vumc.org|
20529188|NCT02572453|Dana-Farber Cancer Institute|Jillian Foreman|1-877-338-7425|jillianM_foreman@dfci.harvard.edu|
20529189|NCT03877744|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
20529190|NCT03361306|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20529191|NCT03861091|Wake Forest Baptist Comprehensive Cancer Center|Biostatistician|336-716-5440|blevine@wakehealth.edu|
20529192|NCT00321906|The University of Chicago|Edward Garrity, MD|(773) 834-1119|egarrity@uchicago.edu|
20529193|NCT02778152|The Research Institute at Nationwide Children's Hospital|Dr. Peter Minneci|614-722-3066|peter.minneci@nationwidechildrens.org|
20529194|NCT02038179|University of Alabama at Birmingham|Dr. Elizabeth Rahn|205-996-6552|elizabethrahn@uabmc.edu|
20529195|NCT03626701|AVITA Medical|Elizabeth Kirshner|661-877-6869|ekirshner@avitamedical.com|
20529196|NCT00807885|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
20529197|NCT03489343|Symphogen AS|Medical Director|0045 45265050|info@symphogen.com|
20529198|NCT00327717|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affairs|81-3-3817-3914||
20529199|NCT01912950|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20529200|NCT03242941|Medtronic|Lilian Kornet|+31433566710|lilian.kornet@medtronic.com|
20529201|NCT01630135|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529202|NCT04767373|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20529203|NCT01502033|Mayo Clinic|Dr. Paul Croarkin|(507) 293-2557|croarkin.paul@mayo.edu|
20529204|NCT02658669|VA San Diego Healthcare System|Dr. Henry Orff|(858) 642-6492|Henry.Orff@va.gov|
20529205|NCT00186485|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
20529206|NCT02247739|Pharming Group NV|VP Clinical Research & Medical Affairs||a.relan@pharming.com|
20529207|NCT02550743|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD, Principal Investigator|14018633000|kayla_rosati@brown.edu|
20529208|NCT03804268|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20529209|NCT01246895|Piramal Healthcare (Canada) Limited - Bio-Orthopaedics Division|David Castelo, Clinical Research Manager|450-686-2437|david.castelo@piramal.com|313
20529210|NCT00838097|Amgen Inc.|Study Director|866-572-6436||
20529211|NCT01156805|Hospital General de Granollers|Dr. Esteve Llargues|938425000|ellargues@fhag.es|2675
20562479|NCT01102231|IFCT|Communications Officer|+33156811045|contact@ifct.fr|
20562480|NCT03903822|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562481|NCT00995904|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20562482|NCT01792830|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20529212|NCT03311841|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529213|NCT02017093|University of Haifa|Prof. Eli Carmeli|972-4-8288-397|ecarmeli@univ.haifa.ac.il|
20562483|NCT05274217|University of Washington|Teresa Evans-Campbell|206-543-6075|tecamp@uw.edu|
20516926|NCT02175095|Asan Medical Center|Yong Sang Hong, M.D., Ph.D.|+82-2-3010-3227|yshong@amc.seoul.kr|
20516927|NCT00462345|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20516928|NCT03909607|Maimonides Medical Center|Sergey Motov MD|718-283-8693|smotov@maimonidesmed.org|
20516929|NCT03255733|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
20516930|NCT02146105|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
20516931|NCT04347018|University at Buffalo|Mohammed Al-Zainal|7168292845|malzaina@buffalo.edu|
20516932|NCT03122535|University of Utah|Elizabeth Nuttall|8012133461|elizabeth.nuttall@hsc.utah.edu|
20516933|NCT02718326|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20516934|NCT02646124|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
20516935|NCT05025345|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
20516936|NCT03040362|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20516937|NCT00857454|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20516938|NCT00984022|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
20516939|NCT01153503|University of Texas Southwestern Medical Center|Irina Gasanova, MD, PhD|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
20516940|NCT00573443|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
20516941|NCT03591458|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
20516942|NCT02472366|Hopital Lariboisiere|Professor Pascale Massin|0149 95 24 74|pascale.massin@lrb.aphp.FR|
20516943|NCT01707420|University of Colorado|Thomas Notides|720-777-6005|thomas.notides@childrenscolorado.org|
20516944|NCT03699020|University of California San Diego|Maile Young Karris|1-619-543-5039|m1young@health.ucsd.edu|
20516945|NCT00280904|Codman & Shurtleff|J. Thomas Megerian|1-508-828-8274|jmegeri1@its.jnj.com|
20516946|NCT00448019|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Cancer Center Leukemia Department|713-792-7734|CR_Study_Registration@mdanderson.org|
20516947|NCT01273805|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942|Brian_Wolpin@dfci.harvard.edu|
20516948|NCT02647944|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20516949|NCT02325531|Kaiser Permanente Center for Health Research|Rachel Gold|5033352400|rachel.gold@kpchr.org|
20516950|NCT02760368|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
20516951|NCT01565902|Novartis Pharmaceuticals|Study Director|862-778-8300||
20516952|NCT03645785|Albany Medical Center|Vikas Bhatt|5182623341|bhattv@amc.edu|
20516953|NCT04533594|JOHNS HOPKINS HOSPITAL|Dulce M. Cruz-Oliver, MD|4109558305|dcruzoli@jhmi.edu|
20516954|NCT02757105|RedHill Biopharma Ltd.|Dr. Terry F. Plasse|972-(0)3-541-3131|terry@redhillbio.com|
20516955|NCT00717405|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20516956|NCT00473330|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20516957|NCT01975948|Dalhousie University, Department of Psychiatry|Dr. Bianca Lauria-Horner|902-473-5633|bianca.horner@dal.ca|
20516958|NCT02937870|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20516959|NCT03749252|Guerbet|Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20516960|NCT00609674|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516961|NCT03098394|University of Maryland School of Medicine|Richard Gentry Wilkerson|4103285555|gwilkerson@som.umaryland.edu|
20516962|NCT00204373|The University of Alabama at Birmingham|Dr. C. Mel Wilcox|205-934-6060|melw@uab.edu|
20516963|NCT01885117|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20516964|NCT00244764|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516965|NCT02701556|Valeant Pharmaceuticals|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
20516966|NCT01001208|Amgen Inc.|Study Director|866-572-6436||
20516967|NCT03546842|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20516968|NCT01723397|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
20516969|NCT01884519|GlaxoSmithKline|GSK Response Center|866-435-7343||
20516970|NCT01870856|Alcon Research, Ltd.|Anne Brobst, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20516971|NCT02352259|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
20516972|NCT00833937|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20516973|NCT03031847|UPMC Presbyterian Hospital|Eric Pasquantonio|4126478210|pasquantonioej@upmc.edu|
20516974|NCT01353664|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20516975|NCT01237054|National Cancer Institute|Dr. Peter Choyke|301-402-8409|pchoyke@mail.cc.nih.gov|
20516976|NCT05323396|University of North Carolina at Chapel Hill|Melisa Reimer-McAtee, MD|265 175 5056|melissa_reimer-mcatee@med.unc.edu|
20516977|NCT00913627|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20516978|NCT02444715|Luxembourg Institute of Science and Technology|Dr. Lübomira Spassova|+352 275 888 1|lubomira.spassova@list.lu|
20516979|NCT01944930|Lahey Hospital and Medical Center|Thomas Schnelldorfer|781-744-5100|thomas.schnelldorfer@lahey.org|
20516980|NCT00095212|Massachusetts General Hospital|Steven Grinspoon, MD|617 724 9109|sgrinspoon@partners.org|
20562484|NCT00311363|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20516981|NCT04234997|The University of Texas Health Science Center at Houston|Robert Suchting, MD|713-486-2521|Robert.Suchting@uth.tmc.edu|
20516982|NCT02242201|Mayo Clinic|Dr. Rebecca L. Johnson|507-266-2049|Johnson.Rebecca1@mayo.edu|
20516983|NCT03681470|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
20516984|NCT05593965|University of North Carolina at Chapel Hill|Justin Riddle, PhD|(919) 966-4584|justin_riddle@med.unc.edu|
20529214|NCT00765856|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
20516985|NCT02066922|Alcon Research, Ltd.|Clinical Lead, Vision Care Development|1-888-451-3937|alcon.medinfo@alcon.com|
20516986|NCT03020641|Ramon y Cajal University Hospital|Characterization of changes in peritoneal cells gene expression after standard versus low pressure l|610 312962|aserranor@salud.madrid.org|+34
20516987|NCT04611789|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20516988|NCT02851992|Zimmer Biomet|Lisette Smid, Clinical Project Lead|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
20516989|NCT03238781|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20516990|NCT03161405|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20516991|NCT00837486|Medtronic Neuromodulation|Eric Williamson, Clinical Evidence Specialist|763-526-7982|medtronicneurotrials@medtronic.com|
20516992|NCT02655679|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20516993|NCT02039908|Florida International University|William E. Pelham, Jr., Ph.D.|305-348-0477|wpelham@fiu.edu|
20516994|NCT01597245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20516995|NCT00731783|Washington University|Stephanie A. Fritz, M.D., M.S.C.I.|314-454-6050|fritz_s@kids.wustl.edu|
20516996|NCT02674152|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20516997|NCT00579345|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20516998|NCT01921894|University of Pittsburgh|Dr. Juan C. Celedon, Niels K. Jerne Professor of Pediatrics|412-692-8429|juan.celedon@chp.edu|
20516999|NCT02267187|University of Pittsburgh|Patsy Simon|412-648-9207|simonpa@upmc.edu|
20517000|NCT02222818|Medtronic Cardiac Rhythm and Heart Failure|CRTee Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
20517001|NCT00508651|MedImmune, LLC|Judith Falloon, MD|301 398 0000|falloonj@medimmune.com|
20517002|NCT03155425|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Clinical Operation Director: Chenglei Qiao|+86-18036618600|chenglei.qiao@hengrui.com|
20517003|NCT01530880|Columbia University|Michael Schmidt|212-305-8745|mjs2134@columbia.edu|
20517004|NCT02713425|Mayo Clinic|Stephen P. Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
20517005|NCT00738049|University of Texas Medical School at Houston|K. Lance Gould, MD|713-500-6611|K.Lance.Gould@uth.tmc.edu|
20517006|NCT03874715|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20517007|NCT00461786|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20517008|NCT00934050|Transition Therapeutics Ireland Limited and Transition Therapeutics USA Inc.|Susan Abushakra, MD, Chief Medical Officer|+1 650 425 6370|susan.abushakra@tthi.us|
20517009|NCT00875550|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
20517010|NCT00835991|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517011|NCT00829309|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517012|NCT01705574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20517013|NCT00777023|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
20517014|NCT02659150|Massachusetts General Hospital|Ahmed Tawakol, MD|617-724-3699|atawakol@mgh.harvard.edu|
20517015|NCT01215279|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
20517016|NCT00274781|The Cleveland Clinic|Mikkael Sekeres, MD, MS|216-445-9353|sekerem@ccf.org|
20517017|NCT02214615|VAMC and Yale University|Stephen Waxman|203-937-3802|stephen.waxman@yale.edu|
20517018|NCT01200810|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|(732) 235-8675|steinmn@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
20517019|NCT02477202|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi, MD|212-639-5016|chid@MSKCC.ORG|
20517020|NCT00904215|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517021|NCT00640562|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20517022|NCT00448591|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20517023|NCT00003659|Memorial-Sloan Kettering Cancer Center|Dr. David Scheinberg|646-888-2190|scheinbd@mskcc.org|
20517024|NCT03925532|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
20517025|NCT05446870|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20517026|NCT05244421|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20517027|NCT02689505|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517028|NCT00424619|McMaster University|Dr. Alexandra Papaioannou|905-521-2100|papaioannou@hhsc.ca|77715
20517029|NCT04405570|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
20517030|NCT04499963|Duke University|Richard Bedlack, MD, PhD|919-668-2839|richard.bedlack@duke.edu|
20517031|NCT01005745|H. Lee Moffitt Cancer Center and Research Institute|Amod Sarnaik, M.D.|813-745-8581|amod.sarnaik@moffitt.org|
20517032|NCT03444090|Evergreen General Hospital, Taoyuan, Taiwan|Dr. Chi-Liang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
20517033|NCT02399917|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Associate Professor|713-794-4392|NDaver@mdanderson.org|
20517034|NCT01208337|University of Pittsburgh|Dr. Rakesh Sindhi|412-692-6110|rakesh.sindhi@chp.edu|
20517035|NCT03226522|Axsome Therapeutics|Study Director|212-332-5061|cstreicher@axsome.com|
20517036|NCT00984126|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20517037|NCT01938066|The Ohio State University|Gayle Gordillo|6142938566|gayle.gordillo@osumc.edu|
20517038|NCT00501345|UT MD Anderson Cancer Center|Jean-Bernard Durand, MD / Professor||CR_Study_Registration@mdanderson.org|
20517039|NCT03335761|Medtronic|Mylène Champs (Sr Clinical Research Specialist)|+17635261627|mylene.champs@medtronic.com|
20517040|NCT02739997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20517041|NCT02196675|Ethicon|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20517042|NCT02009163|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20562485|NCT03811574|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20562486|NCT01697969|Alcon Research, Ltd.|Danyel Crout Carr, MS, CCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20562487|NCT01542229|Charleston VAMC|Dr. Anouk L. Grubaugh|843-789-5853|grubaugh@musc.edu|
20562488|NCT05360901|Brigham and Women's Hospital|Jessica M. Lipschitz|617-732-6548|jlipschitz@bwh.harvard.edu|
20562489|NCT05609032|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@cumc.columbia.edu|
20562490|NCT03764475|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20562491|NCT02574455|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20562492|NCT02189915|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
20562493|NCT06243796|Nakhon Phanom hospital|Dr.Kriengkrai Prasert|+6642199222|gpsiam28@gmail.com|1091
20562494|NCT00995150|Medicines360|Emily Morris|415.951.8700|emorris@medicines360.org|
20562495|NCT01373346|Gangnam severance hospital|Seung Ho Choi, M.D., Ph.D.|82-2-2019-3374|choish@yuhs.ac|
20562496|NCT01198028|MD Anderson Cancer Center|Dr. Bonnie Glisson, MD,Professor, Thoracic-Head & Neck Med Onc|(713) 792-6363|bglisson@mdanderson.org|
20562497|NCT01186198|Abbott Medical Devices|Jessie Coe|224 668 5360|Jessie.coe@abbott.com|
20562498|NCT00970359|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho|646-888-4235|hoa@mskcc.org|
20562499|NCT01759771|Ralph H. Johnson Veterans Affairs Medical Center|Stephen J. Savage, MD, Chief Section of Urology|843 789 7330|savages@musc.edu|
20562500|NCT03631550|Neurolief Ltd.|Michal Kedar-Datel|+972-52-6659806|michal.kedar-datel@neurolief.com|
20562501|NCT03887650|Hartford Hospital|Dr. Kevin Finkel|860-972-1778|Kevin.Finkel@hhchealth.org|
20562502|NCT01170962|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20562503|NCT04515641|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562504|NCT02101190|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20562505|NCT03276871|Cleveland Clinic|Aldo Fafaj|2162195943|fafaja@ccf.org|
20562506|NCT00716859|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562507|NCT00700336|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
20562508|NCT02701257|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
20562509|NCT03762213|Arkansas Children's Hospital|Dr. Saumya V Joshi|501-364-4619|svjoshi@uams.edu|
20562510|NCT00411216|Emory|Susan J Herdman, PT, PhD|4047120612|sherdma@emory.edu|
20562511|NCT04578496|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
20562512|NCT01029587|Johns Hopkins University|Benjamin Philosophe|443-287-7178|bphilosophe@jhmi.edu|
20562513|NCT03350542|Boston Scientific|Patricia O'Mara|518-744-0046|patricia.omara@bsci.com|
20562514|NCT01251354|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20562515|NCT03546608|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20562516|NCT06630390|University of Rochester Medical Center|Mark Oldham|585-275-3592|mark_oldham@urmc.rochester.edu|
20562517|NCT00130117|BIDMC|Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
20517043|NCT00359281|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
20517044|NCT01474551|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
20517045|NCT02155465|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
20517046|NCT04395222|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
20517047|NCT03373162|University of California, Irvine|Dr. Craig Stark, Professor|949-824-4201|cestark@uci.edu|
20517048|NCT03686033|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20517049|NCT01854047|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20517050|NCT01302548|University of Florida|Richard F Petrik, MD|352-265-5911|rpetrik@ufl.edu|
20517051|NCT03134222|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20517052|NCT03482882|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20517053|NCT01114893|Alcon Research, Lt.d|Alcon Clinical|888.451.3937|medinfo@alconlabs.com|817.568.67
20517054|NCT00520234|Mycoses Study Group|Luis Ostrosky-Zeichner, MD|(713) 500-6733|Luis.Ostrosky-Zeichner@uth.tmc.edu|
20517055|NCT04659603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20517056|NCT03254420|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
20517057|NCT02124122|Tulane SPHTM|Richard Oberhelman|5049882511|oberhel@tulane.edu|
20562518|NCT03422276|University of Washington|Dr. Jeanne Hoffman|(206) 221-6511|jeanneh@uw.edu|
20562519|NCT05165485|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20562520|NCT05686408|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
20562521|NCT03133182|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20562522|NCT03237481|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
20562523|NCT03481777|Aarhus University Hospital|Dr. Rolf Blauenfeldt|0045 78450000|rolfblau@rm.dk|
20562524|NCT03591770|Boston Medical Center|Sharmeel K. Wasan, MD|(617) 638-6116|sharmeel.wasan@bmc.org|
20562525|NCT04139668|Centre for Addiction and Mental Health|Dr. Bernard Le Foll|416-535-8501|bernard.lefoll@camh.ca|33111
20562526|NCT04046848|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
20562527|NCT05386238|Rush University Medical Center|Melissa Crane|312-563-0269|melissa_m_crane@rush.edu|
20562528|NCT04907474|Eyenovia, Inc.|Michael Rowe|833-393-6684|mmrowe@eyenovia.com|
20517058|NCT02089997|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20562529|NCT01353313|University of New Mexico Health Sciences|Kristi Watterberg|505-272-8609|kwatterberg@salud.unm.edu|
20562530|NCT03613740|University of Guadalajara|PhD. Karina G. Pérez Rubio|+52 1 3310585200|karina.prubio@academicos.udg.mx|
20562531|NCT02541565|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
20562532|NCT02036424|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
20562533|NCT00610649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562534|NCT03567252|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
20562535|NCT05848817|Mann Eye Institute|Phillip Brunson|1-713-580-2500|brunsonphillip@gmail.com|
20562536|NCT02597920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20562537|NCT00642850|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20562538|NCT02168400|University of Minnesota|Jazmin Camchong|(612) 625-3330|camch002@umn.edu|
20562539|NCT03733028|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
20562540|NCT05489484|Guna S.p.a.|Vincenzo Miranda (Clinical Research Manager); Kamilia Laarej (TSU&CRA)|02 280.18.(358)-(359)|v.miranda@guna.it; k.laarej@guna.it|
20517059|NCT00017953|Wake Forest School of Medicine|Dr. Mark Espeland, Principal Investigator|336-922-2072|mespelan@wakehealth.edu|
20517060|NCT05844553|Imperial College London, National Heart & Lung Institute and RBH|Prof. Omar Usmani|02073518053|o.usmani@imperial.ac.uk|
20517061|NCT02374853|University of Alberta|Dr. John Mullen|780-902-6327|jmullen@ualberta.ca|
20517062|NCT02281084|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20517063|NCT02335658|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20517064|NCT02305758|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20517065|NCT02032888|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20517066|NCT04494867|Attune Medical|Erik Kulstad, MD|+1-708-651-0736|ekulstad@gmail.com|
20517067|NCT01421277|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
20517068|NCT00811655|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
20517069|NCT02820350|SeaStar Medical|Eric Schlorff, CEO|844-427-8100|eric@seastarmed.com|
20517070|NCT01754597|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20517071|NCT03161158|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49 6172 609 93488|Jennifer.Braun@fmc-ag.com|
20517072|NCT02149420|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20517073|NCT02598089|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
20517074|NCT00834067|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517075|NCT00440518|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
20517076|NCT02246920|Teva Pharmaceuticals USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
20517077|NCT02678286|Recro Pharma|Randall Mack|484-35-2470|rmack@recropharma.com|2406
20517078|NCT05342597|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20517079|NCT01246076|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20517080|NCT02902211|University of Nebraskat at Omaha|Sara Myers|402-554-3246|samyers@unomaha.edu|
20517081|NCT01891994|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
20517082|NCT01727180|Far Eastern Memorial Hospital|Hon-Yen Wu, MD, PHD|+886-2-8966-7000|honyenwu@gmail.com|1164
20517083|NCT00202722|Sorlandet Hospital HF|Tor Tveit|+4738073608|tor.tveit@sshf.no|
20517084|NCT03247972|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kbliden@lifebridgehealth.org|
20517085|NCT03500341|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
20517086|NCT02576938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20517087|NCT01010555|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20517088|NCT00968812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20517089|NCT01593852|Catharina Hospital Eindhoven|Lukas Dekker, MD, PhD|+31 40 239 7000|lukas.dekker@catharina_ziekenhuis.nl|
20562541|NCT01414738|UT Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|ROBERT.TIMMERMAN@UTSouthwestern.edu|
20562542|NCT04204993|Imperial College London|Professor Chris Chiu|+44 (0)20 8383 2301|c.chiu@imperial.ac.uk|
20517090|NCT00838630|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20562543|NCT01266122|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|617-724-0817|ssafren@partners.org|
20517091|NCT00571064|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20517092|NCT04022954|Abbott|Principal Scientist Clinical Research|1 202 253 5981|eric.horvath@abbott.com|
20517093|NCT03017885|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517094|NCT04267276|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517095|NCT03702608|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
20517096|NCT01312844|Massachusetts General Hospital|Dr. John Matthews|617-643-9095|jmatthews@partners.org|
20517097|NCT02648438|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20517098|NCT03138967|UT MD Anderson Cancer Center|Dr. Farzin Goravanchi / Anesthesiology & Perioperative Medicine|713-291-1163|fgoravan@mdanderson.org|
20517099|NCT04604275|University of Miami|Amanda Fifi|305-243-3166|amandacfifi@gmail.com|
20517100|NCT02258074|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|216-444-9938|gassmaj@ccf.org|
20517101|NCT00723710|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20517102|NCT02107300|Medical University of South Carolina|Chitra Lal|(843) 792-7776|lalch@musc.edu|
20517103|NCT01615198|Novartis|Study Director|862-778-8300||
20517104|NCT01686438|Crescenz VA Medical Center|Dr. Samuel T. Kuna|215-823-4400|Samuel.Kuna@va.gov|
20517105|NCT01029340|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
20517106|NCT01864174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20517107|NCT02648347|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
20517108|NCT01639222|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20517109|NCT00214097|University of Wisconsin|Diana Trask|608-263-9528|trask@humonc.wisc.edu|
20517110|NCT00468286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20517111|NCT00741858|university of illinois at chicago|k.v. slavin|312-996-4842|kslavin@uic.edu|
20517112|NCT02308475|Medical University of South Carolina|Brian Jacobs - Program Assistant|843-876-4922|jacobsbr@musc.edu|
20517113|NCT01415986|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
20517114|NCT03359356|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
20517115|NCT01681745|Pacira Cryotech, Inc.|Kent Jones/ Sr. Director Quality and Medical Affairs|(510)933-1513|kent.jones@pacira.com|
20517116|NCT04419311|Aksaray University Training and Research Hospital|Dr. Erdem Aras Sezgin|+905057777697|sezginmd@hotmail.com|
20517117|NCT03122457|Icahn School of Medicine at Mount Sinai|Dr. Anjali Vekaria|212-241-3288|anjali.shroff@mssm.edu|
20517118|NCT01045161|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20517119|NCT00925119|University of Maryland|Dr. Amber Beitelshees|410-706-0118|abeitels@medicine.umaryland.edu|
20517120|NCT01085825|Planned Parenthood of NYC|Research Director|212-274-7255|cti@ppnyc.org|
20517121|NCT03110003|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
20517122|NCT00819741|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20517123|NCT01802320|The University of Texas MD Anderson Cancer Center, Clinical Research Operations|Dr. Scott Kopetz/Associate Professor, GI Medical Oncology|713-792-2828|SKopetz@mdanderson.org|
20517124|NCT04115293|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20517125|NCT02571907|Cook Research Incorporated|Alan Saunders, MS, Senior Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
20517126|NCT05265624|University of Utah Moran Eye Center|Paul Bernstein, Principal Investigator|801-585-7231|Paul.Bernstein@hsc.utah.edu|
20517127|NCT00001703|National Cancer Institute, National Institutes of Health|Samir N. Khleif, M.D.|301-496-0901|khleifs@mail.nih.gov|
20517128|NCT03071575|Centers for Disease Control and Prevention|Dr. Takudzwa SAYI|404-718-3797|prp2@cdc.gov|
20517129|NCT03666026|UCLA|Principal Investigator|(310) 206-6328|pszilagyi@mednet.ucla.edu|
20517130|NCT00834795|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517131|NCT03447353|National Advanced Driving Simulator, University of Iowa|Timothy Brown|3193354785|timothy-l-brown@uiowa.edu|
20517132|NCT01376037|Center for Clinical and Cosmetic Research|Mark S. Nestor, M.D., Ph.D|305-933-6716|nestormd@ADMCORP.com|
20517133|NCT00561015|Janssen Research & Development, LLC|Clinical Leader|609-730-3174||
20517134|NCT03570749|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20517135|NCT03616535|NYU Grossman School of Medicine and Langone Health|Dr. Mara McAdams DeMarco|1-646-987-1358|mara.mcadamsdemarco@nyulangone.org|
20517136|NCT00101647|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20517137|NCT00583453|University of Iowa|Douglas Van Daele|319-353-8162|douglas-van-daele@uiowa.edu|
20517138|NCT02436005|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
20517139|NCT00905606|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517140|NCT03635320|Johnson & Johnson Medical (Shanghai) Ltd.|Jie, Zhou|+86 18600551010|JZHOU138@its.jnj.com|
20517141|NCT04512781|Vapotherm|Amy Bergeski|570-351-6966|Abergeski@vtherm.com|
20517142|NCT00804856|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517143|NCT01558635|Medtronic, Bakken Research Center, Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen, Sr Clinical Research Manager|+31653227763|ber.kleijnen@medtronic.com|
20517144|NCT00455312|Masonic Cancer Center, University of Minnesota|Dr. Jakub Tolar, MD||tolar003@umn.edu|
20517145|NCT03868891|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
20562544|NCT00421889|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
20562545|NCT00978042|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20529215|NCT00395993|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20562546|NCT00529516|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562547|NCT03224390|Duke University|Dr. Eric Green|9196817289|eric.green@duke.edu|
20562548|NCT00703820|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
20562549|NCT02639910|MorphoSys AG|Peter Kelemen MD, PhD - Director, Clinical Program Leader|+498989927|peter.kelemen@morphosys.com|26856
20562550|NCT00761605|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2-2094-4804||
20562551|NCT00785512|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
20562552|NCT00546754|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20562553|NCT00396084|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D.|(216) 368-1949|jlj@case.edu|
20562554|NCT04556981|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20562555|NCT04110743|University of California Davis|Dr. Lorenzo Nardo|916-731-9004|lnardo@ucdavis.edu|
20562556|NCT05113771|Denovo Biopharma|Julie Doostzadeh, Executive Director|858-799-1021|jdoostzadeh@denovobiopharma.com|709
20562557|NCT05510245|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562558|NCT02665988|Houston Methodist Hospital|Dr. Alok Madan|832-930-1662|amadan@houstonmethodist.org|
20562559|NCT01565148|University of Nebraska|Quan Dong Nguyen|4025592020|quan.nguyen@unmc.edu|
20562560|NCT05368831|NorthSea Therapeutics BV|CLIENT TO PROVIDE|31 035760 65 05|info@northseatherapeutics.com|
20562561|NCT00529659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20562562|NCT03565315|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
20562563|NCT00262730|Adult Brain Tumor Consortium Central Office- Johns Hopkins|Director of Adult Brain Tumor Consortium|410-955-3657|jfisher@jhmi.edu|
20562564|NCT01503749|Seoul National University Hospital|Pf. Jung-Hwan Yoon|82-2-2072-2228|yoonjh@snu.ac.kr|
20562565|NCT01083316|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
20562566|NCT04200365|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
20562567|NCT01499199|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562568|NCT01692730|University of Rochester|Scott McIntosh|585-275-0511|scott_mcintosh@urmc.rochester.edu|
20562569|NCT01199575|University of California, San Diego|Thomas Kipps, MD PhD|858-534-5400|tkipps@ucsd.edu|
20562570|NCT02139943|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20562571|NCT01819883|Massachusetts General Hospital|Karen Miller|617-726-3870|KKMiller@MGH.Harvard.edu|
20562572|NCT02299375|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562573|NCT03226899|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
20562574|NCT02047981|UCSF F.I. Proctor Foundation|Ying Lin|4155144709|ying.lin@ucsf.edu|
20562575|NCT00704184|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562576|NCT01429350|Penumbra, Inc.|Michaella Corso|510-995-2079|mcorso@penumbrainc.com|
20562577|NCT01550549|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20562578|NCT00590369|Cleveland Clinic|Nancy M. Albert PhD, RN|216-444-7028|albertn@ccf.org|
20562579|NCT01998984|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20562580|NCT02476695|Wuxi HISKY Medical Technologies Co., Ltd.|Peng Lu|13816688340|yixuebu@fibrotouch.com|
20562581|NCT03346538|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20562582|NCT05672667|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
20562583|NCT03079024|University of Minnesota|Melissa Fisher|(612) 273-9812|mafisher@umn.edu|
20562584|NCT04279574|Solventum US LLC|Paula Myhre|6513842714|pemyhre1@solventum.com|
20562585|NCT03575052|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|58-261|medicalinformation@acadia-pharm.com|2897
20562586|NCT04188379|argenx BV|Regulatory Manager|+32 9 310 3400|regulatory@argenx.com|
20562587|NCT03043599|H Lee Moffitt Cancer Center & Research Institute|Bradford Perez, MD|813-745-8234|Bradford.Perez@moffitt.org|
20562588|NCT04928001|Montana State University|Dr. Katey T. Franklin|406-570-6056|katey.franklin@montana.edu|
20562589|NCT01693120|Medtronic AF Solutions|Bob Hokanson, Clinical Research Manager|763.526.2811|robert.hokanson@medtronic.com|
20517146|NCT04111965|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
20517147|NCT00905840|Johannes-Gutenberg-University Mainz|Prof. Dr. Dr Bilal Al-Nawas, Principal Investigator|0049 6131 17|al-nawas@mkg.klinik.uni-mainz.de|3083
20517148|NCT03181594|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20517149|NCT02355886|University of Washington|George Schade|2065986190|grschade@uw.edu|
20517150|NCT00960297|Study Chair|David R. Spigel, M.D.|1-877-MY-1-SCRI|David.Spigel@scresearch.net|
20517151|NCT05763147|BD China|MA manager of Clinical Trial|0086 21 2325 4853|justina.zhu@bd.com|
20517152|NCT01299454|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3974||
20517153|NCT02362997|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|philippe_armand@dfci.harvard.edu|
20517154|NCT01518972|VA Puget Sound Health Care System|Tracy L. Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
20517155|NCT03410862|Cleveland Clinic|Jeff Negrey Study Coordinator|2166365504|negreyj2@ccf.org|
20517156|NCT02600403|Wills Eye Hospital|Michael Waisbourd|2159283000|MWaisbourd@willseye.org|
20517157|NCT02363803|Washington University in St. Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
20517158|NCT03140631|Michigan Medicine|Dr. Hakan Oral|734-936-8214|oralh@med.umich.edu|
20529216|NCT01466361|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562590|NCT01741363|Department of Internal Medicine, National Taiwan University Hospita|Han-Mo CHIU|+886-2-23123456|hanmochiu@ntu.edu.tw|63354
20562591|NCT03827304|Sheffield Hallam University|Ivan Phelan|+44 114 225 6955|i.phelan@shu.ac.uk|
20562592|NCT05406258|Shirley Ryan AbilityLab|Dr. Megan O'Brien, PhD|312-238-2289|mobrien02@sralab.org|
20562593|NCT02411084|ADIENNE S.A|Renata Palmieri|+41.91.210.47.22|renata.palmieri@adienne.com|
20562594|NCT03624972|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
20562595|NCT03112174|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20562596|NCT01164098|University of Miami|George W. Burke, M.D.|3053555315|gburke@med.miami.edu|
20562597|NCT00802464|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562598|NCT00825630|Sharon Hospital|Dr. Haim Shirin|0097239372231|haims3@clalit.org.il|
20562599|NCT00335036|Children's National|Charles Berul, MD|202-476-5710|cberul@childrensnational.org|
20562600|NCT01537419|Center for Family Intervention Science, Drexel University|Guy Diamond, Ph.D.|215-571-3420|gd342@drexel.edu|
20562601|NCT02706717|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20562602|NCT03401190|CalciMedica, Inc.|Sudarshan Hebbar, MD|816-838-7105|sudarshan@calcimedica.com|
20562603|NCT00444600|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
20562604|NCT05132478|UW School of Medicine and Public Health|Corrine Voils, PhD|(608) 262-9636|voils@surgery.wisc.edu|
20562605|NCT00106080|Department of Veterans Affairs, Health Services Research and Development|David H. Au, MD, MS|206-764-2430|david.au@va.gov|
20562606|NCT05608564|School Of Dental Medicine, University Of Belgrade, Department of Periodontology and Oral Medicine|Assistant Professor Dr. Iva Milinkovic|+381642041811|iva.milinkovic@gmail.com|
20562607|NCT03833661|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20562608|NCT03756571|Seattle Children's Research Institute|Kristie Bjornson, PT, PhD|206-884-2066|Kristie.bjornson@seattlechildrens.org|
20562609|NCT01625104|University of Michigan|Eva Kline-Rogers MS, RN|734 9985909|evakline@med.umich.edu|
20562610|NCT02283749|Brown University Oncology Research Group (BrUOG)|Kayla Rosati|14018633000|kayla_rosati@brown.edu|
20562611|NCT01007396|Samsung Medical Center|Won-Jung Koh|82-2-3410-3429|wjkoh@skku.edu|
20562612|NCT00741455|Dartmouth-Hitchcock Medical Center|Darcie Findley|603-650-4595|darcie.l.findley@hitchcock.org|
20562613|NCT01319617|UCSD|Felipe Medeiros|858 82245-92|fmedeiros@glaucoma.ucsd.edu|
20562614|NCT03689920|Boston Scientific|Director of Clinical Sciences|661-949-4350|roshini.jain@bsci.com|
20562615|NCT03283371|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20562616|NCT01985334|Novartis Pharmaceuticals|Study Director|862-778-8300||
20562617|NCT01290341|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
20562618|NCT01796236|Ear Nose Throat, University Medical Center Utrecht, Utrecht|Professor Robert Stokroos|0031 8875 56644|R.J.Stokroos@umcutrecht.nl|
20562619|NCT00895531|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
20562620|NCT01195883|Cleveland Clinic|Daniel I. Sessler, MD|216-444-4900|DS@OR.org|
20562621|NCT03231358|American University|Caroline Kuo, DPhil, MPhil|2028857385|ckuo@american.edu|
20562622|NCT02943590|MassGH|Tomas Neilan|617726200|tneilan@partners.org|
20562623|NCT00580866|Vanderbilt|William Obremskey|6159363630|william.obremskey@Vanderbilt.Edu|
20562624|NCT01388361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20562625|NCT01763970|SKCCC at Johns Hopkins|Matthew Ladra,MD|(202) 537-4788|mladra@jhmi.edu|
20562626|NCT02528188|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562627|NCT05330234|Imperial College London|Mr Gianpaolo Fusari|--|g.fusari@imperial.ac.uk|
20562628|NCT00440011|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
20562629|NCT00419341|CSL Behring|Clinical Trial Disclosure Manager|Use email contact.|clinicaltrials@cslbehring.com|
20562630|NCT02808585|PhaseBio|Dr. John Lee, Chief Medical Officer|6109816500|john.lee@PhaseBio.com|
20562631|NCT00282971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20562632|NCT01849055|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20562633|NCT00223795|VA Greater Los Angeles Healthcare System|Meika A. Fang, MD|310-268-4503|meika.fang@va.gov|
20562634|NCT00513526|AMC|Group Statistician|501-526-6712|jylee@uams.edu|
20562635|NCT00475501|Geriatric Research Education and Clinical Center|Stephen Borst, Ph.D|352-374-6114|stephen.borst@va.gov|5033
20562636|NCT01239316|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
20517159|NCT02169115|Charité- Dpt. of Dermatology and Allergy|Professor Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
20517160|NCT02159950|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20517161|NCT00575159|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517162|NCT01499147|University of Illinois Cancer Center|Damiano Rondelli, MD|312-996-6179|drond@uic.edu|
20517163|NCT03872128|Yale University|Nia Fogelman|(917)861-9865|nia.fogelman@yale.edu|
20517164|NCT02926677|Stanford University|Hilit Kletter|650-723-5511|hkletter@stanford.edu|
20517165|NCT00958334|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20517166|NCT02448862|Gangnam Severance hospital, Seoul, Korea|Dr. Jae Chul Koh, MD|82-01087023931|aneskoh@yuhs.ac|
20517167|NCT03169062|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20562637|NCT04585191|Division of Research, Kaiser Permanente Northern California|Dr. Richard Grant|5108213969|Richard.W.Grant@kp.org|
20562638|NCT01701986|University of Texas MD Anderson Cancer Center|Dr. Yago Nieto, MD, PhD/ Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderson.org|
20562639|NCT04917588|CROMA - PHARMA|Head of Clinical Operations|+43 0226268468|clinical.studies@croma.at|
20562640|NCT02237417|Otsuka|Wilt, Timothy|240.683.3095|timothy.wilt@otsuka-us.com|
20562641|NCT04156581|Hospital for Special Surgery|Dr. Justas Lauzadis|212-774-2946|lauzadisj@hss.edu|
20562642|NCT03602612|National Cancer Institute|Dr. James Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
20562643|NCT06336629|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
20562644|NCT03960463|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20562645|NCT04043455|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20562646|NCT05568615|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20562647|NCT05194917|University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention|Dr. Adrienne Johnson|608-262-8673|aljohnson43@ctri.wisc.edu|
20562648|NCT05786391|The University of Texas Health Science Center at Houston|Randa J Jalloul, MD|713-566-5749|Randa.J.Jalloul@uth.tmc.edu|
20562649|NCT03817684|Tetra Therapeutics|CEO|616-224-0084|info@tetratherapeutics.com|
20517168|NCT04108858|University of Texas M D Anderson Cancer Center|Dr. Senthil Damodaran, MD. PhD.|(832) 829-4307|sdamodaran@mdanderson.org|
20562650|NCT05505045|University of Missouri|Anna Boone, PhD|573-882-7023|booneae@umsystem.edu|
20562651|NCT01643070|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
20562652|NCT05540535|New York University|Liraz Arie|3478661117|la1816@nyu.edu|
20562653|NCT04941287|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20517169|NCT03663179|University of Pennsylvania|Leah Bernardo|2157467162|lleah@pennmedicine.upenn.edu|
20517170|NCT03117296|Henry Ford Hospital|Adele Myszenski, PT, DPT|313-916-1334|amyszen1@hfhs.org|
20517171|NCT02453386|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
20517172|NCT02601625|AstraZeneca AB|Anifrolumab Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20517173|NCT01935934|University Health Network - Princess Margaret Cancer Centre|Dr. Neesha Dhani|416-946-4501|neesha.dhani@uhn.ca|2361
20517174|NCT01289262|DrLutfiKirdarTRH|DR CEM TURAN|00905323513423|cemturan@gmail.com|
20517175|NCT00833586|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517176|NCT00838279|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517177|NCT04608188|University of South Carolina|Robert Weaver|8037775605|weaverrg@mailbox.sc.edu|
20517178|NCT03380845|MGH|Dr. Sandeep Saluja|6466621084|sandeep.s.saluja@gmail.com|
20517179|NCT00304187|New York State Psychiatric Institute|Dr. Michael Devlin|212-543-5748|mjd5@columbia.edu|
20517180|NCT05646251|Geisinger|Dr Pugazhendhi Vijayaraman|5708086020|pvijayaraman1@geisinger.edu|
20517181|NCT03792477|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517182|NCT00840411|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517183|NCT03670017|Washington University School of Medicine|Grant Bochicchio, Harry Edison Professor of Surgery, Chief of Acute and Critical Care Surgery|314-362-9347|gbochicchio@wustl.edu|
20517184|NCT03173547|Therapeutics, Inc.|Clinical Project Manager|858-571-1800|ClinicalResearch@therapeuticsinc.com|
20517185|NCT00657553|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-569-6990|pettynathanm@uams.edu|2461
20517186|NCT00446563|Novartis Pharmaceuticals|Study Director|862-778-8300||
20517187|NCT01169558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20517188|NCT02911701|University of New Mexico, Division of Maternal-Fetal Medicine|Dr. Nathan Blue|505-272-6309|nblue1297@gmail.com|
20517189|NCT00852696|Cleveland Clinic Florida|Cecilia Calvo|954-659-5637|calvoc@ccf.org|
20517190|NCT02409355|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20517191|NCT05528588|UT Southwestern Medical Center|Ambarish Pandey, Principal Investigator|2146200286|Ambarish.pandey@utsouthwestern.edu|
20517192|NCT02605928|Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital and University of Helsinki, Finland|PhD MD Ritva Peltomaa||ritva.peltomaa@hus.fi|
20517193|NCT00906165|UCL Eastman Dental lnstitute University College London|Professor N Donos|+4420 3456 1075|n.donos@eastman.ucl.ac.uk|
20517194|NCT02530905|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
20517195|NCT00322439|Amgen Inc.|Study Director|866-572-6436||
20517196|NCT01231906|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20517197|NCT01110005|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
20517198|NCT04646213|Virginia Commonwealth University|Dr. Ashlee Loughan|804-828-4178|ashlee.loughan@vcuhealth.org|
20517199|NCT02441309|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
20517200|NCT00415363|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20517201|NCT01077596|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517202|NCT01136174|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517203|NCT04322500|University of Molise|Prof. Ciro Costagliola|+39 0874 404861/ 0874 404896|ciro.costagliola@unimol.it|
20517204|NCT00119015|University of Chicago|Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
20517205|NCT03429712|Duke University Medical Center|Daniele Marin|919-684-2711|daniele.marin@duke.edu|
20517206|NCT02286739|Stryker|Kevin Barga|201 831 5073|kevin.barga@stryker.com|
20517207|NCT02057835|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517208|NCT04299087|University of Florida|Dr. David Vaillancourt|(352) 294 - 1770|vcourt@ufl.edu|
20517209|NCT03025087|Duke University|Joseph Mathew, MD|919-681-6646|joseph.mathew@duke.edu|
20562654|NCT03025789|Drugs for Neglected Diseases initiative (DNDi)|Dr. Olaf Valverde Mordt|+41795431713|ovalverde@dndi.org|
20562655|NCT05057897|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20562656|NCT04524390|Mirum Pharmaceuticals, Inc.|Mirum Clinical Trials|16506674085|medinfo@mirumpharma.com|
20562657|NCT01631214|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20562658|NCT05288283|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20562659|NCT03285763|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20562660|NCT04987021|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
20562661|NCT00332241|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@BMS.com|
20562662|NCT01534494|New York University Grossman School of Medicine|Michael Bogenschutz|5059999325|Michael.Bogenschutz@nyulangone.org|
20562663|NCT05137236|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20562664|NCT00924807|St. Luke's Roosevelt Hospital Center|Seth Cohen, MD|212-523-7289|secohen@chpnet.org|
20562665|NCT02880137|Mayo Clinic|Dr. Jonathan Johnson|507-255-7013|johnson.jonathan@mayo.edu|
20562666|NCT03504423|Cornerstone Pharmaceuticals Inc.|Sanjeev Luther|585-978-1351|sanjeev.luther@cornerstonepharma.com|
20562667|NCT00431834|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
20562668|NCT04071756|Dana-Farber Cancer Institute|Nicole LeBoeuf, MD, MPH|617-632-6571|nicole_leboeuf@dfci.harvard.edu|
20562669|NCT03628885|Indiana University|Dr. Gregory Zimet|3172748812|gzimet@iu.edu|
20562670|NCT01643616|HELIOS-Kliniken Schwerin, Germany|Dr. Ronald Seidel|0049 385 5204251|ronald.seidel@helios-kliniken.de|
20562671|NCT02622568|University of Texas Southwestern|Dr. Nnenna Agim|2144561631|Nnenna.Agim@childrens.com|
20562672|NCT04512482|Indiana University School of Dentistry, Department of Orthodontics|Kelton T. Stewart, Department Chair|317-278-1087|keltstew@iu.edu|
20562673|NCT01939899|Millennium Pharmaceuticals, Inc.|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
20562674|NCT00324350|University of California, San Francisco|Dr. Ann Schwartz|415-514-8000|aschwartz@psg.ucsf.edu|
20562675|NCT02647905|Senseonics|Vice President, Clinical Sciences|3015157260|katherine.tweden@senseonics.com|
20562676|NCT00265200|James Graham Brown Cancer Center, University of Louisville|Goetz H Kloecker, MD|502-562-4358|ghkloe01@louisville.edu|
20562677|NCT03285542|Cleveland Clinic|Viktor Krebs|216-445-3843|krebsv@ccf.org|
20562678|NCT05119855|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20562679|NCT02932579|University of Rochester Eastman Institute for Oral Health|Yanfang Ren, Professor|5852735588|yanfang_ren@urmc.rochester.edu|
20562680|NCT04059042|University of Kansas Medical Center|Dr. Rebecca Lepping|913-588-0287|rlepping@kumc.edu|
20562681|NCT02549170|Shire|Study Director|+18668425335|ClinicalTransparency@shire.com|
20562682|NCT00111813|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562683|NCT03051165|Emory University|Raj Dedhia, MD, MS|(404) 778-3381|raj.dedhia@emory.edu|
20562684|NCT00818246|RoseLab Skin Optics Laboratory|Dr Daniel Barolet|(514) 343-4444|daniel.barolet@mcgill.ca|
20562685|NCT00574834|University of Maryland Baltimore|Stephen N. Davis, MBBS- Principal Investigator|410-328-2488|sdavis@medicine.umaryland.edu|
20562686|NCT02121002|Amneal Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amneal.com|
20562687|NCT01250769|Philips Healthcare, Office of Medical and Health Affairs|Director of Clinical Operations|425 908-1208|wendy.jenkins@philips.com|
20562688|NCT00914589|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20562689|NCT04247074|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
20562690|NCT00174382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20562691|NCT00807937|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20562692|NCT03233633|Connecticut Hospice|Jim Prota, Director of Pharmacy|203-848-0660|jprota@hospice.com|
20562693|NCT02088853|Göteborgs University|Professor Lars Fandriks|+46313424123|lars.fandriks@gastro.gu.se|
20562694|NCT03337399|Massachusetts General Hospital/Harvard Medical School|Jennifer Temel|617-724-4000|jtemel@mgh.harvard.edu|
20562695|NCT00603954|CHU de Liège|Dr. Frédéric Baron|003243667201|f.baron@ulg.ac.be|
20562696|NCT02708108|Childrens Hospital Los Angeles|Dr Etan Orgel|13233612121|eorgel@chla.usc.edu|
20562697|NCT03049969|NYU Langone Health|Leigh Charvet, MD|9294555141|Leigh.Charvet@nyulangone.org|
20562698|NCT03783026|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20562699|NCT04814186|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562700|NCT01853748|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
20562701|NCT03342027|University of Chicago|Dr. Seth Himelhoch|773-834-4314|seth.himelhoch@bsd.uchicago.edu|
20562702|NCT04751526|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
20562703|NCT03088813|Ipsen Bioscience, Inc.|Medical Director|see email|clinical.trials@ipsen.com|
20562704|NCT04656925|Washington State University|Abigail Bowen|(425) 736-1354|abigail.bowen@wsu.edu|
20562705|NCT02217904|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562706|NCT01903811|SWOG Statistical Center|S1304 Statistician|2066674623|rachaels@crab.org|
20517210|NCT05604170|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20517211|NCT03697109|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20517212|NCT03032172|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20517213|NCT06284525|Northern Arizona University|Principal investigator|928-523-1787|Zachary.Lerner@nau.edu|
20517214|NCT01111461|Eisai, Inc.|Eisai Medical Services|18884224743|esi_medinfo@eisai.com|
20517215|NCT01415232|UPittsburgh'|Dr. Manuel Vallejo|4126414260|vallejomc@anes.upmc.edu|
20517216|NCT02545283|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WO29519|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
20517217|NCT04523168|Mayo Clinic|Dr. Amir Lerman|507-255-2446|lerman.amir@mayo.edu|
20562707|NCT04540913|TEOXANE SA|Clinical Research Scientist|+41(0) 22 344 96 36|clinical@teoxane.com|
20562708|NCT04440176|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562709|NCT04153565|Merck Sharp& Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562710|NCT02991807|Boston Children's Hospital|Dr. Mustafa Sahin|617-355-8994|Mustafa.Sahin@childrens.harvard.edu|
20562711|NCT02300298|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20562712|NCT00402246|Medtronic, Inc|CONNECT Clinical Trial Specialist||medtronicCRMtrials@medtronic.com|
20562713|NCT01808339|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562714|NCT00439413|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
20562715|NCT00409838|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20562716|NCT04788641|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20562717|NCT00243503|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562718|NCT01919450|Cardiovascular Imaging Technologies, LLC|Timothy M. Bateman, MD|816-531-2842|tbateman@cvit.com|
20562719|NCT00093015|Amgen Inc.|Study Director|866-572-6436||
20562720|NCT02561702|University of Rochester|David Herrmann|585-275-4568|david_herrmann@urmc.rochester.edu|
20562721|NCT00520546|German Federal Armed Forces Hospital, Ulm|Major Medical Corps Dr. Markus Hartenbach|0049 731 1710 1851|markushartenbach@bundeswehr.org|
20562722|NCT03076515|Theranica Bio-Electronics Ltd|Dagan Harris|+972723909755|daganh@theranica.com|
20562723|NCT00595790|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
20562724|NCT03988023|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20562725|NCT02101281|Dompé|Flavio Mantelli, MD, PhD|+39 513138|info@dompe.it|
20562726|NCT00296036|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
20562727|NCT00194714|University of Washington - Cancer Vaccine Institute|Director of Clinical Operations|2062459258|childj@uw.edu|
20562728|NCT03403413|Loui9s Stokes Cleveland VAMC|Dr. Stephen Selkirk|440-552-0493|stephen.selkirk@va.gov|
20562729|NCT03501264|University of Pittsburgh, Graduate School of Public Health|James Egan|412-624-2255|jee48@pitt.edu|
20562730|NCT00529100|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20562731|NCT03733119|University of Wisconsin Carbone Cancer Center|Kari Wisinski, MD|608-262-2876|kbwisinski@medicine.wisc.edu|
20562732|NCT02253537|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
20562733|NCT03951805|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20562734|NCT03684044|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20562735|NCT03703336|POLYVAC|Nguyen Thuy Huong, Ph.D, Vice Director|+84 912514309|huong72us@yahoo.com|
20562736|NCT00595413|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20562737|NCT00533910|Hunter Holmes McGuire VAMC|Jasmohan Bajaj|804 675 5802|jasmohan@gmail.com|
20562738|NCT04629950|Department of Dermatology, Weill Cornell Medicine|Dr. Richard D. Granstein|(646) 962-7546|rdgranst@med.cornell.edu|
20562739|NCT01198145|Mayo Clinic|Robert C. Miller, M.D., M.S.||miller.robert@mayo.edu|
20562740|NCT03830866|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20562741|NCT02568683|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20562742|NCT00510887|Duke University Medical Center|Dr. David Rizzieri|919-668-1000|rizzi003@mc.duke.edu|
20562743|NCT00891436|Rush University Medical College|James N. Moy, M.D.|312-942-6176|jmoy@rush.edu|
20562744|NCT02214550|NorthShore University HealthSystem|Dr. Frank Tu|8475702520|ftu@northshore.org|
20517218|NCT03343535|TransMedics, Inc.|VP, Clinical Affairs|978-552-0900|ldamme@transmedics.com|
20517219|NCT01158118|Washington University School of Medicine|Mark Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
20517220|NCT04994535|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20517221|NCT02909907|Cleveland Clinic Foundation|Hubert H Fernandez|2164451108|FERNANH@ccf.org|
20517222|NCT02699866|Institut Straumann AG|Dr. Michael McCaskey, Team Leader Clinical Research|+41619651741|michael.mccaskey@straumann.com|
20517223|NCT02157623|Cleveland Clinic|Edward Maytin, MD, PhD|216-445-6676|maytine@ccf.org|
20517224|NCT04238754|Johns Hopkins Univeristy|Cecilia Bergeria|410-550-1979|cberge21@jhmi.edu|
20517225|NCT03302780|University of Texas McGovern Medical School - Houston|Sheng Li, MD, PhD|7137977125|sheng.li@uth.tmc.edu|713
20517226|NCT01294917|Centre for Contact Lens Research|Clinical Scientist|519-888-4567|marc.schulze@uwaterloo.ca|36590
20517227|NCT03285594|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20517228|NCT02558491|University of Virginia Center for Diabetes Technology|Daniel R. Chernavvsky, MD|434-982-0602|mc7m@virginia.edu|
20517229|NCT00834431|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517230|NCT00746395|University of South Alabama|Jack A. DiPalma, M.D.|251-660-5555|jdipalma@usouthal.edu|
20517231|NCT03733444|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20517232|NCT03637764|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20517233|NCT01218867|National Cancer Institute|Dr. Steven Rosenberg|301- 496-4164|sar@mail.nih.gov|
20517234|NCT01424293|Maimonides Medical Center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
20517235|NCT05239754|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20517236|NCT01304641|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517237|NCT01576042|Duke Clinical Research Institute|Sana M. Al-Khatib, MD, MHS|919-668-8649|sana.alkhatib@dm.duke.edu|
20517238|NCT00465270|Abbott|Dr. Laura O'Brien||laura.obrien@abbott.com|
20517239|NCT03233724|National Cancer Institute|Dr. David S. Schrump|240-760-6239|david_schrump@nih.gov|
20517240|NCT02252133|Alcon Research, Ltd.|Senior Manager, Clinical Development, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
20517241|NCT00651820|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|817-900-4000|bert.slade@healthpoint.com|
20517242|NCT02388191|Planned Parenthood League of Massachusetts|Principal Investigator|6176298603|jfortin@pplm.org|
20517243|NCT01921062|University Medical Center Groningen|Dieuwke Broekstra, PhD; postdoctoral researcher|0031503613531|d.c.broekstra@umcg.nl|
20517244|NCT01911676|Yale University|Christina Luddy|203-932-5711|christina.luddy@yale.edu|4549
20517245|NCT05178927|UF Health Proton Therapy Institute|Dr. Perry Johnson|904-588-1253|PBJohnson@floridaproton.org|
20517246|NCT00773253|University of California San Francisco|Graham A. Glass, MD|415-353-2311|Graham.Glass@ucsf.edu|
20517247|NCT01141374|University of São Paulo|Leonice Fumiko Sato Kurebayashi|55-11-91126023|fumie_ibez@yahoo.com.br|
20517248|NCT01566721|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20517249|NCT03769025|Perelman School of Medicine|Kyle M Kampman MD Principal Investigator|215 746 2764|kampman@pennmedicine.upenn.edu|
20517250|NCT03374176|Centro Universitario de Tonalá, Universidad de Guadalajara|Dr. Arieh Roldán Mercado Sesma|+52 (33) 20 00 23 00|arieh.mercado@academicos.udg.mx|6400
20517251|NCT00398983|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD / Associate Professor|713-745-0394|eharrison@mdanderson.org|
20517252|NCT03123471|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20517253|NCT01863030|University of Kentucky Medical Center|Scott Roth M.D.|859-323-6346|sroth@uky.edu|240
20517254|NCT05341622|University of Pennsylvania|Shivan Mehta|215-898-9807|shivan.mehta@pennmedicine.upenn.edu|
20517255|NCT01594047|Fondazione IRCCS Istituto nazionale dei Tumori|Tognoli Emiliano MD|+39 0223902282|Emiliano.Tognoli@istitutotumori.mi.it|
20517256|NCT02658084|University of Miami|Dr. Reshma Mahtani|954-698-3639|rmahtani@miami.edu|
20562745|NCT00194896|University of Washington|Jerry P. Palmer, MD|206-764-2495|jpp@u.washington.edu|
20517257|NCT01051570|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath M.D.|313-576-8717|vaishamu@karmanos.org|
20517258|NCT03290781|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20517259|NCT02957942|University of Minnesota|Mo Chen|612-624-5220|mchen@umn.edu|
20517260|NCT02233985|Instituto Mexicano del Seguro Social|Dr. Gloria Patricia Sosa-Bustamante|01 52 4777174800|patriciasosab@hotmail.com|31828
20517261|NCT01249651|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20517262|NCT01462279|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
20517263|NCT04044521|University of Wisconsin-Madison|Dr. Andrew Quanbeck|608-609-7308|andrew.quanbeck@fammed.wisc.edu|
20517264|NCT02538523|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
20517265|NCT01258933|The University of Texas MD Anderson Cancer Center|William Wierda, MD./Professor|713-745-0428|wwierda@mdanderson.org|
20517266|NCT03801707|The Ohio State University|Brenda Cuson|614-293-6883|Brenda.Cuson@osumc.edu|
20517267|NCT04189848|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20517268|NCT01588236|Jiangsu Kanion Pharmaceutical Co. Ltd|Weiyi Liu, MD|3016533500|liuweiyi65@hotmail.com|
20517269|NCT02608177|Kidney Research Institute, University of Washington|Dr. Ian de Boer, Associate Director|2067444029|IDeBoer@Nephrology.washington.edu|
20517270|NCT05302908|Wake Forest School of Medicine|Scott Rhodes, Ph.D|336-713-5080|srhodes@wakehealth.edu|
20517271|NCT03761173|Inari Medical, Now Part of Stryker|Ashleigh Willson|925-330-3446|Ashleigh.Willson@Stryker.com|
20517272|NCT00316186|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517273|NCT02635750|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517274|NCT04196907|Masimo Corporation|Vikram Ramakanth|949-297-7000|clinicalresearchdept@masimo.com|
20517275|NCT00526188|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20517276|NCT02642653|University of California Davis|Dr. Randi Hagerman|9167030247|rjhagerman@ucdavis.edu|
20517277|NCT02875392|Taipei Municipal Wanfang Hospital|Ming-Shun Wu|+886229307930|vw1017@gmail.com|
20517278|NCT04974684|IKEM Prague|Dr. Zuzana Tucanova|+420 776292211|zuzana.tucanova@ikem.cz|
20517279|NCT00834717|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517280|NCT02798458|Massachusetts General Hospital|Dr. Braden Kuo and Dr. Claire-Zar-Kessler|617-724-6038|bkuo@mgh.harvard.edu, czarkessler@mgh.harvard.edu|
20517281|NCT00594035|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
20517282|NCT00795821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20517283|NCT01285713|New York University, Langone Medical Center|Dr. Kari Posner|212-263-7300|kariposner@gmail.com|
20517284|NCT04210557|Yale University|Dr. Philip Corlett|203 974 7866|belieflab@yale.edu|
20517285|NCT00712959|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20517286|NCT00238615|Stanford University|Dr. Heather Wakelee|650-736-7221|hwakelee@stanford.edu|
20517287|NCT05244447|Midwest Evaluation and Research|Dr. Matthew Shepherd|833-643-9377|matt.shepherd@midwestevaluation.com|
20517288|NCT05292963|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20517289|NCT04516967|Sobi Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
20517290|NCT03165994|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
20517291|NCT00665470|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20517292|NCT00163657|Baylor University Medical Center|Goran Klintmalm, MD Director|214-820-2050|michelle.acker@baylorhealth.edu|
20562746|NCT01248936|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20562747|NCT03485950|UT MD Anderson Cancer Center|Issam Raad,MD - Chair, Infectious Diseases|(713) 792-7943|iraad@mdanderson.org|
20517293|NCT02303405|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
20562748|NCT00609336|University of Washington|Andrew Coveler, MD|206-288-7509|acoveler@uw.edu|
20562749|NCT02477605|Alcon, A Novartis Division|Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20562750|NCT00567489|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20562751|NCT01061034|Assaf Harofeh medical center|Dr. Keren Doenyas-Barak|972-57-7346651|kerendoenyas@gmail.com|
20517294|NCT01867164|Global Clinical Operations Mexico|Clinical Research Director|+52 55 5484 3184||
20517295|NCT03086460|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20517296|NCT03600805|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20517297|NCT06195579|University of Lincoln|Dr Nima Moghaddam|01522882000|nmoghaddam@lincoln.ac.uk|
20517298|NCT01735994|Pennington Biomedical Research Center|Dr. Tiffany Stewart, Director, Behavior Technology Laboratory|2257632554|tiffany.stewart@pbrc.edu|
20517299|NCT03123094|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517300|NCT00604162|Given Imaging|Hila Debby|+972 4 9097774|Hila.Debby@givenimaging.com|
20517301|NCT04808362|Peptomyc|Dr Niewel|+34932543450|mniewel@peptomyc.com|8684
20517302|NCT00736190|Gilead Sciences, Inc.|Eduardo Bruno Martins, MD, DPhil, Sr. Director, Medical Affairs - Hepatitis|650-522-5792|eduardo.martins@gilead.com|
20517303|NCT01450189|University of North Carolina at Chapel Hill|William C Miller|9199669407|bill_miller@unc.edu|
20517304|NCT03128723|JnJ Worldwide|Gboyega Adenaike|908-874-1214|aadenaike@its.jnj.com|
20517305|NCT01688609|St. Luke's International Hospital|Dr. Teruo Yamauchi|+81-3-3541-5151|tryhi@luke.ac.jp|
20517306|NCT03270462|"University of Colorado Denver | Anschutz"|Larry Chan|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20517307|NCT02115347|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20517308|NCT02849457|University of Alabama at Birmingham|E. Martina Bebin M.D., M.P.A.|205-975-2890|ebebin@uabmc.edu|
20517309|NCT01667679|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
20517310|NCT01175018|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@mcvh-vcu.edu|
20517311|NCT00620711|Vanderbilt university|William F Walsh|615-322-0545|bill.walsh@vanderbilt.edu|
20517312|NCT00835263|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517313|NCT01020474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517314|NCT03987191|University of Colorado Anschutz Medical Campus|Dr. Viral Shah, Principal Investigator|303-724-8186|viral.shah@cuanschutz.edu|
20517315|NCT03406156|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20517316|NCT03450850|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
20517317|NCT02838420|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20517318|NCT03419403|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20517319|NCT00796653|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517320|NCT01341730|The Catholic University of Korea|Dr. Eun Ho Choo|82-10-8500-4569|cmcchu@catholic.ac.kr|
20517321|NCT02738086|University of Colorado Denver|Cory L. Christiansen|303-724-9101|cory.christiansen@cuanschutz.edu|
20517322|NCT01940341|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20517323|NCT03552393|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20517324|NCT02414152|Northwell Health|Dr. Andrea Vambutas|718-470-7550|avambuta@northwell.edu|
20517325|NCT00539110|Shriners Hospitals for Children|Michele Gottschlich PhD|513-872-6298|mgottschlich@shrinenet.org|
20517326|NCT01910688|Columbia University Medical Center|Dr. Julian Abrams|(212) 235-1496|ja660@cumc.columbia.edu|
20517327|NCT04887415|University of Florida|Emily K. Plowman, Ph.D. CCC-SLP|(352)273-8632|eplowman@ufl.edu|
20517328|NCT00838136|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517329|NCT01250912|University of Maryland, Baltimore|Dr. Timm-Michael Dickfeld|410-328-7801|tdickfel@som.umaryland.edu|
20517330|NCT00803686|Tarsa Therapeutics, Inc|Nicholas LaBella, Jr. Vice-President Global RA/QA|267-273-7944|nlabella@tarsatherapeutics.com|
20517331|NCT01641380|Johns Hopkins University School of Medicine|Maria Trent, MD, MPH, Principal Investigator|443-287-8945|mtrent2@jhmi.edu|
20517332|NCT01581658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517333|NCT03682653|UCSF FI Proctor|Dr. Thomas Lietman|(414) 476-1442|tom.lietman@ucsf.edu|
20517334|NCT00787254|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20517335|NCT06907719|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20517336|NCT02740413|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517337|NCT04037969|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20517338|NCT01414153|Lpath, Inc.|Susan E. Hazel|858-926-3205|shazel@lpath.com|
20517339|NCT01343004|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
20517340|NCT00089011|Fred Hutch|David G Maloney, MD PhD|(206) 667-5616|dmaloney@fredhutch.org|
20517341|NCT02392286|Yale|Dr. Loren Laine|203-785-7312|loren.laine@yale.edu|
20517342|NCT01660243|Toray Industries, Inc|Clinical Trials Information Desk||clinical-trials.toray.mb@mail.toray|
20517343|NCT03821675|Baylor College of Medicine|Prof. Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
20562752|NCT00068601|SWOG Statistics and Data Management Center|Cancer Survivorship Committee Statistician|206-667-4623||
20562753|NCT01061671|University of Minnesota|Sarah Lindberg|612-626-9011|sharnden@ccbr.umn.edu|
20562754|NCT02570022|Henry Ford Hospital|Dr. Kelechi Okoroha|8324239895|krokoroha@gmail.com|
20517344|NCT02255149|University of Michigan|Dr. Hsun-Liang Chan|734-763-3325|hlchan@umich.edu|
20517345|NCT01701674|H. Lee Moffitt Cancer Center and Research Institute|Dr. Amod Sarnaik|813-745-8581|amod.sarnaik@moffitt.org|
20517346|NCT05700383|Massachusetts General Hospital|Ana-Maria Vranceanu, PhD|617-724-4977|avranceanu@mgh.harvard.edu|
20517347|NCT04726345|Columbia University|Ezra J. Margolin, MD|212-305-0114|ejm2182@cumc.columbia.edu|
20517348|NCT02925884|Pacific University|Yu-Chi Tai|503-352-2289|ytai@pacificu.edu|
20517349|NCT04516434|Duke University Medical Center|Cindy Amundsen, MD|919-401-1000|cindy.amundsen@duke.edu|
20517350|NCT00834522|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517351|NCT00519194|St. Jude Medical|Sue Walgren, Manager Sr., Clinical Project|6517563210|swalgren@sjm.com|
20517352|NCT02301975|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517353|NCT01379222|Medtronic|Thushari Alahapperuma|763.526.8119|thushari.r.alahapperuma@medtronic.com|
20517354|NCT04278560|Hebrew SeniorLife|On-Yee Lo|6179715331|AmyLo@hsl.harvrd.edu|
20517355|NCT01319383|UNC Chapel Hill School of Medicine|Dr. David Margolis|919-966-6388|dmargo@med.unc.edu|
20517356|NCT01531894|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20517357|NCT04757298|University of Illinois Urbana Champaign|Dr. Liliane Windsor|217-300-1782|lwindsor@illinois.edu|
20517358|NCT02651272|Bosotn Medical Center|Elizabeth Klings, MD|617-638-7480|elizabeth.klings@bmc.org|
20517359|NCT00462228|Department of Physical Medicine and Rehabilitation, University of Missouri|Dr. S. Jon Rupright|573-882-3101|RuprightJ@health.missouri.edu|
20517360|NCT00567320|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20517361|NCT00834340|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517362|NCT00395694|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517363|NCT05956925|University of Nevada, Las Vegas|Dieu-My Tran (PI)|17028953371|dieu-my.tran@unlv.edu|
20517364|NCT00392665|Massachusetts General Hospital|Lori J. Wirth, MD|617-724-4000|LWIRTH@mgh.harvard.edu|
20517365|NCT02599558|Mayo Clinic|Jeffrey A. Alexander, M.D.|507+284-0474|Alexander.Jeffrey14@mayo.edu|
20517366|NCT02197481|The Second Affiliated Hospital of Anhui Medical University|Dr.Jiang-ming Chen|15855518651|chenjm10@126.com|86
20517367|NCT03673670|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
20562755|NCT04992390|P1vital Products Ltd|Dr Amy Beckenstrom|+44(0)1865 522 030|abeckenstrom@p1vital.com|
20517368|NCT04408794|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20517369|NCT00187720|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
20517370|NCT03437265|Norgine|Lucy Clayton|+441895826669|LClayton@norgine.com|
20517371|NCT00252967|Brown University|Samuel Dudley, MD, PhD|4014443024|samuel_dudley@brown.edu|
20517372|NCT02294786|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20517373|NCT01778010|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
20517374|NCT04859517|INVIVYD, Inc.|Study Inquiry|17818190080|ClinicalTrials@invivyd.com|
20517375|NCT01068821|Mayo Clinic, Florida|Dr. Mary Ellen Wechter|904 412 7351|wechter.mary@mayo.edu|
20517376|NCT02154672|Yale University School of Medicine|Dr. Preston Sprenkle|2037852815|preston.sprenkle@yale.edu|
20517377|NCT03517085|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20517378|NCT01124305|AORI|Knee Project Director|7036194423|nparks@aori.org|
20517379|NCT01244620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517380|NCT00840073|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517381|NCT02321098|Galderma|Farzaneh Sidou Clinical Project Manager|04 93 95 70 51|farzaneh.sidou@galderma.com|33
20517382|NCT01663233|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
20517383|NCT01788423|Indiana University, Department of Speech and Hearing Sci|Larry E. Humes|812-855-3507|humes@indiana.edu|
20517384|NCT01913405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20562756|NCT04474314|Imara, Inc.|Rahul Ballal|617-206-2020|rballal@imaratx.com|
20517385|NCT03856320|William S. Middleton VA Hospital|Dr. Luke Funk|608-256-1901|Luke.Funk@va.gov|17899
20517386|NCT03261167|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20517387|NCT04813354|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20517388|NCT00705666|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20517389|NCT00374231|University of Cincinnati|E. Steve Woodle, MD|(513) 558-6001|woodlees@uc.edu|
20517390|NCT03259139|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
20517391|NCT02105272|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
20517392|NCT00064038|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
20517393|NCT03359863|University of California at San Francisco|Aida Venado, MD, MAS|4153532577|aida.venado@ucsf.edu|
20517394|NCT02964039|Ralph H. Johnson VAMC / MUSC|Jesse Dean|8437929566|deaje@musc.edu|
20517395|NCT05479058|Galapagos N.V.|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20517396|NCT05630885|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20517397|NCT01878292|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20517398|NCT00950989|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20517399|NCT01686477|ImperialC|Luke Mills|+447989748017|l.mills@imperial.ac.uk|
20517400|NCT01471041|Vital Access|Mark Crawford|8014339390|mcrawford@vital-access.com|
20517401|NCT00813592|Huntsman Cancer institute|Randy Jensen, MD, PhD|801-585-0255|randy.jensen@hci.utah.edu|
20517402|NCT01391273|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20562757|NCT04919590|Truth Initiative|Dr. Amanda Graham|202-525-6473‬|vapestudy@truthinitiative.org|
20562758|NCT04847479|University of Pennsylvania|Robert Gross|215-898-2437|grossr@pennmedicine.upenn.edu|
20562759|NCT02975505|University of California, San Francisco Division of Nephrology|Dr. Elaine Ku|415-502-7760|elaine.ku@ucsf.edu|
20562760|NCT05233098|Boston Scientific|Jessie Stockwell, Sr. Clinical Trial Specialist|6126181136|jessie.stockwell@bsci.com|
20562761|NCT04076293|Hanmi Pharmaceutical Co., Ltd.|Jiyeon Kang|8224100377|jiyeon.kang@hanmi.co.kr|
20562762|NCT04201834|University of Rochester|Ruth Schneider, MD|585-341-7500|Ruth_schneider@urmc.rochester.edu|
20562763|NCT03089125|Massachusetts General Hospital|Joseph A. Greer, Ph.D.|617-643-2143|jgreer2@mgh.harvard.edu|
20562764|NCT04104321|Galmed Pharmaceuticals|Dr. Yossi Gilgun-Sherki|0543314054|yossigs@galmedpharma.com|
20562765|NCT02980276|University of Galway|Professor Fidelma Dunne|+35391492117|fidelma.f.dunne@universityofgalway.ie|
20517403|NCT03873272|Columbia University Irving Medical Center|Melissa Accordino, MD|646-317-4692|mkg2134@cumc.columbia.edu|
20517404|NCT04493684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20517405|NCT03331289|UTexas_SanAntonio|Ralph A DeFronzo|2105676691|defronzo@uthscsa.edu|
20517406|NCT05152576|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
20517407|NCT00859430|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517408|NCT02324660|Azienda Ospedaliera Universitaria di Ferrara|Gianluca Campo, PI of the study|0532237079|cmpglc@unife.it|+39
20562766|NCT04354337|University of Washington|Weichao Yuwen|2536924478|wyuwen@uw.edu|
20562767|NCT03554265|University of Texas Medical Branch|Randall Urban, MD|409-772-5476|rurban@utmb.edu|
20562768|NCT02652260|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20562769|NCT02723955|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20517409|NCT03423654|VA|April Maa|4043216111|april.maa2@va.gov|206817
20517410|NCT04310345|Vanderbilt School of Nursing|Dr. Mary Jo Gilmer|6153430938|maryjo.gilmer@vanderbilt.edu|
20517411|NCT03049748|Johns Hopkins University (Former Faculty at University of Michigan)|Dr. Jesus Casida|3132047665|jcasida1@jhu.edu|
20517412|NCT00835484|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517413|NCT04162899|ReistoneBiopharma|Roger Liu, Medical Director|8613917512446|roger.liu@reistonebio.com|
20517414|NCT01909713|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
20517415|NCT01011413|University of New South Wales|Sean Emery|02 9385 0900|semery@kirby.unsw.edu.au|
20517416|NCT05014828|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20517417|NCT02682238|Botanix Pharmaceuticals|Anthony Robinson, MS, CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20517418|NCT01370317|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20517419|NCT00075478|Fred Hutchinson Cancer Research Center/|Dr. Brenda Sandmaier|206-667-4961|bsandmai@fhcrc.org|
20517420|NCT04665375|University Health Network|Sharon Walmsley|416-340-5077|sharon.walmsley@uhn.ca|
20517421|NCT00002601|City of Hope|Paul Frankel, Ph.D.|(626)256-4673|pfrankel@och.org|65265
20517422|NCT02075463|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517423|NCT00673660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517424|NCT01527006|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20517425|NCT00824291|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517426|NCT00933686|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
20517427|NCT01776190|University of Texas Southwestern Medical Center|Benjamin Chong, MD|214-645-2400|ben.chong@utsouthwestern.edu|
20517428|NCT00123734|AGEN Biomedical Ltd|Dr Michael Gerometta|+61 408 885 416|mgerometta@agenix.com|
20517429|NCT00113386|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
20517430|NCT01648582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20517431|NCT02159183|ZMK University of Bern, Clinic of Periodontology|Prof. Dr. med. dent., Dr. h.c., M.S. Anton Sculean|004131 632 25 72|anton.sculean@zmk.unibe.ch|77
20517432|NCT01444378|Abbott Vascular|Robert McGreevy|408-845-3932|Robert.mcgreevy@abbott.com|
20517433|NCT00840476|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517434|NCT00556322|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20517435|NCT00796328|IWK Health Centre|Dr. Ron George|470-6627|rbgeorge@dal.ca|
20517436|NCT03249454|The University of Texas Health Science Center at Houston|Radha Korupolu, MD, MS|713-797-6976|Radha.Korupolu@uth.tmc.edu|
20517437|NCT00835146|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517438|NCT03669861|Massachusetts General Hospital|DRAI Director of Clinical Trials|6176920668|JHSTONE@mgh.harvard.edu|
20517439|NCT02760927|Hollister Incorporated|Stacy Haddad, Director Global Clinical Affairs|+1.847.680.2837|stacy.haddad@hollister.com|
20517440|NCT03256695|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20517441|NCT01103713|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517442|NCT05454956|Tarsus Pharmaceuticals, Inc.|Kavita Dhamdhere, Vice President of Clinical Development|650-223-4062|kdhamdhere@tarsusrx.com|
20517443|NCT03435835|Purdue University/Indiana University|Dr. Bruno Roseguini|7654962612|brosegui@purdue.edu|
20517444|NCT01929863|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562770|NCT03657212|University of California, Irvine|Dr Sara Mednick|8589457904|mednicks@uci.edu|
20517445|NCT00251979|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20517446|NCT00284518|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20517447|NCT06185088|University of Michigan|Meghan Arnold|734-936-8978|meghanar@med.umich.edu|
20562771|NCT04999085|University of North Carolina Lineberger Comprehensive Cancer Center|Christopher E. Jensen, MD, MSCR|+1 984-987-1072|cejensen@med.unc.edu|
20517448|NCT00323882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20517449|NCT00835536|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517450|NCT05168735|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
20517451|NCT00429416|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
20517452|NCT03077451|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
20517453|NCT00730691|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20517454|NCT02178787|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
20517455|NCT02554890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20517456|NCT01521780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20517457|NCT00834275|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517458|NCT03649477|Levo Therapeutics|Vice President of Clinical Development|1-847-901-9260|contactus@levotx.com|
20517459|NCT04544410|Spruce Biosciences|Spruce Clinical Trials|415-655-4169|clinicaltrials@sprucebio.com|
20517460|NCT02430480|National Cancer Institute|Dr. Fatima Karzai|301-480-7174|karzaifh@mail.nih.gov|
20517461|NCT01030133|Medical University of South Carolina|Dr. Jeffery J Borckardt|843.792.3127|borckardt@musc.edu|
20517462|NCT01963728|Inova Health Care System|Anne Whitney Brown, MD Principal Investigator|703.776.3067|anne.brown@inova.org|
20517463|NCT04870606|Suzhou Kintor Pharmaceuticals,Inc.|Millie Gu|+86- 512 6263 9938|PR@kintor.com.cn|
20517464|NCT01718301|Infetious disesases|Dr Josep Mallolas Masferrer|932275400|jmallolas@clinic.ub.es|3312
20517465|NCT05776901|University of California, Irvine|Dr. Melissa Pinto, Associate Professor, Sue & Bill Gross School of Nursing|949-824-9272|mdpinto@uci.edu|
20517466|NCT00682461|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517467|NCT00828295|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
20517468|NCT01402050|Phoenix Perinatal Associates - Mednax|Ana Braescu|602-614-0488|ana_braescu@mednax.com|
20517469|NCT02028221|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
20517470|NCT03581097|Ospedale Regionale di Bellinzona e Valli (ORBV)|Dr. med. Andrea Saporito, Vice-Chair Department of Anesthesia|091/811.91.11|andrea.saporito@eoc.ch|
20517471|NCT03220958|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20517472|NCT03098485|Washington University in St. Louis School of Medicine|Kimberly Reske, MPH|3147474041|kreske@wustl.edu|
20562772|NCT03717415|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
20562773|NCT04431050|Imperial|Joan Nanan|+44 (0)20 7594 9000|j.nanan@imperial.ac.uk|
20517473|NCT04200833|Medical University of Graz|PD MD Andrea Skrabl-Baumgartner|+43 316 385|andrea.skrabl-baumgartner@medunigraz.at|111
20517474|NCT01361633|Anxiety Disorders Center, Institute of Living/Hartford Hospital|Gretchen Diefenbach, Ph.D.|860-545-7685|gdiefen@harthosp.org|5-7396
20517475|NCT02328040|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
20517476|NCT00761813|University of Minnesota|Principal Investigator|612.273.8000|swion001@umn.edu|
20517477|NCT01471353|University of Florida|Dr. Thomas J. George, Jr.|352-273-8008|thom.george@medicine.ufl.edu|
20517478|NCT00836472|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517479|NCT00529191|Children's Hospital of Philadelphia|Steven Willi, MD|215-590-3174|willi@chop.email.edu|
20517480|NCT03246503|BiliCam, LLC|James Taylor|2064194923|uncjat@google.com|
20517481|NCT03382925|University of Utah, Department of Physical Medicine and Rehabilitation|Dr. Zachary McCormick|801-587-5432|PMR.Research@hsc.utah.edu|
20517482|NCT00529464|UT MD Anderson Cancer Center|Helen E. Rhodes, MD / Assistant Professor|713-792-2933|CR_Study_Registration@mdanderson.org|
20517483|NCT00466167|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517484|NCT03199963|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
20517485|NCT01144494|University of Nebraska Medical Center|Carol Toris|402-559-1852|ctoris@unmc.edu|
20517486|NCT02645409|Indiana University|Courtney Dhondt, Clinical Research Nurse|317-274-1791|cgerler@iu.edu|
20517487|NCT03466866|Thomas Jefferson University|Barry Rovner,MD|215-503-1243|Barry.Rovner@Jefferson.edu|
20517488|NCT02089685|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20517489|NCT02068820|Florida Hospital Gynecologic Oncology|Robert W. Holloway|407-303-2400|robhollowaymd@gmail.com|
20517490|NCT00318461|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20517491|NCT01172145|Brown University|Laura L. Frakey|401-729-3163|lfrakey@gmail.com|
20517492|NCT04134091|Lipocine Inc|Senior Director of Clinical Development|801-994-7383|admin@lipocine.com|
20517493|NCT02354339|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uice@prodigy.net.mx|34212
20517494|NCT00505622|Eisai Call Center|Eisai Inc.|888-422-4743||
20517495|NCT03084471|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20517496|NCT04405765|University of Texas Southwestern Medical Center|Tara Kristof - research coordinator|214-648-9007|tara.kristof@utsouthwestern.edu|
20517497|NCT03393208|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20517498|NCT00868374|University Hospitals Cleveland Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
20517499|NCT01848938|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@umu.se|
20517500|NCT01757392|Nielsen Biosciences, Inc|David Burney|858-571-2726|david@nielsenbio.com|
20517501|NCT01218672|Boston Scientific Corporation|Teresa Takle-Flach, Director, Clinical Operations|(952)930-6000|teresa.takle-flach@bsci.com|
20562774|NCT00003042|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20562775|NCT03990649|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20562776|NCT05773313|Mayo Clinic|Nathan Delafield, M.D.|480-574-1920|Delafield.Nathan@mayo.edu|
20562777|NCT03050814|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|julius.strauss@nih.gov|
20562778|NCT01443845|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20562779|NCT01471691|Thomas Hanscom AMC|Thomas O'Hearn MD|310-829-3303|tohearn@gmail.com|
20562780|NCT01854385|University of Washington|Dr. Jeanne Hoffman|(206) 221-6511|jeanneh@uw.edu|
20562781|NCT02386553|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20562782|NCT01610297|Novartis|Study Director|862-778-8300||
20562783|NCT01929759|Boston Medical Center, Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
20562784|NCT03399604|Liquidia Technologies|Chief Medical Offier|919-328-4400|safety@liquidia.com|
20562785|NCT01828554|University of Madison Carbone Cancer Center|Kari B. Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
20562786|NCT01561989|Roswell Park Cancer Institute|Dr. Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
20562787|NCT02346526|Massachusetts General Hospital|Philip Saylor, MD|617-724-5197|psaylor@mgh.harvard.edu|
20562788|NCT01381406|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562789|NCT03930420|University of Washington|Margaret Hannon, PhD|206-616-7859|peggyh@uw.edu|
20562790|NCT04661410|The WELL Center|Dr. Adrienne Juarascio|443-801-8093|asj32@drexel.edu|
20562791|NCT03635151|University of Cincinnati College of Nursing|Tamilyn Bakas|513-558-2254|tamilyn.bakas@uc.edu|
20517502|NCT03703791|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20517503|NCT00207090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20517504|NCT01552317|University of Oxford|Principal Investigator|+441865287794|chris.ocallaghan@ndm.ox.ac.uk|
20517505|NCT00841698|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517506|NCT00835692|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517507|NCT01149733|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|866-384-5525|clinicaltrialqueries@tevausa.com|
20517508|NCT00545506|Dep. Anesthesia And Intensive Care|Helmut Hager|+43 1 40400 4102|helmut.hager@meduniwien.ac.at|
20517509|NCT04078022|University of Maryland, Baltimore Center for Vaccine Development and Global Health (CVD)|Dr. Wilbur Chen|410-706-5328|wchen@som.umaryland.edu|
20517510|NCT00191815|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20517511|NCT03644550|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|hassanr@mail.nih.gov|
20517512|NCT00099047|Cleveland Clinic|Matt Kalaycio, MD|216-444-3705|kalaycm@ccf.org|
20517513|NCT01348789|Northwestern Memorial Hospital|Dr. Jerome M. Garden|312-280-0891|j-garden@northwestern.edu|
20517514|NCT01668602|Emory University|Trisha Kesar, PT, PhD|404-712-5803|trisha.m.kesar@emory.edu|
20517515|NCT01636661|University of Minnesota|Dr. Bernadette Gillick|612.626.6415|brown029@umn.edu|
20517516|NCT00830024|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517517|NCT01983969|UT MD Anderson Cancer Center|Nieto, Yago / Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
20517518|NCT02619682|Fred Hutchinson Cancer Care Center|Dr Leona A Holmberg|206-667-6447|lholmber@fredhutch.org|
20517519|NCT00268203|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517520|NCT03600376|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
20517521|NCT03804983|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20517522|NCT02152163|Delray Medical Center|Russell Weisz, MD|561-213-9371|rdweisz@gmail.com|
20517523|NCT02067611|Techfields|Dr. Chongxi Yu|571 276 5371|chongxiyu@hotmail.com|
20517524|NCT02358538|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20517525|NCT06999265|University of Michigan at Ann Arbor|Tim Bruns|(734) 647-8727|bruns@umich.edu|
20517526|NCT01154231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517527|NCT03190005|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
20517528|NCT04377087|UPMC|Barbara Stadterman, MPH, CCRP|7245532539|stadtermanbm@upmc.edu|
20517529|NCT00835705|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517530|NCT01750294|Indiana University & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
20517531|NCT00665925|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20517532|NCT04035187|University of Maryland Baltimore|Dr. James Polli|410-706-8292|jpolli@rx.umaryland.edu|
20517533|NCT01881763|Northwell Health|Georgios Petrides, MD, PI|718-470-8569|gpetride@northwell.edu|
20517534|NCT00128219|University of Pittsburgh School of Medicine|Sharon Hillier, Ph.D.|412-641-6435|hillsl@mwri.magee.edu|
20517535|NCT05090839|University of Miami|Dr. Roger McIntosh|3052435166|r.mcintosh@miami.edu|
20517536|NCT00373256|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517537|NCT01987765|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
20517538|NCT01528696|University of Michigan|Mark Chames|734 764-1406|mchames@med.umich.edu|
20529217|NCT02358031|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20562792|NCT01877343|University of Florida|Dr. Curt DeGroff|352-273-7770|degroffc@peds.ufl.edu|
20562793|NCT00856739|Stanford University, Palo Alto Veterans Hospital|Dr. Thomas P. Andriacchi, Ph.D.|650-723-8024|tandriac@stanford.edu|
20517539|NCT01056484|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
20562794|NCT01136486|North Shore LIJ|Dr. Rosemarie Basile|718 226-6501|rbasile1@siuh.edu|
20562795|NCT03799783|University Hospital Padova|Angela Amigoni, MD|339 8333765|Angela.amigoni@aopd.veneto.it|++39
20517540|NCT02776774|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
20517541|NCT00033917|Yale University School of Medicine|Dr. Laura Ment|203-785-5708|laura.ment@yale.edu|
20517542|NCT00446966|Carient Heart and Vascular|Dr Chirag Sandesara|7033358750|csandesara@carient.org|
20517543|NCT00835575|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517544|NCT01440803|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
20517545|NCT02557035|Helsinn Healthcare SA|Daniel Voisin|+41 91 985 2121|daniel.voisin@helsinn.com|
20517546|NCT01515891|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20517547|NCT05058430|Saliwell Ltd.|Dr. Andy Wolff|+972508801852|awolff@saliwell.com|
20517548|NCT02768701|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS ACRP-CP, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
20517549|NCT02718963|Seoul National University Bundang Hospital, Seoul National University College of Medicine|Ju Seok Ryu|82-31-787-7739|jseok337@snu.ac.kr|
20517550|NCT01547286|Massachusetts General Hospital|Dr. Robert Scott Harris, MD|617-726-9429|rsharris@mgh.harvard.edu|
20517551|NCT00540995|City of Hope Medical Center|Dr. Anthony Stein|626-359-8111||
20517552|NCT01695239|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20517553|NCT02007863|University of Miami|Martin Andreansky MD|305-243-0850|mandreansky@med.miami.edu|
20517554|NCT04383587|Mayo Clinic|Mark A. Parkulo, MD|9049532000|parkulo.mark@mayo.edu|
20517555|NCT03502811|Abbott|Nadia Bouhdi|32-479-94-10-37|nadia.bouhdi@abbott.com|
20517556|NCT03913377|Johnson & Johnson Vision Care|Elizabeth Dow, PRINCIPAL RESEARCH OPTOMETRIST|+1800-843-2020|edow1@its.jnj.com|
20517557|NCT02241551|University of Pittsburgh Cancer Institute|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
20517558|NCT01205035|Eye Center of Northern Colorado, PC|Dr. Arthur Korotkin, MD|970-221-2222|retina@eyecenternoco.com|
20517559|NCT01556906|Aegerion Pharmaceutical|Chief Medical Officer|617-500-7867||
20517560|NCT02331108|Albert Einstein Healthcare Network|Jonathan Roth, M.D.|2154567979|rothj@einstein.edu|
20517561|NCT02751424|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20517562|NCT01896934|Vanderbilt University Medical Center|Dr. Warren D Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
20517563|NCT02197416|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517564|NCT01492439|Centre for Addiction and Mental Health|Dr. Sean A. Kidd|416-535-8501|sean.kidd@camh.ca|6295
20517565|NCT00716625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517566|NCT01204294|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517567|NCT04590027|University of Tuebingen, Department of Anaesthesiology and Intensive Care Medicine|Dr. Barbara Schlisio|+4970712985535|barbara.schlisio@med.uni-tuebingen.de|
20517568|NCT01383486|Bayer HealthCare LLC, Consumer Care|Head Clinical and Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
20517569|NCT00245063|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20517570|NCT01370369|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20517571|NCT01839279|Acorda Therapeutics, Inc.|Executive Medical Director|914-437-4300|paupperle@acorda.com|5263
20517572|NCT01907607|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
20517573|NCT01505933|Penn State Health Milton S. Hershey Medical Center|Dr. Uma R Parekh, MBBS, DNB, FRCA, FFARCSI|717531-4264|uparekh@pennstatehealth.psu.edu|
20517574|NCT00840216|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517575|NCT03276754|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517576|NCT01058668|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
20517577|NCT00316277|McLean Hospital/Harvard Medical School|Roger D. Weiss, M.D.|617-855-2242|rweiss@mclean.harvard.edu|
20517578|NCT05373173|Vanderbilt University Medical Center|Zachary Warren, Ph.D.|615-875-3085|zachary.e.warren@vumc.org|
20517579|NCT02777580|KU Leuven|Prof Frans Van de Werf|003216342111|frans.vandewerf@kuleuven.be|
20517580|NCT00927069|Innovaderm Research, Inc.|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
20517581|NCT02911792|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD - Chief Diabetes Division - Medicine|210 567 6706|defronzo@uthscsa.edu|
20517582|NCT00848536|Alcon Research, Ltd.|Director Alcon Clinical|888.451.3937 or 817.568.6725||
20517583|NCT00908128|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517584|NCT00107991|UPenn|Jennifer Goldfarb|215-662-2540|jennifer.goldfarb@uphs.upenn.edu|
20517585|NCT01535222|The Medicines Company|Andreas van de Locht|+4989244180862|andreas.locht@themedco.com|
20517586|NCT03930732|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20517587|NCT04708028|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD|919-966-9731|ljacox@live.unc.edu|
20517588|NCT02825680|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|Laura.Damschroder@va.gov|
20551359|NCT00598663|University Children's Hospital Vrazov trg 1 SI-1525 Ljubljana, Slovenia|Tadej Battelino|+386 1 522 50 50|tadej.battelino@mf.uni-lj.si|
20517589|NCT02913924|New York State Psychiatric Institute|John Mariani MD|646-774-8181|john.mariani@nyspi.columbia.edu|
20517590|NCT03808376|Senseonics|Vice President, Clinical Sciences|301-515-7260|katherine.tweden@senseonics.com|
20517591|NCT01097577|US Air Force|Julie Meek, Clinical Pharmacist|210-808-2200|julie.m.meek.mil@mail.mil|
20517592|NCT00748072|University of Bari|Dr. Carlo Manno|390805478878|c.manno@nephro.uniba.it|
20551360|NCT03336853|AOUCareggi|Dr. Riccardo Pace|+390557945608|riccardo.pace@unifi.it|
20551361|NCT00278655|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
20551362|NCT00310791|Children's Hospital Boston|Dr. Catherine Gordon|401-444-4712|cgordon1@lifespan.org|
20562796|NCT02020252|University of Chicago Medicine|Toni M Cipriano|574-339-0652|tcipriano@uchicago.edu|
20562797|NCT02793154|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20562798|NCT04426500|Icahn School of Medicine at Mount Sinai|Dr. Reza Mehrazin|(212) 241-4812|reza.mehrazin@mountsinai.org|
20562799|NCT02372253|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Anath Shalev, MD|205-996-4777|shalev@uab.edu|
20562800|NCT01803555|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20562801|NCT01923480|Baxter Healthcare|Aparna Valluru, Clinical Project Manager|224.270.6063|Aparna_Valluru@baxter.com|
20562802|NCT01551355|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster|212-241-3852|valentin.fuster@mssm.edu|
20562803|NCT02409667|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20562804|NCT01094184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20562805|NCT01925339|University of Michigan|Dr. Hom-Lay Wang|734-763-3383|homlay@umich.edu|
20562806|NCT01985542|Helsinki University Hospital|Dr. Sanna Salmi|+358505431421|sanna.salmi@helsinki.fi|
20517593|NCT03114891|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
20562807|NCT01205048|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20562808|NCT01255670|Helsinki University Central Hospital|Dr. Karin Blomgren|+358504271579|karin.blomgren@hus.fi|
20562809|NCT03664960|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20562810|NCT00823472|UMC Utrecht|Prof. dr. B.C.J.M. Fauser|+31-88-7557524|b.c.fauser@umcutrecht.nl|
20562811|NCT04019444|The Hope Clinic of the Emory Vaccine Center|Varun K. Phadke, MD|404-712-9046|vphadke@emory.edu|
20562812|NCT00903162|Dana-Farber Cancer Institute|Ann Partridge, MD, MPH|617.632.3800|ann_partridge@dfci.harvard.edu|
20517594|NCT01952691|Hacettepe University|Gul Oznur Karabicak|+90 505 3569409|guloznur@gmail.com|
20517595|NCT00199901|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20517596|NCT01279109|Wake Forest School of Medicine|Dr. Sabina B. Gesell|336-713-8738|sgesell@wakehealth.edu|
20562813|NCT02960204|Histogen Inc.|Mark Hubka, Executive Director, Medical Affairs|858-526-3109|mhubka@histogen.com|
20517597|NCT00917735|University of Minnesota|Dr. Mindy Kurzer|612-624-9789|mkurzer@umn.edu|
20517598|NCT04517604|Edward Hines Jr., VA Hospital|Dr. Amy Herrold|708-202-5867|amy.herrold@va.gov|
20517599|NCT04336332|Cancer Institute of New Jersey|Dr. Sabiha Hussain|+1 732-718-3253|hussaisa@rwjms.rutgers.edu|
20517600|NCT02225106|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732-|Ramon.Diaz-Arrastia@uphs.upenn.edu|
20517601|NCT01958294|Silk Road Medical, Inc.|Ric Ruedy, Exec VP, Clinical Affairs|408-585-2112|ric@silkroadmed.com|
20517602|NCT02566850|Ekso Bionics|Katherine Strausser PhD|(510) 529-2529|kstrausser@eksobionics.com|
20517603|NCT01116739|University of Colorado Denver|Patricia A. Braun|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20517604|NCT05511935|KDH Research & Communication Inc.|President|4043958711|kholtz@kdhrc.com|
20517605|NCT01624233|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20562814|NCT03087708|VA Long Beach Health Care System|Dr. Pankaj Gupta|562-826-8000|pankaj.gupta@va.gov|
20517606|NCT05710718|Becton, Dickinson and Company|Director Clinical Affairs and Medical Affairs Strategy|551-225-1164|Kirsten.Hammitt@bd.com|
20517607|NCT04372238|Brown University School of Public Health|Brandon DL Marshall, PhD|4018636427|brandon_marshall@brown.edu|
20517608|NCT04241458|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517609|NCT00334815|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fhcrc.org|
20517610|NCT06144424|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20517611|NCT03121586|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|844-422-2342|medicalinformation@acadia-pharm.com|
20517612|NCT06381102|University of Miami|Marlon Wong, Associate Professor of Clinical|3052842670|mwong2@miami.edu|
20517613|NCT03119025|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD Study Principal Investigator|383-236-03-29|ct_lab@mail.ru; ostanin62@mail.ru|+7
20517614|NCT02832063|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20517615|NCT03733730|Alcon Research, LLC|Sr. Clinical Project Lead, CRD Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20517616|NCT00772603|Supernus Pharmaceuticals, Inc|Stefan Schwabe, M.D., Ph.D., Chief Medical Officer|301-838-2500|sschwabe@supernus.com|2527
20517617|NCT00836004|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517618|NCT01564394|Huntsman Cancer Institute, University of Utah|Anita Y. Kinney, PhD|801-585-1151|anita.kinney@hci.utah.edu|
20517619|NCT02826694|The University of North Carolina at Chapel Hill|Dr. Cynthia M. Powell|9199667646|powellcm@med.unc.edu|
20517620|NCT01988376|Far Eastern Memorial Hospital|Hsiao, Sheng-Mou|(02)89667000|smhsiao2@gmail.com|1424
20517621|NCT00443651|Genentech, Inc.|Medical Communications|800-821-8590||
20517622|NCT03606174|Mirati Therapeutics|Director, Clinical Operations|858-381-5289|LatvenL@Mirati.com|
20517623|NCT00859521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517624|NCT01609257|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20517625|NCT02125461|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20517626|NCT02888756|Erasmus MC|Dr R.A. Gruters|+31 10 7032100|r.gruters@erasmusmc.nl|
20517627|NCT02305732|Cerus|Carol Moore, Senior VP Regulatory Affairs & Quality|925-288-6361|cmoore@cerus.com|
20517628|NCT00834132|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517629|NCT01246258|Imperial Health|Joanne Rimmer|0061402931120|rimmer.joanne@gmail.com|
20517630|NCT03415308|Duke Center for Research to Advance Healthcare Equity|Alesha Majors|919-660-7545|alesha.majors@duke.edu|
20517631|NCT02342535|Northwestern University|Dr. Namratha Kandula|312-503-6470|nkandula@nm.org|
20562815|NCT01996605|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
20562816|NCT03997916|University Hospitals Cleveland Medical Center|Eric Yeh, MD|216-844-1867|eric.yeh@uhhospitals.org|
20562817|NCT04220229|City of Hope|Lee Cranmer, MD, PhD|626-256-4673|lcranmer@coh.org|
20562818|NCT01827787|Dana-Farber Cancer Institute|Dr. Erica Mayer|617-632-2335|Erica_Mayer@dfci.harvard.edu|
20562819|NCT03807778|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20562820|NCT01207492|Dana-Farber Cancer Institute|Andrew Wagner, MD, PhD|617.632.5204|andrew_wagner@dfci.harvard.edu|
20562821|NCT02769858|University of Michigan|Dr. Leslie Swanson|734-239-2248|LMSwan@med.umich.edu|
20562822|NCT04242940|Oticon Medical|Manager of Clinical Affairs|609-366-0424|studyinfo@oticonmedical.com|
20562823|NCT04939246|Miami Cancer Institute at Baptist Health, Inc.|Director, Concept Development & Data Management|(786) 527-9546|mciresearchconceptandprotocoldev@baptisthealth.net|
20562824|NCT01304277|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20562825|NCT04708509|The Ottawa Hospital|Dr. Andrew Seely|613-737-8899|aseely@toh.ca|74052
20562826|NCT04870645|M D Anderson Cancer Center|Jason Johnson, MD|713-792-8443|jasonjohnson@mdanderson.org|
20562827|NCT04192747|Elixir Medical Corporation|Tina Cordaro, Sr. Director, Clinical Trials|585-360-7270|tcordaro@ElixirMedical.com|
20562828|NCT01216176|University of Miami|Joyce Slingerland MD PhD FCRP(C)|305-243-7265|jslingerland@med.miami.edu|
20562829|NCT00880425|Thomas Jefferson University|Jessica Ailani, MD/ Headache Fellow|631-807-8194|Jessica.Ailani@gmail.com|
20562830|NCT05056246|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20562831|NCT05857644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562832|NCT05096819|Oxford University Hospitals|Dr Elizabeth Orchard|01865 741166|elizabeth.orchard@ouh.nhs.uk|
20562833|NCT03324984|Montefiore Medical Center|Dr. Elilary Montilla Medrano|929-263-3302|emontill@montefiore.org|
20562834|NCT03845829|Department of Vascular Surgery, Shanghai Ninth People's Hospital|Kaichuang Ye|+86-021-2327166|ykaichuang@163.com|
20562835|NCT02152137|Mayo Clinic|Robert C. Smallridge, M.D.|904-953-2392|smallridge.robert@mayo.edu|
20562836|NCT04878354|ALK-Abelló A/S|Senior Director, Clinical Data Science|+4545747576|clinicaltrials@alk.net|
20562837|NCT03358875|BeiGene|Study Director|1-877-828-5568|Clinicaltrials@beigene.com|
20562838|NCT03599648|University of Oregon|Dr. Laura Lee McIntyre|541-346-7452|llmcinty@uoregon.edu|
20562839|NCT03363854|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
20562840|NCT06382064|The Ohio State University College of Optometry|Dr. Jennifer Fogt|614-292-0882|fogt.78@osu.edu|
20562841|NCT06194214|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20562842|NCT05687903|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20562843|NCT04847999|University of British Columbia|Dr Jonathan Little|2508786893|jonathan.little@ubc.ca|
20562844|NCT02879448|Abbott Medical|Jordan Anderson, Clinical Scientist|651 756 3360|ClinicalTrials.gov_SH_Inquiries@abbott.com|
20562845|NCT04300231|Indiana University Department of Anesthesiology|Yar Luan Yeap, MD|317-274-0275|yyeap@iupui.edu|
20562846|NCT02014129|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20562847|NCT00998881|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20562848|NCT01121991|EMD Serono Canada Inc., an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+1-888-737-6668|david.sciberras@emdserono.com|5248
20562849|NCT03128359|City of Hope Medical Center|Dr. Monzr M.Al Malki, MD|6263598111|malmalki@coh.org|
20562850|NCT02590432|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20562851|NCT02006758|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
20562852|NCT02740231|Bone Therapeutics|Dr Olivier Godeaux Medical Officer|+32 71 12 10 00|jta.koa1@bonetherapeutics.com|
20562853|NCT01188369|Aarhus University Hospital|Dr. Peter Juhl-Olsen|+4578451199|peter.juhl-olsen@ki.au.dk|
20562854|NCT05052996|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20562855|NCT04149002|Duke University|Sarahn M. Wheeler, MD|(919) 684-6327|sarahn.wheeler@duke.edu|
20562856|NCT04704284|Mayo Clinic|Julie Guerin, M.D.|507-293-3698|Guerin.Julie@mayo.edu|
20562857|NCT00957242|University of Chicago Hospital|Imre Noth, MD, Associate Professor of Medicine|773-834-1832|inoth@medicine.bsd.uchicago.edu|
20562858|NCT01736215|Janssen Cilag Thailand|Medical Affairs Director|+6627927232||
20562859|NCT01066026|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|55 51 30262633|cientifico@cbed.org.br|
20562860|NCT03447249|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20562861|NCT00988858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20562862|NCT02238483|AstraZeneca|Ziad Taib|+46 708 46 73 56|ziad.taib@astrazeneca.com|
20562863|NCT00390299|Mayo Clinic|Evanthia Galanis, M.D.|+1 (507) 266-0584|Galanis.Evanthia@mayo.edu|
20562864|NCT00593866|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
20562865|NCT01172418|University of Miami|George W. Burke, M.D.|305-355-5315|gburke@med.miami.edu|
20517632|NCT05239195|Vanderbilt University Medical Center|Jonathan D Casey, MD, MSc|615-875-4681|Jonathan.d.Casey@vumc.org|
20517633|NCT03170219|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-668-5590|rachel.e.olson@duke.edu|
20517634|NCT03552484|Rush University Medical Center|Jori Fleisher, MD MSCE|3125632900|jori_fleisher@rush.edu|
20517635|NCT03499353|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517636|NCT00081653|Hoffmann-La Roche|Clinical Trials Study Director|+1 973 235 5000||
20517637|NCT02741687|Emory University|Maya Fayfman, MD|404-778-1664|maya.fayfman@emory.edu|
20562866|NCT00331136|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
20562867|NCT02692417|University of Michigan|Dr. Tim Bruns|(734) 647-8727|bruns@umich.edu|
20562868|NCT03359889|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517638|NCT01015287|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20562869|NCT01215344|Vanderbilt-Ingram Cancer Center|Madan Jagasa, M.D.|(6150 936-8422|madan.jagasia@vanderbilt.edu|
20562870|NCT00393484|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20562871|NCT00629850|Texas State Respiratory Care Department|Chris Russian, Associate Professor|512-245-3794|cr23@txstate.edu|
20562872|NCT03750968|University of Utah John A. Moran Eye Center|Paul Bernstein, MD, PhD|801-581-4069|Paul.Bernstein@hsc.utah.edu|
20562873|NCT00879060|Tufts Medical Center|Martin Maron, MD|(617) 636-8066|mmaron@tuftsmedicalcenter.org|
20562874|NCT03294499|Imperial College Healthcare NHS Trust|Dr Farai Nyatsanza|n/a|farai.nyatsanza@nhs.net|
20562875|NCT04767698|Johns Hopkins University, School of Medicine|Dimitrios Ladakis|410-614-1522|dladaki1@jhmi.edu|
20562876|NCT01381471|GlaxoSmithKline|GSK Response Center|866-435-7343||
20562877|NCT00132964|Hospital for Sick Children|Kathy Boutis|4168138982|kathy.boutis@sickkids.ca|
20562878|NCT02178098|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20562879|NCT02382744|Department of Anesthesia, St. Paul's Hospital/Providence Health Care|Dr. Stephan Schwarz, Director of Research|(604) 806-8337|stephan.schwarz@ubc.ca|
20562880|NCT00194610|University of Washington|Claire Yang, MD|206-744-6384|cyang@uw.edu|
20562881|NCT02318134|First Affiliated Hospital of Nanchang University|Dr. Ling Ding|15279196058|2495802456@qq.com|
20562882|NCT00031694|Montefiore Medical Center-New York cancer Consortium|Joseph Sparano|718-405-8404|jsparano@montefiore.org|
20562883|NCT04766034|NYU Langone Health|Pasquale Rummo, MPH, PhD|914-316-5907|Pasquale.rummo@nyulangone.org|
20562884|NCT03892564|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
20562885|NCT00475241|VA Ann Arbor Healthcare System|Dr. Sheila A.M. Rauch|734-845-3545|sherauch@med.umich.edu|
20562886|NCT05094141|UT Southwestern Medical Center|Dr. Sarah Rebstock|214-456-8106|sarah.rebstock@utsouthwestern.edu|
20562887|NCT06546657|University of Stirling|Julie Johnson|07815893076|julie.johnson1@stir.ac.uk|
20562888|NCT01600014|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20562889|NCT03954184|University of Wisconsin - Madison|Todd Molfenter, PhD|608-262-1685|todd.molfenter@wisc.edu|
20562890|NCT04842500|Vanderbilt University|Dr. Joseph Lambert|615-343-0824|joseph.m.lambert@vanderbilt.edu|
20562891|NCT03397108|The Hospital for Sick Children|Dr. Shinya Ito|4168135776|shinya.ito@sickkids.ca|
20562892|NCT01563341|Mayo Clinic|Ryan J. Uitti, MD|904-953-2000|uitti.ryan@mayo.edu|
20562893|NCT04337372|University of Florida|Lisa Scott|352-273-2125|lscott@ufl.edu|
20562894|NCT05307783|Merit Medical|Vicky Brunk|(385) 766-9152|vicky.brunk@merit.com|
20562895|NCT04883645|Medical University of South Carolina|Dr. Angela J. Yoon|8437924496|yoona@musc.edu|
20562896|NCT00977691|National Heart Lung and Blood Institute|Courtney Fitzhugh, MD, Investigator|+1 301 402 6496|courtney.fitzhugh@nih.gov|
20562897|NCT03460236|Stanford University|Christine Hoang, Clinical Research Coordinator|650-721-7630|c1hoang@stanford.edu|
20562898|NCT05613205|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20562899|NCT03890913|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20562900|NCT03494504|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20562901|NCT04881162|Silk Road Medical|Heather Smith|763-335-5160|hsmith@silkroadmed.com|
20562902|NCT04869982|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20562903|NCT04608045|University of Kansas Medical Center|Dr. John A Taylor|9135888170|jtaylor27@kumc.edu|
20562904|NCT05833789|Vanderbilt University Medical Center|Michael McGill|615-322-0128|michael.g.mcgill@vumc.org|
20562905|NCT02473250|Columbia University Irving Medical Center|Martin Lan MD PhD|646 774 7610|martin.lan@nyspi.columbia.edu|
20562906|NCT03103321|Mayo Clinic|Jon C. Tilburt, MD|5072661105|tilburt.jon@mayo.edu|
20562907|NCT01704079|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
20562908|NCT06023082|Citruslabs|Patrick Renner|(805) 292-0714|hello@citruslabs.com|
20562909|NCT03584516|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20562910|NCT05986565|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|
20517639|NCT01592240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517640|NCT01117623|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20517641|NCT03264092|Texas Tech University Health Sciences Center|Dr. Antonio Mendoza Ladd|9152154678|antonio.mendoza-ladd@ttuhsc.edu|
20517642|NCT00862563|Department of Psychiatry, Boston Univ School of Medicine|Dr. Domenic A Ciraulo, Professor|617-414-1990|dciraulo@bu.edu|
20562911|NCT04500301|Wake Forest|Danielle M Boselli|2017903385|Danielle.Boselli@AtriumHealth.org|
20517643|NCT00469898|Vanderbilt-Ingram Cancer Center|Leora Horn, M.D.|615-322-4967|leora.horn@vanderbilt.edu|
20517644|NCT01426360|Sun Yat-sen University|Dr. Liu Hongchun|86-0-13826189071|hongchun751@sina.com|
20517645|NCT02663349|Minneapolis VA Health Care System|Tasha Nienow, PhD|612-467-1004|tasha.nienow@va.gov|
20517646|NCT01572662|The University of Texas MD Anderson Cancer Center|Uday Popat, M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
20562912|NCT05846646|ImmuneSensor Therapeutics, Inc.|Patrick Widhelm, Senior Director Clinical Operations and Project Management|830-730-8176|pwidhelm@immunesensor.com|
20517647|NCT03317444|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
20562913|NCT00670046|UTHSCSA|Ron Rodriguez, MD, PhD|2105675643|rodriguezr32@uthscsa.edu|
20517648|NCT04547192|KWAME NKRUMAH UNIVERSITY/SCIENCE/TECH|Dr Adam Gyedu|+233248228838|drgyedu@gmail.com|
20517649|NCT02479763|Montreal General Hospital|Dr. De QH Tran|514-934-1934|de_tran@hotmail.com|43261
20517650|NCT00935012|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517651|NCT01442155|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20562914|NCT06146374|DynPort Vaccine Company, a GDIT Company|George A. Saviolakis, MD, PhD|301-835-4101|George.Saviolakis@gdit.com|
20562915|NCT01261052|Legacy Health System|Dr. W Kenneth Ward|503-413-5171|kenward503@msn.com|
20562916|NCT03655262|UCLA|Michelle Craske, Ph. D|(310) 825 8403|mcraske@mednet.ucla.edu|
20562917|NCT02554786|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20562918|NCT01695954|NYU School of Medicine|Carlos Malvestutto, MD, MPH|212-263-3570|carlos.malvestutto@nyumc.org|
20562919|NCT03921866|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562920|NCT04328727|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20562921|NCT03794024|Cleveland Clinic|Robert Bolash|216-444-3134|bolashr@ccf.org|
20562922|NCT02395978|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
20562923|NCT02131597|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/ Professor|713-745-3428|ggarciam@mdanderson.org|
20562924|NCT03032406|University of Pennsylvania|Dr Angela DeMichele|2156624000|angela.demichele@pennmedicine.upenn.edu|
20562925|NCT04583423|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562926|NCT03351699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20562927|NCT05644730|Ideal Medical Technologies|Dr. Leon DeJournett/Chief Medical Officer|8283379960|leondej@idealmedtech.com|
20562928|NCT03330795|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
20562929|NCT05782231|Massachusetts General Hospital|Ana-Maria Vranceanu, PhD|617-724-4977|avranceanu@mgh.harvard.edu|
20562930|NCT05018910|University of New Mexico|Jessie Maxwell, MD, MBA|505-272-3967|JRMaxwell@salud.unm.edu|
20562931|NCT01070069|Endologix|Elisa Hebb|949-598-4628|ehebb@endologix.com|
20562932|NCT00041938|Columbia University|Dr. J.L.P. (Seamus) Thompson|212-342-1252|jlt12@columbia.edu|
20562933|NCT02538341|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis|205-975-2176|jrcurtis@uabmc.edu|
20562934|NCT02321514|Abbott|Karine Miquel, PhD|+32 479 600 107|karine.miquel@abbott.com|
20517652|NCT04626414|Shield Therapeutics|Jackie Mitchell|+44 (0) 191 511 8500|jackie.mitchell@shieldtx.com|
20562935|NCT00536341|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20562936|NCT00533546|University of Rochester|Curtis Benesch, M.D., M.P.H.|585 275-2530|curtis_benesch@urmc.rochester.edu|
20562937|NCT04732338|Hackensack Meridian Health|Alphonsa Thomas, DO|7328364504|Alphonsa.Thomas@hmhn.org|
20562938|NCT00780234|Rocky Mountain Regional VA Medical Center|Robert L. Keith, MD|720-857-5120|robert.keith@ucdenver.edu|
20562939|NCT04011631|SMART Clinical Products|Ellie Coumans|+31 (0)6 53 82 70 16|e.coumans@smartclinicalproducts.com|
20562940|NCT00088413|National Cancer Institute|Dr. James Gulley|301-480-8870|james_gulley@nih.gov|
20562941|NCT02539225|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20562942|NCT01044303|East Carolina University|Dr. Paul Bolin|252-744-3773|bolinp@ecu.edu|
20562943|NCT01411592|University of Kiel|Dr. Martin Sasse, D.M.D., Assistant Professor|+494315972874|sekretariat@proth.uni-kiel.de|
20562944|NCT00212134|Stanford University School of Medicine|Scott R Lambert, MD, Study Chairman|650-498-4242|lambert7@stanford.edu|
20562945|NCT01109524|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20517653|NCT02284867|Ain Shams university (AinShamsU)|Ahmed Mohammed Abass , Ass.lecturer in faculty of medicine|002-01066903903|ahmedmams@hotmail.com|
20562946|NCT03101371|University of Colorado, Anshcutz Medical Campus|Saketh Guntupalli, MD|303-724-2033|saketh.guntupalli@cuanschutz.edu|
20517654|NCT01590563|Synexus Hungary|Dr. Beata Szoczei, MD|+36 1 436 7330||
20517655|NCT02927639|Children's Hospital of Philadelphia|Tara Kaushal, MD|6177322603|tara.kaushal@joslin.harvard.edu|
20517656|NCT04342663|Washington University School of Medicine|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
20517657|NCT03279250|UT MD Anderson Cancer Center|Dr. Christopher Logothetis, MD-Professor, Genitourinary Medical Oncology|(713) 563-7210|clogothe@mdanderson.org|
20517658|NCT06539676|Dentsply IH AB d.b.a Dentsply Sirona Implants|Clinical Research Manager|+4631 3763191|freja.freedman@dentsplysirona.com|
20517659|NCT00911274|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517660|NCT00909038|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20517661|NCT01640197|Northumbria University|Emma Wightman|(+44) 0191 2437253|emma.l.wightman@northumbria.ac.uk|
20517662|NCT03480763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20517663|NCT01895335|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20517664|NCT01169753|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante, MD / Chair, General Internal Medicine||CR_Study_Registration@mdanderson.org|
20517665|NCT00702377|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20517666|NCT01838681|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@lundbeck.com|
20529218|NCT01212094|NINDS, NIH|Dr. Bibiana Bielekova, Prinicipal Investigator|301-402-4488|bibiana.bielekova@nih.gov|
20551363|NCT03730948|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20551364|NCT00670800|University of Michigan|Yolanda Smith|(734) 936-7401|ysmith@umich.edu|
20551365|NCT01786629|Braintree Laboratories, Inc.|John McGowan, Director Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
20551366|NCT00410761|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20551367|NCT03694171|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20551368|NCT01852942|University of Minnesota|Timothy Schacker, MD|612-626-6577|olso7966@umn.edu|
20551369|NCT00696696|NYU Cancer Institute|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
20551370|NCT02642614|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551371|NCT01485640|Sunovion|Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20551372|NCT05359666|Irrimax Corporation|Director of Clinical Trials|770-807-3355|cs@irrisept.com|
20562947|NCT01553058|University of Pennsylvania|Suzette Baez VanderBeek, MPH|215-662-3514|suzettev@upenn.edu|
20517667|NCT00796562|Johns Hopkins University|Heather Symons, MD|4105029961|hsymons2@jhmi.edu|
20517668|NCT00424047|Celgene Corporation|Anne McClain, Senior Manager|1-866-260-1599|ClinicalTrialDisclosure@celgene.com|
20517669|NCT02664961|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
20517670|NCT03100344|Galderma|Kenny Frazier|817-961-5120|Kenny.frazier@galderma.com|
20517671|NCT01010503|Hoffmann- LaRoche.|Medical Communications|800-821-8590|genentech@druginfo.com|
20517672|NCT02433977|University of Pittsburgh|Stacy Gelhaus Wendell|412-648-1351|gstacy@pitt.edu|
20517673|NCT03599193|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20517674|NCT00798603|Roswell Park Cancer Institute|Grace K. Dy, M.D.|507-284-9265|grace.dy@roswellpark.org|
20517675|NCT03256227|Minneapolis VA Health Care System|Laura Meis, PhD|612-467-4516|laura.meis@va.gov|
20517676|NCT02645253|AstraZeneca AB|AZD7594 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20517677|NCT04145635|Procyrion, Inc.|Rubi Reyes-Fuentez, Clinical Research Associate II|-|rubi@procyrion.com|
20517678|NCT02727192|Oslo University Hospital|Professor Lars Gullestad|+4797644772|lars.gullestad@medisin.uio.no|
20517679|NCT00928057|BD Medical, Medical Affairs|Kenneth Kassler-Taub, MD|201 847 6729|kenneth_kassler-taub@bd.com|
20517680|NCT03206749|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20517681|NCT02451696|NYU Langone|Dr. Orrin Devinsky|646-558-0800|od4@nyu.edu|
20517682|NCT01557751|University of Pittsburgh Medical Center (UPMC)|Dr. Jacques Chelly, MD, PHD MBA|412-623-6382|chelje@anes.upmc.edu|
20517683|NCT02752074|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20517684|NCT00721162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20517685|NCT03674892|Tufts Medical Center|Pedram Hamrah, MD|617-636-5720|pedram.hamrah@tuftsmedicine.org|
20517686|NCT05099380|Johnson & Johnson Vision Care, Inc.|John R. Buch-Sr. Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
20517687|NCT00041392|Duke University|Dr. Mark F. Newman|919-681-6646|newma005@mc.duke.edu|
20517688|NCT01384591|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8126|melmoore@utmb.edu|
20517689|NCT01959672|University of Nebraska Medical Center|Chi Lin|402-552-3844|clin@unmc.edu|
20517690|NCT02392195|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
20517691|NCT00907907|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517692|NCT00545792|Dana-Farber Cancer Institute|Akila N. Viswanathan, MD, MPH|617-732-6331|aviswanathan@lroc.harvard.edu|
20517693|NCT02891863|Boston Scientific CRM|Greg Voss|651-581-3068|gregory.voss@bsco.com|
20517694|NCT02842853|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20517695|NCT04089553|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20517696|NCT01798264|Intarcia|Michelle Braon|510-782-7800||
20517697|NCT03682601|GTO Pharma|Clinical Trial Coordinator|9175436934|akhmea01@gmail.com|
20517698|NCT01175135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517699|NCT03364192|VA Center for Integrated Healthcare|Emily M. Johnson, Ph.D., PI|315-425-4400|Emily.Johnson1@va.gov|53487
20517700|NCT04692155|UAB|Amitkumar Mehta|2059968400|amitkumarmehta@uabmc.edu|
20517701|NCT02699463|ResMed Ltd|Dr Alison Wimms|+61 8884 1123|alison.wimms@resmed.com|
20517702|NCT01108445|Duke University Medical Center|Dr. Andrew J Armstrong|919-668-4615|andrew.armstrong@duke.edu|
20517703|NCT02488239|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
20517704|NCT03283982|Cleveland Clinic Foundation|Dr. Ajita Prabhu|2164444790|prabhua@ccf.org|
20517705|NCT01370733|University of California Los Angeles|Dr. Andrew Leuchter, MD|(310) 825-0207|afl@ucla.edu|
20517706|NCT02294981|UCSF Psoriasis and Skin Treatment Center|Tina Bhutani|4159147618|psoriasis@ucsf.edu|
20517707|NCT02960295|Kaiser Permanente Southern California|Steven Jacobsen MD, PhD. Director, Department of Research and Evaluation|626-564-3470|Steven.J.Jacobsen@nsmtp.kp.org|
20517708|NCT00909753|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517709|NCT04345653|JFK University Medical Center - Hackensack Meridian Health|Dr. Jawad Kirmani|7327745805|jawad.kirmani@hmhn.org|
20517710|NCT03214588|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20517711|NCT01370811|Quest Research Institute|Aaron L. Ellenbogen, OD, MPH|+1 248 644 7770|aellenbogen@comcast.net|
20517712|NCT01647828|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
20517713|NCT00418938|Amgen Inc.|Study Director|866-572-6436||
20517714|NCT01718873|National Cancer Institute, IRCCS, G. Pascale Foundation|Antonio Avallone, Dierctor of Experimental Abdominal Medcial Oncology|+390815903629|a.avallone@istitutotumori.na.it|
20517715|NCT00115063|PenningtonBRC|Tiffany Prather, RN, CDE|225-763-2979|tiffany.prather@pbrc.edu|
20517716|NCT00205777|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517717|NCT00700739|DePuy Synthes Spine|Mark Lotito|(508) 880-8045|Mlotito@its.jnj.com|
20517718|NCT03734861|Connecticut Children's Medical Center, Asthma Center|Dr. Jessica Hollenbach, PhD|860-837-5333|jhollenbach@connecticutchildrens.org|
20517719|NCT02314403|Massachusetts General Hospital|Tatsuo Kawai, MD PhD|617-726-0289|tkawai@mgh.harvard.edu|
20517720|NCT00185458|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20517721|NCT03503318|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20517722|NCT02687126|Shahid Gangalal National Heart Centre|Santosh Sharma Parajuli|+9779806532132|santoshparajuli77@hotmail.com|
20517723|NCT01794845|University of Miami|Matthew C. Abramowitz MD|305-243-4319|MAbramowitz@med.miami.edu|
20517724|NCT02139826|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
20517725|NCT01125163|UTexas_Houston|Dr. Kathleen A. Kennedy|713-500-6708|Kathleen.A.Kennedy@uth.tmc.edu|
20517726|NCT00436163|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20562948|NCT05123742|Rutgers School of Dental Medicine|Cecile A. Feldman, DMD, MBA|9739724634|feldman@sdm.rutgers.edu|
20562949|NCT05028582|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20562950|NCT02576509|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20562951|NCT05873062|Autifony Therapeutics Ltd|Head of Clinical Project Management|+447909228562|Alice.Sharman@autifony.com|
20562952|NCT03481660|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
20562953|NCT03398148|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20562954|NCT04278586|Cambridge Health Alliance|Dr. Zev Schuman-Olivier|617-591-6056|zschuman@cha.harvard.edu|
20562955|NCT02791230|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20562956|NCT00212355|Nobelpharama|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
20562957|NCT05769595|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20562958|NCT03661359|University of Toledo|Heather Klepacz, M.D, Principle Investigator|419-383-6754|heather.klepacz@utoledo.edu|
20562959|NCT04310735|The Pennsylvania State University|Stephen Wilson|8148656219|sjw42@psu.edu|
20562960|NCT03012841|Medtronic|Mary Sauline, Clinical Research Specialist|440-596-3529|mary.k.sauline@medtronic.com|
20562961|NCT00186992|St. Jude Children's Research Hospital|Matthew Krasin, MD|(901) 595-3226|matthew.krasin@stjude.org|
20562962|NCT05696080|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20562963|NCT03398200|University of Rochester|Omar Aljitawi, MD|(585) 275-4099|Omar_Aljitawi@URMC.Rochester.edu|
20562964|NCT01649271|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20562965|NCT05644002|Rutgers, the State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
20562966|NCT05756075|Radboudumc|Drs. D. de Graaf|+31243613450|debbie.degraaf@radboudumc.nl|
20562967|NCT03433469|University of California, San Francisco|Dr. Collin M. Blakely, MD, PhD|(415) 502-6959|collin.blakely@ucsf.edu|
20562968|NCT04605198|University of California, Los Angeles|Dr. Dana Rose Garfin, Associate Professor|415-407-9498|dgarfin@ucla.edu|
20562969|NCT04065048|Case Western Reserve University|Abigail Raffner Basson, Principal Investigator & Study Coordinator|2163276003|axb860@case.edu|
20562970|NCT02605837|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20562971|NCT05104697|Emma Pendleton Bradley Hospital|Dr. Kristen Benito|401-432-1054|kbenito@lifespan.org|
20562972|NCT04898023|University of Missouri Healthcare|Ryan Camden|(575) 882-4141|camdenr@health.missouri.edu|
20562973|NCT04468776|CPMCRI|Dr. Katie Stone|(510) 427-4562|katie.Stone@ucsf.edu|
20562974|NCT03569176|Stanford University|Dr. Dennis P. Wall|650-497-9214|dpwall@stanford.edu|
20562975|NCT04832360|University of Georgia|Dr. Michelle vanDellen|706-542-8991|mvd@uga.edu|
20562976|NCT05952076|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20562977|NCT05332340|Biozeus Biopharmaceutical S.A.|Joaquim Herzog de Oliveira Knox|+55 (21) 25239089|joaquim.knox@biozeus.com.br|
20562978|NCT04143061|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20562979|NCT03602014|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
20562980|NCT05540002|Brigham and Women's Hospital|Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
20562981|NCT04732494|BeiGene, Ltd.|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20562982|NCT02728557|University of Haifa|Prof. Sigal Zilcha-Mano|972-4-8249047|sigalzil@gmail.com|
20562983|NCT03416010|The Ohio State University|Dr. Bernadette Melnyk|6142924844|melnyk.15@osu.edu|
20562984|NCT03625323|Immutep|Immutep CMO|+ 49 30 88716843|regulatoryaffairs@immutep.com|
20562985|NCT03948763|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20562986|NCT02488863|University o fFlorida|Eric Weber|352-273-7802|ebweber@ufl.edu|
20562987|NCT06629454|University of Pennsylvania|Doraid Jarrar|2156627878|doraid.jarrar@pennmedicine.upenn.edu|
20562988|NCT05273723|Northwell Health|Karina Davidson|(516) 562-3467|kdavidson2@northwell.edu|
20562989|NCT00448240|Henry Ford Health System|Tiffany Pearce, Director of Clinical Trials|313-575-8046|tpearce1@hfhs.org|
20562990|NCT03755141|Korea university Guro hospital|In Hae Park|+82-2-2626-3172|parkih@korea.ac.kr|
20562991|NCT01285635|University of Michigan Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
20562992|NCT00505934|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20562993|NCT01296646|University of North Carolina at Chapel Hill|James C. Garbutt, M.D., Professor of Psychiatry|919-966-4652|jc_garbutt@med.unc.edu|
20562994|NCT02461628|Duke University|Wendy O'Meara, PhD|16099103091|wpo@duke.edu|
20562995|NCT02015520|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20562996|NCT04759833|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20562997|NCT03446157|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|919-445-4208|Melahat_Canter@med.unc.edu|
20562998|NCT06027229|UW School of Medicine and Public Health|Dr. Freddy Caldera, DO, PhD, MS|(608) 263-1995|fcaldera@medicine.wisc.edu|
20562999|NCT04630301|Johns Hopkins University|Dr. Jeffrey Thiboutot|410-502-2533|jthibou1@jhmi.edu|
20563000|NCT06459401|Boston University|Ashlyn Aiello|617-500-3645|ajma@bu.edu|
20563001|NCT01619410|University of Pennsylvania|Michael Z. David/Assistant Professor|215-662-6932|michdav@pennmedicine.upenn.edu|
20517727|NCT03719040|Abbott|Dr. Kwangdeok Lee|9725269673|kwangdeok.lee@abbott.com|
20517728|NCT02709018|University of California San Diego|Murray B. Stein MD, MPH|858-534-6451|mstein@health.ucsd.edu|
20563002|NCT03405714|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20563003|NCT02462759|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20563004|NCT04110054|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20563005|NCT03693937|Sensus Healthcare|Isabelle Raymond|561-922-5808|iraymond@sensushealthcare.com|
20563006|NCT01000480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20563007|NCT00570700|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20563008|NCT02410018|IMBiotechnologies Ltd|President|780-945-6609|mstewart@tbwifi.ca|
20563009|NCT03101930|Vanderbilt University Medical Center|Dr. James M. Luther, MD MSCI (Principal Investigator)|(615) 936-3420|james.luther@vumc.org|
20563010|NCT00262301|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
20563011|NCT01771731|University of California San Francisco|Donald I. Abrams, MD|415-476-4082|Donald.Abrams@ucsf.edu|444
20563012|NCT03201562|Presbyopia Therapies, LLC|Jerry Horn, MD|(847)-772-8885|visionxcl@icloud.com|
20563013|NCT00001277|NIDDK|Dr. Smita Jha|301-827-1930|smita.jha@nih.gov|
20563014|NCT00065260|NIH NHLBI|Dr. Bhavisha Patel|301.402.3477|bhavisha.patel@nih.gov|
20563015|NCT03161327|Saint Louis University|Dr. Keith Pereira|314-268-5782|keith.pereira@health.slu.edu|
20563016|NCT01976312|Novartis|Study Director|862-778-8300||
20563017|NCT01538719|Boston University School of Medicine|Eric A Stratton, Sr. Clinical Research Manager|6174142507|eas@bu.edu|
20551373|NCT03633487|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20563018|NCT03010631|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20563019|NCT02556138|Mayo Clinic|Dr. Kymberly Watt|507-266-1686|Watt.Kymberly@mayo.edu|
20563020|NCT05239182|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20563021|NCT01609218|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20563022|NCT03640949|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
20563023|NCT00774852|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20563024|NCT04428112|UCSF|Dr. Veronica Yank|415-476-9654|veronica.yank@ucsf.edu|
20563025|NCT05158153|University of California, San Francisco|Dr. Ian McCoy|415-476-2172|ian.mccoy@ucsf.edu|
20563026|NCT02807779|University of California, San Francisco|Warren Gasper, MD|415-353-4366|warren.gasper@ucsf.edu|
20517729|NCT01910831|Center for Clinical and Cosmetic Research|Andrew Frisina, Clinical Research Coordinator|305 933 6716|A.Frisina@admcorp.com|
20517730|NCT06647173|Emory University|Dr. Aaron Siegler|404-712-9733|asiegle@emory.edu|
20517731|NCT02923349|Incyte Corporation Call Centre|Incyte Biosciences International Sàrl|8554633463|RA@incyte.com|
20517732|NCT00363077|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517733|NCT01120028|University of Oxford|Prof Peter Friend|01865223872|ccc@ctsu.ox.ac.uk|
20517734|NCT03250117|Titan Pharmaceuticals, Inc.|Kate Beebe DeVarney, PhD|650-244-4990|medinfo@titanpharm.com|
20517735|NCT04063878|Dentsply IH AB d.b.a Dentsply Sirona Implants|Clinical Research Manager|+46 31 376 44 11|marie.ahlson@dentsplysirona.com|
20517736|NCT02751827|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20517737|NCT01248728|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-425-6220|eanagnostou@hollandbloorview.ca|6005
20517738|NCT01841554|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20517739|NCT01767103|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
20517740|NCT04633564|Mylan GmbH|Keri Vaughan, Senior Director|+215.280.2846|keri.vaughan@viatris.com|
20517741|NCT00725322|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
20517742|NCT05350137|Tongji Hospital affiliated Tongji Medical College of Huazhong University of Science and Technology|Dr. Wei Ping|+8613437101581|247046170@qq.com|
20517743|NCT00926887|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20517744|NCT02584608|Indiana Univerity School of Medicine|Micheal Econs|317-274-1339|mecons@iu.edu|
20517745|NCT02324335|Innovation Pharmaceuticals Inc.|Arthur P. Bertolino MD, PhD, MBA|978.921.4125|abertolino@IPharmInc.com|
20517746|NCT00640341|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
20517747|NCT03578809|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20517748|NCT00830258|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517749|NCT01002287|Integra LifeSciences|Stefani Battaglia|44 7880 732691|stefani.battaglia@integralife.com|
20551374|NCT02489344|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20551375|NCT00605813|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551376|NCT00183092|UCaliforniaSF|Michael Geschwind, MD, PhD|415-476-2901|mgeschwind@memory.ucsf.edu|
20551377|NCT00573755|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
20551378|NCT00870363|University of California Davis Medical Center|David M Asmuth|(916) 734-8695|dasmuth@ucdavis.edu|
20551379|NCT01870583|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
20551380|NCT02350881|Casa di Cura VIlla Berica|Dr Stefano Fieschi||stefanofieschi@gmail.com|
20551381|NCT00159250|Imperial College London|Francesco Muntoni|+44 02075941872|f.muntoni@ucl.ac.uk|
20551382|NCT00385996|Weill Cornell Medical College|Nasser Altorki, MD|212-746-5156|nkaltork@med.cornell.edu|
20551383|NCT00674661|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
20551384|NCT02064166|Brigham & Women's Hospital|Peter Novak, MD PhD|617-732-8896|pnovak2@bwh.harvard.edu|
20551385|NCT06273124|Tandem Diabetes Care|Supervisor, Clinical Operations|(858) 366-6900|clinicalaffairs@tandemdiabetes.com|
20551386|NCT01516424|Shang Hai Mental health center|Dr.HuafangLi|13641625395|lhlh_5@163.com|
20551387|NCT00597766|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3529|rwilson@metrohealth.org|
20551388|NCT00676455|Lahey Clinic|Christopher Wald, MD|781-744-8710|Christopher.Wald@lahey.org|
20551389|NCT01166763|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
20551390|NCT01909479|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20563027|NCT06024174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20563028|NCT03757949|SWOG|Danika Lew|206-667-2272|dlew@fredhutch.org|
20563029|NCT03725722|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20563030|NCT04592198|Xiamen LP Pharmaceutical Co.,Ltd|Matthew H Nieder|(415) 516-9498|matthew@lppharma.com|
20563031|NCT06241794|Hitit University faculty of medicine|Guvenc Dogan|06342193000|guvencdogan@gmail.com|
20563032|NCT01489813|Emory University|Omer Kucuk|404-778-4729|okucuk@emory.edu|
20563033|NCT06180967|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20563034|NCT04038957|Sumitomo Pharma America Inc|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20563035|NCT05656911|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20563036|NCT01536886|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20563037|NCT04541043|Calliditas Therapeutics|Clinical Program Leader|0737456451|kristin.onnestam@calliditas.com|
20563038|NCT04607044|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
20563039|NCT05403801|Dana Farber Cancer Institute|Desiree Azizoddin|(617) 632-3000|desiree_azizoddin@dfci.harvard.edu|
20563040|NCT05075408|Galderma Research & Development, LLC|Sponsor|8179615000|aestheticclinicaltrials@galderma.com|
20563041|NCT03416023|OstomyCure AS|Johan Järte|+46 706 524 532|jjaerte@ostomycure.com|
20563042|NCT01727518|Ludwig Boltzmann Institute for Lung Health|Dr Robab Breyer-Kohansal|+436505398439|Robab.Breyer-Kohansal@lunghealth.lbg.ac.at|
20563043|NCT02780388|Viela Bio|Viela Bio Clinical Operations|+1 240-558-0038|ClinicalTrials@VielaBio.com|
20563044|NCT04527146|UPenn|Rachel Paul, Genetic Counselor|215-490-5816|rachel.paul3@pennmedicine.upenn.edu|
20563045|NCT05107401|Columbia University|Dr. Alissa Davis|212-851-2224|ad3324@columbia.edu|
20563046|NCT03857620|University of Texas MD Anderson Cancer Center|George J. Chang, MD, MS|713-563-1875|gchang@mdanderson.org|
20563047|NCT02201108|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20563048|NCT03438188|Perlman School of Medicine, University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
20563049|NCT05215847|Aardvark Therapeutics|Manasi Jaiman MD, MPH, Chief Medical Officer|(858) 225-7696|MJaiman@aardvarktherapeutics.com|
20563050|NCT03433339|Lindner Center of HOPE/ University of Cincinnati Department of Psychiatry and Behavioral Neurosciences|Dr. Francisco Romo-Nava|513-536-0725|romofo@ucmail.uc.edu|
20563051|NCT03830177|Northwestern University|Lucy Bilaver, PhD|312-503-5618|l-bilaver@northwestern.edu|
20563052|NCT04970407|Ipsen Innovation|Laurent Pons/Clinical Pharmacology Director|see email|clinical.trials@ipsen.com|
20563053|NCT02960230|University of California, San Francisco|Dr. Sabine Mueller, MD PhD|(415) 502-1600|Sabine.Mueller@ucsf.edu|
20563054|NCT03289039|Dana-Farber Cancer Institute|Jose Pablo Leone, MD|617-632-3800|josep_leone@dfci.harvard.edu|
20563055|NCT03055858|Abbott Laboratories|Ebony Kargbo|612-209-8185|Ebony.Kargbo@abbott.com|
20563056|NCT04586920|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20563057|NCT04761302|University of Puerto Rico: Department of Orthopedic Surgery|Dr. Hans Hess|787-365-5755|hans.hess1@upr.edu|
20563058|NCT01718743|University of Texas M D Anderson Cancer Center|Dr. Krina Patel|(713) 792-6662|kpatel1@mdanderson.org|
20517750|NCT00488774|Janssen Research & Development|Senior Director|215-793-7540||
20563059|NCT00753987|SickKids|Felix Ratjen|4168137500|felix.ratjen@sickkids.ca|
20563060|NCT05136404|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
20563061|NCT00632203|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20563062|NCT02641912|GlaxoSmithKline|GSK Response Center|866-435-7343||
20563063|NCT04452318|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20563064|NCT01426412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20563065|NCT05021133|UMass Chan Medical School|Mayuko Ito Fukunaga|5088561975|mayuko.itofukunaga@umassmed.edu|
20563066|NCT02376790|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20563067|NCT03014453|Shengjing Hospital of China Medical University|Dr. Shucheng Zhang|862496615|zhangshucheng76@126.com|57911
20563068|NCT05450458|RodillaActiva Medical Center|Dr. Julio Carlos Vélez de Lachica|5215518338063|activeknee@gmail.com|
20563069|NCT03148496|The University of Texas Health Science Center at Houston|Julie Holihan, MD|713-500-7188|Julie.L.Holihan@uth.tmc.edu|
20563070|NCT02141074|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20563071|NCT00539734|Prince of Songkla University|Patama Bhurayanontachai|66-74-451380|tpatama@hotmail.com|
20563072|NCT00839241|Astra Tech AB|Head of Clinical Research Area Health Care|+46317761000||
20563073|NCT04484935|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20563074|NCT04820686|Assembly BioSciences Inc.|Director of Clinical Operations|415-366-5172|psalstrand@assemblybio.com|
20563075|NCT04377308|The University of Toledo Department of Psychiatry|Cheryl McCullumsmith, M.D., Ph.D.|419-383-5669|cheryl.mccullumsmith@utoledo.edu|
20563076|NCT03988842|Cedars-Sinai Medical Center|Victor Tapson|919-971-6441|Victor.Tapson@cshs.org|
20563077|NCT02150967|QED Therapeutics, Inc.|David van Veenhuyzen, Vice President, Clinical Development|1 650 391-9740|david.vanveenhuyzen@bridgebio.com|103
20563078|NCT04048382|San Diego State University|Dr. Aaron J. Blashill|6195942245|ajblashill@sdsu.edu|
20563079|NCT00490100|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
20563080|NCT03498196|Baylor College of Medicine|Jennifer M. Taylor, MD, MPH|713-797-7670|Jennifer.Taylor@bcm.edu|
20563081|NCT01037985|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517751|NCT05523895|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2289|medicalinformation@acadia-pharm.com|
20517752|NCT05041361|University of California, San Francisco|Ashley Mason, PhD|415 514 6820|ashley.mason@ucsf.edu|
20517753|NCT01642277|Loyola University Chicago, Microbiology and Immunology|Dr. Alan J. Wolfe|224-392-4002|awolfe@luc.edu|
20517754|NCT03679598|University of Alabama at Birmingham|Dr. James Wells|2059345555|LungHealth@uabmc.edu|
20517755|NCT03605342|VA Connecticut Healthcare System|Dr Ismene Petrakis|203-932-5711|Ismene.Petrakis@va.gov|1-2244
20517756|NCT00629122|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-8720|mea9008@med.cornell.edu|
20517757|NCT01403194|Mayo Clinic|Dr. Seema Kumar|507-538-2724|kumar.seema@mayo.edu|
20517758|NCT01447017|Centre for Clinical Studies in Malmö|Dr. Pekka Koskinen|+46 (0)40 97 12 60|pekka@clsm.se|
20517759|NCT03428750|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
20517760|NCT01919112|Beth Israel Deaconess Medical Center|Sandeep Kumar, MD|617-632-8917|skumar@bidmc.harvard.edu|
20517761|NCT02944617|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20517762|NCT02554877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517763|NCT04474405|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20517764|NCT00274651|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
20517765|NCT00918645|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
20517766|NCT05133180|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20517767|NCT03446768|University of California, San Diego, La Jolla, CA|Carl Stepnowsky, PhD|858-642-1240|cstepnowsky@health.ucsd.edu|
20517768|NCT01604941|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20517769|NCT03366792|NYU Langone Health - Perlmutter Cancer Center|Samir S. Taneja, MD|(212) 263-6301|Samir.Taneja@nyulangone.org|
20517770|NCT05283148|University of California Davis Comprehensive Cancer Center|Oyebimpe Adesina, MD, MS|9167035166|adesina@ucdavis.edu|
20517771|NCT00095784|University of Chicago|Olatoyosi Odenike, MD|773-702-3354|todenike@medicine.bsd.uchicago.edu|
20517772|NCT00158925|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
20517773|NCT03325881|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20517774|NCT03676634|California Department of Public Health|Stephen S. Arnon, M.D., M.P.H., Chief, Infant Botulism Treatment and Prevention Program|510-231-7600|Stephen.Arnon@cdph.ca.gov|
20517775|NCT02121067|University of North Carolina|Matthew Zerden, MD, MPH|6179352394|mzerden@gmail.com|
20517776|NCT03556618|University of California, Los Angeles|Dr. Elizabeth Barnert, Principal Investigator, Associate Professor|(310) 206-1483|ebarnert@mednet.ucla.edu|
20517777|NCT02213263|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517778|NCT01188681|Emergent BioSolutions|Scott C. Stromatt|206-859-6675|sstromatt@ebsi.com|
20517779|NCT02277093|Washington University School of Medicine|Benjamin R. Tan|314-362-9915|btan@wustl.edu|
20517780|NCT04428307|Duke University|Wendy Prudhomme-O'Meara, PhD|919-613-4406|wendy.omeara@duke.edu|
20517781|NCT01316055|Vice President - Clinical Development & Medical Affairs (CDMA)|Herbert Henney, PharmD|(914) 347-4300|hhenney@acorda.com|5138
20517782|NCT00003470|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20551391|NCT01092559|GeNO, LLC|Director of Clinical Development|321-785-2613|matthew.rush@genollc.com|
20517783|NCT02992067|Zhejiang Cancer Hospital|Yu Xingfei|057188122001|yuxf1177@zjcc.org.cn|+86
20517784|NCT02679729|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
20517785|NCT04667338|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20517786|NCT00748566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517787|NCT01124786|Clovis Oncology, Inc.|VP Clinical Development|415-409-5440|clinicaltrialinfo@clovisoncology.com|
20517788|NCT00883233|Galderma|Jean-Charles Dhuin|+33492952921|jean-charles.dhuin@galderma.com|
20517789|NCT01442376|Helsinn Healthcare SA|Spinelli Tulla|+4191985 21 21|tulla.spinelli@helsinn.com|
20517790|NCT04404725|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
20551392|NCT00383149|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
20551393|NCT01166724|Cleveland Clinic|Dr. Stuart Flechner|216 445-5772|FLECHNS@ccf.org|
20551394|NCT03721276|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
20551395|NCT01150981|University of Massachusetts Medical School|Samir Malkani, MD|5088563800|samir.malkani@umassmemorial.org|
20551396|NCT01340898|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551397|NCT02417701|Memorial Sloan Kettering Cancer Center|Dr. Paul Paik, MD|646-608-3759|paikp@mskcc.org|
20551398|NCT02375113|The University of Texas at San Antonio|Dr. Meizi He|2104585416|meizi.he@utsa.edu|
20551399|NCT01214629|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20551400|NCT03107754|University of Hawaii|Dr. Reni Soon|808-983-6000|rsoon@hawaii.edu|
20551401|NCT00734903|VA BOSTON|Lisa Najavits, PhD|617-299-1620|lisa.najavits@va.gov; najavits@bu.edu|
20551402|NCT00877383|Novartis Pharmaceuticals|Study Director|862 778-8300||
20551403|NCT00459108|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20551404|NCT01857232|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-875149|GabrielFox@acaciapharma.com|149
20551405|NCT00416078|VAGLAHS at West Los Angeles|Dr. Theodore Hahn|3102684108|thahn@ucla.edu|
20551406|NCT02733588|Joslin Diabetes Center|Mary-Elizabeth Patti, MD|617-309-2665|mary.elizabeth.patti@joslin.harvard.edu|
20551407|NCT01551082|Alliance of Cardiac Vascular and Thoracic Surgeons|Jeremy Smith RN|4236245200|jsmith@actvsurgeons.com|
20551408|NCT01705652|The University of Texas Health Science Center at San Antonio Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1109|swansong@uthscsa.edu|
20551409|NCT00656474|Glycotex|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
20551410|NCT01614067|University of California, San Francisco|Mitchell Rosen, MD|415-353-7475||
20551411|NCT01505868|UT MD Anderson Cancer Center|Paul Corn, MD PHD- Chair Ad Interim, Genitourinary Medical Oncology|(713) 563-7208|pcorn@mdanderson.org|
20563082|NCT03582722|Emory University|Michele Marcus, PhD, MPH|404-727-8010|mmarcus@emory.edu|
20563083|NCT05134337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20563084|NCT01259401|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|9173
20563085|NCT03683069|Brigham and Women's Hospital|Gordon H. Williams, Professor of Medicine|617-223-1611|gwilliams@bwh.harvard.edu|
20517791|NCT01075516|Department of Cardiology, San Filippo Neri Hospital - Rome|Dr. Renato P. Ricci||renatopietroricci@tin.it|
20517792|NCT02911025|Brigham and Women's Hospital|Dr. Milena Pavlova|6174772129|mpavlova@bwh.harvard.edu|
20517793|NCT00815087|Wang tyng|Dr.Wang TG|+886-2-23123456|patty.jt@gmail.com|67587
20517794|NCT01278953|Abbott|Lori Rusch, Ph.D.|651-756-2668|lori.rusch@abbott.com|
20517795|NCT01473953|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20517796|NCT00312897|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
20517797|NCT02011945|Bristol-Myers squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@BMS.com|
20517798|NCT00902538|Daiichi Sankyo Europe GmbH|Bettina Ammentorp|0049 89 7808 0|bettina.ammentorp@daiichi-sankyo.eu|585
20517799|NCT01935674|Hospital Clinic of Barcelona|Dr. Esteban Martínez|+34 93 227 54 00|estebanm@clinic.cat|
20517800|NCT03527485|Yale School of Medicine|Gustavo A. Angarita, MD, MHS|(203) 974-7536|gustavo.angarita@yale.edu|
20517801|NCT01279486|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
20517802|NCT04198363|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20517803|NCT05344118|Nationwide Children's Hospital|Dr. Joseph D Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
20517804|NCT03067987|University of Miami|Ranjith Ramasamy|3052434873|ramasamy@miami.edu|
20517805|NCT03442322|University of Pittsburgh|Natalie Leland|(412) 383-3405|NEL24@pitt.edu|
20517806|NCT01885949|MGH Cancer Center|Dr. Dror Michaelson|6177244000|dmichaelson1@mgh.harvard.edu|
20517807|NCT04827394|University of Oklahoma Health Sciences Center|Birju Shah, MD|405-271-5215|birju-shah@ouhsc.edu|42167
20517808|NCT01404988|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
20517809|NCT00477594|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20517810|NCT02488109|University of California, San Francisco, Department of Pediatrics|Andrea Garber, PhD, RD|415-514-2180|andrea.garber@ucsf.edu|
20517811|NCT02302716|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20517812|NCT02906813|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20517813|NCT00557245|University of Washington|Dr. Connie Celum|206-520-3824|ccelum@uw.edu|
20517814|NCT00521586|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517815|NCT02244554|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20517816|NCT00834964|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517817|NCT02722239|Biocard Research LLC|Nadiya Rizvanova|+74993088278|n.rizvanova@biocard.com|
20517818|NCT00491738|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20517819|NCT01662960|Albert Einstein Healthcare Network|Dr. Steven Jax|215-870-0196|stevenandrewjax@gmail.com|
20517820|NCT00433745|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
20517821|NCT00585286|University of California, Irvine|Christopher Zachary, FRCP, MBBS/Prinicipal Investigator|(949) 824-7103|czachary@uci.edu|
20517822|NCT04188392|Baylor College of Medicine|Melissa B Jones, MD|713-791-1414|melissa.jones2@bcm.edu|24747
20517823|NCT01161420|Inspire Medical Systems|Quan Ni|763-205-7968|quanni@inspiresleep.com|
20517824|NCT00608322|Cooper University Hospital|Stephen Trzeciak, MD, MPH|856-342-3342|trzeciak-stephen@cooperhealth.edu|
20517825|NCT03497130|Department of Dermatology at Johns Hopkins University|Dr. Anna Chien|410-502-7546|achien3@jhmi.edu|
20517826|NCT04002648|IRCCSSRaffaele|Prof. Michele De Bonis|+390226437102|debonis.michele@hsr.it|
20517827|NCT03060486|AOU Careggi|Riccardo Pace, DMD|00390557945608|riccardo.pace@unifi.it|
20517828|NCT00493805|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20563086|NCT03845465|Vanderbilt University Medical Center|Sarah Jaser, PhD|6153436775|sarah.jaser@vumc.org|
20563087|NCT05307978|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20563088|NCT03651895|Imperial College|Farne Hugo|+44 (0)20 7589 5111|h.farne@imperial.ac.uk|
20563089|NCT02837510|University of Pennsylvaina|James Loughead PhD|215-746-6827|loughead@pennmedicine.upenn.edu|
20563090|NCT05419505|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
20517829|NCT00216736|Joseph Epstein Centre for Emergency Medicine Research|Prof Anne-Maree Kelly|+61383456666|anne-maree.kelly@wh.org.au|
20563091|NCT05683392|Tandem Diabetes Care, Inc|Supervisor, Clinical Affairs|(877) 801-6901|clinicalaffairs@tandemdiabetes.com|
20563092|NCT02380612|AVITA Medical|VP Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
20563093|NCT02721381|Michigan State University|Dr. Brooke Ingersoll|517-930-2275|ingers19@msu.edu|
20563094|NCT00979576|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563095|NCT05166135|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517830|NCT03158727|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20517831|NCT01528150|St. Jude Medical|Director Clinical Studies|+1 818 493 3648|aoza@sjm.com|
20517832|NCT00918684|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
20517833|NCT01051349|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20517834|NCT00402103|Novartis Pharmaceuticals|Study Director|862-778-8300||
20517835|NCT00418145|Icahn School of Medicine at Mount Sinai|Dr. Fred Lublin|212-241-6854|fred.lublin@mssm.edu|
20517836|NCT00624286|Novartis Pharmaceuticals|Study Director|862 778-8300||
20563096|NCT04855760|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
20563097|NCT04840199|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20563098|NCT03271151|Anesthesiology Critical Care & Pain Management|Dr. Jacques Yadeau|2127742224|Yadeauj@hss.edu|
20563099|NCT04118452|University of California, Los Angeles & Kaiser Permanente School of Medicine|Dr. Paul Chung, Professor and Principal Investigator|626-710-0389|paul.j.chung@kp.org|
20563100|NCT05178810|Ferrer|Clinical Operations Head|+34 649 442 389|nalbareda@ferrer.com|
20563101|NCT02553642|Memorial Sloan Kettering Cancer Center|Dr. Samuel Funt, MD|646-888-4718|funts@mskcc.org|
20563102|NCT04424927|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20563103|NCT03727061|Roswell Park Compressive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|adrienne.groman@roswellpark.org|
20563104|NCT02134951|New York State Psychiatric Institute|Marlene Carlson|646-774-8436|mc157@columbia.edu|
20563105|NCT01376700|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20563106|NCT05623345|Acelyrin Inc.|Clinical Trials Information Desk|+18054564393|clinicaltrials@acelyrin.com|
20563107|NCT05384730|University of Southampton|Dr Samantha Meredith|0238120|s.j.meredith@soton.ac.uk|4656
20563108|NCT03732820|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20517837|NCT00863330|Aurora Health Care|IIR regulatory specialist|414-219-7886|jackie.blundon@aurora.org|
20563109|NCT03144518|University of Nottingham|Dr Kieran Ayling|+44 1158466908|kieran.ayling@nottingham.ac.uk|
20517838|NCT02252016|Merck Sharp & Dohme Corp.|Senior Vice President, Glocal Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20517839|NCT00674128|Mayo Clinic|Gregory Altemose MD|480-301-8000|altemose.gregory@mayo.edu|
20517840|NCT04631562|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
20517841|NCT02319824|Fred Hutchinson Cancer Research Center|Seth Pollack|206-667-6629|spollack@fhcrc.org|
20517842|NCT01825798|Holland Bloorview Kids Rehabilition Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
20517843|NCT04171115|Resilience Government Services|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
20517844|NCT00834873|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517845|NCT02811003|Smith+Nephew, Inc.|Samantha Andrews|978.971.8990|samantha.andrews@smith-nephew.com|
20517846|NCT02055547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20517847|NCT01456221|Coordinacion de Investigacion en Salud, Mexico|Dr. Mardia Guadalupe Lopez Alarcon||marsau2@prodigy.net.mx|
20517848|NCT04025021|MetroHealth Medical Center|Stephanie Merlino Barr|216-778-3269|SMERLINO@METROHEALTH.ORG|
20517849|NCT03498560|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
20517850|NCT00867360|Stanford University|Dr. Alan Schatzberg|650-723-6811|afschatz@stanford.edu|
20517851|NCT05604209|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-843-2726|cynthia_gay@med.unc.edu|
20517852|NCT02096692|Biotronik, Inc.|Clinical Studies Engineer|503-451-8049|justin.michalski@biotronik.com|
20517853|NCT01004510|Rochester General Hospital|Todd Sheppard, MD|585-922-4409|todd.sheppard@rochestergeneral.org|
20517854|NCT03275623|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
20517855|NCT00112437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20517856|NCT00659828|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
20517857|NCT01824576|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5606|nburkhart@zoll.com|
20517858|NCT03703258|University of Washington School of Medicine|Dr. Emily R. Dworkin|206-221-6932|edworkin@uw.edu|
20517859|NCT00351039|Fox Chase Cancer Center (formerly at H. Lee Moffitt Cancer Center & Research Institute)|George Simon, M.D.|215-728-2509|george.simon@fccc.edu|
20517860|NCT03218787|Abbott|Lijuan Jenn Wang, Advisor, Clinical Affairs|01-408-8453133|Lijuan.wang1@abbott.com|
20517861|NCT00147498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517862|NCT01229150|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
20517863|NCT03531827|National Cancer Institute|Dr. Ravi Madan|301.480-7168|madanr@mail.nih.gov|
20517864|NCT01494532|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517865|NCT00849797|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517866|NCT00679081|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinicaltrials@organo.com|
20517867|NCT03500094|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20517868|NCT00829764|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517869|NCT04594252|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20517870|NCT03506633|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20517871|NCT03944057|Antengene Corporation|Shimin Sun|+8613701803117|jasmine.sun@antengene.com|
20517872|NCT02973269|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20517873|NCT00258856|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20517874|NCT03247686|Resolve Therapeutics LLC|James Posada|208 727 7010|jp@resolvebio.com|
20517875|NCT00159419|Indiana University School of Medicine|Dr. Linda DiMeglio|317-944-3889||
20517876|NCT01109849|Penn State College of Medicine|James Waxmonsky MD|7175318646|jwaxmonsky@pennstatehealth.psu.edu|
20517877|NCT03930849|Department of Veterans Affairs|Carolyn Turvey, Ph.D.|319 338 0581|Carolyn.Turvey@va.gov|637714
20517878|NCT05259852|Case Western Reserve University|Jin Kim-Mozeleski|216-368-6793|jin.kim-mozeleski@case.edu|
20517879|NCT01251393|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
20563110|NCT02374307|OsloMet - Oslo Metropolitan University|Maria Bjerk|+4767236683|maria.bjerk@oslomet.no|
20563111|NCT01989455|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
20563112|NCT03928522|Washington University|Venessa Riegler|314-362-1721|rieglerv@wustl.edu|
20563113|NCT02885636|Mayo Clinic|Dr. Barry Borlaug|507-284-8846|borlaug.barry@mayo.edu|
20563114|NCT04287985|Visterra, Inc.|Mohit Mathur, MD|+1-617-498-1070|mmathur@visterrainc.com|
20563115|NCT02638337|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20563116|NCT00604669|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20563117|NCT01340066|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
20563118|NCT01363492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20563119|NCT01691079|University of California, San Francisco|Mona Luke-Zeitoun, MD||lukezeitounm@peds.ucsf.edu|
20563120|NCT00011986|Gynecologic Oncology Group Statistical and Data Center|Linda Gedeon, BS, CCRP|716-845-1169|lgedeon@gogstats.org|
20563121|NCT03771352|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
20563122|NCT02376530|SUNYBuffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
20563123|NCT00445315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563124|NCT03338816|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20563125|NCT05187442|National Taiwan University|PIAO-YI CHIOU, doctoral|+886-2-23123456|piaoyi@ntu.edu.tw|288427
20563126|NCT01948661|E.O. Ospedali Galliera|Andrea DeCensi|010563|andrea.decensi@galliera.it|4501
20563127|NCT03271489|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20563128|NCT01467427|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20563129|NCT06061081|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20563130|NCT02252172|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20563131|NCT05575076|Cassava Sciences|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
20563132|NCT03380390|Aclaris Therapeutics|Dr. David Gordon|484-540-6273|dgordon@aclaristx.com|
20563133|NCT02886286|University Hospitals Cleveland Medical Center|Salim M. Hayek, MD, PhD|2168442685|salim.hayek@uhhospitals.org|
20563134|NCT01127373|Memorial Sloan Kettering Cancer Center|Dr. Simon Powell, MD|212-639-3639|powells@mskcc.org|
20563135|NCT02633267|University of Michigan|Dr. Joseph Himle|(734) 615-0611|himlej@umich.edu|
20563136|NCT02290613|Thoraxklinik Heidelberg gGmbH at Heidelberg University Hospital|Prof. Dr. med. E. Grünig|+49 6221 396|ekkehard.gruenig@med.uni-heidelberg.de|8053
20563137|NCT01017146|GlaxoSmithKline|GSK Response Center|866-435-7343||
20563138|NCT00087139|ECOG Statistical Office|Study Statistician|617-632-3012||
20563139|NCT00976495|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20551412|NCT02062879|UC Health University of Cincinnati Medical Center|Sheila Takieddine|513-585-6195|Sheila.Takieddine@UCHealth.com|
20551413|NCT00056407|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551414|NCT00616655|Sunovion|Eszopiclone Medical Director|866-503-7813|clinicaltrialdisclosure@sunovion.com|
20551415|NCT03761147|Hebrew Univeristy|Anna Shaphir|+972 50 716 7309|shaphira@hadassah.org.il|
20551416|NCT00309842|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
20551417|NCT01026792|BC Cancer Agency, Vancouver Clinic, Vancouver, BC, Canada|Dr. Anna Tinker|604 877 6217|atinker@bccancer.bc.ca|
20551418|NCT01710254|University of Utah, Dept. of Radiology Research|Edward DiBella, Ph.D.|801-585-5543|edward.dibella@hsc.utah.edu|
20551419|NCT00492115|UCSD|Dr. Sonia Ancoli-Israel|858 822 7710|sancoliisrael@ucsd.edu|
20551420|NCT03143569|WASHINGTON UNIVERSITY|Thomas J Graetz|3147474155|graetzt@wustl.edu|
20551421|NCT03564145|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
20551422|NCT02045797|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551423|NCT02811445|Tufts University HNRCA|Michael Lustgarten|617-556-3399|Michael.Lustgarten@tufts.edu|
20551424|NCT00353262|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20551425|NCT05286307|NYU Langone Health|Eric J Strauss, MD|646 501-7223|Eric.Strauss@nyulangone.org|
20551426|NCT06029673|Stanford University|Research Team|(650) 497-5175|gynresearch@stanford.edu|
20551427|NCT04219891|Alcon Research, LLC|Clinical Projects Director, Surgical|8884513937|alcon.medinfo@alcon.com|
20551428|NCT00597012|The Brigham and Women's Hospital|Jeffrey N. Katz, MD, MSc|617-732-5338|jnkatz@bwh.harvard.edu|
20551429|NCT05636098|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20551430|NCT03712904|Thomas Jefferson University|Wenyin Shi, MD, PhD|(215) 955-6702|wenyin.shi@jefferson.edu|
20551431|NCT00602576|University of Pennsylvania|Dr. Ravi Amaravadi|2157965159|ravi.amaravadi@pennmedicine.upenn.edu|
20551432|NCT00772772|The Rockefeller University|Dr. Mansih Ponda|212-327-7631|mponda@rockefeller.edu|
20551433|NCT03525574|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20551434|NCT00905554|Valduce Hospital - Como - Italy|Vittorio Terruzzi, MD|+39031324009|vterruzzi@valduce.it|
20551435|NCT06119529|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20551436|NCT01074450|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20551437|NCT00587483|Mayo Clinic|Dr. William Mauermann|507-255-4240|mauermann.william@mayo.edu|
20551438|NCT02621242|University of Washington|Dr. Joanne Stekler|206-744-8312|jstekler@uw.edu|
20551439|NCT04344314|Becton, Dickinson and Company|Christopher Rini, Associate Director Translational and Clinical Sciences Center of Excellence|+1 984 389 1186|christopher.rini@bd.com|
20551440|NCT04473937|Massachusetts General Hospital|Chirayu Patel, MD|617-724-9627|CPATEL@MGH.HARVARD.EDU|
20551441|NCT02369341|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517880|NCT01541215|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20517881|NCT02633241|Boston Children's Hospital|Joseph P. Cravero|617-355-4292|Joseph.Cravero@childrens.harvard.edu|
20517882|NCT03232736|University of Colorado Anschutz Medical Campus|William Cornwell|16142961686|william.cornwell@ucdenver.edu|
20517883|NCT03102879|Universidad de los Andes|Claudia Brizuela|56 2 26181166|clau@cibrizuela.com|
20563140|NCT02272816|Centre for Experimental Cancer Medicine, Barts Cancer Institute, QMUL|Project Lead|02078828277|bci-carpet@qmul.ac.uk|
20517884|NCT00851409|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
20517885|NCT01127087|Mayo Clinic|Dr. John C. Lieske|507-266-7960|lieske.john@mayo.edu|
20517886|NCT02316223|Icahn School of Medicine at Mount Sinai|Dr. Alex Federman|212-824-7565|alex.federman@mountsinai.org|
20517887|NCT01275664|NRG Oncology|Linda Gedeon for Helen Huang, MS|716-845-1169|lgedeon@gogstats.org|
20517888|NCT00529763|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20517889|NCT03669250|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
20517890|NCT00828321|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517891|NCT02997176|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517892|NCT04039022|Axsome Therapeutics, Inc.|Caroline Streicher, Senior Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
20517893|NCT00365053|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20563141|NCT04154384|Emory University|Mara L. Schenker|404-778-1550|mara.schenker@emory.edu|
20563142|NCT01136876|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
20563143|NCT05321069|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20563144|NCT01241916|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
20563145|NCT02412748|Rush University College of Nursing|Dr. Wrenetha Julion, Professor|3129426272|Wrenetha_A_Julion@rush.edu|
20563146|NCT04128319|Xenikos|Eric van Hooren, Chief Development Officer|+31 6 109 345 84|e.vanhooren@xenikos.com|
20563147|NCT00972439|USC/Norris Comprehensive Cancer Center|Celeste Pearce, Ph.D.|323 865 0437|cpearce@usc.edu|
20563148|NCT02891915|Vanderbilt Vaccine Research Program|Dr. C. Buddy Creech|615-343-0332|buddy.creech@vanderbilt.edu|
20563149|NCT01522924|University of Louisville|Dr. Jacqueline Singleton|502-852-2611|jasing02@louisville.edu|
20563150|NCT03939312|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20563151|NCT04881175|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20563152|NCT03481816|National Cancer Institute|Dr. Marijo Bilusic|240-760-6064|marijo.bilusic@nih.gov|
20563153|NCT01704196|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
20563154|NCT02730871|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
20563155|NCT05368558|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20563156|NCT04994509|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20563157|NCT04402294|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
20563158|NCT04459416|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng, MD, PhD|646-608-8556|dengg@MSKCC.ORG|
20563159|NCT03744312|Columbia University|Patrick J. Lao, PhD|212-305-9079|pjl2133@cumc.columbia.edu|
20563160|NCT04579380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20517894|NCT02985749|Massachusetts General Hospital|Gagan Joshi, MD|617-724-1541|gjoshi@mgh.harvard.edu|
20517895|NCT01630616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20517896|NCT00691704|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
20517897|NCT03390257|SF Otolaryngology|Dr. Jacob Johnson|4153625443|jjohnson@sfotomed.com|
20517898|NCT04406194|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
20517899|NCT04102345|HealthPartners Neuroscience Research|Bhavani Kashyap, MBBS, PhD|651-495-6358|bhavani.x.kashyap@healthpartners.com|
20517900|NCT00385736|Abbott|Global Medical Services|800-633-9110||
20517901|NCT01380782|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|6176322166|pwen@partners.org|
20517902|NCT01701063|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20517903|NCT02043132|Beaumont Health|Dr. J. Michael Wiater|248-551-3140|J.Michael.Wiater@beaumont.edu|
20517904|NCT04194801|CStone Pharmaceuticals|Hua Hu|+86 021-60333416|CstoneRA@cstonepharma.com|
20517905|NCT00506831|Stanford University|Lorinda Chung|650-493-5000|shauwei@stanford.edu|62042
20517906|NCT02464657|The University of Texas MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, MD/Professor|(713)745-0394|fravandi@mdanderson.org|
20517907|NCT01410227|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20517908|NCT01808651|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20517909|NCT01165047|Aurora Health Care|Katernie Slotke|414-649-2615|katherine.Slotke@aurora.org|
20517910|NCT04313751|University of North Carolina at Chapel Hill|Yamnia Cortes, PhD, MPH, RN|319-335-1131|yamnia-cortes@uiowa.edu|
20517911|NCT00835614|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517912|NCT00829712|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517913|NCT00606281|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20517914|NCT00617396|UNC Chapel Hill|Dr. Douglas Drossman|919-966-0141|douglas_drossman@med.unc.edu|
20517915|NCT03131895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20517916|NCT01339247|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517917|NCT05752721|NYU Langone Health|Pasquale Rummo|646-501-3371|Pasquale.Rummo@nyulangone.org|
20563161|NCT05768373|Solventum|Helen Han|6517856568|mhan3@solventum.com|
20563162|NCT05478525|Glyscend Therapeutics|Ashish Nimgaonkar, MD|6175483513|ashish.nimgaonkar@gmail.com|
20563163|NCT01991977|Mayo Clinic|Nadia N. Laack, MD|507/284-2511|Laack.Nadia@mayo.edu|
20563164|NCT03821844|Brown University|Ellen McCreedy, PhD|401-863-7345|Ellen_McCreedy@brown.edu|
20563165|NCT04799197|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
20563166|NCT03913195|TaiMed Biologics|Dr. Kuei-Ling Kuo|+886-2-26580058|kkuo@taimedbio.com|118
20563167|NCT03899961|Oslo University Hospital|Leiv Arne Rosseland|92204274|lrossela@ous-hf.no|+47
20563168|NCT03547908|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20563169|NCT02525692|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
20563170|NCT05510232|Hospital for Special Surgery|Dr. Peter Fabricant|(212) 606-1996|fabricantstaff@hss.edu|
20563171|NCT05794763|Stanford University|Dr. Eric Stice|6507237885|estice@stanford.edu|
20563172|NCT00567398|Vantive|Clinical Trials Disclosure Group|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20563173|NCT03517553|University of Iowa|Dr Bradley S. Dixon|319-356-1626|bradley-dixon@uiowa.edu|
20563174|NCT03229811|Fresenius Medical Care|Dr. Amaka Eneanya|267-769-5455|amakaeneanya@gmail.com|
20517918|NCT02280863|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
20517919|NCT02903407|Duke University|Angela Lowenstern|919-684-0111|angela.sandelin@duke.edu|
20517920|NCT05143047|Vanderbilt University Medical Center|Alison Carroll, MD, MPH|615-875-5025|alison.carroll@vumc.org|
20517921|NCT02287480|Geneva University Hospitals|Prof. Claire-Anne Siegrist|0041 22 379 5778|claire-anne.siegrist@unige.ch|
20517922|NCT02622386|University of Michigan|Johann Gudjonsson|(734) 615-4508|johanng@med.umich.edu|
20517923|NCT02890992|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20517924|NCT03236311|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20517925|NCT00669162|University of Kansas Cancer Center|Xinglei Shen, MD|913-588-3600|ctnursenav@kumc.edu|
20517926|NCT00807495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20517927|NCT00484679|University of Minnesota|Maria Hordinsky, MD|612-624-5721|hordi001@umn.edu|
20517928|NCT00841542|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517929|NCT01631552|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20517930|NCT00463684|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20517931|NCT05143801|University of New Mexico|Dr. Christine Mermier|5052772664|cmermier@unm.edu|
20517932|NCT02462837|Southern Illinois University School of Medicine|Dr. Danuta Dynda|217-545-7443|ddynda@siumed.edu|
20517933|NCT01075282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20517934|NCT04029545|Prollenium Medical Technologies|Director Clinical Affairs|19055081469|clinicaltrials@prolleniumus.com|
20517935|NCT01252953|Nuffield Department of Population Health, University of Oxford|Prof Martin Landray|+44 (0)1865 743743|martin.landray@ndph.ox.ac.uk|
20517936|NCT01026402|AstraZeneca|Bryony Harrop|01625 582828|ClinicalTrialTransparency@astrazeneca.com|
20517937|NCT00906399|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20517938|NCT00075608|Boston Medical Center|Principal Investigator|617-638-8261|sfenness@bu.edu|
20517939|NCT02177617|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
20517940|NCT03488108|Mayo Clinic|Alison J. Bruce, M.B., Ch.B|904-953-6412|Bruce.Alison@mayo.edu|
20517941|NCT00794547|University of Michigan Comprehensive Cancer Center|Dr. Nithya Ramnath|734-647-1417|nithyar@umich.edu|
20517942|NCT00685477|Temple University|Alan Maurer, MD|215-707-8269|amaurer@temple.edu|
20517943|NCT02615249|Allerderm (dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smartpractice.com|7208
20517944|NCT05098743|Vanderbilt University|Dr. Christa Hartch, PI|203-979-2044|christahartch@me.com|
20517945|NCT01457196|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20517946|NCT00838162|Jan-Cil UK|VP Head of Discovery & Early Development|44 1494 553458|ksimmen1@its.jnj.com|
20517947|NCT02896296|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
20517948|NCT02597049|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20517949|NCT02463487|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20517950|NCT03124758|Masimo|Tala Harake||studies@masimo.com|
20517951|NCT03329209|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20517952|NCT00227370|Duke Clinical Research Institute|Scott M. Palmer, MD, MHS|919 684 0254|scott.palmer@duke.edu|
20517953|NCT05157048|University of Pennsylvania|Victoria Constantine|215-746-4069|vmcl@pennmedicine.upenn.edu|
20517954|NCT00754052|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20517955|NCT02466087|University of Vermont|Emily Tarleton, MS, RD|802-847-4730|emily.tarleton@uvm.edu|
20517956|NCT01086228|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20529219|NCT01490892|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Flemming Forsberg|215-955-4870|flemming.forsberg@jefferson.edu|
20529220|NCT02772666|Mashhad University of Medical Sciences|Dr. Amirhossein Vejdani|+9151105411|amirhosein_vejdani@yahoo.com|
20563175|NCT04093362|Taiho Oncology, Inc|Taiho|609-250-7336|clinicaltrialinfo@taihooncology.com|
20563176|NCT05265312|Johns Hopkins University School of Medicine|Dr. Eva Tseng|410-583-2774|etseng3@jhmi.edu|
20529221|NCT04789382|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20563177|NCT04247542|Acurx Pharmaceuticals, Inc.|Robert J DeLuccia|914-949-3898|rjdeluccia@acurxpharma.com|
20517957|NCT02658019|University of Miami|Lynn G. Feun, MD|305-243-6606|lfeun@med.miami.edu|
20517958|NCT00697801|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20563178|NCT03055377|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20563179|NCT03401853|University of Washington|Stephen Smith, MD|(206) 606-6546|ssmith50@fredhutch.org|
20563180|NCT01898494|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20563181|NCT02819843|Memorial Sloan Kettering Cancer Center|Dr. Christopher Barker, MD|212-639-8168|barkerc@mskcc.org|
20563182|NCT05145257|Citruslabs|Patrick Renner|4242450284|hello@citruslabs.com|
20563183|NCT04905407|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|info@syros.com|
20563184|NCT06072404|University of Palermo|Prof. Olga Di Fede|00393294030298|olga.difede@unipa.it|
20563185|NCT01938547|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20563186|NCT03564600|University of Pittsburgh School of Medicine|Professor Debra K. Weiner, M.D.|4124016811|dweiner@pitt.edu|
20563187|NCT02226341|Columbia University|Anca Askanase MD, MPH|212 305 0856|ada20@cumc.columbia.edu|
20563188|NCT02793687|Pharmasoft|Meshcherskiy Y.E., Medical director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
20563189|NCT03467542|Terumo Neuro|Robert Gash|714-247-8000|robert.gash@microvention.com|
20563190|NCT01673984|Ipsen|Medical Director, Uro-Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20563191|NCT05568004|Ege University Faculty of Medicine Sport Medicine Department|Dr. Yunus Emre Meydanal|905068046512|yemremeydanal@gmail.com|
20563192|NCT05968495|Pearl Plastic Surgery|Christopher Nichols, MD|360-878-9300|cnichols@pearlplasticsurgery.com|
20563193|NCT00150813|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20563194|NCT05271903|University of Utah|Melissa Watt|801-587-2100|melissa.watt@hsc.utah.edu|
20563195|NCT01820260|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20563196|NCT05444192|University of Central Lancashire|Dr Graham Chapman|01772894949|gchapman2@uclan.ac.uk|
20563197|NCT04522713|Karolinska Institutet|Dr. Erland Axelsson|0706171039|erland.axelsson@ki.se|+46
20563198|NCT00894543|University of Pennsylvania School of Medicine|Dr. Ellen W. Freeman|215-349-5521|freemane@mail.med.upenn.edu|
20563199|NCT04048681|Beth Israel Deaconess Medical Center|Dr. Olivia Farr|6176678636|ofarr@bidmc.harvard.edu|
20563200|NCT02808676|Lawson Health Research Institute|Dr. Manuel Montero-Odasso|519-685-4292|manuel.monteroodasso@sjhc.london.on.ca|42179
20563201|NCT02919449|Vyriad|Alice Bexon MD Chief Medical Officer|+1-617-417-7300|alice.bexon@bexonclinical.com|
20563202|NCT02058108|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20563203|NCT01154192|UC San Diego School of Medicine|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
20563204|NCT00727909|VA TVHS|Gene W. Bratt, Ph.D.|615-873-6068|gene.bratt@va.gov|
20563205|NCT01696773|The Ohio State University|Steven J. Schwartz|614-292-2934|schwartz.177@osu.edu|
20563206|NCT04752163|The University of MD Anderson Cancer Center|Naval Daver MD./Professor|713-794-4392|NDaver@mdanderson.org|
20563207|NCT00411151|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|M. Kabisch|++49 (0)6131-179922|kabisch@izks-mainz.de|
20563208|NCT02191085|University of Calgary|Dr. Sachin Pendharkar|403-210-8617|sachin.pendharkar@ucalgary.ca|
20563209|NCT01881412|Rhode Island Hospital and Brown University|Dr. Aris Garro|401-480-8682|arisgarro1@gmail.com|
20563210|NCT04600752|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20563211|NCT00448669|National Institutes of Health|Dr. Michael Thigpen|1-240-669-2877|michael.thigpen@nih.gov|
20563212|NCT05751785|The Geneva Foundation|Ms. Elizabeth Metzger, Senior Scientific Program Manager|253-383-1398|emetzger@genevausa.org|
20517959|NCT02485158|University of Chicago|Dr. Harriet de Wit|773-702-1537|hdew@uchicago.edu|
20517960|NCT01098851|Covidien|Fran Haury|303 305-2314|fran.haury@covidien.com|
20517961|NCT03087786|Niconovum USA|Dr. Abraham Varghese|336-741-2315|varghea@rjrt.com|
20517962|NCT01472432|Second University Naples|Dr Raffaele Marfella|++390815665110|raffaele.marfella@unina2.it|
20517963|NCT03234907|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20517964|NCT02986139|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20517965|NCT00414726|Massachusetts General Hospital|Aneesh B. Singhal, MD|617 726 8459|asinghal@partners.org|
20517966|NCT02107196|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
20517967|NCT01993186|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20517968|NCT04158687|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20517969|NCT04523480|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|3052434562|ramasamy@miami.edu|
20517970|NCT00640393|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
20517971|NCT02109458|Johns Hopkins University School of Medicine|Dr. Lonny Yarmus|4105025224|lyarmus@jhmi.edu|
20517972|NCT00845130|Univeristy of Kansas Medical Center|In-Young Choi, Ph.D.|913-588-0174|ichoi@kumc.edu|
20517973|NCT05497557|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20517974|NCT02920476|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20517975|NCT03540160|Menlo Therapeutics, Inc.|Iain Stuart, PhD|1-800-775-7936|Iain.Stuart@foamix.com|
20517976|NCT00198133|IndianaU|Patrick J. Loehrer, Sr., M.D.|(317)944-0920|ploehrer@iu.edu|
20517977|NCT02518945|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
20517978|NCT00835666|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20517979|NCT00635648|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20517980|NCT02511535|Med Uni Wien, Institut für Spezifische Prophylaxe und Tropenmedizin|Erika Garner-Spitzer, PhD|0043 1 40160|erika.garner-spitzer@meduniwien.ac.at|38255
20517981|NCT03827395|Emory University|Evan J. Anderson, MD|404-727-1746|evanderson@emory.edu|
20517982|NCT01923740|Abbott Vascular|Siok Hwee Tan|+1 408-845-3581|siokhwee.tan@abbott.com|
20563213|NCT02789020|University of Florida|David Vaillancourt|3522941770|vcourt@ufl.edu|
20563214|NCT04349072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20517983|NCT01537887|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20517984|NCT04723693|Oxford university Hospitals NHS Foundation Trust|Simon Fletcher|01865 225316|simon.fletcher@ouh.nhs.uk|
20517985|NCT00294047|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517986|NCT02157974|University of Colorado Anschutz Medical Campus|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
20517987|NCT00538031|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20517988|NCT01484912|Sinphar Pharmaceutical Co., Ltd. Taiwan|Justine Tang||justine@sinphar.com.tw|
20517989|NCT00540423|GlaxoSmithKline|GSK Response Center|866-435-7343||
20517990|NCT04077645|University of Illinois Urbana Champaign|Dr. Sean P Mullen|217-244-4502|spmullen@illinois.edu|
20517991|NCT00731939|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
20517992|NCT00263588|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20517993|NCT02412852|TheraVasc Inc.|Tony Giordano|3183493851|tgiordano@theravasc.com|
20517994|NCT00985439|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
20517995|NCT01174186|Silkeborg Regional Hospital|René Oestgaard|0045 78 41 50 00|ostgard@immunology.au.dk|
20517996|NCT05274763|Emory University|Dr. Jennifer Mascaro|404-727-4301|jmascar@emory.edu|
20517997|NCT02351700|Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center|Andrew S. Little, MD|602-406-3181|neuropub@dignityhealth.org|
20517998|NCT01906372|University of Pittsburgh, Division of Rheumatology|Rohit Aggarwal, MD|412-647-2840|aggarwalr@upmc.edu|
20517999|NCT03629054|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518000|NCT00924638|Medtronic, Inc.|Medtronic CRDM clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
20518001|NCT00367133|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
20518002|NCT01447511|University of Minnesota|Dr. Richard Brundage|612-624-3115|brund001@umn.edu|
20518003|NCT00847535|Cook MyoSite, Inc.|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
20518004|NCT02336074|Imperial College London|Professor Sarah Fidler|004420331|s.fidler@imperial.ac.uk|26790
20518005|NCT00958724|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20518006|NCT00836758|University of Florida|Richard B. Berry, MD|352-262-1575|sleep_doc@msn.com|
20518007|NCT02121184|Northwestern University|Paul Fitzgerald|312 695 1064|p-fitzgerald2@northwestern.edu|
20518008|NCT00840203|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518009|NCT02674711|Brooke Army Medical Center|Dr Dan Rhon|210-916-3303|daniel.i.rhon.ctr@mail.mil|
20518010|NCT03393754|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
20518011|NCT03349567|Iowa City VA Health Care System|Daniel Livorsi|319-688-3871|daniel-livorsi@uiowa.edu|
20518012|NCT00989950|CoxHealth|Arie Ashkenasi, MD|011 972 50 3007477|ashkenasi1@gmail.com|
20518013|NCT00101439|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20518014|NCT01851772|Xoft, Inc.|Crystal Leonard, CCRP|9375038588|cleonard@icadmed.com|
20518015|NCT04739735|Faculty of dentistry, Alexandria University, Egypt|Dr. Rodaina Helmy|00201100001193|rodaina.helmy@alexu.edu.eg|
20518016|NCT02845336|Johns Hopkins University|Timothy J McCulley, MD|4105503000|tmccull5@jhmi.edu|
20518017|NCT01665508|Massachusetts General Hospital|Nandita S. Scott|6177241739|nsscott@partners.org|
20518018|NCT02054715|University of Rochester Medical Center|Gary R. Morrow, PhD, MS; Deans Professor of Oncology|585-275-9961|Gary_Morrow@urmc.rochester.edu|
20518019|NCT00858780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518020|NCT01001403|Seoul National University Hospital|CW Jung|82-2-2072-2467|spss@snuh.org|9
20518021|NCT03867838|Stanford University|Cole Simpson|4049077708|cole.simpson@stanford.edu|
20518022|NCT02153645|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|908-809-1357|gwagner@osmotica.ccom|
20518023|NCT00860938|University Hospital Basel, Switzerland|Jörg D. Leuppi, MD PhD, principle investigator|+41-61-2654294|jleuppi@uhbs.ch|
20518024|NCT03969641|Duke University|Dr. Geeta Swamy|919.681.5220|geeta.swamy@duke.edu|
20518025|NCT01006967|Geisel School of Medicine at Dartmouth|Jon D. Lurie, MD, MS|603 653-3575|jon.d.lurie@dartmouth.edu|
20518026|NCT01023776|University of Rochester|John Treanor< M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
20518027|NCT05485662|UT Health San Antonio|Bennett Amaechi, BDS, MD, PhD|210 567 3185|amaechi@uthscsa.edu|
20518028|NCT01439620|Massachusetts General Hospital|Gary Tearney, MD|Optical Frequency Domain Imagi|gtearney@partners.org|
20518029|NCT05604014|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|241
20518030|NCT01867658|C.R. Bard Inc.|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
20518031|NCT02426918|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20518032|NCT01496118|Sarah Cannon Development Innovations, LLC|Dr. Jesus Berdeja|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20518033|NCT03272685|University of Minnesota|Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
20518034|NCT00834405|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518035|NCT01190865|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20518036|NCT00574847|Duke University Medical Center|Wei Jiang, MD|919-668-0762|jiang001@mc.duke.edu|
20518037|NCT00178178|University of Rochester|Dr. Robert Bronstein|585-275-1024|robert_bronstein@urmc.rochester.edu|
20518038|NCT02471807|Edwards Lifesciences|Ted Feldman, MD|949-250-2500|Feldman_Info@edwards.com|
20518039|NCT05327777|Thomas Jefferson University Hospital|Research Resident|516-547-7676|ryan.lamm@jefferson.edu|
20518040|NCT00932477|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20551442|NCT02972554|University of North Carolina at Chapel Hill|Dr. Keely A. Muscatell|919-843-9113|kmuscatell@unc.edu|
20529222|NCT04980014|Takeda|Study Director|+1 877-825-3327|TrialDisclosures@takeda.com|
20529223|NCT00715559|Mount Sinai School of Medicine|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
20529224|NCT00675987|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
20529225|NCT02787304|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
20529226|NCT01450319|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20529227|NCT00078403|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20529228|NCT00419757|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20529229|NCT02100280|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
20529230|NCT04421040|Mayo Clinic|Dr. Grace Lin|507-255-1267|lin.grace@mayo.edu|
20529231|NCT01950299|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
20529232|NCT02946892|UTSW|Ryan Butts|2144565822|ryan.butts@utsouthwestern.edu|
20529233|NCT02196857|The University of Texas MD Anderson Cancer Center|Ravandi-Kashani,Farhad MD./Professor|713-745-0394|fravandi@mdanderson.org|
20529234|NCT00737100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20529235|NCT03870334|NImmune|Project Management|(540) 944-4545|pm@nimmun.com|
20529236|NCT00705757|Summa Health System ( at the time of the trial)|Deepak P. Edward, MD|330-780-0399|deepak.edward@gmail.com|
20529237|NCT01443858|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
20529238|NCT01272908|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20529239|NCT02221648|Yale University School of Medicine|Bahman Jabbari M.D, , Professor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
20529240|NCT00149396|Medigene|Associate Director Regulatory Affairs|858-586-2252|p.larson@medigeneusa.com|
20529241|NCT01168921|The University of Texas MD Anderson Cancer Center|William Wierda MD/Professor|713-745-0428|wwierda@mdanderson.org|
20529242|NCT02937623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20529243|NCT00810069|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529244|NCT00719160|Yale University|Karl L. Insogna, M.D.|203-737-2871|Karl.insogna@yale.edu|
20529245|NCT02899065|UC Davis Medical Center|Larissa May, MD, MSHS, MSPH, Director of Emergency Medicine Innovation and External Partnerships|916-734-1593|lsmay@ucdavis.edu|
20529246|NCT02983045|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20529247|NCT02533934|University of California San Francisco|Rodney Rogers|+14155951226|Rodney.Rogers@ucsf.edu|
20529248|NCT05225389|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
20529249|NCT01585246|Michigan State University|Dr. Gwen Wyatt|517-884-4630|gwyatt@msu.edu|
20529250|NCT03421379|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20529251|NCT01951417|Galderma Labratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
20529252|NCT00977613|Beth Israel Cancer Center|Victoria Rosenwald|212 844-8285|vrosenwa@chpnet.org|
20529253|NCT00382785|University of Delaware|Paula Klemm, PhD, RN, OCN|(302) 831-8501|klemmpa@udel.edu|
20529254|NCT01598610|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
20529255|NCT03742986|NYU Langone Health - Perlmutter Cancer Center|Maryann Kwa, MD|(212) 731-6364|maryann.kwa@nyulangone.org|
20529256|NCT02925858|Jewish General Hospital|Dr Matthew Cameron|514-340-8222|matthew.cameron@mcgill.ca|25701
20529257|NCT03771963|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20529258|NCT03066830|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
20529259|NCT03360019|University of Florida|Glenn Smith|352-273-6556|glennsmith@ufl.edu|
20529260|NCT04878120|University of Virginia|Dr. Chiara Fabris|4344220240|cf9qe@virginia.edu|
20529261|NCT00520039|West Virginia School of Osteopathic Medicine|Dr. Karen Steele|(304)667-4255|ksteele@osteo.wvsom.edu|
20529262|NCT00325819|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216|jackson.L@ghc.org|
20529263|NCT00223665|University of Washington|Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
20529264|NCT00534417|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20529265|NCT02058589|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529266|NCT02049983|Levita Magnetics International Corp|Alberto Rodriguez-Navarro, MD|6506557625|info@levita.com|
20529267|NCT00490971|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609-730-2436||
20563215|NCT05512962|Oxular Limited|Friedrich Asmus, MD|'+1 631 292 1207|friedrich.asmus@oxular.com|
20563216|NCT04950127|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20563217|NCT01711632|Memorial Sloan Kettering Cancer Center|Dr. Jae Park, MD|646-608-3743|parkj6@mskcc.org|
20563218|NCT04315181|University of Kentucky|Director for the Center on Drug and Alcohol Research|859-257-6485|Sharon.Walsh@uky.edu|
20563219|NCT00522951|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20563220|NCT02713126|Mayo Clinic|Dr. Barry Borlaug|507-255-1051|borlaug.barry@mayo.edu|
20563221|NCT00100698|Massachusetts General Hospital|Janet Lo|617-724-9109|jlo@partners.org|
20563222|NCT05494788|Cardiol Therapeutics Inc.|Andrea B. Parker, MSc., PhD, Senior Director of Clinical Operations|+1 289 9100862|andrea.parker@cardiolrx.com|
20563223|NCT05480943|VA Sierra Nevada Healthcare System|Elisabeth Mates, MD,PhD, Principal investigator|775-786-7200|Elisabeth.Mates@va.gov|5273
20529268|NCT00593450|CATT Research Group|Dr. Maureen Maguire|215-615-1501|maguirem@mail.med.upenn.edu|
20529269|NCT06450457|The University of Texas Health Science Center at Houston|Kaitlin Benjamin, PT, DPT|610-639-0431|Kaitlin.Benjamin@memorialhermann.org|
20529270|NCT04754542|University of Colorado Denver|Eric Engebretson|3037244518|eric.engebretson@cuanschutz.edu|
20529271|NCT04570709|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|9199620000|Melahat_Canter@med.unc.edu|
20563224|NCT00136435|Dana Farber Cancer Institute|Dr. Dan DeAngelo|617-582-8410|Daniel_Deangelo@dfci.harvard.edu|
20518041|NCT03031795|OhioHealth|John O. Elliott PhD, MPH Research Specialist Medical Education|614-566-3643|john.elliott@ohiohealth.com|
20518042|NCT04060251|Brigham Health|Dr. Wolfgang Fitz|617-732-9501|wfitz@bwh.harvard.edu|
20518043|NCT00487435|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20518044|NCT01807026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518045|NCT01155531|Theracos, Inc|Monica Tettamanti, MSc|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
20518046|NCT01087502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518047|NCT01653704|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
20518048|NCT02705716|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518049|NCT01151618|Philips Respironics|Bob Romano, Biomedical Engineer|724-387-7781|bob.romano@philips.com|
20518050|NCT00562718|UT Southwestern Medical Center|ann spangler|(214) 648-3111|ResearchRegistry@utsouthwestern.edu|
20518051|NCT02227238|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20518052|NCT01608906|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20518053|NCT00985751|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518054|NCT00868998|Columbia University|Robert Fine|212-305-1168|rlf20@columbia.edu|
20518055|NCT02047305|Medtronic MITG-RGI|Senior Director of Clinical Affairs|303-581-7064|Tumordirectedtherapiesclinical@Medtronic.com|
20518056|NCT01986647|University of Pittsburgh|Jennifer S. Brach, PhD, PT|412-383-6533|jbrach@pitt.edu|
20518057|NCT01483820|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
20518058|NCT01507662|University of Iowa|Dr. Fredric Wolinsky|(319) 384-3821|fredric-wolinsky@uiowa.edu|
20518059|NCT04541173|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20518060|NCT03985657|Johns Hopkins University|Mudiaga Sowho|4105506264|msowho1@jhmi.edu|
20518061|NCT01790685|Johns Hopkins|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
20518062|NCT03541252|Bispebjerg Hospital|Dr. Emily Wenande, MD, PhD|+4540505590|emily.cathrine.wenande@regionh.dk|
20518063|NCT03349632|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20518064|NCT01960296|Icahn School of Medicine at Mount Sinai|Dr. Celia M. Divino|212-241-5499|celia.divino@mountsinai.org|
20518065|NCT02003391|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20518066|NCT02272803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20518067|NCT02611323|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20518068|NCT00858403|H. Lee Moffitt Cancer Center and Research Institute|Eric Haura, M.D., via Moffitt Cancer Center|813-745-6827|eric.haura@moffitt.org|
20518069|NCT02264977|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
20518070|NCT00243347|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20518071|NCT03573544|OBI Pharma, Inc.|Dr. Wayne Saville, Chief Medical Officer|619-537-7821|waynesaville@obipharmausa.com|
20518072|NCT01899053|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20518073|NCT04364191|University of Pennsylvania|Miranda McPhillips|215-898-8281|mvarr@nursing.upenn.edu|
20518074|NCT03105297|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20518075|NCT01345539|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MSCR|412-647-5554|stadtermanbm@upmc.edu|
20518076|NCT03846193|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20518077|NCT04693429|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
20518078|NCT03961204|Merck Healthcare KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
20518079|NCT01189747|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20518080|NCT02452463|Roswell Park|CTRP/CT.gov Registry Coordnator|716-845-1073|KIM.BROSIUS@ROSWELLPARK.ORG|
20518081|NCT03867760|University of Washington Bothell|Dr. Linda Eaton|4253523645|lineaton@uw.edu|
20518082|NCT01073631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518083|NCT03544216|Marshall B. Ketchum University (The Ohio State University during study data collection)|Erin Rueff, OD, PhD|7654145644|em.rueff@gmail.com|
20518084|NCT00412464|Children's Hospital Los Angeles|Guy Young|323-361-5507|gyoung@chla.usc.edu|
20563225|NCT02965846|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
20563226|NCT01424670|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20563227|NCT00761189|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
20563228|NCT01494922|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563229|NCT02759016|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563230|NCT00709098|Actelion Pharmaceuticals Ltd|Laila Rouault, MD/International Clinical Leader|+ 41 61 565 8128||
20563231|NCT01967836|Ascension Wisconsin|Dr Maureen Greene|414-447-2716|maureen.greene@ascension.org|
20563232|NCT02119650|Incyte Corporation|Study Director|855 463-3463||
20563233|NCT02269475|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
20563234|NCT05928624|Columbia University|Giuseppe Cullaro, MD MAS|8454067438|gc2576@cumc.columbia.edu|
20518085|NCT01730846|Yale School of Medicine|Sherry McKee, PhD|203-737-3529|sherry.mckee@yale.edu|
20518086|NCT01018862|Meda Pharmaceuticals Inc|Sr.Director Medical Scientific Affairs|732 564 2200|David.ginsberg@meda.us|
20563235|NCT01303445|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518087|NCT01222234|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-9252|jstubbs@kumc.edu|
20529272|NCT03621956|Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com|
20518088|NCT01968031|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20518089|NCT01891357|on behalf of Westdeutsche Studiengruppe GmbH|Anja Braschoss, Consultant Clinical Research and Medical Writing|0049-176-82119153|anja.braschoss@wsg-online.com|
20518090|NCT00840879|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518091|NCT01851876|Karadeniz Technical University, School of Medicine, Dept Obs and Gyn.|Dr. Suleyman Guven, Director of clinical trial|+904623775869|drsuleymanguven@yahoo.com|
20518092|NCT02015832|European Cardiovascular Research Institute|Dr. Ernest Spitzer|+31102062828|E.Spitzer@ECRI-Trials.com|
20518093|NCT02313558|Guanghua School of Stomatology, Sun Yat-sen University,|Dr. Hongchun Liu|0086-0-13826189071|hongchun751@sina.com|
20518094|NCT01911429|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20518095|NCT03707587|National Cancer Institute|Dr. Scott Norberg|301-275-9668|scott.norberg@nih.gov|
20518096|NCT01370083|Toronto Rehabilitation Institute - University Health Network|Prof. Catriona Steele|4165973422|catriona.steele@uhn.ca|7603
20518097|NCT02450539|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20518098|NCT00834444|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518099|NCT02052895|Mochida Pharmaceutical|Hironori Sato|+81-3-3225-6331|hnsato@mochida.co.jp|
20518100|NCT05780463|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
20518101|NCT02704091|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
20518102|NCT00472212|The Ohio State University College of Optometry|Marjean Kulp|614-688-3336|kulp.6@osu.edu|
20518103|NCT00425308|Novartis Pharmaceuticals|Study Director|862-778-8300||
20518104|NCT01007994|Northwell|Christine Sethna|7184703423|csethna@northwell.edu|
20518105|NCT00726830|University of Texas MD Anderson Cancer Center|Michael J. Fisch, MPH/Clinical Professor, General Oncology|(713) 563-9905|mfisch@mdanderson.org|
20518106|NCT00114504|Kurume University|Hisashi Kai|+81-942-31-7562|naikai@med.kurume-u.ac.jp|
20518107|NCT01266902|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20518108|NCT03616379|McLean Hospital|Dr. R. Kathryn McHugh|617-855-2000|kmchugh@mclean.harvard.edu|
20518109|NCT02484807|Centre for pulmonary hypertension of the Thoraxclinic at the University Hospital Heidelberg|Professor Dr. med. Ekkehard Grünig|+4962213968053|ekkehard.gruenig@med.uni-heidelberg.de|
20518110|NCT05562011|Wake Forest University School of Medicine|Timothy Harwood, M.D.|336.716.8830|tharwood@wakehealth.edu|
20518111|NCT01945580|Boston Scientific|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
20518112|NCT02933060|Cooper University Health System|Dr. Christopher Jones|856-342-2627|jones-christopher@cooperhealth.edu|
20518113|NCT04540094|University of Edinburgh|Prof Alasdair Gray|0131 242 1340|alasdair.gray@ed.ac.uk|
20518114|NCT04411680|Partner Therapeutics, Inc.|Medical Information|1-888-479-5385|PartnerTx@medcomminc.com|
20518115|NCT05034874|InterveXion Therapeutics, LLC|Chief Operating Officer|501-554-2377|intervexion@gmail.com|
20518116|NCT03101358|US Biotest, Inc.|Gere diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
20518117|NCT02640235|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20518118|NCT02045108|The Mind Research Network|Dr. Eric Claus|505-272-5028|eclaus@mrn.org|
20518119|NCT02463981|UESTC|Prof. Keith Kendrick|+86028-61830811|k.kendrick.uestc@gmail.com|
20563236|NCT04924062|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20518120|NCT03810703|University of Chicago|Dave Arndt|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20518121|NCT00495222|Ethicon Endo-Surgery|Susan Knippenberg|513 337-3452|sknippen@its.jnj.com|
20518122|NCT00073307|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20518123|NCT01438060|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20518124|NCT03499873|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20518125|NCT04608448|UT Health San Antonio|Ellen Kraig, PhD|210-567-3818|kraig@uthscsa.edu|
20518126|NCT01964950|Takeda Pharmaceutical Company Limited|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20518127|NCT01149057|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20518128|NCT03602339|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20518129|NCT01297504|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20518130|NCT00690495|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
20518131|NCT01024855|Abbott Medical Optics, Inc.|Nick Tarantino, Head, Clinical Research and Development|714-247-8613|nicholas.tarantino@amo.abbott.com|
20518132|NCT00840281|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20563237|NCT03236441|UT Southwestern Medical Center|Oladipupo Olafiranye, MD, MS|2148572923|oladipupo.olafiranye@utsouthwestern.edu|
20563238|NCT04955717|USC|Dr. Jeffrey D. Klausner|415-876-8901|jdklausner@med.usc.edu|
20563239|NCT04059354|University of Wisconsin - Madison, Waisman Center|Houri K. Vorperian, PhD, Senior Scientist Emerita|608-213-3257|vorperian@waisman.wisc.edu|
20563240|NCT03888989|Stanford University|Philip Grant|650-521-3540|pmgrant@stanford.edu|
20563241|NCT03611153|Mayo Clinic|Dr. Barry A. Borlaug|507-255-2200|borlaug.barry@mayo.edu|
20563242|NCT03805594|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-7171|Rahul.Aggarwal@ucsf.edu|
20563243|NCT03424811|University of Pennsylvania|Tanja Kral|(215) 573-7512|tkral@nursing.upenn.edu|
20563244|NCT05931861|Laboratoires Théa|Clinical Affairs Director|0473981436|Corentin.LECAMUS@theapharma.com|
20563245|NCT04899115|University of Michigan|Patricia Bloom, MD|734-647-5944|ppbloom@med.umich.edu|
20563246|NCT04868110|University of Kansas Medical Center|Dr. Holly Hull|9135881000|hhull@kumc.edu|
20518133|NCT01003938|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
20518134|NCT00076622|University of Pennsylvania|Joel Streim||Joel.Streim@uphs.upenn.edu|
20518135|NCT03306277|AveXis, Inc|US Medical Information|833-828-3947|medinfo@avexis.com|
20518136|NCT03209505|University of Houston College of Optometry|Eric Ritchey, OD, PhD|713-743-1933|erritche@central.uh.edu|
20518137|NCT00326872|Mayo Clinic|Dr. Dusica Babovic-Vuksanovic||dbabovic@mayo.edu|
20518138|NCT00829452|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518139|NCT03082586|Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr tingfeng Chen|86-021-37798364|tingfeng138138@163.com|
20518140|NCT01296841|VA Palo Alto|Roy Soetikno|650-493-5000|soetikno@earthlink.net|64800
20518141|NCT04431518|Indiana University School of Medicine|Samir K. Gupta|3172747926|sgupta1@iu.edu|
20518142|NCT00881751|Medical University of South Carolina|Kate Anderton, MPH, CCRP|anderton@musc.edu|anderton@musc.edu|
20518143|NCT02436200|Imperial College London|Professor Alun Davies, Professor of Vascular Surgery|+44 (0)20 3311 7309|a.h.davies@imperial.ac.uk|
20518144|NCT05032807|King's College London|Dr Edward Chesney|+44 (0)20 7848 0728|edward.chesney@kcl.ac.uk|
20518145|NCT01559363|Kadmon, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20518146|NCT00957021|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
20518147|NCT00746421|Emory University|Jeffrey Rakofsky, MD|404-712-5083|jrakofs@emory.edu|
20518148|NCT01822119|The HEARing CRC & Hearworks, Audiology Hearing and Speech Science, Melbourne, Australia|Professor Robert Cowan|+61 3 9035 5346|r.cowan@unimelb.edu.au|
20518149|NCT03966911|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
20518150|NCT01395017|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20518151|NCT01663896|St. Jude Medical|Sr. Manager, Global Clinical Affairs|651-756-5585|mwagner2@sjm.com|
20518152|NCT01780350|University of Texas Health Science Center San Antonio|David Wampler, PhD|210.567.7598|wamplerd@uthscsa.edu|
20518153|NCT00999687|Chang Gung Memorial Hospital|Lin Yin-Ku MD.Ph.D.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
20518154|NCT02818894|Emory University|Thomas L. Bradbury, MD|404-759-3912|tombradburymd@gmail.com|
20518155|NCT00842309|Massachusetts General Hospital|Dr. Hilary Weingarden|617-643-6206|hilary_weingarden@mgh.harvard.edu|
20518156|NCT03727139|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20518157|NCT00566722|Abbott|Global Medical Services|800-633-9110||
20518158|NCT05203146|University Hospitals of Geneva|Dr Johan N. Siebert|+41795534072|Johan.Siebert@hcuge.ch|
20518159|NCT02218216|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
20518160|NCT03111381|Yale Urology|Jamil Syed|2037852815|Jamil.syed@yale.edu|
20518161|NCT02589067|The Lundquist Institute at Harbor-UCLA|Dr. Loren G. Miller|310-222-3775|lmiller@lundquist.org|
20518162|NCT01401062|NYU Langone Medical Center|Nelly Huppert|212-731-5003|Nelly.Huppert@nyumc.org|
20518163|NCT00755235|Group Health Research Institute|Gregory Simon, Principal Investigator|206-287-2979|simon.g@ghc.org|
20518164|NCT01131260|The George Washington University Biostatistics Center|Rebecca Clifton, Ph.D.|301-881-9260|rclifton@bsc.gwu.edu|
20518165|NCT00438750|Orthopaedic Hand and Upper Extremity Service, Massachusetts General Hospital|David Ring, MD, PhD|617-724-3953|dring@partners.org|
20518166|NCT01165450|University of Maryland School of Medicine|Bennie H. Jeng, MD, MS|667-214-1111|bjeng@som.umaryland.edu|
20518167|NCT03684928|CooperVision,Inc.|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
20518168|NCT00874276|University of Florida|Dr. Peter Stacpoole/Principal Investigator|1-352-273-9023|pws@ufl.edu|
20518169|NCT03733145|Atrium Health Wake Forest Baptist|Rohesh J. Fernando, MD|336.716.2712|rfernan@wakehealth.edu|
20518170|NCT00527098|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
20518171|NCT03922490|Hospital for Special Surgery|Jessica Rios|212-774-7321|riosj@hss.edu|
20518172|NCT01487499|University of Florida|Michael A. Jantz, MD|352-273-8737|michael.jantz@medicine.ufl.edu|
20518173|NCT01691430|Yale University|Dr. Manisha Juthani-Mehta|(203)785-4140|manisha.juthani@yale.edu|
20518174|NCT00660387|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20518175|NCT01622660|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
20518176|NCT02259348|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
20518177|NCT04211766|Fred Hutchinson Cancer Center|Dr. Johanna Lampe|(206) 667-6580|JLampe@fredhutch.org|
20518178|NCT02583048|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20518179|NCT02155257|Wake Forest University Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
20518180|NCT00516295|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20518181|NCT02034513|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20518182|NCT00960154|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20518183|NCT00757705|Janssen Research & Development|Medical Director|886 2 23762155||
20518184|NCT00660660|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
20518185|NCT03544242|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
20518186|NCT02218541|University of North Carolina at Chapel Hill|Gidgetta Jenkins|919-537-3968|gidget_jenkins@unc.edu|
20518187|NCT04661202|National Cheng Kung University|Dr. Kuan-Yin Lin|06-2353535|10802003@gs.ncku.edu.tw|6737
20518188|NCT00856349|Medtronic Cardiac Rhythm Disease Management|Daniel Lexcen, Clinical Research Specialist|763-526-9702|daniel.lexcen@medtronic.com|
20518189|NCT02578641|Tessa Therapeutics|Khong-Bee Kang, Senior Manager Clinical Development|+65 6978 6594|kangkhongbee@tessacell.com|
20518190|NCT02132910|DVCIPM|Chester Buckenmaier|301-816-4710|cbuckenmaier@dvcipm.org|
20563247|NCT03263026|DeNovo Biopharma|Gracielli Hage-Kautz, Associate Director Clinical Operations|858-799-1021|gkautz@denovobiopharma.com|746
20563248|NCT04823611|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20563249|NCT05535062|Neuronetics|Neha Goyal|763-528-1599|neha.goyal@neurostar.com|
20563250|NCT03655132|VA Bedford Healthcare System|Dr. Erin D. Reilly|781-724-4191|Erin.Reilly@va.gov|
20563251|NCT05919082|LEO Pharma|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
20563252|NCT03737058|Stanford University School of Medicine|Manali I Patel, MD MPH MS|650-723-4000|manalip@stanford.edu|
20563253|NCT05535257|Mayo Clinic Florida|Suzanne Langley OTR/L|9044724288|langley.suzanne@mayo.edu|
20563254|NCT05415410|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
20518191|NCT02297230|New York University School of Medicine|Sylvia Formenti|646.962.4073|lao2003@med.cornell.edu|
20518192|NCT02998541|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20518193|NCT01876992|Johns Hopkins University|Sally Radovick|7322359524|sradovick@jhmi.edu|7733073353
20518194|NCT01134549|Amgen, Inc|Study Director|866-572-6436||
20518195|NCT01513239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20518196|NCT00396162|University of Michigan|Jeffrey E. Terrell|734 936 7633|terrelj@umich.edu|
20518197|NCT05293106|Weill Cornell Medicine|Marianne Nellis, MD|2127463056|man9026@med.cornell.edu|
20518198|NCT02694536|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20518199|NCT01741545|Bristol Myers Squibb|Bristol Myers Squibb Study Director|Please email|clinical.trials@bms.com|
20518200|NCT01456962|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Peter Anderson, Pharm D|303-724-6128|peter.anderson@ucdenver.edu|
20518201|NCT02856594|Massachusetts General Hospital|Dr, Oluwaseun Johson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
20518202|NCT02837913|Cedars-Sinai Medical Center|Dr. Mark Zakowski|310-423-5841|mark.zakowski@cshs.org|
20518203|NCT01944722|Becton, Dickinson and Company|Clinical Study Manager|410-316-4000|BDClinicalTrials@bd.com|
20518204|NCT01310855|UCL and CTC Cancer Trials Centre|Mark Phillips|0207 679 9139|ctc.doric@ucl.ac.uk|
20518205|NCT01085539|Covidien|Fran Haury, RRT Research Coordinator|303 305-2314|fran.haury@covidien.com|
20518206|NCT06078501|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20518207|NCT03358147|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
20518208|NCT01634139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518209|NCT01694563|Atricure Inc.|Nfii K. Ndikintum, PhD, MBA / VP, Clinical Affairs and Biometrics|513-644-8192|NNdikintum@atricure.com|
20518210|NCT01168856|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20518211|NCT00979147|Minneapolis VAMC|Terence Gioe M.D.|612-467-1780|tjgioe@gmail.com|
20518212|NCT00387153|Myriad Therapeutics, Inc.|Richard Wenstrup, MD, VP Chief Medical Officer|801-584-3009|rwenstru@myriad.com|
20518213|NCT04567329|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20518214|NCT00841659|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518215|NCT01322633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518216|NCT02420353|Hopsital For Special Surgery and University of Michigan|Dr. Christopher Mendias|212-249-2373|mendiasc@hss.edu|
20518217|NCT00654186|Oncology Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
20518218|NCT03053245|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
20518219|NCT01968551|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20518220|NCT00819169|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20518221|NCT02096705|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20518222|NCT00595153|University of California, San Francisco|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
20518223|NCT03486938|agenebio|Richard Mohs|317-997-3241|richard.mohs@agenebio.com|
20518224|NCT00804973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518225|NCT02701101|Bruin Biometrics|Vignesh Iyer|3102689494|viyer@bruinbiometrics.com|
20518226|NCT01046084|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518227|NCT00474188|Celgene Corporation|Robert Kinght, M.D.|908-673-9749|rknight@celgene.com|
20518228|NCT03614728|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20518229|NCT05412121|University of Michigan|Anne Murphy|734-936-5566|aemurph@med.umich.edu|
20518230|NCT01533038|NeoTract|Director of Clinical Affairs|925-401-0641|ehergenreter@neotract.com|
20518231|NCT04476277|National Heart, Lung, and Blood Institute (NHLBI)|Mathew Hsieh, M.D.|301.402.7687|matthewhs@nhlbi.nih.gov|
20518232|NCT01962298|Antwerp University Hospital|Dr Tom Schepens|003238213265|tom.schepens@uza.be|
20518233|NCT01576705|Institut Jérôme Lejeune|Dr Clotilde Mircher|00 33 1 56 58 63 00|clotilde.mircher@institutlejeune.org|
20518234|NCT01390948|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20518235|NCT00787124|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
20518236|NCT05740098|University of Vermont|Stephen T. Higgins, PhD., P.I.|802-656-9615|stephen.higgins@uvm.edu|
20518237|NCT00919113|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
20518238|NCT05984290|Bausch & Lomb Incorporated|Director, Medical Affairs, Vision Care R&D|585-413-6397|marjorie.rah@bausch.com|
20518239|NCT02588339|Moffitt Cancer Center|Lia E. Perez, MD|813-745-3665|Lia.Perez@moffitt.org|
20518240|NCT04573309|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20518241|NCT00605150|Carolinas Healthcare System|David Iannitti, MD|704-446-4838|jessica.drummond@carolinashealthcare.org|
20518242|NCT01894230|Duke University|Dr. Deepak Voora|919-668-1755|Deepak.vorra@duke.edu|
20518243|NCT02756949|World Bank|Ms Marelize Gorgens|0012024730547|mgorgens@worldbank.org|
20563255|NCT04848974|The University of Texas MD Anderson Cancer Center|Tapan Kadia MD/Professor|713-563-3534|tkadia@mdanderson.org|
20529273|NCT05664581|AbbVie|Global Medical Services|001 8006339110|abbvieclinicaltrials@abbvie.com|
20529274|NCT05541939|Vogenx|Chief Scientific Officer|919-659-5677|info@vogenx.com|
20529275|NCT03101150|King Fahd Medical City|Consultant Obstetritian and Gynecologist|00966539417217|amali@kfmc.med.sa|
20529276|NCT01317641|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
20529277|NCT01051921|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|(858) 457- 7227|MHuyghe@conatuspharma.com|
20529278|NCT01116921|Unviersity of Minnesota|Kari D. Roberts, MD|612-625--9577|rober694@umn.edu|
20529279|NCT01325350|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20529280|NCT03429348|University of Arizona|Jeff Burgess, MD., MS, MPH, Assoc Dean of Research|520-626-4918|jburgess@email.arizona.edu|
20529281|NCT01460303|UMass Medical School|Dr. Michael K. Flynn||Michael.Flynn@umassmemorial.org|
20529282|NCT02962427|University of Colorado|Cristina Wood, MD|7208483323|cristina.wood@ucdenver.edu|
20529283|NCT01716806|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20529284|NCT02692586|Inari Medical|Ashleigh Willson|877-923-4747|ashleigh.willson@inarimedical.com|
20529285|NCT02880254|Baystate Medical Center|Rushika Conroy MD|413 794 5437|rushika.conroy@bhs.org|
20529286|NCT02189668|Nationwide Children's Hospital|Peter Minneci|6147223066|peter.minneci@nationwidechildrens.org|
20529287|NCT03799614|Virginia Commonwealth University|Dr. Ingrid Pretzer-Aboff|804-828-3340|iaboff@vcu.edu|
20529288|NCT03316586|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-2335|Sara_Tolaney@dfci.harvard.edu|
20529289|NCT01491022|University of Miami|Dr Corneliu Luca|3052432235|cluca@med.miami.edu|
20529290|NCT03934216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20529291|NCT01053741|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)614-8762|ejfuchs@jhmi.edu|
20529292|NCT00619827|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20529293|NCT03407313|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
20529294|NCT01396083|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20529295|NCT01063855|Janssen Research & Development, LLC|CDTL, Cardiovascular and Metabolism|1 908 704-4648||
20529296|NCT00735709|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20529297|NCT01165307|Mayo Clinic|Dr. Abimbola O. Famuyide|507-284-7035|Famuyide.Abimbola@mayo.edu|
20529298|NCT01126099|VA Puget Sound|Lucy Wang|206-277-5089|wanglucy@u.washington.edu|
20529299|NCT02472730|Baylor College of Medicine|Dr. Kalpesh K. Patel|7137980947|kalpeshp@bcm.edu|
20529300|NCT02163395|Clinical Research|Intsitut Straumann AG|0041619651111|research@straumann.com|
20529301|NCT01195779|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529302|NCT01401595|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, Ph.D.|215-898-2823|kca@mail.med.upenn.edu|
20529303|NCT02537951|Erasmus MC|Joost L.M. Jongen|+31107041415|j.jongen@erasmusmc.nl|
20563256|NCT02365766|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20563257|NCT05166811|University of Utah|Dr. Michael D. Johnson|(801) 935-0503|mike.johnson@hsc.utah.edu|
20563258|NCT05272852|BostonScientific|Karin Froidcourt|+0032471636566|Karin.Froidcourt@bsci.com|
20563259|NCT04058626|Imperial College London/ Imperial College Healthcare NHS Trust|Mr Pasha Normahani|020 3312 6666|p.normahani@imperial.ac.uk|switch
20563260|NCT02991534|VA Greater Los Angeles Healthcare System|Dr. Bevanne Bean-Mayberry|818-891-7711|bevanne.bean-mayberry@va.gov|36009
20563261|NCT02155010|Haeundae paik hospital, Inje University|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
20563262|NCT04791709|University of Miami|Dr. Daniel Jimenez|305-243-2776|dej18@miami.edu|
20563263|NCT02724956|UT MD Anderson Cancer Center|Carin Hagberg, MD/Chief Academic Officer, CAO Office|713-792-5888|chagberg@mdanderson.org|
20563264|NCT00650104|GlaxoSmithKline|GSK Response Center|866-435-7343||
20563265|NCT01532388|Karolinska Institutet|Dr Kristina Sinadinovic|+46812345735|kristina.sinadinovic@socialstyrelsen.se|
20563266|NCT03385629|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|suchitra.nelson@case.edu|
20563267|NCT00792636|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518244|NCT02219009|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20518245|NCT03086135|Radboud University Medical center, Nijmegen|Professor Emmanuel Mylanus|+31 24 361 49 34|Emmanuel.Mylanus@radboudumc.nl|
20518246|NCT01023061|University of Washington|Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20518247|NCT02966340|UW Madison|John J. Curtin|608-262-0387|jjcurtin@wisc.edu|
20518248|NCT00202839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20518249|NCT00642993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20518250|NCT03119662|GE Healthcare|Francois Tranquart, M.D., Ph.D.|00-44-1494-543037|francois.tranquart@ge.com|
20518251|NCT02817828|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
20518252|NCT04956289|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
20518253|NCT03123874|Cornell University|Sarah Reyes|208-921-4967|smr296@cornell.edu|
20529304|NCT00521365|AstraZeneca|Gerard Lynch|09645895|ClinicalTrialTransparency@astrazeneca.com|4415
20563268|NCT01046136|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
20518254|NCT02308241|Memorial Sloan Kettering Cancer Center|Dr. David Pfister MD|646-888-4237|pfisterd@MSKCC.ORG|
20529305|NCT03627832|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
20529306|NCT03150082|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20529307|NCT01718483|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20563269|NCT04579250|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20563270|NCT04711135|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20563271|NCT05050682|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563272|NCT02664558|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
20563273|NCT04436107|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20563274|NCT01095796|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20563275|NCT00999167|Horizon Therapeutics, Inc.|Julia Egofske||clinicaltrials@horizonpharma.com|
20563276|NCT00274469|AstraZeneca|Jasmine Lichfield|07585404954|jasmine.lichfield@astrazeneca.com|
20563277|NCT04238247|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Michelle Macy|312-227-6676|mmacy@luriechildrens.org|
20563278|NCT03833167|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20563279|NCT03517969|Dana Farber Cancer Institute|Dr. Atish D Choudhury|617-6326328|atish_choudhury@dfci.harvard.edu|
20563280|NCT02860130|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20563281|NCT03811535|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20563282|NCT02140645|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563283|NCT02371395|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
20563284|NCT06647238|Atrium Health|Lyndsi Roland|828-434-5434|lyndsi.roland@advocatehealth.org|
20563285|NCT02137850|Novo Nordisk A/S|Clinical Reporting Office (2834)|866-867-7178|clinicaltrials@novonordisk.com|(+1)
20563286|NCT02794480|GlaxoSmithKline|GSK Response Center|866-435-7343||
20563287|NCT02814838|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20563288|NCT00593489|Lawson Research Institute|Dr. Stewart Harris|519 858-5028|sharris1@uwo.ca|
20563289|NCT01747486|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
20563290|NCT01256840|UCLA Department of Psychology|Dr. A. Janet Tomiyama|3102066875|tomiyama@psych.ucla.edu|
20563291|NCT01084707|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20563292|NCT00901901|BAYER|Therapeutic Area Head|(+)1-888-84-22937|clinical-trials-contact@bayer.com|
20563293|NCT00073749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563294|NCT00632749|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563295|NCT04999592|MaineHealth Maine Medical Center - Portland|David J. Gagnon, PharmD - Principal Investigator|207-662-0111|dgagnon@mmc.org|
20563296|NCT00215787|Head and Neck Surgery Associates|Scott Phillips|317-926-1056|sphillips@hnsaonline.com|
20563297|NCT02672033|Jonsson Comprehensieve Cancer Center|Dr. Percy Lee|310 825-9771|percylee@mednet.ucla.edu|
20563298|NCT01748916|University of Hohenheim|Dr. Ralf Schweiggert|0049-711-459-22995|ralf.schweiggert@uni-hohenheim.de|
20563299|NCT02671435|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20563300|NCT04095104|University of Colorado School of Medicine|Jaime Moore, MD MPH|303-724-8419|jaime.moore@cuanschutz.edu|
20563301|NCT03547999|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20563302|NCT05048186|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
20563303|NCT00976937|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20563304|NCT03069313|Cleveland Clinic Florida|Zeina Nahleh, MD (previoulsy PI at Texas Tech university HSC-EP)|9546595840|nahlehz@ccf.org|
20563305|NCT04218266|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20563306|NCT01637246|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20563307|NCT01011946|University of Chicago|Dr. Daniel Appelbaum|(773) 834-2012|dappelbaum@radiology.bsd.uchicago.edu|
20563308|NCT00352976|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2961|macmi002@umn.edu|
20563309|NCT01227265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20563310|NCT04623775|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20563311|NCT01959698|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20563312|NCT03638427|Stanford University|Paul Blumenthal, MD|(650) 725-6035|gynresearch@stanford.edu|
20563313|NCT04499950|SKCCC|Jennifer Sheng|410-614-0762|jsheng7@jhmi.edu|
20563314|NCT04491968|Rutgers Robert Wood Johnson Medical School|Dr. Nina Cooperman, Associate Professor|7322358569|cooperna@rwjms.rutgers.edu|
20563315|NCT02428192|DFCI|Dr. Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
20563316|NCT02396199|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20563317|NCT04112316|University of Pennsylvania|Theresa M Scattergood, MSN|215-898-5664|theresa.scattergood@pennmedicine.upenn.edu|
20563318|NCT03535727|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, M.D.|443-287-0002|Dle@jhmi.edu|
20563319|NCT02597946|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563320|NCT04995484|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20563321|NCT03743636|Northwestern University|Mary M. McDermott, MD|312-503-6419|mdm608@northwestern.edu|
20563322|NCT05485922|Coloplast, Clinical strategies|Medical Writer|+4549112057|dkmhla@coloplast.com|
20563323|NCT06190678|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20563324|NCT05194969|University of North Carolina at Chapel Hill|Christopher J. Sayed, MD|984-974-3900|christopher_sayed@med.unc.edu|
20563325|NCT05343390|University of North Carolina at Chapel Hill|Nora E. Rosenberg, PhD|(919) 966-3761|nrosenbe@email.unc.edu|
20563326|NCT02278562|VA TN Valley Healthcare System|Alp Ikizler MD|615-322-5000|alp.ikizler@vanderbilt.edu|
20563327|NCT04178733|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20563328|NCT04119284|Nemours Hospital for Children|Suken Shah, MD, Orthopedics Department Chair|3025472557|suken.shah@nemours.org|
20563329|NCT01974245|Federal University of São Paulo|Dr. Lilian Cuppari|+551159048499|lcuppari@uol.com.br|
20563330|NCT04437433|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20563331|NCT00611559|GlaxoSmithKline|GSK Response Center|866-435-7343||
20563332|NCT00879333|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20563333|NCT02467166|University of California, San Diego Health System|Gregory K. Feld, MD, Director CCEP|(858) 246-2972|gfeld@health.ucsd.edu|
20563334|NCT02742519|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20563335|NCT00620698|Beth Israel Deaconess Medical Center|Seward Rutkove|617-667-8130|srutkove@bidmc.harvard.edu|
20563336|NCT03432858|WellSpan Health|Clinical Research Associate|(717) 851-7634|cbush@wellspan.org|
20563337|NCT01872078|AstraZeneca Pharmaceuticals LP|Martin L. Scott, MD/PhD|781-472-5130|martin.scott@astrazeneca.com|
20563338|NCT03169894|Avalo Therapeutics, Inc.|Garry Neil, MD|908-720-2691|gneil@avalotx.com|
20563339|NCT00766649|National Eye Institute|Wai T. Wong|(301) 905-7301|wongw@nei.nih.gov|
20563340|NCT01721291|Imperial College London|Dr Omar Usmani|+440(0) 207351 8051|o.usmani@imperial.ac.uk|
20563341|NCT01091168|INSTITUT DE RECHERCHE PIERRE FABRE|Dr Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
20563342|NCT03242148|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
20563343|NCT03859869|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20563344|NCT03767517|University of Alabama at Birmingham|Dr. Ronit Elk|205-996-1702|relk@uabmc.edu|
20563345|NCT03448458|Emory University|Mehmet Asim Bilen, MD|404-778-1900|mehmet.a.bilen@emory.edu|
20563346|NCT05239039|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563347|NCT06377358|University of Malaga|José Rioja Villodres|(+34) 952 137 278|jose.rioja@uma.es|
20518255|NCT00659815|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
20518256|NCT02651987|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
20518257|NCT04408924|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20518258|NCT00486434|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+4522901317|bjr@nordicbioscience.com|
20518259|NCT02725515|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|
20518260|NCT01981044|Allergan Medical|Marcio Torre, M.D., M.A., Medical Monitor|805-683-6761|torre_marcio@allergan.com|
20518261|NCT02889393|University of Miami|Dr. D. Dante Yeh|3055851178|dxy154@med.miami.edu|
20518262|NCT04707846|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
20518263|NCT01759251|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20518264|NCT02906917|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20518265|NCT00687739|University of Colorado Anschutz Medical Campus|Wendy M Kohrt, PhD|3037241913|wendy.kohrt@ucdenver.edu|
20518266|NCT02542462|Cincinnati Childrens Hospital Medical Center|Nancy Back RN MPH|513-636-2479|Nancy.Back@cchmc.org|
20518267|NCT03599362|NYU Langone Health|Fraustina Hsu|6467547124|Fraustina.Hsu@nyulangone.org|
20518268|NCT02312154|Konkuk University|Yang Won Lee|8220305172|20130112@kuh.ac.kr|
20518269|NCT01167829|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
20518270|NCT02072096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518271|NCT01044537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518272|NCT04442503|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20518273|NCT03068780|Amryt Research Limited|Janet Boylan|+3531518|Janet.boylan@amrytpharma.com|0200
20518274|NCT00474058|UCB|UCB Clinical Trial Call Center|+1877 822 9493||
20518275|NCT03334734|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
20518276|NCT02974907|ReGenTree, LLC|Shinwook Kang|609-649-5505|swkang@regentreellc.com|
20518277|NCT01545193|NorthShore University HealthSystem|Glenn S. Murphy,MD|847-570-2760|dgmurphy2@yahoo.com|
20518278|NCT00503867|Sirtex Medical|Medical Director|011 61 2 9964 8470|dcade@sirtex.com|
20518279|NCT05616728|Enanta Pharmaceuticals, Inc.|Justin Aubin|857-760-0591|jaubin@enanta.com|
20518280|NCT00577655|Teval Global Respiratory Research LLC|Teva Study Physician|215-293-6482||
20518281|NCT04306952|Northwestern University|Jennifer Mundt PhD|312-503-2846|jennifer.mundt@nm.org|
20518282|NCT00672984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20518283|NCT00009945|NSABP Foundation, Inc.|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
20518284|NCT00406393|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20518285|NCT01632306|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518286|NCT01156987|University of MN|Curt Corum|(612) 625-5000|corum003@umn.edu|
20518287|NCT00380588|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518288|NCT02905435|PolyNovo Biomaterials Pty Ltd|Tim Barker, PhD|+61386814054|tim.b@polynovo.com|
20518289|NCT02377349|GlaxoSmithKline|GSK Response Center|866-435-7343|en736091@gsk.com|
20563348|NCT03690206|Zealand Pharma A/S|Head of clinical operations|+45 8877 3600|info@zealandpharma.com|
20563349|NCT03978637|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20518290|NCT03504020|Medtronic CRM Clincial Research|CRM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
20518291|NCT02235870|Obalon Therapeutics, Inc.|Amy VandenBerg, Vice-President, Clinical Affairs and Regulatory Affairs|760.795.6551|avandenberg@obalon.com|
20518292|NCT03366428|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20518293|NCT02166606|Boston Scientific|Dipl.-Ing. (FH) Jens Goetzke|+49171|jens.goetzke@bsci.com|5426813
20518294|NCT02083809|University of Hawaii|Dr.|8082036500|whrc@ucera.org|
20518295|NCT01958476|Tufts Medical Center Floating Hospital for Children|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
20518296|NCT02670551|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20518297|NCT01971645|Nationwide Children's Hospital|Giorgio Veneziano, MD|6147224200|Giorgio.Veneziano@nationwidechildrens.org|
20518298|NCT00714051|Edward Hines Jr., VA Hospital|Eileen Collins PhD, RN|708-202-3525|eileen.collins@va.gov|
20518299|NCT00570128|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20518300|NCT03868631|Point Loma Nazarene University|Dr. Heidi Lynch|619-806-3306|hlynch@pointloma.edu|
20518301|NCT02286466|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
20518302|NCT00835081|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518303|NCT01139762|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518304|NCT01675596|Edwards Lifesciences|Tenley Koepnick||tenley.koepnick@edwards.com|
20563350|NCT03152786|Wake Forest School of Medicine|Ashok Hemal, MD|336-716-5694|ahemal@wakehealth.edu|
20563351|NCT04923347|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20563352|NCT02349412|Massachusetts General Hospital Cancer Center|Jennifer Temel, MD|(617) 724-0453|jtemel@partners.org|
20563353|NCT04505774|University of Pittsburgh|Dr. Stephen Wisniewski|412-383-4696|stevewis@pitt.edu|
20563354|NCT04788537|University of Pennsylvania|Edward S Brodkin, MD|1-215-746-0118|ebrodkin@pennmedicine.upenn.edu|
20563355|NCT03379168|University of New Mexico Health Sciences Center|Dustin Richter, MD; Vice Chair of Research|505-272-4107|DLRichter@salud.unm.edu|
20563356|NCT05320432|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20563357|NCT05038566|Liberating Technologies, Inc.|Dr. Todd Farrell|774-233-0873|todd.farrell@liberatingtech.com|
20563358|NCT03285321|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20563359|NCT04286282|University of Minnesota|Sarah Lofgren|612-624-9996|Lofg0020@umn.edu|
20551443|NCT00614315|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
20563360|NCT05806788|UT Health San Antonio|Dr. Lisa Smith Kilpela|210-450-8121|kilpela@uthscsa.edu|
20563361|NCT00739648|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
20563362|NCT05996744|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20563363|NCT02840474|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
20563364|NCT03192891|Brigham and Women's Hospital|Raymond Y. Kwong, MD MPH|8573071960|rykwong@bwh.harvard.edu|
20563365|NCT04850807|Brown University|Ellen McCreedy, PhD|401-863-7345|Ellen_McCreedy@brown.edu|
20563366|NCT03739996|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|ACTG Network Coordinating Cent|ACTGCT.gov@fstrf.org|
20563367|NCT02387853|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20563368|NCT05141903|Prolacta Bioscience|Dr. David Rechtman VP, Medical Affairs|8887765228|drechtman@prolacta.com|
20563369|NCT04716634|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20563370|NCT05387447|University of Nebraska Medical Center|Marcia Shade|402-559-6641|marcia.shade@unmc.edu|
20563371|NCT05126862|University of Virginia School of Nursing|Jessie Gibson, PhD, RN|434-924-0107|js6zn@virginia.edu|
20518305|NCT04236596|University of Michigan|Timothy Bruns|(734) 647-8727|bruns@umich.edu|
20518306|NCT01120899|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
20551444|NCT03756688|Mayo Clinic|Dr. Landon Trost|507-202-1995|landontrost@gmail.com|
20551445|NCT00527943|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20551446|NCT05407675|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20551447|NCT00857220|Sunovion|CNS Medical Director|866-503-6357||
20551448|NCT00742001|Terumo BCT|Marty Huntington / Sr Mgr Global Clinical Affairs|+1 (303) 231-4849|Marty.Huntington@terumobct.com|
20551449|NCT00137423|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20551450|NCT03187262|Dana-Farber Cancer Institute|Dr. Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
20551451|NCT00535990|UCSD|Dr. Jonathan Li|6618603471|jzl023@health.ucsd.edu|
20551452|NCT04105998|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
20551453|NCT01050257|Hoffman-LaRoche|Medical Communications|800-821-8590||
20551454|NCT00171223|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20551455|NCT00584558|University of Oklahoma Health Sciences Center|Karen Beckman, MD|405-271-9696|karen-beckman@ouhsc.edu|37536
20551456|NCT02604212|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20551457|NCT00278109|Indiana University School of Medicine|Richard Zellars MD|3179444505|rzellars@iu.edu|
20551458|NCT02580357|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
20551459|NCT04339296|Health Systems Evaluation & Evidence - Alberta Health Services|Research and Evaluation Coordinator|4036489255|armghan.ahmad@albertahealthservices.ca|
20551460|NCT00450333|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20551461|NCT01689701|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
20551462|NCT01347008|Federal University of Sao Paulo|Fernando Villela Andrigueti, MD|+55 11 55764239|fernando.andrigueti@usp.br|
20551463|NCT01829230|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
20563372|NCT02651324|Albany medical center|Farzana Afroze|518-262-4300|afrozef@amc.edu|
20518307|NCT02664415|MHRP|Biostatistician|3015003715|spinyakorns@hivresearch.org|
20518308|NCT01151280|Boston Scientific Corporation|Alexis James, Clinical Project Manager|508-683-4074|jamesa@bsci.com|
20518309|NCT00183196|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
20518310|NCT03387462|Bridge HIV, San Francisco Department of Public Health|Dr. Susan Buchbinder|628-217-7479|susan.buchbinder@sfdph.org|
20518311|NCT01460628|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
20518312|NCT04179396|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20518313|NCT03820258|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20518314|NCT01664039|Alcon Research, Ltd|Global Brand Lead, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20518315|NCT01853176|Emory University|Albert Losken MD|404-686-8143|alosken@emory.edu|
20518316|NCT00874822|University of Nebraska Medical Center|Jason Shiffermiller, MD, MPH|402-559-7299|jshiffermiller@unmc.edu|
20518317|NCT02854800|West Virginia University|Dr. Melissa Blank|304-293-8341|Melissa.Blank@mail.wvu.edu|
20518318|NCT03056144|The Hong Kong Polytechnic University|Dr Tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
20518319|NCT04224753|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20518320|NCT00875524|Sanofi Pasteur SA|Medical Director||Contact-US@sanofi.com|
20518321|NCT01370863|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20518322|NCT02016235|Mayo Clinic|John C. Lieske, M.D.|507-266-7960|Lieske.John@mayo.edu|
20518323|NCT01852799|Shanghai Changzheng Hospital|Jian Hou, PhD|86021-63610109-73221|houjian@medmail.com.cn|
20518324|NCT03504085|UC San Diego|Erik Groessl, PhD|858-642-6347|egroessl@ucsd.edu|
20518325|NCT05533411|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
20518326|NCT03276559|Weill Cornell Medicine|Hillary Winoker|646-962-7143|hiw4002@med.cornell.edu|
20518327|NCT00834561|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518328|NCT02442687|Duke University|Dr. Manal F. Abdelmalek|919-684-8356|manal.abdelmalek@duke.edu|
20518329|NCT01926119|Stanford University|Kevin Johnson, PhD RN|(650) 721-1988|johnsk@stanford.edu|
20518330|NCT02654145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20518331|NCT00354835|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20518332|NCT00645853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20518333|NCT00431041|Astellas Pharma Global Development|Astellas Medical Monitor||ClinicalTrials@us.astellas.com|
20518334|NCT02637141|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20518335|NCT03885934|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20518336|NCT03255980|Helsinn Healthcare SA|Dr. Fabio Macchi|0041919852121|fabio.macchi@helsinn.com|
20518337|NCT01597791|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.eud|
20518338|NCT04090658|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20518339|NCT01728116|GI Dynamics, Inc|Brian Callahan|781.357.3302|bcallahan@gidynamics.com|
20518340|NCT03277248|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20529308|NCT03049501|University of Miami|David Loewenstein|305-355-7016|dloewenstein@miami.edu|
20529309|NCT04547140|Grifols Therapeutics LLC|Rhonda Griffin, Clinical Program Leader/Director|+1 919 757 1744|Rhonda.griffin@grifols.com|
20529310|NCT02119299|Scientific Intake|Richard P. Schneider|917-676-6251|rschneider@scientificintake.com|
20529311|NCT00873730|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20529312|NCT02787499|Massachusetts General Hospital/Harvard Medical School|Mark Siedner|6177264686|msiedner@mgh.harvard.edu|
20529313|NCT00048035|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20529314|NCT04110314|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20529315|NCT05137717|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20529316|NCT04685993|Lipocine Inc|Senior Director of Clinical Development|801.994.7383|admin@lipocine.com|
20529317|NCT02619617|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20529318|NCT00509899|Incyte Corporation|Study Director|1-855-463-3463||
20529319|NCT04658797|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
20529320|NCT01711983|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
20529321|NCT02326272|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20529322|NCT05270980|NYU Langone Health|Dr. Joshua Chodosh|212-263-6768|Joshua.Chodosh@nyulangone.org|
20529323|NCT00735943|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529324|NCT00115778|Columbia University Medical Cetner|Selim Arcasoy, MD|212-305-7771|sa2059@columbia.edu|
20529325|NCT00500578|UT MD Anderson Cancer Center|Roy F Chemaly, MD/MPH, MBA /Associate Professor|713-745-1116|rfchemaly@mdanderson.org|
20529326|NCT02185417|Boston VAHCS|Dr. Sarah Leatherman|857-364-4201|sarah.leatherman@va.gov|
20529327|NCT02147613|Arizona State University - Downtown Phoenix Campus|Siddhartha S. Angadi, PhD., FACSM|6028272254|sangadi@asu.edu|
20529328|NCT02595502|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S., F.A.A.O - Senrior Principal Research Optometrist|904-443-1290|BPALL@its.jnj.com|
20529329|NCT06331507|University of Michigan|Prachi Agarwal|734-232-5132|prachia@med.umich.edu|
20529330|NCT01687114|Tufts University|Oliver Chen|617-5563128|oliver.chen@tufts.edu|
20529331|NCT01278342|Novartis Pharmaceuticals|Study Director|862-778-8300||
20529332|NCT03871153|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20518341|NCT03515044|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20529333|NCT03225170|NHGRI|Dr. Lori Erby|301-443-2635|lori.erby@nih.gov|
20529334|NCT05017272|Q2i LLC Telephone: 646-660-2151 Email: sjenkins@q2i-group.com|Steve Jenkins|646-660-2151|sjenkins@q2i-group.com|
20563373|NCT02249949|Georgetown University|Michael J. Pishvaian, MD, PhD|202-444-2144|pishvaim@georgetown.edu|
20563374|NCT05054374|Memorial Sloan Kettering Cancer Center|Dr. Ezra Rosen, MD, PhD|646-888-6955|rosene1@mskcc.org|
20563375|NCT05691309|Children's Hospital of Philadelphia|Dr. Kevin Downes|215-590-4024|downeskj@chop.edu|
20563376|NCT01707030|Department of Veterans Affairs|Dr. Micheal Cucciare|501-257-1068|Michael.Cucciare@va.gov|
20563377|NCT04245501|University of Denver|Michelle Rozenman, Ph.D., Director, BRAVE Lab & Associate Professor, Department of Psychology|303-871-6448|michelle.rozenman@du.edu|
20563378|NCT01549899|University of Arizona|Daniel J. Taylor, Ph.D.|5206219289|danieljtaylor@arizona.edu|
20563379|NCT06064916|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
20563380|NCT02697136|Abionyx Pharma|Constance Peyrottes|+33673045380|cpeyrottes@abionyx.com|
20563381|NCT03295734|UAB|Thomas W. Buford, PhD|205-996-3008|twbuford@gmail.com|
20563382|NCT03578536|Minneapolis VA Health Care System|Andrew Hansen, PhD|612-467-2910|Andrew.Hansen2@va.gov|
20563383|NCT02538900|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
20563384|NCT04431726|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20563385|NCT04281485|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563386|NCT04004325|FORMA Therapeutics, Inc.|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20563387|NCT04093752|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20563388|NCT01101451|NRG Oncology|Helen Huang on behalf of Wei Deng Ph.D.|7168452318|huangh@nrgoncology.org|
20518342|NCT01451541|Sunovion|Respiratory Medical Director|1-866-503-6351||
20518343|NCT04164758|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
20518344|NCT02248714|6thShanghaiJiaotongU|Dr. Yuqian Bao|(021)64369181|byq522@163.com|
20518345|NCT02119936|UNC Chapel Hill|Holly Krohn|919-445-0218|holly_krohn@med.unc.edu|
20518346|NCT05315713|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20518347|NCT02243579|Fred Hutchinson Cancer Research Center|Asa Davis|206-667-5300|akdavis@fredhutch.org|
20518348|NCT00757172|Washington University School of Medicine|Dr. A. Craig Lockhart|314-454-8306|alockhar@dom.wustl.edu|
20518349|NCT02161705|Johns Hopkins University School of Medicine|Dr. Pathik Aravind|4437879385|paravin1@jhmi.edu|
20518350|NCT03555695|Rush University Medical Center|Dr. Jori Fleisher|312-563-2900|jori_fleisher@rush.edu|
20518351|NCT01971554|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20518352|NCT01426854|Alcon (China) Ophthalmic Product Co., Ltd.|Terence Li, Clinical Research Manager, Development & Medical Affairs, China|+86 10 5829 1452|Terence.li@alcon.com|
20518353|NCT03505151|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518354|NCT04116957|University of Missouri|Jung Hyup Kim|5738840354|kijung@missouri.edu|
20518355|NCT01942135|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518356|NCT01499043|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20518357|NCT04203823|Medtronic|Clinical Study Manager|8185765849|carrie.corrigan@medtronic.com|
20518358|NCT01566435|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-7402|dadkins@wustl.edu|
20518359|NCT03193021|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
20518360|NCT02535923|Department of Veterans Affairs|Elizabeth A Klingaman PhD|410-259-7810|elizabeth.klingaman@va.gov|
20518361|NCT05471349|University of Wisconsin - Madison|Mark Zehner|608-262-7568|mark.zehner@wisc.edu|
20518362|NCT00685334|New York State Psychiatric Institute|Evelyn Attia, MD|212-253-5923|ea12@columbia.edu|
20518363|NCT02957331|UCHealth|Thomas J. Schroeppel, MD, MS|719 365 2422|thomas.schroeppel@uchealth.org|
20518364|NCT03388008|Washington University in St. Louis|Ramsey Hachem, MD|(314) 454-7953|Rhachem@wustl.edu|
20518365|NCT01520987|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20518366|NCT02005562|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20518367|NCT02300987|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
20563389|NCT05386069|Prisma Health|Manager OBGYN Research|864-455-1510|patti.parker@prismahealth.org|
20518368|NCT00929981|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518369|NCT04590781|Xencor, Inc|Benjamin Thompson, MD, PhD|858-480-3133|bthompson@xencor.com|433
20518370|NCT04313296|Pen Bay Medical Center|Caroline Knight|207-301-8959|caroline.knight@mainehealth.org|
20518371|NCT02400463|University of Michigan Rogel Cancer Center|Ryan Wilcox|734-615-1482|rywilcox@umich.edu|
20518372|NCT00820599|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
20518373|NCT03686215|Lumicell|Jorge Ferrer, PhD|617-571-0592|jmferrer@lumicell.com|
20518374|NCT00522041|Allergan plc|Susan Fox, PhD|201-427-8225|susan.fox@allergan.com|
20518375|NCT00874549|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20518376|NCT01710358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518377|NCT00084864|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20518378|NCT00831987|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20518379|NCT03538795|University of Alabama of Birmingham|Gitendra Uswatte|205-975-5089|guswatte@uab.edu|
20518380|NCT01327976|EnteroMedics|Director of Clinical Research|651-634-3209|mbroich@enteromedics.com|
20518381|NCT01721772|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20518382|NCT01095887|Mayo Clinic|Dr. Mark D. Stegall|507-266-2812|stegall.mark@mayo.edu|
20563390|NCT04838613|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20563391|NCT04854096|NS Pharma, Inc.|Medical Affairs|+1-201-986-3860|trialinfo@nspharma.com|
20518383|NCT04542694|A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation|Academician Dmitry Pushkar|+7495-609-67-00|dmitry.pushkar@gmail.com|
20563392|NCT06207058|Tricore|Medical Director|505-938-8461|michael.crossey@tricore.org|
20563393|NCT06155721|Badalona Serveis Assistencials|Jose Ferrer Costa|+34 937407482|jfcosta@bsa.cat|
20563394|NCT00715884|Cordis|Amy Orlick, Associate Director Clinical Research|908-541-4347|AOrlick@its.jnj.com|
20563395|NCT00951379|University of Texas (UT) MD Anderson Cancer Center|University of Texas MD Anderson Phase I/II Prevention Consortium||CR_Study_Registration@mdanderson.org|
20563396|NCT00738023|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20563397|NCT02057939|Duke University|Andrew Armstrong, MD ScM|919-668-4615|andrew.armstrong@duke.edu|
20563398|NCT03912831|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20563399|NCT03580369|Novartis Pharmaceuticals|Study Director|1 (862) 778-8300|novartis.email@novartis.com|
20563400|NCT03527160|Cincinnati Children's Hospital Medical Center|Dr. Stuart Goldstein|513-636-2209|stuart.goldstein@cchmc.org|
20563401|NCT02910713|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20563402|NCT04430634|Nerudia|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
20563403|NCT04442126|Numab Therapeutics AG|Josephine Adams|00447712295851|j.adams@numab.com|
20563404|NCT05511467|Medical University of South Carolina|Principal Investigator|(843) 792-3435|heisek@musc.edu|
20563405|NCT06066541|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
20563406|NCT04533022|Vicore Pharma AB|Chief medical officer Bertil Lindmark|+46 707661505|info@vicorepharma.com|
20563407|NCT02163447|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
20563408|NCT06240091|Woebot Health|Tim Campellone, PhD|(415) 209-5642|research@digitaltherapeutic.io|
20563409|NCT05415436|The University of Toledo Medical Center|Kristi Baker BSN, RN|4193836223|kristi.baker@utoledo.edu|
20563410|NCT04030130|Medical University of South Carolina|Evan Graboyes, MD, MPH|843-792-0719|graboyes@musc.edu|
20563411|NCT03157167|Navidea Biopharmaceuticals|Michael Blue, MD|6145714313|mblue@navidea.com|
20518384|NCT00969124|Avantis Medical Systems , Inc.|Jack Higgins, MD - Chief Medical Officer|4086367226|jhiggins@avantismedical.com|
20563412|NCT01939275|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
20518385|NCT05387408|Washington University|Dr. Ann Marie Dale, Principal Investigator|3144548470|amdale@wustl.edu|
20518386|NCT00496860|Altor Bioscience|Hing C. Wong, Chief Clinical Officer|9544438600|hingwong@altorbioscience.com|
20518387|NCT04462198|Pipeline Therapeutics, Inc.|Stephen Huhn, MD|858-333-5280|SHuhn@pipeline-tx.com|
20518388|NCT01202253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518389|NCT00000136|The Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
20563413|NCT03697070|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
20518390|NCT01897077|Johns Hopkins School of Medicine|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
20518391|NCT02786953|Vanderbilt University Medical Center|Sarah S Jaser|6153436775|sarah.jaser@vumc.org|
20518392|NCT05278858|University Hospitals Cleveland Medical Center|Dr. Sonal Shah, Director of Pediatric Dermatology|216-286-7285|Sonal.Shah@UHhospitals.org|
20518393|NCT00840658|University of California, San Diego|Steffanie Strathdee, PhD|(858) 822-1952|sstrathdee@ucsd.edu|
20518394|NCT04697173|Virginia Commonwealth University|Nikki Miller Ferguson MD|804-828-4080|nikki.millerferguson@vcuhealth.org|
20518395|NCT01632423|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20518396|NCT04848688|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
20518397|NCT00582205|University of Oklahoma|Dr. Joan Walker|405-271-8707|joan-walker@ouhsc.edu|
20518398|NCT05004649|University of Pennsylvania|Dr. David Brainard|215-573-7579|brainard@psych.upenn.edu|
20518399|NCT00301964|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
20518400|NCT02385708|Vanderbilt University Medical Center|Steven Klintworth|615-936-3298|steven.klintworth@vumc.org|
20518401|NCT01859637|Sandoz Biopharmaceutical, Hexal AG|Roumen Nakov|+49 8024 4764704|roumen.nakov@sandoz.com|
20518402|NCT01143337|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20518403|NCT02761915|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20518404|NCT04133311|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20518405|NCT02911909|University of Missouri|Ennio Rizzo|573-882-7615|eardvb@health.missouri.edu|
20518406|NCT00728754|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20518407|NCT01859598|The George Institute for Global Health at Peking University Health Science Center|Pro. Linong Ji|82800577|jiln@bjmu.edu.cn|
20518408|NCT00270634|Isotechnika Pharma Inc.|Robert Huizinga|780 487 1600|robert.huizinga@isotechnika.com|223
20518409|NCT00573313|University of California Davis|Dr. Charles H. Halsted|530-752-4054|chhalsted@ucdavis.edu|
20518410|NCT00835588|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518411|NCT01991548|Medtronic Diabetes|Clinical Research Manager|818-576-5000||
20518412|NCT00354159|Medtronic CRDM|REDUCEhf Clinical Research Specialist|1-800-328-2518|medtronicCRMtrials@medtronic.com|62736
20563414|NCT03484702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20563415|NCT01226979|SKCCC at Johns Hopkinis|Amol Narang, MD|(410) 955-7390|anarang2@jhmi.edu|
20563416|NCT02630823|Washington University School of Medicine|Premal Thaker, M.D., MSc.|314-362-1740|thakerp@wustl.edu|
20563417|NCT04272619|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|kristen.sorice@fccc.edu|
20563418|NCT02287311|Baylor College of Medicine|Dr. Rayne Rouce|832-824-4647|rouce@bcm.edu|
20563419|NCT05519228|ZimmerBio|Andrea Singer|(0)79 318 06 55|andrea.singer@zimmerbiomet.com|+41
20518413|NCT02229084|University of Arkansas for Medical Sciences|Sorena Lo|5016868274|SBLo@uams.edu|
20518414|NCT05128058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518415|NCT01868243|Hospital Ana Nery|Andre Rodrigues Duraes|+557191888399|andreduraes@gmail.com|
20518416|NCT00467597|Portland VA Health Care System (PORVAHCS)|Kathryn Chung, MD|503.220.8262|CHUNGKA@OHSU.EDU|51091
20518417|NCT05248399|The University of Texas Health Science Center at Houston|Maria E Fernandez Esquer, PhD|(713) 500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
20518418|NCT00379353|University of Texas M.D. Anderson Cancer Center|Dr. Eduardo Bruera, Professor|713-563-4157|ammarin@mdanderson.org|
20518419|NCT01050764|Stanford University Medical Center|Everett H Meyer, MD, PhD; Assistant Professor of Medicine|650-725-5816|evmeyer@stanford.edu|
20518420|NCT00924053|Theracos, Inc|Yuan-Di Halvorsen|617 726-4236|yhalvorsen@ccib.mgh.harvard.edu|
20518421|NCT00758758|Zimmer, Inc|Laura Herdrich, Sr. CRA|952-830-6224|laura.herdrich@zimmer.com|
20518422|NCT01929681|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
20518423|NCT01717040|Univeristy Hospitals Cleveland Medical Center|Carla Conroy, MPH|216-844-2871|carla.conroy@UHhospitals.org|
20518424|NCT04194151|Hospital Central de la Defensa Gomez Ulla|Dr. Paula Agostina VULLO|+34681054151|agosvullo@hotmail.com|
20563420|NCT05653856|Curium|Darcy Denner|314-506-3511|Solar@curiumpharma.com|
20563421|NCT04414644|University of Pennsylvania|Kelly Allison, PhD|215-898-2823|kca@pennmedicine.upenn.edu|
20563422|NCT05059262|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
20563423|NCT03414814|Seoul National University Hospital|Ji-Sook Kim|821025866440|kbj3075814@snu.ac.kr|
20518425|NCT03196284|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20518426|NCT03018925|Institut d'Investigació Biomèdica de Girona - Hosp Univ Dr Josep Trueta|MD PhD X Aldeguer|34972940200|xaldeguer.girona.ics@gencat.cat; abahi@idibgi.org|2401
20518427|NCT00087529|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20518428|NCT02282722|Dana-Farber Cancer Institute|Dr. Deb Schrag|617-582-8301|deb_schrag@dfci.harvard.edu|
20518429|NCT02233751|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
20518430|NCT01253564|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20518431|NCT01723202|The Ohio State University Comprehensive Cancer Center|Dr. Bhavana Konda|614-366-5068|Bhvana.konda@osumc.edu|
20518432|NCT03694197|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20518433|NCT01800838|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Elma Baron|216-368-4971|elma.baron@uhhospitals.org|
20518434|NCT04729101|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
20518435|NCT02940522|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20518436|NCT00274625|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
20518437|NCT00762411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518438|NCT02959840|Rutgers-Robert Wood Johnson Medical School|Dr. Shaul Cohen, M.D., Professor of Clinical Anesthesiology, Director of Obstetric Anesthesia|732-937-8841|cohensh@rwjms.rutgers.edu|
20518439|NCT02497235|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
20518440|NCT00377572|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20518441|NCT01273857|Okayama University Hospital|Prof. Hidemasa Oh|+81-086-235-6506|hidemasa@md.okayama-u.ac.jp|
20518442|NCT00769314|BioAlliance Pharma|Dr Pierre ATTALI|+33145587600|pierre.attali@bioalliancepharma.com|
20518443|NCT03480685|Avinger, Inc.|Thomas Lawson, PhD|650-241-7030|tlawson@avinger.com|
20518444|NCT00704496|milton s hershey medical center|timothy craig,|717-531-6525|tcraig@psu.edu|1
20518445|NCT01662024|Brigham and Women's Hospital|Christopher C. Thompson, MD, MSc|617-525-8266|ccthompson@bwh.harvard.edu|
20518446|NCT04768296|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20551464|NCT00969150|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20551465|NCT03305822|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20551466|NCT03087760|University of Pennsylvania|Ching Lai|267-250-9244|ching.lai@pennmedicine.upenn.edu|
20551467|NCT02573857|Medicines for Malaria Venture|Dr Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
20551468|NCT04128267|Vanderbilt-Ingram Cancer Center|Teresa Melton|(615) 936-7423|teresa.melton@vumc.org|
20551469|NCT04501666|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20551470|NCT01183897|Memorial Sloan Kettering Cancer Center|Brian Kushner MD|212-639-6793|kushnerb@mskcc.org|
20551471|NCT01364207|Massachusetts Eye and Ear Infirmary|Dr. Louis R. Pasquale|617-573-4240|aliya_jiwani@meei.harvard.edu|4240
20551472|NCT03439670|ReveraGen BioPharma Inc.|Dr. Eric Hoffman|301-762-7980|ericphoffman@gmail.com|
20551473|NCT03388294|University of North Carolina at Chapel Hill|Linda R. Watson, EdD|919-966-1007|lwatson@med.unc.edu|
20551474|NCT02626520|Essentia Health|Dr. Bret Friday|218-786-3625|bret.friday@essentiahealth.org|
20551475|NCT00535223|Atlanta VA Medical Center|David J. Ready,Ph.D.|(404) 321-6111|David.Ready@va.gov|7082
20551476|NCT01765153|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
20551477|NCT00319644|University of California, San Francisco|Julin Tang, MD|415-206-5274|tangj@anesthesia.ucsf.edu|
20551478|NCT03915496|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551479|NCT02663674|Duke Clinical Vaccine Unit|Emmanuel Walter, M.D., M.P.H.|919-620-5346|walte002@mc.duke.edu|
20551480|NCT02893878|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551481|NCT02472795|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+1 908 435 2675|viatrisinnovationclinicaltrials@viatris.com|
20551482|NCT04166513|Medical College of Wisconsin|Sara Pillay|414-955-4482|Sapillay@mcw.edu|
20563424|NCT04469036|UC Davis Health|Raynald Dizon|9167344736|rodizon@ucdavis.edu|
20563425|NCT06320964|University of California, San Francisco|Nadia Diamond-Smith, PhD, MS|(415) 502-5800|nadia.diamond-smith@ucsf.edu|
20563426|NCT03606642|HonorHealth Research Institute|Joanne Saczynski, MSN, RN, ACRP-CP|480-323-1046|jsaczynski@honorhealth.com|
20563427|NCT04737772|RVO Health|Helena Berlin|702-620-4965|hberlin@rvohealth.com|
20563428|NCT02549339|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20563429|NCT02728076|Froedtert and the Medical college of Wisconsin|Adam Currey, MD|414-805-4462|acurrey@mcw.edu|
20563430|NCT05106257|Rush University Medical Center|Amanda R. Mathew, PhD|(312 563-1273|amanda_mathew@rush.edu|
20563431|NCT04301778|Sidney Kimmel Cancer Center at Johns Hopkins|Lei Zheng, MD PhD|646-239-3110|Lzheng6@jhmi.edu|
20518447|NCT01863186|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
20518448|NCT00452348|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518449|NCT01490190|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20518450|NCT01390415|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20518451|NCT02560051|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
20518452|NCT02435433|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@Lilly.com|
20518453|NCT00072514|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
20518454|NCT01119625|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518455|NCT03237156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20518456|NCT02754492|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
20518457|NCT00217724|OHSU Knight Cancer Institute|Joseph Bublao|503-494-1054|bubaloj@ohsu.edu|
20518458|NCT00397254|Clinvest|M.E. Beach|417-841-3618|mbeach@clinvest.com|
20518459|NCT00210639|Janssen R&D US|Director, Clinical Research|1 609 730-3158||
20518460|NCT05014438|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20518461|NCT02627963|AVEO Pharmaceuticals, Inc.|AVEO Clinical Trial Office|857-400-0101|Clinical@aveooncology.com|
20518462|NCT03073798|Johns Hopkins University|Nadia N Hansel, MD MPH|410-550-2935|nhansel@jhmi.edu|
20518463|NCT01186458|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20518464|NCT05053360|Inova Health System|Jaimee Robinson, Labor and delivery Clinical Nurse Educator|7038586028|jaimee.robinson@inova.org|
20518465|NCT02372006|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518466|NCT00295490|University of Southampton|Dr Sarah Brien|07870642667|sbb@southampton.ac.uk|
20518467|NCT04473326|Brigham and Women's Hospital|Julie Lauffenburger, PharmD, PhD|617-525-8865|jlauffenburger@bwh.harvard.edu|
20518468|NCT02611362|Rhode Island Hospital|Dr. Larry K. Brown|(401) 793-8808|lkbrown@lifespan.org|
20518469|NCT00458822|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|LandauH@mskcc.org|
20518470|NCT03405363|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518471|NCT01328782|Children's Hospital Colorado|Gaia Georgopoulos, MD|720-777-2588|Gaia.Georgopoulos@childrenscolorado.org|
20518472|NCT00630253|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
20518473|NCT02533466|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518474|NCT01532908|MassBiologics|Director of Clinical Affairs|617-474-3000|Mblclinicaldirector@Umassmed.edu|
20518475|NCT01559116|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518476|NCT04610580|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20518477|NCT01993940|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
20518478|NCT03922750|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20518479|NCT03660787|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|1150
20518480|NCT01670097|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
20518481|NCT01824498|USDA, GFHNRC|Susan Raatz, PhD, RD|701-795-8294|susan.raatz@ars.usda.gov|
20518482|NCT01567527|Otsuka Pharmaceutical Development & Commercialization, Inc.|Joan Amatniek, Senior Director, Global Clinical Development|(609) 512-4464|joan.amatniek@otsuka-us.com|
20518483|NCT00325780|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
20518484|NCT02311894|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20518485|NCT04736537|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
20518486|NCT00537095|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20518487|NCT00533507|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518488|NCT01377441|NYU School of Medicine|Lisa Doan, MD|212.263.5072|lisa.doan@nyumc.org|
20518489|NCT02943096|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
20518490|NCT05065619|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
20529335|NCT04073303|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
20563432|NCT04820855|University of New Mexico Health Sciences Center|Dr. Angela Dao|5059678428|angela.dao@gmail.com|
20563433|NCT04838262|The University of Texas at Arlington|Dr. Jody Greaney|8172727891|jody.greaney@uta.edu|
20563434|NCT04539574|M.D. Anderson Cancer Center|Max Wintermark, MD|713-792-0845|mwintermark@mdanderson.org|
20518491|NCT00939523|Cedars-Sinai Medical Center|Odelia Cooper|310-423-4774|coopero@cshs.org|
20518492|NCT03786770|Revance Therapeutics, Inc.|Domenico Vitarella, Sr. Director, Clinical Development|510-742-3400|dvitarella@revance.com|
20563435|NCT04179149|Ponce Research Institute, Ponce Health Sciences University|Dr. Idhaliz Flores|787-840-2575|iflores@psm.edu|2206
20529336|NCT01158261|Ethicon, Inc|Director of Clinical Development|908-218-2492|jbatill2@its.jnj.com|
20563436|NCT03526861|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20563437|NCT03610490|M D Anderson Cancer Center|Amir A Jazaeri, MD|713-792-8578|aajazaeri@mdanderson.org|
20563438|NCT04382898|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20563439|NCT05956002|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563440|NCT02307565|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
20563441|NCT05849051|UNC Lineberger Comprehensive Cancer Center|Adam O Goldstein|919-270-6491|AOG@med.unc.edu|
20518493|NCT03790137|Massachusetts General Hospital|Dr. Elizabeth Thiele|6177266540|ethiele@mgh.harvard.edu|
20518494|NCT01528735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518495|NCT00556673|Novartis Pharmaceuticals|Study Director|862-778-8300||
20518496|NCT00494013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518497|NCT00421304|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20518498|NCT04750239|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
20518499|NCT01912807|University of Saskatchewan|Andrea Vasquez Camargo|306 7660444|a.vasquez@usask.ca|
20518500|NCT00903877|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
20518501|NCT02614196|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20518502|NCT00919711|Amgen Inc.|Study Director|866-572-6436||
20518503|NCT01562613|Abbott|Taco Baardman||taco.baardman@abbott.com|
20518504|NCT04388787|Virginia Commonwealth University|Olivier Rolin, MD, PhD|(804) 828-4230|olivier.rolin@vcuhealth.org|
20518505|NCT00663234|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20518506|NCT00840840|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518507|NCT05194202|Children's Mercy Hospital|Dr. Kimberly Randell|816-302-3503|karandell@cmh.edu|
20518508|NCT01639664|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Guido Bertolini|035 4535 313|guido.bertolini@marionegri.it|
20518509|NCT02710214|University of California, San Francisco|Dr. Riley Bove|415-595-2795|riley.bove@ucsf.edu|
20518510|NCT02832167|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20518511|NCT01754376|MGH Cancer Center|Ryan Sullivan|617-724-4000|rsullivan7@mgh.harvard.edu|
20518512|NCT04556734|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518513|NCT04264819|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20518514|NCT01680016|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20518515|NCT02937506|Mount Carmel Health System|Anantha Padmanabhan, MD|614-234-1079|apadmanabhan@mchs.com|
20518516|NCT01134198|new york state psychiatric institute|wilfrid raby, md|212-923-3031|wilfrid.raby@nyspi.columbia.edu|
20518517|NCT02846883|Roudebush VA Medical Center|Michael P. Murphy, MD|317-988-4049|mipmurph@iupui.edu|
20518518|NCT00927251|Medtronic, Bakken Research Center|Model 4296 Left Ventricular (LV) Lead Study Sr. CRS|+31-43-3566602|margriet.kruijshoop@medtronic.com|
20518519|NCT01550367|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
20518520|NCT04492397|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
20518521|NCT00442351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20518522|NCT05353036|Nationwide Children's Hospital|Dr. Joseph D. Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
20518523|NCT04489303|Photozig, Inc.|Bruno Kajiyama|6506947496|info@photozig.com|
20518524|NCT00603564|IRCCS Fondazione Po.Ma.Re, Milan, Italy|Roberto Cosentini, MD|00390255033602|roberto.cosentini@policlinico.mi.it|
20518525|NCT00108628|Philadelphia VA Medical Center|Dr. Richard Ross|(215) 823-4046|Richard.Ross2@va.gov|
20518526|NCT01453153|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
20518527|NCT01813435|Jessa Ziekenhuis, Hasselt, Belgium|Dr. Pascal Vranckx|+32 11 30 9589|pascal.vranckx@jessazh.be|
20518528|NCT02415387|Center for Biostatistics, The Ohio State University|Juan Peng|614-293-5869|juan.peng@osumc.edu|
20518529|NCT03035890|WVCTSI|Tara Riddle|304-581-1829|tlr0011@hsc.wvu.edu|
20551483|NCT04616547|Markey Cancer Center|Dr. Zin Myint|866-340-4488|zin.myint@uky.edu|
20551484|NCT00861146|Yale University School of Medicine|Ned L. Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
20551485|NCT01132482|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|Taylor-CousarJ@NJHealth.org|
20551486|NCT05333900|University of Minnesota|Alexander Khoruts|612-624-2101|khoru001@umn.edu|
20551487|NCT01277523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551488|NCT00302042|Northwestern University|Dr. Ronald T. Ackermann|3126036400|r.ackermann@northwestern.edu|
20551489|NCT03724812|Abbott|Angelic Roach|+1 651 756 3379|angelic.roach@abbott.com|
20551490|NCT01851720|Johns Hopkins School of Medicine|Alex Coon|410-955-2438|acoon2@jhmi.edu|
20551491|NCT01394523|Nationwide Children's Hospital|Tarun Bhalla, MD|6147224200|Tarun.Bhalla@nationwidechildrens.org|
20551492|NCT02389998|Boston Children's Hospital|Dr Samuel Nurko|6173556055|samuel.nurko@childrens.harvard.edu|
20551493|NCT01770379|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20551494|NCT01516957|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
20551495|NCT02929823|PPD|Joseph Pollard|+1 910 558 4428|joseph.pollard@ppdi.com|
20551496|NCT05855005|Northwestern University|Kendra Marks|2069991423|kendra.marks@northwestern.edu|
20551497|NCT02728895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20551498|NCT02769247|Walter Reed National Military Medical Center|Dr. Shana Miles|318 456 6389|shana.m.miles2.mil@mail.mil|
20551499|NCT04788953|Brigham and Women's Hospital|Dr. Kirsi-Marja Zitting|617-525-8339|kzitting@bwh.harvard.edu|
20518530|NCT03243396|Duke University|Kathryn Whetten, PhD, MPH|919-613-5313|k.whetten@duke.edu|
20518531|NCT04578132|An organization designated by the Sponsor|A person designated by the Sponsor|+34934344412|investigacion@mfar.net|
20518532|NCT05113563|NYSPI|Diana Martinez|646-771-7774|dm437@cumc.columbia.edu|
20518533|NCT01243151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518534|NCT00544167|Sarah Cannon Research Institute|John Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20518535|NCT02898740|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
20518536|NCT02413034|Hospital del Mar|Daniel Pérez-Prieto|0034932483196|dperezprieto@hospitaldelmar.cat|
20518537|NCT03343639|Chief Scientific Officer|Paul Kwon|650-486-1416|pkwon@menlotx.com|
20518538|NCT00076245|Department of Psychology, University of Vermont|Kelly J. Rohan, Ph.D.|802-656-0798|kelly.rohan@uvm.edu|
20518539|NCT00735696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518540|NCT02460835|University of Michigan Rogel Cancer Center|Dr. Theodore Lawrence|734-647-9955|tsl@umich.edu|
20518541|NCT02655224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20518542|NCT01151449|Princess Margaret Cancer Centre|Dr. Srikala Sridhar|416-946-2662|srikala.sridhar@uhn.ca|
20518543|NCT02951195|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20518544|NCT00963430|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
20518545|NCT00063258|University of Texas M.D. Anderson Cancer Center|Mellanie Price, B.S.|713-792-4392|mejprice@mdanderson.org|
20518546|NCT01250730|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518547|NCT04281472|Argenx|Regulatory manager|Please email:|regulatory@argenx.com|
20518548|NCT05109104|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20518549|NCT00897676|The Children's Hospital of Philadelphia|Diva DeLeon, MD|267-426-5529|deleon@email.chop.edu|
20518550|NCT01055834|Eisai Co., Ltd.|Kenya Nakai, Study Director|+81-3-3817-3865|k3-nakai@hhc.eisai.co.jp|
20518551|NCT01717313|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20518552|NCT00400634|Ceregene, Inc.|Raymond T. Bartus, Executive Vice President and Cheif Scientific Officer|858-458-8823|rtbartus@ceregene.com|
20518553|NCT00994604|Johns Hokpins Medical Institutions|Dr. Robert Brown|410-614-5451|rbrown2@jhmi.edu|
20518554|NCT01745094|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512 Ext:|motoko.ida@astellas.com|
20518555|NCT01097694|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
20518556|NCT02179190|Medtronic Plc|Senior Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
20518557|NCT01170715|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
20518558|NCT02571634|Womack Army Medical Center|Michael Bartoszek, MD|910-907-6000|michael.w.bartoszek.mil@mail.mil|
20518559|NCT00881569|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20518560|NCT03480022|Woman's Hospital|Director of Research|12252315278|karen.elkind-hirsch@womans.org|
20551500|NCT00469092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20518561|NCT02948426|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
20518562|NCT00668395|Indiana University School of Medicine|Zeruesenay Desta, PhD|317-274-2823|zdesta@iu.edu|
20518563|NCT03259165|Indiana University School of Medicine|Peter S. Pang|317-880-3900|ppang@iu.edu|
20518564|NCT01949532|Amgen, Inc.|Study Director|866-572-6436||
20518565|NCT05665387|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20518566|NCT01277510|Amgen Inc.|Study Director|866-572-6436||
20518567|NCT00021541|National Institutes of Health, National Cancer Institute|Brigitte Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
20518568|NCT01874535|Kaohsiung Chang Gung Memorial Hospital, Taiwan|Dr. Seng-Kee Chuah and Dr. Wei-Chen Tai|886-975056007|chuahsk@seed.net.tw|
20518569|NCT00784095|VA Health Services Research and Development|Dr. Karen Steinhauser|9196682148|karen.steinhauser@va.gov|
20518570|NCT01215721|UC Irvine|Thomas Ahlering, MD|714-456-6068|tahlerin@uci.edu|
20518571|NCT03828539|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20518572|NCT05263505|Washington University School of Medicine|Dr. Michael Paley, Director of the Ocular Rheumatology Clinic|314-273-7556|paleym@wustl.edu|
20518573|NCT02616380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20518574|NCT00826241|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|gilbertmr@nih.gov|
20518575|NCT00950300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20518576|NCT00538863|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602-910-2617|ldillaha@insysrx.com|
20551501|NCT02150954|Duke University Medical Center|Chad Grotegut , MD||chad.grotegut@dm.duke.edu|
20551502|NCT03642210|Medicines360|Emily Morris|415.951.8700|emorris@medicines360.org|
20551503|NCT01086540|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20551504|NCT03164928|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20551505|NCT01053819|University of Alabama at Birmingham|Boni Elewski, MD|205-502-9960|beelewski@gmail.com|
20551506|NCT03777007|Stanford University|Derek F. Amanatullah|(650) 723-2257|dfa@stanford.edu|
20551507|NCT05811234|Almirall S.A|Head of Global Clinical Development|+34932913000|gco@almirall.com|
20551508|NCT02707991|Johns Hopkins University|Laura Starbird|9787587909|Lstarbi1@jhu.edu|
20551509|NCT01770483|SIMS|Prof. Faisal Masud|00923004260213|faisalmasud@hotmail.com|
20551510|NCT00641862|Harvard T.H. Chan School of Public Health|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
20551511|NCT04519645|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20551512|NCT05074693|University of Houston|Michael Zvolensky, Ph.D.|713-743-8056|mjzvolen@Central.UH.EDU|
20551513|NCT04600414|University of Washington|John Fortney, Professor|2066856955|fortneyj@uw.edu|
20518577|NCT01596127|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Associate Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
20518578|NCT00438633|Massachusetts General Hospital|Dr. Neal Chen|6177264700|nchen1@partners.org|
20518579|NCT01539239|Ivantis|Richard Hope|949-333-1310|rhope@ivantisinc.com|
20518580|NCT00633022|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518581|NCT01994980|Denver Health|Dr Fredric Pieracci|303-436-4029|Fredric.Pieracci@dhha.org|
20518582|NCT01751087|Planned Parenthood League of Massachusetts, Inc.|Principal Investigator|617.616.1600||
20518583|NCT02061358|Emergent BioSolutions|Clinical Development Representative||ctgov@ebsi.com|
20518584|NCT03023709|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20518585|NCT00122447|Emory University School of Medicine|Mary Rhee, M.D.|404-778-1660|mrhee@emory.edu|
20518586|NCT04225260|Galderma Research & Development|Galderma Research & Development|817-961-5000|clinical.studies@galderma.com|
20518587|NCT01074008|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20518588|NCT00578968|Mayo Clinic|Bruce D. Johnson, PhD|507-284-4441|johnson.bruce@mayo.edu|
20518589|NCT00945334|Cedars-Sinai Medical Center|Mark Pimentel|3104233792|chuak@cshs.org|
20518590|NCT01350934|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20518591|NCT03547635|Integra LifeSciences|Jessica Knowlton, Sr Mgr, Clinical Research & PMCF Strategy|609-325-0111|jessica.knowlton@integralife.com|
20518592|NCT01011335|Uniformed Services University of the Health Sciences|David Tribble, MD, DrPH|301-816-8404|dtribble@idcrp.org|
20518593|NCT01435824|The Hospital for Sick Children|Dr. Shinya Ito|416-813-5776|shinya.ito@sickkids.ca|205776
20518594|NCT03028896|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|31
20518595|NCT00275275|University of Kansas Medical Center|Kelly E. Lyons, PhD|913-588-7159|klyons@kumc.edu|
20518596|NCT00117806|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli@va.gov|
20518597|NCT01765751|Palmer College of Chiropractic|Maruti R. Gudavalli, PhD|563-884-5260|gudavalli_r@palmer.edu|
20518598|NCT00859040|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
20518599|NCT02318550|Lancaster General Health|Project Manager|7175447395|Tawnya.Vernon@pennmedicine.upenn.edu|
20518600|NCT03167606|Columbia University|Dr. Rebecca Schnall, RN, MPH, PhD, Professor of Disease Prevention and Health Promotion (in Nursing)|212-342-6886|rb897@cumc.columbia.edu|
20518601|NCT00059332|UCLA, David Geffen School of Medicine|Dr. Jeffrey Saver|310-794-6379|jsaver@mednet.ucla.edu|
20518602|NCT02483416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518603|NCT04808908|University of Minnesota|Kevin Escandón|612-626-9344|escan012@umn.edu|
20518604|NCT02587143|Servicio de Urgencias, Hospital de Basurto, Bilbao, España|Dr. Ballesteros-Peña|(+34)946012804|sendoa.ballesteros@ehu.eus|
20518605|NCT03314857|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
20518606|NCT00555893|Marshfield Clinic Research Foundation|Edward Belongia, MD|715-389-3783|belongia.edward@mcrf.mfldclin.edu|
20518607|NCT01286805|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
20518608|NCT00152451|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20518609|NCT00323258|Duke University Medical Center|Sara Calvert, PharmD|919-668-7540|sara.calvert@duke.edu|
20518610|NCT04436198|Regional Clinical Investigation Program|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20518611|NCT00743145|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
20518612|NCT00697827|Synthes|Ann Marie Simon|610-719-5418|simon.annmarie@synthes.com|
20518613|NCT03174158|Massachusetts General Hospital|Dr. Gina Kruse|6177243157|gkruse@partners.org|
20518614|NCT02004691|Sanofi-Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20518615|NCT00884390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518616|NCT01152112|Hologic, Inc.|Christina Mastandrea / Clinical Research manager|5082638772|christina.mastandrea@hologic.com|
20518617|NCT01691612|Brigham & Women's Hospital|Elliot Israel, M.D.|617-732-8110|eisrael@partners.org|
20518618|NCT03617419|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
20518619|NCT02623218|AOMA Graduate School of Integrative Medicine|Dr. John Finnell|512-492-3057|jfinnell@aoma.edu|
20518620|NCT01726803|University of Utah|Julie Fritz|801-581-6861|julie.fritz@hsc.utah.edu|
20518621|NCT00759707|Brigham and Women's Hospital|Dr. Joshua Beckman|6175257053|jbeckman@partners.org|
20518622|NCT02805517|Loma Linda University Health|Dr. Duane Baldwin|909-588-4000|dbaldwin@llu.edu|44196
20518623|NCT01211262|Immunocore, LLC|Chris Holland, Executive Director Head of Biostatistics|1-267-589-9204|chris.holland2@immunocore.com|
20518624|NCT04207333|University of North Carolina at Chapel Hill|Lee Stoner, PhD, MPH|919-962-0534|stonerl@unc.edu|
20518625|NCT04049097|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
20518626|NCT02005276|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
20518627|NCT01970592|Medical University of South Carolina|Chris Gregory|8437921078|gregoryc@musc.edu|
20518628|NCT00499473|The Ohio State University Comprehensive Cancer Center|Robert Cavaliere, MD|614-293-4968|Robert.Cavaliere@osumc.edu|
20518629|NCT01320722|Brigham and Women's Hospital|John P Forman, MD||jforman@partners.org|
20518630|NCT03980522|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
20518631|NCT01091363|University of Massachusetts Medical School|Dr. Sun S Kim|201-388-2656|sun.kim@umb.edu|
20518632|NCT01689155|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
20518633|NCT00045162|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
20518634|NCT00936351|Roudebush VA Medical Center|Louanne W. Davis PsyD|317-988-4523|louanne.davis@va.gov|
20529337|NCT00971867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials.@bms.com|
20563442|NCT05873751|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563443|NCT03926819|Hillhurst Bio|President and CEO|858 232 9495|admin@hillhurstbio.com|
20563444|NCT02323321|TransMedics Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
20563445|NCT02500758|Universidad Complutense de Madrid|Dr. Ricardo Becerro de Bengoa Vallejo|914590409|ribebeva@enf.ucm.es|
20563446|NCT02345720|Johnson & Johnson Vision Care Inc.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
20563447|NCT02874534|University of North Carolina at Chapel Hill|Gabriel S. Dichter, PhD|9194450132|dichter@med.unc.edu|
20563448|NCT02923180|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Dr. Emmanuel Antonarakis|410-502-8341|eantona1@jhmi.edu|
20563449|NCT05198310|Kiniksa Pharmaceuticals, Ltd.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
20563450|NCT02926911|Duke university|Dr. Shelley Hwang|919-668-6688|shelley.hwang@duke.edu|
20563451|NCT04116736|Johnson & Johnson Vision Care (JJVC)|Graeme Young|+44(0) 1252 718719|g.young@visioncare.co.uk|
20563452|NCT00731341|Galil Medical|Joy Benson, CRA|651-287-5112|joy.benson@galilmedical.com|
20563453|NCT03526354|UMass Chan Medical School|Dr. Xiaoduo Fan|5088566463|xiaoduo.fan@umassmed.edu|
20563454|NCT06041139|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
20563455|NCT02317783|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah|
20563456|NCT04970654|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20563457|NCT04757610|Opthea Limited|Chief Officer|+61 (0) 3 9826 0399|info@opthea.com|
20563458|NCT03811366|Hospital das clínicas- Faculdade de Medicina da Universidade São Paulo|Dra Joyce Hisae Yamamoto|41988263757|vmsakata@yahoo.com.br|
20563459|NCT04277936|Vanderbilt University Medical Center|Stephan Heckers|6159222665|stephan.heckers@vumc.org|
20563460|NCT06450405|University of California, San Diego|Antoni Duleba|858-657-7000|aduleba@health.ucsd.edu|
20563461|NCT05338086|mAbxience Research S.L.|Susana Millan , PhD|(+34) 917.711.500|Susana.Millan@mabxience.com|
20563462|NCT03217565|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20563463|NCT03897686|RCBIOFORM|Julia Melentyeva Commercial Director|+7 (495) 223-70-95|md@bioform.ru|
20563464|NCT04052516|NorthSea Therapeutics BV|Chief Scientific Officer|31 035760 65 05|info@northseatherapeutics.com|
20563465|NCT03264131|UNC Lineberger Comprehensive Cancer Center|Melahat Garipagaoglu Canter|919-962-0000|Melahat_Canter@med.unc.edu|
20563466|NCT03819686|Emory University|Dr. Kimberly Jacob Arriola|404)-727-2600|kjacoba@emory.edu|
20563467|NCT05386355|University of Arkansas for Medical Sciences|Songthip Ounpraseuth|501-686-7233|stounpraseuth@uams.edu|
20563468|NCT06143670|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20563469|NCT04690673|Helsinki and Uusimaa Hospital District, Pain clinic|Dr Johanna Kujala|+358400780411|johanna.kujala@helsinki.fi|
20563470|NCT04712994|University of Washington|Anjuli Wagner|9784602331|anjuliw@uw.edu|
20563471|NCT04842643|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20563472|NCT01894061|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. David Peereboom|1-866-223-8100|TaussigResearch@ccf.org|
20563473|NCT04173663|Vanderbilt University Medical Center|Julie Lounds Taylor, PhD, principal investigator|615-343-5659|julie.l.taylor@vumc.org|
20563474|NCT03679611|Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network|Dr. Jean Wong, MD, FRCPC.|416-603-5800|tojean.wong@uhn.ca|3635
20563475|NCT03636503|Dana-Farber Cancer Institute|Caron Jacobson, MD|617-632-6404|caron_jacobson@dfci.harvard.edu|
20563476|NCT03089398|Icahn School of Medicine at Mount Sinai|Dr. Emilia Bagiella|212-659-9580|emilia.bagiella@mountsinai.org|
20563477|NCT05439603|Ancora Bio, Inc dba EmbarkNeuro|Chief Medical Officer|610 871-4891|info@embarkneuro.com|
20563478|NCT00579124|Children's Hospital of Philadelphia|Patricia Hankins|215 590 5168|hankinsp@chop.edu|
20563479|NCT03854578|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563480|NCT03896516|National Institute on Drug Abuse (NIDA)|Dr Lorenzo Leggio, M.D., Ph.D.|1-667-312-5188|lorenzo.leggio@nih.gov|
20563481|NCT05461131|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
20563482|NCT04172441|Zealand Pharma A/S|Charlotte Teglman Schiøler|+45 5060 3722|cschioler@zealandpharma.com|
20563483|NCT05783219|University of Louisville Medical Center|Rodger Rothenberger|(502) 588-7660|Rodger.rothenberger@louisville.edu|
20563484|NCT03739450|UT Southwestern Medical Center|Dr. Shannon Juengst|8328480674|Shannon.Juengst@UTSouthwestern.edu|
20563485|NCT04538417|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Zachary McCormick, MD|801-587-1493|u6014808@umail.utah.edu|
20563486|NCT05693610|Northwestern University|Varsha Rallapalli|847-467-0897|varsha8904@gmail.com|
20563487|NCT03984695|KUMCRI|Jaime Caldwell|913-588-1261|spa@kumc.edu|
20563488|NCT04549168|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
20563489|NCT04204278|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20563490|NCT02662062|ANZUP|Dr Anthony Uccellini - ANZUP Research fellow|61 2 9046 8954|trials@anzup.org.au|
20518635|NCT01044433|Abramson Cancer Center|Dr. Corey Langer|215-615-5121|Corey.Langer@uphs.upenn.edu|
20518636|NCT01540045|Instituto Nacional de Cancerología de México|Dr. Oscar Arrieta|5628-0400|ogarrieta@gmail.com|832
20518637|NCT01341405|CrystalGenomics, Inc|Sang-Yoon Lee, M.D.|82-31-628-2871|sang-yoon.lee@cgxinc.com|
20518638|NCT03407729|Case Western Reserve University|Dr. Michael J. Decker|2163682467|mjd6@case.edu|
20563491|NCT02097420|Abbott|Vinny Podichetty, Clinical Program Director|+1 779-209-9425|vinny.podichetty@abbott.com|
20563492|NCT04864912|Cochlear|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20563493|NCT03393975|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20563494|NCT02384317|ChemoCentryx|Study Director|650-210-2900|medinfo@amgen.com|
20518639|NCT01849458|Tornier Inc.|Marcela Bravo|9526837481|marcela.bravo@tornier.com|
20563495|NCT04950192|Philips IGTD|Rashmi Ram, Director of Clinical Development|719-464-6326|rashmi.ram@philips.com|
20563496|NCT04936035|Alnylam Pharmaceuticals|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20563497|NCT04401800|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20563498|NCT05751382|Dentsply Sirona Implants and Consumables|AnnaKarin Lungren Dr.|0046 702 666 492|annakarin.lundgren@dentsplysirona.com|
20563499|NCT05767437|University of Valencia|Jose casaña Granell|677361782|jose.casana@uv.es|
20518640|NCT04387617|Mayo Clinic|Karen L. Stern, M.D.|480-342-3868|Stern.Karen@mayo.edu|
20518641|NCT02413008|ITF Research Pharma SLU|Concepción Nieto Magro|0034916572323|concepcion@itfsp.com|
20518642|NCT00024258|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner|212-639-6793|kushnerb@mskcc.org|
20518643|NCT03950674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20518644|NCT01898598|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20518645|NCT03833427|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20518646|NCT00176891|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|(612) 626-2313|orcha001@umn.edu|
20518647|NCT02707276|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
20518648|NCT03711396|University of Colorado School of Medicine|Dr. Hillary D. Lum|303-724-1911|hillary.lum@cuanschutz.edu|
20518649|NCT03428945|Yale University|Dr. Kevan Herold|203-785-6507|Kevan.Herold@yale.edu|
20518650|NCT00982228|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20518651|NCT03231345|University Medical Center of Southern Nevada|Dr. Zitek|702-383-7885|zitek10@gmail.com|
20518652|NCT04841967|University of Illinois Chicago|Patricia Hershberger|3129961305|phersh@uic.edu|
20518653|NCT00360490|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20518654|NCT02179788|University of Cincinnati|Dr. Laurie Nommsen-Rivers|513-558-0461|laurie.rivers@uc.edu|
20518655|NCT00987480|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
20518656|NCT05135273|Laboratory of Malaria Immunology and Vaccinology, NIAID/NIH|Dr. David Cook|240.627.3066|david.cook@nih.gov|
20518657|NCT00968019|Johnson and Johnson Medical Iberia|Mayda Lopez-Belmonte, PhD|+34 91 7228481|tlopezbe@its.jnj.com|
20518658|NCT02569541|Arrevus, Inc.|Carl Kraus, MD (CEO)|9193665503|ckraus@arrevus.com|
20518659|NCT03460990|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20518660|NCT01109576|VHAPORHCS|Mitchel Turbin, PhD|503-220-8262|Bonnie.Becker@va.gov|
20518661|NCT01958060|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518662|NCT01705717|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20518663|NCT01188226|UCLA|Neal Garrett, MD||ngarrett@ucla.edu|
20518664|NCT04980456|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20518665|NCT02293460|LFB Biotechnologies|Clinical trial information desk|0033169827010|supportqcm@lfb.fr|
20518666|NCT01427881|Fred Hutchinson Cancer Research Center|Marco Mielcarek, MD|206-667-2827|mmielcar@fredhutch.org|
20518667|NCT00706719|Repros Therapeutics, Inc|Ronald Wiehle, PhD|281.719.3406|rwiehle@reprosrx.com|
20518668|NCT00500318|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20518669|NCT04284553|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
20518670|NCT00224484|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518671|NCT02805309|Hebrew SeniorLife Marcus Institute for Aging Research|Dr. Dae Hyun Kim, Associate Scientist|617-632-5362|daehyunkim@hsl.harvard.edu|
20518672|NCT01196117|Medical College of Wisconsin|B. Tucker Woodson|414-805-7667|bwoodson@mcw.edu|
20518673|NCT01636934|UT MD Anderson Cancer Center|Zhongxing Liao, MD/ Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
20518674|NCT03239496|FIDEC Corporation|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
20518675|NCT03687242|Spruce BioSciences Inc.|Spruce CMO, MD|415-655-4169|clinicaltrials@sprucebio.com|
20518676|NCT04632641|Aurora Health Care|Dr. Mahmoud Ali|(262) 948-6630|mahmoud.ali@aah.org|
20518677|NCT02383706|Duke University Medical Center|Dr Jennifer Dominguez|(919) 668-2024|jennifer.dominguez@dm.duke.edu|
20518678|NCT02153723|Montefiore Medical Center|Aleksandra Djukic|718 920 4378|adjukic@montefiore.org|
20518679|NCT02274558|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20518680|NCT01257581|Massachusetts General Hospital|Nazem Atassi, MD|617-643-1807|natassi@partners.org|
20518681|NCT01157234|University of Florida|Alfonso H. Santos Jr, M,D,|352-273-6374|Alfonso.santos@medicine.ufl.edu|
20518682|NCT03033134|Boston Scientific Japan|Yutaka Gomi|+81.3.6853.7500|Yutaka.Gomi@bsci.com|
20518683|NCT02212106|bioCSL PTY LTD|Clinical Program Director||bioCSL.ClinicalTrials@biocsl.com.au|
20518684|NCT02509260|Cleveland Clinic Foundation|Dr. David Liska|1-216-444-9219|liskad@ccf.org|
20518685|NCT01853371|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
20518686|NCT00517192|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518687|NCT01876953|City of Hope Medical Center|Ahmed Aribi|626-359-8111|aaribi@coh.org|
20518688|NCT00964353|University of Chicago|Dr David Meltzer|773-702-0836|dmeltzer@medicine.bsd.uchicago.edu|
20518689|NCT02733627|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518690|NCT02246764|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20518691|NCT01408888|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518692|NCT00487695|Johns Hopkins University School of Medicine Division of Gastroenterology and Hepatology|Dr. Marcia Canto.|410-614-5388|mcanto@jhmi.edu|
20518693|NCT02104817|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
20563500|NCT01772472|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20563501|NCT04391894|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20563502|NCT01889199|University of California, Los Angeles|Daniel A. Dumesic, MD|310-794-5542|DDumesic@mednet.ucla.edu|
20563503|NCT00446225|Fundación GECP|Eva Pereira|+34934302006|epereira@gecp.org|
20563504|NCT04450342|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20563505|NCT05633407|argenx BV|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20563506|NCT05741489|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
20563507|NCT00220740|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20563508|NCT01057433|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
20563509|NCT03361748|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20563510|NCT01762059|Massachusetts General Hospital|Dr. Steven J. Russell|617-726-1848|sjrussell@mgh.harvard.edu|
20563511|NCT03113422|Dana-Farber Cancer Institute|Mr Opeyemi Jegede|(617) 582-7613|ojegede@jimmy.harvard.edu|
20563512|NCT02318901|WRMC|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
20563513|NCT00084552|Fox Chase Cancer Center|Eric Horwitz|215-728-2995|Eric.Horwitz@fccc.edu|
20563514|NCT04774380|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20563515|NCT04774237|Visus Therapeutics, Inc.|Visus Therapeutics|800-281-4536|trials.info@visustx.com|
20563516|NCT04572750|VA Palo Alto Health Care System|Keith Humphreys, PhD|(650) 493-5000|keith.humphreys@va.gov|
20563517|NCT05005221|University of Michigan|Manjunath Pai|734/647-0006|amitpai@med.umich.edu|
20563518|NCT04455035|The University of Texas Health Science Center at Houston|Brett Chiquet, DDS, PhD, Associate Professor|7135008220|Brett.T.Chiquet@uth.tmc.edu|
20518694|NCT03490916|UMass Medical School|Principal Investigator|4136279111|vincent.kan08@gmail.com|
20563519|NCT03747484|Fred Hutchinson Cancer Center|Joshua Veatch|206.667.5108|jveatch@fredhutch.org|
20563520|NCT04563793|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20563521|NCT03625882|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20563522|NCT02643667|Washington University School of Medicine|Dr. Russell K. Pachynski|314-286-2341|rkpachynski@wustl.edu|
20563523|NCT05058391|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20563524|NCT02790931|University of Sao Paulo|Isabel de Camargo Neves Sacco|+551130918426|icnsacco@usp.br|
20563525|NCT03833245|University of Utah|Gerald Cochran, PhD|801-213-0799|jerry.cochran@hsc.utah.edu|
20563526|NCT05161715|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20563527|NCT03775109|Imperial College, London|Professor Mark Thursz|+44 (0) 203 3126454|m.thursz@imperial.ac.uk|
20563528|NCT05549726|UCSF|Tamara Clark|415-517-3444|tamara.clark@ucsf.edu|
20563529|NCT05110495|University of Oxford|Dr Simon Lord|01865 227212|simon.lord@oncology.ox.ac.uk|
20563530|NCT03931291|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20563531|NCT04402489|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|Please E-mail|information@mt-pharma-us.com|
20563532|NCT04847544|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20563533|NCT06391177|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
20563534|NCT03818191|Mayo Clinic|Victor Karpyak, MD, PhD|(507)284-8891|karpyak.victor@mayo.edu|
20563535|NCT05418296|Mentia|Dr Mandy Salomon|4156326872|mandy@mentia.me|
20563536|NCT02682316|Memorial Sloan Kettering Cancer Center|Dr. Mario Leitao, MD|212-639-3987|leitaom@mskcc.org|
20563537|NCT04630262|DePuy Synthes|Kelly Francher, Staff Clinical Research Scientist|574-241-6581|kfranche@its.jnj.com|
20518695|NCT04633642|Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain|Dr. Francisco Javier Álvaro Afonso|913-941-502|alvaro@ucm.es|+34
20518696|NCT00611884|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20518697|NCT00981799|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
20518698|NCT02167594|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20563538|NCT01195831|Leo Pharma|Malin Jaernkrants|+4544945888|malin.jaernkrants@leo-pharma.com|
20563539|NCT04419168|University of Pittsburgh|Dr. Charles Jonassaint|412-586-9850|cjonassaint@pitt.edu|
20563540|NCT05595629|Women & Infants Hospital of Rhode Island|Adam Lewkowitz|401-274-1122|alewkowitz@kentri.org|
20563541|NCT04640961|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20563542|NCT03713086|CureVac|CureVac SE|+49 (0) 697680587-0|clinicaltrials@curevac.com|
20563543|NCT05009251|Geisinger|Gail Rosenbaum|800-275-6401|grosenbaum@geisinger.edu|
20563544|NCT01582711|CDC|Andrey Borisov, MD, MPH, Study Director|(404) 639-3311|pha5@cdc.gov|
20563545|NCT02784509|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20563546|NCT05374837|Rutgers School of Public Health|Shauna Downs|973-972-7212|sd1081@sph.rutgers.edu|
20563547|NCT04049747|Imperial College London|Ms Puja Jadav|020 7594 7773|p.jadav@imperial.ac.uk|
20563548|NCT00676715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20563549|NCT02829814|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 799-8599|greg.sullivan@tonixpharma.com|
20563550|NCT04356027|Abbott|Tarn Teraphongphom, Principal Clinical Research Scientist|+1 (408) 931-0504|tarn.teraphongphom@abbott.com|
20563551|NCT04831281|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
20563552|NCT05249439|Imperial College London|Professor Tricia Tan|44 207 594 9048|t.tan@imperial.ac.uk|
20563553|NCT00616967|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|vstearn1@jhmi.edu|
20563554|NCT02910583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20563555|NCT03161379|Sidney Kimmel Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
20563556|NCT05449795|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
20563557|NCT05021640|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20563558|NCT04638829|Sobi,Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
20518699|NCT03433703|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20518700|NCT02181140|Interdisciplinary Endoscopy Department and Clinic University Hospital Hamburg-Eppendorf|Professor Dr. Thomas Rösch|+4940 7410|t.roesch@uke.de|50098
20518701|NCT01207752|Southern California College of Optometry at MBKU|Jerry Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
20518702|NCT01586039|Brigham and Women's Hospital|Dr. Steven W. Lockley|617-732-4977|slockley@hms.harvard.edu|
20518703|NCT02518139|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20518704|NCT01698554|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20563559|NCT04088630|Wake Forest University School of Medicine|Carol Kittel, Senior Biostatistician|336-399-3832|c.kittel@wakehealth.edu|
20563560|NCT03315754|Memorial Sloan Kettering Cancer Center, New York, NY, USA|Jonathan Coleman, MD|+1-646-422-4432|colemanj@mskcc.org|
20563561|NCT02954341|CHU de Lille - Institut Coeur Poumon|Dr Pascal De Groote|33 (0)3 20 44 50 38|Pascal.DEGROOTE@chu-lille.fr|
20563562|NCT03381261|Weill Cornell Medicine|Dr. Lisa Gfrerer|646.962.4250|lig4013@med.cornell.edu|
20563563|NCT05695989|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20563564|NCT04089371|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
20563565|NCT05229120|Henry Ford Health|Julia Felton, PhD|704-995-7832|jfelton4@hfhs.org|
20563566|NCT05134350|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20563567|NCT03932682|Seqirus|Clinical Trial Disclosure Manager|+1 855 358 8966|seqirus.clinicaltrials@seqirus.com|
20563568|NCT00601900|Memorial Sloan-Kettering Cancer Center|Maura Dickler, M.D.||dicklerm@mskcc.org|
20563569|NCT04410042|St. Jude Children's Research Hospital|Michael D. Neel, MD|901-259-1600|mneel@orthosouth.org|
20563570|NCT01494662|Dana-Farber Cancer Institute|Rachel Freedman, MD|617-632-3800|Rachel_Freedman@dfci.harvard.edu|
20563571|NCT04072822|Indiana University School of Medicine|Samer Gawrieh, MD|(317) 278-9326|sgawrieh@iu.edu|
20563572|NCT03526874|Children's Hospital of Philadelphia|Dr. Christina Szperka|12155901719|szperka@chop.edu|
20563573|NCT05268302|University of Maryland, Baltimore Center for Vaccine Development and Global Health (CVD)|Kirsten E. Lyke, MD|410-706-5328|klyke@som.umaryland.edu|
20563574|NCT02811679|Massachusetts General Hospital|Jeffrey Barnes, MD, PhD|6177244000|JABARNES@mgh.harvard.edu|
20563575|NCT00753090|Zimmer Biomet|Lisette Smid|0623956378|lisette.smid@zimmerbiomet.com|
20563576|NCT05574426|University of British Columbia|Dr. Jonathan Little|250-807-9876|jonathan.little@ubc.ca|
20563577|NCT05113966|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20563578|NCT02815813|Dartmouth-Hitchcock|Dr. Kelly Aschbrenner|603-440-7722|kelly.a.aschbrenner@dartmouth.edu|
20563579|NCT00837369|University of Nebraska Medical Center|Thomas Porter|402-559-5151|trporter@unmc.edu|
20563580|NCT02485834|Weill Medical College of Cornell University|Manish A. Shah MD|646-962-6200|mas9313@med.cornell.edu|
20518705|NCT02429583|The Rockefeller University|Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
20563581|NCT03347383|iD3 Medical|Clinical Research Professional|+32 (0)52252745|office@iD3medical.com|
20563582|NCT04030169|Lykos Therapeutics|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|877-627-7722|trialdata@lykospbc.com|
20563583|NCT05691452|Vanderbilt University School of Nursing|Dr. Chorong Park|6153436075|chorong.park@vanderbilt.edu|
20518706|NCT01943435|University of Pittsburgh|Michael Schneider, PhD, DC - Associate Professor and Principal Investigator|412-383-6640|mjs5@pitt.edu|
20518707|NCT01412281|Crucell Switzerland|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20518708|NCT01728636|Northwestern University|Luanne Carabini MD|312-695-0061|l-carabini@northwestern.edu|
20518709|NCT01617096|International Partnership for Microbicides|Dr John Steytler|+27218602300|jsteytler@ipmglobal.org|
20518710|NCT01753362|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
20518711|NCT01936662|IndianaU|Nicole Horn, MD|3179449981|ndhorn@hotmail.com|
20518712|NCT02046122|Duke University|Anthony Sung, MD|919-668-1002|anthony.sung@duke.edu|
20518713|NCT00106106|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
20518714|NCT04535986|Verona Pharma plc|Chief Medical Officer|See email|info@veronapharma.com|
20518715|NCT01196390|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20518716|NCT00252564|US Oncology|Allen L. Cohn|303- 388-4876|Allen.Cohn@USOncology.com|
20518717|NCT01632215|Federal University of São Paulo|Dr. Rioko K. Sakata|055 11 5084 7463|riokoks.dcir@epm.br|
20518718|NCT01885897|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
20518719|NCT03141151|Vanderbilt University Medical Center|William Heerman, MD MPH|615-322-7080|bill.heerman@vumc.org|
20518720|NCT04561115|Grifols Therapeutics LLC|Rhonda Griffin|+1 919 757 1744|rhonda.griffin@grifols.com|
20518721|NCT03732833|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
20518722|NCT05068661|Duke University School of Medicine|Dr. Ashraf Habib|9196682024|habib001@mc.duke.edu|
20563584|NCT03604263|Medtronic CRHF|Krestyn Thomas|6123236613|krestyn.j.thomas@medtronic.com|
20518723|NCT02099318|University Hospitals Cleveland Medical Center|Valerie Cwiklinski Clinical Research Nurse|216-983-5144|valerie.cwiklinski1@uhhospitals.org|
20518724|NCT01863433|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20518725|NCT03490227|Pennington Biomedical Research Center|Dr. Leanne Redman|225-763-0947|leanne.redman@pbrc.edu|
20518726|NCT00697619|Sun Yat-sen University Cancer Centre|Dr. Li Zhang|86-20-87343458(O)|zhangli6@mail.sysu.edu.cn|
20518727|NCT00288704|Regeneron Pharmaceuticals|Doug Nadler, MS Statistics|914 345 7905|clinicaltrials@regeneron.com|
20518728|NCT01579006|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20518729|NCT00799708|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20563585|NCT05902793|The Second Affiliated Hospital of Zhejiang University School of Medicine|Dr. Zhijun Pan|0571-87783777|zepzj@163.com|
20563586|NCT05121740|PharmaMar, S.A.|Clinical Development Virology Business Unit PharmaMar|91 846 60 00|virologytrials@pharmamar.com; clinicaltrials@pharmamar.com|
20563587|NCT04311996|University of Minnesota|Bonny Donzella|6126244351|donzella@umn.edu|
20563588|NCT03676582|Sheffield Teaching Hospitals NHS Trust|Lise Sproson|07753827428|Lise.Sproson@nihr.ac.uk|
20563589|NCT03744936|Mayo Clinic|Dr. Victor Montori|507-284-1920|montori.victor@gmail.com|
20563590|NCT03328702|University of California, Davis|Dr. Peter Belafsky|8582053366|pcbelafsky@ucdavis.edu|
20563591|NCT05993078|Tianjin Medical University General Hospital|Jiayue Ding|18518347837|sjnkzz2@163.com|
20563592|NCT04674358|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20563593|NCT05382936|Stemline|Carlos Garay, M.D.|877-332-7967|clinicaltrials@menarinistemline.com|
20563594|NCT03703700|Center for Reproductive Medicine, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Dr. Dongzi Yang|8602081332233|yangdz@mail.sysu.edu.cn|
20563595|NCT03101904|Bangor Univeristy|Dr Jamie Hugo Macdonald|+44 1248 38|j.h.macdonald@bangor.ac.uk|3272
20563596|NCT05114460|New York State Psychiatric Institute|Jermaine Jones PhD: Research Scientist/Associate Professor|646 774-6113|jermaine.jones@nyspi.columbia.edu|
20563597|NCT04703322|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20563598|NCT04638998|University of Alabama at Birmingham|Dr. Jarred Younger|205-975-5821|youngerlab@uab.edu|
20563599|NCT03262779|Yale School of Medicine|Scott Gettinger, MD|(203) 200-5864|scott.gettinger@yale.edu|
20563600|NCT03988634|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20518730|NCT00880334|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard/edu|
20563601|NCT05406921|AMGA|Elizabeth Ciemins, PhD, SVP Research|4062813275|eciemins@amga.org|
20563602|NCT04299009|Pittsburgh VA Healthcare System|Isabella Soreca|412 3606815|Isabella.Soreca@va.gov|
20563603|NCT05061095|Lineberger Comprehensive Cancer Center|Dr. Daniel Richardson|(919) 966-4432|daniel_richardson@med.unc.edu|
20563604|NCT02207062|University of Washington|Dr. Ajay Gopal, Professor|206-606-2037|agopal@uw.edu|
20563605|NCT04263311|NYU Langone Health|Jennifer Zanowiak|(646) 501-3502|Jennifer.Zanowiak@nyulangone.org|
20563606|NCT03958955|LEO Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20518731|NCT02473393|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20518732|NCT01149434|Huntsman Cancer Institute Unversity of Utah|Sunil Sharma, MD|801-585-0255|sunil.sharma@hci.utah.edu|
20518733|NCT01775722|University of California, Irvine. Beckamn Laser Institute|J Stuart Nelson|9498247997|jsnelson@uci.edu|
20518734|NCT05393271|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20518735|NCT02048813|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20563607|NCT04673929|The Royal Marsden Hospital|Professor Vinidh Paleri|02078082732|vinidh.paleri@rmh.nhs.uk|
20518736|NCT01708954|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20518737|NCT05996198|NYU Langone Health|Heidi Schambra, MD|212-598-6000|Heidi.Schambra@nyulangone.org|
20518738|NCT01192776|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
20518739|NCT03542344|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518740|NCT03408730|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
20518741|NCT00413049|Novartis Pharmaceuticals|Study Director|862 778-8300||
20518742|NCT01884844|Department of Psychiatry, Universtity of Massachusetts|Director of the Bipolar Disorders Specialty Clinic|508-334-5052|wendy.marsh@umassmemorial.org|
20518743|NCT00287053|Pennington Biomedical Reseach Center|Corby Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
20518744|NCT00695110|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
20518745|NCT00264381|University of Oklahoma Health Sciences Center|Suman Rathbun MD,MS|405271-4742|suman-rathbun@ouhsc.edu|44773
20518746|NCT03211039|Rady Children's Institute for Genomic Medicine|Dr. Stephen F. Kingsmore|816 854 0882|skingsmore@rchsd.org|
20518747|NCT02575339|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20518748|NCT04675775|University of Michigan|Elliot Tapper|734-647-9252|etapper@med.umich.edu|
20518749|NCT05431777|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20518750|NCT02340780|Canadian Cancer Trials Group|Bingshu Chen|613-533-2430|bchen@ctg.queensu.ca|
20518751|NCT01957150|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20518752|NCT02985398|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20518753|NCT01653405|Rand Corporation|Dr. Adam Rose|617-338-2059|arose@rand.org|8672
20518754|NCT00283842|Wyeth|U.S. Contact Center||clintrialresults@wyeth.com|
20518755|NCT00550147|Indiana University School of Medicine|David W. Dunn, MD|317-944-8162|ddunn@iupui.edu|
20518756|NCT04320745|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20518757|NCT00046839|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20518758|NCT02472639|Cedars Sinai Medical Center|Karen Zaghiyan, MD|310-289-9224|kzaghiyan@yahoo.com|
20563608|NCT02927769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20563609|NCT05082909|Imperial College London|Dr Timothy Rawson|07891750151|antibiotic.research@imperial.ac.uk|
20518759|NCT00751023|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
20518760|NCT04768114|Washington University School of Medicine|Alex T. Ramsey, Ph.D.|314-362-5370|aramsey@wustl.edu|
20563610|NCT05227209|Sumitomo Pharma America Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@suniovion.com|
20529338|NCT00367003|Emory University|Dr. Patricio Riva Posse||privapo@emory.edu|
20563611|NCT04024813|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20563612|NCT05493787|Geisinger|Gail Rosenbaum|570-243-1199|grosenbaum@geisinger.edu|
20563613|NCT04783935|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20563614|NCT01600222|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20563615|NCT05275842|Medical University of South Carolina|Cristina Lopez|843-792-2945|lopezcm@musc.edu|
20563616|NCT04419389|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20563617|NCT05493423|Hemotek Medical Inc|Chief Scientific Officer|7074942895|patrick@hemotekmedical.com|
20563618|NCT06074523|Lehigh University|Nancy Carlisle|610-758-5122|nbc415@lehigh.edu|
20563619|NCT04140708|Vanderbilt University Medical Center|Dr. Daniel Claassen|615-322-6103|daniel.claassen@vumc.org|
20563620|NCT01253824|Nobelpharama|Department director of clinical development department 1|+81-23-5651-1177|murakami@nobelpharma.co.jp|
20563621|NCT05524233|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20563622|NCT03070184|The University of Alabama at Birmingham|Nehal Vekariya, MS - Clinical Research Coordinator III|2059347173|nvekariya@uabmc.edu|
20563623|NCT05327101|Abbott Medical Devices|Stephanie Delgado|818-493-3285|stephanie.delgado1@abbott.com|
20563624|NCT04638309|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20563625|NCT05337748|University of Pretoria|Professor De Wet Swanepoel|+27827824009|dewet.swanepoel@up.ac.za|
20563626|NCT02506959|The University of Texas MD Anderson Cancer Center|Yago Nieto, MD / Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderosn.org|
20563627|NCT04969419|Momentum Data Ltd|Dr Andrew McGovern|+44 7531221970|andy.mcgovern@momentumdata.co.uk|
20563628|NCT03453619|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20563629|NCT04321031|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563630|NCT02900924|Veryan Medical|Nick Yeo|+441403258984|nick.yeo@veryanmed.com|
20563631|NCT04080531|Emory University|Craig C. Hofmeister, MD, MPH|404-778-0519|craig.hofmeister@emory.edu|
20563632|NCT05536440|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563633|NCT03940963|Axogen|Stacy Arnold, VP of Product Development and Clinical Research|770-833-2570|sarnold@axogeninc.com|
20563634|NCT01198366|Aeras|Product Director|301-547-2919|blandry@aeras.org|
20563635|NCT04812535|InflaRx GmbH|Dr. Camilla Chong, CMO|+49 3641-508-180|camilla.chong@inflarx.com|
20563636|NCT03436745|National Cancer Institute|William D. Figg, Pharm.D.|240-760-6179|figgw@mail.nih.gov|
20563637|NCT02589275|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
20563638|NCT00931710|Novartis Pharmaceuticals|Study Director|862-778-8300||
20563639|NCT05671029|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
20563640|NCT03338790|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20563641|NCT05592418|AIM ImmunoTech Inc.|Diane Young|352-448-7797|diane.young@aimimmuno.com|
20563642|NCT03822845|University of Iowa Health Care|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
20563643|NCT02386371|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
20563644|NCT05481320|UC Davis|Ladson Hinton, MD|9167343485|lwhinton@ucdavis.edu|
20563645|NCT06365086|University of Texas at Austin|Sara Hussain, PhD|5122322686|sara.hussain@austin.utexas.edu|
20563646|NCT04314895|NanOlogy, LLC|Mark Mitchell|8179004074|mark.mitchell@dfb.com|
20563647|NCT03930342|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu|
20563648|NCT02520063|UAB|Erica Stringer-Reasor|2059759375|esreasor@uabmc.edu|
20563649|NCT04521478|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563650|NCT05062265|Atlantic Orthopaedic|Dr. Ashley Suttmiller|7573213300|suttmilera@atlanticortho.com|6283
20563651|NCT04236856|Corindus|Clinical Scientist|6173012445|hamid.rai@siemens-healthineers.com|
20518761|NCT01685008|MorphoSys AG|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
20563652|NCT04975880|Quanta Dialysis Technologies|Dr. Paul Komenda|(204) 510-5219|paul.komenda@quantadt.com|
20563653|NCT03692676|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563654|NCT01180634|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
20563655|NCT03692611|University of Pittsburgh|Dr. Jessica Merlin|(412) 383-0617|merlinjs@upmc.edu|
20563656|NCT04868227|University of Edinburgh|Professor Malcolm Dunlop|+44 (0) 131 651 8602|malcolm.dunlop@ed.ac.uk|
20563657|NCT04490915|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20563658|NCT06311084|Imperial College London|Dr Martina Di Simplicio|0208 383 4162|m.di-simplicio@imperial.ac.uk|
20563659|NCT04725240|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20563660|NCT03222128|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
20563661|NCT04453592|FIFA|Dr Andreas Serner|+41796253899|andreas.serner@fifa.org|
20563662|NCT04092387|University of Vermont|Stephen T. Higgins, PhD|802-735-6267|stephen.higgins@uvm.edu|
20563663|NCT02312960|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20563664|NCT04060355|Emory University, School of Nursing|Kenneth Hepburn, PhD|404-712-9286|khepbur@emory.edu|
20563665|NCT01140880|Friends Research Institute, Inc.|Dr. Cathy J. Reback|323-463-1601|reback@friendsresearch.org|
20563666|NCT02724878|Dana-Farber Cancer Institute|Toni Choueiri|617-632-5456|toni_choueiri@dfci.harvard.edu|
20518762|NCT01321177|Northwell Health|Patricia Marcy|347-439-8035|pmarcy@northwell.edu|
20563667|NCT03779204|Unity Health Toronto|Dr. Naomi Thulien|647-460-0781|naomi.thulien@unityhealth.to|
20563668|NCT04421378|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20563669|NCT04258709|University of Pittsburgh|Dr. Jill Demirci|412-648-9236|JVR5@pitt.edu|
20563670|NCT02592330|Massachusetts Eye and Ear|Michael Cheung, MS, CCRP (Clinical Research Project Manager)|617-573-6981|mcheung0@meei.harvard.edu|
20563671|NCT03090152|Hospital for Special Surgery|Dr. Kethy Jules-Elysee|2126061036|JulesElyseeK@HSS.EDU|
20563672|NCT02807636|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20518763|NCT03720704|W. L. Gore & Associates|Austin Phillips|+1 928 864 3641|agphilli@wlgore.com|
20563673|NCT03175029|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3293-2455|toiawase@taiho.co.jp|
20563674|NCT05633953|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
20563675|NCT02729311|University of California, San Francisco|Deborah Barnes, PhD|415-221-4810|Deborah.Barnes@ucsf.edu|4221
20563676|NCT04034251|National Cancer Institute|Dr. Andrew Blakely|240-760-7647|blakelyam@nih.gov|
20563677|NCT05034952|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20563678|NCT02287610|Horizon Pharma Ireland, Ltd.|Mike Marshall, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
20563679|NCT00961571|Georgetown University, Department of Medicine and Oncology|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
20563680|NCT05862870|UConn Health|Mark D. Litt, PhD|860-679-4680|Litt@uchc.edu|
20563681|NCT04541706|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563682|NCT05974046|Clinical Development|Global Director|(804) 594-4488|trialdisclosure@indivior.com|
20563683|NCT05323084|Pennington Biomedical Research Institute|Prachi Singh|15072068331|prachi.singh@pbrc.edu|
20563684|NCT03846505|Medical University of South Carolina - Institute of Psychiatry|Stacey Sellers, Lab Manager|8437925807|sellersst@musc.edu|
20563685|NCT05611073|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
20563686|NCT05319860|University of Miami|Dr. Debbie Anglade|305-284-2388|d.anglade@miami.edu|
20563687|NCT03941860|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20563688|NCT05328648|University of North Carolina at Chapel Hill|Emilia Goland, MMSc|919-966-2017|emilia_goland@unc.edu|
20563689|NCT01361711|Northwestern University|Shuo Ma, MD, PhD|312-908-5250|shuo-ma@northwestern.edu|
20563690|NCT02596126|Centro Nacional de Investigaciones Cardiovasculares Carlos III F.S.P (CNIC)|Antonio J Quesada, PhD|+34 914531200|aquesada@cnic.es|(#1163)
20563691|NCT03717506|Gage Development Company|Gage Development Clinical Trials|1-847-999-0600|clinicalinfo@capstonedevservices.com|
20563692|NCT03748342|UT Southwestern Medical Center|Dr. Tiffany Moon|469/419-5790|Tiffany.Moon@UTSouthwestern.edu|
20563693|NCT05792423|MGH|Anthony Samir|6176432009|asamir@mgh.harvard.edu|
20563694|NCT02471638|Endologix|Tammy Stiver|5136731452|tstiver@endologix.com|
20563695|NCT01328262|Haukeland University Hospital|Elin Opheim Netland|+4755976050|elin.opheim.netland@helse-bergen.no|
20563696|NCT05529966|Stanford University|Robert T. Chang, MD|650-725-5743|christyr@stanford.edu|
20563697|NCT04578912|University of Minnesota|Christine Conelea|(612) 261-3127|cconelea@umn.edu|
20563698|NCT02187003|Biossil Inc.|Head of Regulatory|978-245-7397|debora@biossil.ai|
20563699|NCT05816551|Institute for Exercise and Environmental Medicine|Craig Crandall, PhD, Primary Investigator|214-345-4623|craigcrandall@texashealth.org|
20563700|NCT02379156|James J. Peters VA Medical Center|John P. Handrakis|718-584-9000|John.Handrakis@va.gov|3129
20563701|NCT04593472|Johns Hopkins Bloomberg School of Public Heath|Dr. Jennifer Wolff|4105020458|jwolff2@jhu.edu|
20563702|NCT05159583|University of California, Berekeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
20563703|NCT04833777|University of Saskatchewan|Dr. David Sauder|306-955-9800|sauderdave@gmail.com|
20563704|NCT01525966|City of Hope Medical Center|Dr. Yuan Yuan|626-359-8111|Yuyuan@coh.org|
20563705|NCT03648840|Indiana University - Indianapolis|Dr. Martin H. Plawecki, MD, PhD|317 944 8164|mplaweck@iu.edu|
20563706|NCT03158805|Lindner Center of HOPE|Susan McElroy|5135360700|susan.mcelroy@lindnercenter.org|
20563707|NCT05063994|Diurnal Limited|Clinical Trials Information|+44 (0) 292 068 2069|info@diurnal.co.uk|
20563708|NCT05543746|University of North Carolina at Chapel Hill|Rachel Kozik|919-590-0813|rachel_kozik@med.unc.edu|
20563709|NCT03149315|Johns Hopkins University School of Medicine|Melanie Dispenza, MD, PhD|410-550-1815|mdispen1@jhmi.edu|
20563710|NCT04600323|University of Colorado Denver|Dr. Jessica Kendrick|3037244837|jessica.kendrick@cuanschutz.edu|
20563711|NCT03841669|AdventHealth Research Institute|Dr. Kirk I. Erickson|4125763724|Kirk.Erickson@adventhealth.com|
20563712|NCT01331005|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
20518764|NCT02013050|Soligenix, Inc.|Dr. Richard Straube||rstraube@soligenix.com|
20563713|NCT03205800|University of Maryland, Baltimore|Se-Lim Oh|4107063708|soh@umaryland.edu|
20563714|NCT02193958|FUJIFILM Pharmaceuticals U.S.A, Inc.|Vice President of Clinical Operations|(617) 945-3763|fphucontact@fujifilm.com|
20563715|NCT05264376|Stanford University|Dr. Eric Stice|650-723-7885|estice@stanford.edu|
20563716|NCT03016169|Abbott|Karine Miquel, Associate Director of Project Management|+32 479 600 107|karine.miquel@abbott.com|
20563717|NCT03131648|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
20563718|NCT02496780|University of Minnesota|Antoinette Moran|612-624-5409|moran001@umn.edu|
20563719|NCT05680675|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
20518765|NCT01285076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20518766|NCT00715676|Deltanoid Pharmaceuticals|Hector F. DeLuca, President and Chief Executive Officer|608-238-7710|info@deltanoid.com|
20518767|NCT01963260|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529339|NCT00905424|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20563720|NCT04150718|University of Pennsylvania|Dr. Jennifer Goldschmied|215-573-2774|jrgolds2@pennmedicine.upenn.edu|
20529340|NCT00379899|Amgen Inc.|Study Director|866-572-6436||
20563721|NCT05150860|San Diego State University|Assistant Vice President for Research Support Services|(619) 594-5938|rgulizia@sdsu.edu|
20563722|NCT03164980|NOGGO e.V.|Jasmin Yamamoto|+49 30 4036865 32|jasmin.yamamoto@noggo.de|
20563723|NCT05324124|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20563724|NCT04950660|Children's Mercy Kansas City|Anne Stuedemann MSN, RN, CPNP|8162343693|astuedemann@cmh.edu|
20563725|NCT02111798|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
20563726|NCT03761537|LEO Pharma A/S|Disclosure|44 94 58 88|disclosure@leo-pharma.com|+45
20563727|NCT02437318|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20563728|NCT06093659|Imperial Brands PLC|Tasnim Abusalem|+44 (0) 117 332 2343|tasnim.abusalem@impbrands.com|
20563729|NCT00512070|VA Puget Sound Health Care System|Amanda Wood, PhD|253-583-1652|amanda.wood@va.gov|
20563730|NCT03818659|University of California, San Francisco|Dr. Mark Pletcher|415-514-8008|mark.pletcher@ucsf.edu|
20563731|NCT03143153|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20563732|NCT04237298|NUMalaysia|Dr Asma Ashari, Orthodontist and Senior Lecturer, Principal Investigator|+60192228440|asmaashari@ukm.edu.my|
20563733|NCT02530671|University Kiel|Dr. Sonja Sälzer|00494315972810|saelzer@konspar.uni-kiel.de|
20563734|NCT05448651|Upstream Bio|Sumathi Sivapalasingam, Vice President of Clinical Development|917-499-0789|sumathi.sivapalasingam@upstreambio.com|
20563735|NCT05551195|Woebot Health|Kate Martin|(415) 209-5642|kate@woebothealth.com|
20563736|NCT04251299|University of New Mexico|Dr. Cindy Blair|15059257907|CiBlair@salud.unm.edu|
20563737|NCT05722704|Gulf Medical University|Dr. Rania Zaarour|+971 6 7431333|dr.rania@gmu.ac.ae|4184
20563738|NCT03094663|Hospital for Special Surgery, Anesthesiology|Dr. David Kim|2126061036|kimd@hss.edu|
20563739|NCT01566695|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20563740|NCT04882449|Bodyport Inc.|Dorothy Kwok, Head of Clinical Operations|669-240-3077|dorothy@bodyport.com|
20563741|NCT03763708|Medtronic Neuromodulation|SCS Research Study Team|800-633-8766|rs.scsresearch@medtronic.com|
20563742|NCT01416831|Earle A. Chiles Research Institute, Providence Cancer Institute|Brendan Curti, M.D.|503-215-6588|brendan.curti@providence.org|
20563743|NCT05470400|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20563744|NCT04784559|PharmaMar|Clinical Development Virology Business Unit|+34 918466000|virologytrials@pharmamar.com|
20563745|NCT04294225|Mayo Clinic|Tufia C Haddad MD|507/284-2511|Haddad.Tufia@mayo.edu|
20563746|NCT02790502|Department of Agriculture, Environmental and Development Economics, Ohio State University|Brian Roe|614-688-5777|roe.30@osu.edu|
20563747|NCT03661840|University of Colorado Hospital|Elissa Kolva, MD|7208488090|elissa.kolva@va.gov|
20563748|NCT04927065|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20563749|NCT03924986|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20563750|NCT04922502|Baylor College of Medicine|Dr. Eric Storch|(713) 798-3579|eric.storch@bcm.edu|
20563751|NCT05147155|University of Thessaly|Research Committee - Special Account for Research Grants University of Thessaly|+306971894688|raniakotsiou@gmail.com|
20563752|NCT03562377|LEO Pharma A/S|Disclosure|+45|disclosure@leo-pharma.com|44945888
20563753|NCT04831216|University of Arkansas for Medical Sciences|Krista Langston|479-713-8000|KNLangston@uams.edu|
20563754|NCT04739956|Imperial College Healthcare NHS Trust|Dr Margaret Pikovsky|+447870276373|m.pikovsky@nhs.net|
20563755|NCT05371652|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563756|NCT03978871|University of Illinois, Urbana-Champaign|Dr. Karen Rudolph|217-333-8624|krudolph@illinois.edu|
20563757|NCT03095274|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
20563758|NCT03964350|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20563759|NCT04222660|Iowa City VA Healthcare System|Dr. Mark Yorek|13193380581|mark.yorek@va.gov|637696
20563760|NCT05098795|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
20563761|NCT03394846|University of South Carolina|Robert Glenn Weaver|8037775605|weaverrg@mailbox.sc.edu|
20563762|NCT04501861|Cleveland Clinic Foundation|Dr. Mariya Geube|216-444-2779|Geubem@ccf.org|
20563763|NCT04234698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563764|NCT01007591|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20563765|NCT04083235|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
20563766|NCT00920621|Brigham and Women's Hospital|Scott T. Weiss, MD, MS|617-525-2278|scott.weiss@channing.harvard.edu|
20563767|NCT01426425|Medtronic|Jo Krueger, Senior Clinical Research Specialist|7635261551|jo.krueger@medtronic.com|
20563768|NCT04956861|University of Colorado|Christopher DeSouza Ph.D.|303-492-2988|desouzac@colorado.edu|
20563769|NCT02891096|Swiss Paraplegic Research|Dr Gabi Mueller|+41419395563|gabi.mueller@paraplegie.ch|
20563770|NCT05285618|University of California, Santa Barbara|Michael Beyeler|(805) 893-4321|mbeyeler@ucsb.edu|
20518768|NCT04994431|UMass Memorial Health Care|Feiran Lou|5083348996|feiran.lou@umassmemorial.org|
20518769|NCT04892147|Duke University|Guy G. Potter, PhD|919-668-1269|guy.potter@duke.edu|
20518770|NCT01547728|Mayo Clinic Rochester|Dr. William Oliver|507-255-4240|oliver.william@mayo.edu|
20518771|NCT00057941|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20518772|NCT02760433|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
20518773|NCT00766493|W. L. Gore & Associates|Bryan Randall|(800) 437-8181|BRandall@WLGore.com|
20518774|NCT04721145|Johns Hopkins Medicine|Dr. Risa Wolf|410-955-6463|rwolf@jhu.edu|
20518775|NCT03439085|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, Chief Patient Experience Ofc, Ofc of Chief Operating Officer|(713) 792-9599|mfrumovitz@mdanderson.org|
20563771|NCT00170573|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
20518776|NCT00193492|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
20518777|NCT00830167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518778|NCT02224053|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20518779|NCT03448692|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518780|NCT02289820|MedImmune LLC|Judith Falloon, MD, FACP, FIDSA, Senior Director, Clinical Development|+1-301-398-4010|information.center@astrazeneca.com|
20518781|NCT02054754|e-Therapeutics Plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
20518782|NCT02786927|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518783|NCT01801917|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20518784|NCT01924364|University of Pittsburgh Plastic Surgery|Danielle Minteer|412-383-4804|minteerdm@upmc.edu|
20518785|NCT00265785|SWOG Statistical Center|Study Statistician|206-667-4623||
20518786|NCT03919695|San Diego State University|Assist. Vice President Research Support Services|619-594-5938|rgulizia@sdsu.edu|
20518787|NCT01688882|Novartis Pharmaceuticals|Study Director|862-778-8300||
20518788|NCT01706263|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518789|NCT02416934|West Virginia University Department of Orthopaedics|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
20518790|NCT00591760|Federico II University|Prof. Antonio Cittadini|0039(0)817464375|antonio.cittadini@unina.it|
20518791|NCT00608634|Arizona Cancer Center|Steven P. Stratton, PhD|520-626-9295|sstratton@azcc.arizona.edu|
20518792|NCT00804999|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
20518793|NCT00789776|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
20518794|NCT02627001|San Antonio Military Medical Center|Dr. Michael D. April|(210) 916-0808|Michael.D.April@post.harvard.edu|
20518795|NCT01337596|Eli Lilly Company|Chief Medical Officer|1-800-545-5979||
20518796|NCT02946255|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
20518797|NCT03201003|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20518798|NCT00834613|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20518799|NCT03646162|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
20518800|NCT01709903|Novartis Pharmaceuticals|Study Director|862-778-8300||
20518801|NCT03093025|Taisho Pharmaceutical R&D Inc.|Taisho Pharmaceutical R&D Inc. Study Director|800-602-0203|ClinicalTrials@taisho-rd.com|
20518802|NCT05590039|Cynosure|Jamie Trimper|(201) 479-9612|jamie.trimper@cynosure.com|
20518803|NCT03403439|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518804|NCT00851006|University of Utah|Douglas Kondo, M.D.|801-587-1549|doug.kondo@hsc.utah.edu|
20518805|NCT04662710|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20518806|NCT00673764|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20518807|NCT02339415|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
20518808|NCT05480800|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20518809|NCT01528293|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research, MGUH Center for Wound Healing and HBOT|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
20518810|NCT00377156|Mayo Clinic|Paul Brown, M.D.|507-538-0948|Brown.Paul@mayo.edu|
20518811|NCT00324896|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
20518812|NCT01802216|University of California, San Francisco|Dr. Vanessa Grubbs|415-206-5649|Vanessa.Grubbs@ucsf.edu|
20518813|NCT05061992|University of Michigan|Dr. Elliot Tapper|734-647-9252|etapper@med.umich.edu|
20518814|NCT01833754|Amgen Inc.|Study Director|866-572-6436||
20518815|NCT03978598|UNM Obstetrics & Gynecology|Family Planning Research Team|505-205-4118|HSC-FamilyPlanningResearch@salud.unm.edu|
20518816|NCT05693805|BUCA School of Medicine, Psychiatry; Boston Veterans Administration|Barbara L Niles, PhD|857-364-4128|barbara.niles@va.gov|
20518817|NCT03807661|LimFlow SA|Kristi McCaffrey|+1 559 970-1012|kristi.mccaffrey@stryker.com|
20518818|NCT05212948|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20518819|NCT05347693|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20518820|NCT03223909|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20518821|NCT03971578|Intelligent Hearing Systems|Dr. Rafael E. Delgado, Director of Research & Development|305-668-6102|redelgado@ihsys.com|
20518822|NCT01856192|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20518823|NCT00098475|ECOG Statistical Office|Study Statistician|617-632-3012||
20518824|NCT03422068|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518825|NCT01583530|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518826|NCT02416180|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518827|NCT00640926|Melinta Therapeutics, Inc.|Sue Cammarata, MD|(203) 624-5606|scammarata@melinta.com|
20518828|NCT02564016|Medical University of South Carolina|Laura L Roberts MD, Assistant Professor|843 792 2322|roberll@musc.edu|
20518829|NCT01841073|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
20518830|NCT02858037|International Partnership for Microbicides|Dr John Steytler|+27 21 860 2300|jsteytler@ipmglobal.org|
20518831|NCT04404907|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
20518832|NCT01282086|Abbott (Ukraine)|Global Medical Services|1-800-633-9110||
20518833|NCT01181596|University of California - San Diego|Jae Kim, MD|619-543-3759|neojae@ucsd.edu|
20518834|NCT02050321|University of Arizona Cancer Center|Dr. Lee Cranmer|520 626-0501|lcranmer@uacc.arizona.edu|
20518835|NCT01176981|Hospital for Sick Children|Dr. Abha Gupta|14168137744|abha.gupta@sickkids.ca|
20563772|NCT04556656|Prilenia|Prilenia|+972 775558|info@prilenia.com|
20563773|NCT03498651|University of Virginia Department of Psychology|Dr. Bethany Teachman|434-924-0676|bethanyteachman@gmail.com|
20563774|NCT05563246|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20563775|NCT02167867|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20563776|NCT02897531|Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital|Sung-Bum Kang, MD, PhD|+82-031-787-7093|kangsb@snubh.org|
20518836|NCT00160524|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20518837|NCT01816230|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
20563777|NCT03138512|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20563778|NCT05200247|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563779|NCT04382404|University of Pittsburgh|Dr. Catherine Chappell|412-641-1403|chappelca@upmc.edu|
20563780|NCT03420833|Mayo Clinic|Dr. Yong-Mei Cha|507-255-0774|ycha@mayo.edu|
20563781|NCT05102409|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20518838|NCT01067521|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|001-215-591-3000|info.era-clinical@teva.de|
20518839|NCT01837537|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
20518840|NCT02667951|School of Nursing, College of Medicine, Chang Gung University, Taoyuan, Taiwan|Dr. Yea-Ing L. Shyu|+886-3-211 8800|yeaing@mail.cgu.edu.tw|5275
20518841|NCT02151149|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20518842|NCT03419962|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518843|NCT05653362|Indiana University School of Medicine|Claire Edelman|3176509107|ceedelma@iu.edu|
20518844|NCT04142658|Artivion|Melissa Thalin, Director, New Indications|770-419-3355|melissa.thalin@artivion.com|
20518845|NCT01781234|University of Illinois College of Pharmacy|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
20518846|NCT02033317|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20518847|NCT03294317|Medtronic CRM Clinical|Nonye Harcourt|6122421785|nonye.o.harcourt@medtronic.com|
20518848|NCT02911935|Washington University School of Medicine.|Dr. Avraham Beigelman|314-454-2694|beigelmana@wustl.edu|
20518849|NCT00603512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518850|NCT04979858|Georgia Institute of Technology|Dr. Sundaresan Jayaraman|404.894.2461|sundaresan.jayaraman@gatech.edu|
20518851|NCT04253236|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
20518852|NCT03493919|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20518853|NCT04640194|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518854|NCT02061280|Nemours Children's Specialty Care|Kathryn Blake, Pharm.D.|9046865047|kathryn.blake@nemours.org|904
20518855|NCT00096460|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
20518856|NCT05186415|Nemours Children's Hospital, Delaware|Shannon Nees, MD|302-651-6600|shannon.nees@nemours.org|
20518857|NCT02722616|Johns Hopkins, East Baltimore|Dr. Amol Narang|410-913-3395|anarang2@jhmi.edu|
20518858|NCT02031237|University of Michigan Comprehensive Cancer Center|Dr. Yue Cao|(734) 936-8695|yuecao@umich.edu|
20518859|NCT01474915|The Ohio State University Department of Anesthesiology|Andrew Otey|6142933559|Andrew.otey@osumc.edu|
20518860|NCT01841736|UCSF Helen Diller Family Comprehensive Cancer Center|Emily Bergsland, M.D.|415-353-9888|emily.bergsland@ucsf.edu|
20518861|NCT00676650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518862|NCT00292591|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
20518863|NCT02297841|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20518864|NCT05707403|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518865|NCT04254198|University of New Mexico Health Sciences|Janet Page-Reeves|505-272-1694|JPage-Reeves@salud.unm.edu|
20518866|NCT02152982|Mayo Clinic|Jann N. Sarkaria, MD|507-284-8227|Sarkaria.jann@mayo.edu|
20518867|NCT05661344|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518868|NCT00527475|Texas Retina Associates|David Callanan, MD|817-261-9625|dcallanan@texasretina.com|
20518869|NCT03230487|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518870|NCT01755975|Memorial Sloan Kettering Cancer Center|Dr. Steven Horwitz, MD|646-608-2680|horwitzs@mskcc.org|
20518871|NCT05148299|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|medical.info@sobi.com|
20518872|NCT02161549|MotusGI|Ravit Peled -Director of Clinical Trial|+972 (0)4 6214447|ravit@motusgi.com|203
20518873|NCT01405469|University Hospital Hamburg-Eppendorf|Prof. Dr. Thomas Rösch, Principal Investigator|+49 40 7410 50098|t.roesch@uke.de|
20518874|NCT05633862|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20518875|NCT00702507|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518876|NCT02585245|ThedaCare|Lori Hartz MS, RDN Manager of Nutrition and Diabetes Education|920 831-5077|lori.hartz@thedacare.org|
20518877|NCT04720547|Wayne State University|Dr. Abdulghani Sankari|313-576-3548|atarbich@med.wayne.edu|
20518878|NCT01499160|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
20518879|NCT02287636|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
20529341|NCT01261390|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|sredline1@rics.bwh.harvard.edu|
20563782|NCT05687916|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20563783|NCT01261312|Astex Pharmaceuticals, Inc.|Dr. Harold Keer|925-560-2913|harold.keer@astx.com|
20518880|NCT02361736|Tianjin Medical University General Hospital|Dr. Yuanyuan Zhang|13821685913|doctorkelly@126.com|
20518881|NCT01438476|UT MD Anderson Cancer Center|Dr. Jean-Nicolas Vauthey,MD/Professor, Surgical Oncology|713- 792-2022|jvauthey@mdanderson.org|
20518882|NCT03538262|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-724-9611|michaels@helix.mgh.harvard.edu|
20518883|NCT03566238|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
20518884|NCT02095340|University of Houston|Andres G Viana, Ph.D., Associate Professor|832-842-0234|agviana@uh.edu|
20518885|NCT00860262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518886|NCT00124618|Mayo Clinic|Aminah Jatoi, M.D.|507/538-0268|jatoi.aminah@mayo.edu|
20518887|NCT05467540|AORN Cardarelli|Dr. Prof. Mario Muto|+39800019774|mutomar2@gmail.com|
20518888|NCT03061903|Columbia University|Roshan P. Shah, MD|212-305-8193|rs3464@cumc.columbia.edu|
20518889|NCT04315272|UCSF FI Proctor Foundation|Dr Catherine Oldenburg|(415) 502-8843|catherine.oldenburg@ucsf.edu|
20518890|NCT06107036|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20518891|NCT03382041|The University of Alabama at Birmingham (UAB)|Dr. Clay Spitler|205-934-6413|caspitler@uabmc.edu|
20518892|NCT00688844|Emory University|Rani H. Singh|404-448-8519|rsingh@emory.edu|
20518893|NCT03297541|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632500|amanda.staiano@pbrc.edu|
20518894|NCT04490057|Yale University|E. Jennifer Edelman, MD, MHS|203-727-7115|ejennifer.edelman@yale.edu|
20518895|NCT04771286|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518896|NCT06891729|Next Life Sciences|Darlene Walley|415-407-5229|darlene.walley@nextlifesciences.org|
20518897|NCT04584983|The University of Texas Health Science Center at Houston|Lindsay F Holzapfel, MD, MS|713-500-6422|Lindsay.N.Fleig@uth.tmc.edu|
20518898|NCT05377489|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|000|clinical-trials@grunenthal.com|
20518899|NCT00724958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialDisclosure@merck.com|
20518900|NCT05718648|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518901|NCT01891812|Columbia University Irving Medical Center|Dr. Daniel Tsze, Professor of Pediatrics|212 305 9825|dst2141@cumc.columbia.edu|
20518902|NCT02459418|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
20518903|NCT00653159|The University of Chicago Department of Health Studies, Biostatistics Laboratory|Dr. Sydeaka Watson, PhD|773-834-2378|swatson@health.bsd.uchicago.edu|
20518904|NCT01872715|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
20518905|NCT00329160|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20518906|NCT02419573|Unviersity of Texas Health Science Center at Houston|Henry E. Wang, MD, MS|713-500-7878|henry.e.wang@uth.tmc.edu|
20518907|NCT02315261|Faculty of Medicine Siriraj Hospital|Dr.Mingkwan Wongyingsinn|66824197995|minkcheerful@hotmail.com|81
20518908|NCT00623636|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20518909|NCT04167618|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
20518910|NCT02877017|Boston Children's Hospital|Alisa Khan, MD, MPH|6173552565|alisa.khan@childrens.harvard.edu|
20518911|NCT01402128|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Soo-Wan Chae, MD|82-63-276-8284|soowan@jbnu.ac.kr|
20518912|NCT03653026|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20518913|NCT05560555|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518914|NCT01933919|AbbVie|Global Medical Services|800-633-9110||
20518915|NCT00852917|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20518916|NCT01358877|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20518917|NCT00784030|New York University School of Medicine|Dr. Irina Barash|212.263.5851|irina.barash@nyumc.org|
20518918|NCT01312181|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
20518919|NCT05552261|Dompé Farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinicaltrials@dompe.com|
20518920|NCT02003222|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20518921|NCT03760003|ABIVAX|Fabio Cataldi|+33 (0) 1 53 83 08 41|clinicaltrials@abivax.com|
20518922|NCT04941768|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20518923|NCT01737619|M.D. Anderson Cancer Center|Pamela Soliman, MD|713-745-2352|psoliman@mdanderson.org|
20518924|NCT03302078|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518925|NCT01886872|Ohio State University|Jennifer Woyach, MD|614-685-5667|jennifer.woyach@osumc.edu|
20518926|NCT05383170|Cytovation ASA|CEO|+4747718809|contact@cytovation.com|
20518927|NCT00979212|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20518928|NCT04269993|Brown University|Elizabeth Aston, PhD|401-863-6668|elizabeth_aston@brown.edu|
20518929|NCT03287687|University of Iowa|Dr. Warren Bishop, Professor of Pediatrics|319 356 2977|warren-bishop@uiowa.edu|
20518930|NCT04116658|Enterome|Jan Fagerberg|+33175772785|info@enterome.com|
20518931|NCT00177164|UPMC|K.N. Roy Chengappa|412-246-5006|chengappakn@upmc.edu|
20518932|NCT05584553|Zimmer Biomet|Dr Nesma Bayrich|+41793001484|nesma.bayrich@zimmerbiomet.com|
20518933|NCT00965757|Eisai Co., Ltd.|Kota Nagai|+81-3-3817-5238||
20518934|NCT03807440|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20518935|NCT02451358|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
20518936|NCT06128525|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
20518937|NCT00960414|UCSF Osher Center for Integrative Medicine|Rick Hecht, MD|4153739743|rick.hecht@ucsf.edu|
20563784|NCT05134636|University of Pennsylvania|Ronac Mamtani|215-662-7606|ronac.mamtani@pennmedicine.upenn.edu|
20563785|NCT03662607|Spectrum Health|Dr. Ryan Madder|6163916660|stephen.orey@corewellhealth.org|
20563786|NCT05165108|IndianaU|Thomas Nowak, MD|3179484272|tvnowak@iu.edu|
20563787|NCT01809691|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
20563788|NCT01580488|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20563789|NCT03336333|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20563790|NCT05470517|Johns Hopkins All Children's Hospital|Nicole M. Chandler, MD|727-767-4170|nicole.chandler@jhmi.edu|
20563791|NCT04588298|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20529342|NCT01005576|Washington University School of Medicine|Dr. Shalini Shenoy|314-454-6018|shalinishenoy@wustl.edu|
20563792|NCT04621266|The University of Hong Kong|Dr Kris Lok|39176690|krislok@hku.hk|
20563793|NCT02085421|University of Minnesota|Caroline Demro|(612) 625-3330|schi0599@umn.edu|
20563794|NCT04021602|University of Kansas Medical Center|Lisette T. Jacobson, Ph.D., MPA, M.A., Associate Professor, Obstetrics and Gynecology|316-293-3484|ljacobson@kumc.edu|
20563795|NCT02243709|Brown University|Prof. Carolina Haass-Koffler|4155191385|carolina_haass-koffler@brown.edu|
20563796|NCT03151616|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20563797|NCT01458782|University Hospital North Norway|Dr.Ann Kristin Hansen|+4777669763|ann.kristin.hansen@unn.no|
20563798|NCT01748448|UZLeuven|Prof. Dr. M. Garmyn|0032 16 33 79 50|marjan.garmyn@uzleuven.be|
20563799|NCT02226276|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20518938|NCT01398787|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
20563800|NCT03699709|University of Washington School of Public Health Department of Epidemiology|Dr. Amanda Fretts|2065431065|amfretts@uw.edu|
20563801|NCT02907099|The University of Texas MD Anderson Cancer Center|Brandon Smaglo, MD|(713) 745-8763|bgsmaglo@mdanderson.org|
20563802|NCT02689284|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
20563803|NCT05569252|Daiichi Sankyo|Contact for Clinical Trial Information|9089926400|CTRinfo_us@daiichisankyo.com|
20563804|NCT03665597|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20563805|NCT03272373|Zimmer Biomet|Director of Clinical Operations|800-613-6131|clinicaloperations@zimmerbiomet.com|
20563806|NCT04663087|University of Alabama at Birmingham|Dr. Jan Jansen|205-975-3030|jjansen@uabmc.edu|
20563807|NCT03818711|Vanderbilt University Medical Center|Senior ClinicalTrials.gov Administrator|615-322-3581|natalie.dilts@vumc.org|
20563808|NCT02913872|University of Leicester|Dr Erol Gaillard|+44116 252 3261|eag15@le.ac.uk|
20563809|NCT02386722|Cantonal Hospital Baselland|Dr. Claudia Gregoriano|+41619253765|claudia.gregoriano@ksbl.ch|
20563810|NCT03519581|University of California, Davis Eye Center|Clinical Research Supervisor|916 734-6303|dcmacias@ucdavis.edu|
20563811|NCT05516147|Hopeful Aging|Michael Skrajner|440-477-7881|mike@hopefulaging.com|
20563812|NCT03110315|EvergreenHealth Research|Theodore Brown|4258995385|trbrown@evergreenhealthcare.org|
20563813|NCT01781468|Mayo Clinic Arizona|Alyx B. Porter Umphrey, M.D.|480-301-4062|Porter.alyx@mayo.edu|
20563814|NCT03302494|Coherex Medical, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20563815|NCT05590312|Düzce University Faculty of Medicine|Assistant Professor Özlem Ersoy Karka|+905337293978|drozlemersoy@gmail.com|
20563816|NCT05071807|Penn State University|DCH Lab|8148638056|dchlab@psu.edu|
20518939|NCT03414034|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
20529343|NCT04235504|Medtronic Diabetes|Javier Castaneda|+31 433566566|javier.castaneda@medtronic.com|
20529344|NCT04001803|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20529345|NCT02329327|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20529346|NCT04888494|Northwestern University|A. Vania Apkarian|+1 312 503 0404|a-apkarian@northwestern.edu|
20529347|NCT03430856|Biocon Research limited|Dr. Subramanian L|080-28082808|subramanian.l101@biocon.com|1323
20529348|NCT00565604|Lake Washington Vascular Surgery|Daniel Pepper, MD|(425) 453-1772||
20529349|NCT03713684|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20529350|NCT00528424|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20529351|NCT00974311|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529352|NCT03131167|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20529353|NCT03286218|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
20529354|NCT00458003|Northwestern University|Paul Fitzgerald|312-6951064|p-fitzgerald2@northwestern.edu|
20529355|NCT01164202|FFCD|Mrs Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20529356|NCT00643201|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20518940|NCT02351167|Washington University School of Medicine|Li-Shiun Chen, M.D.|314-362-3932|li-shiun@wustl.edu|
20518941|NCT04010227|Indiana University|Dr. Catherine Mosher|3172746769|cemosher@iupui.edu|
20518942|NCT02308696|Univ. WI Madison|Amy Amessoudji|608-263-2621|amessoudji@surgery.wisc.edu|
20518943|NCT02522780|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20518944|NCT02260635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518945|NCT01992874|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20518946|NCT00462839|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|(312)926-9015|r-mccarthy@northwestern.edu|
20518947|NCT02466386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20529357|NCT02976519|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563817|NCT04952909|Pi-Cardia|Hadas Givon, VP CA/RA|+972-8-9484800|hadas@pi-cardia.net|
20563818|NCT03729999|Nationwide Children's Hospital|Dr. Alok Moharir|614-722-4200|alok.moharir@nationwidechildrens.org|
20563819|NCT05308004|University of Maryland School of Nursing|Dr. Joan Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
20563820|NCT04267172|Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford.|Professor Jonathan Rees|01865737540|jonathan.rees@ndorms.ox.ac.uk|
20563821|NCT04552223|University of Miami|Jose Lutzky MD|+1 (305) 6896500|jose.lutzky@med.miami.edu|
20563822|NCT04072380|Suven Life Sciences|Ramakrishna Nirogi, PhD|+9140 2319 3956|nvsrk@suven.com|
20563823|NCT04406441|Geisinger Health System|Dr. Lisa Bailey-Davis|570-214-9625|ldbaileydavis@geisinger.edu|
20563824|NCT03468218|Emory University|Dr. Nabil Saba|404-778-1900|nfsaba@emory.edu|
20563825|NCT01214616|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563826|NCT04280445|Trent Doctorate in Clinical Psychology Programme, University of Nottingham, UK|Dr Daniell De Boos|+44 (0)115 84 67523|danielle.deboos@nottingham.ac.uk|
20563827|NCT01212029|National Institute of Child Health and Human Development|Dr. Amir Gandjbakhche|2402742949|gandjbaa@mail.nih.gov|
20563828|NCT03973320|Hospital for Special Surgery, Anesthesiology|Dr. Jiabin Liu|2126061036|liuji@hss.edu|
20563829|NCT03400059|Chordate Medical AB|Dr Jan Hermansson|+46 8 400 115 86|jan.hermansson@chordate.com|
20563830|NCT05634226|Children's Hospital of Pittsburgh|Dr. Tarek Alsaied|5136521226|tarek.alsaied84@gmail.com|
20563831|NCT03047928|CCIT-DK|Prof. MD, Inge Marie Svane|38683868|inge.marie.svane@regionh.dk|+45
20563832|NCT05086016|Renata Medical|Dali Alarian|8553184988|dali@renatamedical.com|6
20563833|NCT03281291|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20563834|NCT02736409|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20563835|NCT01415154|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
20563836|NCT03126019|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20563837|NCT03972813|University of Michigan|Abram Wagner|7347632330|awag@umich.edu|
20563838|NCT06069713|Wake Forest University Health Sciences|Olivia Horton MSW, MPH|000.000.0000|ohorton@wakehealth.edu|
20563839|NCT06283173|Covalon Technologies Inc.|Director of Regulatory Affairs|888-236-4944|customerservice@covalon.com|
20563840|NCT03332017|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20563841|NCT01969539|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563842|NCT02682342|Medical College of Wisconsin|Michael E. Widlansky, MD|414-955-6708|mwidlans@mcw.edu|
20563843|NCT05868772|Cataract & Laser Institute|Dr Justin Spaulding|541-779-2020|justinophtho@gmail.com|
20563844|NCT03406871|NationalCCHE,JAPAN|Dr.Kohei Shitara|+81-4-7133-1111|regonivo_core@east.ncc.go.jp|
20563845|NCT05102591|University of Calgary/Alberta Health Services|Dr. Serena Orr|403-955-7728|serena.orr@albertahealthservices.ca|
20563846|NCT02380885|Bar-Ilan University|Prof. Ilanit Hasson-Ohayon|+972-3-5317673|ilanithasson@gmail.com|
20563847|NCT06064955|Ohio State University|Karen O. Moss|(614) 688-3100|Moss.391@osu.edu|
20563848|NCT02281955|University of North Carolina at Chapel Hill|Dr. Colette Shen|984-974-0400|cjshen@email.unc.edu|
20563849|NCT04768569|Washington University in St. Louis|Dr. Craig Buchman, Lindburg Professor & Chair, Department of Otolaryngology-Head & Neck Surgery|314-362-2914|buchmanc@wustl.edu|
20563850|NCT05473234|UCSF FI Proctor|Dr. Catherine E. Oldenburg|415-502-8843|catherine.oldenburg@ucsf.edu|
20563851|NCT03535272|Centers for Disease Control and Prevention|Kristina Angelo|404-718-4876|kangelo@cdc.gov|
20563852|NCT04302493|Johns Hopkins School of Medicine|Elisabeth B. Marsh, MD|410-550-8703|ebmarsh@jhmi.edu|
20563853|NCT03892616|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563854|NCT04511286|Karolinska Institutet|Dr. Erland Axelsson|0706171039|erland.axelsson@ki.se|+46
20563855|NCT04750473|Emory University/Winship Cancer Institute|Dr. David Schuster|404-712-4859|dschust@emory.edu|
20563856|NCT04177823|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20563857|NCT04229992|Vanderbilt University Medical Center|Dr. Martha Shrubsole, Dr. Qi Dai|(615)936-0707|Martha.shrubsole@vanderbilt.edu, qi.dai@vanderbilt.edu|
20563858|NCT04347161|University of Pennsylvania|Katharine A Rendle, PhD,MSW,MPH|215-349-5442|Katharine.Rendle@pennmedicine.upenn.edu|
20563859|NCT04169373|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20563860|NCT04610892|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20563861|NCT05520190|University of Rochester|Aileen Aldalur|(585) 371-6125|aileen_aldalur@urmc.rochester.edu|
20563862|NCT03683719|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20563863|NCT05081583|Washington State University|Dr. Mary Paine|5093587759|mary.paine@wsu.edu|
20563864|NCT03232138|University of Pittsburgh Cancer Institute|Jian-Min Yuan M.D., Ph.D.|412-864-7889|yuanj@upmc.edu|
20563865|NCT03001414|Northern Therapeutics, Inc.|Duncan Stewart, Clinical Trial Medical Consultant|613-737-8899|djstewart@toh.ca|76686
20563866|NCT03920111|University of Liverpool|Dr Lance Turtle|01517957554|lance.turtle@liverpool.ac.uk|
20563867|NCT05268393|Children's National Hospital|Dr. Eleanor Mackey|202-476-5307|emackey@childrensnational.org|
20563868|NCT05256706|Emory University|Dr. Arshed Quyyumi|404-712-2741|aquyyum@emory.edu|
20563869|NCT05009004|Environment and Health Group|Patricia Weitzman|6174555976|pat.weitzman@ehgcambridge.com|
20518948|NCT05317195|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20518949|NCT02922582|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20518950|NCT02169336|Recro Pharma, Inc|Randall Mack|484-395-2400|rmack@recropharma.com|
20518951|NCT00420095|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20518952|NCT00393705|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20518953|NCT03346902|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|9493796569
20518954|NCT00268762|University of Texas Health Science Center at Houston|Andrew D. Barreto, MD|713-500-7002|andrew.d.barreto@uth.tmc.edu|
20563870|NCT03898986|Stanford University|Philip Grant, MD|6507239001|pmgrant@stanford.edu|
20563871|NCT03850678|University of Nebraska-Lincoln|Marc Brennan|4024723132|marc.brennan@unl.edu|
20563872|NCT05523154|Mayo Clinic|Dr. Marina Walther-Antonio|(507) - 284-2282|waltherantonio.marina@mayo.edu|
20563873|NCT04640298|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20563874|NCT03720795|Baylor College of Medicine|Dr. Eric Storch|(713) 798-3579|eric.storch@bcm.edu|
20563875|NCT04322643|Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center|Dr. Moshe Ornstein|866-223-8100|TaussigResearch@ccf.org|
20563876|NCT05134233|Fralin Biomedical Research Institute at VTC|Jessica Florig|540-526-2261|jnw@vtc.vt.edu|
20563877|NCT01573442|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-4565|cloprinzi@mayo.edu|
20563878|NCT05710107|Medical University of South Carolina|Ellen Johnson|843-792-2322|hayell@musc.edu|
20563879|NCT04166773|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20563880|NCT04510974|James J Peters VA Medical Center|Dr. Caitlyn Peters|9733243588|cpeters@kesslerfoundation.org|
20563881|NCT04763265|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+43 2262 684680|clinical.studies@croma.at|
20563882|NCT04115540|Stanford University|Michael Eisenberg MD|650-723-3391|meisenb@stanford.edu|
20563883|NCT04418466|Delpor, Inc.|Eesha Gupta|415-289-1770|eesha.gupta@delpor.com|
20563884|NCT03269136|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20563885|NCT04856163|RAND|Dr. Lori Uscher-Pines|703-413-1100|luscherp@rand.org|
20563886|NCT03762915|University of Minnesota|Michelle Arnette|6126243457|marnett@umn.edu|
20563887|NCT05369533|University of California, Los Angeles|Steven Cramer|424-522-7874|SCCramer@mednet.ucla.edu|
20563888|NCT03158714|Auburn University|Francesca Adler-Baeder|334-844-4151|adlerfr@auburn.edu|
20563889|NCT02515773|University of Cincinnati|Casey Moore|513-558-6307|casey.moore@uc.edu|
20518955|NCT03370510|Yale Child Study Center|Dr. Pamela Ventola|(203) 737-4378|ventolalab@yale.edu|
20518956|NCT01374451|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20518957|NCT00178711|University of Texas Health Science Center|Guy L Clifton|2024224824|guy@guyclifton.com|
20518958|NCT00089973|GlaxoSmithKline|GSK Response Center|866-435-7343||
20518959|NCT01223027|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
20518960|NCT01475487|Department of Anesthesia and Pain Management, Mount Sinai Hospital Toronto, Canada|Dr Naveed Siddiqui|4165864800|naveed.siddiqui@uhn.ca|5270
20518961|NCT00857818|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20518962|NCT01745952|UZ Leuven|Prof W Van Paesschen & Dr L Seynaeve|+3216349062|laura.seynaeve@uzleuven.be|
20518963|NCT01977456|University of Cincinnati|Dr. Opeolu Adeoye|513-558-3117|opeolu.adeoye@uc.edu|
20518964|NCT01756885|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
20518965|NCT00965731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20518966|NCT00683592|PGxHealth, LLC|Director of Medical Affairs|203-786-3400||
20518967|NCT02814708|Biomedizinische Forschung & Bio-Produkte AG|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
20518968|NCT02697617|Indiana University School of Medicine|Dr. Sharon Moe|317 278 2868|smoe@iu.edu|
20518969|NCT03303417|University of Nottingham|Robin Spiller|0115 823 1090|robin.spiller@nottingham.ac.uk|
20518970|NCT01578317|NIH|John Tsang|301-496-0304|tsangjs@mail.nih.gov|
20518971|NCT00381849|Mayo Clinic|Beverly Tietje, Study Coordinator|507-255-0401|tietje.beverly@mayo.edu|
20518972|NCT02824640|Prisma Health|Megan Groome|864-382-1023|megan.groome@primsahealth.org|
20518973|NCT01504711|Barbara Ann Karmanos Cancer Institute|Dr. Philip A. Philip, M.D., Ph.D., F.R.C.P|(313)576-8624|philipp@karmanos.org|
20518974|NCT01765270|Duke Clinical Research Institute|L. Kristin Newby, MD, MHS|919-668-8805|kristin.newby@duke.edu|
20518975|NCT00493792|Mayo Clinic, Rochester, MN|Emilee Andersen, M.A., Clinical Research Coordinator|507-266-9807|andersen.emilee@mayo.edu|
20518976|NCT02426541|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20518977|NCT00745134|M D Anderson Cancer Center|Dr. Jillian Gunther|832-710-7864|JGunther@mdanderson.org|
20518978|NCT02943993|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20518979|NCT04178096|VA Pittsburgh Healthcare System|Dr. Shari Rogal|412 360 6177|shari.rogal@va.gov|
20518980|NCT00876265|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
20518981|NCT01507233|University of Miama/Jackson Memorial Hospital|Keith Candiotti, MD|305-585-5332|info@jhsmiami.org|
20518982|NCT04443569|Massachusetts General Hospital|Christopher Arkfeld|4029803860|carkfeld@mgh.harvard.edu|
20518983|NCT00996437|Diabetic Retinopathy Clinical Research Network|Adam R. Glassman|813-975-8761|drcrstat4@jaeb.org|
20518984|NCT02510261|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20518985|NCT02046317|The University of Texas Health Science Center at Houston|Carlos J Roldan, MD|713-745-7246|Carlos.J.Roldan@uth.tmc.edu|
20518986|NCT04886063|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
20518987|NCT02988882|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
20518988|NCT01214980|University South Florida|Dr. Lisa Gould|(410) 736-4646|lgould44@hotmail.com|
20518989|NCT01344018|EORTC (European Organisation for Research and Treatment of Cancer)|EORTC HEADQUARTERS|+32 2 774 16 11|eortc@eortc.be|
20518990|NCT05070754|Medical University of South Carolina|Dr. Lara Wine Lee|(843) 792-3021|winelee@musc.edu|
20518991|NCT02339038|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
20518992|NCT00726895|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20563890|NCT05434078|Baylor College of Medicine|Dr. Bijan Najafi|+1 (424) 467-7127|bijan.najafi@bcm.edu|
20518993|NCT03702816|Cleveland Clinic|Aaron Ritter, MD|17024836000|rittera@ccf.org|
20563891|NCT04918823|BostonSight|Dr. Daniel Brocks|7817267337|dbrocks@bostonsight.org|
20563892|NCT03033576|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|sbellasea@fredhutch.org|
20563893|NCT03557697|NYU Langone Health|Lu Hu|646 501 3438|lu.hu@nyulangone.org|
20563894|NCT05026320|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20563895|NCT05565092|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20563896|NCT05297864|University of Oklahoma Health Sciences Center|James Battiste, MD|405-271-8777|James-Battiste@ouhsc.edu|
20563897|NCT04390048|University of Miami|Brian Arwari|305-284-5418|b.arwari@umiami.edu|
20563898|NCT02038569|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20563899|NCT04682106|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20563900|NCT04106583|Penumbra, Inc.|Brooke Lawson|+15109952183|blawson@penumbrainc.com|
20563901|NCT02651428|CorMedix Inc.|Head of Clinical Operations|908-517-9500|lmasson@cormedix.com|
20563902|NCT05481216|Research Organization (KC) Ltd|HIV COCO Project Manager|+44 (0) 7494 795 982|hivcoco@rokcservices.com|
20563903|NCT04005716|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20563904|NCT02783300|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20563905|NCT05845398|Dicerna Pharmaceuticals, Inc., a Novo Nordisk company|Clinical Reporting Office (2834)|866-867-7178|clinicaltrials@novonordisk.com|(+1)
20563906|NCT01787383|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leopharma.com|
20563907|NCT05391893|SpectrumLakeland|Rachelle Pichot; Clinical Research Specialist|(240)389-7340|rachelle.pichot@corewellhealth.org|
20563908|NCT05178316|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20563909|NCT03770273|National Institute of Allergy and Infectious Diseases|Hirsh Komarow|+1 301 594 2197|komarowh@niaid.nih.gov|
20563910|NCT00418886|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20563911|NCT04060654|Indivior Inc|Sunita Shinde|804 379-1090|sunita.shinde@indivior.com|
20563912|NCT03707951|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20563913|NCT04533347|Fast-Track Drugs and Biologics, LLC|Bernadette Tock|240-401-8634|btock@fasttrackresearch.com|
20563914|NCT00277394|Leo Pharma|Torsten Skov, Senior Medical Advisor|+45 72263990|tosdk@leo-pharma.com|
20563915|NCT03907397|Icahn School of Medicine at Mount Sinai|Dr. Scott Sicherer|212-241-5548|scott.sicherer@mssm.edu|
20563916|NCT05369403|Chief Medical Officer|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20563917|NCT05521308|Sonova|Bilal Sheikh - Research Audiologist|2268083260|bilal.sheikh@sonova.com|
20563918|NCT05337943|University of Pennsylvania|Dr. Lea Ann Matura|2157468819|matura@nursing.upenn.edu|
20518994|NCT04194008|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|0542220121|daganh@theranica.com|
20518995|NCT01785615|University of Florida College of Medicine Jacksonville|Dr. Gladys Velarde|(904)244-2060|Gladys.Velarde@jax.ufl.edu|
20529358|NCT00928434|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20529359|NCT05439421|Wake Forest University Health Sciences|Erin L. Sutfin, PhD|336.713.5282|esutfin@wakehealth.edu|
20529360|NCT03760224|University of Hong Kong|Dr. Derek Cheung|39176652|derekcheung@hku.hk|
20529361|NCT01139996|Memorial University Medical Center|Imran Siddiqui, MD|912-350-8707|research2@memorialhealth.com|
20529362|NCT01477762|Emory University|Dr. Tanja Jovanovic|(404) 778-1485|tjovano@emory.edu|
20529363|NCT02276963|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
20529364|NCT02154139|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20518996|NCT01881737|Stanford University School of Medicine|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
20518997|NCT02608476|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20518998|NCT04106817|WCCT Global|Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
20518999|NCT03310619|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20519000|NCT01812473|Universitaire Ziekenhuizen Leuven|Kim Vanstraelen, PharmD|0032 16 342339|kim_vanstraelen@hotmail.com|
20519001|NCT00926367|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519002|NCT02725411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519003|NCT03847974|LIB Therapeutics|Evan A Stein MD PhD FACC|18596533141|estein@libtherapeutics.com|
20519004|NCT04307849|NYU Langone Health|Marie Brault, PhD|210-276-9012|Marie.Brault@nyulangone.org|
20519005|NCT01294449|University of Rochester Heart Research Follow-up Program|Dr. Arthur Moss|585-275-5291|Arthur.Moss@heart.rochester.edu|
20519006|NCT02846233|University of California San Francisco, Fresno Medical Education Program|SOE NAING|5593239236|snaing@fresno.ucsf.edu|
20519007|NCT03259789|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20519008|NCT02063217|Washington University School of Medicine|Dr. Brendan Lucey|314-362-4342|luceyb@wustl.edu|
20519009|NCT00889252|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
20519010|NCT02710591|EspeRare Fondation|Florence Porte-Thomé|22 794 4004|porte.florence@esperare.org|+41
20519011|NCT04235660|Indiana University School of Medicine|Paul Haste|317-944-5005|phaste@iu.edu|
20519012|NCT02387762|Acerta Pharma|Ahmed Hamdy, MD, VP of Early Development|650-591-2800|a.hamdy@acerta-pharma.com|145
20519013|NCT04203667|Interscope, Inc.|Alexis James, Global Director of Clinical Affairs|508-847-9478|alexis.james@interscopemed.com|
20519014|NCT00593827|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20519015|NCT01833169|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20519016|NCT03718039|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
20519017|NCT01183884|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
20563919|NCT03792256|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20529365|NCT02130999|Vince and Associates Clinical Research|Melodie Armstrong, MD, MPH|913-696-1601||
20563920|NCT04760678|Insitute of Tropical Medicine|Carolien Hoof|0470102562|choof@itg.be|
20563921|NCT05368103|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20563922|NCT04864691|Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.|Feng Gao|13581936066|gaofengletter@sina.com|
20563923|NCT03675282|Weill Cornell Medicine|Carly Skudin; Research Program Manager|212-746-2003|cas4010@med.cornell.edu|
20563924|NCT05784662|University at Buffalo, School of Social Work|Patricia Logan-Greene|7166451533|pblogang@buffalo.edu|
20563925|NCT03611621|Hansa Biopharma AB|Study Director|+46 46 16 56 70|clinicalstudyinfo@hansabiopharma.com|
20563926|NCT05424549|Aldeyra Therapeutics, Inc.|Bill Cavanagh|781-257-3063|bcavanagh@aldeyra.com|
20563927|NCT03662698|University of Colorado Hospital|Jamie Studts|303-724-2284|jamie.studts@cuanschutz.edu|
20563928|NCT05177848|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas-Lemos|(540)526-2106|rflemos@vtc.vt.edu|
20563929|NCT03992339|Antengene Corporation|Yumei Tang|18301318100|yumei.tang@antengene.com|
20563930|NCT03396926|University of California, San Francisco|Dr.Chloe Atreya, MD, PhD|(415) 353-9888|chloe.atreya@ucsf.edu|
20563931|NCT02035787|University of North Carolina Lineberger Comprehensive Cancer Center|Lauren Higgins|919- 966-4432|lqhiggin@ad.unc.edu|
20563932|NCT06414213|Appalachian State University|Dr. Jared Skinner|828-262-2512|skinnerjw@appstate.edu|
20563933|NCT03778112|Rush University Medical Center|Dian Wang, MD|(708) 660-3476|Dian_Wang@rush.edu|
20563934|NCT01997840|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20563935|NCT03555448|Washington University|R. Delos Santos|3143628351|delossantos@wustl.edu|
20563936|NCT05079789|University Hospital Tuebingen|Dr. Anja Schork|+49 707129 83172|Anja.Schork@med.uni-tuebingen.de|
20563937|NCT05486078|Guna S.p.a|Dr. Vincenzo Miranda, Clinical Research & Scientific Service Manager|02 280.18.(358)|v.miranda@guna.it|
20563938|NCT03649659|University of Michigan|Dr. Margherita Fontana|734-763-3988|mfontan@umich.edu|
20563939|NCT05305235|University of North Carolina at Chapel Hill|Nicole Short, PhD|702-895-3305|nicole.short@unlv.edu|
20563940|NCT04799704|UZ Leuven|Heleen Delbeke, MD|003216342229|heleen.delbeke@uzleuven.be|
20563941|NCT03150810|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20563942|NCT04526704|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20563943|NCT00881621|Georgetown University|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
20563944|NCT04359108|Johns Hopkins Applied Physics Laboratory|Seth Billings|240-228-7462|seth.billings@jhuapl.edu|
20529366|NCT00473655|AstraZeneca|Gerard Lynch|09645895|aztrial_results_posting@astrazeneca.com|44 15
20529367|NCT03933449|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529368|NCT02087774|Marshall University|Rebecca Hayes, M.D.|3046173570|hayes79@live.marshall.edu|
20529369|NCT02076100|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529370|NCT02513550|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529371|NCT00243919|Duke University|Pamela W. Duncan, PT, PhD, FAHA, FAPTA|919-681-2060|pamela.duncan@duke.edu|
20529372|NCT00496340|H. Lee Moffitt Cancer Center and Research Institute|Marcie Riches, MD|813-745-6284|marcie.riches@moffitt.org|
20529373|NCT04176939|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20529374|NCT01039467|Fuwai Hospital|Dr. Shu Zhang|861088398833|zsfuwai@vip.163.com|
20529375|NCT04742673|Vanderbilt University Medical Center|Christopher Hughes|615-322-5000|christopher.hughes@vumc.org|
20529376|NCT06290089|Scandinavian Biopharma Holding AB / Etvax|Head of Clinical Development|004684705600|info@scandinavianbiopharma.se|
20529377|NCT01368263|Washington University School of Medicine|Timothy Pluard, M.D.|314-362-5645|tpluard@saint-lukes.org|
20529378|NCT03107208|"University of Colorado Denver | Anschutz"|Rebecca Ohman, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20563945|NCT03983018|Örebro University|Prof Susanne Bejerot|+46701655102|susanne.bejerot@oru.se|
20519018|NCT01160640|University of Pittsburgh|Dr. Harold Wiesenfeld|412-641-1403|wieshc@mail.magee.edu|
20519019|NCT04718129|Vanderbilt University|Principal Investigator|615-330-5605|jgarber.vanderbilt@gmail.com|
20519020|NCT02212457|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519021|NCT01598896|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
20519022|NCT00681473|Massachusetts General Hospital|Helen A. Shih, MD|617-724-9627|HSHIH@Partners.org|
20519023|NCT00642811|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20519024|NCT01120691|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20519025|NCT00938782|Stanford University|Dr. David R Drover|650-725-0364|ddrover@stanford.edu|
20519026|NCT04553406|SperoTherapeutics|Dr. Jon Bruss|(+1) 269-352-3766|jbruss@sperotherapeutics.com|
20519027|NCT00772148|Veloxis Pharmaceuticals|Christina Sylvest|+45 20553877|csy@veloxis.com|
20519028|NCT00749658|University of Minnesota|Marc Mooney PhD||moon0078@umn.edu|
20519029|NCT03573336|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20519030|NCT01525628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519031|NCT02614898|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
20519032|NCT00239005|Novartis Pharmaceuticals|Study Director|862-778-8300||
20519033|NCT03108820|University of Wisconsin School of Medicine and Public Health|Dr. Ben Zarzaur|(608) 265-9574|zarzaur@surgery.wisc.edu|
20519034|NCT00787605|Novartis Pharmaceuticals|Study Director|862-778-8300||
20519035|NCT02299869|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20519036|NCT02528409|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
20519037|NCT04428645|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
20519038|NCT01834027|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
20563946|NCT06393088|IR Technology LLC|Consulting Director of Clinical Trials|404 915-5938|andyn@invisaredtech.com|
20563947|NCT04176965|BVI medical|Rebecca McQuaid|+353871212615|RMcQuaid@bvimedical.com|
20563948|NCT03903146|University of Kentucky|Dr. Ana Maria Linares, PI|8593234726|am.linares@uky.edu|
20563949|NCT03652688|PIRE|Dr. Brenda A. Miller|5105205889|BMiller@prev.org|
20563950|NCT02949362|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20563951|NCT04015167|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
20563952|NCT05492318|Italfarmaco SpA|Dr. Paolo Bettica, MD|+39 02 64431 (centralino)|p.bettica@italfarmacogroup.com|
20563953|NCT05008835|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
20563954|NCT04876118|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20563955|NCT04986501|Sunbio|Min-Jung Ahn|+82-31-423-5467|mjahn@sunbio.com|
20563956|NCT05089734|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20563957|NCT05093829|University of Maryland School of Medicine|Wilbur H. Chen, M.D., M.S., FACP, FIDSA|410-706-5328|wchen@som.umaryland.edu|
20529379|NCT00426764|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20529380|NCT01922258|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
20529381|NCT04396626|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529382|NCT04552132|Saint Louis University|Dr. David Bingham|208-851-0618|davidbingham1623@gmail.com|
20529383|NCT01657162|Radius Health, Inc.|Radius Head of Clinical Operations|(617) 551-4700||
20529384|NCT01431339|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatx.com|
20529385|NCT01497067|Alcon Research|Sr. Clinical Trial Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20529386|NCT04786691|University of Arkansas for Medical Sciences|Jessica Yeh|(501) 686-6114|jyeh@uams.edu|
20529387|NCT01871077|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|drricardollamas@gmail.com|1259
20529388|NCT00096538|Memorial Sloan Kettering Cancer Center|Dr. Ariela Noy|212-639-7423|noya@mskcc.org|
20529389|NCT01211756|UCSD|David Feifel||dfeifel@kadimanp.com|
20529390|NCT02686164|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20529391|NCT01691378|Rocky Mountain MIRECC|Lisa Brenner|720-723-6488|lisa.brenner@va.gov|
20529392|NCT02465164|Central Clinical Trials Office|Central Clinical Trials Office|3139537454|smarl1@hfhs.org|
20529393|NCT02324361|Partners Healthcare|Study Project Manager|4259856430|szan@mail.harvard.edu|
20529394|NCT01481558|University of Sao Paulo|Claudia Kimie Suemoto|551130618249|cksuemoto@usp.br|
20529395|NCT02371876|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20529396|NCT00870467|Abbott|Global Medical Services|800-633-9110||
20529397|NCT03839394|Duke University|Nwora Lance Okeke, MD, MPH|919-684-2579|lance.okeke@duke.edu|
20529398|NCT00101868|University of Illinois|James F. Graumlich, MD, Professor of Medicine|309-655-7734|jfg@uic.edu|
20529399|NCT01733745|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20529400|NCT01931397|Oregon Health & Science University|Dr. Amira Al-Uzri , Professor of Pediatrics|503-494-6956|aluzria@ohsu.edu|
20529401|NCT02472262|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manarymj@wustl.edu|
20529402|NCT01367249|Bausch & Lomb Incorporated|James Gow|949-788-6000|james.gow@bausch.com|
20529403|NCT02493517|Ipsen|Medical Director, Oncology||clinical.trials@ipsen.com|
20529404|NCT02249104|Galderma Laboratories L.P.|Dr. Jay Mashburn|817 961 5027|jay.mashburn@galderma.com|
20529405|NCT03718429|University of Florida|Dominick Angiolillo, MD,PhD|904-244-3378|dominick.angiolillo@jax.ufl.edu|
20529406|NCT05404711|University of Pittsburgh School of Medicine|Mary Ellen Vajravelu, MD,MSHP|412-692-6533|vajravelume@upmc.edu|
20529407|NCT02346877|Amgen Inc.|Study Director|866-572-6436||
20529408|NCT00691652|OHSU Knight Cancer Institute|Dr. Craig Okada|503-494-1080|Okadac@ohsu.edu|
20529409|NCT01683604|HoffmannLaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20529410|NCT06236113|North Memorial Health Robbinsdale Hospital|Michaela A West, MD, PhD|763-581-3704|Michaela.West@NorthMemorial.com|
20529411|NCT01900847|University of Arizona|Jaiva Larsen|5039396612|jlarsen@aemrc.arizona.edu|
20529412|NCT00962078|Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany|Dr. Rainer Gloeckl|+49 8652 931630|rgloeckl@schoen-klinik.de|
20529413|NCT02002871|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
20529414|NCT01395810|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20529415|NCT04940156|Oxford University Hospitals NHS Trust|Dr Richard Varini|01865220256|richard.varini@ouh.nhs.uk|
20529416|NCT03877224|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
20529417|NCT01001429|Rutgers New Jersey Medical School|Anuradha Patel, MD|973 972-1886|patelan@njms.rutgers.edu|
20529418|NCT03143257|Medtronic Xomed|Sr Manager, Clinical Affairs|904-296-9600|rs.entgm@medtronic.com|
20529419|NCT01095497|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20529420|NCT02492802|University Medical Center Groningen|Jan-Willem Alffenaar, PhD|+31503614035|j.w.c.alffenaar@umcg.nl|
20529421|NCT03234036|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20563958|NCT04889755|Boston University|Associate Professor|(617) 358-4296|kalong@bu.edu|
20563959|NCT04353661|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20563960|NCT02671903|Imperial College London|Dr Zachary I Whinnett|+44 (0)20 7594 5735|z.whinnett@imperial.ac.uk|
20529422|NCT01099358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529423|NCT04033146|Georgia Insitute of Technology|Dr. Gregory S. Sawicki; Professor Mechanical Engineering|919 448 5099|gregory.sawicki@me.gatech.edu|
20563961|NCT03376321|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20563962|NCT02992925|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp, clinicaldevelopment@mail.biken.or.jp|
20563963|NCT02995434|University of British Columbia|Dr. Bernie Garrett|604 822 7443|bernie.garrett@ubc.ca|
20563964|NCT05273749|Tonix Pharmaceuticals|Gregory Sullivan, MD|8629040355|greg.sullivan@tonixpharma.com|
20563965|NCT05097430|Centre for Addiction and Mental Health (CAMH)|Dr. Paul Shuper|416-535-8501|paul.shuper@camh.ca|34097
20563966|NCT04951492|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
20563967|NCT00378105|Dana-Farber Cancer Institute|Dr. Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
20563968|NCT03623321|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
20563969|NCT03378570|University of Iowa Hospitals & Clinics|Dr. Nicholas Trapp|(319) 467-8188|nicholas-trapp@uiowa.edu|
20563970|NCT04241068|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20563971|NCT03843151|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563972|NCT01999075|CHEO Research Institute|Dr. Sherri Katz (Principal Investigator)|613-737-7600|skatz@cheo.on.ca|2956
20563973|NCT01413100|Fred Hutchinson Cancer Center|Dr. Leona Holmberg|206-667-6447|lholmb@fredhutch.org|
20563974|NCT04750525|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
20563975|NCT02203552|The Ohio State University Comprehensive Cancer Center|Dr. Bhuvaneswari Ramaswamy|614-293-7484|Bhuvaneswari.Ramaswamy@osumc.edu|
20563976|NCT04606069|University of Maryland Medical Center|Dr. Christine Lau, MD, MBA, Department of Surgery, Surgeon-in-Chief|410-328-8407|CLLau@som.umaryland.edu|
20563977|NCT04059770|Universidade Federal de Ciências da Saúde de Porto Alegre|Professor Alessandro C. Pasqualotto|5551999951614|pasqualotto@ufcspa.edu.br|
20563978|NCT05570175|Chang Gung University of Science and Technology|Su-Hui Chen|886-3-2118999|sophee@mail.cgust.edu.tw|3216
20563979|NCT04562649|Columbia University|Rebecca Schnall, PhD, MPH, RN|212-342-6886|rb897@cumc.columbia.edu|
20519039|NCT01214239|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519040|NCT01321697|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
20519041|NCT00243152|Boston Children's Hospital|Dr. David Borsook|617-281-7135|david.borsook@childrens.harvard.edu|
20519042|NCT01049581|ChangGungMH|Dr Chia- Ling Chen|886-3-3281200|clingchen@gmail.com|3846
20519043|NCT02625974|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20519044|NCT01142661|Eisai Inc.|Prash Gopalakrishna|888-422-4743||
20519045|NCT01195116|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
20519046|NCT04773600|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20519047|NCT02129062|UT MD Anderson Cancer Center|Jan Burger, MD/ UT MD Anderson Associate Professor, Leukemia|713-794-4329|CR_Study_Registration@mdanderson.org|
20519048|NCT00003404|Dartmouth Hitchcock Medical Center|Richard J. Barth Jr., MD|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
20519049|NCT04814459|Oakland University|Dr. Sara Arena|2483648682|arena@oakland.edu|
20519050|NCT01841060|Institut Bergonie|Pr Simone Mathoulin-Pélissier|33556333333|s.mathoulin@bordeaux.unicancer.fr|
20519051|NCT02786719|Baylor College of Medicine|Sarah Whittle, MD MS|8328241471|whittle@bcm.edu|
20519052|NCT01848210|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20519053|NCT04592419|Kodiak Sciences Inc.|Pablo Velazquez-Martin, MD|1 (650) 281-0850|ClinOps@kodiak.com|
20519054|NCT02252445|Keimyung university|Assistant professor|+821028862876|onidori1979@gmail.com|
20519055|NCT05838456|The University of Texas Health Science Center at Houston|Sunil A. Sheth, MD|713-500-7897|Sunil.A.Sheth@uth.tmc.edu|
20519056|NCT00685035|University of Minnesota School of Medicine|Dr. Robert Kempainen|612-873-6413|kempa001@umn.edu|
20519057|NCT00784979|Tampa General Hospital|Dr. John Leone|813-844-5666|jpleone@tgh.org|
20519058|NCT01114997|Cedars Sinai Medical Center|Dr. Roya Yumul|310-423-1682|Roya.Yumul@cshs.org|
20519059|NCT00894933|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
20519060|NCT02812771|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
20519061|NCT01503333|Michigan State University College of Nursing|Dr. Lorraine Robbins|517-353-3011|Lorraine.Robbins@hc.msu.edu|
20519062|NCT04241133|Montana State University|Dr. Carmen Byker Shanks|406-994-1952|cbykershanks@montana.edu|
20519063|NCT00468208|Vasculitis Clinical Research Consortium|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
20519064|NCT00631007|InteKrin Therapeutics|Chief Executive Officer|650-941-5501|Info@intekrin.com|
20519065|NCT00683787|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20519066|NCT02674633|Akili Interactive Labs|Kathryn Jenkins|8572543399|kjenkins@akiliinteractive.com|
20519067|NCT00460109|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.|507/284-4642|ansell.stephen@mayo.edu|
20519068|NCT01235715|Hospital for Special Surgery|Dr. Mark P. Figgie|212-606-1932|figgiem@hss.edu|
20519069|NCT02994394|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20519070|NCT03619876|Columbia University|Laura Geraldino-Pardilla, MD|212-305-4308|lbg2124@cumc.columbia.edu|
20519071|NCT02344745|Keck School of Medicine|Begum Ozel, M.D.|323-226-3416|ozel@usc.edu|
20519072|NCT02788513|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519073|NCT04982445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20519074|NCT00646763|Emory University Winship Cancer Institute|Edmund Waller, MD, PhD|1-888-946-7447|ewaller@emory.edu|
20519075|NCT04968925|Johnson & Johnson Vision Care, Inc. (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
20563980|NCT05817708|Senhwa Biosciences, Inc.|Gina Huang|+886-2-89119856|ginahuang@senhwabio.com|111
20563981|NCT03056040|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20563982|NCT04650087|Duke University Medical Center|Dr. Thomas Ortel|919-684-5350|thomas.ortel@duke.edu|3
20563983|NCT03445988|Stanford University|Beth Darnall, PhD|N/A|bdarnall@stanford.edu|
20563984|NCT05065658|Medical University of Graz|Dr. Juergen Prattes|004331638530046|juergen.prattes@medunigraz.at|
20563985|NCT04274764|University of Michigan|Paula Anne Newman-Casey|734 763-6967|panewman@med.umich.edu|
20563986|NCT03427580|Bar-Ilan University|Prof. Ilanit Hasson-Ohayon|+972-3-5317673|ilanithasson@gmail.com|
20563987|NCT03210272|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20563988|NCT05694286|University of Pennsylvania|Ivona Percec, MD, PhD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
20563989|NCT01728857|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20529424|NCT01607593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529425|NCT04428385|Duke University|Wendy Prudhomme - O'Meara, PhD|919-613-4406|wendy.omeara@duke.edu|
20529426|NCT02515630|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20529427|NCT00165503|Brigham and Women's Hospital|Dr. David Sugarbaker|617-732-5004|dsugarbaker@partners.org|
20529428|NCT02346708|University of Colorado Denver - Anschutz Medical Campus|Isabelle Buard, PhD|(303)724-5973|Isabelle.Buard@cuanschutz.edu|
20529429|NCT03416270|University Health Network|Dr. David Cherney|416.340.4151|david.cherney@uhn.ca|
20529430|NCT00483652|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|(914) 347-4300|ablight@acorda.com|102
20529431|NCT00848016|Mayo Clinic Cancer Center|Michael E. Menefee, M.D.||menefee.michael@mayo.edu|
20529432|NCT00891813|Abbott|Global Medical Services|1-800-633-9110||
20529433|NCT04474483|University at Buffalo, SUNY|Sanjay Sethi MD|7168884864|ssethi@buffalo.edu|
20529434|NCT00685516|UCLA|Susanne Henning, Ph.D., Principal Investigator|310-825-9345|shenning@mednet.ucla.edu|
20529435|NCT00597818|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20529436|NCT03250689|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20529437|NCT02157519|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
20529438|NCT01656395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529439|NCT02318849|University of Hawaii|Cheryl Albright, PhD, Prinicipal Investigator|808-956-9716|cherylal@hawaii.edu|
20529440|NCT04919317|Temple University Hospital|George Taylor, MD, MS; surgical resident|2678150512|George.Taylor@tuhs.temple.edu|
20529441|NCT00230048|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
20529442|NCT02869789|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20529443|NCT02389959|Stanford University|Peter H. Hwang, MD|(650) 723-5281|hwangph@stanford.edu|
20529444|NCT00676403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20529445|NCT03506048|Emory University|Dr. Taofeek Owonikoko|412-647-9975|owonikokotk2@upmc.edu|
20529446|NCT00297648|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20529447|NCT04585919|Harvard TH Chan School of Public Health|James Daly|617-384-8915|jdaly@hsph.harvard.edu|
20529448|NCT05209880|Brigham and Women's Hospital|Kei Ouchi, MD, MPH|6175257771|kouchi@bwh.harvard.edu|
20529449|NCT01982695|Nationwide Children's Hopsital|Dr. Jerry R. Mendell|(614) 722-5615|Jerry.Mendell@NationwideChildrens.org|
20529450|NCT05044429|GWUniversity|Principal Investigator|202-823-4259|eheinz@mfa.gwu.edu|
20563990|NCT03853746|Johns Hopkins Universtiy|Bardia Nourbakhsh|410-614-1522|bnourba1@jhmi.edu|
20563991|NCT00450658|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
20529451|NCT03675360|Tulane University School of Public Health and Tropical Medicine|Dr. Kirsten Dorans, Assistant Professor, Department of Epidemiology|15049880883|kdorans@tulane.edu|
20529452|NCT03143101|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
20529453|NCT05227118|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529454|NCT01435759|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20529455|NCT02541864|Kaohsiung Veterans General Hospital|Dr. Feng-Woei Tsay|+886-7-3422121|fwchaie@vghks.gov.tw|8233
20529456|NCT03727841|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
20529457|NCT01601496|Getinge Group|Elizabeth Bulger|603 880 1433 ext 5368|Elizabeth.Bulger@getinge.com|
20529458|NCT03126786|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20529459|NCT03243305|Evofem, Inc.|Chief Medical Officer|858 550 1900|kculwell@evofem.com|
20529460|NCT02689804|Columbia University|Carolyn L. Westhoff, MD|212-305-4805|clw3@columbia.edu|
20529461|NCT00227539|University of Washington|Renato G. Martins|206-288-6680|rgmart@uw.edu|
20529462|NCT01655719|University of Michigan|Tim Muth|734-615-8914|tmuth@med.umich.edu|
20529463|NCT00673257|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20529464|NCT01569126|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529465|NCT01166750|University of Kansas Medical Center|Michael A. Rapoff, PhD., Principal Investigator|913-588-6323|mrapoff@kumc.edu|
20529466|NCT00289094|DePuy Orthopaedics, Inc.|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
20529467|NCT02417753|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@nih.gov|
20563992|NCT01083758|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20529468|NCT03113968|Department of Psychiatry, Mass General Brigham, and Harvard Medical School|Dr. Amit Anand|6177266421|aanand7@bwh.harvard.edu|
20529469|NCT01387178|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519076|NCT02046863|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
20519077|NCT00396630|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519078|NCT02327325|Health Services Research & Development, Durham VA Healthcare System|Kelli Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
20519079|NCT02919111|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|22648
20519080|NCT00951093|Clinica Gastrobese|Carlos AS Madalosso, Director of Department of Metabolic and Bariatric Surgery|+55(54)3045-4070|madalosso@gastrobese.com.br|
20519081|NCT01118026|Alliance for Clinical Trials in Oncology|Ann S. LaCasce, MD|617-632-5959|alacasce@partners.org|
20519082|NCT02457819|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20519083|NCT03330236|Yale University|Lingzhong Meng, MD|(203) 785-2198|lingzhong.meng@yale.edu|
20519084|NCT00763555|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20519085|NCT00974350|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20519086|NCT02725645|Universidade Fernando Pessoa|Sandra Beatriz Pereira Rodrigues||sandrar@ufp.edu.pt|
20519087|NCT01332968|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20519088|NCT00194792|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20519089|NCT02448563|Boston Medical Center|Ashley McCarthy, Clinical Research Manager|617-638-5906|ashley.mccarthy@bmc.org|
20519090|NCT00113919|University of Arkansas for Medical Sciences|Nathan Petty|501-837-3894|pettynathanm@uams.edu|
20519091|NCT01194908|Emory University School of Medicine|Ruth O'Regan, MD|404-778-4824|roregan@emory.edu|
20519092|NCT01742208|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20519093|NCT02340962|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7020|lwchang@taigenbiotech.com|1227
20519094|NCT00722436|The Childrens Hospital of Pittsburgh of UPMC|Franklyn Cladis|412-692-5260|cladfp@upmc.edu|
20519095|NCT02092857|University of Alberta|Dr. Tom Clandinin|7804925188|tclandin@ualberta.ca|
20519096|NCT01292837|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
20519097|NCT00216060|Hoosier Oncology Group|Christopher Sweeney, M.B., B.S.|(617) 632 4524|christopher_sweeney@dfci.harvard.edu|
20519098|NCT02174276|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20519099|NCT01206439|University of Cincinnati|Jack Rubinstein|513-558-3062|rubinsjk@ucmail.uc.edu|
20519100|NCT03417739|Dana Farber Cancer Institute|Elizabeth Buchbinder, MD|617-632-5055|Elizabeth_buchbinder@dfci.harvard.edu|
20519101|NCT02661022|Stemline Therapeutics, Inc.|Ira Gupta, MD, Senior Vice President, Clinical Development & Medical Affairs - Hematology|877-332-7967|clinicaltrials@menarinistemline.com|
20519102|NCT05889039|LECOM|Dr. Santiago Lorenzo|941-782-5974|slorenzo@lecom.edu|
20519103|NCT01055886|VA Medical Center|Angela Kirby|919-286-0411|angela.kirby@va.gov|5526
20519104|NCT00609154|Albert Einstein College of Medicine|Dr. Daniel Stein|718-430-2237|daniel.stein@einsteinmed.edu|
20519105|NCT04531527|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20519106|NCT01272076|TLC Eyecare and Laser Centers|Carmelina Gordon, MD|(517) 7821213|shellie.fuentes@tlcmi.com|
20519107|NCT00569660|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
20519108|NCT03937791|National Cancer Institute|Scott Norberg, D.O.|301-275-9668|scott.norberg@mail.nih.gov|
20519109|NCT02180230|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
20519110|NCT01819064|Women and Children's Hospital of Buffalo, State University of New York at Buffalo|Dr. Jerrold Lerman|7168787701|jlerman@buffalo.edu|
20551514|NCT01270711|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519111|NCT04155840|University of Washington|Dr. Ryan Lynch|206-606-1739|rclynch@uw.edu|
20519112|NCT00434837|Rhode Island Hospital|Dr. Braden C. Fleming|401-316-4737|braden_fleming@brown.edu|
20519113|NCT01077258|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20519114|NCT00142116|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
20519115|NCT04079452|Hospital de Bellvitge|Clinical Project Manager|+34675335888|anavarroa@bellvitgehospital.cat|
20519116|NCT00345033|Massachusetts General Hospital|David C. Henderson|(617) 912-7800|dchenderson@partners.org|
20519117|NCT02102932|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20519118|NCT01658995|Mayo Clinic|Petra M. Casey, M.D.|507-266-9873|Casey.Petra@mayo.edu|
20519119|NCT01186562|University of Minnesota|Melena D. Bellin|612-624-5409|bell0130@umn.edu|
20519120|NCT01517867|Johns Hopkins University|Deborah Gross|410-614-5311|debgross@jhu.edu|
20519121|NCT01266603|U T MD Anderson Cancer Center|Dr. Michael A Davies, BA,MD,PHD/Melanoma Medical Oncology|713-792-3454|MDavies@mdanderson.org|
20519122|NCT01685216|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20519123|NCT00645827|Emory University|G. Randy Smith Jr.|404.686.6730|grsmith@emory.edu|
20519124|NCT00756717|Loyola University Medical Center|Dr. Kathy Albain|708-327-3102|KALBAIN@lumc.edu|
20519125|NCT02654015|Icahn School of Medicine at Mount Sinai|Samantha St. Elin|(212) 241-1497|samantha.stelin@mountsinai.org|
20519126|NCT02418754|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20551515|NCT00453544|UC San Diego|Dr. Barton Palmer|858-246-0765|bpalmer@ucsd.edu|
20551516|NCT02315170|Raj K M|Raj K Maturi MD|3178171414|maturi.md@midwesteye.com|
20551517|NCT00619801|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20551518|NCT02172742|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
20551519|NCT01471106|M D Anderson Cancer Center|Dr. Arun K. Banu|(713) 792-2817|barun@mdanderson.org|
20551520|NCT01953120|UCLA|Dr. Suphamai Bunnapradist|3107948516|bunnapradist@mednet.ucla.edu|
20551521|NCT00233103|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
20551522|NCT03855280|Medexus Pharma|Julissa Leon|3125483125|julissa.leon@medexus.com|
20563993|NCT01084876|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
20563994|NCT04727554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20563995|NCT05763823|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20563996|NCT04487145|University of Califronia San Francisco|Liusheng Huang(Co-Investigator and Drug Research Unit Co-Director)|415-502-2594|liusheng.huang@ucsf.edu|
20563997|NCT05311384|University of Alabama at Birmingham|Sarah dos Anjos|205.934.7323|smanjos@uab.edu|
20563998|NCT05329493|Massachusetts General Hospital|Dr. Dieter Manstein|617-726-4893|dmanstein@mgh.harvard.edu|
20563999|NCT05386758|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20564000|NCT02908477|Mayo Clinic|Katharine Price M.D.|507-284-6139|Price.Katharine@mayo.edu|
20564001|NCT02924272|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20564002|NCT05326776|UC San Diego|Dr. Laura Case|858-246-4968|lcase@health.ucsd.edu|
20564003|NCT06213194|Ibn Haldun University|Dr. Dilruba Sönmez|905365646640|dilrubasonmez@gmail.com|
20564004|NCT05116787|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20564005|NCT02737436|University of Iowa|Dr Lane Strathearn|2193849464|lane-strathearn@uiowa.edu|
20564006|NCT02919683|Dana-Farber Cancer Institute|Jonathan Schoenfeld, M.D. M.P.H.|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
20564007|NCT01552473|The University of Texas at Dallas, Center for BrainHealth|Dr. Daniel Krawczyk, Primary Investigator|214-905-3007|dck061000@utdallas.edu|
20564008|NCT05551637|National Institute of Nutrient|Dr. Nguyen Song Tu|0912322602|nguyensongtu@gmail.com|
20519127|NCT01896505|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20519128|NCT04291508|Massachsetts General Hospital|PETAL Network Coordinatine Center PI, B. Taylor Thompson, MD|617 872-2882|tthompson1@mgh.harvard.edu|
20519129|NCT03298880|University of Exeter, Royal Devon and Exeter Hospital|Dr Andrew Appelboam, Isabel FitzGerald|07515688294|andy.appelboam@nhs.net ; if223@exeter.ac.uk|
20519130|NCT01992094|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20519131|NCT03168906|Tufts Medical Center|Jaime Chisholm|617-636-5409|jchisholm1@tuftsmedicalcenter.org|
20519132|NCT02367872|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20519133|NCT02625298|Faculty of Dentistry, University of Belgrade|Dr. Dejan Markovic, professor at Clinic for Pediatric and Preventive Dentistry|+381600203041|dejan.markovic@stomf.bg.ac.rs|
20519134|NCT02710240|University of Pennsylvania|Marie Kerr, Project Manager|215-829-6720|marie.kerr@pennmedicine.upenn.edu|
20519135|NCT00559637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20519136|NCT04231409|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
20519137|NCT04129944|Unity Biotechnology, Inc.|Chief Medical Officer|650-416-1192|Clinicaltrials@unitybiotechnology.com|
20519138|NCT04501094|National Cancer Institute|Dr. Andrea B. Apolo|301-480-0536|andrea.apolo@nih.gov|
20519139|NCT02076776|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
20519140|NCT00835796|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20519141|NCT00651183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519142|NCT00357955|Providence VA Medical Center|Wen-Chih Wu, MD; Principal Investigator|4012737100|wen-chih.wu@va.gov|6237
20519143|NCT02014441|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20519144|NCT02576717|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20519145|NCT00399893|Duke University Medical Center|Michael Freemark, MD|919-684-5091|andrea.haqq@albertahealthservices.ca|
20519146|NCT01363011|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20519147|NCT06217796|Eyenovia|Greg M. Bennett, VP, Clinical Program Strategy and Development|833-393-6684|gbennett@eyenovia.com|5
20519148|NCT01191476|Abbott|Global Medical Services|800-633-9110||
20519149|NCT01901848|Durham Veterans Health Care System|Eric Dedert, Ph.D.|919-384-8582|eric.dedert@va.gov|4055
20519150|NCT01729026|South Texas Veterans Health Care System; University of Texas Health Science Center at San Antonio|Dr. Stephen Stern|210-887-3754|stephen.stern@va.gov; sterns@uthscsa.edu|
20519151|NCT00493064|PaloAltoMF|Renee Kaneshiro, study coordinator|650-853-4744|kaneshr@pamf.org|
20519152|NCT00407745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20519153|NCT00108082|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519154|NCT02419924|Mayo Clinic|Dr. Amy Foxx-Orenstein|480-301-6990|foxx-orenstein.amy@mayo.edu|
20519155|NCT00955552|Eurofarma Laboratórios|Eurofarma Laboratórios|08007043876||
20519156|NCT02940730|University of Colorado|Dr. Tyree Kiser|3037242883|ty.kiser@ucdenver.edu|
20519157|NCT03449199|Teijin America, Inc.|President|1-415-887-9742|clinical-trials-contact@teijinpo.com|
20519158|NCT03307564|SKCCC @ Johns Hopkins|Amol Narang. MD|410-955-7390|anarang2@jhmi.edu|
20519159|NCT00906373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20519160|NCT01597479|Hospital de la Santa Creu i Sant Pau|Dra. Mireia Rodriguez Prieto|677896054|mrodriguezpr@santpau.cat|
20519161|NCT00348816|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1103|swansong@uthscsa.edu|
20519162|NCT00848042|Nanospectra Biosciences, Inc.|Robin Dickson|7138422720|rdickson@nanospectra.com|216
20519163|NCT01470196|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
20519164|NCT02916693|Johns Hopkins University|Dr. Arthur L. Burnett|410-614-3986|aburnet1@jhmi.edu|
20519165|NCT01190930|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20519166|NCT05932810|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
20519167|NCT01628549|Allergan|Thearpeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20519168|NCT00115869|Fred Hutchinson Cancer Research Center|Arthur V. Peterson, Jr. PhD|206-667-5131|avpeters@fhcrc.org|
20564009|NCT05179837|Washington University School of Medicine|Vladimir Kushnir, M.D.|314-362-3685|vkushnir@wustl.edu|
20564010|NCT03158129|MD Anderson Cancer Center|Tina Cascone, MD|713-792-6363|tcascone@mdanderson.org|
20564011|NCT03719443|Parexel International|Principal Investigator|(781) 487-9900|info@parexel.com|
20564012|NCT04782973|Massachusetts General Hospital|Kaavya Paruchuri, MD|617-726-1843|kparuchuri@mgh.harvard.edu|
20564013|NCT04924660|Vanderbilt University Medical Center|Sean P. Collins, MD|615-343-8010|vcc@vumc.org|
20564014|NCT00554788|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20564015|NCT06491433|Department of Cardiology at Gangnam Severance hospital|Byoung Kwon Lee|+82-10-2721-8813|CARDIOBK@yuhs.ac|
20564016|NCT04572399|Cedars-Sinai|Melissa Hampton|3104230617|Melissa.Hampton@cshs.org|
20564017|NCT05796583|University of California San Diego|Professor of Anesthesiology|(858) 220-5714|bilfeld@health.ucsd.edu|
20564018|NCT05093478|The University of Texas Health Science Center at Houston|Kunal R Shetty, MD|713-486-5000|Kunal.R.Shetty@uth.tmc.edu|
20564019|NCT05582746|University of Kansas Medical Center|Dr. Jason E Glenn|9135880076|jglenn4@kumc.edu|
20564020|NCT03721952|University of Washington|Dr. Ruth Engelberg|206-744-9523|rengel@uw.edu|
20564021|NCT05891353|University of Central Florida|Abigail Anderson|4078231026|Abigail.Wilson@ucf.edu|
20564022|NCT04541147|Duke University|Eileen M. Raynor, MD|919-613-4573|eileen.raynor@duke.edu|
20564023|NCT03476460|Hospital Universitario Ramón y Cajal, IRYCIS|Coordinator of Research Support Unit, Internal Medicine Dept.|0034913369082|martin.fabregate@salud.madrid.org|
20564024|NCT05332366|Leo Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
20564025|NCT04026555|Icahn School of Medicine at Mount Sinai|Dr. Matthew Levin|212-241-8382|matthew.levin@mssm.edu|
20564026|NCT05184192|Washington University, Department of Otolaryngology - Head and Neck Surgery|Jay F. Piccirillo|314-362-8641|piccirj@wustl.edu|
20564027|NCT02649842|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|1+ 714-247-8429|djanaki1@its.jnj.com|
20564028|NCT05480124|University of Michigan|Stephan Taylor|(734) 936-4955|sftaylor@med.umich.edu|
20564029|NCT03703492|UW School of Medicine and Public Health|Amy Fowler, MD, PhD|608-262-2122|afowler@uwhealth.org|
20564030|NCT04550468|University of British Columbia|Dr. Jonathan Little|250-807-9876|jonathan.little@ubc.ca|
20564031|NCT03640312|Washington University in St. Louis|Guhan Iyer|3147479487|guhaniyer@wustl.edu|
20564032|NCT05733975|Duke Univerisity Medical Center|Dr. Monica Lemmon|919-668-0477|monica.lemmon@duke.edu|
20519169|NCT04205162|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20519170|NCT01999894|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
20519171|NCT02958319|Servicio de Reumatología del Hospital Universitario|David Vega-Morales MD|52 81 80485210|drdavidvega@yahoo.com.mx|
20519172|NCT02914457|Medtronic Bakken Research Center|Richard Cornelussen|+31433566651|richard.cornelussen@medtronic.com|
20519173|NCT01769222|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
20519174|NCT00781079|Pittsburgh VA|Matthew Chinman|412 360-2438|matthew.chinman@va.gov|
20519175|NCT01450800|Duke University Medical Center|Dr. Alexis Dieter|919-401-1006|alexis.dieter@duke.edu|
20519176|NCT03316976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20519177|NCT02058160|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20519178|NCT05862844|School of Medicine, Virginia Commonwealth University|Asmaa Namoos|804-628-4754|Asmaa.Namoos@vcuhealth.org|
20519179|NCT00152516|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20519180|NCT02767947|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
20519181|NCT03224520|University of Massachusetts Medical School|Rajani Sadasivam|508-856-8923|rajani.sadasivam@umassmed.edu|
20519182|NCT01086969|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20519183|NCT01041209|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43070140|slaip@intramed.net|
20519184|NCT01139294|Vanderbilt University Medical Center|Thomas Abramo, MD||tjabramo@uams.edu|
20519185|NCT02762994|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
20519186|NCT00176930|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
20519187|NCT01488448|Children's Hospital at Montefiore/Albert Einstein College of Medicine|Dr. Alyssa Silver|718-741-2304|alysilve@montefiore.org|
20519188|NCT00654641|West Viginia University|Michael L. Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
20519189|NCT00810602|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-764-8630|sungchoi@med.umich.edu|
20519190|NCT03840382|Rhode Island Hospital|Dr. Larry Brown|+1 (401) 793-8808|lkbrown@lifespan.org|
20519191|NCT00434590|Novartis Pharmaceuticals|Study Director|862-778-8300||
20519192|NCT03429049|Centrexion Therapeutics, Inc.|Director of Clinical Operations|617-837-6911|info@centrexion.com|
20519193|NCT04703855|Abbott|Carlo Gazzola|+3227746811|carlo.gazzola@abbott.com|
20519194|NCT00571194|Arkansas Children's Hospital|Dr. Eileen Ellis|501-364-1847|elliseileenn@uams.edu|
20519195|NCT01560819|Helen DeVos Children's Hospital of Spectrum Health Hospitals|Dr. Sachin Kunde|616-267-2100|sachin.kunde@helendevoschildrens.org|
20519196|NCT04412057|Avalo Therapeutics, Inc.|Scott White, MD|484-763-3080|swhite@avalotx.com|
20519197|NCT00114231|Memorial Sloan Kettering Cancer Center|Julio Garcia-Aguilar, MD|212-639-5506|garciaaj@mskcc.org|
20519198|NCT02156154|Cleveland Clinic|Alparslan Turan, MD|216-445-0998|turana@ccf.org|
20519199|NCT02051595|University of Florida|Dr. Ettore Crimi|617-697-2861|ettorecrimi@gmail.com|
20519200|NCT01625507|University of Alberta|Dr. Catherine Chan|780-492-9939|cbchan@ualberta.ca|
20519201|NCT01961882|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20519202|NCT00368316|PDMI, NICHD, NIH|Dr. Rachel Schneerson, Co-Director|301-469-0850|schneerr@mail.nih.gov|
20519203|NCT00928226|Stanford University|Scott Soltys, Associate Professor of Radiation Oncology|65072441569|sgsoltys@stanford.edu|
20564033|NCT05455086|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20564034|NCT06037369|Chang Gung University, Taiwan|Yen-Fan Chin|032118800|yenfan@mail.cgu.edu.tw|5189
20564035|NCT05603143|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20564036|NCT05783102|Case Western Reserve University|Kylie Meyer|216-368-1928|knm77@case.edu|
20564037|NCT03993509|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
20564038|NCT05179395|James A Haley Veterans' Hospital and Clinics|Dr. Jeffrey Heckman|813.972.2000|jeffrey.t.heckman@va.gov|7506
20564039|NCT00812461|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20564040|NCT05302596|State University of NY at Buffalo|Husam Ghanim|7168818924|ghanim@buffalo.edu|
20564041|NCT00667251|Novartis Pharmaceuticals|Clinical Disclosure Office|1-862-778-8300|Novartis.email@novartis.com|
20564042|NCT04927637|Dartmouth Health Orthopaedics|Dr. Ida Leah Gitajn|(603) 650-5133|Ida.Leah.Gitajn@hitchcock.org|
20564043|NCT02754882|Samsung Bioepis Co., Ltd|Director of Clinical Trials|031-8061-1096|sbregistry@samsung.com|
20564044|NCT04363515|Hennepin Healthcare Research Institute|Dr. Allyson Hart|612-873-6998|allyson.hart@hcmed.org|
20564045|NCT02543281|Cleveland Clinic, Lerner Research Institute|Larisa Tereshchenko|2164442445|tereshl@ccf.org|
20564046|NCT05247489|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20564047|NCT04323137|Geisinger Health|Amir Goren, PhD|570-214-4395|agoren@geisinger.edu|
20564048|NCT05215314|University of Wisconsin-Madison|Daniel Grupe|608-263-7572|grupe@wisc.edu|
20564049|NCT04179500|TB Alliance|Antonio Lombardi|917-601-0024|Antonio.Lombardi-Consultant@tballiance.org|
20564050|NCT03992274|Columbia University|Kathrine Meyers, DrPH, MPP, MSc|2123046110|kam2157@cumc.columbia.edu|
20564051|NCT03366649|Emory University|Dr. Robert Guyton|404 686-4499|rguyton@emory.edu|
20564052|NCT03673111|Imperial College London|Professor Tricia Tan|020 8383 8038|t.tan@imperial.ac.uk|
20564053|NCT03792555|Crinetics Pharmaceuticals Inc.|Crinetics Clinical Trials|+1 858-450-6464|clinicaltrials@crinetics.com|
20564054|NCT04485039|SIGA Technologies|Emily Blum, Director of Clinical Development|541-224-1305|eblum@siga.com|
20564055|NCT01744782|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
20564056|NCT01747863|Research Institute of the McGill University Health Center|Dr. Guilherme Sant'Anna|(514) 412-4400|guilherme.santanna@mcgill.ca|23489
20564057|NCT02120456|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20529470|NCT04805671|INVIVYD, Inc.|Study Inquiry|+1 781-819-0080|ClinicalTrials@invivyd.com|
20529471|NCT02111174|Johns Hopkins SKCCC|Thomas Smith, M.D.|410-955-2091|tsmit136@jhmi.edu|
20529472|NCT00901342|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
20529473|NCT02849587|University of California, San Diego; Center for Medicinal Cannabis Research|Thomas D. Marcotte, Phd|619-543-5044|tmarcotte@ucsd.edu|
20529474|NCT00687908|Galderma|Clinical Project Manager|+33 492 95 29 21|jean-charles.dhuin@galderma.com|
20551523|NCT01879332|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20551524|NCT00461682|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551525|NCT05020990|CooperVision Inc.|Director Global Clinical Affairs|+19256213761|jvega2@coopervision.com|
20551526|NCT00642941|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
20551527|NCT00553150|Mayo Clinic|Jann N. Sarkaria, M.D.|507/284-3559|sarkaria.jann@mayo.edu|
20551528|NCT01895855|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
20551529|NCT03559257|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20551530|NCT03204305|Johns Hopkins School of Medicine|Dr. Elise M. Weerts, PhD, Professor|443-550-2781|eweerts@jhmi.edu|
20551531|NCT00455429|Janssen Research and Development, 3210 Merryfield Row San Diego, CA 92121|William Barchuk, M.D.|858-784-3111||
20551532|NCT01165554|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
20551533|NCT01865539|Canandaigua VA Medical Center|Dr. Paul Dougherty, PI|585-463-2673|paul.dougherty@va.gov|
20551534|NCT00196716|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
20564058|NCT05192200|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519204|NCT03710590|Virginia Commonwealth University|Dr. Alison Breland|804 628 2300|abbrelan@vcu.edu|
20519205|NCT02488824|VAORD|Dr John Handrakis|(718) 584-9000|John.Handrakis@va.gov|5439
20519206|NCT03765996|Dr. İsmail Atabek Physiotherapy and Rehabilitation Center|Ertan Şahinoğlu|+90 532 647 86 53|ertan.sahinoglu@hotmail.com|
20519207|NCT02970552|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joni@email.unc.edu|
20519208|NCT02668822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519209|NCT01522950|University of Minnesota|Jay N. Cohn, M.D., Professor of Medicine|612.625.5646|cohnx001@umn.edu|
20519210|NCT01795079|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|fregni.felipe@mhg.harvard.edu|
20519211|NCT03036839|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20519212|NCT01701037|Vanderbilt-Ingram Cancer Center|Mark C. Kelley|615-936-7423|mark.kelley@vanderbilt.edu|
20519213|NCT00412737|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20519214|NCT04057248|Diabetes and Endocrinology Consultants of Pennsylvania, LLC (Decpa LLC)|Dr. Alan Schorr|2157501691|abs@sugardoc.com|
20519215|NCT01064531|Smith & Nephew, Inc|Tracey Brengola, MS|978-749-1491|Tracey.brengola@smith-nephew.com|
20519216|NCT00298740|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20519217|NCT02740920|Canadian Cancer Trials Group|Janet Dancey|613-533-2430|jdancey@ctg.queensu.ca|
20519218|NCT00513617|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
20551535|NCT03251508|UNC Food Allergy Initiative|Edwin Kim, MD, MS|919-537-3193|edwinkim@email.unc.edu|
20564059|NCT01785719|Cornell University|Marla Lujan, PhD|(607) 255-3153|mel245@cornell.edu|
20564060|NCT03443323|Children's Hospital of Philadelphia|Dr. Thomas J. Power|215-590-7447|power@chop.edu|
20564061|NCT04492007|University of North Carolina Lineberger Comprehensive Cancer Center|Xianming Tan PhD|919-966-8450|xianming@email.unc.edu|
20564062|NCT03463824|Virginia Commonwealth University|Dr. James Thomas|740-591-1563|jthomas32@vcu.edu|
20564063|NCT04887129|University of Rochester|John Foxe, Phd|585 - 275 - 2591|John_foxe@urmc.rochester.edu|
20564064|NCT04294290|Duke University|Joanne Kurtzberg, MD|919-668-1119|joanne.kurtzberg@duke.edu|
20564065|NCT04896476|Sonavex|Katy Feeny, Director of Clinical Affairs|443-862-2024|KFEENY@SONAVEX.COM|
20564066|NCT03476187|ZOLL|Nicole Bianco|4129683333|NBianco@zoll.com|14410
20564067|NCT04406857|University of Kentucky|Dr. Charles Kunos|859-323-6486|Charles.Kunos@uky.edu|
20564068|NCT05948670|Woebot Health|Tim Campellone, PhD|(415) 209-5642|research@digitaltherapeutic.io|
20564069|NCT00390793|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD./ Professor|713-745-0394|fravandi@mdanderson.org|
20564070|NCT00583349|Columiba University Medical Center|Dr. James McKiernan, John K. Lattimer Professor and Chair of Department of Urology|212-342-3976|jmm23@cumc.columbia.edu|
20564071|NCT00845481|LEO Pharma|Torsten Skov, Senior Medical Advisor|+45 20 73 62 94|torsten.skov@leo-pharma.com|
20564072|NCT05260684|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20564073|NCT03064217|University of Maryland, Baltimore|Se-Lim Oh|4107063708|soh@umaryland.edu|
20564074|NCT02724631|Children's Hospital of Philadelphia|Sharon Y Irving|215 590-1000|irvings@chop.edu|
20564075|NCT05076708|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
20564076|NCT04971395|Xentria, Inc.|Tom Matthews, Director of Clinical Research|224.443.4615|tmatthews@xentria.com|
20564077|NCT02487056|Cardiovascular Academy Society|Dr. Mehdi Zoghi|3904001|mehdi_zoghi@hotmail.com|
20564078|NCT05087693|UNiversity of BRitish COlumbia|Michael Koehle|8229331|michael.koehle@ubc.ca|
20564079|NCT04721912|University of New Mexico|Katrina Nardini, CNM, WHNP-BC, MPH|505-205-4118|hsc-familyplanningresearch@salud.unm.edu|
20564080|NCT01814501|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-3873|John.Hays@osumc.edu|
20564081|NCT05051124|NYU Langone Health|Jessica Gjonaj|646-501-3663|Jessica.gjonaj@nyulangone.org|
20564082|NCT06181006|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20564083|NCT06205407|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20564084|NCT02936752|Yale School of Medicine|Amer Zeidan, MBBS|(203) 200-4363|amer.zeidan@yale.edu|
20564085|NCT05894577|Duke University|Susanna Naggie, MD|919-684-2584|susanna.naggie@duke.edu|
20564086|NCT03241459|Surmodics|Kimberly Hawkinson|952-500-7563|khawkinson@surmodics.com|
20564087|NCT05191472|University of California, San Francisco|Dr. Alfred Chung, MD|(415) 476-1000|Alfred.Chung@ucsf.edu|
20564088|NCT02132936|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20529475|NCT03380377|Cedars Sinai Medical Center|Stan Jordan, MD|3104232641|stan.jordan@cshs.org|
20529476|NCT02716779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20529477|NCT00910845|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20529478|NCT02600923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529479|NCT00792909|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529480|NCT04865029|Tulane University|Franck Mauvais-Jarvis|504-259-1139|fmauvais@tulane.edu|
20529481|NCT04907214|Vanderbilt University Medical Center|Dr. Mona Mashayekhi|615-936-1760|mona.mashayekhi@vumc.org|
20529482|NCT01275144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529483|NCT05607576|Cincinnati Children's Hospital Medical Center|Deborah Elder; Associate Professor|5136364744|Deborah.Elder@cchmc.org|
20529484|NCT01377636|New York University Langone Medical Center, Anesthesiology|Patrick Linton, MD, Director of Adult Off-Site Anesthesia Services|212-263-5072|Patrick.Linton@nyumc.org|
20529485|NCT03030625|Hospital Universitario de La Princesa|Dr. Almudena Zapatero Laborda|+34 915 20 22 00|almudena.zapatero@salud.madrid.org|
20529486|NCT02223351|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20529487|NCT00003471|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20529488|NCT03571724|22nd Century Group, Inc.|Karen E. Delaney|716-270-1523|kdelaney@xxiicentury.com|
20529489|NCT00735007|Merck Serono International, S.A., an affiliate of Merck KGaA, Darmstadt, Germany|Elisabetta Verdun di Cantogno|+41 22 414 4887|elisabetta.verdun@merckserono.net|
20529490|NCT00715403|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20529491|NCT02104895|Radiation-Oncology Unit, AOU Careggi, Florence University, Florence, Italy|Dr. Icro Meattini|+39055794|icro.meattini@unifi.it|7719
20529492|NCT01815502|MUSC|Dr. Andrew M Atz|843-876-1698|atzam@musc.edu|
20529493|NCT01817075|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20529494|NCT00816777|Generic Devices Consulting, Inc|John Greenbaum|772-353-5301|genericd@bellsouth.net|
20529495|NCT02481050|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20529496|NCT01386606|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
20564089|NCT03197662|Montefiore Medical Center|Dr. Eric Hollander|718-839-7516|eholland@montefiore.org|
20564090|NCT05292365|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
20564091|NCT06398886|Istanbul Nisantasi Universitesi|Metin Çınaroğlu|009053247320|metincinaroglu@gmail.com|
20564092|NCT01463423|Stanford University|Maximilian Diehn, MD, PhD|650-725-4783|diehn@stanford.edu|
20564093|NCT04495894|Emory University|Viraj Master, MD, PhD|404-778-4898|vmaster@emory.edu|
20564094|NCT03364647|University of Kentucky|Brian Noehren|859-323-1100|b.noehren@uky.edu|
20564095|NCT01000961|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
20564096|NCT05184894|Mayo Clinic|Erin Barreto, PharmD, MS|507-284-2511|barreto.erin@mayo.edu|
20564097|NCT05746455|Columbia University|Dr. Alice Saperstein|646-774-8464|ams2334@cumc.columbia.edu|
20564098|NCT03307343|West Virginia University|Bethany Barone Gibbs|304-581-1779|bethany.gibbs@hsc.wvu.edu|
20564099|NCT01120223|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20564100|NCT03447470|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
20564101|NCT04592549|Resilience Government Services|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
20564102|NCT04295798|Hebrew SeniorLife|Junhong Zhou|617-971-5346|JunhongZhou@hsl.harvard.edu|
20564103|NCT05538754|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|2905
20564104|NCT04624633|Dana-Farber Cancer Institute|Jennifer R Brown MD PhD|617-632-4894|Jennifer_Brown@dfci.harvard.edu|
20564105|NCT01959425|Biosense Webster Inc.|Stephanie Lyke|(949) 285-7966|SLyke@its.jnj.com|
20564106|NCT04471038|SAB Biotherapeutics|Senior Director Clinical Operations|8326221699|ssinclair@sab.bio|
20519219|NCT01091103|Medivation, Inc.|Mohammad Hirmand, MD, VP, Clinical Development|415-829-4126|mohammad.hirmand@medivation.com|
20564107|NCT01902173|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
20564108|NCT01824394|Biosense Webster, Inc.|Megan Holden|(949) 923-4700|mholden8@its.jnj.com|
20564109|NCT05364671|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20564110|NCT03382652|Zimmer Biomet|Esther Foo|+41787183202|esther.foo@zimmerbiomet.com|
20564111|NCT04709783|University of Florida|Chiung-ju (CJ) Liu|352-273-6496|c.liu1@phhp.ufl.edu|
20564112|NCT04810650|University of California, San Francisco|Douglas Black|4158063016|douglas.black@ucsf.edu|
20564113|NCT05794243|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20564114|NCT01422434|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
20529497|NCT04159714|Mayo Clinic|Dr. Robert Hyde|507-255-4137|Hyde.Robert1@mayo.edu|
20529498|NCT02357459|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20529499|NCT03246347|Wake Forest|Danielle Boselli|2017903385|danielle.boselli@atriumhealth.edu|
20529500|NCT01548599|University of California, San Francisco|Sheri Weiser|(415) 314-0665|Sheri.Weiser@ucsf.edu|
20529501|NCT02188160|Kala Pharmaceuticals, Inc.|VP, Clinical Development|781-996-5252|results002@kalarx.com|
20529502|NCT04113694|Medtronic Diabetes|Emma Pham, MSHS (Clinical Study Manager)|818 576 4878|emma.pham@medtronic.com|
20529503|NCT00464685|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20529504|NCT00916578|UT MD Anderson Cancer Center|Woodward,Wendy,M.D., PH.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
20529505|NCT01228591|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
20529506|NCT00754741|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|chphsr@hfhs.org|
20529507|NCT01334086|Princess Margaret Cancer Centre|Dr. Karen Yee, Hematology and Medical Oncology Site Group Lead|416-946-4501|Karen.Yee@uhn.ca|4495
20529508|NCT04152200|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20529509|NCT04969289|Columbia University|Lauren Chernick, MD, MSc|212-305-9825|lc2243@columbia.edu|
20564115|NCT02761057|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
20564116|NCT03637660|University of Alabama at Birmingham|Edward W. Hook, III|205-932-4204|ehooks@uabmc.edu|
20564117|NCT04505904|University of Arizona|Brian Arizmendi|9168473623|arizmendi@email.arizona.edu|
20564118|NCT03629990|Medical University of South Carolina|Brian Sherman, Ph.D.|843-792-8174|shermanb@musc.edu|
20564119|NCT04277442|The Ohio State University|Dr. Alice Mims|(614) 293-3196|Alice.Mims@osumc.edu|
20564120|NCT05084508|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20519220|NCT01270620|Stanford University School of Medicine|Dr. Pedro Tanaka|6507244066|ptanaka@stanford.edu|
20519221|NCT00684567|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519222|NCT03136406|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20519223|NCT01201759|UNIVERSITY OF MIAMI- The Miami Project to Cure Paralysis|Dr. Mark S. Nash|(305) 243-3628|MNash@med.miami.edu|
20519224|NCT01045707|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20519225|NCT02744755|Hexal AG/Sandoz Inc.|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
20519226|NCT04317599|Pierre Fabre|Project leader|+33(0)1 49 10 81 84|farida.beghdad@pierre-fabre.com|
20519227|NCT00809965|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Development Head Cardiovascular/Urology|1 215 628-5257||
20519228|NCT02780167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519229|NCT02315066|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519230|NCT00035555|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20519231|NCT00337428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519232|NCT02618382|Dignity Health Research Institute|Lisa Arnold, Clinical Research Operations Manager|602-406-9593|lisa.arnold@arrowneuro.org|
20519233|NCT05181800|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20529510|NCT00593814|W.L. Gore and Associates|Tab Bonny|928 864 4275|tbonny@wlgore.com|
20529511|NCT02699996|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
20564121|NCT04836195|Pacylex Pharmaceuticals|VP Operations|1 (888) 580-4483|ryan.heit@pacylex.com|
20564122|NCT05609760|Universidad de concepción|Rosa Figueroa I, Associate Professor|+56412204247|rosa.figueroa@biomedica.udec.cl|
20564123|NCT03396588|University of Kentucky|Dr. Henrietta Bada|8593231019|henrietta.bada@uky.edu|
20564124|NCT01388777|UT MD Anderson Cancer Center|Hwang, Rosa, M.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
20564125|NCT05351554|Kinevant|Study Director|Please email|kinevant.resolve-heart@kinevant.com|
20564126|NCT06132867|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20564127|NCT03509116|Guy's & St Thomas' NHS Foundation Trust|Dr Alastair Duncan|02071882010|alastair.duncan@gstt.nhs.uk|
20564128|NCT04806594|Relife Srl|Clinical Trial Coordinator|055 56809345|sdipalma@relifecompany.it|
20564129|NCT05593510|UT Southwestern Medical Center|Kelseanna Hollis-Hansen|214-645-7676|kelseanna.hollis-hansen@utsouthwestern.edu|
20564130|NCT03457142|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
20564131|NCT06020534|Erasmus Medical Center|Drs. Yitian Fang|+31 645680154|y.fang.1@erasmusmc.nl|
20564132|NCT04977947|University of Cincinnati|Cathleen Stough, Ph.D.|513-556-5589|odarcc@ucmail.uc.edu|
20564133|NCT02921230|Boston Scientific|Andrew Campbell|763-494-2722|Andrew.Campbell@bsci.com|
20564134|NCT01926496|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
20564135|NCT04142788|University of Glasgow|Prof John Cleland|0141 330 7774|john.cleland@glasgow.ac.uk|
20519234|NCT00372996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519235|NCT00721955|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|:jcassella@alexza.com|
20519236|NCT01362192|Main Line Center for Laser Surgery|Eric F. Bernstein, M.D., M.S.E.|610-645-5551|dermguy@dermguy.com|
20519237|NCT00515216|Washington University School of Medicine|A. Craig Lockhart, M.D.|314-362-5740|alockhar@dom.wustl.edu|
20529512|NCT01921517|University of Pennsylvania Perelman School of Medicine|Felix W. Wehrli, Principal Investigator|215-662-7951|felix.wehrli@pennmedicine.upenn.edu|
20519238|NCT01562132|Yale University|Dr. Ana-Claire Meyer|203-737-8372|ana-claire.meyer@yale.edu|
20519239|NCT03496298|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20519240|NCT00676494|Pathway Medical Technologies, Inc.|Kevin Peters/Director of Clinical Affairs|425-636-4053|petersk@pathwaymedical.com|
20519241|NCT01203917|AstraZeneca|Haiyi Jiang|+86 21 60302408|aztrial_results_posting@astrazeneca.com|
20519242|NCT00218335|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
20519243|NCT01115933|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20519244|NCT00090753|Hoffmann-La Roche|Medical Communications|800-821-8590||
20519245|NCT01160445|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20519246|NCT01466036|Dana-Farber Cancer Institute|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
20519247|NCT01514513|Tec Laboratories, Inc.|Wendy Langley|5419264577|wendy@teclabsinc.com|338
20519248|NCT03401918|Stanford University|Ruth Bunker Lathi|(650) 498-7911|clinicaltrials-gov@stanford.edu|
20519249|NCT00819767|Novartis Pharmaceuticals|Study Director|862 778-8300||
20519250|NCT03222037|Johnson & Johnson Vision Care, INC.|Chantal Coles-Brennan -PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
20519251|NCT00250705|The University of Iowa|An Open Label Trial of Aripiprazole in the Treatment of Conduct Disorder in Adolescents.|319-356-1482|Samuel-Kuperman@uiowa.edu|
20519252|NCT05103657|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20529513|NCT02723188|Tel Aviv University|Yair Bar-Haim|97236406393|yair1@post.tau.ac.il|
20529514|NCT01095835|Hoffmann-La Roche|Medical Communications|800-821-8590||
20529515|NCT00991081|Stanford University|Sean P. David, MD, SM, DPhil|650-498-4687|spdavid@stanford.edu|
20529516|NCT00871624|Tufts Medical Center|Russel Roberts, PharmD|617-636-4576|rroberts@tuftsmedicalcenter.org|
20551536|NCT00101907|Amgen Inc.|Study Director|866-572-6436||
20551537|NCT03676218|Institut Bergonié, Bordeaux Comprehensive Cancer Center|Carine Bellera, PhD|+33 5 56 33 04 95|c.bellera@bordeaux.unicancer.fr|
20551538|NCT03055000|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
20551539|NCT02315755|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551540|NCT04568590|Wake Forest University School of Medicine|Elizabeth Halvorson, MD, MS|336-716-4999|ehalvors@wakehealth.edu|
20551541|NCT04693507|Antev Ltd|Carol MacLean|+447525177617|cmaclean@antev.co.uk|
20551542|NCT01277354|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
20551543|NCT01829516|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
20551544|NCT04708886|Northwestern University Feinberg School of Medicine|Thomas Schnitzer|3125032315|tjs@northwestern.edu|
20551545|NCT01729754|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
20551546|NCT00202644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20551547|NCT02750592|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
20551548|NCT02981342|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20551549|NCT01372501|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
20551550|NCT04741074|Geisinger|Alexander Chang|570-271-8026|achang@geisinger.edu|
20551551|NCT02432846|Immunicum Aktiebolag (AB)|Chief Medical Officer|+46 (0)8 732 84 00|info@immunicum.com|
20551552|NCT01912287|NYU Langone Health|Naomi Simon|646-754-4507|Naomi.Simon@nyulangone.org|
20551553|NCT03226392|Novartis pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
20551554|NCT00937157|Buffalo Neuroimaging Analysis Center|Robert Zivadinov, MD, PhD|716-859-7040|rzivadinov@bnac.net|
20551555|NCT02278263|Ko Awatea|Dr Marinus Stowers|+64 276 0044|msto062@aucklanduni.ac.nz|2219
20551556|NCT01312818|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612-672-7422||
20551557|NCT01998737|Bone Index Finland Ltd.|CTO|+358 45 896 2650|janne.karjalainen@boneindex.fi|
20529517|NCT02486692|Ralph H. Johnson VAMC|Anouk Grubaugh|843-532-6672|grubaugh@musc.edu|
20551558|NCT04631029|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
20564136|NCT01396278|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564137|NCT05392192|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20564138|NCT00999804|Baylor College of Medicine|Dr. Mothaffar Rimawi|7137981311|rimawi@bcm.edu|
20519253|NCT02203578|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
20564139|NCT05229146|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
20564140|NCT05653427|Janssen Research & Development, LLC|Global Medical Head Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564141|NCT01264406|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
20564142|NCT04256941|University of Texas M D Anderson Cancer Center|Dr. Senthil Damodaran|713-792-2817|sdamodaran@mdanderson.org|
20564143|NCT04145466|Department of Health and Sport Sciences, TUM School of Medicine and Health, Technical University of Munich|Christoph Hoechsmann|+49 (89) 289 - 24492|christoph.hoechsmann@tum.de|
20564144|NCT02933970|University at Buffalo|Andrew Talal|7168884737|AHTALAL@BUFFALO.EDU|
20564145|NCT03300648|Michigan State University|Terrie E. Taylor|5178988467|ttmalawi@msu.edu|
20564146|NCT05717907|Mahidol university|Pattamon Leelachaikul|+66863019830|pattamonl@hotmail.com|
20564147|NCT05590403|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20564148|NCT05908344|The Pennsylvania State University|Dr. Anne-Marie Chang|814-863-5226|amchang@psu.edu|
20564149|NCT04259632|University of Minnesota|Niki Oldenberg|612-625-8781|olden019@umn.edu|
20564150|NCT04717492|UAB Lung Health Center|Mark Dransfield|205-934-5425|mdransfield@uabmc.edu|
20564151|NCT03575897|University of Alabama at Birmingham|Dr. Ariel Salas|205-934-4680|asalas@peds.uab.edu|
20564152|NCT05275231|Emory University|Dr. Megha K. Shah|404-778-6944|mkshah@emory.edu|
20564153|NCT03829410|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
20564154|NCT02577835|Italian Institute of Telemedicine|Stefano Omboni|00390331984176|stefano.omboni@iitelemed.org|
20564155|NCT04749615|Hospital for Special Surgery|Justas Lauzadis, PhD|212-774-2946|lauzadisj@hss.edu|
20564156|NCT03611491|CROMA - PHARMA|Head of Clinical Operations|+43 2262 68468|clinical.studies@croma.at|
20564157|NCT04676022|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20564158|NCT05746494|University of Texas at Dallas|Dr. Linlin Fan|+(853) 8822 4226|linlin.fan@utdallas.edu; linlinfan@um.edu.mo|
20564159|NCT02235909|Azurity Pharmaceuticals, Inc.|David Sequeira|(913) 389-7961|david.sequeira@azurity.com|
20564160|NCT03547869|UTDallas|Sven Vanneste|n/a|sven.vanneste@utdallas.edu|
20564161|NCT02274662|Sumitomo Pharma America, Inc.|Director Clinical Operations|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
20564162|NCT03194217|BenevolentAI|Administrator|+44 20 3781 9360|LondonAdmin@benevolent.ai|
20564163|NCT02962895|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20564164|NCT03659734|Stanford University|Dr. Jennifer Hah|650-723-4000|map_pain_study@stanford.edu|
20564165|NCT05805865|Loma Linda University Health|Professor, Director of Student Research|909 558 5118|sorankwon@llu.edu|
20564166|NCT03793972|UAntwerpen|Stefan Morreel|003232658721|stefan.morreel@uantwerpen.be|
20564167|NCT03274310|Columbia University Vagelos College of Physicians and Surgeons|Dr. Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
20564168|NCT05282173|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
20564169|NCT03134196|NYU Langone Health|Elisabeth Cohen, MD|9294552412|Elisabeth.Cohen@nyulangone.org|
20564170|NCT06165146|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20564171|NCT02222155|ChemoCentryx|Study Director|650-210-2900||
20564172|NCT03477968|Diagnostica STAGO S.A.S|Nathalie THUILLIER|+33 146 882 167|nathalie.thuillier@stago.com|
20564173|NCT06190340|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
20564174|NCT06469138|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
20564175|NCT02305277|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20564176|NCT01798498|Croma Pharma|Head of Clinical Operations|+43 2262 68468|clinical.studies@croma.at|
20564177|NCT03896789|University of Washington|Dr. Monica S. Vavilala|206-744-7235|vavilala@uw.edu|
20519254|NCT00398073|Memorial Sloan Kettering Cancer Center|Jedd Wolchok, MD, Chief Attending|+1646-888-2315|wolchokj@MSKCC.ORG|
20519255|NCT01263561|Department of Ophthalmology and Vision Sciences, University of Toronto|Dr Yvonne Buys|416-603-5682|y.buys@utoronto.ca|
20519256|NCT00879684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519257|NCT00708682|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
20519258|NCT02132650|Malcom Randall VA Medical Center|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
20519259|NCT04084990|Washington University in St. Louis|Alexander Hincker, Associate Professor of Anesthesiology|3143231312|hinckera@wustl.edu|
20519260|NCT03185741|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
20519261|NCT04547036|Dept. Ophthalmology at Paracelsus Medical University Salzburg|PD Dr. Markus Lenzhofer PhD FEBO|+43 57255|m.lenzhofer@salk.at|24201
20519262|NCT01923311|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20519263|NCT02304406|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519264|NCT02839798|Butler Hospital|Dr. Linda Carpenter|401-455-6349|Linda_Carpenter_MD@brown.edu|
20519265|NCT05258630|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
20519266|NCT03431337|Albany Medical College|Dr. Paul Sorum|518-262-7500|sorump@amc.edu|
20519267|NCT00401245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519268|NCT03519282|CooperVision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|MNguyen@coopervision.com|
20564178|NCT06429319|RCBIOFORM|Julia Melentyeva Commercial Director|84952237095|md@bioform.ru|
20564179|NCT04927364|VA Palo Alto Healthcare System|Claudia Padula|650-849-1211|padula@stanford.edu|
20564180|NCT05087992|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564181|NCT06321809|Hacettepe University|Assoc.Prof. Duygu Ayhan Baser|+90-505-664-5210|dr.duyguayhan@gmail.com|
20564182|NCT04625283|Vanderbilt University Medical Center|Dr. Britany Martin|+1 (615)322-8476|britany.l.raymond@vumc.org|
20564183|NCT05020249|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20564184|NCT05505292|SUNY College of Optometry|Danielle Iacono|2129385936|diacono@sunyopt.edu|
20564185|NCT03536754|ChemoCentryx|Study Director|650-210-2900|clinicaltrials@chemocentryx.com|
20564186|NCT04891224|Advocate Health Care|Ramona Donovan, Research Project Manager|847-723-5792|ramona.donovan@aah.org|
20564187|NCT00686335|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
20564188|NCT03524612|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20564189|NCT05194514|Cedars-Sinai|Fardad Esmailian|310-248-7132|fardad.esmailian@cshs.org|
20564190|NCT02727699|Actinogen Medical Limited|Director of Drug Development & Strategy|+61289647401|info@actinogen.com.au|
20564191|NCT04648033|University of Oxford|Professor Geoff Higgins|01865 617311|geoffrey.higgins@oncology.ox.ac.uk|
20564192|NCT03270956|ProKidney|to be determined|n/a|info@prokidney.com|
20564193|NCT05228730|Murdoch Children's Research Institute|Ms Kathryn Bright|+61 3 99366656|kathrynbright@mcri.edu.au|
20564194|NCT04318548|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20564195|NCT05417009|Queen Mary University of London|Professor Gareth Ackland|02035940348|g.ackland@qmul.ac.uk|
20564196|NCT01333969|Hospital for Special Surgery|Dr. Stavros Memtsoudis|646-797-8522|MemtsoudisS@hss.edu|8522
20564197|NCT04029688|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20564198|NCT05875142|We The Village, Inc.|Jane Macky, PI/CEO|91768344267|jane@wethevillage.co|
20564199|NCT03436290|Vanderbilt University Medical Center|Myrick Shinall, principal investigator|615-343-5613|ricky.shinall@vumc.org|
20564200|NCT02677298|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
20564201|NCT03988608|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20564202|NCT05441579|Nationwide Children's Hospital|Dr. Vanessa Olbrecht|614-722-4200|vanessa.olbrecht@nationwidechildrens.org|
20564203|NCT03338933|VA Portland Health Care System|Dr. William Hoffman|503-220-8262|hoffmaw@ohsu.edu|56214
20564204|NCT02143726|Memorial Sloan-Kettering Cancer Center|Eric J. Sherman, M.D.|646-888-4234|shermane@mskcc.org|
20564205|NCT04764448|Dicerna Pharmaceuticals, Inc., a Novo Nordisk company|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20564206|NCT03812679|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20564207|NCT05028634|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20564208|NCT04671446|Queen Mary University of London|Dr Myles Lewis, Dr Paul Pfeffer|+4420 7882 5555|myles.lewis@qmul.ac.uk; p.pfeffer@qmul.ac.uk|
20564209|NCT03891667|Lyme Research Center New York State Psychiatric Institute, New York, New York, United States, 10032|Dr. Brian A. Fallon|646-774-8052|baf1@cumc.columbia.edu|
20564210|NCT04622943|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
20564211|NCT05659537|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20564212|NCT03771417|Louisiana State University|Brian A. Irving, PhD|12255787179|brianairving@lsu.edu|
20564213|NCT04456517|Vanderbilt University Medical Center|Michael McGill|615-322-4643|michael.g.mcgill@vumc.org|
20564214|NCT03766009|University of Wisconsin School of Medicine and Public Health|Heather B. Neuman, MD, MS|608-265-5852|neuman@surgery.wisc.edu|
20564215|NCT01106209|University of Utah - Pediatrics|Christian Con Yost, MD|801-518-7052|christian.yost@u2m2.utah.edu|
20564216|NCT01963793|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20564217|NCT02975882|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20564218|NCT03936322|UNIVERSITY OF MIAMI|Rodrigo Ruano MD PhD|(305) 585-5610|rodrigoruano@hotmail.com|
20564219|NCT01160211|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20564220|NCT02734290|Providence Portland Medical Center|Dr. David B. Page|5032156588|david.page2@providence.org|
20564221|NCT03736720|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kristopher.Attwood@roswellpark.org|
20529518|NCT03110354|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20564222|NCT05119023|MGH-Institute of Health Professions|Sofia Vallila Rohter, Project Principle Investigator|617-724-3824|svallilarohter@mghihp.edu|
20564223|NCT03408340|Emory University|Justin B. Long, MD, Associate Professor|404-785-6670|justin.bradley.long@emory.edu|
20564224|NCT04806451|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20564225|NCT00817219|LEO Pharma A/S|Malin Järnkrants|+45 7226 2990|malin.jaernkrants@leo-pharma.com|
20564226|NCT03676764|University of California, San Francisco FI Proctor Foundation|Dr. Thomas Lietman, Director of the UCSF FI Proctor Foundation|415-476-1442|tom.lietman@ucsf.edu|
20564227|NCT04461405|Oregon Health & Science University|Dr. Deborah Cohen|503-781-8795|cohendj@ohsu.edu|
20564228|NCT02561585|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20564229|NCT00875277|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20529519|NCT01204736|Rehabilitation Institute of Chicago|Dr. Wendy Murray|3122386965|w-murray@northwestern.edu|
20529520|NCT00001322|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
20564230|NCT03800108|Cleveland Clinic|Dr. Darlene Floden|216-444-1298|flodend@ccf.org|
20529521|NCT00116688|Amgen Inc.|Study Director|866-572-6436||
20529522|NCT01640548|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20529523|NCT02864069|UCSD|Dr. Amy Jak|8586423742|ajak@ucsd.edu|
20529524|NCT01775670|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
20529525|NCT03593200|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20529526|NCT01298700|Allergan, Inc|Michael Robinson, MD|714-246-4500|clinicaltrials@allergan.com|
20529527|NCT04006145|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
20529528|NCT01053156|MIND Institute, University of California Davis Medical Center|Randi J. Hagerman MD, Medical Director of the MIND Institute|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
20529529|NCT00010257|ECOG Statistical Office|Study Statistician|617-632-3012||
20529530|NCT02169440|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20529531|NCT00643760|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20529532|NCT02063672|Lutonix|Heidi Ronhovde|7634632900|heidi.ronhovde@crbard.com|
20529533|NCT00857506|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20529534|NCT01307787|UMCG|G.Breedland||g.breedland@cvr.umcg.nl|
20529535|NCT00313729|UCSF Neuro-Oncology|Susan Chang MD|415-353-2966|Susan.Chang@ucsf.edu|
20529536|NCT01547715|Novartis Vaccines and Diagnostics SRL|Posting Director||RegistryContactVaccinesUS@novartis.com|
20529537|NCT03353792|Associate Professor of Medicine|Raimund Herzog, MD, MHS|(877) 925-3637|raimund.herzog@yale.edu|
20529538|NCT00789321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20529539|NCT01965327|Children's Hospital of Philadelphia|David Lynch, MD, PhD|215-590-1719|lynch@email.chop.edu|
20529540|NCT00104052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20529541|NCT03477162|Dartmouth Hitchcock Medical Center|Joseph Phillips, MD|603-650-5000|Joseph.D.Phillips@hitchcock.org|
20529542|NCT02498678|Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo|Dr. Ricardo Vieira Carlos|55-11-99911-6677|ricardovieirac@gmail.com|
20529543|NCT01294423|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20529544|NCT01145482|The University of Texas at Austin|Dr. Andreana Haley|512-232-0863|haley@psy.utexas.edu|
20529545|NCT04773223|University Clinical Centre of Serbia|Petar Zlatanovic|+381644961020|petar91goldy@gmail.com|
20529546|NCT01405560|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529547|NCT02067858|University of Pittsburgh|Karen Holeva|412-623-1275|holevakd@upmc.edu|
20529548|NCT01959113|University of California, San Diego|Director of Clinical Trials Unit|858-657-8390|dermstudies@ucsd.edu|
20529549|NCT01699750|Alcon Research, Ltd.|Jessie Lemp, DrPH|1-888-451-3937|alcon.medinfo@alcon.com|
20529550|NCT00710931|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20529551|NCT01484951|Alcon Global Medical Affairs|Abayomi Ogundele, Pharm.D|1-888-451-3937||
20529552|NCT02452047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529553|NCT01868646|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20529554|NCT01831427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20529555|NCT02169505|UT MD Anderson Cancer Center|Ahmed,Sairah,MD / Stem Cell Transplantation|713-792-7734|sahmed3@mdanderson.org|
20529556|NCT02035553|ACADIA Pharmaceuticals Inc.|James Youakim, Vice President, Clinical Development|609-250-6900|jyouakim@acadia-pharm.com|
20529557|NCT02735980|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20529558|NCT01854697|AbbVie|Global Medical Information|800-633-9110||
20551559|NCT01463644|McMaster University|Dr. Parameswaran Nair|905-522-1155|parames@mcmaster.ca|34934
20551560|NCT00326950|Eisai Call Center|Eisai Inc.|888-422-4743||
20551561|NCT01514760|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-3264|perrytamarat@uams.edu|43264
20551562|NCT00519818|Diurnal Ltd|Richard JM Ross|0044 114 2712386|r.j.ross@sheffield.ac.uk|
20551563|NCT02092662|University of Haifa|Sharon Israely|972-523-755-091|sharonis@mh.org.il|
20551564|NCT01132547|SunCoast CCOP Research Base at the University of South Florida|Angelina Fink, Research Base Administrator|813-396-9245|angelina.fink@epi.usf.edu|
20551565|NCT02710045|University of Tasmania|Katie Flanagan|+61 3 6777 4081|katie.flanagan@ths.tas.gov.au|
20551566|NCT04499781|NYU Langone Health|Ann-Margaret Navarra, PhD, CPNP-PC|631-638-0859|amd363@nyu.edu|
20551567|NCT01275833|Boston Scientific|Elke Sommerijns|+32479767156|elke.sommerijns@bsci.com|
20551568|NCT00227305|AstraZeneca|Seroquel Medical Science Director, MD||AZTrial_Results_Posting@astrazeneca.com|
20551569|NCT02118012|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Christopher Koh, M.D.|(301) 443-9402|kohchris@mail.nih.gov|
20551570|NCT01304966|Queen Sirikit Nation Institute of Thailand|Dr.Pavinee Intakorn|06623548333|pintakorn@yahoo.com|2301
20551571|NCT00870896|University of South Florida|Thomas Truncale|813 974 8952|ttruncal@health.usf.edu|
20551572|NCT04232670|Oregon Health and Science University|Gregory Cote|503-494-4373|coteg@ohsu.edu|
20551573|NCT04447755|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20551574|NCT03424265|University of Arkansas for Medical Sciences|Scott Schutzler, R.N.|501-526-5734|seschutzler@uams.edu|
20551575|NCT01422772|Helixmith Co., Ltd.|Jinsub Lee PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
20551576|NCT03051607|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
20551577|NCT01196923|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
20551578|NCT03338855|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
20551579|NCT02738450|AC Immune|Olivier Sol|+41 21 345 91 21|clinicaltrials@acimmune.com|
20564231|NCT03443388|University of Pennsylvania|Michael Gelfand, MD, PhD|215 662 3606|epilepsytrials@pennmedicine.upenn.edu|
20564232|NCT05916664|RSV Opco 5, Inc. (dba Kinto)|Joseph T Chung|(857) 600-2273|joe@kinto.care|
20564233|NCT04064164|University of Kansas School of Nursing|Kristine Williams|7859797879|kwilliams1@kumc.edu|
20564234|NCT04719390|Partnership to End Addiction|Dr. Sarah Dauber|212-841-5270|sdauber@toendaddiction.org|
20564235|NCT06190691|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20564236|NCT05130762|Becton, Dickinson and Company|Stephan Hofmann|+49 160 105 3421|Stephan.Hofmann@bd.com|
20564237|NCT02023866|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
20564238|NCT03016754|ZOLL|Nicole Bianco|4129683333|nbianco@zoll.com|14410
20564239|NCT03839940|Mayo Clinic|Dr. Kathryn J. Ruddy|507-293-1732|ruddy.kathryn@mayo.edu|
20564240|NCT04683744|Indiana University|Dr. Peter H. Schwartz|317-278-4037|phschwar@iu.edu|
20564241|NCT02432404|University of Washington|Christine Johnston|206-520-4340|cjohnsto@uw.edu|
20564242|NCT05136417|Mayo Clinic|Dr. Mohamad Alkhouli|507-255-2502|Alkhouli.Mohamad@mayo.edu|
20564243|NCT04150900|University of Maryland, Baltimore|Dr. Ranee Mehra|410-328-4059|umgccregulatory@umm.edu|
20564244|NCT01606215|Imperial College London|Professor Paolo Muraro|02075946670|p.muraro@imperial.ac.uk|
20564245|NCT05851573|University of Central Florida|Dr. Deena Schwen Blackett|407-823-0909|deena.blackett@ucf.edu|
20564246|NCT04114877|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu|
20564247|NCT03524118|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20564248|NCT03916510|University of Oxford|CEDAR Trial Manager, Oncology Clinical Trials Office (OCTO)|01865 617085|octo-CEDAR@oncology.ox.ac.uk|
20564249|NCT03483610|University of Rochester|Research Administrator|585-274-1509|peter_macdowell@urmc.rochester.edu|
20564250|NCT04316871|Assiut University|Dr Muhammad Shawqi|01100671067|m.shawqi@med.au.edu.eg|+20
20564251|NCT04650269|University of Miami Miller School of Medicine|Hansel Tookes|3056897030|hetookes@miami.edu|
20564252|NCT01437709|Memorial Sloan Kettering Cancer Center|Dr. Paul Hamlin, MD|646-608-1667|hamlinp@mskcc.org|
20564253|NCT04091750|Georgetown University|Geoffrey T. Gibney, MD|202-444-2223|Geoffrey.T.Gibney@gunet.georgetown.edu|
20564254|NCT04473222|University of Oregon|Ariel Williamson|971-352-4004|arielaw@uoregon.edu|
20564255|NCT02919306|Janssen Vaccines and Prevention BV|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564256|NCT03560609|NYU Langone Health|Jamika Singleton-Garvin|(212) 263-2573|jamika.singleton-garvin@nyulangone.org|
20564257|NCT04293055|The Miriam Hospital|Dr. Jacqueline Hayes|401-793-8917|jhayes3@lifespan.org|
20564258|NCT02839161|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
20564259|NCT03123848|Janssen Pharmaceutical K.K.|Director, IDV Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564260|NCT01369355|Janssen Research & Development, LLC|Vice President|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564261|NCT02436096|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
20564262|NCT02319759|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564263|NCT06424236|Washington University|Administrative Director|(314) 221-8344|DIAN-TUDataRequest@wustl.edu|
20564264|NCT04213872|ASU/PVHMC|Dr. Francisco Munoz|909-753-8391|fmunoz007@verizon.net|
20564265|NCT02262728|Janssen Research & Development, a division of Janssen Pharmaceutica NV|Medical Leader Hepatitis C, GCO ED&CP||ClinicalTrialDisclosure@its.jnj.com|
20529559|NCT02539992|Stryker European Operations BV|Dr. Eric Garling, Director Medical & Scientific Affairs Europe|+31 20 219 2660|eric.garling@stryker.com|
20529560|NCT00917124|University Hospital Center Zagreb|Zeljko Colak|00385915624189|zcolak2000@yahoo.com|
20529561|NCT00565461|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
20529562|NCT00723827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20529563|NCT02048722|Northwestern University|Mary Mulcahy, MD|312 695 4440|m-mulcahy@northwestern.edu|
20529564|NCT01575080|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
20529565|NCT01529606|UTHSC|Professor|901-448-2369|lhong2@uthsc.edu|
20529566|NCT03437694|University of North Texas Health Science Center|Crystal Hodge|8177350131|crystal.hodge@unthsc.edu|
20529567|NCT05635045|Columbia University Medical Center|Mathew Maurer|2123058274|msm10@cumc.columbia.edu|
20529568|NCT00934375|Eisai Inc.|Anita Murthy, Study Director|201-692-1100||
20529569|NCT02674503|Birmingham VA - GRECC Director; Professor at UAB|Dr. Alayne Markland|205-558-7067|alayne.markland@va.gov|
20529570|NCT01022203|Southeast Louisiana Veterans Health Care System (SLVHCS)|Frederic Sautter, Ph.D.|504-988-3026|Fsautter@tulane.edu|
20529571|NCT04350593|Saint Luke's Hospital of Kansas City|DARE-19 Global Project Manager|816-932-9858|DARE-19@saint-lukes.org|
20529572|NCT03638128|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20529573|NCT03163446|ContraFect|Medical Director|914-207-2300|clinicalstudies@contrafect.com|
20529574|NCT00611806|Massachusetts General Hospital|Joshua L. Roffman, MD|617-724-1920|jroffman@partners.org|
20529575|NCT00587067|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-3624|jarnagiw@mskcc.org|
20529576|NCT00329108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20529577|NCT02371616|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529578|NCT02576899|VISN 1 MIRECC|Megan M. Kelly, Ph.D.|781-687-3317|Megan.Kelly1@va.gov|
20529579|NCT00500448|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
20529580|NCT04069715|KGK Science Inc.|Malkanthi Evans (Ph.D.), Chief Scientific officer|5194389374|mevans@kgkscience.com|239
20564266|NCT02619838|Duke University|Mark Easley, M.D.|919-660-5066|mark.e.easley@duke.edu|
20564267|NCT00227344|Biosense Webster, Inc.|Pat Ticknor, Clinical Operations|909-839-8500|PTicknor@its.jnj.com|
20564268|NCT02677805|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
20519269|NCT02667821|Canadian Memorial Chiropractic College|Dr. Nicholas Moser|416-482-2340|nmoser@cmcc.ca|319
20519270|NCT04364737|NYU Langone Health|Mila B. Ortigoza, MD, PhD|646-634-7803|Mila.Ortigoza@nyulangone.org|
20519271|NCT01220609|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20519272|NCT02407171|Yale School of Medicine|Allison Campbell, MD/PhD: Assistant Professor of Clinical Therapeutic Radiology|(203) 863-3700|allison.campbell@yale.edu|
20519273|NCT04090879|Brown University|Jennifer W. Tidey|4018636418|jennifer_tidey@brown.edu|
20519274|NCT01519947|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20519275|NCT01077817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519276|NCT01186016|University of Nebraska Medical Center|Julia F Houfek|402-660-4046|jhoufek@unmc.edu|
20519277|NCT00890916|Louis Stokes Cleveland VAMC|Dr. Kevin Kilgore|216-9573657|klk4@case.edu|
20519278|NCT03843125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20519279|NCT01386125|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20519280|NCT03173560|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20519281|NCT02525263|CTI|Dr William S Aronstein|5135989290|baronstein@ctifacts.com|
20519282|NCT03460899|Medical University of Graz|Assoc.-Prof. Harald Sourij, MD|0043 316 385|ha.sourij@medunigraz.at|81310
20519283|NCT04254809|Southeast Louisiana Veterans Health Care System|Joseph Boffa, PhD|504-507-2000|joseph.boffa@va.gov|67372
20519284|NCT01928615|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20519285|NCT02972515|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
20519286|NCT01889797|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3627|jmanola@jimmy.harvard.edu|
20519287|NCT01589601|Duke University Medical Center|Joseph G. Rogers, MD|919-681-1370|joseph.rogers@duke.edu|
20519288|NCT03023137|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|5521999737500|sclapauch@gmail.com|
20519289|NCT02250651|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20519290|NCT02907073|Mayo Clinic|Dr. Timothy R. DeGrado|507-293-3793|DeGrado.Timothy@mayo.edu|
20519291|NCT00732160|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|James.Luther@Vanderbilt.edu|
20519292|NCT02795676|Protalix Ltd.|Sari Alon, MSc|+972-4-9028100|sari@protalix.com|215
20519293|NCT01264835|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20551580|NCT00706407|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
20551581|NCT01387347|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
20551582|NCT03251079|Senseonics, Incorporated|Katherine Tweden, PhD|651.335.2205|Katherine.Tweden@senseonics.com|
20551583|NCT02658357|Braeburn|Christine Kampf|6104678728|ckampf@braeburnrx.com|
20551584|NCT00951808|New England Research Institutes|Hae-Young Kim|617-972-3251|hkim@nerisicence.com|
20551585|NCT01603459|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20551586|NCT00399360|Massachusetts General Hospital|Dr. Steven Grinspoon, Principal Investigator|617-726-3890|sgrinspoon@partners.org|
20551587|NCT02014844|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20551588|NCT02953314|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20551589|NCT02335099|University of Virginia|Emaad Abdel-Rahman, MD|434-924-5820|ea6n@virginia.edu|
20551590|NCT04948450|National Geriatric Hospital|Dr Nguyen Xuan Thanh|0983277646|xuanthanhbmlk@hmu.edu.vn|
20551591|NCT00735787|Abbott Laboratories|Global Medical Services|1-800-633-9110||
20551592|NCT03930446|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20551593|NCT01997515|Rhode Island Hospital|Director of Research|401-444-4933|mark.kendall@lifesapn.org|
20551594|NCT01474876|AbbVie|Global Medical Information|800-633-9110||
20551595|NCT02291055|Advaxis, Inc.|Surya Vangala|609-423-2528|vangala@advaxis.com|
20551596|NCT01762631|Pennington Biomedical Research Center|Leanne Redman, PhD|2257630947|leanne.redman@pbrc.edu|
20551597|NCT04035161|Becton Dickinson|Erin Zook, PhD|224-358-5019|erin.zook@bd.com|
20551598|NCT01523886|Herlev Hospital|Mona R Gätke, MD, PH.D.|004538662420|mona.gatke@regionh.dk|
20551599|NCT00631566|Infectious Disease Clinical Research Program, USUHS and HJF|Dr. Brian Agan, Deputy Science Director|301-816-8446|bagan@idcrp.org|
20551600|NCT00733746|Alliance for Clinical Trials in Oncology|Peter Pisters, MD||ppisters@mdanderson.org|
20551601|NCT01367158|Novartis Vaccines|Posting Director||RegistryContactVaccineUS@novartis.com|
20551602|NCT03658538|Johns Hopkins University|Dr. Nadia Hansel|410-955-3841|nhansel1@jhmi.edu|
20551603|NCT02921776|The Ohio State University|Mary Beth Happ, PhD, RN|614-292-8336|happ.3@osu.edu|
20551604|NCT02631850|University of Massachusetts Lowell|Lynne Gauthier|9789345383|lynne_gauthier@uml.edu|
20551605|NCT01462084|Stanford Sleep Medicine|Michelle Cao, DO, FAASM|(650) 723-6601|michellecao2007@gmail.com|
20551606|NCT03992781|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551607|NCT01996826|Mass. Eye and Ear|Reza Dana, M.D., M. Sc, MPH|6175734331|Reza_Dana@meei.harvard.edu|
20551608|NCT00695396|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Head of Hematology and Nephrology||pbowers@its.jnj.com|
20551609|NCT02734979|Stanford University|Dr. Stanley G Rockson, Allan and Tina Neill Professor of Lymphatic Research and Medicine|650-725-7571|rockson@stanford.edu|
20551610|NCT00518323|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader (CDTL)|609-730-4530||
20551611|NCT04318990|Baylor Scott and White Resarch Institute|Sarah Hale|469-814-4845|sarah.hale@bswhealth.org|
20519294|NCT01201486|StavangerUH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
20519295|NCT00680524|VA Puget Sound Health Care System|Bradford Felker, MD|(206)277-1191|Bradford.Felker@VA.GOV|
20551612|NCT03706053|UVA Health|Dr. Alex Kadl|434-243-4851|AK5SC@uvahealth.org|
20529581|NCT03205150|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20529582|NCT04735705|Perfect Care Distribution|Mihnea Mihalache, Chief Executive Officer|+40 786 749 087|contact@perfectcare.ro|
20529583|NCT03652818|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
20529584|NCT03964207|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20529585|NCT00830219|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20529586|NCT04789304|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20529587|NCT01241279|Valeant Pharmaceuticals/Bausch & Lomb|Johnson Varughese|908-927-1162|Johnson.Varughese@valeant.com|
20529588|NCT03041441|Duke University Dept of Radiology|Research Coordiantor|(919) 684-7732|christopher.vallanat@duke.edu|
20529589|NCT05252858|UPMC|Amy Monroe|412-623-6382|monroeal@upmc.edu|
20529590|NCT00239720|University of Chicago|Marcus Clark, MD|773-702-0202|mclark@medicine.bsd.uchicago.edu|
20529591|NCT01783743|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
20529592|NCT02771275|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
20529593|NCT05556148|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20564269|NCT04111536|University of Pennsylvania|Theresa M Scattergood, MSN|215-898-5664|theresa.scattergood@pennmedicine.upenn.edu|
20564270|NCT04187833|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|James Isaacs, MD|1-866-223-8100|TaussigResearch@ccf.org|
20564271|NCT04171999|University of Chicago|Emily Abramsohn|7738344832|eabramsohn@bsd.uchicago.edu|
20564272|NCT04282148|Abbott|Ikuko Kishimoto, Principal Research Scientist|480-482-8279|ikuko.kishimoto@abbott.com|
20564273|NCT02876588|Columbia University|Dr. Jason Adelman|646-317-4803|adelman.jason@columbia.edu|
20564274|NCT04873401|New York State Psychiatric Institute|Dr. Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
20519296|NCT00108550|VA San Diego Healthcare System|J. H. Atkinson MD|858-642-3775|joseph.atkinson@va.gov|
20519297|NCT02427399|Fenway Health|Dr. Jennifer Potter|617-416-0986|jpotter@bidmc.harvard.edu|
20519298|NCT04660032|University of Michigan|Dr. Jourdan Triebwasser|734-764-1406|jtriebwa@med.umich.edu|
20519299|NCT01609582|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20519300|NCT04784637|University of Virginia|Sue Brown|434-982-0602|sab2f@virginia.edu|
20519301|NCT00761176|Regenesis Biomedical, Inc.|VP of Clinical Research and Regulatory|602-309-2118|mark.davis@regenesisbio.com|
20519302|NCT02020967|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
20519303|NCT03507686|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20519304|NCT00585312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519305|NCT00129116|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519306|NCT01104090|The University of Texas Health Science Center at Houston|Davide Cattano, MD, PhD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
20519307|NCT02539368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519308|NCT01148225|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20519309|NCT04728620|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
20519310|NCT03689894|Dartmouth Hitchcock Medical Center|Director of Clinical Research|2167129120|sean.hobson@hitchcock.org|
20519311|NCT00569777|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
20519312|NCT00709306|Fox Chase Cancer Center|Carolyn Heckman, PhD|215-214-3962|carolyn.heckman@fccc.edu|
20519313|NCT02030535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519314|NCT01169038|Vanderbilt University|Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
20519315|NCT03257254|Boston Scientific|Timothy Keo|425-599-3814|Timothy.Keo@bsci.com|
20519316|NCT02329431|UNC Chapel Hill|Kathleen Thomas|919-966-3387|kathleen_thomas@unc.edu|
20519317|NCT01557582|VentriPoint, Inc.|Jim bodtke, Vice President Clinical Affairs and Development|206-283-0221|jbodtke@ventripoint.com|
20519318|NCT02843659|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20519319|NCT03203642|Kadmon, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20519320|NCT02413294|University of Michigan|Dr. Amanda Leggett|734-232-0538|leggetta@med.umich.edu|
20519321|NCT00548431|Rigshospitalet, Juliane Marie Centret|Thomas Frandsen|+45 35458364|thomas.leth.frandsen@rh.regionh.dk|
20519322|NCT03169816|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@columbia.edu|
20519323|NCT04149535|Boston Scientific|Sarah Zanon - Director Clinical Trials, Interventional Cardiology|+41798407006|sarah.zanon@bsci.com|
20519324|NCT03388502|Rush University Medical Center|Dr Philip Louie|2539069256|louie.philip@gmail.com|
20519325|NCT00991510|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20519326|NCT02356211|TVHS GRECC, Nashville TN|James S. Powers MD, Clinical Associate Director, GRECC|615-873-8032|james.powers2@va.gov|
20519327|NCT01185028|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
20519328|NCT00988208|Celgene Corporation|Senior Manager , Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20519329|NCT00271739|Columbia University|Walter Palmas, M.D.|212-305-3163|wp56@columbia.edu|
20519330|NCT01796964|Alcon Research, Ltd.|Clinical Project Group Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20519331|NCT03180801|SEEK|Dr Olga Pleguezuelos|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
20519332|NCT03173170|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20519333|NCT00868296|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20529594|NCT03191799|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20564275|NCT04130438|Stanford University|Jennifer A. Tremmel, MD, MS|(650) 723-0180|nocad_study@stanford.edu|
20519334|NCT00112294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20564276|NCT03499821|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|
20564277|NCT04515576|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20564278|NCT02140554|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
20564279|NCT02289209|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20564280|NCT03953508|University of Oklahoma Health Sciences Center|Amy Cohn, PhD|4052711903|amy-cohn@ouhsc.edu|
20564281|NCT02100813|LEO Pharma A/S|Clinical Trial Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20564282|NCT02884011|Rush University Medical Center|Joshua DeMott|312-947-0226|joshua_demott@rush.edu|
20564283|NCT05835336|VIZO Specs|Yael Richter, PhD|972-54-7384809|yaelr@vizo-o.com|
20564284|NCT04489771|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20564285|NCT04509674|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564286|NCT04660201|University of Maryland School of Medicine|James Campbell, MD|410-706-5328|Jcampbel@som.umaryland.edu|
20564287|NCT04059484|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20564288|NCT05467345|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
20564289|NCT04185298|Saint John's Cancer Institute|Dr. Jennifer Bramen|310-525-0865|jennifer.bramen@providence.org|
20564290|NCT03339713|Janssen Research & Development, LLC|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20529595|NCT02654639|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
20564291|NCT05403827|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20564292|NCT01715285|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564293|NCT01987895|Actelion Pharmaceuticals Ltd|Clinical Trial disclosure Desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
20564294|NCT05780437|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
20564295|NCT05006872|Health Research Institute of the Balearic Islands|Dra. Rocío Zamanillo Campos|+34 971175883|rocio.zamanillo@ssib.es|
20564296|NCT05328362|Dartmouth College|Catherine Stanger|603-646-7023|catherine.stanger@dartmouth.edu|
20564297|NCT01753414|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20564298|NCT03913702|University of Texas Medical Branch Galveston|Dr. Jeremy Somerson|409-747-5701|jesomers@utmb.edu|
20564299|NCT02573493|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
20564300|NCT04971681|Indiana University|Dr. Martin H. Plawecki, MD, PhD|3179486550|mplaweck@iu.edu|
20564301|NCT03798093|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
20564302|NCT02433613|Medtronic GmbH|Dr. Ralf Meyer|01755810431|ralf.meyer@medtronic.com|
20529596|NCT04821063|Italfarmaco SpA|Maurizio Caserini, MD|+39 02 6443 2575|m.caserini@italfarmacogroup.com|
20529597|NCT01746862|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20529598|NCT04074265|University of California, Los Angeles|Rachel Thompson|8472200324|rathompson@mednet.ucla.edu|
20529599|NCT02233530|University of Ibadan, Ibadan, Nigeria|Dr Adesola Ogunniyi|+2348038094173|aogunniyi892@gmail.com|
20529600|NCT02577640|Ohio State University|Casey McClurkin|614-293-6255|casey.mclurkin@osumc.edu|
20529601|NCT03834493|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529602|NCT05796791|Medical University of South Carolina|Emily Amador|916-279-6481|emmcamador@gmail.com|
20529603|NCT04144322|University of Michigan|Dr. Tae-Ju Oh|7346473320|taejuoh@umich.edu|
20529604|NCT02277028|now at Northwestern University, Department of PM&R|Mary Ellen Stoykov|312-503-3106|mstoykov@sralab.org|
20529605|NCT02718911|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20529606|NCT04817332|University of Dundee, UK|Professor James D Chalmers|01382660111|jchalmers@dundee.ac.uk|
20529607|NCT01867008|Cochlear Americas|Clinical Project Manager|303-264-2340|knix@cochlear.com|
20529608|NCT00983372|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20529609|NCT01898403|Stanford University Medical Center|Dana T Lin, MD; Clinical Assistant Professor|650-498-6000|danalin@stanford.edu|
20529610|NCT03077893|Regenesis Biomedical|Heather M Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
20529611|NCT02554760|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20529612|NCT02078193|East Carolina University, Division of Nephrology|Austin Rice|252-744-1904|riceau15@ecu.edu|
20529613|NCT00936455|University of California San Diego|Dr Brett Meyer|619-543-7760|bcmeyer@ucsd.edu|
20529614|NCT00385918|University of Maryland Rehabiitation and Orthopaedic Institute|Peter H. Gorman, MD Chief Division of Rehabilitation Medicine|410-448-6261|pgorman@umm.edu|
20529615|NCT00128661|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529616|NCT03758157|Wello, Inc.|Alan C. Heller|469-522-5200|allen.heller@welloinc.com|
20529617|NCT00614172|Loma Linda University Health|David Bush, MD, Vice Chair Clinical Affairs Radiation Medicine|909 558 1000|DBush@llu.edu|
20529618|NCT02782741|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20529619|NCT04157088|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20529620|NCT02421419|Penn State Milton S. Hershey Medical Center|Kenneth Taylor, M.D.|(717) 531-5638|ktaylor2@pennstatehealth.psu.edu|
20529621|NCT00726180|Universtiy of Michigan|Anne F. Schott, MD|734-936-6000|aschott@umich.edu|
20529622|NCT01676701|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529623|NCT02115607|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
20529624|NCT03377270|Northwestern University|Dr. Bonnie Martin-Harris|847-467-0407|bonnie.martinharris@northwestern.edu|
20564303|NCT02291302|Boston Children's Hospital|Wanda Phipatanakul, MD. MS.|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
20564304|NCT04350463|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20564305|NCT04652700|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20564306|NCT01898754|University of Washington|Professor Lisa Frenkel|+1 206 987-5140|lfrenkel@uw.edu|
20529625|NCT05918406|Oyster Point Pharma Inc|Marian Macsai, MD|312-259-2477|marian.macsai@viatris.com|
20564307|NCT04547920|Avation Medical|Clinical Operations Project Manager|(614) 591-4201|customercare@avation.com|
20564308|NCT04209465|Black Diamond Therapeutics, Inc.|Medical Monitor|617-401-8444|ClinicalTrials@bdtx.com|
20564309|NCT03097549|Umeå University|Towe Wadensten|0046907865000|towe.wadensten@umu.se|
20564310|NCT05647304|REGEnLIFE|Guillaume Blivet|+33434481535|gblivet@regenlife.com|
20564311|NCT03544281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20564312|NCT03092518|National Cancer Institute|Dr. Jeremy Davis|2408583731|jeremy.davis@nih.gov|
20564313|NCT02301910|SuperGene LLC|Markin Sergey|(495) 287-98-07|info@supergene.ru|+7
20564314|NCT02547987|Baylor College of Medicine|Mothaffar Rimawi, M.D.|713-798-1311|rimawi@bcm.edu|
20529626|NCT00196105|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
20529627|NCT04863872|Kaiser Permanente Washington Health Research Institute|James Ralston, MD, MPH|206-287-2076|James.D.Ralston@kp.org|
20529628|NCT05117112|UAMS|David Church|5015265769|dchurch@uams.edu|
20529629|NCT04058028|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20529630|NCT04010461|University of Michigan|Stephan Taylor|(734) 936-4955|sftaylor@med.umich.edu|
20529631|NCT02227784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529632|NCT00102596|NINDS/NIH|Mark Hallett, M.D.|301-496-9526|hallettm@ninds.nih.gov|
20529633|NCT00909064|UC Davis|Gavin Pereira|916-534-0919|gcpereira@ucdavis.edu|
20529634|NCT01827592|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20529635|NCT03110133|Finch Therapeutics|Dr. Shrish Budree|(857) 322-4646|sbudree@finchtherapeutics.com|646
20529636|NCT00808067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20529637|NCT00689338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529638|NCT02284386|Pacira|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
20529639|NCT05254340|Indiana University|Dr. Huiping Xu|317-278-6735|huipxu@iu.edu|
20529640|NCT04414787|Duke University|Christopher Cox|919-681-7232|christopher.cox@duke.edu|
20529641|NCT00418028|GEICAM (Grupo Español de Investigación en Cancer de Mama)|The Oncologist 2015;20:1-2 http://www.theoncologist.com/ Scientific Director and CEO|+34916592870|geicam@geicam.org|
20529642|NCT02532283|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20529643|NCT01945944|Rainbow Babies and Children's Hospital|Steven Shein, MD|216-844-3310|drstevenshein@gmail.com|
20529644|NCT04376515|University of California, Irvine|Dr. Dominic Ugarte|949-508-0135|dugarte@hs.uci.edu|
20529645|NCT03811821|Mayo Clinic|Adil Bharucha, M.B.B.S., M.D.|507-266-6931|bharucha.adil@mayo.edu|
20529646|NCT03574974|Yale University|Ilan Harpaz-Rotem Professor|203-937-4760|ilan.harpaz-rotem@yale.edu|
20529647|NCT04369833|Pusan national university hospital|Dr. Sang Soo Kim|+82-51-240-7837|drsskim7@gmail.com|
20529648|NCT05027815|University of California, San Francisco|Jonathan Esensten MD, PhD|415-502-3785|Jonathan.Esensten@ucsf.edu|
20529649|NCT03574038|Study's principal investigator|Dr. Mersedeh Bahr-Hosseini|3107941195|MBahrHosseini@mednet.ucla.edu|
20529650|NCT00674206|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emoryhealthcare.org|
20529651|NCT00447902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20529652|NCT00126594|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
20529653|NCT00468585|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org|
20529654|NCT03769649|InMode|Maria Shusterman|855.411.2639|marias@inmodemd.com|
20564315|NCT02146378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20564316|NCT01743807|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20564317|NCT04973254|Boston Medical Center|Laura Fletcher, LCSW MSW MPH|857-225-5183|laura.fletcher@bmc.org|
20564318|NCT01814813|Mayo Clinic|Ian Parney, MD, PhD|507-284-8167|Parney.Ian@mayo.edu|
20529655|NCT01421498|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20529656|NCT02532036|University of Oxford|Professor Helen McShane|+44 (0)1865 617606|helen.mcshane@ndm.ox.ac.uk|
20529657|NCT02059239|Weill Cornell Medicine|Dr. Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
20529658|NCT02204917|Children's Hospital of Philadelphia|Dr. Kassa Darge, MD, PhD, Radiologist-in-Chief|267-425-7110|DARGE@email.chop.edu|
20529659|NCT02219685|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20529660|NCT00698815|Massachusetts General Hospital|Rebecca S. Heist, MD||rheist@partners.org|
20529661|NCT03519009|Johns Hopkins University|Professor|4436176051|ksilverm@jhmi.edu|
20529662|NCT00731822|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529663|NCT02127658|Indiana University|Dr. Paul Musey|(317) 880-3900|pmusey@iu.edu|
20529664|NCT00359203|Medtronic Italia SpA|Silvia Giuli|003932814224|silvia.giuli@medtronic.com|
20529665|NCT01218542|Emory University|Dr. Hui-Kuo Shu|404-778-2161|hgshu@emory.edu|
20529666|NCT01062893|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-8278|ppan@wakehealth.edu|
20529667|NCT02131064|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20529668|NCT00593918|University of Wisconsin-Madison|Theresa Guilbert, MD|608-263-9608|tguilbert@wisc.edu|
20564319|NCT05089019|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
20529669|NCT02638974|University of Manchester|Dr Kerry Gutridge, Trial Manager|0161-306-7931|kerry.gutridge@manchester.ac.uk|
20564320|NCT05170009|Weill Cornell Medicine|Dr. Mirella Salvatore|(646) 318-8506|mis2053@med.cornell.edu|
20564321|NCT04925986|Yale School of Medicine|Sarah Goldberg, MD, MPH: Associate Professor of Internal Medicine (Medical Oncology)|(203) 200-5864|sarah.goldberg@yale.edu|
20564322|NCT06181760|Island Pharmaceuticals|David Foster, CEO|510-393-6523|dfoster@islandpharmaceuticals.com|
20564323|NCT05838313|University of South Florida Morsani College of Medicine, Department of Obstetrics and Gynecology|Anjali Kaimal, MD, MAS|(813) 259-8680|akaimal@usf.edu|
20564324|NCT04629716|Florida State University|Nicole Ennis, PhD|850-644-2334|nicole.ennis@med.fsu.edu|
20564325|NCT04770532|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20564326|NCT01414400|Stanford University School of Medicine|Subhas Banerjee|650-723-2623|sbanerje@stanford.edu|
20564327|NCT05457647|Studio Italiano di Oftalmologia|Dr. Marco Lombardo, Study Director|+393313438300|studiolombardo@visioeng.it|
20564328|NCT04938492|University of Rochester|Dr. Lisham Ashrafioun|585-430-2026|lisham_ashrafioun@urmc.rochester.edu|
20564329|NCT03854214|Kennedy Krieger Institute|Ann S. Choe, Ph.D.|443-923-9500|choea@kennedykrieger.org|
20564330|NCT03865498|Columbia University|Sunmoo Yoon|+1 212 300 7081|sy2102@cumc.columbia.edu|
20564331|NCT02396134|City of Hope|Dr. Ryotaro Nakamura|626-359-8111|rnakamura@coh.org|
20564332|NCT01424150|Alfred Health|Professor Paul Myles|61 3 9076 3176|p.myles@alfred.org.au|
20564333|NCT01648023|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
20564334|NCT01986712|St. Luke's University Health Network|Neil Belman|484-503-4673|neil.belman@sluhn.org|
20564335|NCT05296525|Gamida Cell|Associate director, Clinical Operations|+972556660324|aurelie@gamida-cell.com|
20564336|NCT04137289|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564337|NCT03994653|Imperial College London|Dr James Flanagan|44 2075942127|j.flanagan@imperial.ac.uk|
20564338|NCT02547363|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20564339|NCT03931174|Northwestern University|Sara Becker|312-503-4203|sara.becker@northwestern.edu|
20564340|NCT05386030|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
20564341|NCT05228457|University of Pennsylvania|Walid Makhoul|215-573-2409|walid.makhoul@pennmedicine.upenn.edu|
20564342|NCT04382664|Ultimovacs ASA|Øivind Foss, Head of Clinical Operation|97008357|oivind.foss@ultimovacs.com|
20564343|NCT04528173|The Children's Hospital of Philadelphia|Tori Nicole Sutherland MD MPH|443-631-5032|sutherlant@chop.edu|
20564344|NCT03213691|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20564345|NCT03161028|VA Portland Medical Center|Dr. Rebecca Spain|503-346-0768|rebecca.spain@va.gov|
20564346|NCT02862210|Brown University|Edward Huey, MD|401-455-6403|edward_huey@brown.edu|
20564347|NCT03492216|University of California, San Francisco (UCSF)|Dr. Gabriel Chamie|415-476-4082|gabriel.chamie@ucsf.edu|445
20564348|NCT00736723|University|Prof. Dr. Manfred Weiss|#49 731 500 60226|manfred.weiss@uni-ulm.de|
20564349|NCT02587403|RTI Surgical|Jennifer Johnson, Senior Clinical Manager|386-418-8888|jljohnson@rtix.com|
20564350|NCT01799265|Bluebird Consulting|Melinda Swanson|6123084500|melinda@bluebirddevice.com|
20564351|NCT03134092|University of Pennsylvania Perelman School of Medicine|Dr. Zachary Meisel|215-746-5618|zfm@pennmedicine.upenn.edu|
20564352|NCT05030233|The Ohio State University College of Nursing|Marliese D. Nist|614-247-5781|nist.10@osu.edu|
20564353|NCT04728347|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
20564354|NCT04682587|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20564355|NCT01186367|Memorial Sloan Kettering Cancer Center|Dr. Jessica Scott, PhD|646-888-8093|scottj1@mskcc.org|
20564356|NCT04574024|Rutgers, The State University of New Jersey|Suhayl Dhib-Jalbut|732-235-7335|jalbutsu@rwjms.rutgers.edu|
20564357|NCT02105766|National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)|Matthew Hsieh M.D.|301.402.7687|matthewhs@nhlbi.nih.gov|
20564358|NCT03867500|Mayo Clinic|Michael D. Jensen, M.D.|507-255-6515|jensen@mayo.edu|
20564359|NCT02702102|Columbia University|William Kreisl, MD|212-305-9194|wck2107@cumc.columbia.edu|
20564360|NCT02985957|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1(800) 332-2056|Clinical.Trials@bms.com|
20564361|NCT04342494|University of Michigan|Amy Bohnert|(734) 936-4280|amybohne@med.umich.edu|
20564362|NCT03153410|SKCCC Johns Hopkins Medical Institution|Ana De Jesus-Acosta, MD|443-287-0411|adejesu1@jhmi.edu|
20564363|NCT05409183|Tufts Medical Center|James Udelson, MD|(617) 636-8066|James.Udelson@tuftsmedicine.org|
20564364|NCT04711447|University of Manitoba|Dr. Trisha Scribbans|(204) 272-1699|trisha.scribbans@umanitoba.ca|
20564365|NCT03059030|Northwestern University|Riad Salem MD|312-695-6371|rsalem1@nm.org|
20564366|NCT05682937|Prince of Songkla University|Anucha Thatrimontrichai|66 74451257|tanucha@medicine.psu.ac.th|
20564367|NCT05373862|Biosense Webster, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564368|NCT04292223|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
20564369|NCT00753545|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20564370|NCT02485938|Capricor, Inc.|Vice President of Clinical Research and Development Operations|858-727-1755|clinicaltrialsgov@capricor.com|
20564371|NCT04633122|Zai Lab|Medical Director|+86 4008201022|Medinfo@zailaboratory.com|
20564372|NCT04799899|Massachusetts General Hopsital|Dr. Christina Luberto|617-643-9453|CLUBERTO@mgh.harvard.edu|
20564373|NCT04019873|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20564374|NCT01842542|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
20529670|NCT04663685|UBC/Arthritis Research Canada|Ellen Wang|2266980999|ewang@arthritisresearch.ca|
20529671|NCT00394888|Medical College of Wisconsin|Dr. Beth Drolet|414-266-1569|bdrolet@mcw.edu|
20564375|NCT01098812|Abbott Medical Optics|Kristen Featherstone|714-247-8621|kristen.featherstone@amo.abbott.com|
20564376|NCT04908722|Janssen Vaccines & Prevention B.V.|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564377|NCT05597085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20564378|NCT04098263|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
20564379|NCT04858321|University of Portsmouth|Dr Anthony Shepherd|02392845289|ant.shepherd@port.ac.uk|
20564380|NCT03885518|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20564381|NCT04863378|Oregon Heatlh & Science University|Raina Croff, PhD Study investigator/ KL2 trainee|503-494-2367|croff@ohsu.edu|
20564382|NCT05832996|University of Iowa|Douglas Jin, MD|319-356-3185|Douglas-Jin@uiowa.edu|
20564383|NCT03629678|The Ohio State University|Dr Robert Cronin|6146889220|robert.cronin@osumc.edu|
20564384|NCT06238609|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20564385|NCT01363388|ChemoCentryx|Study Director|650-210-2900||
20564386|NCT04537715|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
20564387|NCT02852330|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
20564388|NCT04543357|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20564389|NCT04623671|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
20564390|NCT03448107|NYU Dentistry|Richard Niederman|917-280-5920|r.niederman@nyu.edu|
20564391|NCT04025554|National Institutes of Health|Dr. Daniel S. Reich|301-496-1801|reichds@ninds.nih.gov|
20564392|NCT03115476|LEO Pharma|Clinical Trial Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20551613|NCT03033511|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20564393|NCT04980248|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20564394|NCT05257486|Xoft, Inc.|Robert Burnside|14084931533|rob.burnside@elekta.com|
20564395|NCT02310646|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20564396|NCT04700163|The Rockefeller University|Marina Caskey|2123277396|mcaskey@rockefeller.edu|
20564397|NCT00613106|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
20564398|NCT00670358|Mayo Clinic|Dr. Grzegorz Nowakowski|507-284-5096|Nowakowski.Grzegorz@mayo.edu|
20564399|NCT05543629|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@BMS.com|
20564400|NCT03313076|University of North Carolina at Chapel Hill|Matt Mauck, MD, PhD|919-966-5136|matt_mauck@med.unc.edu|
20564401|NCT05869383|Sriwijaya University|Nur Riviati|+6281377671384|eviqodir@yahoo.com|
20564402|NCT04473430|University of Miami|Dr. Rodolfo Galindo|305-284-3781|rodolfo.galindo@miami.edu|
20564403|NCT02535338|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20564404|NCT04307355|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|najafi.bijan@gmail.com|
20519335|NCT03346850|The University of Texas Health Science Center at Houston|Raymond Parlar-Chun, MD|713-500-5666|Raymond.L.Chun@uth.tmc.edu|
20519336|NCT01142908|Veterans Administration HSRD, Durham COIN|Hayden B. Bosworth, PhD, Assoc Dir, Durham HSR&D COIN|919-286-0411|hayden.bosworth@va.gov|6936
20519337|NCT01601691|Oulu University Hospital|Dr. Markku Vaarala|+3588315|markku.h.vaarala@ppshp.fi|2840
20519338|NCT02418455|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20519339|NCT03235479|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20519340|NCT00367016|University of California-Davis, Department of Dermatology|Fu-Tong Liu, M.D., Ph.D.|916-734-6556|fliu@ucdavis.edu|
20519341|NCT03110380|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20519342|NCT01734694|Augusta University|Jose Vazquez|(706) 723-0105|JVAZQUEZ@augusta.edu|
20519343|NCT00529217|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
20551614|NCT03742037|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+1 908 435 2675|viatrisinnovationclinicaltrials@viatris.com|
20551615|NCT01994629|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20551616|NCT03338062|IndianaU|Dr. Ryan Rhome|(317) 944-1367|rrhome@iu.edu|
20551617|NCT02422745|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|COSMOS Study Director|1-800-633-6913|cosmostrial@partners.org|
20551618|NCT01899300|Asian Institute of Gastroenterology|Rajesh Gupta, MD|+91 4023378888|drrajeshgupta98@gmail.com|
20551619|NCT00391274|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20551620|NCT01991457|University of Alabama at Birmingham|Dr. Omer Jamy|2059349294|omerjamy@uabmc.edu|
20551621|NCT00894322|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
20551622|NCT00531817|Hoffmann-La Roche|Medical Communications|800-821-8590||
20551623|NCT03965533|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20551624|NCT00975481|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551625|NCT00112593|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
20551626|NCT03447990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20551627|NCT03630120|Moffitt Cancer Center|Christine Chung, MD|813-745-5061|Christine.Chung@moffitt.org|
20551628|NCT01519960|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|61 6878333|global.trial_information@roche.com|
20551629|NCT01169610|Mayo Clinic|Mark A. Frye, MD|507-255-9391|mfrye@mayo.edu|
20551630|NCT02654483|Stanford University|Irene Bailey, CRC|650-721-7149|baileyhi@stanford.edu|
20551631|NCT00423150|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20551632|NCT01288287|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20564405|NCT04065841|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20564406|NCT04531280|Brigham and Women's Hospital|Dr. David Levine|6177328925|dmlevine@bwh.harvard.edu|
20564407|NCT01420237|Stryker Orthopaedics|Kevin Barga, Senior Manager, Clinical Affairs|201-831-5000|Kevin.Barga@stryker.com|
20564408|NCT04338061|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20564409|NCT03374787|Oticon Medical|Director of Clinical Affairs|0046-31-7486100|studyinfo@oticonmedical.com|
20564410|NCT04492722|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20564411|NCT04074759|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20564412|NCT03752203|Children's Hospital Colorado|Dr. Todd Hankinson|7207776100|todd.hankinson@childrenscolorado.org|
20564413|NCT03631784|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20564414|NCT05329220|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
20564415|NCT04204265|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20564416|NCT02465268|University of Florida|Duane Mitchell, MD, PhD|352-273-9000|duane.mitchell@neurosurgery.ufl.edu|
20564417|NCT03322267|National Taiwan University Hospital|Dr Chih-Hung Hsu|+886-23123456|chihhunghsu@ntu.edu.tw|
20564418|NCT05792085|University of Pennsylvania|Lauren Eberly|2676244449|Lauren.Eberly@pennmedicine.upenn.edu|
20564419|NCT03046251|Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY, USA.|Dr. Bianca Weinstock-Guttman|716-829-4415|bw8@buffalo.edu|
20564420|NCT04797897|Smith+Nephew, Inc|Senior Manager Clinical Compliance|07811407089|datasharing.gcs@smith-nephew.com|
20564421|NCT05966870|Indiana University|Nana Gletsu Miller|812-8557643|ngletsum@indiana.edu|
20519344|NCT01546519|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20519345|NCT00779402|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
20519346|NCT03068949|University of Rochester|Dr. Angela Branche|5852750526|angela_branche@urmc.rochester.edu|
20529672|NCT04458675|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
20529673|NCT01579513|Medical University of South Carolina|Eric Graham, MD|843-792-9570|grahamem@musc.edu|
20529674|NCT00570401|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
20529675|NCT00871234|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iupui.edu|
20529676|NCT01710020|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529677|NCT01764841|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20529678|NCT00866905|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20529679|NCT04202497|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20529680|NCT04344301|Dartmouth College|Dr. Paul Barr|+1-603-653-0863|paul.j.barr@dartmouth.edu|
20529681|NCT01747499|Washington University School of Medicine|Mark A. Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
20529682|NCT00072410|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20529683|NCT02903446|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Angelo Gaffo, MD; Associate Professor|205-996-6086|agaffo@uab.edu|
20529684|NCT00549549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529685|NCT02155699|Northwestern University|Dr. Vijay A Mittal|847-467-3880|vijay.mittal@northwestern.edu|
20529686|NCT02108977|Health Services Research & Development, Durham VAMC|Dr. Santanu Datta, Health Sciences Research Specialist, HSR&D|(919) 286-0411|Santanu.Datta@va.gov|7580
20529687|NCT02688933|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20529688|NCT00248651|Mayo Clinic|Dr. Yuri A. Saito Loftus|507-266-9094|saito.yuri@mayo.edu|
20529689|NCT00828113|University of Wisconsin School of Medicine and Public Health|Douglas E. Jorenby, Ph.D.|6082627527|dej@ctri.medicine.wisc.edu|
20529690|NCT01365130|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
20529691|NCT05547386|Mayo Clinic|Geoffrey Johnson, M.D., Ph.D.|507-284-4104|johnson.geoffrey@mayo.edu|
20529692|NCT04622969|University of South Carolina|Director, Office of Research Compliance|8037777095|lisaj@mailbox.sc.edu|
20529693|NCT05616013|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20529694|NCT05116202|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20529695|NCT03834506|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20529696|NCT05067972|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529697|NCT04391842|Medical Pain Consultants|Dr. Ralph Ortiz|(607) 844-9979|drortizmpc@gmail.com|
20529698|NCT00810199|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20529699|NCT01121939|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20529700|NCT00992017|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
20529701|NCT02864407|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20529702|NCT02992119|MORU|Lorenz von Seidlein|662036663|Lorenz@tropmedres.ac|
20519347|NCT00693225|Mayo Clinic|Dr. Yvonne Romero|507-266-9156|romero.yvonne@mayo.edu|
20519348|NCT01315028|University of Glasgow|Professor Andrew Gumley|0044 141 211 3927|andrew.gumley@glasgow.ac.uk|
20519349|NCT02274948|Faculty of Medicine, University of Colombo|Prof V Pujitha Wickramasinghe|+94112688748|pujithaw@yahoo.com|170
20519350|NCT03636386|Universidad Andrés Bello|Professor Hernán Andrés de la Barra Ortiz|+56984706322|quiropraxiayequilibrio@gmail.com|
20519351|NCT00452543|Massachusetts General Hospital|Dr. Janet Witte|617-726-5104|jwitte@partners.org|
20519352|NCT01098539|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519353|NCT02359864|William Beaumont Hospital|Dr. James Fontanesi, Professor of Neurosurgery, Director of Radiation Oncology|947-521-8121|james.fontanesi@beaumont.org|
20519354|NCT00725764|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519355|NCT04480307|GeNeuro SA|David Leppert, Study director|225524800|dl@geneuro.com|+41
20564422|NCT03084536|Washington University School of Medicine|Ryan C. Guffey, M.D.|314-286-2883|rguffey@wustl.edu|
20564423|NCT05002608|Massachusetts General Hospital|Elyse R. Park|6177246836|epark@mgh.harvard.edu|
20564424|NCT00506519|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
20564425|NCT03131154|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20564426|NCT03959696|Massachusetts General Hospital|Karen Sepucha|617-724-3350|ksepucha@mgh.harvard.edu|
20564427|NCT03452579|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|David Peereboom, MD|1-866-223-8100|TaussigResearch@ccf.org|
20564428|NCT03474679|Janssen Pharmaceutical K.K.|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564429|NCT05490459|Element Science, Inc.|Chief Medical Officer|4158726500|zubin@elementsci.com|
20564430|NCT05604508|RAND|William Shadel|4126832300|shadel@rand.org|4489
20564431|NCT01539083|Janssen R&D|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20564432|NCT05499377|Virginia Commonwealth University|Augustus Whiet|(804) 828-8892|whiteam25@vcu.edu|
20564433|NCT04149704|Dana-Farber Cancer Institute|Jennifer Snaman|617632-5548|jennifer_snaman@dfci.harvard.edu|
20564434|NCT04332926|Virginia Commonwealth University|Caroline Cobb, PhD, PI|804-828-8687|cobbco@vcu.edu|
20564435|NCT00528268|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
20564436|NCT06215430|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20564437|NCT04376502|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
20564438|NCT04632992|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20564439|NCT02268253|Stemline Therapeutics, Inc.|Ira Gupta, MD|1-877-332-7967|clinicaltrials@menarinistemline.com|
20564440|NCT05714761|Icahn School of Medicine at Mount Sinai|Dr. Grenye O'Malley|212-241-7173|omallg01@mssm.edu|
20564441|NCT03001713|Kaiser Permanente Center for Health Research|Rachel Gold, PhD MPH|503-335-2400|rachel.gold@kpchr.org|
20564442|NCT02547233|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20564443|NCT05235750|University of Arkansas for Medical Sciences|Dr. Mei Bai|501-603-1900|MBai@uams.edu|
20564444|NCT06019559|Kallyope Inc|Clinical Director|917-336-3279|contactus@kallyope.com|
20564445|NCT05949788|ShenzhenBMCHH|Dr. Jun Luo|015818671195|luojun-78@163.com|
20564446|NCT05213390|Newcastle University|Prof Edward Meinert|191 208 6000|edward.meinert@newcastle.ac.uk|
20564447|NCT01824537|McGill University|Eduardo L Franco|514-398-6032|eduardo.franco@mcgill.ca|
20564448|NCT05986682|Duke University School of Medicine|Dr. Thomas W. LeBlanc|919-668-2115|thomas.leblanc@duke.edu|
20564449|NCT06215521|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20564450|NCT04096040|ZOLL Medical|Director of Scientific Affairs|4129683333|nbianco@zoll.com|14410
20564451|NCT03333590|Abigail Wexner Research Institute at Nationwide Children's Hospital|Dr. Kevin Flanigan|614-355-2947|kevin.flanigan@nationwidechildrens.org|
20564452|NCT03603600|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bausch.com|
20564453|NCT04044768|Adaptimmune|Clinical Trials Management|+1 (215) 825 9260|clinicaltrials@adaptimmune.com|
20564454|NCT03344094|University of Chicago|anthony t reder|773-702-6204|areder@neurology.bsd.uchicago.edu|
20564455|NCT03808818|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20564456|NCT03858634|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20564457|NCT05415722|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
20564458|NCT04518917|Washington University in St. LOuis|Gammon Earhart|314-286-1407|earhartg@wustl.edu|
20564459|NCT02724449|North Shore University Hospital|Mary Brennan, Assist Director WOCN|516-562-8252|mbrennan@northwell.edu|
20564460|NCT03435614|MUHC-RIMUHC|Marc Perreault|514-343-6111|marc.perreault@umontreal.ca|3788
20564461|NCT02683447|Sunnybrook Health Sciences Centre|Dr. Fahad Alam|416-480-4864|fahad.alam@sunnybrook.ca|
20564462|NCT04215146|Oncolytics Biotech Inc.|Chief Medical Officer|(403) 670-7377|info@oncolyticsbiotech.com|
20564463|NCT04542317|University of California, Davis|Ladson Hinton, MD|9167343485|lwhinton@ucdavis.edu|
20564464|NCT03509402|"University of Campania Luigi Vanvitelli"|Prof. Marco Annunziata|0815665515|marco.annunziata@unicampania.it|0039
20564465|NCT03021096|Hospital for Special Surgery, Anesthesiology|Dr Jacques Yadeau|2126061036|Yadeauj@hss.edu|
20564466|NCT05590962|University of Pennsylvania|Dr. Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
20564467|NCT03848065|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20564468|NCT04131686|Boryung|Ji-Yeon Kim|82-2-708-8128|jiyeonkim@boryung.co.kr|
20564469|NCT05194540|Leo Pharma|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
20564470|NCT04573517|University of Texas Medical Branch|Dr. Marissa Berry|402-772-4099|majberry@utmb.edu|
20519356|NCT03604549|Penn State Health Milton S. Hershey Medical Center|Richard S. Legro, M.D., Principal Investigator|717-531-6210|rsl1@psu.edu|
20519357|NCT00605176|Graceway Pharmaceuticals LLC|Sharon F. Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
20519358|NCT01808248|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20519359|NCT02690935|ECSOR|Dr. Stephane Heijmans|3267444093|Jacques.Bruhwyler@ecsor.com|
20519360|NCT00685750|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519361|NCT04974580|Ohio State University College of Public Health|Dr. Elizabeth G. Klein|614-292-5424|klein.232@osu.edu|
20519362|NCT00587431|Memorial Sloan-Kettering Cancer Center|Dr. Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
20519363|NCT05467982|Dartmouth-Hitchcock|Sarah Pratt, PhD-Contact PI|603-496-2665|sarah.i.pratt@dartmouth.edu|
20564471|NCT04137367|University of Oslo|Nils Inge Landrø|+4795038479|n.i.landro@psykologi.uio.no|
20564472|NCT05144009|ADC Therapeutics|Contact ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20564473|NCT03270501|Department of Rheumatology, Gent University Hospital|Professor Dirk Elewaut|+32 9 332 22 30|reumatologie@uzgent.be|
20564474|NCT04158804|Massachusetts General Hospital|Michael K. Mansour, MD, Ph.D.|617-726-6726|mkmansour@mgb.org|
20564475|NCT00764751|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20564476|NCT04710498|Stanford University|Dr. Vasu Divi|650-725-5968|vdivi@stanford.edu|
20564477|NCT04406623|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
20564478|NCT01623167|National Heart Lung and Blood Institute (NHLBI)|Neal S. Young, M.D, NIH Principal Investigator|301-496-5093|youngns@nhlbi.nih.gov|
20564479|NCT02918890|Columbia University|Dr. Andrew M. Gordon|212.678.3332|ag275@columbia.edu|
20564480|NCT01175356|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20564481|NCT00324805|ECOG-ACRIN Statistical Center|Study Statistician|617-632-3012||
20564482|NCT04364048|Hoosier Cancer Research Network|Andrew Benson|317-921-2050|abenson@hoosiercancer.org|
20564483|NCT05977530|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
20564484|NCT05692960|The University of Tennessee, Knoxville|Noël Arring, DNP, PhD, RN|865-974-1988|narring@utk.edu|
20564485|NCT04719832|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20564486|NCT04285515|Intra-Cellular Therapies, Inc.|Susan Kozauer, MD|646 440-9333|ITCIClinicalTrials@itci-inc.com|
20564487|NCT02618577|Universitätsklinikum Hamburg-Eppendorf|Prof. Dr. Paulus Kirchhof|+49 (0)40 7410-52438|p.kirchhof@uke.de|
20564488|NCT05192109|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
20564489|NCT04515849|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20564490|NCT04078191|Navidea|Michael Blue, MD|6145714313|mblue@navidea.com|
20564491|NCT04164888|CiVi Biopharma, Inc.|Chief, Clinical Development|484-674-5456|chuck.shear@civibiopharma.com|
20564492|NCT04049643|The University of Iowa|Dr. Yu-Hsiang Wu|319-3359758|yu-hsiang-wu@uiowa.edu|
20564493|NCT04437615|Olympus Corporation|Jeremy Bolt, Global GI Lead|5085798495|jeremy.bolt@olympus.com|
20564494|NCT03450980|Schepens Eye Research Institute of Mass Eye & Ear, Harvard Medical School, Boston, MA, USA|Gang Luo|(617) 573-4177|gang_luo@MEEI.HARVARD.EDU|
20564495|NCT03491969|Zhongshan hospital, Fudan University|Dr. Hanchuan Chen|18459111985|chenhanchuan66@126.com|
20564496|NCT02696707|Ottawa Hospital Research Institute|Dr. John Hilton|613-737-7700|jfhilton@toh.ca|70170
20564497|NCT00636077|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20564498|NCT05044793|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
20564499|NCT01461655|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20564500|NCT05546749|Albert Einstein College of Medicine|Hector Perez|7189205756|heperez@montefiore.org|
20564501|NCT06181227|Aviceda Therapeutics|David Callanan|817-312-9258|dcallanan@avicedarx.com|
20564502|NCT05292872|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20564503|NCT05456360|The University of Texas MD Anderson Cancer Center|Dr. Vijaya Gottumukkala|(713) 794-1398|vgottumukkala@mdanderson.org|
20564504|NCT06516705|National Tainan Junior College of Nursing|Mei-Chuan Huang|886-0956646992|mayhuang@ntin.edu.tw|
20564505|NCT05453773|Ohio State University Comprehensive Cancer Center|Marielle Brinkman|614-688-3226|brinkman.224@osu.edu|
20564506|NCT00391365|Center For Limb Loss Prevention and Prosthetic Engineering, VA Puget Sound Health Care System|Alan Wesley, Program Manager|206 277 1079|alan.wesley@va.gov|
20564507|NCT03241745|Memorial Sloan Kettering Cancer Center|Dr. Claire Friedman, MD|646-888-4247|friedmac@mskcc.org|
20564508|NCT00470704|Dana-Farber Cancer Institute|Nancy Lin|6176322335|Nancy_Lin@dfci.harvard.edu|
20564509|NCT05263037|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
20564510|NCT02561247|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20564511|NCT05210608|University of Colorado-Boulder|Anahi Collado, Assistant Research Professor|3037354140|anco7407@colorado.edu|
20564512|NCT04963270|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20564513|NCT04802967|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20564514|NCT01857245|Prisma Health|Dr. Claire Stam - Director, Addiction Medicine Center|(864) 979-6749|claire.stam@prismahealth.org|
20564515|NCT03122847|Aarhus University Hospital|Dr. Torben Harsløf|+4578455470|torbhars@rm.dk|
20564516|NCT04636528|Sword Health Inc|Fernando Dias Correia|+1 (646) 379-6751|fcorreia@swordhealth.com|
20564517|NCT02979327|Mayo Clinic|Anna Svatikova, M.D., Ph.D.|507-284-3685|Svatikova.Anna@mayo.edu|
20564518|NCT01073566|Calibra Medical|Vice President Clinical Affairs|650-298-4750|ddreon@calibra.com|
20564519|NCT01389856|Actelion Pharmaceuticals Ltd|Pegah Nowbakht/Senior Clinical Trial Scientist|+41 61 565 68 41|pegah.nowbakht@actelion.com|
20564520|NCT02100891|Fred Hutchinson Cancer Center|Monica Thakar, MD - Professor of Pediatrics|206-667-5000|isioc@fredhutch.org|
20564521|NCT03309306|Department of Agricultural, Environmental & Development Economics, Ohio State University|Brian Roe|614-688-5777|roe.30@osu.edu|
20564522|NCT03916042|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20529703|NCT01720316|McLean Hospital|Dr. Deborah L. Levy|617-855-2854|dlevy@mclean.harvard.edu|
20529704|NCT02287038|Ralph H. Johnson VA Medical Center|Dr. Zhewu Wang|8437897949|zhewu.wang@va.gov|
20529705|NCT02731300|Department of Physiology; Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.|Paradee Auvichayapat|66896222624|aparad@kku.ac.th|
20529706|NCT02713178|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20529707|NCT01298167|Yale University|David Leffell, MD|203 785 7999|david.leffell@yale.edu|
20529708|NCT05502302|University of Minnesota, Masonic Cancer Center|Dr. Rachel Vogel|612-624-6928|isak0023@umn.edu|
20529709|NCT01105312|Mayo Clinic|Winston Tan MD|507-284-1159|tan.winston@mayo.edu|
20529710|NCT00441285|Universidad Peruana Cayetano Heredia|Hector H. Garcia, MD, PhD|+511 3287360|hgarcia@jhsph.edu|
20564523|NCT05337306|GogyUp|Ned Zimmerman-Bence, Co-Founder|6124605358|ned.zb@gogyup.com|
20564524|NCT05533359|University of Utah|Dr. Guilherme Del Fiol|801-581-4080|guilherme.delfiol@utah.edu|
20519364|NCT00260689|NHLBI, NIH|Danielle Townsley MD|301-402-3477|townsleydm@nhlbi.nih.gov|
20564525|NCT05672069|SERF|Sponsor|+33 4.72.05.60.10|clinical@serf.fr|
20564526|NCT05362487|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564527|NCT02191618|Sequent Medical, Inc|Director, Clinical Operations|714-247-8000|anne.hurley@microvention.com|
20564528|NCT04997148|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20564529|NCT03031470|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20564530|NCT03461276|Araclon Biotech, S.L.|Maria Pascual Lucas|+34976796562|mpascual@araclon.com|
20564531|NCT01943409|Toronto General Hospital|Scientific Associate|4163405159|kschweng@uhnresearch.ca|
20564532|NCT02489903|EpicentRx, Inc|Bryan Oronsky|858-229-1062|mstirn@epicentrx.com|
20564533|NCT01802788|Abbott|Vinny Podichetty, Clinical Program Director|779-209-9425|vinny.podichetty@abbott.com|
20564534|NCT03496168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20564535|NCT05530603|University of South Dakota|Soonhee Roh|6053571593|Soonhee.Roh@usd.edu|
20564536|NCT02043678|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20564537|NCT03216057|Hospital Infantil de Mexico Federico Gomez|Blanca Estela Del Rio Navarro|+525552289917|leijamjj@gmail.com|2444
20564538|NCT04568603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20564539|NCT04564742|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20564540|NCT05827094|University of Washington School of Nursing|Associate Professor|2068493301|ozasl@uw.edu|
20519365|NCT02997722|University of Mississippi Medical Center|Allen Richert, MD|(601) 984-4820|arichert@umc.edu|
20564541|NCT06264986|Blanquerna Institute - Universitat Ramon Llull|Olivia Coope|+447882461097|oliviacharlottec@blanquerna.url.edu|
20519366|NCT01493596|Catalyst Pharmaceutical Partners, Inc.|Douglas Winship, Vice President of Regulatory Operations|305 529-2522|dwinship@catalystpharma.com|12
20519367|NCT04381481|University of North Carolina at Chapel Hill|Marissa Hall, PhD|919-962-5907|mghall@unc.edu|
20519368|NCT00220727|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20519369|NCT02221817|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20519370|NCT02508116|University of Pennsylvania School of Medicine|Sony Tuteja, PharmD, MS|215-573-7834|sonyt@pennmedicine.upenn.edu|
20519371|NCT00109850|SWOG Statistical Center|Study Statistician|206-667-4623||
20519372|NCT04234464|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
20519373|NCT00476593|Department of Ophthalmology, St. Olavs Hospital, Trondheim Norway|Dr Alexandra Wexler|99716763|a.wexler@online.no|0074
20519374|NCT00983528|UC San Diego|MCC Clinical Trials Office|(858) 534-5417|tkipps@ucsd.edu|
20519375|NCT03635983|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20519376|NCT03430011|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20519377|NCT04763278|Point Designs|Director of Clinical Research|7206004753|research@pointdesigns.com|
20519378|NCT03604432|Corewell Health|Dr. Charles Willekes|616-459-7258|Charles.Willekes@corewellhealth.org|
20519379|NCT02578745|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
20519380|NCT00330460|Amgen Inc.|Study Director|866-572-6436||
20519381|NCT03712124|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20519382|NCT01332721|TRACON Pharmaceuticals|Dr Charles Theuer|8585500780|ctheuer@traconpharma.com|233
20519383|NCT01290237|Boston Children's Hospital|Dr. Alicia Demirjian||alicia.demirjian@post.harvard.edu|
20519384|NCT00388037|Cancer Centre of Southeastern Ontario at Kingston|Dr. James Biagi|(613) 544-2630|jim.biagi@krcc.on.ca|
20519385|NCT00602537|University of Pennsylvania|Dr. Jay Amsterdam|(215) 662-3462|jamsterd@mail.med.upenn.edu|
20519386|NCT02941523|Noxopharm Limited|Clinical Manager|+61 499005049|marinella.messina@noxopharm.com|
20519387|NCT04330157|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
20519388|NCT00337987|Yale University School of Medicine|Francine Foss, MD|203-737-5312|francine.foss@yale.edu|
20519389|NCT04314843|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20519390|NCT01020526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519391|NCT01899326|Albert Einstein College of Medicine|Dr. Amit Verma|718-430-4091|amit.verma@einsteinmed.edu|
20519392|NCT03558139|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20519393|NCT00373425|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Oncology||clinicaltrial.disclosure@us.astellas.com|
20519394|NCT02752802|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|952-955-8236|mshepard@ospreymed.com|
20519395|NCT02808819|AstraZeneca|AstraZeneca Information Center|+1 8002369933|information.center@astrazeneca.com|
20519396|NCT00251316|NIDDK, NIH|Dr. Monica Skarulis|301-496-6087|monicas@intra.niddk.nih.gov|
20519397|NCT00127166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519398|NCT00105157|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20519399|NCT01237080|Department of Anaesthesiology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark|Mogens Ydemann|+4531155995|clinicaltrials@ydemann.dk|
20519400|NCT01396421|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20519401|NCT01378962|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20519402|NCT04511208|CCF|Daniel Sessler, MD|216-444-4900|sseslerd@ccf.org|
20519403|NCT02248662|Dana-Farber Cancer Institute|Rinaa Punglia, MD|617-582-8759|rinaa_punglia@dfci.harvard.edu|
20519404|NCT01835548|Neos Tx|Carolyn Sikes, PhD|972-408-1300|csikes@neostx.com|1255
20564542|NCT04478643|ASST SPEDALI CIVILI - UNIVERSITY OF BRESCIA|Dr. Magda Mensi|+390303995784|magda.mensi@unibs.it|
20564543|NCT03298477|Endologix LLC|Tammy Stiver, Manager, Clinical Affairs|+15136731452|tstiver@endologix.com|
20564544|NCT02690558|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20564545|NCT05269667|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20564546|NCT05448105|Vanderbilt University Medical Center|William Martinez, MD, MS|615-936-1010|william.martinez@vumc.org|
20564547|NCT04349371|Columbia University|Anca Askanase, MD|212-305-0856|ada20@cumc.columbia.edu|
20564548|NCT05022329|University Health Network|Kevin Yau|416 480 4592|Kevin.Yau@uhn.ca|
20564549|NCT04948697|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20564550|NCT05246280|Navidea Biopharmaceuticals|Michael Blue, MD|6145714313|mblue@navidea.com|
20564551|NCT04599062|University of Iowa, Holden Comprehensive Cancer Center|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
20564552|NCT04032704|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20564553|NCT02993159|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
20564554|NCT04992520|PATH|Patricia Njuguna/Senior Medical Officer|+254 20 3877177|pnjuguna@path.org|
20519405|NCT02490800|Basilea Pharmaceutica International Ltd, Allschwil|Thomas Kaindl, MD|+41 61 567 15 24|thomas.kaindl@basilea.com|
20519406|NCT01634854|Vanderbilt University Medical Center|Angela Wilson-Liverman CNM||angela.wilson-liverman@vanderbilt.edu|
20519407|NCT00987831|Oklahoma Medical Research Foundation|Joan T Merrill, M.D|405-271-7805|JTMmail@aol.com|
20519408|NCT02219308|University of California, San Diego|Dr. Sheila Mody|858-249-1205|smody@ucsd.edu|
20519409|NCT02175368|Ivoclar Vivadent AG|Dr. Erik Braziulis||erik.braziulis@ivoclarvivadent.com|
20519410|NCT02875028|Medical University of Vienna|Bernd Jilma|+4314040029910|bernd.jilma@meduniwien.ac.at|
20519411|NCT05068284|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20519412|NCT04974736|Massachusetts General Hospital|Jonathan P. WInickoff|(617) 726-2728|jwinickoff@mgh.harvard.edu|
20519413|NCT01621906|Memorial Sloan Kettering Cancer Center|Dr. Andrew Seidman, MD|646-888-4559|seidmana@MSKCC.ORG|
20519414|NCT03180528|Stanford University|Kavita Yang Sarin|(650) 723-6316|ksarin@stanford.edu|
20519415|NCT02447887|Fox Chase Cancer Center|Dr. Daniel M. Geynisman|215-728-3889|daniel.geynisman@fccc.edu|
20519416|NCT00109837|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
20519417|NCT03941834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519418|NCT02717078|University of Minnesota|Anne Bantle|612-625-8673|endofixer@umn.edu|
20519419|NCT02688387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20519420|NCT04100096|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800 562-3974|clinicaltransparency@otsuka-us.com|
20519421|NCT02137382|Abbott|Suntje Sander - Struckmeier|+49 (0) 511 6750 3254|suntje.sander-struckmeier@abbott.com|
20519422|NCT01976728|Ferring Pharmaceuticals|Clinical Development Support|+1 833-548-1402|DK0-Disclosure@ferring.com|
20519423|NCT01563237|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
20519424|NCT03170388|Bausch Health Americas, Inc|Study Director|5102595284|aloncaric@bauschhealth.com|
20519425|NCT02000531|HoffmannLa Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20519426|NCT02285634|Mayo Clinic|Dr. Tobias Kummer|507 255 4732|vanmeter.derek@mayo.edu|
20519427|NCT00317642|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20519428|NCT00556491|St Louis University|Tarek El-Achkar|317 278 6822|telachka@iu.edu|
20519429|NCT01602471|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
20519430|NCT00418522|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20519431|NCT02695719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20519432|NCT01163084|UT MD Anderson Cancer Center|Logothetis, Christopher, M.D. / Genitourinary Medical Oncology|7137922830|clogothe@mdanderson.org|
20519433|NCT01652729|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
20519434|NCT00483548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20519435|NCT04523324|Centers for Disease Control and Prevention|Dr. Ashley Fowlkes|4046394830|afowlkes@cdc.gov|
20519436|NCT01049412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20519437|NCT04735068|University of Pennsylvania|Melissa Volpe|215-220-9703|melissa.volpe@Pennmedicine.upenn.edu|
20519438|NCT03440424|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20519439|NCT05966090|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20519440|NCT00804141|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20519441|NCT02445287|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
20519442|NCT02001051|National Cancer Institute|Dr. Dhaval Patel|301-827-4989|pateldt@nih.gov|
20519443|NCT01148524|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20519444|NCT01992016|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
20519445|NCT01303068|University of New Mexico|Hengameh Raissy|5052725484|hraissy@salud.unm.edu|
20519446|NCT03750695|Duke University|Dr. William Todd Cade|919-660-9825|todd.cade@duke.edu|
20519447|NCT00448227|Novartis Pharmaceuticals|Study Director|862-778-8300||
20564555|NCT05245682|Emory University|Nicole Schmitt|404-778-0278|nicole.cherie.schmitt@emory.edu|
20519448|NCT02255487|Irrimax Corporation|Chevy Brown, Clinical Trials Manager|770-807-3355|chevy.brown@irrisept.com|15
20519449|NCT01256060|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
20519450|NCT02684396|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20519451|NCT03904550|UT Southwestern Medical Center|Tiffany Moon, MD|(214) 648-6400|tiffany.moon@utsouthwestern.edu|
20519452|NCT01903564|University of Wisconsin-Madison|Ronald Wakai, Ph.D.|6082654988|rtwakai@wisc.edu|
20519453|NCT01557920|Massachusetts General Hospital|Dr. Matthias Eikermann|6176434408|meikermann@partners.org|
20519454|NCT00981227|Bial-Portela & Cª, S.A.|Head of Clinical Research Section|+351 22 986 6100|clinical.trials@bial.com|
20519455|NCT02994290|Yale University|Dr. Sangini Sheth|203-785-5545|Sangini.Sheth@yale.edu|
20519456|NCT00496262|CSL Behring|Program Director, Clinical R&D|Use email contact.|clinicaltrials@cslbehring.com|
20519457|NCT01216410|Duke University Medical Center|Ashraf Habib|919 668 6266|habib001@dm.duke.edu|
20519458|NCT01857206|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20519459|NCT02681406|University of Pennsylvania|James McKay|215-746-7704|jimrache@upenn.edu|
20519460|NCT01679054|The Chinese University of Hong Kong|Vivian Lee|+85239438012|vivianlee@cuhk.edu.hk|
20519461|NCT00575380|Inspire|Mike Schiewe|919-941-9777|mschiewe@inspirepharm.com|
20519462|NCT01334957|Cumberland Pharmaceuticals Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
20519463|NCT04126343|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20519464|NCT00559364|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20519465|NCT01235442|Amgen Inc.|Study Director|866-572-6436||
20519466|NCT00136760|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
20519467|NCT01857973|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20519468|NCT00908882|Eastern Colorado Health Care System|Catherine Battaglia PhD RN|720-857-5099|catherine.battaglia@va.gov|
20519469|NCT01701973|Vanderbilt University Medical Center|Dr. Jessica Devin|6159361665|jessica.devin@vanderbilt.edu|
20519470|NCT02663882|Yeshiva University|Dr. Andrea Weinberger|(646) 592-4474|andrea.weinberger@yu.edu|
20519471|NCT04458467|UC San Diego|John Finneran|(619) 543-2202|jfinneran@health.ucsd.edu|
20519472|NCT00597428|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
20519473|NCT04499482|Pennington Biomedical Research Center|Dr. Candida Rebello|2252882411|Candida.Rebello@pbrc.edu|
20519474|NCT00869440|PAION UK Ltd|Trial Information||reg_paion@paion.com|
20519475|NCT00551616|HRA Pharma|Henri Mathé|+33140331130|medical2914@hra-pharma.com|
20519476|NCT03546647|University of Houston|Kathryn Richdale OD, PhD|713-743-1974|richdale@central.uh.edu|
20519477|NCT00124462|Boston Univeristy|ClinicalTrials.gov Administrator|617 638 8862|damusk@bu.edu|617
20519478|NCT03139240|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20519479|NCT03314662|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20551633|NCT03519347|NYU Langone Health|David M Charytan, MD, MSc|646-501-9086|david.charytan@nyulangone.org|
20551634|NCT03194555|Allodynic Therapeutics, Inc.|Dr. Annette Toledano, Sponsor-Investigator|+13058956808|annette.toledano@allodynic.com|
20551635|NCT01831154|James A Haley Veterans Hosptial|Dr. Sierra Gower|(813) 972-2000|sierra.gower@va.gov|5946
20551636|NCT01641692|GlaxoSmithKline|GSK Response Center|866-435-7343||
20551637|NCT03831347|Butler Hospital|Dr. Lisa Uebelacker|401-455-6200|LUebelacker@butler.org|
20551638|NCT01685996|Johns Hopkins University School of Medicine|Dr. Annie Umbricht, M.D.|410-550-1917|annieumbricht@jhu.edu|
20551639|NCT00841087|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20551640|NCT02515045|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
20551641|NCT01412021|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20551642|NCT00238121|University of Chicago Comprehensive Cancer Center|Dr. Gini Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
20551643|NCT02221284|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20551644|NCT01166178|Novartis|Study Director|41 61 324 1111||
20551645|NCT00484939|Hoffmann-La Roche|Medical Communications|800 821-8590||
20551646|NCT00624052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551647|NCT00471848|European Group for Blood and Marrow Transplantation|Prof. Judith Marsh|+31 (0)71 5265005|a.j.barrois@lumc.nl|
20551648|NCT00529542|Milton S. Hershey Medical Center|Richard S. Legro|717-531-8478|rsl1@psu.edu|
20551649|NCT01566461|Medtronic Endovascular Therapies|Arslan Malik, Sr. Clinical Research Manager||arslan.malik@medtronic.com|
20551650|NCT04640519|Columbia University|Imama Naqvi, MD|646-426-3876|ian2108@cumc.columbia.edu|
20551651|NCT03141281|Florida State University|Dr. Neil Charness|850-644-6686|charness@psy.fsu.edu|
20551652|NCT02467465|Universidad Complutense de Madrid|Miguel Suárez Varela|+34913941518|misuarezvarela@gmail.com|
20551653|NCT01499563|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinialTrials@itci-inc.com|
20551654|NCT04262232|Fred Hutchinson Cancer Center|Megan Shen|206-667-4172|mshen2@fredhutch.org|
20551655|NCT03333044|NYU Langone Health|Shinu Mammen|646-501-3484|shinu.mammen@nyulangone.org|
20551656|NCT03649711|University of Arkansas for Medical Sciences|Dr. Nishank Jain, Associate Professor of Medicine|5016865295|njain2@uams.edu|
20551657|NCT01721330|Massachusetts General Hospital|Leah Feinberg|617-726-4651|lkfeinberg@mgh.harvard.edu|
20551658|NCT00296374|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20551659|NCT06308822|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20551660|NCT00708942|Photocure|Bjørn Klem, Project Director|+47 22 06 22 10|bk@photocure.no|
20551661|NCT04734652|CAPRISA|Dr Anushka Naidoo|031 655 0668|anushka.naidoo@caprisa.org|0669
20551662|NCT05027438|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD (Principal Investigator)|(412) 360-2806|adam.bramoweth@va.gov|
20551663|NCT00555750|Brigham and Women's Hospital|Dr. John Winkelman, MD, PhD|617-278-0061|jwwinkelman@partners.org|
20551664|NCT01921179|San Francisco VA HCS|Dr Tatjana Novakovic-Agopian|415-753-3888|tatjana.novakovic-agopian@va.gov|
20551665|NCT02710890|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20529711|NCT02155985|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20529712|NCT02998151|Cincinnati Children's Hospital Medical Center|Dr. Craig Erickson|513-636-0523|craig.erickson@cchmc.org|
20529713|NCT00952315|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
20529714|NCT01628848|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
20529715|NCT02667301|StratejikYG|Murat Haluk Ozkul|0905327777842|kbbhaluk@gmail.com|
20529716|NCT01939314|Indiana University School of Medicine|Jason Schaffer, MD|317-962-8026|jtschaff@iupui.edu|
20551666|NCT01190254|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20551667|NCT04146545|University of Chicago|Emily Abramsohn|7738344832|eabramsohn@bsd.uchicago.edu|
20551668|NCT00773292|Imperial College London|Graham P Taylor|0207 594 3910|g.p.taylor@imperial.ac.uk|
20551669|NCT04729127|University of Pennsylvania|Melanie Pellecchia|215-746-1950|melanie.pellecchia@pennmedicine.upenn.edu|
20551670|NCT01245270|University of Aberdeen Rowett Institute of Nutrition and Health|Dr Nigel Hoggard|[+44] (0) 1224 438700|N.Hoggard@abdn.ac.uk|
20551671|NCT00542919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20551672|NCT03927612|Indiana University School of Medicine|Clinical Research Specialist|317-274-8670|vrlab@iupui.edu|
20551673|NCT01959542|Brigham and Women's Hospital/Dana-farber Cancer Institute|Dr. Fiona Fennessy|617 632 4891|ffennessy@bwh.harvard.edu|
20551674|NCT03050619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551675|NCT01716013|OptMed|Associate Director of Quality Assurance|(908) 720-2372|nyajnik@optmed.com|
20551676|NCT01998633|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20551677|NCT04098107|Children's Hospital of Philadelphia|Elliot Greenberg|215-590-1527|GREENBERGE@chop.edu|
20551678|NCT00536107|AstraZeneca|Sharon Chang||aztrial_results_posting@astrazeneca.com|
20551679|NCT00371254|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20551680|NCT03329690|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20551681|NCT01817725|Chang Gung Memorial Hospital, Linkou Branch|Dr. Ming-Wei Lai|886-3-3281200|a22141@adm.cgmh.org.tw|8969
20551682|NCT02290106|Massachusetts General Hospital|Takara Stanley, MD|6177249109|tstanley@mgh.harvard.edu|
20551683|NCT02337907|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20551684|NCT03141242|University of Colorado|Hillary Lum, MD, PhD|3037241911|hillary.lum@cuanschutz.edu|
20551685|NCT02409459|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610.650.4200|mfalone@luitpold.com|844
20564556|NCT05281562|Prisma Health|J. Benjamin Jackson|803-296-9610|benjamin.jackson@prismahealth.org|
20564557|NCT05746299|University of Pennsylvania|Anna Schapiro|215-898-0482|aschapir@sas.upenn.edu|
20564558|NCT03058289|Intensity Therapeutics|Lewis Bender|2032217377|LBender@intensityTherapeutics.com|
20564559|NCT06212804|Visterra, Inc.|Mohit Mathur, MD|+1-617-498-1070|mmathur@visterrainc.com|
20564560|NCT03869866|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20564561|NCT05579899|Evommune|Eugene Bauer, M.D., Chief Medical Officer|310-721-3364|eugene.bauer@evommune.com|
20564562|NCT03023410|Stryker|Kevin Barga|+12018315073|Kevin.Barga@stryker.com|
20564563|NCT04475679|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20564564|NCT03379675|Janssen Research and Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564565|NCT04502888|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
20564566|NCT05540665|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20564567|NCT03381196|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564568|NCT02675751|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan Ph.D.|+1 408-273-4081|skasthur@its.jnj.com|
20519480|NCT01393457|The University of Texas Health Science Center at Houston|Charles Green, PhD|713-500-6402|charles.green@uth.tmc.edu|
20519481|NCT01867606|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-4918|jatoi.aminah@mayo.edu|
20519482|NCT03922139|UW School of Medicine and Public Health|Michael Suer, MD|608-265-3207|suer@rehab.wisc.edu|
20519483|NCT00292227|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20519484|NCT00739973|Novartis Pharmaceuticals|Study Director|862 778-8300||
20519485|NCT01989676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519486|NCT02012452|VA Boston healthcare system|Sandra Japuntich|6082398018|sjjapuntich@gmail.com|
20519487|NCT02190279|National Cancer Institute|Dr. Maria Liza Lindenberg|240-760-6109|liza.lindenberg@nih.gov|
20519488|NCT02938442|University of Arkansas for Medical Sciences|Sorena Lo|5016868274|SBLo@uams.edu|
20519489|NCT04403399|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
20519490|NCT00802178|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519491|NCT01606228|Janssen China|Medical Affairs Director, CNS, Asia Pacific|8610 5821 8766||
20519492|NCT01115855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519493|NCT00480324|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519494|NCT00966381|UNC Greensboro|Cheryl Lovelady|336 256-0310|cheryl_lovelady@uncg.edu|
20519495|NCT02211014|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
20519496|NCT01119807|Mecklenburg EMS Agency|Jonathan R Studnek PhD|7049436046|jonst@medic911.com|
20519497|NCT01124695|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20519498|NCT02960438|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
20519499|NCT03686150|University of Arkansas for Medical Sciences|Songthip Ounpraseuth|501-686-7233|stounpraseuth@uams.edu|
20519500|NCT01922219|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jm2233@cumc.columbia.edu|
20519501|NCT02265341|Mayo Clinic|Mitesh J. Borad, MD|480/301-8335|Borad.Mitesh@mayo.edu|
20519502|NCT02443324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20519503|NCT03404401|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20519504|NCT01844531|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519505|NCT04894084|Coloplast A/S|Medical Affairs Project Manager|+4549111341|dkteaa@coloplast.com|
20519506|NCT03122587|University of North Carolina at Chapel Hill|Stacey Daughters, PhD|9199629924|daughter@unc.edu|
20519507|NCT01573533|Mayo Clinic|Fernando C. Fervenza, M.D., Ph.D.|507-266-1045|Fervenza.Fernando@mayo.edu|
20519508|NCT01613378|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20519509|NCT00794417|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20519510|NCT02956616|Montefiore Medical Center|Peter S. Bernstein, MD, MPH|718-904-2767|pbernste@montefiore.org|
20519511|NCT03764735|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
20519512|NCT01345318|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519513|NCT00255151|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20519514|NCT00450983|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
20519515|NCT00792623|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519516|NCT00743509|University of Michigan|Scott Schuetze|734-647-8925|scotschu@umich.edu|
20519517|NCT01239472|Hospital e Maternidade Marieta Konder Bornhausen|Dr Andre Barreto Pereira|+55 47 984482826|andrebarper@yahoo.com.br|
20519518|NCT00232479|UMiami|Judith Hurley|305-243-6698|jhurley@miami.edu|
20519519|NCT00263887|Talecris Biotherapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20519520|NCT01714739|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
20519521|NCT01028911|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519522|NCT00707434|UT MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20519523|NCT03585959|Medtronic|Katie Bayliss|(763) 647-5547|katie.j.bayliss@medtronic.com|
20519524|NCT02531594|Cincinnati Children's Hospital Medical Center|Dr. Melinda Mahabee-Gittens|513-636-7966|melinda.mahabee-gittens@cchmc.org|
20519525|NCT00614822|Christiana Care Health System|Dr. Michael Guarino|302 366 1200|mguarino@cbg.org|
20519526|NCT00931463|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
20519527|NCT01175473|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20519528|NCT02630316|United Therapeutics|United Therapeutics Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20519529|NCT00084799|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20519530|NCT05070390|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519531|NCT02412722|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20519532|NCT04449341|Carl R Darnall Army Medical Center|Matthew Perdue|(254) 553-4653|matthewperdue94@gmail.com|
20519533|NCT00931996|Ullinois|Dr. Jeffrey Bishop|312-413-3495|jbishop@uic.edu|
20519534|NCT03073811|Durham VA Health Care System|Kathryn Starr, PhD, RD; Research Health Scientist|919-660-7571|kathryn.starr2@va.gov|
20519535|NCT02400476|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|1-424-248-6500|clinicaltrials@pumabiotechnology.com|
20519536|NCT02487082|Stony Brook Medicine Dept. of Neurology|Ruth A. Reinsel Ph.D., Clinical Research Associate II|(631) 638-2087|ruth.reinsel@stonybrookmedicine.edu|
20519537|NCT03297294|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20519538|NCT05022563|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519539|NCT02692482|Istituto Ortopedico Rizzoli|Cristiana Forni|0516366694|cristiana.forni@ior.it|0039
20519540|NCT01841216|Sport & Spine Rehab Clinical Research Foundation|Jena Etnoyer, Clinical Research Coordinator|240-766-0300|jetnoyer@ssrehab.com|838
20519541|NCT00605917|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519542|NCT01610063|Mayo Clinic|Dr. Daniel K. Hall-Flavin|507-255-4151|flavin.daniel@mayo.edu|
20519543|NCT02919826|Queen's University|Dr. Muhammad Ayub|613-549-7944|ma84@queensu.ca|
20519544|NCT00925301|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20519545|NCT03043560|Icahn School of Medicine at Mount Sinai|Dr, James Murrough|212-585-4640|james.murrough@mssm.edu|
20519546|NCT01117766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519547|NCT04405739|Ridgeback Biotherapeutics|Wendy Painter, MD, MPH|786-687-2495|EIDD2801@ridgebackbio.com|
20519548|NCT05766787|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20519549|NCT00438659|Mayo Clinic|Robert C. Miller, M.D.||miller.robert@mayo.edu|
20519550|NCT01839695|Medtronic Vascular|Taryn Dellaripa, Principal Clinical Research Specialist|541-301-3181|taryn.dellaripa@medtronic.com|
20519551|NCT02056652|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
20519552|NCT01588548|AstraZeneca|Karen Keating|+1 781 839 4182|karen.keating@astrazeneca.com|
20519553|NCT01114581|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
20519554|NCT00537017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519555|NCT00948792|University of Oklahoma Health Sciences Center|Doug Dannaway|4052715215|douglas-dannaway@ouhsc.edu|42048
20519556|NCT03365791|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20519557|NCT03253094|SCYNEXIS|Dr. David Angulo|(201) 884 - 5471|david.angulo@scynexis.com|
20519558|NCT00576303|F. Hoffmann-La Roche AG|Name/Official Title:Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20529717|NCT00078286|Duke University|Dr. Ranga Krishnan|919-668-3647|krish001@mc.duke.edu|
20529718|NCT02951312|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20529719|NCT05770713|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529720|NCT01107925|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529721|NCT04877990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20529722|NCT02895295|Stanford University|Dr. M. Kate Bundorf|6507250067|bundorf@stanford.edu|
20529723|NCT04000438|Dilafor AB|Gunvor Ekman-Ordeberg|+467060833111|gunvor.ekman-ordeberg@dilafor.com|
20529724|NCT01949142|Otonomy, Inc|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20529725|NCT00490919|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20529726|NCT01317940|Children's Hospital Los Angeles|Dr. Etan Orgel|3233612672|eorgel@chla.usc.edu|
20529727|NCT03256578|Leiden University Medical Center|Dr. Arjan te Pas|+31 71 5265839|a.b.te_pas@lumc.nl|
20564569|NCT03628924|Janssen Research & Development, LLC|Product development portfolio leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564570|NCT04341896|New York University|Rhiannon Reed|205-999-3360|rjd1125@uab.edu|
20564571|NCT03032107|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
20564572|NCT02619994|Seoul National University|Dr. Prof. JJ Yim|82-02-1588-5700|yimjj@snu.ac.kr|
20564573|NCT05126433|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20564574|NCT03907878|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20564575|NCT04625686|Cincinnati Children's Hospital Medical Center|Rosalie Hemphill LSW|5044940883|rosalie.hemphill@cchmc.org|
20529728|NCT01198002|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529729|NCT00129441|University of Pittsburgh|David A. Lewis, MD|(412) 246-6010|lewisda@upmc.edu|
20529730|NCT01811732|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
20529731|NCT05310877|The Miriam Hospital|Emily Gathright, PhD|401-793-8271|Emily.Gathright@lifespan.org|
20529732|NCT01657617|University of Kentucky|Ronald McGarry|859 323 6486|rcmcga2@email.uky.edu|
20529733|NCT00536510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529734|NCT02026141|University of Saskatchewan-Department of Anesthesia|Dr. Ian Chan|306-717-8028|iac549@mail.usask.ca|
20529735|NCT01249417|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20529736|NCT03102762|Cairo University|Dr. Hussein Ghanem, Directer of this clinical trial|01001176111|hmhghanem@gmail.com|
20529737|NCT02779491|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
20529738|NCT03074695|Duke University|Ashraf Habib, M.D.|919-681-4544|ashraf.habib@duke.edu|
20529739|NCT00960193|Mutual Pharmaceutical Company, Inc.|Medical Drector|215-697-1743|clinicaltrials@urlmutual.com|
20529740|NCT03362944|Frohlich Lab - University of North Carolina at Chapel HIll|Trevor McPherson|919-966-4755|trevor_mcpherson@med.unc.edu|
20529741|NCT00728494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20529742|NCT03843372|Sleep Center, Chang Gung Memorial Hospital, Keelung, Taiwan|Dr. Chung-Chieh Yu|886+22432-9292|terminatorchieh@yahoo.com.tw|2658
20529743|NCT02337062|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|GabrielFox@acaciapharma.com|
20529744|NCT01232790|Yale University School of Medicine, Department of Psychiatry|Cenk Tek MD, Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7484|cenk.tek@yale.edu|
20529745|NCT00083915|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
20529746|NCT01239797|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20529747|NCT00853762|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20529748|NCT03059914|Loma Linda University Health|Sarat Ummethala|909 558 4983|saratdoc@yahoo.com|
20529749|NCT00956085|Stanford University|Carolyn Rodriguez, MD, PhD, Assistant Professor|6507236158|cr2163@stanford.edu|
20529750|NCT01290718|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20529751|NCT00915590|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
20529752|NCT02631941|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
20529753|NCT00501631|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
20529754|NCT00719901|Mayo Clinic|A. Keith Stewart|480-301-4411|stewart.keith@mayo.edu|
20529755|NCT03836586|University of Florida|Dr. Ellen Terry|352-273-6441|elterry@ufl.edu|
20529756|NCT04456686|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20529757|NCT00578903|Baylor College of Medicine|Kathryn Leung|832-824-4269|kleung@bcm.edu|
20529758|NCT02858401|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20529759|NCT03722576|Mayo Clinic|Elizabeth J. Carey, M.D.|480-342-1094|Carey.Elizabeth@mayo.edu|
20529760|NCT00748241|Astra Tech AB|Head of Clinical Research Area Dental|+46317763000||
20529761|NCT01240382|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20529762|NCT02456727|Albert Einstein College of Medicine|Diane McKee|718-430-2952|Diane.Mckee@einstein.yu.edu|
20529763|NCT02643693|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
20529764|NCT00492297|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20529765|NCT00193453|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|askSarah@scresearch.net|
20529766|NCT01408706|Wheaton Franciscan Healthcare - All Saints|Dr. James Taylor|262-687-5000|james.taylor@wfhc.org|
20529767|NCT01268267|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
20529768|NCT01222104|St Jude Medical|Andrew Campbell|651-756-5538|acampbell2@sjm.com|
20529769|NCT01307956|University of Nebraska Medical Center|Jean L Grem|402-559-5166|jgrem@unmc.edu|
20529770|NCT00888654|Barbara Ann Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8715|heathe@karmanos.org|
20529771|NCT01418339|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20529772|NCT00685815|Luitpold Pharmaceuticals, Inc.|Angie Butcher|610-650-4200|abutcher@lpicrd.com|
20529773|NCT03669549|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
20529774|NCT00909844|Ipsen Pharma|Medical Director, Endocrinology||clinical.trials@ipsen.com|
20529775|NCT04023578|Ossur Iceland ehf|Kristleifur Kristleifsson|6641112|kkristjansson@ossur.com|+354
20529776|NCT02974868|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529777|NCT00706004|University of Arkansas for Medical Sciences|Catherine O'Brien|501-364-1828|obriencatherinee@uams.edu|
20529778|NCT02674516|Nanyang Technological University|Dr. Olivia Choy|(65) 65921522|oliviachoy@ntu.edu.sg|
20529779|NCT01064479|UT MD Anderson Cancer Center|Dr. Xiuning Le, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 792-6980|xle1@mdanderson.org|
20529780|NCT02634073|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529781|NCT01900444|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20529782|NCT00072384|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20529783|NCT01825200|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20529784|NCT01255163|National Institute on Aging (NIA/NIH)|Dimitrios Kapogiannis, Clinical Investigator|410-350-3953|kapogiannisd@mail.nih.gov|
20529785|NCT00490035|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20529786|NCT06058390|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20529787|NCT02495389|Loyola University Chicago|Alan Wolfe, Ph.D.|708-216-5814|awolfe@luc.edu|
20529788|NCT01297283|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
20529789|NCT02265965|University of California, San Francisco|Jennifer Lucero, MD|415-476-5535|jennifer.lucero@ucsf.edu|
20564576|NCT03904147|Abbott|Natalie Richardson, Senior Clinical Project Manager|651-756-3842|natalie.richardson@abbott.com|
20564577|NCT02809443|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
20564578|NCT05270408|UT Southwestern Medical Center|Dr Christian LoBue|2146485265|Christian.LoBue@utsouthwestern.edu|
20564579|NCT03768505|MEI Pharma|Richard Ghalie, MD CMO|858 898 0956|rghalie@meipharma.com|
20564580|NCT05331053|Penn State University|Lacy M. Alexander, Ph.D.|8148671781|lma191@psu.edu|
20564581|NCT02815566|University Health Network|Dr. Sharon Walmsley|416-340-3871|sharon.walmsley@uhn.ca|
20564582|NCT06044090|University of Pittsburgh|Gabriella Alvarez, PhD|412-624-4500|gabyalvarez@pitt.edu|
20564583|NCT02861300|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. David Bajor|(216) 286-4414|david.bajor@uhhospitals.org|
20564584|NCT04910152|The Ohio State University Comprehensive Cancer Center|Dr. Hannah Choe|614-293-3196|Hannah.choe@osumc.edu|
20564585|NCT05038878|Icahn School of Medicine at Mount Sinai|Dr. Alice C. Levine|(212) 241-3422|alice.levine@mountsinai.org|
20564586|NCT05034328|Pharmndev Experts|Dr Bernard Gout|+41798659000|bgout@pharmndev.ch|
20564587|NCT03468868|Shepherd Center, Atlanta, GA|Deborah Backus, PT, PhD|404-352-2020|deborah.backus@shepherd.org|
20564588|NCT00986856|LEO Pharma|Anders Rhod Larsen, Scientific advisor|+45 72262990|anders.larsen@leo-pharma.com|
20564589|NCT02969707|Stanford University|Dr. David Spiegel|650-723-6421|dspiegel@stanford.edu|
20564590|NCT05201079|Mikrobiomik Healthcare Company S.L.|Olaia Aurtenetxe Saez|+34 944 540 166|ensayosclinicos@mikrobiomik.net|
20564591|NCT05825755|vitalera (FollowHealth SL)|Data Scientist of vitalera|+34644499760|val-hic@humanitcare.com|
20564592|NCT04103580|Washington University|Kyle Pitzer: Study Statistical Data Analyst|314-747-5361|kyleapitzer@wustl.edu|
20564593|NCT04145440|HI-Bio, A Biogen Company|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20564594|NCT03697096|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
20564595|NCT05562401|UColima|Fabian Rojas Larios|3121206804|frojas@ucol.mx|
20564596|NCT04436276|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564597|NCT01767636|Mayo Clinic|Brian Costello MD|507/284-2511|Costello.Brian@mayo.edu|
20564598|NCT03852472|Chemocentryx|Study Director|650-210-2900|medinfo@amgen.com|
20564599|NCT01919554|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 55 59 20 00|mroux@stallergenes.com|
20564600|NCT06457802|Vanderbilt University School of Nursing|Dr. Shelagh Mulvaney, PhD|6153221198|shelagh.mulvaney@vanderbilt.edu|
20564601|NCT01652196|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-6529|John.hay@osumc.edu|
20564602|NCT04524442|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20564603|NCT02675777|Kaiser Permanente Washington Health Research Institute|Katharine Bradley, MD, MPH|206-948-1933|katharine.a.bradley@kp.org|
20564604|NCT04324359|Surface Ophthalmics Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
20564605|NCT04898673|Cochlear Limited|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20564606|NCT05778695|University of Michigan|Nicolaas Bohnen, MD, PhD|734-936-1168|nbohnen@umich.edu|
20564607|NCT04649476|Hospital of Stomatology, Wuhan university|Gang Chen, MD|+86 02787686215|geraldchan@whu.edu.cn|
20564608|NCT01544114|Horizon Pharma, Inc.|Julie Ball, Executive Director of Clinical Development & Operations||clinicaltrials@horizonpharma.com|
20564609|NCT04223505|University of Ottawa Heart Institute|Dr. Benjamin Chow|6136966786|bchow@ottawaheart.ca|
20564610|NCT05526430|Icahn School of Medicine at Mount Sinai|Jessica L Ables|(212) 241-2774|jessica.ables@mssm.edu|
20564611|NCT03085810|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20564612|NCT02601313|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
20529790|NCT03585270|Idorsia Pharmaceutical Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
20529791|NCT05559905|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529792|NCT04003103|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529793|NCT02756910|Peking Union Medical College Hospital|Lijian Pei|＋86 10 69152020|hazelbeijing@vip.163.com|
20529794|NCT01211145|AstraZeneca|Jamie Mullen, Medical Science Director|781-472-5032|jamie.mullen@astrazeneca.com|
20529795|NCT00791999|Medical Advisor of the Clinical Trial|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
20529796|NCT00617357|LifeCell|Dr Michael Franz|908 947 1100|mfranz@lifecell.com|
20529797|NCT00427908|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529798|NCT03976752|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
20529799|NCT00485069|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529800|NCT00791219|Mayne Pharma|Stuart Mudge, VP Scientific Affairs|+613 8614 7704|stuart.mudge@maynepharma.com|
20529801|NCT02573259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529802|NCT00751140|H. Lee Moffitt Cancer Center and Research Institute|Philippe E. Spiess, M.D.|813-745-8343|philippe.spies@moffitt.org|
20529803|NCT03160716|Q-Med AB|Reception|+46184749000|reception.seupp@galderma.com|
20529804|NCT05630196|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20529805|NCT03438266|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20529806|NCT00903201|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529807|NCT01094288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20529808|NCT00563290|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
20529809|NCT02611882|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|2264
20529810|NCT01389232|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20529811|NCT04678284|Hennepin Healthcare|Dr. Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
20529812|NCT00945243|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
20529813|NCT01162343|Vanderbilt University Medical Center|Dr. Jin Han, MD|615-936-0253|jin.h.han@vanderbilt.edu|
20529814|NCT00641056|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20529815|NCT00896493|Stanford University Medical Center|Wen-Kai Weng, Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
20529816|NCT00896064|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529817|NCT01774981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529818|NCT00902577|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
20529819|NCT03322293|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
20529820|NCT01607658|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
20529821|NCT02000921|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
20529822|NCT02914834|University of Illinois Chicago|Judith Schlaeger, PhD|3124134669|jschlaeg@uic.edu|
20529823|NCT03108482|Esteve Pharmaceuticals, S.A.|Dr. Neus Gascon|+34934446000|ngascon@esteve.com|
20529824|NCT03885908|Memorial Sloan Kettering Cancer Center|Dr. Armin Shahrokni, MD, MPH|646-888-3651|shahroka@mskcc.org|
20529825|NCT03817606|Riverside Medical Center|Cynthia Koehn, Clinical Research Nurse|815-933-1671|ckoehn@rhc.net|
20529826|NCT01639352|University of Miami|Lynn Feun, M.D.|305-243-4909|lfeun@med.miami.edu|
20529827|NCT01663402|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
20529828|NCT00678418|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
20529829|NCT03575702|R-Pharm|Georgiy Sharvadze, Medical Advisor|0074959567937|sharvadze@rpharm.ru|1175
20529830|NCT03903172|Wright State University|Sheela Barhan, MD|937-208-2850|sheela.barhan@wright.edu|
20529831|NCT01545388|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529832|NCT03918811|Hospitalsantojanni|Professor Mauro Andreu|+541168788298|mfandreu@gmail.com|
20529833|NCT01802385|University of Minnesota|Joshua Rhein|612-624-1966|joshua.rhein@gmail.com|
20529834|NCT04683640|University of Florida|Yenisel Cruz-Almeida|(352) 294-5845|cryeni@ufl.edu|
20529835|NCT03041636|The University of Texas MD Anderson Cancer Center|Zeev Extrov MD./Professor|713-794-1675|zestrov@mdanderson.org|
20529836|NCT01664091|Dana-Farber Cancer Institute|Julia Wong, MD|617-632-3591|JWONG@LROC.HARVARD.EDU|
20529837|NCT04195594|TRCGEN+ (managed by Trans Russian Co)|Nikolaos Tzenios|+447583902071|Nicolas@trccolleges.com|
20529838|NCT01172873|New York State Psychiatric Institute/Columbia University|Moira A. Rynn, M.D.|646-774-5805|RynnM@nyspi.columbia.edu|
20529839|NCT05518539|Newsom Eye|T Hunter Newsom|813-908-2020|hunter@newsomeye.net|
20529840|NCT02783898|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
20529841|NCT02053493|Duke Clinical Research Insitute|Dr. Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
20529842|NCT03569397|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
20529843|NCT03589807|Emory Children's Center|Evan J. Anderson, MD|404-727-5642|evanderson@emory.edu|
20529844|NCT01076543|University of Chicago|Dr. Sonali Smith, Professor of Medicine|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
20529845|NCT00338741|EMD Serono|Liz Gedney/Clinical Trial Leader|+781 681-2179||
20529846|NCT01534273|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529847|NCT01619865|University of Iowa Holden Comprehensive Cancer Center|Sue O'Dorisio, MD, PhD|319-356-7873|sue-odorisio@uiowa.edu|
20529848|NCT03586050|ETHICON|Jaclyn Calia Stanziola|908-808-6380|jcalia@its.jnj.com|
20529849|NCT01494818|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
20564613|NCT03800654|VA San Diego Healthcare System|Dr. Matthew Herbert|858-642-1411|Matthew.Herbert2@va.gov|
20564614|NCT03459729|Froedtert and the Medical college of Wisconsin|Stuart Wong, MD|414-805-4600|swong@mcw.edu|
20519559|NCT00824369|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519560|NCT00442546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20519561|NCT00392782|Masonic Cancer Center, University of Minnesota|Daniel Weisdorf, M.D.|612-624-0123|weisd001@umn.edu|
20519562|NCT00101413|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20519563|NCT00858013|Ajou University|Kwan Woo Lee|82-31-219-4526|lkw65@ajou.ac.kr|
20519564|NCT00760526|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|direcnet@jaeb.org|
20519565|NCT04815850|University of Leicester|Dr Matthew Graham-Brown|01162588043|mgb23@le.ac.uk|
20519566|NCT00831233|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20519567|NCT00784134|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
20519568|NCT03785145|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
20519569|NCT00097786|Novartis Pharmaceuticals|Study Director|862 778-8300||
20519570|NCT01647711|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519571|NCT01316419|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519572|NCT00455962|Massachusetts General Hospital|Janet E. Hall, MD|617-877-1112|jehall@partners.org|
20519573|NCT01344616|PHCC LP|James G. Christian|7195468633|jim@phcclp.com|
20519574|NCT02451150|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20519575|NCT03244475|VA San Diego Health System|Dr. Mingxiong Huang|858-534-1254|mingxiong.huang@va.gov|
20519576|NCT02948257|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|408-470-7119|Terry_Alverson@cardivamedical.com|
20519577|NCT04025684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20519578|NCT03008837|VAORD|Dr. Anna Woodbury|404-321-6111|anna.woodbury@va.gov|
20519579|NCT02070757|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519580|NCT01546922|University Medical Center Groningen|A. P. van Beek, MD PhD|00315036110388|a.p.van.beek@umcg.nl|
20519581|NCT01685073|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
20519582|NCT00934596|Cardiothoracic Surgery, Skåne University Hospital Lund|Dr. Bansi Koul MD, PhD, Principal Investigator|+46 46 171649|bansi.koul@skane.se|
20519583|NCT00880087|University of Utah|Dr. Rich Holubkov, Professor of Pediatrics|807-587-3326|richard.holubkov@hsc.utah.edu|
20519584|NCT01534078|Massachusetts General Hospital|Jeremy Abramson, MD|617-724-4000|JABRAMSON@mgh.harvard.edu|
20519585|NCT01280617|Lahey Hospital & Medical Ctr|Mary Ann Simpson, Ph.D|781-744-2500|Mary.a.Simpson@Lahey.org|
20519586|NCT00573170|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519587|NCT00572039|Thomas Jefferson University|Barry W. Rovner, MD|2155031254|Barry.Rovner@jefferson.edu|
20519588|NCT01845116|Atrium Health Levine Children's Hospital|Ricardo A. Caicedo, MD|704-381-8840|ricardo.caicedo@atriumhealth.org|
20519589|NCT02147587|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519590|NCT01355302|Eisai Inc.|Eisai Medical Services|888-422-4743||
20519591|NCT03649412|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20519592|NCT00530348|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20519593|NCT04364763|Renibus Therapeutics|Stacey Ruiz|682-285-1711|sruiz@renibus.com|
20519594|NCT00985231|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.t.reindel@bausch.com|
20519595|NCT00838981|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20519596|NCT02913131|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
20519597|NCT01083680|AbbVie|Global Medical Information|800-633-9110||
20519598|NCT00003531|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20519599|NCT00346164|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
20519600|NCT02260258|BIDMC|Mike Donnino|6177542882|mdonnino@bidmc.harvard.edu|
20519601|NCT03496987|Yale University School of Medicine|Jonathan Puchalski, MD|2037375699|jonathan.puchalski@yale.edu|
20519602|NCT01506908|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519603|NCT01818518|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
20519604|NCT03718117|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519605|NCT01246713|BIDMC|Michael Ganetsky, MD|6177542323|mganetsk@bidmc.harvard.edu|
20519606|NCT00206102|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20519607|NCT01917968|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
20519608|NCT03623035|Wake Forest Baptist Health|Christopher Edwards|3367168222|chedward@wakehealth.edu|
20519609|NCT01435928|Sunovion|Medical Director, CNS|1-866-503-6351||
20519610|NCT00834236|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20529850|NCT01791985|Imperial College London|Michael Seckl|+44 (0)20 3311 1421|m.seckl@imperial.ac.uk|
20529851|NCT04195061|Massachusetts General Hospital|Melanie S. Haines, MD|617-726-3870|mshaines@mgh.harvard.edu|
20529852|NCT04406714|University of North Carolina Lineberger Comprehensive Cancer Center|Alexis Moore|+1 919-962-5409|alexis.moore@unc.edu|
20529853|NCT02201342|Mezzion Pharmaceuticals|Won Geun Kim|3128980292|wg.kim@mezzion.com|
20529854|NCT00086190|University of Rochester Medical Center|Irene H. Richard, MD|585-341-7500|irene_richard@urmc.rochester.edu|
20529855|NCT00249834|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20519611|NCT00862537|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
20529856|NCT01787006|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
20529857|NCT00004547|National Cancer Institute, National Institutes of Health|Marybeth S. Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
20529858|NCT03902613|Columbia University Irving Medical Center|Dr. Martin Lan|646 774 7610|martin.lan@nyspi.columbia.edu|
20529859|NCT04467515|Precirix|Jonathan Delara, Clinical Trial Manager|+1 (512) 589-2114|jonathan.delara@precirix.com|
20529860|NCT04252625|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20529861|NCT03014206|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529862|NCT01091246|MedImmune, LLC|Judy Falloon, MD/ Sr Director Clinical Development|301-398-0000|falloonj@medimmune.com|
20529863|NCT01676012|Radboudumc|Dr. Erik van der Heijden|0031243614579|Erik.vanderHeijden@radboudumc.nl|
20564615|NCT06182033|Crane Center for Early Childhood Research and Policy at The Ohio State University|Dr. Laura Justice|614-247-7488|justice.57@osu.edu|
20529864|NCT01217827|VA Palo Alto HCS|Paul Heidenreich|650-849-1205|paul.heidenreich@va.gov|
20529865|NCT00596271|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 206 20|info@valneva.com|0
20529866|NCT01533116|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20529867|NCT04460326|Boston Medical Center|Sara M Alexanian, MD|617-638-8545|sara.alexanian@bmc.org|
20529868|NCT04794751|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
20529869|NCT02421354|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD. Professor|713-745-3429|sverstov@mdanderson.org|
20529870|NCT03528551|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20529871|NCT00969228|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529872|NCT03311945|Hospital Clinic of Barcelona|Esteban Martínez|+34 93 227 54 00|estebanm@clinic.cat|
20529873|NCT01619878|Novartis Pharmaceuticals|Study Director|862-778-8300||
20564616|NCT05704543|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
20564617|NCT02272998|The Ohio State University Comprehensive Cancer Center|Dr. Sameek Roychowdhury|614-685-5842|Sameek.roychowdhury@osumc.edu|
20564618|NCT02938377|University of Alabama at Birmingham|Karen Cropsey, Psy.D|(205) 975-4204|kcropsey@uab.edu|
20564619|NCT05476328|Cochlear|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20564620|NCT04830800|PATH|Dr. Thang Tran Cong, Medical office|84-913301883|thangtran@path.org|
20564621|NCT02626533|Hospital for Special Surgery, Anesthesiology|Dr. Meghan Kirksey|2126061036|KirkseyM@hss.edu|
20564622|NCT03701763|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20564623|NCT05493072|Imperial College NHS Healthcare Trust|Calandra Feather|07977185577|calandra.feather@nhs.net|
20564624|NCT05576155|University of Iowa|Kelsey Schwartz|319-467-3096|kelsey-schwartz@uiowa.edu|
20564625|NCT02975375|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20564626|NCT04081103|Amber Ophthalmics|Director of Clinical Trials|858-539-3418|clinical@Amberophthalmics.com|
20564627|NCT05123118|State University of New York at Buffalo|Dr. Xiaozhong Wen|7168296811|xiaozhon@buffalo.edu|
20564628|NCT04581564|Assistant Professor. Speech, Language and Hearing|Dr. Yune Lee|972-883-5639|yune.lee@utdallas.edu|
20564629|NCT03365882|SWOG Statistics and Data Management Center|Gastrointestinal Committee Statistician|2066674623|scolby@fredhutch.org|
20564630|NCT04828005|Opiant Pharmaceuticals|Clinical Director|+1 804 379 1090|PatientSafetyNA@Indivior.com|
20564631|NCT03287817|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
20564632|NCT05251909|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20564633|NCT05543915|NYU Langone Health|Guiseppina Pilloni|646-501-9274|giuseppina.pilloni@nyulangone.org|
20564634|NCT04321395|Washington University in St. Louis|Assistant Professor|314-362-8708|ssfarabi@wustl.edu|
20564635|NCT04987320|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20564636|NCT00085735|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
20564637|NCT01824875|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20564638|NCT02014649|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
20564639|NCT04195698|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20564640|NCT00433329|Actelion Pharmaceuticals, US, Inc.|Rajiv Patni/Medical Officer|(650) 624-6900||
20564641|NCT05459688|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20564642|NCT01129102|Nobelpharma|Department director of clinical development department 1|+81-5651-1177|murakami@nobelpharma.co.jp|
20564643|NCT02817776|Biosense Webster Inc|Kendra McInnis|+1 949 322-8010|kmcinnis@its.jnj.com|
20564644|NCT05349500|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
20564645|NCT03462030|Johns Hopkins University|Dr. Robert Wood|410-955-5883|rwood@jhmi.edu|
20564646|NCT03371381|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564647|NCT04002830|Shaare Zedek Medical Center|Majdolen Istaiti|972526659995|joleenist@szmc.org.il|
20564648|NCT02359890|Biosense Webster|Robert Stagg|(800) 729-9010|RStagg@its.jnj.com|
20529874|NCT01883895|UW Madison|Nalini Sehgal|608-263-8639|sehgal@rehab.wisc.edu|
20529875|NCT04344028|University of Wisconsin - Madison|Dr. C. Shawn Green|(608) 263-4868|csgreen2@wisc.edu|
20529876|NCT02007720|Novartis Pharma AG|Study Director|+41613241111|novartis.email@novartis.com|
20529877|NCT03810456|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 578-5513|Ellen.Teng@va.gov|
20529878|NCT00738426|Cosmetic Surgery|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
20529879|NCT00641563|University Hospital Bern, Switzerland|Dr. M. Hänggi|0316323029|matthias.haenggi@insel.ch|
20564649|NCT05368402|Dompé Farmaceutici SpA|Clinical Development & Operations|+30 902 583831|clinicaltrials@dompe.com|
20529880|NCT01655901|CHEO Research Institute|Dr. Jean-Philippe Chaput|613-737-7600|jpchaput@cheo.on.ca|3683
20529881|NCT00352118|Masonic Cancer Center, University of Minnesota|Frank Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
20529882|NCT02997163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529883|NCT00922636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529884|NCT00870727|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
20529885|NCT00557466|Novartis Pharmaceuticals|Study Director|862-778-8300||
20529886|NCT01712516|Novartis Pharmaceuticals|Study Director|862-778-8300||
20529887|NCT03268343|Achieve Life Sciences|Daniel Cain, Senior Director Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20529888|NCT01251952|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|(313) 576-8022|alkadhiz@karmanos.org|
20529889|NCT00496769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20529890|NCT03028142|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
20529891|NCT02308046|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
20529892|NCT00869414|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20529893|NCT00607243|Seoul National University Hospital|Myoung-don Oh, M.D.|+82-2-2072-2945|mdohmd@snu.ac.kr|
20529894|NCT02810418|National Cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
20529895|NCT02224625|Bioscience Labs|C Beausoleil|406-587-5735|cbeausoleil@bioscience.com|
20529896|NCT01181167|Daiichi Sankyo Co., Ltd.|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
20529897|NCT02812186|Stony Brook University|Dr. Ruchir Gupta|917-443-1263|gupta2005@yahoo.com|
20529898|NCT01573000|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529899|NCT01996371|OhioU|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
20529900|NCT01125098|Department of Oncology Haematology and Respiratory Diseases|Leonardo Fabbri|+39 059422|leonardo.fabbri@unimore.it|4227
20529901|NCT00729521|Medical College of Wisconsin|Peter Layde, MD, MSc|414-955-8113|playde@mcw.edu|
20529902|NCT01100853|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
20529903|NCT01384877|BC Cancer|Dr. Philippa Hawley|604-877-6000|phawley@bccancer.bc.ca|67-2752
20529904|NCT01507181|Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai|Dr. J. W. Murrough|212-241-7574|james.murrough@mssm.edu|
20529905|NCT04161391|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20529906|NCT01968421|Peking Union Medical College Hospital|Dr. Jinming Gao, Director of Clinical Trials|8610691550549|gjinming@yahoo.com|
20529907|NCT01130272|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20529908|NCT01548404|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20529909|NCT01962675|Shepherd Center|Edelle Field-Fote|404-603-4274|edelle_field-fote@shepherd.org|
20529910|NCT03657069|Stanford University|Dung Nguyen, MD, PharmD, FACS|(650) 498-6004|nguyendh@stanford.edu|
20529911|NCT01878799|National Institute of Allergy and Infectious Diseases|Dr. Shyam Kottilil|+1 301 435 0936|skottilil@niaid.nih.gov|
20529912|NCT03845894|Wake Forest School of Medicine|Jonathan Doug Jaffe DO|336-716-4498|jjaffe@wakehealth.edu|
20529913|NCT01248455|National Cancer Institute|Dr. Dickran Kazandijian|301-480-0532|kazandjiandg@mail.nih.gov|
20529914|NCT01117870|McMaster University/ St. Joseph's Healthcare Hamilton|Dr. Harsha Shanthanna|905-522-1155|harshamd@gmail.com|
20529915|NCT01324102|VA Boston Healthcare System|Jennifer Moye|774-826-3721|jennifer.moye@va.gov|
20529916|NCT03238417|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|818-891-7711|elizabeth.yano@va.gov|36031
20529917|NCT04753034|Aditum Bio|VP, Clinical Operations|(510) 227-2102|Chris.resburg@aditumbio.com|
20529918|NCT01249131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20529919|NCT00433836|Novartis Pharmaceuticals|Study Director|862-778-8300||
20529920|NCT00192114|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20529921|NCT00113607|Janssen R&D US|Director Clinical Research Medical Leader|908 704 5779||
20529922|NCT01535118|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529923|NCT00749398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20529924|NCT00379145|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
20529925|NCT03924323|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20529926|NCT02425306|University of Virginia|Craig Slingluff, MD, Professor of Surgery|434-924-9311|cls8h@virginia.edu|
20529927|NCT00898937|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
20529928|NCT01380366|Northwestern University|Dr. Jonathan Fryer, MD|312-695-2125|jfryer@nmh.org|
20529929|NCT04219189|Virginia Commonwealth University|Dr. Caroline Cobb|(804) 827-3562|cobbco@vcu.edu|
20529930|NCT03863353|University of Michigan|Dr. Terri Voepel-Lewis|734-6466803|terriv@umich.edu|
20529931|NCT04079790|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20529932|NCT05817669|Argenx|Regulatory manager|Please email:|regulatory@argenx.com|
20529933|NCT02184208|Boston Children's Hospital|Brian Kendall Walsh|617-919-3692|brian.walsh@childrens.harvard.edu|
20529934|NCT00323063|Rutgers Cancer Institute of|Deborah Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu|
20529935|NCT03055936|Orion Corporation, Orion Pharma|Clinical Study Director|+358104264184|clinicaltrials@orionpharma.com|
20564650|NCT05260112|University of Pennsylvania|Lily Arya, MD|267-785-8024|larya@pennmedicine.upenn.edu|
20529936|NCT02115984|Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences|Dr. Sergey S. Bogachev|+7-963-946-57-69|labmolbiol@mail.ru|
20529937|NCT05002972|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
20529938|NCT01447888|Allina Health|John Mrachek, MD|612-871-7639|John.Mrachek@allina.com|
20529939|NCT02240667|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20529940|NCT01578772|UCLA|Dr. Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
20529941|NCT04613518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20529942|NCT03217591|Akebia Therapeutics|Akebia Therapeutics|6178446128|trials@akebia.com|
20529943|NCT04577794|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20529944|NCT03724357|University of Maryland, Baltimore|Marcelo Sztein, MD|410-706-5328|msztein@som.umaryland.edu|
20529945|NCT00953290|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
20529946|NCT02849080|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20529947|NCT00965237|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20529948|NCT01819727|BioMarin Pharmaceutical Inc.|Principal Scientist I, Clinical Sciences|415-506-6348|dlounsbury@bmrn.com|
20529949|NCT01831895|Vascular Dynamics|VP Clinical Affairs|949-942-1640|clinical@vasculardynamics.com|
20529950|NCT02864732|University of Pittsburgh|Research Assistant|412 4822283|mza7@pitt.edu|
20529951|NCT02530437|University of Texas MD Anderson Cancer Center|Dr. Jaffer Ajani|(713) 792-2828|jajani@mdanderson.org|
20529952|NCT01121263|Icahn School of Medicine at Mount Sinai|Deborah Ascheim, MD|212-659-9567|deborah.ascheim@mssm.edu|
20529953|NCT01702909|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
20529954|NCT01461733|The Ottawa Hospital Research Institute|Salmaan Kanji|613-737-8899|skanji@toh.on.ca|78159
20529955|NCT04059250|University of California San Francisco|Dr. Peter Rechmann|4155143225|Peter.Rechmann@ucsf.edu|
20529956|NCT00161213|UMDNJ|Dr. Susan Goodin (Deputy Director, Associate Director for Clinical Science)|732-235-6783|goodin@umdnj.edu|
20529957|NCT03103503|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
20529958|NCT05088772|University of Toronto|Dr. Connor Brenna|416 340 3598|connor.brenna@mail.utoronto.ca|
20529959|NCT03342001|University of Maryland School of Medicine|Dr. Kashif Munir|443-682-6873|kmunir@som.umaryland.edu|
20529960|NCT01433159|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20529961|NCT00301834|University of California San Francisco|Dr. Morton Cowan|4154762188|mcowan@peds.ucsf.edu|
20529962|NCT02870868|Vanderbilt University Medical Center|Alfredo Gamboa|(615) 322-5000|alfredo.gamboa@vumc.org|
20529963|NCT00288912|Durham VA HSR&D|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
20529964|NCT02105324|Massachusetts General Hospital|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
20529965|NCT00183430|VA Puget Sound HCS|Murray A. Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
20529966|NCT00883181|Amgen Inc.|Study Director|866-572-6436||
20529967|NCT04040439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20529968|NCT00526474|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20529969|NCT00426270|Octapharma USA|Michael Eppolito|201 604-1155|michael.eppolito@octapharma.com|
20529970|NCT01309386|Neuroscience department, Clinical science department, R&D in Janssen, Chiyodaku, Tokyo 101-0065, Japan|Manager|+81-3-4411-5509||
20529971|NCT02062437|Tornier SAS|Nathalie Trétout|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
20529972|NCT01674725|AbbVie|Global Medical Information|800-633-9110||
20529973|NCT02089347|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20529974|NCT00001566|National Cancer Institute (NCI), National Institutes of Health (NIH)|Crystal Mackall, M.D.|301-402-5940|mackallc@mail.nih.gov|
20529975|NCT03439137|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
20529976|NCT02378662|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
20529977|NCT01474486|Phoenix VA Health Care System|Diane J. Parrington|602-277-5551|diane.parrington@va.gov|7532
20529978|NCT05057221|University of Michigan|Lena M. Napolitano MD|734-615-4775|lenan@med.umich.edu|
20529979|NCT05222880|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen|(904)254-0152|TKarkkai@its.jnj.com|
20529980|NCT00904007|Veterans Affairs Boston Healthcare System|Dr. B. Price Kerfoot|7742869230|price.kerfoot@gmail.com|
20529981|NCT01077323|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20529982|NCT02956382|Seattle Cancer Care Alliance|Chaitra Ujjani, MD|(206) 606-1955|ujjani@uw.edu|
20529983|NCT00535652|University of Ulm|Prof. Dr. Henne-Bruns, PI|++4973150053500|doris.henne-bruns@uniklinik-ulm.de|
20529984|NCT02408198|King's College London|Dr Amy Hardy|0207 848 0033|amy.hardy@kcl.ac.uk|
20529985|NCT02848664|James Madison University|Dr. Erin Kamarunas|540-568-8846|kamaruee@jmu.edu|
20529986|NCT00732069|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
20529987|NCT00577317|NRG Oncology|Linda Gedeon for Helen Huang, MS.|716-845-1169|Linda.gedeon@roswellpark.org|
20529988|NCT00767572|UCSF|Dr. Doreen DeFaria Yeh|617-643-7024|ddefariayeh@partners.org|
20529989|NCT01405898|Queen Mary University London|Professor Amrita Ahluwalia|02078825720|a.ahluwalia@qmul.ac.uk|
20529990|NCT02283658|Mayo Clinic|Gerardo Colon-Otero, M.D.|(904) 953-2000|gcolonotero@mayo.edu|
20529991|NCT01835912|BrockU|Panagiota Klentrou|19056885550|nklentrou@brocku.ca|4538
20529992|NCT01687218|Division of Infectious Diseases - UPMC|Ross D. Cranston, MD, FRCP|412-383-2054|rdc27@pitt.edu|
20529993|NCT03301636|Lumos Pharma Inc. (Formerly NewLink Genetics)|Lumos Pharma|515-598-2921|clinical.trials@lumos-pharma.com|
20529994|NCT01645059|Hospital San Pedro Alcántara|Dr. Santiago González Santiago||santidatvs@hotmail.com|
20529995|NCT00974363|GlaxoSmithKline|GSK Response Center|866-435-7343||
20529996|NCT03459625|Loma Linda University|Cameron Leigh Neece|909 558 4000|cneece@llu.edu|
20529997|NCT01789047|Rush University Medical Center|Director of Clinical Research|312 942 8002|Teresa_Chmura@rush.edu|
20564651|NCT06180954|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20564652|NCT05459857|Imperial Brands PLC|Libby Clarke|+44 (0117) 3320221|libby.clarke@impbrands.com|
20529998|NCT03644017|Merit Medical Systems, Inc.|Casey Holland, Senior Director Clinical Operations|+1 (617) 842-0251|casey.holland@merit.com|
20564653|NCT03133546|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki, PhD|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
20564654|NCT03532282|Stanford University|Rachel Manber, PhD|(650) 498-9111|rmanber@stanford.edu|
20529999|NCT02700048|University of Minnesota|Amir Moheet|6126249990|mohee002@umn.edu|
20564655|NCT04520191|University of New Mexico Health Sciences Center|Vallabh Shah, PhD. Principal Investigator|505-272-9615|VShah@salud.unm.edu|
20564656|NCT01501955|Zimmer Biomet|Linda Meijer|+31786292929|linda.meijer@zimmerbiomet.com|
20564657|NCT03482557|Beth Israel Deaconess MEdical Center|Marc Mccall|617-418-9216|mmccall1@bidmc.harvard.edu|
20564658|NCT05399459|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20564659|NCT05651308|Weill Cornell Medicine|Lisa M. Kern, MD, MPH|646-962-5889|lmk2003@med.cornell.edu|
20564660|NCT05135650|Fred Hutch/University of Washington Cancer Consortium|Dr. Alpana Waghmare (Study Principal Investigator)|206-667-7329|awaghmar@fredhutch.org|
20564661|NCT03625167|Charité - Universitätsmedizin Berlin|Monira El Genedy-Kalyoncu|+49 30 450 529 434|monira.el-genedy@charite.de|
20530000|NCT02175225|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-632-8913|mselim@bidmc.harvard.edu|
20530001|NCT02340000|Albany Medical College|Paul Sorum, MD|5182627500|sorump@mail.amc.edu|
20530002|NCT02668640|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20530003|NCT01062308|Christian Medical College and Hospital, Ludhiana, Punjab, India|Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
20530004|NCT01305564|Bard Peripheral Vascular|Ryan Melloy|480-350-6074|ryan.melloy@crbard.com|
20530005|NCT04541355|University of California, San Francisco|Dr. Hyunseok Kang, MD|(888) 689-8273|hyunseok.kang@ucsf.edu|
20530006|NCT01414244|Tulane University|QiQi Zhou|988-7800|qiqi06@gmail.com|
20530007|NCT02322749|AstraZeneca|Information Centre||Information.centre@astrazeneca.com|
20530008|NCT02121860|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20530009|NCT00073918|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
20530010|NCT01409239|The Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
20530011|NCT01190813|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20530012|NCT02033759|Mercy Integrative Medicine|Sarah Stolker, MSPT, CLT-LANA|13145402858|sarah@stolker.com|
20530013|NCT04347408|Queen's University Belfast|Dr Thomas Waterfield|028 9024 5133|t.waterfield@qub.ac.uk|
20530014|NCT01190085|Brown University|Dr. Lorenzo Leggio|401-863-1000|Lorenzo_Leggio@Brown.edu|
20530015|NCT00807365|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|4105506484|registerclinicaltrials@jhmi.edu|
20530016|NCT00060606|George Washington University Biostatistics Center|Dr. Elizabeth A Thom|301-881-9260|e_thom@bsc.gwu.edu|8035
20530017|NCT04821830|University of Michigan|Dr. Roger Albin|734-936-9115|ralbin@med.umich.edu|
20530018|NCT04853043|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20530019|NCT00919633|Medtronic, Inc.|Study Trial Manager|763-505-4594|sarah.mische@medtronic.com|
20530020|NCT01526785|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20530021|NCT05163392|UCSF|Sylvie Baudart|415-203-4027|sylvie.baudart@ucsf.edu|
20530022|NCT00960804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530023|NCT00545623|Boston University|Bei-Hung Chang|508-856-8959|bhchang@bu.edu|
20530024|NCT02100124|Penn State College of Medicine|Dr. Cynthia Chuang|7175318161|CChuang@psu.edu|
20530025|NCT04350827|The Ohio State University|Dr. Michael Baria|614-293-8196|michael.baria@osumc.edu|
20530026|NCT04265261|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20530027|NCT02990000|University of Massachusetts Amherst|Dr. Michael J. Constantino|4135451388|mconstantino@psych.umass.edu|
20530028|NCT01949545|Amgen, Inc.|Study Director|866-572-6436||
20530029|NCT03631641|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-6529|John.Hays@osumc.edu|
20530030|NCT01050153|Denver Health Medical Center|Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
20530031|NCT00194129|UHCMC Mood Disorders Program|David Kemp, MD|216-844-2865|David.Kemp@UHhospitals.org|
20530032|NCT01929889|Northwestern University|Dr. John Csernansky|312-503-9096|jcsernan@nmff.org|
20530033|NCT01669434|University of Nebraska Medical Center|Dr. Jason Shiffermiller|402-559-7299|jshiffermiller@unmc.edu|
20530034|NCT01003106|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Peter A. Campochiaro, MD|(410) 955-5106|pcampo@jhmi.edu|
20530035|NCT02579629|Emory University|Katherine Egan|404-727-8463|kfegan@emory.edu|
20530036|NCT01930539|University of Nebraska Medical Center|Lynn Mack|402-559-6276|lmack@unmc.edu|
20530037|NCT01190891|Madigan Army Medical Center|Troy Patience, Research Operations Service|(253) 968-1160|usarmy.jblm.medcom-mamc.mbx.dci@mail.mil|
20564662|NCT02231164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564663|NCT06103188|Jordan University Hospital|Dr Omar Ismail|+962791301329|omar.moh.isml@gmail.com|
20564664|NCT01541553|LEO Pharma A/S|Clinical trial disclosure|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
20564665|NCT05445427|Mayo Clinic|Dr. Ryan T. Hurt, MD, PhD|507-284-4461|hurt.ryan@mayo.edu|
20564666|NCT05283304|UT Southwestern Medical Center|Madhukar Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
20564667|NCT02268461|University of Minnesota|Kate Frost|612-626-4913|jahnke.k.131@gmail.com|
20530038|NCT01739335|Bronx VA Medical Center|Dr. Julia Golier; Chief of Psychiatry|718-584-9000|julia.golier@va.gov|6587
20530039|NCT02659501|Loma Linda University, Department of Plastic Surgery|Saba Motakef, Resident Physican|714-925-8932|smotakef@llu.edu|
20530040|NCT01218308|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530041|NCT00723229|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
20564668|NCT06074172|Colorado State University Pueblo|Dr. Moussa Diawara|719-549-2813|Moussa.Diawara@csupueblo.edu|
20564669|NCT03020199|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20564670|NCT05583578|University of Florida|Dr. Clayton Swanson|3522735919|clayton.swanson@ufl.edu|
20564671|NCT04313972|Endeavor Health|Urogynecology Research Coordinator|847-570-4729|JLee5@northshore.org|
20564672|NCT05877976|NYU Langone Health|Lita Anglin|212-263-2519|Lita.anglin@nyulangone.org|
20564673|NCT00967447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564674|NCT04314713|Pharmaron|Paolo DePetrillo|240-673-0500|paolo.depetrillo@pharmaron.com|1731
20564675|NCT00248287|Baylor Sammons Cancer Center|Dr. Joyce O'Shaughnessy|(214) 370 -1796|Joyce.OShaughnessy@usoncology.com|
20564676|NCT04447469|Kiniksa Pharmaceuticals, Ltd.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
20564677|NCT02714257|Milton S. Hershey Medical Center|Christopher Sciamanna, MD, MPH|717-531-4417|csciamanna@pennstatehealth.psu.edu|
20564678|NCT03569631|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20564679|NCT02749006|University Of British Columbia|Dr. Lakshmi Yatham|604-822-7310|l.yatham@ubc.ca|
20564680|NCT04700176|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20564681|NCT04568486|University of Kentucky|Brittany Smalls|859-323-4916|brittany.smalls@uky.edu|
20564682|NCT04248725|University of Washington|Dawn Ehde, PhD|206-591-3780|ehde@uw.edu|
20564683|NCT01210807|University Eye Clinic, Tubingen, Germany|PD Dr. med. Peter Szurman|49-7071-29-84915|peter.szurman@med.uni-tuebingen.de|
20564684|NCT00704262|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20564685|NCT03029884|University of California, San Francisco|Prasad Shirvalkar MD, PhD - Principal Investigator|415-885-7246|Prasad.Shirvalkar@ucsf.edu|
20564686|NCT03656510|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564687|NCT05322044|Imperial College London|Dr Louise Fleming|02073528121|l.fleming@imperial.ac.uk|2938
20564688|NCT05312008|Indiana University|Dr. Ann E.K. Kosobud|3172740087|akosobud@iu.edu|
20564689|NCT05698875|University of Stirling|Julie Johnson|07815893076|julie.johnson1@stir.ac.uk|
20564690|NCT03728790|Columbia University|Dr. Leslie Moroz|646-532-8208|lm3000@cumc.columbia.edu|
20564691|NCT04880863|NeoTX Therapeutics Ltd.|Dr. Ilana Lorber, VP of Clinical Operations|+972-3-912-5853|ilanal@neotx.com|213
20564692|NCT05239455|Terumo BCT, Inc|Erin Goodhue, DO, MPH, Director, Clinical Affairs|614-400-4638|Erin.Goodhue@TerumoBCT.com|
20564693|NCT05844137|Duke University|Anastasia Alexopoulos|1 919 684 4005|anastasia.alexopoulos@duke.edu|
20564694|NCT04082143|Virginia Commonwealth University|Lyndon Cooper, Dean|(804) 828-7235|cooperlf@vcu.edu|
20564695|NCT03576885|AdventHealth|Hussnain Mirza MD|9736263952|Hussnain.Mirza.MD@adventhealth.com|
20564696|NCT05658224|USouthDakota|Dr. Kory Zimney|6056586373|kory.zimney@usd.edu|
20564697|NCT03785964|SpringWorks Therapeutics|Head of Clinical Operations|877-279-4870|clinical@springworkstx.com|
20564698|NCT05070728|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
20564699|NCT02151981|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20564700|NCT03847311|University of Arizona|Dr. Mohab Ibrahim|(520) 626-7221|mohab@arizona.edu|
20564701|NCT00597909|Horizon Pharma plc|Bruce Scharschmidt, MD||bscharschmidt@horizonpharma.com|
20564702|NCT03272217|Hoosier Cancer Research Network|Fauzia Sharmin|317-634-5842|fsharmin@hoosiercancer.org|75
20564703|NCT05095779|The University of Oklahoma Health Sciences|Dr. Darla E. Kendzor|(405) 271-7848|Darla-Kendzor@ouhsc.edu|
20564704|NCT02276885|NYU Langone Health|Naamit Gerber, MD|2127316338|Naamit.Gerber@nyulangone.org|
20564705|NCT01574274|Dana-Farber Cancer Institute|Dr. Lewis Silverman|16176326191|lewis_silverman@dfci.harvard.edu|
20564706|NCT04881903|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
20564707|NCT04676763|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20564708|NCT03626766|Columbia University|Dr. Anthony Lin|(917) 628-6522|akl17@cumc.columbia.edu|
20564709|NCT05477095|Vaxxinity, Inc.|Executive Director, Clinical Development|254-244-5739|info@vaxxinity.com|
20564710|NCT01593917|Abbott Medical Devices, Structural Heart Divison|Clinical Scientist, Tissue Heart Valves|+1 651-756-2320|Roland.MaudeGriffin@Abbott.com|
20564711|NCT04663737|Senhwa Biosciences, Inc.|Kacy Huang, Director of Clinical Department|+886-2-8911-9856|kacyhuang@senhwabio.com|214
20564712|NCT04016662|Jaeb Center for Health Research|Robert Henderson|(813) 975-8690|Rhenderson@jaeb.org|
20564713|NCT04499924|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20564714|NCT01037881|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20564715|NCT02841579|Catalan Institute of Oncology, Institut d'Investigació en Ciències, de la Salut Germans Trias i Pujol|Dr. Rafael Rosell|+34 935 543 050|rrosell@iconcologia.net|
20564716|NCT04563546|Duke University|Julian T. Hertz, MD|919-681-0196|julian.hertz@duke.edu|
20564717|NCT03011333|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
20564718|NCT02998268|Weill Cornell Medicine|Dr. Manish Shah|646-962-6200|mas9313@med.cornell.edu|
20564719|NCT04225273|QMedAB|Clinical Project Manager|18179615000|aestheticclinicaltrials@galderma.com|
20564720|NCT03652389|NYU Langone Health|Antoinette M. Schoenthaler|646-501-3434|Antoinette.Schoenthaler@nyulangone.org|
20564721|NCT04413708|Duke University|Sara LeGrand|919-438-0448|sara.legrand@duke.edu|
20564722|NCT05757453|NXTech|Principal Investigator for Study 31380|7814721140|external+studyinvestigator@nxtech.co|
20564723|NCT03974178|Drugs for Neglected Diseases initiative (DNDi)|Dr. Olaf Valverde Mordt|+41229069239/+41795431713|ovalverde@dndi.org|
20519612|NCT04232540|UNC Chapel Hill|Amanda Poliseno|919-962-5344|amanda_poliseno@unc.edu|
20519613|NCT02105701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20530042|NCT02709746|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
20530043|NCT02900352|Virginia Commonwealth University|Dr. Albert Arias|8048285793|albert.arias@vcuhealth.org|
20530044|NCT00752089|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530045|NCT00458237|Beth Israel Deaconess Medical Center|Gerburg Wulf|(617) 667-1910|gwulf@bidmc.harvard.edu|
20530046|NCT02461693|University of Alabama at Birmingham|Dr. David Allison, PI|205-975-9169|dallison@uab.edu|
20530047|NCT03060473|University of Texas Medical Branch|Dr. Nkechinyere Emezienna|4097476651|nkemezie@utmb.edu|
20530048|NCT00975416|National Institute on Drug Abuse|Mary R. Lee, M.D.|301-825-0545|leemary@mail.nih.gov|
20530049|NCT00106002|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20530050|NCT01997125|The Ohio State University|Marcia Bockbrader MD PhD|6142937604|bockbrader.13@osu.edu|
20530051|NCT04896216|University of Minnesota|Kumi Smith|612.301.3051|smi00831@umn.edu|
20530052|NCT01245101|University of Miami|Rafael E. Campo|305-689-7030|rcampo@med.miami.edu|
20530053|NCT01225549|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20530054|NCT01329198|University of Florida Center for Movement Disorders & Neurorestoration|Assistant Director of Clinical Trials|352-294-5000|stacy.merritt@neurology.ufl.edu|
20530055|NCT01122173|Auris Health, Inc.|Emir Deljkich/Sr. Director, Clinical Affairs|650-397-2677|emir.deljkich@aurisrobotics.com|
20530056|NCT02730962|University of Minnesota|Dr. Alexander Khoruts|612-624-2101|khoru001@umn.edu|
20530057|NCT00473083|BC Cancer Agency|Dr. Barbara Melosky, Principal Investigator|604-877-6000|BMelosky@bccancer.bc.ca|
20530058|NCT02915835|University of Michigan|Dr. Cathie Spino|7346155469|spino@umich.edu|
20530059|NCT01184872|Novartis Pharmaceutical|Study Director|862 778 8300||
20530060|NCT03426345|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20530061|NCT02431598|Duke University Medical Center|Dr. Mustafa Bashir|919-684-8111|mustafa.bashir@duke.edu|
20530062|NCT02446691|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
20530063|NCT00466817|University of Alabama in Birmingham|David Kimberlin, MD|205-934-2424|dkimberlin@peds.uab.edu|
20530064|NCT04210986|Vice President of Operations|Suzanne Liv Page|970-401-8770|spage@sprivail.org|
20564724|NCT04283149|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|2905
20519614|NCT03234608|Portland State University|Dr. Christina Nicolaidis|503-725-9603|nicol22@pdx.edu|
20519615|NCT01362296|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519616|NCT03693950|BIOCAD|Yulia Linkova Medical Director|+7 (495) 992 66 28 ext. 930|linkova@biocad.ru|
20519617|NCT00248170|Novartis|Study Director|862-778-8300||
20519618|NCT03123783|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
20519619|NCT05427045|UArkansas|Dr. Santos-Horta|507-250-5880|ESantoshorta@uams.edu|
20519620|NCT01598545|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
20519621|NCT00749411|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519622|NCT04947150|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
20519623|NCT03581188|The University of Sydney, Australia|Associate Professor Katy Bell|+61 415 764 321|katy.bell@sydney.edu.au|
20519624|NCT01619579|VA Medical Center & UCSD Center for Pain Medicine|Tobias Moeller-Bertram, MD|858-552-8585|tmoellerbertram@ucsd.edu|3123
20519625|NCT03907241|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
20519626|NCT01684215|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519627|NCT02234752|George Washington University, Washington, DC|Maju Koola|678-200-8613|majumkoola@gmail.com|
20519628|NCT02760264|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
20519629|NCT00983918|Baylor College of Medicine|Jaime Ortiz, MD|713-873-2860|jaimeo@bcm.edu|
20519630|NCT05918822|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20519631|NCT03346070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519632|NCT03325972|NYU Langone Health|Lisa Doan, MD|212.201.1004|Lisa.Doan@nyulangone.org|
20519633|NCT04086641|University of Washington|Conrad Slater|5409318478|conslate13@gmail.com|
20519634|NCT00126126|Miami VAHS & University of Miami, Department of PT|Robert Gailey, PhD, PT|305-284-4535|rgailey@miami.edu|
20519635|NCT04975321|University of Washington|Mariella Garcia|2065431740|mgarciaf@uw.edu|
20519636|NCT00986570|Biolab Sanus Farmacêutica Ltda.|Priscilla Padilha, MD|55(11)35736335|ppadilha@biolabfarma.com.br|
20519637|NCT02225665|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
20519638|NCT03488030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20519639|NCT05045469|CGMH|Dr. HuanHsuan Hsu|0978839349|10356017a@cgmh.org.tw|
20519640|NCT03460158|University of Pennsylvania|Ivona Percec, MD, PhD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
20519641|NCT01011556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20519642|NCT01098110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519643|NCT03920280|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20519644|NCT01839838|Hospital of the University of Pennsylvania|Gary Freedman, MD|215-615-6767|Gary.freedman@pennmedicine.upenn.edu|
20519645|NCT00089076|Mayo Clinic|Dr. Stephen Ansell|507-284-0923|ansell.stephen@mayo.edu|
20519646|NCT00808509|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20519647|NCT05633082|CooperVision Inc.|José A. Vega OD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
20519648|NCT03170869|University of Colorado|Dr. Thor Johnson|720-848-1765|thor.johnson@ucdenver.edu|
20519649|NCT04936594|University of Kentucky|Dr. Gopalkumar Rakesh|859-562-2348|gopalkumar.rakesh@uky.edu|
20519650|NCT02438540|Nanjing university of TCM|Dr. Amir Firouzjaei|+989125397047|amirfi@yahoo.com|
20530065|NCT00286182|Columbia University|Mathew Maurer, MD, Professor of Medicine at the Columbia University Medical Center|212-305-9808|msm10@cumc.columbia.edu|
20564725|NCT03982459|University of California, San Francisco|Dr. Sue Yom, MD|415-353-7175|sue.yom@ucsf.edu|
20530066|NCT00000575|Johns Hopkins Bloomberg School of Public Health, Dept of Epidemiology|Alice Sternberg|410-955-3752|asternbe@jhsph.edu|
20530067|NCT02886923|Johnson & Johnson Vision|Ross Franklin - PRINCIPAL RESEARCH OPTOMETRIST|904 4431768|RFrankl1@its.jnj.com|
20530068|NCT02984982|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20530069|NCT00549393|Johns Hopkins University|Dr. Aaron Milstone|4106143917|amilsto1@jhmi.edu|
20530070|NCT02153918|National Cancer Institute|Dr. Peter Pinto|301-496-6353|pintop@nih.gov|
20530071|NCT02144701|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
20530072|NCT02616783|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20530073|NCT03327324|NYU Langone Health|Joshua Chodosh, MD, MSHS|(212) 263-6768|Joshua.Chodosh@nyulangone.org|
20530074|NCT01103323|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20530075|NCT00372424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530076|NCT01342354|The University of Chicago|Dr. Stanley Liauw|(773) 702-0817|Stanley.Liauw@uchospitals.edu|
20530077|NCT04536701|Ohio State University|Dr. Karen Rose|614-292-4844|rose.1482@osu.edu|
20530078|NCT05214118|Virginia Commonwealth University|Dr. Caitlin E. Martin|(804) 628-7023|caitlin.martin@vcuhealth.org|
20530079|NCT03797898|Seattle Children's|Tumaini R. Coker, MD, MBA|206-884-0559|Tumaini.Coker@seattlechildrens.org|
20530080|NCT02314728|Montefiore Medical Center|Kafui A. Demasio, MD, MPH, Maternal Fetal Medicine, Dept of Obstetrics/Gynecology and Women's Health|718-920-2767|kdemasio@montefiore.org|
20530081|NCT01614470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20530082|NCT04232839|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530083|NCT05324306|Medical University of South Carolina|Dr. Konrad Rajab|843-792-1414|tkrajab@uams.edu|
20530084|NCT00069264|Eisai Inc.|Dr. Peter Tarassoff|888-422--4743||
20530085|NCT03177148|University of Michigan|Mx. Emerson Delacroix|734-764-2014|emmed@med.umich.edu|
20530086|NCT02360488|UCLA|Steve Cramer|424-522-7273|sccramer@mednet.ucla.edu|
20530087|NCT00846586|Novartis Pharmaceuticals|Study Director|862 778-8300||
20530088|NCT00875810|MedtronicSpineECA|Cristina Faria|+41 21 802 70 00|cristina.faria@medtronic.com|
20530089|NCT00780975|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
20530090|NCT01061606|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20530091|NCT01204671|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530092|NCT02743364|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
20530093|NCT03106077|UT MD Anderson Cancer Center|Stacy Moulder, Professor, Breast Medical Oncology|(713) 792-2817|smoulder@mdanderson.org|
20530094|NCT01274533|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20530095|NCT03669588|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20530096|NCT02008526|Friends Research Institute|Dr. Cathy Reback|3234631601|reback@friendsresearch.org|
20530097|NCT00492726|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20530098|NCT04386902|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
20530099|NCT01100502|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20530100|NCT00721799|The University of Iowa Department of Radiology|Yusuf Menda, MD|319-356-3214|yusuf-menda@uiowa.edu|
20530101|NCT02337764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20530102|NCT03653741|Weill Cornell Medical College|David Chuang, MD|212-746-5519|dtc9002@med.cornell.edu|
20530103|NCT02860988|University of Kentucky|Dr. Joseph Calvert|(859) 323-5771|joe.calvert@uky.edu|
20530104|NCT01926028|NovaDigm Therapeutics, Inc.|Chief Scientific Officer|2676405189|john_hennessey@novadigm.net|
20530105|NCT00737048|JANSSEN PHARMACEUTICAL. K.K. , Neuroscience Department, Clinical Science Division|Medical Director|+81-3-4411-5509||
20530106|NCT04635839|University of California, Los Angeles|Dr. Thalia Mok|310-794-7274|tmok@mednet.ucla.edu|
20530107|NCT02737358|Medical University of South Carolina|Erin A. McClure, Ph.D.|843-792-7192|mccluree@musc.edu|
20530108|NCT01115452|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530109|NCT00744939|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20530110|NCT01587885|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20530111|NCT02209064|EpiEP|Pam Bunes CEO & Founder|+1 864 423 2526|pbunes@epiep.com|
20530112|NCT01118299|Abbott|Sripad Bellary|408845814|sripad.bellary@abbott.com|
20530113|NCT02932943|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20564726|NCT03899259|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20564727|NCT01152450|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564728|NCT05670587|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564729|NCT03738852|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
20564730|NCT01205828|Georgetown University Medical Center|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
20564731|NCT01733316|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
20564732|NCT05482698|MC2 Therapeutics|Chief Medical Officer|+45 2018 1111|info@mc2theraprutics.com|
20564733|NCT03879863|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20530114|NCT02337491|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
20530115|NCT00386334|Sepracor Inc.|Lunesta Medical Director|1-866-503-6351||
20564734|NCT01674140|SWOG Statistics and Data Management Center|Breast Committee Statistician|2066674623|jmiao@fredhutch.org|
20530116|NCT02280252|NYU Langone Health|Dr. Nelly Huppert|(212) 731-5003|Nelly.Huppert@nyulangone.org|
20530117|NCT02133508|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20564735|NCT02305888|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20564736|NCT05139810|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20564737|NCT05533918|University of Utah|Dr. Guilherme Del Fiol|801-581-4080|guilherme.delfiol@utah.edu|
20564738|NCT04914676|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20564739|NCT03024437|University at Buffalo|Dr. Roberto Pili|(716) 881-8918|rpili@buffalo.edu|
20564740|NCT05546411|Dana Farber Cancer Institute|Kimberly Perez, MD|617-632-5370|KIMBERLY_PEREZ@DFCI.HARVARD.EDU|
20564741|NCT02606422|Johns Hopkins University School of Medicine|Kyrana Tsapkini|410-614-2646|tsapkini@jhmi.edu|
20564742|NCT04625465|Georgia State University|Dr. Dominic Parrott, Distinguished University Professor of Psychology|+1 (404) 413-6287|parrott@gsu.edu|
20564743|NCT04947397|University of California San Francisco|Daniel Abelson|510 428 3000|daniel.abelson@ucsf.edu|
20564744|NCT03128021|University of Pittsburgh|Rachel Berta|4128607406|goodra@upmc.edu|
20564745|NCT03584633|Cleveland Clinic|Dr. Wei F. Chen|319-333-6166|chenw6@ccf.org|
20564746|NCT05566639|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20519651|NCT02010996|changhai hospital|Bi-Hongda|86-13918233009|bihongda0411@yahoo.com.cn|
20519652|NCT01501110|Hospital de Clínicas de Porto Alegre|Josi Vidart|+55 51 98472520|josividart@gmail.com|
20519653|NCT03420768|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20519654|NCT00983476|VA Greater Los Angeles Healthcare System, Los Angeles, CA|Dr. Alexander S. Young|310-794-7219|alexander.young@va.gov|
20519655|NCT02969876|Massachusetts General Hospital|Dr. Andrew Nierenberg|6175122641|anierenberg@mgh.harvard.edu|
20519656|NCT01997723|UIllinois|Bharati Prasad|3129968433|bpradsad@uic.edu|
20519657|NCT04019054|UCLA Psychiatry|Dr. Michael K. Leuchter|3108906943|mkleuchter@mednet.ucla.edu|
20519658|NCT01040793|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519659|NCT00807209|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20519660|NCT00843830|University of Michigan Comprehensive Cancer Center|Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
20519661|NCT01143649|Laboratory of Neuromodulation and Center of Clinical Research Training. Spaulding Rehabilitation Hospital.|Dr. Felipe Fregni|617.952.6153|info@neuromodulationlab.org|
20519662|NCT03877926|Emergent BioSolutions Inc.|Bojan Drobic, Director, Clinical Research|204 275 4196|bdrobic@ebsi.com|
20519663|NCT01352182|Cincinnati Children's Hospital Medical Center|Jennifer Kaplan|513-636-4259|jennifer.kaplan@cchmc.org|
20519664|NCT00588731|Yale University|Mohini Ranganathan, M.D.|203-932-5711|mohini.ranganathan@yale.edu|2546
20519665|NCT00467831|NHGRI/NIH|Dr. Thomas Markello|301-451-1305|markellot@mail.nih.gov|
20519666|NCT01832402|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
20519667|NCT01198873|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
20519668|NCT00860743|Wayne State University and John D. Dingell VA Medical Center|Jason H. Mateika|313-576-4481|jmateika@med.wayne.edu|
20564747|NCT04731818|Eastern Virginia Medical School|Andrea Thurman MD, Principal Investigator|7574465808|thurmaar@evms.edu|
20564748|NCT05166577|Viracta Therapeutics|Dr. Darrel Cohen|858-400-8470|ClinicalTrials@Viracta.com|
20564749|NCT04054193|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20564750|NCT02966873|Medical University of South Carolina|Stacey Sellers|843-792-5807|sellersst@musc.edu|
20564751|NCT04753697|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20564752|NCT04200456|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20564753|NCT05446168|University of Michigan|Nicolaas Bohnen, MD, PhD|734-936-1168|nbohnen@umich.edu|
20564754|NCT04339101|City of Hope Medical Center|Dr. Ali Haris|626-359-8111|aharis@coh.org|
20564755|NCT03257410|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20564756|NCT02598388|Janssen Vaccines & Prevention B.V.|MEDICAL LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20564757|NCT03069924|Medical University of South Carolina|Dr. Benjamin Toll|843-876-1132|toll@musc.edu|
20564758|NCT05256017|Drugs for Neglected Disease initiative (DNDi)|Dr Junior Matanglia|+243 970 756 890|jmatangila@dndi.org|
20564759|NCT04500613|Hospital for Special Surgery|Marko Popovic|646-797-8948|popovicm@hss.edu|
20564760|NCT03854227|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_lnquiries@pfizer.com|
20519669|NCT02776553|University of Arkansas for Medical Sciences|Arny A. Ferrando, Ph.D.|501-526-5711|aferrando@uams.edu|
20519670|NCT02898103|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
20519671|NCT04569786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519672|NCT01684878|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20519673|NCT00810888|Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center|Dr Jane Khoury, Professor of Pediatrics|513-636-2690|jane.khoury@cchmc.org|
20519674|NCT01435031|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
20530118|NCT01026493|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20530119|NCT03194334|University Ghent|Prof. Wim Derave|+32/9/2646326|wim.derave@ugent.be|
20564761|NCT03668236|Rigshospitalet, University of Copenhagen|Prof. Anders Perner|+45 35458333|anders.perner@regionh.dk|
20564762|NCT06132282|Texas Christian University|Danica Knight|817-257-4391|d.knight@tcu.edu|
20564763|NCT03748953|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20564764|NCT05082116|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20564765|NCT04119843|Ascelia Pharma AB|Andreas Norlin|+46 735179119|an@ascelia.com|
20564766|NCT04418232|University of Kansas Medical Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
20530120|NCT03093181|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20530121|NCT00514618|MemorialCare Health Services LBMC|Lorna Camfield, Research Compliance Analyst|714-377-3227|lcamfield@memorialcare.org|
20530122|NCT03154086|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20530123|NCT04710004|Emory University|Dr. Robert Gross|404-727-2354|rgross@emory.edu|
20530124|NCT01701245|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
20530125|NCT01774591|University of Chicago|George L. Bakris, MD|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
20530126|NCT01159574|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
20530127|NCT01183923|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
20530128|NCT03555149|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20530129|NCT00289211|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20530130|NCT02666222|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
20530131|NCT00630916|Sorin Group USA|Director of Clinical and Medical Affairs|512-435-3602|barbara.mathews@sorin.com|
20530132|NCT02443623|Emergent Biosolutions Inc.|Clinical Development Representative|(204) 275-4196|ctgov@ebsi.com|
20530133|NCT02295644|University at Buffalo, School of Dental Medicine, Oral Diagnostic Sciences|Dr. Willard D McCall|(716)829-3559|wdmccall@buffalo.edu|
20530134|NCT02147626|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|6175258264|jr33@partners.org|
20530135|NCT03504917|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WN39434|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
20530136|NCT01299584|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530137|NCT00572832|University of Pittsburgh|Richard Zimmerman|412-383-2354|zimmer@pitt.edu|
20530138|NCT00966433|Wake Forest University Health Sciences|Dr. Thomas Templeton, MD|336-716-4285|ttemplet@wakehealth.edu|
20530139|NCT00324155|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20530140|NCT00390689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530141|NCT01253161|Moffitt Cancer Center|Jonathan Strosberg, MD|813-745-6585|Jonathan.Strosberg@moffitt.org|
20530142|NCT03871556|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20530143|NCT03101020|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Lucas Villalta Santos|+5515998197899|lucasvillalta.s@gmail.com|
20530144|NCT01924533|AstraZeneca|Gershon Locker Global Clinical Lead (GCL)||gershon.locker@astrazeneca.com|
20530145|NCT04233879|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20530146|NCT03292016|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20530147|NCT03810183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20530148|NCT00072449|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
20530149|NCT04275336|Children's Hospital of Fudan University|Ms.Yu Zhuowen|18017591126|yzw100@126.com|
20530150|NCT03167242|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20530151|NCT04664205|University of North Carolina at Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu|
20530152|NCT01909804|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20530153|NCT05401565|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20530154|NCT02439164|Beijing Tiantan Hospital|Dr. Nan Lin|861067096658|linnan127@163.com|
20530155|NCT03080935|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20530156|NCT03118934|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
20530157|NCT02343224|Emory University|Dolly Aguilera MD|404-785-3515|Dolly.Aguilera@choa.org|
20530158|NCT04249427|Duke University|David Jang, MD|919-613-6407|david.jang@duke.edu|
20530159|NCT03886272|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530160|NCT02569892|Stanford University School of Medicine|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
20530161|NCT00402727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20530162|NCT03372798|Oxford University Hospitals NHS Foundation Trust|Dr Tim Betts|0044 01865 220256|ep.doctors@ouh.nhs.uk|
20530163|NCT03608826|Medtronic|Nicole Wood|8006338766|nicole.wood@medtronic.com|
20530164|NCT02084511|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530165|NCT01733277|ArthroLab Inc.|Dr Jean-Pierre Pelletier|15148908000|dr@jppelletier.ca|26666
20530166|NCT00461734|Princess Alexandra Hospital|Dr. Gerald Kaye|07 3176 2111|gerald.kaye@health.qld.gov.au|
20564767|NCT04233216|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20564768|NCT04231149|Coloplast A/S|Medical Affairs Vice President|+45 4911 1111|clinical-studies@coloplast.com|
20564769|NCT03252847|MeiraGTx|Program Manager|+44 (0)20 3866 4320|ocularinfo@meiragtx.com|
20564770|NCT05216315|University of Valencia|Dr Juan C Melendez|+34 963983844|melendez@uv.es|
20564771|NCT05808257|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|212-241-1272|mantu.gupta@mountsinai.org|
20564772|NCT04042233|Houston Methodist Hospital|Thomas Sullivan|2817254460|tsullivan@houstonmethodist.org|
20564773|NCT03986931|University of Iowa|Dr. Linnea Polgreen|(319) 384-3024|linnea-polgreen@uiowa.edu|
20564774|NCT04752709|Elidah, Inc.|Director of Clinical Trials|978.435.4324|customercare@elitone.com|
20564775|NCT00576979|Department of Hematology and Hematopoietic Cell Transplantation, City of Hope|Anthony Stein, MD, corresponding author|626-256-4673|astein@coh.org|62405
20564776|NCT04893239|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
20530167|NCT02236000|NSABP Foundation, Inc.|Judy Langer, Director of Regulatory Affairs|412-339-5300|judy.langer@nsabp.org|
20530168|NCT01754519|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20530169|NCT01257347|Columbia University Medical Center|Ian Kronish, MD, MPH|2123421335|ik2293@columbia.edu|
20530170|NCT03204643|Atrium Health|Dr. Jason Roberge|704-355-0268|Jason.Roberge@AtriumHealth.org|
20530171|NCT01768325|Indiana University School of Medicine|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
20530172|NCT00944710|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20530173|NCT01085643|Cedars-Sinai Medical Center|Edy Soffer, MD|(310) 423-6143|edy.soffer@cshs.org|
20530174|NCT00887484|GlaxoSmithKline|GSK Response Center|888-435-7343||
20530175|NCT00381628|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
20530176|NCT04054544|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20530177|NCT03044314|Duke University Medical Center|Richard Krasuski|919-681-6195|richard.krasuski@duke.edu|
20530178|NCT00264147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20530179|NCT01316224|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20530180|NCT05158140|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20530181|NCT01446705|Center for Health Information and Communication, Roudebush VA Medical Center|Dr. David A. Haggstrom|317-988-2067|dahaggst@iu.edu|
20530182|NCT02349438|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST|904-443-3449|CColesb@ITS.JNJ.com|
20530183|NCT01831219|Think Surgical|Senior Manager of Clinical Applications|510-249-2339|nnetravali@thinksurgical.com|
20530184|NCT00452374|The University of Texas M. D. Anderson Cancer Center|William Wierda, M.D./Associate Professor|713-745-0428|eharriso@mdanderson.org|
20530185|NCT00702780|Seoul National University Hospital|Young Min Choe|82-2-2072-1730|howlow44@daum.net|
20530186|NCT03312738|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20530187|NCT00612235|Beth Israel Deaconess Medical Center|Andrew G. Herzog M.D., M.Sc.|781-431-0277|aherzog@bidmc.harvard.edu|
20530188|NCT00843349|University of Miami|Dr. Myles Wolf, Associate Professor of Medicine, Chief-Division of Nephrology and Hypertension|305-243-7745|mwolf@med.miami.edu|
20530189|NCT02124824|VAMC SLC|Scott Capps|8015821565|Scott.Capps@hsc.utah.edu|
20530190|NCT01863771|Janssen Pharmaceutical K.K.|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20530191|NCT03499795|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20530192|NCT03636256|US Biotest, Inc.|Dr. Gere diZerega|805.595.1300|gere.dizerega@usbiotest.com|
20530193|NCT02426684|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
20530194|NCT00879190|Stanford University, Department of Obstetrics & Gynecology|Anna Girsen, Manager of Maternal-Fetal Medicine Research Operations|(650) 725-0499|agirsen@stanford.edu|
20530195|NCT01040819|Baylor College of Medicine|Dr. Yochai Birnbaum|713-798-0273|ybirnbau@bcm.edu|
20530196|NCT04748718|Northern Vermont University|Dr. Eleanor Beltz|802-635-1329|Eleanor.Beltz@NorthernVermont.edu|
20530197|NCT01450813|Fletcher Allen Health Care at The University of Vermont|Donald Mathews, M.D.|(802) 847-2415|Donald.Mathews@vtmednet.org|
20530198|NCT02090881|Imperial College Healthcare NHS Trust|Dr Mohammed Aslam|02083831000|m.aslam@imperial.ac.uk|1541
20530199|NCT01935089|The Wistar Institute|Luis J. Montaner|+1 (215) 898-9143|montaner@wistar.org|
20530200|NCT01235065|R Adams Cowley Shock Trauma Center|Dale Yeatts, Principal Investigator|443-909-0648|djyeatts@gmail.com|
20530201|NCT00785356|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20530202|NCT01079780|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20530203|NCT01206465|University of Nebraska Medical Center|Jean L Grem|402-559-5166|jgrem@unmc.edu|
20530204|NCT01178294|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20530205|NCT02783066|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
20530206|NCT02251275|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20530207|NCT01004614|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530208|NCT03044418|University of Pecs|Dr. Timea Bocskai|+36 72 507374|timokeri@gmail.com|
20530209|NCT01569022|VA Western New York|Ali El Solh|716-862-6525|ali.el-solh@va.gov|
20530210|NCT00116142|Dana Farber Cancer Institute|Anthony D'Amico|617.732.6310|ADAMICO@LROC.HARVARD.EDU|
20564777|NCT05495555|Cataract & Laser Institute|Dr Justin Spaulding|541-779-2020|justinophtho@gmail.com|
20564778|NCT05534789|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20564779|NCT01710488|Fadoi Foundation|Antonella Valerio|0248005140|antonella.valerio@fadoi.org|
20564780|NCT05477186|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20564781|NCT05496231|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20564782|NCT03896867|University of Minnesota|Benjamin Kloesel|612-301-1245|bkleosel@umn.edu|
20564783|NCT00167674|University of Washington|Grace John-Stewart|206 948 9357|gjohn@uw.edu|
20564784|NCT03819153|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20564785|NCT00691002|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20564786|NCT04508309|PATH|Niranjan Bhat, MD|206 302 4843|nbhat@path.org|
20564787|NCT05940194|PATH|Dr. Thang Tran Cong, Medical office|+84913301883|thangtran@path.org|
20530211|NCT00447083|Wake Forest University Health Sciences|Steve feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
20530212|NCT01302899|Novartis Pharmaceuticals|Study Director|862-778-8300||
20530213|NCT04076917|BIOTRONIK, Inc.|Senior Manager, Scientific Affairs|800-547-0394|crystal.miller@biotronik.com|
20530214|NCT03148262|UT Southwestern Medical Center|Dr. Christina Riccio|214-590-7284|Christina.Riccio@UTSouthwestern.edu|
20530215|NCT02965924|Mayo Clinic|Arthur J. Sit, MD|507-284-2787|Sit.Arthur@mayo.edu|
20564788|NCT03621371|Karolinska Institutet|Dr Benjamin Bohman|701713443|benjamin.bohman@ki.se|+46
20564789|NCT03240016|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20564790|NCT05200403|Boston University School of Medicine|Kevin Thomas, PhD, MBA|617-358-9787|kipthoma@bu.edu|
20564791|NCT04053075|Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Healthcare Institute|Dr. Meghan Baker, MD, ScD|617-867-4946|MBAKER1@BWH.HARVARD.EDU|
20564792|NCT03235544|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20564793|NCT00950742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564794|NCT03162783|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20564795|NCT05436262|Johns Hopkins University|Cherie Marvel|410-387-8510|cmarvel1@jhmi.edu|
20564796|NCT05124704|Zhejiang Cancer Hospital|Jiangling Wang|15168373331|wangjl@zjcc.org.cn|
20564797|NCT05875467|dfusion Inc|Chief Executive Officer|8312225103|tamara.kuhn@dfusioninc.com|
20564798|NCT03463044|INOTREM SA|Executive VP Research and Medical Sciences, INOTREM SA|30 62 86 51|jjg@inotrem.com|+33 (0)6
20564799|NCT04471246|Ottawa Hospital Research Institute|Krishan Yadav|613-798-5555|kyadav@toh.ca|19489
20564800|NCT05764525|Vivozon, Inc.|Chief Medical Officer|609 269 9140|adminus@vivozon.com|
20564801|NCT03334630|Medtronic|Katie Flor, Principal Clinical Research Specialist|+1 763 526 9651|katie.j.flor@medtronic.com|
20564802|NCT04252573|Endologix|Mohamed Moawad|949-595-7244|mmoawad@endologix.com|
20564803|NCT03404115|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20564804|NCT03743532|The University of Oklahoma Health Sciences|Dr. Darla E. Kendzor|(405) 271-7848|Darla-Kendzor@ouhsc.edu|
20519675|NCT03942211|Janssen Cilag International NV|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20519676|NCT00133679|University of California, San Francisco|Roberta Keller, MD|(415) 476-1888|roberta.keller@ucsf.edu|
20519677|NCT01955044|NorthShore University HealthSystem|Brandy L Frost|847-570-2033|bfrost@northshore.org|
20519678|NCT02376257|Boston UCRC|Michael Otto, PhD|617-353-9610|mwotto@bu.edu|
20519679|NCT00104247|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
20519680|NCT00690482|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
20519681|NCT01886937|New York State Psychiatric Institute|Dr. Laurel Mayer|646-774-8067|lsm16@cumc.columbia.edu|646
20519682|NCT04798482|Boston Children's Hospital|Keira Mason MD|617-355-5775|keira.mason@childrens.harvard.edu|
20519683|NCT00925756|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
20519684|NCT01930175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20519685|NCT00789113|University of Minnesota College of Pharmacy|Dr. Rory P. Remmel|6126240472|remme001@umn.edu|
20519686|NCT00890552|Stanford University School of Medicine|Brenda Hann, RN, MBA, CCRC|650-723-0966|bhann@stanford.edu|
20519687|NCT04965389|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20519688|NCT03903159|University of Minnesota|Amy Krentzman|612-625-2312|akrentzm@umn.edu|
20519689|NCT00724373|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20519690|NCT04230876|Amptify|Chris Cardinal|3143999940|Chris@amptify.com|
20519691|NCT02093923|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20519692|NCT01662362|Abbott|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
20519693|NCT04350008|BIOTRONIK SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20519694|NCT00545688|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20519695|NCT02521181|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|(216) 444-9938|gassmaj@ccf.org|
20519696|NCT02449473|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
20519697|NCT03407612|Jameson Crane Sports Medicine Institute|Maria Munsch|614-293-3600|maria.munsch@osumc.edu|
20519698|NCT01301482|Mike O'Callaghan Military Medical Center|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20519699|NCT01682642|Fertility Center AZ Jan Palfijn|dr. Wim Decleer, PI|0032 9 325 92 20|wim.decleer@janpalfijngent.be|09/2248851
20519700|NCT01915940|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20519701|NCT00614926|Columbia University|Judith Rabkin, PhD|212 543 5762|jgr1@columbia.edu|
20519702|NCT03250299|Basilea Pharmaceutica International Ltd (Basilea)|Thomas Kaindl, MD, Global Medical Director|+41615671505|thomas.kaindl@basilea.com|
20519703|NCT02551679|Hemostemix|Dr. Fraser Henderson|2022978858|fhenderson@hemostemix.com|
20519704|NCT00521989|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
20519705|NCT00706095|Eisai Call Center|Eisai Inc.|888-422-4743||
20519706|NCT03662308|SPINAL CORD DAMAGE RESEARCH CENTER|Dr. John Handrakis|718.584.9000|john.handrakis@va.gov|3129
20519707|NCT01005329|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
20519708|NCT02504723|Kaohsiung Veterans General Hospital|Dr. Wen-Chi Chen|886-7-3422121|wcchen@vghks.gov.tw|2139
20519709|NCT03852524|Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
20519710|NCT03756883|Teva Pharmaceuticals, USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
20519711|NCT01470417|University of Florida|Thomas J. George, Jr., MD|(352) 273-8008|thom.george@medicine.ufl.edu|
20519712|NCT02973321|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|
20519713|NCT02136238|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
20519714|NCT03476317|Children's Hospital of Philadelphia|Lindsey Albenberg, DO|267-426-0139|albenbergl@chop.edu|
20519715|NCT00865514|University of Florida|Dr. Peter W. Stacpoole|(352) 273-9023|pws@ufl.edu|
20519716|NCT02865395|George Washington University|Dr. Patrick Mufarrij|2027154000|pmufarrij@gmail.com|
20519717|NCT02423317|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|8937963828|bikramjit.anesth@gmail.com|
20564805|NCT04019977|University of Maryland School of Social Work|Dr. Lisa Berlin|410 706 6392|lberlin@ssw.umaryland.edu|
20564806|NCT03617679|University of Colorado Denver|Bradley Robert Corr, MD|303-724-2066|bradley.corr@cuanschutz.edu|
20564807|NCT05907174|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
20564808|NCT04498390|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20564809|NCT05205460|Tri-service general hospital|Chia-Ying Lai|87923311|pokerface165@gmail.com|13606
20564810|NCT04533737|LEO Pharma A/S|Clinical Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
20564811|NCT05093842|West Virginia University|Bethany Barone Gibbs|304-581-1779|behany.gibbs@hsc.wvu.edu|
20564812|NCT03910478|Fred Hutchinson Cancer Research Center|Michael Boeckh, MD|206-667-6706|mboeckh@fredhutch.org|
20564813|NCT03953417|Stanford University|Principal Investigator|650-736-2233|nbassano@stanford.edu|
20564814|NCT04089137|Georgia State University|Dr. Amanda Gilmore|(404) 413-2000|agilmore12@gsu.edu|
20564815|NCT04383496|Minneapolis VA Health Care System|Wei Duan-Porter|6124675845|wei.duanporter@va.gov|
20564816|NCT03987022|Metrohealth System|Dr. Robert Pollard|2167781446|rpollard@metrohealth.org|
20564817|NCT03478956|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20564818|NCT04168580|AdventHealth Translational Research Institute|Paul M. coen, PhD., Associate Investigator|765-426-9743|paul.coen@adventhealth.com|
20564819|NCT04858451|Thirty Respiratory Ltd|Inva Hoti, PhD|+44 (0) 1235 431200|Inva.Hoti@30.technology|
20564820|NCT03314454|Northeastern University|Dr. Robert Leeman|6173736501|r.leeman@northeastern.edu|
20564821|NCT02895464|Karolinska Institutet|Dr Elisabeth Rydwik|+46852488818|elisabeth.rydwik@ki.se|
20564822|NCT04298983|University of Alabama at Birmingham (UAB)|Andrew McDonald, MD; Principal Investigator|2059345670|ammcdonald@uabmc.edu|
20564823|NCT04907851|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
20519718|NCT04220775|M D Anderson Cancer Center|Dr. Renata Ferrarotto|(713) 745-6774|rferrarotto@mdanderson.org|
20564824|NCT04111874|University of Pennsylvania|Dr. Andrew Guzick|215-573-3708|andrew.guzick@pennmedicine.upenn.edu|
20564825|NCT06176963|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20564826|NCT01456949|Medtronic|Kirsten Rasmussen|763-526-2833|kirsten.l.rasmussen@medtronic.com|
20564827|NCT03710603|Stichting European Myeloma Network (EMN)|Sarah Lonergan|+31 10 268 70 65|sarah.lonergan@emn.life|
20564828|NCT01658930|Canadian Cancer Trials Group|Lois E. Shepherd|6135336430|LShepherd@ctg.queensu.ca|
20564829|NCT05002088|Abbott|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
20564830|NCT05495971|Visioneering Technologies, Inc.|Dr. Douglas P. Benoit|6035459507|dbenoit@vtivision.com|
20564831|NCT04068181|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20564832|NCT02723591|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20564833|NCT02322203|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301.402.0521|mamar@nhlbi.nih.gov|
20564834|NCT03599661|Wake Forest Baptist Comprehensive Cancer Center|Stephanie Bunch|336-716-5180|sbunch@wakeforest.edu|
20564835|NCT04117347|University of Michigan|Dr. Helen Burgess|734-615-8303|bhelen@med.umich.edu|
20564836|NCT03691935|Milton S. Hershey Medical Center|Urology Research Operations Manager|717-531-0003|UrologyResearch@pennstatehealth.psu.edu|287502
20564837|NCT03511664|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20564838|NCT01946789|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20564839|NCT04971031|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20564840|NCT04642820|University of Chicago|Harriet de Wit, Principal Investigator|773-702-1234|hdew@uchicago.edu|
20564841|NCT03905798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20564842|NCT05374798|Medical University of South Carolina|Stacey sellers|843-792-5807|sellersst@musc.edu|
20564843|NCT06473662|Diabetology Ltd|Roger New|07818068012|rn@diabetology.co.uk|
20519719|NCT00436917|Mayo Clinic Jacksonville|Stephanie L. Hines, M.D.|507-266-0800|hines.stephanie@mayo.edu|
20519720|NCT02169791|Northside Hospital|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
20519721|NCT01009515|University of New Mexico|Montaser Shaheen, MD, PhD|505-925-0404|MoShaheen@salud.unm.edu|
20519722|NCT01321437|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20519723|NCT01966809|Medical College of Wisconsin|Dr. Harry T. Whelan|414-266-7516|hwhelan@mcw.edu|
20519724|NCT01439724|Instituto Nacional de Cancer|Dr. Heliton Spindola Antunes|55 21 32076597|hspindola@inca.gov.br|
20519725|NCT00271024|University of Chicago|Dr. Andrea King|7737026181|aking@bsdad.uchicago.edu|
20519726|NCT00703976|University of Pittsburgh|Julie Bauman, MD|412-623-7833|baumanje@upmc.edu|
20519727|NCT01913795|Boston Children's Hospital|Dr. Wanda Phipatanakul|617-355-6117|Wanda.Phipatanakul@childrens.harvard.edu|
20519728|NCT03573817|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20519729|NCT01719562|Wake Forest University|Project Manager|+1(336) 758-3728|jvolpini@wakehealth.edu|
20519730|NCT00508027|Children's Hospital & Research Center Oakland|Dr. Carolyn Hoppe, Principal Investigator|(510)428-3193|choppe@mail.cho.org|
20519731|NCT02240186|Mayo Clinic|Dr. Kenton Kaufman, Principal Investigator|507-284-2262|kaufman.kenton@mayo.edu|
20519732|NCT03554317|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Dr. Mark Markowski|410-614-0567|mmarko12@jhmi.edu|
20519733|NCT00537199|UT MD Anderson Cancer Center|Mark Chambers, MS, DMD / Professor|713-792-6510||
20519734|NCT02039063|EA Pharma Co., Ltd|Corporate Communication Dept.|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
20519735|NCT02621463|University of Utah|Dr. Kai Kuck, PhD|8012051010|kai.kuck@hsc.utah.edu|
20519736|NCT02740179|Massachusetts General Hospital|Dr. Steven K. Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu|
20530216|NCT02785939|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20530217|NCT01787552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20530218|NCT01038687|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
20530219|NCT02175121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530220|NCT02037893|Pernix Therapeutics|Senior Director, Medical and Scientific Affairs|8007932145|egould@pernixtx.com|
20530221|NCT01036802|University of North Carolina, Chapel Hill|Kenneth I. Ataga, MD|919-843-7708|kataga@med.unc.edu|
20564844|NCT02398656|University of Calgary|Dr. Shelagh Coutts|4039444286|scoutts@ucalgary.ca|
20530222|NCT01251042|Wellspect HealthCare|Emma Tällberg, Clinical Research Manager|+46313764000||
20564845|NCT05485779|AQILION AB|Anneli Tinnerholm|+46 730 88 14 15|anneli.tinnerholm@aqilion.com|
20530223|NCT03974282|Virginia Commonwealth University|David Chester|8048287624|dschester@vcu.edu|
20530224|NCT02895347|GWU Medical Faculty Associates|Dr. Gaby Moawad|202-741-2500|jebert@mfa.gwu.edu|
20530225|NCT02589145|UT MD Anderson Cancer Center|Dr. Yago Nieto/Professor, Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
20530226|NCT01673178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530227|NCT02557399|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530228|NCT02456194|NSHA|Ross Leighton|1-902-473-4035|Ross.Leighton@nshealth.ca|
20530229|NCT00931632|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20530230|NCT01439035|Massachusetts General Hospital|Dr. Gary Tearney PI|617-724-2979|gtearney@partners.org|
20530231|NCT01419314|Texas Woman's University|Roberto Sandoval PT|713-859-9351|rsandoval@mail.twu.edu|
20530232|NCT01328964|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530233|NCT03139552|University of Colorado Anschutz Health and Wellness Center|John C. Peters, PhD|303-724-9160|john.c.peters@ucdenver.edu|
20530234|NCT03122171|Rutgers-New Jersey Medical School|Alice Chu, MD|(973) 972-2076|chual@njms.rutgers.edu|
20564846|NCT03138603|University of Chicago Medicine|Peter Nagele, MD, MSc|773-795-3544|pnagele@uchicagomedicine.org|
20564847|NCT03030261|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8323|rvij@wustl.edu|
20564848|NCT04079218|Albert Einstein College of Medicine|Dr. Kerry Murphy|718-839-7885|kerry.murphy@einsteinmed.edu|
20564849|NCT05705518|University of California Berkeley Clinical Research Center|Andrew D. Graham|510-643-9252|agraham@berkeley.edu|
20564850|NCT04032041|University of Iowa|Jason M Wilken, PT, PhD|319-335-9791|jason-wilken@uiowa.edu|
20564851|NCT01275677|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20564852|NCT04567238|Duke University School of Medicine|Angela Kirby|9198247729|angela.kirby@duke.edu|
20564853|NCT04800211|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
20564854|NCT05170841|A Menarini Industrie Farmaceutiche Riunite SrL|Corporate Medical Affair and Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
20564855|NCT03806790|LEO Pharma A/S|Clinical disclosure|+4544945888|disclosure@leo-pharma.com|
20564856|NCT03643744|Wright State University|Dr. Jeffrey Travers|(937)-245-7500|Jeffrey.Travers@Wright.edu|
20564857|NCT06201559|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20564858|NCT00915759|Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir|Principal Investigator|571-231-1600|dha.belvoir.fbch.mbx.wresp-research@health.mil|
20564859|NCT02733159|Cancer Research UK Clincial Trials Unit, University of Birmingham|PePS2 Trial Coordinator|0121 414 8040|peps2@trials.bham.ac.uk|
20564860|NCT04901078|Kinoxis Therapeutics Pty Ltd|Director of Clinical Operations|+61434360596|tiina.ahveninen@kinoxistherapeutics.com|
20564861|NCT03088878|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
20564862|NCT02724969|University of Pittsburgh|Jill R. Demirci, PhD, RN, IBCLC|412-648-9236|jvr5@pitt.edu|
20564863|NCT05216406|Nova Southeastern University|Dr. Jose Antonio|(954) 262-8140|Jose.Antonio@nova.edu|
20564864|NCT03617445|University of Wisconsin-Madison|Dr. Nasia Safdar|608-263-1545|ns2@medicine.wisc.edu|
20564865|NCT04690582|The Ohio State University College of Medicine|Dr. Craig Bryan, PsyD, ABPP|614-814-8612|craig.bryan@osumc.edu|
20564866|NCT04270942|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20564867|NCT06357169|University of Minnesota|Ronda Farah|(612) 625-8625|rfarah@umn.edu|
20564868|NCT04386057|Dana-Farber Cancer Institute|Dr. Kimberly Perez, MD|617-632-5370|Kimberly_Perez@DFCI.HARVARD.EDU|
20564869|NCT04797195|Massachusetts General Hospital Center for Global Health|Katharine Morley, MD|617-726-2000|kemorley@mgh.harvard.edu|
20564870|NCT03221309|Institute of Human Virology, University of Maryland School of Medicine|Dr. Elana Rosenthal / Associate Professor|2403674157|erosenthal@ihv.umaryland.edu|
20564871|NCT04577963|HUTCHMED International, Inc.|William Schelman, MD, PhD, Senior Vice President, Clinical Development, US/Europe|+1 9733064490|williams@hutch-med.com|
20564872|NCT02709161|University of Pittsburgh|Kymberly Young|4126486179|youngk@pitt.edu|
20564873|NCT05121441|Aardvark Therapeutics, Inc.|Manasi Jaiman MD, MPH, Chief Medical Officer|(858) 225-7696|MJaiman@aardvarktherapeutics.com|
20564874|NCT05167864|University of Pennsylvania|Dr. Ivona Percec, PhD, MD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
20564875|NCT04028284|Sunnybrook Health Sciences Centre|Dr. Fahad Alam|416-480-4864|fahad.alam@sunnybrook.ca|
20564876|NCT04059185|Boston College School of Social Work|Catherine Taylor, PhD, LCSW, MPH|(617) 552-4033|catherine.taylor.2@bc.edu|
20564877|NCT05229822|NJSC KARAGANDA MEDICAL UNIVERSITY|Dr. Yermek Turguov|+77016119655|Turgunov@qmu.kz|
20564878|NCT04707326|ErasmusMC|Dr. Casper Rokx|+310107040704|c.rokx@erasmusmc.nl|
20564879|NCT03125070|Fred Hutchinson Cancer Center|Dr. K. Scott Baker|206-667-5594|ksbaker@fredhutch.org|
20530235|NCT03234465|Oragenics, Inc.|Dr. Alan Jolyn|+ 1 813-286-7900|info@oragenics.com|
20530236|NCT00449163|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-4909|bardalan@med.miami.edu|
20530237|NCT00465530|University of Kansas Medical Center|Dr. Julie Wei|(913) 588-6664|jwei@kumc.edu|
20530238|NCT00541242|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20530239|NCT00606307|Italfarmaco S.p.A.|Tiziano Oldoni, MD|+39 02 6443|t.oldoni@italfarmaco.com|2540
20530240|NCT00597272|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
20530241|NCT00628407|Children's Hospital of Philadelphia|Vinay Nadkarni, MD|215-590-7430|nadkarni@email.chop.edu|
20530242|NCT02563899|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530243|NCT03368807|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20530244|NCT03781726|University of Pennsylvania|Peter Reese|215-573-8070|Peter.Reese@pennmedicine.upenn.edu|
20530245|NCT01035749|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530246|NCT00948090|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20530247|NCT02139397|Beat Childhood Cancer|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
20530248|NCT01721447|University of Utah Division of Cardiovascular Medicine|Dr. Brent Wilson|801-585-2341|brent.wilson@hsc.utah.edu|
20530249|NCT01339416|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530250|NCT02949947|UT MD Anderson Cancer Center|Saroj Vadhan,Clinical Professor, Cytokine & Supportive Oncology|(713) 792-7966|svadhanr@mdanderson.org|
20530251|NCT01677741|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20530252|NCT01973218|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20530253|NCT02247466|Department of Anaesthesiology, Herlev Hospital, University of Copenhagen|Roar Borregaard Medici, MD, Research Assistant|+4526390068|roar.borregaard.medici.01@regionh.dk|
20530254|NCT01004939|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530255|NCT00350545|Stanford University|David B. Miklos|650 725-4959|dmiklos@stanford.edu|650
20530256|NCT01794702|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD./Associate Professor|713-745-6080|njain@mdanderson.org|
20530257|NCT00434252|Genentech, Inc.|Medical Communications|800-821-8590||
20530258|NCT02097732|University of Michigan Comprehensive Cancer Center|Dr. Christopher Lao, MD, MPH|(734) 936-4498|clao@med.umich.edu|
20530259|NCT03813108|Radboud university medical center|Matthew McCall, MD, PhD|+3124 3615363|Matthew.mccall@Radboudumc.nl|
20530260|NCT00720278|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
20530261|NCT01677286|Boston Medical Center|John Berk, MD|617-638-4494|jberk@bu.edu|
20530262|NCT00623181|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20530263|NCT03630393|OhioHealth|Dr. Ryan Hedgepeth|614-788-2870|ryan.hedgepeth@ohiohealth.com|
20530264|NCT00408499|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
20530265|NCT01042795|University of Michigan|Cheryl T. Lee|614-685-6666|cheryl.lee@osumc.edu|
20530266|NCT01586195|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20530267|NCT00997334|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468|David_Jackman@dfci.harvard.edu|
20530268|NCT01855958|Hospital de Clínicas de Porto Alegre|Wolnei Caumo, MD,PhD.|+555133598430|caumo@cpovo.net|
20530269|NCT02863666|University of Buffalo|Brooke Lerner PHD,|716.390.3509|lerner@buffalo.edu|
20530270|NCT01507350|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20530271|NCT02420639|Department of Anesthesiology & Intensive Care Medicine, Dnipropetrovsk Medical Academy|Alexander Tsarev|+38 057 701 52 00|tsarev03@rambler.ru|
20530272|NCT03946059|University of California San Diego|Dr. Jyoti Mishra|8582322855|jymishra@ucsd.edu|
20564880|NCT05623228|Private practice|Dr. Stavroula Rakitzi|6989766935|srakitzi@gmail.com|
20564881|NCT02397954|Ophthotech Corp|Keith Westby||Keith.Westby@ophthotech.com|
20564882|NCT04231331|Asan Medical Center|Professor Duk-Hyun Kang|821030103166|dhkang@amc.seoul.kr|
20519737|NCT02326363|Medical University of South Carolina|Nathaniel L Baker|843-792-5028|bakern@musc.edu|
20519738|NCT00612677|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D., via Moffitt Cancer Center|813-745-3050|alberto.chiappori@moffitt.org|
20519739|NCT01491633|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-3000|phammerman@partners.org|
20519740|NCT00823199|Bronx Psychiatric Center|Nigel Bark MD|7188625429|Nigel.Bark@omh.ny.gov|
20519741|NCT01566526|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20519742|NCT05197829|University of Massachusetts Chan Medical School|Mark O'Connor|508-334-1000|mark.oconnor2@umassmed.edu|
20519743|NCT01640184|Peking University International Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
20519744|NCT02927834|Loma Linda University|Dr. Kristin Seiberling|9095582002|kseiberling@llu.edu|
20519745|NCT02492841|UNIVERSIDAD DE LOS ANDES|Dra. CLAUDIA BRIZUELA CORDERO|562226181166|clau@cibrizuela.com|
20519746|NCT03746002|University of Maryland School of Pharmacy|Brent Reed|410-706-1452|breed@rx.umaryland.edu|
20519747|NCT04925713|Morphogenesis, Inc|James Bianco, MD - Chief Executive Officer|8138756600|jbianco@morphogenesis-inc.com|104
20519748|NCT00613730|Amgen Inc.|Study Director|866-572-6436||
20519749|NCT00479388|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20519750|NCT00777855|UCSF|Leslie Benet|(415) 476-3853|leslie.benet@ucsf.edu|
20519751|NCT01876368|Novartis Pharmaceuticals|Study Director|862-778-8300||
20519752|NCT00611325|Duke University Medical Center|Dr. Katherine B. Peters|(919) 684-6173|katherine.peters@duke.edu|
20519753|NCT02563769|Temple University Episcopal Hospital|Yaminah Carter Research Coordinator|2678097602|yaminah.carter@tuhs.temple.edu|
20519754|NCT01644149|PharmaJet, Inc.|Marilyn Dysart, Clinical Affairs Manager|720-214-9399|marilyn.dysart@pharmajet.com|
20519755|NCT01411488|Cleveland Clinic|Nancy Albert|216-444-7028|albertn@ccf.org|
20564883|NCT04752657|Framingham Heart Study, Boston University|Joanne M Murabito, MD ScM|508-935-3461|murabito@bu.edu|
20519756|NCT02820740|Monteris Medical|Clinical Program Manager|763-401-1727|medicalaffairs@monteris.com|
20530273|NCT00266708|Montefiore Medical Center|Maria Coco, MD|718-920-4136|mcoco@montefiore.org|
20530274|NCT02791269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20530275|NCT02351934|Mayo Clinic|Ilya Danelich, Pharm.D., R.Ph.|507-255-5732|Danelich.Ilya@mayo.edu|
20530276|NCT02683109|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530277|NCT00368251|UCB|UCB Cares|+1877 822||9493
20530278|NCT03159143|University of Pittsburgh|Leonard Appleman, MD|412-648-6538|applemanlj@upmc.edu|
20530279|NCT00499122|UM/Sylvester Comprehensive Cancer Center|Alberto Montero MD|305-243-3771|amontero2@med.miami.edu|
20530280|NCT01130844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20530281|NCT02669849|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20530282|NCT04745351|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20530283|NCT02014272|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530284|NCT01483118|Columbia University, Department of OBGYN|Roger A. Lobo M.D.|212-3056337|ral35@columbia.edu|
20530285|NCT00551369|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20530286|NCT02051296|VA HCS Palo Alto|Dr Catherine Curtin|650-493-5000|ccurtin@stanford.edu|
20530287|NCT05379920|University at Buffalo|Haley Chizuk|7162043200|haleychi@buffalo.edu|2188
20530288|NCT01267279|Spokane Joint Replacement Center|Principal Investigator|509-466-6393|dfscott@mac.com|
20530289|NCT03176771|Mitsubishi Tanabe Pharma Corporation|Mitsubishi Tanabe Pharma Corporation Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
20530290|NCT00667511|NxStage Medical, Inc.|Kristen Sheppard|978-687-4700||
20530291|NCT02265510|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20530292|NCT02530385|Massachusetts General Hospital Endocrine Unit|Dr. Elaine Yu|617-726-6723|ewyu@mgh.harvard.edu|
20530293|NCT03613493|University of Miami|Dr. Susan Morgan|7654094919|semorgan@miami.edu|
20530294|NCT02111083|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20530295|NCT00644059|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20530296|NCT02152007|TransDerm, Inc.|Roger Kaspar, PhD|831-420-1684|roger.kaspar@transderminc.com|
20530297|NCT02497469|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20530298|NCT01690663|the University of Pennsylvania|Jiabin Liu, MD, PhD|215-573-8208|jiabin.liu@uphs.upenn.edu|
20530299|NCT03786380|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20530300|NCT02414698|Montefiore Medical Center|Sayed E Wahezi, MD|7189207246|swahezi@montefiore.org|
20530301|NCT01118052|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
20530302|NCT02845674|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
20530303|NCT00349336|Hoffmann-La Roche|Medical Communications|800-821-8590||
20530304|NCT02643875|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
20530305|NCT00843492|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530306|NCT00369343|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20530307|NCT00794664|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20530308|NCT00720499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530309|NCT00457730|MS Center at Evergreenhealth Care|Theodore R. Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
20530310|NCT01618968|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
20530311|NCT01621009|University of Wisconsin Center for Tobacco Research and Intervention|Timothy Baker, PhD, Director of Research|(608) 262-7568|tbb@ctri.wisc.edu|
20530312|NCT01589315|Medical University of South Carolina|Mark S. George, MD|1843876 5142|georgem@musc.edu|
20530313|NCT03400449|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20530314|NCT02230891|Michael E DeBakey Veterans Affairs Hospital|Vijay Nambi|713-794-7300|vijay.nambi@va.gov|
20530315|NCT04356937|Massachusetts General Hospital|DRAI Director of Clinical Trials|617-726-7938|JHSTONE@mgh.harvard.edu|
20530316|NCT00921024|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
20530317|NCT04158219|Hennepin Healthcare|Dr. Andrew Busch|6128736681|andrew.busch@hcmed.org|
20530318|NCT01814007|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20530319|NCT02374320|Ochsner Health System|Ken Bode|504.842.1936|ken.bode@ochsner.org|
20530320|NCT01324947|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20530321|NCT01778413|Hospital Clínic de Barcelona|Dr. Esteban Martinez|932275400|estebanm@clinic.cat|
20530322|NCT04194814|University of Sheffield|Dr Simon Danby|0114 2268515|s.danby@sheffield.ac.uk|
20530323|NCT02873689|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20530324|NCT04166214|NYU Langone Health - Hansjörg Wyss Department of Plastic Surgery|Mary E. Northridge, PhD, MPH, Director of Dental Research|347-377-4342|Mary.Northridge@nyulangone.org|
20530325|NCT00737178|Columbia University|Anne Davis, MD|2123054951|ard4@columbia.edu|
20530326|NCT01477567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20530327|NCT02470741|University of California, San Francisco|Lisa Abinanti, Project Director|415-353-9978|lisa.abinanti@ucsf.edu|
20530328|NCT00485836|Genentech, Inc.|Medical Communications|800-821-8590||
20530329|NCT00750269|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20530330|NCT03895801|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
20530331|NCT04539275|Palo Alto Cooperative Studies Program Coordinating Center|Lisa Zehm, Project Manager|(650)493-5000|lisa.zehm@va.gov|28805
20530332|NCT02466399|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
20530333|NCT01373164|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20530334|NCT00607893|Case Western Reserve University|Reena Mehra|216-445-1698|mehrar@ccf.org|
20530335|NCT01799941|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
20530336|NCT01605903|Massachusetts Eye and Ear Infirmar|Gillian Diercks, MD, MPH|617-573-3190|gillian_diercks@meei.harvard.edu|
20530337|NCT03408899|Johns Hopkins University|Craig Hendrix, MD|4109559707|chendrix@jhmi.edu|
20530338|NCT00606008|H. Lee Moffitt Cancer Center and Research Institute|Dr. Edward Pan|813-745-3871|edward.pan@moffitt.org|
20530339|NCT04596319|Armata Pharmaceuticals, Inc.|Mina Pastagia, MD|(310) 665-2928|mpastagia@armatapharma.com|
20530340|NCT01248416|Nemours Children's Clinic|Dr. Nelly Mauras|904-697-3674|nmauras@nemours.org|
20530341|NCT01244477|Michael E DeBakey VAMC|Wright Williams, PhD, ABPP|713-794-7629|wright.williams@va.gov|
20530342|NCT00547339|University of Texas Southwestern Medical Center Dallas|Dr. Robert Timmerman|214-645-8525|Robert.Timmerman@UTSouthwestern.edu|
20530343|NCT01516216|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu|
20530344|NCT03736967|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20530345|NCT02369653|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20530346|NCT03587636|University of Minnesota|James Flaherty|612-625-7675|jflahert@umn.edu|
20530347|NCT01458587|DUSA Pharmaceuticals, Inc.|Anna Houlihan|9147608796|houlihana@dusapharma.com|
20564884|NCT03056573|Abbott|Angelic Roach, Clinical Program Director|+16517563379|angelic.roach@abbott.com|
20564885|NCT02823145|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20564886|NCT04741776|Dartmouth-Hitchcock Clinic|Fallon Cluxton-Keller, Ph.D.|603-650-4724|Fallon.P.Cluxton-Keller@dartmouth.edu|
20564887|NCT00957047|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
20564888|NCT00462696|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20564889|NCT03936959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20564890|NCT02116530|Indiana University School of Medicine South Bend|Rudolph M. Navari, MD, PhD, FACP|574-252-7225|rmnavari@gmail.com|
20564891|NCT03766685|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20564892|NCT04676165|McGill University|Bettina Habib, Research Project Manager|514-396-1156|bettina.habib@mcgill.ca|
20564893|NCT02927236|National Institute on Drug Abuse (NIDA)|Yihong Yang, PhD|443-740-2648|yihong.yang@nih.gov|
20564894|NCT05297565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20564895|NCT04084288|Hospital for Special Surgery|Dr. Stephanie Cheng|212-606-1206|chengs@hss.edu|
20564896|NCT05299723|Columbia University Irving Medical Center|Ari Shechter|212-342-1335|as4874@cumc.columbia.edu|
20564897|NCT01959607|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|clinicaltrials.pmi@pmi.com|
20564898|NCT03913442|NYU Langone Health|Michael H Pillinger, MD, FACP|646-501-2722|Michael.Pillinger@nyulangone.org|
20564899|NCT03952338|University of Calgary|Dr. Dana Lee Olstad|403-210-8673|dana.olstad@ucalgary.ca|
20564900|NCT04811040|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20564901|NCT05274074|University of Rochester|Dr. Benzi M. Kluger|5852754259|benzi_kluger@urmc.rochester.edu|
20564902|NCT05194956|University Hospitals of Derby and Burton NHS Trust|Mrs Trishna Patel|01332340131|trishnaanil.patel@nhs.net|83556
20519757|NCT03060759|Massachusetts General Hospital|Farrah J. Mateen, MD, PhD, Associate Professor of Neurology|617-724-8653|fmateen@mgh.harvard.edu|
20519758|NCT03770078|Coloplast|Head of Medical Writing and Biostatistics|49113143|dkpen@coloplast.com|+45
20519759|NCT01436643|Novartis Pharmaceuticals|Study Director|862-778-8300||
20519760|NCT01382251|Department of Anesthesiology, The Ottawa Hospital|Dr. Gregory L Bryson|613.761.4169|glbryson@ottawahospital.on.ca|
20519761|NCT01117987|Novartis Pharmaceuticals|Study Director|862-778-8300|Trialandresults.registries@novartis.com|
20519762|NCT04117945|Mayo Clinic|Daniel H. Ahn, D.O.|(480) 342-4800|Ahn.Daniel@mayo.edu|
20519763|NCT02568007|Medical College of Wisconsin|Praveen Goday|4142663690|pgoday@mcw.edu|
20519764|NCT03391115|University of Colorado, College of Nursing|Heather Coats, PhD, APRN-BC, PI|303-724-3740|heather.coats@cuanschutz.edu|
20519765|NCT00562120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519766|NCT02148445|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
20519767|NCT03450629|Sun Pharma Advanced Research Company Limited|Head, Clinical Developmnt|912266455645|clinical.trials@sparcmail.com|
20519768|NCT02774850|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
20519769|NCT03438006|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20564903|NCT03709121|Aldeyra Therapeutics, Inc.|VP, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20564904|NCT05446129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20564905|NCT03512327|Scripps Clinic|Dr. Gauree Konijeti|8585548880|konijeti.gauree@scrippshealth.org|
20564906|NCT06258174|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20564907|NCT01828099|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
20564908|NCT04162665|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
20564909|NCT03859635|Indiana University Department of Anesthesiology|Yar Luan Yeap, MD|3172740275|yyeap@iu.edu|
20564910|NCT05934942|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564911|NCT01922050|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20564912|NCT05645757|DynPort Vaccine Company, a GDIT Company|George Saviolakis|301-835-4101|George.Saviolakis@gdit.com|
20564913|NCT03924635|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20519770|NCT03200535|Kaiser Permanente Colorado|Dr. Emily Schroeder|303-636-2478|emily.b.schroeder@kp.org|
20519771|NCT01451996|University of Chicago|Anup Malani, J.D., Ph.D|773-702-9602|amalani@uchicago.edu|
20519772|NCT01181531|Amgen Inc.|Study Director|866-572-6436||
20530348|NCT01603602|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@Allergan.com|
20530349|NCT01006629|Abbott|Global Medical Services|800-633-9110||
20530350|NCT00316004|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
20530351|NCT00250484|Beth Israel Deaconess|Steven D. Freedman, MD Phd|631-667-2132|sfreedma@bidmc.harvard.edu|
20530352|NCT02665117|UT Southwestern Medical Center|Dr. Wanpen Vongpatanasin|214-648-9078|wanpen.vongpatanasin@utsouthwestern.edu|
20530353|NCT04236284|The University of Texas Health Science Center at Houston|Melba Hernandez Tejada, PhD, DHA|7134862729|Melba.A.HernandezTejada@uth.tmc.edu|
20530354|NCT02271451|Cincinnati Children's Hospital|Dr. Gregory Myer|513-636-4366|gregory.myer@cchmc.org|
20530355|NCT00977197|Mayo Clinic|Yuri A. Saito Loftus, M.D.|507-284-2687|saito.yuri@mayo.edu|
20530356|NCT01432951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20530357|NCT00958074|University of Washington|Dr. Andrei Shustov|206-288-6744|ashustov@uw.edu|
20530358|NCT02025075|Massachusetts General Hospital|Marcos Vidal Melo, MD, PhD|617-726-8980|VidalMelo.Marcos@mgh.harvard.edu|
20530359|NCT00095979|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20530360|NCT03785028|University of Wisconsin - Madison|Brad Postle, PhD|608-262-4330|postle@wisc.edu|
20530361|NCT03712280|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20530362|NCT03558516|Department of Anesthesiology, Faculty of medicine, Siriaj hospital, Mahidol University|Assoc. Prof. Manee Raksakietisak|+66814880620|manee95@hotmail.com|
20530363|NCT00472420|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20530364|NCT01658839|Alcon Research, Ltd.|Theresa Landry, Project Head, Clinical Trial Management|1-888-451-3937|alcon.medinfo@alcon.com|
20530365|NCT03144232|Stanford University|Gregory Sahlem|650-724-0444|gsahlem@stanford.edu|
20530366|NCT04081688|Cancer Institute of New Jersey Rutgers|Dr. Jabbour|732-757-9840|jabbousk@cinj.rutgers.edu|
20530367|NCT01462942|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
20530368|NCT02449434|King's College London|Prof David Bartlett|02071887462|david.bartlett@kcl.ac.uk|
20530369|NCT02737722|Lakewood Amedex|Chief Medical Officer|941 928 7774|poconnor@lakewoodamedex.com|
20530370|NCT02662569|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20530371|NCT00305162|The Medicines Company|Meredith Todd|+19732906088|meredith.todd@themedco.com|
20530372|NCT02668003|University of Aberdeen|Professor Gary Macfarlane|01224 437 143|g.j.macfarlane@abdn.ac.uk|
20564914|NCT00539591|St. Jude Children's Research Hospital|Alberto Pappo, MD|901-595-2322|info@stjude.org|
20564915|NCT04362254|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20564916|NCT04568434|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20564917|NCT05469464|UNION therapeutics A/S|UNION therapeutics A/S|+45 61 77 7435|clinicaltrials@uniontherapeutics.com|
20564918|NCT04421989|Cincinnati Children's Hospital Medical Center|Dr. Claire Aarnio-Peterson|5138037459|claire.aarnio-peterson@cchmc.org|
20564919|NCT04707625|Wake Forest University Health Sciences|Mark Nelson, MD|336.713.1680|mhnelson@wakehealth.edu|
20564920|NCT04826471|Relife Srl|Clinical Trials Coordinator|05556809528|lfabbri@relifecompany.it|
20564921|NCT05293171|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
20564922|NCT02052882|Memorial Sloan Kettering Cancer Center|Dr. Cy Wilkins, MD|646-608-3720|wilkinsc@mskcc.org|
20564923|NCT05012683|Point Designs|Director of Clinical Research|7206004753|research@pointdesignsllc.com|
20564924|NCT00207636|DFCI, Harvard|Jennifer Allen|617-632-2269||
20564925|NCT05590728|DynPort Vaccine Company, a GDIT Company|George A. Saviolakis, MD, PhD|301-835-4101|George.Saviolakis@gdit.com|
20564926|NCT03734679|Surmodics|Thu Huyen Ha|952.500.7261|tha@surmodics.com|
20564927|NCT05546385|Rehaler A/S|Troels Johansen|004540977313|tj@rehaler.com|
20564928|NCT00291525|Artivion|Clinical Project Manager (Yael Goode)|8454800137|Yael.Goode@Artivion.com|
20564929|NCT05987813|Virginia Commonwealth University|Gisela Chelimsky|804-628-5882|gisela.chelimsky@vcuhealth.org|
20564930|NCT02240238|NANO MRNA Co.,Ltd.|NANO MRNA Clinical Info Admin|+81 (0)3-6432-4792|clinical.info@nanomrna.co.jp|
20564931|NCT02657005|Oncternal Therapeutics|Mary Breitmeyer|858-434-1113|clinical@oncternal.com|
20564932|NCT01346540|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564933|NCT04506866|Medtronic|Mylène Champs|612-433-0600|mylene.champs@medtronic.com|
20564934|NCT03362476|New York University|Ralph J DiClemente|+1 (212) 992-3709|rjd438@nyu.edu|
20564935|NCT05487404|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20564936|NCT04911296|Rani Therapeutics|Sr. Director of Clinical Operations|+1 (408) 457-3700|joshua.myers@ranitherapeutics.com|
20564937|NCT06081309|Wave Neuroscience, Inc.|Bill Phillips|714-883-7890|bill@waveneuro.com|
20564938|NCT05679908|Tonix Pharmaceuticals|Gregory Sullivan|(862) 904-0355|greg.sullivan@tonixpharma.com|
20564939|NCT01236781|American College of Radiology|Director Clinical Research Administration|215-574-3150|info@acr.org|
20564940|NCT04587453|Leo Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20564941|NCT04737330|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20564942|NCT04884308|Johns Hopkins University|Noah Lechtzin|410-502-7044|nlechtz@jhmi.edu|4102994561
20564943|NCT02852655|Dana-Farber Cancer Institute|Jose R. McFaline Figueroa, MD, PhD|617-632-2166|jose_mcfalinefigueroa@dfci.harvard.edu|
20564944|NCT00323856|Grifols|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20564945|NCT05309291|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20564946|NCT05209152|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20564947|NCT03100760|University of New Mexico Health Sciences Center|Justin Baca|505-272-5062|jtbaca@salud.unm.edu|
20564948|NCT05292391|Kaiser Permanente Washington Health Research Institute|Lisa A. Jackson, MD, MPH|(206)-442-5216|Lisa.A.Jackson@kp.org|
20564949|NCT02568566|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
20564950|NCT00636389|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20564951|NCT03221426|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20564952|NCT04171141|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519773|NCT02339090|Aravive, Inc.|Chief Operating Officer|(936) 355-1910|clinicaltrials@aravive.com|
20519774|NCT01168687|Ernest Gallo Clinic and Research Center, UCSF|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
20519775|NCT02737592|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20519776|NCT04243096|Boston University|Deepak Kumar, PT, PhD|617-358-3037|kumard@bu.edu|
20519777|NCT02792218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20519778|NCT02664987|Mundipharma Pte Ltd|Valerie Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
20519779|NCT00955721|University of Miami|Peter J. Hosein MD|3052433462|phosein@miami.edu|
20519780|NCT03512002|Atrium Wake Forest Baptist Health School of Medicine|Charles Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
20519781|NCT01631682|Massachusetts General Hospital|Scott P. Orr, Ph.D.|617-643-7269|scott_orr@hms.harvard.edu|
20519782|NCT02408445|University of Colorado|Dr. Shanlee Davis|720-777-6073|shanlee.davis@childrenscolorado.org|
20519783|NCT00503113|Hoffman-LaRoche|Medical Communications|800-821-8590||
20519784|NCT01253317|Boston Children's Hospital|Walter E. Kaufmann, MD|617-355-5230|rettresearch@childrens.harvard.edu|
20519785|NCT02280226|University of Bonn|Dr. Jonas Doerner|017632817006|jonas.doerner@ukb.uni-bonn.de|
20519786|NCT04678817|University of Utah|Lori Gawron, MD|801-213-4989|lori.gawron@hsc.utah.edu|
20519787|NCT05368012|Hospital for Special Surgery|MIDCAB (Mid-Calf Block) for foot surgery: A pilot study|646-797-8948|popovicm@hss.edu|
20519788|NCT02966184|Norton Healthcare|Tristan Murray, PharmD|5026295571|tristan.murray@nortonhealthcare.org|
20519789|NCT03535857|University of Pittsburgh|Dr, Gnankang Sarah Napoe|412-641-7850|napoegs@upmc.edu|
20519790|NCT02121041|UNC Chapel Hill|Dr. Anthony Viera|984-974-4636|viera@med.unc.edu|
20519791|NCT02284347|Medtronic Xomed|Director of Clinical Trials|904-296-9600|dl.nuventstudy@medtronic.com|
20519792|NCT03185182|Lund University|Professor Håkan Axelson|+46 046 2226434|hakan.axelson@med.lu.se|
20519793|NCT01730040|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
20519794|NCT00544817|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20519795|NCT03694808|University Hospitals Cleveland Medical Center|Dr. David Canaday|216-368-5537|dxc44@case.edu|
20519796|NCT02322788|AstraZeneca R&D Gothenburg, SE-431 83 Mölndal, Sweden|Göran Eckerwall, MD, PhD|+46 708467664|goran.eckerwall@astrazeneca.com|
20519797|NCT03326986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519798|NCT02999984|Orchard Therapeutics (Europe) Ltd|Orchard Medical Information|+44 (0) 203 808 8286|medinfo@orchard-tx.com|
20519799|NCT02631837|Imelda ziekenhuis Bonheiden|Dr Jan Baekelandt|+ 32 15 505208|jan.baekelandt@imelda.be|
20519800|NCT00754013|Eisai inc.|Eisai Medical Services|1-888-422-4743||
20519801|NCT04039919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20519802|NCT02310789|Stanford University|Jeff Wine, PhD|650-725-2462|wine@stanford.edu|
20519803|NCT01197417|Medical College of Wisconsin|David Brousseau MD, MS|414-266-2625|dbrousse@mcw.edu|
20519804|NCT01202071|Eisai Co., Ltd.|Masaharu Yokoyama, Director|+81-3-3817-3908|m-yokoyama@hhc.eisai.co.jp|
20519805|NCT02813421|Children's Hospital Los Angeles|Dr. Jessica Ferris|323-361-4606|jeferris@chla.usc.edu|
20519806|NCT00977548|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, Principal Investigator|813-745-4692|rami.komrokji@moffitt.org|
20519807|NCT02548312|BMJ|Dr Sara Schroter|02073836744|sschroter@bmj.com|
20519808|NCT01546142|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20519809|NCT01213836|Astra Zeneca|Gerard Lynch||ClinicalTrailTransparency@astrazeneca.com|
20519810|NCT01332578|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519811|NCT02429375|Memorial Sloan Kettering Cancer Center|Dr. Alison Moskowitz, MD|\646-608-3726|moskowia@mskcc.org|
20519812|NCT01002794|Oslo University Hospital|Professor May Arna Risberg|+4741312776|marisb@ous-hf.no|
20519813|NCT03614494|The University of Hong Kong|Dr Raymond Li|+852 22554517|raymondli@hku.hk|
20519814|NCT01322971|Stanford University|Ruth Lathi||rlathi@stanford.edu|
20519815|NCT01311557|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20519816|NCT00608517|Vanderbilt-Ingram Cancer Center|Brian Engelhardt, M.D.|615-936-1803||
20519817|NCT03478865|National Institutes of Health|Emily Chew, MD, Principal Investigator, NEI|3014966583|emily.chew@nih.gov|
20519818|NCT01333072|MUSouthCarolina|C. Lindsay DeVane, Pharm.D.|8432701818|devaneL@musc.edu|
20519819|NCT00619359|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20519820|NCT05212883|Duke University|Saira Siddiqui, M.P.H.|919-688-8464|saira.siddiqui@duke.edu|
20519821|NCT02075606|Ipsen|Medical Director|00441753627777|clinical.trials@ipsen.com|
20519822|NCT01118845|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
20519823|NCT00574067|Friends Research Institute|Dr. Michael Gordon|410-837-3977|mgordon@friendsresearch.org|251
20519824|NCT01261624|Italfarmaco S.p.A.|Clinical R&D Director|026443|p.bettica@italfarmaco.com|2584
20519825|NCT04155073|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
20519826|NCT02013531|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20519827|NCT00939627|Vanderbilt Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
20519828|NCT03396874|University of Michigan|Morand Piert|734-936-5385|mpiert@med.umich.edu|
20519829|NCT00444821|Medtronic|Kristel Wittebols|707-591-3275|kristel.wittebols@medtronic.com|
20519830|NCT00941720|CCCC|Dr. Ronald Sobecks|216-444-6833|sobeckr@ccf.org|
20530373|NCT00243243|US Army Institute of Surgical Research|David G. Baer, PhD, Director Research|210-539-4327|david.g.baer@us.army.mil|
20530374|NCT02709317|University of Pennsylvania|James McKay|215-746-7704|jimrache@upenn.edu|
20530375|NCT00423046|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530376|NCT01791595|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20530377|NCT03329885|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|clinical.trials@bms.com|
20530378|NCT02027025|Sun Pharma Advanced Research Company Limited|Mudgal Kothekar|912266455645|mudgal.kothekar@sparcmail.com|
20530379|NCT00193375|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
20530380|NCT00828711|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20530381|NCT03883386|University of Michigan Medical School|Professor Kelly Walkovich|734-647-2893|kwalkovi@med.umich.edu|
20530382|NCT01326871|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20530383|NCT01387269|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
20530384|NCT01712711|Tehran University of Medical Sciences|Professor Raika Jamali|00982163120000|jamalira@tums.ac.ir|411
20530385|NCT01200329|UT MD Anderson Cancer Center|Yago Nieto/Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
20530386|NCT00677898|VA VISN 5 Mental Illness Research, Education and Clinical Center|Julie Kreyenbuhl, Pharm.D., Ph.D.|410-637-1864|Julie.Kreyenbuhl@va.gov|
20530387|NCT00525837|Butler Hospital|Noah S. Philip MD|401-455-6258|noah_philip@brown.edu|
20530388|NCT03087058|Vifor Pharma, Inc.|EMERALD Clinical Study Team|+41 588 518 000|EMERALD.study@viforpharma.com|
20530389|NCT01141608|UT Southwestern Medical Center|Dr. Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
20530390|NCT02078817|University of Minnesota|Katherine Cullen|612-273-9732|rega0026@umn.edu|
20530391|NCT02753881|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
20530392|NCT00506675|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-975-8690|pedig@jaeb.org|
20530393|NCT01441973|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20530394|NCT01149655|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20530395|NCT01265498|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
20530396|NCT01502085|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20530397|NCT03684408|University of Missouri|Megha Garg MD|573-882-1026|gargmeg@health.missouri.edu|
20530398|NCT00545025|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530399|NCT00617279|W. L. Gore & Associates, Inc.|Chad Badorek, Clinical Study Manager|928.864.3486|cbadorek@wlgore.com|
20530400|NCT00733278|LA BioMed|Dr. Anita Nelson||anitanelsonwhc@earthlink.net|
20530401|NCT05994963|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530402|NCT01898078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20530403|NCT00542308|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20530404|NCT01075048|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20530405|NCT02305316|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20530406|NCT00761319|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20530407|NCT02741284|Washington University in St Louis|Dr Nandini Raghuraman|314 362 7300|nraghuraman@wustl.edu|
20530408|NCT00183339|University of North Carolina|Linmarie Sikich, MD|919 966 8653|Lsikich@med.unc.edu|
20530409|NCT01715831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20530410|NCT03563222|Fresenius Kabi Germany|Jean-Marc Lohse, PhD|+49 6172|jean-marc.lohse@fresenius-kabi.com|4911
20530411|NCT00900562|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
20530412|NCT03098979|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20530413|NCT02419807|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Stephen Grobmyer|1-866-223-8100|TaussigResearch@ccf.org|
20530414|NCT01065818|Columbia University|K.S. Clifford Chao, MD|212-305-9987|ksc2119@cumc.columbia.edu|
20530415|NCT02202252|Diskapi Training and Research Hospital|Melih Akinci, MD, Associate Prof|90 312 5962080|melihakinci@yahoo.com|
20530416|NCT04459338|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
20530417|NCT03157089|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530418|NCT00784875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20530419|NCT00853385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530420|NCT01951950|Northwestern University|John F. Bebawy, MD, Principal Investigator|312-695-0061|j-bebawy@northwestern.edu|
20530421|NCT00941928|University of Texas MD Anderson Cancer Center|Anna Franklin, MD, Assistant Professor|713-792-3497|rnjackso@mdanderson.org|
20530422|NCT00470548|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
20530423|NCT03073486|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20530424|NCT02300610|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jingsong Zhang|813-745-3973|jingsong.zhang@moffitt.org|
20530425|NCT01829347|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
20530426|NCT04018066|Rutgers, The State University of New Jersey|Dr. Diana Roopchand, Study Investigator|8489320248|roopchand@sebs.rutgers.edu|
20530427|NCT05052580|Duke Clinical Research Institute|Tara Mann, PhD, RN|(919) 668-5111|schoolSETstudy@duke.edu|
20530428|NCT03181308|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
20530429|NCT03248297|University of Alabama at Birmingham|Alan Tita, MD|205-934-5612|atita@uab.edu|
20530430|NCT03530293|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20530431|NCT01663623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20564953|NCT03526887|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20564954|NCT03663569|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20564955|NCT04979442|Rain Oncology|Clinical Research|7082323791|clinicalresearch@rainoncology.com|
20564956|NCT04506307|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20519831|NCT01748955|New York State Psychiatric Institute|Michael F. Grunebaum, MD|6467747573|mgruneb@nyspi.columbia.edu|646
20519832|NCT01998243|Hospital severo ochoa|Dr Luis Ramon Rabago Torre|34914818000|lrabagot@gmail.com|8326
20519833|NCT00268892|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20530432|NCT00686972|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20530433|NCT02219256|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20530434|NCT04465422|Taipei City Hospital|Shu Chun Lee|+886 2 27263141|A1057@tpech.gov.tw|1004
20530435|NCT02667639|Monitor CRO|Murat Özdemir|902122341260|murato@monitorcro.com|
20530436|NCT02182804|Division of Gastroenterology. Department of Medicine. Faculty of Medicine. Chulalongkorn University.|Dr. Piyapan Prueksapanich|6622564000|mpkus1@gmail.com|81001
20530437|NCT02679976|Johnson & Johnson Vision Care Inc.|Tom Karkkainen SR. PRINCIPAL RESEARCH OPTOMETRIST|904-443-3500|TKarkkai@its.jnj.com|3402
20530438|NCT05412134|Duke University|Jason Lang, MD|919-684-3364|jason.lang@duke.edu|
20530439|NCT03072186|Ohio State University Wexner Medical Center|Dr. Daniel Prevedello, MD|(614) 293-7190|Daniel.Prevedello@osumc.edu|
20530440|NCT01218802|Case Western Reserve University|Grace McComsey, MD|2168442739|gam9@case.edu|
20530441|NCT01123655|Memphis VAMC|Arnold E. Postlethwaite,MD Principal Investigator|901 448 5774|apostlet@uthsc.edu|
20530442|NCT00062166|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
20530443|NCT01894906|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
20530444|NCT02368132|Corporal Michael J Crescenz VA Medical Center|Dr. Shahrzad Mavandadi|215.823.5211|shahrzad.mavandadi@va.gov|
20530445|NCT01776554|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20530446|NCT01041859|Janssen Research&Development|Director, Clinical Leader|609-730-6777||
20530447|NCT00595361|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
20530448|NCT01991795|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20530449|NCT06119854|CityUNYSPH|Denis Nash|3473316554|denis.nash@sph.cuny.edu|
20530450|NCT03638323|Groupe Hospitalier de la Rochelle Ré Aunis|Marie-Laure Vignaud, neuropsychologist|+33 (0)5 46 45 63 70|marie-laure.vignaud@ght-atlantique17.fr|
20530451|NCT00251758|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20530452|NCT02147301|University of California, San Francisco|Curt Johanson|415-353-2310|curt.johanson@ucsf.edu|
20530453|NCT01471626|CHU St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@tpierre-bru.be|
20530454|NCT03641508|University of Iowa|Dr. Ericka Lawler|3193563943|ericka-lawler@uiowa.edu|
20530455|NCT02404545|Baptist Health South Florida - Miami Cancer Institute|Murugesan Manoharan MD, FRCS (Eng), FRACS (Urol)|305-595-2141|mmanoharan@baptisthealth.net|
20530456|NCT02577029|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20530457|NCT02764801|Thomas Jefferson University|John Eisenbrey, PhD|(215) 503-5188|John.Eisenbrey@jefferson.edu|
20530458|NCT01274351|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20530459|NCT00535613|University of Wisconsin|Cari Meyer|(608) 265-5980|cmeyer@wisc.edu|
20530460|NCT01296412|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20530461|NCT02160626|Aclaris Therapeutics Inc.|Judith Schnyder|+1-484-329-2144|jschnyder@aclaristx.com|
20530462|NCT03415152|Abbott Laboratories|Irina Solnyshkina|+7 (495) 258-42 80|irina.solnyshkina@abbott.com|
20530463|NCT05471505|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530464|NCT01258374|Hospital Clinic|Dr. Josep Mallolas Masferrer|00 44 93 227 54 00|mallolas@clinic.cat|3312
20530465|NCT04596293|Bridge Biotherapeutics, Inc.|Clinical Trial Lead|031-8092-3280|clinicaltrials.gov_inquiries@bridgebiorx.com|
20530466|NCT02765035|Otto Bock Healthcare GmbH|Director of Clinical Research and Services Vienna|+4315233786733|Milana.Mileusnic@Ottobock.com|
20530467|NCT01381120|Barrie Urology Associates|Dr. Joseph Zadra||joezadra@rogers.com|
20530468|NCT03703895|Center for Clinical and Cosmetic Research|Dr. Mark Nestor|3059336716|nestormd@admcorp.com|
20530469|NCT02732639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20530470|NCT01668797|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20519834|NCT02732691|JenaValve Technologies Inc.|Vinny Podichetty, Vice President: Clinical & Med Affairs|949-767-2110|podichetty@jenavalve.com|1050
20519835|NCT02244424|Michigan State University, College of Nursing|Dr. Mildred A. Horodynski|(517) 355-6744|millie@msu.edu; silkk@msu.edu|
20519836|NCT03366194|Esthetic Education LLC|Study Coordinator|(480) 656-2251|Support@skinstylus.com|
20519837|NCT03291041|Vanda Pharmaceuticals|Vanda Pharmaceuticals|2027343400|clinicaltrials@vandapharma.com|
20519838|NCT01447225|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20519839|NCT00096122|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
20519840|NCT03183141|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
20519841|NCT04052698|Octapharma|Dr. Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
20519842|NCT02756637|Abramson Cancer Center of the University of Pennsylvania|John Christodouleus|215-662-2428|John.Christodouleas@uphs.upenn.edu|
20519843|NCT06442410|Medtronic|Thanh Tran|7278082652|thanh.tran2@medtronic.com|
20519844|NCT01507090|Children's Mercy Hospital|Principal Investigator|816-234-3059|srahman@cmh.edu|
20530471|NCT02515227|University of Virginia|Craig Slingluff, MD|434 924-9311|cls8h@uvahealth.org|
20530472|NCT05998967|VA San Diego HCS|Ariel J Lang, PhD, MPH|(858) 552-8585|ariel.lang@va.gov|
20530473|NCT03316105|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
20530474|NCT00513799|Washington University|Stephanie Fritz|314-454-6050|fritz_s@kids.wustl.edu|
20530475|NCT02834975|University of Miami|Abdulrahman Sinno, MD|+1 (305) 2432233|ak.sinno@med.miami.edu|
20530476|NCT03451071|University of Alabama at Birmingham|Haller Smith|205-934-4986|hjsmith@uabmc.edu|
20530477|NCT01856933|Brown University Oncology Research Group (BrUOG)|Heinrich Elinzano, MD|4018633000|kayla_rosati@brown.edu|
20530478|NCT03482024|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20530479|NCT00217490|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD|503 335 6751|victor.j.stevens@kpchr.org|
20530480|NCT03363906|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20530481|NCT00676143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530482|NCT03937778|National Center for Complementary and Integrative Health|Chesler, Alexander|+1 301 594 1049|alexander.chesler@nih.gov|
20530483|NCT00929669|University of Pennsylvania|Peter J. Snyder, MD|215-898-0208|pjs@mail.med.upenn.edu|
20530484|NCT03261999|Foresee Pharmaceuticals Co., Ltd|John Mao|+886 2-7750-0188|john.mao@foreseepharma.com|
20530485|NCT02714153|Yale School of Medicine|Jude Clancy, MD Associate Professor Term; Director, Lead Management Program|(203) 785-4126|jude.clancy@yale.edu|
20530486|NCT01901185|Amgen Inc.|Study Director|866-572-6436||
20530487|NCT02318264|SUNY Upstate Medical|Michelle Dolphin, Associate Professor|315 464 6917|dolphinm@upstate.edu|
20530488|NCT02065557|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20530489|NCT00250588|CCHMC|Michael Seid|5138030083|michael.seid@cchmc.org|
20530490|NCT00706797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20530491|NCT02330341|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20530492|NCT03502798|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
20530493|NCT03307174|University of California San Francisco|Paul Su|415-885-7246|paul.su@Ucsf.edu|
20530494|NCT01192815|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
20530495|NCT03444584|MedImmune, LLC|Armando Flor|+1-301-398-1955|information.center@astrazeneca.com|
20530496|NCT00863707|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20564957|NCT04005794|Vanderbilt University|Dr. Sohee Park, Professor of Psychology and the principal investigator|615 322 3435|sohee.park@vanderbilt.edu|
20530497|NCT01142336|University of Washington|Ge Li, MD, PhD|(206) 764-2485|gli@uw.edu|
20530498|NCT01704261|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20530499|NCT02722967|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
20530500|NCT00808340|Vistakon|Tom Karkkainen, OD|904-443-3402||
20530501|NCT02783911|LomaLindaU|Dr. Jung-Wei Chen, Program director|9095584690|jwchen@llu.edu|85909
20530502|NCT01048424|University of California, San Francisco|Alison Huang, MD|415-353-9751|ahuang@medicine.ucsf.edu|
20530503|NCT00467519|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20530504|NCT01307813|University Hospitals Cleveland Medical Center|Jeffrey Marks, MD - General Surgeon|216-983-4930|Jeffrey.Marks@uhhospitals.org|
20530505|NCT00747214|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
20530506|NCT04264208|Stanford University|Andrei Iagaru, MD|(650) 725-4711|aiagaru@stanford.edu|
20530507|NCT02475369|BIDMC|Caitlin Barrett|617-667-8266|cbarret5@bidmc.harvard.edu|
20530508|NCT02075125|Department of Cardiology, College of Medicine, Dong-A University.|Dr. Moo Hyun Kim; Director of Global Clinical Trial Center Dong-A University Hospital.|+82 (51) 240-2976|kimmh@dau.ac.kr|
20530509|NCT00885118|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530510|NCT03642990|University of Iowa|Donna L. Hammond, Ph.D Professor|319-335-9595|donna-hammond@uiowa.edu|
20530511|NCT00094445|University of Texas (UT) MD Anderson Cancer Center|Vivek Subbiah, MD / Assistant Professor, Investigational Cancer Therapeutics|713-563-0393|CR_Study_Registration@mdanderson.org|
20530512|NCT02717195|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20530513|NCT00855218|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
20530514|NCT00942786|Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Austria|Elisabeth Mahla, MD|++43316385|elisabeth.mahla@medunigraz.at|13027
20530515|NCT00769561|Department of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Germany|Dr. Meike Shedden Mora|+49-6421-282|m.shedden@staff.uni-marburg.de|3657
20530516|NCT02941640|University Clinical Center Tuzla|Samir Delibegovic|+387 61 149 131|delibegovic.samir@gmail.com|
20530517|NCT02858908|AMO Pharma Ltd.|Dr. Mike Snape, Chief Scientific Officer|+44 (0) 7775915639|mike.snape@amo-pharma.com|
20530518|NCT03824561|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20530519|NCT03191552|Department of Physical medicine and Rehabilitation, Marmara University School of Medicine, Istanbul,Turkey|Esra Giray|+90216624545|girayesra@hotmail.com|6515
20530520|NCT04865588|Icahn School of Medicine at Mount Sinai|Director of The Zena and Michael A. Wiener Cardiovascular Institute|(212) 241-4021|samin.sharma@mountsinai.org|
20564958|NCT03287336|GW University|Homa K. Ahmadzia|2027412500|homa.khorrami@gmail.com|
20564959|NCT00104676|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
20564960|NCT05622812|Q-Med AB|Head of Development|1-817-961-5000|reception.seupp@galderma.com|
20564961|NCT03828799|Institut régional du Cancer de Montpellier|Representative of sponsor|467612446|aurore.moussion@icm.unicancer.fr|+33
20564962|NCT06232590|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
20530521|NCT02370511|Mayo Clinic|Dr. Mayra Guerrero|507-255-1267|Guerrero.Mayra@mayo.edu|
20530522|NCT01162733|Christiana Care Health System|Deb Marco|302 733-4130|dmarco@christianacare.org|
20530523|NCT03092752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530524|NCT03882918|Ovid Therapeutics Inc|Julia Tsai, PhD|(203) 623-1996|jtsai@ovidrx.com|
20530525|NCT06996301|Doc Lab Inc|Roel Chavez|971 570-4008|roel@doclabinc.com|
20530526|NCT04030598|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20530527|NCT03658980|Hiroshima University|Zara Khair|+8801715342168|zara.oikee@gmail.com|
20530528|NCT03141359|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20530529|NCT02003144|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20530530|NCT00747916|Titus Regional Medical Center|Dr. Gordon Downie|903-572-9050|downieg@trhta.net|
20530531|NCT01419535|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
20530532|NCT00929838|Medical College of Wisconsin|Jennifer Campbell|414-955-8829|jacampbell@mcw.edu|
20530533|NCT02344316|UCSF Pediatric Headache Program|Amy Gelfand, MD|415-885-7832|Amy.Gelfand@ucsf.edu|
20530534|NCT05965752|Duke University|Daniel Laskowitz, MD|919-684-0056|daniel.laskowitz@duke.edu|
20530535|NCT02934178|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20530536|NCT04323592|University of Trieste|Prof. Marco Confalonieri|+393356895168|mconfalonieri@units.it|4667
20530537|NCT02340676|Dana-Farber Cancer Institute|Dr. John Koreth, MBBS, DPhil|(617) 632-2949|John_Koreth@dfci.harvard.edu|
20530538|NCT03944616|University of California, Irvine|Dr. Andrew Odegaard|949-824-8544|aodegaar@hs.uci.edu|
20530539|NCT01287936|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
20530540|NCT00296244|Thomas Jefferson University|Carlo Gerardo B Ramirez, MD|215-955-5909|carlo.ramirez@jefferson.edu|
20530541|NCT00703534|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20530542|NCT00427934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20530543|NCT03860753|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|713-486-2800|jin.ho.yoon@uth.tmc.edu|
20530544|NCT00998946|Spectrum Pharmaceuticals, Inc|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20530545|NCT03424304|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20519845|NCT00932282|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20519846|NCT04034355|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46 732344698|kristina.sjoblom@egetis.com|
20519847|NCT02124902|Washington University School of Medicine|Foluso Ademuyiwa, M.D., MPH|314-362-7201|bisiademuyiwa@wustl.edu|
20519848|NCT01961687|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
20519849|NCT03632135|Cordgenics|Pier Paolo Claudio, MD, Chief Scientific Officer|6064657226|claudio@cordgenics.com|
20519850|NCT02928536|Istituto di Ricerche Farmacologiche Mario Negri|Silvano Gallus, head of the Laboratory of Lifestyle Epidemiology|0039023901|silvano.gallus@marionegri.it|4657
20519851|NCT00546910|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20519852|NCT01467479|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20519853|NCT03815240|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
20519854|NCT01552369|University of Pittsburgh - Medicine - Infectious Diseases|Nina Singh, MD|412-360-1688|nis5@pitt.edu|
20519855|NCT00441350|Menarini Group|Angela Capriati, MD PhD - Global Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
20519856|NCT01679197|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
20519857|NCT04213209|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20519858|NCT00892281|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20519859|NCT01680783|University of Chicago|John P. Kress|7737026790|jkress@medicine.bsd.uchicago.edu|
20519860|NCT02129647|NYU Langone|Theodore Nicolaides|212-263-9959|Theodore.Nicolaides@nyualangone.org|
20519861|NCT01833533|AbbVie|Global Medical Information|800-633-9110||
20519862|NCT00256776|EBMT|Clinical Study Unit|+31(0)715265005|ebmtcsu@lumc.nl|
20519863|NCT00685802|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20519864|NCT03233958|University of Toronto|Barna Konkoly-Thege|+1 (705) 549 3181|konkoly.thege.barna@gmail.com|2614
20519865|NCT03093272|Dana-Farber Cancer Institute|Lauren Harshman, MD|617-632-2429|laurenc_harshman@dfci.harvard.edu|
20519866|NCT00103038|Oregon Health and Science University|Gerda Teglassy, MD|5034945626|tothg@ohsu.edu|
20519867|NCT02502734|GlaxoSmithKline|GSK Response Center|866-435-7343||
20519868|NCT01430819|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20519869|NCT01218984|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
20519870|NCT03095118|Mayo Clinic|Dr. Fernando C. Fervenza|507-266-1045|Fervenza.Fernando@mayo.edu|
20519871|NCT01740791|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20519872|NCT01463982|HanmiPharma|Director of clinical research team|8224109038|jajung@hanmi.co.kr|
20519873|NCT01265667|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
20519874|NCT01483625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519875|NCT01731886|Columbia University|Suzanne Lentzsch, MD, PhD, Professor of Medicine|646-317-4840|sl3440@cumc.columbia.edu|
20519876|NCT02280187|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20519877|NCT02094261|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
20519878|NCT04668274|Marshall A. Hayward, Ph.D., Jupiter Orphan Therapeutics Inc.|David Wyatt|305-547-5857|david.wyatt@syneoshealth.com|
20564963|NCT02433379|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
20530546|NCT00148798|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20530547|NCT04452045|University of California, San Francisco|Lauren Asarnow|(415) 353-2273|lauren.asarnow@ucsf.edu|
20530548|NCT00915525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20530549|NCT01391611|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
20530550|NCT00485303|Janssen Research & Development, 10990 Wilshire Blvd, Suite 1200, Los Angeles, California 90024|Senior Director, Clinical Research|(310) 943-8040||2917
20530551|NCT02879032|Bangabandhu Sheikh Mujib Medical University|Dr. Md. Mashiul Alam|+8801724490475|mashiull@gmail.com|
20530552|NCT02423408|Tonix Pharmaceuticals|Judith Gendreau, Senior Medical Director|858-433-5574|judy.gendreau@tonixpharma.com|
20530553|NCT04232137|Vanderbilt University Medical Center|Dr. Tobias Limperg|(615) 343-6710|tobias.limperg@vumc.org|
20530554|NCT05169905|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20530555|NCT00296335|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20530556|NCT01027845|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530557|NCT03306199|Cardiovascular Institute of the South|Research Team Leader|(985) 873-5613|Deanna.Benoit@cardio.com|
20530558|NCT01670292|Palmer Center for Chiropractic Research|Dr. Ting Xia|563-884-5161|ting.xia@palmer.edu|
20564964|NCT00592852|Massachusetts General Hospital|Gagan Joshi, MD|617-503-1084|joshi.gagan@mgh.harvard.edu|
20564965|NCT00248807|James J Peters VAMC|Dr. Jill M. Wecht; Principal Investigator|718 584-9000|JM.Wecht@va.gov|3122
20530559|NCT01308619|Galderma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
20530560|NCT01603277|KaloBios Pharmaceuticals Inc.|Nestor Molfino, MD|650-243-3100|nmolfino@kalobios.com|
20530561|NCT00087178|NRG Oncololgy|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20530562|NCT04494646|NYU Langone Health|Sripal Bangalore, MD, MHA|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
20530563|NCT01692119|ABDA, Department of Medicine|Dr. Martin Schulz|+49 30 40004-514|arzneimittel@abda.de|
20530564|NCT05569174|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@Novartis.com|
20530565|NCT02465450|Corbus Pharmaceuticals|Ajay Aggarwal, MD|781-250-9176|aaggarwal@corbuspharma.com|
20530566|NCT00112957|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20530567|NCT01258049|Xidea Solutions Limited|Dr Daryl Bendel||daryl@xideasolutions.com|
20530568|NCT02309359|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
20530569|NCT01151436|Galderma|Ma May|+33 4 92 38 67 33|may.ma@galderma.com|
20530570|NCT03895086|Maison de la Recherche en Santé|Mr Thomas RULLEAU|6 35 55 03 35|thomas.rulleau@chu-nantes.fr|+33
20530571|NCT01641042|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530572|NCT00477685|Grewal Eye Institute|S.P.S Grewal, MD|+91-172-5056969|drgrewal@gmail.com|
20530573|NCT03451045|Corbus Pharmaceuticals, Inc.|Head of Clinical Operations|6179630100|info@corbuspharma.com|
20530574|NCT01032928|Ralph H Johnson VA Medical Center|Dr. Bonnie Martin Harris|843-792-0879|Bonnie.Martin-Harris@va.gov|
20530575|NCT02391337|University of Birmingham|Prof. Dipak Kotecha|+44 (0) 7974 115676|d.kotecha@bham.ac.uk|
20564966|NCT03744182|Hanmi Pharmaceutical Co., Ltd.|GAEUN PARK|+824108746|gaeun.park@hanmi.co.kr|8746
20530576|NCT04182958|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20530577|NCT04002791|Apex Heart Institute|Chairman|011 91 9824030576|theheartworld@gmail.com|
20530578|NCT03704064|University of Florida|Dr. Rebecca Pearl, Assistant Professor|352-294-5405|rebecca.pearl@ufl.edu|
20530579|NCT01286129|IUCPQ|Louis-Philippe Boulet, principal investigator|418-656-4747|lpboulet@med.ulaval.ca|
20530580|NCT00830128|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530581|NCT02111200|Baylor|Mahshid Azamian|832-822-1529|azamian@bcm.edu|
20530582|NCT04142242|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20530583|NCT00773357|Yale School of Medicine|Sherry McKee|2037373529|sherry.mckee@yale.edu|
20530584|NCT00846053|Washington University|Thomas Ferkol, MD|314 454 6000||
20530585|NCT00111761|Amgen Inc.|Study Director|866-572-6436||
20530586|NCT01604785|Oregon Health & Science University|David Sheridan|503 494-8311|sheridda@ohsu.edu|
20530587|NCT01092767|Medtronic, Inc., Aortic and Peripheral Vascular|Laura Regan, MPH - Study Lead|707-591-2743|laura.e.regan@medtronic.com|
20530588|NCT00982345|Indiana University|Dr. Amit Anand|317-274-7422|aanand@iupui.edu|
20530589|NCT04798027|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20530590|NCT02121210|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20530591|NCT04609514|Duke University|Roger Vilardaga Viera, PhD|919-684-3441|roger.vilardaga@duke.edu|
20530592|NCT00943436|Healthy Eating and Activity Laboratory- University of Tenneessee|Emily Jokisch|865-974-0754|ejokisch@utk.edu|
20530593|NCT02816723|VA Northern California Health Care System|Juliana Baldo|925-372-4649|Juliana.Baldo@VA.gov|
20530594|NCT02873975|Dana-Farber Cancer Institute|Geoffrey Shapiro M.D., PhDDana-Farber Cancer Institute|617-632-6594|Geoffrey_Shapiro@dfci.harvard.edu|
20530595|NCT01981616|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20564967|NCT03374241|HanmiPharma|khseo@hanmi.co.kr|+82 2 410 9042|khseo@hanmi.co.kr|
20530596|NCT03225287|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20530597|NCT03036267|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
20530598|NCT01499810|Research Institute of Cradiology, Siberian Branch of Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
20530599|NCT05117060|LEO Pharma A/S|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
20530600|NCT05079321|Centre for Ocular Research and Education|Lyndon Jones|(519) 888-4567|lwjones@uwaterloo.ca|35030
20530601|NCT05619471|Enspectra Health|President|650 480-6022|clinical@enspectrahealth.com|
20530602|NCT02074514|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20530603|NCT00032591|Palo Alto CSPCC|Bob Edson|(650) 493-5000|Bob.Edson@va.gov|22250
20530604|NCT04239924|BerbeeWalsh Department of Emergency Medicine|Dr. Manish Shah|608-263-9174|mnshah@medicine.wisc.edu|
20530605|NCT00666237|University of Miami|Steven Gedde, MD|305-326-6435|sgedde@med.miami.edu|
20530606|NCT02543840|VA Boston Healthcare System- Center for Healthcare Organization and Implementation Research|Dr. Mark S. Bauer, MD|857-364-6380|mark.bauer@va.gov|
20530607|NCT05399680|Cordis|Rajesh Nathan|(908) 528-3931|rajesh.nathan@cordis.com|
20530608|NCT03370172|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20530609|NCT05610605|University of Cadiz|Cristina Casals|956016216|cristina.casals@uca.es|
20530610|NCT02936999|Inova Health Services|Regulatory Research Coordinator|(571) 472-0239|elizabeth.gebregeorgis@inova.org|
20519879|NCT03767062|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
20519880|NCT02363439|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20519881|NCT00707447|FIDAM|Norbert Hermanns|0049 7931 594|hermanns@diabetes-zentrum.de|553
20519882|NCT04061577|UCLA|Dr. Mersedeh Bahr Hosseini|3107941195|MBahrHosseini@mednet.ucla.edu|
20519883|NCT02127073|Montefiore Medical Center|Dr. Sheldon Feldman, Chief Breast Surgery and Breast Surgery Oncology|929-246-6300|sfeldman@montefiore.org|
20519884|NCT04625062|New York University|Dr. Tara McAllister|212-992-9445|tkm214@nyu.edu|
20519885|NCT03417830|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20519886|NCT00467987|State University of NY at Buffalo|Paresh Dandona|17165351852|dandona@buffalo.edu|
20519887|NCT01396382|Vanderbilt-Ingram Cancer Center|Dr. Ronald Walker|615-343-8516|ronald.walker@vanderbilt.edu|
20519888|NCT03827018|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
20519889|NCT00775528|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
20519890|NCT02087176|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
20519891|NCT03812991|UMissouri - Missouri Orthopaedic Institute|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20519892|NCT00304707|University of Massachusetts Medical School|David Kalman, PhD|9785782371|kalmand@comcast.net|
20519893|NCT01884688|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
20519894|NCT02938013|Johns Hopkins University School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
20519895|NCT00712244|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20519896|NCT00895037|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519897|NCT01043926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20519898|NCT01931527|Washington University School of Medicine|Elisa Fabbrini, MD, PhD|314-362-8156|efabbrini@dom.wustl.edu|
20519899|NCT02470091|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20519900|NCT02598895|University of Washington/Fred Hutchinson Cancer Center|Dr. Heather Cheng|206-606-7416|hhcheng@uw.edu|
20519901|NCT02210052|Mayo Clinic|Dr. Tim J. Lamer, M.D.|507 778-8760|lamer.tim@mayo.edu|
20519902|NCT01192399|Alexion Pharmaceuticals, Inc|Alexion Pharmaceuticals, Inc||clinicaltrials@alexion.com|
20519903|NCT02389101|Turku Univesrity Hospital, Turku, Finland|Heikki Minn, MD|+35823130000|heikki.minn@utu.fi|30149
20519904|NCT01523587|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519905|NCT01298778|Wake Forest School of Medicine|Dr. Jessica Booth|336-718-8278|jbooth@wakehealth.edu|
20519906|NCT00536484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20519907|NCT03182751|Mayo Clinic|Dr. Brandon Yuan|507-255-6112|Yuan.Brandon@mayo.edu|
20519908|NCT00385788|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20519909|NCT03050697|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20519910|NCT02597582|Taichung Veterans General Hospital|Shih-An Liu|+886-4-23592525|saliu@vghtc.gov.tw|5409
20519911|NCT00423683|North Shore LIJ Health System|Valerie Blake|516-562-0100|vblake@nshs.edu|
20519912|NCT02065713|Instituto Medicina Molecular|Elsa Vieira-Sousa|00351 217999544|elsa-sousa@hotmail.com|47221
20519913|NCT02997657|Brown University School of Public Health|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
20519914|NCT02596321|Abbott|Therapeutic Area Clinical Director|+31294477008|dmitri.kazei@abbott.com|
20519915|NCT01231750|University of Cincinnati|Dr. Faisal Khan|513-558-4272|faisal.khan@uc.edu|
20519916|NCT01117337|Moulana Hospital|Mohamed Ismail, Chief Consultant, Moulana Hospital, Perianthalmanna|0091-9447128511|drgargpankaj@yahoo.com, mdismail13@gmail.com|
20519917|NCT01045993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20519918|NCT01659736|The Institute of Living|Gretchen J. Diefenbach, Ph.D|860-545-7685|Gretchen.Diefenbach@hhchealth.org|
20519919|NCT00276549|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
20519920|NCT00474851|Boston Children's Hospital|Dr. Amy D. DiVasta|617-355-3792|Amy.DiVasta@childrens.harvard.edu|
20519921|NCT04862156|OrganOx|Katerina de Metz|19713442167|katerina.demetz@organox.com|
20519922|NCT01746264|Mayo Clinic|Dr. Seema Kumar|507-538-2724|Kumar.Seema@mayo.edu|
20519923|NCT02791893|Mount Sinai Beth Israel, New York, NY|Dr. Benjamin Natelson|212-844-6768|Benjamin.Natelson@mountsinai.org|
20519924|NCT01570283|Center for Cell and Gene Therapy|Dr. Helen Heslop|832-824-4662|heheslop@txch.org|
20519925|NCT04051463|Cornea Research Foundation of America|Marianne Price|317-814-2990|mprice@cornea.org|
20530611|NCT00753519|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
20519926|NCT04943159|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
20519927|NCT02017860|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20519928|NCT03738020|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
20519929|NCT01048502|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
20519930|NCT00493454|The University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
20519931|NCT02593396|UNIVERSITY MALAYA|Dr. Anne Yee|+60379492068|annyee17@um.edu.my|
20519932|NCT02462486|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
20519933|NCT00277524|Medtronic Cardiac Rhythm Disease Management|Melinda Hoey, Clinical Research Specialist|763-526-2831|Melinda.hoey@medtronic.com|
20519934|NCT02310763|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20519935|NCT04647383|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20519936|NCT04099641|OncXerna Therapeutics, Inc.|CDO, OncXerna Therapeutics, Inc.|(781) 907-7810|medical@oncxerna.com|
20519937|NCT02063087|Mayo Clinic|Dr. Erik Hess|507-255-6501|hess.erik@mayo.edu|
20519938|NCT04072315|Pliant Therapeutics, Inc.|Éric Lefebvre, M.D., Chief Medical Officer|1-650-481-6779|ELefebvre@pliantrx.com|
20519939|NCT00303667|Masonic Cancer Center|Sarah Cooley, M.D.|612-626-4024|cool0023@umn.edu|
20519940|NCT01029392|William Beaumont Hospital|Dr. Peter Gerrits|248-551-0487|peter.gerrits@beaumont.org|
20519941|NCT01103479|Northwestern University|Kenzie A. Cameron|312-503-3910|k-cameron@northwestern.edu|
20519942|NCT01770431|Huazhong University of Science and Technology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong Wuhan, Hubei, China|Xiaoping Chen, Professor|+86 27 83663400|chenxp@medmail.com.cn|
20519943|NCT02549573|US WorldMeds|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
20519944|NCT00161382|The University of Texas Health Science Center at Houston (UTHealth) School of Public Health|Dr. Susan R. Tortolero|713-500-9634|Susan.Tortolero@uth.tmc.edu|
20519945|NCT02083926|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
20519946|NCT02610816|Cincinnati Childrens Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|Marc.Rothenberg@cchmc.org|
20519947|NCT02919813|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
20519948|NCT00384176|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20519949|NCT00842530|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
20519950|NCT02939950|Bausch Health Americas, Inc.|Director of Clinical Operations|(585) 338-5306|Daniel.Donatello@bausch.com|
20519951|NCT00440115|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
20519952|NCT02377063|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD - Principal Investigator|310-206-1987|zli@mednet.ucla.edu|
20519953|NCT01524913|Emory University|Gary Bouloux, MD, DDS|404-778-4500|gfboulo@emory.edu|
20519954|NCT00702208|CUNY School of Public Health, Hunter College|Heidi Jones|212-396-7750|hjon@hunter.cuny.edu|
20519955|NCT02767934|University of Washington|Dr. Ryan Cassaday|206-606-1202|cassaday@seattlecca.org|
20519956|NCT00402025|Amgen, Inc.|Study Director|866-572-6436||
20519957|NCT02409329|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
20519958|NCT04290494|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519959|NCT02369354|Duke University School of Medicine|Dr. L. Ebony Boulware|919-613-2099|ebony.boulware@duke.edu|
20519960|NCT03078478|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20519961|NCT04184999|SR Cornea Consultants|Dr. Sanjay Rao|8476685498|sanjaynraomd@gmail.com|
20519962|NCT01172821|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20519963|NCT02642237|Radboud university medical centre|Matthijs Kox|+31243653881|matthijs.kox@radboudumc.nl|
20519964|NCT02953678|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20519965|NCT00380757|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
20519966|NCT03064438|Accuitis, Inc.|Chief Science Officer|678-812-1492|info@accuitis.com|
20519967|NCT01937351|Avinger|Thomas Lawson|650.241.7030|tlawson@avinger.com|
20519968|NCT01432574|H. Lee Moffitt Cancer Center and Research Institute|Anna Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
20519969|NCT01042535|H. Lee Moffitt Cancer Center and Research Institute|Hatem Soliman, M.D.|813-745-4933|hatem.soliman@moffitt.org|
20519970|NCT00682617|Oregon Health & Science University|Dr. Nels Carlson|(503) 494-6420|carlsonn@ohsu.edu|
20519971|NCT00107042|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20519972|NCT03919448|Laboratorios Richmond|Regulatory Affairs Department|(+54 11) 5555 - 1600|info@richmondlab.com|
20519973|NCT03341546|NHS Tayside|Mark Worrall|01382632177|markworrall@nhs.net|
20519974|NCT03438539|University of Kentucky|Craig Rush, Ph.D.|859-257-5388|crush2@uky.edu|
20519975|NCT01221090|Scott & White Hospital|Dr. Samuel N. Forjuoh|(254) 771-7695|SFORJUOH@sw.org|
20519976|NCT00440466|J&J PRD|Peter Bowers|908-927-2116||
20519977|NCT00655850|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
20519978|NCT00140413|Children's Hospital Los Angeles|Dr. Mark Borchert|323-361-6219|mborchert@chla.usc.edu|
20519979|NCT02459665|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
20519980|NCT02062801|Sharp HealthCare|Dr. David R. Gambling|858-395-5668|david.gambling@sharp.com|
20519981|NCT01223235|Memorial Sloan Kettering Cancer Center|Dr. Paul Sabbatini, MD|212-639-4016|sabbatip@mskcc.org|
20519982|NCT00156715|Dartmouth Medical School|Christopher OKeefe, M.A|603-271-5287|chris.okeefe@hitchcock.org|
20519983|NCT00865098|Merck Serono Co., Ltd, Tokyo, Japan|Masataka Ota|+81 0 3 6853 8611||
20519984|NCT00099268|Novartis Pharmaceuticals|Study Director|862 778-8300||
20519985|NCT01360866|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|609 524 6788|clinicaltransparency@otsuka-us.com|
20530612|NCT01750502|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou,China|Dr. JiFei Tang|15968766021|jiftang@126.com|
20530613|NCT01171534|University of Missouri, Department of Orthopaedic Surgery|Gregory J. Della Rocca, MD, PhD, FACS|573-882-6562|dellaroccag@health.missouri.edu|
20530614|NCT03861039|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20530615|NCT01113749|University of North Carolina Chapel Hill|Laura C. Hanson, MD, MPH|9199665945|lhanson@med.unc.edu|
20530616|NCT03427892|UTexasSouthwestern|Dr. E. Sherwood Brown|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
20530617|NCT03255187|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
20530618|NCT02034006|Novartis Pharmaceuticals|Study Director|862-778-8300||
20530619|NCT02100631|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research||dcassie@ebsi.com|
20530620|NCT01125930|University of Michigan|Dr. Lisa Maier|734-936-4192|maierl@med.umich.edu|
20530621|NCT04319224|Jounce Therapeutics, Inc.|Stew Kroll, Chief Development Officer|(650) 576-9679|skroll@jouncetx.com|
20530622|NCT03617588|Theragnostics Ltd|Director of Clinical Operations|+44 330 606 7437|archie.hale@theragnostics.com|
20530623|NCT03261401|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20530624|NCT01715298|Novartis Pharmaceuticals|Study Director|862-778-8300||
20564968|NCT04770402|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20564969|NCT02589795|Imperial College London|Research Integrity Officer|020 7594 1872|rgit@imperial.ac.uk|
20564970|NCT04942613|University of Colorado Denver, Anschutz Medical Campus|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
20564971|NCT04909801|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20564972|NCT02505984|Massachusetts General Hospital|Dr. Sharon Dekel|617-726-1352|sdekel@mgh.harvard.edu|
20564973|NCT03687086|University of California, Los Angeles and VA Greater Los Angeles Healthcare System|Dr. Constance Fung|818 891-7711|Constance.Fung@va.gov|39311
20564974|NCT00321048|Indiana University|Richard Zellars|3179444505|rzellars@iu.edu|
20564975|NCT02038777|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20564976|NCT04299464|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20564977|NCT05299242|University of Oxford|Prof. Sally Hopewell|+441865223458|sally.hopewell@csm.ox.ac.uk|
20564978|NCT04777721|University of Oxford|Professor Helen McShane|01865 617606|helen.mcshane@ndm.ox.ac.uk|
20564979|NCT03916276|The University of Queensland|Dr. Melissa Day, Co-Principal Investigator|+61 7 3365 6421|m.day@uq.edu.au|
20564980|NCT04971109|SIGA Technologies|Emily Blum, Director of Clinical Development|541-224-1305|eblum@siga.com|
20564981|NCT02641639|Mateon Therapeutics Inc|CEO|(650) 635-7000|ir@oncotelic.com|
20564982|NCT03664700|Oxford University Hospitals|Dr Vassilis Athanassoglou|01865|vassilis.athanassoglou@ouh.nhs.uk|221590
20564983|NCT03528928|Womens Health|Teresa Brousseau|866-432-4400|tbrousseau@isapin.com|
20564984|NCT05233800|MedStar Health Research Institute|Hannah Arem, Scientific Director, Implementation Science|2028932430|hannah.arem@medstar.net|
20564985|NCT05123586|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20564986|NCT04487860|Aché Laboratórios Farmacêuticos S.A|Dr. Fabio Ikedo|55 11 26086933|fabio.ikedo@ache.com.br|
20564987|NCT04036253|Biosidus S.A.U.|Director of Clinical Trials|+541149098044|v.berstein@biosidus.com.ar|
20519986|NCT03702049|University of California, Irvine, Sue & Bill Gross School of Nursing|Adeline M Nyamathi|(949) 824-8932|anyamath@hs.uci.edu|
20519987|NCT01057381|Baylor College of Medicine|Olutoyin A. Olutoye, M.D., M.Sc.|(832) 824-5800|oao@bcm.edu|
20519988|NCT03647046|University of Rochester|Study Coordinator|(585) 276-6922|keratoconusstudy@gmail.com|
20519989|NCT00918463|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
20519990|NCT01784666|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
20519991|NCT01014624|Daiichi Sankyo, Inc.|Brian Baker|973-944-2712|bbaker@dsi.com|
20519992|NCT01715896|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
20519993|NCT02834806|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
20519994|NCT01004042|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
20519995|NCT04578886|University of Alabama at Birmingham, Department of Anesthesiology and Perioperative Medicine|Dr. Andrew B. Barker, MD|205-934-6007|abbarker@uabmc.edu|
20519996|NCT03336242|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
20519997|NCT04136951|Columbia University|Maxim Topaz, PhD, Elizabeth Standish Gill Associate Professor of Nursing|6462760460|mt3315@cumc.columbia.edu|
20519998|NCT02457611|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20519999|NCT00384293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520000|NCT03005067|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20520001|NCT00296491|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520002|NCT02560779|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|
20520003|NCT01835379|Smith & Nephew, Inc.|Vice President, Medical & Clinical Affairs|817-302-3914|jaime.dickerson@smith-nephew.com|
20520004|NCT02296853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20520005|NCT02010255|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20520006|NCT01067716|Abbott Medical Optics|Amelia Saliba|408-273-4158|amelia.saliba@amo.abbott.com|
20520007|NCT02646917|Crown Laboratories, Inc.|Thomas Hitchcock, PhD|8883723982|THitchcock@crownlaboratories.com|
20520008|NCT00396331|Genzyme|Medical Monitor||medinfo@genzyme.com|
20530625|NCT02058095|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
20530626|NCT01499511|Imperial College London|Professor Peter Sever|02075941100|p.sever@imperial.ac.uk|
20530627|NCT01653418|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20530628|NCT02842866|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20530629|NCT01432327|Katholieke Universiteit Leuven|Karen Van Hoye|0032498617141|Karen.Vanhoye@faber.kuleuven.be|
20530630|NCT03248037|Cornea Research Foundation of America|Marianne Price|3178142990|mprice@cornea.org|
20530631|NCT00577408|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|edward.nunes@nyspi.columbia.edu|
20530632|NCT03720119|Sofar|Dr Laura Patrucco|+39 02909362|laura.patrucco@sofarfarm.it|1
20530633|NCT01944423|Univeristy of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
20530634|NCT02897349|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530635|NCT01289522|Centre Antoine Lacassagne|Pr. Joël GUIGAY|+33492031000|joel.guigay@nice.unicancer.fr|
20530636|NCT03113955|Zhongda Hospital Southeast University|Dr. Gaojun Teng|13805171500|gjteng@vip.sina.com|+86
20530637|NCT03055013|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20530638|NCT03435055|University of Michigan|Richard Harris|734-998-6996|reharris@umich.edu|
20530639|NCT01951066|Wilmer Eye Institute, Johns Hopkins University School of Medicine|[Peter A. Campochiaro|(410) 955-5106|pcampo@jhmi.edu|
20530640|NCT03817528|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-5340|marlene.carlson@nyspi.columbia.edu|
20530641|NCT01604772|Memorial Sloan Kettering Cancer Center|Alan Ho, M.D.||hoa@mskcc.org|
20530642|NCT00827567|Penn State|Allan Lipton, MD|717-531-5960|alipton@psu.edu|
20530643|NCT04418947|University of Pennsylvania|Dr. Anne Cappola|2155735359|acappola@pennmedicine.upenn.edu|
20530644|NCT01259245|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
20530645|NCT00204737|University of Wisconsin - Madison|Catherine Johnson|608-280-7084|catherine.johnson2@va.gov|
20530646|NCT00368550|University of Pennsylvania|Henry R. Kranzler, M.D.|215-222-3200|kranzler_h@mail.trc.upenn.edu|137
20530647|NCT03072550|DeviceFarm|Jeffrey N Roe|925-895-1584|jeffnroe1@devicefarmtech.com|
20530648|NCT02410629|University of California Irvine|Dr An Do|(714) 456-2332|and@uci.edu|
20530649|NCT05282823|Boston Scientific|Clinical Trial Manager|+6564188833|jamie.kwek@bsci.com|
20530650|NCT04456920|INSTITUT REGIONAL DU CANCER DE MONTPELLIER|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
20530651|NCT06290180|Cambridge Health Alliance|Heather Gray|(617) 575-5612|hgray@cha.harvard.edu|
20530652|NCT06129149|The Ohio State University|Christine Kimpel|614-247-1195|kimpel.28@osu.edu|
20530653|NCT04649359|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530654|NCT04656652|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo_us@daiichisankyo.com|
20530655|NCT05595369|Duke University|Kanecia Zimmerman, MD, PhD, MPH|919-668-8651|kanecia.zimmerman@duke.edu|
20530656|NCT02326064|Centre Hospitalier Départemental Vendée|Dr. Guillaume DUCARME|0251446161|guillaume.ducarme@ght85.fr|
20530657|NCT03040726|The University of Texas MD Anderson Cancer Center|Dr. David Hui|(713) 792-6258|dhui@mdanderson.org|
20530658|NCT02908347|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|36
20530659|NCT03104374|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20530660|NCT03210714|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20530661|NCT02867592|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20530662|NCT00803179|UMass Medical School|Michael Stalvey, MD, Principal Investigator|508-856-4280|mstalvey@peds.uab.edu|
20530663|NCT04158648|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20530664|NCT00909870|Shire Regenerative Medicine|Mollie Carter, MD, Medical Director|(858) 754-5678|mcarter@shire.com|
20530665|NCT01773928|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
20530666|NCT03054428|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20530667|NCT03759379|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20530668|NCT02659865|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20530669|NCT02325414|Northwestern University|Dr. Thomas Schnitzer|312-503-4043|tjs@northwestern.edu|
20530670|NCT05722522|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20530671|NCT04817189|Helsinn|Alessandro Alonzi, Medical Advisor|+41793262091|Alessandro.Alonzi@helsinn.com|
20530672|NCT03834961|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
20530673|NCT02555254|CHU Nantes|Jean-Baptiste Lascarrou|+33251446572|jeanbaptiste.lascarrou@chu-nantes.fr|
20530674|NCT04736199|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20530675|NCT02775851|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|sbellasea@fredhutch.org|
20530676|NCT05918055|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
20530677|NCT04771754|Chelsea and Westminster Hospital NHS Foundation Trust|Dr Ruth Byrne|02033152560|ruthbyrne@nhs.net|
20530678|NCT00959751|NeurAxon, Inc.|Thomas Lategan, PhD|417-673-6697|tlategan@neuraxon.com|
20530679|NCT01708603|Bausch Health|Study Director|510-259-5284||
20530680|NCT00906243|University of Florida|Dr. Johannes Vieweg|352 273-6815|j.vieweg@urology.ufl.edu|
20530681|NCT03177395|Pharmacology, Therapeutics and Toxicology Unit, Centre for Cardiovascular Science, University of Edinburgh, UK|Dr James Dear|+44(0)131 242 9214|james.dear@ed.ac.uk|
20530682|NCT01027949|United Therapeutics|Louis Holdstock, PhD|919-425-8866|lholdstock@unither.com|
20564988|NCT06085547|Michigan State University|Dr. Todd Lucas|810-600-5629|lucastod@msu.edu|
20530683|NCT03315949|College of Medicine, The Catholic University of Korea|Dr. Tae-Geun Gweon|82 32 340 2228|gweontae@naver.com|
20530684|NCT02052635|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20530685|NCT01712178|AbbVie|Global Medical Services|800-633-9110||
20530686|NCT00856180|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
20530687|NCT00671749|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
20530688|NCT01200355|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
20530689|NCT00754923|OSU|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
20530690|NCT01281306|Novartis|Study Director|862-778-8300||
20530691|NCT01401322|Stanford University|Bruno C. Medeiros|650-498-6000||
20530692|NCT00486044|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-280-7000|cmc@medicine.wisc.edu|
20530693|NCT03466346|University of California San Francisco|Susan Meffert MD, MPH; Professor of Psychiatry; MPI|4158765455|susan.meffert@ucsf.edu|
20530694|NCT01206764|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20530695|NCT02456896|AIIMS, Bhubaneswar, India|Dr. Rituparna Maiti|9438884191|rituparnamaiti@gmail.com|
20530696|NCT00997893|University of Illinois at Chicago|Dr. Pauline Maki|312 996-6941|pmaki1@uic.edu|
20530697|NCT00961415|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20530698|NCT00226655|Celtic Pharma Development Services America Inc|Director Medical Sciences|(212) 616 4016|henk-andre.kroon@dev.celticpharma.com|
20530699|NCT05911841|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20530700|NCT03025035|Cedars-Sinai Medical Center|Yuan Yuan, MD, PhD|3108888680|yuan.yuan@cshs.org|
20530701|NCT05892341|ConvaTec Inc.|Cristin Taylor, Senior Director, Medical Affairs, Advanced Wound Care|1-800-422-8811|cristin.taylor@convatec.com|
20530702|NCT04373031|Providence Portland Medical Center|Dr. David Page|503-215-1979|canrsrchstudies@providence.org|
20530703|NCT05597865|Washington University in St. Louis|Rachel Brathwaite|3147282869|rachel.brathwaite@yahoo.com|
20530704|NCT05063448|Colorado State University|Dr. Stephanie Rayburn|970-988-6306|Stephanie.Rayburn@colostate.edu|
20530705|NCT05469438|University Hospitals Cleveland Medical Center (Case Western Reserve University)|Kylie Phillips (Clinical Research Regulatory Specialist III)|(440)328-7964|kylie.phillips@uhhospitals.org|
20530706|NCT04777331|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20530707|NCT02642042|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
20530708|NCT04108468|Leeds Teaching Hospital Trust|Professor Helena Marzo-Ortega|+44 (0) 113 392 4848|H.Marzo-Ortega@leeds.ac.uk|
20530709|NCT03260023|Transgene|Director of Medical Affairs|+ 33 3 88 27 91 00|clinical.trials@transgene.fr|
20530710|NCT05035407|National Cancer Institute|Dr. Scott Norberg|301-275-9668|scoot.norberg@nih.gov|
20530711|NCT05816070|IVIEW Therapeutics Inc.|Bo Liang, PhD|609 773 8580|info@iviewinc.com|
20530712|NCT04004000|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
20530713|NCT06121609|Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Scien|aijun xu|+8618627784217|ajxu@tjh.tjmu.edu.cn|
20530714|NCT06494761|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20530715|NCT05432232|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
20530716|NCT04865289|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20530717|NCT01232283|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20530718|NCT04589650|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20530719|NCT01652690|Amgen Inc.|Study Director|866-572-6436||
20530720|NCT01884597|Retina Consultants of Hawaii, Inc.|Gregg Kokame, MD|(808) 487-8928|retinahi@aol.com|
20530721|NCT02097823|Prevea Health/St Vincent Hospital|Dr. Catherine Long|9204338670|cathy.long@prevea.com|
20530722|NCT01081626|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20530723|NCT03114150|The University of Iowa|Dr. Michelle Voss, Study Principal Investigator|319-335-2057|michelle-voss@uiowa.edu|
20530724|NCT04530630|Weill Cornell Medicine|Catherine Small, MD|212-746-9803|cbs9003@med.cornell.edu|
20530725|NCT03675308|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20530726|NCT05032183|The Univeristy of Texas MD Anderson Cancer Center|Ghayas Issa MD./Associate Professor|713-745-6798|GCIssa@mdanderson.org|
20530727|NCT06125964|University of Southern California|Genevieve Dunton (Principal Investigator)|323-442-8224|dunton@usc.edu|
20530728|NCT04006457|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20530729|NCT03729362|Amicus Therapeutics, Inc.|Patient advocacy|001 6096622000|clinicaltrials@amicusrx.com|
20530730|NCT05172609|University of Pennsylvania|Dr. Emily Becker-Haimes|215-573-5614|emily.haimes@pennmedicine.upenn.edu|
20530731|NCT03737994|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20530732|NCT00042289|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20530733|NCT01950663|Dean McGee Eye Institute / University of Oklahoma Health Sciences Center|Dr. Stephen R. Fransen|405-271-1092|stephen-fransen@dmei.org|
20530734|NCT00863122|Johns Hopkins School of Medicine|Jaishri Blakeley|410-955-6827|jblakel3@jhmi.edu|
20530735|NCT03973996|Ohio State University|Dr. Richard Bruno|8603358494|bruno.27@osu.edu|
20530736|NCT04953338|Pfizer Ltd|John Nesnas|01304 616161|john.nesnas@pfizer.com|
20564989|NCT06122194|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20564990|NCT04314778|University of Pennsylvania|S. Ryan Greysen, MD (Principal Investigator)|215-614-0095|Ryan.Greysen@pennmedicine.upenn.edu|
20564991|NCT05218096|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20530737|NCT02194465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20530738|NCT04810962|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
20530739|NCT02412657|MaisonneuveRH|Dr Veronique Brulotte|(514)252-3400|veronique.brulotte@umontreal.ca|
20530740|NCT00534469|City of Hope Medical Center|Dr. Anthony Stein|626-5375748|AStein@coh.org|
20530741|NCT03431584|Centre Hospitalier Departemental Vendée|Dr. Grégoire CORMIER|251446197|gregoire.cormier@ght85.fr|+33
20530742|NCT04530552|University of Arizona|Betsy Wertheim|5207771666|betsy@arizona.edu|
20530743|NCT01225055|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
20530744|NCT04287816|Ohio State University|Dr. Richard Bruno|6142925522|bruno.27@osu.edu|
20530745|NCT04220021|University of Florida|Laura P.W. Ranum, PhD|(352) 294-5209|ranum@ufl.edu|
20530746|NCT03512652|University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr Erich Hohenauer|+41 81 300 01 75|erich.hohenauer@supsi.ch|
20530747|NCT04935879|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20530748|NCT05706610|Cincinnati Children's Hospital Medical Center|Dr. Meghan McGrady|513-803-8044|meghan.mcgrady@cchmc.org|
20530749|NCT03540771|Albert Einstein Healthcare Network|Manisha Verma, MD, MPH. Director, Research|2154561026|Manisha.Verma@jefferson.edu|
20530750|NCT05366725|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 06151725200|service@emdgroup.com|
20530751|NCT02839707|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20530752|NCT02634710|Froedtert and the Medical college of Wisconsin|Ciani Ellison, MD|414-805-4400|cellison@mcw.edu|
20530753|NCT03150043|UTMB|Katherine Jelliffe|2146635394|katherine.emilie@gmail.com|
20530754|NCT00548327|Clinical Brain Disoders Branch-National Institute of Mental Health (NIMH)-National Institute of Health (NIH)|Jose A. Apud MD, PhD|301 5946561|apudj@mail.nih.gov|
20530755|NCT01673386|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
20530756|NCT00109343|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20530757|NCT01721798|FHI 360|Catherine Todd|+1-919-544-7040|ctodd@fhi360.org|
20530758|NCT00336544|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
20530759|NCT01649765|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20530760|NCT00961064|National Heart Lung and Blood Institute|Bhavisha Patel, MD|301.402.3477|bhavisha.patel@nih.gov|
20530761|NCT01408641|FDA|Bernard Fischer, M.D.|240-402-4511|Bernard.Fischer@fda.hhs.gov|
20530762|NCT00715208|Millennium Pharmaceuticals|Carol Ann Satler, MD, PhD|617- 551-3729|carol.satler@mpi.com|
20530763|NCT01648764|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20530764|NCT01316614|Washington University School of Medicine|Daniel K. Mullady, M.D.|314-362-8546|dmullady@dom.wustl.edu|
20530765|NCT03427411|National Cancer Institute|Dr. Julius Strauss|240-858-3999|julius.strauss@nih.gov|
20530766|NCT00076570|NIDDK, National Institutes of Health|Dr. Monique Cho|3014355058|moniquec@intra.niddk.nih.gov|
20530767|NCT01294046|Cleveland Clinic|Kathryn O'Connor||oconnok@ccf.org|
20530768|NCT00089648|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20530769|NCT00420745|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530770|NCT00423605|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Director Clinical Development & Medical Monitor|650-496-3777||
20530771|NCT02156258|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20530772|NCT03183908|Duke University|Dr. Kenneth Schmader|919-660-7572|kenneth.schmader@duke.edu|
20530773|NCT03738696|University of Alabama at Birmingham, Department of Orthopaedics|Dr. Amit Momaya|205-930-8339|amomaya@uabmc.edu|
20530774|NCT00409825|University of Pittsburgh|Steve N. Caritis, MD|412-641-4874|scaritis@mail.magee.edu|
20564992|NCT03571581|The Miriam Hospital|Elena Salmoirago-Blotcher|401-793-8325|Elena_Salmoirago_Blotcher@brown.edu|
20530775|NCT02019069|Stanford University|Rondeep Singh Brar|(650) 498-6000|rbrar@stanford.edu|
20530776|NCT01588509|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20530777|NCT01983930|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
20530778|NCT01454284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20530779|NCT00795340|Division of Medical Oncology, the Ottawa Hospital, Ottawa, Ontario, Canada|Dr. Scott Laurie|1-613-737-7700|slaurie@toh.on.ca|
20530780|NCT00393367|The Children's Hospital of Philadelphia|Cynthia J. Mollen|215-590-4410|mollenc@email.chop.edu|
20530781|NCT00091819|Theravance, Inc.|Steven Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20530782|NCT05001620|University of Maryland School of Nursing|Dr. Joan G. Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
20530783|NCT00481676|Novartis Pharmaceuticals|Study Director|862 778-8300||
20530784|NCT02911116|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
20530785|NCT00819039|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20530786|NCT04796415|Indiana University School of Nursing|Yvonne Lu, PhD, RN, FGSA, FAAN, Professor, Science of Nursing Care Department|3172782042|yuelu@iu.edu|
20564993|NCT01309672|University of Colorado, School of Medicine|Dr. Thomas W. Flaig, MD||Thomas.Flaig@ucdenver.edu|
20564994|NCT03283722|Medtronic|Jenell Lorenz, Sr. Clinical Research Specialist|651-269-4768|jenell.m.lorenz@medtronic.com|
20564995|NCT04141891|University of Colorado|Dr. Marian Betz|303-550-5669|marian.betz@cuanschutz.edu|
20564996|NCT01188928|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20564997|NCT03295721|Heron Therapeutics, Inc.|Vice President, Clinical Operations|855-251-7232|svisonneau@herontx.com|
20564998|NCT01651403|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20530787|NCT00397579|University of Texas Southwestern Medical Center at Dallas|Clinical Research Office|214-648-7097|studyfinder@utsouthwestern.edu|
20530788|NCT02524119|UT Southwestern Medical Center|Dr. Muhammad Beg|2146484180|Muhammad.Beg@UTSouthwestern.edu|
20530789|NCT02054156|Seattle Children's Hospital|Margaret Kloster|2068847862|margaret.kloster@seattlechildrens.org|
20530790|NCT03185208|University of Pittsburgh|Ariel Gildengers, M.D.|412-246-6002|ariel.gildengers@pitt.edu|
20530791|NCT02366871|University of Colorado, Anschutz Medical Campus|Dr. Saketh Guntupalli|303-724-2033|saketh.guntupalli@cuanschutz.edu|
20530792|NCT02841046|Guangzhou Panyu central Hospital|Dr. Yang Lin|+8615915721012|salinyangyl@163.com|
20530793|NCT01311661|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530794|NCT00701363|Ipsen|Medical Director, Clinical Endocrinology and Metabolism|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20530795|NCT04759131|Bioverativ Therapeutics Inc. (a Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20530796|NCT05144945|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20530797|NCT00843466|Unilever|Jamie Regan|203-381-4448|Jamie.Regan@unilever.com|
20530798|NCT00465179|The University of Texas (UT) MD Anderson Cancer Center|Nizar M Tannir, MD, Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
20530799|NCT00976339|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
20530800|NCT01434511|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20530801|NCT00833755|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
20530802|NCT04062227|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6363|Bhavani.X.Kashyap@HealthPartners.com|
20530803|NCT00560404|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20530804|NCT05219162|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20530805|NCT03506061|Emory University|Eric Sorscher, MD|205-612-1327|esorscher@emory.edu|
20530806|NCT02187783|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
20530807|NCT00171249|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20530808|NCT00471497|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20530809|NCT04386785|Venclose|Mai-Ly Wilcox|415-254-1930|mwilcox@venclose.com|
20530810|NCT01222299|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20530811|NCT01420536|Araraquara Dental School -Universidade Estadual Paulista (Sao Paulo State University)|Prof. Marco Antonio Compagnoni|+55-16-3331-6411|compagno@foar.unesp.br|
20530812|NCT04711005|Duke University School of Medicine|Michelle Mack|919 613 1107|michelle.mack@duke.edu|
20530813|NCT00764790|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530814|NCT03533751|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
20530815|NCT01899911|University of California, San Francisco (UCSF)|Philip E. Bickler, MD, PhD, Professor of Anesthesia|415-476-1411|Philip.Bickler@UCSF.edu|
20530816|NCT05462821|Jaeb Center for Health Research - Pediatric Eye Disease Investigator Group|Victoria Woodard, Publications Manager|813-975-8690|pedigpublications@jaeb.org|
20530817|NCT06070610|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20530818|NCT07000981|Inonu University|Asst. Prof. Gürkan ÖZDEN|+90 505 715 62 65|gurkan.ozden@inonu.edu.tr|
20530819|NCT02485860|Centre Hospitalier Departemental Vendée|Dr. Emeric ABET|02 51 44 61 48|emeric.abet@ght85.fr|+33
20530820|NCT03586479|University of Kansas|Rebecca Swinburne Romine|7857668612|swin0024@ku.edu|
20530821|NCT00576758|Hoffman-LaRoche|Medical Communications|800-821-8590||
20530822|NCT00903968|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|Irene_Ghobrial@dfci.harvard.edu|
20530823|NCT00726453|Medtronic Vascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20530824|NCT01513590|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20530825|NCT01056276|Sarah Cannon Development Innovations|Charles Davis, RAC||charles.davis2@scri-innovations.com|
20530826|NCT04154956|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20530827|NCT00147238|UT MD Anderson Cancer Center|Haesun Choi, MD / Professor|713-745-4693||
20530828|NCT04424901|UConnHealth|Ellen Ciesielski|860-679-6004|eciesielski@uchc.edu|
20530829|NCT01348269|University Hospital Wuerzburg - Department of Orthopaedics (Clinical Study Unit)|Dr. Lothar Seefried|+499318033590|l-seefried.klh@uni-wuerzburg.de|
20530830|NCT00805532|VA Portland Health Care System|Amy W. Wagner, Ph.D.|(503) 220-8262|amy.wagner@va.gov|33365
20530831|NCT01859741|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
20530832|NCT00154466|National Taiwan University Hospital|Dr. Bai-Chin Lee|0223123456|lebai@ntu.edu.tw|63352
20530833|NCT00890721|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20530834|NCT03834350|University of Chicago|Dr. Valerie Press|773-702-5170|vpress@bsd.uchicago.edu|
20530835|NCT02701634|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20530836|NCT00537277|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20530837|NCT03620162|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20530838|NCT02767531|UT Southwestern Medical Center|Abhimanyu Garg, MD|2146482895|abhimanyu.garg@utsouthwestern.edu|
20530839|NCT05824026|Coloplast A/S|Clinical Strategy Project Manager: Johanne Louise Gotfredsen|004549113350|dkjoat@coloplast.com|
20530840|NCT04009837|University of Delaware|Dr. Gregory Hicks, PT, PhD, FAPTA, FGSA|(302) 831-2690|ghicks@udel.edu|
20530841|NCT03134768|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
20530842|NCT00284856|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20564999|NCT05090683|University of the Fraser Valley|Dr. Cynthia Thomson|6045047441|cynthia.thomson@ufv.ca|2518
20565000|NCT04032847|Achilles Therapeutics UK Limited|Dr Matilde Saggese|0786 9814607|matildesaggese@gmail.com|
20530843|NCT05853120|Emory University|Colleen Kelley|404-712-1823|scolleen.kelley@emory.edu|
20530844|NCT03207399|Duke University Medical Center|Dr. Omar Mohamedaly|919-684-4589|omar.mohamedaly@duke.edu|
20530845|NCT03692949|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20530846|NCT06309394|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20530847|NCT04431206|Wake Forest University School of Medicine|Dr. James Eisenach|3367164182|james.eisenach@advocatehealth.org|
20530848|NCT03350919|University of Rochester|Steven E. Feldon, MD|585-273-1050|Steven_Feldon@urmc.rochester.edu|
20530849|NCT02592824|Linköping University Hospital|Dr Jonas Holm|+46101034498|jonas.holm@regionostergotland.se|
20530850|NCT03426878|Kaiser Permanente Center for Health Research|Joanna Bulkley, PhD|5033352400|joanna.e.bulkley@kpchr.org|
20530851|NCT02855268|Sanofi-Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20530852|NCT00465517|Marinus Pharmaceuticals, Inc.|Marinus|(484) 801-4670|clinicaltrials@marinuspharma.com|
20530853|NCT05033041|Northwestern University|Paul C. Fitzgerald,RN,BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
20530854|NCT01090180|Veterans Affairs North Texas Health Care System|Alina Suris|817-715-0625|alina.suris@va.gov|
20530855|NCT00289276|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
20530856|NCT00869960|UAB|Jennifer King|205-934-2696|jenking@uab.edu|
20530857|NCT00726609|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20530858|NCT03084237|Shanghai Henlius Biotech|Head of Clinical Development|+86 021-33395800|contact@henlius.com|
20530859|NCT01067586|University of Minnesota|Dorothy Hatsukami, PhD|612-626-2121|hatsu001@umn.edu|
20530860|NCT00706563|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530861|NCT00746551|Mahidol University, Department of Obstetrics and Gynaecology, Division of Maternal Fetal Medicine, Faculty of Medicine, Siriraj Hospital|Pharuhas Chanprapaph|+66819920053|pharuhasc@gmail.com|
20530862|NCT00914069|Bard Access Systems, Inc.|Gina Gilbert|407-489-0835|Gina.Gilbert@crbard.com|
20530863|NCT02029417|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20530864|NCT01451372|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
20530865|NCT00071981|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20530866|NCT00262925|ECOG Statistical Office|Study Statistician|617-632-3012||
20530867|NCT04682301|Fred Hutchinson Cancer Center|Madison Snidarich, Clinical Research Coordinator|2066674589|msnidari@fredhutch.org|
20530868|NCT06015490|Virginia Polytechnic Institute and State University|Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
20530869|NCT04513366|Swedish Orphan Biovitrum AB (publ)|Blank Clinical Study Physician, MD|+46 8 697 20 00|medical.info@sobi.com|
20530870|NCT00392223|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20530871|NCT01498549|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
20530872|NCT03344757|University of Miami|Dr. Frank Penedo|305-284-4290|fpenedo@miami.edu|
20530873|NCT00269152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20530874|NCT04622345|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20530875|NCT02814526|Alzheimer's Disease Cooperative Study (ADCS)|Clinical Operations|858-246-1333|alzinfo@ucsd.edu|
20530876|NCT01132508|Synthes GmbH|Clinical Research Scientist|+41619656592|clinicalaffairs.emea@synthes.com|
20530877|NCT01749956|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
20530878|NCT03082729|University of Pennsylvania|Joel Gelfand, MD, MSCE|215-662-2737|joel.gelfand@pennmedicine.upenn.edu|
20530879|NCT04176224|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20530880|NCT01533259|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20530881|NCT01191749|University of Texas (UT) MD Anderson Cancer Center|Tapan Kadia, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20530882|NCT03454555|RTI International|Dr. Lauren McCormack|919-541-6277|lmac@rti.org|
20530883|NCT00850642|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530884|NCT06128954|Orphalan SA|Carla Bennett|07918380893|carla.bennett@orphalan.com|
20530885|NCT05335161|Purdue University|Bruno Tesini Roseguini|7654962612|brosegui@purdue.edu|
20565001|NCT03213665|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20530886|NCT05019430|University of Kentucky|William W. Stoops|8592575388|william.stoops@uky.edu|
20565002|NCT03325985|NYU Langone Health|Keith Goldfeld|(212) 263-5550|Keith.Goldfeld@nyulangone.org|
20530887|NCT01288430|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20530888|NCT05539131|Yongin Severance Hospital|Woo Jung Kim|01092827943|woojungkim@yuhs.ac|
20530889|NCT03405870|University of Florida College of Medicine|Dr. Faheem Guirgis, MD|352-733-1469|fguirgis@ufl.edu|
20530890|NCT02987868|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
20530891|NCT00498550|Dartmouth Medical School|Christopher OKeefe|603-271-5287|chris.okeefe@hitchcock.org|
20530892|NCT02807259|Karnataka Health Promotion Trust|Prakash Javalkar|+91 80 4040 0200|prakashj@khpt.org|
20530893|NCT00849056|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530894|NCT03643848|Florida International University|Dana L. McMakin, PhD, ABPP|305-348-0042|dmcmakin@fiu.edu|
20565003|NCT03034356|VA Eastern Colorado Health Care System|Jason Tregellas, PhD|303-724-6232|jason.tregellas@va.gov|
20565004|NCT02684227|MD Anderson Cancer Center|Shannon Westin, MD|713-794-4314|swestin@mdanderson.org|
20565005|NCT05104463|CuraSen Therapeutics, Inc|Clinical Trial Information Desk|+1 650 475 2842|clinicaltrials@curasen.com|
20530895|NCT01566370|Yale/VA Connecticut Healthcare system|Albert Arias|2039325711|albert.arias@va.gov|8155
20565006|NCT05267470|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20565007|NCT04070573|Weill Cornell Medicine|Dr Line Malha|6469622606|lim9120@med.cornell.edu|
20565008|NCT04428203|University of Kentucky|Dr. Zin Myint|8593233964|zin.myint@uky.edu|
20565009|NCT04622774|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20565010|NCT04086121|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565011|NCT04857723|CooperVision Inc.|Paul Chamberlain|+19257306754|pchamberlain@coopervision.com|
20565012|NCT05593900|University of California Davis|Jennifer Rosenthal|9167344719|rosenthal@ucdavis.edu|
20520009|NCT00680186|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520010|NCT00606138|Rush University Medical Center|Mathew MacCumber, MD, PhD|312-563-4032|denise_voskuil-marre@rush.edu|
20520011|NCT01351350|Takeda|Medical Director, Clinical Science|+1-866-835-2233|trialdisclosures@takeda.com|
20520012|NCT02080507|Emory University|Dr. William McDonald|404-712-6945|wmcdona@emory.edu|
20520013|NCT01099631|Masonic Cancer Center, University of Minnesota|Daniel Saltzman|612 626 4214|saltz002@umn.edu|
20520014|NCT00873119|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
20520015|NCT03648879|National Cancer Institute|Dr. Jeremy L. Davis|240-760-6229|jeremy.davis@nih.gov|
20520016|NCT00285584|NYU School of Medicine|Michael Marmor, Ph.D.|212-263-6667|michael.marmor@nyumc.org|
20520017|NCT04776954|University of Minnesota|Michael Todd|6126264551|mmtodd@umn.edu|
20520018|NCT00466726|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
20520019|NCT03851588|University of Cape Town|Prof Gary Maartens|214066008|gary.maartens@uct.ac.za|+27
20520020|NCT00738361|Ohio State University Comprehensive Cancer Center|Thomas Olencki, D.O.|614-293-2886|Thomas.Olencki@osumc.edu|
20520021|NCT01807117|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Raj Paspulati|1-800-641-2422|Raj.Paspulati@UHhospitals.org|
20520022|NCT00834899|University of North Carolina at Chapel Hill|Kenneth I. Ataga, MD|919-966-0178|kataga@med.unc.edu|
20520023|NCT04070287|Saint Louis University|Dr. Juliet Iwelunmor|2405280123|juliet.iwelunmor@slu.edu|
20520024|NCT00572117|Stanford University School of Medicine|Michael J. Ostacher, MD, MPH, MMSc|650-493-5000|ostacher@stanford.edu|
20520025|NCT02709486|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520026|NCT00489281|Johns Hopkins University|F Javier Bolanos Meade, MD|4106146398|fbolano2@jhmi.edu|
20520027|NCT00606502|Allos Therapeutics, Inc|Medical Monitor|303-426-6262|gweems@allos.com|
20520028|NCT01615887|SUNY University at Buffalo|Ralph Benedict|716-323-0556|benedict@buffalo.edu|
20520029|NCT00737737|National Institutes of Health Clinical Center|Andrew Mannes, M.D.|301-594-3427|Andrew.Mannes@nih.gov|
20520030|NCT02540447|Mansoura Faculty of Medicine|Amr Mohamed Yassen Ali Badawy|+201001497044|amryassen@hotmail.com|
20520031|NCT02443545|Chiesi Canada Corp.|Fernando Tricta, MD|1-800-854-3534|f.tricta@chiesi.com|7049
20520032|NCT00604201|National Heart Lung and Blood Institute|Childs, William|+1 301 451 7128|childsr@nhlbi.nih.gov|
20520033|NCT02139124|Purdue Pharma|Dr Lance Payne|1-800-384-5349|Lance.Payne@purdue.ca|
20520034|NCT02691741|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20520035|NCT01425528|University of utah|Kathryn Swoboda MD|801-585-9717|Swoboda@genetics.utah.edu|
20520036|NCT00307931|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20520037|NCT02697773|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520038|NCT00613834|The Ohio State University|Dr. Michelle Isley|614-293-4203|Michelle.Isley@osumc.edu|
20520039|NCT02243293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20520040|NCT03069417|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
20520041|NCT01769274|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520042|NCT00784524|Masonic Cancer Center, University of Minnesota|Dr. Douglas Yee|612-626-8487|yeexx006@umn.edu|
20520043|NCT00118378|New York State Psychiatric Institute|Dr. Judith Rabkin|212.543.5762|jgr1@columbia.edu|
20520044|NCT02516410|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20520045|NCT01252719|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
20520046|NCT04051684|Montefiore Medical Center|Dr. Karina Gritsenko|718-920-7246|kgritsen@montefiore.org|
20520047|NCT01475253|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20520048|NCT03135899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520049|NCT04146363|Eli Lilly and Company|Chief Medical officer|800-549-5929|ClinicalTrials.gov@lilly.com|
20520050|NCT03660241|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520051|NCT06141824|Pfizer|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520052|NCT02914236|Aerin Medical, Inc.|Scott Wolf, M.D., Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
20520053|NCT04776746|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
20520054|NCT00856830|Univeristy of Alabama at Birmingham|Francisco Robert, MD, Department of Medicine, Division of Hematology and Oncology|205-934-5077|pacorobertuab@cs.com|
20520055|NCT01891305|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
20520056|NCT03768726|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520057|NCT00836719|LSU Health Sciences Center-New Orleans|Jesus Lovera MD|5045686700|jlover@lsuhsc.edu|
20520058|NCT01005706|Medical University of South Carolina|Charles F. Bratton, MD|843-792-4003|brattocf@musc.edu|
20520059|NCT02694549|CaveoMed GmbH|Albertus M. Scheule, MD, PhD, MBA|+49(0)7071-53982-10|albertus.scheule@caveomed.com|
20520060|NCT01567826|Icahn School of Medicine at Mount Sinai|Dr. Pedro R. Moreno||pedro.moreno@mountsinai.org|
20530896|NCT02314546|Bassett Healthcare Network|David A. Ullman, MD, Senior Attending Anesthesiologist|607-547-3153|david.ullman@bassett.org|
20530897|NCT00274456|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20530898|NCT00375752|Novartis Pharmaceuticals|Study Director|862-778-8300||
20530899|NCT03042546|Harboview|research coordinator|206.744.4406|bagel@uw.edu|
20530900|NCT03588624|Sight Sciences|VP Medical and Clinical Affairs|(877) 266-1144|info@sightsciences.com|
20530901|NCT00890162|National Institute of Allergy and Infectious Diseases|Carter, Melody|+1 301 496 8772|mc396j@nih.gov|
20530902|NCT01140906|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20530903|NCT04889040|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20530904|NCT03801252|University of Oklahoma Health Sciences Center|Dr. Stephanie Pierce|(405) 271-8787|stephanie-pierce@ouhsc.edu|
20530905|NCT02690727|Algorithme Pharma Inc.|Dr. Eric Sicard|(514) 858-6077|esicard@algopharm.com|
20530906|NCT02567422|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20530907|NCT05352815|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20530908|NCT06831786|prince of songkla university|Sarunyou Chusri|+66897340446|sarunyouchusri@hotmail.com|
20530909|NCT01316575|University of Saskatchewan|Dr. William McKay|306-655-1202|william.mckay@saskatoonhealthregion.ca|
20530910|NCT00402831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20530911|NCT04773028|Kartal Kosuyolu Hihg Speciality Training and Research Hospital|Dr.Ahmet Zengin|+905365022173|dr.zenginahmet@gmail.com|
20530912|NCT00671788|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
20530913|NCT03043053|Massachusetts General Hospital|Elizabeth A. Lawson, MD, MMSc|617-726-3870|ealawson@mgh.harvard.edu|
20530914|NCT02792504|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565013|NCT06214559|Eurofins Dermscan Pharmascan|Project Manager|+33 (0)4 72 82 36 56|manon.laune@cpt.eurofinseu.com|
20565014|NCT02844465|MedtronicNeuro|Clinical Study Manager|(877) 590-7835|rs.slatestudy@medtronic.com|
20565015|NCT03711734|Hospital for Special Surgery|Dr. Stephanie Cheng|212-606-1206|chengs@hss.edu|1206
20565016|NCT04228042|M D Anderson Cancer Center|Mehrad Adibi, MD|713-563-7458|mllozano@mdanderson.org|
20565017|NCT05029622|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20565018|NCT05671653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565019|NCT03812549|West China Hospital, Sichuan University|Prof. You Lu|13398179653|radyoulu@hotmail.com|
20520061|NCT01612884|Indiana University School of Medicine|Rolf Kreutz, MD|3179620500|rkreutz@iu.edu|
20520062|NCT03623620|Massachusetts General Hospital, Center for Women's Mental Health|Lee Cohen, MD|617-724-8020|lcohen2@mgh.harvard.edu|
20520063|NCT00811434|Riley Hospital|Girish Subbarao|317-944-3774|gsrao@iupui.edu|
20520064|NCT03265288|Laurent Pharmaceuticals Inc.|Dr Jean-Marie Houle, VP Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
20520065|NCT02790034|Newron Pharmaceuticals S.p.A.|Ravi Anand MD, Chief Medical Officer|+41 793741364|regulatoryaffairs@newron.com|
20520066|NCT02678442|Mayo Clinic|Dr. Michael B. Wallace|904-953-2222|wallace.michael@mayo.edu|
20520067|NCT03465748|Illinois College of Optometry|Dr. Yi Pang|3129497287|YPang@ico.edu|
20520068|NCT03575871|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520069|NCT05506358|The University of British Columbia|Pranav Shrestha|6507893270|pranav.shrestha@alumni.ubc.ca|
20520070|NCT00391079|GW Pharmaceuticals|Richard Potts Clinical Operations Director|+44 1223 266800|rp@gwpharm.com|
20520071|NCT03050203|Istituto Ortopedico Rizzoli|Cristiana Forni|0039516366|cristiana.forni@ior.it|694
20520072|NCT00251225|University of Pittsburgh Cancer Institute|Leonard J. Appleman, MD, PhD|412-648-6507|applemanlj@upmc.edu|
20520073|NCT00252174|McLean Hospital at time of study|John H. Halpern, M.D.|6179065063|jhalpern@recoverycoa.com|
20520074|NCT02546362|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
20520075|NCT01138826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520076|NCT05206448|University of Iowa|Rachel Mejia, DO|319-356-3143|rachel-mejia@uiowa.edu|
20520077|NCT03360916|University of Kansas Medical Center|John P. Thyfault|913-588-1790|jthyfault@kumc.edu|
20520078|NCT00754442|University of Maryland School of Medicine|Elizabeth A Streeten, MD|410-328-6219|estreete@medicine.umaryland.edu|
20520079|NCT01557842|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
20520080|NCT03053583|Anesthesiology|Jerrold Lerman MD|716-323-6570|jlerman@buffalo.edu|
20520081|NCT05560763|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
20520082|NCT06972251|Health Systems Research Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Allison Lewinski, PhD, MPH, RN, FAAN|919-286-0411|allison.lewinski@va.gov|
20520083|NCT00949988|UCSD Moores Cancer Center|Kimberly Aguilar, Clinical Trials Manager|858-534-5201|k1aguilar@ucsd.edu|
20520084|NCT01929395|Dartmouth Hitchcock Medical Center|Dr Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
20520085|NCT01980342|Johns Hopkins University School of Medicine|Jenny Robinson, MD MP FACOG|4105500337|mailto:jrobin87@jhmi.edu|
20520086|NCT03604341|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
20520087|NCT00484419|Daiichi Sankyo Inc.|John Raia, Director, Professional Affairs|973-630-2683|jraia@dsus.com|
20520088|NCT01453413|Taking Control of Your Diabetes|Dr. Steven Edelman, MD|858-755-5683|svedelman@vapop.ucsd.edu|
20530915|NCT01035138|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20530916|NCT01535924|The Ohio State University|Dr. Beth Christian|614-293-7807|Beth.Christian@osumc.edu|
20530917|NCT00848497|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
20565020|NCT01197378|Horizon Pharma USA, Inc.|Evelyn Olson|224-383-3000|clinicaltrials@horizonpharma.com|
20520089|NCT01829113|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20520090|NCT00845975|McDonald hearing Aid Centers|Louis A Looper, MA, CCC-A|916-218-4100|llooper@hearingmed.com|
20520091|NCT00355472|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
20520092|NCT03453840|University of California San Francisco|Liusheng Huang (Co-Investigator and Drug Research Unit Co-Director)|415-502-2594|liusheng.huang@ucsf.edu|
20520093|NCT03581214|Washington University in St Louis|Nandini Raghuraman|3144548181|nraghuraman@wustl.edu|
20520094|NCT02674386|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520095|NCT04625673|University of Pennsylvania|Regulatory Lead|215.573.7101|psom-ind-ide@pobox.upenn.edu|
20520096|NCT04744155|Children's Mercy Kansas City|Melissa K. Miller MD|8162343430|mmiller@cmh.edu|
20520097|NCT00351351|IU Health Methodist Hospital|James Lingeman, MD|317-962-0870|lrawlings@iuhealth.org|
20520098|NCT03208673|Allergan|Medical Director|714-246-4500|CTRegistration@allergan.com|
20520099|NCT03891329|BIOTRONIK SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20520100|NCT03176784|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
20520101|NCT02990806|Nichi-Iko Pharmaceutical Co., Ltd|Hiroshi Anekawa|+81-3-6262-1564|hiroshi-anekawa@nichiiko.co.jp|
20520102|NCT01010750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20520103|NCT02269631|Emory Unioversity|Hartman, Terry Professor, SPH Epidemiology|404-727-8713|terryl.johnson.hartman@emory.edu|
20520104|NCT00171340|Novartis Pharmaceuticals|Study Director|862- 778 8300||
20520105|NCT01682148|Ipsen|Medical Director, Neurology|clinicaltrials@ipsen.com|clinicaltrials@ipsen.com|
20520106|NCT01056640|Mayo Clinic|Dr. Paul Takahashi|507-284-2511|takahashi.paul@mayo.edu|
20520107|NCT01803269|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20520108|NCT01202877|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20520109|NCT00350402|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
20520110|NCT01376310|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20520111|NCT04844021|Northwestern University|Dr. Rinad Beidas|312-503-0546|rinad.beidas@northwestern.edu|
20520112|NCT00645944|Yale University|Cenk Tek, M.D.|203-974-7484|cenk.tek@yale.edu|
20520113|NCT02339740|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20520114|NCT00706355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520115|NCT02463799|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-8341|eantona1@jhmi.edu|
20520116|NCT04179019|Brigham and Women's Hospital|Anand Vaidya|6177325666|anandvaidya@bwh.harvard.edu|
20520117|NCT01855048|Organization:Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
20520118|NCT03465436|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20520119|NCT01813071|PATH|Jennifer O'Reilly|202-540-4510|joreilly@path.org|
20520120|NCT01688726|Alcon Research, Ltd.|Abayomi Ogundele, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20520121|NCT04553913|Atrium Health Wake Forest Baptist|Seiha Kim, DO|336-716-4498|sekim@wakehealth.edu|
20520122|NCT00965055|UCSD|Ori Ben-Yehuda|9179697273|obenyehuda@ucsd.edu|
20520123|NCT00710749|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
20520124|NCT02985879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20520125|NCT03821272|University of Arkansas for Medical Sciences|Mayumi Nakagawa, M.D., Ph.D.|(501) 686-8635|MNakagawa@uams.edu|
20520126|NCT05904769|Mayo Clinic|Guru Kowlgi M.B.B.S., M.S.|507-422-0549|Kowlgi.NarayanGurukripa@mayo.edu|
20520127|NCT05626803|Vaxart|Melanie Drayton|650-392-3109|ClinicalTrials@Vaxart.com|
20520128|NCT04974619|Moffitt Cancer Center|Dr. Shannon Christy|813-745-8840|Shannon.Christy@moffitt.org|
20520129|NCT03860207|Y-mAbs Therapeutics|Joris Wilms|+45 7026 1414|clinicaltrials@ymabs.com|
20520130|NCT03959527|GARDP|Dr Alison Luckey|+41 22 559 05 39|aluckey@gardp.org|
20520131|NCT01688466|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
20520132|NCT06357286|Cornell University|Heather Schofield|6172334775|hws44@cornell.edu|
20520133|NCT01000610|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20520134|NCT00635830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520135|NCT05529511|University Hospitals of Derby and Burton NHS Foundation Trust|Hayley Carter|01332254631|hayley.carter1@nhs.net|
20520136|NCT03740113|Univeristy of Virginia|Dr. Jamie Zoellner|434-962-4488|jz9q@virginia.edu|
20520137|NCT02658487|Vanderbilt University Medical Center|Stephen Strickland, MD|(615) 936-8422|stephen.strickland@vumc.org|
20520138|NCT01885182|Mundipharma (China) Pharmaceutical Co. LTD|Clinical study manager|0086-10-65636800|Wei.Zhu@mundipharma.com.cn|6900
20520139|NCT03707041|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
20520140|NCT02277704|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|862-904-0355|greg.sullivan@tonixpharma.com|
20520141|NCT00380692|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20520142|NCT02676284|Zambon S.A.U.|Antonio Esteras, MD|+34 93 544 64 00|antonio.esteras@zambongroup.com|
20520143|NCT00735917|University of Colorado Cancer Center|Wells A. Messersmith, M.D.||wells.messersmith@ucdenver.edu|
20520144|NCT00708708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520145|NCT05017974|University of California, San Francisco|Dr. Jennifer Felder|415-476-7014|jennifer.felder@ucsf.edu|
20520146|NCT02473783|Tri-Service General Hospital, National Defense Medical center|Dr. Chin-bin Yeh|886-2-87923311|chinbinyeh@gmail.com|17387
20530918|NCT01832766|University of Colorado Denver|Lynn Johnson, Pharm.D.|303 724 6221|lynn.johnson@ucdenver.edu|
20530919|NCT02139540|Washington University|Principal Investigator|7737022544||
20530920|NCT01114724|Medtronic Inc., Aortic and Peripheral Vascular|Celeste Claudy - Study Lead|763-514-0130|celeste.m.claudy@medtronic.com|
20530921|NCT02966834|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20530922|NCT03699748|Stanford University|Dr. Manali Patel|6504859462|manalip@stanford.edu|
20530923|NCT02866643|Stanford University|Clinical Research Manager|6507247826|gynresearch@stanford.edu|
20530924|NCT04585893|UNC Lineberger Comprehensive Cancer Center|Matthew S Painschab|919-966-4431|matthew_painschab@med.unc.edu|
20530925|NCT02431299|Indiana University Purdue University Indianapolis|Dr. Alan B. McGuire|3179882725|abmcguir@iupui.edu|
20530926|NCT03880474|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
20530927|NCT01526408|House Institute Foundation|Mahta Marefat|(213) 770-1808|mmarefat@hifla.org|
20530928|NCT03573297|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20530929|NCT03415178|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20530930|NCT01366092|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|JKoreth@partners.org|
20530931|NCT03456245|Harvard TH Chan School of Public Health|Dr. David Bloom|6174320650|dbloom@hsph.harvard.edu|
20530932|NCT02273167|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
20530933|NCT01093846|Novartis Pharmaceuticals|Study Director|862-778-8300||
20530934|NCT00763360|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20530935|NCT04066374|Cleveland Clinic|Yuki Kuramochi, BSN, RN|216-445-4063|kuramoy@ccf.org|
20530936|NCT02781324|Children's Hospital Colorado|Eun Kim, Spine Research Assistant|720-777-8026|eun.kim@childrenscolorado.org|
20530937|NCT00834041|Novartis Pharmaceuticals|Study Director|862 778-8300||
20530938|NCT03074500|Marmara University School of Medicine|Gulseren Derya Akyuz|+90 216 657 06 06|girayesra@hotmail.com|1628
20530939|NCT03321721|St. Louis University School of Medicine|Dr. Trevor L. Tredway|314-577-5630|trevor.tredway@health.slu.edu|
20530940|NCT02634177|Genomind|Chief Medical Officer|267-989-3461|dkrause@genomind.com|
20530941|NCT01416571|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530942|NCT03608163|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-430-2903|meredith.hawkins@einsteinmed.edu|
20530943|NCT03353220|Columbia University|Sharon Wardlaw, MD|212-305-3725|sw22@cumc.columbia.edu|
20530944|NCT06649409|Santhera Pharmaceuticals LTD|Shabir Hasham MD, Chief Medical Officer|+41 79 520 95 18|shabir.hasham@santhera.com|
20530945|NCT03857256|Montreal Heart Institute|Dr Jean-Claude Tardif|514-376-3330|jean-claude.tardif@icm-mhi.org|3612
20530946|NCT00315341|University of California, Los Angeles|Walter Ling, M.D.|(310) 933-8111|lwalter@ucla.edu|
20530947|NCT00661388|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20530948|NCT04240314|Nationwide Children's Hospital|Megan Waldrop, Sponsor-Investigator|614-722-2231|megan.waldrop@nationwidechildrens.org|
20530949|NCT04770753|Agios Pharmaceuticals, Inc .|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
20530950|NCT04780659|Karolinska University Hospital|Soo Aleman Sponsor representative|+46 72595 7225|soo.aleman@regionstockholm.se|
20530951|NCT05507437|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20530952|NCT06583096|University of Michigan|Adam Horwitz|(734) 764-0231|ahor@med.umich.edu|
20530953|NCT04588259|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20530954|NCT04460885|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20530955|NCT02688803|Ottawa Hospital Research Institute|Dr. John Hilton|613-737-7700|jfhilton@toh.ca|70170
20530956|NCT02469233|Department of Psychology, University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
20530957|NCT03979313|Astrazeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
20530958|NCT00396292|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com|
20530959|NCT02631057|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20530960|NCT03837847|Mayo Clinic|Roberto P. Benzo, M.D.|507-284-0561|Benzo.Roberto@mayo.edu|
20530961|NCT02443077|University of California|Dr. Charalambos Andreadis|415-353-8363|candreadis@medicine.ucsf.edu|
20530962|NCT00656617|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
20530963|NCT02030600|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20530964|NCT02736617|Oregon Health and Sciences University, Knight Cancer Institute|Dr. Stephen E. Spurgeon, Associate Professor of Medicine|503-494-8950|spurgeos@ohsu.edu|
20530965|NCT01718691|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1125||
20530966|NCT01240694|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20530967|NCT01881425|InnFocus, Inc. (a Santen Company)|Sharon Herbert, Director of Global Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
20530968|NCT05452239|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20530969|NCT01385176|Institut Lorrain du Coeur et des Vaisseaux, CHU de Nancy, France|Principal Investigator of the Study, Prof. Faiez Zannad|+33 3 83 15 73 22|f.zannad@chu-nancy.fr|
20530970|NCT06469372|Columbia University Irving Medical Center|Timothy J. Poterucha, MD|(212) 932-4537|tp2558@cumc.columbia.edu|
20530971|NCT05082025|The University of Texas MD Anderson Cancer Center|Dr. Timothy Yap|(713) 839-5458|tyap@mdanderson.org|
20530972|NCT04458922|National Cancer Institute|Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
20530973|NCT02921256|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5261|langerj@nrgoncology.org|
20530974|NCT01933594|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20530975|NCT04848480|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20530976|NCT05352763|Cassava Sciences|Project Manager|5125013180|closedstudyinfo@cassavasciences.com|
20530977|NCT00362232|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20530978|NCT02612857|Idera|Senior Development Operations Director|877-888-6550|clinicaltrials@iderapharma.com|2
20530979|NCT00855582|Eli Lilly and Company|Chief Medical Office|800-545-5979||
20530980|NCT01107015|University of Maryland, Baltimore|Cindy Geppi|4107062406||
20530981|NCT01155323|Johnson and Johnson K.K.|Wakana Katabami|81-34411-8040|wkatabam@its.jnj.com|22025
20530982|NCT02606253|Lipscomb University College of Pharmacy|Dr. Zachary Cox, Associate Professor|6159667163|zac.cox@lipscomb.edu|
20530983|NCT02765165|Proximagen, LLC|Chief Medical Officer|952-658-7440|tcmeng@proximagen.com|
20530984|NCT01189266|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20530985|NCT00410163|GlaxoSmithKline|GSK Response Center|866-435-7343||
20530986|NCT04428151|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20530987|NCT02783690|Mayo Clinic|Robert Mutter, M.D.|507-284-2511|mutter.robert@mayo.edu|
20530988|NCT02421939|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20530989|NCT03836066|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
20530990|NCT04770779|Agios Pharmaceuticals, Inc.|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
20530991|NCT02799602|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20530992|NCT06006208|Thomas Jefferson University|Associate Professor|3059784358|moritayoshihisa2016@gmail.com|
20530993|NCT05430204|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD|713-500-6421|Michal.F.Bartal@uth.tmc.edu|
20530994|NCT04345913|Washington University in St. Louis School of Medicine|Nusayba Bagegni|3142733022|nbagegni@wustl.edu|
20530995|NCT05881733|Erasmus MC|Dr. Sing-Chien Yap|+31650031551|s.c.yap@erasmusmc.nl|
20530996|NCT05516758|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20530997|NCT02251821|Fred Hutchinson Cancer Center|Rachel Salit|206-667-1317|rsalit@fredhutch.org|
20530998|NCT03818854|University of California San Francisco|Dr. Michael Matthay|415-476-1079|michael.matthay@ucsf.edu|
20530999|NCT06178991|BioNTech SE|BioNTech clinical trials patient information|+49 6131 90840|patients@biontech.de|
20531000|NCT04739800|NRG Oncology|Christopher Purdy on behalf of Austin Miller, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20531001|NCT05227677|Nagase Diagnostics Co.,Ltd.|Takuji Kohzuma|09080045463|takuji.kohzuma@nagase.co.jp|
20531002|NCT03907488|SWOG|Hongli Li|206-667-6077|hongli@fredhutch.org|
20531003|NCT02394769|Massachusetts General Hospital|Andrew T. Chan, MD, MPH|(617) 726-3212|achan@partners.org|
20531004|NCT03570892|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
20531005|NCT03914612|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20531006|NCT04320888|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
20531007|NCT01509105|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531008|NCT05493111|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
20531009|NCT03836053|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20531010|NCT00788671|UT MD Anderson Cancer Center|Dr. Shannon N. Westin, MD, Associate Professor, Gyn Onc & Reproductive Med|(713) 794-4314|swestin@mdanderson.org|
20531011|NCT04486716|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20531012|NCT03846479|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-6021|john.levine@mssm.edu|
20531013|NCT02332707|Merck Sharp & Dohme Corp.|Senior VIce President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20531014|NCT01473134|Clinical Affairs Associate Director|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
20531015|NCT04761822|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20531016|NCT02700841|University of Nebraska Medical Center|IIT Office|402-559-4596|IITOffice@unmc.edu|
20531017|NCT06023563|Indiana University|Dr. Georgia Frey, Faculty, Department of Kinesiology|(812) 855-1262|gfrey@iu.edu|
20531018|NCT05423743|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
20531019|NCT02233413|Massachusetts General Hospital|Dr. Rajiv Gupta|617-726-0369|rgupta1@mgh.harvard.edu|
20531020|NCT00090103|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531021|NCT01799889|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20531022|NCT03265964|VA Salt Lake City Health Care System, VISN 19 Rocky Mountain MIRECC for Veteran Suicide Prevention|Dr. Douglas Kondo|801-587-1549|douglas.kondo@va.gov|
20531023|NCT04476043|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20531024|NCT06217380|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20531025|NCT06633965|Center for Diabetes Technology|Dr. Marc Breton|434-982-6484|mb6nt@virginia.edu|
20565021|NCT05196919|Xalud Therapeutics, Inc.|Director of Medical Inquiries|212-301-6673|medical.information@xaludthera.com|
20565022|NCT02460458|Hematology and Transfusion Medicine, L. Sacco University Hospital, University of Milan, Via G. B. Grassi, 74 20157 Milan, Italy|Prof. Augusto B. Federici|+39-0250319895|augusto.federici@unimi.it|
20565023|NCT00696111|University of Chicago|Karla Temple, Clinical Research Manager|773-702-3334|katemple@uchicago.edu|
20565024|NCT05299073|mAbxience Research S.L.U.|Susan Millan PhD|+34 917711500|susana.millan@mabxience.com|
20565025|NCT04850898|SAB Biotherapeutics|Senior Director Clinical Operations|8326221699|ssinclair@sabbio.com|
20565026|NCT04550221|University of Washington|Susan M. Graham|206-351-0414|grahamsm@uw.edu|
20565027|NCT04176601|University of Rochester|Dr. Kim Van Orden|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
20531026|NCT00782067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20531027|NCT02471183|Actelion Pharmaceuticals Ltd|Global Post approval studies Director||lperchen@its.jnj.com|
20531028|NCT02478671|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
20531029|NCT03726476|University of New Mexico Health Sciences Center|Cassandra Darley|505-967-8428|cjdarley@salud.unm.edu|
20531030|NCT02328105|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20531031|NCT00614393|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20531032|NCT03345004|Diamyd Medical AB|Director of Clinical Development|+46 (0) 8 661 00 26|clinicaltrials@diamyd.com|
20531033|NCT06094647|University of North Carolina at Chapel Hill|Kelsey Ludwig, PhD|919-962-1401|kelsey_ludwig@med.unc.edu|
20531034|NCT01013753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20531035|NCT03556683|University of North Carolina at Chapel Hill|Carole Robinette|919-966-5638|carole_robinette@med.unc.edu|
20531036|NCT04757636|Opthea Limited|Chief Officer|+61 (0) 3 9826 0399|info@opthea.com|
20531037|NCT03286504|Weill Cornell Medicine|Dr. Daniel Fitzgerald|646-962-8140|dwf2001@med.cornell.edu|
20531038|NCT02730130|Memorial Sloan Kettering Cancer Center|Christopher Barker, MD|212-639-8168|barkerc@mskcc.org|
20531039|NCT00141921|Amgen Inc.|Study Director|866-572-6436||
20531040|NCT00621530|Wake Forest School of Medicine|Dr. James C. Eisenach|336-716-4498|jimeisenach@gmail.com|
20531041|NCT03813654|Brigham and Women's Hospital|Jeanne F. Duffy, Principal Investigator|617-732-7995|jduffy@bwh.harvard.edu|
20531042|NCT01732692|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20531043|NCT02805998|UCSF|Dr. Jennifer Felder|415-476-7014|jennifer.felder@ucsf.edu|
20531044|NCT02081807|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20531045|NCT03104413|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20531046|NCT01208051|University of Chicago|Chih-Yi Liao, MD|(773) 702-6241|andyliao@medicine.bsd.uchicago.edu|
20531047|NCT02721069|Neurelis, Inc.|Cyndi Guerra|9736156258|cguerra@neurelis.com|
20531048|NCT02349386|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
20531049|NCT00973973|AbbVie|Global Medical Services|800-633-9110||
20531050|NCT02471339|National Cancer Institute|Staci M. Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
20531051|NCT02567188|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20531052|NCT02511717|Lawson Health Institute|Dr Blayne Welk|5196466000|lawson@lawsonsresearch.com|
20531053|NCT02026297|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
20531054|NCT01426581|University of Chicago|Valerie G. Press, MD, MPH|73-702-5170|vpress@medicine.bsd.uchicago.edu|
20531055|NCT00655889|Biologics Consulting Group|Dr. Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
20531056|NCT04880850|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20531057|NCT04091451|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20531058|NCT04284774|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20531059|NCT07169032|First Affiliated Hospital of Jinan University|LI ZHEN ZHONG|+8613711706774|nicolezlz@foxmail.com|
20531060|NCT05020015|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20531061|NCT02515253|University of Portsmouth|Dr Emma Sharland||emma.sharland@port.ac.uk|
20531062|NCT00320086|University of New Mexico|Aaron Jacobs, MD|(505)272-5551|Ajacobs@salud.unm.edu|
20531063|NCT00947544|Hyperion Therapeutics|Craig James-Associate Director, Clinical Operations|650-745-7840|craig.james@hyperiontx.com|
20531064|NCT00300053|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
20531065|NCT02385318|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20531066|NCT03095287|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20531067|NCT02594111|VA NY Harbor Healthcare System|Dr. Binita Shah|212-686-7500|binita.shah@va.gov|
20531068|NCT01963611|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20531069|NCT02394275|St. Joseph's Healthcare Hamilton, ON|Dr. Marek Smieja|905 521 6021|smiejam@mcmaster.ca|
20531070|NCT00984867|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20531071|NCT01541748|Coloplast|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
20531072|NCT06057064|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20531073|NCT03340883|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
20531074|NCT01675778|Jacobi Medical Center|Dr. Shujun Xia|718-918-5800|shujun.xia@nbhn.net|
20531075|NCT02240329|University of Florida|Erin Pearson Ph.D CCC/SLP|352-339-4100|epearson@ufl.edu|
20531076|NCT00785629|Denver Nephrologists, P.C.|Geoffrey A. Block, MD|303-364-4775|gablock@denverneph.net|
20531077|NCT00851591|Texas Tech University Health Sciences Center|Thomas Hale, PhD.|806-354-5528|thomas.hale@ttuhsc.edu|
20531078|NCT01038765|Radboud University Medical Centre|Anne E.M. Speckens|0031243610449|a.speckens@psy.umcn.nl|
20565028|NCT02317887|VegaVect, Inc.|Dr. Rob Lin|412-560-9760|r.lin@avistatx.com|
20565029|NCT02593773|Horizon Pharma Ireland, Ltd, Dublin Ireland|Julie Ball, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
20565030|NCT05050149|Palvella Therapeutics, Inc.|Christine Kampf, Vice President of Regulatory Affairs|484-844-0865|christine.kampf@palvellatx.com|
20565031|NCT04447040|Johnson & Johnson Consumer, Inc.|Assoc Dir Med Sci Leader US Self Care Pain|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20531079|NCT00634504|BTG International Inc.|SVP, Clinical Development|610-278-1660|angela.ogden@btgplc.com|
20531080|NCT02110693|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|276
20531081|NCT02210195|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20531082|NCT01928849|Duke University Department of Anesthesiology|Thomas Buchheit, MD Division Chief, Pain Medicine|9196811924|Thomas.Buchheit@duke.edu|
20531083|NCT00297167|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 2634||
20531084|NCT01898130|Northwestern University|Priya Kumthekar, MD|312-503-1818|p-kumthekar@northwestern.edu|
20531085|NCT00920816|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531086|NCT03823131|University of California, San Francisco|Dr Chase Heaton, MD|(415) 502-1889|Chase.Heaton@ucsf.edu|
20531087|NCT01180777|Johnson & Johnson Vision Care|Michael S. Mayers, O.D., FAAO|1-904-443-3252|MMayers@its.jnj.com|
20531088|NCT04491994|Pak Emirates Military Hospital (PEMH) Rawalpindi|Sultan Mehmood Kamran|+923008501100|sultanmajoka79@hotmail.com|
20531089|NCT01953237|University of Maryland, Baltimore|Julie Kreyenbuhl|410-637-1864|jkreyenb@som.umaryland.edu|
20531090|NCT04167462|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20531091|NCT02674659|Harapan Kita National Cardiovascular Center|Bambang Dwiputra, MD, FIHA|0215684093|bambangdwiputra@gmail.com|
20531092|NCT01572792|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20531093|NCT03530696|George Washington Cancer Center|Dr. Pavani Chalasani|(202) 741-2277|pavani.chalasani@email.gwu.edu|
20531094|NCT03416179|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531095|NCT01129128|University of Washington|James A Taylor, MD|206-616-1206|uncjat@uw.edu|
20531096|NCT06438601|CooperVision, Inc.|Jose A. Vega, OD, MSc, PhD|925-621-3761|javega@coopervision.com|
20531097|NCT01900314|University of Michigan|Stephan Taylor|734-936-4955|sftaylor@umich.edu|
20531098|NCT02013414|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
20531099|NCT03282097|Indiana University School of Medicine; Indiana University Center for Aging Research; Regenstrief Institute, Inc.|Nicole R. Fowler, PhD, MHSA; Associate Professor of Medicine|317-274-9021|fowlern@iu.edu|
20531100|NCT02226159|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
20531101|NCT01056536|Travel Clinic, Department of Ambulatory Care and Community Medicine, University Hospital of Lausanne|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
20531102|NCT04497883|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20531103|NCT03136198|Indiana University|Peter S. Pang|317-880-3900|ppang@iu.edu|
20531104|NCT01394276|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20531105|NCT04084015|Massachusetts General Hospital|Dr. David D'Alessandro|617-726-8841|DADALESSANDRO@MGH.HARVARD.EDU|
20531106|NCT02696798|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20531107|NCT01277861|University of Texas Southwestern Medical Center at Dallas|Girish P. Joshi, MD|214-590-7259|girish.joshi@utsouthwestern.edu|
20531108|NCT03311555|Duke University|Andrew Armstrong, MD|919-668-8797|andrew.armstrong@duke.edu|
20531109|NCT00505635|UT MD Anderson Cancer Center|Nicholas E. Papadopoulos, MD / Professor|713-792-2921|CR_Study_Registration@mdanderson.org|
20531110|NCT04213261|Castle Creek Biosciences|Associate VP of Clinical Trials|16506901024|rblumenthal@castlecreekbio.com|
20531111|NCT02566005|Mount Sinai Health Systems|Dr. Zainab Al-Ibraheemi||Zainab.Al-ibraheemi@mountsinai.org|
20551686|NCT00525733|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
20551687|NCT00613015|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
20551688|NCT03632655|Weill Cornell Medicine|Dr. Jim C. Hu|(646) 962-9600|jch9011@med.cornell.edu|
20551689|NCT01179477|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
20551690|NCT00189228|University of New Mexico Health Sciences Center|Dr. Mark Schuyler|5059254197|mschuyler@salud.unm.edu|
20551691|NCT04327388|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20551692|NCT04829318|Janssen-Cilag Limited|Director Global Medical Affairs Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20551693|NCT00728130|Simmons Cancer Institute at Southern Illinois University School of Medicine|Director of Clinical Trials|217-545-1946|krobinson@siumed.edu|
20551694|NCT02730299|Gamida Cell|Associate Director, Clinical Operations|+972-073-2064774|aurelie@gamida-cell.com|
20551695|NCT04053023|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20551696|NCT00071760|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20551697|NCT02073279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20551698|NCT02014363|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
20551699|NCT01558752|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8899|pbeaule@toh.ca|73265
20551700|NCT01980355|Spectrum Health|G. Paul Wright, MD|6162678540|paul.wright@spectrumhealth.org|
20551701|NCT04340362|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20551702|NCT01601782|University of Michigan|Jon Jacobson, MD|734-936-4365|jjacobsn@umich.edu|
20551703|NCT01519414|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|(614) 293-6196|Paul.Monk@osumc.edu|
20551704|NCT04387435|University of California, Los Angeles|Olujimi Ajijola, MD, Phd|310-206-2235|oajijola@mednet.ucla.edu|
20551705|NCT00561080|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20551706|NCT02951156|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20551707|NCT01092182|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|roschewskimj@nih.gov|
20565032|NCT01208662|Dana-Farber Cancer Institute|Ajantha Nithi|857-215-2829|ajantha_nithi@dfci.harvard.edu|
20565033|NCT04076618|Wake Forest University School of Medicine|Kristen Beavers, PhD, MPH, RD|336-758-5855|kbeavers@wakehealth.edu|
20565034|NCT01928394|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20565035|NCT03209973|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20531112|NCT01294514|Covidien|Ulf Borg, Director of Clinical Affairs|303 305 2400|ulf.borg@covidien.com|
20531113|NCT01104285|Maimonides Medical Center|Yizhak Kupfer MD|718-283-8380|ykupfer@maimonidesmed.org|
20531114|NCT02018107|Brigham & Women's Hospital INC|Paul Shyn, MD|6177326304|PSHYN@BWH.HARVARD.EDU|
20531115|NCT05350423|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|212-241-1272|Mantu.Gupta@mountsinai.org|
20531116|NCT02097277|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
20531117|NCT04398966|University of North Carolina at Chapel Hill|Markeela Lipscomb|919-843-3670|markeela_lipscomb@med.unc.edu|
20531118|NCT00671060|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
20531119|NCT00626639|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
20531120|NCT01461551|Ruijin Hospital|Dr. Lijie Jia|13916667704|litery0301@163.com|
20531121|NCT00303186|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531122|NCT03473197|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
20531123|NCT00267670|Northwestern University|Mary E. Rinella, MD|312-503-4592|m-rinella@northwestern.edu|
20531124|NCT02020941|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
20531125|NCT01114555|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak, MD|212-639-7623|modaks@mskcc.org|
20531126|NCT02832037|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20531127|NCT02326883|Kaiser Permanente Washington Health Research Institute|Gregory Simon, Investigator|206-287-2979|gregory.e.simon@kp.org|
20531128|NCT04773795|Nitinotes Ltd.|Ravit Peled- Director of clinical operations|0526145354|ravit@nitinotesurgical.com|
20520147|NCT01286558|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520148|NCT00362817|The Ohio State University Medical Center and James Cancer Hospital & Solove Research Inst.|Herbert Newton,|614-293-4448|newton.12@osu.edu|
20520149|NCT01787279|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20520150|NCT02148913|Corewell Health|Esther Peariso|616-486-0358|esther.peariso@corewellhealth.org|
20520151|NCT01191242|Intermountain Heart Institute|John Carlquist, PhD|8014081028|john.carlquist@imail.org|74707
20520152|NCT01287039|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20520153|NCT05016622|Montefiore Medical Center|Dr. Balazs Halmos|718-405-8404|bahalmos@montefiore.org|
20520154|NCT01304693|Alcon Research, Ltd.|Georges Weissgerber, Executive Director, Novartis Pharma AG|1-888-451-3937|alcon.medinfo@alcon.com|
20520155|NCT00836017|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20520156|NCT02164734|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@amc.edu|
20520157|NCT03923699|Washington University School of Medicine|Thomas Kannampallil|(314) 273-7801|thomas.k@wustl.edu|
20520158|NCT03301532|University of Texas Southwestern Medical Center|Dr. Juan Pascual|214-648-3550|juan.pascual@utsouthwestern.edu|
20520159|NCT03438396|Genmab A/S|Ibrahima Soumaoro|+1 609 430 2481|clinicaltrials@genmab.com|
20520160|NCT00262041|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20520161|NCT00834652|Washington University School of Medicine|Patrick J. Lustman, Ph.D.|3142861320|lustmanp@psychiatry.wustl.edu|
20520162|NCT03578237|University of California San Diego|Program Manager|(858) 220-5714|baabdullah@health.ucsd.edu|
20520163|NCT01173471|AstraZeneca|Stuart McIntosh||ClinicalTrialTransparency@astrazeneca.com|
20520164|NCT04132336|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20520165|NCT01011075|University of Pittsburgh Cancer Institute|Julie E. Bauman, MD|412-648-6507|baumanje@upmc.edu|
20520166|NCT00584844|USAMRIID|Mark Goldberg, MD|301-619-4562|mark.goldberg@amedd.mil|
20520167|NCT02488330|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20520168|NCT00946348|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|603-650-7549|alan.i.green@dartmouth.edu|
20520169|NCT00171301|Novartis Pharmaceuticals|Study Director|862-778-8300||
20520170|NCT04060719|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520171|NCT04319159|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32|ameluz@biofrontera.com|66
20520172|NCT00894517|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20520173|NCT06005597|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20520174|NCT03998436|Novalead Pharma Pvt. Ltd.|Supreet K. Deshpande|7066233033|supreet@novaleadpharma.com|
20520175|NCT02100319|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20520176|NCT00971737|Johns Hopkins University|Leisha Emens, MD, PhD||emensle@jhmi.edu|
20520177|NCT02370914|Stanford University|Dr. Paul Auerbach|(650) 725-9445|auerbach@stanford.edu|
20520178|NCT02224573|Greenwich Biosciences|Medical Enquiries|1-833-424-6724|medinfo@greenwichbiosciences.com|
20520179|NCT01790113|Arthrex|Clinical Affairs Manager|2392161894|melissa.hirschberg@arthrex.com|
20520180|NCT04317313|Second Affiliated Hospital, School of Medicine, Zhejiang University|Dr. Xiaohui Zhang|+86-571-87767188|zhanghui4127@zju.edu.cn|
20520181|NCT01341587|University of Maryland Baltimore|*Administrator, Division of Gerontology|4107062406|cquinn@som.umaryland.edu|
20520182|NCT02654587|OSE Immunotherapeutics|Chief Medical Officer Immuno-Oncology|+33 2 28 29 10 10|contact@ose-immuno.com|
20520183|NCT01825837|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20531129|NCT02107898|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20531130|NCT03329989|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
20531131|NCT01401166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20531132|NCT04383132|Şehit Prof. Dr. İlhan Varank Eğitim Ve Araştırma Hastanesi|Dr. Beslen Göksoy|05349530112|beslengoksoy@gmail.com|
20531133|NCT03901300|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632500|amanda.staiano@pbrc.edu|
20531134|NCT01283386|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20531135|NCT02469857|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
20531136|NCT00937950|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20531137|NCT01531153|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
20531138|NCT03483103|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
20531139|NCT00435942|Bolton Medical, Inc.|Annie Weiller|954-838-9699|AWeiller@boltonmedical.com|
20531140|NCT04727749|University of Saskatchewan|Dr. Colleen Dell|306-966-5912|Colleen.Dell@usask.ca|
20531141|NCT02378181|Public Health Management Corporation|Adam C. Brooks, Ph.D.|215-399-0636|abrooks@tri.phmc.org|
20531142|NCT03988647|Stanford University|Susan J Knox, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
20531143|NCT02320396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20531144|NCT03331562|Translational Genomics Research Institute (TGen) An Affiliate of City of Hope|Derek Cridebring, PhD. Director, Molecular Medicine Division|6023438629|dcridebring@tgen.org|
20531145|NCT03718000|University of Georgia|Dr. Jamie Cooper, Associate Professor|706-542-4903|jamie.cooper@uga.edu|
20531146|NCT02234180|Memorial Sloan-Kettering Cancer Center|Yelena Y. Janjigian MD|646-888-4186|janjigiy@mskcc.org|
20531147|NCT02475213|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20531148|NCT01186770|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20531149|NCT00505921|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Associate Professor|713-792-8848|pmcadams@mdanderson.org|
20531150|NCT02441283|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20531151|NCT01033136|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 578-5513|Ellen.Teng@va.gov|
20531152|NCT00630292|University of North Carolina|William Irvin, Jr. MD / Co-Principal Investigator|919-966-6735|william_irvin@med.unc.edu|
20531153|NCT02382939|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20531154|NCT04342169|University of Utah School of Medicine Division of Infectious Diseases|Dr. Adam Spivak|8015871964|adam.spivak@hsc.utah.edu|
20531155|NCT00142415|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20531156|NCT05383209|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
20531157|NCT02411643|Northwestern University|Stephanie Rangel|3125035942|stephanie.rangel@northwestern.edu|
20531158|NCT00321763|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531159|NCT00717886|Memorial Sloan Kettering Cancer Center|Dr. Leslie Montgomery|(212) 639-5386|Montgoml@mskcc.org|
20531160|NCT00716417|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20531161|NCT01553851|Washington University School of Medicine|Dr. Douglas Atkins|314-747-8475|datkins@dom.wustl.edu|
20531162|NCT01807455|Q-Med AB|Chief Medical Officer|+ 46 (0) 18 474 90 00|Reception.SEUPP@galderma.com|
20531163|NCT02472353|Avera|Stacy Kehoe|605.322.3082|Stacy.Kehoe@avera.org|
20531164|NCT02101294|Finger Relief|Molly Choate Summers|703-517-8951|summers.molly@gmail.com|
20531165|NCT00797563|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20531166|NCT00149643|University of Pittsburgh|Jack R. Cornelius, M.D.|412-246-6906|corneliusjr@upmc.edu|
20531167|NCT00475332|University of Florida|Bridget Fitzgerald, Clinical trials coordinator|(352) 265-0680|fitzgb@shands.ufl.edu|87829
20531168|NCT00688597|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
20531169|NCT03822416|University of Minnesota|Harry Lando, PhD|612-624-1877|lando001@umn.edu|
20531170|NCT05233761|Defined Research Institute|Paul Muchowski|415-413-8666|paul.muchowski@definedresearch.org|
20531171|NCT04058717|Penn State College of Medicine|Nicolle Krebs|7175315673|nkrebs@pennstatehealth.psu.edu|
20531172|NCT03513952|Fred Hutchinson Cancer Center|Cancer Immunotherapy Trials Network Trial Manager|514-718-2858|citn@fredhutch.org|
20531173|NCT01093417|University Hospitals Case Medical Center|Grace McComsey, MD|2168443607|gam9@case.edu|
20531174|NCT00846365|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20531175|NCT03133676|Calibr, a Division of Scripps Research|Study Director|(858) 242 1000|KA34ph1@scripps.edu|
20531176|NCT03654417|Duke University|Dr. Laura Havrilesky|(919) 684-0188|laura.havrilesky@duke.edu|
20531177|NCT01925417|Rebiotix|Sarah Mische PhD, Associate Director of Clinical Research|6512122839|smische@rebiotix.com|
20531178|NCT05203185|NYU Langone Health|Safiya Richardson, MD, MPH|212-263-8313|Safiya.Richardson@nyulangone.org|
20531179|NCT02072200|Mundipharma Korea Ltd|Kim Bu Yeon|+82 2 568 5689|BuYeon.Kim@mundipharma.co.kr|
20531180|NCT03308669|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20531181|NCT01157845|Virginia Commonwealth University|R. Todd Stravitz|804-828-8514|rstravit@vcu.edu|
20531182|NCT01890577|Amgen Inc.|Study Director|866-572-6436||
20531183|NCT00835926|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20531184|NCT03320369|Northwestern University|Nirmala Gonsalves|312-695-4054|n-gonzalves@northwestern.edu|
20531185|NCT01155141|Stanford University|Dr. Richard Lafayette|650-498-6063|czar@stanford.edu|
20531186|NCT00844519|University of California San Francisco|Dr. Priscilla Hsue|415-206-8257|phsue@medsfgh.ucsf.edu|
20531187|NCT01303419|GE Healthcare|Jean-Paul Antonini|+33 130709703|Jean-Paul.antonini@ge.com|
20565036|NCT04066205|University of Washington|Teresa Ward, Professor, Department of Pediatrics|206-884-1439|teresa.ward@seattlechildrens.org|
20565037|NCT04870307|University of Oklahoma Tulsa|Dr. Juell Homco|918-660-3038|juell-homco@ouhsc.edu|
20531188|NCT03769493|Brown University|Ethan Moitra, Ph.D.|4014441949|ethan_moitra@brown.edu|
20531189|NCT02709369|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
20531190|NCT00743093|Denver Heatlh Rocky Mountain Poison and Drug Center|Jody Green, PhD|303-389-1246|jody.green@rmpdc.org|
20531191|NCT01732211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531192|NCT02755090|University of New Mexico|Sharla Biefeld Research Coordinator|505-272-9703|hsc-familyplanningresearch@salud.unm.edu|
20531193|NCT05473039|SEID|Ana Gavilán|+34 630928812|agavilan@lab-seid.com|
20531194|NCT02337829|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
20531195|NCT04325386|University of Maryland, Baltimore|Dr Deanna L. Kelly, PharmD, BCPP|410-402-6861|dlkelly@som.umaryland.edu|
20531196|NCT02373865|GWT-TUD GmbH, Study center Prof. Hanefeld|Prof. Dr. Markolf Hanefeld|+49 351 44005|Markolf.Hanefeld@gwtonline.de|82
20531197|NCT01052948|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531198|NCT01551173|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20531199|NCT04530344|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20531200|NCT01402700|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20531201|NCT03507790|Cogntion Therapeutics Inc|Dr. Anthony Caggiano|914-221-6730|acaggiano@cogrx.com|
20531202|NCT03279952|Penn State College of Medicine|Raman Baweja, MD|7175318521|rbaweja@pennstatehealth.psu.edu|
20531203|NCT00157755|Medtronic Neuromodulation|Clinical Program Manager|763-526-8172|medtronicneurotrials@medtronic.com|
20531204|NCT02141555|University of California, San Diego|Dr. Sheila Mody||smody@ucsd.edu|
20531205|NCT01719653|Gastroenterology Services, Ltd|David Gerard, MD|630 969 1167|davidpgerard@comcast.net|
20531206|NCT03314935|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20531207|NCT00168298|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20531208|NCT03869268|The University of Sheffield|Dr William Parker|01142266159|w.parker@sheffield.ac.uk|
20531209|NCT03331341|University of Washington|Dr. Ryan Lynch, Associate Professor|206-606-1739|rclynch@uw.edu|
20531210|NCT05352399|Yale School of Medicine|Cameron Gettel|717-228-7759|cameron.gettel@yale.edu|
20531211|NCT02340949|MFAR Clinical Research|Pau Doñate Macian|0034934344412|investigacion@mfar.net|
20531212|NCT01192178|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531213|NCT01579214|Massachusetts General Hospital|Dr. Mark Siedner|617-726-4686|msiedner@mgh.harvard.edu|917
20531214|NCT01977846|Foundation Fighting Blindness|Chief Scientific Officer|410-423-0600|info@FightBlindness.org|
20531215|NCT02164916|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408|smcdonou@fredhutch.org|
20531216|NCT00296517|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531217|NCT03229499|Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine|Dr. Steven M Kawut, MD, MS|646-352-1654|kawut@upenn.edu|
20531218|NCT01143324|MedtronicSpineECA|Christel Van Dam|+31433566523|christel.van.dam@medtronic.com|
20531219|NCT02630030|Emory University|Dr. Jeffrey Olson|404-778-5770|jolson@emory.edu|
20531220|NCT01484340|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|443-287-2969|jgolub@jhmi.edu|
20531221|NCT00596635|Yale University School of Medicine|Manisha Juthani-Mehta, MD|(203)785-4140|manisha.juthanimehta@yale.edu|
20531222|NCT01010763|Zimmer Biomet G.K.|Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
20531223|NCT01101178|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20531224|NCT01850641|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20531225|NCT00141817|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531226|NCT01643213|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
20531227|NCT00127803|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20531228|NCT00944554|Johns Hopkins University|Maxine Stitzer, PhD|410-550-0042|mstitze1@jhmi.edu|
20531229|NCT01020123|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20531230|NCT04901624|University of Southern California|Dr. Jason Doctor|213.821.8142|jdoctor@usc.edu|
20531231|NCT02587936|UT Southwestern Medical Center|Miguel A Vazquez|214-648-8884|Miguel.Vazquez@UTSouthwestern.edu|
20531232|NCT03479905|UTexasSouthwestern|Christina Riccio|214-590-7284|Christina.Riccio@utsouthwestern.edu|
20531233|NCT00862992|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20531234|NCT00720759|VAHSRD|Stephen E. Nadeau|352-374-6082|stephen.nadeau@va.gov|
20531235|NCT01047319|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20531236|NCT02318940|Universidad de Chile|Dr. Pietro Pietroboni Fuster|+56982261539|pietroboni@gmail.com|
20531237|NCT03100747|University of North Carolina at Chapel Hill|Emily Gower, PhD|919-966-1420|egower@unc.edu|
20531238|NCT04376567|University of Arizona|Tze-Woei Tan|3234426835|tze-woei.tan@med.usc.edu; ttan@arizona.edu|
20531239|NCT00658619|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20531240|NCT03261193|UPMC|Nicholas Schott, MD|412-692-4503|schottnj@upmc.edu|
20531241|NCT05032196|Wave Life Sciences USA, Inc|Medical Director, MD|+1 617-949-2900|info@wavelifesci.com|
20531242|NCT00857389|UT MD Anderson Cancer Center|Kris M Mahadeo, Associate Professor, Pediatrics - Patient Care|(713) 792-2873|kmmahadeo@mdanderson.org|
20531243|NCT04356833|Royal Free London NHS Foundation Trust|Professor Pratima Chowdary|0207 794 0500|p.chowdary@nhs.net|35921
20531244|NCT04817410|Rutgers New Jersey Medical School|Ethan Cowan|917-447-4964|ethan.cowan@rutgers.edu|
20531245|NCT03595748|Albert Einstein College of Medicine|Dr. Ladan Golestaneh|718-920-5442|lgolesta@montefiore.org|
20531246|NCT04809974|Massachusetts General Hospital|Edmarie Guzmán-Vélez|6176436107|eguzman-velez@mgh.harvard.edu|
20531247|NCT03166709|Center for Suicide Prevention and Recovery, University of Washington|Dr. Katherine Anne Comtois|206-744-1752|uwcspar@uw.edu|
20531248|NCT04070703|Oregon Research Institute|Fuzhong Li|5414842123|fuzhongl@ori.org|
20531249|NCT00549055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531250|NCT01134042|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531251|NCT01733953|University of Minnesota|Cameron Naughton|612-625-3623|naug0009@umn.edu|
20531252|NCT00674297|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
20531253|NCT01091259|Perlmutter Cancer Center at NYU Lagone|Franco Muggia, MD|212-263-6485|Franco.Muggia@nyumc.org|
20531254|NCT01137786|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
20531255|NCT00770367|Medical University of South Carolina|Dana King MD|843-792-8112|kingde@musc.edu|
20531256|NCT01989975|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
20531257|NCT01545336|University of Pennsylvania|Dr. Steven M. Kawut|215-573-0258|kawut@upenn.edu|
20531258|NCT03881371|Zambon S.p.A|Valentina Zanin|+39 02 665241|valentina.zanin@zambongroup.com|
20531259|NCT01101100|Valeant Pharmaceuticals International|Lindsey Mathew|908|lindsey.mathew@valeant.com|
20531260|NCT02508389|Galera Therapeutics, Inc.|Kara Terry|610-725-1500|kterry@galeratx.com|
20531261|NCT01869374|New York State Psychiatric Institute|Stefan Rowny, MD|(646) 774-5417|stefan.rowny@nyspi.columbia.edu|
20531262|NCT04666298|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20531263|NCT01532089|Duke University|Thomas E. Stinchcombe, M.D.|507/284-4565|thomas.stinchcombe@duke.edu|
20531264|NCT01995201|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20531265|NCT03329001|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20531266|NCT01138046|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531267|NCT02178956|Sumitomo Dainippon Pharma Oncology|Marilyn Fontaine|617-674-8556|mfontaine@bostonbiomedical.com|
20531268|NCT00622518|University of Washington|James A. Taylor, MD|206-616-1206|uncjat@u.washington.edu|
20531269|NCT03149770|University of Minnesota|Anjali Kumar|612-301-7040|studydiabetes@umn.edu|
20531270|NCT00963235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531271|NCT00585182|University of Utah|Dr Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
20531272|NCT01104766|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
20531273|NCT01136915|Bracco Diagnostics, Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
20531274|NCT01756235|AbbVie|Global Medical Information|800-633-9110||
20531275|NCT04225832|RAND|Laura Bogart, PhD|3103830411|lbogart@rand.org|7281
20531276|NCT02327078|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20531277|NCT04940221|Christiana Care Health System|Heather Bittner Fagan, MD MPH|302 320 4110|hbittner-fagan@christianacare.org|
20531278|NCT01138735|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20531279|NCT04797169|Icahn School of Medicine at Mount Sinai|Thomas B Hildebrandt, Psy.D.|(212) 659-8673|tom.hildebrandt@mssm.edu|
20531280|NCT02236364|University of Toledo|Basil Akpunonu, MD|419-383-4909|Basil.Akpunonu@utoledo.edu|
20531281|NCT03839641|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
20531282|NCT04291131|VA Boston Healthcare System|Marilyn Moy, MD, MSc|857-203-6622|marilyn.moy@va.gov|
20531283|NCT04221490|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20531284|NCT05850494|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20531285|NCT05653843|Boston Scientific|Andrea Burbage, Principal Clinical Trial Manager|7812544679|andrea.burbage@bsci.com|
20565038|NCT04432506|The University of Texas MD Anderson Cancer Center|Paolo Strati, MD|(713) 745-1776|pstrati@mdanderson.org|
20565039|NCT03249090|University of North Carolina at Chapel Hill|Principal Investigator|9194456223|symptom_study@unc.edu|
20565040|NCT02432261|Health Decisions|Kimberly Myer|9842381297|Kimberly.Myer@premier-research.com|
20565041|NCT04200911|UT Health San Antonio|Mitzi Gonzales, PhD|210-450-9047|Gonzalesm20@uthscsa.edu|
20565042|NCT04359654|University College London|Ms Donna Basire|+44-2031087748|d.basire@ucl.ac.uk|
20565043|NCT05841004|Coloplast A/S|Christian Riis Forman, Medical writer|49111756|dkcrif@coloplast.com|
20565044|NCT04024020|University of Pennsylvania|Philip Gehrman|2157463578|philip.gehrman@pennmedicine.upenn.edu|
20565045|NCT05193409|Bionomics Limited|SVP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
20565046|NCT04134208|The University of Texas M D Anderson Cancer Center|Dr. Gregory Ravizzini|(713) 518-9866|gravizzini@mdanderson.org|
20565047|NCT04726371|The Mongan Institute at Massachusetts General Hospital|Dr. Stephen Bartels|617-726-5213|sjbartels@mgh.harvard.edu|
20565048|NCT05863156|Uskudar Univercity|Tugba YILMAZ ESENCAN|05057084946|tugba.yilmazesencan@uskudar.edu.tr|
20565049|NCT05061069|Ghent University|Prof. Dr. Leen Maes|093324066|leen.maes@ugent.be|+32
20565050|NCT03672916|Zimmer Biomet|Martina Hersberger, Clinical Project Lead|+41 79 535 90 29|martina.hersberger@zimmerbiomet.com|
20565051|NCT04083170|Fred Hutchinson Cancer Center|Dr. Filippo Milano|206.667.5925|fmilano@fredhutch.org|
20565052|NCT03513302|Indiana University Indianapolis|Dr. Andrew Coggan|3172740656|acoggan@iu.edu|
20565053|NCT05256654|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20565054|NCT02112526|Acerta Pharma LLC|Study Director|1-888-292-9613|acertamc@dlss.com|
20565055|NCT00866684|Charité Universitätsmedizin Berlin Augustenburger Platz 1 13353 Berlin|Prof. Dr. Petra Reinke|+49 30 450 653 490|petra.reinke@charite.de|
20565056|NCT04862416|Radboud university medical center|Dr. Matthew McCall|+31 24 361 43 56|Matthew.McCall@radboudumc.nl|
20565057|NCT00746096|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
20565058|NCT05207982|University at Buffalo, Department of Psychiatry|Daniel Antonius|7168582792|danielan@buffalo.edu|
20565059|NCT02807545|Scottish Rite for Children|Karina Zapata|214-559-7790|karina.zapata@tsrh.org|
20531286|NCT00722020|Winthrop University|Jon Roberts, MD|516-663-4600|jroberts@winthrop.org|
20531287|NCT03188822|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
20531288|NCT04537299|Mayo Clinic|Brandon Verdoorn, M.D.|507-266-6201|Verdoorn.Brandon@mayo.edu|
20531289|NCT00392041|Princeton University|Lesley Allen, Ph.D.|609-924-9213|lesleyaallen@gmail.com|
20531290|NCT00957359|NYU Langone Health|Stephen Ross, MD|212-263-7264|Stephen.Ross@nyulangone.org|
20531291|NCT03034967|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20531292|NCT03806296|University of Pittsburgh School of Medicine|Brant Hasler, PhD|412-246-6413|haslerbp@upmc.edu|
20531293|NCT04297917|Vaccitech Plc|Tom Evan, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
20531294|NCT04279483|University of Pennsylvania|Emily Falk|215-573-9901|emilybfalk@falklab.org|
20531295|NCT01998360|University of New England|Peter S. Millard, MD, PhD|2078663503|pmillard@mac.com|
20531296|NCT04613453|Yale University|Brooke Rivera|203-974-2241|Brooke.rivera@yale.edu|
20531297|NCT02084797|Oakland University|Tamara Hew-Butler|248-364-8686|hew@oakland.edu|
20531298|NCT02763566|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20531299|NCT00790036|Novartis Pharmaceuticals|Study Director|862-778-8300||
20531300|NCT03197129|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972-2-6776135|fuxavia@gmail.com|
20531301|NCT02442349|AstraZeneca|Global Clinical Lead, Yuri Rukazenkov|+441625231825||
20531302|NCT01285518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531303|NCT00879658|Novartis Pharmaceuticals|Study Director||Novartis.email@novartis.com|
20531304|NCT00639509|Memorial Sloan-Kettering Cancer Center|Ghassan K. Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
20531305|NCT05457855|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20531306|NCT01654276|University of Texas Southwestern Medical Center|Naim Maalouf. MD|214-648-2954|naim.maalouf@utsouthwestern.edu|
20531307|NCT02657551|Dana-Farber Cancer Institute|Kartik Seghal|000-000-0000|Kartik_Sehgal@dfci.harvard.edu|
20531308|NCT04478266|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20531309|NCT00964782|Milton S. Hershey Medical Center|Compliance Specialist|7175310003|clinicaltrials.gov@pennstatehealth.psu.edu|287544
20531310|NCT05260008|Allay Therapeutics, Inc|Study Director|669-679-5081|clinicaltrialsinfo@allaytx.com|
20531311|NCT00001305|National Institute of Child Health and Human Development|Marini, Joan|+1 301 594 3418|marinij@mail.nih.gov|
20531312|NCT04584788|Masimo Corporation|Cristina Johnson|(949) 297-7576|clinicalresearchdept@masimo.com|
20531313|NCT02546570|National Center for PTSD|Dr. Lauren Sippel|802-295-9363|lauren.m.sippel@dartmouth.edu|6082
20531314|NCT01740206|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
20531315|NCT01080261|Boston Scientific Corporation|Ruth Starzyk, Ph.D.|508-683-6577|ruth.starzyk@bsci.com|
20531316|NCT01240746|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20531317|NCT02472405|University of Miami|Keyvan Nouri MD|305-243-3380|KNouri@med.miami.edu|
20531318|NCT01431976|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531319|NCT00055237|National Cancer Institute, National Institutes of Health|Robert Yarchoan, M.D.|301-496-0328|Robert.Yarchoan@nih.gov|
20531320|NCT04601506|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
20531321|NCT00867932|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.||ClinicalTrials@Alexion.com|
20531322|NCT01126424|Astellas Pharma Europe Ltd.|Associate Medical Director Urology||clinicaltrials@us.astellas.com|
20531323|NCT02127671|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20531324|NCT00248560|Barbara Ann Karmanos Cancer Institute|Ammar Sukari, M.D.|313-576-8751|sukaria@karmanos.org|
20531325|NCT03834168|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|2059754720|parora@uabmc.edu|
20531326|NCT00764517|Knight Cancer Institute, Oregon Health & Science University|Dr. Stephen E. Spurgeon MD|503-494-4606|spurgeos@ohsu.edu|
20531327|NCT00520468|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
20531328|NCT01433913|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
20531329|NCT04706221|Zynex Monitoring Solutions|Donald Gregg|(800) 495-6670|dgregg@zynex.com|3802
20531330|NCT02239328|Washington University|Dr. Benjamin Kozower|314-362-8089|kozower@wustl.edu|
20531331|NCT00460798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531332|NCT04115059|Dana-Farber Cancer Institute|Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
20531333|NCT03589703|Johns Hopkins University|Nada Lukkahatai, PhD, MSN, RN, CNE, FAAN|410-614-5297|nada.lukkahatai@jhu.edu|
20531334|NCT01088789|SKCCC Johns Hopkins Medical Institution|Daniel Laheru, MD|410-955-8974|Laherda@jhmi.edu|
20531335|NCT03517137|EORTC|Catherine Fortpied|+32 2 774 1681|catherine.fortpied@eortc.org|
20531336|NCT03575364|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
20531337|NCT02321527|The University of Texas (UT) MD Anderson Cancer Center|Dr. Basak Dogan/Diagnostic Radiology|713-792-7734|CR_Study_Registration@mdanderson.org|
20531338|NCT01654887|Icahn School of Medicine at Mount Sinai|Dr. James Tsung|212-241-6272|james.tsung@mountsinai.org|
20531339|NCT02313155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20531340|NCT05376358|University of Pittsburgh|Dr. Ana Radovic|4126927227|anr94@pitt.edu|
20531341|NCT00311168|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
20531342|NCT01234116|Henry Ford Health Sytem|Indira Brar, MD|313-916-2565|ibrar1@hfhs.org|
20531343|NCT03965923|Fred Hutchinson Cancer Center|Daniel Szydlo|2066677451|dszydlo@fredhutch.org|
20531344|NCT02452190|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20565060|NCT04295512|San Diego State University|Kelsey Dickson|(619) 594-5380|kdickson@sdsu.edu|q
20565061|NCT04089059|UCSF School of Medicine|Liviu Klein|415-476-2143|liviu.klein@ucsf.edu|
20531345|NCT04635345|Barts Health NHS Trust|Jessica Gaddie|020 7480 4737|j.gaddie1@nhs.net|
20531346|NCT06001021|University of Gujrat|Dr. Sameera Shafiq (Lecturer, M. Phil, QAU; Ph.D., UOG)|923345116648|sameera.shafiq@uog.edu.pk|
20565062|NCT03728608|University of Florida|Leslie Parker|352 273 6384|parkela@ufl.edu|
20565063|NCT02329262|The Ohio State University Martha S. Pitzer Center for Women, Children and Youth|Principal Investigator|16142924578|smith.5764@osu.edu|
20565064|NCT05207956|University of Pennsylvania|Dr. David Mandell|(215) 573 7494|david.mandell@pennmedicine.upenn.edu|
20565065|NCT04243070|BIOTRONIK SE & Co. KG|Senior Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20520184|NCT00904748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520185|NCT04403763|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20520186|NCT01534637|Comprehensive Cancer Center of Wake Forest University|James Lovato, MS|336-713-4172|jlovato@wakehealth.edu|
20520187|NCT02377921|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20520188|NCT01481740|Department of Women's & Obstetric Anesthesia, IWK Health Centre|Dr. Ronald B George|902-470-6627|rbgeorge@dal.ca|
20520189|NCT02510014|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
20520190|NCT01020799|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20520191|NCT04209335|University of Salford|ISOMETRIC CORE MUSCLE ENDURANCE IN HEALTHY ACTIVE AND NON-ACTIVE WORKING AGE POPULATIONS|07488550768|H.Holmberg@edu.salford.ac.uk|
20520192|NCT00754468|University of Miami|Dr. Alfonso Ribeiro|305-243-4000|Aribeiro@med.miami.edu|
20520193|NCT00787020|Duke University Medical Center|DaiWai M Olson|9196683751|Olson006@mc.duke.edu|
20520194|NCT00233987|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
20520195|NCT00656968|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3422121|pihsu@isca.vghks.gov.tw|8233
20520196|NCT03377023|Moffitt Cancer Center|Dr. Jhanelle E. Gray|813-745-7282|jhanelle.gray@moffitt.org|
20520197|NCT04141696|National Institute of Nursing Research (NINR)|Dr. Leorey Saligan, PhD.|+1 301 451 1685|saliganl@mail.nih.gov|
20520198|NCT04583163|Hackensack Meridian Health|Tania Zielonka|5519964452|tania.zielonka@hmhn.org|
20520199|NCT03943537|McLean Hospital|Virginie-Anne Chouinard|617-855-3034|vchouinard@mclean.harvard.edu|
20520200|NCT05599269|Ivoclar Vivadent AG|Dr. med. dent. Ronny Watzke|+423 235 3401|Ronny.Watzke@ivoclar.com|
20520201|NCT01010126|Mayo Clinic|Henry Pitot, M.D.|(507) 284-2511|pitot.henry@mayo.edu|
20520202|NCT00493246|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20520203|NCT05218109|University of Florida|Sarah Bottari, M.S.|(352) 273-6455|sbottari@ufl.edu|
20520204|NCT00595335|Mayo Clinic|Dr. Rebecca S. Bahn|507-284-2462|bahn.rebecca@mayo.edu|
20520205|NCT01959490|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
20520206|NCT04859699|University of Washington|Linda K. Ko|+1 206 707-5624|lindako@uw.edu|
20520207|NCT03028948|Rutgers Cancer Institute of New Jersey|Dr. Sharon Manne|7322356759|mannesl@cinj.rutgers.edu|
20520208|NCT04718545|Goteborg University|Dr Olivier Carcuac|317863124|olivier.carcuac@gu.se|+46
20520209|NCT04843566|Weill Cornell Medicine|Jim Hu|2127463418|jch9011@med.cornell.edu|
20520210|NCT04963569|NHS Lothian/University of Edinburgh|Dr John (Jack) Cafferkey|0|j.cafferkey@ed.ac.uk|
20520211|NCT00493779|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20520212|NCT01647958|EndoGastric Solutions|Adrian Lobontiu|650-474-9259|alobontiu@endogastricsolutions.com|
20520213|NCT01131299|NIH NHLBI|Dr. Marcelo Amar|301-402-0521|mamar@mail.nih.gov|
20520214|NCT01300624|Brain Rehabilitation Research Center, Malcom Randall VA, Gainesville, FL|Lisa Edmonds, PhD|352.262.4465|lisa.annamarie.edmonds@gmail.com|
20520215|NCT01398059|University of Prince Edward Island|Dr. Travis Saunders|902-566-0641|trsaunders@upei.ca|
20520216|NCT01207440|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20520217|NCT03341000|MCRA, LLC|Nicole Harris|202-552-5800|nharris@mcra.com|5823
20520218|NCT01592721|UTexas_SanAntonio|Anand B. Karnad, MD|2104501365|regulatoryaffairs@uthscsa.edu|
20520219|NCT01642914|Forest Research Institute|Steven Shiff, Executive Director, Clinical Development|201-427-8000|Steven.Shiff@actavis.com|8077
20520220|NCT02566993|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 918466000|clinicaltrials@pharmamar.com|
20520221|NCT04323098|BioMarin Pharmaceutical Inc.|Tara M Robinson, MD, PhD, Senior Medical Director, Late-Stage Clinical Development|415-455-7931|tara.robinson@bmrn.com|
20520222|NCT02589522|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
20520223|NCT01478828|The SKCCC at Johns Hopkins|Dr. Phuoc Tran|410-614-6477|tranp@jhmi.edu|
20520224|NCT05611996|Massachusetts General Hospital|Dr. Jin Hui Joo|6177245317|jhjoo@mgh.harvard.edu|
20520225|NCT04479475|Johns Hopkins University|Haneefa Saleem, PhD, MPH|443-287-5130|haneefa.saleem@jhu.edu|
20520226|NCT02025010|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
20520227|NCT01122316|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
20520228|NCT01300052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520229|NCT04572243|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20520230|NCT01661881|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
20520231|NCT01231373|BTG International Inc.|David Wright MBBS|610-278-1660|david.wright@btgplc.com|
20520232|NCT03451006|Mayo Clinic|Mandeep Singh, M.D.|507-255-2398|Singh.Mandeep@mayo.edu|
20520233|NCT00775606|Rush University Medical Center|Allan R. Tenorio|312-942-3665|allan_s_tenorio@rush.edu|
20520234|NCT02278718|MediWound|Keren David Zarbiv|972-77-9714103|kerend@mediwound.com|
20520235|NCT04440449|University of Texas Health San Antonio|Rozmin Jiwani|210-450-8498|jiwani@uthscsa.edu|
20520236|NCT02547766|University of Utah|Associate Director of Clinical Trials|801-581-5318|heather.thiesset@hsc.utah.edu|
20520237|NCT00767338|University of Michigan|Gregory Christman, MD|734-764-8142|growthh@umich.edu|
20520238|NCT03253744|National Cancer Institute|Dr. Deborah E. Citrin|240-760-6206|citrind@mail.nih.gov|
20531347|NCT06001866|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
20531348|NCT00207740|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
20531349|NCT03916926|Case Western Reserve University|Suchitra Nelson|216-368-3469|suchitra.nelson@case.edu|
20531350|NCT04800627|UT MD Anderson Cancer Center|Dr. Michael Overman,MD- Assoc VP, CN Research, SVP, Cancer NW Clin & Acad Dev|(713) 792-2828|moverman@mdanderson.org|
20531351|NCT04926233|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20531352|NCT02802228|Cumberland Pharmaceuticals|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
20531353|NCT05984030|UNC Institute for Global Health and Infectious Diseases|Sarah Rutstein, MD, PhD|919-966-2537|sarah_rutstein@med.unc.edu|
20531354|NCT01925794|CeloNova BioSciences Inc.|Mark Barakat, MD|(210) 489-4004|mbarakat@celonova.com|
20531355|NCT01901562|Montefiore Medical Center|Dr. Sheldon Feldman, Chief Breast Surgery and Breast Surgery Oncology|929-246-6300|sfeldman@montefiore.org|
20531356|NCT01564407|University of Pittsburgh|Amy Steele, RN, MSN, CCRC|412-641-3728|steeleam@upmc.edu|
20531357|NCT05007925|Shockwave Medical|Denise Winn|410-991-9311|dwinn@its.jnj.com|
20531358|NCT03126110|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20531359|NCT00294658|University of Alabama at Birmingham|Dr. Gary Cutter, Professor|205-975-5048|cutter@uab.edu|
20531360|NCT00580840|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20531361|NCT00208975|Emory University|Dr. Christopher Flowers|404-778-3942|crflowe@emory.edu|
20531362|NCT00976027|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20531363|NCT05049122|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20531364|NCT01910441|Novartis|Study Director|862-778-8200||
20531365|NCT03636477|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
20531366|NCT02864992|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20531367|NCT02382380|Loyola University Medical Center|Ari Goldberg, M.D.|708-216-2229|argoldberg@lumc.edu|
20531368|NCT05168800|Dartmouth College|Glyn Elwyn|(603) 646-5623|glynelwyn@gmail.com|
20531369|NCT04958707|University of Medicine and Pharmacy at Ho Chi Minh City|Dr. Nguyen Tran To Tran|+84 979635889|nguyentrantotran@ump.edu.vn|
20531370|NCT02489539|W.L. Gore & Associates|Charee Robe|928-864-4048|crobe@wlgore.com|
20531371|NCT02629159|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20531372|NCT05722015|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20531373|NCT05523297|Toronto General Hospital|Dr Keyvan Karkouti|(416) 340-8597|keyvan.karkouti@uhn.ca|
20531374|NCT02512419|Brown University|Dr. Bess Marcus|401-863-9858|bess_marcus@brown.edu|
20531375|NCT00830765|UMississippi|Dr John Morrison|601-984-5300|jmorrison@umc.edu|
20531376|NCT00315445|Purdue Pharma L.P.|Medical Director|800-733-1333||
20531377|NCT01299909|University of Wisconsin|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
20531378|NCT02460289|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20531379|NCT01155570|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20531380|NCT02530541|BSL|C. Beausoleil|406-587-5735|cbeausoleil@biosciencelabs.com|
20531381|NCT02353780|University of Pittsburgh|Larry Moreland, MD|412-648-4098|lwm5@pitt.edu|
20531382|NCT02774889|University of Wisconsin-Madison|Associate Research Specialist|6082631105|wpalmer3@wisc.edu|
20531383|NCT00858988|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454-2178|manary@kids.wustl.edu|
20531384|NCT02525523|Atlantic Pharmaceuticals|Dr Chris Dunk, Director of Clinical Development|+44 1799 513391|chris.dunk@atlantichc.com|
20531385|NCT01349595|Mayo Clinic|Dr. Mark Stegall|507-266-2812|Stegall.Mark@mayo.edu|
20531386|NCT01706328|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531387|NCT06481579|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20531388|NCT01369433|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
20531389|NCT02196831|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@mgh.harvard.edu|
20531390|NCT06525727|Marmara University School of Medicine|Dr. Emre Kudu|+902166254545|dr.emre.kudu@gmail.com|
20531391|NCT00933933|Abbott Diagnostic Division|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
20531392|NCT01341470|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20531393|NCT04057235|Integrity Implants Inc|Lauren Kamer, Senior Director of Regulatory and Clinical Affairs|+1.561.529.3861|lkamer@integrityimplants.com|
20531394|NCT03225482|VA San Diego Healthcare System|Elizabeth Twamley, PhD|858-642-3848|Elizabeth.Twamley@va.gov|
20531395|NCT05658887|University of Iowa Hospitals and Clinics|Dr. Colin Johnson|3193561616|colin-johnson@uiowa.edu|
20531396|NCT04341636|King Abdulaziz University|Dr. Zuhair Natto|9666943899|znatto@kau.edu.sa|
20531397|NCT03112603|Call Center|Incyte Corporation|1.855.463.3463|medinfo@incyte.com|
20531398|NCT04725188|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20531399|NCT00390013|University of Iowa|Colleen Kennedy Stockdale, MD, MS|319-384-6849|colleen-stockdale@uiowa.edu|
20531400|NCT03765073|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531401|NCT02550795|Gil hospital|Dr. Youn Yi Jo|82324603636|endless37@gilhospital.com|
20531402|NCT00695019|Amarillo Biosciences, Inc.|Martin J. Cummins, Director of Clinical & Regulatory Affairs|806-376-1741|mcummins@amarbio.com|14
20531403|NCT02225587|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20531404|NCT00924898|The University of North Carolina|Dr. Cynthia Gay|919-843-2726|cynthia_gay@med.unc.edu|
20531405|NCT03116230|Stanford University|Thomas Andriacchi|650-|tandriac@stanford.edu|
20531406|NCT04896385|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20531407|NCT05258721|Arcadia Consumer Healthcare, Inc.|Jai Shewale|504-913-4344|jshewale@arcadiach.com|
20531408|NCT04512924|Medical University of South Carolina|Dr. Brantlee Broome|843-792-3370|broomeb@musc.edu|
20531409|NCT05291689|Morphic Therapeutic Inc.|Head of Clinical Development|781-996-0955|clinicaltrials@morphictx.com|
20531410|NCT01931098|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@nih.gov|
20531411|NCT00230737|University of Pennsylvania|Dr. Nalaka Gooneratne|2674083789|ngoonera@upenn.edu|
20531412|NCT02278354|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20531413|NCT00562328|Mayo Clinic|Timothy G. Call, M.D.|507-266-4671|Call.Timothy@mayo.edu|
20531414|NCT02612155|Duke University|Dr. Kim Fisher, Ph.D., FNP-BC|919-681-4913|kimberley.fisher@duke.edu|
20531415|NCT03073759|Johns Hopkins University|Mohammad Khoshnoodi|410-955-5460|mkhoshn1@jhmi.edu|
20531416|NCT01014091|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531417|NCT06026813|UT Southwestern Medical Center|Dr. Peter Crisologo|214/648-7284|Peter.Crisologo@UTSouthwestern.edu|
20531418|NCT01601977|GSTT|Gill Arbane, Clinical trials coordinator|02071888070|gill.arbane@gstt.nhs.uk|
20531419|NCT02879695|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20531420|NCT04235374|University of Maryland|Barbara Resnick|410 706 5178|resnick@umaryland.edu|
20531421|NCT00314145|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20531422|NCT02572167|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20531423|NCT05495997|Yale School of Medicine|Sule Tinaz|203-737-6158|sule.tinaz@yale.edu|
20531424|NCT04612400|The University of Arkansas for Medical Sciences|Katie Rose Hisrch, Ph.D.|5015265708|krhirsch@uams.edu|
20531425|NCT03837704|Philip Morris Products S.A.|Global Head Clinical Development & Operations|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20531426|NCT06181799|I.M. Sechenov First Moscow State Medical University (Sechenov University)|Basheer Abdullah Marzoog|+7(996) 960 28 20|marzug@mail.ru|
20531427|NCT02296125|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
20531428|NCT04357795|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
20531429|NCT05845619|University of California San Francisco|Pamela Murnane|4155021000|pamela.murnane@ucsf.edu|
20531430|NCT04967222|Icahn School of Medicine at Mount Sinai|Dr. Harold W Koenigsberg|(718) 584-9000|harold.koenigsberg@mssm.edu|
20531431|NCT01295944|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
20531432|NCT04279522|Neurolief Ltd.|Yaron Gruper, Director of Clinical affairs|+972-544330712|Yaron.Gruper@neurolief.com|
20531433|NCT04383223|Emory University|Dr. Sophia Hussen|404-727-2446|sophia.ahmed.hussen@emory.edu|
20531434|NCT05277207|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
20531435|NCT01802281|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
20531436|NCT02685735|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
20531437|NCT02401230|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
20531438|NCT04812015|Wayne State University|Danielle Taylor, PhD|6166486793|dtaylo@med.wayne.edu|
20531439|NCT00831844|Children's Oncology Group|Results Reporting Coordinator|626-241-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
20531440|NCT04133909|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20531441|NCT03133156|Joslin Diabetes Center|Laura Simpson|617-735-3924|laura.simpson@joslin.harvard.edu|
20531442|NCT05020743|Vigil Neuro|VP, Clinical & Medical Sciences|+18572280538|jchavez@vigilneuro.com|
20531443|NCT02390284|University of Miami|Dr. Vittorio Porciatti|3053266050|vporciatti@med.miami.edu|
20531444|NCT00724945|Vistakon|Thomas Karkkainen OD|904-443-3402|tkarkkai@its.jnj.com|
20531445|NCT05166876|Clear Creek Bio, Inc.|Vikram Sheel Kumar|(617) 765-2252|kumar@clearcreekbio.com|
20531446|NCT04409002|Massachusetts General Hospital|Theodore Hong, MD|617-726-6050|TSHONG1@mgh.harvard.edu|
20531447|NCT02924376|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20531448|NCT01120197|Faculty of Health Sciences, Oslo University College, Oslo, Norway|Professor, Ph. D, Researcher. Astrid Bergland.|+4722452507|astrid.bergland@hf.hio.no|
20531449|NCT03481049|Washington State University|Michael G. McDonell|509-368-6967|mmcdonell@wsu.edu|
20531450|NCT00770809|University of North Carolina - Lineberger Comprehensive Cancer Center|Lisa Carey, M.D.||lisa_carey@med.unc.edu|
20531451|NCT01787838|Carilion Clinic|Rebecca Culver Clark|540-588-8184|rcclark@carilionclinic.org|
20531452|NCT00350220|University of Rochester Medical Center|Jill M. Cholette MD|585-275-0189|Jill_Cholette@urmc.rochester.edu|
20531453|NCT03755076|Albert Einstein Healthcare Network|Dr. Shailesh Kantak|562-385-7111|skantak@ranchoresearch.org|
20531454|NCT01866592|University of Pennsylvania|Suzette Baez VanderBeek, MPH|2156623514|suzette.baezvanderbeek@uphs.upenn.edu|
20531455|NCT05522751|University of California San Francisco|Khaled Moussawi|415-502-6343|khaled.moussawi@ucsf.edu|
20531456|NCT06420232|University of Texas Medical Branch, Galveston|Heather Celkis, OTR, PPOTD|409-|hdcelkis@UTMB.EDU|
20531457|NCT01325441|Sumitomo Pharma Oncology|Tegan Nguyen|6176748745|tegan.nguyen@oncology.sumitomo-pharma.com|
20531458|NCT01582451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20531459|NCT01838876|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20531460|NCT00689936|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20531461|NCT01682031|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20531462|NCT01932606|Mayo Clinic|Dr. Barry A. Borlaug|507-284-6704|Borlaug.Barry@mayo.edu|
20565066|NCT01009788|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-835-2285|SISAKOFF@mgh.harvard.edu|
20565067|NCT02800356|San Raffaele Hospital|Prof. Giuseppe Querques|00390226434004|querques.giuseppe@hsr.it|
20565068|NCT03626220|An Nan Hospital, China Medical University, Tainan, Taiwan|Dr. Chien-Chen Huang|886-6-3553111|chenchinh2013@gmail.com|2231
20531463|NCT04092777|Massachusetts General Hospital|Dr. Margarita Alegria|617-724-1237|malegria@mgh.harvard.edu|
20565069|NCT06180980|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20565070|NCT03911141|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
20565071|NCT05565820|Alliance Pharmaceuticals|R&D Director|01249 466966|medaffairs@allianceph.com|+44
20565072|NCT02795858|Dana-Farber Cancer Institute|Dr. Jennifer Chan, MD|617-632-6315|jennifer_chan@dfci.harvard.edu|
20520239|NCT05444543|University Hospitals Cleveland Medical Center|Dr. Thomas Sferra|(216)844-1765|Thomas.Sferra@UHhospitals.org|
20520240|NCT03847194|Seattle Children's Research Institute|Joyce Yi-Frazier|2068841456|joyce.yi-frazier@seattlechildrens.org|
20520241|NCT01134627|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20520242|NCT00768118|Barbara Ann Karmanos Cancer Institute|Fazlul Sarkar, Ph.D.|(313) 576-8327|sarkarf@karmanos.org|
20520243|NCT01144403|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20520244|NCT05472116|University of Minnesota|Jonathan Strutt|(314) 578-8045|strutt@umn.edu|
20520245|NCT04740931|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20520246|NCT02096588|SKCCC SOM Onc Breast and Ovarian Cancer|Dr. Karen Smith ; Clinical Associate|2026606500|ksmith60@jhmi.edu|
20520247|NCT00176631|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20520248|NCT00589849|Creighton University|Dr. Aryan Mooss|402-280-4566|aryanmooss@creighton.edu|
20520249|NCT02854059|Hansa Biopharma AB|Elisabeth Sonesson (Director Clinical Operations)|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
20520250|NCT01343095|Wake Forest Baptist Health|Matthew C. Miles|336-716-7765|mmiles@wakehealth.edu|
20520251|NCT00654654|CBR International Corp.|Kevin Hennegan|(720)746-1190|khennegan@cbrintl.com|
20520252|NCT05012865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520253|NCT01949116|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20520254|NCT03399318|University of Rochester|Professor Gretchen L. Birbeck|+ 1(517) 505-0283|gretchen_birbeck@urmc.rochester.edu|
20520255|NCT01510652|Institute of Cardiology, Univ. of Bologna, Bologna, Italy|Prof. Giuseppe Boriani||giuseppe.boriani@unibo.it|
20520256|NCT04079127|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
20520257|NCT00578071|Duke University Medical Center Radiation Oncology|Dr Brian Czito|668-7336|brian.czito@duke.edu|
20520258|NCT05307887|Imperial College NHS Foundation Trust|Dr Thomas Sewell|02033122152|thomas.sewell2@nhs.net|
20520259|NCT01560507|Duke University Medical Center|Dr. Jed Rose|919-668-5055|jed.rose@duke.edu|
20520260|NCT01138111|Piramal Imaging|Juergen Hirschfeld, Senior Director Regulatory Affairs|+49 30 461 1246 15|juergen.hirschfeld@piramal.com|
20520261|NCT00706992|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20520262|NCT04400760|The University of the West Indies, St. Augustine|Dr. Naveen Seecheran|18687537686|nseecheran@gmail.com|
20520263|NCT02746627|Vanderbilt University Medical Center|Sarah Jaser, PhD|615-343-6775|sarah.jaser@vanderbilt.edu|
20520264|NCT00515034|Johnson and Johnson Pharmaceutical Research and Development L.L.C.|Senior Director of Clinical Development|510 248-2310||
20520265|NCT02858726|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20520266|NCT01972035|University of Minnesota|Henry Balfour, MD|612-625-3998|balfo001@umn.edu|
20520267|NCT02508259|University of California, San Diego School of Medicine|Dr. Robert K. Naviaux, MD, PhD|619-543-2904|naviaux@ucsd.edu|
20520268|NCT01699763|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
20520269|NCT01481324|Shriners Hospital for Children|Dr. Todd Milbrandt|859-266-2101|tmilbrandt@shrinenet.org|
20520270|NCT01036490|Hines VA Hospiral|David J. Leehey, M.D.|(708)2022589|david.leehey@va.gov|
20520271|NCT02332980|Mayo Clinic|Wei Ding|5072845096|Ding.Wei@mayo.edu|
20520272|NCT00522171|Ethicon Endo-Surgery|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
20520273|NCT02698865|DePuy Synthes|FRANCHISE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20520274|NCT03861481|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20520275|NCT00773734|Celgene Corporation|Anne McClain|888-243-1360|clinicaltrialdisclosure@celgene.com|
20520276|NCT03715998|Quantum Genomics|Dr Bruno Besse|+33 1 85 34 77 73|bruno.besse@quantum-genomics.com|
20520277|NCT01660191|University of Kansas Medical Center|Julie-Ann Dutton|913-588-4064|JDUTTON@kumc.edu|
20520278|NCT01220297|Stanford Univesity|Laura Johnston, MD|650-723-0822|laura.johnston@stanford.edu|
20520279|NCT03111914|Duke University|Dr. Daniele Marin|919-684-7366|daniele.marin@duke.edu|
20520280|NCT02119286|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520281|NCT04109313|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20520282|NCT01272921|Northwestern University|Mark Kendall, M.D.|312-695-2528|m-kendall@northwestern.edu|
20520283|NCT01132664|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
20520284|NCT00882206|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612.672.7422||
20520285|NCT01996332|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20520286|NCT02113189|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|2146481559|karen.mccain@utsouthwestern.edu|
20520287|NCT02954159|Medical College Of Wisconsin|Andres Yarur, MD; Principal Investigator|414-955-6858|ayarur@mcw.edu|
20520288|NCT01237353|University of California San Francisco|Dr. Leslie Benet|415-476-3853|leslie.benet@ucsf.edu|
20520289|NCT02581163|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20520290|NCT03394755|Cellphire Therapeutics, Inc.|Mike Fitzpatrick, PhD|240-268-2470|mfitzpatrick@cellphire.com|
20520291|NCT01744093|Weill Cornell Medicine|Mei Wang, BS, CCRP|646-962-2672|mew2001@med.cornell.edu|
20520292|NCT02006628|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20565073|NCT05828017|Sonova|Bilal Sheikh - Research Audiologist|2268083260|bilal.sheikh@sonova.com|
20565074|NCT02361216|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
20565075|NCT03825588|University of Texas Southwestern Medical Center, University of Pittsburgh|Dr. Beth Dohoney Kennard; Dr. David Brent|214.456.4244|beth.kennard@utsouthwestern.edu|
20565076|NCT06130410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531464|NCT05219552|University of California School of Nursing|Dr. Emily Tuthill|2078411983|emily.g.tuthill@gmail.com|
20531465|NCT03330197|Alaunos Therapeutics|Jaymes Holland|650 273-2627|jholland@alaunos.com|
20531466|NCT00876343|Otsuka Pharmaceutical Co., Ld.|Director of Clinical Research and Development|+81-3-6361-7366||
20531467|NCT01670006|Cochlear|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
20531468|NCT00848185|IVI Madrid|Dra Cerrillo|911802900|maria.cerrillo@ivi.es|
20531469|NCT00005047|University of Southern California|Dr. Susan Groshen|323-865-0375|Susan.Groshen@med.usc.edu|
20565077|NCT05809453|University of Texas at Southwestern|Dr. Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
20565078|NCT05098158|Washington State University|Marian Wilson|509-324-7443|marian.wilson@wsu.edu|
20565079|NCT01002235|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20565080|NCT03916185|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20565081|NCT04197310|Dana Farber Cancer Institute|Dr. Kimberly Perez|617-632-5960|Kimberly_Perez@DFCI.HARVARD.EDU|
20565082|NCT03725384|Sunnybrook Health Sciences Centre|Dr. Yulia Lin|4164804042|yulia.lin@sunnybrook.ca|
20565083|NCT05370040|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20565084|NCT06415292|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
20565085|NCT04778397|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20565086|NCT04294641|National Cancer Institute|Dr. Steven Z. Pavletic|240-760-6174|sp326h@nih.gov|
20565087|NCT01627574|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-2830|lmurphy@uri.edu|
20565088|NCT05089877|AtriCure|Nfii Ndikintum, VP of Clinical Affairs and Biometerics|5136448192|NNdikintum@atricure.com|
20565089|NCT00957684|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20565090|NCT04685135|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20565091|NCT02315703|Janssen Vaccines & Prevention B.V.|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565092|NCT05974501|University of Miami|Dr. Victor H. Hernandez|305-243-4000|vhh1@med.miami.edu|
20565093|NCT04660539|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20565094|NCT03268382|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20565095|NCT03808961|VAORD|Chandramohan Wakade|7067211106|cwakade@augusta.edu|
20565096|NCT03756662|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
20520293|NCT03533374|Aarhus University Hospital|Professor Sandor Beniczky|+4526981536|sbz@filadelfia.dk|
20520294|NCT01206816|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520295|NCT01939496|Janssen Scientific Affairs, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20520296|NCT02384941|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20520297|NCT02493777|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
20520298|NCT00468728|Optimer Pharmaceuticals, Inc.|Chief Scientific Officer|1-855-343-4243|medinfo@optimerpharma.com|
20520299|NCT01705236|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20520300|NCT03028740|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20520301|NCT01359748|Aguiflai Iberica, SL|Angel Pons Ferré|+34 93 7540370|calidad@keito.com|
20520302|NCT03212794|Brigham and Women's Hospital|Joji Suzuki, MD|617-732-5752|Jsuzuki2@bwh.harvard.edu|
20520303|NCT05528861|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20520304|NCT01652976|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20520305|NCT01602172|VA Pittsburgh Healthcare System|Lauren M. Broyles, PhD, RN|412-360-2269|Lauren.Broyles@va.gov|
20520306|NCT02556307|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20520307|NCT03438227|Brown University|Dr. Methodius Tuuli|401-430-1575|MTuuli@wihri.org|
20520308|NCT02994355|University of Washington|Dr. R. Scott McClelland|+206-543-4278|mcclell@uw.edu|
20520309|NCT02039414|Western Kentucky University|Dr. Rachel Tinius, Assistant Professor|2707455026|rachel.tinius@wku.edu|
20520310|NCT03050918|Vanderbilt University Medical Center|Maame Yaa Yiadom|615-936-0087|maya.yiadom@vumc.org|
20520311|NCT02972502|OhioHealth Research Institute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
20520312|NCT03832738|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
20520313|NCT03852459|Aponia Labs|Kenneth Corroon|917-574-5335|kcorroon@aponialabs.com|
20520314|NCT00049842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20520315|NCT00430950|Daiichi Sankyo|Global Clinical Leader|908-992-6400|DataSharing@dsi.com|
20520316|NCT02537873|Virginia Commonwealth University|F. Gerard Moeller, M.D.|804-628-7788|lmbobb@vcu.edu|
20520317|NCT00293202|University of California, Davis|George Kaysen MD PhD|916-734-3774|gakaysen@ucdavis.edu|
20520318|NCT02442271|AbbVie|Global Medical Services|800 633-9110||
20520319|NCT01251978|New England Retina Associates|Leslie Hurst- study coordinator|203-288-2020|lhurst@retinamd.com|
20531470|NCT00261040|The Ottawa Hospital - Ottawa Hospital Research Institute|Dr Paul Kim|613-737-8920|pkim@toh.ca|
20531471|NCT04435626|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20520320|NCT00703508|Virginia Commonwealth University|Dr. Kai Cheang|(804) 828-2257|kicheang@vcu.edu|
20520321|NCT03657108|Icahn School of Medicine at Mount Sinai|Ketan Badani|(212) 241-3919|ketan.badani@mountsinai.org|
20520322|NCT00831623|LomaLindaU|Dr. Jason Slater|909-558-4243|jaslater@llu.edu|
20520323|NCT00408564|Medical University of South Carolina|Kate Anderton, MPH, CCRP|843-792-2708|anderton@musc.edu|
20520324|NCT01564459|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520325|NCT00486018|Genentech, Inc.|Medical Communications|800-821-8590||
20520326|NCT00106938|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
20520327|NCT00631852|Southern Illinois University School of Medicine|Director of Oncology Clinical Trials|217-545-8000|krobinson@siumed.edu|
20520328|NCT02080832|VCU|F. Gerard Moeller, M.D.|804-828-4134|frederick.moeller@vcuhealth.org|
20520329|NCT02416011|Moffitt Cancer Center|Dr. Thomas Bradon|(813) 745-1750|Thomas.Brandon@moffitt.org|
20520330|NCT00560937|Durham Veterans Affairs Medical Center|Christine E. Marx, MD, MA|919 286-0411|marx0001@mc.duke.edu|7426
20520331|NCT01118117|Terumo Medical Corporation|Adam Thompson, Clinical Program Manager|201-398-3283|adam.thompson@terumomedical.com|
20520332|NCT01660022|Medicines for Malaria Venture|Fiona Macintyre|0041 22 555 0319|macintyref@mmv.org|
20520333|NCT01448356|Singapore Eye Research Institute|Dr Andrea Petznick|+65 6322|andrea.petznick@seri.com.sg|4512
20520334|NCT03545191|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
20520335|NCT00306163|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20520336|NCT03179163|Penn State|Lacy M. Alexander, Ph.D.|8148671781|lma191@psu.edu|
20520337|NCT01277718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20520338|NCT00195013|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
20520339|NCT02149121|Celltrion, Inc.|SungYoung Lee|+82 32 850 6532|SungYoung.Lee@celltrion.com|
20520340|NCT04464993|Arizona State University|Matthew P Buman, PhD, Director & Professor|602-496-8617|mbuman@asu.edu|
20520341|NCT03166124|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20520342|NCT01398839|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
20520343|NCT00788593|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20520344|NCT01862419|Yale University School of Medicine|Francis Perry Wilson, MD MSCE|2037371704|francis.p.wilson@yale.edu|
20520345|NCT02655016|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20520346|NCT04459715|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20520347|NCT00952276|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20520348|NCT02427984|Medical technology laboratory, Rizzoli Orthopaedic Institute|Susanna Stea|00390516366861|stea@tecno.ior.it|
20520349|NCT03714555|HonorHealth|Gayle Jameson, MSN, ACNP-BC, AOCN|480-323-1364|clinicaltrials@honorhealth.com|
20531472|NCT04426656|University of North Carolina at Chapel Hill|Chunyan Li, MSc|919-966-6695|chunyli@live.unc.edu|
20531473|NCT01771107|Emmes Company|Kimberly Mosby-Griffin|301 251-1161|kmosby@emmes.com|10158
20531474|NCT00619528|Northwestern University|Joseph Leventhal MD, PhD|312-695-0427|jleventh@nm.org|
20531475|NCT01160614|Purdue Pharma L.P.|Medical Services|888-726-7535, option 1||
20531476|NCT03805841|Rain Oncology Inc.|Chief Medical Officer|(510) 953-5559|info@rainoncology.com|
20531477|NCT05248386|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|000|clinical-trials@grunenthal.com|000
20531478|NCT02595892|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos, MD, PhD|617-632-5269|panagiotis_konstantinopoulos@dfci.harvard.edu|
20531479|NCT01139879|Wolcott and Associates|Randy Wolcott|806-793-8869|lisa@randallwolcott.com|
20531480|NCT03621592|University of Miami|Hadar Lev-Tov, MD|305-243-4472|hlevtov@med.miami.edu|
20531481|NCT05807477|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20531482|NCT01149083|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20531483|NCT03785366|Sebela Women's Health|Elizabeth Gray|760.593.8383|Elizabeth.Gray@sebelapharma.com|
20531484|NCT03240874|Northwestern University|Lynn Yee, MD, MPH|312-472-4685|lynn.yee@northwestern.edu|
20531485|NCT05252702|Abbott Medical Devices, Cardiac Rhythm Management|Nicole Harbert, Director of Clinical Research|972-526-4841|nicole.harbert@abbott.com|
20531486|NCT04153864|Sinai Health System (Canada)|Dr. Daisy R Singla|416-535-8501|daisy.singla@utoronto.ca|39423
20531487|NCT06442800|University of North Carolina at Chapel Hill|Marissa Hall, PhD|919-445-1310|mghall@unc.edu|
20531488|NCT03834688|Dana-Farber Cancer Institute|Opeyemi Jegede, Statistician|(617) 582-7613|ojegede@ds.dfci.harvard.edu|
20531489|NCT03036254|Icahn School of Medicine at Mount Sinai|Dr. Mary Sano|(212) 659-8838|mary.sano@mssm.edu|
20531490|NCT00278408|Saarland University Medical School|Dr. Viola Poeschel|+4968411615014|dshnhl@uks.eu|
20531491|NCT03033355|houston methodist Hospital|Dr. Rose Khavari|713-363-9154|rkhavari@houstonmethodist.org|
20531492|NCT02783274|Johnson & Johnson MedTech|Kirstin Cosgrove|+1 574 4049398|kcosgro1@its.jnj.com|
20531493|NCT04717557|Duke University|Dr. Richard Moon|919-684-8762|richard.moon@duke.edu|9199065651
20531494|NCT02213003|Diabetes Research Institute/University of Miami|Rodolfo Alejandro, MD|305-243-3389|Ralejand@med.miami.edu|
20531495|NCT05484778|IstanbulU|Aysen Elif YILMAZ|+905059466301|aysen.elif4@gmail.com|
20531496|NCT06354257|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20531497|NCT03488524|Amylyx Pharmaceuticals, Inc.|Chief Medical Officer|(877) 374-1208|medinfo@amylyx.com|
20531498|NCT01811238|Samsung Medical Center|Dr.Sungsoo Chung|82-3410-1226|ssc0385@skku.edu|
20531499|NCT03980223|University of California, San Francisco|Anne Luetkemeyer|415-502-5753|annie.luetkemeyer@ucsf.edu|
20531500|NCT00434434|Genentech, Inc.|Medical Communications|800-821-8590||
20531501|NCT02517658|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
20531502|NCT01922934|Denver Health|Dr. Daniel H. Bessesen|303-602-5021|daniel.bessesen@ucdenver.edu|
20531503|NCT02916927|Alameda Health Systemt - Highland Hospital|Dr. Andrew Herring|(510) 437-4564|aherring@alamedahealthsystem.org|
20531504|NCT02290184|University of California San Francisco|Melinda Sarmiento Bender, PhD, RN|415 502 5668|melinda.bender@ucsf.edu|
20531505|NCT02354118|TriHealth|Rachel Baker, Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20531506|NCT01069939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20531507|NCT00658528|Eisai Call Center|Eisai Inc.|888-422-4743||
20531508|NCT02402062|MFAR Clinical Research|Federico Nepote|0034934344412|investigacion@mfar.net|102
20531509|NCT04685811|Weill Cornell Medical College|Dr. Juana Martinez Zuloaga|212-746-6000|jum4005@med.cornell.edu|
20531510|NCT01270659|University of Oklahoma Health Sciences Center Tulsa|Dr. Nasir Mushtaw|918/660-3680|Nasir-Mushtaq@ouhsc.edu|
20531511|NCT03160170|University of Miami Miller School of Medicine|Ian Cote|305-256-4492|Icote@med.miami.edu|
20531512|NCT02811159|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20531513|NCT01859091|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20531514|NCT04603066|Washington University in St Louis|Simon Haroutounian|3132861715|sharout@wustl.edu|
20531515|NCT01525589|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
20531516|NCT05759338|Wake Forest University Health Sciences|Amy McMichael|704-355-2000|Amy.Mcmichael@Advocatehealth.org|
20531517|NCT01471639|Cleveland Clinic Healthcare System|Sharon Mace MD|216-445-4598|maces@ccf.org|
20531518|NCT04835441|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20531519|NCT04611126|National Center for Cancer Immune Therapy (CCIT-DK)|MD, PhD Tine Juul Monberg|38682983|tine.monberg@regionh.dk|
20531523|NCT02328014|Acerta Pharma|Global Clinical Lead|1-877-240-9497|information.center@astrazeneca.com|
20531527|NCT04175639|Duke University School of Medicine|Tamara Somers, PhD|919-416-3408|tamara.somers@duke.edu|
20531529|NCT04338581|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20531531|NCT05028569|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20531535|NCT04609553|Rutgers University|Manuel Jimenez, MD, MS|732-235-9300|jimenema@rwjms.rutgers.edu|
20531541|NCT04390750|New York University|Bei Wu|12129925951|bw75@nyu.edu|
20531544|NCT03829475|Brigham and Women's Hospital|Jessica Allegretti MD MPH|617-525-7322|jallegretti@bwh.harvard.edu|
20531546|NCT04190225|Brown University|Dr. Shira Dunsiger, Biostatistician|401-863-6747|shira_dunsiger@brown.edu|
20531549|NCT04429971|Rutgers New Jersey Medical School|Ethan Cowan, MD, MS, FACEP|917-447-4964|ethan.cowan@rutgers.edu|
20531550|NCT00626236|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
20531552|NCT06487390|University of Alabama at Birmingham|Dr. Lynn Matthews|2059348148|lynnmatthews@uabmc.edu|
20531554|NCT04044690|CSL Behring|Study Director|16108784697|clinicaltrials@cslbehring.com|
20551708|NCT03255382|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20531562|NCT05472142|University of Kentucky|Mary E. Lacy, PhD, Study PI|8595621126|mary.lacy@uky.edu|
20531564|NCT05075200|Sunnybrook Health Sciences Centre|Dr. Angela Jerath|416-480-4864|angela.jerath@sunnybrook.ca|
20531567|NCT04703192|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20531575|NCT03981055|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
20531579|NCT05561400|University of Minnesota|Sharyl Samargia-Grivette|218-726-8347|samargia@umn.edu|
20531587|NCT03483584|The Chinese University of Hong Kong|Prof. Grace Lui|+852 35051716|gracelui@cuhk.edu.hk|
20531590|NCT04063163|ShanghaiHenliusBiotech|Fan Zhang|021-33395800*6334|Fan_Zhang2@henlius.com|
20531594|NCT06407375|University Hospital Zurich|Dr. Toni Rabadi|043 254 41 10|radiologie@usz.ch|
20565097|NCT00179400|Albert Einstein College of Medicine|Prof. Meredith A. Hawkins|718 430 3186|meredith.hawkins@einsteinmed.edu|
20565098|NCT03895996|Avotres Inc.|Tuochuan Dong, Director, Business & Operations|7169093370|tuochuan.dong@avotres.com|
20520350|NCT00140621|Sanofi|Trial Transparency Team||Contact-US@Sanofi.com|
20520351|NCT02312713|University of North Carolina at Chapel HIll|Kelli Allen|919-966-0558|kdallen@email.unc.edu|
20520352|NCT00897949|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520353|NCT01763918|Amgen Inc.|Study Director|866-572-6436||
20520354|NCT01553747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20520355|NCT00102687|Celgene Corporation|CL Beach||CLBeach@celgene.com|
20520356|NCT01490931|Univeristy of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD Professor of Pharmacology|215-898-9686|evhersh@pobox.upenn.edu|
20520357|NCT02408120|Emory University|Dr. Priyathama Vellanki|404-251-8957|priyathama.vellanki@emory.edu|
20520358|NCT00754494|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
20520359|NCT00867048|University of Minnesota|Birgit Grund|612-624-8076|birgit@umn.edu|
20520360|NCT00977431|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520361|NCT03739138|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520362|NCT03069677|University of Pennsylvania|Veena Graff MD, MS|(215) 662-8244|veena.graff@uphs.upenn.edu|
20520363|NCT00518882|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20520364|NCT04475250|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|joseph.tobias@nationwidechildrens.org|
20520365|NCT02696031|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
20520366|NCT00597116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20520367|NCT01258101|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20520368|NCT00253981|William Beaumont Army Medical Center|COL Richard Petri, Chief Integrative Pain Management|915-742-3245|richard.petri@amedd.army.mil|
20520369|NCT00063882|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20520370|NCT01829919|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
20520371|NCT02903238|Northwestern University Medical School|Dr. Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
20520372|NCT01553201|National Institute of Neurological Disorders & Stroke|Barbara Karp, MD|301-496-0150|karpb@ninds.nih.gov|
20520373|NCT02743728|University of Minnesota|Dr. Bernadette Gillick|612-626-5898|gillick@umn.edu|
20520374|NCT04588688|University of Michigan|Tobias Else|734-936-1319|telse@med.umich.edu|
20520375|NCT00700817|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20520376|NCT00594620|The University of Kansas|Jeffrey Holzbeierlein, MD, FACS|913-945-8239|jholzbeierlein@kumc.edu|
20520377|NCT00767520|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20520378|NCT02777918|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
20520379|NCT01338987|National Cancer Institute|Dr. Christopher Kanakry|240-760-6171|christopher.kanakry@nih.gov|
20520380|NCT00757848|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20520381|NCT02071953|University of Pennslyvania|Ricardo Walter|215-898-9164|walterr@dental.upenn.edu|
20520382|NCT00058214|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20520383|NCT00411398|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
20520384|NCT02480582|University of Leeds|Dr Graham Finlayson|0113 343 7601|g.s.finlayson@leeds.ac.uk|
20520385|NCT00958126|Seqirus|Clinical Trials Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20520386|NCT00720226|Johns Hopkins University School of Medicine|Robert A. Wise|410 550 0545|rwise@jhmi.edu|
20520387|NCT00733369|DePuy Ortho Joint US|Kimberly Dwyer, PhD, CCRA||kdwyer2@its.jnj.com|
20520388|NCT03401073|BIDMC|Christopher Gibbons MD|617-632-8454|cgibbons@bidmc.harvard.edu|
20520389|NCT00279955|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
20520390|NCT01470612|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520391|NCT01606852|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
20520392|NCT03856593|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
20520393|NCT01602016|University of Arkansas for Medical Sciences|Tracy Gatlin|501-686-6803|tlgatlin@uams.edu|
20520394|NCT04632706|MedinCell S.A.|Joel Richard - Chief Development Officer|00336984590|joel.richard@medincell.com|99
20520395|NCT03078582|Ra Pharmaceuticals, Inc|Sponsor Ra Pharmaceuticals, Inc.|+1 617 401 4060|trials@rapharma.com|
20520396|NCT01045031|Health and Prevention Center, Sanatorium Hera, Vienna, Austria|Dr. Robert Winker|0043(1)-31350|robert.winker@hera.co.at|45666
20520397|NCT02046525|Washington University in St. Louis|Kimberly Reske, MPH|3147474041|kreske@wustl.edu|
20520398|NCT01825122|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
20520399|NCT02689063|AFT Pharmaceuticals|Jennifer Zhang -Project Manager|+ 64 9 488 0232|jenniferz@aftpharm.com|710
20520400|NCT00766831|Medical Affairs|Clinical Research Associate|82-2-2094-4835||
20520401|NCT01392326|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20520402|NCT02340221|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20520403|NCT00518622|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20520404|NCT03487848|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20520405|NCT00094094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520406|NCT00603291|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20520407|NCT03755336|University of Nebraska Omaha|Nathaniel Hunt|402-554-4195|nhunt@unomaha.edu|
20520408|NCT06029959|University of Washington|Sandeep Khot, MD|206-744-3251|skhot@uw.edu|
20520409|NCT00003138|ECOG Statistical Office|Study Statistician|617-632-3012||
20520410|NCT04495283|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
20520411|NCT03692312|AMO Pharma Ltd.|Dr. Mike Snape, Chief Scientific Officer|+44 (0) 7775915639|mike.snape@amo-pharma.com|
20520412|NCT05506930|Medical University of South Carolina|Natalie Barnett|(843) 792-5454|barnettn@musc.edu|
20520413|NCT02631876|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20520414|NCT02786277|Yale University|F. Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
20520415|NCT01013649|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20520416|NCT04285567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20520417|NCT01408563|Massachusetts General Hospital|Dr. Zachariah DeFilipp|617-643-3944|ZDEFILIPP@mgh.harvard.edu|
20520418|NCT00996931|Sutter Institute for Medical Research|Carol Parise, PhD|916-733-4413|PariseC@sutterhealth.org|
20520419|NCT02287909|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
20520420|NCT02091141|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20520421|NCT02246439|RedHill Biopharma Ltd.|Dr. Terry Plasse|+972-(0)3-541-3131|terry@redhillbio.com|
20520422|NCT03439852|University of Hawaii at Manoa, Office of Research Studies|Sharleen Andreshak|808 356 5762|sfa2@hawaii.edu|
20520423|NCT00666848|Vanderbilt University School of Medicine|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
20520424|NCT00289757|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520425|NCT04271735|National Heart Lung and Blood Institute (NHLBI)|Michael Sack, M.D. Principal Investigator, NIH, NHLBI|301.402.9259|sackm@nhlbi.nih.gov|
20531603|NCT00984399|Memorial Sloan Kettering Cancer Center|Dr. Shari Goldfarb, MD|646-888-5080|goldfars@mskcc.org|
20531605|NCT01723774|Washington University School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
20531607|NCT02964182|MD Anderson Cancer Center|Jason Robinson, PhD|713-792-2265|nicotinestudy@mdanderson.org|
20531609|NCT01964404|Dartmouth Hitchcock|Dr. Mary F. Brunette|603-646-7019|Mary.F.Brunette@Hitchcock.org|
20531611|NCT05528510|Janssen Research & Development, LLC|Senior Medical Leader Pediatrics Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20531615|NCT03275168|Johns Hopkins University|Dr Maria Trent|4109552910|mtrent2@jhu.edu|
20531619|NCT05360056|The Ohio State University|Dr. Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
20531621|NCT03013751|Mezzion Pharmaceuticals, Inc|Director of Clinical Operatons|3128980292|wg.kim@mezzion.com|
20531624|NCT05567172|Boston Scientific|Nilou Zilinek|5086836127|nilou.zilinek@bsci.com|
20531636|NCT04707469|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20531642|NCT04798768|Boston Scientific|Julie West|651-582-4721|Julie.West@bsci.com|
20531649|NCT04364646|Center for Sleep and Circadian Rhythms, AHWFB|Katherine M. Sharkey, MD, PhD|336-716-4657|katherine.sharkey@advocatehealth.org|
20565099|NCT01254864|The University of Texas MD Anderson Cancer Center|Paul Corn, MD|(713) 563-7208|pcorn@mdanderson.org|
20565100|NCT04625725|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20531655|NCT02003924|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565101|NCT01828112|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
20565102|NCT04308681|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20531662|NCT06081829|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
20520426|NCT03197558|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
20520427|NCT00353652|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
20520428|NCT01936519|Penn State Milton S Hershey Medical Center|Dr Zakiyah Kadry|717 531 5921|zkadry@pennstatehealth.psu.edu|
20520429|NCT00931268|Q-Med AB|Head of Clinical Development|+46 (0)18 4749000|reception.SEUPP@galderma.com|
20520430|NCT02072148|Icahn School of Medicine at Mount Sinai|Dr. Raymond L Chai|(212) 844-8775|Raymond.Chai@mountsinai.org|
20520431|NCT02466230|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
20520432|NCT00430495|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20520433|NCT00158756|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520434|NCT02400671|University of Washington|Dr. Keshet Ronen|206-685-4363|keshet@uw.edu|
20520435|NCT01421342|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Gary R. Johnson, MS|(203) 932-5711|gary.johnson4@va.gov|3774
20520436|NCT03633448|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20520437|NCT03656874|HealthPartners Institute|Dr. D. Brad Rindal|952.967.5026|D.Brad.Rindal@HealthPartners.com|
20520438|NCT00723645|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20520439|NCT03052322|Fresenius Kabi Swiss BioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
20520440|NCT00973765|Washington Hospital Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
20520441|NCT02274844|University of Wisconsin-Madison|Susan Andreae|608-265-8195|sandreae@wisc.edu|
20520442|NCT01892657|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
20520443|NCT01507155|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
20520444|NCT02712333|Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
20520445|NCT03463993|University of Zimbabwe|Dr Chipo Gwanzura|+263774718381|chipo.gwanzura@gmail.com|
20520446|NCT01610453|Stavanger UH|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
20520447|NCT02003911|Mount Sinai Kravis Children's Hospital|Dr. Lindsey Douglas|2122416500|lindsey.douglas@mssm.edu|
20520448|NCT03808740|Vanderbilt University Medical Center|Dr Cyndya Shibao|6159364584|cyndya.shibao@vumc.org|
20520449|NCT01933464|UCSD Dermatology Clincal Trials|Dermatology Clinical Trial Manager|(858)657-8390|dermstudies@ucsd.edu|
20520450|NCT03977701|San Diego State University|Dr Jessica Barlow, Principal Investigator|6195943807|jbarlow@sdsu.edu|
20520451|NCT02429934|University of California at Los Angeles|Dr. Bevra Hahn|8184869745|bhahn@mednet.ucla.edu|8184869745
20520452|NCT00869024|University of Minnesota|Dr. Ganesh Raveendran|612-626-4283|ravee001@umn.edu|
20520453|NCT01064323|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|410-550-5717|hsilber@jhmi.edu|
20520454|NCT02519621|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20520455|NCT03676751|UCSF FI Proctor|Pr Thomas Lietman|(415) 476-1442|tom.lietman@ucsf.edu|
20520456|NCT00775684|University of Pennsylvania|Professor of Medicine, Director of Translational Research Program|215 746-0025|rickels@pennmedicine.upenn.edu|
20520457|NCT02025751|Evoke Pharma|Chief Medical Officer|8589457189|mcarlson@evokepharma.com|
20520458|NCT00653991|Annenberg School for Communication and Journalism, University of Southern California|Professor Lynn Carol Miller|310-874-3402|lmiller@usc.edu|
20520459|NCT02181296|University of Pennsylvania|Dr. Nabil M Elkassabany|(215) 662-3793|Nabil.Elkassabany@uphs.upenn.edu|
20520460|NCT01568866|Amgen Inc.|Study Director|866-572-6436||
20520461|NCT03864042|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520462|NCT01698775|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520463|NCT01019707|University of California Los Angeles|Edythe D London|310 825 0606|elondon@mednet.ucla.edu|
20520464|NCT02143583|ANERGIS SA|G. DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
20520465|NCT01244061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520466|NCT04527328|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
20520467|NCT03499119|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20520468|NCT04143243|Baylor College of Medicine|Lilian Dindo|713-440-4637|lilian.dindo@bcm.edu|
20520469|NCT00313443|Unité de Recherches Thérapeutiques. Service de Médecine Interne A. Hôpital Lariboisière. Paris, France|Dr Carmelo Lafuente-Lafuente|+33 1 49 95 63 37|c.lafuente@nodo3.net|
20520470|NCT04718194|Yale|Dr. Dani Chiaramonte|3479310195|danielle.chiaramonte@yale.edu|
20520471|NCT05713552|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
20520472|NCT04551911|OPKO Health Inc|OPKO Health Inc|305-575-4100|contact@opko.com|
20520473|NCT01215513|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20520474|NCT01383421|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20520475|NCT00821873|RTI Biologics|Robin Waite, Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
20531667|NCT03608033|Omeros|Skylar Liles|206-676-5000|ctinfo@omeros.com|
20531669|NCT03483012|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
20531672|NCT02900976|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20531674|NCT04735367|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531675|NCT02360579|Iovance Biotherapeutics|Rana Fiaz, Executive Medical Director|661-645-3572|rana.fiaz@iovance.com|
20531678|NCT04550936|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531684|NCT03682848|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20531690|NCT02483429|Johns Hopkins University|David E. Newman-Toker|443-287-9593|toker@jhu.edu|
20531697|NCT06910332|Acıbadem University, Department of Physiotherapy and Rehabilitation|Ali Ömer ACAR|+90 216 500 44 44|aliomer.acar@acibadem.edu.tr|3578
20565103|NCT05086796|Cedars-Sinai Medical Center|Itai Danovitch, MD|310-423-2600|itai.danovitch@cshs.org|
20565104|NCT02573779|Baylor College of Medicine/Texas Children's Hospital|Dr. Amy B. Hair|832-826-1398|abhair@bcm.tmc.edu|
20565105|NCT03746106|University of California, San Francisco|Dr. Kathleen Giacomini|4155144363|kathy.giacomini@ucsf.edu|
20565106|NCT05873556|University of Washington|Dr. Anne Fairlie|2062215896|afairlie@uw.edu|
20565107|NCT04047602|Indiana University Health|Kevin Shiue, MD|317 944 2524|kshiue@iuhealth.org|
20520476|NCT00134043|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|manisha.shah@osumc.edu|
20520477|NCT02177136|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20520478|NCT00131378|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
20520479|NCT00729248|Northwestern University|Lorenzo Gallon, MD - Study Principal Investigator|312-695-4457|l-gallon@northwestern.edu|
20520480|NCT03573505|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20520481|NCT04268316|Stanford University|Margot Paul|415-625-3127|mdpaul@stanford.edu|
20520482|NCT00746018|Memorial Sloan Kettering Cancer Center|Nadeem Abu-Rustum, M.D.|212-639-7051|abu-rusn@mskcc.org|
20520483|NCT02040779|Teva Branded Pharmaceutical Products R&D|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20520484|NCT02132637|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20520485|NCT00866658|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20520486|NCT01385306|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20520487|NCT02751359|University of California Los Angeles|Dr. Ziva Cooper, Principal Investigator|310-206-9942|zcooper@mednet.ucla.edu|
20520488|NCT03949244|Icahn School of Medicine at Mount Sinai|Harriet Lloyd|212-979-4672|hlloyd@nyee.edu|
20520489|NCT02145026|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20520490|NCT04920916|University of Virginia Health System|William Petri|434-305-9633|wap3g@virginia.edu|
20520491|NCT00076804|Johns Hopkins University Center for TB Research|Richard E. Chaisson|4109551755|rchaiss@jhmi.edu|
20520492|NCT00354341|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20565108|NCT03606408|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
20520493|NCT01825889|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20565109|NCT04689256|UMass Chan Medical School/UMass Memorial Health|Dr. Brian Silver|508-334-5989|Brian.Silver@umassmemorial.org|
20565110|NCT03556293|Dartmouth College|Dr. Jeremiah Brown|(603) 646-5409|jeremiah.r.brown@dartmouth.edu|
20520494|NCT05080426|Purdue University|Dr. Ellen Ernst Kossek|(765) 494-6852|ekossek@purdue.edu|
20520495|NCT01884064|University of Minnesota|Dr. Teresa Jacobson Kimberley|612-626-4096|tjk@umn.edu|
20520496|NCT01546649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20520497|NCT01570348|FHCRC|Dr. George Georges|(206) 667-6886|ggeorges@fredhutch.org|
20520498|NCT02494817|University of Hawaii|Jason W. Mitchell, PhD, MPH|8082196729|jasonmit@hawaii.edu|
20520499|NCT02684201|University of Pittsburgh|Dr. Lee Fisher, PhD|412-383-1077|lef44@pitt.edu|
20520500|NCT00038649|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-794-5783|CR_Study_Registration@mdanderson.org|
20520501|NCT02994251|Yale University|Dr. Todd Schlachter|203-785-5885|todd.schlachter@yale.edu|
20520502|NCT01901874|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
20520503|NCT01347866|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520504|NCT02728752|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
20520505|NCT02939014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20520506|NCT01869478|Mayo Clinic|Kevin M. Barrett, MD|904-953-9740|Barrett.Kevin@mayo.edu|
20520507|NCT01641133|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520508|NCT02220725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20520509|NCT03351231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
20520510|NCT03052972|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20520511|NCT03020719|Seattle Children's Hospital|Arthur Baines|2068841431|Arthur.Baines@seattlechildrens.org|
20520512|NCT02333487|H. LUndbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20520513|NCT00123955|Wake Forest Baptist Health|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
20520514|NCT01558297|Yale Medical School|Dr. Rachel Barnes|2037856395|rachel.barnes@yale.edu|
20520515|NCT02218307|University of Miami|Dr. Roy Casiano|305-243-1870|rcasiano@miami.edu|
20520516|NCT04189445|Taiho Oncology, Inc|Taiho Oncology, Inc|609-250-7336|clinicaltrialinfo@taihooncology.com|
20520517|NCT00102518|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
20520518|NCT02960893|Biohaven Pharmaceuticals|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20520519|NCT06204887|Recep Tayyip Erdogan University|Dr. Ahter Şanal Çıkman|05069293341|ahter.sanalcikman@erdogan.edu.tr|
20520520|NCT05142566|Essential Medical LLC (a subsidary of Teleflex, Inc.)|Darra Bigelow, Sr. Manager, Clinical Operations|610-331-7299|darra.bigelow@teleflex.com|
20520521|NCT00997139|Northwestern University Department of Dermatology|Clinical Trials Unit Coordinator|312-695-6829|mandybrowning2015@u.northwestern.edu|
20520522|NCT02054130|MedImmune, LLC|Fred Reid|+44 (0) 203 749 6512|information.center@astrazeneca.com|
20520523|NCT01386684|AbbVie|Global Medical Services|800-633-9110||
20520524|NCT00364949|Northwestern University|Dr. Andrea Dunaif|312-503-2902|a-dunaif@northwestern.edu|
20520525|NCT00094458|Centocor Ortho Biotech Services, L.L.C.|Study Director|215 325-7405||
20520526|NCT02130583|Alpert Brown Medical School|Shirley Yen, Ph.D., Principal Investigator|4014441915|Shirley_Yen_PhD@Brown.edu|
20520527|NCT02149290|ZOLL LifeVest|VP of Medical Affairs|412-968-3333|stevens@zoll.com|14400
20520528|NCT01995266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
20520529|NCT03247517|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
20520530|NCT03310411|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20520531|NCT00619112|UCSF|Nicholas Butowski|4153532966|Butowski@neurosurg.ucsf.edu|
20520532|NCT04029311|Tohoku University|Dr. Yasue Tanaka|+81227178396|yasue.tanaka.b3@tohoku.ac.jp|
20520533|NCT03623386|Yale School of Medicine|Sule Tinaz, MD, PhD: Associate Professor of Neurology|(877) 925-3637|sule.tinaz@yale.edu|
20520534|NCT01996943|University of California, San Francisco|Dr. Gregory Marcus|(415) 353-2554|Greg.Marcus@ucsf.edu|
20520535|NCT00515541|Invitrox, Inc|Dr. Don A. Gabriel|(919) 485-4600|dgabriel@invitrox.com|
20520536|NCT01030653|University of Michigan|Manjuanth Pai|7346470006|amitpai@med.umich.edu|
20520537|NCT00922272|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20520538|NCT00003224|University of Virginia|Craig Slingluff|434-924-1730|cls8h@virginia.edu|
20520539|NCT02588950|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20520540|NCT00652028|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
20520541|NCT02072824|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520542|NCT01280409|University of Texas Health Science Center at Houston|Dr Jerrie Refuerzo|713.500.7780|Jerrie.S.Refuerzo@uth.tmc.edu|
20520543|NCT01403064|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20520544|NCT02528123|London Vision Clinic|Prof Dan Z Reinstein|02072214005|dzr@londonvisionclinic.com|
20520545|NCT03760250|University of Pennsylvania|Jenny Wei|2153165151|jenny.wei@pennmedicine.upenn.edu|
20520546|NCT01598350|University of Puget Sound|Julia Looper, PT PhD|253 879 2895|jlooper@pugetsound.edu|
20520547|NCT02011113|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20520548|NCT01338649|Massachusetts General Hospital|Aleksandar Videnovic|855-644-6387|avidenovic@mgh.harvard.edu|
20520549|NCT02669940|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20520550|NCT03840616|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
20531699|NCT06910202|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas Lemos|5405262106|rflemos@vtc.vt.edu|
20536593|NCT01928433|Universityhospital Gießen and Marburg, Germany|Prof. Dr. med. Florian Wagenlehner|+49-641-98544516|Florian.Wagenlehner@chiru.med.uni-giessen.de|
20536594|NCT01740687|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20536595|NCT00936663|University of Nebraska Medical Center|Vijay Shivaswamy|402-559-6208|vshivaswamy@unmc.edu|
20551709|NCT02448654|Yale University|Elise E. DeVito, Ph.D./ Associate Research Scientist|203-737-4882|elise.devito@yale.edu|
20551710|NCT02466555|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
20551711|NCT01556581|Madigan Army Medical Center|Dr. Dan Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
20551712|NCT03839212|University of Miami|Daniel E. Jimenez, Ph.D., Associate Professor|3052432776|dej18@miami.edu|
20551713|NCT00657241|SUNYBuffalo|Joseph L. Izzo Jr. M.D.|716-898-5625|jizzo@buffalo.edu|
20551714|NCT01173718|W. L. Gore & Associates|Debby Pfile, Clinical Research Associate|623-234-5226|dpfile@wlgore.com|
20551715|NCT02113956|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-5858|michele@innovativepublichealth.org|801
20551716|NCT01498458|University Hospital Heidelberg|Dr. Andreas Schneeweiss|+49 (0)6221 56 36051|andreas.schneeweiss@med.uni-heidelberg.de|
20551717|NCT02226003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20551718|NCT03578081|University of Alabama at Birmingham|Dr Rudolph M. Navari|205-975-2833|rnavari@uabmc.edu|
20551719|NCT03279692|Massachusetts General Hospital|Priscilla Brastianos, MD|617-724-8770|pbrastianos@partners.org|
20551720|NCT05198843|University of Texas M D Anderson Cancer Center|Dr. Rachel Layman|(713) 745-8401|RLayman@mdanderson.org|
20551721|NCT02588833|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20551722|NCT01975909|Beth Israel Deaconess Medical Center|Brad Manor, Ph.D.|617-971-5332|bmanor@bidmc.harvard.edu|
20551723|NCT04709341|Medical University of South Carolina|Samuel Bidwell- Research Manager|843-792-2305|bidwells@musc.edu|
20551724|NCT05247229|Department of Medicine, Division of Occupational, Environmental, and Climate Medicine, University of California|Matthew O. Gribble|‭(949) 350-6134‬|matt.gribble@ucsf.edu|
20551725|NCT04537234|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20551726|NCT07114198|Inonu|Assistant Professor Merve Bilmez Selen|5457673089|merve.selen@inonu.edu.tr|
20551727|NCT04318080|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20551728|NCT02926924|University of Michigan|Rakesh Patel|734 615-2002|rakeshpa@med.umich.edu|
20551729|NCT04916600|Wayne State University School of Medicine|Dr. Mark Greenwald, Professor|3139933965|mgreen@med.wayne.edu|
20551730|NCT00939809|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
20551731|NCT02603809|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 19 77|clinical-trials-disclosure@idorsia.com|
20551732|NCT03970733|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
20551733|NCT02341807|Spark Therapeutics|Clinical Director|1-866-647-7275|clinicaltrials@sparktx.com|
20551734|NCT01139450|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
20551735|NCT01010906|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20551736|NCT02385266|Northwestern University|Camila Bonin Pinto, PhD|3125033971|camila.pinto@northwestern.edu|
20551737|NCT00265343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20551738|NCT02535741|Stryker European Operations BV|Doug McGurty|+44(0)1635 500690|doug.mcgurty@stryker.com|
20551739|NCT01030523|Dentsply Sirona Implants|Manager of Global Clinical Research|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
20565111|NCT04867278|Emory University|Dr. Adam Boissonneault|(404) 616-1000|adam.boissonneault@emory.edu|
20551740|NCT00426283|Cincinnati Children's Hospital Medical Center|Marc E Rothenberg|513-636-7177|rothenberg@cchmc.org|
20551741|NCT02807350|Jaeb Center for Health Research|Raymond Kraker, Coordinating Center Director|(813)-975-8690|rkraker@jaeb.org|
20551742|NCT03662542|Janssen Research & Development, LLC|Head of Gastroenterology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20551743|NCT01854905|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20551744|NCT01217060|UT MD Anderson Cancer Center|Steven H. Lin, Associate Professor, Radiation Oncology Department|(713) 563-8490|shlin@mdanderson.org|
20551745|NCT03202264|McMaster University|Dr. Dee Mangin|905-525-9140|mangind@mcmaster.ca|21219
20551746|NCT03388138|Johnson & Johnson Vision Care, Inc.|Brian Pall O.D, MS, FAAO|1-800-843-2020|bpall@its.jnj.com|
20551747|NCT01528072|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
20551748|NCT03001258|BRAC|Anita Sharif Chowdhury/Research Fellow of BRAC Research and Evaluation Division|+88029846448|anita.sc@brac.net|3719
20551749|NCT02996864|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
20551750|NCT02430337|Georgia State University|Shannon Self Brown, PhD|404-413-1283|sselfbrown@gsu.edu|
20565112|NCT02584647|Columbia University|Gulam A. Manji|212 305 0592|gam2140@cumc.columbia.edu|
20565113|NCT04862234|Emory University|Georgia Davis, MD|404-251-8957|georgia.marie.davis@emory.edu|
20531707|NCT01092923|Austin Health|Dr Phil Peyton|9496 5000|phil.peyton@austinhealth.org.au|5704
20531708|NCT00639093|GRAP, Clinique de Psychologie au Travail|Benoît Girard|418-542-2030|g.r.a.p@videotron.ca|
20531709|NCT01089595|Fox Chase Cancer Center|Margaret von Mehren, Principal Investigator|215-728-4300|margaret.vonmehren@fccc.edu|
20531710|NCT00177671|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
20531711|NCT02293499|University of Rochester School of Nursing|Hyekyun Rhee PhD, RN, FAAN|585-276-3775|Hyekyun_Rhee@urmc.rochester.edu|
20531712|NCT00690898|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20531713|NCT05977868|West Virginia University|Dr. Joy J. Juskowich|304-293-3306|jjuskowi@hsc.wvu.edu|3
20531714|NCT05370326|Yale School of Medicine|Melissa B. Weimer, DO, MCR, DFASAM|(203) 859-2962|melissa.weimer@yale.edu|
20531715|NCT04385888|George Washington University|Allison Sylvetsky|202-994-5602|asylvets@gwu.edu|
20531716|NCT02880176|Fox Chase Cancer Center|Dr. Marshall Strother|555-555-5555|m12912988@gmail.com|
20531717|NCT01991314|Barts Health NHS Trust|Prof David Rampton|+442035943500|d.rampton@qmul.ac.uk|7885
20531718|NCT01136954|Eisai Call Center|Eisai Inc.|888-422-4743||
20531719|NCT03317496|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531720|NCT01035788|Department of Veterans Affairs|Dr. Louanne Davis|317-988-4523|louanne.davis@va.gov|
20531721|NCT00410488|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
20531722|NCT03841513|TMC|Dr Tsung Mou|6176365890|tmou@tuftsmedicalcenter.org|
20531723|NCT00704353|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
20565114|NCT04484428|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20565115|NCT04132518|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20565116|NCT03092453|University of Pennsylvania|Regulatory Lead|215-573-7101|psom-ind-ide@pobox.upenn.edu|
20565117|NCT05425420|Duke University|Kanecia Zimmerman|919-668-8651|kanecia.zimmerman@duke.edu|
20565118|NCT03673501|Deciphera Pharmaceuticals, LLC|INTRIGUE Clinical Team|781-209-6400|clinicaltrials@deciphera.com|
20565119|NCT04599634|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
20565120|NCT02946736|Oregon Health & Science University|Dr. Leslie Hammer, PI|503-494-9313|hammerl@ohsu.edu|
20565121|NCT01385189|George Washington University|Dr. David J. Diemert, Associate Professor|202.994.2909|ddiemert@gwu.edu|
20565122|NCT02631746|Duke University - Duke Cancer Institute LAO|Christy Arrowood|919-613-6130|christy.arrowood@duke.edu|
20565123|NCT04571619|University of Pennsylvania|Natalie Kuzla|2155732935|nkuzla@pennmedicine.upenn.edu|
20565124|NCT04167553|Hanmi Pharmaceutical Co., Ltd.|Jiyeon Kang|+8224100377|jiyeon.kang@hanmi.co.kr|
20565125|NCT03812289|OHSU Knight Cancer Institute|Nima Nabavizadeh, MD|503-418-3685|nabaviza@ohsu.edu|
20565126|NCT04479761|New York University|Prof. Anat Lubetzky|2129989195|anat@nyu.edu|
20565127|NCT03963518|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Carine Bellera|+33556333333|c.bellera@bordeaux.unicancer.fr|
20565128|NCT05361031|Helixmith, Co., Ltd.|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
20565129|NCT04183283|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20565130|NCT03397654|Imperial College London|Dr David Pinato|+44 20 7594 2799|david.pinato@imperial.ac.uk|
20565131|NCT03220035|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20565132|NCT05452460|Department of Physical Education and Sport Sciences, National Taiwan Normal University|Dr. Yu-Kai Chang|+886277493223|yukaichangnew@gmail.com|
20565133|NCT03208049|VA Palo Alto Health Care System, Palo Alto, CA|Dr. Andrea Goldstein-Piekarski|(650) 493-5000|Andrea.Goldstein2@va.gov|60584
20565134|NCT03676192|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
20565135|NCT04731129|Centre hospitalier universitaire de liège|Dr Olivier Bonhomme|003243239580|obonhomme@chuliege.be|
20565136|NCT03386578|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20565137|NCT03841773|Tonix Pharmaceuticals|Gregory Sullivan, MD|862-904-0355|greg.sullivan@tonixpharma.com|
20565138|NCT02694822|Agenus, Inc.|Clinical Trial Information|1-781-674-4265|clinicaltrialinfo@Agenusbio.com|
20565139|NCT02424617|BerGenBio ASA|BerGenBio Clinical Team|+ 47 55961159|registry.postings@bergenbio.com|
20565140|NCT01868997|Horizon Pharma USA, Inc.|Julie Ball, Executive Director||clinicaltrials@horizonpharma.com|
20565141|NCT01960452|University of Wisconsin|Meredith Rumble, PhD|608-232-3171|rumble@wisc.edu|
20565142|NCT05133739|TEOXANE SA|Clinical Research Scientist|+41(0) 22 344 96 36|clinical@teoxane.com|
20565143|NCT04766892|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20565144|NCT04730739|Zimmer Biomet|Octavia Gladden, Clinical Research Speaclist|704.493.0178|octavia.gladden@zimmerbiomet.com|
20565145|NCT03308877|University of Rochester Medical Center|Marc T. Swogger, Associate Professor, Psychiatry and Medicine|585-301-7738|marc_swogger@urmc.rochester.edu|
20565146|NCT03397706|Viracta Therapeutics|Medical Director|858-400-8470|ClinicalTrials@Viracta.com|
20565147|NCT05163496|University of Washington|Anthony Back MD|2066194367|tonyback@uw.edu|
20565148|NCT05646355|NYU Langone Health|Aasma Shaukat|6465012906|Aasma.Shaukat@nyulangone.org|
20565149|NCT04738591|Health Research Institute of the Balearic Islands (IdISBa)|Dr. Rocío Zamanillo Campos|971175897|rocio.zamanillo@ssib.es|
20565150|NCT03523572|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20565151|NCT03625115|Children's Hospital of Philadelphia|Dr. James Guevara|2155901130|guevara@chop.edu|
20531724|NCT00255177|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
20531725|NCT02199496|NIAID - LCIM|Fuss, Ivan|+1 301 496 9663|ifuss@niaid.nih.gov|
20531726|NCT02696616|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565152|NCT04197336|Johns Hopkins University|Clifford Weiss, MD|410-614-1046|cweiss@jhmi.edu|
20531727|NCT00884065|Catalan Institut of Health - Servei de Rhb Sant Ildefons|Martín Eusebio Barra López||martinbarra@gmail.com|
20531728|NCT01732783|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20531729|NCT01970371|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
20531730|NCT01481779|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20531731|NCT02145676|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20531732|NCT03318341|MUSC|Na Jin Seo, PhD|8437920084|seon@musc.edu|
20531733|NCT00487188|Hoffman-LaRoche|Medical Communications|800-821-8590||
20531734|NCT04132050|Kissei Pharmaceutical Co., Ltd.|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
20531735|NCT05965427|Research Organization (KC) Ltd|MASH1 Clinical Project Manager|+44 (0) 7494 795 982|mash1@rokcservices.com|
20531736|NCT03168672|DePuy Synthes|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
20531737|NCT00927472|Taro Pharmaceuticals U.S.A.,|Director, Clinical Research|914-345-9001|Natalie.Yantovskiy@Taro.com|
20531738|NCT00433537|ECOG Statistical Office|Study Statistician|617-632-3012||
20531739|NCT05436613|University of East Lonson|Professor Cynthia Fu|020 8223 4119|c.fu@uel.ac.uk|
20531740|NCT03771716|AdventHealth Research Institute|Dr. Kirk I. Erickson|4125763724|Kirk.Erickson@adventhealth.com|
20565153|NCT04304144|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20565154|NCT05868382|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20565155|NCT04585815|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565156|NCT04362085|St. Michael's Hospital|Dr. Michelle Sholzberg|4168606060|michelle.sholzberg@unityhealth.to|
20565157|NCT02497950|Rigshospitalet Copenhagen, Denmark|Prof. Finn Gustafsson|+4535459743|finn.gustafsson@regionh.dk|
20565158|NCT04249362|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20565159|NCT03655028|Edward Hines Jr., VA Hospital|Eileen Collins|312-3550118|ecollins@uic.edu|
20565160|NCT03852550|McMaster University|Research Coordinator|9055259140|galuppi@mcmaster.ca|27852
20565161|NCT04618315|Northwestern University|Sumitrajit Dhar|847 491 8542|s-dhar@northwestern.edu|
20565162|NCT02945176|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
20565163|NCT05244187|MEDIcept Inc|Adelina Paunescu, VP Clinical Affairs|781-526-8152|apaunescu@medicept.com|
20565164|NCT04410328|Rutgers New Jersey Medical School|Dr. Amit Singla|319-512-3558|as3321@njms.rutgers.edu|
20565165|NCT02393885|AtriCure, Inc.|Nfii Ndikintum|1-513-755-4100|nndikintum@atricure.com|
20565166|NCT00429364|New England Research Institutes, Inc.|Paul Stark, PhD|617-972-3362|pstark@neriscience.com|
20565167|NCT04871529|SWOG|Melissa Plets|206 667 2707|mplets@fredhutch.org|
20565168|NCT05184452|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20565169|NCT05586490|University of Michigan|Chatkaew Pongmala, PhD|734-936-1168|pchatkae@umich.edu|
20565170|NCT03292484|Aimmune Therapeutics, a Nestlé Health Science Company|Jay Patel|(800) 422-2752|jay.patel@uk.nestle.com|
20565171|NCT05290493|Nobias Therapeutics, Inc.|Patrick Dougherty|(215) 821-4698|dougherty@nobiastx.com|
20565172|NCT05419830|University of Pittsburgh|Shachi Tyagi, MD, MS|4126471274|sht55@pitt.edu|
20565173|NCT03914742|Johns Hopkins University|Program Manager Adult Brain Tumor Consortium (ABTC) and Brain Cancer Program|410-955-8837|jfisher@jhmi.edu|
20565174|NCT02567409|City of Hope|Paul Frankel. Ph.D.|626-218-5265|pfrankel@coh.org|
20565175|NCT03714815|Actelion Pharmaceuticals Ltd|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565176|NCT05987072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565177|NCT04056611|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565178|NCT03733925|Johnson & Johnson Private Limited|Medical Advisor Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565179|NCT00544414|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20565180|NCT05035654|Lyra Therapeutics|Senior Vice President, Clinical Affairs|617-393-4600|lyraclinical@lyratx.com|
20565181|NCT04750941|Columbia University|Jennifer E. Amengual, MD|212-326-5720|jea2149@cumc.columbia.edu|
20565182|NCT04560595|Johns Hopkins University|Dr. Dustin C. Lee|410-550-4035|dlee214@jhmi.edu|
20565183|NCT05814211|Coloplast A/S|Christian Riis Forman, Medical writer|49111756|dkcrif@coloplast.com|
20565184|NCT05856435|Cincinnati Children's Hospital Medical Center|Katie Nause|513-803-1506|Katie.Fox@cchmc.org|
20565185|NCT05660434|West Virginia University|Dr. Marian Reven, PhD, RN, AHN-BC, CNE, RA|304-293-3399|marian.reven@hsc.wvu.edu|
20565186|NCT04750538|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
20565187|NCT02828358|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20565188|NCT03298945|Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center|Yu-Xiao Yang, MD, MSCE|215-823-5800|yuxiao.yang@va.gov|
20565189|NCT04951076|Bionomics Limited|SVP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
20565190|NCT03702270|VANDERBILT UNIVERSITY MEDICAL CENTER|Dr. Cosby A Stone, Jr.|6153223412|Cosby.a.stone@vumc.org|
20565191|NCT05285137|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
20565192|NCT03717753|Hospital for Special Surgery|Dr. Jacques YaDeau, MD PhD|212- 606-1206|yadeauj@hss.edu|
20565193|NCT03106740|Massachusetts General Hospital|Marco Loggia|(617) 643-7267|marco.loggia@mgh.harvard.edu|
20565194|NCT04565990|Actelion Pharmaceuticals Ltd|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565195|NCT04797858|University of Pennsylvania|Robert Gross|2158982437|grossr@pennmedicine.upenn.edu|
20531741|NCT05317546|Medical University of South Carolina|Dr. Lindsay Squeglia|843-792-5454|squegli@musc.edu|
20531742|NCT05350202|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20531743|NCT01063114|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
20531744|NCT04115098|The University of Texas Health Science Center at Houston|Mark C. Hwang, MD|(713) 500-6597|Mark.C.Hwang@uth.tmc.edu|
20531745|NCT04635423|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20531746|NCT05556057|The University of Texas Health Science Center at Houston|Radha Korupolu, MD|713-797-5233|Radha.Korupolu@uth.tmc.edu|
20531747|NCT04431960|University of Connecticut|Ock K. Chun|18604866275|ock.chun@uconn.edu|
20531748|NCT05748626|Northwestern University|Paul C. Fitzgerald, RN, BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
20531749|NCT01147458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531750|NCT01034553|Mayo Clinic|Alexander Keith Stewart, M.B.CH.B|(480)301-4411|stewart.keith@mayo.edu|
20531751|NCT01017250|Duke University Radiation Oncology|John Kirkpatrick, MD, PhD|919 668-7342|robert.clough@dm.duke.edu|
20531752|NCT00832975|Hospital Clínico Universitario Puerta de Hierro|Dr Ignacio Fernández Lozano|913445000|iflozano@secardiologia.es|
20531753|NCT05253807|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20531754|NCT06717399|Saint Joseph's University|Nabila Enam|2155967348|nenam@sju.edu|
20531755|NCT01793935|University of Pittsburgh|Dr. K.N. Roy Chengappa - PI|412-246-5006|chengappakn@upmc.edu|
20531756|NCT01121926|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20531757|NCT02782468|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20531758|NCT00458835|Covis Pharma|Clinical Trials Interest|1-877-374 -4177|CTInterest@covispharma.com|
20531759|NCT00356590|Amgen Inc.|Study Director|866-572-6436||
20531760|NCT01149785|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531761|NCT01201863|Craig Hospital|Don Gerber, PsyD|303-789-8478|dgerber@craighospital.org|
20531762|NCT00448357|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
20531763|NCT00817063|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531764|NCT01496456|UMichigan|Dr. Mathilde C Peters||mcpete@umich.edu|
20531765|NCT04919161|Gaylord Hospital Inc.|Dr. Henry C. Hrdlicka, Research Coordinator|203-284-2864|hhrdlicka@gaylord.org|
20531766|NCT02489773|Asahi Kasei Pharma Corporation|Takuji Kohzuma PhD|+81-3-3296-3617|kouzuma.tb@om.asahi-kasei.co.jp|
20531767|NCT00584285|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
20565196|NCT04433208|Prolacta Bioscience|Dr David Rechtman VP, Medical Affairs|8887765228|drechtman@prolacta.com|
20531768|NCT02362451|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20531769|NCT00620542|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20531770|NCT01500083|Lundbeck Canada Inc.|Lundbeck Canada Inc.|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
20531771|NCT01555931|University of North Carolina School of Medicine|Dr. Gretchen Stuart|919-962-4880|gstuart@med.unc.edu|
20531772|NCT06540170|National Healthcare Group Polyclinics|Senior Wound Nurse Clinician|64966611|julia_zhu@nhgp.com.sg|
20531773|NCT04882800|Sonova US|Principal Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
20531774|NCT05696847|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20531775|NCT01697579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20531776|NCT01044498|Hoffmann-La Roche|Medical Communications|800 821-8590||
20531777|NCT00820534|Novartis Consumer Health|Head of Clinical Research|+4122363311||
20531778|NCT05513950|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20531779|NCT02903914|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
20531780|NCT03093844|University of Colorado|Dr. Jonathan Gutman|303-724-9562|JONATHAN.GUTMAN@CUANSCHUTZ.EDU|
20531781|NCT01963234|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
20531782|NCT04225039|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20531783|NCT02320175|Boston Children's Hospital|Isabella Liss, Patient and Family Centered I-PASS SCORE Study Coordinator|857-218-3229|isabella.liss@childrens.harvard.edu|
20531784|NCT00975923|Vanderbilt University School of Medicine|Dr. Theodore Speroff|615-636-9476|ted.speroff@vanderbilt.edu|
20531785|NCT00088153|Massachusetts General Hospital|Anne Klibanski|617-726-3870|aklibanski@partners.org|
20531786|NCT00373672|Northwestern University|Herbert Y Meltzer|1 312 503 0309|h-meltzer@northwestern.edu|
20531787|NCT02246777|Alcon, A Novartis Division|Associate, Medical Group 1, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
20531788|NCT01470170|Department of Thoracic Medicine|Dr. Yu-Lun, Lo|+886-3-3281200|loyulun@hotmail.com|5108
20531789|NCT03331250|Massachusetts General Hospital|Gregory Cote, MD, PhD|617-726-8748|GCOTE@mgh.harvard.edu|
20531790|NCT06480032|Rehman Medical Institute|Dr.Iftikhar qayum|+92 91 5838 333|iftikhar.qayum@rmi.edu.pk|4708
20531791|NCT03884374|University of Florida|Eric Weber|352-273-7802|ebweber@ufl.edu|
20531792|NCT05708924|Masonic Cancer Center|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu|
20531793|NCT04262219|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
20531794|NCT03069989|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20531795|NCT02145390|University of Miami|Adrian Ishkanian MD|305-243-4200|aishkanian@miami.edu|
20531796|NCT06231511|Shirley Ryan Abilitylab|Sara Prokup PT, DPT|312-238-1355|sprokup@sralab.org|
20531797|NCT03421561|Philips|Nicolas Aguirre|612-297-6655|nicolas.aguirre@philips.com|
20531798|NCT01692015|Imperial College London|professor Claire Shovlin|+44 (0)20 7589 5111|c.shovlin@imperial.ac.uk|
20531799|NCT00143507|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
20531800|NCT00876395|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20531801|NCT00000142|Johns Hopkins Bloomberg School of Public Health|Dr. Curtis Meinert|410-955-8175|cmeinert@jhsph.edu|
20531802|NCT00970944|Spaulding Rehabilitation Hospital|Joseph T Giacino, PhD|617-573-2757|jgiacino@partners.org|
20531803|NCT00972738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20531804|NCT03915067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20531805|NCT03071744|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
20531806|NCT01988415|Abbott Medical Optics|Janice Tarrant|408-273-4163|janice.tarrant@abbott.com|
20531807|NCT02034591|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20531808|NCT00597675|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20531809|NCT00599313|Texas Oncology Cancer Center|Dr. Guru Sonpavde|2813327505|Guru.Sonpavde@USOncology.com|
20531810|NCT00712920|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
20531811|NCT01063907|Kyowa Hakko Kirin Pharma, Inc.|Senior VP Drug Development|609-919-1100|clinical.info@kyowa-kirin-pharma.com|
20531812|NCT04398134|Assembly Biosciences|Executive Director of Clinical Operations|833-509-4583|Clinicaltrials@assemblybio.com|
20531813|NCT03802110|Boston Scientific Cardiac Rhythm Management|Stephen J. Hahn, PhD|1-800-227-3422|stephen.hahn@bsci.com|
20531814|NCT05142774|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20531815|NCT04443452|University of Nottingham|Professor Ana Valdes|0115823114|ana.valdes@nottingham.ac.uk|
20531816|NCT02242630|Keesler Medical Center|Matthew B. Carroll|228-376-3629|matthew.carroll.1@us.af.mil|
20531817|NCT04556097|McLean Hospital|Dr. Brent Forester|617-855-3622|bforester@mclean.harvard.edu|
20531818|NCT03409367|Oregon Health & Science University|Director of Clinical Trials|503-764-8544|michaell@ohsu.edu|
20531819|NCT04164979|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
20531820|NCT04046471|University of Kansas Medical Center|Dr. Joseph Donnelly|785-864-1687|jdonnelly2@kumc.edu|
20531821|NCT03824158|University of Pittsburgh|Yael Schenker, MD, MAS, FAAHPM|415-254-9958|yas28@pitt.edu|
20531822|NCT05423756|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
20531823|NCT06455111|Boston University School of Medicine Endocrinology, Diabetes, Nutrition & Weight Management|Nicole L Spartano, PhD|315-415-2040|spartano@bu.edu|
20531824|NCT02141113|Rochester Center for Behavioral Medicine|Joel L. Young, MD|2486088800|jyoung@rcbm.net|
20531825|NCT00357565|Masonic Cancer Center|Christen Ebens, MD, MPH|(612) 626-2961|ebens012@umn.edu|
20531826|NCT07021443|UZ Brussel|Prof. dr. Hendrik Reynaert|+32 2 477 68 11|hendrik.reynaert@uzbrussel.be|
20531827|NCT05666245|Center for Vaccine Development and Global Health (CVD)|Wilbur Chen, MD, MS|410-706-5328|wilbur.chen@som.umaryland.edu|
20531828|NCT02337686|UT MD Anderson Cancer Center|Dr. Vinaykumar Puduvalli, MD-Chair, Neuro-Oncology|(713) 745-2343|vpuduval@mdanderson.org|
20531829|NCT02266576|Stanford University|Jan J. Vasquez|408-858-4457|jan.vasquez@stanford.edu|
20531830|NCT02606305|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20531831|NCT00879359|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
20531832|NCT02008370|Maimonides Medical Center|Dr G Trunfio|718-283-6000|gtrunfio@maimonidesmed.org|
20531833|NCT00662259|University of California San Diego|Gregory G. Brown|858-246-0607|gbrown@ucsd.edu|
20531834|NCT00601627|Alliance for Clinical Trials in Oncology|George P. Kim, M.D.|507-284-4918||
20531835|NCT02693418|Evofem Biosciences|Kelly Culwell, MD, MPH, FACOG|858-550-1900|kculwell@evofem.com|225
20531836|NCT01199614|Columbia University|John P. Bilezikian, MD|212-305-6257|jpb2@cumc.columbia.edu|
20531837|NCT01750346|National Institutes of Health|Dr. Codrin Lungu|301-402-0976|lunguci@ninds.nih.gov|
20531838|NCT01001104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20531839|NCT03439514|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531840|NCT02175758|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20531841|NCT02887586|Clinical Cancer Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences|Hebin|13520253895|hebinbj68@163.com|
20531842|NCT02299167|Dammam University|Roshdi R. Al-Metwalli|+966 50 289 3485|rmetwalli@iau.edu.sa|
20531843|NCT03600428|Vanderbilt University Medical Center|C. Buddy Creech, MD, MPH|6153430332|buddy.creech@vumc.org|
20531844|NCT04803279|Oticon Medical|Nicole Amichetti, PhD, MS, Manager of Clinical Affairs|6093660424|nitc@oticonmedical.com|
20531845|NCT03954535|Columbia University School of Social Work|Dr. Traci Schwinn|212-851-2280|tms40@columbia.edu|
20531846|NCT04871074|UW School of Medicine and Public Health|Barbara Bendlin, PhD, MA|(608) 265-2483|bbb@medicine.wisc.edu|
20531847|NCT06011798|Unity Biotechnology, Inc.|Anirvan Ghosh|-|anirvan.ghosh@unitybiotechnology.com|
20531848|NCT03506477|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
20531849|NCT03462680|Charlie Norwood VAMC|Dr. Chandramohan Wakade|706-733-0188|chandramohan.wakade@va.gov|2379
20531850|NCT01757847|VA San Diego Healthcare System|Niloofar Afari, PhD|858-642-3387|niloofar.afari@va.gov|
20531851|NCT02516241|AstraZeneca|Medical Science Director|1-877-240-9479|information.center@astrazeneca.com|
20565197|NCT02010242|Calliditas Therapeutics|Richard Philipson, MD Chief Medical Officer|+46 556659-9766|richard.philipson@calliditas.com|
20565198|NCT05575219|The University of Texas Health Science Center at Houston|Andrea Leigh Heifner, MD|407-729-2972|andrea.heifner@stjude.org|
20565199|NCT04267120|Washington University School of Medicine|Joel Picus, M.D.|314-362-9115|jpicus@wustl.edu|
20565200|NCT03476343|Cincinnati Children's Hospital Medical Center|Dr. Beth Kline-Fath|(513) 636-1856|beth.kline-fath@cchmc.org|
20565201|NCT03711474|West Virginia University|Scott Daffner, MD|304-293-1172|sdaffner@hsc.wvu.edu|
20565202|NCT05147116|University of Portsmouth|Dr Anthony Shepherd|02392845289|ant.shepherd@port.ac.uk|
20565203|NCT06007781|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
20565204|NCT05204654|University at Buffalo|No Dr. Alexandria Newton|716-829-2845|amnewton@buffalo.edu|
20531852|NCT04057365|Massachusetts General Hospital|Joseph Franses, MD, PhD|617-724-4000|JFRANSES@MGH.HARVARD.EDU|
20531853|NCT04738487|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20531854|NCT04336943|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
20531855|NCT05184842|Montefiore Medical Center|Mendel Goldfinger, MD|718-920-4826|mgoldfin@montefiore.org|
20531856|NCT00325416|H. Lee Moffitt Cancer Center and Research Institute|Daniel M. Sullivan, M.D.|813-745-3878|dan.sullivan@moffitt.org|
20531857|NCT06239610|Parkview Health System|Jan Powers PhD, RN, CCNS, CCRN, CNRN, NE-BC, FCCM|260-266-7761|jan.powers@parkview.com|
20531858|NCT01683526|Beth Israel Medical center|Michael Silverberg|2124202377|msilverberg2@chpnet.org|
20531859|NCT01260948|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20531860|NCT00462462|Orfagen|Clinical Project Manager|+33 5 34 50 64 62|info@orfagen.com|
20531861|NCT02555878|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20531862|NCT00765076|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531863|NCT01163617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20531864|NCT02875080|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20531865|NCT02394756|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan- PRINCIPAL RESEARCH OPTOMETRIST|1 904 443 3449|CColesb@ITS.JNJ.com|
20531866|NCT00768053|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531867|NCT01164475|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20531868|NCT02335944|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20531869|NCT01744821|Northwestern University|Assistant Professor|312-472-4684|dcarson@nm.org|
20531870|NCT02830087|Wake Forest University Health Sciences|Maxwell Langfit, MD||mlangfit@wakehealth.edu|
20531871|NCT02916771|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|Irene_Ghobrial@DFCI.Harvard.edu|
20531872|NCT05635370|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20551751|NCT01859494|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20551752|NCT00862186|Seattle Children's Hospital|Catherine Fiona Macpherson, PhD|206-987-2032|catherine.macpherson@seattlechildrens.org|
20551753|NCT02381418|Abbott|Global Clinical Director|+31294477184|serge.vandewitte@abbott.com|
20551754|NCT04014075|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
20551755|NCT01879228|University of Pennsylvannia|Paola Alvarado|215-746-2081|paola.alvarado@pennmedicine.upenn.edu|
20551756|NCT02312726|University of New Mexico - Family Planning Research Division|Michel Paves, Research Specialist|505-272-9703|mdaliva@salud.unm.edu|
20551757|NCT02357901|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20565205|NCT01221948|Bostons Scientific Neuromodulation|Nic Van Dyck, Director International Clinical Operations|+31 43 3568328|vandyckn@bsci.com|
20551758|NCT04259762|University of New Mexico Health Sciences Center|Dr. Shiraz Mishra|505-925-6085|smishra@unm.edu|
20551759|NCT01203046|Dr. Silvia M. Pinango L|Dr. Silvia M. Pinango L.|+584169267988|pinangosilvia@yahoo.com|
20551760|NCT03453684|"University of Colorado Denver | Anschutz"|Melissa Brooks-Peterson, MD|30372411111|clinicalresearchsupportcenter@ucdenver.edu|
20551761|NCT02063516|tianjinMUGH|Dr. Haiyun Wang|008613752211206|wanghy819@hotmail.com|
20551762|NCT00491387|University of Cincinnati|Myron Gerson MD|5135583974|myron.gerson@uc.edu|
20551763|NCT02293655|Cincinnati Children's Hospital Medical Center|Tanya Froehlich, MD|5136361154|tanya.froehlich@cchmc.org|
20551764|NCT00413192|Eisai Ltd. Mosquito Way, Hatfield, Hertfordshire, AL 10 9SN|Gitta Irmer Associate Director, Data Quality & Standards Global Regulatory Operations|+44 (0) 845 676 1618||
20551765|NCT03814746|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20551766|NCT05089682|Mayo Clinic|Dr. Gregory A. Worrell|507-538-4880|Worrell.Gregory@mayo.edu|
20551767|NCT00772707|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
20551768|NCT03019107|Liberate Medical|Angus Mclachlan|+1 (833) 203-4663|info@liberatemedical.com|
20551769|NCT00644280|University of California San Francisco|Shan C. Lin, MD|415-353-2608|lins@vision.ucsf.edu|
20551770|NCT01192282|Groote Schurr Hospital / University of Cape Town|Dr Shahila Tayib|0060195773376|syarq@yahoo.com|
20551771|NCT00483379|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20551772|NCT00391989|GIMEMA|Dr. Paola Fazy; Dr. Marco Vignetti|+39 06.70390521|gimema@gimema.it|
20551773|NCT00862810|Duke University Health System|Emmanuel Walter MD, MPH|919-620-5346|walte002@mc.duke.edu|
20551774|NCT01592344|Bioness|Charlene Myers, Contractor|9499101655|cahanderson@msn.com|
20551775|NCT00545155|University of Rochester|Manish N. Shah|585-463-2920|manish.shah@rochester.edu|
20551776|NCT04147455|Emory University|Dr. Kathryn Yount|404-727-8511|kyount@emory.edu|
20551777|NCT03311659|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20551778|NCT00449644|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
20551779|NCT03448185|University of Texas Southwestern Medical Center|Eriko Iwatate|214-648-3680|Eriko.Iwatate@UTSouthwestern.edu|
20551780|NCT00679263|Medicinova Inc|Kazuko Matsuda, MD, Vice President Clinical Development|858-373-1500|matsuda@medicinova.com|132
20551781|NCT00862446|Vanderbilt University Medical Center|William Walsh|615-322-3476|bill.walsh@vumc.org|
20551782|NCT03479307|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
20551783|NCT05986019|Medical University of South Carolina|Dr. Bashar Badran|843-792-6076|badran@musc.edu|
20551784|NCT02446990|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
20551785|NCT01064401|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20551786|NCT03158051|University of Wisconsin School of Medicine and Public Health|Kara Hoppe, DO|608-417-4224|khoppe2@wisc.edu|
20551787|NCT02738151|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20531873|NCT01018979|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
20531874|NCT01695746|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20531875|NCT02324153|Johns Hopkins University School of Medicine|Karin Neufeld MD MPH: PI of Trial|410-550-0197|kneufel2@jhmi.edu|
20531876|NCT01937299|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20531877|NCT03018938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20531878|NCT01202591|Astrazeneca|Richard Mather|+44 1763 263593|ClinicalTrialTransparency@astrazeneca.com|
20531879|NCT00191100|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20531880|NCT01769586|VA Connecticut Healthcare System|Dr. Loren Laine|203-932-5711|loren.laine@yale.edu|
20531881|NCT02406612|Essential Medical|Sam Nardone|6105571009|sam@essmedclosure.com|
20531882|NCT03424148|Cutera|Margout Doucette|415-656-9612|mdoucette@cutera.com|
20531883|NCT01235377|Veterans Health Administration Pharmacy Benefits Management|Madeline McCarren, PhD|7087867987|madeline.mccarren@va.gov|
20531884|NCT04882709|Sonova Canada Inc.|Dr. Jinyu Qian|6472624826|jinyu.qian@sonova.com|
20531885|NCT03611946|Johns Hopkins CIR|Dr Anna Durbin|410-955-7283|adurbin1@jhu.edu|
20531886|NCT04950686|innovation Research and Training|Tracy Scull, PhD|9194937700|tscull@irtinc.us|
20531887|NCT03496129|University of Louisville|Dr. Martha Bickford|502-852-3527|martha.bickford@louisville.edu|
20531888|NCT00632359|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20531889|NCT02872714|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20531890|NCT05061888|Pennington Biomedical Research Center|Corby Martin|225-763-2585|corby.martin@pbrc.edu|
20531891|NCT04253626|Stanford University|Deirdre J. Lyell, MD|(650) 498-4069|dlyell@stanford.edu|
20531892|NCT06904404|Wolfe Eye Clinic|Edward Hu|(319) 362-8032|ehu@wolfe.com|
20531893|NCT03043573|Weill Cornell Medicine|Dr. Dimitris Kiosses|914-997-4381|dkiosses@med.cornell.edu|
20531894|NCT05291975|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
20531895|NCT06400914|CooperVision, Inc.|Jose A. Vega, OD, MSc, FAAO|925-621-3761|javega@coopervision.com|
20531896|NCT05578872|Anaveon AG|Medical Director, MD|+41615218383|anaveonclinicaltrials@anaveon.com|
20531897|NCT01440920|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20531898|NCT02626611|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
20531899|NCT00479232|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20531900|NCT05399771|Atrium Health Wake Forest Baptist|Nicole Levi|336-716-4171|nlevi@wakehealth.edu|
20531901|NCT01680172|Mayo Clinic|Robert Bright, MD|480-301-4853|bright.robert@mayo.edu|
20531902|NCT05463055|Varian Medical Systems|Sophia Shao|+86-21-23156400|sophia.shao@varian.com|
20531903|NCT00484159|Johns Hopkins|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
20531904|NCT04766333|Rutgers University|Shawna V. Hudson|848-932-0215|hudsonsh@rutgers.edu|
20531905|NCT00104234|BioMarin Pharmaceutical Inc.|Medical Information Services|8009834587|medinfo@bmrn.com|
20531906|NCT01239680|Truman Medical Center|Charles W. Van Way, III, M.D.|816.235.2553|vanwayc@umkc.edu|
20531907|NCT03033901|James A. Haley Veterans' Hospital|Risa Richardson, PhD|813-972-2000|Risa.Richardson@va.gov|5309
20531908|NCT01797185|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
20531909|NCT00729586|NRG Oncology|Angela Kuras on behalf of Virginia Filiaci|716-845-5702|kurasa@nrgoncology.org|
20531910|NCT02734667|Stanford University|Dr. Korey Hood|6504976899|kkhood@stanford.edu|
20531911|NCT05177094|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20531912|NCT01033942|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20531913|NCT02737618|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20531914|NCT02397837|Brigham and Women's Hospital|Dr. Katherine Burdick|617-732-5789|kburdick1@bwh.harvard.edu|
20531915|NCT04764604|University College London Hospitals NHS Foundation Trust|Brian Saccente-Kennedy, Speech and Language Therapist|+44 20 3456 5180|brian.saccente-kennedy@nhs.net|
20531916|NCT01111370|Dexcom, Inc|Andy Balo/Sr. VP|8582000203|abalo@dexcom.com|
20531917|NCT03928327|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20531918|NCT00407511|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20531919|NCT02493855|AbbVie|Global Medical Services|800-633-9110||
20531920|NCT03086343|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20531921|NCT01716195|University of California Davis|Dr. Megan Daly|916-734-5428|medaly@ucdavis.edu|
20531922|NCT00741611|CR Bard|Anne Marie Harcarik|908-277-8051|annemarie.harcarik@crbard.com|
20531923|NCT01385644|The Prince Chalres Hospital|Assoc Professor Daniel Chambers|+61 7 3139 4000|daniel.chambers@health.qld.gov.au|
20531924|NCT01922011|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20531925|NCT01510756|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
20531926|NCT00924482|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|wallacea@anesthesia.ucsf.edu|3732
20531927|NCT01566162|Sunovion|Medical Director CNS Clinical Trials|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20531928|NCT03562507|University of Michigan Rogel Cancer Center|ClinicalTrials.gov Cancer Center Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20565206|NCT03314688|Yale School of Medicine|Tara Sanft, MD|(203) 200-2328|tara.sanft@yale.edu|
20531929|NCT00549328|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531930|NCT00770484|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
20531931|NCT00063622|Virginia Commonwealth University|Arun J. Sanyal||asanyal@mcvh-vcu.edu|
20565207|NCT02446236|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20531932|NCT03384966|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+41 58 844 07 44|viatrisinnovationclinicaltrials@viatris.com|
20531933|NCT02202616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20531934|NCT00367458|National Cancer Institute|Frank Maldarelli|301-435-8019|fmalli@mail.nih.gov|
20531935|NCT02556788|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
20531936|NCT04502524|Fred Hutchinson Cancer Center|Jaimee Heffner, Ph.D., Associate Professor|206.667.7314|jheffner@fredhutch.org|
20531937|NCT04327271|University of Washington|Caryl Feldacker|+1-314-600-6743|cfeld@uw.edu|
20531938|NCT04339972|Medical University of South Carolina|Dr. Mark George or Dr. Bashar Badran|843-792-6076|georgem@musc.edu|
20531939|NCT00776997|Torax Medical|Amy Derosier, VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
20531940|NCT02403271|Pharmacyclics LLC, An AbbVie Company|Thorsten Graef|(408) 215-3127|tgraef@pcyc.com|
20531941|NCT04837521|Duke University|Dr. Andrada Neacsiu|+1 919 684 6714|andrada.neacsiu@duke.edu|
20531942|NCT05221866|University of Nebraska Medical Center|Karsten Bartels|402-559-4081|anesthesiology.research@unmc.edu|
20531943|NCT03487445|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+41 58 844 07 44|viatrisinnovationclinicaltrials@viatris.com|
20531944|NCT00221104|Translational Research Informatics Center, Kobe, Hyogo|Director of Medical Statistics Division|+81-78-303-9108|kagimura@tri-kobe.org|
20531945|NCT02989389|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20531946|NCT01666652|WRAIR|Robin Nielsen, RN|301-319-9063|trials.clinical@amedd.army.mil|
20531947|NCT04470427|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20531948|NCT01563081|GlaxoSmithKline|GSK Response Center|866-435-7343||
20531949|NCT01428245|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
20531950|NCT06170827|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@GSK.com|
20531951|NCT03599713|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20531952|NCT03641924|Corporal Michael J. Crescenz VAMC|Dr. James Cobb Scott|2158235800|James.Scott2de50a@va.gov|207138
20531953|NCT04333498|New York State Psychiatric Institute/ HIV Center|Research Program Manager|646-774-6904|christopher.ferraris@nyspi.columbia.edu|
20531954|NCT01565694|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|310715455050|astellas.resultsdisclosure@astellas.com|
20531955|NCT01373229|Duke University Medical Center|Danielle Brander, MD|919-286-6897|danielle.brander@duke.edu|
20531956|NCT02906618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20531957|NCT00587457|MedImmune, LLC.|Mark C Lanasa|301-398-0000|clinicaltrialenquiries@medimmune.com|
20531958|NCT03234881|VA Connecticut Healthcare System|Robin Masheb, PhD|203-932-5711|Robin.Masheb@va.gov|3954
20531959|NCT00541229|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20531960|NCT03720847|University of North Carolina at Chapel Hill|Tory Eisenlohr-Moul|859-317-0503|moul@med.unc.edu|
20531961|NCT01858948|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu|
20531962|NCT02513199|Icahn School of Medicine at Mount Sinai|Michael Buckstein|212-241-7502|michael.buckstein@mountsinai.org|
20531963|NCT01115231|Ralph H. Johnson VA Medical Center, Division of Research, Charleston, SC, USA|Baerbel Rohrer, PhD; VA Research Scientist|843-792-5086|rohrer@musc.edu|
20531964|NCT03014362|Walter Reed National Military Medical Center|Christopher E Hines, MD|301-319-8122|christopher.e.hines.civ@mail.mil|
20531965|NCT01143792|The Ohio State University|Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
20531966|NCT02260986|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20531967|NCT03235414|Cincinnati Children's Hospital Medical Center; Department of Radiology|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
20531968|NCT00313170|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20531969|NCT05276804|Atrium Health|Gregory T. Scarola|704 355-5379|gregory.scarola@advocatehealth.org|
20531970|NCT00607594|Cross Cancer Institute|Dr. Heather-Jane Au|780-432-8500|heathera@cancerboard.ab.ca|
20531971|NCT02827708|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20531972|NCT01733888|DMG Dental Material Gesellschaft|Manager Clinical Research|+494084006|clinicalresearch@mtcompanies.com|0
20531973|NCT02199574|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20531974|NCT00898807|Johns Hopkins|Anne Casper|410-955-8183|ashankl1@jhu.edu|
20531975|NCT00529035|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
20531976|NCT01521364|University of Groningen, University Medical Center Groningen|Dr. J.W.C. Alffenaar|+31-50-3614070|j.w.c.alffenaar@umcg.nl|40378
20531977|NCT02636283|University of Minnesota|Otto Sanchez|615-833-9867'|sanc0050@umn.edu|
20565208|NCT03085719|Dana-Farber Cancer Institute|Jonathan Schoenfeld, MD, MPH|617-582-8731|Jonathan_Schoenfeld@dfci.harvard.edu|
20520551|NCT03949803|Universidad de Murcia|Prof. Marta Garaulet Aza|+34868889478|garaulet@um.es|
20520552|NCT05065983|Emergent BioSolutions|Dr. Sufia Muhammad|346-732-7331|muhammads@ebsi.com|
20520553|NCT00986180|Janssen Pharmaceuticals|Vice President, Medical Affairs, Internal Medicine|1 908 218-7250||
20520554|NCT03261960|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20520555|NCT03251963|University of Utah|Christopher Pannucci|801 581 2121|christopher.pannucci@hsc.utah.edu|
20520556|NCT04295135|Indiana University|Dr. Christopher A. Harle|317 278 3245|charle@iu.edu|
20520557|NCT00334061|Penumbra Inc|Siu Po Sit, PhD Study Coordinator|510 748 3200|siupo.sit@penumbrainc.com|221
20520558|NCT01732874|Nationwide Childrens Hospital|Dr. Christina J. Valentine MD,MS,RD|(614) 722-2000|Christina.Valentine@nationwidechildrens.org|
20520559|NCT02923674|Wake Forest School of Medicine|Barbara Nicklas, MD|336-713-8569|bnicklas@wakehealth.edu|
20520560|NCT04539886|Pulse Biosciences, Inc.|William A. Knape, VP Clinical, Regulatory and Quality Affairs|510-906-4649|bknape@pulsebiosciences.com|
20531978|NCT03418675|University of Chicago|Dr. Jon E. Grant|7738341325|jgrant4@bsd.uchicago.edu|
20531979|NCT01879852|University of Florida|Dr. Terese Chmielewski|(352)273-6104|tchm@ufl.edu|
20531980|NCT02115386|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20531981|NCT02409901|University of Illinois Chicago|Shyreen Kamal, Director of Clinical Research|2068830173|shyreen@uic.edu|
20531982|NCT02453048|ILIAD Biotechnologies|Ken Solovay|9543360777|ken@iliadbio.com|
20531983|NCT02111980|UC San Diego School of Medicine|Dr. Ulrika Birgersdotter-Green|858-657-5310|ubgreen@ucsd.edu|
20531984|NCT01482221|AstraZeneca|Sanjeev Pathak||ClinicalTrialTransparency@astrazeneca.com|
20531985|NCT04900272|Northwestern University Feinberg School of Medicine|Katherine O'Brien|314-747-5361|obrien.k@wustl.edu|
20531986|NCT05059080|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20531987|NCT01047501|Amarin Pharma, Inc.|Alex Giaquinto|+1 908 326 1324|alex.giaquinto@amarincorp.com|
20531988|NCT04602000|Celltrion, Inc|Yun Ju Bae / Head of Clinical Planning 1 Department|+82 32 850 4160|YunJu.Bae@celltrion.com|
20531989|NCT05607043|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|732 824 7241|subramga@sdm.rutgers.edu|
20531990|NCT01846871|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
20531991|NCT00478036|University of Colorado, Dept. of Ophthalmology|Malik Kahook, MD|720-848-2501|Malik.kahook@ucdenver.edu|
20531992|NCT04871113|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20531993|NCT02447029|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20531994|NCT01239745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531995|NCT01257542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20531996|NCT00081458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20531997|NCT02132468|Mateon Therapeutics|Clinical Operations|6506357000|ca@mateon.com|
20531998|NCT00243061|Juravinski Cancer Centre|Dr. Elaine McWhirter|905-387-9495|elaine.mcwhirter@hrcc.on.ca|67559
20531999|NCT03097315|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20532000|NCT00153920|Dana-Farber Cancer Institute|Paul G. Richardson|617.632.2104|Paul_Richardson@dfci.harvard.edu|
20532001|NCT03780387|University of North Carolina at Chapel Hill|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
20532002|NCT06069609|Bausch & Lomb|Jeffery Schafer, OD, MS Director, Clinical Research|585-338-5664|jeffery.schafer@bausch.com|
20532003|NCT02948400|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu|
20532004|NCT01716156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532005|NCT04822194|Rice University|Bryan Denny|713-348-8257|bryan.denny@rice.edu|
20532006|NCT03976375|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20532007|NCT02717611|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20532008|NCT04598828|Atrium Health Wake Forest Baptist|Project Manager|336-713-8793|richarlette.hightower@advocatehealth.org|
20532009|NCT04818112|University of Arizona|Dr. Aleeca Bell|5206260575|aleecab@arizona.edu|
20532010|NCT02676973|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
20532011|NCT02580604|University of Colorado Anschutz Medical Campus|Dr. Sarah Wherry|303-724-1927|sarah.wherry@cuanschutz.edu|
20532012|NCT01078662|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
20532013|NCT03279458|University of Mississippi Medical Center|Dr. Madhankumar Sathyamoorthy, Principal Investigator|6018157066|msathyamoorthy@umc.edu|
20532014|NCT01913353|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20532015|NCT00385840|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532016|NCT04017962|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou, MD|212-639-6483|papanicg@mskcc.org|
20532017|NCT00700635|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20532018|NCT06937346|Karaganda Medical University|Amirbekova Mariyam Sayatovna|+77472224951|Amirbekova31081998@gmail.com|
20532019|NCT03580928|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
20532020|NCT02798952|GlaxoSmithKline|GSK Response Center|866-435-7343|eg763112@gsk.com|
20532021|NCT03807843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532022|NCT01312129|The Mind Research Network|Kent Hutchison, Ph.D.|720-663-0745|khutchison@mrn.org|
20532023|NCT00990288|Hospital for Special Surgery|Mark P. Figgie MD|212-606-1932|figgiem@hss.edu|
20532024|NCT00924651|University of Rochester Medical Center|Karen M. Mustian, PhD, MPH, Associate Professor|585-273-1796|Karen_Mustian@urmc.rochester.edu|
20532025|NCT04772547|University of Florida|Dr. Carolina B. Maciel|(352) 273-5550|carolina.maciel@ufl.edu|
20532026|NCT02506036|Johns Hopkins University School of Medicine|Dr. Argye Hillis|410-614-2381|argye@jhmi.edu|
20532027|NCT04119336|Massachusetts General Hospital|Andrew Yee, MD|617-724-4000|AYEE1@mgh.harvard.edu|
20532028|NCT01410604|Hospital Regional de Alta Especialidad del Bajio|M.D. Maria L. Evia-Viscarra|+52 (477) 267-2000|evialola@hotmail.com|1405
20532029|NCT01178411|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532030|NCT00753142|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20532031|NCT02383173|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
20532032|NCT01625182|Novartis Pharmaceuticals|Study Director|862-778-8300||
20532033|NCT00263562|Baylor College of Medicine|Andrea T. Cruz, MD, MPh|832-824-5582|acruz@bcm.edu|
20532034|NCT00731198|Changhai Hospital, Second Military Medical University, Shanghai, China|Zhaoshen Li M.D.|86-21-81873271|zhaoshenlismmu@gmail.com|
20532035|NCT00429299|GlaxoSmithKline|GSK Response Center|866-435-7343||
20565209|NCT05012163|Geisinger|Gail Rosenbaum|800-275-6401|grosenbaum@geisinger.edu|
20532036|NCT01565551|University of California, San Francisco|Geoffrey Manley, MD, PhD|415-206-8300|manleyg@neurosurg.ucsf.edu|
20532037|NCT00315822|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
20532038|NCT00693303|Shenandoah University|Deborah Marr ScD, OTR/L|540-678-4312|dmarr@su.edu|
20532039|NCT02162433|Massachusetts Eye and Ear|Dr. Makara Cayer|617-573-3380|makara_cayer@meei.harvard.edu|
20532040|NCT01946802|Seoul National University Hospital|Pf. Gil Joon Suh|82-2-2072-2196|suhgil@snu.ac.kr|
20532041|NCT00195429|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20532042|NCT02143778|Exalenz Bisocience|Clinical Trial Manager|97289737500|avrahamh@exalenz.com|
20532043|NCT01334515|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20532044|NCT03637374|Johns Hopkins University|Dr. James H. Black, III|(410) 955-5165|jhblack@jhmi.edu|
20532045|NCT03683901|MetroHealth Rehabilitation Institute|Dr. Victoria Whitehair|216-778-4414|vwhitehair@metrohealth.org|
20532046|NCT05561140|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532047|NCT01163656|The Children's Hospital of Philadelphia|John Fiadjoe, MD|215-590-3916|fiadjoej@email.chop.edu|
20532048|NCT00781950|St. Boniface Hospital Research Centre|Dr. Grant Pierce|(204) 235-3414|GPierce@sbrc.ca|
20532049|NCT02949934|University of Colorado School of Medicine|Joseph P. Schacht, Ph.D.|(303) 724-3773|joseph.schacht@cuanschutz.edu|
20532050|NCT01684592|Battelle|Dr. Victoria Coleman-Cowger|4103722748|colemancowger@battelle.org|
20532051|NCT00657605|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
20532052|NCT04069520|Emory University|Dr. Kim Barber Foss|404-544-1306|kim.barberfoss@emory.edu|
20532053|NCT00849472|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532054|NCT00825175|University of Michigan|Julia Looper|253 534 8499|jlooper@umich.edu|
20532055|NCT04615507|Johnson & Johns Vision Care Inc.|Thomas Karkkainen- Sr. Research Principal Optometrist|1-800-843-2020|tkarkkai@its.jnj.com|
20532056|NCT00248547|Oregon Health & Science University, Knight Cancer Institute|Joseph Bubalo, PharmD|503-494-1054|bubaloj@ohsu.edu|
20565210|NCT05716763|Unither-Pharmaceuticals|Non-clinical & clinical Project Manager|33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
20565211|NCT03381586|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20565212|NCT01130519|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
20565213|NCT05280574|Outcomes Research Consortium, Department of Anesthesiology, Cleveland Clinic, Cleveland, Ohio|Daniel I. Sessler MD, Professor and Michael Cudahy Chair|216-870-2620|DS@OR.org|
20565214|NCT05363163|Eurofins Dermscan Pharmascan|Florence REBER|0472823656|Florence.Reber@cpt.eurofinseu.com|+33
20565215|NCT04197869|UCLA Health|Dr. Alexandra Goodwin|917-969-1654|zangoodwin@gmail.com|
20565216|NCT04180462|Washington University School of Medicine|Allison King, M.D., Ph.D., MPH|314-454-4291|king_a@wustl.edu|
20565217|NCT05735652|Boston Scientific|Taimin.Yue|18911590729|Taimin.yue@bsci.com|
20565218|NCT05838027|University of Pennsylvania|Eva Fabian|760-791-2633|eva.fabian@pennmedicine.upenn.edu|
20565219|NCT03213873|Karolinska Institutet|Erika Franzén|08-52488878|erika.franzen@ki.se|
20565220|NCT04709419|The University of Texas Health Science Center at San Antonio|Lawrence Lavery, DPM|214-399-5381|lavery@uthscsa.edu|
20565221|NCT05046639|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20565222|NCT03367754|Clinical Center|Kovacs, Joseph|+1 301 496 9907|jkovacs@mail.nih.gov|
20565223|NCT03824366|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
20565224|NCT04587024|Johns Hopkins University|Dr. Cozumel S. Pruette|410-955-2467|csouthe1@jhmi.edu|
20565225|NCT05069896|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20565226|NCT04068831|Memorial Sloan Kettering Cancer Center|Dr. Ritesh Kotecha, MD|646-422-4791|kotechar@mskcc.org|
20565227|NCT05395871|Imperial College London|Amish Acharya|0203312 6666|aa2107@ic.ac.uk|
20565228|NCT04538378|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
20565229|NCT04580914|Boston Scientific|Claire Dietzsch, Senior Clinical Trials Specialist|9529306745|Claire.Dietzsch@bsci.com|
20565230|NCT05715528|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20565231|NCT03118518|Medtronic|Erika Pouliot|17635261270|erika.pouliot@medtronic.com|
20565232|NCT04667468|University of Pittsburgh|Dr. Jason Sperry|412-215-7025|sperryjl@upmc.edu|
20565233|NCT05205486|B. Braun Medical Inc.|Director, Scientific Affairs Operations|610-596-2512|kevin.minnich@bbraunusa.com|
20565234|NCT02998528|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20565235|NCT05210569|Image Plus Laser Eye Centre|Dr James Wiens|1-204-943-6287|jamesjwiens@gmail.com|
20565236|NCT04204083|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20565237|NCT02484430|Mayo Clinic|Aref Al-Kali, M.D.|(507) 284-2511|alkali.aref@mayo.edu|
20565238|NCT03624465|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20565239|NCT02413489|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565240|NCT04011644|Dept of Family Medicine and Community Health, UW-Madison|Dr. Andrew Quanbeck|608-609-7308|andrew.quanbeck@fammed.wisc.edu|
20565241|NCT05493852|Boston Scientific|Dr Xiuyue Jia|+86 15104673346|xiuyue.jia@bsci.com|
20565242|NCT01199133|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 55 59 29 70|mroux@stallergenes.com|
20565243|NCT05100628|Noxopharm|Lorena Figueroa, Director Clinical Operations|+ 61 2 9144 2223|lorena.figueroa@noxopharm.com|
20565244|NCT04588415|University of Ottawa|Dr. James Downar|613 562 6262|jdownar@toh.ca|1502
20532057|NCT00118287|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
20565245|NCT02575950|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20565246|NCT04230681|Washington University|Dr. Greg Miller|314-454-6000|g.c.miller@wustl.edu|
20565247|NCT03057054|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20565248|NCT05270876|Cochlear|PRS Specialist|+61294286555|cltd-prs-admin@cochlear.com|
20565249|NCT05906784|University of California, San Francisco|Maria Chao, DrPH, MPA, Principal Investigator|415-353-7749|Maria.Chao@ucsf.edu|
20565250|NCT05269966|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20565251|NCT05427253|Vicore Pharma AB|Cecilia Ganslandt, MD, MSc, Global Medical Director|+46 317880560|info@vicorepharma.com|
20565252|NCT04101357|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20565253|NCT05618587|University at Buffalo|Thomas Guttuso, Jr., MD|716-932-6080|tguttuso@buffalo.edu|
20565254|NCT03442309|New York University|Richard Niederman|917-280-5920|r.niederman@nyu.edu|
20565255|NCT05176093|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20565256|NCT04136912|UNC Lineberger Comprehensive Cancer Center|Desma Jones|(919) 843-9463|desma_jones@med.unc.edu|
20565257|NCT00661141|Horizon Pharma USA, Inc.|Beth Robinson, Executive Director||clinicaltrials@horizonpharma.com|
20565258|NCT03804788|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
20565259|NCT04615273|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650-461-4835|ads@ascendispharma.com|
20565260|NCT03018366|Mayo Clinic|Dr. Chrisandra Shufelt|904-953-7224|shufelt.chrisandra@mayo.edu|
20565261|NCT04003246|University of Texas Southwestern Medical Center|Dr. Yuanyuan Zhang|2146458525|yuanyuan.zhang@utsouthwestern.edu|
20565262|NCT05062330|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20565263|NCT03703908|ChemoCentryx|Study Director|650-210-2900|clinicaltrials@chemocentryx.com|
20565264|NCT04999111|Janssen R&D US|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565265|NCT03169972|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20565266|NCT00670241|LEO Pharma|Anders Rhod Larsen, Scientific Advisor|+4572262990|anders.larsen@leo-pharma.com|
20565267|NCT05776875|Yale University|Wei Cheng|203-737-7005|w.cheng@yale.edu|
20565268|NCT05683340|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
20565269|NCT03931408|University of Louisville|Dr. Harkema|502-582-7676|lori.clark2@louisville.edu|
20565270|NCT02224144|Columbia University|Thomas Nickolas MD, MS|2123053273|tln2001@cumc.columbia.edu|
20565271|NCT03505008|Keio University School of Medicine|Prof. Y Kaneko|+81-3-5363-3786|ykaneko@z6.keio.jp|
20565272|NCT02437136|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
20565273|NCT06193070|Fred Hutchinson Cancer Center|Dr. Megan Shen, Associate Professor|206-667-4172|mshen2@fredhutch.org|
20565274|NCT03276676|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
20565275|NCT04753788|LSHTM|Professor Michael Marks|+44020 7636 8636|michael.marks@lshtm.ac.uk|
20565276|NCT02962076|Mercy Research|Michelle Bryant, MPH|314-251-8827|michelle.bryant@mercy.net|
20565277|NCT02780700|Boehringer Ingelheim|Boehringer IIngelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565278|NCT03926130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20565279|NCT03583333|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20565280|NCT05723575|University of Wisconsin - Madison|Carrie Niziolek, PhD|(608) 262-7583|cniziolek@wisc.edu|
20565281|NCT06397443|IRCCS Istituto Ortopedico Rizzoli|Dr. Manila Boarini|+39 051 63666062|manila.boarini@ior.it|
20565282|NCT01569659|Northwestern University|Herbert Meltzer, MD|312-503-9096|h-meltzer@northwestern.edu|
20565283|NCT03687762|The University of Queensland|Dr. Melissa Day, Co-Principal Investigator|+61 7 3365 6421|m.day@uq.edu.au|
20565284|NCT03149822|University of Colorado Hospital|Dr. Elaine Lam|7208480723|elaine.lam@cuanschutz.edu|
20565285|NCT01866163|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20565286|NCT04723147|Emory University|Dr. Jennifer Felger|404-727-3987|jfelger@emory.edu|
20565287|NCT03640286|Neurovalens|Head of Clinical and Regulatory|02890991835|sinead.watson@neurovalens.com|
20565288|NCT03181516|Georgetown University Medical Center|Dr. Daniel Merenstein|2026872745|djm23@georgetown.edu|
20565289|NCT03485729|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
20565290|NCT02988661|Emory University|Cristina Drenkard, MD, PhD|404-251-8901|cdrenka@emory.edu|
20565291|NCT02839265|Montefiore Medical Center|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
20565292|NCT04934072|Fresenius Kabi SwissBioSim GmbH|Clinical Development|+41 793075735|medinfo_biosim@fresenius-kabi.com|
20565293|NCT03421340|Boston Scientific|Pooja Goswamy|15086834335|pooja.goswamy@bsci.com|
20520561|NCT01517659|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20520562|NCT00003875|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20520563|NCT01621191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20520564|NCT04355663|Third Faculty of Medicine, Charles University|PhDr. Kamila Řasová, Ph.D.|+420604511416|kamila.rasova@gmail.com|
20520565|NCT01026181|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
20520566|NCT03529461|Bristol Hospital|Makram Gedeon, MD|8605853339|mgedeon@bristolhospital.org|
20520567|NCT05420012|University of Utah|Josef Stehlik|801-585-9797|josef.stehlik@hsc.utah.edu|
20520568|NCT03395639|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20520569|NCT00942331|Memorial Sloan-Kettering Cancer Center|Jonathan Rosenberg, MD|646-422-4461|rosenbj1@mskcc.org|
20520570|NCT01397617|Nobel Biocare Services AG|Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
20520571|NCT00567476|Novartis Pharmaceuticals|Study Director|862 778-8300||
20520572|NCT00995085|Alcobra Inc|Jonathan Rubin, MD, MBA|610-504-7814|jrubin@alcobra-pharma.com|
20565294|NCT06324344|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20565295|NCT00780494|Stanford University|Pamela Kunz|650-725-8738|pkunz@stanford.edu|
20532058|NCT05494632|Washington University School of Medicine|Jill B Firszt, PhD|314-362-4760|firsztj@wustl.edu|
20532059|NCT03091439|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20532060|NCT03122106|Washington University School of Medicine|William Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
20532061|NCT05172570|Indiana Univeristy School of Medicine|Randomized prospective study comparing variable Gabapentin dosages for postoperative analgesia follo|317-274-0275|yyeap@iupui.edu|
20532062|NCT00640289|Children's Hospital of Orange County|Clinical Trial Coordinator||KBirschbach@choc.org|
20532063|NCT03550209|Nationwide Children's Hospital|Dr. Sarah Keim|1-800-792-8401|sarah.keim@nationwidechildrens.org|52849
20532064|NCT01590875|Medical College of Wisconsin|Marcie Berger, MD|414-955-6806|mgberger@mcw.edu|
20532065|NCT02347787|University of Pennsylvania School of Medicine|Lindsey Norton|215-573-9961|lindsey.turr@uphs.upenn.edu|
20532066|NCT00306488|National Eye Institute|Wai Wong, MD, PhD|301-496-7566|wongw@mail.nih.gov|
20532067|NCT02013427|Northwestern University|Apkar Vania Apkarian|+1 312 503 0404|a-apkarian@northwestern.edu|
20532068|NCT04298853|Indiana University School of Medicine|Anna Thomas, MD|317-944-9392|aeschwar@iu.edu|
20532069|NCT04050605|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20532070|NCT03244189|Duke University|Charles D. Scales Jr, MD MSHS FACS|919-684-1999|chuck.scales@duke.edu|
20532071|NCT02850406|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532072|NCT04928339|University of Wisconsin - Madison|Jeremy Sullivan|6082639976|jasullivan@wisc.edu|
20532073|NCT04633447|Janssen Research & Development, LLC|Manager Clinical Science Translational|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20532074|NCT05416203|Department of Veteran Affairs|Dr. Nicholas Allan|8502740567|nicholas.allan@va.gov|
20532075|NCT02787291|Abbott CAHF CRM|Dr. Adam Cline- Clinical Scientist|818-493-2025|adam.cline@abbott.com|
20532076|NCT03128086|HOSPITAL UNIVERSITARIO GENERAL DE CASTELLÓN, SPAIN. CONSELLERIA SANITAT|DR. ALBERTO BELENGUER-MUNCHARAZ|964 72 50 00|belengueralberto8@gmail.com|
20532077|NCT00639379|Vistakon|Kurt Moody, OD|904-443-3088||
20532078|NCT04757584|Weill Cornell Medicine|Maryam Hyder|646-962-5904|mah4022@med.cornell.edu|
20532079|NCT05630755|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20532080|NCT04868682|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 891-7711|cathy.alessi@va.gov|39311
20532081|NCT03880565|University of Minnesota|Demetri Yannopoulos, MD|612-626-2935|yanno001@umn.edu|
20532082|NCT03759184|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
20532083|NCT00363168|Johns Hopkins University|Neil M. Bressler|410-955-8342|nbressler@jhmi.edu|
20565296|NCT05664958|Duke Unversity School of Medicine|Ashraf Haib|919-668-2024|ashraf.habib@duke.edu|
20565297|NCT04456296|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
20565298|NCT05900154|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565299|NCT00758862|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20565300|NCT03655080|Washington University School of Medicine|Hiram A. Gay, M.D.|314-362-8516|hiramgay@wustl.edu|
20565301|NCT02641730|Janssen Pharmaceutical K.K.|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565302|NCT05460871|University of Iowa Hospitals and Clinics|Dr. Lee Kral|(319) 384-6593|lee-kral@uiowa.edu|
20565303|NCT04271046|Kaiser Permanente Washington Health Research Institute|Robert Penfold|206-287-2232|robert.b.penfold@kp.org|
20565304|NCT03309644|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20565305|NCT05158504|IstanbulSBU|HKARTAL|05378870982|kartal_hilal@yahoo.com|
20565306|NCT03606512|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565307|NCT05513937|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|055 5680459|pfabrizzi@menarini.it|+39
20565308|NCT02846545|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565309|NCT06468982|Atatürk University|Dr. Ümit Arslan|05418209007|kvcumit@gmail.com|
20532084|NCT04795323|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20532085|NCT01479530|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20565310|NCT04181736|Stanford University|Laura Hack, MD, PhD|650-724-7478|lhack@stanford.edu|
20565311|NCT05080283|Cochlear Ltd.|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20565312|NCT03993392|Indivior, Inc|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
20565313|NCT06149338|Saint Andrew's General Hospital of Patras|Dr. Vasileios Boviatsis|+306982925945|billboviatsis@gmail.com|
20565314|NCT00696124|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20565315|NCT06262477|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20565316|NCT01064440|Helixmith, Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20565317|NCT03426891|Moffitt Cancer Center|Dr. Peter Forsyth|813-745-3063|Peter.Forsyth@moffitt.org|
20565318|NCT01880515|Instituto Nacional de Cancerología de México|Oscar Gerardo Arrieta Rodriguez|+52 1 55 56 28 04 00|ogar@unam.mx|71101
20565319|NCT05365958|University of Houston|Dr. Chakema Carmack, Ph.D., Associate Professor|713-743-6231|ccarmack@central.uh.edu|
20565320|NCT05247034|Universidad Anáhuac México Norte|Dr. Carlos Alberto Cuéllar Ramos|5556270210|carlos.cuellarra@anahuac.mx|8736
20565321|NCT03489122|VA Bedford Healthcare System|Administrative Officer/R&D|781-687-2903|karen.smith9@va.gov|
20565322|NCT04414722|Dept. of Family Medicine, Georgetown University Medical Center|Dan Merenstein, Director of Research Programs|202-687-1600|djm23@georgetown.edu|
20565323|NCT02668692|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
20565324|NCT04491617|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
20532086|NCT02836769|Sunnybrook Research Institute|Dr. Sara McEwen|416-226-6780|sara.mcewen@sunnybrook.ca|7957
20532087|NCT00585650|Wake Forest Baptist Health, Department of Dermatology|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
20532088|NCT02120079|Tufts Medical Center|Dr. Pedram Hamrah|617-636-5321|phamrah@tuftsmedicalcenter.org|
20532089|NCT00303628|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20532090|NCT04925934|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20532091|NCT00376506|James Madison University|Christy L. Ludlow, PhD|540-568-3876|ludlowcx@jmu.edu|
20532092|NCT03158688|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20532093|NCT00565864|Oregon Health & Science University|Dr. Mary Samuels|5034945242|samuelsm@ohsu.edu|
20532094|NCT05955378|Shirley Ryan AbilityLab|Arun Jayaraman|312-238-6875|ajayaraman@sralab.org|
20532095|NCT01188447|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
20532096|NCT03301714|Kornber School of Dentistry|Dr. Marisol Tellez Merchan|2177071773|marisol@temple.edu|
20532097|NCT02522845|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
20532098|NCT02112552|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio, Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
20532099|NCT04285411|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
20532100|NCT03349515|Medical University of South Carolina|Dr. Michelle Rovner|843-792-2322|rovner@musc.edu|
20532101|NCT02317549|Leading BioSciences|Tom Hallam, PhD, MBA|631-739-3088|tom.hallam@leadingbiosciences.com|
20532102|NCT04055519|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20532103|NCT02635035|NYU Langone Health|Terry Leon|1 646 754 4841|Terry.Leon@nyulangone.org|
20532104|NCT01403584|Universitätsklinik, Essen|Prof. Helmut Teschler|0201 433 4001|teschlerh@t-online.de|
20532105|NCT02503865|Republican Scientific Center for Emergency care at Nazarbayev University|Dr. Kuat Oshakbayev|+77013999141|okp.kuat@mail.ru|
20565325|NCT05524402|Massachusetts General Hospital|Dr. Jonathan Greenberg|617-643-9402|jgreenberg5@mgh.harvard.edu|
20565326|NCT05976334|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20565327|NCT05237284|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20565328|NCT04117178|Department of Neurology, Zealand University Hospital|Michael Fischer|+4547322800|mihh@regionsjaelland.dk|
20565329|NCT02056834|Synthes GmbH|Clinical Research Scientist Biomaterials|0041327204465|clinicalaffairs.emea@synthes.com|
20565330|NCT04312841|The Ohio State University Comprehensive Cancer Center|Dr. John Reneau|614-293-3196|John.Reneau@osumc.edu|
20565331|NCT05482360|University of Washington|Anjuli Wagner, PI|978 460 2331|anjuliw@uw.edu|
20565332|NCT03980925|MFAR Clinical Research|Federico Nepote|+34 93 434 44 12|investigacion@mfar.net|
20565333|NCT05130814|Emoled srl|Duccio Rossi Degl'Innocenti|+390550751960|d.rossi@emoled.com|
20565334|NCT04820322|INQUIS Clinical Research|Principal Scientist|4168619177|twolever@inquis.com|
20565335|NCT03156465|University of Iowa|Camille Dunn|319-353-8776|camille-dunn@uiowa.edu|
20565336|NCT04380337|Stanford University|Dr. Erqi Pollom|650-498-0484|erqiliu@stanford.edu|
20565337|NCT04444518|University of Rochester|Cynthia Rand, PI|5852759316|cynthia_rand@urmc.rochester.edu|
20565338|NCT03580356|Novartis Pharmaceuticals|Study Director|1 (862) 778-8300|novartis.email@novartis.com|
20565339|NCT04544007|University of Alabama at Birmingham|Coretta Thomas, Scientist & Data Manager for NF Consortium|205-975-8629|coretta@uab.edu|
20565340|NCT03536884|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20565341|NCT03331835|LEO Pharma AS|Clinical Disclosure|(+1) 877-557-1168|disclosure@leo-pharma.com|
20565342|NCT05791435|Nemours Children Health System|Tariq Rahman|302 651 6831|trahman@nemours.org|
20565343|NCT06029452|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565344|NCT04880733|University California-Irvine|Jeffery Dusek|617-519-8082|jdusek@hs.uci.edu|
20565345|NCT05848947|Sirtex Medical|Janet Bell, Director, Clinical Research Operations|978-866-1798|jbell@sirtex.com|
20565346|NCT05533190|The Institute of Cancer Research|Prof Ceire Costelloe|20 3437 6777|ceire.costelloe@icr.ac.uk|
20565347|NCT02323880|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20565348|NCT03631290|Duke University Medical Center|Rasheeda Hall, M.D.|919-660-6861|rasheeda.hall@duke.edu|
20565349|NCT03213678|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20565350|NCT04218851|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20565351|NCT03174275|University of North Carolina Lineberger Comprehensive Cancer Center|Dr. Jared Weiss|+1 919-843-7718|jared_weiss@med.unc.edu|
20565352|NCT04601480|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
20565353|NCT03717935|University of Colorado|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
20565354|NCT01820611|Zimmer Biomet|Linda Meijer|+31 6 57933741|linda.meijer@zimmerbiomet.com|
20565355|NCT03484819|Mayo Clinic|Nora Bennani, M.D.|(507) 284-2511|bennani.nora@mayo.edu|
20565356|NCT05970861|Asfendiyarov Kazakh National Medical University|Prof. Abdugani Musayev|+77772509406|musaev.dr56@gmail.com|
20565357|NCT05736458|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
20565358|NCT02990338|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20565359|NCT00971087|Hologic|Jennifer Bartoshevich, Sr Manager of Clinical Affairs|781-999-7764|jennifer.bartoshevich@hologic.com|
20532106|NCT05073315|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20532107|NCT01529268|Johns Hopkins Data Coordinating Center|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
20565360|NCT04186819|Blue Earth Diagnostics|Head of R&D|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
20565361|NCT03235440|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20565362|NCT02944968|Johnson and Johnson Medical NV/SA|Nathalie Macours, Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
20532108|NCT00303953|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|mleblanc@fhcrc.org|
20532109|NCT01132755|Memorial Sloan Kettering Cancer Center|Dr. Peter Kingham MD|212-639-5260|kinghamt@mskcc.org|
20532110|NCT02393755|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20532111|NCT02207608|University of Rome Tor Vergata|Prof. Enrico Finazzi Agro|+393296152920|efinazzi@tin.it|
20532112|NCT05800145|Wake Forest University Health Sciences|Deepak Palakshappa, MD|3367161795|dpalaksh@wakehealth.edu|
20532113|NCT05643794|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20532114|NCT02813447|Duke University Medical Center|Neil MacIntyre|919 681 2720|macin001@mc.duke.edu|
20532115|NCT04167670|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|Please email|medicalinformation@phathompharma.com|
20532116|NCT01192698|Carolinas Medical Center|Dr. Mark W. Russo|704-355-6649|mark.russo@carolinashealthcare.org|
20532117|NCT01127061|University of Michigan School of Medicine|Dr. Sara Saberi, MD, MS|734-764-4500|saberis@med.umich.edu|
20532118|NCT04827446|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20532119|NCT00962598|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
20532120|NCT03921541|Immedica Pharma AB|Vice President, Head of Global Integrated Evidence / Global Head of Genetic and Metabolic Diseases|+46 8 533 39 500|Clinical@immedica.com|
20532121|NCT04706403|UMass Chan Medical School|Dr. Kimberly Fisher|(508)8561975|Kimberly.Fisher@umassmemorial.org|
20532122|NCT00182637|UC Irvine|Dr. Lauren Pinter-Brown|(714) 456-5153|lpinterb@uci.edu|
20532123|NCT04941898|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20532124|NCT01112267|Janssen Korea/ Seoul|Therapeutic area Scientist|+82-2-2094-4802||
20532125|NCT00003456|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20532126|NCT00420407|University of Texas Health Science Center at San Antonio|Stephen Cohn, M.D.|210-567-5724|mccarthyj@uthscsa.edu|
20532127|NCT03690544|Mayo Clinic|Alison J. Bruce, M.B., Ch.B.|904-953-6402|Bruce.Alison@mayo.edu|
20532128|NCT06059066|Houston Methodist Hospital|Julu Benoy|(713) 441-6455|jbenoy@houstonmethodist.org|
20565363|NCT00721149|Biosense Webster, Inc.|Diana Bordley, Director, Regulatory Affairs|800-729-9010|dbordley@its.jnj.com|8604
20565364|NCT03663205|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20565365|NCT05215613|Zimmer Biomet|Andrea Singer|(0)79 318 06 55|andrea.singer@zimmerbiomet.com|+41
20565366|NCT03995979|University of Florida|Dr. Salvatore Scali|(352) 376-1611|salvatore.scali@surgery.ufl.edu|
20565367|NCT02518048|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20565368|NCT05654662|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20565369|NCT05962814|Bionics Institute|Prof Colette McKay|+61 408698202|cmckay@bionicsinstitute.org|
20565370|NCT03505710|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo_us@daiichisankyo.com|
20565371|NCT05879991|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565372|NCT03981926|University of California, Los Angeles|April W. Armstrong, MD, MPH; Professor and Chief of Dermatology|424-365-4129|skinstudy@mednet.ucla.edu|
20565373|NCT06262347|University of Cincinnati|T. John Winhusen, PhD.|513-585-8292|winhust@ucmail.uc.edu|
20565374|NCT03154190|Stanford University School of Medicine|Manali Patel|650-723-4000|manalip@stanford.edu|
20565375|NCT01314105|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565376|NCT04526886|Dartmouth Hitchcock Medical Center|Gabriel Brooks|(603) 650-4344|gabriel.a.brooks@hitchcock.org|
20565377|NCT05015751|Rhaeos, Inc.|Anna Somera|855-814-3569|info@rhaeos.com|
20565378|NCT04417998|Mayo Clinic|Bradley J. Kemp, Ph.D.|507-284-4399|Kemp.Brad@mayo.edu|
20565379|NCT02827838|Wake Forest Baptist Comprehensive Cancer Center|Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
20565380|NCT01449513|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20565381|NCT02874001|Institut Bergonié|S Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
20565382|NCT04227288|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
20565383|NCT04075318|Vaxxinity, Inc.|Executive Director, Clinical Development|254-244-5739|info@vaxxinity.com|
20565384|NCT06435624|Nanjing Mingzhou Rehabilitation Hospital|Jingzhi Zhang|16677137704|170787717@qq.com|86
20565385|NCT04874948|Klinikum der Universität München (LMU)|Dr. med. vet. Julia Dreisbach|+49 89 4400|julia.dreisbach@med.uni-muenchen.de|59825
20565386|NCT03988621|University of Pennsylvania|Barbara Riegel, PhD, RN, Professor|2158989927|briegel@nursing.upenn.edu|
20520573|NCT01155778|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20520574|NCT02595008|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20520575|NCT03407118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20520576|NCT04017754|Aalborg University Hospital, Gynecologic and Obstetric department|Caroline Nørgaard-Pedersen|+45 41120267|carolinenp94@gmail.com|
20520577|NCT03508687|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@med.umich.edu|
20520578|NCT02447926|Northwestern University|Dr. Josh Levitsky|312-695-4837|j-levitsky@northwestern.edu|
20520579|NCT01401257|Hôpital La Timone, Marseille|Pr Shahram ATTARIAN|04 91 38 65|shahram.attarian@ap-hm.fr|79
20520580|NCT01491035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
20520581|NCT03345394|Federal University of Sao Paulo|Dr. André Miguel|+55 11 965884111|aqcmiguel@gmail.com|
20520582|NCT02687360|Columbia Univeristy|Diana Martinez|646-774-6160|dm437@cumc.columbia.edu|
20520583|NCT02999477|Dana-Farber Cancer Institute|Adrienne Waks, MD|617-632-3800|adrienne_waks@dfci.harvard.edu|
20520584|NCT04722601|University of Chicago|Dr. Sonali Smith|855-702-8222|smsmith@bsd.uchicago.edu|
20532129|NCT05417113|Icahn School of Medicine at Mount Sinai|Dr. Christina Jeng|212-241-4743|christina.jeng@Mountsinai.org|
20532130|NCT00134719|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532131|NCT01807520|Novartis Pharmaceuticals|Study Director|862-778-8300||
20565387|NCT05013385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565388|NCT04247802|Oxford University Hospitals NHS Foundation Trust|Mrs Martha Batting|01865|martha.batting@ouh.nhs.uk|737526
20565389|NCT05265065|Murdoch Children's Research Institute|Kim Mulholland|+61 3 99366656|kim.mulholland@mcri.edu.au|
20565390|NCT01447719|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20565391|NCT04778410|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20565392|NCT03252288|University of South Carolina|Jan Ostermann|+1803-777-8747|jano@mailbox.sc.edu|
20565393|NCT02905331|Janssen Research & Development, LLC|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565394|NCT05408663|Extend Biosciences|Laura Hales PhD|(732) 599-8581|lhales@extendbio.com|
20565395|NCT01240122|Abbott Medical Optics|Senior Manager, Clinical Research|714.247.8723|eugenia.kao@amo.abbott.com|
20565396|NCT04984590|OnPoint Vision Inc.|Head of Clinical|949-688-0660|larcher@onpoint-vision.com|
20565397|NCT04583280|Janssen Research & Development LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565398|NCT04614948|Janssen Vaccines & Prevention B.V.|VICE PRESIDENT Medical Affairs IDV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565399|NCT04129554|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565400|NCT01570361|Johnson & Johnson Medical N.V., Biosense Webster|Liesbeth Vanderlinden|+32 (0) 2 746 3446|lvanderl@its.jnj.com|
20565401|NCT01146704|Department of Veterans Affairs, VAGLAHS|Dr. Joseph Pisegna|3104783711|Joseph.Pisegna@va.gov|41664
20565402|NCT03969563|VA Northern California Health Care System|Dr. Jerry Nadler, Chief of Research|9168432776|Jerry.Nadler@va.gov|
20565403|NCT03691298|Smith+Nephew|Laura Everson|+447718320892|laura.everson@smith-nephew.com|
20565404|NCT04072861|Renibus Therapeutics|Donald J Keyser, Chief Operating Officer|18178756991|jkeyser@renibus.com|
20565405|NCT02492711|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
20565406|NCT05932407|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20565407|NCT04633538|Oxford University Hospital|Dr Elizabeth Orchard|01865223084|elizabeth.orchard@ouh.nhs.uk|
20565408|NCT02938520|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20565409|NCT05070741|University of Kansas Medical Center|Paige Geiger, PhD|913-588-7408|pgeiger@kumc.edu|
20565410|NCT03245840|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20565411|NCT01116895|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20565412|NCT03582033|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20565413|NCT06010836|Johns Hopkins|Associate Professor|4109552611|jsampso4@jhmi.edu|
20565414|NCT04206787|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565415|NCT04505410|University of Miami Miller School of Medicine|Associate Professor, Director of Translational Studies for the Crohn's and Colitis Center|3057733573|odamas@med.miami.edu|
20565416|NCT06834490|Pharmasoft|Y.E. Meshcherskiy, Medical Director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
20565417|NCT04108130|Columbia University Medical Center|Dr. Marcos F. Vidal Melo|2123424799|mv2869@cumc.columbia.edu|
20565418|NCT05507333|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
20565419|NCT01130883|Abbott|Global Medical Services|1-800-633-9110||
20565420|NCT04998305|Columbia University|Hiroshi Mitsumoto, MD|212-305-1319|hm264@cumc.columbia.edu|
20565421|NCT03972150|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565422|NCT05464069|Theranica|Dr Dagan Harris, VP Clinical and Regulatory Affairs|+972542220121|daganh@theranica.com|
20565423|NCT05320406|Emory University|Dr. Sagar Patel|404-778-1900|sagar.patel@emory.edu|
20565424|NCT03677141|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20565425|NCT05465239|Barron Associates, Inc.|Jason Burkholder|434-973-1215|burkholder@bainet.com|
20565426|NCT06038708|BIOTRONIK Italy|Paola Napoli, Clinical Project Manager|3357369277|paola.napoli@biotronik.com|0039
20565427|NCT05423730|Beth Israel Deaconess Medical Center|Kenneth J Mukamal|617-754-1401|kmukamal@hsph.harvard.edu|
20565428|NCT04276935|Memorial Sloan Kettering Cancer Center|Dr. Thomas M. Atkinson|646-888-0089|atkinsot@mskcc.org|
20565429|NCT04536012|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
20565430|NCT06106022|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
20565431|NCT05850052|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
20565432|NCT04209595|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
20565433|NCT04200313|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|kruedy@jaeb.org|
20565434|NCT05524116|Boston University|Dr. Deepak Kumar|3026901455|kumard@bu.edu|
20565435|NCT01540994|Sharp Healthcare|Dr. Geoffrey Weinstein|858-939-5010|geoffrey.weinstein@sharp.com|
20565436|NCT02834390|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20565437|NCT04393207|Yale|Antonio Gonzalez|203.785.2802|antonio.gonzalez-fiol@yale.edu|
20565438|NCT06197360|Yangzhou University|Yueqi Zhao|13390676131|mz120221975@stu.yzu.edu.cn|
20532132|NCT05124184|W. L. Gore & Associates|Austin Phillips|+1 928 864 3641|agphilli@wlgore.com|
20565439|NCT01726257|Endologix|Tammy Stiver|5136731452|tstiver@endologix.com|
20565440|NCT05552508|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20532133|NCT03096353|National Center for Complementary and Integrative Health|Catherine Bushnell|+1 301 496 2222|mary.bushnell@nih.gov|
20532134|NCT01847209|Brigham and Women's Hospital|Dr. Raphael Bueno|617-732-8148|rbueno@partners.org|
20532135|NCT03298061|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20532136|NCT01956942|Ophthalmology Department The George Washington University|Dr. David Belyea|2027412800|dbelyea@mfa.gwu.edu|
20532137|NCT04307394|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|brandon_gaudiano@brown.edu|
20532138|NCT00138294|Baylor College of Medicine|Pedro A Piedra, MD|713-798-5240|ppiedra@bcm.edu|
20532139|NCT01724190|Nationwide Childrens Hospital|Kathryn Obrynba|6147224425|kathryn.obrynba@nationwidechidrens.org|
20532140|NCT00818272|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20532141|NCT02536794|Northwestern University|Ami Shah, MD|312 503 5488|amishah@northwestern.edu|
20532142|NCT00416949|SKCCC|George Sgouros|4106140116|gsgouros@jhmi.edu|
20532143|NCT03228914|The University of Texas Health Science Center at Houston|William C. Yao, MD|713-500-5410|william.c.yao@uth.tmc.edu|
20532144|NCT01471574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20532145|NCT01177410|Salix Pharmaceuticals, Inc.|Vice President of Clinical Operations|919-862-1000|enoch.bortey@salix.com|
20532146|NCT05427916|Icahn School of Medicine at Mount Sinai|John C Lantis II|(212) 523-4797|John.Lantis@mountsinai.org|
20532147|NCT00800540|Alcon Research, Ltd.|Director, Global Medical Affairs|1-888-451-3937||
20532148|NCT00357162|Washington University|Amanda Cashen, M.D.||acashen@im.wustl.edu|
20532149|NCT03927157|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20532150|NCT00726557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20532151|NCT02249793|Upenn|Dr. Carsten Skarke|215-573-0673|cskarke@pennmedicine.upenn.edu|
20532152|NCT05950906|Calibr-Skaggs|Director of Clinical Operations|(858) 242-1000|abrooks@scripps.edu|
20532153|NCT02541903|UAB|Dr. Lisle Nabell, MD, Professor|(205) 934-3061|lnabell@uabmc.edu|
20532154|NCT00021255|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20532155|NCT02232698|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
20532156|NCT00728923|New York State Psychiatric Institute|Dr. Carolyn Rodriguez|212-543-5637|cr2163@columbia.edu|
20532157|NCT05324371|Boston Scientific|Nilou Zilinek|508-683-6127|nilou.zilinek@bsci.com|
20532158|NCT01131585|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
20532159|NCT01786109|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
20532160|NCT02641834|Department of Experimental and Clinical Medicine, University of Florence, Italy|Prof. Francesco Sofi|+390557949429|francescosofi@gmail.com|
20532161|NCT03491917|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20532162|NCT01068912|MediVector, Inc., managing member MDVI, LLC|Dr. Carol Epstein, Chief Medical Officer|617-439-4500|cepstein@medivector.com|
20532163|NCT02762604|Albert Einstein College of Medicine|Dr. Helena Blumen|7184303810|helena.blumen@einsteinmed.edu|
20532164|NCT05893823|IRCCS Istituto Ortopedico Rizzoli|Francesco Castagnini|0516366418|francescocastagnini@hotmail.it|+39
20532165|NCT04057768|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
20532166|NCT01257438|Bard Peripheral Vascular|Josh Smale, Associate Director Clinical Affairs|(480) 603-8140|Josh.Smale@crbard.com|
20532167|NCT00627978|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
20532168|NCT03442569|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20532169|NCT03290768|Savvysherpa, LLC|Jared Jones|763-549-3540|JaredJones@savvysherpa.com|8116
20532170|NCT02943213|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
20532171|NCT02239289|Université du Québec à Trois-Rivières|Martin Descarreaux|1-819-376-5011|martin.descarreaux@uqtr.ca|3791
20532172|NCT03010501|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
20532173|NCT04507321|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20532174|NCT01059851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532175|NCT01917773|Riley Hospital for Children, Indiana University|Joseph Croffie|317-944-3774|jcroffie@iupui.edu|
20532176|NCT02260622|Ottawa Hospital Research Institute|Penny Phillips|613-737-8899|pphillips@ohri.ca|
20532177|NCT00308685|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20532178|NCT04937387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20532179|NCT00153842|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|Cancer.Research.Nurse@Dartmouth.edu|
20532180|NCT06048068|Columbia University Irving Medical Center|Dr. Sachin Agarwal, MD MPH|212-305-7236|sa2512@cumc.columbia.edu|
20532181|NCT03853798|Agios Pharmaceuticals, Inc.|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
20532182|NCT02743494|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20532183|NCT05399485|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532184|NCT02955394|University of Colorado Hospital|Anthony Elias|720-848-0300|anthony.elias@cuasnchutz.edi|
20532185|NCT01363076|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|
20532186|NCT02642679|Brigham and Women's Hospital|Indranil Sinha, MD|617-732-5282|isinha@bwh.harvard.edu|
20532187|NCT01653262|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20532188|NCT00371631|Michael E. DeBakey Veterans Affairs|Dr. Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
20532189|NCT01022580|University of California, San Francisco|Roberta A Ballard, MD|415-476-4193|roberta.ballard@ucsf.edu|
20532190|NCT03439839|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20532191|NCT04529980|Children's Health Children's Medical Center|Dr. Mayra Garcia, DNP, APRN, PCNS-BC, EBP-C|12144567990|Mayra.Garcia@childrens.com|
20532192|NCT01500096|Johns Hokpins University|Adriana Andrade|410-955-7287|aandrade@jhmi.edu|
20532193|NCT00723944|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20532194|NCT01870596|Sidney Kimmel Comprehensive Cancer Center|B. Douglas Smith|(410) 287-2935|bdsmith@JHMI.edu|
20532195|NCT04575324|Chestnut Health Systems|Dr. Dennis Watson|312-274-5316|dpwatson@chestnut.org|
20532196|NCT02582632|AbbVie|Global Medical Services|800-633-9110||
20532197|NCT00580398|Massachusetts General Hospital|Elyse Park, Ph.D., MPH|617-724-6836|epark@partners.org|
20532198|NCT01771913|Faculdade de Medicina - Universidade de Sao Paulo|Dr. Luiz Alexandre Lorico Tissiani|55-11-981798707|latissiani@gmail.com|
20532199|NCT00992836|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
20532200|NCT01617967|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|1-877-256-9526|medinfo@alnylam.com|
20532201|NCT02985710|Massachusetts General Hospital|PI|6177260580|akaraa@mgh.harvard.edu|
20532202|NCT03380572|Imperial College London|Mr R Aggarwal|02033126840|r.aggarwal@ic.ac.uk|
20532203|NCT00447278|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532204|NCT03677401|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
20532205|NCT02810327|Medical University of South Carolina|Kimberly Brown Foil|843-792-6474|foilk@musc.edu|
20532206|NCT06262607|Clexio Biosciences Ltd|Regulatory Affairs Lead|972-733318704|myriam.belahcen@clexio.com|
20532207|NCT01692756|Univerisity of Kentucky|Cale Jacobs, ATC, PhD|8592183065|Kycartilagedoc@gmail.com|
20532208|NCT02969018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532209|NCT01365611|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
20532210|NCT01119222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532211|NCT01186406|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
20532212|NCT03142750|Children's Hospital Colorado|Pediatric Surgery Research Fellow|720-777-5371|youngmeeyoungmee@gmail.com|
20532213|NCT03144635|Kyushu University Hospital|Dr. Eiichi Ogawa / Assistant Professor|81926425909|eogawa@gim.med.kyushu-u.ac.jp|
20532214|NCT02942407|Duke Universitey|Christopher Granger, MD|919-668-8900|christopher.granger@duke.edu|
20532215|NCT00933166|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20532216|NCT04618471|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20532217|NCT00374868|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532218|NCT03325439|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20532219|NCT00774748|UNC Chapel Hill School of Medicine Dept. Hematology|Clinical Research Coordinator|919-966-2359|catherine_soriano@med.unc.edu|
20532220|NCT04913636|Procter & Gamble|Clinical Trial Manager|513-622-4601|conde.e.1@pg.com|
20532221|NCT02337946|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20532222|NCT00927082|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20532223|NCT00729807|University of Maryland Greenebaum Cancer Center|Edward A. Sausville, M.D., Ph.D.|410-328-7394|esausville@umm.edu|
20532224|NCT02723331|University of Colorado Hospital|Wells Messersmith, MD|303-724-0747|wells.messersmith@cuanschutz.edu|
20532225|NCT01648959|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
20532226|NCT06061952|University Hospitals Cleveland Medical Center|Martha Sajatovic, MD|216-844-2808|martha.sajatovic@UHHospitals.org|
20532227|NCT04185246|Trust Biosonics, Inc.|Charly Kang|+886-3-668-4965|charlykang@trust-biosonics.com|211
20532228|NCT00942851|Office of the Clinical Director, NINDS, NIH|Codrin Lungu, MD|301-496-5295|lunguci@ninds.nih.gov|
20532229|NCT00544882|Teva Branded Pharmaceutical Products R&D|Director of Clinical Research|610-786-7047|clinicaltrialsdisclosure@tevapharm.com|
20532230|NCT03770455|Tulane University School of Medicine|Jodi L. Layton, MD|504-988-6121|jlayton@tulane.edu|
20532231|NCT02583269|Wake Forest University Health Sciences|Study Nurse|336-713-7748|saverill@wakehealth.edu|
20532232|NCT01039675|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532233|NCT03579771|Robert H. Lurie Comprehensive Cancer Center of Northwestern University Clinical Cancer Center|Shishir Maithel, MD|312-908-5250|shishir.maithel@nm.org|
20532234|NCT02068794|Mayo Clinic|Evanthia Galanis MD|(507) 284-2511|galanis.evanthia@mayo.edu|
20532235|NCT03712852|Università degli studi G. D'ANNUNZIO|Prof. Michele Paolantonio|3395204073|mpaolantonio@unich.it|
20565441|NCT03314740|Istituto di Ricerche Farmacologiche Mario Negri|Elena Biagioli|+39 0239014650|elena.biagioli@marionegri.it|
20565442|NCT04451772|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20565443|NCT04311632|ITB-MED LLC|Jesse Scott, MPH|+46 8 410 02 887|KTX@itb-med.com|
20565444|NCT04632225|Helixmith Co, Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20520585|NCT01583218|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20520586|NCT03168321|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
20520587|NCT02522403|Universidad Autonoma de Nuevo Leon|Carlos Acosta-Olivo|528183467798|dr.carlosacosta@gmail.com|
20520588|NCT00856973|Sunovion|CNS Medical Director|866-503-6357||
20520589|NCT01108666|University of Pennsylvania|Dr. Abigail Berman|215-615-3659|Abigail.Berman@uphs.upenn.edu|
20520590|NCT02664363|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
20520591|NCT04556552|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
20520592|NCT01796912|Imperiwal College London|Dudley Pennell|+44 (0)20 3811 6871|d.pennell@imperial.ac.uk|
20520593|NCT00841906|Sleep Center of Greater Pittsburgh|Sukhdev Grover MD|412-681-7771|Info@SleepCenterOfGreaterPittsburgh.com|
20520594|NCT01196078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20520595|NCT00127036|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
20532236|NCT04764539|iTherapy, LLC|Lois Brady, CEO|9258120037|lois@itherapyllc.com|
20532237|NCT00977184|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
20532238|NCT00784927|Mayo Clinic Arizona|Craig B. Reeder, MD||Reeder.Craig@mayo.edu|
20532239|NCT01779362|George Washington University Biostatistics Center|Sharon Edelstein, Lead Research Scientist|301-881-9260|sharone@bsc.gwu.edu|
20532240|NCT00714272|eXcorLab GmbH|Dr. Horst-Dieter Lemke|+49-6022-812648|horstdieter.lemke@excorlab.de|
20532241|NCT01137812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20532242|NCT00845182|UTexas_SanAntonio|Devjit Tripathy|2105676691|tripathy@uthscsa.edu|
20532243|NCT04621760|University of California, San-Francisco|Dr. Dominika Seidman|(415) 353-2119|Dominika.Seidman@ucsf.edu|
20532244|NCT02421211|Janssen Research & Development|Trial Physician, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20532245|NCT00886236|Medical University of South Carolina|Larry Field|843-876-5744|field@musc.edu|
20532246|NCT00471354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532247|NCT00743262|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5252550|f.hilgers@nki.nl|
20532248|NCT02639559|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
20532249|NCT04999020|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20532250|NCT05706701|Yale University|Stephen R Baldassarri, M.D.|203-785-3627|stephen.baldassarri@yale.edu|
20532251|NCT00827242|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532252|NCT00471107|NIH/NINDS|Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
20532253|NCT03925220|Tufts University|Dr. Margie Skeer|8579191262|margie.skeer@tufts.edu|
20532254|NCT04425018|Dana-Farber Cancer Institute|Adrienne G. Waks, MD|617-632-3800|adrienne_waks@dfci.harvard.edu|
20532255|NCT01944774|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
20532256|NCT03914703|Zimmer Biomet|Jarrod Hunnicutt, Clinical Affairs Manager|574-453-7834|jarrod.hunnicutt@zimmerbiomet.com|
20532257|NCT05774977|University of Pennsylvania Perelman School of Medicine|Dr. Mathias Basner, MD, PhD, MScEpi|215-573-5866|basner@pennmedicine.upenn.edu|
20532258|NCT03188185|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
20532259|NCT00896233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20532260|NCT02965456|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
20532261|NCT04465955|NGM Biopharmaceuticals|VP, Clinical Operations|(650)243-5555|ngm282@ngmbio.com|
20532262|NCT05101317|Peking University|Dr. Ruiping Xiao|86-010-62757243|xiaor@pku.edu.cn|
20532263|NCT05399355|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|baabdullah@health.ucsd.edu|
20532264|NCT01327703|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20532265|NCT00812097|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20532266|NCT02513563|Moffitt Cancer Center|Jhanelle E. Gray, MD|813-745-2677|Jhanelle.Gray@moffitt.org|
20532267|NCT04056468|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20532268|NCT00317369|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20532269|NCT02991521|Medical City Arlington, 3301 Matlock Rd, Arlington, TX 76015|Danielle A Pigneri, MD, FACS|(502) 387-3117|dpigneri@gmail.com|
20532270|NCT03573700|St. Jude Children's Research Hospital|Aimee Talleur, MD|8662785833|referralinfo@stjude.org|
20532271|NCT03674411|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan|(612) 626-5654|macmi002@umn.edu|
20532272|NCT06428591|Tandem Diabetes Care|Manager, Clinical Affairs|8583666900|clinicalaffairs@tandemdiabetes.com|
20532273|NCT06086340|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532274|NCT06038643|McGill University|Maiya R. Geddes|514-398-8751|maiya.geddes@mcgill.ca|
20532275|NCT02227199|University of Washington|Dr. Ajay Gopal|26-606-2037|agopal@uw.edu|
20532276|NCT01767415|Weill Cornell Medicine|Anita Ou|646-962-8188|ano2014@med.cornell.edu|
20532277|NCT03998462|North Florida/South Georgia VA Healthcare System|Dr. Dawn Schiehser, Ph.D.|352-376-1611|Dawn.Schiehser@va.gov|107538
20532278|NCT05710224|Instituto Butantan|Fernanda Castro Boulos - Diretoria Médica, Centro de Ensaios Clínicos e Farmacovigilância|+55 11 3723-6797|fernanda.boulos@fundacaobutantan.org.br|
20532279|NCT03369223|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20532280|NCT03573882|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532281|NCT03677206|University of Arizona|Dr. Mohab Ibrahim|(520) 626-7221|mohab@arizona.edu|
20532282|NCT01181479|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
20532283|NCT01685437|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20532284|NCT03969420|Sumitomo Pharma Oncology, Inc|Reyna Bishop|512-363-8755|reyna.bishop@oncology.Sumitomo-Pharma.com|
20532285|NCT01121575|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532286|NCT00223821|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
20532287|NCT03656133|Moffitt Cancer Center|Jimmy Caudell, MD, PhD|813-745-8226|jimmy.caudell@moffitt.org|
20532288|NCT02369458|Washington University School of Medicine|Peter Oppelt, M.D.|636-916-9922|poppelt@wustl.edu|
20532289|NCT04439175|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20532290|NCT01631188|Rutgers University|Enrique Pantin, MD|7328900640|pantinej@rwmjs.rutgers.edu|
20532291|NCT03600350|University of Wisconsin Carbone Cancer Center|Douglas McNeel, MD, PhD|(608) 263-4198|dm3@medicine.wisc.edu|
20532292|NCT00835978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532293|NCT01105130|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20532294|NCT01002105|Shaar Menashe Mental Health Center|Prof. Alexander Grinshpoon|+972-4-6278719|alexander.grinshpoon@sm.health.gov.il|
20532295|NCT05027282|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20532296|NCT01363440|Regeneron|Clinical Trial Management|914 847 7000|clinicaltrials@regeneron.com|
20532297|NCT03695094|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
20532298|NCT01166945|University of Wisconsin School of Medicine and Public Health|Ellen Wald, MD|608-263-8558|erwald@pediatrics.wisc.edu|
20532299|NCT02313597|Services Institute of Medical Sciences|Dr, Shabbar Hussain Changazi|923059700111|shabbarchangazi246@gmail.com|
20532300|NCT01263379|Abeona Therapeutics|Chief Medical Officer|(216) 282-8150|clinicalresults@abeonatherapeutics.com|
20532301|NCT00552058|UCB|Study Director|+1 877 822 9493||
20532302|NCT03520569|University of Virginia|Eugene Barrett|434-924-1263|EJB8X@VIRGINIA.EDU|
20532303|NCT01952678|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
20532304|NCT02965716|SWOG Data Management Center|Melanoma Committee Statistician|206-667-4623|jmoon@fredhutch.org|
20532305|NCT05558410|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20532306|NCT04368910|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
20532307|NCT02265744|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20532308|NCT00923702|International Agency for Research on Cancer|Dr Partha Basu|+3347273|basup@iarc.fr|8167
20532309|NCT05161936|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20532310|NCT01086475|Christian Sarkine Autism Treatment Center|Dr. Minshawi|317-944-8162|nminshaw@iupui.edu|
20532311|NCT01158404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20532312|NCT02313272|Moffitt Cancer Center|Peter Forsyth, MD|813-745-3063|peter.forsyth@moffitt.org|
20532313|NCT02441114|Seoul National University Hospital|Clinical Pharmacology and Therapeutics|82-2-2072-4081|rheesjin@gmail.com|
20532314|NCT00593645|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20532315|NCT04790201|University of North Carolina at Chapel Hill|Bradley Gaynes, MD, MPH|(919) 445-0214|bradley_gaynes@med.unc.edu|
20532316|NCT02609633|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20532317|NCT02320292|Mayo Clinic|Dr. Thomas E Witzig|507-266-4994|witzig.thomas@mayo.edu|
20532318|NCT01431846|Eastern Colorado Health Care System|Dr. Michael Ho|720-857-5115|michael.ho@va.gov|
20532319|NCT00997126|MinneapolisMRF|James Miner|6128732493|miner015@umn.edu|
20532320|NCT02691663|Campbell University|Snezana Petrovic, MD, PhD, FASN|(910) 893-1751|spetrovic@campbell.edu|
20532321|NCT04268979|Moffitt Cancer Center|Margaret Byrne, Ph.D.|813-745-5569|Margaret.Byrne@moffitt.org|
20532322|NCT01769443|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20532323|NCT01835756|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
20532324|NCT04828486|Mayo Clinic|Nguyen H Tran MD MPH|507-284-2511|Tran.Nguyen@mayo.edu|
20532325|NCT00837447|Ewha Womans University School of Medicine|Young-Hoo Kim, MD|822-26505900|younghookim@ewha.ac.kr|
20532326|NCT00866320|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
20532327|NCT02508207|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20532328|NCT02122952|AveXis, Inc.|Doug Feltner, MD|833-828-3947|medinfo@avexis.com|
20532329|NCT03412890|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
20532330|NCT02063724|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Czerniecki|813-745-7575|brian.czerniecki@moffitt.org|
20532331|NCT02315625|National Cancer Institute|Dr. Naris Nilubol|240-760-6154|niluboln@nih.gov|
20532332|NCT00387127|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532333|NCT02085551|Penumbra, Inc.|Michaella Corso|+1 510-995-2079|mcorso@penumbrainc.com|
20532334|NCT02965833|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
20532335|NCT03370302|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20532336|NCT02475837|Stanford University|Ken Mahaffey MD|650.723.3096|kmahaf@stanford.edu|
20532337|NCT00371449|Mountain Home VA Medical Center|Sherri L. Smith|423.926.1171|sherri.smith@va.gov|7569
20532338|NCT00250718|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
20532339|NCT03407482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20532340|NCT05942040|Rutgers University|Dr. Elizabeth Luth, Principal Investigator|6465120670|eluth@rwjms.rutgers.edu|
20532341|NCT04337021|Cprl. Michael J. Crescenz VA Medical Center|Dr. Amy Helstrom|215-823-4164|amy.helstrom@va.gov|
20532342|NCT00500890|UT MD Anderson Cancer Center|Dr. Richard Gorlick, MD/Division Head, Pediatrics Administration|713- 563-2516|rgorlick@mdanderson.org|
20532343|NCT06818708|University of California San Diego|Baharin Abdullah|+1 858-220-5714|baabdullah@health.ucsd.edu|
20532344|NCT03393013|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
20532345|NCT03860584|Ohio State University|Richard Bruno|8603358494|bruno.27@osu.edu|
20532346|NCT06923033|Moffitt Cancer Center|Dr. Christine Vinci, Ph.D.|813-745-5421|Christine.Vinci@Moffitt.org|
20532347|NCT03554473|National Cancer Institute|Dr. Anish Thomas|2407607343|anish.thomas@nih.gov|
20532348|NCT05206604|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532349|NCT03735498|Massachusetts General Hospital|Dr. Deborah Forst|617-724-8770|dforst@partners.org|
20532350|NCT00160615|Cares|UCB|+1844 599||2273
20532351|NCT05675020|Florida State University|Rachel Sharp|850-865-4443|rls14c@fsu.edu|
20532352|NCT03787212|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, OD - Principal Research Optometrist|904 443 3449|CColesb@its.jnj.com|
20532353|NCT02014103|University of Cincinnati|Rita Alloway|513.558.1568|rita.alloway@uc.edu|
20532354|NCT05638737|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20532355|NCT00504231|University of Washington|Ru-Chien Chi B.S., M.D., M.S.|206 768-5217|rchi@u.washington.edu|
20532356|NCT00943904|University of California, Riverside|Dr. Karen Noblett|(951) 827-7581|karen.noblett@ucr.edu|
20532357|NCT00327171|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20532358|NCT00266812|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20532359|NCT00530075|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
20532360|NCT03422718|University of Michigan|Principal Investigator|734-615-2766|mdome@umich.edu|
20532361|NCT03309605|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
20532362|NCT01129284|Columbia University Medical Center|Dr. Andrew S. Bomback, MD, MPH|212-305-0320|asb68@columbia.edu|
20532363|NCT00422461|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532364|NCT02357485|UCLA Medical Center|Peter Fodor, MD|3102039818|pbfodor@centurysurgery.com|
20532365|NCT01028053|GE Healthcare|Paul Sherwin M.D.|16095146820|Paul.Sherwin@ge.com|
20532366|NCT02346916|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
20532367|NCT00574951|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
20532368|NCT01060111|Medical Affairs / Janssen-Cil Korea|Clinical Research Associate|82-2-2094-4837||
20532369|NCT01004393|Seirei Hamamatsu General Hospital|Masanori Mori, MD|81-53-474-2222|Masanori.Mori@sis.seirei.or.jp|
20532370|NCT03281538|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20532371|NCT01336972|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20532372|NCT05278065|Brown University|Alexander Sokolovsky|401-863-6629|alexander_sokolovsky@brown.edu|
20532373|NCT03446573|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20532374|NCT02029443|Acerta Pharma BV|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20532375|NCT01793909|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
20532376|NCT01279187|University of Michigan|Jill Bashutski||jillbashutski@gmail.com|
20532377|NCT00875329|Tampa VAMC|Rodney Vanderploeg, Ph.D|(813) 972-2000|Rodney.Vanderploeg@va.gov|6728
20532378|NCT03270241|Johns Hopkins Medicine Dermatology Cutaneous Translational Research Program|Ruizhi Wang|4105027546|rwang@jhmi.edu|
20532379|NCT02070991|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
20532380|NCT02448043|Department of Ophthalmology, Northwestern University Feinberg School of Medicine|Dr. David J. Palmer|3126958150|dpalmermd@comcast.net|
20532381|NCT05762679|Johns Hopkins school of medicine|Dr. Preeti Raghavan|9174889626|praghavan@jhmi.edu|
20532382|NCT01197898|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
20532383|NCT02487485|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
20532384|NCT02068599|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20532385|NCT03838874|Mayo Clinic|Dr. Matthew Abdel|507-538-1296|Abdel.Matthew@mayo.edu|
20532386|NCT02958527|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532387|NCT06042855|Duke University|Susanna Naggie, MD|919-684-2584|susanna.naggie@duke.edu|
20532388|NCT05901467|Massachusetts General Hospital|Stephanie Seminara|617-726-1309|MGHKisspeptinResearch@partners.org|
20532389|NCT02691572|Department of Anesthesia and Surgical Intensive Care, Mansoura University Hospitals, Mansoura, Egypt.|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
20532390|NCT01947933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532391|NCT01769365|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@isca.vghks.gov.tw|8233
20532392|NCT01428128|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Chul S. Ha, MD, Professor and Chair|210-450-1109|hac@uthscsa.edu|
20532393|NCT03159195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532394|NCT01750073|University of Nebraska Medical Center|Amulya C Yellala|402-559-5388|amulya.yellala@unmc.edu|
20565445|NCT04605159|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20565446|NCT05599334|Pierre Fabre Médicament|Medical Director (Jeanne Suissa)|+33149108269|jeanne.suissa@pierre-fabre.com|
20565447|NCT00844415|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565448|NCT03015532|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
20565449|NCT03165786|University of Illinois Chicago|Pamela Martyn-Nemeth, Professor|(312) 996-7903|pmartyn@uic.edu|
20565450|NCT03914469|UT Southwestern Medical Center|Dr. Makris|214 648 3133|una.makris@utsouthwestern.edu|
20565451|NCT05308979|UC Irvine Medical Center|Dr. Carly Crowder|7144562911|crowderc@hs.uci.edu|
20565452|NCT03318159|Seoul National University Hospital|Dr. Koh|82220727217|go01@snu.ac.kr|
20565453|NCT04574583|National Cancer Institute|Dr. James Gulley|301-480-8870|james.gulley@nih.gov|
20565454|NCT05422885|Marcus Institute|Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
20565455|NCT04084574|Duke University|Crystal Tyson, MD, MHS|919-660-6671|crystal.simpson@duke.edu|
20532395|NCT05259033|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20532396|NCT01068249|UT MD Anderson Cancer Center|Dr. Pamela Soliman,Professor, Gyn Onc & Reproductive Med|(713) 745-2352|psoliman@mdanderson.org|
20532397|NCT04234568|University of Kentucky|Dr. Susanne Arnold|859-323-8043|susanne.arnold@uky.edu|
20532398|NCT04210375|Salubris Biotherapeutics, Inc|SVP, Clinical Development|16176459160|amanda.mcewen@salubrisbio.com|
20532399|NCT00424008|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20532400|NCT02593864|Stanford University|Constance Chu, MD|650-723-5643|chucr@stanford.edu|
20532401|NCT01405911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532402|NCT06375655|University Hospitals Cleveland Medical Center|Dr. Furman|216-844-3971|Lydia.Furman@UHhospitals.org|
20565456|NCT01121588|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565457|NCT00942877|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@nih.gov|
20565458|NCT04102111|Janssen Research & Development, LLC|Vice President|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565459|NCT02542631|Johnson & Johnson Diabetes Companies|Brian Levy, MD-Chief Medical Officer|484 328-6128|BLevy1@its.jnj.com|
20565460|NCT03334695|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565461|NCT02938923|Washington University in St. Louis School of Medicine|Dr. Ellen F. Binder, Professor of Medicine and Occupational Therapy|314-286-2707|ebinder@wustl.edu|
20565462|NCT02561611|Pennington Biomedical Research Center|Corby Martin|225-763-2585|Corby.Martin@pbrc.edu|
20565463|NCT03812614|University of Pittsburgh School of Medicine|Ann-Marie Rosland, MD, MS|412-648-5660|roslandam@pitt.edu|
20565464|NCT04923776|Columbia University|Brian Henick, MD|212-342-5162|bh2682@cumc.columbia.edu|
20565465|NCT04817176|Florida State University College of Medicine|Dr. Julia Sheffler|850-644-4199|julia.sheffler@med.fsu.edu|
20565466|NCT04763772|UH Cleveland Medical Center|Ian Neeland|216-844-5965|ian.neeland@uhhospitals.org|
20565467|NCT03419052|Indiana University|Daniel Clark, PhD|317-274-9292|daniclar@iu.edu|
20565468|NCT05123027|Medical University of South Carolina|Dr. Ralph Ward|843-876-6110|wardrc@musc.edu|
20565469|NCT04046094|University of Kansas Medical Center|Faith Rahman|913-588-2502|frahman2@kumc.edu|
20565470|NCT02585323|University of British Columbia|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
20565471|NCT05311176|Imugene|Study Director|+61 2 9423 0881|info@imugene.com|
20565472|NCT03550170|Case Western Reserve University|Dr. Matthew Plow|216-368-8969|map208@case.edu|
20565473|NCT04089865|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD, MBA|(212) 606-1206|memtsoudiss@hss.edu|
20565474|NCT03489434|Georgia State University|Amanda Gilmore|404-413-2000|agilmore12@gsu.edu|
20565475|NCT05405985|Galderma|Clinical Operations|08179615000|Clinical.Studies@galderma.com|1
20565476|NCT05860114|Italfarmaco SpA|Maurizio Caserini, MD|+39 02 64431|m.caserini@italfarmacogroup.com|
20565477|NCT02787031|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20565478|NCT05717400|M D Anderson Cancer Center|Harrys A. Torres, MD|(713) 792-6503|htorres@mdanderson.org|
20565479|NCT05424380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20565480|NCT03204825|University of Stirling|Dr Chris Seenan|+441413318151|christopher.seenan@stir.ac.uk|
20565481|NCT03858517|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
20565482|NCT05172232|Linköping University|Professor Magnus Falk|+46708106176|magnus.falk@liu.se|
20565483|NCT04012931|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565484|NCT02473445|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
20520596|NCT04397445|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
20520597|NCT01429051|Takeda|Medical Director|+1-800-778-2860|clinicaltrialregistry@tpna.com|
20520598|NCT03921151|Virginia Commonwealth University|Liangsuo Ma, PhD|(804) 828-2871|liangsuo.ma@vcuhealth.org|
20520599|NCT01207648|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20520600|NCT00857792|The University of Chicago Medical Center|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
20520601|NCT03275766|University of Bern, University Hospital of Psychiatry, Bern|Prof. Sebastian Walther|+41 632 8979|sebastian.walther@upd.unibe.ch|
20520602|NCT01387581|MelaSciences|Mrinalini Roy|800-729-8849|mishti@melasciences.com|
20520603|NCT03001219|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20520604|NCT01797835|RAND|Dr. Elizabeth D'Amico|3103930411|damico@rand.org|6487
20520605|NCT03733210|Stanford Medicine at Stanford University|Yu-Jin Lee, MD, MS|650-725-4711|yujinlee@stanford.edu|
20520606|NCT03728634|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20520607|NCT00929331|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520608|NCT02963441|IDx LLC|IDx President, Dr. Michael Abramoff|319-248-5620|info@eyediagnosis.net|
20520609|NCT04688931|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
20520610|NCT00361335|Centocor, Inc.|Senior Director Clinical Research|1-800-457-6399||
20520611|NCT01765582|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20520612|NCT04493320|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|bret.rutherford@nyspi.columbia.edu|
20520613|NCT00616941|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20520614|NCT00688376|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20520615|NCT00557076|Edward Hines, Jr VA Hospital|Dr. Theresa Pape|708-202-4953|Theresa.Pape@va.gov|
20520616|NCT03041324|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
20520617|NCT02303041|Stanford University|Anne Lynn S. Chang/ Associate Professor of Dermatology|650-723-6316|alschang@stanford.edu|
20520618|NCT00886288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520619|NCT00289874|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520620|NCT04972123|University of Wisconsin - Madison Cardiovascular Medicine|Mohamed H. Hamdan, MD, MBA|608-263-4856|mhamdan@medicine.wisc.edu|
20520621|NCT00136318|Kliniken Essen-Mitte, Department of Psychiatry|Professor Dr. Martin Schaefer|+49201-17430001|m.schaefer@kliniken-essen-mitte.de|
20520622|NCT03835325|Eurofarma Laboratórios S.A|Sandra Rodrigues|1150908600|sandra.rodrigues@eurofarma.com.br|8417
20520623|NCT01370213|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
20520624|NCT00472797|EMD Serono, INc.|Fernando Dangond, MD|781 681 2348|fernando.dangond@emdserono.com|
20565485|NCT04629339|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20565486|NCT06356285|Imperial College London|Dr Kate Grailey|07912563290|k.grailey18@imperial.ac.uk|
20532403|NCT04249778|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
20565487|NCT04158739|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20532404|NCT02530242|UCSF Benioff's Children's Hospital Oakland|Ashutosh Lal, MD||Ashutosh.Lal@ucsf.edu|
20532405|NCT03837938|Dompé Farmaceutici SpA|Mauro P Ferrari, Pharm D|+39 02 583831|clinical.trials@dompe.com|
20532406|NCT01789775|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
20532407|NCT01397747|Exact Sciences|Director of Clinical Operations|608-284-5700|tvaughn@exactsciences.com|
20532408|NCT03828383|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
20532409|NCT02643199|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20532410|NCT00504309|Penn State University|Ann Skulas-Ray|814-863-0856|aus164@psu.edu|
20532411|NCT03345095|EORTC|Dr. Thierry Gorlia|+32 2 7741652|thierry.gorlia@eortc.org|
20532412|NCT02665455|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|+44 1993 863094|joe.bugler@abbott.com|
20532413|NCT03812328|Tetherex Pharmaceuticals|Jonathan Stocker, Ph.D.|855-222-0722|jstocker@tetherex.com|
20532414|NCT01671059|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20532415|NCT06922760|University of Michigan|Njira Lugogo|734-647-6477|nlugogo@med.umich.edu|
20532416|NCT01501513|Braintree Laboratories, Inc.|Head of R&D, GI|781-843-2202|studydirector@sebelapharma.com|
20532417|NCT03166631|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20532418|NCT03083379|University of Virginia Health System|Daniel D. Rowley, MSc, RRT-ACCS, FAARC|434-465-7235|ddr8a@virginia.edu|
20532419|NCT02400736|Tuscaloosa VA Medical Center|Lori L. Davis, M.D.|205-554-2000|Lori.Davis@va.gov|1-3819
20532420|NCT02927145|University of Oxford|Dr Angela Minassian|0044 01865611425|angela.minassian@ndm.ox.ac.uk|
20532421|NCT02323334|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532422|NCT00442689|Northwestern University|Dr. Laura Torchen|312-227-6492|ltorchen@luriechildrens.org|
20532423|NCT03202550|Johns Hopkins University|Katrina Thaler|410-550-8506|kstouff3@jhmi.edu|
20532424|NCT01795937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20532425|NCT01875237|UT MD Anderson Cancer Center|Champlin,Richard,M.D. / Stem Cell Transplantation|713-792-8750|rchampli@mdanderson.org|
20532426|NCT00875667|Celgene Corporationi|Anne McClain, Senior Manager, Clinical Trial Disclosure|8882601599|ClinicalTrialDisclosure@Celgene.com|
20532427|NCT00505362|Stanford University|Anna Girsen, Manager of Research Operations|6507250499|agirsen@stanford.edu|
20532428|NCT02384460|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
20532429|NCT00625378|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20532430|NCT04270760|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20532431|NCT04018001|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532432|NCT01017497|Duke University Medical Center|John Kirkpatrick MD|919 6687342|john.kirkpatrick@dm.duke.edu|
20532433|NCT04022694|University of Pennsylvania|Deputy Director of PEACH Lab|2158987093|thepeachlab@gmail.com|
20532434|NCT03670628|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|305-243-4562|ramasamy@miami.edu|
20532435|NCT03034928|Alcon, A Novartis Division|Sr CDMA Project Lead, GCRA - Vision Care|1-888-451-3937|Alcon.medinfo@alcon.com|
20532436|NCT00634972|University of South Alabama|Fabien Eyal, MD|251-415-1055|feyal@health.southalabama.edu|
20532437|NCT04149353|North Carolina State University|David Lalush|919-513-7671|dslalush@ncsu.edu|
20532438|NCT00887588|Novartis Pharmaceuticals|Study Director|862-778-8300||
20532439|NCT00366535|Symptoms Biology Unit, DIR, NINR, NIH|Leorey Saligan, Chief|301-451-1685|saliganl@mail.nih.gov|
20532440|NCT00106535|Hoffmann-La Roche|Medical Communications|800-821-8590||
20532441|NCT00699751|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20532442|NCT04136366|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20532443|NCT06100250|University of Michigan|Dr. Akshay Sharma|734-647-0151|akshaydr@umich.edu|
20532444|NCT05537571|Silence Therapeutics plc|Global Regulatory|+442034576900|global-regulatory@silence-therapeutics.com|
20532445|NCT05866367|HealthPartners Institute Neuroscience Research|Clinical Research Coordinator|651-495-6363|ClinicalTrials@HealthPartners.com|
20532446|NCT05877586|Duke University|Cristina C. Hendrix, DNS, GNP, FAAN|919-684-9358|cristina.hendrix@duke.edu|
20532447|NCT04439123|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20532448|NCT04124965|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20532449|NCT02184156|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20532450|NCT01276652|University of Iowa|Brian Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
20532451|NCT02213575|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
20532452|NCT00002874|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20532453|NCT03233217|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
20565488|NCT03866837|Columbia University|Gary M. Brittenham, M.D.|212 305 7005|gmb31@cumc.columbia.edu|
20565489|NCT00677365|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
20565490|NCT01385202|Biosense Webster, Inc.|Robert Stagg, Manager, Clinical Operations|(800) 729-9010|RStagg@its.jnj.com|8611
20565491|NCT04332211|University of Maryland School of Medicine, Department of Emergency Medicine|Siamak Moayedi MD|4103288025|Mak.Moayedi@som.umaryland.edu|
20532454|NCT02114684|CAPRISA|Mrs Nonhlanhla Yende-Zuma|0027312604392|Nonhlanhla.Yende@caprisa.org|
20565492|NCT00964392|Biosense Webster, Inc.|Robert Stagg, Clinical Franchise|(800) 729-9010|RStagg@its.jnj.com|
20532455|NCT00283959|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20532456|NCT01214720|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20532457|NCT05591755|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20532458|NCT01346683|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20532459|NCT05865886|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20532460|NCT07085845|Medical College of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
20532461|NCT03651609|Institute of Clinical Neurophysiology, Division of Neurology, University Medical Centre Ljubljana, Slovenia|Gregor|+38631226546|gregor.omejec@kclj.si|
20532462|NCT02564978|National Institutes of Health|Tiarnan Keenan, MD, PhD, Principal Investigator, NEI|301-451-6330|tiarnan.keenan@nih.gov|
20532463|NCT01729091|The University of Texas MD Anderson Cancer Center|Samer Srour, MD / Stem Cell Transplantation|713-794-4354|SSrour@mdanderson.org|
20532464|NCT04971837|Colorado State University|Dr. Christopher Bell, Director, Laboratory of Integrative Physiology|(970) 491-7522|Christopher.Bell@colostate.edu|
20532465|NCT02740582|University of California, San Franciso|Jennifer Mitchell, PhD|510-985-3522|jennifer.mitchell@ucsf.edu|
20532466|NCT00142597|University of Michigan|Richard E. Harris|734-998-6996|reharris@med.umich.edu|
20532467|NCT00567580|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20532468|NCT03022630|Vanderbilt University Medical Center|Dr. Cheryl Gatto|6153432252|cheryl.l.gatto.1@vumc.org|
20532469|NCT00884949|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
20532470|NCT00382070|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20532471|NCT01552889|Washington University School of Medicine|Dr. Robert Carney|314-286-1313|carneyr@wustl.edu|
20532472|NCT01292265|UCB, Inc.|Study Director|+1 887 822 9493||
20532473|NCT01629563|PregLem|Dr Pablo Arriagada|0041228840355|info@preglem.com|
20532474|NCT03017261|Think Surgical|Valentina Campanelli|510-249-2314|vcampanelli@thinksurgical.com|
20532475|NCT00456612|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
20532476|NCT03989570|Minia university|Dr. Hassan Elshorbagy|1204427271|Hassan.Hetta@mu.edu.eg|0020
20532477|NCT00358579|Singapore General Hospital|A/Prof Marcus Ong Eng Hock|+6563213590|marcus.ong.e.h@sgh.com.sg|
20532478|NCT03073109|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532479|NCT01297244|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
20532480|NCT03558672|Tactile Medical|Director of Clinical Research|612.540.5267|astone@tactilemedical.com|
20532481|NCT00666978|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
20532482|NCT00983957|Bristol-Myers Squibb International Corporation|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20532483|NCT03055195|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20532484|NCT00986232|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532485|NCT00790933|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20532486|NCT03395990|Duke University Medical Center|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
20532487|NCT00894647|Graceway Pharmaceuticals|Vice President Medical Affairs|267-948-0400|Sharon.levy@gracewaypharma.com|
20532488|NCT04017910|Sonavex|Katy Feeny|443-862-2024|kfeeny@sonavex.com|
20532489|NCT01967277|Capillus LLC|Patricia Schnoor|7868881874|pschnoor@capillus.com|
20532490|NCT04565288|Brown University|Dr. Robert Miranda Jr.|401-863-6658|Robert_Miranda_Jr@brown.edu|
20532491|NCT01913470|Emory University|Miriam Vos, MD, MSPH|404-727-9930|mvos@emory.edu|
20532492|NCT00727337|Department of Veterans Affairs|Rachel McArdle|727-398-6661|Rachel.mcardle@va.gov|17479
20532493|NCT00412451|ThromboGenics NV|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
20532494|NCT02573467|Novartis Pharmaceuticals|Study Director|862-778-8300||
20532495|NCT01829165|Stanford University|Amit Etkin, MD, PhD|(650) 725-5736|aetkin@stanford.edu|
20532496|NCT04285684|Ketamine Research Foundation|Philip E Wolfson, MD|415-550-1700|ketamine.research@gmail.com|
20532497|NCT03300336|HSRD ADAPT|S. Nicole Hastings|919-286-6936|susan.hastings@va.gov|
20532498|NCT01404260|Shanghai Chest Hospital|Shun LU|86-2162821990|shun_lu11@163.com|
20532499|NCT00710970|Baylor College of Medicine|Seth P. Lerner, M.D., F. A. C. S.|713-798-6841|slerner@bcm.edu|
20532500|NCT01028560|Jacobi Medical Center / Albert Einstein College of Medicine|Gabriele de Vos, M.D.|7184152809|gabriele.de-vos@einstein.yu.edu|
20532501|NCT02153827|University of St. Augustine|Eric Chaconas|904-826-0084|echaconas@usa.edu|1275
20532502|NCT01033227|Children's Hospital Los Angeles|Dr. Thomas Coates|323 361 3841|TCoates@chla.usc.edu|
20532503|NCT01901588|NYU School of Medicine|Assistant Professor, Department of Anesthesiology, Perioperative Care, and Pain Medicine|212.263.5072|wanda.chin@nyumc.org|
20532504|NCT01960842|AbbVie|Global Medical Information|1-800-633-9110||
20532505|NCT00397930|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20532506|NCT02391584|Entellus Medical|Clinical Affairs Manager|7634631595|rschacherer@entellusmedical.com|
20532507|NCT03676725|AlkaliDx|Lynn Feldman|16178791670|lynn@alkalidx.com|
20565493|NCT00303459|Actelion Pharmaceuticals Ltd|Jonathan Tolson|+41 61 565 56 04|jonathon.tolson@actelion.com|
20565494|NCT05571267|IVERIC Bio, Inc.|Medical Director|609-474-6755|info@ivericbio.com|
20565495|NCT04214834|RTI International|Dr. Abhik Das|3017708214|adas@rti.org|
20565496|NCT04924400|Geisinger|Dr. Thomas Morland|703-593-0088|tmorland@geisinger.edu|
20565497|NCT04424316|Pfizer Inc.|PfizerClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532508|NCT01030575|RTI International|Dr. Abhik Das|301-770-8214|adas@rti.org|
20532509|NCT02296801|NSABP Foundation Inc|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
20532510|NCT05696158|Mahana Therapeutics|Kathryn Jenkins|17742666693|kathryn@mahanatherapeutics.com|
20565498|NCT04265807|University of Washington|Graham Nichol|206 521 1784|nichol@uw.edu|
20520625|NCT01550744|Janssen Biotech, Inc|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20520626|NCT00436904|Mayo Clinic|Dr. Clive Zent|507-284-5362|zent.clive@mayo.edu|
20520627|NCT02660528|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
20520628|NCT00706381|NIDDK|Kong Chen, Ph.D.|301-451-1636|chenkong@niddk.nih.gov|
20520629|NCT01782482|Alcon Research, Ltd.|Sharon Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
20520630|NCT01194973|Alexion Pharmaceuticals Inc|Alexion Pharmaceuticals Inc||clinicaltrials@alexion.com|
20520631|NCT01846273|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20520632|NCT00891839|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20520633|NCT02037165|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520634|NCT03431974|Syntrix Pharmaceuticals|Aaron Schuler|253-833-8009|aschuler@syntrixbio.com|21
20520635|NCT00695435|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20520636|NCT02192164|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520637|NCT00851643|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20520638|NCT00359788|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520639|NCT00673933|Dermatology Institute|Dr Ashish Bhatia|630-942-5040|acbhatia@gmail.com|
20520640|NCT04932941|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|36
20520641|NCT00103402|University of Pennsylvania|J. Richard Landis, PhD|215-573-4922|hultman@upenn.edu|
20520642|NCT01393730|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-582-7221|mary_taplin@dfci.harvard.edu|
20520643|NCT01673698|ReShape Medical|Director of Clinical Operations|94429-6680|lfong@reshapemedical.com|
20520644|NCT01297322|Daniel & Daniel Consulting, LLC|Michael A. Daniel, Consulting VP Regulatory Affairs|7753922970|madaniel@clinregconsult.com|
20520645|NCT02013375|University of Illinois at Chicago|Dr Damiano Rondelli|312-996-6179|drond@uic.edu|
20520646|NCT00712985|Milton S. Hershey Medical Center|Allan Lipton, MD|717-531-5960|alipton@hmc.psu.edu|
20520647|NCT02674061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520648|NCT01856361|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
20520649|NCT03182582|Stanford University|Geoffrey C. Gurtner, MD|650-736-2776|ggurtner@stanford.edu|
20520650|NCT03334721|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
20520651|NCT01663727|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20520652|NCT01902628|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20520653|NCT01232491|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20520654|NCT02646449|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
20520655|NCT02932228|VA Palo Alto Health Care System|Dr Donna Zulman|650-493-5000|Donna.Zulman@va.gov|29113
20520656|NCT01045421|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20520657|NCT01553279|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520658|NCT00605865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520659|NCT03955471|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20520660|NCT03012672|University of Washington|Anna Halpern, MD|206-606-1978|halpern2@uw.edu|
20520661|NCT01030341|Johns Hopkins Data Coordinating Center|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
20520662|NCT03805100|Xbrane Biopharma AB|Clinical Affairs|+46 85-590 56 00|xbregistry@xbrane.com|
20520663|NCT01884311|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
20520664|NCT01461226|University of Antwerp/Antwerp University Hospital|dr. Luc bruyndonckx|003238213000|luc.bruyndonckx@uza.be|
20520665|NCT02856880|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520666|NCT00793780|Yale University|Erin Sullivan|+1 (203) 974-7317|erin.reutenauer@yale.edu|
20520667|NCT02858492|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20520668|NCT00573157|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20520669|NCT00915928|Odense University Hospital, Odense, Denmark|Frantz Rom Poulsen, Professor, consultant|0045 65413600|frantz.r.poulsen@rsyd.dk|
20520670|NCT01032018|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
20520671|NCT00937378|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20520672|NCT04425538|Neely Center for Clinical Research, Tufts Medical Center|Director of Clinical Trials|617-636-5000|ncccr@tuftsmedicalcenter.org|3264
20520673|NCT03853148|Medical University of South Carolina|Teresa Kelechi, Associate Dean for Research and PhD Studies|843-792-4602|kelechtj@musc.edu|
20520674|NCT00281671|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, MD MPH|312 227 1551|jmcostello@luriechildrens.org|
20520675|NCT00599521|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
20520676|NCT01293539|Johns Hopkins|Monica Pearl, M.D.|410-955-8525|msmit135@jhmi.edu|
20520677|NCT00418301|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20520678|NCT01248013|Mind-Body Digestive Center|Charles D. Gerson, M.D.|212 496 6161|cgerson@yahoo.com|
20520679|NCT00725530|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20520680|NCT01388166|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520681|NCT00782821|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
20565499|NCT04109066|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20565500|NCT05652010|Coloplast A/S|Senior Scientific Manager|+4549113192|dkmbs@coloplast.com|
20565501|NCT05864040|Rob Surgical Systems|Jaume Amat, CEO|+34 93 013 08 83|jaume.amat@robsurgical.com|
20565502|NCT05451693|HealthPartners Institute|Bhavani Kashyap, PhD, MBBS|651-495-6363|Bhavani.x.kashyap@healthpartners.com|
20565503|NCT03681912|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|850-644-2334|sylvie.naar@med.fsu.edu|
20565504|NCT04707768|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|6178446128|trials@akebia.com|
20565505|NCT05953740|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20565506|NCT05890105|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565507|NCT05117008|Medical College of Wisconsin|Meera Mohan MD, MS|414-805-4600|memohan@mcw.edu|
20565508|NCT02361658|Toronto Western Hospital, University Health Network|Emad Al Azazi|4166035800|emad.alazazi@uhnresearch.ca|2508
20565509|NCT03735979|Medical University of South Carolina|Jordan J. Elm, PhD|843-876-1605|elmj@musc.edu|
20565510|NCT05958927|Usak University Medical Faculty|Suzan Doğruya|05322270732|sdogruya@hotmail.com|
20565511|NCT00319111|Actelion Pharmaceuticals Ltd|Loïc Perchenet PhD/Clinical Trial Leader|+41 61 565 6457||
20565512|NCT04330040|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20565513|NCT06229119|Carolina Eyecare Physicians, LLC|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
20565514|NCT02461134|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
20565515|NCT03165955|Athenex Inc.|Regional Project Manager|+886-978365735|lmeiying@athenex.com|
20565516|NCT03745716|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20565517|NCT02994927|ChemoCentryx, Inc.|Clinical trial disclosure|650.210.2900|clinicaltrials@chemocentryx.com|
20565518|NCT00626795|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20565519|NCT03875339|University of Kentucky|Dr. Matthew L. Bush, Professor and Chair of Otolaryngology- Head and Neck Surgery|(859)218-2139|matthew.bush@uky.edu|
20565520|NCT03533257|Amylyx Pharmaceuticals, Inc.|Chief Medical Officer|(877) 374-1208|medinfo@amylyx.com|
20565521|NCT02865538|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20565522|NCT06946888|Kaohsiung Veterans General Hospital|Li-Ying Lin|07-3422121|llylin@vghks.gov.tw|71571
20565523|NCT05505578|225.763.2500 Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20565524|NCT01917084|New England Research Institutes|Felicia Trachtenberg|617-972-3120|FTrachtenberg@neriscience.com|
20565525|NCT03571386|Vanderbilt University|David Vago|236-516-6530|vago.dave@gmail.com|
20565526|NCT02278211|University of Edinburgh|Professor Dave Newby|0131 242 6515|D.E.Newby@ed.ac.uk|
20565527|NCT02909686|University of Alabama at Birmingham|Dr. Jarred Younger|205-975-5821|youngerlab@uab.edu|
20565528|NCT05268276|Faculty of nursing /cairo university|Asmaa Abdallah Ahmed Hussein|01006961502|asmaaabdallah.cu@cu.edu.eg|
20565529|NCT06037668|Sumitomo Pharma America|Director, Frontier Business Office|1-866-503-6351|gazeleh.vakili@us.sumitomo-pharma.com|
20565530|NCT04804540|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20565531|NCT01828021|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
20565532|NCT02997202|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20565533|NCT03778801|Aksaray University training and Research Hospital|Principal Investigator|905555289493|mlk.aykut@gmail.com|
20565534|NCT04502186|University of Michigan School of Social Work|Dr. Addie Weaver|734-615-2122|weaverad@umich.edu|
20565535|NCT03681262|Stanford University|Vafi Salmasi, MD. MS.|6507250246|vsalmasi@stanford.edu|
20565536|NCT04370834|National Cancer Institute|Dr. Richard Little, Principal Investigator|240-276-6093|littler@mail.nih.gov|
20565537|NCT02782676|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head of Clinical Sciences|714-247-8613|kendra.hileman@abbott.com|
20565538|NCT05007080|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565539|NCT02874742|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565540|NCT04068792|Janssen Research & Development, LLC|Senior director medical leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565541|NCT00631475|Actelion Pharmaceuticals Ltd|Isabelle Leconte, PhD/Data Science Group Leader, Director|+ 41 61 565 64 18|isabelle.leconte@actelion.com|
20565542|NCT05985382|University of Central Florida|Abigail Anderson|4078231026|Abigail.Wilson@ucf.edu|
20565543|NCT06609486|Hanyang University Seoul Hospital|Jongshill Lee, Ph.D.|+82-10-6209-4260|netlee@hanyang.ac.kr|
20565544|NCT05205161|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20565545|NCT05741294|Almirall S.A|Valentina Cappello/Global Medical Operations Manager|+34932913000|valentina.cappello@almirall.com|
20565546|NCT04704869|The University of Texas Health Science Center at Houston|Bryan A Cotton, MD|713-500-7313|Bryan.A.Cotton@uth.tmc.edu|
20565547|NCT04325815|University College London|Professor Laurence B Lovat|020-7679-9060|l.lovat@ucl.ac.uk|
20565548|NCT03880955|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
20565549|NCT02510235|Dompé farmaceutici SpA|Clinical Development & operations|+39583831|clinical.trials@dompe.com|
20520682|NCT02667288|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
20520683|NCT04408599|NextCure, Inc|Chief Medical Officer|(240) 399-4900|NCClin@nextcure.com|
20520684|NCT00714493|Centocor Ortho Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-6811|Ddeckto2@its.jnj.com|
20520685|NCT04505293|Duke University|Anthony 'Tony' T. Fuller, MD, MScGH|919-613-1813|anthony.fuller@duke.edu|
20520686|NCT00506129|University of Texas (UT) MD Anderson Cancer Center|Chitra M. Hosing, Professor, Stem Cell Transplantation|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
20532511|NCT00489268|Mayo Clinic, Arizona|David E. Fleischer, M.D.|(480) 301-4461|fleischer.david@mayo.edu|
20532512|NCT02056288|Baylor College of Medicine|Chris D. Glover, MD, MBA, Principal Investigator|832-824-5800|cdglover@texaschildrens.org|
20532513|NCT01579305|Allergan, Inc.|Medical Monitor|805 961 5000|devicetrials@allergan.com|
20532514|NCT02400580|University of Pittsburgh Medical Center|Dr. Noah Rindos|(412) 641-8769|rindosnb@upmc.edu|
20532515|NCT00965094|Novartis Pharmaceuticals|Study Director|862-778-8300||
20532516|NCT01441414|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532517|NCT01773889|The Cancer and Therapy Center at The University of Texas Health Science Center San Antonio|Tyler Curiel, MD|210-562-5287|CURIELT@UTHSCSA.EDU|
20532518|NCT04233580|University of Texas Southwestern Medical Center|Tara Kristof|214-648-8602|tara.kristof@utsouthwestern.edu|
20532519|NCT03123588|Incyte Corporation|Call Center|1.855.463.3463|medinfo@incyte.com|
20532520|NCT02822287|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532521|NCT01623752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532522|NCT01814332|San Francisco VA Medical Center|Jennifer Hlavin|415-221-4810|jennifer.hlavin@va.gov|26624
20532523|NCT00668564|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
20532524|NCT02697422|VA Puget Sound Health Care System|Dr. Karin Nelson|(206)277-4507|karin.nelson@va.gov|
20532525|NCT01659541|MetroHealth Medical Center|Anthony F. DiMarco, MD|216-778-3906|afd3@case.edu|
20532526|NCT03296345|Valley Children's Hospital|Jonathan Bryan Cooper-Sood, MD|559-353-3000|coopersoodj@usacs.com|
20532527|NCT01871727|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20532528|NCT01263028|Kaiser Permanente|John J. Sim, MD||john.j.sim@kp.org|
20532529|NCT03019588|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532530|NCT00294398|CHOP|Esther Sampayo MD MPH|215-590-1944|sampayo@email.chop.edu|
20532531|NCT00985790|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532532|NCT00762177|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
20532533|NCT02939781|Great Ormond Street Hospital NHS Trust|Dr Samiran Ray|4420274059200|samiran.ray@gosh.nhs.uk|8213
20532534|NCT03753542|Institute of Nursing Dow University of Health Sciences, Karachi/Sindh Nurses Examination Board, Karachi|Nomi Waqas Gul, Student MSN DUHS ION and Asst. Controller Sindh Nurses Examination Board, Karachi|0345-2506790|nomiwg@gmail.com|
20532535|NCT00990769|Duke University Medical Center|Dr. Heather Frederick|919-812-6204|heather.frederick@duke.edu|
20532536|NCT03694652|University of New Mexico|Dr. Tracie Collins|505-272-4979|tccollins@salud.unm.edu|
20532537|NCT03158311|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20532538|NCT03011372|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20532539|NCT02860000|Mayo Clinic|Dr Tufia C Haddad|507-284-2511|Haddad.Tufia@mayo.edu|
20532540|NCT02169401|Abbott|Robyn Capobianco|512-286-4274|robyn.capobianco@abbott.com|
20532541|NCT01258855|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20532542|NCT04289298|Weill Cornell Medical College|Dr. Patricia Marino, PhD|914-997-8691|pam2029@med.cornell.edu|
20532543|NCT01734928|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20532544|NCT00620035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20532545|NCT01778985|University of Texas Southwestern Medical Center|David D. Rahn, M.D.|214-648-6430|david.rahn@utsouthwestern.edu|
20532546|NCT04290676|EyePoint Pharmaceuticals|Dario Paggiarino, MD|(617) 610-3411|dpaggiarino@eyepointpharma.com|
20532547|NCT04229381|The Ohio State University Comprehensive Cancer Center|Dr. Carolyn Presley|614-293-9424|Carolyn.Presley@osumc.edu|
20532548|NCT00088881|ECOG Statistical Office|Study Statistician|617-632-3012||
20532549|NCT03761914|Sellas Life Sciences|Dr Dragan Cicic, Chief Development Officer|646-200-5278|info@sellaslife.com|
20532550|NCT01309880|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
20532551|NCT02370394|Butler Hospital/Women and Infants Hospital|Caron Zlotnick, Ph.D.|(401) 455-6529|CZlotnick@Butler.org|
20532552|NCT01834261|Stony Brook University|Lilianne Mujica Parodi, PhD / Study Principal Investigator|631-632-1008|lilianne.strey@stonybrook.edu|
20532553|NCT02316613|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20532554|NCT01108796|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20532555|NCT00758043|Vertex Pharmaceuticals Incorporated|Robert Kauffman, MD, PhD|617-444-6158|Robert_Kauffman@vrtx.com|
20532556|NCT02545127|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20532557|NCT05788328|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532558|NCT00771602|UT MD Anderson Cancer Center|Stefan Faderl, MD / Professor|713-745-4613||
20532559|NCT01629862|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
20532560|NCT03197935|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20532561|NCT00145327|Novartis Pharmaceuticals|Study Director|862-778-8300||
20532562|NCT00908388|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
20532563|NCT00960856|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
20532564|NCT04027946|National Cancer Institute|Dr. Azam Ghafoor|240-858-3289|azam.ghafoor@nih.gov|
20565550|NCT00450216|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
20532565|NCT03593629|Jomo Kenyatta University of Agriculture and Technology and University of Washington|Kenneth Ngure|+254722362219|kngure@uw.edu|
20565551|NCT05008055|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20532566|NCT03315689|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
20532567|NCT00864513|Georgetown University|Dr. Jimmy Hwang|202-444-2198|jh96@gunet.georgetown.edu|
20532568|NCT05938010|Scripps Optometric Group|Dr Jay Mashouf|1-858-530-2800|jaymashouf@gmail.com|
20532569|NCT02197104|Rush University Medical Center|Dr. Deborah A Hall|312-563-2900|Movementdisorder@rush.edu|
20532570|NCT00985192|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Dr. Zev Wainberg|310 794-6500|zwainberg@mednet.ucla.edu|
20532571|NCT02083263|Karolinska University Hospital|Maria Cecilia Rodriguez Hortal|0046709558699|cecilia.rodriguez-hortal@karolinska.se|
20532572|NCT01348698|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
20532573|NCT02595749|USC Dept. of Preventive Medicine|Matthew Kirkpatrick|3234428221|mgkirkpa@usc.edu|
20532574|NCT00669331|Pharmaxis Ltd|Dr Brett Charlton, Medical Director|+61 2 94547210|brett.charlton@pharmaxis.com.au|
20532575|NCT01454063|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
20532576|NCT00069329|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Goldbach-Mansky, Raphaela|+1 301 435 6243|goldbacr@mail.nih.gov|
20532577|NCT02707744|Imperial College|Yura Mareev|+79166364410|mareev84@gmail.com|
20520687|NCT02163486|DorkuzEU|Bahar Kuvaki|902324122836|ozbilginsule@gmail.com|
20532578|NCT02331407|Columbia University|Dr. Tomoko Kitago|212-305-8389|tk2229@columbia.edu|
20532579|NCT01562444|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532580|NCT01286324|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
20532581|NCT00546273|UTE. Fund. Inst. Germans Trias i Pujol|Cristina Vilaplana, MD|+34 93 497 86 81|cvilaplana@gmail.com|
20532582|NCT03387046|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20532583|NCT00509600|UT MD Anderson Cancer Center|Robert J. Wells, MD / Professor|713-792-6620||
20532584|NCT01908842|University of Virginia|Dr. Erik Gunderson, MD, FASAM|(434) 202-8612|EWG2N@hscmail.mcc.virginia.edu|
20532585|NCT02568423|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20532586|NCT00038610|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, MD/Leukemia||CR_Study_Registration@mdanderson.org|
20532587|NCT02550210|Dartmouth Hitchcock Medical Center|Dr. Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
20532588|NCT03794544|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20565552|NCT03003533|Spark Therapeutics|Spark Therapeutics|Please Email|clinicaltrials@sparktx.com|
20565553|NCT00640822|LeoPharma|Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
20565554|NCT03011034|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565555|NCT04564209|University of Colorado College of Nursing|Dr. Samantha Stonbraker, Study PI|720-880-8194|Samantha.Stonbraker@CUAnschutz.edu|
20565556|NCT01438853|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Office|855-797-9277|Bobby.Reddy@Immunitybio.com|
20565557|NCT04807777|Columbia University|Alexander Wei, MD|212-305-7115|aw3056@cumc.columbia.edu|
20565558|NCT04761198|Mereo BioPharma|Mereo BioPharma|Please Email|enquiries@mereobiopharma.com|
20565559|NCT05305560|MedinCell|Head of Clinical Development|6 40 38 93 83|caroline.denot@medincell.com|0033
20520688|NCT01284296|University of California, San Francisco|Ronald D. Miller|415 476-9034|millerr@anesthesia.ucsf.edu|
20520689|NCT01400919|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20520690|NCT00251719|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20520691|NCT05227300|Indiana University School of Dentistry|Dr. Kenneth Spolnik|317-274-7280|kspolnik@iu.edu|
20520692|NCT02792959|Institute Bergonie|Dr. Anne Laure Cazeau, Coordinating Investigator|0556337860|A.Cazeau@bordeaux.unicancer.fr|
20520693|NCT04392583|Smith+Nephew, Inc|Judith Horner|+44 1482 673251|judith.horner@smith-nephew.com|
20520694|NCT03201250|Vanderbilt University Medical Center|Muhamed Baljevic, MD|615-936-8422|muhamed.baljevic@vumc.org|
20520695|NCT02408068|Simbec Research Ltd|Dr G Sharma|0800 691995|contact@simbec.com|
20520696|NCT03484117|Massachusetts General Hospital|Dr. Julie Levison, PI|617-724-4698|jlevison@partners.org|
20520697|NCT01780987|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
20520698|NCT04168190|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520699|NCT02335983|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20520700|NCT01070771|University Hospital Southampton NHS Foundation Trust|Professor Nick Curzen|+44 023 80777222|nick.curzen@uhs.nhs.uk|
20520701|NCT03127644|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20520702|NCT05070546|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20520703|NCT01227655|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20520704|NCT04982874|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
20520705|NCT02787408|Edwards Lifesciences|Ted Feldman, MD|949-250-2500|Feldman_Info@edwards.com|
20520706|NCT00511992|University of Oklahoma|Ingrid Block, CTO Director|405 271-8001|ingrid-block@ouhsc.edu|
20520707|NCT03096847|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20520708|NCT01797484|University Heart Centre Hamburg Eppendorf|Dr. Tjark F. Schwemer|+49 40 7410|t.schwemer@uke.de|56800
20520709|NCT02093221|Grifols Therapeutics LLC|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
20520710|NCT00534794|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
20520711|NCT03097588|Department of Pharmacy Services, Oregon health & Science University Hospital|Joseph Bubalo, PharmD (Oncology Clinical Pharmacy Specialist)|5034948007|bubaloj@ohsu.edu|
20520712|NCT00731549|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20532589|NCT01027416|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20520713|NCT00588640|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl|646-888-2681|moryln@mskcc.org|
20532590|NCT00421733|Abbott|Global Medical Services|800-633-9110||
20532591|NCT00120250|Massachusetts General Hospital|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
20532592|NCT00720083|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
20532593|NCT03050489|First State Pavlov Medical University|Nikolay Bunenkov|+7-950-028-17-40|bunenkov2006@gmail.com|
20532594|NCT00245570|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532595|NCT01676350|WellSpan York Hospital|Brent Becker|717-851-2223|bbecker2@wellspan.org|
20532596|NCT00103506|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
20532597|NCT00585585|University of Cincinnati|Erik Nelson, MD|513-558-5115|erik.nelson@uc.edu|
20532598|NCT02002208|Atopix Therapeutics Limited|Chief Medical Officer|+44 1235 841 522|atopix@atopixtherapeutics.co.uk|
20532599|NCT00393380|The EMMES Corporation|Adam Mendizabal, Statistician|301-251-1161|amendizabal@emmes.com|221
20532600|NCT02993302|Dr. Cipto Mangunkusumo Hospital|Dyah Purnamasari|62213907703|dyah_p_irawan@yahoo.com|
20532601|NCT05987540|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
20532602|NCT02959892|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20532603|NCT02061592|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
20532604|NCT03338023|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20532605|NCT04996264|Ophirex, Inc.|Tim Platts-Mills, Chief Medical Officer|5592406073|tim@ophirex.com|
20532606|NCT04433975|University of Michigan Medical School|Dr. Mark Ilgen|734-845-3646|marki@med.umich.edu|
20532607|NCT02734147|Christiana Care Health Services|Jamie Rosini, Pharm D|302-733-6364|jrosini@christianacare.org|
20532608|NCT04392635|Stanford University|Study Team|650-723-6189|smeyer27@stanford.edu|
20532609|NCT04514458|Yale University|Tariq Ahmad|203-843-1667|tariq.ahmad@yale.edu|
20532610|NCT04180696|Medtronic, Bakken Research Center B.V.|Lidwien Vainer|+31610419653|lidwien.vainer@medtronic.com|
20532611|NCT01740427|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532612|NCT05752487|Biosense Webster, Inc.|Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20532613|NCT00963508|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 -345-9001|natalie.yantovskiy@taro.com|
20532614|NCT01860989|Novartis Pharmaceuticals|Study Director|862-778-8300||
20532615|NCT02759458|Rush University Medical Center|Nikhil Verma, MD|(312) 563-2214|nikhil.verma@rushortho.com|
20532616|NCT03585543|Medical University of South Carolina College of Nursing|Shannon Phillips, PhD, RN, Associate Professor|843-792-9379|phillipss@musc.edu|
20532617|NCT04739709|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
20532618|NCT00759096|Alcon Research, Ltd.|Benny Li, PhD|+86 21 6375 8762|Benny.Li@Alconlabs.com|
20532619|NCT00314106|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20532620|NCT01033071|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20532621|NCT00727064|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20532622|NCT03684057|Brown University|Dr. Judson Brewer|401-863-2826|judson.brewer@brown.edu|
20565560|NCT03493542|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20532623|NCT04132466|Kestra Medical Technologies, Inc.|Laura Gustavson|14255264759|laura.gustavson@kestramedical.com|
20532624|NCT05890586|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20532625|NCT02082483|Kidney Transplant Research|Dr. John Gill|6046822344|jgill@providencehealth.bc.ca|64706
20532626|NCT02181621|Smith & Nephew, Inc.|Matthew Christensen|+1-303-249-5812|Matthew.Christensen@smith-nephew.com|
20532627|NCT00762788|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|1 904 443-1032|kosborn@its.jnj.com|
20532628|NCT01524705|University of Washington|Jeffrey L Probstfield, MD|206-616-0292|jeffprob@uw.edu|
20532629|NCT01567020|VA Portland Health Care System|Dr. Frederick Gallun|5032208262|Frederick.Gallun@va.gov|57472
20532630|NCT01433978|Eisai Call Center|Eisai Inc.|888-422-4743||
20532631|NCT03954938|University of Kentucky|William W. Stoops|8592575388|william.stoops@uky.edu|
20532632|NCT00976391|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532633|NCT00617903|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20532634|NCT02565186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20532635|NCT01371565|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20532636|NCT02217982|Rocky Mountain MS Research Group|Tammy Hoyt|8014085711|thoyt@rmmsc.com|
20532637|NCT04676646|AstraZeneca|Global Clinical Lead|18772409479|information.center@astrazeneca.com|
20532638|NCT05156125|Oppilan Pharma Ltd|Clinical Trial Contact|+1(888)-411-5176|clinicaltrials@ventyxbio.com|108
20532639|NCT04863807|Imperial College Healthcare NHS Trust|Dr Alex Wickham|+4420233121248|alex.wickham@nhs.net|
20565561|NCT04499521|University of Virginia|Kara Romano, MD|434-982-6278|ked7c@uvahealth.org|
20532640|NCT01755637|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532641|NCT02933476|Stanford School of Medicine|Raumin Neuville|6507236709|raumin@stanford.edu|
20532642|NCT04389671|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|
20565562|NCT05525104|Erasmus Medical center|I.J. de Heer, MD|+31107040704|i.deheer@erasmusmc.nl|
20532643|NCT01421134|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20532644|NCT00685698|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
20532645|NCT03896217|UCL Institute of Neurology|Prof. Richard Nicholas|0208 383 0675|richard.nicholas3@nhs.net|
20532646|NCT02213107|University of Rochester|Chunkit Fung, MD|585 - 275 - 5823|chunkit_fung@urmc.rochester.edu|
20532647|NCT02030418|Abbott Cardiac Rhythm Management|Nicole Harbert, Director Clinical Research|972-526-4841|nicole.harbert@abbott.com|
20532648|NCT00724893|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20532649|NCT01810952|Baylor College of Medicine|Professor of Medicine|713-660-9902|glennc@bcm.edu|
20532650|NCT01290731|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
20532651|NCT01279200|University of Michigan|Senait Fisseha, MD, JD|734-763-4323|sfisseha@med.umich.edu|
20532652|NCT01399099|Neodyne Biosciences|Sr. Director of R&D|510-456-4128|jjackson@neodynebio.com|128
20532653|NCT04308694|Duke University|William John, Ph.D.|919-681-7291|william.john@duke.edu|
20532654|NCT01179516|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20532655|NCT01149538|University of Minnesota|Jeffrey R. Wozniak, Ph.D.|612-273-9741|jwozniak@umn.edu|
20532656|NCT00888849|Ethicon Endo Surgery, Inc|Sheryl Helsinger/Clinical Affairs Director|513-337-3079|shelsing@its.jnj.com|
20532657|NCT05064800|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532658|NCT00629239|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20532659|NCT01851369|National Cancer Institute|Dr. Alice P.Chen|2407813320|chenali@mail.nih.gov|
20532660|NCT02636322|University of Texas M D Anderson Cancer Center|Dr. Jason Westin|(713) 792-3750|jwestin@mdanderson.org|
20532661|NCT02502071|University of Colorado School of Medicine|Dr. Petter Bjornstad, Assistant Professor|7207774659|petter.bjornstad@childrenscolorado.org|
20532662|NCT00395512|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20532663|NCT03983109|Flat Medical Co., Ltd|LI YU LIN|+886 25672959|liyulin@flatmedical.com|16
20532664|NCT01980888|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20532665|NCT04625972|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20532666|NCT00433290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532667|NCT01483651|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
20532668|NCT01018953|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20532669|NCT00724503|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
20532670|NCT03927716|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20532671|NCT01186419|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20532672|NCT04115228|Nine Continents Medical, Inc.|Peter Jacobson|6128105810|PETERJACOBSON777@YAHOO.COM|
20532673|NCT01928771|AstraZeneca|Mitchell Goldman , Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
20532674|NCT01937117|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Jenna Canzoniero, MD|410-955-8983|jcanzon1@jhmi.edu|
20532675|NCT01407367|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-382-4822|jfink@som.umaryland.edu|
20532676|NCT02269488|MedImmune, LLC, a wholly-owned subsidiary of AstraZeneca PLC|Raburn Mallory|+1 301-398-5799|malloryr@medimmune.com|
20532677|NCT01245062|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532678|NCT06025695|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20532679|NCT01452347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20532680|NCT05762744|University of Maryland School of Medicine|Simeon Taylor, MD, PhD (Professor of Medicine0|4107066439|staylor2@som.umaryland.edu|
20532681|NCT03630354|Oregon Health & Science University|Dr. Kerri Winters-Stone|503-494-0813|wintersk@ohsu.edu|
20532682|NCT01560416|Dana-Farber Cancer Institute|Nancy Lin|617-632-2335|Nancy_Lin@dfci.harvard.edu|
20532683|NCT02507284|Azevan Pharmaceuticals, Inc.|Neal Simon, PhD|(610) 419-1057|ngsimon@azevan.com|
20532684|NCT00853047|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
20532685|NCT03018730|Protalix Ltd.|Sari Alon|+972-4-9028100|sari@protalix.com|215
20532686|NCT00254072|UC Irvine Medical Center|Ninh T. Nguyen, M.D.|714-456-8580|ninhn@uci.edu|
20532687|NCT01695772|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20532688|NCT00004859|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20532689|NCT04073407|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
20532690|NCT05136430|Brown University|Cara M. Murphy, Ph.D.|4018636519|murphybrownlab@brown.edu|
20532691|NCT01717859|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
20532692|NCT00899847|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
20532693|NCT02216851|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20532694|NCT00183391|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey H Newcorn|212-659-8705|jeffrey.newcorn@mssm.edu|
20532695|NCT02336503|Botanix Pharmaceuticals|Vice President, Head of Development|+1 (445) 300-3403|trials@botanixpharma.com|
20532696|NCT03712618|National Institutes of Health, Clinical Center (NIH CC)|Dr. Willy Flegel|+1 301 594 7401|bill.flegel@nih.gov|
20532697|NCT01478087|Mayo Clinic|Jeffrey Lawrence Winters, MD|507-538-1707|winters.jeffrey@mayo.edu|
20532698|NCT02618187|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|617-945-9626|mtrucksis@serestherapeutics.com|
20532699|NCT04584554|Duke University School of Nursing|Tolu Oyesanya, PI of study|919-684-5292|tolu.oyesanya@duke.edu|
20532700|NCT01254877|JohnHopkinsU|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
20532701|NCT02583477|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20532702|NCT05507450|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20532703|NCT02904356|Baylor College of Medicine|Sameer Sheth, MD, PhD|713-798-4696|sasheth@bcm.edu|
20532704|NCT05436288|Kiora Pharmaceuticals, Inc.|Eric Daniels|858-353-0469|edaniels@kiorapharma.com|
20532705|NCT03948386|Thomas Jefferson University|Eric S Schwenk, MD|215-955-6161|eric.schwenk@jefferson.edu|
20532706|NCT01118091|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20532707|NCT00464464|Rutgers- Robert Wood Johnson Medical School|Dr. Roseanne Dobkin|732-235-4051|dobkinro@rutgers.edu|
20532708|NCT03767894|Columbia University|Dr. Joel Stein|(212) 305-4818|js1165@columbia.edu|
20532709|NCT03501277|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20532710|NCT04097223|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20532711|NCT01222351|Columbia University|Yaakov Stern|212-342-1350|ys11@columbia.edu|
20532712|NCT01436500|Cumberland Pharmaceuticals Inc|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
20532713|NCT05610267|Integra LifeSciences|Dr. Dennis Adam Young|443 766 2569|dennis.young@integralife.com|
20532714|NCT01873833|USC Norris Comprehensive Cancer Center|Victoria Soto, Regulatory Administrator|323-865-0432|Victoria.Soto@med.usc.edu|
20532715|NCT03055507|University of Washington, Department of Otolaryngology - Head & Neck Surgery|Dr. Greg Davis, Director of Rhinology and Skull Base|(206) 598-4022|GEDavis@uw.edu|B
20532716|NCT04560309|Nationcal Cardiovascular Center Harapan Kita|I Made Adi Parmana, M.D.|+62 812-4601-212|adiparmana13@gmail.com|
20532717|NCT04146909|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
20532718|NCT01860404|Children's Hospital of Philadelphia|Dr. Daniel Corwin|215-327-2306|corwind@chop.edu|
20532719|NCT00632970|Medical Faculty Associates|Gary Simon|202 741-2234|Gsimon@mfa.gwu.edu|
20532720|NCT00676689|Edwards Lifesciences|Sharanjeet Dhanjal|949-250-2083|sharanjeet_dhanjal@edwards.com|
20532721|NCT01106950|Masonic Cancer Center, University of Minnesota|Jeffrey S. Miller, M.D.|612-625-7409|mille011@umn.edu|
20532722|NCT00356421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20532723|NCT00567112|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532724|NCT04689009|EMOLED SRL|Dr. Rossi Degl'Innocenti Duccio, Clinical Affairs Manager|+390550751960|d.rossi@emoled.com|
20532725|NCT05089357|Q-Med AB|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20532726|NCT04906421|Sagimet Biosciences, Inc.|Study Director|650-561-8675|sitecontact@sagimet.com|
20532727|NCT04796207|University of Arizona|Floyd H. Chilton|520-621-5327|fchilton@arizona.edu|
20532728|NCT03003468|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20532729|NCT04203056|University of California, Los Angeles|Kenneth Subotnik, PhD|3108250334|ksubotnik@mednet.ucla.edu|
20532730|NCT00421993|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20532731|NCT02193152|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5737|danielmorgensztern@wustl.edu|
20532732|NCT00165698|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
20532733|NCT02641353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20532734|NCT02547935|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20565563|NCT02039401|Helixmith, LLC|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20565564|NCT04479514|DFCI|Jennifer Huang|6173558937|jennifer.huang@childrens.harvard.edu|
20565565|NCT04427007|Liberating Technologies, Inc.|Brianna Rozell|774-233-0876|brianna.rozell@liberatingtech.com|
20565566|NCT04165213|University of Pennsylvania, School of Nursing|Emily Summerhayes, Project Manager|6099233786|esummer@nursing.upenn.edu|
20565567|NCT04464564|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|smb_clinicaltranspa@otsuka-us.com|
20565568|NCT05512650|Tufts University|Nancy Baker, Professor|617 627 5562|nancy.baker@tufts.edu|
20565569|NCT03364127|University of Illinois Chicago|Judith M. Schlaeger, PhD, CNM, LAc, FAAN|(312) 413-4469|jschlaeg@uic.edu|
20565570|NCT04466098|University of Minnesota, Masonic Cancer Center|Dr. David Ingbar|612-624-9452|ingba001@umn.edu|
20565571|NCT04389957|San Francisco Veterans Affairs Medical Center|Dr. Tonya Kaltenbach|(415) 221-4810|tonya.kaltenbach@va.gov|24406
20565572|NCT04214860|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20565573|NCT04282980|Zai Lab|Medical Director|+86 4008201022|Medinfo@zailaboratory.com|
20565574|NCT03938246|Sagimet Biosciences Inc.|Study Director|650-561-8675|sitecontact@sagimet.com|
20565575|NCT04881461|ALK-Abelló A/S|Senior Director, Clinical Data Science, Global Clinical Development|+4545747576|clinicaltrials@alk.net|
20565576|NCT04938726|University of Alabama at Birmingham|Dr. Eric P. Plaisance|2057090980|plaisep@uab.edu|
20565577|NCT04055012|The University of Pittsburgh|Study Coordinator|412-692-2084|kesslerl@upmc.edu|
20565578|NCT05633147|Cinclus Pharma Holding AB|Kajsa Larsson, CMO|+46 706750128|kajsa.larsson@cincluspharma.com|
20565579|NCT03188692|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp, clinicaldevelopment@mail.biken.or.jp|
20565580|NCT01474122|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
20565581|NCT03652272|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
20565582|NCT02326974|Dana-Farber Cancer Institute|Project Manager|617-632-3500|ctopm@dfci.harvard.edu|
20565583|NCT02577354|Mainstay Medical|Vice President Clinical Affairs|7637727637|diane.burnside@mainstay-medical.com|
20565584|NCT04801368|Mayo Clinic|Dr. Matthew Ziegelmann|507-266-3982|Ziegelmann.Matthew@mayo.edu|
20565585|NCT05043064|Aalborg University Hospital|Dr Gennady V Atroshchenko|97 66 46 49|g.atroshchenko@rn.dk|45
20565586|NCT04947137|Navidea Biopharmaceuticals|Senior Medical Director|6149737555|mblue@navidea.com|
20565587|NCT06097494|Pfizer Ltd|Ranjit Nagra|01304 616161|ranjit.nagra@pfizer.com|
20565588|NCT05683158|Department of Physiotherapy, University of Valencia|PI. Jose Casaña Granell|+34 656-437-371|jose.casana@uv.es|
20565589|NCT04490109|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20565590|NCT03372057|Secura Bio, Inc.|Ohad Bentur, MD, MHA, MSc|1-702-254-0011|obentur@securabio.com|
20565591|NCT01768013|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
20565592|NCT05112900|Huntsman Cancer Institute at the University of Utah|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu|
20532735|NCT01398475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532736|NCT00086307|NIMH|Dr. Carlos A. Zarate|301-451-0861|zaratec@mail.nih.gov|
20532737|NCT01767285|Duke University|Dr. Beverly Gray|919-684-8111|beverly.gray@dm.duke.edu|
20532738|NCT03888274|Tivic Health Systems|Blake Gurfein|5615737652|blake.gurfein@tivichealth.com|
20532739|NCT01727154|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
20532740|NCT00003474|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20532741|NCT03020888|Endomag|Dr Matthew Womack|+44 7851 247439|mwomack@endomag.com|
20532742|NCT01799278|Weill Cornell Medical College|Dr. Himisha Beltran|(646) 962-2072|GUONC@med.cornell.edu|
20532743|NCT01184118|UW Madison|Mihaela Teodorescu, MD|608-256-1901|mt3@medicine.wisc.edu|
20532744|NCT05067270|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20532745|NCT03461861|Medical College of Wisconsin|Dr. Yang Wang|4149555473|yangwang@mcw.edu|
20532746|NCT01198548|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20532747|NCT01455519|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
20532748|NCT01271855|Northwestern University|Kimberly Kenton MD, MS|312-472-3874|kkenton@nm.org|
20532749|NCT02186171|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20532750|NCT00574353|Memorial Sloan Kettering Cancer Center|Dr. John Humm, PhD|212-639-7367|hummj@MSKCC.ORG|
20532751|NCT02015104|National Cancer Institute|Dr. Raju Chelluri|240-858-3700|raju.chelluri@nih.gov|
20532752|NCT01301092|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532753|NCT03334175|UCSF|Meghana Gadgil|4153537922|meghana.gadgil@ucsf.edu|
20532754|NCT01350973|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20532755|NCT03738215|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20532756|NCT02638493|University of North Carolina at Chapel Hill|Julie B. Dumond, PharmD, MS, BCPS, AAHIVP|919-966-5017|jdumond@unc.edu|
20532757|NCT00126737|Edward Hines, Jr. VA Hospital|Elly Budiman-Mak, MS MPH MD|708-202-2414|elly.mak@va.gov|
20532758|NCT02724644|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
20532759|NCT04193176|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20532760|NCT00944645|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532761|NCT05715346|Levation Pharma|Houman Hemmati, M.D., Ph.D.|424 274 2642|info@levationpharma.com|
20532762|NCT03928704|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20532763|NCT01245751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532764|NCT01783015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532765|NCT02320825|Memorial Sloan Kettering Cancer Center|Dr. Ilya Laufer, MD|212-639-2368|lauferi@mskcc.org|
20532766|NCT01045265|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
20532767|NCT01428713|Baylor College of Medicine/TCH|Dr. Lakshmi Srivaths|832-822-1514|lvsrivat@txch.org|
20532768|NCT00289978|Novartis Pharmaceuticals|Study Director|862 778-8300||
20532769|NCT00903344|University of Kansas Medical Center|Dr. Leigh Eck|913-588-6022|leck2@kumc.edu|
20532770|NCT03055221|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20532771|NCT01243424|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20532772|NCT02011464|Maimonides Medical Center|Dr. Piyush M Gupta|7182837189|pgupta@maimonidesmed.org|
20532773|NCT01215240|University of Alberta|Dr. Lindsay Ryerson|780 407 3396|ryerson@ualberta.ca|780
20532774|NCT01160744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20532775|NCT04366583|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|Dr. Huay-Min Wang|+886-7-3422121|hmwang@vghks.gov.tw|2075
20532776|NCT00500110|MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
20532777|NCT03646188|Medicus Pharma|Dr. Huma Qamar, MD., Chief Scientific Officer|610- 540-7515|hqamar@medicuspharma.com|106
20532778|NCT03791060|Beth Israel Deaconess Medical Center|Co-Director Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS)|6176675834|mporter3@bidmc.harvard.edu|
20532779|NCT02421510|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20532780|NCT02852434|Stanford University Division of Family Planning Services and Research|Stanford University, Department of OB/GYN|6507211562|familyplanningresearch@stanford.edu|
20532781|NCT05075772|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20532782|NCT03203512|University of Reading|Professor Parveen Yaqoob|+443787113|p.yaqoob@reading.ac.uk|
20532783|NCT01058005|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20532784|NCT01698008|University of Nebraska Medical Center|Whitney Goldner|402-559-3579|wgoldner@unmc.edu|
20565593|NCT05496140|UCSF|Lauren M. Haack|415-502-8060|lauren.haack@ucsf.edu|
20565594|NCT05386589|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20565595|NCT02919917|Icahn School of Medicine at Mount Sinai|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
20565596|NCT04743973|Mayo Clinic|Dr. Ivana T. Croghan|507-284-2511|GIMRESEARCHSTUDIES@mayo.edu|
20565597|NCT06412965|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565598|NCT03998488|Weill Cornell Medicine|Dr. Randy Longman|646-962-6289|ral2006@med.cornell.edu|
20565599|NCT01756300|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
20565600|NCT04678856|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20565601|NCT04244175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20565602|NCT03417284|The University of Texas MD Anderson Cancer Center|Qaiser Bashir, MD / Stem Cell Transplantation|713-794-4422|QBashir@mdanderson.org|
20532785|NCT02287025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20532786|NCT04053452|Duke University|Natalia Gonzalez, MD|919-684-5422|natalia.gonzalez@duke.edu|
20532787|NCT00122187|VAHSRD|Linda Humphrey|503-220-8262|linda.humphrey@va.gov|57176
20532788|NCT03099863|MetroHealth Medical Center|Dr. Jeffrey Mangel|2167784444|jmangel@metrohealth.org|
20532789|NCT00580294|Icahn School of Medicine at Mount Sinai|Marco Pappagallo, MD|212-241-7749|dionne.bobb@mountsinai.org|
20532790|NCT05574764|Duke University|Emily M. D'Agostino, DPH, MS, MEd, MA|646-853-1223|emily.m.dagostino@duke.edu|
20532791|NCT03528577|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
20532792|NCT04882215|University of Glasgow|Professor Jonathan Evans|0141 330 3299|Jonathan.Evans@glasgow.ac.uk|
20532793|NCT03911687|Columbia University|Sarah Collins Rossetti, PhD|2123056605|sac2125@cumc.columbia.edu|
20532794|NCT04098302|UConn Health|Jonathan Covault Study PI|860-679-7560|jocovault@uchc.edu|
20532795|NCT04402957|Arch Biopartners Inc.|Richard Muruve|647-428-7031|rm@archbiopartners.com|
20532796|NCT05061706|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
20532797|NCT01584388|MGH Rheumatology|John H Stone|617-726-7938|jhstone@partners.org|
20532798|NCT02043847|University of Illinois at Chicago|Dr. Rondelli|312-996-6179|drond@uic.edu|
20532799|NCT03362957|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20532800|NCT04246476|Washington University in St. LOuis|Gammon Earhart|3142861407|earhartg@wustl.edu|
20532801|NCT02181738|Bristol Myers Squibb|Bristol Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
20532802|NCT01668537|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20532803|NCT01968317|Obstetrics and Gynecology Hospital of Fudan University|Xiaojun Chen|33189900|xiaojunchen2013@sina.com|
20532804|NCT00191152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20532805|NCT00114777|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20532806|NCT04219774|Duke University|David Hasan, MD, MSc|919-684-7777|david.hasan@duke.edu|
20532807|NCT01181128|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20532808|NCT02371252|Mahidol University|Dr. Aasis Unnanuntana|+66836871159|uaasis@gmail.com|
20532809|NCT04477486|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20532810|NCT01543503|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20532811|NCT02460380|Maimonides Medical Center|Mohamad Irani|3472862167|mohamad.irani@hotmail.com|
20532812|NCT02957123|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD|+7 (383) 236-03-29|ostanin62@mail.ru|
20532813|NCT04576949|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20532814|NCT00052715|North American Brain Tumor Consortium|Michael Prados, MD|410-955-8837|jfisher@jhmi.edu|
20532815|NCT01936974|CTCA|Jessica Coats, RN|6232073899|jessica.coats@ctca-hope.com|
20532816|NCT00986583|Cleveland Clinic|Alparslan Turan, M.D.|216-444-4000|turana@ccf.org|9857
20532817|NCT01853085|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20532818|NCT01708525|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20532819|NCT02280499|Smith & Nephew|Evita Leiber, Clinical Study Manager|+41 41 766 2205|evita.leiber@smith-nephew.com|
20532820|NCT01482286|Pennington Biomedical Research Center|Dr. Joshua R. Sparks|2257632928|joshua.sparks@pbrc.edu|
20532821|NCT02826551|Cedars-Sinai|Josh Page|3104233198|josh.page@cshs.org|
20532822|NCT01109381|Synergy Pharmaceuticals Pte Ltd|Medical Director|+64 9 522 4278|damian@pethica.net|
20532823|NCT02018809|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
20532824|NCT05254210|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20532825|NCT03511066|Celltrion|Clinical Planning Department Leader|82328505000|contact@celltrion.com|
20532826|NCT01270867|Concentric Medical / Stryker Neurovascular Inc|Paula Schmidt, Clinical Project Manager|510-413-2271|paula.schmidt@stryker.com|
20532827|NCT00625729|Masonic Cancer Center, University of Minnesota|Veronika Bachanova, M.D.|612-625-5469|bach0173@umn.edu|
20532828|NCT05085405|University of Michigan|Dr. Jacob E Kurlander, MD, MS|734-647-9252|jkurland@umich.edu|
20532829|NCT05001165|VA Greater Los Angeles|Boback Ziaeian|310-478-3711|boback.ziaeian@va.gov|
20532830|NCT04193527|GE Healthcare Ltd.|Yongqing Tang, MD, PhD|21 38774044|Yongqing.Tang@ge.com|+86
20532831|NCT03808909|University of New Mexico, Health Sciences Center|Pilar Sanjuan|505/272-7055|psanjuan@salud.unm.edu|
20532832|NCT01827943|Institut Bergonie|Dr Nadine Houede, oncologist|05.56.33.33.33|nadine.HOUEDE@chu-nimes.fr|
20532833|NCT00501085|Apollo Endosurgery, Inc.|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
20532834|NCT01487161|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20532835|NCT00663351|Smith & Nephew, Inc.|Rachael Winter, Director, Global Clinical Operations|+44 1482 673475|rachael.winter@smith-nephew.com|
20532836|NCT03113136|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20532837|NCT02362412|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
20532838|NCT00977561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532839|NCT04159480|University of Colorado, Anschutz Medical Campus|Lisa Brenner|7208481980|lisa.2.brenner@cuanschutz.edu|
20532840|NCT02021318|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
20532841|NCT00689052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20532842|NCT02405962|The Hong Kong Polytechnic University|Dr. Yim Wah Mak|(852) 2766-6421|yw.mak@polyu.edu.hk|
20532843|NCT03601052|Viridian Therapeutics (formerly miRagen Therapeutics)|Regulatory Affairs|720-722-5917|clinicaltrials@viridiantherapeutics.com|
20565603|NCT03636490|Columbia University Irving Medical Center|Daichi Shimbo|‭(646) 317-0305‬|ds2231@cumc.columbia.edu|
20532844|NCT00837330|Southeast Retina Center, P.C.|Dr. Dennis M Marcus Principal Investigator|706-650-0061|dmarcus@southeastretina.com|
20532845|NCT05894564|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20532846|NCT03882801|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20532847|NCT01567085|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc. (Sponsor)||clinicaltrials@alexion.com|
20532848|NCT03150797|UCSF|Dr. Amy Gelfand|415-502-1914|amy.gelfand@ucsf.edu|
20532849|NCT03537729|Grand Valley State University|Dr. Rebecca Davis|616.331.3079|davirebe@gvsu.edu|
20532850|NCT03404167|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
20532851|NCT01148420|Harbor - UCLA Medical Center|Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
20532852|NCT03403517|Rigshospitalet|Kristin steinthorsdottir|004531666112|kjs@dadlnet.dk|
20532853|NCT01389284|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
20532854|NCT00504556|Daiichi Sankyo Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
20532855|NCT00676052|GlaxoSmithKline|GSK Response Center|866-435-7343||
20532856|NCT02930941|University of California, Davis Medical Center|Aimee Moulin, MD|916-703-6110|akmoulin@ucdavis.edu|
20532857|NCT02979054|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
20532858|NCT00382928|Atlanta Research and Education Foundation|Dr. A. Maziar Zafari|404-321-6111|azafari@emory.edu|4019
20532859|NCT00585169|Yale Unviersity|Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
20532860|NCT03794323|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20532861|NCT01034527|Mayo Clinic|Dr. Timothy Hewett|513-636-5971|hewett.timothy@mayo.edu|
20532862|NCT00299221|Newark Beth Israel Medical Center|David Baran MD|973-926-7205|dbaran@barnabashealth.org|
20532863|NCT01964560|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20532864|NCT03926598|Research Scientist|Jiten Chhabra|4048942000|jiten@imtc.gatech.edu|
20532865|NCT00710554|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20532866|NCT01093885|University of Pennsylvania Health System|Dr. Chris Derk|215-662-2792|chris.derk@uphs.upenn.edu|
20532867|NCT01301001|University of Tennessee Health Science Center|Dr. Candace Brown|9014124341|CSBROWN@TENNESSEE.EDU|
20532868|NCT01560988|Brigham and Women's Hospital|Dr. Joshua Boyce|617-525-1261|jboyce@partners.org|
20532869|NCT03737032|University of Pittsburgh Medical Center, Department of Psychiatry|Dr. Erika Forbes|412-383-5438|forbese@upmc.edu|
20532870|NCT02301429|Medtronic Regional Clinical Center|Clinical Study manager|0039(0)22 241371|laura.manotta@medtronic.com|
20532871|NCT01502072|UT MD Anderson Cancer Center|Roy F. Chemaly, MD,MPH- Professor, Infectious Diseases|(713) 745-1116|rfchemaly@mdanderson.org|
20532872|NCT01368185|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532873|NCT04250363|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20532874|NCT01507103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20532875|NCT04535362|Yale School of Medicine|Mehmet Sofuoglu, MD, PhD: Professor of Psychiatry; Director of VA New England Mental Illness Researc|(203) 937-4809|mehmet.sofuoglu@yale.edu|
20532876|NCT03611062|University of Massachusetts Lowell|Dr. Jiabin Shen|978-934-3965|jiabin_shen@uml.edu|
20532877|NCT02018887|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20532878|NCT01145222|PAION UK Ltd|Trial Information||reg_paion@paion.com|
20532879|NCT00927186|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532880|NCT00604383|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
20532881|NCT02053584|Wolfson Medical Center|Dr. Julio Weinstein|972-3-5028371|vainstein@wolfson.health.gov.il|
20532882|NCT00508300|lausanne university hospital|martin hübner|+41795561506|martin.hubner@chuv.ch|
20532883|NCT01011283|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
20532884|NCT00943202|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
20532885|NCT00290758|NorthwesternU|Seema Khan, MD|312-695-0288|skhan@nmh.org|
20532886|NCT01556100|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
20532887|NCT03677180|Henry Ford Hospital|Dr. Mir Babar Basir|313-916-2896|mbasir1@hfhs.org|
20532888|NCT04786600|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20532889|NCT01509807|University of South Florida|Jorge Marcet, MD|813-844-4545|jmarcet@health.usf.edu|
20532890|NCT02187055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532891|NCT03336866|InterveXion Therapeutics|Chief Operating Officer|5015542377|misty.stevens@intervexion.com|
20532892|NCT01666314|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20565604|NCT04079972|Dongguk University|Dr.NaNa Keum|+82 10-6793-6654|nak212@mail.harvard.edu|
20565605|NCT06237686|Medical Consultant|Principal Investigator: Søren Meisner, MD|+4520117378|sm_meisner@hotmail.com|
20565606|NCT04734197|Surface Ophthalmics, Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
20565607|NCT02095691|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
20565608|NCT00887198|Janssen R&D US|SENIOR DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
20565609|NCT03967379|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
20565610|NCT03329937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20532893|NCT04501445|Rush University Medical Center|Jared A Greenberg|312-942-6744|jared_greenberg@rush.edu|
20532894|NCT02512445|UCSD|Dr. Sonya Norman|858-518-8266|snorman@ucsd.edu|
20532895|NCT02082288|al-azhar university|wael mohamed hamed|002-01001556162|wael79hamed@yahoo.com|
20532896|NCT03462563|Ethicon SARL|Richard Kocharian|+1 609 6423787|rkochar1@its.jnj.com|
20532897|NCT05737745|Virginia Tech Carilion Clinic|Shannon Armbruster MD, MPH|540-581-0160|sdarmbruster@carilionclinic.org|
20565611|NCT04442165|Insitute of Tropical Medicine|Brecht Ingelbeen|+32(0)33455787|bingelbeen@itg.be|
20565612|NCT01223352|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
20565613|NCT05960032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20565614|NCT05830799|Vicore Pharma AB|Cecilia Ganslandt, MD, MSc|+46 31788 05 60|info@vicorepharma.com|
20565615|NCT04173247|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
20565616|NCT02163694|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20565617|NCT05061017|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20565618|NCT04369911|HealthPartners Institute|Amanda Herrmann, PhD|6514956565|amanda.a.herrmann@healthpartners.com|
20565619|NCT03817983|Addenbrookes Hospital, Cambridge, UK|Dr Deepak Jadon|01223 805000|deepak.jadon@addenbrookes.nhs.uk|
20565620|NCT03744676|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20565621|NCT04078152|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20565622|NCT05990335|Kansas State|Study Director|(785) 532-6850|external+studydirector@nxtech.co|
20565623|NCT04099732|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565624|NCT05454514|HIDO TECHNOLOGIES, INC.|Charles Gellman, CEO|5108137224|charles@hidohealth.com|
20565625|NCT05541484|Washington University School of Medicine|Janet McGill, Professor Medicine|314-273-3929|jmcgill@wustl.edu|
20520714|NCT00507546|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
20520715|NCT02384850|GSO Global Clinical Research B.V., EBC Amsterdam, Keizersgracht 62-64, 1015 CS Amsterdam|Dr. Anne L. Kranich|+49 40 44 19 54 60|kranich@gsoglobal.com|
20520716|NCT01524302|Michigan State University|Dr. Gary E. Stein|517-353-5126|steing@msu.edu|
20520717|NCT00986453|Medtronic Surgical Technologies|Robert Swain, PhD|+1 (603) 294-5428|robert.e.swain@medtronic.com|
20520718|NCT03512262|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
20520719|NCT01418482|Uppsala Akademiska Hospital, Dept. of Plastic Surgery|Fredrik Huss|+46 771 405 405|Fredrik.Huss@surgsci.uu.se|
20520720|NCT00375492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20520721|NCT03303625|Janssen Vaccines and Prevention B.V.|Trial Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20520722|NCT04319718|University of Pittsburgh|Dr. Leslie Meyn, Research Assistant Professor|412-641-4233|meynla@mwri.magee.edu|
20520723|NCT05392907|INAIL|Ing. Emanuele Gruppioni|+39 051 6936 609|e.gruppioni@inail.it|
20520724|NCT03340064|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20520725|NCT02221037|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20520726|NCT00321828|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
20520727|NCT02307266|Galderma|Gaëlle Charier|+33 4 93 95 70 68|gaelle.charier@galderma.com|
20520728|NCT03474432|Jesse Brown VAMC|Dr. Mladen Vidovich, study PI|312-996-6730|miv@uic.edu|
20520729|NCT02944383|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
20520730|NCT01453894|Northwestern University Feinberg School of Medicine|David W. Baker, MD, MPH|312-503-6400|dbaker1@nmff.org|
20565626|NCT05785130|ChangGung Memorial Hospital|Ya-Ching, Nien|+886 913112012|yaching79@cgmh.org.tw|
20565627|NCT02624050|Milton S. Hershey Medical Center|Dr. Anthony Bonavia|717-531-6140|abonavia@pennstatehealth.psu.edu|
20565628|NCT02785991|Medtronic Ibérica|Patricia Pascual|636183869|patricia.pascual@medtronic.com|
20565629|NCT04157517|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20565630|NCT01536938|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20565631|NCT03279978|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565632|NCT00329836|Doylestown Hospital|Abraham Ashkenazi, M.D./ Prinicpal Investigator|215-625-2894|aashkenazi@yahoo.com|
20565633|NCT04780581|IBSAL|Project manager|+34 923 29 11 00|uicec.coordinacion@ibsal.es|55779
20565634|NCT01651000|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
20565635|NCT03734029|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20565636|NCT05883345|Konkuk University Medical Center|Sun-Young Lee|82-2-2030-7747|sunyoung1973.lee@gmail.com|7505
20520731|NCT00256984|Ethicon Endo-Surgery|Susan Knippenberg, Clinical Scientist|513 337-3452|sknippen@its.jnj.com|
20520732|NCT00858143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20520733|NCT00090610|Duke University Medical Center|Angeles Alvarez Secord, Director of Gynecologic Oncology Clinical Trials|919-684-3765|secor002@mc.duke.edu|
20520734|NCT02802449|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
20520735|NCT03882528|Walter Reed Army Institute of Research|Dr. James Moon, Principal Investigator|301-319-9176|James.e.moon.mil@mail.mil|
20520736|NCT00609518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20520737|NCT05855616|Marques de Valdecilla University Hospital|Raquel Pelayo Alonso, Head Nurse of Nephrology, RN|+34 649443488|raquel.pelayo@scsalud.es|
20520738|NCT04032158|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@merckgroup.com|
20520739|NCT00059787|Montefiore Medical Center - New York Cancer Consortium|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
20520740|NCT03667014|UCSF|Tina Bhutani|4153537800|tina.bhutani@ucsf.edu|
20520741|NCT04421586|Duke University|Lavanya Vasudevan, Ph.D.|919-613-1423|lavanya.vasudevan@duke.edu|
20520742|NCT01968694|Brigham & Women's Hospital|Dr. Antje M Barreveld|617-243-6298|abarreveld@partners.org|
20520743|NCT00846521|Yale University School of Medicine|Tania Burgurt, MD|203-785-7152|tania.burgurt@yale.edu|
20520744|NCT00119067|CDC|Jennifer G Wright||jgwright@cdc.gov|
20520745|NCT03052959|Unity Health Toronto|Dr. Aisha Lofters|4163236400|aisha.lofters@utoronto.ca|3832
20520746|NCT02032706|Advanced Brain Monitoring, Inc.|Daniel Levendowski|760 720 0099|dan@b-alert.com|x6040
20520747|NCT00928707|Italfarmaco SpA|Carlo Bianchini, MD|+39 02 6443 2540|c.bianchini@italfarmaco.com|
20520748|NCT03562559|Vancouver General Hospital|Marcus Tholin|604-875-4111|marcus.tholin@vch.ca|
20520749|NCT00160641|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20520750|NCT00985712|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20520751|NCT03736928|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
20520752|NCT03844789|University of Virginia Center for Diabetes Technology|Marc Breton|434-982-6484|mb6nt@virginia.edu|
20520753|NCT00359632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520754|NCT01875471|Johnson & Johnson Vision Care|Daria Wicks|1 904 443-1391|RA-VISUS-ClnclStds@its.jnj.com|
20520755|NCT02931045|1st Chair and Department of Cardiology, Medical University of Warsaw|Aleksandra Gasecka, MD, PhD|+48225991951|alesandra.gasecka@wum.edu.pl|
20520756|NCT03978091|ARLG - Albany College of Pharmacy and Health Sciences|Thomas Lodise, PharmD, PhD|1 (518) 694-7292|Thomas.Lodise@acphs.edu|
20520757|NCT02477774|University of California, San Francisco|Rahul Seth, MD|415-353-9500|Rahul.Seth@ucsf.edu|
20520758|NCT02324673|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20520759|NCT02214420|Scripps Clinic|Dr. Paul Pockros|(858) 554-8879|Pockros.paul@scrippshealth.org|
20520760|NCT04700280|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20520761|NCT01843348|Novartis Pharmaceuticals|Study Director|862-779-8300||
20520762|NCT00251641|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20520763|NCT00257920|Abbott|Medical Information Specialist|1-800-633-9110||
20520764|NCT00770692|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
20520765|NCT01230892|Emory University|Dr. Habib Samady|404-778-5299|hsamady@emory.edu|
20520766|NCT00679913|Seoul National University Hospital|Sun-Whe Kim, M.D., Ph.D., FACS|82-2-2072-2310|sunkim@plaza.snu.ac.kr|
20520767|NCT00725621|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20520768|NCT01189500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520769|NCT00062751|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20520770|NCT01000493|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520771|NCT03629028|Principal investigator of the research|Şafak Yılmaz Baran, MD|+903224586868|safakyilmazbaran@gmail.com|
20520772|NCT01635062|Brigham and Women's Hospital|Dr. Anand Vaidya (Asst Professor of Medicine)|6175258285|avaidya1@partners.org|617
20520773|NCT03828448|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20520774|NCT05069155|University of Pennsylvania|Clinical research coordinator|7574471579|aileen.oon@pennmedicine.upenn.edu|
20520775|NCT02206620|Oregon Health & Science University|Dr. Martina Mancini|5034182602|mancinim@ohsu.edu|
20520776|NCT01929031|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520777|NCT02150759|Inje University, Haeundae paik hospital|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
20520778|NCT05816200|Federal University of Rio Grande do Norte|PhD Cristianne Kalinne Santos Medeiros|+55(84)3342-2341|cristiannekalinne@gmail.com|
20520779|NCT01366443|University of Utah Medical Center, Dept. of OB/GYN|Dr. Michael Draper, MD University of Utah Medical Center, Dept. of OB/GYN|801-581-7647|mike.draper@hsc.utah.edu|
20520780|NCT02394730|University of New South Wales|Sean Emery, Chief Principal Investigator|+61 2 9385 0897|s.emery@unsw.edu.au|
20520781|NCT01111019|Merck Healthcare, a business of Merck KGaA|Merck KGaA Communication Center|+49 6151 72 5200|service@merckgroup.com|
20520782|NCT02664545|Miach Orthopaedics|Rita Paparazzo|1-800-590-6995 x107|rpaparazzo@miachortho.com|
20520783|NCT04062448|Janssen Pharmaceutical K.K.|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20520784|NCT04710979|University of Minnesota|Dr. Daheia J. Barr-Anderson|240-475-2806|barra027@umn.edu|
20520785|NCT03535675|Johns Hopkins University|Channing Paller; M.D.|4109558239|cpaller1@jhmi.edu|
20520786|NCT00912093|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20520787|NCT02070302|Arizona Arthritis & Rheumatology Research, PLLC|Amanda Santimaw|4806266653|amanda.santimaw@azarthritis.com|
20520788|NCT00891371|Ipsen|Medical Director, Gastroenterology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20520789|NCT00307034|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520790|NCT00971841|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20520791|NCT00026221|The Ohio State University Comprehensive Cancer Center|William E. Carson III, MD|614-293-6306|William.Carson@osumc.edu|
20520792|NCT00967044|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD / Assistant Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
20520793|NCT00450619|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
20520794|NCT02034058|Stryker Neurovascular|Alice Lin, Clinical Program Manager|510 413 2673|alice.lin@stryker.com|
20520795|NCT02836496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20520796|NCT00063635|Columbia University Medical Center|Joel E. Lavine, MD, PhD||jl3553@columbia.edu|
20520797|NCT01663935|University of Wisconsin, Madison|Dr Michael Struck|608 263-6429|mcstruck@wisc.edu|
20520798|NCT02075671|The George Washington University, Medical Faculty Associates|Dermatology Research Fellow|202-741-2632|knelson@mfa.gwu.edu|
20520799|NCT03300544|M D Anderson Cancer Center|Arvind Dasari|(713) 792-2828|adasari@mdanderson.org|
20520800|NCT03914950|Medical University of Graz, Department of Radiology, Division of Nuclear Medicine|Dr. Susanne Stanzel|+43-316-385-81789|susanne.stanzel@medunigraz.at|
20520801|NCT00894738|Washington University School of Medicine|Dr. Ginger Nicol|(314) 362-2461|nicolg@psychiatry.wustl.edu|
20532898|NCT02569242|Ono Pharmaceutical Co. Ltd|Medical Information Center|ー|clinical_trial@ono.co.jp|
20520802|NCT02575911|Alcon, A Novartis Division|Global Brand Med Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20520803|NCT03579966|Catalyst Pharmaceuticals, Inc.|Gary Ingenito, MD, Chief Medical Officer|3054203200|gingenito@catalystpharma.com|
20520804|NCT01249365|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520805|NCT01340768|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520806|NCT02620150|University of Pennsylvania|Chelsea Voytek|215-746-3711|chelseav@pennmedicine.upenn.edu|
20520807|NCT02878486|University of Kansas|Amber Watts, PhD|785-864-2604|amberwatts@ku.edu|
20520808|NCT03056157|VA Boston Healthcare System|Dr. Brett Litz|(617)5849314|brett.litz@va.gov, litzb@bu.edu|
20520809|NCT00140426|University of Colorado School of Medicine, Childrens Hospital Colorado|Jennifer Hagman MD|720-777-2539|jennifer.hagman@childrenscolorado.org|
20520810|NCT00950963|Denver Health|Raymond Estaico, MD|303-860-9900|Ray.Estacio@cpcmed.org|
20520811|NCT01675661|Medical University of South Carolina|Kevin Gray, MD|843-792-6330|graykm@musc.edu|
20520812|NCT04765384|Janssen Vaccines & Prevention B.V.|Vice President Medical Affairs IDV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20520813|NCT00987389|McMaster University, Hamilton, Ontario|Dr. Michael Walsh|905-522-1155|lastwalsh1975@gmail.com|34055
20520814|NCT01342107|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20520815|NCT02992418|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20520816|NCT00289536|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20520817|NCT03246126|NYU Langone Health|Thomas Maldonado|212-263-7311|Thomas.Maldonado@nyulangone.org|
20520818|NCT02468570|BioMarin Pharmaceutical Inc.|Karen Gu/Director, BioStatistics|650-829-4017|kgu@bmrn.com|
20520819|NCT00629265|Boston Medical Center|Dr. Susan Langmore, PhD, Director of Speech Language Pathology|617-414-1753|langmore@bu.edu|
20520820|NCT04465630|SIght Sciences, Inc|Kavita Dhamdhere, MD|877-266-1144|kdhamdhere@sightsciences.com|
20520821|NCT01006135|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520822|NCT02356003|University of Calgary|Frank MacMaster|403-955-2784|fmacmast@ucalgary.ca|
20520823|NCT01912274|Helsinn HealthcareSA|Edwin de Wit - Head of Clinical development|+ 41 919852121|info-HHC@helsinn.com|
20520824|NCT01684436|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20520825|NCT01732484|Medical University of Vienna|Prof. Dr. R. Menapace|+43 699 19660272|rupert.menapace@meduniwien.ac.at|
20520826|NCT01169532|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
20520827|NCT01775865|University of Iowa|Gary Pierce|319-335-9487|gary-pierce@uiowa.edu|
20520828|NCT01087489|Miami Veterans Affairs Medical Center|Dr. Ninel Gregori, MD|305-575-7000|ngregori@med.miami.edu|3081
20520829|NCT01708590|Bausch Health|Study Director|510-259-5284||
20520830|NCT00893737|Clinvest|Rebecca Browning|(417) 841-3664|rbrowning@clinvest.com|
20520831|NCT01156142|Mayo Clinic|Robert C. Miller, M.D.|507/266-6247|Miller.Robert@mayo.edu|
20520832|NCT00132028|SWOG Statistical Center|Study Statistician|206-667-4623||
20520833|NCT02140411|Novartis Pharmaceuticals|Study Director|862-778-1873||
20520834|NCT03584724|Eye Pharma|Elena Meloni|7862187339|elena.meloni@eyepharma.com|
20520835|NCT03981419|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20520836|NCT02337959|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
20520837|NCT01330459|Oregon Health and Science University|Alison Edelman, MD, Assistant Professor|(503) 494-3666|edelmana@ohsu.edu|
20520838|NCT01231399|City of Hope|Paul Frankel, Ph.D.|(626) 218-5265|pfrankel@coh.org|
20520839|NCT02005887|International Breast Cancer Study Group|Meredith M. Regan|+1 617-632-3012|mregan@jimmy.harvard.edu|
20520840|NCT04988152|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20520841|NCT04771403|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
20520842|NCT01615263|Institut universitaire de cardiologie et de pneumologie de Québec, Laval University|Dr Jean S. Bussières, anesthesiologist, director of research|418 656-4870|jbuss@criucpq.ulaval.ca|
20520843|NCT01640873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520844|NCT01321008|University of Texas MD Anderson Cancer Center|Bouthaina Dabaja, MD / Associate Professor, Radiation Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
20520845|NCT02749292|Massachusetts General Hospital- Vasculitis and Glomerulonephritis Center|John L Niles|617-726-4132|JLNILES@mgh.harvard.edu|
20520846|NCT00876018|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520847|NCT00888459|Mayo Clinic|Jon O. Ebbert|507-266-1944|ebbert.jon@mayo.edu|
20520848|NCT00686582|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20520849|NCT03323723|Rinovum Subsidiary 2, LLC.|Clinical Development Manager|7242418932|hwhitelam@rinovum.com|
20520850|NCT01144364|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20520851|NCT03456960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20520852|NCT01346774|University of Michigan|Betsy Foxman, Hunein F. and Hilda Maassab Professor of Epidemiology|734-764-5487|bfoxman@umich.edu|
20520853|NCT00321594|Department of Clinical Oncology, The Chinese University of Hong Kong|Professor Winnie Yeo|852-2632|winnieyeo@cuhk.edu.hk|2118
20520854|NCT03736213|New York University|Dr. Tara McAllister|212-992-9445|tkm214@nyu.edu|
20520855|NCT00609466|Grunenthal|René Allard|49 241 569 3223|Clinical-Trials@grunenthal.com|
20520856|NCT01299805|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20520857|NCT03510182|University of Michigan|Carol Persad|734-615-8112|cpersad@umich.edu|
20520858|NCT01319773|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20520859|NCT05882279|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20520860|NCT01334710|Emory University|Dr. Bassel El-Rayes|404-778-1900|belraye@emory.edu|
20520861|NCT03083821|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20520862|NCT00586482|Mayo Clinic|David O. Warner, MD|507-255-4288|warner.david@mayo.edu|
20520863|NCT00290251|NICHD, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
20520864|NCT04221789|IECS|Dr Fernando Rubinstein|01147778767|frubinstein@iecs.org.ar|
20520865|NCT04385277|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20520866|NCT04905290|Medtronic|James Burrell, Senior Statistician|18006338766|burrej3@medtronic.com|
20520867|NCT03295318|Serum Institute of India Pvt. Ltd.|Abhijeet Dharmadhikari|+91-20-26602855|abhijeet.dharmadhikari@seruminstitute.com|2855
20520868|NCT03747601|BIDMC|Daniel Press, MD Chief of Cognitive Neurology Unit|617-667-4074|dpress@bidmc.harvard.edu|
20520869|NCT05140954|Departments of Global Health and Epidemiology, University of Washington|Kenneth K. Mugwanya, MBChB, MS, PhD|+1 206 520-3800|mugwanya@uw.edu|
20520870|NCT03696953|Marquette University, College of Nursing|Dr. Lisa Hanson|1-414-288-3841|lisa.hanson@marquette.edu|
20520871|NCT03502707|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20520872|NCT00461253|Center for Epidemiology and Health Research, Germany|Dr. Jürgen Dinger|0049 (0) 30 945 101 20|dinger@zeg-berlin.de|
20520873|NCT02766374|Rutgers - Robert Wood Johnson Medical School|Paul M. Lehrer, PhD|(732) 235-4413|lehrer@rutgers.edu|
20520874|NCT00852969|Tufts Medical Center|Mark Sarnak, MD|617 636-1182|msarnak@tuftsmedicalcenter.org|
20520875|NCT02440022|Becton Dickinson (BD)|Heidi Ronhovde|480-597-8579|Heidi.Ronhovde@bd.com|
20520876|NCT02358343|Center for Biomedical Statistics, University of Washington|Tessa Rue, Biostatistician|206-543-4246|ruet@uw.edu|
20520877|NCT00807248|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20520878|NCT00577395|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20520879|NCT04322149|Eledon Pharmaceuticals|Laura Batterman|949-874-3487|lbatterman@eledon.com|
20520880|NCT03716076|BC Women's Hospital|Dr. Anthony Chau|604-875-2158|anton.chau@ubc.ca|
20520881|NCT02135653|University of Pennsylvania|Dr. Neha Vapiwala|(215) 662-2337|Neha.Vapiwala@pennmedicine.upenn.edu|
20520882|NCT01276301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520883|NCT01700049|Mayo Clinic|Dr. Scott Fosko|904-953-2303|fosko.scott@mayo.edu|
20520884|NCT01404078|St John's Research Institute|Dr. Alben Sigamani|+918049467080|alben@sjri.res.in|
20520885|NCT03084367|Philips (Volcano)|Becky Inderbitzen, Global Director, Clinical Development|+1.858.764.1336|becky.inderbitzen@philips.com|
20520886|NCT01206101|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20520887|NCT00569530|University of California, San Francisco|Roberta R. Keller, MD|415-514-3192|roberta.keller@ucsf.edu|
20520888|NCT01859130|Zimmer Biomet|Clinical Research Specialist|5745497606|tim.swanson@zimmerbiomet.com|
20520889|NCT04325204|Emory University|Fayron Epps, PhD, RN|404-727-6936|fepps@emory.edu|
20520890|NCT00903448|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
20520891|NCT00820443|MicroPort Orthepedics|Matt C. Paul, Project Manager|(901) 867-4350|mpaul@ortho.microport.com|
20520892|NCT03426137|University of Maryland School of Nursing|Research Coordinator|410-706-5975|NRSCollocaLab@umaryland.edu|
20520893|NCT00103311|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20520894|NCT03687658|Stanford University|Russell Poldrack, PhD|(650) 497-8488|poldrack@stanford.edu|
20520895|NCT00166036|Emory University|Arshed A Quyyumi, MD|404 712 2741|aquyyum@emory.edu|
20520896|NCT03827564|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20565637|NCT04631016|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20532899|NCT01125748|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20532900|NCT01751685|University of California, San Francisco|Wendy Katzman, PT|415-353-7598|Wendy.Katzman@ucsf.edu|
20532901|NCT01028391|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372||
20532902|NCT01107457|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532903|NCT00694161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532904|NCT00694122|Massachusetts General Hospital|David M. Nathan, MD|617-726-1848|dnathan@partners.org|
20532905|NCT00105508|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
20532906|NCT00683384|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532907|NCT00120874|NYU Langone Medical Center|Barry Reisberg|121-263-8550|barry.reisberg@nyumc.org|
20532908|NCT00845000|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532909|NCT01348490|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20532910|NCT00300495|Houston Methodist Hospital|Min Kim|7134415177|mpkim@houstonmethodist.org|
20532911|NCT00908687|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
20532912|NCT03834883|Purdue University|James E. Tisdale, PharmD|317-880-5418|jtisdale@purdue.edu|
20532913|NCT01030900|National Cancer Institute|Dr. Wyndham Wilson|(240) 760-6092|wilsonw@mail.nih.gov|
20532914|NCT01179399|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20532915|NCT00441896|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
20565638|NCT02506673|Hospital for Special Surgey|Danya DeMeo, Research Assistant|2127742678|demeod@hss.edu|
20520897|NCT00270257|Fred Hutchinson Cancer Research Center|Senior Statistical Analyst|206-667-6167|geetha@scharp.org|
20520898|NCT01195103|Mayo Clinic|John B Leslie MD|480-301-8000|leslie.john@mayo.edu|
20520899|NCT02621034|Zahedan university of medical sciences|Seyed Roholla Havaei|+989215257093|marty_zl@yahoo.com|
20520900|NCT02920918|Virginia Commonwealth University|Salvatore Carbone|804 628 3980|scarbone@vcu.edu|
20520901|NCT03537274|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20565639|NCT04967599|University of Southern California|Susan Luczak, PI of study|2137402203|luczak@usc.edu|
20520902|NCT03254602|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
20520903|NCT03309007|UNewMexico|MArk Burge|5052724658|mburge@salud.unm.edu|
20520904|NCT02963311|The Medicines Company|Frank Bosley, Vice-President, Regulatory Operaions|9732906016|frank.bosley@themedco.com|
20520905|NCT01691820|GlaxoSmithKline|GSK Response Center|866-435-7343|biliana.v.nestorova@gsk.com|
20520906|NCT03426566|Wroclaw Medical University|Dr Sutkowska Edyta|0048503077016|edytasutkowska@yahoo.com|
20520907|NCT04442490|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20520908|NCT00333879|Atlanta VA Rehab R&D Center|David Ross|404-321-6111|rosss0128@bellsouth.net|6817
20520909|NCT02044796|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
20520910|NCT02372071|Hadassah Hospital located in Jerusalem, Israel|PROF. BAR-OZ BENJAMIN|02-6774919|baroz@hadassah.org.il|
20520911|NCT01449279|Stanford Cancer Institute|Dr. Susan J Knox|650-725-2720|sknox@stanford.edu|
20520912|NCT03347422|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20520913|NCT03709823|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20520914|NCT03161964|University of Utah|Dr. Anu Sharma|(801) 581-7761|Anu.Sharma@hsc.utah.edu|
20520915|NCT02038907|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20520916|NCT02737332|SPARC|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
20520917|NCT02252718|Medical University of Warsaw|Katarzyna Wojtyniak|(+48) 223179536|wojtyniakkasia@gmail.com|
20520918|NCT02618408|Supernus|Gianpiera Ceresoli-Borroni, PhD, Director of Clinical Research|301-838-2521|gceresoliborroni@supernus.com|
20520919|NCT01246011|Massachusetts General Hospital|Anne Philip, Data Manager|617 726 0423|alphilip@partners.org|
20520920|NCT01155024|The Ohio Willow Wood Company|Applied Research Engineer|740-869-3377|mariag@owwco.com|
20520921|NCT02397408|University of California, Los Angeles|Albert J. Chang, MD, PhD|(310) 82509771|ajchang@mednet.ucla.edu|
20520922|NCT03551496|Boston Scientific|Dana Hromyak|1 216-526-8534|Dana.Hromyak@bsci.com|
20520923|NCT01524679|IZKS of the University Medical Center of the Johannes Gutenberg University Mainz|Christian Ruckes|+49 6131 17|ruckes@izks-mainz.de|9919
20520924|NCT01551888|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20520925|NCT03801265|University of Pittsburgh|Sharad Khetarpal, MD|4126235020|khetarpalsk@upmc.edu|
20520926|NCT03321630|NYU Langone Health|Paul Oberstein|2127316120|paul.oberstein@nyulangone.org|
20520927|NCT02458092|US Army Medical Research Unit - Kenya|Nekoye Otsyula|254-722-239-828|notsyula@wrp-ksm.org|
20520928|NCT00621049|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20520929|NCT00899470|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20520930|NCT02989168|Global Blood Therapeutics|Nick Vlahakis|16508228756|nvlahakis@gbt.com|
20520931|NCT00532935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20520932|NCT00456495|The New York Eye Cancer Center|Clinic Coordinator|212-832-8170|kchin@eyecancer.com|
20520933|NCT01301508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520934|NCT01300923|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
20520935|NCT03329079|University of Nebraska Medical Center|Kevin Kupzyk|402-552-7262|kkupzyk@unmc.edu|
20520936|NCT01940497|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20520937|NCT02707861|TaiMed Biologics USA Corp.|Manager - Clinical Operations|713-478-2927|bbell@taimedbio.com|
20520938|NCT03123861|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH, Professor of OBGYN|919-966-0014|jennifer_wu@med.unc.edu|
20520939|NCT02494102|Penn State Health Milton S. Hershey Medical Center|Zyad J. Carr, M.D., FASA|717-531-8521|zcarr@pennstatehealth.psu.edu|
20520940|NCT03554603|Memorial University|Peter Daley MD MSc|7097772089|pkd336@mun.ca|
20520941|NCT00448136|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20520942|NCT02287493|University Medical Center Hamburg-Eppendorf|Dr. Christina König|+49 040 7410 -0|ch.koenig@uke.de|
20520943|NCT03407430|University of North Carolina Medical Center|Dr. Benyam Muluneh|919-966-3213|benyam.muluneh@unchealth.unc.edu|
20520944|NCT03218163|SKCCC|Dr. Philip Imus|4109558873|pimus1@jhmi.edu|
20520945|NCT00922987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520946|NCT02811263|University of California, San Francisco|Yvonne W. Wu, MD, MPH|(415) 353-2400|Yvonne.Wu@ucsf.edu|
20520947|NCT04969861|Nektar Therapeutics|Study Director|415-482-5300|StudyInquiry@nektar.com|
20520948|NCT05101486|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20520949|NCT02788045|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20520950|NCT00144781|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20520951|NCT04092894|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|7814750572|bsubrama@bidmc.harvard.edu|
20520952|NCT00541970|GlaxoSmithKline|GSK Response Center|866-435-7343||
20520953|NCT03107026|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20520954|NCT00062010|ECOG Statistical Office|Study Statistician|617-632-3012||
20520955|NCT01183221|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
20520956|NCT02470390|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
20520957|NCT03758404|MeiraGTx|Program Manager|020 3866 4320|CNGA3@meiragtx.com|
20520958|NCT00678041|University of Pittsburgh, UPP13 WH Uro Gynecology - Cor|Gary Sutkin, MD|412--641-1440|gsutkin@mail.magee.edu|
20520959|NCT03596151|Antiviral Research Center, University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
20520960|NCT01700036|University of Michigan Cancer Center|Dr. Pavan Reddy, MD|734-936-8785|reddypr@umich.edu|
20532916|NCT03572218|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Pearl|215-746-5129|rpearl@pennmedicine.upenn.edu|
20532917|NCT03277274|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20532918|NCT06765889|A*STAR|Alessandro Sparacio|80728247|Alessandro_Sparacio@sics.a-star.edu.sg|
20532919|NCT01793129|RTI International|Dr. Abhik Das|301-770-8214|adas@rti.org|
20532920|NCT04128215|University of Florida|Dr. Demetra Christou|3522941715|ddchristou@ufl.edu|
20532921|NCT00324857|VA|Said A. Ibrahim, MD, MPH|215 823 5800|Said.Ibrahim2@va.gov|7163
20532922|NCT00284934|Novartis Pharmaceuticals|Study Director|862-778-8300||
20532923|NCT00454142|National Cancer Centre Singapore|Dr. Wan Teck LIM|65-64368174|dmolwt@nccs.com.sg|
20532924|NCT04634903|Stony Brook University|Dr. Jessica Schleider|917-439-1872|jessica.schleider@stonybrook.edu|
20532925|NCT00476788|Greenville Hospital System|Elaine Moreland MD|8644545661|emoreland@ghs.org|
20532926|NCT01748552|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20532927|NCT02741193|NYU Langone Health|Anli Liu|9294552340|Anli.Liu@nyulangone.org|
20532928|NCT02502383|University of New Mexico Health Sciences|Alberta Kong|505-272-5551|AKong@salud.unm.edu|
20532929|NCT01084759|SKCCC at Johns Hopkins|Dr. Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
20532930|NCT00527748|University of Missouri|Dr. Saul G Trevino|573/884-8840|trevinos@health.missouri.edu|
20532931|NCT02164721|University of Rochester|Valentina Kutyifa MD, PhD|585-275-2676|valentina.kutyifa@heart.rochester.edu|
20532932|NCT02016885|Dermira Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
20532933|NCT01990352|George Washington Cancer Center|Dr. Pavani Chalasani|(202)-741-2277|pavani.chalasani@email.gwu.edu|
20532934|NCT03992482|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
20532935|NCT01975285|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
20532936|NCT03774810|University of Pennsylvania|Michael L. Perlis, PHD|215-746-3577|mperlis@upenn.edu|
20565640|NCT04163991|Horizon Therapeutics USA, Inc.|Ilias Alevizos, PhD, DMD|866-479-6742|clinicaltrials@horizontherapeutics.com|
20565641|NCT03418740|The Children's Hospital of Philadelphia|Dr. David Lynch|215-590-2242|lynchd@pennmedicine.upenn.edu|
20565642|NCT05933772|CooperVision|Jose A. Vega,OD,MSc,FAAO|925-621-3761|jvega2@coopervision.com|
20565643|NCT04881110|University of Campania Luigi Vanvitelli|Prof. Katherine Esposito, Head of the Division of Endocrinology and Metabolic Diseases|+390815665031|katherine.esposito@unicampania.it|
20565644|NCT01475786|Helixmith|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20565645|NCT01897441|Albert Einstein College of Medicine|Dr. Jesus Anampa Mesias|718-405-8505|janampa@montefiore.org|
20565646|NCT04159519|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20565647|NCT01499368|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
20565648|NCT02765412|VA Ann Arbor Healthcare System|Angela Larkin|734-845-3612|angela.larkin@va.gov|
20565649|NCT03781089|Duke University Medical Center|Dr. John Middleton|919-684-8111|j.p.middleton@duke.edu|
20565650|NCT02246127|Grupo Español de Tumores Neuroendocrinos y Endocrinos (GETNE)|GETNE Secretary|0034934344412|getne@getne.org|
20565651|NCT03635567|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20565652|NCT04310423|University of California, Los Angeles|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
20565653|NCT00942734|University of Texas (UT) MD Anderson Cancer Center|Vali Papadimitrakopoulou, MD||CR_Study_Registration@mdanderson.org|
20565654|NCT05147584|Raydiant Oximetry, Inc.|Laura Kemp|4083751465|laurakemp@raydiantoximetry.com|
20565655|NCT04664959|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20565656|NCT01950234|University of Minnesota|Sarah Hikbert|612-624-7745|hilbe010@umn.edu|
20565657|NCT02765854|Atrium Health Wake Forest Baptist Comprehensive Cancer Center|Leon Bernal-Mizrachi, MD|336-716-9253|lbernalm@wakehealth.edu|
20565658|NCT03884101|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20565659|NCT03370913|BioMarin Pharmaceutical Inc.|Tara Robinson, MD, PhD, Senior Medical Director, Clinical Sciences|415-455-7931|tara.robinson@bmrn.com|
20520961|NCT02444793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520962|NCT01685411|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
20520963|NCT00679926|Oklahoma State University Center for Health Sciences|Johnny Stephens|918-382-3527|johnny.stephens@okstate.edu|
20520964|NCT03996148|Cooper University Hospital|Ludmil Mitrev|(800) 826-6737|mitrev-ludmil@cooperhealth.edu|
20520965|NCT02504671|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20520966|NCT02518919|Children's Hospital of Michigan|Dr. Nirupama Kannikeswaran, Associate Professor of Pediatrics and Emergency Medicine|313-745-5260|nkannike@dmc.org|
20520967|NCT04498403|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20520968|NCT01951885|Case Comprehensive Cancer Center|Betty Hamilton MD|866-223-8100|TaussigResearch@ccf.org|
20520969|NCT02031458|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20520970|NCT03062228|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
20520971|NCT02910674|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303.724.6713|satish.garg@ucdenver.edu|
20520972|NCT01687478|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20520973|NCT03188718|University of Colorado Denver|Michelle Sobremonte-King, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20532937|NCT03994120|National Institutes of Health/NINDS|Dr. Eric Wasserman|301-495-0151|wassermanne@ninds.nih.gov|
20532938|NCT01111292|Northwestern University|Dr. Seema Khan|(312) 503-4236|SKhan@nm.org|
20532939|NCT04914000|Moffitt Cancer Center|Dr. Ursula Martinez|813-745-1754|Ursula.Martinez@moffitt.org|
20532940|NCT02619812|Mayo Clinic|Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20532941|NCT01096186|Impax Laboratories, Inc.|Daven Mody, PharmD, MBA, Director, Regulatory Affairs|510-240-6073|dmody@impaxlabs.com|
20532942|NCT02728726|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
20532943|NCT02203786|Centre for Addiction and Mental Health|Dr. Daniela Lobo, Qualified Investigator for Study, Clinician-Scientist|416-535-8501|Daniela.Lobo@camh.ca|36568
20532944|NCT00793611|University of New Mexico Health Sciences Center and CTSC|Yuko Komesu MD|505-925-4395|ykomesu@salud.unm.edu|
20532945|NCT00673114|Duke University Medical Center|Dr. Joanne Kurtzberg|919-668-1100|kurtz001@mc.duke.edu|
20532946|NCT00799864|Janssen R&D BE|Director 1 Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20532947|NCT04865978|Inova Schar Heart and Vascular|Dr. Palak Shah|703-776-2213|palak.shah@inova.org|
20532948|NCT05587998|AstraZeneca|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20532949|NCT04263532|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
20532950|NCT04072432|Renibus Therapeutics|Stacey Ruiz, PhD / VP, Drug Development|424-209-2734|sruiz@renibus.com|
20532951|NCT03225989|Lokon Pharma|Angelica Loskog CEO|+46 18-50 74 44|angelica.loskog@lokonpharma.com|
20532952|NCT00601107|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20532953|NCT03892915|RAND Corporation|Glenn Wagner|310-393-0411|gwagner@rand.org|7695
20532954|NCT03364686|University of Pittsburgh|Darrell J. Triulzi, MD|412-209-7304|triudj@upmc.edu|
20532955|NCT02201628|King's College Hospital NHS Foundation Trust|Dr Emily Haberman|07890549924|emilysaffer@gmail.com|
20532956|NCT03095976|Indiana University School of Dentistry|Dr. Yusuke Hamada|317-274-5121|yuhamada@iupui.edu|
20532957|NCT03566550|University of Nottingham|Professor Alan Smyth|01158230612|alan.smyth@nottingham.ac.uk|
20532958|NCT02614768|Medical University of Graz|Mader, Julia, Assoz. Dr.med.univ.|0043316385|julia.mader@medunigraz.at|12383
20532959|NCT01210443|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532960|NCT02807181|Sirtex|Director, Clinical Research Operations|+1-888-474-7839|info-us@sirtex.com|
20532961|NCT00063999|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-545-8321|lgedeon@gogstats.org|
20532962|NCT03335267|Weill Cornell Medical College|Dr. Ellen K. Ritchie|646-962-2700|ritchie@med.cornell.edu|
20532963|NCT02497755|University of Washington|Dr. Amy Bauer|206.221.8385|abauer1@uw.edu|
20532964|NCT01774370|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20532965|NCT00514917|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20532966|NCT04243837|PureTech Health, Inc|Director of Clinical Trials|6034982261|ckorth@puretechhealth.com|
20532967|NCT02555098|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20532968|NCT02829957|Indiana University|Dr. Jeffrey Kline|317-880-3869|jefkline@iu.edu|
20532969|NCT00400205|Emory University Winship Cancer Institute|Nabil Saba, MD|1-888-946-7447|nfsaba@emory.edu|
20532970|NCT00137280|Greater Los Angeles Veterans Healthcare Center|Dr. Alexander S. Young|310-268-3416|alexander.young@va.gov|
20532971|NCT00309244|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20532972|NCT01266083|Sellas Life Sciences|Dragan Cicic|646-200-5278|info@sellaslife.com|
20532973|NCT00545948|Duke University Medical Center|Neal Ready, PhD, MD|919-681-6932|neal.ready@duke.edu|
20532974|NCT03467945|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20532975|NCT06171399|Wake Forest University School of Medicine|Dr. Beth Reboussin|336-713-5213|brebouss@wakehealth.edu|
20532976|NCT00541775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20532977|NCT00032487|Hines CSPCC|Project Manager|708-202-5785|tamara.paine@va.gov|
20532978|NCT04267328|HealthPartners Institute - Neuroscience|Clinical Research Coodinator|651-495-6360|clincialtrials@HealthPartners.com|
20532979|NCT04913675|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20532980|NCT02975700|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20532981|NCT01541254|MicroVention, Inc.|Mary Schmitz|714-247-8025|mary.schmitz@microvention.com|
20532982|NCT03378336|University of Pennsylvania|Dr. Alexis Ogdie-Beatty|215-614-2454|alexis.ogdie@pennmedicine.upenn.edu|
20532983|NCT01227395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532984|NCT01940146|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
20532985|NCT03259308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20532986|NCT00809146|University of Michigan|Robert Silbergleit MD, Principal Investigator|734-232-2142|robie@umich.edu|
20532987|NCT01807104|VOA Research Foundation|Dr. William P. Barrett, MD|425-656-5060|wpbarrett@comcast.net|3063
20532988|NCT03632720|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20532989|NCT01117350|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20532990|NCT03389750|New York State Psychiatric Institute|Jermaine Jones|646 774-6113|jermaine.jones@nyspi.columbia.edu|
20532991|NCT04902144|University of Washington|Dr. Marianne Dubard-Gault|206-606-6990|mdg2019@uw.edu|
20532992|NCT01049828|Washington University in St. Louis|Dr. Andre Wineland|314-362-5296|winelanda@ent.wustl.edu|
20532993|NCT00290238|RS Medical|Clinical Research Manager|360-891-7299||
20532994|NCT03076164|Memorial Sloan Kettering Cancer Center|Dr. Helene Yu, MD|646-608-3912|YuH@mskcc.org|
20532995|NCT03312114|University of Texas Southwestern Medical Center|Phase II trial of Concurrent Anti-PD-L1 and SAbR for Patients with Persistent or Recurrent Epithelia|(214) 645-7296|kevin.albuquerque@utsouthwestern.edu|
20532996|NCT01260324|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20532997|NCT03607695|University of Washington|Valerie E. Kelly, PT, PhD|206-598-5350|vekelly@uw.edu|
20532998|NCT01346709|European Society of anaesthesiology|Brigitte Leva, Research Team Leader|+3222109414|research@esahq.org|
20532999|NCT00949078|Johns Hopkins University School of Medicine|Professor Robert Wood, M.D.|rwood@jhmi.edu|rwood@jhmi.edu|
20533000|NCT02194088|Brigham and Women's Hospital|Edwards Robert|617-732-9486|rredwards@partners.org|
20533001|NCT01282138|Alcon Research|Head, Global Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
20533002|NCT04821245|Benaroya Research Institute|Joseph M. Neal, MD|206-223-6980|Joseph.Neal@virginiamason.org|
20533003|NCT00605657|NIAID|V. Koneti Rao, MD|301-496-6502|korao@niaid.nih.gov|
20533004|NCT02284854|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20565660|NCT06603766|faculty of medicine Benha University|Dr. Heba Morsy Saad El Din El Ganady|+201111211367|Heba.Aljanadi21@fmed.bu.edu.eg|
20565661|NCT04560179|Stanford University School of Medicine|Erik Jensen, MD, MSCE|267-648-2720|jensene@stanford.edu|
20565662|NCT04496752|Linus Health|Dr. Sean Tobyne|(617) 433-1777|stobyne@linus.health|
20520974|NCT02358135|Keck School of Medicine of University of Southern California|April W. Armstrong, MD, MPH; Associate Dean of Clinical Research|323-865-3871|april.armstrong@med.usc.edu|
20520975|NCT00394524|Emory University|Guillermo Umpierrez, MD|404-778-1665|geumpie@emory.edu|
20520976|NCT01462318|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20520977|NCT02238626|MediciNova, Inc.|Director, Scientific Affairs|8583444535|makhay@medicinova.com|
20520978|NCT01969448|Washington University School of Medicine|Marissa J. Tenebaum, M.D.|314-996-8800|tenenbaumm@wustl.edu|
20520979|NCT02227147|Dompé|Flavio Mantelli, MD, PhD|02 583831|info@dompe.com|
20520980|NCT01289665|AdventHealth|Dr. Ashley Hill|407-303-1444|Ashley.Hill.MD@adventhealth.com|
20520981|NCT00158600|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20520982|NCT01593696|National Cancer Institute|Dr. Nirali N. Shah|240-760-6199|shahnn@nih.gov|
20520983|NCT01936623|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
20520984|NCT00242619|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
20520985|NCT04941521|The University of Texas Health Science at Houston|Joy M Schmitz, PhD|713-486-2867|Joy.M.Schmitz@uth.tmc.edu|
20520986|NCT00369655|Mayo Clinic|Dr. Timothy Hobday|507-284-1159|hobday.timothy@mayo.edu|
20520987|NCT04049617|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20520988|NCT00801099|Swiss Tropical Institute|Franziska Saxer, MD||franziskabrenneke@yahoo.com|
20520989|NCT04078126|AstraZeneca AB|AstraZeneca AB|877-240-9479|information.center@astrazeneca.com|1
20520990|NCT02669758|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20520991|NCT02149108|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20520992|NCT03402750|University of Miami|Brian McCabe|305-248-1530|bmccabe@miami.edu|
20520993|NCT02981303|HiberCell|Chief Medical Officer|651.675.0300|CMO@hibercell.com|
20520994|NCT02325518|Alcon, A Novartis Division|Novartis Pharma KK|1-888-451-3937|alcon.medinfo@alcon.com|
20520995|NCT03393806|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20520996|NCT00080938|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20520997|NCT01775852|Baylor College of Medicine|Lilian Dindo, PhD|713-791-1414|lilian.dindo@bcm.edu|10296
20520998|NCT04561375|Cleveland Clinic|Dr. Daniel Sessler|2168702620|ds@ccf.org|
20520999|NCT00706511|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
20521000|NCT01025271|University of Pittsburgh|Karin Byers, MD|412-648-6553|dlp5@pitt.edu|
20521001|NCT04645264|Rush University Medical Center|Kern Singh, MD|(312) 432-2435|kern.singh@rushortho.com|
20521002|NCT02116608|University of Colorado Denver|Jeremy Prager, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20521003|NCT00988442|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 6283313|ACTGCT.Gov@s-3.com|
20521004|NCT01830205|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20521005|NCT02623348|University of California, San Francisco|Anoop Sheshadri|415-221-4810|anoop.sheshadri@ucsf.edu|22576
20521006|NCT04740320|Imperial College London|Clinical Project Manager|+442083831284|polly.fox@imperial.ac.uk|
20521007|NCT04620135|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. VP, Clinical Development and Medical Affairs|+1 908-947-3551|msenchyna@aeriepharma.com|
20521008|NCT02272634|Yungjin Pharm. Co., Ltd.|Director of Clinical Trials|82-2-2041-8318|mhlee2017@yungjin.co.kr|
20521009|NCT01437943|Brigham and Women's Hospital|Anil Chandraker, MD|617-732-7412|achandraker@partners.org|
20521010|NCT00535587|Oregon Health & Science University|Kim Dupree Jones|503 494 3837|joneskim@ohsu.edu|
20521011|NCT01660334|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521012|NCT00546572|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521013|NCT00988065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20521014|NCT03979820|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20521015|NCT01229735|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
20521016|NCT02130882|National Institute of Allergy and Infectious Diseases, NIH|Dr. Amy Klion|301-435-8903|aklion@nih.gov|
20521017|NCT00520286|National Institutes of Health|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
20521018|NCT01715064|University of Guelph-Humber|Dr. Daniel Santa Mina|416-798-1331|daniel.santamina@guelphhumber.ca|6065
20521019|NCT00548171|GlaxoSmithKline|GSK Response Center|866-435-7343||
20521020|NCT02257541|Memorial Sloan Kettering Cancer Center|Dr. William Tap, MD|646-888-4163|tapw@mskcc.org|
20521021|NCT00502801|Janssen Scientific Affairs, LLC|Vice President, Data Generation|908 927-2943||
20533005|NCT02773537|Medical University of South Carolina|Dr. Eric Bolin|843-792-2322|bolin@musc.edu|
20521022|NCT01565616|Emory University|Lakshmanan Krishnamurti, MD||lakshmanan.krishnamurti@emory.edu|
20521023|NCT03322384|University of California, Davis|Analyst|9167348053|nlogihara@ucdavis.edu|
20521024|NCT03176459|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20565663|NCT03662022|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
20533006|NCT01840163|University of Michigan|Dr. Sarah Hawley|734-936-8816|sarahawl@med.umich.edu|
20533007|NCT00662038|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20533008|NCT00397046|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20533009|NCT00383565|MD Anderson Cancer Center|Dr. Luis E. Fayad / Associate Professor|713-792-2860|jmdennison@mdanderson.org|
20533010|NCT03636269|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20533011|NCT01291160|Ogenix|S.Sarangapani|7817026732|ssarangapani@ogenix.com|
20533012|NCT03021005|Johns Hopkins University|Dr. Yu-Hsiang Hsieh|410-735-6413|yhsieh1@jhmi.edu|
20533013|NCT03156621|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844 734 6643|clinicaltrials@regeneron.com|
20533014|NCT02350998|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20533015|NCT00087672|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes, M.D./ Professor|713-794-5783|eharriso@mdanderson.org|
20533016|NCT02264821|CHU Brugmann|Dr Madeleine Wilwerth|003224773996|madeleine.wilwerth@chu-brugmann.be|
20533017|NCT03835117|Autism Discovery & Treatment Foundation|Richard E Frye|844-ADTF-Research|DrFrye@AutismDiscovery.org|1
20533018|NCT06083493|University of Michigan|Zirui Huang|734-615-2875|huangzu@med.umich.edu|
20533019|NCT03093870|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
20533020|NCT02318277|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20533021|NCT01520714|The Heart Hospital Baylor Plano|Research Manager|469-814-4712|natalie.settele@baylorhealth.edu|
20533022|NCT00185900|Stanford University|Dr. Anna Girsen|(650) 725-5720|agirsen@stanford.edu|
20533023|NCT04957082|Michigan State University|Dr. Todd Lucas|810-600-5629|lucastod@msu.edu|
20533024|NCT02719366|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20533025|NCT01078545|Abbott|Global Medical Services|1-800-633-9110||
20533026|NCT02864914|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20533027|NCT01895647|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|886-975837711|jeff01@mmh.org.tw|
20533028|NCT01489358|Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr Julie E Ledgerwood||ledgerwood@mail.nih.gov|
20533029|NCT03722030|University of Wisconsin - Madison|Dr. Lisa Cadmus-Bertram|608-262-1167|lisa.bertram@wisc.edu|
20533030|NCT00098293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533031|NCT03193307|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533032|NCT03518203|Cincinnati Children's Hospital Medical Center|Sonata Jodele, MD|(513) 636-5917|Sonata.Jodele@cchmc.org|
20533033|NCT01457430|MGH Allergy Associates|Dr. Aleena Banerji|617-726-3850|abanerji@mgh.harvard.edu|
20533034|NCT00754559|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20533035|NCT00345592|S. Anna Hospital|Giovanni Luca Botto|0315851|gluca.botto@gmail.com|+39
20533036|NCT01663987|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533037|NCT01829503|University of Pittsburgh Cancer Institute|Dr. Annie P. Im|412-623-2393|imap@upmc.edu|
20533038|NCT01783236|Weill Cornell Medicine|Hugh Hemmings, MD, PhD|212-746-2953|hchemmi@med.cornell.edu|
20533039|NCT04000724|Friends Research Institute, Inc.|Cathy Reback|3234631601|reback@friendsresearch.org|
20533040|NCT00455455|CCLR|Dr Craig A Woods|519 888 4567|cawoods@uwaterloo.ca|36547
20533041|NCT01370538|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
20533042|NCT01084135|Duke University Medical Center|Jane Ann Baker,MS, CGC|919-668-4576|janeann.mckillop@duke.edu|
20533043|NCT03335566|GE Healthcare|Francois Tranquart, M.D, PhD|011-44-1494-543037|francois.tranquart@ge.com|
20533044|NCT02366130|UT MD Anderson Cancer Center|Dr. Naoto T Ueno, Professor, Breast Medical Oncology|(713) 792-8754|nueno@mdanderson.org|
20533045|NCT01065766|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-888-577-8839|ClinicalTrialsDisclosure@merck.com|
20533046|NCT02945046|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20533047|NCT02468700|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
20533048|NCT03907579|Dartmouth-Hitchcock Norris Cotton Cancer Center|Director of Community Education and Prevention|603-653-9960|nccc.community.outreach@dartmouth.edu|
20533049|NCT03587857|UCSF|Dr. Parya Saberi|415-502-1000 ext. 17171|parya.saberi@ucsf.edu|
20533050|NCT02675452|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20533051|NCT02821793|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20533052|NCT04595370|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20533053|NCT05660538|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20533054|NCT04518410|ACTG Network Coordinating Center, DLH|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20533055|NCT02218268|University of Florida|Michael Haller|352-265-0111|hallemj@peds.ufl.edu|
20533056|NCT03651336|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
20533057|NCT01341990|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20533058|NCT03361072|Helsinki University Hospital|Dr Paula Kauppi|+358504286802|paula.kauppi@hus.fi|
20533059|NCT01537367|Division of HIV/AIDS (Epidemiology Branch), National Center for HIV/Hepatitis/STD/Tuberculosis Prevention, Centers for Disease Control and Prevention|Lytt I. Gardner, Ph.D., CDC Project Officer|(404) 639-6163|lig0@cdc.gov|
20533060|NCT06173648|State Univeristy of Paulista Júlio de Mesquita Filho, School of Dentistry at Araraquara|Dr. Renato de Toledo Leonardo|+55-16-3301-6391|rleonard@foar.unesp.br|
20533061|NCT02487199|AbbVie|Global Medical Services|800-633-9110||
20533062|NCT04826731|Ankara Sanatoryum Training and Research Hospital|Dr. Kerem Ensarioğlu|905426142727|kerem.ensarioglu@gmail.com|
20551788|NCT02047747|University of California, San Diego|David Piccioni M.D., Ph.D.|(858) 822-6346|dpiccioni@ucsd.edu|
20521025|NCT00446199|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20533063|NCT03181009|The Sean N. Parker Center for Allergy and Asthma Research at Stanford University|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|650 - 521 - 7237|andresap@stanford.edu|
20533064|NCT03885206|Landsforeningen for hjerte- og lungesyke|Senior Consultant|0047 95706313|irene.steinsvik@lhl.no|
20533065|NCT01213251|Medtronic plc|PRomPT Clinical Team|+1 800-328-2518|MedtronicCRMtrials@medtronic.com|
20533066|NCT00594308|Indiana University School of Medicine|Robert Nelson, MD|317-278-6871|ronelson@iupui.edu|
20533067|NCT03453515|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
20533068|NCT00520572|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20533069|NCT03548415|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
20533070|NCT02504775|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533071|NCT04605588|Rutgers, The State University of New Jersey|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@Rutgers.edu|
20533072|NCT02527265|MannKind Corporation|Clinical Development|844.323.7399|mapp@mannkindcorp.com|
20533073|NCT01803737|University of Arizona|David O. Garcia, PhD|520-626-4641|davidogarcia@email.arizona.edu|
20533074|NCT01529112|Eisai Call Center|Eisai Inc.|888-422-4743||
20533075|NCT01530256|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20533076|NCT04621786|University of New Mexico|Dr. Chris Abbott|5052720406|cabbott@salud.unm.edu|
20533077|NCT02799290|Tampere University Hospital|Ilkka Kaartinen|505687096|ilkka.kaartinen@pshp.fi|
20533078|NCT02123511|Mayo Clinic|Michele Halyard, M.D.; Robert Foote, M.D.|480-301-4567|mhalyard@mayo.edu; foote.robert@mayo.edu|
20533079|NCT00458705|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|landauh@mskcc.org|
20533080|NCT01531803|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
20533081|NCT00378560|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20533082|NCT00337194|The Ohio State University|Dr. Kristie Blum||kristie.blum@osumc.edu|
20533083|NCT03188705|University of Maryland School of Medicine|Joshua P. Lewis, PhD|410-706-5087|jlewis2@som.umaryland.edu|
20533084|NCT03074643|Wake Forest University School of Medicine|Dr. Denise Houston|336-713-8558|dhouston@wakehealth.edu|
20533085|NCT02212977|Duke University Medical Center|Dr. Charles Kim|9196847424|charles.kim@duke.edu|
20533086|NCT01834651|Cedars-Sinai Medical Center|Dr. Edwin Posadas|310-423-7600|Edwin.Posadas@cshs.org|
20533087|NCT00948935|Abramson Cancer Center|Bruce Giantonio|(215) 615-5858|bruce.giantonio@uphs.upenn.edu|
20533088|NCT00201773|The Ohio State University Comprehensive Cancer Center|Steven Provoski, MD|614-293-8700|Stephen.Povoski@osumc.edu|
20533089|NCT01658735|University of Utah School of Medicine|Matthew A Hughes, MD, MPH|8015814800|matthew.hughes@hsc.utah.edu|
20565664|NCT05275556|Verily|Dr. Scooter Plowman|650-861-9783|splowman@verily.com|
20533090|NCT04032327|Walter Reed National Military Medical Center|Katherine L Dengler, MD|301-400-2468|katherine.l.dengler.mil@mail.mil|
20533091|NCT03757715|UAB|Dr. Jessica W. Grayson|205-801-7801|jgrayson@uabmc.edu|
20533092|NCT03302936|Icahn School of Medicine at Mount Sinai|Annacecilia Peacher-Holderied|2104887216|apeacher4@gmail.com|
20533093|NCT01122680|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533094|NCT04985682|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20533095|NCT00501943|UCSF|Dr Emmanuelle Waubant, MD|415- 514 2468|Emmanuelle.Waubant@ucsf.edu|
20521026|NCT04018664|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
20521027|NCT06218823|University of Wisconsin Center for Tobacco Research and Intervention|Associate Director of Research|6082628673|demccarthy@ctri.wisc.edu|
20521028|NCT06077487|University of California, San Francisco|Dr. Brian Anderson|(415) 476-1000|Brian.Anderson@ucsf.edu|
20521029|NCT04394351|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20521030|NCT01288053|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
20521031|NCT03188666|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20521032|NCT02068092|Houston Methodist Neal Cancer Center|Jenny Chang|713.790.3333|ccresearch@houstonmethodist.org|
20521033|NCT02799095|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
20521034|NCT01933113|Allegheny Health Network|Donald Whiting, MD|412-359-6200|donald.whiting@ahn.org|
20521035|NCT02297438|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521036|NCT06262191|Northern Arizona University|PI|928-523-1787|zachary.lerner@nau.edu|
20521037|NCT02935686|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521038|NCT00759902|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
20521039|NCT02579161|Northwell Health|Dr. Zeph Okeke|516-734-8500|zokeke@northwell.edu|
20521040|NCT02327117|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
20521041|NCT02128217|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20521042|NCT05071313|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521043|NCT00210249|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20521044|NCT04280705|Organization:NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20521045|NCT03222583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20521046|NCT03576183|Valneva Austria GmbH|Head Global Medical Affairs|20620|info@valneva.com|0
20565665|NCT03248479|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20565666|NCT04679389|Mayo Clinic|Eva Morava-Kozicz, M.D., Ph.D.|507-266-9140|Morava-Kozicz.Eva@mayo.edu|
20533096|NCT01694186|Eyepoint Pharmacueticals|Clinical Affairs|6179726204|fleonin@eyepointpharma.com|
20533097|NCT03760640|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20533098|NCT03016403|Latino Research and Policy Center, University of Colorado Denver|Evelinn Borrayo, Associate Director|303-724-0884|Evelinn.Borrayo@cuanschutz.edu|
20533099|NCT05463705|Brigham and Women's Hospital|Nancy Haff, MD, MPH|857-307-3826|nhaff@mgb.org|
20533100|NCT00576407|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
20533101|NCT00225758|Dartmouth-Hitchcock Medical Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
20533102|NCT00079781|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
20533103|NCT00621322|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533104|NCT04641975|Astellas Pharma Global Development Inc|Clinical Trial Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20533105|NCT04299425|Vanderbilt University Medical Center|Dr. Carmen C Solorzano|615-343-2735|carmen.solorzano@vumc.org|
20533106|NCT01259024|Washington University|Patricia Nieters, RN, BSN, Clinical Research Specialist|314-362-3371|nietersp@wustl.edu|
20565667|NCT05257603|State University of New York at Buffalo|Dr. Kathleen Parks|(716) 887-3301|kparks@buffalo.edu|
20533107|NCT01657500|Case Western Reserve Univ and University Hospitals Case Medical Center|Jonathan Lass MD|2168445893|jonathan.lass@uhhospitals.org|
20533108|NCT00756444|Amgen Inc.|Study Director|866-572-6436||
20533109|NCT00564070|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|(305) 284-2818|ssafren@miami.edu|
20533110|NCT00552279|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533111|NCT00619242|The University of Chicago|Ezra Cohen, MD|773/702-4137|ecohen@medicine.bsd.uchicago.edu|
20533112|NCT03142334|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533113|NCT02346370|Halozyme, Inc.|Halozyme Study Information|1-844-855-4256|medinfo@halozyme.com|
20533114|NCT01217047|Kennedy Krieger Institute|Daniel Becker, M.D.|888-923-9222|dbecke13@jhu.edu|
20533115|NCT04034056|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20533116|NCT01530997|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20533117|NCT00428077|University of Utah Huntsman Cancer Institute|Michael Deininger, MD, PhD|801-585-3229|michael.deininger@hci.utah.edu|
20533118|NCT02298491|UMaryland|Horea Rus|410-706-3170|hrus@som.umaryland.edu|
20533119|NCT01362270|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|underwos@ohsu.edu|
20533120|NCT02046200|UCLA Department of Psychology|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
20533121|NCT02453191|University of Iowa, Holden Comprehensive Cancer Cente|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
20533122|NCT01691482|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533123|NCT00483509|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
20533124|NCT00682838|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
20533125|NCT01986751|University of Alabama Birmingham|Dr. Promil Kukreja|205-996-7025|pkukreja@uabmc.edu|
20533126|NCT05938816|Oregon Health and Science University|Josh Kaplan, PhD|503) 494-8311|kaplajos@ohsu.edu|
20533127|NCT00407030|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
20533128|NCT01968785|Medstar Health Research Institute|Megan Rowland|2028772959|megan.e.rowland@medstar.net|
20533129|NCT03343886|Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Madrid, Spain.|José Luis Ayuso Mateos||joseluis.ayuso@uam.es|
20533130|NCT00712075|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
20533131|NCT04223687|University of North Carolina at Chapel Hill|Marissa Hall, PhD|(919) 445-1310|mghall@unc.edu|
20533132|NCT01608308|The University of Texas Health Science Center at Houston|Davide Cattano|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
20533133|NCT03520387|VA Puget Sound Health Care System Seattle Division, Seattle, WA|Pradeep Suri, MD|206-764-2673|Pradeep.Suri@va.gov|
20533134|NCT01945242|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20533135|NCT03163264|VA New York Harbor Manhattan|Dr. Melanie Jay|212-686-7500|melanie.jay@va.gov|5097
20533136|NCT00286455|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20533137|NCT02730169|Mereo BioPharma Group|Jackie Parkin|+44 (0) 333 023 7300|enquiries@mereobiopharma.com|
20533138|NCT03004183|Houston Methodist Cancer Center|Jenny C Chang, MD|713-441-0629|ccresearch@houstonmethodist.org|
20533139|NCT03681093|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20533140|NCT02698787|Cochlear|Naomi Croghan|+13032642131|ncroghan@cochlear.com|
20533141|NCT00295503|UT Southwestern|Jonathan Dowell|214-648-4180|jonathan.dowell@utsouthwestern.edu|
20533142|NCT01882829|Icahn School of Medicine at Mount Sinai|Dr. James W Murrough|212-241-7574|james.murrough@mssm.edu|
20533143|NCT01557244|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533144|NCT01313676|GlaxoSmithKline|GSK Response Center|866-435-7343||
20565668|NCT03076021|University of Washington|Dr. Mary Hebert|206-616-5016|mhebert@u.washington.edu|
20565669|NCT04024059|Johns Hopkins University School of Medicine|Kenneth Silverman, Ph.D.|4436176051|ksilverm@jhmi.edu|
20565670|NCT05954546|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565671|NCT04177771|RxSight|Jeffrey Ha, VP Clinical Affairs|949-521-7870|jha@rxsight.com|
20565672|NCT03250676|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20565673|NCT04633278|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20565674|NCT02076009|Janssen R&D US|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20533145|NCT00800345|Vector Oncology|Vice President of Scientific Affairs|901.435.5570|mwalker@vectoroncology.com|1759
20533146|NCT06358144|Wake Forest University Health Sciences|Beth Reboussin, PhD|336-713-5213|brebouss@wakehealth.edu|
20533147|NCT02469961|Maimonides Medical Center|Piyush Gupta, Director of clinical affairs|718-283-7189|pgupta@maimonidesmed.org|
20533148|NCT02935036|Taro Pharmaceuticals U.S.A., Inc.|Manager, Clinical Research|9143459001|Businessdevelopment@taro.com|
20533149|NCT00326495|National Cancer Institute|Dr. Alice Chen|240-276-6565|chenali@mail.nih.gov|
20533150|NCT02933151|Dialysis Clinic, Inc. /Tufts Medical Center|Dr. Daniel Weiner|6176365070|dweiner@tuftsmedicalcenter.org|
20533151|NCT00394472|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20533152|NCT03532490|Johns Hopkins University|Gem Roy|4432875796|groy2@jhu.edu|
20533153|NCT02802865|University of Iowa|Dr. Rachel Mejia|319-356-3143|rachel-mejia@uiowa.edu|
20533154|NCT01723839|John Theurer Cancer Center at Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20533155|NCT01230814|University of Arkansas for Medical Sciences|Shelly Lensing, MS|501-686-8203|sylensing@uams.edu|
20533156|NCT04630626|NuVasive, Inc.|Nicole Czaplewski, Manager Clinical Affairs|308-660-2021|nczaplewski@nuvasive.com|
20533157|NCT01161121|St. Louis University|Dr. Michael Lim|314-268-7992|limmj@slu.edu|
20533158|NCT02004275|Levine Cancer Institute|Peter Voorhees|980-442-5219|peter.voorhees@carolinashealthcare.org|
20533159|NCT00292370|Ralph H. Johnson VA Medical Center|Mark Hamner, MD|843-789-7799|Mark.Hamner@va.gov|
20533160|NCT02533674|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
20521047|NCT02049450|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20521048|NCT02381626|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Leng, MD, MPH|646-888-8057|lengj@mskcc.org|
20521049|NCT00292188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20521050|NCT04709835|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20521051|NCT05339334|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521052|NCT00368979|GlaxoSmithKline|GSK Response center|866-435-7343||
20521053|NCT00974974|Impax Laboratories, Inc.|Michelle Landolfi, Director, Regulatory Affairs|510-240-6402|mlandolfi@impaxlabs.com|
20521054|NCT01959035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
20521055|NCT01911897|Vascular Dynamics|Director, Clinical Operations|9492317602|lgreen@vasculardynamics.com|
20521056|NCT02181426|Medical University of South Carolina, Department of Anesthesia and Perioperative Medicine|Research Coordinator for Anesthesia and Perioperative Medicine|843-792-2322|joneswr@musc.edu|
20521057|NCT01659866|Northwestern University|Dr. Anthony Schaeffer|312-908-1615|ajschaeffer@northwestern.edu|
20521058|NCT05183217|University of Wisconsin - Madison|Heidi Brown|619-695-4714|heidi.w.brown@kp.org|
20521059|NCT03412396|The University of Texas MD Anderson Cancer Center|Dr. John Davis|(713) 792-3250|johndavis@mdanderson.org|
20521060|NCT02713386|NRG Oncology|Christopher Purdy on behalf of Michael Sill, PhD|716-845-1300|purdyc@nrgoncology.org|2296
20521061|NCT02122406|University of Pavia|Vittorio Grosso MD|+393332605945|vittorio.grosso@gmail.com|
20521062|NCT00415194|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20521063|NCT01297465|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20521064|NCT00969540|Hologenix, LLC|Seth Casden|310-600-3673|seth.casden@celiant.com|
20521065|NCT00631449|University of California, San Francisco|Steven Deeks, MD|415-476-4082|Steven.Deeks@ucsf.edu|404
20521066|NCT01259115|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
20521067|NCT01971970|Erasmus University Medical Centre - Sophia Childrens Hospital|Professor J.C. Escher|+31107036076|j.escher@erasmusmc.nl|
20521068|NCT00848107|United Therapeutics Corporation|Rex Mauthe, Assoc VP, Regulatory Affairs|(919) 485-8350|RMauthe@unither.com|
20521069|NCT01460901|Children's Mercy Hospitals and Clinics|Dr. Gary Douglas Myers|8163026817|gdmyers@cmh.edu|7-6817
20521070|NCT05297578|Vaxcyte|Vice President of Clinical Development|650-585-0029|clinicaltrialsgov@vaxcyte.com|
20521071|NCT00117325|GlaxoSmithKline|GSK Response Center|866-435-7343||
20521072|NCT00895947|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
20521073|NCT02266134|Kaiser Permanente Washington Health Research Institute|Dr. Cara C. Lewis|206-422-4076|Cara.C.Lewis@kp.org|
20521074|NCT00831766|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
20521075|NCT05472662|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20521076|NCT04647721|Merz Aesthetics|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
20521077|NCT02697240|Children's National Medical Center|Suvankar Majumdar|2024763800|smajumdar@childrensnational.org|
20521078|NCT02666352|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521079|NCT00857259|Novartis Pharmaceuticals|Study Director|862-778-8300||
20521080|NCT02701413|Northwestern University|Dr. Christina Lewicky-Gaupp|312-472-3874|christina.lewickygaupp@nm.org|
20521081|NCT02138136|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-556-3314|clinicaltrials@mnk.com|
20521082|NCT01359644|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Trials@bms.com|
20521083|NCT04795908|West Virginia University|Jessica Frey|304-598-6127|jessica.frey@hsc.wvu.edu|
20521084|NCT00311311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521085|NCT02685202|University of North Carolina at Chapel Hill|Anne E. Sanders, PhD|919-537-3275|anne_sanders@unc.edu|
20521086|NCT02327741|shiraz university of medical sciences|Professor|009836250352|kojurij@yahoo.com|
20521087|NCT03003949|University of North Carolina at Chapel Hill|Susan Girdler, PhD|919-590-0813|rachel_kozik@med.unc.edu|
20521088|NCT02615171|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
20521089|NCT00016718|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20533161|NCT02365064|Sleep and Human Health Institute|Dr. Barry Krakow|(505) 9987204|bkrakow@sleeptreatment.com|
20533162|NCT00548691|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
20533163|NCT01749293|University of Illinois|Dr. Pritesh Patel|312-996-5762|prpatel8@uic.edu|
20533164|NCT03008213|UCSD|Eric Roeland, MD|858- 534-7079|eroeland@ucsd.edu|
20533165|NCT03939494|Cincinnati Children's Hospital|Mary Banks|513-636-2147|mary.banks@cchmc.org|
20533166|NCT00493285|MedImmune, LLC|Elissa Malkin, DO, MPH|301-398-0000|malkine@medimmune.com|
20533167|NCT04498273|University of Pittsburgh|Dr. Frank Sciurba|412-648-6494|sciurbafc@upmc.edu|
20533168|NCT01174459|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533169|NCT03615534|Al-Kindy College of Medicine, ////university of Baghdad|Lewai Sharki Abdulaziz|750 659 0024|lewaisharki@kmc.uobaghdad.edu.iq|+964
20533170|NCT05688657|CooperVision|Jose A. Vega, OD, MSc, FAAO|925-621-3761|jvega2@coopervision.com|
20533171|NCT01429623|Bar Ilan University|Jonathan Rabinowitz, PhD|+972544643889|Jonathan.Rabinowitz@biu.ac.il|
20533172|NCT00981175|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20533173|NCT01750281|AstraZeneca|Dr Gabriella Mariani|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
20533174|NCT04189588|TerSera Therapeutics Inc.|Executive Director Clinical Development|888 600 8116|jnorth@tersera.com|
20533175|NCT01433081|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
20533176|NCT00271570|University of California, San Diego|Jane Burns, MD, Professor|858-246-0155|jcburns@ucsd.edu|
20533177|NCT01379937|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533178|NCT01431573|NYSPI|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
20533179|NCT00063362|University Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
20533180|NCT01655069|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
20533181|NCT06399471|Georgia Institute of Technology|Kinsey Herrin, MSPO, C/LPO, FAAOP, Senior Research Scientist|470-578-7600|kinsey.herrin@gatech.edu|
20533182|NCT05529173|Rutgers - NJ Medical School|Dr. Dennis Grech|973 972-5007|grechde@njms.rutgers.edu|
20533183|NCT00609973|University of North Carolina|Hans Herfarth|9199666806|hherf@med.unc.edu|
20533184|NCT01309100|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
20533185|NCT03063164|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
20533186|NCT02540434|Weill Cornell Medicine|Michele Steinkamp|2127462953|mls9004@med.cornell.edu|
20533187|NCT00736476|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20533188|NCT01796470|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20533189|NCT01927861|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20533190|NCT01905267|University of Illinois at Chicago|Rachel Jacobs|3124139178|rjacobs@psych.uic.edu|312
20533191|NCT02991859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20533192|NCT04217057|Washington University School of Medicine|Dr. Farrokh Dehdashti|314-362-1474|dehdashtif@wustl.edu|
20533193|NCT01064284|"Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano"|Prof. Flora Peyvandi|0039 0255035414|flora.peyvandi@unimi.it|
20533194|NCT01016015|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
20533195|NCT04648241|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533196|NCT02057666|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20533197|NCT05661734|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20533198|NCT02489045|Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
20533199|NCT02970812|Family Medicine Clinic, Pusan National University Yangsan Hospital|Sang Yeoup Lee|3601442|saylee@pnu.edu|55
20533200|NCT01312675|B. Braun Medical Inc.|Dr. Diana Velencia, Associate Director of Clinical Affairs|610-596-2875|diana.valencia@bbraunusa.com|
20533201|NCT00930176|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
20533202|NCT01108055|Stanford University|Sandy Srinivas, MD|650 498 6000|sandysri@stanford.edu|
20533203|NCT03339453|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20533204|NCT00362609|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20533205|NCT04857281|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
20533206|NCT01569763|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|Eugenes@minervasurgical.com|
20533207|NCT01926509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533208|NCT02529488|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20533209|NCT05033561|FIDEC Corporation|Ricardo Rüttimann|+5491161188536|rruttimann@fidec-online.org|
20533210|NCT04668599|The MetroHealth|Vidya Krishnan|2167784527|vkrishnan@metrohealth.org|
20533211|NCT02821000|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533212|NCT01862029|National Institute of Health, NHLBI, Laboratory of Obesity and Aging Research|Jay H. Chung, Ph.D, MD|301-496-3075|chungj@nhlbi.nih.gov|
20533213|NCT03254147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533214|NCT03931785|Ironwood Pharmaceuticals, Inc.|Wilmin Bartolini, Ph.D.|617.621.8314|wbartolini@ironwoodpharma.com|
20533215|NCT03211858|Trial Transparency Team|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20533216|NCT01013870|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
20533217|NCT01386645|VA Puget Sound Hlthcare System|Kristina Utzschneider|206-277-3568|kutzschn@uw.edu|6-3568
20533218|NCT00678574|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
20533219|NCT01423084|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20533220|NCT02551809|United Neuroscience|Responsible Medical Officer|+(353) 1 524 0397|info@unitedneuroscience.com|
20533221|NCT03850431|Center to Improve Veteran Involvement in Care (CIVIC), HSR&D Center of Innovation, VA Portland Health Care System|Dr. Alan Teo|5032208262|alan.teo@va.gov|52461
20533222|NCT01133977|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20533223|NCT02462057|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
20521090|NCT02581007|Northside Hospital|Dr. Melhem Solh|404-255-1930|msolh@bmtga.com|
20521091|NCT04764630|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
20521092|NCT00741936|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
20521093|NCT00369382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521094|NCT03110601|Stimgenics|VP of Clinical Affairs|309-662-4321|clinicalSG@stimgenics.com|217
20521095|NCT03935464|University of California San Francisco|Dr. Monica Gandhi|415 260 6709|monica.gandhi@ucsf.edu|
20521096|NCT05730556|Mayo Clinic|Amaal Starling, M.D.|715-537-1345|Starling.Amaal@mayo.edu|
20521097|NCT05011123|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
20521098|NCT05742347|Medline Industries, LP|Julie J. Finley|(800) 33-5463|jjfinely@medline.com|
20521099|NCT01670487|Cleveland Clinic|Dr. Sharon Mace|216-445-4598|maces@ccf.org|
20521100|NCT03845296|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20521101|NCT05104073|Penn State College of Medicine|Ian Paul, MD|7175318006|ipaul@pennstatehealth.psu.edu|
20521102|NCT04732221|MSD|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521103|NCT04791969|University of California San Francisco|Glenn-Milo Santos|(415) 476-1435|glenn-milo.santos@ucsf.edu|
20521104|NCT04002063|VHAPTH|Judith A. Callan PhD, RN|412-628-1534|judith.callan@va.gov|
20521105|NCT05327816|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521106|NCT01106014|Actelion Pharmaceuticals Ltd|Clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
20521107|NCT01972919|Medical College of Wisconsin|Beth Erickson, MD|414-805-4462|BErickson@mcw.edu|
20521108|NCT05367336|Corewell Health Lakeland|Rachelle Pichot; Clinical Research Specialist|240-389-7340|rachelle.pichot@corewellhealth.org|
20521109|NCT04763564|University of North Carolina at Chapel Hill|Hans Herfarth, MD, PhD|9199666806|hherf@med.unc.edu|
20521110|NCT00658658|Amgen Inc.|Study Director|866-572-6436||
20521111|NCT00671918|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
20521112|NCT03182244|Astellas Pharma Inc|Clinical Transparency|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20521113|NCT00824616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521114|NCT04711902|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20521115|NCT04870138|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|919-843-6893|mmhobbs@med.unc.edu|
20521116|NCT03365752|Hospital for Special Surgery|Marla Sharp, MPH, MA|646-797-8419|sharpm@hss.edu|
20521117|NCT02633488|University of Virginia|Eugene J. Barrett MD PhD|434-924-1263|ejb8x@virginia.edu|
20521118|NCT01383135|Stanford University|Andrei Iagaru, MD|6507362859|aiagaru@stanford.edu|
20521119|NCT03167723|Atrium Health Wake Forest|Bradley Thomas MD|704-355-3176|bradley.thomas@atriumhealth.org|
20521120|NCT01646138|National Institute of Allergy and Infectious Diseases|Matthew J. Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
20521121|NCT01683838|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
20521122|NCT03397771|Ixaltis|Chief Development Officer|33457260076|svanberg@ixaltis.com|
20521123|NCT03614897|Transcend Medical Group|Alicia Harbison|5708874882|aliciajeanbrown@gmail.com|
20521124|NCT04040322|CiVi Biopharma, Inc.|Chief Executive Officer|301-968-2390|sj@civibio.com|
20521125|NCT02455050|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20521126|NCT01831765|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20521127|NCT00859586|NIH NHLBI|Dr. Minoo Battiwalla|301-827-0939|battiwam@nhlbi.nih.gov|
20521128|NCT02524730|Stryker|Britta von den Brincken, Sr. Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
20521129|NCT00507130|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
20521130|NCT01772758|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
20521131|NCT00556400|NICHD|Dr. Pamela Stratton|301 496-9079|strattop@mail.nih.gov|
20521132|NCT02605993|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
20521133|NCT00121472|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|(781) 852-8334|psood@thoratec.com|
20521134|NCT01383213|IRCCS Fondazione Cà Granda Policlinico Milano|Dr Roberto Cosentini|+390255033618|r.cosentini@gmail.com|3618
20521135|NCT03493386|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20521136|NCT04645966|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521137|NCT04146116|University of Wisconsin, Madison|Dr. Marin Schweizer|6082631545|mschweizer@medicine.wisc.edu|
20521138|NCT03272464|Massachusetts General Hospital|David M. Miller, MD, PhD|617-726-2667|dmiller4@mgh.harvard.edu|
20521139|NCT03468075|University of Iowa, Holden Comprehensive Cancer Center|Clinical Assistant Professor|319-384-9497|varun-monga@uiowa.edu|
20521140|NCT00271154|Medtronic CRDM|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
20521141|NCT01992523|Careggi Hospital|Guido Parodi|00390557947732|parodiguido@gmail.com|
20521142|NCT04536935|University of Washington|Morgan Johnson|715-416-1493|mjohn23@uw.edu|
20521143|NCT03456583|Hologic|Muhammad Waqas|5088267183|Muhammad.Waqas@hologic.com|
20521144|NCT00759187|Colgate Palmolive|William DeVizio- DMD|732-878-7901|William_Devizio@colpal.com|
20533224|NCT03606213|University of California, San Francisco (UCSF)|Professor of Medicine|14154761000|Steven.Deeks@ucsf.edu|
20533225|NCT04315961|Johns Hopkins University School of Medicine|Dustin Lee|410-550-4035|dlee214@jhmi.edu|
20533226|NCT01908699|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
20533227|NCT02105012|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
20533228|NCT03917901|University of Houston|Brooke Kauffman|(713) 743-8056|bkauffma@central.uh.edu|
20533229|NCT04046952|Long Beach VA Healthcare System|Dr. Arnold Seto|562-826-8000|arnold.seto@va.gov|12876
20533230|NCT00474968|CytoCore, Inc.|Richard Domanik, Ph.D.|312-222-9550|rdomanik@cytocoreinc.com|
20533231|NCT00215553|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
20533232|NCT05345405|University of Washington|Principal Investigator|206-503-3287|edworkin@uw.edu|
20533233|NCT01896986|MCRI|Dr. Nigel Crawford|9345 4772|nigel.crawford@rch.org.au|
20533234|NCT02193347|Duke University|Katy Peters, M.D., Ph.D.|919-684-6173|katherine.peters@duke.edu|
20533235|NCT00281580|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533236|NCT03071965|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20533237|NCT00986102|Jan-Cil Singapore|VP MEDICAL AFFAIRS ASIA PACIFIC|+65 6827 6753||
20533238|NCT04635280|Air Liquide|Marie-Danielle MILCENT / Clinical Project Manager|+33 (0)1 84 76 42 39|fralsi-ctpublication@airliquide.com|
20533239|NCT04135352|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20533240|NCT00965991|University of New Mexico|Lisa Moore|5052727028|hkhawaja@salud.unm.edu|
20533241|NCT01392495|Novartis Pharmaceuticals|Study Director|862-778-8300||
20533242|NCT00449007|Perelman School of Medicine, University of Pennsylvania|Maria A. Oquendo, M.D., Ph.D.|215-662-2818|moquendo@pennmedicine.upenn.edu|
20533243|NCT00819832|UT MD Anderson Cancer Center|Dawid Schellingerhout, MD/Asst. Professor||CR_Study_Registration@mdanderson.org|
20533244|NCT01452789|Thomas Jefferson University|Walter Kraft|215 955 9077|walter.kraft@jefferson.edu|
20533245|NCT00147537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533246|NCT01089543|Eisai Inc.|Yoshiumi Okubo, Study Director|+81-3-3817-3908|y4-okubo@hhc.eisai.co.jp|
20533247|NCT03124602|Masimo|Tala Harake|9492977459|studies@masimo.com|
20533248|NCT00468546|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20533249|NCT05370209|Circius Pharma AB|Maria Carlsson|+46 (0) 31-81 84 00|RAQA@circiuspharma.com|
20533250|NCT00472641|Stanford University School of Medicine|Dr. Po W. Wang|650-723-2483|wangp0@stanford.edu|
20533251|NCT02006654|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20533252|NCT01933425|Herlev Hospital, University of Copenhagen, Department of Anesthesiology|Dr. Matias Vested Madsen|+4538689058|matias.vested.madsen@regionh.dk|
20533253|NCT03438656|University of Washington|Assistant Professor|414-331-4871|jennessj@uw.edu|
20533254|NCT00684554|New York State Psychiatric Institute|Dr. Frances Levin|646-774-6137|frl2@columbia.edu|
20533255|NCT03319654|Antwerp University Hospital, Belgium|Dr. Alessa Sugihara|00328213684|alessa.sugihara@uza.be|
20533256|NCT02882178|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
20533257|NCT04128228|Department of Psychiatry, Yale University School of Medicine|Dongju Seo|475-441-3457|dongju.seo@yale.edu|
20533258|NCT05652140|Department of Physical Education and Sport Sciences, National Taiwan Normal University|Dr. Yu-Kai Chang|+886277493223|yukaichangnew@gmail.com|
20533259|NCT03375164|Sarepta Therapeutics, Inc.|Medical Director|888-727-3782|SareptAlly@sarepta.com|
20533260|NCT02402036|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
20533261|NCT04401293|System Director - Anticoagulation and Clinical Thrombosis Services Northwell Health at Lenox Hill Hospital Affiliation: Northwell Health|Alex Spyropoulos, MD|(212) 434-6776|aspyropoul@northwell.edu|
20533262|NCT01026038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533263|NCT03679884|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
20533264|NCT02774278|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20533265|NCT05181657|University of California, San Diego|Dr. Steffanie Strathdee|858-822-1952|sstrathdee@health.ucsd.edu|
20533266|NCT03782103|Zurex Pharma|Andrew Morgan Exec. VP RA/QA Clinical|16082175239|amorgan1@charter.net|
20533267|NCT00066937|Johns Hopkins University|Jennifer Haythornthwaite|410-550-7985|jhaytho1@jhmi.edu|
20533268|NCT00063232|National Institute of Diabetes and Digestive and Kidney Diseases|Jay Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
20533269|NCT02903381|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|irene_ghobrial@dfci.harvard.edu|
20533270|NCT00236197|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
20533271|NCT06868667|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20533272|NCT05330429|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20533273|NCT00655746|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20533274|NCT03178942|Encube Ethicals Pvt ltd|GM-Strategy & Commercial|+91-22-6228-8000|Pratik.K@EncubeEthicals.com|8003
20533275|NCT06097273|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20533276|NCT03020082|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
20533277|NCT00684138|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20565675|NCT01144455|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
20565676|NCT05643196|NYU Langone Health|Wei Qi|212-961-4492|wei.qi@nyulangone.org|
20565677|NCT04282109|APICES|Juan Luis Sanz (MW)|+34 918166804|juanluis.sanz@apices.es|103
20565678|NCT03786926|HUTCHMED Limited|Chao Pan|(+86)15215192478|chaop@hutch-med.com|
20533278|NCT03435107|Academic Research Office, Clinical Trial Center, Asan Medical Center|Project manager|82-2-3010-7187|jiyun.an@amc.seoul.kr|
20565679|NCT01746979|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
20565680|NCT05988398|University of Michigan|Dr. Katie M Edwards|734-647-8812|edkatie@umich.edu|
20565681|NCT05891275|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565682|NCT00319046|Actelion Pharmaceuticals Ltd|Cécile Luzy, MSc/Clinical Research Scientist|+ 41 61 565 6386||
20565683|NCT05757193|Duke University|Senthil Selvaraj, MD|919-660-0730|Senthil.Selvaraj@duke.edu|
20565684|NCT04323397|Prince of Songkla University|Anucha Thatrimontrichai|66 74451257|tanucha@medicine.psu.ac.th|
20565685|NCT04908930|Wake Forest University Health Sciences|Jillian Urban, PhD|336.716.0947|jurban@wakehealth.edu|
20565686|NCT03771612|UCLA|Naomi Eisenberger|3108494330|neisenbe@ucla.edu|
20565687|NCT05334355|Montclair State University|Dr. Evan Matthews, Associate Professor|9736553948|matthewse@montclair.edu|
20565688|NCT05698368|Stanford University|Dr. Melissa Boswell|(650) 725-4009|boswellm@stanford.edu|
20565689|NCT04494958|APICES|Juan Luis Sanz|91 816 68 04|juanluis.sanz@apices.es|112
20565690|NCT03547271|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
20565691|NCT04835363|University of Malaga|Garcia-perez, Patricia|+34 675447206|terapiaocupacional.patricia@gmail.com|
20565692|NCT04198701|Medtronic, Inc.|Clinical Research Specialist|800-328-2518|medtroniccrmtrials@medtronic.com|
20565693|NCT06065735|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20565694|NCT02532621|Phraxis, Inc.|Cindy Setum, PhD|612-801-6730|csetum@phraxis.com|
20565695|NCT03522298|Kazia|Jeremy Simpson|+61 400 410 974|jeremy.simpson@kaziatherapeutics.com|
20565696|NCT04795245|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565697|NCT03904576|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20521145|NCT01468818|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
20565698|NCT01992913|Corporal Michael J Crescenz VA Medical Center|Steven L. Sayers, Ph.D.|(215) 823-5196|steven.sayers@va.gov|
20565699|NCT05718687|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565700|NCT05215054|Eurofins Dermscan Pharmascan|Florence REBER|0472823656|Florence.Reber@cpt.eurofinseu.com|+33
20565701|NCT02933489|ECOG-ACRIN|Director Clinical Research Administration|800-227-5463|dhartfeil@acr.org|4765
20565702|NCT04626427|Becton Dickinson|Simon Lubek, Clinical Program Manager|+33 6 07 56 66 08|simon.lubek@bd.com|
20521146|NCT00296231|University of Iowa|Tarah Colaizy||tarah-colaizy@uiowa.edu|
20521147|NCT02731326|Columbia University|Suzanne Bakken, PhD, RN|212-305-1278|sbh22@columbia.edu|
20521148|NCT01119716|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521149|NCT01442688|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20521150|NCT02643355|Hennepin Healthcare|Dr. Marc Martel|612-873-7448|Edresearch@hcmed.org|
20521151|NCT04380090|Cleveland Clinic Lutheran Hospital|Kathleen Gonzalez|2162174226|gonzalk2@ccf.org|
20521152|NCT01974440|Janssen Research & Development, LLC|Executive Medial Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521153|NCT00762437|AbbVie|Sally Hallas, RN|209-294-5571|sally.hallas@abbvie.com|
20521154|NCT00302081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20521155|NCT04480710|Hepion Pharmaceuticals Inc|Clinical Operations|732-902-4016|jgreytok@hepionpharma.com|
20521156|NCT04480021|University of Washington|Dr. Amritha Bhat|206-543-3117|amritha@uw.edu|
20521157|NCT05084963|Revolo Biotherapeutics|Chief Medical Officer|(888) 599-7431|clinicaltrials@revolobio.com|
20521158|NCT03569228|Department of Veterans Affairs|Candice Quinn, Principal Investigator|919-922-8046|candice.quinn@va.gov|
20521159|NCT03819049|Janssen Research & Development, LLC|Trial Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521160|NCT01986010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521161|NCT00115297|UMass|Craig M. Lilly, MD|508-868-5106|craig.lilly@umassmed.edu|
20521162|NCT01335997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521163|NCT00536263|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20521164|NCT00826449|University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, Associate Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
20521165|NCT01103466|Coloplast A/S|Dr. Lis Hentze Poulsen|4549111111|dklhp@coloplast.com|
20521166|NCT02994940|UC Davis Anesthesiology & Pain Medicine|Richard L. Applegate II MD|916-734-5028|rapplegate@ucdavis.edu|
20521167|NCT01019928|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
20521168|NCT02331368|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
20521169|NCT04300010|UW School of Medicine and Public Health|Eric Cotter, MD|920.362.9221|ecotter@uwhealth.org|
20521170|NCT03670264|Children's Hospital of Philadelphia|Dr. Brian Jenssen|215-554-4390|jenssenb@chop.edu|
20521171|NCT00725751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521172|NCT02302859|The University of Texas (UT) MD Anderson Cancer Center|Dr. Lorna McNeill, MPH,PHD/ Chair, Health Disparities Research|713- 563-1103|lmcneill@mdanderson.org|
20521173|NCT02365870|Johns Hopkins University School of Medicine|Dr. Gregory Pontone|(410) 502 - 0477|gpontone@jhmi.edu|
20521174|NCT02205983|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
20521175|NCT03283761|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
20521176|NCT01941940|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20521177|NCT02523196|University of Colorado Denver|Dr. Amanda Wieland|720-848-2291|amanda.wieland@cuanschutz.edu|
20533279|NCT04566510|UCSF|Dr. Grant Dorsey|628-206-4680|grant.dorsey@ucsf.edu|
20533280|NCT03635996|Milestone Pharmaceuticals Inc.|Cameron Szakacs _PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
20533281|NCT04359680|Romark, L.C.|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
20533282|NCT01832038|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20533283|NCT02596893|Celgene Corporation|Anne Mcclain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20533284|NCT03280615|Institute of Nutrition and Food Technology University of Chile|Dr. Francisco Perez Bravo, Director|+5629781411|fperez@inta.uchile.cl|
20533285|NCT03052257|Durham VA Medical Center, Durham, NC|Dr. Kelly Muir|919-286-0411|Kelly.Muir@va.gov|174035
20533286|NCT00004228|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20533287|NCT01267136|Children's Hospitals and Clinics of Minnesota|Andrea Postier/Clinical Research Program Manager|612-813-6409|andrea.postier@childrensmn.org|
20533288|NCT00432991|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
20533289|NCT01755156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533290|NCT03048019|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kbliden@lifebridgehealth.org|
20533291|NCT00862277|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20533292|NCT00382863|Paracor Medical, Inc.|Michael Kolber, General Manager, VP of Regulatory Affairs|408-734-6000|info@paracor.com|
20533293|NCT01292473|Genentech, Inc|Medical Communications|800 821-8590||
20533294|NCT04432298|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1346|jcharpentier@fibrogen.com|
20533295|NCT00348374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20533296|NCT02062008|University of California San Francisco|miguel hernandez pampaloni|4153531886|miguel.pampaloni@ucsf.edu|
20533297|NCT03777176|Zealand Pharma|Sune Birch|+45 5060 3864|SBirch@zealandpharma.com|
20533298|NCT02070380|Bracco Diagnostics, Inc.|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
20533299|NCT03023683|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20533300|NCT01682603|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
20533301|NCT01791205|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20533302|NCT01697501|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20533303|NCT02242903|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20533304|NCT02197065|Hospital for Special Surgery|Anne R. Bass, MD|212-774-7043|bassa@hss.edu|
20533305|NCT01018056|Johns Hopkins University|Dr. Harvey S. Singer|410-955-7212|hsinger@jhmi.edu|
20533306|NCT00983801|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20533307|NCT02261532|Taiho Pharmaceutical co., ltd.|Clinical Trial Registration Contact|+81-3-3293-2113|toiawase@taiho.co.jp|
20533308|NCT01063881|Janssen Research & Development, LLC|Sr. Director CDTL, RA CVM Urology|1 908 704-4648||
20533309|NCT01340170|Dentsply Sirona Implants|Manager of Global Clinical Reseach|+46313763500|clinicalresearchmolndal@dentsplysirona.com|
20533310|NCT00066170|Jazz Pharmaceuticals, Inc|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
20533311|NCT01370642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533312|NCT01928576|Johns Hopkins|Amber Michalik|667-306-8336|amichal2@jhmi.edu|
20533313|NCT00987935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533314|NCT00452530|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20533315|NCT02222181|Unesp|Fernanda Mariana de Oliveira|+551636640217|femoliveira12@gmail.com|
20533316|NCT03888482|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20533317|NCT03721107|4D pharma plc|Programme Development Director|+4401138950130|clinicaltrials@4dpharmaplc.com|
20533318|NCT02294019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533319|NCT00846482|Montefiore Medical Center|Dr. Sanjay Goel|718-405-8404|sgoel@montefiore.org|
20533320|NCT01189227|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
20533321|NCT00968968|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20533322|NCT01083472|LifeCell|Sandra VanGuldener|310612504695|svanguldener@lifecell.com|
20533323|NCT00964444|Pinnacle Health|David B. Peisner MD|717-231-8472|dpeisner@pinnaclehealth.org|
20533324|NCT03315559|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20533325|NCT04002557|Imperial College London|Ms Ann-Eneli Allas|07508775892|anastassija@hotmail.com|
20533326|NCT02687165|New York State Psychiatric Institute|Alla Landa PhD|6467746717|AL2898@cumc.columbia.edu|
20533327|NCT02278237|University of Chicago|Valerie G. Press, MD, MPH|773-702-5170|vpress@medicine.bsd.uchicago.edu|
20533328|NCT01300065|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20533329|NCT00682435|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
20533330|NCT03760666|Clear Creek Bio, Inc.|Vice President, Clinical Operations|(617) 765-2252|clinical@clearcreekbio.com|
20533331|NCT02129556|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
20533332|NCT03721367|Baylor College of Medicine|Dr. Lindsay Burrage|832-822-4280|burrage@bcm.edu|
20533333|NCT01800058|Hospital Universitario de La Princesa|Almudena Zapatero, MD PhD|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
20533334|NCT00800384|Population Health Research Institute, McMaster University|Dr. Jeff Healey|001 905 330 6760|jeff.healey@phri.ca|
20565703|NCT03990883|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+43 2262 684680|clinical.studies@croma.at|
20565704|NCT01612351|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20565705|NCT03697408|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20565706|NCT04595331|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20521178|NCT03118570|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20521179|NCT00006721|SWOG Statistical Center|Study Statistician|206-667-4623||
20521180|NCT03653507|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20521181|NCT05205772|University of North Carolina at Chapel Hill|Miriam Sklerov, MD, MS|984-974-4401|miri@email.unc.edu|
20521182|NCT03299088|U of California Davis|Leslie Garcia|916-734-0156|lesgarcia@ucdavis.edu|
20521183|NCT03986138|Guerbet|Frantz Hebert, Global Head of Clinical Development|+33 (0)6 80 24 93 34|frantz.hebert@guerbet.com|
20521184|NCT04305587|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521185|NCT01523457|Yale University|Jill Lacy|+1 (203) 737-1600|jill.lacy@yale.edu|
20521186|NCT01367665|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20521187|NCT02492880|Boston Scientific|Director of Clincial Sciences|855-213-9890|BSNClinicalTrials@bsci.com|
20521188|NCT01200992|Prometic Biosciences Inc.|Aline Hagerimana, MD, Senior Director Clinical Affairs|(514) 781-0115|a.hagerimana@prometic.com|
20521189|NCT00792935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521190|NCT03186781|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
20521191|NCT05984186|Vapotherm|Katherine Gerich|5854696753|kgerich@vtherm.com|
20521192|NCT03398070|Massachusetts General Hospital|David Perez|6177262000|dlperez@partners.org|
20521193|NCT00197392|Codman & Shurtleff, Inc|J. Thomas Megerian, MD|508.880.8274|jmegeri1@its.jnj.com|
20521194|NCT02622113|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20521195|NCT00667810|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521196|NCT02369900|Beth Israel Deaconess Medical Center|Michael N. Cocchi MD|617-754-2388|mcocchi@bidmc.harvard.edu|
20521197|NCT01570686|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20521198|NCT00673153|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS|(206) 667-3599||
20521199|NCT01916590|UColorado|Colleen Dingmann R.N. Ph.D.|303-724-7494|colleen.dingmann@ucdenver.edu|
20521200|NCT04112173|University of Delaware|Jeremy Crenshaw, Ph.D.|302-831-4795|crenshaw@udel.edu|
20521201|NCT01561430|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20521202|NCT01736241|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20521203|NCT00622466|The University of Texas Southwestern Medical Center|Dr. Barbara Haley|214-648-4180|barbara.haley@utsouthwestern.edu|
20521204|NCT02654860|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
20521205|NCT04453202|Janssen Vaccines & Prevention B.V.|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521206|NCT00001586|National Cancer Institute, National Institutes of Health|Wyndham H. Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
20521207|NCT01355159|Ottawa Hospital Research Institute|Dr. Mark Walker|6137378899|mwalker@ohri.ca|76655
20521208|NCT03276221|Massachusetts General Hospital|Randi M. Schuster, PhD|617-643-6673|rschuster@mgh.harvard.edu|
20521209|NCT00424775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20521210|NCT00681590|University of Miami|Dr. Silvina Levis|305-575-3388|slevis@miami.edu|
20521211|NCT02912650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521212|NCT02562482|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Grace Chen, Deputy Chief, Clinical Trials Program, Vaccine Research Center|240-669-2809|grace.chen@nih.gov|
20521213|NCT02876926|Brown University School of Public Health|Dr. Tyler Wray|401-863-6659|tyler_wray@brown.edu|
20521214|NCT00916136|Vanderbilt|William Obremskey MD MPH|615-936-0112|william.obremskey@vanderbilt.edu|
20521215|NCT00975286|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20521216|NCT02357342|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
20521217|NCT01674647|Bayer HealthCare AG|Bayer HealthCare AG||clinical-trials-contact@bayerhealthcare.com|
20521218|NCT00944749|National Heart Lung and Blood Institute|Dr Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
20521219|NCT01490866|SCRI Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
20521220|NCT04135196|Worcester Polytechnic Institute|Dr. Karen Troy|1-(508)-831-5000|ktroy@wpi.edu|6093
20521221|NCT01733147|Mayo Clinic|Dr. Prasad Iyer|507-293-7911|iyer.Prasad@mayo.edu|
20521222|NCT03212521|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20521223|NCT00444457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521224|NCT01401049|NYU School of Medicine|Mitchell Lee, MD|212.263.5071|mitchell.lee@nyumc.org|
20521225|NCT00914459|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521226|NCT03201211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20521227|NCT01970865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521228|NCT01661179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20521229|NCT01946191|University of Utah|Dr. Molly Conroy|801-581-8310|Molly.Conroy@hsc.utah.edu|
20521230|NCT02041091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20521231|NCT01083810|Abbott|Global Medical Services|1-800-633-9110||
20521232|NCT01602965|Istituto Ortopedico Rizzoli|Mariela Terrafino|0516366694|cristiana.forni@ior.it|0039
20533335|NCT01064622|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
20533336|NCT03772340|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|2027343400|clinicaltrials@vandapharma.com|
20533337|NCT02946996|Medical University of South Carolina|Tricia Bentz CTO Administrative Director|8437921415|adraleta@musc.edu|
20533338|NCT04967417|Samsung Medical Center|Myung-Ju Ahn|+82-2-3410-3438|silkahn@skku.edu|
20533339|NCT01245049|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533340|NCT00450749|University of Texas MD Anderson Phase I/II Prevention Consortium|Powel H Brown, MD, PhD/Professor of Medicine and Cancer Prevention|713-792-2830|PHBrown@mdanderson.org|
20533341|NCT02151604|Oxford University Hospitals NHS Foundation Trust|Avianna Laws, Clinical Research Operations Manager|01865 (2)26221|avianna.laws@ouh.nhs.uk|
20533342|NCT00537082|Novartis Pharmaceuticals|Study Director|862-778-8300||
20533343|NCT01395537|Case Comprehensive Cancer Center|David Adelstein MD|216-444-9310|adelstd@ccf.org|
20533344|NCT02568254|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan BSc, OD, FAAOPrincipal Research Optometrist|904 443 3449|CColesb@ITS.JNJ.com|
20533345|NCT04495478|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20533346|NCT02931539|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20533347|NCT02059642|Alcobra|Dr. Jonathan Rubin|610-940-1631|jrubin@alcobra-pharma.com|
20533348|NCT03061214|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20533349|NCT00107614|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
20533350|NCT02722330|ENT Department, Royal Hallamshire Hospital, Sheffield|Professor Jaydip Ray|+44 (0)114 271 1900|jaydip.Ray@sth.nhs.uk|
20533351|NCT04392362|University of Pretoria|Dr. Amanda Makhubela|0722746091|neurosurgeon76@gmail.com|
20533352|NCT01934231|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533353|NCT02457546|Ethicon, Inc.|Richard Kocharian, MD, PhD|1-908-218-2013|rkochar1@its.jnj.com|
20533354|NCT01897896|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20533355|NCT00363467|H. Lee Moffitt Cancer Center|Jeffrey Lancet MD|813-745-6841|Jeffrey.Lancet@moffitt.org|
20533356|NCT02918630|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|(713) 486-2796|Jin.Ho.Yoon@uth.tmc.edu|
20533357|NCT05069415|Carolina Eyecare Physicians, LLC|Director of Clinical Trials|8438813937|hps@cepmd.com|
20533358|NCT03160573|University Health Resources Group|Sushma Nachnani, MS, PhD|(310) 645-8576|sushnach@yahoo.com|
20533359|NCT00101400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20533360|NCT01620047|Gulf-to-Bay Anesthesiology Associates LLC|Director of Research|813-844-4413|rkarlnoski@fgtba.com|
20533361|NCT01489826|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
20533362|NCT03142451|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20533363|NCT00090402|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
20533364|NCT04250675|Purdue University|Bruno Roseguini|7654906284|brosegui@purdue.edu|
20533365|NCT02743312|San Francisco State University|Dr. Diane Allen|4153386837|ddallen@sfsu.edu|
20533366|NCT00871000|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533367|NCT01052428|University of Alabama at Birmingham|Louis J. Dell'Italia, M.D.|205-934-0850|loudell@uab.edu|
20533368|NCT02168439|Children's Hospital of Pittsburgh of UPMC|Desiree Neville|4126927692|desiree.neville@chp.edu|
20533369|NCT03400787|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20533370|NCT03912805|Clinical Research Management Group|Patrick Murphy|(866) 337-1868|p.murphy@crmg-usa.com|
20533371|NCT02451007|Pharma Mar, S.A.|Clinical Development Department of PharmaMar's Oncology Business Unit|+34 91 846 60 00|clinicaltrials@pharmamar.com|
20533372|NCT00449787|Montefiore Medical Center|Benjamin Friedman|718-920-6626|bwfriedmanmd@gmail.com|
20533373|NCT01716559|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20533374|NCT01631929|HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE|Ferreira Juan Pablo MD|+5491136085959|ferreirajuanpablo@hotmail.com|
20533375|NCT04334681|Principal investigator|Dr. Alpaslan Şahin|0332310500|drasahin@gmail.com|50510
20533376|NCT00782379|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
20533377|NCT02327143|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20533378|NCT01585207|Icahn School of Medicine at Mount Sinai|Dr. Barbara J. Coffey|212-659-1663|Barbara.coffey@mssm.edu|
20533379|NCT02595437|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
20533380|NCT02695771|Corewell Health|Dr. Brian Lane|616-267-7333|brian.lane@corewellhealth.org|
20533381|NCT02925143|Herlev Hospital|Dr. Jakob Thomsen|004538683868|dr.j@demants.dk|
20533382|NCT02180672|The Children's Hospital of Philadelphia|Ignacio Tapia, MD, Principal Investigator, Associate Professor|(267) 426-5842|tapia@chop.edu|
20565707|NCT05207033|University of Massachusetts Chan Medical School|Elise Stevens, Assistant Professor|(774) 455-6684|elise.stevens@umassmed.edu|56684
20565708|NCT04300127|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
20521233|NCT01822574|Mayo Clinic|Robert T. Trousdale, M.D.|507-284-6586|trousdale.robert@mayo.edu|
20521234|NCT03071094|Transgene|Associate Medical Director|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
20521235|NCT02312063|Kansai Electric Power Medical Research Institute|Dr. Daisuke Yabe|+81-6-6458-5821|ydaisuke-kyoto@umin.ac.jp|
20521236|NCT04625426|Tan Tock Seng Hospital|George Glass, Nurse Researcher|+65 6903-5440|glass_george_frederick@ttsh.com.sg|
20521237|NCT01573169|Stroke Unit and Division of Internal and Cardiovascular Medicine University of Perugia, Santa Maria della Misericordia Hospital|Dr. Maurizio Paciaroni|+390755786424|maurizio.paciaroni@unipg.it|
20521238|NCT00321737|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20533383|NCT03574389|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565709|NCT05412004|Eli Lilly and Company|Chief Medical Officer|800-459-5979|ClinicalTrials.gov@lilly.com|
20565710|NCT04644029|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521239|NCT01079832|Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
20521240|NCT02283294|University of South Florida|David Rose, MD|813-259-8577|drose1@usf.edu|
20521241|NCT00594646|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org|
20521242|NCT03544879|UC San Diego|Dr. Erik Groessl|858-642-6347|egroessl@ucsd.edu|
20521243|NCT01769339|Janssen Philippines|Medical Affairs Manager|+6328248935||
20521244|NCT01195272|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20521245|NCT01745211|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20521246|NCT03548064|University of Maryland|Wilbur H. Chen, MD, MS|410-706-1188|wchen@som.umaryland.edu|
20521247|NCT04941729|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20521248|NCT05424042|Wake Forest University School of Medicine|Cynthia Stowe|336-716-0686|cynthia.stowe@advocatehealth.org|
20521249|NCT05091307|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521250|NCT03611543|Hologic, Inc.|Muhammad Waqas, Director of Global Clinical Affairs, BSH|(508) 263-8935|ClinicalResearch@Hologic.com|
20521251|NCT03047473|Clinique Neuro-Outaouais|Dr Francois Jacques|819-777-2500|francois.jacques@neuro-outaouais.ca|217
20521252|NCT01167257|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
20521253|NCT02752906|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20521254|NCT03283319|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
20521255|NCT01480843|Joslin Diabetes Center|Medha Munshi, MD|617-309-4683|medha.munshi@joslin.harvard.edu|
20521256|NCT00721630|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-5209|trainat@mskcc.org|
20521257|NCT03402555|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
20521258|NCT02213510|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
20521259|NCT04820530|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20521260|NCT03954834|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20521261|NCT01812681|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
20521262|NCT01404923|Laboratoires Mayoly Spindler|Clinical trials Manager|33 134805555|contact_essais_cliniques@mayoly-spindler.fr|
20521263|NCT04208958|Vedanta Biosciences|Jeffrey Silber|(857) 706-1427|ConsortiumIO-ctinquiries@vedantabio.com|
20521264|NCT02326337|AOTI Ltd.|Dr. Mike Griffiths (Medical Director)|+1(760) 431 4700|mike.griffiths@aotinc.net|
20521265|NCT01076686|Pacira Pharmaceuticals|Executive Medical Director|203-837-6500|erolo@pacira.com|
20521266|NCT02244918|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
20521267|NCT00505375|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
20521268|NCT03688282|TheraNova|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
20521269|NCT04234984|Department of Anaesthesiology & Pain Medicine, Maastricht University Medical Centre, Postbus 5800, 6202 AZ Maastricht, The Netherlands.|Prof. Dr. Jan Van Zundert|(+32) 475687657|jan.van.zundert@mumc.nl|
20521270|NCT04796779|University of Virginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20521271|NCT01055132|Johnson & Johnson Vision Care|Ross Franklin|1-904-443-1379|RFrankl1@its.jnj.com|
20521272|NCT02746471|Medtronic|Erika Pouliot|17635261270|erika.pouliot@medtronic.com|
20521273|NCT02564211|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521274|NCT00858962|Yale University AIDS Program|R. Douglas Bruce, MD, MA|(203) 737-6133|robert.bruce@yale.edu|
20521275|NCT04594707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20521276|NCT02534844|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
20521277|NCT00655876|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20521278|NCT00326963|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20521279|NCT00470067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20521280|NCT01265433|Sellas Life Sciences|Dr. Dragan Cicic|646-200-5278|info@sellaslife.com|
20521281|NCT01714232|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20521282|NCT00338455|Scios R&D, Inc.|Sr. Director Clinical Leader|650 564-5084||
20521283|NCT02176408|NYU Langone Health|Kristin Szuhany|6467545161|kristin.szuhany@nyulangone.org|
20521284|NCT01243112|Scott & White Healthcare|James Collins, MD|254-724-7508|jbcollins@swmail.sw.org|0612
20521285|NCT03756506|Prevent-Plus|Jeff Elbl|314-606-5046|jeff.elbl@prevent-plus.com|
20521286|NCT01059344|The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcertive Colitis|Brian G. Feagan et al|Gastroenterology 2013; 145:||149-157
20521287|NCT01739348|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521288|NCT00328016|National Institute on Aging|Jessica McNeeley, Research Fellow|410-558-8110|mcneeleyj@mail.nih.gov|
20521289|NCT01434186|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
20521290|NCT01447420|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20521291|NCT03362112|Nanjing First Hospital|Ma Jianhua|8625-52887092|majianhua196503@126.com|
20521292|NCT04562155|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20521293|NCT00790335|Washington University in St. Louis|Dr. Suresh Vedantham, Principal Investigator|3143622900|vedanthams@mir.wustl.edu|314
20521294|NCT01085201|BloodCenter of Wisconsin|Dr. Joshua J. Field|414-937-3848|joshua.field@bcw.edu|
20533384|NCT05166902|CooperVision|Jose A Vega, OD, MSc, FAAO|9256213761|javega2@coopervision.com|
20533385|NCT00779909|Boston University School of Dental Medicine|Raul I Garcia, DMD|617-638-6385|rig@bu.edu|
20533386|NCT03436420|Emory University|Miriam Vos, MD|404-727-9930|mvos@emory.edu|
20533387|NCT02944461|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
20533388|NCT01061710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533389|NCT00159874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533390|NCT01234714|University of Zurich|Dr Dimitri Aristotle Raptis, Principal Investigator|+41442553300|dimitri.raptis@usz.ch|
20533391|NCT01550965|AbbVie|Global Medical Information|800-633-9110||
20533392|NCT03093246|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
20533393|NCT04045145|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20533394|NCT03374956|Mayo Clinic|Andres Acosta|507-266-6931|acosta.andres@mayo.edu|
20533395|NCT02771145|Alcon, A Novartis Division|Sr. Clinical Project Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20533396|NCT00276380|Ipsen|Medical Director||clinical.trials@ipsen.com|
20533397|NCT01651208|University of Miami|Ana M. Palacio|3052439754|apalacio2@med.miami.edu|
20533398|NCT01391299|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20533399|NCT02067156|University of California, San Diego Moores Cancer Center|Dr. David Piccioni|858-657-7000|dpiccioni@ucsd.edu|
20533400|NCT03596983|NYU Langone Health|Susan Malone, PhD, RN|212 992-7047|Susan.Malone@nyulangone.org|
20533401|NCT03473301|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
20533402|NCT04829214|Otonomy, Inc.|Medical Information|+1 844-686-4636|medinfo@otonomy.com|
20533403|NCT05287685|Florida International University|Shayl Griffith, PhD|305-348-9891|shagriff@fiu.edu|
20533404|NCT02571244|Federal University of Juiz de Fora/Brazil|Dr. Erica Cruvinel|55-32-99174-8855|ericacruvinel@gmail.com|
20533405|NCT01696214|University of California San Diego|Dr. Joe Ramsdell|619-543-7241|jramsdell@ucsd.edu|
20533406|NCT01570192|University of Florida, Department of Medicine|Dr. George L. Drusano|407-313-7060|gdrusano@ufl.edu|
20533407|NCT02134028|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20533408|NCT02965976|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
20533409|NCT00806026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533410|NCT00930787|LifeCell|Dr Michael Franz|908094701100|mfranz@lifecell.com|
20533411|NCT02777190|Penn State Milton S. Hershey Medical Center|Dr. Jaimey Pauli|717-531-8142|jpauli@pennstatehealth.psu.edu|5
20533412|NCT01903733|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533413|NCT01248468|Novartis Consumer Health|Clinical Project Leader|973-503-8000||
20533414|NCT00563316|Amgen Inc.|Study Director|866-572-6436||
20533415|NCT00908908|Eisai Call Center|Eisai Inc.|888-422-4743||
20533416|NCT00425854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533417|NCT01378273|University of Washington|Sandra Juul MD, PhD|2062216814|sjuul@uw.edu|
20533418|NCT00567229|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
20533419|NCT00979615|Alcon Research, Ltd.|Maria J. Tort, PhD|(817) 302-5968|Maria.Tort@alconlabs.com|
20533420|NCT01630811|Sutter Medical Group, Neurology|Michael Chez, MD|(916) 454-6667|ChezM@sutterhealth.org|
20533421|NCT01217411|University of Texas (UT) MD Anderson Cancer Center|Morris D. Groves, MD / Professor|713-792-2573|mgroves@mdanderson.org|
20533422|NCT04818086|Virginia Commonwealth University|Dr. Frederick Gerald Moeller|804-828-4134|fgmoeller@vcu.edu|
20533423|NCT05094102|University of Wisconsin School of Medicine and Public Health|Heather Neuman, MD, MS|(608) 262-2025|neuman@surgery.wisc.edu|
20533424|NCT06048705|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20533425|NCT03508440|University of Missouri|Rebecca Schneider, Assistant Director of Research|573-882-2549|schneiderri@health.missouri.edu|
20533426|NCT02113878|Dana Farber Cancer Institute|Glenn J. Hanna, MD|617.632.6799|GJHanna@partners.org|
20533427|NCT01251965|The University of Texas (UT) MD Anderson Cancer Center|Srdan Verstovsek, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20533428|NCT01027754|Albert Einstein College of Medicine/Montefiore Medical Center|Dr. Shadi Nahvi|718 920 5379|SNAHVI@montefiore.org|
20533429|NCT00530257|The Children's Hospital of Philadelphia|Dr. Nathan Blum|215-590-6336|blum@email.chop.edu|
20533430|NCT00385515|Mucosal Therapeutics, LLC|Eward G. Fey, PhD|857-228-1100||
20533431|NCT02562040|Brigham and Women's Hospital|Dr. Susan Redline|(617) 732-5500|sredline@bwh.harvard.edu|
20533432|NCT05130281|Weill Cornell Medicine|Maddy Schier|(646) 289-5271|mas4019@med.cornell.edu|720
20533433|NCT00368849|The University of Iowa|Leigh J. Beglinger, Ph.D.|319-335-8765|leigh-beglinger@uiowa.edu|
20533434|NCT04804709|Columbia University Irving Medical Center|Cheng-Chia Wu, MD, PhD|646-317-3033|cw2666@cumc.columbia.edu|
20533435|NCT02006836|Huazhong University of Science and Technology|Dr.Yu|862783662883|xfyu188@163.com|
20533436|NCT01902303|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
20565711|NCT05020353|Li Ka Shing Knowledge Institute, St. Michael's Hospital|Sean B. Rourke|(416) 878-2779|sean.rourke@utoronto.ca|
20565712|NCT05132400|NYU Langone Health|Marco Campello, PT, PhD|212-255-6690|Marco.campello@nyulangone.org|
20565713|NCT00640978|UT MD Anderson Cancer Center|Milind Javle, MD/Associate Professor|713-792-2828|mjlim@mdanderson.org|
20565714|NCT03801616|Cedars-Sinai Medical Center|Dr. Alice Chung|3104239331|alice.chung@cshs.org|
20565715|NCT02611687|Bioprojet Pharma|Clinical Project Manager|+33 (0)1 47 03 66 23|a.viatte@bioprojet.com|
20533437|NCT01699685|Novartis Pharmaceuticals|Study Director|862-778-8300||
20533438|NCT05058456|Shockwave Medical|Kavita Arjungi|1-510-279-4262|karjungi@shockwavemedical.com|
20533439|NCT01654250|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533440|NCT01866150|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20533441|NCT03810365|School of Nursing, University at Buffalo|Dr Suzanne S. Dickerson|716-829-3254|sdickers@buffalo.edu|
20533442|NCT00600704|Larissa University Hospital Dept. of Anesthesiology|Dr Athina Kleitsaki|00306948481865|theoath1@gmail.com|
20533443|NCT03137407|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20533444|NCT02683954|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
20533445|NCT02255279|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20533446|NCT02389738|Johns Hopkins/NIH|Principal Investigator|4109558837|sjacks78@jhmi.edu|
20533447|NCT01730729|Northwestern University|Cesar Santa-Maria, MD|312-695-6180|cancertrials@northwestern.edu|
20533448|NCT01889563|Federal university of Sao Carlos|Audrey Borghi e Silva|+55 163351-8952|audrey@ufscar.br|
20533449|NCT03408808|NHS Grampian|Miss Katharine Hamlin|0845 456 6000|katharine.hamlin@nhs.scot|56755
20533450|NCT02402907|Icahn School of Medicine at Mount Sinai|Dr. Joanne Stone|212-241-5681|joanne.stone@mssm.edu|
20533451|NCT03701074|University of South Alabama|Ramachandra Bhat|2514151055|rbhat@health.southalabama.edu; rambhat79@gmail.com|
20533452|NCT01644331|Duke Clinical Research Institute|G. Michael Felker, MD|919-668-8919|Michael.Felker@duke.edu|
20533453|NCT02685436|Manicure university children hospital|Dr.Ahmed Zaki|0201008335567|drahmedmd17@yahoo.com|
20533454|NCT00661687|Bausch & Lomb Incorporated|Gerard Cairns|(585)338 - 5170|gerard.cairns@bausch.com|
20533455|NCT02837952|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533456|NCT01362530|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533457|NCT01517178|Bispebjerg Hospital|Tonny Karlsmark||tkar0002@bbh.regionh.dk|
20533458|NCT01959919|Pfizer Clinical Trial.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrails.gov_Inquiries@Pfizer.com|
20533459|NCT02923167|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@mgh.harvard.edu|
20533460|NCT02094885|Ethicon, Inc|Jonathan Batiller, Senior Clinical Director|+1 908 218-2492|JBatill2@its.jnj.com|
20533461|NCT02003898|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20533462|NCT01537432|Novartis Pharmaceuticals|Study Director|862-778-8300||
20533463|NCT01998477|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20533464|NCT01104870|United Therapeutics, Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
20533465|NCT02134808|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu|
20533466|NCT02317042|University of Western Australia|Prof Nigel McArdle & Prof Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
20533467|NCT02150863|Massachusetts General Hospital|Elizabeth Morehouse, Clinical Research Coordinator|617-724-2168|emorehouse@partners.org|
20533468|NCT05965323|University of Washington|Linda K Ko, PhD, Principal Investigator|2062568261|lindako@uw.edu|
20533469|NCT00511199|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20533470|NCT01714063|Department of Pediatrics UAMS/COM|Ariel Perlinkski MT||berlinskiariel@uams.edu|
20533471|NCT03878602|Ospedale Buon Consiglio Fatebenefratelli|Dr.Giuseppe De Bernardo|3357441303|pinodebtin@gmail.com|+39
20533472|NCT03733483|University of Colorado, Anschutz Medical Campus|Christine Swanson, MD, MCR, Assistant Professor|(303)724-0073|christine.swanson@cuanschutz.edu|
20533473|NCT02191397|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533474|NCT00318136|Genentech, Inc.|Medical Communications|800-821-8590||
20533475|NCT02176525|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533476|NCT00478140|The University of Texas (UT) MD Anderson Cancer Center|Dr. Ahmed Kaseb / Associate Professor|713-792-2828|akaseb@mdanderson.org|
20533477|NCT04274218|US Department of Veterans Affairs|Matthew Major|3125035731|matthew.major2@va.gov|
20533478|NCT01185366|UT MD Anderson Cancer Center|Amado Zurita-Saavedra,Associate Professor, Genitourinary Medical Oncology|(713) 563-6966|azurita@mdanderson.org|
20533479|NCT02205359|CRM|Janelle van Wel|+3166 273 886 62|janelle.van.wel@medtronic.com|
20533480|NCT02427672|Nanyang Technological University|Dr. Olivia Choy|(65)65921522|oliviachoy@ntu.edu.sg|
20533481|NCT01684033|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20533482|NCT00480025|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533483|NCT00667589|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
20533484|NCT02792257|Johns Hopkins University|Dr. Paul Rosenberg|4105509883|prosenb9@jhmi.edu|
20533485|NCT02189629|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
20533486|NCT03726879|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20533487|NCT02766478|Emory University|Dr. Jessica Alvarez|404-727-1390|jessica.alvarez@emory.edu|
20533488|NCT01093573|Case Comprehensive Cancer Center|Brenda Cooper MD|(216) 844-3213|Brenda.cooper@uhhospitals.org|
20533489|NCT00553475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20533490|NCT02496156|Nemours Children's Health System|Vicky Funanage, PhD, Operational Vice President for Research|302-651-6819|vfunanag@nemours.org|
20533491|NCT00089583|ViiV Healthcare|GSK Response Center|866-435-7343||
20533492|NCT01412983|Bausch & Lomb|Dr. Robert Steffen|1 585 338 6399|robbert.steffen@bausch.com|
20533493|NCT01623154|Otsuka America Pharmaceutical, Inc|Tao Wang, PhD|240-683-3213|Tao.Wang@otsuka-us.com|
20533494|NCT00890097|Alcon Research, Ltd.|Dana Sager, Clinical Manager Group Leader|1-888-451-3937|alcon.medinfo@alcon.com|
20533495|NCT04349098|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20533496|NCT01703221|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533497|NCT06896734|Eminence Clinical Research, Inc.|Nick Leppo|719-400-7464|nleppo@ecr-inc.com|
20533498|NCT03645681|W. L. Gore & Associates|Bre Lester|480-698-6670|blester@wlgore.com|
20533499|NCT05333965|CooperVision|Jose A. Vega, OD, MSc, FAAO|9256213761|jvega2@coopervision.com|
20533500|NCT02570425|Sydney Medical School, University of Sydney & Woolcock Institute of Medical Research|Assoc Prof Sinthia Bosnic-Anticevich|+61 2 9114 0040|sinthia.bosnic-anticevich@sydney.edu.au|
20533501|NCT00835549|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20521295|NCT00528411|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20533502|NCT00835042|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20533503|NCT04008069|Stanford University, School of Medicine, Immunology & Rheumatology|Dr. Matthew C. Baker, Principal Investigator|650- 498-4528|mbake13@stanford.edu|
20533504|NCT04543786|University of Pittsburgh|Lee Fisher|412-383-1329|lef44@pitt.edu|
20533505|NCT04601493|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
20533506|NCT02314247|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20533507|NCT01953354|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20533508|NCT00489359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20533509|NCT03180138|Johns Hopkins University|Sanjay K Jain|4105028241|sjain5@jhmi.edu|
20533510|NCT04191733|DePuy Orthopaedics|FRANCHISE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20533511|NCT01775410|Avinger, Inc.|Director of Clinical Trials|650 241 7030|tlawson@avinger.com|
20533512|NCT01260311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533513|NCT02633527|Supernus|Joseph Hull, PhD, Director Clinical Research|240-403-5324|jhull@supernus.com|
20533514|NCT01950039|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 2635|mary.elizabeth.patti@joslin.harvard.edu|
20533515|NCT04135443|dfusion, Inc|Tamara Kuhn, Vice President and Research Scientist|831-222-5003|tamara.kuhn@dfusioninc.com|
20533516|NCT00728182|NoNO Inc.|Roberta Anderson, Vice President of Clinical Development|613 833-1020|randerson@nonoinc.ca|
20533517|NCT02236767|Hartford Hospital|Gretchen Diefenbach|860-545-7396|gretchen.diefenbach@hhchealth.org|
20533518|NCT03856177|University of New Mexico|Dr. James F. Cavanagh|4158670303|jcavanagh@unm.edu|
20533519|NCT01898091|Medical University of South Carolina|Susan G. Reed, DDS, MPH, DrPH|843 792-1577|reedsg@musc.edu|
20533520|NCT03211832|Prevention Research Center, Brown School, Washington University in St. Louis|Ross Brownson|3149350121|rbrownson@wustl.edu|
20533521|NCT03000751|University of California San Francisco|Rebecca Smith-Bindman, MD|415-353-4946|rebecca.smith-bindman@ucsf.edu|
20533522|NCT02268305|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20533523|NCT03888287|Hackensack Meridian Health|Hooman Azmi, MD|201-342-2550|hooman.azmi@hmhn.org|
20533524|NCT02913326|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533525|NCT01514422|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
20533526|NCT01725308|Astellas Pharma Inc.|Head of Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
20533527|NCT02598973|Crescenz VA Medical Center|James Morley|215-823-5934|james.morley@va.gov|
20533528|NCT02844075|Yonsei University|Byoung Chul Cho|+82 2 2228 4190|cbc1971@yuhs.ac|
20533529|NCT02592655|Marcus Migura|Marcus Migura|(619) 436-7323|mwmigura@gmail.com|
20533530|NCT02971137|VA Connecticut Healthcare System|Dr. Lori A. Bastian|203-932-5711|lori.bastian@va.gov|2655
20533531|NCT01217515|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
20533532|NCT00215657|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20533533|NCT02614066|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
20533534|NCT04565756|Exonate|Loic Lhuillier|+44 (0)1223 734716|loic.lhuillier@exonate.com|
20533535|NCT01331330|Abbott Medical Devices|Devyani Nanduri|+1 510-561-4328|devyani.nanduri@abbott.com|
20533536|NCT05226884|Clinical Research Coordinator|Diana Hill|713-526-1600|diana.hill@berkeleyeye.com|
20533537|NCT03688139|Weill Medical College of Cornell University|Dr. Jennifer N. Bress|914-997-8683|jeb2061@med.cornell.edu|
20533538|NCT00420056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533539|NCT03274661|Miami Cancer Institute at Baptist Health, Inc.|Dr. John Diaz, Principal Investigator|(786) 527-8284|johnpd@baptisthealth.net|
20533540|NCT01691313|Laguna Pharmaceuticals, Inc.|Howard C. Dittrich|858-405-1429|HDittrich@lagunarx.com|
20533541|NCT00127933|Hoffman-LaRoche|Medical Communications|800-821-8590||
20533542|NCT01339013|Region Skane, Lund University Hospital, Lund, Sweden|Dr Louise Walther Sturesson|+46 46 171953|louise.waltersturesson@skane.se|
20533543|NCT00308282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20533544|NCT01783938|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20565716|NCT03934931|University of California Irvine|Professor Adithya Cattamanchi|415-206-5489|adithya.cattamanchi@uci.edu|
20521296|NCT03893565|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20521297|NCT00851318|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
20521298|NCT05961215|Cedars-Sinai Medical Center|Robert Vescio, MD|3104231825|robert.vescio@cshs.org|
20521299|NCT02944071|BSC International Medical Trading (Shanghai) Co., Ltd|Junyang Bai|+13671646036|junyang.bai@bsci.com|
20521300|NCT01096368|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20521301|NCT06354998|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20521302|NCT05442866|MedStar Health Research Institute|Dr. Hunter Groninger|202-877-7445|hunter.groninger@medstar.net|
20521303|NCT05407714|BSC International Medical Trading (Shanghai) Co., Ltd|Associate Clinical Trial Manager|+13671646036|junyang.bai@bsci.com|
20521304|NCT01616953|University of Michigan|Dr. Darnell Kaigler|734-615-4023|dkaigler@umich.edu|
20565717|NCT05448014|Umeå University|Inga Dennhag, Associate Professor|+46706217414|inga.dennhag@umu.se|
20565718|NCT02047500|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
20565719|NCT03952520|University of North Carolina at Chapel Hill|Jane Chen, PhD|919-966-2537|janechen@live.unc.edu|
20565720|NCT00739908|CeNeRx BioPharma Inc.|Mahnaz Asgharnejad, Pharm.D.; Daniel Burch, M.D.|(919) 655 1435; (919) 674 6041|masgharnejad@cenerx.com; danburch@cenerx.com|
20565721|NCT05157841|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20565722|NCT02299349|TriHealth Hatton Research Institute|Angela N Fellner PhD CCRP|513-862-2330|Angie_Fellner@trihealth.com|
20565723|NCT02075554|Globus Medical Inc.|Brandon Bucklen|610-930-1800|bbucklen@globusmedical.com|2517
20565724|NCT00624442|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
20565725|NCT04933474|Cedars-Sinai Medical Center|Samuel Eberlein|310-423-6721|samuel.eberlein@cshs.org|
20565726|NCT01773993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565727|NCT04993677|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20521305|NCT01568320|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20521306|NCT00762931|electroCore LLC|Clinical Affairs electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
20521307|NCT00816361|MedImmune LLC|Susan Perez MD, MSc|+1 301-398-2827|information.center@astrazeneca.com|
20521308|NCT01394952|Eli Lilly and Company|Chief Medical Officer|800-545-5979|www.ClinicalTrials.gov@lilly.com|
20521309|NCT01031953|Oregon Health & Science University|Dr. Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
20521310|NCT01763684|Zimmer Biomet|Linda Meijer, Clinical Operations Manager|+31786292935|linda.meijer@zimmerbiomet.com|
20521311|NCT02987959|Fox Chase Cancer Center|Protocol Developer|215-728-4097|ryan.romasko@fccc.edu|
20521312|NCT02642575|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20521313|NCT02853370|U.O.C. Haematology - A.O.U. Policlinico Paolo Giaccone, Palermo (Italy)|Dr. Emilio Iannitto|+39 091 6554415|emilio.iannitto@gmail.com|
20521314|NCT01520532|Medtronic AF Solutions|Jay Kelley, Director of Clinical Research|+1.760.827.0076|jay.l.kelley@medtronic.com|
20521315|NCT00643565|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20521316|NCT02317614|Western Michigan University|Dr. Anthony DeFulio|269-387-4459|anthony.defulio@wmich.edu|
20521317|NCT00673244|Department of Anesthesiology and Critical Care Medicine, George Washington University|Lakhmir S. Chawla|202-994-7903|minkchawla@gmail.com|
20521318|NCT03285308|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20521319|NCT02283983|Centre Hospitalier Départemental Vendée|Dr. Frank PRIOU|0251446161|frank.priou@ght85.fr|+33
20521320|NCT03055650|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
20521321|NCT00669071|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20521322|NCT00168311|Monash Alfred Psychiatry Research Centre|Professor Paul Fitzgerald|+61 3 9076 6564|p.fitzgerald@alfred.org.au|
20521323|NCT01157897|WRAIR|Donna Tosh|301-319-9332|donna.m.tosh.ctr@mail.mil|
20521324|NCT01270724|Nationwide Children's Hospital|Megan Blue|614-722-3686|megan.blue@nationwidechildrens.org|
20521325|NCT01791153|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20521326|NCT01150890|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20521327|NCT03970837|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20521328|NCT01412372|University of Utah|Dr. Ashok Tuteja|801-581-5679|Ashok.Tuteja@hsc.utah.edu|
20521329|NCT02876575|Medtronic|Melody LaBeau, Director of Clinical Operations|7635262931|melody.a.labeau@medtronic.com|
20521330|NCT04773301|Complejo Asistencial Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL)|Dr. Agustín Díaz Álvarez|0034 923291353|adiazal@saludcastillayleon.es|
20521331|NCT03786718|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
20521332|NCT00945100|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
20521333|NCT03190213|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
20521334|NCT03244644|Rebiotix inc, a Ferring Company|Clinical Development|651-705-8778|US8-StudyInfo@ferring.com|
20521335|NCT01997216|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20521336|NCT01781481|Children's HOspital of Eastern Ontario|Dr. Janice Cohen|613-737-7600|cohen@cheo.on.ca|2497
20521337|NCT00372411|Dept. of Veterans Affairs, Cooperative Studies Program, West Haven, CT|Peter Guarino, MPH, PhD, Director, WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
20521338|NCT01398514|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
20521339|NCT00754650|Hoffmann-La Roche|Medical Communications|800 821-8590||
20521340|NCT03514641|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
20521341|NCT01345175|Memorial Sloan Kettering Cancer Center|Dr. Philip Paty, MD|212-639-6703|patyp@MSKCC.ORG|
20521342|NCT00642694|UT Southwestern Medical Center|Dr.Prabha Sunderajan- Assistant Professor|214-645-6964|psunderajan@utsouthwestern.edu|
20521343|NCT02906930|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20521344|NCT02570113|Ablative Solutions Inc|Kate Rumrill|+1 (650) 688-9743|krumrill@ablativesolutions.com|
20521345|NCT00910091|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20521346|NCT01908816|Novartis Pharmaceuticals|Study Director|862-778-8300||
20521347|NCT02551432|Seoul National University Hospital|Bhumsuk Keam|82+10-3231-2208|bhumsuk@snu.ac.kr|
20521348|NCT01007942|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20521349|NCT04492020|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20533545|NCT01390584|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20533546|NCT00498485|Rutgers|Dr Benjamin Natelson|973-2236370|bnatelson@chpnet.org|
20533547|NCT03406975|Mayo Clinic|Dr. Barham Abu Dayyeh|507-266-4347|AbuDayyeh.Barham@mayo.edu|
20533548|NCT03072875|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|research@ebpi.org|83
20533549|NCT03111732|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
20533550|NCT00401830|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
20533551|NCT01943825|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20533552|NCT00907088|The Hospital for Sick Children|Dr. Patricia Parkin|416-813-7654|patricia.parkin@sickkids.ca|301544
20533553|NCT04679818|Cleveland Clinic|Kurt Ruetzler|216 636-0561|ruetzlk@ccf.org|
20533554|NCT01292538|Regulatory Insight, Inc.|Elvira Walls|615-712-9743|elvira@reginsight.com|
20533555|NCT00452400|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533556|NCT01539525|Yale University School of Medicine|Kimberly A Yonkers|203-764-6621|kimberly.yonkers@yale.edu|
20533557|NCT01712074|Pfizer|Pfizer|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533558|NCT02268851|Dana-Farber Cancer Institute|Matthew Davids, MD, MMSc|617-632-6331|matthew_davids@dfci.harvard.edu|
20533559|NCT03378635|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
20533560|NCT01472835|Johns Hopkins|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
20533561|NCT02413346|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20533562|NCT01835431|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20533563|NCT02301793|Johns Hopkins Medical Institutions|Elliott R Haut M.D, PhD, Associate Professor of Surgery, Anesthesiology &Critical Care Medicine|410-502-3122|ehaut1@jhmi.edu|
20533564|NCT02978508|Mayne Pharma LLC|Associate Director, Clinical Operations|919 573 7948|phoevos.hughes@maynepharma.com|
20533565|NCT03810495|Go Medical Industries, Pty Ltd|Director of Operations|61(8) 9388 1700|ctc@gomedical.com.au|
20533566|NCT04921800|Northwestern University|Shuai Xu|312-695-3721|stevexu@northwestern.edu|
20533567|NCT04028960|HealthPartners Institute dba International Diabetes Center|Anders Carlson, MD|952-993-1927|Anders.L.Carlson@HealthPartners.Com|
20533568|NCT00954538|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533569|NCT02318979|Denver Research Institute|Judith Jung, DRI Executive Director|303-501-0540|Judith.Jung@dri-va.org|
20533570|NCT01905683|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20533571|NCT01157429|Tulane University|Dr. Michael Scheeringa|5049882167|mscheer@tulane.edu|
20533572|NCT03404375|UTMB Galveston|Antonio Saad|4097721571|afsaad@utmb.edu|
20533573|NCT02290574|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
20533574|NCT01879826|University of California San Francisco|Cynthia Kim|(415)353-1328|cynthia.kim@ucsf.edu|
20533575|NCT03439072|Xeris Pharmaceuticals, Inc.|Martin J. Cummins|312-736-1624|mcummins@xerispharma.com|
20533576|NCT05084885|Centre for Addiction and Mental Health|Dr. Nigel Turner|416-535-8501|nigel.turner@camh.ca|36063
20533577|NCT03992872|Bavarian Nordic|Medical Information|1-844-422-8274|medical.information_NA@bavarian-nordic.com|
20533578|NCT03446690|University of Alabama at Birmingham|Chung How Kau|205-934-1289|ckau@uab.edu|
20533579|NCT00889005|New York Langone Medical Center Department of Psychiatry|Arieh Y. Shalev, M.D.|6467544782|arieh.shalev@nyumc.org|
20533580|NCT00128492|Gilead Sciences, Inc.|Mark Bresnik, Director of Clinical Research|650-522-5934|Mark.Bresnik@gilead.com|
20533581|NCT00612768|SmartPractice|Kathy Shannon|602-225-0595|kshannon@smarthealth.com|7208
20533582|NCT03704922|University of North Carolina at Chapel Hill|Matthew S. Karafin MD MS|984-974-1583|matthew.Karafin@unchealth.unc.edu|
20533583|NCT00756314|IMIP - Instituto Materno Infantil Prof. Fernando Figueira|Ana Laura Carneiro Gomes Ferreira - MD|+558121224779|analaura@imip.org.br|
20533584|NCT04629157|Alder Hey Children's NHS Foundation Trust|Miss Rachel Harwood|0151 228 4811|rachel.harwood@alderhey.nhs.uk|
20533585|NCT02872142|Grifols Bioscience Industrial Group|Michael Woodward|+34 938008784|michael.woodward@grifols.com|
20533586|NCT03956082|Mercy Hospital St. Louis|David Levine, MD|314-251-7650|DAVID.LEVINE@MERCY.NET|
20533587|NCT01079390|Mass General Hospital|Jian Kong|617-726-7893|kongj@nmr.mgh.harvard.edu|
20533588|NCT01903720|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20533589|NCT03627468|Botanix Pharmaceuticals|Anthony Robinson, MS, MBA, CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20533590|NCT00692237|Sapienza University of Rome|Dr Andrea Isidori|+39 0649970540|andrea.isidori@uniroma1.it|
20533591|NCT01347086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533592|NCT02624687|University of Pittsburgh|Bethany Barone Gibbs|4123834002|bbarone@pitt.edu|412
20533593|NCT03111108|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533594|NCT01514357|Mayo Clinic|Dr. John C. Burnett|507-284-7932|burnett.john@mayo.edu|
20533595|NCT00347269|University of Washington|Peter Roy-Byrne MD Professor of Psychiatry|206-313-8504|roybyrne@u.washington.edu|
20533596|NCT01853280|Massachusetts General Hospital|Dr. Craig Surman|617-726-8422|csurman@partners.org|
20533597|NCT00104884|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20533598|NCT03032484|University of Texas Health San Antonio|Andrew Brenner, MD|210-562-4090|brennera@uthscsa.edu|
20533599|NCT03654326|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20533600|NCT01689649|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
20533601|NCT04893811|Pfizer Inc.|PfizerClinicalTrials.gov Call Center|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533602|NCT03492385|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
20533603|NCT03760081|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20533604|NCT02662582|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20533605|NCT01725282|Astellas Pharma Inc.|Vice President, Clinical Development Administration||clinicaltrials@us.astellas.com|
20565728|NCT04243759|Northeastern University|Robert Leeman|6173736501|r.leeman@northeastern.edu|
20565729|NCT05875701|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20565730|NCT00449748|The University of Texas M. D. Anderson Cancer Cent|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
20565731|NCT03944915|University of Chicago|Dr. Ari Rosenberg|855-702-8222|arirosenberg@bsd.uchicago.edu|
20521350|NCT04585789|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20521351|NCT01175811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20521352|NCT02109419|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
20521353|NCT02628743|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20521354|NCT04257552|University of Pittsburgh, Magee Womens Research Institute|Dr. Katherine Himes|(412) 641-1805|himekp@upmc.edu|
20521355|NCT00552578|SUNY Buffalo|R Blondell|716-898-4971|blondell@buffalo.edu|
20521356|NCT01059539|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
20521357|NCT01110135|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
20521358|NCT02085135|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
20521359|NCT02971735|Linkou Chang Gung Memorial Hospital|Dr. Li-Ang Lee|886 33281200|5738@cgmh.org.tw|3972
20521360|NCT04091659|University of Pennsylvania|Nicholas A. Giordano, PhD RN|(215) 898-8281|ngio@upen.edu|
20521361|NCT00626392|Abbott|Medical Information Specialist|800-633-9110||
20521362|NCT00375830|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|650-725-4711|aiagaru@stanford.edu|
20521363|NCT03678285|University of Wyoming|Dr. Evan Johnson|307-766-5282|ejohns54@uwyo.edu|
20521364|NCT00997204|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20521365|NCT01715571|Johns Hopkins University School of Medicine|Arthur Burnett, MD|410-614-3986|aburnet1@jhmi.edu|
20521366|NCT01687972|Johns Hopkins Univesity School of Medicine|Janice Henderson, MD Assistant Professor|443-287-2783|jhender7@jhmi.edu|
20521367|NCT01708629|Bausch Health|Study Director|510-259-5284||
20521368|NCT04558918|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20521369|NCT01696279|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20521370|NCT04658095|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|877-266-1144|jdickerson@sightsciences.com|
20521371|NCT05788289|Memorial Sloan Kettering Cancer Center|Dr. Anita Kumar, MD|646-608-3780|kumara2@mskcc.org|
20521372|NCT05187013|George Washington University|Ramin Asgary|(202) 994-6803|raminasgary1@gwu.edu|
20521373|NCT02737748|Transwell Biotech Co., Ltd.|Dr. Bin-Ru She|+886-3-5670399|binru.she@tw-bio.com|207
20521374|NCT02387983|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521375|NCT00077857|Hoffman-LaRoche|Medical Communications|800-821-8590||
20521376|NCT04823975|Huntsman Cancer Institute|Anne Kirchhoff|801-587-4084|Anne.Kirchhoff@hci.utah.edu|
20521377|NCT05779943|Emory University|Dr. David Schuster|4047781900|dschust@emory.edu|
20521378|NCT06187909|Department of Anesthesia, Intensive Care, and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt|Yasser Mohamed Reyad Ahmed El-Mansoury|01000286206|yassermoahmed0102107@med.asu.edu.eg|
20521379|NCT04740814|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20521380|NCT00085423|Dartmouth-Hitchcock|Dr. Marc Ernstoff|603 650 5534|marc.s.ernstoff@hitchcock.org|
20521381|NCT02440568|University of Illinois at Chicago|Dr. John Quigley|312-413-1300|seanq@uic.edu|
20521382|NCT01948986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521383|NCT01011179|The Hospital for Sick Children|Dr. Jennifer Stinson|416-813-7654|jennifer.stinson@sickkids.ca|304514
20521384|NCT05308368|NC State University|Nitin Sharma|9195130787|nsharm23@ncsu.edu|
20521385|NCT04305496|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20521386|NCT01795105|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
20521387|NCT00939120|Research institute at Deaconess Clinic|Dr. Paul Siami|812-426-9548|paul.siami@deaconess.com|
20521388|NCT01181271|Mass General Hospital|Yi-Bin Chen, MD|617-726-5765|ychen6@partners.org|
20521389|NCT01408628|University of Kansas Medical Center|Virginia Lewis|913-588-2097|vlewis@kumc.edu|
20521390|NCT02980874|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20521391|NCT02435836|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20521392|NCT01753336|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
20521393|NCT01121666|Five Office Ltd|Dr. Melanie Ruf|+41 44 9324132|clin@five.ch|
20521394|NCT03082664|University of Chicago|Dr. Maritza G. Gonzalez|7737026118|mggonzalez@bsd.uchicago.edu|
20521395|NCT04048343|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
20521396|NCT01629966|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20521397|NCT01855074|Janssen. Pharmaceutical Companies of Johnson and Johnson|Medical Manager Neurosciences|+507-3989740|dmuschet@its.jnj.com|
20521398|NCT01174082|UT MD Anderson Cancer Center|Qazilbash,Muzaffar,M.D. / Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
20521399|NCT02991430|Scion NeuroStim, LLC|Dr. Robert Black|(919) 260-5528|rblack@scionneurostim.com|
20521400|NCT02132754|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20521401|NCT02304991|University of North Carolina School of Medicine|Edwin Kim, MD, MS|919-962-4960|edwinkim@email.unc.edu|
20521402|NCT03801382|Philips Research|Clinical product lead|+31646802217|daisy.van.minde@philips.com|
20521403|NCT01531738|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20533606|NCT04064567|University of Arkansas for Medical Sciences|Director, Research Programs|501-686-6427|hkhorton@uams.edu|
20533607|NCT04581629|Calcilytix Therapeutics, Inc., a BridgeBio company|Medical Information|650.600.3610|MedInfo@bridgebio.com|
20533608|NCT03255200|Mainstay Medical|Director, Clinical Affairs|877 702-8488|clinical@mainstaymedical.com|
20533609|NCT02739828|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20533610|NCT01687595|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
20533611|NCT03719300|Anchiano Therapeutics, Israel Ltd.1 Kendall Square, Building 1400, Suite 105 Cambridge, MA 02139|David Kerstein, M.D.,Chief Medical Officer|857-259-4626|David.Kerstein@anchiano.com|
20533612|NCT04130425|Mayo Clinic|Stephanie Kannas, OTR/L, OTD, CHT|507-284-8841|kannas.stephanie@mayo.edu|
20533613|NCT05451329|VivaVision Biotech, Inc.|Xiao-Yan (Joanne) Li, M.D.|(858) 692-9752|joanne.li@vivavisionbio.com|
20533614|NCT02349477|Medical University of South Carolina|Dr. Michaela Hoffman|8437927758|HoffmaMi@musc.edu|
20533615|NCT02202577|Virginia Commonwealth University Health System|Edward H Springel, MD|804-828-8468|edward.springel@vcuhealth.org|
20533616|NCT04792970|Duke University Medical Center|Scott Shofer|(919) 668-2402|scott.shofer@duke.edu|
20533617|NCT02369159|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20533618|NCT02214628|Ophthotech Corp.|Keith Westby|732-824-7474|keith.westby@ophthotech.com|
20533619|NCT02364271|Chinese University of Hong Kong|Professor Timothy Rainer|00 852 2632 1034|thrainer@cuhk.edu.hk|
20533620|NCT03511209|VA Greater Los Angeles Healthcare System|Constance H. Fung, MD, MSHS|818-891-7711|Constance.Fung@va.gov|39311
20533621|NCT03189433|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
20533622|NCT04743206|University of Florida|Silvia Delgado Villalta|7185684198|silviadelgado@ufl.edu|
20533623|NCT02628145|University of Rhode Island|Matthew Delmonico|4018745440|delmonico@uri.edu|
20533624|NCT03000166|University of Wisconsin-Milwaukee|Jeanne M. Erickson, PhD, RN|414-229-6920|ericksoj@uwm.edu|
20533625|NCT04409418|William Beaumont Hospitals|Dr. Amit Bahl|248 898-9111|amit.bahl@corewellhealth.org|
20533626|NCT02757963|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20533627|NCT00911157|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533628|NCT03769467|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
20533629|NCT05259722|LEO Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
20533630|NCT01887600|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
20533631|NCT00962650|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20533632|NCT00231465|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
20533633|NCT00298155|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20533634|NCT00291226|Yale University School of Medicine|Scott W. Woods, MD|203-974-7038|scott.woods@yale.edu|
20533635|NCT03377127|Beaumont Health|Dr. Alexandra Halalau|2485513481|alexandra.halalau@beaumont.org|
20533636|NCT02539394|HospitalSS|Catherine Himo Gang|917-260-4603|gangh@hss.edu|
20533637|NCT02403778|Univesity Colorado Ansshutz Medical Campus|Martin McCarter|303-724-2728|martin.mccarter@ucdenver.edu|
20533638|NCT01098578|Ottawa Hospital Research Institute|Dr. Shaun Kilty|613-798-5555|skilty@ottawahospital.on.ca|18514
20533639|NCT01044693|Vanderbilt University|Italo Biaggioni MD|615-936-3420|italo.biaggioni@vanderbilt.edu|
20533640|NCT03425188|Respicardia, Inc.|Tim Meyer, VP Clinical Affairs|952-540-4479|tmeyer@respicardia.com|
20533641|NCT01316900|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533642|NCT00562861|Tufts Medical Center|Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
20533643|NCT00761137|NeuroHealing Pharmaceuticals|Daniel Katzman|617-965-0872|info@neurohealing.com|
20533644|NCT01152385|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
20533645|NCT02656173|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
20533646|NCT03449147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
20533647|NCT02043860|UIC Cancer Center Clinical Trials Office|Annette Kinsella, RN, CCRC, QA Education Specialist|312-996-5931|annettek@uic.edu|
20533648|NCT00992394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533649|NCT00561821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533650|NCT01657942|Insightec|Nadir Alikacem|214-630-9900|nadira@insightec.com|
20533651|NCT04681885|Sunstar Americas, Inc.|Toru Saito|1-847-794-4271|toru.saito@us.sunstar.com|
20533652|NCT01197300|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20533653|NCT04744831|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20533654|NCT02376010|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
20533655|NCT01428635|The University of Texas MD Anderson Cancer Center|Gautam Borthakur MD./Professor|713-563-1586|GBorthak@mdanderson.org|
20533656|NCT05170061|SUNYBuffalo|Joseph Izzo MD|7168985625|jizzo@buffalo.edu|
20533657|NCT03443401|USouthDakota|Kory Zimney, PhD|6056586373|kory.zimney@usd.edu|
20533658|NCT02363283|UT MD Anderson Cancer Center|Dr. Sapna Pradyuman Patel,MD/ Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
20533659|NCT02257138|The University of Texas MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani|713-745-0394|fravandi@mdanderson.org|
20533660|NCT03676270|Institut Bergonié|Pr Antoine Italiano|335 56333333|a.italiano@bordeaux.unicancer.fr|
20533661|NCT01394185|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20533662|NCT05401409|Westmead Hospital and Westmead Institute for Medical Research|Prof Gopala Rangan|8627 3000|g.rangan@sydney.edu.au|
20533663|NCT02371889|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-746-1943|kranzler@pennmedicine.upenn.edu|
20533664|NCT06844812|mazhar osman mental and nervous diseases hospital|Dr. Enes Faruk ALTUNKILIÇ|+905077362191|enesfarukaltunkilic@gmail.com|
20533665|NCT05520333|RTI International|Nisha Gottfredson O'Shea|9192481826|nishaoshea@rti.org|
20533666|NCT01509404|Medical University of South Carolina|James Fleming|843-792-0312|fleminj@musc.edu|
20533667|NCT02410200|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20533668|NCT04565353|Behavior Change for Good initiative|Dr. Joseph Kay|2157466609|jskay@wharton.upenn.edu|
20533669|NCT02144337|University of Nottingham (UK)|Helen Quirk|01157484325|ntxhq1@nottingham.ac.uk|
20533670|NCT00203242|Thomas Jefferson University/Jefferson Headache Center|Stephen D. Silberstein-Principal Investigator|215-955-9477|Stephen.Silberstein@jefferson.edu|
20533671|NCT00866775|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
20533672|NCT01500135|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20533673|NCT01661595|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
20533674|NCT00912509|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
20533675|NCT05538728|Galderma Research and Development, LLC|Clinical Project Manager|817-961-5000|aestheticclinicaltrials@galderma.com|
20533676|NCT02593630|University of New England|Peter S. Millard, MD, Phd|2072992131|pmillard@mac.com|207
20533677|NCT01034657|Novartis|Study Director|862-778-8300||
20533678|NCT02715856|UT MD Anderson Cancer Center|Dr. Robert Satcher, Associate Professor, Orthopaedic Oncology|(713) 794-5242|rlsatcher@mdanderson.org|
20533679|NCT01050218|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20533680|NCT02336555|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533681|NCT01772693|Insightec|Nadir Alikacem, Ph.D., VP Clinical Research|214-630-2000|nadira@insightec.com|
20533682|NCT00781898|University Of Pennsylvania|Charle P. O'Brien|215-222-3200|obrien@mail.med.upenn.edu|
20533683|NCT01633112|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20533684|NCT02790736|NY State Psychiatric Institute|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
20533685|NCT03682367|UC Davis Health|Arnaud Bewley|9167342704|abewley@ucdavis.edu|
20533686|NCT01132690|Protalix Biotherapeutics|Senior VP Development|+972-4-902-8100|einat@protalix.com|
20533687|NCT02605967|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20533688|NCT04019704|Axsome Therapeutics, Inc.|Caroline Streicher, Senior Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
20533689|NCT00601731|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20533690|NCT04526158|Minneapolis VAMC|Dr. Diana Burgess|612-567-1591|diana.burgess@va.gov|
20533691|NCT00677040|Essentia Health|Ken Dornfeld|218 786-1311|kenneth.dornfeld@essentiahealth.org|
20533692|NCT05201495|Element Science, Inc.|Chief Medical Officer|(415) 872-6500|zubin@elementsci.com|
20533693|NCT04576481|Children's Hospital of Philadelphia|James Guevara, MD MPH|215-590-1130|guevara@chop.edu|
20533694|NCT03689179|University of Utah|Rebecca Utz|801 699 5685|rebecca.utz@utah.edu|
20533695|NCT03464461|University of Missouri|Dr. Matthew Robinson|573 884-4400|robinsonmt@health.missouri.edu|
20533696|NCT05524948|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
20533697|NCT05155085|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20533698|NCT01397591|OHSU Knight Investigational Cancer Services|Jeff Donovan|503-494-7702|mastersj@ohsu.edu|
20533699|NCT05261490|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533700|NCT01722734|Harvard School of Public Health|Dr Günther Fink|6174327389|gfink@hsph.harvard.edu|
20533701|NCT01837550|Sodra Alvsborg, Hearing Organisation|Milijana Malmberg, PhD student|0046 703 80 36 63|milijana.lundberg.malmberg@vgregion.se|
20533702|NCT02100644|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533703|NCT02470377|University of Minnesota|Yoon-Hee Cha|612-301-2738|ycha@umn.edu|
20565732|NCT04408755|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|smb_clinicaltranspa@otsuka-us.com|
20565733|NCT06655818|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20565734|NCT06664684|İstanbul Bilgi University|Dr. Tugce Ozlu Karahan|+90 212 311 5042|tugce.karahan@bilgi.edu.tr|
20565735|NCT03901534|Columbia University|Sanja Jelic, MD|212-543-8875|sj366@cumc.columbia.edu|
20565736|NCT04567316|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565737|NCT04214418|Columbia University|Gulam Manji, MD, PhD|212-304-6357|gam2140@cumc.columbia.edu|
20565738|NCT02637609|Johns Hopkins Bloomberg School of Public Health|John FP Bridges|614-685-2543|john.bridges@osumc.edu|
20565739|NCT05836012|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
20565740|NCT03907982|Barts and London NHS trust|Dr Malcolm Finlay, Principal Investigator|+442037658635|malcolm.finlay1@nhs.net|
20565741|NCT06017115|Universitat Internacional de Catalunya|Dr. Jordi Gargallo|+34 935 04 20 00|jgargallo@uic.es|
20565742|NCT02777593|W.L. Gore|Meier Hsu|928-864-3338|mhsu@wlgore.com|
20565743|NCT05485935|Coloplast A/S|Malene Hornbak Landauro, Medical writer of Clinical strategies|+4549112057|dkmhla@coloplast.com|
20565744|NCT02806726|Johnson & Johnson Surgical Vision, Inc.|Priya Janakiraman|1 714 2478628|djanaki1@its.jnj.com|
20565745|NCT05129501|University of Nebraska-Lincoln, Nebraska Center for Research on Children, Youth, Families, and Schools/Interpersonal Violence Research Laboratory|Katie M Edwards, PhD|402-472-2448|katie.edwards@unl.edu|
20565746|NCT03982186|Janssen Sciences Ireland UC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565747|NCT02325154|Hospital for Special Surgery, Anesthesiology|Dr. Sean Garvin|2126061036|GarvinS@hss.edu|
20565748|NCT01265537|St. Paul's Hospital|Dr. Jagbir Gill|6046822344|JAGill@providencehealth.bc.ca|64706
20565749|NCT03512301|Psychology Software Tools, Inc.|Anthony Zuccolotto|412-449-0078|anthony.zuccolotto@pstnet.com|
20565750|NCT06024642|Imbrium Therapeutics L.P.|Clinical Leader|1-888-827-0622|Medinfo@imbriumthera.com|
20533704|NCT03478787|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20533705|NCT02474901|University of Colorado|Adriana Weinberg, MD|3037244480|adriana.weinberg@ucdenver.edu|
20533706|NCT00655356|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
20533707|NCT01044459|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20533708|NCT04105725|Medical University of South Carolina|Dr. Kathryn Gex|(843) 876-2084|soltisk@musc.edu|
20533709|NCT05346640|Cionic|Rebecca Webster, Clinical Operations Manager|9257886649|rebecca@cionic.com|
20533710|NCT04634331|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
20533711|NCT05626686|Coloplast|Zenia Størling, Senior Director of Clinical Strategies|+4549111869|dkzenst@coloplast.com|
20533712|NCT00289900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533713|NCT04132427|Arizona State University|James B. Adams|480 965-3316|jim.adams@asu.edu|
20533714|NCT05177328|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20533715|NCT03927846|Wake Forest Health Sciences|Dennis Ang, Primary Investigator|336-705-8701|dang@wakehealth.edu|
20533716|NCT03878069|Chiesi Canada Corp.|Anna Rozova, MD, Clinical Program Leader|1-800-854-3534|a.rozova@chiesi.com|7038
20533717|NCT00834587|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20533718|NCT00176254|University of Kentucky|Dr. Emily Van Meter/Assistant Professor, Division of Cancer Biostatistics|859-323-3076|emily.vanmeter@uky.edu|
20533719|NCT03289741|Memorial Sloan Kettering Cancer Center|Dr. Nitya Raj, MD|646-888-4849|rajn@mskcc.org|
20533720|NCT00879619|University of California, Irvine|Nicole Macaranas, Clinical Research Specialist|714-456-6550|nicole.macaranas@uci.edu|
20533721|NCT02536339|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20533722|NCT02037984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533723|NCT03338686|University of Alabama at Birmingham|Ramzi Abou-Arraj|2059344506|rva@uab.edu|
20533724|NCT00974233|University of Wisconsin|Julie E. Chang, MD|608-262-3970|jc2@medicine.wisc.edu|
20533725|NCT01691092|Yale University - Psychiatry Department|Irina Esterlis, Ph.D.|(203)737-6820|irina.esterlis@yale.edu|
20565751|NCT02720068|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20565752|NCT03094052|University of California, San Francisco|Dr. A. Jo Chien, MD|(415) 885-7577|Jo.Chien@ucsf.edu|
20565753|NCT05002738|University of Colorado Anschutz Medical Campus|Eva Dindinger|3037242019|eva.dindinger@cuanschutz.edu|
20565754|NCT04174170|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20565755|NCT04664881|Mayo Clinic|Joerg Herrmann, M.D.|507-255-1267|Herrmann.Joerg@mayo.edu|
20565756|NCT00324415|AMC|Director, AMC Statistical Center|501-526-6712|jylee@uams.edu|
20565757|NCT06102421|Second Faculty of Medicine, Charles University|Mgr. Jakub Katolicky|+420702088258|jakubkatolicky@gmail.com|
20565758|NCT04772534|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20565759|NCT04194450|University of British Columbia|Dr. Jonathan Little|(250) 807-9876|jonathan.little@ubc.ca|
20565760|NCT05265871|Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University|Kefang Lai|18928868231|klai@vip.163.com|
20565761|NCT00308997|Yale University School of Medicine|Ralph Hoffman, MD|203-688-9734|Ralph.Hoffman@yale.edu|
20565762|NCT04490356|Duke University Medical Center|Kathryn Starr, Ph.D.|919-660-7571|kathryn.starr@duke.edu|
20565763|NCT00412607|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
20565764|NCT03816397|F.I. Proctor Foundation, University of California, San Francisco|Nisha Acharya, MD, MS|(415) 476-6687|nisha.acharya@ucsf.edu|
20565765|NCT04819191|Johns Hopkins Bloomberg School of Public Health|Jennifer Wolff, PhD|(410) 502-0458|jwolff2@jhu.edu|
20565766|NCT04602611|Wake Forest|Danielle M Boselli|2017903385|Danielle.Boselli@AtriumHealth.org|
20565767|NCT00503971|Fundación GECP|Eva Pereira|+34 934302006|secretaria@gecp.org|
20565768|NCT05592223|Fred Hutchinson Cancer Center|Dr. Elizabeth Chandler Church|2066676982|cchurch2@fredhutch.org|
20565769|NCT04675034|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20565770|NCT05292222|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6565|bhavani.x.kashyap@healthpartners.com|
20565771|NCT05966766|Tufts Medical Center|Dan Drzymalski, MD|617-913-8168‬‬‬‬‬‬‬‬‬‬‬‬‬‬|dan.drzymalski@tuftsmedicine.org|
20565772|NCT03884439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565773|NCT03351998|University of Kansas Medical Center|John P. Thyfault|913-588-1790|jthyfault@kumc.edu|
20565774|NCT02360371|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
20565775|NCT03092674|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
20565776|NCT03587805|LEO Pharma A/S|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
20565777|NCT01527188|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 33 55 59 29 70|mroux@stallergenes.com|
20565778|NCT03520114|Wake Forest University|Sachin Nalin Vyas, MS,PhD|336-713-4098|svyas@wakehealth.edu|
20565779|NCT04518943|VA Puget Sound Health Care System|Dr. Paul Hebert|(206) 277-4165|paul.hebert2@va.gov|
20533726|NCT00088699|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
20533727|NCT00590317|Emory University|Dr. Daniel Wu|(404) 251-8875|dtwu@emory.edu|
20533728|NCT04280783|Emory University|Dr. Jacob Kariuki|4047272353|jacob.kariuki@emory.edu|
20533729|NCT04616196|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20533730|NCT02904265|Mayo Clinic|Dr. Katherine Nickels|5072660774|nickels.katherine@mayo.edu|
20521404|NCT00193427|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
20521405|NCT04271020|NeoTract, Inc.|Emily Friedland, Director, Global Clinical Affairs|1-610-331-7299|emily.friedland@teleflex.com|
20521406|NCT02683265|Rhodes Pharmaceuticals L.P.|Inder Chaudhary|401-262-9272|inder.chaudhary@rhodespharma.com|
20521407|NCT04682730|University of Pittsburgh|Dr. Deborah Polk, PhD|14126488656|dpolk@pitt.edu|
20521408|NCT02582866|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20521409|NCT00771745|University of Cincinnati|Dr. Rita Alloway|513-558-1568|Rita.Alloway@uc.edu|
20533731|NCT00185614|Stanford University School of Medicine|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
20533732|NCT02735642|Yale University School of Nursing|Ann Kurth|N/A|ann.kurth@yale.edu|
20533733|NCT04255381|Yale University|Dr. Stuart Weinzimer|203-785-5831|stuart.weinzimer@yale.edu|
20533734|NCT06151418|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20533735|NCT03829514|Medical University of South Carolina|Misti Leyva|endo office|leyva@musc.edu|
20533736|NCT01339091|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatherapeutics.com|
20533737|NCT00003907|ECOG Statistical Office|Study Statistician|617-632-3012||
20533738|NCT01557569|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
20533739|NCT02254460|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533740|NCT00993473|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
20533741|NCT00129974|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
20533742|NCT05122143|Altamira Medica Ltd.|Thomas Meyer|0041 61 201 13|ra@altamiramedica.com|50
20533743|NCT01475825|Kastle Therapeutics, LLC|Medical Information|1-800-745-4447|medinfo@genzyme.com|
20533744|NCT00160563|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20533745|NCT04157738|Emory University|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
20533746|NCT00309946|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
20533747|NCT02118831|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
20533748|NCT02244957|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|
20533749|NCT02579057|Johns Hopkins Hospital|Stuart Russell MD|4109555708|srusse14@jhmi.edu|
20533750|NCT03232892|University of California, San Francisco|Dr. Collin Blakely, MD PhD.|(415) 502-6959|Collin.Blakely@ucsf.edu|
20533751|NCT00395447|BIOTRONIK, Inc|Crystal Miller, Clinical Studies Engineer|503-451-8051|crystal.miller@biotronik.com|
20533752|NCT03766906|Oregon Research Behavioral Intervention Strategies, Inc. dba Behavioral Influents Innovations|Jessie Marquez|541-484-2123|jessie.marquez@influentsin.com|
20533753|NCT02090894|Indiana University School of Medicine|Dr. Ally-Khan Somani|317-944-7744|somania@iupui.edu|
20533754|NCT02811419|University of California San Francisco|Trilokesh Kidambi|909-973-0629|tkgastromd@gmail.com|
20533755|NCT04691115|AnaMar AB|Chief Medical Officer|+46 (0)46-275 60 00|info@anamar.com|
20533756|NCT01514279|School of Medicine, Case Western Reserve University|Dr. Elaine Borawski, PhD|216)368-1024|exb11@case.edu|
20533757|NCT01047540|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
20533758|NCT04250207|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20533759|NCT02772302|Massachusetts General Hospital|Brian Edlow|6177246352|bedlow@mgh.harvard.edu|
20533760|NCT02758626|NYU Langone Health, Comprehensive Epilepsy Center|Orrin Devinsky, MD|6465580803|Orrin.Devinsky@nyulangone.org|
20533761|NCT01971593|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
20533762|NCT01682720|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20533763|NCT04204902|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20533764|NCT01307618|University of Chicago Comprehensive Cancer Center|Tomas Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
20533765|NCT01646216|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
20533766|NCT00113373|NRG Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20533767|NCT02395627|University of California, San Francisco|Dr. Pamela Munster, MD|(415) 502-3598|Pamela.Munster@ucsf.edu|
20533768|NCT06091956|Mayo Clinic|Aaron Mangold, M.D.|480-301-6169|Mangold.Aaron@mayo.edu|
20533769|NCT01586897|Massachusetts General Hospital|Steven J. Atlas, Director of Massachusetts General Primary Care Practice Based Research Network|617-724-4736|satlas@partners.org|
20533770|NCT00742157|University of Nebraska Medical Center|Fedja Rochling, MD|402-559-3652|frochling@unmc.edu|
20533771|NCT04710303|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20533772|NCT04717479|University of Michigan|Sarah Yon|734-763-0412|shlim@umich.edu|
20533773|NCT01681849|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
20533774|NCT03813121|Wake Forest University School of Medicine|Dr. Merideth Addicott|336-716-7792|maddicot@wakehealth.edu|
20533775|NCT02852005|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20533776|NCT04629521|Alcon Research, LLC|Director, Clinical Projects - CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20533777|NCT01618708|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20533778|NCT02554474|University of British Columbia|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
20533779|NCT02770365|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
20533780|NCT00489476|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20533781|NCT00214526|Boston Scientific Corporation|Mark G. Grubb|412-749-1423|Mark.Grubb@bsci.com|
20533782|NCT03769116|Sarepta Therapeutics, Inc.|Medical Director|888-727-3782|SareptAlly@sarepta.com|
20533783|NCT01512251|University of California, San Francisco|Alain Algazi|(415) 353-7552|alain.algazi@ucsf.edu|
20565780|NCT03873805|City of Hope Medical Center|Dr. Tanya Dorff|626 218 8231|tdorff@coh.org|
20533784|NCT02181413|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20533785|NCT04003142|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20533786|NCT00890656|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
20533787|NCT01924065|Akdeniz Sifa Konyaalti Medical Center|Mehmet Ozaydin|905533354243|mehmetozaydin@hotmail.com|
20533788|NCT03657407|University of Maryland Medical Center|Anna Reinert, MD|6029089960|anna.reinert@gmail.com|
20533789|NCT01444924|University of Wisconsin Hospitals and Clinics|Dr. David Kushner|608-263-0796|dmkushner@facstaff.wisc.edu|
20533790|NCT04755231|Alcon Research, LLC|Director, Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20533791|NCT03624036|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20533792|NCT02916433|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
20533793|NCT05670756|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|joseph.tobias@nationwidechildrens.org|
20533794|NCT04526925|Rush University|Jie Li|3125634643|jie_li@rush.edu|
20533795|NCT00581100|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20533796|NCT04129398|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20533797|NCT04110145|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20533798|NCT02579759|Pharnext|Susanne Dorn|+33 (0)1 41 09 22 30|contact@pharnext.com|
20533799|NCT00963638|William Beaumont Hospitals|Catherine Coleman, RN, BSN|248-655-5865|cjcoleman@beaumont.edu|
20533800|NCT01254214|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
20533801|NCT02553473|Sørlandet hospital HF|Anne Marit Solheim, MD|0047 38 07 39 10|anne.marit.solheim@sshf.no|
20533802|NCT03895476|University of Alabama at Birmingham|Hussein Basma, DDS, MS|2059344506|basma86@uab.edu|
20533803|NCT01630109|Genesys Regional Medical Center Office of Research|Dr. Steven Brooks|8106067722|Steven.Brooks@genesys.org|
20533804|NCT01085903|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|501 526 7773|msmennemeier@uams.edu|
20533805|NCT04556006|Kilis 7 Aralık University|Dr. Uğur Doğan|+903488139301|63ugurdogan@gmail.com|
20533806|NCT00770679|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|4105505717|hsilber@jhmi.edu|
20533807|NCT00944021|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212 227 7540|Dan.Everitt@tballiance.org|
20533808|NCT03680521|Mirati Therapeutics|Sr. Clinical Operations Trial Manager|858-332-3540|hallinm@mirati.com|
20533809|NCT01935947|Johns Hopkins University|Gary Rosner|410-955-4884|grosner1@jhmi.edu|
20533810|NCT00752219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533811|NCT05898178|Maribor University Medical Centr|Borut Kovačič||Borut.KOVACIC@ukc-mb.si|0038631211
20533812|NCT00830336|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20533813|NCT00867334|George Mason University|Emanuel Petricoin|571-830-4166|epetrico@gmu.edu|
20533814|NCT01220687|OUHSC College of Medicine, Pediatrics, Neonatal-Perinatal Medicine|Krishnamurhty Sekar, MD, Professor of Pediatrics|405-271-5215|kris-sekar@ouhsc.edu|
20533815|NCT01148771|Center for Anti-Infective Research and Development, Hartford Hospital|Joseph L. Kuti, Pharm.D. / Associate Director, Clinical and Economic Studies|860-545-3612|jkuti@harthosp.org|
20533816|NCT01437189|ZhejiangU|Bo Wang|87784711|wangke1121@163.com|
20533817|NCT05263791|MacKay Memorial Hospital|Chien-Chung Huang|02-25433535|titanh@gmail.com|3009
20533818|NCT03168529|Wayne State University|Phillip Levy, MD|3135771214|plevy@med.wayne.edu|
20533819|NCT04463914|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
20533820|NCT05463952|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20533821|NCT00595075|Sentara Neurology Specialists|Daniel Cohen|757-388-6323|dacohen@sentara.com|
20533822|NCT02360085|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
20533823|NCT02732145|Ginekološka poliklinika Dr. Vesna Harni|Dr. Vesna Harni|0038512923648|vesnaharni@gmail.com|
20533824|NCT04103814|Rush University Medical cEnter|Dr E Bailey Terhune|8018249805|bailey.terhune@rushortho.com|
20533825|NCT01244412|University of Rochester|David Kleinman, MD||david_kleinman@urmc.rochester.edu|
20533826|NCT03876808|University of Missouri - Columbia|Dr. Boris Mraovic, Professor of Clinical Anesthesiology|573-882-2568|mraovicb@health.missouri.edu|
20533827|NCT00456365|PKD Research Group, University of Colorado Anschutz Medical Campus|Melissa Cadnapaphornchai, MD|3037241690|pkd@ucdenver.edu|
20533828|NCT05273437|University of California San Diego|Dr. Eric Hekler|8584299370|ehekler@health.ucsd.edu|
20533829|NCT03579719|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20533830|NCT04525183|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-362-2334|alexi_wright@dfci.harvard.edu|
20533831|NCT01166646|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
20533832|NCT00967486|Vascular center of excellence (CAMC medical staff-with admitting privileges)|Ali Fawazi AbuRahma MD|304-388-9973||
20533833|NCT01335685|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20533834|NCT02542280|Ain Shams Maternity Hospital|Ahmed Bahaa|+20 1111700556|abahaa0503@yahoo.com|
20533835|NCT03777020|University of Maryland School of Nursing|Dr. Erika Friedmann|410 706 0659|friedmann@umaryland.edu|
20533836|NCT03460704|Zambon S.p.A.|Michela Meroni - Clinical Trial Manager|+39 02 665241|clinicaltrials@zambongroup.com|
20533837|NCT01767857|Janssen Research & Development, LLC|Product Development Portfolio Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20533838|NCT01421459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20565781|NCT03705793|Washington University in St. Louis|Pawina JIramongkolchai, MD|314-362-5296|pawina@wustl.edu|
20533839|NCT04126174|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
20565782|NCT01167010|Eurofarma Laboratórios S.A|Sandra Rodrigues (Clinical Research)|1150908600|sandra.rodrigues@eurofarma.com.br|8417
20565783|NCT03340428|Johns Hopkins University|Christopher Hoffmann|410-614-4257|choffmann@jhmi.edu|
20565784|NCT04757753|SEPTODONT|Dr. Farid BENABDALLAH|+33785662179|clinical-operations@septodont.com|
20565785|NCT04868656|Durham VA Medical Center|Dr. Susan N. Hastings, MD, M.H.Sc|(919) 286-6936|susan.hastings@va.gov|
20565786|NCT02954809|University at Buffalo|Dr. Carleara Weiss|716-829-2006|carleara@buffalo.edu|
20565787|NCT02295891|Johns Hopkins University|Kristen Rodgers- Research Program Manager, Dept, of Thoracic Surgery|410-955-9047|kpelosk1@jhmi.edu|
20565788|NCT03910218|The University of Texas Health Science Center at Houston|Diane Santa Maria, DrPH|713-500-2187|diane.m.santamaria@uth.tmc.edu|
20565789|NCT05441683|Department of Periodontology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China|Dr. Yan-Min Wu|+86-13757119560|wuyanmin@zju.edu.cn|
20565790|NCT05109871|Liverpool University Hospitals NHS Foundation Trust|Richard Norris|0151529 2534|richard.norris2@liverpoolft.nhs.uk|
20565791|NCT05769634|Icahn School of Medicine at Mount Sinai|Allison C.Waters|(212) 523-8832|allison.waters@mssm.edu|
20565792|NCT00704769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20565793|NCT05374538|VITRAC Therapeutics, LLC|Linda Paradiso, DVM, Chief Development Officer|713-898-8965|linda.paradiso@vitractherapeutics.com|
20565794|NCT03733626|William Beaumont Hospitals|Jad Khalil, MD|(248) 663-1900|jad.khalil@corewellhealth.org|
20565795|NCT04107116|Stanford University School of Medicine|Manali I Patel, MD MPH MS|650-723-4000|manalip@stanford.edu|
20565796|NCT05886452|Mann Eye Institute|Dr Phillip Brunson|17135802500|Phillip.Brunson@manneye.com|
20565797|NCT04093869|Duke University|Stephanie K. Mabe, MS|919-668-3555|stephanie.mabe@duke.edu|
20565798|NCT04731233|University of Florida|Dr. Charles G. Widmer|352-273-5696|widmer@dental.ufl.edu|
20565799|NCT04281498|Icahn School of Medicine at Mount Sinai|Dr. John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
20565800|NCT01220531|Sumitomo Pharma America, Inc.|Director Clinical Operations|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
20565801|NCT01553149|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20565802|NCT01607853|Leo Pharma A/S|Clinical Trial Disclosure Manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
20565803|NCT05866926|Ferrer|Clinical Operations Head|649442389|nalbareda@ferrer.com|
20533840|NCT03138382|UCSD|Dr Paul McGeoch|858-232-3312|pdmcgeoch@ucsd.edu|
20533841|NCT01422382|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
20533842|NCT04754399|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20533843|NCT02069184|Montefiore Medical Center|Jeffrey Bernstein|718-920-4317|JBernste@montefiore.org|
20533844|NCT00025233|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20533845|NCT01720602|University of Washington|Hannah Linden, MD|206-288-6989|hmlinden@u.washington.edu|
20533846|NCT03109769|Riyadh Colleges of Dentistry and Pharmacy|Omar Alkadhi|966505154754|omar.alkadhi@riyadh.edu.sa|
20533847|NCT00507507|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20533848|NCT01694771|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20533849|NCT01941628|Dept. of Anaesthesiology and Intensive Medicine, General University Hospital in Prague|Assoc. Prof. Jan Blaha, MD, PhD|+420 224962243|jan.blaha@lf1.cuni.cz|
20533850|NCT00527878|NIAID, NIH|Alexandra Freeman MD, Staff Clinician, Lead Associate Investigator for Protocol|301-594-9045|freemaal@mail.nih.gov|
20533851|NCT00353119|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
20533852|NCT02310269|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
20533853|NCT00839930|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20533854|NCT00137449|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20533855|NCT02296099|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
20533856|NCT01356940|MS Center at Evergreenhealth|Theodore R. Brown, MD|425-899-5350|trbrown@evergreenhealth.com|
20533857|NCT00668642|Northshore University Healthsystem|Dr. Daniel Shevrin|847-570-2515|Dshevrin@northshore.org|
20533858|NCT03283241|AddBio AB|Ulf Sewerin, CEO|+46708797988|ulf.sewerin@addbio.se|
20533859|NCT01382108|Centre for Contact Lens Research|Kathy Dumbleton|519-888-4567|kdumble@uwaterloo.ca|32694
20533860|NCT00666263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20533861|NCT02439957|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20533862|NCT00586157|Massachusetts General Hospital|Timothy Wilens, MD|617-726-1731|twilens@partners.org|
20533863|NCT02069847|Mayo Clinic|Michael B. Wallace|507-953-2221|wallace.michael@mayo.edu|
20533864|NCT00831389|Medtronic Diabetes|Harry Clark|818-576-5653|bud.clark@medtronic.com|
20533865|NCT01377402|Stavanger University Hospital|Dennis WT Nilsen, MD, phd, professor|+4795777735|dnilsen1@getmail.no|
20533866|NCT00278161|Johns Hopkins University|Lode Swinnen, MD|4106146398|lswinne1@jhmi.edu|
20533867|NCT01817777|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533868|NCT03242434|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20533869|NCT00414609|Novartis Pharmaceuticals|Study Director|862-778-8300||
20533870|NCT00266032|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20533871|NCT00124657|St. Jude Children's Research Hospital|Alberto Broniscer, MD|866-966-5934|info@stjude.org|
20533872|NCT03318393|UT Southwestern Medical Center|Lakshmi Raman|214-456-6222|lakshmi.raman@utsw.edu|
20533873|NCT00814983|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
20533874|NCT03329131|University of Texas Health Science Center in San Antonio|Virginia Kaklamani, MD|210-450-3838|kaklamani@uthscsa.edu|
20533875|NCT00928720|University of Virginia School of Nursing|Ann Gill Taylor, Professor Nursing|434-924-0113|agt@virginia.edu|
20533876|NCT02096354|EpicentRx, Inc|Study Director: Bryan Oronsky, Chief Medical Officer|858-229-1062|boronsky@epicentrx.com|
20533877|NCT02951819|Janssen Scientific Affairs|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20533878|NCT03715829|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533879|NCT03566732|University of Bergen|Professor Dagny F. Haugen|+4747606633|dagny.haugen@uib.no|
20533880|NCT00069953|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20533881|NCT02800785|University of Washington|Erin Fannon|206-685-9770|ecarney@uw.edu|
20533882|NCT03253627|New York University Meyers College of Nursing|John Merriman, PhD, RN|212-998-5375|john.merriman@nyu.edu|
20533883|NCT03829683|Virginia Commonwealth University|Arun J Sanyal, MD|804-828-4060|arun.sanyal@vcuhealth.org|
20533884|NCT03163667|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
20533885|NCT00979407|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533886|NCT02420314|University of Iowa|Dr. Muhammad Furqan|319-356-1616|muhammad-furqan@uiowa.edu|
20533887|NCT03760068|Sr. Director Global Clinical Operations, General Medicine|Keri L. Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
20533888|NCT05430919|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20533889|NCT01469156|Southeast Retina Center|Dr. Dennis Marcus|706-650-0061|dmarcus@southeastretina.com|
20533890|NCT00855166|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20533891|NCT00803049|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20533892|NCT05181085|NorthSea Therapeutics BV|Michelle Yokley|31 035760 65 05|info@northseatherapeutics.com|
20533893|NCT01272219|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20533894|NCT01491919|Duke Clinical Research Institute|Uptal Patel, MD|919-668-4601|uptal.patel@duke.edu|
20533895|NCT04003389|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
20533896|NCT04379271|Immunic AG|Silke Kropp, Specialist Regulatory Operations & Systems|+49|Silke.Kropp@imux.com|1626774453
20533897|NCT04439903|University of Virginia Center for Diabetes Technology|Patricio Colmegna, PhD|434-924-5592|pc2jx@virginia.edu|
20533898|NCT02899754|Philadelphia VA Medical Center (CMCVAMC), Philadelphia, PA|Dr. Marilyn M Schapira, Senior Investigator, Center for Health Equity Research & Promotion (CHERP)|215 898 2022|mschap@pennmedicine.upenn.edu|
20533899|NCT01854762|Fundação Bahiana de Infectologia / Universidade Federal da Bahia|Dr. Carlos Brites|5571992329552|crbrites@gmail.com|
20533900|NCT04818229|Connect Biopharma|Dr. Chin Lee, MD Chief Medial Officer|+1 650 676 9617|clee@connectpharm.com|
20533901|NCT04082364|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20533902|NCT03186378|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
20533903|NCT03784300|Cassava Sciences|Michael R Marsman, PharmD|5125822173|mmarsman@cassavasciences.com|
20533904|NCT02514746|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
20533905|NCT01375140|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
20533906|NCT04042311|Hull University Teaching Hospitals NHS Trust|Dr Sean Pymer|01482 674643|s.pymer@nhs.net|
20533907|NCT03382873|Indiana University|Dr. Carla Miller (current affiliation)|812-855-1608|ckm1@iu.edu|
20533908|NCT05021224|University of Pennsylvania|Dr. Courtney Wolk|215-746-6099|courtney.wolk@pennmedicine.upenn.edu|
20533909|NCT03996395|Baylor College of Medicine|Nancy E. Moran, PhD|713-798-0520|nancy.moran@bcm.edu|
20533910|NCT05375929|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533911|NCT03973489|VA Portland Health Care System|William Hoffman|503-220-8262|hoffmanw@ohsu.edu|56491
20533912|NCT03301415|The University of Alabama at Birmingham|David W. Kimberlin, MD|205-934-5316|dkimberlin@peds.uab.edu|
20533913|NCT03247673|Celltrion|Clinical Planning Department Leader|82328505000|contact@celltrion.com|
20533914|NCT00392288|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20533915|NCT00622843|Infectious Disease Clinical Research Program, Uniformed Services University and HJF|Dr. Brian Agan, Deputy Science Director|240-694-2946|bagan@idcrp.org|
20533916|NCT02184442|Edwards Life Sciences|Tenley Koepnick|949-250-6504|Tenley_Koepnick@Edwards.com|
20533917|NCT00912873|University California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
20533918|NCT02691494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20533919|NCT00966446|Perelman School of Medicine, University of Pennsylvania|Ebbing Lautenbach, MD, MPH, MSCE|215-898-6977|ebbing@mail.med.upenn.edu|
20533920|NCT03249558|Massachusetts General Hospital|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org|
20533921|NCT01426555|VA Boston Healthcare System|Dr. Antonio Lazzari|857-364-6381|antonio.lazzari@va.gov|
20533922|NCT02657356|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20533923|NCT03379870|The Children's Cochlear Implant Center at UNC|Lisa Park, AuD|919-419-1449|lisa_park@med.unc.edu|
20533924|NCT03768336|Massachusetts General Hospital/Harvard Medical Schoool|Dr. Giselle K. Perez|617-724-0765|gperez@mgh.harvard.edu|
20533925|NCT00980044|University of Kentucky College of Medicine|Michelle Lofwall, MD, Associate Professor|8593239321|michelle.lofwall@uky.edu|
20533926|NCT01444781|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20533927|NCT02254291|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20533928|NCT02078869|TCART|Robert F Casper, PI|416-972-0777|casper@lunenfeld.ca|
20533929|NCT06790303|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20533930|NCT03413995|Johns Hopkins University|Mark Markowski, MD|410-614-0567|mmarko12@jhmi.edu|
20533931|NCT05796245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533932|NCT03026777|LSUHSC New Orleans|Dr. David Janz|504-913-5006|djanz@lsuhsc.edu|
20533933|NCT00833703|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
20565804|NCT00709956|Actelion|Laila Rouault, M.D.|+ 41 61 565 8128|laila.rouault@actelion.com|
20565805|NCT01105091|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
20565806|NCT04079517|Karolinska Institutet|Per Hall|+4670750 2110|per.hall@ki.se|
20565807|NCT05073510|BlueDop Medical, Ltd.|Dr. Patrick Kelly|+1 605 521 9831|patrick@bluedopmedical.co.uk|
20565808|NCT00983307|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maria Werner-Wasik|215 955-6702|maria.werner-wasik@jefferson.edu|
20565809|NCT06202560|Institute of dermatology, Thailand|Chinmanat Lekhavat|+66 95-207-2870|chinmanat@gmail.com|
20565810|NCT00968149|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20565811|NCT00447980|Neurotech USA, Inc.|Patricia Davis, Sr. Director of Clinical Operations|401.333.3880|p.davis@neurotechusa.com|
20565812|NCT00113360|UT M. D. Anderson Cancer Center|James Yao, M.D./Associate Professor|713-792-2828|CR_Study_Registration@mdanderson.org|
20565813|NCT00124735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20565814|NCT02467270|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20565815|NCT04632394|St George's University of London|Dr Michael Waight|020 8672 9944|m2110065@citystgeorges.ac.uk|
20565816|NCT02988193|Optima Integrated Health|Gabriela Voskerician|6502233588|gxv4@case.edu|
20565817|NCT05419856|4Moving Biotech|Odile Fleurot|03 20 11 80 30|odile.fleurot@4p-pharma.com|
20565818|NCT04899778|Cedars-Sinai Medical Center|Dr. Melodie Metzger|310-423-7765|Melodie.Metzger@cshs.org|
20533934|NCT02943499|Brown University|Dr. Judson Brewer|401-863-2826|judson_brewer@brown.edu|
20533935|NCT01904279|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20533936|NCT02500836|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
20533937|NCT02267447|Ottawa Hospital Research Institute|Dr. Doug Manuel|613-798-5555|dmanuel@ohri.ca|19108
20533938|NCT03562156|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
20533939|NCT03257657|University of Colorado|Darcy Thompson, Associate Professor|303 724 7471|darcy.thompson@ucdenver.edu|
20533940|NCT02801578|The University of Texas MD Anderson Cancer Center|Prithviraj Bose, MD./Associate Professor|713-792-7747|PBose@mdanderson.org|
20533941|NCT02971839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20533942|NCT03412591|Penn State College of Medicine|Dr. Scott Bunce|2155108295|sbunce@pennstatehealth.psu.edu|
20533943|NCT02272985|University Medical Center Groningen|Dr. C.F.M. Franssen|+0031(0)50 3616161|c.f.m.franssen@umcg.nl|
20533944|NCT00690339|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
20533945|NCT02489279|Think Now, Inc.|Dr. Gregory V. Simpson|4156016522|greg@think-now.com|
20533946|NCT02263547|University of South Florida, COM Neurology|Assistant Director of Research|8139746378|aaungst@health.usf.edu|
20533947|NCT00685295|Harvard/MGH|Stephen Thomas|6177267622|sthomasmd@gmail.com|
20533948|NCT00505687|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20533949|NCT03707821|Johnson & Johnson VIsion|John Buch OD, MS, FAAO Sr. Principal Research Optometrist|9044431707|JBUCH@its.jnj.com|
20533950|NCT00836901|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20533951|NCT01229111|Case Comprehensive Cancer Center|Dr. Smitha Krishnamurthi|216-844-5234|smitha.krishnamurhti@uhhospitals.org|
20533952|NCT04102514|University of Kansas Medical Center|Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
20533953|NCT03268499|The Chinese University of Hong Kong|Simon Chun Ho Yu|+852 35051035|simonyu@cuhk.edu.hk|
20533954|NCT00619918|Children's Hospital Los Angeles|Susan Wu|323-361-6177|suwu@chla.usc.edu|
20533955|NCT04169009|University of Colorado Anschutz Medical Campus|Adriana Weinberg MD|303-724-4480|adriana.weinberg@cuanschutz.edu|
20533956|NCT03533491|Oregon Research Behavioral Intervention Strategies, Inc.|Dana Smith|541-484-2123|dana.smith@influentsin.com|
20533957|NCT04889950|Novoxel Ltd|Ifat Klein|972-6009860|ifat@novoxel.com|
20533958|NCT02517918|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20533959|NCT05702047|Florida State University|Director, Cardiovascular and Applied Physiology Laboratory|8506441828|jwatso@fsu.edu|
20533960|NCT05071027|Montefiore Medical Center|Dr. David Altschul, Department of Neurosurgery|718-920-7498|daltschu@montefiore.org|
20533961|NCT05418426|Daré Bioscience, Inc.|Jessica Hatheway, VP of Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
20533962|NCT00607477|University of Chicago|Michael Maitland, MD, PhD|773-702-4400|mmaitlan@medicine.bsd.uchicago.edu|
20533963|NCT04661839|Emergent BioSolutions Canada Inc.|Clinical Development Representative|204-275-4074|ctgov@ebsi.com|
20533964|NCT03647137|Department of Veteran Affairs|Dr. Nicolaas Bohnen|7347697100|nicolaas.bohnen@va.gov|
20533965|NCT01443026|University of Illinois at Chicago|Dr. Peter Gann|312-355-3723|pgann@uic.edu|
20533966|NCT00829868|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20533967|NCT01548885|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20533968|NCT01813227|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
20533969|NCT03773562|Mayo Clinic|Dr. Todd Schwedt|480-342-2695|schwedt.todd@mayo.edu|
20533970|NCT03131479|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20533971|NCT03285893|University of Minnesota|Joni Jensen|612-624-5178|jense010@umn.edu|
20533972|NCT04806373|Memorial Healthcare System|Mark Block, Chief, Division of Thoracic Surgery|9542651125|mblock@mhs.net|
20533973|NCT02214212|University of Washington|Jeanne Hoffman|2062216511|jeanneh@u.washington.edu|
20533974|NCT00908141|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Robert Dreicer MD|216-445-4623|dreicer@ccf.org|
20533975|NCT01258985|Tufts Medical Center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
20533976|NCT00834574|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20533977|NCT03058952|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|Tracy.Simpson@va.gov|
20533978|NCT00107575|Brown University|Christopher Kahler|(401) 863-6651|Christopher_Kahler@brown.edu|
20533979|NCT05654181|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20533980|NCT04101331|Affimed GmbH|Clinical Operations|+49 621 560030|trials@affimed.com|
20533981|NCT04378153|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
20533982|NCT00500331|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533983|NCT03345550|University of Michigan|Frederick Korley|734 647-0261|korley@med.umich.edu|
20533984|NCT00889330|Johnson & Johnson Vision Care, Inc.|Arthur Shedden, MD|904-443-1557|ashedden@its.jnj.com|
20533985|NCT04622267|Icahn School of Medicine at Mount Sinai|Nicola Tavella|212-241-3888|nicola.tavella@mssm.edu|
20533986|NCT03033784|The University of Toledo|Elissar Andari, PhD|419-383-5227|elissar.andari@Utoledo.edu|
20533987|NCT00267488|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533988|NCT01149460|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20533989|NCT01432444|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20533990|NCT00062764|National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health|Jay H. Hoofnagle, MD|3014961333|hoofnaglej@extra.niddk.nih.gov|
20533991|NCT01225952|Bausch & Lomb Incorporated|Omid Khodai, OD,RAC|(949) 521-7894|omid.khodai@bausch.com|
20533992|NCT02014467|GlaxoSmithKline|GSK Response Center|866-435-7343||
20533993|NCT01230060|Bausch & Lomb Incorporated|Jon Hayashida|(949) 521-7876|jon.hayashida@bausch.com|
20533994|NCT03802916|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
20533995|NCT00480532|University of Hawaii (UH)|Bliss Kaneshiro|808-203-6500|bkaneshiro@ucera.org|
20533996|NCT00443456|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20533997|NCT02157610|Moffitt Cancer Center|Jennifer Vidrine, PhD, MS|813-745-8764|jennifer.vidrine@moffitt.org|
20533998|NCT01592747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20533999|NCT01602484|Brigham and Women's Hospital|Dr. Eric Bluman|6179837363|ebluman@partners.org|
20534000|NCT03177798|Vanderbilt University Medical Center|Dr. Jorge L. Gamboa|615-343-4176|jorge.gamboa@vumc.org|
20534001|NCT03574363|KBP Biosciences USA, Inc.|Kimberly Miller|4847644862|kimberly.miller@kbpbiosciences.com|
20534002|NCT00425555|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20534003|NCT03729609|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20534004|NCT01683812|Boston Children's Hospital|Michele DeGrazia PhD, RN, NNP-BC, FAAN|617-919-1222|Michele.DeGrazia@childrens.harvard.edu|
20534005|NCT01969409|University of Alabama at Birmingham|Steven R. Duncan, MD|(205) 934-5017|duncsr19@uab.edu|
20534006|NCT02799043|Abbott|Anne Sarver, PhD|1-651-756-3813|anne.sarver@abbott.com|
20534007|NCT01603368|University of Linköping|Thomas Abrahamsson, MD PhD|+46.10.1030000|thomas.abrahamsson@liu.se|
20534008|NCT01554904|University of Florida|Richard B Berry, M.D. Principal Investigator|3522621575|Richard.Berry@medicine.ufl.edu|
20534009|NCT02951481|Fundación de investigación Hospital Universitario 12 de Octubre|MD, PhD José María Aguado García|913908000|jaguadog1@gmail.com|4632
20534010|NCT01051661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20534011|NCT01922895|U.T. Southwestern Medical Center|Mack C. Mitchell, MD|2146485036|mack.mitchell@utsouthwestern.edu|
20534012|NCT01916226|GlaxoSmithKline|GSK Response Center|866-435-7343||
20534013|NCT05142306|Emergent BioSolutions Canada Inc|Mila Mirceta, PhD, Senior Scientist, Clinical Research|204-275-4074|mircetam@ebsi.com|
20534014|NCT02915601|University of Colorado Anschutz Medical Campus|Dr. Jessica Kendrick|3037244837|Jessica.Kendrick@cuanschutz.edu|
20534015|NCT00143845|University of Michigan Comprehensive Cancer Center|Dr. John Levine, M.D.|734-936-8456|jelevine@umich.edu|
20534016|NCT00521352|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
20534017|NCT05305651|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20534018|NCT01441492|Baylor College of Medicine|Amy McElhany, Clinical Research Manager|7137981016|pancreas@bcm.edu|
20534019|NCT02100826|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20534020|NCT00967499|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20565819|NCT04726410|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
20534021|NCT00257933|The Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
20534022|NCT02412436|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20534023|NCT02544763|GW Research Ltd|Medical Enquiries|+1 833 424 6724|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
20534024|NCT05135754|Coloplast A/S|Senior Clinical Strategy Project Manager|+4549111341|dkteaa@coloplast.com|
20534025|NCT04091438|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20534026|NCT02370693|Northwestern University|Manu Jain, MD|312-503-4242|m-jain@northwestern.edu|
20534027|NCT00787800|Mayo Clinic|Paul A. Friedman, MD, Professor of Medicine|507-284-7661|friedman.paul@mayo.edu|
20534028|NCT00373360|United Therapeutics Corporation|Rex Mauthe; Senior Director, Regulatory Affairs|919-485-8350|rmauthe@unither.com|
20534029|NCT04309500|University of Michigan|Annalise M. Rahman-Filipiak|734-763-9259|rahmanam@med.umich.edu|
20534030|NCT01270555|Massachusetts General Hospital|Timothy Wilens, MD|617-503-1053|twilens@partners.org|
20534031|NCT00773461|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20534032|NCT00913835|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20565820|NCT02231749|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20534033|NCT01827306|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|7179915595|jslaski@ssrehab.com|
20534034|NCT00637156|Medtronic Spine and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20565821|NCT05377411|University of Florida|Dr. Aprinda Queen|(352) 294-8990|aprinda.indahlas@phhp.ufl.edu|
20565822|NCT03718130|GenevaUSA.org|Elissa K. Thomas, Associate Director, Corporate Strategy|248-802-6095|ethomas@genevausa.org|
20565823|NCT04276779|University of Alabama at Birmingham|Dr. Caitlin Clevenger|205-934-7008|cwclev@uab.edu|
20565824|NCT02823327|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
20565825|NCT03839446|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MSCR, CCRP|412-647-5554|stadtermanbm@upmc.edu|
20565826|NCT04342260|University of North Carolina Lineberger Comprehensive Cancer Center|Amanda Gentry|(336) 655-7743|agentry@email.unc.edu|
20565827|NCT03142009|University of New Mexico College of Population Health|Dr. Nina Wallerstein|404-272-4173|nwallerstein@salud.unm.edu|
20565828|NCT05771467|AkdenizU|Dr. Aslı Cetinkaya Yaprak|+0905069228431|ysf20smt@gmail.com|
20565829|NCT03008382|Virginia Commonwealth University|Dr. Thomas Chelimsky|(804) 628-4859|Thomas.Chelimsky@vcuhealth.org|
20565830|NCT03215706|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20565831|NCT05267639|Liberating Technologies, Inc.|Jen Johansson|774-233-0874|jen.johansson@liberatingtech.com|
20565832|NCT03698669|Boston University|Michael Stein, MD|617 358 1956|mdstein@bu.edu|
20565833|NCT04732871|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20565834|NCT05372042|University of Washington|Dr. Kristen Lindgren|206-658-8083|kpl9716@uw.edu|
20565835|NCT03109873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Adam Luginbuhl|215-240-0748|adam.luginbuhl@jefferson.ed|
20565836|NCT05180539|Lehigh University|Lucy Napper|610 758 4689|lun214@lehigh.edu|
20565837|NCT03779984|UTexasSouthwestern|David Mercier|214-645-3479|David.Mercier@utsouthwestern.edu|
20565838|NCT00994643|Thomas Jefferson University|Dr. Matthew Carabasi|215-955-8874|matthew.carabasi@jefferson.edu|
20565839|NCT02567435|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20565840|NCT02989662|Johns Hopkins University School of Medicine|Mary E McCaul, Ph.D.|4437225728|mmccaul1@jhmi.edu|
20565841|NCT02446600|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
20565842|NCT00328783|Thomas Jefferson University|Rani Anne, MD|215-955-6045|Rani.Anne@jeffersonhospital.org|
20565843|NCT00357682|NICE|Prof Janusz A Z Jankowski|07968 479355|prof.jankowski@outlook.com|
20565844|NCT02514915|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126233272|stadtermanbm@upmc.edu|
20565845|NCT03660930|University of Washington|Lee Cranmer, MD, PhD|206-606-7439|ldcranme@fredhutch.org|
20565846|NCT03228719|University of Delaware|Daniel K. White|3028317607|dkw@udel.edu|
20565847|NCT02656706|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-300|BrUOG@BROWN.EDU|
20565848|NCT03725332|University of Kentucky|Wendy Hansen, MD|859-218-0765|wendy.hansen@uky.edu|
20565849|NCT04098276|Johns Hopkins University|Bushra Sabri|+1 (410) 955-7105|bsabri1@jhu.edu|
20565850|NCT04599296|University of Washington|Dr. Mia Hagen, Associate Professor|206-598-3404|smia@uw.edu|
20565851|NCT03201939|Vanderbilt University Medical Center|C. William Wester|6158750145|william.wester@vumc.org|
20565852|NCT03333915|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20565853|NCT04046549|Horizon Therapeutics USA, Inc.|Todd Wilson, DO|866-479-6742|clinicaltrials@horizontherapeutics.com|
20565854|NCT04012567|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20565855|NCT05047952|Brain and Cognition Discovery Foundation|Dr. Roger S. McIntyre|416-669-5279|roger.mcintyre@bcdf.org|
20565856|NCT04940624|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20565857|NCT02206828|Medtronic|Djamila Bennat|33474089000|djamila.bennat@medtronic.com|1591
20565858|NCT04039113|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20565859|NCT00945724|International Extranodal Lymphoma Study Group (IELSG)|Scientific and Medical Director|+41 58 666|ielsg@ior.usi.ch|7321
20565860|NCT05550636|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20565861|NCT02502266|NRG Oncology|Christopher Purdy on behalf of Austin Miller, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20565862|NCT01976936|Columbia University|Mitchell S.V. Elkind, MD, MS, MPhil|212-305-1710|mse13@cumc.columbia.edu|
20565863|NCT06408870|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565864|NCT03363763|Aucta Pharmaceuticals, Inc.|Dr. Marie Tan|7329129575|Marie.Tan@auctapharma.com|
20565865|NCT05162586|Merck Healthcare KGaA, DarmstadtGermany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|6151-72-5200|service@emdgroup.com|+49
20565866|NCT02945800|Moffitt Cancer Center|Jonathan Metts, MD|813-745-5616|Jonathan.Metts@moffitt.org|
20565867|NCT05030584|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20565868|NCT03705390|CRCTU, University of Birmingham|D3B Trial Mangement Team Leader|+44 (0) 121 371 8027|ALS@trials.bham.ac.uk|
20565869|NCT03047213|Yale School of Medicine: Medical Oncology|Joseph Kim, MD, Associate Professor of Internal Medicine|(203) 200-4822|joseph.w.kim@yale.edu|
20565870|NCT05988957|HealthPartners Institute|Holly Willis|952-993-3219|holly.willis@parknicollet.com|
20565871|NCT06139302|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565872|NCT05394844|uwashington|Dr nicole ehrhardt|2404479566|nehrhard@uw.edu|
20565873|NCT03242915|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20565874|NCT02726386|NeuroDerm Ltd.|Laurence Salin, MD, Senior Medical Director|+33687548073|laurence@neuroderm.com|
20534035|NCT02471144|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20534036|NCT00851084|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20534037|NCT00734032|GlaxoSmithKline|GSK Response Center|866-435-7343||
20534038|NCT02997085|Baylor Scott & White Research Institute|Dr. Mark Powers|2148652409|Mark.Powers1@bswhealth.org|
20534039|NCT03787615|The Pennsylvania State University|Dr. David Conroy|814-863-3451|conroy@psu.edu|
20534040|NCT00492544|GlaxoSmithKline|GSK Response Center|866-435-7343||
20534041|NCT03412929|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
20534042|NCT04989218|The University of Alabama at Birmingham|Dr. Mehmet Akce, Associate Professor|2059342992|makce@uabmc.edu|
20534043|NCT01674062|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20534044|NCT01946880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20534045|NCT02034565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20534046|NCT00581919|University of Wisconsin Hospital and Clinics|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
20534047|NCT02655601|BioMimetix JV, LLC|Sara Penchev|610-308-6640|sara.penchev@bmxpharma.com|
20534048|NCT05007639|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20534049|NCT02412982|UC Health - University of Cincinnati Medical Center|Molly Droege, PharmD|513-584-2126|molly.droege@uchealth.com|
20565875|NCT04955431|University of Montana|Dr. John Quindry|406-243-4268|john.quindry@mso.umt.edu|
20565876|NCT03601897|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
20565877|NCT03598998|City of Hope Medical Center|Dr. Alex Herrera|6263598111|aherrera@coh.org|
20565878|NCT04712903|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20565879|NCT05424718|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@columbia.edu|
20565880|NCT03872466|Barron Associates, Inc.|Richard Adams|4348253435|adams@bainet.com|
20565881|NCT01778686|Rigshospitalet and University of Copenhagen|Gitte Moos Knudsen|+4535456720|gmk@nru.dk|
20565882|NCT06059443|Columbia University School of Nursing|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
20565883|NCT04319887|Saluda Medical|Angela Leitner|651-208-4223|angela.leitner@saludamedical.com|
20565884|NCT04549792|Northwestern University|Principal Investigator|312-503-5944|NUderm-research@northwestern.edu|
20565885|NCT03696433|Vanderbilt University Medical Center|Cassandra Reynolds, BS, CCRC|615-875-9854|cassandra.f.reynolds@vumc.org|
20565886|NCT02890355|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
20565887|NCT05672017|Bournemouth University|Dr Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
20565888|NCT05362474|University of Colorado Denver|Jessica Kendrick|303-724-4837|jessica.kendrick@cuanschutz.edu|
20565889|NCT00353496|Ipsen|Medical Director Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20565890|NCT02379351|University of Utah, Department of Obstetrics & Gynecology|Dr. Erin Clark|801-5818425|erin.clark@hsc.utah.edu|
20565891|NCT02180867|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20565892|NCT04974047|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20565893|NCT02719574|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20565894|NCT03027128|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20565895|NCT00630487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20565896|NCT01969916|University of Chicago|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
20565897|NCT00495677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565898|NCT00575016|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20565899|NCT04129164|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20565900|NCT00195403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20565901|NCT02306161|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20565902|NCT03983382|Memorial Sloan Kettering Cancer Center|Dr. Anthony Yu, MD|212-639-5154|yua3@mskcc.org|
20565903|NCT03694262|Medical College of Wisconsin|William Bradley, MD|414-805-6606|wbradley@mcw.edu|
20565904|NCT02348632|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
20565905|NCT02757898|Emory University|Dr. John Roback|404-712-1774|jroback@emory.edu|
20565906|NCT03744559|Medical University of South Carolina|Dr Michael Saladin|(843) 792-5306|saladinm@musc.edu|
20565907|NCT02166463|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20565908|NCT06393127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565909|NCT02466971|NRG Oncology|Christopher Purdy on behalf of Wei Deng, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20565910|NCT02831283|Columbia University|Patrick Lao|2123421351|PJL2133@CUMC.COLUMBIA.EDU|
20565911|NCT04174560|Cincinnati Children's Hospital|Robert Frenck, Jr., MD|513-636-4463|Robert.Frenck@cchmc.org|
20565912|NCT04591080|University at Buffalo|Thikriat Al-Jewair, Program Director|17168296190|thikriat@buffalo.edu|
20565913|NCT04479787|Abbott|Devyani Nanduri, Sr. Director, Clinical and Regulatory Affairs|+16698329450|Udoka.okaro@abbott.com|
20565914|NCT02586974|Città della Salute e della Scienza di Torino - Ospedale Molinette|Dr. Marco Oderda|+393479383465|marco.oderda@libero.it|
20565915|NCT05495945|University of Michigan|Zirui Huang|(734) 615-2875|huangzu@med.umich.edu|
20565916|NCT04129450|Boston Medical Center|Natalia Morone, MD, MS|617-414-6652|natalia.morone@bmc.org|
20565917|NCT03391466|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20534050|NCT05781685|UT Southwestern Medical Center|Chance Ryan Strenth|337-274-7647|chance.strenth@utsouthwestern.edu|
20534051|NCT01257750|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
20534052|NCT02796651|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20565918|NCT03653364|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20534053|NCT04248153|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
20534054|NCT04079920|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534055|NCT03975660|Stanford University School of Medicine|Dr. Brendan Carvalho|(650) 861-8607|bcarvalho@stanford.edu|
20534056|NCT02365688|Duke University Medical Center, Department of Anesthesiology|Timothy Miller MB ChB, FRCA|(+1) 919 6819660|timothy.miller2@duke.edu|
20534057|NCT00050011|Novartis Pharmaceuticals|Study Director|862-778-8300||
20534058|NCT02614248|Genesis Medical Center|Michelle Martin, RN|562-421-7743|MartinMi@genesishealth.com|
20534059|NCT04197583|Boston Scientific|Director, Clinical Operations|5133058628|teresa.takle-flach@bsci.com|
20534060|NCT04134936|MorphoSys|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
20534061|NCT03518060|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20534062|NCT05078112|Duke University|Sujay Kansagra, MD|919-668-0477|sujay.kansagra@duke.edu|
20534063|NCT04629196|NYU Langone Health|David Hudesman, MD|646-501-9327|David.Hudesman@nyulangone.org|
20534064|NCT03792737|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
20534065|NCT05810597|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20534066|NCT01450631|KCI USA, Inc.|Jill Twardowski, Director of Clinical Operations|210-515-4166|jill.twardowski@kci1.com|
20534067|NCT02170519|Duke University Medical Center|Neil MacIntyre, MD|919-681-2720|neil.macintyre@dm.duke.edu|
20534068|NCT03630679|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
20534069|NCT02061085|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
20534070|NCT04903093|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534071|NCT03213405|Pontificia Universidad Católica de Chile|Dr. Alexis Kalergis|+56223541924|akalergis@bio.puc.cl|
20534072|NCT03555994|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20534073|NCT03204812|UT MD Anderson Cancer Center|Dr. Sumit Subudhi, PhD-Associate Professor, Genitourinary Medical Oncology|(713) 792-2830|sksubudhi@mdanderson.org|
20534074|NCT01027351|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20534075|NCT03926247|University of New Mexico|Dr. Jessica Goodkind|505-277-2501|jgoodkin@unm.edu|
20534076|NCT00057577|Vanderbilt University|Dr. Steven D. Hollon|615-322-3369|steven.d.hollon@vanderbilt.edu|
20534077|NCT04090749|Johns Hopkins University School of Nursing|Martha Abshire Saylor|4433406201|mabshir1@jhu.edu|
20534078|NCT02528305|University of Striling|Dr Niels Vollaard|+441786466488|n.vollaard@stir.ac.uk|
20534079|NCT01852214|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
20534080|NCT00421408|Yale University|Dr. Karl Insogna|203-737-2871|Karl.insogna@yale.edu|
20534081|NCT04691492|University at Buffalo|Jennifer Read, PhD.|(716) 645-0193|jpread@buffalo.edu|
20534082|NCT02481141|SBI Pharmaceuticals Co, Ltd.|Dr. Riyadh Rehani, President of MENA Region|+973 66394100|rrehani@sbigroup.co.jp|
20534083|NCT02679274|University of Texas Medical Branch|Dr. Edgar L. Dillon|409 772 8701|eldillon@utmb.edu|
20534084|NCT00461812|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20534085|NCT01308788|Indiana University|Alon Harris|3170278-0177|alharris@indiana.edu|
20534086|NCT00322218|Spectrum Pharmaceuticals,Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
20565919|NCT05186740|ProVerum|"Vice President, Clinical Affairs |"|"+1-720-472-1504|"|diane@proverummedical.com|
20565920|NCT01864538|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilso2112@gmail.com|
20565921|NCT00909649|Mansoura university hospital|Elnakeeb Ayman|0106752021|elnakeebayman@yahoo.com|
20565922|NCT01171976|Novartis Pharmaceuticals|Study Director|862-778-8300||
20565923|NCT01318694|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20565924|NCT03820544|Sidney Kimmel Cancer Center at Thomas Jefferson University|Thomas Kowalski, MD|215-955-9396|Thomas.Kowalski@jefferson.edu|
20565925|NCT00003222|University of Virginia|Craig L. Slingluff, MD|434-924-1730|CLS8H@hscmail.mcc.virginia.edu|
20565926|NCT00410423|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|Joanne.Filicko@jefferson.edu|
20565927|NCT01380743|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
20565928|NCT05858905|Shockwave Medical|Josh Popp|1-510-279-4262|jpopp@shockwavemedical.com|
20565929|NCT02115282|ECOG-ACRIN Cancer Research Group|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
20565930|NCT01313559|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
20565931|NCT02754596|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
20565932|NCT06415045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|001
20565933|NCT02101853|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20565934|NCT02752685|NYU Langone Health|Sylvia Adams, MD|212-731-5795|Sylvia.Adams@nyulangone.org|
20565935|NCT02112916|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20565936|NCT06995755|Pro-Change Behavior Systems, Inc.|Sara Johnson, PhD|401.360.2980|sjohnson@prochange.com|
20565937|NCT03782116|Elidah, Inc.|Director of Clinical Trials|978.435.4324|customercare@elitone.com|
20565938|NCT05714059|Medtronic Diabetes|DZ Dai, Sr Statistician|8185764034|dz.dai@medtronic.com|
20565939|NCT04899674|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565940|NCT03774472|M D Anderson Cancer Center|Debasish Tripathy|713-794-4385|dtripathy@mdanderson.org|
20565941|NCT05648890|Thomas Bata Hospital, Zlin, Czech Republic|Dr. Klára Nekvindová|+420 577 552 280|klara.nekvindova@bnzlin.cz|
20534087|NCT04548219|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20565942|NCT03150862|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20534088|NCT03193437|Georgetown University|Chul Kim, MD|(202) 444-2223|Chul.Kim@gunet.georgetown.edu|
20534089|NCT04976855|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
20534090|NCT05487378|APR Applied Pharma Research s.a.|Chief Scientific Officer|+41.91.6957020|giorgio.reiner@apr.ch|
20534091|NCT04603560|Brigham and Women's Hospital|Nancy Haff, MD, MPH|617-278-0930|nhaff@mgb.org|
20534092|NCT05472870|Shanghai Jiaotong University School of Medicine Xinhua Hospital|Fei Li|18930830950|feili@shsmu.edu.cn|
20534093|NCT04778709|NYU College of Dentistry|Aikaterini Georgantza|212-998-9986|ag4222@nyu.edu|
20534094|NCT01385995|Brigham and Women's Hospital|Dr. Susan Redline|857-307-0352|sredline1@rics.bwh.harvard.edu|
20534095|NCT02414841|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
20534096|NCT00112385|Brigham and Women's Hospital|A Pilot Study of Etanercept in Dermatomyositis|617-732-8046|aamato@partners.org|
20534097|NCT04136288|Mayo Clinic|Chandler Chapman, DHSc, MPH, Senior Clinical Research Coordinator|9049538681|Chapman.Chandler@mayo.edu|
20534098|NCT03053362|Brain and Cognition Discovery Foundation|Dr. Roger McIntyre|(416) 943-6284|rogermcintyre28@gmail.com|
20534099|NCT06003829|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534100|NCT02842242|MyoKardia Inc.|Dr. Amy Sehnert|650-741-7798|asehnert@myokardia.com|
20534101|NCT03673176|Stanford University|Joseph Shrager, MD|(650) 721-2086|shrager@stanford.edu|
20534102|NCT02301897|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20534103|NCT00337168|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4623||
20534104|NCT02378480|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
20534105|NCT01189760|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20534106|NCT04642976|University of Pennsylvania|Timothy Markman|215-615-4332|timothy.markman@pennmedicine.upenn.edu|
20534107|NCT01217892|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20534108|NCT03226691|National Heart Lung and Blood Institute|John Tisdale|+1 301 402 6497|johntis@nhlbi.nih.gov|
20534109|NCT01052779|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20534110|NCT03663582|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20534111|NCT01285102|Fox Chase Cancer Center|Dr. Efrat Dotan|215-214-4283|Efrat.Dotan@fccc.edu|
20534112|NCT04189484|U.S. Food and Drug Administration|David Strauss, MD, PhD|3017966323|David.Strauss@fda.hhs.gov|
20534113|NCT00557440|Novartis Pharmaceuticals|Study Director|862-778-8300||
20534114|NCT03524157|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20534115|NCT04507763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534116|NCT03322566|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20534117|NCT02367885|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20534118|NCT01378195|Photozig, Inc.|Bruno Kajiyama|650-694-7496|info@photozig.com|
20534119|NCT03427619|University of Iowa|Dr. Richard Smith|319-356-2177|richard-smith@uiowa.edu|
20534120|NCT00498628|NIAAA|Dr. Raye Litten|301-443-0636||
20534121|NCT05763381|The Geneva Foundation|Elizabeth Metzger, Scientific Program Manager|253-383-1398|emetzger@genevausa.org|
20534122|NCT02853136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20534123|NCT00841815|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20534124|NCT04805593|Alcon Research, LLC|Clinical Projects Director, Surgical|18884513937|alcon.medinfo@alcon.com|
20534125|NCT01661283|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
20534126|NCT01704157|Pacira Bioscience, Inc.|Pacira MedInfo|1-855-793-9729|MedInfo@Pacira.com|
20534127|NCT00605189|KCI, an Acelity Company|Senior Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
20534128|NCT02697448|Medical University of South Carolina|George Guldan|(843) 792-2322|guldan@musc.edu|
20534129|NCT06045273|Johns Hopkins Center for Indigenous Health|Dr. Victoria O'Keefe|410-955-6931|vokeefe3@jhu.edu|
20534130|NCT04547556|UMC Utrecht|Dr Cristina Prat Aymerich|+31631118128|c.prataymerich-2@umcutrecht.nl|
20534131|NCT03411044|Zimmer Biomet|Esther Foo|+41787183202|esther.foo@zimmerbiomet.com|
20534132|NCT02947048|Yamo Pharmaceuticals|Tracy Fischer|8596855862|tfischer@yamopharma.com|
20534133|NCT05014919|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20534134|NCT00680914|GlaxoSmithKline|GSK Response Center|866-435-7343||
20534135|NCT02971163|Mount Sinai Medical Center|Dr. Marc A. Probst|212-824-8094|marc.probst@mssm.edu|
20534136|NCT01848457|The Children's Hospital of Philadelphia|Frank Balis, MD|2674265414|balisf@email.chop.edu|
20534137|NCT04104477|University of Florida|Jennifer Nichols, Ph.D.|352-294-8803|jnichols@ufl.edu|
20534138|NCT04910165|Saint Luke's University Health Network|Dr. Chinenye Nwachuku|6096101054|chinenye.nwachuku@sluhn.org|
20534139|NCT02940223|UT MD Anderson Cancer Center|Sriram Yennu,Professor, MD- Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20534140|NCT00526799|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20534141|NCT00522379|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20534142|NCT03135067|University of Pennsylvania|Dr. Harsha Thirumurthy|215-746-0410|hthirumu@upenn.edu|
20534143|NCT05070819|Petrovsky NRCS|Dr. Artem Gubko|+79684241490|gubko@artvig.ru|
20534144|NCT02298946|National Cancer Institute|Dr. Tim F. Greten|301-451-4723|gretentf@mail.nih.gov|
20534145|NCT00323622|GlaxoSmithKline|GSK Response Center|866-435-7343||
20534146|NCT00835354|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20534147|NCT03538808|University of Alabama at Birmingham|Samantha Schiavon|9515509388|sschiavon@uabmc.edu|
20534148|NCT01111552|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20534149|NCT02097225|Massachusetts General Hospital|Ryan Sullivan, MD|617-643-3614|RSULLIVAN7@PARTNERS.ORG|
20534150|NCT04650893|University of Nebraska Medical Center|Peter Danielson|402-559-1703|peter.danielson@unmc.edu|
20534151|NCT05293314|Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University，Shanghai, China|Jin-Fu Xu|008621 65115006|jfxu@tongji.edu.cn|
20534152|NCT00934180|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20534153|NCT00835172|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20534154|NCT05700422|Scheie Eye Institute|Ophthalmology Clinical Research|215-662-8038|ophth.clinicalresearch@pennmedicine.upenn.edu|
20534155|NCT02397720|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Professor|713-794-4392|NDaver@mdanderson.org|
20534156|NCT03549507|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
20534157|NCT02613507|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20534158|NCT03941093|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1337|lapis@fibrogen.com|
20534159|NCT03918031|University of Houston|Brooke Kauffman|(713) 743-8056|byredmond@central.uh.edu|
20534160|NCT04732468|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20534161|NCT00821821|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20534162|NCT02605616|University of Virginia|Dr. Rita Basu|434-924-5183|rb4vd@virginia.edu|
20534163|NCT05339659|Kaiser Permanente|Dr. Jennifer McClure|206-287-2737|jennifer.b.mcclure@kp.org|
20534164|NCT01415453|Columbia University Medical Center|Dr Ronald Silverman|2123055484|rs3072@columbia.edu|
20534165|NCT03648372|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20534166|NCT03514134|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
20534167|NCT02947984|Massachusetts General Hospital|Nina Sanford, MD||NSANFORD@PARTNERS.ORG|
20534168|NCT04073056|Icahn School of Medicine at Mount Sinai|Dr. Ali Shariat|212-523-2500|AliNima.Shariat@mountsinai.org|
20534169|NCT04717258|University of York|Sarah Cockaiyne|01904321736|sarah.cockayne@york.ac.uk|
20534170|NCT00363298|Stanford University Medical Center, Department of Psychiatry|Lorrin M. Koran, M.D.|650 498-5035|lkoran@stanford.edu|
20565943|NCT05517902|Mallinckrodt|Medical Information Call Center|1-800-844-2830|medinfo@mnk.com|
20534171|NCT02085980|The Christ Hospital - Cincinnati, OH|Dr. Mickey Karram|(513) 463-2500|mickey.karram@thechristhospital.com|
20534172|NCT03332056|University of Washington|Jonathan Harper|2065988279|jdharper@uw.edu|
20534173|NCT02374255|Icahn School of Medicine at Mount Sinai|Radhi Yagnik|212-659-5933|radhi.yagnik@mountsinai.org|
20534174|NCT02093520|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
20534175|NCT03014089|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20534176|NCT00321932|Masonic Cancer Center, University of Minnesota|Linda Burns, M.D.|612-624-8144|burns023@umn.edu|
20534177|NCT01798225|Medical University of South Carolina|Renata Leite|843-792-3908|leiter@musc.edu|
20534178|NCT03360344|Loma Linda University|Donnamarie Krause|7347642243|donnamarie.krause@gmail.com|
20534179|NCT01145183|Baylor College of Medicine|Thomas Kosten, MD|713 798 8628|kosten@bcm.edu|
20534180|NCT00133705|University of Rochester|Dr. Kevin Fiscella|585-271-1206|kevin_fiscella@urmc.rochester.edu|205
20534181|NCT03840967|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20534182|NCT01765400|University of Nebraska Medical Center|Paul P Dobesh|402-559-3982|pdobesh@unmc.edu|
20534183|NCT04881058|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20534184|NCT01342666|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (INCMNSZ)|Favorable effect of tomato consumption on HDL-c serum levels|525555133891|shiverqks@hotmail.com|
20534185|NCT04033640|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
20534186|NCT01892189|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20534187|NCT01599286|Children's National Hospital|Robert McCarter|202-476-3140|RMcCarte@childrensnational.org|
20534188|NCT01992757|University of Pennsylvania Hospital|Rupa Chowdary|215-615-4105|rupa.chowdary@uphs.upenn.edu|
20534189|NCT03440411|Fondazione EMN Italy Onlus|Fondazione EMN Italy Onlus|+39 011 0243236|clinicaltrialoffice@emnitaly.org|
20534190|NCT00688740|sanofi-aventis|International Clinical Development Study Director||Contact-us@sanofi-aventis.com|
20534191|NCT01344356|Mercy Research|Mercy Research Manager - Regulatory Operations|314-251-8827|michelle.bryant@mercy.net|
20534192|NCT00095576|Merck, Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20534193|NCT01943227|UC Davis Medical Center|Neal Fleming, MD, PhD|916-734-5046|nwfleming@ucdavis.edu|
20534194|NCT00856557|Jesse Brown VA Medical Center|Dr. Saul J. Weiner|3125192697|Saul.Weiner@va.gov|
20534195|NCT02327169|Takeda|Takeda Study Registration Call Center|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
20534196|NCT01847014|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani|6508086586|scott.tsurutani@actelion.com|
20534197|NCT00361712|Rabin Medical Center|Dr Leonid Edilman|972-9376850|leidelman@clalit.org.il|
20534198|NCT02743221|Institut de Recherches Internationales Servier (I.R.I.S.)|Dr Patrick Therasse|+33 1 55 72 43 47|patrick.therasse@servier.com|
20534199|NCT03528902|Vanderbilt University Medical Center|Research Programs Manager|615-322-4703|ph_research@vumc.org|
20534200|NCT03658304|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20534201|NCT04620668|University of New Brunswick|Luke MacNeill|506-648-5500|luke.macneill@unb.ca|
20534202|NCT03685149|University of Rochester|Dr. Wojciech Zareba|585-275-5391|wojciech_zareba@urmc.rochester.edu|
20534203|NCT02609503|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20534204|NCT06301815|University of Winchester|Amelia Shaw|01962 717478|a.shaw2.18@unimail.winchester.ac.uk|
20565944|NCT01513122|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
20565945|NCT05039021|Ethicon Endo-Surgery, Inc.|Senior Director Medical Affair-Endomechanical and Trx|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20534205|NCT04481685|University of Kansas Medical Center|Gregory Gan, MD PhD|913 588 5881|ggan@kumc.edu|
20534206|NCT01881932|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
20534207|NCT03900650|Arizona State University|Kelly Cue Davis|602-496-3217|Kelly.Cue.Davis@asu.edu|
20534208|NCT00823797|University of Washington|Maciej Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
20534209|NCT02014376|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
20534210|NCT00802503|Geneva University Hospitals, Division of Intensive Care,Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14/Switzerland|Dr CP Heidegger|+41223827440|claudia-paula.heidegger@hcuge.ch|
20534211|NCT01531335|Pontificia Universidad Javeriana|Dr Saul Rugeles|5715946161|rujeles@javeriana.edu.co|2240
20534212|NCT00356187|Denver Health and Hospital Authority|Elizabeth Kingsley, Senior Grants Analyst|3036027061|elizabeth.kingsley@dhha.org|
20534213|NCT00721110|Cleveland Clinic|Daniel Sessler, MD|216-444-4200|sesslerd@ccf.org|
20534214|NCT01833078|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
20534215|NCT02457065|Dartmouth-Hitchcock Medical Center|Michael S Chapman, MD|(603) 650-5000|Michael.Shane.Chapman@hitchcock.org|
20534216|NCT01969214|Analyze & Realize|Felix Alt|+49 30 4000 8194|FAlt@a-r.com|
20534217|NCT01202162|Northwestern University|Gildasio De Oliveira, M.D.|312-926-8371|g-jr@northwestern.edu|
20534218|NCT01840072|Tulane University|Dr. Jiang He|5049885165|jhe@tulane.edu|
20534219|NCT04642079|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534220|NCT02226653|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20534221|NCT04011241|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20534222|NCT00759395|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20534223|NCT00086515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534224|NCT02871440|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
20534225|NCT05360784|Bausch and Lomb|Johnson Varughese|908-927-1162|johnson.varughese@bausch.com|
20534226|NCT02251041|UZLeuven|Diethard Monbaliu|+32 16 348727|diethard.monbaliu@uzleuven.be|
20534227|NCT04918771|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20534228|NCT01046669|Spectral Diagnostics Inc.|Debra Foster, VP Clinical Development|4166263233|dfoster@spectraldx.com|2001
20534229|NCT02702999|The University of Texas Health Science Center at Houston|Olaide Azizat Ashimi Balogun, MD|(713) 500-6412|Olaide.A.Ashimi@uth.tmc.edu|
20534230|NCT00811850|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20534231|NCT01287208|Massachusetts General Hospital|Anne Thorndike, MD, MPH|617-724-4608|athorndike@partners.org|
20534232|NCT01299961|UCLA|Veena K. Ranganath, MD, MS Assistant Clinical Professor|310-825-3061|vranganath@mednet.ucla.edu|
20534233|NCT01813357|Monash University and Alfred Health|Dr Janine Trevillyan|03 90762000|janine.trevillyan@monash.edu|
20534234|NCT03863574|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
20534235|NCT05697380|University of Chicago|Dr. Emily Rogalski|855-824-7887|emily.rogalski@bsd.uchicago.edu|
20534236|NCT03048682|Wake Forest Baptist Health|Dr. Catherine Matthews|336-716-4131|camatthe@wakehealth.edu|
20534237|NCT05964166|Nationwide Children's Hospital|Dr. Joseph Tobias|6147224200|Joseph.Tobias@nationwidechildrens.org|
20534238|NCT00003645|UT MD Anderson Cancer Center|Dr. Curtis A. Pettaway, M.D.- Professor, Urology|713-792-7734|cpettawa@mdanderson.org|
20534239|NCT00462826|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20534240|NCT00499447|Comprehensive Cancer Center of Wake Forest University|Dr. James Urbanic|336-713-3600|jurbanic@wakehealth.edu|
20534241|NCT02296476|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534242|NCT00488293|Department of Veterans Affairs|John D. Whited, MD, MHS|919-286-6926|john.whited@va.gov|
20534243|NCT03436732|National Cancer Institute|Dr. Raffit Hassan|240-760-6322|rh276q@nih.gov|
20534244|NCT00939185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20534245|NCT01198691|TriHealth|Donna Lambers, MD|513-862-2828|donna_lambers@trihealth.com|
20534246|NCT00836706|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20534247|NCT02989857|Servier Pharmaceuticals LLC|Medical Affairs|888-788-1735|clinical.trial.management@servier.com|
20534248|NCT02682056|Emory University|Eric Felner MD|404-727-7651|efelner@emory.edu|
20534249|NCT02332928|Virginia Commonwealth University Massey Cancer Center|Massey Cancer Center Cancer Prevention & Control Team|877-462-7739|masseycpc@vcu.edu|
20534250|NCT04484857|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-096Study@fibrogen.com|
20534251|NCT01425814|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20534252|NCT00863304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534253|NCT03931330|Medical College of Wisconsin|Gisela Chelimsky, MD|414-266-3690|gchelimsky@mcw.edu|
20534254|NCT01182350|Dana-Farber Cancer Institute|Karen Wright|617.632.6740|KarenD_Wright@dfci.harvard.edu|
20534255|NCT04330859|University of Virginia Children's Hospital|Santina Zanelli|4349242697|sz5d@virginia.edu|
20534256|NCT04897568|University of Colorado|Dan Mattlock|(303)724-9941|daniel.matlock@cuanschutz.edu|
20534257|NCT05473715|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
20534258|NCT05498870|Medical University of South Carolina|Carey Brewbaker|843-792-2322|brewbake@musc.edu|
20534259|NCT02919618|Washington University|Dr. Phillip Cuculich|314-454-7698|pcuculic@wustl.edu|
20534260|NCT02592863|University of Missouri|Assistant Director of Research|573-882-2549|schneiderri@health.missouri.edu|
20534261|NCT03559530|Unversidade de Sao Paulo|Dr Priscila Rosalba Domingos de Oliveira|551126616900|priscila.rosalba@hc.fm.usp.br|
20534262|NCT00023595|Duke University Health System|Dr. Eric Velazquez|919-668-8700|velaz002@mc.duke.edu|
20534263|NCT05889468|Duke University Medical Center|Brenna L. Hughes, MD, MSc|919-684-8111|brenna.hughes@duke.edu|
20534264|NCT01309230|Gradalis, Inc.|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
20534265|NCT05468918|Sonova USCS|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20565946|NCT05595213|BUCA School of Medicine, Endocrinology|Michael F Holick, PhD MD|(617) 358-6139|mfholick@bu.edu|
20565947|NCT06003075|University of Kentucky|Dr. Ralph Zinner|859-562-2864|ralph.zinner@uky.edu|
20565948|NCT06203990|Washington University in St. Louis|Gammon Earhart|314-286-1407|earhartg@wustl.edu|
20565949|NCT05288348|University of Pittsburgh|Francis X Guyette|412 651 1077|guyettef@upmc.edu|
20565950|NCT03053960|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Lionel Gold|215-955-6215|Lionel.Gold@jefferson.edu|
20565951|NCT01260896|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20565952|NCT01925144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20565953|NCT00982644|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20565954|NCT04612244|BSC|Allison Anderson|651-582-5077|allison.anderson@bsci.com|
20565955|NCT02224729|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Joanne Filicko, O'Hara|215-955-8874|joanne.filicko@jeffersron.edu|
20565956|NCT03767335|Menarini Ricerche S.p.A.|Clinical Sciences|+39 05556809990|martine.piccart@bordet.be|
20565957|NCT05856266|Biovitrum|CPL|0795914760|rolf.schlosshauer@sobi.com|
20565958|NCT03213457|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20565959|NCT02951052|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20565960|NCT04227600|JCR Pharmaceuticals|Study Director|+81 797 32 8582|clinical_development@jp.jcrpharm.com|
20565961|NCT00391443|Actelion Pharmaceuticals Ltd|Isabelle Leconte,PhD -Data Science Group Leader, Director|+41 61 565 64 18|isabelle.leconte@actelion.com|
20565962|NCT03875001|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565963|NCT04261790|Johns Hopkins Universtiy|Bardia Nourbakhsh|410-614-1522|bnourba1@jhmi.edu|
20565964|NCT05934292|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20565965|NCT05545280|Cleveland Clinic Foundation|Kurt Ruetzler, MD|216 636-0561|RUETZLK@ccf.org|
20565966|NCT04121741|Medical College of WI|Principal Investigator: Jacquelyn P Kulinski|414-955-6896|jakulinski@mcw.edu|
20565967|NCT01084863|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
20565968|NCT04056910|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20565969|NCT03473223|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
20534266|NCT00427700|Hospital de Clínicas de Porto Alege|Dr. Ricardo Francalacci Savaris|51 33598405|rsavaris@hcpa.edu.br|
20534267|NCT00103844|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20534268|NCT03038087|SENSE Diagnostics, Inc.|Joe Korfhagen|844-373-6730|jkorfhagen@senseneuro.com|
20534269|NCT01648322|Generon (shanghai) corporation|Chief Medical Officer|8621-61760866|tangt@generonbiomed.com|
20534270|NCT01435356|EAU Research Foundation|Wim P.J. Witjes, MD, PhD Scientific and Clinical Research Director|+31 26 389 0677|w.witjes@uroweb.org|
20534271|NCT00209131|Emory University|Dr. Kenneth Ogan|404-778-4898|kogan@emory.edu|
20534272|NCT04554836|Evangelisches Krankenhaus Hamm Werler Str. 110, 59063 Hamm|Prof. Dr. Alexander Baraniskin|+49 (0) 2381 / 589 1863|Alexander.Baraniskin@ruhr-uni-bochum.de|
20534273|NCT02871219|The University of Texas MD Anderson Cancer Center|Jason Westin, MD|(713) 792-3750|jwestin@mdanderson.org|
20534274|NCT05081843|University of Pittsburgh School of Public Health|Dr. Jaime Sidani|412-383-0733|jes107@pitt.edu|
20534275|NCT03034044|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534276|NCT02120261|The University of Texas Health Science Center at Houston|Carlos J. Roldan, MD||Carlos.J.Roldan@uth.tmc.edu|
20534277|NCT04906512|Ruijin Hospital|Dr. Hongping Qu|021-64370045|rjhcrc@126.com|
20534278|NCT03211416|Roswell Park Comprehensive Cancer Center|Kris Attwood|8772757724|Kris.Attwood@roswellpark.org|
20534279|NCT01950520|NIDDK|Kong Chen, PhD, MSCI|301-451-1636|chenkong@niddk.nih.gov|
20534280|NCT03709472|University of Miami|Victoria Mitrani|3052849139|vmitrani@miami.edu|
20534281|NCT03559556|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214-645-7637|robert.timmerman@utsouthwestern.edu|
20534282|NCT03506360|Mayo Clinic|Yi Lin|5072845096|Lin.Yi@mayo.edu|
20534283|NCT01969058|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20534284|NCT00723632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20534285|NCT03207347|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20534286|NCT02085720|Chinese University of Hong Kong|Dr Susanna Ng SS|85226322211|drsssng123@yahoo.com.hk|
20534287|NCT00689884|Dartmouth-Hitchcock Medical Center|John M. Hill, MD - Principal Investigator|603-650-4628|john.m.hill@hitchcock.org|
20534288|NCT02038036|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20534289|NCT05251805|UZ Brussel|Head of the anesthesiology department|024776001|anesthesiology.clinicaltrials@uzbrussel.be|+32
20534290|NCT05572567|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20534291|NCT05528445|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
20565970|NCT04505722|Janssen R&D US|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565971|NCT04755595|SUNY Downstate Health Sciences University|Jared Jagdeo MD, MS|(718) 270-1229|jared.jagdeo@downstate.edu|
20565972|NCT04959812|University of Texas Southwestern Medical Center|Craig Crandall|214-345-4623|CraigCrandall@texashealth.org|
20565973|NCT05787054|Catholic University of the Sacred Heart, Fondazione Policlinico Gemelli|Dr Alessandra Familiari|+393285887422|alessandra.familiari@policlinicogemelli.it|
20534292|NCT02185183|ENZO|Dr. Elazar Rabbani|2125830100|erabbani@enzo.com|
20534293|NCT01373281|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
20534294|NCT01397253|University of Pittsburgh|Kenneth J Smith, MD, MS|4126474794|smithkj2@upmc.edu|
20534295|NCT00775658|Vanderbilt Medical Center|John Fahrenholz, M.D.|615-936-2727|john.m.fahrenholz@vanderbilt.edu|
20534296|NCT03502681|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20534297|NCT03468998|University of Alabama at Birmingham|Ramzi Abou-Arraj|2059341125|rva@uab.edu|
20534298|NCT00959049|Seqirus|Clinical Program Director||Seqirus.ClinicalTrials@Seqirus.com|
20534299|NCT01467557|Vistakon|Jurandir Araujo|+1 904 443-1379|jaraujo7@its.jnj.com|
20534300|NCT01905540|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20534301|NCT03847519|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
20565974|NCT02566889|Janssen Scientific Affairs|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20565975|NCT02377700|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
20565976|NCT03140670|Abramson Cancer Center|Pancreas Research Program Manager|2672575567|mazali@pennmedicine.upenn.edu|
20565977|NCT00220805|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20565978|NCT02325466|Icahn School of Medicine at Mount Sinai|Dr. Robert S. Rosenson|212-241-9101|robert.rosenson@mssm.edu|
20565979|NCT03699163|Imperial College London|Professor George Hanna|02033122124|g.hanna@imperial.ac.uk|
20565980|NCT01639131|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
20565981|NCT00176800|University of Michigan Comprehensive Cancer Center|Dr. Susan Urba, M.D.|734-615-4762|surba@umich.edu|
20565982|NCT01964300|Pediatric Brain Tumor Consortium|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
20565983|NCT00557492|UPMC CancerCenter|Herbert Zeh, MD|4126922852|zehxhx@upmc.edu|
20565984|NCT02524769|Loyola University Chicago|Dr. Elizabeth Mueller|708-216-2180|EMUELLE@lumc.edu|
20565985|NCT04334317|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20565986|NCT01149759|Rockefeller University|Emma Guttman Yassky, MD|212-327-8333|skhattri@rockefeller.edu|
20565987|NCT06065501|National Cheng Kung University|Professor Miaofen Yen / Professor of Nursing department|886-6-2353535|miaofen@mail.ncku.edu.tw|5823
20565988|NCT03286114|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20565989|NCT02956642|University of California San Francisco|Dr. Jenise Wong|415-476-3316|jenise.wong@ucsf.edu|
20565990|NCT00943917|Intarcia Therapeutics, Inc|Michelle Baron MD|510-782-7800|clinicaltrials@intarcia.com|
20565991|NCT04018495|Medical College of Wisconsin|Rose Franco, MD|414-955-7040|rfranco@mcw.edu|
20565992|NCT02879318|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
20565993|NCT04908514|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20565994|NCT06637774|University of Pittsburgh|James Coyle|4123836608|jcoyle@pitt.edu|
20565995|NCT04059406|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20565996|NCT05155306|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20565997|NCT04158141|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20565998|NCT00319696|Actelion Pharmaceuticals Ltd|Andjela Kusic-Pajic, MD/Clinical Project Team Leader|+41 61 565 64 17||
20565999|NCT05501548|Johns Hopkins University|Channing Paller, M.D., principal investigator|410-955-8239|cpaller1@jhmi.edu|
20566000|NCT00743951|University of Ottawa, Ottawa Hospital Research Institute|Dawn Stacey|613-737-8899|dstacey@uottawa.ca|73817
20566001|NCT05747599|RTIInternational|Yukiko Washio, PhD|9194852794|ywashio@rti.org|
20566002|NCT03485287|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20566003|NCT00655499|GERCOR|Regulatory affairs|00331 40 29 85 00|Regulatory.Affairs@gercor.com.fr|
20566004|NCT02454283|Laguna Pharmaceuticals|Chief Medical Officer|858-405-1429|hdittrich@imager.com|
20566005|NCT01596972|Planned Parenthood League of Massachusetts|Director of Clinical Research and Training|617.616.1600|agoldberg@pplm.org|
20566006|NCT02285270|University of Pennsylvania|Daniel Pryma|215-349-5272|daniel.pryma@uphs.upenn.edu|
20566007|NCT00439270|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20566008|NCT04098575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566009|NCT05274321|University of California, San Francisco|Julius Oatts, MD|(415) 353-2800|Julius.Oatts@ucsf.edu|
20566010|NCT04121546|Indiana University School of Medicine|Dr. Michael Bushey|3179637300|mabushey@iu.edu|
20566011|NCT03183050|Georgetown University|Suzanne O'Neill|202-687-0869|sco4@georgetown.edu|
20566012|NCT03304418|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov and CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
20566013|NCT03248492|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo_us@daiichisankyo.com|
20566014|NCT04495621|Menarini Ricerche S.p.A.|Clinical Sciences|+39 0555680|martine.piccart@bordet.be|9990
20566015|NCT03260569|University of Cincinnati|Michael Goodman|5135585661|michael.goodman@uc.edu|
20566016|NCT05707351|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20566017|NCT01996436|The University of Texas Health Science Center at Houston|Peng Roc Chen, MD|713-486-8016|Peng.R.Chen@uth.tmc.edu|
20566018|NCT02382003|University of Virginia Department of Psychology|Dr. Bethany Teachman|434-924-0676|bethanyteachman@gmail.com|
20566019|NCT03857646|Stanford University|Cody Arnold|(650) 723-8772|codya@stanford.edu|
20566020|NCT03850899|Indiana University School of Medicine|Samer Gawrieh|(317) 278-9326|sgawrieh@iu.edu|
20566021|NCT04305327|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20566022|NCT02500576|M D Anderson Cancer Center|Dr. Rodabe Amaria|(713) 792-2921|rnamaria@mdanderson.org|
20534302|NCT02743962|University of Bradford|Hilary Pape|01274 236228|hpape@bradford.ac.uk|
20534303|NCT04023045|Orthocare Innovations, LLC|Sarah Chang|425-771-0797|schang@orthocareinnovations.com|1007
20534304|NCT00725985|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20534305|NCT02546323|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20534306|NCT04476784|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20534307|NCT00478257|UCSD|Dr. Sonia Ancoli-Israel|858 642-7710|sancoliisrael@ucsd.edu|
20534308|NCT06582732|Glaukos Corporation|Study Director|714-478-2287|ldoan@glaukos.com|
20534309|NCT04770285|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20534310|NCT05030766|University of Miami|Dr. Taghrid Asfar|+1 (901) 371-7229|tasfar@miami.edu|
20534311|NCT03895372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534312|NCT04047355|New York State Institute for Basic Research|J. Helen Yoo, Ph.D.|718-494-5295|jhelen.yoo@opwdd.ny.gov|
20534313|NCT01362790|National Cancer Institute|Dr. Raffit Hassan|301-451-8742|raffit_hassan@nih.gov|
20534314|NCT01251757|Kaiser Permanente Center for Health Research|William M Vollmer, PhD|503-335-2400|william.vollmer@kpchr.org|
20534315|NCT05807945|ABC Medical Center|Angel Cruz Miranda|5516647121|cruz.angel@aol.com|
20534316|NCT00635050|UAB|John Carpenter, M.D.|205-910-8886 or 205-934-2084|jtc4321@bellsouth.net|
20534317|NCT00437073|GlaxoSmithKline|GSK Response Center|866-435-7343||
20534318|NCT03485157|MIMEDX|Chief Medical Officer|(770) 651-9100|CTInquiries@mimedx.com|
20534319|NCT01849276|Northwestern University|Dr. Jessica Altman|312-503-1761|J-altman@northwestern.edu|
20534320|NCT00539500|University of Texas MD Anderson Cancer Center|Laura L. Worth, MD / Professor, Pediatrics|713-792-6620|CR_Study_Registration@mdanderson.org|
20534321|NCT02657343|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
20534322|NCT02011542|University of Utah, Dept. of Gastroenterology|Dr. Ashok Tuteja|801-581-5679|ashok.tuteja@hsc.utah.edu|
20534323|NCT02904096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20534324|NCT03988205|Froedtert and the Medical college of Wisconsin|Laura Michaelis, MD|414-805-6700|lmichaelis@mcw.edu|
20534325|NCT00663260|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20534326|NCT01799135|Dana Farber Cancer Institute|Raymond H. Mak|617.632.3591|RMAK@PARTNERS.ORG|
20534327|NCT02678377|Northwestern University|Dr. Kimberly Kenton|3124723874|kkenton@nm.org|
20534328|NCT01979185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20534329|NCT00980798|Janssen-Cilag Ireland|EMEA Medical Affairs Director Analgesia|0035 878 339174||
20534330|NCT02607722|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20534331|NCT04347538|Vanderbilt University Medical Center|Justin H. Turner, MD, PhD|615-343-8848|justin.h.turner@vumc.org|
20534332|NCT02135133|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(877) 442-3324|Jennifer_Brown@dfci.harvard.edu|
20534333|NCT02259231|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20534334|NCT03238196|Vanderbilt-Ingram Cancer Center|Brent Rexer, MD, PhD, Assistant Professor|615-322-4967|brent.rexer@vumc.org|
20534335|NCT04562090|Astellas Pharma China, Inc.|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
20534336|NCT00847730|KCI|VP, Global Clinical Affairs|2102555595|jane.hart@kci1.com|
20534337|NCT04341012|Mayo Clinic|Tushar Patel|9049532000|patel.tushar@mayo.edu|
20534338|NCT04938427|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20534339|NCT02402647|VA San Diego|Catherine Ayers|858-220-4041|catherine.ayers1@va.gov|
20534340|NCT03637348|Cornea Research Foundation of America|Marianne Price, PhD|3178142990|mprice@cornea.org|
20534341|NCT00553969|University of Minnesota Medical School|Jay N. Cohn, M.D.|612.625.5646|cohnx001@umn.edu|
20534342|NCT05216380|UMass Chan Medical School|Jamie Faro|7744553744|Jamie.faro@umassmed.edu|
20534343|NCT04727151|Triumvira Immunologics|Maria Apostolopoulou, Clinical Scientist|518-892-8426|mapostolopoulou@triumvira.com|
20534344|NCT00391716|The Scripps Research Institute|Dr. Barbara J. Mason|858-784-7324|mason@scripps.edu|
20534345|NCT02457793|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20534346|NCT04316143|BIAL - Portela & Ca, SA|Responsible of Clinical Research & Operations|+351229866100|clinical.trials@bial.com|
20534347|NCT03814044|Smith + Nephew, Inc.|Judith Horner|+44 1482 673251|Judith.Horner@smith-nephew.com|
20534348|NCT02757768|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20534349|NCT05218434|Simbec Orion|Dr Annelize Koch|01443694313|gabrielle.brill@simbecorion.com|
20534350|NCT00835367|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20534351|NCT05929326|Hung Vuong Hospital|Dr. Huan N Pham|+84906884435|huanpmd@gmail.com|
20534352|NCT04890509|BerGenBio ASA|BerGenBio Clinical Team|+ 47 559 61 159|cmo@bergenbio.com|
20534353|NCT02625428|Mayo Clinic|J. Scott Kriegshauser|480-342-5664|skriegshauser@mayo.edu|
20534354|NCT04093453|Imperial College London|Dr. Edward Chambers|+44 20 7594 0959|e.chambers@imperial.ac.uk|
20534355|NCT02495883|UCSD|Fatta Nahab, MD|858-822-5871|fnahab@health.ucsd.edu|
20534356|NCT03557502|University of Oregon|Dr. Christopher Minson|541-953-2231|minson@uoregon.edu|
20534357|NCT02620865|Karmanos Cancer Institute|Dr. Anthony Shields|313-576-8735|shieldsa@karmanos.org|
20534358|NCT04632030|RAND|William G. Shadel|412-683-2300|shadel@rand.org|4489
20534359|NCT00543127|Department of Medical Oncology, Hospital Universitario Gregorio Marañón|Dr. Miguel Martin||miguel.martin@salud.madrid.org|
20534360|NCT02520154|University of Texas M D Anderson Cancer Center|Dr. Amir Jazaeri MD|(713) 745-1613|aajazaeri@mdanderson.org|
20534361|NCT00710944|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
20566023|NCT06229106|Carolina Eyecare Physicians, LLC|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
20534362|NCT00791648|Vanderbilt University|Frederic Billings|615-343-6268|frederic.t.billings@vanderbilt.edu|
20534363|NCT04976777|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20534364|NCT03977155|Boston Pharmaceuticals, Inc.|Craig Basson|(617) 655-9681|clinicaltrials@bostonpharmaceuticals.com|
20534365|NCT00936936|University of Texas MD Anderson Cancer Center|Dr. Yago Nieto, PhD. / Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderson.org|
20534366|NCT02278003|Memorial Sloan Kettering Cancer Center|Dr. Eric Kelhoffer, MD|212-639-8781|kelhoffe@mskcc.org|
20534367|NCT03369158|Medacta International|Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
20534368|NCT00442702|Hoffman-LaRoche|Medical Communications|800-821-8590||
20534369|NCT00313560|Sidney Kimmel Comprehensive Cancer Center|Dr. Amol Narang|410-502-3823|anarang2@jhmi.edu|
20534370|NCT03744637|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534371|NCT04123704|Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center|Dr. C. Kent Osborne|713-798-1640|kosborne@bcm.edu|
20534372|NCT03440385|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20534373|NCT02956473|Dana-Farber/Brigham Cancer Center|Dr. Tari King|617-582-8292|tking7@bwh.harvard.edu|
20534374|NCT03552029|Daiichi Sankyo|Contact for Clinical Trial Disclosure Information|908-992-6400|CTRinfo@dsi.com|
20534375|NCT03134209|NYU Langone Health|Ran Schwarzkopf, MD|646-356-9405|Ran.Schwarzkopf@nyulangone.org|
20534376|NCT00730327|Apollo Endosurgery|Laura Eaton, Study Director, RN, BSN, CCRN-R,|949-468-9301|laura.eaton@apolloendo.com|
20566024|NCT03399500|University of Oklahoma Health Sciences|Michael Businelle|405-271-8001|michael-businelle@ouhsc.edu|50460
20534377|NCT05012579|Cala Health|Alex Kent|267-973-4180|alex.kent@calahealth.com|
20534378|NCT03122184|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
20534379|NCT00633126|Cerexa, Inc.|David Friedland, MD|510-285-9200|clinicaltrials@cerexa.com|
20534380|NCT00793520|Forest Research Institute|Allan Spera|201-427-8399|allan.spera@frx.com|
20534381|NCT01882816|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@mskcc.org|
20534382|NCT02541591|ZOL Genk|Koen Ameloot|0485685969|koen.ameloot@zol.be|
20534383|NCT01212900|National Heart Lung and Blood Institute|Mehta, Nehal|+1 301 827 0483|mehtann@mail.nih.gov|
20534384|NCT05157360|Department of Surgery, University of Kansas School of Medicine-Wichita|Dr. Thomas Resch|316-268-5990|tresch@wsspa.com|
20534385|NCT00567502|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20534386|NCT03835078|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20534387|NCT01638507|Medtronic, Coronary Clinical Affairs|Lisa Bousquette, Clinical Research Director|(707) 591-2967|lisa.r.bousquette@medtronic.com|
20534388|NCT01497197|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20566025|NCT01983683|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
20534389|NCT01332981|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20534390|NCT03901430|University of New Mexico|Julia Hess|5052724462|jmhess@unm.edu|
20534391|NCT01385579|Northwestern University|Dr. Muriel Jean-Jacques, Assistant professor|312-503-9642|mjean@nmff.org|
20534392|NCT01681147|Joslin Diabetes Center|Dr. Florence Brown|617-309-2675|Florence.Brown@joslin.harvard.edu|
20534393|NCT00565747|Origio A/S|Chief Scientific Officer|+45 46790200|sbendz@origio.com|
20534394|NCT01697709|NYSPI|john mariani. MD|212-923-3031|John.mariani@nyspi.columbia.edu|
20534395|NCT04734210|Surface Ophthalmics, Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
20534396|NCT02684461|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|gmelahat@med.unc.edu|
20534397|NCT02390076|Minneapolis VA Health Care System|Seth Disner|3105605990|disne014@umn.edu|
20534398|NCT04507204|Purdue Pharma L.P.|Jaromir Mikl, PhD MSPH|800-745-7445|jaromir.mikl@pharma.com|7277
20534399|NCT03580044|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534400|NCT01206517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534401|NCT05870345|University of CHicago|Alisa Brennan, Pediatric Emergency Medicine Fellow, Physician, Co-PI|9787585263|Brennanak@gmail.com|
20534402|NCT00952692|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
20534403|NCT03408262|Imperial College London|Research Integrity Officer|020 7594 1872|rgit@imperial.ac.uk|
20534404|NCT03633058|Vanderbilt University Medical Center|Jeffrey L. Neul, MD, PhD, Principal Investigator|615-322-8242|jeffrey.l.neul@vumc.org|
20534405|NCT03607500|University of Michigan|Abhijit Naik|734-763-0990|abhinaik@med.umich.edu|
20534406|NCT03312543|Johnson & Johnson Consumer Inc.|Sidney Hornby|908-874-2756|SHornby@its.jnj.com|
20534407|NCT04507269|Brii Biosciences Limited|Clinical Research|86 10 6299 8808|clinicaltrials@briibio.com|
20534408|NCT05852340|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534409|NCT00375713|UCB Pharma|UCB Clinical Trial Call Center|+ 1 877 822 9493||
20534410|NCT01722669|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617-667-9299|jzwicker@bidmc.harvard.edu|
20534411|NCT01350479|VA Maryland Healthcare System|Mary-Claire Roghmann|410-706-0062|mroghman@epi.umaryland.edu|
20534412|NCT02927964|Stanford University|Dr. Ronald Levy|(650) 725-6452|levy@stanford.edu|
20534413|NCT02496000|Orange County Research Center|Joel M. Neutel, M. D.|714-541-5591|jmneutel@aol.com|
20534414|NCT02255656|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20534415|NCT01877278|University of Messina|Gianfilippo Bagnato|00390902212502|gianbagnato@gmail.com|
20566026|NCT05365997|University of Pennsylvania|Dr. Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
20566027|NCT00319020|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
20566028|NCT01078909|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
20534416|NCT03510715|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20534417|NCT03546439|Saint Luke's Hospital of Kansas City|Sanjaya Gupta, MD|8169311883|sgupta@saint-lukes.org|
20534418|NCT04262479|NTNU|Ingrid K Hals|+47 73412207|ingrid.hals@ntnu.no|
20534419|NCT05318287|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
20534420|NCT04983979|Queen Mary University of London|Emily Kirkpatrick|02078825673|cvctu@qmul.ac.uk|
20534421|NCT04144517|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
20534422|NCT03164356|University of Washington|Daniel Ballesteros|206-221-5873|danieb25@uw.edu|
20534423|NCT00895921|Veterans Medical Research Foundation|Jonathan M. Meyer, MD|858-964-0777|jmmeyer@ucsd.edu|
20534424|NCT01358734|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20534425|NCT01822925|NeuroBo Pharmaceuticals, Inc.|Vice President Clinical Operations|617-313-7331|nikki.shannon@neurobopharma.com|
20534426|NCT01731782|Cleveland Clinic Florida Region|Dr. Conor Delaney|954-659-6001|DELANEC@ccf.org|
20534427|NCT01195597|University of Catania|Prof Riccardo Polosa|0957436413|polosa@unict.it, p.caponnetto@unict.it|0039
20534428|NCT03243084|UNC Chapel Hill|Julianna Prim|919-962-5271|jhprim@email.unc.edu|
20534429|NCT03641287|University of Washington Medical Center|Kathryn Pennington, MD|206-598-8300|katypenn@uw.edu|
20534430|NCT00600340|CECOG|MD. Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
20534431|NCT00127439|University of Louisville|Andrea L. Behrman, PhD, PT|502-582-7451|andreabehrman@catholichealth.net|
20534432|NCT00376558|nyspi|Diana Martinez|212-543-6628|dm437@columbia.edu|
20566029|NCT03971539|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566030|NCT06336967|University of Pennsylvania|Dr. Heather Nuske, PI|(215) 746-6041|heather.nuske@pennmedicine.upenn.edu|
20566031|NCT03373916|University of Michigan|Paul Pfeiffer, MD|734-845-3645|ppfeiffe@med.umich.edu|
20566032|NCT02422615|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20566033|NCT01036724|CTI Clinical Trials and Consulting|Dr. Tina Hunter, Consulting Statistician to Biosense Webster|513-619-5541|tinah@s2stats.com|
20566034|NCT01288443|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
20566035|NCT04327843|Case Western Reserve University|Kaylee Sarna|(216) 368-3577|kns17@case.edu|
20566036|NCT01617369|University of North Carolina Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
20566037|NCT00557284|IMMUNOe International Research Centers|Dr. Isaac Melamed, principle investigator|303-773-9000|melamedi@immunoe.com|
20566038|NCT00692913|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20566039|NCT02291913|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20566040|NCT01637402|University of California, San Francisco|Dr. Terry Friedlander, MD|415-514-6380|Terence.Friedlander@ucsf.edu|
20566041|NCT00351299|BrighamHospital|Dr. Gerald Weinhouse|617-732-5499|gweinhouse@partners.org|
20566042|NCT04876417|University of Iowa|Thorsten Rudroff, PhD, Associate Professor|(319) 467-0363|thorsten-rudroff@uiowa.edu|
20566043|NCT02111096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20566044|NCT01143142|University of Colorado|Amanda Dempsey|303-724-6679|amanda.dempsey@ucdenver.edu|
20566045|NCT01268306|Arthur B. Epstein, OD|Dr. Arthur Epstein|424-226-2020|artepstein@yahoo.com|
20566046|NCT03621735|University of Michigan|Susan Shore|734-647-2116|sushore@umich.edu|
20566047|NCT03875313|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
20566048|NCT05441449|Spinal Cord Damage research Center, James J. Peters VA Medical Center|Dr. John Handrakis|(718) 584-9000|john.handrakis@va.gov|5439
20566049|NCT00686595|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20566050|NCT01342367|The University of Chicago|Dr. Stanley Liauw|7737026870|sliauw@radonc.uchicago.edu|
20566051|NCT02964741|University of Michigan|Jacqueline Dobson|734-763-8469|contacthope@umich.edu|
20566052|NCT00610558|University of California, Irvine|Dr. Lydia Su|(949) 824-4925|msu@uci.edu|
20566053|NCT01074294|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20566054|NCT00640159|Baylor College of Medicine/Houston Methodist|William G. Ondo , MD|713-363-8930|wondo@houstonmethodist.org|
20566055|NCT00112359|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
20566056|NCT01209195|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20566057|NCT00312208|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
20566058|NCT01315132|Sidney Kimmel Cancer Center at Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|Neal.Flomenberg@jefferson.edu|
20566059|NCT03433794|Old Dominion University|Dr. Abby Braitman|757-683-3708|abraitma@odu.edu|
20566060|NCT03593356|University of California, Irvine|Greg John Duncan|(949) 824-7831|gduncan@uci.edu|
20566061|NCT05521516|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|bilfeld@health.ucsd.edu|
20566062|NCT03275285|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20566063|NCT04032106|Ohio State University|Dr. Paul Reiter|614-292-4803|reiter.36@osu.edu|
20566064|NCT03400150|BioProtect|Dafna Carmi Yinon|+972 (9) 7731-929|dafna@bioprotect.com|
20566065|NCT04882917|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20566066|NCT05357989|Annovis Bio, Inc.|Matthew Peterson, PhD|484-875-3192|peterson@annovisbio.com|
20534433|NCT02095106|Orthopaedic Institute for Children|Dr. Mauricio Silva|213-742-1109|msilva@mednet.ucla.edu|
20534434|NCT03373435|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-272-6138|info@eigerbio.com|
20534435|NCT00553254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534436|NCT00189137|University of Michigan Comprehensive Cancer Center|Dr. Scott Schuetze, M.D., Ph.D.|1-800-865-1125|scotschu@umich.edu|
20534437|NCT02314923|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534438|NCT06034340|Emory University|Dr. Eric Felner -Professor of Pediatrics|404-785-0935|efelner@emory.edu|
20534439|NCT04700800|Mayo Clinic|Lori Roust|(602) 543-4254|Roust.Lori@mayo.edu|
20534440|NCT01055028|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
20534441|NCT01381679|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534442|NCT04023487|University of Southern California|Beth Pyatak|323-442-2615|beth.pyatak@chan.usc.edu|
20534443|NCT03898180|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20534444|NCT02507934|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20534445|NCT04503616|NYU Langone Health|Kelli Cole, NP|646-501-4848|Kelli.Cole@NYULangone.org|
20534446|NCT03766399|AstraZeneca Clinical Study Information Center|Global Clinical Head|+1-877-240-94 79|information.center@astrazeneca.com|
20534447|NCT00645658|VA Palo Alto Health Care System|Jonathan Myers|6504503440|drj993@aol.com|
20534448|NCT04258631|Mayo Clinic|Sean C. Dowdy, M.D.|507-266-0225|Dowdy.Sean@mayo.edu|
20534449|NCT03093415|Oregon Health and Sciences University|Andrew Seaman, MD|1 (971) 271 - 6102|seaman@ohsu.edu|
20534450|NCT03896633|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20534451|NCT01722643|Dartmouth-Hitchcock|Dr. Catherine Stanger|603-646-7023|catherine.stanger@dartmouth.edu|
20534452|NCT01559935|Weill Cornell Medicine|Ruben Niesvizky, MD|6469626500|run9001@med.cornell.edu|
20534453|NCT01472185|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20534454|NCT05078437|University of Kentucky|Daniela Moga, Associate Professor|8593239682|daniela.moga@uky.edu|
20534455|NCT02958865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534456|NCT02661815|Dana-Farber Cancer Insitute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
20534457|NCT01767987|Kettering Health Network|Suzanne Coleman, PhD|937-395-8390|suzanne.coleman@khnetwork.org|
20534458|NCT03232567|Altimmune|Stephanie Holland, Clinical Project Manager|240-654-1450|sholland@altimmune.com|40
20534459|NCT01153516|University of Texas Southwestern at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20534460|NCT05837481|Massachusetts General Hospital|Chien Yi Maximilian Png, MD|617-726-5308|cypng@mgh.harvard.edu|
20534461|NCT04581395|IU school of Medicine, Department of Anesthesiology|Dr. Leighan Bye, Assistant Professor of Clinical Anesthesia|317-274-0275|lbye@iu.edu|
20534462|NCT05112640|University of Texas Medical Branch|Brett Goldman|9542632359|brettryangoldman@gmail.com|
20534463|NCT02527512|Boston Children's Hospital|Lauren Hutchinson, Clinical Research Manager|6179191632|lauren.hutchinson@childrens.harvard.edu|
20534464|NCT00189475|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|4123594099|dskoner@wpahs.org|
20534465|NCT00815633|Icahn School of Medicine at Mount Sinai|Dr. Joshua Zeichner||joshzeichner@gmail.com|
20534466|NCT02474498|Piracicaba Dental School - University of Campinas|Prof.Dr. Enilson Antonio Sallum|+55 19 2106-5301|easallum@fop.unicamp.br|
20534467|NCT00244985|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20534468|NCT00654355|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3885|sfeldman@wfubmc.edu|
20534469|NCT05022719|Medtronic|Melanie Crystal|774-245-8756|melanie.crystal@medtronic.com|
20534470|NCT01605097|BC Cancer|Dr Juanita Crook|250 712 3958|jcrook@bccancer.bc.ca|
20534471|NCT05006495|Seoul National University Hospital|Researcher of Clinical Trials|+821049051485|junhiya@snu.ac.kr|
20534472|NCT02284893|AstraZeneca|Katarina Fridman|+46(31)7762040|katarina.fridman@astrazeneca.com|62040
20534473|NCT04116684|Cleveland Clinic|Venu Menon, M. D.|216-445-5390|menonv@ccf.org|
20534474|NCT03078868|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
20534475|NCT01983111|Mundipharma Korea Ltd.|PhD. Miyoung Song||miyoung.song@mundipharma.co.kr|
20534476|NCT03038620|UT Southwestern Medical Center|Dr. Parag Joshi|2146458000|parag.joshi@utsouthwestern.edu|
20534477|NCT03817580|Eurofins EVIC|Commercial Manager|40 213357090|luciachirita@eurofins.com|
20534478|NCT04380142|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
20534479|NCT00105066|National Institute On Aging|Dr. James Strait|4105588084|straitj@mail.nih.gov|
20534480|NCT02908178|Yale University|Shi-Yi Wang, MD, PhD|2037852886|shiyi.wang@yale.edu|
20534481|NCT05205616|University of Califronia, San Francisco|Sepehr Hashemi, DMD|4133674736|sepehr.hashemi@ucsf.edu|
20534482|NCT04875533|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_lnquiries@pfizer.com|
20534483|NCT01275300|Upenn|Wenliang Song, MD|215-662-4652.|wenliangsong@gmail.com|
20534484|NCT03338920|Currax Pharmaceuticals LLC|Dr. Michael Kyle|708.834.8254|mkyle@curraxpharma.com|
20534485|NCT00982280|Grünenthal GmbH|Dr. Ilona Steigerwald|+49 241 569 0|Clinical-Trials@grunenthal.com|
20534486|NCT01506726|Duke University Medical Center|Harvey J. Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
20534487|NCT02231580|Ipsen|Vice President Early Development & Clinical Pharmacology||clinical.trials@ipsen.com|
20534488|NCT03781570|Dartmouth College|Tor D Wager, PhD|(603)-646-2196|Tor.D.Wager@Dartmouth.edu|
20534489|NCT01107496|Supernus Pharmaceuticals, Inc.|Jonathan Rubin, MD, Senior Vice President and Chief Medical Officer|240-403-5710|jrubin@supernus.com|
20534490|NCT01346592|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20534491|NCT05185453|University of Pittsburgh|Dr. Alison Culyba|412-692-6056|alison.culyba@chp.edu|
20534492|NCT04569084|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|908-607-1980|information@mt-pharma-us.com|
20534493|NCT00964678|Virginia Commonwealth University Health System|Dan Grinnan, MD|804-828-9000|daniel.grinnan@vcuhealth.org|
20534494|NCT03359395|Wake Forest Health Science|T. Quinn McCutchen, MD|336.716.4498|tmccutch@wakehealth.edu|
20534495|NCT00131885|University of Utah|Patricia Murphy, DrPH|801-793-5729|patricia.murphy@nurs.utah.edu|
20534496|NCT06022107|Yale University|Li Yan McCurdy, PhD|2037372912|liyan.mccurdy@yale.edu|
20534497|NCT02953457|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@Roswellpark.org|
20534498|NCT05943990|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20534499|NCT04494971|Pennington Biomedical Research Center|Dr. Hanim Ecem Diktas|(225) 763-2832|hanim.diktas@pbrc.edu|
20534500|NCT02333799|Global Alliance for TB Drug Development|Eugene Sun, MD|212-227-7540|eugene.sun@tballiance.org|
20534501|NCT05484895|Emory University|Dr. Don Operario|404-727-0503|don.operario@emory.edu|
20534502|NCT02964377|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
20534503|NCT02552225|Boson Medical Center|Pieter Noordzij, MD|(617) 414-1756|pieter.noordzij@bmc.org|
20534504|NCT01168596|University of Florida Center for Movement Disorders and Neurorestoration|Irene A. Malaty, MD|352-273-5550|Irene.Malaty@neurology.ufl.edu|
20534505|NCT00876447|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20534506|NCT00123630|University of Utah|Dr. John Fang|801-581-7802|john.fang@hsc.utah.edu|
20534507|NCT02297516|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
20534508|NCT00710593|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20534509|NCT04490278|Washington University|Chris Palmer|314-215-7384|cmpalmer@wustl.edu|
20534510|NCT02965781|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
20534511|NCT00525421|University of California San Francisco|Nita Chainani-Wu|415-476-2045|nita.wu@ucsf.edu|
20534512|NCT00366457|Massachusetts General Hospital|Lawrence S. Blaszkowsky, MD|6172191230|LBLASZKOWSKY@mgh.harvard.edu|
20534513|NCT00189423|Advanced Circulatory Systems, Inc.|Director of Clinical Trials|651-403-5600|csetum@advancedcirculatory.com|
20534514|NCT02323048|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
20534515|NCT01999530|Centre for Addiction and Mental Health|Bernard Le Foll|416-535-8501|bernard.lefoll@camh.ca|34772
20534516|NCT03359161|St. Elizabeth's Medical Center|Dr. Lana Tsao|617-789-3036|lana.tsao@steward.org|
20534517|NCT00183248|University of Miami|George W. Burke III, M.D.|(305) 355-5060|Gburke@med.miami.edu|
20534518|NCT05093621|Yale School of Medicine|Jeffrey Testani, MD, MTR Associate Professor of Medicine|(203) 785-7191|jeffrey.testani@yale.edu|
20534519|NCT03493958|Clinical Center|Wallen, Gwenyth|+1 301 496 0596|gwallen@cc.nih.gov|
20534520|NCT01029535|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20534521|NCT02836249|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20534522|NCT03605693|Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center|Dr. Ian Kronish|212-342-1335|ik2293@columbia.edu|
20534523|NCT04752566|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20534524|NCT03331354|VA North Texas Health Care System|James LePage|214-857-0240|james.lepage@va.gov|
20534525|NCT00304161|University of Pennsylvania|Dr. Daniel Weintraub|215-349-8207|daniel.weintraub@uphs.upenn.edu|
20534526|NCT01646827|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20534527|NCT05134649|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20534528|NCT04618276|University Hospital Zurich|PD Dr. med. Yvonne Achermann|+41 44 396 74 18|yvonne.achermann@usz.ch|
20534529|NCT00928668|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20534530|NCT04392154|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20534531|NCT02038647|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20534532|NCT02757430|Abbott|Clinical Research Scientist|6517562885|amber.miller@abbott.com|
20534533|NCT04486677|VA San Diego|Dr. Emily Treichler|6192288075|emily.treichler@va.gov|
20534534|NCT05036343|Mayo Clinic|Ana L. Creo, M.D.|507-284-3300|Creo.Ana@mayo.edu|
20534535|NCT02733757|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
20534536|NCT02106832|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20534537|NCT02878785|University of Maryland Greenebaum Cancer Center|Maria Baer, M.D.|410-328-8708|mbaer@umm.edu|
20534538|NCT01483560|University of Glasgow|Prof John Petrie|+44 141 330|John.Petrie@glasgow.ac.uk|3325
20534539|NCT00265122|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
20534540|NCT04716894|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20534541|NCT00608062|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau. PI|303-724-1914|kerrie.moreau@cuanschutz.edu|
20534542|NCT04992065|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20534543|NCT03648892|NIH|Dr. Kevin Hall|301-402-8248|kevinh@niddk.nih.gov|
20534544|NCT01467466|MAVERIC, VA Boston|Christopher Donnelly, Chief of Data Management|857-364-2332|christopher.donnelly2@va.gov|
20534545|NCT02268656|Gil hospital|Dr. Hyun Jeong Kwak|82324603636|hyun615@gilhospital.com|
20534546|NCT01772654|Mayo Clinic|Cheolsu Shin, M.D.|507-284-4961|shin@mayo.edu|
20534547|NCT03261505|Massachusetts General Hospital|Prof. Jian Kong|16179620978|kongj@nmr.mgh.harvard.edu|
20534548|NCT01262105|Nimbic Systems|Sean Self|281-565-5700|self@nimbicsystems.com|
20534549|NCT00330733|Phoenix VA Health Care System|Peter Reaven|602 277 5551|Peter.Reaven@va.gov|5817
20534550|NCT01890031|University of Rochester|Robert Block, MD, MPH; Clinical Trial Director|585-275-3356|robert_block@urmc.rochester.edu|
20534551|NCT04724837|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-94|information.center@astrazeneca.com|79
20566067|NCT04926740|Lawson Health Research Institute|Kristine Van Aarsen (Research Associate)|5196858500|kristine.vanaarsen@lhsc.on.ca|76089
20534552|NCT04079738|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20534553|NCT00071032|Rutgers Robert Wood Johnsom Medical School|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@rutgers.edu|
20534554|NCT01889251|Alcon Japan, Ltd.|Group Manager, Clinical Development|+81368995277||
20534555|NCT02784587|Maine Medical Center|Research coordinator|2076622862|richaj3@mmc.org|
20534556|NCT05852470|Alcon Research, LLC|Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20534557|NCT06071104|Alcon Research LLC|Sr. Principal Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20534558|NCT00085839|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
20534559|NCT01903863|Duke University Hospital|Dr. Caroline Ozment|919-681-2554||
20534560|NCT04261985|UCLA DGSOM|Dr. Alma Guerrero|3102672789|aguerrero@mednet.ucla.edu|
20534561|NCT04312022|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20534562|NCT01344226|Discover Vision Centers|Melissa Morrison Toyos|8164781230|mtoyos@discovervision.com|
20534563|NCT05677347|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20534564|NCT04118764|Columbia University|Elisa Konofagou, PhD, Robert and Margaret Hariri Professor in Biomedical Engineering and Radiology|212-342-0863|ek2191@columbia.edu|
20534565|NCT02420717|The University of Texas MD Anderson Cancer Center|Dr. Nitin Jain MD./Associate Professor|713-745-6080|njain@mdanderson.org|
20534566|NCT04116489|UMass Chan Medical School; Tan Chingfen Graduate School of Nursing|Donna Perry, PhD, RN|508-856-3621|DonnaJ.Perry@umassmed.edu|
20534567|NCT03734536|Smith+Nephew|Samantha Andrews|9789718990|samantha.andrews@smith-nephew.com|
20534568|NCT00937105|University Hospitals Eye Institute|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
20566068|NCT04980300|University of Delaware|Daniel White|302-831-7607|dkw@udel.edu|
20566069|NCT04528459|Columbia University|Wakenda K. Tyler, MD, MPH|2123059192|wkt2106@cumc.columbia.edu|
20566070|NCT01347255|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20566071|NCT05709860|Northwestern University|Research Assistant Professor|312-503-0274|allison.pack@northwestern.edu|
20566072|NCT02278185|University of Colorado School of Medicine|Dr. Elizabeth R Kessler|720-848-0402|elizabeth.kessler@cuanschutz.edu|
20566073|NCT01663363|Abbott Medical Optics|Ann Murphy, Manager, Clinical Research|619-518-4158|Ann.Murphy@abbott.org|
20566074|NCT04530487|M D Anderson Cancer Center|Jeremy S Connors, MD|(713) 792-6624|jsconnors@mdanderson.org|
20566075|NCT04977583|Department of Veterans Affairs|Dr. Grant Huang|(202) 443-5700|CSP@va.gov|
20566076|NCT04406272|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|patrick_wen@dfci.harvard.edu|
20566077|NCT00979459|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20566078|NCT00753337|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
20566079|NCT00210106|Digestive Tumours Unit, Institut Bergonie|Pr Serge Evrard|s.evrard@brdeaux.unicancer.fr||
20566080|NCT00786864|University of the Witwatersrand|Gina L Fanucchi|+27 11 616 4400|gfanucs@mweb.co.za|
20566081|NCT00825344|Johns Hopkins|Dr. Steven P. Cohen|410-955-1818|scohen40@jhmi.edu|
20566082|NCT01675063|Emory University|James Blum|404-778-3482|jmblum@emory.edu|
20566083|NCT03876457|University Hospitals Cleveland Medical Center|Dr. Amrou Sarraj|(216)844-0474|Amrou.Sarraj@UHhospitals.org|
20566084|NCT02967458|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Ethan Halpern|215-955-5345|ethan.halpern@jefferson.edu|
20566085|NCT01574716|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20566086|NCT01411137|Impax Laboratories, Inc.|Michelle Landolfi, Senior Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
20566087|NCT03709706|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20566088|NCT01105975|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20566089|NCT04868617|Coloplast A/S|Pernille Nonboe|+4549113143|dkpen@coloplast.com|
20566090|NCT00698867|Zimmer Biomet|Kelly Francher, Clinical Affairs Manager|574-371-9783|kelly.francher@zimmerbiomet.com|
20566091|NCT02797132|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20566092|NCT02502526|Alcon, A Novartis Division|Dir Surg Instrumentation, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20566093|NCT06199986|University of Chicago|Dr. Ted Skolarus|773 702-0881|tskolarus@bsd.uchicago.edu|
20566094|NCT01371994|Astellas Pharma Global Development, Inc.|Medical Director, Urology||clinicaltrials@us.astellas.com|
20566095|NCT00087685|The University of Texas (UT) MD Anderson Cancer Center|Karen H. Lu, MD, Chair, Gynecologic Oncology & Reproductive Medicine|713-745-8902|CR_Study_Registration@mdanderson.org|
20566096|NCT04529616|RxSight, Inc.|Associate Director, Clinical Trials|9494215463|dgoffredo@rxsight.com|
20566097|NCT05601882|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20566098|NCT00115934|New England Research Institutes|Lynn Sleeper, ScD|617-972-3235|lsleeper@neriscience.com|
20566099|NCT00747565|Abbott Medical Optics, Inc.|Nicholas Tarantino, O.D., Head, Global Clinical Research & Development|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
20566100|NCT03777657|BeiGene|Study Director|877-828-5568|Clinicaltrials@beigene.com|
20566101|NCT06284941|Jiangyan District Hospital of traditional Chinese medicine attached to the Nanjing University of Chinese Medicine|Yang Zhang|15861013918|617405180@qq.com|
20566102|NCT03789110|Dana-Farber Cancer Institute|Sara Tolaney|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
20566103|NCT05827068|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20566104|NCT00227266|University of Utah|Sandra Reyna, M.D.|801-581-3551|sreyna@genetics.utah.edu|
20566105|NCT00650078|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
20534569|NCT02538614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20534570|NCT02829996|Inotek Pharmaceuticals Corp.|Roni Cohen|781-676-2100|rcohen@inotekpharma.com|
20566106|NCT02549352|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20566107|NCT01470144|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD||thomas.pfister@actelion.com|
20534571|NCT01098747|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534572|NCT03302767|Institut Bergonié|Véronique GERAT-MULLER|0556337839|v.gerat-muller@bordeaux.unicancer.fr|
20534573|NCT00400686|Cleveland Clinic|Beth Faiman, MSN,CNP, AOCN|216-445-3738|faimanb@ccf.org|
20534574|NCT01383005|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20534575|NCT02458235|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
20534576|NCT00845702|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20534577|NCT00030264|Children's Hospital of Philadelphia|Ratnakar Patti|267-426-5503||
20534578|NCT02300545|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-8475|bvantine@wustl.edu|
20534579|NCT00687076|Baylor College of Medicine|Gerd Brunner, PhD|713-790-5800|gbrunner@bcm.edu|
20534580|NCT01517984|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20534581|NCT04903288|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20534582|NCT00573768|Novartis Consumer Health|Sandy Hamelsky|+19735037258|sandy.hamelsky@novartis.com|
20534583|NCT05296824|SacEP Research|Arash Aryana, MD, PhD|916-453-2684|a_aryana@outlook.com|
20534584|NCT02134184|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20534585|NCT01137890|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
20534586|NCT04617860|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
20534587|NCT00806585|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDevelopment@merck.com|
20534588|NCT02621892|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20534589|NCT01968980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534590|NCT04537650|KITE Research Institute - University Health Network|Catriona M. Steele, PhD|14165973422|catriona.steele@uhn.ca|7802
20534591|NCT02347410|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|6512568503|Rgriffith@spineology.com|
20534592|NCT01957384|Coloplast A/S|Marian Dyreborg Sinvani, Clinical Manager|+45 4911 2356|dkmards@coloplast.com|
20534593|NCT03199079|Advanced Tactile Imaging, Inc.|Egorov Vladimir, Principal Investigator|609 883-0100|egorov@tactile-imaging.com|
20534594|NCT03773484|University of Southern California|Dr. Jason Doctor|213-821-8142|jdoctor@usc.edu|
20534595|NCT03620981|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|06-6943-7722|CL_OPCJ_RDA_Team@otsuka.jp|
20534596|NCT05552859|Sanofi|Trial Transparency email recommended (Toll free for US & Canada)|800-633-1610|Contact-us@sanofi.com|Option 6
20534597|NCT01380080|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20534598|NCT04251533|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20534599|NCT05634538|Corindus|Alison Lord|617-943-5472|alison.lord@siemens-healthineers.com|
20534600|NCT06378008|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20534601|NCT00210132|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20534602|NCT02711202|Institute for Clinical and Experimental Medicine|Prof. Ondřej Viklický, M.D., Ph.D.|+420 2 6136 4110|ondrej.viklicky@ikem.cz|
20534603|NCT00432965|Acelity|Sr Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
20534604|NCT04716725|University of California, San Francisco|Dr. Ivan de Kouchkovsky, MD|(415) 221-4810|ivan.dekouchkovsky@ucsf.edu|2129
20534605|NCT03909971|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534606|NCT05177354|Medtronic Neuromodulation|Nancy McClelland|1-800-633-8766|nancy.l.mcclelland@medtronic.com|
20534607|NCT03229057|University of Pennsylvania|Dr Anuja Dokras|215-615-0085|adokras@pennmedicine.upenn.edu|
20534608|NCT06028464|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20534609|NCT03636022|Minnesota HealthSolutions|Sara Seifert|6128036998|sara@minnhealth.com|
20534610|NCT03140969|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599 7887|contact@sepulbio.com|
20534611|NCT03448393|National Cancer Institute|Dr. Nirali N. Shah|240-760-6970|shahnn@mail.nih.gov|
20534612|NCT01587196|University of Pennsylvania|Daniel Langleben, MD|215-760-7067|langlebe@pennmedicine.upenn.edu|
20534613|NCT00642759|Massachusetts General Hospital|Dr. Rebecca Heist|6177244000|rheist@partners.org|
20534614|NCT03826472|California Health Sciences University College of Osteopathic Medicine|Emily Johnston|9737685888|eajohnst@gmail.com|
20534615|NCT04604431|Northwestern University Feinberg School of Medicine|Lucy Bilaver, Associate Professor of Pediatrics, iREACH Co-Investigator|312-503-5618|l-bilavere@northwestern.edu|
20534616|NCT02096107|Medical University of South Carolina|David Taber|843-792-3368|taberd@musc.edu|
20534617|NCT03612570|Pulse Biosciences, Inc.|William A. Knape|(510) 906-4649|bill.knape@pulsebiosciences.com|
20534618|NCT02476448|Cleveland Clinic Florida|Dr. Eric Hurtado|954-659-5559|hurtade@ccf.org|
20534619|NCT03537508|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20534620|NCT02516813|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20534621|NCT01972659|Kocaeli University Medical Faculty|Assistant Professor Dr Z Ipek ARSLAN AYDIN|00905325011339|zehraipek48@gmail.com|
20534622|NCT02399228|University of Texas Health Science Center at San Antonio|Dr. Ying Li, M.D., Ph.D.|210-450-1719|liy8@uthscsa.edu|
20534623|NCT04652765|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Cathy Handy Marshall|4109550231|chm@jhmi.edu|
20534624|NCT03664544|Mitsubishi Tanabe Pharma Europe Ltd|General Information|Please e-mail|regulatory@mt-pharma-eu.com|
20534625|NCT04308512|Baylor College of Medicine|Dr. Bijan Najafi|(424) 467-7127|najafi.bijan@gmail.com|
20534626|NCT03176173|Stanford University|Clinical Associate Professor, Radiation Oncology - Radiation Therapy|(650) 723-6171|mgens@stanford.edu|
20534627|NCT05715827|Medtronic|Yewon Lee|1031132023|yewon.lee@medtronic.com|
20534628|NCT03274466|"KCI | 3M"|Director of Clinical Research|(210) 515-4060|actate@mmm.com|
20534629|NCT02513641|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
20534630|NCT05847686|University of Washington|Anthony Back MD|2066194367|tonyback@uw.edu|
20534631|NCT03716830|Massachusetts General Hospital|Jian Kong, PI of the clinical trial|6177267893|kongj@nmr.mgh.harvard.edu|
20534632|NCT05489328|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534633|NCT03021486|UT MD Anderson Cancer Center|David Hui, MD- Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
20534634|NCT04795531|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20534635|NCT04887831|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20534636|NCT01323192|Janssen Pharm KK Japan|Medical Director|+81-3-4411-5509||
20534637|NCT03396445|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20534638|NCT04622592|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
20534639|NCT01664624|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20534640|NCT02369536|IRCCS Neuromed|Dr. Chiara Cerletti, operative responsible of the trial and corresponding author of the data public|0865915246|chiara.cerletti@moli-sani.org|
20534641|NCT02243358|Henry Ford Cancer Institute|Dr. Gazala Khan, MD|313-598-2860|gkhan1@hfhs.org|
20534642|NCT00904371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20534643|NCT04252014|Georgetown University|Darren Mays|2026878937|dmm239@georgetown.edu|
20534644|NCT03594500|VA NY Harbor Healthcare System|Dr. Joshua Chodosh|212-686-7500|joshua.chodosh@va.gov|5043
20534645|NCT02300233|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20534646|NCT00833690|The Parkinson Study Group|Michael A. Schwarzschild, MD, PhD|617-724-9611|mschwarzschild@partners.org|
20534647|NCT04773665|VBI Vaccines Inc|Francisco Diaz-Mitoma, MD, PhD|613-749-4200|fdiazmitoma@vbivaccines.com|
20534648|NCT03057548|SacEP Research|Arash Aryana, MD, PhD|916-453-2684|a_aryana@outlook.com|
20534649|NCT03057704|Wake Forest University School of Medcine|Timothy N. Harwood MD|3367164498|tharwood@wakehealth.edu|
20534650|NCT04462471|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
20534651|NCT05805150|CooperVision|Jose Vega|925-621-3761|jvega2@coopervision.com|
20534652|NCT00855335|Janssen Scientific Affairs, LLC|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
20534653|NCT01734525|Federal University of Rio de Janeiro|Marcio Nucci|5521-39382463|mnucci@hucff.ufrj.br|
20534654|NCT00731484|TearLab, Inc.|Dr. Benjamin Sullivan|855-832-7522|bdsulliv@TearLab.com|
20534655|NCT05126303|Guard Therapeutics|Sara Thuresson, Head of Clinical Operations|+46733319438|sara.thuresson@guardtherapeutics.com|
20534656|NCT02526290|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20534657|NCT00509288|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20534658|NCT02082977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20534659|NCT00049543|NCIC Clinical Trials Group|Dr. Keyue Ding|1-613-533-6000|king@ctg.queensu.ca|77705
20534660|NCT00737360|The University of Texas M.D, Anderson Cancer Center|Dr. Anne Tsao, Principal Investigator|713-792-6363||
20534661|NCT00538850|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
20534662|NCT04138056|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20534663|NCT03815344|Maimonides Medical Center|Pedram Bral, MD|7182836000|pbral@maimonidesmed.org|
20534664|NCT02421094|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
20534665|NCT02706392|Fred Hutchinson Cancer Center|Dr. David Maloney|2066675616|dmaloney@fredhutch.org|
20534666|NCT03290027|Dr. Reddys Laboratories Inc.|Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20534667|NCT00619866|AbbVie|Global Medical Services|800-633-9110||
20534668|NCT06203717|Butler Hospital|Mascha van 't Wout-Frank|401-680-4198|mascha_vant_wout@brown.edu|
20534669|NCT01138514|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20534670|NCT01098422|UC San Diego|Dr. Tony Reid|8583531942|treid@ucsd.edu|
20534671|NCT01474109|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
20534672|NCT01276106|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
20534673|NCT03078452|Emory University|Dr. Ajay Nooka|404-778-1900|anooka@emory.edu|
20534674|NCT01242514|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20534675|NCT01082939|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
20534676|NCT00862940|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20534677|NCT00787150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534678|NCT00879398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534679|NCT03112902|University of Colorado|Brice McConnell|303-724-3897|brice.mcconnell@cuanschutz.edu|
20534680|NCT05705375|University of Texas at Arlington|Ziyad Ben Taleb|817-272-8297|ziyad.bentaleb@uta.edu|
20534681|NCT05901636|Janssen Research & Development, LLC|Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20534682|NCT02303821|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20534683|NCT02302222|Acelity|Sr Director, Global Clinical Development|2102555595|jane.hart@acelity.com|
20534684|NCT03193801|Edwards Lifesciences|Director of Research|949-250-2500|THV_ct.gov@edwards.com|
20534685|NCT03138564|Emory University|Mi-Kyung Song, PhD, RN|404-727-3134|mi-kyung.song@emory.edu|
20566108|NCT00593840|Washington University School of Medicine|Wade Thorstad, M.D.|314-362-8516|thorstad@radonc.wustl.edu|
20534686|NCT06517394|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Principal investigator|6177267913|apresciutti@mgh.harvard.edu|
20534687|NCT00643279|Medtronic|Dana Wigert|763-526-2802|dana.wigert@medtronic.com|
20534688|NCT04846868|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20534689|NCT04116853|Advocate Aurora Research Institute|Kathryn Ross, PhD MPH|414-647-6312|Kathryn.Ross@aah.org|
20534690|NCT05212168|Vaxart|Maria Apkarian|+1 (650) 779-4560|mapkarian@vaxart.com|
20534691|NCT02371187|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
20534692|NCT05395936|Atrium Health Wake Forest Baptist Comprehensive Cancer Center|Adam Katz|336-716-4171|akatz@wakehealth.edu|
20534693|NCT03326245|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Dardo Tomasi|+1 301 496 1589|tomasidg@mail.nih.gov|
20534694|NCT02180828|Peking University|Shangrong Fan|860755-83923333|fanshangrong@163.com|5502
20534695|NCT02276040|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
20534696|NCT02835690|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534697|NCT03674281|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
20534698|NCT00582907|Shaare Zedek Medical Center/Cleveland Clinic|Philip Hashkes, MD, MSc|972-2-6555307|hashkesp@szmc.org.il|
20534699|NCT03226418|University of Nebraska Medical Center|Vijaya Bhatt|402-559-5520|IITOffice@unmc.edu|
20534700|NCT01441960|Mass General Hospital|Ala Nozari|978-318-3933|anozari@partners.org|
20534701|NCT02481414|University of Arkansas for Medical Sciences|Matthew Kovak, Director of Clinical Trials|501-686-8274|MRKovak@uams.edu|
20534702|NCT03309202|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534703|NCT00415636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20534704|NCT01263119|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20534705|NCT02138825|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20534706|NCT03014635|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
20534707|NCT02090764|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
20534708|NCT01864434|University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
20534709|NCT00673920|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20534710|NCT01650402|UConn Health|William White, MD|860-679-4556|wwhite@uchc.edu|
20534711|NCT02610634|Newcastle University|Professor Lynn Rochester|0191 208 1291|lynn.rochester@ncl.ac.uk|
20534712|NCT03746015|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20534713|NCT04562116|Galderma|Clinical Operations|08179615000|Clinical.Studies@galderma.com|1
20534714|NCT01838226|Durham VAHCS HSR&D|Dr. David Edelman|919-286-6936|david.edelman@va.gov|
20534715|NCT04198012|DEKA Research|Regulatory Affairs Manager|603-669-6491|psmolenski@dekaresearch.com|
20534716|NCT02329587|Butler Hospital|Sarah Garnaat|401-455-6659|sgarnaat@butler.og|
20534717|NCT00455702|Massachusetts General Hopsital|Donald C Goff|617-912-7899|goff@psych.mgh.harvard.edu|
20534718|NCT03139721|Medtronic|Jessica Halverson, Clinical Research Director|763-514-9756|rs.CSHHAMMOCKPAS@medtronic.com|
20534719|NCT03502200|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20534720|NCT03097289|Terumo BCT, Inc.|Ned Cosgriff, MD|+1 303-239-2316|ned.cosgriff@TerumoBCT.com|
20534721|NCT03949517|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
20534722|NCT01121757|Duke University Health Center|Anne Beaven, MD, Associate Professor|9196848964|anne.beaven@duke.edu|
20534723|NCT03861338|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
20534724|NCT03213509|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
20534725|NCT02297412|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
20534726|NCT05047627|Dartmouth College|Nicholas Jacobson|(603) 646-7037|Nicholas.C.Jacobson@dartmouth.edu|
20534727|NCT03584490|Northwestern University|James W. Griffith, PhD|3125035345|j-griffith@northwestern.edu|
20534728|NCT05196776|Temple University Hospital|Ryan Gibbons|2157075522|ryan.gibbons@tuhs.temple.edu|
20534729|NCT02876172|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20534730|NCT03330847|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20534731|NCT03532256|University of Pennsylvania|Mucio Delgado, MD, Principal Investigator|215-746-8256|mucio.delgado@pennmedicine.upenn.edu|
20534732|NCT05211596|National Center for Deaf Health Research|Steven Barnett, PhD|585-506-9484|steven_barnett@urmc.rochester.edu|
20534733|NCT02769481|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20534734|NCT06272383|University of Manitoba|Dr Alex Aregbesola|2047893957|Alex.Aregbesola@umanitoba.ca|
20534735|NCT04398706|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20534736|NCT06899100|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20534737|NCT00618787|Tyco Healthcare Group|Tonya Eggleston, RN, MPH, Study Director|(508) 261-8420|Tonya.Eggleston@Covidien.com|
20534738|NCT01107886|AstraZeneca LP|Boaz Hirshberg MD, MBA|1 302 885 4997|ClinicalTrialTransparency@astrazeneca.com|
20534739|NCT01346176|University of Pennsylvania School of Medicine|Scott D. Halpern|215.573.9461|elcooney@exchange.upenn.edu|
20534740|NCT01994876|Coloplast A/S|Director of Clinical Affairs|+45 4911 25 23|dkdac@coloplast.com|
20534741|NCT05819398|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20534742|NCT04522973|Virginia Commonwealth University|Michelle Peace, PhD|804-828-8240|mrpeace@vcu.edu|
20534743|NCT04630769|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu|
20534744|NCT01649869|University of Alabama at Birmingham|David Kimberlin, MD|(205) 638-2530|DKimberlin@peds.uab.edu|
20534745|NCT02776735|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20534746|NCT01139515|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534747|NCT05201807|Johnson & Johnson Vision Care, Inc.|John R. Buch-Senior Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
20534748|NCT01690273|Universidade Sao Paulo|Andrea Lopes Gallinaro; Researcher|55112601|algallinaro@gmail.com|8022
20534749|NCT01209767|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20534750|NCT01702298|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534751|NCT01752049|St. Michael's Hospital|Dr. Marie Faughnan|416-864-6060|marie.faughnan@unityhealth.to|5412
20534752|NCT00560508|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20534753|NCT05077969|Leidos, Inc.|Tilly Lawrence|703-578-7034|tilly.lawrence@leidos.com|
20534754|NCT02367456|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534755|NCT02862574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20534756|NCT03136055|University of California, San Francisco|Dr. Emily Bergsland|(415) 353-9888|Emily.Bergsland@ucsf.edu|
20534757|NCT00284180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20534758|NCT01161771|Allergan, Inc.|Vice President, Global Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20534759|NCT02410772|Centers for Disease Control and Prevention|Dr. Ekaterina Kurbatova, MD, PhD, MPH|4046392017|ies3@cdc.gov|
20534760|NCT04573972|Carnegie Mellon University|Gretchen Chapman, PhD|4122687380|gchapman@andrew.cmu.edu|
20534761|NCT00822094|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
20534762|NCT05067335|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20534763|NCT02724839|Cincinnati Children's Hospital Medical Center|Dr.Kristen Copeland|5136361687|kristen.copeland@cchmc.org|
20534764|NCT01645176|Stanford University School of Medicine|Mark C. Genovese|650-498-4528|genovese@stanford.edu|
20534765|NCT00949533|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20534766|NCT01493089|Norgine Ltd|Dr. Richard Ng Kwet Shing|+441895453584|RNg@Norgine.com|
20534767|NCT03807089|Massachusetts General Hospital|Dr. Norman Nishioka|617-726-4422|nnishioka@partners.org|
20534768|NCT02164864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20534769|NCT01870869|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20534770|NCT00557193|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20534771|NCT00652834|UCLA Kidney Transplant Research Program|Dr. Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu|
20534772|NCT01948427|Horizon Therapeutics, LLC|Horizon Therapeutics, LLC|866-479-6742|clinicaltrials@horizontherapeutics.com|
20534773|NCT00402987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20534774|NCT01668004|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534775|NCT00419744|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20534776|NCT02668666|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20534777|NCT05528770|Center for Diabetes Technology|Manager of Clinical Research|434-982-0602|mc7m@uvahealth.org|
20534778|NCT03462745|American University of Beirut Medical Center|Dr. Roland Kaddoum|01350000|rk16@aub.edu.lb|6704
20534779|NCT01190527|University of Michigan Comprehensive Cancer Center|Dr. Shruti Jolly, M.D.|734-936-4300|shrutij@umich.edu|
20534780|NCT01117779|Boston Scientific|Chantal Laframboise, Clinical Research Manager|613-882-0876|chantal.laframboise@bsci.com|
20534781|NCT02448381|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
20534782|NCT02008617|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale, M.D.|312-695-4814|rrahangd@nmff.org|
20534783|NCT01500317|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20534784|NCT00976456|Krankenhaus Martha-Maria Halle-Doelau gGmbH|Prof. Dr. Wolfgang Schuette|+49 345 5591440|wolfgang.schuette@martha-maria.de|
20534785|NCT00335829|Johns Hopkins, Interventional Radiology|Jeff Geschwind, MD|410-614-6597|jfg@jhmi.edu|
20534786|NCT00583219|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|petrou.steven@mayo.edu|
20534787|NCT02037529|Mayo Clinic|Minetta Liu|5072930526|Liu.Minetta@mayo.edu|
20534788|NCT02131766|UVA|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
20534789|NCT00754572|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20534790|NCT00718315|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20566109|NCT04559698|Yale University School of Public Health|Dr. Zachary Soulliard|646-344-4060|zachary.soulliard@yale.edu|
20566110|NCT03437733|Biosense Webster, Inc.|Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20534791|NCT02384421|Stanford University|Dr. Helen Bronte-Stewart, MD, MSE|650-723-6709|bronte-stewart-lab@stanford.edu|
20566111|NCT01982682|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Dolores Grosso|215-955-0182|dolores.grosso@jefferson.edu|
20566112|NCT02760654|University of Michigan School of Nursing|Robert Knoerl, Doctoral Student|734-536-9369|rjknoerl@umich.edu|
20566113|NCT00146172|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20566114|NCT00712179|Ralph H Johnson VA Medical Center|Dr. Steven A Kautz|843-792-3867|kautz@musc.edu|
20566115|NCT03684590|University of Texas Southwestern|Tiffany Moon, MD|2145345456|tiffany.moon@utsouthwestern.edu|
20566116|NCT01184326|Dana-Farber Cancer Institute|Dr. Mark Pomerantz|617-632-4524|mark_pomerantz@dfci.harvard.edu|
20566117|NCT01084694|Northside Hospital|Dr. Dawn Speckhart, PhD|404-255-1930|dawn.speckhart@northside.com|
20534792|NCT01874392|Sansum Diabetes Research Institute|Director of Research and Innovation|8056827640|dkerr@sansum.org|
20534793|NCT01959685|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20566118|NCT02414633|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20566119|NCT02432300|EmotEd, LLC|Dawn Neumann|716-713-5048|dneumann73@gmail.com|
20566120|NCT02438137|UMichigan|Tiffany Braley, M.D., M.S.|734-232-1147|tbraley@med.umich.edu|
20566121|NCT00945321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20566122|NCT03406325|Hong Kong Sanatorium & Hospital|Prof. Tak Hong Lee|28358430|TakHong.Lee@hksh.com|
20566123|NCT03614663|Zynerba Pharmaceuticals|Stephen O'Quinn, PharmD|919-271-1339|oquinns@Zynerba.com|
20566124|NCT00605306|Novartis Pharmaceuticals|Study Director|862-778-8300||
20566125|NCT01750684|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|acorda@acorda.com|
20566126|NCT01970410|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
20534794|NCT00427037|Emory University School of Medicine|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
20534795|NCT01394159|Center for Interventional Endoscopy, Florida Hospital|Dr Shyam Varadarajulu|407-303-2570|svaradarajulu@yahoo.com|
20534796|NCT03229538|Duke University|Kevin Hill, MD|919-681-6846|kevin.hill@duke.edu|
20566127|NCT00702884|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab|614-293-6529|Tanios.Bekaii-Saab@osumc.edu|
20566128|NCT02185794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20566129|NCT00336505|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
20566130|NCT01092416|Cardiovascular Systems, Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
20566131|NCT00246805|Medtronic BRC - Medtronic Italia|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
20566132|NCT03878979|Johns Hopkins University|Dr. Tanguy Seiwert|443-287-8312|tseiwert@jhmi.edu|
20566133|NCT02284113|Pacira Pharmaceuticals, Inc.|Medical Information||MedInfo@Pacira.com|
20566134|NCT04191824|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
20566135|NCT01218009|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20566136|NCT01324310|Celgene Corporation|Senior Manager|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20566137|NCT03170882|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20566138|NCT04027439|Verona Pharma|Verona Pharma|+44 (0)203 283 4200|info@veronapharma.com|
20566139|NCT05018143|University of Pennsylvania|Dr. José A. Bauermeister|215-898-3242|bjose@upenn.edu|
20566140|NCT01830595|Minneapolis Medical Research Foundation|Jason Baker|612-873-2705|baker@umn.edu|
20566141|NCT05116774|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20566142|NCT03834740|Ivy Brain Tumor Center|Dr. Nader Sanai|602-406-8605|research@ivybraintumorcenter.org|
20566143|NCT03891758|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp, clinicaldevelopment@mail.biken.or.jp|
20566144|NCT03691493|Emory University|Dr. Mylin Torres|404-778-1900|matorre@emory.edu|
20566145|NCT05507970|Medicines for Malaria Venture|Project Director|+41 22 555 03 00|info@mmv.org|
20566146|NCT05464732|Carolina Eyecare Physicians, LLC|Director of Clinical Trials|8438813937|hps@cepmd.com|
20566147|NCT05501600|University of Pittsburgh|Keith Vogt|412-647-3147|vogtkm@upmc.edu|
20566148|NCT05019742|Shanghai Pharma Biotherapeutics USA Inc.|CSO|8587755354|kenneth@sphbio.com|
20566149|NCT03959423|Medtronic Diabetes|DZ Dai, Sr Statistician|8185764034|dz.dai@medtronic.com|
20566150|NCT05617300|HealthPartners Neuroscience Research|Leah Hanson, PhD|6514956352|Leah.R.Hanson@HealthPartners.com|
20566151|NCT05704725|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20566152|NCT05864209|NYU Langone Health|Linda G Kahn, PhD, MPH|(917) 439-8069|linda.kahn@nyulangone.org|
20566153|NCT04207736|Aldeyra Therapeutics, Inc.|Bill Cavanagh|781-257-3063|bcavanagh@aldeyra.com|
20566154|NCT02722434|Mayo Clinic|Charles L Loprinzi MD|507/284-2511|cloprinzi@mayo.edu|
20566155|NCT01211106|Cpl Micheal J Crescenz VA Medical Center|David Oslin, MD|215-823-5894|dave.oslin@va.gov|
20566156|NCT00290537|U.T. M.D. Anderson Cancer Center|Vali Papadimitrakopoulou, MD / Associate Professor|713-792-6363||
20566157|NCT04017611|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
20566158|NCT00366249|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20566159|NCT01561300|Unilever R&D Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
20566160|NCT03478969|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20566161|NCT01185600|University of Miami|Wenche Jy, PhD, Research Associate Professor, Principal Investigator|305-243-6617|wjy@med.miami.edu|
20566162|NCT01436175|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20566163|NCT00739934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566164|NCT03455985|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
20566165|NCT01500200|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20566166|NCT01952366|Sykehuset Innlandet|Dr. Tom Borza|+47 91834607|tom.borza@sykehuset-innlandet.no|
20566167|NCT04860505|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
20566168|NCT00857766|GlaxoSmithKline|GSK Response Center|866-435-7343||
20566169|NCT01961609|Novartis Pharmaceuticals|Study Director|862-778-1873||
20566170|NCT01988402|San Antonio Military Medical Center|Jay B Higgs,|2109160797|jay.b.higgs.civ@mail.mil|
20566171|NCT01212744|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
20534797|NCT00998010|University of California at Los Angeles|Mark Glover|(310) 794-8742|mglover@mednet.ucla.edu|
20566172|NCT01262339|University of Wisconsin- Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
20566173|NCT02167451|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
20534798|NCT02303262|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
20534799|NCT00934921|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20534800|NCT01728246|Janssen Pharmaceutica|Medical Affairs Manager|+632-8247901||
20534801|NCT01143402|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646 888 4162|chapmanp@mskcc.org|
20534802|NCT02481557|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20534803|NCT02135484|UT MD Anderson Cancer Center|John C. Araujo, Associate Professor, Genitourinary Medical Oncology|(713) 792-2830|johna@mdanderson.org|
20534804|NCT01959932|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20534805|NCT00397540|Seoul National University Hospital Boramae Medical Center|Won Kim|82 2 870 2233|wonshiri@yahoo.com|
20534806|NCT01656161|Debiopharm International|Eija Lundstrom, Medical Director|+41 21 321 06 03|eija.lundstrom@debiopharm.com|
20534807|NCT00963872|University of Minnesota|Dr. Claudio Brunstein|612-625-3918|bruns072@umn.edu|
20534808|NCT00776230|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43120620|info@valneva.com|0
20534809|NCT01215851|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|dan.everitt@tballiance.org|
20534810|NCT03510273|PATH|Dr. Silvia de Sanjose|2062853500|sdesanjose@path.org|
20534811|NCT01606150|Georgetown University NICU|Judith Palafoutas, Research Director|202 444 8756|jxp11@gunet.georgetown.edu|
20534812|NCT02589938|Wake Forest NCORP Research Base|Lead Biostatistician (Dr. Emily Dressler)|336-716-0891|NCORP@wakehealth.edu|
20534813|NCT00485173|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20534814|NCT04237584|MANA RBM|Penelope Manasco, CEO|9195566456|pmanasco@manarbm.com|
20534815|NCT02445911|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
20534816|NCT02581930|University of North Carolina at Chapel Hill|Dr. Stergios Moschos|919-843-7713|stergios_moschos@med.unc.edu|
20534817|NCT01400412|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
20534818|NCT05395338|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20534819|NCT01083602|Novartis Pharmaceuticals|Study Director|862-778-8300||
20534820|NCT01657370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20534821|NCT04043286|Loma Linda University, School of Dentistry|Dr. Sasiya Bhumpattarachai|6267565156|sbhumpattarachai@llu.edu|
20534822|NCT03698279|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20534823|NCT02004158|Massachusetts General Hospital|Jeff Huffman|617-724-2910|jhuffman@partners.org|
20534824|NCT04987372|UZ Ghent|dr. Harlinde Peperstraete|+3293325185|harlinde.peperstraete@uzgent.be|
20534825|NCT02649920|Centre Hospitalier Départemental Vendée|Dr. Guillaume DUCARME|02 51 44 61 61|guillaume.ducarme@ght85.fr|
20534826|NCT01198587|Boston Children's Hospital|Michelle Niescierenko MD MPH|617-919-4121|michelle.niescierenko@childrens.harvard.edu|
20534827|NCT02234362|MGH Center for Women's Mental Health|Dr. Marlene Freeman|617-723-6403|mfreeman@partners.org|
20534828|NCT01959529|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20534829|NCT01440764|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|(617)667-0572|rbanzett@bidmc.harvard.edu|
20534830|NCT00560417|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20534831|NCT02569853|Dr. Reddy's|Director, Clinical Development|609-375-9900|ebrandschieber@drreddys.com|
20534832|NCT00261833|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20534833|NCT00622726|University of Texas Health Science Center-Houston|Helen Mintz-Hittner, M.D.|713-559-5277|Helen.A.Mintz-Hittner@uth.tmc.edu|
20534834|NCT04358406|BioAegis Therapeutics Inc.|Mark J. DiNubile, MD|609-706-5866|mdinubile@bioaegistx.com|
20534835|NCT02434081|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|NICOLAS@etop-eu.org|
20534836|NCT03130569|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Hay|646-888-0039|hayj@mskcc.org|
20534837|NCT00854360|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20534838|NCT01528592|Northwestern University|Darren Gitelman, MD|312-908-8266|d-gitelman@northwestern.edu|
20534839|NCT02271880|Florida International University|Dr. William Pelham|305-348-0477|wpelham@fiu.edu|
20566174|NCT00571649|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20566175|NCT02555306|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
20566176|NCT03066609|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20566177|NCT01566890|Medical College of Wisconsin Department of Hematology|Joshua Field, MD|414-937-6896|JField@Versiti.org|
20566178|NCT02534285|Technical University Dresden, Dept. of Anaesthesiology|Prof. Dr. Matthias Hübler|+4945814002|matthias.huebler@uniklinikum-dresden.de|
20566179|NCT03983434|Indiana University|Dr. Huiping Xu|317-278-6735|huipxu@iu.edu|
20566180|NCT00588471|Mayo Clinic|Dr. Amir Lerman|507-255-7760|lerman.amir@mayo.edu|
20566181|NCT04124432|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20566182|NCT01357512|Oulu University Hospital and Univeristy of Oulu|Chief urologist Markku Vaarala|+3588315|markku.vaarala@oulu.fi|2840
20566183|NCT00523419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20566184|NCT00811941|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20566185|NCT03885232|University of Colorado at Anschutz Medical Campus|Sean O'Leary, MD, MPH - Principal Investigator|(303)724-1582|sean.oleary@cuanschutz.edu|
20566186|NCT02397096|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20534840|NCT00474903|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.||limburg.paul@mayo.edu|
20534841|NCT00399529|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Leisha Emens|412-623-3239|emensla@upmc.edu|
20534842|NCT02735200|Dammam University|Dr Dalal Bubshait|+966505848281|dbubshait@ud.edu.sa|
20534843|NCT01416025|JohnHopkinsU|Dr. Darin Ostrander|(443) 287-6217|dostrander@jhu.edu|
20534844|NCT00744861|Bioventus LLC|Manager Clinical Affairs|1-800-396-4325||
20534845|NCT04856527|University of Cincinnati|Sarah Schwab|5135587477|schwabsr@mail.uc.edu|
20534846|NCT02493764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534847|NCT01561976|GlaxoSmithKline|GSK Response Center|866-435-7343||
20534848|NCT02468583|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20534849|NCT01463527|Yale University|Dr. Melissa Langhan|203-737-7413|melissa.langhan@yale.edu|
20534850|NCT01493414|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20534851|NCT01072526|University of Missouri|Lenworth Johnson, MD|573-882-8473|JohnsonLN@health.missouri.edu|
20534852|NCT03443635|Tulane University Goldring Center for Culinary Medicine|Principal Investigator|3373290724|dominique.monlezun@gmail.com|
20534853|NCT01977222|Boston Children's Hospital|Dr. Fred Wu|6173556508|fred.wu@cardio.chboston.org|
20534854|NCT04165824|Mitsubishi Tanabe Pharma Development America, Inc.|Clinical Trials, Information Desk|Please email|information@mt-pharma-us.com|
20534855|NCT04403919|NYU Langone Health|Ran Schwarzkopf, MD|646-501-7070|Ran.Schwarzkopf@nyulangone.org|
20534856|NCT04319809|Minnesota HealthSolutions|Sara Seifert, President|6128036998|sara@minnhealth.com|
20534857|NCT01605669|Naval Medical Center San Deigo|LCDR William Bennett MD FACC|619-532-7400|william.bennett5@med.navy.mil|
20534858|NCT04846231|Cleveland Clinic|Luke Laffin, MD|216-372-4315|Laffinl@ccf.org|
20534859|NCT02980107|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
20534860|NCT03648385|Brown University Health, Center for Advanced Lung Care|Corey Ventetuolo, MD|401-444-2733|corey_ventetuolo@brown.edu|
20534861|NCT05448950|Phraxis, Inc.|Cindy Setum, PhD|16128016730|csetum@phraxis.com|
20534862|NCT03781479|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|3054203200|gingenito@catalystpharma.com|
20534863|NCT01014871|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
20534864|NCT00829244|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20534865|NCT04222673|Pittsburgh VA|Matthew Chinman|8184813909|chinman@rand.org|
20534866|NCT02274571|Pennington Biomedical Research Center|Dr. Eric Ravussin|2252844345|eric.ravussin@pbrc.edu|
20534867|NCT03374306|HK Polytechnic University|Prof. Henry Chan|+85227667937|henryhl.chan@polyu.edu.hk|
20534868|NCT05322408|Masonic Cancer Center|Melissa Geller, MD, MS|612-626-3111|gelle005@umn.edu|
20534869|NCT04583618|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
20534870|NCT04212442|University of Pennsylvania|Dr. Rebecca Brown|215-573-2021|rebecca.brown@pennmedicine.upenn.edu|
20534871|NCT00016354|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-4192|awolff@jhmi.edu|
20534872|NCT03110562|Karyopharm Therapeutics Inc.|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20534873|NCT01561469|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534874|NCT02160808|Dartmouth-Hitchcock Medical Center|Timothy B. Gardner MD MS|603-650-6472|timothy.b.gardner@hitchcock.org|
20534875|NCT03189719|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20534876|NCT03012880|Mayo Clinic|Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
20534877|NCT01355627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20534878|NCT04532749|Janssen Research & Development, LLC|Executive Director CDTL Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20534879|NCT04756531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534880|NCT05239221|Amolyt Pharma|Senior VP of Clinical Development and Regulatory Affairs|+33 428 01 21 54|contact@amolyt.com|
20534881|NCT04696146|Cedars-Sinai Medical Center|Noriko Ammerman|3102488186|noriko.ammerman@cshs.org|
20534882|NCT00285779|Stanford University Department of Dermatology|David Fiorentino|650-723-6316|fiorentino@stanford.edu|
20534883|NCT04164277|Michigan State University|Jiying Ling|5173538591|lingjiyi@msu.edu|
20534884|NCT01334918|Astellas Scientific and Medical Affairs, Inc. / Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||ClinicalTrials.Disclosure@us.astellas.com|
20534885|NCT00529633|University of California, Davis|George Kaysen MD PhD, Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
20534886|NCT01270529|University of California, San Francisco|Dr. Kirsten Johansen|415-221-4810|kirsten.johansen@ucsf.edu|23598
20534887|NCT01576783|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
20534888|NCT04096417|Mayo Clinic|Tanios Bekaii-Saab M.D.|480-342-2000|Bekaii-Saab.Tanios@mayo.edu|
20534889|NCT01897493|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20534890|NCT01658059|Hadassah Medical Organization|Moti Moskovitz||motim@ekmd.huji.ac.il|
20534891|NCT01227785|Guidant, a Boston Scientific Company|Paji Vitoff, Senior Clinical Manager|651-582-5415|paji.vitoff@bsci.com|
20534892|NCT02777086|Texas Christian University|Wayne E.K. Lehman, Ph.D.|18172577226|w.lehman@tcu.edu|
20534893|NCT01133665|The University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
20534894|NCT01819272|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
20534895|NCT01732536|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
20534896|NCT00805389|GlaxoSmithKline|GSK Response Center|866-435-7343||
20534897|NCT01409096|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
20534898|NCT05111145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20534899|NCT02359006|Yale University|Dr. Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
20566187|NCT03840902|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20534900|NCT01276704|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-205-6382|bkimler@kumc.edu|
20534901|NCT01359956|NCI Naples|Paolo A Ascierto, M.D., Ph.D|+39 081 5903431|p.ascierto@istitutotumori.na.it|
20534902|NCT03728933|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20534903|NCT01784029|Children's Hospital at Montefiore|Hina Talib|718-920-6781|htalib@montefiore.org|
20534904|NCT00370292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20534905|NCT01444911|University of Wisconsin Carbone Cancer Center|Dr. David Kushner|608-263-1210|dmkushner@facstaff.wisc.edu|
20534906|NCT00276419|Mayo Clinic|Dr. Robin L. Smith|507-284-1210|smith.robin@mayo.edu|
20534907|NCT00069641|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20534908|NCT03186638|University of Rochester Medical Center, Dept of Surgery, Supportive Care in Cancer|Michelle Janelsins, PhD, MPH|585-276-4656|michelle_janelsins@urmc.rochester.edu|
20534909|NCT02239926|Mayo Clinic|Dr. Yuri Saito Loftus|507-255-3680|saito.yuri@mayo.edu|
20534910|NCT02704208|San Diego State University|Keith J. Horvath|619-594-3346|khorvath@sdsu.edu|
20534911|NCT03801525|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20534912|NCT01766102|Massachusetts General Hospital|Michelle Specht, MD|617-726-0340|MSPECHT@mgh.harvard.edu|
20534913|NCT03545672|Renji Hospital, Shanghai Jiaotong University School of Medicine|Dr. Meng Jiang|+86 13788912766|jiangmeng0919@163.com|
20534914|NCT01628913|Novartis Pharmaceuticals|Study Director|862-778-8300||
20534915|NCT02673944|Laborie|Clinical Researcher|905-612-1170|sbitzos@laborie.com|1755
20534916|NCT04388826|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
20534917|NCT04047446|Hospital for Special Surgery|Dr. David H. Kim|212-606-1036|kimd@hss.edu|
20534918|NCT00329420|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20534919|NCT00548886|Emory University|Dr. Peter Seth Fischbach|404-256-2593|pfischb@emory.edu|
20534920|NCT03983421|Department of Psychiatry and Behavioral Sciences, Health Sciences Center, University of New Mexico|Annette Crisanti, PhD|5052726238|acrisanti@salud.unm.edu|
20534921|NCT03386773|Colorado School of Public Health|Susan L. Moore, PhD, MSPH|303-724-8858|susan.l.moore@cuanschutz.edu|
20534922|NCT03639610|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
20534923|NCT00892008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20534924|NCT03564886|University of Missouri, Department of Orthopaedics|Lasun Oladeji, MD|573-884-7796|OladejiL@health.missouri.edu|
20534925|NCT01636284|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
20534926|NCT05878067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20534927|NCT01170663|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20534928|NCT02006927|William Beaumont Hospitals|Deborah Hasenau, RN|248 551-0804|deborah.hasenau@beaumont.org|
20534929|NCT02746809|Medtronic|Phuong-Uyen Le|763-526-0989|phuong-uyen.n.le@medtronic.com|
20534930|NCT01093014|University of Iowa / Iowa City VA Medical Center|Richard K. Shields PhD, PT|319-335-9791|richard-shields@uiowa.edu|
20534931|NCT00742625|Massachusetts General Hospital Cancer Center|Eyal Attar, MD|617-724-1124|eattar@partners.org|
20534932|NCT01164007|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20534933|NCT00894387|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20534934|NCT02519842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534935|NCT02274675|Universiti Teknologi Malaysia|Project Leader||cfyeong@utm.my|
20534936|NCT01230411|Thomas Jefferson University- Jefferson Headache Center|Dr. Hsiangkuo Yuan|2159552243|Hsiangkuo.Yuan@jefferson.edu|
20534937|NCT02106429|NYU Langone Health|Jeffrey Berger, MD|212-263-4004|jeffrey.berger@nyulangone.org|
20534938|NCT05643495|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20534939|NCT00253422|Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Judith Bliss (Director of ICR-CTSU)|+44 0208 722|aude.espinasse@icr.ac.uk|4349
20534940|NCT02661672|Icahn School of Medicine at Mount Sinai|Sydney Edwards|212-241-2524|sydney.edwards@mountsinai.org|
20534941|NCT02319486|Zhongshan Ophthalmic Center, Sun Yat-sen University|Huasheng Yang|+862087331539|yanghs64@126.com|
20534942|NCT01295710|Neovii|Anne Kuan|781 966 3832|anne.kuan@neovii.com|
20534943|NCT00859833|Univesity of Utah|Sheldon Litwin|801-581-7715|sheldon.litwin@hsc.utah.edu|
20534944|NCT00427193|Duke University Medical Center|William E. Kraus, Director of Clinical Research, Duke Center for Living|919-681-6733|william.kraus@duke.edu|
20534945|NCT00698828|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20534946|NCT02013609|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20534947|NCT01816295|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20534948|NCT01076010|AVEO Pharmaceuticals, Inc.|Cheif Medical officer|857-400-0101|Clinical@aveooncology.com|
20534949|NCT01612676|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20534950|NCT02976181|Medtronic|Carina Leone, Latam CVG Trial Leader|+5411 5789 8521|carina.leone@medtronic.com|
20534951|NCT01204788|University of Texas (UT) MD Anderson Cancer Center|Emil Freireich, MD, Professor, Department of Medical Education|713-745-2723|CR_Study_Registration@mdanderson.org|
20534952|NCT05200845|Virginia Tech|Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
20534953|NCT02412670|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20534954|NCT02622191|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
20534955|NCT00565409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20534956|NCT01038323|Wake Forest|dennis ang|336-716-4209|dang@wakehealth.edu|
20534957|NCT00431964|Seattle Children's Hospital|Nicole Hamblett|206-987-5725|tdncc@seattlechildrens.org|
20534958|NCT02170064|BIAL - Portela & Cª, SA|Head of Clinical Research|+351-22 9866100|clinical.trials@bial.com|
20534959|NCT04442893|National Yang Ming University|Chiu-Yueh Yang, Professor|886-2-28267388|cyyang3@ym.edu.tw|8862282673
20534960|NCT01734902|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20534961|NCT00758563|Colgate Palmolive|William DeVizio - DMD|732-878-7901|William_DeVizio@colpal.com|
20534962|NCT03961308|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20534963|NCT01800786|Brigham and Women's Hospital|Ina Djonlagic|617 667 5129|idjonlag@bidmc.harvard.edu|
20534964|NCT00659425|MedImmune, LLC|Mark Lanasa, MD Associate Director, Clinical Development, Oncology|301-398-0000|information.center@AstraZeneca.com|
20534965|NCT03358030|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20534966|NCT03342560|Massachusetts General Hospital|Anthony E. Samir|6176432009|asamir@mgh.harvard.edu|
20534967|NCT02604511|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
20551789|NCT01892371|The University of Texas MD Anderson Cancer Center|Yesid Alvarado MD./Associate Professor|713-794-4364|yalvarado@mdanderson.org|
20551790|NCT01928524|Odense University Hospital|Per Pfeiffer|+45-26283844|per.pfeiffer@rsyd.dk|
20551791|NCT06013176|Abramson Cancer Center|Dr. Samuel Takvorian|267-438-8269|Samuel.takvorian@pennmedicine.upenn.edu|
20566188|NCT03736564|Mayo Clinic|Dr. Stephen Broski|507-293-6155|broski.stephen@mayo.edu|
20566189|NCT01447706|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20566190|NCT00918203|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20566191|NCT06456723|Imperial College London|Professor Rohini Sharma|0203 313 3720|r.sharma@imperial.ac.uk|
20566192|NCT03029286|Georgetown University|Suzanne O'Neill, PhD|202-687-0869|sco4@georgetown.edu|
20566193|NCT05139992|ASH Research Collaborative|Nicole Mortier|866-828-1231|nmortier@ashrc.org|
20566194|NCT01208974|University of Miami|Cristiane Takita MD|305-243-4337|ctakita@med.miami.edu|
20566195|NCT03593226|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
20566196|NCT00545545|HiberCell|Michele A. Gargano, MSC/ VP Clin Ops and Prg Mngt|651.675.0300|mgargano@hibercell.com|
20566197|NCT02678689|BioMarin Pharmaceutical Inc|Pascal Reisewitz, Global Medical Director, PhD|1-800-983-4587|medinfo@bmrn.com|
20566198|NCT04153890|West Virginia University School of Nursing|Dr. Ubolrat Piamjariyakul, PhD, RN|3042936729|ubolrat.piamjariyakul@hsc.wvu.edu|
20566199|NCT02798471|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20566200|NCT01162096|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
20566201|NCT05747014|Medtronic|Rianna Rapson - Clinical Study Manager|763-526-2170|rianna.k.rapson@medtronic.com|
20566202|NCT02896907|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. James Posey|215-503-6442|James.Posey@jefferson.edu|
20566203|NCT04503681|Cooper University Health Care|Brian Roberts|856-342-2352|roberts-brian-w@cooperhealth.edu|
20566204|NCT01596231|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
20566205|NCT03352713|Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine|Dr. Shea Lemley|603-646-7040|behavior.change@dartmouth.edu|
20566206|NCT01812759|UT MD Anderson Cancer Center|Kumar Alagappan,Chair, Emergency Medicine|(713) 745-9911|kalagappan@mdanderson.org|
20566207|NCT00536120|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
20566208|NCT04989816|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20566209|NCT03987581|Duke University School of Medicine|Angela Kirby|9198247729|angela.caison.kirby@gmail.com|
20566210|NCT02186509|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
20566211|NCT04213807|Anthos Therapeutics|Debra Freedholm|609-439-8246|Deb.f@anthostherapeutics.com|
20566212|NCT00145587|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
20566213|NCT01128595|GlaxoSmithKline|GSK Response Center|866-435-7343||
20566214|NCT00372775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566215|NCT00777049|Translational Research in Oncology (TRIO)|Valérie Bee-Muntenau, Director of Project Management|+33 1 58 10 09 09|Valerie.Bee@trioncology.org|
20566216|NCT00609869|H. Lee Moffitt Cancer Center and Research Institute|Javier Pinilla-Ibarz|813-745-1387|javier.pinilla@moffitt.org|
20566217|NCT00743574|Yale University|Dr. Lubna Pal|203-737-5619|lubna.pal@yale.edu|
20566218|NCT00724126|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
20566219|NCT01214759|The University of Texas Health Science Center at Houston|Dr. Karen Vigil|(713) 500-6703|Karen.J.Vigil@uth.tmc.edu|
20566220|NCT05405244|University of North Carolina at Chapel Hill|Kyle Burger, PhD, RD, MPH|9198439933|Kyle_burger@unc.edu|
20566221|NCT03418922|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
20566222|NCT03577106|UPMC|Scott Ward|412-683-7105|wards7@upmc.edu|
20566223|NCT01579318|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
20566224|NCT00635700|Yale University|Scott W. Woods, M.D.|203-974-7038|scott.woods@yale.edu|
20566225|NCT03601715|Federal University of Santa Catarina|Inaihá Benincá|(+55 48) 3721-6255|inaiha.b@gmail.com|
20566226|NCT02347332|Institut de Recherche Pierre Fabre, Toulouse France|Zahida Issiakhem, Clinical Development Physician|+33 5 34 50 61 71|zahida.issiakhem@pierre-fabre.com|
20551792|NCT02070744|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20551793|NCT03084081|Cleveland Clinic|Miriam Cremer, M.D.|216-213-6460|cremerm@ccf.org|
20551794|NCT03795298|Boston Scientific|Anne Cornaille|+1-800-227-3422|anne.cornaille@bsci.com|
20551795|NCT01252940|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20551796|NCT04199117|University of Wisconsin School of Medicine and Public Health|Danielle McCarthy, Ph.D.|6082655949|demccarthy@ctri.wisc.edu|
20551797|NCT04383743|University of Washington|Dr. Petros Grivas|2066061943|pgrivas@uw.edu|
20551798|NCT05230693|Medical University of South Carolina|Ennis James, MD|843-792-3769|jamesw@musc.edu|
20534968|NCT03770286|Children's Hospital Los Angeles|Alexander Alcaraz|323-361-2130|aalcaraz@chla.usc.edu|
20534969|NCT04951193|MUSC|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
20534970|NCT02293551|Chief Medical Officer|Eli Lilly and Company|800-545-5979||
20534971|NCT02936323|Tarveda Therapeutics, Inc.|Tarveda Clinical Information Center|(617) 923-4100|clinical.information@tarvedatx.com|
20534972|NCT02781558|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20534973|NCT02666560|University College London|Joanne Lindop|07909116145|joanne.lindop.12@ucl.ac.uk|
20534974|NCT02257528|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
20534975|NCT00404248|Adult Brain Tumor Consortium Central Office - Johns Hopkins|Director of Adult Brain Tumor Consortum|410-955-3657|jfisher@jhmi.edu|
20534976|NCT00698841|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20534977|NCT00789555|Alcon Research|Terri Pasquine, Sr. Clinical Lead|817-551-4760|terri.pasquine@alconlabs.com|
20534978|NCT04646005|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20534979|NCT03802396|Duke University|Miles Berger, MD, PhD|919-684-8679|miles.berger@duke.edu|
20566227|NCT01929291|GlaxoSmithKline|GSK Response Center|866-435-7343||
20534980|NCT01005290|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
20534981|NCT01150357|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20534982|NCT02114177|Janssen Infectious Diseases BVBA|Associate Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20534983|NCT03198871|University of Pittsburgh School of Medicine / UPMC|Dr. Kathirvel Subramaniam MD MPH FASE|7247995852|subramaniamk@upmc.edu|
20534984|NCT02336815|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20534985|NCT03376516|Octapharma AG|Sylvia Werner|604-1149|sylvia.werner@octapharma.com|+1 (201)
20534986|NCT01581684|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20534987|NCT02986074|Abbott|Yagna Pathak|+1-469-243-0088|yagna.pathak@abbott.com|
20534988|NCT00598650|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
20534989|NCT02415556|Beth Israel Deaconess Medical Center (BIDMC)|Dr. Vera Novak, Principal Investigator|6176328680|vnovak@bidmc.harvard.edu|
20534990|NCT00524121|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20534991|NCT01146613|NIAAA|Megan Ryan, M.B.A.|301-443-4225|mryan1@mail.nih.gov|
20534992|NCT00320606|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
20534993|NCT03984825|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20534994|NCT02250417|The Ohio State University|Ulysses J. Magalang|614-292-6563|magalang.1@osu.edu|
20534995|NCT02196922|Northwell Health|Renee Pekmezaris, Ph.D., Vice President Community Health & Health Services Research|516 465-3161|rpekmeza@northwell.edu|
20534996|NCT02115321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20534997|NCT02639390|Department of Veterans Affairs|Peter Lum|12023195181|lum@cua.edu|
20534998|NCT01908140|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20566228|NCT01478594|AVEO|Medical Director|1.617.588.1960|clinical@aveooncology.com|
20566229|NCT01119755|Hypertension Center, Third Department of Medicine, University of Athens, Greece|George S Stergiou, Associate Professor of Internal Medicine and Hypertension|+302107763117|gstergi@med.uoa.gr|
20566230|NCT01313884|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
20566231|NCT01970007|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20566232|NCT02854436|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20534999|NCT01119287|Alcon Research|Head, Alcon Clinical|1-888-451-3937||
20535000|NCT00680628|Indiana University School of Medicine|Jeffrey Kline|3172873004|jefkline@iupui.edu|
20535001|NCT01156844|Novartis Pharmaceuticals|Study Director|862-778-8300||
20535002|NCT03892317|Imperial College Healthcare Trust|Goodall Dawn|+44 (0)20 7589 5111|dawn.goodall1@nhs.net|
20535003|NCT00945659|Nemours Foundation: Dept. of Biomedical Research|Tim Wysocki, PhD|904-697-3483|twysocki@nemours.org|
20535004|NCT04067011|Emergent Biosolutions|Clinical Development Representative|+1 (204) 275-4196|ctgov@ebsi.com|
20535005|NCT03767881|Boston Scientific|Evelyne Ho, Clinical Project Manager|1-978-483-8856|Evelyne.ho@bsci.com|
20535006|NCT00534001|Roswell Park Cancer Institute|Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
20535007|NCT00476645|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
20535008|NCT02284191|NHS Lothian|Prof Alasdair Gray Chief Investigator|0131 242 1284|alasdair.gray@ed.ac.uk|
20535009|NCT04064905|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20535010|NCT02257684|Jazz Pharmaceuticals|Head of Clinical Development|650-496-3777||
20535011|NCT01448616|University of Washington|Rachel Bender Ignacio, MD MPH|2065204340|rbi13@uw.edu|
20535012|NCT00760552|Iowa City VA Health Care System|Dr. Gary Rosenthal|319-338-0581|gary-rosenthal@uiowa.edu|
20535013|NCT02943473|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|(212) 241-7873|ajai.chari@mountsinai.org|
20535014|NCT04211363|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844)692-6729|medinfo@arcutis.com|
20535015|NCT01465841|Penumbra, Inc.|Michaella Corso|415-815-8904|mcorso@penumbrainc.com|
20535016|NCT02092181|Evergreenhealth|Gowri Rajendran|425-899-5370|grajendran@evergreenhealth.com|
20535017|NCT00956293|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
20535018|NCT02359903|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20535019|NCT03383666|Cerenovus|Michael Liao|510-770-5376|mliao7@its.jnj.com|
20535020|NCT02536664|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535021|NCT00790673|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
20535022|NCT03381989|National Heart Lung and Blood Institute|Lederman, Robert|+1 301 402 6769|lederman@nih.gov|
20535023|NCT02972996|Stratton V.A. Medical Center|Margaret M. Wilson MS, RD, LD/N, CD/N, CNSC, CDE|518 626-6889|margaret.wilson2@va.gov|
20535024|NCT03507127|Brown University|Dr. Jennifer Tidey|4018636418|jennifer_tidey@brown.edu|
20535025|NCT01240863|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20535026|NCT01497756|uNewMexico|Mark Hauswald MD|505-269-6699|markhauswald@gmail.com|
20535027|NCT02625181|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
20535028|NCT00746811|Biofortis Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
20535029|NCT00867139|FHCRC|Michael Boeckh MD|206 667 6706|mboeckh@fhcrc.org|
20535030|NCT02505425|The University of Alabama at Birmingham, School of Nursing|Marie A. Bakitas, DNSc, NP-C, FAAN|(205) 934-5277|mbakitas@uab.edu|
20535031|NCT02031302|Boston Scientific Corp.|Blessie Concepcion, Director Clinical Trials|408-385-8604|Blessie.Concepcion@bsci.com|
20535032|NCT02579811|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Moshe Ornstein|1-866-223-8100|TaussigResearch@ccf.org|
20535033|NCT03050710|CROMA - PHARMA|Head of Clinical Operations|+43 0226268468|clinical.studies@croma.at|
20535034|NCT01370551|Medinova|Doerthe Bassfeld|+41 44 306 1371|bassfeld.doerthe@medinova.ch|
20535035|NCT00833521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20535036|NCT01280942|Washington Univ Sch of Medicine|Thomas C. Bailey, MD|314-454-8293|tbailey@dom.wustl.edu|
20535037|NCT00545779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20535038|NCT01405196|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535039|NCT01542788|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20535040|NCT01356147|Stanford University School of Medicine/Division of Neonatology|Dr. Melissa Scala|650-724-9653|mscala@stanford.edu|
20535041|NCT01729039|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
20535042|NCT03449576|Rehabilitation Research & Development|Dr. Shirley Groer (Scientific Program Manager)|202-553-9899|shirley.groer@va.gov|
20535043|NCT02918942|Grace Medical, Inc.|Robert Stroup|901-386-0990|robert.stroup@gracemedical.com|
20535044|NCT05788991|Medinova|Dr. Anahí Hurtado|+41443061396|hurtado.anahi@medinova.ch|
20535045|NCT04464473|Florida State University|Dr. Derek Nee|8506441963|dnee@fsu.edu|
20535046|NCT04066829|University of Michigan|Kao-Ping Chua|(734) 615-8169|chuak@med.umich.edu|
20535047|NCT03586973|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20535048|NCT01770743|Emergent BioSolutions|Dr. Gurdyal Kalsi|301-216-9927|kalsig@ebsi.com|
20535049|NCT00652743|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535050|NCT03233828|Nova Scotia Health|Principal Investigator|9024736177|carman.giacomantonio@nshealth.ca|
20535051|NCT02495285|B. Braun Melsungen|Study Manager|05661/71|studies@bbraun.com|0
20535052|NCT01585025|Imperial College London|Prof Julian Walters|+442033132361|julian.walters@imperial.ac.uk|
20535053|NCT00503984|University of Miami|Rakesh Singal MD|305-243-9544|rsingal@med.miami.edu|
20535054|NCT01246960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535055|NCT03430349|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
20535056|NCT00716820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535057|NCT02122380|Vanderbilt University Medical Center|Dr. Jessica Devin|970-875-2708|jessica.devin@vumc.org|
20535058|NCT00952705|MedImmune, LLC|JA Sliman, MD, MPH, Director, Clinical Development|301-398-0000|SlimanJ@medimmune.com|
20535059|NCT00140140|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20535060|NCT04102007|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20566233|NCT05230433|Happy Trails Nutrition|Jennifer Meijer|6036505250|jen@htnutrition.com|
20566234|NCT00754065|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20566235|NCT04497727|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
20566236|NCT04353492|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20566237|NCT04250194|Vanderbilt University Medical Center|Dr. Fabien Maldonado|615-322-2386|fabien.maldonado@vumc.org|
20566238|NCT03893318|University of California, San Diego|Michael Kelly, MD|508-410-9567|mpkelly@ucsd.edu|
20566239|NCT00623194|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20566240|NCT00647400|Abbott|Global Medical Services|800-633-9110||
20566241|NCT01218659|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20566242|NCT00588406|North Shore Long Island Jewish Health System|Dr. Robert Silverman|718-470-7501|rsilverman@nshs.edu|
20566243|NCT03355573|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20566244|NCT01201772|University of Florida|Dominick Angiolillo|904-244-3933|dominick.angiolillo@jax.ufl.edu|
20566245|NCT03938337|O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham|Eddy S. Yang|12059960780|eyang@uab.edu|
20566246|NCT00174252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20566247|NCT03357952|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566248|NCT02016872|Memorial Sloan Kettering Cancer Center|Dr. Jacob Shin, MD|848-225-6436|shinj2@mskcc.org|
20566249|NCT06688357|University of Florida - Norman Fixel Brain Institute|Dawn Bowers, Ph.D.|(352) 273-6617|dawnbowers@phhp.ufl.edu|
20566250|NCT03222609|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20566251|NCT04057820|University of Arkansas for Medical Sciences|Dr. Songthip Ounpraseuth|5016867233|stounpraseuth@uams.edu|
20535061|NCT05173974|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
20535062|NCT03289143|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535063|NCT00948688|Massachusetts General Hospital|Lawrence S. Blaszkowsky, M.D.|617-219-1230|lblaszkowsky@mgh.harvard.edu|
20535064|NCT00730756|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535065|NCT01152307|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
20535066|NCT01840943|Xian Janssen Pharmaceutical LTD|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
20535067|NCT01446874|Washington University School of Medicine|Varun Puri, M.D.|314-362-4191|varunpuri@wustl.edu|
20535068|NCT01135992|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20535069|NCT01977898|Northwestern University|Feyce Peralta, MD|312-472-3585|f-peralta@northwestern.edu|
20535070|NCT05130593|Pennington Biomedical Research Center|Jennifer C Rood, PhD|225-763-2524|jennifer.rood@pbrc.edu|
20535071|NCT04563767|HealthPartners Neurology|Michael Rosenbloom, MD|651-495-6363|michael.h.rosenbloom@healthpartners.com|
20535072|NCT02660229|Mundipharma Korea Ltd.|Mrs Suyoun Yang/CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
20535073|NCT01453166|Instituto de Ensino e Pesquisa do Hospital do Coração|Dr. Otavio Berwanger|+ 55 11 30536677|oberwanger@hcor.com.br|8201
20535074|NCT01466491|Oregon Health & Science University|Dr. Paula Bednarek|503-494-3666|whru@ohsu.edu|
20535075|NCT01049373|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiss|0049/641/7960-0|klinischeforschung@pascoe.de|
20535076|NCT01693367|AO Foundation|Clinical Operations Manager of Clinical Investigation and Documentation|0041 44 200 24 67|andreas.faeh@aofoundation.org|
20535077|NCT03610048|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
20535078|NCT01155050|PenningtonBRC|Ronald Horswell|225-763-2931|Ronald.Horswell@pbrc.edu|
20535079|NCT02136914|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
20535080|NCT04136145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20535081|NCT00329030|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20535082|NCT02468830|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
20535083|NCT01213082|University of California Davis|Susanna Park, MD|9167346074|sscpark@ucdavis.edu|
20535084|NCT00129285|University of Pennsylvania Treatment Research Center|Kyle Kampman|215-746-2764|kampman@mail.med.upenn.edu|
20535085|NCT01627691|Boston Scientific|Anne Cornaille|+33608863659|anne.cornaille@bsci.com|
20535086|NCT03218917|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@Insmed.com|
20535087|NCT05209386|University of Pittsburgh|Taylor Abel|412-692-9631|abeltj@upmc.edu|
20535088|NCT01484652|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20535089|NCT03440008|VA Puget Sound Health Care System|Dr. Joseph Iaquinto|206-277-1738|Joseph.Iaquinto@va.gov|
20535090|NCT04700423|Swiss TPH|Prof. Dr. Jennifer Keiser|+41612848218|jennifer.keiser@swisstph.ch|
20535091|NCT02958345|Tulane University|Dr. Luis Balart|504-988-3047|lbalart@tulane.edu|
20535092|NCT04849897|University of Southern California|Steven Richeimer|323-442-6202|steven.richeimer@med.usc.edu|
20535093|NCT01570387|Boston Medical Center|Vaishali Sanchorawala|617-638-7017|vaishali.sanchorawala@bmc.org|
20535094|NCT03139448|Vanderbilt University Medical Center|Koffi Kla, MD|615-343-9419|koffi.m.kla@vumc.org|
20535095|NCT03398330|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
20535096|NCT02347605|University of Minnesota|Michael Kotlyar|612-251-8780|kotly001@umn.edu|
20535097|NCT01567722|AMC Statistical Center|Madhu Mazumdar|(212) 659-9558|madhu.mazumdar@mountsinai.org|
20535098|NCT03261830|UMissouri|Vicki Jones|573-882-7583|jonesvicki@health.missouri.edu|
20535099|NCT01918189|VA Boston Healthcare System|Diana M. Higgins, PhD|857-364-2221|diana.higgins2@va.gov|
20535100|NCT03323164|Wills Eye Hospital|Dr. Daniel Lee|12159283197|daniellee@willseye.org|
20535101|NCT01823289|Department of Respiratory Medicine, SHANGHAI First People's Hospital Affiliated to SHANGHAI JiaoTong University|Director of Respiratory Department|86-21-63071428|xzhou53@163.com|
20535102|NCT02814656|AstraZeneca|Ioannis Psallidas||ClinicalTrialTransparency@astrazeneca.com|
20535103|NCT01736917|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20535104|NCT01259011|Emory University|Dr. Mi-Kyung Song|404-727-3134|mi-kyung.song@emory.edu|
20535105|NCT01911260|Federal University of Sao Paulo|Ana Paula Poblacion|+55 11 55391783|anapoblacion@yahoo.com.br|
20535106|NCT00654732|UT MD Anderson Cancer Center|Dr. Hun Ju Lee, Associate Professor, Lymphoma/Myeloma|713 794-1829|hunlee@mdanderson.org|
20535107|NCT01951391|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
20535108|NCT00060944|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20535109|NCT01126957|University of Missouri-Columbia|Dr. David Henry|573/884-2582|henryda@missouri.edu|
20535110|NCT05270863|Visus Therapeutics, Inc.|Visus Therapeutics|800-281-4536|trials.info@visustx.com|
20535111|NCT04712669|Sumitomo Pharma America|Ravi Grewal|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
20535112|NCT04577404|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|908-607-1980|information@mt-pharma-us.com|
20535113|NCT00775671|Vanderbilt University|Nancy J Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
20535114|NCT00639457|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
20535115|NCT03235050|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
20535116|NCT00508521|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|janis.daly@neurology.ufl.edu|6603
20535117|NCT01622296|UCSF School of Dentistry|Dr. Susan Parveen Tavana|415-476-1891|susan.tavana@ucsf.edu|
20535118|NCT00105534|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535119|NCT02935192|Institute of Virology, Vaccines and Sera, Torlak|Katarina Ilic|+381 11 3953 700|kilic@torlak.rs|214
20535120|NCT01561833|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
20535121|NCT02465931|RTI International|Dr. Don Bailey|(919) 541-6488|dbailey@rti.org|
20535122|NCT00492557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535123|NCT01574144|Medtronic, Inc|Amy Lautenbach|7633609163|amy.a.lautenbach@medtronic.com@medtronic.com|
20535124|NCT00372957|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535125|NCT03423121|Johns Hopkins University School of Medicine|Dr. Pavan Bhargava|410-614-1522|pbharga2@jhmi.edu|
20535126|NCT01354223|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|978-658-6888||151
20535127|NCT04606927|University Medical Center Groningen|Dr. Jozine ter Maaten|0503616161|j.m.ter.maaten@umcg.nl|
20535128|NCT02727322|University of Pittsburgh|Halina Zyczynski|421-641-1440|hzyczynski@upmc.edu|
20535129|NCT02852967|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
20535130|NCT02903823|Vanderbilt University Medical Center|Peter Konrad, MD PhD - PI|6153439822|peter.konrad@vumc.org|
20535131|NCT00325143|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535132|NCT02286895|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20535133|NCT03036852|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20535134|NCT00991809|Johns Hopkins University, School of Medicine|Dr. D. Andrew Tompkins|410-550-5953|dtompki1@jhmi.edu|
20535135|NCT00399035|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20535136|NCT01987414|University of Minnesota|Chih-Huang Yu|6126262443|yuxxx648@umn.edu|
20535137|NCT01999192|Biotest AG|Xuefei Zhou Manager Strategy & Development|+496103801|xuefei_zhou@biotest.de|1229
20535138|NCT02949011|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20535139|NCT01541371|CDMA, Beijing|Therapeutic Area Manager|00861058218352||
20535140|NCT02441218|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
20535141|NCT01131052|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20535142|NCT00163189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535143|NCT03435380|Duke University|Kevin Oeffinger, MD|919-668-2122|kevin.oeffinger@duke.edu|
20535144|NCT02431325|Massachusetts General Hospital|Janet Lo, M.D., M.MSc.|617-724-3425|jlo@mgh.harvard.edu|
20535145|NCT01008618|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
20535146|NCT01128569|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535147|NCT03338400|Cleveland Clinic Florida|Dr. David Ossin|954-659-5559|ossind@ccf.org|
20535148|NCT02941614|Kaiser Permanente Southern California Department of Research and Evaluation|Erin Hahn|626-564-3505|Erin.E.Hahn@kp.org|
20535149|NCT01865487|Aeras|Dr. Dereck Tait|27214424991|dtait@aeras.org|
20535150|NCT03758261|University of Pittsburgh Medical Center|Dr. Charles Luke|4127485589|lukecb@upmc.edu|
20535151|NCT01307449|Emory University|Rouphael, Nadine|404-712-1435|nroupha@emory.edu|
20535152|NCT00383071|SAIC/National Institute of Allergy and Infectious Diseases|John Beigel, M.D.|+1 301 451 9881|jbeigel@niaid.nih.gov|
20535153|NCT03019887|Okada hospital|Dr. Ryota Ataniya|+81-4-7124-6151|ryotaataniya@pbt.nir.jp|
20535154|NCT01531998|University of Texas (UT) MD Anderson Cancer Center|Jatin J. Shah, MD/Associate Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
20535155|NCT02604459|University of Missouri|Dr. Quinn Johnson|573-882-2568|johnsonql@health.missouri.edu|
20535156|NCT02927795|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535157|NCT02581891|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20535158|NCT03259295|University of Florida|Juan Carlos Roig|352-273-8985|roigjc@peds.ufl.edu|
20535159|NCT03421886|University of Alabama at Birmingham|Chung How Kau, chair and professor|(205) 934-2782|ckau@uab.edu|
20535160|NCT01130337|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535161|NCT03886493|Johns Hopkins University School of Medicine|Kenneth Pienta, M.D.|410-502-3137|kpienta1@jhmi.edu|
20535162|NCT00181844|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
20535163|NCT02918669|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
20535164|NCT00107276|SWOG|Study statistician|206-667-4623||
20535165|NCT03179761|Vanderbilt-Ingram Cancer Center|Natasha Halasa, MD, MPH|800-811-8480|natasha.halasa@vumc.org|
20535166|NCT04661033|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20535167|NCT00584857|UAB|J. Michael Straughn, MD|205-934-4986|Michael.straughn@ccc.uab.edu|
20535168|NCT03498716|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20535169|NCT00265850|Alliance for Clinical Trials in Oncology|Alan Venook, M.D.||Venook@cc.ucsf.edu|
20535170|NCT02108288|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
20535171|NCT01991860|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|Gabrielfox@acaciapharma.com|
20535172|NCT01306292|Bracco Diagnostics Inc.|Dr. Maria Luigia Storto|609-514-2262|marialuigia.storto@diag.bracco.com|
20535173|NCT01812057|Duke University Medical Center|Dr Terrence K Allen|9196682024|terrence.allen@duke.edu|
20535174|NCT01880957|Stony Brook University|Dr. Christine DeLorenzo|(631) 638-1523|Christine.Delorenzo@stonybrookmedicine.edu|
20535175|NCT02951780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20535176|NCT03060902|University of Oregon|Maureen Zalewski|541-346-7073|zalewski@uoregon.edu|
20535177|NCT02289469|SAI Interactive|Dr. Dane Boyington|(423) 521-2309|dane@thinkingmedia.com|
20535178|NCT04655157|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MCCR|412-647-5554|stadtermanbm@upmc.edu|
20535179|NCT04704193|Massachusetts General Hospital|Daniel Chung, MD|617-726-8687|chung.daniel@mgh.harvard.edu|
20535180|NCT00542178|Wake Forest University School of Medicine|Dr. Walter Ambrosius, PhD|336-716-6281|wambrosi@wakehealth.edu|
20535181|NCT02611037|Moffit Cancer Center|Bela Kis, MD, PhD|813-745-8425|Bela.Kis@Moffitt.org|
20535182|NCT00829998|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20566252|NCT04517435|Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center|Dr. Deepa Jagadeesh|1-866-223 8100|TaussigResearch@ccf.org|
20566253|NCT03211247|DBV Technologies|Pharis Mohideen, MD, Chief Medical Officer|908-679-5200|clinicaltrials@dbv-technologies.com|
20535183|NCT00834197|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20535184|NCT00163293|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20535185|NCT02561962|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20535186|NCT04133415|Washington University School of Medicine|Matthew Spraker, M.D., Ph.D.|314-362-8567|mspraker@wustl.edu|
20535187|NCT02051426|Herzog Hospital|Uriel Heresco-Levy, M.D.|+972-2-5316906|urielh@ekmd.huji.ac.il|
20535188|NCT01492426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20535189|NCT03549338|Symphogen A/S|Vice President, Global Oncology|+45 8838 2600|info@symphogen.com|
20535190|NCT00322049|U.S. Army Medical Component Armed Forces Research Institute of Medical Services|Wipa Chawachalasai|662-696-2700|wipac@afrims.org|4351
20535191|NCT01714323|Massachusetts General Hospital|Nancy Rigotti, MD|617-724-4709|nrigotti@partners.org|
20535192|NCT00939107|Back and Rehabilitation Center Copenhagen|Tom Petersen|+45 35304974|tom.petersen@suf.kk.dk|
20535193|NCT04099277|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20535194|NCT01621178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535195|NCT04778592|Eliem Therapeutics|Clinical Operations|+1-888-506-2573|studyinfo@eliemtx.com|
20535196|NCT03246087|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20535197|NCT04790786|UPMC|Erin McCreary|4845159589|mccrearye3@upmc.edu|
20535198|NCT01126190|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20535199|NCT01114737|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
20535200|NCT01123148|University of Michigan|Jane Huggins, PhD|734-936-7177|janeh@umich.edu|
20535201|NCT02808897|Montreal Heart Institute|Philippe Demers|5143763330|philippe.demers@icm-mhi.org|
20535202|NCT01496287|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20535203|NCT01823107|DSM Biomedical|Forde Hansell|484-713-2152|forde.hansell@dsm.com|
20535204|NCT00256126|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20535205|NCT02217618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535206|NCT02652221|Cincinnati Children's Hospital Medical Center|Andrew T. Trout, MD|513-803-3004|andrew.trout@cchmc.org|
20535207|NCT00506142|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
20535208|NCT02133573|Children's Hospital of Philadelphia|Dr. J. William Gaynor|215-590-5806|gaynor@chop.edu|
20535209|NCT00454116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20535210|NCT02213250|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|(001)8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535211|NCT03085680|University of Florida|Dr. Robert Mankowski|+1 (352) 294-5055|r.mankowski@ufl.edu|
20535212|NCT02261961|Central Arkansas Veterans Healthcare System|Richard Dennis|501-257-5583|richard.dennis2@va.gov|
20535213|NCT03500211|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
20535214|NCT01917318|University of Colorado|Michael H. Allen, M.D.|(303) 724-3300|Michael.Allen@ucdenver.edu|
20535215|NCT04460183|Thirty Respiratory Ltd|Alison Bracchi, MSc|+447763882519|alison.bracchi@30.technology|
20535216|NCT01175343|Princess Margaret Cancer Centre|Dr. Amit M. Oza|416-946-2818|amit.oza@uhn.ca|
20535217|NCT01138475|William Beaumont Hospital|Kerstyn Zalesin|248-655-5900|Kerstyn.zalesin@beaumont.edu|
20535218|NCT01534481|University of Iowa|Dr. Tarah Colaizy|319-356-3508|tarah-colaizy@uiowa.edu|
20535219|NCT05525910|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535220|NCT02831660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535221|NCT02287779|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
20535222|NCT01987557|WilfridLU|Matthew Lasswell|9056992087|lass3260@mylaurier.ca|
20535223|NCT01832727|Amgen, Inc|Study Director|866-572-6436|medinfo@amgen.com|
20535224|NCT01180127|Columbia University Medical Center, Division of Behavioral Medicine in Psychiatry|Richard Sloan|646-774-8940|rps7@cumc.columbia.edu|
20535225|NCT01419119|Umea University, Umeå, Sweden|Dr Margareta Norberg|+46702618614|margareta.norberg@umu.se|
20535226|NCT01538199|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
20535227|NCT02081586|University of Pittsburgh School of Nursing|Dr. Judith A. Callan PhD, RN|412-383-5321|callanja@pitt.edu|
20535228|NCT01832610|Medtronic|Thomas Vassiliades, MD - VP MCS Clinical/Medical Affairs|+15085321956|thomas.a.vassiliades@medtronic.com|
20535229|NCT03708367|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan, PhD|+1 408 5335282|skasthur@ITS.JNJ.com|
20535230|NCT02874092|NYU Langone|Dr. Jeffrey Berger|212-263-0855|Jeffrey.Berger@nyulangone.org|
20535231|NCT04540367|Houston Methodist Hospital|Bradley Lambert|8326872483|bslambert@houstonmethodist.org|
20535232|NCT00606489|Cumberland Pharmaceuticals|Amy Rock, Doctor of Philosophy (Ph.D.)|6152550068|arock@cumberlandpharma.com|
20535233|NCT01563055|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535234|NCT01816048|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-262-4961|jybruce@medicine.wisc.edu|
20535235|NCT01816984|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
20535236|NCT05899829|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20535237|NCT01147302|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20535238|NCT02121509|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566254|NCT02415127|Horizon Pharma Ireland, Ltd. Dublin, Ireland|Julie Ball, Executive Director Clinical Development & Operations||clinicaltrials@horizonpharma.com|
20566255|NCT02761187|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20535239|NCT01061528|University of Texas at Austin|Dr. Richard A. Brown|512-471-8584|brown2@utexas.edu|
20535240|NCT00636181|Stanford Sleep Medicine Center|Clete A. Kushida, MD, PhD|(650) 721-7560|clete@stanford.edu|
20566256|NCT02868970|Canadian Center for Vaccinology, Dalhousie University|Dr. Jennifer Isenor|902-494-2378|jennifer.isenor@dal.ca|
20566257|NCT05048394|Point Designs|Becca Connolly|720-600-4753|becca@pointdesigns.com|
20566258|NCT00490139|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20566259|NCT00872729|Horizon Orphan LLC|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
20566260|NCT03664804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20566261|NCT05529992|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20566262|NCT06140290|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566263|NCT03301467|ChemoCentryx, Inc.|Clinical trial disclosure|650.210.2900|clinicaltrials@chemocentryx.com|
20566264|NCT01779141|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20566265|NCT03752684|University of Alabama at Birmingham|John Knight|205-996-2295|johnknight@uabmc.edu|
20566266|NCT05250115|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566267|NCT03758638|Washington University in St. Louis|Rachel Tabak|3149350153|rtabak@wustl.edu|
20566268|NCT00582972|University of Wisconsin|Dr. Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
20566269|NCT01567605|Simon Fraser University|Dr Victoria Claydon (Principal Investigator)|7787828513|victoria_claydon@sfu.ca|
20566270|NCT02169869|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20566271|NCT02101775|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-4501|Amit.Oza@uhn.ca|3911
20566272|NCT02195232|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
20566273|NCT01211184|Södertälje Hospital|Robert Hahn|+46855024670|robert.hahn@sodertaljesjukhus.se|4670
20566274|NCT01421667|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20566275|NCT00822120|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
20566276|NCT00503906|UM/Sylvester Comprehensive Cancer CEnter|Stefan Gluck MD|305-243-4909|sgluck@med.miami.edu|
20566277|NCT02999763|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
20566278|NCT04060212|University of Rochester|Matthew Rand|585-275-5459|matthew_rand@urmc.rochester.edu|
20566279|NCT03631407|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20566280|NCT01378416|Eisai Inc.|Yufang Lu, MD PhD|1-888-422-4743||
20566281|NCT01437319|Johnson &Johnson Vision Care, Inc|Tawnya Wilson, OD Principal Research Optometrist|904-443-3500|TWilson@ITS.JNJ.com|1834
20566282|NCT01499849|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781.257.2536|mhuber@tesarobio.com|
20566283|NCT03496545|Weill Cornell Medicine|Judy Ch'ang, MD|(212) 746-2596|jhc9010@med.cornell.edu|
20566284|NCT03802994|Ralph H. Johnson VA Medical Center|ACOS/R, R. Amanda C. LaRue|843-789-6707|Rutha.LaRue@va.gov|
20566285|NCT00983294|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20566286|NCT00622700|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20566287|NCT00942266|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20566288|NCT03611556|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20566289|NCT02139436|Spaulding Rehabilitation Hospital|Glen Picard|6177585511|gpicard@partners.org|
20566290|NCT03664011|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566291|NCT01693822|Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Judith Bliss (Director of ICR-CTSU)|+44 0208 722 4297|apredict-icrctsu@icr.ac.uk|
20566292|NCT02646618|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
20566293|NCT02844439|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
20566294|NCT04023175|Atrium Health|Dr. Elizabeth Braxton|8032613377|egwbraxton@gmail.com|
20566295|NCT04035447|Duke University School of Medicine|Caroline Dorfman, PhD|919-416-3473|caroline.dorfman@duke.edu|
20566296|NCT03473743|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566297|NCT00980954|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20566298|NCT03950817|Maimonides Medical Center|Dr. Sergey Motov (Director of Emergency Medicine Research)|718-283-8693|smotov@maimo.org|
20566299|NCT03304587|Michigan State University College of Nursing|Dr. Horng-Shiuann Wu, Associate Professor|517-884-4643|wuhorngs@msu.edu|
20566300|NCT03500549|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20566301|NCT00979121|ARDS Network|David A. Schoenfeld, PhD ARDSNet CCC PI|617-726-6111|dschoenfeld@mgh.harvard.edu|
20566302|NCT02107261|Icahn School of Medicine at Mount Sinai|David Simpson, M.D.|2122418748|david.simpson@mssm.edu|
20566303|NCT01913314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20566304|NCT04337931|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
20566305|NCT02431273|Auritec Pharmaceuticals|Sarjan Shah|909-210-9715|sshah@auritecpharma.com|
20566306|NCT01738438|Dana-Farber Cancer Institute|Sara Tolaney, MD|617.632.2335|Sara_Tolaney@DFCI.HARVARD.EDU|
20566307|NCT00645359|University of Michigan Comprehensive Cancer Center|Dr. Daniel Lebovic, M.D.|734-936-5310|dlebovic@umich.edu|
20566308|NCT02928172|Cedars Sinai Medical Center|Dr. Ofelia Loani Elvir Lazo, Research Project Advisor|310-423-1682|loani.elvir-lazo@cshs.org|
20566309|NCT01532999|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|
20535241|NCT03820011|Board of Trustees at University of Illinois|Dr. Mary Khetani, Associate Professor|312-996-0942|mkhetani@uic.edu|
20566310|NCT02408887|National Cancer Institute|Dr. Naris Nilubol|240-760-6154|niluboln@mail.nih.gov|
20566311|NCT03333109|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20566312|NCT04474496|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
20566313|NCT00701701|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20566314|NCT00589875|Candel Therapeutics|Garrett Nichols (CMO)|617-916-5445|Gnichols@candeltx.com|
20566315|NCT00859781|Weill Cornell Medicine|Sarah Yuan|6469626040|say7008@med.cornell.edu|
20566316|NCT03280030|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20566317|NCT06191679|Children's Hospital of Philadelphia|Shannon Hammer|2678878580|bresslers@chop.edu|
20566318|NCT03997474|Achilles Therapeutics UK Limited|Dr Matilde Saggese|0786 9814607|matildesaggese@gmail.com|
20566319|NCT04538352|The Cleveland Clinic Foundation|Research Administrator|(216) 445-4791|jenkink@ccf.org|
20566320|NCT05630833|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20535242|NCT02371356|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3749|De-Kun.Li@kp.org|
20535243|NCT04549454|Loyola Marymount University|Dr. Bradley Trager, Research Scientist|3103385238|bradley.trager@lmu.edu|
20535244|NCT00867035|Department of Orofacial Sciences, University of California, San Francisco|Milton Robert Wirthlin, DDS, MS|415-476-1731|m.robert.wirthlin@ucsf.edu; ddsmmr@att.net|
20535245|NCT04336826|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20535246|NCT05437419|Teijin America, Inc.|President|+1 (415) 887-9742|clinical-trials-contact@teijinpo.com|
20535247|NCT05076045|Baycrest Academy for Research & Education|Claude Alain|416-785-2500|calain@research.baycrest.org|3523
20535248|NCT05175014|Epicentre|Dr Matthew E Coldiron|+33 1 40 21 55 55|matthew.coldiron@epicentre.msf.org|
20535249|NCT03801993|Seattle Children's Hospital|Dr. Christopher H. Goss M.D., M.Sc.|(206) 987-5725|cgoss@uw.edu|
20535250|NCT00713193|Ohio State University|Spero R Cataland|6142939441|spero.cataland@osumc.edu|
20535251|NCT01143636|Spaulding Rehabilitation Hospital, Boston, MA.|Dr. Felipe Fregni, Director of the Laboratory of Neuromodulation|617.952.6153|info@neuromodulationlab.org|
20535252|NCT03402841|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20535253|NCT02993263|Cleveland Clinic|Daniel Sessler, MD|216-444-9400|sesslers@ccf.org|
20535254|NCT01347060|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535255|NCT02735421|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20535256|NCT00427011|Eisai Call Center|Eisai Inc.|888-422-4743||
20535257|NCT02921789|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20535258|NCT02896257|VA Puget Sound Health Care System|Dr. David Au|206-764-2504|David.Au@va.gov|
20535259|NCT03793621|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535260|NCT03423602|Vivasure Medical Ltd|Dr Chris Martin|+353 91 395 442|chris.martin@vsuremed.com|
20535261|NCT01192126|Bausch & Lomb Incorporated|Dr. Robert Steffen OD|585-338-6399|robert.steffen@bausch.com|
20566321|NCT03459196|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
20566322|NCT02303392|The Ohio State University Comprehensive Cancer Center|Dr. Jennifer Woyach|614-293-8165|Jennifer.Woyach@osumc.edu|
20566323|NCT01171898|Aragon Pharmaceuticals, Inc.|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566324|NCT02932410|Actelion Pharmaceuticals Ltd|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566325|NCT00048932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20566326|NCT02261805|Lombardi Comprehensive Cancer Center|Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
20566327|NCT01083732|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20566328|NCT00065182|GlaxoSmithKline|GSK Response Center|866-435-7343||
20566329|NCT02633215|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
20566330|NCT00754325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20566331|NCT03442777|Belgian Healthcare Knowledge Centre|Jillian Harrison|+32 2 287 33 89|jillian.harrison@kce.fgov.be|
20566332|NCT03801148|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20566333|NCT00790569|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.ed|
20566334|NCT01627561|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20566335|NCT03244800|MedImmune Limited|Victoria Parker|+44 747 1357152|information.center@astrazeneca.com|
20566336|NCT02330588|Department of Pediatrics, University of Alberta|Dr. Geoff Ball|780-248-5490|gdball@ualberta.ca|
20566337|NCT02803749|University of Rochester|Dr. Ruth Schneider|584-341-7500|ruth_schneider@urmc.rochester.edu|
20566338|NCT00890591|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsus.com|
20566339|NCT02941549|Afimmune|Study Director|+3532946380|info@afimmune.com|
20566340|NCT03234374|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20566341|NCT01664741|Johns Hopkins School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
20566342|NCT03451422|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20566343|NCT01816971|University of Chicago Medical Center|Andrzej Jakubowiak, MD, PhD|773-702-4005|ajakubowiak@medicine.bsd.uchicago.edu|
20566344|NCT04384172|University of Michigan|Tim Bruns|734-647-8727|bruns@umich.edu|
20566345|NCT04033445|Janssen Research & Development, LLC|Medical Director IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566346|NCT00776009|Novartis Pharmaceuticals|Study Director|862 778-8300||
20566347|NCT01640951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20535262|NCT03759600|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20535263|NCT03257358|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20535264|NCT01248793|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
20535265|NCT02580877|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8631|cjgreen@benaroyaresearch.org|
20535266|NCT00355030|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535267|NCT00339040|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20535268|NCT01462929|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20535269|NCT02499887|UBMD Emergency Medicine|Heather Lindstrom|716-898-4564|hlindstrom@ecmc.edu|
20535270|NCT02554799|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
20535271|NCT03046446|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
20535272|NCT00688467|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535273|NCT02970136|University of Miami|Olveen Carrasquillo|305-243-5505|ocarrasquillo@miami.edu|
20535274|NCT00690794|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20535275|NCT03012334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20535276|NCT00305448|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20535277|NCT01343888|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566348|NCT04949542|University of Washington (affiliate) / University of North Carolina at Chapel Hill|Dr. Benjamin Buck, Associate Professor|(919) 445-4330|buckbe@uw.edu|
20566349|NCT01536093|Seoul National University College of Medicine|Dr. Juyoung Lee|82-31-787-7301|lamb4122@snu.ac.kr|
20566350|NCT00135200|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|(734) 936-5310|mkaminsk@umich.edu|
20535278|NCT00030147|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
20535279|NCT00003816|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
20535280|NCT00558636|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20535281|NCT04108273|NYU Langone Health|Francisco Castellanos, MD|6467545194|Francisco.Castellanos@nyulangone.org|
20535282|NCT02764996|Mike O'Callaghan Miltary Medical Center|Jill Clark, Senior Research Associate/Research Manager|(702) 653-3298|Jill.M.Clark15.ctr@mail.mil|
20535283|NCT00800735|Hoffmann-La Roche|Medical Communications|800 821-8590||
20535284|NCT02154061|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20535285|NCT01103414|Mstabolic Solutions Company. LLC|Dr. Jerry Colca, President & CSO|269.343.6732|jcolca@msdrx.com|
20535286|NCT01936831|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20535287|NCT03715790|Medtronic Cardiac Rhythm Management|CRM Clinical Research|1-800-328-2518|rs.medtronicCRMtrials@medtronic.com|
20535288|NCT00487981|Boston Scientific|Lyn M. Pimentel, M.B.A.|(661) 949-4174|Lyn.Pimentel@bsci.com|
20535289|NCT01365793|University of California, Davis (UC Davis Health)|Nathan Kuppermann|916-734-1535|nkuppermann@ucdavis.edu|
20535290|NCT02808429|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20535291|NCT02348203|University of Arizona|Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
20535292|NCT02633735|HealthPartners Institute|Elyse Kharbanda|952-967-5038|elyse.o.kharbanda@healthpartners.com|
20535293|NCT01133847|University of Texas Health Science Center Houston|Dr. Carolyn Denton|713-500-3891|carolyn.a.denton@uth.tmc.edu|
20535294|NCT04436744|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535295|NCT01120405|Population Health Research Institute - Mc Master University, Hamilton CANADA|Yannick LE MANACH, MD, PhD|0012892606840|Yannick.Lemanach@phri.ca|
20535296|NCT01854528|AbbVie|Global Medical Information|800-633-9110||
20535297|NCT02961244|Dokuz Eylul University Medicine Faculty, General Surgery Department|Ali Kadir Degirmenci|+902324122901|alikadir@hotmail.com|
20535298|NCT03789292|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
20535299|NCT00967616|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20535300|NCT01696643|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
20535301|NCT00518180|Novartis Vaccine and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
20535302|NCT00575666|UMass Medical School|Xiaoduo Fan, MD, MPH, MS|508-856-3881|Xiaoduo.Fan@umassmed.edu|
20535303|NCT00508482|Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences|Dr. Zhishun Liu|0086-010-88001124|liuzhishun@aliyun.com|
20535304|NCT01227057|VASDHS|Catherine Ayers|8585528585|catherine.ayers1@va.gov|2976
20535305|NCT03508050|Institut universitaire de cardiologie et de pneumologie de Québec|Dr Jean S. Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|
20535306|NCT01082614|Loma Linda University|Tonya Hamilton|909-558-9408|thamilton@llu.edu|
20535307|NCT03710889|Radius Health, Inc.|Associate Director, Clinical Operations|(617) 551-4000|info@radiuspharm.com|
20535308|NCT00421148|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535309|NCT04881760|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20535310|NCT03722810|BIHAM, University of Bern|Prof. Michael Harris|+44 1761 241366|michael.harris@biham.unibe.ch|
20535311|NCT00928772|VAMC|Grigory Chernyak, MD|405-326-1885|grigory.chernyak@va.gov|
20535312|NCT00902330|Virginia Commonwealth University|Debra Lyon, RN, PhD, FNP|804-828-7743|delyon@vcu.edu|
20535313|NCT00165789|Eisai Call Center|Eisai Inc.|888-422-4743||
20535314|NCT04290624|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20535315|NCT01847443|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535316|NCT03571971|The Ohio State University|Stephanie Di Stasi, Principal Investigator|614-293-4220|stephanie.distasi@osumc.edu|
20535317|NCT04067492|R-Pharm|D.V. Bukhanova, Medical Adviser|0074959567|bukhanova@rpharm.ru|3838
20535318|NCT06158867|Taipei Medical University Hospital|Dr. Leon Tsung-Ju Lee|+886-2-27372181|TJ.LEE.SKIN@GMAIL.COM|8281
20535319|NCT00956384|University Health Network|Dr. Toni Zhong|4163404800|kbutler@uhnresearch.ca|2343
20535320|NCT03096886|University of Pennsylvania|Dr. Yvette Sheline|(215) 573-0082|sheline@pennmedicine.upenn.edu|
20535321|NCT03950856|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535322|NCT00656370|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
20535323|NCT03366454|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
20535324|NCT03984188|University of Miami|Trishul Siddharthan|305-243-6388|tsiddhar@miami.edu|
20535325|NCT03384875|Cytosorbents|Darlene Lambert-Christie/ Director, Clinical Operations|732.822.3332|DLambert-Christie@cytosorbents.com|
20535326|NCT02006108|Stanford University, Department of Radiology|Dr. Heike E. Daldrup-Link|650-497-8601|emisquez@stanford.edu|
20535327|NCT00269113|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535328|NCT01978145|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535329|NCT01173679|Massachusetts General Hospital|Philip C. Amrein, M.D.|6177243456|pamrein@partners.org|
20535330|NCT01250054|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
20535331|NCT02026011|University of California, Los Angeles|Lara Ray|310-794-5383|lararay@psych.ucla.edu|
20566351|NCT02365597|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566352|NCT02275611|University of North Carolina at Chapel Hill|Dr. Cort A. Pedersen|(919) 966-4447|Cort_Pedersen@med.unc.edu|
20535332|NCT03372161|Scilex Pharmaceuticals, Inc.|Associate Director Clinical Operations|(650) 386-6709|cambrose@scilexpharma.com|
20566353|NCT00909324|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20535333|NCT01312519|Vidacare Corporation|Senior Director of Science and Clinical|210-375-8500|thomas.philbeck@vidacare.com|
20535334|NCT00755807|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535335|NCT05010070|University of Michigan|Laura Saslow, Associate Professor|(734) 764-7836|saslowl@umich.edu|
20535336|NCT03531814|National Cancer Institute|Staci M Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
20535337|NCT00628498|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
20535338|NCT00529243|Kaiser Permanente|William Towner, MD|323-783-7855|William.J.Towner@KP.org|
20535339|NCT01053507|Clinvest/A Division of Banyan Group, Inc.|Dr. Roger K. Cady|417-841-3673|jtarrasch@clinvest.com|
20535340|NCT02094118|Mayo Clinic|Dr. Daryl Kor|507-255-6051|kor.daryl@mayo.edu|
20535341|NCT01788943|University of Pennsylvania|Jacob Dubroff,M.D., Ph.D., Assistant Professor of Radiology|215-662-3041|jacob.dubroff@uphs.upenn.edu|
20535342|NCT00811954|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20535343|NCT02103127|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20535344|NCT00186628|Stanford University Medical Center|David Miklos, MD, PhD; Associate Professor of Medicine (Blood and Marrow Transplantation)|650-725-4626|dmiklos@stanford.edu|
20535345|NCT01247064|Cincinnati Children's Hospital Medical Center|Todd Florin|513-636-7966|todd.florin@cchmc.org|
20535346|NCT04828707|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|+972723909755|daganh@theranica.com|
20535347|NCT03134326|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20535348|NCT04207320|University of Chicago|Dr. John Cunningham|773-702-6808|jcunning@bsd.uchicago.edu|
20535349|NCT01188967|Massachusetts General Hospital|Maurizio Fava M.D.|617-724-2513|mfava@partners.org|
20535350|NCT04031729|Massachusetts General Hospital|Dr. Tracey Simon|617-724-2401|tgsimon@partners.org|
20535351|NCT00523978|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA - AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
20535352|NCT00461708|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535353|NCT02394561|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20535354|NCT00501644|UT MD Anderson Cancer Center|Michael E. Garcia, RN, BSN||mgarcia@mdanderson.org|
20535355|NCT02553629|Leiden University Medical Center|Prof. Dr. A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
20535356|NCT03434834|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
20535357|NCT02797821|Alexion Pharmaceuticals|Alexion Pharmaceuticals|475-230-2596|ClinicalTrials@Alexion.com|
20535358|NCT04577781|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20535359|NCT02148588|Washington University School of Medicine|Simon Haroutounian|3142861715|simon.haroutounian@wustl.edu|314
20535360|NCT01657305|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
20535361|NCT03763747|OrbusNeich|Stephen M. Rowland, PhD - Vice-President, Research and Development|954-730-0711|srowland@orbusneich.com|
20535362|NCT02478489|Boston University School of Public Health and School of Medicine|Richard Saitz, MD MPH|(617) 358-1343|rsaitz@bu.edu|
20535363|NCT00696878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535364|NCT04103450|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20535365|NCT02259114|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535366|NCT03937479|Verona Pharma Plc|Nancy Herje|+1 646-951-0961|nancy.herje@veronapharma.com|
20535367|NCT02578901|University of Washington|Dr. Susanne May|206-685-1302|sjmay@uw.edu|
20535368|NCT02411461|Vanderbilt University Medical Center|Ashley Shoemaker, Principal Investigator|6153438116|ashley.h.shoemaker@vanderbilt.edu|
20535369|NCT00940602|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20535370|NCT01378117|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
20535371|NCT00740181|Brown Univeristy Oncology Research Group|James Butera|401-863-3000|Kayla_Rosati@brown.edu|
20535372|NCT01463033|Children's National Medical Center|Dr. Pavel Klein, P.I.|301-704-4925|kleinp@epilepsydc.com|
20535373|NCT01074125|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
20535374|NCT01129206|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii Saab, MD|614-293-6529|Tanio.Saab@osumc.edu|
20535375|NCT01374425|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535376|NCT00546481|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20535377|NCT00587041|Mayo Clinic|Use of Symbiotics to Reduce Urinary Oxalate Excretion|507-266-7960|lieske.john@mayo.edu|
20535378|NCT01847755|Jupiter Medical Center|Dr. Barry Miskin|561-263-5791|clinicaltrials@jupitermed.com|
20535379|NCT01193101|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
20535380|NCT00746187|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
20535381|NCT02347085|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20535382|NCT03368066|University of Virginia|Dr. Brian Wentworth|9739436781|bw8xz@hscmail.mcc.virginia.edu|
20535383|NCT02761642|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535384|NCT00950651|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20535385|NCT01044030|Boston Children's Hospital|Louis Vernacchio, MD, MSc|617-919-4283|louis.vernacchio@childrens.harvard.edu|
20535386|NCT03783780|Masimo|Tala Harake|1-949-297-7100|studies@masimo.com|
20535387|NCT01205503|Markey Cancer Center Biostatistics Shared Resource Facility|Emily Dressler, PhD|859 323-3076|emilydressler@uky.edu|
20535388|NCT02742129|Duke Clinical Research Institute|Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
20535389|NCT01111162|University of Pennsylvania|Pablo Tebas|2153498092|pablo.tebas@uphs.upenn.edu|
20566354|NCT03911271|Rigshospitalet-Glostrup|Niklas Cyril Hansen MD-PhD|+45 31433244|niklas.cyril.hansen@regionh.dk|
20535390|NCT02850978|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535391|NCT00114127|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
20535392|NCT00570713|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
20535393|NCT02765399|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-47171990|marja-riitta.taskinen@helsinki.fi|
20535394|NCT02393339|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972507410935|fuxavia@gmail.com|
20535395|NCT00768261|Washington University|John G. Csernansky, MD|(312) 926-2323|jgc@northwestern.edu|
20535396|NCT02651545|UBMD Neurology|Michael Jaworski|716-323-0550|mgjawors@buffalo.edu|
20535397|NCT02103062|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20535398|NCT00120627|VA San Diego Healthcare System|Jill E. Bormann, PhD, RN, FAAN|858-552-8585|jill.bormann@va.gov|2378
20535399|NCT01182298|NIAID|Shyam Kottilil||Skottilil@niaid.nih.gov|
20535400|NCT04016714|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535401|NCT01677988|Medical University of South Carolina|Paul O'Brien, MD|843-792-4271|obrienpe@musc.edu|
20535402|NCT00271544|Medtronic CRDM Clinical Research|Hang Nguyen|800-328-2518|hang.t.nguyen@medtronic.com|62832
20535403|NCT01822665|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535404|NCT01685684|Collegium Pharmaceutical|Clinical Scientist|+1.781.232.0764|clinicaltrials@collegiumpharma.com|
20535405|NCT00907621|Department of General practice, University of Oslo|Dr. Holgeir Skjeie|+4722850550|Holgeir.Skjeie@medisin.uio.no|
20535406|NCT04089020|Children's Mercy Kansas City|Jordan Carlson, PhD.|816-234-9240|jacarlson@cmh.edu|
20535407|NCT00038948|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20535408|NCT00896012|University at Buffalo|Oleh G. Pankewycz, MD||opankewycz@kaleidahealth.org|
20535409|NCT03247829|Abbott_Medical_Devices|Dr. Marie-Elena Brett, PhD; Principal Scientist Clinical Research|17815283613|marieelena.brett@abbott.com|
20535410|NCT01783444|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20535411|NCT02722408|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
20535412|NCT00272792|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
20535413|NCT01058239|Massachusetts General Hospital|Jeremy Abramson, M.D|617-724-4000|JABRAMSON@mgh.harvard.edu|
20535414|NCT03121144|Masimo Corporation|Vikram Ramakanth|(949) 297-7000|clinicalresearchdept@masimo.com|
20535415|NCT00288015|Northwestern University|Mark Agulnik, MD|312-695-6182|magulnik@nm.org|
20535416|NCT00443703|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20535417|NCT01047007|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535418|NCT04552041|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20535419|NCT03702179|SOGUG|A contact designated by the Sponsor|+34671422325|secretaria@sogug.es|
20535420|NCT02098304|Clark & Watson Dental Practice|Dr Charles Ormond|+44 (0)1324 623445|charlesormond@nhs.net|
20535421|NCT01669902|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535422|NCT00305877|ECOG Statistical Office|Study Statistician|617-632-3012||
20535423|NCT00517699|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535424|NCT02332187|University of Kentucky|Gerald Supinski, MD, Professor|859-494-3480|gsupi2@email.uky.edu|
20535425|NCT00457392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535426|NCT00980148|University of Arkansas for Medical Sciences|Shelly Lensing, Statistician|501-686-8203|sylensing@uams.edu|
20535427|NCT03886948|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20535428|NCT01747915|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535429|NCT00988156|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
20535430|NCT03663855|NYU Langone Health|David Goldfarb, MD|(212) 263-7300|David.Goldfarb@nyulangone.org|
20535431|NCT00887159|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
20535432|NCT02259725|USC / Norris Comprehensive Cancer Center|Victoria Soto|3238653000|soto_v@med.usc.edu|
20535433|NCT06164691|University of Pittsburgh|Dr. Matthew Neal|412-647-1158|nealm2@upmc.edu|
20535434|NCT00812955|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
20535435|NCT02391311|UAB|Pariya L Fazeli, PhD|205-996-0330|plfazeli@uab.edu|
20535436|NCT01309204|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20535437|NCT03183063|Beaumont Health|Joanne Gondert|248 551-0439|joanne.gondert@beaumont.org|
20535438|NCT00925002|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535439|NCT02163577|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20535440|NCT01073293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535441|NCT00002766|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
20535442|NCT01451411|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20535443|NCT00328172|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566355|NCT00293397|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20566356|NCT01759862|Stanford University|Paul Grimm|6507237903||
20535444|NCT00077974|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20535445|NCT01990742|University of Rochester|Dr. Helena Temkin-Greener|585-275-8713|Helena_Temkin-Greener@urmc.rochester.edu|
20535446|NCT03443687|University of New Mexico, Dept OBGYN|Dr. Gena Dunivan|5052729712|gdunivan@salud.unm.edu|
20535447|NCT02178800|Fred Hutch Cancer Research Center|Gordon Chau|2066672118|gchau@fredhutch.org|
20535448|NCT00901303|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
20535449|NCT00099021|Masonic Cancer Center, University of Minnesota|Frank G. Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
20535450|NCT03848416|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20535451|NCT01469039|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823||
20535452|NCT03500289|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
20535453|NCT02609425|Henry Ford Health System|Sarah Meehan|313-916-9387|smeehan1@hfhs.org|
20535454|NCT00856609|National Institutes of Health|Dr. Jonathan Krakoff|602-200-5217|jkrakoff@mail.nih.gov|
20535455|NCT00783432|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|wwheeler@medapharma.us|
20535456|NCT01436110|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535457|NCT03273907|Alcon Research, LLC|CDMA Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20535458|NCT00110214|Thomas Jefferson University|William Kevin Kelly, DO||wm.kevin.kelly@jefferson.edu|
20535459|NCT01088503|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535460|NCT01847092|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20535461|NCT03623698|Imperial College London|Mrs. Natalia Galaz Souza|07751842851|natalia.galaz-souza16@imperial.ac.uk|
20535462|NCT03604497|University of Alabama at Birmingham|Dr David Schwebel|2059348745|schwebel@uab.edu|
20535463|NCT01016067|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20535464|NCT01100112|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|contact@santarus.com|
20535465|NCT01331681|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20535466|NCT01976871|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org|
20535467|NCT01673646|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20535468|NCT01580410|Wake Forest University Health Sciences|Dr. Edward Levine|336-716-2763|elevine@wakehealth.edu|
20535469|NCT00658541|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20535470|NCT01063348|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
20535471|NCT00269087|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535472|NCT02304159|Southern California Research Center|Dr. Tarek Hassanein|619-319-3993|thassanein@livercenters.com|
20535473|NCT01876381|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20535474|NCT00332696|Novartis Pharmaceuticals|Study Director|862-778-8300||
20535475|NCT02160288|Massachusetts General Hospital|Dr Liliana Bordeianou|6176430541|lsavitt@mgh.harvard.edu|
20535476|NCT01464879|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20535477|NCT02455167|"University of Colorado Denver | Anschutz"|Amanda Wieland, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20535478|NCT00814255|NYUmed|Howard Trachtman|646-501-2663|howard.trachtman@nyumc.org|
20535479|NCT02712788|Indiana University|Heather Cero, RN - research cooordinator|317-396-1398|hcero@iupui.edu|
20535480|NCT01368614|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
20535481|NCT00244621|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20535482|NCT02271529|Cook Research Incorporated|Scott Snyder, Director, Clinical Affairs|765-463-7537|SSnyder@medinst.com|
20535483|NCT00956761|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
20535484|NCT01904721|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20535485|NCT01957865|Massachusetts General Hospital|Jessica Haberer|617 724 0351|jhaberer@partners.org|
20535486|NCT02524561|Brigham and Women's Hospital|Dr. Rulla Tamimi|617-525-0862|rulla.tamimi@channing.harvard.edu|
20535487|NCT00811720|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20535488|NCT01077063|Sidney Kimmel Comprehensive Cancer Center at JHMI|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
20535489|NCT02750930|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20535490|NCT00553631|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20535491|NCT00552071|Cedars-Sinai Medical Center|Vivian Hwe|4224-315-4489|hwev@cshs.org|
20535492|NCT01900067|Mölnlycke Health Care AB, Surgical Division|Jenny Höglind|0046 31 722 30 00|Jenny.Hoglind@molnlycke.com|
20535493|NCT03557125|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsonsh@musc.edu|
20535494|NCT00937495|University of Wisconsin|Steven Attia, D.O.||sa2@medicine.wisc.edu|
20535495|NCT00441272|National Institute of Allergy and Infectious Diseases|Colleen Hadigan, MD, MPH|301-594-5754|hadiganc@niaid.nih.gov|
20535496|NCT05518461|University of Wisconsin - Madison|Dr. Rachel Gicquelais|(608) 890-1837|gicquelais@wisc.edu|
20535497|NCT01886235|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20535498|NCT00382174|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-280-1992|nturjman@regenerx.com|108
20535499|NCT03119168|Texas Tech University Health Sciences Center at El Paso|The Effect Of Adding High Dose Simethicone To A Standard Polyethylene Glycol Preparation On Adenoma|915-215-4678|antonio.mendoza-ladd@ttuhsc.edu|
20535500|NCT03734822|Nationwide Children's Hospital|Anne May, MD|614-722-4766|Anne.May@nationwidechildrens.org|
20535501|NCT03894891|Dana-Farber Cancer Institute|Robert Haddad, MD|617.632.3090|Robert_Haddad@dfci.harvard.edu|
20535502|NCT01585402|National Heart, Lung, and Blood Institute (NHLBI)|Alessandra Brofferio, M.D.|301.496.2634|alessandra.brofferio@nih.gov|
20535503|NCT01730872|Ora|Keith Lane|9786858900|klane@oraclinical.com|
20535504|NCT03768427|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535505|NCT01937520|Rutgers, The State University of New Jersey|Dennis Grech, MD|973 972-5007|grechde@njms.rutgers.edu|
20535506|NCT01644643|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
20535507|NCT02756403|MedStar Washington Hospital Center|Principal Investigator|202-877-7479|peggy.ye@medstar.net|
20535508|NCT00527618|University of Washington, Virology Research Clinic|Tara Perti, MD|(206) 520-4340|tarap@u.washington.edu|
20535509|NCT02099084|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20535510|NCT01490918|The Catholic University of Korea, Seoul St Mary's Hospital|Yoon Hee Choi|82-2-2258-8288|choiyh@catholic.ac.kr|
20535511|NCT00776789|AIIMS|Dr Anu Thukral|01126594605|dranuthukral@yahoo.com|
20535512|NCT02537730|Coopervision Japan|Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
20535513|NCT00648037|Memorial Sloan Kettering Cancer Center|Papadopoulos, Esperanza, MD (Attending)|+1212-639-8276|papadope@mskcc.org|
20535514|NCT02967679|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
20535515|NCT02379195|Center for Cancer Immune Therapy, Herlev Hospital|Dr. Inge Marie Svane|38683868|inge.marie.svane@regionh.dk|
20535516|NCT02404168|University of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
20535517|NCT01197547|Boston Scientific|Meaghan Wilk|5086834113|wilkm@bsci.com|
20535518|NCT01953211|University Reproductive Associates|Michael Cho|(201) 288-6330|michaelcho@nyc.com|
20535519|NCT03188263|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
20535520|NCT00699413|USC|Michael Goran|323.442.3027|goran@usc.edu|
20535521|NCT02779777|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|ko-tip-003@kuraoncology.com|
20535522|NCT00881894|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20535523|NCT04005586|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
20535524|NCT00469833|Cincinnati VAMC|David D'Alessio, MD, Section head, Endocrinology, Cincinnati VAMC|513-475-6478|david.d'alessio@va.gov|
20535525|NCT01253369|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
20535526|NCT03289533|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535527|NCT00539240|Southern Arizona VA Health Care System|Christopher Wendel, MS|520 792 1450|christopher.wendel@va.gov|1824
20535528|NCT01628523|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wusm.wustl.edu|
20535529|NCT01284959|Chonbuk National University Hospital|Prof. Youngchul Chung|+82-63-250-2185|chungyc@chonbuk.ac.kr|
20535530|NCT01055613|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D.- Research Principle Optometrist|904-443-1290|BPALL@its.jnj.com|
20535531|NCT00363311|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535532|NCT00401843|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
20535533|NCT03175731|Qilu Hospital of Shandong University|Prof. Gao|+86-531-82169386|gaoyanjing@sdu.edu.cn|
20535534|NCT01974284|Yale University School of Medicine|Dr. Glenda Callendar|203-737-2036|glenda.callender@yale.edu|
20535535|NCT02629861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@Tevapharm.com|
20535536|NCT02525679|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535537|NCT00959907|CBED|Débora Zechmeister do Prado|55 51 30262633|cbed@cbed.org.br|
20535538|NCT03958331|Cincinnati Children's Hospital Medical Center|Dr. Avani Modi|513-636-4864|avani.modi@cchmc.org|
20535539|NCT00730886|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
20535540|NCT01991483|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535541|NCT04344184|Virginia Commonwealth University|Dr. Alpha Fowler|(804) 519-4369|alpha.fowler@vcuhealth.org|
20535542|NCT02030821|Duke University|Michael Bolognesi, M.D.|919-668-4732|michael.bolognesi@duke.edu|
20535543|NCT02665260|Montefiore Medical center|Dr. Steven Cohen|718-920-8470|dermpharmeinstein@gmail.com|
20535544|NCT01722929|Northwestern University|Murad Alam, MD|312-695-4761|m-alam@northwestern.edu|
20535545|NCT00716274|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20535546|NCT01932788|Professor of Pediatrics|Carol,Wagner, MD|843-792-8829|wagnercl@musc.edu|
20535547|NCT01171677|NYUMED|John Rotrosen|212 951 3294|john.rotrosen@nyumc.org|
20535548|NCT00601367|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20535549|NCT02421757|University of Maryland School of Medicine|Dr. Peter Rock|410-328-6933|prock@som.umaryland.edu|
20535550|NCT03111030|Unviersity of British Columbia|Dr. Kathleen Martin Ginis|250-807-9768|Kathleen_martin.ginis@ubc.ca|
20535551|NCT04021290|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20535552|NCT00553410|International Breast Cancer Study Group (IBCSG)|Meredith M. Regan|+1 617 632 3012|mregan@jimmy.harvard.edu|
20535553|NCT03391882|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20535554|NCT03092479|Geisinger Clinic|Michelle Lent, PhD|5702141004|mrlent1@geisinger.edu|
20535555|NCT04683913|University of British Columbia|Dr. Michael Hunt|604-827-4721|michael.hunt@ubc.ca|
20535556|NCT04422431|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20535557|NCT03913130|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599 7887|contact@sepulbio.com|
20535558|NCT01174563|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20535559|NCT00444106|Novartis Pharmaceuticals|Study Director|862-778-8300||
20535560|NCT01349114|University of Alabama at Birmingham|David A. Calhoun, MD|205-934-4633|dcalhoun@uab.edu|
20535561|NCT02317627|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
20535562|NCT00279214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20535563|NCT01280968|Duke University Medical Center|Alexey G Mukhin, M.D., Ph.D.|Telephone: 919-668-5055|amukhin@duke.edu|
20535564|NCT04050384|Nationwide Children's Hospital|Dr. Lance M. Relland|614-722-5971|lance.relland@nationwidechildrens.org|
20535565|NCT00577278|City of Hope Medical Center|Dr. Matthew Mei|626-359-8111|mamei@coh.org|
20535566|NCT04743011|São Paulo State University (UNESP)|Professor Matheus Bertanha, Ph.D.|+551438801444|matheusbertanha@gmail.com|
20535567|NCT00954447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535568|NCT04592341|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20535569|NCT00692003|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
20535570|NCT01535287|University of Iowa|Martin Mueller|3193562633|martin-mueller@uiowa.edu|
20535571|NCT01047189|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
20535572|NCT03341637|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20535573|NCT05547412|NovaSignal|Manja Lenkin|8776387251|manja.lenkin@novasignal.com|
20535574|NCT03181971|Stanford University|Anisha Patel, MD|(650) 497-1181|anipatel@stanford.edu|
20535575|NCT02291133|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
20535576|NCT01815424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535577|NCT04723355|Hospital Israelita Albert Einstein|Clinical Trialist|551121515915|karla.santo@einstein.br|
20535578|NCT03374358|Helsinki University Hospital|Dr Jussi Sutinen|+358407480437|jussi.sutinen@hus.fi|
20535579|NCT01127633|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535580|NCT01805687|Cornerstone Therapeutics, Inc.|W. James Alexander, MD, MPH|919-678-6925|jim.alexander@chiesi.com|
20535581|NCT02805790|Stealth BioTherapeutics Inc.|Rekha Sathyanarayana, Executive Director, Clinical Operations|617-762-2579|Rekha.Sathyanarayana@stealthbt.com|
20535582|NCT02189889|UT Southwestern Medical Center|Philip Greilich -PROFESSOR|214/645-8018|PHILIP.GREILICH@UTSouthwestern.edu|
20535583|NCT01144143|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
20535584|NCT04512001|Fresenius Kabi SwissBioSim GmbH|Clinical Development|793075735|clinical.development@fresenius-kabi.com|+41
20535585|NCT02776683|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535586|NCT00616642|University of California Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
20535587|NCT03856359|Duke University Hospital|Dr. Paul V. Suhocki|919-684-7284|suhoc001@mc.duke.edu|
20535588|NCT01773954|Mid Atlantic Retina|Michele Formoso|215-928-3092|research@midatlanticretina.com|
20535589|NCT03391986|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@columbia.edu|
20535590|NCT01664247|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20535591|NCT01553292|University of Manitoba|Dr Yahya Al Ethawi|0012049634721|yalethawi@hsc.mb.ca|
20535592|NCT01102738|Imperial College London|Dr. Kathleen Sim|(+44) (0)20 7594 3695|k.sim@imperial.ac.uk|
20535593|NCT01881009|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
20535594|NCT01000506|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535595|NCT03064074|Baylor|dianne Nguyen|7137986694|diannen@bcm.edu|
20535596|NCT03417466|Medtronic Minimed|Fen Peng, Biostatistician|8185763253|fen.peng@medtronic.com|
20535597|NCT05018689|Penn State College of Medicine|Dr. Deepa Sekhar|717-531-0003|dsekhar@pennstatehealth.psu.edu|x281334
20535598|NCT03326063|Brigham and Women's Hospital|Tanya Laidlaw, MD|617-525-1034|tlaidlaw@bwh.harvard.edu|
20535599|NCT01859013|University of Minnesota|Claudia Fox|612-626-6616|lusc0001@umn.edu|
20535600|NCT02216526|Charité Universitätsmedizin Berlin, Germany|PD Dr. Jan Kottner|+49 (0)30 450 518 218|jan.kottner@charite.de|
20535601|NCT02750514|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20535602|NCT01882465|Johnson & Johnson Vision Care Inc.|Charis Lau, PharmD, OD, FAAO- Principal Research Optometrist|904-433-3500|charislau@gmail.com|
20535603|NCT03824392|aTyR Pharma|Lisa Carey|858 731 8389|clinicaltrials@atyrpharma.com|
20535604|NCT02230189|University of California, San Francisco|PI: Prescott G. Woodruff, MD, MPH|415-514-2061|prescott.woodruff@ucsf.edu|
20535605|NCT00532844|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
20535606|NCT03988426|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
20535607|NCT04389866|Advanced Dermatology|Dr. Amy Forman Taub|8474596400|drtaub@advdermatology.com|
20535608|NCT01186250|Stanford University|Kiran K. Khush, MD|650-721-3241|kiran@stanford.edu|
20535609|NCT01313507|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
20535610|NCT00800982|University of California San Francisco|Dr Ethan Levin|4154764019|levine@derm.ucsf.edu|
20535611|NCT01824290|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20535612|NCT03046836|Medical University of South Carolina - Institute of Psychiatry|Stacey Sellers|8437925807|sellersst@musc.edu|
20535613|NCT04940130|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Patrick Duffy|301.761.5089|patrick.duffy@nih.gov|
20535614|NCT02240121|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
20535615|NCT01545765|Galderma|Farzaneh Sidou Clinical Project Manager)|00.33.4.93.95.70.70|farzaneh.sidou@galderma.com|
20535616|NCT05501639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535617|NCT00251693|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20535618|NCT01030822|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535619|NCT01508910|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
20535620|NCT01595529|Westat|Dr. Elizabeth Rowley|(919) 941-8325|ElizabethRowley@westat.com|
20535621|NCT01600287|Postgraduate Institute of Medical Education and Research|Dr G D Puri|00919914209509|gdpuri007@hotmail.com|
20535622|NCT03198156|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
20535623|NCT01846702|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535624|NCT01333436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535625|NCT00543985|University of Missouri|Kevin C. Dellsperger, MD, PhD, Professor, Internal Medicine|573-884-2013|dellspergerk@health.missouri.edu|
20535626|NCT01634152|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535627|NCT01152437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535628|NCT01900665|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535629|NCT02199041|St. Jude Children's Research Hospital|Brandon Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
20535630|NCT04046939|Knopp Biosciences|Vice President, Clinical and Translational Medicine|4124881776|calman@knoppbio.com|
20535631|NCT00403130|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
20535632|NCT01903005|TRY Research|Kent Hoffman, DO|(407) 691-3960|Suboxdoc1@yahoo.com|
20535633|NCT01352286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20535634|NCT00000134|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
20535635|NCT03682965|Pharma Initiatives|Mark Shapiro|9193063675|mshapiro@pharmainitiatives.com|
20535636|NCT00953706|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
20535637|NCT01404234|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20535638|NCT02670473|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
20535639|NCT01214837|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20535640|NCT05414175|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20535641|NCT04028648|seca gmbh & co. kg|Kristin Klückmann|040200000232|kristin.klueckmann@seca.com|
20535642|NCT00457626|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20535643|NCT03559270|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20535644|NCT04790279|Prisma Health Upstate|Katelyn Pratt|2176223524|katelyn.pratt@prismahealth.org|
20535645|NCT03930771|Weill Cornell Medicine|Rajiv Magge|212-746-6575|ram9116@med.cornell.edu|
20535646|NCT01222117|Grifols Therapeutics|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
20535647|NCT03402932|Western Michigan University|Jing Shen|2693878067|jing.shen@wmich.edu|
20535648|NCT00678288|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20535649|NCT03611881|Massachusetts General Hospital|Elyse Park, PhD, Professor of Psychiatry and Medicine, Harvard Medical School|617.724.6836|epark@mgh.harvard.edu|
20535650|NCT04472650|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20535651|NCT01861665|Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine.|Dr. Glenn Schattman, Associate Professor|646-962-3836|glschatt@med.cornell.edu|
20535652|NCT04011592|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|713-486-2837|Sudhakar.Selvaraj@uth.tmc.edu|
20535653|NCT02549989|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
20535654|NCT01856322|National Cancer Institute|Dr. Marybeth Hughes|301-594-9341|hughesm@mail.nih.gov|
20535655|NCT00298389|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
20535656|NCT02628444|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20535657|NCT02079909|FUJIFILM Toyama Chemical|Project Manager|+81-3-6427-6245|fftc-clinicaltrial-info1@fujifilm.com|
20535658|NCT01713582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535659|NCT01364480|University of Pittsburgh|Debbie Harrington, CCRP, senior research coordinator|4123831355|debbie.harrington@pitt.edu|
20535660|NCT04776161|Brigham and Women's Hospital|Candace Feldman, MD, MPH, ScD|617-525-1035|CFELDMAN@BWH.HARVARD.EDU|
20535661|NCT04254692|University of Wisconsin School of Medicine and Public Health|Venkat Rao, MD, MBA|(608) 263-1223|rao@surgery.wisc.edu|
20535662|NCT01475721|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535663|NCT02364037|Washington University School of Medicine|Rachel Paul|3147478176|paulr@wustl.edu|
20535664|NCT00559104|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|anademanee@coh.org|62691
20535665|NCT00387088|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535666|NCT01244711|Weill Cornell Medical College|james kocsis|212-746-5913|jhk2002@med.cornell.edu|
20535667|NCT00290810|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
20535668|NCT01639469|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20535669|NCT01119443|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535670|NCT00420381|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20535671|NCT02329743|Auven Therapeutics|S Weiss|201 486-0396|sid.weiss@auventx.com|
20535672|NCT01428219|University of Michigan Comprehensive Cancer Center|Dr. David C. Smith, M.D.|734-764-3066|dcsmith@umich.edu|
20535673|NCT02071771|Alcon Research, Ltd.|Sr Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20535674|NCT02078752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535675|NCT01424943|Institute for Families in Society, University of South Carolina|Dr. Cheri Shapiro|803-777-8760|cshapiro@mailbox.sc.edu|
20535676|NCT01291108|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20535677|NCT00439335|Baylor College of Medicine|Shital Patel, MD|713-798-3793|shitalp@bcm.tmc.edu|
20535678|NCT01435174|University of Michigan College of Pharmacy|Bruce A. Mueller|7346154578|muellerb@umich.edu|
20535679|NCT00512278|Cleveland Clinic|Nizar Zein|216-444-6126|zeinn@ccf.org|
20535680|NCT01482195|King Faisal Specialist Hospital and Research Center|Dr. Fowzan Al Kuraya|+966 11 442 7875|falkuraya@kfshrc.edu.sa|
20535681|NCT00753948|James J. Peters VAMC|Joshua Hobson|(718) 584-9000|joshua.hobson@va.gov|3129
20535682|NCT03432494|National Heart, Lung, and Blood Institute (NHLBI)|Dr. Robert Lederman, Principal Investigator|301.402.6769|ledermar@nhlbi.nih.gov|
20535683|NCT00775268|National Cancer Institute|Dr. Esther Mena|240-760-6111|esther.menagonzalez@nih.gov|
20535684|NCT00825994|Massachusetts General Hospital|Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
20535685|NCT02921295|University of Pittsburgh|Dr. Goeran Fiedler|4126246475|gfiedler@pitt.edu|
20535686|NCT00592631|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
20535687|NCT00437398|Mayo Clinic|Dr. Yogish Kudva|507-284-3964|kudva.yogish@mayo.edu|
20535688|NCT01244035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535689|NCT01162551|CHOP|Susan Rheingold, MD|215-590-2801|cancertrials@email.chop.edu|
20535690|NCT01833494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20535691|NCT03068897|Montefiore|Dr. Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
20535692|NCT01694433|UCLA|Dr. Jenny Kim|310-825-5420|jekim@mednet.ucla.edu|
20535693|NCT03071861|University of Utah|Tara DuPont|8015814178|tara.dupont@hsc.utah.edu|
20535694|NCT00374595|University of Nebraska Medical Center|Jennifer Larsen|(402) 559-4837|jlarsen@unmc.edu|
20535695|NCT00410189|University of Texas (UT) MD Anderson Cancer Center|Anne S. Tsao, MD / Associate Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
20535696|NCT03745768|Washington University School of Medicine St. Louis|Pilar Cristancho M.D.|314 362 2413|cristanchopimiento.l@wustl.edu|
20535697|NCT00443118|FUNDASAMIN-Fundacion para la Salud Materno Infantil|Edgardo Szyld MD, MSc|5491144093095|eszyld@gmail.com|
20535698|NCT03723980|Dow University of Health Sciences|Dr. Juzer Shabbir Saifee|92-333-2352134|dr.juzer.shabbir@gmail.com|
20535699|NCT03975153|Oregon Health & Science University|Teri Greiling, MD, PhD, FAAD|503-494-3376|PRPStudy@ohsu.edu|
20535700|NCT04232943|PATH|Rahsan Erdem, MD, Senior Medical Officer|+1 202 540 4546|rerdem@path.org|
20535701|NCT01212471|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20535702|NCT01023217|Asan Medical Center|Professor Young-Suk Lim|+82-2-3010-5933|limys@amc.seoul.kr|
20535703|NCT00400517|Cleveland Clinic|Dr. Jorge Garcia|2164447774|Garciaj4@ccf.org|
20535704|NCT01718522|Kinder- und Jugendkrankenhaus Auf der Bult|Prof. Dr. Thomas Danne|0511-8115-3331|danne@hka.de|
20535705|NCT02298868|University of Virginia|Dr. Zachary Henry|434-243-2718|zhenry@virginia.edu|
20535706|NCT01194245|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
20535707|NCT01118780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535708|NCT03962855|University of Massachusetts Medical School|Jeffrey J Rade MD|774-441-6310|jeffrey.rade@umassmed.edu|
20535709|NCT02457247|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20535710|NCT01684839|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
20535711|NCT01646814|PLxPharma|Regulatory Affairs Director|17138421249|regaffairs@plxpharma.com|
20535712|NCT01911351|NYCHHC Jacobi Medical Center|Dr. Sandra Cunningham|718 918 5250|sandra.cunningham@nbhn.net|
20535713|NCT02751814|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20535714|NCT02015039|National Institutes of Health|Dr. Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
20535715|NCT03848455|Zhujiang Hospital of Southern Medical University|Xiaoya Gao|18680282869|4356975@qq.com|
20535716|NCT03210701|School of Pharmacy, Memorial University|Dr. Debbie Kelly|709 864 7805|dvkelly@mun.ca|
20535717|NCT04749914|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20535718|NCT01897532|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535719|NCT01088906|Fundación GECP|Eva Pereira|+34 934302006|epereira@gecp.org|
20535720|NCT00027560|Memorial Sloan-Kettering Cancer Center|Dr. Hugo Castro-Malaspina|212-639-8197|castro-h@mskcc.org|
20535721|NCT03508674|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20566357|NCT04614454|Massachusetts General Hospital|Michael Levy|6177267565|mlevy11@mgh.harvard.edu|
20566358|NCT04187573|Cerus Endovascular, part of Stryker Corporation|Vanessa Sarge|5103292048|vanessa.sarge@stryker.com|
20566359|NCT01458366|Sidney Kimmel Cancer Center at Thomas Jefferson University|Joanna Filicko-O'Hara, MD|215-503-7787|Joanna.Filicko@jefferson.edu|
20566360|NCT00317720|UT MD Anderson Cancer Center|Dr. Francisco Esteva|713-563-0742|CR_Study_Registration@mdanderson.org|
20566361|NCT04647487|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20566362|NCT03466411|J&J Innovative Medicine|Senior Medical Leader PEDIATRICS IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566363|NCT04375072|The University of Arizona|Hyochol Brian Ahn|520.626.1769|hbrian@arizona.edu|
20566364|NCT02667418|Hines VA|Dr. Stuart Johnson|708--202-8387|Stuart.Johnson2@va.gov|257772
20566365|NCT03498612|University of Washington|Ajay Gopal, MD|206-606-2037|agopal@uw.edu|
20566366|NCT05580003|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566367|NCT01753999|Rutgers Robert Wood Johnson Medical School|Dr. Jag Sunderram|732-235-7038|sunderja@rwjms.rutgers.edu|
20566368|NCT05440344|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20566369|NCT00274261|NICHD|Jason Woo, MD, MPH|301-496-1662|woojj@mail.nih.gov|
20566370|NCT02392234|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20566371|NCT02029235|Penn State Health Milton S. Hershey Medical Center|Alexander Payatakes, MD|717-531-4805|apayatakes@pennstatehealth.psu.edu|
20566372|NCT01387516|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
20566373|NCT03582475|UCLA / Department of Radiology|Sara Rodriguez|310-794-2877|SaraRodriguez@mednet.ucla.edu|
20566374|NCT02972424|Hospital for Special Surgery|Dr. Jeri W. Nieves|2126061604|nievesje@hss.edu|
20566375|NCT03170648|Dana-Farber Cancer Institute|Weidong Lu, MB, MPH, PhD|617-632-3322|weidong_lu@dfci.harvard.edu|
20566376|NCT02052440|Denver Veterans Administration Medical Center|Daniel Heppe MD|303 399 8020|daniel.heppe@ucdenver.edu|3940
20566377|NCT04325828|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566378|NCT05509816|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20535722|NCT01415583|Massachusetts Eye and Ear Infirmary|Dr. Christopher Hartnick, Division Director, Pediatric Otolaryngology Director, Pediatric Airway, V|617-573-4206|christopher_hartnick@meei.harvard.edu|
20535723|NCT01333722|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20535724|NCT02224508|Group Health Research Institute|Michael Von Korff, ScD|206-287-2874|vonkorff.m@ghc.org|
20535725|NCT00784368|Global Medical Organization; Janssen R&D|Director, Established Products|(609) 730-7674||
20535726|NCT02277249|University of California, Los Angeles|Clinical Instructor - Department of Obstetrics and Gynecology|3107942257|priyabatra@mednet.ucla.edu|
20535727|NCT01784367|University Medical Center Hamburg-Eppendorf, Germany|Prof. Dr. Stefan Kluge|+49-40-7410|skluge@uke.de|57011
20535728|NCT00720356|Northwestern University|Jeffery Raizer, MD|312-503-4724|Jeffrey.Raizer@nm.org|
20535729|NCT01869634|University of California, Davis Health, Department of Internal Medicine|Dr. David Asmuth, Professor of Medicine|916-734-8695|dasmuth@UCDAVIS.EDU|
20535730|NCT02237001|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
20535731|NCT00342628|PDMI, NICHD, NIH|Feng-Ying (Kimi) Lin, MD, MPH|301-496-0295|link@mail.nih.gov|
20535732|NCT03427814|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20535733|NCT03846427|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20535734|NCT01334554|Vanderbilt University Medical Center|Cyndya A. Shibao|6159364584|cyndya.shibao@vanderbilt.edu|
20535735|NCT02071901|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Sudipto Mukherjee|1-866-223-8100|TaussigResearch@ccf.org|
20535736|NCT02393859|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20535737|NCT01944020|Columbia University|Ari Shechter|2123424487|as4874@cumc.columbia.edu|
20535738|NCT01979614|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20535739|NCT00661830|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|A. Kaiser|++49(0)6131-179921|kaiser@izks-mainz.de|
20535740|NCT00488514|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535741|NCT03951610|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20535742|NCT00628446|Carolinas Healthcare System|Dr. Jesse Lieberman|704-355-0649|Jesse.Lieberman@Carolinashealthcare.org|
20535743|NCT00756275|Brown University|Damaris Rohsenow, PhD|401-863-6665|Damaris_Rohsenow@brown.edu|
20535744|NCT03394781|DURECT Corporation|Executive Director, Regulatory Affairs|408-777-1829|jill.burns@durect.com|
20535745|NCT04971967|University of North Carolina at Chapel Hill Project - China|Ms. Xumeng Yan|+8615330225941|xumeng_yan@seshglobal.org|
20535746|NCT00052910|Yale Cancer Center|Charles S. Fuchs, MD, MPH|(203) 785-4095|charles.fuchs@yale.edu|
20535747|NCT00535769|MGH Curtis|Dr. Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
20535748|NCT00682929|UC Davis Health|Janelle Butters, NP|916-734-6276|jbutters@ucdavis.edu|
20535749|NCT00938912|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20535750|NCT00803738|Perrigo Pharmaceuticals|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
20535751|NCT01048242|University of Pennsylvania|Nalaka Gooneratne|215 349 5938|ngoonera@mail.med.upenn.edu|
20535752|NCT01772550|Becton, Dickinson and Company|Randall Jones, MD|801 565-2843|randall_jones@bd.com|
20535753|NCT01104402|Johns Hopkins University & University of Washington|Dr. Noah Lechtzin & Dr. Christopher Goss|410-502-7044|nlechtz@jhmi.edu|
20535754|NCT01109108|Boston Medical Center|Stephen I Pelton|617-414-5591|spelton@bu.edu|
20535755|NCT00441766|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20535756|NCT02897115|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20535757|NCT03420742|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20535758|NCT00856323|Friends Research Institute, Inc.|Dr. Cathy Reback|323-463-1601|reback@friendsresearch.org|
20535759|NCT00856635|Teva Pharmaceuticals, Medical Affairs|Scott Kolodny, M.D.|440-327-1811|scott.kolodny@tevapharm.com|
20535760|NCT02383862|Regenstrief Institute|Research Coordintor|317-274-9288|tltalib@regenstrief.org|
20535761|NCT01029912|MetroHealth Medical Center|Dr. Jayme Knutson|2167787342|jsk12@case.edu|216
20535762|NCT03389308|Castle Creek Pharmaceuticals|Mary C. Spellman, MD|312-847-1291|mspellman@castlecreekpharma.com|
20535763|NCT03198767|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20535764|NCT01891396|Anika Therapeutics, Inc.|Carol Pekar, VP Clinical Affairs|781.457.9218|cpekar@anikatherapeutics.com|
20535765|NCT02820844|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20535766|NCT04231097|Massachusetts General Hospital|Christina Luberto, PhD|617-643-9453|cluberto@mgh.harvard.edu|
20535767|NCT02266147|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
20535768|NCT00413660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535769|NCT01896687|Virginia Commonwealth University|Dr. Angela Starkweather|8048283986|astarkweathe@vcu.edu|
20535770|NCT03896477|PATH|Mark Alderson|+ 206.302.4859|malderson@path.org|
20535771|NCT01106157|University of Florida|Michael J Haller|3522739264|hallemj@peds.ufl.edu|
20535772|NCT01154335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20535773|NCT03091361|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
20535774|NCT03141255|The University of Chicago|Jonathan D. Paul, MD|(773) 702-9461|jpaul@bsd.uchicago.edu|
20535775|NCT00846846|Medtronic Cardiovascular|Lisa Bousquette, Director Clinical Research Coronary and Renal Denervation||lisa.r.bousquette@medtronic.com|
20535776|NCT02706925|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535777|NCT00600067|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
20535778|NCT01224236|University of Texas Health Science Center - Houston|Kathleen Kennedy|+1 (713) 500-5651|Kathleen.A.Kennedy@uth.tmc.edu|
20535779|NCT04615624|University of Hawaii and Hawaii Pacific Health|Melanie Maykin|8089836000|mmaykin@hawaii.edu|
20535780|NCT04571060|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20535781|NCT03301779|Hemanext|William Iselin|7813017446|william.iselin@hemanext.com|
20535782|NCT04410159|UNIVERSITI SAINS ISLAM MALAYSIA|NURUL AZMAWATI MOHAMED|+603 42892400|drnurul@usim.edu.my|2417
20566379|NCT04436289|Johns Hopkins University|Christopher Hoffmann|410-614-4257|choffmann@jhmi.edu|
20535783|NCT02358993|University of Pennsylvania|Dr Uduak Andy|215-662-7709|uduak.andy@pennmedicine.upenn.edu|
20535784|NCT02246010|American University of Beirut|Dr. Mona Nabulsi|9611350000|mn04@aub.edu.lb|5523
20535785|NCT00761345|Fox Chase Cancer Center|Dr. Steven J. Cohen|215-728-4300|steven.cohen@fccc.edu|
20535786|NCT03192137|InSite Vision|Senior Manager, Clinical Sciences|+91 9987096080|manjiri.desai@sparcmail.com|
20566380|NCT02130557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566381|NCT04066075|University of California Los Angeles|Ava K. Bittner, OD, PhD|310-206-9566|researchatvrc@gmail.com|
20566382|NCT00309166|GlaxoSmithKline|GSK Response Center|866-435-7343||
20566383|NCT05120856|Monash University|Dr Joshua B. B. Garfield|+61 3 8413 8711|joshuag@turningpoint.org.au|
20566384|NCT05140902|University of Alabama at Birmingham|Dr. Harrison Kim|205-996-4088|hyunkikim@uabmc.edu|
20566385|NCT05786612|Coloplast, Clinical strategies|Malene Hornbak Landauro, Medical writer of Clinical strategies|004549112057|dkmhla@coloplast.com|
20566386|NCT05890794|AM-Pharma|AM-Pharma Office|31 (0)30 228 92 22|office@am-pharma.com|
20566387|NCT03905694|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20566388|NCT03277989|Stryker|Jennifer Seidman, Manager, Clinical Research|9016338616|jennifer.seidman@stryker.com|
20566389|NCT03083366|University of Utah|Karena McDonald|801-699-9740|karena.mcdonald@hsc.utah.edu|
20566390|NCT03668899|CairoU|Dr. Amira Farouk|01007192834|Amirafarouk77@gmail.com|
20566391|NCT06056310|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20566392|NCT04440228|University of Pennsylvania|Dr. Courtney Wolk|215-746-6099|courtney.wolk@pennmedicine.upenn.edu|
20566393|NCT02702843|Cleveland Clinic Florida|Lo Menzo, M.D.,Emanuele|9546595000|lomenze@ccf.org|
20566394|NCT02986789|Masimo Corporation|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
20566395|NCT05802173|Technoderma Medicines|Arthur P. Bertolino MD, PhD, MBA Chief Medical Officer|+1.616.928.1145|arthur.bertolino@innovationderm.com|
20566396|NCT00360269|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5215|mcraeal@musc.edu|
20566397|NCT02351791|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com|
20566398|NCT02232737|University of Vermont|Stephen T. Higgins, PhD, Professor|802-735-6267|stephen.higgins@uvm.edu|
20566399|NCT04779177|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|6464409333|ITCIClinicalTrials@itci-inc.com|
20566400|NCT02866942|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
20566401|NCT00918333|Mayo Clinic Cancer Center|Shaji Kumar, MD|507-284-2511|Kumar.shaji@mayo.edu|
20566402|NCT00263757|Mayo Clinic|Dr. Sean M. Caples|507-293-1031|Caples.Sean@mayo.edu|
20566403|NCT00713596|Mayo Clinic|Dr. Oren Friedman|507-538-1392||
20566404|NCT04545619|Biosense Webster, Inc.|Associate Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20535787|NCT01261975|Bausch & Lomb|Omid Khodai|(949) 521-7894|Omid.Khodai@bausch.com|
20535788|NCT00405288|The Hospital for Sick Children|Dr. Gideon Koren||gkoren@sickkids.ca|
20535789|NCT01342094|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20535790|NCT03069716|Vanderbilt University Medical Center|Dr. Evan L. Brittain|(615) 322-4382|Evan.brittain@vumc.org|
20535791|NCT01328743|Brown University|Christopher Kahler|4018636651|christopher_kahler@brown.edu|
20535792|NCT05653700|Wake Forest University Health Sciences|Kevin Lobdell, MD|704.355.1585|kevin.lobdell@atriumhealth.org|
20535793|NCT02878382|University of Sao Paulo Medical School Brazil|Dr Luis Torezan Associate Professor Dermatology|+551138491888|torezanluis@uol.com.br|
20535794|NCT01085214|Massey Cancer Center, Virginia Commonwealth University|Steven Grant, M.D.|804-828-5211|stgrant@vcu.edu|
20535795|NCT01482715|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20535796|NCT01074931|Abbott|Global Medical Services|1-800-633-9110||
20535797|NCT03132467|UT MD Anderson Cancer Center|Dr. Jennifer Litton, MD- VP, Clinical Research, Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
20535798|NCT05599100|University of Washington School of Public Health, Department of Health Systems and Population Health|Magaly Ramirez, PhD, MS, MS|206-543-9773|maggiera@uw.edu|
20535799|NCT01453036|The Catholic University of Korea|Dr. Jin Il Kim|+82-2-3779-2382|jikim@catholic.ac.kr|
20535800|NCT04072835|Milestone Pharmaceuticals Inc.|Cameron Szakacs _PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
20535801|NCT01336712|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
20535802|NCT00399568|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20535803|NCT01147393|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
20535804|NCT01516632|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|(877) 302-6858|michele@innovativepublichealth.org|1-801#
20535805|NCT00344175|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
20535806|NCT00570323|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
20535807|NCT04263766|Georgia Institute of Technology|Dr. Dobromir Rahnev|6466378219|rahnev@psych.gatech.edu|
20566405|NCT04732000|Stanford University|Professor of Anesthesia|650-723-6412|ang@stanford.edu|
20566406|NCT00482911|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-435-7507|sbpso@mail.nih.gov|
20566407|NCT00390884|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20566408|NCT00756574|McMaster University|Dr. Mark Loeb|905-525-9140|loebm@mcmaster.ca|26066
20566409|NCT04622332|Sironax|Lisa Fitzgerald, Senior Director Clinical Operation|781-201-3892|Lisa.Fitzgerald@sironax.com|
20535808|NCT03350451|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20535809|NCT02639247|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20535810|NCT00581048|Vanderbilt University Medical Center|Ryszard Dworski|615-322-3412|ryszard.dworski@Vanderbilt.Edu|
20535811|NCT03462758|University of California, San Diego|Dr. Sarah Averbach, MD, MAS|858-329-4464|familyplanningresearch@health.ucsd.edu|
20535812|NCT00573391|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
20535813|NCT02607124|Cincinnati Childrens Hosptial Medical Center|Renee Doughman|513-636-1699|renee.doughman@cchmc.org|
20535814|NCT02141672|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20535815|NCT00739310|Maimonides, Department of Pulmonary Medicine|Kathryn Fitzgerald, NP|718-283-7339|kfitzgerald@maimonidesmed.org|
20535816|NCT02954887|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20535817|NCT02803203|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-608-3912|YuH@mskcc.org|
20535818|NCT02343302|Johns Hopkins University|Director of Clinical Trials|410-955-7518|sleung7@jhu.edu|
20535819|NCT00598819|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
20535820|NCT02694601|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20535821|NCT04581785|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20535822|NCT02948582|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20566410|NCT05036278|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20566411|NCT06122935|Fresenius Kabi|Jason Friedmann|847-550-2365|jason.friedmann@fresenius-kabi.com|
20566412|NCT01946204|Janssen Research & Development, LLC|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566413|NCT02787005|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20566414|NCT03516812|University of Washington|Michael Schweizer|206-606-6252|schweize@uw.edu|
20566415|NCT02313675|University of Pittsbur|John R Fowler, MD|412-605-3245|fowlerjr@upmc.edu|
20566416|NCT03509909|VA San Diego Healthcare System|Ariel J Lang|858-552-8585|ariel.lang@va.gov|5359
20566417|NCT03431350|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566418|NCT06571058|The Ohio State University Comprehensive Cancer Center|Karen Meade|614-366-5060|Karen.Meade@osumc.edu|
20566419|NCT00258830|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20566420|NCT01939288|Imperial College London|Miss Katherine Williams|020 3311 7335|k.williams@imperial.ac.uk|
20566421|NCT03224481|Queen Mary University of London|Professor Padhraig Fleming|02073777397|padhraig.fleming@qmul.ac.uk|
20566422|NCT04801420|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|0
20566423|NCT03414684|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
20566424|NCT02078648|Stemline Therapeutics, Inc.|Clinical Development & Medical Affairs - Solid Tumors|1-973-775-2845|clinicaltrials@menarinistemline.com|
20566425|NCT04088227|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
20566426|NCT01675492|Abbott Medical Optics|Director, Clinical Operations|714-247-8628|lachelle.arredondo@abbott.com|
20566427|NCT03160885|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
20566428|NCT02307682|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
20566429|NCT01713660|AMO|Carrie Garufis|7145663728|carrie.garufis@amo.abbott.com|
20566430|NCT04306367|Lombardi Comprehensive Cancer Center|Aiwu Ruth He, MD|202-444-2223|Aiwu.R.He@gunet.georgetown.edu|
20566431|NCT02751528|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20566432|NCT05485805|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20566433|NCT04218357|Brown University|Carolina Haass-Koffler, PharmD, PhD|4155191385|carolina_haass-koffler@brown.edu|
20566434|NCT05349838|Research Organisation (KC) Ltd|Clinical Project Manager|07376618244|WISARD@rokcservices.com|
20566435|NCT04640974|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20566436|NCT04484623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20566437|NCT05037513|University of Kentucky|Dr. Hilary Surratt|8595622458|hilary.surratt@uky.edu|
20566438|NCT05886777|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566439|NCT03773107|Levine Cancer Institute|Jim Symanowski, PhD|9804422371|james.symanowski@atriumhealth.org|
20566440|NCT04257994|St George's, University of London|Dr Angeliki Asimaki|+447484764641|aasimaki@sgul.ac.uk|
20566441|NCT00984815|Horizon Pharma|Amy Y. Grahn, MS|224-383-3012|agrahn@horizonpharma.com|
20566442|NCT03367156|UT MD Anderson Cancer Center|Dr. David Hui- Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
20566443|NCT04803370|Son Llàtzer University Hospital|Joan Bargay Lleonart|34871202000|khaoulahelhaji@gmail.com|
20566444|NCT02036970|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20566445|NCT02298842|Terumo BCT|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
20566446|NCT01727167|Duke University Medical Center|John J. Freiberger, M.D.|919-684-6726|john.freiberger@duke.edu|
20566447|NCT03738228|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
20566448|NCT06212752|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20566449|NCT01641900|Massachusetts General Hospital|Dara S. Manoach, Principal Investigator|617-724-6148|dara.manoach@mgh.harvard.edu|
20566450|NCT02568215|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20566451|NCT00371345|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20566452|NCT00123409|Philadelphia VAMC|David Oslin|2158235894|dave.oslin@upenn.edu|
20566453|NCT05896267|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20535823|NCT01635998|Icahn School of Medicine at Mount Sinai|Sam Cammack|(212) 824-8931|sam.cammack@mountsinai.org|
20535824|NCT04419467|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20535825|NCT00243191|SARC|SARC, Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
20535826|NCT02471313|National Institutes of Health Clinical Center|Dr. Elliot Levy, Staff Clinician, Radiology & Imaging Sciences|301-402-5368|levyeb@cc.nih.gov|
20535827|NCT00869167|California Pacific Medical Center|Brandon Lu, M.D., M.S.|415-923-3421|lubs@sutterhealth.org|
20535828|NCT00943631|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
20535829|NCT04684576|University of Washington Department of Rehabilitation Medicine|Dr. Heather Feldner, Study PI|2065433721|hfeldner@uw.edu|
20535830|NCT01361217|University of Washington|Nina Isoherranen|206-5432517|ni2@uw.edu|
20535831|NCT01220401|University of Tulsa|Dr. Noelle Balliett|918-631-3976|noelle-balliett@utulsa.edu|
20535832|NCT03386435|Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea|Jun-Gol Song, MD, PhD|+82-2-3010-3869|jungol.song@amc.seoul.kr|
20535833|NCT04068922|University of Florida|Dr. Emily Bartley|352-273-8934|ebartley@dental.ufl.edu|
20535834|NCT03542266|Weill Cornell Medical College|Jia Ruan, MD, PhD|646-962-2064|jruan@med.cornell.edu|
20535835|NCT00625586|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20535836|NCT01072136|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
20535837|NCT01176877|Northwestern University, Feinberg School of Medicine, Department of Dermatology|Dr. Steven Nwe, Clinical Research Fellow|312-695-4625|steven.nwe@northwestern.edu|
20535838|NCT02153489|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20535839|NCT00657267|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
20535840|NCT02737501|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20535841|NCT01070979|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20535842|NCT00833027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535843|NCT01939145|MGUH Center for Wound Healing and Hyperbaric Medicine|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
20535844|NCT02806414|UCSD Dermatology|Director of Clinical Trials Unit|8586571697|dermstudies@ucsd.edu|
20535845|NCT02382588|Northwestern Universtiy|Dr. Robert Feder|3126958150|r-feder@northwestern.edu|
20535846|NCT01985022|Emory University|Nathan Call, PhD|404-785-9400|nathan.call@choa.org|
20535847|NCT02481258|Mayo Clinic|Jordan D. Miller, Ph.D.|507-293-0813|Miller.Jordan@mayo.edu|
20535848|NCT04421404|UCSF|Dr. Annie Luetkemeyer|415-476-4082|annie.luetkemeyer@ucsf.edu|130
20535849|NCT00806260|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|day@vivus.com|
20566454|NCT05966155|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
20566455|NCT04122196|University of Missouri|Eliza DeFroda|573-882-4141|elddmc@health.missouri.edu|
20566456|NCT04795167|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
20566457|NCT02257736|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566458|NCT02940249|King's College London|Dr Wendy Hall|020 7836 5454|wendy.hall@kcl.ac.uk|
20566459|NCT02628626|Mayo Clinic|Dr. Adil Bharucha|507-284-2687|bharucha.adil@mayo.edu|
20566460|NCT02744066|Magee Womens, UPMC Hamot Hospital|Dr. Michael J. Balsan|814-877-3190|balsanmj@upmc.edu|
20566461|NCT04144868|Affiliated Hospital of Jiujiang University|Zhiying Chen|+86 13767263459|zychenjj@jju.edu.cn|
20566462|NCT05051982|Indiana University School of Medicine (Dept of Anesthesia)|Dr. Timothy Webb|2196893636|ttwebb@iu.edu|
20566463|NCT01400958|H. Lee Moffitt Cancer Center and Research Institute|Peter A. Forsyth, M.D.|813-745-3063|peter.forsyth@moffitt.org|
20566464|NCT05663866|Janssen Research & Development LLC|Senior Medical Director Global Medical Affair Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566465|NCT03598907|Department of anesthesiology and intensive care medicine, Charles University and Motol Hospital|prof. Miroslav Durila|+420224435440|miroslav.durila@fnmotol.cz|
20566466|NCT00972621|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head, Clinical Research & Development|714-247-8613|kendra.hileman@abbott.com|
20566467|NCT03656718|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20566468|NCT01855750|Janssen Research & Development, LLC|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566469|NCT05379270|George Washington University|Allison Sylvetsky|202-994-5602|asylvets@gwu.edu|
20566470|NCT03425682|Aziyo Biologics, Inc.|Associate Director, Clinical Operations|678-492-4712|srichardson@aziyo.com|
20566471|NCT03610581|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566472|NCT05637970|UCLA|David Tehrani|8583360666|davidmtehrani@gmail.com|
20566473|NCT00489307|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20566474|NCT05162261|Novoxel Ltd|Dr. Ifat Klein|+972-52-6009860|ifat@novoxel.com|
20566475|NCT02517268|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Harish Lavu|215-955-6888|Harish.Lavu@jefferson.edu|
20566476|NCT05579730|Bausch & Lomb|Daniel Donatello|585-338-5306|Daniel.Donatello@bausch.com|
20566477|NCT03044158|University of California Irvine|Adithya Cattamanchi|714-456-2959|Adithya.Cattamanchi@uci.edu|
20566478|NCT02401815|Cogent Biosciences, Inc.|VP, Head of Clinical Development Operations|617-945-5576|clinops@cogentbio.com|
20566479|NCT00748709|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566480|NCT04660721|Sealantium Medical Ltd.|Prof. Orgad Laub, Chief Executive Officer|+972 0544434387|orgad@sealantium-med.com|
20566481|NCT05483517|Tri-service general hospital|Lai Chia-Ying|87923311|pokerface165@gmail.com|18792
20566482|NCT05961995|The Ohio State University Hospital|Dr. Thangam Venkatesan|614-293-6255|thangam.venkatesan@osumc.edu|
20566483|NCT07204444|University of Florida|Laura R. Shannonhouse, PhD|352-273-4332|lshannonhouse@coe.ufl.edu|
20535850|NCT00237042|University of Washington|Dr. Judith Turner|206-543-3997|jturner@u.washington.edu|
20535851|NCT02965989|Hospital Universitario 12 de Octubre de Madrid|Ph.D. Ignacio Zaragoza-García|913908000|izaragoz@ucm.es|4646
20535852|NCT05223673|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
20535853|NCT00810277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535854|NCT02836470|Palisade Bio|Mitchell Jones, CMO|858-704-4900|mitchell.jones@palisadebio.com|
20535855|NCT00532129|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535856|NCT04551898|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20535857|NCT03145064|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20535858|NCT00548197|Iran university of medical Sciences|Mehdi Modarres|009888602217|mmodarres51@yahoo.com|
20535859|NCT01187095|Aarhus University|Yoon Frederiksen|+4587565871|yoonf@psy.au.dk|
20535860|NCT04103112|Imperial College London|Professor Alun Davies|02033117320|a.h.davies@imperial.ac.uk|
20535861|NCT00288886|Salem Veterans Affairs Medical Center|Steven Lash, Ph.D.|(540)982-2463|Steven.Lash@va.gov|2593
20535862|NCT00456755|Department of Otorhinolaryngology, Head & Neck Surgery, West China Hospital, Sichuan University, China|Zhao Yu||yutzhao@gmail.com|
20535863|NCT04005391|University of Colorado|Margo Harrison|19176555178|margo.harrison@cuanschutz.edu|
20535864|NCT04343092|College of Medicine-University of Baghdad|Faiq I. Gorial|009647801730696|faiqig@gmail.com|
20535865|NCT03358355|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
20535866|NCT02477527|Midtown Medical Center|Edward W Braun, MD|8139353221|Dr.Braun@DrEdwardBraun.com|
20535867|NCT04567524|Lyndra Therapeutics|Nayana Nagaraj, Senior Medical Director|3023040091|Nnagaraj@lyndra.com|
20535868|NCT01349673|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20566484|NCT05246709|Columbia University|Seon Mi Jeong|646-317-5238|smj9007@nyp.org|
20566485|NCT00092534|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20566486|NCT02386098|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20566487|NCT02677766|University of Modena and Reggio Emilia|Stefania Costi|+390522522441|stefania.costi@unimore.it|
20566488|NCT03002194|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20566489|NCT03849937|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588 1673|kwilliams1@kumc.edu|
20566490|NCT04162210|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20566491|NCT04497415|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
20566492|NCT05579600|Butler Hospital|Sarah Arias|909-753-9444|sarias@butler.org|
20566493|NCT02463448|Beaumont Hospitals|Jennifer Giordano|248-551-3517|jennifer.geiordano@beaumont.org|
20566494|NCT03021993|Medical University of South Carolina|Alan Brisendine, Sponsor-Investigator Support Unit Manager|843-792-9007|brisend@musc.edu|
20566495|NCT04230941|University of Rochester|Allison Magnuson, (Principal Investigator), Associate Professor of Medicine|585-276-7155|allison_magnuson@urmc.rochester.edu|
20566496|NCT03304639|University of Pittsburgh Medical Center|Dr. Jason Luke|412-647-2811|lukejj@upmc.edu|
20566497|NCT03890289|"Policlinico S.Orsola-Malpighi - Istituto di Ematologia Seragnoli"|Lisa Argnani|051 214 3827|lisa.argnani@unibo.it|
20566498|NCT02867059|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
20566499|NCT03660618|University of Iowa Healthcare|Dr. Randy Kardon|319-356-8299|randy-karon@uiowa.edu|
20566500|NCT00291694|University of Kansas Medical Center|Dr. Carol Fabian|913-588-3666|cfabian@kumc.edu|
20566501|NCT02816398|Avenu Medical - Sponsor|Gene Reu|949 276 2483|greu@avenumedical.com|102
20566502|NCT00853606|Vivus, Inc|Wesley W Day PhD|650-934-5200||
20566503|NCT01273610|City of Hope|Dr. Daneng Li|626-359-8111|danli@coh.org|
20566504|NCT04041219|Mayo Clinic|Heather P. May, Pharm.D.|507-266-7405|May.Heather@mayo.edu|
20566505|NCT01588951|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Margaret Showel, MD|410-614-0675|mshowel1@jhmi.edu|
20566506|NCT03683576|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|Gossamer Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
20566507|NCT01595282|PPLM|Principal Investigator|617-616-1600||
20566508|NCT01593020|UT MD Anderson Cancer Center|Dr. Valero Vicente, Professor, Breast Medical Oncology|(713) 563-0751|vvalero@mdanderson.org|
20566509|NCT02350634|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|AVD_Clinical_Ops@lists.lilly.com|
20566510|NCT04205487|Florida International University|Adam W. Carrico, PhD|305-348-7887|acarrico@fiu.edu|
20566511|NCT04241848|James J. Peters VA Medical Center, Spinal Cord Damage Research Center|Dr. Ann Spungen|(718) 584-9000|Ann.Spungen@va.gov|5814
20566512|NCT02990858|CytoDyn|Vice President, Clinical Operations|36009808524|jmeidling@cytodyn.com|
20566513|NCT03492177|Actelion Pharmaceuticals Ltd|Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566514|NCT02499328|Astrazeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20566515|NCT03102034|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20566516|NCT02766517|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20566517|NCT02063659|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
20566518|NCT02972359|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
20566519|NCT02788019|UT Southwestern Medical Center|Anthony Machi, MD, Assistant Professor|214-648-6400|Anthony.Machi@UTSouthwestern.edu|
20566520|NCT03488719|Saniona A/S|Janus Schreiber Larsen|+45 7070 5225|janus.larsen@saniona.com|
20566521|NCT04724759|Massachusetts General Hospital|Jingping Wang - Principal Investigator|617-643-2729|jwang23@mgh.harvard.edu|
20535869|NCT01665911|Indiana University School of Dentistry|Frank Lippert|317-274-8822|flippert@iu.edu|
20566522|NCT03477175|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20535870|NCT00641108|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
20535871|NCT00347932|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
20535872|NCT00506779|University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD|713-745-2565|DGershen@mdanderson.org|
20535873|NCT01821326|Shanghai Jiaotong University|Dr.Zhizheng GE|86-68383015|tanwei_1987@163.com|
20535874|NCT02817594|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20535875|NCT05069649|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20535876|NCT00533429|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535877|NCT00127855|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535878|NCT00920556|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535879|NCT01299389|Janssen Pharmaceutical K.K|Medical director|+81-3-4411-5509||
20535880|NCT02834819|Children's Hospital Colorado/University of Colorado|Cortney Braund, MD|4406696880|Cortney.Braund@childrenscolorado.org|
20535881|NCT04245709|Duke University|Dwight Koeberl, MD,PhD|919-681-9919|dwight.koeberl@duke.edu|
20535882|NCT03637491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535883|NCT02020590|Bone Therapeutics|Chief Medical Officer|+32 71 12 10 00|regulatory@bonetherapeutics.com|
20535884|NCT01339936|Optometric Technology Group|Dr Michel Guillon|+44 2072224224|mguillon@otg.co.uk|
20535885|NCT02251496|University of Iceland|Dr. Áróra Rós Ingadóttir|8461601|aroraros@landspitali.is|
20535886|NCT00889707|Sophiris Bio Corp (formerly Protox Therapeutics)|Chief Medical Officer|858-255-4711|richard@sophiris.com|
20535887|NCT02185534|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 1000|ClinicalTrialTransparency@astrazeneca.com|
20535888|NCT03465722|Blueprint Medicines|Medical Information Call Center|1-888-258-7768|medinfo@blueprintmedicines.com|
20535889|NCT03542019|University of Jordan|Dr. Ahmad El-Ma'aita|+9626535 5000|a.maaita@ju.edu.jo|
20535890|NCT01151020|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20535891|NCT02041299|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
20535892|NCT02389465|University of Pennsylvania|Dr. Yvette Sheline, McLure Professor of Radiology, Neurology and Psychiatry|(215) 573-0082|sheline@pennmedicine.upenn.edu|
20535893|NCT01925768|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20535894|NCT03511001|California State University San Marcos|Dr. Kim Pulvers|760 750 4127|kpulvers@csusm.edu|
20535895|NCT00003631|Memorial Sloan Kettering Cancer Center|Dr. Joachim Yahalom|1212-639-5999|yahalomj@mskcc.org|
20535896|NCT04339413|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20535897|NCT03502915|University of North Carolina at Chapel Hill|Kathleen A. Smith, MD|9199665136|ksmith@aims.unc.edu|
20535898|NCT00530634|City of Hope|Jeff Longmate, Ph.D.|626-256-4673|jlongmat@coh.org|62478
20535899|NCT00087698|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20535900|NCT00362882|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20535901|NCT01853462|Aristotle University of Thessaloniki|Lazaros Lazarou||lazarosphysiotherapist@gmail.com|
20535902|NCT03139032|Arena Pharmaceuticals, Inc.|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
20535903|NCT02073162|The Cleveland Clinic Foundation|Dr. Daniel Sessler|216-444-4900|ds@or.org|
20535904|NCT03943290|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20535905|NCT04970069|Cleveland Clinic|Dr. Alparslan Turan|2162172312|turana@ccf.org|
20535906|NCT00955474|Massachusetts General Hospital|John D. Matthews, MD|6177249144|jdmatthews@partners.org|
20535907|NCT04342091|Yale University|Brett King|(203) 785-7421|Brett.King@yale.edu|
20535908|NCT04179305|Weill Cornell Medicine|Sophia Kakarala|(646) 962-5650|sok4004@med.cornell.edu|
20535909|NCT00361972|university of utah|kathryn peterson|8015817804|kathryn.peterson@hsc.utah.edu|
20535910|NCT02272946|University of California, San Francisco|Priscilla Hsue, MD|628-206-5801|Priscilla.hsue@ucsf.edu|
20535911|NCT00149799|Rhode Island Hospital|Katharine A. Phillips, MD|401-444-1646|katharine_phillips@brown.edu|
20535912|NCT03503396|University of Missouri|Dr. Denis McCarthy|573-882-0426|mccarthydm@missouri.edu|
20535913|NCT01591408|NavalMCSD|Julie Onton|619-553-6228|julie.a.onton.ctr@mail.mil|
20535914|NCT00142792|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
20535915|NCT04819113|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535916|NCT00437268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20535917|NCT01569815|Novartis Pharmaceuticals|Study Director|862-778-8300||
20535918|NCT02382991|OTTOBOCK FRANCE|Aurélie LACROIX|0033 (0)7 86 29 52 03|market.access@ottobock.fr|
20535919|NCT00444925|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20535920|NCT03870048|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
20535921|NCT02317692|Marquette University|Dr. Alyson Gerdes|414-288-6145|alyson.gerdes@mu.edu|
20535922|NCT02573948|UMR 1058 (Inserm/University of Montpellier/EFS)|NAGOT NICOLAS|+33 4 34 35 91 09|n-nagot@chu-montpellier.fr|
20535923|NCT01673126|Coma Science Group, University of Liège|Aurore Thibaut and Pr Steven Laureys|003243662362|athibaut@ulg.ac.be|
20535924|NCT01876212|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
20535925|NCT03111316|University of Oklahoma Health Sciences Center|Director of Women's Health Research|4052718001|christy-zornes@ouhsc.edu|48137
20566523|NCT03371017|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20566524|NCT05525572|University of Miami, Miller School of Medicine|Thomas A Masterson, III|(305) 243 - 6260|TMasterson@med.miami.edu|
20535926|NCT01913327|University of California San Francisco|Michael Minzenberg|5104122199|MMinzenberg@mednet.ucla.edu|
20566525|NCT05116163|Brigham and Women's Hospital|Dr. Candace Feldman|617-525-1035|chfeldman@partners.org|
20535927|NCT04500457|Florida State University|Jesse Cougle|8506458729|cougle@psy.fsu.edu|
20535928|NCT04566731|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
20535929|NCT04267926|Department of Veterans Affairs MS Center of Excellence-West and Portland, Oregon Health & Science University|Vijayshree Yadav MBBS, MCR|503-494-3813|yadavv@ohsu.edu|
20535930|NCT03718325|University of Michigan|Dr. Scott Lempka|734-647-9052|NeuromodulationLab@med.umich.edu|
20535931|NCT01396187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535932|NCT01898286|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
20535933|NCT02257242|Brown University Oncology Research Group|BrUOG|4018633000|BrUOG@BROWN.EDU|
20535934|NCT02433496|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
20535935|NCT00551031|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20535936|NCT03460652|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
20535937|NCT02964273|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20535938|NCT02469701|Brown University Oncology Research Group|Kristen M. Mitchell, CCRP|4018633000|kristen_mitchell@brown.edu|
20535939|NCT00841776|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535940|NCT04245449|Medical University of South Carolina|Michelle Woodbury, PhD|843-792-0651|woodbuml@musc.edu|
20535941|NCT03073525|Gradalis, Inc|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
20535942|NCT01976299|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|9529558236|mshepard@ospreymed.com|
20535943|NCT03692403|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20535944|NCT00672594|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
20535945|NCT02848092|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|513-636-8296|jeff.epstein@cchmc.org|
20535946|NCT00913510|Wellspect HealthCare|Dikran Shamoun|+46313764000||
20535947|NCT05160363|Medicines for Malaria|Senior Director, Program Leadership and Strategy|+41 22 555 03 26|borghinii@mmv.org|
20535948|NCT02126319|Fox Chase Cancer Center|Dr. Suzanne M. Miller|215 728-4069|Suzanne.Miller@fccc.edu|
20535949|NCT02462187|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20535950|NCT03688919|University of Michigan School of Public Health|Professor Alison Miller|7346157459|alimill@umich.edu|
20535951|NCT00118274|University of Virginia|Dr. Craig Slingluff|4349249311|cls8h@virginia.edu|
20535952|NCT01724216|Spectrum Health|Mark Charles DeLano, M.D., Principal Investigator|616-363-7339|delanom@msu.edu|
20535953|NCT00564733|University of Washington|Keith D. Eaton, MD, PhD|2062886249|kdeaton@uw.edu|
20535954|NCT01285024|Cleveland Clinic|President and CEO Cleveland Clinic Florida|216-444-7515|barsouw@ccf.org|
20535955|NCT02621476|Kaiser Permanente Northern California|Julie Schmittdiel, PhD, MA|5108913872|Julie.A.Schmittdiel@kp.org|
20535956|NCT01484496|GlaxoSmithKline|GSK Response Center|866-435-7343||
20535957|NCT01645735|Cerexa, Inc|Medical Monitor|(510) 285-9200||
20535958|NCT04105868|University of Pittsburgh|Mary Woody, PhD Assistant Professor of Psychiatry|4123832143|mlw114@pitt.edu|
20566526|NCT05025384|Vanderbilt University Medical Center|Krista Vermillion|615-875-1921|krista.k.vermillion@vumc.org|
20566527|NCT04686266|University of Pennsylvania|Lauren Massimo, PhD, CRNP|215-349-5863|lmassimo@upenn.edu|
20566528|NCT03436992|Augusta University|Dr. Ryan Harris|706-721-5483|ryharris@augusta.edu|
20566529|NCT03227861|Janssen Scientific Affairs, LLC|Senior director medical leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566530|NCT05075395|University of Nebraska Medical Center|Breanna Hetland|402-559-5460|breanna.hetland@unmc.edu|
20566531|NCT05071430|HB Biotech|Tomer Seifan|917-685-7351|tomer.seifan@hbbio.com|
20566532|NCT01958021|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20566533|NCT00085982|NIDDK|Rebecca Brown, MD|301-594-0609|brownrebecca@mail.nih.gov|
20566534|NCT05256797|Brigham and Women's Hospital|Shirley Wang|617-525-8376|swang1@bwh.harvard.edu|
20566535|NCT05810285|Permedicaspa|Lorenzo Banci, study coordinator - clinical affairs|0399514811|lorenzo.banci@permedica.it|
20566536|NCT05470114|Leo Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
20566537|NCT04649047|Ohio State University College of Nursing|Dr. Mei-Wei Chang|614-247-7211|chang.1572@osu.edu|
20566538|NCT02488408|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|trialsites@bergenbio.com|
20566539|NCT00719888|Fred Hutchinson Cancer Center|Dr. Ann Dahlberg|206-667-1959|adahlber@fredhutch.org|
20566540|NCT05199571|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20566541|NCT03762850|Travere Therapeutics, Inc|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
20566542|NCT02200705|IceCure Medical|Clinical Trial Manager|+972-4-623-0333|ronitl@icecure-medical.com|
20566543|NCT04083976|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566544|NCT03284359|University of Pennsylvania|Dr. Katherine Courtright|267-978-5083|Katherine.Courtright@pennmedicine.upenn.edu|
20566545|NCT00808834|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20566546|NCT03376659|Georgetown University|Benjamin Weinberg, MD|202-444-2223|benjamin.a.weinberg@gunet.georgetown.edu|
20566547|NCT00512252|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-454-8304|guy@dom.wustl.edu|
20566548|NCT00705406|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
20566549|NCT02357966|XBiotech USA, Inc.|Haritha Pallapotu|512-386-2992|hpallapotu@xbiotech.com|
20535959|NCT01456130|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20535960|NCT00382265|George Washington University|Andrew Meltzer, MD, MS|202-741-2952|ameltzer@mfa.gwu.edu|
20535961|NCT04091048|Medtronic Cardiovascular|Katie Flor, Clinical Research Manager|262 693 6127|katie.j.flor@medtronic.com|
20566550|NCT01779700|Indiana University|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
20535962|NCT01791517|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST, Global Med Affairs|904-443-3500|CColesb@ITS.JNJ.com|3449
20535963|NCT00589797|Aesculap Inc.|Associate Director of Medical and Scientific Affairs|800-258-1946|mikhail.chkolnik@aesculap.com|5173
20535964|NCT01692743|University of Maryland School of Medicine|Raymond K. Cross, MD, MS, AGAF|410-706-3387|rcross@som.umaryland.edu|
20535965|NCT05197049|Janssen-Cilag International NV|Senior Medical Leader IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20535966|NCT03230318|Basilea Pharmaceutica International Ltd, Allschwil|Dr Manuel Häckl, MD|+41 76 302 53 10|manuel.haeckl@basilea.com|
20535967|NCT00353301|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848-0655|Thomas.Flaig@ucdenver.edu|
20535968|NCT04011735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20535969|NCT02831855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535970|NCT03368196|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20535971|NCT02688192|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
20535972|NCT00075764|SWOG|Breast Committee Statistician|206-667-4623||
20535973|NCT03012191|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
20535974|NCT02010593|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
20535975|NCT01773967|Cincinnati Children's Hospital Medical Center|Dr. David Schnadower|5138035526|david.schnadower@cchmc.org|
20535976|NCT01135459|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20535977|NCT01531582|University of South Florida, Morsani College of Medicine|Edwin J. Weeber, Ph.D.|(813) 396-9995|eweeber@health.usf.edu|
20535978|NCT03885154|University of Kentucky|Kimberly Jones, MD|859-218-5011|kimberly.jones@uky.edu|
20535979|NCT01057693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535980|NCT02236572|Yale Cancer Center|Lajos Pusztai, MD, DPhil|(203) 200-2328|lajos.pusztai@yale.edu|
20535981|NCT02413996|IRCCS Istituto Ortopedico Galeazzi, Milano|Davide Tornese|0266214046|davidzai@tin.it|
20535982|NCT04345900|BeyondSpring Pharmaceuticals|Ramon Mohanlal|6468491102|rmohanlal@beyondspringpharma.com|
20535983|NCT02651116|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20535984|NCT00705874|Progen Pharmaceuticals Pty Ltd|Director of Clinical Trials|+61 7 32739133|darrynb@progen-pharma.com|
20535985|NCT00041470|University of Washington|Julie Gralow, MD|206-288-2053|pink@u.washington.edu|
20535986|NCT01459666|University Hospitals Cleveland Medical Center|Dr. Kevin Cooper|216-844-3100|Kevin.Cooper@UHhospitals.org|
20535987|NCT01061385|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
20535988|NCT01492088|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20535989|NCT03800030|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
20535990|NCT02379052|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20535991|NCT00786422|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20535992|NCT04466384|Medtronic|Ami Stuart PhD|8017934800|ami.stuart@medtronic.com|
20535993|NCT04522167|Formycon AG|Public Register Contact|+49 89 864667 100|clinicaltrials@formycon.com|
20535994|NCT02489318|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20535995|NCT01306643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20535996|NCT00709319|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrstat3@jaeb.org|
20535997|NCT03889028|Clinical University Hospital of Valencia|David Navarro|+34961973500|david.navarro@uv.es|
20535998|NCT00579553|University of Oklahoma Health Science Center|Andrew Elimian, MD|19146465194|aelimian@aol.com|
20535999|NCT00090779|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20536000|NCT02032758|Mayo Clinic in Arizona|Dr. Charles H. Adler|480-301-8100|cadler@mayo.edu|
20536001|NCT04860869|University of Texas Medical Branch|Randall Urban|409-772-5476|rurban@utmb.edu|
20536002|NCT00515528|Department of Medicine|Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
20536003|NCT01404650|Sarah Cannon Research Institute|Johanna Bendell, MD|877-691-7274|asksarah@sarahcannon.com|
20536004|NCT00590967|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|grigsby@radonc.wustl.edu|
20536005|NCT01881789|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20536006|NCT01887717|BTG International Inc.|Manager of Clinical Development|613-801-1844|TheraSphereClinical@btgplc.com|
20536007|NCT02592421|University of Texas Health San Antonio|Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
20536008|NCT02655887|Becton Dickinson (BPV)|Megan Hill|480-350-6468|Megan.Hill@bd.com|
20536009|NCT00833443|UCLA|Keith Heinzerling MD|323-461-3106|kheinzerling@mednet.ucla.edu|
20536010|NCT01791491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20536011|NCT02148263|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
20536012|NCT00003869|Mayo Clinic|Dr. Edith A. Perez||perez.edith@mayo.edu|
20536013|NCT01964378|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20536014|NCT00326599|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|716-845-4101|alex.adjei@roswellpark.org|
20536015|NCT03364231|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20536016|NCT00585637|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu|
20536017|NCT01183429|Memorial Sloan Kettering Cancer Center|Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
20536018|NCT03662282|University of South Florida|Thao Ho|813-844-3437|tho1@usf.edu|
20536019|NCT02012218|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20536020|NCT03484429|Central Virginia Veterans Affairs Health Care System|Dr. Denise Lester|804-675-5000|denise.lester@va.gov|
20536021|NCT01342926|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536022|NCT04792190|University of Rochester|Mehmet Aktas, MD|585-275-4775|mehmet_aktas@urmc.rochester.edu|
20536023|NCT03390504|Janssen Research & Development, LLC|SR DIRECTOR ONCOLOGY CDTL|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536024|NCT00980538|Janssen Research & Development, LLC|DIRECTOR CLINICAL LEADER EST PRODUCTS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536025|NCT04570384|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
20536026|NCT00707993|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20536027|NCT03654274|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
20536028|NCT02752490|The University of Texas Health Science Center at Houston|Nana-Ama E Ankumah, MD|713-500-6421|Nana.Ama.E.Ankumah@uth.tmc.edu|
20536029|NCT01102491|Joint Reconstruction Center, Seoul National University Bundang Hospital|TK Kim|82-31-787-7196|osktk@snubh.org|
20536030|NCT01265992|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20536031|NCT02454530|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536032|NCT00326001|Biotronik GmbH&Co. KG, Berlin, Germany|Dejan Danilovic|+49 9131 8924 7832|dejan.danilovic@biotronik.com|
20536033|NCT03265145|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20536034|NCT05005273|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@BMS.com|
20536035|NCT04409834|Brigham and Women's Hospital|COVID-PACT Project Manager|(617) 278-0145|covid-pact@bwh.harvard.edu|
20536036|NCT02137070|University of Florida|Dr. Ronald Cohen|352-273-6124|roncohen@ufl.edu|
20536037|NCT02151786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20536038|NCT02043145|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
20536039|NCT02112656|Imunon, Inc.|Chief Medical Officer|(609) 896-9100|clinical@imunon.com|
20536040|NCT03941483|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20536041|NCT04749745|Butler Hospital|Dr. Shiwen Yuan|2025783000|shiwen_yuan@brown.edu|
20536042|NCT02161536|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|+972 526145354|ravit@motusgi.com|
20536043|NCT04541667|University of Nebraska Medical Center|Chinenye Dike|402-955-5700|chinenye.dike@unmc.edu|
20536044|NCT03670160|University of Tennessee Medical Center|Janet Parkey, Director - Research Compliance|865-305-6194|jparkey@utmck.edu|
20536045|NCT01365455|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536046|NCT00971282|Galderma|Florence Paliargues|0033 4 92 95 29 57|Florence.Paliargues@Galderma.com|
20536047|NCT03965403|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|6179526319|pbonato@partners.org|
20536048|NCT02292537|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20536049|NCT03154476|Mayo Clinic|Dr. Alexander Egbe|507-284-3725|Egbe.Alexander@mayo.edu|
20536050|NCT02685826|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20536051|NCT01444430|AstraZeneca Research and Development|Carin Jorup, Global Clinical Lead (GCL) SYMBICORT|+46 31 7761000|Carin.Jorup@astrazeneca.com|
20536052|NCT03816176|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20536053|NCT03300206|Hologic|Hologic Clinical Research Team|508.263.2900|ClinicalResearch@Hologic.com|
20536054|NCT05393245|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20536055|NCT03137771|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20536056|NCT00972023|Barbara Ann Karmanos Cancer Institute|Elaina Gartner|800-527-6266|egartner@seagen.com|
20536057|NCT02220426|University of North Carolina at Chapel Hill|Rosa Tamara Branca, PhD|9199622229|rtbranca@unc.edu|
20536058|NCT02595879|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20536059|NCT01147965|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20536060|NCT01650831|Exalenz.Bioscience Ltd.|Avraham Hershkowitz, Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
20536061|NCT04988295|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536062|NCT01139411|Weight Control and Diabetes Research Center|Dr. Elissa Jelalian|(401) 793-9716|elissa_jelalian@brown.edu|
20536063|NCT04312932|Nationwide Children's Hospital|Sarah Keim|614-722-2000|sarah.keim@nationwidechildrens.org|
20536064|NCT01465386|FHCRC|Elihu Estey, MD|206-288-7176|eestey@seattlecca.org|
20536065|NCT02656836|Queen's University Belfast|Augusto Azuara-Blanco|2890976350|a.azuara-blanco@qub.ac.uk|
20536066|NCT02746406|Laborie|Clinical Researcher|9056121170|sbitzos@laborie.com|1755
20536067|NCT02479880|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20536068|NCT00355368|Medical Intensive care unit, University Hospital Basel|Stephan Marsch|+ 41 61 265 2525|smarsch@uhbs.ch|
20536069|NCT01279044|San Francisco Department of Public Health|Dr. Phillip Coffin, Director of Substance Abuse Research Unit|(415) 437 6282|phillip.coffin@sfdph.org|
20536070|NCT01408277|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20536071|NCT02840253|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
20536072|NCT03346083|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20536073|NCT03801928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536074|NCT00348946|Thomas Jefferson University|Judith L. Ross, M.D.|215-955-1648|judith.ross@jefferson.edu|
20536075|NCT02763059|King Abdulaziz University|Prof. Maha A Bahammam|00966126400000|mbahammam@kau.edu.sa|
20536076|NCT02370368|The University of the West Indies, Mona|Dr. Sharmella Roopchand-Martin|876-927-2235|sharmella.roopchandmartin@uwimona.edu.jm|
20536077|NCT03369665|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20536078|NCT04908683|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536079|NCT03901963|Janssen Research & Development|Director Clinical Research Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536080|NCT02933879|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20536081|NCT01816776|Respicardia, Inc.|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
20536082|NCT05226598|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20536083|NCT02959463|The University of Texas MD Anderson Cancer Center|Matthew Stephen Ning, MD, MPH|(832) 710-8779|msning@mdanderson.org|
20536084|NCT01672879|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20536085|NCT01775553|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
20536086|NCT03748641|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536087|NCT04834726|University of Pennsylvania|Dr. Shivan Mehta|215-898-6027|shivan.mehta@pennmedicine.upenn.edu|
20536088|NCT03810014|Duke University|Wendy P O'Meara, PhD|919-681-7711|wpo@duke.edu|
20536089|NCT02213068|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
20536090|NCT03606486|University of Washington|Dr. Barbara Norquist|206-543-3669|bnorquis@uw.edu|
20536091|NCT00442416|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20536092|NCT01107964|Milton S. Hershey Medical Center|Dr. David Liang|717-497-9469|dliang12@yahoo.com|
20536093|NCT01737762|Smith and Nephew|Dr Innes Cargill|817-302-3913|innes.cargill@smith-nephew.com|
20536094|NCT00503425|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20536095|NCT03328832|Kaohsiung Chang Gung Memorial Hospital|Dr. Wang JW|+886-7-7317123|wangjw@adm.cgmh.org.tw|8003
20536096|NCT00873821|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20536097|NCT04373421|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
20536098|NCT04872569|University of Michigan|Dr. Claire Kalpakjian|734-763-0153|clairez@umich.edu|
20536099|NCT00742170|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
20536100|NCT02881775|University of North Carolina at Chapel Hill|Deborah Givens, PhD|919-843-8660|deborah_givens@med.unc.edu|
20536101|NCT02268383|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20536102|NCT00943761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20536103|NCT00714948|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
20536104|NCT04581811|UAB Hospital|David Page - PI|205-975-7387|dpage1@uabmc.edu|
20536105|NCT02708680|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
20536106|NCT04162470|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20536107|NCT02568722|Unity Health Toronto|Dr. Ron Wald|(416) 867-3703|ron.wald@unityhealth.to|
20536108|NCT03382912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20536109|NCT03533660|University of Pittsburgh|Andrea DiMartini|14122164550|dimartiniaf@upmc.edu|
20536110|NCT04685213|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20536111|NCT02975804|The Hong Kong Polytechnic University|Dr tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
20536112|NCT00901225|Duke University Medical Center|Mitchell E Horwitz, MD, Principal Investigator|919-668-1045|mitchell.horwitz@duke.edu|
20536113|NCT03783962|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
20536114|NCT04423939|Duke University Medical Center|Dr. Anthony Sung|919-668-1000|anthony.sung@duke.edu|
20536115|NCT04024436|Taiho Oncology, Inc|Taiho Oncology, Inc|+1 844-878-2446|medicalinformation@taihooncology.com|
20536116|NCT01169337|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20536117|NCT01134614|ECOG Statistical Office|Study Statistician|617-632-3012||
20536118|NCT00540592|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536119|NCT04701411|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20536120|NCT03279237|Massachusetts General Hospital|Dr. Theodore Hong|(617) 726-2000|TSHONG1@mgh.harvard.edu|
20536121|NCT02661997|VA Boston Healthcare System|Barbara L. Niles, Ph.D.|857-364-4128|barbara.niles@va.gov|
20536122|NCT02168101|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANNDLClinicalScience@HCAHealthcare.com|
20536123|NCT05507567|Pneumagen Ltd|CEO|+44 7748357352|douglas.thomson@pneumagen.com|
20536124|NCT03569878|Department of Psychiatry, University of Washington School of Medicine|Douglas Zatzick|206 744-6701|dzatzick@uw.edu|
20536125|NCT01722994|University of Mississippi Medical Center|Dr. Robert Brodell|601-815-8000|rbrodell@umc.edu|
20536126|NCT01206140|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20536127|NCT01803880|Smith & Nephew, Inc|Stephan Mangin, Director, Global Clinical Strategy|M +1 (512) 913-8192|stephan.mangin@smith-nephew.com|
20536128|NCT03703232|University of Washington|Murray Maitland PT, PhD, Associate Professor|425-286-5278|mmaitlan@uw.edu|
20536129|NCT01766037|Aspire Bariatrics, Inc.|VP Regulatory & Quality|484-200-1031|monica.ferrante@aspirebariatrics.com|
20536130|NCT02179424|University of Hong Kong|Professor Lam Tai-Hing|39179287|hrmrlth@hku.hk|
20536131|NCT00318929|Virginia Commonwealth University|Alan R. Towne, MD|804-282-9869|atowne@mcvh-vcu.edu|
20536132|NCT00958477|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20566551|NCT01026805|Interlace Medical, Inc.|John Vozella, V.P. Clinical & Regulatory Affairs|508-875-1343|john@interlacemedical.com|112
20536133|NCT03205358|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20536134|NCT00633087|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20536135|NCT03579693|University of Washington|Bryan Kestenbaum, MD|206-685-7343|brk@uw.edu|
20536136|NCT02503085|Reckitt Benckiser Healthcare (UK) Ltd.|Clinical Research Director|+441482 326151||
20536137|NCT01027559|University of Pennsylvania|Dr. Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
20536138|NCT01841021|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lubomir Sokol|813-745-8212|lubomir.sokol@moffitt.org|
20536139|NCT01162473|The Children's Hospital of Philadelphia|Rushani W. Saltzman MD|215-590-2549|allergyandimmunology@email.chop.edu|
20536140|NCT01144416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20536141|NCT00124072|CTSU, University of Oxford|CTSU Reception|01865 743743|secretary@ctsu.ox.ac.uk|
20536142|NCT02534883|St. Louis University|Donald Gregory Ward, MD|314-781-1505|dgreg.ward@health.slu.edu|1
20536143|NCT00886769|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536144|NCT00414076|UT MD Anderson Cancer Center|Coleman,Robert,M.D. / Gyn Onc & Reproductive Medicine|7137923203|RColeman@mdanderson.org|
20536145|NCT00778336|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
20536146|NCT04417257|Laurent Pharmaceuticals Inc.|Vice president Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
20536147|NCT04951622|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536148|NCT04181827|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536149|NCT02101788|NRG Oncology|Linda Gedeon for Austin Miller, PhD|716-845-1169|linda.gedeon@roswellpark.org|
20536150|NCT04587869|RAND|Laura Bogart|3103930411|lbogart@rand.org|7281
20536151|NCT02157909|Alcon Research, Ltd.|Head Clinical Development, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20536152|NCT04687917|The Ohio State University|Dr. Bryan R. Garner|6142573462|bryan.garner@osumc.edu|
20536153|NCT04538664|Janssen Research & Development|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536154|NCT05441527|University of Iowa|Dr. Robert Bowers|(319) 467-3199|robert-bowers@uiowa.edu|
20536155|NCT03929913|National Heart, Lung, and Blood Institute (NHLBI)|Dr. Robert Lederman, Principal Investigator|301.402.6769|ledermar@nhlbi.nih.gov|
20536156|NCT01544348|MedImmune|Claire Birrell, Senior Clinical Scientist|301-398-0000|birrellc@medimmune.com|
20536157|NCT01445847|King Saud University Medical City - College of Medicine|Dr. Khalid Al-Faleh, Chairman, Institutional Review Board|966556031222|kfaleh@ksu.edu.sa|
20536158|NCT00947219|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
20536159|NCT00766116|University of California, San Diego|Edward D. Ball, MD|858-822-6600|tball@ucsd.edu|
20536160|NCT03381287|HighTide Therapeutics|Dr. Adrian Di Bisceglie, CMO|314-791-0593|adibisceglie@hightidetx.com|
20536161|NCT02847169|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
20536162|NCT01837680|Roosevelt Hospital, Mount Sinai Health System|Dr. Kimberly M. Herrera||kimmerher@gmail.com|
20536163|NCT03008070|Inventiva S.A.|Dr Michael Cooreman, Chief Medical Officer|+33380447616|native.public@inventivapharma.com|
20536164|NCT03081689|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20536165|NCT03960684|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20536166|NCT03761056|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20536167|NCT00996658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20536168|NCT04446312|Braintree Laboratories, Inc.|Head of R&D, GI|781-843-2202|studydirector@sebelapharma.com|
20536169|NCT00932035|City of Hope|Carolyn Behrendt, Ph.D.|(626)359-8111|Cbehrendt@coh.org|61148
20536170|NCT02610972|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
20536171|NCT04487080|Janssen Research & Development|Global Medical Head Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536172|NCT03451851|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536173|NCT03581292|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20536174|NCT01142388|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20536175|NCT04150913|Massachusetts General Hospital|Director, Cellular Immunotherapy Program|857-367-1486|mghcancercenter@partners.org|
20536176|NCT03052608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536177|NCT01834287|Brown University|Bess Marcus|4018636850|bess_marcus@brown.edu|
20536178|NCT02522429|UCLA|Principal Investigator|3108258546|monti@ucla.edu|
20536179|NCT00600106|Cedars-Sinai Medical Center|C. Noel Bairey Merz|310-423-9680|Noel.BaireyMerz@cshs.org|
20536180|NCT00252512|Minneapolis VA Health Care System|Hildi Hagedorn|612-467-3875|hildi.hagedorn@va.gov|
20536181|NCT05554146|Montefiore Medical Center|Dr. Deepika Slawek|718-920-3786|dslawek@montefiore.org|
20536182|NCT01683630|Unversity of Manotiba|Salah Mahmud|204-272-3139|salah.mahmud@umanitoba.ca|
20536183|NCT04667949|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20536184|NCT02213926|AstraZeneca Clinical -Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20536185|NCT01273038|Coloplast A/S|Director of Medical Affairs|4549111111|dkbir@coloplast.com|
20536186|NCT05887908|Clinical Development Department|Meiji Seika Pharma Clinical Trial Administrator|(+81) 3-3273-3745|clinical-trials@meiji.com|
20536187|NCT01537315|University of Arkansas for Medical Sciences|Dumitru Rotaru, MD, PI|501/526-6919|drotaru@uams.edu|
20536188|NCT03323853|University of Arkansas for Medical Sciences|Dr. Michael Wilson|501-686-5515|MPWilson@uams.edu|
20536189|NCT02197572|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20536190|NCT01179984|Bard Peripheral Vascular|Associate Director of Clinical Affairs|480-379-2838|josh.smale@crbard.com|
20536191|NCT01947335|Heart Institute (Incor)|Dr. Pedro A. Lemos|+55 11 2661 5000|pedro.lemos@incor.usp.br|
20536192|NCT03458325|scPharmaceuticals|Sr. Vice President, Clinical Development and Medical Affairs|(855) 727 4276|jmohr@scpharma.com|
20536193|NCT02630693|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
20536194|NCT00175916|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20536195|NCT04503551|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20536196|NCT05371054|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
20536197|NCT04930198|Vanderbilt University Medical Center|Dr. Martin Were|(617) 319-6462|martin.c.were@vumc.org|
20536198|NCT05384834|Emory University|Dr. Holly Gooding|404-778-1429|holly.gooding@emory.edu|
20536199|NCT03951766|Massachusetts General Hospital, Psychiatry Department|Dr. Bettina Hoeppner|6176431988|bhoeppner@mgh.harvard.edu|
20536200|NCT02623972|Dana-Farber Cancer Institute|Filipa Lynce, MD|617-632-4056|Filipa_Lynce@DFCI.HARVARD.EDU|
20536201|NCT05710640|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20536202|NCT04188509|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536203|NCT04158375|Mayo Clinic|Dr. Sreekumaran Nair - Principal Investigator|507-284-2511|nair.sree@mayo.edu|
20536204|NCT04847843|University of Utah|Tanya Halliday, PhD, RD|801-213-1364|tanya.halliday@utah.edu|
20536205|NCT05615220|Emalex Biosciences Inc.|Drug Development and Medical Affairs|773 343 0671|mmiller@emalexbiosciences.com|
20536206|NCT02388880|Advanced Circulatory Systems|Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
20536207|NCT04570371|Mayo Clinic|Dr. Andrea Cheville|(507) 284-2747|cheville.andrea@mayo.edu|
20536208|NCT04828135|Duke University|Loretta Que|919-681-8551|loretta.que@duke.edu|
20536209|NCT05089292|Icahn School of Medicine at Mount Sinai|Lina Jandorf|(212) 659-5506|lina.jandorf@mssm.edu|
20536210|NCT04229888|Indiana University School of Optometry|Anna Tichenor|812-855-0520|annatich@iu.edu|
20536211|NCT01282866|Laser & Skin Surgery Medical Group Inc.|Suzanne Kilmer, MD|916-456-0400|Study@skinlasers.com|
20536212|NCT01541865|Boston Scientific|Angela Schutt, Clinical Trial Manager|763-494-2166|angela.schutt@bsci.com|
20536213|NCT01757301|Richard L. Roudebush VA Medical Center|Erica Evans|317-988-3476|erica.evans2@va.gov|
20536214|NCT00730353|Hoosier Oncology Group|Nasser Hanna, M.D.|317-274-3515|nhanna@iupui.edu|
20536215|NCT00415870|UCSD|Project Coordinator|858-534-9329|ldillon@ucsd.edu|
20536216|NCT00049257|Translational Oncology Research International|Dr. Fairooz Kabbinavar, Chief Medical Officer|310 824 1934|FKabbina@mednet.ucla.edu|
20536217|NCT04721158|Johns Hopkins Medicine|Dr. Risa Wolf|410-955-6463|rwolf@jhu.edu|
20536218|NCT05110781|University of California, Davis|Principal Investigator|916-734-2790|abewley@UCDAVIS.EDU|
20536219|NCT03674970|Penn State College of Medicine|Patricia Sue Grigson|717-531-5772|pgrigsonkennedy@pennstatehealth.psu.edu|
20536220|NCT03462719|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536221|NCT03129464|Cleveland Clinic Florida|Pamela Frazzini Padilla|9546595559f|frazzip@ccf.org|
20536222|NCT04108208|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20536223|NCT05119582|Bispebjerg University Hospital|Prof. Joergen Serup|+1 21424888|joergen.vedelskov.serup@regionh.dk|
20536224|NCT03670355|San Francisco Department of Public Health|Dr. Albert Liu|4154377408|albert.liu@sfdph.org|
20536225|NCT03517436|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
20536226|NCT04271540|Brigham and Women's Hospital|Brittany Weber, MD, PhD|6177326291|bweber@bwh.harvard.edu|
20536227|NCT03307785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20536228|NCT05111613|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@stryker.com|
20536229|NCT05526521|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20536230|NCT03919929|University of Colorado Anschutz Medical Campus|Melanie Cree, MD, PhD|720-777-5743|melanie.cree@childrenscolorado.org|
20536231|NCT01402869|Loma Linda University|Dr. Lauren Gutenberg|909-558-4690|lgutenberg@llu.edu|
20536232|NCT00642707|CytoDyn, Inc.|Kush Dhody|301-956-2536|kushd@amarexcro.com|
20536233|NCT02891226|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20536234|NCT00841412|Tennessee Valley Healthcare System, GRECC and Vanderbilt University, School of Medicine, Division of Geriatrics, Center for Quality Aging|Sandra F. Simmons, PhD, Associate Professor of Medicine|615-343-6729|Sandra.Simmons@Vanderbilt.edu|
20536235|NCT00325130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20536236|NCT01671956|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20536237|NCT03368781|Acutus Medical, Inc.|Steve McQuillan|4422326080|steven.mcquillan@acutus.com|
20536238|NCT01566149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20536239|NCT01848977|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
20536240|NCT01032954|Brazilian Center for Studies in Dermatology|Dr Doris Hexsel|555130262633|cientifico@cbed.org.br|
20536241|NCT03687957|Washington University School of Medicine|Dr. Milan Chheda|314-747-2712|mchheda@wustl.edu|
20536242|NCT03132532|Mayo Clinic|Dr. Steven E. Schild|480-342-4800|sschild@mayo.edu|
20536243|NCT01530178|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
20536244|NCT03844672|Medical University of South Carolina|Dr. Tracy Smith|8437925164|smithtra@musc.edu|
20536245|NCT01693250|University of California San Francisco|Dr. Jyu-Lin Chen|415-502-6015|jyu-lin.chen@ucsf.edu|
20536246|NCT02709512|Polaris Pharmaceuitcals Inc|Dr. Mirla Langlois|858-452-6688|mlanglois@polarispharma.com|161
20536247|NCT02155101|University of Liverpool|Professor Anna Maria Geretti|+44(0)151 795 9625|Geretti@liverpool.ac.uk|
20536248|NCT05327660|Consumer Wellness Solutions/RVO Health|Dr. Kristina Mullis|765-265-9169|kmullis@rvohealth.com|
20536249|NCT02297815|Children's Hospital of Philadelphia|Dr. Jeffrey Gerber|(267) 426-8775|gerberj@email.chop.edu|
20566552|NCT00442104|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
20536250|NCT02346903|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
20536251|NCT03440463|Old Dominion University|Dr. Abby Braitman|757-683-3708|abraitma@odu.edu|
20536252|NCT00620373|Mayo Clinic|Dr. Deborah J. Rhodes|507-538-1703|rhodes.deborah@mayo.edu|
20536253|NCT01897727|University of Alabama at Birmingham|Dr. Eric Judd|205 934-9281|ejudd@uab.edu|
20536254|NCT01061723|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20536255|NCT00293813|Amgen Inc.|Study Director|866-572-6436||
20536256|NCT02956746|Synermore Biologics Co., Ltd.|Director of Clinical Trials|+886 2 2659 0988|achuang@synermore.com|
20536257|NCT00460655|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536258|NCT03650413|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20536259|NCT00910910|Celgene Corporation|Anne McClain, Senior Manager of Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20536260|NCT01973231|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20536261|NCT01692496|GEIS|Clinical Trial Coordinating Investigator|912866807|secretaria@grupogeis.org|
20536262|NCT01194219|Celgene Corporation|Anne McClain|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20536263|NCT05338710|OHSU|Allison Lindauer, PhD, APRN|5034944347|lindauer@ohsu.edu|
20536264|NCT01081951|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20536265|NCT03377816|University of Haifa|Johanna Czamanski-Cohen|+97246146234|jczamansk@univ.haifa.ac.il|
20536266|NCT01871545|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
20536267|NCT01523743|Hopital Raymond poincare|Pref. Emmanuel Chartier-kastler|+33 1 42 17 71 29|emmanuel.chartier-kastler@psl.aphp.fr|
20536268|NCT02734004|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20536269|NCT01081262|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
20536270|NCT01393899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536271|NCT02622295|University of Iowa Department of Physical Therapy and Rehabilitation Science|Dr. Richard K. Shields|319-335-9791|richard-shields@uiowa.edu|
20536272|NCT00132301|VA Puget Sound Health Care System|Dr. Bruce Montgomery|206-277-6878|Robert.Montgomery@va.gov|
20536273|NCT00480740|Children's National Medical Center|Dr. Julia Finkel|202-476-4867|jfinkel@childrensnational.org|
20536274|NCT04585269|Rutgers Cancer Institute|Dr. Katie Devine (PI)|7322357549|katie.devine@rutgers.edu|
20536275|NCT04209387|VA Bedford Healthcare System|Mo Modarres, PhD|2164966169|mmodarres@verizon.net|
20536276|NCT00125788|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
20536277|NCT02842086|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20536278|NCT00928187|UMI 233 IRD Montpellier|Dr Laura Ciaffi|00237 694926786|lauraciaffi2002@yahoo.fr|
20536279|NCT01144624|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
20536280|NCT02524145|University of Texas Southwestern Medical Center|Dr. Satyam Sarma|214-345-7111|SatyamSarma2@texashealth.org|
20536281|NCT07214935|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20536282|NCT00316706|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536283|NCT00802997|Baylis Medical|Meghal Khakhar, Director of Regulatory and Scientific Affairs|9056024875|mkhakhar@baylismedical.com|
20536284|NCT04357730|Denver Health Medical Center|Dr. Ernest Moore, Director of Surgical Research|3036021820|ernest.moore@dhha.org|
20536285|NCT03640325|Dana-Farber Cancer Institute|Dr Abby Rosenberg|617.632.5286|abbyr_rosenberg@dfci.harvard.edu|
20536286|NCT05112679|University of Pittsburgh|Sashwati Roy, PI|412 6240422|sar453@pitt.edu|
20536287|NCT05730725|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20536288|NCT05265728|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20536289|NCT03493451|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536290|NCT03046927|University of Mass Medical|Benjamin U. Nwosu, MD|5083406936|bnwosu1@northwell.edu|
20536291|NCT01133756|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20536292|NCT02234713|Hospital for Sick Children|Dr. Ann Yeh|416-813-7353|ann.yeh@sickkids.ca|207353
20536293|NCT03574610|Houston Methodist Hospital|Rose Khavari, MD|7134419118|rkhavari@houstonmethodist.org|
20536294|NCT03501992|Mayo Clinic|Robert M Jacobson, MD|507-250-4576|jacobson.robert@mayo.edu|
20536295|NCT03941873|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20536296|NCT03276728|Amgen (EUROPE) GmbH|IHQ Medical Info-Clinical Trials|866-572-6436|MedInfoInternational@amgen.com|
20536297|NCT02415244|University of Iowa Hosptials and Clinics|Kenichi Ueda|3193562633|kenichi-ueda@uiowa.edu|
20536298|NCT01234480|Becton Dickinson|Karen Yanson|410-316-4793|karen_a_yanson@bd.com|
20536299|NCT02982772|Florida International University|Maria Jose Miguez|561-839-0223|mjmiguez@fiu.edu|
20536300|NCT02974140|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20536301|NCT00617084|Medtronic Bakken Research Center B.V.|Miraida Weldam|+ 31 43 356|miraida.weldam@medtronic.com|6652
20536302|NCT03370419|Wayen State University|Heather Fritz|313-577-9499|heather.fritz@wayne.edu|
20536303|NCT06219967|SUNY Upstate Department of Emergency Medicine|Michael Keenan, MD|315-416-4457|keenanm@upstate.edu|
20536304|NCT05875727|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536305|NCT00310375|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536306|NCT04169529|Medtronic|Andy St. Martin|(952) 220-4009|andy.stmartin@medtronic.com|
20536307|NCT03726658|Gate Neurosciences, Inc|Chief Medical Officer|203-247-3895|ron.burch@gateneuro.com|
20536308|NCT00412958|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
20536309|NCT01318135|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20536310|NCT01017042|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20536311|NCT01152788|NCIC Clinical Trials Group|Dr. Janet Dancey|1-613-533-6430|jdancey@ctg.queensu.ca|
20536312|NCT00598507|H. Lee Moffitt Cancer Center and Research Institute|Ronald DeConti, M.D., Principal Investigator|813-745-8466|ronald.deconti@moffitt.org|
20536313|NCT04767061|Weill Cornell Medicine|Princess Osma|646-962-5910|pro4001@med.cornell.edu|
20536314|NCT03782064|Beth Israel Deaconess Medical Center|Emma Logan, Director of Research Nursing|6176675984|eklogan@bidmc.harvard.edu|
20536315|NCT00363142|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536316|NCT02137447|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|6177248604|dyeh2@partners.org|
20536317|NCT00604552|Medtronic Vascular|Angela Parsons|707-591-2293|angela.r.parsons@medtronic.com|
20536318|NCT00049322|University of California Los Angeles|Carolyn Britten, M.D.|310 829 4971|cbritten@mednet.ucla.edu|
20536319|NCT03994211|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536320|NCT02625220|Johnson & Johnson Vision Care Inc.|Benjamin Straker, BAppSc(Optom)(HonS) Principal Research Optometrist|904-443-3500|Bstraker@ITS.JNJ.com|1380
20536321|NCT01140867|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
20536322|NCT01926444|PCC INC.|Patrick Colin|514-586 9297|PCOLIN@VIDEOTRON.CA|
20536323|NCT00881530|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20536324|NCT01272037|SWOG Statistics and Data Management Center|Breast Committee Statistician|206-667-4623|dlew@fredhutch.org|
20536325|NCT02880228|Mayo Clinic|Shaji K Kumar MD|5072842511|kumar.shaji@mayo.edu|
20536326|NCT03035864|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20536327|NCT03163134|University of Pittsburgh|Benita Valappil|412.864.1744|valappilb2@upmc.edu|
20536328|NCT02720523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20536329|NCT02340169|Taro Pharmaceuticals|Senior Director, Clinical Research|+1 914-345-9001|natalie.yantovskiy@taro.com|
20536330|NCT01890265|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|067study@fibrogen.com|
20536331|NCT01158820|Department of Anesthesiology & Critical Care|Jeff E Mandel MD MS|2156150553|mandelj@uphs.upenn.edu|
20536332|NCT06006078|Cleveland Clinic Foundation|Dr. John Vargo|2164455012|vargoj@ccf.org|
20536333|NCT05102383|The Ohio State University College of Optometry|Jennifer Fogt, OD MS|16142928858|OPTEyeStudies@osu.edu|
20536334|NCT05069012|Beth Israel Deaconess Medical Center|Philip Hess|617-667-3112|phess@bidmc.harvard.edu|
20536335|NCT00100802|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
20536336|NCT02709720|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20536337|NCT01941927|University of California, San Francisco|Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
20536338|NCT03079531|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
20536339|NCT00648648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20536340|NCT06590441|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
20536341|NCT02683980|Boston Scientific|Clinical Program Manager|612-322-1189|teri.bird@bsci.com|
20536342|NCT06875284|RTI International|Marni Kan, PhD|919-248-1836|mkan@rti.org|
20536343|NCT06631274|Florida State University|Dr. Lyndsay Jenkins|(850) 644-4592|lnjenkins@fsu.edu|
20536344|NCT03896750|Alliance for Multispecialty Research|William Smith, MD|(865) 305-9100|william.smith@amrllc.com|
20536345|NCT04266912|M.D. Anderson Cancer Center|Timothy A. Yap|713-563-1930|tyap@mdanderson.org|
20536346|NCT00626782|Wills Eye Hospital|Prinicipal Investigator|484-434-2700|mpro2020@yahoo.com|
20536347|NCT01238991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536348|NCT03573206|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
20536349|NCT00276406|Mayo Clinic|Adil E. Bharucha, MD|507-284-6439|bharucha.adil@mayo.edu|
20536350|NCT00662831|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20536351|NCT01961297|Icahn School of Medicine at Mount Sinai|Dr. Kristina Simonyan|212-241-0656|kristina.simonyan@mssm.edu|
20536352|NCT02482298|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 10 00||
20536353|NCT00960401|Winthrop-University Hospital, Division of Hematology and Oncology|Dr. Alexander Hindenburg|516-663-9500|AHindenburg@winthrop.org|
20536354|NCT01685242|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20536355|NCT01188551|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
20536356|NCT01794312|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
20536357|NCT02569476|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536358|NCT01071954|Amgen (EUROPE) GmbH|IHQ Medical Info-Clinical Trials||MedInfoInternational@amgen.com|
20536359|NCT01434654|St Vincent's Hospital, Sydney|Prof. Bruce Brew|+61 2 8382 1111|b.brew@unsw.edu.au|4100
20536360|NCT00703963|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7068|schaff@mayo.edu|
20536361|NCT02528942|Thomas Jefferson University|Yevgeniy Vinogradskiy PhD|2159553605|yevgeniy.vinogradskiy@Jefferson.edu|
20536362|NCT03900728|Columbia University Irving Medical Center|Carolyn Westhoff, MD|2123057070|clw3@cumc.columbia.edu|
20536363|NCT02100930|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
20536364|NCT00763256|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
20536365|NCT03751371|The Ohio State University|Anne Kloos|614-688-5942|kloos.4@osu.edu|
20536366|NCT00517010|University of California Davis|Susanna Park MD PhD|916-734-6074|sscpark@ucdavis.edu|
20536367|NCT00906178|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1-801#
20536368|NCT02969915|Johns Hopkins University|Gregory M. Lucas|410 614 0560|glucas@jhmi.edu|
20536369|NCT00995436|ChestyerfieldNDRH|Jonathan Sandler|01246512106|JonSandler57@gmail.com|
20536370|NCT01740258|Duke University|Annick Desjardins, MD, FRCPC|919-681-1691|annick.desjardins@duke.edu|
20536371|NCT00418093|Dana-Farber Cancer Institute|Neil Horowitz, MD|617-732-8843|nhorowitz@partners.org|
20536372|NCT03506412|Mayo Clinic|Naveen L. Pereira, M.D.|507-284-8612|Pereira.Naveen@mayo.edu|
20536373|NCT00289289|Medtronic CRDM Clinical|Jen Lahr||jen.lahr@medtronic.com|
20536374|NCT00577707|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
20536375|NCT03299244|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20536376|NCT03146663|NuCana Plc|Medical and Scientific Affairs Department|01313571116|info@nucana.com|
20536377|NCT03666988|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20536378|NCT05588440|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
20536379|NCT01154452|Memorial Sloan Kettering Cancer Center|Dr. Mrinal Gounder|646-888-4167|gounderm@mskcc.org|
20536380|NCT00962871|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20536381|NCT03706430|Masimo|Dr. William C. Wilson, CMO, SVP|949-297-7000|william.wilson@masimo.com|
20536382|NCT00145626|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
20536383|NCT01392573|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20536384|NCT00436436|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
20536385|NCT02132572|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20536386|NCT01682356|Washington University School of Medicine|Linda R. Peterson, MD|314-362-4577|lpeterso@wustl.edu|
20536387|NCT05823974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20536388|NCT02744612|City of Hope Medical Center|Dr. Alex Herrera, MD|6263598111|aherrera@coh.org|
20536389|NCT04956731|University of California, San Diego|Office of Clinical Trials Administration|858-822-2940|octa@ucsd.edu|
20536390|NCT00283803|University of Washington|Dr. Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
20536391|NCT01127607|Florida International University|Dr. James Waxmonsky|717 531 8646|jwaxmons@fiu.edu|
20536392|NCT02220855|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
20536393|NCT03419897|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20536394|NCT02052661|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536395|NCT04105738|University of Massachusetts|Arlene Williams|508-856-5584|arlene.williams@umassmed.edu|
20536396|NCT01945216|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20536397|NCT04473950|University of California, San Francisco|David Andrew Tompkins, MD, MHS|628-206-3645|david.tompkins@ucsf.edu|
20536398|NCT01541735|Instituto Mexicano del Seguro Social|PhD. Manuel González Ortiz|33 36176000|uiec@prodigy.net.mx|31494
20536399|NCT01664117|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20536400|NCT01905943|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20536401|NCT00416494|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
20536402|NCT02574078|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20536403|NCT02222688|University of California, San Diego|Thomas Kipps, MD, PhD|858-534-5400|tkipps@ucsd.edu|
20536404|NCT05935878|University of Oxford, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences|Professor David W Murray|+44 01865 27457|david.murray@ndorms.ox.ac.uk|
20536405|NCT03980743|Washington University School of Medicine|Dr. Ginger E. Nicol|314-747-1862|nicolg@wustl.edu|
20536406|NCT04248712|Mayo Clinic|Dawn Francis, M.D.|904-953-2254|Francis.Dawn@mayo.edu|
20536407|NCT00294671|Amyloidosis Center, Boston Medical Center|Dr. John L. Berk|617-638-4494|jberk@bu.edu|
20536408|NCT01966354|Complejo Hospitalario de Navarra|Dr. Mikel Batllori|0034 848422174|mikel.batllori.gaston@cfnavarra.es|
20536409|NCT00332579|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
20536410|NCT02476032|University of Minnesota|Patricia Lenton Director of Oral Health Research Clinic||lento001@umn.edu|
20536411|NCT02140970|University of Colorado|Dr. Kyle Rove|720 777 5893|kyle.rove@childrenscolorado.org|
20536412|NCT05069597|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20536413|NCT00735553|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20536414|NCT02705105|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20536415|NCT00422448|Medical University of Graz - Austria|Prof. Dr. Iris Zalaudek|+436763328269|iris.zalaudek@gmail.com|
20536416|NCT04556591|University of Michigan|Dr. Noelle E. Carlozzi|734-764-0644|PMR-CODAlab@med.umich.edu|
20536417|NCT03332173|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536418|NCT02553928|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
20536419|NCT01485796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20536420|NCT04830215|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20536421|NCT02440139|Virginia Tech|Dr. ShihChung Benedict Lo|301-9215754|benlo@vt.edu|
20536422|NCT03754556|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20536423|NCT00211172|Kaiser Permanente Center for Heatlh Research|David H. Smith|503-335-6302|david.h.smith@kpchr.org|
20536424|NCT02509936|"Wuqu' Kawoq | Maya Health Alliance"|Dr Peter Rohloff|6174473034|peter@wuqukawoq.org|
20536425|NCT00770562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20536426|NCT01643408|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20536427|NCT03697161|Ovid Therapeutics|Todd F. Baumgartner, M.D., MPH|8027525168|tbaumgartner@ovidrx.com|
20536428|NCT00292045|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20536429|NCT04474197|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20566553|NCT04608409|University of Kentucky|Dr. Frederick Ueland|859-257-1613|frederick.ueland@uky.edu|
20566554|NCT02927249|Dana Farber Cancer Institute|Wendy Chen|617-632-3800|Wendy_chen@dfci.harvard.edu|
20566555|NCT03712371|Medical University of South Carolina, Hollings Cancer Center, Clinical Trials|Alan Brisendine, CCRP, Manager, Sponsor-Investigator Support Unit|843-792-9007|brisend@musc.edu|
20566556|NCT02723929|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|Fregni.felipe@mgh.harvard.edu|
20566557|NCT05462912|UC Davis Orthopaedic Surgery|Eric Giza, MD|916-734-6805|egiza@ucdavis.edu|
20566558|NCT00229658|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20566559|NCT02157116|Duke University|Richard Riedel, MD|919-681-6932|richard.riedel@duke.edu|
20566560|NCT00975585|Vistakon|Sheila Hickson-Curran, MCOptom/ Director, Medical Affairs|904-443-1754||
20566561|NCT01953224|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
20566562|NCT01082575|Covidien|Fran Haury Clinical Program Manager II|303 305-2314|fran.haury@covidien.com|
20536430|NCT00606411|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org|
20536431|NCT00237666|The Medical Research Network, LLC|Dr. Michael Liebowitz|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
20536432|NCT00624468|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20536433|NCT02346643|St. Jude Medical|Roni Diaz|+1 972 309 8601|RDiaz@sjm.com|
20536434|NCT00635349|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
20536435|NCT00645840|UT Southwestern Medical Center|Perrin White|214 648 6875|perrin.white@utsouthwestern.edu|
20536436|NCT01340664|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 908 927-5775||
20536437|NCT03232827|UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR|Dr. Theodore Wagener|405-271-4407|theodore-wagener@ouhsc.edu|50486
20536438|NCT01823198|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Stem Cell Transplantation Department|713-792-3618|rchampli@mdanderson.org|
20536439|NCT01653587|Santa Casa de Marília|Dr. Pedro Beraldo de Andrade|+551434025561|pedroberaldo@gmail.com|
20536440|NCT02691416|The Third Central Clinical College of Tianjin Medical University, Tianjin the Third Central Hospital|Dr.Haiyun Wang|13752211206|why819@126.com|
20536441|NCT03012828|Medicines Development Limited|Sally Kinrade, Vice President (Clinical Development)|+613 9629 6111|sally.kinrade@medicinesdevelopment.com|
20536442|NCT02544750|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20536443|NCT04396795|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Dr Ranjith Ramasamy|305-243-4562|ramasamy@miami.edu|
20536444|NCT01637584|UPittsburgh|Dr. Anne Germain|4123832150|germax@upmc.edu|
20536445|NCT02366923|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
20536446|NCT02484443|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20536447|NCT02595866|HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute|Kathryn Lurain, M.D.|240-858-3257|kathryn.lurain@nih.gov|
20536448|NCT02520388|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
20536449|NCT01232127|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20536450|NCT02375373|University of Florida|Volker Mai, PhD, MPH|352-273-9398|vmai@epi.ufl.edu|
20536451|NCT00200967|Penn State College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
20536452|NCT00980460|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20536453|NCT05696444|Medtronic|Michele Masters, Sr. Clinical Research Program Manager|4848948925|michele.masters@medtronic.com|
20536454|NCT05200572|University of Rochester|Lee Kehoe, Ph.D.|(585) 276-7686|leekehoephd@gmail.com|
20536455|NCT01734785|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20536456|NCT02397915|GlaxoSmithKline|GSK Response Center|866-435-7343||
20536457|NCT03292874|Cedars Sinai Medical Center|Dr. Hyung L Kim|310-423-4700|kimhl@cshs.org|
20536458|NCT00368745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20536459|NCT01308814|University of North Carolina at Chapel Hill|Susan S. Girdler, Ph.D.|919-966-2179|susan_girdler@med.unc.edu|
20536460|NCT00106119|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Kong Chen|3014511636|chenkong@niddk.nih.gov|
20536461|NCT02414607|University of Missouri|Dr. David Beversdorf|(573) 882-6081|beversdorfd@health.missouri.edu|
20536462|NCT03053440|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20536463|NCT01582009|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20536464|NCT02998684|Medical University of South Carolina|Dr. Jane Joseph|843-792-7683|josep@musc.edu|
20536465|NCT00391053|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20536466|NCT02248766|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
20536467|NCT01947283|Disparities Research Unit, Department of Medicine, Massachusetts General Hospital|Margarita Alegria|617-724-4987|malegria@mgh.harvard.edu|
20536468|NCT00430989|Bayside health|Professor Paul Myles|+61390762000|p.myles@alfred.org.au|3176
20536469|NCT05002985|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
20536470|NCT03782259|University of Washington|Francis Kim, MD|206-744-8305|fkim@uw.edu|
20536471|NCT03050450|Johns Hopkins All Children's Hospital (St. Petersburg, FL)|Dr Stacie Stapleton|17274701017|stacie.stapleton@jhmi.edu|
20536472|NCT04077424|Vanderbilt University Medical Center|Spyros Kalams, MD|6153222035|Joan.e.eason@vumc.org|
20536473|NCT00603941|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20536474|NCT03592771|Emory University|Ilana Graetz, PhD|404-727-1483|ilana.graetz@emory.edu|
20536475|NCT01642901|MetroHealth Rehabilitation Institute|Christina V Oleson, MD|216-778-4414|coleson@metrohealth.org|
20536476|NCT02943070|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
20536477|NCT01014767|Tufts Medical Center|Research Administration|617-636-1142|mcoughlin@tuftsmedicalcenter.org|
20536478|NCT02802293|University of Texas Health -- San Antonio|Felipe S. Salinas, Ph.D.|210-567-8214|salinasf@uthscsa.edu|
20536479|NCT00984165|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
20536480|NCT00131352|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20536481|NCT03024112|University of Colorado, Denver|Dr. Jason Brainard|720-848-3257|Jason.Brainard@ucdenver.edu|
20536482|NCT01771991|Sanford Health|Dr Chad Spanos MD|605-328-8200||
20536483|NCT04381052|Columbia University|David J. Cohen, MD|212-305-3273|djc5@cumc.columbia.edu|
20536484|NCT01399229|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
20536485|NCT03809078|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
20536486|NCT02526212|Montefiore Medical Center-Albert Einstein College of Medicine|Aaron Fox, Principal Investigator|718-920-7173|adfox@montefiore.org|
20536487|NCT01390298|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
20536488|NCT02443337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20536489|NCT02096952|Massachusetts General Hospital|Dr. Gahan Joshi|617-726-8392|joshi.gagan@mgh.harvard.edu|
20536490|NCT00040742|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20536491|NCT02544035|National Institute of Child Health and Human Development|Dr. Diane Putnick|301-496-6291|putnickd@mail.nih.gov|
20536492|NCT00253513|OHSU Knight Cancer Institute|Eneida Nemecek, MD|(503) 494-0829|nemeceke@ohsu.edu|
20536493|NCT01313910|UCaliforniaDavis|David Asmuth, MD|9167348695|david.asmuth@ucdmc.ucdavis.edu|
20536494|NCT02446769|Philips|Chuck Cain|412-542-3605|chuck.cain@philips.com|
20536495|NCT04482439|Newsom Eye and Laser Center|T. Hunter Newsom, MD|813-908-2020|hunter@newsomeye.net|
20536496|NCT01103440|Icahn School of Medicine at Mount Sinai|Dr. Annapoorna S Kini|(212) 241-4181|Annapoorna.Kini@mountsinai.org|
20536497|NCT03072043|Moffitt Cancer Center|David Sallman, MD|813-745-6841|David.Sallman@moffitt.org|
20536498|NCT00402324|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20536499|NCT01277822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20536500|NCT02923531|X4 Pharmacueticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
20536501|NCT00997984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20536502|NCT01569737|HRA Pharma|Christine Adelbrecht, Clinical Trial Coordinator|+33 1 40 33 32 74|c.adelbrecht@hra-pharma.com|
20536503|NCT03786224|Massachusetts General Hospital|Randi Schuster, PhD|617-643-6673|rschuster@mgh.harvard.edu|
20536504|NCT00894699|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20536505|NCT02626156|Medical University of South Carolina|Teresa J. Kelechi|843-792-4602|kelechtj@musc.edu|
20536506|NCT00295646|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
20536507|NCT02243371|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20536508|NCT02441101|University of Iowa|Barry London|319-356-2750|barry-london@uiowa.edu|
20536509|NCT02725476|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|114
20536510|NCT01445613|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20536511|NCT00407602|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director of Clinical and Scientific Affiars|8188335089|jdorn@secondsight.com|
20536512|NCT00431444|Novartis Pharmaceuticals|Study Director|862-778-8300||
20536513|NCT05007899|Nationwide Children's Hospital|Chelsea Kebodeaux|(614) 722-2250|Chelsea.Kebodeaux@nationwidechildrens.org|
20536514|NCT02368093|Taichung Veterans General Hospital|Der-Yuan Chen|884-4-23592525|dychen@vghtc.gov.tw|3354
20536515|NCT01763333|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20536516|NCT02517398|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
20536517|NCT01166347|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
20536518|NCT03541499|Vanderbilt Vaccine Research Program|Dr. C Buddy Creech|615-3430332|buddy.creech@vanderbilt.edu|
20536519|NCT02131662|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20536520|NCT03554018|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20536521|NCT01618240|Massachusetts General Hospital|Hooman Mirzakhani|617-291-9779|hmirzakhani@partners.org|
20536522|NCT02142803|Dana Farber Cancer Institute|Christine Sceppa McCluskey|617-632-5394|christine_sceppa@dfci.harvard.edu|
20536523|NCT00130039|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
20536524|NCT01562886|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
20566563|NCT00683800|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566564|NCT04053270|CLINUVEL PHARMACEUTICAL LIMITED|Dr. Dennis Wright|+ 61 3 9660 4900|mail@clinuvel.com|
20566565|NCT04941703|University of Maryland School of Medicine|Wonder Drake|410-710-1412|WDrake@som.umaryland.edu|
20566566|NCT00463229|McMaster University|Maureen Markle-Reid|905-525-9140|mreid@mcmaster.ca|22306
20566567|NCT00455650|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
20566568|NCT04033315|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
20566569|NCT03552276|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
20536525|NCT01016132|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20566570|NCT03502447|Sight Sciences, Inc.|VP Medical & Clinical Affairs|877-266-1144|info@sightsciences.com|
20536526|NCT01198574|South East Asia Ministers of Education Organization, Regional Center for Food and Nutrition|Dr. Min Kyaw Htet, Township Health Officer, Ministry of Health, Myanmar|+62-857-27262672|kyawhtet@gmail.com|
20536527|NCT00556439|Cleveland Clinic|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
20536528|NCT02100423|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Paolo Caimi|1-800-641-2422|paolo.caimi@uhhospitals.org|
20536529|NCT03759639|IntraBio Ltd|Taylor Fields, Chief Product Development Officer|+44 8081 641283|tfields@intrabio.com|
20536530|NCT00958360|Hines VA Blind Center|Joan Stelmack, O.D., M.P.H.|708-202-2124|joan.stelmack@va.gov|
20536531|NCT03107052|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20536532|NCT03015363|CardioVascular Research New Brunswick (CVR-NB)|Sohrab Lutchmedial, MD, FRCP(C)|506-648-6101|sohrab.lutchmedial@horizonnb.ca|
20536533|NCT00078806|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20536534|NCT02200757|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20536535|NCT02013778|University of Pennsylvania|Gregory Nadolski, MD, Principal Investigator|215-662-7892|gregory.nadolski@pennmedicine.upenn.edu|
20536536|NCT02331589|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
20536537|NCT02719691|University of Colorado|Jennifer Diamond, MD|303-724-5499|jennifer.diamond@cuanschutz.edu|
20536538|NCT01658709|University of Kentucky|Phillip Gribble|8592180885|phillip.gribble@uky.edu|
20536539|NCT00861757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20536540|NCT04397939|Mount Sinai Hospital|Annapoorna S Kini, M.D.|(212) 241-4181|annapoorna.kini@mountsinai.org|
20536541|NCT00776594|Dana Farber Cancer Institute|Mary-Ellen Taplin, MD|617-632-6328|Mary_taplin@dfci.harvard.edu|
20566571|NCT02406092|Hoffman-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20566572|NCT03041233|Abbott|Clinical Scientist|7639541350|emily.jesser@abbott.com|
20566573|NCT05783843|Wake Forest University School of Medicine|Erin L. Sutfin, PhD|336-713-5282|esutfin@wakehealth.edu|
20566574|NCT00853593|Medtronic, Inc|4396 Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62808
20566575|NCT04200664|Ear Institute, University College London|Dr N Kharytaniuk (Clinical Research Fellow)|02076792000|n.kharytaniuk@ucl.ac.uk|
20566576|NCT02586857|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20566577|NCT06193590|Indiana University Health|Dr. Alissa M Conklin|317.944.8231|alconkli@iu.edu|
20566578|NCT03362190|IVERIC bio, Inc|Hersh Patel, OD / Zimura Medical Director|609-474-6755|clinicaltrials@ivericbio.com|
20566579|NCT00687219|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20566580|NCT04816955|Bournemouth University|Dr Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
20566581|NCT02707198|Whiteside Institute for Clinical Research/St. Luke's Hospital Duluth|Lynsie Radovich, PhD|216-726-7940|lradovic@d.umn.edu|
20566582|NCT01367236|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
20566583|NCT02235298|University of Miami|Gianluca Iacobellis, MD|305-243-3636|giacobellis@miami.edu|
20566584|NCT04960813|Columbia University|Kate D. Fitzgerald|646-774-5681|kf2688@cumc.columbia.edu|
20566585|NCT02227706|ETHICON Inc|Patricia Schleckser|9082182244|pschleck@its.jnj.com|
20566586|NCT01732120|Washington University School of Medicine|Manager of Clinical Trials|3147479781|klima@wustl.edu|
20566587|NCT00914966|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20566588|NCT04038580|University of Michigan|Dr. Deanna Gates|7346472698|gatesd@umich.edu|
20566589|NCT04021862|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566590|NCT04300023|University of Wisconsin - Madison|Kristen Pickett, PhD|(608) 890-2103|Kristen.pickett@wisc.edu|
20566591|NCT04057131|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20566592|NCT05251363|BIOTRONIK, Inc.|Crystal Miller|(503) 475-4984|crystal.miller@biotronik.com|
20566593|NCT03835754|TransMedics, Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
20566594|NCT02830204|Baylor Scott and White Research Institute|Walter Cerqueira|469-814-3393|walter.cerqueira@bswhealth.org|
20566595|NCT02921555|Grupo Español de Trabajo en Enfermedad de Crohn y colitis Ulcerosa|Dr. Eugeni Domènech|635899553|soporte@geteccu.org|
20566596|NCT03861052|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20566597|NCT04612868|AEYE Health Inc.|Zack Dvey-Aharon, PhD|8662627343|info@aeyehealth.com|
20566598|NCT01410409|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
20566599|NCT02683174|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
20566600|NCT04566861|Johns Hopkins Bloomberg School of Public Health|Dr. Pamela Surkan|4105027396|psurkan@jhu.edu|
20566601|NCT00504023|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi, MD|212-639-5016|chid@mskcc.org|
20566602|NCT02639637|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153644022|nancy.j.brown@vanderbilt.edu|
20566603|NCT00205179|University of Wisconsin|Dr. Carey Gleason|608-280-7000|ceg@medicine.wisc.edu|
20566604|NCT01359150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566605|NCT01700205|Monell Chemical Senses Center|Julia A. Mennella, PhD|267-519-4880|mennella@monell.org|
20566606|NCT01728324|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566607|NCT01619059|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762484
20566608|NCT03578965|Washington University School of Medicine|Mary M. Mullen, M.D.|314-655-8750|marymullen@wustl.edu|
20566609|NCT01787032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566610|NCT02040870|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20566611|NCT00388726|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20566612|NCT04971733|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20566613|NCT03229408|University of Illinois at Chicago|Frank González|(312) 413-1984|frgz12@uic.edu|
20566614|NCT03745313|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20566615|NCT03292133|Massachusetts General Hospital|Zofia Piotrowska, MD|6176439707|Zofia.Piotrowska@MGH.HARVARD.EDU|
20566616|NCT01706159|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20566617|NCT02454959|Pearl Therapeutics, Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20566618|NCT03611075|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20566619|NCT01701401|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20566620|NCT02962102|Brigham and Women's Hospital|Dr. David Leaf|617-525-7612|deleaf@bwh.harvard.edu|
20566621|NCT02823028|University of California Irvine|Professor Cornelia Pechmann|3108920619|cpechman@uci.edu|
20566622|NCT06211530|GE HealthCare|Principal Engineer|+358 (40) 7755194|100012917@gehealthcare.com|
20566623|NCT05807074|University of California, San Francisco|Dr. Merisa Piper, MD|(415) 353-4320|Merisa.Piper@ucsf.edu|
20566624|NCT05785832|Tandem Diabetes Care|Sr. Supervisor of Clinical Operations|18583666900|clinicalaffairs@tandemdiabetes.com|
20566625|NCT04445831|AC Immune|Olivier Sol|+41 21 345 91 21|clinicaltrials@acimmune.com|
20566626|NCT03268421|Cincinnati Children's Hospital|Susmita Kashikar-Zuck, PhD|513-636-6337|susmita.kashikar-zuck@cchmc.org|
20566627|NCT05613907|Leeds Vascular Institute|Dr Assad Khan|0113|assad.khan3@nhs.net|
20566628|NCT04728711|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20566629|NCT05080777|University of Connecticut Center on Aging|Dr. Richard Fortinsky|860-679-8069|fortinsky@uchc.edu|
20566630|NCT04705415|NeurobBo|Sr. Vice President Clinical Operations|8572991035|crinfo@neurobopharma.com|
20566631|NCT03789656|Crinetics Pharmaceuticals, Inc|Crinetics Clinical Trials|+1 858-450-6464|clinicaltrials@crinetics.com|
20566632|NCT01586104|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. David Walterhouse|3122274000|d-walterhouse@northwestern.edu|
20566633|NCT02473276|Columbia University|Richard Smiley|212 305 5006|rms7@cumc.columbia.edu|
20566634|NCT06214052|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20566635|NCT05325294|Medtronic Diabetes|Fang Niu, Sr Statistician|8185763319|fang.niu@medtronic.com|
20566636|NCT03110575|Tonix Pharmaceuticals|Gregory Sullivan, MD|862-904-0355|greg.sullivan@tonixpharma.com|
20566637|NCT04701203|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
20566638|NCT04577651|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20566639|NCT02842749|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20566640|NCT05293717|University of Rochester|Anna De Benedetto, MD|(585) 275-7546|anna_debenedetto@urmc.rochester.edu|
20566641|NCT04202133|University of Pennsylvanai|Dr. Ariana Chao|215-746-7183|arichao@upenn.edu|
20566642|NCT04837937|Northwestern University- Feinberg School of Medicine- Division of Geriatrics|Vanessa Ramirez-Zohfeld|+1 312 503 3916|vanessa-ramirez-0@northwestern.edu|
20566643|NCT05422339|MapHabit|Matt Golden|9143301776|mgolden@maphabit.com|
20566644|NCT04172675|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566645|NCT05029284|University of Minnesota|Dr. Emily Kringle|(612) 624-8994|ekringle@umn.edu|
20566646|NCT03070392|Immunocore, Ltd|Study Director|1-844-IMMUNO-1|clinicaltrials@immunocore.com|
20566647|NCT02972034|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20566648|NCT03009344|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
20566649|NCT00378898|Vanderbilt University Medical Center|Dr. Michael Vaezi|615-322-3739|michael.vaezi@vanderbilt.edu|
20566650|NCT02794428|Vanderbilt-Ingram Cancer Center|Douglas Morgan|615-936-7423|drmorgan@uabmc.edu|
20566651|NCT03560323|University of Texas Health -San Antonio|Yuejuan Qin, Assistant Professor|210-358-7200|qiny@uthscsa.edu|
20566652|NCT01427517|University of Minnesota|Mary Holmay|612-812-5854|holma101@umn.edu|
20566653|NCT02372799|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20566654|NCT01354444|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
20566655|NCT03150875|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
20566656|NCT04652869|University of Pittsburgh|Dr. Cynthia Conklin|4125869840|conkca@upmc.edu|
20566657|NCT00562094|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20566658|NCT01613417|Executive Director, MRI|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
20566659|NCT00019604|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
20566660|NCT01379651|Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy|Dr. Iride Dello Iacono|+39 824 771111|iridedello@hotmail.com|
20566661|NCT00454194|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507-284-9265|alex.adjei@roswellpark.org|
20566662|NCT01556594|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20566663|NCT01703598|Oregon Health & Science University|Matthew Brodsky MD|503-494-9054|brodskym@ohsu.edu|
20566664|NCT01542255|Dartmouth-Hitchcock|Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
20566665|NCT00093496|Mayo Clinic Cancer Center|Charles Erlichman, M.D.||erlichman.charles@mayo.edu|
20566666|NCT00586313|Indiana University Hospital|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
20566667|NCT01932970|Amgen Inc.|Study Director|866-572-6436||
20566668|NCT01979276|Weill Cornell Medical College|Jennifer Hess|646-962-9440|jmh2004@med.cornell.edu|
20566669|NCT03205566|Guy's & St. Thomas' NHS Foundation Trust|Dr Julie Fox|020 7188 7188|julie.fox@gstt.nhs.uk|
20566670|NCT03184987|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20566671|NCT00853580|The University of Alabama at Birmingham|Bruce R. Korf|205.934.9411|bkorf@uabmc.edu|
20566672|NCT01767467|GlaxoSmithKline|GSK Response Center|866-435-7343||
20566673|NCT01085513|Given Imaging|director of clinical affairs|+972-4-9097774|Hila.debby@givenimaging.com|
20566674|NCT03542305|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566675|NCT01335867|University of Pennsylvania Treatment Research Center|Kyle M. Kampman, M.D.|215 746 2764|kampman@pennmedicine.upenn.edu|
20566676|NCT00748982|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20566677|NCT03113409|NYS Psychiatric Institute|Adam Bisaga MD|646-774-6155|adam.bisaga@nyspi.columbia.edu|
20566678|NCT00176202|University of Illinois at Chicago|Dr Mani Pavuluri|3124130064|mpavuluri@psych.uic.edu|
20566679|NCT00731614|San Francisco VA Medical Center|John R. McQuaid, Ph.D.|415-221-4810|john.mcquaid@va.gov|4106
20566680|NCT01160354|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jan Burger, Associate Professor, Leukemia|7137927734|CR_Study_Registration@mdanderson.org|
20566681|NCT01006538|King's College Hospital, London|Mr Tim Jackson|+44 2032999000|t.jackson1@nhs.net|1297
20566682|NCT00600353|University of Kansas Medical Center|Dr. Omar Aljitawi|913-588-6029|oaljitawi@kumc.edu|
20566683|NCT04941482|Hanoi Medical University|Dr. Thao Thi Phuong Nguyen|+84916911897|dr.nguyenthiphuongthao.hmu@gmail.com|
20566684|NCT04827732|Washington University School of Medicine|Dr. Michael Waters|314-747-7236|m.r.waters@wustl.edu|
20566685|NCT01690624|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566686|NCT03024866|Xoft Inc.|Robert Burnside|14084931533|rob.burnside@elekta.com|
20566687|NCT01804166|Janssen Scientific Affairs, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566688|NCT05001139|Relife Srl|Prof. Giuseppe Micali|05556809528|lfabbri@relifecompany.it|
20566689|NCT02434328|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
20566690|NCT00491894|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20566691|NCT01563185|Horizon Pharma|Julie Ball, Senior Director of Clinical Development & Operations|224-383-3059|jball@horizonpharma.com|
20566692|NCT03427463|Medical University of South Carolina|Katherine Hatter, M.D.|(843) 792-5454|herbertk@musc.edu|
20566693|NCT01278030|St. Jude Medical|John Gill|818-493-2609|jgill@sjm.com|
20566694|NCT02949297|Endologix, LLC|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
20566695|NCT00458783|Cleveland Clinic|Andra Duncan, MD|216-445-2372|duncana@ccf.org|
20566696|NCT01737398|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20566697|NCT06307457|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566698|NCT00089609|National Cancer Institute, National Institutes of Health|Ravi Madan, M.D.|301-480-7168|rm480i@nih.gov|
20566699|NCT03706261|Columbia University|Adam M. Brickman, PhD|212-342-1348|amb2139@cumc.columbia.edu|
20566700|NCT05815342|Insulet Corporation|Dr. Trang Ly|9786007628|Tly@insulet.com|
20566701|NCT03116464|VA New York Harbor Healthcare System|Dr. Cory K. Chen|212-686-7500|cory.chen@va.gov|4002
20566702|NCT00747006|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20566703|NCT00357994|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20566704|NCT01655563|Hospital for Sick Children|Dr. Seema Mital|416-813-7418|seema.mital@sickkids.ca|207418
20566705|NCT00345046|Indiana University|Louis B. Cantor|317-278-2651|lcantor@iupui.edu|
20566706|NCT03559205|Keele University|Jonathan Hill|01782 733900|j.hill@keele.ac.uk|
20566707|NCT03689946|Cedars-Sinai Medical Center|Daniel Berman|310-423-4224|daniel.berman@cshs.org|
20566708|NCT01555138|Novartis Pharmaceuticals|Study Director|862-778-8300||
20566709|NCT03220724|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20566710|NCT01583868|Bausch Health|Study Director||robert.steffen@bausch.com|
20566711|NCT00599196|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20566712|NCT02522104|Addmedica|Medical director|+33 1 72 69 01 86|corinne.duguet@addmedica.com|
20566713|NCT04689932|Rockwell Medical|Raymond D Pratt, MD|2489609009|rpratt@rockwellmed.com|
20566714|NCT03345979|Alkermes, Inc|Eva Stroynowski|7816097000|eva.stroynowski@alkermes.com|
20566715|NCT00620854|Tarsa Therapeutics, Inc.|Thomas Wicks, Ph.D., Vice-President Global RA/QA|267 273 7946|twicks@tarsatherapeutics.com|
20566716|NCT01354145|Bioiberica|Marta Herrero - Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
20566717|NCT00734578|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20566718|NCT00999596|Philips Healthcare|Sarah Baxter or Linda Jalbert|425-487-7665 / 978-659-7434|sarah.baxter@philips.com, linda.jalbert@philips.com|
20566719|NCT02095145|University of Wisconsin Carbone Cancer Center|David Jarrard|608-262-0759|jarrard@urology.wisc.edu|
20566720|NCT02085941|Brigham & Women's Hospital/Dana-Farber Cancer Institute|Thomas C. Lee, MD|617-732-7260|tchlee@bwh.harvard.edu|
20566721|NCT03447912|George Washington University|Carla Berg, PhD, MBA, LP|202-994-0168|carlaberg@email.gwu.edu|
20566722|NCT01477177|Mayo Clinic|Herbert C. Wolfsen, M.D.|904-953-6319|Wolfsen.Herbert@mayo.edu|
20566723|NCT01351376|Rehabilitation Medicine, New York University School of Medicine|Tara Denham, MD|212 263 8240|Tara.Denham@nyumc.org|
20566724|NCT01170208|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
20566725|NCT02483468|Ralph H. Johnson VA Medical Center, Charleston, SC & Medical University of South Carolina|Jeffrey J Borckardt, PhD|843.792.3295|borckard@musc.edu|
20566726|NCT03335488|Horizon Therapeutics, LLC|Horizon Therapeutics, LLC|866-479-6742|clinicaltrials@horizontherapeutics.com|
20566727|NCT03849066|University of Colorado Denver|James Feinstein, MD, MPH, Principal Investigator|303-724-4186|james.feinstein@cuanschutz.edu|
20566728|NCT03805672|Oregon Health & Science University|Samantha Underwood|503-494-8481|underwos@ohsu.edu|
20566729|NCT00641537|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20566730|NCT03758742|University of Alabama at Birmingham|Dr. Courtney M. Peterson|205-934-0122|cpeterso@uab.edu|
20536542|NCT01521923|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20566731|NCT02743819|University of Chicago|Daniel Olson, Clinical Instructor|773-834-4183|daniel.olson2@uchospitals.edu|
20566732|NCT03389802|PediatricBTC|Catherine Billups|901-595-3370|catherine.billups@stjude.org|
20566733|NCT02426138|University of North Carolina at Chapel Hill|Dr. Seth A. Berkowitz|919-966-2276|seth__berkowitz@med.unc.edu|
20566734|NCT03387189|HealthPartners|Kamalini Das|651-293-8233|Kamalini.X.Das@HealthPartners.Com|
20566735|NCT04677738|Morinaga Milk Industry Co., Ltd.|Director of Clinical Trials|+81-46-252-3067|izen-ri138@morinagamilk.co.jp|
20566736|NCT02502461|Dept. of Anesthesia, University of Saskatchewan|Dr. William P. McKay|306 655 1202|bill.mckay@usask.ca|
20566737|NCT03697603|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20566738|NCT00553332|The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute|Tanios Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
20566739|NCT04119063|Northern Arizona University|Zach Lerner, Associate Professor|928-523-1787|Zachary.Lerner@nau.edu|
20566740|NCT03520036|Mitsubishi Tanabe Pharma Development America, Inc.|Clinical Trials, Information Desk|888-449-2670|information@mt-pharma-us.com|
20566741|NCT01536366|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|jose.rocha@bial.com|
20566742|NCT00467272|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|iraad@mdanderson.org|
20566743|NCT00145470|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20566744|NCT04762277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566745|NCT05824559|MEI Pharma|Richard Ghalie, MD CMO|619 990-1153|rghalie@meipharma.com|
20566746|NCT02954432|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|Fregni.felipe@mgh.harvard.edu|
20566747|NCT05885763|CSL Vifor|Milica Enoiu|+41 58 851 82 64|milica.enoiu@viforpharma.com|
20566748|NCT04912856|Xenon Pharmaceuticals|Dr. Noam Butterfield|604 484 3300|nbutterfield@xenon-pharma.com|
20566749|NCT00647387|Abbott Structural Heart|Ryan Palmer, Director of Clinical Programs|+1 651-202-8362|ryan.palmer@abbott.com|
20566750|NCT03147287|Dana-Farber Cancer Institute|Project Manager|617-632-3800|ctopm@dfci.harvard.edu|
20566751|NCT03850379|Henry Ford Health|Shatha Farhan|3137133910|sfarhan1@hfhs.org|
20566752|NCT02534233|Johns Hopkins Hospital|Dr Marcia Canto, Director of Clinical Research|443-287-8083|mcanto1@jhmi.edu|
20566753|NCT00925548|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20566754|NCT04456413|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|Joshua.Zenreich@hmhn.org|
20566755|NCT01372085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20566756|NCT03819543|University of Manitoba|Dr. Marcus Ng|204-787-2684|marcus.ng@umanitoba.ca|
20566757|NCT00047385|Early Detection Research Group, NCI, NIH|Christine D. Berg, M.D.|301-496-8544|bergc@mail.nih.gov|
20566758|NCT03865732|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20566759|NCT00252382|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
20566760|NCT01545583|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20566761|NCT01509183|Propeller Health|Research Team at Propeller Health|9545369563|leanne.kaye@propellerhealth.com|
20566762|NCT03783936|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
20566763|NCT01009645|Northwestern University|Kenzie Cameron, PhD, MPH|312-503-3910|kcameron@northwestern.edu|
20566764|NCT01218048|University of Pittsburgh Cancer Institute|Robert Ferris, MD, PhD|412-623-3205|ferrrl@upmc.edu|
20566765|NCT03883724|UPittsburgh|Shachi Tyagi|4126471274|sht55@pitt.edu|
20566766|NCT03187678|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
20566767|NCT01786876|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20566768|NCT00795184|Mauna Kea Technologies|Christophe Bailleul|+ 33 1 70 08 09 74|christopheb@maunakeatech.com|
20566769|NCT03781375|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20566770|NCT02079649|Alcon Research, Ltd.|Clinical Project Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20566771|NCT03760913|OliPass Corporation|OliPass Call Center|82-2-6488-2200|clinicaltrials.inquiries@olipass.com|
20566772|NCT00229970|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20566773|NCT03739866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20566774|NCT01968967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566775|NCT03489369|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
20566776|NCT02785159|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20566777|NCT02203799|Baylor College of Medicine|Carla M. Davis, MD|832-824-1319|carlad@bcm.edu|
20566778|NCT02168309|Central Coast Perinatology|Kathryn Sharma|8058980258|katy.jones@gmail.com|
20566779|NCT01604824|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20566780|NCT02630966|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20566781|NCT01801007|MicroVention, Inc., A TERUMO Group Company|Senior Manager, Clinical Quality Compliance and Clinical Operations|714-247-8000|jennifer.jelf@microvention.com|
20566782|NCT00665392|GERCOR|Regulatory Affairs|+33 (0)1 40 29 85 00|regulatory.affairs@gercor.com.fr|
20566783|NCT05414682|University of Kansas Medical Center|Dr. Ashley Shaw|913-945-5023|ashaw10@kumc.edu|
20566784|NCT00003459|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20566785|NCT03340415|CUHK|Dr Samuel Ling|35052010|samuel-kk-ling@alumni.cuhk.net|
20566786|NCT01683409|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20566787|NCT05350501|Enterome|Dr Jan Fagerberg|+33175772785|info@enterome.com|
20566788|NCT04218864|Women & Infants Hospital|Dr. Caron Zlotnick|4014743332|czlotnick@butler.org|
20566789|NCT03637296|New York State Psychiatric Institute|Thomas Smith, MD|(646)774-8442|thomas.smith@nyspi.columbia.edu|
20566790|NCT00873782|University of North Carolina at Chapel HIll|William J. Powers, MD|919 966 8178|powersw@neurology.unc.edu|
20566791|NCT06110546|The University of Texas Health Science Center at Houston|Pascal Kingah, MD,MPH|713-500-6828|Pascal.L.Kingah@uth.tmc.edu|
20566792|NCT04745676|University of Rochester Medical Center, Wilmot Cancer Institute|Research Project Manager|585 410 5044|cait_fallone@urmc.rochester.edu|
20566793|NCT04502472|Inova Health Systems|Anne Whitney Brown, MD|7037763067|anne.brown@inova.org|
20566794|NCT02628106|West China Hospital of Sichuan University|Mr.Zhi-cheng Li|+86 13795581617|wangcaizi2@163.com|
20566795|NCT00676091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566796|NCT03160521|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
20566797|NCT00692185|New York State Psychiatric Institute|Evelyn Attia, MD|212-543-5923|ea12@columbia.edu|
20566798|NCT00933270|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
20566799|NCT00989196|Octapharma AG|Dr. Sigurd Knaub|+41 554512141|sigurd.knaub@octapharma.com|
20566800|NCT03975400|northwell|Michael Birnbaum|718-470-8305|mbirnbaum@northwell.edu|
20566801|NCT02734355|Research Institute for Complex Problems of Cardiovascular Diseases, Russia|Dr. Sergey Mamchur|+73842643308|reception@kemcardio.ru|
20566802|NCT02409680|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
20566803|NCT05366751|Sage Therapeutics|Carrie Vaudreuil|+1-857-259-4766|carrie.vaudreuil@sagerx.com|
20566804|NCT01850355|Massachusetts General Hospital|Dr. Gagan Joshi|617-724-1541|joshi.gagan@mgh.harvard.edu|
20566805|NCT04906057|Cleveland Clinic|Donayja Harris|2164454125|harrisD47@ccf.org|
20566806|NCT05395351|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566807|NCT06072170|Altasciences|Senior Regulatory Affairs Associate|450 973 3155|mgalarza@altasciences.com|112084
20566808|NCT03678688|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20566809|NCT03136159|Loyola University Medical Center|Dr Jean Goodman|7082165459|Jrgoodman@lumc.edu|
20566810|NCT00489554|GlaxoSmithKline|GSK Response Center|866-435-7343||
20566811|NCT01732757|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20566812|NCT02278796|Inselspital University Hospital Bern|Thomas Pabst, Prof Dr. med|+41 31 632 84 30|thomas.pabst@insel.ch|
20566813|NCT03214081|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20566814|NCT02962284|Sun Pharma Global FZE|Harin Mehta|97145520096, 912266455645|clinicaltrials@sparcmail.com, harin.mehta@sparcmail.com|
20566815|NCT01767688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20566816|NCT00686257|Tufts Medical Center|Nicholas Hill MD|617-636-4288|nhill@tuftsmedicalcenter.org|
20566817|NCT02132949|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20566818|NCT00982072|Imperial College NHS Trust|Dr Megan Griffith|02033137309|m.e.griffith@imperial.ac.uk|
20566819|NCT01583166|UMass Worcester|Michael Flynn, MD|508-334-9840|michael.flynn@umassmemorial.org|
20566820|NCT00887224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20566821|NCT01600482|Vasorum Ltd|Dr James Coleman|00 353 1 4035460|jcoleman@vasorum.ie|
20566822|NCT01429454|University of California San Diego|Dr. Kristin Cadenhead|(619) 543-6445|kcadenhead@ucsd.edu|
20566823|NCT02000752|Fundación Investigación Biomédica Príncipe de Asturas|Beatriz López Garrido (Midwife)|+34 678210013|bealopega@gmail.com|
20566824|NCT03903692|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
20566825|NCT02431741|Faculty Hospital Kralovske Czech Republic|Prof. Dr. Petr Arenberger|+420 267 16 11 11|avemedica@email.cz|
20566826|NCT00790699|Texas Diabetes & Endocrinology|Thomas Blevins,MD|5812.334.3505|blevins@texasdiabetes.com|
20566827|NCT03732807|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566828|NCT03392194|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|SREDLINE@BWH.HARVARD.EDU|
20566829|NCT01263132|Merck S.A. de C.V., Mexico, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
20566830|NCT02489357|Johns Hopkins University/Sidney Kimmel Cancer Center|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
20566831|NCT01079806|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
20566832|NCT02124304|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
20566833|NCT04228952|Masonic Cancer Center|Susan Murphy, PhD|612-624-7633|murph062@umn.edu|
20566834|NCT02788981|University of Chicago|Dr. Nan Chen|773-702-6149|nchen@bsd.uchicago.edu|
20566835|NCT05553366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20566836|NCT00249769|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20566837|NCT01505166|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
20566838|NCT02022657|Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora|Dr. Peter Anderson|3037246821|peter.anderson@ucdenver.edu|
20566839|NCT03274076|University of Michigan|Dinesh Khanna|734-763-7182|khannad@med.umich.edu|
20566840|NCT02909959|University of North Carolina at Chapel Hill|Laura Politte, MD|919-350-1726|lpolitte@wakemed.org|
20566841|NCT00843050|Piramal Healthcare Limited|Dr. Alan Hatfield|02230275000|alan.hatfield@piramal.com|5002
20566842|NCT00836498|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
20566843|NCT01034306|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
20566844|NCT04273672|University of Massachusetts Medical School|Kara Smith, MD|5083342527|kara.smith@umassmed.edu|
20566845|NCT02384382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566846|NCT01953692|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20566847|NCT02022670|University of Colorado Boulder|Dr. Allison DeVan|303-735-6410|allison.devan@colorado.edu|
20566848|NCT02113449|GlaxoSmithKline|GSK Response Center|866-435-7343||
20566849|NCT05313412|CooperVision|Jose A. Vega, OD, MSc, FAAO|925-621-3761|JVega2@coopervision.com|
20566850|NCT01328496|St. Jude Children's Research Hospital|Amr Qudeimat, MD|901-595-8342|amr.qudeimat@stjude.org|
20566851|NCT03960957|QMedAB|Clinical Project Manager|8179615000|aestheticclinicaltrials@galderma.com|
20566852|NCT02091752|Novartis|Study Director|862-778-8300||
20566853|NCT01708278|University of Michigan|Fernando Martinez|(734) 763-2540|fmartine@umich.edu|
20566854|NCT04029090|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608|cti-inq-ml@ml.mt-pharma.co.jp|
20566855|NCT01065779|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20566856|NCT02157948|Amgen Inc.|Study Director|866-572-6436||
20566857|NCT03067948|Johns Hopkins University SOM (Adjunct)|Anne Monroe MD|202-994-0251|amonroe@gwu.edu|
20566858|NCT03617835|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566859|NCT04111510|Yale School of Medicine|Michael Hurwitz, MD, PhD|(877) 925-3637|michael.hurwitz@yale.edu|
20566860|NCT04205903|The Ohio State University Comprehensive Cancer Center|Dr. Nicole Williams|(614) 293-0066|Nicole.Williams@osumc.edu|
20566861|NCT00544115|City of Hope|Dr. Monzr Al Malki, MD|626359811|malmalki@coh.org|
20566862|NCT04248803|TamilNadu MU|Dr Geeth Deepika|9952331820|geethdeepika@gmail.com|
20566863|NCT03683030|Biosense Webster, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20566864|NCT00684242|UT MD Anderson Cancer Center|Sriram Yennurajalingam, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20566865|NCT06677203|Asceneuron S.A.|Asceneuron Clinical Research|+41213538245|clinicaltrials.gov@asceneuron.com|
20566866|NCT03343704|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566867|NCT01341301|Thomas Jefferson University|Dr. Neal Flomenberg|215-955-8874|neal.flomenberg@jefferson.edu|
20566868|NCT04104022|University of Vermont|Dr. Kelly R. Peck, Ph.D.|8026569610|Kelly.Peck@uvm.edu|
20566869|NCT03715946|UPMC Hillman Cancer Center|Barbara Stadterman, MPH|4126475554|stadtermanbm@upmc.edu|
20566870|NCT00302211|Actelion Pharmaceuticals US, Inc.|Gary Palmer SVP, US Medical Affairs|650-624-6900||
20566871|NCT03954106|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20566872|NCT00551421|Dana-Farber Cancer Institute|Dr. Kimmie Ng|617-632-4150|kimmie_ng@dfci.harvard.edu|
20566873|NCT03823703|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
20566874|NCT00799409|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
20566875|NCT03137459|Yale School of Medicine|Dr. Terri Fried|203-932-5711|terri.fried@yale.edu|5412
20566876|NCT04323800|The Johns Hopkins University School of Medicine|Shmuel Shoham|410-614-6431|sshoham1@jhmi.edu|
20566877|NCT00731692|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20566878|NCT04921358|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20566879|NCT04926857|Medtronic|Nirav Patel|1 (800) 633-8766|nirav.a.patel@medtronic.com|
20566880|NCT02637063|Oregon Center for Applied Science|Amelia J Birney (PI), Director of Research|541-342-7227|abirney@orcasinc.com|541
20566881|NCT00491400|Boston University|Joseph A. Vita, MD|617-638-8700|jvita@bu.edu|
20566882|NCT05741450|CooperVision, Inc.|José A. Vega OD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
20566883|NCT00745875|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20566884|NCT02310581|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20566885|NCT01833455|University of Wisconsin|Stephen Wasmund, PhD|801-587-3740|stephen.wasmund@carma.utah.edu|
20566886|NCT01256359|University of Oxford|Professor Mark Middleton|+44 (0)1865 617331|mark.middleton@oncology.ox.ac.uk|
20566887|NCT03960645|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20566888|NCT04938453|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566889|NCT03292406|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20566890|NCT00639418|MedImmune LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
20566891|NCT00343083|University of Maryland Baltimore|Ritesh Kataria|410-328-8018|rkataria@umm.edu|
20566892|NCT00487240|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20566893|NCT01698918|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20566894|NCT04237792|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566895|NCT04693637|AlloVir, Inc|Michelle Matzko, MD, PhD|617-433-2605|mmatzko@allovir.com|
20566896|NCT00910962|GlaxoSmithKline|GSK Response Center|866-435-7343||
20566897|NCT01629589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20566898|NCT00797212|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20566899|NCT02304757|Tenth People's Hospital of Tongji University|Chao Ma|02125078593|mc_7419@hotmail.com|86
20566900|NCT03057600|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
20566901|NCT03395080|Leap Therapeutics, Inc.|Cynthia Sirard, MD, Chief Medical Officer|+1-617-714-0360|csirard@leaptx.com|
20566902|NCT04233567|The Ohio State University Comprehensive Cancer Center|Dr. Sameek Roychowdhury|614-685-5842|Sameek.Roychowdhury@osumc.edu|
20566903|NCT05352230|UAB|Orlando Gutierrez|2059962736|ogutierrez@uabmc.edu|
20566904|NCT04399837|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20566905|NCT02060487|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20566906|NCT03088800|Maimonides Medical Center|Sergey Motov, MD|7182836000|smotov@maimonidesmed.org|
20566907|NCT05182606|University of Pittsburgh|Dr. Jessica Merlin|(412) 383-0617|merlinjs@upmc.edu|
